
83378517|NCT02700451|Acetaminophen|acetaminophen|mesh-list
83378518|NCT02700451|Ketorolac|ketorolac|mesh-list
83378519|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83378520|NCT02700451|Analgesics|analgesics|mesh-ancestor
83378521|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
83378522|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378523|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378524|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
83378525|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83378526|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83378527|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83378528|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83378529|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378530|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378531|NCT00722865|Bevacizumab|bevacizumab|mesh-list
83378532|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83378533|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378534|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83378535|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83378536|NCT00722865|Growth Substances|growth substances|mesh-ancestor
83378537|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378538|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
83378539|NCT02700529|Ubenimex|ubenimex|mesh-list
83378540|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83378541|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
83378542|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378543|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83378544|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378545|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83378546|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378547|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
83378548|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378549|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378550|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83378551|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83378552|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
83378553|NCT04146493|Heparin|heparin|mesh-list
83378554|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
83378555|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83378556|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83378557|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378558|NCT00723099|Cyclosporine|cyclosporine|mesh-list
83378559|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
83378560|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
83378561|NCT00723099|Fludarabine|fludarabine|mesh-list
83378562|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
83378563|NCT00723099|Cyclosporins|cyclosporins|mesh-list
83378564|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83378565|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
83378566|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378567|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83378568|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83378569|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
83378570|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378571|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378572|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83378573|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83378574|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
83378575|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378576|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
83378577|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378578|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
83378579|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83378580|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83378581|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83378582|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
83378583|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83378584|NCT01508936|Reslizumab|reslizumab|mesh-list
83378585|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83378586|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
83378587|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
83378588|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83378589|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
83378590|NCT04146259|Calcium|calcium|mesh-list
83378591|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83378592|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378593|NCT04146259|Antacids|antacids|mesh-ancestor
83378594|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378595|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83378596|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83378597|NCT04146259|Vitamins|vitamins|mesh-ancestor
83378598|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
83378599|NCT05100186|Dexamethasone|dexamethasone|mesh-list
83378600|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83378601|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
83378602|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
83378603|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378604|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378605|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83378606|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
83378607|NCT05100186|Hormones|hormones|mesh-ancestor
83378608|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83378609|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83378610|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378611|NCT04323462|Insulin|insulin|mesh-list
83378612|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83378613|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
83378614|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83378615|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378616|NCT00723177|Ibudilast|ibudilast|mesh-list
83378617|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83378618|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
83378619|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378620|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378621|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83378622|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
83378623|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83378624|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378625|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378626|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83378627|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
83378628|NCT04318392|Dimercaprol|dimercaprol|mesh-list
83378629|NCT04318392|Chelating Agents|chelating agents|mesh-ancestor
83378630|NCT04318392|Sequestering Agents|sequestering agents|mesh-ancestor
83378631|NCT04318392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378632|NCT04698434|Esketamine|esketamine|mesh-list
83378633|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
83378634|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83378635|NCT04142749|Oltipraz|oltipraz|mesh-list
83378636|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
83378637|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378638|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
83378639|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83378640|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
83378641|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83378642|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83378643|NCT04142749|Protective Agents|protective agents|mesh-ancestor
83378644|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378645|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378646|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83378647|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83378648|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378649|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378650|NCT01508702|Lesinurad|lesinurad|mesh-list
83378651|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
83378652|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83378653|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
83378654|NCT04024813|Seladelpar|seladelpar|mesh-list
83378655|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83378656|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
83378657|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378658|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83378659|NCT01276041|Paclitaxel|paclitaxel|mesh-list
83378660|NCT01276041|Trastuzumab|trastuzumab|mesh-list
83378661|NCT01276041|Pertuzumab|pertuzumab|mesh-list
83378662|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83378663|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378664|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
83378665|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
83378666|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
83378667|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378668|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83378669|NCT04150770|Infliximab|infliximab|mesh-list
83378670|NCT04150770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83378671|NCT04150770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83378672|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
83378673|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83378674|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83378675|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
83378676|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
83378677|NCT04026438|Protective Agents|protective agents|mesh-ancestor
83378678|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378679|NCT01275339|Tadalafil|tadalafil|mesh-list
83378680|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
83378681|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83378682|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83378683|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378684|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378685|NCT01275339|Urological Agents|urological agents|mesh-ancestor
83378686|NCT01520402|Warfarin|warfarin|mesh-list
83378687|NCT01520402|Anticoagulants|anticoagulants|mesh-list
83378688|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
83378689|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83378690|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378691|NCT05108220|Cannabidiol|cannabidiol|mesh-list
83378692|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
83378693|NCT03027674|Nifedipine|nifedipine|mesh-list
83378694|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
83378695|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
83378696|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83378697|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83378698|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378699|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378700|NCT03027674|Urological Agents|urological agents|mesh-ancestor
83378701|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83378702|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83378703|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83378704|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378705|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
83378706|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83378707|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
83378708|NCT04144153|Anesthetics|anesthetics|mesh-list
83378709|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83378710|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378711|NCT04144153|Narcotics|narcotics|mesh-ancestor
83378712|NCT04144153|Analgesics|analgesics|mesh-ancestor
83378713|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
83378714|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378715|NCT04094948|Clenbuterol|clenbuterol|mesh-list
83378716|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83378717|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83378718|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
83378719|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378720|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378721|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378722|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83378723|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
83378724|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378725|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83378726|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
83378727|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
83378728|NCT04023565|Perindopril|perindopril|mesh-list
83378729|NCT04023565|Moxonidine|moxonidine|mesh-list
83378730|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83378731|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
83378732|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378733|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378734|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83378735|NCT01506908|Nicotine|nicotine|mesh-list
83378736|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83378737|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
83378738|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378739|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378740|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83378741|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83378742|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
83378743|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378744|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378745|NCT01519778|Tedizolid|tedizolid|mesh-list
83378746|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83378747|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378748|NCT04144933|Acetaminophen|acetaminophen|mesh-list
83378749|NCT04144933|Dexamethasone|dexamethasone|mesh-list
83378750|NCT04144933|Lidocaine|lidocaine|mesh-list
83378751|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
83378752|NCT04144933|Sufentanil|sufentanil|mesh-list
83378753|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
83378754|NCT04144933|Ketamine|ketamine|mesh-list
83378755|NCT04144933|Gabapentin|gabapentin|mesh-list
83378756|NCT04144933|Dsuvia|dsuvia|mesh-list
83378757|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
83378758|NCT04144933|Ondansetron|ondansetron|mesh-list
83378759|NCT04144933|Sevoflurane|sevoflurane|mesh-list
83378760|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83378761|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83378762|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
83378763|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
83378764|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378765|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378766|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83378767|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
83378768|NCT04144933|Hormones|hormones|mesh-ancestor
83378769|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83378770|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83378771|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378772|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
83378773|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
83378774|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83378775|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
83378776|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83389735|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83378777|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83378778|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83378779|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83378780|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378781|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83378782|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83378783|NCT04144933|Analgesics|analgesics|mesh-ancestor
83378784|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83378785|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83378786|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83378787|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
83378788|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378789|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83378790|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83378791|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
83378792|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83378793|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83378794|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
83378795|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83378796|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83378797|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
83378798|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83378799|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83378800|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83378801|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
83378802|NCT04144933|Narcotics|narcotics|mesh-ancestor
83378803|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
83378804|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
83378805|NCT04144933|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83378806|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83378807|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
83378808|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83378809|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83378810|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
83378811|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83378812|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83378813|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83378814|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
83378815|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83378816|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378817|NCT04149067|Incretins|incretins|mesh-ancestor
83378818|NCT04149067|Hormones|hormones|mesh-ancestor
83378819|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83378820|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83378821|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
83378822|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378823|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378824|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83378825|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
83378826|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
83378827|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378828|NCT05087862|Anesthetics|anesthetics|mesh-list
83378829|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
83378830|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83378831|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378832|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
83378833|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378834|NCT01519700|Lenograstim|lenograstim|mesh-list
83378835|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83378836|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
83378837|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378838|NCT04143685|Misoprostol|misoprostol|mesh-list
83378839|NCT04143685|Oxytocin|oxytocin|mesh-list
83378840|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
83378841|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83378842|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378843|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83378844|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
83378845|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83378846|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83378847|NCT04148599|Lidocaine|lidocaine|mesh-list
83378848|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
83378849|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
83378850|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
83378851|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83378852|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378853|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
83378854|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378855|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83378856|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83378857|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83378858|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83378859|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378860|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83378861|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83378863|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83378864|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83378865|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83378866|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
83378867|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378868|NCT04930458|Listerine|listerine|mesh-list
83378869|NCT04930458|Calcium|calcium|mesh-list
83378870|NCT04930458|Fluorides|fluorides|mesh-list
83378871|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
83378872|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
83378873|NCT04930458|Caseins|caseins|mesh-list
83378874|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83378875|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378876|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
83378877|NCT04930458|Protective Agents|protective agents|mesh-ancestor
83378878|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83378879|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378880|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
83378881|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
83378882|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378883|NCT04917588|Lidocaine|lidocaine|mesh-list
83378884|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
83378885|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
83378886|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83378887|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378888|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
83378889|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378890|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83378891|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83378892|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83378893|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83378894|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378895|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
83378896|NCT05101356|Vaccines|vaccines|mesh-list
83378897|NCT05101356|Sargramostim|sargramostim|mesh-list
83378898|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
83378899|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378900|NCT04022317|Insulin|insulin|mesh-list
83378901|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83378902|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378903|NCT04022005|Rituximab|rituximab|mesh-list
83378904|NCT04022005|Gemcitabine|gemcitabine|mesh-list
83378905|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
83378906|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83378907|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378908|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
83378909|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378910|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83378911|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83378912|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
83378913|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378914|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
83378915|NCT05099250|Bupivacaine|bupivacaine|mesh-list
83378916|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
83378917|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
83378918|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83378919|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378920|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
83378921|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378922|NCT05099250|Analgesics|analgesics|mesh-ancestor
83378923|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83378924|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
83378925|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83378926|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83378927|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378928|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83378929|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
83378930|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83378931|NCT04143451|Imiquimod|imiquimod|mesh-list
83378932|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83378933|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
83378934|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378935|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378936|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
83378937|NCT05105412|Gemcitabine|gemcitabine|mesh-list
83378938|NCT05105412|Lenalidomide|lenalidomide|mesh-list
83378939|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83378940|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
83378941|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378942|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378943|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
83378944|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378945|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83378946|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83378947|NCT05105412|Growth Substances|growth substances|mesh-ancestor
83378948|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
83378949|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
83378950|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83378951|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83378952|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378953|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83378954|NCT04766047|Analgesics|analgesics|mesh-ancestor
83378955|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
83378956|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378957|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83378958|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83378959|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83378960|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
83378961|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378962|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378963|NCT05105022|Propofol|propofol|mesh-list
83378964|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83378965|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83378966|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378967|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83378968|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
83378969|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
83378970|NCT02080819|Levodopa|levodopa|mesh-list
83378971|NCT02080819|Carbidopa|carbidopa|mesh-list
83378972|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83378973|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83378974|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
83378975|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378976|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378977|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378978|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83378979|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378980|NCT05104788|Carboplatin|carboplatin|mesh-list
83378981|NCT05104788|Pemetrexed|pemetrexed|mesh-list
83378982|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378983|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378984|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378985|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83378986|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83378987|NCT04405843|Ivermectin|ivermectin|mesh-list
83378988|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83378989|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378990|NCT04316364|Paclitaxel|paclitaxel|mesh-list
83378991|NCT04316364|Carboplatin|carboplatin|mesh-list
83378992|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83378993|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378994|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
83378995|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
83378996|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
83378997|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378998|NCT03916003|Primaquine|primaquine|mesh-list
83378999|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
83379000|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83379001|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83379002|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379003|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
83379004|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83379005|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379006|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
83379007|NCT04018872|Itraconazole|itraconazole|mesh-list
83379008|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
83379009|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379010|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83379011|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83379012|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379013|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379014|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83379015|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
83379016|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379017|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379018|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83379019|NCT03896737|Thalidomide|thalidomide|mesh-list
83379020|NCT03896737|Dexamethasone|dexamethasone|mesh-list
83379021|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
83379022|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
83379024|NCT03896737|Daratumumab|daratumumab|mesh-list
83379025|NCT03896737|BB 1101|bb 1101|mesh-list
83379026|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83379027|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
83379028|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379029|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83379030|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83379031|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
83379032|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379033|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379034|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83379035|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83379036|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
83379037|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
83379038|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379039|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83379040|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
83379041|NCT03896737|Hormones|hormones|mesh-ancestor
83379042|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379043|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83379044|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
83379045|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379046|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
83379047|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83379048|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379049|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83379050|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83379051|NCT03896737|Growth Substances|growth substances|mesh-ancestor
83379052|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
83379053|NCT05076786|Carboplatin|carboplatin|mesh-list
83379054|NCT05076786|Etoposide|etoposide|mesh-list
83379055|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379056|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83379057|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83379058|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83379059|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379060|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379061|NCT03476317|Vancomycin|vancomycin|mesh-list
83379062|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
83379063|NCT03476317|Neomycin|neomycin|mesh-list
83379064|NCT03476317|Fluconazole|fluconazole|mesh-list
83379065|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83379066|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83379067|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379068|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83379069|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83379070|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379071|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379072|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379073|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83379074|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83379075|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
83379076|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83379077|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83379078|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
83379079|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379080|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379081|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83379082|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83379083|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83379084|NCT03476317|Laxatives|laxatives|mesh-ancestor
83379085|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83379086|NCT02658084|Trastuzumab|trastuzumab|mesh-list
83379087|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83379088|NCT02658084|Vinorelbine|vinorelbine|mesh-list
83379089|NCT02658084|Maytansine|maytansine|mesh-list
83379090|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83379091|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379092|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83379093|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
83379094|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
83379095|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
83379096|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379097|NCT02658084|Immunotoxins|immunotoxins|mesh-ancestor
83379098|NCT02658084|Immunoconjugates|immunoconjugates|mesh-ancestor
83379099|NCT02658084|Immunologic Factors|immunologic factors|mesh-ancestor
83379100|NCT02658084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379101|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83379102|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83379103|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379104|NCT03588715|Interferons|interferons|mesh-list
83379105|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
83379106|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
83379107|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83379108|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
83379109|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379110|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
83379111|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379112|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
83379113|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379114|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
83379115|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379116|NCT04140409|Octreotide|octreotide|mesh-list
83379117|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83379118|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83379119|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379120|NCT04527432|Antibodies|antibodies|mesh-list
83379121|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
83379122|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379123|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
83379124|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83379125|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83379126|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83379127|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83379128|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379129|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
83379130|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83379131|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379132|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83379133|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379134|NCT04642950|Sargramostim|sargramostim|mesh-list
83379135|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
83379136|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379137|NCT04374240|Tretazicar|tretazicar|mesh-list
83379138|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379139|NCT05109390|Cyclosporine|cyclosporine|mesh-list
83379140|NCT05109390|Simethicone|simethicone|mesh-list
83379141|NCT05109390|Omeprazole|omeprazole|mesh-list
83379142|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
83379143|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
83379144|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83379145|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
83379146|NCT05109390|Antacids|antacids|mesh-list
83379147|NCT05109390|Tacrolimus|tacrolimus|mesh-list
83379148|NCT05109390|Cyclosporins|cyclosporins|mesh-list
83379149|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379150|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83379151|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
83379152|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83379153|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379154|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379155|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
83379156|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379157|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
83379158|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83379159|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83379160|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83379161|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
83379162|NCT05109390|Emollients|emollients|mesh-ancestor
83379163|NCT04030182|Vitamin D|vitamin d|mesh-list
83379164|NCT04030182|Vitamins|vitamins|mesh-ancestor
83379165|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
83379166|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379167|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83379168|NCT05109312|Acetaminophen|acetaminophen|mesh-list
83379169|NCT05109312|Ibuprofen|ibuprofen|mesh-list
83379170|NCT05109312|Bupivacaine|bupivacaine|mesh-list
83379171|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
83379172|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
83379173|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379174|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379175|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
83379176|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379177|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83379178|NCT05109312|Analgesics|analgesics|mesh-ancestor
83379179|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
83379180|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83379181|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83379182|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83379183|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83379184|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379185|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379186|NCT03661632|Nivolumab|nivolumab|mesh-list
83379187|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83379188|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379189|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83379190|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379191|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
83379192|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83379193|NCT04748250|Estrogens|estrogens|mesh-ancestor
83379194|NCT04748250|Hormones|hormones|mesh-ancestor
83379195|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379196|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379197|NCT04726878|Acetaminophen|acetaminophen|mesh-list
83379198|NCT04726878|Oxycodone|oxycodone|mesh-list
83379199|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379200|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379201|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83379202|NCT04726878|Analgesics|analgesics|mesh-ancestor
83379203|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
83379204|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379205|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
83379206|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83379207|NCT04726878|Narcotics|narcotics|mesh-ancestor
83379208|NCT04525638|Nivolumab|nivolumab|mesh-list
83379209|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83379210|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83379211|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379212|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83379213|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379214|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83379215|NCT01482962|Gemcitabine|gemcitabine|mesh-list
83379216|NCT01482962|Romidepsin|romidepsin|mesh-list
83379217|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83379218|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
83379219|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379220|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379221|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83379222|NCT01482962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83379223|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379224|NCT04701060|Apatinib|apatinib|mesh-list
83379225|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379226|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83379227|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379228|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379229|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83379230|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
83379231|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379232|NCT05116098|Protective Agents|protective agents|mesh-ancestor
83379233|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379234|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83379235|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83379236|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379237|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83379238|NCT04464408|Favipiravir|favipiravir|mesh-list
83379239|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
83379240|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379241|NCT04339218|Carboplatin|carboplatin|mesh-list
83379242|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
83379243|NCT04339218|Pemetrexed|pemetrexed|mesh-list
83379244|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379245|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83379246|NCT04339218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83379247|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379248|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379249|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83379250|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83379251|NCT03895801|Prednisone|prednisone|mesh-list
83379252|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
83379253|NCT03895801|Vilobelimab|vilobelimab|mesh-list
83379254|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83379255|NCT03895801|Hormones|hormones|mesh-ancestor
83379256|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379257|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379258|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83379259|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379260|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83379261|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83379262|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
83379263|NCT03021421|Bupivacaine|bupivacaine|mesh-list
83379264|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
83379265|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
83379266|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379267|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379268|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
83379269|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379270|NCT04521582|Amlodipine|amlodipine|mesh-list
83379271|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83379272|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83379273|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83379274|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379275|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83379276|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379277|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
83379278|NCT03588091|Docetaxel|docetaxel|mesh-list
83379279|NCT03588091|Trastuzumab|trastuzumab|mesh-list
83379280|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379281|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
83379282|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
83379283|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
83379284|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379285|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83379286|NCT05065554|Rituximab|rituximab|mesh-list
83379287|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
83379288|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83379289|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379290|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
83379291|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379292|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83379293|NCT04436172|Anesthetics|anesthetics|mesh-list
83379294|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379295|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379296|NCT03587779|Sevoflurane|sevoflurane|mesh-list
83379297|NCT03587779|Desflurane|desflurane|mesh-list
83379298|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83379299|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83379300|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
83379301|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
83379302|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379303|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379304|NCT04405921|Azithromycin|azithromycin|mesh-list
83379305|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
83379306|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83379307|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379308|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
83379309|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83379310|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83379311|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379312|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379313|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83379314|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83379315|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83379316|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
83379317|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379318|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83379319|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
83379320|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83379321|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379322|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83379323|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83379324|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83379325|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
83379326|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83379327|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83379328|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
83379329|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
83379330|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
83379331|NCT03581149|Laxatives|laxatives|mesh-list
83379332|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379333|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
83379334|NCT03581149|Protective Agents|protective agents|mesh-ancestor
83379335|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379336|NCT03581149|Vitamins|vitamins|mesh-ancestor
83379337|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
83379338|NCT03581149|Cathartics|cathartics|mesh-ancestor
83379339|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83379340|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83379341|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379342|NCT04765267|Vitamin D|vitamin d|mesh-list
83379343|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
83379344|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
83379345|NCT04765267|Vitamins|vitamins|mesh-ancestor
83379346|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
83379347|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379348|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83379349|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83379350|NCT04765267|Astringents|astringents|mesh-ancestor
83379351|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
83379352|NCT05583409|Osimertinib|osimertinib|mesh-list
83379353|NCT05583409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379354|NCT05583409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83379355|NCT05583409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379356|NCT05583409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379357|NCT03020953|Estrogens|estrogens|mesh-list
83379358|NCT03020953|Hormones|hormones|mesh-ancestor
83379359|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379360|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379361|NCT05583175|Venetoclax|venetoclax|mesh-list
83379362|NCT05583175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379363|NCT03891901|Isoniazid|isoniazid|mesh-list
83379364|NCT03891901|Rifabutin|rifabutin|mesh-list
83379365|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
83379366|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379367|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83379368|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379369|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379371|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83379372|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379373|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83379374|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83379375|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
83379376|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83379377|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83379378|NCT03580681|Vitamin E|vitamin e|mesh-list
83379379|NCT03580681|Vitamins|vitamins|mesh-ancestor
83379380|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
83379381|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379383|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379384|NCT03580681|Protective Agents|protective agents|mesh-ancestor
83379385|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83379386|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83379387|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379388|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
83379389|NCT05040126|Linezolid|linezolid|mesh-list
83379390|NCT05040126|Bedaquiline|bedaquiline|mesh-list
83379391|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83379392|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379393|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83379394|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379395|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379396|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
83379397|NCT03217201|Methamphetamine|methamphetamine|mesh-list
83379398|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83379399|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379400|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
83379401|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
83379402|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379403|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
83379404|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83379405|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379406|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
83379407|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83379408|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83379409|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83379410|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83379411|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
83379412|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83379413|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
83379414|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379415|NCT03069300|Expectorants|expectorants|mesh-ancestor
83379416|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
83379417|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83379418|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
83379419|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379420|NCT03069300|Protective Agents|protective agents|mesh-ancestor
83379421|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379422|NCT03069300|Antidotes|antidotes|mesh-ancestor
83379423|NCT05582317|Simvastatin|simvastatin|mesh-list
83379424|NCT05582317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83379425|NCT05582317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83379426|NCT05582317|Antimetabolites|antimetabolites|mesh-ancestor
83379427|NCT05582317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379428|NCT05582317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83379429|NCT05582317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83379430|NCT05582317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379431|NCT03891355|Dexamethasone|dexamethasone|mesh-list
83379432|NCT03891355|Lenalidomide|lenalidomide|mesh-list
83379433|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83379434|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
83379435|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
83379436|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379437|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379438|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83379439|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
83379440|NCT03891355|Hormones|hormones|mesh-ancestor
83379441|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379442|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83379443|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379444|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
83379445|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83379446|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83379447|NCT03891355|Growth Substances|growth substances|mesh-ancestor
83379448|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
83379449|NCT05582083|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83379450|NCT05582083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83379451|NCT05582083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379452|NCT05582083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379453|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
83379454|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
83379455|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83379456|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379457|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379458|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83379459|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
83379460|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83379461|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379462|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83379463|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
83379464|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83379465|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379466|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379467|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379468|NCT02936388|Cisplatin|cisplatin|mesh-list
83379469|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379470|NCT03586141|Chrysarobin|chrysarobin|mesh-list
83379471|NCT03586141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83379472|NCT03586141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83379473|NCT03586141|Analgesics|analgesics|mesh-ancestor
83379474|NCT03586141|Sensory System Agents|sensory system agents|mesh-ancestor
83379475|NCT03586141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379476|NCT03586141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379477|NCT03586141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83379478|NCT03586141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83379479|NCT03020563|Bupivacaine|bupivacaine|mesh-list
83379480|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
83379481|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
83379482|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379483|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379484|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
83379485|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379486|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
83379487|NCT04591626|Dulaglutide|dulaglutide|mesh-list
83379488|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83379489|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379490|NCT04518306|Amlodipine|amlodipine|mesh-list
83379491|NCT04518306|Telmisartan|telmisartan|mesh-list
83379492|NCT04518306|Indapamide|indapamide|mesh-list
83379493|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83379494|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83379495|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83379496|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379497|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83379498|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379499|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
83379500|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83379501|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83379502|NCT04518306|Diuretics|diuretics|mesh-ancestor
83379503|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
83379504|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83379506|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379507|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83379508|NCT03901573|Atezolizumab|atezolizumab|mesh-list
83379509|NCT03901573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83379510|NCT03901573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379511|NCT03901573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83379512|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379513|NCT03585829|Prednisolone|prednisolone|mesh-list
83379514|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
83379515|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83379516|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
83379517|NCT03585829|Hormones|hormones|mesh-ancestor
83379518|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379519|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379520|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83379521|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379522|NCT05701969|Melatonin|melatonin|mesh-list
83379523|NCT05701969|Antioxidants|antioxidants|mesh-ancestor
83379524|NCT05701969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379525|NCT05701969|Protective Agents|protective agents|mesh-ancestor
83379526|NCT05701969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379527|NCT05701969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379528|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83379529|NCT03585751|Simvastatin|simvastatin|mesh-list
83379530|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379531|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83379532|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83379533|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
83379534|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379535|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83379536|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83379537|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379538|NCT03583333|Linezolid|linezolid|mesh-list
83379539|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83379540|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379541|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83379542|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379543|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379544|NCT03585673|Docetaxel|docetaxel|mesh-list
83379545|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
83379546|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379547|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
83379548|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
83379549|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
83379550|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379551|NCT01602510|Lamotrigine|lamotrigine|mesh-list
83379552|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
83379553|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83379554|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83379555|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379556|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83379557|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379558|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83379559|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83379560|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379561|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83379562|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83379563|NCT03899467|Androgens|androgens|mesh-list
83379564|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
83379565|NCT03899467|Hormones|hormones|mesh-ancestor
83379566|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379567|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379568|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
83379569|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
83379570|NCT05701813|Inositol|inositol|mesh-list
83379571|NCT05701813|Vitamin B Complex|vitamin b complex|mesh-ancestor
83379572|NCT05701813|Vitamins|vitamins|mesh-ancestor
83379573|NCT05701813|Micronutrients|micronutrients|mesh-ancestor
83379574|NCT05701813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379575|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
83379576|NCT03586219|Narcotics|narcotics|mesh-ancestor
83379577|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379578|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379580|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
83379581|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379582|NCT05118984|Azithromycin|azithromycin|mesh-list
83379583|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83379584|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379585|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83379586|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83379587|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379588|NCT02802852|Lenograstim|lenograstim|mesh-list
83379589|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83379590|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
83379591|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379592|NCT03158389|Sirolimus|sirolimus|mesh-list
83379593|NCT03158389|Atezolizumab|atezolizumab|mesh-list
83379594|NCT03158389|Palbociclib|palbociclib|mesh-list
83379595|NCT03158389|Temsirolimus|temsirolimus|mesh-list
83379596|NCT03158389|MTOR Inhibitors|mtor inhibitors|mesh-list
83379597|NCT03158389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83379598|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379599|NCT03158389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83379600|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379601|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83379602|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389736|NCT04020263|Simendan|simendan|mesh-list
83379603|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83379604|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
83379605|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379606|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83379607|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379608|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83379609|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
83379610|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
83379611|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83379612|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
83379613|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379614|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83379615|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83379616|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
83379617|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379618|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379619|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83379620|NCT05118048|Chrysarobin|chrysarobin|mesh-list
83379621|NCT05118048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83379622|NCT05118048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83379623|NCT05118048|Analgesics|analgesics|mesh-ancestor
83379624|NCT05118048|Sensory System Agents|sensory system agents|mesh-ancestor
83379625|NCT05118048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379626|NCT05118048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379627|NCT05118048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83379628|NCT05118048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83379629|NCT04405375|Dexamethasone|dexamethasone|mesh-list
83379630|NCT04405375|Etoposide|etoposide|mesh-list
83379631|NCT04405375|Pegaspargase|pegaspargase|mesh-list
83379632|NCT04405375|Gemcitabine|gemcitabine|mesh-list
83379633|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83379634|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
83379635|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
83379636|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379637|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379638|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83379639|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
83379640|NCT04405375|Hormones|hormones|mesh-ancestor
83379641|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379642|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83379643|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379644|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83379645|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83379646|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83379647|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379648|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379649|NCT04405375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83379650|NCT04405375|Antimetabolites|antimetabolites|mesh-ancestor
83379651|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
83379652|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
83379653|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379654|NCT03029611|Paclitaxel|paclitaxel|mesh-list
83379655|NCT03029611|Carboplatin|carboplatin|mesh-list
83379656|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83379657|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83379658|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379659|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
83379660|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
83379661|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
83379662|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379663|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
83379664|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83379665|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
83379666|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379667|NCT03589495|Expectorants|expectorants|mesh-ancestor
83379668|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
83379669|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83379670|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
83379671|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379672|NCT03589495|Protective Agents|protective agents|mesh-ancestor
83379673|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379674|NCT03589495|Antidotes|antidotes|mesh-ancestor
83379675|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83379676|NCT03159559|Alprostadil|alprostadil|mesh-list
83379677|NCT03159559|Clopidogrel|clopidogrel|mesh-list
83379678|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379679|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379680|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83379681|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83379682|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83379683|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83379684|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
83379685|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83379686|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
83379687|NCT03159559|Urological Agents|urological agents|mesh-ancestor
83379688|NCT03159403|Oritavancin|oritavancin|mesh-list
83379689|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83379690|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379691|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
83379692|NCT03583567|Ranitidine|ranitidine|mesh-list
83379693|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83379694|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83379695|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83379696|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83379697|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
83379698|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
83379699|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83379700|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379701|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379702|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
83379703|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
83379704|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83379705|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83379706|NCT03583489|Ondansetron|ondansetron|mesh-list
83379707|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
83379708|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
83379709|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379710|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379711|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83379712|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
83379713|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
83379714|NCT03583489|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83379715|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83379716|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
83379717|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83379718|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379719|NCT03158935|Aldesleukin|aldesleukin|mesh-list
83379720|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
83379721|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
83379722|NCT03158935|Fludarabine|fludarabine|mesh-list
83379723|NCT03158935|Interleukin-2|interleukin-2|mesh-list
83379724|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83379725|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
83379726|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379727|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83379728|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83379729|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
83379730|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379731|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379732|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83379733|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83379734|NCT03158935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83379735|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83379736|NCT03158935|Analgesics|analgesics|mesh-ancestor
83379737|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
83379738|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379739|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83379740|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83379741|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
83379742|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379743|NCT04818372|Dexamethasone|dexamethasone|mesh-list
83379744|NCT04818372|Lenalidomide|lenalidomide|mesh-list
83379745|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83379746|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
83379747|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
83379748|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379749|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379750|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83379751|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
83379752|NCT04818372|Hormones|hormones|mesh-ancestor
83379753|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379754|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83379755|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379756|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
83379757|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83379758|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83379759|NCT04818372|Growth Substances|growth substances|mesh-ancestor
83379760|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
83379761|NCT05701189|Immunoglobulins|immunoglobulins|mesh-list
83379762|NCT05701189|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83379763|NCT05701189|Antibodies|antibodies|mesh-list
83379764|NCT05701189|gamma-Globulins|gamma-globulins|mesh-list
83379765|NCT05701189|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83379766|NCT05701189|Immunologic Factors|immunologic factors|mesh-ancestor
83379767|NCT05701189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379768|NCT01462578|Azacitidine|azacitidine|mesh-list
83379769|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83379770|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
83379771|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379772|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379773|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379774|NCT03059173|Inositol|inositol|mesh-list
83379775|NCT03059173|Clomiphene|clomiphene|mesh-list
83379776|NCT03059173|Enclomiphene|enclomiphene|mesh-list
83379777|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
83379778|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83379779|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
83379780|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379781|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379782|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83379783|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
83379784|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83379785|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83379786|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83379787|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
83379788|NCT03059173|Vitamins|vitamins|mesh-ancestor
83379789|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
83379791|NCT05122338|Ropivacaine|ropivacaine|mesh-list
83379793|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
83379794|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
83379795|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379796|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379797|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
83379798|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379799|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83379800|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83379801|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83379802|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83379803|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379804|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
83379805|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83379806|NCT03157843|Heparin|heparin|mesh-list
83379807|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83379808|NCT03157843|Tinzaparin|tinzaparin|mesh-list
83379809|NCT03157843|Dalteparin|dalteparin|mesh-list
83379810|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
83379811|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83379812|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83379813|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379814|NCT03589027|Ritonavir|ritonavir|mesh-list
83379815|NCT03589027|Darunavir|darunavir|mesh-list
83379816|NCT03589027|Rilpivirine|rilpivirine|mesh-list
83379817|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
83379818|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83379819|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83379820|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
83379821|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379822|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379823|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83379824|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83379825|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
83379826|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379827|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83379828|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83379829|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83379830|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
83379831|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83379832|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379833|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83379834|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83379835|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83379836|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83379837|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83379838|NCT03874494|Aripiprazole|aripiprazole|mesh-list
83379839|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
83379840|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
83379841|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83379842|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83379843|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83379844|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379845|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379846|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
83379847|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
83379848|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83379849|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379850|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83379851|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83379852|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
83379853|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83379854|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83379855|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83379856|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83379857|NCT03156439|Huperzine A|huperzine a|mesh-list
83379858|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83379859|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379860|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379861|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
83379862|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83379863|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379864|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83379865|NCT03156439|Protective Agents|protective agents|mesh-ancestor
83379866|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
83379867|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83379869|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83379870|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
83379871|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83379872|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379873|NCT05690035|Tislelizumab|tislelizumab|mesh-list
83379874|NCT05690035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83379875|NCT05690035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379876|NCT05002530|Vitamin D|vitamin d|mesh-list
83379877|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
83379878|NCT05002530|Cholecalciferol|cholecalciferol|mesh-list
83379879|NCT05002530|Vitamins|vitamins|mesh-list
83379880|NCT05002530|Tretinoin|tretinoin|mesh-list
83379881|NCT05002530|Isotretinoin|isotretinoin|mesh-list
83379882|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
83379883|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379884|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83379885|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83379886|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379887|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
83379888|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
83379889|NCT03583021|Neostigmine|neostigmine|mesh-list
83379890|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83379891|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379892|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379893|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
83379894|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83379895|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379896|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83379897|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
83379898|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379899|NCT04510194|Metformin|metformin|mesh-list
83379900|NCT04510194|Ivermectin|ivermectin|mesh-list
83379901|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
83379902|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83379903|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379904|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83379905|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379906|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83379907|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83379908|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379909|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83379910|NCT04510194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83379911|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83379912|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83379913|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379914|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83379915|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
83379916|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83379917|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
83379918|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83379919|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83379920|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379921|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83379922|NCT03155971|Paclitaxel|paclitaxel|mesh-list
83379923|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83379924|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379925|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
83379926|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
83379927|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
83379928|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379929|NCT03582319|Formaldehyde|formaldehyde|mesh-list
83379930|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
83379931|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379932|NCT00307242|Adefovir|adefovir|mesh-list
83379933|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83379934|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
83379935|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379936|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83379937|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83379938|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379939|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379940|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83379941|NCT03582007|Murepavadin|murepavadin|mesh-list
83379942|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83379943|NCT05120622|Tremelimumab|tremelimumab|mesh-list
83379944|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379945|NCT02895373|Alprostadil|alprostadil|mesh-list
83379946|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83379947|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
83379948|NCT02895373|Urological Agents|urological agents|mesh-ancestor
83379949|NCT05698771|Niacinamide|niacinamide|mesh-list
83379950|NCT05698771|Niacin|niacin|mesh-list
83379951|NCT05698771|Nicotinic Acids|nicotinic acids|mesh-list
83379952|NCT05698771|Vitamin B Complex|vitamin b complex|mesh-ancestor
83379953|NCT05698771|Vitamins|vitamins|mesh-ancestor
83379954|NCT05698771|Micronutrients|micronutrients|mesh-ancestor
83379955|NCT05698771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379956|NCT05698771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83379957|NCT05698771|Antimetabolites|antimetabolites|mesh-ancestor
83379958|NCT05698771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379959|NCT05698771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83379960|NCT05698771|Vasodilator Agents|vasodilator agents|mesh-ancestor
83379961|NCT05698147|Rituximab|rituximab|mesh-list
83379962|NCT05698147|Methotrexate|methotrexate|mesh-list
83379963|NCT05698147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83379964|NCT05698147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83379965|NCT05698147|Immunologic Factors|immunologic factors|mesh-ancestor
83379966|NCT05698147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379967|NCT05698147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83379968|NCT05698147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83379969|NCT05698147|Abortifacient Agents|abortifacient agents|mesh-ancestor
83379970|NCT05698147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83379971|NCT05698147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83379972|NCT05698147|Antimetabolites|antimetabolites|mesh-ancestor
83379973|NCT05698147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83379974|NCT05698147|Dermatologic Agents|dermatologic agents|mesh-ancestor
83379975|NCT05698147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379976|NCT05698147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83379977|NCT05698147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83379978|NCT05698147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83379979|NCT03156907|Buprenorphine|buprenorphine|mesh-list
83379980|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83379981|NCT03156907|Narcotics|narcotics|mesh-ancestor
83379982|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83379983|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379984|NCT03156907|Analgesics|analgesics|mesh-ancestor
83379985|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
83379986|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83379987|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83379988|NCT03156829|Betamethasone|betamethasone|mesh-list
83379989|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83379990|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
83379991|NCT03156829|Hormones|hormones|mesh-ancestor
83379992|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83379993|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83379994|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83379995|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
83379996|NCT05229276|Bone wax|bone wax|mesh-list
83379997|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
83379998|NCT05229276|Coagulants|coagulants|mesh-ancestor
83379999|NCT03581773|Folic Acid|folic acid|mesh-list
83380000|NCT03581773|Hematinics|hematinics|mesh-ancestor
83380001|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
83380002|NCT03581773|Vitamins|vitamins|mesh-ancestor
83380003|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
83380004|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380005|NCT04425174|Anesthetics|anesthetics|mesh-list
83380006|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83380007|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380008|NCT05119452|Adalimumab|adalimumab|mesh-list
83380009|NCT05119452|Infliximab|infliximab|mesh-list
83380010|NCT05119452|Golimumab|golimumab|mesh-list
83380011|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
83380012|NCT05119452|Etanercept|etanercept|mesh-list
83380013|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
83380014|NCT05119452|Tofacitinib|tofacitinib|mesh-list
83380015|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83380016|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380017|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
83380018|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83380019|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83380020|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83380021|NCT05119452|Analgesics|analgesics|mesh-ancestor
83380022|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
83380023|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380024|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380025|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83380026|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
83380027|NCT05119452|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83380028|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83380029|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380030|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380031|NCT02788591|Esomeprazole|esomeprazole|mesh-list
83380032|NCT02788591|Omeprazole|omeprazole|mesh-list
83380033|NCT02788591|Pantoprazole|pantoprazole|mesh-list
83380034|NCT02788591|Lansoprazole|lansoprazole|mesh-list
83380035|NCT02788591|Sucralfate|sucralfate|mesh-list
83380036|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83380037|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83380038|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83380039|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380040|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380041|NCT05229042|Ricolinostat|ricolinostat|mesh-list
83380042|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380043|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83380044|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380045|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380046|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
83380047|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
83380048|NCT03267498|Nivolumab|nivolumab|mesh-list
83380049|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380050|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380051|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83380052|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380053|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83380054|NCT03076164|Trametinib|trametinib|mesh-list
83380055|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380056|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83380057|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380058|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380059|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
83380060|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
83380061|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83380062|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83380063|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83380064|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83380065|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83380066|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380067|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380068|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380069|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83380070|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
83380071|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83380072|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380073|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83380074|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83380075|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83380076|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
83380077|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83380078|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83380079|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83380080|NCT01670773|Analgesics|analgesics|mesh-ancestor
83380081|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
83380082|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380083|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380084|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380085|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380086|NCT05228418|Naltrexone|naltrexone|mesh-list
83380087|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83380088|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83380089|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380090|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
83380091|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380092|NCT01676233|Insulin|insulin|mesh-list
83380093|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83380094|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
83380095|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83380096|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380097|NCT01670929|Progesterone|progesterone|mesh-list
83380098|NCT01670929|Progestins|progestins|mesh-ancestor
83380099|NCT01670929|Hormones|hormones|mesh-ancestor
83380100|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83380101|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380102|NCT02673996|Phenylephrine|phenylephrine|mesh-list
83380103|NCT02673996|Isoproterenol|isoproterenol|mesh-list
83380104|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
83380105|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83380106|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
83380107|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
83380108|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380109|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380110|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
83380111|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83380112|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
83380113|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
83380114|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83380115|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83380116|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83380117|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
83380118|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380119|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380120|NCT02673996|Protective Agents|protective agents|mesh-ancestor
83380121|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83380122|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83380123|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83380124|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
83380125|NCT04746937|Norfloxacin|norfloxacin|mesh-list
83380126|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83380127|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83380128|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83380129|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83380130|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83380131|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380132|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380133|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380134|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83389737|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83380135|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83380136|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
83380137|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83380138|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83380139|NCT05220319|Prednisolone|prednisolone|mesh-list
83380140|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
83380141|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83380142|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
83380143|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380144|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
83380145|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
83380146|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380147|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380148|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83380149|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
83380150|NCT05220319|Hormones|hormones|mesh-ancestor
83380151|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83380152|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83380153|NCT05220319|Protective Agents|protective agents|mesh-ancestor
83380154|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83380155|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380157|NCT03155035|Albendazole|albendazole|mesh-list
83380158|NCT03155035|Calcium|calcium|mesh-list
83380159|NCT03155035|Vitamins|vitamins|mesh-ancestor
83380160|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
83380161|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380162|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83380163|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83380164|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
83380165|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83380166|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83380167|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
83380168|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83380169|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83380170|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
83380171|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
83380172|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
83380173|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380174|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380175|NCT04497870|Peppermint oil|peppermint oil|mesh-list
83380176|NCT04497870|Menthol|menthol|mesh-list
83380177|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
83380178|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
83380179|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
83380180|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
83380181|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380182|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380183|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83380184|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
83380185|NCT03154723|Vitamin A|vitamin a|mesh-list
83380186|NCT03154723|Vitamins|vitamins|mesh-ancestor
83380187|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
83380188|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380189|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83380190|NCT04080908|Hematinics|hematinics|mesh-ancestor
83380191|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83380192|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83380193|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
83380194|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83380195|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380196|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83380197|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380198|NCT03154567|Yohimbine|yohimbine|mesh-list
83380199|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
83380200|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
83380201|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380202|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380203|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83380204|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83380205|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83380206|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
83380207|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380208|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380209|NCT03154567|Urological Agents|urological agents|mesh-ancestor
83380210|NCT04310748|Anesthetics|anesthetics|mesh-list
83380211|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83380212|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380213|NCT03154645|Ibuprofen|ibuprofen|mesh-list
83380214|NCT03154645|Acetazolamide|acetazolamide|mesh-list
83380215|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83380216|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83380217|NCT03154645|Analgesics|analgesics|mesh-ancestor
83380218|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
83380219|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380220|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380221|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380222|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380223|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83380224|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380225|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380226|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
83380227|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83380228|NCT03154645|Diuretics|diuretics|mesh-ancestor
83380229|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
83380230|NCT01631292|Vitamin D|vitamin d|mesh-list
83380231|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
83380232|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
83380233|NCT01631292|Vitamins|vitamins|mesh-list
83380234|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
83380235|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380236|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83380237|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83380238|NCT01671709|Montelukast|montelukast|mesh-list
83380239|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83380240|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
83380241|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83380242|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
83380243|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83380244|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380245|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83380246|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83380247|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380248|NCT05222256|Simendan|simendan|mesh-list
83380249|NCT05222256|Epinephrine|epinephrine|mesh-list
83380250|NCT05222256|Racepinephrine|racepinephrine|mesh-list
83380251|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
83380252|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83380253|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83380254|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
83380255|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380256|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380257|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380258|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83380259|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83380260|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
83380261|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380262|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83380263|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83380264|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
83380265|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
83380266|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83380267|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83380268|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
83380269|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83380270|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83380271|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380272|NCT05222256|Protective Agents|protective agents|mesh-ancestor
83380273|NCT01671787|Tenofovir|tenofovir|mesh-list
83380274|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
83380275|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83380276|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83380277|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83380278|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380279|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380280|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83380281|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83380282|NCT05229510|Ribavirin|ribavirin|mesh-list
83380283|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
83380284|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380285|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
83380286|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83380287|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83380288|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83380289|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
83380290|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
83380291|NCT00698022|Risperidone|risperidone|mesh-list
83380292|NCT00698022|Mifepristone|mifepristone|mesh-list
83380293|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83380294|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
83380295|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380296|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380297|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380298|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83380299|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83380300|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83380301|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83380302|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83380303|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
83380304|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83380305|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
83380306|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83380307|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83380308|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83380309|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83380310|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
83380311|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83380312|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83380313|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
83380314|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83380315|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
83380316|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83380317|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83380318|NCT02570503|Ketorolac|ketorolac|mesh-list
83380319|NCT02570503|Clonidine|clonidine|mesh-list
83380320|NCT02570503|Epinephrine|epinephrine|mesh-list
83380321|NCT02570503|Ropivacaine|ropivacaine|mesh-list
83380322|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
83380323|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
83380324|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83380325|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380326|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
83380327|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380328|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83380329|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83380330|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
83380331|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380332|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380333|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83380334|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83380335|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
83380336|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83380337|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
83380338|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
83380339|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
83380340|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83380341|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83380342|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83380343|NCT02570503|Analgesics|analgesics|mesh-ancestor
83380344|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380345|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380346|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83380347|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380348|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83380349|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
83380350|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83380351|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
83380352|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83380353|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83380354|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380355|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83380356|NCT02492269|Analgesics|analgesics|mesh-ancestor
83380357|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
83380358|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380359|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83380360|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83380361|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83380362|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
83380363|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380364|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380365|NCT05561179|Hyaluronic Acid|hyaluronic acid|mesh-list
83380366|NCT05561179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83380367|NCT05561179|Immunologic Factors|immunologic factors|mesh-ancestor
83380368|NCT05561179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380369|NCT05561179|Viscosupplements|viscosupplements|mesh-ancestor
83380370|NCT05561179|Protective Agents|protective agents|mesh-ancestor
83380371|NCT02467153|Vitamin D|vitamin d|mesh-list
83380372|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
83380373|NCT02467153|Vitamins|vitamins|mesh-ancestor
83380374|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
83380375|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380376|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83380377|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83380378|NCT04933903|Nivolumab|nivolumab|mesh-list
83380379|NCT04933903|Ipilimumab|ipilimumab|mesh-list
83380380|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380381|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380382|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83380383|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380384|NCT03153163|Trastuzumab|trastuzumab|mesh-list
83380385|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83380386|NCT03153163|Maytansine|maytansine|mesh-list
83380387|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380388|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380389|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83380390|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
83380391|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
83380392|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
83380393|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380394|NCT03153163|Immunotoxins|immunotoxins|mesh-ancestor
83380395|NCT03153163|Immunoconjugates|immunoconjugates|mesh-ancestor
83380396|NCT03153163|Immunologic Factors|immunologic factors|mesh-ancestor
83380397|NCT03153163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380398|NCT03153085|Ipilimumab|ipilimumab|mesh-list
83380399|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380400|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380401|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83380402|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380403|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
83380404|NCT03589339|Nivolumab|nivolumab|mesh-list
83380405|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380406|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380407|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83380408|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380409|NCT03463525|Osimertinib|osimertinib|mesh-list
83380410|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380411|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83380412|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380413|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380414|NCT01675128|Irinotecan|irinotecan|mesh-list
83380415|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83380416|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83380417|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380418|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380419|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380420|NCT02626507|Fulvestrant|fulvestrant|mesh-list
83380421|NCT02626507|Goserelin|goserelin|mesh-list
83380422|NCT02626507|Palbociclib|palbociclib|mesh-list
83380423|NCT02626507|Gedatolisib|gedatolisib|mesh-list
83380424|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83380425|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380426|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83380427|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83380428|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
83380429|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83380430|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380431|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83380432|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380433|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380434|NCT03413995|Rucaparib|rucaparib|mesh-list
83380435|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83380436|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380437|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380438|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380439|NCT04508244|Propranolol|propranolol|mesh-list
83380440|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83380441|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83380442|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
83380443|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380444|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380445|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380446|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83380447|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83380448|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
83380450|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83380451|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
83380452|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83380453|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
83380454|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380455|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380456|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
83380457|NCT04764955|Vitamin D|vitamin d|mesh-list
83380458|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
83380459|NCT04764955|Vitamins|vitamins|mesh-ancestor
83380460|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
83380461|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380462|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83380463|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83380464|NCT03126331|Nivolumab|nivolumab|mesh-list
83380465|NCT03126331|Ipilimumab|ipilimumab|mesh-list
83380466|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380467|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380468|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83380469|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380470|NCT01674127|Methyldopa|methyldopa|mesh-list
83380471|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83380472|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
83380473|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
83380474|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380475|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380476|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83380477|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83380478|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83380479|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
83380480|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380481|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380482|NCT02081443|Ticagrelor|ticagrelor|mesh-list
83380483|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83380484|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83380485|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83380486|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83380487|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
83380488|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380489|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380490|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380491|NCT01674205|Vaccines|vaccines|mesh-list
83380492|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
83380493|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380494|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83380495|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
83380496|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
83380497|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83380498|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
83380499|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83380500|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83380501|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
83380502|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380503|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380504|NCT03151057|Idelalisib|idelalisib|mesh-list
83380505|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380506|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380507|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380508|NCT01674283|Glucagon|glucagon|mesh-list
83380509|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83380510|NCT01674283|Hormones|hormones|mesh-ancestor
83380511|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83380512|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380513|NCT04404517|Adalimumab|adalimumab|mesh-list
83380514|NCT04404517|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83380515|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380516|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380517|NCT01674517|Montelukast|montelukast|mesh-list
83380518|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83380519|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
83380520|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83380521|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
83380522|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83380523|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380524|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83380525|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83380526|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380528|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380529|NCT01670071|Risperidone|risperidone|mesh-list
83380530|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83380531|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83380532|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
83380533|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380534|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380535|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380536|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83380537|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83380538|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83380539|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83380540|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83380541|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
83380542|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83380543|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83380544|NCT01427309|Vaccines|vaccines|mesh-list
83380545|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
83380546|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380547|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
83380548|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83380549|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83380550|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
83380551|NCT03855007|Prednisone|prednisone|mesh-list
83380552|NCT03855007|Methotrexate|methotrexate|mesh-list
83380553|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380554|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
83380555|NCT03855007|Hormones|hormones|mesh-ancestor
83380556|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83380557|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380558|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83380559|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380560|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83380561|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
83380562|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83380563|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83380564|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
83380565|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380566|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
83380567|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380568|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83380569|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83380570|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
83380571|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380572|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83380573|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
83380574|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83380575|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83380576|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83380577|NCT03852901|Empagliflozin|empagliflozin|mesh-list
83380578|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83380579|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380580|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83380581|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380582|NCT01675999|Leucovorin|leucovorin|mesh-list
83380583|NCT01675999|Cetuximab|cetuximab|mesh-list
83380584|NCT01675999|Fluorouracil|fluorouracil|mesh-list
83380585|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
83380586|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380587|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380588|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
83380589|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380590|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83380591|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83380592|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
83380593|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380595|NCT01675999|Protective Agents|protective agents|mesh-ancestor
83380596|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
83380597|NCT01675999|Vitamins|vitamins|mesh-ancestor
83380598|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
83380599|NCT01425359|Ranolazine|ranolazine|mesh-list
83380600|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83380601|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83380602|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380603|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83380604|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83380605|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380606|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380607|NCT04404751|Folic Acid|folic acid|mesh-list
83380608|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
83380609|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
83380610|NCT04404751|Iron|iron|mesh-list
83380611|NCT04404751|Vitamins|vitamins|mesh-ancestor
83380612|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
83380613|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380614|NCT04404751|Trace Elements|trace elements|mesh-ancestor
83380615|NCT04404751|Hematinics|hematinics|mesh-ancestor
83380616|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
83380617|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
83380618|NCT01403051|Vitamin D|vitamin d|mesh-list
83380619|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
83380620|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
83380621|NCT01403051|Vitamins|vitamins|mesh-list
83380622|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
83380623|NCT01403051|Calcium|calcium|mesh-list
83380624|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
83380625|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380626|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83380627|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83380628|NCT01403051|Antacids|antacids|mesh-ancestor
83380629|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380630|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83380631|NCT03873337|Nicotine|nicotine|mesh-list
83380632|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83380633|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
83380634|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380635|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380636|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83380637|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83380638|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
83380639|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380640|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380641|NCT03841357|Abatacept|abatacept|mesh-list
83380642|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83380643|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380644|NCT03841357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380645|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380646|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83380647|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
83380648|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380649|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380650|NCT04115748|Adalimumab|adalimumab|mesh-list
83380651|NCT04115748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83380652|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380653|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380654|NCT03838159|Paclitaxel|paclitaxel|mesh-list
83380655|NCT03838159|Carboplatin|carboplatin|mesh-list
83380656|NCT03838159|Nivolumab|nivolumab|mesh-list
83380657|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83380658|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380659|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
83380660|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
83380661|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
83380662|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380663|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380664|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83380665|NCT04747015|Oxytocin|oxytocin|mesh-list
83380666|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
83380667|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83380668|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380669|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
83380670|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83380671|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83380672|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380673|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83380674|NCT04747171|Analgesics|analgesics|mesh-ancestor
83380675|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
83380676|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380677|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83380678|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83380679|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83380680|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
83380681|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380682|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380683|NCT02082769|Allopurinol|allopurinol|mesh-list
83380684|NCT02082769|Febuxostat|febuxostat|mesh-list
83380685|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
83380686|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380687|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380688|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
83380689|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380690|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83380691|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
83380692|NCT02082769|Protective Agents|protective agents|mesh-ancestor
83380693|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380694|NCT03751423|Fentanyl|fentanyl|mesh-list
83380695|NCT03751423|Ketamine|ketamine|mesh-list
83380696|NCT03751423|Morphine|morphine|mesh-list
83380697|NCT03751423|Analgesics|analgesics|mesh-ancestor
83380698|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
83380699|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380700|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380701|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83380702|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83380703|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
83380704|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
83380705|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83380706|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83380707|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83380708|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380709|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380710|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83380711|NCT03751423|Narcotics|narcotics|mesh-ancestor
83380712|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83380713|NCT03745729|Allopurinol|allopurinol|mesh-list
83380714|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
83380715|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380716|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380717|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
83380718|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380719|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83380720|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
83380721|NCT03745729|Protective Agents|protective agents|mesh-ancestor
83380722|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380723|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
83380724|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83380725|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
83380726|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83380727|NCT04904952|Expectorants|expectorants|mesh-ancestor
83380728|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
83380729|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83380730|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
83380731|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380732|NCT04904952|Protective Agents|protective agents|mesh-ancestor
83380733|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380734|NCT04904952|Antidotes|antidotes|mesh-ancestor
83380735|NCT03661411|Aspirin|aspirin|mesh-list
83380736|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83380738|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83380739|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83380740|NCT03661411|Analgesics|analgesics|mesh-ancestor
83380741|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
83380742|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380743|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380744|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380745|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380746|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83380747|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83380748|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380749|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83380750|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83380751|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380752|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
83380753|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83380754|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83380755|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83380756|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
83380757|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380758|NCT05048784|Sotorasib|sotorasib|mesh-list
83380759|NCT05048784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83380760|NCT05048784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380761|NCT05048784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380762|NCT05048784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380763|NCT03742297|Dexamethasone|dexamethasone|mesh-list
83380764|NCT03742297|Prednisone|prednisone|mesh-list
83380765|NCT03742297|Lenalidomide|lenalidomide|mesh-list
83380766|NCT03742297|Bortezomib|bortezomib|mesh-list
83380767|NCT03742297|Melphalan|melphalan|mesh-list
83380768|NCT03742297|Daratumumab|daratumumab|mesh-list
83380769|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380770|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
83380771|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
83380772|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380773|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380774|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83380775|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
83380776|NCT03742297|Hormones|hormones|mesh-ancestor
83380777|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83380778|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83380779|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380780|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
83380781|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83380782|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83380783|NCT03742297|Growth Substances|growth substances|mesh-ancestor
83380784|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
83380785|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83380786|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
83380787|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380788|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83380789|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83380790|NCT01677403|Tobramycin|tobramycin|mesh-list
83380791|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83380792|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83380793|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
83380794|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83380795|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83380796|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83380797|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
83380798|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380799|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380800|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380801|NCT03441750|Metformin|metformin|mesh-list
83380802|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83380803|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380804|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
83380805|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83380806|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
83380807|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
83380808|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83380809|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380810|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83380811|NCT03826693|Analgesics|analgesics|mesh-ancestor
83380812|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
83380813|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380814|NCT03660553|Insulin|insulin|mesh-list
83380815|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83380816|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
83380817|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
83380818|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
83380819|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83380820|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380821|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83380822|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83380823|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83380824|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380825|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380826|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83380827|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83380828|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380829|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
83380830|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380831|NCT03825757|Aspirin|aspirin|mesh-list
83380832|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
83380833|NCT03825757|Salicylates|salicylates|mesh-list
83380834|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83380835|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
83380836|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
83380837|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
83380838|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83380839|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83380840|NCT03825757|Analgesics|analgesics|mesh-ancestor
83380841|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
83380842|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380843|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380844|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380845|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380846|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83380847|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380848|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380849|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83380850|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83380851|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83380852|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
83380853|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83380854|NCT03657433|Hematinics|hematinics|mesh-ancestor
83380855|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83380856|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83380857|NCT04827030|Ropivacaine|ropivacaine|mesh-list
83380858|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
83380859|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
83380860|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83380861|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380862|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
83380863|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380864|NCT03820141|Trastuzumab|trastuzumab|mesh-list
83380865|NCT03820141|Durvalumab|durvalumab|mesh-list
83380866|NCT03820141|Pertuzumab|pertuzumab|mesh-list
83380867|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380868|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380869|NCT03651895|Metformin|metformin|mesh-list
83380870|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83380871|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380872|NCT03818191|Acamprosate|acamprosate|mesh-list
83380873|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83380874|NCT02398656|Tenecteplase|tenecteplase|mesh-list
83380875|NCT02398656|Clopidogrel|clopidogrel|mesh-list
83380876|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83380877|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83380878|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83380879|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83380880|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
83380881|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83380882|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380883|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380884|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83380885|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83380886|NCT03807037|Tocotrienols|tocotrienols|mesh-list
83380887|NCT03807037|Vitamin E|vitamin e|mesh-list
83380888|NCT03807037|Tocopherols|tocopherols|mesh-list
83380889|NCT03807037|Tocovid|tocovid|mesh-list
83380890|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
83380891|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380892|NCT03807037|Protective Agents|protective agents|mesh-ancestor
83380893|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380894|NCT03807037|Vitamins|vitamins|mesh-ancestor
83380895|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
83380896|NCT03805399|Sirolimus|sirolimus|mesh-list
83380897|NCT03805399|Paclitaxel|paclitaxel|mesh-list
83380898|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83380899|NCT03805399|Capecitabine|capecitabine|mesh-list
83380900|NCT03805399|Everolimus|everolimus|mesh-list
83380901|NCT03805399|Apatinib|apatinib|mesh-list
83380902|NCT03805399|Temsirolimus|temsirolimus|mesh-list
83380903|NCT03805399|MTOR Inhibitors|mtor inhibitors|mesh-list
83380904|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83380905|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83380906|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380907|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
83380908|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
83380909|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
83380910|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380911|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83380912|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
83380913|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83380914|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380915|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83380916|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
83380917|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380918|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83380919|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83380920|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83380921|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
83380922|NCT03802591|Capecitabine|capecitabine|mesh-list
83380923|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
83380924|NCT03802591|Antibodies|antibodies|mesh-list
83380925|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83380926|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
83380927|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380928|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83380929|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
83380930|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380931|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380932|NCT03725059|Paclitaxel|paclitaxel|mesh-list
83380933|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
83380934|NCT03725059|Doxorubicin|doxorubicin|mesh-list
83380935|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
83380936|NCT03725059|Epirubicin|epirubicin|mesh-list
83380937|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83380938|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83380939|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
83380940|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
83380941|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
83380942|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380943|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83380944|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
83380945|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380946|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380947|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83380948|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
83380949|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83380950|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83380951|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83380952|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83380953|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83380954|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380955|NCT03725059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83380956|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83380957|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
83380958|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83380959|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83380960|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83380962|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83380963|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380964|NCT04403503|Thrombin|thrombin|mesh-list
83380965|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83380966|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
83380967|NCT04403503|Coagulants|coagulants|mesh-ancestor
83380968|NCT00249795|Irbesartan|irbesartan|mesh-list
83380969|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83380970|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83380971|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83380972|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83380973|NCT04404127|Basiliximab|basiliximab|mesh-list
83380974|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83380975|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
83380976|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380977|NCT02651220|Adapalene|adapalene|mesh-list
83380978|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
83380979|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83380980|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
83380981|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83380982|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83380983|NCT02651220|Analgesics|analgesics|mesh-ancestor
83380984|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
83380985|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380986|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380987|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83380988|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83380989|NCT01279551|Lidocaine|lidocaine|mesh-list
83380990|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
83380991|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
83380992|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
83380993|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83380994|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83380995|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
83380996|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380997|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83380998|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83380999|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83381000|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83381001|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381002|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
83381003|NCT03738696|Bupivacaine|bupivacaine|mesh-list
83381004|NCT03738696|Ropivacaine|ropivacaine|mesh-list
83381005|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
83381006|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
83381007|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381008|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381009|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
83381010|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381011|NCT00780403|Cetirizine|cetirizine|mesh-list
83381012|NCT00780403|Desloratadine|desloratadine|mesh-list
83381013|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83381014|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83381015|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83381016|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
83381017|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
83381018|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381019|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381020|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381021|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83381022|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
83381023|NCT04209504|Bupivacaine|bupivacaine|mesh-list
83381024|NCT04209504|Ropivacaine|ropivacaine|mesh-list
83381025|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
83381026|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
83381027|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381028|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381029|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
83381030|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381031|NCT03704610|Infliximab|infliximab|mesh-list
83381032|NCT03704610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83381033|NCT03704610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83381034|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
83381035|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83381036|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381037|NCT01979796|Nicotine|nicotine|mesh-list
83381038|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83381039|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
83389738|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
83381040|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381041|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381042|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83381043|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83381044|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
83381045|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381046|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381048|NCT03630211|Thiotepa|thiotepa|mesh-list
83381049|NCT03630211|Rituximab|rituximab|mesh-list
83381050|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
83381051|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
83381052|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83381053|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
83381054|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83381055|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
83381056|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83381057|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83381058|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
83381059|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381060|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381061|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83381062|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
83381063|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381064|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381065|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83381066|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83381067|NCT03628339|Tepotinib|tepotinib|mesh-list
83381068|NCT03628339|Midazolam|midazolam|mesh-list
83381069|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83381070|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83381071|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381072|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381073|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83381074|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83381075|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83381076|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83381077|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
83381078|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
83381079|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
83381080|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
83381081|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381082|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381083|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381084|NCT03792763|Denosumab|denosumab|mesh-list
83381085|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83381086|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83381087|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381088|NCT04412694|Dexamethasone|dexamethasone|mesh-list
83381089|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
83381090|NCT04412694|BB 1101|bb 1101|mesh-list
83381091|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83381092|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
83381094|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381095|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381096|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83381097|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
83381098|NCT04412694|Hormones|hormones|mesh-ancestor
83381099|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83381100|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83381101|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381102|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
83381103|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381104|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381105|NCT03627715|Propagermanium|propagermanium|mesh-list
83381106|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381107|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
83381108|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
83381109|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381110|NCT00246753|Lapatinib|lapatinib|mesh-list
83381111|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381112|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83381113|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381114|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381115|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
83381116|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83381117|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83381118|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
83381119|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381120|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381121|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381122|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
83381123|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
83381124|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381125|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
83381126|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83381127|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
83381128|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
83381129|NCT00246129|Daclizumab|daclizumab|mesh-list
83381130|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83381131|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381132|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83381133|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
83381134|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381135|NCT01274247|Benzocaine|benzocaine|mesh-list
83381136|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
83381137|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
83381138|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381139|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381140|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
83381141|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381142|NCT03783715|Ketoprofen|ketoprofen|mesh-list
83381143|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83381144|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83381145|NCT03783715|Analgesics|analgesics|mesh-ancestor
83381146|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
83381147|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381148|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381149|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83381150|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381151|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83381152|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381153|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381154|NCT01279629|Tazarotene|tazarotene|mesh-list
83381155|NCT01279629|Calcipotriene|calcipotriene|mesh-list
83381156|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
83381157|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
83381158|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83381159|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83381160|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
83381161|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381162|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381163|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83381164|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
83381165|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
83381166|NCT01274325|Hormones|hormones|mesh-ancestor
83381167|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83381168|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
83381169|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
83381170|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381171|NCT01274403|Thalidomide|thalidomide|mesh-list
83381172|NCT01274403|Prednisone|prednisone|mesh-list
83381173|NCT01274403|Melphalan|melphalan|mesh-list
83381174|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83381175|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
83381176|NCT01274403|Hormones|hormones|mesh-ancestor
83381177|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83381178|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381179|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83381180|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381181|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83381182|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
83381183|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381184|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83381185|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83381186|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
83381187|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
83381188|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83381189|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381190|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83381191|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83381192|NCT01274403|Growth Substances|growth substances|mesh-ancestor
83381193|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
83381194|NCT03700099|Docetaxel|docetaxel|mesh-list
83381195|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381196|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
83381197|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
83381198|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
83381199|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381200|NCT01274481|Iloprost|iloprost|mesh-list
83381201|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83381202|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
83381203|NCT00245583|Topiramate|topiramate|mesh-list
83381204|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
83381205|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83381206|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381207|NCT01379989|Carboplatin|carboplatin|mesh-list
83381208|NCT01379989|Doxorubicin|doxorubicin|mesh-list
83381209|NCT01379989|Trabectedin|trabectedin|mesh-list
83381210|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381211|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83381212|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83381213|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83381214|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381215|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381216|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83381217|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
83381218|NCT00754845|Letrozole|letrozole|mesh-list
83381219|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381220|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83381221|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83381222|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381223|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381224|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83381225|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
83381226|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83381227|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381228|NCT02652156|Bupivacaine|bupivacaine|mesh-list
83381229|NCT02652156|Ropivacaine|ropivacaine|mesh-list
83381230|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
83381231|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
83381232|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381233|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381234|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
83381235|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381236|NCT03699865|Nicotine|nicotine|mesh-list
83381237|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83381238|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
83381239|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381240|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381241|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83381242|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83381243|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
83381244|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381245|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381246|NCT03699319|Leucovorin|leucovorin|mesh-list
83381247|NCT03699319|Folic Acid|folic acid|mesh-list
83381248|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
83381249|NCT03699319|Irinotecan|irinotecan|mesh-list
83381250|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
83381251|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381252|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381253|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83381254|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83381255|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381256|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381257|NCT03699319|Antidotes|antidotes|mesh-ancestor
83381258|NCT03699319|Protective Agents|protective agents|mesh-ancestor
83381259|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
83381260|NCT03699319|Vitamins|vitamins|mesh-ancestor
83381261|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
83381262|NCT03699319|Hematinics|hematinics|mesh-ancestor
83381263|NCT00754923|Sorafenib|sorafenib|mesh-list
83381264|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381265|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83381266|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381267|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381268|NCT03696199|Anesthetics|anesthetics|mesh-list
83381269|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381270|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381271|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83381272|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
83381273|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83381274|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83381275|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83381276|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381277|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381278|NCT02117076|Gabapentin|gabapentin|mesh-list
83381279|NCT02117076|Analgesics|analgesics|mesh-ancestor
83381280|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
83381281|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381282|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381283|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
83381284|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83381285|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83381286|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381287|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83381288|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83381289|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83381290|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381291|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381292|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
83381293|NCT01274793|Mosapride|mosapride|mesh-list
83381294|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381295|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83381296|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83381297|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
83381298|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381299|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381300|NCT00746889|Triamcinolone|triamcinolone|mesh-list
83381301|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83381302|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83381303|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83381304|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83381305|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
83381306|NCT00746889|Hormones|hormones|mesh-ancestor
83381307|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83381308|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381309|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83381310|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
83381311|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381312|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381314|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
83381315|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
83381316|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83381317|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83381318|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
83381319|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
83381320|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381321|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381322|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381323|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83381324|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
83381325|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83381326|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83381327|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
83381328|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83381329|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83381330|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83381331|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381332|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83381333|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83381334|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381335|NCT03704688|Trametinib|trametinib|mesh-list
83381336|NCT03704688|Ponatinib|ponatinib|mesh-list
83381337|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381338|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83381339|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381340|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381341|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
83381342|NCT03600649|Topotecan|topotecan|mesh-list
83381343|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83381344|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
83381345|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381346|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381347|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83381348|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
83381349|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381350|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381351|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83381352|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83381353|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83381354|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381355|NCT00244881|Cediranib|cediranib|mesh-list
83381356|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381357|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381358|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381359|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83381360|NCT00530517|Sumatriptan|sumatriptan|mesh-list
83381361|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83381362|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83381363|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83381364|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
83381365|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381366|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381367|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381368|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83381369|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83381370|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83381371|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
83381372|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381373|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83381374|NCT03765541|Cytarabine|cytarabine|mesh-list
83381375|NCT03765541|Dexamethasone|dexamethasone|mesh-list
83381376|NCT03765541|Azacitidine|azacitidine|mesh-list
83381377|NCT03765541|Amsacrine|amsacrine|mesh-list
83381378|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83381379|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
83381380|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
83381381|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381382|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381383|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83381384|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
83381385|NCT03765541|Hormones|hormones|mesh-ancestor
83381386|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83381387|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83381388|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381389|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83381390|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
83381391|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381392|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
83381393|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381394|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83381395|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
83381396|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381397|NCT05123976|Olanzapine|olanzapine|mesh-list
83381398|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
83381399|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
83381400|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381401|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381402|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83381403|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83381404|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83381405|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381406|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83381407|NCT05123976|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83381408|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83381409|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83381410|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381411|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381412|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
83381413|NCT00005803|Cytarabine|cytarabine|mesh-list
83381414|NCT00005803|Cyclosporine|cyclosporine|mesh-list
83381415|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
83381416|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
83381418|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
83381419|NCT00005803|Carmustine|carmustine|mesh-list
83381420|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83381421|NCT00005803|Fludarabine|fludarabine|mesh-list
83381422|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
83381423|NCT00005803|Etoposide|etoposide|mesh-list
83381424|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
83381425|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
83381426|NCT00005803|Cyclosporins|cyclosporins|mesh-list
83381427|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83381428|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
83381429|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381430|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381431|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83381432|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
83381433|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381434|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381435|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83381436|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83381437|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
83381438|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83381439|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83381440|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83381441|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381442|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
83381443|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381444|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
83381445|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
83381446|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83381447|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83381448|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83381449|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
83381450|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83381451|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
83381452|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
83381453|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
83381454|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
83381455|NCT00244725|Warfarin|warfarin|mesh-list
83381456|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
83381457|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
83381458|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83381459|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381460|NCT04185012|Benralizumab|benralizumab|mesh-list
83381461|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83381462|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
83381463|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
83381465|NCT01275183|Docetaxel|docetaxel|mesh-list
83381466|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381467|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
83381468|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
83381469|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
83381470|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381471|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83381472|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83381473|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
83381474|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381475|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83381476|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83381477|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381478|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
83381479|NCT05126004|Azacitidine|azacitidine|mesh-list
83381480|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83381481|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83381482|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
83381483|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381484|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381485|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381486|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
83381487|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381488|NCT05126004|Expectorants|expectorants|mesh-ancestor
83381489|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
83381490|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83381491|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
83381492|NCT05126004|Protective Agents|protective agents|mesh-ancestor
83381493|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381494|NCT05126004|Antidotes|antidotes|mesh-ancestor
83381495|NCT03672643|Crizotinib|crizotinib|mesh-list
83381496|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381497|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83381498|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381499|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381500|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
83381501|NCT00350701|Testosterone|testosterone|mesh-list
83381502|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
83381503|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
83381504|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83381505|NCT00350701|Androgens|androgens|mesh-ancestor
83381506|NCT00350701|Hormones|hormones|mesh-ancestor
83381507|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83381508|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381509|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83381510|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381511|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
83381512|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
83381513|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83381514|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83381515|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83381516|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83381517|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381518|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
83381519|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381520|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381521|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83381522|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381523|NCT01505114|Tenofovir|tenofovir|mesh-list
83381524|NCT01505114|Emtricitabine|emtricitabine|mesh-list
83381525|NCT01505114|Maraviroc|maraviroc|mesh-list
83381526|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
83381527|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381528|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83381529|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83381530|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480176|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83381531|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381532|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83381533|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83381534|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83381535|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83381536|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83381537|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
83381538|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83381539|NCT03666559|Azacitidine|azacitidine|mesh-list
83381540|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83381541|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
83381542|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381543|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381544|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381545|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
83381546|NCT04187898|Docetaxel|docetaxel|mesh-list
83381547|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83381548|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
83381549|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381550|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381551|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83381552|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
83381553|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381554|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381555|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83381556|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
83381557|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
83381558|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
83381559|NCT01275729|Furosemide|furosemide|mesh-list
83381560|NCT01275729|Diuretics|diuretics|mesh-ancestor
83381561|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
83381562|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381563|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83381564|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83381565|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381566|NCT00243867|Paclitaxel|paclitaxel|mesh-list
83381567|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83381568|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381569|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
83381570|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
83381571|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
83381572|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381573|NCT01679899|Vildagliptin|vildagliptin|mesh-list
83381574|NCT01679899|Gliclazide|gliclazide|mesh-list
83381575|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83381576|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381577|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83381578|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
83381579|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381580|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381581|NCT01276821|Epinephrine|epinephrine|mesh-list
83381582|NCT01276821|Racepinephrine|racepinephrine|mesh-list
83381583|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
83381584|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83381585|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83381586|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
83381587|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381588|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381589|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381590|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83381591|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83381592|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
83381593|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381594|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83381595|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
83381596|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
83381597|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
83381598|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83381599|NCT00245037|Cyclosporine|cyclosporine|mesh-list
83381600|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
83381601|NCT00245037|Methotrexate|methotrexate|mesh-list
83381602|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
83381603|NCT00245037|Fludarabine|fludarabine|mesh-list
83381605|NCT00245037|Phenytoin|phenytoin|mesh-list
83381606|NCT00245037|Cyclosporins|cyclosporins|mesh-list
83381607|NCT00245037|Lenograstim|lenograstim|mesh-list
83381608|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83381609|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
83381610|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83381611|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381612|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83381613|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
83381614|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381615|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381616|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
83381617|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381618|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83381619|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83381620|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
83381621|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381622|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83381623|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
83381624|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381625|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83381626|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83381627|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83381628|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
83381629|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83381630|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
83381631|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83381632|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83381633|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83381634|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
83381635|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83381636|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83381637|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83381638|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83381639|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83381640|NCT03532399|Bivalirudin|bivalirudin|mesh-list
83381641|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
83381642|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83381643|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
83381644|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381645|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381646|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
83381647|NCT00241839|Allopurinol|allopurinol|mesh-list
83381648|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
83381649|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
83381650|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381651|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381652|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
83381653|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381654|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83381655|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
83381656|NCT00241839|Protective Agents|protective agents|mesh-ancestor
83381657|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381658|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83381659|NCT00241839|Diuretics|diuretics|mesh-ancestor
83381660|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
83381661|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83381662|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83381663|NCT05347381|Dexamethasone|dexamethasone|mesh-list
83381664|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83381665|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
83381666|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
83381667|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381668|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381669|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83381670|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
83381671|NCT05347381|Hormones|hormones|mesh-ancestor
83381672|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83381673|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83381674|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381675|NCT02651688|Enclomiphene|enclomiphene|mesh-list
83381676|NCT02651688|Clomiphene|clomiphene|mesh-list
83381677|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
83381678|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83381679|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
83381680|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83381681|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381682|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83381683|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
83381684|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83381685|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83381686|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83381687|NCT01276353|Donepezil|donepezil|mesh-list
83381688|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83381689|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381690|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381691|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
83381692|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381693|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381694|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
83381695|NCT03809013|Trastuzumab|trastuzumab|mesh-list
83381696|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83381697|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381698|NCT03807921|Aspirin|aspirin|mesh-list
83381699|NCT03807921|Warfarin|warfarin|mesh-list
83381700|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83381701|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83381702|NCT03807921|Analgesics|analgesics|mesh-ancestor
83381703|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
83381704|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381705|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381706|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83381707|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381708|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83381709|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83381710|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381711|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83381712|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83381713|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381714|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
83381715|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
83381716|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83381717|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83381718|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83381719|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83381720|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83381721|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
83381722|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381723|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381724|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381725|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
83381726|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83381727|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
83381728|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83381730|NCT00762177|Fluorides|fluorides|mesh-list
83381731|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
83381732|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
83381733|NCT00762177|Protective Agents|protective agents|mesh-ancestor
83381734|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381735|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83381736|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381737|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83381738|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83381739|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
83381740|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381741|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83381743|NCT03458455|Nivolumab|nivolumab|mesh-list
83381744|NCT03458455|Ipilimumab|ipilimumab|mesh-list
83381745|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83381746|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381747|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83381748|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381749|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83381750|NCT02536794|Durvalumab|durvalumab|mesh-list
83381751|NCT02536794|Ipilimumab|ipilimumab|mesh-list
83381752|NCT02536794|Tremelimumab|tremelimumab|mesh-list
83381753|NCT02536794|Antibodies|antibodies|mesh-list
83381754|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
83381755|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83381756|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
83381757|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381758|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381759|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83381760|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381761|NCT00777855|Rifampin|rifampin|mesh-list
83381762|NCT00777855|Warfarin|warfarin|mesh-list
83381763|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
83381764|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83381765|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
83381766|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83381767|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381768|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
83381769|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83381770|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381771|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381772|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83381773|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83381774|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83381775|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83381776|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83381777|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83381778|NCT03523429|Blinatumomab|blinatumomab|mesh-list
83381779|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381780|NCT05125380|Acetic Acid|acetic acid|mesh-list
83381781|NCT05125380|Retinol acetate|retinol acetate|mesh-list
83381782|NCT05125380|Lugol's solution|lugol's solution|mesh-list
83381783|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83381784|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381785|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83381786|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
83381787|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381788|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83381789|NCT05125380|Protective Agents|protective agents|mesh-ancestor
83381790|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381791|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
83381792|NCT05125380|Coagulants|coagulants|mesh-ancestor
83381793|NCT00762645|Travoprost|travoprost|mesh-list
83381794|NCT00762645|Pilocarpine|pilocarpine|mesh-list
83381795|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83381796|NCT00762645|Miotics|miotics|mesh-ancestor
83381797|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
83381798|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381799|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381800|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83381801|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83381802|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
83381803|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381804|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381806|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83381807|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381808|NCT02403193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83381809|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381810|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
83381811|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
83381812|NCT03807297|Propofol|propofol|mesh-list
83381813|NCT03807297|Sevoflurane|sevoflurane|mesh-list
83381814|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83381815|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381816|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381817|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83381818|NCT03807297|Analgesics|analgesics|mesh-ancestor
83381819|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
83381820|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381821|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83381822|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83381823|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83381824|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
83381825|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381826|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381827|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83381828|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
83381829|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
83381830|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83381831|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83381832|NCT03573349|Ketamine|ketamine|mesh-list
83381833|NCT03573349|Analgesics|analgesics|mesh-ancestor
83381834|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
83381835|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381836|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381837|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83381838|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83381839|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
83381840|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
83381841|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381842|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83381843|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83381844|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381845|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381846|NCT05387148|Cannabidiol|cannabidiol|mesh-list
83381847|NCT05387148|Anticonvulsants|anticonvulsants|mesh-ancestor
83381848|NCT03809637|Pemetrexed|pemetrexed|mesh-list
83381849|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381850|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381851|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381852|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83381853|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83381854|NCT03513445|Epinephrine|epinephrine|mesh-list
83381855|NCT03513445|Morphine|morphine|mesh-list
83381856|NCT03513445|Ropivacaine|ropivacaine|mesh-list
83381857|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83381858|NCT03513445|Narcotics|narcotics|mesh-ancestor
83381859|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381860|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381861|NCT03513445|Analgesics|analgesics|mesh-ancestor
83381862|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
83381863|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381864|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83381865|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83381866|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
83381867|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381868|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381869|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83381870|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83381871|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
83381872|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83381873|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
83381874|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
83381875|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
83381876|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83381877|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
83381878|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
83381879|NCT03802071|Doxorubicin|doxorubicin|mesh-list
83381880|NCT03802071|Durvalumab|durvalumab|mesh-list
83381881|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83381882|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381883|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83381884|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83381885|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381886|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381887|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83381888|NCT03809793|Acipimox|acipimox|mesh-list
83381889|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83381890|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
83480177|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381891|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381892|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83381893|NCT00758667|Mesna|mesna|mesh-list
83381894|NCT00758667|Protective Agents|protective agents|mesh-ancestor
83381895|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381896|NCT05041920|Omeprazole|omeprazole|mesh-list
83381897|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83381898|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83381899|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83381900|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381901|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381902|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83381903|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83381904|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83381905|NCT03508921|Trimethoprim|trimethoprim|mesh-list
83381906|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
83381907|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83381908|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83381909|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381910|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
83381911|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83381912|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381913|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381914|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83381915|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83381916|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381917|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
83381918|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381919|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83381920|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
83381921|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83381922|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83381923|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83381924|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381925|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83381926|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83381927|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83381928|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83381929|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83381930|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381931|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
83381932|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
83381933|NCT04412850|Analgesics|analgesics|mesh-ancestor
83381934|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
83381935|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83381936|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381937|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
83381938|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381939|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83381940|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
83381941|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83381942|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83381943|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381944|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83381945|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
83381946|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83381948|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83381949|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381950|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83381951|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83381952|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381953|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
83381954|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381955|NCT00778869|Infliximab|infliximab|mesh-list
83381956|NCT00778869|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83381957|NCT00778869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83381958|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
83381959|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83381960|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381961|NCT05008536|Fludarabine|fludarabine|mesh-list
83381962|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
83381963|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381964|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381965|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83381966|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
83381967|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381968|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381969|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83381970|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
83381971|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83381972|NCT04345419|Remdesivir|remdesivir|mesh-list
83381973|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
83381974|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381975|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
83381976|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83381977|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
83381978|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83381979|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83381980|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83381981|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
83381982|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83381983|NCT00759603|Rituximab|rituximab|mesh-list
83381984|NCT00759603|Lenalidomide|lenalidomide|mesh-list
83381985|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83381986|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83381987|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
83381988|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381989|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83381990|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83381991|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83381992|NCT00759603|Growth Substances|growth substances|mesh-ancestor
83381993|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
83381994|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83381995|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83381996|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83381997|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381998|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83381999|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83382000|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83382001|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83382002|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
83382003|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382004|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382005|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83382006|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83382007|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
83382008|NCT03510390|Metformin|metformin|mesh-list
83382009|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83382010|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382011|NCT03806673|Bupivacaine|bupivacaine|mesh-list
83382012|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
83382013|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
83382014|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382015|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382016|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
83382017|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382018|NCT03291990|Temozolomide|temozolomide|mesh-list
83382019|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83382020|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
83382021|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382022|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382023|NCT03806595|Lidocaine|lidocaine|mesh-list
83382024|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83382025|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
83382026|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
83382027|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382028|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382029|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
83382030|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382031|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83382032|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83382033|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83382034|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83382035|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382036|NCT03807999|Paclitaxel|paclitaxel|mesh-list
83382037|NCT03807999|Gemcitabine|gemcitabine|mesh-list
83382038|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83382039|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382040|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
83382041|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
83382042|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
83382043|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382044|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382045|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
83382046|NCT04762147|Acetaminophen|acetaminophen|mesh-list
83382047|NCT04762147|Fentanyl|fentanyl|mesh-list
83382048|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83382049|NCT04762147|Narcotics|narcotics|mesh-ancestor
83382050|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382051|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382052|NCT04762147|Analgesics|analgesics|mesh-ancestor
83382053|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
83382054|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382055|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83382056|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83382057|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
83382058|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
83382059|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382060|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
83382061|NCT04273737|Amantadine|amantadine|mesh-list
83382062|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83382063|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83382064|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
83382065|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83382066|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
83382067|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382068|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382069|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382070|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382071|NCT04273737|Analgesics|analgesics|mesh-ancestor
83382072|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
83382073|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382074|NCT02963064|Antibodies|antibodies|mesh-list
83382075|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83382076|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
83382077|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382078|NCT04183062|Gemcitabine|gemcitabine|mesh-list
83382079|NCT04183062|Docetaxel|docetaxel|mesh-list
83382080|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382081|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
83382082|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382083|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382084|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
83382085|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
83382086|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
83382087|NCT04325880|Tamsulosin|tamsulosin|mesh-list
83382088|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
83382089|NCT04325880|Mirabegron|mirabegron|mesh-list
83382090|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83382091|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83382092|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83382093|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
83382094|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382095|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382096|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382097|NCT04325880|Urological Agents|urological agents|mesh-ancestor
83382098|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83382099|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83382100|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
83382101|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83382102|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83382103|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83382104|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83382106|NCT04846218|Progestins|progestins|mesh-ancestor
83382107|NCT04846218|Hormones|hormones|mesh-ancestor
83382108|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83382109|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382110|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
83382111|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83382112|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
83382113|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83382114|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83382115|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83382116|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382117|NCT04152486|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83382118|NCT04152486|Antiviral Agents|antiviral agents|mesh-ancestor
83382119|NCT04152486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83382120|NCT02512692|Gemcitabine|gemcitabine|mesh-list
83382121|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382122|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382123|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
83382124|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382125|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83382126|NCT01594398|Exemestane|exemestane|mesh-list
83382127|NCT01594398|Entinostat|entinostat|mesh-list
83382128|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382129|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83382130|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382131|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382132|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83382133|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83382134|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83382135|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
83382136|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83382137|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382138|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83382139|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
83382140|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
83382141|NCT00782379|Busulfan|busulfan|mesh-list
83382142|NCT00782379|Fludarabine|fludarabine|mesh-list
83382143|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
83382144|NCT00782379|Tacrolimus|tacrolimus|mesh-list
83382145|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83382146|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
83382147|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382148|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382149|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83382150|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
83382151|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382152|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382153|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83382154|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382155|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
83382156|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83382157|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382158|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83382159|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83382160|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
83382161|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83382162|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83382163|NCT04572828|Naproxen|naproxen|mesh-list
83382164|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83382165|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382166|NCT04572828|Analgesics|analgesics|mesh-ancestor
83382167|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
83382168|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382169|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382170|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83382172|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
83382173|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83382174|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382175|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382176|NCT05134350|Omeprazole|omeprazole|mesh-list
83382177|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83382178|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83382179|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83382180|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382181|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382182|NCT05134194|Gemcitabine|gemcitabine|mesh-list
83382183|NCT05134194|Capecitabine|capecitabine|mesh-list
83382184|NCT05134194|Vinorelbine|vinorelbine|mesh-list
83382185|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382186|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
83382187|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382188|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382189|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83382190|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
83382191|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
83382192|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
83382193|NCT00761085|Morphine|morphine|mesh-list
83382194|NCT00761085|Methadone|methadone|mesh-list
83382195|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83382196|NCT00761085|Narcotics|narcotics|mesh-ancestor
83382197|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382198|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382199|NCT00761085|Analgesics|analgesics|mesh-ancestor
83382200|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
83382201|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382202|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
83382203|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
83382204|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
83382205|NCT02145039|Fludarabine|fludarabine|mesh-list
83382206|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83382207|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
83382208|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382209|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382210|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83382211|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
83382212|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382213|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382214|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83382215|NCT03806049|Paclitaxel|paclitaxel|mesh-list
83382216|NCT03806049|Bevacizumab|bevacizumab|mesh-list
83382217|NCT03806049|Carboplatin|carboplatin|mesh-list
83382218|NCT03806049|Niraparib|niraparib|mesh-list
83382219|NCT03806049|Dostarlimab|dostarlimab|mesh-list
83382220|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83382221|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382222|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
83382223|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
83382224|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
83382225|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382226|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83382227|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83382228|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83382229|NCT03806049|Growth Substances|growth substances|mesh-ancestor
83382230|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382231|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
83382232|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83382233|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382234|NCT00089479|Capecitabine|capecitabine|mesh-list
83382235|NCT00089479|Docetaxel|docetaxel|mesh-list
83382236|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382237|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
83382238|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382239|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382240|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
83382241|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
83382242|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
83382243|NCT01463306|Pregabalin|pregabalin|mesh-list
83382244|NCT01463306|Analgesics|analgesics|mesh-ancestor
83382245|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
83382246|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382247|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382248|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
83382249|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83382250|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83382251|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382252|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83382253|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83382254|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83382255|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382256|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83382257|NCT05055726|Benzydamine|benzydamine|mesh-list
83382258|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83382259|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
83382260|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83382261|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83382262|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83382263|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83382264|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382265|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
83382266|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382267|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382268|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83382269|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382270|NCT03451591|Cilostazol|cilostazol|mesh-list
83382271|NCT03451591|Isosorbide|isosorbide|mesh-list
83382272|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83382273|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83382274|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83382275|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
83382276|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382277|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382278|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83382279|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
83382280|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83382281|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83382282|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382283|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83382284|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
83382285|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83382286|NCT03451591|Protective Agents|protective agents|mesh-ancestor
83382287|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83382288|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83382289|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382290|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83382291|NCT03451591|Diuretics|diuretics|mesh-ancestor
83382292|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
83382293|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83382294|NCT05744115|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83382295|NCT05744115|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83382296|NCT05744115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382297|NCT01677559|Paclitaxel|paclitaxel|mesh-list
83382298|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83382299|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382300|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
83382301|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
83382303|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382304|NCT05132712|Losartan|losartan|mesh-list
83382305|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83382306|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83382307|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83382308|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83382309|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382310|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
83382311|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83382312|NCT02149173|Fluorides|fluorides|mesh-list
83382313|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83382314|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382315|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
83382316|NCT02149173|Protective Agents|protective agents|mesh-ancestor
83382317|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382318|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
83382319|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
83382320|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83382321|NCT04789434|Tislelizumab|tislelizumab|mesh-list
83382322|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83382323|NCT04789434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83382324|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382325|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382326|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
83382327|NCT03805503|Procaine|procaine|mesh-list
83382328|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
83382329|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
83382330|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382331|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382332|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
83382333|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382334|NCT01504412|Pregabalin|pregabalin|mesh-list
83382335|NCT01504412|Analgesics|analgesics|mesh-ancestor
83382336|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
83382337|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382338|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382339|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
83382340|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83382341|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83382342|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382343|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83382344|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83382345|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83382346|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382347|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83382348|NCT04702464|Fluconazole|fluconazole|mesh-list
83382349|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
83382350|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83382351|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83382352|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83382353|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382354|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382355|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83382356|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
83382357|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83382358|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382359|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83382360|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83382361|NCT00088465|Olanzapine|olanzapine|mesh-list
83382362|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
83382363|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
83382364|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382365|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382366|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83382367|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83382368|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83382369|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382370|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83382371|NCT00088465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83382372|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83382373|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83382374|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382375|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382376|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
83382377|NCT04405674|Paclitaxel|paclitaxel|mesh-list
83382378|NCT04405674|Bevacizumab|bevacizumab|mesh-list
83382379|NCT04405674|Carboplatin|carboplatin|mesh-list
83382380|NCT04405674|Pemetrexed|pemetrexed|mesh-list
83382381|NCT04405674|Tislelizumab|tislelizumab|mesh-list
83382382|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83382383|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382384|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
83382385|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
83382386|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
83382387|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382388|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83382389|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83382390|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83382391|NCT04405674|Growth Substances|growth substances|mesh-ancestor
83382392|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382393|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
83382394|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382395|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83382396|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83382398|NCT00088153|Estrogens|estrogens|mesh-list
83382399|NCT00088153|Progestins|progestins|mesh-ancestor
83382400|NCT00088153|Hormones|hormones|mesh-ancestor
83382401|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83382402|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382403|NCT02074358|Apixaban|apixaban|mesh-list
83382404|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83382405|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
83382406|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83382407|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
83382408|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382409|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382410|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
83382411|NCT05743725|Magnesium Sulfate|magnesium sulfate|mesh-list
83382412|NCT05743725|Dexmedetomidine|dexmedetomidine|mesh-list
83382413|NCT05743725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83382414|NCT05743725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382415|NCT05743725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382416|NCT05743725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382417|NCT05743725|Analgesics|analgesics|mesh-ancestor
83382418|NCT05743725|Sensory System Agents|sensory system agents|mesh-ancestor
83382419|NCT05743725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382420|NCT05743725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83382421|NCT05743725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83382422|NCT05743725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83382423|NCT05743725|Adrenergic Agents|adrenergic agents|mesh-ancestor
83382424|NCT05743725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382425|NCT05743725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382426|NCT05743725|Anesthetics|anesthetics|mesh-ancestor
83382427|NCT05743725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83382428|NCT05743725|Anticonvulsants|anticonvulsants|mesh-ancestor
83382429|NCT05743725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83382430|NCT05743725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83382431|NCT05743725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83382432|NCT05743725|Tocolytic Agents|tocolytic agents|mesh-ancestor
83382433|NCT05743725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83382434|NCT05547321|Pembrolizumab|pembrolizumab|mesh-list
83382435|NCT05547321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83382436|NCT05547321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382437|NCT05547321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83382438|NCT05547321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382439|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
83382440|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83382441|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382442|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382443|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382444|NCT04912518|Analgesics|analgesics|mesh-ancestor
83382445|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
83382446|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382447|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83382448|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83382449|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83382450|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
83382451|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382452|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382453|NCT00087685|Everolimus|everolimus|mesh-list
83382454|NCT00087685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83382455|NCT00087685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83382456|NCT00087685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382457|NCT00087685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382458|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83382459|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
83382460|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382461|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382462|NCT04094558|Lactulose|lactulose|mesh-list
83382463|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83382464|NCT01502228|Sunitinib|sunitinib|mesh-list
83382465|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382466|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83382467|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83382468|NCT01502228|Growth Substances|growth substances|mesh-ancestor
83382469|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382470|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
83382471|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83382472|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382473|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382474|NCT05011812|Ritonavir|ritonavir|mesh-list
83382475|NCT05011812|Midazolam|midazolam|mesh-list
83382476|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83382477|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83382478|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382479|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382480|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83382481|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83382482|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83382483|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83382484|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
83382485|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
83382486|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
83382487|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
83382488|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382489|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382490|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83382491|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83382492|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
83382493|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382494|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83382495|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83382496|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
83382497|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83382498|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83382499|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83382500|NCT05535231|Curcumin|curcumin|mesh-list
83382501|NCT05535231|Turmeric extract|turmeric extract|mesh-list
83382502|NCT05535231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83382503|NCT05535231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382504|NCT05535231|Analgesics|analgesics|mesh-ancestor
83382505|NCT05535231|Sensory System Agents|sensory system agents|mesh-ancestor
83382506|NCT05535231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382507|NCT05535231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382508|NCT05535231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83382509|NCT05535231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382510|NCT05535231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382511|NCT05535231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382512|NCT05535231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382513|NCT05535231|Antioxidants|antioxidants|mesh-ancestor
83382514|NCT05535231|Protective Agents|protective agents|mesh-ancestor
83382515|NCT01502072|Ribavirin|ribavirin|mesh-list
83382516|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
83382517|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382518|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
83382519|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83382520|NCT01462370|Acetaminophen|acetaminophen|mesh-list
83382521|NCT01462370|Ibuprofen|ibuprofen|mesh-list
83382522|NCT01462370|Etoricoxib|etoricoxib|mesh-list
83382523|NCT01462370|Caffeine|caffeine|mesh-list
83382524|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382525|NCT01462370|Analgesics|analgesics|mesh-ancestor
83382526|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
83382527|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382528|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382529|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
83382530|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83382531|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83382532|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382533|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83382534|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382535|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382536|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83382537|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83382538|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83382539|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83382540|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
83382541|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382542|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83382543|NCT05743179|Zoledronic Acid|zoledronic acid|mesh-list
83382544|NCT05743179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83382545|NCT05743179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382546|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
83382547|NCT01479764|Neostigmine|neostigmine|mesh-list
83382548|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83382549|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382550|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382551|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
83382552|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382553|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382554|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83382555|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
83382556|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382557|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83382558|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83382559|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83382560|NCT01479530|Rasagiline|rasagiline|mesh-list
83382561|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83382562|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382563|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382564|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83382565|NCT01479530|Protective Agents|protective agents|mesh-ancestor
83382566|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382567|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83382568|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83382569|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83382570|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83382571|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382572|NCT01479374|Analgesics|analgesics|mesh-ancestor
83382573|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
83382574|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382575|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382576|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83382577|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382578|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83382579|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83382580|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83382581|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
83382582|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
83382583|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382584|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382585|NCT00087529|Rituximab|rituximab|mesh-list
83382586|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83382587|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382588|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
83382589|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382590|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382591|NCT00794313|Topiramate|topiramate|mesh-list
83382592|NCT00794313|Amantadine|amantadine|mesh-list
83382593|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
83382594|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83382595|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382596|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83382597|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83382598|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
83382599|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83382600|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
83382601|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382602|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382603|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382604|NCT00794313|Analgesics|analgesics|mesh-ancestor
83382605|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
83382606|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382607|NCT05743101|Levofloxacin|levofloxacin|mesh-list
83382608|NCT05743101|Ofloxacin|ofloxacin|mesh-list
83382609|NCT05743101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83382610|NCT05743101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83382611|NCT05743101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83382612|NCT05743101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83382613|NCT05743101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83382614|NCT05743101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382615|NCT05743101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382616|NCT05743101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382617|NCT05743101|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83382618|NCT05743101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83382619|NCT01500434|Aspirin|aspirin|mesh-list
83382620|NCT01500434|Ticlopidine|ticlopidine|mesh-list
83382621|NCT01500434|Clopidogrel|clopidogrel|mesh-list
83382622|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83382623|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382624|NCT01500434|Analgesics|analgesics|mesh-ancestor
83382625|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
83382626|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382627|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382628|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83382629|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382630|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83382631|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83382632|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382633|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83382634|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83382635|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382636|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
83382637|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83382638|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83382639|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83382640|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
83382641|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382642|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83382643|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83382644|NCT00087139|Epothilones|epothilones|mesh-list
83382645|NCT00087139|Epothilone B|epothilone b|mesh-list
83382646|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
83382647|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
83382648|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
83382649|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382650|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382651|NCT00794547|Calcitriol|calcitriol|mesh-list
83382652|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83382653|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382654|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83382655|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83382656|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382657|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83382658|NCT00794547|Vitamins|vitamins|mesh-ancestor
83382659|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
83382660|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83382661|NCT03493165|Everolimus|everolimus|mesh-list
83382662|NCT03493165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83382663|NCT03493165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83382664|NCT03493165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382665|NCT03493165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382666|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83382667|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
83382668|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382669|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382670|NCT00786825|Somatostatin|somatostatin|mesh-list
83382671|NCT00786825|Hormones|hormones|mesh-ancestor
83382672|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83382673|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382674|NCT00768261|Memantine|memantine|mesh-list
83382675|NCT00768261|Donepezil|donepezil|mesh-list
83382676|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83382677|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382678|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382679|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
83382680|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382681|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382682|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
83382683|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83382684|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83382685|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
83382686|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83382687|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83382688|NCT03804723|Prednisone|prednisone|mesh-list
83382689|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83382690|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
83382691|NCT03804723|Hormones|hormones|mesh-ancestor
83382692|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83382693|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382694|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83382695|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382696|NCT00797277|Lorazepam|lorazepam|mesh-list
83382697|NCT00797277|Haloperidol|haloperidol|mesh-list
83382698|NCT00797277|Olanzapine|olanzapine|mesh-list
83382699|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
83382700|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
83382701|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
83382702|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382703|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382704|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83382705|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83382706|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83382707|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382708|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83382709|NCT00797277|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83382710|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83382711|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83382712|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382713|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382714|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
83382715|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83382716|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
83382717|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83382718|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
83382719|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83382720|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83382721|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
83382722|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
83382723|NCT03837015|Estradiol|estradiol|mesh-list
83382724|NCT03837015|Estrogens|estrogens|mesh-ancestor
83382725|NCT03837015|Hormones|hormones|mesh-ancestor
83382726|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83382727|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382728|NCT01500278|Adalimumab|adalimumab|mesh-list
83382730|NCT01500278|Methotrexate|methotrexate|mesh-list
83382731|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83382732|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
83382733|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83382734|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382735|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382736|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
83382737|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382738|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382739|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
83382740|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382741|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83382742|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83382743|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
83382744|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382745|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83382746|NCT01500278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83382747|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83382748|NCT00086281|Zolpidem|zolpidem|mesh-list
83382749|NCT00086281|Modafinil|modafinil|mesh-list
83382750|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83382751|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382752|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83382753|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83382754|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83382755|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382756|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83382757|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83382758|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382759|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83382760|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
83382761|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
83382762|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382763|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
83382765|NCT00787761|Methotrexate|methotrexate|mesh-list
83382766|NCT00787761|Fludarabine|fludarabine|mesh-list
83382767|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
83382768|NCT00787761|Tacrolimus|tacrolimus|mesh-list
83382769|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
83382770|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83382771|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83382772|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
83382773|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382774|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382775|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83382776|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
83382777|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382778|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382779|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83382780|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83382781|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
83382782|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83382783|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382784|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
83382785|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
83382786|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382787|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83382788|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83382789|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83382790|NCT01478828|Lovastatin|lovastatin|mesh-list
83382791|NCT01478828|L 647318|l 647318|mesh-list
83382792|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
83382793|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83382794|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83382795|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
83382796|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382797|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83382798|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83382799|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382800|NCT00085423|Aldesleukin|aldesleukin|mesh-list
83382801|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
83382802|NCT00085423|Fludarabine|fludarabine|mesh-list
83382803|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
83382805|NCT00085423|Molgramostim|molgramostim|mesh-list
83382806|NCT00085423|Sargramostim|sargramostim|mesh-list
83382807|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83382808|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
83382809|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382810|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382811|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83382812|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
83382813|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382814|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382815|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83382816|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382817|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
83382818|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382819|NCT00085423|Analgesics|analgesics|mesh-ancestor
83382820|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
83382821|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382822|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83382823|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83382824|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
83382825|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83382826|NCT04079192|Umirolimus|umirolimus|mesh-list
83382827|NCT04079192|Paclitaxel|paclitaxel|mesh-list
83382828|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83382829|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382830|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
83382831|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
83382832|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
83382833|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382834|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83382835|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83382836|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
83382837|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382838|NCT03087877|Acetaminophen|acetaminophen|mesh-list
83382839|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382840|NCT03087877|Analgesics|analgesics|mesh-ancestor
83382841|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
83382842|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382843|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382844|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
83382845|NCT05742477|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83382846|NCT05742477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83382847|NCT03447379|Aspirin|aspirin|mesh-list
83382848|NCT03447379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83382849|NCT03447379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382850|NCT03447379|Analgesics|analgesics|mesh-ancestor
83382851|NCT03447379|Sensory System Agents|sensory system agents|mesh-ancestor
83382852|NCT03447379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382853|NCT03447379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382854|NCT03447379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83382855|NCT03447379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382856|NCT03447379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83382857|NCT03447379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83382858|NCT03447379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382859|NCT03447379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83382860|NCT03447379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83382861|NCT03447379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382862|NCT03447379|Antipyretics|antipyretics|mesh-ancestor
83382863|NCT03803553|Fluorouracil|fluorouracil|mesh-list
83382864|NCT03803553|Nivolumab|nivolumab|mesh-list
83382865|NCT03803553|Irinotecan|irinotecan|mesh-list
83382866|NCT03803553|Cetuximab|cetuximab|mesh-list
83382867|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
83382868|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382869|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382870|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382871|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83382872|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
83382873|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382874|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83382875|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83382876|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83382877|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83382878|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382879|NCT05740449|Decitabine|decitabine|mesh-list
83382880|NCT05740449|Venetoclax|venetoclax|mesh-list
83382881|NCT05740449|Navitoclax|navitoclax|mesh-list
83382882|NCT05740449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382883|NCT05740449|Antimetabolites|antimetabolites|mesh-ancestor
83382884|NCT05740449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382885|NCT05740449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382886|NCT05740449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382887|NCT03485677|Eliglustat|eliglustat|mesh-list
83382888|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382889|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382890|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
83382891|NCT01677949|Etoposide|etoposide|mesh-list
83382892|NCT01677949|Clofarabine|clofarabine|mesh-list
83382893|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83382894|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
83382895|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382896|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83382897|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83382898|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
83382899|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382900|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382901|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83382902|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83382903|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83382904|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83382905|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382906|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382907|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
83382908|NCT03483883|Gemcitabine|gemcitabine|mesh-list
83382909|NCT03483883|Avelumab|avelumab|mesh-list
83382910|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83382911|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
83382912|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382913|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382914|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83382915|NCT03482167|Niacinamide|niacinamide|mesh-list
83382916|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
83382917|NCT03482167|Vitamins|vitamins|mesh-ancestor
83382918|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
83382919|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382920|NCT00799227|Dexamethasone|dexamethasone|mesh-list
83382921|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83382922|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
83382923|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
83382924|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382925|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382926|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83382927|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
83382928|NCT00799227|Hormones|hormones|mesh-ancestor
83382929|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83382930|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83382931|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382932|NCT03439267|Calcium|calcium|mesh-list
83382933|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83382934|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382935|NCT00770133|Ketotifen|ketotifen|mesh-list
83382936|NCT00770133|Naphazoline|naphazoline|mesh-list
83382937|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
83382938|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
83382939|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83382940|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
83382941|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
83382942|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382943|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382944|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382945|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83382946|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83382947|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83382948|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
83382949|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
83382950|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83382951|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
83382952|NCT00770757|Pomalidomide|pomalidomide|mesh-list
83382953|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
83382954|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382955|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83382956|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83382957|NCT00770757|Growth Substances|growth substances|mesh-ancestor
83382958|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
83382959|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382960|NCT01425281|Everolimus|everolimus|mesh-list
83382961|NCT01425281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83382962|NCT01425281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83382963|NCT01425281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83382964|NCT01425281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382965|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83382966|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
83382967|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382968|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382969|NCT04384653|Furosemide|furosemide|mesh-list
83382970|NCT04384653|Diuretics|diuretics|mesh-ancestor
83382971|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
83382972|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382973|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83382974|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83382975|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382976|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
83382977|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
83382978|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83382979|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83382980|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382981|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83382982|NCT04113720|Analgesics|analgesics|mesh-ancestor
83382983|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
83382984|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83382985|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83382986|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83382987|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83382988|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
83382989|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83382990|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382992|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
83382993|NCT01402817|Sunitinib|sunitinib|mesh-list
83382994|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83382995|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83382996|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83382997|NCT01402817|Growth Substances|growth substances|mesh-ancestor
83382998|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382999|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
83383000|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83383001|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383002|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383003|NCT01425203|Ribavirin|ribavirin|mesh-list
83383004|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83383005|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
83383006|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383007|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
83383008|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383009|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
83383010|NCT04215120|Hematinics|hematinics|mesh-ancestor
83383011|NCT00081289|Leucovorin|leucovorin|mesh-list
83383012|NCT00081289|Folic Acid|folic acid|mesh-list
83383013|NCT00081289|Fluorouracil|fluorouracil|mesh-list
83383014|NCT00081289|Capecitabine|capecitabine|mesh-list
83383015|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
83383016|NCT00081289|Irinotecan|irinotecan|mesh-list
83383017|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
83383018|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
83383019|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383020|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83383021|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383022|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83383023|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
83383024|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383025|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83383026|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83383027|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383028|NCT00081289|Antidotes|antidotes|mesh-ancestor
83383029|NCT00081289|Protective Agents|protective agents|mesh-ancestor
83383030|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
83383031|NCT00081289|Vitamins|vitamins|mesh-ancestor
83383032|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
83383033|NCT00081289|Hematinics|hematinics|mesh-ancestor
83383034|NCT01478594|Bevacizumab|bevacizumab|mesh-list
83383035|NCT01478594|Tivozanib|tivozanib|mesh-list
83383036|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83383037|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383038|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83383039|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83383040|NCT01478594|Growth Substances|growth substances|mesh-ancestor
83383041|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383042|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
83383043|NCT01478594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83383044|NCT01478594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383045|NCT01478594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383046|NCT01424813|Albuterol|albuterol|mesh-list
83383047|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83383048|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
83383049|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383050|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383051|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83383052|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
83383053|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
83383054|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83383055|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83383056|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83383057|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83383058|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
83383059|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383060|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383061|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
83383062|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83383063|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383064|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383065|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83383066|NCT03480061|Analgesics|analgesics|mesh-ancestor
83383067|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
83383068|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383069|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83383070|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83383071|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83383072|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
83383073|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383074|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383075|NCT03389022|Ketamine|ketamine|mesh-list
83383076|NCT03389022|Analgesics|analgesics|mesh-ancestor
83383077|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
83383078|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383079|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383080|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83383081|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83383082|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
83383083|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
83383084|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383085|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83383086|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83383087|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383088|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383089|NCT00080899|Fenretinide|fenretinide|mesh-list
83383090|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383091|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83383092|NCT00080899|Protective Agents|protective agents|mesh-ancestor
83383093|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383094|NCT03627858|Beclomethasone|beclomethasone|mesh-list
83383095|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
83383096|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
83383097|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83383098|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
83383099|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383100|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383101|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83383102|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
83383103|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83383104|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83383105|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83383106|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
83383107|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383108|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383109|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83383110|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
83383111|NCT03627858|Hormones|hormones|mesh-ancestor
83383112|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83383113|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83383114|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83383115|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83383116|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
83383117|NCT03086785|Apatinib|apatinib|mesh-list
83383118|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383119|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83383120|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383121|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383122|NCT03259698|Tenofovir|tenofovir|mesh-list
83383123|NCT03259698|Emtricitabine|emtricitabine|mesh-list
83383124|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83383125|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
83383126|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383127|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83383128|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83383129|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383130|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383131|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83383132|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83383133|NCT00089635|Panitumumab|panitumumab|mesh-list
83383134|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83383135|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383136|NCT03445728|Nicorandil|nicorandil|mesh-list
83383137|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83383138|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83383139|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
83383140|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
83383141|NCT03445728|Vitamins|vitamins|mesh-ancestor
83383142|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
83383143|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383144|NCT02795520|OTS167|ots167|mesh-list
83383145|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83383146|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383147|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383148|NCT03159000|Lidocaine|lidocaine|mesh-list
83383149|NCT03159000|Bupivacaine|bupivacaine|mesh-list
83383150|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
83383151|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
83383152|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383153|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383154|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
83383155|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383156|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83383157|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83383158|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83383159|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83383160|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383161|NCT00086671|Antibodies|antibodies|mesh-list
83383162|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83383163|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
83383164|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383165|NCT02464878|Etanercept|etanercept|mesh-list
83383166|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
83383167|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83383168|NCT02464878|Basiliximab|basiliximab|mesh-list
83383169|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83383170|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
83383171|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83383172|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83383173|NCT02464878|Analgesics|analgesics|mesh-ancestor
83383174|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
83383175|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383176|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383177|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83383178|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83383179|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83383180|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83383181|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
83383182|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83383183|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83383184|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
83383185|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383186|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383187|NCT02010606|Bevacizumab|bevacizumab|mesh-list
83383188|NCT02010606|Temozolomide|temozolomide|mesh-list
83383189|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83383190|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383191|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83383192|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83383193|NCT02010606|Growth Substances|growth substances|mesh-ancestor
83383194|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383195|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
83383196|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83383197|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
83383198|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383199|NCT00084253|Ritonavir|ritonavir|mesh-list
83383200|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83383201|NCT00084253|Lamivudine|lamivudine|mesh-list
83383202|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83383203|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83383204|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
83383205|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383206|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383207|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83383208|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83383209|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
83383210|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383211|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83383212|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83383213|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83383214|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83383215|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
83383216|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83383217|NCT02951364|Ledipasvir|ledipasvir|mesh-list
83383218|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
83383219|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383220|NCT01678417|Rituximab|rituximab|mesh-list
83383221|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83383222|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383223|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
83383224|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383225|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83383226|NCT00083941|Interleukin-2|interleukin-2|mesh-list
83383227|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383228|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83383229|NCT00083941|Analgesics|analgesics|mesh-ancestor
83383230|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
83383231|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383232|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383233|NCT02856438|Dexamethasone|dexamethasone|mesh-list
83383234|NCT02856438|Lenalidomide|lenalidomide|mesh-list
83383235|NCT02856438|Elotuzumab|elotuzumab|mesh-list
83383236|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83383237|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
83383238|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
83383239|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383240|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383241|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83383242|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
83383243|NCT02856438|Hormones|hormones|mesh-ancestor
83383244|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83383245|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83383246|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383247|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
83383248|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83383249|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83383250|NCT02856438|Growth Substances|growth substances|mesh-ancestor
83383251|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
83383252|NCT01678495|Plasminogen|plasminogen|mesh-list
83383253|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83383254|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83383255|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83383256|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383257|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
83383258|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383259|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83383260|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383261|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383262|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
83383263|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83383264|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383265|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83383266|NCT01678651|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83383267|NCT01678651|Hormones|hormones|mesh-ancestor
83383268|NCT01678651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83383269|NCT01678651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383270|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83383271|NCT03084523|Hematinics|hematinics|mesh-ancestor
83383272|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83383273|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83383274|NCT04094090|Riboflavin|riboflavin|mesh-list
83383275|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
83383276|NCT04094090|Vitamins|vitamins|mesh-ancestor
83383277|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
83383278|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383279|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83383280|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
83383281|NCT04670796|Trastuzumab|trastuzumab|mesh-list
83383282|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83383283|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383284|NCT01019616|Paclitaxel|paclitaxel|mesh-list
83383285|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83383286|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383287|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
83383288|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
83383289|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
83383290|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383291|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
83383292|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83383293|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383294|NCT03083197|Azithromycin|azithromycin|mesh-list
83383295|NCT03083197|Doxycycline|doxycycline|mesh-list
83383296|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83383297|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383298|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
83383299|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83383300|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83383301|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
83383302|NCT03086239|Immunoconjugates|immunoconjugates|mesh-ancestor
83383303|NCT03086239|Immunologic Factors|immunologic factors|mesh-ancestor
83383304|NCT03086239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383305|NCT01678963|Squalamine|squalamine|mesh-list
83383306|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83383307|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383308|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83383309|NCT01678963|Protective Agents|protective agents|mesh-ancestor
83383310|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383311|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383312|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83383313|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83383314|NCT01678963|Growth Substances|growth substances|mesh-ancestor
83383315|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
83383316|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83383317|NCT00790335|Plasminogen|plasminogen|mesh-list
83383318|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83383319|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83383320|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383321|NCT05136534|Anesthetics|anesthetics|mesh-list
83383322|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383323|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383324|NCT05135442|Bortezomib|bortezomib|mesh-list
83383325|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383326|NCT05130684|Paclitaxel|paclitaxel|mesh-list
83383327|NCT05130684|Cisplatin|cisplatin|mesh-list
83383328|NCT05130684|Nivolumab|nivolumab|mesh-list
83383329|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83383330|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383331|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
83383332|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
83383333|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
83383334|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383335|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83383336|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83383337|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
83383338|NCT04402411|Narcotics|narcotics|mesh-ancestor
83383339|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383340|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383341|NCT04402411|Analgesics|analgesics|mesh-ancestor
83383342|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
83383343|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383344|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
83383345|NCT05265507|Ondansetron|ondansetron|mesh-list
83383346|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
83383347|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
83383348|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383349|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383350|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83383351|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
83383352|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
83383353|NCT05265507|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83383354|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83383355|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
83383356|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480252|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383357|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383358|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83383359|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83383360|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83383361|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
83383362|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83383363|NCT05135286|Carbachol|carbachol|mesh-list
83383364|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83383365|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83383366|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83383367|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83383368|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
83383369|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383370|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383371|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383372|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83383373|NCT05135286|Miotics|miotics|mesh-ancestor
83383374|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
83383375|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383376|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83383377|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
83383378|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83383379|NCT05135286|Analgesics|analgesics|mesh-ancestor
83383380|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
83383381|NCT05135286|Protective Agents|protective agents|mesh-ancestor
83383382|NCT03089671|Vitamins|vitamins|mesh-list
83383383|NCT03089671|Riboflavin|riboflavin|mesh-list
83383384|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
83383385|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
83383386|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383387|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83383388|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
83383389|NCT05136924|Varenicline|varenicline|mesh-list
83383390|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83383391|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83383392|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
83383393|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383394|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383395|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383396|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
83383397|NCT00791037|Sargramostim|sargramostim|mesh-list
83383398|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83383399|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
83383400|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383401|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83383402|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83383403|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
83383404|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383405|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383406|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83383407|NCT04403191|Ondansetron|ondansetron|mesh-list
83383408|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
83383409|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
83383410|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383411|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383412|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83383413|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
83383414|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
83383415|NCT04403191|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83383416|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83383417|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
83383418|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383419|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383420|NCT04383093|Tadalafil|tadalafil|mesh-list
83383421|NCT04383093|Tamsulosin|tamsulosin|mesh-list
83383422|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
83383423|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83383424|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83383425|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383426|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383427|NCT04383093|Urological Agents|urological agents|mesh-ancestor
83383428|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83383429|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83383430|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83383431|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
83383432|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383433|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383434|NCT05301660|Nicotine|nicotine|mesh-list
83383435|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83383436|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
83383437|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383438|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383439|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83383440|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83383441|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
83383442|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383443|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383444|NCT01401959|Trastuzumab|trastuzumab|mesh-list
83383445|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83383446|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383447|NCT04767035|Midazolam|midazolam|mesh-list
83383448|NCT04767035|Ketamine|ketamine|mesh-list
83383449|NCT04767035|Analgesics|analgesics|mesh-ancestor
83383450|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
83383451|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383452|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383453|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83383454|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83383455|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
83383456|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
83383457|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383458|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83383459|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83383460|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383461|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383462|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83383463|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83383464|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83383465|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83383466|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83383467|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
83383468|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
83383469|NCT03081169|Heparin|heparin|mesh-list
83383470|NCT03081169|Enoxaparin|enoxaparin|mesh-list
83383471|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
83383472|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
83383473|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83383474|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83383475|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383476|NCT03803163|Treprostinil|treprostinil|mesh-list
83383477|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83383478|NCT05287308|Paclitaxel|paclitaxel|mesh-list
83383479|NCT05287308|Docetaxel|docetaxel|mesh-list
83383480|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83383481|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
83383482|NCT05287308|Doxorubicin|doxorubicin|mesh-list
83383483|NCT05287308|Epirubicin|epirubicin|mesh-list
83383484|NCT05287308|Pirarubicin|pirarubicin|mesh-list
83383485|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83383486|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383487|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
83383488|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
83383489|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
83383490|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383491|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83383492|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
83383493|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383494|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83383495|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83383496|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
83383497|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83383498|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83383499|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83383500|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83383501|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383502|NCT00801723|Budesonide|budesonide|mesh-list
83383503|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83383504|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83383505|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
83383506|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383507|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383508|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83383509|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
83383510|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
83383511|NCT00801723|Hormones|hormones|mesh-ancestor
83383512|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83383513|NCT05346211|Curcumin|curcumin|mesh-list
83383514|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83383515|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83383516|NCT05346211|Analgesics|analgesics|mesh-ancestor
83383517|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
83383518|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383519|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383520|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83383521|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83383522|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383523|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383524|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383526|NCT05694897|Bupivacaine|bupivacaine|mesh-list
83383527|NCT05694897|Anesthetics, Local|anesthetics, local|mesh-ancestor
83383528|NCT05694897|Anesthetics|anesthetics|mesh-ancestor
83383529|NCT05694897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383530|NCT05694897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383531|NCT05694897|Sensory System Agents|sensory system agents|mesh-ancestor
83383532|NCT05694897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383533|NCT05694897|Analgesics|analgesics|mesh-ancestor
83383534|NCT05694897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83383535|NCT05694897|Anticonvulsants|anticonvulsants|mesh-ancestor
83383536|NCT05694897|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83383537|NCT05694897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83383538|NCT05694897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383539|NCT05694897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83383540|NCT05694897|Tocolytic Agents|tocolytic agents|mesh-ancestor
83383541|NCT05694897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83383542|NCT01478048|Dexamethasone|dexamethasone|mesh-list
83383543|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
83383544|NCT01478048|Bortezomib|bortezomib|mesh-list
83383545|NCT01478048|Elotuzumab|elotuzumab|mesh-list
83383546|NCT01478048|BB 1101|bb 1101|mesh-list
83383547|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83383548|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
83383549|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
83383550|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383551|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383552|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83383553|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
83383554|NCT01478048|Hormones|hormones|mesh-ancestor
83383555|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83383556|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83383557|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383558|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
83383559|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383560|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383561|NCT04585776|Insulin|insulin|mesh-list
83383562|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83383563|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383564|NCT01401647|Lidocaine|lidocaine|mesh-list
83383565|NCT01401647|Amiodarone|amiodarone|mesh-list
83383566|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
83383567|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
83383568|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383569|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383570|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
83383571|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383572|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83480253|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
83383573|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83383574|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83383575|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83383576|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383577|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
83383578|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83383579|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83383580|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83383581|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383582|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83383583|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83383584|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83383585|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83383586|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83383587|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83383588|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383589|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383590|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83383591|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83383592|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83383593|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83383594|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83383595|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383596|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383597|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83383598|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83383600|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83383601|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83383602|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
83383603|NCT03088891|Antioxidants|antioxidants|mesh-list
83383604|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383605|NCT03088891|Protective Agents|protective agents|mesh-ancestor
83383606|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383607|NCT01477892|Remifentanil|remifentanil|mesh-list
83383608|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83383609|NCT01477892|Narcotics|narcotics|mesh-ancestor
83383610|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383611|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383612|NCT01477892|Analgesics|analgesics|mesh-ancestor
83383613|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
83383614|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383615|NCT00801801|Docetaxel|docetaxel|mesh-list
83383616|NCT00801801|Sorafenib|sorafenib|mesh-list
83383617|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383618|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
83383619|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
83383620|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
83383621|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383622|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83383623|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383624|NCT01499576|Acetic Acid|acetic acid|mesh-list
83383625|NCT01499576|Retinol acetate|retinol acetate|mesh-list
83383626|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83383627|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383628|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83383629|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
83383630|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383631|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83383632|NCT01499576|Protective Agents|protective agents|mesh-ancestor
83383633|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383634|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
83383635|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
83383636|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83383637|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383638|NCT04546074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83383639|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383640|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83383641|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383642|NCT00802113|Fludarabine|fludarabine|mesh-list
83383643|NCT00802113|Busulfan|busulfan|mesh-list
83383645|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383646|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383647|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83383648|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
83383649|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383650|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
83383651|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83383652|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83383653|NCT03084601|Calcium|calcium|mesh-list
83383654|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83383655|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383656|NCT00791973|Fluticasone|fluticasone|mesh-list
83383657|NCT00791973|Xhance|xhance|mesh-list
83383658|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83383659|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83383660|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
83383661|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383662|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383663|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83383664|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
83383665|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
83383666|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83383667|NCT00773955|Acetic Acid|acetic acid|mesh-list
83383668|NCT00773955|Retinol acetate|retinol acetate|mesh-list
83383669|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
83383670|NCT00773955|Gossypol|gossypol|mesh-list
83383671|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83383672|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383673|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83383674|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
83383675|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383676|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83383677|NCT00773955|Protective Agents|protective agents|mesh-ancestor
83383678|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383679|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83383680|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
83383681|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83383682|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83383683|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83383684|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83383685|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83383686|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
83383687|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83383688|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383689|NCT01498952|Sorafenib|sorafenib|mesh-list
83383690|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383691|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83383692|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383693|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383694|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
83383695|NCT04499196|Hormones|hormones|mesh-ancestor
83383696|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83383697|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383698|NCT04608266|Camostat|camostat|mesh-list
83383699|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
83383700|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383701|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383702|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83383703|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83383704|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83383705|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83383706|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
83383707|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83383708|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383709|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83383710|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83383711|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83383712|NCT04460352|Leucovorin|leucovorin|mesh-list
83383713|NCT04460352|Paclitaxel|paclitaxel|mesh-list
83383714|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83383715|NCT04460352|Carboplatin|carboplatin|mesh-list
83383716|NCT04460352|Fluorouracil|fluorouracil|mesh-list
83383717|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
83383718|NCT04460352|Calcium|calcium|mesh-list
83383719|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
83383720|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83383721|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383722|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
83383723|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
83383724|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
83383725|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383726|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83383727|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383728|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
83383729|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83383730|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83383731|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
83383732|NCT04460352|Antidotes|antidotes|mesh-ancestor
83383733|NCT04460352|Protective Agents|protective agents|mesh-ancestor
83383734|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
83383735|NCT04460352|Vitamins|vitamins|mesh-ancestor
83383736|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
83383737|NCT03083353|Isradipine|isradipine|mesh-list
83383738|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83383739|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83383740|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83383741|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383742|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83383743|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383744|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
83383746|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83383747|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83383748|NCT01421303|Analgesics|analgesics|mesh-ancestor
83383749|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
83383750|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383751|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383752|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83383753|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83383754|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83383755|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83383756|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
83383757|NCT03703375|Gemcitabine|gemcitabine|mesh-list
83383758|NCT03703375|Azacitidine|azacitidine|mesh-list
83383759|NCT03703375|Romidepsin|romidepsin|mesh-list
83383760|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83383761|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
83383762|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383763|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383764|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383765|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83383766|NCT03703375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83383767|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83383768|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83383769|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83383770|NCT05303688|Analgesics|analgesics|mesh-ancestor
83383771|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
83383772|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383773|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383774|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83383775|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83383776|NCT04383717|Azithromycin|azithromycin|mesh-list
83383777|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
83383778|NCT04383717|Levamisole|levamisole|mesh-list
83383779|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
83383780|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83383781|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383782|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
83383783|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83383784|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83383785|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383786|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383787|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83383788|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83383789|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
83383790|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383791|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
83383792|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
83383793|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
83383795|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83383796|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
83383797|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383798|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383799|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83383800|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83383801|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
83383802|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383803|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383804|NCT05685277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83383805|NCT05685277|Ramipril|ramipril|mesh-list
83383806|NCT05685277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83383807|NCT05685277|Diuretics|diuretics|mesh-ancestor
83383808|NCT05685277|Natriuretic Agents|natriuretic agents|mesh-ancestor
83383809|NCT05685277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383810|NCT05685277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83383811|NCT05685277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83383812|NCT05685277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383813|NCT05685277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83383814|NCT05685277|Protease Inhibitors|protease inhibitors|mesh-ancestor
83383815|NCT05685277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383816|NCT00809055|Caffeine|caffeine|mesh-list
83383817|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
83383818|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383819|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83383820|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383821|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83383822|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383823|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83383824|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83383825|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
83383826|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383827|NCT01421225|Insulin|insulin|mesh-list
83383828|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83383829|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83383830|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383831|NCT03082885|Thymalfasin|thymalfasin|mesh-list
83383832|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83383833|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
83383834|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383835|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83383836|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
83383837|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383838|NCT05688631|Antioxidants|antioxidants|mesh-list
83383839|NCT05688631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383840|NCT05688631|Protective Agents|protective agents|mesh-ancestor
83383841|NCT05688631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383842|NCT04348032|Apatinib|apatinib|mesh-list
83383843|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383844|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83383845|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383846|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383847|NCT05007873|Decitabine|decitabine|mesh-list
83383848|NCT05007873|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83383849|NCT05007873|Dasatinib|dasatinib|mesh-list
83383850|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83383851|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
83383852|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383853|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383854|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383855|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83383856|NCT01474772|Pregabalin|pregabalin|mesh-list
83383857|NCT01474772|Analgesics|analgesics|mesh-ancestor
83383858|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
83383859|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383860|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383861|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
83383862|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83383863|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83383864|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383865|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83383866|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83383867|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83383868|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383869|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83383870|NCT03082339|Cortisone|cortisone|mesh-list
83383871|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83383872|NCT03801759|Adefovir|adefovir|mesh-list
83383873|NCT03801759|Digoxin|digoxin|mesh-list
83383874|NCT03801759|Furosemide|furosemide|mesh-list
83383875|NCT03801759|Diuretics|diuretics|mesh-ancestor
83383876|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
83383877|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383878|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83383879|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83383880|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383881|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83383882|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83383883|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383884|NCT03801759|Protective Agents|protective agents|mesh-ancestor
83383885|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
83383886|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383887|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83383888|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83383889|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
83383890|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83383891|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383892|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83383893|NCT03082573|Hormones|hormones|mesh-ancestor
83383894|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83383895|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383896|NCT01497938|Insulin|insulin|mesh-list
83383897|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83383898|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383899|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
83383900|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
83383901|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383902|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83383903|NCT04301310|Rifampin|rifampin|mesh-list
83383904|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83383905|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
83383906|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83383907|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383908|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
83383909|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83383910|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383911|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383912|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83383913|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83383914|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83383915|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83383916|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83383917|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83383918|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
83383919|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383920|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
83383921|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
83383922|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
83383923|NCT00804609|Lidocaine|lidocaine|mesh-list
83383924|NCT00804609|Morphine|morphine|mesh-list
83383925|NCT00804609|Anesthetics|anesthetics|mesh-list
83383926|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
83383927|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83383928|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383929|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
83383930|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83383931|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83383932|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83383933|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83383934|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83383935|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383936|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83383937|NCT00804609|Narcotics|narcotics|mesh-ancestor
83383938|NCT00804609|Analgesics|analgesics|mesh-ancestor
83383939|NCT03082183|Rifampin|rifampin|mesh-list
83383940|NCT03082183|BI 425809|bi 425809|mesh-list
83383941|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83383942|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
83383943|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83383944|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383945|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
83383946|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83383947|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383948|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383949|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83383950|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83383951|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83383952|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83383953|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83383954|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83383955|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
83383956|NCT03361735|Leuprolide|leuprolide|mesh-list
83383957|NCT03361735|Goserelin|goserelin|mesh-list
83383958|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83383959|NCT03361735|Hormones|hormones|mesh-list
83383960|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83383961|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383962|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83383963|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
83383964|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83383965|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83383966|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383967|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83383968|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83383969|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383970|NCT04283604|Methylphenidate|methylphenidate|mesh-list
83383971|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83383972|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83383973|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83383974|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83383975|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83383976|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383977|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
83383978|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83383979|NCT00810303|Efavirenz|efavirenz|mesh-list
83383980|NCT00810303|Ezetimibe|ezetimibe|mesh-list
83383981|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83383982|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83383983|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
83383984|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83383985|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83383986|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83383987|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83383988|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83383989|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
83383990|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83383991|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83383992|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83383993|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83383994|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83480254|NCT04423055|Etonogestrel|etonogestrel|mesh-list
83383995|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83383996|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83383998|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
83383999|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384000|NCT05645107|Immunoglobulins|immunoglobulins|mesh-list
83384001|NCT05645107|gamma-Globulins|gamma-globulins|mesh-list
83384002|NCT05645107|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83384003|NCT05645107|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83384004|NCT05645107|Immunologic Factors|immunologic factors|mesh-ancestor
83384005|NCT05645107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384006|NCT04227756|Psilocybin|psilocybin|mesh-list
83384007|NCT04227756|Mescaline|mescaline|mesh-list
83384008|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
83384009|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384010|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83384011|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83384012|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
83384013|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384014|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384015|NCT01460342|Tadalafil|tadalafil|mesh-list
83384016|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
83384017|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83384018|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83384019|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384020|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384021|NCT01460342|Urological Agents|urological agents|mesh-ancestor
83384022|NCT04198506|Tacrolimus|tacrolimus|mesh-list
83384023|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83384024|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
83384025|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384026|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83384027|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384028|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384029|NCT00775671|Metoprolol|metoprolol|mesh-list
83384030|NCT00775671|Nebivolol|nebivolol|mesh-list
83384031|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83384032|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83384033|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
83384034|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
83384035|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384036|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384037|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83384038|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83384039|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83384040|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
83384041|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384042|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384043|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
83384044|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83384045|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83384046|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83384047|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83384048|NCT03800745|Laxatives|laxatives|mesh-ancestor
83384049|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83384050|NCT01459796|Rilonacept|rilonacept|mesh-list
83384051|NCT01459796|Allopurinol|allopurinol|mesh-list
83384052|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
83384053|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384054|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384055|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
83384056|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384057|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83384058|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
83384059|NCT01459796|Protective Agents|protective agents|mesh-ancestor
83384060|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384061|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384062|NCT04721691|Cannabidiol|cannabidiol|mesh-list
83384063|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
83384064|NCT04760821|Trimetazidine|trimetazidine|mesh-list
83384065|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
83384066|NCT04382079|Propolis|propolis|mesh-list
83384067|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384068|NCT05688007|Hormones|hormones|mesh-list
83384069|NCT05688007|Parathyroid Hormone|parathyroid hormone|mesh-list
83384070|NCT05688007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384071|NCT05688007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384072|NCT05688007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83384073|NCT01459718|Deferasirox|deferasirox|mesh-list
83384074|NCT01459718|Deferoxamine|deferoxamine|mesh-list
83384075|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83384076|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
83384077|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
83384078|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384079|NCT01459718|Siderophores|siderophores|mesh-ancestor
83384080|NCT04918407|Empagliflozin|empagliflozin|mesh-list
83384081|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83384082|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384083|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83384084|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384085|NCT04989660|Phenol|phenol|mesh-list
83384086|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83384087|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384088|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
83384089|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83384090|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83384091|NCT02970318|Rituximab|rituximab|mesh-list
83384092|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83384093|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
83384094|NCT02970318|Idelalisib|idelalisib|mesh-list
83384095|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83384096|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384097|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
83384098|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384099|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384100|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83384101|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
83384102|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384103|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384104|NCT03081325|Immunomodulating Agents|immunomodulating agents|mesh-list
83384105|NCT03081325|Immunologic Factors|immunologic factors|mesh-ancestor
83384106|NCT03081325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384107|NCT04384731|Poractant alfa|poractant alfa|mesh-list
83384108|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83384109|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
83384110|NCT05042466|Psilocybin|psilocybin|mesh-list
83384111|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
83384112|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384113|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83384114|NCT05615467|Metformin|metformin|mesh-list
83384115|NCT05615467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83384116|NCT05615467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384118|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83384119|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384120|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384121|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83384122|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83384123|NCT03800433|Protective Agents|protective agents|mesh-ancestor
83384124|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384125|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
83384126|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83384127|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
83384128|NCT03395899|Bevacizumab|bevacizumab|mesh-list
83384129|NCT03395899|Atezolizumab|atezolizumab|mesh-list
83384130|NCT03395899|Ipatasertib|ipatasertib|mesh-list
83384131|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83384132|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384133|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83384134|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83384135|NCT03395899|Growth Substances|growth substances|mesh-ancestor
83384136|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384137|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
83384138|NCT03395899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83384139|NCT03395899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384140|NCT03395899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83384142|NCT02900976|Rituximab|rituximab|mesh-list
83384143|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83384144|NCT02900976|Antibodies|antibodies|mesh-list
83384145|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
83384146|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83384147|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
83384148|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384149|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384150|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384151|NCT05602597|Itraconazole|itraconazole|mesh-list
83384152|NCT05602597|Fluconazole|fluconazole|mesh-list
83384153|NCT05602597|Rifampin|rifampin|mesh-list
83384154|NCT05602597|Rabeprazole|rabeprazole|mesh-list
83384155|NCT05602597|Antifungal Agents|antifungal agents|mesh-ancestor
83384156|NCT05602597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384157|NCT05602597|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83384158|NCT05602597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83384159|NCT05602597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384160|NCT05602597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384161|NCT05602597|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83384162|NCT05602597|Hormone Antagonists|hormone antagonists|mesh-ancestor
83384163|NCT05602597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384164|NCT05602597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384165|NCT05602597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83384166|NCT05602597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83384167|NCT05602597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83384168|NCT05602597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83384169|NCT05602597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83384170|NCT05602597|Antitubercular Agents|antitubercular agents|mesh-ancestor
83384171|NCT05602597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83384172|NCT05602597|Leprostatic Agents|leprostatic agents|mesh-ancestor
83384173|NCT05602597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83384174|NCT05602597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83384175|NCT05602597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83384176|NCT05602597|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83384177|NCT05602597|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83384178|NCT05602597|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83384179|NCT05602597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83384180|NCT05602597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83384181|NCT05602597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83384182|NCT04608201|Nicotine|nicotine|mesh-list
83384183|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83384184|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
83384185|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384186|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384187|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83384188|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83384189|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
83384190|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384191|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384192|NCT03323437|Risperidone|risperidone|mesh-list
83384193|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83384194|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
83384195|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384196|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384197|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384198|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83384199|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83384200|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384201|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83384202|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83384203|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
83384204|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
83384205|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
83384206|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83384207|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83384208|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384209|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384210|NCT04110444|Urological Agents|urological agents|mesh-ancestor
83384211|NCT04951986|Levofloxacin|levofloxacin|mesh-list
83384212|NCT04951986|Rifampin|rifampin|mesh-list
83384213|NCT04951986|Isoniazid|isoniazid|mesh-list
83384214|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
83384215|NCT04951986|Ethambutol|ethambutol|mesh-list
83384216|NCT04951986|Prednisone|prednisone|mesh-list
83384217|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384218|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
83384219|NCT04951986|Hormones|hormones|mesh-ancestor
83384220|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384221|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384222|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83384223|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384224|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83384225|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384226|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83384227|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83384228|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83384229|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384230|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384231|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83384232|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83384233|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83384234|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
83384235|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
83384236|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83384237|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83384238|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83384239|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83384240|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83384241|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83384242|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83384243|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83384244|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83384245|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
83384246|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83384247|NCT04278859|Antibodies|antibodies|mesh-list
83384248|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83384249|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
83384250|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384251|NCT04484337|Cabotegravir|cabotegravir|mesh-list
83384252|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83384253|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83384254|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83384255|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83384256|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384257|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384258|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83384259|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83384260|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
83384261|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384262|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83384263|NCT04484337|Analgesics|analgesics|mesh-ancestor
83384264|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
83384265|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384266|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384267|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384268|NCT01474538|Insulin|insulin|mesh-list
83384269|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83384270|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
83384271|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
83384272|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83384273|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384274|NCT04278703|Oxycodone|oxycodone|mesh-list
83384275|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83384276|NCT04278703|Narcotics|narcotics|mesh-ancestor
83384277|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384278|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384279|NCT04278703|Analgesics|analgesics|mesh-ancestor
83384280|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
83384281|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384282|NCT02647788|Acetaminophen|acetaminophen|mesh-list
83384283|NCT02647788|Ibuprofen|ibuprofen|mesh-list
83384284|NCT02647788|Codeine|codeine|mesh-list
83384285|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83384286|NCT02647788|Analgesics|analgesics|mesh-ancestor
83384287|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
83384288|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384289|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384290|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
83384291|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83384292|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384293|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384294|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83384295|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384296|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384297|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83384298|NCT02647788|Narcotics|narcotics|mesh-ancestor
83384299|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384300|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
83384301|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
83384302|NCT04382859|Bupivacaine|bupivacaine|mesh-list
83384303|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
83384304|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
83384305|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384306|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384307|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
83384308|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384309|NCT03318133|Anesthetics|anesthetics|mesh-list
83384310|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384311|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384312|NCT04520217|Imipramine|imipramine|mesh-list
83384313|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83384314|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
83384315|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83384316|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83384317|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83384318|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83384319|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384320|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
83384321|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384322|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384323|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83384324|NCT04134663|Oxytocin|oxytocin|mesh-list
83384325|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
83384326|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83384327|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384328|NCT05431764|Gemcitabine|gemcitabine|mesh-list
83384329|NCT05431764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83384330|NCT05431764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384331|NCT05431764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384332|NCT05431764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83384333|NCT05431764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83384334|NCT05431764|Antimetabolites|antimetabolites|mesh-ancestor
83384335|NCT04311411|Liraglutide|liraglutide|mesh-list
83384336|NCT04311411|Tirzepatide|tirzepatide|mesh-list
83384337|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83384338|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384339|NCT04311411|Incretins|incretins|mesh-ancestor
83384341|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384342|NCT00843531|Everolimus|everolimus|mesh-list
83384343|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83384344|NCT00843531|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83384345|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83384346|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384347|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384348|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83384349|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
83384350|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384351|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384353|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83384354|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384355|NCT00813111|Epinephrine|epinephrine|mesh-list
83384356|NCT00813111|Bupivacaine|bupivacaine|mesh-list
83384357|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
83384358|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
83384359|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384360|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384361|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
83384362|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384363|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83384364|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83384365|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
83384366|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384367|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384368|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83384369|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83384370|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
83384371|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83384372|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
83384373|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
83384374|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
83384375|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83384376|NCT00845481|Calcitriol|calcitriol|mesh-list
83384377|NCT00845481|Betamethasone|betamethasone|mesh-list
83384378|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384379|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
83384380|NCT00845481|Hormones|hormones|mesh-ancestor
83384381|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384382|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384383|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83384384|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
83384385|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83384386|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83384387|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83384388|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384389|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83384390|NCT00845481|Vitamins|vitamins|mesh-ancestor
83384391|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
83384392|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83384393|NCT03641001|Micronutrients|micronutrients|mesh-list
83384394|NCT03641001|Trace Elements|trace elements|mesh-list
83384395|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384396|NCT01421069|Etanercept|etanercept|mesh-list
83384397|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83384398|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83384399|NCT01421069|Analgesics|analgesics|mesh-ancestor
83384400|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
83384401|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384402|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384403|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384404|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384405|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83384406|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83384407|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
83384408|NCT04276233|Albuterol|albuterol|mesh-list
83384409|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83384410|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
83384411|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384412|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384413|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83384414|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
83384415|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
83384416|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83384417|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83384418|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83384419|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83384420|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
83384421|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384422|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384423|NCT04681430|Gabexate|gabexate|mesh-list
83384424|NCT04681430|Camostat|camostat|mesh-list
83384425|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
83384426|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384427|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384428|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83384429|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83384430|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
83384431|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
83384432|NCT00814671|Rifampin|rifampin|mesh-list
83384433|NCT00814671|Rifapentine|rifapentine|mesh-list
83384434|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83384435|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
83384436|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83384437|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384438|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
83384439|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83384440|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384441|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384442|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83384443|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83384444|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83384445|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83384446|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83384447|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83384448|NCT03379051|Lenalidomide|lenalidomide|mesh-list
83384449|NCT03379051|Venetoclax|venetoclax|mesh-list
83384450|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
83384451|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384452|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83384453|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83384454|NCT03379051|Growth Substances|growth substances|mesh-ancestor
83384455|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
83384456|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384457|NCT01473836|Metronidazole|metronidazole|mesh-list
83384458|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
83384459|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384460|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83384461|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83384462|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83384463|NCT03340909|Prednisolone|prednisolone|mesh-list
83384464|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384465|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
83384466|NCT03340909|Hormones|hormones|mesh-ancestor
83384467|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384468|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384469|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83384470|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384471|NCT05686915|Cobalt|cobalt|mesh-list
83384472|NCT05686915|Chromium|chromium|mesh-list
83384473|NCT05686915|Trace Elements|trace elements|mesh-ancestor
83384474|NCT05686915|Micronutrients|micronutrients|mesh-ancestor
83384475|NCT05686915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384476|NCT03674151|Povidone|povidone|mesh-list
83384477|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
83384478|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
83384479|NCT03643965|Budesonide|budesonide|mesh-list
83384480|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384481|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83384482|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
83384483|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384484|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384485|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83384486|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
83384488|NCT03643965|Hormones|hormones|mesh-ancestor
83389739|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83384489|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384490|NCT02979522|Doxorubicin|doxorubicin|mesh-list
83384491|NCT02979522|Dacarbazine|dacarbazine|mesh-list
83384492|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83384493|NCT02979522|Vinblastine|vinblastine|mesh-list
83384494|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83384495|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384496|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83384497|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83384498|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384499|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384500|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83384501|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
83384502|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83384503|NCT02979522|Immunotoxins|immunotoxins|mesh-ancestor
83384504|NCT02979522|Immunoconjugates|immunoconjugates|mesh-ancestor
83384505|NCT02979522|Immunologic Factors|immunologic factors|mesh-ancestor
83384506|NCT02979522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384507|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83384508|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
83384509|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
83384510|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
83384511|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
83384512|NCT01420679|Aminopterin|aminopterin|mesh-list
83384513|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83384514|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384515|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384516|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384517|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83384518|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83384519|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83384520|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
83384521|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384522|NCT04401007|Lidocaine|lidocaine|mesh-list
83384523|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
83384524|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
83384525|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384526|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384527|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
83384528|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384529|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83384530|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83384531|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83384532|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83384533|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384534|NCT01496846|Lidocaine|lidocaine|mesh-list
83384535|NCT01496846|Carticaine|carticaine|mesh-list
83384536|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
83384537|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
83384538|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384539|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384540|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
83384541|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384542|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83384543|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83384544|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83384545|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83384546|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384547|NCT00964002|Efavirenz|efavirenz|mesh-list
83384548|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83384549|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83384550|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384551|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384552|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
83384553|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384554|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83384555|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83384556|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83384557|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83384558|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83384559|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83384560|NCT00818337|Aspirin|aspirin|mesh-list
83384561|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83384562|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83384563|NCT00818337|Analgesics|analgesics|mesh-ancestor
83384564|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
83384565|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384566|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384567|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384568|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384569|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83384570|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83384571|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384572|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83384573|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83384574|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384575|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
83384576|NCT02577120|Decanoic acid|decanoic acid|mesh-list
83384577|NCT02577120|Petrolatum|petrolatum|mesh-list
83384578|NCT02577120|Emollients|emollients|mesh-ancestor
83384579|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
83384580|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
83384581|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384582|NCT01399697|Methotrexate|methotrexate|mesh-list
83384583|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83384584|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
83384585|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83384586|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384587|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83384588|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
83384589|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384590|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384591|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
83384592|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384593|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83384594|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83384595|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
83384596|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384597|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83384598|NCT00853671|Adenosine|adenosine|mesh-list
83384599|NCT00853671|Analgesics|analgesics|mesh-ancestor
83384600|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
83384601|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384602|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384603|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83384604|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
83384605|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83384606|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
83384607|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
83384608|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384609|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384610|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83384611|NCT00818805|Tranilast|tranilast|mesh-list
83384612|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83384613|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83384614|NCT00818805|Analgesics|analgesics|mesh-ancestor
83384615|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
83384616|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384617|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384618|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384619|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384620|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83384621|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83384622|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83384623|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
83384624|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
83384625|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384626|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384627|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83384628|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83384629|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83384630|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83384631|NCT00854061|Prednisone|prednisone|mesh-list
83384632|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
83384633|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83384634|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
83384635|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83384636|NCT00854061|Prednisolone|prednisolone|mesh-list
83384637|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83384638|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
83384639|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384640|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
83384641|NCT00854061|Hormones|hormones|mesh-ancestor
83384642|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384643|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384644|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83384645|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384646|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
83384647|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
83384648|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384649|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83384650|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83384651|NCT00854061|Protective Agents|protective agents|mesh-ancestor
83384652|NCT01473602|Vitamin D|vitamin d|mesh-list
83384653|NCT01473602|Teriparatide|teriparatide|mesh-list
83384654|NCT01473602|Calcium|calcium|mesh-list
83384655|NCT01473602|Vitamins|vitamins|mesh-ancestor
83384656|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
83384657|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384658|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83384659|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83384660|NCT03336073|Dexamethasone|dexamethasone|mesh-list
83384661|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
83384662|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83384663|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
83384664|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384665|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384666|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83384667|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
83384668|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384669|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384670|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83384671|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384672|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
83384673|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
83384674|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384675|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83384676|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
83384677|NCT03336073|Hormones|hormones|mesh-ancestor
83384678|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384679|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83384680|NCT05334433|Anesthetics|anesthetics|mesh-list
83384681|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384682|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384683|NCT01496612|Buspirone|buspirone|mesh-list
83384684|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83384685|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83384686|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384687|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384688|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83384689|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83384690|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
83384691|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384692|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384693|NCT00790218|Adenosine|adenosine|mesh-list
83384694|NCT00790218|Analgesics|analgesics|mesh-ancestor
83384695|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
83384696|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384697|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384698|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83384699|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
83384700|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83384701|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
83384702|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
83384703|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384704|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384706|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83384707|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83384708|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83384709|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83384710|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384711|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
83384712|NCT00818961|Busulfan|busulfan|mesh-list
83384713|NCT00818961|Rituximab|rituximab|mesh-list
83384714|NCT00818961|Methotrexate|methotrexate|mesh-list
83384715|NCT00818961|Fludarabine|fludarabine|mesh-list
83384716|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
83384717|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
83384718|NCT00818961|Tacrolimus|tacrolimus|mesh-list
83384719|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83384720|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
83384721|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384722|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384723|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83384724|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
83384725|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384726|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384727|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83384728|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83384729|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83384730|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
83384731|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83384732|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83384733|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
83384734|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
83384735|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384736|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83384737|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83384738|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83384739|NCT05431218|Cholecalciferol|cholecalciferol|mesh-list
83384740|NCT05431218|Vitamin D|vitamin d|mesh-list
83384741|NCT05431218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83384742|NCT05431218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384743|NCT05431218|Vitamins|vitamins|mesh-ancestor
83384744|NCT05431218|Micronutrients|micronutrients|mesh-ancestor
83384745|NCT05431218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83384746|NCT05431062|Bupivacaine|bupivacaine|mesh-list
83384747|NCT05431062|Anesthetics, Local|anesthetics, local|mesh-ancestor
83384748|NCT05431062|Anesthetics|anesthetics|mesh-ancestor
83384749|NCT05431062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384750|NCT05431062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384751|NCT05431062|Sensory System Agents|sensory system agents|mesh-ancestor
83384752|NCT05431062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384753|NCT00819507|Fluocinonide|fluocinonide|mesh-list
83384754|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384755|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
83384756|NCT00819507|Hormones|hormones|mesh-ancestor
83384757|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384758|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384759|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83384760|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83384761|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
83384762|NCT03696121|Coagulants|coagulants|mesh-ancestor
83384763|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83384764|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
83384765|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384766|NCT01995669|Lenalidomide|lenalidomide|mesh-list
83384767|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
83384768|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
83384769|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384770|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83384771|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83384772|NCT01995669|Growth Substances|growth substances|mesh-ancestor
83384773|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
83384774|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384775|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83384776|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83384777|NCT03298945|Laxatives|laxatives|mesh-ancestor
83384778|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83384779|NCT01457924|Ofatumumab|ofatumumab|mesh-list
83384780|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83384781|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384782|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
83384783|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384784|NCT05237115|Amoxicillin|amoxicillin|mesh-list
83384785|NCT05237115|Clarithromycin|clarithromycin|mesh-list
83384786|NCT05237115|Esomeprazole|esomeprazole|mesh-list
83384787|NCT05237115|Bismuth|bismuth|mesh-list
83384788|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83384789|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384790|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83384791|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83384792|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83384793|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384794|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384795|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83384796|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83384797|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83384798|NCT05237115|Antacids|antacids|mesh-ancestor
83384799|NCT04040621|Ceftazidime|ceftazidime|mesh-list
83384800|NCT04040621|Avibactam|avibactam|mesh-list
83384801|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83384802|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83384803|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384804|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83384805|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384806|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384807|NCT00856791|ON 01910|on 01910|mesh-list
83384808|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384809|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83384810|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384811|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384812|NCT00857493|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83384813|NCT00857493|Antiviral Agents|antiviral agents|mesh-ancestor
83384814|NCT00857493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384815|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
83384816|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83384817|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83384818|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384819|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
83384820|NCT05236569|Coagulants|coagulants|mesh-ancestor
83384821|NCT05090371|Ofatumumab|ofatumumab|mesh-list
83384822|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384823|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
83384824|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83384825|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384826|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384827|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83384828|NCT00857727|Analgesics|analgesics|mesh-ancestor
83384829|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
83384830|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384831|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83384832|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83384833|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83384834|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
83384835|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384836|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384837|NCT00857961|Testosterone|testosterone|mesh-list
83384838|NCT00857961|Androgens|androgens|mesh-ancestor
83384839|NCT00857961|Hormones|hormones|mesh-ancestor
83384840|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384841|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384842|NCT03839433|Ciclesonide|ciclesonide|mesh-list
83384843|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
83384844|NCT03839433|Hormones|hormones|mesh-ancestor
83384845|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384846|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384847|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83384848|NCT05033041|Metoclopramide|metoclopramide|mesh-list
83384849|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
83384850|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
83384851|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384852|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384853|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83384854|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83384855|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83384856|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
83384857|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384858|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384859|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83384860|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83384861|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
83384862|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384863|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384864|NCT00824733|Trastuzumab|trastuzumab|mesh-list
83384865|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83384866|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384867|NCT02150499|Albuterol|albuterol|mesh-list
83384868|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83384869|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
83384870|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384871|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384872|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83384873|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
83384874|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
83384875|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83384876|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83384877|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83384878|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83384879|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
83384880|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384881|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384882|NCT03287947|Nintedanib|nintedanib|mesh-list
83384883|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384884|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83384885|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384886|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384887|NCT05685667|Hyaluronic Acid|hyaluronic acid|mesh-list
83384888|NCT05685667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83384889|NCT05685667|Immunologic Factors|immunologic factors|mesh-ancestor
83384890|NCT05685667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384891|NCT05685667|Viscosupplements|viscosupplements|mesh-ancestor
83384892|NCT05685667|Protective Agents|protective agents|mesh-ancestor
83384893|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
83384894|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83384895|NCT00859131|Daclizumab|daclizumab|mesh-list
83384896|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
83384897|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384898|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83384899|NCT00859833|Adenosine|adenosine|mesh-list
83384900|NCT00859833|Regadenoson|regadenoson|mesh-list
83384901|NCT00859833|Analgesics|analgesics|mesh-ancestor
83384902|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
83384903|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384904|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384905|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83384906|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
83384907|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83384908|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
83384909|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
83384910|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384911|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384912|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83384913|NCT02154477|Insulin|insulin|mesh-list
83384914|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83384915|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384916|NCT00860379|Selenium|selenium|mesh-list
83384917|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
83384918|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384919|NCT00860379|Protective Agents|protective agents|mesh-ancestor
83384920|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384921|NCT00860379|Trace Elements|trace elements|mesh-ancestor
83384922|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
83384923|NCT00860457|Rituximab|rituximab|mesh-list
83384924|NCT00860457|Fludarabine|fludarabine|mesh-list
83384925|NCT00860457|Lenalidomide|lenalidomide|mesh-list
83384926|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83384927|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83384928|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
83384929|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384930|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83384931|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83384932|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83384933|NCT00860457|Growth Substances|growth substances|mesh-ancestor
83384934|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
83384935|NCT00827073|Lidocaine|lidocaine|mesh-list
83384936|NCT00827073|Tetracaine|tetracaine|mesh-list
83384937|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
83384938|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
83384939|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384940|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384941|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
83384942|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384943|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83384944|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83384945|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83384946|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83384947|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384948|NCT00860847|Ubiquinone|ubiquinone|mesh-list
83384949|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
83384950|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
83384951|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384952|NCT00860847|Vitamins|vitamins|mesh-ancestor
83384953|NCT04347733|Triamcinolone|triamcinolone|mesh-list
83384954|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83384955|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83384956|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83384957|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384958|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
83384959|NCT04347733|Hormones|hormones|mesh-ancestor
83384960|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83384961|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384962|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83384963|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
83384964|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384965|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384966|NCT02155101|Ritonavir|ritonavir|mesh-list
83384967|NCT02155101|Lopinavir|lopinavir|mesh-list
83384968|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83384969|NCT02155101|Darunavir|darunavir|mesh-list
83384970|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83384971|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83384972|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
83384973|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83384974|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384975|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83384976|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83384977|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
83384978|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83384979|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83384980|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83384981|NCT02155257|Gabapentin|gabapentin|mesh-list
83384982|NCT02155257|Modafinil|modafinil|mesh-list
83384983|NCT02155257|Analgesics|analgesics|mesh-ancestor
83384984|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
83384985|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83384986|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83384987|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
83384988|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83384989|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83384990|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83384991|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83384992|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83384993|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83384994|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83384995|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83384996|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
83384997|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83384998|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83384999|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83385000|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83385001|NCT03243019|Sirolimus|sirolimus|mesh-list
83385002|NCT03243019|Temsirolimus|temsirolimus|mesh-list
83385003|NCT03243019|MTOR Inhibitors|mtor inhibitors|mesh-list
83385004|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385005|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385006|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83385007|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385008|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
83385009|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385010|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
83385011|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385012|NCT03243019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83385013|NCT03243019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385014|NCT03243019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385015|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
83385016|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
83385017|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83385018|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83385019|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385020|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385021|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385022|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83385023|NCT01673646|Pasireotide|pasireotide|mesh-list
83385024|NCT01673646|Hormones|hormones|mesh-ancestor
83385025|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385026|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385027|NCT00862563|Topiramate|topiramate|mesh-list
83385028|NCT00862563|Zonisamide|zonisamide|mesh-list
83385029|NCT00862563|Levetiracetam|levetiracetam|mesh-list
83385030|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
83385031|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83385032|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385033|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
83385034|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83385035|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83385036|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385037|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83385038|NCT04278937|Azithromycin|azithromycin|mesh-list
83385039|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385040|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385041|NCT02647944|Liraglutide|liraglutide|mesh-list
83385042|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83385043|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385044|NCT02647944|Incretins|incretins|mesh-ancestor
83385045|NCT02647944|Hormones|hormones|mesh-ancestor
83385046|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385047|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
83385048|NCT04278547|Valganciclovir|valganciclovir|mesh-list
83385049|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
83385050|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385051|NCT05261269|Niraparib|niraparib|mesh-list
83385052|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83385053|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385054|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385055|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385056|NCT00863109|Ribavirin|ribavirin|mesh-list
83385057|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83385058|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
83385059|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385060|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
83385061|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385062|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83385063|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83385064|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385065|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
83385066|NCT05246371|Propofol|propofol|mesh-list
83385067|NCT05246371|Desflurane|desflurane|mesh-list
83385068|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83385069|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83385070|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385071|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83385072|NCT05246371|Analgesics|analgesics|mesh-ancestor
83385073|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
83385074|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385075|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83385076|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83385077|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83385078|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
83385079|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385080|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385081|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83385082|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
83385083|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
83385084|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83385085|NCT00863265|Ezetimibe|ezetimibe|mesh-list
83385086|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83385087|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83385088|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
83385089|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385090|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83385091|NCT00831675|Vaccines|vaccines|mesh-list
83385092|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
83385093|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385094|NCT01397825|Rituximab|rituximab|mesh-list
83385095|NCT01397825|Vincristine|vincristine|mesh-list
83385096|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83385097|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385098|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
83385099|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385100|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83385101|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83385102|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
83385103|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
83385104|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83385105|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385106|NCT05373186|Insulin Lispro|insulin lispro|mesh-list
83385107|NCT05373186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83385108|NCT05373186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385109|NCT05353764|Ropivacaine|ropivacaine|mesh-list
83385110|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
83385111|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
83385112|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83385113|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385114|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
83385115|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385117|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
83385118|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385119|NCT05239884|Nicotine|nicotine|mesh-list
83385120|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83385121|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
83385122|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385123|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385124|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83385125|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83385126|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
83385127|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385128|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385129|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
83385130|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
83385131|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385132|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
83385133|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385134|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83385135|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83385136|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
83385137|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385138|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385139|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83385140|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83385141|NCT03836352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83385142|NCT01397201|Fluticasone|fluticasone|mesh-list
83385144|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83385145|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83385146|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
83385147|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385148|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385149|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83385150|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
83385151|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
83385152|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83385153|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83385154|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83385155|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
83385156|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83385157|NCT00834171|Tobramycin|tobramycin|mesh-list
83385158|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385159|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385160|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83385161|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83385162|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
83385163|NCT05205577|Iodine|iodine|mesh-list
83385164|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83385165|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385166|NCT05205577|Trace Elements|trace elements|mesh-ancestor
83385167|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
83385168|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385169|NCT00835185|Leucovorin|leucovorin|mesh-list
83385170|NCT00835185|Folic Acid|folic acid|mesh-list
83385171|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
83385172|NCT00835185|Necitumumab|necitumumab|mesh-list
83385173|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
83385174|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83385175|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385176|NCT00835185|Antidotes|antidotes|mesh-ancestor
83385177|NCT00835185|Protective Agents|protective agents|mesh-ancestor
83385178|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385179|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
83385180|NCT00835185|Vitamins|vitamins|mesh-ancestor
83385181|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
83385182|NCT00835185|Hematinics|hematinics|mesh-ancestor
83385183|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83385184|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
83385185|NCT04399525|Cetirizine|cetirizine|mesh-list
83385186|NCT04399525|Loratadine|loratadine|mesh-list
83385187|NCT04399525|Levocetirizine|levocetirizine|mesh-list
83385188|NCT04399525|Desloratadine|desloratadine|mesh-list
83385189|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83385190|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83385191|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
83385192|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
83385193|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385194|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385195|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385196|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83385197|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83385198|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
83385199|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
83385200|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
83385201|NCT00864123|Cycloserine|cycloserine|mesh-list
83385202|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83385203|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385204|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83385205|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
83385206|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385207|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
83385208|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385209|NCT03858465|Phenylephrine|phenylephrine|mesh-list
83385210|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
83385211|NCT03858465|Ephedrine|ephedrine|mesh-list
83385212|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83385213|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
83385214|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
83385215|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385216|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385217|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
83385218|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83385219|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
83385220|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
83385221|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83385222|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83385223|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83385224|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
83385225|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385226|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385227|NCT03858465|Protective Agents|protective agents|mesh-ancestor
83385228|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83385229|NCT05155579|Vaccines|vaccines|mesh-list
83385230|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
83385231|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385232|NCT00867789|Trimethoprim|trimethoprim|mesh-list
83385233|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83385234|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
83385235|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83385236|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385237|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
83385238|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83385239|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83385240|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83385241|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385242|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385243|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83385244|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83385245|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83385246|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385247|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
83385248|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
83385249|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385250|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385251|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385252|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
83385253|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
83385254|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83385255|NCT04797013|Plasminogen|plasminogen|mesh-list
83385256|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83385257|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83385258|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385259|NCT00838695|Phenylephrine|phenylephrine|mesh-list
83385260|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
83385261|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83385262|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
83385263|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
83385264|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385265|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385266|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
83385267|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83385268|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
83385269|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
83385270|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83385271|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83385272|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83385273|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
83385274|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385275|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385276|NCT00838695|Protective Agents|protective agents|mesh-ancestor
83385277|NCT04775173|Sirolimus|sirolimus|mesh-list
83385278|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385279|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385280|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83385281|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385282|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
83385283|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385284|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
83385285|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385286|NCT01396265|Rifampin|rifampin|mesh-list
83385287|NCT01396265|Afatinib|afatinib|mesh-list
83385288|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83385289|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
83385290|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385291|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385292|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
83385293|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83385294|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385295|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385296|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83385297|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83385298|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83385299|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83385300|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83385301|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83385302|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385303|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83385304|NCT04760431|Paclitaxel|paclitaxel|mesh-list
83385305|NCT04760431|Docetaxel|docetaxel|mesh-list
83385306|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83385307|NCT04760431|Trastuzumab|trastuzumab|mesh-list
83385308|NCT04760431|Pertuzumab|pertuzumab|mesh-list
83385309|NCT04760431|Taxane|taxane|mesh-list
83385310|NCT04760431|Tucatinib|tucatinib|mesh-list
83385311|NCT04760431|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83385312|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83385313|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385314|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
83385315|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
83385316|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
83385317|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385318|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83385319|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83385320|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385321|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83385322|NCT00839319|Testosterone|testosterone|mesh-list
83385323|NCT00839319|Acyline|acyline|mesh-list
83385324|NCT00839319|Androgens|androgens|mesh-ancestor
83385325|NCT00839319|Hormones|hormones|mesh-ancestor
83385326|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385327|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385328|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83385329|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
83385331|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83385332|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83385333|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83385334|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385335|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83385336|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83385337|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83385338|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83385339|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
83385340|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385341|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385342|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83385343|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83385344|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
83385345|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83385346|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83385347|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
83385348|NCT02647866|KHK4083|khk4083|mesh-list
83385349|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
83385350|NCT02246127|Everolimus|everolimus|mesh-list
83385351|NCT02246127|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83385352|NCT02246127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83385353|NCT02246127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385354|NCT02246127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385355|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385356|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
83385357|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385358|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385359|NCT04277923|SMOFlipid|smoflipid|mesh-list
83385360|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83385361|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83385362|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83385363|NCT00870363|Efavirenz|efavirenz|mesh-list
83385364|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83385365|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
83385366|NCT00870363|Maraviroc|maraviroc|mesh-list
83385367|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83385368|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385369|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385370|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
83385371|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385372|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83385373|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83385374|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83385375|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83385376|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83385377|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83385378|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83385379|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83385380|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83385381|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83385382|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83385383|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83385384|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83385385|NCT03104634|Bromides|bromides|mesh-list
83385386|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
83385387|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83385388|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
83385389|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385390|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385391|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83385392|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
83385393|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83385394|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83385395|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83385396|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83385397|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385398|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385399|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
83385400|NCT00871689|Aldesleukin|aldesleukin|mesh-list
83385401|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
83385402|NCT00871689|Fludarabine|fludarabine|mesh-list
83385403|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
83385404|NCT00871689|Interleukin-2|interleukin-2|mesh-list
83385405|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385406|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
83385407|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385408|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83385409|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83385410|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
83385411|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385412|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385413|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83385414|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83385415|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
83385416|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
83385417|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385418|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83385419|NCT00871689|Analgesics|analgesics|mesh-ancestor
83385420|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
83385421|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385422|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83385423|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83385424|NCT02084797|Vasopressins|vasopressins|mesh-list
83385425|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
83385426|NCT02084797|Tolvaptan|tolvaptan|mesh-list
83385427|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
83385428|NCT02084797|Coagulants|coagulants|mesh-ancestor
83385429|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83385430|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83385431|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
83385432|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385433|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83385434|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385435|NCT00873327|Tazobactam|tazobactam|mesh-list
83385436|NCT00873327|Piperacillin|piperacillin|mesh-list
83385437|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83385438|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385439|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385440|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83385441|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385442|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385443|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
83385444|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83385445|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385446|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
83385447|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83385448|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385449|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83385450|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385451|NCT00841971|Fluconazole|fluconazole|mesh-list
83385452|NCT00841971|Anidulafungin|anidulafungin|mesh-list
83385453|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
83385454|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385455|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83385456|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83385457|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385458|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385459|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83385460|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
83385461|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385462|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385463|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83385464|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83385465|NCT00842751|Finasteride|finasteride|mesh-list
83385466|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83385467|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83385468|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385469|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385470|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
83385471|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385472|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385473|NCT00842751|Urological Agents|urological agents|mesh-ancestor
83385475|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385476|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385477|NCT03907969|AZD7648|azd7648|mesh-list
83385478|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83385479|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385480|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385481|NCT04399213|Histamine|histamine|mesh-list
83385482|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
83385483|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
83385484|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
83385485|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385486|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385487|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385488|NCT02154243|Midodrine|midodrine|mesh-list
83385489|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
83385490|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
83385491|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385492|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385493|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83385494|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83385495|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83385496|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83385497|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
83385498|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385499|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385500|NCT03995004|Dexamethasone|dexamethasone|mesh-list
83385501|NCT03995004|Melatonin|melatonin|mesh-list
83385502|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
83385503|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83385504|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
83385505|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
83385506|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385507|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385508|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83385509|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
83385510|NCT03995004|Hormones|hormones|mesh-ancestor
83385511|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385512|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83385513|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385514|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
83385515|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385516|NCT03995004|Protective Agents|protective agents|mesh-ancestor
83385517|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83385518|NCT03995004|Cathartics|cathartics|mesh-ancestor
83385519|NCT03216525|Alvimopan|alvimopan|mesh-list
83385520|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83385521|NCT03249181|Dolutegravir|dolutegravir|mesh-list
83385522|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83385523|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83385524|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385525|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385526|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83385527|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83385528|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
83385529|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385530|NCT03216447|Tacrolimus|tacrolimus|mesh-list
83385531|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385532|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
83385533|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385534|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83385535|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385536|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385538|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385539|NCT03957876|Cytarabine|cytarabine|mesh-list
83385540|NCT03957876|Daunorubicin|daunorubicin|mesh-list
83385541|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83385542|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
83385543|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385544|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385545|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
83385546|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385547|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385548|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
83385549|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385550|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83385551|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83385552|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83385553|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385554|NCT03837925|Atorvastatin|atorvastatin|mesh-list
83385555|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83385556|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83385557|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
83385558|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385559|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83385560|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83385561|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385562|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
83385563|NCT04398589|Ropivacaine|ropivacaine|mesh-list
83385564|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83385565|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83385566|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385567|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83385568|NCT04398589|Analgesics|analgesics|mesh-ancestor
83385569|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
83385570|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385571|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83385572|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83385573|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83385574|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
83385575|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385576|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385577|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
83385578|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
83385579|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
83385580|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
83385581|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83385582|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83385583|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385584|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385585|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83385586|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83385587|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385588|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385589|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385590|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
83385591|NCT03882060|Hematinics|hematinics|mesh-ancestor
83385592|NCT01376505|Vaccines|vaccines|mesh-list
83385593|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
83385594|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385595|NCT00875277|Betamethasone|betamethasone|mesh-list
83385596|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
83385597|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83385598|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
83385599|NCT00875277|Calcipotriene|calcipotriene|mesh-list
83385600|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83385601|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83385602|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
83385603|NCT00875277|Hormones|hormones|mesh-ancestor
83385604|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385605|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385606|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83385607|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
83385608|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
83385609|NCT04634539|Paclitaxel|paclitaxel|mesh-list
83385610|NCT04634539|Gemcitabine|gemcitabine|mesh-list
83385611|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83385612|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385613|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
83385614|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
83385615|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
83385616|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385617|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83385618|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
83385619|NCT03750786|Leucovorin|leucovorin|mesh-list
83385620|NCT03750786|Antidotes|antidotes|mesh-ancestor
83385621|NCT03750786|Protective Agents|protective agents|mesh-ancestor
83385622|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385623|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
83385624|NCT03750786|Vitamins|vitamins|mesh-ancestor
83385625|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
83385626|NCT04457245|Fluorides|fluorides|mesh-list
83385627|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
83385628|NCT04457245|Protective Agents|protective agents|mesh-ancestor
83385629|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385630|NCT03828799|Folfirinox|folfirinox|mesh-list
83385631|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385632|NCT01395017|Dasatinib|dasatinib|mesh-list
83385633|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385634|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83385635|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385636|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385637|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
83385638|NCT03299088|Trametinib|trametinib|mesh-list
83385639|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83385640|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385641|NCT03299088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83385642|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385643|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83385644|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385645|NCT03235986|Poractant alfa|poractant alfa|mesh-list
83385646|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83385647|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
83385648|NCT03657342|Cyclosporine|cyclosporine|mesh-list
83385649|NCT03657342|Cyclosporins|cyclosporins|mesh-list
83385650|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385651|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385652|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385653|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
83385654|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385655|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
83385656|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385657|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
83385658|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83385659|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83385660|NCT03600090|Paclitaxel|paclitaxel|mesh-list
83385661|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83385662|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385663|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
83385664|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
83385665|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
83385666|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385667|NCT02912988|Letrozole|letrozole|mesh-list
83385668|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385669|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83385670|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83385671|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385672|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385673|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83385674|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
83385675|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385676|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385677|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83385678|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83385679|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83385680|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83480255|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83385681|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385682|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
83385683|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385684|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385685|NCT00876915|Dalteparin|dalteparin|mesh-list
83385687|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83385688|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
83385689|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83385690|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83385691|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385692|NCT02854488|Ipilimumab|ipilimumab|mesh-list
83385693|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83385694|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385695|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83385696|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385697|NCT02804022|Morphine|morphine|mesh-list
83385698|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83385699|NCT02804022|Narcotics|narcotics|mesh-ancestor
83385700|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83385701|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385702|NCT02804022|Analgesics|analgesics|mesh-ancestor
83385703|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
83385704|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385705|NCT00876993|Bevacizumab|bevacizumab|mesh-list
83385706|NCT00876993|Irinotecan|irinotecan|mesh-list
83385707|NCT00876993|Temozolomide|temozolomide|mesh-list
83385708|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83385709|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385710|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83385711|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83385712|NCT00876993|Growth Substances|growth substances|mesh-ancestor
83385713|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385714|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
83385715|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83385716|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83385717|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385718|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385719|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83385720|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
83385721|NCT00896181|Carboplatin|carboplatin|mesh-list
83385722|NCT00896181|Docetaxel|docetaxel|mesh-list
83385723|NCT00896181|Fluorouracil|fluorouracil|mesh-list
83385724|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385725|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
83385726|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
83385727|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
83385728|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385729|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
83385730|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83385731|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385732|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
83385733|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385734|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83385735|NCT02647320|Firuglipel|firuglipel|mesh-list
83385736|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83385737|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385738|NCT02647320|Incretins|incretins|mesh-ancestor
83385739|NCT02647320|Hormones|hormones|mesh-ancestor
83385740|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385741|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83385742|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
83385743|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385744|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385745|NCT03457896|Trastuzumab|trastuzumab|mesh-list
83385746|NCT03457896|Cetuximab|cetuximab|mesh-list
83385747|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83385748|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385749|NCT04380597|Betamethasone|betamethasone|mesh-list
83385750|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
83385751|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83385752|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
83385753|NCT04380597|Calcipotriene|calcipotriene|mesh-list
83385754|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83385755|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83385756|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
83385757|NCT04380597|Hormones|hormones|mesh-ancestor
83385758|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385759|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385760|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83385761|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
83385762|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
83385764|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
83385765|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83385766|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83385767|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385768|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385769|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
83385770|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
83385771|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83385772|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
83385773|NCT04424862|Cyclosporine|cyclosporine|mesh-list
83385774|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
83385775|NCT04424862|Prednisone|prednisone|mesh-list
83385776|NCT04424862|Cyclosporins|cyclosporins|mesh-list
83385777|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83385778|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
83385779|NCT04424862|Hormones|hormones|mesh-ancestor
83385780|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385781|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385782|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83385783|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385784|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385785|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385786|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385787|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
83385788|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
83385789|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385790|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
83385791|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83385792|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83385793|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83385794|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83385795|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
83385796|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385797|NCT00882687|Lifitegrast|lifitegrast|mesh-list
83385798|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83385799|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83385801|NCT04313166|Trace Elements|trace elements|mesh-ancestor
83385802|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
83385803|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385804|NCT00883233|Adapalene|adapalene|mesh-list
83385805|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83385806|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83385807|NCT00883233|Analgesics|analgesics|mesh-ancestor
83385808|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
83385809|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385810|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385811|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83385812|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83385813|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
83385814|NCT01394939|Irinotecan|irinotecan|mesh-list
83385815|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83385816|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83385817|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385818|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385819|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385820|NCT01394627|Eplerenone|eplerenone|mesh-list
83385821|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83385822|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
83385823|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385824|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385825|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83385826|NCT01394627|Diuretics|diuretics|mesh-ancestor
83385827|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
83385828|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83385829|NCT02288377|Lanreotide|lanreotide|mesh-list
83385830|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385832|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83385833|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83385834|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
83385835|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
83385836|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385837|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385838|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83385839|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83385840|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83385841|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
83385842|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385843|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385844|NCT01391663|Alogliptin|alogliptin|mesh-list
83385845|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83385846|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385847|NCT01391663|Incretins|incretins|mesh-ancestor
83385848|NCT01391663|Hormones|hormones|mesh-ancestor
83385849|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83385850|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83385851|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
83385852|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385853|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385854|NCT03176173|Immunomodulating Agents|immunomodulating agents|mesh-list
83385855|NCT03176173|Immunologic Factors|immunologic factors|mesh-ancestor
83385856|NCT03176173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385857|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
83385858|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
83385859|NCT02220985|Thiotepa|thiotepa|mesh-list
83385860|NCT02220985|Methotrexate|methotrexate|mesh-list
83385861|NCT02220985|Fludarabine|fludarabine|mesh-list
83385862|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
83385863|NCT02220985|Tacrolimus|tacrolimus|mesh-list
83385864|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385865|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
83385866|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385867|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83385868|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83385869|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
83385870|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385871|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385872|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83385873|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83385874|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
83385875|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83385876|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83385877|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
83385878|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
83385879|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385880|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83385881|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83385882|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83385883|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83385884|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83385885|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
83385886|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385887|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385888|NCT05072106|Bosentan|bosentan|mesh-list
83385889|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83385890|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83385891|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385892|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83385893|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
83385894|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385895|NCT03367533|Ketamine|ketamine|mesh-list
83385896|NCT03367533|Analgesics|analgesics|mesh-ancestor
83385897|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
83385898|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385899|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385900|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83385901|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83385902|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
83385903|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
83385904|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83385905|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83385906|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83385907|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385908|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385910|NCT03358875|Tislelizumab|tislelizumab|mesh-list
83385911|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385912|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
83385913|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
83385914|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
83385915|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385916|NCT03358875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83385917|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
83385918|NCT05071482|Flumatinib|flumatinib|mesh-list
83385919|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385920|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83385921|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385922|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385923|NCT03213249|Gentamicins|gentamicins|mesh-list
83385924|NCT03213249|Cefazolin|cefazolin|mesh-list
83385925|NCT03213249|Bacitracin|bacitracin|mesh-list
83385926|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385927|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83385928|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83385929|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385930|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385931|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83385932|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
83385933|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83385934|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83385935|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385936|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83385937|NCT03317067|Analgesics|analgesics|mesh-ancestor
83385938|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
83385939|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385940|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83385941|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83385942|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83385943|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
83385944|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385945|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385946|NCT04440007|Abivertinib|abivertinib|mesh-list
83385947|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385948|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385949|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83385950|NCT00888459|Nicotine|nicotine|mesh-list
83385951|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83385952|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
83385953|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385954|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385955|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83385956|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83385957|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
83385958|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83385959|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385960|NCT05312541|Bupivacaine|bupivacaine|mesh-list
83385961|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
83385962|NCT05312541|Anesthetics|anesthetics|mesh-list
83385963|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83385964|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385965|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
83385966|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83385967|NCT04398823|Polidocanol|polidocanol|mesh-list
83385968|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83385969|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83385970|NCT04410913|Psilocybin|psilocybin|mesh-list
83385971|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
83385972|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385974|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
83385975|NCT02013336|Irinotecan|irinotecan|mesh-list
83385976|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83385977|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
83385978|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385979|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83385980|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83385981|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
83385982|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385983|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83385984|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83385985|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83385986|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83385987|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385988|NCT04397653|Ezetimibe|ezetimibe|mesh-list
83385989|NCT04397653|Evolocumab|evolocumab|mesh-list
83385990|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83385991|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83385992|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
83385993|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385994|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83385995|NCT04397653|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83385996|NCT04397653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83385997|NCT04397653|Protease Inhibitors|protease inhibitors|mesh-ancestor
83385998|NCT04397653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385999|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
83386000|NCT03212781|Dextrans|dextrans|mesh-list
83386001|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
83386002|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
83386003|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
83386004|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
83386005|NCT03212781|Trace Elements|trace elements|mesh-ancestor
83386006|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
83386007|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386008|NCT03212781|Hematinics|hematinics|mesh-ancestor
83386009|NCT03212937|Carboplatin|carboplatin|mesh-list
83386010|NCT03212937|Etoposide|etoposide|mesh-list
83386011|NCT03212937|Ifosfamide|ifosfamide|mesh-list
83386012|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386013|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83386014|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83386015|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83386016|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386017|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386018|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83386019|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
83386020|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
83386021|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83386022|NCT04412538|Vaccines|vaccines|mesh-list
83386023|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
83386024|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386025|NCT04397341|Docetaxel|docetaxel|mesh-list
83386026|NCT04397341|Fluorouracil|fluorouracil|mesh-list
83386027|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386028|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
83386029|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
83386030|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
83386031|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386032|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
83386033|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83386034|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386035|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
83386036|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386037|NCT03940326|Levetiracetam|levetiracetam|mesh-list
83386038|NCT03940326|Valproic Acid|valproic acid|mesh-list
83386039|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
83386040|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
83386041|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386042|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386043|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
83386044|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386045|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386046|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
83386047|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83386048|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386049|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83386050|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
83386051|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
83386052|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83386053|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83386054|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386055|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386056|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386057|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83386058|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83386059|NCT01473524|Cathartics|cathartics|mesh-ancestor
83386060|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83386061|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83386062|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
83386063|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386064|NCT03696355|GDC-0084|gdc-0084|mesh-list
83386065|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386066|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386067|NCT03882996|Atorvastatin|atorvastatin|mesh-list
83386068|NCT03882996|Ezetimibe|ezetimibe|mesh-list
83386069|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83386070|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83386071|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
83386072|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386073|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83386074|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83386075|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386076|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83386077|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83386078|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83386079|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386080|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386081|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83386082|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83386083|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83386084|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83386085|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
83386086|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386087|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386088|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83386089|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83386090|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
83386091|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83386092|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83386093|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
83386094|NCT05070468|Dexamethasone|dexamethasone|mesh-list
83386095|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83386096|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
83386097|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
83386098|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386099|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386100|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83386101|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
83386102|NCT05070468|Hormones|hormones|mesh-ancestor
83386103|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83386104|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83386105|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386106|NCT01390181|Losartan|losartan|mesh-list
83386107|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83386108|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83386109|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83386110|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83386111|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386112|NCT02641080|Aspirin|aspirin|mesh-list
83386113|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83386114|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83386115|NCT02641080|Analgesics|analgesics|mesh-ancestor
83386116|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
83386117|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386118|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386119|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83386120|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83386121|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83386122|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83386123|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386124|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83386125|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83386126|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386127|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
83386128|NCT03101280|Atezolizumab|atezolizumab|mesh-list
83386129|NCT03101280|Rucaparib|rucaparib|mesh-list
83386130|NCT03101280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83386131|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386132|NCT03101280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386133|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386134|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83386135|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386136|NCT03672487|Benzonidazole|benzonidazole|mesh-list
83386137|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386138|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
83386139|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386140|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83386141|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83386142|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83386143|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386144|NCT04015739|Bevacizumab|bevacizumab|mesh-list
83386145|NCT04015739|Durvalumab|durvalumab|mesh-list
83386146|NCT04015739|Olaparib|olaparib|mesh-list
83386147|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386148|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386149|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83386150|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83386151|NCT04015739|Growth Substances|growth substances|mesh-ancestor
83386152|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386153|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
83386154|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83386155|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386156|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386157|NCT03867318|Atorvastatin|atorvastatin|mesh-list
83386158|NCT03867318|Ezetimibe|ezetimibe|mesh-list
83386159|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83386160|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83386161|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
83386162|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386163|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83386164|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83386165|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386166|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83386167|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386168|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83386169|NCT05360615|Empagliflozin|empagliflozin|mesh-list
83386170|NCT05360615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83386171|NCT05360615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386172|NCT05360615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83386173|NCT05360615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386174|NCT04381377|Bromides|bromides|mesh-list
83386175|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
83386176|NCT01457846|Paclitaxel|paclitaxel|mesh-list
83386177|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83386178|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386179|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
83386180|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
83386181|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
83386182|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386183|NCT04032119|Epinephrine|epinephrine|mesh-list
83386184|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83386185|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83386186|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
83386187|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386188|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386189|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386190|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83386191|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83386192|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
83386193|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386194|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83386195|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
83386196|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
83386197|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
83386198|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83386199|NCT03211455|Lidocaine|lidocaine|mesh-list
83386200|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
83386201|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
83386202|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386203|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386204|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
83386205|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386206|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83386207|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83386208|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83386209|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83386210|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386211|NCT04375033|Buprenorphine|buprenorphine|mesh-list
83386212|NCT04375033|Naloxone|naloxone|mesh-list
83386213|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83386214|NCT04375033|Narcotics|narcotics|mesh-ancestor
83386215|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386216|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386217|NCT04375033|Analgesics|analgesics|mesh-ancestor
83386218|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
83386219|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386220|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83386221|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
83386222|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386223|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386224|NCT03172819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83386225|NCT03172819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386226|NCT01389323|Interferons|interferons|mesh-list
83386227|NCT01389323|Ribavirin|ribavirin|mesh-list
83386228|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
83386229|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
83386230|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83386231|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386232|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
83386233|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386234|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
83386235|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386236|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
83386237|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386238|NCT05310591|Nivolumab|nivolumab|mesh-list
83386239|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386240|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386241|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83386242|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386243|NCT05314569|Fentanyl|fentanyl|mesh-list
83386244|NCT05314569|Midazolam|midazolam|mesh-list
83386245|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
83386246|NCT05314569|Ketamine|ketamine|mesh-list
83386247|NCT05314569|Isoflurane|isoflurane|mesh-list
83386248|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83386249|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386250|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386251|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83386252|NCT05314569|Analgesics|analgesics|mesh-ancestor
83386253|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
83386254|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386255|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83386256|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83386257|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83386258|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
83386259|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386260|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386261|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83386262|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83386263|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
83386264|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
83386265|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83386266|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83386267|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83386268|NCT05314569|Narcotics|narcotics|mesh-ancestor
83386269|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83386270|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83386271|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83386272|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83386273|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
83386274|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
83386275|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83386276|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83386277|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
83386278|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83386279|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83386280|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386281|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
83386282|NCT03167905|Fentanyl|fentanyl|mesh-list
83386283|NCT03167905|Meperidine|meperidine|mesh-list
83386284|NCT03167905|Remifentanil|remifentanil|mesh-list
83386285|NCT03167905|Nitrous Oxide|nitrous oxide|mesh-list
83386286|NCT03167905|Ropivacaine|ropivacaine|mesh-list
83386287|NCT03167905|Entonox|entonox|mesh-list
83386288|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
83386290|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386291|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386292|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
83386293|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386294|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83386295|NCT03167905|Narcotics|narcotics|mesh-ancestor
83386296|NCT03167905|Analgesics|analgesics|mesh-ancestor
83386297|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83386298|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83386299|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
83386300|NCT03167905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83386301|NCT03167905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83386302|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83386303|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83386304|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
83386305|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386306|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83386307|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
83386308|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386309|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386310|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83386311|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83386312|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83386313|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
83386314|NCT02638389|Sirolimus|sirolimus|mesh-list
83386315|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83386316|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386317|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83386318|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386319|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
83386320|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386321|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
83386322|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386323|NCT01494584|Ezogabine|ezogabine|mesh-list
83386324|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
83386325|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83386326|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386327|NCT03211143|Esomeprazole|esomeprazole|mesh-list
83386328|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83386329|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83386330|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83386331|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386332|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386333|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83386334|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83386335|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83386336|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
83386337|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386338|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386339|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83386340|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83386341|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
83386342|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386343|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
83386344|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
83386345|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83386346|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83386347|NCT00882895|Prednisolone|prednisolone|mesh-list
83386348|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
83386349|NCT00882895|Tacrolimus|tacrolimus|mesh-list
83386350|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
83386351|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83386352|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83386353|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
83386354|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386355|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
83386356|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386357|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83386358|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386359|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386360|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83386361|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386362|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83386363|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
83386364|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83386365|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386366|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83386367|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
83386368|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
83386369|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386370|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83386371|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
83386372|NCT00882895|Hormones|hormones|mesh-ancestor
83386373|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83386374|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83386375|NCT00882895|Protective Agents|protective agents|mesh-ancestor
83386376|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83386377|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83386378|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
83386379|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
83386380|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83386381|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83386382|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83386383|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386384|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83386385|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83386386|NCT00893997|Vaccines|vaccines|mesh-list
83386387|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
83386388|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386389|NCT00512317|Ganaxolone|ganaxolone|mesh-list
83386390|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
83386391|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386392|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386393|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386394|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
83386395|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
83386396|NCT01494506|Leucovorin|leucovorin|mesh-list
83386397|NCT01494506|Fluorouracil|fluorouracil|mesh-list
83386398|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
83386399|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386400|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83386401|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386402|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386403|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
83386404|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386405|NCT01494506|Antidotes|antidotes|mesh-ancestor
83386406|NCT01494506|Protective Agents|protective agents|mesh-ancestor
83386407|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
83386408|NCT01494506|Vitamins|vitamins|mesh-ancestor
83386409|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
83386410|NCT03024905|Misoprostol|misoprostol|mesh-list
83386411|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83386412|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
83386413|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83386414|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386415|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83386416|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83386417|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
83386418|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
83386419|NCT02643420|Docetaxel|docetaxel|mesh-list
83386420|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386421|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
83386422|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386423|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83386424|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83386425|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
83386426|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386427|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386428|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83386429|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
83386430|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
83386431|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83386432|NCT01830465|Rituximab|rituximab|mesh-list
83386433|NCT01830465|Bortezomib|bortezomib|mesh-list
83386434|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386435|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386436|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
83386437|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386438|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83386439|NCT00894465|Midazolam|midazolam|mesh-list
83386440|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83386441|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83386442|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386443|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386444|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83386445|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83386446|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83386447|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83386448|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
83386449|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
83386450|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
83386451|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
83386452|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386453|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386454|NCT01456130|Alogliptin|alogliptin|mesh-list
83386455|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
83386456|NCT01456130|Secretagogues|secretagogues|mesh-list
83386457|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83386458|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386459|NCT01456130|Incretins|incretins|mesh-ancestor
83386460|NCT01456130|Hormones|hormones|mesh-ancestor
83386461|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83386462|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83386463|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
83386464|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386465|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386466|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83386467|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83386468|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83386469|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83386470|NCT03219645|Aspirin|aspirin|mesh-list
83386471|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83386472|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83386473|NCT03219645|Analgesics|analgesics|mesh-ancestor
83386474|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
83386475|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386476|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386477|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83386478|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83386479|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83386480|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83386481|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386482|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83386483|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83386484|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386485|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
83386486|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
83386487|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83386488|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386489|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83386490|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83386491|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386492|NCT01387607|Pregabalin|pregabalin|mesh-list
83386493|NCT01387607|Analgesics|analgesics|mesh-ancestor
83386494|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
83386495|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386496|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386497|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
83386498|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83386499|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83386500|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386501|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83386502|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83386503|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83386504|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386505|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83386506|NCT05069454|Vaccines|vaccines|mesh-list
83386507|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
83386508|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386509|NCT05069688|Rifampin|rifampin|mesh-list
83386510|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83386511|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
83386512|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83386513|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386514|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
83386515|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83386516|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386517|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386518|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83386519|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83386520|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83386521|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83386522|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83386523|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83386524|NCT01830777|Cytarabine|cytarabine|mesh-list
83386525|NCT01830777|Etoposide|etoposide|mesh-list
83386526|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
83386527|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83386528|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83386529|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386530|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83386531|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83386532|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386533|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386534|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83386535|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
83386536|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
83386537|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386538|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386539|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
83386540|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386541|NCT01830777|Analgesics|analgesics|mesh-ancestor
83386542|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
83386543|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386544|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386545|NCT01830777|Immunotoxins|immunotoxins|mesh-ancestor
83386546|NCT01830777|Immunoconjugates|immunoconjugates|mesh-ancestor
83386547|NCT04479306|Osimertinib|osimertinib|mesh-list
83386548|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386549|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83386550|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386551|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386552|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
83386553|NCT03215277|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83386554|NCT03215277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83386555|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386556|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
83386557|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386558|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83386559|NCT03218631|Oxandrolone|oxandrolone|mesh-list
83386560|NCT03218631|Androgens|androgens|mesh-ancestor
83386561|NCT03218631|Hormones|hormones|mesh-ancestor
83386562|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83386563|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386564|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
83386565|NCT03451045|Dronabinol|dronabinol|mesh-list
83386566|NCT03451045|Lenabasum|lenabasum|mesh-list
83386567|NCT03451045|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83386568|NCT03451045|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83386569|NCT03451045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386570|NCT03451045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386571|NCT03451045|Hormones|hormones|mesh-ancestor
83386572|NCT03451045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83386573|NCT03451045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386574|NCT03451045|Hallucinogens|hallucinogens|mesh-ancestor
83386575|NCT03451045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83386576|NCT03451045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83386577|NCT03451045|Analgesics|analgesics|mesh-ancestor
83386578|NCT03451045|Sensory System Agents|sensory system agents|mesh-ancestor
83386579|NCT03451045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386580|NCT01831011|Aspirin|aspirin|mesh-list
83386581|NCT01831011|Cinepazide|cinepazide|mesh-list
83386582|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
83386583|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83386584|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83386585|NCT01831011|Analgesics|analgesics|mesh-ancestor
83386586|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
83386587|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386588|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386589|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83386590|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83386591|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83386592|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83386593|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386594|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83386595|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83386596|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386597|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
83386598|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
83386599|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83386600|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
83386602|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
83386603|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386604|NCT03218553|Dexamethasone|dexamethasone|mesh-list
83386605|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83386606|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
83386607|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
83386608|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386609|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386610|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83386611|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
83386612|NCT03218553|Hormones|hormones|mesh-ancestor
83386613|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83386614|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83386615|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386616|NCT03430843|Paclitaxel|paclitaxel|mesh-list
83386617|NCT03430843|Docetaxel|docetaxel|mesh-list
83386618|NCT03430843|Irinotecan|irinotecan|mesh-list
83386619|NCT03430843|Tislelizumab|tislelizumab|mesh-list
83386620|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83386621|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386622|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
83386623|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
83386624|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
83386625|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386626|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83386627|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83386628|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386629|NCT03430843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386630|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
83386631|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83386632|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
83386633|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83386634|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83386635|NCT01831323|Rifaximin|rifaximin|mesh-list
83386636|NCT01831323|Mesalamine|mesalamine|mesh-list
83386637|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83386638|NCT01831323|Psyllium|psyllium|mesh-list
83386639|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386640|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83386641|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83386642|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83386643|NCT01831323|Analgesics|analgesics|mesh-ancestor
83386644|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
83386645|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386646|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386647|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83386648|NCT01831323|Cathartics|cathartics|mesh-ancestor
83386649|NCT03221400|Leucovorin|leucovorin|mesh-list
83386650|NCT03221400|Folic Acid|folic acid|mesh-list
83386651|NCT03221400|Fluorouracil|fluorouracil|mesh-list
83386652|NCT03221400|Niraparib|niraparib|mesh-list
83386653|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
83386654|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
83386655|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386656|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83386657|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386658|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386659|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
83386660|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386661|NCT03221400|Antidotes|antidotes|mesh-ancestor
83386662|NCT03221400|Protective Agents|protective agents|mesh-ancestor
83386663|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
83386664|NCT03221400|Vitamins|vitamins|mesh-ancestor
83386665|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
83386666|NCT03221400|Hematinics|hematinics|mesh-ancestor
83386667|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83386668|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386670|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
83386671|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
83386672|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386673|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386674|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
83386675|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386676|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83386677|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83386678|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83386679|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83386680|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386681|NCT00114517|Hormones|hormones|mesh-list
83386682|NCT00114517|Estradiol|estradiol|mesh-list
83386683|NCT00114517|Estrogens|estrogens|mesh-list
83386684|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83386685|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386686|NCT01831479|Olmesartan|olmesartan|mesh-list
83386687|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83386688|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83386689|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83386690|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83386691|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
83386692|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386693|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83386694|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83386695|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386696|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83386697|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83386698|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83386699|NCT03099720|Ropivacaine|ropivacaine|mesh-list
83386700|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
83386701|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
83386702|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386703|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386704|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
83386705|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386706|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
83386707|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83386708|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386709|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386710|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83386711|NCT03025295|Analgesics|analgesics|mesh-ancestor
83386712|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
83386713|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386714|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83386715|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83386716|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83386717|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
83386718|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386719|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386720|NCT01471574|Interferons|interferons|mesh-list
83386721|NCT01471574|Ribavirin|ribavirin|mesh-list
83386722|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
83386723|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
83386724|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83386725|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386726|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
83386727|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386728|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
83386729|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386730|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
83386731|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386732|NCT01383707|Leucovorin|leucovorin|mesh-list
83386733|NCT01383707|Bevacizumab|bevacizumab|mesh-list
83386734|NCT01383707|Fluorouracil|fluorouracil|mesh-list
83386735|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
83386736|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
83386737|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386738|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386739|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83386740|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83386741|NCT01383707|Growth Substances|growth substances|mesh-ancestor
83386742|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386743|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
83386744|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
83386745|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386746|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83386747|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386748|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
83386749|NCT01383707|Antidotes|antidotes|mesh-ancestor
83386750|NCT01383707|Protective Agents|protective agents|mesh-ancestor
83386751|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
83386752|NCT01383707|Vitamins|vitamins|mesh-ancestor
83386753|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
83386754|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
83386755|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83386756|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
83386757|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83386758|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
83386759|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386760|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386761|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
83386762|NCT03306901|Fluorouracil|fluorouracil|mesh-list
83386763|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386764|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
83386765|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386766|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83386767|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386768|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
83386769|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386770|NCT01455428|Pregabalin|pregabalin|mesh-list
83386771|NCT01455428|Analgesics|analgesics|mesh-ancestor
83386772|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
83386773|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386774|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386775|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
83386776|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83386777|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83386778|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386779|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83386780|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83386781|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83386782|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386783|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83386784|NCT01831947|Ranibizumab|ranibizumab|mesh-list
83386785|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83386786|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83386787|NCT01831947|Growth Substances|growth substances|mesh-ancestor
83386788|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386789|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
83386790|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386791|NCT01383161|Curcumin|curcumin|mesh-list
83386792|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83386793|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83386794|NCT01383161|Analgesics|analgesics|mesh-ancestor
83386795|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
83386796|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386797|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386798|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83386799|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83386800|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386801|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386802|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386803|NCT00894699|Sufentanil|sufentanil|mesh-list
83386804|NCT00894699|Triazolam|triazolam|mesh-list
83386805|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83386806|NCT00894699|Narcotics|narcotics|mesh-ancestor
83386807|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386808|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386809|NCT00894699|Analgesics|analgesics|mesh-ancestor
83386810|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
83386811|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386812|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83386813|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83386814|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
83386815|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
83386816|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83386817|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83386818|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83386819|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
83386821|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386822|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386823|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
83386824|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386825|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386826|NCT03087019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83386827|NCT03087019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386828|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83386829|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
83386830|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83386831|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83386832|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
83386833|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386834|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
83386835|NCT01382225|Protective Agents|protective agents|mesh-ancestor
83386836|NCT01381679|Ezetimibe|ezetimibe|mesh-list
83386837|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83386838|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83386839|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
83386840|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386841|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83386842|NCT01832415|Bevacizumab|bevacizumab|mesh-list
83386843|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386844|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386845|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83386846|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83386847|NCT01832415|Growth Substances|growth substances|mesh-ancestor
83386848|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386849|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
83386850|NCT01455194|Ciclesonide|ciclesonide|mesh-list
83386851|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
83386852|NCT01455194|Hormones|hormones|mesh-ancestor
83386853|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83386854|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386855|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83386856|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
83386857|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83386858|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386859|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386860|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83386861|NCT03216759|Analgesics|analgesics|mesh-ancestor
83386862|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
83386863|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386864|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83386865|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83386866|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83386867|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
83386868|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386869|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386870|NCT03799445|Nivolumab|nivolumab|mesh-list
83386871|NCT03799445|Ipilimumab|ipilimumab|mesh-list
83386872|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386873|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386874|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83386875|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386876|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83386877|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83386878|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83386879|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386880|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386881|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
83386882|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386883|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83386884|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83386885|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83386886|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83386887|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386888|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83386889|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
83386890|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386891|NCT04007393|Topiramate|topiramate|mesh-list
83386892|NCT04007393|Phentermine|phentermine|mesh-list
83386893|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
83386894|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83386895|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386896|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83386897|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
83386898|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83386899|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
83386900|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
83386901|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386902|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
83386903|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386904|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386905|NCT05368805|Dabigatran|dabigatran|mesh-list
83386906|NCT05368805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83386907|NCT05368805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83386908|NCT05368805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83386909|NCT05368805|Antimetabolites|antimetabolites|mesh-ancestor
83386910|NCT05368805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386911|NCT05368805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83386912|NCT05368805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83386913|NCT05368805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386914|NCT05368805|Antithrombins|antithrombins|mesh-ancestor
83386915|NCT05368805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83386916|NCT05368805|Protease Inhibitors|protease inhibitors|mesh-ancestor
83386917|NCT05368805|Anticoagulants|anticoagulants|mesh-ancestor
83386918|NCT03304717|Tenofovir|tenofovir|mesh-list
83386919|NCT03304717|Emtricitabine|emtricitabine|mesh-list
83386920|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
83386921|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386922|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83386923|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83386924|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386925|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386926|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83386928|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
83386929|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
83386930|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386931|NCT01839981|Protective Agents|protective agents|mesh-ancestor
83386932|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386933|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
83386934|NCT01839981|Vitamins|vitamins|mesh-ancestor
83386935|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
83386936|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
83386937|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
83386938|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83386939|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
83386940|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386941|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386942|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83386943|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
83386944|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83386945|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83386946|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83386947|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
83386948|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386949|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386950|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83386951|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83386952|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83386953|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
83386954|NCT01494350|Gentamicins|gentamicins|mesh-list
83386955|NCT01494350|Paromomycin|paromomycin|mesh-list
83386956|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83386957|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386958|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83386959|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386960|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386961|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83386962|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83386963|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83386964|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386965|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
83386966|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
83386968|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
83386969|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386970|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
83386971|NCT03258385|Hematinics|hematinics|mesh-ancestor
83386972|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
83386973|NCT03024515|Narcotics|narcotics|mesh-ancestor
83386974|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83386975|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386976|NCT03024515|Analgesics|analgesics|mesh-ancestor
83386977|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
83386978|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83386979|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
83386980|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83386981|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83386982|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83386983|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386984|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
83386985|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83386986|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83386987|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
83386988|NCT04287829|Lenvatinib|lenvatinib|mesh-list
83386989|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83386990|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83386991|NCT04287829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83386992|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83386993|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83386994|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83386995|NCT03083821|Entecavir|entecavir|mesh-list
83386996|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
83386997|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83386998|NCT05367869|Methylene Blue|methylene blue|mesh-list
83386999|NCT05367869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387000|NCT05367869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387001|NCT01720095|Niacin|niacin|mesh-list
83387002|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
83387003|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83387004|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
83387005|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387006|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83387007|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
83387008|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
83387009|NCT01720095|Vitamins|vitamins|mesh-ancestor
83387010|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
83387011|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387012|NCT05366777|Acetaminophen|acetaminophen|mesh-list
83387013|NCT05366777|Ibuprofen|ibuprofen|mesh-list
83387014|NCT05366777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83387015|NCT05366777|Analgesics|analgesics|mesh-ancestor
83387016|NCT05366777|Sensory System Agents|sensory system agents|mesh-ancestor
83387017|NCT05366777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387018|NCT05366777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387019|NCT05366777|Antipyretics|antipyretics|mesh-ancestor
83387020|NCT05366777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83387021|NCT05366777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83387022|NCT05366777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83387023|NCT05366777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83387024|NCT05366777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387025|NCT05366777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387026|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83387027|NCT04021043|Nivolumab|nivolumab|mesh-list
83387028|NCT04021043|Ipilimumab|ipilimumab|mesh-list
83387029|NCT04021043|Antibodies|antibodies|mesh-list
83387030|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
83387031|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83387032|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
83387033|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387034|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387035|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83387036|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387037|NCT03836157|Bevacizumab|bevacizumab|mesh-list
83387038|NCT03836157|Maytansine|maytansine|mesh-list
83387039|NCT03836157|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
83387040|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83387041|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387042|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83387043|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83387044|NCT03836157|Growth Substances|growth substances|mesh-ancestor
83387045|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387046|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
83387047|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83387048|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
83387049|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
83387050|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
83387051|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387052|NCT03836157|Immunoconjugates|immunoconjugates|mesh-ancestor
83387053|NCT03836157|Immunologic Factors|immunologic factors|mesh-ancestor
83387054|NCT03080545|Calcitriol|calcitriol|mesh-list
83387055|NCT03080545|Betamethasone|betamethasone|mesh-list
83387056|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83387057|NCT03080545|Calcipotriene|calcipotriene|mesh-list
83387058|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83387059|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
83387060|NCT03080545|Hormones|hormones|mesh-ancestor
83387061|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83387062|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387063|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83387064|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
83387065|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83387066|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83387067|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83387068|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387069|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83387070|NCT03080545|Vitamins|vitamins|mesh-ancestor
83387071|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
83387072|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83387073|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
83387074|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
83387075|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83387076|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83387077|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387078|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
83387079|NCT03101124|Coagulants|coagulants|mesh-ancestor
83387080|NCT02985203|Vinorelbine|vinorelbine|mesh-list
83387081|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83387082|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387083|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
83387084|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
83387085|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
83387086|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387087|NCT04283617|Insulin|insulin|mesh-list
83387088|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83387089|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387090|NCT05247619|Paclitaxel|paclitaxel|mesh-list
83387091|NCT05247619|Bevacizumab|bevacizumab|mesh-list
83387092|NCT05247619|Carboplatin|carboplatin|mesh-list
83387093|NCT05247619|Tislelizumab|tislelizumab|mesh-list
83387094|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83387095|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387096|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
83387097|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
83387098|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
83387099|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387100|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83387101|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83387102|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83387103|NCT05247619|Growth Substances|growth substances|mesh-ancestor
83387104|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387105|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
83387106|NCT04018937|Fludarabine|fludarabine|mesh-list
83387107|NCT04018937|Melphalan|melphalan|mesh-list
83387108|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
83387109|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387110|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387111|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83387112|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
83387113|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387114|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83387116|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83387117|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83387118|NCT00805584|Desloratadine|desloratadine|mesh-list
83387119|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83387120|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
83387121|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387122|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387123|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387124|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83387125|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83387126|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
83387127|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
83387128|NCT01833351|Vitamins|vitamins|mesh-list
83387129|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
83387130|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
83387131|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387132|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
83387133|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387134|NCT01833351|Protective Agents|protective agents|mesh-ancestor
83387135|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83387136|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83387137|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83387138|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387139|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
83387140|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387141|NCT03049189|Everolimus|everolimus|mesh-list
83387143|NCT03049189|Edotreotide|edotreotide|mesh-list
83387144|NCT03049189|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
83387145|NCT03049189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83387146|NCT03049189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83387147|NCT03049189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387148|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387149|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83387150|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
83387151|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387152|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387153|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83387154|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83387155|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83387156|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83387157|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83387158|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387159|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
83387160|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387161|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387162|NCT00795522|Desloratadine|desloratadine|mesh-list
83387163|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83387164|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
83387165|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387166|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387167|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387168|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83387169|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83387170|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
83387171|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
83387172|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
83387173|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83387174|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83387175|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83387176|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83387177|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387178|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
83387179|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387180|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387181|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83387182|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387183|NCT05243251|Olanzapine|olanzapine|mesh-list
83387184|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
83387185|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
83387186|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387187|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387188|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83387189|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83387190|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83387191|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83387192|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83387193|NCT05243251|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83387194|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83387195|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83387196|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387197|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387198|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
83387199|NCT05242705|Cystatins|cystatins|mesh-list
83387200|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83387201|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
83387202|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387203|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387204|NCT00216671|Risperidone|risperidone|mesh-list
83387205|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83387206|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
83387207|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387208|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387209|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387210|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83387211|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83387212|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83387213|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83387214|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83387215|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
83387216|NCT00783354|Loratadine|loratadine|mesh-list
83387217|NCT00783354|Desloratadine|desloratadine|mesh-list
83387218|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83387219|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
83387220|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387221|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387222|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387223|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83387224|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83387225|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
83387226|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
83387227|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
83387228|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
83387229|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83387230|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
83387231|NCT01833663|Estrogens|estrogens|mesh-list
83387232|NCT01833663|Hormones|hormones|mesh-ancestor
83387233|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83387234|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387235|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83387236|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83387237|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
83387238|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387239|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387240|NCT01833663|Urological Agents|urological agents|mesh-ancestor
83387241|NCT01720875|Dexamethasone|dexamethasone|mesh-list
83387242|NCT01720875|Bortezomib|bortezomib|mesh-list
83387243|NCT01720875|Vorinostat|vorinostat|mesh-list
83387244|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83387245|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
83387246|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
83387247|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387248|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387249|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83387250|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
83387251|NCT01720875|Hormones|hormones|mesh-ancestor
83387252|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83387253|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83387254|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387255|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83387256|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387257|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387258|NCT04277143|Daptomycin|daptomycin|mesh-list
83387259|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83387260|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387261|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
83387262|NCT00750750|Amoxicillin|amoxicillin|mesh-list
83387263|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83387264|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387265|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83387266|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
83387267|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83387268|NCT05066802|Folfirinox|folfirinox|mesh-list
83387269|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387270|NCT04379739|Apatinib|apatinib|mesh-list
83387271|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387272|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83387273|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387274|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387275|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83387276|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83387277|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387278|NCT05248633|Dexamethasone|dexamethasone|mesh-list
83387279|NCT05248633|Lenalidomide|lenalidomide|mesh-list
83387280|NCT05248633|Bortezomib|bortezomib|mesh-list
83387281|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83387282|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
83387283|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
83387284|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387285|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387286|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83387287|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
83387289|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83387290|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83387291|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387292|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
83387293|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83387294|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83387295|NCT05248633|Growth Substances|growth substances|mesh-ancestor
83387296|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
83387297|NCT00216203|Pemetrexed|pemetrexed|mesh-list
83387298|NCT00216203|Cetuximab|cetuximab|mesh-list
83387299|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387300|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387301|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387302|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83387303|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83387304|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83387305|NCT01727271|Interferons|interferons|mesh-list
83387306|NCT01727271|Tenofovir|tenofovir|mesh-list
83387307|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
83387308|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
83387309|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83387310|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387311|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
83387312|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387313|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83387314|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83387315|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387316|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387317|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83387318|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83387319|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
83387320|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387321|NCT00653796|Atorvastatin|atorvastatin|mesh-list
83387322|NCT00653796|Ezetimibe|ezetimibe|mesh-list
83387323|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83387324|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83387325|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
83387326|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387327|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83387328|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83387329|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387330|NCT01833819|Lidocaine|lidocaine|mesh-list
83387331|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
83387332|NCT01833819|Remifentanil|remifentanil|mesh-list
83387333|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
83387334|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
83387335|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83387336|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387337|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
83387339|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83387340|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83387341|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83387342|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83387343|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387344|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83387345|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83387346|NCT01833819|Analgesics|analgesics|mesh-ancestor
83387347|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83387348|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83387349|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83387350|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
83387351|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387352|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83387353|NCT01833819|Narcotics|narcotics|mesh-ancestor
83387354|NCT05244109|Antibodies|antibodies|mesh-list
83387355|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
83387356|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
83387357|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387358|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83387359|NCT00651144|Ezetimibe|ezetimibe|mesh-list
83387360|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83387361|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83387362|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
83387363|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387364|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83387365|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83387366|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387367|NCT01721031|Tramadol|tramadol|mesh-list
83387368|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83387369|NCT01721031|Narcotics|narcotics|mesh-ancestor
83387370|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83387371|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387372|NCT01721031|Analgesics|analgesics|mesh-ancestor
83387373|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
83387374|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387375|NCT03218683|Venetoclax|venetoclax|mesh-list
83387376|NCT03218683|AZD5991|azd5991|mesh-list
83387377|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387378|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
83387379|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
83387380|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387381|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83387382|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83387383|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83387384|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387385|NCT04378647|Immunotoxins|immunotoxins|mesh-ancestor
83387386|NCT04378647|Immunoconjugates|immunoconjugates|mesh-ancestor
83387387|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
83387388|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387389|NCT00370890|Gemcitabine|gemcitabine|mesh-list
83387390|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387391|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83387392|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
83387393|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387394|NCT02669953|Aflibercept|aflibercept|mesh-list
83387395|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83387396|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83387397|NCT02669953|Growth Substances|growth substances|mesh-ancestor
83387398|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387399|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
83387400|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387401|NCT03216967|Everolimus|everolimus|mesh-list
83387402|NCT03216967|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83387403|NCT03216967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83387404|NCT03216967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387405|NCT03216967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387406|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83387407|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
83387408|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387409|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387410|NCT01721655|Spironolactone|spironolactone|mesh-list
83387411|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83387412|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
83387413|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83387414|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387415|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83387417|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
83387418|NCT00904995|Voriconazole|voriconazole|mesh-list
83387419|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
83387420|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387421|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83387422|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83387423|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387424|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387425|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83387426|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
83387427|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83387428|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387429|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83387430|NCT05249725|Irsogladine|irsogladine|mesh-list
83387431|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
83387432|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387433|NCT05249725|Antacids|antacids|mesh-ancestor
83387434|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83387435|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83387436|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387437|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83387438|NCT05249725|Protective Agents|protective agents|mesh-ancestor
83387439|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387440|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83387441|NCT01834209|Prednisone|prednisone|mesh-list
83387442|NCT01834209|Prednisolone|prednisolone|mesh-list
83387443|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
83387444|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83387445|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
83387446|NCT01834209|Hormones|hormones|mesh-ancestor
83387447|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83387448|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387449|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83387450|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387451|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83387452|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387453|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387454|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
83387455|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83387456|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
83387457|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83387458|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387459|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83387460|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83387461|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387462|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387463|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387464|NCT02488135|Hemostatics|hemostatics|mesh-list
83387465|NCT02488135|Coagulants|coagulants|mesh-ancestor
83387466|NCT01727973|Doxycycline|doxycycline|mesh-list
83387467|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83387468|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387469|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
83387470|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83387471|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83387472|NCT03100734|Etanercept|etanercept|mesh-list
83387473|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83387474|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83387475|NCT03100734|Analgesics|analgesics|mesh-ancestor
83387476|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
83387477|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387478|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387479|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83387480|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83387481|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83387482|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83387483|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
83387484|NCT05243706|Loratadine|loratadine|mesh-list
83387485|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
83387486|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
83387487|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83387488|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83387489|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83387490|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
83387491|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
83387492|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387493|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387494|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387495|NCT01728051|Melphalan|melphalan|mesh-list
83387496|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83387497|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
83387498|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387499|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387500|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83387501|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83387502|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
83387503|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387504|NCT01722201|Risperidone|risperidone|mesh-list
83387505|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83387506|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
83387507|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387508|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387509|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387510|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83387511|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83387512|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83387513|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83387514|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83387515|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
83387516|NCT01722513|Alprostadil|alprostadil|mesh-list
83387517|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83387518|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
83387519|NCT01722513|Urological Agents|urological agents|mesh-ancestor
83387520|NCT03179995|Octreotide|octreotide|mesh-list
83387521|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83387522|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83387523|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387524|NCT01728441|Paclitaxel|paclitaxel|mesh-list
83387525|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83387526|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83387527|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387528|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
83387529|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
83387530|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
83387531|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387532|NCT03099408|Metronidazole|metronidazole|mesh-list
83387533|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387534|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83387535|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83387536|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83387537|NCT04984200|Mydriatics|mydriatics|mesh-list
83387538|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
83387539|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387540|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387541|NCT00912873|Ropivacaine|ropivacaine|mesh-list
83387542|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
83387543|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
83387544|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83387545|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387546|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
83387547|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387548|NCT01494038|Isoniazid|isoniazid|mesh-list
83387549|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
83387550|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83387551|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387552|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83387553|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83387554|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
83387555|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387556|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83387557|NCT05059782|Coal Tar|coal tar|mesh-list
83387558|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
83387559|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
83387560|NCT05242081|Sufentanil|sufentanil|mesh-list
83387561|NCT05242081|Ketamine|ketamine|mesh-list
83387562|NCT05242081|Esketamine|esketamine|mesh-list
83387563|NCT05242081|Analgesics|analgesics|mesh-ancestor
83387564|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
83387565|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387566|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387567|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83387568|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83387569|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
83387570|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
83387571|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83387572|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83387573|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83387574|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387575|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387576|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83387577|NCT05242081|Narcotics|narcotics|mesh-ancestor
83387578|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83387579|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
83387580|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83387581|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
83387582|NCT03149029|Trametinib|trametinib|mesh-list
83387583|NCT03149029|Dabrafenib|dabrafenib|mesh-list
83387584|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83387585|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387586|NCT03149029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83387587|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387588|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83387589|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387590|NCT04412304|Dalteparin|dalteparin|mesh-list
83387591|NCT04412304|Tinzaparin|tinzaparin|mesh-list
83387592|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83387593|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
83387594|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83387595|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83387596|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387597|NCT00915603|Paclitaxel|paclitaxel|mesh-list
83387598|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83387599|NCT00915603|Bevacizumab|bevacizumab|mesh-list
83387600|NCT00915603|Everolimus|everolimus|mesh-list
83387601|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83387602|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387603|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
83387604|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
83387605|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
83387606|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387607|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83387608|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83387609|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83387610|NCT00915603|Growth Substances|growth substances|mesh-ancestor
83387611|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387612|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
83387613|NCT00915603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83387614|NCT00915603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83387615|NCT00915603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387616|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83387617|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
83387618|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83387619|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83387620|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
83387621|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387622|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387623|NCT01929421|Gemcitabine|gemcitabine|mesh-list
83387624|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83387625|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
83387626|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387627|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387628|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
83387629|NCT04474002|Cathartics|cathartics|mesh-ancestor
83387630|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83387631|NCT01929577|Peficitinib|peficitinib|mesh-list
83387632|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387633|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387634|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83387635|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
83387636|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387637|NCT03142321|Vedolizumab|vedolizumab|mesh-list
83387638|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83387639|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83387640|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387641|NCT03836703|Iron|iron|mesh-list
83387642|NCT03836703|Trace Elements|trace elements|mesh-ancestor
83387643|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
83387644|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387645|NCT02398825|Ponatinib|ponatinib|mesh-list
83387646|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387647|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83387648|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387649|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387650|NCT01723059|Amoxicillin|amoxicillin|mesh-list
83387651|NCT01723059|Metronidazole|metronidazole|mesh-list
83387652|NCT01723059|Clarithromycin|clarithromycin|mesh-list
83387653|NCT01723059|Omeprazole|omeprazole|mesh-list
83387654|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83387655|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387656|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83387657|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83387658|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83387659|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83387660|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83387661|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387662|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387663|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83387664|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83387665|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83387666|NCT04379271|Calcium|calcium|mesh-list
83387667|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83387668|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387669|NCT01728909|Oxytocin|oxytocin|mesh-list
83387670|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
83387671|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83387672|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387673|NCT01922713|Vitamin A|vitamin a|mesh-list
83387674|NCT01922713|Beta Carotene|beta carotene|mesh-list
83387675|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
83387676|NCT01922713|Vitamins|vitamins|mesh-ancestor
83387677|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
83387678|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387679|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
83387680|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387681|NCT01922713|Protective Agents|protective agents|mesh-ancestor
83387682|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83387683|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387684|NCT01922713|Provitamins|provitamins|mesh-ancestor
83387685|NCT05061732|Amoxicillin|amoxicillin|mesh-list
83387686|NCT05061732|Metronidazole|metronidazole|mesh-list
83387687|NCT05061732|Clarithromycin|clarithromycin|mesh-list
83387688|NCT05061732|Doxycycline|doxycycline|mesh-list
83387689|NCT05061732|Levofloxacin|levofloxacin|mesh-list
83387690|NCT05061732|Tetracycline|tetracycline|mesh-list
83387691|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
83387692|NCT05061732|Rabeprazole|rabeprazole|mesh-list
83387693|NCT05061732|Bismuth|bismuth|mesh-list
83387694|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387695|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83387696|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387697|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83387698|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83387699|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83387700|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387701|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83387702|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83387703|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
83387704|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83387705|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83387706|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83387707|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387708|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83387709|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83387710|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83387711|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83387712|NCT05061732|Antacids|antacids|mesh-ancestor
83387713|NCT05061732|Diuretics|diuretics|mesh-ancestor
83387714|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
83387715|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387716|NCT05061732|Expectorants|expectorants|mesh-ancestor
83387717|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
83387718|NCT02391571|Naltrexone|naltrexone|mesh-list
83387719|NCT02391571|Oxycodone|oxycodone|mesh-list
83387720|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83387721|NCT02391571|Narcotics|narcotics|mesh-ancestor
83387722|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83387723|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387724|NCT02391571|Analgesics|analgesics|mesh-ancestor
83387725|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
83387726|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387727|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83387728|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83387729|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
83387730|NCT01728987|Vitamin D|vitamin d|mesh-list
83387731|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83387732|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387733|NCT01728987|Vitamins|vitamins|mesh-ancestor
83387734|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
83387735|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83387736|NCT01834989|Mitogens|mitogens|mesh-list
83387737|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
83387738|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387739|NCT01835067|Ranibizumab|ranibizumab|mesh-list
83387740|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83387741|NCT01835067|Plasminogen|plasminogen|mesh-list
83387742|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83387743|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83387744|NCT01835067|Growth Substances|growth substances|mesh-ancestor
83387745|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387746|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
83387747|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387748|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83387749|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83387750|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387751|NCT03100422|Armin|armin|mesh-list
83387752|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83387753|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387754|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387755|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
83387756|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387757|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387758|NCT00639769|Cisplatin|cisplatin|mesh-list
83387759|NCT00639769|Irinotecan|irinotecan|mesh-list
83387760|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387761|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83387762|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83387763|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387764|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387765|NCT01723371|Carvedilol|carvedilol|mesh-list
83387766|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83387767|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83387768|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
83387769|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387770|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387771|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387772|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83387773|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
83387774|NCT01723371|Protective Agents|protective agents|mesh-ancestor
83387775|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83387776|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83387777|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83387778|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
83387779|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83387780|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83387781|NCT00639457|Pioglitazone|pioglitazone|mesh-list
83387782|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83387783|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387784|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
83387785|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83387786|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83387787|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83387788|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387789|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
83387790|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387791|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387792|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83387793|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387794|NCT01723527|Buprenorphine|buprenorphine|mesh-list
83387795|NCT01723527|Methadone|methadone|mesh-list
83387796|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83387797|NCT01723527|Narcotics|narcotics|mesh-ancestor
83387798|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83387799|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387800|NCT01723527|Analgesics|analgesics|mesh-ancestor
83387801|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
83387802|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387803|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83387804|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
83387806|NCT00639223|Pravastatin|pravastatin|mesh-list
83387807|NCT00639223|Red yeast rice|red yeast rice|mesh-list
83387808|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83387809|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83387810|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
83387811|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387812|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83387813|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83387814|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387815|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83387816|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
83387817|NCT03519984|Cytarabine|cytarabine|mesh-list
83387818|NCT03519984|Vincristine|vincristine|mesh-list
83387819|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83387820|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
83387821|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387822|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387823|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
83387824|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387825|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83387826|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
83387827|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387828|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83387829|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
83387830|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
83387831|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
83387832|NCT05056896|Aspirin|aspirin|mesh-list
83387833|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
83387834|NCT05056896|Salicylates|salicylates|mesh-list
83387835|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83387836|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83387837|NCT05056896|Analgesics|analgesics|mesh-ancestor
83387838|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
83387839|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387840|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387841|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83387842|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83387843|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83387844|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83387845|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387846|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83387847|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83387848|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387849|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
83387850|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387851|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
83387852|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
83387853|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
83387854|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83387855|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
83387856|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387857|NCT01835691|Vitamin D|vitamin d|mesh-list
83387858|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
83387859|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
83387860|NCT01835691|Vitamins|vitamins|mesh-list
83387861|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
83387862|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387863|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83387864|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83387865|NCT01729767|Acyclovir|acyclovir|mesh-list
83387866|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
83387868|NCT00913263|Flutamide|flutamide|mesh-list
83387869|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
83387870|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
83387871|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
83387872|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83387873|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387874|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83387875|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387877|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83387878|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387879|NCT04377867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83387880|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387881|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83387882|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
83387883|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387884|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83387885|NCT00637273|Pioglitazone|pioglitazone|mesh-list
83387886|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83387887|NCT00637273|Exenatide|exenatide|mesh-list
83387888|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83387889|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387890|NCT00637273|Incretins|incretins|mesh-ancestor
83387891|NCT00637273|Hormones|hormones|mesh-ancestor
83387892|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83387893|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83387894|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
83387895|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387896|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387897|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83387898|NCT01923259|Donepezil|donepezil|mesh-list
83387899|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83387900|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387901|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387902|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
83387903|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387904|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387905|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
83387906|NCT01923337|Irinotecan|irinotecan|mesh-list
83387907|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83387908|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83387909|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387910|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387911|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387912|NCT03098160|Ipilimumab|ipilimumab|mesh-list
83387913|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83387914|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387915|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83387916|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387917|NCT01720563|Leucovorin|leucovorin|mesh-list
83387918|NCT01720563|Tegafur|tegafur|mesh-list
83387919|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387920|NCT01720563|Antidotes|antidotes|mesh-ancestor
83387921|NCT01720563|Protective Agents|protective agents|mesh-ancestor
83387922|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387923|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
83387924|NCT01720563|Vitamins|vitamins|mesh-ancestor
83387925|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
83387926|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83387927|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
83387928|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387929|NCT01724385|Bevacizumab|bevacizumab|mesh-list
83387930|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83387931|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83387932|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83387933|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83387934|NCT01724385|Growth Substances|growth substances|mesh-ancestor
83387935|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387936|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
83387937|NCT04377789|Quercetin|quercetin|mesh-list
83387938|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
83387939|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387940|NCT04377789|Protective Agents|protective agents|mesh-ancestor
83387941|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387943|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83387944|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83387945|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387946|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
83387947|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387948|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387949|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83387950|NCT00988117|Protective Agents|protective agents|mesh-ancestor
83387951|NCT01728753|Favipiravir|favipiravir|mesh-list
83387952|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
83387953|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387954|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
83387955|NCT01724619|Androgens|androgens|mesh-ancestor
83387956|NCT01724619|Hormones|hormones|mesh-ancestor
83387957|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83387958|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387959|NCT05045508|Varenicline|varenicline|mesh-list
83387960|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83387961|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83387962|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
83387963|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387964|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387965|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387966|NCT00637195|Vaccines|vaccines|mesh-list
83387967|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
83387968|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387969|NCT05045274|Aspirin|aspirin|mesh-list
83387970|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
83387971|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
83387972|NCT05045274|Giapreza|giapreza|mesh-list
83387973|NCT05045274|Clopidogrel|clopidogrel|mesh-list
83387974|NCT05045274|Ticagrelor|ticagrelor|mesh-list
83387975|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83387976|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83387977|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
83387978|NCT05045274|Diuretics|diuretics|mesh-list
83387979|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83387980|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83387981|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83387982|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
83387983|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83387984|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83387985|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83387986|NCT05045274|Analgesics|analgesics|mesh-ancestor
83387987|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
83387988|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387989|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83387990|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83387991|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83387992|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83387993|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83387994|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83387995|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83387996|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83387997|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
83387998|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83387999|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83388000|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83388001|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
83388002|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388003|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83388004|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83388005|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83388006|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83388007|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
83388008|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83388009|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
83388010|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83388011|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
83388012|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83388013|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83388014|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
83388015|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
83388016|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388017|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83388018|NCT05045274|Hormones|hormones|mesh-ancestor
83388019|NCT01721733|Ubiquinone|ubiquinone|mesh-list
83388020|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
83388021|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388022|NCT01720485|Prednisolone|prednisolone|mesh-list
83388023|NCT01720485|Betamethasone|betamethasone|mesh-list
83388024|NCT01720485|Desloratadine|desloratadine|mesh-list
83388025|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
83388026|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388027|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
83388028|NCT01720485|Hormones|hormones|mesh-ancestor
83388029|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388030|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388031|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83388032|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388033|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83388034|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
83388035|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83388036|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
83388037|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388038|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388039|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83388040|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83388041|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
83388042|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
83388043|NCT01726725|Desflurane|desflurane|mesh-list
83388044|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83388045|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
83388046|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
83388047|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388048|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388049|NCT05044728|Paclitaxel|paclitaxel|mesh-list
83388050|NCT05044728|Carboplatin|carboplatin|mesh-list
83388051|NCT05044728|Antibodies|antibodies|mesh-list
83388052|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83388053|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388054|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
83388055|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
83388056|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
83388057|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388058|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
83388059|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388060|NCT05054478|Daratumumab|daratumumab|mesh-list
83388061|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388062|NCT01041807|Losartan|losartan|mesh-list
83388063|NCT01041807|Amlodipine|amlodipine|mesh-list
83388064|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83388065|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83388066|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83388067|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388068|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83388069|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388071|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83388072|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83388073|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83388074|NCT01724931|Aminopterin|aminopterin|mesh-list
83388075|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83388076|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388077|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388078|NCT00635089|Reslizumab|reslizumab|mesh-list
83388079|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83388080|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
83388081|NCT01725009|Levetiracetam|levetiracetam|mesh-list
83388082|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
83388083|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
83388084|NCT01725087|Tapentadol|tapentadol|mesh-list
83388085|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83388086|NCT01725087|Narcotics|narcotics|mesh-ancestor
83388087|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388088|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388089|NCT01725087|Analgesics|analgesics|mesh-ancestor
83388090|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
83388091|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388092|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83388093|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83388094|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83388095|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388096|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
83388097|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388098|NCT04151082|Prednisone|prednisone|mesh-list
83388099|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
83388100|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83388101|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83388102|NCT04151082|Prednisolone|prednisolone|mesh-list
83388103|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
83388104|NCT04151082|Cortisone|cortisone|mesh-list
83388105|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83388106|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
83388107|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388108|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
83388109|NCT04151082|Hormones|hormones|mesh-ancestor
83388110|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388111|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388112|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83388113|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388114|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
83388115|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
83388116|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388117|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83388118|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83388119|NCT04151082|Protective Agents|protective agents|mesh-ancestor
83388120|NCT00634543|Acetaminophen|acetaminophen|mesh-list
83388121|NCT00634543|Gabapentin|gabapentin|mesh-list
83388122|NCT00634543|Tramadol|tramadol|mesh-list
83388123|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83388124|NCT00634543|Analgesics|analgesics|mesh-ancestor
83388125|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
83388126|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388127|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388128|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
83388129|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
83388130|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83388131|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83388132|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388133|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83388134|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83388135|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83388136|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388137|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388138|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
83388139|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83388140|NCT00634543|Narcotics|narcotics|mesh-ancestor
83388141|NCT05054322|Fluticasone|fluticasone|mesh-list
83388142|NCT05054322|Xhance|xhance|mesh-list
83388143|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388144|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83388145|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
83388146|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388147|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388148|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83388149|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
83388150|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
83388151|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83388152|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83388153|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
83388154|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388155|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
83388156|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83388157|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
83388158|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388159|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388160|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83388161|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
83388162|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
83388163|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83388164|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
83388165|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388166|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388167|NCT04759729|Vitamin D|vitamin d|mesh-list
83388168|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
83388169|NCT04759729|Cholecalciferol|cholecalciferol|mesh-list
83388170|NCT04759729|Vitamins|vitamins|mesh-list
83388171|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
83388172|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388173|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83388174|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83388175|NCT05053386|Epirubicin|epirubicin|mesh-list
83388176|NCT05053386|Idarubicin|idarubicin|mesh-list
83388177|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83388178|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388179|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83388180|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83388181|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388182|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388183|NCT01725243|Carbetocin|carbetocin|mesh-list
83388184|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
83388185|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83388186|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388187|NCT01725477|Methylene Blue|methylene blue|mesh-list
83388188|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388189|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388190|NCT03096990|Apremilast|apremilast|mesh-list
83388191|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83388192|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83388193|NCT03096990|Analgesics|analgesics|mesh-ancestor
83388194|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
83388195|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388196|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388197|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388198|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388199|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83388200|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83388201|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388202|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388203|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
83388204|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83388205|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388206|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
83388207|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
83388208|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
83388209|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
83388210|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
83388211|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388212|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
83388213|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83388214|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83388215|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
83388216|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388217|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83388218|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83388219|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388220|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388221|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
83388222|NCT03836781|Ketorolac|ketorolac|mesh-list
83388223|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83388224|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388225|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
83388226|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83388227|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83388228|NCT03836781|Analgesics|analgesics|mesh-ancestor
83388229|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
83388230|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388231|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388232|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388233|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388234|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83388235|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388236|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388237|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83388238|NCT01360866|Fluoxetine|fluoxetine|mesh-list
83388239|NCT01360866|Paroxetine|paroxetine|mesh-list
83388240|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83388241|NCT01360866|Sertraline|sertraline|mesh-list
83388242|NCT01360866|Escitalopram|escitalopram|mesh-list
83388243|NCT01360866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83388244|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83388245|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83388246|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388247|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388248|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
83388249|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388250|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388251|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83388252|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
83388253|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83388254|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83388255|NCT01360866|Analgesics|analgesics|mesh-ancestor
83388256|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
83388257|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
83388258|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83388259|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83388260|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388261|NCT00984061|Clarithromycin|clarithromycin|mesh-list
83388262|NCT00984061|Colchicine|colchicine|mesh-list
83388263|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83388264|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388265|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83388266|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388267|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388268|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83388269|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83388270|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
83388271|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388272|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
83388273|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
83388274|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
83388275|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388276|NCT01046643|Estradiol|estradiol|mesh-list
83388277|NCT01046643|Progesterone|progesterone|mesh-list
83388278|NCT01046643|Estrogens|estrogens|mesh-ancestor
83388279|NCT01046643|Hormones|hormones|mesh-ancestor
83388280|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388281|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388282|NCT01046643|Progestins|progestins|mesh-ancestor
83388283|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
83388284|NCT03096756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83388285|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
83388286|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388287|NCT03096756|Protective Agents|protective agents|mesh-ancestor
83388288|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388289|NCT00983905|Colchicine|colchicine|mesh-list
83388290|NCT00983905|Theophylline|theophylline|mesh-list
83388291|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
83388292|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388293|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
83388294|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
83388295|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
83388296|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388297|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388298|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83388299|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
83388300|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388301|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388302|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83388303|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
83388304|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83388305|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388306|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
83388307|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83388308|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83388309|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
83388310|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388311|NCT01046565|Adapalene|adapalene|mesh-list
83388312|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83388313|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83388314|NCT01046565|Analgesics|analgesics|mesh-ancestor
83388315|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
83388316|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388318|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388319|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388320|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
83388321|NCT01046253|Lansoprazole|lansoprazole|mesh-list
83388322|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
83388323|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83388324|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83388325|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83388326|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388327|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388328|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83388329|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83388330|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83388331|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83388332|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388333|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388334|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388335|NCT05050656|Analgesics|analgesics|mesh-ancestor
83388336|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
83388337|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388338|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
83388339|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83388340|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
83388342|NCT00983515|Colchicine|colchicine|mesh-list
83388343|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83388344|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83388345|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
83388346|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388347|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388348|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83388349|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83388350|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
83388351|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388352|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83388353|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83388354|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
83388355|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388356|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
83388357|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
83388358|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
83388359|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388360|NCT05033574|Hormones|hormones|mesh-list
83388361|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388362|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388363|NCT04471818|Ketamine|ketamine|mesh-list
83388364|NCT04471818|Analgesics|analgesics|mesh-ancestor
83388365|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
83388366|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388367|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388368|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83388369|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83388370|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
83388371|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
83388372|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388373|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83388374|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83388375|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388376|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388377|NCT05050188|Lansoprazole|lansoprazole|mesh-list
83388378|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
83388379|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83388380|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83388381|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83388382|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388383|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388384|NCT04434378|Tamsulosin|tamsulosin|mesh-list
83388385|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83388386|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83388387|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83388388|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
83388389|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388390|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388391|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388392|NCT04434378|Urological Agents|urological agents|mesh-ancestor
83388393|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
83388394|NCT00981799|Methotrexate|methotrexate|mesh-list
83388396|NCT00981799|Lenograstim|lenograstim|mesh-list
83388397|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83388398|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
83388399|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388400|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388401|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83388402|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
83388403|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388404|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388405|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83388406|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83388407|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
83388408|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83388409|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83388410|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
83388411|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
83388412|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388413|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83388414|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83388415|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83388416|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83388417|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83388418|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83388419|NCT05033106|Bevacizumab|bevacizumab|mesh-list
83388420|NCT05033106|Ranibizumab|ranibizumab|mesh-list
83388421|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83388422|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388423|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83388424|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83388425|NCT05033106|Growth Substances|growth substances|mesh-ancestor
83388426|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388427|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
83388428|NCT03095040|Everolimus|everolimus|mesh-list
83388429|NCT03095040|Vorolanib|vorolanib|mesh-list
83388430|NCT03095040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83388431|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83388432|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388433|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388434|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83388435|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
83388436|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388437|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388438|NCT03099499|TIC10 compound|tic10 compound|mesh-list
83388439|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388440|NCT03096522|Phenytoin|phenytoin|mesh-list
83388441|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
83388442|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83388443|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83388444|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83388445|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388446|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83388447|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83388448|NCT01045161|Bromides|bromides|mesh-list
83388449|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
83388450|NCT05032248|Tacrolimus|tacrolimus|mesh-list
83388451|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83388452|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
83388453|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388454|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83388455|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388456|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388457|NCT00633217|Fluticasone|fluticasone|mesh-list
83388458|NCT00633217|Xhance|xhance|mesh-list
83388459|NCT00633217|Norflurane|norflurane|mesh-list
83388460|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83388461|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83388462|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388463|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83388464|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
83388465|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388466|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388467|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83388468|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
83388469|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
83388470|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83388471|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83388472|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83388473|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83388474|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
83388475|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388476|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388477|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
83388478|NCT00633217|Hormones|hormones|mesh-ancestor
83388479|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388480|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
83388481|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
83388482|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388483|NCT01673490|Tamsulosin|tamsulosin|mesh-list
83388484|NCT01673490|Dutasteride|dutasteride|mesh-list
83388485|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83388486|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83388487|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83388488|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
83388489|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388490|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388491|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388492|NCT01673490|Urological Agents|urological agents|mesh-ancestor
83388493|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83388494|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83388495|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388496|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
83388497|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388498|NCT00633061|Enoxaparin|enoxaparin|mesh-list
83388499|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
83388500|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83388501|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83388502|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388503|NCT00632827|Leucovorin|leucovorin|mesh-list
83388504|NCT00632827|Cytarabine|cytarabine|mesh-list
83388505|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
83388506|NCT00632827|Carmustine|carmustine|mesh-list
83388507|NCT00632827|Gemcitabine|gemcitabine|mesh-list
83388508|NCT00632827|Doxorubicin|doxorubicin|mesh-list
83388509|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83388510|NCT00632827|Methotrexate|methotrexate|mesh-list
83388511|NCT00632827|Etoposide|etoposide|mesh-list
83388512|NCT00632827|Vincristine|vincristine|mesh-list
83388513|NCT00632827|Vinorelbine|vinorelbine|mesh-list
83388514|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
83388515|NCT00632827|Lenograstim|lenograstim|mesh-list
83388516|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83388517|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
83388518|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388519|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388520|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83388522|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388523|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388524|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83388525|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83388526|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
83388527|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83388528|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83388529|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83388530|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388531|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83388532|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
83388533|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83388534|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
83388535|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83388536|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83388537|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83388538|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
83388539|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388540|NCT00632827|Antidotes|antidotes|mesh-ancestor
83388541|NCT00632827|Protective Agents|protective agents|mesh-ancestor
83388542|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
83388543|NCT00632827|Vitamins|vitamins|mesh-ancestor
83388544|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
83388545|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
83388546|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
83388547|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
83388548|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83388549|NCT00214019|Fluticasone|fluticasone|mesh-list
83388550|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83388551|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83388552|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388553|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83388554|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
83388555|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388556|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388557|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83388558|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
83388559|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
83388560|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83388561|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83388562|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83388563|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83388564|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
83388565|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388566|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388567|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
83388568|NCT00214019|Hormones|hormones|mesh-ancestor
83388569|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388570|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
83388571|NCT03097848|Sorafenib|sorafenib|mesh-list
83388572|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388573|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83388574|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388575|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388576|NCT05047848|Fulvestrant|fulvestrant|mesh-list
83388577|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83388578|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388579|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83388580|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83388581|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
83388582|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388583|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388584|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
83388585|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388586|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83388587|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388588|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388589|NCT01044459|Bromides|bromides|mesh-list
83388590|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
83388591|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83388592|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
83388593|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
83388594|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388595|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388596|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83388597|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83388598|NCT01837329|Growth Substances|growth substances|mesh-ancestor
83388599|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388600|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
83388601|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388602|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
83388603|NCT03993353|Tadalafil|tadalafil|mesh-list
83388604|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83388605|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388606|NCT03993353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83388607|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388608|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
83388609|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83388610|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83388611|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388612|NCT03993353|Urological Agents|urological agents|mesh-ancestor
83388613|NCT05040906|Rituximab|rituximab|mesh-list
83388614|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83388615|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388616|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
83388617|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388618|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388619|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
83388620|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83388621|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388622|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83388623|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
83388624|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83388625|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388626|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388627|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388628|NCT05040828|Montelukast|montelukast|mesh-list
83388629|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83388630|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
83388631|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83388632|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
83388633|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388634|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388635|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83388636|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83388637|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388638|NCT00983437|Modafinil|modafinil|mesh-list
83388639|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83388640|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388641|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83388642|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83388643|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83388644|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388645|NCT05031234|Morphine|morphine|mesh-list
83388646|NCT05031234|Anesthetics|anesthetics|mesh-list
83388647|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388648|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388649|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83388650|NCT05031234|Narcotics|narcotics|mesh-ancestor
83388651|NCT05031234|Analgesics|analgesics|mesh-ancestor
83388652|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
83388653|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388654|NCT03599609|Simvastatin|simvastatin|mesh-list
83388655|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83388656|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83388657|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
83388658|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388659|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83388660|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83388661|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388662|NCT05040594|Lidocaine|lidocaine|mesh-list
83388663|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
83388664|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
83388665|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388666|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388667|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
83388668|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388669|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83388670|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83388671|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83388672|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83388673|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388674|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
83388675|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83388676|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388677|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83388678|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388679|NCT03598673|Nebivolol|nebivolol|mesh-list
83388680|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83388681|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
83388682|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83388683|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83388684|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83388685|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
83388686|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388687|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388688|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388689|NCT05039580|Dexamethasone|dexamethasone|mesh-list
83388690|NCT05039580|Antibodies|antibodies|mesh-list
83388691|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83388692|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
83388693|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388694|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388695|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
83388696|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
83388697|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388698|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83388699|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
83388700|NCT05039580|Hormones|hormones|mesh-ancestor
83388701|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388702|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83388703|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388704|NCT05025228|Acetaminophen|acetaminophen|mesh-list
83388705|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83388706|NCT05025228|Analgesics|analgesics|mesh-ancestor
83388707|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
83388708|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388709|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388710|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
83388711|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
83388712|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388713|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
83388714|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388715|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388716|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83388717|NCT05024604|Progesterone|progesterone|mesh-list
83388718|NCT05024604|Progestins|progestins|mesh-ancestor
83388719|NCT05024604|Hormones|hormones|mesh-ancestor
83388720|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388721|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388722|NCT03597893|Oxytocin|oxytocin|mesh-list
83388723|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
83388724|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83388725|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388726|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83388727|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
83388728|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388729|NCT05024448|Prednisone|prednisone|mesh-list
83388730|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388731|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
83388732|NCT05024448|Hormones|hormones|mesh-ancestor
83388733|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388734|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388735|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83388736|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388737|NCT03596957|Tolvaptan|tolvaptan|mesh-list
83388738|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83388739|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388740|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
83388741|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388742|NCT03408015|Lifitegrast|lifitegrast|mesh-list
83388743|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83388744|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83388745|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
83388746|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83388747|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
83388748|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83388749|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83388750|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388751|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83388752|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388753|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83388754|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388755|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83388756|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388757|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388758|NCT03596099|Acetic Acid|acetic acid|mesh-list
83388759|NCT03596099|Retinol acetate|retinol acetate|mesh-list
83388761|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388762|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83388763|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
83388764|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388765|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83388766|NCT03596099|Protective Agents|protective agents|mesh-ancestor
83388767|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388768|NCT01041417|Molgramostim|molgramostim|mesh-list
83388769|NCT01041417|Sargramostim|sargramostim|mesh-list
83388770|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
83388771|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388772|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388773|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
83388774|NCT03595397|Fentanyl|fentanyl|mesh-list
83388775|NCT03595397|Bupivacaine|bupivacaine|mesh-list
83388776|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
83388777|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
83388778|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388779|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388780|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
83388781|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388782|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83388783|NCT03595397|Narcotics|narcotics|mesh-ancestor
83388784|NCT03595397|Analgesics|analgesics|mesh-ancestor
83388785|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83388786|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83388787|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
83388788|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83388789|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
83388790|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83388791|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83480256|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388792|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388793|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83388794|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
83388795|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83388796|NCT03595319|Sevoflurane|sevoflurane|mesh-list
83388797|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83388798|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83388799|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
83388800|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
83388801|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388802|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388803|NCT01040871|Prednisone|prednisone|mesh-list
83388804|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
83388805|NCT01040871|Rituximab|rituximab|mesh-list
83388806|NCT01040871|Doxorubicin|doxorubicin|mesh-list
83388807|NCT01040871|Vincristine|vincristine|mesh-list
83388808|NCT01040871|Bortezomib|bortezomib|mesh-list
83388809|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83388810|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
83388811|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388812|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388813|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83388814|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
83388815|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388816|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388817|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83388818|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83388819|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83388820|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83388821|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83388822|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388823|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388824|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
83388825|NCT01040871|Hormones|hormones|mesh-ancestor
83388826|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388827|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83388828|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83388829|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
83388830|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
83388831|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
83388832|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
83388833|NCT01040169|Calcium|calcium|mesh-list
83388834|NCT01040169|Fluorides|fluorides|mesh-list
83388835|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83388837|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
83388838|NCT01040169|Protective Agents|protective agents|mesh-ancestor
83388839|NCT01040169|Antacids|antacids|mesh-ancestor
83388840|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388841|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83388842|NCT01044381|Luliconazole|luliconazole|mesh-list
83388843|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
83388844|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388845|NCT03594461|Aflibercept|aflibercept|mesh-list
83388846|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83388847|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83388848|NCT03594461|Growth Substances|growth substances|mesh-ancestor
83388849|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388850|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
83388851|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388852|NCT03407703|Grazoprevir|grazoprevir|mesh-list
83388853|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83388854|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
83388855|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388856|NCT03594149|Levofloxacin|levofloxacin|mesh-list
83388857|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83388858|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388859|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83388860|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83388861|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83388862|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388863|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388864|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388865|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83388866|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83388867|NCT00916539|Calpastatin|calpastatin|mesh-list
83388868|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83388869|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
83388870|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388871|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388872|NCT03593447|Ribavirin|ribavirin|mesh-list
83388873|NCT03593447|Yimitasvir|yimitasvir|mesh-list
83388874|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
83388875|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388876|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
83388877|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388878|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83388879|NCT03593291|Dalteparin|dalteparin|mesh-list
83388880|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
83388881|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83388882|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83388883|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388884|NCT03593135|Metformin|metformin|mesh-list
83388885|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83388886|NCT03593135|Acetic Acid|acetic acid|mesh-list
83388887|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83388888|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388889|NCT03593135|Incretins|incretins|mesh-ancestor
83388890|NCT03593135|Hormones|hormones|mesh-ancestor
83388891|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83388892|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83388893|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
83388894|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388895|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388896|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83388897|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388898|NCT03592901|Anesthetics|anesthetics|mesh-list
83388899|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388900|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388901|NCT03830385|Carboplatin|carboplatin|mesh-list
83388902|NCT03830385|Bleomycin|bleomycin|mesh-list
83388903|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83388904|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83388905|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
83388906|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
83388907|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83388908|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83388909|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388910|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83388911|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388912|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388913|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
83388914|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83388915|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388916|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83388917|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388918|NCT03406689|Nepafenac|nepafenac|mesh-list
83388919|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
83388920|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83388921|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83388922|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83388923|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83388924|NCT03406689|Analgesics|analgesics|mesh-ancestor
83388925|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
83388926|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388927|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388928|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388929|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83388930|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83388931|NCT03591575|Deferiprone|deferiprone|mesh-list
83388933|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
83388934|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
83388935|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388936|NCT03406533|Fentanyl|fentanyl|mesh-list
83388937|NCT03406533|Midazolam|midazolam|mesh-list
83388938|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
83388939|NCT03406533|Remifentanil|remifentanil|mesh-list
83388940|NCT03406533|Propofol|propofol|mesh-list
83388941|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83388942|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388943|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388944|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83388945|NCT03406533|Analgesics|analgesics|mesh-ancestor
83388946|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
83388947|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83388948|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83388949|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83388950|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83388951|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
83388952|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83388953|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388954|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83388955|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
83388956|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
83388957|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83388958|NCT03406533|Narcotics|narcotics|mesh-ancestor
83388959|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83388960|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83388961|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83388962|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83388963|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
83388964|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
83388965|NCT03591341|Melatonin|melatonin|mesh-list
83388966|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
83388967|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388968|NCT03591341|Protective Agents|protective agents|mesh-ancestor
83388969|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388970|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83388971|NCT04377399|Vitamin D|vitamin d|mesh-list
83388972|NCT04377399|Vitamins|vitamins|mesh-ancestor
83388973|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
83388974|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388975|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83388976|NCT03400995|Ziresovir|ziresovir|mesh-list
83388977|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
83388978|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83388979|NCT03590873|Vasopressins|vasopressins|mesh-list
83388980|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
83388981|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388982|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
83388983|NCT03590873|Coagulants|coagulants|mesh-ancestor
83388984|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83388985|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83388986|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
83388987|NCT02155335|Golimumab|golimumab|mesh-list
83388988|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83388989|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83388990|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83388991|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83388992|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
83388993|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83388994|NCT05024526|Edaravone|edaravone|mesh-list
83388995|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83388996|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
83388997|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388998|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83388999|NCT05024526|Protective Agents|protective agents|mesh-ancestor
83389000|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389001|NCT03597035|Spironolactone|spironolactone|mesh-list
83389002|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83389003|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
83389004|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389005|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389006|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83389007|NCT03597035|Diuretics|diuretics|mesh-ancestor
83389008|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
83389009|NCT03400683|Letrozole|letrozole|mesh-list
83389010|NCT03400683|Misoprostol|misoprostol|mesh-list
83389011|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389012|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83389013|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83389014|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389015|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389016|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83389017|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
83389018|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389019|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389020|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83389021|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
83389022|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83389023|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83389024|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83389025|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
83389026|NCT05037240|Quercetin|quercetin|mesh-list
83389027|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
83389028|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389029|NCT05037240|Protective Agents|protective agents|mesh-ancestor
83389030|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389031|NCT05037006|Anesthetics|anesthetics|mesh-list
83389032|NCT05037006|Sevoflurane|sevoflurane|mesh-list
83389033|NCT05037006|Neostigmine|neostigmine|mesh-list
83389034|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389035|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389036|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83389037|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83389038|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
83389039|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83389040|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389041|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389042|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
83389043|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389044|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83389045|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
83389046|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389047|NCT03093090|Furosemide|furosemide|mesh-list
83389048|NCT03093090|Diuretics|diuretics|mesh-ancestor
83389049|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
83389050|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389051|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83389052|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83389053|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389054|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
83389055|NCT03093168|Fludarabine|fludarabine|mesh-list
83389056|NCT03093168|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
83389057|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83389058|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
83389059|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389060|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389061|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83389062|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
83389063|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389064|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389065|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83389066|NCT03093168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83389068|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
83389069|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389070|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
83389071|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
83389072|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
83389073|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389074|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389075|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
83389076|NCT05018364|Hematinics|hematinics|mesh-ancestor
83389077|NCT03593213|Cariprazine|cariprazine|mesh-list
83389078|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83389079|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83389080|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389081|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389082|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83389083|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83389084|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83389085|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
83389086|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389087|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389088|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389089|NCT03595163|Folic Acid|folic acid|mesh-list
83389090|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
83389091|NCT03595163|Propofol|propofol|mesh-list
83389092|NCT03595163|Sevoflurane|sevoflurane|mesh-list
83389093|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83389094|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389095|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389096|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83389097|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
83389098|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
83389099|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83389100|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83389101|NCT03595163|Hematinics|hematinics|mesh-ancestor
83389102|NCT03595163|Vitamins|vitamins|mesh-ancestor
83389103|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
83389104|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83389105|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83389106|NCT04199819|Entecavir|entecavir|mesh-list
83389107|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
83389108|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389109|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
83389110|NCT00918723|Rituximab|rituximab|mesh-list
83389111|NCT00918723|Fludarabine|fludarabine|mesh-list
83389112|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
83389113|NCT00918723|Vorinostat|vorinostat|mesh-list
83389114|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83389115|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
83389116|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389117|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389118|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83389119|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
83389120|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389121|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389122|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83389123|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83389124|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83389125|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
83389126|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83389127|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389128|NCT04192331|Paclitaxel|paclitaxel|mesh-list
83389129|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83389130|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83389131|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389132|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
83389133|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
83389134|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
83389135|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389136|NCT00919035|Temsirolimus|temsirolimus|mesh-list
83389137|NCT00919035|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83389138|NCT00919035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83389139|NCT00919035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389140|NCT00919035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389141|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83389142|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
83389143|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389144|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389145|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
83389146|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83389147|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
83389148|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83389149|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
83389150|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389151|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389152|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
83389153|NCT04374981|Celecoxib|celecoxib|mesh-list
83389154|NCT04374981|Montelukast|montelukast|mesh-list
83389155|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83389156|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83389157|NCT04374981|Analgesics|analgesics|mesh-ancestor
83389158|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
83389159|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389160|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389161|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83389162|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389163|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83389164|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83389165|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389166|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389167|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83389168|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
83389169|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83389170|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
83389171|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389172|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83389173|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83389174|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83389175|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
83389176|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83389177|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
83389178|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389179|NCT03090516|Donepezil|donepezil|mesh-list
83389180|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83389181|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389182|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389183|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
83389184|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389185|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389186|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
83389187|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83389188|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83389189|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389190|NCT03092310|Pancrelipase|pancrelipase|mesh-list
83389191|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83389192|NCT03405207|Vitamin D|vitamin d|mesh-list
83389193|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
83389194|NCT03405207|Vitamins|vitamins|mesh-ancestor
83389195|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
83389196|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389197|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83389198|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83389199|NCT04197323|Alprostadil|alprostadil|mesh-list
83389200|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83389201|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
83389202|NCT04197323|Urological Agents|urological agents|mesh-ancestor
83389203|NCT04196855|Teriparatide|teriparatide|mesh-list
83389204|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83389205|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389206|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83389207|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
83389208|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83389209|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83389210|NCT04196309|Heparin|heparin|mesh-list
83389211|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83389212|NCT04196309|Tinzaparin|tinzaparin|mesh-list
83389213|NCT04196309|Dalteparin|dalteparin|mesh-list
83389214|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
83389215|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83389216|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83389217|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389218|NCT03090048|Vitamin A|vitamin a|mesh-list
83389219|NCT03090048|Azithromycin|azithromycin|mesh-list
83389220|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
83389221|NCT03090048|Vitamins|vitamins|mesh-ancestor
83389222|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
83389223|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389224|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83389225|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389226|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
83389227|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389228|NCT03090048|Protective Agents|protective agents|mesh-ancestor
83389229|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83389230|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389231|NCT04195997|Heparin|heparin|mesh-list
83389232|NCT04195997|Bivalirudin|bivalirudin|mesh-list
83389233|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
83389234|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83389235|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83389236|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389237|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
83389238|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83389239|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
83389240|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389241|NCT05023122|Vitamin D|vitamin d|mesh-list
83389242|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
83389243|NCT05023122|Calcium|calcium|mesh-list
83389244|NCT05023122|Vitamins|vitamins|mesh-ancestor
83389245|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
83389246|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389247|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83389248|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83389249|NCT04195373|Flucytosine|flucytosine|mesh-list
83389250|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
83389251|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389252|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
83389253|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389254|NCT04194827|Adalimumab|adalimumab|mesh-list
83389255|NCT04194827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83389256|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83389257|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389258|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83389259|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83389260|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
83389261|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83389262|NCT04194905|Estradiol|estradiol|mesh-list
83389263|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83389264|NCT04194905|Estrogens|estrogens|mesh-ancestor
83389265|NCT04194905|Hormones|hormones|mesh-ancestor
83389266|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389267|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389268|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83389269|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
83389270|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83389271|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83389272|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83389273|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83389274|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83389275|NCT05017428|Niacinamide|niacinamide|mesh-list
83389276|NCT05017428|Niacin|niacin|mesh-list
83389277|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
83389278|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
83389279|NCT05017428|Vitamins|vitamins|mesh-ancestor
83389280|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
83389281|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389282|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83389283|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
83389284|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389285|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83389286|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
83389287|NCT04196231|Insulin|insulin|mesh-list
83389288|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83389289|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83389290|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389291|NCT00013611|Aldesleukin|aldesleukin|mesh-list
83389292|NCT00013611|Interleukin-2|interleukin-2|mesh-list
83389293|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389294|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83389295|NCT00013611|Analgesics|analgesics|mesh-ancestor
83389296|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
83389297|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389298|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389299|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83389300|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83389301|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
83389302|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389303|NCT04194515|Metformin|metformin|mesh-list
83389304|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83389305|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389306|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83389307|NCT03094182|Hematinics|hematinics|mesh-ancestor
83389309|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
83389310|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389311|NCT05022030|Cetuximab|cetuximab|mesh-list
83389312|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83389313|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389314|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
83389315|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83389316|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83389317|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389318|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
83389319|NCT04192643|Coagulants|coagulants|mesh-ancestor
83389320|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
83389321|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83389322|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389323|NCT03753659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83389324|NCT03753659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389325|NCT00010257|Paclitaxel|paclitaxel|mesh-list
83389326|NCT00010257|Carboplatin|carboplatin|mesh-list
83389327|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83389328|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389329|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
83389330|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
83389331|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
83389332|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389333|NCT05022186|Cannabidiol|cannabidiol|mesh-list
83389334|NCT05022186|Tramiprosate|tramiprosate|mesh-list
83389335|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
83389336|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
83389337|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
83389338|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389339|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389340|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389341|NCT02240043|Hormones|hormones|mesh-list
83389342|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389343|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389344|NCT03404037|Endostatins|endostatins|mesh-list
83389345|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389346|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83389347|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83389348|NCT03404037|Growth Substances|growth substances|mesh-ancestor
83389349|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389350|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
83389351|NCT02240199|Lidocaine|lidocaine|mesh-list
83389352|NCT02240199|Pregabalin|pregabalin|mesh-list
83389353|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
83389354|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
83389355|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389356|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389357|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
83389358|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389359|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83389360|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83389361|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83389362|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83389363|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389364|NCT02240199|Analgesics|analgesics|mesh-ancestor
83389365|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
83389366|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83389367|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83389368|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83389369|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83389371|NCT04190927|Estradiol|estradiol|mesh-list
83389372|NCT04190927|Progesterone|progesterone|mesh-list
83389373|NCT04190927|Estrogens|estrogens|mesh-ancestor
83389374|NCT04190927|Hormones|hormones|mesh-ancestor
83389375|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389376|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389377|NCT04190927|Progestins|progestins|mesh-ancestor
83389378|NCT00919191|Adapalene|adapalene|mesh-list
83389379|NCT00919191|Tretinoin|tretinoin|mesh-list
83389380|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83389381|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
83389382|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83389383|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83389384|NCT00919191|Analgesics|analgesics|mesh-ancestor
83389385|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
83389386|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389387|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389388|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83389389|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389390|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389391|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
83389392|NCT03962465|Cytarabine|cytarabine|mesh-list
83389393|NCT03962465|Prednisone|prednisone|mesh-list
83389394|NCT03962465|Methotrexate|methotrexate|mesh-list
83389395|NCT03962465|Vincristine|vincristine|mesh-list
83389396|NCT03962465|Daunorubicin|daunorubicin|mesh-list
83389397|NCT03962465|Pegaspargase|pegaspargase|mesh-list
83389398|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83389399|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83389400|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
83389401|NCT03962465|Hormones|hormones|mesh-ancestor
83389402|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389403|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389404|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83389405|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389406|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83389407|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
83389408|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83389409|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83389410|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
83389411|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389412|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
83389413|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389414|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83389415|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83389416|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
83389417|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389418|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83389419|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
83389420|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389421|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83389422|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
83389423|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
83389424|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
83389425|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83389426|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83389427|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83389428|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83389429|NCT03962465|Immunotoxins|immunotoxins|mesh-ancestor
83389430|NCT03962465|Immunoconjugates|immunoconjugates|mesh-ancestor
83389431|NCT05021406|Carvedilol|carvedilol|mesh-list
83389432|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83389433|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83389434|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
83389435|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389436|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389437|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389438|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83389439|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
83389440|NCT05021406|Protective Agents|protective agents|mesh-ancestor
83389441|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83389442|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83389443|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83389444|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
83389445|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83389446|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83389447|NCT04766177|Bumetanide|bumetanide|mesh-list
83389448|NCT04766177|Diuretics|diuretics|mesh-ancestor
83389449|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
83389450|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389451|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83389452|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83389453|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389454|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
83389455|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
83389456|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83389457|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83389458|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389459|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389460|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389461|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389462|NCT05016180|Ropivacaine|ropivacaine|mesh-list
83389463|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
83389464|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
83389465|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389466|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389467|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
83389468|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389469|NCT03023501|Gabapentin|gabapentin|mesh-list
83389470|NCT03023501|Analgesics|analgesics|mesh-ancestor
83389471|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
83389472|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389473|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389474|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
83389475|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83389476|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83389477|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389478|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83389479|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83389480|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83389481|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389482|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389483|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
83389484|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
83389485|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83389486|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83389487|NCT05015322|Prednisolone|prednisolone|mesh-list
83389488|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
83389489|NCT05015322|Bupivacaine|bupivacaine|mesh-list
83389490|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83389491|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
83389492|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
83389493|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
83389494|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389495|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389496|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
83389497|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389498|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83389499|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
83389500|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
83389501|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83389502|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
83389503|NCT05015322|Hormones|hormones|mesh-ancestor
83389504|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389505|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83389506|NCT05015322|Protective Agents|protective agents|mesh-ancestor
83389507|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83389508|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389509|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
83389510|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389511|NCT00919503|Cyclosporine|cyclosporine|mesh-list
83389512|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
83389513|NCT00919503|Methotrexate|methotrexate|mesh-list
83389514|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
83389516|NCT00919503|Treosulfan|treosulfan|mesh-list
83389517|NCT00919503|Busulfan|busulfan|mesh-list
83389518|NCT00919503|Tacrolimus|tacrolimus|mesh-list
83389519|NCT00919503|Cyclosporins|cyclosporins|mesh-list
83389520|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
83389521|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83389522|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83389523|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
83389524|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83389525|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389526|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83389527|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
83389528|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389529|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389530|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
83389531|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389532|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83389533|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83389534|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
83389535|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389536|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83389537|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83389538|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
83389539|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389540|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83389541|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83389542|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
83389543|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83389544|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83389545|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
83389546|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83389547|NCT05020704|Empagliflozin|empagliflozin|mesh-list
83389548|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83389549|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389550|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83389551|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389552|NCT02979665|Ranibizumab|ranibizumab|mesh-list
83389553|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83389554|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83389555|NCT02979665|Growth Substances|growth substances|mesh-ancestor
83389556|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389557|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
83389558|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389559|NCT03092076|Ticagrelor|ticagrelor|mesh-list
83389560|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83389561|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83389562|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83389563|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83389564|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
83389565|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389566|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389567|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389568|NCT04193501|Melatonin|melatonin|mesh-list
83389569|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
83389570|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389571|NCT04193501|Protective Agents|protective agents|mesh-ancestor
83389572|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389573|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389574|NCT04374279|Bicalutamide|bicalutamide|mesh-list
83389575|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
83389576|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
83389577|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389578|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389579|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389580|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
83389581|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83389582|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389583|NCT03957551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83389584|NCT03957551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389585|NCT02240433|Sorafenib|sorafenib|mesh-list
83389586|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389587|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83389588|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389589|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389590|NCT03403647|Vitamin D|vitamin d|mesh-list
83389591|NCT03403647|Vitamins|vitamins|mesh-ancestor
83389592|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
83389593|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389594|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83389595|NCT05014464|Crizotinib|crizotinib|mesh-list
83389596|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389597|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83389598|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389599|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389600|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
83389601|NCT03403101|Irinotecan|irinotecan|mesh-list
83389602|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389603|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83389604|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83389605|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389606|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389607|NCT00211757|Valproic Acid|valproic acid|mesh-list
83389608|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
83389609|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389610|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389611|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
83389612|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389613|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389614|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
83389615|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83389616|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389617|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83389618|NCT04373967|Metformin|metformin|mesh-list
83389619|NCT04373967|Liraglutide|liraglutide|mesh-list
83389620|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83389621|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389622|NCT04373967|Incretins|incretins|mesh-ancestor
83389623|NCT04373967|Hormones|hormones|mesh-ancestor
83389624|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389625|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
83389626|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83389627|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
83389628|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389629|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
83389630|NCT04026191|Protective Agents|protective agents|mesh-ancestor
83389631|NCT04022057|Ropivacaine|ropivacaine|mesh-list
83389632|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
83389633|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
83389634|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389635|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389636|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
83389637|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389638|NCT00921843|Methadone|methadone|mesh-list
83389639|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83389640|NCT00921843|Narcotics|narcotics|mesh-ancestor
83389641|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389642|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389643|NCT00921843|Analgesics|analgesics|mesh-ancestor
83389644|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
83389645|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389646|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
83389647|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
83389648|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
83389649|NCT04020653|Lumefantrine|lumefantrine|mesh-list
83389650|NCT04020653|Artemether|artemether|mesh-list
83389651|NCT04020653|Artemisinins|artemisinins|mesh-list
83389652|NCT04020653|Artemisinin|artemisinin|mesh-list
83389653|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83389654|NCT04020653|Citric Acid|citric acid|mesh-list
83389655|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
83389656|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
83389657|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83389658|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
83389659|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
83389660|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389661|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
83389662|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83389663|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83389664|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389665|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83389666|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
83389667|NCT04020653|Trace Elements|trace elements|mesh-ancestor
83389668|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
83389669|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389670|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
83389671|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
83389672|NCT05008458|Coagulants|coagulants|mesh-ancestor
83420976|NCT05700006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83420977|NCT05700006|Hormone Antagonists|hormone antagonists|mesh-ancestor
83420978|NCT05700006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83420979|NCT05700006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420981|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83420982|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
83420983|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83420984|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
83420985|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83420986|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420987|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83420988|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83420989|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420990|NCT00116857|Sertraline|sertraline|mesh-list
83420991|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
83420992|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83420993|NCT00116857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83420994|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83420995|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83420996|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420997|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420998|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
83420999|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421000|NCT05547828|Tislelizumab|tislelizumab|mesh-list
83421001|NCT05547828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421002|NCT05547828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421003|NCT01672983|Ritonavir|ritonavir|mesh-list
83421004|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83421005|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83421006|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
83421007|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421008|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421009|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83421010|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83421011|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
83421012|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421013|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83421014|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83421015|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
83421016|NCT00117715|Caffeine|caffeine|mesh-list
83421017|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83421018|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421019|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83421020|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421021|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421022|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83421023|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83421024|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
83421025|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421026|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
83421027|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
83421028|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83421029|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83421030|NCT00228943|Tryptophan|tryptophan|mesh-list
83421031|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83421032|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
83421033|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83421035|NCT01879085|Docetaxel|docetaxel|mesh-list
83421036|NCT01879085|Vorinostat|vorinostat|mesh-list
83421037|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83421038|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
83421039|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421040|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421041|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
83421042|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
83421043|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
83421044|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83421045|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421046|NCT01439204|Abatacept|abatacept|mesh-list
83421047|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83421048|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421049|NCT01439204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421050|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421051|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421052|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
83421053|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421054|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421055|NCT00063635|Vitamin E|vitamin e|mesh-list
83421056|NCT00063635|Metformin|metformin|mesh-list
83421057|NCT00063635|Vitamins|vitamins|mesh-ancestor
83421058|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
83421059|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421060|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83421061|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
83421062|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421063|NCT00063635|Protective Agents|protective agents|mesh-ancestor
83421064|NCT01439126|Clonidine|clonidine|mesh-list
83421065|NCT01439126|Analgesics|analgesics|mesh-ancestor
83421066|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
83421067|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421068|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421069|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83421070|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
83421071|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
83421072|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83421073|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83421074|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83421075|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
83421076|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421077|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421078|NCT00066677|Docetaxel|docetaxel|mesh-list
83421079|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421080|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
83421081|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
83421082|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
83421083|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421084|NCT01615731|Digoxin|digoxin|mesh-list
83421085|NCT01615731|Misoprostol|misoprostol|mesh-list
83421086|NCT01615731|Mifepristone|mifepristone|mesh-list
83421087|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83421088|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
83421089|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83421090|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421091|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83421092|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83421093|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
83421094|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83421095|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83421096|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421097|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421098|NCT01615731|Protective Agents|protective agents|mesh-ancestor
83421099|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83421100|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83421101|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83421102|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83421103|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
83421104|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83421105|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83421106|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
83421107|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421108|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
83421109|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83421110|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83421111|NCT02334800|Palbociclib|palbociclib|mesh-list
83421112|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421113|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83421114|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421115|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421116|NCT01665144|Siponimod|siponimod|mesh-list
83421117|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83421118|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421119|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421120|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
83421121|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421122|NCT01675635|Morphine|morphine|mesh-list
83421123|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83421124|NCT01675635|Narcotics|narcotics|mesh-ancestor
83421125|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83421126|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421127|NCT01675635|Analgesics|analgesics|mesh-ancestor
83421128|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
83421129|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421130|NCT01615809|Amphotericin B|amphotericin b|mesh-list
83421131|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83421132|NCT01615809|Amebicides|amebicides|mesh-ancestor
83421133|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83421134|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83421135|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421136|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83421137|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
83421138|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
83421139|NCT01676415|Prednisone|prednisone|mesh-list
83421140|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
83421141|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83421142|NCT01676415|Hormones|hormones|mesh-ancestor
83421143|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421144|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421145|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83421146|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421147|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
83421148|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83421149|NCT05547516|Gemcitabine|gemcitabine|mesh-list
83421150|NCT05547516|Epirubicin|epirubicin|mesh-list
83421151|NCT05547516|Mitomycins|mitomycins|mesh-list
83421152|NCT05547516|Mitomycin|mitomycin|mesh-list
83421153|NCT05547516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83421154|NCT05547516|Antimetabolites|antimetabolites|mesh-ancestor
83421155|NCT05547516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421156|NCT05547516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421157|NCT05547516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83421158|NCT05547516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83421159|NCT05547516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83421160|NCT05547516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421161|NCT05547516|Alkylating Agents|alkylating agents|mesh-ancestor
83421162|NCT05547516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83421163|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83421164|NCT01678443|Antibodies|antibodies|mesh-list
83421165|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
83421166|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83421167|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
83421168|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421169|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421170|NCT01707225|Octreotide|octreotide|mesh-list
83421171|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83421172|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83421173|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421174|NCT01707381|Timolol|timolol|mesh-list
83421175|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421176|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83421177|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83421178|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
83421179|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421180|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421181|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83421182|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83421183|NCT05552586|Melatonin|melatonin|mesh-list
83421184|NCT05552586|Antioxidants|antioxidants|mesh-ancestor
83421185|NCT05552586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421186|NCT05552586|Protective Agents|protective agents|mesh-ancestor
83421187|NCT05552586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421188|NCT05552586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83421189|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83421190|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421191|NCT00072449|Rituximab|rituximab|mesh-list
83421192|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421193|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421194|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
83421195|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421196|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421197|NCT04756661|Misoprostol|misoprostol|mesh-list
83421198|NCT04756661|Oxytocin|oxytocin|mesh-list
83421199|NCT04756661|Carbetocin|carbetocin|mesh-list
83421200|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
83421201|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83421202|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421203|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83421204|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
83421205|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83421206|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83421207|NCT01708629|Ustekinumab|ustekinumab|mesh-list
83421208|NCT01708629|Brodalumab|brodalumab|mesh-list
83421209|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83421210|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
83421211|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
83421212|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421213|NCT00073073|Vitamin D|vitamin d|mesh-list
83421214|NCT00073073|Exemestane|exemestane|mesh-list
83421215|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
83421216|NCT00073073|Calcium|calcium|mesh-list
83421217|NCT00073073|Vitamins|vitamins|mesh-ancestor
83421218|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
83421219|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421220|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83421221|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83421222|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421223|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83421224|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83421225|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421226|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421227|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83421228|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
83421229|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421230|NCT00073073|Antacids|antacids|mesh-ancestor
83421231|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83421232|NCT00074165|Cytarabine|cytarabine|mesh-list
83421233|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
83421234|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
83421235|NCT00074165|Rituximab|rituximab|mesh-list
83421236|NCT00074165|Carboplatin|carboplatin|mesh-list
83421237|NCT00074165|Etoposide|etoposide|mesh-list
83421238|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
83421239|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421240|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
83421241|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421242|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421243|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83421244|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
83421245|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421246|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421247|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83421248|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421249|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83421250|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83421251|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83421252|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421253|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83421254|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
83421255|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
83421256|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421257|NCT00074165|Antidotes|antidotes|mesh-ancestor
83421258|NCT00074165|Protective Agents|protective agents|mesh-ancestor
83421259|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
83421260|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
83421261|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83421262|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
83421263|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
83421264|NCT01466660|Gefitinib|gefitinib|mesh-list
83421265|NCT01466660|Afatinib|afatinib|mesh-list
83421266|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421267|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83421268|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421269|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421270|NCT00075335|Plerixafor|plerixafor|mesh-list
83421271|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83421272|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83421273|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
83421274|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421275|NCT01680549|Gabapentin|gabapentin|mesh-list
83421276|NCT01680549|Analgesics|analgesics|mesh-ancestor
83421277|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
83421278|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421279|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421281|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83421282|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83421283|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83421284|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83421285|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83421286|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83421287|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421288|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421289|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
83421290|NCT01466348|Acetaminophen|acetaminophen|mesh-list
83421291|NCT01466348|Caffeine|caffeine|mesh-list
83421292|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83421293|NCT01466348|Analgesics|analgesics|mesh-ancestor
83421294|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
83421295|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421296|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421297|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
83421298|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83421299|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83421300|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421301|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421302|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83421303|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83421304|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
83421305|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421306|NCT01466270|Donepezil|donepezil|mesh-list
83421307|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83421308|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421309|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421310|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
83421311|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421312|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421313|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
83421314|NCT02235987|Octreotide|octreotide|mesh-list
83421315|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83421316|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83421317|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421318|NCT01466192|Ribavirin|ribavirin|mesh-list
83421319|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83421320|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
83421321|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421322|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
83421323|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421324|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
83421325|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83421326|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83421327|NCT00120523|Analgesics|analgesics|mesh-ancestor
83421328|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
83421329|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421330|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421331|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83421332|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421333|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
83421334|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421335|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
83421336|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83421337|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421338|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421339|NCT01438814|Metformin|metformin|mesh-list
83421340|NCT01438814|Linagliptin|linagliptin|mesh-list
83421341|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83421342|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421343|NCT01438814|Incretins|incretins|mesh-ancestor
83421344|NCT01438814|Hormones|hormones|mesh-ancestor
83421345|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421346|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83421347|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
83421348|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421349|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421350|NCT04425876|Fluzoparib|fluzoparib|mesh-list
83421351|NCT04425876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83421352|NCT04425876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421353|NCT04425876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421354|NCT04425876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421356|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83421357|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
83421358|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83421359|NCT00121225|Vorinostat|vorinostat|mesh-list
83421360|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421361|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83421362|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421363|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421364|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
83421365|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83421366|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421367|NCT05545800|Insulin|insulin|mesh-list
83421368|NCT05545800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83421369|NCT05545800|Metformin|metformin|mesh-list
83421370|NCT05545800|Insulin Glargine|insulin glargine|mesh-list
83421371|NCT05545800|Empagliflozin|empagliflozin|mesh-list
83421372|NCT05545800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83421373|NCT05545800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421374|NCT05545800|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83421375|NCT05545800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421376|NCT00230737|Melatonin|melatonin|mesh-list
83421377|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
83421378|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421379|NCT00230737|Protective Agents|protective agents|mesh-ancestor
83421380|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421381|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83421382|NCT04425564|Capecitabine|capecitabine|mesh-list
83421383|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
83421384|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83421385|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
83421386|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421387|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421388|NCT01686165|Rituximab|rituximab|mesh-list
83421389|NCT01686165|Belinostat|belinostat|mesh-list
83421390|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83421391|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421392|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421393|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
83421394|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421395|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421396|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83421398|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421399|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
83421400|NCT00123643|Glyburide|glyburide|mesh-list
83421401|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83421402|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421403|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
83421404|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
83421405|NCT00235573|Vitamins|vitamins|mesh-ancestor
83421406|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
83421407|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421408|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
83421409|NCT00235573|Hematinics|hematinics|mesh-ancestor
83421410|NCT01687179|Sirolimus|sirolimus|mesh-list
83421411|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
83421412|NCT01687179|Temsirolimus|temsirolimus|mesh-list
83421413|NCT01687179|MTOR Inhibitors|mtor inhibitors|mesh-list
83421414|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83421415|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421416|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83421417|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421418|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
83421419|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421420|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
83421421|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421422|NCT01687179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83421423|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421424|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421425|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
83421426|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83421427|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83421428|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421429|NCT00124579|Thalidomide|thalidomide|mesh-list
83421430|NCT00124579|Dexamethasone|dexamethasone|mesh-list
83421431|NCT00124579|Bortezomib|bortezomib|mesh-list
83421432|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83421433|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
83421434|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
83421435|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421436|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421437|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83421438|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
83421439|NCT00124579|Hormones|hormones|mesh-ancestor
83421440|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421441|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83421442|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421443|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421444|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
83421445|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
83421446|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83421447|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421448|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83421449|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83421450|NCT00124579|Growth Substances|growth substances|mesh-ancestor
83421451|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
83421452|NCT05550246|Oxybutynin|oxybutynin|mesh-list
83421453|NCT05550246|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83421454|NCT05550246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83421455|NCT05550246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83421456|NCT05550246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83421457|NCT05550246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421458|NCT05550246|Adrenergic Agents|adrenergic agents|mesh-ancestor
83421459|NCT05550246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421460|NCT05550246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421461|NCT05550246|Parasympatholytics|parasympatholytics|mesh-ancestor
83421462|NCT05550246|Autonomic Agents|autonomic agents|mesh-ancestor
83421463|NCT05550246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421464|NCT05550246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83421465|NCT05550246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83421466|NCT05550246|Cholinergic Agents|cholinergic agents|mesh-ancestor
83421467|NCT05550246|Urological Agents|urological agents|mesh-ancestor
83421468|NCT05550090|Immunomodulating Agents|immunomodulating agents|mesh-list
83421469|NCT05550090|Immunologic Factors|immunologic factors|mesh-ancestor
83421470|NCT05550090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421471|NCT00124735|Rocuronium|rocuronium|mesh-list
83421472|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83421473|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83421474|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83421475|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421476|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421478|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83421479|NCT05340309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83421480|NCT05340309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421481|NCT05340309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421482|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421483|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
83421484|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421485|NCT00125515|Naltrexone|naltrexone|mesh-list
83421486|NCT00125515|Memantine|memantine|mesh-list
83421487|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83421488|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83421489|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421490|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
83421491|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421492|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83421493|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83421494|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
83421495|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421496|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421497|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83421498|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83421499|NCT00125593|Simvastatin|simvastatin|mesh-list
83421500|NCT00125593|Ezetimibe|ezetimibe|mesh-list
83421501|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83421502|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83421503|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
83421504|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421505|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83421506|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83421507|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421508|NCT01689441|Calcitriol|calcitriol|mesh-list
83421509|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83421510|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421511|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83421512|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83421513|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421514|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83421515|NCT01689441|Vitamins|vitamins|mesh-ancestor
83421516|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
83421517|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83421518|NCT00236977|Iron|iron|mesh-list
83421519|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83421520|NCT00236977|Trace Elements|trace elements|mesh-ancestor
83421521|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
83421522|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421523|NCT00236977|Hematinics|hematinics|mesh-ancestor
83421524|NCT04753177|Paclitaxel|paclitaxel|mesh-list
83421525|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
83421526|NCT04753177|Doxorubicin|doxorubicin|mesh-list
83421527|NCT04753177|Fulvestrant|fulvestrant|mesh-list
83421528|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83421529|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83421530|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421531|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
83421532|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
83421533|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
83421534|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421535|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421536|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
83421537|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421538|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421539|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83421540|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
83421541|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83421542|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83421543|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83421544|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83421545|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421546|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83421547|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83421548|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83421549|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
83421550|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421551|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
83421552|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83421553|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
83421554|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83421555|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83421556|NCT01691313|Vanoxerine|vanoxerine|mesh-list
83421557|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83421558|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83421559|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83421560|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421561|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
83421562|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421563|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421564|NCT00079001|Vitamin D|vitamin d|mesh-list
83421565|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
83421566|NCT00079001|Calcium|calcium|mesh-list
83421567|NCT00079001|Androgens|androgens|mesh-list
83421568|NCT00079001|Vitamins|vitamins|mesh-ancestor
83421569|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
83421570|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421571|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83421572|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83421573|NCT00079001|Hormones|hormones|mesh-ancestor
83421574|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421575|NCT05234307|Nivolumab|nivolumab|mesh-list
83421576|NCT05234307|Adenosine|adenosine|mesh-list
83421577|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
83421578|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421579|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421580|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83421581|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421582|NCT05234307|Analgesics|analgesics|mesh-ancestor
83421583|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
83421584|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421585|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421586|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83421587|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
83421588|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83421589|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
83421590|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
83421591|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421592|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83421593|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83421594|NCT00238615|Carboplatin|carboplatin|mesh-list
83421595|NCT00238615|Docetaxel|docetaxel|mesh-list
83421596|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421597|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
83421598|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
83421599|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
83421600|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421601|NCT02243943|Neostigmine|neostigmine|mesh-list
83421602|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83421603|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421604|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421605|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
83421606|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421607|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421608|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83421609|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
83421610|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421611|NCT03088631|Metformin|metformin|mesh-list
83421612|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83421613|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421614|NCT00131677|Tenofovir|tenofovir|mesh-list
83421615|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
83421616|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421617|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83421618|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83421619|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421620|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421621|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83421622|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83421623|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
83421624|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83421625|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
83421626|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421627|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421628|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83421629|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
83421630|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83421631|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
83421632|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421633|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421634|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83421635|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
83421636|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
83421637|NCT00240487|Protective Agents|protective agents|mesh-ancestor
83421638|NCT02126917|Ethanol|ethanol|mesh-list
83421639|NCT02126917|Hydrocodone|hydrocodone|mesh-list
83421640|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83421641|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421642|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83421643|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421644|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83421645|NCT02126917|Narcotics|narcotics|mesh-ancestor
83421646|NCT02126917|Analgesics|analgesics|mesh-ancestor
83421647|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
83421648|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421649|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
83421650|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
83421651|NCT01895075|Budesonide|budesonide|mesh-list
83421652|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83421653|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83421654|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
83421655|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421656|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421657|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83421658|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
83421659|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
83421660|NCT01895075|Hormones|hormones|mesh-ancestor
83421661|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421662|NCT05168475|Infliximab|infliximab|mesh-list
83421663|NCT05168475|Rituximab|rituximab|mesh-list
83421664|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421665|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421666|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
83421667|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421668|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421669|NCT05168475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83421670|NCT05168475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83421671|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
83421672|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83421673|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
83421674|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
83421675|NCT03088709|Tacrolimus|tacrolimus|mesh-list
83421676|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421677|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
83421678|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421679|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421680|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83421681|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
83480257|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83421682|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421683|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421684|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83421685|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83421686|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421687|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83421688|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83421689|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
83421690|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83421691|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421692|NCT03139305|Glucagon|glucagon|mesh-list
83421693|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83421694|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83421695|NCT03139305|Hormones|hormones|mesh-ancestor
83421696|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421697|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421698|NCT03139305|Incretins|incretins|mesh-ancestor
83421699|NCT00084149|Ritonavir|ritonavir|mesh-list
83421700|NCT00084149|Lopinavir|lopinavir|mesh-list
83421701|NCT00084149|Lamivudine|lamivudine|mesh-list
83421702|NCT00084149|Zidovudine|zidovudine|mesh-list
83421703|NCT00084149|Abacavir|abacavir|mesh-list
83421704|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83421705|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83421706|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
83421707|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421708|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421709|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83421710|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83421711|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
83421712|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421713|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83421714|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83421715|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83421716|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83421717|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
83421718|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
83421719|NCT02959905|Fludarabine|fludarabine|mesh-list
83421720|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
83421721|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421722|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
83421723|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421724|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421725|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83421726|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
83421727|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421728|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421729|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83421730|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83421731|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
83421732|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
83421733|NCT00134017|Busulfan|busulfan|mesh-list
83421734|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421735|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
83421736|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421737|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421738|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83421739|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
83421740|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421741|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421742|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83421743|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
83421744|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
83421745|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83421746|NCT04783051|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83421747|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
83421748|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83421749|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83421750|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421751|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83421752|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421753|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421754|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83421755|NCT04783051|Antiviral Agents|antiviral agents|mesh-ancestor
83421756|NCT00243061|Cediranib|cediranib|mesh-list
83421757|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421758|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421759|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421760|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83421761|NCT00245557|Sertraline|sertraline|mesh-list
83421762|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
83421763|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83421764|NCT00245557|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83421765|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83421766|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83421767|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421768|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421769|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
83421770|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421771|NCT00245635|Fluoxetine|fluoxetine|mesh-list
83421772|NCT00245635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83421773|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83421774|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83421775|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421776|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421777|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
83421778|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421779|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83421780|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
83421781|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83421782|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83421783|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83421784|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421785|NCT00141115|Levetiracetam|levetiracetam|mesh-list
83421786|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
83421787|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
83421788|NCT00249379|Acamprosate|acamprosate|mesh-list
83421789|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83421790|NCT00141739|Etanercept|etanercept|mesh-list
83421791|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83421792|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83421793|NCT00141739|Analgesics|analgesics|mesh-ancestor
83421794|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
83421795|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421796|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421797|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83421798|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421799|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83421800|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421801|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
83421802|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83421803|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
83421804|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421805|NCT00086957|Docetaxel|docetaxel|mesh-list
83421806|NCT00086957|Trastuzumab|trastuzumab|mesh-list
83421807|NCT00086957|Gefitinib|gefitinib|mesh-list
83421808|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421809|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
83421810|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
83421811|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
83421812|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421813|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421814|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83421815|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421816|NCT00144391|Testosterone|testosterone|mesh-list
83421817|NCT00144391|Androgens|androgens|mesh-ancestor
83421818|NCT00144391|Hormones|hormones|mesh-ancestor
83421819|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421820|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421821|NCT00145249|Fluconazole|fluconazole|mesh-list
83421822|NCT00145249|Amphotericin B|amphotericin b|mesh-list
83421823|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83421824|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
83421825|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421826|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83421827|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83421828|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421829|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421830|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83421831|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
83421832|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421833|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421834|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83421835|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83421836|NCT00145249|Amebicides|amebicides|mesh-ancestor
83421837|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83421838|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83421839|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83421840|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83421841|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421842|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83421843|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421844|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421845|NCT00252967|Atorvastatin|atorvastatin|mesh-list
83421846|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83421847|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83421848|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
83421849|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421850|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83421851|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83421852|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421853|NCT00088985|Trastuzumab|trastuzumab|mesh-list
83421854|NCT00088985|Vinorelbine|vinorelbine|mesh-list
83421855|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421856|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421857|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83421858|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
83421859|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
83421860|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
83421861|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421862|NCT00156923|Naltrexone|naltrexone|mesh-list
83421863|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83421864|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83421865|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421866|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
83421867|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421868|NCT00093041|Zalutumumab|zalutumumab|mesh-list
83421869|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421870|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421871|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83421872|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
83421873|NCT01769885|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83421874|NCT01769885|Tivozanib|tivozanib|mesh-list
83421875|NCT01769885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83421876|NCT01769885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421877|NCT01769885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421878|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83421879|NCT01895231|Hematinics|hematinics|mesh-ancestor
83421880|NCT04745663|Iodine|iodine|mesh-list
83421881|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
83421882|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
83421883|NCT04745663|Povidone|povidone|mesh-list
83421884|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83421885|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421886|NCT04745663|Trace Elements|trace elements|mesh-ancestor
83421887|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
83421888|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421889|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
83421890|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
83421891|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
83421892|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83421893|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83421894|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
83421895|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421896|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421897|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421898|NCT01747577|Urological Agents|urological agents|mesh-ancestor
83421899|NCT00159263|Budesonide|budesonide|mesh-list
83421900|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
83421901|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83421902|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83421903|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
83421904|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421905|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421906|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83421907|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
83421908|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
83421909|NCT00159263|Hormones|hormones|mesh-ancestor
83421910|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83421911|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83421912|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83421913|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83421914|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
83421915|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421916|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421917|NCT00159419|Alendronate|alendronate|mesh-list
83421918|NCT00159419|Pamidronate|pamidronate|mesh-list
83421919|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83421920|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421921|NCT00159965|Sertraline|sertraline|mesh-list
83421922|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
83421923|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83421924|NCT00159965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83421925|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83421926|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83421927|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421928|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83421929|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
83421930|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421931|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
83421932|NCT02926833|Fludarabine|fludarabine|mesh-list
83421933|NCT02926833|Atezolizumab|atezolizumab|mesh-list
83421934|NCT02926833|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83421935|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421936|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
83421937|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421938|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421939|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83421940|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
83421941|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421942|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421943|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83421944|NCT02926833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83421945|NCT02926833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83421946|NCT00096161|Cyclosporine|cyclosporine|mesh-list
83421947|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
83421948|NCT00096161|Vidarabine|vidarabine|mesh-list
83421949|NCT00096161|Pentostatin|pentostatin|mesh-list
83421950|NCT00096161|Cyclosporins|cyclosporins|mesh-list
83421951|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421952|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421953|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421954|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
83421955|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421956|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
83421957|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421958|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
83421959|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421960|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83421961|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83421962|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421963|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83421964|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
83421965|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83421966|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83421968|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
83421969|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83421970|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421971|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
83421972|NCT01898039|Vaccines|vaccines|mesh-list
83421973|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
83421974|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421975|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83421976|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421977|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83421978|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
83421979|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421980|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83421981|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83421982|NCT00099047|Celecoxib|celecoxib|mesh-list
83421983|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83421984|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83421985|NCT00099047|Analgesics|analgesics|mesh-ancestor
83421986|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
83421987|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83421988|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83421989|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83421990|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83421991|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83421992|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83421993|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421994|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421995|NCT02851797|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
83421996|NCT02851797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83421997|NCT02851797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83421998|NCT02851797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421999|NCT00253435|Carboplatin|carboplatin|mesh-list
83422000|NCT00253435|Etoposide|etoposide|mesh-list
83422001|NCT00253435|Melphalan|melphalan|mesh-list
83422002|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422003|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83422004|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83422005|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83422006|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422007|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422008|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
83422009|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422010|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83422011|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
83422012|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83422013|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83422014|NCT00253513|Fludarabine|fludarabine|mesh-list
83422015|NCT00253513|Treosulfan|treosulfan|mesh-list
83422016|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422017|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422018|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83422019|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
83422020|NCT05033847|Vaccines|vaccines|mesh-list
83422021|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
83422022|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422023|NCT04963725|Ustekinumab|ustekinumab|mesh-list
83422024|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
83422026|NCT02098993|Calcium heparin|calcium heparin|mesh-list
83422027|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
83422028|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83422029|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83422030|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422031|NCT04930107|Fluconazole|fluconazole|mesh-list
83422032|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
83422033|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422034|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83422035|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83422036|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480258|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83422037|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422038|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83422039|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
83422040|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83422041|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422042|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83422043|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83422045|NCT00100841|Bevacizumab|bevacizumab|mesh-list
83422046|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83422047|NCT00100841|Cetuximab|cetuximab|mesh-list
83422048|NCT00100841|Fluorouracil|fluorouracil|mesh-list
83422049|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
83422050|NCT00100841|Antibodies|antibodies|mesh-list
83422051|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
83422052|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83422053|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
83422054|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422055|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83422056|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83422057|NCT00100841|Growth Substances|growth substances|mesh-ancestor
83422058|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422059|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
83422060|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
83422061|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
83422062|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422063|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83422064|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83422065|NCT00100841|Antidotes|antidotes|mesh-ancestor
83422066|NCT00100841|Protective Agents|protective agents|mesh-ancestor
83422067|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
83422068|NCT00100841|Vitamins|vitamins|mesh-ancestor
83422069|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
83422070|NCT04908579|Ketamine|ketamine|mesh-list
83422071|NCT04908579|Bupivacaine|bupivacaine|mesh-list
83422072|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
83422073|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
83422074|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422075|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422076|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
83422077|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422078|NCT04908579|Analgesics|analgesics|mesh-ancestor
83422079|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83422080|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83422081|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
83422082|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83422083|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83422084|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422085|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422086|NCT00147199|Treprostinil|treprostinil|mesh-list
83422087|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83422088|NCT05709171|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83422089|NCT05709171|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83422090|NCT05709171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422091|NCT00149227|Valsartan|valsartan|mesh-list
83422092|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
83422093|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83422094|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83422095|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422096|NCT00445965|Antibodies|antibodies|mesh-list
83422097|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83422098|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
83422099|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422100|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
83422101|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83422102|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83422103|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83422104|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83422105|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83422106|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422107|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
83422108|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422109|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422110|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83422111|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422113|NCT05708235|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83422114|NCT05708235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422115|NCT05708235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422116|NCT02240589|Memantine|memantine|mesh-list
83422117|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83422118|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83422119|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
83422120|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422121|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422122|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422123|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83422124|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83422125|NCT00258349|Trastuzumab|trastuzumab|mesh-list
83422126|NCT00258349|Vorinostat|vorinostat|mesh-list
83422127|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83422128|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422129|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83422130|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422131|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422132|NCT01713621|Artefenomel|artefenomel|mesh-list
83422133|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
83422134|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83422135|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83422136|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422137|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
83422138|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83422139|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
83422140|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422141|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422142|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83422143|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
83422144|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
83422145|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83422146|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
83422147|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422148|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422149|NCT00258817|Vaccines|vaccines|mesh-list
83422150|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
83422151|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422152|NCT05686863|Remifentanil|remifentanil|mesh-list
83422153|NCT05686863|Propofol|propofol|mesh-list
83422154|NCT05686863|Esketamine|esketamine|mesh-list
83422155|NCT05686863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83422156|NCT05686863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422157|NCT05686863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422158|NCT05686863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83422159|NCT05686863|Anesthetics, General|anesthetics, general|mesh-ancestor
83422160|NCT05686863|Anesthetics|anesthetics|mesh-ancestor
83422161|NCT05686863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83422162|NCT05686863|Narcotics|narcotics|mesh-ancestor
83422163|NCT05686863|Analgesics|analgesics|mesh-ancestor
83422164|NCT05686863|Sensory System Agents|sensory system agents|mesh-ancestor
83422165|NCT05686863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422166|NCT05686863|Antidepressive Agents|antidepressive agents|mesh-ancestor
83422167|NCT05686863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83422168|NCT00259285|Pemetrexed|pemetrexed|mesh-list
83422169|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422170|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422171|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422172|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83422173|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83422174|NCT01716039|Adalimumab|adalimumab|mesh-list
83422175|NCT01716039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83422177|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422178|NCT01716195|Paclitaxel|paclitaxel|mesh-list
83422179|NCT01716195|Carboplatin|carboplatin|mesh-list
83422180|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83422181|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422182|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
83422183|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
83422184|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
83422185|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422186|NCT02249481|Bupivacaine|bupivacaine|mesh-list
83422187|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
83422188|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
83422189|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422190|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422191|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
83422192|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422193|NCT01717053|Prednisone|prednisone|mesh-list
83422194|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
83422195|NCT01717053|Androgens|androgens|mesh-list
83422196|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83422197|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
83422198|NCT01717053|Hormones|hormones|mesh-ancestor
83422199|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83422200|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422201|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83422202|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422203|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83422204|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422205|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422206|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
83422207|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83422208|NCT01666314|Prednisone|prednisone|mesh-list
83422209|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83422210|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
83422211|NCT01666314|Hormones|hormones|mesh-ancestor
83422212|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83422213|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422214|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83422215|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422216|NCT01717209|Epoprostenol|epoprostenol|mesh-list
83422217|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
83422218|NCT01717209|Tezosentan|tezosentan|mesh-list
83422219|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83422220|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
83422221|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422222|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422223|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83422224|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
83422225|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83422226|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
83422227|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422228|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422229|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83422230|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
83422231|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
83422232|NCT01717209|Protective Agents|protective agents|mesh-ancestor
83422233|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83422234|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83422235|NCT00260689|Cyclosporine|cyclosporine|mesh-list
83422236|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
83422237|NCT00260689|Cyclosporins|cyclosporins|mesh-list
83422238|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83422239|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
83422240|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422241|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422242|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83422243|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
83422244|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422245|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
83422246|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422247|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
83422248|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422249|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83422250|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83422251|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422252|NCT00262639|Gabapentin|gabapentin|mesh-list
83422253|NCT00262639|Flumazenil|flumazenil|mesh-list
83422254|NCT00262639|Analgesics|analgesics|mesh-ancestor
83422255|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
83422256|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422257|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422258|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
83422259|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83422260|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83422261|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422262|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83422263|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83422264|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83422265|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422266|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422267|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
83422268|NCT00262639|Antidotes|antidotes|mesh-ancestor
83422269|NCT00262639|Protective Agents|protective agents|mesh-ancestor
83422270|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
83422271|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
83422272|NCT01062451|Candesartan|candesartan|mesh-list
83422273|NCT01062451|Perindopril|perindopril|mesh-list
83422274|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83422275|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83422276|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83422277|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422278|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83422279|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
83422280|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422281|NCT04639843|Doxorubicin|doxorubicin|mesh-list
83422282|NCT04639843|Romidepsin|romidepsin|mesh-list
83422283|NCT04639843|Azacitidine|azacitidine|mesh-list
83422284|NCT04639843|Cc-486|cc-486|mesh-list
83422285|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83422286|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422287|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83422288|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83422289|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422290|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422291|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83422292|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
83422293|NCT04639843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83422294|NCT01718691|Rituximab|rituximab|mesh-list
83422295|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83422296|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422297|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
83422298|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422299|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422300|NCT05699148|Ivacaftor|ivacaftor|mesh-list
83422301|NCT05699148|Elexacaftor|elexacaftor|mesh-list
83422302|NCT05699148|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83422303|NCT05699148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83422304|NCT05699148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422305|NCT04638517|Danazol|danazol|mesh-list
83422306|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83422307|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
83422308|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83422309|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422310|NCT04467723|Pirfenidone|pirfenidone|mesh-list
83422311|NCT04467723|Atezolizumab|atezolizumab|mesh-list
83422312|NCT04467723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83422313|NCT04467723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422314|NCT04467723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83422315|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422316|NCT04467723|Analgesics|analgesics|mesh-ancestor
83422317|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
83422318|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422319|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422320|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83422321|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83422322|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83422323|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422324|NCT05539872|Insulin|insulin|mesh-list
83422325|NCT05539872|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83422326|NCT05539872|Insulin Aspart|insulin aspart|mesh-list
83422327|NCT05539872|Insulin, Long-Acting|insulin, long-acting|mesh-list
83422328|NCT05539872|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83422329|NCT05539872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83422330|NCT05539872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422331|NCT04425642|Methamphetamine|methamphetamine|mesh-list
83422332|NCT04425642|SMOFlipid|smoflipid|mesh-list
83422333|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83422334|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422335|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
83422336|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
83422337|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422338|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
83422339|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422340|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422341|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
83422342|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83422343|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83422344|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83422345|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83422346|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83422347|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83422348|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83422349|NCT00266851|Azithromycin|azithromycin|mesh-list
83422350|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83422351|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422352|NCT00015847|Interferons|interferons|mesh-list
83422353|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
83422354|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
83422355|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422356|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
83422357|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422358|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
83422359|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422360|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83422361|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422362|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422363|NCT01665768|Rituximab|rituximab|mesh-list
83422364|NCT01665768|Everolimus|everolimus|mesh-list
83422365|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83422366|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422367|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
83422368|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422369|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422370|NCT01665768|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83422371|NCT01665768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83422372|NCT01665768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422373|NCT01665768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422374|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83422375|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
83422376|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
83422377|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422378|NCT04617457|Leucovorin|leucovorin|mesh-list
83422379|NCT04617457|Folic Acid|folic acid|mesh-list
83422380|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
83422381|NCT04617457|Irinotecan|irinotecan|mesh-list
83422382|NCT04617457|Fluorouracil|fluorouracil|mesh-list
83422383|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
83422384|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422385|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83422386|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83422387|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422388|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422389|NCT04617457|Antidotes|antidotes|mesh-ancestor
83422390|NCT04617457|Protective Agents|protective agents|mesh-ancestor
83422391|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422392|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
83422393|NCT04617457|Vitamins|vitamins|mesh-ancestor
83422394|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
83422395|NCT04617457|Hematinics|hematinics|mesh-ancestor
83422396|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
83422397|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83422398|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83422399|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
83422400|NCT00017563|Docetaxel|docetaxel|mesh-list
83422401|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
83422402|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422403|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
83422404|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
83422405|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
83422406|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422407|NCT00017563|Analgesics|analgesics|mesh-ancestor
83422408|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
83422409|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422410|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422411|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83422412|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83422413|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422414|NCT00018031|Ribavirin|ribavirin|mesh-list
83422415|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83422416|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
83422417|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
83422418|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422419|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
83422420|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422421|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
83422422|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422423|NCT04734210|Betamethasone|betamethasone|mesh-list
83422424|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
83422425|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83422426|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
83422427|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83422428|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83422429|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
83422430|NCT04734210|Hormones|hormones|mesh-ancestor
83422431|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83422432|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422433|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83422434|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
83422435|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
83422436|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422437|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83422438|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422439|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422440|NCT04221451|Venglustat|venglustat|mesh-list
83422441|NCT04221451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422442|NCT04221451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422443|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
83422444|NCT04476511|Vitamin D|vitamin d|mesh-list
83422445|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83422446|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422447|NCT04476511|Vitamins|vitamins|mesh-ancestor
83422448|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
83422449|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83422450|NCT05609565|Bupivacaine|bupivacaine|mesh-list
83422451|NCT05609565|Prilocaine|prilocaine|mesh-list
83422452|NCT05609565|Anesthetics|anesthetics|mesh-list
83422453|NCT05609565|Anesthetics, Local|anesthetics, local|mesh-ancestor
83422454|NCT05609565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422455|NCT05609565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422456|NCT05609565|Sensory System Agents|sensory system agents|mesh-ancestor
83422457|NCT05609565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422458|NCT00026221|Interferons|interferons|mesh-list
83422459|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
83422460|NCT00026221|Bevacizumab|bevacizumab|mesh-list
83422461|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83422462|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422463|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83422464|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83422465|NCT00026221|Growth Substances|growth substances|mesh-ancestor
83422466|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422467|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
83422468|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
83422469|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422470|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
83422471|NCT00028093|Ribavirin|ribavirin|mesh-list
83422472|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83422473|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
83422474|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
83422475|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422476|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
83422477|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422478|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
83422479|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422480|NCT01721967|Ranolazine|ranolazine|mesh-list
83422481|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83422482|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83422483|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422484|NCT04026451|Propofol|propofol|mesh-list
83422485|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83422486|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422487|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422488|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83422489|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
83422490|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
83422491|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
83422492|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83422493|NCT01722435|Narcotics|narcotics|mesh-ancestor
83422494|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422495|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422496|NCT01722435|Analgesics|analgesics|mesh-ancestor
83422497|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
83422498|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422499|NCT00029107|Rituximab|rituximab|mesh-list
83422500|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83422501|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422502|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
83422503|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422504|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422505|NCT04389229|Aldesleukin|aldesleukin|mesh-list
83422506|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
83422507|NCT04389229|Fludarabine|fludarabine|mesh-list
83422508|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83422509|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
83422510|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422511|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422512|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83422513|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
83422514|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422515|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422516|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83422517|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83422518|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83422519|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
83422520|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422521|NCT03861702|Irinotecan|irinotecan|mesh-list
83422522|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83422523|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83422524|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422525|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422526|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422527|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
83422528|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83422529|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422530|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83422531|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422532|NCT05538702|Menthol|menthol|mesh-list
83422533|NCT05538702|Antipruritics|antipruritics|mesh-ancestor
83422534|NCT05538702|Dermatologic Agents|dermatologic agents|mesh-ancestor
83422535|NCT00271219|Buprenorphine|buprenorphine|mesh-list
83422536|NCT00271219|Methadone|methadone|mesh-list
83422537|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83422538|NCT00271219|Narcotics|narcotics|mesh-ancestor
83422539|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422540|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422541|NCT00271219|Analgesics|analgesics|mesh-ancestor
83422542|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
83422543|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422544|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83422545|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
83422546|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
83422547|NCT02240667|Vitamin K|vitamin k|mesh-list
83422548|NCT02240667|Dabigatran|dabigatran|mesh-list
83422549|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
83422550|NCT02240667|Vitamins|vitamins|mesh-ancestor
83422551|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
83422552|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422553|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
83422554|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83422555|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
83422556|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422557|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422558|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
83422559|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83422560|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83422562|NCT02240667|Coagulants|coagulants|mesh-ancestor
83422563|NCT00272311|Aspirin|aspirin|mesh-list
83422564|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83422565|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83422566|NCT00272311|Analgesics|analgesics|mesh-ancestor
83422567|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
83422568|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422569|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422570|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83422571|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422572|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83422573|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83422574|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422575|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83422576|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83422577|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422578|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
83422579|NCT00038857|Fludarabine|fludarabine|mesh-list
83422580|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
83422581|NCT00038857|Melphalan|melphalan|mesh-list
83422582|NCT00038857|Thiotepa|thiotepa|mesh-list
83422583|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
83422584|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83422585|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422586|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83422587|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
83422588|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422589|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83422590|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
83422591|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422592|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83422593|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
83422594|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83422595|NCT03097068|Ranibizumab|ranibizumab|mesh-list
83422596|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83422597|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83422598|NCT03097068|Growth Substances|growth substances|mesh-ancestor
83422599|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422600|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
83422601|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422602|NCT01729845|Cytarabine|cytarabine|mesh-list
83422603|NCT01729845|Etoposide|etoposide|mesh-list
83422604|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
83422605|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
83422606|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
83422607|NCT01729845|Decitabine|decitabine|mesh-list
83422608|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83422609|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422610|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83422611|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83422612|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422613|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422614|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83422615|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
83422616|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
83422617|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422618|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83422619|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
83422620|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422621|NCT01729845|Analgesics|analgesics|mesh-ancestor
83422622|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
83422623|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422624|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
83422625|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
83422626|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
83422627|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
83422628|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
83422629|NCT01729923|Celecoxib|celecoxib|mesh-list
83422630|NCT01729923|Capecitabine|capecitabine|mesh-list
83422631|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
83422632|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83422633|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
83422634|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422635|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422636|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83422637|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83422638|NCT01729923|Analgesics|analgesics|mesh-ancestor
83422639|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
83422640|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422641|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422642|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83422643|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422644|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83422645|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83422646|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422647|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83422648|NCT02584452|Dexamethasone|dexamethasone|mesh-list
83422649|NCT02584452|Fentanyl|fentanyl|mesh-list
83422650|NCT02584452|Bupivacaine|bupivacaine|mesh-list
83422651|NCT02584452|Ropivacaine|ropivacaine|mesh-list
83422652|NCT02584452|Mepivacaine|mepivacaine|mesh-list
83422653|NCT02584452|Propofol|propofol|mesh-list
83422654|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83422655|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
83422656|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
83422657|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422658|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422659|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83422660|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
83422661|NCT02584452|Hormones|hormones|mesh-ancestor
83422662|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83422663|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83422664|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422665|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
83422666|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
83422667|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422668|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
83422669|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83422670|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83422671|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
83422672|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83422673|NCT02584452|Narcotics|narcotics|mesh-ancestor
83422674|NCT02584452|Analgesics|analgesics|mesh-ancestor
83422675|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83422676|NCT02502006|Celecoxib|celecoxib|mesh-list
83422677|NCT02502006|Naproxen|naproxen|mesh-list
83422678|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83422679|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83422680|NCT02502006|Analgesics|analgesics|mesh-ancestor
83422681|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
83422682|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422683|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422684|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83422685|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422686|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83422687|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83422688|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422689|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422690|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
83422691|NCT05679102|Amlodipine|amlodipine|mesh-list
83422692|NCT05679102|Atorvastatin|atorvastatin|mesh-list
83422693|NCT05679102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83422694|NCT05679102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83422695|NCT05679102|Antimetabolites|antimetabolites|mesh-ancestor
83422696|NCT05679102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422697|NCT05679102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83422698|NCT05679102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83422699|NCT05679102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422700|NCT05679102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83422701|NCT05679102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83422702|NCT05679102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83422703|NCT05679102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83422704|NCT05679102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422705|NCT05679102|Vasodilator Agents|vasodilator agents|mesh-ancestor
83422706|NCT03520491|Nivolumab|nivolumab|mesh-list
83422707|NCT03520491|Ipilimumab|ipilimumab|mesh-list
83422708|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83422709|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422710|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83422711|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422712|NCT05588934|Caffeine|caffeine|mesh-list
83422713|NCT05588934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83422714|NCT05588934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422715|NCT05588934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83422716|NCT05588934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422717|NCT05588934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422718|NCT05588934|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83422719|NCT05588934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83422720|NCT05588934|Purinergic Agents|purinergic agents|mesh-ancestor
83422721|NCT05588934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422722|NCT02243007|Paclitaxel|paclitaxel|mesh-list
83422723|NCT02243007|Gemcitabine|gemcitabine|mesh-list
83422724|NCT02243007|Capecitabine|capecitabine|mesh-list
83422725|NCT02243007|Folfirinox|folfirinox|mesh-list
83422726|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83422727|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422728|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
83422729|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
83422730|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
83422731|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422732|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83422733|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
83422734|NCT05536596|Hydroxocobalamin|hydroxocobalamin|mesh-list
83422735|NCT05536596|Vitamin B 12|vitamin b 12|mesh-list
83422737|NCT05536596|Antioxidants|antioxidants|mesh-ancestor
83422738|NCT05536596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422739|NCT05536596|Protective Agents|protective agents|mesh-ancestor
83422740|NCT05536596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422741|NCT05536596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422742|NCT05536596|Hematinics|hematinics|mesh-ancestor
83422743|NCT05536596|Vitamin B Complex|vitamin b complex|mesh-ancestor
83422744|NCT05536596|Vitamins|vitamins|mesh-ancestor
83422745|NCT05536596|Micronutrients|micronutrients|mesh-ancestor
83422746|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
83422747|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422748|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83422749|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422750|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422751|NCT05488626|Immunomodulating Agents|immunomodulating agents|mesh-list
83422752|NCT05488626|Immunologic Factors|immunologic factors|mesh-ancestor
83422753|NCT05488626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422754|NCT03430791|Nivolumab|nivolumab|mesh-list
83422755|NCT03430791|Ipilimumab|ipilimumab|mesh-list
83422756|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83422757|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422758|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83422759|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422760|NCT05536128|Fulvestrant|fulvestrant|mesh-list
83422761|NCT05536128|Olaparib|olaparib|mesh-list
83422762|NCT05536128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83422763|NCT05536128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422764|NCT05536128|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83422765|NCT05536128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83422766|NCT05536128|Hormone Antagonists|hormone antagonists|mesh-ancestor
83422767|NCT05536128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83422768|NCT05536128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422769|NCT05536128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83422770|NCT05536128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422771|NCT05536128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422773|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83422774|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422775|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
83422776|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422777|NCT05316675|Isotretinoin|isotretinoin|mesh-list
83422778|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
83422779|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
83422780|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83422781|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422782|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83422783|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422784|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
83422785|NCT01736865|Vitamin D|vitamin d|mesh-list
83422786|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83422787|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422788|NCT01736865|Vitamins|vitamins|mesh-ancestor
83422789|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
83422790|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83422791|NCT01736943|Doxorubicin|doxorubicin|mesh-list
83422792|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83422793|NCT01736943|Bortezomib|bortezomib|mesh-list
83422794|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83422795|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422796|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83422797|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83422798|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422799|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422800|NCT01739361|Acetaminophen|acetaminophen|mesh-list
83422801|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83422802|NCT01739361|Analgesics|analgesics|mesh-ancestor
83422803|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
83422804|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422805|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422806|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
83422807|NCT01743729|Lifitegrast|lifitegrast|mesh-list
83422808|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83422809|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83422810|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
83422811|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83422812|NCT01744353|Paclitaxel|paclitaxel|mesh-list
83422813|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422814|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422815|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83422816|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
83422817|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
83422818|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
83422819|NCT01744821|Vitamin D|vitamin d|mesh-list
83422820|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
83422821|NCT01744821|Vitamins|vitamins|mesh-ancestor
83422822|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
83422823|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422824|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83422825|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83422826|NCT04369365|Azithromycin|azithromycin|mesh-list
83422827|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83422828|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422829|NCT01745055|Methotrexate|methotrexate|mesh-list
83422830|NCT01745055|Tofacitinib|tofacitinib|mesh-list
83422831|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83422832|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
83422833|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83422834|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422835|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83422836|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
83422837|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422838|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422839|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
83422840|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422841|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83422842|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83422843|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
83422844|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422845|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83422846|NCT01745055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83422847|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83422848|NCT01745133|Calcitriol|calcitriol|mesh-list
83422849|NCT01745133|Clobetasol|clobetasol|mesh-list
83422850|NCT01745133|Calcipotriene|calcipotriene|mesh-list
83422851|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83422852|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
83422853|NCT01745133|Hormones|hormones|mesh-ancestor
83422854|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83422855|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422856|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
83422857|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83422858|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83422859|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83422860|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422861|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83422862|NCT01745133|Vitamins|vitamins|mesh-ancestor
83422863|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
83422864|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83422865|NCT05302011|Carboplatin|carboplatin|mesh-list
83422866|NCT05302011|Docetaxel|docetaxel|mesh-list
83422867|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
83422868|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422869|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
83422870|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
83422871|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
83422872|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422873|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83422874|NCT05302011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83422875|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
83422876|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83422877|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422878|NCT04246359|Interferons|interferons|mesh-list
83422879|NCT04246359|Rituximab|rituximab|mesh-list
83422880|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83422881|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422882|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
83422883|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422884|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422885|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
83422886|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422887|NCT05213169|Apomorphine|apomorphine|mesh-list
83422888|NCT05213169|Emetics|emetics|mesh-ancestor
83422889|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422890|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
83422891|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422892|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83422893|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
83422894|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
83422895|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422896|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422897|NCT05192265|Artesunate|artesunate|mesh-list
83422898|NCT05192265|Lumefantrine|lumefantrine|mesh-list
83422899|NCT05192265|Artemether|artemether|mesh-list
83422900|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83422901|NCT05192265|Pyronaridine|pyronaridine|mesh-list
83422902|NCT05192265|Antimalarials|antimalarials|mesh-list
83422903|NCT05192265|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83422904|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83422905|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83422906|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422907|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422908|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
83422909|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
83422910|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83422911|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
83422912|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
83422913|NCT01748643|Rocuronium|rocuronium|mesh-list
83422914|NCT01748643|Neostigmine|neostigmine|mesh-list
83422915|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83422916|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83422917|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83422918|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422919|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422920|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83422921|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422922|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422923|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
83422924|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422925|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83422926|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
83422927|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83422928|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83422929|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83422930|NCT00106535|Methotrexate|methotrexate|mesh-list
83422931|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83422932|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
83422933|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83422934|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422935|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83422936|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
83422937|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422938|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83422939|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
83422940|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83422941|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83422942|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83422943|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
83422944|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83422945|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83422946|NCT01748799|Ethanol|ethanol|mesh-list
83422947|NCT01748799|Nabiximols|nabiximols|mesh-list
83422948|NCT01748799|Dronabinol|dronabinol|mesh-list
83422949|NCT01748799|Cannabidiol|cannabidiol|mesh-list
83422950|NCT01748799|Peppermint oil|peppermint oil|mesh-list
83422951|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
83422952|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83422953|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83422954|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422955|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422956|NCT01748799|Analgesics|analgesics|mesh-ancestor
83422957|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
83422958|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422959|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
83422960|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83422961|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83422962|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83422963|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83422964|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422965|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422967|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83422968|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
83422969|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
83422970|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83422971|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
83422972|NCT04107051|Nalmefene|nalmefene|mesh-list
83422973|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83422974|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422975|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
83422976|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422977|NCT05696886|Meperidine|meperidine|mesh-list
83422978|NCT05696886|Tramadol|tramadol|mesh-list
83422979|NCT05696886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83422980|NCT05696886|Narcotics|narcotics|mesh-ancestor
83422981|NCT05696886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422982|NCT05696886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422983|NCT05696886|Analgesics|analgesics|mesh-ancestor
83422984|NCT05696886|Sensory System Agents|sensory system agents|mesh-ancestor
83422985|NCT05696886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83422986|NCT05696886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83422987|NCT01748955|Bupropion|bupropion|mesh-list
83422988|NCT01748955|Paroxetine|paroxetine|mesh-list
83422989|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83422990|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
83422991|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83422992|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83422993|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83422994|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83422995|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83422996|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
83422997|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83422998|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83422999|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83423000|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83423001|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423002|NCT01748955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83423003|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
83423005|NCT05687448|Apixaban|apixaban|mesh-list
83423006|NCT05687448|Anticoagulants|anticoagulants|mesh-ancestor
83423007|NCT05687448|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83423008|NCT05687448|Antithrombins|antithrombins|mesh-ancestor
83423009|NCT05687448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83423010|NCT05687448|Protease Inhibitors|protease inhibitors|mesh-ancestor
83423011|NCT05687448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423012|NCT05687448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423013|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
83423014|NCT05156268|Olaparib|olaparib|mesh-list
83423015|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83423016|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423017|NCT05156268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83423018|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423019|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83423020|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423021|NCT01749501|Rocuronium|rocuronium|mesh-list
83423022|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83423023|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83423024|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83423025|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423026|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423027|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83423028|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83423029|NCT02255175|Estradiol|estradiol|mesh-list
83423030|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83423031|NCT02255175|Progesterone|progesterone|mesh-list
83423032|NCT02255175|Estrogens|estrogens|mesh-ancestor
83423033|NCT02255175|Hormones|hormones|mesh-ancestor
83423034|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423035|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423036|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83423037|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
83423038|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83423039|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83423040|NCT02255175|Progestins|progestins|mesh-ancestor
83423041|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83423042|NCT02585778|Alirocumab|alirocumab|mesh-list
83423043|NCT02585778|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83423044|NCT02585778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83423045|NCT02585778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83423046|NCT02585778|Antimetabolites|antimetabolites|mesh-ancestor
83423047|NCT02585778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423048|NCT02585778|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83423049|NCT02585778|Protease Inhibitors|protease inhibitors|mesh-ancestor
83423050|NCT02585778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423051|NCT02585778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83423052|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423053|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
83423054|NCT03899103|Rituximab|rituximab|mesh-list
83423055|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83423056|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423057|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
83423058|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423059|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423060|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83423061|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83423062|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
83423063|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83423064|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423065|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423066|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423067|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
83423068|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423069|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83423070|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480259|NCT04418401|Antibodies|antibodies|mesh-list
83423071|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423072|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
83423073|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423074|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423075|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83423077|NCT01438424|Entecavir|entecavir|mesh-list
83423078|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83423079|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83423080|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423081|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423082|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
83423083|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423084|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83423085|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83423086|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
83423087|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423088|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83423089|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
83423090|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83423091|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
83423092|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
83423093|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423094|NCT05299866|Ketamine|ketamine|mesh-list
83423095|NCT05299866|Esketamine|esketamine|mesh-list
83423096|NCT05299866|Analgesics|analgesics|mesh-ancestor
83423097|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
83423098|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423099|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423100|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83423101|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83423102|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
83423103|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
83423104|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423105|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83423106|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83423107|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423108|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423109|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
83423110|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83423111|NCT04133376|Nicotine|nicotine|mesh-list
83423112|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83423113|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
83423114|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423115|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423116|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83423117|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83423118|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
83423119|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423120|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423121|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
83423122|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83423123|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
83423124|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423125|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423126|NCT05267886|Dobutamine|dobutamine|mesh-list
83423127|NCT05267886|Milrinone|milrinone|mesh-list
83423128|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83423129|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
83423130|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
83423131|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423132|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423133|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83423134|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83423135|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83423136|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
83423137|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423138|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423139|NCT05267886|Protective Agents|protective agents|mesh-ancestor
83423140|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83423142|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83423143|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83423144|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423145|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
83423146|NCT02250807|Simeprevir|simeprevir|mesh-list
83423147|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
83423148|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423149|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
83423150|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423151|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423152|NCT05694936|Cetuximab|cetuximab|mesh-list
83423153|NCT05694936|Panitumumab|panitumumab|mesh-list
83423154|NCT05694936|Valproic Acid|valproic acid|mesh-list
83423155|NCT05694936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83423156|NCT05694936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423157|NCT05694936|Anticonvulsants|anticonvulsants|mesh-ancestor
83423158|NCT05694936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423159|NCT05694936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423160|NCT05694936|GABA Agents|gaba agents|mesh-ancestor
83423161|NCT05694936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423162|NCT05694936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423163|NCT05694936|Antimanic Agents|antimanic agents|mesh-ancestor
83423164|NCT05694936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83423165|NCT05694936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423166|NCT05694936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83423167|NCT00168389|Dexamethasone|dexamethasone|mesh-list
83423168|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423169|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
83423170|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
83423171|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423172|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423173|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83423174|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
83423175|NCT00168389|Hormones|hormones|mesh-ancestor
83423176|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423177|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83423178|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423179|NCT02252445|Propofol|propofol|mesh-list
83423180|NCT02252445|Sevoflurane|sevoflurane|mesh-list
83423181|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83423182|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423183|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423184|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83423185|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
83423186|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
83423187|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83423188|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83423189|NCT04592952|Calcitonin|calcitonin|mesh-list
83423190|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
83423191|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83423192|NCT04592952|Erenumab|erenumab|mesh-list
83423193|NCT04592952|Katacalcin|katacalcin|mesh-list
83423194|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83423195|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423196|NCT04592952|Analgesics|analgesics|mesh-ancestor
83423197|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
83423198|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423199|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423200|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83423201|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83423202|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
83423203|NCT00176423|Galantamine|galantamine|mesh-list
83423204|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83423205|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423206|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423207|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
83423208|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423209|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423210|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83423211|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
83423212|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423213|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
83423215|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
83423216|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423218|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423219|NCT00110513|Antithrombins|antithrombins|mesh-list
83423220|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
83423221|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83423222|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
83423223|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423224|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423225|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
83423226|NCT05691426|Nitric Oxide|nitric oxide|mesh-list
83423227|NCT05691426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83423228|NCT05691426|Autonomic Agents|autonomic agents|mesh-ancestor
83423229|NCT05691426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423230|NCT05691426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423231|NCT05691426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83423232|NCT05691426|Respiratory System Agents|respiratory system agents|mesh-ancestor
83423233|NCT05691426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83423234|NCT05691426|Antioxidants|antioxidants|mesh-ancestor
83423235|NCT05691426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423236|NCT05691426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423237|NCT05691426|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83423238|NCT05691426|Vasodilator Agents|vasodilator agents|mesh-ancestor
83423239|NCT05691426|Gasotransmitters|gasotransmitters|mesh-ancestor
83423240|NCT05691426|Protective Agents|protective agents|mesh-ancestor
83423241|NCT05696574|Misoprostol|misoprostol|mesh-list
83423242|NCT05696574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83423243|NCT05696574|Abortifacient Agents|abortifacient agents|mesh-ancestor
83423244|NCT05696574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83423245|NCT05696574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423246|NCT05696574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83423247|NCT05696574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83423248|NCT05696574|Oxytocics|oxytocics|mesh-ancestor
83423249|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
83423250|NCT00112151|Testosterone|testosterone|mesh-list
83423251|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
83423252|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
83423253|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83423254|NCT00112151|Androgens|androgens|mesh-ancestor
83423255|NCT00112151|Hormones|hormones|mesh-ancestor
83423256|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423257|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423258|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83423259|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423260|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
83423261|NCT05162742|Colchicine|colchicine|mesh-list
83423262|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
83423263|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423264|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
83423265|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
83423266|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
83423267|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423268|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423269|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
83423270|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83423271|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423272|NCT00113321|Decitabine|decitabine|mesh-list
83423273|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83423274|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
83423275|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423276|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423277|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423278|NCT05669742|Empagliflozin|empagliflozin|mesh-list
83423279|NCT05669742|Olanzapine|olanzapine|mesh-list
83423280|NCT05669742|Antiemetics|antiemetics|mesh-ancestor
83423281|NCT05669742|Autonomic Agents|autonomic agents|mesh-ancestor
83423282|NCT05669742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423283|NCT05669742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423284|NCT05669742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83423285|NCT05669742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83423286|NCT05669742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83423287|NCT05669742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423288|NCT05669742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83423289|NCT05669742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83423290|NCT05669742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83423291|NCT05669742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83423292|NCT05669742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423293|NCT05669742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423294|NCT05669742|Serotonin Agents|serotonin agents|mesh-ancestor
83423295|NCT05669742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83423296|NCT05669742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83423297|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
83423298|NCT00177047|Melphalan|melphalan|mesh-list
83423299|NCT00177047|Lenograstim|lenograstim|mesh-list
83423300|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83423301|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
83423302|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423303|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423304|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83423305|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
83423306|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423307|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423308|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83423309|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83423311|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
83423312|NCT00178841|Bexarotene|bexarotene|mesh-list
83423313|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83423314|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423315|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423316|NCT01756209|Acetaminophen|acetaminophen|mesh-list
83423317|NCT01756209|Ibuprofen|ibuprofen|mesh-list
83423318|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83423319|NCT01756209|Analgesics|analgesics|mesh-ancestor
83423320|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
83423321|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423322|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423323|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
83423324|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83423325|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423326|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423327|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83423328|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423329|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423330|NCT00116207|Niacinamide|niacinamide|mesh-list
83423331|NCT00116207|Allopurinol|allopurinol|mesh-list
83423332|NCT00116207|Antioxidants|antioxidants|mesh-list
83423333|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
83423334|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423335|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423336|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
83423337|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423338|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83423339|NCT00116207|Protective Agents|protective agents|mesh-ancestor
83423340|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423341|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
83423342|NCT00116207|Vitamins|vitamins|mesh-ancestor
83423343|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
83423344|NCT04129398|Letermovir|letermovir|mesh-list
83423345|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83423346|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423347|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423348|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423349|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
83423350|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423351|NCT00178919|Trimethaphan|trimethaphan|mesh-list
83423352|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
83423353|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423354|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83423355|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83423356|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83423357|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
83423358|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423359|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423360|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83423361|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83423362|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
83423363|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423364|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
83423365|NCT05609682|Gabapentin|gabapentin|mesh-list
83423366|NCT05609682|Analgesics|analgesics|mesh-ancestor
83423367|NCT05609682|Sensory System Agents|sensory system agents|mesh-ancestor
83423368|NCT05609682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423369|NCT05609682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423370|NCT05609682|Anticonvulsants|anticonvulsants|mesh-ancestor
83423371|NCT05609682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83423372|NCT05609682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83423373|NCT05609682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423374|NCT05609682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83423375|NCT05609682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83423376|NCT05609682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83423377|NCT05609682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423378|NCT05609682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423379|NCT05609682|Antimanic Agents|antimanic agents|mesh-ancestor
83423380|NCT04284839|Warfarin|warfarin|mesh-list
83423381|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
83423382|NCT04284839|Dabigatran|dabigatran|mesh-list
83423383|NCT04284839|Apixaban|apixaban|mesh-list
83423384|NCT04284839|Edoxaban|edoxaban|mesh-list
83423385|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
83423386|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83423387|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
83423388|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83423389|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
83423390|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423391|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423392|NCT05656248|Cytarabine|cytarabine|mesh-list
83423393|NCT05656248|Hydrocortisone|hydrocortisone|mesh-list
83423394|NCT05656248|Methotrexate|methotrexate|mesh-list
83423395|NCT05656248|Daunorubicin|daunorubicin|mesh-list
83423396|NCT05656248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83423397|NCT05656248|Abortifacient Agents|abortifacient agents|mesh-ancestor
83423398|NCT05656248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83423399|NCT05656248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423400|NCT05656248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83423401|NCT05656248|Antimetabolites|antimetabolites|mesh-ancestor
83423402|NCT05656248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423403|NCT05656248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423404|NCT05656248|Dermatologic Agents|dermatologic agents|mesh-ancestor
83423405|NCT05656248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423406|NCT05656248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83423407|NCT05656248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83423408|NCT05656248|Immunologic Factors|immunologic factors|mesh-ancestor
83423409|NCT05656248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423410|NCT05656248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83423411|NCT05656248|Antiviral Agents|antiviral agents|mesh-ancestor
83423412|NCT05656248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423413|NCT05656248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423414|NCT05656248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83423415|NCT05656248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83423416|NCT05656248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83423417|NCT05577000|Cyclophosphamide|cyclophosphamide|mesh-list
83423418|NCT05577000|Fludarabine|fludarabine|mesh-list
83423419|NCT05577000|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
83423420|NCT05577000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83423421|NCT05577000|Immunologic Factors|immunologic factors|mesh-ancestor
83423422|NCT05577000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423423|NCT05577000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423424|NCT05577000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83423425|NCT05577000|Alkylating Agents|alkylating agents|mesh-ancestor
83423426|NCT05577000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423427|NCT05577000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423428|NCT05577000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83423429|NCT05577000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83423430|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83423431|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423432|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423433|NCT00122447|Aspirin|aspirin|mesh-list
83423434|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
83423435|NCT00122447|Olmesartan|olmesartan|mesh-list
83423436|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83423437|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83423438|NCT00122447|Analgesics|analgesics|mesh-ancestor
83423439|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
83423440|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423441|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423442|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423443|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423444|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83423445|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83423446|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423447|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83423448|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83423449|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423450|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
83423451|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83423452|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83423453|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83423454|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
83423455|NCT00122447|Protective Agents|protective agents|mesh-ancestor
83423456|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
83423457|NCT00122447|Vitamins|vitamins|mesh-ancestor
83423458|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
83423459|NCT00125957|Bupropion|bupropion|mesh-list
83423460|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83423461|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
83423462|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83423463|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83423464|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83423465|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83423466|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423467|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
83423468|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423469|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423470|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83423471|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83423472|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423473|NCT00183443|Valproic Acid|valproic acid|mesh-list
83423474|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83423475|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
83423476|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83423477|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83423478|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83423479|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423480|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423481|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423482|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423483|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
83423484|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
83423485|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
83423486|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423487|NCT02579928|Midazolam|midazolam|mesh-list
83423488|NCT02579928|Ketamine|ketamine|mesh-list
83423489|NCT02579928|Analgesics|analgesics|mesh-ancestor
83423490|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
83423491|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423492|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423493|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83423494|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83423495|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
83423496|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
83423497|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423498|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83423499|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83423500|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423501|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423502|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83423503|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83423504|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83423505|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83423506|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83423507|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
83423508|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
83423509|NCT00183677|Escitalopram|escitalopram|mesh-list
83423510|NCT00183677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83423511|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83423512|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83423513|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423514|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423515|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
83423516|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423517|NCT00186017|Olanzapine|olanzapine|mesh-list
83423518|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
83423519|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
83423520|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423521|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423522|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83423523|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83423524|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83423525|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423526|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83423527|NCT00186017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83423528|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83423529|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83423530|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423531|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423532|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
83423533|NCT00041119|Paclitaxel|paclitaxel|mesh-list
83423534|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
83423535|NCT00041119|Doxorubicin|doxorubicin|mesh-list
83423536|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83423537|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83423538|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423539|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
83423540|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
83423541|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
83423542|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423543|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83423544|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
83423545|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423546|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423547|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83423548|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
83423549|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83423550|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83423551|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83423552|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83423553|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423555|NCT00186875|Dexamethasone|dexamethasone|mesh-list
83423556|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
83423557|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
83423558|NCT00186875|Methotrexate|methotrexate|mesh-list
83423559|NCT00186875|Etoposide|etoposide|mesh-list
83423560|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
83423561|NCT00186875|Vincristine|vincristine|mesh-list
83423562|NCT00186875|Asparaginase|asparaginase|mesh-list
83423563|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
83423564|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
83423565|NCT00186875|Vinblastine|vinblastine|mesh-list
83423566|NCT00186875|Pegaspargase|pegaspargase|mesh-list
83423567|NCT00186875|Teniposide|teniposide|mesh-list
83423568|NCT00186875|BB 1101|bb 1101|mesh-list
83423569|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83423570|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
83423571|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423572|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423573|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83423574|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
83423575|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423576|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423577|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83423578|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423579|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
83423580|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
83423581|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423582|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83423583|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
83423584|NCT00186875|Hormones|hormones|mesh-ancestor
83423585|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423586|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83423587|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
83423588|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423589|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83423590|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
83423591|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83423592|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83423594|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
83423595|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83423596|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83423597|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83423598|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83423599|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83423600|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
83423601|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423602|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
83423603|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
83423604|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
83423605|NCT00186875|Analgesics|analgesics|mesh-ancestor
83423606|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
83423607|NCT00551460|Methotrexate|methotrexate|mesh-list
83423608|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
83423609|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
83423610|NCT00551460|Tretinoin|tretinoin|mesh-list
83423611|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
83423612|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83423613|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
83423614|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83423615|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423616|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83423617|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
83423618|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423619|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423620|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
83423621|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423622|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83423623|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83423624|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
83423625|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423626|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83423627|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
83423628|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83423629|NCT00551460|Immunotoxins|immunotoxins|mesh-ancestor
83423630|NCT00551460|Immunoconjugates|immunoconjugates|mesh-ancestor
83423631|NCT04751227|Modafinil|modafinil|mesh-list
83423632|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83423633|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423634|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83423635|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83423636|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83423637|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423638|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
83423639|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83423640|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
83423641|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423642|NCT02579772|Expectorants|expectorants|mesh-ancestor
83423643|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
83423644|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83423645|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
83423646|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423647|NCT02579772|Protective Agents|protective agents|mesh-ancestor
83423648|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423649|NCT02579772|Antidotes|antidotes|mesh-ancestor
83423650|NCT05535036|Dexamethasone|dexamethasone|mesh-list
83423651|NCT05535036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423652|NCT05535036|Antiemetics|antiemetics|mesh-ancestor
83423653|NCT05535036|Autonomic Agents|autonomic agents|mesh-ancestor
83423654|NCT05535036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423655|NCT05535036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423656|NCT05535036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83423657|NCT05535036|Glucocorticoids|glucocorticoids|mesh-ancestor
83423658|NCT05535036|Hormones|hormones|mesh-ancestor
83423659|NCT05535036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423660|NCT05535036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83423661|NCT05535036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423662|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83423663|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83423664|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83423665|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423666|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423667|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83423668|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83423669|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83423670|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83423671|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
83423672|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423673|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423674|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83423675|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83423676|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
83423677|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83423678|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83423679|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
83423681|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83423682|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83423683|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
83423684|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423685|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
83423686|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83423687|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
83423688|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423689|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423690|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83423691|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
83423692|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423693|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423694|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83423695|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
83423696|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
83423697|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83423698|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423699|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423700|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83423701|NCT04953156|Analgesics|analgesics|mesh-ancestor
83423702|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
83423703|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423704|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83423705|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83423706|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83423707|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
83423708|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423709|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423710|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
83423712|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423713|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83423714|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423715|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423716|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83423717|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423718|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83423719|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423720|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423721|NCT00278863|Capecitabine|capecitabine|mesh-list
83423722|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83423723|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
83423724|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423725|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423726|NCT01762059|Pancrelipase|pancrelipase|mesh-list
83423727|NCT01762059|Pancreatin|pancreatin|mesh-list
83423728|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83423729|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
83423730|NCT04938024|Vitamins|vitamins|mesh-ancestor
83423731|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
83423732|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423733|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
83423734|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423735|NCT04938024|Protective Agents|protective agents|mesh-ancestor
83423736|NCT01808547|Bromfenac|bromfenac|mesh-list
83423737|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83423738|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83423739|NCT01808547|Analgesics|analgesics|mesh-ancestor
83423740|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
83423741|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423742|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423743|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423744|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423745|NCT00187655|Cefotaxime|cefotaxime|mesh-list
83423746|NCT00187655|Cefoxitin|cefoxitin|mesh-list
83423747|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83423748|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423749|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83423750|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423751|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83423752|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423753|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423754|NCT02579616|Lenvatinib|lenvatinib|mesh-list
83423755|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423756|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83423757|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423758|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423759|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
83423760|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83423761|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
83423762|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83423763|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423764|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83423765|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83423766|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83423767|NCT05534802|Urinastatin|urinastatin|mesh-list
83423768|NCT05534802|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83423769|NCT05534802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83423770|NCT05534802|Protease Inhibitors|protease inhibitors|mesh-ancestor
83423771|NCT05534802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423772|NCT05534802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423773|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83423774|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83423775|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83423776|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83423777|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423778|NCT01790893|Aflibercept|aflibercept|mesh-list
83423779|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83423780|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83423781|NCT01790893|Growth Substances|growth substances|mesh-ancestor
83423782|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423783|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
83423784|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423785|NCT02256111|Androgens|androgens|mesh-list
83423786|NCT02256111|Hormones|hormones|mesh-ancestor
83423787|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423788|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423789|NCT01790971|Morphine|morphine|mesh-list
83423790|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83423791|NCT01790971|Narcotics|narcotics|mesh-ancestor
83423792|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423793|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423794|NCT01790971|Analgesics|analgesics|mesh-ancestor
83423795|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
83423796|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423797|NCT00189137|Gemcitabine|gemcitabine|mesh-list
83423798|NCT00189137|Docetaxel|docetaxel|mesh-list
83423799|NCT00189137|Doxorubicin|doxorubicin|mesh-list
83423800|NCT00189137|Ifosfamide|ifosfamide|mesh-list
83423801|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83423802|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
83423803|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423804|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423805|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
83423806|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
83423807|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
83423808|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83423809|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83423810|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83423811|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423812|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83423813|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
83423814|NCT02099461|Denosumab|denosumab|mesh-list
83423815|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83423816|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423817|NCT04860960|Betadex|betadex|mesh-list
83423818|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
83423819|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423820|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83423821|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83423822|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423823|NCT02256189|Incretins|incretins|mesh-ancestor
83423824|NCT02256189|Hormones|hormones|mesh-ancestor
83423825|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423826|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83423827|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
83423828|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423829|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423830|NCT00193037|Docetaxel|docetaxel|mesh-list
83423831|NCT00193037|Doxorubicin|doxorubicin|mesh-list
83423832|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83423833|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423834|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
83423835|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
83423836|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
83423837|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423838|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83423839|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83423840|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83423841|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423842|NCT02100007|Topotecan|topotecan|mesh-list
83423843|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83423844|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83423845|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423846|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423847|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423848|NCT05392764|Empagliflozin|empagliflozin|mesh-list
83423849|NCT05392764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83423850|NCT05392764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423851|NCT05392764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83423852|NCT05392764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423853|NCT02866383|Nivolumab|nivolumab|mesh-list
83423854|NCT02866383|Ipilimumab|ipilimumab|mesh-list
83423855|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83423856|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423857|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83423858|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423859|NCT01809639|Progesterone|progesterone|mesh-list
83423860|NCT01809639|Progestins|progestins|mesh-ancestor
83423861|NCT01809639|Hormones|hormones|mesh-ancestor
83423862|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423863|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423864|NCT05391750|Venetoclax|venetoclax|mesh-list
83423865|NCT05391750|Immunoglobulins|immunoglobulins|mesh-list
83423866|NCT05391750|Immunoglobulin G|immunoglobulin g|mesh-list
83423867|NCT05391750|Immunologic Factors|immunologic factors|mesh-ancestor
83423868|NCT05391750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423869|NCT05391750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423870|NCT01763931|Digoxin|digoxin|mesh-list
83423871|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83423872|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83423873|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423874|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423875|NCT01763931|Protective Agents|protective agents|mesh-ancestor
83423876|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423877|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83423878|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423879|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423880|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83423881|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83423882|NCT04677114|Buprenorphine|buprenorphine|mesh-list
83423883|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83423884|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423885|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
83423886|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83423887|NCT04677114|Narcotics|narcotics|mesh-ancestor
83423888|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423889|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423890|NCT04677114|Analgesics|analgesics|mesh-ancestor
83423891|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
83423892|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423893|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83423894|NCT02783859|Amoxicillin|amoxicillin|mesh-list
83423895|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
83423896|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
83423897|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83423898|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83423899|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423900|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423901|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423902|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83423903|NCT01765803|Thioridazine|thioridazine|mesh-list
83423904|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83423905|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83423906|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423907|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423908|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83423909|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83423910|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
83423911|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423912|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423913|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
83423914|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83423915|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
83423916|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423917|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423918|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83423919|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
83423920|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423921|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423922|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83423923|NCT01811355|Mexiletine|mexiletine|mesh-list
83423924|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83423925|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83423926|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83423927|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83423928|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423929|NCT05534334|Hydrocortisone|hydrocortisone|mesh-list
83423930|NCT05534334|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83423931|NCT05534334|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83423932|NCT05534334|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83423933|NCT05534334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423934|NCT01767285|Etonogestrel|etonogestrel|mesh-list
83423935|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83423936|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
83423937|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83423938|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423939|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83423940|NCT02100891|Immunomodulating Agents|immunomodulating agents|mesh-list
83423941|NCT02100891|Immunologic Factors|immunologic factors|mesh-ancestor
83423942|NCT02100891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423943|NCT01465802|Doxycycline|doxycycline|mesh-list
83423944|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
83423945|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83423946|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83423947|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
83423948|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83423949|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83423950|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423951|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
83423952|NCT01465802|Hormones|hormones|mesh-ancestor
83423953|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423954|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423955|NCT01813149|Clonidine|clonidine|mesh-list
83423956|NCT01813149|Phenylephrine|phenylephrine|mesh-list
83423957|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
83423958|NCT01813149|Anesthetics|anesthetics|mesh-list
83423959|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
83423960|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83423961|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423962|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
83423963|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83423964|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83423965|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
83423966|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
83423967|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
83423968|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83423969|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
83423970|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
83423971|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83423972|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83423973|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83423974|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
83423975|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83423976|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83423977|NCT01813149|Protective Agents|protective agents|mesh-ancestor
83423978|NCT01813149|Analgesics|analgesics|mesh-ancestor
83423979|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83423980|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
83423981|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83423982|NCT00137969|Acetaminophen|acetaminophen|mesh-list
83423983|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
83423984|NCT00137969|Promethazine|promethazine|mesh-list
83423985|NCT00137969|Prednisone|prednisone|mesh-list
83423986|NCT00137969|Rituximab|rituximab|mesh-list
83423987|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83423988|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423989|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
83423990|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83423991|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83423992|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423993|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
83423994|NCT00137969|Hormones|hormones|mesh-ancestor
83423995|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423996|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83423997|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83423998|NCT00137969|Analgesics|analgesics|mesh-ancestor
83423999|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
83424000|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424001|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
83424002|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83424003|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83424004|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83424005|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
83424006|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
83424007|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
83424008|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
83424009|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83424010|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83424011|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
83424012|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
83424013|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424014|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424015|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83424016|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
83424017|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
83424018|NCT01437878|Iloprost|iloprost|mesh-list
83424019|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83424020|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
83424021|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
83424022|NCT04767308|Fludarabine|fludarabine|mesh-list
83424023|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83424024|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
83424025|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424026|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424027|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83424028|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
83424029|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424030|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424031|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83424032|NCT00138125|Trastuzumab|trastuzumab|mesh-list
83424033|NCT00138125|Fulvestrant|fulvestrant|mesh-list
83424034|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83424035|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424036|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83424037|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83424038|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83424039|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
83424040|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424041|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424042|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83424044|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83424045|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83424046|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
83424047|NCT01465178|Vitamin D|vitamin d|mesh-list
83424048|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83424049|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424050|NCT01465178|Vitamins|vitamins|mesh-ancestor
83424051|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
83424052|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83424053|NCT00138203|Vorinostat|vorinostat|mesh-list
83424054|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424055|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83424056|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424057|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424058|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83424059|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83424060|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83424061|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424062|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424063|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83424064|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83424065|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424066|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
83424067|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424068|NCT00194129|Valproic Acid|valproic acid|mesh-list
83424069|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
83424070|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
83424071|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83424072|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424073|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424074|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
83424075|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83424076|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83424077|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424078|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
83424079|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
83424080|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424081|NCT01817907|Trazodone|trazodone|mesh-list
83424082|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83424083|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83480260|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
83424084|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83424085|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424086|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83424087|NCT01817907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83424088|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83424089|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83424090|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424091|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424092|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
83424093|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83424094|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
83424095|NCT01445678|Metronidazole|metronidazole|mesh-list
83424096|NCT01445678|Meropenem|meropenem|mesh-list
83424097|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424098|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83424099|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83424100|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83424101|NCT01818063|Paclitaxel|paclitaxel|mesh-list
83424102|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
83424103|NCT01818063|Carboplatin|carboplatin|mesh-list
83424104|NCT01818063|Doxorubicin|doxorubicin|mesh-list
83424105|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83424106|NCT01818063|Veliparib|veliparib|mesh-list
83424107|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83424108|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424109|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
83424110|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
83424111|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
83424112|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424113|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83424114|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
83424115|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424116|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424117|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83424118|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
83424119|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83424120|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83424121|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83424122|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83424123|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424124|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83424125|NCT04273139|Venetoclax|venetoclax|mesh-list
83424126|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424127|NCT01465022|Estrogens|estrogens|mesh-list
83424128|NCT01465022|Progestins|progestins|mesh-list
83424129|NCT01465022|Hormones|hormones|mesh-ancestor
83424130|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424131|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424132|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83424133|NCT02258217|Hormones|hormones|mesh-ancestor
83424134|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424135|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424136|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83424137|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83424138|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424139|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83424140|NCT01464788|Argatroban|argatroban|mesh-list
83424141|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83424142|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83424143|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424144|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
83424145|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83424146|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
83424147|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424148|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
83424149|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83424150|NCT01444898|Exenatide|exenatide|mesh-list
83424151|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83424152|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424153|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83424154|NCT01444898|Incretins|incretins|mesh-ancestor
83424155|NCT01444898|Hormones|hormones|mesh-ancestor
83424156|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424157|NCT00201773|Celecoxib|celecoxib|mesh-list
83424158|NCT00201773|Exemestane|exemestane|mesh-list
83424159|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83424160|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83424161|NCT00201773|Analgesics|analgesics|mesh-ancestor
83424162|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
83424163|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424164|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424165|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424166|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424167|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83424168|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83424169|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424170|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424171|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424172|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83424173|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83424174|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83424175|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
83424176|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424177|NCT00256217|Anastrozole|anastrozole|mesh-list
83424178|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83424179|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424180|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83424181|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83424182|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424183|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424184|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83424185|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
83424186|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424187|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424188|NCT05643066|Ketamine|ketamine|mesh-list
83424189|NCT05643066|Propofol|propofol|mesh-list
83424190|NCT05643066|Esketamine|esketamine|mesh-list
83424191|NCT05643066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83424192|NCT05643066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83424193|NCT05643066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424194|NCT05643066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83424195|NCT05643066|Anesthetics, General|anesthetics, general|mesh-ancestor
83424196|NCT05643066|Anesthetics|anesthetics|mesh-ancestor
83424197|NCT05643066|Analgesics|analgesics|mesh-ancestor
83424198|NCT05643066|Sensory System Agents|sensory system agents|mesh-ancestor
83424199|NCT05643066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424200|NCT05643066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83424201|NCT05643066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83424202|NCT05643066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83424203|NCT05643066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424204|NCT05643066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424205|NCT05643066|Antidepressive Agents|antidepressive agents|mesh-ancestor
83424206|NCT05643066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83424207|NCT00256451|Ethanol|ethanol|mesh-list
83424208|NCT00256451|Naltrexone|naltrexone|mesh-list
83424209|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83424210|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424211|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83424212|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424213|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83424214|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83424215|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
83424216|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424217|NCT03582618|Sorafenib|sorafenib|mesh-list
83424218|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424219|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83424220|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424221|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424222|NCT00257309|Tenecteplase|tenecteplase|mesh-list
83424223|NCT00257309|Clopidogrel|clopidogrel|mesh-list
83424224|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83424225|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83424226|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83424227|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83424228|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
83424229|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424230|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424231|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424232|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83424233|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83424234|NCT01444742|Cytarabine|cytarabine|mesh-list
83424235|NCT01444742|Clofarabine|clofarabine|mesh-list
83424236|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83424237|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
83424238|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424239|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424240|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
83424241|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424242|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83424243|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
83424244|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424245|NCT01770483|Interferons|interferons|mesh-list
83424246|NCT01770483|Ribavirin|ribavirin|mesh-list
83424247|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
83424248|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
83424249|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424250|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
83424251|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424252|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
83424253|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424254|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
83424255|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424256|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83424257|NCT00257933|Prednisolone|prednisolone|mesh-list
83424258|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83424259|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
83424260|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83424261|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
83424262|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83424263|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
83424264|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424265|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
83424266|NCT00257933|Hormones|hormones|mesh-ancestor
83424267|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424268|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424269|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83424271|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
83424272|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
83424273|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424274|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83424275|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83424276|NCT00257933|Protective Agents|protective agents|mesh-ancestor
83424277|NCT01734525|Anidulafungin|anidulafungin|mesh-list
83424278|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
83424279|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424280|NCT01819935|Vancomycin|vancomycin|mesh-list
83424281|NCT01819935|Linezolid|linezolid|mesh-list
83424282|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83424283|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424284|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83424285|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424286|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424287|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83424288|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83424289|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424290|NCT00264641|Insulin|insulin|mesh-list
83424291|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83424292|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83424293|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424294|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
83424295|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424296|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
83424297|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83424298|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83424299|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424300|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
83424301|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424302|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424303|NCT00266279|Capecitabine|capecitabine|mesh-list
83424304|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
83424305|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83424306|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
83424307|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424308|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424309|NCT01736085|Nicotine|nicotine|mesh-list
83424310|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83424311|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
83424312|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424313|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424314|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83424315|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83424316|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
83424317|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424318|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424319|NCT00210353|Rituximab|rituximab|mesh-list
83424320|NCT00210353|Chlorambucil|chlorambucil|mesh-list
83424321|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83424322|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424323|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
83424324|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424325|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424326|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83424327|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
83424328|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424329|NCT00267059|Lenalidomide|lenalidomide|mesh-list
83424330|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
83424331|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424332|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83424333|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83424334|NCT00267059|Growth Substances|growth substances|mesh-ancestor
83424335|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
83424336|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424337|NCT00213239|Remifentanil|remifentanil|mesh-list
83424338|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83424339|NCT00213239|Narcotics|narcotics|mesh-ancestor
83424340|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83424341|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424342|NCT00213239|Analgesics|analgesics|mesh-ancestor
83424343|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
83424344|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424345|NCT01444430|Budesonide|budesonide|mesh-list
83424346|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83424347|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424348|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83424349|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
83424350|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424351|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424352|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83424353|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
83424355|NCT01444430|Hormones|hormones|mesh-ancestor
83424356|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424357|NCT01774149|Diazepam|diazepam|mesh-list
83424358|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83424359|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
83424360|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
83424361|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
83424362|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424363|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424364|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83424365|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83424366|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83424367|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83424368|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83424369|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83424370|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83424371|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83424372|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83424373|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
83424374|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
83424375|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
83424376|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
83424377|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424378|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424379|NCT01898507|Nicotine|nicotine|mesh-list
83424380|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83424381|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
83424382|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424383|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424384|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83424385|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83424386|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
83424387|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424388|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424389|NCT00267293|Acetaminophen|acetaminophen|mesh-list
83424390|NCT00267293|Ibuprofen|ibuprofen|mesh-list
83424391|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83424392|NCT00267293|Analgesics|analgesics|mesh-ancestor
83424393|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
83424394|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424395|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424396|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
83424397|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83424398|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424399|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424400|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83424401|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424402|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424403|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83424404|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
83424405|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83424406|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83424407|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424408|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83424409|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83424410|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83424411|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424412|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
83424413|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424414|NCT02579382|Vesatolimod|vesatolimod|mesh-list
83424415|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
83424416|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424417|NCT01774851|Paclitaxel|paclitaxel|mesh-list
83424418|NCT01774851|Trastuzumab|trastuzumab|mesh-list
83424419|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83424420|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424421|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
83424422|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
83424423|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
83480261|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424424|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424425|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83424426|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
83424427|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
83424428|NCT02990013|Povidone|povidone|mesh-list
83424429|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83424430|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424431|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
83424432|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
83424433|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
83424434|NCT03440112|Clarithromycin|clarithromycin|mesh-list
83424435|NCT03440112|Flumazenil|flumazenil|mesh-list
83424436|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83424437|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424438|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83424439|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424440|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424441|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83424442|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83424443|NCT03440112|Antidotes|antidotes|mesh-ancestor
83424444|NCT03440112|Protective Agents|protective agents|mesh-ancestor
83424445|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424446|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
83424447|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
83424448|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424449|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83424450|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
83424451|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83424452|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83424453|NCT01775865|Analgesics|analgesics|mesh-ancestor
83424454|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
83424455|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424456|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424457|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424458|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424459|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83424460|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424461|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424462|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83424463|NCT01419236|Testosterone|testosterone|mesh-list
83424464|NCT01419236|Androgens|androgens|mesh-ancestor
83424465|NCT01419236|Hormones|hormones|mesh-ancestor
83424466|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424467|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424468|NCT03323658|Bexarotene|bexarotene|mesh-list
83424469|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424470|NCT01443026|Lycopene|lycopene|mesh-list
83424471|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424472|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
83424473|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424474|NCT01443026|Protective Agents|protective agents|mesh-ancestor
83424475|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424476|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83424477|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83424479|NCT01879371|Ibuprofen|ibuprofen|mesh-list
83424480|NCT01879371|Caffeine|caffeine|mesh-list
83424481|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83424482|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83424483|NCT01879371|Analgesics|analgesics|mesh-ancestor
83424484|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
83424485|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424486|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424487|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424488|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424489|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83424490|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424491|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424492|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83424494|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83424495|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83424496|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
83424497|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424498|NCT01733745|Vitamins|vitamins|mesh-list
83424499|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83424500|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
83424501|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424502|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83424503|NCT03276468|Atezolizumab|atezolizumab|mesh-list
83424504|NCT03276468|Venetoclax|venetoclax|mesh-list
83424505|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
83424506|NCT03276468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83424507|NCT03276468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424508|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83424509|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424510|NCT01442714|Lenalidomide|lenalidomide|mesh-list
83424511|NCT01442714|Azacitidine|azacitidine|mesh-list
83424512|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
83424513|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424514|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83424515|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83424516|NCT01442714|Growth Substances|growth substances|mesh-ancestor
83424517|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
83424518|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424519|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83424520|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
83424521|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424522|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424523|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
83424524|NCT05532852|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83424525|NCT05532852|Antiviral Agents|antiviral agents|mesh-ancestor
83424526|NCT05532852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424527|NCT05532618|Levobupivacaine|levobupivacaine|mesh-list
83424528|NCT05532618|Anesthetics, Local|anesthetics, local|mesh-ancestor
83424529|NCT05532618|Anesthetics|anesthetics|mesh-ancestor
83424530|NCT05532618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83424531|NCT05532618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424532|NCT05532618|Sensory System Agents|sensory system agents|mesh-ancestor
83424533|NCT05532618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424534|NCT05501574|Tacrolimus|tacrolimus|mesh-list
83424535|NCT05501574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83424536|NCT05501574|Immunologic Factors|immunologic factors|mesh-ancestor
83424537|NCT05501574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424538|NCT05501574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83424539|NCT05501574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424540|NCT05501574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424541|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83424542|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83424543|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83424544|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83424545|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424546|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83424547|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83424548|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83424549|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83424550|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
83424551|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424552|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424553|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83424554|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83424555|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
83424556|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83424557|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83424558|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
83424559|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
83424560|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83424561|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424562|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
83424563|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83424564|NCT01828515|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83424565|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83424566|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83424567|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424568|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424570|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424571|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83424572|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83424573|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
83424574|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83424575|NCT01828593|Antibodies|antibodies|mesh-list
83424576|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
83424577|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424578|NCT01781169|Vitamin D|vitamin d|mesh-list
83424579|NCT01781169|Vitamins|vitamins|mesh-ancestor
83424580|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
83424581|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424582|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83424583|NCT00216125|Docetaxel|docetaxel|mesh-list
83424584|NCT00216125|Etoposide|etoposide|mesh-list
83424585|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424586|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
83424587|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
83424588|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
83424589|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424590|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83424591|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83424592|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83424593|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424594|NCT01781403|Capecitabine|capecitabine|mesh-list
83424595|NCT01781403|Temozolomide|temozolomide|mesh-list
83424596|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83424597|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
83424598|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424599|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424600|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83424601|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
83424602|NCT00218387|Modafinil|modafinil|mesh-list
83424603|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83424604|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424605|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83424606|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83424607|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83424608|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424609|NCT00218465|Glycine|glycine|mesh-list
83424610|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
83424611|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424612|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424613|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424614|NCT01898585|Vemurafenib|vemurafenib|mesh-list
83424615|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424616|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83424617|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424618|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424619|NCT00220961|Pioglitazone|pioglitazone|mesh-list
83424620|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83424621|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424622|NCT00222131|Esomeprazole|esomeprazole|mesh-list
83424623|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83424624|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83424625|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83424626|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424627|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424628|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83424629|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83424630|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83424631|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83424632|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
83424633|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424634|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424635|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83424636|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
83424637|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424638|NCT01782963|Dexamethasone|dexamethasone|mesh-list
83424639|NCT01782963|Lenalidomide|lenalidomide|mesh-list
83424640|NCT01782963|Bortezomib|bortezomib|mesh-list
83424641|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424642|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
83424643|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
83424644|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424645|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424646|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83424647|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
83424648|NCT01782963|Hormones|hormones|mesh-ancestor
83424649|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424650|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83424651|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424652|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
83424653|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83424654|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83424655|NCT01782963|Growth Substances|growth substances|mesh-ancestor
83424656|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
83424657|NCT01829217|Sunitinib|sunitinib|mesh-list
83424658|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424659|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83424660|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83424661|NCT01829217|Growth Substances|growth substances|mesh-ancestor
83424662|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424663|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
83424664|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83424665|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424666|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424667|NCT05327751|Celecoxib|celecoxib|mesh-list
83424668|NCT05327751|Capecitabine|capecitabine|mesh-list
83424669|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83424670|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
83424671|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424672|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424673|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83424674|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83424675|NCT05327751|Analgesics|analgesics|mesh-ancestor
83424676|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
83424677|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424678|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424679|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424680|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424681|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83424682|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83424683|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424684|NCT02096861|Infliximab|infliximab|mesh-list
83424685|NCT02096861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83424686|NCT02096861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424687|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
83424688|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83424689|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424690|NCT01829919|Paroxetine|paroxetine|mesh-list
83424691|NCT01829919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83424692|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83424693|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83424694|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424695|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424696|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
83424697|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424698|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83424699|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
83424700|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83424701|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83424702|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83424703|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424704|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
83424705|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83424706|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83424707|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
83424708|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
83424709|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424710|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83424711|NCT00274781|Immunotoxins|immunotoxins|mesh-ancestor
83424713|NCT00274781|Immunologic Factors|immunologic factors|mesh-ancestor
83424714|NCT00274781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424715|NCT00226577|Gemcitabine|gemcitabine|mesh-list
83424716|NCT00226577|Pemetrexed|pemetrexed|mesh-list
83424717|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83424718|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
83424719|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424720|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424721|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424722|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83480262|NCT04407754|Inositol|inositol|mesh-list
83424723|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83424725|NCT01830699|Rilonacept|rilonacept|mesh-list
83424726|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424727|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
83424728|NCT01830699|Hormones|hormones|mesh-ancestor
83424729|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424730|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424731|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
83424732|NCT00280241|Rituximab|rituximab|mesh-list
83424733|NCT00280241|Fludarabine|fludarabine|mesh-list
83424734|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83424735|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
83424736|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424737|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424738|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83424739|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
83424740|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424741|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424742|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83424743|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83424744|NCT01899755|Adalimumab|adalimumab|mesh-list
83424745|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83424746|NCT01899755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83424747|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424748|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424749|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83424750|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83424751|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424752|NCT00229619|Rituximab|rituximab|mesh-list
83424753|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83424754|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424755|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
83424756|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424757|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83424758|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83424759|NCT00281021|Digoxin|digoxin|mesh-list
83424760|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424761|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83424762|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424763|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424764|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83424765|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83424766|NCT00281021|Protective Agents|protective agents|mesh-ancestor
83424767|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424768|NCT01786161|Vancomycin|vancomycin|mesh-list
83424769|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83424770|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424771|NCT01786239|Risperidone|risperidone|mesh-list
83424772|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83424773|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
83424774|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424775|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424776|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424777|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83424778|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83424779|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83424780|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83424781|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83424782|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
83424783|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
83424784|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
83424785|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424786|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424787|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83424788|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
83424789|NCT01833741|Bimatoprost|bimatoprost|mesh-list
83424790|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83424791|NCT02261727|Prednisone|prednisone|mesh-list
83424792|NCT02261727|Cortisone|cortisone|mesh-list
83424793|NCT02261727|Theophylline|theophylline|mesh-list
83424794|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424795|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
83424797|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424798|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424799|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83424800|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424801|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83424802|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
83424803|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424804|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83424805|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
83424806|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83424807|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424808|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424809|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
83424810|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83424811|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83424812|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
83424813|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424814|NCT02261805|Doxorubicin|doxorubicin|mesh-list
83424815|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83424816|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424817|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83424818|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83424819|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424820|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424821|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83424822|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83424823|NCT05300841|Estradiol|estradiol|mesh-list
83424824|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83424825|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
83424826|NCT05300841|Estrogens|estrogens|mesh-ancestor
83424827|NCT05300841|Hormones|hormones|mesh-ancestor
83424828|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424829|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424830|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83424831|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
83424832|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83424833|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83424834|NCT05300841|Progestins|progestins|mesh-ancestor
83424835|NCT00232505|Carboplatin|carboplatin|mesh-list
83424836|NCT00232505|Cetuximab|cetuximab|mesh-list
83424837|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424838|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83424839|NCT00232583|Metformin|metformin|mesh-list
83424840|NCT00232583|Pioglitazone|pioglitazone|mesh-list
83424841|NCT00232583|Glyburide|glyburide|mesh-list
83424842|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83424843|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424844|NCT00232739|Sirolimus|sirolimus|mesh-list
83424845|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83424846|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424847|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83424848|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424849|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
83424850|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83424851|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
83424852|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424853|NCT01789905|Tigecycline|tigecycline|mesh-list
83424854|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83424855|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424856|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83424857|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424858|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424859|NCT01790685|Dexamethasone|dexamethasone|mesh-list
83424860|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424861|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
83424862|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
83480263|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
83424863|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424864|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424865|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83424866|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
83424868|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424869|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83424870|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424871|NCT01838655|Nitisinone|nitisinone|mesh-list
83424872|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424873|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424874|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83424875|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
83424876|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424877|NCT00282971|Insulin|insulin|mesh-list
83424878|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83424879|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424880|NCT01791465|Exenatide|exenatide|mesh-list
83424881|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83424882|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424883|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83424884|NCT01791465|Incretins|incretins|mesh-ancestor
83424885|NCT01791465|Hormones|hormones|mesh-ancestor
83424886|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424887|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83424888|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83424889|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424890|NCT00285467|Vitamin D|vitamin d|mesh-list
83424891|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
83424892|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83424893|NCT00285467|Vitamins|vitamins|mesh-ancestor
83424894|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
83424895|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424896|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83424897|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83424898|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83424899|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
83424900|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424901|NCT05261321|Dronabinol|dronabinol|mesh-list
83424902|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
83424903|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424904|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83424905|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83424906|NCT05261321|Analgesics|analgesics|mesh-ancestor
83424907|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
83424908|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424909|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83424910|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83424911|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424912|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424913|NCT05261321|Hormones|hormones|mesh-ancestor
83424914|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424915|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
83424916|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83424917|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424918|NCT01676753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83424919|NCT01676753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424920|NCT01794039|Dexamethasone|dexamethasone|mesh-list
83424921|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
83424922|NCT01794039|Lenalidomide|lenalidomide|mesh-list
83424923|NCT01794039|Pomalidomide|pomalidomide|mesh-list
83424924|NCT01794039|Ichthammol|ichthammol|mesh-list
83424925|NCT01794039|BB 1101|bb 1101|mesh-list
83424926|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424927|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
83424928|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
83424929|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424930|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424931|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83424932|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
83424933|NCT01794039|Hormones|hormones|mesh-ancestor
83424934|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83424935|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83424936|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424937|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
83424938|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83424939|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83424940|NCT01794039|Growth Substances|growth substances|mesh-ancestor
83424941|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
83424942|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
83424943|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424944|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424945|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
83424946|NCT00281827|Thalidomide|thalidomide|mesh-list
83424947|NCT00281827|Carboplatin|carboplatin|mesh-list
83424948|NCT00281827|Gemcitabine|gemcitabine|mesh-list
83424949|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83424950|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83424951|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
83424952|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424953|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83424954|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
83424955|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424956|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
83424957|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83424958|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83424959|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83424960|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83424961|NCT00281827|Growth Substances|growth substances|mesh-ancestor
83424962|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
83424963|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
83424964|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83424965|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83424966|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424967|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83424968|NCT01898819|Analgesics|analgesics|mesh-ancestor
83424969|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
83424970|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424971|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83424972|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83424973|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83424974|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
83424975|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83424976|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424977|NCT01794741|Fluticasone|fluticasone|mesh-list
83424979|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83424980|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83424981|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
83424982|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83424983|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424984|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83424985|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
83424986|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
83424987|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83424988|NCT04446871|Methylene Blue|methylene blue|mesh-list
83424989|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424990|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83424991|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
83424992|NCT04085419|Denosumab|denosumab|mesh-list
83424993|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83424994|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424995|NCT02989623|Copper|copper|mesh-list
83424996|NCT02989623|Trace Elements|trace elements|mesh-ancestor
83424997|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
83424998|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83424999|NCT00052429|Fluorouracil|fluorouracil|mesh-list
83425000|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425001|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
83425002|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425003|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83425004|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83425005|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
83425006|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425007|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
83425008|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83425009|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425010|NCT03972397|Bupivacaine|bupivacaine|mesh-list
83425011|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
83425012|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
83425013|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83425014|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425015|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
83425016|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425017|NCT00287053|Valproic Acid|valproic acid|mesh-list
83425018|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
83425019|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425020|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425021|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
83425022|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425023|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425024|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
83425025|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83425026|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83425027|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83425028|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83425029|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83425030|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83425031|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83425032|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83425033|NCT01435460|Analgesics|analgesics|mesh-ancestor
83425034|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
83425035|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425036|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425037|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83425038|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425039|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83425040|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83425041|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
83425042|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
83425043|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425044|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425045|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
83425046|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83425047|NCT00236951|Hematinics|hematinics|mesh-ancestor
83425048|NCT00287287|Lenalidomide|lenalidomide|mesh-list
83425049|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
83425050|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425051|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83425052|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83425053|NCT00287287|Growth Substances|growth substances|mesh-ancestor
83425054|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
83425055|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425056|NCT04871061|Fentanyl|fentanyl|mesh-list
83425057|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83425058|NCT04871061|Narcotics|narcotics|mesh-ancestor
83425059|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83425060|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425061|NCT04871061|Analgesics|analgesics|mesh-ancestor
83425062|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
83425063|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425064|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83425065|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83425066|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
83425067|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
83425069|NCT00287989|Carboplatin|carboplatin|mesh-list
83425070|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83425071|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83425072|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425073|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
83425074|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
83425075|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
83425076|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425077|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83425078|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425079|NCT00288067|Rituximab|rituximab|mesh-list
83425080|NCT00288067|Fenretinide|fenretinide|mesh-list
83425081|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83425082|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425083|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
83425084|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425085|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425086|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83425087|NCT00288067|Protective Agents|protective agents|mesh-ancestor
83425088|NCT00285779|Etanercept|etanercept|mesh-list
83425089|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83425090|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83425091|NCT00285779|Analgesics|analgesics|mesh-ancestor
83425092|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
83425093|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425094|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425095|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83425096|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425097|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425098|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83425099|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
83425100|NCT04827537|Metronidazole|metronidazole|mesh-list
83425101|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425102|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83425103|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83425104|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83425105|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83425106|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
83425107|NCT04728087|Coagulants|coagulants|mesh-ancestor
83425108|NCT01435382|Bococizumab|bococizumab|mesh-list
83425109|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83425110|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83425111|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
83425112|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425113|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83425114|NCT01801449|Rilonacept|rilonacept|mesh-list
83425115|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83425116|NCT00286325|Rituximab|rituximab|mesh-list
83425117|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83425118|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425119|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
83425120|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425121|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425122|NCT00238355|Voriconazole|voriconazole|mesh-list
83425123|NCT00238355|Caspofungin|caspofungin|mesh-list
83425124|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
83425125|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425126|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83425127|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83425128|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425129|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425130|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83425131|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
83425132|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425133|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425134|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83425135|NCT01791439|Lidocaine|lidocaine|mesh-list
83425136|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
83425137|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
83425138|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83480264|NCT04407754|Vitamins|vitamins|mesh-ancestor
83425139|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425140|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
83425141|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425142|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83425143|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83425144|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83425145|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83425146|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425147|NCT01650701|Rituximab|rituximab|mesh-list
83425148|NCT01650701|Lenalidomide|lenalidomide|mesh-list
83425149|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83425150|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83425151|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425152|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
83425153|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425154|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425155|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83425156|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83425157|NCT01650701|Growth Substances|growth substances|mesh-ancestor
83425158|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
83425159|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83425160|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
83425161|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425162|NCT00290329|Vaccines|vaccines|mesh-list
83425164|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425165|NCT04058678|Danazol|danazol|mesh-list
83425166|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83425167|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
83425168|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425169|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425170|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83425171|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83425172|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83425173|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83425174|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425175|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
83425176|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425177|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425178|NCT00287339|Esomeprazole|esomeprazole|mesh-list
83425179|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83425180|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425181|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83425182|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425183|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425184|NCT00291655|Levetiracetam|levetiracetam|mesh-list
83425185|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
83425186|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
83425187|NCT01846455|Promethazine|promethazine|mesh-list
83425188|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
83425189|NCT01846455|Buprenorphine|buprenorphine|mesh-list
83425190|NCT01846455|Naloxone|naloxone|mesh-list
83425191|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83425192|NCT01846455|Narcotics|narcotics|mesh-ancestor
83425193|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83425194|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425195|NCT01846455|Analgesics|analgesics|mesh-ancestor
83425196|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
83425197|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425198|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83425199|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
83425200|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
83425201|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83425202|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
83425203|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
83425204|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425205|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425206|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83425207|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83425208|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83425209|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
83425210|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
83425211|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
83425212|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
83425213|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425214|NCT03366415|Cisplatin|cisplatin|mesh-list
83425215|NCT03366415|Gemcitabine|gemcitabine|mesh-list
83425216|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425217|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83425218|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
83425219|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425220|NCT00292591|Vitamin D|vitamin d|mesh-list
83425221|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
83425222|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
83425223|NCT00292591|Vitamins|vitamins|mesh-list
83425224|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
83425225|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425226|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83425227|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83425228|NCT01847001|Paclitaxel|paclitaxel|mesh-list
83425229|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83425230|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
83425231|NCT01847001|Doxorubicin|doxorubicin|mesh-list
83425232|NCT01847001|Trastuzumab|trastuzumab|mesh-list
83425233|NCT01847001|Pertuzumab|pertuzumab|mesh-list
83425234|NCT01847001|Propranolol|propranolol|mesh-list
83425235|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83425236|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425237|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
83425238|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
83425239|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
83425240|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425241|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83425242|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
83425243|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425244|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425245|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83425246|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
83425247|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83425248|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83425249|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83425250|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83425251|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425252|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83425253|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83425254|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83425255|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
83425256|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425257|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83425258|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83425259|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
83425260|NCT01847469|Zonisamide|zonisamide|mesh-list
83425261|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
83425262|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83425263|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83425264|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425265|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83425266|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425267|NCT01804101|Cytarabine|cytarabine|mesh-list
83425268|NCT01804101|Daunorubicin|daunorubicin|mesh-list
83425269|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83425270|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
83425271|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425272|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425273|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
83425274|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425275|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83425276|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
83425277|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425278|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83425279|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83425280|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83425281|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425282|NCT00287729|Pirfenidone|pirfenidone|mesh-list
83425283|NCT00287729|Analgesics|analgesics|mesh-ancestor
83425284|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
83425285|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425286|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425287|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83425288|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83425289|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83425290|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425291|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425292|NCT01433978|Maleic acid|maleic acid|mesh-list
83425293|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425294|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425295|NCT00289211|Complement C1s|complement c1s|mesh-list
83425296|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83425297|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83425298|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
83425299|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425300|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83425301|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83425302|NCT01619111|Lapatinib|lapatinib|mesh-list
83425303|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425304|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83425305|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425306|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425307|NCT01727193|Azathioprine|azathioprine|mesh-list
83425308|NCT01727193|Leflunomide|leflunomide|mesh-list
83425309|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
83425310|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425311|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83425312|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425313|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83425314|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
83425315|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425316|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425317|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425318|NCT00181701|Paclitaxel|paclitaxel|mesh-list
83425319|NCT00181701|Carboplatin|carboplatin|mesh-list
83425320|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83425321|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425322|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
83425323|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
83425324|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
83425325|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425326|NCT01849419|Oxytocin|oxytocin|mesh-list
83425327|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
83425328|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83425329|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425330|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
83425331|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83425332|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425333|NCT05098067|Ondansetron|ondansetron|mesh-list
83425334|NCT05098067|Metoclopramide|metoclopramide|mesh-list
83425335|NCT05098067|Capsaicin|capsaicin|mesh-list
83425336|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
83425337|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
83425338|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425339|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425340|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425341|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
83425342|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
83425343|NCT05098067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83425344|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83425345|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
83425346|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425347|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425348|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
83425349|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83425350|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83425351|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
83425352|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83425353|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83425354|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83425355|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83425356|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425357|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425358|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425359|NCT01852383|Analgesics|analgesics|mesh-ancestor
83425360|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
83425361|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425362|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
83425363|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83425364|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
83425365|NCT04272333|Nivolumab|nivolumab|mesh-list
83425366|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83425367|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425368|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83425369|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425370|NCT02273115|Oxytocin|oxytocin|mesh-list
83425371|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
83425372|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83425373|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425374|NCT01853085|Bimatoprost|bimatoprost|mesh-list
83425375|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83425376|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83425377|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83425378|NCT02989467|Aprepitant|aprepitant|mesh-list
83425379|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
83425380|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
83425381|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425382|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425383|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425384|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83425385|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425386|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425387|NCT01853553|Spironolactone|spironolactone|mesh-list
83425388|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83425389|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
83425390|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425391|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425392|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83425393|NCT01853553|Diuretics|diuretics|mesh-ancestor
83425394|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
83425395|NCT05748561|Methylprednisolone|methylprednisolone|mesh-list
83425396|NCT05748561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83425397|NCT05748561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83425398|NCT05748561|Prednisolone|prednisolone|mesh-list
83425399|NCT05748561|Prednisolone acetate|prednisolone acetate|mesh-list
83425400|NCT05748561|Epoetin Alfa|epoetin alfa|mesh-list
83425401|NCT05748561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83425402|NCT05748561|Prednisolone phosphate|prednisolone phosphate|mesh-list
83425403|NCT05748561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83425404|NCT05748561|Antiemetics|antiemetics|mesh-ancestor
83425405|NCT05748561|Autonomic Agents|autonomic agents|mesh-ancestor
83425406|NCT05748561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425407|NCT05748561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425408|NCT05748561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425409|NCT05748561|Glucocorticoids|glucocorticoids|mesh-ancestor
83425410|NCT05748561|Hormones|hormones|mesh-ancestor
83425411|NCT05748561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425412|NCT05748561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83425413|NCT05748561|Protective Agents|protective agents|mesh-ancestor
83425414|NCT05748561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83425415|NCT05748561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425416|NCT05748561|Hematinics|hematinics|mesh-ancestor
83425417|NCT00290537|Paclitaxel|paclitaxel|mesh-list
83425418|NCT00290537|Carboplatin|carboplatin|mesh-list
83425419|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83425420|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425421|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
83425422|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
83425423|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
83425424|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425425|NCT05748483|Topiramate|topiramate|mesh-list
83425426|NCT05748483|Anticonvulsants|anticonvulsants|mesh-ancestor
83425427|NCT05748483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83425428|NCT05748483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425429|NCT00290615|Bevacizumab|bevacizumab|mesh-list
83425430|NCT00290615|Cetuximab|cetuximab|mesh-list
83425431|NCT00290615|Capecitabine|capecitabine|mesh-list
83425432|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
83425433|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83425434|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425435|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83425436|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83425437|NCT00290615|Growth Substances|growth substances|mesh-ancestor
83425438|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425439|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
83425440|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83425441|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
83425442|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425443|NCT01854177|Aprepitant|aprepitant|mesh-list
83425444|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
83425445|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
83425446|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
83425447|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425448|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425449|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425450|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83425451|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425452|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425453|NCT01591577|Temozolomide|temozolomide|mesh-list
83425454|NCT01591577|Lapatinib|lapatinib|mesh-list
83425455|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83425456|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
83425457|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425458|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425459|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83425460|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425461|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
83425462|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425463|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83425464|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425465|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425466|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
83425468|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83425469|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
83425470|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425471|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83425472|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425473|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425474|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83425475|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425476|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83425477|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
83425478|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83425479|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425480|NCT03799731|Trifluridine|trifluridine|mesh-list
83425481|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
83425482|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425483|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
83425484|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425485|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
83425486|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425487|NCT00244985|Rituximab|rituximab|mesh-list
83425488|NCT00244985|Doxorubicin|doxorubicin|mesh-list
83425489|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83425490|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83425491|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425492|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
83425493|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425494|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425495|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83425496|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83425497|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83425498|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425499|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425500|NCT01857297|Vaccines|vaccines|mesh-list
83425501|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
83425502|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425503|NCT00300391|Haloperidol|haloperidol|mesh-list
83425504|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
83425505|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
83425506|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
83425507|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425508|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425509|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425510|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83425511|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83425512|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83425513|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83425514|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83425515|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
83425516|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425517|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425518|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83425519|NCT01859013|Topiramate|topiramate|mesh-list
83425520|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
83425521|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83425522|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425523|NCT00294515|Valganciclovir|valganciclovir|mesh-list
83425524|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
83425525|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425526|NCT00300469|Atorvastatin|atorvastatin|mesh-list
83425527|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83425528|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83425529|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
83425530|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425531|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83425532|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83425533|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425534|NCT01543763|Abexinostat|abexinostat|mesh-list
83425535|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83425536|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425537|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425538|NCT01859637|Lenograstim|lenograstim|mesh-list
83425539|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83425540|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
83425541|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425542|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
83425543|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83425544|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
83425545|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425546|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425547|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83425548|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83425549|NCT02117141|Hydrocodone|hydrocodone|mesh-list
83425550|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83425551|NCT02117141|Narcotics|narcotics|mesh-ancestor
83425552|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83425553|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425554|NCT02117141|Analgesics|analgesics|mesh-ancestor
83425555|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
83425556|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425557|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
83425558|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
83425559|NCT00299741|Sunitinib|sunitinib|mesh-list
83425560|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425561|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83425562|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83425563|NCT00299741|Growth Substances|growth substances|mesh-ancestor
83425564|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425565|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
83425566|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83425567|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425568|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425569|NCT00328861|Aldesleukin|aldesleukin|mesh-list
83425570|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
83425571|NCT00328861|Fludarabine|fludarabine|mesh-list
83425572|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83425573|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
83425574|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425575|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425576|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83425577|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
83425578|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425579|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425580|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83425581|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83425582|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83425583|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
83425584|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425585|NCT00248807|Enalaprilat|enalaprilat|mesh-list
83425586|NCT00248807|Enalapril|enalapril|mesh-list
83425587|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83425588|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
83425589|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425590|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425591|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83425592|NCT01860807|Ibudilast|ibudilast|mesh-list
83425593|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83425594|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
83425595|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425596|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425597|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83425598|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
83425599|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83425600|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425601|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425602|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83425603|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
83425604|NCT00330421|Sorafenib|sorafenib|mesh-list
83425605|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425606|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83425607|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425608|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425609|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
83425610|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83425611|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83480265|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
83425612|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425613|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
83425614|NCT04350645|Coagulants|coagulants|mesh-ancestor
83425615|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83425616|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83425617|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83425618|NCT00330733|Analgesics|analgesics|mesh-ancestor
83425619|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
83425620|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425621|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425622|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83425623|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425624|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
83425625|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83425626|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425627|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83425628|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83425629|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425630|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425631|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425632|NCT05185973|Micronutrients|micronutrients|mesh-list
83425633|NCT05185973|Trace Elements|trace elements|mesh-list
83425634|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425635|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
83425636|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83425637|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425638|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
83425639|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83425640|NCT00251225|Docetaxel|docetaxel|mesh-list
83425641|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
83425642|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425643|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
83425644|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
83425645|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
83425646|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425647|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83425648|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425649|NCT02979327|Adderall|adderall|mesh-list
83425650|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83425651|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425652|NCT00251303|Riluzole|riluzole|mesh-list
83425653|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
83425654|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83425655|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83425656|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425657|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425658|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425659|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83425660|NCT00251303|Protective Agents|protective agents|mesh-ancestor
83425661|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83425662|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
83425663|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425664|NCT00303823|Protective Agents|protective agents|mesh-ancestor
83425665|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425666|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83425667|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83425668|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425669|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83425670|NCT00300677|Voriconazole|voriconazole|mesh-list
83425671|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
83425672|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425673|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83425674|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83425675|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425676|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425677|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83425678|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
83425679|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425680|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425681|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83425682|NCT00559845|Paclitaxel|paclitaxel|mesh-list
83425683|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
83425684|NCT00559845|Bevacizumab|bevacizumab|mesh-list
83425685|NCT00559845|Fluorouracil|fluorouracil|mesh-list
83425686|NCT00559845|Epirubicin|epirubicin|mesh-list
83425687|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83425688|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425689|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
83425690|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
83425691|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
83425692|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425693|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83425694|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
83425695|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425696|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425697|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83425698|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
83425699|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83425700|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83425701|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83425702|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83425703|NCT00559845|Growth Substances|growth substances|mesh-ancestor
83425704|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
83425705|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
83425706|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83425707|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83425708|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83425709|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83425710|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425711|NCT00304187|Erythromycin|erythromycin|mesh-list
83425712|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
83425713|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83425714|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
83425715|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83425716|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425717|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425718|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83425719|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425720|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425721|NCT00334633|Metronidazole|metronidazole|mesh-list
83425722|NCT00334633|Tinidazole|tinidazole|mesh-list
83425723|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425724|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83425725|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83425726|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83425727|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
83425728|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425729|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83425730|NCT01393964|Dexamethasone|dexamethasone|mesh-list
83425731|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
83425732|NCT01393964|Lenalidomide|lenalidomide|mesh-list
83425733|NCT01393964|Elotuzumab|elotuzumab|mesh-list
83425734|NCT01393964|BB 1101|bb 1101|mesh-list
83425735|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83425736|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
83425737|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
83425738|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425739|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425740|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425741|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
83425742|NCT01393964|Hormones|hormones|mesh-ancestor
83425743|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425744|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83425745|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425746|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
83425747|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425748|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425749|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
83425750|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83425751|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83425752|NCT01393964|Growth Substances|growth substances|mesh-ancestor
83425753|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
83425755|NCT01790555|Dronabinol|dronabinol|mesh-list
83425756|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83425757|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
83425758|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
83425759|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
83425760|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425761|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425762|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425763|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83425764|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83425765|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83425766|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83425767|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83425768|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83425769|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83425770|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83425771|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
83425772|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
83425773|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
83425774|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
83425775|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425776|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425777|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
83425778|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83425779|NCT01790555|Analgesics|analgesics|mesh-ancestor
83425780|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
83425781|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83425782|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83425783|NCT01790555|Hormones|hormones|mesh-ancestor
83425784|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425785|NCT00335725|Hormones|hormones|mesh-list
83425786|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83425787|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425788|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425789|NCT01393730|Prednisone|prednisone|mesh-list
83425790|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
83425791|NCT01393730|Dutasteride|dutasteride|mesh-list
83425792|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83425793|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
83425794|NCT01393730|Hormones|hormones|mesh-ancestor
83425795|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425796|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425797|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83425798|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425799|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83425800|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425801|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425802|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
83425803|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83425804|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83425805|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
83425806|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83425807|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425808|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83425809|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
83425810|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83425811|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425812|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425813|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425814|NCT00337987|Prednisone|prednisone|mesh-list
83425815|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
83425816|NCT00337987|Vincristine|vincristine|mesh-list
83425817|NCT00337987|Doxorubicin|doxorubicin|mesh-list
83425818|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83425819|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
83425820|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83425821|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
83425822|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425823|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83425824|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83425825|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
83425826|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425827|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425828|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83425829|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83425830|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
83425831|NCT00337987|Hormones|hormones|mesh-ancestor
83425832|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425833|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83425834|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83425835|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
83425836|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
83425837|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
83425838|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83425839|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83425840|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83425841|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425842|NCT01393106|Idelalisib|idelalisib|mesh-list
83425843|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425844|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425845|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425846|NCT00553059|Dexamethasone|dexamethasone|mesh-list
83425847|NCT00553059|Dronabinol|dronabinol|mesh-list
83425848|NCT00553059|Palonosetron|palonosetron|mesh-list
83425849|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83425850|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
83425851|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
83425852|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425853|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425854|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425855|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
83425856|NCT00553059|Hormones|hormones|mesh-ancestor
83425857|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425858|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83425859|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83425860|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83425861|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83425862|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
83425863|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425864|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425865|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
83425866|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83425867|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83425868|NCT00553059|Analgesics|analgesics|mesh-ancestor
83425869|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
83425870|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83425871|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83425872|NCT04047836|Nicotine|nicotine|mesh-list
83425873|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83425874|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
83425875|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425876|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425877|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83425878|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83425879|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
83425880|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425881|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425882|NCT02989311|Iron|iron|mesh-list
83425883|NCT02989311|Trace Elements|trace elements|mesh-ancestor
83425884|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
83425885|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425886|NCT00325403|Treprostinil|treprostinil|mesh-list
83425887|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83425888|NCT02015611|Vitamin D|vitamin d|mesh-list
83425889|NCT02015611|Vitamins|vitamins|mesh-ancestor
83425890|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
83425891|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425892|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83425893|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
83425894|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83425895|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83425896|NCT01413542|Enalaprilat|enalaprilat|mesh-list
83425897|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83425898|NCT01413542|Bradykinin|bradykinin|mesh-list
83425899|NCT01413542|Glucagon|glucagon|mesh-list
83425900|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83425901|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83425902|NCT01413542|Substance P|substance p|mesh-list
83425903|NCT01413542|Neurokinin A|neurokinin a|mesh-list
83425904|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83425905|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425906|NCT01413542|Incretins|incretins|mesh-ancestor
83425907|NCT01413542|Hormones|hormones|mesh-ancestor
83425908|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425909|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
83425910|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425911|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425912|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83425913|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
83425914|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
83425915|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83425916|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425917|NCT01873989|Testosterone|testosterone|mesh-list
83425918|NCT01873989|Androgens|androgens|mesh-ancestor
83425919|NCT01873989|Hormones|hormones|mesh-ancestor
83425920|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425921|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425922|NCT01875159|Caffeine|caffeine|mesh-list
83425923|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
83425924|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425925|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83425926|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425927|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83425928|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425929|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83425930|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83425931|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
83425932|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425933|NCT01432574|Vaccines|vaccines|mesh-list
83425934|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
83425935|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425936|NCT00339079|Fluoxetine|fluoxetine|mesh-list
83425937|NCT00339079|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83425938|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83425939|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83425940|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425941|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83425942|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
83425943|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425944|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83425945|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
83425946|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83425947|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83425948|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83425949|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425950|NCT01392560|Empagliflozin|empagliflozin|mesh-list
83425951|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83425952|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425953|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83425954|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425955|NCT00342355|Ritonavir|ritonavir|mesh-list
83425956|NCT00342355|Lopinavir|lopinavir|mesh-list
83425957|NCT00342355|Lamivudine|lamivudine|mesh-list
83425958|NCT00342355|Zidovudine|zidovudine|mesh-list
83425959|NCT00342355|Stavudine|stavudine|mesh-list
83425960|NCT00342355|Didanosine|didanosine|mesh-list
83425961|NCT00342355|Efavirenz|efavirenz|mesh-list
83425962|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83425963|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83425964|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
83425965|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83425966|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83425967|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83425968|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83425969|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
83425970|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83425971|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83425972|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83425973|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83425974|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83425975|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
83425976|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83425977|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83425978|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83425979|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83425980|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83425981|NCT00306163|Fluticasone|fluticasone|mesh-list
83425982|NCT00306163|Ciclesonide|ciclesonide|mesh-list
83425983|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83425984|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83425985|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
83425986|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83425987|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83425988|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83425989|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
83425990|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
83425991|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83425992|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
83425993|NCT00306163|Hormones|hormones|mesh-ancestor
83425994|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83425995|NCT01861665|Bupivacaine|bupivacaine|mesh-list
83425996|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
83425997|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
83425998|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83425999|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426000|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
83426001|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426002|NCT00330161|Vorinostat|vorinostat|mesh-list
83426003|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426004|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83426005|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426006|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426007|NCT00552279|Vaccines|vaccines|mesh-list
83426008|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
83426009|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426010|NCT00309751|Atorvastatin|atorvastatin|mesh-list
83426011|NCT00309751|Pitavastatin|pitavastatin|mesh-list
83426012|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83426013|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83426014|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
83426015|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426016|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83426017|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83426018|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426019|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83426020|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426021|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426022|NCT02988999|Erythritol|erythritol|mesh-list
83426023|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
83426024|NCT00313729|Temozolomide|temozolomide|mesh-list
83426025|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83426026|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
83426027|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426028|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426029|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83426030|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83426031|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426032|NCT05266651|Tadalafil|tadalafil|mesh-list
83426033|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
83426034|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83426035|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83426036|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426037|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426038|NCT05266651|Urological Agents|urological agents|mesh-ancestor
83426039|NCT05746689|Sirolimus|sirolimus|mesh-list
83426040|NCT05746689|Prednisone|prednisone|mesh-list
83426041|NCT05746689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83426042|NCT05746689|Glucocorticoids|glucocorticoids|mesh-ancestor
83426043|NCT05746689|Hormones|hormones|mesh-ancestor
83426044|NCT05746689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83426045|NCT05746689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426046|NCT05746689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83426047|NCT05746689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426048|NCT05746689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83426049|NCT05746689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426050|NCT05746689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83426051|NCT05746689|Antifungal Agents|antifungal agents|mesh-ancestor
83426052|NCT05746689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83426053|NCT05746689|Immunologic Factors|immunologic factors|mesh-ancestor
83426054|NCT01412060|Cariprazine|cariprazine|mesh-list
83426055|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83426056|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83426057|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426058|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426059|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83426060|NCT00345865|Cytarabine|cytarabine|mesh-list
83426061|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
83426062|NCT00345865|Carmustine|carmustine|mesh-list
83426063|NCT00345865|Etoposide|etoposide|mesh-list
83426064|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83426065|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
83426066|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426067|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83426068|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83426069|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
83426070|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426071|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426072|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83426073|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83426074|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83426075|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83426076|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426077|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83426078|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
83426079|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
83426080|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426081|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83426082|NCT00551421|Cetuximab|cetuximab|mesh-list
83426083|NCT00551421|Pertuzumab|pertuzumab|mesh-list
83426084|NCT00551421|Irinotecan|irinotecan|mesh-list
83426085|NCT00551421|Antibodies|antibodies|mesh-list
83426086|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
83426087|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83426088|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
83426089|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426090|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426091|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83426092|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83426093|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426094|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426095|NCT01791751|Clomiphene|clomiphene|mesh-list
83426096|NCT01791751|Enclomiphene|enclomiphene|mesh-list
83426097|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
83426098|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83426099|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
83426100|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83426101|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426102|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83426103|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
83426104|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83426105|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83426106|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83426107|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
83426108|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
83426109|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
83426110|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83426111|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426112|NCT05266261|Vitamins|vitamins|mesh-ancestor
83426113|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
83426114|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83426115|NCT05266261|Antacids|antacids|mesh-ancestor
83426116|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426117|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83426118|NCT04830813|Chiauranib|chiauranib|mesh-list
83426119|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426120|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83426121|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426122|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426123|NCT05266105|Palbociclib|palbociclib|mesh-list
83426124|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426125|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83426126|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426127|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426128|NCT01891643|Dexamethasone|dexamethasone|mesh-list
83426129|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
83426130|NCT01891643|Lenalidomide|lenalidomide|mesh-list
83426131|NCT01891643|Elotuzumab|elotuzumab|mesh-list
83426132|NCT01891643|BB 1101|bb 1101|mesh-list
83426133|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83426134|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
83426135|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
83426136|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426137|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426138|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83426139|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
83426140|NCT01891643|Hormones|hormones|mesh-ancestor
83426141|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83426142|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83426143|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426144|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
83426145|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426146|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426147|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
83426148|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83426149|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83426150|NCT01891643|Growth Substances|growth substances|mesh-ancestor
83426151|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
83426152|NCT05265793|Apatinib|apatinib|mesh-list
83426153|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426154|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83426155|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426156|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426157|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
83426158|NCT04005599|Remifentanil|remifentanil|mesh-list
83426159|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83426160|NCT04005599|Narcotics|narcotics|mesh-ancestor
83426161|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426162|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426163|NCT04005599|Analgesics|analgesics|mesh-ancestor
83426164|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
83426165|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426166|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
83426167|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83426168|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
83426169|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83426170|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83426171|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426172|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83426174|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83426175|NCT00330863|Olanzapine|olanzapine|mesh-list
83426176|NCT00330863|Risperidone|risperidone|mesh-list
83426177|NCT00330863|Aripiprazole|aripiprazole|mesh-list
83426178|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83426179|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83426180|NCT00330863|Ziprasidone|ziprasidone|mesh-list
83426181|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83426182|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
83426183|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426184|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426185|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426186|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83426187|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83426188|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426189|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83426190|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83426191|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
83426192|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
83426193|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
83426194|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426195|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83426196|NCT00330863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83426197|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83426198|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83426199|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
83426200|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
83426201|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83426202|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83426203|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83426204|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83426205|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
83426206|NCT01899521|Astringents|astringents|mesh-ancestor
83426207|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426208|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
83426209|NCT01790009|Acetaminophen|acetaminophen|mesh-list
83426210|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83426211|NCT01790009|Analgesics|analgesics|mesh-ancestor
83426212|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
83426213|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426214|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426215|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
83426216|NCT05737329|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83426217|NCT05737329|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83426218|NCT05737329|Estradiol|estradiol|mesh-list
83426219|NCT05737329|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83426220|NCT05737329|Estrogens|estrogens|mesh-ancestor
83426221|NCT05737329|Hormones|hormones|mesh-ancestor
83426222|NCT05737329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83426223|NCT05737329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426224|NCT05737329|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83426225|NCT05737329|Contraceptive Agents|contraceptive agents|mesh-ancestor
83426226|NCT05737329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83426227|NCT05737329|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83426228|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
83426229|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83426230|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
83426231|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426232|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
83426233|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83426234|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426235|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83426236|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83426237|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426238|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426239|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426240|NCT05266937|Paclitaxel|paclitaxel|mesh-list
83426241|NCT05266937|Carboplatin|carboplatin|mesh-list
83426242|NCT05266937|Atezolizumab|atezolizumab|mesh-list
83426243|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83426244|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426245|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
83426247|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
83426248|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426249|NCT05266937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83426250|NCT05266937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83426251|NCT00332579|Naltrexone|naltrexone|mesh-list
83426252|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83426253|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83426254|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426255|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
83426256|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426257|NCT00318409|Bupropion|bupropion|mesh-list
83426258|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83426259|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
83426260|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83426261|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83426262|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83426263|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83426264|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426265|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
83426266|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426267|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426268|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83426269|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83426270|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426271|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
83426272|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83426273|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426274|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83426275|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
83426276|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83426277|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426278|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426279|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426280|NCT04129619|Ether|ether|mesh-list
83426281|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83426282|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
83426283|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
83426284|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426285|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426286|NCT00353119|Etanercept|etanercept|mesh-list
83426287|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83426288|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83426289|NCT00353119|Analgesics|analgesics|mesh-ancestor
83426290|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
83426291|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426292|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426293|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83426294|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83426295|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83426296|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83426297|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
83426298|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
83426299|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83426300|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426301|NCT04971187|Cisplatin|cisplatin|mesh-list
83426302|NCT04971187|Carboplatin|carboplatin|mesh-list
83426303|NCT04971187|Pemetrexed|pemetrexed|mesh-list
83426304|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426305|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426306|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426307|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83426308|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83426309|NCT00353977|Vaccines|vaccines|mesh-list
83426310|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
83426311|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426312|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
83426313|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83426314|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83426315|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83426316|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83426317|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426318|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
83426319|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426320|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426321|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83426322|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426323|NCT01792375|Dinoprostone|dinoprostone|mesh-list
83426324|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
83426325|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83426326|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426327|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83426328|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
83426329|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426330|NCT00320671|Risperidone|risperidone|mesh-list
83426331|NCT00320671|Aripiprazole|aripiprazole|mesh-list
83426332|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83426333|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
83426334|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426335|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426336|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426337|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83426338|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83426339|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426340|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83426341|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83426342|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
83426343|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
83426344|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
83426345|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83426346|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83426347|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83426348|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83426349|NCT00320749|Gemcitabine|gemcitabine|mesh-list
83426350|NCT00320749|Capecitabine|capecitabine|mesh-list
83426351|NCT00320749|Docetaxel|docetaxel|mesh-list
83426352|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83426353|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
83426354|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426355|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426356|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
83426357|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
83426358|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
83426359|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
83426360|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
83426361|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426362|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83426364|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426365|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
83426366|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83426367|NCT01432262|Vaccines|vaccines|mesh-list
83426368|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83426369|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
83426370|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426371|NCT00322309|Mirtazapine|mirtazapine|mesh-list
83426372|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
83426373|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83426374|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83426375|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
83426376|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
83426377|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426378|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426379|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426380|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83426381|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83426382|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426383|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83426385|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83426386|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
83426387|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83426388|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83426389|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
83426390|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83426391|NCT04046744|Lidocaine|lidocaine|mesh-list
83426392|NCT04046744|Analgesics|analgesics|mesh-list
83426393|NCT04046744|Ropivacaine|ropivacaine|mesh-list
83426394|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
83426395|NCT04046744|Anesthetics|anesthetics|mesh-list
83426396|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426397|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426398|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
83426399|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426400|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83426401|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83426402|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83426403|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83426404|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426405|NCT01431950|Fluticasone|fluticasone|mesh-list
83426406|NCT01431950|Xhance|xhance|mesh-list
83426407|NCT01431950|Albuterol|albuterol|mesh-list
83426408|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83426409|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83426410|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
83426411|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426412|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426413|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83426414|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
83426415|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
83426416|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83426417|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
83426418|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83426419|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83426420|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83426421|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83426422|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
83426423|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426424|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426425|NCT00551031|Vaccines|vaccines|mesh-list
83426426|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
83426427|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426428|NCT01431716|Epoprostenol|epoprostenol|mesh-list
83426429|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83426430|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83426431|NCT00550953|Amlodipine|amlodipine|mesh-list
83426432|NCT00550953|Telmisartan|telmisartan|mesh-list
83426433|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83426434|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83426435|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83426436|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83426437|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426438|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83426439|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426440|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
83426441|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83426442|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83426443|NCT00322465|Azithromycin|azithromycin|mesh-list
83426444|NCT00322465|Doxycycline|doxycycline|mesh-list
83426446|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83426447|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426448|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
83426449|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83426450|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83426451|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
83426452|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426453|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83426454|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83426455|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
83426456|NCT03021993|Nivolumab|nivolumab|mesh-list
83426457|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83426458|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426459|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83426460|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426461|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83426462|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
83426463|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426464|NCT00558753|Pregabalin|pregabalin|mesh-list
83426465|NCT00558753|Analgesics|analgesics|mesh-ancestor
83426466|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
83426467|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426468|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426469|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
83426470|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83426471|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83426472|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426473|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83426474|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83426475|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83426476|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426477|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83426478|NCT00324259|Estradiol|estradiol|mesh-list
83426479|NCT00324259|Estrogens|estrogens|mesh-ancestor
83426480|NCT00324259|Hormones|hormones|mesh-ancestor
83426481|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83426482|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426483|NCT04598451|Prednisone|prednisone|mesh-list
83426484|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83426485|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
83426486|NCT04598451|Hormones|hormones|mesh-ancestor
83426487|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83426488|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426489|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83426490|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426491|NCT04600141|Heparin|heparin|mesh-list
83426492|NCT04600141|Calcium heparin|calcium heparin|mesh-list
83426493|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
83426494|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83426495|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83426496|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426497|NCT00324415|Fluorouracil|fluorouracil|mesh-list
83426498|NCT00324415|Cetuximab|cetuximab|mesh-list
83426499|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426500|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
83426501|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426502|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83426503|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83426504|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
83426505|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426506|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83426507|NCT00390559|Nicotine|nicotine|mesh-list
83426508|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83426509|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
83426510|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426511|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426512|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83426513|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83426514|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
83426515|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426516|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426518|NCT02107339|Hydromorphone|hydromorphone|mesh-list
83426519|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83426520|NCT02107339|Narcotics|narcotics|mesh-ancestor
83426521|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426522|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426523|NCT02107339|Analgesics|analgesics|mesh-ancestor
83426524|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
83426525|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426526|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
83426527|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
83426528|NCT00392041|Eszopiclone|eszopiclone|mesh-list
83426529|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83426530|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426531|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426532|NCT01390844|Ribavirin|ribavirin|mesh-list
83426533|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83426534|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
83426535|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426536|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
83426537|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426538|NCT04035278|Vaccines|vaccines|mesh-list
83426539|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
83426540|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426541|NCT00395161|Selenium|selenium|mesh-list
83426542|NCT00395161|Metoclopramide|metoclopramide|mesh-list
83426543|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
83426544|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426545|NCT00395161|Protective Agents|protective agents|mesh-ancestor
83426546|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426547|NCT00395161|Trace Elements|trace elements|mesh-ancestor
83426548|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
83426549|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
83426550|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
83426551|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426552|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83426553|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83426554|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83426555|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
83426556|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426557|NCT01409564|Cilostazol|cilostazol|mesh-list
83426558|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83426559|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
83426560|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426561|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426562|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83426563|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
83426564|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83426565|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83426566|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426567|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83426568|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
83426569|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83426570|NCT01409564|Protective Agents|protective agents|mesh-ancestor
83426571|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83426572|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83426573|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426574|NCT02009449|Leucovorin|leucovorin|mesh-list
83426575|NCT02009449|Paclitaxel|paclitaxel|mesh-list
83426576|NCT02009449|Docetaxel|docetaxel|mesh-list
83426577|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83426578|NCT02009449|Carboplatin|carboplatin|mesh-list
83426579|NCT02009449|Gemcitabine|gemcitabine|mesh-list
83426580|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
83426581|NCT02009449|Fluorouracil|fluorouracil|mesh-list
83426582|NCT02009449|Capecitabine|capecitabine|mesh-list
83426583|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
83426584|NCT02009449|Nivolumab|nivolumab|mesh-list
83426585|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
83426586|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83426587|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426588|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
83426589|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
83426590|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
83426591|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426592|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83426593|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
83426594|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83426595|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83426596|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83426597|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
83426598|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426599|NCT02009449|Antidotes|antidotes|mesh-ancestor
83426600|NCT02009449|Protective Agents|protective agents|mesh-ancestor
83426601|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
83426603|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
83426604|NCT01794091|Eplerenone|eplerenone|mesh-list
83426605|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83426606|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
83426607|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83426608|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426609|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83426610|NCT01794091|Diuretics|diuretics|mesh-ancestor
83426611|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
83426612|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83426613|NCT01794169|Cytarabine|cytarabine|mesh-list
83426614|NCT01794169|Azacitidine|azacitidine|mesh-list
83426615|NCT01794169|Daunorubicin|daunorubicin|mesh-list
83426616|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83426617|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
83426618|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426619|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426620|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
83426621|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426622|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83426623|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
83426624|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426625|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426626|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83426627|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83426628|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83426629|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83426630|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
83426631|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426632|NCT01390220|Midazolam|midazolam|mesh-list
83426633|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83426634|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83426635|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426636|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426637|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83426638|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83426639|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83426640|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83426641|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
83426642|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
83426643|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
83426644|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
83426645|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426646|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426647|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
83426648|NCT00357331|Diuretics|diuretics|mesh-ancestor
83426649|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
83426650|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426651|NCT00357331|Expectorants|expectorants|mesh-ancestor
83426652|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
83426653|NCT00550173|Pemetrexed|pemetrexed|mesh-list
83426654|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83426655|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426656|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426657|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426658|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83426659|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83426660|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83426661|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
83426662|NCT04163107|Dexamethasone|dexamethasone|mesh-list
83426663|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83426664|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
83426665|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
83426666|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426667|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426668|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83426669|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
83426670|NCT04163107|Hormones|hormones|mesh-ancestor
83426671|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83426672|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83426673|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426674|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
83426675|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83426676|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83426677|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426678|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426679|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426680|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83426681|NCT01429298|Hydromorphone|hydromorphone|mesh-list
83426682|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83426683|NCT01429298|Narcotics|narcotics|mesh-ancestor
83426684|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426685|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426686|NCT01429298|Analgesics|analgesics|mesh-ancestor
83426687|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
83426688|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426689|NCT01408628|Insulin|insulin|mesh-list
83426690|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83426691|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426692|NCT01389752|Charcoal|charcoal|mesh-list
83426693|NCT01389752|Antidotes|antidotes|mesh-ancestor
83426694|NCT01389752|Protective Agents|protective agents|mesh-ancestor
83426695|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426696|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
83426697|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426698|NCT00358501|Defibrotide|defibrotide|mesh-list
83426699|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83426700|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83426701|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426702|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83426703|NCT01427972|Eplerenone|eplerenone|mesh-list
83426704|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83426705|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
83426706|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83426707|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426708|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83426709|NCT01427972|Diuretics|diuretics|mesh-ancestor
83426710|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
83426711|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83426712|NCT00336323|Bevacizumab|bevacizumab|mesh-list
83426713|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83426714|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426715|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83426716|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83426717|NCT00336323|Growth Substances|growth substances|mesh-ancestor
83426718|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426719|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
83426720|NCT01427738|Nystatin|nystatin|mesh-list
83426721|NCT01427738|Gentian Violet|gentian violet|mesh-list
83426722|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83426723|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426724|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
83426725|NCT01427738|Ionophores|ionophores|mesh-ancestor
83426726|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83426727|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426728|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83426729|NCT01426958|Ritonavir|ritonavir|mesh-list
83426730|NCT01426958|Afatinib|afatinib|mesh-list
83426731|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83426732|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83426733|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
83426734|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426735|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426736|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83426737|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83426738|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
83426739|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426740|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83426741|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83426743|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83426744|NCT00397813|Cyclosporine|cyclosporine|mesh-list
83426745|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
83426746|NCT00397813|Fludarabine|fludarabine|mesh-list
83426747|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
83426748|NCT00397813|Cyclosporins|cyclosporins|mesh-list
83426749|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426750|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83426751|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
83426752|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426753|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83426754|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
83426755|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426756|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426757|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
83426758|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426759|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
83426760|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83426761|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83426762|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83426763|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83426764|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
83426765|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83426766|NCT00398983|Decitabine|decitabine|mesh-list
83426767|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83426768|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
83426769|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426770|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426771|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426772|NCT00358579|Vasopressins|vasopressins|mesh-list
83426773|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
83426774|NCT00358579|Epinephrine|epinephrine|mesh-list
83426775|NCT00358579|Racepinephrine|racepinephrine|mesh-list
83426776|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
83426777|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426778|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83426779|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83426780|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
83426781|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426782|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426783|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83426784|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83426785|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
83426786|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426787|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83426788|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
83426789|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
83426790|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
83426791|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83426792|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
83426793|NCT00358579|Coagulants|coagulants|mesh-ancestor
83426794|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83426795|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
83426796|NCT00338039|Gemcitabine|gemcitabine|mesh-list
83426797|NCT00338039|Capecitabine|capecitabine|mesh-list
83426798|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
83426799|NCT00338039|Cetuximab|cetuximab|mesh-list
83426800|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83426801|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
83426802|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426803|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426804|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83426805|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
83426806|NCT00358657|Sirolimus|sirolimus|mesh-list
83426807|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
83426808|NCT00358657|Fludarabine|fludarabine|mesh-list
83426809|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
83426810|NCT00358657|Tacrolimus|tacrolimus|mesh-list
83426811|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83426812|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
83426813|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426814|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83426815|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83426816|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
83426817|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426818|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426819|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83426820|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83426821|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
83426822|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83426823|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426824|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83426825|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83426826|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
83426827|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83426828|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426829|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
83426831|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
83426832|NCT00340379|Ziprasidone|ziprasidone|mesh-list
83426833|NCT00340379|Sertraline|sertraline|mesh-list
83426834|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
83426835|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83426836|NCT00340379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83426837|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83426838|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83426839|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426840|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426841|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
83426842|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426843|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
83426844|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
83426845|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426846|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83426847|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83426848|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83426849|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426850|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83426851|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
83426852|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83426853|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83426854|NCT00342563|Mecamylamine|mecamylamine|mesh-list
83426855|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83426856|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83426857|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
83426858|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426859|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426860|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83426861|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83426862|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
83426863|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426864|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426865|NCT00358735|Enoxaparin|enoxaparin|mesh-list
83426866|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
83426867|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83426868|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83426869|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426870|NCT01793519|Adalimumab|adalimumab|mesh-list
83426871|NCT01793519|Infliximab|infliximab|mesh-list
83426872|NCT01793519|Etanercept|etanercept|mesh-list
83426873|NCT01793519|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83426874|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83426875|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83426876|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
83426877|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83426878|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83426879|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83426880|NCT01793519|Analgesics|analgesics|mesh-ancestor
83426881|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
83426882|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426883|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426884|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83426885|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
83426886|NCT00345371|Topiramate|topiramate|mesh-list
83426887|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
83426888|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83426889|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426890|NCT03006276|Celecoxib|celecoxib|mesh-list
83426891|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83426892|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83426893|NCT03006276|Analgesics|analgesics|mesh-ancestor
83426894|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
83426895|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426896|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426898|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83426899|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83426900|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83426901|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426902|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426903|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
83426904|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83426905|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426906|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83426907|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83426908|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83426909|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83426910|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426911|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426912|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426913|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
83426914|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83426915|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426916|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426917|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83426918|NCT00351299|Analgesics|analgesics|mesh-ancestor
83426919|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
83426920|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426921|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83426922|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83426923|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83426924|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
83426925|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426926|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426927|NCT00352001|Lenalidomide|lenalidomide|mesh-list
83426928|NCT00352001|Azacitidine|azacitidine|mesh-list
83426929|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
83426930|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426931|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83426932|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83426933|NCT00352001|Growth Substances|growth substances|mesh-ancestor
83426934|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
83426935|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426936|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83426937|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
83426938|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426939|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426940|NCT00401401|Zalutumumab|zalutumumab|mesh-list
83426941|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426942|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83426943|NCT00352781|Nicotine|nicotine|mesh-list
83426944|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83426945|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
83426946|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426947|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426948|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83426949|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83426950|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
83426951|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426952|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426953|NCT02812524|Ipilimumab|ipilimumab|mesh-list
83426954|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83426955|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426956|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83426957|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426958|NCT01793753|Propofol|propofol|mesh-list
83426959|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83426960|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83426961|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426962|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83426963|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
83426964|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
83426965|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
83426966|NCT00360685|Methotrexate|methotrexate|mesh-list
83426968|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83426969|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
83426970|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83426971|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426972|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83426973|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
83426974|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83426975|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83426976|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
83426977|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426978|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83426979|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83426980|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
83426981|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83426982|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83426983|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83426984|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83426985|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83426986|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
83426987|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83426988|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83426990|NCT05487456|Nicotine|nicotine|mesh-list
83426991|NCT05487456|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83426992|NCT05487456|Autonomic Agents|autonomic agents|mesh-ancestor
83426993|NCT05487456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426994|NCT05487456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426995|NCT05487456|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83426996|NCT05487456|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83426997|NCT05487456|Cholinergic Agents|cholinergic agents|mesh-ancestor
83426998|NCT05487456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83426999|NCT05487456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427000|NCT05487456|Antipruritics|antipruritics|mesh-ancestor
83427001|NCT05487456|Dermatologic Agents|dermatologic agents|mesh-ancestor
83427002|NCT00558519|Cytarabine|cytarabine|mesh-list
83427003|NCT00558519|Dexamethasone|dexamethasone|mesh-list
83427004|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
83427005|NCT00558519|Doxorubicin|doxorubicin|mesh-list
83427006|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83427007|NCT00558519|Methotrexate|methotrexate|mesh-list
83427008|NCT00558519|Vincristine|vincristine|mesh-list
83427009|NCT00558519|Daunorubicin|daunorubicin|mesh-list
83427010|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
83427011|NCT00558519|Pegaspargase|pegaspargase|mesh-list
83427012|NCT00558519|Thioguanine|thioguanine|mesh-list
83427013|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83427014|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
83427015|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427016|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427017|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83427018|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
83427019|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427020|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427021|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83427022|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83427023|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
83427024|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
83427025|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427026|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83427027|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
83427028|NCT00558519|Hormones|hormones|mesh-ancestor
83427029|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427030|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83427031|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83427032|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83427033|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83427034|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427035|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83427036|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
83427037|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83427038|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83427039|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
83427040|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
83427041|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83427042|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83427043|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
83427044|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83427045|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83427046|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
83427047|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
83427048|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
83427050|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83427051|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83427052|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427053|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
83427054|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427055|NCT03023631|Vaccines|vaccines|mesh-list
83427056|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
83427057|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427058|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
83427059|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83427060|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83427061|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83427062|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
83427063|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427064|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427065|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427066|NCT01389596|Pregabalin|pregabalin|mesh-list
83427067|NCT01389596|Analgesics|analgesics|mesh-ancestor
83427068|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
83427069|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427070|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427071|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
83427072|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83427073|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83427074|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427075|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83427076|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83427077|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83427078|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427079|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83427080|NCT00558207|Gemcitabine|gemcitabine|mesh-list
83427081|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83427082|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
83427083|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427084|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427085|NCT00407485|Aflibercept|aflibercept|mesh-list
83427086|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83427087|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83427088|NCT00407485|Growth Substances|growth substances|mesh-ancestor
83427089|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427090|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
83427091|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427092|NCT00354887|Capecitabine|capecitabine|mesh-list
83427093|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
83427094|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83427095|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
83427096|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427097|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427098|NCT02111863|Aldesleukin|aldesleukin|mesh-list
83427099|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
83427100|NCT02111863|Fludarabine|fludarabine|mesh-list
83427101|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83427102|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
83427103|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427104|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427105|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83427106|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
83427107|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427108|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427109|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83427110|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83427111|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83427112|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
83427113|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83427114|NCT02660411|Propofol|propofol|mesh-list
83427115|NCT02660411|Sevoflurane|sevoflurane|mesh-list
83427116|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83427117|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427118|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427119|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83427120|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
83427121|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
83427122|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83427123|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83427124|NCT02078492|Ketorolac|ketorolac|mesh-list
83427125|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83427126|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83427127|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83427128|NCT02078492|Analgesics|analgesics|mesh-ancestor
83427129|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
83427130|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427131|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427132|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83427133|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427134|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83427135|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427136|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427137|NCT02988921|Paclitaxel|paclitaxel|mesh-list
83427138|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83427139|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427140|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
83427141|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83427142|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83427143|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427144|NCT04528563|Ketorolac|ketorolac|mesh-list
83427145|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83427146|NCT04528563|Morphine|morphine|mesh-list
83427147|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83427148|NCT04528563|Narcotics|narcotics|mesh-ancestor
83427149|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427150|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427151|NCT04528563|Analgesics|analgesics|mesh-ancestor
83427152|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
83427153|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427154|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83427155|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83427156|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83427157|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427158|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83427159|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427160|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427161|NCT00355199|Rituximab|rituximab|mesh-list
83427162|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427163|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427164|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
83427165|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427166|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427167|NCT01791647|Inositol|inositol|mesh-list
83427168|NCT01791647|Metformin|metformin|mesh-list
83427169|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83427170|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427171|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
83427172|NCT01791647|Vitamins|vitamins|mesh-ancestor
83427173|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
83427174|NCT00363883|Vorinostat|vorinostat|mesh-list
83427175|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427176|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83427177|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427178|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427179|NCT00364819|Rituximab|rituximab|mesh-list
83427180|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427181|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427182|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
83427183|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427184|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427185|NCT04524351|Phenserine|phenserine|mesh-list
83427186|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83427187|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427188|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427190|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427191|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427194|NCT04523961|Prilocaine|prilocaine|mesh-list
83427195|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83427196|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
83427197|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
83427198|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427199|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427200|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
83427201|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427202|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83427203|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83427204|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83427205|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83427206|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427207|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83427208|NCT01792505|Imiquimod|imiquimod|mesh-list
83427209|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83427210|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
83427211|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427212|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427213|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
83427214|NCT00365053|Belinostat|belinostat|mesh-list
83427215|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427216|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83427217|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427218|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427219|NCT00555789|Tacrolimus|tacrolimus|mesh-list
83427220|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83427221|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
83427222|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427223|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83427224|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427225|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427226|NCT04288895|Vortioxetine|vortioxetine|mesh-list
83427227|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
83427228|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83427229|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83427230|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83427231|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427232|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427233|NCT04288895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83427234|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83427235|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83427236|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427237|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427238|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
83427239|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83427240|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83427241|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83427242|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83427243|NCT00365209|Curcumin|curcumin|mesh-list
83427244|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83427245|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83427246|NCT00365209|Analgesics|analgesics|mesh-ancestor
83427247|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
83427248|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427249|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427250|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83427251|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427252|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427253|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427254|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427255|NCT04417257|Fenretinide|fenretinide|mesh-list
83427256|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427257|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83427258|NCT04417257|Protective Agents|protective agents|mesh-ancestor
83427259|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427260|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83427261|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83427262|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83427263|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
83427264|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427265|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427266|NCT00409825|Progestins|progestins|mesh-ancestor
83427267|NCT00409825|Hormones|hormones|mesh-ancestor
83427268|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83427269|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427270|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83427271|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427272|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427273|NCT04749069|Remifentanil|remifentanil|mesh-list
83427274|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83427275|NCT04749069|Narcotics|narcotics|mesh-ancestor
83427276|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427277|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427278|NCT04749069|Analgesics|analgesics|mesh-ancestor
83427279|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
83427280|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427281|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83427282|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
83427283|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83427284|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83427285|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83427286|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427287|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427288|NCT03239015|Trastuzumab|trastuzumab|mesh-list
83427289|NCT03239015|Everolimus|everolimus|mesh-list
83427290|NCT03239015|Olaparib|olaparib|mesh-list
83427291|NCT03239015|Palbociclib|palbociclib|mesh-list
83427292|NCT03239015|Gefitinib|gefitinib|mesh-list
83427293|NCT03239015|Afatinib|afatinib|mesh-list
83427294|NCT03239015|Vemurafenib|vemurafenib|mesh-list
83427295|NCT03239015|Dabrafenib|dabrafenib|mesh-list
83427296|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83427297|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427298|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427299|NCT03239015|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83427300|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83427301|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427302|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427303|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83427304|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
83427305|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427306|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83427307|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83427308|NCT03239015|Growth Substances|growth substances|mesh-ancestor
83427309|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
83427310|NCT00356993|Nicotine|nicotine|mesh-list
83427311|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83427312|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
83427313|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427314|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427315|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83427316|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83427317|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
83427318|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427319|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427320|NCT01793077|Leuprolide|leuprolide|mesh-list
83427321|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83427322|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
83427323|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83427324|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427325|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83427326|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427327|NCT00555477|Anastrozole|anastrozole|mesh-list
83427328|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83427329|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427330|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83427331|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83427332|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427333|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427334|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83427335|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
83427336|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427337|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427338|NCT00365599|Tamoxifen|tamoxifen|mesh-list
83427339|NCT00365599|Vorinostat|vorinostat|mesh-list
83427340|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427341|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83427342|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
83427343|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427344|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427345|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83427346|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427347|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83427348|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83427349|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83427350|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83427351|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427352|NCT00554619|Ambrisentan|ambrisentan|mesh-list
83427353|NCT00554619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83427354|NCT02104739|Exenatide|exenatide|mesh-list
83427355|NCT02104739|Saxagliptin|saxagliptin|mesh-list
83427356|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83427357|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427358|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83427359|NCT02104739|Incretins|incretins|mesh-ancestor
83427360|NCT02104739|Hormones|hormones|mesh-ancestor
83427361|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427362|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83427363|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
83427364|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427365|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427366|NCT00411619|Everolimus|everolimus|mesh-list
83427367|NCT00411619|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83427368|NCT00411619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83427369|NCT00411619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427370|NCT00411619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427371|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83427372|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
83427373|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427374|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427375|NCT00412087|Vitamin D|vitamin d|mesh-list
83427376|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
83427377|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
83427378|NCT00412087|Vitamins|vitamins|mesh-list
83427379|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
83427380|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427381|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83427382|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83427383|NCT00312923|Policosanol|policosanol|mesh-list
83427384|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83427385|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83427386|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
83427387|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427388|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83427389|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83427390|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
83427391|NCT00412243|Clofarabine|clofarabine|mesh-list
83427392|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83427393|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
83427394|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427395|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427396|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83427397|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
83427398|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427399|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427400|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83427401|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83427402|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
83427403|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83427404|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
83427405|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427406|NCT00315341|Buprenorphine|buprenorphine|mesh-list
83427407|NCT00315341|Methadone|methadone|mesh-list
83427408|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83427409|NCT00315341|Naloxone|naloxone|mesh-list
83427410|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83427411|NCT00315341|Narcotics|narcotics|mesh-ancestor
83427412|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427413|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427414|NCT00315341|Analgesics|analgesics|mesh-ancestor
83427415|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
83427416|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427417|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83427418|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
83427419|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
83427420|NCT02277249|Digoxin|digoxin|mesh-list
83427421|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83427422|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83427423|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427424|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427425|NCT02277249|Protective Agents|protective agents|mesh-ancestor
83427426|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427427|NCT04767542|Acetaminophen|acetaminophen|mesh-list
83427428|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427429|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83427430|NCT04767542|Analgesics|analgesics|mesh-ancestor
83427431|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
83427432|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427433|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
83427434|NCT01794533|Lidocaine|lidocaine|mesh-list
83427435|NCT01794533|Epinephrine|epinephrine|mesh-list
83427436|NCT01794533|Racepinephrine|racepinephrine|mesh-list
83427437|NCT01794533|Fentanyl|fentanyl|mesh-list
83427438|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
83427439|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
83427440|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
83427441|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427442|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427443|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
83427444|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427445|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83427446|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83427447|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83427448|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83427449|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427450|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83427451|NCT01794533|Narcotics|narcotics|mesh-ancestor
83427452|NCT01794533|Analgesics|analgesics|mesh-ancestor
83427453|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83427454|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83427455|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
83427456|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83427457|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83427458|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
83427459|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427460|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83427461|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83427462|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
83427463|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83427464|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
83427465|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
83427466|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
83427467|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83427468|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83427469|NCT00412867|Plasminogen|plasminogen|mesh-list
83427470|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83427471|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83427472|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427473|NCT01730833|Paclitaxel|paclitaxel|mesh-list
83427474|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83427475|NCT01730833|Trastuzumab|trastuzumab|mesh-list
83427476|NCT01730833|Pertuzumab|pertuzumab|mesh-list
83427477|NCT01730833|Antibodies|antibodies|mesh-list
83427478|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
83427479|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83427480|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427481|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
83427482|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
83427483|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
83427484|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427485|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
83427486|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427487|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427488|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
83427489|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83427490|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427491|NCT00414271|Docetaxel|docetaxel|mesh-list
83427492|NCT00414271|Capecitabine|capecitabine|mesh-list
83427493|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427494|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
83427495|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
83427496|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
83427497|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427498|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83427499|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
83427500|NCT00360971|Cisplatin|cisplatin|mesh-list
83427501|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427502|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
83427503|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83427504|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83427505|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83427506|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83427507|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427508|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
83427509|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427510|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427511|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83427512|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427513|NCT03636503|Rituximab|rituximab|mesh-list
83427514|NCT03636503|Avelumab|avelumab|mesh-list
83427515|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427516|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427517|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
83427518|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427519|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427520|NCT03448159|Fluoxetine|fluoxetine|mesh-list
83427521|NCT03448159|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83427522|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83427523|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83427524|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427525|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427526|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
83427527|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427528|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83427529|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
83427530|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83427531|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83427532|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83427533|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427534|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
83427535|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83427536|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
83427537|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83427538|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
83427539|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83427540|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427541|NCT03438487|Vaccines|vaccines|mesh-list
83427542|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
83427543|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427544|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83427545|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427546|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427547|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
83427548|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83427549|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83427550|NCT01792037|Prednisolone|prednisolone|mesh-list
83427551|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
83427552|NCT01792037|Midazolam|midazolam|mesh-list
83427553|NCT01792037|Etomidate|etomidate|mesh-list
83427554|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83427555|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
83427556|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83427557|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83427558|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427559|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427560|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83427561|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83427562|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83427563|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83427564|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
83427565|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
83427566|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
83427567|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
83427568|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427569|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427570|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83427571|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
83427572|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
83427573|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427574|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83427575|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
83427576|NCT01792037|Hormones|hormones|mesh-ancestor
83427577|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427578|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83427579|NCT01792037|Protective Agents|protective agents|mesh-ancestor
83427580|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83427581|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427582|NCT00373399|Dronabinol|dronabinol|mesh-list
83427583|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
83427584|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427585|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83427586|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83427587|NCT00373399|Analgesics|analgesics|mesh-ancestor
83427588|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
83427589|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427590|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83427591|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83427592|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427593|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427594|NCT00373399|Hormones|hormones|mesh-ancestor
83427595|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427596|NCT00318929|Valproic Acid|valproic acid|mesh-list
83427597|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
83427598|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480266|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427599|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427600|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
83427601|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427602|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427603|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
83427604|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83427605|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427606|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83427607|NCT00418093|Bevacizumab|bevacizumab|mesh-list
83427608|NCT00418093|Gemcitabine|gemcitabine|mesh-list
83427609|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
83427610|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427611|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427612|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83427613|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83427614|NCT00418093|Growth Substances|growth substances|mesh-ancestor
83427615|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427616|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
83427617|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83427618|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
83427619|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427620|NCT03855371|Decitabine|decitabine|mesh-list
83427621|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
83427622|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83427623|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
83427624|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427625|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427626|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427627|NCT03284723|Letrozole|letrozole|mesh-list
83427628|NCT03284723|Palbociclib|palbociclib|mesh-list
83427629|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427630|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83427631|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83427632|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427633|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427634|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83427635|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
83427636|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427637|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427638|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83427639|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
83427640|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83427641|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427642|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83427643|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
83427644|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83427645|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83427646|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427647|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427648|NCT00418951|Voriconazole|voriconazole|mesh-list
83427649|NCT00418951|Amphotericin B|amphotericin b|mesh-list
83427650|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83427651|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
83427652|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83427653|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83427654|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83427655|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427656|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427657|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83427658|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
83427659|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427660|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427661|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83427662|NCT00418951|Amebicides|amebicides|mesh-ancestor
83427663|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83427664|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83427665|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83427666|NCT00363077|Vaccines|vaccines|mesh-list
83427667|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
83427668|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427669|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83480267|NCT04404283|Rituximab|rituximab|mesh-list
83427670|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83427671|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83427672|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83427673|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427674|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427675|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427677|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
83427678|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427679|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
83427680|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83427681|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
83427682|NCT00421603|Topiramate|topiramate|mesh-list
83427683|NCT00421603|Adderall|adderall|mesh-list
83427684|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
83427685|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83427686|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427687|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83427688|NCT00363779|Cyclosporine|cyclosporine|mesh-list
83427689|NCT00363779|Cyclosporins|cyclosporins|mesh-list
83427690|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427691|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427692|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83427693|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
83427694|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427695|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
83427696|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83427697|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
83427698|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427699|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83427700|NCT01405820|Natalizumab|natalizumab|mesh-list
83427701|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
83427702|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427703|NCT01405742|Factor VIII|factor viii|mesh-list
83427704|NCT01405742|Coagulants|coagulants|mesh-ancestor
83427705|NCT01794767|Heparin|heparin|mesh-list
83427706|NCT01794767|Calcium heparin|calcium heparin|mesh-list
83427707|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
83427708|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83427709|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83427710|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427711|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
83427712|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83427713|NCT02076152|Bevacizumab|bevacizumab|mesh-list
83427714|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427715|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427716|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83427717|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83427718|NCT02076152|Growth Substances|growth substances|mesh-ancestor
83427719|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427720|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
83427721|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
83427722|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427723|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427724|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83427725|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427726|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83427727|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427728|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427729|NCT01405508|Brivaracetam|brivaracetam|mesh-list
83427730|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
83427731|NCT00426283|Fluticasone|fluticasone|mesh-list
83427732|NCT00426283|Xhance|xhance|mesh-list
83427733|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83427734|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83427735|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
83427736|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427737|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427738|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83427739|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
83427740|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
83427741|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83427742|NCT00322439|Etanercept|etanercept|mesh-list
83427743|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83427744|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83427745|NCT00322439|Analgesics|analgesics|mesh-ancestor
83427746|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
83427747|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427748|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427749|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83427750|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427751|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83427752|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83427753|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
83427754|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
83427755|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427756|NCT00365261|Eszopiclone|eszopiclone|mesh-list
83427757|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83427758|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427759|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427760|NCT00426517|Sirolimus|sirolimus|mesh-list
83427761|NCT00426517|Busulfan|busulfan|mesh-list
83427762|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
83427763|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83427764|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83427765|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83427766|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427767|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
83427768|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83427769|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
83427770|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427771|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427772|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
83427773|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83427774|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83427775|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427776|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
83427777|NCT00365417|Bevacizumab|bevacizumab|mesh-list
83427778|NCT00365417|Docetaxel|docetaxel|mesh-list
83427779|NCT00365417|Doxorubicin|doxorubicin|mesh-list
83427780|NCT00365417|Capecitabine|capecitabine|mesh-list
83427781|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83427782|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
83427783|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427784|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427785|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83427786|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
83427787|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427788|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427789|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83427790|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427791|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83427792|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83427793|NCT00365417|Growth Substances|growth substances|mesh-ancestor
83427794|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
83427795|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
83427796|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
83427797|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
83427798|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83427799|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83427800|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83427801|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427802|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83427803|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
83427804|NCT00427297|Ritonavir|ritonavir|mesh-list
83427805|NCT00427297|Lopinavir|lopinavir|mesh-list
83427806|NCT00427297|Tenofovir|tenofovir|mesh-list
83427807|NCT00427297|Lamivudine|lamivudine|mesh-list
83427808|NCT00427297|Zidovudine|zidovudine|mesh-list
83427809|NCT00427297|Nevirapine|nevirapine|mesh-list
83427810|NCT00427297|Abacavir|abacavir|mesh-list
83427811|NCT00427297|Stavudine|stavudine|mesh-list
83427812|NCT00427297|Didanosine|didanosine|mesh-list
83427813|NCT00427297|Efavirenz|efavirenz|mesh-list
83427814|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
83427815|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83427816|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83427817|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
83427818|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427819|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427821|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83427822|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
83427823|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83427824|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83427825|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83427826|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83427827|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83427828|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
83427829|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83427830|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83427831|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83427832|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83427833|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83427834|NCT00427765|Melphalan|melphalan|mesh-list
83427835|NCT00427765|Busulfan|busulfan|mesh-list
83427836|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83427837|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
83427838|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427839|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427840|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83427841|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83427842|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
83427843|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427844|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
83427845|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
83427846|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427847|NCT00384865|Aspirin|aspirin|mesh-list
83427848|NCT00384865|Simvastatin|simvastatin|mesh-list
83427849|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83427850|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83427851|NCT00384865|Analgesics|analgesics|mesh-ancestor
83427852|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
83427853|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427854|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427855|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83427856|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83427857|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83427858|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83427859|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427860|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83427861|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83427862|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427863|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
83427864|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83427865|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83427866|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
83427867|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83427868|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83427869|NCT00367601|Bevacizumab|bevacizumab|mesh-list
83427870|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83427871|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83427872|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427873|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83427874|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83427875|NCT00367601|Growth Substances|growth substances|mesh-ancestor
83427876|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427877|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
83427878|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83427879|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427880|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427881|NCT00385801|Risperidone|risperidone|mesh-list
83427882|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83427883|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
83427884|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427885|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427886|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427887|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83427888|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83427889|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83427890|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83427891|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83427892|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
83427893|NCT00429403|Goserelin|goserelin|mesh-list
83427894|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83427895|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427896|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
83427897|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83427898|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83427899|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83427900|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83427901|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427902|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427903|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427904|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83427905|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83427906|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83427907|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83427908|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
83427909|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427910|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427911|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83427912|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83427913|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83427914|NCT00429949|Dasatinib|dasatinib|mesh-list
83427915|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427916|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83427917|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427918|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427919|NCT02078726|Glucagon|glucagon|mesh-list
83427920|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83427921|NCT02078726|Hormones|hormones|mesh-ancestor
83427922|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427923|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427924|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
83427925|NCT00431041|Oxybutynin|oxybutynin|mesh-list
83427926|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83427927|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83427928|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
83427929|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427930|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427931|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427932|NCT00431041|Urological Agents|urological agents|mesh-ancestor
83427933|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
83427934|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
83427935|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427936|NCT00390611|Paclitaxel|paclitaxel|mesh-list
83427937|NCT00390611|Carboplatin|carboplatin|mesh-list
83427938|NCT00390611|Sorafenib|sorafenib|mesh-list
83427939|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83427940|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427942|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
83427943|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
83427944|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427945|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83427946|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427947|NCT00391079|Nabiximols|nabiximols|mesh-list
83427948|NCT00391079|Analgesics|analgesics|mesh-ancestor
83427949|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
83427950|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427951|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427952|NCT00387751|Bevacizumab|bevacizumab|mesh-list
83427953|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83427954|NCT00387751|Sorafenib|sorafenib|mesh-list
83427955|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
83427956|NCT00387751|Antibodies|antibodies|mesh-list
83427957|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
83427958|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83427959|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
83427960|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427961|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83427962|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83427963|NCT00387751|Growth Substances|growth substances|mesh-ancestor
83427964|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427965|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
83427966|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
83427967|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83427968|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83427969|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427970|NCT01795235|Atenolol|atenolol|mesh-list
83427971|NCT01795235|Glucagon|glucagon|mesh-list
83427972|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83427973|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83427974|NCT01795235|Hormones|hormones|mesh-ancestor
83427975|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427976|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427977|NCT01795235|Incretins|incretins|mesh-ancestor
83427978|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83427979|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83427980|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
83427981|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
83427982|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83427983|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83427984|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83427985|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83427986|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
83427987|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83427988|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427989|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83427990|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83427991|NCT00387829|Estradiol|estradiol|mesh-list
83427992|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83427993|NCT00387829|Estrogens|estrogens|mesh-ancestor
83427994|NCT00387829|Hormones|hormones|mesh-ancestor
83427995|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83427996|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83427997|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83427998|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
83427999|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83428000|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83428001|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
83428002|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428003|NCT00392951|Sirolimus|sirolimus|mesh-list
83428004|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83428005|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428006|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83428007|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428008|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
83428009|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83428010|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
83428011|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428012|NCT01424930|Prednisone|prednisone|mesh-list
83428013|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83428014|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
83428015|NCT01424930|Hormones|hormones|mesh-ancestor
83428016|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428017|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428018|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83428019|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428020|NCT00389857|Vaccines|vaccines|mesh-list
83428021|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
83428022|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428023|NCT01795183|Amisulpride|amisulpride|mesh-list
83428024|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83428025|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83428026|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83428027|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428028|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83428029|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83428030|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
83428031|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428032|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428033|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83428034|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
83428035|NCT01424228|Prucalopride|prucalopride|mesh-list
83428036|NCT01424228|Laxatives|laxatives|mesh-ancestor
83428037|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83428038|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83428039|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83428040|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
83428041|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428042|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428043|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428044|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
83428045|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
83428046|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428047|NCT04750603|Fluticasone|fluticasone|mesh-list
83428048|NCT04750603|Xhance|xhance|mesh-list
83428049|NCT04750603|Albuterol|albuterol|mesh-list
83428050|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83428051|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83428052|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
83428053|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428054|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428055|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83428056|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
83428057|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
83428058|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83428059|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
83428060|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83428061|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83428062|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83428063|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83428064|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
83428065|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428066|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428067|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
83428068|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83428069|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428070|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83428071|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83428072|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428073|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428074|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428075|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
83428076|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83428077|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
83428078|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428079|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
83428080|NCT00436969|Protective Agents|protective agents|mesh-ancestor
83428081|NCT00455689|Leuprolide|leuprolide|mesh-list
83428082|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83428083|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
83428084|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83428085|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428086|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83428087|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428088|NCT00394277|Ribavirin|ribavirin|mesh-list
83428089|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83428090|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
83428091|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
83428092|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428093|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
83428094|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428095|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
83428096|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428097|NCT00395057|Ranibizumab|ranibizumab|mesh-list
83428098|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428099|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428100|NCT00395057|Growth Substances|growth substances|mesh-ancestor
83428101|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428102|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428103|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428104|NCT00438451|Lamotrigine|lamotrigine|mesh-list
83428105|NCT00438451|Carbamazepine|carbamazepine|mesh-list
83428106|NCT00438451|Levetiracetam|levetiracetam|mesh-list
83428107|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
83428108|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
83428109|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83428110|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83428111|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428112|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83428113|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428114|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83428115|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83428116|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83428117|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83428118|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83428119|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
83428120|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83428121|NCT00438451|Analgesics|analgesics|mesh-ancestor
83428122|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
83428123|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428124|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83428125|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83428127|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
83428128|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428129|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83428130|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83428131|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83428132|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83428133|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83428134|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
83428135|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428136|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428137|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428138|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83428139|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
83428140|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83428141|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
83428142|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83428143|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428144|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83428145|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83428146|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428147|NCT01423604|Capecitabine|capecitabine|mesh-list
83428148|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83428149|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
83428150|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428151|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428152|NCT01402544|Ranibizumab|ranibizumab|mesh-list
83428153|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428154|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428155|NCT01402544|Growth Substances|growth substances|mesh-ancestor
83428156|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428157|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428158|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428159|NCT00460993|Eszopiclone|eszopiclone|mesh-list
83428160|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83428161|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83428162|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428163|NCT00441883|Latanoprost|latanoprost|mesh-list
83428164|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83428165|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83428166|NCT00461773|Bevacizumab|bevacizumab|mesh-list
83428167|NCT00461773|Letrozole|letrozole|mesh-list
83428168|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428169|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428170|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428171|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428172|NCT00461773|Growth Substances|growth substances|mesh-ancestor
83428173|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428174|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428175|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83428176|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83428177|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428178|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428179|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83428180|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
83428181|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428182|NCT00461851|Carboplatin|carboplatin|mesh-list
83428183|NCT00461851|Gemcitabine|gemcitabine|mesh-list
83428184|NCT00461851|Sorafenib|sorafenib|mesh-list
83428185|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428186|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83428187|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
83428188|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428189|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83428190|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428191|NCT00442507|Bevacizumab|bevacizumab|mesh-list
83428192|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83428193|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428194|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428195|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428196|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428197|NCT00442507|Growth Substances|growth substances|mesh-ancestor
83428198|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428199|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428200|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83428201|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428202|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428203|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
83428204|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428205|NCT01387022|Tenofovir|tenofovir|mesh-list
83428206|NCT01387022|Lamivudine|lamivudine|mesh-list
83428207|NCT01387022|Efavirenz|efavirenz|mesh-list
83428208|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
83428209|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428210|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83428211|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83428212|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428213|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428214|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83428215|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83428216|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83428217|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83428218|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83428219|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83428220|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83428221|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83428222|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
83428223|NCT00374231|Prednisone|prednisone|mesh-list
83428224|NCT00374231|Tacrolimus|tacrolimus|mesh-list
83428225|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83428226|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
83428227|NCT00374231|Hormones|hormones|mesh-ancestor
83428228|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428229|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428230|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83428231|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428232|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83428233|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
83428234|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83428235|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428236|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428237|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83428238|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83428239|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
83428240|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83428241|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428244|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428245|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
83428246|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
83428247|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
83428248|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428249|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
83428250|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83428251|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83428252|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
83428253|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428254|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83428255|NCT01386554|Hormones|hormones|mesh-ancestor
83428256|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428257|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428258|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
83428259|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83428260|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83428261|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
83428262|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428263|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83428264|NCT00448201|Methotrexate|methotrexate|mesh-list
83428265|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
83428266|NCT00448201|Fludarabine|fludarabine|mesh-list
83428267|NCT00448201|Busulfan|busulfan|mesh-list
83428268|NCT00448201|Tacrolimus|tacrolimus|mesh-list
83428269|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83428270|NCT00448201|Sargramostim|sargramostim|mesh-list
83428271|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83428272|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
83428273|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83428274|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428275|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83428276|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
83428277|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428278|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428279|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
83428280|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428281|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83428282|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83428283|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
83428284|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83428285|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83428286|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83428287|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
83428288|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83428289|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83428290|NCT05287607|Bilirubin|bilirubin|mesh-list
83428291|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
83428292|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428293|NCT05287607|Protective Agents|protective agents|mesh-ancestor
83428294|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428295|NCT00375713|Cetirizine|cetirizine|mesh-list
83428296|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
83428297|NCT00375713|Levocetirizine|levocetirizine|mesh-list
83428298|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83428299|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83428300|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83480268|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83428302|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
83428303|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
83428304|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428305|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428306|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428308|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83428309|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
83428310|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428311|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83428312|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83428313|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
83428314|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428315|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428316|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83428317|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
83428318|NCT00376805|Fludarabine|fludarabine|mesh-list
83428319|NCT00376805|Interleukin-2|interleukin-2|mesh-list
83428320|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83428321|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
83428322|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428323|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83428324|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83428325|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
83428326|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428327|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428328|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83428329|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83428330|NCT00376805|Analgesics|analgesics|mesh-ancestor
83428331|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
83428332|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428333|NCT00448357|Methotrexate|methotrexate|mesh-list
83428334|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
83428335|NCT00448357|Fludarabine|fludarabine|mesh-list
83428336|NCT00448357|Busulfan|busulfan|mesh-list
83428337|NCT00448357|Tacrolimus|tacrolimus|mesh-list
83428338|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83428339|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
83428340|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83428341|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
83428342|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83428343|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428344|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83428345|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
83428346|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428347|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428348|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
83428349|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428350|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83428351|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83428352|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
83428353|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83428354|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83428355|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83428356|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
83428357|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83428358|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83428359|NCT00450073|Vitamin D|vitamin d|mesh-list
83428360|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
83428361|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
83428362|NCT00450073|Vitamins|vitamins|mesh-list
83428363|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
83428364|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428365|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83428366|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83428367|NCT00467077|Interferons|interferons|mesh-list
83428368|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
83428369|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
83428370|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83428371|NCT00467077|Gefitinib|gefitinib|mesh-list
83428372|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428373|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
83428374|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428375|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
83428376|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428377|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83428378|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428379|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428380|NCT00467389|Donepezil|donepezil|mesh-list
83428381|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83428382|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428383|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428384|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
83428385|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428386|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428387|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
83428388|NCT00377741|Valganciclovir|valganciclovir|mesh-list
83428389|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
83428390|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428391|NCT00379145|Trabectedin|trabectedin|mesh-list
83428392|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83428393|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
83428394|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428395|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428396|NCT00382031|Zalutumumab|zalutumumab|mesh-list
83428397|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83428398|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428399|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428400|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
83428401|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428402|NCT00382265|Tamsulosin|tamsulosin|mesh-list
83428403|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83428404|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83428405|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83428406|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
83428407|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428408|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428409|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428410|NCT00382265|Urological Agents|urological agents|mesh-ancestor
83428411|NCT00383747|Nicotine|nicotine|mesh-list
83428412|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83428413|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
83428414|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428415|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428416|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83428417|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83428418|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
83428419|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428420|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428421|NCT01421342|Aripiprazole|aripiprazole|mesh-list
83428422|NCT01421342|Bupropion|bupropion|mesh-list
83428423|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
83428424|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83428425|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83428426|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83428427|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83428428|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83428429|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428430|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
83428431|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428432|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428433|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83428434|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83428435|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428436|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83428437|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83428438|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83428439|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
83428440|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83428441|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83428442|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
83428443|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83428444|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83428445|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83428446|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83428447|NCT00403403|Bevacizumab|bevacizumab|mesh-list
83428448|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428449|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428450|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428451|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428452|NCT00403403|Growth Substances|growth substances|mesh-ancestor
83428453|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428454|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428455|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
83428457|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
83428458|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
83428459|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83428460|NCT00405353|Androgens|androgens|mesh-ancestor
83428461|NCT00405353|Hormones|hormones|mesh-ancestor
83428462|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428463|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428464|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83428465|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428466|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
83428467|NCT01384292|Naloxegol|naloxegol|mesh-list
83428468|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83428469|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428470|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
83428471|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428472|NCT00450463|Metronidazole|metronidazole|mesh-list
83428473|NCT00450463|Molgramostim|molgramostim|mesh-list
83428474|NCT00450463|Flutamide|flutamide|mesh-list
83428475|NCT00450463|Sargramostim|sargramostim|mesh-list
83428476|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
83428477|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428478|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428479|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428480|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83428481|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83428482|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83428483|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
83428484|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
83428485|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428486|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83428487|NCT00407381|Ranibizumab|ranibizumab|mesh-list
83428488|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428489|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428490|NCT00407381|Growth Substances|growth substances|mesh-ancestor
83428491|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428492|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428493|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428494|NCT00384449|Ranibizumab|ranibizumab|mesh-list
83428495|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428496|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428497|NCT00384449|Growth Substances|growth substances|mesh-ancestor
83428498|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428499|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428500|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428501|NCT00452335|Lubiprostone|lubiprostone|mesh-list
83428502|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83428503|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83428504|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428505|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
83428506|NCT00386243|Analgesics|analgesics|mesh-list
83428507|NCT00386243|Narcotics|narcotics|mesh-ancestor
83428508|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83428509|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428510|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
83428511|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428512|NCT01400516|Vitamin D|vitamin d|mesh-list
83428513|NCT01400516|Teriparatide|teriparatide|mesh-list
83428514|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83428515|NCT01400516|Calcium|calcium|mesh-list
83428516|NCT01400516|Vitamins|vitamins|mesh-ancestor
83428518|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428519|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83428520|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83428521|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83428522|NCT01383356|Metformin|metformin|mesh-list
83428523|NCT01383356|Linagliptin|linagliptin|mesh-list
83428524|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83428525|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428527|NCT01383356|Hormones|hormones|mesh-ancestor
83428528|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428529|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83428530|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
83428531|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428532|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428533|NCT02111447|Propofol|propofol|mesh-list
83428534|NCT02111447|Sevoflurane|sevoflurane|mesh-list
83428535|NCT02111447|Isoflurane|isoflurane|mesh-list
83428536|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83428537|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83428538|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428539|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83428540|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
83428541|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
83428542|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83428543|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83428544|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
83428545|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83428546|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428547|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
83428548|NCT00453193|Pentostatin|pentostatin|mesh-list
83428549|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428550|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428551|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83428552|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428553|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428554|NCT00387023|Rituximab|rituximab|mesh-list
83428555|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428556|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428557|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
83428558|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428559|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83428560|NCT00472849|Cytarabine|cytarabine|mesh-list
83428561|NCT00472849|Rituximab|rituximab|mesh-list
83428562|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
83428563|NCT00472849|Fludarabine|fludarabine|mesh-list
83428564|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428565|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428566|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
83428567|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428568|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83428569|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83428570|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
83428571|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428572|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83428573|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
83428574|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428575|NCT00453895|Sunitinib|sunitinib|mesh-list
83428576|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428577|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428578|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428579|NCT00453895|Growth Substances|growth substances|mesh-ancestor
83428580|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428581|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428582|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83428583|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428584|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428585|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
83428586|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83428587|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83428588|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83428589|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83428590|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428591|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
83428592|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428593|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428594|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83428595|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428596|NCT00409565|Bevacizumab|bevacizumab|mesh-list
83428597|NCT00409565|Cetuximab|cetuximab|mesh-list
83428598|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428599|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428600|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428601|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428602|NCT00409565|Growth Substances|growth substances|mesh-ancestor
83428603|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428604|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428606|NCT00475501|Finasteride|finasteride|mesh-list
83428607|NCT00475501|Testosterone|testosterone|mesh-list
83428608|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
83428609|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
83428610|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83428611|NCT00475501|Androgens|androgens|mesh-ancestor
83428612|NCT00475501|Hormones|hormones|mesh-ancestor
83428613|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428614|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428615|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83428616|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428617|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
83428618|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83428619|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83428620|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428621|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428622|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
83428623|NCT00475501|Urological Agents|urological agents|mesh-ancestor
83428624|NCT00529555|Minocycline|minocycline|mesh-list
83428625|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83428626|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428627|NCT00387335|Sunitinib|sunitinib|mesh-list
83428628|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428629|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428630|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428631|NCT00387335|Growth Substances|growth substances|mesh-ancestor
83428632|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428633|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428634|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83428635|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428636|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428637|NCT01797757|Orlistat|orlistat|mesh-list
83428638|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428639|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428640|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83428641|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83428642|NCT01796899|Brivaracetam|brivaracetam|mesh-list
83428643|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
83428644|NCT00477451|Alprazolam|alprazolam|mesh-list
83428645|NCT00477451|Doxapram|doxapram|mesh-list
83428646|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83428647|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83428648|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428649|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83428650|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83428651|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83428652|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
83428653|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
83428654|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428655|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428656|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83428657|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
83428658|NCT00530803|Lidocaine|lidocaine|mesh-list
83428659|NCT00530803|Tetracaine|tetracaine|mesh-list
83428660|NCT00530803|Prilocaine|prilocaine|mesh-list
83428661|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83428662|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
83428663|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
83428664|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83428665|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428666|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
83428667|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428668|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83428669|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83428670|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83428671|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83428672|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428673|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83428674|NCT04372927|Cisplatin|cisplatin|mesh-list
83428675|NCT04372927|Etoposide|etoposide|mesh-list
83428676|NCT04372927|Pemetrexed|pemetrexed|mesh-list
83428677|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
83428678|NCT04372927|Durvalumab|durvalumab|mesh-list
83428679|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
83428680|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
83428681|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83428682|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
83428683|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428684|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83428685|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83428686|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83428687|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428688|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428689|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83428690|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83428691|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428692|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
83428693|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428694|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
83428695|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
83428696|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
83428697|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
83428698|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
83428699|NCT01381874|Prednisone|prednisone|mesh-list
83428700|NCT01381874|Prednisolone|prednisolone|mesh-list
83428701|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83428702|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
83428703|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83428704|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
83428705|NCT01381874|Exemestane|exemestane|mesh-list
83428706|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
83428707|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83428708|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
83428709|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83428710|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
83428711|NCT01381874|Hormones|hormones|mesh-ancestor
83428712|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428713|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428714|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83428715|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428716|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
83428717|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
83428718|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428719|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83428720|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83428721|NCT01381874|Protective Agents|protective agents|mesh-ancestor
83428722|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83428723|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83428724|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428725|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428726|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83428727|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
83428728|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83428729|NCT01399190|Bevacizumab|bevacizumab|mesh-list
83428730|NCT01399190|Capecitabine|capecitabine|mesh-list
83428731|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
83428732|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428733|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428734|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428735|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428736|NCT01399190|Growth Substances|growth substances|mesh-ancestor
83428737|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428738|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428739|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83428740|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
83428741|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428742|NCT01381718|Modafinil|modafinil|mesh-list
83428743|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83428744|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428745|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83428746|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83428747|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83428748|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428750|NCT05365178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83428751|NCT05365178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428752|NCT05365178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83428753|NCT05365178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83428754|NCT05365178|Hormone Antagonists|hormone antagonists|mesh-ancestor
83428755|NCT05365178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428756|NCT05365178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428757|NCT00479089|Dexamethasone|dexamethasone|mesh-list
83428758|NCT00479089|Docetaxel|docetaxel|mesh-list
83428759|NCT00479089|Gefitinib|gefitinib|mesh-list
83428760|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83428761|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
83428762|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
83428763|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428764|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428765|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83428766|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
83428767|NCT00479089|Hormones|hormones|mesh-ancestor
83428768|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428769|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83428770|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428771|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
83428772|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
83428773|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
83428774|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428775|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83428776|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428777|NCT01398956|Levetiracetam|levetiracetam|mesh-list
83428778|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
83428779|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
83428780|NCT00410423|Cytarabine|cytarabine|mesh-list
83428781|NCT00410423|Etoposide|etoposide|mesh-list
83428782|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
83428783|NCT00410423|Bortezomib|bortezomib|mesh-list
83428784|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83428785|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428786|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83428787|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83428788|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428789|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428790|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83428791|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
83428792|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
83428793|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428794|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83428795|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
83428796|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428797|NCT00410423|Analgesics|analgesics|mesh-ancestor
83428798|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
83428799|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428800|NCT00387959|Cyclosporine|cyclosporine|mesh-list
83428801|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
83428802|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
83428803|NCT00387959|Rituximab|rituximab|mesh-list
83428804|NCT00387959|Fludarabine|fludarabine|mesh-list
83428805|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
83428806|NCT00387959|Cyclosporins|cyclosporins|mesh-list
83428807|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83428808|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
83428809|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428810|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83428811|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83428812|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
83428813|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428814|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428815|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83428816|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428817|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83428818|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
83428819|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428820|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
83428821|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428822|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
83428823|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83428824|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83428825|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83428826|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
83428827|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83428828|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
83428829|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83428830|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428831|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83428832|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83428833|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83428834|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83428835|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428836|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428837|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428839|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83428840|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428841|NCT01381016|Hormones|hormones|mesh-list
83428842|NCT01381016|Estradiol|estradiol|mesh-list
83428843|NCT01381016|Progesterone|progesterone|mesh-list
83428844|NCT01381016|Estrogens|estrogens|mesh-list
83428845|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83428846|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428847|NCT01381016|Progestins|progestins|mesh-ancestor
83428848|NCT00412451|Plasminogen|plasminogen|mesh-list
83428849|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83428850|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83428851|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428852|NCT01398410|Rabeprazole|rabeprazole|mesh-list
83428853|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83428854|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83428855|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83428856|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428857|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428858|NCT00412529|Entecavir|entecavir|mesh-list
83428859|NCT00412529|Telbivudine|telbivudine|mesh-list
83428860|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
83428861|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428862|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83428863|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428864|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428865|NCT00412841|Atorvastatin|atorvastatin|mesh-list
83428866|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83428867|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83428868|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
83428869|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428870|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83428871|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83428872|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428873|NCT01796483|Clonidine|clonidine|mesh-list
83428874|NCT01796483|Analgesics|analgesics|mesh-ancestor
83428875|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
83428876|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83428877|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428878|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83428879|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
83428880|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
83428881|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83428882|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83428883|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83428884|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
83428885|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428886|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428887|NCT00414167|Bupropion|bupropion|mesh-list
83428888|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83428889|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
83428890|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83428891|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83428892|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83428893|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83428894|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428895|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
83428896|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428897|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428898|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83428899|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83428900|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428902|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428903|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83428904|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428905|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428906|NCT00534001|Bupropion|bupropion|mesh-list
83428907|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83428908|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
83428909|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83428910|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83428911|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83428912|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83428913|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428914|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
83428915|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83428916|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428917|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83428918|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83428919|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428920|NCT00481351|Simvastatin|simvastatin|mesh-list
83428921|NCT00481351|Ezetimibe|ezetimibe|mesh-list
83428922|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83428923|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83428924|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
83428925|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428926|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83428927|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83428928|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428929|NCT00455975|Bevacizumab|bevacizumab|mesh-list
83428930|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428931|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428932|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83428933|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83428934|NCT00455975|Growth Substances|growth substances|mesh-ancestor
83428935|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428936|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
83428937|NCT05366192|Ritonavir|ritonavir|mesh-list
83428938|NCT05366192|Nirmatrelvir|nirmatrelvir|mesh-list
83428939|NCT05366192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83428940|NCT05366192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83428941|NCT05366192|Protease Inhibitors|protease inhibitors|mesh-ancestor
83428942|NCT05366192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428943|NCT05366192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428945|NCT05366192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83428946|NCT05366192|Antiviral Agents|antiviral agents|mesh-ancestor
83428947|NCT05366192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83428948|NCT05366192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83428949|NCT05366192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83428950|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
83428951|NCT04013672|Sargramostim|sargramostim|mesh-list
83428952|NCT04013672|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83428953|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428954|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428955|NCT04013672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83428956|NCT04013672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428957|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
83428958|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428959|NCT04013672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83428960|NCT02078882|Abatacept|abatacept|mesh-list
83428961|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83428962|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428963|NCT02078882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428964|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428965|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83428966|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
83428967|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428968|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83428969|NCT00458237|Trastuzumab|trastuzumab|mesh-list
83428970|NCT00458237|Everolimus|everolimus|mesh-list
83428971|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83428972|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428973|NCT00458237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83428974|NCT00458237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83428975|NCT00458237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428976|NCT00458237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428977|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83428978|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
83428979|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428980|NCT00418457|Anesthetics|anesthetics|mesh-list
83428981|NCT00418457|Propofol|propofol|mesh-list
83428982|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83428983|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428984|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83428985|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83428986|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
83428987|NCT00482677|Temozolomide|temozolomide|mesh-list
83428988|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83428989|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
83428990|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428991|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83428992|NCT01397552|Dexamethasone|dexamethasone|mesh-list
83428993|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
83428994|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83428995|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83428996|NCT01397552|Prednisolone|prednisolone|mesh-list
83428997|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
83428998|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83428999|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
83429000|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83429001|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
83429002|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
83429003|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429004|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429005|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83429006|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
83429007|NCT01397552|Hormones|hormones|mesh-ancestor
83429008|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83429009|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83429010|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429011|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83429012|NCT01397552|Protective Agents|protective agents|mesh-ancestor
83429013|NCT05368376|Metoprolol|metoprolol|mesh-list
83429014|NCT05368376|Labetalol|labetalol|mesh-list
83429015|NCT05368376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83429016|NCT05368376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83429017|NCT05368376|Sympatholytics|sympatholytics|mesh-ancestor
83429018|NCT05368376|Autonomic Agents|autonomic agents|mesh-ancestor
83429019|NCT05368376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429020|NCT05368376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429021|NCT05368376|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83429022|NCT05368376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83429023|NCT05368376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83429024|NCT05368376|Adrenergic Agents|adrenergic agents|mesh-ancestor
83429025|NCT05368376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429026|NCT05368376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429027|NCT05368376|Sympathomimetics|sympathomimetics|mesh-ancestor
83429028|NCT05368376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83429029|NCT05368376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83429030|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
83429031|NCT00482911|Lenalidomide|lenalidomide|mesh-list
83429032|NCT00482911|Sunitinib|sunitinib|mesh-list
83429033|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83429034|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
83429035|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429036|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83429037|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83429038|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
83429039|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429040|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429041|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83429042|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83429043|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83429044|NCT00482911|Growth Substances|growth substances|mesh-ancestor
83429045|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
83429046|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83429047|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429048|NCT01397162|Fluticasone|fluticasone|mesh-list
83429049|NCT01397162|Xhance|xhance|mesh-list
83429050|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83429051|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83429052|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
83429053|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429054|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429055|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83429056|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
83429057|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
83429058|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83429059|NCT05362916|Letermovir|letermovir|mesh-list
83429060|NCT05362916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83429061|NCT05362916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429062|NCT05362916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429063|NCT05362916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429064|NCT05362916|Antiviral Agents|antiviral agents|mesh-ancestor
83429065|NCT05362916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429066|NCT00483223|Carboplatin|carboplatin|mesh-list
83429067|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429068|NCT01397084|Esomeprazole|esomeprazole|mesh-list
83429069|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83429070|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83429071|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83429072|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429073|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429074|NCT00420017|Amiodarone|amiodarone|mesh-list
83429075|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83429076|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
83429077|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83429078|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83429079|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429080|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83429081|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83429082|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83429083|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429084|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83429085|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83429086|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83429087|NCT04092673|Trastuzumab|trastuzumab|mesh-list
83429088|NCT04092673|Sotorasib|sotorasib|mesh-list
83429089|NCT04092673|Fulvestrant|fulvestrant|mesh-list
83429090|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83429091|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429092|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83429093|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83429094|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83429095|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
83429096|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83429097|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429098|NCT04092673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83429099|NCT04092673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429100|NCT00484393|Tetracaine|tetracaine|mesh-list
83429101|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
83429102|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
83429103|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429104|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429105|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
83429106|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429107|NCT00485485|Docetaxel|docetaxel|mesh-list
83429108|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
83429109|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429110|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
83429111|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
83429112|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
83429113|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429114|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83429115|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429117|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83429118|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
83429119|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83429120|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429121|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83429122|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83429123|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83429124|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
83429125|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83429126|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83429127|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
83429128|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83429129|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
83429130|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83429131|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83429132|NCT01396148|Sunitinib|sunitinib|mesh-list
83429133|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429134|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83429135|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83429136|NCT01396148|Growth Substances|growth substances|mesh-ancestor
83429137|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429138|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
83429139|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83429140|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429141|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429142|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
83429143|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83429144|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83429145|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429146|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83429147|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480269|NCT04404283|Lenalidomide|lenalidomide|mesh-list
83429148|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83429149|NCT00486031|Balsalazide|balsalazide|mesh-list
83429150|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83429151|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83429152|NCT00486031|Analgesics|analgesics|mesh-ancestor
83429153|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
83429154|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429155|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429156|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83429157|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83429158|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83429159|NCT04019834|Bupivacaine|bupivacaine|mesh-list
83429160|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
83429161|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
83429162|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429163|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429164|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
83429165|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429166|NCT04017962|Letermovir|letermovir|mesh-list
83429167|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83429168|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429169|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429170|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429171|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
83429172|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429173|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83429174|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83429175|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429176|NCT01396070|Immunotoxins|immunotoxins|mesh-ancestor
83429177|NCT01396070|Immunoconjugates|immunoconjugates|mesh-ancestor
83429178|NCT01396070|Immunologic Factors|immunologic factors|mesh-ancestor
83429179|NCT01396070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429180|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
83429181|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83429182|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429183|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429184|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83429185|NCT02108171|Analgesics|analgesics|mesh-ancestor
83429186|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
83429187|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429189|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83429190|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83429191|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
83429192|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429193|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429194|NCT03940807|Estradiol|estradiol|mesh-list
83429195|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83429196|NCT03940807|Estrogens|estrogens|mesh-ancestor
83429197|NCT03940807|Hormones|hormones|mesh-ancestor
83429198|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83429199|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429200|NCT00535873|Lenalidomide|lenalidomide|mesh-list
83429201|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
83429202|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429203|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83429204|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83429205|NCT00535873|Growth Substances|growth substances|mesh-ancestor
83429206|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
83429207|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429208|NCT00487669|Paclitaxel|paclitaxel|mesh-list
83429209|NCT00487669|Pemetrexed|pemetrexed|mesh-list
83429210|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83429211|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83429212|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429213|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
83429214|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
83429215|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
83429216|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429217|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429218|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83429219|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83429220|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
83429222|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
83429223|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83429224|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83429225|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429226|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83429227|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83429228|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
83429229|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429230|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429231|NCT02120287|Bevacizumab|bevacizumab|mesh-list
83429232|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83429233|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429234|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83429235|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83429236|NCT02120287|Growth Substances|growth substances|mesh-ancestor
83429237|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429238|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
83429239|NCT00536341|Rituximab|rituximab|mesh-list
83429240|NCT00536341|Fludarabine|fludarabine|mesh-list
83429241|NCT00536341|Lenalidomide|lenalidomide|mesh-list
83429242|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83429243|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429244|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
83429245|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429246|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83429247|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83429248|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83429249|NCT00536341|Growth Substances|growth substances|mesh-ancestor
83429250|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
83429251|NCT02122471|Plecanatide|plecanatide|mesh-list
83429252|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83429253|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
83429254|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429255|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83429256|NCT00461591|Apaziquone|apaziquone|mesh-list
83429257|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429258|NCT00533117|Fluoxetine|fluoxetine|mesh-list
83429259|NCT00533117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83429260|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83429261|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83429262|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429263|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429264|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
83429265|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429266|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83429267|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
83429268|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83429269|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83429270|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83429271|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429272|NCT00423683|PENTA|penta|mesh-list
83429273|NCT00423683|Fondaparinux|fondaparinux|mesh-list
83429274|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83429275|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
83429276|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83429277|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
83429278|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429279|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429280|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
83429281|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83429282|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83429283|NCT00424619|Vitamin D|vitamin d|mesh-list
83429284|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
83429285|NCT00424619|Cholecalciferol|cholecalciferol|mesh-list
83429286|NCT00424619|Vitamins|vitamins|mesh-list
83429287|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
83429288|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429289|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83429290|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83429291|NCT00425477|Bexarotene|bexarotene|mesh-list
83429292|NCT00425477|Sargramostim|sargramostim|mesh-list
83429293|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
83429294|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429295|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429296|NCT00427037|Vitamin D|vitamin d|mesh-list
83429297|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
83429298|NCT00427037|Vitamins|vitamins|mesh-ancestor
83429299|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
83429300|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429301|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83429302|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83429303|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
83429304|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83429305|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429306|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83429307|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429308|NCT00427661|Cyclosporine|cyclosporine|mesh-list
83429309|NCT00427661|Fludarabine|fludarabine|mesh-list
83429310|NCT00427661|Busulfan|busulfan|mesh-list
83429311|NCT00427661|Cyclosporins|cyclosporins|mesh-list
83429312|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429313|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429314|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83429315|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
83429316|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429317|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429318|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
83429319|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429320|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
83429321|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83429322|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83429323|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
83429324|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83429325|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83429326|NCT00427973|Cediranib|cediranib|mesh-list
83429327|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429328|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429329|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429330|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83429331|NCT01795703|Prednisolone|prednisolone|mesh-list
83429332|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83429333|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
83429334|NCT01795703|Hormones|hormones|mesh-ancestor
83429335|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83429336|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429337|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83429338|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429339|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
83429340|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
83429341|NCT00429143|Tacrolimus|tacrolimus|mesh-list
83429342|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83429343|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
83429344|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429345|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83429346|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83429347|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
83429348|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429349|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429350|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83429351|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83429352|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429353|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83429354|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83429355|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
83429356|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83429357|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429358|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
83429359|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83429360|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83429361|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83429362|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83429363|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429364|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
83429365|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429366|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429367|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83429368|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429369|NCT00433745|Vaccines|vaccines|mesh-list
83429370|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
83429371|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429372|NCT01395758|Gemcitabine|gemcitabine|mesh-list
83429374|NCT01395758|Pemetrexed|pemetrexed|mesh-list
83429375|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83429376|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83429377|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
83429378|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429379|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429380|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
83429381|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
83429382|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
83429383|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429384|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83429385|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83429386|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83429387|NCT00462605|Entinostat|entinostat|mesh-list
83429388|NCT00462605|Sargramostim|sargramostim|mesh-list
83429389|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83429390|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
83429391|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429392|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429393|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429394|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429395|NCT00534833|Vaccines|vaccines|mesh-list
83429396|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
83429397|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429398|NCT00434993|Albuterol|albuterol|mesh-list
83429399|NCT00434993|Dimercaprol|dimercaprol|mesh-list
83429400|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83429401|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
83429403|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429404|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83429405|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
83429406|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
83429407|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83429408|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83429409|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83429410|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83429411|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
83429412|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429413|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429414|NCT00434993|Chelating Agents|chelating agents|mesh-ancestor
83429415|NCT00434993|Sequestering Agents|sequestering agents|mesh-ancestor
83429417|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83429418|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429419|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
83429420|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429422|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
83429423|NCT04338698|Oseltamivir|oseltamivir|mesh-list
83429424|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83429425|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429426|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
83429427|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83429428|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83429429|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480270|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83429430|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429431|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83429432|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
83429433|NCT00435539|Plasminogen|plasminogen|mesh-list
83429434|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
83429435|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83429436|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83429437|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480271|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480272|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
83480273|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480274|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480275|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83480276|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83480277|NCT04404283|Growth Substances|growth substances|mesh-ancestor
83429439|NCT00464711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83429440|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83429441|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83429442|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429443|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429444|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
83429445|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429446|NCT02078180|Bupropion|bupropion|mesh-list
83429447|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83429448|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
83429449|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83429450|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83429451|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83480278|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
83480279|NCT04404283|Immunotoxins|immunotoxins|mesh-ancestor
83429452|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83429453|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429454|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
83429455|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429456|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429457|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83429458|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83429459|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429460|NCT00535613|Propofol|propofol|mesh-list
83429461|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83429462|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429463|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429464|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83429465|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
83429466|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
83429467|NCT00466661|Acamprosate|acamprosate|mesh-list
83429468|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83429469|NCT05360576|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83429470|NCT05360576|Etonogestrel|etonogestrel|mesh-list
83429471|NCT05360576|NuvaRing|nuvaring|mesh-list
83429472|NCT05360576|Estradiol|estradiol|mesh-list
83429473|NCT05360576|Estrogens|estrogens|mesh-ancestor
83429474|NCT05360576|Hormones|hormones|mesh-ancestor
83480280|NCT04404283|Immunoconjugates|immunoconjugates|mesh-ancestor
83429475|NCT05360576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83429476|NCT05360576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429477|NCT05360576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83429478|NCT05360576|Contraceptive Agents|contraceptive agents|mesh-ancestor
83429479|NCT05360576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83429480|NCT05360576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83429481|NCT05360576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83429482|NCT05360576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83429483|NCT00535925|Aspirin|aspirin|mesh-list
83429484|NCT00535925|Atenolol|atenolol|mesh-list
83429485|NCT00535925|Amlodipine|amlodipine|mesh-list
83429486|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83429488|NCT00535925|Ramipril|ramipril|mesh-list
83429489|NCT00535925|Irbesartan|irbesartan|mesh-list
83429490|NCT00535925|Doxazosin|doxazosin|mesh-list
83429491|NCT00535925|Furosemide|furosemide|mesh-list
83429492|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
83429493|NCT00535925|Simvastatin|simvastatin|mesh-list
83429494|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429495|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83429496|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83429497|NCT00535925|Analgesics|analgesics|mesh-ancestor
83429498|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
83429499|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429500|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83429501|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83429502|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83429503|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83429504|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429505|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83429506|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83429507|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429508|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
83480281|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
83429509|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83429510|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83429511|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83480282|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83429512|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83429513|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
83429514|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83429515|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83429516|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
83429517|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83429518|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83429519|NCT00535925|Diuretics|diuretics|mesh-ancestor
83429520|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
83429521|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83480283|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429522|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83429524|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
83429525|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83429526|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83429527|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83429528|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
83429529|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429530|NCT00535925|Hematinics|hematinics|mesh-ancestor
83429531|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83429532|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
83429533|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83429534|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83429535|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83429536|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83429537|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83429538|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83429539|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83429540|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83429541|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83429542|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83429543|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
83429544|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429545|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429546|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429547|NCT01796093|Digoxin|digoxin|mesh-list
83429548|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83429549|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83429550|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429551|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429552|NCT01796093|Protective Agents|protective agents|mesh-ancestor
83429553|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429554|NCT00537511|Etoposide|etoposide|mesh-list
83429555|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
83429556|NCT00537511|Pomalidomide|pomalidomide|mesh-list
83429557|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429558|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83429560|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83429561|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429562|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429563|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
83429564|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429565|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83429566|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83429567|NCT00537511|Growth Substances|growth substances|mesh-ancestor
83429568|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
83429569|NCT00435929|Ritonavir|ritonavir|mesh-list
83429570|NCT00435929|Saquinavir|saquinavir|mesh-list
83429571|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83429572|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83429573|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
83429574|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480284|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429575|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429576|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83429578|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
83429579|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429580|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83429581|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83429582|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
83429583|NCT00436475|Vitamin D|vitamin d|mesh-list
83429584|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
83429585|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
83429586|NCT00436475|Vitamins|vitamins|mesh-list
83429587|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
83429588|NCT00436475|Calcium|calcium|mesh-list
83429589|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
83429590|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429591|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83429592|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83429593|NCT00436475|Antacids|antacids|mesh-ancestor
83429594|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429595|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83429596|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
83429598|NCT03595514|Dexamethasone|dexamethasone|mesh-list
83429599|NCT03595514|Lidocaine|lidocaine|mesh-list
83429600|NCT03595514|Epinephrine|epinephrine|mesh-list
83429601|NCT03595514|Bupivacaine|bupivacaine|mesh-list
83429602|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83429603|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
83429604|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
83429605|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429606|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429607|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83429608|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
83429610|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83429611|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83429612|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429613|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
83429615|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429616|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
83429617|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83429618|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83429619|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83429620|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83429621|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429622|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83429623|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83429625|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429626|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83429627|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83429628|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83429629|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
83429630|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
83429631|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
83429632|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83429633|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
83429634|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
83429635|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429636|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
83429637|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429639|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
83429640|NCT03595046|Ropivacaine|ropivacaine|mesh-list
83429641|NCT03595046|BB 1101|bb 1101|mesh-list
83429642|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83429643|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
83429644|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
83429645|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429646|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429647|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83429648|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
83429649|NCT03595046|Hormones|hormones|mesh-ancestor
83429650|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83429651|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83429653|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
83429654|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429655|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429656|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
83429657|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
83429658|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429659|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
83429661|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83429662|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83429663|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
83429664|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429665|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429666|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83429667|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
83429668|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
83429669|NCT00217022|Hormones|hormones|mesh-ancestor
83430136|NCT05630768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429670|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83429671|NCT03594968|Progesterone|progesterone|mesh-list
83429672|NCT03594968|Progestins|progestins|mesh-ancestor
83429673|NCT03594968|Hormones|hormones|mesh-ancestor
83430137|NCT00506155|Bevacizumab|bevacizumab|mesh-list
83429674|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83429675|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429676|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
83429677|NCT00538915|Antibodies|antibodies|mesh-list
83429678|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
83429679|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83429681|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
83429682|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429683|NCT00490009|Acetaminophen|acetaminophen|mesh-list
83429684|NCT00490009|Iodine|iodine|mesh-list
83429685|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
83429687|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
83429688|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
83429689|NCT00490009|Lugol's solution|lugol's solution|mesh-list
83429690|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83429691|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83429692|NCT00490009|Analgesics|analgesics|mesh-ancestor
83429693|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
83429694|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429695|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429696|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
83429697|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83429698|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429699|NCT00490009|Trace Elements|trace elements|mesh-ancestor
83429700|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
83429701|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83429702|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83429703|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429704|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
83429705|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
83429706|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
83429707|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
83429708|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83429709|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83429710|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
83429711|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
83429712|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430139|NCT00506155|Doxorubicin|doxorubicin|mesh-list
83429713|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429715|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
83429716|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
83429717|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429718|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
83429720|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
83429722|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83429723|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429724|NCT03769532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83429725|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429726|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83429727|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
83429728|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429729|NCT00490477|Polymyxins|polymyxins|mesh-list
83429730|NCT00490477|Polymyxin B|polymyxin b|mesh-list
83429731|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83429732|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429733|NCT03997370|Carboplatin|carboplatin|mesh-list
83429734|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429735|NCT00492973|Cefuroxime|cefuroxime|mesh-list
83429737|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83429738|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83429739|NCT00492973|Prednisolone|prednisolone|mesh-list
83429740|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
83429741|NCT00492973|Clonidine|clonidine|mesh-list
83429742|NCT00492973|Epinephrine|epinephrine|mesh-list
83429743|NCT00492973|Morphine|morphine|mesh-list
83429744|NCT00492973|Bupivacaine|bupivacaine|mesh-list
83429745|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83429746|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
83429747|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
83429749|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429750|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429751|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
83429752|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429753|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83429754|NCT00492973|Narcotics|narcotics|mesh-ancestor
83429755|NCT00492973|Analgesics|analgesics|mesh-ancestor
83429756|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83429757|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
83429758|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
83429759|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83429761|NCT00492973|Hormones|hormones|mesh-ancestor
83430140|NCT00506155|Methotrexate|methotrexate|mesh-list
83430141|NCT00506155|Vinblastine|vinblastine|mesh-list
83430142|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83429762|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83429763|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83429764|NCT00492973|Protective Agents|protective agents|mesh-ancestor
83429765|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83429766|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429767|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83429768|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83429769|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
83429770|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429771|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429772|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83429773|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83429774|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83429775|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
83429776|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
83429777|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
83429778|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83429779|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83429780|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
83429781|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83429782|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83429783|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429784|NCT05630534|Minocycline|minocycline|mesh-list
83429785|NCT05630534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83429786|NCT05630534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429787|NCT00495079|Vincristine|vincristine|mesh-list
83429788|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83429789|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429790|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
83429791|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
83429792|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
83429793|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429794|NCT05630222|Acetaminophen|acetaminophen|mesh-list
83429795|NCT05630222|Ibuprofen|ibuprofen|mesh-list
83429796|NCT05630222|Morphine|morphine|mesh-list
83429797|NCT05630222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83429798|NCT05630222|Narcotics|narcotics|mesh-ancestor
83429799|NCT05630222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429800|NCT05630222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429801|NCT05630222|Analgesics|analgesics|mesh-ancestor
83429802|NCT05630222|Sensory System Agents|sensory system agents|mesh-ancestor
83429803|NCT05630222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429804|NCT05630222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83429805|NCT05630222|Antipyretics|antipyretics|mesh-ancestor
83429806|NCT05630222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83429807|NCT05630222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83429808|NCT05630222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83429809|NCT05630222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83429810|NCT05630222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429811|NCT05630222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429812|NCT03594188|Anesthetics|anesthetics|mesh-list
83429813|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429814|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429815|NCT00539695|Aldesleukin|aldesleukin|mesh-list
83429816|NCT00539695|Interleukin-2|interleukin-2|mesh-list
83429817|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429818|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83429819|NCT00539695|Analgesics|analgesics|mesh-ancestor
83429820|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
83429821|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429822|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429823|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83429824|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83429825|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
83429826|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429827|NCT03593954|Ritonavir|ritonavir|mesh-list
83429828|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83429830|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
83429831|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429832|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429833|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83429834|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83429835|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
83429836|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429837|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83429838|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83429839|NCT03340675|Ifetroban|ifetroban|mesh-list
83429840|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83429841|NCT03590210|Nivolumab|nivolumab|mesh-list
83429842|NCT03590210|Trabectedin|trabectedin|mesh-list
83429843|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83429844|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429845|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83429846|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429847|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83429848|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
83429850|NCT05632328|Gemcitabine|gemcitabine|mesh-list
83429851|NCT05632328|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83429852|NCT05632328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83429853|NCT05632328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429854|NCT05632328|Tubulin Modulators|tubulin modulators|mesh-ancestor
83429855|NCT05632328|Antimitotic Agents|antimitotic agents|mesh-ancestor
83429856|NCT05632328|Mitosis Modulators|mitosis modulators|mesh-ancestor
83429857|NCT05632328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429858|NCT05632328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83429859|NCT05632328|Antimetabolites|antimetabolites|mesh-ancestor
83429860|NCT05632328|Immunologic Factors|immunologic factors|mesh-ancestor
83429861|NCT05632328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429862|NCT03976310|Benralizumab|benralizumab|mesh-list
83429863|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83429864|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
83429865|NCT03599726|Donepezil|donepezil|mesh-list
83429866|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83429867|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429868|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429869|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
83429870|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429871|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429875|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429876|NCT04406870|Sirolimus|sirolimus|mesh-list
83429877|NCT04406870|Propranolol|propranolol|mesh-list
83429879|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429880|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83429881|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429882|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
83429883|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83429884|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
83429885|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430143|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430144|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83430145|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83429886|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429887|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83429888|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83429889|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
83429890|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429891|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83429892|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83429893|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
83429894|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83429895|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
83429896|NCT03985514|Tazobactam|tazobactam|mesh-list
83429897|NCT03985514|Piperacillin|piperacillin|mesh-list
83429898|NCT03985514|Metronidazole|metronidazole|mesh-list
83430147|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430148|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
83429899|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83429900|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83429901|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429902|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
83429903|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83429904|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83429905|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430150|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83429906|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429907|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429908|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83429909|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83429910|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83429911|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83429912|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83429913|NCT00540007|Lenalidomide|lenalidomide|mesh-list
83429914|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
83429915|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429916|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83429917|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83429918|NCT00540007|Growth Substances|growth substances|mesh-ancestor
83429919|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
83429920|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83429922|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
83429923|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
83429924|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
83429925|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429926|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429927|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
83429928|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429929|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83429931|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
83429932|NCT02982889|Protective Agents|protective agents|mesh-ancestor
83429933|NCT01867333|Metronidazole|metronidazole|mesh-list
83429934|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429935|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83429936|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83429937|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83429938|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83429939|NCT03592082|Bismuth|bismuth|mesh-list
83429940|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83429941|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83429942|NCT03592082|Antacids|antacids|mesh-ancestor
83430151|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83430152|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429943|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429944|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83429945|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
83429946|NCT03598868|Vortioxetine|vortioxetine|mesh-list
83429947|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
83429948|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83429950|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83429951|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429952|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429953|NCT03598868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83429954|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83429955|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83429956|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429957|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429958|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
83429959|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83429960|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83429961|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83429962|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83429964|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83429965|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83429966|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429967|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
83429968|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429969|NCT05631704|Midazolam|midazolam|mesh-list
83429970|NCT05631704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83429971|NCT05631704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83429972|NCT05631704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429973|NCT05631704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429975|NCT05631704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83429976|NCT05631704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83429978|NCT05631704|Anesthetics, General|anesthetics, general|mesh-ancestor
83429979|NCT05631704|Anesthetics|anesthetics|mesh-ancestor
83429981|NCT05631704|GABA Agents|gaba agents|mesh-ancestor
83429982|NCT05631704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83429983|NCT05631704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429984|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
83429985|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83429986|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429987|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429988|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83429989|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83429991|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429992|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
83429993|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83429994|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
83429995|NCT00501943|Interferons|interferons|mesh-list
83429996|NCT00501943|Interferon-beta|interferon-beta|mesh-list
83429997|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
83429999|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430000|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
83430002|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
83430003|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430004|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83430005|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
83430006|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83430007|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83430008|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430009|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430010|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83430011|NCT00501943|Protective Agents|protective agents|mesh-ancestor
83430014|NCT03598634|Vitamins|vitamins|mesh-ancestor
83430015|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
83430016|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430017|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83430019|NCT03598556|Vitamin D|vitamin d|mesh-list
83430020|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
83430021|NCT03598556|Vitamins|vitamins|mesh-ancestor
83430022|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
83430023|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430024|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83430025|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83430027|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83430028|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83430029|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83430030|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430031|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
83430032|NCT03590912|Cetirizine|cetirizine|mesh-list
83430033|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83430034|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
83430036|NCT03590912|Phenylephrine|phenylephrine|mesh-list
83430037|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
83430038|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
83430039|NCT03590912|Levocetirizine|levocetirizine|mesh-list
83430040|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
83430041|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83430042|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430043|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83430044|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
83430046|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83430047|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430048|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83430049|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430050|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
83430051|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430052|NCT03590912|Protective Agents|protective agents|mesh-ancestor
83430053|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
83430054|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83430055|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83430056|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
83430057|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480285|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83430058|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430059|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83430060|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83430061|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
83430062|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
83430063|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83430064|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
83430065|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83430066|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
83430067|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83430068|NCT00503113|Alendronate|alendronate|mesh-list
83430069|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
83430070|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83430071|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430072|NCT00542971|Cytarabine|cytarabine|mesh-list
83430073|NCT00542971|Sorafenib|sorafenib|mesh-list
83430074|NCT00542971|Idarubicin|idarubicin|mesh-list
83430075|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83480286|NCT04385602|Analgesics|analgesics|mesh-ancestor
83430077|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430078|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430079|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
83430080|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430081|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83430082|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
83430083|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430084|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83430085|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430086|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83430087|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83430088|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83430089|NCT00504751|Dexamethasone|dexamethasone|mesh-list
83430090|NCT00504751|Rituximab|rituximab|mesh-list
83430091|NCT00504751|Etoposide|etoposide|mesh-list
83430092|NCT00504751|Bortezomib|bortezomib|mesh-list
83430094|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83430095|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430096|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
83430097|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430098|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83430099|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83430100|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
83430101|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
83430102|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416194|NCT01517243|Temsirolimus|temsirolimus|mesh-list
83480288|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480289|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83430182|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430183|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83430184|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
83430185|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430186|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
83430187|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83430188|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83430189|NCT04005170|Paclitaxel|paclitaxel|mesh-list
83430190|NCT04005170|Cisplatin|cisplatin|mesh-list
83430191|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83430192|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430193|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
83430194|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
83430195|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
83430196|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430197|NCT03597308|Acetaminophen|acetaminophen|mesh-list
83430198|NCT03597308|Ibuprofen|ibuprofen|mesh-list
83430199|NCT03597308|Oxycodone|oxycodone|mesh-list
83430200|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83430201|NCT03597308|Analgesics|analgesics|mesh-ancestor
83430202|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
83430203|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430204|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430205|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
83430206|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83430207|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83430208|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83430209|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83430210|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480290|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83430211|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430213|NCT03597308|Narcotics|narcotics|mesh-ancestor
83430214|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430215|NCT04750135|Metformin|metformin|mesh-list
83480291|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83430217|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430218|NCT04003922|Adalimumab|adalimumab|mesh-list
83430219|NCT04003922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83430220|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83430221|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83430222|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
83430223|NCT03781934|Lenvatinib|lenvatinib|mesh-list
83430224|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83430225|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430226|NCT03781934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480293|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480518|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430227|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430228|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83430229|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430230|NCT00558571|Empagliflozin|empagliflozin|mesh-list
83430231|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83430232|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430233|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83430234|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430235|NCT03970382|Aldesleukin|aldesleukin|mesh-list
83430236|NCT03970382|Nivolumab|nivolumab|mesh-list
83430237|NCT03970382|Interleukin-2|interleukin-2|mesh-list
83430238|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83430239|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430240|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480519|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83430241|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430242|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83430243|NCT03970382|Analgesics|analgesics|mesh-ancestor
83430244|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
83430245|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430246|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430247|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83430248|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83430249|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
83430250|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430251|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83430252|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83430253|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430254|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
83430255|NCT01797913|Gemcitabine|gemcitabine|mesh-list
83430256|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83430257|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
83430258|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430259|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430260|NCT03596294|Rifampin|rifampin|mesh-list
83430261|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83430262|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
83430264|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430265|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
83430266|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83430267|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430268|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430269|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83430270|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83430271|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83430272|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83430273|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83430274|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83430275|NCT00537407|Ribavirin|ribavirin|mesh-list
83430276|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83430277|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
83430278|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430279|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
83430281|NCT00214916|Insulin|insulin|mesh-list
83430282|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83430283|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83430284|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430285|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83480520|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83480521|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430286|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83430287|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83430288|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83480597|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430289|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430290|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430291|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430292|NCT00438971|Analgesics|analgesics|mesh-ancestor
83430293|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
83430294|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430295|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
83430296|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83430297|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
83430298|NCT00219284|Levodopa|levodopa|mesh-list
83430299|NCT00219284|Carbidopa|carbidopa|mesh-list
83430300|NCT00219284|Entacapone|entacapone|mesh-list
83430301|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83430302|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83430303|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83430304|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
83430306|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430307|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430308|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83430310|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83430311|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83430312|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
83430313|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
83430314|NCT00509041|Dasatinib|dasatinib|mesh-list
83430316|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83430317|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480598|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430318|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430319|NCT03781700|Prednisolone|prednisolone|mesh-list
83430320|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83430321|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
83430322|NCT03781700|Hormones|hormones|mesh-ancestor
83480599|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83460162|NCT05600660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430323|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83430324|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430325|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83430327|NCT00439673|Azacitidine|azacitidine|mesh-list
83430328|NCT00439673|Valproic Acid|valproic acid|mesh-list
83430329|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83430330|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
83460163|NCT05600660|Dermatologic Agents|dermatologic agents|mesh-ancestor
83430331|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430332|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430333|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430334|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
83430335|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
83430336|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430337|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430339|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83430340|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430341|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83430342|NCT03596060|Fentanyl|fentanyl|mesh-list
83430343|NCT03596060|Morphine|morphine|mesh-list
83430344|NCT03596060|Propofol|propofol|mesh-list
83430345|NCT03596060|Rocuronium|rocuronium|mesh-list
83430346|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83430347|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430348|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430349|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83430351|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
83430352|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83430353|NCT03596060|Narcotics|narcotics|mesh-ancestor
83430354|NCT03596060|Analgesics|analgesics|mesh-ancestor
83430355|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
83430356|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430357|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83460164|NCT05600660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430358|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83430359|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83430361|NCT00473837|Chloroquine|chloroquine|mesh-list
83430362|NCT00473837|Amebicides|amebicides|mesh-ancestor
83430363|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83430364|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83430365|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430366|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
83430367|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83430369|NCT04198922|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83430370|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430371|NCT04198922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83430372|NCT04198922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430373|NCT04198922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430374|NCT00509197|Fluticasone|fluticasone|mesh-list
83430375|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83430376|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83430377|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
83430378|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430379|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430380|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83430381|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
83430382|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
83430383|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83430384|NCT00442013|Lansoprazole|lansoprazole|mesh-list
83430385|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
83430386|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83430387|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83430388|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83430389|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430390|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430391|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
83430392|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83430393|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
83430394|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83430395|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430396|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83430397|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83430398|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83430399|NCT00509665|Gemcitabine|gemcitabine|mesh-list
83430400|NCT00509665|Doxorubicin|doxorubicin|mesh-list
83430401|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83430402|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83430403|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
83430404|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430405|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430406|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83430407|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83430408|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83430409|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430410|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
83430411|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83430412|NCT00513799|Mupirocin|mupirocin|mesh-list
83430413|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83430414|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430415|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
83430416|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
83430417|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83430418|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83430419|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460165|NCT05600660|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83430420|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430421|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83430423|NCT00216476|Aripiprazole|aripiprazole|mesh-list
83430424|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83430425|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83430426|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
83430427|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430428|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430429|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430430|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83430431|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83430432|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430434|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83430435|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
83430436|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
83430437|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
83430438|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83430439|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83430440|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83430441|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83430443|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
83430444|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83430445|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83430446|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83430447|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83430448|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430449|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
83430450|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430451|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430452|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83430453|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430454|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83430455|NCT00216086|Capecitabine|capecitabine|mesh-list
83430456|NCT00216086|Irinotecan|irinotecan|mesh-list
83430457|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83430458|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
83430459|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430460|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430461|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83430462|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83430463|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430464|NCT00474851|Norethindrone|norethindrone|mesh-list
83430465|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
83430466|NCT00474851|Estrogens|estrogens|mesh-list
83430467|NCT00474851|Hormones|hormones|mesh-ancestor
83430468|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83430469|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430470|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83430471|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83430472|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83430473|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
83430474|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83430475|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83430476|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83430477|NCT00215150|Ziprasidone|ziprasidone|mesh-list
83430478|NCT00215150|Sertraline|sertraline|mesh-list
83430479|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
83430480|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83430481|NCT00215150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83430482|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83430483|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83430484|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430485|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430486|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
83430487|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430488|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83430489|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83430490|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83430491|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430492|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83430493|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
83430494|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83430495|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430496|NCT04198844|Warfarin|warfarin|mesh-list
83430497|NCT04198844|Apixaban|apixaban|mesh-list
83430498|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
83430499|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83430500|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
83430501|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83430502|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
83430503|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430504|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430505|NCT03023852|Oseltamivir|oseltamivir|mesh-list
83430506|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
83430507|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430508|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460166|NCT05600660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83430509|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430510|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
83430511|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83430512|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430513|NCT00516217|Galiximab|galiximab|mesh-list
83430514|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83430515|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430516|NCT04001504|Vaccines|vaccines|mesh-list
83430517|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
83430518|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430519|NCT00516919|Orlistat|orlistat|mesh-list
83430520|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430521|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430522|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83430523|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83430524|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83430525|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430526|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83430527|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430528|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430529|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83430530|NCT04195100|Pilocarpine|pilocarpine|mesh-list
83430531|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83430532|NCT04195100|Miotics|miotics|mesh-ancestor
83430533|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
83430534|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430535|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430536|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83430537|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83430538|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
83430539|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430540|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430541|NCT04193774|Anesthetics|anesthetics|mesh-list
83430542|NCT04193774|Benoxinate|benoxinate|mesh-list
83430543|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83430544|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
83430545|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430546|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430548|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
83430549|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
83430550|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430551|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
83430552|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83430553|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83430554|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83430555|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430556|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83430557|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83430558|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430559|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430560|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430561|NCT02985242|Empagliflozin|empagliflozin|mesh-list
83430562|NCT02985242|Glimepiride|glimepiride|mesh-list
83430563|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83430564|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430565|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83430566|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430567|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83430568|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83430569|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
83430570|NCT03023774|Lenograstim|lenograstim|mesh-list
83430571|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83430572|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
83430573|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430574|NCT04196426|Calcium|calcium|mesh-list
83430575|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83430576|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430577|NCT00518713|Clobazam|clobazam|mesh-list
83430578|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
83430579|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83430580|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83430581|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430582|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430583|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83430584|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83430585|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
83430586|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
83430587|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430588|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430589|NCT03948464|Morphine|morphine|mesh-list
83430590|NCT03948464|Methadone|methadone|mesh-list
83430591|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83430592|NCT03948464|Narcotics|narcotics|mesh-ancestor
83430593|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430594|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430595|NCT03948464|Analgesics|analgesics|mesh-ancestor
83430596|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
83430597|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430598|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
83430599|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
83430600|NCT04196270|Ropivacaine|ropivacaine|mesh-list
83430601|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
83430602|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
83430603|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430604|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430605|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
83430606|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430607|NCT03948074|Dronabinol|dronabinol|mesh-list
83430608|NCT03948074|Cannabidiol|cannabidiol|mesh-list
83430609|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
83430610|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
83430611|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430612|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83430613|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83430614|NCT03948074|Analgesics|analgesics|mesh-ancestor
83430615|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
83430616|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430617|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83430618|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83430619|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430620|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430621|NCT03948074|Hormones|hormones|mesh-ancestor
83430622|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83430623|NCT04020380|Azithromycin|azithromycin|mesh-list
83430624|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83430625|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430626|NCT00521989|Prednisolone|prednisolone|mesh-list
83430627|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83430628|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
83430629|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83430630|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
83430631|NCT00521989|Dipyridamole|dipyridamole|mesh-list
83430632|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83430633|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
83430634|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83430635|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
83430637|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83430638|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430639|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83430640|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430641|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
83430642|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
83430643|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430644|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83430645|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83430646|NCT00521989|Protective Agents|protective agents|mesh-ancestor
83430647|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83430648|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430649|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430650|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83430651|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
83430652|NCT04029350|Osimertinib|osimertinib|mesh-list
83430653|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430654|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83430655|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460167|NCT05600660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83430656|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430657|NCT00548197|Bevacizumab|bevacizumab|mesh-list
83430658|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83430659|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430660|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83430661|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83430662|NCT00548197|Growth Substances|growth substances|mesh-ancestor
83430663|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430664|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
83430665|NCT04029272|Metformin|metformin|mesh-list
83430666|NCT04029272|Exenatide|exenatide|mesh-list
83430667|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83460168|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
83430668|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430669|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83430670|NCT04029272|Incretins|incretins|mesh-ancestor
83430671|NCT04029272|Hormones|hormones|mesh-ancestor
83430672|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83430673|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
83430674|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
83430675|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430676|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83430677|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430678|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83430679|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
83430680|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430681|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83430682|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430683|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
83430685|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
83430686|NCT04028804|Protective Agents|protective agents|mesh-ancestor
83430687|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430688|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
83430689|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430690|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
83430691|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430692|NCT00524017|Cetuximab|cetuximab|mesh-list
83430693|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83430694|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430696|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83430697|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430698|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83430699|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430701|NCT05560165|Anesthetics|anesthetics|mesh-list
83430702|NCT05560165|Anesthetics, Local|anesthetics, local|mesh-list
83430703|NCT05560165|Fluorides|fluorides|mesh-list
83430705|NCT05560165|Cariostatic Agents|cariostatic agents|mesh-ancestor
83430706|NCT05560165|Protective Agents|protective agents|mesh-ancestor
83430707|NCT05560165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430708|NCT05560165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430709|NCT05560165|Sensory System Agents|sensory system agents|mesh-ancestor
83430710|NCT05560165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430711|NCT05560165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83430712|NCT05560165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430713|NCT00525421|Curcumin|curcumin|mesh-list
83430714|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83430715|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83430716|NCT00525421|Analgesics|analgesics|mesh-ancestor
83430717|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
83430718|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430719|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430720|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83430721|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83430722|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430723|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430724|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430725|NCT04023110|Carvedilol|carvedilol|mesh-list
83430726|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83430727|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83430728|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
83430729|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430730|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430731|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430732|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83430733|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
83430734|NCT04023110|Protective Agents|protective agents|mesh-ancestor
83430735|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83430736|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83430737|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83430738|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
83430739|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83430740|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83430741|NCT00525733|Ritonavir|ritonavir|mesh-list
83430742|NCT00525733|Darunavir|darunavir|mesh-list
83430743|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
83430744|NCT00525733|Maraviroc|maraviroc|mesh-list
83430745|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83430746|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83430747|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
83430748|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430749|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430750|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83430751|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83430752|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
83430753|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430754|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83430755|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83430756|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83430757|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83430758|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83430759|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83430760|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83430761|NCT04028024|Urinastatin|urinastatin|mesh-list
83430762|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83430763|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83430764|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
83430765|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430766|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430767|NCT00526591|Everolimus|everolimus|mesh-list
83430768|NCT00526591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83430769|NCT00526591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83430770|NCT00526591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430771|NCT00526591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430772|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83430773|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
83430774|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430775|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430776|NCT05559619|Calcium, Dietary|calcium, dietary|mesh-list
83430777|NCT05559619|Vitamin D|vitamin d|mesh-list
83430779|NCT05559619|Calcium Carbonate|calcium carbonate|mesh-list
83430780|NCT05559619|Calcium|calcium|mesh-list
83430781|NCT05559619|Vitamins|vitamins|mesh-ancestor
83430782|NCT05559619|Micronutrients|micronutrients|mesh-ancestor
83430783|NCT05559619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430784|NCT05559619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83430785|NCT05559619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83430786|NCT05559619|Antacids|antacids|mesh-ancestor
83430787|NCT05559619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430788|NCT05559619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83430789|NCT04194086|Posaconazole|posaconazole|mesh-list
83430790|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
83430791|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430792|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83430793|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83430794|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83430795|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83430796|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83430798|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430799|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83430800|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
83430801|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83430802|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430804|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83430805|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
83430806|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430808|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83430809|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
83430810|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430811|NCT04023266|Expectorants|expectorants|mesh-ancestor
83460169|NCT00972959|Dexamethasone|dexamethasone|mesh-list
83430812|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
83430813|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83430814|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
83430815|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430816|NCT04023266|Protective Agents|protective agents|mesh-ancestor
83430817|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430818|NCT04023266|Antidotes|antidotes|mesh-ancestor
83430819|NCT00475085|Dexamethasone|dexamethasone|mesh-list
83430820|NCT00475085|Aprepitant|aprepitant|mesh-list
83430821|NCT00475085|Palonosetron|palonosetron|mesh-list
83430822|NCT00475085|Granisetron|granisetron|mesh-list
83430823|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
83430824|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83430825|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
83430826|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
83430827|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430828|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430829|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83430830|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
83430831|NCT00475085|Hormones|hormones|mesh-ancestor
83430832|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83430833|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83430834|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430835|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83430836|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430837|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460170|NCT00972959|Bortezomib|bortezomib|mesh-list
83430838|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83430839|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83430840|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
83430841|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83430842|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83430843|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430844|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83430845|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83430846|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
83430847|NCT00551707|Prednisolone|prednisolone|mesh-list
83430848|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83430849|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
83430850|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83430852|NCT00551707|Dipyridamole|dipyridamole|mesh-list
83430853|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83430854|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
83430855|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83430856|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
83430857|NCT00551707|Hormones|hormones|mesh-ancestor
83430858|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83430859|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430860|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83430861|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430863|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
83430864|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430865|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83430866|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83430868|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83430869|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430870|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430871|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83430873|NCT04193930|Letrozole|letrozole|mesh-list
83430874|NCT04193930|Menotropins|menotropins|mesh-list
83430875|NCT04193930|Hormones|hormones|mesh-list
83430876|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83430877|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83430878|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430879|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430880|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83430881|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83430882|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430883|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430884|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83430885|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
83430886|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83430887|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
83430888|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83430890|NCT00445211|Calcium heparin|calcium heparin|mesh-list
83430891|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
83430892|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83430893|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83430894|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430895|NCT04193852|Dienogest|dienogest|mesh-list
83430896|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83430898|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83430899|NCT04193852|Estradiol|estradiol|mesh-list
83430900|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83430901|NCT04193852|Nandrolone|nandrolone|mesh-list
83430902|NCT04193852|Estrogens|estrogens|mesh-ancestor
83430903|NCT04193852|Hormones|hormones|mesh-ancestor
83430904|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83430905|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430906|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83430908|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83430909|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83430910|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83430911|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83430912|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83430913|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
83430914|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83430915|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430916|NCT04193852|Androgens|androgens|mesh-ancestor
83430917|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
83430918|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
83430919|NCT00552409|Vitamin D|vitamin d|mesh-list
83430920|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83430921|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430923|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
83430924|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83430925|NCT03830918|Temozolomide|temozolomide|mesh-list
83430926|NCT03830918|Atezolizumab|atezolizumab|mesh-list
83430928|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83430929|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83430930|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
83430931|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430932|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430933|NCT03830918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83430934|NCT03830918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83430935|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
83430936|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430937|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83430938|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430939|NCT00553735|Cyclosporine|cyclosporine|mesh-list
83430940|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
83430941|NCT00553735|Cyclosporins|cyclosporins|mesh-list
83430942|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430943|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430944|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83430945|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
83430946|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430947|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
83430948|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430949|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
83430950|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83430951|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83430952|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83430953|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83430955|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83430956|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83430958|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430959|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83430960|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83430961|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430962|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430963|NCT04027166|Methadone|methadone|mesh-list
83430964|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83430965|NCT04027166|Narcotics|narcotics|mesh-ancestor
83430966|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430967|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430968|NCT04027166|Analgesics|analgesics|mesh-ancestor
83430969|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
83430970|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430971|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
83430972|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
83430973|NCT00543101|Darunavir|darunavir|mesh-list
83430976|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
83430977|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430978|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430979|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83430980|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83430981|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
83430982|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430983|NCT00553969|Carvedilol|carvedilol|mesh-list
83430984|NCT00553969|Lisinopril|lisinopril|mesh-list
83430985|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83430986|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83430987|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
83430988|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430989|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430990|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430991|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83430992|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
83430993|NCT00553969|Protective Agents|protective agents|mesh-ancestor
83430994|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83430995|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83430996|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83430997|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
83430998|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83430999|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83431000|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83431001|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
83431002|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431003|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83431005|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83431006|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431008|NCT05533567|Dsuvia|dsuvia|mesh-list
83431009|NCT05533567|Propofol|propofol|mesh-list
83431010|NCT05533567|Cisatracurium|cisatracurium|mesh-list
83431011|NCT05533567|Atracurium|atracurium|mesh-list
83431012|NCT05533567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83431013|NCT05533567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83431014|NCT05533567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431015|NCT05533567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83431016|NCT05533567|Anesthetics, General|anesthetics, general|mesh-ancestor
83431017|NCT05533567|Anesthetics|anesthetics|mesh-ancestor
83431018|NCT05533567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83431019|NCT05533567|Narcotics|narcotics|mesh-ancestor
83431020|NCT05533567|Analgesics|analgesics|mesh-ancestor
83431021|NCT05533567|Sensory System Agents|sensory system agents|mesh-ancestor
83431022|NCT05533567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431023|NCT05533567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83431024|NCT05533567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83431025|NCT05533567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83431026|NCT05533567|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83431027|NCT05533567|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83431028|NCT05533567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83431029|NCT05533567|Cholinergic Agents|cholinergic agents|mesh-ancestor
83431030|NCT05533567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431031|NCT05533567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431032|NCT04026464|Acetaminophen|acetaminophen|mesh-list
83431034|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83431036|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
83431037|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431038|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431039|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
83431040|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83431041|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83431042|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431043|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83431044|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431045|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431046|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
83431047|NCT04192916|Apixaban|apixaban|mesh-list
83431048|NCT04192916|Edoxaban|edoxaban|mesh-list
83431049|NCT04192916|Dabigatran|dabigatran|mesh-list
83431050|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83431051|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
83431052|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83431053|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
83431054|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431055|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431056|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
83431057|NCT01797991|Dexamethasone|dexamethasone|mesh-list
83431058|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
83431059|NCT01797991|BB 1101|bb 1101|mesh-list
83431060|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83431061|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
83431062|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
83431063|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431064|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431065|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83431066|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
83431067|NCT01797991|Hormones|hormones|mesh-ancestor
83431068|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83431069|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83431070|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431071|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
83431072|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431073|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431074|NCT00475319|Rebamipide|rebamipide|mesh-list
83431075|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83431076|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83431077|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
83431078|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431080|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431081|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431082|NCT04026074|Clonidine|clonidine|mesh-list
83431083|NCT04026074|Fentanyl|fentanyl|mesh-list
83431084|NCT04026074|Remifentanil|remifentanil|mesh-list
83431085|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83431086|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83431087|NCT04026074|Narcotics|narcotics|mesh-ancestor
83431088|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83431089|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431090|NCT04026074|Analgesics|analgesics|mesh-ancestor
83431091|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
83431092|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431093|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83431094|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83431095|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
83431096|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
83431097|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83431098|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
83431099|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
83431100|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83431101|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83431102|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83431103|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
83431104|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431105|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431106|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
83431107|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83431108|NCT00555997|Ziprasidone|ziprasidone|mesh-list
83431109|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83431110|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
83431111|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431112|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431113|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431114|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83431115|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83431116|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83431117|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83431118|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83431119|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
83431120|NCT00446147|Pyridoxine|pyridoxine|mesh-list
83431121|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
83431122|NCT00446147|Vitamins|vitamins|mesh-ancestor
83431123|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
83431124|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431125|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83431126|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83431127|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83431128|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83431129|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431130|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431131|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431132|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
83431133|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83431134|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
83431136|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
83431137|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83431138|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431139|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83431140|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83431141|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83431142|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83431143|NCT04192292|Gliclazide|gliclazide|mesh-list
83431144|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83431145|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83431146|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431148|NCT04192292|Hormones|hormones|mesh-ancestor
83431149|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83431150|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
83431151|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431152|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431153|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83431154|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83431155|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83431156|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
83431157|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431158|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431159|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431160|NCT00448175|Urological Agents|urological agents|mesh-ancestor
83431161|NCT04176835|Oxytocin|oxytocin|mesh-list
83431162|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
83431163|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83431164|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431166|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83431167|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431168|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83431169|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83431170|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
83431171|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83431172|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431173|NCT00477191|Etanercept|etanercept|mesh-list
83431174|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83431175|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83431176|NCT00477191|Analgesics|analgesics|mesh-ancestor
83431177|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
83431178|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431179|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431180|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83431181|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431182|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83431183|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83431184|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
83431185|NCT04025918|Phenylephrine|phenylephrine|mesh-list
83431186|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
83431187|NCT04025918|Ephedrine|ephedrine|mesh-list
83431188|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83431189|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83431190|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
83431191|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
83431192|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431193|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431194|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
83431195|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
83431196|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
83431197|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83431198|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83431199|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83431200|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
83431201|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431202|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431203|NCT04025918|Protective Agents|protective agents|mesh-ancestor
83431204|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83431205|NCT05415397|Celecoxib|celecoxib|mesh-list
83431206|NCT05415397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83431207|NCT05415397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83431208|NCT05415397|Analgesics|analgesics|mesh-ancestor
83431209|NCT05415397|Sensory System Agents|sensory system agents|mesh-ancestor
83431210|NCT05415397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431211|NCT05415397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431212|NCT05415397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83431213|NCT05415397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431214|NCT05415397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83431215|NCT05415397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83431216|NCT05415397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431217|NCT05415397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431218|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
83431219|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83431220|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431221|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
83431222|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83431223|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431224|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83431226|NCT02115581|Ubiquinone|ubiquinone|mesh-list
83431227|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
83431228|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
83431229|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431230|NCT02115581|Vitamins|vitamins|mesh-ancestor
83431231|NCT00477659|Donepezil|donepezil|mesh-list
83431232|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83431233|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431234|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431235|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
83431236|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431237|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431238|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
83431239|NCT04191278|Varenicline|varenicline|mesh-list
83431240|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83431241|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83431242|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
83431243|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431244|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431245|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431246|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
83431247|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83431248|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83431249|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431250|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431251|NCT03988387|Tenofovir|tenofovir|mesh-list
83431252|NCT03988387|Emtricitabine|emtricitabine|mesh-list
83431253|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
83431254|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431255|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83431256|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83431257|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431258|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431259|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83431260|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83431261|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
83431262|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83431263|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
83431264|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431265|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431266|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83431267|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
83431268|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83431269|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
83431270|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431271|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431272|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83431273|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
83431274|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
83431275|NCT03748082|Protective Agents|protective agents|mesh-ancestor
83431276|NCT00478361|Paclitaxel|paclitaxel|mesh-list
83431277|NCT00478361|Gemcitabine|gemcitabine|mesh-list
83431278|NCT00478361|Doxorubicin|doxorubicin|mesh-list
83431279|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83431280|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83431281|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431282|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
83431283|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
83431284|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
83431285|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431286|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83431287|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
83431288|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83431289|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83431290|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83431291|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431292|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
83431293|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431294|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
83431295|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83431296|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83431297|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431298|NCT02129725|Urological Agents|urological agents|mesh-ancestor
83431299|NCT00483509|Doxorubicin|doxorubicin|mesh-list
83431300|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83431301|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431302|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83431303|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83431304|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431305|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431306|NCT03864211|Immunomodulating Agents|immunomodulating agents|mesh-list
83431307|NCT03864211|Immunologic Factors|immunologic factors|mesh-ancestor
83431308|NCT03864211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431310|NCT03840200|Ipatasertib|ipatasertib|mesh-list
83431311|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83431312|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431313|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431314|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431315|NCT03840200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83431316|NCT03842839|Albuterol|albuterol|mesh-list
83431317|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
83431318|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83431319|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
83431320|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431321|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431322|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83431323|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
83431324|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
83431325|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83431326|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
83431327|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431328|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431329|NCT03842839|Tocolytic Agents|tocolytic agents|mesh-ancestor
83431330|NCT03842839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83431331|NCT03842839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83431332|NCT03842839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83431333|NCT03842839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83431334|NCT03842839|Adrenergic Agents|adrenergic agents|mesh-ancestor
83431335|NCT00450983|Methotrexate|methotrexate|mesh-list
83431336|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
83431337|NCT00450983|Fludarabine|fludarabine|mesh-list
83431339|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
83431340|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83431341|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
83431342|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83431343|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431344|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83431345|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
83431346|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431347|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431348|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
83431350|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83431351|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83431353|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431354|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83431355|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83431356|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
83431357|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83431358|NCT01796405|Clofarabine|clofarabine|mesh-list
83431359|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83431360|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
83431361|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431362|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431363|NCT03298295|Insulin|insulin|mesh-list
83431364|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83431365|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431366|NCT03649321|Paclitaxel|paclitaxel|mesh-list
83431367|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83431368|NCT03649321|Gemcitabine|gemcitabine|mesh-list
83431369|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83431370|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431371|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
83431372|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
83431373|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
83431374|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431375|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83431376|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
83431378|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
83431379|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
83431380|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83431381|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431382|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
83431383|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431384|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83431385|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83431386|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83431387|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83431388|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431389|NCT01797601|Insulin|insulin|mesh-list
83431390|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83431391|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83431392|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431393|NCT02984930|Esomeprazole|esomeprazole|mesh-list
83431394|NCT02984930|Mosapride|mosapride|mesh-list
83431395|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83431396|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83431397|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83431398|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431399|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431400|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83431401|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
83431402|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431403|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431404|NCT02123017|Lactulose|lactulose|mesh-list
83431405|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83431406|NCT04149626|Midazolam|midazolam|mesh-list
83431407|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
83431408|NCT04149626|Remifentanil|remifentanil|mesh-list
83431409|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83431411|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431412|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83431413|NCT04149626|Analgesics|analgesics|mesh-ancestor
83431414|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
83431415|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431416|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83431417|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83431418|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83431419|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
83431420|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431421|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431422|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83431423|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83431424|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83431425|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83431426|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83431427|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
83431428|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
83431430|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
83431431|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83431432|NCT04149626|Narcotics|narcotics|mesh-ancestor
83431433|NCT00486863|Praziquantel|praziquantel|mesh-list
83431434|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
83431435|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83431436|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431437|NCT03934814|Rituximab|rituximab|mesh-list
83431438|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
83431439|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83431441|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
83431442|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431443|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431444|NCT03934814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83431445|NCT03934814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431447|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83431448|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431450|NCT00452387|Sorafenib|sorafenib|mesh-list
83431451|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
83431452|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83431453|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
83431454|NCT00452387|Hormones|hormones|mesh-ancestor
83431455|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83431456|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431457|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83431458|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431459|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83431460|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431461|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431462|NCT00452387|Analgesics|analgesics|mesh-ancestor
83431463|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
83431464|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431465|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83431466|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83431467|NCT03945656|Insulin|insulin|mesh-list
83431468|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83431469|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
83431470|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83431471|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431473|NCT00452543|Dexetimide|dexetimide|mesh-list
83431474|NCT00452543|Citalopram|citalopram|mesh-list
83431475|NCT00452543|Escitalopram|escitalopram|mesh-list
83431476|NCT00452543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83431477|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83431478|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83431479|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431480|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431481|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
83431482|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431483|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83431484|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83431485|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
83431486|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
83431487|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431488|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83431489|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83431490|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
83431491|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83431492|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
83431493|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83431494|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83431495|NCT04961359|Vaccines|vaccines|mesh-list
83431496|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
83460172|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
83431497|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431498|NCT05621707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83431499|NCT05621707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431500|NCT05621707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83431501|NCT05621707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431502|NCT04765904|Fluorides|fluorides|mesh-list
83431503|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
83431504|NCT04765904|Protective Agents|protective agents|mesh-ancestor
83431505|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431507|NCT05621551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83431508|NCT05621551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431509|NCT05621551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83431510|NCT05621551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431511|NCT00565669|Cyclosporine|cyclosporine|mesh-list
83431512|NCT00565669|Cyclosporins|cyclosporins|mesh-list
83431513|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431514|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431516|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
83431517|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431518|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
83431519|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431520|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
83431521|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431522|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83431523|NCT04165135|Factor VIII|factor viii|mesh-list
83431524|NCT04165135|Coagulants|coagulants|mesh-ancestor
83431525|NCT02132533|Nifedipine|nifedipine|mesh-list
83431526|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83431527|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83431528|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431529|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83431530|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431531|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
83431532|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
83431533|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83431534|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83431535|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431536|NCT00567229|Rituximab|rituximab|mesh-list
83431537|NCT00567229|Lenalidomide|lenalidomide|mesh-list
83460173|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
83431538|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83431539|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431540|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
83431541|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431542|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431543|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83431544|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83431545|NCT00567229|Growth Substances|growth substances|mesh-ancestor
83431546|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
83431547|NCT04148846|Dexamethasone|dexamethasone|mesh-list
83431548|NCT04148846|Ketoprofen|ketoprofen|mesh-list
83431549|NCT04148846|Theophylline|theophylline|mesh-list
83431550|NCT04148846|Gabapentin|gabapentin|mesh-list
83431551|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83431552|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
83431553|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
83431554|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431555|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431557|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
83431558|NCT04148846|Hormones|hormones|mesh-ancestor
83431559|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83431560|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83431561|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431562|NCT04148846|Analgesics|analgesics|mesh-ancestor
83431563|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
83431564|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
83431565|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83431566|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83431567|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83431568|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83431569|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83431570|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83431571|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431572|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431573|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
83431574|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83431575|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83431576|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431577|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83431578|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431579|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83431580|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83431581|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
83431582|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83431583|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
83431584|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83431585|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83431586|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
83431588|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83431590|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431591|NCT00568087|Expectorants|expectorants|mesh-ancestor
83431592|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
83431593|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83431594|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
83431595|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431596|NCT00568087|Protective Agents|protective agents|mesh-ancestor
83431597|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431598|NCT00568087|Antidotes|antidotes|mesh-ancestor
83431600|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
83431601|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431602|NCT00487721|Protective Agents|protective agents|mesh-ancestor
83431603|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431604|NCT00568633|Cyclosporine|cyclosporine|mesh-list
83431605|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
83431606|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
83431607|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83431608|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83431609|NCT00568633|Prednisolone|prednisolone|mesh-list
83431610|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
83431611|NCT00568633|Cyclosporins|cyclosporins|mesh-list
83431612|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
83431613|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83431614|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83431615|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
83431616|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431617|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431619|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
83431620|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431621|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
83431622|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431623|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
83431624|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431625|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83431626|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83431627|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431628|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83431629|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
83431630|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83431631|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83431632|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
83431633|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
83431634|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431635|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83431636|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
83431637|NCT00568633|Hormones|hormones|mesh-ancestor
83431638|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83431639|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83431640|NCT00568633|Protective Agents|protective agents|mesh-ancestor
83431641|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83431642|NCT03022838|Caffeine|caffeine|mesh-list
83431643|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83431644|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431645|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83431646|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431647|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431648|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83431649|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83431650|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
83431651|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431652|NCT05363449|Naftifine|naftifine|mesh-list
83431653|NCT05363449|Antifungal Agents|antifungal agents|mesh-ancestor
83431654|NCT05363449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431655|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
83431656|NCT00489281|Sirolimus|sirolimus|mesh-list
83431657|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
83431658|NCT00489281|Fludarabine|fludarabine|mesh-list
83431659|NCT00489281|Levetiracetam|levetiracetam|mesh-list
83431660|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
83431661|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83431662|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83431663|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
83431664|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431665|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431666|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83431667|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
83431668|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431669|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431670|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83431671|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83431672|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83431673|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
83431674|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83431675|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431677|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
83431678|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
83431679|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
83431680|NCT05362513|Ivermectin|ivermectin|mesh-list
83431681|NCT05362513|Permethrin|permethrin|mesh-list
83431682|NCT05362513|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83431683|NCT05362513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431684|NCT05362513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431685|NCT05362513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431686|NCT04457297|Trifluridine|trifluridine|mesh-list
83431687|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
83431688|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431689|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
83431690|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431691|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
83431693|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
83431694|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
83431695|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83431696|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431697|NCT04145804|Insulin|insulin|mesh-list
83431698|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83431699|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431700|NCT02120261|Triamcinolone|triamcinolone|mesh-list
83431701|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83431702|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83431703|NCT02120261|Lidocaine|lidocaine|mesh-list
83431704|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83431705|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
83431706|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
83431707|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83431708|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431709|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
83431710|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431711|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83431712|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83431713|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83431714|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83431715|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431716|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83431717|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
83431719|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83431720|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83431721|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
83431722|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431723|NCT03907046|Aspirin|aspirin|mesh-list
83431724|NCT03907046|Apixaban|apixaban|mesh-list
83431725|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83431726|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83431727|NCT03907046|Analgesics|analgesics|mesh-ancestor
83431728|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
83431729|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431730|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431731|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83431732|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431733|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83431734|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83431735|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431736|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83431737|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83431738|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431739|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
83431740|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83431741|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
83431742|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83431743|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
83431744|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
83431745|NCT03840421|Cisplatin|cisplatin|mesh-list
83431746|NCT03840421|Gemcitabine|gemcitabine|mesh-list
83431747|NCT03840421|Fluorouracil|fluorouracil|mesh-list
83431748|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431749|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83431750|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
83431751|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431752|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83431753|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
83431754|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431755|NCT00492089|Bevacizumab|bevacizumab|mesh-list
83431756|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83431757|NCT00492089|Antibodies|antibodies|mesh-list
83431758|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
83431759|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83431760|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431761|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83431762|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83431763|NCT00492089|Growth Substances|growth substances|mesh-ancestor
83431764|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431765|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
83431766|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
83431767|NCT01798537|Vancomycin|vancomycin|mesh-list
83431768|NCT01798537|Colistin|colistin|mesh-list
83431769|NCT01798537|Neomycin|neomycin|mesh-list
83431770|NCT01798537|Nystatin|nystatin|mesh-list
83431771|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83431772|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431773|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83431774|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431775|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431776|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
83431777|NCT01798537|Ionophores|ionophores|mesh-ancestor
83431778|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83431779|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83431780|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83431781|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431782|NCT03805477|Nintedanib|nintedanib|mesh-list
83431783|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431784|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83431785|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431786|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431787|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83431788|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83431789|NCT01797341|Tacrolimus|tacrolimus|mesh-list
83431790|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83431791|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
83431792|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431793|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83431794|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460174|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431795|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431797|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431798|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83431799|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431800|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431801|NCT04145492|Vitamin D|vitamin d|mesh-list
83431802|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
83431803|NCT04145492|Calcifediol|calcifediol|mesh-list
83431804|NCT04145492|Vitamins|vitamins|mesh-list
83431805|NCT04145492|Vitamin K|vitamin k|mesh-list
83431806|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
83431808|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431809|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83431810|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83431811|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83431812|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83431813|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431815|NCT04145492|Coagulants|coagulants|mesh-ancestor
83431816|NCT04147754|Morphine|morphine|mesh-list
83431817|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83431818|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431819|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83431820|NCT04147754|Narcotics|narcotics|mesh-ancestor
83431821|NCT04147754|Analgesics|analgesics|mesh-ancestor
83431822|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
83431823|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431824|NCT00492401|Decitabine|decitabine|mesh-list
83431825|NCT00492401|Azacitidine|azacitidine|mesh-list
83431826|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83431827|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
83431828|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431829|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431830|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431831|NCT03674827|Immunomodulating Agents|immunomodulating agents|mesh-list
83431832|NCT03674827|Immunologic Factors|immunologic factors|mesh-ancestor
83431833|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431834|NCT04147286|Atorvastatin|atorvastatin|mesh-list
83431835|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83431836|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83431837|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
83431838|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431839|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83431840|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83431841|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431842|NCT00493181|Oprelvekin|oprelvekin|mesh-list
83431843|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431844|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
83431845|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
83431846|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83431847|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
83431848|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83431849|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431850|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83431851|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83431852|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83431853|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83431854|NCT00493805|Interferons|interferons|mesh-list
83431855|NCT00493805|Ribavirin|ribavirin|mesh-list
83431856|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
83431857|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
83431858|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83431859|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431860|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
83431861|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431862|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
83431863|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431864|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
83431865|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431867|NCT04145102|Fluorides|fluorides|mesh-list
83431868|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
83431869|NCT04145102|Protective Agents|protective agents|mesh-ancestor
83431870|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431871|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431872|NCT05581706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83431873|NCT05581706|Calcium|calcium|mesh-list
83460175|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431874|NCT05581706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83431875|NCT05581706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431876|NCT05581706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431877|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83431878|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
83431879|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431880|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83431881|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431882|NCT03588494|Endostar protein|endostar protein|mesh-list
83431883|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83431884|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83431885|NCT03588494|Growth Substances|growth substances|mesh-ancestor
83431886|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431887|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
83431888|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431889|NCT00550277|Panobinostat|panobinostat|mesh-list
83431890|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431891|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83431892|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431893|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431894|NCT03921242|Metformin|metformin|mesh-list
83431895|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83431896|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83431897|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83431898|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431899|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431900|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
83431901|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431902|NCT00550589|Cidofovir|cidofovir|mesh-list
83431903|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
83431904|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83431905|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431906|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431908|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
83431909|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431910|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83431911|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431912|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83431913|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431914|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83431915|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83431916|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
83431917|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431918|NCT03588338|Acetaminophen|acetaminophen|mesh-list
83431919|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83431920|NCT03588338|Analgesics|analgesics|mesh-ancestor
83431921|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
83431922|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431923|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431924|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
83431925|NCT05099185|Trace Elements|trace elements|mesh-list
83431926|NCT05099185|Micronutrients|micronutrients|mesh-list
83431927|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431928|NCT05068609|Nivolumab|nivolumab|mesh-list
83431929|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83431930|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431931|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83431932|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431933|NCT00496379|Epothilones|epothilones|mesh-list
83431935|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
83431936|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
83431937|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
83431938|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431939|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431940|NCT00497081|Mirtazapine|mirtazapine|mesh-list
83431941|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
83431942|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83431943|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83431944|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
83431945|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
83431946|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431947|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431948|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431949|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83431950|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83431951|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83431952|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83431953|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83431954|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83431955|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
83431956|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83431957|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83431958|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
83431959|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83431960|NCT01796951|Aspirin|aspirin|mesh-list
83431961|NCT01796951|Celecoxib|celecoxib|mesh-list
83431962|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83431963|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83431964|NCT01796951|Analgesics|analgesics|mesh-ancestor
83431965|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
83431966|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431967|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431968|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83431969|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431970|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83431971|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83431972|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431973|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83431974|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83431975|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431977|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83431978|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
83431979|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83431980|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83431981|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431982|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431983|NCT03895502|Edoxaban|edoxaban|mesh-list
83431984|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83431985|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
83431988|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431989|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431991|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
83431992|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83431993|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83431994|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83431995|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83431996|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431997|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
83431998|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431999|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432000|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83432001|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432002|NCT03587558|Flecainide|flecainide|mesh-list
83432003|NCT03587558|Carvedilol|carvedilol|mesh-list
83432004|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83432005|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83432006|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
83432007|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432008|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432009|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432011|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
83432012|NCT03587558|Protective Agents|protective agents|mesh-ancestor
83432014|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83432015|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83432016|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
83432017|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83432018|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83432019|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83432020|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83432021|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83432022|NCT04415905|Propofol|propofol|mesh-list
83432023|NCT04415905|Sevoflurane|sevoflurane|mesh-list
83432024|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83432025|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432026|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432027|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83432028|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
83432029|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
83432030|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83432031|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83432032|NCT02979704|Atorvastatin|atorvastatin|mesh-list
83432033|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83432034|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83432035|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83432036|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
83432037|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432038|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83432039|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83432041|NCT03587324|Clopidogrel|clopidogrel|mesh-list
83432042|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83432043|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83432044|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83432045|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83432046|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
83432047|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432048|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432049|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432050|NCT03919292|Valproic Acid|valproic acid|mesh-list
83432051|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
83432052|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432053|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432054|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
83432055|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432056|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432057|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
83432058|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83432059|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432060|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83432061|NCT01798459|Methylphenidate|methylphenidate|mesh-list
83432062|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83432063|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432064|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83432065|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83432066|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83432067|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432068|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
83432069|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432070|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
83432071|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83432072|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83432073|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432074|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
83432076|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
83432077|NCT00555321|Abatacept|abatacept|mesh-list
83432079|NCT00555321|Basiliximab|basiliximab|mesh-list
83432080|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83432081|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
83432082|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432083|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83432084|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432085|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432086|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83432087|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432088|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83432089|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
83432090|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83432091|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432092|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83432093|NCT00555321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432094|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432095|NCT05583266|Pentoxifylline|pentoxifylline|mesh-list
83432096|NCT05583266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83432097|NCT05583266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432098|NCT05583266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432099|NCT05583266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83432100|NCT05583266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83432101|NCT05583266|Protective Agents|protective agents|mesh-ancestor
83432102|NCT05583266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432103|NCT05583266|Vasodilator Agents|vasodilator agents|mesh-ancestor
83432104|NCT05583266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83432105|NCT05583266|Antioxidants|antioxidants|mesh-ancestor
83432106|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
83432107|NCT04142840|Propofol|propofol|mesh-list
83432108|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83432109|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432110|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432111|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83432112|NCT04142840|Analgesics|analgesics|mesh-ancestor
83432113|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
83432114|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432115|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83432116|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83432117|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83432118|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
83432119|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432120|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432121|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83432122|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
83432123|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
83432125|NCT04142762|Rifampin|rifampin|mesh-list
83432126|NCT04142762|Midazolam|midazolam|mesh-list
83432128|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
83432129|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83432130|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83432131|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
83432132|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
83432133|NCT04142762|Estradiol|estradiol|mesh-list
83432135|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83432136|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432137|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432138|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83432139|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83432140|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83432141|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83432142|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
83432144|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
83432145|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
83432146|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432147|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432148|NCT04142762|Estrogens|estrogens|mesh-ancestor
83432149|NCT04142762|Hormones|hormones|mesh-ancestor
83432150|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83432151|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83432152|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83432153|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83432154|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83432155|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83432156|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83432157|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432158|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
83432159|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432160|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83432161|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83432162|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83432163|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
83432164|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83432165|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83432166|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83432167|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
83432168|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83432169|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
83432170|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83432171|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83432172|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83432173|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83432174|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83432175|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83432176|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83432177|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83432178|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83432179|NCT05582876|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83432180|NCT05582876|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83432181|NCT05582876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432182|NCT02139007|Alendronate|alendronate|mesh-list
83432183|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83432184|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432186|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83432187|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432188|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432189|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432190|NCT03586466|Buprenorphine|buprenorphine|mesh-list
83432191|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83432192|NCT03586466|Naloxone|naloxone|mesh-list
83432193|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83432194|NCT03586466|Narcotics|narcotics|mesh-ancestor
83432195|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432196|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432197|NCT03586466|Analgesics|analgesics|mesh-ancestor
83432198|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
83432199|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432200|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83432201|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
83432202|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83432203|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
83432204|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432205|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432206|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83432207|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
83432208|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83432209|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
83432210|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432211|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432212|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83432213|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
83432214|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
83432215|NCT00570349|Protective Agents|protective agents|mesh-ancestor
83432216|NCT03586388|Immunomodulating Agents|immunomodulating agents|mesh-list
83432217|NCT03586388|Immunologic Factors|immunologic factors|mesh-ancestor
83432218|NCT03586388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432219|NCT02985086|Cefoxitin|cefoxitin|mesh-list
83432220|NCT02985086|Misoprostol|misoprostol|mesh-list
83432221|NCT02985086|Oxytocin|oxytocin|mesh-list
83432222|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
83432223|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83432224|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432225|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83432226|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
83432227|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83432228|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83432229|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83432230|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432231|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
83432232|NCT04157985|Nivolumab|nivolumab|mesh-list
83432233|NCT04157985|Ipilimumab|ipilimumab|mesh-list
83432234|NCT04157985|Atezolizumab|atezolizumab|mesh-list
83432235|NCT04157985|Cemiplimab|cemiplimab|mesh-list
83432236|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83432237|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432238|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432239|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432240|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
83432241|NCT03889418|Narcotics|narcotics|mesh-ancestor
83432242|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432243|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432244|NCT03889418|Analgesics|analgesics|mesh-ancestor
83432245|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
83432246|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432247|NCT00609739|Cytarabine|cytarabine|mesh-list
83432248|NCT00609739|Cyclosporine|cyclosporine|mesh-list
83432249|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
83432250|NCT00609739|Methotrexate|methotrexate|mesh-list
83432251|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
83432252|NCT00609739|Tretinoin|tretinoin|mesh-list
83432253|NCT00609739|Isotretinoin|isotretinoin|mesh-list
83432254|NCT00609739|Cyclosporins|cyclosporins|mesh-list
83432255|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83432256|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
83432257|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83432258|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432259|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432260|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
83432261|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432262|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432263|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
83432264|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432265|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83432266|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83432267|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
83432268|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432269|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83432270|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
83432271|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432272|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
83432273|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83432274|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83432275|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
83432276|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
83432277|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432278|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83432279|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
83432280|NCT00609739|Hormones|hormones|mesh-ancestor
83432281|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83432282|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83432283|NCT00609739|Protective Agents|protective agents|mesh-ancestor
83432284|NCT00609739|Analgesics|analgesics|mesh-ancestor
83432285|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
83432286|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83432287|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83432288|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
83432289|NCT03397004|Doxycycline|doxycycline|mesh-list
83432290|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83432291|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432292|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
83432293|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83432294|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83432295|NCT00610987|Cefazolin|cefazolin|mesh-list
83432296|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83432297|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432298|NCT04140578|Ertapenem|ertapenem|mesh-list
83432299|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83432300|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432301|NCT00574171|Capecitabine|capecitabine|mesh-list
83432302|NCT00574171|Lapatinib|lapatinib|mesh-list
83432303|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432304|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
83432305|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432306|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432307|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83432308|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432309|NCT03585998|Cisplatin|cisplatin|mesh-list
83432310|NCT03585998|Etoposide|etoposide|mesh-list
83432311|NCT03585998|Durvalumab|durvalumab|mesh-list
83432312|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432313|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83432314|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83432315|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83432316|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432317|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432318|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432319|NCT00612235|Lamotrigine|lamotrigine|mesh-list
83432320|NCT00612235|Carbamazepine|carbamazepine|mesh-list
83432321|NCT00612235|Levetiracetam|levetiracetam|mesh-list
83432322|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
83432323|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
83432324|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83432325|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83432326|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432327|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83432328|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432329|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83432330|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83432331|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432332|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83432333|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83432334|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
83432335|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83432336|NCT00612235|Analgesics|analgesics|mesh-ancestor
83432337|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
83432338|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432339|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83432340|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83432341|NCT00575029|Megestrol|megestrol|mesh-list
83432342|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
83432343|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83432344|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83432345|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83432346|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
83432347|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83432348|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432349|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83432350|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83432351|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83432352|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432353|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
83432354|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83432356|NCT00499109|Gemcitabine|gemcitabine|mesh-list
83432357|NCT00499109|Docetaxel|docetaxel|mesh-list
83432358|NCT00499109|Vinorelbine|vinorelbine|mesh-list
83432359|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
83432360|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432361|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
83432362|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432363|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
83432364|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
83432365|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
83432366|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83432367|NCT03585530|Raltitrexed|raltitrexed|mesh-list
83432368|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432369|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
83432370|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432371|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432372|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83432373|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432374|NCT03021590|Amoxicillin|amoxicillin|mesh-list
83432375|NCT03021590|Clarithromycin|clarithromycin|mesh-list
83432376|NCT03021590|Levofloxacin|levofloxacin|mesh-list
83432377|NCT03021590|Tinidazole|tinidazole|mesh-list
83432378|NCT03021590|Esomeprazole|esomeprazole|mesh-list
83432379|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83432380|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432381|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83432382|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83432383|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83432384|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432385|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432386|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83432387|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83432388|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83432389|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83432390|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83432391|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83432392|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432393|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83432394|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
83432395|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83432396|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83432397|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83432398|NCT02125721|Penicillamine|penicillamine|mesh-list
83432399|NCT02125721|Antidotes|antidotes|mesh-ancestor
83432400|NCT02125721|Protective Agents|protective agents|mesh-ancestor
83432401|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432402|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
83432403|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
83432404|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432405|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432406|NCT00552695|Lidocaine|lidocaine|mesh-list
83432407|NCT00552695|Tetracaine|tetracaine|mesh-list
83432408|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
83432409|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
83432410|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432411|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432412|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
83432413|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432414|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83432415|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83432416|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83432417|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83432418|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432420|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83432421|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
83432422|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
83432423|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432424|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432425|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83432426|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83432427|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83432428|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432429|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83432430|NCT00615433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83432431|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83432432|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83432433|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432434|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432435|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
83432436|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83432437|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83432438|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83432439|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
83432440|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83432441|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83432442|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83432443|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83432444|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
83432445|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
83432446|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83432447|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432448|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83432449|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432450|NCT03585374|Acetaminophen|acetaminophen|mesh-list
83432451|NCT03585374|Ketoprofen|ketoprofen|mesh-list
83432452|NCT03585374|Morphine|morphine|mesh-list
83432453|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
83432454|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83432455|NCT03585374|Narcotics|narcotics|mesh-ancestor
83432456|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432457|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432458|NCT03585374|Analgesics|analgesics|mesh-ancestor
83432459|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
83432460|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432461|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83432462|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
83432463|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83432464|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83432465|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432466|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83432467|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432468|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432469|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83432470|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
83432471|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
83432472|NCT00499343|Rituximab|rituximab|mesh-list
83432473|NCT00499343|Etoposide|etoposide|mesh-list
83432474|NCT00499343|Ifosfamide|ifosfamide|mesh-list
83432475|NCT00499343|Isophosphamide mustard|isophosphamide mustard|mesh-list
83432476|NCT00499343|Sargramostim|sargramostim|mesh-list
83432477|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432478|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432479|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
83432480|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432481|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432482|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83432483|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83432484|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83432485|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432486|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432487|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83432488|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
83432489|NCT00615589|Fludarabine|fludarabine|mesh-list
83432490|NCT00615589|Busulfan|busulfan|mesh-list
83432491|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432492|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432493|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83432494|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
83432495|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432496|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
83432497|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83432498|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83432500|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83432501|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432502|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83432503|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432504|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432505|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83432506|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83432507|NCT00499655|Analgesics|analgesics|mesh-ancestor
83432508|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
83432509|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432510|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432511|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83432512|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432513|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83432514|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83432515|NCT03585140|Doxycycline|doxycycline|mesh-list
83432517|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83432518|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432519|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
83432520|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83432521|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83432522|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83432523|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83432524|NCT03585140|Analgesics|analgesics|mesh-ancestor
83432525|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
83432526|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432527|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432528|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83432529|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432530|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
83432531|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83432532|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
83432533|NCT03584984|Coagulants|coagulants|mesh-ancestor
83432534|NCT00575887|Temozolomide|temozolomide|mesh-list
83432535|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83432536|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
83432537|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432538|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432539|NCT00575965|Simvastatin|simvastatin|mesh-list
83432540|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83432541|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83432542|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
83432543|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432544|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83432545|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83432546|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432547|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
83432548|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432549|NCT03623828|Apomorphine|apomorphine|mesh-list
83432550|NCT03623828|Emetics|emetics|mesh-ancestor
83432551|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432552|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
83432553|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432554|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83432555|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
83432556|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
83432557|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432558|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432559|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
83432560|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83432561|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
83432562|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432563|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432564|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83432565|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
83432566|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432567|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432568|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83432569|NCT03589898|Gabapentin|gabapentin|mesh-list
83432570|NCT03589898|Analgesics|analgesics|mesh-ancestor
83432571|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
83432572|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432573|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432574|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
83432575|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83432576|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83432577|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432578|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83432579|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83432580|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83432581|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432582|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432583|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
83432584|NCT00577135|Furosemide|furosemide|mesh-list
83432585|NCT00577135|Diuretics|diuretics|mesh-list
83432586|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83432587|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
83432588|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432589|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83432590|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432591|NCT00502853|Rituximab|rituximab|mesh-list
83432592|NCT00502853|Methotrexate|methotrexate|mesh-list
83432593|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432594|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432595|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
83432596|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432597|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432598|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83432599|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
83432600|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83432601|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432602|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
83432603|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432604|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
83432605|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432606|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83432607|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83432608|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83432609|NCT00617539|Irinotecan|irinotecan|mesh-list
83432610|NCT00617539|Temozolomide|temozolomide|mesh-list
83432611|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83432612|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83432613|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432614|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432615|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432616|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83432617|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
83432618|NCT03620123|Docetaxel|docetaxel|mesh-list
83432619|NCT03620123|Nivolumab|nivolumab|mesh-list
83432620|NCT03620123|Ipilimumab|ipilimumab|mesh-list
83432621|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432622|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
83432623|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
83432624|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
83432625|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432626|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432627|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83432628|NCT00578071|Capecitabine|capecitabine|mesh-list
83432629|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
83432630|NCT00578071|Panitumumab|panitumumab|mesh-list
83432631|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432632|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
83432633|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432634|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432635|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432636|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
83432637|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432638|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83432639|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432640|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432641|NCT00504023|Imiquimod|imiquimod|mesh-list
83432642|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83432643|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
83432644|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432645|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432646|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
83432647|NCT03589430|Protein C|protein c|mesh-list
83432648|NCT03589430|Antithrombins|antithrombins|mesh-list
83432649|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
83432650|NCT03589430|Protein S|protein s|mesh-list
83432651|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83432652|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
83432653|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432654|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432655|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
83432656|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83432657|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83432658|NCT05702762|Gentamicins|gentamicins|mesh-list
83432659|NCT05702762|Cephalexin|cephalexin|mesh-list
83432660|NCT05702762|Nitrofurantoin|nitrofurantoin|mesh-list
83432661|NCT05702762|Cefdinir|cefdinir|mesh-list
83432662|NCT05702762|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83432663|NCT05702762|Trimethoprim|trimethoprim|mesh-list
83432664|NCT05702762|Sulfamethoxazole|sulfamethoxazole|mesh-list
83432665|NCT05702762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83432666|NCT05702762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432667|NCT05702762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83432668|NCT05702762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432669|NCT05702762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432670|NCT05702762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83432671|NCT05702762|Antimalarials|antimalarials|mesh-ancestor
83432672|NCT05702762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83432673|NCT05702762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83432674|NCT05702762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83432675|NCT05702762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83432676|NCT05702762|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83432677|NCT05702762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83432678|NCT03580694|Cemiplimab|cemiplimab|mesh-list
83432679|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432680|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432681|NCT03583892|Gabapentin|gabapentin|mesh-list
83432682|NCT03583892|Analgesics|analgesics|mesh-ancestor
83432683|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
83432684|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432685|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432686|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
83432687|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83432688|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83432689|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432690|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83432691|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83432692|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83432693|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432694|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432695|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
83432696|NCT03589040|Darunavir|darunavir|mesh-list
83432697|NCT03589040|Rilpivirine|rilpivirine|mesh-list
83432698|NCT03589040|Etonogestrel|etonogestrel|mesh-list
83432699|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83432700|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83432701|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
83432702|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432703|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432704|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83432705|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83432706|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
83432707|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432708|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83432709|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83432710|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83432711|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
83432712|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83432713|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432714|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83432716|NCT03583424|Etoposide|etoposide|mesh-list
83432717|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
83432718|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
83432719|NCT03583424|Melphalan|melphalan|mesh-list
83432720|NCT03583424|Venetoclax|venetoclax|mesh-list
83432721|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
83432722|NCT03583424|Carmustine|carmustine|mesh-list
83432723|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83432724|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83432725|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432726|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83432727|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83432728|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432729|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432730|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432731|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
83432732|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
83432733|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432734|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83432735|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
83432736|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432737|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83432738|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
83432739|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83432740|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
83432741|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
83432742|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
83432743|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
83432744|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
83432745|NCT00578305|Folic Acid|folic acid|mesh-list
83432746|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
83432747|NCT00578305|Rituximab|rituximab|mesh-list
83432748|NCT00578305|Methotrexate|methotrexate|mesh-list
83432749|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432750|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432751|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
83432752|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432753|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432754|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83432755|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
83432756|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83432757|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432758|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
83432759|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432760|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
83432761|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432762|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83432763|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83432764|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83432765|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83432766|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
83432767|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
83432768|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432769|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83432770|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
83432771|NCT00578305|Hormones|hormones|mesh-ancestor
83432772|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83432773|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83432774|NCT00578305|Protective Agents|protective agents|mesh-ancestor
83432775|NCT00578305|Hematinics|hematinics|mesh-ancestor
83432776|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
83432777|NCT00578305|Vitamins|vitamins|mesh-ancestor
83432778|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
83432779|NCT00578461|Cytarabine|cytarabine|mesh-list
83432780|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
83432781|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83432782|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
83432783|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432784|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432785|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83432786|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
83432787|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432788|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432789|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83432790|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432791|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
83432792|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
83432793|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432794|NCT03580070|Immunomodulating Agents|immunomodulating agents|mesh-list
83432795|NCT03580070|Immunologic Factors|immunologic factors|mesh-ancestor
83432796|NCT03580070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432797|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
83432798|NCT03156296|Bupivacaine|bupivacaine|mesh-list
83432799|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
83432800|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
83432801|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83432802|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432803|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
83432804|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432805|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83432806|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83432807|NCT03156296|Analgesics|analgesics|mesh-ancestor
83432808|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83432809|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83432810|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83432811|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
83432812|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432813|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432814|NCT00578539|Cytarabine|cytarabine|mesh-list
83432815|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
83432816|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
83432817|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83432818|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
83432819|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432820|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432821|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83432822|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
83432823|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432824|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432825|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83432826|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432827|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
83432828|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
83432829|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432830|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432831|NCT00578617|Amiodarone|amiodarone|mesh-list
83432832|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432833|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83432834|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
83432835|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83432836|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83432837|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83432838|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83432839|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83432840|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432841|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83432842|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83432843|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83432844|NCT00505895|Rituximab|rituximab|mesh-list
83432845|NCT00505895|Fludarabine|fludarabine|mesh-list
83432846|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
83432847|NCT00505895|Melphalan|melphalan|mesh-list
83432848|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432849|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432850|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
83432851|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432852|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432853|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432854|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
83432855|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432856|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83432857|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83432858|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
83432859|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83432860|NCT03582332|Indomethacin|indomethacin|mesh-list
83432861|NCT03582332|Etoricoxib|etoricoxib|mesh-list
83432862|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83432863|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83432864|NCT03582332|Analgesics|analgesics|mesh-ancestor
83432865|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
83432866|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432867|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432868|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83432869|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432870|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
83432871|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
83432872|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83432873|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83432874|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432875|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432876|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83432878|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83432879|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
83432880|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83432881|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
83432882|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432883|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83432884|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83432885|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
83432886|NCT03410615|Durvalumab|durvalumab|mesh-list
83432887|NCT03410615|Tremelimumab|tremelimumab|mesh-list
83432888|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432889|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432890|NCT03582098|Rituximab|rituximab|mesh-list
83432891|NCT03582098|Idelalisib|idelalisib|mesh-list
83432892|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432893|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432894|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
83432895|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432896|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432897|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432898|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432899|NCT00555893|Oseltamivir|oseltamivir|mesh-list
83432900|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
83432901|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432902|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432903|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432904|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83432905|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83432906|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83432907|NCT00578929|Analgesics|analgesics|mesh-ancestor
83432908|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
83432909|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432910|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432911|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83432912|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83432913|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83432914|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83432915|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83432916|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
83432917|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
83432918|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432919|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432920|NCT00556049|Gemcitabine|gemcitabine|mesh-list
83432921|NCT00556049|Sunitinib|sunitinib|mesh-list
83432922|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83432923|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
83432924|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432925|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432926|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83432927|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83432928|NCT00556049|Growth Substances|growth substances|mesh-ancestor
83432929|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432930|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
83432931|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83432932|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432933|NCT01797107|Azithromycin|azithromycin|mesh-list
83432934|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83432935|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432936|NCT03155984|Antibodies|antibodies|mesh-list
83432937|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
83432938|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432939|NCT00620191|Metformin|metformin|mesh-list
83432940|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83432941|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432942|NCT00506597|Asparaginase|asparaginase|mesh-list
83432943|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432944|NCT03589976|Sirolimus|sirolimus|mesh-list
83432945|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83432946|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83432947|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83432948|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432949|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
83432950|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83432951|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
83432952|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432953|NCT03581630|Naltrexone|naltrexone|mesh-list
83432954|NCT03581630|Bupropion|bupropion|mesh-list
83432955|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83432956|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83432957|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432958|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
83432959|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432960|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83432961|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
83432962|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83432963|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83432964|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83432965|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83432966|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432967|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
83432968|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432969|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83432970|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83432971|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432972|NCT00506675|Atropine|atropine|mesh-list
83432973|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83432974|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83432975|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83432976|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
83432977|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83432978|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432979|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83432980|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
83432981|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
83432982|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
83432983|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83432984|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83432985|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
83432986|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432987|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432988|NCT00507767|Dasatinib|dasatinib|mesh-list
83432989|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432990|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83432991|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83432992|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83432993|NCT00621049|Bevacizumab|bevacizumab|mesh-list
83432994|NCT00621049|Carboplatin|carboplatin|mesh-list
83432995|NCT00621049|Docetaxel|docetaxel|mesh-list
83432996|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83432997|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83432998|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83432999|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83433000|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83433001|NCT00621049|Growth Substances|growth substances|mesh-ancestor
83433002|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433003|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
83433004|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
83433005|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
83433006|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
83433007|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433008|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83433009|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433010|NCT00508469|Timolol|timolol|mesh-list
83433011|NCT00508469|Travoprost|travoprost|mesh-list
83433012|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83433013|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83433014|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83433015|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83433016|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
83433017|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433018|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433019|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433020|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83433021|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83433022|NCT05702996|Eculizumab|eculizumab|mesh-list
83433023|NCT05702996|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83433024|NCT05702996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83433025|NCT05702996|Immunologic Factors|immunologic factors|mesh-ancestor
83433026|NCT05702996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433027|NCT00580333|Paclitaxel|paclitaxel|mesh-list
83433028|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
83433029|NCT00580333|Bevacizumab|bevacizumab|mesh-list
83433030|NCT00580333|Doxorubicin|doxorubicin|mesh-list
83433031|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83433032|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433033|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
83433034|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
83433035|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
83433036|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433037|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83433038|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
83433039|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433040|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83433041|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83433042|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
83433043|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83433044|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83433045|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83433046|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83433047|NCT00580333|Growth Substances|growth substances|mesh-ancestor
83433048|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
83433049|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83433050|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83433051|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83433052|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433053|NCT00580645|Varenicline|varenicline|mesh-list
83433054|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83433055|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83433056|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
83433057|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433058|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433059|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433060|NCT00580957|Trimethaphan|trimethaphan|mesh-list
83433061|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83433062|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83433063|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83433064|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
83433065|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433066|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433067|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83433068|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83433069|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
83433070|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433071|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433072|NCT00509249|Aflibercept|aflibercept|mesh-list
83433073|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
83433074|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83433075|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83433076|NCT00509249|Growth Substances|growth substances|mesh-ancestor
83433077|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433078|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
83433079|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433080|NCT00624013|Sertraline|sertraline|mesh-list
83433081|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
83433082|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83433083|NCT00624013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83433084|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83433085|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83433086|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433088|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
83433089|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433090|NCT02121041|Losartan|losartan|mesh-list
83433091|NCT02121041|Amlodipine|amlodipine|mesh-list
83433092|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
83433093|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83433094|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83433095|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83433096|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433097|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83433098|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433099|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
83433100|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83433101|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83433102|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83433103|NCT02121041|Diuretics|diuretics|mesh-ancestor
83433104|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
83433105|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83433106|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
83433107|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83433108|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83433109|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83433110|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83433111|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83433112|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83433113|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433114|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433115|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433116|NCT02133781|Vaccines|vaccines|mesh-list
83433117|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
83433118|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433119|NCT01855451|Cetuximab|cetuximab|mesh-list
83433120|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433121|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83433122|NCT02134951|Ketamine|ketamine|mesh-list
83433123|NCT02134951|Analgesics|analgesics|mesh-ancestor
83433124|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
83433125|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433126|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433127|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83433128|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83433129|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
83433130|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
83433131|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433132|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83433133|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83433134|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433135|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433136|NCT03029780|Nivolumab|nivolumab|mesh-list
83433137|NCT03029780|Ipilimumab|ipilimumab|mesh-list
83433138|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83433139|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433140|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83433141|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433142|NCT00624559|Celecoxib|celecoxib|mesh-list
83433143|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83433144|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83433145|NCT00624559|Analgesics|analgesics|mesh-ancestor
83433146|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
83433147|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433148|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433149|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83433150|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83433151|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83433152|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83433153|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433154|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433155|NCT00510809|Ethanol|ethanol|mesh-list
83433156|NCT00510809|Policosanol|policosanol|mesh-list
83433157|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83433158|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83433159|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83433160|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433161|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433162|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83433163|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83433164|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
83433165|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433166|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433167|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83433168|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83433169|NCT00625729|Aldesleukin|aldesleukin|mesh-list
83433170|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
83433172|NCT00625729|Fludarabine|fludarabine|mesh-list
83433173|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
83433174|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83433175|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
83433176|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433177|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83433178|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83433179|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
83433180|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433181|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433182|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83433183|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83433184|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83433185|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
83433186|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83433187|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83433188|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
83433189|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83433190|NCT00581971|Celecoxib|celecoxib|mesh-list
83433191|NCT00581971|Paclitaxel|paclitaxel|mesh-list
83433192|NCT00581971|Carboplatin|carboplatin|mesh-list
83433193|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83433194|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433195|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
83433196|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
83433197|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
83433198|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433199|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83433200|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83433201|NCT00581971|Analgesics|analgesics|mesh-ancestor
83433202|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
83433203|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433204|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433205|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83433206|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83433207|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83433208|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83433209|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433210|NCT03029234|Dexamethasone|dexamethasone|mesh-list
83433211|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83433212|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
83433213|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
83433214|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433215|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433216|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83433217|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
83433218|NCT03029234|Hormones|hormones|mesh-ancestor
83433219|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433220|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83433222|NCT01670318|Chromium|chromium|mesh-list
83433223|NCT01670318|Everolimus|everolimus|mesh-list
83433224|NCT01670318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83433225|NCT01670318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83433226|NCT01670318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433227|NCT01670318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433228|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83433229|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
83433230|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433231|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433232|NCT01670318|Trace Elements|trace elements|mesh-ancestor
83433233|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
83433234|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
83433235|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83433236|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
83433237|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433238|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433239|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83433240|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
83433241|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
83433242|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83433243|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
83433244|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433245|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433246|NCT03111992|Spartalizumab|spartalizumab|mesh-list
83433247|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83433248|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433249|NCT03111992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83433250|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433251|NCT00626431|Leuprolide|leuprolide|mesh-list
83433252|NCT00626431|Hormones|hormones|mesh-list
83433253|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83433254|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433255|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433256|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83433257|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
83433258|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83433259|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83433260|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433261|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83433262|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83433263|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83433264|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433265|NCT00582205|Paclitaxel|paclitaxel|mesh-list
83433266|NCT00582205|Cisplatin|cisplatin|mesh-list
83433267|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83433268|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433269|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
83433270|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
83433271|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
83433272|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433273|NCT00626743|Amlodipine|amlodipine|mesh-list
83433274|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83433275|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83433276|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83433277|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433278|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83433279|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433280|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
83433281|NCT03155048|Estradiol|estradiol|mesh-list
83433282|NCT03155048|Estrogens|estrogens|mesh-list
83433283|NCT03155048|Hormones|hormones|mesh-ancestor
83433284|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433285|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433286|NCT01661647|Anesthetics|anesthetics|mesh-list
83433287|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433288|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433289|NCT00627367|Hydromorphone|hydromorphone|mesh-list
83433290|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83433291|NCT00627367|Narcotics|narcotics|mesh-ancestor
83433292|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433293|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433295|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
83433296|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433297|NCT00627679|Budesonide|budesonide|mesh-list
83433298|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83433299|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83433300|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
83433301|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433302|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433303|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83433304|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
83433305|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
83433306|NCT00627679|Hormones|hormones|mesh-ancestor
83433307|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433308|NCT00514709|Vaccines|vaccines|mesh-list
83433309|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
83433310|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433311|NCT03154814|Urinastatin|urinastatin|mesh-list
83433312|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83433313|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83433314|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
83433315|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433316|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433317|NCT00515021|Eplerenone|eplerenone|mesh-list
83433318|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83433319|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
83433320|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433322|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83433323|NCT00515021|Diuretics|diuretics|mesh-ancestor
83433324|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
83433325|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83433326|NCT00515177|Eszopiclone|eszopiclone|mesh-list
83433327|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83433328|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433329|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433330|NCT01671410|Morphine|morphine|mesh-list
83433331|NCT01671410|Buprenorphine|buprenorphine|mesh-list
83433332|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83433333|NCT01671410|Narcotics|narcotics|mesh-ancestor
83433334|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433335|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433336|NCT01671410|Analgesics|analgesics|mesh-ancestor
83433337|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
83433338|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433339|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83433340|NCT00630253|Cyclosporine|cyclosporine|mesh-list
83433341|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
83433342|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
83433343|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
83433344|NCT00630253|Fludarabine|fludarabine|mesh-list
83433345|NCT00630253|Cyclosporins|cyclosporins|mesh-list
83433346|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83433347|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83433348|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
83433349|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433350|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83433351|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83433352|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
83433353|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433354|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433355|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83433356|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433357|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
83433358|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83433359|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
83433360|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83433361|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83433362|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83433363|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
83433364|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83433365|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83433366|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
83433367|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
83433368|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433369|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83433370|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
83433371|NCT00630253|Hormones|hormones|mesh-ancestor
83433372|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433373|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83433374|NCT00630253|Protective Agents|protective agents|mesh-ancestor
83433375|NCT01671722|Montelukast|montelukast|mesh-list
83433376|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83433377|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
83433378|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83433379|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
83433380|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433381|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433382|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83433383|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83433384|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433385|NCT00584701|Risperidone|risperidone|mesh-list
83433386|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83433387|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
83433388|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433389|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433390|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433391|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83433392|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83433393|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433394|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83433395|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83433396|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
83433397|NCT00630409|Gemcitabine|gemcitabine|mesh-list
83433398|NCT00630409|Doxorubicin|doxorubicin|mesh-list
83433399|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83433400|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
83433401|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433402|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433403|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83433404|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83433405|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83433406|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433407|NCT00630955|Memantine|memantine|mesh-list
83433408|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83433409|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83433410|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
83433411|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433412|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433413|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433414|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83433415|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83433416|NCT00584857|Paclitaxel|paclitaxel|mesh-list
83433417|NCT00584857|Carboplatin|carboplatin|mesh-list
83433418|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83433419|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433420|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
83433421|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
83433422|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
83433423|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433424|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
83433425|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83433426|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
83433427|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433428|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433429|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83433430|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
83433431|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83433432|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
83433433|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433434|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433435|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83433436|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
83433437|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
83433438|NCT00585013|Protective Agents|protective agents|mesh-ancestor
83433439|NCT01672112|Oxycodone|oxycodone|mesh-list
83433440|NCT01672112|Codeine|codeine|mesh-list
83433441|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83433442|NCT01672112|Narcotics|narcotics|mesh-ancestor
83433443|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433444|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433445|NCT01672112|Analgesics|analgesics|mesh-ancestor
83433446|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
83433447|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433448|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
83433449|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
83433450|NCT00585637|Vitamin D|vitamin d|mesh-list
83433451|NCT00585637|Vitamins|vitamins|mesh-ancestor
83433452|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
83433453|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433454|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83433455|NCT03158792|Enoxaparin|enoxaparin|mesh-list
83433456|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
83433457|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
83433458|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83433459|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83433460|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433461|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83433462|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83433463|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
83433464|NCT03158480|Immunomodulating Agents|immunomodulating agents|mesh-list
83433465|NCT03158480|Immunologic Factors|immunologic factors|mesh-ancestor
83433466|NCT03158480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433467|NCT00633919|Prednisone|prednisone|mesh-list
83433468|NCT00633919|Budesonide|budesonide|mesh-list
83433469|NCT00633919|Albuterol|albuterol|mesh-list
83433470|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
83433471|NCT00633919|Desloratadine|desloratadine|mesh-list
83433472|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83433473|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
83433474|NCT00633919|Hormones|hormones|mesh-ancestor
83433475|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433476|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433477|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83433478|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433479|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83433480|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
83433481|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433482|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83433483|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
83433484|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83433485|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83433486|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83433487|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
83433488|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433489|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433490|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
83433491|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83433492|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83433493|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
83433494|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83433495|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83433496|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
83433497|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
83433498|NCT03158246|Vitamin D|vitamin d|mesh-list
83433499|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
83433500|NCT03158246|Calcium|calcium|mesh-list
83433501|NCT03158246|Vitamins|vitamins|mesh-ancestor
83433502|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
83433503|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433504|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83433505|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83433506|NCT00515411|Leucovorin|leucovorin|mesh-list
83433507|NCT00515411|Cisplatin|cisplatin|mesh-list
83433508|NCT00515411|Docetaxel|docetaxel|mesh-list
83433509|NCT00515411|Fluorouracil|fluorouracil|mesh-list
83433510|NCT00515411|Trastuzumab|trastuzumab|mesh-list
83433511|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433512|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
83433513|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
83433514|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
83433515|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433516|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
83433517|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83433518|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83433519|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
83433520|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433521|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83433522|NCT00515411|Antidotes|antidotes|mesh-ancestor
83433523|NCT00515411|Protective Agents|protective agents|mesh-ancestor
83433524|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
83433525|NCT00515411|Vitamins|vitamins|mesh-ancestor
83433526|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
83433527|NCT00586261|Pioglitazone|pioglitazone|mesh-list
83433528|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
83433529|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83433530|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433531|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
83433532|NCT00515723|Olanzapine|olanzapine|mesh-list
83433533|NCT00515723|Risperidone|risperidone|mesh-list
83433534|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83433535|NCT00515723|Ziprasidone|ziprasidone|mesh-list
83433536|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83433537|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
83433538|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433539|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433540|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433541|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83433542|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83433543|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433544|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83433545|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83433546|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
83433547|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
83433549|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433550|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83433551|NCT00515723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83433552|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83433553|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83433554|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
83433555|NCT04405154|Cisplatin|cisplatin|mesh-list
83433556|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433557|NCT00586573|Memantine|memantine|mesh-list
83433558|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83433559|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83433560|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
83433561|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433562|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433563|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433564|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83433565|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83433566|NCT01799005|Micronutrients|micronutrients|mesh-list
83433567|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433568|NCT00515879|Cycloserine|cycloserine|mesh-list
83433569|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83433570|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83433571|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83433572|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
83433573|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83433574|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
83433575|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433576|NCT03152942|Aminophylline|aminophylline|mesh-list
83433577|NCT03152942|Progesterone|progesterone|mesh-list
83433578|NCT03152942|Progestins|progestins|mesh-ancestor
83433579|NCT03152942|Hormones|hormones|mesh-ancestor
83433580|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433581|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433582|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83433583|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
83433584|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433585|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83433586|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
83433587|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83433588|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83433589|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433590|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433591|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83433592|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83433593|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
83433594|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433595|NCT03152942|Protective Agents|protective agents|mesh-ancestor
83433597|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83433598|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83433599|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83433600|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83433601|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433602|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433603|NCT01672346|Adenosine|adenosine|mesh-list
83433604|NCT01672346|Analgesics|analgesics|mesh-ancestor
83433605|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
83433606|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433607|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433608|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83433609|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
83433610|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83433611|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
83433612|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
83433613|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433614|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433615|NCT00516503|Ketamine|ketamine|mesh-list
83433616|NCT00516503|Amitriptyline|amitriptyline|mesh-list
83433617|NCT00516503|Baclofen|baclofen|mesh-list
83433618|NCT00516503|Analgesics|analgesics|mesh-ancestor
83433619|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
83433620|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433621|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433622|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83433623|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83433624|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
83433625|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
83433626|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433627|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83433628|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83433629|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433630|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433631|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83433632|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83433633|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83433634|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
83433635|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
83433636|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83433637|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
83433638|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83433639|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83433640|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83433641|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83433642|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83433643|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
83433644|NCT03157310|Gefitinib|gefitinib|mesh-list
83433645|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433646|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83433647|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433648|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433649|NCT03157388|Vancomycin|vancomycin|mesh-list
83433650|NCT03157388|Gentamicins|gentamicins|mesh-list
83433651|NCT03157388|Meropenem|meropenem|mesh-list
83433652|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83433653|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83433654|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83433655|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433656|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433657|NCT03156920|Sumatriptan|sumatriptan|mesh-list
83433658|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83433659|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83433660|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83433661|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
83433662|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433663|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433664|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433665|NCT05247385|Ticagrelor|ticagrelor|mesh-list
83433666|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83433667|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83433668|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83433669|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83433670|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83433671|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
83433672|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433673|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433674|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433675|NCT03156842|Amlodipine|amlodipine|mesh-list
83433676|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83433677|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83433678|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83433679|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83433680|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433681|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83433682|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433683|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
83433684|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83433685|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83433686|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
83433687|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83433688|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83433689|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433690|NCT01672580|Vitamins|vitamins|mesh-list
83433691|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
83433692|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433693|NCT00636649|Escitalopram|escitalopram|mesh-list
83433694|NCT00636649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83433695|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83433696|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83433697|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433698|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433699|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
83433700|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433702|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83433703|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83433704|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
83433705|NCT00636805|Dexamethasone|dexamethasone|mesh-list
83433706|NCT00636805|Palonosetron|palonosetron|mesh-list
83433707|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83433708|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
83433709|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
83433710|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433711|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433712|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83433713|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
83433714|NCT00636805|Hormones|hormones|mesh-ancestor
83433715|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433716|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83433717|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433718|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83433719|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83433720|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
83433721|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433722|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433723|NCT05247151|Oxytocin|oxytocin|mesh-list
83433724|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
83433725|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83433726|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433727|NCT01676246|Flupirtine|flupirtine|mesh-list
83433728|NCT01676246|Analgesics|analgesics|mesh-ancestor
83433729|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
83433730|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433731|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433732|NCT00517595|Bevacizumab|bevacizumab|mesh-list
83433733|NCT00517595|Gemcitabine|gemcitabine|mesh-list
83433734|NCT00517595|Pemetrexed|pemetrexed|mesh-list
83433735|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83433736|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433737|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83433738|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83433739|NCT00517595|Growth Substances|growth substances|mesh-ancestor
83433740|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433741|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
83433742|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83433743|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
83433744|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433745|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433746|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83433747|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83433748|NCT01672814|Riboflavin|riboflavin|mesh-list
83433749|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83433750|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83433751|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
83433752|NCT01672814|Vitamins|vitamins|mesh-ancestor
83433753|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
83433754|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433755|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83433756|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
83433757|NCT00524225|Oprelvekin|oprelvekin|mesh-list
83433758|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433759|NCT00669019|Saracatinib|saracatinib|mesh-list
83433760|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433761|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433762|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433763|NCT05560373|Huperzine A|huperzine a|mesh-list
83433764|NCT05560373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83433765|NCT05560373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433766|NCT05560373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433767|NCT05560373|Cholinergic Agents|cholinergic agents|mesh-ancestor
83433768|NCT05560373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433769|NCT05560373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433770|NCT05560373|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83433771|NCT05560373|Protective Agents|protective agents|mesh-ancestor
83433772|NCT00670267|Nadolol|nadolol|mesh-list
83433773|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83433774|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83433775|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
83433776|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433777|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433778|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433779|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83433780|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83433782|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
83433783|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433784|NCT05621915|Nadroparin|nadroparin|mesh-list
83433785|NCT05621915|Anticoagulants|anticoagulants|mesh-ancestor
83433786|NCT05621915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83433787|NCT05621915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83433788|NCT05621915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433789|NCT01673204|Calcitriol|calcitriol|mesh-list
83433790|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83433791|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433792|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83433793|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83433794|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433795|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83433796|NCT01673204|Vitamins|vitamins|mesh-ancestor
83433797|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
83433798|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83433799|NCT04393298|Leucovorin|leucovorin|mesh-list
83433800|NCT04393298|Trifluridine|trifluridine|mesh-list
83433801|NCT04393298|Fluorouracil|fluorouracil|mesh-list
83433802|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433803|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
83460176|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83460177|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
83433804|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433805|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83433806|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460178|NCT00972959|Hormones|hormones|mesh-ancestor
83433807|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83433808|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
83433809|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
83433810|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83433811|NCT04393298|Antidotes|antidotes|mesh-ancestor
83433812|NCT04393298|Protective Agents|protective agents|mesh-ancestor
83433813|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
83433814|NCT04393298|Vitamins|vitamins|mesh-ancestor
83433815|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
83433816|NCT00641563|Midazolam|midazolam|mesh-list
83433817|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
83433818|NCT00641563|Remifentanil|remifentanil|mesh-list
83433819|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83433820|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433821|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433822|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83433823|NCT00641563|Analgesics|analgesics|mesh-ancestor
83433824|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
83433825|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433826|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83433827|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83433828|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83433829|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
83433830|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433831|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433832|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83433833|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83433834|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83433835|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83433836|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83433837|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
83433838|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
83433839|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
83433841|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83433842|NCT00641563|Narcotics|narcotics|mesh-ancestor
83433843|NCT05621759|Cyclophosphamide|cyclophosphamide|mesh-list
83433844|NCT05621759|Abatacept|abatacept|mesh-list
83433845|NCT05621759|Tacrolimus|tacrolimus|mesh-list
83433846|NCT05621759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83433847|NCT05621759|Immunologic Factors|immunologic factors|mesh-ancestor
83433848|NCT05621759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433849|NCT05621759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83433850|NCT05621759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83433851|NCT05621759|Alkylating Agents|alkylating agents|mesh-ancestor
83480600|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83433852|NCT05621759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433853|NCT05621759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433854|NCT05621759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83433855|NCT05621759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83433856|NCT05621759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433857|NCT05621759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83433858|NCT05621759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83433859|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83433860|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83480601|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433861|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433862|NCT00641641|Tenofovir|tenofovir|mesh-list
83433863|NCT00641641|Emtricitabine|emtricitabine|mesh-list
83433864|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
83433865|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
83433866|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83433867|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83433868|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83433869|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433870|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433871|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83433872|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83433873|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83433874|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83433875|NCT03152474|Vitamin A|vitamin a|mesh-list
83433876|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
83433877|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83433878|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83433880|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
83433881|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83433882|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
83433883|NCT03152474|Vitamins|vitamins|mesh-ancestor
83433884|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
83433885|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433886|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83433887|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
83433888|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
83433889|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433890|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83433891|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
83433892|NCT03152474|Hormones|hormones|mesh-ancestor
83433893|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433894|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83433895|NCT03152474|Protective Agents|protective agents|mesh-ancestor
83433896|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83433897|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433898|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
83433899|NCT00641797|Promethazine|promethazine|mesh-list
83433900|NCT00641797|Meclizine|meclizine|mesh-list
83433901|NCT00641797|Lorazepam|lorazepam|mesh-list
83433902|NCT00641797|Ondansetron|ondansetron|mesh-list
83433903|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
83433904|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
83433905|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83433906|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433907|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83433908|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
83433909|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
83433910|NCT00641797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83433911|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83433912|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
83433913|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433914|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433915|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83433916|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83433917|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83433918|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
83433919|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
83433920|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
83433921|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83433922|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
83433923|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
83433924|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83433925|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
83433926|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83433927|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83433928|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83433929|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
83433930|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
83433931|NCT00641797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83433932|NCT00641797|Cholinergic Agents|cholinergic agents|mesh-ancestor
83433933|NCT04333459|Vaccines|vaccines|mesh-list
83433934|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
83433935|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433936|NCT00671515|Pioglitazone|pioglitazone|mesh-list
83433937|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83433938|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433939|NCT01893320|Decitabine|decitabine|mesh-list
83433940|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83433941|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
83433942|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433943|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433944|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433945|NCT04157725|Clomiphene|clomiphene|mesh-list
83433946|NCT04157725|Enclomiphene|enclomiphene|mesh-list
83433947|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
83433948|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83433949|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
83433950|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83433951|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433952|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83433953|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
83433954|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83433955|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83433956|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83433957|NCT04120766|Nicorandil|nicorandil|mesh-list
83433958|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83433959|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83433960|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
83433961|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
83433962|NCT04120766|Vitamins|vitamins|mesh-ancestor
83433963|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
83433964|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433965|NCT00673075|Carvedilol|carvedilol|mesh-list
83433966|NCT00673075|Nebivolol|nebivolol|mesh-list
83433967|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83433968|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83433969|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
83433970|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83433971|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433972|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433973|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83433974|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
83433975|NCT00673075|Protective Agents|protective agents|mesh-ancestor
83433976|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83433977|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83433978|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83433979|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
83433980|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83433981|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83433982|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83433983|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83433984|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83433985|NCT02250014|Sargramostim|sargramostim|mesh-list
83433986|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
83433987|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83433988|NCT04022096|Lansoprazole|lansoprazole|mesh-list
83433989|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
83433990|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83433991|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83433992|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83433993|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83433994|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83433995|NCT00673153|Vorinostat|vorinostat|mesh-list
83433996|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
83433997|NCT00673153|Calicheamicins|calicheamicins|mesh-list
83433998|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433999|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83434000|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434001|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434002|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434003|NCT00673153|Immunotoxins|immunotoxins|mesh-ancestor
83434004|NCT00673153|Immunoconjugates|immunoconjugates|mesh-ancestor
83434005|NCT00673153|Immunologic Factors|immunologic factors|mesh-ancestor
83434006|NCT00673153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434007|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83434008|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83434009|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
83434010|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83434011|NCT00654511|Fentanyl|fentanyl|mesh-list
83434012|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
83434013|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83434014|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434015|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434016|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83434017|NCT00654511|Analgesics|analgesics|mesh-ancestor
83434018|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
83434019|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434020|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83434021|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83434022|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83434023|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
83434024|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434025|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434026|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83434027|NCT00654511|Narcotics|narcotics|mesh-ancestor
83434028|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83434029|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83434030|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
83434031|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
83434032|NCT01670084|Leucovorin|leucovorin|mesh-list
83434033|NCT01670084|Cytarabine|cytarabine|mesh-list
83434034|NCT01670084|Dexamethasone|dexamethasone|mesh-list
83434035|NCT01670084|Prednisone|prednisone|mesh-list
83434036|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
83434037|NCT01670084|Rituximab|rituximab|mesh-list
83434038|NCT01670084|Doxorubicin|doxorubicin|mesh-list
83434039|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83434040|NCT01670084|Methotrexate|methotrexate|mesh-list
83434041|NCT01670084|Vincristine|vincristine|mesh-list
83434042|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
83434043|NCT01670084|Mesna|mesna|mesh-list
83434044|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83434045|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
83434046|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434047|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434048|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83434049|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
83434050|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434051|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434052|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83434053|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434054|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434055|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
83434056|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
83434057|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434058|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83434059|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
83434060|NCT01670084|Hormones|hormones|mesh-ancestor
83434061|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83434062|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83434063|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83434064|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83434065|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83434066|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434067|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83434068|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
83434069|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83434070|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83434071|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
83434072|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
83434073|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83434074|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83434075|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
83434076|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434077|NCT01670084|Antidotes|antidotes|mesh-ancestor
83434078|NCT01670084|Protective Agents|protective agents|mesh-ancestor
83434079|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
83434081|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
83434082|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83434083|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
83434084|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
83434085|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
83434086|NCT01670162|Aflibercept|aflibercept|mesh-list
83434087|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83434088|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83434089|NCT01670162|Growth Substances|growth substances|mesh-ancestor
83434090|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434091|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
83434092|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434093|NCT04345783|Apatinib|apatinib|mesh-list
83434094|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434095|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83434096|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434097|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434098|NCT00675259|Paclitaxel|paclitaxel|mesh-list
83434099|NCT00675259|Bevacizumab|bevacizumab|mesh-list
83434100|NCT00675259|Carboplatin|carboplatin|mesh-list
83434101|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83434102|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434103|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
83434104|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
83434105|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
83434106|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434107|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434108|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83434109|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83434110|NCT00675259|Growth Substances|growth substances|mesh-ancestor
83434111|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434112|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
83434113|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
83434114|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83434115|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434116|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83434117|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83434118|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434119|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434120|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434121|NCT01670240|Adalimumab|adalimumab|mesh-list
83434122|NCT01670240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83434123|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434124|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434125|NCT04404686|Indomethacin|indomethacin|mesh-list
83434126|NCT04404686|Nifedipine|nifedipine|mesh-list
83434127|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83434128|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83434129|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434130|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83434131|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434132|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
83434133|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
83434134|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83434135|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83434136|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83434137|NCT04404686|Analgesics|analgesics|mesh-ancestor
83434138|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
83434139|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434140|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434141|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434142|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
83434143|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83434144|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434145|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
83434146|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434147|NCT00658411|Deferoxamine|deferoxamine|mesh-list
83434148|NCT00658411|Siderophores|siderophores|mesh-ancestor
83434149|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83434150|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
83434151|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
83434152|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434153|NCT01674530|Lubiprostone|lubiprostone|mesh-list
83434154|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83434155|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83434156|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434157|NCT00676897|Simvastatin|simvastatin|mesh-list
83434158|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83434159|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83434160|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
83434161|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434162|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83434163|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83434164|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434165|NCT02115074|Celecoxib|celecoxib|mesh-list
83434166|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83434167|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83434168|NCT02115074|Analgesics|analgesics|mesh-ancestor
83434169|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
83434170|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434171|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434172|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434173|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434174|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83434175|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83434176|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434177|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434178|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
83434179|NCT01674686|Atorvastatin|atorvastatin|mesh-list
83434180|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83434181|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83434182|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
83434183|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434184|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83434185|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83434186|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434187|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83434188|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83434189|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83434190|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83434191|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
83434192|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434193|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434194|NCT02082392|Escitalopram|escitalopram|mesh-list
83434195|NCT02082392|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83434196|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83434197|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83434198|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434199|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434200|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
83434201|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434202|NCT03355976|Nivolumab|nivolumab|mesh-list
83434203|NCT03355976|Ipilimumab|ipilimumab|mesh-list
83434204|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434205|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434206|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83434207|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434208|NCT01674842|Cisplatin|cisplatin|mesh-list
83434209|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434210|NCT03845894|Bupivacaine|bupivacaine|mesh-list
83434211|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
83434212|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
83434213|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434214|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434215|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
83434216|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434217|NCT03161132|Doxorubicin|doxorubicin|mesh-list
83434218|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83434219|NCT03161132|Olaparib|olaparib|mesh-list
83434220|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83434221|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434222|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83434223|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83434224|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434225|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434226|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83434227|NCT03844256|Capecitabine|capecitabine|mesh-list
83434228|NCT03844256|Nivolumab|nivolumab|mesh-list
83434229|NCT03844256|Ipilimumab|ipilimumab|mesh-list
83434230|NCT03844256|Mitomycins|mitomycins|mesh-list
83434231|NCT03844256|Mitomycin|mitomycin|mesh-list
83434232|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83434233|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
83434234|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434235|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434236|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434237|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83434238|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83434239|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
83434240|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83434241|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434242|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
83434243|NCT01675076|Apixaban|apixaban|mesh-list
83434244|NCT01675076|Dabigatran|dabigatran|mesh-list
83434245|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83434246|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
83434247|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83434248|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
83434249|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434250|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434251|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
83434252|NCT03018080|Paclitaxel|paclitaxel|mesh-list
83434253|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
83434254|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83434255|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434256|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
83434257|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
83434258|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
83434259|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434260|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434261|NCT03018080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83434262|NCT03838796|Lenvatinib|lenvatinib|mesh-list
83434263|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434264|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83434265|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434266|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434267|NCT03719690|Tipifarnib|tipifarnib|mesh-list
83434268|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434269|NCT01675466|Anesthetics|anesthetics|mesh-list
83434270|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434271|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434272|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
83434273|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
83434274|NCT01676558|Rituximab|rituximab|mesh-list
83434275|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434276|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434277|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
83434278|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434279|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434280|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
83434281|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83434282|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83434283|NCT02510300|Ledipasvir|ledipasvir|mesh-list
83434284|NCT02510300|Velpatasvir|velpatasvir|mesh-list
83434285|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
83434286|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434287|NCT00678535|Capecitabine|capecitabine|mesh-list
83434288|NCT00678535|Cetuximab|cetuximab|mesh-list
83434289|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434290|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83434291|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
83434292|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434293|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434294|NCT00659737|Scopolamine|scopolamine|mesh-list
83434295|NCT00659737|Aprepitant|aprepitant|mesh-list
83434296|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
83434297|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83434298|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
83434299|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
83434300|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434301|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434302|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83434303|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83434304|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434305|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434306|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83434307|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
83434308|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83434309|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
83434310|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83434311|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
83434313|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83434314|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83434315|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83434316|NCT04763876|Analgesics|analgesics|mesh-ancestor
83434317|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
83434318|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434319|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434320|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434321|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434322|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83434323|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434324|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434325|NCT00680797|Testosterone|testosterone|mesh-list
83434326|NCT00680797|Estrogens|estrogens|mesh-list
83434327|NCT00680797|Androgens|androgens|mesh-ancestor
83434328|NCT00680797|Hormones|hormones|mesh-ancestor
83434329|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83434330|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434331|NCT02984852|Tenofovir|tenofovir|mesh-list
83434332|NCT02984852|Emtricitabine|emtricitabine|mesh-list
83434333|NCT02984852|Darunavir|darunavir|mesh-list
83434334|NCT02984852|Cobicistat|cobicistat|mesh-list
83434335|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
83434336|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434337|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83434338|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83434339|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434340|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434341|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83434342|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83434343|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83434344|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83434345|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
83434346|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83434347|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83434348|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
83434349|NCT00557193|Leucovorin|leucovorin|mesh-list
83434350|NCT00557193|Folic Acid|folic acid|mesh-list
83434351|NCT00557193|Cytarabine|cytarabine|mesh-list
83434352|NCT00557193|Dexamethasone|dexamethasone|mesh-list
83434353|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
83434354|NCT00557193|Prednisone|prednisone|mesh-list
83434355|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
83434356|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83434357|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83434358|NCT00557193|Prednisolone|prednisolone|mesh-list
83434359|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
83434360|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
83434361|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83434362|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83434363|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83434364|NCT00557193|Cortisone|cortisone|mesh-list
83434365|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
83434366|NCT00557193|Methotrexate|methotrexate|mesh-list
83434367|NCT00557193|Etoposide|etoposide|mesh-list
83434368|NCT00557193|Vincristine|vincristine|mesh-list
83434369|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
83434370|NCT00557193|Daunorubicin|daunorubicin|mesh-list
83434371|NCT00557193|Asparaginase|asparaginase|mesh-list
83434372|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
83434373|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
83434374|NCT00557193|Pegaspargase|pegaspargase|mesh-list
83434375|NCT00557193|Lenograstim|lenograstim|mesh-list
83434376|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83434377|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
83434378|NCT00557193|BB 1101|bb 1101|mesh-list
83434379|NCT00557193|Calcium|calcium|mesh-list
83434380|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
83434381|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83434382|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
83434383|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434384|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434385|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83434386|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
83434387|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434388|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434389|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83434390|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434391|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
83434392|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
83434393|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434394|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83434395|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
83434396|NCT00557193|Hormones|hormones|mesh-ancestor
83434397|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83434398|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83434399|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
83434400|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434401|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83434402|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83434403|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83434404|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
83434405|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83434406|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83434407|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
83434408|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
83434409|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83434410|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83434411|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83434412|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83434413|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83434414|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
83434415|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434416|NCT00557193|Antidotes|antidotes|mesh-ancestor
83434417|NCT00557193|Protective Agents|protective agents|mesh-ancestor
83434418|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
83434419|NCT00557193|Vitamins|vitamins|mesh-ancestor
83434420|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
83434421|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83434422|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
83434423|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
83434424|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
83434425|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83434426|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83434427|NCT00557193|Hematinics|hematinics|mesh-ancestor
83434428|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
83434429|NCT00660517|Fluticasone|fluticasone|mesh-list
83434430|NCT00660517|Xhance|xhance|mesh-list
83434431|NCT00660517|Azelastine|azelastine|mesh-list
83434432|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434433|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83434434|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
83434435|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434436|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434437|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83434438|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
83434439|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
83434440|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83434441|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83434442|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434443|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434444|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83434445|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83434446|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
83434447|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
83434448|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434449|NCT02141581|Vaccines|vaccines|mesh-list
83434450|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
83434451|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434452|NCT03826628|Sirolimus|sirolimus|mesh-list
83434453|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83434454|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434455|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83434456|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434457|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
83434458|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83434459|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
83434460|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434461|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83434462|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83434463|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434464|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434465|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83434466|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83434467|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434468|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
83434469|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434470|NCT03751436|Venetoclax|venetoclax|mesh-list
83434471|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434472|NCT03819530|Micronutrients|micronutrients|mesh-list
83434473|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434474|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83434475|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
83434476|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83434477|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83434478|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83434479|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434480|NCT03750968|Carotenoids|carotenoids|mesh-list
83434481|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
83434482|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434483|NCT03750968|Protective Agents|protective agents|mesh-ancestor
83434484|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434485|NCT03818672|Rifaximin|rifaximin|mesh-list
83434486|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83434487|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434488|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83434489|NCT03749018|Prednisone|prednisone|mesh-list
83434490|NCT03749018|Cortisone|cortisone|mesh-list
83434491|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
83434492|NCT03749018|Rituximab|rituximab|mesh-list
83434493|NCT03749018|Doxorubicin|doxorubicin|mesh-list
83434494|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83434495|NCT03749018|Nivolumab|nivolumab|mesh-list
83434496|NCT03749018|Etoposide|etoposide|mesh-list
83434497|NCT03749018|Vincristine|vincristine|mesh-list
83434498|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
83434499|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
83434500|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83434501|NCT03749018|Antibodies|antibodies|mesh-list
83434502|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
83434503|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83434504|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83434505|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
83434506|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434507|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434508|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83434509|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
83434510|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434511|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434512|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83434513|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83434514|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83434515|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83434516|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434517|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434518|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
83434519|NCT03749018|Hormones|hormones|mesh-ancestor
83434520|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83434521|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83434522|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83434523|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83434524|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
83434525|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
83434526|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
83434527|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
83434528|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
83434529|NCT01931163|Everolimus|everolimus|mesh-list
83434530|NCT01931163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83434531|NCT01931163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83434532|NCT01931163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434533|NCT01931163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434534|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83434535|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
83434536|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434537|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434538|NCT04763486|Cefazolin|cefazolin|mesh-list
83434539|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83434540|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434541|NCT02988063|Polidocanol|polidocanol|mesh-list
83434542|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83434543|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83434544|NCT03877406|Empagliflozin|empagliflozin|mesh-list
83434545|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83434546|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83434547|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434548|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434549|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
83434550|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
83434551|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434552|NCT03744026|Carboplatin|carboplatin|mesh-list
83434553|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434554|NCT03869996|Cytarabine|cytarabine|mesh-list
83434555|NCT03869996|Methotrexate|methotrexate|mesh-list
83434556|NCT03869996|Etoposide|etoposide|mesh-list
83434557|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83434558|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
83434559|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434560|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434561|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
83434562|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434563|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83434564|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
83434565|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434566|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83434567|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83434568|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83434569|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434570|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83434571|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
83434572|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83434573|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
83434574|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83434575|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434576|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83434577|NCT03869450|Lidocaine|lidocaine|mesh-list
83434578|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
83434579|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
83434580|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
83434581|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434582|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434583|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
83434584|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434585|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83434586|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83434587|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83434588|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83434589|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434590|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83434591|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
83434592|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
83434593|NCT03869450|Protective Agents|protective agents|mesh-ancestor
83434594|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
83434595|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
83434596|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434597|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
83434598|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434599|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434600|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83434601|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83434602|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83434603|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83434604|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434605|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
83434606|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434607|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434608|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83434609|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434610|NCT01101464|Asenapine|asenapine|mesh-list
83434611|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83434612|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83434613|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434614|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434615|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83434616|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
83434617|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83434618|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
83434619|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
83434620|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434621|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434622|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83434623|NCT03736538|Analgesics|analgesics|mesh-ancestor
83434624|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
83434625|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434626|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83434627|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
83434628|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434629|NCT03725930|Clonidine|clonidine|mesh-list
83434630|NCT03725930|Analgesics|analgesics|mesh-ancestor
83434631|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
83434632|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434633|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434634|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83434635|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
83434636|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
83434637|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83434638|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83434639|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83434640|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
83434641|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434642|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434643|NCT03781388|Bupivacaine|bupivacaine|mesh-list
83434644|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
83434645|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
83434646|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434647|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434648|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
83434649|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434650|NCT03779048|Phentermine|phentermine|mesh-list
83434651|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83434652|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434653|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
83434654|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83434655|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
83434656|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
83434657|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434658|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
83434659|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434660|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434661|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
83434662|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
83434663|NCT03778580|Vitamins|vitamins|mesh-ancestor
83434664|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
83434665|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434666|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
83434667|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434668|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434669|NCT03722342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83434670|NCT03722342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434671|NCT03722108|Irinotecan|irinotecan|mesh-list
83434672|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83434673|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83434674|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434675|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434676|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434677|NCT03775070|Simvastatin|simvastatin|mesh-list
83434678|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83434679|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83434680|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
83434681|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434682|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83434683|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83434685|NCT02083406|Artefenomel|artefenomel|mesh-list
83434686|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
83434687|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83434688|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83434689|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434690|NCT03773666|Durvalumab|durvalumab|mesh-list
83434691|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434692|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434693|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
83434694|NCT04762784|Hormones|hormones|mesh-ancestor
83434695|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83434696|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434697|NCT00003644|Paclitaxel|paclitaxel|mesh-list
83434698|NCT00003644|Carboplatin|carboplatin|mesh-list
83434699|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83434700|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434701|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
83434702|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
83434703|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
83434704|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434705|NCT02142049|Lenalidomide|lenalidomide|mesh-list
83434706|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
83434707|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434708|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83434709|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83434710|NCT02142049|Growth Substances|growth substances|mesh-ancestor
83434711|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
83434712|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434713|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
83434714|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83434715|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434716|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83434717|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434718|NCT03716180|Paclitaxel|paclitaxel|mesh-list
83434719|NCT03716180|Trastuzumab|trastuzumab|mesh-list
83434720|NCT03716180|Pertuzumab|pertuzumab|mesh-list
83434721|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83434722|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434723|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
83434724|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
83434725|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
83434726|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434727|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434728|NCT03715244|Anesthetics|anesthetics|mesh-list
83434729|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
83434730|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434731|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434732|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
83434733|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434734|NCT03714620|Ketamine|ketamine|mesh-list
83434735|NCT03714620|Analgesics|analgesics|mesh-ancestor
83434736|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
83434737|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434738|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434739|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83434740|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83434741|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
83434742|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
83434743|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434744|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83434745|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83434746|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434747|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434748|NCT03629288|Azithromycin|azithromycin|mesh-list
83434749|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83434750|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434751|NCT04763096|Tacrolimus|tacrolimus|mesh-list
83434752|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83434753|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
83434754|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434755|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83434756|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434757|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434758|NCT00680953|Denosumab|denosumab|mesh-list
83434759|NCT00680953|Alendronate|alendronate|mesh-list
83434760|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83434761|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434762|NCT00660985|Adapalene|adapalene|mesh-list
83434763|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83434764|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83434765|NCT00660985|Analgesics|analgesics|mesh-ancestor
83434766|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
83434767|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434768|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434769|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434770|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434771|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
83434772|NCT03551522|Seladelpar|seladelpar|mesh-list
83434773|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83434774|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
83434775|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434776|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83434777|NCT03704714|Prednisone|prednisone|mesh-list
83434778|NCT03704714|Cortisone|cortisone|mesh-list
83434779|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
83434780|NCT03704714|Rituximab|rituximab|mesh-list
83434781|NCT03704714|Doxorubicin|doxorubicin|mesh-list
83434782|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83434783|NCT03704714|Nivolumab|nivolumab|mesh-list
83434784|NCT03704714|Vincristine|vincristine|mesh-list
83434785|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83434786|NCT03704714|Antibodies|antibodies|mesh-list
83434787|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
83434788|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83434789|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83434790|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
83434791|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434792|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434793|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83434794|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
83434795|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434796|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434797|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83434798|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83434799|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83434800|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83434801|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434802|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434803|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
83434804|NCT03704714|Hormones|hormones|mesh-ancestor
83434805|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83434806|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83434807|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83434808|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83434809|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
83434810|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
83434811|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
83434812|NCT00661141|Ethanol|ethanol|mesh-list
83434813|NCT00661141|Fomepizole|fomepizole|mesh-list
83434814|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83434815|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434816|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434817|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434818|NCT00661141|Antidotes|antidotes|mesh-ancestor
83434819|NCT00661141|Protective Agents|protective agents|mesh-ancestor
83434820|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434821|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434822|NCT03616574|Trifluridine|trifluridine|mesh-list
83434823|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
83434824|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434825|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
83434826|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434827|NCT00681265|Glycerol|glycerol|mesh-list
83434828|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83434829|NCT00681265|Protective Agents|protective agents|mesh-ancestor
83434830|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434831|NCT01677104|Liraglutide|liraglutide|mesh-list
83434832|NCT01677104|Exenatide|exenatide|mesh-list
83434833|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83434834|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83434835|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434836|NCT01677104|Incretins|incretins|mesh-ancestor
83434837|NCT01677104|Hormones|hormones|mesh-ancestor
83434838|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83434839|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83434840|NCT00661453|Valproic Acid|valproic acid|mesh-list
83434841|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
83434842|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434843|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434844|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
83434845|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434846|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434847|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
83434848|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83434849|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434850|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83434851|NCT03547622|Galantamine|galantamine|mesh-list
83434852|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83434853|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434854|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434855|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
83434856|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434857|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434858|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83434859|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
83434860|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434861|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
83434862|NCT00681889|Ranibizumab|ranibizumab|mesh-list
83434863|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83434864|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83434865|NCT00681889|Growth Substances|growth substances|mesh-ancestor
83434866|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434867|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
83434868|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434869|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
83434870|NCT03610490|Fludarabine|fludarabine|mesh-list
83434871|NCT03610490|Interleukin-2|interleukin-2|mesh-list
83434872|NCT03610490|Mitogens|mitogens|mesh-list
83434873|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83434874|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
83434875|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434876|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83434877|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83434878|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
83434879|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434880|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434881|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83434882|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83434883|NCT03610490|Analgesics|analgesics|mesh-ancestor
83434884|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
83434885|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434886|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
83434887|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
83434888|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83434889|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83434890|NCT00682357|Prednisolone|prednisolone|mesh-list
83434891|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
83434892|NCT00682357|Lidocaine|lidocaine|mesh-list
83434893|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83434894|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
83434895|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
83434896|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
83434897|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434898|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434899|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
83434900|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434901|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83434902|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83434903|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83434904|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83434905|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434906|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434907|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
83434908|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
83434909|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83434910|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
83434911|NCT00682357|Hormones|hormones|mesh-ancestor
83434912|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83434913|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83434914|NCT00682357|Protective Agents|protective agents|mesh-ancestor
83434915|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83434916|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434917|NCT00662155|Zolpidem|zolpidem|mesh-list
83434918|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83434919|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83434920|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83434921|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434922|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83434923|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
83434924|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
83434925|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83434926|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434927|NCT03546608|Tepotinib|tepotinib|mesh-list
83434928|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434929|NCT00662545|Tenofovir|tenofovir|mesh-list
83434930|NCT00662545|Lamivudine|lamivudine|mesh-list
83434931|NCT00662545|Emtricitabine|emtricitabine|mesh-list
83434932|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83434933|NCT00662545|Entecavir|entecavir|mesh-list
83434934|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83434935|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
83434936|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434937|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83434938|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83434939|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434940|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434941|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83434942|NCT03539198|Nivolumab|nivolumab|mesh-list
83434943|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434944|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434945|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83434946|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434947|NCT00663169|Dexamethasone|dexamethasone|mesh-list
83434948|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
83434949|NCT00663169|BB 1101|bb 1101|mesh-list
83434950|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83434951|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83434952|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
83434953|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
83434954|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83434955|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434956|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83434957|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
83434958|NCT00663169|Hormones|hormones|mesh-ancestor
83434959|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83434960|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83434961|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434962|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
83434963|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434964|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434965|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
83434966|NCT00663403|Daptomycin|daptomycin|mesh-list
83434967|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83434968|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83434969|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
83434970|NCT00663793|Finasteride|finasteride|mesh-list
83434971|NCT00663793|Testosterone|testosterone|mesh-list
83434972|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
83434973|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
83434974|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83434975|NCT00663793|Acyline|acyline|mesh-list
83434976|NCT00663793|Androgens|androgens|mesh-ancestor
83434977|NCT00663793|Hormones|hormones|mesh-ancestor
83434978|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83434979|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83434980|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83434981|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434982|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
83434983|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83434984|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83434985|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83434986|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434987|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
83434988|NCT00663793|Urological Agents|urological agents|mesh-ancestor
83434989|NCT03690986|Nivolumab|nivolumab|mesh-list
83434990|NCT03690986|Ipilimumab|ipilimumab|mesh-list
83434991|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83434992|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83434993|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83434994|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83434995|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
83434996|NCT03605654|Tacrolimus|tacrolimus|mesh-list
83434997|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83434998|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
83434999|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435000|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83435001|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435002|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435003|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83435004|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435005|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83435006|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
83435007|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83435008|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435009|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
83435010|NCT02336438|Cathartics|cathartics|mesh-ancestor
83435011|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83435013|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
83435014|NCT00667615|Rituximab|rituximab|mesh-list
83435015|NCT00667615|Etoposide|etoposide|mesh-list
83435016|NCT00667615|Vorinostat|vorinostat|mesh-list
83435017|NCT00667615|Lenograstim|lenograstim|mesh-list
83435018|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83435019|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
83435020|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435021|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83435022|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83435023|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
83435024|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435025|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435026|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83435027|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83435028|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83435029|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
83435030|NCT00667615|Hormones|hormones|mesh-ancestor
83435031|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435032|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83435033|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83435034|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83435035|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83435036|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435037|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83435038|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83435039|NCT03683810|Lactoferrin|lactoferrin|mesh-list
83435040|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
83435041|NCT03683810|Hematinics|hematinics|mesh-ancestor
83435042|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435043|NCT01587235|Simvastatin|simvastatin|mesh-list
83435044|NCT01587235|Ezetimibe|ezetimibe|mesh-list
83435045|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83435046|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83435047|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83435048|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
83435049|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435050|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83435051|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83435052|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435053|NCT03532880|Olaparib|olaparib|mesh-list
83435054|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83435055|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435056|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435057|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435058|NCT03601442|Tisagenlecleucel|tisagenlecleucel|mesh-list
83435059|NCT03601442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83435060|NCT03601442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435062|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83435063|NCT00652717|Simvastatin|simvastatin|mesh-list
83435064|NCT00652717|Ezetimibe|ezetimibe|mesh-list
83435065|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83435066|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83435067|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
83435068|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435069|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83435070|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83435071|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435072|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
83435073|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83435074|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
83435075|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83435076|NCT00684775|Naltrexone|naltrexone|mesh-list
83435077|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83435078|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83435079|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435080|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
83435081|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435082|NCT03593408|Fentanyl|fentanyl|mesh-list
83435083|NCT03593408|Midazolam|midazolam|mesh-list
83435084|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
83435085|NCT03593408|Morphine|morphine|mesh-list
83435086|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83435087|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83435088|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435089|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83435091|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
83435092|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435093|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83435094|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83435095|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83435096|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
83435097|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435098|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435099|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83435100|NCT03593408|Narcotics|narcotics|mesh-ancestor
83435101|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83435102|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83435103|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
83435104|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
83435105|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83435106|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83435107|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83435108|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
83435109|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
83435110|NCT00395473|Ezetimibe|ezetimibe|mesh-list
83435111|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83435112|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83435113|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
83435114|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435115|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83435116|NCT00393211|Etoricoxib|etoricoxib|mesh-list
83435117|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435118|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435119|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435120|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83435121|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83435122|NCT00393211|Analgesics|analgesics|mesh-ancestor
83435123|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
83435124|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83435125|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83435126|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83435127|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83435128|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435129|NCT03676556|Lidocaine|lidocaine|mesh-list
83435130|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
83435131|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
83435132|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83435133|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435134|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
83435135|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435136|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83435137|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83435139|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83435140|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435141|NCT03519230|Pamiparib|pamiparib|mesh-list
83435142|NCT03519230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83435143|NCT03519230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435144|NCT03519230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435145|NCT03519230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435146|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
83435147|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435148|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
83435149|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
83435150|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
83435151|NCT03592472|Abexinostat|abexinostat|mesh-list
83435152|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83435153|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435154|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435155|NCT00269191|Ibuprofen|ibuprofen|mesh-list
83435156|NCT00269191|Etoricoxib|etoricoxib|mesh-list
83435157|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83435158|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83435159|NCT00269191|Analgesics|analgesics|mesh-ancestor
83435160|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
83435161|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435162|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435163|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83435164|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83435165|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83435166|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435167|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435168|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83435169|NCT00690235|Pramlintide|pramlintide|mesh-list
83435170|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83435171|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435172|NCT00092833|Ezetimibe|ezetimibe|mesh-list
83435173|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83435174|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83435175|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
83435176|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435177|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83435178|NCT01799083|Decitabine|decitabine|mesh-list
83435179|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83435180|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
83435181|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435182|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435183|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435184|NCT01799161|Theophylline|theophylline|mesh-list
83435185|NCT01799161|Vaccines|vaccines|mesh-list
83435186|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
83435187|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435188|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83435189|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
83435190|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435191|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83435192|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
83435193|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83435194|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435195|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435196|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
83435197|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83435198|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83435199|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
83435200|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435201|NCT00006110|Paclitaxel|paclitaxel|mesh-list
83435202|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
83435203|NCT00006110|Doxorubicin|doxorubicin|mesh-list
83435204|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83435205|NCT00006110|Trastuzumab|trastuzumab|mesh-list
83435206|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83435207|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435208|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
83435209|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
83435210|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
83435211|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435212|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83435213|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
83435214|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435215|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83435216|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83435217|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
83435218|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83435219|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83435220|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83435221|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83435222|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435223|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83435225|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
83435226|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435227|NCT00692185|Olanzapine|olanzapine|mesh-list
83435228|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
83435229|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
83435230|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435231|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435232|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83435233|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83435234|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83435235|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83435236|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83435237|NCT00692185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83435238|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83435239|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83435240|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435241|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435242|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
83435243|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
83435244|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
83435245|NCT00692341|Axitinib|axitinib|mesh-list
83435246|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435247|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83435248|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435249|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435250|NCT03511976|Methylphenidate|methylphenidate|mesh-list
83435251|NCT03511976|Amphetamine|amphetamine|mesh-list
83435252|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83435253|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435254|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83435255|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83435256|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83435257|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435258|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
83435259|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435260|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
83435261|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
83435262|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435263|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
83435264|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83435265|NCT00694603|Cetuximab|cetuximab|mesh-list
83435266|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83435267|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435268|NCT03582722|Orlistat|orlistat|mesh-list
83435269|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435270|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435271|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83435272|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83435273|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
83435274|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83435275|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435276|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435277|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83435278|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83435279|NCT00590161|Protective Agents|protective agents|mesh-ancestor
83435280|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435281|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
83435282|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83435283|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
83435284|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83435285|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83435286|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435287|NCT00006170|Bupropion|bupropion|mesh-list
83435288|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83435289|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
83435290|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83435291|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83435292|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83435293|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83435294|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435295|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
83435296|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435297|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435298|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83435299|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83435300|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435301|NCT02123849|Aspirin|aspirin|mesh-list
83435302|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83435303|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83435304|NCT02123849|Analgesics|analgesics|mesh-ancestor
83435305|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
83435306|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435307|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435308|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83435309|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83435310|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83435311|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83435312|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435313|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83435314|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83435315|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435316|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
83435317|NCT05347160|Calcium|calcium|mesh-list
83435318|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83435319|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435320|NCT00671528|Gentamicins|gentamicins|mesh-list
83435321|NCT00671528|Clotrimazole|clotrimazole|mesh-list
83435322|NCT00671528|Miconazole|miconazole|mesh-list
83435323|NCT00671528|Betamethasone|betamethasone|mesh-list
83435324|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
83435325|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83435326|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
83435327|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83435328|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83435329|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
83435330|NCT00671528|Hormones|hormones|mesh-ancestor
83435331|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435332|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435333|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83435334|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
83435335|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83435336|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435337|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83435338|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435339|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435340|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83435341|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
83435342|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83435343|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83435344|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83435345|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
83435346|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83435347|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83435348|NCT00590863|Dexetimide|dexetimide|mesh-list
83435349|NCT00590863|Mirtazapine|mirtazapine|mesh-list
83435350|NCT00590863|Citalopram|citalopram|mesh-list
83435351|NCT00590863|Bupropion|bupropion|mesh-list
83435352|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83435353|NCT00590863|Escitalopram|escitalopram|mesh-list
83435354|NCT00590863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83435355|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83435356|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83435357|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435358|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435359|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
83435360|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435361|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83435362|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83435363|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
83435364|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
83435365|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435366|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83435367|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83435368|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
83435369|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83435370|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
83435371|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83435372|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83435373|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
83435374|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83435375|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83435376|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435377|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83435378|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83435379|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
83435380|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
83435381|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83435382|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83435383|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83435384|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83435385|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83435386|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83435387|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
83435388|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83435389|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83435390|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83435391|NCT00591019|Modafinil|modafinil|mesh-list
83435392|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83435393|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435394|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83435395|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83435396|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83435397|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435398|NCT02996695|Artesunate|artesunate|mesh-list
83435399|NCT02996695|Chloroquine|chloroquine|mesh-list
83435400|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
83435401|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83435402|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83435403|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435404|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435405|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
83435406|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
83435407|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83435408|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
83435409|NCT02996695|Amebicides|amebicides|mesh-ancestor
83435410|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83435411|NCT00359138|Cetirizine|cetirizine|mesh-list
83435412|NCT00359138|Loratadine|loratadine|mesh-list
83435413|NCT00359138|Levocetirizine|levocetirizine|mesh-list
83435414|NCT00359138|Desloratadine|desloratadine|mesh-list
83435415|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83435416|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83435417|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
83435418|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
83435419|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435420|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435421|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435422|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83435423|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83435424|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
83435425|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
83435426|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
83435427|NCT05503979|Sofosbuvir|sofosbuvir|mesh-list
83435428|NCT05503979|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83435429|NCT05503979|Velpatasvir|velpatasvir|mesh-list
83435430|NCT05503979|Antiviral Agents|antiviral agents|mesh-ancestor
83435431|NCT05503979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435432|NCT04703621|Daratumumab|daratumumab|mesh-list
83435433|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435434|NCT02996227|Bupivacaine|bupivacaine|mesh-list
83435435|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
83435436|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
83435437|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83435438|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435439|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
83435440|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435441|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
83435442|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83435443|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83435444|NCT00698035|Testosterone|testosterone|mesh-list
83435445|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
83435446|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
83435447|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83435448|NCT00698035|Estradiol|estradiol|mesh-list
83435449|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83435450|NCT00698035|Androgens|androgens|mesh-ancestor
83435451|NCT00698035|Hormones|hormones|mesh-ancestor
83435452|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435453|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435454|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83435455|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435456|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
83435457|NCT00698035|Estrogens|estrogens|mesh-ancestor
83435458|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83435459|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
83435460|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83435461|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83435462|NCT02129075|Poly I-C|poly i-c|mesh-list
83435463|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83435464|NCT02129075|Poly ICLC|poly iclc|mesh-list
83435465|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
83435466|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
83435467|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
83435468|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435469|NCT02129075|Laxatives|laxatives|mesh-ancestor
83435470|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83435471|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
83435472|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435473|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83435474|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83435475|NCT02129075|Protective Agents|protective agents|mesh-ancestor
83435476|NCT02775903|Azacitidine|azacitidine|mesh-list
83435477|NCT02775903|Durvalumab|durvalumab|mesh-list
83435478|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83435479|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
83435480|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435481|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435482|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435483|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83435484|NCT01782443|Aflibercept|aflibercept|mesh-list
83435485|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83435486|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83435487|NCT01782443|Growth Substances|growth substances|mesh-ancestor
83435488|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435489|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
83435490|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435491|NCT01933425|Rocuronium|rocuronium|mesh-list
83435492|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83435493|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83435494|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83435495|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435496|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435497|NCT04239599|Leuprolide|leuprolide|mesh-list
83435498|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83435499|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
83435500|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83435501|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435502|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83435503|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435504|NCT03487016|Paclitaxel|paclitaxel|mesh-list
83435505|NCT03487016|Gemcitabine|gemcitabine|mesh-list
83435506|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
83435507|NCT03487016|Irinotecan|irinotecan|mesh-list
83435508|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83435509|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435510|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
83435511|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
83435512|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
83435513|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435514|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83435515|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
83435516|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83435517|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83435518|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435519|NCT05346926|Calpastatin|calpastatin|mesh-list
83435520|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83435521|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
83435522|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435523|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435524|NCT05292209|Riluzole|riluzole|mesh-list
83435525|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
83435526|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83435527|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83435528|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435529|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435530|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435531|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83435532|NCT05292209|Protective Agents|protective agents|mesh-ancestor
83435533|NCT03023319|Pemetrexed|pemetrexed|mesh-list
83435534|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435535|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435536|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435537|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83435538|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83435539|NCT02980653|Megestrol|megestrol|mesh-list
83435540|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
83435541|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83435542|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83435543|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83435544|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
83435545|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83435546|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435547|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83435548|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83435549|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83435550|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435551|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
83435552|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83435553|NCT05265065|Vaccines|vaccines|mesh-list
83435554|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
83435555|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435556|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83435557|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83435558|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435559|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
83435560|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
83435561|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435562|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83435563|NCT03087968|Prednisolone|prednisolone|mesh-list
83435564|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83435565|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
83435566|NCT03087968|Hormones|hormones|mesh-ancestor
83435567|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435568|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435569|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83435570|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435571|NCT03845049|Aflibercept|aflibercept|mesh-list
83435572|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83435573|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83435574|NCT03845049|Growth Substances|growth substances|mesh-ancestor
83435575|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435576|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
83435577|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435578|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83435579|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83435580|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435581|NCT03790839|Incretins|incretins|mesh-ancestor
83435582|NCT03790839|Hormones|hormones|mesh-ancestor
83435583|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435584|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83435585|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
83435586|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435587|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435588|NCT03088046|Progesterone|progesterone|mesh-list
83435589|NCT03088046|Progestins|progestins|mesh-ancestor
83435590|NCT03088046|Hormones|hormones|mesh-ancestor
83435591|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435592|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435593|NCT01677884|Bevacizumab|bevacizumab|mesh-list
83435594|NCT01677884|Capecitabine|capecitabine|mesh-list
83435595|NCT01677884|Irinotecan|irinotecan|mesh-list
83435596|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83435597|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435598|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83435599|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83435600|NCT01677884|Growth Substances|growth substances|mesh-ancestor
83435601|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435602|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
83435603|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83435604|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
83435605|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435606|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83435607|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83435608|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435609|NCT02124083|Vorinostat|vorinostat|mesh-list
83435610|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435612|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435613|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435614|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
83435615|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83435616|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83435617|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435618|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
83435619|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
83435620|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435621|NCT00701389|Sumatriptan|sumatriptan|mesh-list
83435622|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83435623|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83435624|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83435625|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
83435626|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435627|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435628|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435629|NCT02336594|Verinurad|verinurad|mesh-list
83435630|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
83435631|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83435632|NCT01799317|Vitamin D|vitamin d|mesh-list
83435633|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
83435634|NCT01799317|Vitamins|vitamins|mesh-ancestor
83435635|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
83435636|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435637|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83435638|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83435639|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
83435640|NCT03925025|Nimodipine|nimodipine|mesh-list
83435641|NCT03925025|Analgesics|analgesics|mesh-ancestor
83435642|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
83435643|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435644|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435645|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
83435646|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83435647|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83435648|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
83435649|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83435650|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83435651|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435652|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83435653|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
83435654|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83435655|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83435656|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
83435657|NCT01677962|Poly ICLC|poly iclc|mesh-list
83435658|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
83435659|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
83435660|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435661|NCT00595153|Budesonide|budesonide|mesh-list
83435662|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83435663|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83435664|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
83435665|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435666|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435667|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83435668|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
83435669|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
83435670|NCT00595153|Hormones|hormones|mesh-ancestor
83435671|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435672|NCT02995291|Phentolamine|phentolamine|mesh-list
83435673|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83435674|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83435675|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
83435676|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435677|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435678|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435679|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83435680|NCT00595231|Rufinamide|rufinamide|mesh-list
83435681|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
83435682|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83435683|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83435684|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83435685|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435686|NCT02995057|Nickel|nickel|mesh-list
83435687|NCT02995057|Trace Elements|trace elements|mesh-ancestor
83435688|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
83435689|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435690|NCT02474173|Paclitaxel|paclitaxel|mesh-list
83435691|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83435692|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83435693|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435694|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
83435695|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
83435696|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
83435697|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435698|NCT03482102|Durvalumab|durvalumab|mesh-list
83435699|NCT03482102|Tremelimumab|tremelimumab|mesh-list
83435700|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83435701|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435702|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83435703|NCT02402270|Laxatives|laxatives|mesh-ancestor
83435704|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83435705|NCT00701935|Exenatide|exenatide|mesh-list
83435706|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83435707|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435708|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83435709|NCT00701935|Incretins|incretins|mesh-ancestor
83435710|NCT00701935|Hormones|hormones|mesh-ancestor
83435711|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435712|NCT02984696|Estradiol|estradiol|mesh-list
83435713|NCT02984696|Estrogens|estrogens|mesh-ancestor
83435714|NCT02984696|Hormones|hormones|mesh-ancestor
83435715|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435716|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435717|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83435718|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
83435719|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435720|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83435721|NCT00596167|Vancomycin|vancomycin|mesh-list
83435722|NCT00596167|Levofloxacin|levofloxacin|mesh-list
83435723|NCT00596167|Gentamicins|gentamicins|mesh-list
83435724|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435725|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83435726|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83435727|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83435728|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435729|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435730|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435731|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83435732|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83435734|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
83435735|NCT03087032|Liraglutide|liraglutide|mesh-list
83435736|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83435737|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435738|NCT03087032|Incretins|incretins|mesh-ancestor
83435739|NCT03087032|Hormones|hormones|mesh-ancestor
83435740|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435741|NCT02994745|Atorvastatin|atorvastatin|mesh-list
83435742|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83435743|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83435744|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
83435745|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435746|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83435747|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83435748|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435749|NCT00703261|Atorvastatin|atorvastatin|mesh-list
83435750|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83435751|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83435752|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
83435753|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435754|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83435755|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83435756|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435757|NCT04912115|Midazolam|midazolam|mesh-list
83435758|NCT04912115|Ketamine|ketamine|mesh-list
83435759|NCT04912115|Analgesics|analgesics|mesh-ancestor
83435760|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
83435761|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435762|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435763|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83435764|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83435765|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
83435766|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
83435767|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83435768|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83435769|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83435770|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435771|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435772|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83435773|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83435774|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83435775|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83435776|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83435777|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
83435778|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
83435779|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
83435780|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435781|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83435782|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435783|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435784|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83435785|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83435786|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
83435787|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
83435788|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
83435789|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435790|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83435791|NCT04200833|Golimumab|golimumab|mesh-list
83435792|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83435793|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83435794|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83435795|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
83435796|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435797|NCT01678352|Imiquimod|imiquimod|mesh-list
83435798|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83435799|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
83435800|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435801|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435802|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
83435803|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83435804|NCT01678430|Chlorambucil|chlorambucil|mesh-list
83435805|NCT01678430|Ofatumumab|ofatumumab|mesh-list
83435806|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83435807|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
83435808|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435809|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435810|NCT01678664|Doxorubicin|doxorubicin|mesh-list
83435811|NCT01678664|Everolimus|everolimus|mesh-list
83435812|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83435813|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435814|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83435815|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83435816|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435817|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435818|NCT01678664|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83435819|NCT01678664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83435820|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83435821|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
83435822|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435823|NCT00597493|Temozolomide|temozolomide|mesh-list
83435824|NCT00597493|Sorafenib|sorafenib|mesh-list
83435825|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83435826|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
83435827|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435828|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435829|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83435830|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435831|NCT03086954|Immunomodulating Agents|immunomodulating agents|mesh-list
83435832|NCT03086954|Immunologic Factors|immunologic factors|mesh-ancestor
83435833|NCT03086954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435834|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83435836|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
83435837|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435838|NCT04402112|Pitavastatin|pitavastatin|mesh-list
83435839|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83435840|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83435841|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83435842|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
83435843|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435844|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435845|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83435846|NCT00597727|Glycerol|glycerol|mesh-list
83435847|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83435848|NCT00597727|Protective Agents|protective agents|mesh-ancestor
83435849|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435850|NCT03952403|Bevacizumab|bevacizumab|mesh-list
83435851|NCT03952403|Carboplatin|carboplatin|mesh-list
83435852|NCT03952403|Pemetrexed|pemetrexed|mesh-list
83435853|NCT03952403|Antibodies|antibodies|mesh-list
83435854|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83435855|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435856|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83435857|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83435858|NCT03952403|Growth Substances|growth substances|mesh-ancestor
83435859|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435860|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
83435861|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
83435862|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435863|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435864|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83435865|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83435866|NCT03474770|Huperzine A|huperzine a|mesh-list
83435867|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83435868|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435869|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435870|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
83435871|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435872|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435873|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83435874|NCT03474770|Protective Agents|protective agents|mesh-ancestor
83435875|NCT02998645|Cyclosporine|cyclosporine|mesh-list
83435876|NCT02998645|Cyclosporins|cyclosporins|mesh-list
83435877|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435878|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435879|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83435880|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
83435881|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435882|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
83435883|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435884|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
83435885|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83435886|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83435887|NCT03450122|Aldesleukin|aldesleukin|mesh-list
83435888|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
83435889|NCT03450122|Interleukin-2|interleukin-2|mesh-list
83435890|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83435891|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
83435892|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435893|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83435894|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83435895|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
83435896|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435897|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435898|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83435899|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83435900|NCT03450122|Analgesics|analgesics|mesh-ancestor
83435901|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
83435902|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435903|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83435904|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83435905|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
83435906|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83435907|NCT00707863|Escitalopram|escitalopram|mesh-list
83435908|NCT00707863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83435909|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83435910|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83435911|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435912|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435913|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
83435914|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435915|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83435916|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
83435917|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83435918|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
83435919|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435920|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
83435921|NCT00565643|Protective Agents|protective agents|mesh-ancestor
83435922|NCT00565643|Laxatives|laxatives|mesh-ancestor
83435923|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83435924|NCT01798277|Amiodarone|amiodarone|mesh-list
83435925|NCT01798277|Sotalol|sotalol|mesh-list
83435926|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83435927|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
83435928|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83435929|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83435930|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435931|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83435932|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83435933|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83435934|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83435935|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83435936|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83435937|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83435938|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83435939|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83435940|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
83435941|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435942|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435943|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
83435944|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
83435945|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435946|NCT00598507|Sagopilone|sagopilone|mesh-list
83435947|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435948|NCT00566813|Exenatide|exenatide|mesh-list
83435949|NCT00566813|Etanercept|etanercept|mesh-list
83435950|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83435951|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83435952|NCT00566813|Analgesics|analgesics|mesh-ancestor
83435953|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
83435954|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435955|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435956|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83435957|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83435958|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83435959|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83435960|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
83435961|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83435962|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83435964|NCT00566813|Hormones|hormones|mesh-ancestor
83435965|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435966|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
83435967|NCT00088166|Hormones|hormones|mesh-ancestor
83435968|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435969|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435970|NCT00566969|Carvedilol|carvedilol|mesh-list
83435971|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83435972|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83435973|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
83435974|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83435975|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435976|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435977|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83435978|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
83435979|NCT00566969|Protective Agents|protective agents|mesh-ancestor
83435980|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83435981|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83435982|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83435983|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
83435984|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83435985|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83435986|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
83435987|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83435988|NCT03086564|Estrogens|estrogens|mesh-ancestor
83435989|NCT03086564|Hormones|hormones|mesh-ancestor
83435990|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83435991|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435992|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83435993|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83435994|NCT00598663|Insulin|insulin|mesh-list
83435995|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83435996|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83435997|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435998|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
83435999|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
83436000|NCT00704353|Hematinics|hematinics|mesh-ancestor
83436001|NCT00087698|Pemetrexed|pemetrexed|mesh-list
83436002|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436003|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436004|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436005|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83436006|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83436007|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
83436008|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83436009|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436010|NCT03755739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83436011|NCT03755739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436012|NCT05245721|Nalbuphine|nalbuphine|mesh-list
83436013|NCT05245721|Bupivacaine|bupivacaine|mesh-list
83436014|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
83436015|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
83436016|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436017|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436018|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
83436019|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436020|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83436021|NCT05245721|Narcotics|narcotics|mesh-ancestor
83436022|NCT05245721|Analgesics|analgesics|mesh-ancestor
83436023|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
83436024|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
83436025|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83436026|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436027|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436028|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
83436030|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436031|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436032|NCT03472586|Nivolumab|nivolumab|mesh-list
83436033|NCT03472586|Ipilimumab|ipilimumab|mesh-list
83436034|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83436035|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436036|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83436037|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436038|NCT02987985|Acetaminophen|acetaminophen|mesh-list
83436039|NCT02987985|Dexamethasone|dexamethasone|mesh-list
83436040|NCT02987985|Lidocaine|lidocaine|mesh-list
83436041|NCT02987985|Fentanyl|fentanyl|mesh-list
83436042|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
83436043|NCT02987985|Ketamine|ketamine|mesh-list
83436044|NCT02987985|Gabapentin|gabapentin|mesh-list
83436045|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
83436046|NCT02987985|Ondansetron|ondansetron|mesh-list
83436047|NCT02987985|Sevoflurane|sevoflurane|mesh-list
83436048|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83436049|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
83436050|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
83436051|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436052|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436053|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83436054|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
83436055|NCT02987985|Hormones|hormones|mesh-ancestor
83436056|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436057|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83436058|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436059|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
83436061|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436062|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
83436063|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83436064|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83436065|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83436066|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83436067|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436068|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83436069|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83436070|NCT02987985|Analgesics|analgesics|mesh-ancestor
83436071|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83436072|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83436073|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83436074|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
83436075|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436076|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83436077|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83436078|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
83436079|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83436080|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83436081|NCT02987985|Narcotics|narcotics|mesh-ancestor
83436082|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83436083|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
83436084|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83436085|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83436086|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
83436087|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83436088|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83436089|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83436090|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
83436091|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
83436092|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
83436093|NCT02987985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83436094|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83436095|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
83436096|NCT00708721|Clofarabine|clofarabine|mesh-list
83436097|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83436098|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
83436099|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436100|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436101|NCT00087152|Capecitabine|capecitabine|mesh-list
83436102|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
83436103|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83436104|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
83436105|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436106|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436107|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83436108|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436109|NCT05362799|Metformin|metformin|mesh-list
83436110|NCT05362799|Letrozole|letrozole|mesh-list
83436111|NCT05362799|Lactitol|lactitol|mesh-list
83436112|NCT05362799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83436113|NCT05362799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436114|NCT05362799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436115|NCT05362799|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83436116|NCT05362799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83436117|NCT05362799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436118|NCT05362799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436119|NCT05362799|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83436120|NCT05362799|Hormone Antagonists|hormone antagonists|mesh-ancestor
83436121|NCT05362799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436122|NCT05362799|Cathartics|cathartics|mesh-ancestor
83436123|NCT05362799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83436124|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
83436125|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83436126|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83436127|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436128|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
83436129|NCT01940523|Coagulants|coagulants|mesh-ancestor
83436130|NCT04403282|Eflornithine|eflornithine|mesh-list
83436131|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436132|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83436133|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83436134|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83436135|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436136|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83436137|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436138|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436139|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
83436140|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83436141|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
83436142|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
83436143|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436144|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436145|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83436146|NCT02994433|Analgesics|analgesics|mesh-ancestor
83436147|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
83436148|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436149|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83436150|NCT04388189|Bupropion|bupropion|mesh-list
83436151|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83436152|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
83436153|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83436154|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83436155|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83436156|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83436157|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436158|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
83436159|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436160|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436161|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83436162|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83436163|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436164|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83436165|NCT04388189|Analgesics|analgesics|mesh-ancestor
83436166|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
83436167|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436168|NCT00599053|Azithromycin|azithromycin|mesh-list
83436169|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83436170|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436171|NCT01941927|Trametinib|trametinib|mesh-list
83436172|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436173|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83436174|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436175|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436176|NCT05220917|Insulin|insulin|mesh-list
83436177|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83436178|NCT05220917|Metformin|metformin|mesh-list
83436179|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
83436180|NCT05220917|Pioglitazone|pioglitazone|mesh-list
83436181|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83436182|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
83436183|NCT05220917|Liraglutide|liraglutide|mesh-list
83436184|NCT05220917|Empagliflozin|empagliflozin|mesh-list
83436185|NCT05220917|Exenatide|exenatide|mesh-list
83436186|NCT05220917|Glimepiride|glimepiride|mesh-list
83436187|NCT05220917|Linagliptin|linagliptin|mesh-list
83436188|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
83436189|NCT05220917|Canagliflozin|canagliflozin|mesh-list
83436190|NCT05220917|Saxagliptin|saxagliptin|mesh-list
83436191|NCT05220917|Alogliptin|alogliptin|mesh-list
83436192|NCT05220917|Dulaglutide|dulaglutide|mesh-list
83436193|NCT05220917|Glyburide|glyburide|mesh-list
83436194|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
83436195|NCT05220917|Lixisenatide|lixisenatide|mesh-list
83436196|NCT05220917|Glipizide|glipizide|mesh-list
83436197|NCT05220917|Xultophy|xultophy|mesh-list
83436198|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83436199|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83436200|NCT05220917|Simvastatin|simvastatin|mesh-list
83436201|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
83436202|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83436203|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436204|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83436205|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83436206|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
83436207|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436208|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83436209|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83436210|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436211|NCT05220917|Incretins|incretins|mesh-ancestor
83436212|NCT05220917|Hormones|hormones|mesh-ancestor
83436213|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436214|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
83436215|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83436216|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83436217|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83436218|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
83436219|NCT00086996|Fluorouracil|fluorouracil|mesh-list
83436220|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
83436221|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
83436222|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436223|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83436224|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436225|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83436226|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
83436227|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436228|NCT01943565|Hydromorphone|hydromorphone|mesh-list
83436229|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436230|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436231|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83436232|NCT01943565|Narcotics|narcotics|mesh-ancestor
83436233|NCT01943565|Analgesics|analgesics|mesh-ancestor
83436234|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
83436235|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436236|NCT03316859|Naloxegol|naloxegol|mesh-list
83436237|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83436238|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436239|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
83436240|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436241|NCT04401878|Lidocaine|lidocaine|mesh-list
83436242|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
83436243|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
83436244|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436245|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436246|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
83436247|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436248|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83436249|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83436250|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83436251|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83436252|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436253|NCT05362019|Norethindrone|norethindrone|mesh-list
83436254|NCT05362019|Norethindrone enanthate|norethindrone enanthate|mesh-list
83436255|NCT05362019|Norethindrone Acetate|norethindrone acetate|mesh-list
83436256|NCT05362019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83436257|NCT05362019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83436258|NCT05362019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83436259|NCT05362019|Contraceptive Agents|contraceptive agents|mesh-ancestor
83436260|NCT05362019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83436261|NCT05362019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436262|NCT05362019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83436263|NCT05362019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83436264|NCT03654105|Aspirin|aspirin|mesh-list
83436265|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83436266|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83436267|NCT03654105|Analgesics|analgesics|mesh-ancestor
83436268|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
83436269|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436270|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436271|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83436272|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83436273|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83436274|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83436275|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436276|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83436277|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83436278|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436279|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
83436280|NCT04388111|Morphine|morphine|mesh-list
83436281|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83436282|NCT04388111|Narcotics|narcotics|mesh-ancestor
83436283|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436284|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436286|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
83436287|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436288|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
83436289|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83436290|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436291|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
83436292|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
83436293|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
83436294|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
83436295|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436296|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436297|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
83436298|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436299|NCT01944423|Cycloserine|cycloserine|mesh-list
83436300|NCT01944423|Nicotine|nicotine|mesh-list
83436301|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83436302|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
83436303|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436304|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436305|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83436306|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83436307|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
83436308|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436309|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436310|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83436311|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436312|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83436313|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
83436314|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83436315|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
83436316|NCT05305313|Propofol|propofol|mesh-list
83436317|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83436318|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436319|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436320|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83436321|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
83436322|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
83436323|NCT00600925|Gentamicins|gentamicins|mesh-list
83436324|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83436325|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436326|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83436327|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436328|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436329|NCT02338973|Interferons|interferons|mesh-list
83436330|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
83436331|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436332|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
83436333|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436334|NCT00601627|Gemcitabine|gemcitabine|mesh-list
83436335|NCT00601627|Fluorouracil|fluorouracil|mesh-list
83436336|NCT00601627|Capecitabine|capecitabine|mesh-list
83436337|NCT00601627|Panitumumab|panitumumab|mesh-list
83436338|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83436339|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
83436340|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436341|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436342|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83436343|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
83436344|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436345|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83436346|NCT01947153|Metformin|metformin|mesh-list
83436347|NCT01947153|Linagliptin|linagliptin|mesh-list
83436348|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83436349|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436350|NCT01947153|Incretins|incretins|mesh-ancestor
83436351|NCT01947153|Hormones|hormones|mesh-ancestor
83436352|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436353|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83436354|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
83436355|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436356|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436357|NCT02476409|Tolvaptan|tolvaptan|mesh-list
83436358|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83436359|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436360|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
83436361|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436362|NCT01269853|Bevacizumab|bevacizumab|mesh-list
83436363|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83436364|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436365|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83436366|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83436367|NCT01269853|Growth Substances|growth substances|mesh-ancestor
83436368|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436369|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
83436370|NCT02993575|Floxacillin|floxacillin|mesh-list
83436371|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83436372|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436374|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
83436375|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436376|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436377|NCT01886937|Phentermine|phentermine|mesh-list
83436378|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83436379|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436380|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
83436381|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83436382|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
83436383|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
83436384|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436385|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
83436386|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436387|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436388|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
83436389|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83436390|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83436391|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436392|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
83436393|NCT02993341|Coagulants|coagulants|mesh-ancestor
83436394|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
83436395|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83436396|NCT01219075|Estrogens|estrogens|mesh-ancestor
83436397|NCT01219075|Hormones|hormones|mesh-ancestor
83436398|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436399|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436400|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
83436401|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
83436402|NCT02987907|Dexamethasone|dexamethasone|mesh-list
83436403|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83436404|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
83436405|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
83436406|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436407|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436408|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83436409|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
83436410|NCT02987907|Hormones|hormones|mesh-ancestor
83436411|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436412|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83436413|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436414|NCT01887171|Tacrolimus|tacrolimus|mesh-list
83436415|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83436416|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
83436417|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436418|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83436419|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436420|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436421|NCT00713479|Varenicline|varenicline|mesh-list
83436422|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83436423|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83436424|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
83436425|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436426|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436427|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436428|NCT03467750|Ketorolac|ketorolac|mesh-list
83436429|NCT03467750|Morphine|morphine|mesh-list
83436430|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83436431|NCT03467750|Narcotics|narcotics|mesh-ancestor
83436432|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436433|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436434|NCT03467750|Analgesics|analgesics|mesh-ancestor
83436435|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
83436436|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436437|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83436438|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83436439|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83436440|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83436441|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83436442|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436443|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436444|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
83436445|NCT04402580|Rituximab|rituximab|mesh-list
83436446|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83436447|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436448|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
83436449|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436450|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83436451|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83436452|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83436453|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
83436454|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83436455|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436456|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436457|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436458|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
83436459|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436460|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436461|NCT02987751|Insulin|insulin|mesh-list
83436462|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
83436463|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83436464|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436465|NCT04385719|Remdesivir|remdesivir|mesh-list
83436466|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
83436467|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436468|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
83436469|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436470|NCT00082628|Hormones|hormones|mesh-list
83436471|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436472|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436473|NCT01275859|Letrozole|letrozole|mesh-list
83436474|NCT01275859|Lapatinib|lapatinib|mesh-list
83436475|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436476|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83436477|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83436478|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436479|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436480|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83436481|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
83436482|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436483|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436484|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83436486|NCT01950039|Glycine|glycine|mesh-list
83436487|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
83436488|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436489|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436490|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436491|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83436492|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
83436493|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83436494|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
83436495|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83436496|NCT01275937|Esomeprazole|esomeprazole|mesh-list
83436497|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83436498|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83436499|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83436500|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436501|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436502|NCT02990455|Nicotine|nicotine|mesh-list
83436503|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83436504|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
83436505|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436506|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436507|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83436508|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83436509|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
83436510|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436511|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436512|NCT01889667|Insulin|insulin|mesh-list
83436513|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83436514|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83436515|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436516|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
83436517|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83436518|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83436519|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83436520|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83436521|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436522|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
83436523|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436524|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436525|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83436526|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436527|NCT02130635|Nemiralisib|nemiralisib|mesh-list
83436528|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83436529|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436530|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436531|NCT01276093|Amiodarone|amiodarone|mesh-list
83436532|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83436533|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
83436534|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83436535|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83436536|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436537|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83436538|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83436539|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83436540|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436541|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83436542|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83436543|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83436544|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
83436545|NCT00557973|Baclofen|baclofen|mesh-list
83436546|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83436547|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436548|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83436549|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436550|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83436551|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
83436552|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
83436553|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436554|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436555|NCT00726739|Aldesleukin|aldesleukin|mesh-list
83436556|NCT00726739|Interleukin-2|interleukin-2|mesh-list
83436557|NCT00726739|Vaccines|vaccines|mesh-list
83436558|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
83436559|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436560|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436561|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83436562|NCT00726739|Analgesics|analgesics|mesh-ancestor
83436563|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
83436564|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436565|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83436566|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83436567|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
83436568|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436569|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83436570|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
83436571|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436572|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
83436573|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83436574|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83436575|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
83436576|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436577|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436578|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436579|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83436580|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
83436581|NCT02991781|Varenicline|varenicline|mesh-list
83436582|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83436583|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83436584|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
83436585|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436586|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436587|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436589|NCT01893801|Cisplatin|cisplatin|mesh-list
83436590|NCT01893801|Gemcitabine|gemcitabine|mesh-list
83436591|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83436592|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436593|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
83436594|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
83436595|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
83436596|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436597|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83436598|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
83436599|NCT00570089|Ranolazine|ranolazine|mesh-list
83436600|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83436601|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83436602|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436603|NCT00727597|Efavirenz|efavirenz|mesh-list
83436604|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
83436605|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83436606|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83436607|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436608|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436609|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
83436610|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436611|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83436612|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83436613|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83436614|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83436615|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83436616|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83436617|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83436618|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83436619|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
83436620|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83436621|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83436622|NCT00571259|Gentamicins|gentamicins|mesh-list
83436623|NCT00571259|Heparin|heparin|mesh-list
83436624|NCT00571259|Citric Acid|citric acid|mesh-list
83436625|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
83436626|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
83436627|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83436628|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
83436629|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
83436630|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436631|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83436632|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83436633|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83436634|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436635|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83436636|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436637|NCT01893879|Ketoprofen|ketoprofen|mesh-list
83436638|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83436639|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83436640|NCT01893879|Analgesics|analgesics|mesh-ancestor
83436641|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
83436642|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436643|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436644|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83436645|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83436646|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83436647|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436648|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436649|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
83436650|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83436651|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
83436652|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83436653|NCT00571493|Cytarabine|cytarabine|mesh-list
83436654|NCT00571493|Etoposide|etoposide|mesh-list
83436655|NCT00571493|Bortezomib|bortezomib|mesh-list
83436656|NCT00571493|Melphalan|melphalan|mesh-list
83436657|NCT00571493|Carmustine|carmustine|mesh-list
83436658|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83436659|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436660|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83436661|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83436662|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436663|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436664|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83436665|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
83436666|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
83436667|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436668|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83436669|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
83436670|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436671|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83436672|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
83436673|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83436674|NCT00571961|Ritonavir|ritonavir|mesh-list
83436675|NCT00571961|Lopinavir|lopinavir|mesh-list
83436676|NCT00571961|Buprenorphine|buprenorphine|mesh-list
83436677|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83436678|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83436679|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
83436680|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436681|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436682|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83436683|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83436684|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
83436685|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436686|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83436687|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83436688|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83436689|NCT00571961|Narcotics|narcotics|mesh-ancestor
83436690|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436691|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436692|NCT00571961|Analgesics|analgesics|mesh-ancestor
83436693|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
83436694|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436695|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83436697|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
83436698|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83436699|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436700|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
83436701|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83436702|NCT01895127|Antibodies|antibodies|mesh-list
83436703|NCT01895127|Eculizumab|eculizumab|mesh-list
83436704|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
83436705|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436706|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83436707|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83436708|NCT01953081|Metoclopramide|metoclopramide|mesh-list
83436709|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
83436710|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
83436711|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436712|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436713|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83436714|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83436715|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83436716|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
83436717|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436718|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436719|NCT00572897|Fludarabine|fludarabine|mesh-list
83436720|NCT00572897|Melphalan|melphalan|mesh-list
83436721|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436722|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436723|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83436724|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
83436725|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436726|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83436727|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
83436728|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83436729|NCT01276717|Vorinostat|vorinostat|mesh-list
83436730|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436731|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83436732|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436733|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436734|NCT02991157|Nimodipine|nimodipine|mesh-list
83436735|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83436736|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83436737|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83436738|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436739|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83436740|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436741|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
83436742|NCT04386499|Folic Acid|folic acid|mesh-list
83436743|NCT04386499|Resveratrol|resveratrol|mesh-list
83436744|NCT04386499|Hematinics|hematinics|mesh-ancestor
83436745|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
83436746|NCT04386499|Vitamins|vitamins|mesh-ancestor
83436747|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
83436748|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436749|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
83436750|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436751|NCT04386499|Protective Agents|protective agents|mesh-ancestor
83436752|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436753|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83436754|NCT00573287|Risperidone|risperidone|mesh-list
83436755|NCT00573287|Clozapine|clozapine|mesh-list
83436756|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83436757|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
83436758|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436759|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436760|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436761|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83436762|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83436763|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436764|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83436765|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83436766|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
83436767|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
83436768|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
83436769|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
83436770|NCT01896921|Dolutegravir|dolutegravir|mesh-list
83436771|NCT01896921|Maraviroc|maraviroc|mesh-list
83436772|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83436773|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83436774|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
83436775|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436776|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83436777|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83436778|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436779|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436780|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83436781|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83436782|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83436784|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
83436785|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
83436786|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436787|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436788|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
83436789|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436790|NCT02991937|Tazobactam|tazobactam|mesh-list
83436791|NCT02991937|Piperacillin|piperacillin|mesh-list
83436792|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83436793|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83436794|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436795|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83436796|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436797|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436798|NCT00420667|Enoxaparin|enoxaparin|mesh-list
83436799|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
83436800|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83436801|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83436802|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436803|NCT01277107|Zaleplon|zaleplon|mesh-list
83436804|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
83436805|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83436806|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436807|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436808|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
83436809|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
83436810|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436811|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436812|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
83436813|NCT01277185|Calcium|calcium|mesh-list
83436814|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83436815|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436816|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83436817|NCT01274533|Lenalidomide|lenalidomide|mesh-list
83436818|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
83436819|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436820|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83436821|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83436822|NCT01274533|Growth Substances|growth substances|mesh-ancestor
83436823|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
83436824|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436825|NCT01277497|Calcium|calcium|mesh-list
83436826|NCT01277497|Sevelamer|sevelamer|mesh-list
83436827|NCT01277497|Calcium acetate|calcium acetate|mesh-list
83436828|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83436829|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436830|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
83436831|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
83436832|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436833|NCT05735535|Antiviral Agents|antiviral agents|mesh-list
83436834|NCT05735535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436835|NCT01270087|Adalimumab|adalimumab|mesh-list
83436836|NCT01270087|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83436837|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83436838|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83436839|NCT01958073|Estradiol|estradiol|mesh-list
83436840|NCT01958073|Estrogens|estrogens|mesh-list
83436841|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83436842|NCT01958073|Hormones|hormones|mesh-ancestor
83436843|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436844|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436845|NCT01270165|Telbivudine|telbivudine|mesh-list
83436846|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
83436847|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436848|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83436849|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436850|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436851|NCT05740215|Lenvatinib|lenvatinib|mesh-list
83436852|NCT05740215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436853|NCT05740215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83436854|NCT05740215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436855|NCT05740215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436856|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
83436857|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83436858|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83436859|NCT01277731|Prednisolone|prednisolone|mesh-list
83436860|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
83436861|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83436862|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
83436863|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83436864|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
83436865|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
83436866|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436867|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436868|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83436869|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
83436870|NCT01277731|Hormones|hormones|mesh-ancestor
83436871|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436872|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83436873|NCT01277731|Protective Agents|protective agents|mesh-ancestor
83436874|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83436875|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436876|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83436877|NCT05735379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83436878|NCT05735379|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83436879|NCT05735379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436880|NCT05735379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436881|NCT05735379|Cholinergic Agents|cholinergic agents|mesh-ancestor
83436882|NCT05735379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436883|NCT05735379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436884|NCT00751777|Vaccines|vaccines|mesh-list
83436885|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
83436886|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436887|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83436888|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
83436889|NCT01902459|Coagulants|coagulants|mesh-ancestor
83436890|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
83436891|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83436892|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83436893|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83436894|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83436895|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436896|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
83436897|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436898|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436899|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83436900|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436901|NCT05735145|Paclitaxel|paclitaxel|mesh-list
83436902|NCT05735145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83436903|NCT05735145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83436904|NCT05735145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436905|NCT05735145|Tubulin Modulators|tubulin modulators|mesh-ancestor
83436906|NCT05735145|Antimitotic Agents|antimitotic agents|mesh-ancestor
83436907|NCT05735145|Mitosis Modulators|mitosis modulators|mesh-ancestor
83436908|NCT05735145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436909|NCT01903005|Buprenorphine|buprenorphine|mesh-list
83436910|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83436911|NCT01903005|Naloxone|naloxone|mesh-list
83436912|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83436913|NCT01903005|Narcotics|narcotics|mesh-ancestor
83436914|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436915|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436916|NCT01903005|Analgesics|analgesics|mesh-ancestor
83436917|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
83436918|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436919|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83436920|NCT00614029|Sumatriptan|sumatriptan|mesh-list
83436921|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83436922|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83436923|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83436924|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
83436925|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83436926|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436927|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436928|NCT01905423|Albendazole|albendazole|mesh-list
83436929|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
83436930|NCT01905423|Piperazine|piperazine|mesh-list
83436931|NCT01905423|Mebendazole|mebendazole|mesh-list
83436932|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
83436933|NCT01905423|Citric Acid|citric acid|mesh-list
83436934|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
83436935|NCT01905423|DMP 777|dmp 777|mesh-list
83436936|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
83436937|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83436938|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
83436939|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
83436940|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436941|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
83436942|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83436943|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83436944|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
83436945|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83436946|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83436947|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
83436948|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
83436949|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
83436950|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436951|NCT01905423|Filaricides|filaricides|mesh-ancestor
83436952|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
83436953|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83436954|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436955|NCT05734911|Niraparib|niraparib|mesh-list
83436956|NCT05734911|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83436957|NCT05734911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436958|NCT05734911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436959|NCT05734911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436960|NCT01906515|Chrysarobin|chrysarobin|mesh-list
83436961|NCT01906515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83436962|NCT01906515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83436963|NCT01906515|Analgesics|analgesics|mesh-ancestor
83436964|NCT01906515|Sensory System Agents|sensory system agents|mesh-ancestor
83436965|NCT01906515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436966|NCT01906515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436967|NCT01906515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83436968|NCT01906515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83436969|NCT00730483|Doxorubicin|doxorubicin|mesh-list
83436970|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83436971|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83436972|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436973|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83436974|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83436975|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436976|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436977|NCT01907607|Palbociclib|palbociclib|mesh-list
83436978|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436979|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83436980|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83436981|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436983|NCT00753337|Trace Elements|trace elements|mesh-ancestor
83436984|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
83436985|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436986|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
83436987|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83436988|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
83436989|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
83436990|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83436991|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436992|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83436993|NCT01911351|Analgesics|analgesics|mesh-ancestor
83436994|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
83436995|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83436996|NCT04385407|Ribavirin|ribavirin|mesh-list
83436997|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
83436998|NCT04385407|Simeprevir|simeprevir|mesh-list
83436999|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
83437000|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437001|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
83437002|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437003|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
83437004|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437005|NCT00573989|Pemetrexed|pemetrexed|mesh-list
83437006|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83437007|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437008|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437009|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437010|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83437011|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83437012|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83437013|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
83437014|NCT02286921|Testosterone|testosterone|mesh-list
83437015|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
83437016|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
83437017|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83437018|NCT02286921|Androgens|androgens|mesh-ancestor
83437019|NCT02286921|Hormones|hormones|mesh-ancestor
83437020|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437021|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437022|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83437023|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437024|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
83437025|NCT00574067|Buprenorphine|buprenorphine|mesh-list
83437026|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83437027|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83437028|NCT00574067|Narcotics|narcotics|mesh-ancestor
83437029|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437030|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437031|NCT00574067|Analgesics|analgesics|mesh-ancestor
83437032|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
83437033|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437035|NCT05734443|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83437036|NCT05734443|Luteolytic Agents|luteolytic agents|mesh-ancestor
83437037|NCT05734443|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83437038|NCT05734443|Contraceptive Agents|contraceptive agents|mesh-ancestor
83437039|NCT05734443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83437040|NCT05734443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437041|NCT05734443|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83437042|NCT05734443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83437043|NCT05734443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437044|NCT01913535|Aticaprant|aticaprant|mesh-list
83437045|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83437046|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437047|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
83437048|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437049|NCT01914159|Ranibizumab|ranibizumab|mesh-list
83437050|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83437051|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83437052|NCT01914159|Growth Substances|growth substances|mesh-ancestor
83437053|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437054|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
83437055|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437056|NCT00576251|Tobramycin|tobramycin|mesh-list
83437057|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
83437058|NCT00576251|Dexamethasone|dexamethasone|mesh-list
83437059|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83437060|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
83437061|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
83437062|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437063|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437064|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83437065|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
83437066|NCT00576251|Hormones|hormones|mesh-ancestor
83437067|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437068|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83437069|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437070|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83437071|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437072|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83437073|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83437074|NCT00578279|Ethanol|ethanol|mesh-list
83437075|NCT00578279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83437076|NCT00578279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437077|NCT00578279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437078|NCT00578279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437079|NCT00578669|Fluoxetine|fluoxetine|mesh-list
83437080|NCT00578669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83437081|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83437082|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83437083|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437084|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437085|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
83437086|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437087|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83437088|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
83437089|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83437090|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83437091|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83437092|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437093|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
83437095|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
83437096|NCT00578903|Tacrolimus|tacrolimus|mesh-list
83437097|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83437098|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
83437099|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437100|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83437101|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83437102|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
83437103|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437104|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437105|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83437106|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83437107|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
83437108|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83437109|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83437110|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
83437111|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
83437112|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437113|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83437114|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83437115|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83437116|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83437117|NCT01918761|Pemetrexed|pemetrexed|mesh-list
83437118|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437119|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437120|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437121|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83437122|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83437123|NCT00579137|Fludarabine|fludarabine|mesh-list
83437124|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
83437125|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437126|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83437127|NCT00580073|Leucovorin|leucovorin|mesh-list
83437128|NCT00580073|Fluorouracil|fluorouracil|mesh-list
83437129|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
83437130|NCT00580073|Cetuximab|cetuximab|mesh-list
83437131|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
83437132|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437133|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83437134|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437135|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83437136|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
83437137|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437138|NCT00580073|Antidotes|antidotes|mesh-ancestor
83437139|NCT00580073|Protective Agents|protective agents|mesh-ancestor
83437140|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
83437141|NCT00580073|Vitamins|vitamins|mesh-ancestor
83437142|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
83437143|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83437144|NCT00580151|Clonidine|clonidine|mesh-list
83437145|NCT00580151|Analgesics|analgesics|mesh-ancestor
83437146|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
83437147|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437148|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437149|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83437151|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
83437152|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83437153|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83437154|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83437155|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
83437156|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437157|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437158|NCT01919697|Plecanatide|plecanatide|mesh-list
83437159|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83437160|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
83437161|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437162|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83437163|NCT00580229|Prednisone|prednisone|mesh-list
83437164|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83437165|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
83437166|NCT00580229|Hormones|hormones|mesh-ancestor
83437167|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437168|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437169|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83437170|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437171|NCT00580853|Bupropion|bupropion|mesh-list
83437172|NCT00580853|Varenicline|varenicline|mesh-list
83437173|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83437174|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
83437175|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83437176|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83437177|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83437178|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83437179|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437180|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
83437181|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437182|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437183|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83437184|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83437185|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437186|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83437187|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83437188|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
83437189|NCT05739045|Nivolumab|nivolumab|mesh-list
83437190|NCT05739045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83437191|NCT05739045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437192|NCT05739045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83437193|NCT05739045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437194|NCT00604019|Dopamine|dopamine|mesh-list
83437195|NCT00604019|Norepinephrine|norepinephrine|mesh-list
83437196|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83437197|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83437198|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
83437199|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437200|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437201|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437202|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
83437203|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
83437204|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437205|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83437206|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83437207|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
83437208|NCT00604019|Protective Agents|protective agents|mesh-ancestor
83437209|NCT01922115|Trospium chloride|trospium chloride|mesh-list
83437210|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
83437211|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
83437212|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437213|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437214|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83437215|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83437216|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
83437217|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437218|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437219|NCT01922115|Urological Agents|urological agents|mesh-ancestor
83437220|NCT00081770|Ribavirin|ribavirin|mesh-list
83437221|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83437222|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
83437223|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83437224|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
83437225|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437226|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
83437227|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437228|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
83437230|NCT05731323|Cycloserine|cycloserine|mesh-list
83437231|NCT05731323|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83437232|NCT05731323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437233|NCT05731323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83437234|NCT05731323|Antitubercular Agents|antitubercular agents|mesh-ancestor
83437235|NCT05731323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83437236|NCT05731323|Antimetabolites|antimetabolites|mesh-ancestor
83437237|NCT05731323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437238|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83437239|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83437240|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
83437241|NCT00605423|Hormones|hormones|mesh-ancestor
83437242|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437243|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437244|NCT01923129|Prazosin|prazosin|mesh-list
83437245|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83437246|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83437247|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83437248|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83437249|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
83437250|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437251|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437252|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437253|NCT00581867|Insulin|insulin|mesh-list
83437254|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83437255|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
83437256|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83437257|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437258|NCT01925469|Benzocaine|benzocaine|mesh-list
83437259|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
83437260|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
83437261|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437262|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437263|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
83437264|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437265|NCT01925781|Nicotine|nicotine|mesh-list
83437266|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83437267|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
83437268|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437269|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437271|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83437272|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
83437273|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437274|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437275|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83437276|NCT01927887|Hematinics|hematinics|mesh-ancestor
83437277|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83437278|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83437279|NCT00081458|Teduglutide|teduglutide|mesh-list
83437280|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83437281|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83437282|NCT00081458|Protective Agents|protective agents|mesh-ancestor
83437283|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437284|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
83437285|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
83437286|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
83437287|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437288|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437289|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83437290|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83437291|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83437292|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437293|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83437294|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83437295|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
83437296|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437297|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437298|NCT01929291|Vaccines|vaccines|mesh-list
83437299|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
83437300|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437301|NCT01929759|Tenofovir|tenofovir|mesh-list
83437302|NCT01929759|Emtricitabine|emtricitabine|mesh-list
83437303|NCT01929759|Cobicistat|cobicistat|mesh-list
83437304|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83437306|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
83437307|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437308|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83437309|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83437310|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437311|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437312|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83437313|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83437314|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83437315|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83437316|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83437317|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
83437318|NCT03437330|Empagliflozin|empagliflozin|mesh-list
83437319|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83437320|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437321|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83437322|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437323|NCT01271803|Vemurafenib|vemurafenib|mesh-list
83437324|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437325|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83437326|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437327|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437328|NCT00585377|Bevacizumab|bevacizumab|mesh-list
83437329|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83437330|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83437331|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437332|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83437333|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83437334|NCT00585377|Growth Substances|growth substances|mesh-ancestor
83437335|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437336|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
83437337|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83437338|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437339|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437340|NCT00080288|Modafinil|modafinil|mesh-list
83437341|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83437342|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437343|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83437344|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83437345|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83437346|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437347|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
83437348|NCT00610883|Methotrexate|methotrexate|mesh-list
83437349|NCT00610883|Asparaginase|asparaginase|mesh-list
83437350|NCT00610883|Daunorubicin|daunorubicin|mesh-list
83437351|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83437352|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
83437353|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437354|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83437355|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83437356|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
83437357|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437358|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437359|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83437360|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83437361|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
83437362|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83437363|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83437364|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
83437365|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
83437366|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437367|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83437368|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83437369|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83437370|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83437371|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83437372|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
83437373|NCT03084380|Fludarabine|fludarabine|mesh-list
83437374|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83437375|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
83437376|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437377|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83437378|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83437379|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
83437380|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437381|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437382|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83437383|NCT00084344|Afimoxifene|afimoxifene|mesh-list
83437384|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437385|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83437386|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
83437387|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437388|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437389|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83437390|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83437391|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
83437392|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
83437393|NCT00611351|Busulfan|busulfan|mesh-list
83437394|NCT00611351|Tacrolimus|tacrolimus|mesh-list
83437395|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83437396|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83437397|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
83437398|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437399|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83437400|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83437401|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
83437402|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437403|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437404|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83437405|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83437406|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437407|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83437408|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83437409|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
83437410|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83437411|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437412|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
83437413|NCT00611897|Ketamine|ketamine|mesh-list
83437414|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83437415|NCT00611897|Analgesics|analgesics|mesh-ancestor
83437416|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
83437417|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437418|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437419|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83437420|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83437421|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
83437422|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
83437423|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437424|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83437425|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83437426|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437427|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437428|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
83437429|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437430|NCT00611897|Expectorants|expectorants|mesh-ancestor
83437431|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
83437432|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83437433|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
83437434|NCT00611897|Protective Agents|protective agents|mesh-ancestor
83437435|NCT00611897|Antidotes|antidotes|mesh-ancestor
83437436|NCT05711823|Dexamethasone|dexamethasone|mesh-list
83437437|NCT05711823|Dexamethasone acetate|dexamethasone acetate|mesh-list
83437438|NCT05711823|Aprepitant|aprepitant|mesh-list
83437440|NCT05711823|BB 1101|bb 1101|mesh-list
83437441|NCT05711823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83437442|NCT05711823|Antiemetics|antiemetics|mesh-ancestor
83437443|NCT05711823|Autonomic Agents|autonomic agents|mesh-ancestor
83437444|NCT05711823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437445|NCT05711823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437446|NCT05711823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83437447|NCT05711823|Glucocorticoids|glucocorticoids|mesh-ancestor
83437448|NCT05711823|Hormones|hormones|mesh-ancestor
83437449|NCT05711823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437450|NCT05711823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83437451|NCT05711823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437452|NCT05711823|Protease Inhibitors|protease inhibitors|mesh-ancestor
83437453|NCT05711823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437454|NCT05711823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437455|NCT05711823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83437456|NCT05711823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437457|NCT05711823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83437458|NCT05711823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83437459|NCT05711823|Serotonin Agents|serotonin agents|mesh-ancestor
83437460|NCT03080324|Fentanyl|fentanyl|mesh-list
83437461|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83437462|NCT03080324|Narcotics|narcotics|mesh-ancestor
83437463|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437464|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437465|NCT03080324|Analgesics|analgesics|mesh-ancestor
83437466|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
83437467|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437468|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83437469|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83437470|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
83437471|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
83437472|NCT03083834|Cosyntropin|cosyntropin|mesh-list
83437473|NCT03083834|Hormones|hormones|mesh-ancestor
83437474|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437475|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437476|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
83437477|NCT03404180|Propofol|propofol|mesh-list
83437478|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83437479|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437480|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437481|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83437482|NCT03404180|Analgesics|analgesics|mesh-ancestor
83437483|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
83437484|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437485|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83437486|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83437487|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83437488|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
83437489|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437490|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437491|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83437492|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
83437493|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
83437494|NCT02780609|Dexamethasone|dexamethasone|mesh-list
83437495|NCT02780609|Melphalan|melphalan|mesh-list
83437496|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
83437497|NCT02780609|Aprepitant|aprepitant|mesh-list
83437498|NCT02780609|Antiemetics|antiemetics|mesh-list
83437499|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83437500|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
83437501|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437502|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437503|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83437504|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
83437505|NCT02780609|Hormones|hormones|mesh-ancestor
83437506|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437507|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83437508|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437509|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83437510|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
83437511|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437512|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83437513|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83437514|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
83437515|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83437516|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437517|NCT03086096|Irinotecan|irinotecan|mesh-list
83437518|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83437519|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83437520|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437521|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437522|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437523|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83437524|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83437525|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83437526|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437527|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437528|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83437529|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83437530|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83437531|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83437532|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
83437533|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437534|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437535|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83437536|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83437537|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
83437538|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83437539|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83437540|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
83437541|NCT05346146|Paclitaxel|paclitaxel|mesh-list
83437543|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83437544|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437545|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
83437546|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
83437547|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
83437548|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437549|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83437550|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
83437551|NCT00613379|Leronlimab|leronlimab|mesh-list
83437552|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
83437553|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83437554|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83437555|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437556|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83437557|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83437558|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
83437559|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437560|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
83437561|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437562|NCT01271725|Paclitaxel|paclitaxel|mesh-list
83437563|NCT01271725|Vinorelbine|vinorelbine|mesh-list
83437564|NCT01271725|Afatinib|afatinib|mesh-list
83437565|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83437566|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437567|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
83437568|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
83437569|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
83437570|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437571|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83437572|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437573|NCT00587483|Lidocaine|lidocaine|mesh-list
83437574|NCT00587483|Amiodarone|amiodarone|mesh-list
83437575|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
83437576|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
83437577|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437578|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437579|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
83437580|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437581|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83437582|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83437583|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83437584|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83437585|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437586|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
83437587|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83437588|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83437589|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83437590|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437591|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83437592|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83437593|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83437594|NCT03401060|Denosumab|denosumab|mesh-list
83437595|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83437596|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437597|NCT01270321|Everolimus|everolimus|mesh-list
83437598|NCT01270321|Pasireotide|pasireotide|mesh-list
83437599|NCT01270321|Somatostatin|somatostatin|mesh-list
83437600|NCT01270321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83437601|NCT01270321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83437602|NCT01270321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437603|NCT01270321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437604|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83437605|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
83437606|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437607|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437608|NCT01270321|Hormones|hormones|mesh-ancestor
83437609|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437610|NCT03400826|Simvastatin|simvastatin|mesh-list
83437611|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83437612|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83437613|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
83437614|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437615|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83437616|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83437617|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437618|NCT01271023|Insulin|insulin|mesh-list
83437619|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83437620|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437621|NCT03086486|Linezolid|linezolid|mesh-list
83437622|NCT03086486|Bedaquiline|bedaquiline|mesh-list
83437623|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83437624|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437625|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83437626|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437627|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437628|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
83437629|NCT02287779|Volixibat|volixibat|mesh-list
83437630|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83437631|NCT00732901|Escitalopram|escitalopram|mesh-list
83437632|NCT00732901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83437633|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83437634|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83437635|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437636|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437637|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
83437638|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437639|NCT03083210|Lanreotide|lanreotide|mesh-list
83437640|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437641|NCT00616109|Sunitinib|sunitinib|mesh-list
83437642|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437643|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83437644|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83437645|NCT00616109|Growth Substances|growth substances|mesh-ancestor
83437646|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437647|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
83437648|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83437649|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437650|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437651|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83437652|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
83437653|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437655|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
83437656|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437657|NCT03434678|Fentanyl|fentanyl|mesh-list
83437658|NCT03434678|Bupivacaine|bupivacaine|mesh-list
83437659|NCT03434678|Propofol|propofol|mesh-list
83437660|NCT03434678|Rocuronium|rocuronium|mesh-list
83437661|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
83437662|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
83437663|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437664|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437665|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
83437666|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437667|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83437668|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83437669|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
83437670|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83437671|NCT03434678|Narcotics|narcotics|mesh-ancestor
83437672|NCT03434678|Analgesics|analgesics|mesh-ancestor
83437673|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83437674|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83437675|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83437676|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83437678|NCT05445921|Anesthetics, Local|anesthetics, local|mesh-ancestor
83437679|NCT05445921|Anesthetics|anesthetics|mesh-ancestor
83437680|NCT05445921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437681|NCT05445921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437682|NCT05445921|Sensory System Agents|sensory system agents|mesh-ancestor
83437683|NCT05445921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437684|NCT03389750|Oxymorphone|oxymorphone|mesh-list
83437685|NCT03389750|Morphine|morphine|mesh-list
83437686|NCT03389750|Oxycodone|oxycodone|mesh-list
83437687|NCT03389750|Hydromorphone|hydromorphone|mesh-list
83437688|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83437689|NCT03389750|Narcotics|narcotics|mesh-ancestor
83437690|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437691|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437692|NCT03389750|Analgesics|analgesics|mesh-ancestor
83437693|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
83437694|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437695|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83437696|NCT03837873|Cytarabine|cytarabine|mesh-list
83437697|NCT03837873|Dexamethasone|dexamethasone|mesh-list
83437698|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
83437699|NCT03837873|Rituximab|rituximab|mesh-list
83437700|NCT03837873|Doxorubicin|doxorubicin|mesh-list
83437701|NCT03837873|Etoposide|etoposide|mesh-list
83437702|NCT03837873|Vincristine|vincristine|mesh-list
83437703|NCT03837873|Lenalidomide|lenalidomide|mesh-list
83437704|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83437705|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
83437706|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437707|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83437708|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83437709|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
83480676|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83437710|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437711|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437712|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83437713|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83437714|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83437715|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
83437716|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
83437717|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437718|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83437719|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
83437720|NCT03837873|Hormones|hormones|mesh-ancestor
83437721|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437722|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83437723|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83437724|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83437725|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83437726|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437727|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83437728|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83437729|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
83437730|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
83437731|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437732|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
83437733|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
83437734|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
83437735|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83437736|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83437737|NCT03837873|Growth Substances|growth substances|mesh-ancestor
83437738|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
83437739|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83437740|NCT03082742|Furosemide|furosemide|mesh-list
83437741|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83437742|NCT03082742|Diuretics|diuretics|mesh-ancestor
83437743|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
83480677|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
83437744|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437745|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83437746|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83437747|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437748|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83437749|NCT05434533|Tranexamic Acid|tranexamic acid|mesh-list
83437750|NCT05434533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83437751|NCT05434533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83437752|NCT05434533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437753|NCT05434533|Hemostatics|hemostatics|mesh-ancestor
83437754|NCT05434533|Coagulants|coagulants|mesh-ancestor
83437755|NCT03432650|Dexamethasone|dexamethasone|mesh-list
83437756|NCT03432650|Bupivacaine|bupivacaine|mesh-list
83437757|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83437759|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
83437760|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437761|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437762|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83437763|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
83437764|NCT03432650|Hormones|hormones|mesh-ancestor
83437765|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437766|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83437767|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437769|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
83437770|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437772|NCT00248833|Vaccines|vaccines|mesh-list
83437773|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
83437774|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437775|NCT00668525|Dexetimide|dexetimide|mesh-list
83437776|NCT00668525|Citalopram|citalopram|mesh-list
83437777|NCT00668525|Escitalopram|escitalopram|mesh-list
83437778|NCT00668525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83437779|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83437780|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83437781|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437782|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437783|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
83437784|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437785|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83437786|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83437787|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
83437788|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
83437789|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437790|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83437791|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83437792|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
83437793|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83437794|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
83437795|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83437796|NCT05736549|Dexamethasone|dexamethasone|mesh-list
83437797|NCT05736549|Methylprednisolone|methylprednisolone|mesh-list
83437798|NCT05736549|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83437799|NCT05736549|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83437800|NCT05736549|Prednisolone|prednisolone|mesh-list
83437801|NCT05736549|Prednisolone acetate|prednisolone acetate|mesh-list
83437802|NCT05736549|Dexamethasone acetate|dexamethasone acetate|mesh-list
83437803|NCT05736549|Bupivacaine|bupivacaine|mesh-list
83437804|NCT05736549|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83437806|NCT05736549|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83437807|NCT05736549|BB 1101|bb 1101|mesh-list
83437808|NCT05736549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83437809|NCT05736549|Antiemetics|antiemetics|mesh-ancestor
83437810|NCT05736549|Autonomic Agents|autonomic agents|mesh-ancestor
83437811|NCT05736549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437812|NCT05736549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437813|NCT05736549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83437815|NCT05736549|Hormones|hormones|mesh-ancestor
83437816|NCT05736549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437817|NCT05736549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83437818|NCT05736549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437819|NCT05736549|Anesthetics, Local|anesthetics, local|mesh-ancestor
83437820|NCT05736549|Anesthetics|anesthetics|mesh-ancestor
83437821|NCT05736549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437822|NCT05736549|Sensory System Agents|sensory system agents|mesh-ancestor
83437823|NCT05736549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83437824|NCT05736549|Protective Agents|protective agents|mesh-ancestor
83437825|NCT05736549|Protease Inhibitors|protease inhibitors|mesh-ancestor
83437826|NCT05736549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437827|NCT05736549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437828|NCT05688488|Curcumin|curcumin|mesh-list
83437829|NCT05688488|Mitomycins|mitomycins|mesh-list
83437830|NCT05688488|Mitomycin|mitomycin|mesh-list
83437831|NCT05688488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83437832|NCT05688488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437833|NCT05688488|Alkylating Agents|alkylating agents|mesh-ancestor
83437834|NCT05688488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437835|NCT05688488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83437836|NCT05688488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437837|NCT05688488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83437838|NCT05688488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83437839|NCT05688488|Analgesics|analgesics|mesh-ancestor
83437840|NCT05688488|Sensory System Agents|sensory system agents|mesh-ancestor
83437841|NCT05688488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437842|NCT05688488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437843|NCT05688488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83437844|NCT05688488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83437845|NCT00669383|Betamethasone|betamethasone|mesh-list
83437846|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83437847|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
83437848|NCT00669383|Hormones|hormones|mesh-ancestor
83437849|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437850|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437851|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83437852|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
83437853|NCT00733993|Caffeine|caffeine|mesh-list
83437854|NCT00733993|Amphetamine|amphetamine|mesh-list
83437855|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83437856|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437857|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83437858|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437859|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437860|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83437861|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83437862|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
83437863|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437864|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
83437865|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
83437866|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437867|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
83437868|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
83437869|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83437870|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83437871|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83437872|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83437873|NCT01271257|Misoprostol|misoprostol|mesh-list
83437874|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83437875|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
83437876|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83437877|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437878|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83437879|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83437880|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
83437881|NCT03082352|Metoprolol|metoprolol|mesh-list
83437882|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83437883|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83437884|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
83437885|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
83437886|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437887|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437888|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83437889|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83437890|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83437891|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
83437892|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437893|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437894|NCT03431168|Azithromycin|azithromycin|mesh-list
83437895|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83437897|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437898|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83437899|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
83437900|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83437901|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83437902|NCT05737563|Capecitabine|capecitabine|mesh-list
83437903|NCT05737563|Irinotecan|irinotecan|mesh-list
83437904|NCT05737563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83437905|NCT05737563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83437906|NCT05737563|Antimetabolites|antimetabolites|mesh-ancestor
83437907|NCT05737563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437908|NCT05737563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437909|NCT05737563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83437910|NCT05737563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83437911|NCT05737563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437912|NCT05737563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83437913|NCT03398252|Doxazosin|doxazosin|mesh-list
83437915|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83437916|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83437917|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83437918|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
83437919|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437920|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437921|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437922|NCT02285283|Itraconazole|itraconazole|mesh-list
83437923|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
83437924|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437925|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83437926|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83437927|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437928|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437929|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83437930|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
83437931|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437932|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437933|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83437934|NCT05688098|Amlodipine|amlodipine|mesh-list
83437935|NCT05688098|Irbesartan|irbesartan|mesh-list
83437936|NCT05688098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83437937|NCT05688098|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83437938|NCT05688098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83437939|NCT05688098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437940|NCT05688098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83437941|NCT05688098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437942|NCT05688098|Vasodilator Agents|vasodilator agents|mesh-ancestor
83480678|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437943|NCT05688098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83437944|NCT05688098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83437946|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83437947|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
83437948|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437949|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
83437950|NCT03429140|Protective Agents|protective agents|mesh-ancestor
83437951|NCT03081494|Spartalizumab|spartalizumab|mesh-list
83437952|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480679|NCT03504397|Antidotes|antidotes|mesh-ancestor
83480680|NCT03504397|Protective Agents|protective agents|mesh-ancestor
83480681|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
83480683|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
83480684|NCT03504397|Hematinics|hematinics|mesh-ancestor
83480685|NCT03498716|Paclitaxel|paclitaxel|mesh-list
83480686|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
83480687|NCT03498716|Doxorubicin|doxorubicin|mesh-list
83480688|NCT03498716|Atezolizumab|atezolizumab|mesh-list
83480689|NCT03498716|Epirubicin|epirubicin|mesh-list
83480690|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83480691|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480692|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
83480693|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
83480694|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
83480695|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480696|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480697|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
83480698|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480699|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480700|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83480701|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
83480702|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83480703|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83480704|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83480705|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83480706|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480707|NCT03498716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480708|NCT03498716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480709|NCT03429543|Empagliflozin|empagliflozin|mesh-list
83480710|NCT03429543|Linagliptin|linagliptin|mesh-list
83480711|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83480712|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480713|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83480714|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480715|NCT03429543|Incretins|incretins|mesh-ancestor
83480716|NCT03429543|Hormones|hormones|mesh-ancestor
83480717|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480718|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83480719|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
83480720|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480721|NCT03417544|Trastuzumab|trastuzumab|mesh-list
83480722|NCT03417544|Atezolizumab|atezolizumab|mesh-list
83480723|NCT03417544|Pertuzumab|pertuzumab|mesh-list
83480724|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480725|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480726|NCT03417544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480727|NCT03417544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480728|NCT03363464|Empagliflozin|empagliflozin|mesh-list
83480729|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83437953|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437954|NCT03081494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83437955|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83437956|NCT03081728|Acetaminophen|acetaminophen|mesh-list
83437957|NCT03081728|Diclofenac|diclofenac|mesh-list
83437958|NCT03081728|Ropivacaine|ropivacaine|mesh-list
83437959|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
83437960|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
83437961|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83437962|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437963|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
83437964|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437965|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83437966|NCT03081728|Analgesics|analgesics|mesh-ancestor
83437967|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
83437968|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83437969|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83437970|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83437971|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83437972|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437973|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437974|NCT05651217|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83437975|NCT05651217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83437976|NCT05688020|Epinephrine|epinephrine|mesh-list
83437977|NCT05688020|Tranexamic Acid|tranexamic acid|mesh-list
83437978|NCT05688020|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83437979|NCT05688020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83437980|NCT05688020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83437981|NCT05688020|Hemostatics|hemostatics|mesh-ancestor
83437982|NCT05688020|Coagulants|coagulants|mesh-ancestor
83437983|NCT05688020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83437984|NCT05688020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83437985|NCT05688020|Adrenergic Agents|adrenergic agents|mesh-ancestor
83437986|NCT05688020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83437987|NCT05688020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437988|NCT05688020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83437989|NCT05688020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83437990|NCT05688020|Autonomic Agents|autonomic agents|mesh-ancestor
83437991|NCT05688020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437992|NCT05688020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83437993|NCT05688020|Respiratory System Agents|respiratory system agents|mesh-ancestor
83437994|NCT05688020|Mydriatics|mydriatics|mesh-ancestor
83437995|NCT05688020|Sympathomimetics|sympathomimetics|mesh-ancestor
83437996|NCT05688020|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83437997|NCT00618917|Manganese|manganese|mesh-list
83437998|NCT00618917|Paclitaxel|paclitaxel|mesh-list
83437999|NCT00618917|Carboplatin|carboplatin|mesh-list
83438000|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
83438001|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83438002|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438003|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
83438005|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
83438006|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438007|NCT00618917|Trace Elements|trace elements|mesh-ancestor
83438008|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
83438009|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438010|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83438011|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
83438012|NCT00618917|Protective Agents|protective agents|mesh-ancestor
83438013|NCT05736081|Dexamethasone|dexamethasone|mesh-list
83438014|NCT05736081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83438015|NCT05736081|Antiemetics|antiemetics|mesh-ancestor
83438016|NCT05736081|Autonomic Agents|autonomic agents|mesh-ancestor
83438017|NCT05736081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438018|NCT05736081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438019|NCT05736081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83438020|NCT05736081|Glucocorticoids|glucocorticoids|mesh-ancestor
83438021|NCT05736081|Hormones|hormones|mesh-ancestor
83438022|NCT05736081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83438023|NCT05736081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83438024|NCT05736081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438026|NCT00619073|Clopidogrel|clopidogrel|mesh-list
83480807|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438027|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83438028|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83438029|NCT00619073|Analgesics|analgesics|mesh-ancestor
83438030|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
83438031|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438032|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438033|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83438034|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83438035|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83438036|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83438037|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438038|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83438039|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83438040|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438041|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
83438042|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83438043|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83438044|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83438045|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
83438046|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438047|NCT00670241|Betamethasone|betamethasone|mesh-list
83438048|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
83438049|NCT00670241|Calcipotriene|calcipotriene|mesh-list
83438050|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83438052|NCT00670241|Hormones|hormones|mesh-ancestor
83438053|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83438054|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438055|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83438056|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
83438057|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
83438058|NCT03088670|Metformin|metformin|mesh-list
83438059|NCT03088670|Vildagliptin|vildagliptin|mesh-list
83438060|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83438061|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438062|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83438063|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
83438064|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438065|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438066|NCT03088358|Enoxaparin|enoxaparin|mesh-list
83438067|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
83438068|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83438069|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83480808|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83438070|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438071|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83438072|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83438073|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83438074|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83480809|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438075|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438076|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83438077|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83438078|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83438079|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83438080|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
83438081|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438082|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438083|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83438084|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83438085|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
83438086|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83438087|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83438088|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
83438089|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
83438090|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83438091|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83438092|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
83438093|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438094|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438095|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438096|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83438097|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
83438099|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83438100|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
83438101|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83438102|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438103|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83438104|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438105|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
83438106|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
83438107|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83438108|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83438109|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438110|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83438111|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438112|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83438113|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83438114|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
83438115|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83438116|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
83438117|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
83438118|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83438119|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83438120|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438121|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438122|NCT03382106|Urological Agents|urological agents|mesh-ancestor
83438123|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
83438124|NCT00622895|Fludarabine|fludarabine|mesh-list
83438125|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
83438126|NCT00622895|Tacrolimus|tacrolimus|mesh-list
83438127|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438128|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83438129|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
83438130|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438131|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438132|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
83438133|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438134|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83438135|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438136|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83438137|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83438138|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
83438139|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83438140|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438141|NCT00672737|Remifentanil|remifentanil|mesh-list
83438142|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83438143|NCT00672737|Narcotics|narcotics|mesh-ancestor
83438144|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438145|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438146|NCT00672737|Analgesics|analgesics|mesh-ancestor
83438147|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
83438148|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438149|NCT00673127|Ketoconazole|ketoconazole|mesh-list
83438150|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
83438151|NCT00673127|Dutasteride|dutasteride|mesh-list
83438152|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83438153|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
83438154|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438155|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83438156|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83438157|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438158|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438159|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83438160|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
83438161|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83438162|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438163|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83438164|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83438166|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
83438167|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83438168|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
83438169|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438170|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438171|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438172|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83438173|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438174|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83438175|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83438176|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
83438178|NCT00673439|Warfarin|warfarin|mesh-list
83438179|NCT00673439|Fondaparinux|fondaparinux|mesh-list
83438180|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
83438181|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83438182|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
83438183|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83438184|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
83438185|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438186|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438187|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83438188|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83438189|NCT03316118|Bupivacaine|bupivacaine|mesh-list
83438190|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
83438191|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
83438192|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438193|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438194|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
83438195|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438197|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438198|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83438199|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438200|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438202|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83438203|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83438204|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
83438205|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438206|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438207|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438208|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83438209|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83438210|NCT00246025|Dabigatran|dabigatran|mesh-list
83438211|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
83438212|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83438213|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
83438214|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438215|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438216|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
83438218|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83438219|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438220|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438221|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438222|NCT05069051|Belimumab|belimumab|mesh-list
83438223|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438224|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
83438225|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438226|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83438227|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
83438228|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83438229|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83438230|NCT00624923|Analgesics|analgesics|mesh-ancestor
83438231|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
83438232|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438233|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438234|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83438235|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83438236|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83438237|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438238|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438239|NCT05593653|Suvorexant|suvorexant|mesh-list
83438240|NCT05593653|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83438241|NCT05593653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83438242|NCT05593653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438243|NCT05593653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438244|NCT05593653|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83438245|NCT05593653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438246|NCT05593653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438247|NCT04954287|Vaccines|vaccines|mesh-list
83438248|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
83438249|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438250|NCT00735787|Adalimumab|adalimumab|mesh-list
83438251|NCT00735787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83438252|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83438253|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83438254|NCT00628589|Loxapine|loxapine|mesh-list
83438255|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83438256|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83438257|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438258|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438259|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83438260|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83438261|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
83438262|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438263|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438264|NCT04953897|Decitabine|decitabine|mesh-list
83438265|NCT04953897|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83438266|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83438267|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
83438268|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438269|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438271|NCT03375242|Crizotinib|crizotinib|mesh-list
83438272|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438273|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83438274|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438275|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438276|NCT01271569|Fospropofol|fospropofol|mesh-list
83438277|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83438278|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438279|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438280|NCT05589597|Nivolumab|nivolumab|mesh-list
83438281|NCT05589597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83438282|NCT05589597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438283|NCT05589597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83438284|NCT05589597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438286|NCT05686772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83438287|NCT05686772|Sympathomimetics|sympathomimetics|mesh-ancestor
83438288|NCT05686772|Autonomic Agents|autonomic agents|mesh-ancestor
83438289|NCT05686772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438290|NCT05686772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438291|NCT05686772|Dopamine Agents|dopamine agents|mesh-ancestor
83438292|NCT05686772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438293|NCT05686772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438294|NCT05686772|Protective Agents|protective agents|mesh-ancestor
83438295|NCT04771871|Paclitaxel|paclitaxel|mesh-list
83438296|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
83438297|NCT04771871|Carboplatin|carboplatin|mesh-list
83438298|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83438299|NCT04771871|Epirubicin|epirubicin|mesh-list
83438300|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83438301|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438302|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
83438303|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
83438304|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
83438305|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438306|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438307|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
83438308|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438309|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83438310|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83438311|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
83438312|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83438313|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83438314|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83438315|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83438316|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438318|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
83438319|NCT04386577|Vitamins|vitamins|mesh-ancestor
83438320|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
83438321|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438322|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83438323|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83438324|NCT04270669|RC28-E protein|rc28-e protein|mesh-list
83438325|NCT04270669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83438326|NCT04270669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83438327|NCT04270669|Growth Substances|growth substances|mesh-ancestor
83438328|NCT04270669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438329|NCT04270669|Growth Inhibitors|growth inhibitors|mesh-ancestor
83438330|NCT04270669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438331|NCT05680454|Vaccines|vaccines|mesh-list
83438332|NCT05680454|Immunologic Factors|immunologic factors|mesh-ancestor
83438333|NCT05680454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438334|NCT04928703|Ketamine|ketamine|mesh-list
83438335|NCT04928703|Analgesics|analgesics|mesh-ancestor
83438336|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
83438337|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438338|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438339|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83438340|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83438341|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
83438342|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
83438343|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438344|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83438345|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83438346|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438347|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438348|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
83438350|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
83438351|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
83438352|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83438353|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438354|NCT00755755|Iron|iron|mesh-list
83438355|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
83438356|NCT00755755|Trace Elements|trace elements|mesh-ancestor
83438357|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
83438358|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438359|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83438360|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
83438361|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83438362|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83438363|NCT05686616|Dapagliflozin|dapagliflozin|mesh-list
83438364|NCT05686616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83438365|NCT05686616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438366|NCT05686616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83438367|NCT05686616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438368|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83438369|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
83438370|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83438371|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83438372|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83438373|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438374|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438375|NCT05567601|Doxorubicin|doxorubicin|mesh-list
83438376|NCT05567601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83438377|NCT05567601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83438378|NCT05567601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438379|NCT05567601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83438380|NCT05567601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83438381|NCT05567601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438382|NCT05567601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438383|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83438384|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
83438385|NCT00755911|Coagulants|coagulants|mesh-ancestor
83438386|NCT00737737|Morphine|morphine|mesh-list
83438387|NCT00737737|Oxycodone|oxycodone|mesh-list
83438388|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83438389|NCT00737737|Narcotics|narcotics|mesh-ancestor
83438390|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438391|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438392|NCT00737737|Analgesics|analgesics|mesh-ancestor
83438393|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
83438394|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438395|NCT05199051|Cytarabine|cytarabine|mesh-list
83438396|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
83438397|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83438398|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
83438399|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438400|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438401|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
83438402|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438403|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438404|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
83438405|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438406|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83438407|NCT05199051|Immunotoxins|immunotoxins|mesh-ancestor
83438408|NCT05199051|Immunoconjugates|immunoconjugates|mesh-ancestor
83438409|NCT00245011|Ifosfamide|ifosfamide|mesh-list
83438410|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
83438411|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438412|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83438413|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
83438414|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438415|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438416|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83438417|NCT00245011|Analgesics|analgesics|mesh-ancestor
83438418|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
83438419|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438420|NCT05539053|Acetylcysteine|acetylcysteine|mesh-list
83438421|NCT05539053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83438422|NCT05539053|Antiviral Agents|antiviral agents|mesh-ancestor
83438423|NCT05539053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438424|NCT05539053|Expectorants|expectorants|mesh-ancestor
83438425|NCT05539053|Respiratory System Agents|respiratory system agents|mesh-ancestor
83438426|NCT05539053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83438427|NCT05539053|Antioxidants|antioxidants|mesh-ancestor
83438428|NCT05539053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438429|NCT05539053|Protective Agents|protective agents|mesh-ancestor
83438430|NCT05539053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438432|NCT00629525|Everolimus|everolimus|mesh-list
83438433|NCT00629525|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83438434|NCT00629525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83438435|NCT00629525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438436|NCT00629525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438437|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438438|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
83438439|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438440|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438441|NCT00244855|Dexamethasone|dexamethasone|mesh-list
83438442|NCT00244855|Rituximab|rituximab|mesh-list
83438443|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83438444|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438445|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
83438446|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438447|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83438448|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83438450|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
83438451|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438452|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83438453|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
83438454|NCT00244855|Hormones|hormones|mesh-ancestor
83438455|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83438456|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83438457|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
83438458|NCT00737893|Hematinics|hematinics|mesh-ancestor
83438459|NCT00631319|Hydromorphone|hydromorphone|mesh-list
83438460|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83438461|NCT00631319|Narcotics|narcotics|mesh-ancestor
83438462|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438463|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438464|NCT00631319|Analgesics|analgesics|mesh-ancestor
83438465|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
83438466|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438467|NCT00244621|Candesartan|candesartan|mesh-list
83438468|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
83438469|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83438470|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83438471|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83438472|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438473|NCT00680225|Ranibizumab|ranibizumab|mesh-list
83438474|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83438475|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83438476|NCT00680225|Growth Substances|growth substances|mesh-ancestor
83438477|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438478|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
83438479|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438480|NCT04603391|Cannabidiol|cannabidiol|mesh-list
83438481|NCT04603391|Methylphenidate|methylphenidate|mesh-list
83438482|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83438483|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438484|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83438485|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83438486|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83438487|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438488|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
83438489|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438490|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
83438491|NCT00738049|Darusentan|darusentan|mesh-list
83438492|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83438493|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438494|NCT04416633|Durvalumab|durvalumab|mesh-list
83438495|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83438496|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438498|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83438499|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438501|NCT00680459|Heparin|heparin|mesh-list
83438502|NCT00680459|Anticoagulants|anticoagulants|mesh-list
83438503|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83438504|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83438505|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438506|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83438507|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438508|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438509|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438510|NCT00632411|Nicotine|nicotine|mesh-list
83438511|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83438512|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
83438513|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438514|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438515|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83438516|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83438517|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
83438518|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438519|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438520|NCT05685836|Bevacizumab|bevacizumab|mesh-list
83438521|NCT05685836|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
83438522|NCT05685836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83438523|NCT05685836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438524|NCT05685836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83438525|NCT05685836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83438526|NCT05685836|Growth Substances|growth substances|mesh-ancestor
83438527|NCT05685836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438528|NCT05685836|Growth Inhibitors|growth inhibitors|mesh-ancestor
83438529|NCT05685836|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83438530|NCT05685836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438531|NCT00632489|Capecitabine|capecitabine|mesh-list
83438532|NCT00632489|Lapatinib|lapatinib|mesh-list
83438533|NCT00632489|Panobinostat|panobinostat|mesh-list
83438534|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83438535|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
83438536|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438537|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438538|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83438539|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438540|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83438541|NCT05096481|Temozolomide|temozolomide|mesh-list
83438542|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83438543|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
83438544|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438545|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438546|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
83438547|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
83438548|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438549|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
83438550|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438551|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438553|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83438554|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83438555|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438556|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438557|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83438558|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83438559|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83438560|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83438561|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
83438563|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
83438564|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
83438565|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438566|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438567|NCT00738361|Paclitaxel|paclitaxel|mesh-list
83438568|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83438569|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83438570|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438571|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
83438572|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
83438573|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
83438574|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438575|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83438576|NCT01279213|Clozapine|clozapine|mesh-list
83438577|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83438578|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83438579|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438580|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438581|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83438582|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83438583|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83438585|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438586|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438587|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83438588|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83438589|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
83438590|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
83438591|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
83438592|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83438593|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83438594|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83438595|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83438596|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438597|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438598|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438599|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83438601|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83438602|NCT01279291|Paclitaxel|paclitaxel|mesh-list
83438603|NCT01279291|Carboplatin|carboplatin|mesh-list
83438605|NCT01279291|Doxorubicin|doxorubicin|mesh-list
83438606|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83438607|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83438608|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438609|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
83438610|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
83438611|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
83438612|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438613|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83438614|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
83438615|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83438616|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83438617|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83438618|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438620|NCT04367883|Histamine Antagonists|histamine antagonists|mesh-list
83438621|NCT04367883|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83438622|NCT04367883|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83438623|NCT04367883|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83438624|NCT04367883|Antiviral Agents|antiviral agents|mesh-ancestor
83438625|NCT04367883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438626|NCT04367883|Dopamine Agents|dopamine agents|mesh-ancestor
83438627|NCT04367883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438628|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438629|NCT04367883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438630|NCT04367883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83438631|NCT04367883|Analgesics|analgesics|mesh-ancestor
83438632|NCT04367883|Sensory System Agents|sensory system agents|mesh-ancestor
83438633|NCT04367883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438634|NCT04367883|Histamine Agents|histamine agents|mesh-ancestor
83438635|NCT04329039|Somatostatin|somatostatin|mesh-list
83438637|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83438638|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438639|NCT00635609|Doxycycline|doxycycline|mesh-list
83438640|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83438641|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438642|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
83438643|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83438644|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83438645|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
83438646|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83438647|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83438648|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83438649|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83438651|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
83438652|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438653|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83438654|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83438655|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438656|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83438657|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83438658|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
83438659|NCT05315336|Antibodies|antibodies|mesh-list
83438660|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
83438661|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438662|NCT04746495|Eplerenone|eplerenone|mesh-list
83438663|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83438664|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
83438665|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83438666|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438667|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83438668|NCT04746495|Diuretics|diuretics|mesh-ancestor
83438669|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
83438670|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83438671|NCT03347786|Verapamil|verapamil|mesh-list
83438672|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83438673|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83438674|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83438675|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438676|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83438677|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438678|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
83438679|NCT03288974|Pomalidomide|pomalidomide|mesh-list
83438680|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
83438681|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438682|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83438683|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83438684|NCT03288974|Growth Substances|growth substances|mesh-ancestor
83438685|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
83438686|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438687|NCT03286634|Cytarabine|cytarabine|mesh-list
83438688|NCT03286634|Prednisolone|prednisolone|mesh-list
83438689|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
83438690|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
83438691|NCT03286634|Methotrexate|methotrexate|mesh-list
83438692|NCT03286634|Vincristine|vincristine|mesh-list
83438693|NCT03286634|Daunorubicin|daunorubicin|mesh-list
83438694|NCT03286634|Asparaginase|asparaginase|mesh-list
83438695|NCT03286634|Epirubicin|epirubicin|mesh-list
83438696|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
83438697|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438698|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
83438699|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438700|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83438701|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83438702|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
83438703|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438704|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438705|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83438706|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83438707|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
83438708|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83438709|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83438710|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
83438711|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
83438712|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438713|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83438714|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83438715|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
83438716|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438717|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83438718|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
83438719|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
83438720|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
83438721|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83438722|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
83438724|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83438725|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83438726|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83438727|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83438728|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83438729|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83438730|NCT03286556|Autoantibodies|autoantibodies|mesh-list
83438731|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438732|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
83438733|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438735|NCT05000294|Tivozanib|tivozanib|mesh-list
83438736|NCT05000294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83438737|NCT05000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438738|NCT05000294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83438739|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438740|NCT05000294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83438741|NCT05000294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438742|NCT00637247|Gemcitabine|gemcitabine|mesh-list
83438743|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83438744|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
83438745|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438746|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438748|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83438749|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438750|NCT04388033|Temozolomide|temozolomide|mesh-list
83438751|NCT04388033|Interleukin-12|interleukin-12|mesh-list
83438753|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
83438754|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438755|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83438756|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
83438757|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438758|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438759|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83438760|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83438761|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83438763|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
83438764|NCT03267680|Indomethacin|indomethacin|mesh-list
83438765|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
83438766|NCT03267680|Omeprazole|omeprazole|mesh-list
83438767|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438768|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
83438769|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438770|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83438771|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83438772|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
83438773|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438774|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438775|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83438776|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83438777|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83438778|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83438779|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438780|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83438781|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83438782|NCT03267680|Analgesics|analgesics|mesh-ancestor
83438783|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
83438784|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438785|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83438786|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
83438787|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
83438788|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83438789|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83438790|NCT02980731|Venetoclax|venetoclax|mesh-list
83438791|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438792|NCT05564390|Cytarabine|cytarabine|mesh-list
83438793|NCT05564390|Azacitidine|azacitidine|mesh-list
83438794|NCT05564390|Daunorubicin|daunorubicin|mesh-list
83438795|NCT05564390|Venetoclax|venetoclax|mesh-list
83438796|NCT05564390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83438797|NCT05564390|Antimetabolites|antimetabolites|mesh-ancestor
83438798|NCT05564390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438799|NCT05564390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438800|NCT05564390|Antiviral Agents|antiviral agents|mesh-ancestor
83438801|NCT05564390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438802|NCT05564390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438803|NCT05564390|Immunologic Factors|immunologic factors|mesh-ancestor
83438804|NCT05564390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438805|NCT05564390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438806|NCT05564390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83438807|NCT05564390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83438808|NCT05564390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83438809|NCT04725591|Insulin|insulin|mesh-list
83438810|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83438811|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438812|NCT02980497|Ethanol|ethanol|mesh-list
83438813|NCT02980497|Listerine|listerine|mesh-list
83438814|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83438815|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
83438816|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438817|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438818|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438819|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
83438820|NCT02980497|Protective Agents|protective agents|mesh-ancestor
83438821|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
83438822|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83438823|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
83438824|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438825|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438826|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83438827|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
83438828|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83438829|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
83438830|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438831|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438832|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83438833|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
83438834|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
83438835|NCT02652429|Protective Agents|protective agents|mesh-ancestor
83438836|NCT02294253|Buprenorphine|buprenorphine|mesh-list
83438837|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83438839|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83438840|NCT02294253|Narcotics|narcotics|mesh-ancestor
83438841|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438842|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438843|NCT02294253|Analgesics|analgesics|mesh-ancestor
83438844|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
83438845|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438846|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83438847|NCT04926818|Ofatumumab|ofatumumab|mesh-list
83438848|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83438849|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83438850|NCT04926818|Siponimod|siponimod|mesh-list
83438851|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438852|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
83438853|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438854|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83480886|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83438855|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438856|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438857|NCT00684983|Capecitabine|capecitabine|mesh-list
83438858|NCT00684983|Lapatinib|lapatinib|mesh-list
83438859|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83438860|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83438861|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
83480887|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83438862|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438863|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438864|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83438865|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438866|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
83438867|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438868|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
83438869|NCT03339596|Hematinics|hematinics|mesh-ancestor
83438870|NCT00638651|Imiquimod|imiquimod|mesh-list
83438871|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83438873|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438874|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438875|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
83438876|NCT02584647|Sirolimus|sirolimus|mesh-list
83480888|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83438877|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83438878|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438879|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83438880|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438881|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
83438882|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438883|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
83438884|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438885|NCT00685139|Zonisamide|zonisamide|mesh-list
83438886|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
83438887|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83438889|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438890|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83480889|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
83438891|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438892|NCT00685295|Fentanyl|fentanyl|mesh-list
83438893|NCT00685295|Oxycodone|oxycodone|mesh-list
83438894|NCT00685295|Lansoprazole|lansoprazole|mesh-list
83438895|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
83438896|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83438897|NCT00685295|Narcotics|narcotics|mesh-ancestor
83438898|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438899|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438901|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
83438902|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438903|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83438904|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83438905|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
83438906|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
83438907|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83438908|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83438909|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83438910|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438911|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438912|NCT00686231|Lidocaine|lidocaine|mesh-list
83438913|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
83438914|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
83438916|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438917|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438918|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
83438919|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438920|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83438921|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83438922|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83438923|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83438924|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438925|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
83438926|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83438927|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83438928|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438930|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83438931|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83438932|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83438933|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83438935|NCT03335540|Ipilimumab|ipilimumab|mesh-list
83438936|NCT03335540|Relatlimab|relatlimab|mesh-list
83438937|NCT03335540|Linrodostat|linrodostat|mesh-list
83438938|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83438939|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438940|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83438941|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438942|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438943|NCT00643097|Temozolomide|temozolomide|mesh-list
83438945|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83438946|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
83438947|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438949|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
83438950|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438951|NCT03333668|Guanfacine|guanfacine|mesh-list
83438952|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83438953|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83438954|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438955|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83438956|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83438957|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83438958|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438959|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
83438960|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438961|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83438962|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83438963|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83438964|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83438965|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
83438966|NCT03280160|Ofatumumab|ofatumumab|mesh-list
83438967|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438968|NCT04683315|Paclitaxel|paclitaxel|mesh-list
83438969|NCT04683315|Gemcitabine|gemcitabine|mesh-list
83438970|NCT04683315|Fluorouracil|fluorouracil|mesh-list
83438971|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83438972|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438973|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
83438974|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
83438975|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
83438976|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438977|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83438978|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
83438979|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438980|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
83438981|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438982|NCT05502146|Norepinephrine|norepinephrine|mesh-list
83438983|NCT05502146|Bupivacaine|bupivacaine|mesh-list
83438984|NCT05502146|Anesthetics, Local|anesthetics, local|mesh-ancestor
83438985|NCT05502146|Anesthetics|anesthetics|mesh-ancestor
83438986|NCT05502146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83438987|NCT05502146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438988|NCT05502146|Sensory System Agents|sensory system agents|mesh-ancestor
83438989|NCT05502146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83438990|NCT05502146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83438991|NCT05502146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83438993|NCT05502146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83438994|NCT05502146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438995|NCT05502146|Sympathomimetics|sympathomimetics|mesh-ancestor
83438996|NCT05502146|Autonomic Agents|autonomic agents|mesh-ancestor
83438997|NCT05502146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83438998|NCT04027361|Amphetamine|amphetamine|mesh-list
83438999|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83439000|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439001|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
83439002|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
83439003|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439004|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
83439005|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439006|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439007|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
83439008|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83439009|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83439010|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439011|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83439012|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83439014|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83439015|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83439016|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
83439017|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
83439018|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
83439019|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439020|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439021|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
83439022|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439023|NCT03793439|Prednisone|prednisone|mesh-list
83439024|NCT03793439|Tofacitinib|tofacitinib|mesh-list
83439025|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439026|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
83439027|NCT03793439|Hormones|hormones|mesh-ancestor
83439028|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83439029|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439030|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83439031|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439032|NCT03793439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83439033|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83439034|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480890|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439035|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439037|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
83439038|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83439039|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439040|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439041|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83439042|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439043|NCT00687713|Bupropion|bupropion|mesh-list
83439044|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83439045|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
83439046|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83439047|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83439048|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83439049|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439050|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439051|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
83439052|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439053|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439054|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83439055|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83439056|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439057|NCT02304159|Ribavirin|ribavirin|mesh-list
83439058|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
83439059|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
83439060|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439061|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
83439062|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83439063|NCT02143973|Nalbuphine|nalbuphine|mesh-list
83439064|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83439065|NCT02143973|Narcotics|narcotics|mesh-ancestor
83439066|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439067|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439068|NCT02143973|Analgesics|analgesics|mesh-ancestor
83439069|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
83439070|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439071|NCT03028701|Budesonide|budesonide|mesh-list
83439072|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
83439073|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439074|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83439075|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
83439076|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439077|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439078|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83439079|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
83439080|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
83439081|NCT03028701|Hormones|hormones|mesh-ancestor
83439082|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83439083|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83439084|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83439085|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83439086|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
83439087|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439088|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439089|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83439090|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83439091|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83439092|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83439093|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
83439094|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480966|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439095|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480967|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
83439096|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439097|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
83439098|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439099|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
83439100|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83439101|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
83439102|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439103|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439104|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83439105|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
83439106|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83439107|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
83439108|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439109|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439110|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83439111|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
83439112|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
83439113|NCT02267655|Protective Agents|protective agents|mesh-ancestor
83439114|NCT02209545|Pyridoxine|pyridoxine|mesh-list
83439115|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
83439116|NCT02209545|Misoprostol|misoprostol|mesh-list
83439117|NCT02209545|Vitamins|vitamins|mesh-ancestor
83439118|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
83439119|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439120|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83439121|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
83439122|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83439123|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83439124|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83439125|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
83439126|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
83439127|NCT04858958|Aflutinib|aflutinib|mesh-list
83439129|NCT04858958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439130|NCT04858958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439131|NCT00690833|Desonide|desonide|mesh-list
83439132|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439133|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
83439134|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
83439135|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83439136|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83439137|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480968|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83439138|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439139|NCT03686306|Urological Agents|urological agents|mesh-ancestor
83439140|NCT04078269|Immunomodulating Agents|immunomodulating agents|mesh-list
83439142|NCT04078269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439143|NCT00644657|Clopidogrel|clopidogrel|mesh-list
83439144|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83439145|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83439146|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83480969|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
83439147|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83439148|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
83439149|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439150|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439151|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439152|NCT04613024|Topiramate|topiramate|mesh-list
83439153|NCT04613024|Gabapentin|gabapentin|mesh-list
83439154|NCT04613024|Analgesics|analgesics|mesh-ancestor
83439155|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
83439156|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439157|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439158|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
83439159|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83439160|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83439161|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439162|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83439163|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83439164|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83439166|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439169|NCT01933815|Bevacizumab|bevacizumab|mesh-list
83439170|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83439171|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439172|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83439173|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83439174|NCT01933815|Growth Substances|growth substances|mesh-ancestor
83439175|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439176|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
83439177|NCT03239210|Ondansetron|ondansetron|mesh-list
83439178|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
83439179|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
83439180|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439181|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439182|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83439183|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
83439184|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
83439185|NCT03239210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83439186|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83439187|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
83439188|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439189|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439190|NCT04606316|Nivolumab|nivolumab|mesh-list
83439192|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83439193|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439194|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83439195|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439196|NCT03480971|Tempol|tempol|mesh-list
83439197|NCT03480971|TEMPO|tempo|mesh-list
83439198|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
83439199|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439200|NCT03480971|Protective Agents|protective agents|mesh-ancestor
83439201|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439202|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83439203|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439204|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83439205|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83439206|NCT00646763|Lenograstim|lenograstim|mesh-list
83439207|NCT00646763|Sargramostim|sargramostim|mesh-list
83439209|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83439210|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
83439211|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439212|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
83439213|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439214|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
83439215|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83439216|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439217|NCT03237572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83439218|NCT03237572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439219|NCT02986347|Epinephrine|epinephrine|mesh-list
83439220|NCT02986347|Racepinephrine|racepinephrine|mesh-list
83439221|NCT02986347|Anesthetics|anesthetics|mesh-list
83439222|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
83439223|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439224|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439225|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83439226|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83439227|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
83439228|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439229|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439230|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83439231|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83439232|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
83439233|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439234|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83439235|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
83439236|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
83439237|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
83439238|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83439239|NCT00649961|Melatonin|melatonin|mesh-list
83439240|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
83439241|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439242|NCT00649961|Protective Agents|protective agents|mesh-ancestor
83439243|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439244|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439246|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
83439248|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83439249|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83439250|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
83439251|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439252|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439253|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439254|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83439255|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83439256|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83439257|NCT01781637|Omalizumab|omalizumab|mesh-list
83439258|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83439259|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83439260|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
83439261|NCT00652145|Mesalamine|mesalamine|mesh-list
83439262|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83439263|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83439264|NCT00652145|Analgesics|analgesics|mesh-ancestor
83439265|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
83439266|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439267|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439268|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439269|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83439271|NCT03231722|Fluorouracil|fluorouracil|mesh-list
83439272|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
83439273|NCT03231722|Irinotecan|irinotecan|mesh-list
83439274|NCT03231722|Panitumumab|panitumumab|mesh-list
83439275|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
83439276|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
83439277|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439278|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83439279|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439280|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83439281|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
83439282|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439283|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83439284|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83439285|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439286|NCT03231722|Antidotes|antidotes|mesh-ancestor
83439287|NCT03231722|Protective Agents|protective agents|mesh-ancestor
83439288|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
83439289|NCT03231722|Vitamins|vitamins|mesh-ancestor
83439290|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
83439291|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83439293|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83439294|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83439295|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
83439296|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439297|NCT02959775|Vaccines|vaccines|mesh-list
83439298|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
83439299|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439300|NCT04761848|Cilostazol|cilostazol|mesh-list
83439301|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83439302|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
83439303|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439304|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439305|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83439306|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
83439307|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83439308|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83439309|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439310|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83439311|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
83439312|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83439313|NCT04761848|Protective Agents|protective agents|mesh-ancestor
83439314|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83439315|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83439316|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439317|NCT03277196|Ivacaftor|ivacaftor|mesh-list
83439318|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83439319|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439320|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439321|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83439322|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
83439323|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439324|NCT04056962|Tacrolimus|tacrolimus|mesh-list
83439325|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83439326|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
83439327|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439328|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83439329|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439330|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439331|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83439332|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83439333|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83439334|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83439335|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83439336|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
83439337|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439338|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439339|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439340|NCT00693719|Irinotecan|irinotecan|mesh-list
83439341|NCT00693719|Etoposide|etoposide|mesh-list
83439342|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83439343|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83439344|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439345|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439346|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439347|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83439348|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83439349|NCT00653861|Lidocaine|lidocaine|mesh-list
83439350|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
83439351|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
83439352|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439353|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439354|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
83439355|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439356|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83439357|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83439358|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83439359|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439360|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439361|NCT00654329|Fentanyl|fentanyl|mesh-list
83439362|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
83439363|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83439364|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439365|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439366|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83439368|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
83439369|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439370|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83439371|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83439372|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83439373|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
83439374|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439375|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439376|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83439378|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83439379|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83439380|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
83439381|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
83439382|NCT00695435|Tobramycin|tobramycin|mesh-list
83439383|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
83439384|NCT00695435|Dexamethasone|dexamethasone|mesh-list
83439386|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439387|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
83439388|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
83439389|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439390|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439391|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83439393|NCT00695435|Hormones|hormones|mesh-ancestor
83439394|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83439395|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83439396|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439397|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83439398|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83439399|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83439400|NCT00654953|Gabapentin|gabapentin|mesh-list
83439401|NCT00654953|Sertraline|sertraline|mesh-list
83439402|NCT00654953|Analgesics|analgesics|mesh-ancestor
83439403|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
83439404|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439405|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439406|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
83439407|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83439408|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83439409|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439410|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83439411|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83439412|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83439413|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439414|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439415|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
83439416|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
83439417|NCT00654953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83439418|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83439419|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439420|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
83439421|NCT01790165|Terbinafine|terbinafine|mesh-list
83439422|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
83439423|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83439424|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439425|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439426|NCT02299089|Octreotide|octreotide|mesh-list
83439427|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83439428|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83439429|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439431|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
83439432|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
83439433|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
83439434|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439435|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439436|NCT03931551|Trastuzumab|trastuzumab|mesh-list
83439437|NCT03931551|Olaparib|olaparib|mesh-list
83439438|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83439439|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439440|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83439441|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439442|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439443|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83439444|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83439445|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83439446|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439447|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439448|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439449|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439450|NCT00696293|Analgesics|analgesics|mesh-ancestor
83439451|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
83439452|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439453|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
83439454|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83439455|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
83439456|NCT00696449|Adapalene|adapalene|mesh-list
83439457|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83439458|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83439459|NCT00696449|Analgesics|analgesics|mesh-ancestor
83439460|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
83439461|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439462|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439463|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439464|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83439465|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
83439466|NCT03916263|Metformin|metformin|mesh-list
83439467|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83439468|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439469|NCT00696761|Alfuzosin|alfuzosin|mesh-list
83439470|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83439471|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83439472|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83439473|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
83439474|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439475|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439476|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439477|NCT00696761|Urological Agents|urological agents|mesh-ancestor
83439478|NCT00656201|Progesterone|progesterone|mesh-list
83439479|NCT00656201|Progestins|progestins|mesh-ancestor
83439480|NCT00656201|Hormones|hormones|mesh-ancestor
83439481|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83439482|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439483|NCT00759291|Acipimox|acipimox|mesh-list
83439484|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83439485|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
83439486|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439487|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83439488|NCT00756405|Antioxidants|antioxidants|mesh-list
83439489|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439490|NCT00756405|Protective Agents|protective agents|mesh-ancestor
83439491|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439492|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83439493|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83439494|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83439495|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83439496|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83439497|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83439498|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83439499|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
83439500|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439501|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439502|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439504|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83439505|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439506|NCT00657917|Gentamicins|gentamicins|mesh-list
83439507|NCT00657917|Paromomycin|paromomycin|mesh-list
83439508|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83439509|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83439510|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83439511|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439512|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439513|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83439514|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83439516|NCT01959945|Vaccines|vaccines|mesh-list
83439517|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
83439518|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439519|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
83439520|NCT01959945|Coagulants|coagulants|mesh-ancestor
83439521|NCT00700661|Montelukast|montelukast|mesh-list
83439522|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83439523|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
83439524|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83439525|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
83439526|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83439527|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439528|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83439529|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83439530|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439531|NCT00652847|Ezetimibe|ezetimibe|mesh-list
83439532|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83439533|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83439534|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
83439535|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439536|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83439537|NCT00652301|Simvastatin|simvastatin|mesh-list
83439538|NCT00652301|Ezetimibe|ezetimibe|mesh-list
83439540|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83439541|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
83481044|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439542|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439543|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83439544|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83439545|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439546|NCT01961271|Buprenorphine|buprenorphine|mesh-list
83439547|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83439548|NCT01961271|Narcotics|narcotics|mesh-ancestor
83439549|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439550|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439551|NCT01961271|Analgesics|analgesics|mesh-ancestor
83439552|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
83439553|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439555|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
83439556|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83439557|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83439558|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
83481045|NCT00813293|Sorafenib|sorafenib|mesh-list
83439559|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439560|NCT03822351|Durvalumab|durvalumab|mesh-list
83439561|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83439562|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83439563|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439565|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439566|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83439567|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83439568|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439570|NCT01963845|Hormones|hormones|mesh-ancestor
83439571|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83439572|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83439573|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
83439574|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439575|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439576|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83439577|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83439578|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83439579|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83439580|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83439582|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439583|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439584|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439585|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
83439586|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83439587|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
83439588|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439589|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439590|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83439591|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439592|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
83439593|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83439594|NCT04575584|Molnupiravir|molnupiravir|mesh-list
83439595|NCT04575584|Antiviral Agents|antiviral agents|mesh-ancestor
83439596|NCT04575584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83439597|NCT04277702|Montelukast|montelukast|mesh-list
83439598|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83439599|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
83439600|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83439601|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
83439602|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83439603|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439604|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83439605|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83439606|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439607|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83439608|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439610|NCT00699491|Temsirolimus|temsirolimus|mesh-list
83439611|NCT00699491|MTOR Inhibitors|mtor inhibitors|mesh-list
83439612|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83439613|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83439614|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83439615|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83439616|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439617|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
83439618|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83439619|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
83439620|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439621|NCT00699491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83439622|NCT00699491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439623|NCT00699491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439624|NCT04493216|Dolutegravir|dolutegravir|mesh-list
83439625|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83439626|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83439627|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439628|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439630|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83439632|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83439633|NCT03721965|Prednisone|prednisone|mesh-list
83439634|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
83439635|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439636|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
83439637|NCT03721965|Hormones|hormones|mesh-ancestor
83439638|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83439639|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439640|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83439641|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439644|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439645|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83439646|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83439647|NCT03721965|Protective Agents|protective agents|mesh-ancestor
83439648|NCT04399148|Ketotifen|ketotifen|mesh-list
83439650|NCT04399148|Desloratadine|desloratadine|mesh-list
83439651|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
83439652|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
83439653|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439654|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439655|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83439656|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83439657|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439658|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439659|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83439660|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
83439661|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83439662|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83439663|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
83439664|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
83439665|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
83439666|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
83439667|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83439668|NCT04672382|Morphine|morphine|mesh-list
83439669|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83439670|NCT04672382|Narcotics|narcotics|mesh-ancestor
83439671|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439672|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439673|NCT04672382|Analgesics|analgesics|mesh-ancestor
83439674|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
83439675|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439677|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
83439678|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83439679|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
83439680|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83439681|NCT00699803|Prednisolone|prednisolone|mesh-list
83439682|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83439683|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
83439684|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439685|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
83439686|NCT00699803|Hormones|hormones|mesh-ancestor
83481046|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439687|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83439688|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439689|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83439690|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439691|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
83439692|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
83439693|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439694|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83439695|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83439696|NCT00699803|Protective Agents|protective agents|mesh-ancestor
83439697|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
83439698|NCT01967433|Promethazine|promethazine|mesh-list
83439699|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83439700|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83439701|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439703|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
83439704|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
83439705|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
83439706|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439708|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
83439709|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83439710|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83439711|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
83439712|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
83439713|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439714|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439715|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83439716|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
83439717|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
83439718|NCT00551447|Simvastatin|simvastatin|mesh-list
83439720|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83439721|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83439722|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
83439723|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439724|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83439725|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83439726|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439727|NCT01968057|Cyclosporine|cyclosporine|mesh-list
83439728|NCT01968057|Cyclosporins|cyclosporins|mesh-list
83439729|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439730|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439731|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83439732|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
83439733|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439734|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
83439735|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83439736|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
83439737|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83439738|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83439739|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
83439740|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
83439741|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83439742|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83439743|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439744|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83439745|NCT00658697|Bevacizumab|bevacizumab|mesh-list
83439746|NCT00658697|Docetaxel|docetaxel|mesh-list
83439747|NCT00658697|Bicalutamide|bicalutamide|mesh-list
83439748|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83439749|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439750|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83439751|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83439752|NCT00658697|Growth Substances|growth substances|mesh-ancestor
83439753|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439754|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
83439755|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
83439756|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
83439757|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
83439758|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439759|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
83439760|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
83439761|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83439762|NCT03873116|Berotralstat|berotralstat|mesh-list
83439763|NCT03873116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83439764|NCT03873116|Protease Inhibitors|protease inhibitors|mesh-ancestor
83439765|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439766|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439767|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
83439769|NCT04399226|Propofol|propofol|mesh-list
83439770|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83439771|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439772|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439773|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83439774|NCT04399226|Analgesics|analgesics|mesh-ancestor
83439775|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
83439776|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439777|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83439778|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83439779|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83439780|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
83439781|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439782|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439783|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83439784|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
83439785|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
83439786|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83439787|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83439788|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83439789|NCT00659165|Insulin|insulin|mesh-list
83439790|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83439791|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
83439792|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
83439793|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83439794|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439795|NCT00542087|Diclofenac|diclofenac|mesh-list
83439796|NCT00542087|Etoricoxib|etoricoxib|mesh-list
83439797|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83439798|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83439799|NCT00542087|Analgesics|analgesics|mesh-ancestor
83439800|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
83439801|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439802|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439803|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439804|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83439805|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83439806|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439807|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439808|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83439809|NCT00541697|Atorvastatin|atorvastatin|mesh-list
83439810|NCT00541697|Simvastatin|simvastatin|mesh-list
83439811|NCT00541697|Ezetimibe|ezetimibe|mesh-list
83439812|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83439813|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83439814|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
83439815|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439816|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83439817|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83439818|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439819|NCT03223376|Paclitaxel|paclitaxel|mesh-list
83439820|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83439821|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83439822|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439823|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
83439824|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
83439825|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
83439826|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439827|NCT00395603|Atorvastatin|atorvastatin|mesh-list
83439828|NCT00395603|Simvastatin|simvastatin|mesh-list
83439829|NCT00395603|Ezetimibe|ezetimibe|mesh-list
83439830|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83439831|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83439832|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
83439833|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439834|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83439835|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83439836|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439838|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
83439839|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
83439840|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439841|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439842|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
83439843|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439844|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83439845|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83439846|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83439847|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439848|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439849|NCT00328523|Ezetimibe|ezetimibe|mesh-list
83439850|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83439851|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83439852|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
83439853|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439854|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83439855|NCT00701675|Sertraline|sertraline|mesh-list
83439856|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
83439857|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83439858|NCT00701675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83439859|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83439860|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439861|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439862|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439863|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
83439864|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439865|NCT04639310|Ezogabine|ezogabine|mesh-list
83439866|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
83439867|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439868|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439869|NCT03246074|Paclitaxel|paclitaxel|mesh-list
83439870|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83439871|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439872|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
83439873|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
83439874|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
83439875|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439876|NCT02300727|Curcumin|curcumin|mesh-list
83439877|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83439878|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83439879|NCT02300727|Analgesics|analgesics|mesh-ancestor
83439880|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
83439881|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439882|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439883|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439884|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83439885|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439886|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439887|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439889|NCT00250445|Etoricoxib|etoricoxib|mesh-list
83439890|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83439891|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83439892|NCT00250445|Analgesics|analgesics|mesh-ancestor
83439893|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
83439894|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439895|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439896|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439897|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83439898|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83439899|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439900|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439901|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83439902|NCT00242489|Diclofenac|diclofenac|mesh-list
83439903|NCT00242489|Etoricoxib|etoricoxib|mesh-list
83439904|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83439905|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83439906|NCT00242489|Analgesics|analgesics|mesh-ancestor
83439907|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
83439908|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439909|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439910|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83439911|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83439912|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83439913|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439914|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439915|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83439916|NCT00659945|Ondansetron|ondansetron|mesh-list
83439917|NCT00659945|Aprepitant|aprepitant|mesh-list
83439918|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
83439919|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
83439920|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439921|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439922|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83439923|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
83439924|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
83439925|NCT00659945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83439926|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83439927|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
83439928|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439929|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439930|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83439931|NCT04387565|Vanadium|vanadium|mesh-list
83439932|NCT04387565|Trace Elements|trace elements|mesh-ancestor
83439933|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
83439934|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439935|NCT02141555|Misoprostol|misoprostol|mesh-list
83439936|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83439937|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
83439938|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83439939|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439940|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83439941|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83439942|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
83439943|NCT01799057|Metformin|metformin|mesh-list
83439944|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83439945|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439946|NCT00588965|Propranolol|propranolol|mesh-list
83439948|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83439949|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
83439950|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439951|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439952|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439953|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83439954|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83439955|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
83439956|NCT00702299|Paclitaxel|paclitaxel|mesh-list
83439957|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83439958|NCT00702299|Cisplatin|cisplatin|mesh-list
83439959|NCT00702299|Pemetrexed|pemetrexed|mesh-list
83439960|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83439961|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439962|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
83439963|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
83439964|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
83439965|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439966|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439967|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83439968|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83439969|NCT00661583|Ranibizumab|ranibizumab|mesh-list
83439970|NCT00661583|Mitomycins|mitomycins|mesh-list
83439971|NCT00661583|Mitomycin|mitomycin|mesh-list
83439972|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83439973|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83439974|NCT00661583|Growth Substances|growth substances|mesh-ancestor
83439975|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439976|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
83439977|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439978|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83439979|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
83439980|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439981|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83439982|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439983|NCT00661895|Metoprolol|metoprolol|mesh-list
83439984|NCT00661895|Atenolol|atenolol|mesh-list
83439985|NCT00661895|Amlodipine|amlodipine|mesh-list
83439986|NCT00661895|Valsartan|valsartan|mesh-list
83439987|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83439988|NCT00661895|Clonidine|clonidine|mesh-list
83439989|NCT00661895|Lisinopril|lisinopril|mesh-list
83439990|NCT00661895|Doxazosin|doxazosin|mesh-list
83439991|NCT00661895|Hydralazine|hydralazine|mesh-list
83439992|NCT00661895|Nifedipine|nifedipine|mesh-list
83439993|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83439994|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83439995|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439996|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439997|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83439998|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439999|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
83440000|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83440001|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83440002|NCT00661895|Diuretics|diuretics|mesh-ancestor
83440003|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
83440004|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83440005|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83440006|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
83440007|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
83440008|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440009|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83440010|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83440011|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83440012|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
83440013|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440014|NCT00661895|Analgesics|analgesics|mesh-ancestor
83440015|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
83440016|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83440017|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83440018|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83440019|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
83440020|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83440021|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83440022|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
83440023|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440024|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83440025|NCT00661895|Protective Agents|protective agents|mesh-ancestor
83440026|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83440027|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83440028|NCT02312258|Ixazomib|ixazomib|mesh-list
83440029|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440030|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
83440031|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440032|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440033|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
83440034|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83440035|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440036|NCT02301039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83440037|NCT02301039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440038|NCT00662675|Pancrelipase|pancrelipase|mesh-list
83440039|NCT00662675|Pancreatin|pancreatin|mesh-list
83440040|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83440041|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
83440042|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83440043|NCT00591305|Protective Agents|protective agents|mesh-ancestor
83440044|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440045|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440046|NCT01799603|Simeprevir|simeprevir|mesh-list
83440047|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
83440048|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440049|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
83440050|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440051|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440052|NCT03816176|Isavuconazole|isavuconazole|mesh-list
83440053|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
83440054|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440055|NCT00666029|Atorvastatin|atorvastatin|mesh-list
83440056|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83440057|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83440058|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
83440059|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440060|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83440061|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83440062|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440063|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
83440064|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83440065|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83440066|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440067|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
83440068|NCT04372940|Coagulants|coagulants|mesh-ancestor
83440070|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83440071|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440072|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
83440073|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440074|NCT03221426|Leucovorin|leucovorin|mesh-list
83440075|NCT03221426|Docetaxel|docetaxel|mesh-list
83440076|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
83440077|NCT03221426|Fluorouracil|fluorouracil|mesh-list
83440078|NCT03221426|Capecitabine|capecitabine|mesh-list
83440079|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
83440080|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440081|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
83440082|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
83440083|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
83440084|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440085|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83440086|NCT03221426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83440087|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
83440088|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83440089|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440090|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
83440091|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440092|NCT03221426|Antidotes|antidotes|mesh-ancestor
83440093|NCT03221426|Protective Agents|protective agents|mesh-ancestor
83440094|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
83440095|NCT03221426|Vitamins|vitamins|mesh-ancestor
83440096|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
83440097|NCT01989195|Manganese|manganese|mesh-list
83440098|NCT01989195|Trace Elements|trace elements|mesh-ancestor
83440099|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
83440100|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440101|NCT00592943|Modafinil|modafinil|mesh-list
83440102|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83440103|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440104|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83440105|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83440106|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83440107|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440108|NCT01973205|Aspirin|aspirin|mesh-list
83440109|NCT01973205|Acetaminophen|acetaminophen|mesh-list
83440110|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83440111|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83440113|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
83440114|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440115|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440116|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83440117|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83440118|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83440119|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83481047|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83440120|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440121|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83440122|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83440123|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440124|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
83440125|NCT01990677|Eplerenone|eplerenone|mesh-list
83440126|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83440128|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440129|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440130|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83440131|NCT01990677|Diuretics|diuretics|mesh-ancestor
83440132|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
83440133|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83440134|NCT00593645|Cytarabine|cytarabine|mesh-list
83440135|NCT00593645|Clofarabine|clofarabine|mesh-list
83440136|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
83440137|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83440138|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83440139|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
83440140|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440141|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440142|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
83440143|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440144|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440145|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
83440146|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440147|NCT03194126|Misoprostol|misoprostol|mesh-list
83440148|NCT03194126|Mifepristone|mifepristone|mesh-list
83440149|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83440150|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
83440151|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83440152|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440154|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83440155|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
83440156|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83440157|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83440158|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83440159|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83440160|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
83440161|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83440162|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83440163|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
83440164|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440165|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
83440166|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83440167|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83440168|NCT03219086|Bupivacaine|bupivacaine|mesh-list
83440169|NCT03219086|Prilocaine|prilocaine|mesh-list
83440170|NCT03219086|Anesthetics|anesthetics|mesh-list
83440171|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
83440172|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440173|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440174|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
83440175|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440177|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440178|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
83440179|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83440180|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
83440181|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440182|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440183|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83440184|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
83440185|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83440187|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440188|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440189|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83440190|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
83440191|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
83440192|NCT04398290|Protective Agents|protective agents|mesh-ancestor
83440194|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
83440195|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83440196|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83440197|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440199|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83440200|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
83440201|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
83481048|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440202|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440203|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
83440204|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440205|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
83440206|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440207|NCT03708224|Atezolizumab|atezolizumab|mesh-list
83440208|NCT03708224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83440209|NCT03708224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440210|NCT03708224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83440211|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440213|NCT03632642|Penicillin G|penicillin g|mesh-list
83440214|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83440215|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
83440216|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83440217|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440218|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83440219|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83440220|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83440221|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
83440222|NCT04317404|Triamcinolone|triamcinolone|mesh-list
83440223|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83440224|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83440225|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83440226|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83440227|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
83440228|NCT04317404|Hormones|hormones|mesh-ancestor
83440229|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440230|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440231|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440232|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
83440233|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440234|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440235|NCT04399070|Ketamine|ketamine|mesh-list
83440236|NCT04399070|Esketamine|esketamine|mesh-list
83440237|NCT04399070|Analgesics|analgesics|mesh-ancestor
83440239|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440240|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440241|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83440242|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83440243|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
83440244|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
83440245|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440246|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83440247|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83440248|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440249|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440250|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
83440251|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83440252|NCT03650114|Ofatumumab|ofatumumab|mesh-list
83440253|NCT03650114|Vaccines|vaccines|mesh-list
83440254|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83440255|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83440256|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
83440257|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440258|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440259|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83440260|NCT00667589|Fluocinonide|fluocinonide|mesh-list
83440261|NCT00667589|Tazarotene|tazarotene|mesh-list
83440262|NCT00667589|Emollients|emollients|mesh-list
83440263|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
83440264|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
83440265|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83440266|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
83440267|NCT00667589|Hormones|hormones|mesh-ancestor
83440268|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440269|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440270|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83440271|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
83440273|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83440274|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440275|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440276|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
83440277|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83440278|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440279|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440280|NCT03173612|Cytarabine|cytarabine|mesh-list
83440281|NCT03173612|Etoposide|etoposide|mesh-list
83440282|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
83440283|NCT03173612|Idarubicin|idarubicin|mesh-list
83440284|NCT03173612|Dasatinib|dasatinib|mesh-list
83440285|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
83440286|NCT03173612|Lenograstim|lenograstim|mesh-list
83440287|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83440288|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440289|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83440290|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83440291|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481126|NCT05363670|Respiratory System Agents|respiratory system agents|mesh-ancestor
83440292|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440293|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83440294|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
83440295|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
83440296|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440297|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440298|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
83440299|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440300|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83440301|NCT03173612|Analgesics|analgesics|mesh-ancestor
83440302|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
83440303|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440304|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83440305|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83440306|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83440307|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83440308|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
83440309|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440310|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440311|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83440312|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
83440313|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83440314|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83440315|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83440316|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
83440317|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440318|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440320|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83440321|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440322|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83440323|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83440324|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440325|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440326|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440327|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83440328|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83440329|NCT00705107|Ribavirin|ribavirin|mesh-list
83440330|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83440331|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
83440332|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
83440333|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440334|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
83440335|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440336|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
83440337|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440338|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83440339|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83440340|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83440341|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
83440342|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440343|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83440344|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83440345|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440346|NCT00240097|Carboplatin|carboplatin|mesh-list
83440347|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
83440348|NCT00240097|Irinotecan|irinotecan|mesh-list
83440349|NCT00240097|Etoposide|etoposide|mesh-list
83440350|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440351|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83440352|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83440353|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481128|NCT05363670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83440354|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440355|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83440356|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83440357|NCT04270487|Octylonium|octylonium|mesh-list
83440358|NCT04270487|Bromides|bromides|mesh-list
83440359|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
83440360|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83440361|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83440362|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440363|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83440364|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440365|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83440366|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
83440367|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
83440368|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440369|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83440370|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83440371|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
83440372|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440373|NCT00739999|Atorvastatin|atorvastatin|mesh-list
83440374|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83440375|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83440376|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
83440377|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440378|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83440379|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83440380|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440381|NCT02997995|Durvalumab|durvalumab|mesh-list
83440382|NCT02997995|Tremelimumab|tremelimumab|mesh-list
83440383|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83440384|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440385|NCT03620162|Vaccines|vaccines|mesh-list
83440386|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
83440387|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440388|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
83440390|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83440391|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83440392|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83440393|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440394|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440395|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440397|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83440398|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83440399|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83440400|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83440401|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440402|NCT03809923|Lidocaine|lidocaine|mesh-list
83440403|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
83440404|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
83440405|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
83440406|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440407|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440408|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
83440409|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440410|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83440411|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83440413|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83440414|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440415|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83440416|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83440417|NCT03809923|Analgesics|analgesics|mesh-ancestor
83440418|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83440419|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83440420|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83440421|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
83440422|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440423|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
83440424|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83440425|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440426|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
83440427|NCT00602225|Cytarabine|cytarabine|mesh-list
83440428|NCT00602225|Clofarabine|clofarabine|mesh-list
83440429|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83440430|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
83440431|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440432|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440433|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
83440434|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440435|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440436|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
83440437|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440439|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
83440440|NCT00602771|Tipifarnib|tipifarnib|mesh-list
83440441|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83440442|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440443|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83440444|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83440445|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440446|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440447|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
83440448|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83481129|NCT05363670|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83440449|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440450|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83440451|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83440452|NCT04248998|Metformin|metformin|mesh-list
83440453|NCT04248998|Paclitaxel|paclitaxel|mesh-list
83440454|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
83440455|NCT04248998|Doxorubicin|doxorubicin|mesh-list
83440456|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83440457|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440458|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
83440459|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
83440460|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
83440461|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440462|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440463|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
83440464|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440465|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83440466|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83440467|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
83440468|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83440469|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83440470|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83440471|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83440472|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83440473|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440474|NCT00714233|Metformin|metformin|mesh-list
83440475|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
83440476|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
83440477|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83440478|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83440479|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83440480|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440481|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83440482|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83440483|NCT00746395|Lubiprostone|lubiprostone|mesh-list
83440484|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83440485|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83440486|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440487|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
83440488|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
83440489|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83440490|NCT04205786|Vitamins|vitamins|mesh-ancestor
83440492|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440493|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
83440494|NCT04205786|Hematinics|hematinics|mesh-ancestor
83440495|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83440496|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440497|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440498|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83440499|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
83481130|NCT05363670|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83440500|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440501|NCT00719966|Letrozole|letrozole|mesh-list
83440502|NCT00719966|Anastrozole|anastrozole|mesh-list
83440503|NCT00719966|Exemestane|exemestane|mesh-list
83440504|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440505|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83440506|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83440508|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440509|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83440510|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
83440511|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440512|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440513|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83440515|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83440516|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440517|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440518|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
83440519|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440520|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440521|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
83440522|NCT04183868|Empagliflozin|empagliflozin|mesh-list
83440524|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83440525|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481131|NCT05363670|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83440527|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440528|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83440529|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440530|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
83440531|NCT02997215|Lidocaine|lidocaine|mesh-list
83440532|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
83440533|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
83440534|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83481132|NCT05363670|Adrenergic Agents|adrenergic agents|mesh-ancestor
83440535|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440536|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
83440537|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440538|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83481133|NCT05363670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440539|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83440540|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83440541|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83440542|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440544|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83440545|NCT02990507|Testosterone|testosterone|mesh-list
83440546|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
83440547|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
83440548|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83440549|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440550|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
83440551|NCT02990507|Hormones|hormones|mesh-ancestor
83440552|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440553|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440554|NCT02990507|Androgens|androgens|mesh-ancestor
83440555|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
83440556|NCT03331484|Ticagrelor|ticagrelor|mesh-list
83440557|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83440558|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83440560|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83440561|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
83440562|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440563|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440564|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440565|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83440567|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83440568|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
83440569|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440570|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
83440571|NCT00721513|Docetaxel|docetaxel|mesh-list
83440572|NCT00721513|Fluorouracil|fluorouracil|mesh-list
83440573|NCT00721513|Cetuximab|cetuximab|mesh-list
83440574|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440575|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
83440576|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
83440577|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
83481211|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440578|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440580|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83440581|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440582|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
83440583|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440584|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83440586|NCT00706121|Vitamin E|vitamin e|mesh-list
83440587|NCT00706121|Tocopherols|tocopherols|mesh-list
83440588|NCT00706121|Tocotrienols|tocotrienols|mesh-list
83440589|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
83440590|NCT00706121|Selenium|selenium|mesh-list
83440591|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
83440592|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440593|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
83440594|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440595|NCT00706121|Protective Agents|protective agents|mesh-ancestor
83440596|NCT00706121|Trace Elements|trace elements|mesh-ancestor
83440597|NCT00746863|Bupivacaine|bupivacaine|mesh-list
83440598|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
83440599|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
83440600|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440601|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440602|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
83440603|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440604|NCT04115384|Insulin|insulin|mesh-list
83440605|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83440606|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83440607|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440608|NCT04385563|Docetaxel|docetaxel|mesh-list
83440609|NCT04385563|Trastuzumab|trastuzumab|mesh-list
83440610|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440611|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
83440612|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
83440614|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440615|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83440617|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
83440618|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83440619|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83440620|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440621|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
83440622|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
83440624|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
83440625|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440627|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83440628|NCT00759187|Triclosan|triclosan|mesh-list
83440629|NCT00759187|Fluorides|fluorides|mesh-list
83440630|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
83440631|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
83440632|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
83440633|NCT00759187|Protective Agents|protective agents|mesh-ancestor
83440634|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440635|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83440636|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440637|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
83440638|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
83440639|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83440640|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83440641|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
83440642|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440643|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83440644|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
83440645|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
83440646|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83440648|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440649|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440650|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440651|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83440652|NCT01279915|Linaclotide|linaclotide|mesh-list
83440653|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83440654|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
83440655|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440656|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83440657|NCT03809455|Fentanyl|fentanyl|mesh-list
83440658|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83440660|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440661|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440662|NCT03809455|Analgesics|analgesics|mesh-ancestor
83440663|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
83440664|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440665|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83440666|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83440667|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
83440668|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
83440669|NCT03618134|Durvalumab|durvalumab|mesh-list
83440670|NCT03618134|Ipilimumab|ipilimumab|mesh-list
83440671|NCT03618134|Tremelimumab|tremelimumab|mesh-list
83440672|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
83440673|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83440674|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
83440675|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83440676|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440677|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
83440678|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440679|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83440680|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440681|NCT02997059|Fluconazole|fluconazole|mesh-list
83440682|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
83440683|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440684|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83440685|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83440686|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440687|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440688|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83440689|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
83440690|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440691|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440692|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83440693|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83440694|NCT00759811|Methotrexate|methotrexate|mesh-list
83440695|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83440696|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
83440697|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83440698|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440699|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83440700|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
83440701|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440702|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440703|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
83440704|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440706|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440707|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
83440708|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83440709|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83440711|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
83440712|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83440713|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440715|NCT01276613|Losartan|losartan|mesh-list
83440716|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83440717|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
83440718|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440719|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440720|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83440722|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83440723|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83440724|NCT02428205|Propranolol|propranolol|mesh-list
83440725|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83440726|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83440727|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
83440728|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440729|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440730|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440731|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83440732|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83440733|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
83440734|NCT01276691|Aspirin|aspirin|mesh-list
83440735|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83440736|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83440737|NCT01276691|Analgesics|analgesics|mesh-ancestor
83440738|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
83440739|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440740|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440741|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83440743|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83440744|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83440745|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440746|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83440747|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83440748|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440749|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
83440750|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
83440751|NCT03081416|Dexamethasone|dexamethasone|mesh-list
83440752|NCT03081416|Ketorolac|ketorolac|mesh-list
83440753|NCT03081416|Ketamine|ketamine|mesh-list
83440754|NCT03081416|Metoclopramide|metoclopramide|mesh-list
83440755|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83440756|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
83440757|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
83440758|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440759|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440760|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83440761|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
83440762|NCT03081416|Hormones|hormones|mesh-ancestor
83440763|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440764|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83440765|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440766|NCT03081416|Analgesics|analgesics|mesh-ancestor
83440767|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
83440768|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83440769|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83440770|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
83440771|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
83440772|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440773|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83440774|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83440775|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440776|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440777|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83440778|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83440779|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83440780|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83440781|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440782|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83440783|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83440784|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
83440785|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83440786|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83440787|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
83440788|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83440789|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
83440790|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
83440791|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83440792|NCT00706589|Aripiprazole|aripiprazole|mesh-list
83440793|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
83440794|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83440795|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83440796|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83440797|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440798|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440800|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
83440801|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440802|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440803|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83440804|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83440805|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
83440806|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83440807|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83440808|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83440809|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83440810|NCT01276769|Paclitaxel|paclitaxel|mesh-list
83440811|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83440812|NCT01276769|Carboplatin|carboplatin|mesh-list
83440813|NCT01276769|Epirubicin|epirubicin|mesh-list
83440814|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83440815|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440816|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
83440817|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
83440818|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
83440819|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440820|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83440821|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83440822|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83440823|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440824|NCT01279681|Leucovorin|leucovorin|mesh-list
83440825|NCT01279681|Bevacizumab|bevacizumab|mesh-list
83440826|NCT01279681|Fluorouracil|fluorouracil|mesh-list
83440827|NCT01279681|Capecitabine|capecitabine|mesh-list
83440828|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
83440829|NCT01279681|Calcium|calcium|mesh-list
83440831|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83440832|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440833|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83440834|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83440835|NCT01279681|Growth Substances|growth substances|mesh-ancestor
83440836|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440837|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
83440838|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83440839|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
83440840|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440841|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83440842|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440843|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
83440844|NCT01279681|Antidotes|antidotes|mesh-ancestor
83440845|NCT01279681|Protective Agents|protective agents|mesh-ancestor
83440846|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
83440847|NCT01279681|Vitamins|vitamins|mesh-ancestor
83440848|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
83440850|NCT01276925|Ropivacaine|ropivacaine|mesh-list
83440851|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
83440852|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
83440853|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440854|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440855|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
83440856|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440857|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
83440858|NCT00728507|Rifampin|rifampin|mesh-list
83440859|NCT00728507|Isoniazid|isoniazid|mesh-list
83440860|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
83440861|NCT00728507|Ethambutol|ethambutol|mesh-list
83440862|NCT00728507|Rifapentine|rifapentine|mesh-list
83440863|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83440865|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83440866|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83440867|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440868|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440869|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440870|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83440871|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
83440872|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
83440873|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83440874|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83440875|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83440876|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83440877|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83440878|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83440879|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83440880|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83440881|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83440882|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
83440883|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83440884|NCT01279057|Fluticasone|fluticasone|mesh-list
83440885|NCT01279057|Xhance|xhance|mesh-list
83440886|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83440887|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83440888|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
83440889|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440890|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440891|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83440892|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
83440893|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
83440894|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83440895|NCT04384783|Hormones|hormones|mesh-list
83440896|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440897|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440899|NCT03186326|Cetuximab|cetuximab|mesh-list
83440900|NCT03186326|Avelumab|avelumab|mesh-list
83440901|NCT03186326|Panitumumab|panitumumab|mesh-list
83440902|NCT03186326|Aflibercept|aflibercept|mesh-list
83440903|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83440904|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440905|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83440906|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83440907|NCT03186326|Growth Substances|growth substances|mesh-ancestor
83440908|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440909|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
83440910|NCT02999633|Acetaminophen|acetaminophen|mesh-list
83440911|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
83440912|NCT02999633|Promethazine|promethazine|mesh-list
83440913|NCT02999633|Dexamethasone|dexamethasone|mesh-list
83440914|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
83440915|NCT02999633|Ranitidine|ranitidine|mesh-list
83440916|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83440917|NCT02999633|BB 1101|bb 1101|mesh-list
83440918|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83440919|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
83440920|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
83440921|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440922|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440923|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83440924|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
83440925|NCT02999633|Hormones|hormones|mesh-ancestor
83440926|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440927|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83440928|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440929|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
83440930|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440931|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440932|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83440933|NCT02999633|Analgesics|analgesics|mesh-ancestor
83440934|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
83440935|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
83440936|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83440937|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83440938|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440939|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
83440940|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
83440941|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83440942|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
83440943|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
83440944|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440945|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83440946|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
83440947|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
83440948|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83440949|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83440950|NCT04749797|Bupivacaine|bupivacaine|mesh-list
83440951|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
83440952|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
83440953|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440954|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440955|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
83440956|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83440958|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
83440959|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440960|NCT02996513|Vitamin A|vitamin a|mesh-list
83440961|NCT02996513|Vitamins|vitamins|mesh-ancestor
83440962|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
83440963|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440964|NCT04276688|Interferons|interferons|mesh-list
83440965|NCT04276688|Ritonavir|ritonavir|mesh-list
83440966|NCT04276688|Ribavirin|ribavirin|mesh-list
83440967|NCT04276688|Lopinavir|lopinavir|mesh-list
83440968|NCT04276688|Interferon-beta|interferon-beta|mesh-list
83440969|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
83440970|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440971|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
83440972|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440973|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83440974|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83440975|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
83440976|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440977|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440978|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83440979|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83440980|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83440981|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83440982|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
83440983|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
83440984|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440985|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83440986|NCT01277627|Efavirenz|efavirenz|mesh-list
83440987|NCT01277627|Nevirapine|nevirapine|mesh-list
83440988|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83440989|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
83440990|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83440991|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83440992|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440993|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83440994|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
83440995|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440996|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83440997|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83440998|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83440999|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83441000|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83441001|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83441002|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83441003|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83441004|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83441005|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83441006|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83441007|NCT01270451|Insulin|insulin|mesh-list
83441008|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83441009|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441010|NCT00706979|Nicotine|nicotine|mesh-list
83441011|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83441012|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
83441013|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441014|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441015|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83441016|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83441017|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
83441018|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441019|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441020|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
83441021|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83441022|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441023|NCT00716963|Fluticasone|fluticasone|mesh-list
83441025|NCT00716963|Budesonide|budesonide|mesh-list
83441026|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441027|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83441028|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
83441029|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441030|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441031|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83441032|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
83441034|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83441035|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
83441036|NCT00716963|Hormones|hormones|mesh-ancestor
83441037|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441038|NCT01270997|Etanercept|etanercept|mesh-list
83441039|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83441040|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83441041|NCT01270997|Analgesics|analgesics|mesh-ancestor
83441042|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
83441043|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441044|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441045|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441046|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441047|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83441048|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83441049|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
83441050|NCT01278745|Rituximab|rituximab|mesh-list
83441051|NCT01278745|Tacrolimus|tacrolimus|mesh-list
83441052|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83441053|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441054|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
83441055|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441056|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441057|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83441058|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83441059|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441060|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441061|NCT02995655|Azacitidine|azacitidine|mesh-list
83441062|NCT02995655|Heparin|heparin|mesh-list
83441063|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83441064|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
83481289|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83441065|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441066|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441067|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441068|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
83441069|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83441070|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83441072|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83441074|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
83441075|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441076|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441077|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83441078|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83441079|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83441080|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
83441081|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481369|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481370|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481371|NCT04749914|Dabigatran|dabigatran|mesh-list
83481372|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83481373|NCT04749914|Lasmiditan|lasmiditan|mesh-list
83481374|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83481375|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83481376|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
83481449|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83441082|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441083|NCT01271153|Protective Agents|protective agents|mesh-ancestor
83441084|NCT03809065|Labetalol|labetalol|mesh-list
83441085|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
83441086|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
83441087|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83441088|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83441089|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
83441090|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441091|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441092|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441093|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83441094|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
83441095|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
83441096|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441097|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83441098|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83441099|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
83441101|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83441102|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441103|NCT03006926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83441104|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441105|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83441106|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441107|NCT02995187|Apatinib|apatinib|mesh-list
83441108|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441109|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83441110|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441111|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441112|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83441114|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83441115|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83441116|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83441117|NCT01272089|Analgesics|analgesics|mesh-ancestor
83441118|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
83441119|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441120|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441121|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441122|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441123|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83441124|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83441125|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83441126|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
83441127|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
83441128|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441129|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441130|NCT00748657|Bevacizumab|bevacizumab|mesh-list
83441131|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83441132|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
83441133|NCT00748657|Antibodies|antibodies|mesh-list
83441134|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
83441135|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83441136|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
83441137|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441138|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83441139|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83441140|NCT00748657|Growth Substances|growth substances|mesh-ancestor
83441141|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441142|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
83441143|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
83441144|NCT02994953|Avelumab|avelumab|mesh-list
83441145|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83441146|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83441147|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441148|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
83441149|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441150|NCT01273051|Capecitabine|capecitabine|mesh-list
83441151|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83441152|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
83441153|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441155|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
83441156|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83441157|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
83441158|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441159|NCT02994875|Expectorants|expectorants|mesh-ancestor
83441160|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
83441161|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83441162|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
83441163|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441164|NCT02994875|Protective Agents|protective agents|mesh-ancestor
83441165|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441166|NCT02994875|Antidotes|antidotes|mesh-ancestor
83441167|NCT03809143|Buprenorphine|buprenorphine|mesh-list
83441168|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83441169|NCT03809143|Narcotics|narcotics|mesh-ancestor
83441170|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83441171|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441172|NCT03809143|Analgesics|analgesics|mesh-ancestor
83441173|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
83441174|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441176|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
83441177|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
83441178|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83441179|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83441180|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441181|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441182|NCT02390960|Urological Agents|urological agents|mesh-ancestor
83441183|NCT00720473|Lamotrigine|lamotrigine|mesh-list
83441184|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
83441185|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83441186|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83441187|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441188|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83441189|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441190|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83441191|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83441192|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83441193|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83441194|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83441195|NCT00637832|Prednisolone|prednisolone|mesh-list
83441196|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
83441197|NCT00637832|Rituximab|rituximab|mesh-list
83441199|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83441200|NCT00637832|Vincristine|vincristine|mesh-list
83441201|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83441202|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
83441203|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441204|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441205|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83441206|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
83441207|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441208|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441209|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83441210|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83441211|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83441212|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83441213|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83441214|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441215|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83441216|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
83441217|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
83441218|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
83441219|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441220|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
83441221|NCT00637832|Hormones|hormones|mesh-ancestor
83441222|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441223|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83441224|NCT00720629|Methotrexate|methotrexate|mesh-list
83441225|NCT00720629|Tacrolimus|tacrolimus|mesh-list
83441226|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
83441227|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83441228|NCT00720629|Visilizumab|visilizumab|mesh-list
83441229|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83441230|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
83441231|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83441232|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441233|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83441234|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
83441235|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441236|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441237|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
83441238|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441239|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83441240|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83441241|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
83441242|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441243|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83441244|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83441245|NCT01276327|Pioglitazone|pioglitazone|mesh-list
83441246|NCT01276327|Linagliptin|linagliptin|mesh-list
83441247|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83441248|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441249|NCT01276327|Incretins|incretins|mesh-ancestor
83441250|NCT01276327|Hormones|hormones|mesh-ancestor
83441251|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441252|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83441253|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
83441254|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441255|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441256|NCT05245760|Paclitaxel|paclitaxel|mesh-list
83441257|NCT05245760|Carboplatin|carboplatin|mesh-list
83441258|NCT05245760|Tislelizumab|tislelizumab|mesh-list
83441259|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83441260|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441261|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
83441262|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
83441263|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
83441264|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441265|NCT05245760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83441266|NCT02674958|Aspirin|aspirin|mesh-list
83441267|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83441268|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83441269|NCT02674958|Analgesics|analgesics|mesh-ancestor
83441270|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
83441271|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441272|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441273|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441274|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441275|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83441276|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83441277|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441279|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83441280|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441281|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
83441282|NCT00760435|Infliximab|infliximab|mesh-list
83441283|NCT00760435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83441284|NCT00760435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441285|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
83441286|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83441287|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441289|NCT03808129|Bupivacaine|bupivacaine|mesh-list
83441290|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
83441291|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
83441292|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83441293|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441294|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
83441295|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441296|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83441297|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83441298|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83441299|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83441300|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441301|NCT00749125|Escitalopram|escitalopram|mesh-list
83441302|NCT00749125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83441303|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83441304|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83441305|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441306|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441307|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
83441308|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441309|NCT02144675|Cytarabine|cytarabine|mesh-list
83441310|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
83441311|NCT02144675|Salicylates|salicylates|mesh-list
83441312|NCT02144675|Idarubicin|idarubicin|mesh-list
83441313|NCT02144675|Choline|choline|mesh-list
83441314|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83441316|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441317|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441318|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
83441319|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441320|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83441321|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
83441322|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441323|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83441325|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83441326|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441327|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
83441328|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83441329|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83441330|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83441331|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
83441332|NCT02144675|Analgesics|analgesics|mesh-ancestor
83441333|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
83441334|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441335|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83441336|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83441337|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441338|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441339|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83441340|NCT00749515|Deferasirox|deferasirox|mesh-list
83441342|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83441343|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
83441344|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
83441345|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441346|NCT00749515|Siderophores|siderophores|mesh-ancestor
83441347|NCT01272557|Doxorubicin|doxorubicin|mesh-list
83441348|NCT01272557|Sorafenib|sorafenib|mesh-list
83441349|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83441350|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441351|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83441352|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83441353|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441354|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441355|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83441356|NCT00639002|Dexamethasone|dexamethasone|mesh-list
83441357|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441359|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
83441360|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441361|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441362|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83441363|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
83441364|NCT00639002|Hormones|hormones|mesh-ancestor
83441365|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441366|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83441367|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441369|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
83441371|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441372|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441373|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83441374|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83441375|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
83441376|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441377|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441378|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83441379|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83441380|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441381|NCT01273493|Dexamethasone|dexamethasone|mesh-list
83441382|NCT01273493|Trabectedin|trabectedin|mesh-list
83441383|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441384|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
83441385|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
83441386|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441387|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441388|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83441389|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
83441390|NCT01273493|Hormones|hormones|mesh-ancestor
83441391|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441392|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83441393|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441394|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83441395|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
83441396|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441397|NCT00638456|Budesonide|budesonide|mesh-list
83441398|NCT00638456|Lansoprazole|lansoprazole|mesh-list
83441399|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
83441400|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441401|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83441402|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
83441403|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441404|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441405|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83441406|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
83441407|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
83441408|NCT00638456|Hormones|hormones|mesh-ancestor
83441409|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441410|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83441411|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83441412|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83441413|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441414|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441415|NCT01273571|Metformin|metformin|mesh-list
83441416|NCT01273571|Canagliflozin|canagliflozin|mesh-list
83441417|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83441418|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441419|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83441420|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441421|NCT02147899|Secnidazole|secnidazole|mesh-list
83441422|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83441423|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83441424|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441425|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
83441426|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83441427|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441428|NCT02565992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83441429|NCT02565992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441430|NCT03132116|Gentamicins|gentamicins|mesh-list
83441431|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83441432|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441433|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83441434|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441435|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441436|NCT00762619|Triclosan|triclosan|mesh-list
83441437|NCT00762619|Fluorides|fluorides|mesh-list
83441438|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
83441439|NCT00762619|Protective Agents|protective agents|mesh-ancestor
83441440|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441441|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83441442|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441443|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83441444|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83441445|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
83441446|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441447|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83441448|NCT00735449|Timolol|timolol|mesh-list
83441449|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83441450|NCT00735449|Latanoprost|latanoprost|mesh-list
83441451|NCT00735449|Maleic acid|maleic acid|mesh-list
83441452|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441453|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441454|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83441455|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83441456|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
83441457|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441458|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441459|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83441460|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83441461|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83441462|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83441463|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83441464|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83441465|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83441466|NCT01273831|Cisatracurium|cisatracurium|mesh-list
83441467|NCT01273831|Atracurium|atracurium|mesh-list
83441468|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83441469|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83441470|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441471|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441472|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83441473|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83441474|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83441475|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
83441476|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441477|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441478|NCT00735917|Saracatinib|saracatinib|mesh-list
83441479|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83441480|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83441481|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441482|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441483|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441484|NCT00736073|Aprepitant|aprepitant|mesh-list
83441485|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
83441486|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
83441487|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441488|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441489|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83441490|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83441491|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441492|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441493|NCT00736229|Exenatide|exenatide|mesh-list
83441494|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83441495|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441497|NCT00736229|Incretins|incretins|mesh-ancestor
83441498|NCT00736229|Hormones|hormones|mesh-ancestor
83441499|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441500|NCT00737243|Paclitaxel|paclitaxel|mesh-list
83441501|NCT00737243|Bevacizumab|bevacizumab|mesh-list
83441502|NCT00737243|Carboplatin|carboplatin|mesh-list
83441503|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83441504|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83441505|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441507|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
83441508|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
83441509|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441510|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83441511|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83441512|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83441513|NCT00737243|Growth Substances|growth substances|mesh-ancestor
83441514|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441515|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
83441516|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83441517|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441518|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
83441520|NCT00707759|Prednisolone|prednisolone|mesh-list
83441521|NCT00707759|Tacrolimus|tacrolimus|mesh-list
83441522|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441523|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
83441525|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441526|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441527|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83441528|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441529|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83441530|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
83441531|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83441532|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481450|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441533|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441534|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83441535|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83441536|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
83441537|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83441538|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441539|NCT01273727|Dexamethasone|dexamethasone|mesh-list
83441540|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
83441541|NCT01273727|BB 1101|bb 1101|mesh-list
83441542|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441543|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
83441544|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
83441545|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481452|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83441546|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441547|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83441548|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
83481453|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83441550|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441551|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83441552|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441553|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
83441554|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481454|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83481455|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441555|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441557|NCT00708071|Thrombin|thrombin|mesh-list
83441558|NCT00708071|Aprotinin|aprotinin|mesh-list
83441559|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
83441560|NCT00708071|Coagulants|coagulants|mesh-ancestor
83441561|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83441562|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83441563|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
83441564|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441565|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441566|NCT02994485|Simvastatin|simvastatin|mesh-list
83441567|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83441568|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83441569|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
83441570|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441571|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83441572|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83441573|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441574|NCT02994173|Ketamine|ketamine|mesh-list
83441575|NCT02994173|Oxycodone|oxycodone|mesh-list
83441576|NCT02994173|Esketamine|esketamine|mesh-list
83441577|NCT02994173|Analgesics|analgesics|mesh-ancestor
83441578|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
83441579|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441580|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441581|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83441582|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83441583|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
83441584|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
83441585|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83441586|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83441587|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83441588|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441589|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441590|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83441591|NCT02994173|Narcotics|narcotics|mesh-ancestor
83441592|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
83441593|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83441594|NCT00723749|Buprenorphine|buprenorphine|mesh-list
83441595|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83441596|NCT00723749|Naloxone|naloxone|mesh-list
83441597|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83441598|NCT00723749|Narcotics|narcotics|mesh-ancestor
83441599|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83441600|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441601|NCT00723749|Analgesics|analgesics|mesh-ancestor
83441602|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
83441603|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441604|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83441605|NCT00723827|Temozolomide|temozolomide|mesh-list
83441606|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83441607|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
83441608|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441609|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441611|NCT00779311|Bevacizumab|bevacizumab|mesh-list
83441612|NCT00779311|Sorafenib|sorafenib|mesh-list
83441613|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83441614|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441615|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83441616|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83441617|NCT00779311|Growth Substances|growth substances|mesh-ancestor
83441618|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441619|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
83441620|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83441621|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441622|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441623|NCT01274039|Acetazolamide|acetazolamide|mesh-list
83441624|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
83441625|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83441626|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441627|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441628|NCT01274039|Diuretics|diuretics|mesh-ancestor
83441629|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
83441630|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441631|NCT01274195|Busulfan|busulfan|mesh-list
83441632|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
83441633|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441634|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83441636|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441637|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83441638|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441639|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83441640|NCT00779701|Insulin|insulin|mesh-list
83441641|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83441642|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441644|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83441646|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441647|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83441648|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83441649|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83441650|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83441651|NCT03809221|Hormones|hormones|mesh-list
83441652|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83441653|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441654|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441655|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
83441656|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83441657|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
83441658|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83441659|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83441660|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83441661|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441662|NCT02993159|Tamoxifen|tamoxifen|mesh-list
83441663|NCT02993159|Afimoxifene|afimoxifene|mesh-list
83441664|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83441665|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
83441666|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441667|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441668|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83441670|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83441671|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83441672|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83441673|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83441674|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
83441675|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441676|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
83441677|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83441678|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441679|NCT00762853|Triclosan|triclosan|mesh-list
83441680|NCT00762853|Fluorides|fluorides|mesh-list
83441681|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
83441682|NCT00762853|Protective Agents|protective agents|mesh-ancestor
83441683|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441684|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83441685|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441686|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83441687|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83441688|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
83441689|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441690|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83441691|NCT00724009|Clofarabine|clofarabine|mesh-list
83441692|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83441693|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
83441694|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441695|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441696|NCT01279499|Remifentanil|remifentanil|mesh-list
83441697|NCT01279499|Propofol|propofol|mesh-list
83441698|NCT01279499|Sevoflurane|sevoflurane|mesh-list
83441699|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83441700|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83441701|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441702|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83441703|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
83441704|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
83441705|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83441706|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83441707|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83441708|NCT01279499|Narcotics|narcotics|mesh-ancestor
83441709|NCT01279499|Analgesics|analgesics|mesh-ancestor
83441710|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
83441711|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441712|NCT02992925|Vaccines|vaccines|mesh-list
83441713|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
83441714|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441715|NCT00780715|Metformin|metformin|mesh-list
83441716|NCT00780715|Pioglitazone|pioglitazone|mesh-list
83441717|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83441718|NCT00780715|Gliclazide|gliclazide|mesh-list
83441719|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83441720|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441721|NCT00780715|Incretins|incretins|mesh-ancestor
83441722|NCT00780715|Hormones|hormones|mesh-ancestor
83441723|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441724|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83441725|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
83441726|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441727|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441728|NCT05318443|Paclitaxel|paclitaxel|mesh-list
83441729|NCT05318443|Carboplatin|carboplatin|mesh-list
83441730|NCT05318443|Bevacizumab|bevacizumab|mesh-list
83441731|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83441732|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441733|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
83441734|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
83441735|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
83441736|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441737|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83441738|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83441739|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83441740|NCT05318443|Growth Substances|growth substances|mesh-ancestor
83441741|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441742|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
83441743|NCT00740831|Leuprolide|leuprolide|mesh-list
83441744|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
83441745|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83441746|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
83441748|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441749|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83441750|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441751|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83441752|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
83441753|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83441754|NCT01275287|Eculizumab|eculizumab|mesh-list
83441755|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83441756|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83441757|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
83441758|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441759|NCT01275443|Rilpivirine|rilpivirine|mesh-list
83441760|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83441761|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83441762|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441763|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441764|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
83441765|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441766|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83441767|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83441768|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83441769|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83441770|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441771|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83441772|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83441773|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83441774|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441775|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
83441776|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441777|NCT00741455|Cyclosporine|cyclosporine|mesh-list
83441778|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
83441779|NCT00741455|Methotrexate|methotrexate|mesh-list
83441780|NCT00741455|Fludarabine|fludarabine|mesh-list
83441781|NCT00741455|Cyclosporins|cyclosporins|mesh-list
83441782|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83441783|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
83441784|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441785|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441786|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83441787|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
83441788|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441789|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441790|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83441791|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83441792|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
83441793|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83441794|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83441795|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
83441796|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
83441797|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441798|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83441799|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83441800|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
83441801|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441802|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83441803|NCT00742313|Hemostatics|hemostatics|mesh-list
83441804|NCT00742313|Coagulants|coagulants|mesh-ancestor
83441805|NCT00742469|Rifaximin|rifaximin|mesh-list
83441806|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83441807|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441808|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83441810|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83441811|NCT01275599|Naloxone|naloxone|mesh-list
83441812|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83441813|NCT01275599|Narcotics|narcotics|mesh-ancestor
83441814|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83441815|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441816|NCT01275599|Analgesics|analgesics|mesh-ancestor
83441817|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
83441818|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441819|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83441820|NCT02992457|Interferons|interferons|mesh-list
83441822|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
83441823|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
83441824|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83441825|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
83441826|NCT02992457|Ledipasvir|ledipasvir|mesh-list
83441827|NCT02992457|Simeprevir|simeprevir|mesh-list
83441828|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83441829|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441830|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
83441831|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441832|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
83441833|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441834|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
83441836|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
83441837|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441838|NCT00782821|Rituximab|rituximab|mesh-list
83441839|NCT00782821|Bortezomib|bortezomib|mesh-list
83441840|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
83441841|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83441842|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83441843|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441844|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
83441845|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441846|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441847|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83441849|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83441850|NCT00743093|Analgesics|analgesics|mesh-ancestor
83441851|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
83441852|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441853|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441854|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
83441855|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
83441856|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83441857|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83441858|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441859|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83441860|NCT03805945|Analgesics|analgesics|mesh-ancestor
83441861|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
83441862|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441863|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83441864|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83441865|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83441866|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
83441867|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441868|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441869|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83441870|NCT04270019|Laxatives|laxatives|mesh-ancestor
83441871|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83441873|NCT02992301|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83441874|NCT02992301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83441875|NCT02992301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83441876|NCT02992301|Antimetabolites|antimetabolites|mesh-ancestor
83441877|NCT02992301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441878|NCT02992301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83441879|NCT02992301|Protease Inhibitors|protease inhibitors|mesh-ancestor
83441880|NCT02992301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441881|NCT02992301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83441883|NCT00743717|Trace Elements|trace elements|mesh-ancestor
83441884|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
83441885|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441887|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83441888|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441889|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
83441890|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
83441891|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83441892|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83441893|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441894|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441895|NCT00763867|Urological Agents|urological agents|mesh-ancestor
83441896|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
83441897|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83441898|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
83441899|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441900|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
83441901|NCT00711347|Protective Agents|protective agents|mesh-ancestor
83441902|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
83441903|NCT01276223|Difluprednate|difluprednate|mesh-list
83441904|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
83441905|NCT01276223|Hormones|hormones|mesh-ancestor
83441906|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441907|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441908|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441909|NCT00784225|Vitamins|vitamins|mesh-list
83441910|NCT00784225|Vitamin E|vitamin e|mesh-list
83441911|NCT00784225|Tocopherols|tocopherols|mesh-list
83441912|NCT00784225|Tocotrienols|tocotrienols|mesh-list
83441913|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
83441914|NCT00784225|Selenium|selenium|mesh-list
83441915|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
83441916|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441917|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
83441918|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441919|NCT00784225|Protective Agents|protective agents|mesh-ancestor
83441920|NCT00784225|Trace Elements|trace elements|mesh-ancestor
83441921|NCT02991911|MEDI3726|medi3726|mesh-list
83441922|NCT02991911|Immunoconjugates|immunoconjugates|mesh-ancestor
83441923|NCT02991911|Immunologic Factors|immunologic factors|mesh-ancestor
83441924|NCT02991911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441925|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
83441926|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83441927|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441928|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
83441929|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
83441930|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83441931|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83441932|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441933|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441934|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441935|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441936|NCT01273181|Aldesleukin|aldesleukin|mesh-list
83441937|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
83441938|NCT01273181|Fludarabine|fludarabine|mesh-list
83441939|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83441940|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
83441941|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441942|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441943|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83441944|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
83441945|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441946|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441947|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83441948|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83441949|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83441950|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
83441951|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83441953|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83441954|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83441955|NCT01272947|Analgesics|analgesics|mesh-ancestor
83441956|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
83441957|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83441958|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441959|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441960|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441961|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83441962|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441963|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441964|NCT01279343|Misoprostol|misoprostol|mesh-list
83441965|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83441966|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
83441967|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83441968|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441969|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83441970|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83441971|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
83441972|NCT01278797|Amlodipine|amlodipine|mesh-list
83441973|NCT01278797|Telmisartan|telmisartan|mesh-list
83441974|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83441975|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83441976|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83441977|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83441978|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441979|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83441980|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441981|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
83441982|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83441983|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83441984|NCT01272635|Azithromycin|azithromycin|mesh-list
83441985|NCT01272635|Prednisolone|prednisolone|mesh-list
83441986|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83441987|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
83441988|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83441989|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
83441990|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83441991|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
83441992|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83441993|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
83441994|NCT01272635|Hormones|hormones|mesh-ancestor
83441995|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83441996|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441997|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83441998|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441999|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
83442000|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
83442001|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442002|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83442003|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83442004|NCT01272635|Protective Agents|protective agents|mesh-ancestor
83442005|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83442006|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442008|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83442009|NCT04387097|Narcotics|narcotics|mesh-ancestor
83442010|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83442011|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442012|NCT04387097|Analgesics|analgesics|mesh-ancestor
83442013|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
83442014|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442015|NCT01270841|Enclomiphene|enclomiphene|mesh-list
83442017|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
83442018|NCT01270841|Testosterone|testosterone|mesh-list
83442019|NCT01270841|Androgens|androgens|mesh-ancestor
83442020|NCT01270841|Hormones|hormones|mesh-ancestor
83442021|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83442022|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442023|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83442024|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
83442025|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83442026|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
83442027|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83442028|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83442029|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83442030|NCT01278407|Donepezil|donepezil|mesh-list
83442031|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83442032|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442033|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442035|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442036|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442037|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
83442039|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
83442040|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442041|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442042|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
83442043|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442044|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442045|NCT00784303|Lenvatinib|lenvatinib|mesh-list
83442047|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83442048|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442049|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442050|NCT00750815|Dexamethasone|dexamethasone|mesh-list
83442051|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
83442052|NCT00750815|Doxorubicin|doxorubicin|mesh-list
83442053|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83442054|NCT00750815|Bortezomib|bortezomib|mesh-list
83442055|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442056|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
83442057|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442058|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442059|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83442060|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
83442061|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442062|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442063|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83442064|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442065|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
83442066|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
83442067|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442068|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83442069|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
83442071|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83442072|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83442073|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83442074|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83442075|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83442076|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442077|NCT00784849|Methylene Blue|methylene blue|mesh-list
83442078|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442079|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442080|NCT00786019|Vitamins|vitamins|mesh-list
83442081|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
83442082|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
83442083|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442085|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442086|NCT00786019|Protective Agents|protective agents|mesh-ancestor
83442087|NCT01277861|Fentanyl|fentanyl|mesh-list
83442088|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83442089|NCT01277861|Narcotics|narcotics|mesh-ancestor
83442090|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83442091|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442092|NCT01277861|Analgesics|analgesics|mesh-ancestor
83442093|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
83442094|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442095|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83442096|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83442097|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
83442098|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
83442099|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83442100|NCT00786487|Glycerol|glycerol|mesh-list
83442101|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83442102|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83442104|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83442105|NCT00786487|Protective Agents|protective agents|mesh-ancestor
83442106|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442107|NCT03805633|Pancrelipase|pancrelipase|mesh-list
83442108|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83442110|NCT01276847|Ustekinumab|ustekinumab|mesh-list
83442111|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83442112|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442113|NCT01276847|Analgesics|analgesics|mesh-ancestor
83442114|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
83442115|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442116|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442117|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442118|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442119|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83442120|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442121|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
83442122|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
83442125|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
83442126|NCT00945269|Immunotoxins|immunotoxins|mesh-list
83442127|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442128|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442130|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
83442131|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442132|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442133|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83442134|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83442135|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
83442136|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442137|NCT00945269|Immunoconjugates|immunoconjugates|mesh-ancestor
83442138|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
83442139|NCT01272791|Gemcitabine|gemcitabine|mesh-list
83442140|NCT01272791|Bavituximab|bavituximab|mesh-list
83442141|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83442142|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
83442143|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442144|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442145|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83442146|NCT00765661|Tacrolimus|tacrolimus|mesh-list
83442147|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442148|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
83442149|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442150|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83442151|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442152|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442153|NCT00765895|Nortriptyline|nortriptyline|mesh-list
83442154|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83442155|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
83442156|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83442157|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83442158|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83442159|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83481532|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442160|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442161|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
83442162|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442163|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442165|NCT01276457|Everolimus|everolimus|mesh-list
83442166|NCT01276457|Cyclosporins|cyclosporins|mesh-list
83442167|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442168|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442169|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442170|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
83442171|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442172|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
83442173|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442174|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
83442175|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442176|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83442177|NCT01276457|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83442178|NCT01276457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83442179|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442180|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83442181|NCT03804931|Prednisone|prednisone|mesh-list
83442182|NCT03804931|Mesalamine|mesalamine|mesh-list
83442183|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442184|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
83442185|NCT03804931|Hormones|hormones|mesh-ancestor
83442186|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83442187|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442188|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83442189|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442190|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83442191|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442192|NCT03804931|Analgesics|analgesics|mesh-ancestor
83442193|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
83442194|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442195|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442196|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
83442197|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83442198|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442199|NCT02991131|Linezolid|linezolid|mesh-list
83442200|NCT02991131|Tedizolid|tedizolid|mesh-list
83442201|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
83442202|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83442203|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442204|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83442205|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442206|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442207|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83442208|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
83442209|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83442211|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
83442212|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442213|NCT00767767|Thiopental|thiopental|mesh-list
83442214|NCT00767767|Propofol|propofol|mesh-list
83442215|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83442216|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83442217|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442218|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83442219|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
83442220|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
83442221|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
83442222|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
83442223|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
83442224|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442225|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442226|NCT00761345|Gemcitabine|gemcitabine|mesh-list
83442227|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83442228|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83442229|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
83442230|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442231|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442232|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83442233|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442234|NCT00762515|Triclosan|triclosan|mesh-list
83442235|NCT00762515|Fluorides|fluorides|mesh-list
83442236|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
83442237|NCT00762515|Protective Agents|protective agents|mesh-ancestor
83442238|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442239|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83442240|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442241|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83442242|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83442244|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442245|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83442246|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
83442247|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83442248|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83442249|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83442250|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83442251|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83442252|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442253|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
83442254|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442255|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442256|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83442257|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442258|NCT00753935|Aspirin|aspirin|mesh-list
83442259|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83442260|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442261|NCT00753935|Analgesics|analgesics|mesh-ancestor
83442263|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442264|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442265|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442267|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83442268|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83442269|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442270|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83442271|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83442272|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442274|NCT00779285|Doxorubicin|doxorubicin|mesh-list
83442275|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83442276|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83442277|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442278|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83442279|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83442280|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442281|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442283|NCT00786643|Interferons|interferons|mesh-list
83442284|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
83442285|NCT00786643|Bevacizumab|bevacizumab|mesh-list
83442286|NCT00786643|Fluorouracil|fluorouracil|mesh-list
83442287|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
83442288|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83442289|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442290|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83442291|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83442292|NCT00786643|Growth Substances|growth substances|mesh-ancestor
83442293|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442294|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
83442295|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
83442296|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442297|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83442298|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442299|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
83442301|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442302|NCT00786643|Antidotes|antidotes|mesh-ancestor
83442303|NCT00786643|Protective Agents|protective agents|mesh-ancestor
83442304|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
83442305|NCT00786643|Vitamins|vitamins|mesh-ancestor
83442306|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
83442307|NCT01276379|Leucovorin|leucovorin|mesh-list
83442308|NCT01276379|Folic Acid|folic acid|mesh-list
83442309|NCT01276379|Fluorouracil|fluorouracil|mesh-list
83442310|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
83442311|NCT01276379|Irinotecan|irinotecan|mesh-list
83442312|NCT01276379|Cetuximab|cetuximab|mesh-list
83442313|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
83442314|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
83442315|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442316|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83442317|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442318|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442319|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
83442320|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442321|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83442322|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83442323|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442324|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83442326|NCT01276379|Protective Agents|protective agents|mesh-ancestor
83442327|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
83442329|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
83442330|NCT01276379|Hematinics|hematinics|mesh-ancestor
83442331|NCT01275547|Midazolam|midazolam|mesh-list
83442332|NCT01275547|Ketamine|ketamine|mesh-list
83442333|NCT01275547|Morphine|morphine|mesh-list
83442335|NCT01275547|Analgesics|analgesics|mesh-ancestor
83442336|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
83442337|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442338|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442339|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83442340|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83442341|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
83442342|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
83442343|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83442344|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83442345|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83442346|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481535|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
83442347|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442348|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83442349|NCT01275547|Narcotics|narcotics|mesh-ancestor
83442350|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83442351|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83442352|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83442353|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83442354|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83442355|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
83442356|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
83442357|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
83442358|NCT00789685|Interferons|interferons|mesh-list
83442359|NCT00789685|Interferon-beta|interferon-beta|mesh-list
83442360|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442361|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
83442363|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
83442364|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442365|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
83442366|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83442367|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83442368|NCT03804229|Protective Agents|protective agents|mesh-ancestor
83442369|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442370|NCT05742607|Paclitaxel|paclitaxel|mesh-list
83442371|NCT05742607|Cisplatin|cisplatin|mesh-list
83442372|NCT05742607|Carboplatin|carboplatin|mesh-list
83442373|NCT05742607|Pemetrexed|pemetrexed|mesh-list
83442374|NCT05742607|Durvalumab|durvalumab|mesh-list
83442375|NCT05742607|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83442376|NCT05742607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83442377|NCT05742607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442378|NCT05742607|Tubulin Modulators|tubulin modulators|mesh-ancestor
83442379|NCT05742607|Antimitotic Agents|antimitotic agents|mesh-ancestor
83442380|NCT05742607|Mitosis Modulators|mitosis modulators|mesh-ancestor
83442381|NCT05742607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442382|NCT05742607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442383|NCT05742607|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83442384|NCT05742607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83442385|NCT05742607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83442386|NCT05742607|Immunologic Factors|immunologic factors|mesh-ancestor
83442387|NCT05742607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442388|NCT02149303|Dabigatran|dabigatran|mesh-list
83442389|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
83442390|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83442391|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
83442392|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442393|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442394|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
83442395|NCT03803449|Fentanyl|fentanyl|mesh-list
83442396|NCT03803449|Midazolam|midazolam|mesh-list
83442397|NCT03803449|Propofol|propofol|mesh-list
83442398|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83442399|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83442400|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442401|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83442402|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
83442403|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
83442404|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83442405|NCT03803449|Narcotics|narcotics|mesh-ancestor
83442406|NCT03803449|Analgesics|analgesics|mesh-ancestor
83442407|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
83442408|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442409|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83442410|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83442411|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83442412|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83442413|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
83442414|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
83442415|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442416|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442417|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
83442418|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83442419|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442420|NCT00789997|Levofloxacin|levofloxacin|mesh-list
83442421|NCT00789997|Prednisone|prednisone|mesh-list
83442422|NCT00789997|Etanercept|etanercept|mesh-list
83442423|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442424|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
83442426|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83442427|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442428|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83442430|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83442431|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442432|NCT00789997|Analgesics|analgesics|mesh-ancestor
83442433|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
83442434|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442435|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442436|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83442437|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442438|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
83442439|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83442440|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442441|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83442442|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83442443|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83442444|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481536|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442445|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442446|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83442447|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83442448|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
83442449|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83442450|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
83442451|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442452|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442453|NCT03803215|Theophylline|theophylline|mesh-list
83442454|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83442455|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
83442456|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442457|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442458|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83442459|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
83442460|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83442461|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481537|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83442462|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442463|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
83442464|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83442465|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83442466|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
83442467|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442468|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83442469|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83442470|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
83442471|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442472|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442473|NCT03802747|Durvalumab|durvalumab|mesh-list
83442474|NCT03802747|Tremelimumab|tremelimumab|mesh-list
83442475|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83442476|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83442477|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442478|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
83442479|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442480|NCT00791323|Ketorolac|ketorolac|mesh-list
83442481|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83442482|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
83442483|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83442484|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83442485|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442487|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
83442488|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442489|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442490|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442491|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442492|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83442493|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442494|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442495|NCT00772915|Dexamethasone|dexamethasone|mesh-list
83442496|NCT00772915|Lenalidomide|lenalidomide|mesh-list
83442497|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442498|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
83442499|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
83442500|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442501|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442502|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83442503|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
83442504|NCT00772915|Hormones|hormones|mesh-ancestor
83442505|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83442506|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83442507|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442508|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
83442509|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83442510|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83442511|NCT00772915|Growth Substances|growth substances|mesh-ancestor
83442512|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
83442513|NCT05497453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83442514|NCT05497453|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83442515|NCT05497453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83442516|NCT05497453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442517|NCT05497453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442518|NCT05497453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83442519|NCT05497453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442520|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
83442521|NCT03801733|Atorvastatin|atorvastatin|mesh-list
83442522|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83442523|NCT03801733|Simvastatin|simvastatin|mesh-list
83442524|NCT03801733|Pravastatin|pravastatin|mesh-list
83442525|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83442526|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83442527|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
83442528|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442529|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83442530|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83442531|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442532|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442533|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83442534|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442535|NCT03801733|Analgesics|analgesics|mesh-ancestor
83442536|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
83442537|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442538|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442539|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442540|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442541|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83442542|NCT00775411|Dexamethasone|dexamethasone|mesh-list
83442543|NCT00775411|Ranibizumab|ranibizumab|mesh-list
83442544|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442545|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
83442546|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
83442547|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442548|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442549|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83442550|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
83442552|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83442553|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83442554|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442555|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83442556|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83442557|NCT00775411|Growth Substances|growth substances|mesh-ancestor
83442558|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
83442559|NCT03801499|Lenvatinib|lenvatinib|mesh-list
83442560|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442561|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83442563|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442564|NCT00808405|Acyclovir|acyclovir|mesh-list
83442566|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442567|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
83442568|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
83442569|NCT00775645|Vitamins|vitamins|mesh-ancestor
83442570|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
83442571|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442572|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
83442573|NCT01974687|Itraconazole|itraconazole|mesh-list
83442574|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
83442575|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
83442576|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442577|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83442578|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83442579|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442580|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442581|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83442582|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
83442583|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83442584|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442585|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83442586|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
83442587|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
83442588|NCT00795145|Linezolid|linezolid|mesh-list
83442589|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83442590|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442591|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83442592|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83442593|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442594|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442595|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442596|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83442597|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
83442598|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83442599|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442600|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
83442601|NCT00809185|Everolimus|everolimus|mesh-list
83442602|NCT00809185|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83442603|NCT00809185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83442604|NCT00809185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442605|NCT00809185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442606|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442607|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
83442608|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442609|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442610|NCT03800953|Avelumab|avelumab|mesh-list
83442611|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83442612|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442613|NCT00795769|Ondansetron|ondansetron|mesh-list
83442614|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
83442615|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
83442616|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442617|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442618|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83442619|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
83442620|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
83442621|NCT00795769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83442622|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83442623|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
83442624|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442625|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442626|NCT01975935|Amlexanox|amlexanox|mesh-list
83442627|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83442629|NCT02305017|Opicapone|opicapone|mesh-list
83442630|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442631|NCT02305017|Analgesics|analgesics|mesh-ancestor
83442632|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
83442633|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442634|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442635|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
83442636|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83442637|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442638|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442639|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83442640|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83442642|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
83442643|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
83442644|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442645|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442646|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442647|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
83442648|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83442649|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
83442650|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442651|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442652|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83442653|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
83442654|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83442655|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
83442656|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442657|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442658|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83442659|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
83442660|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
83442661|NCT03602781|Protective Agents|protective agents|mesh-ancestor
83442662|NCT02280239|Acetaminophen|acetaminophen|mesh-list
83442663|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442664|NCT02280239|Analgesics|analgesics|mesh-ancestor
83442665|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
83442666|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442667|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442668|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
83442669|NCT01993875|Lubiprostone|lubiprostone|mesh-list
83442670|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83442671|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83442672|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442673|NCT00796705|Adalimumab|adalimumab|mesh-list
83442674|NCT00796705|Etanercept|etanercept|mesh-list
83442675|NCT00796705|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83442676|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442677|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442678|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83442679|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442680|NCT00796705|Analgesics|analgesics|mesh-ancestor
83442681|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
83442682|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442683|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442684|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83442685|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442686|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
83442687|NCT00809809|Zinc|zinc|mesh-list
83442688|NCT00809809|Trace Elements|trace elements|mesh-ancestor
83442689|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
83442690|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442691|NCT00248651|Amitriptyline|amitriptyline|mesh-list
83442693|NCT00248651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83442694|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83442695|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83442696|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442697|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442698|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
83442699|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442700|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442701|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
83442702|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83442703|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83442704|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442705|NCT00248651|Analgesics|analgesics|mesh-ancestor
83442706|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
83442707|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83442708|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
83442709|NCT03800797|Loxoprofen|loxoprofen|mesh-list
83442710|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83442711|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442712|NCT03800797|Analgesics|analgesics|mesh-ancestor
83442713|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
83442714|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442715|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442716|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442717|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442718|NCT04383067|Aldesleukin|aldesleukin|mesh-list
83442719|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442721|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83442722|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
83442723|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442724|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83442725|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
83442726|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83442727|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83442728|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442729|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
83442730|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442731|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442732|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83442733|NCT00248495|Pemetrexed|pemetrexed|mesh-list
83442734|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442735|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442736|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442737|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83442738|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83442739|NCT04739371|Insulin|insulin|mesh-list
83442740|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83442741|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83442742|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442743|NCT03809767|Antibodies|antibodies|mesh-list
83442744|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83442745|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
83442746|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442747|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
83442748|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83442749|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83442750|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442751|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442752|NCT03800641|Analgesics|analgesics|mesh-ancestor
83442753|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
83442754|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442755|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83442756|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83442757|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83442758|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
83442759|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442760|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442761|NCT03807011|Fentanyl|fentanyl|mesh-list
83442762|NCT03807011|Remifentanil|remifentanil|mesh-list
83442763|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83442764|NCT03807011|Narcotics|narcotics|mesh-ancestor
83442765|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83442766|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442767|NCT03807011|Analgesics|analgesics|mesh-ancestor
83442768|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
83442769|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442770|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83442771|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83442772|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
83442773|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
83442775|NCT02986503|Doxorubicin|doxorubicin|mesh-list
83442776|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83442777|NCT02986503|Methotrexate|methotrexate|mesh-list
83442778|NCT02986503|Ifosfamide|ifosfamide|mesh-list
83442779|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
83442780|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442781|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83442782|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83442783|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83442784|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442785|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442786|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83442788|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83442789|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442790|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83442791|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
83442792|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
83442793|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83442794|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442795|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
83442796|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442797|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83442798|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83442799|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
83442800|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
83442801|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83442802|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83442803|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
83442804|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442805|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83442806|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83442807|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442808|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442809|NCT00763061|Timolol|timolol|mesh-list
83442810|NCT00763061|Travoprost|travoprost|mesh-list
83442811|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83442812|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83442813|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83442814|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83442815|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
83442816|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442817|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442818|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442819|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83442820|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83442821|NCT03806335|Anesthetics|anesthetics|mesh-list
83442822|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83442823|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442824|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
83442825|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83442826|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83442827|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442828|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442829|NCT03806777|Analgesics|analgesics|mesh-ancestor
83442830|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
83442831|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442832|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83442833|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83442834|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83442835|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
83442836|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442837|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442839|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83442840|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442841|NCT00754247|Vitamin E|vitamin e|mesh-list
83442842|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
83442843|NCT00754247|Vitamins|vitamins|mesh-ancestor
83442844|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
83442845|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442846|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442848|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442849|NCT00754247|Protective Agents|protective agents|mesh-ancestor
83442850|NCT02305329|Opicapone|opicapone|mesh-list
83442851|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83442852|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442853|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442854|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83442855|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83442856|NCT01979445|Clopidogrel|clopidogrel|mesh-list
83442857|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83442859|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83442860|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83442861|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83442862|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83442863|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
83442864|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442865|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442866|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442868|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83442869|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442870|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83442871|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442873|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
83442874|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442875|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
83442876|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
83442877|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
83442878|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442879|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442880|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83442881|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83442882|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
83442883|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83442884|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83442885|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442886|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
83442887|NCT01981863|Coagulants|coagulants|mesh-ancestor
83442888|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
83442889|NCT00245765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83442890|NCT00245765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442891|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442892|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
83442893|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442894|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83442895|NCT01995045|Triamcinolone|triamcinolone|mesh-list
83442896|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83442897|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83442898|NCT01995045|Bupivacaine|bupivacaine|mesh-list
83442899|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83442900|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
83442901|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
83442902|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83442903|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442904|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
83442905|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442906|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442907|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
83442908|NCT01995045|Hormones|hormones|mesh-ancestor
83442909|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83442910|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83442911|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
83442912|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442913|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442915|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
83442916|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442917|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
83442918|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442919|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
83442920|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442921|NCT01982643|Naltrexone|naltrexone|mesh-list
83442922|NCT01982643|Bupropion|bupropion|mesh-list
83442923|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83442924|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83442925|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442926|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
83442927|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442928|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83442929|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
83442930|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83442931|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83442932|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83442933|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83442934|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442936|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442937|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83442938|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83442939|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442940|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83442941|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83442942|NCT00797797|Milnacipran|milnacipran|mesh-list
83442943|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
83442944|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83442945|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83442946|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83442947|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442948|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442949|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442950|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83442951|NCT00797797|Analgesics|analgesics|mesh-ancestor
83442952|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
83442953|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442954|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
83442955|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83442956|NCT03496233|Grazoprevir|grazoprevir|mesh-list
83442957|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83442958|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
83442959|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442960|NCT04482673|Vitamin D|vitamin d|mesh-list
83442961|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
83442962|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
83442963|NCT04482673|Vitamins|vitamins|mesh-list
83442964|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
83442965|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442966|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83442967|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83442969|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442970|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442971|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442972|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83442974|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
83442975|NCT02151487|Clonidine|clonidine|mesh-list
83442976|NCT02151487|Ropivacaine|ropivacaine|mesh-list
83442977|NCT02151487|BB 1101|bb 1101|mesh-list
83442978|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442980|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
83442981|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442982|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442983|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83442984|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
83442985|NCT02151487|Hormones|hormones|mesh-ancestor
83442986|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83442987|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83442988|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83442989|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
83442990|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442991|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442992|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
83442994|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83442995|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
83442996|NCT02151487|Analgesics|analgesics|mesh-ancestor
83442997|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83442998|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
83442999|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83443000|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83443001|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83443002|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
83443003|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443005|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83443006|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443007|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
83443008|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83443009|NCT00764309|Dasatinib|dasatinib|mesh-list
83443010|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443011|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83443012|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481538|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83443013|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443014|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
83443015|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83443016|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
83481539|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83443017|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443018|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443019|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83443020|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
83443021|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83443023|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443024|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443025|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83443027|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
83443028|NCT02151877|Protective Agents|protective agents|mesh-ancestor
83443029|NCT03970837|Tofacitinib|tofacitinib|mesh-list
83443030|NCT03970837|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83443031|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83443032|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443033|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443034|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83443035|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83443036|NCT00799435|Exenatide|exenatide|mesh-list
83443037|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83443038|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443039|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83443040|NCT00799435|Incretins|incretins|mesh-ancestor
83443041|NCT00799435|Hormones|hormones|mesh-ancestor
83443042|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443043|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
83443044|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83443045|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443046|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443047|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83443048|NCT04329091|Analgesics|analgesics|mesh-ancestor
83443049|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
83443050|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443051|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83443052|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83443053|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83443054|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
83443055|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443056|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443058|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83443059|NCT04382209|Narcotics|narcotics|mesh-ancestor
83443060|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443061|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443062|NCT04382209|Analgesics|analgesics|mesh-ancestor
83443063|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
83443064|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443065|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83443066|NCT04634071|Bupropion|bupropion|mesh-list
83443067|NCT04634071|Nicotine|nicotine|mesh-list
83443068|NCT04634071|Varenicline|varenicline|mesh-list
83443069|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83443070|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
83443071|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443072|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443073|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83443074|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83443075|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
83443076|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443077|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481540|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
83443078|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83443079|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
83443080|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83443081|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83443082|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83443083|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83443084|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
83443085|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83443086|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83443087|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443088|NCT03417921|Paclitaxel|paclitaxel|mesh-list
83443089|NCT03417921|Gemcitabine|gemcitabine|mesh-list
83443090|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83443091|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443093|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83443094|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83443095|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443096|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83443098|NCT03381183|Durvalumab|durvalumab|mesh-list
83443099|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83443101|NCT03378297|Aspirin|aspirin|mesh-list
83443103|NCT03378297|Letrozole|letrozole|mesh-list
83443104|NCT03378297|Olaparib|olaparib|mesh-list
83443105|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83443106|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443107|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443108|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83443109|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83443110|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443111|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443112|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83443113|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
83443114|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443115|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83443116|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83443117|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83443118|NCT03378297|Analgesics|analgesics|mesh-ancestor
83443119|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
83443120|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443121|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83443123|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83443124|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83443125|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83443126|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83443127|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
83443128|NCT03367689|Olaparib|olaparib|mesh-list
83443129|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83443130|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443131|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443132|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443133|NCT00243659|Factor VIII|factor viii|mesh-list
83443134|NCT00243659|Coagulants|coagulants|mesh-ancestor
83443135|NCT00814177|Warfarin|warfarin|mesh-list
83443136|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
83443137|NCT00243347|Cediranib|cediranib|mesh-list
83443138|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443139|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83443140|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443141|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443143|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83443145|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443146|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
83443149|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83443150|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443151|NCT01997229|Eculizumab|eculizumab|mesh-list
83443152|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83443153|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83443154|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
83443155|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443156|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
83443157|NCT00800839|Busulfan|busulfan|mesh-list
83443158|NCT00800839|Fludarabine|fludarabine|mesh-list
83443159|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
83443160|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83443161|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
83443162|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443163|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83443164|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83443165|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
83443166|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443167|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443168|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83443169|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83443170|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
83443171|NCT00814255|Adalimumab|adalimumab|mesh-list
83443172|NCT00814255|Losartan|losartan|mesh-list
83443174|NCT00814255|Atorvastatin|atorvastatin|mesh-list
83443175|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83443176|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83443177|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
83481541|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443178|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443179|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83443180|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83443181|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443182|NCT00814255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83443183|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83443184|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83443185|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83443186|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83443187|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83443188|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83443189|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83443190|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
83443191|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83443192|NCT00814255|Protective Agents|protective agents|mesh-ancestor
83443193|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443194|NCT02000973|Lidocaine|lidocaine|mesh-list
83443195|NCT02000973|Bupivacaine|bupivacaine|mesh-list
83443197|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
83443198|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
83443199|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443200|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443201|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
83443202|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443203|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83443204|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83443205|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83443206|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83443207|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443208|NCT02002767|Velpatasvir|velpatasvir|mesh-list
83443209|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
83443210|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443211|NCT01985685|Thiamine|thiamine|mesh-list
83443212|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
83443213|NCT01985685|Vitamins|vitamins|mesh-ancestor
83443214|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
83443215|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443216|NCT00815347|Bosentan|bosentan|mesh-list
83443217|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83443218|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83443219|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443220|NCT01985763|Genistein|genistein|mesh-list
83443221|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83443222|NCT01985763|Protective Agents|protective agents|mesh-ancestor
83443223|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443224|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443225|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83443226|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443227|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443228|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
83443229|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83443230|NCT01985763|Estrogens|estrogens|mesh-ancestor
83443231|NCT01985763|Hormones|hormones|mesh-ancestor
83443232|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443233|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
83443234|NCT02061969|Linagliptin|linagliptin|mesh-list
83443235|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83443236|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443238|NCT02061969|Hormones|hormones|mesh-ancestor
83443239|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443240|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83443241|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
83443242|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443243|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443244|NCT02003625|Meloxicam|meloxicam|mesh-list
83443245|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83443246|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83443247|NCT02003625|Analgesics|analgesics|mesh-ancestor
83443248|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
83443249|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443250|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443251|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83443252|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83443253|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83443254|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83443255|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443256|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443257|NCT04037683|Misoprostol|misoprostol|mesh-list
83443258|NCT04037683|Oxytocin|oxytocin|mesh-list
83443259|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
83443260|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83443261|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443262|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83443263|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
83443264|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83443265|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83443266|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
83443267|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83443268|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83443269|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443270|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
83443271|NCT04251247|Coagulants|coagulants|mesh-ancestor
83443272|NCT04631029|Carboplatin|carboplatin|mesh-list
83443273|NCT04631029|Etoposide|etoposide|mesh-list
83443274|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
83443275|NCT04631029|Atezolizumab|atezolizumab|mesh-list
83443276|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
83443277|NCT04631029|Entinostat|entinostat|mesh-list
83443278|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83443279|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83443280|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443281|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83443282|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83443283|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83443284|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443285|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443286|NCT04631029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83443287|NCT04631029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83443288|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
83443289|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443290|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
83443291|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
83443292|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
83443294|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
83443295|NCT02396511|Bevacizumab|bevacizumab|mesh-list
83443296|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83443297|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443298|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83443299|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83443300|NCT02396511|Growth Substances|growth substances|mesh-ancestor
83443301|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443302|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
83443303|NCT00816829|Fenofibrate|fenofibrate|mesh-list
83443304|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83443305|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
83443306|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443307|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83443308|NCT02062359|Aldesleukin|aldesleukin|mesh-list
83443309|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
83443310|NCT02062359|Fludarabine|fludarabine|mesh-list
83443311|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83443313|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443315|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83443316|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
83443317|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443318|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443319|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83443320|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83443321|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83443322|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
83443323|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443325|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
83443327|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
83443328|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443329|NCT00816907|Metformin|metformin|mesh-list
83443330|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83443331|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443332|NCT00817219|Betamethasone|betamethasone|mesh-list
83443333|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
83443334|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83443335|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
83443336|NCT00817219|Calcipotriene|calcipotriene|mesh-list
83443337|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83443338|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83443339|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
83443341|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443342|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443343|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83443344|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
83443345|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
83443346|NCT00817843|Simvastatin|simvastatin|mesh-list
83443347|NCT00817843|Ezetimibe|ezetimibe|mesh-list
83443348|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83443349|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83443350|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
83443351|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443352|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83443353|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83443354|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443355|NCT00817999|Clopidogrel|clopidogrel|mesh-list
83443356|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83443357|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83443358|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83443359|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83443360|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
83443361|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443362|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443363|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443364|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83443365|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83443366|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443367|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
83443369|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
83443371|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443372|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443373|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
83443374|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443375|NCT03839251|Aripiprazole|aripiprazole|mesh-list
83443376|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
83443377|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83443378|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83443379|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83443380|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443381|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443382|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
83443383|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
83443384|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443385|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443386|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83443387|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83443388|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
83443389|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83443390|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83443391|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83443392|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83443393|NCT00819403|Simvastatin|simvastatin|mesh-list
83443394|NCT00819403|Ezetimibe|ezetimibe|mesh-list
83443395|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83443396|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83443397|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83443398|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
83443399|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443400|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83443401|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83443402|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443403|NCT02010021|Letrozole|letrozole|mesh-list
83443404|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443405|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83443406|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83443407|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443408|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443409|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83443410|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
83443411|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443412|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443413|NCT02062905|Dexamethasone|dexamethasone|mesh-list
83443414|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83443415|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
83443416|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
83443417|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443418|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443419|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83443420|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
83443421|NCT02062905|Hormones|hormones|mesh-ancestor
83443422|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443423|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83443424|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443425|NCT00820573|Metformin|metformin|mesh-list
83443426|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83443427|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83443428|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443429|NCT00820573|Incretins|incretins|mesh-ancestor
83443430|NCT00820573|Hormones|hormones|mesh-ancestor
83443431|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443432|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83443433|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
83443434|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443435|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443436|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
83443437|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83443438|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83443439|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83443440|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83443441|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443442|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
83443443|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443444|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443445|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83443446|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443448|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83443449|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
83443450|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443451|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443452|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443453|NCT02065479|Ticagrelor|ticagrelor|mesh-list
83443454|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83443455|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83443456|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83443457|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83443458|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83443459|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
83443460|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443461|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443462|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443463|NCT05236621|Dexamethasone|dexamethasone|mesh-list
83443464|NCT05236621|Pomalidomide|pomalidomide|mesh-list
83443465|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83443466|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
83443467|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
83443468|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443469|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443470|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83443471|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
83443472|NCT05236621|Hormones|hormones|mesh-ancestor
83443473|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443474|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83443475|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443476|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
83443477|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83443478|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83443479|NCT05236621|Growth Substances|growth substances|mesh-ancestor
83443480|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
83443481|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
83443482|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83443483|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443484|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443485|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83443486|NCT02066727|Analgesics|analgesics|mesh-ancestor
83443487|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
83443488|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443489|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83443490|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83443492|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
83443493|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443494|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443496|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
83443497|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443498|NCT02812615|Micronutrients|micronutrients|mesh-list
83443499|NCT02812615|Trace Elements|trace elements|mesh-list
83443500|NCT02812615|Albendazole|albendazole|mesh-list
83443501|NCT02812615|Pyrantel|pyrantel|mesh-list
83443502|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
83443503|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
83443504|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83443505|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443506|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
83443507|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83443508|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83443509|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
83443510|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
83443511|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
83443512|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443513|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443514|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443515|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
83443516|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83443517|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83443518|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83443519|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443521|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
83443522|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443523|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83443524|NCT02665117|Diuretics|diuretics|mesh-ancestor
83443525|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
83443526|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443527|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83443528|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83443529|NCT02665117|Cathartics|cathartics|mesh-ancestor
83443530|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83443531|NCT02151253|Modafinil|modafinil|mesh-list
83443532|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83443533|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443534|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83443535|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83443536|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83443537|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443539|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83443540|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83443541|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
83443542|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443543|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443544|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83443545|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
83443546|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
83443547|NCT02069847|Hormones|hormones|mesh-ancestor
83443548|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443549|NCT02070237|Enoxaparin|enoxaparin|mesh-list
83443550|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
83443551|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83443552|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83443553|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443554|NCT02071095|Poly I-C|poly i-c|mesh-list
83443555|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83443556|NCT02071095|Poly ICLC|poly iclc|mesh-list
83443557|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
83443558|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
83443559|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443560|NCT02071095|Laxatives|laxatives|mesh-ancestor
83443561|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83443562|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
83443563|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443565|NCT02348359|Aflibercept|aflibercept|mesh-list
83443566|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443567|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83443568|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83443569|NCT02348359|Growth Substances|growth substances|mesh-ancestor
83443570|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443571|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
83443573|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83443574|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
83443575|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83443576|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
83443577|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443578|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443579|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
83443580|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
83443581|NCT02408445|Testosterone|testosterone|mesh-list
83443583|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
83443584|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83443585|NCT02408445|Androgens|androgens|mesh-ancestor
83443587|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443588|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443589|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83443591|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
83443592|NCT00388921|Vitamin A|vitamin a|mesh-list
83443593|NCT00388921|Vitamins|vitamins|mesh-ancestor
83443594|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
83443595|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443596|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
83443597|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83443598|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83443599|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83443600|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
83443601|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443602|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443603|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443604|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
83443605|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83443606|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443607|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
83443608|NCT00142285|Astringents|astringents|mesh-ancestor
83443609|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443611|NCT02342379|Bevacizumab|bevacizumab|mesh-list
83443612|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83443613|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443614|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83443615|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83443616|NCT02342379|Growth Substances|growth substances|mesh-ancestor
83443617|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443618|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
83443619|NCT02019069|Cytarabine|cytarabine|mesh-list
83443620|NCT02019069|Daunorubicin|daunorubicin|mesh-list
83443621|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83443622|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
83443623|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443624|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443626|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443627|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83443628|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
83443629|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443630|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83443631|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83443632|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83443633|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443634|NCT00821821|Edaravone|edaravone|mesh-list
83443636|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
83443637|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443638|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83443639|NCT00821821|Protective Agents|protective agents|mesh-ancestor
83443640|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443641|NCT00816751|Lidocaine|lidocaine|mesh-list
83443642|NCT00816751|Vasopressins|vasopressins|mesh-list
83443643|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
83443644|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
83443645|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
83443646|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443647|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443648|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
83443649|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443650|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83443651|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83443652|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83443653|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83443654|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443655|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
83443656|NCT00816751|Coagulants|coagulants|mesh-ancestor
83443657|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83443658|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83443659|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
83443660|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
83443661|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83443662|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83443663|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83443664|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83443665|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443666|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
83443667|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443668|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443669|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83443670|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443671|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
83443672|NCT02410707|Propofol|propofol|mesh-list
83443673|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83443674|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443675|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443676|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83443677|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
83443678|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
83443679|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83443680|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83443681|NCT02410707|Analgesics|analgesics|mesh-ancestor
83443682|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
83443683|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443684|NCT02343081|Temozolomide|temozolomide|mesh-list
83443685|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83443686|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
83443687|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443688|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443689|NCT00823303|Calcitriol|calcitriol|mesh-list
83443690|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83443691|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443692|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83443693|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83443694|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443695|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83443696|NCT00823303|Vitamins|vitamins|mesh-ancestor
83443697|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
83443698|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83443699|NCT00823459|Everolimus|everolimus|mesh-list
83443700|NCT00823459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83443701|NCT00823459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83443702|NCT00823459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443703|NCT00823459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443704|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83443705|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
83443706|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443707|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443708|NCT00825565|Allantoin|allantoin|mesh-list
83443709|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
83443710|NCT00803647|Leucovorin|leucovorin|mesh-list
83443711|NCT00803647|Fluorouracil|fluorouracil|mesh-list
83443712|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
83443713|NCT00803647|Cetuximab|cetuximab|mesh-list
83443714|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
83481618|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443715|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443716|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83443717|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443718|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83443719|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
83443720|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443721|NCT00803647|Antidotes|antidotes|mesh-ancestor
83443722|NCT00803647|Protective Agents|protective agents|mesh-ancestor
83443723|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
83443724|NCT00803647|Vitamins|vitamins|mesh-ancestor
83443725|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
83443726|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83443727|NCT00827983|Progesterone|progesterone|mesh-list
83443728|NCT00827983|Progestins|progestins|mesh-ancestor
83443729|NCT00827983|Hormones|hormones|mesh-ancestor
83443730|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443731|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443732|NCT02346903|Capsaicin|capsaicin|mesh-list
83443733|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
83443734|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
83443735|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
83443736|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443737|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443738|NCT02347605|Nicotine|nicotine|mesh-list
83443739|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83443740|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
83443741|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443742|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443743|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83443744|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83443745|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
83443746|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443747|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443748|NCT02153671|Vaccines|vaccines|mesh-list
83443749|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
83443750|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443752|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83443753|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83443754|NCT02413203|Analgesics|analgesics|mesh-ancestor
83443755|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
83443756|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443757|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443758|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83443759|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83443760|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83443761|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83443762|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443763|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443764|NCT02153983|Colchicine|colchicine|mesh-list
83443765|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
83443766|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83443767|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
83443768|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
83443769|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
83443770|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443771|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443772|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
83443773|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83443774|NCT02348775|Glycine|glycine|mesh-list
83443775|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
83443776|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443777|NCT02348775|Expectorants|expectorants|mesh-ancestor
83443778|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
83443779|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83443780|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
83443781|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443782|NCT02348775|Protective Agents|protective agents|mesh-ancestor
83443783|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443784|NCT02348775|Antidotes|antidotes|mesh-ancestor
83443785|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
83443786|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481619|NCT00378326|Tacrolimus|tacrolimus|mesh-list
83443788|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83443789|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
83443790|NCT00828061|Hormones|hormones|mesh-ancestor
83443791|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443792|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443793|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83443794|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443796|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
83443797|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443798|NCT02023125|Esomeprazole|esomeprazole|mesh-list
83443799|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83443800|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83443801|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83443802|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443803|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443804|NCT02349477|Gabapentin|gabapentin|mesh-list
83443805|NCT02349477|Analgesics|analgesics|mesh-ancestor
83443806|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
83443807|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443808|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443809|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
83443810|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83443811|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83443812|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443813|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83443814|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83443815|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83443816|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443817|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443819|NCT00828295|Palonosetron|palonosetron|mesh-list
83443820|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
83443821|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
83443822|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443823|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443824|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83443825|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83443826|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83443827|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
83443828|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443829|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443830|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
83443831|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83443832|NCT02350569|Ledipasvir|ledipasvir|mesh-list
83443833|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
83443834|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443835|NCT02351115|Alprazolam|alprazolam|mesh-list
83443836|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83443837|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443838|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443839|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83443840|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83443841|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83443842|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
83443843|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
83443844|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443845|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443846|NCT02025075|Rocuronium|rocuronium|mesh-list
83443847|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83443848|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83443849|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83443850|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443851|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443852|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
83443853|NCT00242567|Androgens|androgens|mesh-list
83443854|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83443855|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443856|NCT00242567|Hormones|hormones|mesh-ancestor
83443857|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443858|NCT00241631|Fluticasone|fluticasone|mesh-list
83443859|NCT00241631|Xhance|xhance|mesh-list
83443860|NCT00241631|Theophylline|theophylline|mesh-list
83443861|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83443862|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83443863|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
83443864|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443865|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443866|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83443867|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
83443868|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
83443869|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83443870|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83443871|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443872|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443873|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
83443874|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83443875|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83443876|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
83443877|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443878|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
83443879|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
83443880|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83443882|NCT02351739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83443883|NCT02351739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443884|NCT00240071|Tamoxifen|tamoxifen|mesh-list
83443885|NCT00240071|Bevacizumab|bevacizumab|mesh-list
83443886|NCT00240071|Letrozole|letrozole|mesh-list
83443887|NCT00240071|Exemestane|exemestane|mesh-list
83443888|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83443889|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443890|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83443891|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83443892|NCT00240071|Growth Substances|growth substances|mesh-ancestor
83443893|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443894|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
83443895|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83443896|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83443897|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443898|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443899|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83443900|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
83443901|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443902|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83443903|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83443904|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83443905|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83443906|NCT02352363|Levodopa|levodopa|mesh-list
83443907|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83443908|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83443909|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
83443911|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443912|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443913|NCT00765947|Amlodipine|amlodipine|mesh-list
83443914|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83443915|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83443916|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83443917|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83443918|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443919|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83443920|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443921|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
83443923|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
83443924|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83443925|NCT05743907|Dapagliflozin|dapagliflozin|mesh-list
83443926|NCT05743907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83443927|NCT05743907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443928|NCT05743907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83443929|NCT05743907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443931|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83443932|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443933|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83443934|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443935|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
83443936|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83443937|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
83443938|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443939|NCT02352831|Capecitabine|capecitabine|mesh-list
83443940|NCT02352831|Tosedostat|tosedostat|mesh-list
83443941|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83443942|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
83443943|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443944|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443945|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443946|NCT02353299|Zolpidem|zolpidem|mesh-list
83443947|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83443948|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83443949|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443950|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443951|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83443952|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
83443953|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
83443954|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443955|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443956|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83443957|NCT00756977|Laxatives|laxatives|mesh-ancestor
83443958|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83443959|NCT03808961|Vitamins|vitamins|mesh-list
83443960|NCT03808961|Niacin|niacin|mesh-list
83443961|NCT03808961|Niacinamide|niacinamide|mesh-list
83443962|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
83443963|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
83443964|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
83443965|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443966|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83443967|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
83443968|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443969|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83443970|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
83443972|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
83443973|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
83443974|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
83443975|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83443976|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443977|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443978|NCT00421551|Ritonavir|ritonavir|mesh-list
83443979|NCT00421551|Darunavir|darunavir|mesh-list
83443980|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83443981|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83443982|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
83443983|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443984|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443985|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83443986|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83443987|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
83443988|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83443989|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83443990|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83443991|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
83443992|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83443993|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
83443994|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83443995|NCT00767507|Cangrelor|cangrelor|mesh-list
83443996|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83443997|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83443998|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83443999|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83444000|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
83444001|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444002|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444003|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444004|NCT02029755|Anesthetics|anesthetics|mesh-list
83444006|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444007|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444008|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
83444009|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444010|NCT03804749|Suramin|suramin|mesh-list
83444011|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
83444012|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
83444013|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83444014|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444015|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444016|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83444017|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83444018|NCT02312739|Ketorolac|ketorolac|mesh-list
83444019|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83444020|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
83444021|NCT02312739|Analgesics|analgesics|mesh-list
83444023|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83444024|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444025|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
83444026|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444027|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444028|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83444029|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444030|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83444031|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481620|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83444032|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444033|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83444034|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
83444035|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
83444036|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444037|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
83444038|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
83444039|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
83444040|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83444041|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83444042|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83444043|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83444044|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83444045|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
83444046|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
83444047|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444048|NCT02351037|Azacitidine|azacitidine|mesh-list
83444049|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83444050|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
83481621|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
83444051|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444052|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444053|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444054|NCT05718609|Amoxicillin|amoxicillin|mesh-list
83444055|NCT05718609|Clarithromycin|clarithromycin|mesh-list
83444056|NCT05718609|Furazolidone|furazolidone|mesh-list
83444057|NCT05718609|Rabeprazole|rabeprazole|mesh-list
83444058|NCT05718609|Bismuth|bismuth|mesh-list
83444059|NCT05718609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83444060|NCT05718609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444061|NCT05718609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83444062|NCT05718609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444063|NCT05718609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444065|NCT05718609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83444066|NCT05718609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83444067|NCT05718609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83444068|NCT05718609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83444069|NCT05718609|Antacids|antacids|mesh-ancestor
83444070|NCT05718609|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83444071|NCT05718609|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83444072|NCT05718609|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83444073|NCT05718609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83444074|NCT05718609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83444075|NCT05718609|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83444076|NCT02359305|Acetaminophen|acetaminophen|mesh-list
83444077|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444078|NCT02359305|Analgesics|analgesics|mesh-ancestor
83444079|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
83444080|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444081|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444082|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
83444083|NCT02360319|Aripiprazole|aripiprazole|mesh-list
83444084|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
83444085|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
83444086|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83444087|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83444088|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444089|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444090|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
83444091|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
83444092|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444093|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444094|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83444095|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83444096|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
83444097|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83444098|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83444099|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83444100|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83444101|NCT05718531|Aspirin|aspirin|mesh-list
83444102|NCT05718531|Rivaroxaban|rivaroxaban|mesh-list
83444103|NCT05718531|Clopidogrel|clopidogrel|mesh-list
83444104|NCT05718531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83444105|NCT05718531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444106|NCT05718531|Analgesics|analgesics|mesh-ancestor
83444107|NCT05718531|Sensory System Agents|sensory system agents|mesh-ancestor
83444108|NCT05718531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444109|NCT05718531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444110|NCT05718531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83444112|NCT05718531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83444113|NCT05718531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83444114|NCT05718531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444115|NCT05718531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83444116|NCT05718531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83444117|NCT05718531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444118|NCT05718531|Antipyretics|antipyretics|mesh-ancestor
83444119|NCT05718531|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83444120|NCT05718531|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83444121|NCT05718531|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83444122|NCT05718531|Purinergic Agents|purinergic agents|mesh-ancestor
83444123|NCT05718531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444124|NCT05718531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83444125|NCT05718531|Antithrombins|antithrombins|mesh-ancestor
83444126|NCT05718531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83444127|NCT05718531|Protease Inhibitors|protease inhibitors|mesh-ancestor
83444128|NCT05718531|Anticoagulants|anticoagulants|mesh-ancestor
83444129|NCT02360631|Varenicline|varenicline|mesh-list
83444130|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83444131|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83444133|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444134|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444135|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444136|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
83444137|NCT00355095|Hematinics|hematinics|mesh-ancestor
83444138|NCT02366871|Enoxaparin|enoxaparin|mesh-list
83444139|NCT02366871|Apixaban|apixaban|mesh-list
83444140|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
83444141|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83444142|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83481622|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444143|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444144|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83444145|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
83444146|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83444147|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
83444148|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444150|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
83444151|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83444152|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83444153|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444154|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83444155|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444156|NCT03836651|Antioxidants|antioxidants|mesh-list
83444157|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444158|NCT03836651|Protective Agents|protective agents|mesh-ancestor
83444159|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444160|NCT02037555|Antithrombins|antithrombins|mesh-list
83444161|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
83444162|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83444163|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
83444164|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444165|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444167|NCT03804359|Rituximab|rituximab|mesh-list
83444168|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83444170|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
83444171|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444172|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444174|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444175|NCT02369211|Analgesics|analgesics|mesh-ancestor
83444176|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
83444177|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444178|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444179|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
83444180|NCT02038023|Iron|iron|mesh-list
83444181|NCT02038023|Dextrans|dextrans|mesh-list
83444182|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
83444183|NCT02038023|Trace Elements|trace elements|mesh-ancestor
83444184|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
83444185|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444186|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
83444187|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
83444188|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
83444189|NCT02038023|Hematinics|hematinics|mesh-ancestor
83444190|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
83444191|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83444192|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
83444193|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444194|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444195|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83444196|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
83444197|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83444198|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
83444199|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444200|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444201|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83444203|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
83444204|NCT04384133|Protective Agents|protective agents|mesh-ancestor
83444205|NCT02038179|Allopurinol|allopurinol|mesh-list
83444206|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
83444207|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444208|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444209|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
83444210|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444211|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83444212|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
83444213|NCT02038179|Protective Agents|protective agents|mesh-ancestor
83444215|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83444216|NCT02369835|Eusol|eusol|mesh-list
83444217|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83444218|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
83444219|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444220|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83444221|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83444222|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83444223|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
83444225|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444226|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444227|NCT00768521|Urological Agents|urological agents|mesh-ancestor
83444228|NCT00768599|Econazole|econazole|mesh-list
83444229|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
83444230|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444231|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83444232|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83444233|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444234|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444235|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83444236|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
83444237|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444238|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444240|NCT02370693|Bortezomib|bortezomib|mesh-list
83444241|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83444242|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444243|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83444244|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
83444245|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83444246|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444247|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444248|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444250|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83444252|NCT02039115|Hormones|hormones|mesh-ancestor
83444253|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444254|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444255|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83444256|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444257|NCT00759473|Cycloserine|cycloserine|mesh-list
83444258|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83444259|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444260|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83444261|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
83444262|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83444263|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
83444264|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444265|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83444266|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444267|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444268|NCT03809273|Trimetazidine|trimetazidine|mesh-list
83444269|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
83444270|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83444271|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83444273|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83444274|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83444275|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444276|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444277|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
83444278|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444279|NCT00770861|Nebivolol|nebivolol|mesh-list
83444280|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83444281|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
83444282|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83444283|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83444284|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83444285|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
83444286|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444287|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444288|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444289|NCT03808805|Aprepitant|aprepitant|mesh-list
83444290|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
83444291|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
83444292|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
83444293|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
83444294|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444295|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444296|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83444297|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83444298|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444299|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444300|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
83444301|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
83444302|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83444303|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
83444304|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
83444305|NCT03803267|Fentanyl|fentanyl|mesh-list
83444306|NCT03803267|Propofol|propofol|mesh-list
83444307|NCT03803267|Atracurium|atracurium|mesh-list
83444308|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
83444309|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444310|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444311|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83444312|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83444313|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
83444314|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83444315|NCT03803267|Narcotics|narcotics|mesh-ancestor
83444316|NCT03803267|Analgesics|analgesics|mesh-ancestor
83444317|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
83444318|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444319|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83444320|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83444321|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83444322|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83444323|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83444324|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83444325|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
83444326|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444327|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444328|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83444329|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
83444330|NCT03808649|Mannitol|mannitol|mesh-list
83444331|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83444332|NCT03808649|Diuretics|diuretics|mesh-ancestor
83444333|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
83444334|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444335|NCT00788255|Oxytocin|oxytocin|mesh-list
83444336|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
83444337|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83444338|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444339|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83444340|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
83444341|NCT02379195|Fludarabine|fludarabine|mesh-list
83444342|NCT02379195|Interleukin-2|interleukin-2|mesh-list
83444343|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83444344|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
83444345|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444346|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444347|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83444348|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
83444349|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444350|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444351|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83444352|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444354|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
83444355|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444356|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
83444357|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444358|NCT00771875|Acetaminophen|acetaminophen|mesh-list
83444359|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
83444360|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
83444361|NCT00771875|Rituximab|rituximab|mesh-list
83444362|NCT00771875|Bortezomib|bortezomib|mesh-list
83444363|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
83444364|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83444365|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83444366|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
83444367|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83444368|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444369|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
83444370|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444371|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444372|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444373|NCT00771875|Analgesics|analgesics|mesh-ancestor
83444374|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
83444375|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444376|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
83444377|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83444378|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
83444379|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
83444380|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83444381|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
83444382|NCT00771875|Hormones|hormones|mesh-ancestor
83444383|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444384|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83444385|NCT00771875|Protective Agents|protective agents|mesh-ancestor
83444386|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83444387|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83444388|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83444389|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444390|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
83444391|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
83444392|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
83444393|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444394|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444395|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83444396|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83444397|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83444398|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444399|NCT00760019|Analgesics|analgesics|mesh-ancestor
83444400|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
83444401|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444402|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444403|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83444404|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444405|NCT00789113|Lamotrigine|lamotrigine|mesh-list
83444406|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
83444407|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83444408|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83444409|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444410|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83444411|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444412|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83444413|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83444414|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444415|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83444416|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83444417|NCT03808259|Ketamine|ketamine|mesh-list
83444418|NCT03808259|Esketamine|esketamine|mesh-list
83444419|NCT03808259|Analgesics|analgesics|mesh-ancestor
83444420|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
83444421|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444422|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444423|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83444424|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83444425|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
83444426|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
83444427|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444428|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83444429|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83444430|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444431|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444432|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
83444433|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83444434|NCT02051595|Vancomycin|vancomycin|mesh-list
83444435|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83444436|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444437|NCT05742503|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83444438|NCT05742503|Medroxyprogesterone|medroxyprogesterone|mesh-list
83444439|NCT05742503|Etonogestrel|etonogestrel|mesh-list
83444440|NCT05742503|Norgestrel|norgestrel|mesh-list
83444441|NCT05742503|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83444442|NCT05742503|Contraceptive Agents|contraceptive agents|mesh-ancestor
83444443|NCT05742503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83444444|NCT05742503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444445|NCT05742503|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83444446|NCT05742503|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83444447|NCT05742503|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83444448|NCT05742503|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83444449|NCT05742503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83444450|NCT05742503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444451|NCT05742503|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83444452|NCT02388321|Fentanyl|fentanyl|mesh-list
83444453|NCT02388321|Ketamine|ketamine|mesh-list
83444454|NCT02388321|Analgesics|analgesics|mesh-ancestor
83444455|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
83444456|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444457|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444458|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83444459|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83444460|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
83444461|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
83444462|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444463|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83444464|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83444465|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444466|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444467|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83444468|NCT02388321|Narcotics|narcotics|mesh-ancestor
83444469|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83444470|NCT05742425|Bevacizumab|bevacizumab|mesh-list
83444471|NCT05742425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83444472|NCT05742425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444473|NCT05742425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83444474|NCT05742425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83444475|NCT05742425|Growth Substances|growth substances|mesh-ancestor
83444476|NCT05742425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444477|NCT05742425|Growth Inhibitors|growth inhibitors|mesh-ancestor
83444478|NCT02313675|Acetaminophen|acetaminophen|mesh-list
83444479|NCT02313675|Ketorolac|ketorolac|mesh-list
83444480|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83444481|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444482|NCT02313675|Analgesics|analgesics|mesh-ancestor
83444483|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
83444484|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444485|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444486|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
83444487|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83444488|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83444489|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444490|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83444491|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444492|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444494|NCT05568797|Immunologic Factors|immunologic factors|mesh-ancestor
83444495|NCT05568797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444496|NCT03801629|Morphine|morphine|mesh-list
83444497|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83444498|NCT03801629|Narcotics|narcotics|mesh-ancestor
83444499|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444500|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444501|NCT03801629|Analgesics|analgesics|mesh-ancestor
83444502|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
83444503|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444504|NCT05741021|Paclitaxel|paclitaxel|mesh-list
83444505|NCT05741021|Carboplatin|carboplatin|mesh-list
83444506|NCT05741021|Pemetrexed|pemetrexed|mesh-list
83444507|NCT05741021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83444508|NCT05741021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444509|NCT05741021|Tubulin Modulators|tubulin modulators|mesh-ancestor
83444510|NCT05741021|Antimitotic Agents|antimitotic agents|mesh-ancestor
83444511|NCT05741021|Mitosis Modulators|mitosis modulators|mesh-ancestor
83444512|NCT05741021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444513|NCT05741021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444514|NCT05741021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83444515|NCT05741021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83444516|NCT04383977|Etoposide|etoposide|mesh-list
83444517|NCT04383977|Apatinib|apatinib|mesh-list
83444518|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83444519|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444520|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83444521|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83444522|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444523|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444524|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83444525|NCT02389959|Bevacizumab|bevacizumab|mesh-list
83444526|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83444527|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444528|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83444529|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83444530|NCT02389959|Growth Substances|growth substances|mesh-ancestor
83444531|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444532|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
83444533|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
83444534|NCT00775931|Busulfan|busulfan|mesh-list
83444535|NCT00775931|Fludarabine|fludarabine|mesh-list
83444536|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
83444537|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
83444538|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83444539|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
83444540|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444541|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444542|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83444543|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
83444544|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444545|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444546|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83444547|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83444548|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
83444549|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83444550|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83444551|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83444552|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83444553|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
83444554|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444555|NCT05734235|Vitamins|vitamins|mesh-list
83444556|NCT05734235|Vitamin E|vitamin e|mesh-list
83444557|NCT05734235|Micronutrients|micronutrients|mesh-ancestor
83444558|NCT05734235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444559|NCT05734235|Antioxidants|antioxidants|mesh-ancestor
83444560|NCT05734235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444561|NCT05734235|Protective Agents|protective agents|mesh-ancestor
83444562|NCT05732129|Irinotecan|irinotecan|mesh-list
83444563|NCT05732129|Fluzoparib|fluzoparib|mesh-list
83444564|NCT05732129|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83444565|NCT05732129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83444566|NCT05732129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444567|NCT05732129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444568|NCT05732129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444569|NCT05732129|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83444571|NCT02394951|Analgesics|analgesics|mesh-ancestor
83444572|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
83444573|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444574|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444575|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
83444576|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83444577|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83444578|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444579|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83444580|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83444581|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83444582|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444583|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83444584|NCT03838367|Leronlimab|leronlimab|mesh-list
83444585|NCT03838367|Carboplatin|carboplatin|mesh-list
83444586|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
83444587|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444588|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83444589|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83444590|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444591|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83444592|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83444593|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
83444594|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444595|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
83444596|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444597|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
83444598|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83444599|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
83444600|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444601|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
83444602|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83444603|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83444604|NCT04345445|Prednisolone|prednisolone|mesh-list
83444605|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
83444606|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83444607|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
83444608|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83444609|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
83444610|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
83444611|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444612|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444613|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83444614|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
83444615|NCT04345445|Hormones|hormones|mesh-ancestor
83444616|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444617|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83444618|NCT04345445|Protective Agents|protective agents|mesh-ancestor
83444619|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83444620|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444621|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
83444622|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83444623|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444624|NCT05713877|Melatonin|melatonin|mesh-list
83444625|NCT05713877|Antioxidants|antioxidants|mesh-ancestor
83444626|NCT05713877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444627|NCT05713877|Protective Agents|protective agents|mesh-ancestor
83444628|NCT05713877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444629|NCT05713877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444630|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83444631|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83444632|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444633|NCT00795275|Incretins|incretins|mesh-ancestor
83444634|NCT00795275|Hormones|hormones|mesh-ancestor
83444635|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444636|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83444637|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
83444638|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444639|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444640|NCT00777335|Panobinostat|panobinostat|mesh-list
83444641|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444642|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83444643|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444644|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444645|NCT04896645|Albuterol|albuterol|mesh-list
83444646|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83444647|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
83444648|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444649|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444650|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83444651|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
83444652|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
83444653|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83444654|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83444655|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83444656|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83444657|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
83444658|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444659|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444660|NCT05644587|Buprenorphine|buprenorphine|mesh-list
83444661|NCT05644587|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83444662|NCT05644587|Naloxone|naloxone|mesh-list
83444663|NCT05644587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83444664|NCT05644587|Narcotics|narcotics|mesh-ancestor
83444665|NCT05644587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444666|NCT05644587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444667|NCT05644587|Analgesics|analgesics|mesh-ancestor
83444668|NCT05644587|Sensory System Agents|sensory system agents|mesh-ancestor
83444669|NCT05644587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444670|NCT05644587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83444671|NCT03801863|Ropivacaine|ropivacaine|mesh-list
83444672|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
83444673|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
83444674|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444675|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444676|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
83444677|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444678|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
83444679|NCT00355407|Hematinics|hematinics|mesh-ancestor
83444680|NCT00355251|Atorvastatin|atorvastatin|mesh-list
83444681|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83444682|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83444683|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
83444684|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444685|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83444686|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83444687|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444688|NCT03832127|Fludarabine|fludarabine|mesh-list
83444689|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444690|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83444691|NCT04876131|Gentamicins|gentamicins|mesh-list
83444692|NCT04876131|Cephalexin|cephalexin|mesh-list
83444693|NCT04876131|Penicillin G|penicillin g|mesh-list
83444694|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83444695|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
83444696|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444697|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83444698|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444699|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444700|NCT04825275|Posaconazole|posaconazole|mesh-list
83444701|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
83444702|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444703|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83444704|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83444705|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83444706|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83444707|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83444708|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444709|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444710|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83444711|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
83444712|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444713|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444714|NCT00791219|Itraconazole|itraconazole|mesh-list
83444715|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83444716|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
83444717|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444718|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83444719|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83444720|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444721|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444722|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83444723|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
83444724|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444725|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444726|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83444727|NCT04818489|Colchicine|colchicine|mesh-list
83444728|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
83444729|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444730|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
83444731|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
83444732|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
83444733|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444734|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444735|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
83444736|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83444737|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
83444738|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444739|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
83444740|NCT00797459|Protective Agents|protective agents|mesh-ancestor
83444741|NCT04807101|Midazolam|midazolam|mesh-list
83444742|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83444743|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83444744|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444745|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444746|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83444747|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83444748|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83444749|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83444750|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
83444751|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
83444752|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
83444753|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
83444754|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444755|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444756|NCT00355953|Genistein|genistein|mesh-list
83444757|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83444758|NCT00355953|Protective Agents|protective agents|mesh-ancestor
83444759|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444760|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444761|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83444762|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444763|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444764|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
83444765|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83444766|NCT00355953|Estrogens|estrogens|mesh-ancestor
83444767|NCT00355953|Hormones|hormones|mesh-ancestor
83444768|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444769|NCT05419193|Propranolol|propranolol|mesh-list
83444770|NCT05419193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83444771|NCT05419193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83444772|NCT05419193|Adrenergic Agents|adrenergic agents|mesh-ancestor
83444773|NCT05419193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444774|NCT05419193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444775|NCT05419193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444776|NCT05419193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83444777|NCT05419193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83444778|NCT05419193|Vasodilator Agents|vasodilator agents|mesh-ancestor
83444779|NCT05416073|Sufentanil|sufentanil|mesh-list
83444781|NCT05416073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83444782|NCT05416073|Narcotics|narcotics|mesh-ancestor
83444783|NCT05416073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444784|NCT05416073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444785|NCT05416073|Analgesics|analgesics|mesh-ancestor
83444786|NCT05416073|Sensory System Agents|sensory system agents|mesh-ancestor
83444787|NCT05416073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444788|NCT05416073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83444789|NCT05416073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83444790|NCT05416073|Anesthetics, General|anesthetics, general|mesh-ancestor
83444791|NCT05416073|Anesthetics|anesthetics|mesh-ancestor
83444792|NCT05416073|Antidepressive Agents|antidepressive agents|mesh-ancestor
83444793|NCT05416073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83444794|NCT05664971|Paclitaxel|paclitaxel|mesh-list
83444795|NCT05664971|Etoposide|etoposide|mesh-list
83444796|NCT05664971|Docetaxel|docetaxel|mesh-list
83444797|NCT05664971|Carboplatin|carboplatin|mesh-list
83444798|NCT05664971|Pemetrexed|pemetrexed|mesh-list
83444799|NCT05664971|Antibodies|antibodies|mesh-list
83444800|NCT05664971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83444801|NCT05664971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83444802|NCT05664971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444803|NCT05664971|Tubulin Modulators|tubulin modulators|mesh-ancestor
83444804|NCT05664971|Antimitotic Agents|antimitotic agents|mesh-ancestor
83444805|NCT05664971|Mitosis Modulators|mitosis modulators|mesh-ancestor
83444806|NCT05664971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444807|NCT05664971|Immunologic Factors|immunologic factors|mesh-ancestor
83444808|NCT05664971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444809|NCT05664971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83444810|NCT05664971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83444811|NCT05664971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444812|NCT05664971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83444813|NCT05664971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83444814|NCT05594667|Psilocybin|psilocybin|mesh-list
83444815|NCT05594667|Hallucinogens|hallucinogens|mesh-ancestor
83444816|NCT05594667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444817|NCT05594667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83444818|NCT05590299|Immunomodulating Agents|immunomodulating agents|mesh-list
83444819|NCT05590299|Immunologic Factors|immunologic factors|mesh-list
83444820|NCT05590299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444821|NCT04812509|Denosumab|denosumab|mesh-list
83444822|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83444823|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444824|NCT05446623|Sufentanil|sufentanil|mesh-list
83444825|NCT05446623|Dexmedetomidine|dexmedetomidine|mesh-list
83444826|NCT05446623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83444827|NCT05446623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444828|NCT05446623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444829|NCT05446623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444830|NCT05446623|Analgesics|analgesics|mesh-ancestor
83444831|NCT05446623|Sensory System Agents|sensory system agents|mesh-ancestor
83444832|NCT05446623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444833|NCT05446623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83444834|NCT05446623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83444835|NCT05446623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83444836|NCT05446623|Adrenergic Agents|adrenergic agents|mesh-ancestor
83444837|NCT05446623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83444838|NCT05446623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444839|NCT05446623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83444840|NCT05446623|Narcotics|narcotics|mesh-ancestor
83444841|NCT05446623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83444842|NCT05446623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83444843|NCT05446623|Anesthetics, General|anesthetics, general|mesh-ancestor
83444844|NCT05446623|Anesthetics|anesthetics|mesh-ancestor
83444845|NCT00792077|Lenalidomide|lenalidomide|mesh-list
83444846|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
83444847|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444848|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83444849|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83444850|NCT00792077|Growth Substances|growth substances|mesh-ancestor
83444851|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
83444852|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444854|NCT02979015|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83444855|NCT02979015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83444856|NCT02979015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83444857|NCT02979015|Antimetabolites|antimetabolites|mesh-ancestor
83444858|NCT02979015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444859|NCT02979015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83444860|NCT02979015|Protease Inhibitors|protease inhibitors|mesh-ancestor
83444861|NCT02979015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444862|NCT02979015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83444863|NCT04647435|Tramadol|tramadol|mesh-list
83444864|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83444865|NCT04647435|Narcotics|narcotics|mesh-ancestor
83444866|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444867|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444868|NCT04647435|Analgesics|analgesics|mesh-ancestor
83444869|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
83444870|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444871|NCT04637529|Ibuprofen|ibuprofen|mesh-list
83444872|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83444873|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444874|NCT04637529|Analgesics|analgesics|mesh-ancestor
83444875|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
83444876|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444877|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444878|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83444879|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444880|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83444881|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444882|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444883|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83444884|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
83444885|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83444886|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444887|NCT00799643|Analgesics|analgesics|mesh-ancestor
83444888|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
83444889|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444890|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444891|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83444892|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444893|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83444894|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444895|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444896|NCT03835013|Exenatide|exenatide|mesh-list
83444897|NCT03835013|Glucagon|glucagon|mesh-list
83444898|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83444899|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83444900|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444901|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83444902|NCT03835013|Incretins|incretins|mesh-ancestor
83444903|NCT03835013|Hormones|hormones|mesh-ancestor
83444904|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444905|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83444906|NCT05555823|Repaglinide|repaglinide|mesh-list
83444907|NCT05555823|Celecoxib|celecoxib|mesh-list
83444908|NCT05555823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83444909|NCT05555823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83444910|NCT05555823|Analgesics|analgesics|mesh-ancestor
83444911|NCT05555823|Sensory System Agents|sensory system agents|mesh-ancestor
83444912|NCT05555823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444913|NCT05555823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444914|NCT05555823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83444915|NCT05555823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83444916|NCT05555823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83444917|NCT05555823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83444918|NCT05555823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444919|NCT05555823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444920|NCT05555823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83444921|NCT00800345|Topotecan|topotecan|mesh-list
83444922|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83444923|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83444924|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444925|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444926|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444927|NCT03806751|Acetazolamide|acetazolamide|mesh-list
83444928|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
83444929|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83444930|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444931|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444932|NCT03806751|Diuretics|diuretics|mesh-ancestor
83444933|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
83444934|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444935|NCT04383275|Capecitabine|capecitabine|mesh-list
83444936|NCT04383275|Trastuzumab|trastuzumab|mesh-list
83444937|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83444938|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
83444939|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444940|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444941|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83444942|NCT03973229|Estradiol|estradiol|mesh-list
83444943|NCT03973229|Estrogens|estrogens|mesh-ancestor
83444944|NCT03973229|Hormones|hormones|mesh-ancestor
83444945|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444946|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444948|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
83444949|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83444950|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83444951|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444952|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444953|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444954|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
83444955|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
83444956|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
83444957|NCT05319015|Lenvatinib|lenvatinib|mesh-list
83444958|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83444959|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444960|NCT05319015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83444961|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444962|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83444963|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444964|NCT00810719|Gemcitabine|gemcitabine|mesh-list
83444965|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83444966|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83444967|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
83444968|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444969|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444970|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83444971|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444972|NCT03761277|Morphine|morphine|mesh-list
83444973|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83444974|NCT03761277|Narcotics|narcotics|mesh-ancestor
83444975|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83444976|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444977|NCT03761277|Analgesics|analgesics|mesh-ancestor
83444978|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
83444979|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83444980|NCT00810797|Exemestane|exemestane|mesh-list
83444981|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444982|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83444983|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83444984|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444985|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444986|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83444987|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
83444988|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444989|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444990|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83444991|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83444992|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
83444993|NCT04340505|Hormones|hormones|mesh-ancestor
83444994|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83444995|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444997|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
83444998|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83444999|NCT04693715|RNS60|rns60|mesh-list
83445000|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83445001|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83445002|NCT04693715|Analgesics|analgesics|mesh-ancestor
83445003|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
83445004|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445005|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445006|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83445007|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445008|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83445009|NCT00355641|Ropinirole|ropinirole|mesh-list
83445010|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83445011|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83445012|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
83445013|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
83445014|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445015|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445016|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445017|NCT05268237|Liraglutide|liraglutide|mesh-list
83445018|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83445019|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445020|NCT05268237|Incretins|incretins|mesh-ancestor
83445022|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83445023|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
83445024|NCT00356733|Hematinics|hematinics|mesh-ancestor
83445025|NCT04591925|Insulin|insulin|mesh-list
83445026|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83445027|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83445028|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445029|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83445030|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83445031|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83445032|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
83445033|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83445034|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83445035|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83445036|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445037|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445038|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
83445039|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445040|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445041|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83445042|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445043|NCT00801827|Fallypride|fallypride|mesh-list
83445044|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83445045|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83445046|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
83445047|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445048|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445049|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445050|NCT04112823|Dexamethasone|dexamethasone|mesh-list
83445051|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
83445052|NCT04112823|BB 1101|bb 1101|mesh-list
83445053|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83445054|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
83445055|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
83445056|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445057|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445058|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83445059|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
83445060|NCT04112823|Hormones|hormones|mesh-ancestor
83445061|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83445062|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83445063|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445064|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
83445065|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445066|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445067|NCT00802685|Ibuprofen|ibuprofen|mesh-list
83445068|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83445069|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83445070|NCT00802685|Analgesics|analgesics|mesh-ancestor
83445071|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
83445072|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445073|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445074|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83445075|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445076|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83445077|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445078|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445079|NCT03496623|Treprostinil|treprostinil|mesh-list
83445080|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83445081|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83445082|NCT00802919|Varenicline|varenicline|mesh-list
83445083|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83445084|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83445085|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
83445086|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445087|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445088|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445089|NCT04467905|Etripamil|etripamil|mesh-list
83445090|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83445091|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445092|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445093|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83445094|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445095|NCT00803543|Valacyclovir|valacyclovir|mesh-list
83445096|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
83445097|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445098|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
83445099|NCT04099641|Bavituximab|bavituximab|mesh-list
83445100|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83445101|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445102|NCT04099641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83445103|NCT04099641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445104|NCT05051735|Acetaminophen|acetaminophen|mesh-list
83445105|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83445106|NCT05051735|Analgesics|analgesics|mesh-ancestor
83445107|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
83445108|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445109|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445110|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
83445111|NCT04098237|Pancrelipase|pancrelipase|mesh-list
83445112|NCT04098237|Pancreatin|pancreatin|mesh-list
83445113|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83445114|NCT04095221|Irinotecan|irinotecan|mesh-list
83445115|NCT04095221|Prexasertib|prexasertib|mesh-list
83445116|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83445117|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83445118|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445119|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445120|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445121|NCT04095221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83445122|NCT03357627|Venetoclax|venetoclax|mesh-list
83445123|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445124|NCT04923113|Amoxicillin|amoxicillin|mesh-list
83445125|NCT04923113|Minocycline|minocycline|mesh-list
83445126|NCT04923113|Rabeprazole|rabeprazole|mesh-list
83445127|NCT04923113|Bismuth|bismuth|mesh-list
83445128|NCT04923113|Antibodies|antibodies|mesh-list
83445129|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
83445130|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445131|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83445132|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445133|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83445134|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83445135|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83445136|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445137|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445138|NCT04923113|Antacids|antacids|mesh-ancestor
83445139|NCT03250923|Acemannan|acemannan|mesh-list
83445140|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83445141|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
83445142|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445143|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445144|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
83445145|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445146|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83445147|NCT00805493|Riluzole|riluzole|mesh-list
83445148|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
83445149|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83445150|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83445151|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445152|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445153|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445154|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83445155|NCT00805493|Protective Agents|protective agents|mesh-ancestor
83445156|NCT03236649|Sorafenib|sorafenib|mesh-list
83445157|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445158|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83445159|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445160|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445161|NCT00807209|Fentanyl|fentanyl|mesh-list
83445162|NCT00807209|Bupivacaine|bupivacaine|mesh-list
83445163|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
83445164|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
83445165|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445166|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445167|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
83445168|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445169|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83445170|NCT00807209|Narcotics|narcotics|mesh-ancestor
83445172|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83445173|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83445174|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
83445175|NCT03220035|Vemurafenib|vemurafenib|mesh-list
83445176|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445177|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83445178|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445179|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445180|NCT00807989|Lamotrigine|lamotrigine|mesh-list
83445181|NCT00807989|Carbamazepine|carbamazepine|mesh-list
83445182|NCT00807989|Valproic Acid|valproic acid|mesh-list
83445183|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
83445184|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83445185|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445186|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445187|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83445188|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445189|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83445190|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83445191|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445192|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83445193|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83445194|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445195|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
83445196|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445197|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
83445198|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83445199|NCT00807989|Analgesics|analgesics|mesh-ancestor
83445200|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
83445201|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445202|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83445203|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83445204|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83445205|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
83445206|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83445207|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83445208|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
83445209|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445210|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83445211|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83445212|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445213|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445214|NCT04845490|Mitomycins|mitomycins|mesh-list
83445215|NCT04845490|Mitomycin|mitomycin|mesh-list
83445216|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83445217|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445218|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
83445219|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445220|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83445221|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445222|NCT00357045|Paroxetine|paroxetine|mesh-list
83445223|NCT00357045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83445224|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83445225|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445226|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445227|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445228|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
83445229|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445230|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83445231|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
83445232|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83445233|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83445234|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83445235|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445236|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
83445237|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83445238|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83445239|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445240|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445241|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83445242|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445243|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445244|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
83445245|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445246|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83445247|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83445248|NCT04819360|Urological Agents|urological agents|mesh-ancestor
83445249|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83445250|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83445251|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83445252|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
83445253|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445254|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83445255|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83445256|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445257|NCT04436458|Niclosamide|niclosamide|mesh-list
83445258|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
83445259|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83445260|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
83445261|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83445262|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445263|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
83445264|NCT03834753|Bevacizumab|bevacizumab|mesh-list
83445265|NCT03834753|Ranibizumab|ranibizumab|mesh-list
83445266|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83445267|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445268|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83445269|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83445270|NCT03834753|Growth Substances|growth substances|mesh-ancestor
83445271|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445272|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
83445273|NCT00845039|Irinotecan|irinotecan|mesh-list
83445274|NCT00845039|Cetuximab|cetuximab|mesh-list
83445275|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83445276|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83445277|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83445278|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445279|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445280|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445281|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83445282|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
83445283|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445284|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83445285|NCT00845195|Azelastine|azelastine|mesh-list
83445286|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83445287|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83445288|NCT00845195|Analgesics|analgesics|mesh-ancestor
83445289|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
83445290|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445291|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445292|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83445293|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445294|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83445295|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83445296|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83445297|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
83445298|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
83445299|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445300|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445301|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83445302|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
83445303|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83445304|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
83445305|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83445306|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445307|NCT00845507|Exenatide|exenatide|mesh-list
83445308|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83445309|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445310|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83445311|NCT00845507|Incretins|incretins|mesh-ancestor
83445312|NCT00845507|Hormones|hormones|mesh-ancestor
83445313|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83445314|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
83445315|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83445316|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445317|NCT03761914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83445318|NCT03761914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445319|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
83445320|NCT00845663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83445321|NCT00845663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83445322|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83445323|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
83445324|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445325|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445326|NCT03500380|Capecitabine|capecitabine|mesh-list
83445327|NCT03500380|Lapatinib|lapatinib|mesh-list
83445328|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83445329|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
83445330|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445331|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445332|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83445333|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445334|NCT00534430|Cyclosporine|cyclosporine|mesh-list
83445335|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
83445336|NCT00534430|Etoposide|etoposide|mesh-list
83445337|NCT00534430|Busulfan|busulfan|mesh-list
83445338|NCT00534430|Cyclosporins|cyclosporins|mesh-list
83445339|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83445340|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445341|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83445342|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83445343|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445344|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445345|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83445346|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
83445347|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445348|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
83445349|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445350|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
83445351|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445352|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83445353|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83445354|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83445355|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
83445356|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83445357|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
83445358|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83445359|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83445360|NCT03092895|Apatinib|apatinib|mesh-list
83445361|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445362|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83445363|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445364|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445365|NCT03839771|Ivosidenib|ivosidenib|mesh-list
83445366|NCT03839771|Glycine|glycine|mesh-list
83445367|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445368|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445369|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445370|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
83445371|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445372|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445373|NCT03033225|Verteporfin|verteporfin|mesh-list
83445374|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83445375|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
83445376|NCT02593396|Bupropion|bupropion|mesh-list
83445377|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83445378|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
83445379|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83445380|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83445381|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83445382|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445383|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445384|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
83445385|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445386|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445387|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83445388|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83445389|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445390|NCT00848783|Capecitabine|capecitabine|mesh-list
83445391|NCT00848783|Irinotecan|irinotecan|mesh-list
83445393|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445394|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83445395|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
83445396|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445397|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83445398|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83445399|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445400|NCT05372536|Cytarabine|cytarabine|mesh-list
83445401|NCT05372536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83445402|NCT05372536|Antimetabolites|antimetabolites|mesh-ancestor
83445403|NCT05372536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445404|NCT05372536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445405|NCT05372536|Antiviral Agents|antiviral agents|mesh-ancestor
83445406|NCT05372536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445407|NCT05372536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83445408|NCT05372536|Immunologic Factors|immunologic factors|mesh-ancestor
83445409|NCT05372536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445410|NCT00849251|Dexamethasone|dexamethasone|mesh-list
83445411|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
83445412|NCT00849251|Doxorubicin|doxorubicin|mesh-list
83445413|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83445414|NCT00849251|Bortezomib|bortezomib|mesh-list
83445415|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83445416|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
83445417|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445418|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445419|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83445420|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
83445421|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445422|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445423|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83445424|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83445425|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
83445426|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
83445427|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445428|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83445429|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
83445430|NCT00849251|Hormones|hormones|mesh-ancestor
83445431|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83445432|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83445433|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83445434|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83445435|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83445436|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445437|NCT00850889|Lidocaine|lidocaine|mesh-list
83445438|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
83445439|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
83445440|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
83445441|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445442|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445443|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
83445444|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445445|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83445446|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83445447|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83445448|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445449|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445450|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83445451|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
83445452|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
83445453|NCT00850889|Protective Agents|protective agents|mesh-ancestor
83445454|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
83445455|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83445456|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445457|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
83445458|NCT00851357|Nicotine|nicotine|mesh-list
83445459|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83445460|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
83445461|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445462|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445463|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83445464|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83445465|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
83445466|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445467|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445468|NCT05105074|Morphine|morphine|mesh-list
83445469|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83445470|NCT05105074|Narcotics|narcotics|mesh-ancestor
83445471|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445472|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445473|NCT05105074|Analgesics|analgesics|mesh-ancestor
83445474|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
83445475|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445476|NCT00364702|Methylphenidate|methylphenidate|mesh-list
83445477|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83445478|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445479|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83445480|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83445481|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445482|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445484|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445485|NCT00852761|Clobetasol|clobetasol|mesh-list
83445486|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83445487|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
83445488|NCT00852761|Hormones|hormones|mesh-ancestor
83445489|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83445490|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445491|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
83445492|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
83445493|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83445494|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
83445495|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445496|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445497|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83445498|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
83445499|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83445500|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
83445501|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445502|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445503|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83445504|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
83445505|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
83445506|NCT03839537|Protective Agents|protective agents|mesh-ancestor
83445507|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
83445508|NCT04082806|Trazodone|trazodone|mesh-list
83445509|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83445510|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83445511|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445512|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445513|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83445514|NCT04082806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83445515|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83445516|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445517|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445518|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445519|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
83445520|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83445521|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
83445522|NCT05635786|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83445523|NCT05635786|Tenecteplase|tenecteplase|mesh-list
83445524|NCT05635786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83445525|NCT05635786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83445526|NCT05635786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445527|NCT00365950|Warfarin|warfarin|mesh-list
83445528|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
83445529|NCT02487797|Oxytocin|oxytocin|mesh-list
83445530|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
83445531|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83445532|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445533|NCT01733693|Buprenorphine|buprenorphine|mesh-list
83445534|NCT01733693|Methadone|methadone|mesh-list
83445535|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83445536|NCT01733693|Narcotics|narcotics|mesh-ancestor
83445537|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445538|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445539|NCT01733693|Analgesics|analgesics|mesh-ancestor
83445540|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
83445541|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445542|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83445543|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
83445544|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
83445546|NCT00855413|Darunavir|darunavir|mesh-list
83445547|NCT00855413|Etravirine|etravirine|mesh-list
83445548|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83445549|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83445550|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
83445551|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445552|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445553|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83445554|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83445555|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
83445556|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445557|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83445558|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83445559|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83445560|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83445561|NCT05599984|Carboplatin|carboplatin|mesh-list
83445562|NCT05599984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445563|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
83445564|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83445565|NCT00366262|Naproxen|naproxen|mesh-list
83445566|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83445567|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83445568|NCT00366262|Analgesics|analgesics|mesh-ancestor
83445569|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
83445570|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445571|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445572|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83445573|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445574|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
83445575|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83445576|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445577|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445578|NCT00818363|Bupivacaine|bupivacaine|mesh-list
83445579|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
83445580|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
83445581|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445582|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445583|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
83445584|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445585|NCT00828841|Paclitaxel|paclitaxel|mesh-list
83445586|NCT00828841|Carboplatin|carboplatin|mesh-list
83445587|NCT00828841|Gemcitabine|gemcitabine|mesh-list
83445588|NCT00828841|Cetuximab|cetuximab|mesh-list
83445589|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83445590|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445591|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
83445592|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
83445593|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
83445594|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445595|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83445596|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
83445597|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83445598|NCT05445310|Aflutinib|aflutinib|mesh-list
83445599|NCT05445310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83445600|NCT05445310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445601|NCT05445310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445602|NCT00858689|Minocycline|minocycline|mesh-list
83445603|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83445604|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445605|NCT00821795|Insulin|insulin|mesh-list
83445606|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
83445607|NCT00821795|Protamines|protamines|mesh-list
83445608|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83445609|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445610|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
83445611|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445612|NCT00821795|Coagulants|coagulants|mesh-ancestor
83445613|NCT00833365|Ibuprofen|ibuprofen|mesh-list
83445614|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83445615|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83445616|NCT00833365|Analgesics|analgesics|mesh-ancestor
83445617|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
83445618|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445619|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445620|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83445621|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445622|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83445623|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445624|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445625|NCT00821951|Vorinostat|vorinostat|mesh-list
83445626|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445627|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83445628|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445629|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445630|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83445631|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
83445632|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83445633|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83445634|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83445635|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445636|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445637|NCT00860015|Gemcitabine|gemcitabine|mesh-list
83445638|NCT00860015|Pemetrexed|pemetrexed|mesh-list
83445639|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83445640|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
83445641|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445642|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445643|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445644|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83445645|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83445646|NCT00853333|Midazolam|midazolam|mesh-list
83445647|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
83445648|NCT00853333|Propofol|propofol|mesh-list
83445649|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83445650|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445651|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445652|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83445653|NCT00853333|Analgesics|analgesics|mesh-ancestor
83445654|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
83445655|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445656|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83445657|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83445658|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83445659|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
83445660|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445661|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445662|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83445663|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
83445664|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
83445665|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83445666|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83445667|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83445668|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83445669|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
83445670|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
83445671|NCT05227612|Psilocybin|psilocybin|mesh-list
83445672|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
83445673|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445674|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83445675|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83445676|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83445677|NCT00822107|Diuretics|diuretics|mesh-ancestor
83445678|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
83445679|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445680|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83445681|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445682|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445683|NCT05236907|Midazolam|midazolam|mesh-list
83445684|NCT05236907|Melatonin|melatonin|mesh-list
83445685|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83445686|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83445687|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445688|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445689|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83445690|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83445691|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83445692|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83445693|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
83445694|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
83445695|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
83445697|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445698|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445699|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
83445700|NCT05236907|Protective Agents|protective agents|mesh-ancestor
83445701|NCT05217706|Ketamine|ketamine|mesh-list
83445702|NCT05217706|Analgesics|analgesics|mesh-ancestor
83445703|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
83445704|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445705|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445706|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83445707|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83445708|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
83445709|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
83445710|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445711|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83445712|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83445713|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445714|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445715|NCT00833443|Bupropion|bupropion|mesh-list
83445716|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83445717|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
83445718|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83445719|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83445720|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83445721|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445722|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445723|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
83445724|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445725|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445726|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83445727|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83445728|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445729|NCT05207722|Aldesleukin|aldesleukin|mesh-list
83445730|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
83445731|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
83445732|NCT05207722|Trastuzumab|trastuzumab|mesh-list
83445733|NCT05207722|Fludarabine|fludarabine|mesh-list
83445734|NCT05207722|Interleukin-2|interleukin-2|mesh-list
83445735|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83445736|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
83445737|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445738|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445739|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83445740|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
83445741|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445742|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445743|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83445744|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83445745|NCT05207722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83445746|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83445747|NCT05207722|Analgesics|analgesics|mesh-ancestor
83445748|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
83445749|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445750|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83445751|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83445752|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
83445753|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445754|NCT00860171|Iodine|iodine|mesh-list
83445755|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
83445756|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83445757|NCT00860171|Antibodies|antibodies|mesh-list
83445758|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
83445759|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83445760|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
83445761|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445762|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445763|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83445764|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445765|NCT00860171|Trace Elements|trace elements|mesh-ancestor
83445766|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
83445767|NCT00366418|Rituximab|rituximab|mesh-list
83445768|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83445769|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445770|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
83445771|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445772|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445773|NCT00823043|Timolol|timolol|mesh-list
83445774|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445775|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83445776|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83445777|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
83445778|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445779|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445780|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83445781|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83445782|NCT00862745|Fesoterodine|fesoterodine|mesh-list
83445783|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83445784|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83445785|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
83445786|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445787|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445788|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445789|NCT00862745|Urological Agents|urological agents|mesh-ancestor
83445790|NCT02150759|Fentanyl|fentanyl|mesh-list
83445791|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
83445792|NCT02150759|Ketamine|ketamine|mesh-list
83445793|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83445794|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445795|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445796|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83445797|NCT02150759|Analgesics|analgesics|mesh-ancestor
83445798|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
83445799|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445800|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83445801|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83445802|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83445803|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
83445804|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445805|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445806|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83445807|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83445808|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
83445809|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
83445810|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83445811|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83445812|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83445813|NCT02150759|Narcotics|narcotics|mesh-ancestor
83445814|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83445815|NCT04991350|Bevacizumab|bevacizumab|mesh-list
83445816|NCT04991350|Ranibizumab|ranibizumab|mesh-list
83445817|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83445818|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445819|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83445820|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83445821|NCT04991350|Growth Substances|growth substances|mesh-ancestor
83445822|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445823|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
83445824|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
83445825|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
83445826|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445827|NCT04952194|Levodopa|levodopa|mesh-list
83445828|NCT04952194|Carbidopa|carbidopa|mesh-list
83445829|NCT04952194|Entacapone|entacapone|mesh-list
83445830|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83445831|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83445832|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
83445833|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445834|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445835|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445836|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83445837|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445838|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83445839|NCT00835159|Rivastigmine|rivastigmine|mesh-list
83445840|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83445842|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445843|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
83445844|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445845|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445846|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83445847|NCT00835159|Protective Agents|protective agents|mesh-ancestor
83445848|NCT04860856|Ropivacaine|ropivacaine|mesh-list
83445849|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
83445850|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
83445851|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83445852|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445853|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
83445854|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445855|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
83445856|NCT00827099|Fludarabine|fludarabine|mesh-list
83445857|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
83445858|NCT00827099|Melphalan|melphalan|mesh-list
83445859|NCT00827099|Tacrolimus|tacrolimus|mesh-list
83445860|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83445861|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445862|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83445863|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
83445864|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445865|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83445866|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
83445867|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445868|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83445869|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445870|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83445871|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83445872|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
83445873|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83445874|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445875|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83445876|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
83445877|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83445878|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83445879|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83445880|NCT00366652|Desipramine|desipramine|mesh-list
83445881|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83445882|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83445883|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445884|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445885|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445886|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445887|NCT00366652|Analgesics|analgesics|mesh-ancestor
83445888|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
83445889|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445890|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
83445891|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83445892|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
83445893|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83445894|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445895|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83445896|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
83445897|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
83445898|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83445899|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445900|NCT02617888|Bismuth|bismuth|mesh-list
83445901|NCT02617888|Antacids|antacids|mesh-ancestor
83445902|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445903|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83445904|NCT02620774|Tazobactam|tazobactam|mesh-list
83445905|NCT02620774|Ceftolozane|ceftolozane|mesh-list
83445906|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83445907|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83445908|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445909|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83445910|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445911|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445912|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83445913|NCT02625298|Pemetrexed|pemetrexed|mesh-list
83445914|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445915|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445916|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445917|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83445918|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83445919|NCT00858013|Glimepiride|glimepiride|mesh-list
83445920|NCT00858013|Nateglinide|nateglinide|mesh-list
83445921|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83445922|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83445923|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445924|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83445925|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
83445926|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
83445927|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445928|NCT00835861|Insulin|insulin|mesh-list
83445929|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83445930|NCT00835861|Metformin|metformin|mesh-list
83445931|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
83445932|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
83445933|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83445934|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445935|NCT00804973|Sumatriptan|sumatriptan|mesh-list
83445936|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83445937|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83445938|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83445939|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
83445940|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445941|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445942|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445943|NCT02628106|Alprostadil|alprostadil|mesh-list
83445944|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83445945|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
83445946|NCT02628106|Urological Agents|urological agents|mesh-ancestor
83445947|NCT02629354|Ibuprofen|ibuprofen|mesh-list
83445948|NCT02629354|Caffeine|caffeine|mesh-list
83445949|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83445950|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83445951|NCT02629354|Analgesics|analgesics|mesh-ancestor
83445952|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
83445953|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83445954|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445955|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83445956|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83445957|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83445958|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445959|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445960|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83445961|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83445962|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83445963|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83445964|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
83445965|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83445966|NCT02834247|Nivolumab|nivolumab|mesh-list
83445967|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83445968|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445969|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83445970|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445971|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
83445972|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
83445973|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83445974|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83445975|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445976|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83445977|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445978|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83445979|NCT02630992|Amoxicillin|amoxicillin|mesh-list
83445980|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
83445981|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
83445982|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83445983|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83445984|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83445985|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83445986|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83445987|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445988|NCT00836407|Ipilimumab|ipilimumab|mesh-list
83445989|NCT00836407|Vaccines|vaccines|mesh-list
83445990|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
83445991|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445992|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83445993|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83445994|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83445995|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83445996|NCT02631772|Ribavirin|ribavirin|mesh-list
83445997|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
83445998|NCT02631772|Ledipasvir|ledipasvir|mesh-list
83445999|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
83446000|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446001|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
83446002|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446003|NCT02633488|Metformin|metformin|mesh-list
83446004|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83446005|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446006|NCT00859339|Gemcitabine|gemcitabine|mesh-list
83446007|NCT00859339|Sunitinib|sunitinib|mesh-list
83446008|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446009|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83446010|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
83446011|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446012|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83446013|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83446014|NCT00859339|Growth Substances|growth substances|mesh-ancestor
83446015|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446016|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
83446017|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83446018|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446019|NCT00859495|Doxorubicin|doxorubicin|mesh-list
83446020|NCT00859495|Pemetrexed|pemetrexed|mesh-list
83446021|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446022|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83446023|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83446024|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83446025|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446026|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446027|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83446028|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83446029|NCT00355719|Ritonavir|ritonavir|mesh-list
83446030|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83446031|NCT00355719|Nevirapine|nevirapine|mesh-list
83446032|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83446033|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83446034|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
83446035|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446036|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446037|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83446038|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83446039|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
83446040|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446041|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83446042|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83446043|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83446044|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83446045|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83446046|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83446047|NCT00859651|Vitamin D|vitamin d|mesh-list
83446048|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
83446049|NCT00859651|Vitamins|vitamins|mesh-ancestor
83446050|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
83446051|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446052|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83446053|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83446054|NCT02633956|Atorvastatin|atorvastatin|mesh-list
83446055|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83446056|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83446057|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
83446058|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446059|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83446060|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83446062|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83446063|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
83446064|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446065|NCT00806221|Emollients|emollients|mesh-list
83446066|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
83446067|NCT02635828|Promethazine|promethazine|mesh-list
83446068|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
83446069|NCT02635828|Dexamethasone|dexamethasone|mesh-list
83446070|NCT02635828|Palonosetron|palonosetron|mesh-list
83446071|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83446072|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
83446073|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
83446074|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446075|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446076|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83446077|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
83446078|NCT02635828|Hormones|hormones|mesh-ancestor
83446079|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83446080|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83446081|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446082|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83446083|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83446084|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
83446085|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446086|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446087|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
83446088|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
83446089|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83446090|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
83446091|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
83446092|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83446093|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83446094|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83446095|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83446096|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
83446097|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
83446098|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
83446099|NCT02638168|Methylphenidate|methylphenidate|mesh-list
83446100|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83446101|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446102|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83446103|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83446104|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83446105|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446106|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
83446107|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446108|NCT00837031|Gemcitabine|gemcitabine|mesh-list
83446109|NCT00837031|Lenalidomide|lenalidomide|mesh-list
83446110|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83446111|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
83446112|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446113|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446114|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
83446115|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446116|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83446117|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83446118|NCT00837031|Growth Substances|growth substances|mesh-ancestor
83446119|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
83446120|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83446121|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83446122|NCT04344483|Lidocaine|lidocaine|mesh-list
83446123|NCT04344483|Epinephrine|epinephrine|mesh-list
83446124|NCT04344483|Racepinephrine|racepinephrine|mesh-list
83446125|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
83446126|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
83446127|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
83446128|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83446129|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446130|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
83446131|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446132|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83446133|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83446134|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83446135|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83446136|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446137|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83446138|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83446140|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446141|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83446142|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83446143|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
83446144|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83446145|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
83446146|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
83446147|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
83446148|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83446149|NCT02154763|Ropivacaine|ropivacaine|mesh-list
83446150|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
83446151|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
83446152|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83446153|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446154|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
83446155|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446156|NCT02641522|Siltuximab|siltuximab|mesh-list
83446157|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446158|NCT04964427|Methylphenidate|methylphenidate|mesh-list
83446159|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83446160|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446161|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83446162|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83446163|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83446164|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446165|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
83446166|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446167|NCT00357669|Brivaracetam|brivaracetam|mesh-list
83446168|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
83446169|NCT00357747|Docetaxel|docetaxel|mesh-list
83446170|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446171|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
83446172|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
83446173|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
83446174|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446175|NCT00863551|Trospium chloride|trospium chloride|mesh-list
83446176|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
83446177|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
83446178|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446179|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446180|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83446181|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83446182|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
83446183|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446184|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446185|NCT00863551|Urological Agents|urological agents|mesh-ancestor
83446186|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
83446187|NCT03838575|Gentamicins|gentamicins|mesh-list
83446188|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
83446189|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83446190|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83446191|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
83446192|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83446193|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446194|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446195|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83446196|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83446197|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83446198|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
83446199|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446200|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83446201|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83446202|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446203|NCT04339816|Azithromycin|azithromycin|mesh-list
83446204|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
83446206|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446207|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
83446208|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83446209|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83446210|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446211|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446212|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83446213|NCT05588908|Betamethasone|betamethasone|mesh-list
83446214|NCT05588908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83446215|NCT05588908|Antibodies|antibodies|mesh-list
83446216|NCT05588908|Immunoglobulins|immunoglobulins|mesh-list
83446217|NCT05588908|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83446218|NCT05588908|Immunologic Factors|immunologic factors|mesh-ancestor
83446219|NCT05588908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446220|NCT05588908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446221|NCT05588908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83446222|NCT05588908|Glucocorticoids|glucocorticoids|mesh-ancestor
83446223|NCT05588908|Hormones|hormones|mesh-ancestor
83446224|NCT05588908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83446225|NCT05588908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83446226|NCT05588908|Respiratory System Agents|respiratory system agents|mesh-ancestor
83446227|NCT05588830|Belimumab|belimumab|mesh-list
83446228|NCT05588830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83446229|NCT05588830|Immunologic Factors|immunologic factors|mesh-ancestor
83446230|NCT05588830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446231|NCT04740190|Carboplatin|carboplatin|mesh-list
83446232|NCT04740190|Talazoparib|talazoparib|mesh-list
83446233|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446234|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83446235|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446236|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446237|NCT00865969|Belinostat|belinostat|mesh-list
83446238|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446239|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83446240|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446241|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446242|NCT05588518|Propolis|propolis|mesh-list
83446243|NCT05588518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446244|NCT00866749|Cytarabine|cytarabine|mesh-list
83446245|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
83446246|NCT00866749|Doxorubicin|doxorubicin|mesh-list
83446247|NCT00866749|Methotrexate|methotrexate|mesh-list
83446248|NCT00866749|Vincristine|vincristine|mesh-list
83446249|NCT00866749|Daunorubicin|daunorubicin|mesh-list
83446250|NCT00866749|Asparaginase|asparaginase|mesh-list
83446251|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
83446252|NCT00866749|Thioguanine|thioguanine|mesh-list
83446253|NCT00866749|Pegaspargase|pegaspargase|mesh-list
83446254|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83446255|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
83446256|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446257|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83446258|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83446259|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
83446260|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446261|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446262|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83446263|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83446264|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83446265|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83446266|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446267|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83446268|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
83446269|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83446270|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83446271|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
83446272|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
83446273|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83446274|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83446275|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
83446276|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446277|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83446278|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
83446279|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
83446280|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
83446281|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
83446282|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83446283|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
83446284|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446285|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83446286|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83446287|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
83446288|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446289|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446290|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83446291|NCT05587426|Iproplatin|iproplatin|mesh-list
83446292|NCT05587426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446293|NCT00867139|Oseltamivir|oseltamivir|mesh-list
83446294|NCT00867139|Ribavirin|ribavirin|mesh-list
83446295|NCT00867139|Zanamivir|zanamivir|mesh-list
83446296|NCT00867139|Amantadine|amantadine|mesh-list
83446297|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
83446298|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
83446299|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446300|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446301|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446302|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
83446303|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83446304|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83446305|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
83446306|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446307|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446308|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83446309|NCT00867139|Analgesics|analgesics|mesh-ancestor
83446310|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
83446311|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446312|NCT05342818|Ondansetron|ondansetron|mesh-list
83446313|NCT05342818|Metoclopramide|metoclopramide|mesh-list
83446314|NCT05342818|Neostigmine|neostigmine|mesh-list
83446315|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
83446316|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
83446317|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446318|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446319|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83446320|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
83446321|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
83446322|NCT05342818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83446323|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83446324|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
83446325|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446326|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446327|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83446328|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446329|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
83446330|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83446331|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83446332|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83446333|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
83446334|NCT00867217|Vitamin D|vitamin d|mesh-list
83446335|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
83446336|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
83446337|NCT00867217|Vitamins|vitamins|mesh-list
83446338|NCT00867217|Letrozole|letrozole|mesh-list
83446339|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
83446340|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446341|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83446342|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83446343|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446344|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83446345|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83446346|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446347|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446348|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83446349|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
83446350|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83446351|NCT00867451|Melatonin|melatonin|mesh-list
83446352|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
83446353|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446354|NCT00867451|Protective Agents|protective agents|mesh-ancestor
83446355|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446356|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83446357|NCT00867529|Rituximab|rituximab|mesh-list
83446358|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83446359|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446360|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
83446361|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446362|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83446363|NCT05197270|Aflibercept|aflibercept|mesh-list
83446364|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83446365|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83446366|NCT05197270|Growth Substances|growth substances|mesh-ancestor
83446367|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446368|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
83446369|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446370|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
83446371|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
83446372|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446373|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83446374|NCT00889915|Methylphenidate|methylphenidate|mesh-list
83446375|NCT00889915|Amphetamine|amphetamine|mesh-list
83446376|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83446377|NCT00889915|Adderall|adderall|mesh-list
83446378|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83446379|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446380|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83446381|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83446382|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83446383|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446384|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
83446385|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446386|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
83446387|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
83446388|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446389|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
83446390|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83446391|NCT00841087|Insulin|insulin|mesh-list
83446392|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83446393|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
83446394|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
83446395|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83446396|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446397|NCT02685436|Domperidone|domperidone|mesh-list
83446398|NCT02685436|Omeprazole|omeprazole|mesh-list
83446399|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83446400|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83446401|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83446402|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446403|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446404|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
83446405|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
83446406|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446407|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446408|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83446409|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
83446410|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446411|NCT00841555|Temozolomide|temozolomide|mesh-list
83446412|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83446413|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
83446414|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446415|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446416|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83446417|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
83446418|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
83446419|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
83446420|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446421|NCT00868309|Antivenins|antivenins|mesh-list
83446422|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
83446423|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446424|NCT00368134|Vildagliptin|vildagliptin|mesh-list
83446425|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83446426|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446427|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83446428|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
83446429|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446430|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446431|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
83446432|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83446434|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
83446435|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83446436|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
83446437|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446438|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
83446439|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83446440|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446441|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83446442|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446443|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83446444|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83446445|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83446446|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83446447|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446448|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83446449|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83446450|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83446451|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83446452|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
83446453|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446454|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446455|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83446456|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83446457|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
83446458|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83446459|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83446460|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
83446461|NCT02701582|Phenylephrine|phenylephrine|mesh-list
83446462|NCT02701582|Epinephrine|epinephrine|mesh-list
83446463|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
83446464|NCT02701582|Synephrine|synephrine|mesh-list
83446465|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83446466|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83446467|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
83446468|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446469|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446470|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446471|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83446472|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83446473|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
83446474|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446475|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83446476|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
83446477|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
83446478|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
83446479|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83446480|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83446481|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
83446482|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83446483|NCT02701582|Protective Agents|protective agents|mesh-ancestor
83446484|NCT00869791|Levodopa|levodopa|mesh-list
83446485|NCT00869791|Carbidopa|carbidopa|mesh-list
83446486|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83446487|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83446488|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83446489|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
83446490|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446491|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446492|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446493|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83446494|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446495|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83446496|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
83446497|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
83446498|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83446499|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83446500|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83446501|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
83446502|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446503|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83446504|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83446505|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446506|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
83446507|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
83446508|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83446509|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446510|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83446511|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
83446512|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83446513|NCT01622335|Analgesics|analgesics|mesh-ancestor
83446514|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
83446515|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446516|NCT00895531|Morphine|morphine|mesh-list
83446517|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83446518|NCT00895531|Narcotics|narcotics|mesh-ancestor
83446519|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83446520|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446521|NCT00895531|Analgesics|analgesics|mesh-ancestor
83446522|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
83446523|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446524|NCT03215875|Torsemide|torsemide|mesh-list
83446525|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83446526|NCT03215875|Diuretics|diuretics|mesh-ancestor
83446527|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
83446528|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446529|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83446530|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83446531|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446532|NCT02710630|Dabigatran|dabigatran|mesh-list
83446533|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
83446534|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83446535|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
83446536|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446537|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446538|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
83446539|NCT02715700|Methadone|methadone|mesh-list
83446540|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83446541|NCT02715700|Narcotics|narcotics|mesh-ancestor
83446542|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83446543|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446544|NCT02715700|Analgesics|analgesics|mesh-ancestor
83446545|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
83446546|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446547|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
83446548|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
83446549|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
83446550|NCT00338377|Fludarabine|fludarabine|mesh-list
83446551|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
83446552|NCT00338377|Interleukin-2|interleukin-2|mesh-list
83446553|NCT00338377|Mesna|mesna|mesh-list
83446554|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83446555|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
83446556|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446557|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83446558|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83446559|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
83446560|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446561|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446562|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83446563|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83446565|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83446566|NCT00338377|Analgesics|analgesics|mesh-ancestor
83446567|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
83446568|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446569|NCT00338377|Protective Agents|protective agents|mesh-ancestor
83446570|NCT00895921|Olanzapine|olanzapine|mesh-list
83446571|NCT00895921|Aripiprazole|aripiprazole|mesh-list
83446572|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
83446573|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
83446574|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446575|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446576|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83446577|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83446578|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83446579|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83446580|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83446581|NCT00895921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83446582|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83446583|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83446584|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446585|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446586|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
83446587|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
83446588|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
83446589|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
83446590|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83446591|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83446592|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83446593|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83446594|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83446595|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83446596|NCT05315479|Meloxicam|meloxicam|mesh-list
83446597|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83446598|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83446599|NCT05315479|Analgesics|analgesics|mesh-ancestor
83446600|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
83446601|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446602|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446603|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83446604|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83446605|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83446606|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83446607|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446608|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446609|NCT00883675|Carboplatin|carboplatin|mesh-list
83446610|NCT00883675|Docetaxel|docetaxel|mesh-list
83446611|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446612|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
83446613|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
83446614|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
83446615|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446616|NCT03215407|Betamethasone|betamethasone|mesh-list
83446617|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83446618|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
83446619|NCT03215407|Hormones|hormones|mesh-ancestor
83446620|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83446621|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446622|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83446623|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
83446624|NCT05310331|Paclitaxel|paclitaxel|mesh-list
83446625|NCT05310331|Antibodies|antibodies|mesh-list
83446626|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83446627|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446628|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
83446629|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
83446630|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
83446631|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446632|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
83446633|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446634|NCT00885079|Rebamipide|rebamipide|mesh-list
83446635|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83446636|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83446637|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83446638|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83446639|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
83446640|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446641|NCT00885079|Protective Agents|protective agents|mesh-ancestor
83446642|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446643|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446644|NCT00896779|Ranibizumab|ranibizumab|mesh-list
83446645|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83446646|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83446647|NCT00896779|Growth Substances|growth substances|mesh-ancestor
83446648|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446649|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
83446650|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446651|NCT03214939|Immunomodulating Agents|immunomodulating agents|mesh-list
83446652|NCT03214939|Immunologic Factors|immunologic factors|mesh-ancestor
83446653|NCT03214939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446654|NCT03376477|Lenalidomide|lenalidomide|mesh-list
83446655|NCT03376477|Molgramostim|molgramostim|mesh-list
83446656|NCT03376477|Vaccines|vaccines|mesh-list
83446657|NCT03376477|Sargramostim|sargramostim|mesh-list
83446658|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83446659|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
83446660|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446661|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83446662|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83446663|NCT03376477|Growth Substances|growth substances|mesh-ancestor
83446664|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
83446665|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446666|NCT02726620|Lidocaine|lidocaine|mesh-list
83446667|NCT02726620|Atropine|atropine|mesh-list
83446668|NCT02726620|Terlipressin|terlipressin|mesh-list
83446669|NCT02726620|Phenylephrine|phenylephrine|mesh-list
83446670|NCT02726620|Dobutamine|dobutamine|mesh-list
83446671|NCT02726620|Dopamine|dopamine|mesh-list
83446672|NCT02726620|Milrinone|milrinone|mesh-list
83446673|NCT02726620|Isoproterenol|isoproterenol|mesh-list
83446674|NCT02726620|Vasopressins|vasopressins|mesh-list
83446675|NCT02726620|Epinephrine|epinephrine|mesh-list
83446676|NCT02726620|Norepinephrine|norepinephrine|mesh-list
83446677|NCT02726620|Ephedrine|ephedrine|mesh-list
83446678|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
83446679|NCT02726620|Bupivacaine|bupivacaine|mesh-list
83446680|NCT02726620|Ropivacaine|ropivacaine|mesh-list
83446681|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
83446682|NCT02726620|Tetracaine|tetracaine|mesh-list
83446683|NCT02726620|Prilocaine|prilocaine|mesh-list
83446684|NCT02726620|Mepivacaine|mepivacaine|mesh-list
83446685|NCT02726620|Benzocaine|benzocaine|mesh-list
83446686|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
83446687|NCT02726620|Procaine|procaine|mesh-list
83446688|NCT02726620|Anesthetics|anesthetics|mesh-list
83446689|NCT02726620|Propofol|propofol|mesh-list
83446690|NCT02726620|Sevoflurane|sevoflurane|mesh-list
83446691|NCT02726620|Desflurane|desflurane|mesh-list
83446692|NCT02726620|Isoflurane|isoflurane|mesh-list
83446693|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83446694|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
83446695|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
83446696|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83446697|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446698|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
83446699|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446700|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83446701|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83446702|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83446703|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83446704|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446705|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83446706|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83446707|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
83446708|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83446709|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83446710|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83446711|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83446712|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
83446713|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446714|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83446715|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83446716|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
83446717|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83446718|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
83446719|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
83446720|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
83446721|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83446722|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83446723|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
83446724|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83446725|NCT02726620|Protective Agents|protective agents|mesh-ancestor
83446726|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83446727|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
83446728|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83446729|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83446730|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
83446731|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
83446732|NCT02726620|Coagulants|coagulants|mesh-ancestor
83446733|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83446734|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
83446735|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83446736|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83446737|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83446738|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
83446739|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
83446740|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83446741|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83446742|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446743|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83446745|NCT00887575|Carboplatin|carboplatin|mesh-list
83446746|NCT00887575|Sunitinib|sunitinib|mesh-list
83446747|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83446748|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446749|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
83446750|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
83446751|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
83446752|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446753|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83446754|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83446755|NCT00887575|Growth Substances|growth substances|mesh-ancestor
83446756|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446757|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
83446758|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83446759|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446761|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
83446762|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83446763|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83446764|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446765|NCT03238027|Durvalumab|durvalumab|mesh-list
83446766|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83446767|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446768|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
83446769|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83446770|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83446771|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
83446772|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446773|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83446774|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83446775|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446776|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446777|NCT00887965|Denosumab|denosumab|mesh-list
83446778|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83446779|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446780|NCT02729038|Gepotidacin|gepotidacin|mesh-list
83446781|NCT02729038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83446782|NCT02729038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446783|NCT02729038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446784|NCT02729038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446785|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
83446786|NCT05311813|Enoxaparin|enoxaparin|mesh-list
83446787|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
83446788|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83446789|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83446790|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446791|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446792|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446793|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83446794|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
83446795|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83446796|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83446797|NCT03214627|Iron|iron|mesh-list
83446798|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83446799|NCT03214627|Hematinics|hematinics|mesh-list
83446800|NCT03214627|Trace Elements|trace elements|mesh-ancestor
83446801|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
83446802|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446803|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83446804|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446805|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83446806|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446807|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446808|NCT03214393|Antibodies|antibodies|mesh-list
83446809|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
83446810|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446811|NCT00888979|Nicotine|nicotine|mesh-list
83446812|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83446813|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
83446814|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446815|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446816|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83446817|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83446818|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
83446819|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446820|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446821|NCT03214159|Ritonavir|ritonavir|mesh-list
83446822|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83446823|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83446824|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
83446825|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446826|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446827|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83446828|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83446829|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
83446830|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446831|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83446832|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83446833|NCT02737072|Durvalumab|durvalumab|mesh-list
83446834|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83446835|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446836|NCT05446480|Desloratadine|desloratadine|mesh-list
83446837|NCT05446480|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83446838|NCT05446480|Cholinergic Agents|cholinergic agents|mesh-ancestor
83446839|NCT05446480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446840|NCT05446480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446841|NCT05446480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446842|NCT05446480|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83446843|NCT05446480|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83446844|NCT05446480|Histamine Antagonists|histamine antagonists|mesh-ancestor
83446845|NCT05446480|Histamine Agents|histamine agents|mesh-ancestor
83446846|NCT03213145|Rifampin|rifampin|mesh-list
83446847|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83446848|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
83446849|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83446850|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446851|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
83446852|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83446853|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446854|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446855|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83446856|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83446857|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83446858|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83446859|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83446860|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83446861|NCT02722564|Ethanol|ethanol|mesh-list
83446862|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83446863|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446864|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83446865|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446866|NCT05446090|Nitric Oxide|nitric oxide|mesh-list
83446867|NCT05446090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83446868|NCT05446090|Autonomic Agents|autonomic agents|mesh-ancestor
83446869|NCT05446090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83446870|NCT05446090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446871|NCT05446090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83446872|NCT05446090|Respiratory System Agents|respiratory system agents|mesh-ancestor
83446873|NCT05446090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83446874|NCT05446090|Antioxidants|antioxidants|mesh-ancestor
83446875|NCT05446090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446876|NCT05446090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446877|NCT05446090|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83446878|NCT05446090|Vasodilator Agents|vasodilator agents|mesh-ancestor
83446879|NCT05446090|Gasotransmitters|gasotransmitters|mesh-ancestor
83446880|NCT05446090|Protective Agents|protective agents|mesh-ancestor
83446881|NCT05444998|Paclitaxel|paclitaxel|mesh-list
83446882|NCT05444998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83446883|NCT05444998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446884|NCT05444998|Tubulin Modulators|tubulin modulators|mesh-ancestor
83446885|NCT05444998|Antimitotic Agents|antimitotic agents|mesh-ancestor
83446886|NCT05444998|Mitosis Modulators|mitosis modulators|mesh-ancestor
83446887|NCT05444998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446888|NCT05444842|Insulin|insulin|mesh-list
83446889|NCT05444842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83446890|NCT05444842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83446891|NCT05444842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446892|NCT04381741|Antibodies|antibodies|mesh-list
83446893|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83446894|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
83446895|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446896|NCT05444452|Sirolimus|sirolimus|mesh-list
83446897|NCT05444452|Everolimus|everolimus|mesh-list
83446898|NCT05444452|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83446899|NCT05444452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83446900|NCT05444452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446901|NCT05444452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446902|NCT05444452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83446903|NCT05444452|Immunologic Factors|immunologic factors|mesh-ancestor
83446904|NCT05444452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446905|NCT05444452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446906|NCT05444452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83446907|NCT05444452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446908|NCT05444452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83446909|NCT05444452|Antifungal Agents|antifungal agents|mesh-ancestor
83446910|NCT05444374|Bevacizumab|bevacizumab|mesh-list
83446911|NCT05444374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83446912|NCT05444374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446913|NCT05444374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83446914|NCT05444374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83446915|NCT05444374|Growth Substances|growth substances|mesh-ancestor
83446916|NCT05444374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446917|NCT05444374|Growth Inhibitors|growth inhibitors|mesh-ancestor
83446918|NCT05444218|Amoxicillin|amoxicillin|mesh-list
83446919|NCT05444218|Metronidazole|metronidazole|mesh-list
83446920|NCT05444218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83446921|NCT05444218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446922|NCT05444218|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83446923|NCT05444218|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83446924|NCT01830361|Midostaurin|midostaurin|mesh-list
83446925|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446926|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83446927|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446928|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446929|NCT01830517|Losartan|losartan|mesh-list
83446930|NCT01830517|Amlodipine|amlodipine|mesh-list
83446931|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83446932|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83446933|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83446934|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446935|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83446936|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446937|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
83446938|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83446939|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83446940|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83446941|NCT03212833|Insulin|insulin|mesh-list
83446942|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83446943|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446944|NCT05443360|Calcium, Dietary|calcium, dietary|mesh-list
83446945|NCT05443360|Calcium Carbonate|calcium carbonate|mesh-list
83446946|NCT05443360|Calcium|calcium|mesh-list
83446947|NCT05443360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83446948|NCT05443360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446949|NCT05443360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83446950|NCT05443360|Antacids|antacids|mesh-ancestor
83446951|NCT05443360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446952|NCT05443360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83446953|NCT05443282|Hormones|hormones|mesh-list
83446954|NCT05443282|Estradiol|estradiol|mesh-list
83446955|NCT05443282|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83446956|NCT05443282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83446957|NCT05443282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446958|NCT05443282|Estrogens|estrogens|mesh-ancestor
83446959|NCT00904345|Cetuximab|cetuximab|mesh-list
83446960|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83446961|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446962|NCT05442736|Ciprofloxacin|ciprofloxacin|mesh-list
83446963|NCT05442736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83446964|NCT05442736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83446965|NCT05442736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83446966|NCT05442736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83446967|NCT05442736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446968|NCT05442736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446969|NCT05442736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83446970|NCT05442736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83446971|NCT05442736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83446972|NCT01830829|Tamsulosin|tamsulosin|mesh-list
83446973|NCT01830829|Dutasteride|dutasteride|mesh-list
83446974|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83446975|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83446976|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83446977|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
83446978|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83446979|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446980|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446981|NCT01830829|Urological Agents|urological agents|mesh-ancestor
83446982|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83446983|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83446984|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83446985|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
83446986|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83446987|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
83446988|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83446989|NCT03212755|Antibodies|antibodies|mesh-list
83446990|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
83446991|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
83446992|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83446993|NCT05437822|Tranexamic Acid|tranexamic acid|mesh-list
83446994|NCT05437822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83446995|NCT05437822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83446996|NCT05437822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446997|NCT05437822|Hemostatics|hemostatics|mesh-ancestor
83446998|NCT05437822|Coagulants|coagulants|mesh-ancestor
83446999|NCT03212599|Disulfiram|disulfiram|mesh-list
83447000|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83447001|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83447002|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447003|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447004|NCT03212053|Hemostatics|hemostatics|mesh-list
83447005|NCT03212053|Coagulants|coagulants|mesh-ancestor
83447006|NCT05447026|Anti-Infective Agents|anti-infective agents|mesh-list
83447007|NCT05447026|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83447008|NCT05311189|Trastuzumab|trastuzumab|mesh-list
83447009|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83447010|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447011|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
83447012|NCT00369772|Hematinics|hematinics|mesh-ancestor
83447013|NCT03211897|Midazolam|midazolam|mesh-list
83447014|NCT03211897|Haloperidol|haloperidol|mesh-list
83447015|NCT03211897|Olanzapine|olanzapine|mesh-list
83447016|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
83447017|NCT03211897|Ziprasidone|ziprasidone|mesh-list
83447018|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83447019|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83447020|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447021|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447022|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83447023|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83447024|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83447025|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83447026|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
83447027|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
83447028|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
83447029|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
83447030|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447031|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447032|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
83447033|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
83447034|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447035|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83447036|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83447037|NCT03211897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83447038|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83447039|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83447040|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
83447041|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83447042|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
83447043|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83447044|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83447045|NCT01831687|Etodolac|etodolac|mesh-list
83447046|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83447047|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83447048|NCT01831687|Analgesics|analgesics|mesh-ancestor
83447049|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
83447050|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447051|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447052|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83447053|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83447054|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83447055|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83447056|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447057|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447058|NCT05441254|Paclitaxel|paclitaxel|mesh-list
83447059|NCT05441254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83447060|NCT05441254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447061|NCT05441254|Tubulin Modulators|tubulin modulators|mesh-ancestor
83447062|NCT05441254|Antimitotic Agents|antimitotic agents|mesh-ancestor
83447063|NCT05441254|Mitosis Modulators|mitosis modulators|mesh-ancestor
83447064|NCT05441254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447065|NCT00369148|Nateglinide|nateglinide|mesh-list
83447066|NCT00369148|Mitiglinide|mitiglinide|mesh-list
83447067|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83447068|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447069|NCT03816982|Bupivacaine|bupivacaine|mesh-list
83447070|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
83447071|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
83447072|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447073|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447074|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
83447075|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447076|NCT01832467|Cetuximab|cetuximab|mesh-list
83447077|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83447078|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447079|NCT03211351|Dextrans|dextrans|mesh-list
83447080|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
83447081|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
83447082|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
83447083|NCT01832623|Vitamin D|vitamin d|mesh-list
83447084|NCT01832623|Vitamins|vitamins|mesh-ancestor
83447085|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
83447086|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447087|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83447088|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83447089|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83447090|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447091|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83447092|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447093|NCT02470390|Fentanyl|fentanyl|mesh-list
83447094|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83447095|NCT02470390|Narcotics|narcotics|mesh-ancestor
83447096|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447097|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447098|NCT02470390|Analgesics|analgesics|mesh-ancestor
83447099|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
83447100|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447101|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83447102|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83447103|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
83447104|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
83447105|NCT00363532|Calcitonin|calcitonin|mesh-list
83447106|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
83447107|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83447108|NCT00363532|Katacalcin|katacalcin|mesh-list
83447109|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83447110|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447111|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83447112|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
83447114|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447115|NCT00363688|Penicillins|penicillins|mesh-list
83447116|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83447117|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447118|NCT01832935|Insulin|insulin|mesh-list
83447119|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83447120|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
83447121|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
83447122|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
83447123|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
83447124|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83447125|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447126|NCT03216733|Sirolimus|sirolimus|mesh-list
83447127|NCT03216733|Temsirolimus|temsirolimus|mesh-list
83447128|NCT03216733|MTOR Inhibitors|mtor inhibitors|mesh-list
83447129|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83447130|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447131|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83447132|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447133|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
83447134|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83447135|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
83447136|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447137|NCT03216733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83447138|NCT03216733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447139|NCT03216733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447140|NCT03216343|Chiauranib|chiauranib|mesh-list
83447141|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447142|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83447143|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447144|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447145|NCT03333616|Nivolumab|nivolumab|mesh-list
83447146|NCT03333616|Ipilimumab|ipilimumab|mesh-list
83447147|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83447148|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447149|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83447150|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447151|NCT04380181|Milrinone|milrinone|mesh-list
83447152|NCT04380181|Epinephrine|epinephrine|mesh-list
83447153|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83447154|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83447155|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
83447156|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447157|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447158|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447159|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83447160|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83447161|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
83447162|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447163|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83447164|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
83447165|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
83447166|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
83447167|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83447168|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83447169|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83447170|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
83447171|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83447172|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83447173|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447174|NCT04380181|Protective Agents|protective agents|mesh-ancestor
83447175|NCT01833559|Insulin|insulin|mesh-list
83447176|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83447177|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
83447178|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83447179|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447180|NCT05394142|Metformin|metformin|mesh-list
83447181|NCT05394142|Pioglitazone|pioglitazone|mesh-list
83447182|NCT05394142|Spironolactone|spironolactone|mesh-list
83447183|NCT05394142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83447184|NCT05394142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447185|NCT05394142|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83447186|NCT05394142|Hormone Antagonists|hormone antagonists|mesh-ancestor
83447187|NCT05394142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83447188|NCT05394142|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83447189|NCT05394142|Diuretics|diuretics|mesh-ancestor
83447190|NCT05394142|Natriuretic Agents|natriuretic agents|mesh-ancestor
83447191|NCT00901225|Plerixafor|plerixafor|mesh-list
83447192|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83447193|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83447194|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
83447195|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447196|NCT01833715|Morphine|morphine|mesh-list
83447197|NCT01833715|Methadone|methadone|mesh-list
83447198|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83447199|NCT01833715|Narcotics|narcotics|mesh-ancestor
83447200|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447201|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447202|NCT01833715|Analgesics|analgesics|mesh-ancestor
83447203|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
83447204|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447205|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
83447206|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
83447207|NCT05393050|Methotrexate|methotrexate|mesh-list
83447208|NCT05393050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83447209|NCT05393050|Abortifacient Agents|abortifacient agents|mesh-ancestor
83447210|NCT05393050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83447211|NCT05393050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447212|NCT05393050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83447213|NCT05393050|Antimetabolites|antimetabolites|mesh-ancestor
83447214|NCT05393050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447215|NCT05393050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447216|NCT05393050|Dermatologic Agents|dermatologic agents|mesh-ancestor
83447217|NCT05393050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447218|NCT05393050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83447219|NCT05393050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83447220|NCT05393050|Immunologic Factors|immunologic factors|mesh-ancestor
83447221|NCT05393050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83447222|NCT05393050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83447223|NCT03166228|Glycine|glycine|mesh-list
83447224|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
83447225|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447226|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447227|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447228|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
83447229|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83447230|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
83447231|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83447232|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447233|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83447234|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83447235|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83447236|NCT03154996|Topotecan|topotecan|mesh-list
83447237|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83447238|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83447239|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447240|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447241|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447242|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
83447243|NCT02475070|Vildagliptin|vildagliptin|mesh-list
83447244|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83447245|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447246|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83447247|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447248|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83447249|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
83447250|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447251|NCT00902161|Propranolol|propranolol|mesh-list
83447252|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83447253|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83447254|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
83447255|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447256|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447257|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447258|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83447259|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83447260|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
83447261|NCT01834183|Gemcitabine|gemcitabine|mesh-list
83447263|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83447264|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
83447265|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447266|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447267|NCT01834183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83447268|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447269|NCT02478580|Modafinil|modafinil|mesh-list
83447270|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83447271|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447272|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83447273|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83447274|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83447275|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447276|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83447277|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
83447278|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447279|NCT03210025|Methyldopa|methyldopa|mesh-list
83447280|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83447281|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
83447282|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
83447283|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447284|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447285|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83447286|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83447287|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83447288|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
83447289|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447290|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447291|NCT03219853|Selenium|selenium|mesh-list
83447292|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
83447293|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447294|NCT03219853|Protective Agents|protective agents|mesh-ancestor
83447295|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447296|NCT03219853|Trace Elements|trace elements|mesh-ancestor
83447297|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
83447298|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
83447299|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83447300|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
83447301|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447302|NCT02480998|Vaccines|vaccines|mesh-list
83447303|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
83447304|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447305|NCT00905515|Cyclosporine|cyclosporine|mesh-list
83447306|NCT00905515|Tacrolimus|tacrolimus|mesh-list
83447307|NCT00905515|Cyclosporins|cyclosporins|mesh-list
83447308|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83447309|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
83447310|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447311|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83447312|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447313|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447314|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
83447315|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447316|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
83447317|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83447318|NCT03215797|Phenylephrine|phenylephrine|mesh-list
83447319|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
83447320|NCT03215797|Norepinephrine|norepinephrine|mesh-list
83447321|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
83447322|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83447323|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
83447324|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
83447325|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447326|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447327|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
83447328|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83447329|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
83447330|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
83447331|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83447332|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83447333|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
83447334|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447335|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447336|NCT03215797|Protective Agents|protective agents|mesh-ancestor
83447337|NCT02485834|Docetaxel|docetaxel|mesh-list
83447338|NCT02485834|Capecitabine|capecitabine|mesh-list
83447339|NCT02485834|Irinotecan|irinotecan|mesh-list
83447340|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447341|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
83447342|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
83447343|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
83447344|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447345|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83447346|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
83447347|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83447348|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83447349|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447350|NCT01834885|Fluticasone|fluticasone|mesh-list
83447351|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83447352|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83447353|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83447354|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83447355|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
83447356|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447357|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447358|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83447359|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
83447360|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
83447361|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83447362|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83447363|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83447364|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83447365|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
83447366|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447367|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447368|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
83447369|NCT01834885|Hormones|hormones|mesh-ancestor
83447370|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83447371|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
83447372|NCT01834963|Interferons|interferons|mesh-list
83447373|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
83447374|NCT01834963|Cisplatin|cisplatin|mesh-list
83447375|NCT01834963|Fluorouracil|fluorouracil|mesh-list
83447376|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447377|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
83447378|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447379|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83447380|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83447381|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
83447382|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447383|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
83447384|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447385|NCT04380103|Bevacizumab|bevacizumab|mesh-list
83447386|NCT04380103|Capecitabine|capecitabine|mesh-list
83447387|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
83447388|NCT04380103|Irinotecan|irinotecan|mesh-list
83447389|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83447390|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447391|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83447392|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83447393|NCT04380103|Growth Substances|growth substances|mesh-ancestor
83447394|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447395|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
83447396|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83447397|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
83447398|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447399|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83447401|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447402|NCT01954966|Progesterone|progesterone|mesh-list
83447403|NCT01954966|Progestins|progestins|mesh-ancestor
83447404|NCT01954966|Hormones|hormones|mesh-ancestor
83447405|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83447406|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447407|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83447408|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83447409|NCT03836599|Allopurinol|allopurinol|mesh-list
83447410|NCT03836599|Verinurad|verinurad|mesh-list
83447411|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
83447412|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447413|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447414|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
83447415|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83447416|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83447417|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
83447418|NCT03836599|Protective Agents|protective agents|mesh-ancestor
83447419|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447420|NCT01839097|Prednisone|prednisone|mesh-list
83447421|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
83447422|NCT01839097|Doxorubicin|doxorubicin|mesh-list
83447423|NCT01839097|Vincristine|vincristine|mesh-list
83447424|NCT01839097|Belinostat|belinostat|mesh-list
83447425|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83447426|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
83447427|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447428|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83447429|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83447430|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
83447431|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447432|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447433|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83447434|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83447435|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83447436|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83447437|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447438|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83447439|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
83447440|NCT01839097|Hormones|hormones|mesh-ancestor
83447441|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83447442|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83447443|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83447444|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
83447445|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
83447446|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
83447447|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83447448|NCT01835665|Nimodipine|nimodipine|mesh-list
83447449|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83447450|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83447451|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83447452|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447453|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83447454|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447455|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
83447456|NCT01839175|Vaccines|vaccines|mesh-list
83447457|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83447458|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
83447459|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447460|NCT01839253|Atenolol|atenolol|mesh-list
83447461|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83447462|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83447463|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83447464|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
83447465|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
83447466|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447467|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447468|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83447469|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83447470|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83447471|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83447472|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447473|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447474|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
83447475|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447476|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
83447477|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83447478|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
83447479|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447480|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83447481|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83447482|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
83447483|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447484|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447485|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83447486|NCT01839643|Meloxicam|meloxicam|mesh-list
83447487|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83447488|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83447489|NCT01839643|Analgesics|analgesics|mesh-ancestor
83447490|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
83447491|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447492|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447493|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83447494|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83447495|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83447496|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83447497|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447498|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447499|NCT04380025|Pycnogenols|pycnogenols|mesh-list
83447500|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83447501|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
83447502|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447503|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
83447504|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447505|NCT04380025|Protective Agents|protective agents|mesh-ancestor
83447506|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83447507|NCT01836679|Paclitaxel|paclitaxel|mesh-list
83447508|NCT01836679|Carboplatin|carboplatin|mesh-list
83447509|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83447510|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447511|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
83447512|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
83447513|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
83447514|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447515|NCT00369538|Losartan|losartan|mesh-list
83447516|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83447517|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83447518|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83447519|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83447520|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83447521|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447522|NCT00369538|Diuretics|diuretics|mesh-ancestor
83447523|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
83447524|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447525|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83447526|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83447527|NCT02489734|Sevoflurane|sevoflurane|mesh-list
83447528|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83447529|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83447530|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
83447531|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
83447532|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447533|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447534|NCT02490670|Cephalexin|cephalexin|mesh-list
83447535|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83447536|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447537|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
83447538|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83447539|NCT05451472|Calcium|calcium|mesh-list
83447540|NCT05451472|Parathyroid Hormone|parathyroid hormone|mesh-list
83447541|NCT05451472|Hormones|hormones|mesh-list
83447542|NCT05451472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83447543|NCT05451472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447544|NCT05451472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83447545|NCT03218059|Methotrexate|methotrexate|mesh-list
83447546|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83447547|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
83447548|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83447549|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447550|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83447551|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
83447552|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447553|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447554|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
83447555|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447556|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83447557|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83447558|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
83447559|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83447560|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83447561|NCT01839955|Quinacrine|quinacrine|mesh-list
83447562|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83447563|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447564|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83447565|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447566|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447567|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
83447568|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83447569|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
83447570|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83447571|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447572|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
83447573|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83447574|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
83447575|NCT02494102|Modafinil|modafinil|mesh-list
83447576|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83447577|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447578|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83447579|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83447580|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83447581|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447582|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
83447583|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83447584|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83447585|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83447586|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83447587|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447588|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
83447589|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447590|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447591|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83447592|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447594|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83447595|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
83447596|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447597|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447598|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
83447599|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447600|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83447601|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
83447602|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447603|NCT00422578|Tadalafil|tadalafil|mesh-list
83447604|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
83447605|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83447606|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83447607|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447608|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447609|NCT00422578|Urological Agents|urological agents|mesh-ancestor
83447610|NCT02494180|Fentanyl|fentanyl|mesh-list
83447611|NCT02494180|Midazolam|midazolam|mesh-list
83447612|NCT02494180|Diazepam|diazepam|mesh-list
83447614|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83447615|NCT02494180|Narcotics|narcotics|mesh-ancestor
83447616|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447617|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447618|NCT02494180|Analgesics|analgesics|mesh-ancestor
83447619|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
83447620|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447621|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83447622|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83447623|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
83447624|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
83447625|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83447626|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83447627|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83447628|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83447629|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
83447630|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
83447631|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447632|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447633|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
83447634|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
83447635|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
83447636|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83447637|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83447638|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83447639|NCT02494336|Ropivacaine|ropivacaine|mesh-list
83447640|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
83447641|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
83447642|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447643|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447644|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
83447645|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447646|NCT02495038|Rocuronium|rocuronium|mesh-list
83447647|NCT02495038|Atracurium|atracurium|mesh-list
83447648|NCT02495038|Cisatracurium|cisatracurium|mesh-list
83447649|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83447650|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83447651|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83447652|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447653|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447654|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83447655|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83447656|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
83447657|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447658|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447659|NCT04956484|Belimumab|belimumab|mesh-list
83447660|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83447661|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
83447662|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447663|NCT05450458|Sorbitol|sorbitol|mesh-list
83447664|NCT05450458|Hyaluronic Acid|hyaluronic acid|mesh-list
83447665|NCT05450458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83447666|NCT05450458|Immunologic Factors|immunologic factors|mesh-ancestor
83447667|NCT05450458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447668|NCT05450458|Viscosupplements|viscosupplements|mesh-ancestor
83447669|NCT05450458|Protective Agents|protective agents|mesh-ancestor
83447670|NCT05450458|Cathartics|cathartics|mesh-ancestor
83447671|NCT05450458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83447672|NCT01720615|Remifentanil|remifentanil|mesh-list
83447673|NCT01720615|Propofol|propofol|mesh-list
83447674|NCT01720615|Sevoflurane|sevoflurane|mesh-list
83447675|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83447676|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447677|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447678|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83447679|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
83447680|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
83447681|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83447682|NCT01720615|Narcotics|narcotics|mesh-ancestor
83447683|NCT01720615|Analgesics|analgesics|mesh-ancestor
83447684|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
83447685|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447686|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83447687|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83447688|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
83447689|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
83447690|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83447692|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447693|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447694|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83447695|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83447696|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
83447697|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83447698|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
83447699|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447700|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447701|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83447702|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83447703|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
83447704|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83447705|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447706|NCT02504554|Vancomycin|vancomycin|mesh-list
83447707|NCT02504554|Omeprazole|omeprazole|mesh-list
83447708|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83447709|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447710|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83447711|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83447712|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83447713|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447714|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447715|NCT01838473|Lobeline|lobeline|mesh-list
83447716|NCT01838473|Nicotine|nicotine|mesh-list
83447717|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83447718|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
83447719|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447720|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447721|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83447722|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83447723|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
83447724|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447725|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447726|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
83447727|NCT04937452|Rotigotine|rotigotine|mesh-list
83447728|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
83447729|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
83447730|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447731|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447732|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447733|NCT01838707|Fentanyl|fentanyl|mesh-list
83447734|NCT01838707|Morphine|morphine|mesh-list
83447735|NCT01838707|Bupivacaine|bupivacaine|mesh-list
83447736|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
83447737|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
83447738|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447739|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447740|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
83447741|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447742|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83447743|NCT01838707|Narcotics|narcotics|mesh-ancestor
83447744|NCT01838707|Analgesics|analgesics|mesh-ancestor
83447745|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83447746|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83447747|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
83447748|NCT02506114|Ipilimumab|ipilimumab|mesh-list
83447749|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83447750|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447751|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83447752|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447753|NCT05449366|Paclitaxel|paclitaxel|mesh-list
83447754|NCT05449366|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83447755|NCT05449366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83447756|NCT05449366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447757|NCT05449366|Tubulin Modulators|tubulin modulators|mesh-ancestor
83447758|NCT05449366|Antimitotic Agents|antimitotic agents|mesh-ancestor
83447759|NCT05449366|Mitosis Modulators|mitosis modulators|mesh-ancestor
83447760|NCT05449366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447761|NCT04920994|Bupivacaine|bupivacaine|mesh-list
83447762|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
83447764|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447765|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447766|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
83447767|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447768|NCT02506660|Dexamethasone|dexamethasone|mesh-list
83447769|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
83447770|NCT02506660|Bupivacaine|bupivacaine|mesh-list
83447771|NCT02506660|BB 1101|bb 1101|mesh-list
83447772|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83447773|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
83447774|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
83447775|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447776|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447777|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83447778|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
83447779|NCT02506660|Hormones|hormones|mesh-ancestor
83447780|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83447781|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83447782|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447783|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
83447784|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447785|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447786|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
83447787|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
83447788|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447789|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
83447790|NCT02509624|Selonsertib|selonsertib|mesh-list
83447791|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83447792|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447793|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447794|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83447795|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83447796|NCT01726075|Somatostatin|somatostatin|mesh-list
83447797|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83447798|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83447799|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83447800|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83447801|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83447802|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
83447803|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447804|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447805|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447806|NCT01726075|Hormones|hormones|mesh-ancestor
83447807|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83447808|NCT00369694|Terlipressin|terlipressin|mesh-list
83447809|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83447810|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83447811|NCT01721707|Latanoprost|latanoprost|mesh-list
83447812|NCT01721707|Brinzolamide|brinzolamide|mesh-list
83447813|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83447814|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83447815|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83447816|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447817|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447818|NCT05448586|Analgesics, Opioid|analgesics, opioid|mesh-list
83447819|NCT05448586|Narcotics|narcotics|mesh-ancestor
83447820|NCT05448586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447821|NCT05448586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447822|NCT05448586|Analgesics|analgesics|mesh-ancestor
83447823|NCT05448586|Sensory System Agents|sensory system agents|mesh-ancestor
83447824|NCT05448586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447825|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
83447826|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
83447827|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83447828|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83447829|NCT01726465|Prednisolone|prednisolone|mesh-list
83447830|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
83447831|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83447832|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
83447833|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83447834|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83447835|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
83447836|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
83447837|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447838|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447839|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83447840|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
83447841|NCT01726465|Hormones|hormones|mesh-ancestor
83447842|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83447843|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83447844|NCT01726465|Protective Agents|protective agents|mesh-ancestor
83447845|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83447846|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447847|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
83447848|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447849|NCT01726465|Expectorants|expectorants|mesh-ancestor
83447850|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
83447851|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83447852|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
83447853|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447854|NCT01726465|Antidotes|antidotes|mesh-ancestor
83447855|NCT01720303|Insulin|insulin|mesh-list
83447856|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83447857|NCT01720303|Repaglinide|repaglinide|mesh-list
83447858|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
83447859|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
83447860|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
83447861|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83447862|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447863|NCT02733042|Rituximab|rituximab|mesh-list
83447864|NCT02733042|Durvalumab|durvalumab|mesh-list
83447865|NCT02733042|Lenalidomide|lenalidomide|mesh-list
83447866|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83447867|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83447868|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83447869|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
83447870|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447871|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83447872|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83447873|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83447874|NCT02733042|Growth Substances|growth substances|mesh-ancestor
83447875|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
83447876|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83447877|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
83447878|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447879|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83447880|NCT00912301|Cathartics|cathartics|mesh-ancestor
83447881|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83447882|NCT04850638|Furosemide|furosemide|mesh-list
83447883|NCT04850638|Diuretics|diuretics|mesh-ancestor
83447884|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
83447885|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447886|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83447887|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83447888|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447889|NCT05326776|Oxytocin|oxytocin|mesh-list
83447890|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
83447891|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83447892|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447893|NCT01726777|Vitamin D|vitamin d|mesh-list
83447894|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
83447895|NCT01726777|Cholecalciferol|cholecalciferol|mesh-list
83447896|NCT01726777|Vitamins|vitamins|mesh-list
83447897|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
83447898|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447899|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83447900|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83447901|NCT05532306|Ribavirin|ribavirin|mesh-list
83447902|NCT05532306|Antimetabolites|antimetabolites|mesh-ancestor
83447903|NCT05532306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447904|NCT05532306|Antiviral Agents|antiviral agents|mesh-ancestor
83447905|NCT05532306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447906|NCT05602038|Morphine|morphine|mesh-list
83447907|NCT05602038|Bupivacaine|bupivacaine|mesh-list
83447908|NCT05602038|Anesthetics, Local|anesthetics, local|mesh-ancestor
83447909|NCT05602038|Anesthetics|anesthetics|mesh-ancestor
83447910|NCT05602038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447911|NCT05602038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447912|NCT05602038|Sensory System Agents|sensory system agents|mesh-ancestor
83447913|NCT05602038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447914|NCT05602038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83447915|NCT05602038|Narcotics|narcotics|mesh-ancestor
83447916|NCT05602038|Analgesics|analgesics|mesh-ancestor
83447917|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
83447918|NCT01722409|Sevoflurane|sevoflurane|mesh-list
83447919|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83447920|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447921|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447922|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83447923|NCT01722409|Analgesics|analgesics|mesh-ancestor
83447924|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
83447925|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447926|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83447927|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83447928|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83447929|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
83447930|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83447931|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447932|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83447933|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83447934|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
83447935|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
83447936|NCT04307238|Anesthetics|anesthetics|mesh-list
83447937|NCT04307238|Propofol|propofol|mesh-list
83447938|NCT04307238|Sevoflurane|sevoflurane|mesh-list
83447939|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447940|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447941|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83447942|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83447943|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
83447944|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83447945|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83447946|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83447947|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
83447948|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83447949|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
83447950|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447951|NCT01727401|PENTA|penta|mesh-list
83447952|NCT01727401|Fondaparinux|fondaparinux|mesh-list
83447953|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83447954|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
83447955|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83447956|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
83447957|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447958|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447959|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
83447960|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83447961|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83447962|NCT02513212|Fluorides|fluorides|mesh-list
83447963|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
83447964|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
83447965|NCT02513212|Protective Agents|protective agents|mesh-ancestor
83447966|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447967|NCT02513446|Itraconazole|itraconazole|mesh-list
83447968|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
83447969|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447970|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83447971|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83447972|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447973|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447974|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83447975|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
83447976|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83447977|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447978|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83447979|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83447980|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83447981|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447982|NCT00363844|Incretins|incretins|mesh-ancestor
83447983|NCT00363844|Hormones|hormones|mesh-ancestor
83447984|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83447985|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83447986|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
83447987|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83447988|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83447989|NCT04687800|Dexamethasone|dexamethasone|mesh-list
83447990|NCT04687800|Difluprednate|difluprednate|mesh-list
83447991|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83447992|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
83447993|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
83447994|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83447995|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83447996|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83447997|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
83447998|NCT04687800|Hormones|hormones|mesh-ancestor
83447999|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83448000|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83448001|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448002|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
83448003|NCT00864383|Rifampin|rifampin|mesh-list
83448004|NCT00864383|Isoniazid|isoniazid|mesh-list
83448005|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
83448006|NCT00864383|Ethambutol|ethambutol|mesh-list
83448007|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83448008|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448009|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83448010|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83448011|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448012|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448013|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448014|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83448015|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
83448016|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
83448017|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83448018|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83448019|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83448020|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83448021|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83448022|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83448023|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83448024|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83448025|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83448026|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
83448027|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83448028|NCT05532072|Sirolimus|sirolimus|mesh-list
83448029|NCT05532072|Methylprednisolone|methylprednisolone|mesh-list
83448030|NCT05532072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83448031|NCT05532072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83448032|NCT05532072|Prednisolone|prednisolone|mesh-list
83448033|NCT05532072|Prednisolone acetate|prednisolone acetate|mesh-list
83448034|NCT05532072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83448035|NCT05532072|Prednisolone phosphate|prednisolone phosphate|mesh-list
83448036|NCT05532072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83448037|NCT05532072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448038|NCT05532072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83448039|NCT05532072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448040|NCT05532072|Antifungal Agents|antifungal agents|mesh-ancestor
83448041|NCT05532072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83448042|NCT05532072|Immunologic Factors|immunologic factors|mesh-ancestor
83448043|NCT05532072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448044|NCT05532072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448046|NCT05532072|Autonomic Agents|autonomic agents|mesh-ancestor
83448047|NCT05532072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448048|NCT05532072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83448049|NCT05532072|Glucocorticoids|glucocorticoids|mesh-ancestor
83448050|NCT05532072|Hormones|hormones|mesh-ancestor
83448051|NCT05532072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83448052|NCT05532072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83448053|NCT05532072|Protective Agents|protective agents|mesh-ancestor
83448054|NCT05532072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83448055|NCT00864539|Vitamin D|vitamin d|mesh-list
83448056|NCT00864539|Calcium|calcium|mesh-list
83448057|NCT00864539|Vitamins|vitamins|mesh-ancestor
83448058|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
83448059|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448060|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83448061|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83448062|NCT00827255|Cyclosporine|cyclosporine|mesh-list
83448063|NCT00827255|Cyclosporins|cyclosporins|mesh-list
83448064|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448065|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448066|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83448067|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
83448068|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448069|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
83448070|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448071|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
83448072|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448073|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83448074|NCT04458610|Rituximab|rituximab|mesh-list
83448075|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83448076|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
83448077|NCT04458610|Antibodies|antibodies|mesh-list
83448078|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
83448079|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83448080|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
83448081|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448082|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448083|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448084|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83448085|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448086|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448087|NCT02153489|Bromides|bromides|mesh-list
83448088|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
83448089|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
83448090|NCT04627012|Tislelizumab|tislelizumab|mesh-list
83448091|NCT04627012|Lenvatinib|lenvatinib|mesh-list
83448092|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448093|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448094|NCT04627012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83448095|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448096|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83448097|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448098|NCT00866879|Sirolimus|sirolimus|mesh-list
83448099|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83448100|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448101|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83448102|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448103|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
83448104|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83448105|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
83448106|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448107|NCT02311920|Nivolumab|nivolumab|mesh-list
83448108|NCT02311920|Ipilimumab|ipilimumab|mesh-list
83448109|NCT02311920|Temozolomide|temozolomide|mesh-list
83448110|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448111|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448112|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83448113|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448114|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83448115|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
83448116|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
83448117|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
83448118|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83448119|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
83448120|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448121|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83448122|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448123|NCT00828191|Progesterone|progesterone|mesh-list
83448124|NCT00828191|Progestins|progestins|mesh-ancestor
83448125|NCT00828191|Hormones|hormones|mesh-ancestor
83448126|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83448127|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448128|NCT00867659|Cetrorelix|cetrorelix|mesh-list
83448129|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83448130|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
83448131|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83448132|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448133|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
83448134|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83448135|NCT05531058|Vaccines|vaccines|mesh-list
83448136|NCT05531058|Immunologic Factors|immunologic factors|mesh-ancestor
83448137|NCT05531058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448138|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
83448139|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83448140|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83448141|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448142|NCT00828347|Vitamins|vitamins|mesh-ancestor
83448143|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
83448144|NCT02939872|Aspirin|aspirin|mesh-list
83448145|NCT02939872|Clopidogrel|clopidogrel|mesh-list
83448146|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83448147|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83448148|NCT02939872|Analgesics|analgesics|mesh-ancestor
83448149|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
83448150|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448151|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448152|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448153|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448154|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83448155|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83448156|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448157|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83448158|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83448159|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448160|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
83448161|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83448162|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83448163|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83448164|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
83448165|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448166|NCT00829049|Adapalene|adapalene|mesh-list
83448167|NCT00829049|Tazarotene|tazarotene|mesh-list
83448168|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83448169|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83448170|NCT00829049|Analgesics|analgesics|mesh-ancestor
83448171|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
83448172|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448173|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448174|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448175|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448176|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
83448177|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
83448178|NCT02859064|Lanreotide|lanreotide|mesh-list
83448179|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448180|NCT04303702|Oxytocin|oxytocin|mesh-list
83448181|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
83448182|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83448183|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448184|NCT01727557|Anesthetics|anesthetics|mesh-list
83448185|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83448186|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448187|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83448188|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448189|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83448191|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
83448192|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
83448193|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83448194|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448195|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
83448196|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448197|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83448198|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83448199|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83448200|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83448201|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448202|NCT00869141|Timolol|timolol|mesh-list
83448203|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83448204|NCT00869141|Dorzolamide|dorzolamide|mesh-list
83448205|NCT00869141|Brinzolamide|brinzolamide|mesh-list
83448206|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83448207|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83448208|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
83448209|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448210|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448211|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448212|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83448213|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83448214|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83448215|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83448216|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83448217|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83448218|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448219|NCT01722799|Paclitaxel|paclitaxel|mesh-list
83448220|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83448221|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448222|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
83448223|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
83448224|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
83448225|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448226|NCT04260022|Blinatumomab|blinatumomab|mesh-list
83448227|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448228|NCT01606176|Nabiximols|nabiximols|mesh-list
83448229|NCT01606176|Analgesics|analgesics|mesh-ancestor
83448230|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
83448231|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448232|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448233|NCT00913081|Quercetin|quercetin|mesh-list
83448234|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
83448235|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448236|NCT00913081|Protective Agents|protective agents|mesh-ancestor
83448237|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448238|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
83448239|NCT04077424|Vaccines|vaccines|mesh-list
83448240|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
83448241|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448242|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
83448243|NCT04077424|Coagulants|coagulants|mesh-ancestor
83448244|NCT01727869|Cetuximab|cetuximab|mesh-list
83448245|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83448246|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448247|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448248|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83448249|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448250|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448251|NCT00371020|Heparin|heparin|mesh-list
83448252|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83448253|NCT00371020|Tinzaparin|tinzaparin|mesh-list
83448254|NCT00371020|Dalteparin|dalteparin|mesh-list
83448255|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
83448256|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83448257|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83448258|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448259|NCT04476628|Budesonide|budesonide|mesh-list
83448260|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448261|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83448262|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
83448263|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448264|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448265|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83448266|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
83448267|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
83448268|NCT04476628|Hormones|hormones|mesh-ancestor
83448269|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83448270|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83448271|NCT01728181|Tivozanib|tivozanib|mesh-list
83448272|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448273|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83448274|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448275|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448276|NCT04378231|Amoxicillin|amoxicillin|mesh-list
83448277|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
83448278|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
83448279|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83448280|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83448281|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448282|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83448283|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448284|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448285|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
83448286|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83448287|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
83448288|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448289|NCT01728571|Vitamin D|vitamin d|mesh-list
83448290|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
83448291|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
83448292|NCT01728571|Vitamins|vitamins|mesh-list
83448293|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
83448294|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448295|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83448296|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83448297|NCT00832637|Gemcitabine|gemcitabine|mesh-list
83448298|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83448299|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448300|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83448301|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
83448302|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448303|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83448304|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448305|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83448306|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448307|NCT00370240|Ropivacaine|ropivacaine|mesh-list
83448308|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
83448309|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
83448310|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83448311|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448312|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
83448313|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448314|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
83448315|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83448316|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
83448317|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448318|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
83448319|NCT03408145|Protective Agents|protective agents|mesh-ancestor
83448320|NCT02475772|Cisplatin|cisplatin|mesh-list
83448321|NCT02475772|Doxorubicin|doxorubicin|mesh-list
83448322|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83448323|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448324|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83448325|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83448326|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83448327|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448328|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448329|NCT00915655|Ritonavir|ritonavir|mesh-list
83448330|NCT00915655|Darunavir|darunavir|mesh-list
83448331|NCT00915655|Lamivudine|lamivudine|mesh-list
83448332|NCT00915655|Zidovudine|zidovudine|mesh-list
83448333|NCT00915655|Abacavir|abacavir|mesh-list
83448334|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83448335|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83448336|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
83448337|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448338|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448339|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83448340|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83448341|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
83448342|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448343|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83448344|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83448345|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83448346|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83448347|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
83448349|NCT03835507|Hematinics|hematinics|mesh-ancestor
83448350|NCT05524974|Paclitaxel|paclitaxel|mesh-list
83448351|NCT05524974|Oxaliplatin|oxaliplatin|mesh-list
83448352|NCT05524974|Apatinib|apatinib|mesh-list
83448353|NCT05524974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83448354|NCT05524974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448355|NCT05524974|Tubulin Modulators|tubulin modulators|mesh-ancestor
83448356|NCT05524974|Antimitotic Agents|antimitotic agents|mesh-ancestor
83448357|NCT05524974|Mitosis Modulators|mitosis modulators|mesh-ancestor
83448358|NCT05524974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448359|NCT05524974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83448360|NCT05524974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448361|NCT00870467|Adalimumab|adalimumab|mesh-list
83448362|NCT00870467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83448363|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448364|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448365|NCT00370318|Acetaminophen|acetaminophen|mesh-list
83448366|NCT00370318|Vaccines|vaccines|mesh-list
83448367|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83448368|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
83448369|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448370|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83448371|NCT00370318|Analgesics|analgesics|mesh-ancestor
83448372|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
83448373|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448374|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
83448375|NCT01728961|Lumefantrine|lumefantrine|mesh-list
83448376|NCT01728961|Artemether|artemether|mesh-list
83448377|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83448378|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
83448379|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83448380|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83448381|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448382|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
83448383|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83448384|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448385|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
83448386|NCT00872027|Escitalopram|escitalopram|mesh-list
83448387|NCT00872027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83448388|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83448389|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83448390|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448391|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448392|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
83448393|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448394|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
83448395|NCT01854814|Losartan|losartan|mesh-list
83448396|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83448397|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448398|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83448399|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
83448400|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83448401|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448402|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448403|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448404|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83448405|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83448406|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83448407|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83448408|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
83448409|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448410|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448411|NCT01723657|Immunotoxins|immunotoxins|mesh-ancestor
83448412|NCT01723657|Immunoconjugates|immunoconjugates|mesh-ancestor
83448413|NCT01723657|Immunologic Factors|immunologic factors|mesh-ancestor
83448414|NCT01723657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448415|NCT02576652|Tetracycline|tetracycline|mesh-list
83448416|NCT02576652|Demeclocycline|demeclocycline|mesh-list
83448417|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83448418|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448419|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83448420|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448421|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448422|NCT01743742|Vitamins|vitamins|mesh-list
83448423|NCT01743742|Vitamin E|vitamin e|mesh-list
83448424|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
83448425|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448426|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
83448427|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448428|NCT01743742|Protective Agents|protective agents|mesh-ancestor
83448429|NCT01723735|Ezetimibe|ezetimibe|mesh-list
83448430|NCT01723735|Alirocumab|alirocumab|mesh-list
83448431|NCT01723735|Fenofibrate|fenofibrate|mesh-list
83448432|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83448433|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83448434|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
83448435|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448436|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83448437|NCT01723735|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83448438|NCT01723735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83448439|NCT01723735|Protease Inhibitors|protease inhibitors|mesh-ancestor
83448440|NCT01723735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448441|NCT00872729|Cysteamine|cysteamine|mesh-list
83448442|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83448443|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448444|NCT04640376|Acetaminophen|acetaminophen|mesh-list
83448445|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83448446|NCT04640376|Analgesics|analgesics|mesh-ancestor
83448447|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
83448448|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448449|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448450|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
83448451|NCT00832871|Mifepristone|mifepristone|mesh-list
83448452|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83448453|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
83448454|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83448455|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448456|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83448457|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83448458|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83448459|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
83448460|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83448461|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83448462|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
83448463|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83448464|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
83448465|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83448466|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83448467|NCT05530200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83448468|NCT05530200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448469|NCT05530200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448470|NCT05530200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448471|NCT01729663|Interferons|interferons|mesh-list
83448472|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
83448473|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
83448474|NCT01729663|Molgramostim|molgramostim|mesh-list
83448475|NCT01729663|Sargramostim|sargramostim|mesh-list
83448476|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
83448477|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448478|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
83448479|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448480|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
83448481|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448482|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83448483|NCT05530122|Adalimumab|adalimumab|mesh-list
83448484|NCT05530122|Infliximab|infliximab|mesh-list
83448485|NCT05530122|Golimumab|golimumab|mesh-list
83448486|NCT05530122|Ustekinumab|ustekinumab|mesh-list
83448487|NCT05530122|Vedolizumab|vedolizumab|mesh-list
83448488|NCT05530122|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83448489|NCT05530122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448490|NCT05530122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448491|NCT05530122|Dermatologic Agents|dermatologic agents|mesh-ancestor
83448492|NCT05530122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83448493|NCT05530122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83448494|NCT05530122|Immunologic Factors|immunologic factors|mesh-ancestor
83448495|NCT05530122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448496|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
83448497|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
83448498|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448499|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
83448500|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
83448501|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83448502|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83448503|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448504|NCT05529888|Isotretinoin|isotretinoin|mesh-list
83448505|NCT05529888|Dermatologic Agents|dermatologic agents|mesh-ancestor
83448506|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
83448507|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448508|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448509|NCT02444741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83448510|NCT02444741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448511|NCT05518578|Huperzine A|huperzine a|mesh-list
83448512|NCT05518578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83448513|NCT05518578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448514|NCT05518578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448515|NCT05518578|Cholinergic Agents|cholinergic agents|mesh-ancestor
83448516|NCT05518578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448517|NCT05518578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448518|NCT05518578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83448519|NCT05518578|Protective Agents|protective agents|mesh-ancestor
83448520|NCT05518500|Vaccines|vaccines|mesh-list
83448521|NCT05518500|Immunologic Factors|immunologic factors|mesh-ancestor
83448522|NCT05518500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448523|NCT03058978|Etonogestrel|etonogestrel|mesh-list
83448524|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83448525|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
83448526|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83448527|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448528|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83448529|NCT00212134|Dipivefrin|dipivefrin|mesh-list
83448530|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83448531|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
83448532|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448533|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448534|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448535|NCT00913627|Ibuprofen|ibuprofen|mesh-list
83448536|NCT00913627|Naproxen|naproxen|mesh-list
83448537|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83448538|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83448539|NCT00913627|Analgesics|analgesics|mesh-ancestor
83448540|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
83448541|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448542|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448543|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448544|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448545|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83448546|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448547|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448548|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
83448549|NCT04297254|Lenvatinib|lenvatinib|mesh-list
83448550|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448551|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83448552|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448553|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448554|NCT04297176|Vancomycin|vancomycin|mesh-list
83448555|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83448556|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448557|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
83448558|NCT02425306|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83448560|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
83448561|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448562|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83448563|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448564|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83448565|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
83448566|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448567|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448568|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83448569|NCT02425306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83448570|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
83448571|NCT04052698|Factor VIII|factor viii|mesh-list
83448572|NCT04052698|Coagulants|coagulants|mesh-ancestor
83448573|NCT05523102|Acetaminophen|acetaminophen|mesh-list
83448574|NCT05523102|Ketorolac|ketorolac|mesh-list
83448575|NCT05523102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83448576|NCT05523102|Analgesics|analgesics|mesh-ancestor
83448577|NCT05523102|Sensory System Agents|sensory system agents|mesh-ancestor
83448578|NCT05523102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448579|NCT05523102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448580|NCT05523102|Antipyretics|antipyretics|mesh-ancestor
83448581|NCT05523102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83448582|NCT05523102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448583|NCT05523102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448584|NCT05523102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83448585|NCT05523102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448586|NCT05523102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448587|NCT03407209|Anesthetics|anesthetics|mesh-list
83448588|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
83448589|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83448590|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448591|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
83448592|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448593|NCT04141020|Sirolimus|sirolimus|mesh-list
83448594|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83448595|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448596|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83448597|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448598|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
83448599|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83448600|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
83448601|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448602|NCT03999268|Insulin|insulin|mesh-list
83448603|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83448604|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448605|NCT05517330|Tislelizumab|tislelizumab|mesh-list
83448606|NCT05517330|Afatinib|afatinib|mesh-list
83448607|NCT05517330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448608|NCT05517330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448609|NCT05517330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83448610|NCT05517330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448611|NCT05517330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448612|NCT05517174|Vaccines|vaccines|mesh-list
83448613|NCT05517174|Immunologic Factors|immunologic factors|mesh-ancestor
83448614|NCT05517174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448615|NCT01729897|Fentanyl|fentanyl|mesh-list
83448616|NCT01729897|Propofol|propofol|mesh-list
83448617|NCT01729897|Etomidate|etomidate|mesh-list
83448618|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83448619|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83448620|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448621|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83448622|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
83448623|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
83448624|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83448625|NCT01729897|Narcotics|narcotics|mesh-ancestor
83448626|NCT01729897|Analgesics|analgesics|mesh-ancestor
83448627|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
83448628|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448629|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83448630|NCT01048177|Lidocaine|lidocaine|mesh-list
83448631|NCT01048177|Heparin|heparin|mesh-list
83448632|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
83448633|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
83448634|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83448635|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448636|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
83448637|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448638|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83448639|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83448640|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83448641|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83448642|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448643|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
83448644|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83448645|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83448646|NCT02740582|Tolcapone|tolcapone|mesh-list
83448647|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83448648|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83448649|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83448650|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448651|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448652|NCT05453266|Tranexamic Acid|tranexamic acid|mesh-list
83448653|NCT05453266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83448654|NCT05453266|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83448655|NCT05453266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83448656|NCT05453266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448657|NCT05453266|Hemostatics|hemostatics|mesh-ancestor
83448658|NCT05453266|Coagulants|coagulants|mesh-ancestor
83448659|NCT02740660|Caffeine|caffeine|mesh-list
83448660|NCT02740660|Albuterol|albuterol|mesh-list
83448661|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83448662|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448663|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83448664|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448665|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448666|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83448667|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83448668|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
83448669|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448670|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83448671|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
83448672|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448673|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83448674|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
83448675|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
83448676|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83448677|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83448678|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83448679|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83448680|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
83448681|NCT05516862|Camphor|camphor|mesh-list
83448682|NCT05516862|Salicylates|salicylates|mesh-list
83448683|NCT05516862|Methyl salicylate|methyl salicylate|mesh-list
83448684|NCT05516862|Menthol|menthol|mesh-list
83448685|NCT05516862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83448686|NCT05516862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448687|NCT05516862|Antipruritics|antipruritics|mesh-ancestor
83448688|NCT05516862|Dermatologic Agents|dermatologic agents|mesh-ancestor
83448689|NCT05516862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83448690|NCT05516862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83448691|NCT05516862|Analgesics|analgesics|mesh-ancestor
83448692|NCT05516862|Sensory System Agents|sensory system agents|mesh-ancestor
83448693|NCT05516862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448694|NCT05516862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448695|NCT05516862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448696|NCT05516862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448697|NCT05516862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83448698|NCT05516862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448699|NCT05516862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448700|NCT03929068|Levodopa|levodopa|mesh-list
83448701|NCT03929068|Carbidopa|carbidopa|mesh-list
83448702|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83448703|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83448704|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83448705|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
83448706|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448707|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448708|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448709|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83448710|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448711|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83448712|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
83448713|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
83448714|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83448715|NCT03910972|Vaccines|vaccines|mesh-list
83448716|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
83448717|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448718|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83448719|NCT03910972|Antacids|antacids|mesh-ancestor
83448720|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448721|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83448722|NCT05516784|Clopidogrel|clopidogrel|mesh-list
83448723|NCT05516784|Ticagrelor|ticagrelor|mesh-list
83448724|NCT05516784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83448725|NCT05516784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83448726|NCT05516784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83448727|NCT05516784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83448728|NCT05516784|Purinergic Agents|purinergic agents|mesh-ancestor
83448729|NCT05516784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448730|NCT05516784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448731|NCT05516784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448732|NCT02571972|Timolol|timolol|mesh-list
83448733|NCT02571972|Dorzolamide|dorzolamide|mesh-list
83448734|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83448735|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83448736|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
83448737|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448738|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448739|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448740|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83448741|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83448742|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83448743|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448744|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83448745|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
83448746|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448747|NCT04996134|Domperidone|domperidone|mesh-list
83448748|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
83448749|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
83448750|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448751|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448752|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83448753|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83448754|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
83448755|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448756|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448757|NCT00371332|Minocycline|minocycline|mesh-list
83448758|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83448759|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448760|NCT00842075|Pramlintide|pramlintide|mesh-list
83448761|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83448762|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448763|NCT00879359|Paclitaxel|paclitaxel|mesh-list
83448764|NCT00879359|Bevacizumab|bevacizumab|mesh-list
83448765|NCT00879359|Carboplatin|carboplatin|mesh-list
83448766|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83448767|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448768|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
83448769|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
83448770|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
83448771|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448772|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448773|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83448774|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83448775|NCT00879359|Growth Substances|growth substances|mesh-ancestor
83448776|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448777|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
83448778|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83448779|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
83448780|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83448781|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83448782|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83448783|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83448784|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448786|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83448787|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83448788|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83448789|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83448790|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
83448791|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448792|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448793|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448794|NCT05527548|Alendronate|alendronate|mesh-list
83448795|NCT05527548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83448796|NCT05527548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448798|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
83448799|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
83448800|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83448801|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448802|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
83448803|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448804|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83448805|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83448806|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83448807|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83448808|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448809|NCT02742532|Oxytocin|oxytocin|mesh-list
83448810|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
83448811|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83448812|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448813|NCT05521386|Caffeine|caffeine|mesh-list
83448814|NCT05521386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83448815|NCT05521386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448816|NCT05521386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83448817|NCT05521386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448818|NCT05521386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448819|NCT05521386|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83448820|NCT05521386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83448821|NCT05521386|Purinergic Agents|purinergic agents|mesh-ancestor
83448822|NCT05521386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448823|NCT00370630|Triamcinolone|triamcinolone|mesh-list
83448824|NCT00370630|Bevacizumab|bevacizumab|mesh-list
83448825|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448826|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448827|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83448828|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83448829|NCT00370630|Growth Substances|growth substances|mesh-ancestor
83448830|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448831|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
83448832|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448833|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
83448834|NCT00370630|Hormones|hormones|mesh-ancestor
83448835|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83448836|NCT04984980|Bevacizumab|bevacizumab|mesh-list
83448837|NCT04984980|Gemcitabine|gemcitabine|mesh-list
83448838|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
83448839|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448840|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448841|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83448842|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83448843|NCT04984980|Growth Substances|growth substances|mesh-ancestor
83448844|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448845|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
83448846|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83448847|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
83448848|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448849|NCT00370786|Bevacizumab|bevacizumab|mesh-list
83448850|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448851|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448852|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83448853|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83448854|NCT00370786|Growth Substances|growth substances|mesh-ancestor
83448855|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448856|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
83448857|NCT04981158|Anesthetics|anesthetics|mesh-list
83448858|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
83448859|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83448860|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448861|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83448862|NCT03387670|Simvastatin|simvastatin|mesh-list
83448863|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83448864|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83448865|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
83448866|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448867|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83448868|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83448869|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448870|NCT04979832|Metronidazole|metronidazole|mesh-list
83448871|NCT04979832|Fosfomycin|fosfomycin|mesh-list
83448872|NCT04979832|Molgramostim|molgramostim|mesh-list
83448873|NCT04979832|Sargramostim|sargramostim|mesh-list
83448874|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448875|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83448876|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83448877|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83448878|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
83448879|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448880|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448881|NCT05521152|Norepinephrine|norepinephrine|mesh-list
83448882|NCT05521152|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83448883|NCT05521152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83448884|NCT05521152|Adrenergic Agents|adrenergic agents|mesh-ancestor
83448885|NCT05521152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448886|NCT05521152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448887|NCT05521152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448888|NCT05521152|Sympathomimetics|sympathomimetics|mesh-ancestor
83448889|NCT05521152|Autonomic Agents|autonomic agents|mesh-ancestor
83448890|NCT05521152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448891|NCT05521152|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83448892|NCT02740114|Oxycodone|oxycodone|mesh-list
83448893|NCT02740114|Bupivacaine|bupivacaine|mesh-list
83448894|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
83448895|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
83448896|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83448897|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448898|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
83448899|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448900|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83448901|NCT02740114|Narcotics|narcotics|mesh-ancestor
83448902|NCT02740114|Analgesics|analgesics|mesh-ancestor
83448903|NCT04906096|GDC-0084|gdc-0084|mesh-list
83448904|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448905|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448906|NCT00371410|Triamcinolone|triamcinolone|mesh-list
83448907|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83448908|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83448909|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83448910|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448911|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
83448912|NCT00371410|Hormones|hormones|mesh-ancestor
83448913|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83448914|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448915|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83448916|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
83448917|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448918|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448919|NCT04659616|Cytarabine|cytarabine|mesh-list
83448920|NCT04659616|Daunorubicin|daunorubicin|mesh-list
83448921|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83448922|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
83448923|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448924|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448925|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
83448926|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448927|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83448928|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
83448929|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448930|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83448931|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83448932|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83448933|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448935|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83448936|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83448937|NCT04295850|Analgesics|analgesics|mesh-ancestor
83448938|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
83448939|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83448940|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448941|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83448942|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83448943|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83448944|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83448945|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448946|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83448947|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83448948|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448949|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
83448950|NCT02166905|Poly I-C|poly i-c|mesh-list
83448951|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83448952|NCT02166905|Poly ICLC|poly iclc|mesh-list
83448953|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
83448954|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
83448955|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448956|NCT02166905|Laxatives|laxatives|mesh-ancestor
83448957|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83448958|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
83448959|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448960|NCT02743078|Bevacizumab|bevacizumab|mesh-list
83448961|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448962|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448963|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83448964|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83448965|NCT02743078|Growth Substances|growth substances|mesh-ancestor
83448966|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448967|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
83448968|NCT03323398|Durvalumab|durvalumab|mesh-list
83448969|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83448970|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448971|NCT00890981|Denosumab|denosumab|mesh-list
83448972|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83448973|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448974|NCT05515770|Cabotegravir|cabotegravir|mesh-list
83448975|NCT05515770|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83448976|NCT05515770|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83448977|NCT05515770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448978|NCT05515770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448979|NCT05515770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83448980|NCT05515770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83448981|NCT05515770|Antiviral Agents|antiviral agents|mesh-ancestor
83448982|NCT05515770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448983|NCT04480138|Interferons|interferons|mesh-list
83448984|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448985|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
83448986|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83448987|NCT00371488|Lapatinib|lapatinib|mesh-list
83448988|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448989|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83448990|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83448991|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83448992|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
83448993|NCT00883415|Hematinics|hematinics|mesh-ancestor
83448994|NCT05526690|Metformin|metformin|mesh-list
83448995|NCT05526690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83448996|NCT05526690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448998|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83448999|NCT04337632|Paclitaxel|paclitaxel|mesh-list
83449000|NCT04337632|Carboplatin|carboplatin|mesh-list
83449001|NCT04337632|Doxorubicin|doxorubicin|mesh-list
83449002|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83449003|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83449004|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449005|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
83449006|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
83449007|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
83449008|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449009|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83449010|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83449011|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83449012|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449013|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83449014|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449015|NCT05349058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83449016|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449017|NCT05348980|Phenylephrine|phenylephrine|mesh-list
83449018|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
83449019|NCT05348980|Synephrine|synephrine|mesh-list
83449020|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83449021|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
83449022|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
83449023|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449024|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449025|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
83449026|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83449027|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
83449028|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
83449029|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83449030|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83449031|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83449032|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
83449033|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449034|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449035|NCT05348980|Protective Agents|protective agents|mesh-ancestor
83449036|NCT00884585|Cyclosporine|cyclosporine|mesh-list
83449037|NCT00884585|Cyclosporins|cyclosporins|mesh-list
83449038|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449039|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449040|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83449041|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
83449042|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449043|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
83449044|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449045|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
83449046|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449047|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83449049|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
83449050|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83449051|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449052|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
83449053|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83449054|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83449055|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83449056|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83449057|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449058|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
83449059|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449060|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449061|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83449062|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449063|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
83449064|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83449065|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449066|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449067|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83449068|NCT03384563|Analgesics|analgesics|mesh-ancestor
83449069|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
83449070|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449071|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83449072|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83449073|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83449074|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
83449075|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449076|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449077|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
83449078|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
83449079|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449080|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83449081|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449082|NCT02748070|Fluticasone|fluticasone|mesh-list
83449083|NCT02748070|Prednisone|prednisone|mesh-list
83449084|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449085|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
83449086|NCT02748070|Hormones|hormones|mesh-ancestor
83449087|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83449088|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449089|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83449090|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449091|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83449092|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
83449093|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449094|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83449095|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
83449096|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
83449097|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83449098|NCT05311709|Sotorasib|sotorasib|mesh-list
83449099|NCT05311709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83449100|NCT05311709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449101|NCT05311709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83449102|NCT05311709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449103|NCT05310383|Tislelizumab|tislelizumab|mesh-list
83449104|NCT05310383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83449105|NCT05310383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449106|NCT05310305|Antibodies|antibodies|mesh-list
83449107|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
83449108|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449109|NCT05149638|Cosyntropin|cosyntropin|mesh-list
83449110|NCT05149638|Hormones|hormones|mesh-ancestor
83449111|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83449112|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449113|NCT05519670|Niraparib|niraparib|mesh-list
83449114|NCT05519670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83449115|NCT05519670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449116|NCT05519670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449117|NCT05519670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449118|NCT05519592|Ropivacaine|ropivacaine|mesh-list
83449119|NCT05519592|Anesthetics, Local|anesthetics, local|mesh-ancestor
83449120|NCT05519592|Anesthetics|anesthetics|mesh-ancestor
83449121|NCT05519592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449122|NCT05519592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449123|NCT05519592|Sensory System Agents|sensory system agents|mesh-ancestor
83449124|NCT05519592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449125|NCT05519514|Budesonide|budesonide|mesh-list
83449126|NCT05519514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449127|NCT05519514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83449128|NCT05519514|Autonomic Agents|autonomic agents|mesh-ancestor
83449129|NCT05519514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449130|NCT05519514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449131|NCT05519514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83449132|NCT05519514|Respiratory System Agents|respiratory system agents|mesh-ancestor
83449133|NCT05519514|Glucocorticoids|glucocorticoids|mesh-ancestor
83449134|NCT05519514|Hormones|hormones|mesh-ancestor
83449135|NCT05519514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83449136|NCT02756572|Cytarabine|cytarabine|mesh-list
83449137|NCT02756572|Cyclosporine|cyclosporine|mesh-list
83449138|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
83449139|NCT02756572|Sirolimus|sirolimus|mesh-list
83449140|NCT02756572|Fludarabine|fludarabine|mesh-list
83449141|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
83449142|NCT02756572|Melphalan|melphalan|mesh-list
83449143|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
83449145|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83449146|NCT02756572|Cladribine|cladribine|mesh-list
83449147|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83449148|NCT02756572|Cyclosporins|cyclosporins|mesh-list
83449149|NCT02756572|Lenograstim|lenograstim|mesh-list
83449150|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449151|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83449152|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
83449153|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449154|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83449155|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
83449156|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449157|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
83449158|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449159|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83449160|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449161|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
83449162|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83449163|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449164|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83449165|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83449166|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83449167|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
83449168|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83449169|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83449170|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
83449171|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83449172|NCT02756572|Analgesics|analgesics|mesh-ancestor
83449173|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
83449174|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449175|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83449176|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83449177|NCT01049035|Vaccines|vaccines|mesh-list
83449178|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83449179|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
83449180|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449181|NCT05131698|Lenvatinib|lenvatinib|mesh-list
83449182|NCT05131698|Tislelizumab|tislelizumab|mesh-list
83449183|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449184|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83449185|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449186|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449187|NCT05131698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83449188|NCT01724983|Fentanyl|fentanyl|mesh-list
83449189|NCT01724983|Ketamine|ketamine|mesh-list
83449190|NCT01724983|Analgesics|analgesics|mesh-ancestor
83449191|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
83449192|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449193|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449194|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83449195|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83449196|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
83449197|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
83449198|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449199|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83449200|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83449201|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449202|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449203|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83449204|NCT01724983|Narcotics|narcotics|mesh-ancestor
83449205|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83449206|NCT02973958|Acetaminophen|acetaminophen|mesh-list
83449207|NCT02973958|Ibuprofen|ibuprofen|mesh-list
83449208|NCT02973958|Ketorolac|ketorolac|mesh-list
83449209|NCT02973958|Bupivacaine|bupivacaine|mesh-list
83449210|NCT02973958|Sevoflurane|sevoflurane|mesh-list
83449211|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
83449212|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
83449213|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449214|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449215|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
83449216|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449217|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83449218|NCT02973958|Analgesics|analgesics|mesh-ancestor
83449219|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
83449220|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83449221|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449222|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449223|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83449224|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449225|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449226|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83449227|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83449228|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
83449229|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
83449230|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83449231|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83449232|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
83449233|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449234|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449235|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83449236|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
83449237|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83449238|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83449239|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83449240|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
83449241|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449242|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449243|NCT05513976|Febuxostat|febuxostat|mesh-list
83449244|NCT05513976|Gout Suppressants|gout suppressants|mesh-ancestor
83449245|NCT05513976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449246|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
83449247|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83449248|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83449249|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
83449250|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449251|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83449252|NCT05348434|Ether|ether|mesh-list
83449253|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83449254|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
83449255|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
83449256|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449257|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449258|NCT05519202|Oxaliplatin|oxaliplatin|mesh-list
83449259|NCT05519202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449260|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
83449261|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83449262|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
83449263|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449264|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
83449265|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83449266|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
83449267|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449268|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449269|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83449270|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
83449271|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83449272|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83449273|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83449274|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
83449275|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449276|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449277|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
83449278|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83449279|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83449280|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83449281|NCT02760862|Mannitol|mannitol|mesh-list
83449282|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449283|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83449284|NCT02760862|Diuretics|diuretics|mesh-ancestor
83449285|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
83449286|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449287|NCT05720637|Serotonin|serotonin|mesh-list
83449288|NCT05720637|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83449289|NCT05720637|Serotonin Agents|serotonin agents|mesh-ancestor
83449290|NCT05720637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449291|NCT05720637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449292|NCT05720637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449294|NCT05720559|Vitamin A|vitamin a|mesh-list
83449295|NCT05720559|Metronidazole|metronidazole|mesh-list
83449296|NCT05720559|Capecitabine|capecitabine|mesh-list
83449297|NCT05720559|Oxaliplatin|oxaliplatin|mesh-list
83449298|NCT05720559|Cetuximab|cetuximab|mesh-list
83449299|NCT05720559|Vitamins|vitamins|mesh-ancestor
83449300|NCT05720559|Micronutrients|micronutrients|mesh-ancestor
83449301|NCT05720559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449302|NCT05720559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83449303|NCT05720559|Antimetabolites|antimetabolites|mesh-ancestor
83449304|NCT05720559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449305|NCT05720559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449306|NCT05720559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83449307|NCT05720559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449308|NCT05720559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83449309|NCT05720559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83449310|NCT05720559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83449311|NCT05720559|Hematinics|hematinics|mesh-ancestor
83449312|NCT05720559|Vitamin B Complex|vitamin b complex|mesh-ancestor
83449313|NCT02761252|Montelukast|montelukast|mesh-list
83449314|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83449315|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
83449316|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83449317|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
83449318|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83449319|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449320|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83449321|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83449322|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449323|NCT05714475|Pancrelipase|pancrelipase|mesh-list
83449324|NCT05714475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83449325|NCT01047007|Cisplatin|cisplatin|mesh-list
83449326|NCT01047007|Adavosertib|adavosertib|mesh-list
83449327|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449328|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449329|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449330|NCT05443984|Esomeprazole|esomeprazole|mesh-list
83449331|NCT05443984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83449332|NCT05443984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83449333|NCT05443984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83449334|NCT05443984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449335|NCT05443984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449336|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
83449337|NCT01725607|Anesthetics|anesthetics|mesh-list
83449338|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449339|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449340|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83449341|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83449342|NCT01725607|Analgesics|analgesics|mesh-ancestor
83449343|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
83449344|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449345|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83449346|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83449347|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83449348|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
83449349|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449350|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449351|NCT03304379|Celecoxib|celecoxib|mesh-list
83449352|NCT03304379|Diclofenac|diclofenac|mesh-list
83449353|NCT03304379|Fasinumab|fasinumab|mesh-list
83449354|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83449355|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83449356|NCT03304379|Analgesics|analgesics|mesh-ancestor
83449357|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
83449358|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449359|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449360|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449361|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449362|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83449363|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83449364|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449365|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449366|NCT00915967|Vancomycin|vancomycin|mesh-list
83449367|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83449368|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449369|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
83449370|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
83449371|NCT01044745|Busulfan|busulfan|mesh-list
83449372|NCT01044745|Rituximab|rituximab|mesh-list
83449373|NCT01044745|Fludarabine|fludarabine|mesh-list
83449374|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
83449375|NCT01044745|Tacrolimus|tacrolimus|mesh-list
83449376|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
83449377|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83449378|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83449379|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
83449380|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449381|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449382|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83449383|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
83449384|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449385|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449386|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83449387|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83449388|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83449389|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
83449390|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83449391|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449392|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83449393|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83449394|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
83449395|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83449396|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449397|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83449398|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449399|NCT05031078|Lidocaine|lidocaine|mesh-list
83449400|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449401|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
83449402|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
83449403|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449404|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
83449405|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449406|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83449407|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83449408|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83449409|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83449410|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449411|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83449412|NCT03270059|Hematinics|hematinics|mesh-ancestor
83449413|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83449414|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83449415|NCT05513664|Osimertinib|osimertinib|mesh-list
83449416|NCT05513664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449417|NCT05513664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83449418|NCT05513664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449419|NCT05513664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449420|NCT03216395|Epinephrine|epinephrine|mesh-list
83449421|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83449422|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83449423|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
83449424|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449425|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449426|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449427|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83449428|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83449429|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
83449430|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449431|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83449432|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
83449433|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
83449434|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
83449435|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83449437|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449438|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
83449439|NCT02767492|Hormones|hormones|mesh-ancestor
83449440|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83449441|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449442|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83449443|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
83449444|NCT01044433|Capecitabine|capecitabine|mesh-list
83449445|NCT01044433|Lapatinib|lapatinib|mesh-list
83449446|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83449447|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
83449448|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449449|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449450|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83449451|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449452|NCT03400969|Glycerol|glycerol|mesh-list
83449453|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83449454|NCT03400969|Protective Agents|protective agents|mesh-ancestor
83449455|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449456|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
83449457|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83449458|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449459|NCT04633278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83449460|NCT04633278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449461|NCT05518812|Carboprost|carboprost|mesh-list
83449462|NCT05518812|Carboprost tromethamine|carboprost tromethamine|mesh-list
83449463|NCT05518812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83449464|NCT05518812|Abortifacient Agents|abortifacient agents|mesh-ancestor
83449465|NCT05518812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83449466|NCT05518812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449467|NCT05518812|Oxytocics|oxytocics|mesh-ancestor
83449468|NCT04334512|Vitamin D|vitamin d|mesh-list
83449469|NCT04334512|Vitamins|vitamins|mesh-list
83449470|NCT04334512|Azithromycin|azithromycin|mesh-list
83449471|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
83449472|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
83449473|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449474|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83449475|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83449476|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449478|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83449479|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83449480|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449481|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449482|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449483|NCT01043185|Lesogaberan|lesogaberan|mesh-list
83449484|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83449485|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83449486|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
83449487|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
83449488|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449489|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449490|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449491|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83449492|NCT01042093|Clonidine|clonidine|mesh-list
83449493|NCT01042093|Epinephrine|epinephrine|mesh-list
83449494|NCT01042093|Ropivacaine|ropivacaine|mesh-list
83449495|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
83449496|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
83449497|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449498|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449499|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
83449500|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449501|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83449502|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83449503|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
83449504|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449505|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449506|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83449507|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83449508|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
83449509|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83449510|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
83449511|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
83449512|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
83449513|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83449514|NCT01042093|Analgesics|analgesics|mesh-ancestor
83449515|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83449516|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
83449517|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83449518|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83449519|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83449520|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449521|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449522|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83449523|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449524|NCT03400735|Cefdinir|cefdinir|mesh-list
83449525|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83449526|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449527|NCT04737928|Latanoprost|latanoprost|mesh-list
83449528|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83449529|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83449530|NCT01041859|Tapentadol|tapentadol|mesh-list
83449531|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83449532|NCT01041859|Narcotics|narcotics|mesh-ancestor
83449533|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449534|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449535|NCT01041859|Analgesics|analgesics|mesh-ancestor
83449536|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
83449537|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449538|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83449539|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83449540|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83449541|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449542|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
83449543|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449544|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83449545|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
83449546|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449547|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83449548|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
83449549|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449550|NCT03400423|Caffeine|caffeine|mesh-list
83449551|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83449552|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449553|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83449554|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449555|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449556|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83449557|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83449558|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
83449559|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449560|NCT01040845|Colchicine|colchicine|mesh-list
83449561|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83449562|NCT01040845|Norethindrone|norethindrone|mesh-list
83449563|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
83449564|NCT01040845|Estradiol|estradiol|mesh-list
83449565|NCT01040845|Estrogens|estrogens|mesh-ancestor
83449566|NCT01040845|Hormones|hormones|mesh-ancestor
83449567|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83449568|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449569|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83449570|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
83449571|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83449572|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83449573|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
83449574|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449575|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
83449576|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
83449577|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
83449578|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449579|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449580|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83449581|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83449582|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83449583|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83449584|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83449585|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
83449586|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83449587|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449588|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83449589|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83449590|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83449591|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
83449592|NCT01040689|Olodaterol|olodaterol|mesh-list
83449593|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83449594|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
83449595|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449596|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449597|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83449598|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
83449599|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
83449600|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83449601|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
83449602|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449603|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449604|NCT00372658|Lidocaine|lidocaine|mesh-list
83449605|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
83449606|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
83449607|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449608|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449609|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
83449610|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449611|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83449612|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83449613|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83449614|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83449615|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449616|NCT03400189|Sulthiame|sulthiame|mesh-list
83449617|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
83449618|NCT04098874|Bupropion|bupropion|mesh-list
83449619|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83449620|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
83449621|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83449622|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83449623|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83449624|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83449625|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449626|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
83449627|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449628|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449629|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83449630|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83449631|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449632|NCT01043029|Pioglitazone|pioglitazone|mesh-list
83449633|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83449634|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449635|NCT04282954|Esomeprazole|esomeprazole|mesh-list
83449636|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83449637|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83449638|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83449639|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449640|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449641|NCT05337436|Calcium|calcium|mesh-list
83449642|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83449643|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449644|NCT04755712|Sufentanil|sufentanil|mesh-list
83449645|NCT04755712|Morphine|morphine|mesh-list
83449646|NCT04755712|Bupivacaine|bupivacaine|mesh-list
83449647|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
83449648|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
83449649|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449650|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449651|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
83449652|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449653|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83449654|NCT04755712|Narcotics|narcotics|mesh-ancestor
83449655|NCT04755712|Analgesics|analgesics|mesh-ancestor
83449656|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83449657|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83449658|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
83449659|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
83449660|NCT04751812|Narcotics|narcotics|mesh-ancestor
83449661|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449662|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449663|NCT04751812|Analgesics|analgesics|mesh-ancestor
83449664|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
83449665|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449666|NCT00372736|Docetaxel|docetaxel|mesh-list
83449667|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449668|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
83449669|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
83449670|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
83449671|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449672|NCT02415712|Fomepizole|fomepizole|mesh-list
83449673|NCT02415712|Antidotes|antidotes|mesh-ancestor
83449674|NCT02415712|Protective Agents|protective agents|mesh-ancestor
83449675|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449676|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449677|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449678|NCT05456698|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83449679|NCT05456698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83449680|NCT05456698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449681|NCT05456698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83449682|NCT05456698|Immunotoxins|immunotoxins|mesh-ancestor
83449683|NCT05456698|Immunoconjugates|immunoconjugates|mesh-ancestor
83449684|NCT05456698|Immunologic Factors|immunologic factors|mesh-ancestor
83449685|NCT05456698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449686|NCT02973724|Remifentanil|remifentanil|mesh-list
83449687|NCT02973724|Propofol|propofol|mesh-list
83449688|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
83449689|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449690|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449691|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83449692|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83449693|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
83449694|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83449695|NCT02973724|Narcotics|narcotics|mesh-ancestor
83449696|NCT02973724|Analgesics|analgesics|mesh-ancestor
83449697|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
83449698|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449699|NCT05456542|Dexamethasone|dexamethasone|mesh-list
83449700|NCT05456542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449701|NCT05456542|Antiemetics|antiemetics|mesh-ancestor
83449702|NCT05456542|Autonomic Agents|autonomic agents|mesh-ancestor
83449703|NCT05456542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449704|NCT05456542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449705|NCT05456542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83449706|NCT05456542|Glucocorticoids|glucocorticoids|mesh-ancestor
83449707|NCT05456542|Hormones|hormones|mesh-ancestor
83449708|NCT05456542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83449709|NCT05456542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83449710|NCT05456542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449711|NCT03215693|Ensartinib|ensartinib|mesh-list
83449712|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449713|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83449714|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449715|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449716|NCT05455918|Paclitaxel|paclitaxel|mesh-list
83449717|NCT05455918|Ifosfamide|ifosfamide|mesh-list
83449718|NCT05455918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83449719|NCT05455918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449720|NCT05455918|Tubulin Modulators|tubulin modulators|mesh-ancestor
83449721|NCT05455918|Antimitotic Agents|antimitotic agents|mesh-ancestor
83449722|NCT05455918|Mitosis Modulators|mitosis modulators|mesh-ancestor
83449723|NCT05455918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449724|NCT05455918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83449725|NCT05455918|Alkylating Agents|alkylating agents|mesh-ancestor
83449726|NCT00889187|Capecitabine|capecitabine|mesh-list
83449727|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83449728|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
83449729|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449730|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449731|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83449732|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83449733|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83449734|NCT04334824|Diuretics|diuretics|mesh-ancestor
83449735|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
83449736|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449737|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83449738|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83449739|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449740|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
83449741|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449742|NCT05314127|Fluorouracil|fluorouracil|mesh-list
83449743|NCT05314127|Imiquimod|imiquimod|mesh-list
83449744|NCT05314127|Tazarotene|tazarotene|mesh-list
83449745|NCT05314127|Petrolatum|petrolatum|mesh-list
83449746|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
83449747|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449748|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83449749|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449750|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83449751|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
83449752|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449753|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83449754|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
83449755|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
83449756|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
83449757|NCT05314127|Emollients|emollients|mesh-ancestor
83449758|NCT03130127|Terlipressin|terlipressin|mesh-list
83449759|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83449760|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83449761|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
83449762|NCT04225078|Loperamide|loperamide|mesh-list
83449763|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
83449764|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83449765|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449766|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83449767|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83449768|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449769|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449770|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449771|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83449772|NCT00373048|Mefloquine|mefloquine|mesh-list
83449773|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
83449774|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83449775|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83449776|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449777|NCT00372892|Rituximab|rituximab|mesh-list
83449778|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83449779|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449780|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
83449781|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449782|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449783|NCT00895817|Fluticasone|fluticasone|mesh-list
83449784|NCT00895817|Esomeprazole|esomeprazole|mesh-list
83449785|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449786|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83449787|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
83449788|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449789|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449790|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83449791|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
83449792|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
83449793|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83449794|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83449795|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83449796|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83449797|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449798|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449799|NCT03020303|Spironolactone|spironolactone|mesh-list
83449800|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83449801|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
83449802|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83449803|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449804|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83449805|NCT03020303|Diuretics|diuretics|mesh-ancestor
83449806|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
83449807|NCT04825522|Vancomycin|vancomycin|mesh-list
83449808|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83449809|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449810|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
83449811|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449812|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83449813|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
83449814|NCT00373282|Triamcinolone|triamcinolone|mesh-list
83449815|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83449816|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83449817|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83449818|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449819|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
83449820|NCT00373282|Hormones|hormones|mesh-ancestor
83449821|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83449822|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449823|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83449824|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
83449825|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449826|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449827|NCT04033354|Paclitaxel|paclitaxel|mesh-list
83449828|NCT04033354|Carboplatin|carboplatin|mesh-list
83449829|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83449830|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449831|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
83449832|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
83449833|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
83449834|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449835|NCT04382027|Vitamins|vitamins|mesh-list
83449836|NCT04382027|Vitamin K|vitamin k|mesh-list
83449837|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
83449838|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
83449839|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449840|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83449841|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83449842|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449843|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
83449844|NCT04382027|Coagulants|coagulants|mesh-ancestor
83449845|NCT00896441|Citalopram|citalopram|mesh-list
83449846|NCT00896441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83449847|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83449848|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83449849|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449850|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449852|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449853|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83449854|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
83449855|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83449856|NCT02790515|Sirolimus|sirolimus|mesh-list
83449857|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
83449858|NCT02790515|Melphalan|melphalan|mesh-list
83449859|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
83449860|NCT02790515|Thiotepa|thiotepa|mesh-list
83449861|NCT02790515|Rituximab|rituximab|mesh-list
83449862|NCT02790515|Fludarabine|fludarabine|mesh-list
83449863|NCT02790515|Blinatumomab|blinatumomab|mesh-list
83449864|NCT02790515|Tacrolimus|tacrolimus|mesh-list
83449865|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
83449866|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83449867|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83449868|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
83449869|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449870|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449871|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83449872|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
83449873|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449874|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449875|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83449876|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83449877|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83449878|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449879|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83449880|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449881|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83449882|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
83449883|NCT03400111|Acetaminophen|acetaminophen|mesh-list
83449884|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83449885|NCT03400111|Analgesics|analgesics|mesh-ancestor
83449886|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
83449887|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449888|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449889|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
83449890|NCT03404791|Gemcitabine|gemcitabine|mesh-list
83449891|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83449892|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
83449893|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449894|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449895|NCT00918931|Obatoclax|obatoclax|mesh-list
83449896|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449897|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449898|NCT03404011|Glycerol|glycerol|mesh-list
83449899|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83449900|NCT03404011|Protective Agents|protective agents|mesh-ancestor
83449901|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449902|NCT01830491|Aspirin|aspirin|mesh-list
83449903|NCT01830491|Clopidogrel|clopidogrel|mesh-list
83449904|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83449905|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83449906|NCT01830491|Analgesics|analgesics|mesh-ancestor
83449907|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
83449908|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449909|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449910|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449911|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449912|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83449913|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83449914|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449915|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83449916|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83449917|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449918|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
83449919|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83449920|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83449921|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83449922|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
83449923|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449924|NCT02778880|Fentanyl|fentanyl|mesh-list
83449925|NCT02778880|Ketamine|ketamine|mesh-list
83449926|NCT02778880|Analgesics|analgesics|mesh-ancestor
83449927|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
83449928|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449929|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449930|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83449931|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83449932|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
83449933|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
83449934|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83449935|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83449936|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83449937|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449938|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449940|NCT02778880|Narcotics|narcotics|mesh-ancestor
83449941|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83449942|NCT05310929|Labetalol|labetalol|mesh-list
83449943|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
83449944|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
83449945|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83449946|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83449947|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
83449948|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83449949|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449950|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449951|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83449952|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
83449953|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
83449954|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449955|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83449956|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83449957|NCT00891995|Insulin|insulin|mesh-list
83449958|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83449959|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449960|NCT02781454|Mexiletine|mexiletine|mesh-list
83449961|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83449962|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83449963|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83449964|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83449965|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449966|NCT00892697|Ribavirin|ribavirin|mesh-list
83449967|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83449968|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
83449969|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449970|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
83449971|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83449972|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83449973|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449974|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83449975|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449976|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449977|NCT01831193|Curcumin|curcumin|mesh-list
83449978|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83449979|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83449980|NCT01831193|Analgesics|analgesics|mesh-ancestor
83449981|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
83449982|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83449983|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449984|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83449985|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449986|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449987|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449988|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449989|NCT01831505|Prednisolone|prednisolone|mesh-list
83449990|NCT01831505|Rituximab|rituximab|mesh-list
83449991|NCT01831505|Doxorubicin|doxorubicin|mesh-list
83449992|NCT01831505|Vincristine|vincristine|mesh-list
83449993|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83449994|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83449995|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449996|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
83449997|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449998|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83449999|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83450000|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83450001|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83450002|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450003|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450004|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83450005|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
83450006|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
83450007|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
83450008|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450009|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
83450010|NCT01831505|Hormones|hormones|mesh-ancestor
83450011|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450012|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83450013|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83450014|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
83450015|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83450016|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450017|NCT03214055|Mannitol|mannitol|mesh-list
83450018|NCT03214055|Diuretics|diuretics|mesh-list
83450019|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83450020|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
83450021|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450022|NCT03405337|Factor VIII|factor viii|mesh-list
83450023|NCT03405337|Coagulants|coagulants|mesh-ancestor
83450024|NCT01831661|Metformin|metformin|mesh-list
83450025|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83450026|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450027|NCT03213977|Prednisone|prednisone|mesh-list
83450028|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
83450029|NCT03213977|Doxorubicin|doxorubicin|mesh-list
83450030|NCT03213977|Etoposide|etoposide|mesh-list
83450031|NCT03213977|Vincristine|vincristine|mesh-list
83450032|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450033|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
83450034|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450035|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450036|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83450037|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
83450038|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450039|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450040|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83450041|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83450042|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83450043|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83450044|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450045|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83450046|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450047|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
83450048|NCT03213977|Hormones|hormones|mesh-ancestor
83450049|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450050|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83450051|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
83450052|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
83450053|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
83450054|NCT05311085|Nicotine|nicotine|mesh-list
83450055|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83450056|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
83450057|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450058|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450059|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83450060|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83450061|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
83450062|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450063|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450064|NCT03400267|Acetaminophen|acetaminophen|mesh-list
83450065|NCT03400267|Fentanyl|fentanyl|mesh-list
83450066|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83450067|NCT03400267|Narcotics|narcotics|mesh-ancestor
83450068|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450069|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450070|NCT03400267|Analgesics|analgesics|mesh-ancestor
83450071|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
83450072|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450073|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83450074|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83450075|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
83450076|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
83450077|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83450078|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
83450079|NCT01832051|Trastuzumab|trastuzumab|mesh-list
83450080|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83450081|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450083|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
83450084|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
83450085|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
83450086|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
83450087|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450088|NCT01832129|Hematinics|hematinics|mesh-ancestor
83450089|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
83450090|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
83450091|NCT03219359|Vedolizumab|vedolizumab|mesh-list
83450092|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
83450093|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450094|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
83450095|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450096|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450097|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83450098|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
83450099|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450100|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450101|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83450102|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450103|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
83450104|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
83450105|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450106|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83450107|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
83450108|NCT03219359|Hormones|hormones|mesh-ancestor
83450109|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450110|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83450111|NCT03219359|Protective Agents|protective agents|mesh-ancestor
83450112|NCT04380857|Dexamethasone|dexamethasone|mesh-list
83450113|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450114|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
83450115|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
83450116|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450117|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450118|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83450119|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
83450120|NCT04380857|Hormones|hormones|mesh-ancestor
83450121|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450122|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83450123|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450124|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83450125|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83450126|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450127|NCT03217643|Immunotoxins|immunotoxins|mesh-ancestor
83450128|NCT03217643|Immunoconjugates|immunoconjugates|mesh-ancestor
83450129|NCT03217643|Immunologic Factors|immunologic factors|mesh-ancestor
83450130|NCT03217643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450131|NCT02903446|Denosumab|denosumab|mesh-list
83450132|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83450133|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450134|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
83450135|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83450136|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83450137|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450138|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450139|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83450140|NCT01832285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83450141|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83450142|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83450143|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450144|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450145|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
83450146|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83450147|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
83450148|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83450149|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83450150|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450151|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83450152|NCT01832363|Xenon|xenon|mesh-list
83450153|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83450154|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
83450156|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450157|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450158|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
83450159|NCT02903836|Nafithromycin|nafithromycin|mesh-list
83450160|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83450161|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450162|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83450163|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83450164|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450165|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450166|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450167|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83450168|NCT00014911|Sirolimus|sirolimus|mesh-list
83450169|NCT00014911|Pentamidine|pentamidine|mesh-list
83450170|NCT00014911|Trimethoprim|trimethoprim|mesh-list
83450171|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
83450172|NCT00014911|Ganciclovir|ganciclovir|mesh-list
83450173|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83450174|NCT00014911|Tacrolimus|tacrolimus|mesh-list
83450175|NCT00014911|Daclizumab|daclizumab|mesh-list
83450176|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450177|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
83450178|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450179|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83450180|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450181|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450182|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83450183|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450184|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83450185|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450186|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
83450187|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83450188|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
83450189|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83450190|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83450191|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83450192|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83450193|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83450194|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83450195|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
83450196|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83450197|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83450198|NCT01832675|Bupivacaine|bupivacaine|mesh-list
83450199|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
83450200|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
83450201|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450202|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450203|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
83450204|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450205|NCT03213587|Apatinib|apatinib|mesh-list
83450206|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450207|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83450208|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450209|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450210|NCT00013897|Lamivudine|lamivudine|mesh-list
83450211|NCT00013897|Zidovudine|zidovudine|mesh-list
83450212|NCT00013897|Efavirenz|efavirenz|mesh-list
83450213|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83450214|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83450215|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83450216|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83450217|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450218|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450219|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
83450220|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450221|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83450222|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83450223|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
83450224|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83450225|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83450226|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83450227|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83450228|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83450229|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83450230|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83450231|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83450232|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
83450234|NCT03219983|Ropivacaine|ropivacaine|mesh-list
83450235|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
83450236|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
83450237|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450238|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450239|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
83450240|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450241|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83450242|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83450243|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83450244|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83450245|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450246|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450247|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450248|NCT04347577|Analgesics|analgesics|mesh-ancestor
83450249|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
83450250|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450251|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
83450252|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83450253|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
83450254|NCT02240017|Carboplatin|carboplatin|mesh-list
83450255|NCT02240017|Gemcitabine|gemcitabine|mesh-list
83450256|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450257|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83450258|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
83450259|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450260|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
83450261|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450262|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
83450263|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
83450264|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
83450265|NCT03219593|Apatinib|apatinib|mesh-list
83450266|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450267|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83450268|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450269|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450270|NCT04375267|Olaparib|olaparib|mesh-list
83450271|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83450272|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83450273|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450274|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450275|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450276|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83450277|NCT03836807|Ketoprofen|ketoprofen|mesh-list
83450278|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
83450279|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83450280|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83450281|NCT03836807|Analgesics|analgesics|mesh-ancestor
83450282|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
83450283|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450284|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450285|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450286|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450287|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83450288|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450289|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450290|NCT02240173|Haloperidol|haloperidol|mesh-list
83450291|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
83450292|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
83450293|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
83450294|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450295|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450296|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83450297|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83450298|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83450299|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450300|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83450301|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83450302|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
83450303|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450304|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450305|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83450306|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
83450307|NCT02240641|Lacidipine|lacidipine|mesh-list
83450308|NCT02240641|Diuretics|diuretics|mesh-list
83450309|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83450310|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83450311|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83450312|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83450313|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
83450314|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450315|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83450316|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
83450317|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450318|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450319|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
83450320|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83450321|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83450322|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83450323|NCT03219671|Nivolumab|nivolumab|mesh-list
83450324|NCT03219671|Ipilimumab|ipilimumab|mesh-list
83450325|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83450326|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450327|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83450328|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450329|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
83450330|NCT03404635|Apixaban|apixaban|mesh-list
83450331|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83450332|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
83450333|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83450334|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
83450335|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450336|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450337|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
83450338|NCT01832987|Trimethoprim|trimethoprim|mesh-list
83450339|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83450340|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
83450341|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83450342|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450343|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
83450344|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83450345|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83450346|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83450347|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450348|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450349|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83450350|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83450351|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83450352|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83450353|NCT03404479|Celecoxib|celecoxib|mesh-list
83450354|NCT03404479|Diacerein|diacerein|mesh-list
83450355|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83450356|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83450357|NCT03404479|Analgesics|analgesics|mesh-ancestor
83450358|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
83450359|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450360|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450361|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450362|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450363|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83450364|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83450365|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450366|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450367|NCT04380467|Vitamin D|vitamin d|mesh-list
83450368|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
83450369|NCT04380467|Vitamins|vitamins|mesh-ancestor
83450370|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
83450371|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450372|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83450373|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83450374|NCT03218657|Cyclosporine|cyclosporine|mesh-list
83450375|NCT03218657|Levamisole|levamisole|mesh-list
83450376|NCT03218657|Cyclosporins|cyclosporins|mesh-list
83450377|NCT03218657|Androgens|androgens|mesh-list
83450378|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481623|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83450379|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450380|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450381|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
83450382|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450383|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
83450384|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450385|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
83450386|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450387|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83450388|NCT03218657|Hormones|hormones|mesh-ancestor
83450389|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450390|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83450391|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
83450392|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
83450393|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83450394|NCT02240719|Everolimus|everolimus|mesh-list
83450395|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83450396|NCT02240719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83450397|NCT02240719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83450398|NCT02240719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450399|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450400|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450401|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
83450402|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450403|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450404|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83450405|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
83450406|NCT01833299|Sorafenib|sorafenib|mesh-list
83450407|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
83450408|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450409|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83450410|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450411|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450412|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83450413|NCT01833299|Estrogens|estrogens|mesh-ancestor
83450414|NCT01833299|Hormones|hormones|mesh-ancestor
83450415|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450416|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450417|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83450418|NCT03213041|Carboplatin|carboplatin|mesh-list
83450419|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
83450420|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450421|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83450422|NCT03213041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83450423|NCT03213041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450424|NCT02240875|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83450425|NCT02240875|Antiviral Agents|antiviral agents|mesh-ancestor
83450426|NCT02240875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450427|NCT01833611|Entecavir|entecavir|mesh-list
83450428|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
83450429|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450430|NCT02240953|Warfarin|warfarin|mesh-list
83450431|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
83450432|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
83450433|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83450434|NCT02241031|Oprelvekin|oprelvekin|mesh-list
83450435|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450436|NCT03212807|Lenalidomide|lenalidomide|mesh-list
83450437|NCT03212807|Durvalumab|durvalumab|mesh-list
83450438|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
83450439|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450440|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83450441|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83450442|NCT03212807|Growth Substances|growth substances|mesh-ancestor
83450443|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
83450444|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450445|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83450446|NCT04373941|Lenograstim|lenograstim|mesh-list
83450447|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83450448|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
83450449|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450450|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
83450451|NCT01833767|Interleukin-2|interleukin-2|mesh-list
83450452|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450453|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
83450454|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450455|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450456|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83450457|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
83450458|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450459|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450460|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83450461|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83450462|NCT01833767|Analgesics|analgesics|mesh-ancestor
83450463|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
83450464|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450465|NCT03213353|Acetaminophen|acetaminophen|mesh-list
83450466|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
83450467|NCT03213353|Phenylephrine|phenylephrine|mesh-list
83450468|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
83450469|NCT03213353|Guaifenesin|guaifenesin|mesh-list
83450470|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83450471|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83450472|NCT03213353|Analgesics|analgesics|mesh-ancestor
83450473|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
83450474|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450475|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450476|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
83450477|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83450478|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
83450479|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
83450480|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
83450481|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83450482|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
83450483|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
83450484|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83450485|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83450486|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83450487|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
83450488|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450489|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450490|NCT03213353|Protective Agents|protective agents|mesh-ancestor
83450491|NCT03213353|Expectorants|expectorants|mesh-ancestor
83450492|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
83450493|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83450495|NCT01834235|Gemcitabine|gemcitabine|mesh-list
83450496|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83450497|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450498|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
83450499|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
83450500|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
83450501|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450502|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83450503|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
83450504|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
83450505|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83450506|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450507|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450508|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83450509|NCT03211871|Analgesics|analgesics|mesh-ancestor
83450510|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
83450511|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450512|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83450513|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83450514|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83450515|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
83450516|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450517|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450518|NCT03838133|Bupivacaine|bupivacaine|mesh-list
83450519|NCT03838133|Ropivacaine|ropivacaine|mesh-list
83450520|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
83450521|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
83450522|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450523|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450524|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
83450525|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450526|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83450527|NCT03217409|Ezetimibe|ezetimibe|mesh-list
83450528|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83450529|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83450530|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
83450531|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450532|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83450533|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83450534|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450535|NCT00895193|Aspirin|aspirin|mesh-list
83450536|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83450537|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83450538|NCT00895193|Analgesics|analgesics|mesh-ancestor
83450539|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
83450540|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450541|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450542|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450543|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450544|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83450545|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83450546|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450547|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83450548|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83450549|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450550|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
83450551|NCT01834547|Caffeine|caffeine|mesh-list
83450552|NCT01834547|Methylphenidate|methylphenidate|mesh-list
83450553|NCT01834547|Modafinil|modafinil|mesh-list
83450554|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83450555|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450556|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83450557|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450558|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450559|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83450560|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83450561|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
83450562|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450563|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83450564|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83450565|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83450566|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
83450567|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83450568|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83450569|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83450570|NCT03216941|Ketamine|ketamine|mesh-list
83450571|NCT03216941|Olanzapine|olanzapine|mesh-list
83450572|NCT03216941|Analgesics|analgesics|mesh-ancestor
83450573|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
83450574|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450575|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450576|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83450577|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83450578|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
83450579|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
83450580|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450581|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83450582|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83450583|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450584|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450585|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
83450586|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
83450587|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83450588|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83450589|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83450590|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83450591|NCT03216941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83450592|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83450593|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83450594|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
83450595|NCT03216707|Capsaicin|capsaicin|mesh-list
83450596|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
83450597|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
83450598|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
83450599|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450600|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450601|NCT01838993|Lidocaine|lidocaine|mesh-list
83450602|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
83450603|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
83450604|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450605|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450606|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
83450607|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450608|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83450609|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83450610|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83450611|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83450612|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450613|NCT03211013|Oxytocin|oxytocin|mesh-list
83450614|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
83450615|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83450616|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450617|NCT01835561|Thalidomide|thalidomide|mesh-list
83450618|NCT01835561|Pomalidomide|pomalidomide|mesh-list
83450619|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
83450620|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450621|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83450622|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83450623|NCT01835561|Growth Substances|growth substances|mesh-ancestor
83450624|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
83450625|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450626|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450627|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
83450628|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83450629|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450630|NCT01835639|Vitamin D|vitamin d|mesh-list
83450631|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
83450632|NCT01835639|Vitamins|vitamins|mesh-ancestor
83450633|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
83450634|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450635|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83450636|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83450637|NCT01839149|Oxytocin|oxytocin|mesh-list
83450638|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
83450639|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83450640|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450641|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
83450642|NCT01839383|Calcium|calcium|mesh-list
83450643|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83450644|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450645|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83450646|NCT00901199|Deferasirox|deferasirox|mesh-list
83450647|NCT00901199|Deferoxamine|deferoxamine|mesh-list
83450648|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83450649|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
83450650|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
83450651|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450652|NCT00901199|Siderophores|siderophores|mesh-ancestor
83450653|NCT01836341|Carboplatin|carboplatin|mesh-list
83450654|NCT01836341|Pemetrexed|pemetrexed|mesh-list
83450655|NCT01836341|Afatinib|afatinib|mesh-list
83450656|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450657|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450658|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450659|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83450660|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83450661|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83450662|NCT00906503|Dexamethasone|dexamethasone|mesh-list
83450663|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83450664|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450665|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
83450666|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
83450667|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450668|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450670|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
83450671|NCT00906503|Hormones|hormones|mesh-ancestor
83450672|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450673|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83450674|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450675|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83450676|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450677|NCT01836575|Carboplatin|carboplatin|mesh-list
83450678|NCT01836575|Pemetrexed|pemetrexed|mesh-list
83450679|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450680|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450681|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450682|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83450683|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83450684|NCT01836653|Bevacizumab|bevacizumab|mesh-list
83450685|NCT01836653|Cetuximab|cetuximab|mesh-list
83450686|NCT01836653|Fluorouracil|fluorouracil|mesh-list
83450687|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
83450688|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83450689|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450690|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83450691|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83450692|NCT01836653|Growth Substances|growth substances|mesh-ancestor
83450693|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450694|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
83450695|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
83450696|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450697|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83450698|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450699|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
83450700|NCT03836885|Apremilast|apremilast|mesh-list
83450701|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83450702|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83450703|NCT03836885|Analgesics|analgesics|mesh-ancestor
83450704|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
83450705|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450706|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450707|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450708|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450709|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83450710|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83450711|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450712|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450713|NCT01837043|Cyclosporine|cyclosporine|mesh-list
83450714|NCT01837043|Abatacept|abatacept|mesh-list
83450715|NCT01837043|Tacrolimus|tacrolimus|mesh-list
83450716|NCT01837043|Cyclosporins|cyclosporins|mesh-list
83450717|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83450718|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450719|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
83450720|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450721|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450722|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450723|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
83450724|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450725|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
83450726|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450727|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83450728|NCT01837043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83450729|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450730|NCT01839773|Paclitaxel|paclitaxel|mesh-list
83450731|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83450732|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83450733|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450734|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
83450735|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
83450736|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
83450737|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450738|NCT00909155|Fluoxetine|fluoxetine|mesh-list
83450739|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83450740|NCT00909155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83481624|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450741|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83450742|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83450743|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450744|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450745|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
83450746|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450747|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83450748|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
83450749|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83450750|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83450751|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83450752|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450753|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83450754|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
83450755|NCT01839851|Hormones|hormones|mesh-ancestor
83450756|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450757|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450758|NCT01839929|Tacrolimus|tacrolimus|mesh-list
83450759|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450760|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
83450761|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450762|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83450763|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450764|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450765|NCT04373083|Cemiplimab|cemiplimab|mesh-list
83450766|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83450767|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450768|NCT03210545|Betamethasone|betamethasone|mesh-list
83450769|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450770|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
83450771|NCT03210545|Hormones|hormones|mesh-ancestor
83450772|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450773|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450774|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83450775|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
83450776|NCT04372849|Insulin|insulin|mesh-list
83450777|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83450778|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450779|NCT03403777|Avelumab|avelumab|mesh-list
83450780|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83450781|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450782|NCT02241421|Amoxicillin|amoxicillin|mesh-list
83450783|NCT02241421|Vancomycin|vancomycin|mesh-list
83450784|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83450785|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450786|NCT01837199|Amoxicillin|amoxicillin|mesh-list
83450787|NCT01837199|Metronidazole|metronidazole|mesh-list
83450788|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83450789|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450790|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83450791|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83450792|NCT00926185|Lifitegrast|lifitegrast|mesh-list
83450793|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83450794|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83450795|NCT02241499|Fluorouracil|fluorouracil|mesh-list
83450796|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
83450797|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
83450798|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450799|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83450800|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450801|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450802|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
83450803|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450804|NCT01837667|Docetaxel|docetaxel|mesh-list
83450805|NCT01837667|LB100|lb100|mesh-list
83450806|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450807|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
83450808|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
83450809|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
83450810|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450811|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450812|NCT03833947|Dexamethasone|dexamethasone|mesh-list
83450813|NCT03833947|Lidocaine|lidocaine|mesh-list
83450814|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450815|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
83450816|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
83450818|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450819|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83450820|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
83450821|NCT03833947|Hormones|hormones|mesh-ancestor
83450822|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450823|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83450824|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450825|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
83450826|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
83450827|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450828|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
83450829|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83450830|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83450831|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83450832|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83450833|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450834|NCT03219437|Methotrexate|methotrexate|mesh-list
83450835|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83450836|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
83450837|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83450838|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450839|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83450840|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
83450841|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450842|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450843|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
83450844|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450845|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83450846|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83450847|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
83450848|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450849|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83450850|NCT03212963|Clobetasol|clobetasol|mesh-list
83450851|NCT03212963|Halobetasol|halobetasol|mesh-list
83450852|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83450853|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450854|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
83450855|NCT03212963|Hormones|hormones|mesh-ancestor
83450856|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450857|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450858|NCT03218969|Ecopipam|ecopipam|mesh-list
83450859|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83450860|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83450861|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450862|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450863|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83450864|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83450865|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
83450866|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450867|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450868|NCT01830101|Temozolomide|temozolomide|mesh-list
83450869|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83450870|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
83450871|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450872|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450873|NCT01830335|Indomethacin|indomethacin|mesh-list
83450874|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83450875|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83450876|NCT01830335|Analgesics|analgesics|mesh-ancestor
83450877|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
83450878|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450879|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450880|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450881|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450882|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
83450883|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
83450884|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83450885|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83450886|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450887|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450888|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
83450889|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83450890|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83450891|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450892|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83450893|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83450894|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450895|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450896|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83450897|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450898|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
83450899|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
83450900|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83450901|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
83450902|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450903|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450904|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83450905|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
83450906|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
83450907|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83450908|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
83450909|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450910|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450911|NCT04371757|Doxazosin|doxazosin|mesh-list
83450912|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
83450913|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83450914|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83450915|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83450916|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83450917|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450918|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450919|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450920|NCT04371601|Oseltamivir|oseltamivir|mesh-list
83450921|NCT04371601|Hormones|hormones|mesh-list
83450922|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83450923|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450924|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
83450925|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450926|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450927|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450928|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
83450929|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
83450930|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83450931|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83450932|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450933|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83450934|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450935|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83450936|NCT02242357|Telmisartan|telmisartan|mesh-list
83450937|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83450938|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83450939|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83450940|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450941|NCT03409835|Ramosetron|ramosetron|mesh-list
83450942|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
83450943|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
83450944|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450945|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450946|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83450947|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83450948|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
83450949|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450950|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450951|NCT02242513|Lidocaine|lidocaine|mesh-list
83450952|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
83450953|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
83450954|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450955|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450956|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
83450957|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450958|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83450959|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83450960|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83450961|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83450962|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450963|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83450964|NCT03409679|Murepavadin|murepavadin|mesh-list
83450965|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450966|NCT04371367|Avdoralimab|avdoralimab|mesh-list
83450967|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83450968|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
83450969|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83450970|NCT02242591|Ropivacaine|ropivacaine|mesh-list
83450971|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
83450972|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
83450973|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450974|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450975|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
83450976|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450977|NCT02982577|Pilocarpine|pilocarpine|mesh-list
83450978|NCT02982577|Miotics|miotics|mesh-ancestor
83450979|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
83450980|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450981|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450982|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83450983|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83450984|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
83450985|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83450986|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83450987|NCT01726205|Pregabalin|pregabalin|mesh-list
83450988|NCT01726205|Ropivacaine|ropivacaine|mesh-list
83450989|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
83450990|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
83450991|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83450992|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83450993|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
83450994|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83450995|NCT01726205|Analgesics|analgesics|mesh-ancestor
83450996|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
83450997|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83450998|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83450999|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451000|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83451001|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83451002|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83451003|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83451004|NCT02242825|Telmisartan|telmisartan|mesh-list
83451005|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
83451006|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83451007|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83451008|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83451009|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451010|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83451011|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83451012|NCT02242825|Diuretics|diuretics|mesh-ancestor
83451013|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
83451014|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451015|NCT04370977|Artesunate|artesunate|mesh-list
83451016|NCT04370977|Lumefantrine|lumefantrine|mesh-list
83451017|NCT04370977|Artemether|artemether|mesh-list
83451018|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83451019|NCT04370977|Amodiaquine|amodiaquine|mesh-list
83451020|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
83451021|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83451022|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83451023|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451024|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451025|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
83451026|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
83451027|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83451028|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
83451029|NCT01726283|Riboflavin|riboflavin|mesh-list
83451030|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
83451031|NCT01726283|Vitamins|vitamins|mesh-ancestor
83451032|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
83451033|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451034|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83451035|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
83451036|NCT04370431|Edaravone|edaravone|mesh-list
83451037|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83451038|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
83451039|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451040|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83451041|NCT04370431|Protective Agents|protective agents|mesh-ancestor
83451042|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451043|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83451044|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451045|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451046|NCT03835871|Beclomethasone|beclomethasone|mesh-list
83451047|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83451048|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
83451049|NCT03835871|Hormones|hormones|mesh-ancestor
83451050|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451051|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451052|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83451053|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
83451054|NCT03402295|Thalidomide|thalidomide|mesh-list
83451055|NCT03402295|Dexamethasone|dexamethasone|mesh-list
83451056|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
83451057|NCT03402295|Bortezomib|bortezomib|mesh-list
83451058|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83451059|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
83451060|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451061|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451062|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83451063|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
83451064|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451065|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451066|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83451067|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83451068|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
83451069|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
83451070|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451071|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83451072|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
83451073|NCT03402295|Hormones|hormones|mesh-ancestor
83451074|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451075|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83451076|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
83451077|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83451078|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451079|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83451080|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83451081|NCT03402295|Growth Substances|growth substances|mesh-ancestor
83451082|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
83451083|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83451084|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83451085|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451086|NCT02244073|Insulin|insulin|mesh-list
83451087|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83451088|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83451089|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451090|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83451091|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
83451092|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83451093|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
83451094|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83451095|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451096|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83451097|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83451098|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451099|NCT03401827|Paclitaxel|paclitaxel|mesh-list
83451100|NCT03401827|Gemcitabine|gemcitabine|mesh-list
83451101|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83451102|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451103|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
83451104|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
83451105|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
83451106|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451107|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83451108|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
83451109|NCT00909545|Isradipine|isradipine|mesh-list
83451110|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83451111|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83451112|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83451113|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451114|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83451115|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451116|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
83451117|NCT02244229|Tamsulosin|tamsulosin|mesh-list
83451118|NCT02244229|Finasteride|finasteride|mesh-list
83451119|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83451120|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83451121|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83451122|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
83451123|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451124|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451125|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451126|NCT02244229|Urological Agents|urological agents|mesh-ancestor
83451127|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83451128|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83451129|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451130|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
83451131|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451132|NCT02157103|Bevacizumab|bevacizumab|mesh-list
83451133|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83451134|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451135|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83451136|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83451137|NCT02157103|Growth Substances|growth substances|mesh-ancestor
83451138|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451139|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
83451140|NCT00924001|Aldesleukin|aldesleukin|mesh-list
83451141|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
83451142|NCT00924001|Fludarabine|fludarabine|mesh-list
83451143|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83451144|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
83451145|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451146|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451147|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83451148|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
83451149|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451150|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451151|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83451152|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83451153|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83451154|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
83451155|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451156|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
83451157|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
83451158|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83451159|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451160|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451161|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451162|NCT03401593|Fentanyl|fentanyl|mesh-list
83451163|NCT03401593|Midazolam|midazolam|mesh-list
83451164|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83451165|NCT03401593|Narcotics|narcotics|mesh-ancestor
83451166|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83451167|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451168|NCT03401593|Analgesics|analgesics|mesh-ancestor
83451169|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
83451170|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451171|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83451172|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83451173|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
83451174|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
83451175|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83451176|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83451177|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83451178|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83451180|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
83451181|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451182|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451183|NCT03401515|Propranolol|propranolol|mesh-list
83451184|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83451185|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83451186|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
83451187|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451188|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451189|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451190|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83451191|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83451192|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
83451193|NCT01726829|Pancrelipase|pancrelipase|mesh-list
83451194|NCT01726829|Pancreatin|pancreatin|mesh-list
83451195|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83451197|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83451198|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451199|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83451200|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451201|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
83451202|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83451203|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83451204|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451205|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
83451206|NCT04367155|Coagulants|coagulants|mesh-ancestor
83451207|NCT01727453|Warfarin|warfarin|mesh-list
83451208|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
83451209|NCT01727531|Chloroquine|chloroquine|mesh-list
83451210|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83451211|NCT01727531|Amebicides|amebicides|mesh-ancestor
83451212|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83451213|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83451214|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451215|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
83451216|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451217|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83451218|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83451219|NCT01727531|Analgesics|analgesics|mesh-ancestor
83451220|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
83451221|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451222|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451223|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83451224|NCT01727531|Filaricides|filaricides|mesh-ancestor
83451225|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
83451226|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
83451227|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
83451228|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83451229|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83451230|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451231|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83451232|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83451233|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451234|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451235|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451236|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83451237|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
83451238|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83451239|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451240|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83451241|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83451242|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83451243|NCT00929071|Lidocaine|lidocaine|mesh-list
83451244|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
83451245|NCT00929071|Anesthetics|anesthetics|mesh-list
83451246|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83451247|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451248|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
83451249|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451250|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83451251|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83451252|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83451253|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83451254|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451256|NCT01721525|Paclitaxel|paclitaxel|mesh-list
83451257|NCT01721525|Carboplatin|carboplatin|mesh-list
83451258|NCT01721525|Afatinib|afatinib|mesh-list
83451259|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83451260|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451261|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
83451262|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
83451263|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
83451264|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451265|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
83451266|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
83451267|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451268|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83451269|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451270|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
83451271|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83451272|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83451273|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451274|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
83451275|NCT01727843|Coagulants|coagulants|mesh-ancestor
83451277|NCT01721915|Vitamins|vitamins|mesh-ancestor
83451278|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
83451279|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451280|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83451281|NCT04357483|Thrombin|thrombin|mesh-list
83451282|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
83451283|NCT04357483|Coagulants|coagulants|mesh-ancestor
83451284|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
83451285|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83451286|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451287|NCT04366609|Methylphenidate|methylphenidate|mesh-list
83451288|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83451289|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451290|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83451291|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83451292|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83451293|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451294|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
83451295|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451296|NCT03407105|Ipilimumab|ipilimumab|mesh-list
83451297|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83451298|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451299|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83451300|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451301|NCT01722227|Liraglutide|liraglutide|mesh-list
83451302|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83451303|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451304|NCT01722227|Incretins|incretins|mesh-ancestor
83451305|NCT01722227|Hormones|hormones|mesh-ancestor
83451306|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451307|NCT01722305|Dexamethasone|dexamethasone|mesh-list
83451308|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
83451309|NCT01722305|Pomalidomide|pomalidomide|mesh-list
83451310|NCT01722305|Ichthammol|ichthammol|mesh-list
83451311|NCT01722305|BB 1101|bb 1101|mesh-list
83451312|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83451313|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
83451314|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
83451315|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451316|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451317|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83451318|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
83451319|NCT01722305|Hormones|hormones|mesh-ancestor
83451320|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451321|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83451322|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451323|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
83451324|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451325|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451326|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
83451327|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83451328|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83451329|NCT01722305|Growth Substances|growth substances|mesh-ancestor
83451330|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
83451331|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
83451332|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83451333|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83451334|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451335|NCT04365517|Incretins|incretins|mesh-ancestor
83451336|NCT04365517|Hormones|hormones|mesh-ancestor
83451337|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451338|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83451339|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
83451340|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451341|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451342|NCT03406871|Nivolumab|nivolumab|mesh-list
83451343|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83451344|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451345|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83451346|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451348|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
83451349|NCT04357093|Fluorides|fluorides|mesh-list
83451350|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
83451351|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
83451352|NCT04357093|Protective Agents|protective agents|mesh-ancestor
83451353|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451354|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83451355|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451356|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83451357|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451358|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
83451359|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451360|NCT03406793|Iron|iron|mesh-list
83451361|NCT03406793|Zinc|zinc|mesh-list
83451362|NCT03406793|Trace Elements|trace elements|mesh-ancestor
83451363|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
83451364|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451365|NCT04365127|Progesterone|progesterone|mesh-list
83451366|NCT04365127|Progestins|progestins|mesh-ancestor
83451367|NCT04365127|Hormones|hormones|mesh-ancestor
83451368|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451369|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451370|NCT00929383|Hemostatics|hemostatics|mesh-list
83451371|NCT00929383|Coagulants|coagulants|mesh-ancestor
83451372|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
83451373|NCT01722539|Piperaquine|piperaquine|mesh-list
83451374|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
83451375|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83451376|NCT01722539|Albendazole|albendazole|mesh-list
83451377|NCT01722539|Praziquantel|praziquantel|mesh-list
83451378|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
83451379|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83451380|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83451381|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451382|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83451383|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451384|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451385|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83451386|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
83451387|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
83451388|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83451389|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
83451390|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
83451391|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
83451392|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451393|NCT03406403|Anesthetics|anesthetics|mesh-list
83451394|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83451395|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451396|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
83451397|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
83451398|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
83451399|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83451400|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83451401|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451402|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451403|NCT03406169|Urological Agents|urological agents|mesh-ancestor
83451404|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83451405|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83451406|NCT03406169|Protective Agents|protective agents|mesh-ancestor
83451407|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451408|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83451409|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
83451410|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
83451411|NCT04357015|Carbetocin|carbetocin|mesh-list
83451412|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83451413|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83451414|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451415|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
83451416|NCT04357015|Coagulants|coagulants|mesh-ancestor
83451417|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
83451418|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83451419|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451420|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83451421|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83451422|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83451423|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451424|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
83451425|NCT03406091|Plerixafor|plerixafor|mesh-list
83451426|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83451427|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83451428|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
83451429|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451430|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
83451431|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
83451432|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83451433|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83451434|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451435|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451436|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451437|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451438|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83451439|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
83451440|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451441|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83451442|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83451443|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
83451444|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451445|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451446|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83451447|NCT02245243|Delafloxacin|delafloxacin|mesh-list
83451448|NCT02245243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451449|NCT01728935|Tenofovir|tenofovir|mesh-list
83451450|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
83451451|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451452|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83451453|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83451454|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451455|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451456|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83451457|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83451458|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
83451459|NCT02904226|Nivolumab|nivolumab|mesh-list
83451460|NCT02904226|Ipilimumab|ipilimumab|mesh-list
83451461|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83451462|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451463|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83451464|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451465|NCT03833999|Ondansetron|ondansetron|mesh-list
83451466|NCT03833999|Lactulose|lactulose|mesh-list
83451467|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
83451468|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
83451469|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451470|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451471|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83451472|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
83451473|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
83451474|NCT03833999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83451475|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83451476|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
83451477|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451478|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451479|NCT04379219|Methotrexate|methotrexate|mesh-list
83451480|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83451481|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
83451482|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83451483|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451484|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83451485|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
83451486|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451487|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451488|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
83451489|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451490|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83451491|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83451492|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
83451493|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451494|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83451495|NCT04347031|Azithromycin|azithromycin|mesh-list
83451496|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
83451497|NCT04347031|Mefloquine|mefloquine|mesh-list
83451498|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83451499|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451500|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
83451501|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83451502|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83451503|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451504|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451505|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451506|NCT02906566|Vitamin A|vitamin a|mesh-list
83451507|NCT02906566|Vitamins|vitamins|mesh-ancestor
83451508|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
83451509|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451510|NCT00913133|Desirudin|desirudin|mesh-list
83451511|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
83451512|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83451513|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83451514|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451515|NCT00373126|Nicotine|nicotine|mesh-list
83451516|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83451517|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
83451518|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451519|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451520|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83451521|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83451522|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
83451523|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451524|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451525|NCT04378283|Lidocaine|lidocaine|mesh-list
83451526|NCT04378283|Epinephrine|epinephrine|mesh-list
83451527|NCT04378283|Tetracaine|tetracaine|mesh-list
83451528|NCT04378283|Anesthetics|anesthetics|mesh-list
83451529|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
83451530|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83451531|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451532|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
83451533|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451534|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83451535|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83451536|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83451537|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83451538|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451539|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83451540|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83451541|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
83451542|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451543|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83451544|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83451546|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83451547|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
83451548|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
83451549|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
83451550|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83451551|NCT04355845|Sumatriptan|sumatriptan|mesh-list
83451552|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83451553|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83451554|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83451555|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
83451556|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451557|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451558|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451559|NCT02789410|Morphine|morphine|mesh-list
83451560|NCT02789410|Hydromorphone|hydromorphone|mesh-list
83451561|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83451562|NCT02789410|Narcotics|narcotics|mesh-ancestor
83451563|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83451564|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451565|NCT02789410|Analgesics|analgesics|mesh-ancestor
83451566|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
83451567|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451568|NCT01729481|Leucovorin|leucovorin|mesh-list
83451569|NCT01729481|Folic Acid|folic acid|mesh-list
83451570|NCT01729481|Gemcitabine|gemcitabine|mesh-list
83451571|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
83451572|NCT01729481|Irinotecan|irinotecan|mesh-list
83451573|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
83451574|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83451575|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
83451576|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451577|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451578|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83451579|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83451580|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451581|NCT01729481|Antidotes|antidotes|mesh-ancestor
83451582|NCT01729481|Protective Agents|protective agents|mesh-ancestor
83451583|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451584|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
83451585|NCT01729481|Vitamins|vitamins|mesh-ancestor
83451586|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
83451587|NCT01729481|Hematinics|hematinics|mesh-ancestor
83451588|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
83451589|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83451590|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
83451591|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451592|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451593|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83451594|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
83451595|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
83451596|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83451597|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
83451598|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451599|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451600|NCT02793154|Exenatide|exenatide|mesh-list
83451601|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
83451602|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83451603|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451604|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83451605|NCT02793154|Incretins|incretins|mesh-ancestor
83451606|NCT02793154|Hormones|hormones|mesh-ancestor
83451607|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451608|NCT01723553|Corticosterone|corticosterone|mesh-list
83451609|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83451610|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83451611|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83451612|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83451613|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451614|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451615|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83451616|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83451617|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451618|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
83451619|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451620|NCT02909140|Lidocaine|lidocaine|mesh-list
83451621|NCT02909140|Phenylephrine|phenylephrine|mesh-list
83451622|NCT02909140|Epinephrine|epinephrine|mesh-list
83451623|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
83451624|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
83451625|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
83451626|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
83451627|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83451628|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451629|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
83451630|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451631|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83451632|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83451633|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83451634|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83451635|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451636|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83451637|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83451638|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
83451639|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451640|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83451641|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83451642|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
83451643|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83451644|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
83451645|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
83451646|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
83451647|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83451648|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83451649|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
83451650|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83451651|NCT02909140|Protective Agents|protective agents|mesh-ancestor
83451652|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
83451653|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83451654|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83451655|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
83451656|NCT01724879|Dasatinib|dasatinib|mesh-list
83451657|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451658|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83451659|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451660|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451661|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
83451662|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83451663|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
83451664|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451665|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451666|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83451667|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
83451668|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451669|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451670|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83451671|NCT03403985|Calcium|calcium|mesh-list
83451672|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83451673|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451674|NCT04364425|Triamcinolone|triamcinolone|mesh-list
83451675|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83451676|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83451677|NCT04364425|Lidocaine|lidocaine|mesh-list
83451678|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83451679|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
83451680|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
83451681|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83451682|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451683|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
83451684|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451685|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83451686|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83451687|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83451688|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83451689|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451690|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83451691|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
83451692|NCT04364425|Hormones|hormones|mesh-ancestor
83451693|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451694|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83451695|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
83451696|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451697|NCT02911324|Nabilone|nabilone|mesh-list
83451698|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
83451699|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
83451700|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451701|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451702|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83451703|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83451704|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83451705|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83451706|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83451707|NCT01729403|Metformin|metformin|mesh-list
83451708|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83451709|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451710|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83451711|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451712|NCT04355455|Citalopram|citalopram|mesh-list
83451713|NCT04355455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83451714|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83451715|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83451716|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451717|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451718|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
83451719|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451720|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83451721|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
83451722|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83451723|NCT04182373|Antithrombins|antithrombins|mesh-list
83451724|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
83451725|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83451726|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
83451727|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451728|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451729|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
83451730|NCT00913913|Bevacizumab|bevacizumab|mesh-list
83451731|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83451732|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451733|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83451734|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83451735|NCT00913913|Growth Substances|growth substances|mesh-ancestor
83451736|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451737|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
83451738|NCT00373594|Rituximab|rituximab|mesh-list
83451739|NCT00373594|Fludarabine|fludarabine|mesh-list
83451740|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83451741|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451742|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
83451743|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451744|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451745|NCT03403829|Gemcitabine|gemcitabine|mesh-list
83451746|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83451747|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
83451748|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451749|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451750|NCT04364113|Benzocaine|benzocaine|mesh-list
83451751|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
83451752|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
83451753|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83451754|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451755|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
83451756|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451757|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
83451758|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83451759|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451760|NCT03197194|Aspirin|aspirin|mesh-list
83451761|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83451762|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83451763|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83451764|NCT03197194|Analgesics|analgesics|mesh-ancestor
83451765|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
83451766|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451767|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451768|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83451769|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451770|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83451771|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83451772|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451773|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83451774|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83451775|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451776|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
83451777|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
83451778|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83451779|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83451780|NCT03834935|Analgesics|analgesics|mesh-ancestor
83451781|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
83451782|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451783|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451784|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83451785|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451786|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
83451787|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83451788|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
83451789|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83451790|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451791|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451792|NCT02796352|Interleukin-2|interleukin-2|mesh-list
83451793|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451794|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83451795|NCT02796352|Analgesics|analgesics|mesh-ancestor
83451796|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
83451797|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451798|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451799|NCT00939367|Zolpidem|zolpidem|mesh-list
83451800|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83451801|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83451802|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83451803|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451804|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83451805|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
83451806|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
83451807|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451808|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451809|NCT03168880|Paclitaxel|paclitaxel|mesh-list
83451810|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83451811|NCT03168880|Carboplatin|carboplatin|mesh-list
83451812|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83451813|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451814|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
83451815|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
83451816|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
83451817|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451818|NCT04347187|Anticoagulants|anticoagulants|mesh-list
83451819|NCT00920075|Alendronate|alendronate|mesh-list
83451820|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83451821|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451822|NCT04364035|Vesatolimod|vesatolimod|mesh-list
83451823|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
83451824|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451825|NCT03403439|Itraconazole|itraconazole|mesh-list
83451826|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
83451827|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451828|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83451829|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83451830|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451831|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451832|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83451833|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
83451834|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451835|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451836|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83451837|NCT04346797|Eculizumab|eculizumab|mesh-list
83451838|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83451839|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83451840|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
83451841|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451842|NCT04364581|Letrozole|letrozole|mesh-list
83451843|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451844|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83451845|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83451846|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451847|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451848|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83451849|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
83451850|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451851|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451852|NCT01049009|Metoprolol|metoprolol|mesh-list
83451853|NCT01049009|Nebivolol|nebivolol|mesh-list
83451854|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83451855|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83451856|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
83451857|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
83451858|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83451859|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451860|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83451861|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83451862|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83451863|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
83451864|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451865|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451866|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
83451867|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83451868|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83451869|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83451870|NCT02850874|Gemcitabine|gemcitabine|mesh-list
83451871|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83451872|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
83451873|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451874|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451875|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83451876|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83451877|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83451878|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83451879|NCT02920918|Canagliflozin|canagliflozin|mesh-list
83451880|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83451881|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451882|NCT02920918|Incretins|incretins|mesh-ancestor
83451883|NCT02920918|Hormones|hormones|mesh-ancestor
83451884|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451885|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83451886|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
83451887|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451888|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451889|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83451890|NCT03403049|Gemcitabine|gemcitabine|mesh-list
83451891|NCT03403049|Capecitabine|capecitabine|mesh-list
83451892|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83451893|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451894|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83451895|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
83451896|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451897|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83451898|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451899|NCT00944047|Paclitaxel|paclitaxel|mesh-list
83451900|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
83451901|NCT00944047|Doxorubicin|doxorubicin|mesh-list
83451902|NCT00944047|Trastuzumab|trastuzumab|mesh-list
83451903|NCT00944047|Mitogens|mitogens|mesh-list
83451904|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83451905|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451906|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
83451907|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
83451908|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
83451909|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451910|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83451911|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
83451912|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451913|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451914|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83451915|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
83451916|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83451917|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83451918|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83451919|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83451920|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451921|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83451922|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
83451923|NCT02921386|Testosterone|testosterone|mesh-list
83451924|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
83451925|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
83451926|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83451927|NCT02921386|Androgens|androgens|mesh-ancestor
83451928|NCT02921386|Hormones|hormones|mesh-ancestor
83451929|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451930|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451931|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83451932|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83451933|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
83451934|NCT03402815|Maraviroc|maraviroc|mesh-list
83451935|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83451936|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83451937|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451938|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83451939|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83451940|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
83451941|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451942|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83451943|NCT02245555|Tamsulosin|tamsulosin|mesh-list
83451944|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83451945|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83451946|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83451947|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
83451948|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451949|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451950|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451951|NCT02245555|Urological Agents|urological agents|mesh-ancestor
83451952|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
83451953|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
83451954|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83451955|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83451956|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451957|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451958|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451959|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451960|NCT02802514|Exenatide|exenatide|mesh-list
83451961|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
83451962|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83451963|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83451964|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451965|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83451966|NCT02802514|Incretins|incretins|mesh-ancestor
83451967|NCT02802514|Hormones|hormones|mesh-ancestor
83451968|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83451969|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
83451970|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
83451971|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83451972|NCT00944671|Famotidine|famotidine|mesh-list
83451973|NCT00944671|Calcium|calcium|mesh-list
83451974|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83451975|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451976|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83451977|NCT00944671|Antacids|antacids|mesh-ancestor
83451978|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451979|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83451980|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83451981|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83451982|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
83451983|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
83451984|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83451985|NCT00944749|Cyclosporine|cyclosporine|mesh-list
83451986|NCT00944749|Cyclosporins|cyclosporins|mesh-list
83451987|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451988|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83451989|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83451990|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
83451991|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83451992|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
83451993|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83451994|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
83451995|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83451996|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83451997|NCT01047293|Leucovorin|leucovorin|mesh-list
83451998|NCT01047293|Bevacizumab|bevacizumab|mesh-list
83451999|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
83452000|NCT01047293|Everolimus|everolimus|mesh-list
83452001|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452002|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452003|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83452004|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83452005|NCT01047293|Growth Substances|growth substances|mesh-ancestor
83452006|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452007|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
83452008|NCT01047293|Antidotes|antidotes|mesh-ancestor
83452009|NCT01047293|Protective Agents|protective agents|mesh-ancestor
83452010|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
83452011|NCT01047293|Vitamins|vitamins|mesh-ancestor
83452012|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
83452013|NCT01047293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83452014|NCT01047293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83452015|NCT01047293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452016|NCT01047293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452017|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83452018|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
83452019|NCT01045967|Lansoprazole|lansoprazole|mesh-list
83452020|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
83452021|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83452022|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83452023|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83452024|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452025|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452026|NCT02808052|Minocycline|minocycline|mesh-list
83452027|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83452028|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452029|NCT02924350|Fluorides|fluorides|mesh-list
83452030|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
83452032|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
83452033|NCT02924350|Protective Agents|protective agents|mesh-ancestor
83452034|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452035|NCT02344498|Tenofovir|tenofovir|mesh-list
83452036|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
83452037|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452038|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83452039|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83452040|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452041|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452042|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83452043|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83452044|NCT00945139|Bevacizumab|bevacizumab|mesh-list
83452045|NCT00945139|Doxorubicin|doxorubicin|mesh-list
83452046|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452047|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452048|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83452049|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83452050|NCT00945139|Growth Substances|growth substances|mesh-ancestor
83452051|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452052|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
83452053|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83452054|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83452055|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83452056|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452057|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452058|NCT02812342|Tofacitinib|tofacitinib|mesh-list
83452059|NCT02812342|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83452060|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83452061|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452062|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452063|NCT03871465|Triamcinolone|triamcinolone|mesh-list
83452064|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83452065|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83452066|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83452067|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452068|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
83452069|NCT03871465|Hormones|hormones|mesh-ancestor
83452070|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452071|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452072|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83452073|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
83452074|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452075|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452076|NCT00931489|Ranibizumab|ranibizumab|mesh-list
83452077|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83452078|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83452079|NCT00931489|Growth Substances|growth substances|mesh-ancestor
83452080|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452081|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
83452082|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452083|NCT04363255|Cisplatin|cisplatin|mesh-list
83452084|NCT04363255|Carboplatin|carboplatin|mesh-list
83452085|NCT04363255|Etoposide|etoposide|mesh-list
83452086|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
83452087|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452088|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83452089|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83452090|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83452091|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452092|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452093|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
83452094|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83452095|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83452096|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83452097|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83452098|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452099|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
83452100|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452101|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452102|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83452103|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452105|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
83452106|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452107|NCT03490825|Protective Agents|protective agents|mesh-ancestor
83452108|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452109|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83452110|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83452111|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83452112|NCT03317899|Lenograstim|lenograstim|mesh-list
83452113|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83452114|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
83452115|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452116|NCT04353505|Dexamethasone|dexamethasone|mesh-list
83452117|NCT04353505|Ketorolac|ketorolac|mesh-list
83452118|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452119|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
83452120|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
83452121|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452122|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452123|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83452124|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
83452125|NCT04353505|Hormones|hormones|mesh-ancestor
83452126|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452127|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83452128|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452129|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83452130|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83452131|NCT04353505|Analgesics|analgesics|mesh-ancestor
83452132|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
83452133|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83452134|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83452135|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452136|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452137|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83452138|NCT02929927|Eusol|eusol|mesh-list
83452139|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
83452140|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452141|NCT02427451|Venetoclax|venetoclax|mesh-list
83452142|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
83452143|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452144|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452145|NCT04362241|Prednisolone|prednisolone|mesh-list
83452146|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83452147|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
83452148|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83452149|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
83452150|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83452151|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
83452152|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452153|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
83452154|NCT04362241|Hormones|hormones|mesh-ancestor
83452155|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452156|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452157|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83452158|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452159|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
83452160|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
83452161|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452162|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83452163|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83452164|NCT04362241|Protective Agents|protective agents|mesh-ancestor
83452165|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
83452166|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
83452167|NCT01384513|Busulfan|busulfan|mesh-list
83452168|NCT01384513|Fludarabine|fludarabine|mesh-list
83452169|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
83452170|NCT01384513|Tacrolimus|tacrolimus|mesh-list
83452171|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83452173|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452174|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83452175|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83452176|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
83452177|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452178|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452179|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83452180|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83452181|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
83452182|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452183|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83452184|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452185|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83452186|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83452187|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
83452188|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83452189|NCT03035617|Bupivacaine|bupivacaine|mesh-list
83452190|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
83452191|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
83452192|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83452193|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452194|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
83452195|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452197|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452198|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452199|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
83452200|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452201|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83452202|NCT05563675|Cholinergic Agents|cholinergic agents|mesh-list
83452203|NCT05563675|Muscarinic Antagonists|muscarinic antagonists|mesh-list
83452204|NCT05563675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452205|NCT05563675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452206|NCT05563675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452207|NCT05563675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83452208|NCT05555251|Trastuzumab|trastuzumab|mesh-list
83452209|NCT05555251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452210|NCT05555251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452211|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
83452212|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
83452213|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83452214|NCT03035305|Amodiaquine|amodiaquine|mesh-list
83452215|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
83452216|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83452217|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83452218|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452219|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83452220|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452221|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452222|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83452223|NCT03034759|Insulin|insulin|mesh-list
83452224|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83452225|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452226|NCT02158273|Fenofibrate|fenofibrate|mesh-list
83452227|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83452228|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
83452229|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452230|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83452231|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83452232|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83452233|NCT04361461|Azithromycin|azithromycin|mesh-list
83452234|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
83452235|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83452236|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452237|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
83452238|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83452239|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83452240|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452241|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452242|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83452243|NCT03002506|Tazobactam|tazobactam|mesh-list
83452244|NCT03002506|Ceftolozane|ceftolozane|mesh-list
83452245|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83452246|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83452248|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83452249|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452250|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452251|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83452252|NCT02822950|Ceftazidime|ceftazidime|mesh-list
83452254|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83452255|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83452256|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452257|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83452258|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452259|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452260|NCT02935738|Prednisolone|prednisolone|mesh-list
83452261|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452262|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
83452263|NCT02935738|Hormones|hormones|mesh-ancestor
83452264|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452265|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452266|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83452267|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452268|NCT05435677|Insulin|insulin|mesh-list
83452269|NCT05435677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83452270|NCT05435677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452271|NCT00939991|Bevacizumab|bevacizumab|mesh-list
83452272|NCT00939991|Temozolomide|temozolomide|mesh-list
83452273|NCT00939991|Vorinostat|vorinostat|mesh-list
83452274|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452275|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452276|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83452277|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83452278|NCT00939991|Growth Substances|growth substances|mesh-ancestor
83452279|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452280|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
83452281|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83452282|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
83452283|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452284|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83452285|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452286|NCT04361305|Tadalafil|tadalafil|mesh-list
83452287|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
83452288|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83452289|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83452290|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452291|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452292|NCT04361305|Urological Agents|urological agents|mesh-ancestor
83452293|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
83452294|NCT02245321|Hematinics|hematinics|mesh-ancestor
83452295|NCT04361149|Capsaicin|capsaicin|mesh-list
83452296|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
83452297|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
83452298|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
83452299|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452300|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452301|NCT05332483|Megestrol|megestrol|mesh-list
83452302|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
83452303|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83452304|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83452305|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83452306|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
83452307|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83452308|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452309|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83452310|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83452311|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83452312|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452313|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
83452314|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83452315|NCT03033589|Bupivacaine|bupivacaine|mesh-list
83452316|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83452317|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
83452318|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
83452319|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83452320|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452321|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
83452322|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452323|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83452324|NCT00947167|Pertuzumab|pertuzumab|mesh-list
83452325|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452326|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83452327|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452328|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452329|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452330|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
83452331|NCT04360759|Chloroquine|chloroquine|mesh-list
83452332|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
83452333|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83452334|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83452335|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452336|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452337|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452338|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83452339|NCT04360759|Amebicides|amebicides|mesh-ancestor
83452340|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83452341|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83452342|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83452343|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
83452344|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452345|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452346|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83452347|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83452348|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
83452349|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452350|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
83452351|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83452352|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83452353|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83452354|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83452355|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452356|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
83452357|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452358|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452359|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83452360|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452361|NCT03033121|Hormones|hormones|mesh-list
83452362|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452363|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452364|NCT03033199|Dexamethasone|dexamethasone|mesh-list
83452365|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452366|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
83452367|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
83452368|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452369|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452370|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83452371|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
83452372|NCT03033199|Hormones|hormones|mesh-ancestor
83452373|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452374|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83452375|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452376|NCT00940927|Albuterol|albuterol|mesh-list
83452377|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83452378|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
83452379|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452380|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452381|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83452382|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83452383|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
83452384|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83452385|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83452386|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83452387|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83452388|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
83452389|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452390|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452391|NCT00934375|Donepezil|donepezil|mesh-list
83452392|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83452393|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452394|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452395|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
83452396|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452397|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452398|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
83452399|NCT03002974|Triamcinolone|triamcinolone|mesh-list
83452400|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83452401|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83452402|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83452403|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83452404|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452405|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
83452407|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452408|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452409|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83452410|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
83452411|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452412|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452413|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83452414|NCT02245477|Mitogens|mitogens|mesh-list
83452415|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
83452416|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
83452417|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452418|NCT02245477|Growth Substances|growth substances|mesh-ancestor
83452419|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452420|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
83452421|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83452422|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83452423|NCT02825212|Ledipasvir|ledipasvir|mesh-list
83452424|NCT02825212|Velpatasvir|velpatasvir|mesh-list
83452425|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
83452426|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452427|NCT00373672|Modafinil|modafinil|mesh-list
83452428|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83452429|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452430|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83452431|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83452432|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83452433|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452434|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
83452435|NCT04941703|Cathartics|cathartics|mesh-ancestor
83452436|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83452437|NCT04359823|Lovastatin|lovastatin|mesh-list
83452438|NCT04359823|L 647318|l 647318|mesh-list
83452439|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
83452440|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83452441|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83452442|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
83452443|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452444|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83452445|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83452446|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452447|NCT03008590|Naltrexone|naltrexone|mesh-list
83452448|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83452449|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83452450|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452451|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
83452452|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452453|NCT04359511|Prednisone|prednisone|mesh-list
83452454|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
83452455|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452456|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
83452457|NCT04359511|Hormones|hormones|mesh-ancestor
83452458|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452459|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452460|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83452461|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452462|NCT03032419|Vaccines|vaccines|mesh-list
83452463|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
83452464|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452465|NCT00373906|Bortezomib|bortezomib|mesh-list
83452466|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452467|NCT00955513|Diclofenac|diclofenac|mesh-list
83452468|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83452469|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83452470|NCT00955513|Analgesics|analgesics|mesh-ancestor
83452471|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
83452472|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452473|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452474|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452475|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83452476|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83452477|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452478|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452479|NCT00935311|Acetaminophen|acetaminophen|mesh-list
83452480|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83452481|NCT00935311|Hydrocodone|hydrocodone|mesh-list
83452483|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83452484|NCT00935311|Analgesics|analgesics|mesh-ancestor
83452485|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
83452486|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452487|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452488|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
83452489|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83452490|NCT00935311|Narcotics|narcotics|mesh-ancestor
83452491|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83452492|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
83452493|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
83452494|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83452495|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452496|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83452497|NCT02946034|Ribavirin|ribavirin|mesh-list
83452498|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
83452499|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452500|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
83452501|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452502|NCT00955747|Tagatose|tagatose|mesh-list
83452503|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83452504|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
83452505|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
83452506|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452507|NCT02946892|Carvedilol|carvedilol|mesh-list
83452508|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83452509|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83452510|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
83452511|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452512|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452513|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452514|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83452515|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
83452516|NCT02946892|Protective Agents|protective agents|mesh-ancestor
83452517|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83452518|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83452519|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83452520|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
83452521|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83452522|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83452523|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
83452524|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
83452525|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83452526|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83452527|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452528|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452529|NCT03402191|Urological Agents|urological agents|mesh-ancestor
83452530|NCT03402113|Midazolam|midazolam|mesh-list
83452531|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
83452532|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83452533|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83452534|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452535|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83452536|NCT03402113|Analgesics|analgesics|mesh-ancestor
83452537|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
83452538|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452539|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83452540|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83452541|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83452542|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83452543|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452544|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452545|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83452546|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83452547|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83452548|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83452549|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83452550|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
83452551|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
83452552|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
83452553|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
83452554|NCT01725113|Calcitriol|calcitriol|mesh-list
83452555|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83452556|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452557|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83452558|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83452559|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452560|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83452561|NCT01725113|Vitamins|vitamins|mesh-ancestor
83452562|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
83452563|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83452564|NCT03031405|Oxytocin|oxytocin|mesh-list
83452565|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
83452566|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83452567|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452568|NCT03031249|Cytarabine|cytarabine|mesh-list
83452569|NCT03031249|Tretinoin|tretinoin|mesh-list
83452570|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
83452571|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83452572|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
83452573|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452574|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452575|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
83452576|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452577|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83452578|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
83452579|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452580|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
83452581|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
83452582|NCT02980315|Immunomodulating Agents|immunomodulating agents|mesh-list
83452583|NCT02980315|Immunologic Factors|immunologic factors|mesh-ancestor
83452584|NCT02980315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452585|NCT01042535|Tryptophan|tryptophan|mesh-list
83452586|NCT01042535|Vaccines|vaccines|mesh-list
83452587|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
83452588|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452589|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83452590|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
83452591|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83452592|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83452593|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
83452594|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83452595|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83452596|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
83452597|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452598|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
83452599|NCT03031327|Protective Agents|protective agents|mesh-ancestor
83452600|NCT03401957|Cetuximab|cetuximab|mesh-list
83452601|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452602|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452603|NCT04358965|Misoprostol|misoprostol|mesh-list
83452604|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
83452605|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83452606|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83452607|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452608|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
83452609|NCT04358965|Coagulants|coagulants|mesh-ancestor
83452610|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83452611|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
83452612|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83452613|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452614|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83452615|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83452616|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
83452617|NCT01041287|Metoprolol|metoprolol|mesh-list
83452618|NCT01041287|Nebivolol|nebivolol|mesh-list
83452619|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83452620|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83452621|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
83452622|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
83452623|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452624|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452625|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83452626|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83452627|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83452628|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
83452629|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452630|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452631|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
83452632|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83452633|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83452634|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83452635|NCT03016741|Prednisone|prednisone|mesh-list
83452636|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
83452637|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452638|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
83452639|NCT03016741|Hormones|hormones|mesh-ancestor
83452640|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452641|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452642|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83452643|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452644|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83452645|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452646|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452647|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
83452648|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83452649|NCT01042925|Paclitaxel|paclitaxel|mesh-list
83452650|NCT01042925|Trastuzumab|trastuzumab|mesh-list
83452651|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83452652|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452653|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
83452654|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
83452655|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
83452656|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452657|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452658|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
83452659|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83452660|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
83452661|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452662|NCT03400709|Expectorants|expectorants|mesh-ancestor
83452663|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
83452664|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83452665|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
83452666|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452667|NCT03400709|Protective Agents|protective agents|mesh-ancestor
83452668|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452669|NCT03400709|Antidotes|antidotes|mesh-ancestor
83452670|NCT02049957|Fulvestrant|fulvestrant|mesh-list
83452671|NCT02049957|Exemestane|exemestane|mesh-list
83452672|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83452673|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452674|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83452675|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83452676|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
83452677|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452678|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452680|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83452681|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452682|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452683|NCT03030937|Irinotecan|irinotecan|mesh-list
83452684|NCT03030937|Apatinib|apatinib|mesh-list
83452685|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83452686|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83452687|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452688|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452689|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452690|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83452691|NCT00950365|Pemetrexed|pemetrexed|mesh-list
83452692|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83452693|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452694|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452695|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452696|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83452697|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83452698|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83452700|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83452701|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
83452702|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
83452703|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452704|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452705|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452706|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83452707|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
83452708|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452709|NCT02246023|Propofol|propofol|mesh-list
83452710|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83452711|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83452712|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452713|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83452714|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
83452715|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
83452716|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83452717|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452718|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83452719|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452720|NCT00357825|Reboxetine|reboxetine|mesh-list
83452721|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
83452722|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83452723|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83452724|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83452725|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83452726|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452727|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
83452728|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452729|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452730|NCT03400241|Bromides|bromides|mesh-list
83452731|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
83452732|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83452733|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
83452734|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452735|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452736|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83452737|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
83452738|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
83452739|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83452740|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
83452741|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452742|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452743|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
83452744|NCT05706987|Lidocaine|lidocaine|mesh-list
83452745|NCT05706987|Anesthetics, Local|anesthetics, local|mesh-ancestor
83452746|NCT05706987|Anesthetics|anesthetics|mesh-ancestor
83452747|NCT05706987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83452748|NCT05706987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452749|NCT05706987|Sensory System Agents|sensory system agents|mesh-ancestor
83452750|NCT05706987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452752|NCT05706987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83452753|NCT05706987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83452754|NCT05706987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83452755|NCT05706987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452756|NCT00729573|Tenofovir|tenofovir|mesh-list
83452757|NCT00729573|Emtricitabine|emtricitabine|mesh-list
83452758|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83452759|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
83452760|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452761|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83452762|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83452763|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452764|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452765|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83452766|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83452767|NCT02951182|Ivacaftor|ivacaftor|mesh-list
83452768|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83452769|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83452770|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452771|NCT03403205|Choline|choline|mesh-list
83452772|NCT03403205|Lipotropic Agents|lipotropic agents|mesh-ancestor
83452773|NCT03403205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83452774|NCT03403205|Antimetabolites|antimetabolites|mesh-ancestor
83452775|NCT03403205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452776|NCT03403205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83452777|NCT03403205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83452778|NCT03403205|Nootropic Agents|nootropic agents|mesh-ancestor
83452780|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
83452781|NCT02959359|Ledipasvir|ledipasvir|mesh-list
83452782|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
83452783|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452784|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
83452785|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452786|NCT02829034|Ranolazine|ranolazine|mesh-list
83452787|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83452788|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83481775|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83452789|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452790|NCT00924209|Bevacizumab|bevacizumab|mesh-list
83452791|NCT00924209|Gemcitabine|gemcitabine|mesh-list
83452792|NCT00924209|Etoposide|etoposide|mesh-list
83452793|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452794|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452795|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83452796|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83452797|NCT00924209|Growth Substances|growth substances|mesh-ancestor
83452798|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452799|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
83452800|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83452801|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
83452802|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452803|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83452804|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83452805|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83452808|NCT05719467|Parasympatholytics|parasympatholytics|mesh-ancestor
83452809|NCT05719467|Autonomic Agents|autonomic agents|mesh-ancestor
83452810|NCT05719467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452811|NCT05719467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452813|NCT05719467|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83452814|NCT05719467|Cholinergic Agents|cholinergic agents|mesh-ancestor
83452815|NCT05719467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452816|NCT05719467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452817|NCT03408119|Vitamin D|vitamin d|mesh-list
83452818|NCT03408119|Calcium|calcium|mesh-list
83452819|NCT03408119|Vitamins|vitamins|mesh-ancestor
83452820|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
83452821|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452822|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83452823|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83452824|NCT03405155|Nivolumab|nivolumab|mesh-list
83452825|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452826|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452827|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83452828|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452829|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83452831|NCT04374929|Hormones|hormones|mesh-ancestor
83452832|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452833|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452834|NCT05717361|Lidocaine|lidocaine|mesh-list
83452835|NCT05717361|Ketamine|ketamine|mesh-list
83452836|NCT05717361|Remifentanil|remifentanil|mesh-list
83452837|NCT05717361|Anesthetics, Local|anesthetics, local|mesh-ancestor
83452838|NCT05717361|Anesthetics|anesthetics|mesh-ancestor
83452839|NCT05717361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83452840|NCT05717361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452841|NCT05717361|Sensory System Agents|sensory system agents|mesh-ancestor
83452842|NCT05717361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452843|NCT05717361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83452844|NCT05717361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83452845|NCT05717361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83452846|NCT05717361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83452847|NCT05717361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452848|NCT05717361|Analgesics|analgesics|mesh-ancestor
83452849|NCT05717361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83452850|NCT05717361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83452851|NCT05717361|Anesthetics, General|anesthetics, general|mesh-ancestor
83452852|NCT05717361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83452853|NCT05717361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83452854|NCT05717361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452855|NCT05717361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83452856|NCT05717361|Narcotics|narcotics|mesh-ancestor
83452857|NCT02951884|Bupivacaine|bupivacaine|mesh-list
83452858|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
83452859|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
83452860|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83452861|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452862|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
83452863|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452864|NCT05574387|Metformin|metformin|mesh-list
83452865|NCT05574387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83452866|NCT05574387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452867|NCT02978001|Glycerol|glycerol|mesh-list
83452868|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83452869|NCT02978001|Protective Agents|protective agents|mesh-ancestor
83452870|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452871|NCT02978313|Cetuximab|cetuximab|mesh-list
83452872|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83452873|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452874|NCT00014495|Cytarabine|cytarabine|mesh-list
83452875|NCT00014495|Bismuth|bismuth|mesh-list
83452876|NCT00014495|Antibodies|antibodies|mesh-list
83452878|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
83452879|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452880|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83452881|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
83481776|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83452882|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452883|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452885|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83452886|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83452887|NCT00014495|Antacids|antacids|mesh-ancestor
83452888|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83452889|NCT05566041|Carboplatin|carboplatin|mesh-list
83452890|NCT05566041|Etoposide|etoposide|mesh-list
83452891|NCT05566041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452892|NCT05566041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83452893|NCT05566041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83452894|NCT05566041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83452896|NCT05566041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452897|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
83452898|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83452899|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83452900|NCT04374071|Prednisolone|prednisolone|mesh-list
83452901|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
83452902|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83452903|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
83452904|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452905|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
83452906|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
83452907|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452908|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452909|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83452910|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
83452911|NCT04374071|Hormones|hormones|mesh-ancestor
83452912|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83452913|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83452914|NCT04374071|Protective Agents|protective agents|mesh-ancestor
83452915|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83452917|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
83452918|NCT00357981|Ortho Evra|ortho evra|mesh-list
83452919|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83452920|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452921|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83452922|NCT03030703|Inositol|inositol|mesh-list
83452923|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
83452924|NCT03030703|Vitamins|vitamins|mesh-ancestor
83452925|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
83452926|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452927|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83452928|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83452929|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
83452930|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
83452931|NCT03030469|Analgesics|analgesics|mesh-list
83452932|NCT03030469|Narcotics|narcotics|mesh-ancestor
83452933|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83452935|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
83452936|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452938|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83452939|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83452940|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452941|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83452942|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452943|NCT05716347|Vaccines|vaccines|mesh-list
83452944|NCT05716347|Immunologic Factors|immunologic factors|mesh-ancestor
83452945|NCT05716347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452946|NCT02959840|Ondansetron|ondansetron|mesh-list
83452947|NCT02959840|Metoclopramide|metoclopramide|mesh-list
83452948|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
83452949|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
83452950|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452951|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452952|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83452953|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
83452954|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
83452955|NCT02959840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83452956|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83452957|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
83452958|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83452959|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452960|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83452961|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83452962|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
83452963|NCT04358341|Doxorubicin|doxorubicin|mesh-list
83452964|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83452965|NCT04358341|Fluorouracil|fluorouracil|mesh-list
83452966|NCT04358341|Irinotecan|irinotecan|mesh-list
83452967|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83452968|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83452969|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83452970|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83452972|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83452974|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83452975|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83452976|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
83452977|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452978|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83452979|NCT02978547|Metformin|metformin|mesh-list
83452981|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452982|NCT02959996|Bupivacaine|bupivacaine|mesh-list
83452983|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
83452984|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
83452985|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83452986|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452987|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
83452988|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452989|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
83452990|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83452991|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83452992|NCT00929981|Prednisolone|prednisolone|mesh-list
83452993|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
83452995|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
83452996|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83452997|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
83452998|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
83452999|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453000|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453001|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83453002|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
83453003|NCT00929981|Hormones|hormones|mesh-ancestor
83453004|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453006|NCT00929981|Protective Agents|protective agents|mesh-ancestor
83453007|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83453010|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
83453011|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
83453013|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
83453014|NCT02240459|Fesoterodine|fesoterodine|mesh-list
83453015|NCT02240459|Oxybutynin|oxybutynin|mesh-list
83453016|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83453017|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83453018|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
83453019|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453020|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453022|NCT02240459|Urological Agents|urological agents|mesh-ancestor
83453023|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
83453024|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
83453025|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453026|NCT02240537|Sargramostim|sargramostim|mesh-list
83453027|NCT02240537|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83453028|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
83453029|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453030|NCT02240537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83453031|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83453032|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83453033|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453034|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83453035|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453036|NCT02240927|Enoxaparin|enoxaparin|mesh-list
83453037|NCT02240927|Warfarin|warfarin|mesh-list
83453038|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
83453039|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
83453040|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83453041|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83481777|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83453042|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453043|NCT03038308|Ropinirole|ropinirole|mesh-list
83453044|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83453045|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83453046|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
83453047|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
83453048|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453049|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453050|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453052|NCT04358497|Polidocanol|polidocanol|mesh-list
83453053|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83453054|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83453055|NCT04358497|Analgesics|analgesics|mesh-ancestor
83453057|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453058|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453059|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83453060|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453061|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83453062|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453063|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453064|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83453065|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83453066|NCT02851108|Primaquine|primaquine|mesh-list
83453067|NCT02851108|Phenothiazine|phenothiazine|mesh-list
83453069|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
83453070|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83453071|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83453072|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83453073|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453074|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453075|NCT00930293|Dexetimide|dexetimide|mesh-list
83453076|NCT00930293|Citalopram|citalopram|mesh-list
83453077|NCT00930293|Escitalopram|escitalopram|mesh-list
83453078|NCT00930293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83453079|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83453080|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83453081|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453082|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453083|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
83453084|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453085|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83453086|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
83453087|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83453088|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83453089|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83453090|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
83453091|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
83453092|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453093|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83453094|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83453095|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
83453096|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83453097|NCT02855086|Cetuximab|cetuximab|mesh-list
83453098|NCT02855086|Antibodies|antibodies|mesh-list
83453099|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
83453100|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83453101|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
83453102|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453103|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453104|NCT05368857|Afamelanotide|afamelanotide|mesh-list
83453105|NCT05368857|Dermatologic Agents|dermatologic agents|mesh-ancestor
83453106|NCT04347005|Allopurinol|allopurinol|mesh-list
83453107|NCT04347005|Febuxostat|febuxostat|mesh-list
83453108|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
83453109|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453110|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453111|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
83453112|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453113|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83453114|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
83453115|NCT04347005|Protective Agents|protective agents|mesh-ancestor
83453116|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453117|NCT00358293|Tizanidine|tizanidine|mesh-list
83453118|NCT00358293|Analgesics|analgesics|mesh-ancestor
83453119|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
83453120|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453121|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453122|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
83453123|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83453124|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83453125|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
83453126|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
83453127|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83453128|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83453129|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83453130|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
83453131|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453132|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453133|NCT02241083|Dopamine|dopamine|mesh-list
83453134|NCT02241083|Norepinephrine|norepinephrine|mesh-list
83453135|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83453136|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83453137|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
83453138|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453139|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453140|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453141|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
83453142|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
83453143|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453144|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83453145|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83453146|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
83453147|NCT02241083|Protective Agents|protective agents|mesh-ancestor
83453148|NCT04372589|Heparin|heparin|mesh-list
83453149|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
83453150|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83453151|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83453152|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453153|NCT04364399|Vaccines|vaccines|mesh-list
83453154|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
83453155|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453156|NCT02982551|Insulin|insulin|mesh-list
83453157|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83453158|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453159|NCT02965924|Phenylephrine|phenylephrine|mesh-list
83453160|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
83453161|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83453162|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
83453163|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
83453164|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453165|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453166|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
83453167|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83453168|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
83453169|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
83453170|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83453171|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83453172|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83453173|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
83453174|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481778|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83453175|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453176|NCT02965924|Protective Agents|protective agents|mesh-ancestor
83453177|NCT04364321|Diazepam|diazepam|mesh-list
83453179|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83453180|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
83453181|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
83453182|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
83453183|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453184|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453185|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83453186|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83453187|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453188|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83453189|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83453190|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83453192|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83453193|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83453194|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
83453195|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
83453196|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
83453197|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
83453198|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453199|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453200|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83453201|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83453202|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
83453203|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453204|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453205|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453207|NCT05528913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83453208|NCT05528913|Respiratory System Agents|respiratory system agents|mesh-ancestor
83453209|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83453210|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453211|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
83453212|NCT04371965|Povidone|povidone|mesh-list
83453213|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
83453214|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
83453215|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83453216|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83453218|NCT02959125|Trace Elements|trace elements|mesh-list
83453219|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453221|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83453222|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83453223|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
83453224|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453225|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453226|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453227|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83453228|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83453229|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
83453230|NCT02241941|Daptomycin|daptomycin|mesh-list
83453231|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83453232|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83453234|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83453235|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453236|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481779|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453238|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83453239|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83453241|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
83453242|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453243|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453244|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83453245|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453246|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83453247|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83453248|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453249|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453250|NCT02242097|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83453251|NCT02242097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83453252|NCT02242097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453253|NCT02242097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453254|NCT00374686|Valganciclovir|valganciclovir|mesh-list
83453255|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
83453256|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83453257|NCT04371575|Carbamazepine|carbamazepine|mesh-list
83453258|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
83453259|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
83453260|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
83453261|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83453262|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453263|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453264|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83453265|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83453266|NCT04371575|Analgesics|analgesics|mesh-ancestor
83453267|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
83453268|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453269|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83453270|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83453271|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453272|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83453273|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83453274|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83453275|NCT00359229|Zolpidem|zolpidem|mesh-list
83453276|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83453277|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83453278|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453279|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453280|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83453281|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
83453282|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
83453283|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453284|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453285|NCT04371341|Bupivacaine|bupivacaine|mesh-list
83453286|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
83453287|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
83453288|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453289|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453290|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
83453291|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453292|NCT00374764|Risperidone|risperidone|mesh-list
83453293|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83453294|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
83453295|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453296|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453297|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453299|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83453300|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453301|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83453302|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83453304|NCT04371185|Ustekinumab|ustekinumab|mesh-list
83453305|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
83453306|NCT01005355|Ramucirumab|ramucirumab|mesh-list
83453307|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453308|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
83453309|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83453310|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83453312|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453313|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453314|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83453315|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
83453316|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
83453317|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83453318|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
83453319|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453320|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453321|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83453322|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83453323|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83453324|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83453325|NCT05285943|Betamethasone|betamethasone|mesh-list
83453326|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
83453327|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83453328|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
83453329|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83453330|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83453331|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
83453332|NCT05285943|Hormones|hormones|mesh-ancestor
83453333|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453334|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453335|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83453336|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
83453337|NCT03030001|Antibodies|antibodies|mesh-list
83453338|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
83453339|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453340|NCT02242331|Telmisartan|telmisartan|mesh-list
83453341|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83453342|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83453343|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83453344|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453345|NCT05495061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83453346|NCT05495061|Latanoprost|latanoprost|mesh-list
83453347|NCT05495061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83453348|NCT03030157|Pirarubicin|pirarubicin|mesh-list
83453349|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453350|NCT00359385|Alendronate|alendronate|mesh-list
83453351|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83453352|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453353|NCT03029455|Ivacaftor|ivacaftor|mesh-list
83453354|NCT03029455|VX-659|vx-659|mesh-list
83453355|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83453356|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83453357|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453358|NCT02245789|Remifentanil|remifentanil|mesh-list
83453359|NCT02245789|Propofol|propofol|mesh-list
83453360|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
83453361|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453362|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453363|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83453364|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83453365|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
83453366|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83453367|NCT02245789|Narcotics|narcotics|mesh-ancestor
83453368|NCT02245789|Analgesics|analgesics|mesh-ancestor
83453369|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
83453370|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453371|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
83453372|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
83453373|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83453374|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83453375|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83453376|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453377|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453378|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453379|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
83453380|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
83453381|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83453382|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83453383|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83453384|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453385|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453386|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453387|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83453388|NCT02242877|Telmisartan|telmisartan|mesh-list
83453389|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83453390|NCT02242877|Diuretics|diuretics|mesh-ancestor
83453391|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
83453392|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453393|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83453394|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83453395|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453396|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83453397|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83453399|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453400|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453401|NCT05475639|Diclofenac|diclofenac|mesh-list
83453402|NCT05475639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83453403|NCT05475639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83453404|NCT05475639|Analgesics|analgesics|mesh-ancestor
83453405|NCT05475639|Sensory System Agents|sensory system agents|mesh-ancestor
83453406|NCT05475639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453407|NCT05475639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453408|NCT05475639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83453409|NCT05475639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453410|NCT05475639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83453411|NCT05475639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453412|NCT05475639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453413|NCT02242955|Diazepam|diazepam|mesh-list
83453414|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83453415|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
83453416|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
83453417|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
83453418|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453419|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453420|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83453421|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83453422|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453423|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83453424|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83453425|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83453426|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83453427|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83453428|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83453429|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
83453430|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
83453431|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
83453433|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453434|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453435|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
83453436|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83453437|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453438|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83453439|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453440|NCT01008319|Citric Acid|citric acid|mesh-list
83453441|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
83453442|NCT01008319|Clomiphene|clomiphene|mesh-list
83453443|NCT01008319|Enclomiphene|enclomiphene|mesh-list
83453444|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
83453445|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
83453446|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83453447|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
83453448|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
83481780|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83453449|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453450|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83453451|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
83453452|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453453|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453454|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83453455|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
83453456|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83453457|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83453458|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83453459|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
83453460|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83453461|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83453462|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83453463|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83453464|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453465|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453466|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453467|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
83453468|NCT00358683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83453469|NCT00358683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83453470|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83453471|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
83453472|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453473|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453474|NCT00967369|Carboplatin|carboplatin|mesh-list
83453475|NCT00967369|Etoposide|etoposide|mesh-list
83453476|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
83453477|NCT00967369|Bortezomib|bortezomib|mesh-list
83453478|NCT00967369|Ifosfamide|ifosfamide|mesh-list
83453479|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
83453480|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
83453481|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453482|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83453483|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83453484|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83481781|NCT05250050|Antacids|antacids|mesh-ancestor
83453486|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453487|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83453488|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
83453489|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
83453490|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
83453491|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
83453492|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
83453493|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
83453494|NCT02245295|Anesthetics|anesthetics|mesh-list
83453495|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453496|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453497|NCT05238207|Psyllium|psyllium|mesh-list
83453498|NCT05238207|Cathartics|cathartics|mesh-ancestor
83453499|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83453500|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
83453501|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83453502|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
83453503|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83453504|NCT00968071|Decitabine|decitabine|mesh-list
83453505|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
83481782|NCT05250050|Diuretics|diuretics|mesh-ancestor
83453506|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83453507|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
83453508|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453509|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453510|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481783|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
83453512|NCT00968071|Immunotoxins|immunotoxins|mesh-ancestor
83453513|NCT00968071|Immunoconjugates|immunoconjugates|mesh-ancestor
83453514|NCT00968071|Immunologic Factors|immunologic factors|mesh-ancestor
83453515|NCT00968071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453516|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
83453517|NCT00971737|Trastuzumab|trastuzumab|mesh-list
83453518|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83453519|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
83453520|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453521|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453522|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83453523|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
83453524|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453525|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453526|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83453527|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83453528|NCT04368377|Aspirin|aspirin|mesh-list
83453529|NCT04368377|PENTA|penta|mesh-list
83453530|NCT04368377|Tirofiban|tirofiban|mesh-list
83453531|NCT04368377|Fondaparinux|fondaparinux|mesh-list
83453532|NCT04368377|Clopidogrel|clopidogrel|mesh-list
83453533|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83453534|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83453535|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83453536|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83453537|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
83453538|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453539|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453540|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453541|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83453542|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83453543|NCT04368377|Analgesics|analgesics|mesh-ancestor
83453544|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
83453545|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453547|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453548|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83453549|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83453550|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83453551|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453552|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
83453553|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83453554|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
83453555|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83453556|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
83453557|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
83453558|NCT04361513|Triamcinolone|triamcinolone|mesh-list
83453559|NCT04361513|Bupivacaine|bupivacaine|mesh-list
83453560|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
83453561|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
83453562|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453563|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453564|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
83453565|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453566|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83453567|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
83453568|NCT04361513|Hormones|hormones|mesh-ancestor
83453569|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453570|NCT05595993|Cilostazol|cilostazol|mesh-list
83453571|NCT05595993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83453572|NCT05595993|Autonomic Agents|autonomic agents|mesh-ancestor
83453573|NCT05595993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453574|NCT05595993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453575|NCT05595993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83453576|NCT05595993|Respiratory System Agents|respiratory system agents|mesh-ancestor
83453577|NCT05595993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83453578|NCT05595993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83453579|NCT05595993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453580|NCT05595993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83453581|NCT05595993|Vasodilator Agents|vasodilator agents|mesh-ancestor
83453582|NCT05595993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83453583|NCT05595993|Protective Agents|protective agents|mesh-ancestor
83453584|NCT05595993|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83453585|NCT05595993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83453586|NCT05595993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453587|NCT05593341|Analgesics, Opioid|analgesics, opioid|mesh-list
83453589|NCT05593341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453590|NCT05593341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453592|NCT05593341|Sensory System Agents|sensory system agents|mesh-ancestor
83453593|NCT05593341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453594|NCT00972205|Paclitaxel|paclitaxel|mesh-list
83453595|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83453596|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83453597|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453598|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
83453599|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
83453600|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
83453601|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453602|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83453603|NCT00928421|Polidocanol|polidocanol|mesh-list
83453604|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83453605|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83453606|NCT03051256|Methadone|methadone|mesh-list
83453607|NCT03051256|D-methadone|d-methadone|mesh-list
83453608|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83453609|NCT03051256|Narcotics|narcotics|mesh-ancestor
83453610|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453611|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453612|NCT03051256|Analgesics|analgesics|mesh-ancestor
83453613|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
83453614|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453616|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83453617|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83453618|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83453619|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83453620|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83453621|NCT00932321|Norethindrone|norethindrone|mesh-list
83453622|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
83453624|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83453627|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453628|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453629|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83453631|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83453632|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83453633|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83453634|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83453635|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83453636|NCT05445609|Nivolumab|nivolumab|mesh-list
83453637|NCT05445609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83453638|NCT05445609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453639|NCT05445609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83453640|NCT05445609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453641|NCT01011829|Varenicline|varenicline|mesh-list
83453642|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83453643|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83453644|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
83453645|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453646|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453647|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453648|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83453649|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
83453651|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83453652|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83453653|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83453654|NCT00932477|Protective Agents|protective agents|mesh-ancestor
83453655|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453656|NCT00932477|Laxatives|laxatives|mesh-ancestor
83453657|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83453658|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
83453659|NCT00972439|Norinyl|norinyl|mesh-list
83453660|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
83453661|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83453662|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453663|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83453664|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83453665|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83453666|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83453668|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83453669|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83453670|NCT02989714|Nivolumab|nivolumab|mesh-list
83453671|NCT02989714|Interleukin-2|interleukin-2|mesh-list
83453672|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83453673|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453674|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83453675|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453676|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83453677|NCT02989714|Analgesics|analgesics|mesh-ancestor
83453678|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
83453679|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453680|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453681|NCT04361279|Rituximab|rituximab|mesh-list
83453682|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83453683|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453684|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
83453685|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453686|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453687|NCT05585229|Psilocybin|psilocybin|mesh-list
83453688|NCT05585229|Hallucinogens|hallucinogens|mesh-ancestor
83453689|NCT05585229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453690|NCT05585229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83453691|NCT05582499|Paclitaxel|paclitaxel|mesh-list
83453692|NCT05582499|Cyclophosphamide|cyclophosphamide|mesh-list
83453694|NCT05582499|Trastuzumab|trastuzumab|mesh-list
83453695|NCT05582499|Letrozole|letrozole|mesh-list
83453696|NCT05582499|Epirubicin|epirubicin|mesh-list
83453697|NCT05582499|Pertuzumab|pertuzumab|mesh-list
83453698|NCT05582499|Goserelin|goserelin|mesh-list
83453699|NCT05582499|Fluzoparib|fluzoparib|mesh-list
83453700|NCT05582499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83453701|NCT05582499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453702|NCT05582499|Tubulin Modulators|tubulin modulators|mesh-ancestor
83453703|NCT05582499|Antimitotic Agents|antimitotic agents|mesh-ancestor
83453704|NCT05582499|Mitosis Modulators|mitosis modulators|mesh-ancestor
83453705|NCT05582499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453706|NCT05582499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83453707|NCT05582499|Immunologic Factors|immunologic factors|mesh-ancestor
83453708|NCT05582499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453709|NCT05582499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453710|NCT05582499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83453711|NCT05582499|Alkylating Agents|alkylating agents|mesh-ancestor
83453712|NCT05582499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83453713|NCT05582499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83453714|NCT05582499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83453715|NCT05582499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83453716|NCT05582499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453717|NCT05582499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83453718|NCT05582499|Hormone Antagonists|hormone antagonists|mesh-ancestor
83453719|NCT05582499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453720|NCT05582499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83453721|NCT05582499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83453722|NCT05582499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83453723|NCT05582499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83453724|NCT05582499|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83453725|NCT02881996|Acetaminophen|acetaminophen|mesh-list
83453727|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83453728|NCT02881996|Analgesics|analgesics|mesh-ancestor
83453729|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
83453730|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453731|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453732|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
83453733|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83453734|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83453736|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83453738|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453739|NCT04367831|Heparin|heparin|mesh-list
83453741|NCT04367831|Enoxaparin|enoxaparin|mesh-list
83453742|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
83453743|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
83453744|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83453745|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83453746|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453747|NCT03051646|Aspirin|aspirin|mesh-list
83453749|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83453750|NCT03051646|Analgesics|analgesics|mesh-ancestor
83453751|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
83453752|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453753|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453754|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83453755|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453756|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83453757|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83453758|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453759|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83453760|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83453761|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453762|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
83453763|NCT04344405|Vitamin D|vitamin d|mesh-list
83453764|NCT04344405|Vitamins|vitamins|mesh-ancestor
83453765|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
83453766|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453767|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83453768|NCT05187429|Nivolumab|nivolumab|mesh-list
83453769|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83453770|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453771|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83453772|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453773|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
83453774|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83453775|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83453776|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453777|NCT02993302|Vitamins|vitamins|mesh-ancestor
83453778|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
83453779|NCT00359853|Norfloxacin|norfloxacin|mesh-list
83453780|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83453781|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83453782|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83453784|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453785|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453786|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453787|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83453788|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83453789|NCT05168709|Vaccines|vaccines|mesh-list
83453790|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
83453791|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453792|NCT04367051|Spironolactone|spironolactone|mesh-list
83453793|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83453794|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
83453795|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453796|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453797|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83453798|NCT04367051|Diuretics|diuretics|mesh-ancestor
83453799|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
83453800|NCT03111316|Dinoprostone|dinoprostone|mesh-list
83453801|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
83453802|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83453803|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453804|NCT03054844|Lidocaine|lidocaine|mesh-list
83453805|NCT03054844|Midazolam|midazolam|mesh-list
83453806|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
83453807|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
83453808|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453809|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453810|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
83453811|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453812|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83453813|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83453814|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83453815|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83453816|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453817|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83453818|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83453819|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83453820|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83453821|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83453822|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83453823|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
83453824|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
83453825|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
83453826|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453827|NCT05405595|Pembrolizumab|pembrolizumab|mesh-list
83453828|NCT05405595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83453829|NCT05405595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453830|NCT05405595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83453831|NCT05405595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453833|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83453834|NCT00359697|Diuretics|diuretics|mesh-ancestor
83453835|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
83453836|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453837|NCT03111628|Omalizumab|omalizumab|mesh-list
83453838|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83453839|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83453840|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
83453841|NCT05120505|Metformin|metformin|mesh-list
83453842|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83453843|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453844|NCT02977533|Acyclovir|acyclovir|mesh-list
83453845|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
83453846|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83453847|NCT01012297|Bevacizumab|bevacizumab|mesh-list
83453848|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83453849|NCT01012297|Gemcitabine|gemcitabine|mesh-list
83453850|NCT01012297|Docetaxel|docetaxel|mesh-list
83453851|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
83453852|NCT01012297|Antibodies|antibodies|mesh-list
83453853|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
83453854|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83453855|NCT01012297|Lenograstim|lenograstim|mesh-list
83453856|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
83453857|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453858|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83453859|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83453860|NCT01012297|Growth Substances|growth substances|mesh-ancestor
83453861|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453862|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
83453863|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
83453864|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83453865|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
83453866|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453867|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
83453868|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
83453869|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
83453870|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83453871|NCT00923117|Sunitinib|sunitinib|mesh-list
83453872|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453873|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83453874|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83453875|NCT00923117|Growth Substances|growth substances|mesh-ancestor
83453876|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453877|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
83453878|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83453879|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453880|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453881|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
83453882|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83453883|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83453884|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83453885|NCT02977611|Hematinics|hematinics|mesh-ancestor
83453886|NCT04360655|Antibodies|antibodies|mesh-list
83453887|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83453888|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
83453889|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453890|NCT00375232|Montelukast|montelukast|mesh-list
83453891|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83453892|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
83453893|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83453894|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
83453895|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453896|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453897|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83453898|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83481784|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453899|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453901|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83453902|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
83453903|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
83453904|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453905|NCT02244437|Acetaminophen|acetaminophen|mesh-list
83453906|NCT02244437|Ibuprofen|ibuprofen|mesh-list
83453907|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83453908|NCT02244437|Analgesics|analgesics|mesh-ancestor
83453909|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
83453910|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453911|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453912|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
83453913|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83481785|NCT05250050|Expectorants|expectorants|mesh-ancestor
83453915|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83453916|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83453917|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453918|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453919|NCT03023527|Dexamethasone|dexamethasone|mesh-list
83453920|NCT03023527|Nivolumab|nivolumab|mesh-list
83453921|NCT03023527|Pomalidomide|pomalidomide|mesh-list
83453922|NCT03023527|Elotuzumab|elotuzumab|mesh-list
83453923|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83453924|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
83453925|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
83453926|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453927|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453928|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83453929|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
83453931|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453932|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83453933|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453934|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83453935|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83453936|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453937|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
83453938|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83453939|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83453940|NCT03023527|Growth Substances|growth substances|mesh-ancestor
83453941|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
83453943|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
83453944|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
83453945|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83453946|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453947|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453948|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83453949|NCT02244515|Analgesics|analgesics|mesh-ancestor
83453951|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453952|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83453953|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83453954|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83453955|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
83453956|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453957|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453958|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
83453959|NCT04360031|Tacrolimus|tacrolimus|mesh-list
83453960|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83453961|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
83453962|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453963|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83453964|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453965|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453966|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83453967|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453968|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83453969|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
83453970|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83453971|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83453972|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
83453974|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
83453975|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83453976|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453977|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83453978|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83453979|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83453980|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83453981|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83453982|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83453983|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
83453984|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453985|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453986|NCT03023059|Levodopa|levodopa|mesh-list
83453987|NCT03023059|Carbidopa|carbidopa|mesh-list
83453988|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83453989|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83453990|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83453992|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453993|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453994|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453995|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83453996|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453997|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83453998|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
83453999|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
83454000|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
83454001|NCT02244827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83454003|NCT02244827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454004|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83454005|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454007|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
83454009|NCT02976987|Cidofovir|cidofovir|mesh-list
83454010|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
83454011|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454012|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454013|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454014|NCT02244281|Tamsulosin|tamsulosin|mesh-list
83454015|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83454016|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83454017|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83454018|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
83454019|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454020|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454021|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454022|NCT02244281|Urological Agents|urological agents|mesh-ancestor
83454024|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
83454025|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
83454026|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454027|NCT03062488|Acetaminophen|acetaminophen|mesh-list
83454028|NCT03062488|Fentanyl|fentanyl|mesh-list
83454029|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83454030|NCT03062488|Narcotics|narcotics|mesh-ancestor
83454031|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454032|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454034|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
83454035|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454036|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83454037|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83454038|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
83454040|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83454041|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
83454042|NCT00936299|Bupropion|bupropion|mesh-list
83454043|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83454044|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
83454045|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83454046|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83454047|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83454048|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454049|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454050|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
83454051|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454052|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454053|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83454054|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83454055|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454056|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83454057|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83454058|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454059|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454060|NCT03117634|Aflibercept|aflibercept|mesh-list
83454061|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83481787|NCT05499390|Pembrolizumab|pembrolizumab|mesh-list
83454062|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83454063|NCT03117634|Growth Substances|growth substances|mesh-ancestor
83454064|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454065|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
83454066|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454067|NCT00937235|Varenicline|varenicline|mesh-list
83454068|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83454069|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83454070|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
83454071|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454072|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454073|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454074|NCT01014403|Enoxaparin|enoxaparin|mesh-list
83454075|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
83454076|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83454077|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83454078|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454079|NCT05405608|Ondansetron|ondansetron|mesh-list
83454080|NCT05405608|Antiemetics|antiemetics|mesh-ancestor
83454081|NCT05405608|Autonomic Agents|autonomic agents|mesh-ancestor
83454082|NCT05405608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454083|NCT05405608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454084|NCT05405608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83454085|NCT05405608|Antipruritics|antipruritics|mesh-ancestor
83454086|NCT05405608|Dermatologic Agents|dermatologic agents|mesh-ancestor
83454087|NCT05405608|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83454088|NCT05405608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83454089|NCT05405608|Serotonin Agents|serotonin agents|mesh-ancestor
83454090|NCT05405608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454091|NCT05405608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454092|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
83454093|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83454094|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83454095|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83454096|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454097|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454098|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
83454099|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454100|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454101|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83454102|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454103|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
83454104|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83454105|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83454106|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454107|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
83454108|NCT00375466|Coagulants|coagulants|mesh-ancestor
83454109|NCT00976183|Vorinostat|vorinostat|mesh-list
83454110|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454111|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83454113|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454114|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
83454115|NCT04357535|Giapreza|giapreza|mesh-list
83454116|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83454117|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
83454118|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83454119|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83481788|NCT05499390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83454120|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454122|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83454125|NCT01015807|Bupivacaine|bupivacaine|mesh-list
83454126|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
83454127|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
83454128|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454129|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454130|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
83454131|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454132|NCT01015807|Analgesics|analgesics|mesh-ancestor
83454133|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83454135|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
83454136|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83454137|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83454138|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83454139|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
83454140|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454141|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454142|NCT01575925|Thalidomide|thalidomide|mesh-list
83454143|NCT01575925|Dexamethasone|dexamethasone|mesh-list
83454144|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
83454145|NCT01575925|Pomalidomide|pomalidomide|mesh-list
83454146|NCT01575925|BB 1101|bb 1101|mesh-list
83454147|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83454148|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
83454149|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
83454150|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454151|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454152|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83454154|NCT01575925|Hormones|hormones|mesh-ancestor
83454155|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83454156|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83454157|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454158|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
83454159|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481789|NCT05499390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454160|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454162|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83454163|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83454164|NCT01575925|Growth Substances|growth substances|mesh-ancestor
83454165|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
83454166|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83454167|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
83454168|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83454169|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454170|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
83454171|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83454172|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454174|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83454175|NCT00936377|Analgesics|analgesics|mesh-ancestor
83454176|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
83454177|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454178|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83454179|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83454180|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83454181|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
83454182|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454183|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454184|NCT04471233|Pregabalin|pregabalin|mesh-list
83454185|NCT04471233|Analgesics|analgesics|mesh-ancestor
83454186|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
83454187|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454188|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454189|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
83454190|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83454191|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454192|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454193|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83454194|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83454195|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83454196|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454197|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83454198|NCT04359095|Tenofovir|tenofovir|mesh-list
83454199|NCT04359095|Emtricitabine|emtricitabine|mesh-list
83454200|NCT04359095|Colchicine|colchicine|mesh-list
83454201|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83454202|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
83454203|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454204|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83454205|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83454206|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454207|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454209|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83454210|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83454211|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83454212|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
83454213|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83481790|NCT05499390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83454214|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83454215|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
83454216|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83454217|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83454218|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83454219|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83454220|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454221|NCT02163421|Vedolizumab|vedolizumab|mesh-list
83454222|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83454224|NCT02982395|Docetaxel|docetaxel|mesh-list
83454225|NCT02982395|Mitomycins|mitomycins|mesh-list
83454226|NCT02982395|Mitomycin|mitomycin|mesh-list
83454227|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454228|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
83454229|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
83454230|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
83454231|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454233|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
83454234|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83454235|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454236|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83454237|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454238|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454239|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454240|NCT02982005|Brodalumab|brodalumab|mesh-list
83454241|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
83454242|NCT04736836|Rifaximin|rifaximin|mesh-list
83454243|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83454244|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454245|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83454246|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83454247|NCT03126370|Emtricitabine|emtricitabine|mesh-list
83454248|NCT03126370|Tenofovir|tenofovir|mesh-list
83454249|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83454250|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
83454251|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83454252|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83454253|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454254|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454255|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
83454256|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454257|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83454258|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83454259|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83454260|NCT04467801|Ipatasertib|ipatasertib|mesh-list
83454261|NCT04467801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454262|NCT04467801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83454263|NCT04467801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454264|NCT04467801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454265|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83454266|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83454267|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83454268|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454269|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454270|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
83454271|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454272|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454273|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83454274|NCT00979615|Azelastine|azelastine|mesh-list
83454275|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83454276|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83454277|NCT00979615|Analgesics|analgesics|mesh-ancestor
83454278|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
83454279|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454280|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454281|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83454282|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83454283|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83454284|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83454285|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83454286|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
83454287|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
83454288|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454289|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454290|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83454291|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
83454292|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83454293|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
83454294|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83454295|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454296|NCT03126682|Bupropion|bupropion|mesh-list
83454297|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83454298|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
83454299|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83454300|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83454301|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83454302|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454303|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454304|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
83454305|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454306|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454307|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83454308|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83454309|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454310|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83454311|NCT05236738|Cobicistat|cobicistat|mesh-list
83454312|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83454313|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83454314|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
83454315|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454316|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454317|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83454318|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83454319|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
83454320|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454321|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83454322|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83454323|NCT00980395|Rituximab|rituximab|mesh-list
83454324|NCT00980395|Bortezomib|bortezomib|mesh-list
83454325|NCT00980395|Cladribine|cladribine|mesh-list
83454326|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83454327|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454328|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
83454329|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454330|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83454331|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83454332|NCT02976597|Morphine|morphine|mesh-list
83454333|NCT02976597|Bupivacaine|bupivacaine|mesh-list
83454334|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
83454335|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
83454336|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454337|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454338|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
83454339|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454340|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83454341|NCT02976597|Narcotics|narcotics|mesh-ancestor
83454342|NCT02976597|Analgesics|analgesics|mesh-ancestor
83454344|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83454345|NCT03020329|Cisplatin|cisplatin|mesh-list
83454346|NCT03020329|Fluorouracil|fluorouracil|mesh-list
83454347|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83454348|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454349|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
83454350|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
83454351|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
83454352|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454353|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
83454354|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83454355|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83454356|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
83454357|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454358|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
83454359|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83454360|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454361|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83454362|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83454363|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454364|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454365|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454366|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83454367|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83454368|NCT00980785|Ramipril|ramipril|mesh-list
83454369|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83454370|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
83454371|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454372|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454373|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83454374|NCT04772547|Vigabatrin|vigabatrin|mesh-list
83454375|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
83454376|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454377|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454378|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
83454379|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454380|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454382|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83454383|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454385|NCT03126760|Hormones|hormones|mesh-ancestor
83454386|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83454387|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454388|NCT05026905|Leucovorin|leucovorin|mesh-list
83454389|NCT05026905|Paclitaxel|paclitaxel|mesh-list
83454390|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83454391|NCT05026905|Gemcitabine|gemcitabine|mesh-list
83454392|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
83454393|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83454394|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454395|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
83454396|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
83454397|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
83481864|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83454398|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454399|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83454400|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
83454401|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454402|NCT05026905|Antidotes|antidotes|mesh-ancestor
83454403|NCT05026905|Protective Agents|protective agents|mesh-ancestor
83454404|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
83454405|NCT05026905|Vitamins|vitamins|mesh-ancestor
83454406|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
83454407|NCT00982189|Lisinopril|lisinopril|mesh-list
83454408|NCT00982189|Pravastatin|pravastatin|mesh-list
83454409|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83454410|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83454411|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
83454412|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454413|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83454414|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83454415|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454416|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83454417|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
83454418|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83454419|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83454420|NCT00982189|Protective Agents|protective agents|mesh-ancestor
83454421|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454423|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83454424|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454425|NCT05017545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83454426|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454427|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83454428|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
83454429|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454430|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83454431|NCT03128008|Paclitaxel|paclitaxel|mesh-list
83454432|NCT03128008|Carboplatin|carboplatin|mesh-list
83454433|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83454434|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454436|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
83454437|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
83454438|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454439|NCT05017311|Escitalopram|escitalopram|mesh-list
83454440|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
83454441|NCT05017311|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83454442|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83454443|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454444|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454445|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454446|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
83454447|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454448|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
83454449|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
83454450|NCT00360087|Bosentan|bosentan|mesh-list
83454451|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83454452|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83454453|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454454|NCT00982423|Furosemide|furosemide|mesh-list
83454455|NCT00982423|Diuretics|diuretics|mesh-ancestor
83454456|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
83454457|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454458|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83454459|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454460|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454461|NCT04719819|Anesthetics|anesthetics|mesh-list
83454462|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454463|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454464|NCT02981719|Gemcitabine|gemcitabine|mesh-list
83454465|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83454466|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
83454467|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454468|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454470|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83454471|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454472|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454473|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
83454474|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454475|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454476|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
83454477|NCT04718961|Volixibat|volixibat|mesh-list
83454478|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83454479|NCT03130738|Miconazole|miconazole|mesh-list
83454480|NCT03130738|Clotrimazole|clotrimazole|mesh-list
83454481|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
83454482|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454483|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83454484|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83454486|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454487|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83454488|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
83454489|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83454491|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83454492|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83454493|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83454494|NCT04996251|Bupivacaine|bupivacaine|mesh-list
83454495|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
83454496|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
83454497|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454498|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454499|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
83454500|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454501|NCT00984139|Vaccines|vaccines|mesh-list
83454502|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
83454503|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454504|NCT04672395|Vaccines|vaccines|mesh-list
83454505|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
83454506|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
83454507|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454508|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83454510|NCT00985543|Lopinavir|lopinavir|mesh-list
83454511|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83454512|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83454513|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
83454514|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454515|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454517|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83454518|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
83454519|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454520|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83454521|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83454522|NCT05394415|Paclitaxel|paclitaxel|mesh-list
83454523|NCT05394415|Carboplatin|carboplatin|mesh-list
83454524|NCT05394415|Tislelizumab|tislelizumab|mesh-list
83454525|NCT05394415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83454526|NCT05394415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454527|NCT05394415|Tubulin Modulators|tubulin modulators|mesh-ancestor
83454528|NCT05394415|Antimitotic Agents|antimitotic agents|mesh-ancestor
83454529|NCT05394415|Mitosis Modulators|mitosis modulators|mesh-ancestor
83454530|NCT05394415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454531|NCT05394415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83454532|NCT04352959|Betadex|betadex|mesh-list
83454533|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
83454534|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454535|NCT00360945|Temozolomide|temozolomide|mesh-list
83454536|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454537|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83454538|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
83454539|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454540|NCT03019237|Omalizumab|omalizumab|mesh-list
83454541|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83454542|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83454543|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
83454544|NCT00361023|Losartan|losartan|mesh-list
83454546|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83454547|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83454549|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454550|NCT03019081|Isoproterenol|isoproterenol|mesh-list
83454551|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83454552|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83454553|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
83454554|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454555|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454556|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454557|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83454558|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
83454559|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454560|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83454561|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
83454562|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83454563|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
83454564|NCT03019081|Protective Agents|protective agents|mesh-ancestor
83454565|NCT00986401|Metformin|metformin|mesh-list
83454566|NCT00986401|Trospium chloride|trospium chloride|mesh-list
83454567|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83454568|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454569|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
83454570|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
83454572|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83454573|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83454574|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
83454575|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454576|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454577|NCT00986401|Urological Agents|urological agents|mesh-ancestor
83454578|NCT00375076|Enoxaparin|enoxaparin|mesh-list
83454579|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
83454580|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83454581|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83454582|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454583|NCT00987415|Allopurinol|allopurinol|mesh-list
83454584|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
83454585|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454586|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454587|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
83454588|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83454589|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83454590|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
83454591|NCT00987415|Protective Agents|protective agents|mesh-ancestor
83454592|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454593|NCT04807504|Ropivacaine|ropivacaine|mesh-list
83454594|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
83454595|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
83454596|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454597|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454598|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
83454599|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454601|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83454602|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83454604|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
83454605|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454606|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454607|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83454608|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83454609|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83454610|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454611|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454612|NCT04707118|Paclitaxel|paclitaxel|mesh-list
83454613|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83454614|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83454615|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454616|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
83454617|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
83454618|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
83454619|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454620|NCT03086356|Dabigatran|dabigatran|mesh-list
83454621|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
83454622|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83454623|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
83454624|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454625|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454626|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
83454627|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
83454628|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83454629|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83454630|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454632|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
83454633|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
83454634|NCT03140722|Hematinics|hematinics|mesh-ancestor
83454635|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83454636|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
83454637|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83454638|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83454639|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83454640|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454641|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454642|NCT00375622|Tamoxifen|tamoxifen|mesh-list
83454643|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83454644|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
83454645|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83454646|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454647|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83454648|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454649|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83454650|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83454651|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83454652|NCT03087604|Lidocaine|lidocaine|mesh-list
83454654|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
83454655|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
83454656|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454657|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454659|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454660|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83454661|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83454662|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83454663|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454664|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454665|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83454666|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83454667|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
83454668|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454669|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83454670|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83454671|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
83454672|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83454673|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
83454674|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
83454675|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
83454677|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83454678|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
83454679|NCT00987727|Glycerol|glycerol|mesh-list
83454680|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83454681|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
83454682|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454684|NCT00987727|Protective Agents|protective agents|mesh-ancestor
83454685|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83454686|NCT00987727|Laxatives|laxatives|mesh-ancestor
83454687|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83454688|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83454689|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83454690|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83454691|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454692|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454693|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83454694|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454695|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454696|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
83454697|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454698|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
83454699|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83454700|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454701|NCT04913337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83454702|NCT04913337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454704|NCT05386459|Interferon-gamma|interferon-gamma|mesh-list
83454705|NCT05386459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454706|NCT05386459|Antiviral Agents|antiviral agents|mesh-ancestor
83454707|NCT05386459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454708|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
83454709|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83454710|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83454711|NCT03018535|Prednisolone|prednisolone|mesh-list
83454712|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
83454713|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
83454714|NCT03018535|Rituximab|rituximab|mesh-list
83454715|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83454716|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
83454717|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83454718|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
83454719|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454720|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83454721|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83454722|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
83454723|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454724|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454725|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83454726|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83454727|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83454728|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
83454729|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
83454730|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454731|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83454732|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
83454733|NCT03018535|Hormones|hormones|mesh-ancestor
83454734|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83454735|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83454736|NCT03018535|Protective Agents|protective agents|mesh-ancestor
83454737|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83454738|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83454739|NCT04890873|Antacids|antacids|mesh-ancestor
83454740|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454741|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83454743|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
83454744|NCT04889547|BB 1101|bb 1101|mesh-list
83454745|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83454746|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
83454747|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
83454748|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454749|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454750|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83454751|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
83454752|NCT04889547|Hormones|hormones|mesh-ancestor
83454753|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83454754|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83454755|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454756|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
83454757|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454758|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454760|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83454761|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83454762|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454763|NCT02977065|Atorvastatin|atorvastatin|mesh-list
83454764|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83454765|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83454766|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83454767|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
83454768|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454769|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83454770|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83454771|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454772|NCT03146806|Ketamine|ketamine|mesh-list
83454773|NCT03146806|Analgesics|analgesics|mesh-ancestor
83454774|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
83454775|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454776|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454777|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83454778|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83454779|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
83454780|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
83454781|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454782|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83454783|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83454784|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454785|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454787|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83454788|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454790|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83454791|NCT03953235|Nivolumab|nivolumab|mesh-list
83454793|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83454794|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454795|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83454796|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454798|NCT03402945|Cefazolin|cefazolin|mesh-list
83454799|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83454800|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454801|NCT03095638|Dolutegravir|dolutegravir|mesh-list
83454802|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83454803|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83454804|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454805|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454806|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83454807|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83454808|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
83454809|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454810|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
83454811|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
83454812|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454813|NCT04450108|Nitric Oxide|nitric oxide|mesh-list
83454814|NCT04450108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83454815|NCT04450108|Autonomic Agents|autonomic agents|mesh-ancestor
83454816|NCT04450108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454817|NCT04450108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454818|NCT04450108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83454819|NCT04450108|Respiratory System Agents|respiratory system agents|mesh-ancestor
83454820|NCT04450108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83454821|NCT04450108|Antioxidants|antioxidants|mesh-ancestor
83454822|NCT04450108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454823|NCT04450108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454824|NCT04450108|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83454825|NCT04450108|Vasodilator Agents|vasodilator agents|mesh-ancestor
83454826|NCT04450108|Gasotransmitters|gasotransmitters|mesh-ancestor
83454827|NCT04450108|Protective Agents|protective agents|mesh-ancestor
83454828|NCT03891849|Octreotide|octreotide|mesh-list
83454829|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83454830|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83454831|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454832|NCT04341831|Teicoplanin|teicoplanin|mesh-list
83454833|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83454834|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454835|NCT00361959|Fluticasone|fluticasone|mesh-list
83454836|NCT00361959|Xhance|xhance|mesh-list
83454837|NCT00361959|Bromides|bromides|mesh-list
83454838|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
83454839|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83454840|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83454841|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83454842|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
83454843|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454844|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454845|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83454846|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
83454848|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83454849|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
83454850|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83454851|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
83454852|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454853|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454854|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83454855|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83454856|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83454857|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
83454858|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
83454859|NCT03158116|Aztreonam|aztreonam|mesh-list
83454860|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83454861|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83454862|NCT03096730|Sufentanil|sufentanil|mesh-list
83454863|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
83454864|NCT03096730|Remifentanil|remifentanil|mesh-list
83454865|NCT03096730|Dsuvia|dsuvia|mesh-list
83454866|NCT03096730|Nalmefene|nalmefene|mesh-list
83454867|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83454868|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454869|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454870|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83454871|NCT03096730|Analgesics|analgesics|mesh-ancestor
83454872|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
83454873|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454874|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83454875|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83454876|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83454877|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
83454878|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454879|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454880|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83454881|NCT03096730|Narcotics|narcotics|mesh-ancestor
83454882|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83454883|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83454884|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
83454885|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
83454886|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83454887|NCT00362037|Irbesartan|irbesartan|mesh-list
83454888|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83454889|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83454890|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83454891|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454892|NCT03161158|Diuretics|diuretics|mesh-list
83454893|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
83454894|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454895|NCT03161938|Dexamethasone|dexamethasone|mesh-list
83454896|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83454897|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
83454898|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
83454899|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454900|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454901|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83454902|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
83454903|NCT03161938|Hormones|hormones|mesh-ancestor
83454904|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83454905|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83454906|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454907|NCT03321045|Trastuzumab|trastuzumab|mesh-list
83454908|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83454909|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454910|NCT00989989|Ranibizumab|ranibizumab|mesh-list
83454911|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83454912|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83454913|NCT00989989|Growth Substances|growth substances|mesh-ancestor
83454914|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454915|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
83454916|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454917|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
83454918|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83454919|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
83454920|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454921|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83454922|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83454924|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454925|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454926|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83454927|NCT03018301|Ketamine|ketamine|mesh-list
83454928|NCT03018301|Analgesics|analgesics|mesh-ancestor
83454929|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
83454930|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454931|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454932|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83454933|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83454934|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
83454935|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
83454936|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454937|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83454938|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83454939|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454940|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454942|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454943|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454945|NCT00991081|Nicotine|nicotine|mesh-list
83454946|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83454948|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454949|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454950|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83454951|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83454952|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
83454953|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454954|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454955|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83454956|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
83454957|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83454958|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83454959|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83454960|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454962|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83454963|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83454964|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454965|NCT03168022|Amitriptyline|amitriptyline|mesh-list
83454966|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
83454967|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83454968|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
83454969|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83454970|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83454971|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454972|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83454973|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454974|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83454975|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83454976|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83454977|NCT03168022|Analgesics|analgesics|mesh-ancestor
83454978|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
83454979|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83454980|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83454981|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454982|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454983|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
83454984|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83454985|NCT03102190|Verapamil|verapamil|mesh-list
83454986|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83454987|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83454988|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454989|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454990|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83454991|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454992|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
83454993|NCT03254667|Brodalumab|brodalumab|mesh-list
83454994|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
83454995|NCT03102736|Nitroprusside|nitroprusside|mesh-list
83454996|NCT03102736|Ketamine|ketamine|mesh-list
83454997|NCT03102736|Analgesics|analgesics|mesh-ancestor
83454998|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
83454999|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455000|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455001|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83455002|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83455003|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
83455004|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
83455005|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455006|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83455007|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83455008|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455009|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455011|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
83455012|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83455013|NCT03743103|Nitroprusside|nitroprusside|mesh-list
83455014|NCT03743103|Esmolol|esmolol|mesh-list
83455015|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83455016|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
83455017|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83455018|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455019|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83455020|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83455021|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83455022|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
83455023|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455024|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455025|NCT04049266|Aflibercept|aflibercept|mesh-list
83455026|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83455027|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83455028|NCT04049266|Growth Substances|growth substances|mesh-ancestor
83455029|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455030|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
83455031|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455032|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
83455033|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83455034|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455035|NCT03217071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83455036|NCT03217071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455037|NCT01502917|Antibodies|antibodies|mesh-list
83455038|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83455039|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
83455040|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455041|NCT00362505|Clevudine|clevudine|mesh-list
83455042|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
83455044|NCT00993187|Metformin|metformin|mesh-list
83455045|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83455046|NCT00993187|Glimepiride|glimepiride|mesh-list
83455047|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83455048|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455049|NCT00993187|Incretins|incretins|mesh-ancestor
83455050|NCT00993187|Hormones|hormones|mesh-ancestor
83460191|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455051|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83455052|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83455053|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
83455054|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455055|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455056|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83455058|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
83455059|NCT03173170|Itraconazole|itraconazole|mesh-list
83455060|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
83455061|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455062|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83455063|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83455064|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455065|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455066|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83455067|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
83455068|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83455069|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455070|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83455071|NCT03106870|Insulin|insulin|mesh-list
83455072|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83455073|NCT03106870|Metformin|metformin|mesh-list
83455074|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
83455075|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83455076|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455077|NCT00375310|Gemcitabine|gemcitabine|mesh-list
83455078|NCT00375310|Sorafenib|sorafenib|mesh-list
83455079|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83455080|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
83455081|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455082|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455083|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83455084|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455085|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83455086|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83455087|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
83455088|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455089|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83455090|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83455091|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
83455092|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
83455093|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455094|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455095|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
83455096|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455097|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83455098|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455099|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455101|NCT00993655|Carboplatin|carboplatin|mesh-list
83455102|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83455103|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455104|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
83455105|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
83455106|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
83455107|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455108|NCT00362583|Fentanyl|fentanyl|mesh-list
83455109|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83455110|NCT00362583|Narcotics|narcotics|mesh-ancestor
83455111|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455112|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455113|NCT00362583|Analgesics|analgesics|mesh-ancestor
83455114|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
83455115|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455116|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83455117|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83455118|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
83455119|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
83455120|NCT00657241|Valsartan|valsartan|mesh-list
83455121|NCT00657241|Carvedilol|carvedilol|mesh-list
83460192|NCT00974051|Insulin|insulin|mesh-list
83455122|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83455123|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83455124|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83455125|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455126|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83455127|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83455128|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
83455129|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455130|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455131|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
83455132|NCT00657241|Protective Agents|protective agents|mesh-ancestor
83455133|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83455134|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83455135|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83455136|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
83455137|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83455138|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83455139|NCT04342065|Celecoxib|celecoxib|mesh-list
83455140|NCT04342065|Pregabalin|pregabalin|mesh-list
83455141|NCT04342065|Analgesics|analgesics|mesh-ancestor
83455142|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
83455143|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455144|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455145|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
83455146|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83455147|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83455148|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455149|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83455150|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83455151|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83455152|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455153|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83455154|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83455155|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83455156|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83455157|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83455158|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83455159|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83455160|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455161|NCT03179410|Avelumab|avelumab|mesh-list
83455162|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83455164|NCT00478465|Valganciclovir|valganciclovir|mesh-list
83455165|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
83455166|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455167|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
83455168|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83455169|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
83455170|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455171|NCT00421785|Expectorants|expectorants|mesh-ancestor
83455172|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
83455173|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83455174|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
83455175|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455176|NCT00421785|Protective Agents|protective agents|mesh-ancestor
83455177|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455178|NCT00421785|Antidotes|antidotes|mesh-ancestor
83455179|NCT02519348|Bevacizumab|bevacizumab|mesh-list
83455180|NCT02519348|Durvalumab|durvalumab|mesh-list
83455181|NCT02519348|Tremelimumab|tremelimumab|mesh-list
83455182|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83455183|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455184|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83455185|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83455186|NCT02519348|Growth Substances|growth substances|mesh-ancestor
83455187|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455188|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
83455189|NCT03653338|Rituximab|rituximab|mesh-list
83455190|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
83455191|NCT03653338|Fludarabine|fludarabine|mesh-list
83455192|NCT03653338|Thiotepa|thiotepa|mesh-list
83455193|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
83455194|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83455195|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455196|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
83455197|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455198|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83455199|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455200|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83455201|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83455202|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
83455203|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83455204|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
83455205|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455206|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83455207|NCT00421863|Amlodipine|amlodipine|mesh-list
83455208|NCT00421863|Telmisartan|telmisartan|mesh-list
83455209|NCT00421863|Clonidine|clonidine|mesh-list
83455210|NCT00421863|Ramipril|ramipril|mesh-list
83455211|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83455212|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83460193|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83455213|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83455214|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455215|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83455216|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455217|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
83455218|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83455219|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83455221|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
83455222|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455223|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
83455224|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
83455225|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83455226|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83455227|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83455228|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
83455229|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455230|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83455231|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
83455232|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455233|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83455234|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83455235|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83455236|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83455237|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455238|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
83460194|NCT00974051|Terbutaline|terbutaline|mesh-list
83455239|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455240|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455241|NCT05363722|Bevacizumab|bevacizumab|mesh-list
83460195|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
83455242|NCT05363722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83455243|NCT05363722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455244|NCT05363722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83455245|NCT05363722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83455246|NCT05363722|Growth Substances|growth substances|mesh-ancestor
83455247|NCT05363722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455248|NCT05363722|Growth Inhibitors|growth inhibitors|mesh-ancestor
83455249|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83455250|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455251|NCT03127137|Triamcinolone|triamcinolone|mesh-list
83455252|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83455253|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83455254|NCT03127137|Lidocaine|lidocaine|mesh-list
83455255|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83455256|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
83455257|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
83455258|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455259|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455260|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
83460196|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83455261|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455262|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83455263|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83455264|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83455265|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83455266|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455267|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83455268|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
83455269|NCT03127137|Hormones|hormones|mesh-ancestor
83455270|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83455271|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83455272|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
83455273|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455274|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
83455275|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83455276|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83455277|NCT03122847|Prednisolone|prednisolone|mesh-list
83455278|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
83455279|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83455280|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
83455281|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83455282|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
83455283|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
83455284|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455285|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455286|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83455287|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
83455288|NCT03122847|Hormones|hormones|mesh-ancestor
83455289|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83455290|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83455291|NCT03122847|Protective Agents|protective agents|mesh-ancestor
83455292|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83455293|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455294|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
83455295|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
83455296|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83455297|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83455298|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455299|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455300|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455301|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83455302|NCT03525028|Metformin|metformin|mesh-list
83455303|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83455304|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455305|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83455306|NCT00754312|Entinostat|entinostat|mesh-list
83455307|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455308|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83455309|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455310|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455311|NCT03623373|Cytarabine|cytarabine|mesh-list
83455312|NCT03623373|Rituximab|rituximab|mesh-list
83455313|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83455314|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
83455315|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83455316|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455317|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
83455318|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455319|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83455320|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83455321|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
83455322|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455323|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
83455324|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455325|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83455326|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83455327|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
83455328|NCT03505762|Prednisone|prednisone|mesh-list
83455329|NCT03505762|Cortisone|cortisone|mesh-list
83455330|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
83455331|NCT03505762|Rituximab|rituximab|mesh-list
83455332|NCT03505762|Doxorubicin|doxorubicin|mesh-list
83455333|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83455334|NCT03505762|Vincristine|vincristine|mesh-list
83455335|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83455336|NCT03505762|Antibodies|antibodies|mesh-list
83455337|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
83455338|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83455339|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83455340|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
83455341|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455342|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83455343|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83455344|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
83455345|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455346|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455347|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83455348|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83455349|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83455350|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83455351|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455352|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83455353|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
83455354|NCT03505762|Hormones|hormones|mesh-ancestor
83455355|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83455356|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83455357|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83455358|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
83455359|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
83455360|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
83455362|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
83455363|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455364|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
83455365|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83455366|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83455367|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83455368|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83455369|NCT03618537|Dexamethasone|dexamethasone|mesh-list
83455370|NCT03618537|Ixazomib|ixazomib|mesh-list
83455371|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83455372|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
83455373|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
83455374|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455375|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455376|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83455377|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
83455379|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83455380|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83455381|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455382|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
83455383|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455384|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455386|NCT03410446|Analgesics|analgesics|mesh-ancestor
83455387|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
83455388|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455389|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455390|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83455391|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83455393|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
83455394|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455395|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83455396|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83455397|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455398|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455399|NCT03617445|Vancomycin|vancomycin|mesh-list
83455400|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83455401|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455402|NCT00375388|Metformin|metformin|mesh-list
83455403|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83455404|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455405|NCT00375778|Memantine|memantine|mesh-list
83455406|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83455407|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83455408|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
83455409|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455410|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455411|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455412|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83455413|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83455414|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83455415|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455416|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83455417|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455418|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455419|NCT03001726|Docetaxel|docetaxel|mesh-list
83455420|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
83455421|NCT03001726|Tegafur|tegafur|mesh-list
83455422|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455423|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
83455424|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
83455425|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
83455426|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455427|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83455428|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
83455429|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
83455430|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
83455431|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
83455432|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455433|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455434|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
83455435|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455436|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
83455437|NCT03577431|Everolimus|everolimus|mesh-list
83455438|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83455439|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
83455440|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455441|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83455442|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83455443|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
83455444|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455445|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455446|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83455448|NCT03577431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83455449|NCT03577431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455450|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
83455451|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83455452|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455453|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83455454|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
83455455|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83455456|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455457|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455458|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455459|NCT04353193|Octreotide|octreotide|mesh-list
83455460|NCT04353193|Terlipressin|terlipressin|mesh-list
83455461|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83455462|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83455463|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455464|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83455465|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83455466|NCT01023841|Bimatoprost|bimatoprost|mesh-list
83455467|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83455468|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83455469|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83455470|NCT00635648|Caspofungin|caspofungin|mesh-list
83455471|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
83455472|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455473|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455474|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455475|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
83455476|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83455478|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
83455479|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
83455480|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83455481|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
83455482|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455483|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455484|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455485|NCT05240456|Urological Agents|urological agents|mesh-ancestor
83455486|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83455487|NCT03574779|Paclitaxel|paclitaxel|mesh-list
83455488|NCT03574779|Bevacizumab|bevacizumab|mesh-list
83455489|NCT03574779|Carboplatin|carboplatin|mesh-list
83455490|NCT03574779|Niraparib|niraparib|mesh-list
83455491|NCT03574779|Dostarlimab|dostarlimab|mesh-list
83455492|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83455493|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455494|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
83455495|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
83455496|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
83455497|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455498|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83455499|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83455500|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83455501|NCT03574779|Growth Substances|growth substances|mesh-ancestor
83455502|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455503|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
83455504|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83455505|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455506|NCT04341883|Paclitaxel|paclitaxel|mesh-list
83455507|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83455508|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83455509|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455510|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
83455511|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
83455512|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
83455513|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455514|NCT00995761|Cisplatin|cisplatin|mesh-list
83455515|NCT00995761|Docetaxel|docetaxel|mesh-list
83455516|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455517|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
83455518|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
83455519|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
83455520|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455521|NCT00362271|Aripiprazole|aripiprazole|mesh-list
83455522|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83455523|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
83455524|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83455525|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83455526|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83455527|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455528|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455529|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
83455530|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
83455531|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455532|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455533|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83455534|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83455535|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
83455536|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83455537|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83455538|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83455539|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83455540|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83455541|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83455542|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83455543|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83455544|NCT00635102|Cycloserine|cycloserine|mesh-list
83455545|NCT00635102|Glycine|glycine|mesh-list
83455546|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83455547|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455548|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83455549|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
83455550|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83455551|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
83455552|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455553|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
83455554|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455555|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455556|NCT03041883|Riboflavin|riboflavin|mesh-list
83455557|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
83455558|NCT03041883|Vitamins|vitamins|mesh-ancestor
83455559|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
83455560|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455561|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83455562|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
83455563|NCT03034005|Budesonide|budesonide|mesh-list
83455564|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83455565|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83455566|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
83455567|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455568|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455569|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83455570|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
83455571|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
83455572|NCT03034005|Hormones|hormones|mesh-ancestor
83460197|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455573|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83455574|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83455575|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83455576|NCT00635024|Melphalan|melphalan|mesh-list
83455577|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83455578|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83455579|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
83455580|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455581|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455582|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83455583|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83455584|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
83455585|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455586|NCT03182920|Lasmiditan|lasmiditan|mesh-list
83455587|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83455588|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
83455589|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455590|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455591|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455592|NCT05406388|Fentanyl|fentanyl|mesh-list
83455593|NCT05406388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83455594|NCT05406388|Narcotics|narcotics|mesh-ancestor
83455595|NCT05406388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455596|NCT05406388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455597|NCT05406388|Analgesics|analgesics|mesh-ancestor
83455598|NCT05406388|Sensory System Agents|sensory system agents|mesh-ancestor
83455599|NCT05406388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455600|NCT05406388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83455601|NCT05406388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83455602|NCT05406388|Anesthetics, General|anesthetics, general|mesh-ancestor
83455603|NCT05406388|Anesthetics|anesthetics|mesh-ancestor
83455605|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455606|NCT03187678|Selexipag|selexipag|mesh-list
83455607|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83455608|NCT02942355|Palbociclib|palbociclib|mesh-list
83455609|NCT02942355|Anastrozole|anastrozole|mesh-list
83455610|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455611|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83455612|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455613|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455614|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83455615|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83455616|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83455617|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83455618|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
83455619|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83455620|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455621|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83455622|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
83455624|NCT03192826|Brinzolamide|brinzolamide|mesh-list
83455625|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83455626|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83455627|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83455628|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83455629|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
83455630|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455631|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455632|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455633|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83455634|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83455635|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83455636|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455637|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
83455639|NCT03287674|Fludarabine|fludarabine|mesh-list
83455640|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
83455641|NCT03287674|Ipilimumab|ipilimumab|mesh-list
83455642|NCT03287674|Interleukin-2|interleukin-2|mesh-list
83455643|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83455644|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
83455645|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455646|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83455647|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83455648|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
83455649|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455650|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455651|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83455652|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83455653|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83455654|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83455655|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
83455656|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83455657|NCT03287674|Analgesics|analgesics|mesh-ancestor
83455658|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
83455659|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455661|NCT00634244|Sirolimus|sirolimus|mesh-list
83455662|NCT00634244|Carboplatin|carboplatin|mesh-list
83455663|NCT00634244|Etoposide|etoposide|mesh-list
83455664|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
83455665|NCT00634244|Topotecan|topotecan|mesh-list
83455666|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
83455667|NCT00634244|Alvocidib|alvocidib|mesh-list
83455668|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455669|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83455670|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83455671|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83455672|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455673|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455674|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83455675|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
83455676|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
83455677|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455678|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83455679|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
83455680|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455681|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83455682|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83455683|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
83455684|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83455685|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83455686|NCT00634244|Analgesics|analgesics|mesh-ancestor
83455687|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
83455688|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455689|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
83455690|NCT00634244|Growth Substances|growth substances|mesh-ancestor
83455691|NCT01922804|Vitamins|vitamins|mesh-list
83455692|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
83455693|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455694|NCT03289858|Bupivacaine|bupivacaine|mesh-list
83455695|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
83455696|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
83455697|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455698|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455699|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
83455700|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455701|NCT03418714|Salvinorin A|salvinorin a|mesh-list
83455702|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
83455703|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455704|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83455706|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83455707|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
83455708|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455709|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455710|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83455711|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83455712|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
83455714|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455715|NCT03294850|Cholic Acids|cholic acids|mesh-list
83455716|NCT03294850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83455717|NCT00996931|Lenalidomide|lenalidomide|mesh-list
83455718|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
83455719|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455720|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83455721|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83455722|NCT00996931|Growth Substances|growth substances|mesh-ancestor
83455723|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
83455724|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455725|NCT00634088|Capecitabine|capecitabine|mesh-list
83455726|NCT00634088|Lapatinib|lapatinib|mesh-list
83455727|NCT00634088|Epothilones|epothilones|mesh-list
83455728|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83455730|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455731|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455732|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83455733|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455734|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83455735|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83455736|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83455737|NCT03428230|Acetaminophen|acetaminophen|mesh-list
83455738|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
83455739|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83455740|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83455741|NCT03428230|Analgesics|analgesics|mesh-ancestor
83455742|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
83455743|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455744|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455745|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
83455746|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
83455747|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
83455748|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455749|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
83455750|NCT03296800|Rifampin|rifampin|mesh-list
83455751|NCT03296800|Probenecid|probenecid|mesh-list
83455752|NCT03296800|Verapamil|verapamil|mesh-list
83455753|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83455754|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
83455755|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83455756|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455757|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
83455758|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83455759|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455760|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455761|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83455762|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83455763|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83455764|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83455765|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83455766|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83455767|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83455768|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83455769|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83455770|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83455771|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455772|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
83455773|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
83455774|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
83455775|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83455776|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83455777|NCT00634010|Morphine|morphine|mesh-list
83455778|NCT00634010|Methadone|methadone|mesh-list
83455779|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83455780|NCT00634010|Narcotics|narcotics|mesh-ancestor
83455781|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455782|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455783|NCT00634010|Analgesics|analgesics|mesh-ancestor
83455784|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
83455785|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455786|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
83455787|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
83455789|NCT00633932|Omeprazole|omeprazole|mesh-list
83455790|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83455791|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83455792|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83455793|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460198|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83455794|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455795|NCT01028677|Oxytocin|oxytocin|mesh-list
83455796|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
83455797|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83455798|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455799|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
83455800|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83455801|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
83455802|NCT01000285|Prednisone|prednisone|mesh-list
83455803|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
83455804|NCT01000285|Doxorubicin|doxorubicin|mesh-list
83455805|NCT01000285|Etoposide|etoposide|mesh-list
83455806|NCT01000285|Vincristine|vincristine|mesh-list
83455807|NCT01000285|Bortezomib|bortezomib|mesh-list
83455809|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
83455810|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455811|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83455812|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83455813|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
83455814|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455815|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455816|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83455817|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83455818|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83455819|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83455820|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455821|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83455823|NCT01000285|Hormones|hormones|mesh-ancestor
83455824|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83455825|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83455826|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83455827|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
83455828|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
83455829|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
83455830|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83455831|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83455832|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
83455833|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455834|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83455835|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83455836|NCT01000987|Varenicline|varenicline|mesh-list
83455837|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83455838|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83455839|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
83455840|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455841|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455842|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455843|NCT00633464|Cetuximab|cetuximab|mesh-list
83455844|NCT00633464|Epothilones|epothilones|mesh-list
83455845|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83455846|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455847|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
83455848|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
83455849|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
83455850|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455851|NCT03437044|Clopidogrel|clopidogrel|mesh-list
83455852|NCT03437044|Ticagrelor|ticagrelor|mesh-list
83455853|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83455854|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83460199|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
83455855|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83455856|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83455857|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
83455858|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455859|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455860|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455861|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83455862|NCT01923194|Hormones|hormones|mesh-ancestor
83455863|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83455864|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455865|NCT03303196|Pancrelipase|pancrelipase|mesh-list
83455866|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83455867|NCT00633152|Linezolid|linezolid|mesh-list
83455868|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83455870|NCT00633152|Aztreonam|aztreonam|mesh-list
83455871|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83455872|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455873|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83455874|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455875|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455876|NCT01030783|Sorafenib|sorafenib|mesh-list
83455877|NCT01030783|Tivozanib|tivozanib|mesh-list
83455878|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455879|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83455880|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455881|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455882|NCT00633074|Vaccines|vaccines|mesh-list
83455883|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
83455884|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455886|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83455887|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455888|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455889|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83455890|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83455891|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455892|NCT01929278|Clindamycin|clindamycin|mesh-list
83455893|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
83455894|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
83455895|NCT01929278|Tretinoin|tretinoin|mesh-list
83455896|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83455897|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83455898|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83455899|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455900|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455901|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455902|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
83455903|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
83455904|NCT03210376|Neostigmine|neostigmine|mesh-list
83455905|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83455906|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455907|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455908|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
83455909|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455910|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455911|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83455912|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
83455913|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455914|NCT01929512|Metformin|metformin|mesh-list
83455915|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83455916|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83455917|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455918|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83455919|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83455920|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
83455921|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455922|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83455923|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83455924|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455925|NCT03211234|Ranibizumab|ranibizumab|mesh-list
83455926|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83455927|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83455928|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83455929|NCT03211234|Growth Substances|growth substances|mesh-ancestor
83455930|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455931|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
83455932|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455934|NCT03105518|Fentanyl|fentanyl|mesh-list
83455935|NCT03105518|Oxycodone|oxycodone|mesh-list
83455936|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83455937|NCT03105518|Narcotics|narcotics|mesh-ancestor
83455938|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455939|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455940|NCT03105518|Analgesics|analgesics|mesh-ancestor
83455941|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
83455942|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455943|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83455944|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83455945|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
83455946|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
83455947|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83455948|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
83455949|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
83455950|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
83455951|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455952|NCT01929668|Protective Agents|protective agents|mesh-ancestor
83455953|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455954|NCT01929668|Vitamins|vitamins|mesh-ancestor
83455956|NCT01929746|Daclizumab|daclizumab|mesh-list
83455957|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83455958|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
83455959|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455960|NCT03933397|Morphine|morphine|mesh-list
83455961|NCT03933397|Hydromorphone|hydromorphone|mesh-list
83455962|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83455963|NCT03933397|Narcotics|narcotics|mesh-ancestor
83455964|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455965|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455966|NCT03933397|Analgesics|analgesics|mesh-ancestor
83455967|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
83455968|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455969|NCT03506048|Lenvatinib|lenvatinib|mesh-list
83455970|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455971|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83455972|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455973|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455974|NCT02161705|Ropivacaine|ropivacaine|mesh-list
83455975|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
83455976|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
83455977|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83455978|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455979|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
83455980|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455981|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
83455982|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83455983|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
83455984|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455985|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455986|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83455987|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
83455988|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83455989|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
83455990|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455991|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83455992|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83455993|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
83455994|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
83455995|NCT01929824|Protective Agents|protective agents|mesh-ancestor
83455996|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
83455997|NCT01031953|Aprepitant|aprepitant|mesh-list
83455998|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
83455999|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
83456000|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456001|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456002|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83456003|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83456004|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456005|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456006|NCT01923584|Ubiquinone|ubiquinone|mesh-list
83456007|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
83456008|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456009|NCT00630344|Everolimus|everolimus|mesh-list
83456010|NCT00630344|Bicalutamide|bicalutamide|mesh-list
83456011|NCT00630344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83456012|NCT00630344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83456013|NCT00630344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456014|NCT00630344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456015|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83456016|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
83456017|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456018|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456019|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
83456020|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
83456021|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456022|NCT01923818|Aspirin|aspirin|mesh-list
83456023|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
83456024|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83456025|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456026|NCT01923818|Analgesics|analgesics|mesh-ancestor
83456027|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
83456028|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456029|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456030|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456031|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456032|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83456033|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83456034|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456035|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83456036|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83456037|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456038|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
83456039|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83456040|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
83456041|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83456042|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
83456043|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
83456044|NCT02169115|Omalizumab|omalizumab|mesh-list
83456045|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83456046|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83456047|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83456048|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
83456049|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
83456050|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456051|NCT00376792|Docetaxel|docetaxel|mesh-list
83456052|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456053|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
83456054|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
83456055|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
83456056|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456057|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
83456058|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
83456059|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83456060|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
83456061|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456062|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456063|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83456064|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
83456065|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83456066|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83456067|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83456068|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
83456069|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456070|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456071|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456072|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
83456073|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83456075|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
83456076|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
83456077|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456078|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456079|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
83456080|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456081|NCT00637130|Travoprost|travoprost|mesh-list
83456082|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83456083|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83456084|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83456085|NCT02847559|Bevacizumab|bevacizumab|mesh-list
83456086|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83456087|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
83456088|NCT02847559|Antibodies|antibodies|mesh-list
83456089|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
83456090|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83456091|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
83456092|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456093|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83456094|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83456095|NCT02847559|Growth Substances|growth substances|mesh-ancestor
83456096|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456097|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
83456098|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
83456099|NCT00637052|Filanesib|filanesib|mesh-list
83456100|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
83456101|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
83456102|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456103|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456104|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
83456105|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
83456106|NCT01921868|Vitamins|vitamins|mesh-ancestor
83456107|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
83456108|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456109|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
83456110|NCT02150785|Streptokinase|streptokinase|mesh-list
83456111|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83456112|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83456113|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456115|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83456116|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456117|NCT03445390|Acetaminophen|acetaminophen|mesh-list
83456118|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456119|NCT03445390|Analgesics|analgesics|mesh-ancestor
83456120|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
83456121|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456122|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456123|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
83456124|NCT00981890|Sunitinib|sunitinib|mesh-list
83456125|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456126|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83456127|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83456128|NCT00981890|Growth Substances|growth substances|mesh-ancestor
83456129|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456130|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
83456131|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83456132|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456133|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456134|NCT03221764|Amiodarone|amiodarone|mesh-list
83456135|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83456136|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
83456137|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83456138|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83456139|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456140|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83456141|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83456142|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83456143|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456144|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83456145|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83456146|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83456147|NCT03122444|Imipramine|imipramine|mesh-list
83456148|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83456149|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
83456150|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83456151|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83456152|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83456153|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83456154|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456155|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
83456156|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456157|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456158|NCT05593627|Lithium Carbonate|lithium carbonate|mesh-list
83456159|NCT05593627|Calcium Carbonate|calcium carbonate|mesh-list
83456160|NCT05593627|Calcium|calcium|mesh-list
83456161|NCT05593627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83456162|NCT05593627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456163|NCT05593627|Antidepressive Agents|antidepressive agents|mesh-ancestor
83456164|NCT05593627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83456165|NCT05593627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456166|NCT05593627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456167|NCT05593627|Antimanic Agents|antimanic agents|mesh-ancestor
83456168|NCT05593627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83456169|NCT05593627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456170|NCT05593627|Antacids|antacids|mesh-ancestor
83456171|NCT05593627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83456172|NCT02169427|Opicapone|opicapone|mesh-list
83456173|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83456174|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456175|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456176|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83456177|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83456178|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
83456179|NCT03454048|Piperaquine|piperaquine|mesh-list
83456180|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
83456181|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83456182|NCT03454048|Atovaquone|atovaquone|mesh-list
83456183|NCT03454048|Proguanil|proguanil|mesh-list
83456184|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83456185|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
83456186|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83456187|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83456188|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456189|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83456190|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456191|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456192|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83456193|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
83456194|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83456195|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83456196|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
83456197|NCT01924286|Prednisone|prednisone|mesh-list
83456198|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456199|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
83456200|NCT01924286|Hormones|hormones|mesh-ancestor
83460200|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456201|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456202|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456203|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83456204|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456205|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
83456206|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83456207|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
83456208|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456209|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456210|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83456211|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
83456212|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83456213|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
83456214|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456215|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456216|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83456217|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
83456218|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
83456219|NCT03455218|Protective Agents|protective agents|mesh-ancestor
83456220|NCT01050907|Miltefosine|miltefosine|mesh-list
83456221|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
83456222|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456223|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456224|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83456225|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83456226|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83456227|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
83456228|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83456229|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83456230|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83456231|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456232|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456234|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
83456235|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456236|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83456237|NCT01920386|Acetaminophen|acetaminophen|mesh-list
83456238|NCT01920386|Tramadol|tramadol|mesh-list
83456239|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456240|NCT01920386|Analgesics|analgesics|mesh-ancestor
83456241|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
83456242|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456243|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456244|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
83456245|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83456246|NCT01920386|Narcotics|narcotics|mesh-ancestor
83456247|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456248|NCT03460990|Ivacaftor|ivacaftor|mesh-list
83456250|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83456251|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83460201|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83456252|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456253|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83456254|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
83456255|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83456256|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
83456257|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456258|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
83456259|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83456260|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456261|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456262|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456264|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
83456265|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456266|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83456267|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83456268|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83456269|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
83456270|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456271|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456272|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
83456273|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83456274|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83456275|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
83456276|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456277|NCT01052701|Ribavirin|ribavirin|mesh-list
83456278|NCT01052701|Abacavir|abacavir|mesh-list
83456280|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456281|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
83456282|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456283|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83456284|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83456285|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456287|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83456288|NCT01921010|Niacin|niacin|mesh-list
83456289|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
83456290|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83456291|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
83456292|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456293|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83456294|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
83456295|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
83456297|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
83456298|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456299|NCT03115424|Liraglutide|liraglutide|mesh-list
83456300|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83456301|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456302|NCT03115424|Incretins|incretins|mesh-ancestor
83456303|NCT03115424|Hormones|hormones|mesh-ancestor
83456304|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456305|NCT03325816|Nivolumab|nivolumab|mesh-list
83456306|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83456307|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83456308|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456309|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83456310|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456311|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83456312|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
83456313|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83456314|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83456315|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83456316|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83456317|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456318|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
83456319|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456320|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456321|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83456322|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456323|NCT00986258|Tapentadol|tapentadol|mesh-list
83456324|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83456325|NCT00986258|Narcotics|narcotics|mesh-ancestor
83456326|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456327|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456328|NCT00986258|Analgesics|analgesics|mesh-ancestor
83456329|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
83456330|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456331|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83456332|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83456334|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456335|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
83456336|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456337|NCT00986180|Oxycodone|oxycodone|mesh-list
83456338|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83456339|NCT00986180|Narcotics|narcotics|mesh-ancestor
83456340|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456341|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456342|NCT00986180|Analgesics|analgesics|mesh-ancestor
83456343|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
83456344|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456345|NCT01056601|Bortezomib|bortezomib|mesh-list
83456346|NCT01056601|Panobinostat|panobinostat|mesh-list
83456347|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456348|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83456349|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456350|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456351|NCT03014947|Adalimumab|adalimumab|mesh-list
83456352|NCT03014947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83456353|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456354|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456355|NCT01057225|Thalidomide|thalidomide|mesh-list
83456356|NCT01057225|Dexamethasone|dexamethasone|mesh-list
83456357|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
83456358|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83456359|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
83456360|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456361|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456362|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83456363|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
83456364|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456365|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456366|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83456367|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456368|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
83456369|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
83456370|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456371|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83456372|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
83456373|NCT01057225|Hormones|hormones|mesh-ancestor
83456374|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456375|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83456376|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
83456377|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83456378|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456379|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83456380|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83456381|NCT01057225|Growth Substances|growth substances|mesh-ancestor
83456382|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
83456383|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
83456385|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83456386|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456387|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456388|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456389|NCT01057381|Analgesics|analgesics|mesh-ancestor
83456390|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
83456391|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456392|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83456393|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83456394|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83456395|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
83456396|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456397|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456399|NCT01057381|Narcotics|narcotics|mesh-ancestor
83456400|NCT00986102|Doripenem|doripenem|mesh-list
83456401|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83456402|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456403|NCT01058239|Rituximab|rituximab|mesh-list
83456404|NCT01058239|Bortezomib|bortezomib|mesh-list
83456405|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83456406|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456408|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456409|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456410|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
83456411|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
83456412|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456413|NCT01058941|Protective Agents|protective agents|mesh-ancestor
83456415|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
83456416|NCT01058941|Vitamins|vitamins|mesh-ancestor
83456417|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
83456418|NCT00985946|Panobinostat|panobinostat|mesh-list
83456419|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456420|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83456421|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456422|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456423|NCT02170519|Iloprost|iloprost|mesh-list
83456424|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83456425|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
83456426|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
83456427|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83456428|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456429|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83456430|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
83456431|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456432|NCT01924910|Vitamin D|vitamin d|mesh-list
83456433|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
83456434|NCT01924910|Vitamins|vitamins|mesh-ancestor
83456435|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
83456436|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456437|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83460202|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
83456438|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83456439|NCT04395638|Vitamin D|vitamin d|mesh-list
83456440|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
83456442|NCT04395638|Vitamins|vitamins|mesh-list
83456443|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
83456444|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456445|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83456446|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83456447|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
83456448|NCT04347980|Dexamethasone|dexamethasone|mesh-list
83456449|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456450|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
83456451|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
83456452|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456453|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456454|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83456455|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
83460203|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
83456457|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456458|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83456459|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456460|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
83456461|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83456462|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83456463|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456464|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456465|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456466|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456467|NCT01925300|Bisoprolol|bisoprolol|mesh-list
83456468|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83456469|NCT01925300|Calcium|calcium|mesh-list
83456470|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83460204|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
83456471|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456473|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83456474|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
83456475|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456476|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83456477|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83456478|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456479|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83456480|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
83456481|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
83456482|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456483|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83456484|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83456485|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83456486|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
83456487|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456488|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83456489|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83456490|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83456492|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456493|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83456494|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83456495|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456496|NCT01925378|Nelfinavir|nelfinavir|mesh-list
83456497|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83456498|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83456499|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
83456500|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456501|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456502|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83456503|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83456504|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
83456505|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456506|NCT01925456|Fesoterodine|fesoterodine|mesh-list
83456507|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83456508|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83456509|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
83456510|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456511|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456512|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456513|NCT01925456|Urological Agents|urological agents|mesh-ancestor
83456515|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83456516|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456517|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456518|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
83456519|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456520|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456521|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
83456522|NCT02226159|Dexamethasone|dexamethasone|mesh-list
83456523|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
83456525|NCT02226159|BB 1101|bb 1101|mesh-list
83456526|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456527|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
83456528|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
83456529|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456530|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456531|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83456532|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
83456533|NCT02226159|Hormones|hormones|mesh-ancestor
83456534|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456535|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83456536|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456537|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
83456538|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456539|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456540|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
83456541|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
83456542|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456543|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
83456544|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83456545|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83456546|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83456547|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83456548|NCT03241030|Acetaminophen|acetaminophen|mesh-list
83456549|NCT03241030|Ibuprofen|ibuprofen|mesh-list
83456550|NCT03241030|Sucralfate|sucralfate|mesh-list
83456551|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456552|NCT03241030|Analgesics|analgesics|mesh-ancestor
83456553|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
83456554|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456555|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456556|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
83460205|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83456557|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83456558|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456559|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456560|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83456561|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456562|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456564|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83456565|NCT02184195|Olaparib|olaparib|mesh-list
83456566|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83456567|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456568|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456569|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456570|NCT03241810|Fulvestrant|fulvestrant|mesh-list
83456571|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83456572|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456573|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83456574|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83456575|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
83456576|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456577|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456578|NCT02129751|Bupropion|bupropion|mesh-list
83456579|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83456580|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
83456581|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83456582|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83456583|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83456584|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83456585|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456586|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
83456588|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456589|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83456590|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83456591|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456592|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
83456593|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83456594|NCT03242590|Testosterone|testosterone|mesh-list
83456595|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
83456596|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
83456597|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83456598|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456599|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
83456600|NCT03242590|Hormones|hormones|mesh-ancestor
83456601|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456602|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456604|NCT03247738|Cangrelor|cangrelor|mesh-list
83456605|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83456606|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83456607|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83456608|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83456609|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
83456610|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456611|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456612|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456614|NCT03345160|Immunologic Factors|immunologic factors|mesh-ancestor
83456615|NCT03345160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456616|NCT01567605|Lidocaine|lidocaine|mesh-list
83456617|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
83456618|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
83456619|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456620|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456621|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
83456622|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456623|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83456624|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83456625|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83456626|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83456627|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456628|NCT02604537|Ketorolac|ketorolac|mesh-list
83456629|NCT02604537|Betamethasone|betamethasone|mesh-list
83456630|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83456631|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456632|NCT02604537|Analgesics|analgesics|mesh-ancestor
83456633|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
83456634|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456636|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456637|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456638|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83456639|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456640|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456642|NCT02604537|Hormones|hormones|mesh-ancestor
83456643|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456644|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83456645|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
83456646|NCT01384773|Riboflavin|riboflavin|mesh-list
83456647|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83456648|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83456649|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
83456650|NCT01384773|Vitamins|vitamins|mesh-ancestor
83456652|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456653|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83456654|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
83456655|NCT01063075|Carboplatin|carboplatin|mesh-list
83456656|NCT01063075|Cetuximab|cetuximab|mesh-list
83456657|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456658|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83456659|NCT01341405|Celecoxib|celecoxib|mesh-list
83456660|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83456661|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456662|NCT01341405|Analgesics|analgesics|mesh-ancestor
83456663|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
83456664|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456665|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456666|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456667|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456668|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83456669|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83456670|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456671|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456674|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
83456675|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83456676|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456677|NCT01921790|Dexamethasone|dexamethasone|mesh-list
83456678|NCT01921790|Gemcitabine|gemcitabine|mesh-list
83456679|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
83456680|NCT01921790|Bevacizumab|bevacizumab|mesh-list
83456681|NCT01921790|Pegaspargase|pegaspargase|mesh-list
83456682|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456683|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
83456684|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
83456685|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456686|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456687|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83456688|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
83456689|NCT01921790|Hormones|hormones|mesh-ancestor
83456690|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456691|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83456692|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456693|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83456695|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456696|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83456697|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83456698|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83456699|NCT01921790|Growth Substances|growth substances|mesh-ancestor
83456700|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
83456701|NCT02153541|Antipyrine|antipyrine|mesh-list
83456702|NCT02153541|Benzocaine|benzocaine|mesh-list
83456703|NCT02153541|Glycerol|glycerol|mesh-list
83456704|NCT02153541|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83456705|NCT02153541|Protective Agents|protective agents|mesh-ancestor
83456706|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456707|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
83456708|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
83456709|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456710|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
83456711|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456712|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83456713|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456715|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456716|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456717|NCT03487276|Vilobelimab|vilobelimab|mesh-list
83456718|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83456719|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83456720|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
83456721|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456722|NCT03489850|Ibudilast|ibudilast|mesh-list
83456723|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83456724|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
83456725|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456726|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456727|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83456728|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
83456729|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83456730|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456731|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456732|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83456733|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
83456734|NCT03490942|Glucagon|glucagon|mesh-list
83456735|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83456736|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83456737|NCT03490942|Hormones|hormones|mesh-ancestor
83456738|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456739|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456740|NCT03490942|Incretins|incretins|mesh-ancestor
83456741|NCT00376870|Pioglitazone|pioglitazone|mesh-list
83456742|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83456743|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456745|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
83456746|NCT03256162|Midazolam|midazolam|mesh-list
83456747|NCT03256162|Ketamine|ketamine|mesh-list
83456748|NCT03256162|Analgesics|analgesics|mesh-ancestor
83456749|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
83456750|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456751|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456752|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83456753|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83456754|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
83456755|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
83456756|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456757|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83456758|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83456759|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456760|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456761|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83456762|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83456763|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83456764|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83456765|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83456766|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
83456768|NCT03493828|Bupivacaine|bupivacaine|mesh-list
83456769|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
83456770|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
83456771|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456772|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456773|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
83456774|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456775|NCT03496324|Ibuprofen|ibuprofen|mesh-list
83456776|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83456777|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456778|NCT03496324|Analgesics|analgesics|mesh-ancestor
83456779|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
83456780|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456781|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456782|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456783|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456784|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83456785|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456786|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456787|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
83456788|NCT03354598|Probenecid|probenecid|mesh-list
83456789|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83456790|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456791|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83456792|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83456793|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456794|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456795|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456796|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83456797|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83456798|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
83456799|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
83456800|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456801|NCT02169895|Opicapone|opicapone|mesh-list
83456802|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
83456803|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83456804|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456805|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456806|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83456807|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83456808|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
83456809|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456810|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456811|NCT01072669|Ambrisentan|ambrisentan|mesh-list
83456812|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83456813|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
83456814|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
83456815|NCT03014713|Dezocine|dezocine|mesh-list
83456816|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83456817|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456818|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456819|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456820|NCT03014713|Analgesics|analgesics|mesh-ancestor
83456822|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456823|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83456824|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83456825|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83456826|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
83456827|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456828|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456829|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83456830|NCT03014713|Narcotics|narcotics|mesh-ancestor
83456831|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83456832|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456833|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456834|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83456835|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456836|NCT01074463|Pramipexole|pramipexole|mesh-list
83456837|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
83456838|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456839|NCT01074463|Protective Agents|protective agents|mesh-ancestor
83456840|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456841|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83456842|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83456843|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
83456844|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
83456845|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456847|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
83456848|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
83456849|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456850|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456851|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
83456852|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456853|NCT01075399|Imidazole|imidazole|mesh-list
83456854|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456855|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456856|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
83456857|NCT03835819|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
83456858|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83456859|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456860|NCT03835819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83456861|NCT03835819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456862|NCT03835819|Immunoconjugates|immunoconjugates|mesh-ancestor
83456863|NCT03835819|Immunologic Factors|immunologic factors|mesh-ancestor
83456864|NCT03835819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456865|NCT03358576|Amoxicillin|amoxicillin|mesh-list
83456866|NCT03358576|Metronidazole|metronidazole|mesh-list
83456867|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
83456868|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
83456869|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
83456870|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83456871|NCT03358576|Ertapenem|ertapenem|mesh-list
83456872|NCT03358576|Lactams|lactams|mesh-list
83456873|NCT03358576|Probenecid|probenecid|mesh-list
83456874|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83456875|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456876|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83456877|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83456878|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83456879|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83456880|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456881|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456882|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456883|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83456884|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83456885|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83456886|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
83456887|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
83456888|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456889|NCT03822013|Miglustat|miglustat|mesh-list
83456890|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456891|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456892|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83456893|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83456894|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
83456895|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456896|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83456897|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83456898|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456899|NCT00376324|Tigecycline|tigecycline|mesh-list
83456900|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83456901|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456902|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83456903|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456904|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456905|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
83456906|NCT00376480|Fludarabine|fludarabine|mesh-list
83456907|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
83456908|NCT00376480|Thiotepa|thiotepa|mesh-list
83456909|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83456910|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456911|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83456912|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
83456913|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456914|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83456915|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
83456916|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456917|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456918|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
83456919|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
83456920|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456921|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83456922|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
83456923|NCT00376480|Hormones|hormones|mesh-ancestor
83460206|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83456924|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83456925|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83456926|NCT00376480|Protective Agents|protective agents|mesh-ancestor
83456927|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83456929|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83456930|NCT03016039|Curcumin|curcumin|mesh-list
83456931|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83456932|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83456933|NCT03016039|Analgesics|analgesics|mesh-ancestor
83456934|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
83456935|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456936|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456937|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83456938|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83456939|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456940|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456941|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456942|NCT03753919|Durvalumab|durvalumab|mesh-list
83456943|NCT03753919|Tremelimumab|tremelimumab|mesh-list
83456944|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83456945|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456946|NCT03498196|Avelumab|avelumab|mesh-list
83456947|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83456948|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456949|NCT03500302|Evolocumab|evolocumab|mesh-list
83456950|NCT03500302|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83456951|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83456952|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83456953|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
83456954|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456955|NCT03500302|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83456956|NCT03500302|Protease Inhibitors|protease inhibitors|mesh-ancestor
83456957|NCT03500302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456958|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83456959|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83456960|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
83456961|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456962|NCT03503578|Ketamine|ketamine|mesh-list
83456964|NCT03503578|Analgesics|analgesics|mesh-ancestor
83456965|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
83456966|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456967|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456968|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83456969|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83456970|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
83456971|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
83456972|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456973|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83456974|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83456975|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83456976|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456977|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83456978|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83456979|NCT03270514|Bupivacaine|bupivacaine|mesh-list
83456980|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
83456981|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
83456982|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456983|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456984|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
83456985|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456986|NCT02178241|Gemcitabine|gemcitabine|mesh-list
83456987|NCT02178241|Halichondrin B|halichondrin b|mesh-list
83456988|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83456989|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
83456990|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456991|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456992|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
83456993|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
83456994|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
83456995|NCT03015727|Docetaxel|docetaxel|mesh-list
83456996|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456997|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
83456998|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
83456999|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
83457000|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457001|NCT03539731|Piperazine|piperazine|mesh-list
83457002|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
83457003|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
83457004|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83457005|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457006|NCT01077973|Ibuprofen|ibuprofen|mesh-list
83457007|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83457008|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83457009|NCT01077973|Analgesics|analgesics|mesh-ancestor
83457010|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
83457011|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457012|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457013|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83457014|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83457015|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83457016|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457017|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457018|NCT02973646|Tenofovir|tenofovir|mesh-list
83457019|NCT02973646|Entecavir|entecavir|mesh-list
83457020|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83457021|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
83457022|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457023|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83457024|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83457025|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457026|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457027|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83457028|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83457029|NCT01078363|Ramipril|ramipril|mesh-list
83457030|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83457031|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
83457032|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457033|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457034|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83457035|NCT03371836|Clobazam|clobazam|mesh-list
83457036|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
83457037|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83457038|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83457039|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457040|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457041|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83457042|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83457043|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
83457044|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
83457045|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457046|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457047|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83457049|NCT01078753|Coagulants|coagulants|mesh-ancestor
83457050|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83457051|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
83457052|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457053|NCT03372382|Acetaminophen|acetaminophen|mesh-list
83457054|NCT03372382|Ibuprofen|ibuprofen|mesh-list
83457055|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83457056|NCT03372382|Analgesics|analgesics|mesh-ancestor
83457057|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
83457058|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457059|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457061|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83457062|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83457063|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83457064|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83457065|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457066|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457067|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83457068|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83457069|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83457070|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457071|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457072|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83457073|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83457074|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457075|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
83457076|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457077|NCT03374176|Amoxicillin|amoxicillin|mesh-list
83457078|NCT03374176|Metronidazole|metronidazole|mesh-list
83457079|NCT03374176|Clindamycin|clindamycin|mesh-list
83457080|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
83457081|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
83457082|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83457083|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457084|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83457085|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83457086|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83457087|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457088|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457089|NCT03281200|Nintedanib|nintedanib|mesh-list
83457090|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
83457091|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
83457092|NCT03281200|Immunomodulating Agents|immunomodulating agents|mesh-list
83457093|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457094|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457095|NCT03281200|Immunologic Factors|immunologic factors|mesh-ancestor
83457096|NCT03281200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457097|NCT03378076|Triamcinolone|triamcinolone|mesh-list
83457098|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83457099|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83457101|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83457102|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83457103|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
83457104|NCT03378076|Hormones|hormones|mesh-ancestor
83457105|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457107|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83457108|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
83457109|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457110|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457111|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
83457112|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
83457114|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
83457115|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457116|NCT03380026|Triamcinolone|triamcinolone|mesh-list
83457117|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83457118|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83457119|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
83457120|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83457121|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83457123|NCT03380026|Hormones|hormones|mesh-ancestor
83457124|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457125|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457126|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83457127|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
83457128|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457129|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457130|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
83457131|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83457132|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457133|NCT01079143|Cyclosporine|cyclosporine|mesh-list
83457134|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
83457135|NCT01079143|Everolimus|everolimus|mesh-list
83457136|NCT01079143|Cyclosporins|cyclosporins|mesh-list
83457137|NCT01079143|Basiliximab|basiliximab|mesh-list
83457138|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457139|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457140|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83457141|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
83457142|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457143|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
83457144|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457145|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
83457146|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83457147|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83457148|NCT01079143|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83457149|NCT01079143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83457150|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457151|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83457152|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83457154|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83457155|NCT03381742|Clopidogrel|clopidogrel|mesh-list
83457156|NCT03381742|Ticagrelor|ticagrelor|mesh-list
83457157|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83457158|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83457159|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83457160|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83457161|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
83457162|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457163|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457164|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457166|NCT04735042|Empagliflozin|empagliflozin|mesh-list
83457167|NCT04735042|Linagliptin|linagliptin|mesh-list
83457168|NCT04735042|Saxagliptin|saxagliptin|mesh-list
83457169|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83457170|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457171|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83457172|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457173|NCT04735042|Incretins|incretins|mesh-ancestor
83457174|NCT04735042|Hormones|hormones|mesh-ancestor
83457175|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457176|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83457177|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
83457178|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457179|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83457180|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83457181|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457182|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
83457183|NCT00376012|Rifampin|rifampin|mesh-list
83457184|NCT00376012|Isoniazid|isoniazid|mesh-list
83457185|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
83457187|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83457188|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
83457189|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83457190|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457191|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
83457192|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83457193|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457194|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457195|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83457196|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83457197|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83457198|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83457199|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83457200|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83457201|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83457202|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83457203|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
83457204|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83457205|NCT02171611|Dabigatran|dabigatran|mesh-list
83457206|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
83457207|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83457208|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
83457209|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457210|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457211|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
83457212|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
83457213|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
83457214|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83457215|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83457216|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457217|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83457218|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457219|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457220|NCT00942305|Brincidofovir|brincidofovir|mesh-list
83457221|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
83457222|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457223|NCT01084759|Etoposide|etoposide|mesh-list
83457224|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
83457225|NCT01084759|Testosterone|testosterone|mesh-list
83457226|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
83457227|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
83457228|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83457229|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83457230|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457231|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83457232|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83457233|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457234|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457236|NCT01084759|Hormones|hormones|mesh-ancestor
83457237|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457238|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457239|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83457240|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
83457241|NCT01110187|Lacosamide|lacosamide|mesh-list
83457242|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
83457243|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
83457244|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83457245|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83457246|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83457247|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457249|NCT01110421|Amoxicillin|amoxicillin|mesh-list
83457250|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
83457251|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
83457252|NCT01110421|Cefepime|cefepime|mesh-list
83457254|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83457255|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83457256|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457257|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83457258|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460207|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83457259|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457260|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
83457261|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83457262|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457263|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457264|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83457265|NCT04358627|Analgesics|analgesics|mesh-ancestor
83457266|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
83457267|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457268|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83457269|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83457270|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83457271|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
83457272|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457273|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457275|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
83457276|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457277|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
83457278|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457279|NCT04356833|Plasminogen|plasminogen|mesh-list
83460208|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
83457280|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83457281|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83457282|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83457283|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457284|NCT05620277|Tocopherols|tocopherols|mesh-list
83457285|NCT05620277|Vitamin E|vitamin e|mesh-list
83457286|NCT05620277|alpha-Tocopherol|alpha-tocopherol|mesh-list
83457287|NCT05620277|Antioxidants|antioxidants|mesh-ancestor
83457288|NCT05620277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457289|NCT05620277|Protective Agents|protective agents|mesh-ancestor
83457290|NCT05620277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457291|NCT05620277|Vitamins|vitamins|mesh-ancestor
83457292|NCT05620277|Micronutrients|micronutrients|mesh-ancestor
83457293|NCT01110499|Bimatoprost|bimatoprost|mesh-list
83457294|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83457295|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83457296|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83457297|NCT02174419|Nalbuphine|nalbuphine|mesh-list
83457298|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83457299|NCT02174419|Narcotics|narcotics|mesh-ancestor
83457300|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457301|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457302|NCT02174419|Analgesics|analgesics|mesh-ancestor
83457303|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
83457304|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457305|NCT05620589|Amoxicillin|amoxicillin|mesh-list
83457307|NCT05620589|Esomeprazole|esomeprazole|mesh-list
83457308|NCT05620589|Bismuth|bismuth|mesh-list
83457309|NCT05620589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83457311|NCT05620589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83457312|NCT05620589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83457313|NCT05620589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83457314|NCT05620589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457315|NCT05620589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457317|NCT05620589|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83457318|NCT01086475|Cycloserine|cycloserine|mesh-list
83457319|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83457320|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457321|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83457322|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
83457323|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83457324|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
83457325|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457326|NCT01112683|Memantine|memantine|mesh-list
83457327|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83457328|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83457329|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
83457330|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457331|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457332|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457333|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83457334|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83457335|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
83457336|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83457337|NCT04355273|Heparin|heparin|mesh-list
83457338|NCT04355273|Calcium heparin|calcium heparin|mesh-list
83457339|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
83457340|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83457341|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83457342|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457344|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83457345|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
83457346|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457347|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457348|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83457349|NCT01114555|Bevacizumab|bevacizumab|mesh-list
83457350|NCT01114555|Irinotecan|irinotecan|mesh-list
83457351|NCT01114555|Temozolomide|temozolomide|mesh-list
83457352|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83457353|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457354|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83457355|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83457356|NCT01114555|Growth Substances|growth substances|mesh-ancestor
83457357|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457358|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
83457359|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83457360|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83457361|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457362|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457363|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83457364|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
83457365|NCT02673931|Exenatide|exenatide|mesh-list
83457366|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83457367|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457368|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83457369|NCT02673931|Incretins|incretins|mesh-ancestor
83457370|NCT02673931|Hormones|hormones|mesh-ancestor
83457371|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457372|NCT01115101|Pirinitramide|pirinitramide|mesh-list
83457373|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83457374|NCT01115101|Narcotics|narcotics|mesh-ancestor
83457375|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457376|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457377|NCT01115101|Analgesics|analgesics|mesh-ancestor
83457378|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
83457379|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457381|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83457382|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83457383|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83457384|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
83457385|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457386|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457387|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457388|NCT02245529|Urological Agents|urological agents|mesh-ancestor
83457390|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83457391|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
83457392|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83457393|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
83457394|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83457395|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
83457397|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
83457398|NCT00947765|Hormones|hormones|mesh-ancestor
83460209|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457399|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457400|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457401|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83457402|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457403|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
83457404|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
83457405|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457406|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83457407|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83457408|NCT00947765|Protective Agents|protective agents|mesh-ancestor
83457409|NCT01089517|Ranibizumab|ranibizumab|mesh-list
83457410|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83457411|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83457412|NCT01089517|Growth Substances|growth substances|mesh-ancestor
83457413|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457414|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
83457415|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457416|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83457417|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83457418|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457419|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
83457420|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457421|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83457422|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457423|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457424|NCT04354961|Paclitaxel|paclitaxel|mesh-list
83457425|NCT04354961|Carboplatin|carboplatin|mesh-list
83457426|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83457427|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457428|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
83457429|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
83457430|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
83457431|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457432|NCT01089751|Trospium chloride|trospium chloride|mesh-list
83457433|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
83457434|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
83457435|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457436|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457437|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83457438|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83457439|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
83457440|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457441|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457442|NCT01089751|Urological Agents|urological agents|mesh-ancestor
83457443|NCT03032315|Amlodipine|amlodipine|mesh-list
83457444|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83457445|NCT03032315|Telmisartan|telmisartan|mesh-list
83457446|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83457447|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83457448|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83457449|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83457450|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457451|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83457452|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457453|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
83457454|NCT03032315|Diuretics|diuretics|mesh-ancestor
83457455|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
83457456|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83457457|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83457458|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83457459|NCT01090921|Bortezomib|bortezomib|mesh-list
83457460|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457461|NCT03537274|Interferons|interferons|mesh-list
83457462|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
83457463|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
83457464|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83457465|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457466|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
83457467|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457468|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
83457469|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457470|NCT00939653|Cytarabine|cytarabine|mesh-list
83457471|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
83457472|NCT00939653|Etoposide|etoposide|mesh-list
83457473|NCT00939653|Clofarabine|clofarabine|mesh-list
83457474|NCT00939653|Lenograstim|lenograstim|mesh-list
83457475|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83457476|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
83457477|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457478|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83457479|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83457480|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
83457481|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457482|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457483|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83457484|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83457485|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83457486|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83457487|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457488|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83457489|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
83457490|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
83457491|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457492|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83457493|NCT04355039|Dexamethasone|dexamethasone|mesh-list
83457494|NCT04355039|Pomalidomide|pomalidomide|mesh-list
83457495|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83457496|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
83457497|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
83457498|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457499|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457500|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83457501|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
83457502|NCT04355039|Hormones|hormones|mesh-ancestor
83457503|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457504|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83457505|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457506|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
83457507|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83457508|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83457510|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
83457511|NCT02524405|Corticosterone|corticosterone|mesh-list
83457512|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83457513|NCT03014323|Galantamine|galantamine|mesh-list
83457514|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83457515|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457516|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457517|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
83457518|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457519|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457520|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83457521|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
83457522|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457523|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
83457525|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83457526|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457527|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
83457528|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83457529|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
83457530|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457531|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457532|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83457533|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
83457534|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83457535|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
83457536|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457537|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457538|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83457539|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
83457540|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
83457541|NCT01092559|Protective Agents|protective agents|mesh-ancestor
83457543|NCT03587428|Trace Elements|trace elements|mesh-ancestor
83457544|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
83457545|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457546|NCT03398278|Oxycodone|oxycodone|mesh-list
83457547|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83457548|NCT03398278|Narcotics|narcotics|mesh-ancestor
83457549|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457550|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457551|NCT03398278|Analgesics|analgesics|mesh-ancestor
83457552|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
83457553|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457554|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
83457555|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83457556|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83457557|NCT03593902|Prednisolone|prednisolone|mesh-list
83457558|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
83457559|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
83457560|NCT03593902|Rituximab|rituximab|mesh-list
83457561|NCT03593902|Fludarabine|fludarabine|mesh-list
83457562|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
83457563|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83457564|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83457565|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
83457566|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83457567|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
83457568|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457569|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83457570|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83457571|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
83457572|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457573|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457574|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83457575|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83457576|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83457577|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
83457578|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
83457579|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457580|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83457581|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
83457582|NCT03593902|Hormones|hormones|mesh-ancestor
83457583|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457584|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83457585|NCT03593902|Protective Agents|protective agents|mesh-ancestor
83457586|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83457587|NCT00948935|Gemcitabine|gemcitabine|mesh-list
83457588|NCT00948935|Irinotecan|irinotecan|mesh-list
83457589|NCT00948935|Panitumumab|panitumumab|mesh-list
83457590|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83457591|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
83457592|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457593|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457594|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83457595|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83457596|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457597|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83457598|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
83457599|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
83457600|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
83457601|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457602|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457603|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83457604|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83457605|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83457606|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457608|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83457609|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
83457610|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457611|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457612|NCT03944681|Droperidol|droperidol|mesh-list
83457613|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83457614|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
83457615|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
83457616|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457617|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457618|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83457619|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83457620|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83457621|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457622|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83457623|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83457624|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83457625|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
83457626|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457627|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460179|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457628|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
83457629|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457630|NCT03031691|Trifluridine|trifluridine|mesh-list
83457631|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
83457632|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457633|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
83457634|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457635|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
83457636|NCT01093183|Lenalidomide|lenalidomide|mesh-list
83457637|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83457638|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
83457639|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457640|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83457641|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83457642|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
83457643|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457644|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457645|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83457646|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83457647|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83457648|NCT01093183|Growth Substances|growth substances|mesh-ancestor
83457649|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
83457650|NCT02430103|Goserelin|goserelin|mesh-list
83457651|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83457652|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457653|NCT03031535|Octreotide|octreotide|mesh-list
83457654|NCT03031535|Hormones|hormones|mesh-list
83457655|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
83457656|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457657|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457658|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83457659|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83457660|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457661|NCT01093417|Vitamin D|vitamin d|mesh-list
83457662|NCT01093417|Vitamins|vitamins|mesh-ancestor
83457663|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
83457664|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457665|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83457667|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83457668|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83457669|NCT04744545|Analgesics|analgesics|mesh-ancestor
83457670|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
83457671|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457672|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457673|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83457674|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83457675|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457676|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457677|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457678|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83457679|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83457680|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457681|NCT01093651|Incretins|incretins|mesh-ancestor
83457682|NCT01093651|Hormones|hormones|mesh-ancestor
83457683|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457684|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83457685|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
83457686|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457687|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457688|NCT00362895|Tobramycin|tobramycin|mesh-list
83457689|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
83457690|NCT00362895|Dexamethasone|dexamethasone|mesh-list
83457691|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
83457692|NCT00362895|BB 1101|bb 1101|mesh-list
83457693|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83457694|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
83457695|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
83457696|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457697|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457698|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83457699|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
83457700|NCT00362895|Hormones|hormones|mesh-ancestor
83460180|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83457701|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457702|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83457703|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457704|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
83457705|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457706|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457707|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83457708|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457709|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83457710|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83457711|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
83457712|NCT04744623|Dapsone|dapsone|mesh-list
83457713|NCT04744623|Prednisolone|prednisolone|mesh-list
83457714|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83457715|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
83457716|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83457717|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
83457718|NCT04744623|Triamcinolone|triamcinolone|mesh-list
83457719|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83457720|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83457721|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83457722|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83457723|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
83457724|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83457725|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457726|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83457727|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
83457728|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83457729|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457730|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457731|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457732|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83457733|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
83457734|NCT04744623|Hormones|hormones|mesh-ancestor
83457735|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457736|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457737|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83457738|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
83457739|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
83457740|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457741|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83457742|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83457743|NCT04744623|Protective Agents|protective agents|mesh-ancestor
83457744|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83457745|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
83457746|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
83457747|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83457748|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83457749|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83457750|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
83457751|NCT00939731|Crizotinib|crizotinib|mesh-list
83457752|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457753|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83457754|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457755|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457756|NCT00633945|Lenalidomide|lenalidomide|mesh-list
83457757|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
83457758|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457759|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83457760|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83457761|NCT00633945|Growth Substances|growth substances|mesh-ancestor
83457762|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
83457763|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457764|NCT03609047|Paclitaxel|paclitaxel|mesh-list
83457765|NCT03609047|Docetaxel|docetaxel|mesh-list
83457766|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
83457767|NCT03609047|Doxorubicin|doxorubicin|mesh-list
83457768|NCT03609047|Epirubicin|epirubicin|mesh-list
83457769|NCT03609047|Palbociclib|palbociclib|mesh-list
83457770|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83457771|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457772|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
83457773|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
83457774|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
83457775|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457776|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83457777|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
83457778|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457780|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83457781|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
83457782|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83457783|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83457784|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83457785|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83457786|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457788|NCT01118845|Rituximab|rituximab|mesh-list
83457789|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83457790|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83457791|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457792|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
83457793|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457794|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83457795|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83457796|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
83457797|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457799|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
83457800|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
83457801|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457802|NCT03162731|Nivolumab|nivolumab|mesh-list
83457803|NCT03162731|Ipilimumab|ipilimumab|mesh-list
83457804|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83457805|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457806|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83457807|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457808|NCT03030911|Fentanyl|fentanyl|mesh-list
83457809|NCT03030911|Midazolam|midazolam|mesh-list
83457810|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
83457811|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83457812|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457813|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457814|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83457815|NCT03030911|Analgesics|analgesics|mesh-ancestor
83457816|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
83457817|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457818|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83457819|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83457821|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
83457822|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457823|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457824|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83457825|NCT03030911|Narcotics|narcotics|mesh-ancestor
83457826|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83457827|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83457828|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
83457829|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
83457830|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83457831|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83457832|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83457833|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
83457834|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
83457835|NCT01120405|Sevoflurane|sevoflurane|mesh-list
83457836|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83457837|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83457838|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
83457839|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
83457840|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457841|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457842|NCT03013387|Octreotide|octreotide|mesh-list
83457843|NCT03013387|Edotreotide|edotreotide|mesh-list
83457844|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83457845|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83457846|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457847|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83457848|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457849|NCT01782989|Doxycycline|doxycycline|mesh-list
83457850|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83457851|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457852|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
83457853|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83457854|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83457855|NCT01120639|Temozolomide|temozolomide|mesh-list
83457856|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83457857|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
83457858|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457859|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457860|NCT01095757|Plerixafor|plerixafor|mesh-list
83457861|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83457862|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83457863|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
83457864|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457865|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83457866|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83457867|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457868|NCT02245451|Ritonavir|ritonavir|mesh-list
83457869|NCT02245451|Tipranavir|tipranavir|mesh-list
83457870|NCT02245451|Methadone|methadone|mesh-list
83457871|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83457872|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83457873|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
83457874|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457875|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457876|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83457877|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83457878|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
83457879|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457880|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83457881|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83457882|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83457883|NCT02245451|Narcotics|narcotics|mesh-ancestor
83457884|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457885|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457886|NCT02245451|Analgesics|analgesics|mesh-ancestor
83457887|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
83457888|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457889|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
83457890|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
83457891|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83457892|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83457893|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83457894|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83457895|NCT00951899|Metformin|metformin|mesh-list
83457896|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83457897|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83457898|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457899|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83457900|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83457901|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
83457902|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457904|NCT01097395|Ribavirin|ribavirin|mesh-list
83457906|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457907|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
83457908|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83457909|NCT00467987|Testosterone|testosterone|mesh-list
83457910|NCT00467987|Androgens|androgens|mesh-ancestor
83457911|NCT00467987|Hormones|hormones|mesh-ancestor
83457912|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457913|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457914|NCT00433589|Tamoxifen|tamoxifen|mesh-list
83457915|NCT00433589|Docetaxel|docetaxel|mesh-list
83457916|NCT00433589|Capecitabine|capecitabine|mesh-list
83457917|NCT00433589|Letrozole|letrozole|mesh-list
83457918|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457919|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
83457920|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
83457921|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
83457922|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457923|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83457924|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
83457925|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83457926|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83457927|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457928|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83457929|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
83457930|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83457931|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457932|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83457933|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83457934|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83457935|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83457936|NCT03013075|Morphine|morphine|mesh-list
83457937|NCT03013075|Bupivacaine|bupivacaine|mesh-list
83457938|NCT03013075|Anesthetics|anesthetics|mesh-list
83457939|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
83457940|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
83457941|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457942|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457943|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
83457944|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457945|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83457946|NCT03013075|Narcotics|narcotics|mesh-ancestor
83457947|NCT03013075|Analgesics|analgesics|mesh-ancestor
83457948|NCT03030677|Lidocaine|lidocaine|mesh-list
83457949|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
83457950|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
83457951|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457952|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457953|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
83457954|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457955|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83457956|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83457957|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83457958|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83457959|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457960|NCT01122901|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83457961|NCT01122901|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83457962|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457963|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457964|NCT01097785|Simvastatin|simvastatin|mesh-list
83457965|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83457966|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83457967|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
83457968|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457969|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83457970|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83457971|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457972|NCT03030287|Paclitaxel|paclitaxel|mesh-list
83457973|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83457974|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83457975|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457976|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
83457977|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
83457978|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
83457979|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457980|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
83457981|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457982|NCT03035357|Daratumumab|daratumumab|mesh-list
83457983|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457984|NCT00940589|Melatonin|melatonin|mesh-list
83457985|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
83457986|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457987|NCT00940589|Protective Agents|protective agents|mesh-ancestor
83457988|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83457989|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457990|NCT02574078|Paclitaxel|paclitaxel|mesh-list
83457992|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83457993|NCT02574078|Bevacizumab|bevacizumab|mesh-list
83457994|NCT02574078|Carboplatin|carboplatin|mesh-list
83457995|NCT02574078|Gemcitabine|gemcitabine|mesh-list
83457996|NCT02574078|Nivolumab|nivolumab|mesh-list
83457997|NCT02574078|Pemetrexed|pemetrexed|mesh-list
83457998|NCT02574078|Crizotinib|crizotinib|mesh-list
83457999|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83458000|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458001|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
83458002|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
83458003|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
83458004|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458005|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83458006|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83458007|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83458008|NCT02574078|Growth Substances|growth substances|mesh-ancestor
83458009|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458010|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
83458011|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83458012|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
83458013|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83458014|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458015|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83458016|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83458017|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83458018|NCT03605914|Acetaminophen|acetaminophen|mesh-list
83458019|NCT03605914|Diclofenac|diclofenac|mesh-list
83458020|NCT03605914|Hydrocodone|hydrocodone|mesh-list
83458021|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83458022|NCT03605914|Analgesics|analgesics|mesh-ancestor
83458023|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
83458024|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458025|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458026|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
83458027|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83458028|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458029|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83458030|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83458031|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458032|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458033|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83458034|NCT03605914|Narcotics|narcotics|mesh-ancestor
83458035|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458036|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
83458037|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
83458038|NCT04353479|Decitabine|decitabine|mesh-list
83458039|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83458040|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83458041|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
83458042|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458043|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458044|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458045|NCT04353479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83458046|NCT03608488|Vitamin D|vitamin d|mesh-list
83458047|NCT03608488|Vitamins|vitamins|mesh-ancestor
83458048|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
83458049|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458050|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83458052|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83458053|NCT03035045|Analgesics|analgesics|mesh-ancestor
83458054|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
83458055|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458056|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458058|NCT03034733|Dexamethasone|dexamethasone|mesh-list
83458059|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458060|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
83458061|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
83458062|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458063|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458064|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83458065|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
83458066|NCT03034733|Hormones|hormones|mesh-ancestor
83458067|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83458068|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83458069|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458071|NCT05512416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458072|NCT05512416|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83458073|NCT05512416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83458074|NCT05512416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458075|NCT05512416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458076|NCT05512416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83458077|NCT05512416|Hormone Antagonists|hormone antagonists|mesh-ancestor
83458078|NCT05512416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83458079|NCT05512416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458080|NCT04290624|Listerine|listerine|mesh-list
83458081|NCT04290624|Fluorides|fluorides|mesh-list
83458082|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
83458083|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
83458084|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
83458085|NCT04290624|Protective Agents|protective agents|mesh-ancestor
83458086|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458088|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458089|NCT03403504|Oxycodone|oxycodone|mesh-list
83458090|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83458091|NCT03403504|Narcotics|narcotics|mesh-ancestor
83458092|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458093|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458094|NCT03403504|Analgesics|analgesics|mesh-ancestor
83458095|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
83458096|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458097|NCT05512728|Midazolam|midazolam|mesh-list
83458098|NCT05512728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83458099|NCT05512728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83458100|NCT05512728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458101|NCT05512728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458102|NCT05512728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83458103|NCT05512728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83458104|NCT05512728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83458105|NCT05512728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83458106|NCT05512728|Anesthetics, General|anesthetics, general|mesh-ancestor
83458107|NCT05512728|Anesthetics|anesthetics|mesh-ancestor
83458108|NCT05512728|GABA Modulators|gaba modulators|mesh-ancestor
83458109|NCT05512728|GABA Agents|gaba agents|mesh-ancestor
83458110|NCT05512728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458111|NCT05512728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458112|NCT02565810|Adalimumab|adalimumab|mesh-list
83458113|NCT02565810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83458114|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458115|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83458116|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
83458117|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
83458118|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83458119|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83458120|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458121|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458122|NCT00940901|Urological Agents|urological agents|mesh-ancestor
83458123|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83458124|NCT04353713|Laxatives|laxatives|mesh-ancestor
83458125|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83458126|NCT04900038|Lamivudine|lamivudine|mesh-list
83458127|NCT04900038|Dolutegravir|dolutegravir|mesh-list
83458128|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83458129|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83458130|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460181|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458131|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458132|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
83458133|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458134|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83458135|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83458136|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83458138|NCT03565666|Insulin|insulin|mesh-list
83458139|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83458140|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
83458141|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
83458142|NCT03565666|Pancrelipase|pancrelipase|mesh-list
83458143|NCT03565666|Pancreatin|pancreatin|mesh-list
83458145|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458146|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83458147|NCT03620890|Protamines|protamines|mesh-list
83458148|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
83458149|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458150|NCT03620890|Coagulants|coagulants|mesh-ancestor
83458151|NCT05507112|Capecitabine|capecitabine|mesh-list
83458152|NCT05507112|Tislelizumab|tislelizumab|mesh-list
83458153|NCT05507112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83458154|NCT05507112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83458155|NCT05507112|Antimetabolites|antimetabolites|mesh-ancestor
83460182|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83458156|NCT05507112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458157|NCT05507112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458158|NCT05507112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83458160|NCT05511948|Antioxidants|antioxidants|mesh-ancestor
83458161|NCT05511948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458162|NCT05511948|Protective Agents|protective agents|mesh-ancestor
83458163|NCT05511948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458164|NCT05511948|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83458166|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
83458167|NCT00952133|Palonosetron|palonosetron|mesh-list
83458168|NCT00952133|BB 1101|bb 1101|mesh-list
83458169|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458170|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
83458171|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
83458172|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458173|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458174|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83458175|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
83458176|NCT00952133|Hormones|hormones|mesh-ancestor
83458177|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83458178|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83458179|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458180|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
83458181|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458182|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458183|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83458184|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83458185|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
83458186|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458187|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
83458188|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83458189|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458191|NCT05042375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458192|NCT05506566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83458193|NCT05506566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83458194|NCT05506566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458195|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
83458196|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83458197|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83458198|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458199|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
83458200|NCT03023189|Coagulants|coagulants|mesh-ancestor
83458201|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
83458202|NCT02561832|Carboplatin|carboplatin|mesh-list
83458204|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83458205|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
83458206|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458207|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83458208|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83458209|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
83458210|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458211|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458212|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83458213|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83458214|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458215|NCT02982161|Celecoxib|celecoxib|mesh-list
83458216|NCT02982161|Tramadol|tramadol|mesh-list
83458217|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83458218|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83458219|NCT02982161|Analgesics|analgesics|mesh-ancestor
83458220|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
83458221|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458222|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458223|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458224|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83458225|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83458226|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83458227|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458228|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458229|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83458230|NCT02982161|Narcotics|narcotics|mesh-ancestor
83458231|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458232|NCT05506488|Dasatinib|dasatinib|mesh-list
83458233|NCT05506488|Quercetin|quercetin|mesh-list
83458234|NCT05506488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458235|NCT05506488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83458236|NCT05506488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458237|NCT05506488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458239|NCT05506488|Protective Agents|protective agents|mesh-ancestor
83458240|NCT05506488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458241|NCT00942149|Daptomycin|daptomycin|mesh-list
83458242|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83458243|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458244|NCT03023111|Miltefosine|miltefosine|mesh-list
83458245|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83458246|NCT03023111|Molgramostim|molgramostim|mesh-list
83458247|NCT03023111|Sargramostim|sargramostim|mesh-list
83458248|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
83458249|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458250|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458251|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
83458252|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458253|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83458254|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83458255|NCT03022253|Acetaminophen|acetaminophen|mesh-list
83458256|NCT03022253|Ibuprofen|ibuprofen|mesh-list
83458257|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83458258|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83458259|NCT03022253|Analgesics|analgesics|mesh-ancestor
83458260|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
83458261|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458262|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458263|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458265|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83458266|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458267|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458268|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
83458269|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
83458270|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83458271|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83458273|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
83458274|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458275|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458276|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458277|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83458278|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
83458279|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83458280|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
83458281|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83458282|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458283|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458285|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
83460183|NCT05609240|Cefuroxime|cefuroxime|mesh-list
83458286|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458288|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83458289|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83458290|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83458291|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83458292|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458293|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
83458294|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458295|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458296|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83458297|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458298|NCT03017495|Midazolam|midazolam|mesh-list
83458299|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83458300|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83458301|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458302|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458303|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83458304|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83458305|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83458306|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83458307|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
83458308|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
83458309|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
83458310|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
83458311|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458312|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458313|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83458315|NCT01039207|Antibodies|antibodies|mesh-list
83458316|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
83458317|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83458318|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
83458319|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458320|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458321|NCT02981615|Levofloxacin|levofloxacin|mesh-list
83458322|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83458323|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458324|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83458325|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83458326|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83458327|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458328|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458329|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458330|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83458331|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83458332|NCT01125163|Iron|iron|mesh-list
83458333|NCT01125163|Trace Elements|trace elements|mesh-ancestor
83458334|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
83458335|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458336|NCT03019991|Ritonavir|ritonavir|mesh-list
83458337|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83458338|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83458339|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
83458340|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458341|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458342|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83458343|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83458344|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
83458345|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458346|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83458347|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83458348|NCT05307835|Molgramostim|molgramostim|mesh-list
83458349|NCT05307835|Sargramostim|sargramostim|mesh-list
83458350|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
83458351|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458352|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458353|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83458354|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458355|NCT03019835|Neostigmine|neostigmine|mesh-list
83458356|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83458357|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458358|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458359|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
83458361|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458362|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83458363|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
83458364|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458365|NCT00955877|Morphine|morphine|mesh-list
83458366|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83458367|NCT00955877|Narcotics|narcotics|mesh-ancestor
83458368|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458369|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458370|NCT00955877|Analgesics|analgesics|mesh-ancestor
83458371|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
83458373|NCT03960658|Ketamine|ketamine|mesh-list
83458374|NCT03960658|Analgesics|analgesics|mesh-ancestor
83458375|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
83458376|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458377|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458378|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83458379|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83458380|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
83458381|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
83458382|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458383|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83458384|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83458385|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458386|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458387|NCT01005407|Vaccines|vaccines|mesh-list
83458388|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
83458389|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458390|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
83458392|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83458393|NCT03633448|Expectorants|expectorants|mesh-ancestor
83458394|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
83458395|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83458396|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83458397|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
83458398|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458399|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458400|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458401|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
83458402|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83458403|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
83458404|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
83458405|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458407|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83458409|NCT05313958|Sorafenib|sorafenib|mesh-list
83458410|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
83458411|NCT05313958|Idarubicin|idarubicin|mesh-list
83458413|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83458414|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
83458415|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458417|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
83458418|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458419|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83458421|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458422|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83458423|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458426|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458427|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83458428|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83458429|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83458430|NCT01006655|Beclomethasone|beclomethasone|mesh-list
83458431|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458432|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
83458434|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83458435|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458436|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83458437|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
83458438|NCT03633526|Ivacaftor|ivacaftor|mesh-list
83458440|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83458441|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83458442|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458443|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
83458444|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458445|NCT03019523|Caffeine|caffeine|mesh-list
83458446|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83460184|NCT05609240|Cefuroxime axetil|cefuroxime axetil|mesh-list
83458447|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458448|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83458449|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458450|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458451|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83458452|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83458453|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
83458454|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458455|NCT01008059|Alfentanil|alfentanil|mesh-list
83458456|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83458457|NCT01008059|Narcotics|narcotics|mesh-ancestor
83458458|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458459|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458460|NCT01008059|Analgesics|analgesics|mesh-ancestor
83458461|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
83458462|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458463|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83458464|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
83458465|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
83458467|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83458468|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458469|NCT01010009|Resveratrol|resveratrol|mesh-list
83458470|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
83458471|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458472|NCT01010009|Protective Agents|protective agents|mesh-ancestor
83458473|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458474|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458475|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83458476|NCT04467424|Lidocaine|lidocaine|mesh-list
83458477|NCT04467424|Ketamine|ketamine|mesh-list
83458478|NCT04467424|Propofol|propofol|mesh-list
83458479|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
83458480|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
83458481|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458482|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458483|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
83458484|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458485|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83458486|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83458487|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83458488|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83458489|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458490|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83458491|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83458492|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
83458493|NCT04467424|Analgesics|analgesics|mesh-ancestor
83458494|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83458495|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83458496|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83458497|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458498|NCT03016715|Sirolimus|sirolimus|mesh-list
83458499|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83458500|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458501|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83458502|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458503|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
83458504|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83458505|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
83458506|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458507|NCT00377104|Alvocidib|alvocidib|mesh-list
83458508|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458509|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
83458510|NCT00377104|Growth Substances|growth substances|mesh-ancestor
83458511|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458512|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83458513|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460185|NCT05609240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83458514|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458516|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
83458517|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83458519|NCT03928522|Tobramycin|tobramycin|mesh-list
83458520|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458521|NCT01010399|Ritonavir|ritonavir|mesh-list
83458522|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
83458523|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83458524|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83458525|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
83458526|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458527|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458528|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83458529|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83458530|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
83458531|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458532|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83458533|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83458534|NCT03638908|Fluoxetine|fluoxetine|mesh-list
83458535|NCT03638908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83458536|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83458537|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83458538|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458539|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458540|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
83458541|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458542|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83458543|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
83458544|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83458545|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83458546|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83458547|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458548|NCT01041781|Celecoxib|celecoxib|mesh-list
83458549|NCT01041781|Carboplatin|carboplatin|mesh-list
83458550|NCT01041781|Gemcitabine|gemcitabine|mesh-list
83458551|NCT01041781|Pemetrexed|pemetrexed|mesh-list
83458552|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458553|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83458555|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458556|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458557|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83458558|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83458559|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83458560|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83458561|NCT01041781|Analgesics|analgesics|mesh-ancestor
83458562|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
83458563|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458564|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458565|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458566|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83458567|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83458568|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83458569|NCT01010477|Nicotine|nicotine|mesh-list
83458570|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83458571|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
83458572|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458573|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458574|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83458575|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83458576|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
83458577|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458578|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458580|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458581|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458582|NCT00953849|Calcitriol|calcitriol|mesh-list
83458583|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83458584|NCT00953849|Vitamin D|vitamin d|mesh-list
83458585|NCT00953849|Celecoxib|celecoxib|mesh-list
83458586|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83458587|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83458588|NCT00953849|Analgesics|analgesics|mesh-ancestor
83458589|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
83458590|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458591|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458593|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83458594|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83458595|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83458596|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458597|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458598|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83458599|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83458600|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83458601|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83458602|NCT00953849|Vitamins|vitamins|mesh-ancestor
83458603|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
83458604|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83458605|NCT04425850|Ivermectin|ivermectin|mesh-list
83458606|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83458607|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458608|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83458609|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83458610|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83458611|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83458612|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458613|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
83458614|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458615|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458616|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83458617|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458618|NCT01042795|Sunitinib|sunitinib|mesh-list
83458619|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458620|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83458621|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83458622|NCT01042795|Growth Substances|growth substances|mesh-ancestor
83458623|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458624|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
83458625|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83458626|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458627|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458628|NCT03644212|Vitamin D|vitamin d|mesh-list
83458629|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
83458630|NCT03644212|Vitamins|vitamins|mesh-list
83458632|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458633|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83458634|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83458635|NCT03906448|Temozolomide|temozolomide|mesh-list
83458636|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83458637|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
83458638|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458639|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458640|NCT01011413|Efavirenz|efavirenz|mesh-list
83458641|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83458642|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83458643|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458644|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458645|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
83458646|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458647|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83458648|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83458649|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83458650|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83458652|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83458653|NCT03889444|Dexamethasone|dexamethasone|mesh-list
83458654|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458655|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
83458656|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
83458657|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458658|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458659|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83458660|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
83458661|NCT03889444|Hormones|hormones|mesh-ancestor
83458662|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83458663|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83458664|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458665|NCT01104025|Dexamethasone|dexamethasone|mesh-list
83458666|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
83458667|NCT01104025|Methotrexate|methotrexate|mesh-list
83458668|NCT01104025|Etoposide|etoposide|mesh-list
83458669|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
83458670|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458672|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
83458673|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458674|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458675|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83458676|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
83458677|NCT01104025|Hormones|hormones|mesh-ancestor
83458678|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83458679|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83458680|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458681|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83458682|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
83458683|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83458684|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83458685|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
83458686|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458687|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
83458688|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458689|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83458690|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83458691|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
83458692|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83458693|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83458694|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83458695|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83458696|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83458697|NCT03649750|Guaifenesin|guaifenesin|mesh-list
83458698|NCT03649750|Expectorants|expectorants|mesh-ancestor
83458699|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
83458701|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83458702|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458703|NCT01105117|Epoprostenol|epoprostenol|mesh-list
83458704|NCT01105117|Tezosentan|tezosentan|mesh-list
83458705|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83458706|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83458707|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
83458708|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
83458709|NCT03885154|Valproic Acid|valproic acid|mesh-list
83458710|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
83458711|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458712|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458714|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458715|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458716|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
83458717|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83458718|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458719|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83458720|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83458721|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
83458722|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
83458723|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83458725|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
83458726|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458727|NCT01106833|Sirolimus|sirolimus|mesh-list
83458728|NCT01106833|Prednisone|prednisone|mesh-list
83458729|NCT01106833|Temsirolimus|temsirolimus|mesh-list
83458730|NCT01106833|MTOR Inhibitors|mtor inhibitors|mesh-list
83458731|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83458732|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458733|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
83458734|NCT01106833|Hormones|hormones|mesh-ancestor
83458735|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83458736|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458737|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83458738|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458739|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83458740|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458741|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83458742|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
83458744|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
83458745|NCT01106833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83458746|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458747|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458748|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83458749|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
83458750|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83458751|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83458752|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83458753|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458754|NCT00957359|Niacin|niacin|mesh-list
83458756|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83458757|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83458759|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458760|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83458761|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
83458762|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
83458763|NCT00957359|Vitamins|vitamins|mesh-ancestor
83458764|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
83458765|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458766|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
83458767|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83458768|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83458769|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
83458770|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458771|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83458773|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
83458774|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83458775|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458776|NCT00957671|Hormones|hormones|mesh-list
83458777|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83458778|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458779|NCT04322968|Ketorolac|ketorolac|mesh-list
83458780|NCT04322968|Ketamine|ketamine|mesh-list
83458781|NCT04322968|Analgesics|analgesics|mesh-ancestor
83458782|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
83458783|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458784|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458785|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83458786|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83458787|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
83458788|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
83458789|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458790|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83458791|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83458792|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458793|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458794|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83458795|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83458796|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458797|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83458798|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83458799|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458800|NCT03018899|Anesthetics|anesthetics|mesh-list
83458801|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458802|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458803|NCT00958919|Naloxone|naloxone|mesh-list
83458805|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83458806|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458807|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
83458808|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458809|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458810|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458811|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
83458812|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83458813|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83458815|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
83458816|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83458817|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
83458818|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458819|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
83458820|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
83458821|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458822|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458823|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83458824|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
83458826|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83458827|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83458828|NCT04323592|Protective Agents|protective agents|mesh-ancestor
83458829|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83458830|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458831|NCT01047241|Sufentanil|sufentanil|mesh-list
83458832|NCT01047241|Ketamine|ketamine|mesh-list
83458833|NCT01047241|Analgesics|analgesics|mesh-ancestor
83458834|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
83458835|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458836|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458837|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83458838|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83458839|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
83458841|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458842|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83458843|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83458844|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458845|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458846|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83458848|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83458850|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
83458851|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
83458852|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458853|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458854|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
83458855|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458856|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83458857|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83458858|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83458859|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83458860|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458862|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83458863|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458864|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83458865|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458866|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83458867|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458868|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458869|NCT03018821|Tenofovir|tenofovir|mesh-list
83458870|NCT03018821|Entecavir|entecavir|mesh-list
83458871|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
83458872|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458873|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83458874|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83458875|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458876|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458877|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83458878|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83458879|NCT03866434|Anagrelide|anagrelide|mesh-list
83458880|NCT03866434|Omeprazole|omeprazole|mesh-list
83458881|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83458882|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83458883|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83458884|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458885|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458886|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83458887|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83458888|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83458889|NCT00962039|Citalopram|citalopram|mesh-list
83458890|NCT00962039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83458891|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83458892|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83458893|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458894|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458895|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
83458896|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458897|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83458898|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
83458899|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83458900|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
83458901|NCT03375385|Propofol|propofol|mesh-list
83458902|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83458903|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458904|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458906|NCT03375385|Analgesics|analgesics|mesh-ancestor
83458907|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
83458908|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458909|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83458910|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83458911|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83458912|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
83458913|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458914|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458915|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83458916|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
83458918|NCT03018665|Metformin|metformin|mesh-list
83458919|NCT03018665|Exenatide|exenatide|mesh-list
83458920|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83458921|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458922|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83458923|NCT03018665|Incretins|incretins|mesh-ancestor
83458924|NCT03018665|Hormones|hormones|mesh-ancestor
83458925|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83458926|NCT03012763|Acetaminophen|acetaminophen|mesh-list
83458927|NCT03012763|Fexofenadine|fexofenadine|mesh-list
83458928|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
83458929|NCT03012763|Valsartan|valsartan|mesh-list
83458930|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83458931|NCT03012763|Analgesics|analgesics|mesh-ancestor
83458932|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
83458933|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458934|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458935|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
83458936|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83458937|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83458938|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83458939|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458940|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83458941|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83458942|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83458943|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
83458944|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
83458945|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458946|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458947|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83458948|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458949|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83458950|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83458951|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83458952|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83458953|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83458954|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460186|NCT05609240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458955|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458957|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458958|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83458959|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83458960|NCT01048879|Oseltamivir|oseltamivir|mesh-list
83458961|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
83458962|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83458963|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
83458964|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458965|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458966|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458967|NCT04290676|Dexamethasone|dexamethasone|mesh-list
83458968|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
83458969|NCT04290676|BB 1101|bb 1101|mesh-list
83458970|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458971|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
83458972|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
83458973|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458974|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458975|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83458976|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
83458977|NCT04290676|Hormones|hormones|mesh-ancestor
83460187|NCT00973739|Lapatinib|lapatinib|mesh-list
83458978|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83458979|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83458980|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458981|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
83458982|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458983|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458984|NCT03112993|Neostigmine|neostigmine|mesh-list
83458985|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83458986|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458987|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458988|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
83458989|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83458990|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458991|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83458992|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
83458993|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458994|NCT03670030|Sirolimus|sirolimus|mesh-list
83458995|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83458996|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83458997|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83458998|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458999|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
83459000|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459001|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
83459002|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459004|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
83459005|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459006|NCT03859960|Insulin|insulin|mesh-list
83459007|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83459008|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83459009|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459010|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83459011|NCT03857230|Hormones|hormones|mesh-ancestor
83459012|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83459013|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459014|NCT02181127|Glucagon|glucagon|mesh-list
83459015|NCT02181127|Pancrelipase|pancrelipase|mesh-list
83459016|NCT02181127|Pancreatin|pancreatin|mesh-list
83459017|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83459018|NCT02181127|Hormones|hormones|mesh-ancestor
83459019|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83459020|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459021|NCT04332094|Azithromycin|azithromycin|mesh-list
83459022|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
83459023|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83459024|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459025|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
83459026|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83459027|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83459028|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459029|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459030|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459031|NCT05314270|Copper|copper|mesh-list
83459032|NCT05314270|Trace Elements|trace elements|mesh-ancestor
83459033|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
83459034|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459036|NCT01167829|Acyline|acyline|mesh-list
83459037|NCT01167829|Androgens|androgens|mesh-ancestor
83459038|NCT01167829|Hormones|hormones|mesh-ancestor
83459039|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83459040|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459041|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
83459042|NCT02066623|Everolimus|everolimus|mesh-list
83459043|NCT02066623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83459044|NCT02066623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83459045|NCT02066623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459046|NCT02066623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459047|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459048|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
83459049|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459050|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459051|NCT04974151|Folic Acid|folic acid|mesh-list
83459052|NCT04974151|Amlodipine|amlodipine|mesh-list
83459053|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83459054|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83459056|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459057|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83459058|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459059|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
83459060|NCT04974151|Hematinics|hematinics|mesh-ancestor
83459061|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
83459062|NCT04974151|Vitamins|vitamins|mesh-ancestor
83459063|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
83459064|NCT01924819|Leucovorin|leucovorin|mesh-list
83459065|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83459066|NCT01924819|Cisplatin|cisplatin|mesh-list
83459067|NCT01924819|Docetaxel|docetaxel|mesh-list
83459068|NCT01924819|Fluorouracil|fluorouracil|mesh-list
83459069|NCT01924819|Capecitabine|capecitabine|mesh-list
83459070|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
83459071|NCT01924819|Epirubicin|epirubicin|mesh-list
83459072|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
83459073|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459074|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
83459075|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
83459076|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
83459077|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459078|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
83459079|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83459080|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459081|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
83459082|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459083|NCT01924819|Antidotes|antidotes|mesh-ancestor
83459084|NCT01924819|Protective Agents|protective agents|mesh-ancestor
83459085|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
83459086|NCT01924819|Vitamins|vitamins|mesh-ancestor
83459087|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
83459088|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83459089|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83459090|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83459091|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459092|NCT01168687|Levetiracetam|levetiracetam|mesh-list
83459093|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
83459094|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
83459095|NCT03685396|Hemostatics|hemostatics|mesh-list
83459096|NCT03685396|Coagulants|coagulants|mesh-ancestor
83459097|NCT01126255|Clobetasol|clobetasol|mesh-list
83459098|NCT01126255|Progesterone|progesterone|mesh-list
83459099|NCT01126255|Progestins|progestins|mesh-ancestor
83459100|NCT01126255|Hormones|hormones|mesh-ancestor
83459101|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83459102|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459103|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83459104|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
83459105|NCT04198948|Gliclazide|gliclazide|mesh-list
83459106|NCT04198948|Omeprazole|omeprazole|mesh-list
83459107|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83459108|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83459109|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83459110|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459111|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459112|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83459113|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459114|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
83459115|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83459116|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459117|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459118|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83459119|NCT01169467|Analgesics|analgesics|mesh-ancestor
83459120|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
83459121|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459122|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83459123|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83459124|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83459125|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
83459126|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459127|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459128|NCT04822363|Aspirin|aspirin|mesh-list
83459129|NCT04822363|Clopidogrel|clopidogrel|mesh-list
83459130|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83459131|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83459132|NCT04822363|Analgesics|analgesics|mesh-ancestor
83459134|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459135|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459136|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83459137|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459138|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83459139|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83459140|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459141|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83459142|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83459143|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459145|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83459146|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83459147|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83459148|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
83459149|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459150|NCT01170247|Ketamine|ketamine|mesh-list
83459151|NCT01170247|Analgesics|analgesics|mesh-ancestor
83459152|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
83459153|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459154|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459155|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83459156|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83459157|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
83459158|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
83459159|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459160|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83459161|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83459162|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459163|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459165|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83459166|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83459167|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83459168|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83459169|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
83459170|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459171|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459172|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459173|NCT01170715|Etanercept|etanercept|mesh-list
83459174|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83459175|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83459176|NCT01170715|Analgesics|analgesics|mesh-ancestor
83459177|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
83459178|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459179|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459180|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83459181|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459182|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83459183|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459184|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
83459185|NCT03809182|Fentanyl|fentanyl|mesh-list
83459186|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
83459187|NCT03809182|Morphine|morphine|mesh-list
83459188|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83459189|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459190|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459191|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83459192|NCT03809182|Analgesics|analgesics|mesh-ancestor
83459193|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
83459194|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459195|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83459196|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83459197|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83459198|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
83459199|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459200|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459201|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83459202|NCT03809182|Narcotics|narcotics|mesh-ancestor
83459203|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83459204|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83459205|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
83459206|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
83459207|NCT01170949|Miltefosine|miltefosine|mesh-list
83459208|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
83459209|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459210|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459211|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83459212|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83459213|NCT03805672|Enoxaparin|enoxaparin|mesh-list
83459214|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
83459215|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
83459216|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83459217|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83459218|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459220|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
83459221|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
83459222|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459223|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459224|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
83459225|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459226|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
83459227|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
83459228|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83459229|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83459230|NCT03797872|Prednisolone|prednisolone|mesh-list
83459231|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
83459232|NCT03797872|Triamcinolone|triamcinolone|mesh-list
83459233|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83459234|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83459235|NCT03797872|Methotrexate|methotrexate|mesh-list
83459236|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83459237|NCT03797872|Leflunomide|leflunomide|mesh-list
83459239|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
83459240|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83459241|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
83459242|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83459243|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459244|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83459245|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
83459246|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459247|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459248|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
83459249|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459250|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83459251|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459252|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
83459253|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459254|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83459255|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83459256|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
83459257|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
83459258|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459259|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83459260|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
83459261|NCT03797872|Hormones|hormones|mesh-ancestor
83459262|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83459263|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83459264|NCT03797872|Protective Agents|protective agents|mesh-ancestor
83459265|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83459266|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459267|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83459268|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83459269|NCT03797872|Analgesics|analgesics|mesh-ancestor
83459270|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
83459271|NCT01127581|Dinoprostone|dinoprostone|mesh-list
83459272|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
83459273|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83459274|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459275|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
83459276|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83459277|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83459278|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459279|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459280|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
83459281|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
83459282|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83459283|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459284|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459285|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83459287|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
83459288|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459289|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83459290|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83459292|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
83459293|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459294|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459295|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
83459296|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83459297|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
83459298|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83459299|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83459300|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83459301|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
83459302|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83459303|NCT02186665|Calcitriol|calcitriol|mesh-list
83459304|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83459305|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459306|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83459307|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83459308|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459309|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83459310|NCT02186665|Vitamins|vitamins|mesh-ancestor
83459311|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
83459312|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83459313|NCT01172197|Ropivacaine|ropivacaine|mesh-list
83459314|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
83459315|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
83459317|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459318|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459319|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
83459320|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459321|NCT04141930|Baloxavir|baloxavir|mesh-list
83459322|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
83459323|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459324|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459325|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459326|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83459327|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83459328|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459329|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83459330|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83459331|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83459332|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459333|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
83459334|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459335|NCT03746002|Metolazone|metolazone|mesh-list
83459336|NCT03746002|Furosemide|furosemide|mesh-list
83459337|NCT03746002|Diuretics|diuretics|mesh-ancestor
83459338|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
83459339|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460188|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459340|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83459341|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83459342|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459343|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83459344|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83459345|NCT04089982|Varenicline|varenicline|mesh-list
83459346|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83459347|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83459348|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
83459349|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459350|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459351|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459352|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83459353|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
83459354|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83459355|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
83459356|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459357|NCT03783130|Antacids|antacids|mesh-ancestor
83459358|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459359|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83459360|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83459361|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83459363|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459365|NCT00983918|Propofol|propofol|mesh-list
83459366|NCT00983918|Sevoflurane|sevoflurane|mesh-list
83459367|NCT00983918|Desflurane|desflurane|mesh-list
83459368|NCT00983918|Isoflurane|isoflurane|mesh-list
83459369|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83459370|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459371|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459372|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83459373|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
83459374|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
83459375|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83459376|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83459377|NCT01926236|Leucovorin|leucovorin|mesh-list
83459378|NCT01926236|Folic Acid|folic acid|mesh-list
83459379|NCT01926236|Fluorouracil|fluorouracil|mesh-list
83459380|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
83459381|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
83459382|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
83459383|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459384|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83459385|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459386|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459387|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
83459388|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459389|NCT01926236|Antidotes|antidotes|mesh-ancestor
83459390|NCT01926236|Protective Agents|protective agents|mesh-ancestor
83459391|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
83459392|NCT01926236|Vitamins|vitamins|mesh-ancestor
83459393|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
83459394|NCT01926236|Hematinics|hematinics|mesh-ancestor
83459395|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
83459396|NCT00983528|Clofarabine|clofarabine|mesh-list
83459397|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83459398|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459399|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83459400|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
83459401|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459402|NCT00983372|Colchicine|colchicine|mesh-list
83459403|NCT00983372|Diltiazem|diltiazem|mesh-list
83459404|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
83459405|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459406|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
83459407|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
83459408|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
83459409|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459410|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459411|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83459412|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83459413|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83459414|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83459415|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459416|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
83459418|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
83459419|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459420|NCT00983294|Azithromycin|azithromycin|mesh-list
83459421|NCT00983294|Colchicine|colchicine|mesh-list
83459422|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83459423|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459424|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
83459425|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459426|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
83459427|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
83459428|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
83459429|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459430|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459431|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
83459432|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83459433|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83459434|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459435|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83459436|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83459437|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
83459438|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83459439|NCT05601830|Cytarabine|cytarabine|mesh-list
83459440|NCT05601830|Cyclophosphamide|cyclophosphamide|mesh-list
83459441|NCT05601830|Fludarabine|fludarabine|mesh-list
83459442|NCT05601830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459443|NCT05601830|Immunologic Factors|immunologic factors|mesh-ancestor
83459444|NCT05601830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459445|NCT05601830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459446|NCT05601830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83459447|NCT05601830|Alkylating Agents|alkylating agents|mesh-ancestor
83459448|NCT05601830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459449|NCT05601830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459450|NCT05601830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83459451|NCT05601830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83459452|NCT05601830|Antimetabolites|antimetabolites|mesh-ancestor
83459453|NCT05601830|Antiviral Agents|antiviral agents|mesh-ancestor
83459454|NCT05601830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459455|NCT00982280|Tapentadol|tapentadol|mesh-list
83459456|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83459457|NCT00982280|Narcotics|narcotics|mesh-ancestor
83459458|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459459|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459460|NCT00982280|Analgesics|analgesics|mesh-ancestor
83459461|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
83459462|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459463|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83459464|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83459465|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83459466|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459467|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
83459468|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459469|NCT01175395|Triamcinolone|triamcinolone|mesh-list
83459470|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83459471|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83459472|NCT01175395|Ranibizumab|ranibizumab|mesh-list
83459473|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83459474|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83459475|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
83459476|NCT01175395|Hormones|hormones|mesh-ancestor
83459477|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83459478|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459479|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459480|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
83459481|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459482|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459483|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83459484|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83459485|NCT01175395|Growth Substances|growth substances|mesh-ancestor
83459486|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
83459487|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459488|NCT03011905|Acetaminophen|acetaminophen|mesh-list
83459489|NCT03011905|Dexamethasone|dexamethasone|mesh-list
83459490|NCT03011905|Etoricoxib|etoricoxib|mesh-list
83459491|NCT03011905|Oxycodone|oxycodone|mesh-list
83459493|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83459495|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
83459496|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459497|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459498|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83459499|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
83459500|NCT03011905|Hormones|hormones|mesh-ancestor
83460189|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83459501|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83459502|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83459503|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459504|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
83459505|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
83459506|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459507|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
83459508|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83459509|NCT03011905|Analgesics|analgesics|mesh-ancestor
83459510|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
83459511|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83459512|NCT03011905|Narcotics|narcotics|mesh-ancestor
83459513|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83459514|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459515|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83460190|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459516|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83459517|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459518|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459520|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459521|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83459522|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459523|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459524|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83459525|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
83459526|NCT00980798|Hydromorphone|hydromorphone|mesh-list
83459527|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83459528|NCT00980798|Narcotics|narcotics|mesh-ancestor
83459529|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459530|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459531|NCT00980798|Analgesics|analgesics|mesh-ancestor
83459532|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
83459533|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459534|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
83459535|NCT01177189|Vitamins|vitamins|mesh-ancestor
83459536|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
83459537|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459538|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
83459539|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459540|NCT01177189|Protective Agents|protective agents|mesh-ancestor
83459541|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
83459542|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83459543|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
83459544|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459545|NCT01177735|Pomalidomide|pomalidomide|mesh-list
83459546|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
83459547|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459548|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83459549|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83459550|NCT01177735|Growth Substances|growth substances|mesh-ancestor
83459551|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
83459552|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459553|NCT01135069|Tretinoin|tretinoin|mesh-list
83459554|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459555|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
83459556|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
83459557|NCT01178281|Thalidomide|thalidomide|mesh-list
83459558|NCT01178281|Pomalidomide|pomalidomide|mesh-list
83459559|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
83459560|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459561|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83459562|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83459563|NCT01178281|Growth Substances|growth substances|mesh-ancestor
83459564|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
83459565|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459566|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459567|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
83459568|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83459569|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459570|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
83459571|NCT01178827|Oxybutynin|oxybutynin|mesh-list
83459572|NCT01178827|Trospium chloride|trospium chloride|mesh-list
83459573|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
83459574|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
83459575|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459576|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459577|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83459578|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83459579|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
83459580|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459581|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459582|NCT01178827|Urological Agents|urological agents|mesh-ancestor
83459583|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83459584|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459585|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
83459586|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83459587|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
83459588|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459589|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459590|NCT02181517|Ranibizumab|ranibizumab|mesh-list
83459591|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83459592|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83459593|NCT02181517|Growth Substances|growth substances|mesh-ancestor
83459594|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459595|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
83459596|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459597|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83459598|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83459599|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
83459600|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83459601|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459602|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83459603|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83459604|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83459606|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
83459607|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459608|NCT03872947|Leucovorin|leucovorin|mesh-list
83459609|NCT03872947|Bevacizumab|bevacizumab|mesh-list
83459610|NCT03872947|Carboplatin|carboplatin|mesh-list
83459611|NCT03872947|Gemcitabine|gemcitabine|mesh-list
83459612|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
83459613|NCT03872947|Nivolumab|nivolumab|mesh-list
83459614|NCT03872947|Irinotecan|irinotecan|mesh-list
83459615|NCT03872947|Topotecan|topotecan|mesh-list
83459616|NCT03872947|Imiquimod|imiquimod|mesh-list
83459617|NCT03872947|Ramucirumab|ramucirumab|mesh-list
83459618|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459619|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459620|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83459621|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83459622|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83459623|NCT03872947|Growth Substances|growth substances|mesh-ancestor
83459624|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459625|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
83459626|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83459627|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
83459628|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83459629|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83459630|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83459631|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459632|NCT03872947|Antidotes|antidotes|mesh-ancestor
83459633|NCT03872947|Protective Agents|protective agents|mesh-ancestor
83459634|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
83459635|NCT03872947|Vitamins|vitamins|mesh-ancestor
83459636|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
83459637|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83459638|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
83459639|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
83459640|NCT02246881|Factor VIII|factor viii|mesh-list
83459641|NCT02246881|Coagulants|coagulants|mesh-ancestor
83459642|NCT00980330|Ribavirin|ribavirin|mesh-list
83459643|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83459644|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
83459645|NCT00980330|Simeprevir|simeprevir|mesh-list
83459646|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
83459647|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459648|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
83459649|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459650|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459651|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
83459652|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459653|NCT01138735|Adapalene|adapalene|mesh-list
83459654|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
83459655|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83459656|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
83459657|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83459658|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83459659|NCT01138735|Analgesics|analgesics|mesh-ancestor
83459660|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
83459661|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459662|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459663|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83459664|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459665|NCT00980174|Denosumab|denosumab|mesh-list
83459666|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83459667|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459668|NCT03064568|Misoprostol|misoprostol|mesh-list
83459669|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83459670|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
83459671|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83459672|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459673|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83459674|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83459675|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
83459676|NCT01138969|Esomeprazole|esomeprazole|mesh-list
83459677|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83459678|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83459679|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83459680|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459681|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459682|NCT01139515|Eletriptan|eletriptan|mesh-list
83459683|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83459684|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
83459685|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459686|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459687|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459688|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83459689|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83459690|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83459691|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83459692|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83459693|NCT00987272|Analgesics|analgesics|mesh-ancestor
83459694|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
83459695|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459696|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459697|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83459698|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459699|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83459700|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83459701|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83459702|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
83459703|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
83459704|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459705|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459707|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83459708|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459709|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
83459710|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83459711|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83459712|NCT00986882|Ibuprofen|ibuprofen|mesh-list
83459713|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83459714|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83459715|NCT00986882|Analgesics|analgesics|mesh-ancestor
83459716|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
83459717|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459718|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459719|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83459720|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459721|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83459722|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459723|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459724|NCT00981656|Fluorouracil|fluorouracil|mesh-list
83459725|NCT00981656|Mitomycins|mitomycins|mesh-list
83459726|NCT00981656|Mitomycin|mitomycin|mesh-list
83459727|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459728|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
83459729|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459730|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83459731|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459732|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
83459733|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459734|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83459735|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
83459736|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83459737|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459738|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
83459739|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83459740|NCT04395170|Antibodies|antibodies|mesh-list
83459741|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
83459742|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459743|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83459746|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
83459747|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459748|NCT01927406|Timolol|timolol|mesh-list
83459749|NCT01927406|Bimatoprost|bimatoprost|mesh-list
83459750|NCT01927406|Travoprost|travoprost|mesh-list
83459751|NCT01927406|Latanoprost|latanoprost|mesh-list
83459752|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459753|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83459754|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83459755|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
83459756|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459757|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459758|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83459759|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83459760|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83459761|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83459762|NCT01182493|Insulin|insulin|mesh-list
83459763|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83459764|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459765|NCT01927484|Methotrexate|methotrexate|mesh-list
83459766|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83459767|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
83459768|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83459769|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459770|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83459771|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
83459772|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459773|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459774|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
83459775|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459776|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83459777|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459778|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
83459779|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459780|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83459781|NCT05607446|Montelukast|montelukast|mesh-list
83459782|NCT05607446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83459783|NCT05607446|Respiratory System Agents|respiratory system agents|mesh-ancestor
83459784|NCT05607446|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83459785|NCT05607446|Hormone Antagonists|hormone antagonists|mesh-ancestor
83459786|NCT05607446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83459787|NCT05607446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459788|NCT05607446|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83459789|NCT05607446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83459790|NCT05607446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459791|NCT02185339|Rocuronium|rocuronium|mesh-list
83459792|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83459793|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83459794|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83459795|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459796|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459797|NCT03831464|Metformin|metformin|mesh-list
83459798|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83459799|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459800|NCT01928498|Paclitaxel|paclitaxel|mesh-list
83459801|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83459802|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459803|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
83459804|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
83459805|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
83459806|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459807|NCT04558502|Amoxicillin|amoxicillin|mesh-list
83459808|NCT04558502|Clarithromycin|clarithromycin|mesh-list
83459809|NCT04558502|Minocycline|minocycline|mesh-list
83459810|NCT04558502|Esomeprazole|esomeprazole|mesh-list
83459811|NCT04558502|Bismuth|bismuth|mesh-list
83459812|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83459813|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459814|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83459815|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83459816|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83459817|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459818|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459819|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83459820|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83459821|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83459823|NCT01218997|Naltrexone|naltrexone|mesh-list
83459824|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83459825|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83459826|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459827|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
83459828|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459829|NCT01219777|Paclitaxel|paclitaxel|mesh-list
83459830|NCT01219777|Bevacizumab|bevacizumab|mesh-list
83459831|NCT01219777|Carboplatin|carboplatin|mesh-list
83459832|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83459833|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459834|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
83459835|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
83459836|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
83459837|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459838|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83459839|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83459840|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83459841|NCT01219777|Growth Substances|growth substances|mesh-ancestor
83459842|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459843|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
83459844|NCT05603156|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83459845|NCT05603156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83459846|NCT05603156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459847|NCT05603156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83459848|NCT05603156|Immunotoxins|immunotoxins|mesh-ancestor
83459849|NCT05603156|Immunoconjugates|immunoconjugates|mesh-ancestor
83459850|NCT05603156|Immunologic Factors|immunologic factors|mesh-ancestor
83459851|NCT05603156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459852|NCT04759742|Ropivacaine|ropivacaine|mesh-list
83459853|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
83459854|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
83459855|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459856|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459857|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
83459858|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459859|NCT01928888|Famotidine|famotidine|mesh-list
83459860|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
83459861|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83459862|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83459863|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83459864|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
83459865|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
83459866|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459867|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459868|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459869|NCT01928888|Antacids|antacids|mesh-ancestor
83459870|NCT04556084|Blinatumomab|blinatumomab|mesh-list
83459871|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459872|NCT04394234|Warfarin|warfarin|mesh-list
83459873|NCT04394234|Anticoagulants|anticoagulants|mesh-list
83459874|NCT02569710|Simeprevir|simeprevir|mesh-list
83459875|NCT02569710|Odalasvir|odalasvir|mesh-list
83459876|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
83459877|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459878|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
83459879|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459880|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459881|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
83459882|NCT04550624|Lenvatinib|lenvatinib|mesh-list
83459883|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83459884|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459885|NCT04550624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83459886|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459887|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83459888|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459889|NCT04550546|Nystatin|nystatin|mesh-list
83459890|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83459891|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459892|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
83459893|NCT04550546|Ionophores|ionophores|mesh-ancestor
83459894|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83459895|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459897|NCT04885998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459898|NCT02984072|Menthol|menthol|mesh-list
83459899|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
83459900|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
83459901|NCT04589832|Entrectinib|entrectinib|mesh-list
83459902|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83459903|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459904|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459905|NCT05506410|Cytarabine|cytarabine|mesh-list
83459906|NCT05506410|Prednisone|prednisone|mesh-list
83459907|NCT05506410|Rituximab|rituximab|mesh-list
83459908|NCT05506410|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83459909|NCT05506410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83459910|NCT05506410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459911|NCT05506410|Immunologic Factors|immunologic factors|mesh-ancestor
83459912|NCT05506410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459913|NCT05506410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459914|NCT05506410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83459915|NCT05506410|Glucocorticoids|glucocorticoids|mesh-ancestor
83459916|NCT05506410|Hormones|hormones|mesh-ancestor
83459917|NCT05506410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83459918|NCT05506410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83459919|NCT05506410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83459920|NCT05506410|Antimetabolites|antimetabolites|mesh-ancestor
83459921|NCT05506410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459922|NCT05506410|Antiviral Agents|antiviral agents|mesh-ancestor
83459923|NCT05506410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459924|NCT05506410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459925|NCT05506410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83459926|NCT05506410|Alkylating Agents|alkylating agents|mesh-ancestor
83459927|NCT05506332|Venetoclax|venetoclax|mesh-list
83459928|NCT05506332|Mercaptopurine|mercaptopurine|mesh-list
83459929|NCT05506332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459931|NCT05506332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459932|NCT05506332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83459933|NCT05506332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83459934|NCT05506332|Immunologic Factors|immunologic factors|mesh-ancestor
83459935|NCT05506332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459936|NCT05506332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83459937|NCT05506332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459938|NCT01927874|Bupivacaine|bupivacaine|mesh-list
83459939|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
83459940|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
83459941|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459942|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459943|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
83459944|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459945|NCT05604638|Tenecteplase|tenecteplase|mesh-list
83459946|NCT05604638|Tirofiban|tirofiban|mesh-list
83459947|NCT05604638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83459948|NCT05604638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83459949|NCT05604638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459950|NCT05604638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83459951|NCT05609630|Upadacitinib|upadacitinib|mesh-list
83459952|NCT05609630|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83459953|NCT05609630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83459954|NCT05609630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459955|NCT05609630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459956|NCT05609630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83459957|NCT03033758|Budesonide|budesonide|mesh-list
83459958|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
83459959|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83459960|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83459961|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
83459962|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83459963|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459964|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83459965|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
83459966|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
83459967|NCT03033758|Hormones|hormones|mesh-ancestor
83459968|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83459969|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83459970|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83459971|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83459972|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
83459973|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83459974|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459975|NCT01016483|Gemcitabine|gemcitabine|mesh-list
83459976|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83459977|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
83459978|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459979|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459980|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
83459981|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
83459982|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83459983|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459984|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83459985|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459986|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459987|NCT00955253|Guanfacine|guanfacine|mesh-list
83459988|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83459989|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83459990|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83459991|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83459992|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83459993|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480287|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
83459994|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83459995|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459996|NCT04394390|Vitamin D|vitamin d|mesh-list
83459997|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
83459998|NCT04394390|Cholecalciferol|cholecalciferol|mesh-list
83459999|NCT04394390|Vitamins|vitamins|mesh-list
83460000|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
83460001|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460002|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83460003|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83460004|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83460005|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
83460006|NCT04120454|Ramucirumab|ramucirumab|mesh-list
83460007|NCT04120454|Antibodies|antibodies|mesh-list
83460008|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
83460009|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83460010|NCT04120454|Lexatumumab|lexatumumab|mesh-list
83460011|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
83460012|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460013|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460014|NCT04120454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83460015|NCT04120454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460016|NCT01017653|Irinotecan|irinotecan|mesh-list
83460017|NCT01017653|Panitumumab|panitumumab|mesh-list
83460018|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83460019|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83460020|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460021|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460022|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460023|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460024|NCT00966641|Naproxen|naproxen|mesh-list
83460025|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83460026|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83460027|NCT00966641|Analgesics|analgesics|mesh-ancestor
83460028|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
83460029|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460030|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460031|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83460032|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83460033|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
83460034|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83460035|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460036|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460037|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
83460038|NCT00970073|Tacrolimus|tacrolimus|mesh-list
83460039|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
83460040|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83460041|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83460042|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
83460043|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460044|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83460045|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460046|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460047|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83460048|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460049|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83460050|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
83460051|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83460052|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460053|NCT00971633|Ondansetron|ondansetron|mesh-list
83460054|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
83460055|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
83460056|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460057|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460058|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83460059|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
83460060|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
83460061|NCT00971633|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83460062|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83460063|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
83460065|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460066|NCT05511246|Ethanol|ethanol|mesh-list
83460067|NCT05511246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83460068|NCT05511246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460069|NCT05511246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460070|NCT05511246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460071|NCT00971789|Sirolimus|sirolimus|mesh-list
83460072|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83460073|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83460074|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460075|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83460076|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460077|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
83460078|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83460079|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
83460080|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460081|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460082|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83460084|NCT05510778|Antidotes|antidotes|mesh-ancestor
83460085|NCT05510778|Protective Agents|protective agents|mesh-ancestor
83460086|NCT05510778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460087|NCT00972335|Bevacizumab|bevacizumab|mesh-list
83460088|NCT00972335|Everolimus|everolimus|mesh-list
83460089|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460091|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83460092|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83460093|NCT00972335|Growth Substances|growth substances|mesh-ancestor
83460094|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460095|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
83460096|NCT00972335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83460097|NCT00972335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83460098|NCT00972335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460099|NCT00972335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460100|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83460101|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
83460102|NCT02337530|Carboplatin|carboplatin|mesh-list
83460104|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460105|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460106|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460107|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83460108|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83460109|NCT03341156|Thrombin|thrombin|mesh-list
83460110|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
83460111|NCT03341156|Coagulants|coagulants|mesh-ancestor
83460112|NCT04122560|Fluconazole|fluconazole|mesh-list
83460113|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
83460114|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460115|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83460116|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83460117|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460118|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460119|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83460120|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
83460121|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83460122|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460123|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83460124|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83460126|NCT02569242|Docetaxel|docetaxel|mesh-list
83460127|NCT02569242|Nivolumab|nivolumab|mesh-list
83460128|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83460129|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460130|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
83460131|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
83460132|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
83460133|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460134|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460135|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83460136|NCT04124588|Hemostatics|hemostatics|mesh-list
83460137|NCT04124588|Coagulants|coagulants|mesh-ancestor
83460138|NCT05501340|Molgramostim|molgramostim|mesh-list
83460139|NCT05501340|Sargramostim|sargramostim|mesh-list
83460140|NCT05501340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460141|NCT05501340|Immunologic Factors|immunologic factors|mesh-ancestor
83460142|NCT05501340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460143|NCT00972725|Chloroquine|chloroquine|mesh-list
83460144|NCT00972725|Amebicides|amebicides|mesh-ancestor
83460145|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83460146|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83460147|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460148|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
83460149|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83460150|NCT05600660|Rituximab|rituximab|mesh-list
83460151|NCT05600660|Methotrexate|methotrexate|mesh-list
83460152|NCT05600660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460153|NCT05600660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460154|NCT05600660|Immunologic Factors|immunologic factors|mesh-ancestor
83460155|NCT05600660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460156|NCT05600660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83460157|NCT05600660|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83460158|NCT05600660|Abortifacient Agents|abortifacient agents|mesh-ancestor
83460159|NCT05600660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83460160|NCT05600660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83460161|NCT05600660|Antimetabolites|antimetabolites|mesh-ancestor
83460210|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460211|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
83460212|NCT03017963|Antidotes|antidotes|mesh-ancestor
83460213|NCT03017963|Protective Agents|protective agents|mesh-ancestor
83460214|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460215|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
83460216|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460217|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
83460218|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83460219|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460221|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
83460222|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83460223|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
83460224|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460226|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83460227|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83460228|NCT04129424|Insulin|insulin|mesh-list
83460229|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83460230|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460231|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
83460232|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83460233|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
83460234|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460235|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460236|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83460237|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
83460238|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83460239|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
83460240|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460241|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460242|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83460243|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
83460244|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
83460245|NCT00955487|Protective Agents|protective agents|mesh-ancestor
83460246|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
83460248|NCT04120922|Sevelamer|sevelamer|mesh-list
83460249|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83460250|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460251|NCT04120922|Antacids|antacids|mesh-ancestor
83460252|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460253|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83460254|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
83460255|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
83460256|NCT01663740|Valganciclovir|valganciclovir|mesh-list
83460257|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
83460258|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460259|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
83460260|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83460261|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
83460262|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460263|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
83460264|NCT02984228|Protective Agents|protective agents|mesh-ancestor
83460265|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83460266|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83460267|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83460268|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
83460269|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460270|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83460271|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83460272|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460274|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83460275|NCT03828032|Diuretics|diuretics|mesh-ancestor
83460276|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
83460277|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460278|NCT03827876|Calcitriol|calcitriol|mesh-list
83460279|NCT03827876|Betamethasone|betamethasone|mesh-list
83460280|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83460282|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83460283|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
83460284|NCT03827876|Hormones|hormones|mesh-ancestor
83460285|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83460286|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460287|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83460288|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
83460289|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83460290|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83460291|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83460292|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460293|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83460295|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
83460296|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83460297|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
83460298|NCT03898934|Vitamin D|vitamin d|mesh-list
83460299|NCT03898934|Vitamins|vitamins|mesh-ancestor
83460300|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
83460301|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460302|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83460303|NCT04128800|Apatinib|apatinib|mesh-list
83460304|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460305|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83460306|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460307|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460308|NCT04129112|Propofol|propofol|mesh-list
83460309|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
83460310|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460311|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460312|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83460313|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83460314|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
83460316|NCT01608893|Carvedilol|carvedilol|mesh-list
83460317|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83460318|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83460319|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
83460320|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
83476341|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
83460321|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460322|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460323|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83460324|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83460325|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83460326|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
83460327|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460328|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460329|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
83460330|NCT01608893|Protective Agents|protective agents|mesh-ancestor
83460331|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83460332|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83460333|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83460334|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
83460335|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83460336|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83460337|NCT04128878|Sotalol|sotalol|mesh-list
83460338|NCT04128878|Dofetilide|dofetilide|mesh-list
83460339|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83460340|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83460341|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
83460342|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460343|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460344|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460345|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83460346|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
83460347|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
83460348|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460349|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83460350|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83460351|NCT00979745|Afamelanotide|afamelanotide|mesh-list
83460352|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
83460353|NCT00042341|Clofarabine|clofarabine|mesh-list
83460354|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83460355|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
83460356|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460357|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460358|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83460359|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
83460360|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
83460361|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460363|NCT04759196|Levetiracetam|levetiracetam|mesh-list
83460364|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
83460365|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83460366|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460367|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
83460368|NCT04128254|Apixaban|apixaban|mesh-list
83460369|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83460370|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
83460371|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83460372|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
83460373|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460374|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460375|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
83460376|NCT04128020|Nivolumab|nivolumab|mesh-list
83460377|NCT04128020|Azacitidine|azacitidine|mesh-list
83460378|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460379|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460380|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83460381|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460382|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83460383|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
83460384|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460386|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83460387|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460388|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
83460389|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460390|NCT05510310|Oxytocin|oxytocin|mesh-list
83460391|NCT05510310|Oxytocics|oxytocics|mesh-ancestor
83460392|NCT05510310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83460393|NCT05510310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460394|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83460395|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
83476342|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
83460396|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83460397|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83460398|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83460399|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460401|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83460402|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460403|NCT04411524|Capecitabine|capecitabine|mesh-list
83460404|NCT04411524|Irinotecan|irinotecan|mesh-list
83460405|NCT04411524|Antibodies|antibodies|mesh-list
83460406|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
83460407|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460408|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83460409|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
83460410|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460411|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460412|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83460413|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83460414|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460415|NCT04127396|Sorafenib|sorafenib|mesh-list
83460416|NCT04127396|Lenvatinib|lenvatinib|mesh-list
83460417|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
83460418|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460419|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83460420|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460421|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460422|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83460423|NCT04127396|Estrogens|estrogens|mesh-ancestor
83460424|NCT04127396|Hormones|hormones|mesh-ancestor
83476343|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
83460425|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83460426|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460427|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83460428|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
83460430|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83460431|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460432|NCT04120064|Vitamins|vitamins|mesh-ancestor
83460433|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
83460434|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83460435|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
83460436|NCT00982007|Hematinics|hematinics|mesh-ancestor
83460437|NCT04814940|Menotropins|menotropins|mesh-list
83460438|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83460439|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
83460440|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83460441|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460442|NCT05042934|Irinotecan|irinotecan|mesh-list
83460443|NCT05042934|Camptothecin|camptothecin|mesh-list
83460444|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83460445|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83460446|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460447|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460448|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460449|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83460451|NCT05505006|Vitamin B 12|vitamin b 12|mesh-list
83460452|NCT05505006|Hematinics|hematinics|mesh-ancestor
83460453|NCT05505006|Vitamin B Complex|vitamin b complex|mesh-ancestor
83460454|NCT05505006|Vitamins|vitamins|mesh-ancestor
83460455|NCT05505006|Micronutrients|micronutrients|mesh-ancestor
83460456|NCT05505006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460458|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
83460459|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
83460460|NCT02979548|Ondansetron|ondansetron|mesh-list
83460461|NCT02979548|Aprepitant|aprepitant|mesh-list
83460462|NCT02979548|Metoclopramide|metoclopramide|mesh-list
83460463|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
83460464|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
83460465|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460466|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460467|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83460468|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
83460469|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
83460470|NCT02979548|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83460471|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83460472|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
83460473|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460474|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460475|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83460476|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83460477|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83460479|NCT03821246|Atezolizumab|atezolizumab|mesh-list
83460480|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83460481|NCT03821246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83460482|NCT03821246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460483|NCT03821246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83476371|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83460484|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460485|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
83460486|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460487|NCT03826316|Nalbuphine|nalbuphine|mesh-list
83460488|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83460489|NCT03826316|Narcotics|narcotics|mesh-ancestor
83460490|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460491|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460492|NCT03826316|Analgesics|analgesics|mesh-ancestor
83460493|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
83460494|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460495|NCT04393610|Lidocaine|lidocaine|mesh-list
83460496|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
83460497|NCT04393610|Fentanyl|fentanyl|mesh-list
83460498|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
83460499|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
83460500|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460501|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460502|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
83460503|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460504|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83460505|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83460506|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83460507|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83460508|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460509|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83460510|NCT04393610|Narcotics|narcotics|mesh-ancestor
83460511|NCT04393610|Analgesics|analgesics|mesh-ancestor
83460512|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83460513|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83460514|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
83460515|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
83460516|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83460517|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83460518|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
83460519|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83460520|NCT03820466|Aspirin|aspirin|mesh-list
83460521|NCT03820466|Atorvastatin|atorvastatin|mesh-list
83460522|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83460523|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83460524|NCT03820466|Analgesics|analgesics|mesh-ancestor
83460525|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
83460526|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460527|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460528|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83460529|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83460530|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83460531|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83460532|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460533|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83460534|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83460535|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460536|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
83460537|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83460538|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83460539|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
83460540|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83476344|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460541|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83460542|NCT03826004|Clemastine|clemastine|mesh-list
83460543|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
83460544|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
83460545|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83460546|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
83460547|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
83460548|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460549|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460550|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460551|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83460553|NCT02338076|Emollients|emollients|mesh-ancestor
83460554|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
83460555|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83460556|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
83460557|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83460558|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83460559|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83460560|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460561|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460562|NCT01222117|Plasminogen|plasminogen|mesh-list
83460563|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83460565|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83460566|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83460567|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460568|NCT03825380|Bimatoprost|bimatoprost|mesh-list
83460569|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83460570|NCT01222195|Lenalidomide|lenalidomide|mesh-list
83460571|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
83460572|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
83460573|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460574|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83460575|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83460577|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
83460578|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460579|NCT01222195|Hematinics|hematinics|mesh-ancestor
83460580|NCT01222273|Vitamin D|vitamin d|mesh-list
83460581|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
83460582|NCT01222273|Vitamins|vitamins|mesh-ancestor
83460583|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
83460584|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460585|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83460586|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83460587|NCT03161912|Aflibercept|aflibercept|mesh-list
83460588|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83460589|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83460590|NCT03161912|Growth Substances|growth substances|mesh-ancestor
83460591|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460592|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
83460593|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460594|NCT01222585|Metronidazole|metronidazole|mesh-list
83460595|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460596|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83460597|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83460598|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83460599|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83476373|NCT01089569|Hormones|hormones|mesh-ancestor
83460600|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
83460601|NCT03829592|Misoprostol|misoprostol|mesh-list
83460602|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83460603|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
83460604|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83460605|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460606|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83460608|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
83460609|NCT01142323|Fenofibrate|fenofibrate|mesh-list
83460610|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83460611|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
83460612|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460613|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83460614|NCT01142947|Beclomethasone|beclomethasone|mesh-list
83460615|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83460616|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
83460617|NCT01142947|Hormones|hormones|mesh-ancestor
83460618|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83460619|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460620|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83460621|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
83460622|NCT02972294|Iron|iron|mesh-list
83460623|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
83460624|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83460625|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
83460627|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
83460628|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460629|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83460630|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83460631|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460632|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
83460633|NCT02972294|Coagulants|coagulants|mesh-ancestor
83460634|NCT02972294|Hematinics|hematinics|mesh-ancestor
83460635|NCT02969798|Metformin|metformin|mesh-list
83460636|NCT02969798|Pioglitazone|pioglitazone|mesh-list
83460637|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
83460638|NCT02969798|Saxagliptin|saxagliptin|mesh-list
83460639|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83460640|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460641|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83460642|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460643|NCT02969798|Incretins|incretins|mesh-ancestor
83460644|NCT02969798|Hormones|hormones|mesh-ancestor
83460645|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83460646|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83460647|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
83460648|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460650|NCT02983214|Clopidogrel|clopidogrel|mesh-list
83460651|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83460652|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83460653|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83460654|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83460655|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
83460656|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460657|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460658|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460659|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83460661|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460662|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83460663|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
83460664|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83460665|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83460666|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
83460667|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83460668|NCT02983214|Protective Agents|protective agents|mesh-ancestor
83460669|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83460670|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83460671|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460672|NCT03825068|Anesthetics|anesthetics|mesh-list
83460673|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
83460674|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460675|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460676|NCT03824834|Morphine|morphine|mesh-list
83460677|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83460678|NCT03824834|Narcotics|narcotics|mesh-ancestor
83460679|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460680|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460681|NCT03824834|Analgesics|analgesics|mesh-ancestor
83460682|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
83460683|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460684|NCT03829124|Ketamine|ketamine|mesh-list
83460685|NCT03829124|Propofol|propofol|mesh-list
83460686|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83460687|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460688|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460689|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83460690|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
83460691|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
83460692|NCT03829124|Analgesics|analgesics|mesh-ancestor
83460693|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
83460694|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460695|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83460696|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83460697|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83460698|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460699|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460700|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
83460701|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83460702|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83460703|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83460704|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83460705|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83460706|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460707|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
83460708|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460709|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460710|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83460711|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460712|NCT03047330|Leuprolide|leuprolide|mesh-list
83460713|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83460714|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
83460715|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83460716|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460717|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83478015|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
83460718|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460719|NCT03008408|Everolimus|everolimus|mesh-list
83460720|NCT03008408|Letrozole|letrozole|mesh-list
83460721|NCT03008408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83460722|NCT03008408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83460723|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460724|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460725|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83460726|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
83460727|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460728|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460729|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83460730|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83460731|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83460732|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
83460733|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83460734|NCT04393220|Bevacizumab|bevacizumab|mesh-list
83460736|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460737|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460738|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83460739|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83460740|NCT04393220|Growth Substances|growth substances|mesh-ancestor
83460741|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460742|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
83460743|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83460744|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460745|NCT01025453|Sirolimus|sirolimus|mesh-list
83460746|NCT01025453|Sorafenib|sorafenib|mesh-list
83460747|NCT01025453|Temsirolimus|temsirolimus|mesh-list
83460748|NCT01025453|MTOR Inhibitors|mtor inhibitors|mesh-list
83460749|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460750|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83460751|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460752|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460753|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83460754|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
83478016|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
83460756|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83460757|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460758|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83460759|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
83460760|NCT05394233|Bevacizumab|bevacizumab|mesh-list
83460761|NCT05394233|Tislelizumab|tislelizumab|mesh-list
83460762|NCT05394233|Pemetrexed|pemetrexed|mesh-list
83460763|NCT05394233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460764|NCT05394233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460765|NCT05394233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83460766|NCT05394233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83460767|NCT05394233|Growth Substances|growth substances|mesh-ancestor
83460768|NCT05394233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460769|NCT05394233|Growth Inhibitors|growth inhibitors|mesh-ancestor
83460770|NCT05394233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460771|NCT05394233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460772|NCT05394233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83460773|NCT05394233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83460774|NCT03823976|Anesthetics|anesthetics|mesh-list
83460775|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460776|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460777|NCT00982553|Ribavirin|ribavirin|mesh-list
83460778|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
83460779|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
83460780|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460781|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
83460782|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460783|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83460784|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83460785|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83460786|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83460787|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460788|NCT02943590|Atorvastatin|atorvastatin|mesh-list
83460789|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83460790|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83460791|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
83460792|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460793|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83460794|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83460795|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460796|NCT02939300|Nivolumab|nivolumab|mesh-list
83460797|NCT02939300|Ipilimumab|ipilimumab|mesh-list
83460798|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460799|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460800|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83460801|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460803|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460804|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460805|NCT02918162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83460806|NCT02918162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460807|NCT04392128|Azithromycin|azithromycin|mesh-list
83460808|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
83460809|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83460810|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460811|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
83460812|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83460813|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83460814|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460815|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460816|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83460817|NCT02891954|Canagliflozin|canagliflozin|mesh-list
83460818|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83460819|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460820|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83460821|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478120|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
83460823|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83460824|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
83460825|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460826|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460827|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460828|NCT04694586|Rifampin|rifampin|mesh-list
83460829|NCT04694586|Isoniazid|isoniazid|mesh-list
83460830|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
83460831|NCT04694586|Ethambutol|ethambutol|mesh-list
83460832|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83460833|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
83460834|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83478380|NCT01229891|Vitamin D|vitamin d|mesh-list
83460835|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83460836|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
83460837|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83460838|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476345|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460839|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460840|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83460841|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83460842|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83460843|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83460844|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83460845|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83460846|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83460847|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83460848|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
83460849|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83460851|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460852|NCT03252938|Avelumab|avelumab|mesh-list
83460853|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460854|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460855|NCT05509374|Dexamethasone|dexamethasone|mesh-list
83460856|NCT05509374|Pomalidomide|pomalidomide|mesh-list
83460857|NCT05509374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83460858|NCT05509374|Antiemetics|antiemetics|mesh-ancestor
83460859|NCT05509374|Autonomic Agents|autonomic agents|mesh-ancestor
83460860|NCT05509374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460861|NCT05509374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460862|NCT05509374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83460863|NCT05509374|Glucocorticoids|glucocorticoids|mesh-ancestor
83460864|NCT05509374|Hormones|hormones|mesh-ancestor
83460865|NCT05509374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83460866|NCT05509374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83460868|NCT05509374|Immunologic Factors|immunologic factors|mesh-ancestor
83460869|NCT05509374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83460870|NCT05509374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83460871|NCT05509374|Growth Substances|growth substances|mesh-ancestor
83460872|NCT05509374|Growth Inhibitors|growth inhibitors|mesh-ancestor
83460873|NCT04124822|Prednisolone|prednisolone|mesh-list
83460874|NCT04124822|Piroxicam|piroxicam|mesh-list
83460875|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83460876|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
83460877|NCT04124822|Hormones|hormones|mesh-ancestor
83460878|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83460879|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478381|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
83460880|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83460881|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460882|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460883|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83460884|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83460885|NCT04124822|Analgesics|analgesics|mesh-ancestor
83460886|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
83460887|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83460888|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83460889|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460890|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460891|NCT05504694|Ofatumumab|ofatumumab|mesh-list
83460892|NCT05504694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460893|NCT02854670|Capsaicin|capsaicin|mesh-list
83460894|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
83460895|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
83460896|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
83460897|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460898|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460899|NCT02937272|Paclitaxel|paclitaxel|mesh-list
83460900|NCT02937272|Gemcitabine|gemcitabine|mesh-list
83460901|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83460902|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460903|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
83460904|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
83460905|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
83476346|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83460906|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460907|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83460909|NCT03519308|Paclitaxel|paclitaxel|mesh-list
83460910|NCT03519308|Gemcitabine|gemcitabine|mesh-list
83460911|NCT03519308|Nivolumab|nivolumab|mesh-list
83460912|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83460913|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460914|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
83460915|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
83460917|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460918|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83460919|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
83460920|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460921|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83460922|NCT03821714|Vitamins|vitamins|mesh-list
83460923|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
83460924|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83460925|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83460926|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83460927|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
83460928|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
83460929|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460930|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83460932|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83460933|NCT02565108|Cannabidiol|cannabidiol|mesh-list
83460934|NCT02565108|Clobazam|clobazam|mesh-list
83460935|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
83460936|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83460937|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83460938|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460939|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460940|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83460941|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83460942|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
83460943|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
83460944|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460945|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460946|NCT03821168|Bevacizumab|bevacizumab|mesh-list
83460947|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
83460948|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83460949|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460950|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83460951|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83460953|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460955|NCT03821168|Hematinics|hematinics|mesh-ancestor
83460956|NCT01454180|Leucovorin|leucovorin|mesh-list
83460957|NCT01454180|Gemcitabine|gemcitabine|mesh-list
83460958|NCT01454180|Capecitabine|capecitabine|mesh-list
83460959|NCT01454180|Fluorouracil|fluorouracil|mesh-list
83460960|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83460961|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
83460962|NCT01454180|Folfirinox|folfirinox|mesh-list
83460963|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83460964|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
83460965|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460966|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83460967|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83460969|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83460970|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
83460971|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460972|NCT01454180|Antidotes|antidotes|mesh-ancestor
83460973|NCT01454180|Protective Agents|protective agents|mesh-ancestor
83460974|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
83460975|NCT01454180|Vitamins|vitamins|mesh-ancestor
83460976|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
83460977|NCT02564952|Cannabidiol|cannabidiol|mesh-list
83460978|NCT02564952|Clobazam|clobazam|mesh-list
83460979|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
83460980|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83460981|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83460982|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460983|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460984|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83460985|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83460986|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
83460987|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
83460988|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460989|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460990|NCT05564286|Dexamethasone|dexamethasone|mesh-list
83460991|NCT05564286|Fosaprepitant|fosaprepitant|mesh-list
83460992|NCT05564286|Aprepitant|aprepitant|mesh-list
83460993|NCT05564286|Tropisetron|tropisetron|mesh-list
83460994|NCT05564286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83460995|NCT05564286|Antiemetics|antiemetics|mesh-ancestor
83460997|NCT05564286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460998|NCT05564286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460999|NCT05564286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83461000|NCT05564286|Glucocorticoids|glucocorticoids|mesh-ancestor
83461001|NCT05564286|Hormones|hormones|mesh-ancestor
83461002|NCT05564286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83461003|NCT05564286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83461004|NCT05564286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461005|NCT05564286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83461006|NCT05564286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461007|NCT05564286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461008|NCT05564286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83478382|NCT01229891|Cholecalciferol|cholecalciferol|mesh-list
83461009|NCT05564286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83461011|NCT01454804|Trastuzumab|trastuzumab|mesh-list
83461012|NCT01454804|Lapatinib|lapatinib|mesh-list
83461013|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83461014|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461015|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83461016|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461017|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461018|NCT03820622|Paclitaxel|paclitaxel|mesh-list
83461019|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83461020|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83461021|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461022|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
83461023|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
83461024|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
83461025|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461026|NCT05504382|Naproxen|naproxen|mesh-list
83461027|NCT05504382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83461028|NCT05504382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83461029|NCT05504382|Analgesics|analgesics|mesh-ancestor
83461030|NCT05504382|Sensory System Agents|sensory system agents|mesh-ancestor
83461031|NCT05504382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461032|NCT05504382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461033|NCT05504382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83461034|NCT05504382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461035|NCT05504382|Gout Suppressants|gout suppressants|mesh-ancestor
83461036|NCT05504382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83461037|NCT05504382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461038|NCT05504382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461039|NCT03823040|Oxiconazole|oxiconazole|mesh-list
83461040|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
83461041|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461042|NCT02566902|Albuterol|albuterol|mesh-list
83461043|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83461044|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
83461045|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461046|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461047|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83461048|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
83461049|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
83461050|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83461051|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83461052|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83461053|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83461054|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
83461055|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461056|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461057|NCT05508516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83461058|NCT05508516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83461059|NCT05508516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83461060|NCT05508516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83461061|NCT05508516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461062|NCT05508516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461063|NCT05508516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461064|NCT05508516|Analgesics|analgesics|mesh-ancestor
83461065|NCT05508516|Sensory System Agents|sensory system agents|mesh-ancestor
83461066|NCT05508516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461067|NCT05508516|Antidepressive Agents|antidepressive agents|mesh-ancestor
83461068|NCT05508516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83461069|NCT05508516|Dopamine Agents|dopamine agents|mesh-ancestor
83461070|NCT02902484|Nintedanib|nintedanib|mesh-list
83461071|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461072|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83461073|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461074|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461075|NCT01455506|Fludarabine|fludarabine|mesh-list
83461076|NCT01455506|Busulfan|busulfan|mesh-list
83461077|NCT01455506|Decitabine|decitabine|mesh-list
83461078|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461079|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83461080|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
83461081|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461082|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83461083|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
83461084|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461085|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
83461086|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83461087|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83461088|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461090|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
83461091|NCT02564796|Trace Elements|trace elements|mesh-ancestor
83461092|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
83461093|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461094|NCT02564796|Hematinics|hematinics|mesh-ancestor
83461095|NCT03829436|Nivolumab|nivolumab|mesh-list
83461096|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83461097|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461098|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83461099|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461100|NCT05563350|Midazolam|midazolam|mesh-list
83461102|NCT05563350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83461103|NCT05563350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83461104|NCT05563350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461105|NCT05563350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461106|NCT05563350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83461107|NCT05563350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83461108|NCT05563350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83461109|NCT05563350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83461110|NCT05563350|Anesthetics, General|anesthetics, general|mesh-ancestor
83461111|NCT05563350|Anesthetics|anesthetics|mesh-ancestor
83461112|NCT05563350|GABA Modulators|gaba modulators|mesh-ancestor
83461113|NCT05563350|GABA Agents|gaba agents|mesh-ancestor
83461114|NCT05563350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461115|NCT05563350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461116|NCT05563350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83461117|NCT05563350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83461118|NCT05563350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83461119|NCT05563350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461120|NCT04273100|Lenvatinib|lenvatinib|mesh-list
83461121|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461122|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83461123|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461124|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461125|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
83461126|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83461127|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
83461128|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83461129|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
83461130|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478384|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
83461131|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461132|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
83461133|NCT01453946|Budesonide|budesonide|mesh-list
83461134|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83461135|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83461137|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461138|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461139|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83461140|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
83461141|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
83461143|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83461144|NCT01455896|Exenatide|exenatide|mesh-list
83461145|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83461146|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461147|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83461148|NCT01455896|Incretins|incretins|mesh-ancestor
83461149|NCT01455896|Hormones|hormones|mesh-ancestor
83461150|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83461151|NCT05562882|Daratumumab|daratumumab|mesh-list
83461152|NCT05562882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461153|NCT05560542|Dexamethasone|dexamethasone|mesh-list
83461154|NCT05560542|Atropine|atropine|mesh-list
83461155|NCT05560542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83461156|NCT05560542|Antiemetics|antiemetics|mesh-ancestor
83461157|NCT05560542|Autonomic Agents|autonomic agents|mesh-ancestor
83461158|NCT05560542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461159|NCT05560542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461160|NCT05560542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83461162|NCT05560542|Hormones|hormones|mesh-ancestor
83461163|NCT05560542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83461164|NCT05560542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83461165|NCT05560542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461166|NCT05560542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83461167|NCT05560542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83461168|NCT05560542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83461169|NCT05560542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83461170|NCT05560542|Respiratory System Agents|respiratory system agents|mesh-ancestor
83461171|NCT05560542|Mydriatics|mydriatics|mesh-ancestor
83461172|NCT05560542|Parasympatholytics|parasympatholytics|mesh-ancestor
83461173|NCT05560542|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83461174|NCT05560542|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83461175|NCT05560542|Cholinergic Agents|cholinergic agents|mesh-ancestor
83461176|NCT05560542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461177|NCT05560542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461178|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
83461179|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83461180|NCT05560308|Trastuzumab|trastuzumab|mesh-list
83461181|NCT05560308|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83461182|NCT05560308|Maytansine|maytansine|mesh-list
83461183|NCT05560308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83461184|NCT05560308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461185|NCT05560308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461186|NCT05560308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83461187|NCT05560308|Tubulin Modulators|tubulin modulators|mesh-ancestor
83461188|NCT05560308|Antimitotic Agents|antimitotic agents|mesh-ancestor
83461189|NCT05560308|Mitosis Modulators|mitosis modulators|mesh-ancestor
83461190|NCT05560308|Immunotoxins|immunotoxins|mesh-ancestor
83461191|NCT05560308|Immunoconjugates|immunoconjugates|mesh-ancestor
83461192|NCT05560308|Immunologic Factors|immunologic factors|mesh-ancestor
83461193|NCT05560308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461195|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
83461196|NCT01456208|Giapreza|giapreza|mesh-list
83461197|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
83461198|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83461199|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83461200|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
83461201|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461202|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461203|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461204|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
83461205|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
83461206|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461207|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83461208|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83461209|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
83461210|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461211|NCT05436522|Propofol|propofol|mesh-list
83461212|NCT05436522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83461213|NCT05436522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461214|NCT05436522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461215|NCT05436522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83461216|NCT05436522|Anesthetics, General|anesthetics, general|mesh-ancestor
83461217|NCT05436522|Anesthetics|anesthetics|mesh-ancestor
83461218|NCT03780010|Paclitaxel|paclitaxel|mesh-list
83461219|NCT03780010|Carboplatin|carboplatin|mesh-list
83461220|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83461221|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461222|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
83461223|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
83461224|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
83461225|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461226|NCT03826550|Diclofenac|diclofenac|mesh-list
83461227|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83461228|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83461229|NCT03826550|Analgesics|analgesics|mesh-ancestor
83461230|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
83461231|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478521|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
83461232|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461233|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83461234|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461235|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83461236|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461237|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461238|NCT03827018|Prednisone|prednisone|mesh-list
83461239|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
83461240|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83461241|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
83461242|NCT03827018|Hormones|hormones|mesh-ancestor
83461243|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83461244|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461245|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83461246|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461247|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461248|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
83461249|NCT05325762|Propofol|propofol|mesh-list
83461250|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83461251|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461252|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461253|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83461254|NCT05325762|Analgesics|analgesics|mesh-ancestor
83461255|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
83461256|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461257|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83461258|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83461259|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83461260|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
83461261|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461262|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461263|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83461264|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
83461265|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
83461266|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
83461267|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83461268|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83461269|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461270|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83461271|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83461272|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
83461273|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83461274|NCT05498064|Ensartinib|ensartinib|mesh-list
83461276|NCT05498064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83461277|NCT05498064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461278|NCT05498064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461279|NCT03767062|Topiramate|topiramate|mesh-list
83461280|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
83461281|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83461282|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461284|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83461285|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83461286|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83461287|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83461288|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83461289|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
83461290|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461291|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461292|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461294|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83461295|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
83461296|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461297|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83461298|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
83461300|NCT04281420|Vitamins|vitamins|mesh-ancestor
83461301|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
83461302|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461303|NCT03765502|Glucagon|glucagon|mesh-list
83461304|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83461305|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83461306|NCT03765502|Hormones|hormones|mesh-ancestor
83461307|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83461308|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461309|NCT03765502|Incretins|incretins|mesh-ancestor
83461310|NCT04447716|Rituximab|rituximab|mesh-list
83461311|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83461312|NCT04447716|Lenalidomide|lenalidomide|mesh-list
83461313|NCT04447716|Venetoclax|venetoclax|mesh-list
83461314|NCT04447716|Piperidine|piperidine|mesh-list
83461315|NCT04447716|Antibodies|antibodies|mesh-list
83461316|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
83461317|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83461318|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
83461319|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461320|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461321|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461322|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83461323|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83461324|NCT04447716|Growth Substances|growth substances|mesh-ancestor
83461325|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
83461326|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461327|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83461328|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83461329|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83461330|NCT05285124|Melatonin|melatonin|mesh-list
83461331|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
83461332|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461333|NCT05285124|Protective Agents|protective agents|mesh-ancestor
83461334|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461335|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461336|NCT01450046|Vitamin E|vitamin e|mesh-list
83461337|NCT01450046|Tocopherols|tocopherols|mesh-list
83461338|NCT01450046|Tocotrienols|tocotrienols|mesh-list
83461339|NCT01450046|Vitamins|vitamins|mesh-ancestor
83461340|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
83461341|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461342|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
83461343|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461344|NCT01450046|Protective Agents|protective agents|mesh-ancestor
83461345|NCT05497596|Vitamin D|vitamin d|mesh-list
83461346|NCT05497596|Vitamins|vitamins|mesh-ancestor
83461347|NCT05497596|Micronutrients|micronutrients|mesh-ancestor
83461348|NCT05497596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461349|NCT05497596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83461350|NCT01450124|Boswellic acid|boswellic acid|mesh-list
83461351|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83461352|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83461353|NCT01450124|Analgesics|analgesics|mesh-ancestor
83461354|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
83461355|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461356|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461357|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83461358|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461359|NCT05243862|Atezolizumab|atezolizumab|mesh-list
83461361|NCT05243862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461362|NCT05243862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83461363|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461364|NCT03751124|Norethindrone|norethindrone|mesh-list
83461365|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
83461366|NCT03751124|Estradiol|estradiol|mesh-list
83461367|NCT03751124|Relugolix|relugolix|mesh-list
83461368|NCT03751124|Estrogens|estrogens|mesh-ancestor
83461369|NCT03751124|Hormones|hormones|mesh-ancestor
83461370|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83461371|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461372|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83461373|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
83461374|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83461375|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83461376|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83461377|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83461378|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83461379|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
83461380|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
83461381|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
83461382|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83461383|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479502|NCT05509777|Mirikizumab|mirikizumab|mesh-list
83461384|NCT02563548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83461385|NCT02563548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461386|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83461387|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461388|NCT04081324|Lasmiditan|lasmiditan|mesh-list
83461389|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83461390|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
83461391|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479578|NCT05427474|Anticonvulsants|anticonvulsants|mesh-ancestor
83461392|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461393|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461394|NCT04042324|Heparin|heparin|mesh-list
83461395|NCT04042324|Calcium heparin|calcium heparin|mesh-list
83461396|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
83461397|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461398|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83461399|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83461400|NCT04391660|Ethanol|ethanol|mesh-list
83461401|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83461402|NCT04391660|Eusol|eusol|mesh-list
83461403|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83461405|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461406|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461407|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461408|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
83461409|NCT04842422|Imiquimod|imiquimod|mesh-list
83461410|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83461411|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
83461412|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461413|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461415|NCT04066426|Acetaminophen|acetaminophen|mesh-list
83461416|NCT04066426|Dexamethasone|dexamethasone|mesh-list
83461417|NCT04066426|Naproxen|naproxen|mesh-list
83461418|NCT04066426|Codeine|codeine|mesh-list
83461419|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83461420|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
83461421|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
83461422|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461423|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461424|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83461425|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
83461426|NCT04066426|Hormones|hormones|mesh-ancestor
83461427|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83461428|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83461429|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461430|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83461431|NCT04066426|Analgesics|analgesics|mesh-ancestor
83461432|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
83461434|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83461435|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461436|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
83461437|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83461438|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461439|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461440|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83461442|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461443|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
83461444|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
83461445|NCT01450514|Pipamperone|pipamperone|mesh-list
83461446|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83461447|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
83461448|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461449|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461450|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461451|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83461452|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83461453|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461454|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83461455|NCT02899052|Dexamethasone|dexamethasone|mesh-list
83461456|NCT02899052|Venetoclax|venetoclax|mesh-list
83461457|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83461458|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
83461459|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
83461460|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461461|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461462|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83461463|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
83461464|NCT02899052|Hormones|hormones|mesh-ancestor
83479579|NCT05427474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83461465|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83461467|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461468|NCT04758728|Epinephrine|epinephrine|mesh-list
83461469|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83461470|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83461471|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
83461472|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461473|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461474|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461475|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83461476|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83461477|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
83461478|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461479|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83461480|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
83461481|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
83461482|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
83461483|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83461484|NCT02559570|Linaclotide|linaclotide|mesh-list
83461485|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83461486|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
83461487|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461488|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83461489|NCT04051684|Ropivacaine|ropivacaine|mesh-list
83461490|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
83461491|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
83461492|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461494|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
83461495|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461496|NCT04840862|Rifabutin|rifabutin|mesh-list
83461497|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83461498|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461500|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
83461501|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
83461502|NCT04840238|Vitamin D|vitamin d|mesh-list
83461503|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83461504|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461505|NCT04840238|Vitamins|vitamins|mesh-ancestor
83461506|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
83461507|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83461508|NCT03829618|Lidocaine|lidocaine|mesh-list
83461509|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
83479580|NCT05427474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83461511|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461512|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461513|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
83461514|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461515|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83480162|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461516|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83461517|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83461518|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83461519|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461520|NCT04272788|Infliximab|infliximab|mesh-list
83461522|NCT04272788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83461524|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83461525|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461526|NCT01457690|Tocopherols|tocopherols|mesh-list
83461527|NCT01457690|Vitamin E|vitamin e|mesh-list
83461528|NCT01457690|Tocotrienols|tocotrienols|mesh-list
83461529|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
83461530|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
83480163|NCT04553692|Antidotes|antidotes|mesh-ancestor
83461531|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461533|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461534|NCT01457690|Vitamins|vitamins|mesh-ancestor
83461535|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
83461536|NCT05497206|Metronidazole|metronidazole|mesh-list
83461537|NCT05497206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461538|NCT05497206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83461539|NCT05497206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83461540|NCT05497206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83461541|NCT01451060|Ephedrine|ephedrine|mesh-list
83461542|NCT01451060|Metaraminol|metaraminol|mesh-list
83461543|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83461544|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461545|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
83461546|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
83461547|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461548|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83461549|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
83461550|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461551|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461552|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83461553|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83461554|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83461556|NCT04904562|Giapreza|giapreza|mesh-list
83461557|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
83461558|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83461559|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83461560|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
83461561|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461562|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461563|NCT01143181|Brincidofovir|brincidofovir|mesh-list
83461564|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
83461565|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461568|NCT01451294|Ephedrine|ephedrine|mesh-list
83461569|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83461570|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
83461571|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
83461572|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461573|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461574|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
83461575|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83461576|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
83461577|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
83461578|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83461579|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83461580|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83461581|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
83461582|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461583|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461585|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83461586|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
83461588|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83461590|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461591|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461592|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83461593|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
83461594|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461595|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461596|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83461597|NCT00378118|Antibodies|antibodies|mesh-list
83461598|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
83461600|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
83461601|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461602|NCT01224145|Bupivacaine|bupivacaine|mesh-list
83461603|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
83461604|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
83461605|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461606|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461607|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
83461608|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461609|NCT01451840|Lidocaine|lidocaine|mesh-list
83461610|NCT01451840|Remifentanil|remifentanil|mesh-list
83461611|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
83461612|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
83461613|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461614|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461615|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
83461616|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461617|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83480164|NCT04553692|Protective Agents|protective agents|mesh-ancestor
83461618|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83461619|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83461620|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83461621|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461622|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83461623|NCT01451840|Narcotics|narcotics|mesh-ancestor
83461624|NCT01451840|Analgesics|analgesics|mesh-ancestor
83461625|NCT01451918|Resveratrol|resveratrol|mesh-list
83461626|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
83461627|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461628|NCT01451918|Protective Agents|protective agents|mesh-ancestor
83461629|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461630|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480165|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
83461632|NCT00378196|Ranibizumab|ranibizumab|mesh-list
83461633|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83461634|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83461635|NCT00378196|Growth Substances|growth substances|mesh-ancestor
83461636|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461637|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
83461638|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461640|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461641|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83461642|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
83461643|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461644|NCT01458236|Beraprost|beraprost|mesh-list
83461645|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83461646|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
83461647|NCT01146457|Morphine|morphine|mesh-list
83461648|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83461649|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83461650|NCT01146457|Narcotics|narcotics|mesh-ancestor
83461651|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461652|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461653|NCT01146457|Analgesics|analgesics|mesh-ancestor
83461655|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461656|NCT04031430|Antihypertensive Agents|antihypertensive agents|mesh-list
83461657|NCT02886962|Vitamin K|vitamin k|mesh-list
83461658|NCT02886962|Vitamins|vitamins|mesh-ancestor
83461659|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
83461660|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461661|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83461662|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83461663|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461664|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
83461665|NCT02886962|Coagulants|coagulants|mesh-ancestor
83461666|NCT05495958|Vitamin D|vitamin d|mesh-list
83461667|NCT05495958|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83461668|NCT05495958|Vitamins|vitamins|mesh-ancestor
83461669|NCT05495958|Micronutrients|micronutrients|mesh-ancestor
83461670|NCT05495958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461671|NCT05495958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83461673|NCT04011592|Ketamine|ketamine|mesh-list
83461674|NCT04011592|Analgesics|analgesics|mesh-ancestor
83461675|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
83461676|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461677|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461678|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83461679|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83461680|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
83461681|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
83461682|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461683|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83461684|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83461685|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461686|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461687|NCT01458470|Memantine|memantine|mesh-list
83461688|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83461689|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83461690|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
83461691|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461692|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461693|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461694|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83461695|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83461696|NCT05025488|Poly ICLC|poly iclc|mesh-list
83461697|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
83461698|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
83461699|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461700|NCT01452542|Eliglustat|eliglustat|mesh-list
83461701|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461702|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461703|NCT01458548|Rituximab|rituximab|mesh-list
83461704|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83461705|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461706|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
83461707|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461708|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461709|NCT05027204|Docetaxel|docetaxel|mesh-list
83461710|NCT05027204|Nivolumab|nivolumab|mesh-list
83461711|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461712|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
83461713|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
83461714|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
83461715|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461716|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83461717|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83461718|NCT01458626|Mirtazapine|mirtazapine|mesh-list
83461719|NCT01458626|Paroxetine|paroxetine|mesh-list
83461720|NCT01458626|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83480166|NCT04553692|Vitamins|vitamins|mesh-ancestor
83461722|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83461723|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461724|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461725|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
83461726|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461727|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83461728|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
83461729|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83461730|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83461731|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83461732|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461733|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83461734|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
83461735|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
83461736|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83461737|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83461738|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461739|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83461740|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83461741|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83461742|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
83480167|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
83461743|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83461744|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83461745|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83461746|NCT00377806|Diclofenac|diclofenac|mesh-list
83461747|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83461748|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83461749|NCT00377806|Analgesics|analgesics|mesh-ancestor
83461750|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
83461751|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461752|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461754|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461755|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83461756|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461757|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461758|NCT05495724|Tislelizumab|tislelizumab|mesh-list
83461759|NCT05495724|Disitamab vedotin|disitamab vedotin|mesh-list
83461760|NCT05495724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83461761|NCT05495724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461762|NCT05495724|Immunoconjugates|immunoconjugates|mesh-ancestor
83461763|NCT05495724|Immunologic Factors|immunologic factors|mesh-ancestor
83461764|NCT05495724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461765|NCT02559414|Aspirin|aspirin|mesh-list
83461766|NCT02559414|Clopidogrel|clopidogrel|mesh-list
83461767|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83461768|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83461769|NCT02559414|Analgesics|analgesics|mesh-ancestor
83461770|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
83461771|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461772|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461773|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83461774|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461775|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83461776|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83461777|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461778|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83461779|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83461780|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461781|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
83480168|NCT04539938|Trastuzumab|trastuzumab|mesh-list
83461782|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83461783|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83461784|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83461785|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
83461786|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461787|NCT03527264|Nivolumab|nivolumab|mesh-list
83461788|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461789|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83461790|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83461791|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461792|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83461793|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83461794|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83461795|NCT04713904|Estradiol|estradiol|mesh-list
83461796|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83461797|NCT04713904|Estrogens|estrogens|mesh-ancestor
83461798|NCT04713904|Hormones|hormones|mesh-ancestor
83461799|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83461800|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461801|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83461802|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
83461803|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83461804|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83461805|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83461806|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83461807|NCT03995680|Mebendazole|mebendazole|mesh-list
83461808|NCT03995680|Piperazine|piperazine|mesh-list
83461809|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
83461810|NCT03995680|DMP 777|dmp 777|mesh-list
83461811|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
83461812|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
83461813|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83461814|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461815|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
83461816|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
83461817|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
83480169|NCT04539938|Tucatinib|tucatinib|mesh-list
83461818|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461819|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461820|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461821|NCT01452698|Lansoprazole|lansoprazole|mesh-list
83461822|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
83461823|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83480170|NCT04539938|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83461824|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83461825|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83461826|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461827|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461828|NCT05029856|Vaccines|vaccines|mesh-list
83461829|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
83461830|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461831|NCT05490342|Antibodies|antibodies|mesh-list
83461832|NCT05490342|Myeloma Proteins|myeloma proteins|mesh-list
83461833|NCT05490342|Paraproteins|paraproteins|mesh-list
83461834|NCT05490342|Immunologic Factors|immunologic factors|mesh-ancestor
83461835|NCT05490342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461836|NCT05495100|Azacitidine|azacitidine|mesh-list
83461837|NCT05495100|Mitoxantrone|mitoxantrone|mesh-list
83461838|NCT05495100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83461839|NCT05495100|Antimetabolites|antimetabolites|mesh-ancestor
83461840|NCT05495100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461841|NCT05495100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461842|NCT05495100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461843|NCT05495100|Analgesics|analgesics|mesh-ancestor
83461844|NCT05495100|Sensory System Agents|sensory system agents|mesh-ancestor
83461845|NCT05495100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461846|NCT05495100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461847|NCT05495100|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83461848|NCT05495100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83461849|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
83461850|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83461851|NCT03325114|Diuretics|diuretics|mesh-ancestor
83461852|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
83461853|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461854|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83461855|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83461856|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461857|NCT01453400|Aspirin|aspirin|mesh-list
83461858|NCT01453400|Acetaminophen|acetaminophen|mesh-list
83461859|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83461860|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83461861|NCT01453400|Analgesics|analgesics|mesh-ancestor
83461862|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
83461863|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461864|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461866|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83461867|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83461868|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83476347|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83461869|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461870|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83461871|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83461872|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461873|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
83461874|NCT05025644|Dobutamine|dobutamine|mesh-list
83461875|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83461876|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
83461877|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
83461878|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461879|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461880|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83461881|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83461882|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83461883|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
83461884|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461885|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461886|NCT05025644|Protective Agents|protective agents|mesh-ancestor
83461887|NCT05494710|Bleomycin|bleomycin|mesh-list
83461888|NCT05494710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83461889|NCT05494710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461890|NCT03810066|Osimertinib|osimertinib|mesh-list
83461891|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461892|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83461893|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461894|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461895|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
83461896|NCT03992482|Antibodies|antibodies|mesh-list
83461897|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
83461898|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83461899|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83461900|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
83461901|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461902|NCT00377494|Vaccines|vaccines|mesh-list
83461903|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
83461904|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461905|NCT01459250|Agomelatine|agomelatine|mesh-list
83461906|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83461907|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83461908|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461909|NCT04303156|Islatravir|islatravir|mesh-list
83461910|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
83461911|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461912|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480595|NCT03675893|Letrozole|letrozole|mesh-list
83461913|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461914|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83461915|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83461916|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83461917|NCT04390334|Efavirenz|efavirenz|mesh-list
83461918|NCT04390334|Famotidine|famotidine|mesh-list
83461919|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83461920|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83461921|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461922|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461923|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
83461924|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461925|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83461926|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83461927|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83461928|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83461929|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83461930|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83461931|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83461932|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83461933|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83461934|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
83461936|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461937|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461938|NCT02880020|Nivolumab|nivolumab|mesh-list
83461939|NCT02880020|Ipilimumab|ipilimumab|mesh-list
83461940|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83461941|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461942|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83461943|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461944|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83461945|NCT03150160|Travoprost|travoprost|mesh-list
83461946|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83461947|NCT03150160|Brinzolamide|brinzolamide|mesh-list
83461948|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83461949|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83461950|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83461951|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83461952|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83461953|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
83461954|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461955|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461956|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461957|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83461958|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461959|NCT01459406|Levan|levan|mesh-list
83461960|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461961|NCT05489952|Iron|iron|mesh-list
83461962|NCT05489952|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83461963|NCT05489952|Trace Elements|trace elements|mesh-ancestor
83461965|NCT05489952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461966|NCT05489952|Hematinics|hematinics|mesh-ancestor
83461967|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
83461968|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83461969|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
83461970|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461971|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
83461972|NCT01459640|Protective Agents|protective agents|mesh-ancestor
83461973|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
83461974|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83461975|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461976|NCT01500772|Ribavirin|ribavirin|mesh-list
83461977|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83461978|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
83461979|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461980|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
83461981|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83461982|NCT04272476|Fluoxetine|fluoxetine|mesh-list
83461983|NCT04272476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83461984|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83461985|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83461986|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461987|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461988|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
83461989|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461990|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83461991|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
83461992|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83461993|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83461994|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83461995|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461996|NCT03984838|Dolutegravir|dolutegravir|mesh-list
83461997|NCT03984838|Rilpivirine|rilpivirine|mesh-list
83461998|NCT03984838|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
83461999|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83462000|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83462001|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462002|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462003|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83462004|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83462005|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
83462006|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462007|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83462008|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83462010|NCT02994576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83462011|NCT02994576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462012|NCT02994576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462013|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462014|NCT01890902|Ketoprofen|ketoprofen|mesh-list
83462015|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83462016|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83462017|NCT01890902|Analgesics|analgesics|mesh-ancestor
83462018|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
83462019|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462020|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462021|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83462022|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83462023|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83462024|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462025|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462026|NCT04423926|Prednisolone|prednisolone|mesh-list
83462027|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
83462028|NCT04423926|Doxorubicin|doxorubicin|mesh-list
83462029|NCT04423926|Vincristine|vincristine|mesh-list
83462030|NCT04423926|Lenalidomide|lenalidomide|mesh-list
83462031|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83462032|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
83462033|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462034|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83462035|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83462036|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
83462037|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462038|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462039|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83462040|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83462041|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83462042|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83462043|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462044|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83462045|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
83462046|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
83462047|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
83462048|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83462049|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83462050|NCT04423926|Growth Substances|growth substances|mesh-ancestor
83462051|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
83462052|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83462053|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
83462054|NCT04423926|Hormones|hormones|mesh-ancestor
83462055|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462056|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83462057|NCT03979066|Atezolizumab|atezolizumab|mesh-list
83462058|NCT03979066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83462059|NCT03979066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462060|NCT03979066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462061|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462062|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
83462063|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462064|NCT05489406|Dolutegravir|dolutegravir|mesh-list
83462065|NCT05489406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83462066|NCT05489406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83462067|NCT05489406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462068|NCT05489406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462069|NCT05489406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83462070|NCT05489406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83462071|NCT05489406|Antiviral Agents|antiviral agents|mesh-ancestor
83462072|NCT05489406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462073|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83462074|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83462076|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
83462077|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83462078|NCT00378820|Caseins|caseins|mesh-list
83462079|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
83462080|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
83462081|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462082|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83462084|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83462085|NCT04758260|Antioxidants|antioxidants|mesh-list
83462086|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462087|NCT04758260|Protective Agents|protective agents|mesh-ancestor
83462088|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462089|NCT01446250|Ribavirin|ribavirin|mesh-list
83462090|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83462091|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
83462092|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462093|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
83462094|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462095|NCT05493618|Dexamethasone|dexamethasone|mesh-list
83462096|NCT05493618|Pembrolizumab|pembrolizumab|mesh-list
83462097|NCT05493618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83462098|NCT05493618|Antiemetics|antiemetics|mesh-ancestor
83462100|NCT05493618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462101|NCT05493618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462102|NCT05493618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83462103|NCT05493618|Glucocorticoids|glucocorticoids|mesh-ancestor
83462104|NCT05493618|Hormones|hormones|mesh-ancestor
83462105|NCT05493618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462106|NCT05493618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83462107|NCT05493618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462108|NCT05493618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462109|NCT05493618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83462110|NCT05493618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462111|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
83462112|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83462113|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462114|NCT04139304|Prednisone|prednisone|mesh-list
83462115|NCT04139304|Cortisone|cortisone|mesh-list
83462116|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
83462117|NCT04139304|Doxorubicin|doxorubicin|mesh-list
83462118|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83462119|NCT04139304|Etoposide|etoposide|mesh-list
83462120|NCT04139304|Vincristine|vincristine|mesh-list
83462121|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
83462122|NCT04139304|Daunorubicin|daunorubicin|mesh-list
83462123|NCT04139304|Daratumumab|daratumumab|mesh-list
83462124|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
83462125|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83462126|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
83462127|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462128|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83462129|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83462130|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
83462131|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462132|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462133|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83462134|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83462135|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83462136|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83462137|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462138|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83462139|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
83462141|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462142|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83462143|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83462144|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
83462145|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
83462146|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
83462147|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
83462148|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
83462149|NCT05020574|Cephalexin|cephalexin|mesh-list
83462150|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83462151|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462153|NCT02936206|Fulvestrant|fulvestrant|mesh-list
83462154|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83462155|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
83462156|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462157|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462158|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83462159|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462160|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83462161|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83462162|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83462163|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83462165|NCT01891526|Alitretinoin|alitretinoin|mesh-list
83462166|NCT01891526|Isotretinoin|isotretinoin|mesh-list
83462167|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462168|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
83462169|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
83462170|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
83462171|NCT01406860|Promethazine|promethazine|mesh-list
83462172|NCT01406860|Droperidol|droperidol|mesh-list
83462173|NCT01406860|Metoclopramide|metoclopramide|mesh-list
83462174|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83462175|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83462176|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462177|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462178|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
83462179|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
83462180|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
83462181|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462182|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
83462183|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
83462184|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83462185|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83462186|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
83462187|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
83462188|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462189|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462190|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83462192|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
83462193|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83462194|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83462195|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
83462196|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83462197|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83462198|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83462199|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83462200|NCT04138212|Paclitaxel|paclitaxel|mesh-list
83462201|NCT04138212|Cisplatin|cisplatin|mesh-list
83462202|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83462203|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462204|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
83462205|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
83462206|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
83462207|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462208|NCT02773576|Risperidone|risperidone|mesh-list
83462209|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83462210|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
83462211|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462212|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462213|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462215|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83462216|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462217|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83462218|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83462219|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
83462220|NCT05022758|Warfarin|warfarin|mesh-list
83462221|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
83462222|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
83462223|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83462224|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
83462225|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83462226|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
83462227|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462228|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462229|NCT05021978|Pramoxine|pramoxine|mesh-list
83462230|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
83462231|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
83462232|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462233|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462234|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
83462235|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462237|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83462238|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462239|NCT05599828|Sotorasib|sotorasib|mesh-list
83462240|NCT05599828|Omeprazole|omeprazole|mesh-list
83462241|NCT05599828|Famotidine|famotidine|mesh-list
83462242|NCT05599828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83462243|NCT05599828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83462244|NCT05599828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83462245|NCT05599828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462246|NCT05599828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462247|NCT05599828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83462248|NCT05599828|Histamine Antagonists|histamine antagonists|mesh-ancestor
83462249|NCT05599828|Histamine Agents|histamine agents|mesh-ancestor
83462250|NCT05599828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462251|NCT05599828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462252|NCT05599828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83462253|NCT05599828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462254|NCT05599828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462255|NCT01350232|Cytarabine|cytarabine|mesh-list
83462256|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
83462257|NCT01350232|Rituximab|rituximab|mesh-list
83462258|NCT01350232|Fludarabine|fludarabine|mesh-list
83462259|NCT01350232|Bortezomib|bortezomib|mesh-list
83462261|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
83462262|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462263|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83462264|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83462265|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
83462266|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462267|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462268|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83462269|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462270|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83462271|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
83462272|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
83462273|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462274|NCT05493228|Dexmedetomidine|dexmedetomidine|mesh-list
83462275|NCT05493228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83462276|NCT05493228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462277|NCT05493228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462278|NCT05493228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83462279|NCT05493228|Analgesics|analgesics|mesh-ancestor
83462280|NCT05493228|Sensory System Agents|sensory system agents|mesh-ancestor
83462281|NCT05493228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462282|NCT05493228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83462284|NCT05493228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83462285|NCT05493228|Adrenergic Agents|adrenergic agents|mesh-ancestor
83462286|NCT05493228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462287|NCT05493228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462289|NCT02758132|Prednisone|prednisone|mesh-list
83462290|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83462291|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
83462292|NCT02758132|Hormones|hormones|mesh-ancestor
83462293|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462294|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462295|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83462296|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462297|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83462299|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
83462300|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
83462301|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462302|NCT01313416|Gemcitabine|gemcitabine|mesh-list
83462303|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83462304|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
83462305|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462306|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462307|NCT05599360|Gemtuzumab|gemtuzumab|mesh-list
83462308|NCT05599360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462309|NCT05599360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462310|NCT05599360|Immunotoxins|immunotoxins|mesh-ancestor
83462311|NCT05599360|Immunoconjugates|immunoconjugates|mesh-ancestor
83462312|NCT05599360|Immunologic Factors|immunologic factors|mesh-ancestor
83462313|NCT05599360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462314|NCT05499234|Acetaminophen|acetaminophen|mesh-list
83462315|NCT05499234|Meperidine|meperidine|mesh-list
83480596|NCT03675893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83462316|NCT05499234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83462317|NCT05499234|Analgesics|analgesics|mesh-ancestor
83462318|NCT05499234|Sensory System Agents|sensory system agents|mesh-ancestor
83462319|NCT05499234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462320|NCT05499234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462321|NCT05499234|Antipyretics|antipyretics|mesh-ancestor
83462322|NCT05499234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83462323|NCT05499234|Narcotics|narcotics|mesh-ancestor
83462324|NCT05499234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462325|NCT05499234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83462326|NCT01269034|Insulin|insulin|mesh-list
83462327|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83462328|NCT01269034|Exenatide|exenatide|mesh-list
83462329|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
83462330|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
83462331|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
83462332|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83462333|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462334|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83462335|NCT01269034|Incretins|incretins|mesh-ancestor
83462336|NCT01269034|Hormones|hormones|mesh-ancestor
83462337|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462338|NCT05599126|Lorazepam|lorazepam|mesh-list
83462339|NCT05599126|Mianserin|mianserin|mesh-list
83462340|NCT05599126|Anticonvulsants|anticonvulsants|mesh-ancestor
83462341|NCT05599126|Antiemetics|antiemetics|mesh-ancestor
83462342|NCT05599126|Autonomic Agents|autonomic agents|mesh-ancestor
83462343|NCT05599126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462344|NCT05599126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462345|NCT05599126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83462346|NCT05599126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83462347|NCT05599126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462348|NCT05599126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83462349|NCT05599126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83462350|NCT05599126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83462351|NCT05599126|GABA Modulators|gaba modulators|mesh-ancestor
83462352|NCT05599126|GABA Agents|gaba agents|mesh-ancestor
83462353|NCT05599126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462354|NCT05599126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462355|NCT05599126|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83462356|NCT05599126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83462357|NCT05599126|Adrenergic Agents|adrenergic agents|mesh-ancestor
83462358|NCT05599126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83462359|NCT05599126|Histamine Antagonists|histamine antagonists|mesh-ancestor
83462361|NCT05599126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83462362|NCT05599126|Serotonin Agents|serotonin agents|mesh-ancestor
83462363|NCT05599126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83462364|NCT05599126|Antidepressive Agents|antidepressive agents|mesh-ancestor
83462365|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
83462366|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83462367|NCT01892150|Protective Agents|protective agents|mesh-ancestor
83462368|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462369|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
83462370|NCT02663752|Deferasirox|deferasirox|mesh-list
83462371|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83462372|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
83462373|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
83462374|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462375|NCT01253668|Antibodies|antibodies|mesh-list
83462376|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83462377|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
83462378|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462379|NCT01890200|Ribavirin|ribavirin|mesh-list
83462380|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83462381|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
83462382|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462383|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
83462384|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462385|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83462386|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83462387|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83462388|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462389|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462390|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83480965|NCT01866930|Ribavirin|ribavirin|mesh-list
83462391|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83462392|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83462393|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
83462394|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462395|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462396|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83462397|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83462398|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
83462399|NCT05586620|Mitomycins|mitomycins|mesh-list
83462400|NCT05586620|Mitomycin|mitomycin|mesh-list
83462401|NCT05586620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83462402|NCT05586620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462403|NCT05586620|Alkylating Agents|alkylating agents|mesh-ancestor
83476348|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462404|NCT05586620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462405|NCT05586620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83462406|NCT05586620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462407|NCT01893788|Eplerenone|eplerenone|mesh-list
83462408|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83462409|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
83462410|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462411|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462412|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83462413|NCT01893788|Diuretics|diuretics|mesh-ancestor
83462414|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
83462415|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83462416|NCT01231750|Capsaicin|capsaicin|mesh-list
83462417|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
83462418|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
83462419|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
83462420|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462421|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462422|NCT05488860|Triamcinolone|triamcinolone|mesh-list
83462423|NCT05488860|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83462424|NCT05488860|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83462425|NCT05488860|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83462426|NCT05488860|Photosensitizing Agents|photosensitizing agents|mesh-list
83462427|NCT05488860|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83462428|NCT05488860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83462429|NCT05488860|Glucocorticoids|glucocorticoids|mesh-ancestor
83462430|NCT05488860|Hormones|hormones|mesh-ancestor
83462431|NCT05488860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462432|NCT05488860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462433|NCT05488860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83462434|NCT05488860|Immunologic Factors|immunologic factors|mesh-ancestor
83462435|NCT05488860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462436|NCT05488860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462437|NCT05488860|Dermatologic Agents|dermatologic agents|mesh-ancestor
83462438|NCT02549716|Acetaminophen|acetaminophen|mesh-list
83462439|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83462440|NCT02549716|Analgesics|analgesics|mesh-ancestor
83462441|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
83462442|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476349|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83462443|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462445|NCT01207726|Azacitidine|azacitidine|mesh-list
83462446|NCT01207726|Entinostat|entinostat|mesh-list
83462447|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83462448|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83462449|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
83462450|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462451|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462452|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462453|NCT02534038|Quinidine|quinidine|mesh-list
83462454|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
83462455|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
83462456|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
83462457|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83462458|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83462459|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462460|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462461|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462462|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83462463|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83462464|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
83462465|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83462466|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
83462467|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83462468|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83462469|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462470|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462471|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83462472|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83462473|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
83462474|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83462475|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83462476|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83462477|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83462478|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83462480|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83462481|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83462482|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
83462483|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462484|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462485|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462486|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83462487|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83462488|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
83462489|NCT02556918|Insulin|insulin|mesh-list
83462490|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83462491|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
83462492|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83462493|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
83462494|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
83462495|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83462496|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462497|NCT02556918|Incretins|incretins|mesh-ancestor
83462498|NCT02556918|Hormones|hormones|mesh-ancestor
83462499|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462500|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83462501|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
83462502|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462503|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462504|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83462505|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
83462506|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83462507|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83462508|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462509|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462510|NCT00379756|Urological Agents|urological agents|mesh-ancestor
83462511|NCT02518750|Cytarabine|cytarabine|mesh-list
83462512|NCT02518750|Dexamethasone|dexamethasone|mesh-list
83462513|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
83462514|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
83462515|NCT02518750|Methotrexate|methotrexate|mesh-list
83462516|NCT02518750|Etoposide|etoposide|mesh-list
83462518|NCT02518750|Bortezomib|bortezomib|mesh-list
83462519|NCT02518750|Asparaginase|asparaginase|mesh-list
83462520|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
83462521|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
83462522|NCT02518750|Clofarabine|clofarabine|mesh-list
83462523|NCT02518750|Panobinostat|panobinostat|mesh-list
83462524|NCT02518750|Pegaspargase|pegaspargase|mesh-list
83462525|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83462526|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
83462527|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462528|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83462529|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83462530|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
83462531|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462532|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462533|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83462534|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83462535|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
83462536|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
83462537|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462538|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83462539|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
83462541|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462542|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83462543|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83462544|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
83462545|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83462546|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83462547|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
83462548|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
83462549|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462550|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83462551|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83462552|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83476350|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83462553|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83462554|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83462555|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
83462556|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462557|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
83462558|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
83462559|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
83462560|NCT02518750|Analgesics|analgesics|mesh-ancestor
83462561|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
83462562|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83462563|NCT01194856|Ritonavir|ritonavir|mesh-list
83462564|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83462565|NCT01194856|Efavirenz|efavirenz|mesh-list
83462566|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83462567|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83462568|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
83462569|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462570|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462571|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83462572|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83462573|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
83462574|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462575|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83462576|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83462577|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83462578|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83462579|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83462580|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83462581|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83462582|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83462583|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83462584|NCT01182610|Paclitaxel|paclitaxel|mesh-list
83462585|NCT01182610|Carboplatin|carboplatin|mesh-list
83462586|NCT01182610|Fluorouracil|fluorouracil|mesh-list
83462587|NCT01182610|Panitumumab|panitumumab|mesh-list
83462588|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83462589|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462590|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
83462591|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
83462592|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
83462593|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462594|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
83462595|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83462596|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83462597|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
83462598|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462599|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462600|NCT05491902|Flutemetamol|flutemetamol|mesh-list
83462601|NCT05491902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83462602|NCT05491902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462603|NCT05485896|Pembrolizumab|pembrolizumab|mesh-list
83462604|NCT05485896|Lenvatinib|lenvatinib|mesh-list
83462605|NCT05485896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462606|NCT05485896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462607|NCT05485896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83462608|NCT05485896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462609|NCT05485896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83462610|NCT05485896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462611|NCT05526430|Harmine|harmine|mesh-list
83462612|NCT05526430|Hallucinogens|hallucinogens|mesh-ancestor
83462613|NCT05526430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462614|NCT05526430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83462615|NCT05526430|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83462616|NCT05526430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462617|NCT05526430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462618|NCT05507398|Metformin|metformin|mesh-list
83462619|NCT05507398|Atorvastatin|atorvastatin|mesh-list
83462620|NCT05507398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83462621|NCT05507398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462622|NCT05507398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83462623|NCT05507398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83462624|NCT05507398|Antimetabolites|antimetabolites|mesh-ancestor
83462625|NCT05507398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462626|NCT05507398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83462627|NCT05507398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83462628|NCT05507398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462629|NCT05487300|Levodopa|levodopa|mesh-list
83462630|NCT05487300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83462631|NCT05487300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83462632|NCT05487300|Dopamine Agents|dopamine agents|mesh-ancestor
83462633|NCT05487300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462634|NCT05487300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462635|NCT05487300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462636|NCT01147042|Interferons|interferons|mesh-list
83462637|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
83462638|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462639|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
83462640|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462641|NCT05485272|Fluorides|fluorides|mesh-list
83462642|NCT05485272|Cariostatic Agents|cariostatic agents|mesh-ancestor
83462643|NCT05485272|Protective Agents|protective agents|mesh-ancestor
83462644|NCT05485272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462645|NCT01108666|Nelfinavir|nelfinavir|mesh-list
83462646|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83462647|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83462648|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
83462649|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476351|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83462650|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462651|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83462652|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83462653|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
83462654|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462655|NCT02317276|Triamcinolone|triamcinolone|mesh-list
83462656|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83462657|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83462658|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83462659|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83462660|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
83462661|NCT02317276|Hormones|hormones|mesh-ancestor
83462662|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462664|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83462665|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
83462666|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462667|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462668|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
83462669|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83462670|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83462671|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83462672|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83462673|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462674|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
83462675|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462676|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462677|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83462678|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462679|NCT00378976|Valacyclovir|valacyclovir|mesh-list
83462680|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
83462681|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462682|NCT05342974|Misoprostol|misoprostol|mesh-list
83462683|NCT05342974|Atorvastatin|atorvastatin|mesh-list
83462684|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83462685|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83462686|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
83462687|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462688|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83462689|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83462690|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462691|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83462692|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
83462693|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83462694|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462695|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83462696|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83462698|NCT02297230|Paclitaxel|paclitaxel|mesh-list
83462699|NCT02297230|Capecitabine|capecitabine|mesh-list
83462700|NCT02297230|Trastuzumab|trastuzumab|mesh-list
83462701|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83462702|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462703|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
83462704|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
83462705|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
83462706|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462707|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83476352|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
83462709|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462710|NCT02282332|Ticagrelor|ticagrelor|mesh-list
83462711|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83462712|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83462713|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83462714|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83462716|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462717|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462718|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462719|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83462720|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83462721|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462722|NCT05486988|Antineoplastic Agents|antineoplastic agents|mesh-list
83462723|NCT02253394|Ambrisentan|ambrisentan|mesh-list
83462724|NCT02253394|Spironolactone|spironolactone|mesh-list
83462725|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83462726|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
83462727|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462728|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462729|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83462730|NCT02253394|Diuretics|diuretics|mesh-ancestor
83462731|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
83462732|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83462733|NCT05479032|Amantadine|amantadine|mesh-list
83462734|NCT05479032|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83462736|NCT05479032|Antiviral Agents|antiviral agents|mesh-ancestor
83462737|NCT05479032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462738|NCT05479032|Dopamine Agents|dopamine agents|mesh-ancestor
83462739|NCT05479032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462740|NCT05479032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462741|NCT05479032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462742|NCT05479032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83462743|NCT05479032|Analgesics|analgesics|mesh-ancestor
83462744|NCT05479032|Sensory System Agents|sensory system agents|mesh-ancestor
83462745|NCT05479032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462747|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83462748|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83462749|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462750|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
83462751|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
83462752|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462753|NCT05484648|Dexamethasone|dexamethasone|mesh-list
83462754|NCT05484648|Dexmedetomidine|dexmedetomidine|mesh-list
83462755|NCT05484648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83462756|NCT05484648|Antiemetics|antiemetics|mesh-ancestor
83462757|NCT05484648|Autonomic Agents|autonomic agents|mesh-ancestor
83462758|NCT05484648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462759|NCT05484648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462760|NCT05484648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83462761|NCT05484648|Glucocorticoids|glucocorticoids|mesh-ancestor
83462763|NCT05484648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462764|NCT05484648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83462765|NCT05484648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462766|NCT05484648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83462767|NCT05484648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476353|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
83462768|NCT05484648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83462769|NCT05484648|Analgesics|analgesics|mesh-ancestor
83462770|NCT05484648|Sensory System Agents|sensory system agents|mesh-ancestor
83462771|NCT05484648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83462772|NCT05484648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83462773|NCT05484648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83462774|NCT05484648|Adrenergic Agents|adrenergic agents|mesh-ancestor
83462775|NCT05484648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462776|NCT05484648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462777|NCT05478954|Pyrimethamine|pyrimethamine|mesh-list
83462778|NCT05478954|Sulfadoxine|sulfadoxine|mesh-list
83462779|NCT05478954|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83462781|NCT05478954|Antimalarials|antimalarials|mesh-ancestor
83462782|NCT05478954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83462783|NCT05478954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83462784|NCT05478954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462785|NCT05478954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83462786|NCT05478954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462787|NCT05478954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462788|NCT05478954|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83462789|NCT02137096|Carboplatin|carboplatin|mesh-list
83462790|NCT02137096|Etoposide|etoposide|mesh-list
83462791|NCT02137096|Ifosfamide|ifosfamide|mesh-list
83462792|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
83462793|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481209|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83462794|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83462795|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83462796|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83462797|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462798|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462799|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83462800|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
83462801|NCT02130622|Promethazine|promethazine|mesh-list
83462802|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
83462803|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
83462804|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
83462805|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83462806|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
83462807|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
83462808|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462809|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462810|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462811|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83462812|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83462813|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83462814|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462815|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
83462816|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
83462817|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
83462818|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462819|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
83462820|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
83462821|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83462822|NCT02134912|Pemetrexed|pemetrexed|mesh-list
83462823|NCT02134912|Crizotinib|crizotinib|mesh-list
83462824|NCT02134912|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83462825|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462826|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462827|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462828|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83462829|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83462830|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83462831|NCT02094352|Ketamine|ketamine|mesh-list
83462832|NCT02094352|Analgesics|analgesics|mesh-ancestor
83462833|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
83462834|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481210|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
83462842|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83462843|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462844|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462845|NCT05478876|Immunomodulating Agents|immunomodulating agents|mesh-list
83462847|NCT05478876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462849|NCT01188421|Buprenorphine|buprenorphine|mesh-list
83462850|NCT01188421|Tramadol|tramadol|mesh-list
83462851|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83462852|NCT01188421|Naloxone|naloxone|mesh-list
83462853|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83462854|NCT01188421|Narcotics|narcotics|mesh-ancestor
83462855|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462856|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462857|NCT01188421|Analgesics|analgesics|mesh-ancestor
83462858|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
83462859|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462860|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83462861|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83462862|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
83462863|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
83462864|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83462865|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83462866|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83462867|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
83462868|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462869|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462870|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
83462871|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83462872|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83462873|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462874|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
83462875|NCT03780894|Coagulants|coagulants|mesh-ancestor
83462876|NCT01006018|Pioglitazone|pioglitazone|mesh-list
83462877|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83462878|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83462879|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462880|NCT01006018|Incretins|incretins|mesh-ancestor
83462881|NCT01006018|Hormones|hormones|mesh-ancestor
83462882|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462883|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83462884|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
83462885|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462886|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462887|NCT00996502|Prednisone|prednisone|mesh-list
83462888|NCT00996502|Bevacizumab|bevacizumab|mesh-list
83462889|NCT00996502|Docetaxel|docetaxel|mesh-list
83481367|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
83462891|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462892|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462893|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83462894|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83462895|NCT00996502|Growth Substances|growth substances|mesh-ancestor
83462896|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462897|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
83462898|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
83462899|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
83462900|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
83462901|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462902|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83462904|NCT00996502|Hormones|hormones|mesh-ancestor
83462905|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462906|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83462907|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83462908|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462909|NCT00984490|Metformin|metformin|mesh-list
83462910|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83462911|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462912|NCT05484024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83462913|NCT05484024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462914|NCT05484024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462915|NCT05484024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462916|NCT02027272|Dexamethasone|dexamethasone|mesh-list
83462917|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
83462918|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83462919|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
83462920|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
83462921|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462922|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462923|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83462924|NCT02027272|Hormones|hormones|mesh-ancestor
83462925|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462926|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83462927|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462928|NCT05475444|Ciprofloxacin|ciprofloxacin|mesh-list
83462929|NCT05475444|Chitosan|chitosan|mesh-list
83462930|NCT05475444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83462931|NCT05475444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462932|NCT05475444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83462933|NCT05475444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83462935|NCT05475444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462936|NCT05475444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462937|NCT05475444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83462938|NCT05475444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83462939|NCT05475444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83462940|NCT05475444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83462941|NCT05475444|Antimetabolites|antimetabolites|mesh-ancestor
83462942|NCT05475444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83462944|NCT05475444|Sequestering Agents|sequestering agents|mesh-ancestor
83462945|NCT05475444|Hemostatics|hemostatics|mesh-ancestor
83462946|NCT05475444|Coagulants|coagulants|mesh-ancestor
83462947|NCT03472092|Amitriptyline|amitriptyline|mesh-list
83462948|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83462949|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
83462950|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83462951|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83462952|NCT03472092|Analgesics|analgesics|mesh-ancestor
83462953|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
83462954|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462955|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462956|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83462957|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83462958|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83462959|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462960|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
83462961|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462962|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
83462963|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462964|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
83462965|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83462966|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83462967|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83462968|NCT01996852|Urological Agents|urological agents|mesh-ancestor
83462969|NCT05478330|Flutamide|flutamide|mesh-list
83462970|NCT05478330|Androgen Antagonists|androgen antagonists|mesh-ancestor
83462971|NCT05478330|Hormone Antagonists|hormone antagonists|mesh-ancestor
83462972|NCT05478330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83462973|NCT05478330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462974|NCT05478330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83462975|NCT05478330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462976|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83462977|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83462978|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462979|NCT04331626|Gemcitabine|gemcitabine|mesh-list
83462980|NCT04331626|Nivolumab|nivolumab|mesh-list
83462981|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83462982|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
83481616|NCT05258292|Insulin|insulin|mesh-list
83462983|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462984|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462985|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83462986|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83462987|NCT03699540|Ethanol|ethanol|mesh-list
83462988|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83462989|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462991|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462992|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83462993|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83462994|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83462995|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
83462996|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462997|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83462998|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83462999|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463000|NCT01973062|Rituximab|rituximab|mesh-list
83463001|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83463002|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83463003|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463004|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
83463005|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463006|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83463008|NCT03661320|Nivolumab|nivolumab|mesh-list
83463009|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463010|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83463012|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463013|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83463014|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83463015|NCT00981370|Deferasirox|deferasirox|mesh-list
83463016|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83463017|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
83463018|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
83481617|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83463019|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463020|NCT00979810|Alovudine|alovudine|mesh-list
83463021|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
83463022|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463023|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83463024|NCT04549116|Progesterone|progesterone|mesh-list
83463025|NCT04549116|Progestins|progestins|mesh-ancestor
83463026|NCT04549116|Hormones|hormones|mesh-ancestor
83463027|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83463028|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463029|NCT00947284|Nalbuphine|nalbuphine|mesh-list
83463030|NCT00947284|Naloxone|naloxone|mesh-list
83463031|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83463032|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463033|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
83463034|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463035|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83463036|NCT00947284|Narcotics|narcotics|mesh-ancestor
83463037|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463038|NCT00947284|Analgesics|analgesics|mesh-ancestor
83463039|NCT03995706|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83463040|NCT03995706|Immunoconjugates|immunoconjugates|mesh-ancestor
83463041|NCT03995706|Immunologic Factors|immunologic factors|mesh-ancestor
83463042|NCT03995706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463043|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83463044|NCT00932152|Bevacizumab|bevacizumab|mesh-list
83463045|NCT00932152|Fulvestrant|fulvestrant|mesh-list
83463046|NCT00932152|Anastrozole|anastrozole|mesh-list
83463048|NCT00932152|Antiemetics|antiemetics|mesh-list
83463049|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83463050|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463051|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83463052|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83463053|NCT00932152|Growth Substances|growth substances|mesh-ancestor
83463054|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463055|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
83463056|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463057|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83463058|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83463059|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83463060|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
83463061|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83463062|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83463063|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83463064|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463065|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463066|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
83463067|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463069|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83463070|NCT01916590|Bupivacaine|bupivacaine|mesh-list
83463071|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
83463072|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
83463073|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463074|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463075|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
83463076|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463077|NCT01890694|Tolvaptan|tolvaptan|mesh-list
83463078|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83463079|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463081|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463082|NCT05474898|Magnesium Sulfate|magnesium sulfate|mesh-list
83463083|NCT05474898|Analgesics|analgesics|mesh-ancestor
83463084|NCT05474898|Sensory System Agents|sensory system agents|mesh-ancestor
83463085|NCT05474898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463086|NCT05474898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463087|NCT05474898|Anesthetics|anesthetics|mesh-ancestor
83463088|NCT05474898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463089|NCT05474898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83463090|NCT05474898|Anticonvulsants|anticonvulsants|mesh-ancestor
83463091|NCT05474898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83463092|NCT05474898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83463093|NCT05474898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463094|NCT05474898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83463095|NCT05474898|Tocolytic Agents|tocolytic agents|mesh-ancestor
83463096|NCT05474898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83463097|NCT03428958|Leucovorin|leucovorin|mesh-list
83463098|NCT03428958|Bevacizumab|bevacizumab|mesh-list
83463099|NCT03428958|Cetuximab|cetuximab|mesh-list
83463100|NCT03428958|Panitumumab|panitumumab|mesh-list
83463101|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
83463102|NCT03428958|Irinotecan|irinotecan|mesh-list
83463103|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
83463104|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83463105|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463106|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83463107|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83463108|NCT03428958|Growth Substances|growth substances|mesh-ancestor
83463109|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463110|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
83463111|NCT03428958|Antidotes|antidotes|mesh-ancestor
83463112|NCT03428958|Protective Agents|protective agents|mesh-ancestor
83463113|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
83463114|NCT03428958|Vitamins|vitamins|mesh-ancestor
83463115|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
83463116|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83463117|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83463118|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463119|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463120|NCT01844206|Morphine|morphine|mesh-list
83463121|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83463122|NCT01844206|Narcotics|narcotics|mesh-ancestor
83463123|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463124|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463126|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
83463127|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463129|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83463130|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83463131|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83463132|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
83463133|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83463134|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463135|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463136|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
83463137|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
83463138|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463140|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
83463141|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463142|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
83463143|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83463144|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83463145|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463146|NCT01830790|Urological Agents|urological agents|mesh-ancestor
83463147|NCT01662102|Rituximab|rituximab|mesh-list
83463148|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83463149|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463150|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
83463151|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463153|NCT03950076|Edoxaban|edoxaban|mesh-list
83463154|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83463156|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83463157|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
83463158|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463160|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
83463161|NCT05292976|Albuterol|albuterol|mesh-list
83463162|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
83463163|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83463164|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
83463165|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463166|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463167|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83463168|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
83463169|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
83463170|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83463171|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83463172|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83463174|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
83463175|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83463176|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463177|NCT05292976|Miotics|miotics|mesh-ancestor
83463178|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83463179|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83463180|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83463181|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83463182|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
83463183|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
83463184|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83463185|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83463186|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83463187|NCT00850720|Vasopressins|vasopressins|mesh-list
83463188|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463189|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
83463190|NCT00850720|Coagulants|coagulants|mesh-ancestor
83463191|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83463192|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83463193|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
83463195|NCT00843310|Dexamethasone|dexamethasone|mesh-list
83463196|NCT00843310|Lenalidomide|lenalidomide|mesh-list
83463197|NCT00843310|Melphalan|melphalan|mesh-list
83463198|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83463199|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
83463200|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
83463201|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463202|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463204|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
83463206|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83463207|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83463208|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463209|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
83463210|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83463211|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83463212|NCT00843310|Growth Substances|growth substances|mesh-ancestor
83463213|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
83463214|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83463215|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
83476354|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83463216|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463217|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83463218|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83463220|NCT00809458|Tocopherols|tocopherols|mesh-list
83463221|NCT00809458|Tocotrienols|tocotrienols|mesh-list
83463222|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
83463223|NCT00809458|Vitamins|vitamins|mesh-ancestor
83463224|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
83463225|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463226|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
83463227|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463228|NCT00809458|Protective Agents|protective agents|mesh-ancestor
83463229|NCT01701622|Febuxostat|febuxostat|mesh-list
83463230|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
83463231|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83463232|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
83463233|NCT00786682|Docetaxel|docetaxel|mesh-list
83463234|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463235|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
83463236|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
83463237|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
83463238|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463240|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83463241|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83463242|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463243|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463244|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83463245|NCT01675960|Gabapentin|gabapentin|mesh-list
83463246|NCT01675960|Analgesics|analgesics|mesh-ancestor
83463247|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
83463248|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463249|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463250|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
83463251|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83463252|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83463253|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463254|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83463255|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83463256|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83463257|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83463258|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463259|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
83463260|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83463261|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83463263|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
83463264|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83463265|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
83463266|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83463267|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463268|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83463269|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
83463270|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83463271|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83463272|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83463273|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83463274|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
83463275|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83463276|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83463277|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83463278|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463279|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83463280|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83463281|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83463282|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83463283|NCT01606150|Lidocaine|lidocaine|mesh-list
83463284|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
83463286|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463287|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463288|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
83463289|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463290|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83463291|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83463292|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83463293|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83463294|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463295|NCT01602016|Leucovorin|leucovorin|mesh-list
83463296|NCT01602016|Folic Acid|folic acid|mesh-list
83463297|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
83463299|NCT01602016|Protective Agents|protective agents|mesh-ancestor
83463300|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463301|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
83463303|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
83463304|NCT01602016|Hematinics|hematinics|mesh-ancestor
83463305|NCT00731770|Fluticasone|fluticasone|mesh-list
83463306|NCT00731770|Xhance|xhance|mesh-list
83463307|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83463308|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83463309|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83463310|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83463311|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
83463312|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463313|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482116|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83463314|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83463315|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
83463316|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
83463317|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83463318|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83463319|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83463320|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83463321|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
83463322|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83463323|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463324|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
83463325|NCT00731770|Hormones|hormones|mesh-ancestor
83463326|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83463328|NCT00719914|Eptifibatide|eptifibatide|mesh-list
83463329|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83463330|NCT01566370|Zonisamide|zonisamide|mesh-list
83463331|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
83463332|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83463333|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83463334|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463335|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83463336|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463337|NCT03414684|Carboplatin|carboplatin|mesh-list
83463338|NCT03414684|Nivolumab|nivolumab|mesh-list
83463339|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463340|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83463341|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83463342|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463343|NCT01558492|Paclitaxel|paclitaxel|mesh-list
83463344|NCT01558492|Carboplatin|carboplatin|mesh-list
83463345|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83463346|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463347|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
83463348|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
83463350|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463352|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463353|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463354|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
83463355|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
83463356|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
83463357|NCT05286190|Bupivacaine|bupivacaine|mesh-list
83463358|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
83463359|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
83463360|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463361|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463362|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
83463363|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463364|NCT03399552|Avelumab|avelumab|mesh-list
83463365|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83463366|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463367|NCT00691444|Melatonin|melatonin|mesh-list
83463368|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
83463369|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463370|NCT00691444|Protective Agents|protective agents|mesh-ancestor
83463371|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463372|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463373|NCT05477004|Ketamine|ketamine|mesh-list
83463374|NCT05477004|Analgesics|analgesics|mesh-ancestor
83463375|NCT05477004|Sensory System Agents|sensory system agents|mesh-ancestor
83463376|NCT05477004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463377|NCT05477004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463378|NCT05477004|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83463379|NCT05477004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83463380|NCT05477004|Anesthetics, General|anesthetics, general|mesh-ancestor
83463381|NCT05477004|Anesthetics|anesthetics|mesh-ancestor
83463382|NCT05477004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463383|NCT05477004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83463384|NCT05477004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83463385|NCT05477004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83463386|NCT05477004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463388|NCT05482464|Chelating Agents|chelating agents|mesh-ancestor
83463389|NCT05482464|Sequestering Agents|sequestering agents|mesh-ancestor
83463390|NCT05482464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463391|NCT01530880|Acetaminophen|acetaminophen|mesh-list
83463392|NCT01530880|Ibuprofen|ibuprofen|mesh-list
83463393|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83463394|NCT01530880|Analgesics|analgesics|mesh-ancestor
83463395|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
83463396|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463397|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463398|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
83463399|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83463400|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83463401|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83463402|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83463403|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463404|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463405|NCT05482074|Olaparib|olaparib|mesh-list
83463406|NCT05482074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83463407|NCT05482074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463408|NCT05482074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463409|NCT05482074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463410|NCT00678574|Fluoxetine|fluoxetine|mesh-list
83463411|NCT00678574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83463412|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83463413|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83463414|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463415|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83463416|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
83463417|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463418|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83463419|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
83463420|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83463421|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83463422|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83463423|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463425|NCT01475500|Chelating Agents|chelating agents|mesh-ancestor
83463426|NCT01475500|Sequestering Agents|sequestering agents|mesh-ancestor
83482193|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83463427|NCT01475500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463428|NCT02551692|Nicotine|nicotine|mesh-list
83463429|NCT02551692|Varenicline|varenicline|mesh-list
83463430|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83463431|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
83463432|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463433|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463434|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83463435|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83463436|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
83463437|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83463438|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463439|NCT00542542|Fentanyl|fentanyl|mesh-list
83463440|NCT00542542|Midazolam|midazolam|mesh-list
83463441|NCT00542542|Propofol|propofol|mesh-list
83463442|NCT00542542|Ropivacaine|ropivacaine|mesh-list
83463443|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83463444|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482194|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
83463445|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463446|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83463447|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
83463448|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
83463449|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
83463450|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
83463451|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463452|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83463453|NCT00542542|Narcotics|narcotics|mesh-ancestor
83463454|NCT00542542|Analgesics|analgesics|mesh-ancestor
83463455|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83463456|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83463457|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83463458|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83463459|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
83463460|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
83463461|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83463462|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463463|NCT05471544|Pyrimethamine|pyrimethamine|mesh-list
83463464|NCT05471544|Sulfadoxine|sulfadoxine|mesh-list
83463465|NCT05471544|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83463466|NCT05471544|Amodiaquine|amodiaquine|mesh-list
83463467|NCT05471544|Antimalarials|antimalarials|mesh-ancestor
83463468|NCT05471544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83463469|NCT05471544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83463470|NCT05471544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463471|NCT05471544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83463472|NCT05471544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463473|NCT05471544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463474|NCT05471544|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83463475|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
83463476|NCT03333486|Fludarabine|fludarabine|mesh-list
83463477|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
83463478|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83463479|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
83463480|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463481|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83463482|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83463483|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
83463484|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463485|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463486|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83463487|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83463488|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
83463489|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
83463490|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83463491|NCT02598778|Listerine|listerine|mesh-list
83463492|NCT02598778|Fluorides|fluorides|mesh-list
83463493|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
83463495|NCT02598778|Protective Agents|protective agents|mesh-ancestor
83463496|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463497|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83463498|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463499|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
83463500|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
83463501|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
83463502|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83463504|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463505|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
83463506|NCT00642382|Protective Agents|protective agents|mesh-ancestor
83463507|NCT05476380|Paclitaxel|paclitaxel|mesh-list
83463508|NCT05476380|Cisplatin|cisplatin|mesh-list
83463509|NCT05476380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83463510|NCT05476380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463511|NCT05476380|Tubulin Modulators|tubulin modulators|mesh-ancestor
83463512|NCT05476380|Antimitotic Agents|antimitotic agents|mesh-ancestor
83463513|NCT05476380|Mitosis Modulators|mitosis modulators|mesh-ancestor
83463514|NCT05476380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463515|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83463516|NCT00634972|Ketorolac|ketorolac|mesh-list
83463517|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83463518|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83463520|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
83463522|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463523|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83463524|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83482518|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
83463525|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83463526|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463527|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463528|NCT00529282|Vancomycin|vancomycin|mesh-list
83463529|NCT00529282|Cefepime|cefepime|mesh-list
83463530|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
83463531|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
83463532|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83463534|NCT00623974|Teriparatide|teriparatide|mesh-list
83463535|NCT00623974|Calcitriol|calcitriol|mesh-list
83463536|NCT00623974|Calcium|calcium|mesh-list
83463537|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
83463538|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83463539|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463540|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83463541|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83463542|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83463543|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463544|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83463545|NCT00623974|Vitamins|vitamins|mesh-ancestor
83463546|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
83463548|NCT02550288|Ezetimibe|ezetimibe|mesh-list
83463549|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83463550|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83463551|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
83463552|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463553|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83463554|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83463556|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
83463557|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
83463558|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83463559|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
83463560|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83463561|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83463562|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463563|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83463564|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463565|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463566|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83463567|NCT00496756|Sorafenib|sorafenib|mesh-list
83463568|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463569|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83463570|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463571|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463572|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
83463573|NCT00500890|Carboplatin|carboplatin|mesh-list
83463574|NCT00500890|Etoposide|etoposide|mesh-list
83463575|NCT00500890|Vincristine|vincristine|mesh-list
83463576|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83463577|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
83463578|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463579|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83463580|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83463581|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
83463582|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463584|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83463585|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83463586|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83463587|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83463588|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463589|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
83463590|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
83463591|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
83463593|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
83463594|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463595|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83482519|NCT00538304|Bimatoprost|bimatoprost|mesh-list
83463596|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83463598|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
83463599|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463600|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83463601|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83463602|NCT00379522|Vasopressins|vasopressins|mesh-list
83463603|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
83463604|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
83463605|NCT00379522|Coagulants|coagulants|mesh-ancestor
83463606|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83463607|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83463608|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
83463609|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463610|NCT00421954|Ziprasidone|ziprasidone|mesh-list
83463612|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
83463613|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83463614|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463615|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463616|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83463617|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83463618|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463619|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83463620|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83463621|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
83463622|NCT01662336|Ritonavir|ritonavir|mesh-list
83463623|NCT01662336|Lopinavir|lopinavir|mesh-list
83463624|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83463625|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83463626|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
83463627|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463628|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463629|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83463630|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83463631|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
83463632|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463633|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83482520|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83463634|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83463635|NCT00000766|Ganciclovir|ganciclovir|mesh-list
83463636|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83463637|NCT00000766|Foscarnet|foscarnet|mesh-list
83463638|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83463639|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
83463640|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463641|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83463642|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463643|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463644|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83463646|NCT00000772|Didanosine|didanosine|mesh-list
83463647|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
83463648|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463649|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
83463650|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463651|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83463652|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83463653|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463654|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83463655|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83463656|NCT00572260|Daptomycin|daptomycin|mesh-list
83463657|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83463658|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463659|NCT00000778|Pyridoxine|pyridoxine|mesh-list
83463660|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
83463661|NCT00000778|Levofloxacin|levofloxacin|mesh-list
83463663|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83463665|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83463666|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83463667|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83463668|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463669|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463670|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463671|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83463672|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83463673|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
83463674|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83463675|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83463676|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
83463677|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83463678|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
83463680|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
83463681|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463683|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
83463684|NCT00000796|Levofloxacin|levofloxacin|mesh-list
83463686|NCT00000796|Rifampin|rifampin|mesh-list
83463687|NCT00000796|Isoniazid|isoniazid|mesh-list
83463688|NCT00000796|Amikacin|amikacin|mesh-list
83463689|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
83463690|NCT00000796|Ethambutol|ethambutol|mesh-list
83463691|NCT00000796|Clofazimine|clofazimine|mesh-list
83463692|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83463693|NCT00000796|Streptomycin|streptomycin|mesh-list
83463694|NCT00000796|Ethionamide|ethionamide|mesh-list
83463695|NCT00000796|Capreomycin|capreomycin|mesh-list
83463696|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83463697|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463698|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83463699|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83463700|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83463701|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463702|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463703|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463704|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83463705|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83463706|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83463707|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
83463708|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
83463709|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83463710|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83463711|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83463712|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83463713|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83463714|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83463715|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83463716|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83463717|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83463718|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
83463719|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83463720|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
83463721|NCT00000796|Vitamins|vitamins|mesh-ancestor
83463722|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
83463723|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463724|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83463725|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83463726|NCT00000802|Dapsone|dapsone|mesh-list
83463728|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463729|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
83463730|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83463732|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83463733|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463734|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463736|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83463737|NCT02389946|Sirolimus|sirolimus|mesh-list
83463738|NCT02389946|Everolimus|everolimus|mesh-list
83463739|NCT02389946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83463740|NCT02389946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83463741|NCT02389946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463742|NCT02389946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463743|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83463744|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
83463745|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463746|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463747|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83463748|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463749|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83463750|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
83463751|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
83463752|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463753|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83463754|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463755|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463756|NCT00268450|Paclitaxel|paclitaxel|mesh-list
83463757|NCT00268450|Bevacizumab|bevacizumab|mesh-list
83463758|NCT00268450|Gemcitabine|gemcitabine|mesh-list
83482612|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
83463760|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463761|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
83463763|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
83463764|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463765|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83463766|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83463767|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83463768|NCT00268450|Growth Substances|growth substances|mesh-ancestor
83463769|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463771|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83463772|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
83463773|NCT00000808|Nevirapine|nevirapine|mesh-list
83463774|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83463775|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83463776|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463777|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463778|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
83482613|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
83463779|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463780|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83463781|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83463782|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83463783|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83463784|NCT01892384|BI 409306|bi 409306|mesh-list
83463785|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83463786|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463787|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463788|NCT00000814|Zidovudine|zidovudine|mesh-list
83463789|NCT00000814|Nevirapine|nevirapine|mesh-list
83463790|NCT00000814|Didanosine|didanosine|mesh-list
83463791|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
83476448|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
83463792|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463793|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83463794|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83463796|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
83463797|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463798|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83463799|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83463800|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83463801|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83463802|NCT02661932|Letrozole|letrozole|mesh-list
83463803|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463804|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83463805|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83463806|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463807|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463808|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83463809|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
83463810|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83463811|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463813|NCT02658890|Ipilimumab|ipilimumab|mesh-list
83463814|NCT02658890|Linrodostat|linrodostat|mesh-list
83463815|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83463817|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83463818|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463819|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463820|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
83463821|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83463822|NCT00177970|Antibodies|antibodies|mesh-list
83463823|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
83463824|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
83463825|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83463826|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
83463827|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483012|NCT03007927|Dexamethasone|dexamethasone|mesh-list
83463828|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83463830|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463831|NCT00088972|Celecoxib|celecoxib|mesh-list
83463832|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83463833|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83463834|NCT00088972|Analgesics|analgesics|mesh-ancestor
83463835|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
83463836|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83463837|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463838|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83463840|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83463841|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83463842|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463843|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463844|NCT00089128|Gemcitabine|gemcitabine|mesh-list
83463845|NCT00089128|Irinotecan|irinotecan|mesh-list
83463846|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83463847|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
83463848|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463849|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463850|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83463851|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83463852|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463853|NCT00000838|Lamivudine|lamivudine|mesh-list
83463854|NCT00000838|Zidovudine|zidovudine|mesh-list
83463855|NCT00000838|Stavudine|stavudine|mesh-list
83463856|NCT00000838|Didanosine|didanosine|mesh-list
83463857|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83463858|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83463859|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463860|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463861|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
83463862|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463863|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83463864|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83463865|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
83463866|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
83463867|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83463869|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
83463870|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83463871|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
83463872|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463873|NCT00000844|Interferons|interferons|mesh-list
83463874|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
83463875|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463876|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
83463877|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463878|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
83463879|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463880|NCT00014560|Antibodies|antibodies|mesh-list
83463881|NCT00014560|Sargramostim|sargramostim|mesh-list
83463882|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83463883|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
83463884|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463885|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
83463887|NCT00020722|Thiotepa|thiotepa|mesh-list
83463888|NCT00020722|Carboplatin|carboplatin|mesh-list
83463890|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
83463891|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83463892|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
83463893|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463894|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83463895|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83463896|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
83463897|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463898|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463899|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83463900|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83463901|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83463902|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83463903|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463904|NCT02649764|Cytarabine|cytarabine|mesh-list
83463905|NCT02649764|Fludarabine|fludarabine|mesh-list
83463906|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
83463907|NCT02649764|Prexasertib|prexasertib|mesh-list
83463908|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463909|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83463910|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
83483013|NCT03007927|Bupivacaine|bupivacaine|mesh-list
83463911|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463912|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83463913|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
83463914|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463915|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
83463916|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463917|NCT02649764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83463918|NCT02649764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463919|NCT04051996|Decitabine|decitabine|mesh-list
83463920|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83463922|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463923|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463924|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463925|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83463926|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83463928|NCT02126878|Hormones|hormones|mesh-ancestor
83463929|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83463930|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463931|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83463933|NCT02634008|Ritonavir|ritonavir|mesh-list
83463934|NCT02634008|Ribavirin|ribavirin|mesh-list
83463935|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83463937|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
83463938|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476449|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83463940|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83463941|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83463942|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
83463943|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83476450|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
83463944|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83463945|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83463946|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
83463947|NCT00000850|Indinavir|indinavir|mesh-list
83463948|NCT00000850|Sargramostim|sargramostim|mesh-list
83463949|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
83483172|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83463950|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463951|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83463952|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83463953|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
83463954|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463955|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463956|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83463957|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83463958|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
83463959|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463961|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83463963|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83463964|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
83463965|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463966|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83463967|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463968|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463969|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83463970|NCT00001810|Voriconazole|voriconazole|mesh-list
83463971|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
83463972|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463973|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83463974|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83463975|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463977|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83463978|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
83463979|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83463980|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463981|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83463982|NCT00000862|Zidovudine|zidovudine|mesh-list
83463983|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
83463984|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463985|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83483173|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83463986|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83463987|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463988|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
83463989|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463990|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83483339|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
83463991|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83463993|NCT02344472|Vinorelbine|vinorelbine|mesh-list
83463994|NCT02344472|Docetaxel|docetaxel|mesh-list
83463995|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83463996|NCT02344472|Capecitabine|capecitabine|mesh-list
83463997|NCT02344472|Trastuzumab|trastuzumab|mesh-list
83463998|NCT02344472|Letrozole|letrozole|mesh-list
83463999|NCT02344472|Fulvestrant|fulvestrant|mesh-list
83464000|NCT02344472|Pertuzumab|pertuzumab|mesh-list
83464001|NCT02344472|Anastrozole|anastrozole|mesh-list
83464002|NCT02344472|Exemestane|exemestane|mesh-list
83464003|NCT02344472|Goserelin|goserelin|mesh-list
83464004|NCT02344472|Leuprolide|leuprolide|mesh-list
83464005|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83464007|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
83464008|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
83464009|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
83464010|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464011|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83464013|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83464014|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83464015|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83464016|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464017|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83464018|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
83464019|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83464020|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464021|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83464022|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83464023|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83464024|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
83464025|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83464026|NCT02338232|Telmisartan|telmisartan|mesh-list
83464027|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83464028|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83464029|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83464030|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464031|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
83464032|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83464033|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83464034|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464035|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
83464036|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464037|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464038|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83464039|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83464040|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
83464041|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464042|NCT00000868|Antacids|antacids|mesh-ancestor
83464043|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464044|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83464045|NCT05586464|Bismuth|bismuth|mesh-list
83464046|NCT05586464|Antacids|antacids|mesh-ancestor
83464047|NCT05586464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464048|NCT05586464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83464049|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
83464050|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83464051|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464052|NCT02627846|Lidocaine|lidocaine|mesh-list
83464054|NCT02627846|Racepinephrine|racepinephrine|mesh-list
83464056|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
83464057|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
83464058|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
83464059|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
83464060|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464061|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464062|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
83464063|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464064|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83464065|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83464066|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83464067|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83464068|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464069|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83464070|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83464071|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
83464072|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464073|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83464074|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83464075|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
83464076|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83464077|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
83464079|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
83464080|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83464081|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83464082|NCT02608268|Decitabine|decitabine|mesh-list
83464083|NCT02608268|Spartalizumab|spartalizumab|mesh-list
83483341|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83464084|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83464085|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
83464086|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464087|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464088|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464089|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83464090|NCT02608268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83464092|NCT00000880|Cyclosporins|cyclosporins|mesh-list
83464093|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464094|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464095|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83464096|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
83464097|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464098|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
83464099|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464100|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
83464101|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83464102|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83464103|NCT02308280|Bortezomib|bortezomib|mesh-list
83464104|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464105|NCT02795156|Afatinib|afatinib|mesh-list
83464106|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464107|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83464108|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464109|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464110|NCT02599454|Atezolizumab|atezolizumab|mesh-list
83464111|NCT02599454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83464112|NCT02599454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464113|NCT02599454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83464114|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464115|NCT02279654|Lenalidomide|lenalidomide|mesh-list
83464116|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
83464117|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464118|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83464119|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83464120|NCT02279654|Growth Substances|growth substances|mesh-ancestor
83464121|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
83483342|NCT00438854|Dasatinib|dasatinib|mesh-list
83464122|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464124|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83464125|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464126|NCT02268656|Propofol|propofol|mesh-list
83464127|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83464128|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464129|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464130|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83464131|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
83464132|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
83464134|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83464135|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464136|NCT02554890|Valsartan|valsartan|mesh-list
83464137|NCT02554890|Enalapril|enalapril|mesh-list
83464138|NCT02554890|Enalaprilat|enalaprilat|mesh-list
83464139|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83464140|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83464141|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83464142|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83464143|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464144|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83464145|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
83464146|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464148|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83464150|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83464151|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
83464152|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464153|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464154|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83464155|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
83464157|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
83464158|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83464159|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83464160|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
83464161|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464162|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464164|NCT02232152|Fluorouracil|fluorouracil|mesh-list
83464165|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
83464166|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464167|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83464168|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464169|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83464170|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
83464171|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464172|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
83464173|NCT02232152|Protective Agents|protective agents|mesh-ancestor
83464174|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
83464175|NCT02232152|Vitamins|vitamins|mesh-ancestor
83464176|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
83464177|NCT02229656|Olaparib|olaparib|mesh-list
83483499|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
83464178|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83476555|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83464180|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464181|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464182|NCT00001870|Acetylcholine|acetylcholine|mesh-list
83464183|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
83464184|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83464185|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
83464186|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464187|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464188|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464190|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
83464191|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
83464192|NCT03252600|Lenalidomide|lenalidomide|mesh-list
83464193|NCT03252600|Elotuzumab|elotuzumab|mesh-list
83464194|NCT03252600|Ichthammol|ichthammol|mesh-list
83464195|NCT03252600|BB 1101|bb 1101|mesh-list
83464197|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
83464198|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464199|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83464210|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
83464211|NCT03252600|Hormones|hormones|mesh-ancestor
83464212|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83464213|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83464214|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83464215|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83464217|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
83464218|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
83464219|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464220|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
83464221|NCT02749526|Tegafur|tegafur|mesh-list
83464222|NCT02749526|Endostar protein|endostar protein|mesh-list
83464223|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464224|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83464225|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
83464226|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464227|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83464228|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83464229|NCT02749526|Growth Substances|growth substances|mesh-ancestor
83464230|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464231|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
83464233|NCT00000916|Zidovudine|zidovudine|mesh-list
83464234|NCT00000916|Stavudine|stavudine|mesh-list
83464235|NCT00000916|Didanosine|didanosine|mesh-list
83464236|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83464237|NCT00000916|Indinavir|indinavir|mesh-list
83464238|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
83476556|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
83464239|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83464240|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83464241|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476557|NCT01049243|Hormones|hormones|mesh-ancestor
83464242|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464243|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
83464244|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464245|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83464246|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83464247|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
83464248|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464249|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
83464250|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83464251|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83464252|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
83464253|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83464255|NCT02744612|Antibodies|antibodies|mesh-list
83464256|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
83464257|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83464258|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
83464259|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
83464260|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464261|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464263|NCT02548364|Vitamin D|vitamin d|mesh-list
83464264|NCT02548364|Calcifediol|calcifediol|mesh-list
83464265|NCT02548364|Vitamins|vitamins|mesh-ancestor
83464266|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
83464267|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464268|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83464269|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83464270|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464272|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83464273|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464274|NCT02221310|Immunotoxins|immunotoxins|mesh-ancestor
83464275|NCT02221310|Immunoconjugates|immunoconjugates|mesh-ancestor
83464276|NCT02221310|Immunologic Factors|immunologic factors|mesh-ancestor
83464277|NCT02221310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464278|NCT00000160|Xenon|xenon|mesh-list
83464279|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83464280|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
83464281|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
83464282|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464283|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464284|NCT00000178|Prednisone|prednisone|mesh-list
83464285|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83464286|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
83464287|NCT00000178|Hormones|hormones|mesh-ancestor
83464288|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83464289|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464290|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83464291|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464292|NCT05480280|Leucovorin|leucovorin|mesh-list
83464293|NCT05480280|Fluorouracil|fluorouracil|mesh-list
83464295|NCT05480280|Calcium|calcium|mesh-list
83464296|NCT05480280|Levoleucovorin|levoleucovorin|mesh-list
83464298|NCT05480280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464299|NCT05480280|Antimetabolites|antimetabolites|mesh-ancestor
83464300|NCT05480280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464301|NCT05480280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83464302|NCT05480280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464303|NCT05480280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83464304|NCT05480280|Immunologic Factors|immunologic factors|mesh-ancestor
83464306|NCT05480280|Protective Agents|protective agents|mesh-ancestor
83464307|NCT05480280|Vitamin B Complex|vitamin b complex|mesh-ancestor
83464308|NCT05480280|Vitamins|vitamins|mesh-ancestor
83464309|NCT05480280|Micronutrients|micronutrients|mesh-ancestor
83464310|NCT00001906|Interleukin-12|interleukin-12|mesh-list
83464312|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83464313|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
83464314|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464315|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83464316|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83464317|NCT00001906|Growth Substances|growth substances|mesh-ancestor
83464318|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
83464319|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464320|NCT00001906|Antacids|antacids|mesh-ancestor
83464321|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464322|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83464324|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83464325|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83464326|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464327|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
83464328|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464329|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
83464330|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83464331|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
83464333|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83464334|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464335|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
83464336|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464337|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
83464338|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83464339|NCT00000946|Protective Agents|protective agents|mesh-ancestor
83464340|NCT02543346|Cetirizine|cetirizine|mesh-list
83464341|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83464342|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83464343|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83464344|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
83464345|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
83464346|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464347|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464348|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464349|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83464350|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
83464351|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83464352|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
83464353|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464354|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
83464355|NCT04390100|Protective Agents|protective agents|mesh-ancestor
83464356|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
83464357|NCT04390100|Coagulants|coagulants|mesh-ancestor
83464358|NCT00000202|Buprenorphine|buprenorphine|mesh-list
83464359|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83464360|NCT00000202|Narcotics|narcotics|mesh-ancestor
83464361|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464362|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464363|NCT00000202|Analgesics|analgesics|mesh-ancestor
83464364|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
83464365|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464366|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83464367|NCT00000208|Buprenorphine|buprenorphine|mesh-list
83464368|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83464369|NCT00000208|Narcotics|narcotics|mesh-ancestor
83464370|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464371|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464372|NCT00000208|Analgesics|analgesics|mesh-ancestor
83464373|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
83464374|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464375|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83464376|NCT00001930|Amantadine|amantadine|mesh-list
83464377|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83464378|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83464379|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
83464380|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464381|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
83464382|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464383|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464384|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464385|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83464386|NCT00001930|Analgesics|analgesics|mesh-ancestor
83464387|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
83464388|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464389|NCT00000964|Foscarnet|foscarnet|mesh-list
83464390|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83464391|NCT00000964|Ranitidine|ranitidine|mesh-list
83464392|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83464393|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83464394|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83464395|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83464396|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
83464397|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
83464398|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464399|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464400|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464402|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464403|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83464404|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83464405|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464407|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
83464408|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
83464409|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464410|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83464411|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83464412|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464413|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
83464414|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464415|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83464416|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83464417|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
83464418|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464419|NCT00000226|Buprenorphine|buprenorphine|mesh-list
83464420|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83464421|NCT00000226|Narcotics|narcotics|mesh-ancestor
83464422|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464423|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464424|NCT00000226|Analgesics|analgesics|mesh-ancestor
83464425|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
83464426|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464427|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83464428|NCT00000982|Zidovudine|zidovudine|mesh-list
83464429|NCT00000982|Didanosine|didanosine|mesh-list
83464430|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
83464431|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464432|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83464433|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83464434|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464435|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
83464436|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464438|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83464439|NCT02549196|Donepezil|donepezil|mesh-list
83464440|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
83464441|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83464442|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464443|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464444|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
83464445|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464446|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464448|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83464449|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83464450|NCT02549196|Urological Agents|urological agents|mesh-ancestor
83464451|NCT00000988|Stavudine|stavudine|mesh-list
83464452|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
83464453|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464454|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83476632|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
83464456|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464457|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
83464458|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464459|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83464460|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83464461|NCT00000232|Buprenorphine|buprenorphine|mesh-list
83464462|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83464463|NCT00000232|Narcotics|narcotics|mesh-ancestor
83464464|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464465|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464467|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
83464468|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464469|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83464470|NCT00000238|Buprenorphine|buprenorphine|mesh-list
83464471|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83464472|NCT00000238|Narcotics|narcotics|mesh-ancestor
83464473|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464474|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464475|NCT00000238|Analgesics|analgesics|mesh-ancestor
83464476|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
83464477|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464478|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83464479|NCT00000244|Dynorphins|dynorphins|mesh-list
83464480|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464481|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464482|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464483|NCT00000994|Zidovudine|zidovudine|mesh-list
83464484|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
83476633|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
83464485|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464487|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83464488|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464489|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
83464490|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464491|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83464492|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83464493|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
83464494|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83464495|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
83464496|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464497|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464498|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83464499|NCT00001006|Protective Agents|protective agents|mesh-ancestor
83464500|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83464501|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83464502|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464503|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464504|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
83464505|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464506|NCT00001954|Etanercept|etanercept|mesh-list
83464507|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83464508|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83464509|NCT00001954|Analgesics|analgesics|mesh-ancestor
83464511|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464512|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464513|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83464514|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83464515|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83464516|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83464517|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
83464518|NCT02904954|Durvalumab|durvalumab|mesh-list
83464519|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83464520|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83464521|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464522|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
83464523|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464524|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
83464525|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83464526|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
83464527|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
83464528|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464529|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483582|NCT00510224|Octreotide|octreotide|mesh-list
83464530|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83464532|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
83464533|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464534|NCT03244020|Aspirin|aspirin|mesh-list
83464535|NCT03244020|Enoxaparin|enoxaparin|mesh-list
83464536|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83464537|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83464538|NCT03244020|Analgesics|analgesics|mesh-ancestor
83464539|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
83464540|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464541|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464542|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83464543|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83464544|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83464545|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83464546|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464547|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83464548|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83464549|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464551|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
83464552|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
83464553|NCT00000262|Sevoflurane|sevoflurane|mesh-list
83464554|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83464555|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83464556|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
83464557|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
83464558|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464560|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83464561|NCT00000262|Analgesics|analgesics|mesh-ancestor
83464562|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
83483811|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
83464563|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464565|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
83464566|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464567|NCT02891538|Protective Agents|protective agents|mesh-ancestor
83464568|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464569|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83464570|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83464571|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464572|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83464573|NCT00001024|Zidovudine|zidovudine|mesh-list
83464574|NCT00001024|Didanosine|didanosine|mesh-list
83464575|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
83464576|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464577|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83464578|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83464579|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464580|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
83464581|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464582|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83464583|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83464584|NCT00000268|Bupropion|bupropion|mesh-list
83464585|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83464586|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
83464587|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83464588|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83464589|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83464590|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83464591|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464592|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
83464593|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464594|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464595|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83464596|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83464597|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464598|NCT02847624|Tolvaptan|tolvaptan|mesh-list
83464599|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83464600|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464601|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
83464603|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83464604|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
83464605|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
83464606|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83464607|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
83464608|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464609|NCT00001042|Antacids|antacids|mesh-ancestor
83464610|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464611|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83464613|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
83464614|NCT00982865|Vitamins|vitamins|mesh-ancestor
83464615|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
83464616|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464618|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
83464619|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464620|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
83464621|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83464622|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483885|NCT00526058|Clotrimazole|clotrimazole|mesh-list
83464623|NCT02521844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83464624|NCT02521844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464626|NCT01226719|Fluorouracil|fluorouracil|mesh-list
83464627|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
83464628|NCT01226719|Irinotecan|irinotecan|mesh-list
83464629|NCT01226719|Panitumumab|panitumumab|mesh-list
83464630|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
83464631|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464632|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83464633|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464634|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83464635|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
83464636|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464637|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83464638|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83464639|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464640|NCT01226719|Antidotes|antidotes|mesh-ancestor
83464641|NCT01226719|Protective Agents|protective agents|mesh-ancestor
83464642|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
83464644|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
83464645|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83464646|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
83464647|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83464648|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
83464649|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464650|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83464651|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464652|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
83464653|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464654|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
83464655|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83464656|NCT00001072|Protective Agents|protective agents|mesh-ancestor
83464657|NCT04331470|Ritonavir|ritonavir|mesh-list
83464658|NCT04331470|Lopinavir|lopinavir|mesh-list
83464659|NCT04331470|Chloroquine|chloroquine|mesh-list
83464660|NCT04331470|Levamisole|levamisole|mesh-list
83464662|NCT04331470|Budesonide|budesonide|mesh-list
83464663|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
83464664|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83464665|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83464666|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
83464667|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464668|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464669|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83464670|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83464671|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
83464672|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464673|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83464674|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83464675|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83464676|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83464677|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
83464678|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464680|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83464681|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
83464682|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
83464683|NCT04331470|Hormones|hormones|mesh-ancestor
83464684|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83464685|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83464686|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83464687|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83464688|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
83464689|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464690|NCT04331470|Amebicides|amebicides|mesh-ancestor
83464691|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83464692|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83464693|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
83464694|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83464695|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
83464696|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
83464697|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83464698|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
83464699|NCT00001090|Sargramostim|sargramostim|mesh-list
83464700|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
83464701|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464702|NCT01147627|Insulin|insulin|mesh-list
83464703|NCT01147627|Pioglitazone|pioglitazone|mesh-list
83464704|NCT01147627|Exenatide|exenatide|mesh-list
83464705|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
83464706|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83464707|NCT01147627|Protamines|protamines|mesh-list
83464708|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83464709|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464710|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83464711|NCT01147627|Incretins|incretins|mesh-ancestor
83464712|NCT01147627|Hormones|hormones|mesh-ancestor
83464713|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83464714|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
83464715|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464716|NCT01147627|Coagulants|coagulants|mesh-ancestor
83464717|NCT02548962|Dexamethasone|dexamethasone|mesh-list
83464718|NCT02548962|Pomalidomide|pomalidomide|mesh-list
83464719|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83464720|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
83464721|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
83464722|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464723|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464724|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83464725|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
83464727|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483886|NCT00526058|Miconazole|miconazole|mesh-list
83464728|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83464729|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464730|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
83464731|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83464732|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83464733|NCT02548962|Growth Substances|growth substances|mesh-ancestor
83464734|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
83464736|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
83464737|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83464738|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83464739|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464740|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464741|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83464742|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83464743|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
83464744|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464745|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464746|NCT02743598|Liraglutide|liraglutide|mesh-list
83464747|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83464748|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464749|NCT02743598|Incretins|incretins|mesh-ancestor
83464750|NCT02743598|Hormones|hormones|mesh-ancestor
83464751|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83464752|NCT00000280|Nimodipine|nimodipine|mesh-list
83483961|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
83464754|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83464755|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83464756|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464757|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83464758|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464759|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
83464761|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83464762|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83464763|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83464764|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464765|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464766|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464767|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83464768|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
83464769|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83483962|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
83464770|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83464771|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83464772|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
83464773|NCT01188577|Epinephrine|epinephrine|mesh-list
83464774|NCT01188577|Racepinephrine|racepinephrine|mesh-list
83464775|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
83464776|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83464777|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83464778|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
83464779|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464780|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464781|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464782|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83464783|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83464785|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464786|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83464788|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
83464789|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
83464790|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83464791|NCT02507336|Thalidomide|thalidomide|mesh-list
83464792|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83464793|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
83464794|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464795|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
83464796|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83464797|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464798|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83464799|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83464801|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
83464802|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464804|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
83464805|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
83464806|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464807|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464808|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
83464809|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464810|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83464811|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83464812|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83464813|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83464814|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464815|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
83464816|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464817|NCT00000298|Buprenorphine|buprenorphine|mesh-list
83464818|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83464819|NCT00000298|Naloxone|naloxone|mesh-list
83464820|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83464821|NCT00000298|Narcotics|narcotics|mesh-ancestor
83464822|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464823|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464824|NCT00000298|Analgesics|analgesics|mesh-ancestor
83464825|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
83464826|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464827|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83464828|NCT00000304|Amphetamine|amphetamine|mesh-list
83464829|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
83464830|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83464831|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464832|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
83464833|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
83464834|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464835|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
83464836|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464837|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464838|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
83464839|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83464840|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83464841|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83464842|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83464843|NCT02548650|Aspirin|aspirin|mesh-list
83464844|NCT02548650|Clopidogrel|clopidogrel|mesh-list
83464846|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83464847|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83464848|NCT02548650|Analgesics|analgesics|mesh-ancestor
83464849|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
83464850|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464851|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464852|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83464853|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83464854|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83464855|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83464856|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464857|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83464858|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83464859|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464861|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83464862|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83464863|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83464864|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
83464865|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464866|NCT00000310|Risperidone|risperidone|mesh-list
83464867|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83464868|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
83464869|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464870|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464871|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464872|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83464873|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83464874|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464875|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83464876|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83464877|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
83464878|NCT02734004|Bevacizumab|bevacizumab|mesh-list
83464879|NCT02734004|Durvalumab|durvalumab|mesh-list
83464880|NCT02734004|Olaparib|olaparib|mesh-list
83464881|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83464882|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464883|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83464884|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83464886|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464887|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
83464888|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83464889|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464890|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464891|NCT01227655|Levodopa|levodopa|mesh-list
83464892|NCT01227655|Carbidopa|carbidopa|mesh-list
83464893|NCT01227655|Opicapone|opicapone|mesh-list
83464894|NCT01227655|Benserazide|benserazide|mesh-list
83464895|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83464896|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83464897|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
83464898|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464899|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464900|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464901|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83464902|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464903|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83464905|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
83464906|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
83464907|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464908|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464909|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
83464910|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464911|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83464912|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83464913|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83464914|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83464915|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464916|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
83464917|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464918|NCT05459532|Molnupiravir|molnupiravir|mesh-list
83464919|NCT05459532|Antiviral Agents|antiviral agents|mesh-ancestor
83464920|NCT05459532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464921|NCT00001990|Atovaquone|atovaquone|mesh-list
83464922|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464923|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
83464924|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83464925|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83464927|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464928|NCT01026623|Sirolimus|sirolimus|mesh-list
83464929|NCT01026623|Temsirolimus|temsirolimus|mesh-list
83464930|NCT01026623|MTOR Inhibitors|mtor inhibitors|mesh-list
83464931|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83464932|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83464933|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464934|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83464935|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464936|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
83464937|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83464938|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
83464939|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464940|NCT01026623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83464941|NCT01026623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464942|NCT01026623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464944|NCT00001996|Pentamidine|pentamidine|mesh-list
83464945|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464946|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
83464947|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83464948|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83464949|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464950|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464951|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
83464952|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83464953|NCT02725424|Docetaxel|docetaxel|mesh-list
83464954|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
83464955|NCT02725424|Trastuzumab|trastuzumab|mesh-list
83464956|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464957|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
83464958|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
83464959|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
83464960|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464961|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83464962|NCT01189279|Bimatoprost|bimatoprost|mesh-list
83464963|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83464964|NCT00001108|Ritonavir|ritonavir|mesh-list
83464965|NCT00001108|Nelfinavir|nelfinavir|mesh-list
83464966|NCT00001108|Saquinavir|saquinavir|mesh-list
83464967|NCT00001108|Lamivudine|lamivudine|mesh-list
83464968|NCT00001108|Nevirapine|nevirapine|mesh-list
83464969|NCT00001108|Stavudine|stavudine|mesh-list
83464970|NCT00001108|Didanosine|didanosine|mesh-list
83464971|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83464972|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83464973|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
83464974|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464975|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464976|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83464977|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83464978|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
83464979|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464980|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83464981|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83464982|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83464983|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83464984|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83464985|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83464986|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
83464987|NCT02157974|Exenatide|exenatide|mesh-list
83464988|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83464989|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464990|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83464992|NCT02157974|Hormones|hormones|mesh-ancestor
83464993|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83464994|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
83464995|NCT00000328|Narcotics|narcotics|mesh-ancestor
83464996|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464997|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464998|NCT00000328|Analgesics|analgesics|mesh-ancestor
83464999|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
83484036|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
83465000|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465001|NCT00380224|Olanzapine|olanzapine|mesh-list
83465002|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
83465003|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
83465004|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465005|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465006|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83465008|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83465009|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83465010|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83465011|NCT00380224|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83465012|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83465013|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83465014|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465015|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465016|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
83465017|NCT00002002|Leucovorin|leucovorin|mesh-list
83465018|NCT00002002|Trimethoprim|trimethoprim|mesh-list
83465019|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
83465020|NCT00002002|Calcium|calcium|mesh-list
83465022|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83465023|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465025|NCT00002002|Protective Agents|protective agents|mesh-ancestor
83465026|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
83465027|NCT00002002|Vitamins|vitamins|mesh-ancestor
83465028|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
83465029|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83465030|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465031|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
83465032|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83465033|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83465034|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83465035|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465036|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465037|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83465038|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83465039|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83465041|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83465042|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83465043|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83465044|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465045|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465046|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465047|NCT02535000|Analgesics|analgesics|mesh-ancestor
83465048|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
83465049|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465050|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
83465051|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83465052|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
83465053|NCT00380380|Vildagliptin|vildagliptin|mesh-list
83465054|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83465055|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484037|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
83465056|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83465057|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
83465058|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465059|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465060|NCT01228903|Allopurinol|allopurinol|mesh-list
83465061|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
83465062|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465063|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465064|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
83465066|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83465067|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
83465068|NCT01228903|Protective Agents|protective agents|mesh-ancestor
83465069|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465070|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83465071|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83465072|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83465073|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465074|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465075|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83465076|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83465077|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465078|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
83465079|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465080|NCT00001126|Cidofovir|cidofovir|mesh-list
83465081|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
83465082|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465083|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465084|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465085|NCT00002008|Sargramostim|sargramostim|mesh-list
83465086|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
83465087|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465088|NCT00001132|Abacavir|abacavir|mesh-list
83465089|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465090|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465091|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465092|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465093|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
83465094|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465095|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465096|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465097|NCT01149733|Tamsulosin|tamsulosin|mesh-list
83465098|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83465099|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83465100|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83465101|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
83465102|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465103|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465104|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465105|NCT01149733|Urological Agents|urological agents|mesh-ancestor
83465107|NCT02498912|Fludarabine|fludarabine|mesh-list
83465108|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465109|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
83465110|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465111|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83465112|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83465113|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
83465115|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465116|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83465117|NCT00002014|Zidovudine|zidovudine|mesh-list
83465118|NCT00002014|Didanosine|didanosine|mesh-list
83465119|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
83465120|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465121|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465122|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465123|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465124|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
83465125|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465126|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465127|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465129|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83465130|NCT00000334|Narcotics|narcotics|mesh-ancestor
83465131|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83484115|NCT01510327|Clopidogrel|clopidogrel|mesh-list
83465136|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83465137|NCT00000340|Pemoline|pemoline|mesh-list
83465138|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83465139|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465140|NCT00002020|Zidovudine|zidovudine|mesh-list
83465141|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
83465142|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465143|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465144|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465145|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465146|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
83465147|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465148|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465149|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465150|NCT00002026|Acyclovir|acyclovir|mesh-list
83465151|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
83465152|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465153|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
83465154|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
83465155|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
83465156|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83465157|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83465158|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484191|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
83465159|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465160|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465162|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83465163|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465165|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
83465166|NCT01229527|Meperidine|meperidine|mesh-list
83465167|NCT01229527|Remifentanil|remifentanil|mesh-list
83465168|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83465169|NCT01229527|Narcotics|narcotics|mesh-ancestor
83465170|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83465171|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465172|NCT01229527|Analgesics|analgesics|mesh-ancestor
83465173|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
83465174|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465175|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83465176|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
83465177|NCT02723162|Varenicline|varenicline|mesh-list
83465178|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83465179|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83465180|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83465181|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
83465182|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465183|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465184|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465185|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
83465186|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465187|NCT02723162|Expectorants|expectorants|mesh-ancestor
83465188|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
83465189|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83465190|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
83465191|NCT02723162|Protective Agents|protective agents|mesh-ancestor
83465192|NCT02723162|Antidotes|antidotes|mesh-ancestor
83465193|NCT00000358|Lofexidine|lofexidine|mesh-list
83465194|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83465195|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83465196|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465197|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
83465198|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465199|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83465200|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83465201|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83465202|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
83465203|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476634|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83465204|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465206|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83465207|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
83465208|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83465209|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465210|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465211|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83465212|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83484192|NCT00115700|Rituximab|rituximab|mesh-list
83465213|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83465215|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465216|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465217|NCT02143388|Cisplatin|cisplatin|mesh-list
83465218|NCT02143388|Capecitabine|capecitabine|mesh-list
83465219|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465220|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83465221|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
83465222|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465223|NCT00001228|Interferons|interferons|mesh-list
83465224|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465225|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
83465227|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83465228|NCT02483936|Olmesartan|olmesartan|mesh-list
83465229|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83465230|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
83465231|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83465232|NCT02483936|Diuretics|diuretics|mesh-ancestor
83465233|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
83465234|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465235|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83465236|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83465237|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465238|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83465239|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83465241|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
83465242|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465243|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83465244|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83465245|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465246|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465247|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83465249|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83465250|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465251|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83465252|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83465253|NCT01894334|Edaravone|edaravone|mesh-list
83465254|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
83465255|NCT01894334|Urinastatin|urinastatin|mesh-list
83465256|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83465257|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83465258|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465260|NCT01894334|Coagulants|coagulants|mesh-ancestor
83465261|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83465262|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
83465263|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83465264|NCT01894334|Protective Agents|protective agents|mesh-ancestor
83465265|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465266|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83465268|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
83465269|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465270|NCT00002044|Zidovudine|zidovudine|mesh-list
83465271|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
83465272|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465273|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465274|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465275|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465276|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
83465277|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465278|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465279|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465280|NCT00001282|Zidovudine|zidovudine|mesh-list
83465281|NCT00001282|Interleukin-2|interleukin-2|mesh-list
83465282|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465283|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83465284|NCT00001282|Analgesics|analgesics|mesh-ancestor
83465285|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
83465286|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465287|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465288|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
83465289|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465290|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465291|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465292|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465293|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
83465294|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465295|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465296|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465297|NCT02478320|Ilorasertib|ilorasertib|mesh-list
83465298|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465299|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83465300|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465301|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465302|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
83465303|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83465304|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465306|NCT00001300|Ifosfamide|ifosfamide|mesh-list
83465307|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83465308|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484193|NCT00115700|Vincristine|vincristine|mesh-list
83465310|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83465311|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465312|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465313|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83465314|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
83465315|NCT00000400|Alendronate|alendronate|mesh-list
83465316|NCT00000400|Teriparatide|teriparatide|mesh-list
83465317|NCT00000400|Hormones|hormones|mesh-list
83465318|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
83465319|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83465320|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465321|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83465322|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83465323|NCT01195597|Nicotine|nicotine|mesh-list
83465324|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83465325|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
83465326|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465327|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465328|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83465329|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83465330|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
83465331|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465332|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465333|NCT00002050|Thymopentin|thymopentin|mesh-list
83465334|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83465335|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
83465337|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
83465338|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83465339|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
83465340|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465341|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
83465342|NCT04389866|Protective Agents|protective agents|mesh-ancestor
83465343|NCT00000412|Alendronate|alendronate|mesh-list
83465344|NCT00000412|Calcitriol|calcitriol|mesh-list
83465345|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83465346|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465347|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83465348|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83465349|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83465350|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465351|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83465352|NCT00000412|Vitamins|vitamins|mesh-ancestor
83465353|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
83465354|NCT00002056|Pentamidine|pentamidine|mesh-list
83465355|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
83465356|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465357|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83465358|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83465359|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83465360|NCT03110562|Dexamethasone|dexamethasone|mesh-list
83465361|NCT03110562|Bortezomib|bortezomib|mesh-list
83465362|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83465363|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
83465364|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
83465365|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465366|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465367|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83465369|NCT03110562|Hormones|hormones|mesh-ancestor
83465370|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83465371|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83465372|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465373|NCT00380614|Lamivudine|lamivudine|mesh-list
83465374|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465375|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465376|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465377|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465378|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
83465379|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465380|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465381|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465382|NCT00000430|Alendronate|alendronate|mesh-list
83465383|NCT00000430|Estrogens|estrogens|mesh-list
83465384|NCT00000430|Progestins|progestins|mesh-list
83465385|NCT00000430|Hormones|hormones|mesh-ancestor
83465386|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83465387|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465388|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83465390|NCT00380770|Stavudine|stavudine|mesh-list
83465391|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
83465392|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465393|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465394|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465395|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465396|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
83465397|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465398|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465399|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465400|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
83465401|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
83465402|NCT01231399|Leucovorin|leucovorin|mesh-list
83465403|NCT01231399|Fluorouracil|fluorouracil|mesh-list
83465404|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
83465405|NCT01231399|Everolimus|everolimus|mesh-list
83465406|NCT01231399|Calcium|calcium|mesh-list
83465407|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
83465408|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83465409|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465410|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83465411|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
83465412|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465413|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83465414|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465415|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465416|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
83465418|NCT01231399|Protective Agents|protective agents|mesh-ancestor
83465419|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
83465420|NCT01231399|Vitamins|vitamins|mesh-ancestor
83465421|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
83465422|NCT01231399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83465423|NCT01231399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83465424|NCT01231399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465425|NCT00002062|Spiramycin|spiramycin|mesh-list
83465426|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83465427|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465429|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83465430|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83465431|NCT01231633|Dexamethasone|dexamethasone|mesh-list
83465432|NCT01231633|Bevacizumab|bevacizumab|mesh-list
83484646|NCT01566409|Laxatives|laxatives|mesh-ancestor
83465433|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83465434|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465435|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83465436|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83465437|NCT01231633|Growth Substances|growth substances|mesh-ancestor
83465438|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465439|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
83465440|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83465442|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
83465443|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465444|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83465445|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
83465446|NCT01231633|Hormones|hormones|mesh-ancestor
83465447|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83465448|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83465449|NCT00000442|Naltrexone|naltrexone|mesh-list
83465450|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83465451|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83465452|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465453|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
83465454|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465455|NCT00002068|Fluconazole|fluconazole|mesh-list
83465456|NCT00002068|Amphotericin B|amphotericin b|mesh-list
83465457|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83465458|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
83465459|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465461|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83465462|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465463|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465464|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83465465|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
83465466|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83465467|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465468|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83465469|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83465470|NCT00002068|Amebicides|amebicides|mesh-ancestor
83465471|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83465472|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83465473|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83465474|NCT00000448|Naltrexone|naltrexone|mesh-list
83465475|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83465476|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83465477|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465478|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
83465479|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465480|NCT00001318|Interferons|interferons|mesh-list
83465481|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
83465482|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465483|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
83465484|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465485|NCT00002074|Fluconazole|fluconazole|mesh-list
83465486|NCT00002074|Amphotericin B|amphotericin b|mesh-list
83465487|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83465488|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
83465489|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465490|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83465491|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83465492|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465493|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465494|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83465495|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
83465496|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83465497|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465498|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83465499|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83465500|NCT00002074|Amebicides|amebicides|mesh-ancestor
83465501|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83465502|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83465503|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83465504|NCT00001354|Zidovudine|zidovudine|mesh-list
83465505|NCT00001354|Interleukin-2|interleukin-2|mesh-list
83465506|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465507|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83465508|NCT00001354|Analgesics|analgesics|mesh-ancestor
83465509|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
83465510|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465511|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465512|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
83465513|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465514|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465515|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465516|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465517|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
83465518|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465519|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465520|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465522|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83465523|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
83465524|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465525|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465526|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83465527|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83465528|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
83465529|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465530|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465531|NCT00002080|Rifabutin|rifabutin|mesh-list
83465532|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83465533|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465534|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83465535|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
83465537|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83465538|NCT00000484|Diuretics|diuretics|mesh-ancestor
83465539|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
83465540|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465541|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83465542|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83465543|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465544|NCT00000496|Aspirin|aspirin|mesh-list
83465545|NCT00000496|Dipyridamole|dipyridamole|mesh-list
83465546|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83465547|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83465548|NCT00000496|Analgesics|analgesics|mesh-ancestor
83465549|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
83465550|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465551|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465552|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83465553|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83465554|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83465555|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83465556|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465557|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83465558|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83465559|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465560|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
83465561|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83465562|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
83465563|NCT00002086|Interferons|interferons|mesh-list
83465564|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
83465565|NCT00002086|Zidovudine|zidovudine|mesh-list
83465566|NCT00002086|Zalcitabine|zalcitabine|mesh-list
83465567|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465568|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
83465569|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465570|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
83465571|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465572|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
83465573|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465574|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465575|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465576|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465577|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465578|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465579|NCT01151449|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83465580|NCT01151449|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83465581|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465582|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465583|NCT00001384|Paclitaxel|paclitaxel|mesh-list
83465584|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
83465585|NCT00001384|Doxorubicin|doxorubicin|mesh-list
83465586|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83465587|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83465588|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465589|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
83465590|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
83465591|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
83465592|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465593|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465594|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
83465595|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465596|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83465597|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83465598|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
83465599|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83465600|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83465601|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83465602|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83465603|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465604|NCT01151761|Cisplatin|cisplatin|mesh-list
83465605|NCT01151761|Carboplatin|carboplatin|mesh-list
83465606|NCT01151761|Gemcitabine|gemcitabine|mesh-list
83465607|NCT01151761|Fluorouracil|fluorouracil|mesh-list
83465608|NCT01151761|Capecitabine|capecitabine|mesh-list
83465609|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465610|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83465611|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
83465612|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465613|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465614|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
83465615|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465616|NCT00002092|Cimetidine|cimetidine|mesh-list
83465617|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83465618|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83465619|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83465620|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
83465621|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
83465622|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465623|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465624|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465625|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83465626|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83465627|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465628|NCT02122562|Ketamine|ketamine|mesh-list
83465629|NCT02122562|Analgesics|analgesics|mesh-ancestor
83465630|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
83465631|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465632|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465633|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83465634|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83465635|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
83465636|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
83465637|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83465638|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83465639|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83465640|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465641|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465642|NCT00002098|Didanosine|didanosine|mesh-list
83465643|NCT00002098|Lentinan|lentinan|mesh-list
83465644|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
83465645|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465646|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465647|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465648|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465649|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
83465650|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465651|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465652|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465653|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83465654|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
83465655|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710811|NCT00918086|Vitamin D|vitamin d|mesh-list
83465656|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465657|NCT02705300|Leucovorin|leucovorin|mesh-list
83465658|NCT02705300|Tocotrienols|tocotrienols|mesh-list
83465659|NCT02705300|Vitamin E|vitamin e|mesh-list
83465660|NCT02705300|Tocopherols|tocopherols|mesh-list
83465661|NCT02705300|Fluorouracil|fluorouracil|mesh-list
83465662|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
83465663|NCT02705300|Irinotecan|irinotecan|mesh-list
83465664|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
83465665|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465666|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
83465667|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465668|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83465669|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465670|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465671|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
83465672|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83465673|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83465674|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465675|NCT02705300|Antidotes|antidotes|mesh-ancestor
83465676|NCT02705300|Protective Agents|protective agents|mesh-ancestor
83465677|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
83465678|NCT02705300|Vitamins|vitamins|mesh-ancestor
83465679|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
83465680|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
83465681|NCT01196377|Albuterol|albuterol|mesh-list
83465682|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83465683|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
83465684|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465685|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465686|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83465687|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
83465688|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
83465689|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83465690|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83465691|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83465692|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83465693|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
83465694|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465695|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465696|NCT00001426|Paclitaxel|paclitaxel|mesh-list
83465697|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
83465698|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83465699|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465700|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
83465701|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
83465702|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
83465703|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465704|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465705|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
83465706|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465707|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83465708|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83465709|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
83465710|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83465711|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
83465712|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465713|NCT00002104|Thalidomide|thalidomide|mesh-list
83465714|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465715|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
83465716|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465717|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
83465718|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83465719|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465720|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83465721|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83465722|NCT00002104|Growth Substances|growth substances|mesh-ancestor
83465723|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
83465724|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465725|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
83465726|NCT00001438|Tretinoin|tretinoin|mesh-list
83465727|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465728|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
83465729|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
83465730|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
83465731|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711103|NCT02581566|Analgesics|analgesics|mesh-ancestor
83465732|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83465733|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465734|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83465735|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465736|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465738|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83465739|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82711234|NCT04137354|Iron|iron|mesh-list
83465741|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
83465742|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465743|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465744|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83465745|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83465746|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83465747|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465748|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465749|NCT00002110|Zidovudine|zidovudine|mesh-list
83465750|NCT00002110|Cysteamine|cysteamine|mesh-list
83465751|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
83465752|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465753|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465754|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465755|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465756|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
83485247|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
83465757|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465758|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465759|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465760|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83465762|NCT00001450|Cisplatin|cisplatin|mesh-list
83465763|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83465764|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465765|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
83465766|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
83465767|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
83465768|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465769|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
83465770|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83465772|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
83465773|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83465774|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
83465775|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465777|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
82711665|NCT04061655|Iron|iron|mesh-list
83465778|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465779|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465780|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465781|NCT00001498|Leucovorin|leucovorin|mesh-list
83465782|NCT00001498|Paclitaxel|paclitaxel|mesh-list
83465783|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
83465784|NCT00001498|Doxorubicin|doxorubicin|mesh-list
83465785|NCT00001498|Fluorouracil|fluorouracil|mesh-list
83465786|NCT00001498|Methotrexate|methotrexate|mesh-list
83465787|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83465788|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465789|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
83465790|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
83465791|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
83465792|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465793|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465794|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
83465795|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465796|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83465797|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83465798|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
83465799|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83465800|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83465801|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83465802|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83465803|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465804|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
83465805|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83465806|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83465807|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
83465808|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83465809|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
83465810|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83465811|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465812|NCT00001498|Antidotes|antidotes|mesh-ancestor
83465813|NCT00001498|Protective Agents|protective agents|mesh-ancestor
83465814|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
83465815|NCT00001498|Vitamins|vitamins|mesh-ancestor
83465816|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
83465817|NCT00001504|Tretinoin|tretinoin|mesh-list
83465818|NCT00001504|Alitretinoin|alitretinoin|mesh-list
83465819|NCT00001504|Isotretinoin|isotretinoin|mesh-list
83465820|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465821|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
83465822|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
83465823|NCT02688140|Cytarabine|cytarabine|mesh-list
83465824|NCT02688140|Methotrexate|methotrexate|mesh-list
83465825|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
83465826|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
83465827|NCT02688140|Idarubicin|idarubicin|mesh-list
83465828|NCT02688140|Tretinoin|tretinoin|mesh-list
83465829|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
83465830|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83465831|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
83465832|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83465833|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465834|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83465835|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
83465836|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465837|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465838|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
83465839|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465840|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83465841|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82712366|NCT04085120|Hormones|hormones|mesh-ancestor
83465842|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
83465843|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83465844|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465845|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
83465846|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465847|NCT02688140|Analgesics|analgesics|mesh-ancestor
83465848|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
83465849|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465850|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83465851|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83465852|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83465853|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
83465854|NCT00002122|Azithromycin|azithromycin|mesh-list
83465856|NCT00002122|Fluconazole|fluconazole|mesh-list
83465857|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83465858|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465859|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
83465860|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83465861|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83465862|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465863|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712498|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
83465864|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83465865|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
83465866|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83465867|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465868|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83465869|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83465870|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83465871|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
83465872|NCT05456334|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83465873|NCT05456334|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83465874|NCT05456334|Dermatologic Agents|dermatologic agents|mesh-ancestor
83465875|NCT00001534|Losartan|losartan|mesh-list
83465876|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83465877|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83465878|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83465879|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83465880|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465881|NCT01027559|Sertraline|sertraline|mesh-list
83465882|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
83465883|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83465884|NCT01027559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83465885|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83465886|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83465887|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465888|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465889|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
83465890|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465891|NCT00002128|Adefovir|adefovir|mesh-list
83465892|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83465893|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
83465894|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465895|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465896|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465897|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485324|NCT00610688|Vitamins|vitamins|mesh-list
83465898|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465899|NCT00001570|Vinblastine|vinblastine|mesh-list
83465900|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83465901|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465902|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
83465903|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
83465904|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
83465905|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465907|NCT00000628|L-697661|l-697661|mesh-list
82712899|NCT00756873|Etoricoxib|etoricoxib|mesh-list
83465908|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
83465909|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465910|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83465911|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465912|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465913|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
83465914|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465915|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83485325|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
83465916|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465918|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83485473|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83465919|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465920|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465921|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465922|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
83465923|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465924|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83465925|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83465926|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83465927|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83465928|NCT01661790|Bevacizumab|bevacizumab|mesh-list
83465929|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83465930|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465931|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83465932|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83465933|NCT01661790|Growth Substances|growth substances|mesh-ancestor
83485474|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83465934|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465935|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
83465936|NCT00002134|Ganciclovir|ganciclovir|mesh-list
83465937|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83465938|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
83465939|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465940|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83465941|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465942|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465943|NCT00985907|Bortezomib|bortezomib|mesh-list
83465944|NCT00985907|Melphalan|melphalan|mesh-list
83465945|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83465946|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465947|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83465948|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
83465949|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465950|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83465951|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465952|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
83465953|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465954|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83465955|NCT00002140|Azithromycin|azithromycin|mesh-list
83465956|NCT00002140|Clarithromycin|clarithromycin|mesh-list
83465957|NCT00002140|Ethambutol|ethambutol|mesh-list
83465958|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83465959|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83465960|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82713688|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713690|NCT04732286|Bevacizumab|bevacizumab|mesh-list
83465961|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476635|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82713824|NCT02677545|Aspirin|aspirin|mesh-list
83465962|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465963|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83465964|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83465965|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
83465966|NCT00000658|Leucovorin|leucovorin|mesh-list
83465967|NCT00000658|Cytarabine|cytarabine|mesh-list
83465968|NCT00000658|Dexamethasone|dexamethasone|mesh-list
83465970|NCT00000658|Doxorubicin|doxorubicin|mesh-list
83465971|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83465972|NCT00000658|Methotrexate|methotrexate|mesh-list
83465973|NCT00000658|Vincristine|vincristine|mesh-list
83465974|NCT00000658|Bleomycin|bleomycin|mesh-list
83465975|NCT00000658|Allopurinol|allopurinol|mesh-list
83465976|NCT00000658|Sargramostim|sargramostim|mesh-list
83465977|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
83465978|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465979|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
83465980|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465981|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83465982|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83465984|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465985|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465986|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83465987|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83465988|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
83465989|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
83465990|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465991|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83465992|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
83465994|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83465995|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82714331|NCT00767559|PENTA|penta|mesh-list
83465996|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83465997|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83465998|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82714545|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
83465999|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466000|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83466001|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
83466002|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83466003|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83466004|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
83466005|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
83466006|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83466007|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466008|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
83466009|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466010|NCT00000658|Antidotes|antidotes|mesh-ancestor
83466011|NCT00000658|Protective Agents|protective agents|mesh-ancestor
83466012|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
83466013|NCT00000658|Vitamins|vitamins|mesh-ancestor
83466014|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
83466015|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83466016|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
83466017|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
83466018|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
83466019|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
83466020|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83466021|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
83466022|NCT02684474|HBOC 201|hboc 201|mesh-list
83466023|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
83466024|NCT01027793|Tretinoin|tretinoin|mesh-list
83466025|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466026|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
83466027|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
83466028|NCT00002146|Foscarnet|foscarnet|mesh-list
83466029|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83466030|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
83466031|NCT00002146|Analgesics|analgesics|mesh-ancestor
83466032|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
83466033|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466034|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466035|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
83466036|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83466037|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83466038|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
83466039|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83466040|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83466041|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466042|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83466043|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
83466044|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83466045|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
83466046|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466047|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466048|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466049|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466050|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
83466051|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83466052|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83476636|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83466053|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466054|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
83466055|NCT04389554|Coagulants|coagulants|mesh-ancestor
83466056|NCT03051516|Vaccines|vaccines|mesh-list
83466057|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
83466058|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466059|NCT01029587|Eculizumab|eculizumab|mesh-list
83466060|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83466061|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83466062|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
82715231|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
83466063|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466065|NCT00000664|Interleukin-2|interleukin-2|mesh-list
83466066|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466067|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83466068|NCT00000664|Analgesics|analgesics|mesh-ancestor
83466069|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
83466070|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466071|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466072|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
83466073|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715448|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83486069|NCT00251576|Heparin|heparin|mesh-list
83466074|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466075|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466076|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466077|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
83466078|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466079|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466080|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466081|NCT00000670|Zidovudine|zidovudine|mesh-list
83466082|NCT00000670|Probenecid|probenecid|mesh-list
83466083|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
83466084|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486070|NCT00251576|Calcium heparin|calcium heparin|mesh-list
83466085|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466086|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466087|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466088|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
83466089|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466090|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466091|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466092|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
83466093|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
83466094|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83466095|NCT02020070|Ipilimumab|ipilimumab|mesh-list
83466096|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83466097|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466098|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83476637|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83466099|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466100|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
83466101|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83466102|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466103|NCT00000694|Interferons|interferons|mesh-list
83466104|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
83466105|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
83466106|NCT00000694|Zidovudine|zidovudine|mesh-list
83466107|NCT00000694|Sargramostim|sargramostim|mesh-list
83466108|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466109|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
83466110|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466111|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
83466112|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466113|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
83466114|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466115|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466116|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466117|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466118|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466119|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466120|NCT01894412|Etanercept|etanercept|mesh-list
83466121|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83466122|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83466123|NCT01894412|Analgesics|analgesics|mesh-ancestor
83466124|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
83466125|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466126|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466127|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83466128|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83466129|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83466130|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83466131|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
83466132|NCT00000700|Zidovudine|zidovudine|mesh-list
83466133|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
83466134|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466135|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466136|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466137|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466138|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
83476857|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
83466139|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466140|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466141|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466142|NCT00002164|Nelfinavir|nelfinavir|mesh-list
83466143|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83466144|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83466145|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
83466146|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466147|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466148|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466149|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466150|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
83466151|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466152|NCT00000706|Zidovudine|zidovudine|mesh-list
83466153|NCT00000706|Quinine|quinine|mesh-list
83466154|NCT00000706|Probenecid|probenecid|mesh-list
83466155|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
82717331|NCT00772031|Topiramate|topiramate|mesh-list
83466156|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466157|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466158|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466159|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466160|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
83466161|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466162|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82717468|NCT04042948|Acetaminophen|acetaminophen|mesh-list
83486371|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466163|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466164|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
83466165|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83466166|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83466167|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83466168|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466169|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82717841|NCT00836914|Idelalisib|idelalisib|mesh-list
83466170|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466171|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83466172|NCT00000706|Analgesics|analgesics|mesh-ancestor
83466173|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
83466174|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
83466175|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
83466176|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83466177|NCT00988325|Oseltamivir|oseltamivir|mesh-list
83466178|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
83466179|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466180|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466181|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466182|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
82718045|NCT00842998|Lapatinib|lapatinib|mesh-list
83466183|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83466184|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
83466185|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466186|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
83466187|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466188|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
83466189|NCT00002302|Hematinics|hematinics|mesh-ancestor
83466190|NCT00002170|Nelfinavir|nelfinavir|mesh-list
83466191|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83466192|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83466193|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
83466194|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466195|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466196|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466197|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466198|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
83466199|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466200|NCT00002308|Stavudine|stavudine|mesh-list
83466201|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
83466202|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718724|NCT05810571|Analgesics|analgesics|mesh-ancestor
83466203|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466204|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466205|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718795|NCT05809414|Amantadine|amantadine|mesh-list
83466206|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
83466207|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466208|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466209|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466210|NCT00000724|Leucovorin|leucovorin|mesh-list
83466211|NCT00000724|Trimetrexate|trimetrexate|mesh-list
83466212|NCT00000724|Calcium|calcium|mesh-list
83466213|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
83466214|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83466215|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466216|NCT00000724|Antidotes|antidotes|mesh-ancestor
83466217|NCT00000724|Protective Agents|protective agents|mesh-ancestor
83466219|NCT00000724|Vitamins|vitamins|mesh-ancestor
83466220|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
83466221|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
83466222|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466223|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83466224|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
83466225|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466226|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466227|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83466228|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466229|NCT00000730|Leucovorin|leucovorin|mesh-list
83466230|NCT00000730|Trimethoprim|trimethoprim|mesh-list
83466231|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83466232|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
83466233|NCT00000730|Pentamidine|pentamidine|mesh-list
83466234|NCT00000730|Trimetrexate|trimetrexate|mesh-list
83466235|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
83466236|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
83466237|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466238|NCT00000730|Antidotes|antidotes|mesh-ancestor
82718929|NCT05696938|Niacinamide|niacinamide|mesh-list
82718930|NCT05696938|Niacin|niacin|mesh-list
82718931|NCT05696938|Nicotinic Acids|nicotinic acids|mesh-list
82718932|NCT05696938|Vitamin B Complex|vitamin b complex|mesh-ancestor
82718934|NCT05696938|Micronutrients|micronutrients|mesh-ancestor
82718935|NCT05696938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718936|NCT05696938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82718937|NCT05696938|Antimetabolites|antimetabolites|mesh-ancestor
82718938|NCT05696938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718939|NCT05696938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82718940|NCT05696938|Vasodilator Agents|vasodilator agents|mesh-ancestor
82718941|NCT05695508|Dexamethasone|dexamethasone|mesh-list
82718942|NCT05695508|Lenalidomide|lenalidomide|mesh-list
82718943|NCT05695508|Bortezomib|bortezomib|mesh-list
82718944|NCT05695508|Daratumumab|daratumumab|mesh-list
82718945|NCT05695508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82718946|NCT05695508|Antiemetics|antiemetics|mesh-ancestor
82718947|NCT05695508|Autonomic Agents|autonomic agents|mesh-ancestor
82718948|NCT05695508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718949|NCT05695508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718950|NCT05695508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82718951|NCT05695508|Glucocorticoids|glucocorticoids|mesh-ancestor
82718952|NCT05695508|Hormones|hormones|mesh-ancestor
82718953|NCT05695508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82718954|NCT05695508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82718955|NCT05695508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718956|NCT05695508|Immunologic Factors|immunologic factors|mesh-ancestor
82718957|NCT05695508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82718958|NCT05695508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82718959|NCT05695508|Growth Substances|growth substances|mesh-ancestor
82718960|NCT05695508|Growth Inhibitors|growth inhibitors|mesh-ancestor
82718961|NCT05679908|Oxytocin|oxytocin|mesh-list
82718962|NCT05679908|Oxytocics|oxytocics|mesh-ancestor
82718963|NCT05679908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82718964|NCT05679908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719002|NCT05653427|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
82719003|NCT05653427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719004|NCT05653427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466239|NCT00000730|Protective Agents|protective agents|mesh-ancestor
82719086|NCT05556200|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82719087|NCT05556200|Immunologic Factors|immunologic factors|mesh-ancestor
82719088|NCT05556200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719089|NCT05556200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719090|NCT05556200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82719091|NCT05556200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719092|NCT05556200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719094|NCT05554133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82719095|NCT05554133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719096|NCT05553691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
82719097|NCT05553691|Hallucinogens|hallucinogens|mesh-ancestor
82719098|NCT05553691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719099|NCT05553691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82719100|NCT05553691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82719101|NCT05553691|Serotonin Agents|serotonin agents|mesh-ancestor
82719102|NCT05553691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82719103|NCT05553691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719104|NCT05553691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82719105|NCT05536154|Cytarabine|cytarabine|mesh-list
82719106|NCT05536154|Etoposide|etoposide|mesh-list
82719107|NCT05536154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82719108|NCT05536154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719109|NCT05536154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82719110|NCT05536154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82719111|NCT05536154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719112|NCT05536154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719114|NCT05536154|Antimetabolites|antimetabolites|mesh-ancestor
83466240|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
83466241|NCT00000730|Vitamins|vitamins|mesh-ancestor
83466242|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
83466243|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83466244|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
83466245|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
83466246|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466247|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83466248|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
82719162|NCT05510089|Etoposide|etoposide|mesh-list
82719163|NCT05510089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82719164|NCT05510089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719165|NCT05510089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82719166|NCT05510089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82719167|NCT05510089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719168|NCT05510089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719169|NCT05510089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82719170|NCT05510089|Antimetabolites|antimetabolites|mesh-ancestor
82719171|NCT05510089|Antiviral Agents|antiviral agents|mesh-ancestor
82719172|NCT05510089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719173|NCT05510089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82719174|NCT05510089|Immunologic Factors|immunologic factors|mesh-ancestor
83466249|NCT00000730|Hormones|hormones|mesh-ancestor
83466250|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83466251|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83466252|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466253|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83466254|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466255|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
83466256|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83466257|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83466258|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83466259|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466260|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466261|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82719230|NCT05441280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82719231|NCT05441280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719232|NCT05441280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719233|NCT05441280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82719234|NCT05441280|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82719235|NCT05441280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82719236|NCT05441280|Serotonin Agents|serotonin agents|mesh-ancestor
82719237|NCT05441280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82719238|NCT05441280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719240|NCT05438082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719241|NCT05427162|Epoprostenol|epoprostenol|mesh-list
82719242|NCT05427162|Tezosentan|tezosentan|mesh-list
82719243|NCT05427162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82719244|NCT05427162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82719245|NCT05427162|Vasodilator Agents|vasodilator agents|mesh-ancestor
82719246|NCT05408091|Antibodies|antibodies|mesh-list
82719247|NCT05408091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82719248|NCT05408091|Immunologic Factors|immunologic factors|mesh-ancestor
82719249|NCT05408091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719257|NCT05396014|Analgesics|analgesics|mesh-ancestor
83486522|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486523|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
83486524|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83486525|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
83486526|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
83486527|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83486528|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719395|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82719396|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82719397|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719434|NCT05242458|Ustekinumab|ustekinumab|mesh-list
82719435|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
82719436|NCT05236946|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82719437|NCT05236946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82719438|NCT05236946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719439|NCT05236946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719440|NCT05222932|Avelumab|avelumab|mesh-list
82719441|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719442|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719443|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
82719444|NCT05216419|Vitamin D|vitamin d|mesh-list
82719445|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82719446|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719447|NCT05216419|Vitamins|vitamins|mesh-ancestor
82719448|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
83466262|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83466263|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83466264|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
83466265|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83466266|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83466267|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83466268|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
83466269|NCT00002176|Nelfinavir|nelfinavir|mesh-list
83466270|NCT00002176|Stavudine|stavudine|mesh-list
83466271|NCT00002176|Didanosine|didanosine|mesh-list
83466272|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
83466273|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466274|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
83466275|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466276|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466277|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466278|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83466279|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83466280|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
83466281|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466282|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466283|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
83466284|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466285|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
83466286|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466287|NCT01990196|Dasatinib|dasatinib|mesh-list
83466288|NCT01990196|Trametinib|trametinib|mesh-list
83466289|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466290|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83466291|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466292|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719808|NCT04540211|Atezolizumab|atezolizumab|mesh-list
83466293|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
83466294|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83466295|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466297|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
83466298|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83466299|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83466300|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83466301|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
83466302|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83466303|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466304|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83466305|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83466306|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83466307|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466308|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
83466309|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83466310|NCT00002320|Lamivudine|lamivudine|mesh-list
83466311|NCT00002320|Zidovudine|zidovudine|mesh-list
83466312|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466313|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466314|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466315|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466316|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
83466317|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466318|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466319|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466320|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
83466321|NCT02167217|Prednisolone|prednisolone|mesh-list
83466322|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83466323|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
83466324|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83466325|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
83466326|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83466327|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
83466328|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83466329|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
83466330|NCT02167217|Hormones|hormones|mesh-ancestor
83466331|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83466332|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466333|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83466334|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466335|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
83466336|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
83466337|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466338|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83466339|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83466340|NCT02167217|Protective Agents|protective agents|mesh-ancestor
83466341|NCT00002326|Zidovudine|zidovudine|mesh-list
83466342|NCT00002326|Adefovir|adefovir|mesh-list
83466343|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
83466344|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486607|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
83466345|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466346|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466347|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466348|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
83466349|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466350|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466351|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466352|NCT01152697|Haloperidol|haloperidol|mesh-list
83466353|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
83466354|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
83466355|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
83466356|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466357|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466358|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83466359|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83466360|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83466361|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83466362|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83466363|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83466364|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
83466365|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83466366|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466367|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83466368|NCT00002188|Alitretinoin|alitretinoin|mesh-list
83466369|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466370|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
83466371|NCT00002332|Thymopentin|thymopentin|mesh-list
83466372|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83466373|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
83466374|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466375|NCT05571644|Leucovorin|leucovorin|mesh-list
83466376|NCT05571644|Fluorouracil|fluorouracil|mesh-list
83466377|NCT05571644|Oxaliplatin|oxaliplatin|mesh-list
83466378|NCT05571644|Irinotecan|irinotecan|mesh-list
83466379|NCT05571644|Levoleucovorin|levoleucovorin|mesh-list
83466380|NCT05571644|Antimetabolites|antimetabolites|mesh-ancestor
83466381|NCT05571644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466382|NCT05571644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83486608|NCT00646646|Propofol|propofol|mesh-list
83466383|NCT05571644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466384|NCT05571644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83466385|NCT05571644|Immunologic Factors|immunologic factors|mesh-ancestor
83466386|NCT05571644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466387|NCT05571644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83466388|NCT05571644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83466389|NCT05571644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466391|NCT05571644|Protective Agents|protective agents|mesh-ancestor
83466392|NCT05571644|Vitamin B Complex|vitamin b complex|mesh-ancestor
83466393|NCT05571644|Vitamins|vitamins|mesh-ancestor
83466394|NCT05571644|Micronutrients|micronutrients|mesh-ancestor
83466395|NCT03011281|Tofacitinib|tofacitinib|mesh-list
83466396|NCT03011281|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83466397|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83466398|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466399|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466400|NCT00002194|Clarithromycin|clarithromycin|mesh-list
83466401|NCT00002194|Erythromycin|erythromycin|mesh-list
83466403|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83466404|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
83466405|NCT00002194|Nevirapine|nevirapine|mesh-list
83466406|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83466407|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466408|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83466409|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466410|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466411|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83466412|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83466413|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466414|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466415|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
83466416|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466417|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466418|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83486684|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83466419|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83466421|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
83466422|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466423|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83466424|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466425|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466426|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
82720982|NCT00856882|Caseins|caseins|mesh-list
83466427|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83466428|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
83466429|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466430|NCT04756622|Expectorants|expectorants|mesh-ancestor
82721041|NCT00424255|Lapatinib|lapatinib|mesh-list
82721126|NCT00717938|Carboplatin|carboplatin|mesh-list
83466431|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
83466433|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
83476858|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83466434|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466435|NCT04756622|Protective Agents|protective agents|mesh-ancestor
83466436|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466437|NCT04756622|Antidotes|antidotes|mesh-ancestor
83466438|NCT00002344|Azithromycin|azithromycin|mesh-list
83466439|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83466440|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466441|NCT01198327|Ranibizumab|ranibizumab|mesh-list
83466442|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83466443|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83466444|NCT01198327|Growth Substances|growth substances|mesh-ancestor
83466445|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466446|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
83466447|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466448|NCT00002200|Abacavir|abacavir|mesh-list
83466449|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466450|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466451|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466452|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466453|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
83466454|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466455|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466456|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466457|NCT00002356|Fomivirsen|fomivirsen|mesh-list
83466458|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
83466459|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466460|NCT00994175|Pioglitazone|pioglitazone|mesh-list
83466461|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83466462|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466464|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83466465|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
83466466|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721614|NCT00859534|Afamelanotide|afamelanotide|mesh-list
83466467|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466468|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466470|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466471|NCT02403986|Lidocaine|lidocaine|mesh-list
83466472|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
83466473|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
83466474|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476934|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
83466475|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466476|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
83466477|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466478|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82721818|NCT00853684|Capecitabine|capecitabine|mesh-list
83466479|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83466480|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83466481|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83466482|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466484|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466485|NCT00002362|Emtricitabine|emtricitabine|mesh-list
83466486|NCT00002362|Efavirenz|efavirenz|mesh-list
83466487|NCT00002362|Abacavir|abacavir|mesh-list
83466488|NCT00002362|Stavudine|stavudine|mesh-list
83466489|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
83466490|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466491|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466492|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466493|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466494|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466495|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466496|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466497|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83466498|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83466499|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83466500|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83466501|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83466502|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83466504|NCT02168309|Labetalol|labetalol|mesh-list
83466505|NCT02168309|Nifedipine|nifedipine|mesh-list
83466506|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83466507|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83466508|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466509|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83466510|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466511|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
83466513|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83466514|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83466515|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83466516|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
83466517|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83466518|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83466519|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
83466520|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
83466521|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722465|NCT00804531|Prednisolone|prednisolone|mesh-list
83466522|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83466523|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83466525|NCT00002368|Nevirapine|nevirapine|mesh-list
83466526|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466527|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466528|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466529|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466530|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
83466531|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466532|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82722611|NCT00805233|Bromfenac|bromfenac|mesh-list
83466533|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466534|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83466535|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83466536|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
83466537|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82722682|NCT00862264|Hormones|hormones|mesh-ancestor
83466538|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
83466539|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
83466540|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83466541|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466542|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466543|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83466544|NCT01199965|Analgesics|analgesics|mesh-ancestor
83466545|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
83466546|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466547|NCT00995501|Insulin|insulin|mesh-list
83466548|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83466549|NCT00995501|Dexamethasone|dexamethasone|mesh-list
83466550|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
83466551|NCT00995501|Anesthetics|anesthetics|mesh-list
83466552|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
83466553|NCT00995501|BB 1101|bb 1101|mesh-list
83466554|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83466555|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466556|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83466557|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
83466558|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
83466559|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466560|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83466561|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
83466562|NCT00995501|Hormones|hormones|mesh-ancestor
83466563|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83466564|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83466565|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466566|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
83466567|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466568|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466569|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83466570|NCT00995501|Cathartics|cathartics|mesh-ancestor
83466571|NCT00002374|Ritonavir|ritonavir|mesh-list
83466572|NCT00002374|Nelfinavir|nelfinavir|mesh-list
83466573|NCT00002374|Saquinavir|saquinavir|mesh-list
83466574|NCT00002374|Stavudine|stavudine|mesh-list
83466575|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82723233|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
83466576|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83466577|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
83466578|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466579|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466580|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466581|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466582|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
83466583|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723453|NCT00738842|Ticagrelor|ticagrelor|mesh-list
83466584|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83466585|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83466586|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
83466587|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466588|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466589|NCT00002380|Nelfinavir|nelfinavir|mesh-list
83466590|NCT00002380|Saquinavir|saquinavir|mesh-list
83466591|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83466592|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83466593|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
83466594|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466595|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466596|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466597|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466598|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
83486838|NCT01230593|BB 1101|bb 1101|mesh-list
83466599|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466600|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83466601|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83466602|NCT00002386|Lamivudine|lamivudine|mesh-list
83466603|NCT00002386|Zidovudine|zidovudine|mesh-list
83466604|NCT00002386|Stavudine|stavudine|mesh-list
83466605|NCT00002386|Didanosine|didanosine|mesh-list
83466606|NCT00002386|Zalcitabine|zalcitabine|mesh-list
83466608|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466609|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466610|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466611|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466612|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
83466613|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466614|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466615|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466616|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
83466617|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83466618|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83466619|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
83466620|NCT01942694|Vitamin D|vitamin d|mesh-list
83466621|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
83466622|NCT01942694|Vitamins|vitamins|mesh-ancestor
83466623|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
83466624|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466625|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83466626|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83466627|NCT01153711|Ketoconazole|ketoconazole|mesh-list
83466628|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
83466629|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466630|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83466631|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83466632|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466633|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466634|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83466635|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
83466636|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83487283|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466637|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466638|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83466640|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82724242|NCT02568488|Metformin|metformin|mesh-list
83466642|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724306|NCT00864604|Analgesics|analgesics|mesh-ancestor
83466643|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466644|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83466645|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83466646|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
83466647|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476935|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83476936|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
83466648|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466650|NCT05751850|Paclitaxel|paclitaxel|mesh-list
83466651|NCT05751850|Gemcitabine|gemcitabine|mesh-list
83466652|NCT05751850|Fluorouracil|fluorouracil|mesh-list
83466653|NCT05751850|Oxaliplatin|oxaliplatin|mesh-list
83466654|NCT05751850|Calcium|calcium|mesh-list
83466655|NCT05751850|Levoleucovorin|levoleucovorin|mesh-list
82724528|NCT00873262|Estradiol|estradiol|mesh-list
83466656|NCT05751850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83466657|NCT05751850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466658|NCT05751850|Tubulin Modulators|tubulin modulators|mesh-ancestor
83466659|NCT05751850|Antimitotic Agents|antimitotic agents|mesh-ancestor
83466660|NCT05751850|Mitosis Modulators|mitosis modulators|mesh-ancestor
83466661|NCT05751850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466662|NCT05751850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83466663|NCT05751850|Antimetabolites|antimetabolites|mesh-ancestor
83466664|NCT05751850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83466665|NCT05751850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466666|NCT05751850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83466667|NCT05751850|Immunologic Factors|immunologic factors|mesh-ancestor
83466668|NCT05751850|Antidotes|antidotes|mesh-ancestor
83466669|NCT05751850|Protective Agents|protective agents|mesh-ancestor
83466670|NCT05751850|Vitamin B Complex|vitamin b complex|mesh-ancestor
83466671|NCT05751850|Vitamins|vitamins|mesh-ancestor
83466672|NCT05751850|Micronutrients|micronutrients|mesh-ancestor
83466675|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83466676|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83466677|NCT01938248|Analgesics|analgesics|mesh-ancestor
83466678|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
83466679|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466680|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466681|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82724873|NCT00414661|Tofacitinib|tofacitinib|mesh-list
83466682|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83466683|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83466684|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83466685|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466686|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83466687|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83466688|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466689|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
83466690|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83466691|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
83466693|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
83466694|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
83466695|NCT00002230|Efavirenz|efavirenz|mesh-list
83466696|NCT00002230|Stavudine|stavudine|mesh-list
83466697|NCT00002230|Didanosine|didanosine|mesh-list
83466698|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
83466699|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466700|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466701|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466702|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466703|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
83466704|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466705|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83466706|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83466707|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83466708|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83466709|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83466710|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83466711|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466712|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
83466713|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
83466714|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466715|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466716|NCT03009877|Fentanyl|fentanyl|mesh-list
83466717|NCT03009877|Midazolam|midazolam|mesh-list
83466718|NCT03009877|Propofol|propofol|mesh-list
83466719|NCT03009877|Rocuronium|rocuronium|mesh-list
83466720|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83466721|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83466722|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466723|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83466724|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
83466725|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
83466726|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83466727|NCT03009877|Narcotics|narcotics|mesh-ancestor
83466728|NCT03009877|Analgesics|analgesics|mesh-ancestor
83466729|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
83466730|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466731|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83466732|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83466733|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83466734|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83466735|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
83466736|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
83466737|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83466738|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466739|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83487510|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83466740|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83466741|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83466743|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83466744|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
83466745|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466746|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
83466747|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83466748|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466749|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83466750|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83466751|NCT00002392|Growth Substances|growth substances|mesh-ancestor
83466752|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
83466753|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466754|NCT00002398|Adefovir|adefovir|mesh-list
83466755|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83466756|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
83466757|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466758|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466759|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466760|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466761|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466762|NCT00997139|Polymyxins|polymyxins|mesh-list
83466763|NCT00997139|Neomycin|neomycin|mesh-list
83466764|NCT00997139|Bacitracin|bacitracin|mesh-list
83466765|NCT00997139|Polymyxin B|polymyxin b|mesh-list
82725630|NCT00813891|Ranibizumab|ranibizumab|mesh-list
83466766|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
83466768|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466769|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83466770|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466771|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466772|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83466773|NCT00002236|Zidovudine|zidovudine|mesh-list
83466774|NCT00002236|Delavirdine|delavirdine|mesh-list
83466775|NCT00002236|Indinavir|indinavir|mesh-list
83466776|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
83466777|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466778|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82725772|NCT00814593|Carmustine|carmustine|mesh-list
83466779|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466780|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466781|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
83466782|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466783|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466784|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466785|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83466786|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83466787|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
83466789|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
83466790|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83466791|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
83466792|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466793|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725901|NCT01041235|Docetaxel|docetaxel|mesh-list
83466794|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
83466795|NCT04998617|Curcumin|curcumin|mesh-list
83466796|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83466797|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83466798|NCT04998617|Analgesics|analgesics|mesh-ancestor
83466799|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
83466800|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466801|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466802|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83466803|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83466804|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466805|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466806|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466807|NCT00002404|Valacyclovir|valacyclovir|mesh-list
83466808|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
83466809|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466810|NCT05593757|Quinidine|quinidine|mesh-list
83466811|NCT05593757|Verapamil|verapamil|mesh-list
83466812|NCT05593757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83466813|NCT05593757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83466814|NCT05593757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83466815|NCT05593757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466816|NCT05593757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83466817|NCT05593757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466818|NCT05593757|Vasodilator Agents|vasodilator agents|mesh-ancestor
83466819|NCT05593757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83466820|NCT05593757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83466821|NCT05593757|Adrenergic Agents|adrenergic agents|mesh-ancestor
83466822|NCT05593757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83466823|NCT05593757|Antimalarials|antimalarials|mesh-ancestor
83466824|NCT05593757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83466825|NCT05593757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83466826|NCT05593757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466827|NCT05593757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466828|NCT05593757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82726034|NCT00650091|Expectorants|expectorants|mesh-ancestor
83466829|NCT05593757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83466830|NCT05593757|Cholinergic Agents|cholinergic agents|mesh-ancestor
83466831|NCT05593757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83466832|NCT05593757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83466833|NCT05593757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83466834|NCT05593757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83466835|NCT01242241|Propofol|propofol|mesh-list
83466836|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83466837|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83466838|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466839|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83466840|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
83466841|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
83466842|NCT02393690|Iodine|iodine|mesh-list
83466843|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
83466844|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83466845|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466846|NCT02393690|Trace Elements|trace elements|mesh-ancestor
83466847|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
83466848|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466849|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
83466850|NCT01200433|Propofol|propofol|mesh-list
83487511|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83466851|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83466852|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83466853|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466854|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83466856|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
83466857|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83466858|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83466859|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83466860|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83466861|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
83466862|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83466863|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466864|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83466865|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
83466866|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
83466867|NCT00002410|Lamivudine|lamivudine|mesh-list
83466868|NCT00002410|Zidovudine|zidovudine|mesh-list
83466869|NCT00002410|Indinavir|indinavir|mesh-list
83466870|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82726419|NCT03897192|Bevacizumab|bevacizumab|mesh-list
83466871|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466872|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466873|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466874|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
83466875|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466876|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466877|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466878|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
83466879|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83466880|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83466881|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
83466883|NCT01243333|Alovudine|alovudine|mesh-list
83466884|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
83466885|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83466886|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83466887|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466888|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
83466889|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
83466890|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466891|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83466892|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466893|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466895|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83466896|NCT01924052|Katacalcin|katacalcin|mesh-list
83487512|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
83466897|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83466898|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466899|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83466900|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
83466901|NCT00002416|Lamivudine|lamivudine|mesh-list
83466902|NCT00002416|Emtricitabine|emtricitabine|mesh-list
83466904|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83466905|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466906|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466907|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
83466908|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466909|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83466910|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83466912|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
83466913|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466914|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
83466915|NCT01897454|Leucovorin|leucovorin|mesh-list
83466916|NCT01897454|Folic Acid|folic acid|mesh-list
83466917|NCT01897454|Gemcitabine|gemcitabine|mesh-list
83466918|NCT01897454|Fluorouracil|fluorouracil|mesh-list
83466919|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
83466920|NCT01897454|Irinotecan|irinotecan|mesh-list
83466921|NCT01897454|Camptothecin|camptothecin|mesh-list
83466922|NCT01897454|Calcium|calcium|mesh-list
83466923|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
83466924|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83466925|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
83466926|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466927|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466928|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83466929|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466930|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83466931|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83466932|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
83466933|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83466934|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83466936|NCT01897454|Antidotes|antidotes|mesh-ancestor
83466937|NCT01897454|Protective Agents|protective agents|mesh-ancestor
83466938|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
83466939|NCT01897454|Vitamins|vitamins|mesh-ancestor
83466940|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
83466941|NCT01897454|Hematinics|hematinics|mesh-ancestor
83466942|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83466943|NCT01243567|Timolol|timolol|mesh-list
83466944|NCT01243567|Bimatoprost|bimatoprost|mesh-list
83466945|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83466946|NCT01243567|Latanoprost|latanoprost|mesh-list
83466947|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83466948|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83466949|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83466950|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
83466951|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83466952|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466953|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466954|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83466955|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83466956|NCT01001195|Bimatoprost|bimatoprost|mesh-list
83466957|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83466958|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83466959|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83466960|NCT00381472|Ropinirole|ropinirole|mesh-list
83466961|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83466962|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83466963|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
83466964|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
83466965|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83466966|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466967|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466968|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83466969|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83466970|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83466971|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83466972|NCT01460654|Alendronate|alendronate|mesh-list
83466973|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
83466974|NCT01460654|Testosterone|testosterone|mesh-list
83466975|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
83466976|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
83466977|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83466978|NCT01460654|Androgens|androgens|mesh-ancestor
83466979|NCT01460654|Hormones|hormones|mesh-ancestor
83476937|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466980|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83466981|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466982|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83466983|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466984|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
83466985|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83466986|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
83466987|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83466988|NCT01001975|Protective Agents|protective agents|mesh-ancestor
83466989|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83466990|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
83466992|NCT01459484|Doxorubicin|doxorubicin|mesh-list
83466993|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83466994|NCT01459484|Methotrexate|methotrexate|mesh-list
83466995|NCT01459484|Ifosfamide|ifosfamide|mesh-list
83466996|NCT01459484|Mifamurtide|mifamurtide|mesh-list
83466997|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
83466998|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83466999|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83467000|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83467001|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83467002|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467003|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467004|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83467005|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
83467006|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83476938|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467007|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467008|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83467009|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
83467010|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
83467011|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83467012|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83467013|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
83467014|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467015|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83467016|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83467017|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
83467018|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83467019|NCT00002260|Alovudine|alovudine|mesh-list
82727770|NCT01035619|Moxidectin|moxidectin|mesh-list
83467020|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
83467021|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467022|NCT01444040|Travoprost|travoprost|mesh-list
82727839|NCT00699374|Sorafenib|sorafenib|mesh-list
83467023|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83467024|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
83467025|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83467026|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
83467027|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467028|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467029|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83467030|NCT00002266|Protective Agents|protective agents|mesh-ancestor
82728067|NCT00605722|Bevacizumab|bevacizumab|mesh-list
83467031|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83467032|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82728142|NCT00882388|Aspirin|aspirin|mesh-list
83467033|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467034|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467035|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
83467036|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467037|NCT05751304|Dexmedetomidine|dexmedetomidine|mesh-list
83467038|NCT05751304|Ketamine|ketamine|mesh-list
83467039|NCT05751304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83467040|NCT05751304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83467041|NCT05751304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467042|NCT05751304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83467043|NCT05751304|Analgesics|analgesics|mesh-ancestor
83467045|NCT05751304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467046|NCT05751304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83467047|NCT05751304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83467048|NCT05751304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83467049|NCT05751304|Adrenergic Agents|adrenergic agents|mesh-ancestor
83467050|NCT05751304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83467051|NCT05751304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467052|NCT05751304|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83467053|NCT05751304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83467054|NCT05751304|Anesthetics, General|anesthetics, general|mesh-ancestor
83467055|NCT05751304|Anesthetics|anesthetics|mesh-ancestor
83467056|NCT05751304|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83467057|NCT05751304|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83467058|NCT01202071|Rabeprazole|rabeprazole|mesh-list
83467059|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83467060|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83467061|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83467062|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728477|NCT01042873|Dobutamine|dobutamine|mesh-list
83467063|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467065|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
83467066|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467067|NCT01422746|Metformin|metformin|mesh-list
83467068|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83467069|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467070|NCT00002272|Foscarnet|foscarnet|mesh-list
83467071|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83467072|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
83467073|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467074|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83467075|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83467076|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467077|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467078|NCT01002755|Lenalidomide|lenalidomide|mesh-list
83467079|NCT01002755|Ofatumumab|ofatumumab|mesh-list
83467080|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83467081|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
83467082|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467083|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83467084|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83467085|NCT01002755|Growth Substances|growth substances|mesh-ancestor
83467086|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
83467087|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467088|NCT00002434|Leucovorin|leucovorin|mesh-list
83467089|NCT00002434|Trimetrexate|trimetrexate|mesh-list
83467090|NCT00002434|Calcium|calcium|mesh-list
83467091|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
83467092|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83467093|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467094|NCT00002434|Antidotes|antidotes|mesh-ancestor
83467095|NCT00002434|Protective Agents|protective agents|mesh-ancestor
83467096|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
83467097|NCT00002434|Vitamins|vitamins|mesh-ancestor
83467098|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
83467099|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
83467100|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467101|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83467102|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
83467103|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467104|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467105|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83467106|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467107|NCT00002278|Diclazuril|diclazuril|mesh-list
83467108|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
83467109|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83467110|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83467111|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467112|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
83467113|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
83467114|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
83467115|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467116|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467117|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83467118|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83467119|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
83467120|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
83467121|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83467122|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467123|NCT01003301|Omalizumab|omalizumab|mesh-list
83467124|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83467125|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83467126|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
83467127|NCT00002440|Ritonavir|ritonavir|mesh-list
83467128|NCT00002440|Nelfinavir|nelfinavir|mesh-list
83467129|NCT00002440|Indinavir|indinavir|mesh-list
83467130|NCT00002440|Saquinavir|saquinavir|mesh-list
83467131|NCT00002440|Amprenavir|amprenavir|mesh-list
83467132|NCT00002440|Abacavir|abacavir|mesh-list
83467133|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83467134|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83467135|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
83467136|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467137|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467138|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83467139|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83467140|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
83467141|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467142|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83467143|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83467144|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83467145|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83467146|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83467147|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
83467148|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83467149|NCT01421810|Dexamethasone|dexamethasone|mesh-list
83467150|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83467151|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
83467152|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
83467153|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467154|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467155|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83467156|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
83487513|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
83467158|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83467159|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83467160|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467161|NCT00002284|Zidovudine|zidovudine|mesh-list
83467162|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
83467163|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467164|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83467165|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83467166|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467167|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
83467168|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467169|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83467170|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83467171|NCT01243957|Fluoxetine|fluoxetine|mesh-list
83467172|NCT01243957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83467173|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83467174|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83467175|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467176|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83467178|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467179|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83467180|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
83467181|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83467182|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83467183|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83467184|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467185|NCT00002446|Fluconazole|fluconazole|mesh-list
83467186|NCT00002446|Posaconazole|posaconazole|mesh-list
83467187|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
83467188|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467189|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83467190|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83467191|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729478|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
83467192|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467193|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83467194|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
83487514|NCT00729482|Everolimus|everolimus|mesh-list
83467195|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83467196|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467197|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83467198|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83467199|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83467200|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83467201|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83467202|NCT01884740|Bevacizumab|bevacizumab|mesh-list
83467203|NCT01884740|Cetuximab|cetuximab|mesh-list
83467204|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83467205|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467206|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83467207|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83467208|NCT01884740|Growth Substances|growth substances|mesh-ancestor
83467209|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467210|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
83467211|NCT00002290|Zidovudine|zidovudine|mesh-list
83467212|NCT00002290|Acyclovir|acyclovir|mesh-list
83467213|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
83476939|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83467214|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467215|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83467216|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83467217|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467218|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
83467219|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467220|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83467221|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83467222|NCT01003769|Acetic Acid|acetic acid|mesh-list
83467223|NCT01003769|Lenalidomide|lenalidomide|mesh-list
83467224|NCT01003769|Retinol acetate|retinol acetate|mesh-list
83467225|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
83467226|NCT01003769|Gossypol|gossypol|mesh-list
83467227|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
83467228|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467229|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83467230|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83467231|NCT01003769|Growth Substances|growth substances|mesh-ancestor
83467232|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
82729890|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
83467233|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467234|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83467235|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467236|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83467237|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83467238|NCT01003769|Protective Agents|protective agents|mesh-ancestor
83467239|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83467240|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
83467241|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83467242|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83467243|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83467244|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83467245|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83467246|NCT00002452|Indinavir|indinavir|mesh-list
82730092|NCT00743886|Mitogens|mitogens|mesh-list
83467247|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83467248|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83467249|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
82730168|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
83467250|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467251|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467252|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83467253|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83467254|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
83467255|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467257|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
83467258|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
83467259|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83467260|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467261|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
83467262|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467263|NCT00002458|Antibodies|antibodies|mesh-list
83467264|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83467265|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
83467266|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467267|NCT00002470|Interferons|interferons|mesh-list
83467268|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
83467269|NCT00002470|Fluorouracil|fluorouracil|mesh-list
83467270|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
83467271|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467272|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83467273|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467274|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83467275|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
83467276|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467277|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
83467278|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467279|NCT00002476|Leucovorin|leucovorin|mesh-list
83467281|NCT00002476|Fluorouracil|fluorouracil|mesh-list
83467282|NCT00002476|Methotrexate|methotrexate|mesh-list
83467284|NCT00002476|Bleomycin|bleomycin|mesh-list
83467285|NCT00002476|Calcium|calcium|mesh-list
83467286|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
83467287|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83467288|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467289|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
83467290|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467291|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83467292|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467293|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83467294|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
83467295|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83467296|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
83467297|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83467298|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
83467299|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467300|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83467301|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467302|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83467303|NCT00002476|Antidotes|antidotes|mesh-ancestor
83467304|NCT00002476|Protective Agents|protective agents|mesh-ancestor
83467305|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
83467306|NCT00002476|Vitamins|vitamins|mesh-ancestor
83467307|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
83467308|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83467309|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
83467310|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
83467311|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
83467312|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83467313|NCT00002476|Trace Elements|trace elements|mesh-ancestor
83467314|NCT01876628|Clindamycin|clindamycin|mesh-list
83467315|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
83467316|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
83467317|NCT01876628|Floxacillin|floxacillin|mesh-list
83467318|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83476940|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
83467319|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467320|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83467321|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467322|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467323|NCT01004705|Aspirin|aspirin|mesh-list
83467324|NCT01004705|Ramipril|ramipril|mesh-list
83467325|NCT01004705|Simvastatin|simvastatin|mesh-list
83467326|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83467327|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83467328|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
83477094|NCT00284180|Trastuzumab|trastuzumab|mesh-list
83467329|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467330|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83467331|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83467332|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467333|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83467334|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83467335|NCT01004705|Analgesics|analgesics|mesh-ancestor
83467336|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
83467337|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467338|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467339|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83467340|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467341|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83467342|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83467343|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83467344|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83467346|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83467347|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
83467348|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83467349|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
83467350|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
83467351|NCT00002482|Antibodies|antibodies|mesh-list
83487515|NCT00729482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83467352|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83467353|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
83467354|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467355|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467356|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83467357|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
83467358|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467359|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467360|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83467362|NCT01004939|Fondaparinux|fondaparinux|mesh-list
83467363|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83467364|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
83467365|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83467366|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
83467367|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467368|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467369|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
83467370|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83467371|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83467372|NCT05750758|Rivaroxaban|rivaroxaban|mesh-list
83467373|NCT05750758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83467374|NCT05750758|Antithrombins|antithrombins|mesh-ancestor
83467375|NCT05750758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83467376|NCT05750758|Protease Inhibitors|protease inhibitors|mesh-ancestor
83467377|NCT05750758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467378|NCT05750758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467379|NCT05750758|Anticoagulants|anticoagulants|mesh-ancestor
83467380|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
83467381|NCT00002488|Etoposide|etoposide|mesh-list
83467382|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83467383|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
83467384|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467385|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467386|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83467387|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
83467388|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467389|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467390|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83487741|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83467391|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83467392|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83467393|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83467394|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731612|NCT04144023|Vaccines|vaccines|mesh-list
83467396|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83467397|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
83467398|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467399|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467400|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83467401|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
83467402|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83467403|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83467404|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467405|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467406|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83467407|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83467408|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
83467409|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83467410|NCT01245595|Protective Agents|protective agents|mesh-ancestor
83467411|NCT01864772|Cetuximab|cetuximab|mesh-list
83467412|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83467413|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467414|NCT00002494|Leucovorin|leucovorin|mesh-list
83467415|NCT00002494|Cobalt|cobalt|mesh-list
83467416|NCT00002494|Cytarabine|cytarabine|mesh-list
83467417|NCT00002494|Dexamethasone|dexamethasone|mesh-list
83467418|NCT00002494|Prednisone|prednisone|mesh-list
83467419|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
83467420|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83467421|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83467422|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83467423|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
83467424|NCT00002494|Ifosfamide|ifosfamide|mesh-list
83467425|NCT00002494|Doxorubicin|doxorubicin|mesh-list
83467426|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83467427|NCT00002494|Methotrexate|methotrexate|mesh-list
83467428|NCT00002494|Etoposide|etoposide|mesh-list
83467429|NCT00002494|Vincristine|vincristine|mesh-list
83467430|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
83467431|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83467432|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
83467433|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467434|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467435|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83467436|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
83467437|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467438|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467439|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83467440|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83467442|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
83467443|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467444|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83467445|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
83467446|NCT00002494|Hormones|hormones|mesh-ancestor
83467447|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83467448|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83467449|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83467450|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83467451|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83467452|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487742|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
83467453|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83467454|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
83467455|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83467456|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83467457|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
83467458|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
83467459|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83467460|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83467461|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83467462|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
83467463|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467464|NCT00002494|Antidotes|antidotes|mesh-ancestor
83467465|NCT00002494|Protective Agents|protective agents|mesh-ancestor
83467466|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
83467467|NCT00002494|Vitamins|vitamins|mesh-ancestor
83467468|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
83467469|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
83467470|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
83467471|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
83467472|NCT00002494|Trace Elements|trace elements|mesh-ancestor
83467473|NCT00002506|Interferons|interferons|mesh-list
83467474|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
83467475|NCT00002506|Isotretinoin|isotretinoin|mesh-list
83467476|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467477|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
83467478|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467479|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
83467480|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467481|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
83467482|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
83467483|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83467484|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467485|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83467486|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
83467487|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83467488|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467489|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467490|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467491|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
83467492|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83467493|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83467494|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83467495|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83487969|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
83467496|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467497|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
82732730|NCT05396898|Tacrolimus|tacrolimus|mesh-list
83467498|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83467499|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467500|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83467501|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467502|NCT01357772|Tamoxifen|tamoxifen|mesh-list
83467503|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83467504|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
83467505|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83467507|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83467508|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467509|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83467510|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82732869|NCT05343156|Hormones|hormones|mesh-ancestor
83467511|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83467512|NCT03866837|Micronutrients|micronutrients|mesh-list
83467513|NCT03866837|Trace Elements|trace elements|mesh-list
83467514|NCT03866837|Lactoferrin|lactoferrin|mesh-list
83467515|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467516|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467517|NCT05750446|Riociguat|riociguat|mesh-list
83467518|NCT05750446|Enzyme Activators|enzyme activators|mesh-ancestor
83467519|NCT05750446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467520|NCT05750290|Irinotecan|irinotecan|mesh-list
83467521|NCT05750290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83467522|NCT05750290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83467523|NCT05750290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467524|NCT05750290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467525|NCT05750290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467526|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
83467527|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467528|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
83467529|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
83467530|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
83467531|NCT04456517|Ranolazine|ranolazine|mesh-list
83467532|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83467533|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83467534|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467535|NCT01840046|Interleukin-2|interleukin-2|mesh-list
83467536|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467537|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83467538|NCT01840046|Analgesics|analgesics|mesh-ancestor
83467539|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
83467540|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467541|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467542|NCT00437216|Clobetasol|clobetasol|mesh-list
83467543|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83467544|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
83467545|NCT00437216|Hormones|hormones|mesh-ancestor
83467546|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83467547|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467548|NCT00002524|Leucovorin|leucovorin|mesh-list
83467549|NCT00002524|Cytarabine|cytarabine|mesh-list
83467550|NCT00002524|Zidovudine|zidovudine|mesh-list
83467551|NCT00002524|Trimethoprim|trimethoprim|mesh-list
83467552|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
83467553|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83467554|NCT00002524|Pentamidine|pentamidine|mesh-list
83467555|NCT00002524|Prednisone|prednisone|mesh-list
83467556|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
83467557|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83467558|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83467559|NCT00002524|Prednisolone|prednisolone|mesh-list
83467560|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
83467561|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
83467562|NCT00002524|Ifosfamide|ifosfamide|mesh-list
83467563|NCT00002524|Doxorubicin|doxorubicin|mesh-list
83467564|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83467565|NCT00002524|Fluorouracil|fluorouracil|mesh-list
83467566|NCT00002524|Methotrexate|methotrexate|mesh-list
83467567|NCT00002524|Etoposide|etoposide|mesh-list
83467568|NCT00002524|Vincristine|vincristine|mesh-list
83467569|NCT00002524|Bleomycin|bleomycin|mesh-list
83467570|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83467571|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
83467572|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
83467573|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83467574|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
83467575|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467576|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488047|NCT00723632|Ribavirin|ribavirin|mesh-list
83467577|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83467578|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
83467579|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467580|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467581|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83467582|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83467583|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83467584|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83467585|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467586|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
83467587|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83467588|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83467589|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
83467590|NCT00002524|Hormones|hormones|mesh-ancestor
83467591|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83467592|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83467593|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82733606|NCT00864981|Bupropion|bupropion|mesh-list
83467594|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
83467595|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83467596|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
83467597|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83488048|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83467598|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83467599|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83467600|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
83467601|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467602|NCT00002524|Antidotes|antidotes|mesh-ancestor
83467603|NCT00002524|Protective Agents|protective agents|mesh-ancestor
83467604|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
83467606|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
83467607|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
83467608|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
83467609|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
83467610|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
83467611|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
83467612|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467613|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83467614|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83467615|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83467616|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83467617|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83467618|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83467619|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
83467620|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83467621|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83467622|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83467623|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83467624|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83467625|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83467626|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
83467627|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83467629|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467630|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83467631|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
83467632|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
83467633|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
83467634|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467635|NCT01203319|Vaccines|vaccines|mesh-list
83467636|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
83467637|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467638|NCT01344200|Celecoxib|celecoxib|mesh-list
83467639|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83467640|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83467641|NCT01344200|Analgesics|analgesics|mesh-ancestor
83467642|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
83467643|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467644|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467645|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83467646|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467647|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83467648|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83467650|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467651|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
83467652|NCT01204255|Promethazine|promethazine|mesh-list
83467653|NCT01204255|Lorazepam|lorazepam|mesh-list
83467654|NCT01204255|Haloperidol|haloperidol|mesh-list
83467655|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
83467656|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83467657|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83467658|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83467659|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467660|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
83467661|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
83467662|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
83467663|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467664|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
83467666|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83467667|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82733922|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
83467668|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
83467669|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
83467670|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83467671|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467672|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83467673|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
83467675|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83467676|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83467677|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83467678|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83467679|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
83467680|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83467681|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
83467682|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83467683|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
83467684|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
83467685|NCT00002542|Tamoxifen|tamoxifen|mesh-list
83467686|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
83467687|NCT00002542|Doxorubicin|doxorubicin|mesh-list
82734051|NCT02534623|Fentanyl|fentanyl|mesh-list
83467688|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83467689|NCT00002542|Fluorouracil|fluorouracil|mesh-list
83467690|NCT00002542|Methotrexate|methotrexate|mesh-list
83467691|NCT00002542|Epirubicin|epirubicin|mesh-list
83467692|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83467693|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
83467694|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467695|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467696|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82734119|NCT00879723|Vitamins|vitamins|mesh-list
83467697|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
83467698|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467699|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467700|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83467701|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83467702|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83467703|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82734187|NCT00369577|Loxapine|loxapine|mesh-list
83467704|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467705|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
83467706|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83467707|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83467708|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
82734266|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
83467710|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
83467711|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83467712|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83467713|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83467714|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
83467715|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83467716|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83467717|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83467718|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83467719|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83467720|NCT01156597|Pioglitazone|pioglitazone|mesh-list
83467721|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83467722|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467723|NCT01823198|Aldesleukin|aldesleukin|mesh-list
83467724|NCT01823198|Fludarabine|fludarabine|mesh-list
83467725|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
83467726|NCT01823198|Busulfan|busulfan|mesh-list
83467727|NCT01823198|Interleukin-2|interleukin-2|mesh-list
83467728|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467729|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83467730|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
83467731|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467732|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83467733|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
83467734|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467735|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
83467736|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83467737|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83467738|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83467739|NCT01823198|Analgesics|analgesics|mesh-ancestor
83467740|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
83467741|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467742|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83467743|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83467744|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
83467745|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467746|NCT05750056|Lidocaine|lidocaine|mesh-list
83467747|NCT05750056|Sufentanil|sufentanil|mesh-list
83467748|NCT05750056|Dsuvia|dsuvia|mesh-list
83467749|NCT05750056|Propofol|propofol|mesh-list
83467750|NCT05750056|Anesthetics, Local|anesthetics, local|mesh-ancestor
83467751|NCT05750056|Anesthetics|anesthetics|mesh-ancestor
83488049|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
83467752|NCT05750056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83467753|NCT05750056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467754|NCT05750056|Sensory System Agents|sensory system agents|mesh-ancestor
83467755|NCT05750056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467756|NCT05750056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83467757|NCT05750056|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83467758|NCT05750056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83467759|NCT05750056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83467760|NCT05750056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467762|NCT05750056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83467763|NCT05750056|Anesthetics, General|anesthetics, general|mesh-ancestor
83467764|NCT05750056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83467765|NCT05750056|Narcotics|narcotics|mesh-ancestor
83467767|NCT05750056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83467768|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
83467769|NCT03011125|Lansoprazole|lansoprazole|mesh-list
83467770|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83467771|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83467772|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83467773|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467774|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467775|NCT05749900|Gemcitabine|gemcitabine|mesh-list
83467777|NCT05749900|Trastuzumab|trastuzumab|mesh-list
83467778|NCT05749900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467779|NCT05749900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82734859|NCT00887367|Ethanol|ethanol|mesh-list
83467781|NCT05749900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467782|NCT05749900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83467783|NCT05749900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83467784|NCT03442751|Riboflavin|riboflavin|mesh-list
83467785|NCT03442751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83467786|NCT03442751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83467787|NCT03442751|Vitamin B Complex|vitamin b complex|mesh-ancestor
83467788|NCT03442751|Vitamins|vitamins|mesh-ancestor
83467789|NCT03442751|Micronutrients|micronutrients|mesh-ancestor
83467790|NCT03442751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467791|NCT03442751|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83467792|NCT03442751|Dermatologic Agents|dermatologic agents|mesh-ancestor
83467793|NCT05749666|Prednisolone|prednisolone|mesh-list
83467794|NCT05749666|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83467795|NCT05749666|Methylprednisolone|methylprednisolone|mesh-list
83467796|NCT05749666|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83467797|NCT05749666|Prednisolone acetate|prednisolone acetate|mesh-list
83467798|NCT05749666|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83467799|NCT05749666|Prednisolone phosphate|prednisolone phosphate|mesh-list
83467800|NCT05749666|Tofacitinib|tofacitinib|mesh-list
83467801|NCT05749666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83467802|NCT05749666|Glucocorticoids|glucocorticoids|mesh-ancestor
83467803|NCT05749666|Hormones|hormones|mesh-ancestor
83467804|NCT05749666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83467805|NCT05749666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467806|NCT05749666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83467807|NCT05749666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467809|NCT05749666|Autonomic Agents|autonomic agents|mesh-ancestor
83467810|NCT05749666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467811|NCT05749666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83467812|NCT05749666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83467813|NCT05749666|Protective Agents|protective agents|mesh-ancestor
83467814|NCT05749666|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83488281|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83467815|NCT05749666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83467816|NCT05749666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467817|NCT05749666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467819|NCT05449535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83467820|NCT05449535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83467821|NCT05449535|Respiratory System Agents|respiratory system agents|mesh-ancestor
83467822|NCT05749276|Daratumumab|daratumumab|mesh-list
83467823|NCT05749276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467824|NCT05749042|Cisplatin|cisplatin|mesh-list
83467825|NCT05749042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467826|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
83467827|NCT02940509|Ketamine|ketamine|mesh-list
83467828|NCT02940509|Analgesics|analgesics|mesh-ancestor
83467829|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
83467830|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467831|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467832|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82735325|NCT00766818|Lopinavir|lopinavir|mesh-list
83467833|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83467834|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
83467835|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
83467836|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83467837|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83467838|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83467839|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83467840|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467841|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83467842|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
83467843|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83467844|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83467845|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83467846|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
83467847|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83467848|NCT02530697|Miltefosine|miltefosine|mesh-list
83467849|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83467850|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
83467851|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83467852|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488508|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
83467853|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467854|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83467855|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83467856|NCT02530697|Protective Agents|protective agents|mesh-ancestor
83467857|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467858|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
83467859|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83467860|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
82735675|NCT00893217|Interferons|interferons|mesh-list
83467861|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
83467862|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467863|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467864|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83467865|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83467866|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83467867|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
83467868|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83467869|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83467870|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83467871|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467872|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
83467873|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83467874|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467875|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467876|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83467877|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83467879|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467880|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
83467881|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83467882|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
83467883|NCT02144831|Aspirin|aspirin|mesh-list
83467884|NCT02144831|Clopidogrel|clopidogrel|mesh-list
82735877|NCT00968578|Prednisolone|prednisolone|mesh-list
83467885|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83467886|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83467887|NCT02144831|Analgesics|analgesics|mesh-ancestor
83467888|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
83467889|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467890|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467891|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83467892|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467893|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83467894|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83477095|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83467895|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467896|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83467897|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83467898|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467899|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
83467900|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83467901|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83467902|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83467903|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
83467904|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83467906|NCT05276219|Isosorbide|isosorbide|mesh-list
83467907|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83467908|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83467909|NCT05276219|Diuretics|diuretics|mesh-ancestor
83467910|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
83467911|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467912|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83467913|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83467914|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467915|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83467916|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
83467917|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83467918|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
83467919|NCT05232461|Celecoxib|celecoxib|mesh-list
83467920|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83467921|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83467922|NCT05232461|Analgesics|analgesics|mesh-ancestor
83467923|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
83467924|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467925|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467926|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83467927|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467928|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83467929|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83467930|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467931|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467932|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83467933|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83467934|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83467935|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83467936|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467937|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83467938|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83467939|NCT01804790|Capecitabine|capecitabine|mesh-list
83467940|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83467941|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
83467942|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467943|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467944|NCT05623774|Imatinib Mesylate|imatinib mesylate|mesh-list
83467945|NCT05623774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467946|NCT05623774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83467947|NCT05623774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467948|NCT05623774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467949|NCT01313702|Atenolol|atenolol|mesh-list
83467950|NCT01313702|Lisinopril|lisinopril|mesh-list
83467951|NCT01313702|Simvastatin|simvastatin|mesh-list
83467952|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83467953|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83467954|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
83467955|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467956|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83467957|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83467958|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467959|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83467960|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
83467961|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83467962|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83467963|NCT01313702|Protective Agents|protective agents|mesh-ancestor
83467964|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467965|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83467967|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
83467968|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83467969|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83467970|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83467971|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83467972|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
83467973|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83467975|NCT04868708|Bevacizumab|bevacizumab|mesh-list
83467976|NCT04868708|Carboplatin|carboplatin|mesh-list
83467977|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83467978|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467979|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
83467980|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
83467981|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
83467982|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467983|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83467984|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83467985|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83467986|NCT04868708|Growth Substances|growth substances|mesh-ancestor
83467987|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467988|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
83467989|NCT05732272|Bupropion|bupropion|mesh-list
83467990|NCT05732272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83467991|NCT05732272|Antidepressive Agents|antidepressive agents|mesh-ancestor
83467992|NCT05732272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83467994|NCT05732272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83467996|NCT05732272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83467997|NCT05732272|Dopamine Agents|dopamine agents|mesh-ancestor
83467998|NCT05732272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83467999|NCT05732272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468000|NCT05732272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83468001|NCT05732272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83468002|NCT05732272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468003|NCT05513872|Nicotine|nicotine|mesh-list
83468004|NCT05513872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83468005|NCT05513872|Autonomic Agents|autonomic agents|mesh-ancestor
83468006|NCT05513872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468007|NCT05513872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468008|NCT05513872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83468009|NCT05513872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83468010|NCT05513872|Cholinergic Agents|cholinergic agents|mesh-ancestor
83468011|NCT05513872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83468012|NCT05513872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468013|NCT05445856|Fentanyl|fentanyl|mesh-list
83468014|NCT05445856|Methadone|methadone|mesh-list
83468015|NCT05445856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83468016|NCT05445856|Narcotics|narcotics|mesh-ancestor
83468017|NCT05445856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83468018|NCT05445856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468019|NCT05445856|Analgesics|analgesics|mesh-ancestor
83468020|NCT05445856|Sensory System Agents|sensory system agents|mesh-ancestor
83468021|NCT05445856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468022|NCT05445856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83468023|NCT05445856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83468024|NCT05445856|Anesthetics, General|anesthetics, general|mesh-ancestor
83468025|NCT05445856|Anesthetics|anesthetics|mesh-ancestor
83468026|NCT05445856|Antitussive Agents|antitussive agents|mesh-ancestor
83468027|NCT05445856|Respiratory System Agents|respiratory system agents|mesh-ancestor
83468029|NCT05481112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83468030|NCT05481112|Narcotics|narcotics|mesh-ancestor
83468031|NCT05481112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83468032|NCT05481112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468033|NCT05481112|Analgesics|analgesics|mesh-ancestor
83468034|NCT05481112|Sensory System Agents|sensory system agents|mesh-ancestor
83468035|NCT05481112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468037|NCT00382330|Ciclopirox|ciclopirox|mesh-list
83468038|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
83468039|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468040|NCT05520892|Immunoglobulins|immunoglobulins|mesh-list
83468041|NCT05520892|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83468042|NCT05520892|Antibodies|antibodies|mesh-list
83468043|NCT05520892|gamma-Globulins|gamma-globulins|mesh-list
83468044|NCT05520892|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83468045|NCT05520892|Immunologic Factors|immunologic factors|mesh-ancestor
83468046|NCT05520892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468047|NCT05397964|Calcium|calcium|mesh-list
83468048|NCT05397964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83468049|NCT05397964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468050|NCT00002548|Interferons|interferons|mesh-list
83468051|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
83468052|NCT00002548|Dexamethasone|dexamethasone|mesh-list
83468053|NCT00002548|Prednisone|prednisone|mesh-list
83468054|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
83468055|NCT00002548|Melphalan|melphalan|mesh-list
83468056|NCT00002548|Carmustine|carmustine|mesh-list
83468057|NCT00002548|Doxorubicin|doxorubicin|mesh-list
83468058|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83468059|NCT00002548|Vincristine|vincristine|mesh-list
83468060|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468061|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
83468062|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468063|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468064|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468065|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
83468066|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468067|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468068|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83468069|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83468070|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
83468071|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
83468072|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468073|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83468074|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
83468075|NCT00002548|Hormones|hormones|mesh-ancestor
83468076|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468077|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468078|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83468079|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468080|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468081|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468082|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
83468083|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468084|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468085|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
83468086|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
83468087|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
83468088|NCT02087306|Brincidofovir|brincidofovir|mesh-list
83468089|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
83468090|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468091|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
83468092|NCT00002554|Busulfan|busulfan|mesh-list
83468093|NCT00002554|Methotrexate|methotrexate|mesh-list
83468094|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468095|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
83468096|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468097|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468098|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468099|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
82737563|NCT00671658|Prednisolone|prednisolone|mesh-list
83468100|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468101|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468102|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83468103|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83468105|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83468106|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468107|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
83468108|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
83468109|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468110|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83468111|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83468112|NCT00002560|Antibodies|antibodies|mesh-list
83468113|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83468114|NCT00002560|Sargramostim|sargramostim|mesh-list
83468115|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
83468116|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468117|NCT00254384|Cisplatin|cisplatin|mesh-list
83468118|NCT00254384|Docetaxel|docetaxel|mesh-list
83468119|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83468120|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468121|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
83468122|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
83468123|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
83468124|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737814|NCT00988780|Efavirenz|efavirenz|mesh-list
83468125|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83468127|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
83468128|NCT00002566|Ifosfamide|ifosfamide|mesh-list
83468129|NCT00002566|Carboplatin|carboplatin|mesh-list
83468130|NCT00002566|Etoposide|etoposide|mesh-list
83468131|NCT00002566|Vinblastine|vinblastine|mesh-list
83468132|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468133|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
83468134|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468135|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468136|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468137|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
83468138|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468139|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468140|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83468141|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468142|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468143|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468144|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468145|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
83468146|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
83468147|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
83468148|NCT00002572|Aldesleukin|aldesleukin|mesh-list
83468149|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
83468150|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468151|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83468152|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83468153|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
83468154|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468155|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
83468156|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468157|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468158|NCT00002578|Leucovorin|leucovorin|mesh-list
83468159|NCT00002578|Cytarabine|cytarabine|mesh-list
83468160|NCT00002578|Methotrexate|methotrexate|mesh-list
83468161|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
83468162|NCT00002578|Calcium|calcium|mesh-list
83468164|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83468165|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468166|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83468167|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
83468168|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83468169|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468170|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
83468171|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468172|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468173|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
83468174|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468175|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83468176|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468177|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
83468178|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468179|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83468180|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
83468181|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468182|NCT00002578|Antidotes|antidotes|mesh-ancestor
83468183|NCT00002578|Protective Agents|protective agents|mesh-ancestor
83468184|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
83468185|NCT00002578|Vitamins|vitamins|mesh-ancestor
83468186|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
83468187|NCT00002590|Leucovorin|leucovorin|mesh-list
83468188|NCT00002590|Cytarabine|cytarabine|mesh-list
83468189|NCT00002590|Prednisone|prednisone|mesh-list
83468190|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
83468191|NCT00002590|Doxorubicin|doxorubicin|mesh-list
83468192|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83468193|NCT00002590|Methotrexate|methotrexate|mesh-list
83468195|NCT00002590|Vincristine|vincristine|mesh-list
83468196|NCT00002590|Daunorubicin|daunorubicin|mesh-list
83468197|NCT00002590|Asparaginase|asparaginase|mesh-list
83468198|NCT00002590|Pegaspargase|pegaspargase|mesh-list
83468199|NCT00002590|Thioguanine|thioguanine|mesh-list
83468200|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
83468201|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468202|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
83468203|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468204|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468205|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468206|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
83468207|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468208|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468209|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83468211|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468212|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468213|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468214|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83468215|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
83468216|NCT00002590|Hormones|hormones|mesh-ancestor
83468217|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468218|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468219|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83468220|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
83468221|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83468222|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468223|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
83468224|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
83468225|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83468226|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83468227|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468228|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
83468229|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468230|NCT00002590|Antidotes|antidotes|mesh-ancestor
83468231|NCT00002590|Protective Agents|protective agents|mesh-ancestor
83468232|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
83468233|NCT00002590|Vitamins|vitamins|mesh-ancestor
83468234|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
83468235|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
82738475|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
83468236|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
83468237|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
83468238|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
83468239|NCT00002596|Carboplatin|carboplatin|mesh-list
83468240|NCT00002596|Etoposide|etoposide|mesh-list
83468241|NCT00002596|Bleomycin|bleomycin|mesh-list
83468242|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468243|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
83468244|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468245|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468246|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468247|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
83468248|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468249|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738621|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
82738622|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82738623|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82738624|NCT00689936|Growth Substances|growth substances|mesh-ancestor
82738625|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
83468250|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83468251|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468252|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468253|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468254|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468255|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83468257|NCT00199082|Dexamethasone|dexamethasone|mesh-list
83468258|NCT00199082|Prednisolone|prednisolone|mesh-list
83468259|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
83468260|NCT00199082|Ifosfamide|ifosfamide|mesh-list
83468261|NCT00199082|Rituximab|rituximab|mesh-list
83468262|NCT00199082|Methotrexate|methotrexate|mesh-list
83468263|NCT00199082|Vincristine|vincristine|mesh-list
82738785|NCT00772356|Insulin|insulin|mesh-list
83468264|NCT00199082|Doxorubicin|doxorubicin|mesh-list
83468265|NCT00199082|Vindesine|vindesine|mesh-list
83468266|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468267|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
83468268|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468269|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468270|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468271|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
83468272|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468273|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468274|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83468275|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83468276|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83468277|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
83468278|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
83468279|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468280|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83468281|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
83468283|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468284|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468285|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83468286|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
83468287|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83468288|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468289|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
83468290|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
83468291|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468292|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83468293|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83468294|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
83468295|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468296|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468297|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
83468298|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
83468299|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
83468300|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83468301|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468302|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468303|NCT00194090|Celecoxib|celecoxib|mesh-list
83468304|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82739097|NCT00776724|Docetaxel|docetaxel|mesh-list
83468305|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83468306|NCT00194090|Analgesics|analgesics|mesh-ancestor
83468307|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
83468308|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468309|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468310|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739165|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
83468311|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468312|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83468313|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83468314|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468315|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468316|NCT00002608|Tamoxifen|tamoxifen|mesh-list
83468317|NCT00002608|Doxorubicin|doxorubicin|mesh-list
83468318|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83468319|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468320|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83468321|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468322|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468323|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468324|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468325|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83468326|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
83468327|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468328|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468329|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468330|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83468331|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83468332|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83468334|NCT00002620|Carmustine|carmustine|mesh-list
83468335|NCT00002620|Mitolactol|mitolactol|mesh-list
83468336|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468337|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
83468338|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468339|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468340|NCT00002620|Trace Elements|trace elements|mesh-ancestor
83468341|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
83468342|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468343|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83468344|NCT00002638|Cytarabine|cytarabine|mesh-list
83468345|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
83468346|NCT00002638|Carmustine|carmustine|mesh-list
83468347|NCT00002638|Etoposide|etoposide|mesh-list
82739503|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
83468348|NCT00002638|Sargramostim|sargramostim|mesh-list
83468349|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468350|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
83468351|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468352|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468353|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468354|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
82739579|NCT00741884|Varenicline|varenicline|mesh-list
83468355|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468356|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468357|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83468358|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468359|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468360|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468361|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468362|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468364|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
83468365|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468366|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83468367|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83468368|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468369|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468370|NCT01896440|Ondansetron|ondansetron|mesh-list
83468371|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
83468372|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
83468373|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468374|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468375|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83468376|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
83468377|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
83468378|NCT01896440|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83468379|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83468380|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
83468381|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83468382|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468383|NCT00002656|NSC 366140|nsc 366140|mesh-list
83468384|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468385|NCT00002662|Paclitaxel|paclitaxel|mesh-list
83468386|NCT00002662|Docetaxel|docetaxel|mesh-list
83468387|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468388|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468389|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
83468390|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
83468391|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
83468392|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468393|NCT00054314|IDN 5109|idn 5109|mesh-list
83468394|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468395|NCT01743950|Bevacizumab|bevacizumab|mesh-list
83468396|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83468397|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468399|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83468400|NCT01743950|Growth Substances|growth substances|mesh-ancestor
83468401|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468402|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
83468403|NCT00002674|Cytarabine|cytarabine|mesh-list
83468404|NCT00002674|Etoposide|etoposide|mesh-list
83468405|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
82739981|NCT00778908|Cisplatin|cisplatin|mesh-list
83468406|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
83468407|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468408|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468409|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468410|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468411|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468412|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468413|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468414|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
83468415|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
83468416|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468417|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468418|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
83468419|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468420|NCT00002674|Analgesics|analgesics|mesh-ancestor
83468421|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
83468422|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468423|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
83468424|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83468426|NCT01743872|Anticoagulants|anticoagulants|mesh-ancestor
83468427|NCT01743872|Plasma Substitutes|plasma substitutes|mesh-ancestor
83468428|NCT01743872|Blood Substitutes|blood substitutes|mesh-ancestor
83468429|NCT00002680|Tamoxifen|tamoxifen|mesh-list
83468430|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
83468431|NCT00002680|Melphalan|melphalan|mesh-list
83468432|NCT00002680|Thiotepa|thiotepa|mesh-list
83468433|NCT00002680|Megestrol|megestrol|mesh-list
83468434|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
83468435|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468436|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
83468437|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468438|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468439|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468440|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
83468441|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468442|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468443|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83468444|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83468445|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
83468446|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468447|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468448|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83468449|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83468450|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83468451|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83468452|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83468453|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83468454|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
83468455|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83468456|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83468457|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83468458|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
83468459|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83468460|NCT00002692|Leucovorin|leucovorin|mesh-list
83468461|NCT00002692|Fluorouracil|fluorouracil|mesh-list
83468462|NCT00002692|Calcium|calcium|mesh-list
83468463|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
83468464|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82740303|NCT00931281|Ritonavir|ritonavir|mesh-list
83468465|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468466|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
83468467|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468468|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468469|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468470|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468471|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
83468473|NCT00002692|Protective Agents|protective agents|mesh-ancestor
83468474|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
83468475|NCT00002692|Vitamins|vitamins|mesh-ancestor
83468476|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
83468477|NCT05293210|Dexamethasone|dexamethasone|mesh-list
83468478|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83468479|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
83468480|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
83468481|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468482|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468483|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83468484|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
83468485|NCT05293210|Hormones|hormones|mesh-ancestor
83468486|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468487|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468488|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468489|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
83468490|NCT01895348|Remifentanil|remifentanil|mesh-list
83468491|NCT01895348|Propofol|propofol|mesh-list
83468492|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83468493|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83468494|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468495|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83468496|NCT01895348|Analgesics|analgesics|mesh-ancestor
83468497|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
83468498|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468499|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83468500|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83468502|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
83468503|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83468504|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488733|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740561|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740562|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740563|NCT00354679|Bevacizumab|bevacizumab|mesh-list
82740564|NCT00354679|Irinotecan|irinotecan|mesh-list
82740565|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82740566|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740567|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83468505|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83468506|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
83468507|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
83468508|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83468509|NCT01895348|Narcotics|narcotics|mesh-ancestor
83468510|NCT04194554|Leuprolide|leuprolide|mesh-list
83468511|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
83468512|NCT04194554|Niraparib|niraparib|mesh-list
83468513|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83468514|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
83468515|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83468516|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468517|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468518|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468519|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82740637|NCT00795678|Paclitaxel|paclitaxel|mesh-list
82740638|NCT00795678|Vinorelbine|vinorelbine|mesh-list
82740639|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82740640|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
82740641|NCT00795678|Gemcitabine|gemcitabine|mesh-list
82740642|NCT00795678|Doxorubicin|doxorubicin|mesh-list
82740643|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82740644|NCT00795678|Capecitabine|capecitabine|mesh-list
82740645|NCT00795678|Trastuzumab|trastuzumab|mesh-list
82740646|NCT00795678|Lapatinib|lapatinib|mesh-list
82740647|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82740668|NCT00753038|Paclitaxel|paclitaxel|mesh-list
83468521|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468522|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
82740695|NCT04058522|Triamcinolone|triamcinolone|mesh-list
83468523|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468524|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83468525|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83468526|NCT05073718|Aspirin|aspirin|mesh-list
83468527|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83468528|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83468529|NCT05073718|Analgesics|analgesics|mesh-ancestor
83468530|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
83468531|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468532|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468533|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83468534|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468535|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83468536|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83477096|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468537|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468538|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83468539|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83468540|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468541|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
83468542|NCT04784000|Carbamazepine|carbamazepine|mesh-list
83468543|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
83468544|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
83468545|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83468546|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83468547|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468548|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83468549|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83468550|NCT04784000|Analgesics|analgesics|mesh-ancestor
83468551|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
83468552|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468553|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83468554|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83468555|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468556|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82741104|NCT00792324|Efavirenz|efavirenz|mesh-list
83468557|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83468558|NCT05271292|Chiauranib|chiauranib|mesh-list
83468559|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468560|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83468561|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468562|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468563|NCT05266846|Bevacizumab|bevacizumab|mesh-list
83468564|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
83468565|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83468566|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468567|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83468568|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83468569|NCT05266846|Growth Substances|growth substances|mesh-ancestor
83468570|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468571|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
83468572|NCT05266846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82741188|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
83468573|NCT05266846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468574|NCT01113476|Paclitaxel|paclitaxel|mesh-list
83468575|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83468576|NCT01113476|Bevacizumab|bevacizumab|mesh-list
83468577|NCT01113476|Gemcitabine|gemcitabine|mesh-list
83468578|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468579|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468580|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
83468581|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
83468582|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
83468583|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468584|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83468585|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83468586|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83468587|NCT01113476|Growth Substances|growth substances|mesh-ancestor
83468588|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468589|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
83468590|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468591|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
83468592|NCT01107236|Naproxen|naproxen|mesh-list
83468593|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83468594|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83468595|NCT01107236|Analgesics|analgesics|mesh-ancestor
83468596|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
83468597|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468598|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468599|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83468600|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468601|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
83468602|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82741525|NCT00748358|Sunitinib|sunitinib|mesh-list
83468603|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468604|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468605|NCT00002704|Leucovorin|leucovorin|mesh-list
83468606|NCT00002704|Cytarabine|cytarabine|mesh-list
83468607|NCT00002704|Dexamethasone|dexamethasone|mesh-list
83468608|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
83468609|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83468610|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83468611|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83468612|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
83468613|NCT00002704|Thiotepa|thiotepa|mesh-list
83468614|NCT00002704|Methotrexate|methotrexate|mesh-list
83468615|NCT00002704|Etoposide|etoposide|mesh-list
83468616|NCT00002704|Vincristine|vincristine|mesh-list
83468617|NCT00002704|Daunorubicin|daunorubicin|mesh-list
83468618|NCT00002704|Asparaginase|asparaginase|mesh-list
83468619|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
83468620|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
83468621|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468622|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
82741645|NCT00537394|Maraviroc|maraviroc|mesh-list
83468623|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468625|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468626|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
83468627|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468628|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468629|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83468630|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83468631|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
83468632|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
83468633|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468634|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83468635|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
83468636|NCT00002704|Hormones|hormones|mesh-ancestor
83468637|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468638|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468639|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83468640|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
83468641|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83468642|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468643|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
83468644|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
83468645|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468646|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83468647|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83468648|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468649|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468650|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468651|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
83468652|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468653|NCT00002704|Antidotes|antidotes|mesh-ancestor
83468654|NCT00002704|Protective Agents|protective agents|mesh-ancestor
83468655|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
83468656|NCT00002704|Vitamins|vitamins|mesh-ancestor
83468657|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
83468658|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
83468659|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
83468660|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
83468661|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83468662|NCT00002716|Leucovorin|leucovorin|mesh-list
83468663|NCT00002716|Dexamethasone|dexamethasone|mesh-list
83468664|NCT00002716|Fluorouracil|fluorouracil|mesh-list
83468665|NCT00002716|Floxuridine|floxuridine|mesh-list
83468666|NCT00002716|Calcium|calcium|mesh-list
83468667|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
83468668|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83468669|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
83468670|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
83468671|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468672|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468673|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83468674|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
83468675|NCT00002716|Hormones|hormones|mesh-ancestor
83468676|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468677|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468678|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741973|NCT00660348|Analgesics|analgesics|mesh-ancestor
83468679|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83468680|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
83468681|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468682|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468683|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468684|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
83468685|NCT00002716|Antidotes|antidotes|mesh-ancestor
83468686|NCT00002716|Protective Agents|protective agents|mesh-ancestor
82742106|NCT01060969|Tadalafil|tadalafil|mesh-list
83468687|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
83468689|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
83468690|NCT02533674|Gemcitabine|gemcitabine|mesh-list
83468691|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468692|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
83468693|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468694|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468695|NCT00002722|Leucovorin|leucovorin|mesh-list
83468696|NCT00002722|Fluorouracil|fluorouracil|mesh-list
83468697|NCT00002722|Calcium|calcium|mesh-list
83468698|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
83468699|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468700|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83468701|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468702|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
83468703|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468704|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83468705|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468706|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
83468707|NCT00002722|Antidotes|antidotes|mesh-ancestor
83468708|NCT00002722|Protective Agents|protective agents|mesh-ancestor
83468709|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
83468710|NCT00002722|Vitamins|vitamins|mesh-ancestor
83468711|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
83468712|NCT00002734|Interferons|interferons|mesh-list
83468713|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
83468714|NCT00002734|Paclitaxel|paclitaxel|mesh-list
83468715|NCT00002734|Topotecan|topotecan|mesh-list
83468716|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82742587|NCT00944853|Zinc|zinc|mesh-list
83468718|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
83468719|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83468720|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468721|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468722|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
83468723|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
83468724|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
83468725|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468726|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
83468727|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468728|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
83468729|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468730|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83468731|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468732|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468733|NCT04783610|Ethanol|ethanol|mesh-list
82742673|NCT00575042|Fenofibrate|fenofibrate|mesh-list
83468734|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83468736|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83468737|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468738|NCT00002740|Cobalt|cobalt|mesh-list
83468739|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
83468740|NCT00002740|Carboplatin|carboplatin|mesh-list
83468741|NCT00002740|Doxorubicin|doxorubicin|mesh-list
83468742|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83468743|NCT00002740|Etoposide|etoposide|mesh-list
83468744|NCT00002740|Vincristine|vincristine|mesh-list
83468745|NCT00002740|Lenograstim|lenograstim|mesh-list
83468746|NCT00002740|Mesna|mesna|mesh-list
83468747|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468748|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
83468749|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468750|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468751|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82742799|NCT05436002|Viscosupplements|viscosupplements|mesh-ancestor
83468753|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468754|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468755|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83468756|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83468757|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468758|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468759|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468760|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82742866|NCT00675506|Hormones|hormones|mesh-list
83468761|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83468762|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
83468763|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
83468764|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
83468765|NCT00002740|Protective Agents|protective agents|mesh-ancestor
83468766|NCT00002740|Trace Elements|trace elements|mesh-ancestor
83468767|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
83468768|NCT00002746|Aldesleukin|aldesleukin|mesh-list
83468769|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468770|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83468771|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83468772|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
83468773|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468774|NCT01049945|Dexamethasone|dexamethasone|mesh-list
83468775|NCT01049945|Lenalidomide|lenalidomide|mesh-list
83468776|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83468777|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82743152|NCT00561951|Fesoterodine|fesoterodine|mesh-list
83468778|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
83468779|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
83468780|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468781|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468782|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82743222|NCT00561795|Paclitaxel|paclitaxel|mesh-list
83468783|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
83468785|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468786|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468787|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468788|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
83468789|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83468790|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83468791|NCT01049945|Growth Substances|growth substances|mesh-ancestor
83468792|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
83468793|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468794|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
83468795|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468796|NCT00002752|Antibodies|antibodies|mesh-list
83468797|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83468798|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
83468799|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468800|NCT01050647|Castor Oil|castor oil|mesh-list
83468801|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83468802|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83468803|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83468804|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
83468805|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468806|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468807|NCT01050647|Progestins|progestins|mesh-ancestor
83468808|NCT01050647|Hormones|hormones|mesh-ancestor
83468809|NCT01050647|Cathartics|cathartics|mesh-ancestor
83468810|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83468811|NCT04825678|Erenumab|erenumab|mesh-list
83468812|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83468813|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468814|NCT04825678|Analgesics|analgesics|mesh-ancestor
83468815|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
83468816|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468817|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468818|NCT03968393|Anticoagulants|anticoagulants|mesh-list
83468819|NCT00002764|Doxorubicin|doxorubicin|mesh-list
83468820|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83468821|NCT00002764|Ifosfamide|ifosfamide|mesh-list
83468822|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83468823|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468824|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468825|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468826|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468827|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468828|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468829|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
83468830|NCT01688492|Ipilimumab|ipilimumab|mesh-list
83468831|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83468832|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468833|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83468834|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468835|NCT05167175|Prednisone|prednisone|mesh-list
83468836|NCT05167175|Olaparib|olaparib|mesh-list
83468837|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
83468838|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83468839|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
83468840|NCT05167175|Hormones|hormones|mesh-ancestor
83468841|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468842|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468843|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468844|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468845|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83468846|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468847|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468848|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82743329|NCT00941967|Sorafenib|sorafenib|mesh-list
83468849|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
83468850|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83468852|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
83468853|NCT00002788|Etoposide|etoposide|mesh-list
83468854|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83468855|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
83468856|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468857|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468858|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83468859|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
83468860|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468861|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468862|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83468863|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83468864|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
83468865|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
83468866|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468867|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83468868|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
83468869|NCT00002788|Hormones|hormones|mesh-ancestor
83468870|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468871|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83468872|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83468873|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83468874|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83468875|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468876|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
83468877|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
83468879|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83468880|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468881|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468882|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468883|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83468884|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
83468885|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
83468886|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468887|NCT04783792|Protective Agents|protective agents|mesh-ancestor
83468888|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468889|NCT04783792|Vitamins|vitamins|mesh-ancestor
83468890|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
83468891|NCT05002816|Elotuzumab|elotuzumab|mesh-list
83468892|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468893|NCT01676402|Vaccines|vaccines|mesh-list
83468894|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
83468895|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468896|NCT01052831|Naltrexone|naltrexone|mesh-list
83468897|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83468898|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83468899|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468900|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
83468901|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468902|NCT04330300|Losartan|losartan|mesh-list
83468903|NCT04330300|Verapamil|verapamil|mesh-list
83468904|NCT04330300|Felodipine|felodipine|mesh-list
83468905|NCT04330300|Amlodipine|amlodipine|mesh-list
83468906|NCT04330300|Valsartan|valsartan|mesh-list
83468907|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83468908|NCT04330300|Telmisartan|telmisartan|mesh-list
83468909|NCT04330300|Candesartan|candesartan|mesh-list
83468910|NCT04330300|Ramipril|ramipril|mesh-list
83468911|NCT04330300|Olmesartan|olmesartan|mesh-list
83468912|NCT04330300|Enalapril|enalapril|mesh-list
83468913|NCT04330300|Lisinopril|lisinopril|mesh-list
83468914|NCT04330300|Irbesartan|irbesartan|mesh-list
83468915|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
83468916|NCT04330300|Perindopril|perindopril|mesh-list
83468917|NCT04330300|Diltiazem|diltiazem|mesh-list
83468918|NCT04330300|Benazepril|benazepril|mesh-list
83468919|NCT04330300|Captopril|captopril|mesh-list
83468920|NCT04330300|Indapamide|indapamide|mesh-list
83468921|NCT04330300|Nicardipine|nicardipine|mesh-list
83468922|NCT04330300|Nimodipine|nimodipine|mesh-list
83468923|NCT04330300|Quinapril|quinapril|mesh-list
83468924|NCT04330300|Metolazone|metolazone|mesh-list
83468925|NCT04330300|Trandolapril|trandolapril|mesh-list
83468926|NCT04330300|Fosinopril|fosinopril|mesh-list
83468927|NCT04330300|Eprosartan|eprosartan|mesh-list
83468928|NCT04330300|Nitrendipine|nitrendipine|mesh-list
83468929|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
83468930|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
83468931|NCT04330300|Nifedipine|nifedipine|mesh-list
83468932|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
83468933|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83468934|NCT04330300|Diuretics|diuretics|mesh-list
83468935|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83468936|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83468937|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468938|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83468939|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83468940|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468941|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
83468942|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83468943|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83468944|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
83468945|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83468946|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
83468947|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468948|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
83468949|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83468950|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83468951|NCT04330300|Protective Agents|protective agents|mesh-ancestor
83468952|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
83468953|NCT04352855|Tazobactam|tazobactam|mesh-list
83468954|NCT04352855|Ceftolozane|ceftolozane|mesh-list
83468955|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83468956|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83468957|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83468958|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83468959|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468960|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468961|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83468962|NCT04782128|RC28-E protein|rc28-e protein|mesh-list
83468963|NCT04782128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83468964|NCT04782128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83468965|NCT04782128|Growth Substances|growth substances|mesh-ancestor
83468966|NCT04782128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468967|NCT04782128|Growth Inhibitors|growth inhibitors|mesh-ancestor
83468968|NCT04782128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83468969|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
83468970|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83468971|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
83468972|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83468973|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468974|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83468975|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83468976|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83468977|NCT00382642|Ondansetron|ondansetron|mesh-list
83468978|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
83468979|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
83468980|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468981|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468982|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83468983|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
83468984|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
83468985|NCT00382642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83468986|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83468987|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
82743505|NCT00658320|Cyclosporine|cyclosporine|mesh-list
83468988|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83468989|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83468990|NCT01054079|Cinacalcet|cinacalcet|mesh-list
83468991|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83468992|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83468993|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83468994|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
83468995|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83468996|NCT04338022|Teriflunomide|teriflunomide|mesh-list
83468997|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83468998|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83468999|NCT04338022|Analgesics|analgesics|mesh-ancestor
83469000|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
83469001|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469002|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469003|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83469004|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469005|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469006|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
83469007|NCT01054625|Zalutumumab|zalutumumab|mesh-list
83469008|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83469009|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469010|NCT02544750|Cannabidiol|cannabidiol|mesh-list
83469011|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
83469012|NCT01662050|Cytarabine|cytarabine|mesh-list
83469013|NCT01662050|Rituximab|rituximab|mesh-list
83469014|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83469015|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83469016|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469017|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
83469018|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469019|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469020|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83469021|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
83469022|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469023|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
83469024|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83469025|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469026|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83469027|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
83469028|NCT04748848|Azacitidine|azacitidine|mesh-list
83469029|NCT04748848|Venetoclax|venetoclax|mesh-list
83469030|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
83469031|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83469032|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
83469033|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743557|NCT00764816|Caseins|caseins|mesh-list
83469034|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469035|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469036|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83469037|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
83469038|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83469039|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83469040|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83469041|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469042|NCT01620788|Losartan|losartan|mesh-list
83469043|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83469044|NCT01620788|Indapamide|indapamide|mesh-list
83469045|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83469046|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83469047|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83469048|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83469049|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469050|NCT01620788|Diuretics|diuretics|mesh-ancestor
83469051|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
83469052|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469053|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83469054|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83469055|NCT03014843|Bromides|bromides|mesh-list
83469056|NCT03014843|Naloxone|naloxone|mesh-list
83469057|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
83469058|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
83469059|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83469060|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469061|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
83469062|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469063|NCT05081375|Enoxaparin|enoxaparin|mesh-list
83469064|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
83469065|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83469066|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83469067|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469068|NCT04755062|Micronutrients|micronutrients|mesh-list
83469069|NCT04755062|Trace Elements|trace elements|mesh-list
83469070|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469071|NCT03852797|Ketamine|ketamine|mesh-list
83469072|NCT03852797|Propofol|propofol|mesh-list
83469073|NCT03852797|Etomidate|etomidate|mesh-list
83469074|NCT03852797|Oxytocin|oxytocin|mesh-list
83469075|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83469076|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83469077|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469078|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83469079|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
83469080|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
83469081|NCT03852797|Analgesics|analgesics|mesh-ancestor
83469082|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
83469083|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469084|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83469085|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83469086|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83469087|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469088|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469089|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
83469090|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83469092|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83469093|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83469094|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
83469095|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469096|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469097|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469098|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83469099|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83469100|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
83469101|NCT01057277|Everolimus|everolimus|mesh-list
83469102|NCT01057277|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83469103|NCT01057277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83469104|NCT01057277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469105|NCT01057277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469106|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469107|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
83469108|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469109|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469110|NCT00866840|Riluzole|riluzole|mesh-list
83469111|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
83469112|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83469113|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83469114|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469115|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469116|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469117|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83469118|NCT00866840|Protective Agents|protective agents|mesh-ancestor
83469119|NCT04349722|Scopolamine|scopolamine|mesh-list
83469120|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83469121|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83469122|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
83469123|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
83469124|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469125|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469126|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83469127|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
83469128|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83469129|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
83469130|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469131|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469132|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83469133|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
83469134|NCT01058993|Plerixafor|plerixafor|mesh-list
83469135|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83469136|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83469137|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
83469138|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83469139|NCT04652518|Pirfenidone|pirfenidone|mesh-list
83469140|NCT04652518|Analgesics|analgesics|mesh-ancestor
83469141|NCT04652518|Sensory System Agents|sensory system agents|mesh-ancestor
83469142|NCT04652518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469143|NCT04652518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469144|NCT04652518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83469145|NCT04652518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83469146|NCT04652518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83469147|NCT04652518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469148|NCT04652518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469149|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83469150|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469151|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83469152|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469153|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469154|NCT04650490|Immunomodulating Agents|immunomodulating agents|mesh-list
83469155|NCT04650490|Immunologic Factors|immunologic factors|mesh-ancestor
83469156|NCT04650490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469157|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
83469158|NCT03850379|Levofloxacin|levofloxacin|mesh-list
83469159|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83469160|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83469161|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83469162|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83469163|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469164|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469165|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469166|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83469167|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83469168|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83469169|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83469170|NCT03014687|Cefdinir|cefdinir|mesh-list
83469171|NCT03014687|Cephalosporins|cephalosporins|mesh-list
83469172|NCT03014687|Trimethoprim|trimethoprim|mesh-list
83469173|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
83469174|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83469175|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83469176|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
83469177|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83469178|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83469179|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83469180|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469181|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469182|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83469183|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83469184|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83469185|NCT04199572|Acetaminophen|acetaminophen|mesh-list
83469187|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83469188|NCT04199572|Analgesics|analgesics|mesh-ancestor
83469189|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
83469190|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469191|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469192|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
83469193|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83469194|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83469195|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469196|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83469197|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469198|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469199|NCT00383032|Mifepristone|mifepristone|mesh-list
83469200|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83469201|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
83469202|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83469203|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469204|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83469205|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83469206|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83469207|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
83469208|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83469209|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83469210|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
83469211|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83469212|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
83469213|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83469214|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83469215|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83469216|NCT02169479|Opicapone|opicapone|mesh-list
83469217|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83469218|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
83469219|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469220|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83469221|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83469222|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
83469223|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
83469224|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469225|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477097|NCT04087460|Vaccines|vaccines|mesh-list
83469226|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83469227|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469228|NCT04302454|Leuprolide|leuprolide|mesh-list
83469229|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83469230|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
83469231|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83469232|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743766|NCT00764036|Artesunate|artesunate|mesh-list
83469233|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83469234|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469235|NCT01059851|Suvorexant|suvorexant|mesh-list
83469236|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83469237|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83469238|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83469239|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469240|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83469241|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469242|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469244|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83469245|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
83469246|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83469247|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469248|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83469249|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83469250|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83469251|NCT01059929|Fentanyl|fentanyl|mesh-list
83469253|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
83469254|NCT01059929|Propofol|propofol|mesh-list
83469255|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83469256|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83469257|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469258|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83469259|NCT01059929|Analgesics|analgesics|mesh-ancestor
83469260|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
83469261|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744020|NCT00814008|Insulin|insulin|mesh-list
83469262|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83469263|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83469264|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83469265|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
83469266|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469267|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469268|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83469269|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
83469270|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
83469271|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83469272|NCT01059929|Narcotics|narcotics|mesh-ancestor
83469273|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83469274|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83469275|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83469276|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83469277|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
83469278|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
83469279|NCT04828031|Vitamin D|vitamin d|mesh-list
83469280|NCT04828031|Vitamins|vitamins|mesh-ancestor
83469281|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
83469282|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469283|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83469284|NCT04162522|Escitalopram|escitalopram|mesh-list
83469285|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
83469286|NCT04162522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83469287|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83469288|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83469289|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744226|NCT00942747|Sirolimus|sirolimus|mesh-list
83469290|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469291|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
83469292|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469293|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
83469294|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
83469295|NCT04896658|Dexamethasone|dexamethasone|mesh-list
83469296|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
83469297|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469298|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
83469299|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469300|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469301|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83469302|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
83469303|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469304|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469305|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83469306|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83469307|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
83469308|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
83469309|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469310|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83469311|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
83469312|NCT04896658|Hormones|hormones|mesh-ancestor
83469313|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83477171|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
83469314|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83469316|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83469317|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83469318|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
83469319|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469320|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83469321|NCT04156828|Dexamethasone|dexamethasone|mesh-list
83469322|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
83469323|NCT04156828|Rituximab|rituximab|mesh-list
83469324|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83469325|NCT04156828|Carboplatin|carboplatin|mesh-list
83469326|NCT04156828|Gemcitabine|gemcitabine|mesh-list
83469327|NCT04156828|Antibodies|antibodies|mesh-list
83469328|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
83469329|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82744633|NCT04047758|Letrozole|letrozole|mesh-list
83469330|NCT04156828|Lenograstim|lenograstim|mesh-list
83469331|NCT04156828|BB 1101|bb 1101|mesh-list
83469332|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
83469333|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469334|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469335|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469336|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83469337|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
83469338|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
83469339|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469340|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83469341|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
83469342|NCT04156828|Hormones|hormones|mesh-ancestor
83469343|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82744700|NCT04098653|Busulfan|busulfan|mesh-list
83469344|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83469345|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83469346|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
83469347|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469348|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83469349|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
83469351|NCT01063049|Bisacodyl|bisacodyl|mesh-list
83469352|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83469354|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83469355|NCT01063049|Laxatives|laxatives|mesh-ancestor
83469356|NCT04883242|Dexamethasone|dexamethasone|mesh-list
83469357|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
83469358|NCT04883242|Pomalidomide|pomalidomide|mesh-list
83469359|NCT04883242|Ichthammol|ichthammol|mesh-list
83469360|NCT04883242|BB 1101|bb 1101|mesh-list
83469361|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83469362|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83469364|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
83469365|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469366|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469367|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83469368|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
83469369|NCT04883242|Hormones|hormones|mesh-ancestor
83469370|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83469371|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83469372|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469373|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
83469374|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469375|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469376|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
83469377|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83469378|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83469379|NCT04883242|Growth Substances|growth substances|mesh-ancestor
82744968|NCT05348200|Hormones|hormones|mesh-ancestor
83469380|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
83469381|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
83469382|NCT04104178|Clindamycin|clindamycin|mesh-list
83469383|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
83469384|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
83469385|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83469386|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83469387|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83469388|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469389|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469390|NCT03661138|Upadacitinib|upadacitinib|mesh-list
83469391|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83469392|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83469393|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469394|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469395|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469397|NCT04588792|Diuretics|diuretics|mesh-ancestor
83469398|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
83469399|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469400|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83469401|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83469402|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469403|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83469404|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83469405|NCT04075396|Lazertinib|lazertinib|mesh-list
83469406|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83469407|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469408|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469409|NCT04038970|Methotrexate|methotrexate|mesh-list
83469410|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83469411|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
83477172|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
83469412|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83469413|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477173|NCT04042142|Glucagon|glucagon|mesh-list
83469414|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83469415|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
83469416|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469417|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469418|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
83469419|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469420|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83469421|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469422|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
83469423|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469424|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83469425|NCT02181738|Doxorubicin|doxorubicin|mesh-list
83469426|NCT02181738|Nivolumab|nivolumab|mesh-list
83469427|NCT02181738|Dacarbazine|dacarbazine|mesh-list
83469428|NCT02181738|Vinblastine|vinblastine|mesh-list
83469429|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83469430|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469431|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82745440|NCT00647556|Adapalene|adapalene|mesh-list
83469433|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469434|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469435|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83469436|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82745516|NCT00815568|Fludarabine|fludarabine|mesh-list
83469437|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83469438|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
83469439|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83469440|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
83469441|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
83469442|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
83469443|NCT05426304|Agomelatine|agomelatine|mesh-list
83469444|NCT05426304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83469445|NCT05426304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83469446|NCT05426304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469447|NCT03955198|Durvalumab|durvalumab|mesh-list
83469448|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83469449|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469450|NCT04494958|Palbociclib|palbociclib|mesh-list
83469451|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469452|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83469453|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469454|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469456|NCT00382954|Idarubicin|idarubicin|mesh-list
83469457|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469458|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83469459|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83469460|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83469461|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469462|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469463|NCT01246063|Dexamethasone|dexamethasone|mesh-list
83469464|NCT01246063|Doxorubicin|doxorubicin|mesh-list
83469465|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83469466|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83469467|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
83469468|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
83469469|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469470|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469471|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82745920|NCT00999700|Cisplatin|cisplatin|mesh-list
83469472|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
83469473|NCT01246063|Hormones|hormones|mesh-ancestor
83469474|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83469475|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83469476|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469477|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83469478|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83469479|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83469480|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469481|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746009|NCT00994006|Antacids|antacids|mesh-ancestor
83469482|NCT03836014|Dexamethasone|dexamethasone|mesh-list
83469483|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
83469484|NCT03836014|Lenalidomide|lenalidomide|mesh-list
83469485|NCT03836014|Daratumumab|daratumumab|mesh-list
83469486|NCT03836014|BB 1101|bb 1101|mesh-list
83469487|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83469488|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83469489|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
83469490|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
82746056|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
83469491|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469492|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469493|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83469494|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
83469495|NCT03836014|Hormones|hormones|mesh-ancestor
83488881|NCT05743634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83469496|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83469497|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83469498|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469499|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
83469500|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469501|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746195|NCT01001962|Metformin|metformin|mesh-list
83469502|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
83469503|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83469504|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83469505|NCT03836014|Growth Substances|growth substances|mesh-ancestor
83469506|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
83469507|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
83469508|NCT01205503|Doxorubicin|doxorubicin|mesh-list
83469509|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469510|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
83469511|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469512|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488882|NCT05743634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83469513|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83469514|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
83469515|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469516|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469517|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83469518|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83469519|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83469520|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83469521|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469523|NCT03187834|Azithromycin|azithromycin|mesh-list
83469524|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83469525|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83469526|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83469527|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83469528|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
83469529|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83469530|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83469532|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
83469533|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
83469534|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83469535|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469536|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
83469537|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469538|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83469539|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83469540|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469541|NCT01158703|Aspirin|aspirin|mesh-list
83469542|NCT01158703|Clopidogrel|clopidogrel|mesh-list
83469543|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83469544|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83469545|NCT01158703|Analgesics|analgesics|mesh-ancestor
83469546|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
83469547|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469548|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469549|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83469550|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469551|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83469552|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83469553|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469554|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83469555|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83469556|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469557|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
83469558|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83469559|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83469560|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83469562|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469563|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
83469564|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83469565|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
83469566|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469567|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469568|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83469569|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
83469570|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83469571|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
83469572|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469573|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469574|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83469575|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
83469576|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
83469577|NCT03009643|Protective Agents|protective agents|mesh-ancestor
83469578|NCT04275232|Plasminogen|plasminogen|mesh-list
83469579|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83469580|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83469581|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469582|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82747095|NCT05476770|Cytarabine|cytarabine|mesh-list
83469583|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
83469584|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469585|NCT04385368|Durvalumab|durvalumab|mesh-list
83469586|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83469587|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469588|NCT03786796|Olaparib|olaparib|mesh-list
83469589|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83469590|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469591|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469592|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469593|NCT03779854|Vidarabine|vidarabine|mesh-list
83469594|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
83469595|NCT03779854|Busulfan|busulfan|mesh-list
83469596|NCT03779854|Thiotepa|thiotepa|mesh-list
83469597|NCT03779854|Methotrexate|methotrexate|mesh-list
83469598|NCT03779854|Fludarabine|fludarabine|mesh-list
83469599|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
83469600|NCT03779854|Tacrolimus|tacrolimus|mesh-list
83469601|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747176|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
83469602|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
83469603|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469604|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469605|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83469606|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
83469607|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469608|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469609|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83469610|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83469611|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
83469612|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83469613|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83469614|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
83469615|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
83469616|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469617|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83469618|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83469619|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83469620|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
83469621|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83469622|NCT03089866|Midazolam|midazolam|mesh-list
83469623|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83469624|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83469625|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83469626|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469627|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83469628|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83469629|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83469630|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83469631|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
83469632|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
83469634|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
83469635|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469636|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469638|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83469639|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469640|NCT00002896|Leucovorin|leucovorin|mesh-list
83469641|NCT00002896|Cobalt|cobalt|mesh-list
83469642|NCT00002896|Fluorouracil|fluorouracil|mesh-list
83469643|NCT00002896|Calcium|calcium|mesh-list
83469644|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
83469645|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83469646|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469647|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
83469648|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489108|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
83469649|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83469650|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469651|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469652|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
83469653|NCT00002896|Antidotes|antidotes|mesh-ancestor
83469654|NCT00002896|Protective Agents|protective agents|mesh-ancestor
83469655|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
83469656|NCT00002896|Vitamins|vitamins|mesh-ancestor
83469657|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
83469658|NCT00002896|Trace Elements|trace elements|mesh-ancestor
83469659|NCT01249027|Everolimus|everolimus|mesh-list
83469660|NCT01249027|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83469661|NCT01249027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83469662|NCT01249027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469663|NCT01249027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469664|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469665|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
83469666|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469667|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469668|NCT00002902|Irinotecan|irinotecan|mesh-list
83469669|NCT00002902|Raltitrexed|raltitrexed|mesh-list
83469670|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83469671|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83469672|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469673|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747486|NCT04652076|Paclitaxel|paclitaxel|mesh-list
83469674|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469675|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83469676|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
83469677|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83469678|NCT02992756|Mitogens|mitogens|mesh-list
83469679|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
83469680|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469681|NCT01250899|Vitamin D|vitamin d|mesh-list
83469682|NCT01250899|Vitamins|vitamins|mesh-ancestor
83469683|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
83469684|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469685|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83469686|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83469687|NCT01212445|Laxatives|laxatives|mesh-list
83469688|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83469689|NCT00002908|Vincristine|vincristine|mesh-list
83469690|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
83469691|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83469692|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469693|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
83469694|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
83469695|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
83469696|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469697|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83469698|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
83469699|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469700|NCT00002920|Tamoxifen|tamoxifen|mesh-list
83469701|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83469702|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
83469703|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83469704|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
83469705|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83469706|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469707|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83469708|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747539|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82747540|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82747541|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82747542|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82747543|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
82747544|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
82747545|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
82747546|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
82747547|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82747548|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747549|NCT04522804|Psilocybin|psilocybin|mesh-list
82747550|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
82747551|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747552|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83469709|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83469710|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83469711|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83469712|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83469713|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83469714|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83469715|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
83469716|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83469717|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83469718|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83469719|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83469720|NCT01250977|Donepezil|donepezil|mesh-list
83469721|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83469722|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469723|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469724|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
83469725|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469726|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469727|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
83469728|NCT01161121|Adenosine|adenosine|mesh-list
83469729|NCT01161121|Regadenoson|regadenoson|mesh-list
83469730|NCT01161121|Analgesics|analgesics|mesh-ancestor
83469731|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
83469732|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469733|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469734|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83469735|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
83469736|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83469737|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
83469738|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
83469739|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469740|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469741|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83469743|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
83469744|NCT03010579|Hematinics|hematinics|mesh-list
83469745|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
83469746|NCT01214083|Naltrexone|naltrexone|mesh-list
83469747|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83469748|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83469749|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83469750|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469751|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
83469752|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469753|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
83469754|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83469755|NCT01214083|Expectorants|expectorants|mesh-ancestor
83469756|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
83469757|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83469758|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
83469759|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469760|NCT01214083|Protective Agents|protective agents|mesh-ancestor
83469761|NCT01214083|Antidotes|antidotes|mesh-ancestor
83469762|NCT01254877|Ondansetron|ondansetron|mesh-list
83469763|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
83469764|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
83469765|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469766|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469767|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83469768|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
83469769|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
83469770|NCT01254877|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83469771|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83469772|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
83469773|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469774|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469775|NCT02189317|Bupivacaine|bupivacaine|mesh-list
83469776|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
83469777|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
83469778|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83489185|NCT05414006|Ketamine|ketamine|mesh-list
83469780|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
83469781|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469782|NCT03713944|Bevacizumab|bevacizumab|mesh-list
83469783|NCT03713944|Atezolizumab|atezolizumab|mesh-list
83469784|NCT03713944|Carboplatin|carboplatin|mesh-list
83469785|NCT03713944|Pemetrexed|pemetrexed|mesh-list
83469786|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747809|NCT03604406|Vaccines|vaccines|mesh-list
83469787|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469788|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83469789|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83469790|NCT03713944|Growth Substances|growth substances|mesh-ancestor
83469791|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469792|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
83469793|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469794|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747889|NCT03448783|Apixaban|apixaban|mesh-list
83469795|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83469796|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83469797|NCT03713944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83469798|NCT01214161|Lidocaine|lidocaine|mesh-list
83469799|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
83469800|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
83489186|NCT05414006|Esketamine|esketamine|mesh-list
83469801|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83469802|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469804|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469805|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83489187|NCT05414006|Analgesics|analgesics|mesh-ancestor
83469806|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83469807|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83469808|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83469809|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469810|NCT02945800|Paclitaxel|paclitaxel|mesh-list
83469811|NCT02945800|Gemcitabine|gemcitabine|mesh-list
83469812|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83469813|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469814|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
83469815|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
83469816|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
83469817|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469818|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83469819|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
83469820|NCT02981329|Metformin|metformin|mesh-list
83469821|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83469822|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469823|NCT00383656|Hormones|hormones|mesh-list
83469824|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83469825|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469826|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
83469827|NCT01214317|Analgesics|analgesics|mesh-ancestor
83469828|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
83469829|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469830|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469831|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469832|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83469833|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83469834|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469835|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469837|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83469838|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469839|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83469840|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83469841|NCT00383812|Growth Substances|growth substances|mesh-ancestor
82748294|NCT01067365|Citric Acid|citric acid|mesh-list
83469842|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469843|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
83469844|NCT02189629|Trifarotene|trifarotene|mesh-list
83469845|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
83469846|NCT00002926|Cytarabine|cytarabine|mesh-list
83469847|NCT00002926|Etoposide|etoposide|mesh-list
83469848|NCT00002926|Idarubicin|idarubicin|mesh-list
83469849|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83469850|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469851|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83469852|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83469853|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469854|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469855|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83469856|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
83469857|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
83469858|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82748349|NCT00816816|Docetaxel|docetaxel|mesh-list
83469859|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469860|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
83469861|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469862|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83469864|NCT01281007|Famciclovir|famciclovir|mesh-list
83469865|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
83469866|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83469867|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83469868|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469869|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469870|NCT02898610|Colchicine|colchicine|mesh-list
83469871|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
83469872|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469873|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
83469874|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
83469875|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
83469876|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469877|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469878|NCT01281475|Levodopa|levodopa|mesh-list
83469879|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83469880|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83469881|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
83469882|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469883|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469884|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469885|NCT00002932|Cisplatin|cisplatin|mesh-list
83469886|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469887|NCT01572662|Methotrexate|methotrexate|mesh-list
83469888|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
83469889|NCT01572662|Fludarabine|fludarabine|mesh-list
83469890|NCT01572662|Busulfan|busulfan|mesh-list
83469891|NCT01572662|Tacrolimus|tacrolimus|mesh-list
83469892|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83469893|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
83469894|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83469895|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469896|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83469897|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
83469898|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469899|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469900|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
83469901|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469902|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83469903|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469904|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
83469905|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83469906|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83469907|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83469908|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
83469909|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83469910|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83469911|NCT02822092|Risperidone|risperidone|mesh-list
83469912|NCT02822092|Aripiprazole|aripiprazole|mesh-list
83469913|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83469914|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
83469915|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469916|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469917|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469918|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83469919|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83469920|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83469921|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83469922|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83469923|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
83469924|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
83469925|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
82748821|NCT00823602|Buserelin|buserelin|mesh-list
83469926|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83469928|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83469929|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83469930|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83469931|NCT01258153|MEN 11420|men 11420|mesh-list
83469932|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83469933|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
83469934|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469935|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469936|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83469937|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
83469938|NCT01555268|Cytarabine|cytarabine|mesh-list
83469939|NCT01555268|Trebananib|trebananib|mesh-list
83469940|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83469941|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
83469942|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469943|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469944|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
83469945|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83469946|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469947|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
83469948|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469949|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83469950|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83469951|NCT01555268|Growth Substances|growth substances|mesh-ancestor
83469952|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
83469953|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83469954|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469955|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
83469956|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83469957|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
83469958|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83469959|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83469960|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83469961|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469962|NCT04781270|Bevacizumab|bevacizumab|mesh-list
83469963|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83469964|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469965|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83469966|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83469967|NCT04781270|Growth Substances|growth substances|mesh-ancestor
83469968|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469969|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
83469970|NCT00003394|Paclitaxel|paclitaxel|mesh-list
83469971|NCT00003394|Carboplatin|carboplatin|mesh-list
83469972|NCT00003394|Leuprolide|leuprolide|mesh-list
83469973|NCT00003394|Goserelin|goserelin|mesh-list
83469974|NCT00003394|Estramustine|estramustine|mesh-list
83469975|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83469976|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469977|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
83469978|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
82749203|NCT02598869|Hormones|hormones|mesh-ancestor
83469979|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
83489337|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83469980|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469981|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83469982|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
83469983|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83469984|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749335|NCT02598791|Hormones|hormones|mesh-ancestor
83469985|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83469986|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83469987|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
83469988|NCT00003400|Melphalan|melphalan|mesh-list
83469989|NCT00003400|Vinorelbine|vinorelbine|mesh-list
83469990|NCT00003400|Carmustine|carmustine|mesh-list
83469991|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469992|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
83469993|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469994|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83469995|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
83469996|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83469997|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83469998|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83469999|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470000|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470001|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470002|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470004|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
83470005|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
83470006|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470007|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83470008|NCT00002944|Carboplatin|carboplatin|mesh-list
83470009|NCT00002944|Vincristine|vincristine|mesh-list
83470010|NCT00002944|Thioguanine|thioguanine|mesh-list
83470012|NCT00002944|Procarbazine|procarbazine|mesh-list
83470013|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470014|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470015|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470016|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470017|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470018|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470019|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470020|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
83470021|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470022|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
83470024|NCT04778072|Trace Elements|trace elements|mesh-ancestor
83470025|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
83470026|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470027|NCT00002950|Topotecan|topotecan|mesh-list
83470028|NCT00002950|Sargramostim|sargramostim|mesh-list
83470029|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83470030|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470031|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470032|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470033|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470034|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
83470035|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470036|NCT00777140|Deferoxamine|deferoxamine|mesh-list
83470037|NCT00777140|Siderophores|siderophores|mesh-ancestor
83470038|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83470040|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
83470041|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470042|NCT00003406|Carboplatin|carboplatin|mesh-list
83470043|NCT00003406|Docetaxel|docetaxel|mesh-list
83470044|NCT00003406|Ifosfamide|ifosfamide|mesh-list
83470045|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470046|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470047|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470048|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470049|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470050|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470051|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
83470052|NCT00003412|Interleukin-12|interleukin-12|mesh-list
83470053|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83470054|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
83470055|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470056|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83470057|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83470058|NCT00003412|Growth Substances|growth substances|mesh-ancestor
83470060|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470061|NCT04780958|Vitamin A|vitamin a|mesh-list
83470062|NCT04780958|Vitamins|vitamins|mesh-ancestor
83470063|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
83470064|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470065|NCT00002968|Edrecolomab|edrecolomab|mesh-list
83470066|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83470067|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
83470068|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470069|NCT04780412|Alprostadil|alprostadil|mesh-list
83470070|NCT04780412|Misoprostol|misoprostol|mesh-list
83470071|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83470072|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
83470073|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83470074|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470075|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83470076|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83470077|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
83470078|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83470079|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
83470080|NCT04780412|Urological Agents|urological agents|mesh-ancestor
83470081|NCT00002974|Carboplatin|carboplatin|mesh-list
83470082|NCT00002974|Etoposide|etoposide|mesh-list
83470083|NCT00002974|Ifosfamide|ifosfamide|mesh-list
83470084|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470085|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470086|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470087|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470088|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470089|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470090|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470091|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
83470092|NCT00754364|Carboplatin|carboplatin|mesh-list
83470093|NCT00754364|Gemcitabine|gemcitabine|mesh-list
83470094|NCT00754364|Pemetrexed|pemetrexed|mesh-list
83470095|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470096|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470097|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
83470098|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470099|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470100|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83470101|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83470102|NCT02612896|Praziquantel|praziquantel|mesh-list
83470103|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
82750301|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
83470104|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83470105|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470106|NCT00002980|Decitabine|decitabine|mesh-list
83470107|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470108|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
83470109|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470110|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470111|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470112|NCT00002986|Topotecan|topotecan|mesh-list
83470113|NCT00002986|Carmustine|carmustine|mesh-list
83470114|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83470115|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470116|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470117|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470118|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470119|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470120|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
83470122|NCT00003418|Exemestane|exemestane|mesh-list
83470123|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470124|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83470125|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
83470126|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83470127|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470128|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83470129|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470130|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83470131|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83470132|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83470133|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83470134|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83470135|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470136|NCT04777838|Amitriptyline|amitriptyline|mesh-list
83470137|NCT04777838|Citalopram|citalopram|mesh-list
83470138|NCT04777838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83470139|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83470140|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83470141|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470142|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83470143|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
83470144|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470145|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83470146|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
83470147|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83470148|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470149|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83470150|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83470151|NCT04777838|Analgesics|analgesics|mesh-ancestor
83470152|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
83470153|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83470154|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
83470155|NCT00003424|Tamoxifen|tamoxifen|mesh-list
83470156|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83470157|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
83470158|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83470159|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470160|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83470161|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470162|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83470163|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83470164|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83470166|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470167|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470168|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
83470169|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470170|NCT00003004|Paclitaxel|paclitaxel|mesh-list
83470171|NCT00003004|Alvocidib|alvocidib|mesh-list
83470172|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470173|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470174|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470175|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470176|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470177|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470178|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
83470179|NCT00003004|Growth Substances|growth substances|mesh-ancestor
83470180|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750521|NCT00271609|Bevacizumab|bevacizumab|mesh-list
83470181|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83470182|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750564|NCT01069081|Docetaxel|docetaxel|mesh-list
83470183|NCT04776512|Bupivacaine|bupivacaine|mesh-list
83470184|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
83470185|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
83470186|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83470187|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470188|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
83470189|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470190|NCT04776590|Tislelizumab|tislelizumab|mesh-list
83470191|NCT04776590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83470192|NCT04776590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470193|NCT00003436|Cytarabine|cytarabine|mesh-list
83470194|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
83470195|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83470196|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83470197|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83470198|NCT00003436|Methotrexate|methotrexate|mesh-list
83470199|NCT00003436|Etoposide|etoposide|mesh-list
83470200|NCT00003436|Daunorubicin|daunorubicin|mesh-list
83470201|NCT00003436|Asparaginase|asparaginase|mesh-list
83470202|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
83470203|NCT00003436|Amsacrine|amsacrine|mesh-list
83470204|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83470205|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
83470206|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83470207|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470208|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470209|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
83470210|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470211|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470212|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
83470213|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470214|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83470215|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470217|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83470218|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83470219|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470220|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470221|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470222|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
83470223|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470224|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83470225|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83470226|NCT00003436|Analgesics|analgesics|mesh-ancestor
83470227|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
83470228|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470229|NCT02432378|Celecoxib|celecoxib|mesh-list
83470230|NCT02432378|Cisplatin|cisplatin|mesh-list
83470231|NCT02432378|Vaccines|vaccines|mesh-list
83470232|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
83470233|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470234|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470235|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83470236|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83470237|NCT02432378|Analgesics|analgesics|mesh-ancestor
83470239|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470240|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83470241|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83470242|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83470243|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83470244|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470245|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470246|NCT00003466|Temozolomide|temozolomide|mesh-list
83470247|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470248|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
83470249|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470250|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470251|NCT00003478|Antibodies|antibodies|mesh-list
83470252|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83470253|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
83470254|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470255|NCT00003016|Tamoxifen|tamoxifen|mesh-list
83470256|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83470257|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
83470258|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83470259|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470260|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83470261|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470262|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83470263|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83470264|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83470265|NCT00003022|Antibodies|antibodies|mesh-list
83470266|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83470267|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
83470268|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470269|NCT01258387|Mitogens|mitogens|mesh-list
83470270|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470271|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470272|NCT00003484|Irinotecan|irinotecan|mesh-list
83470273|NCT00003484|Carmustine|carmustine|mesh-list
83470274|NCT00003484|Antibodies|antibodies|mesh-list
82750787|NCT00547911|Carbidopa|carbidopa|mesh-list
83470275|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83470276|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
83470277|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470278|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83470279|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470280|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489338|NCT00801398|Narcotics|narcotics|mesh-ancestor
83470281|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470282|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470283|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470284|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
83470285|NCT00003490|Prednisone|prednisone|mesh-list
83470286|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
83470287|NCT00003490|Vincristine|vincristine|mesh-list
83470288|NCT00003490|Sargramostim|sargramostim|mesh-list
83470289|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470290|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
83470291|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470293|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470294|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
83470295|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470296|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470297|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83470298|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83470299|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
83470300|NCT00003490|Hormones|hormones|mesh-ancestor
83470301|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83470302|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83470303|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470304|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470305|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470306|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470307|NCT00003034|Doxorubicin|doxorubicin|mesh-list
83470308|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83470309|NCT00003034|Ranpirnase|ranpirnase|mesh-list
83470310|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83470311|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470312|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470313|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470315|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470316|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83470317|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
83470318|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83470319|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83470320|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470321|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83470322|NCT00383890|Analgesics|analgesics|mesh-ancestor
83470323|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
83470324|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470325|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83470326|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83470327|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83470328|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
83470329|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83470330|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470331|NCT00003046|Interleukin-12|interleukin-12|mesh-list
83470332|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83470333|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
83470334|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470335|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83470336|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83470337|NCT00003046|Growth Substances|growth substances|mesh-ancestor
83470338|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
83470339|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470340|NCT00003052|Doxorubicin|doxorubicin|mesh-list
83470341|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83470342|NCT00003052|Etoposide|etoposide|mesh-list
83470343|NCT00003052|Ifosfamide|ifosfamide|mesh-list
83470344|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83470345|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470346|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470347|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470348|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470349|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470350|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470351|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470352|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
83470353|NCT00003058|Troglitazone|troglitazone|mesh-list
83470354|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83470355|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470356|NCT04775732|Infliximab|infliximab|mesh-list
83470357|NCT04775732|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83470358|NCT04775732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83470359|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
83470360|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83470361|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83470362|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83470363|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83470364|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83470365|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83470366|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470367|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83470368|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83470369|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83470370|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
83470371|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83470372|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470373|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83470374|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83470375|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
83470377|NCT00003064|Etoposide|etoposide|mesh-list
83470378|NCT00003064|Carboplatin|carboplatin|mesh-list
83470379|NCT00003064|Topotecan|topotecan|mesh-list
83470380|NCT00003064|Thiotepa|thiotepa|mesh-list
83470381|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
83470382|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470383|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470384|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470385|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470386|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470387|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470388|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470389|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470391|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
83470392|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470393|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83470394|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470395|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
83470396|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83470397|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470398|NCT00003544|Irinotecan|irinotecan|mesh-list
82751581|NCT04233216|Islatravir|islatravir|mesh-list
83470399|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83470400|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470401|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470402|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470403|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470404|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
83470405|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83470406|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470407|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
83470408|NCT01269424|Temozolomide|temozolomide|mesh-list
83470409|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83470410|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470411|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
83477174|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83470412|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470413|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470414|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470415|NCT03395912|Anesthetics|anesthetics|mesh-list
83470416|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
83470417|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83470418|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470419|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
83470420|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470421|NCT00384436|Escitalopram|escitalopram|mesh-list
83470422|NCT00384436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83470423|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83470424|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83470425|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470427|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
83470428|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470429|NCT00003562|Carboplatin|carboplatin|mesh-list
83470430|NCT00003562|Docetaxel|docetaxel|mesh-list
83470431|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470432|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470433|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470434|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470435|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470436|NCT04775576|Anesthetics|anesthetics|mesh-list
83470437|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83470438|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470439|NCT00003568|Aldesleukin|aldesleukin|mesh-list
83470440|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
83470441|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470442|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83470443|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83470444|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
83470445|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470446|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83470447|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
83470448|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470449|NCT00003070|Enalapril|enalapril|mesh-list
83470450|NCT00003070|Enalaprilat|enalaprilat|mesh-list
83470451|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470452|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470453|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83470454|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
83470455|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83470456|NCT00003076|Eflornithine|eflornithine|mesh-list
83470457|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470458|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83470459|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83470460|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83470461|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470462|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83470463|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470464|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470465|NCT01896518|Nicotine|nicotine|mesh-list
83470466|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83470467|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
83470468|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470469|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470470|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83470471|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83470472|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
83470473|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83470474|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470475|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83470476|NCT00003082|Antibodies|antibodies|mesh-list
83470477|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
83470478|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83470479|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
83470480|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470481|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470482|NCT00003088|Paclitaxel|paclitaxel|mesh-list
83470483|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
83470484|NCT00003088|Doxorubicin|doxorubicin|mesh-list
83470485|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83470486|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470488|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470489|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470490|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470491|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470492|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470493|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
83470494|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470495|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83470496|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470497|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
83470498|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83470499|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83470500|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470501|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470502|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470503|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
83470504|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470505|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
83470506|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
83470507|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
83470508|NCT05423210|Atezolizumab|atezolizumab|mesh-list
83470509|NCT05423210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83470510|NCT05423210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470511|NCT05423210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83470512|NCT05423210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470513|NCT00755560|Albendazole|albendazole|mesh-list
83470514|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
83470515|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83470516|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470517|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
83470518|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83470519|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83470520|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470521|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470522|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470523|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470524|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470525|NCT05405894|Zoledronic Acid|zoledronic acid|mesh-list
83470526|NCT05405894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83470527|NCT05405894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470528|NCT00003118|Fluorouracil|fluorouracil|mesh-list
83470529|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752128|NCT00972075|Melatonin|melatonin|mesh-list
83470530|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
83470531|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470532|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470533|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470534|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
83470535|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470536|NCT00003124|Leuprolide|leuprolide|mesh-list
83470537|NCT00003124|Flutamide|flutamide|mesh-list
83470538|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83470539|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
83470540|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83470541|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470542|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83470543|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470544|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
83470545|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
83470546|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83470547|NCT00003580|Amifostine|amifostine|mesh-list
83470548|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83470549|NCT00003580|Protective Agents|protective agents|mesh-ancestor
83470550|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470551|NCT00056498|Risperidone|risperidone|mesh-list
83470552|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83470553|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
83470554|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83470555|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470556|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470557|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83470558|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83470559|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83470560|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83470561|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83470562|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
83470563|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
83470564|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
83470565|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83470566|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83470567|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470568|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470569|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470570|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83470572|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470573|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470574|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470575|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470576|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470577|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470578|NCT00058370|Vincristine|vincristine|mesh-list
83470579|NCT00058370|Lomustine|lomustine|mesh-list
83470580|NCT00058370|Antibodies|antibodies|mesh-list
83470581|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83470582|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
83470583|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470584|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470585|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470586|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470587|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470588|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470589|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470590|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470591|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
83470592|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83470593|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83470594|NCT00059228|Estradiol|estradiol|mesh-list
83470595|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83470596|NCT00059228|Estrogens|estrogens|mesh-ancestor
83470597|NCT00059228|Hormones|hormones|mesh-ancestor
83470598|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83470599|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470600|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83470601|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
83470602|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83470603|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83470604|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83470605|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83470606|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470607|NCT00062738|Paroxetine|paroxetine|mesh-list
83470608|NCT00062738|Nortriptyline|nortriptyline|mesh-list
83470609|NCT00062738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83470610|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83470611|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83470612|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470613|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83470614|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
83470615|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470616|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83470617|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
83470618|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83470619|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83470620|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83470621|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470622|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83470623|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83470624|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
83470625|NCT00063362|Lamotrigine|lamotrigine|mesh-list
83470626|NCT00063362|Valproic Acid|valproic acid|mesh-list
83470627|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
83470628|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
83470629|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83470630|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470631|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470632|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
83470633|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83470634|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83470635|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470636|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
83470637|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83470638|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83470639|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83470640|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83470641|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83470642|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
83470643|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83470644|NCT00064844|Nicotine|nicotine|mesh-list
83470645|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83470646|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
83470647|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489564|NCT01354145|Celecoxib|celecoxib|mesh-list
82753429|NCT00864552|Factor VIII|factor viii|mesh-list
83470648|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470650|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83470651|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
83470652|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83470653|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470655|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83470656|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83470657|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83470658|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83470659|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
83470660|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83470661|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470662|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470663|NCT00067028|Cytarabine|cytarabine|mesh-list
83470664|NCT00067028|Clofarabine|clofarabine|mesh-list
83470665|NCT00067028|Idarubicin|idarubicin|mesh-list
83470666|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470667|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
83470668|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470669|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470670|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
83470671|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470672|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470673|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
83470674|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470675|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83470676|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470677|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470678|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470679|NCT00067808|Decitabine|decitabine|mesh-list
83470680|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470681|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
83470682|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470683|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470684|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470685|NCT05174312|Diuretics|diuretics|mesh-list
83470686|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
83470687|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470688|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
83470689|NCT00493870|Docetaxel|docetaxel|mesh-list
83470690|NCT00493870|Doxorubicin|doxorubicin|mesh-list
83470691|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470692|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
83470693|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470694|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489640|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
83470695|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470697|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470698|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470699|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83470700|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470701|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470702|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470703|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83470704|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470705|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470706|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470707|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
83470708|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83470709|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83470710|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470711|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
83470712|NCT03287336|Coagulants|coagulants|mesh-ancestor
83470713|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
83470714|NCT00003136|Carboplatin|carboplatin|mesh-list
83470715|NCT00003136|Amifostine|amifostine|mesh-list
83470716|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470717|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
83470718|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470719|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83470720|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470721|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
83470722|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470723|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470724|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83470725|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83470726|NCT00003136|Protective Agents|protective agents|mesh-ancestor
83470727|NCT00003598|Tretinoin|tretinoin|mesh-list
83470728|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470729|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
83470730|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
83470731|NCT00003604|Aldesleukin|aldesleukin|mesh-list
83470732|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470733|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83470734|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83470735|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
83470736|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470737|NCT00002794|Carboplatin|carboplatin|mesh-list
83470738|NCT00002794|Vincristine|vincristine|mesh-list
83470739|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470740|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470741|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470742|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470743|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470744|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470745|NCT00003610|Capsaicin|capsaicin|mesh-list
83470746|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
83470747|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
83470748|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
83470749|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470750|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470751|NCT00003616|Irinotecan|irinotecan|mesh-list
83470752|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83470753|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470754|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470755|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470756|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470757|NCT01063829|Letermovir|letermovir|mesh-list
83470758|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83470759|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470760|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470761|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470762|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
83470763|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470764|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
83470765|NCT00072566|Bevacizumab|bevacizumab|mesh-list
83470766|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83470767|NCT00072566|Antibodies|antibodies|mesh-list
83470768|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
83470769|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83470770|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
83470772|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470773|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
83470774|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470775|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83470776|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470777|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
83470778|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754464|NCT00981513|Vaccines|vaccines|mesh-list
83470779|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470780|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83470781|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83470782|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83470783|NCT00072566|Growth Substances|growth substances|mesh-ancestor
83470784|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
83470785|NCT00003622|Paclitaxel|paclitaxel|mesh-list
83470786|NCT00003622|Vinorelbine|vinorelbine|mesh-list
83470787|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470788|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470789|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470790|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470791|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
83477250|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83470792|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470793|NCT00003148|Aldesleukin|aldesleukin|mesh-list
83470794|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470795|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83470796|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83470797|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
83470798|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470799|NCT00384046|Testosterone|testosterone|mesh-list
83470800|NCT00384046|Androgens|androgens|mesh-ancestor
83470801|NCT00384046|Hormones|hormones|mesh-ancestor
83470802|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83470803|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470804|NCT00002800|Cytarabine|cytarabine|mesh-list
83470805|NCT00002800|Etoposide|etoposide|mesh-list
83470806|NCT00002800|Idarubicin|idarubicin|mesh-list
83470807|NCT00002800|Lintuzumab|lintuzumab|mesh-list
83470808|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470809|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470810|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470811|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470812|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470813|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470814|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470815|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
83470816|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
83470817|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470818|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470819|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
83470820|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470821|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83470822|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83470823|NCT05061992|Lactulose|lactulose|mesh-list
82755137|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
83470824|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83470825|NCT00002806|Vincristine|vincristine|mesh-list
83470826|NCT00002806|Lomustine|lomustine|mesh-list
83470827|NCT00002806|Procarbazine|procarbazine|mesh-list
83470828|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470829|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470830|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470831|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470832|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470833|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470834|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470835|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
83470836|NCT00003160|Paclitaxel|paclitaxel|mesh-list
83470837|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470838|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470839|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470840|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470841|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
82755219|NCT00878670|Analgesics|analgesics|mesh-ancestor
83470842|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470844|NCT00002812|Dexamethasone|dexamethasone|mesh-list
83470845|NCT00002812|Prednisone|prednisone|mesh-list
83470846|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
83470847|NCT00002812|Doxorubicin|doxorubicin|mesh-list
83470848|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83470849|NCT00002812|Methotrexate|methotrexate|mesh-list
83470850|NCT00002812|Vincristine|vincristine|mesh-list
83470851|NCT00002812|Daunorubicin|daunorubicin|mesh-list
83470852|NCT00002812|Asparaginase|asparaginase|mesh-list
83470853|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
83470854|NCT00002812|Idarubicin|idarubicin|mesh-list
83470855|NCT00002812|Pegaspargase|pegaspargase|mesh-list
83470856|NCT00002812|Thioguanine|thioguanine|mesh-list
83470857|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470858|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
83477251|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82755560|NCT00800150|Melphalan|melphalan|mesh-list
83470859|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470860|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83470861|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83470862|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
83470863|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470864|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470865|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83470866|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83470868|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
83470869|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470870|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83470871|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
83470872|NCT00002812|Hormones|hormones|mesh-ancestor
83470873|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83470874|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83470875|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83470876|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470877|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470878|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755769|NCT00888732|Insulin|insulin|mesh-list
82755852|NCT00236197|Rabeprazole|rabeprazole|mesh-list
83470879|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83470880|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
83470881|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83470882|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470883|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
83470884|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
83470885|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83470886|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83470887|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
83470888|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470889|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470890|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470891|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470892|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470893|NCT01258855|Aldesleukin|aldesleukin|mesh-list
83470894|NCT01258855|Aflibercept|aflibercept|mesh-list
83470895|NCT01258855|Interleukin-2|interleukin-2|mesh-list
83470896|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
83470897|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83470898|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83470899|NCT01258855|Growth Substances|growth substances|mesh-ancestor
83470900|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470901|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
83470902|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470903|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82755992|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755993|NCT00889434|Vitamins|vitamins|mesh-ancestor
82755994|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
82755995|NCT00612534|Sufentanil|sufentanil|mesh-list
82755996|NCT00612534|Dsuvia|dsuvia|mesh-list
82755997|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82755998|NCT00612534|Narcotics|narcotics|mesh-ancestor
83470905|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
83470906|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470907|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83470908|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83470909|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
83470910|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470911|NCT00003166|Vincristine|vincristine|mesh-list
83470912|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
83470913|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470914|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470915|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470916|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470917|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470918|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470919|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83470920|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
83470921|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470922|NCT00003172|Interferons|interferons|mesh-list
83470923|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
83470924|NCT00003172|Docetaxel|docetaxel|mesh-list
83470925|NCT00003172|Doxorubicin|doxorubicin|mesh-list
83470926|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83470927|NCT00003172|Fluorouracil|fluorouracil|mesh-list
83470928|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
82756046|NCT04037514|Ibuprofen|ibuprofen|mesh-list
83470929|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470930|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470931|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470932|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470933|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470934|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83470935|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470936|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83470937|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470938|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
83470939|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470940|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470941|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
83470942|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470943|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
83470944|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470945|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
83470946|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83470948|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83470949|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470950|NCT02191033|Nicotine|nicotine|mesh-list
83470951|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83470952|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
83470953|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470954|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470955|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83470956|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83470957|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
83470958|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83470959|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470960|NCT00002818|Cytarabine|cytarabine|mesh-list
83470961|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470962|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
83489718|NCT05118854|Sotorasib|sotorasib|mesh-list
83470963|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470964|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470965|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
83470966|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470967|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470968|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
83470969|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470970|NCT00003640|Doxorubicin|doxorubicin|mesh-list
83470971|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83470972|NCT00003640|Methotrexate|methotrexate|mesh-list
83470973|NCT00003640|Vinblastine|vinblastine|mesh-list
83470974|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83470975|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83470976|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83470977|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82756137|NCT00886860|Misoprostol|misoprostol|mesh-list
83470978|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470979|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470980|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83470981|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
83470982|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83470983|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83470984|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83470985|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
83470986|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
83470987|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83470988|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83470989|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
83470990|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83470991|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83470992|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83470993|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
83470994|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470995|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
83470996|NCT00002824|Ganciclovir|ganciclovir|mesh-list
83470997|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83470998|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
83489794|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471000|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83471001|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471002|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471003|NCT00003178|Idarubicin|idarubicin|mesh-list
83471004|NCT00003178|Cladribine|cladribine|mesh-list
83471005|NCT00003178|Lenograstim|lenograstim|mesh-list
83471006|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83471007|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
83471008|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471009|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471010|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471011|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471012|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471013|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471014|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471015|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471016|NCT01260649|Ketamine|ketamine|mesh-list
83471017|NCT01260649|Anesthetics|anesthetics|mesh-list
83471018|NCT01260649|Analgesics|analgesics|mesh-ancestor
83471019|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
83471020|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83471021|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471022|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83471023|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83471024|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
83471025|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83471026|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83471027|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83471028|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83471029|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471030|NCT01260883|Ketorolac|ketorolac|mesh-list
83471031|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83471032|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83471033|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83471034|NCT01260883|Analgesics|analgesics|mesh-ancestor
83471035|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
83471036|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83471037|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471038|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83471039|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471040|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83471041|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471042|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471043|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
83471044|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83471045|NCT00423202|Ambrisentan|ambrisentan|mesh-list
83471046|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83471047|NCT00003184|Vaccines|vaccines|mesh-list
83471048|NCT00003184|Sargramostim|sargramostim|mesh-list
83471049|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
83471050|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
83471051|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471052|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83471053|NCT00003190|Cytarabine|cytarabine|mesh-list
83471054|NCT00003190|Etoposide|etoposide|mesh-list
83471055|NCT00003190|Daunorubicin|daunorubicin|mesh-list
83471056|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
83471057|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471058|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471059|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471060|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471061|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471062|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471063|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471064|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
83471065|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
83471066|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471067|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471068|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
83471069|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471070|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471071|NCT00003652|Fluorouracil|fluorouracil|mesh-list
83471072|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471073|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
83471074|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471075|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471076|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471078|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471080|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
83471081|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
83471082|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83471083|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471084|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
83471085|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83471086|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83471087|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83471088|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83471089|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83471090|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471091|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
83471092|NCT00003658|Rituximab|rituximab|mesh-list
83471093|NCT00003658|Pentostatin|pentostatin|mesh-list
83471094|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471095|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
83471096|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471097|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471098|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471099|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
83471100|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471101|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471102|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83471103|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83471104|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83471105|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471106|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
83471108|NCT00002836|Carmustine|carmustine|mesh-list
83471109|NCT00002836|Cisplatin|cisplatin|mesh-list
83471110|NCT00002836|Etoposide|etoposide|mesh-list
83471111|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471112|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
83471113|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471114|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471115|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471116|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
83471117|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471118|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471119|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83471120|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471121|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471122|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471123|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471124|NCT00003664|Interferons|interferons|mesh-list
83471125|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
83471126|NCT00003664|Aldesleukin|aldesleukin|mesh-list
83471127|NCT00003664|Gemcitabine|gemcitabine|mesh-list
83471128|NCT00003664|Fluorouracil|fluorouracil|mesh-list
83471129|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471131|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471132|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471133|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471134|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
83471135|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471136|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
83471137|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471138|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83471139|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83471140|NCT00003196|Cyclosporine|cyclosporine|mesh-list
83471142|NCT00003196|Cyclosporins|cyclosporins|mesh-list
83471143|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489795|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
83471144|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471145|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471146|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
83471147|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471148|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
82756653|NCT00815048|Atropine|atropine|mesh-list
83471149|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471150|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
83471151|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471152|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83471153|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471154|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471155|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83471156|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
83471157|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83471158|NCT00003202|Gemcitabine|gemcitabine|mesh-list
83471159|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471160|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471161|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
83489796|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
83471162|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471163|NCT00002854|Paclitaxel|paclitaxel|mesh-list
83471164|NCT00002854|Etoposide|etoposide|mesh-list
83471165|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
83471166|NCT00002854|Carboplatin|carboplatin|mesh-list
83471167|NCT00002854|Ifosfamide|ifosfamide|mesh-list
83471168|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471169|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471170|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471171|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471172|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471173|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471174|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471175|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
83471176|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471177|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471178|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471179|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
83471180|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83471181|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471182|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471183|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471185|NCT02308202|Doxazosin|doxazosin|mesh-list
83471186|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83471187|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
83471188|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471189|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471190|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83471191|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83471192|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83471193|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83471194|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
83471195|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83471196|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471197|NCT00003214|Paclitaxel|paclitaxel|mesh-list
83471198|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
83471199|NCT00003214|Carboplatin|carboplatin|mesh-list
83471200|NCT00003214|Doxorubicin|doxorubicin|mesh-list
83471201|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83471202|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471203|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471204|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471205|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471206|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471207|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471208|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82757038|NCT04397406|Analgesics|analgesics|mesh-ancestor
83471209|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
83471210|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471211|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471212|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471213|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
83471214|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83471215|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471216|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471217|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471218|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471219|NCT00384592|Esomeprazole|esomeprazole|mesh-list
83471220|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83471221|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83471222|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83471223|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471224|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471225|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
83471226|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83471227|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
82757182|NCT00888108|Docetaxel|docetaxel|mesh-list
83471228|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471229|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471230|NCT00002866|Docetaxel|docetaxel|mesh-list
83471231|NCT00002866|Epirubicin|epirubicin|mesh-list
83471232|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471233|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471234|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471235|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471236|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471237|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471238|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471239|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471240|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471241|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
83471242|NCT00003232|Prednisone|prednisone|mesh-list
83471243|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
83471244|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83471245|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
83471246|NCT00003232|Hormones|hormones|mesh-ancestor
83471247|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83471248|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471249|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83471250|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471251|NCT00003232|Analgesics|analgesics|mesh-ancestor
83471252|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
83471253|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83471254|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471255|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471256|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471257|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471258|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83471259|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
83471260|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757293|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
82757294|NCT00608322|Protective Agents|protective agents|mesh-ancestor
82757300|NCT00608244|Tacrolimus|tacrolimus|mesh-list
82757301|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82757302|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
83471261|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471262|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471263|NCT00002884|Fluorouracil|fluorouracil|mesh-list
83471264|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471265|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
83471266|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757351|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
83471267|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471268|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471269|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
83471270|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471271|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
83471272|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83471273|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83471274|NCT00003682|Prednisolone|prednisolone|mesh-list
83471275|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
83471276|NCT00003682|Doxorubicin|doxorubicin|mesh-list
83471277|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82757420|NCT00893724|Vitamins|vitamins|mesh-ancestor
83471278|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83471279|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
83471280|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471281|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471282|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82757485|NCT00543387|Docetaxel|docetaxel|mesh-list
83471283|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471284|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471285|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471286|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83471287|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
83471288|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
83471289|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83471290|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471291|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83471292|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
83471293|NCT00003682|Hormones|hormones|mesh-ancestor
83471294|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83471295|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83471296|NCT00003682|Protective Agents|protective agents|mesh-ancestor
83471297|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83471298|NCT00003688|Dactinomycin|dactinomycin|mesh-list
83471299|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83471300|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471301|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471302|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471303|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83471304|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471305|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471306|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83471307|NCT00083174|Exemestane|exemestane|mesh-list
83471308|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471309|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83471310|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83471311|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471312|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471313|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83471314|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
82757686|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
83471315|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83471316|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471317|NCT00003934|Cytarabine|cytarabine|mesh-list
83471318|NCT00003934|Methotrexate|methotrexate|mesh-list
83471319|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
83471320|NCT00003934|Daunorubicin|daunorubicin|mesh-list
83471321|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
83471322|NCT00003934|Tretinoin|tretinoin|mesh-list
83471323|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83471324|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
83471325|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83471326|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471327|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471328|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
83471329|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471330|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471331|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
83471332|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471333|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83471334|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471335|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
83471336|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471337|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83471338|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
83471339|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471340|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471341|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471342|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471343|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
83471344|NCT00003694|Cytarabine|cytarabine|mesh-list
83471345|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
83471346|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471347|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
83471348|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471349|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471350|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
83471351|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471352|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471353|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
83471354|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471355|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471356|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83471357|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471358|NCT00003250|Fenretinide|fenretinide|mesh-list
83471359|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471360|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83471361|NCT00003250|Protective Agents|protective agents|mesh-ancestor
83471362|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471363|NCT00003256|Alvocidib|alvocidib|mesh-list
83471364|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471365|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
83471366|NCT00003256|Growth Substances|growth substances|mesh-ancestor
83471367|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471369|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471370|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471371|NCT00003946|Danazol|danazol|mesh-list
83471372|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83471373|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
83471374|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83471375|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471376|NCT04679480|Cemiplimab|cemiplimab|mesh-list
83471377|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83471378|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471379|NCT00003262|Prednisone|prednisone|mesh-list
83471380|NCT00003262|Doxorubicin|doxorubicin|mesh-list
83471381|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83471383|NCT00003262|Bleomycin|bleomycin|mesh-list
83471384|NCT00003262|Etoposide|etoposide|mesh-list
83471385|NCT00003262|Vincristine|vincristine|mesh-list
83471386|NCT00003262|Vinblastine|vinblastine|mesh-list
83471387|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
83471388|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471389|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471390|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471391|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471392|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471393|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471394|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83471395|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
83471396|NCT00003262|Hormones|hormones|mesh-ancestor
83471397|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83471398|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471399|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83471400|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471401|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471402|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471403|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471404|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
83471405|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471406|NCT00003700|Leucovorin|leucovorin|mesh-list
83471407|NCT00003700|Cytarabine|cytarabine|mesh-list
83471408|NCT00003700|Prednisone|prednisone|mesh-list
83471409|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
83471410|NCT00003700|Methotrexate|methotrexate|mesh-list
83471411|NCT00003700|Vincristine|vincristine|mesh-list
83471412|NCT00003700|Daunorubicin|daunorubicin|mesh-list
83471413|NCT00003700|Asparaginase|asparaginase|mesh-list
83471414|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
83471415|NCT00003700|Allopurinol|allopurinol|mesh-list
83471416|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
83471417|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471418|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
83471419|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471420|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471421|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471422|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
83471423|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471424|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471425|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83471426|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83471427|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
83471428|NCT00003700|Hormones|hormones|mesh-ancestor
83471429|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83471430|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83471431|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83471432|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
83471433|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83471434|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471435|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
83471436|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
83471437|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471438|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83471439|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83471440|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
83471441|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471442|NCT00003700|Antidotes|antidotes|mesh-ancestor
83471443|NCT00003700|Protective Agents|protective agents|mesh-ancestor
83471444|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
83471445|NCT00003700|Vitamins|vitamins|mesh-ancestor
83471446|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
83471447|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471448|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471449|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471450|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471451|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471452|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471453|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471454|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
83471455|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83471456|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
83471457|NCT00003706|Pemetrexed|pemetrexed|mesh-list
83471458|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471459|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471460|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471461|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83471462|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83471463|NCT00003958|Dactinomycin|dactinomycin|mesh-list
83471464|NCT00003958|Cactinomycin|cactinomycin|mesh-list
83471465|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
83471466|NCT00003958|Vincristine|vincristine|mesh-list
83471467|NCT00003958|Topotecan|topotecan|mesh-list
83471468|NCT00003958|Sargramostim|sargramostim|mesh-list
83471469|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471470|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
83471471|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471472|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471473|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471474|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
83471475|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471476|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471477|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83471478|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471479|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471480|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471481|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471482|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83471483|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471484|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471485|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83471486|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471487|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471488|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83471489|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83471490|NCT00003712|Sirolimus|sirolimus|mesh-list
83471491|NCT00003712|Temsirolimus|temsirolimus|mesh-list
83471492|NCT00003712|MTOR Inhibitors|mtor inhibitors|mesh-list
83471493|NCT00003712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83471494|NCT00003712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471495|NCT00003712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471496|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471497|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
83471498|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471499|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471500|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83471501|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471502|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471503|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
83471504|NCT00003268|Cytarabine|cytarabine|mesh-list
83471505|NCT00003268|Idarubicin|idarubicin|mesh-list
83471506|NCT00003268|Amifostine|amifostine|mesh-list
83471507|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471508|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
83471509|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471510|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471511|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
83471512|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471513|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471514|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
82758684|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82758685|NCT00929058|Growth Substances|growth substances|mesh-ancestor
82758686|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471515|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471516|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471517|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471519|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471520|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83471521|NCT00003268|Protective Agents|protective agents|mesh-ancestor
83471523|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83471524|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471526|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
83471527|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
83471528|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471529|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83471530|NCT00003280|Rituximab|rituximab|mesh-list
83471531|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83471532|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471533|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
83471534|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471535|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471536|NCT00384124|Imiquimod|imiquimod|mesh-list
83471537|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83471538|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
83489797|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83471539|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471540|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471541|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
83471543|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471544|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
83471545|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471546|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471547|NCT00003970|Irinotecan|irinotecan|mesh-list
83471548|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83471549|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471550|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471551|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471552|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471553|NCT00085436|Interferons|interferons|mesh-list
83471554|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
83471555|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
83471556|NCT00085436|Aldesleukin|aldesleukin|mesh-list
83471557|NCT00085436|Vaccines|vaccines|mesh-list
83471558|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
83471559|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471560|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471561|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
83471562|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471563|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83471564|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83471566|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471567|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
83471568|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471569|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83471570|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759008|NCT00817466|Racepinephrine|racepinephrine|mesh-list
83471571|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471572|NCT00086138|Sertraline|sertraline|mesh-list
83471573|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
83471574|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83471575|NCT00086138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83471576|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83471577|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83471578|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471579|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83471580|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
83471581|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471582|NCT04329130|Lenalidomide|lenalidomide|mesh-list
83471583|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
83471584|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471585|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83471586|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83471588|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
83471589|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471590|NCT00384280|Rifampin|rifampin|mesh-list
83471591|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83471592|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
83471593|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83471594|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471595|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
83471596|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83471597|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471598|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471599|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83471600|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83471601|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83471602|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83471603|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83471604|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83471605|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
83471606|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471607|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83471608|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471609|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471610|NCT00003730|Fluorouracil|fluorouracil|mesh-list
83471611|NCT00003730|Vinorelbine|vinorelbine|mesh-list
83471612|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
83471613|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489798|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
83471614|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471615|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471616|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471617|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
83471618|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471619|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471620|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471621|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471622|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471623|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83471624|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
83471626|NCT00003292|Ifosfamide|ifosfamide|mesh-list
83471627|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471628|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
83471629|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471630|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471631|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82759540|NCT00990639|Candesartan|candesartan|mesh-list
83471632|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83471633|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83471634|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83471635|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471636|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83471637|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83471638|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83471639|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83471640|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83471641|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83471642|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471643|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83471644|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83471645|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
83471646|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83471647|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83471648|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
83471649|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
83471650|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471651|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83471652|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
83471653|NCT00003994|Carboplatin|carboplatin|mesh-list
83471654|NCT00003994|Fluorouracil|fluorouracil|mesh-list
83471655|NCT00003994|Vincristine|vincristine|mesh-list
83471656|NCT00003994|Amifostine|amifostine|mesh-list
83471657|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471659|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471660|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471661|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471662|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
83471663|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471664|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471665|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471666|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471667|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471668|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83471669|NCT00003994|Protective Agents|protective agents|mesh-ancestor
83471671|NCT00003742|Irinotecan|irinotecan|mesh-list
83471672|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471673|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471674|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471675|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471676|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
83477252|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83471677|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471678|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83471679|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471680|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471681|NCT00003304|Temozolomide|temozolomide|mesh-list
83471682|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471683|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
82759937|NCT03791398|Nivolumab|nivolumab|mesh-list
83471684|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471685|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471686|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
83471687|NCT00004006|Carboplatin|carboplatin|mesh-list
83471688|NCT00004006|Doxorubicin|doxorubicin|mesh-list
83471689|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83471691|NCT00004006|Topotecan|topotecan|mesh-list
83471692|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82760006|NCT00833768|Sevelamer|sevelamer|mesh-list
83471693|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
83471694|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471695|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471696|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471697|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
83471698|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471699|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471700|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83471701|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471702|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471703|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471704|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471705|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471706|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83471708|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471709|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
83471710|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760142|NCT00825188|Diuretics|diuretics|mesh-ancestor
83471711|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471713|NCT00089024|Gemcitabine|gemcitabine|mesh-list
83471714|NCT00089024|Fluorouracil|fluorouracil|mesh-list
83471715|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
83471716|NCT00089024|Calcium|calcium|mesh-list
83471717|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
83471718|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471719|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
83471720|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471721|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471722|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83471723|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471724|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471725|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
83471726|NCT00089024|Antidotes|antidotes|mesh-ancestor
83471727|NCT00089024|Protective Agents|protective agents|mesh-ancestor
83471728|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
83471729|NCT00089024|Vitamins|vitamins|mesh-ancestor
83471730|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
83471731|NCT00003322|Paclitaxel|paclitaxel|mesh-list
83471732|NCT00003322|Cisplatin|cisplatin|mesh-list
83471733|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471734|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471735|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471736|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471737|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
83477253|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83471738|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471740|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83471741|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83471742|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83471743|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83471744|NCT00003748|Irinotecan|irinotecan|mesh-list
83471745|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83471746|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471747|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471748|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471749|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471750|NCT00089102|Gemcitabine|gemcitabine|mesh-list
83471751|NCT00089102|Irinotecan|irinotecan|mesh-list
83471752|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471753|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
83471754|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471756|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83471757|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471758|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471759|NCT00004012|Capecitabine|capecitabine|mesh-list
83471760|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471761|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
83471762|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471763|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471764|NCT00003754|Thalidomide|thalidomide|mesh-list
83471765|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
83471766|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471767|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
83471768|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471769|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471770|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471771|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
83471772|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471773|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471774|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83471775|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
83471776|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83471777|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471778|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83471779|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83471780|NCT00003754|Growth Substances|growth substances|mesh-ancestor
83471781|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
83471782|NCT00003328|Porfiromycin|porfiromycin|mesh-list
83471783|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471784|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471785|NCT00004024|Aldesleukin|aldesleukin|mesh-list
83471786|NCT00004024|Sargramostim|sargramostim|mesh-list
83471787|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
83471788|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
83471789|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471790|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471791|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83471792|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83471793|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
83471794|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471795|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471797|NCT00003334|Doxorubicin|doxorubicin|mesh-list
83471798|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83471799|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471800|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471801|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471802|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471803|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471804|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471805|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471806|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471807|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471808|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471809|NCT00093782|Sirolimus|sirolimus|mesh-list
83471810|NCT00093782|Temsirolimus|temsirolimus|mesh-list
83471811|NCT00093782|MTOR Inhibitors|mtor inhibitors|mesh-list
83471812|NCT00093782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83471813|NCT00093782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471814|NCT00093782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471815|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471816|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
83471817|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471818|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471819|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83471820|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471821|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471822|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
83471824|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471825|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
83471826|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471827|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471828|NCT04771754|Dolutegravir|dolutegravir|mesh-list
83471829|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83471830|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83471831|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489951|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471832|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471833|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83471834|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83471835|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
83471836|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471837|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83471838|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471839|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471840|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471841|NCT00004030|Doxorubicin|doxorubicin|mesh-list
83471842|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83471843|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471844|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471845|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471846|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471847|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471848|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471850|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
83471851|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83471852|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83471853|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471854|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471855|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471856|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471857|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
83471858|NCT00003340|Topotecan|topotecan|mesh-list
83471859|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471860|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
83471861|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471862|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471863|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471864|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
83471865|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471866|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471867|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83471868|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83471869|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471870|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471871|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
83471872|NCT00004036|Carboplatin|carboplatin|mesh-list
83471873|NCT00004036|Sargramostim|sargramostim|mesh-list
83471874|NCT00004036|Amifostine|amifostine|mesh-list
83471875|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471876|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
83471877|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471878|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471879|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471880|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
83471881|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471882|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471883|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83471884|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83471885|NCT00004036|Protective Agents|protective agents|mesh-ancestor
83471886|NCT00003346|Acetaminophen|acetaminophen|mesh-list
83471887|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
83471888|NCT00003346|Carmustine|carmustine|mesh-list
83471889|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83471890|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83471891|NCT00003346|Analgesics|analgesics|mesh-ancestor
83471892|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
83471893|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83471894|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471895|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
83471896|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
83471897|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471898|NCT00003346|Expectorants|expectorants|mesh-ancestor
83471899|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
83471900|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83471901|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
83471902|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471903|NCT00003346|Protective Agents|protective agents|mesh-ancestor
83471904|NCT00003346|Antidotes|antidotes|mesh-ancestor
83471905|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471906|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
83471907|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471908|NCT00096122|Cytarabine|cytarabine|mesh-list
83471909|NCT00096122|Idarubicin|idarubicin|mesh-list
83471910|NCT00096122|Tipifarnib|tipifarnib|mesh-list
83471911|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83471912|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
83471913|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471914|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471915|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
83471916|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83471917|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471918|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
83471919|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471920|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471921|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471922|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471923|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471924|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
83471925|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471926|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471928|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471929|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471930|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83471931|NCT00004042|Antibodies|antibodies|mesh-list
83471932|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
83471933|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83471934|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
83471935|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471936|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471937|NCT00003784|Prednisone|prednisone|mesh-list
83471938|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
83471939|NCT00003784|Doxorubicin|doxorubicin|mesh-list
83471940|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83471941|NCT00003784|Vincristine|vincristine|mesh-list
83471942|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
83471943|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471944|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
83471945|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471946|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471947|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471948|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
83471949|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471950|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471951|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82760736|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
83471952|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471953|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471954|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471955|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471956|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83471957|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
83471958|NCT00003784|Hormones|hormones|mesh-ancestor
83471959|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83471960|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83471961|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471962|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471963|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471964|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471965|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
83471966|NCT00003352|Docetaxel|docetaxel|mesh-list
83471967|NCT00003352|Doxorubicin|doxorubicin|mesh-list
83471968|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83471969|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83471970|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
83471971|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471972|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83471973|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83471974|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
83471975|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471976|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471977|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83471978|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
83471979|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
83471980|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
83471981|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471982|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471983|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471984|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471985|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83471986|NCT00004048|Doxorubicin|doxorubicin|mesh-list
83471987|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83471989|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
83471990|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83471991|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
83471992|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471993|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471994|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83471995|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83471996|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83471997|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471998|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83471999|NCT00003358|Gemcitabine|gemcitabine|mesh-list
83472000|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472001|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472002|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
82760903|NCT01011010|Mitomycin|mitomycin|mesh-list
83472003|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472005|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83472006|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472007|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472008|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472009|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472010|NCT00384826|Paclitaxel|paclitaxel|mesh-list
83472011|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83472012|NCT00384826|Carboplatin|carboplatin|mesh-list
83472013|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83472014|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472015|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
83472016|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
83472017|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
83472018|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472019|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83472020|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472022|NCT00003364|Doxorubicin|doxorubicin|mesh-list
83472023|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83472024|NCT00003364|Etoposide|etoposide|mesh-list
83472025|NCT00003364|Vincristine|vincristine|mesh-list
83472026|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472027|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
83472028|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472029|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472030|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83472031|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
83472032|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472033|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472034|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83472035|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83472036|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83472037|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472038|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472039|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83472040|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
83472041|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
83472042|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
83472043|NCT00004066|Gemcitabine|gemcitabine|mesh-list
83472044|NCT00004066|Docetaxel|docetaxel|mesh-list
83472045|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472046|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
83472047|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472048|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472049|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
83472050|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
82761110|NCT04420299|Bemiparin|bemiparin|mesh-list
83472051|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
83472052|NCT00003370|Irofulven|irofulven|mesh-list
83472053|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83472054|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
83472055|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472056|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472057|NCT00003382|Gemcitabine|gemcitabine|mesh-list
83472058|NCT00003382|Topotecan|topotecan|mesh-list
83472059|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472060|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
83472061|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472062|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472063|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83472064|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472065|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472066|NCT00004834|Imipramine|imipramine|mesh-list
83472067|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83472068|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
83472069|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83472070|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83472071|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83472072|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83472073|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472074|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
83472075|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83472076|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472077|NCT00004840|Hormones|hormones|mesh-list
83472078|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
83472079|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83472080|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472082|NCT00004852|Zidovudine|zidovudine|mesh-list
83472083|NCT00004852|Efavirenz|efavirenz|mesh-list
83472084|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83472085|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83472086|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472087|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472089|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472090|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83472091|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83472092|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
83472093|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83472094|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83472095|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83472096|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83472097|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83472098|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83472099|NCT00004858|Genistein|genistein|mesh-list
83472100|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
83472101|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83472102|NCT00004858|Protective Agents|protective agents|mesh-ancestor
83472103|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472104|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472105|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82762248|NCT00993057|Insulin|insulin|mesh-list
83472106|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472107|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472108|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
83472109|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83472110|NCT00004858|Estrogens|estrogens|mesh-ancestor
82762448|NCT00994071|Veliparib|veliparib|mesh-list
83472112|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83472113|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
83472115|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472116|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
83472117|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
83472118|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
83472119|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472121|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83472122|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
83472123|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472124|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472125|NCT00003802|NSC 366140|nsc 366140|mesh-list
83472126|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472127|NCT02972866|Budesonide|budesonide|mesh-list
83472128|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83472129|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83472130|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
82762952|NCT04731155|Antimetabolites|antimetabolites|mesh-ancestor
82763181|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
82763258|NCT00999219|Zolpidem|zolpidem|mesh-list
83472131|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472132|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472133|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83472134|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
83472135|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
83472136|NCT02972866|Hormones|hormones|mesh-ancestor
83472137|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83472139|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472140|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83472141|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83472142|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83472143|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472144|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83472145|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472146|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472147|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
83472148|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
83472149|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
83472150|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472151|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82763474|NCT05325177|Ibuprofen|ibuprofen|mesh-list
83472152|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472153|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
83472154|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472155|NCT00003850|Thalidomide|thalidomide|mesh-list
83472156|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472157|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
83472158|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763601|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
82763602|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763603|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82763604|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
82763605|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
82763606|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763619|NCT03827213|Bupivacaine|bupivacaine|mesh-list
82763620|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
82763621|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
82763622|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82763623|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763626|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
83472159|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
83472160|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83472161|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472162|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83472163|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83472164|NCT00003850|Growth Substances|growth substances|mesh-ancestor
83472165|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
83472166|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472167|NCT00004072|Carmustine|carmustine|mesh-list
83472168|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83472169|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82763833|NCT01019746|Propofol|propofol|mesh-list
83472170|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
83472171|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472172|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472173|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472174|NCT00004078|Irinotecan|irinotecan|mesh-list
83472175|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83472176|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472177|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472178|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472179|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472180|NCT00003856|Temoporfin|temoporfin|mesh-list
83472181|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472182|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83472183|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
83472184|NCT00014222|Paclitaxel|paclitaxel|mesh-list
83472185|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
83472186|NCT00014222|Doxorubicin|doxorubicin|mesh-list
83472187|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83472188|NCT00014222|Fluorouracil|fluorouracil|mesh-list
83472189|NCT00014222|Epirubicin|epirubicin|mesh-list
83472190|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
83472191|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83472192|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472193|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
83472194|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
83472195|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
83472196|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472197|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472198|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
83472199|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472200|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472201|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83472202|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
83472203|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83472204|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83472205|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83472206|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472207|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472208|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
83472209|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472210|NCT00014222|Hematinics|hematinics|mesh-ancestor
83472211|NCT00004870|Irinotecan|irinotecan|mesh-list
83472212|NCT00004870|Oblimersen|oblimersen|mesh-list
83472213|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83472214|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472215|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472216|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472217|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472218|NCT00004084|Epratuzumab|epratuzumab|mesh-list
83472219|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83472220|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472221|NCT00004876|Thalidomide|thalidomide|mesh-list
83472222|NCT00004876|Carboplatin|carboplatin|mesh-list
83472223|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472224|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472225|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
83472226|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472227|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
83472228|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83472229|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490102|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83472230|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83472231|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83472232|NCT00004876|Growth Substances|growth substances|mesh-ancestor
83472233|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
83472234|NCT00003862|Leucovorin|leucovorin|mesh-list
83472235|NCT00003862|Paclitaxel|paclitaxel|mesh-list
83472236|NCT00003862|Fluorouracil|fluorouracil|mesh-list
83472237|NCT00003862|Calcium|calcium|mesh-list
83472238|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
83472239|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83472240|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472241|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
83472242|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
83472243|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
83472244|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472245|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83472246|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472247|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
83472248|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472249|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472250|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
83472251|NCT00003862|Antidotes|antidotes|mesh-ancestor
83472252|NCT00003862|Protective Agents|protective agents|mesh-ancestor
83472253|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
83472254|NCT00003862|Vitamins|vitamins|mesh-ancestor
83472255|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
83472256|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
83472257|NCT00003868|Methotrexate|methotrexate|mesh-list
83472258|NCT00003868|Antibodies|antibodies|mesh-list
83472259|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83472260|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472261|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
83472262|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472263|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472264|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83472266|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472267|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472268|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83472269|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83472270|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
83472271|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83472272|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472273|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
83472274|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
83472275|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472276|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83472277|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83472278|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83472280|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
83472281|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83472282|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
83472283|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472284|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472285|NCT00004090|Gemcitabine|gemcitabine|mesh-list
83472286|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490103|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83472287|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472288|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
83472289|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472290|NCT00004102|Leucovorin|leucovorin|mesh-list
83472291|NCT00004102|Fluorouracil|fluorouracil|mesh-list
83472292|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
83472293|NCT00004102|Calcium|calcium|mesh-list
83472294|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
83472295|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83472296|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472297|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
83472298|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472299|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472300|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472301|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472302|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
83472303|NCT00004102|Antidotes|antidotes|mesh-ancestor
83472304|NCT00004102|Protective Agents|protective agents|mesh-ancestor
83472305|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
83472306|NCT00004102|Vitamins|vitamins|mesh-ancestor
83472307|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
83472309|NCT00003880|Carboplatin|carboplatin|mesh-list
83472310|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83472311|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472312|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
83472313|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
83472314|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
83472315|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472316|NCT00004108|Exatecan|exatecan|mesh-list
83472317|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83472318|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472319|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472320|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472321|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472322|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
83472323|NCT00004900|Thiotepa|thiotepa|mesh-list
83472324|NCT00004900|Carboplatin|carboplatin|mesh-list
83472325|NCT00004900|Etoposide|etoposide|mesh-list
83472326|NCT00004900|Anastrozole|anastrozole|mesh-list
83472327|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472328|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
83472329|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472330|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472331|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83472332|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
82764806|NCT01020214|Olmesartan|olmesartan|mesh-list
83472333|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472334|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472335|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83472336|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83472337|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83472338|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472339|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472340|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83472341|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83472342|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83472343|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83472344|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
83472345|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83472346|NCT00004114|Cytarabine|cytarabine|mesh-list
83472347|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
83472348|NCT00004114|Fludarabine|fludarabine|mesh-list
83472349|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
83472350|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472351|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
83472352|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472353|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472354|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83472355|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
83472356|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472357|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472358|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83472359|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472360|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
83472361|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
83472362|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472363|NCT00004906|Pamidronate|pamidronate|mesh-list
83472364|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
83472365|NCT00004906|Thiotepa|thiotepa|mesh-list
83472366|NCT00004906|Carboplatin|carboplatin|mesh-list
83472367|NCT00004906|Docetaxel|docetaxel|mesh-list
83472368|NCT00004906|Doxorubicin|doxorubicin|mesh-list
83472369|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83472370|NCT00004906|Etoposide|etoposide|mesh-list
83472371|NCT00004906|Anastrozole|anastrozole|mesh-list
82764933|NCT00935610|Caseins|caseins|mesh-list
83472372|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472373|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
83472374|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472375|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472376|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83472377|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
83472378|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764995|NCT00870038|Paclitaxel|paclitaxel|mesh-list
83472379|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472380|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83472381|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
83472382|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
83472383|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
83472384|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83472385|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83472386|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472387|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472388|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83472389|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82765129|NCT01077427|Gemcitabine|gemcitabine|mesh-list
83472390|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83472391|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83472392|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83472393|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
83472394|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83472395|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83472397|NCT00004918|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83472398|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
83472399|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472400|NCT00004918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83472401|NCT00003892|ISIS 5132|isis 5132|mesh-list
83472402|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472403|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472404|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472405|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
83472406|NCT00004132|Ifosfamide|ifosfamide|mesh-list
83472407|NCT00004132|Etoposide|etoposide|mesh-list
83472408|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472409|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
83472410|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472411|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472412|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83472413|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
83472414|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472415|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472416|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83472417|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83472418|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83472419|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472420|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472421|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83472422|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83472423|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472424|NCT05776940|Dexamethasone|dexamethasone|mesh-list
83472425|NCT05776940|Dexamethasone acetate|dexamethasone acetate|mesh-list
83472426|NCT05776940|Bortezomib|bortezomib|mesh-list
83472427|NCT05776940|Daratumumab|daratumumab|mesh-list
83472428|NCT05776940|BB 1101|bb 1101|mesh-list
83472429|NCT05776940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83472430|NCT05776940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83472431|NCT05776940|Antiemetics|antiemetics|mesh-ancestor
83472432|NCT05776940|Autonomic Agents|autonomic agents|mesh-ancestor
83472433|NCT05776940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472434|NCT05776940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472435|NCT05776940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83472436|NCT05776940|Glucocorticoids|glucocorticoids|mesh-ancestor
83472437|NCT05776940|Hormones|hormones|mesh-ancestor
83472438|NCT05776940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83472439|NCT05776940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83472440|NCT05776940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472441|NCT05776940|Protease Inhibitors|protease inhibitors|mesh-ancestor
83472442|NCT05776940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472443|NCT05776940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472444|NCT05776940|Immunologic Factors|immunologic factors|mesh-ancestor
83472446|NCT05776888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472447|NCT05776862|Ursolic acid|ursolic acid|mesh-list
83472448|NCT05776862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472449|NCT05776862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83472450|NCT05776862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472451|NCT05776862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83472452|NCT05776862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472453|NCT05776862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472454|NCT05776862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83472455|NCT05776862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82765615|NCT00936546|Rituximab|rituximab|mesh-list
83472456|NCT05776862|Analgesics|analgesics|mesh-ancestor
83472457|NCT05776862|Sensory System Agents|sensory system agents|mesh-ancestor
83472458|NCT05776862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472459|NCT05776862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472460|NCT05776862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83472461|NCT05776862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472462|NCT05776758|Cisplatin|cisplatin|mesh-list
83472463|NCT05776758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472464|NCT05776407|Cyclophosphamide|cyclophosphamide|mesh-list
83472465|NCT05776407|Fludarabine|fludarabine|mesh-list
83472466|NCT05776407|Etoposide|etoposide|mesh-list
83472467|NCT05776407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83472468|NCT05776407|Immunologic Factors|immunologic factors|mesh-ancestor
83472469|NCT05776407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472470|NCT05776407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472471|NCT05776407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83472472|NCT05776407|Alkylating Agents|alkylating agents|mesh-ancestor
83472473|NCT05776407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472474|NCT05776407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472475|NCT05776407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83472476|NCT05776407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83490104|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
83472477|NCT05776407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83472478|NCT05776407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472479|NCT05776407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472480|NCT05776212|Fluorides|fluorides|mesh-list
83472481|NCT05776212|Cariostatic Agents|cariostatic agents|mesh-ancestor
83472482|NCT05776212|Protective Agents|protective agents|mesh-ancestor
83472483|NCT05776212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472484|NCT05776186|Bupivacaine|bupivacaine|mesh-list
83472485|NCT05776186|Anesthetics, Local|anesthetics, local|mesh-ancestor
83472486|NCT05776186|Anesthetics|anesthetics|mesh-ancestor
83472487|NCT05776186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83472488|NCT05776186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472489|NCT05776186|Sensory System Agents|sensory system agents|mesh-ancestor
83472490|NCT05776186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472491|NCT05776056|Methylphenidate|methylphenidate|mesh-list
83472492|NCT05776056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83472493|NCT05776056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472494|NCT05776056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83472495|NCT05776056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83472496|NCT05776056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83472497|NCT05776056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472499|NCT05776056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83472500|NCT05776043|Dapagliflozin|dapagliflozin|mesh-list
83472501|NCT05776043|Empagliflozin|empagliflozin|mesh-list
83472502|NCT05776043|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83472503|NCT05776043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472504|NCT05776043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83472505|NCT05776043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472506|NCT05776030|Methamphetamine|methamphetamine|mesh-list
83472507|NCT05776030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83472508|NCT05776030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472509|NCT05776030|Sympathomimetics|sympathomimetics|mesh-ancestor
83472510|NCT05776030|Autonomic Agents|autonomic agents|mesh-ancestor
83472511|NCT05776030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472512|NCT05776030|Dopamine Agents|dopamine agents|mesh-ancestor
83472513|NCT05776030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83472514|NCT05776030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472515|NCT05776030|Adrenergic Agents|adrenergic agents|mesh-ancestor
83472516|NCT05776030|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83472517|NCT05776030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82765844|NCT02542748|Norepinephrine|norepinephrine|mesh-list
83472518|NCT05776030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83472519|NCT05776030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83472520|NCT05775965|Aspirin|aspirin|mesh-list
83472521|NCT05775965|Rivaroxaban|rivaroxaban|mesh-list
83472522|NCT05775965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83472523|NCT05775965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83472524|NCT05775965|Analgesics|analgesics|mesh-ancestor
83472525|NCT05775965|Sensory System Agents|sensory system agents|mesh-ancestor
83472526|NCT05775965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472527|NCT05775965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472528|NCT05775965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83472529|NCT05775965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472530|NCT05775965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83472531|NCT05775965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83472532|NCT05775965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472533|NCT05775965|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83472534|NCT05775965|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83472535|NCT05775965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472536|NCT05775965|Antipyretics|antipyretics|mesh-ancestor
83472537|NCT05775965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83472538|NCT05775965|Antithrombins|antithrombins|mesh-ancestor
83472539|NCT05775965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83472540|NCT05775965|Protease Inhibitors|protease inhibitors|mesh-ancestor
83472541|NCT05775965|Anticoagulants|anticoagulants|mesh-ancestor
83472542|NCT05775939|Deoxyglucose|deoxyglucose|mesh-list
83472543|NCT05775939|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83472544|NCT05775939|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83477254|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83472545|NCT05775939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472546|NCT05775939|Antimetabolites|antimetabolites|mesh-ancestor
83472547|NCT05775939|Antiviral Agents|antiviral agents|mesh-ancestor
83472548|NCT05775939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472549|NCT05775900|Capecitabine|capecitabine|mesh-list
83472550|NCT05775900|Cetuximab|cetuximab|mesh-list
83472551|NCT05775900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472552|NCT05775900|Antimetabolites|antimetabolites|mesh-ancestor
83472553|NCT05775900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472554|NCT05775900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472555|NCT05775900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83472556|NCT05775874|Tislelizumab|tislelizumab|mesh-list
83472557|NCT05775874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83472558|NCT05775874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83472559|NCT05775874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472560|NCT05775874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472561|NCT05775861|Dexmedetomidine|dexmedetomidine|mesh-list
83472562|NCT05775861|Ropivacaine|ropivacaine|mesh-list
83472563|NCT05775861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83472564|NCT05775861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83472565|NCT05775861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472566|NCT05775861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83472567|NCT05775861|Analgesics|analgesics|mesh-ancestor
83472568|NCT05775861|Sensory System Agents|sensory system agents|mesh-ancestor
83472569|NCT05775861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472570|NCT05775861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83472571|NCT05775861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83472572|NCT05775861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83472573|NCT05775861|Adrenergic Agents|adrenergic agents|mesh-ancestor
83472574|NCT05775861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83472575|NCT05775861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472576|NCT05775861|Anesthetics, Local|anesthetics, local|mesh-ancestor
83472579|NCT05775770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83472580|NCT05775770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472581|NCT05775731|Hemostatics|hemostatics|mesh-list
83472582|NCT05775731|Coagulants|coagulants|mesh-ancestor
83472583|NCT05775705|Antibodies|antibodies|mesh-list
83472584|NCT05775705|Immunologic Factors|immunologic factors|mesh-ancestor
83472585|NCT05775705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472586|NCT05775692|Fluconazole|fluconazole|mesh-list
83472587|NCT05775692|Antifungal Agents|antifungal agents|mesh-ancestor
83472588|NCT05775692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472589|NCT05775692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83472590|NCT05775692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83472591|NCT05775692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472592|NCT05775692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472593|NCT05775692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83472594|NCT05775692|Hormone Antagonists|hormone antagonists|mesh-ancestor
83472595|NCT05775692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83472596|NCT05775692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472597|NCT05775692|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83472598|NCT05775692|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83472599|NCT05775536|Aspirin|aspirin|mesh-list
83472600|NCT05775536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83472601|NCT05775536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83472602|NCT05775536|Analgesics|analgesics|mesh-ancestor
83472603|NCT05775536|Sensory System Agents|sensory system agents|mesh-ancestor
83472604|NCT05775536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472605|NCT05775536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472606|NCT05775536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83472607|NCT05775536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472608|NCT05775536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83472609|NCT05775536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83472610|NCT05775536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472611|NCT05775536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83472612|NCT05775536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83472613|NCT05775536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472614|NCT05775536|Antipyretics|antipyretics|mesh-ancestor
83472615|NCT05775159|Bevacizumab|bevacizumab|mesh-list
83472616|NCT05775159|Lenvatinib|lenvatinib|mesh-list
83472617|NCT05775159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83472618|NCT05775159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472619|NCT05775159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83472620|NCT05775159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83472621|NCT05775159|Growth Substances|growth substances|mesh-ancestor
83472622|NCT05775159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472623|NCT05775159|Growth Inhibitors|growth inhibitors|mesh-ancestor
83472624|NCT05775159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83472625|NCT05775159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472626|NCT05775159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472627|NCT00004126|Paclitaxel|paclitaxel|mesh-list
83472628|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
83472629|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83472630|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472631|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
83472632|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
83472633|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
83472634|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472635|NCT05774964|Folic Acid|folic acid|mesh-list
83472636|NCT05774964|Vitamin A|vitamin a|mesh-list
83472637|NCT05774964|Metronidazole|metronidazole|mesh-list
83472638|NCT05774964|Oxaliplatin|oxaliplatin|mesh-list
83472639|NCT05774964|Cetuximab|cetuximab|mesh-list
83472640|NCT05774964|Tegafur|tegafur|mesh-list
83472641|NCT05774964|Vitamins|vitamins|mesh-ancestor
83472642|NCT05774964|Micronutrients|micronutrients|mesh-ancestor
83472643|NCT05774964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472644|NCT05774964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472645|NCT05774964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83472646|NCT05774964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472647|NCT05774964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83472648|NCT05774964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83472649|NCT05774964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83472650|NCT05774964|Hematinics|hematinics|mesh-ancestor
83472651|NCT05774964|Vitamin B Complex|vitamin b complex|mesh-ancestor
83472652|NCT05774964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472653|NCT05774964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472654|NCT05774964|Antimetabolites|antimetabolites|mesh-ancestor
83472656|NCT05774691|Calcium heparin|calcium heparin|mesh-list
83472657|NCT05774691|Protamines|protamines|mesh-list
83472658|NCT05774691|Anticoagulants|anticoagulants|mesh-ancestor
83472659|NCT05774691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83472660|NCT05774691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83472661|NCT05774691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472662|NCT05774691|Heparin Antagonists|heparin antagonists|mesh-ancestor
83472663|NCT05774691|Coagulants|coagulants|mesh-ancestor
83472664|NCT05773976|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83472665|NCT05773976|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83472666|NCT05773963|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83472667|NCT05773963|Lubricant Eye Drops|lubricant eye drops|mesh-list
83472668|NCT05773963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83472669|NCT05773950|Fosaprepitant|fosaprepitant|mesh-list
83472670|NCT05773950|Aprepitant|aprepitant|mesh-list
83472671|NCT05773950|Antiemetics|antiemetics|mesh-ancestor
83472672|NCT05773950|Autonomic Agents|autonomic agents|mesh-ancestor
83472673|NCT05773950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472674|NCT05773950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472675|NCT05773950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83472676|NCT05773950|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83472677|NCT05773950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83472678|NCT05773950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472679|NCT05773222|Apixaban|apixaban|mesh-list
83472680|NCT05773222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83472681|NCT05773222|Antithrombins|antithrombins|mesh-ancestor
83472682|NCT05773222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83472683|NCT05773222|Protease Inhibitors|protease inhibitors|mesh-ancestor
83472684|NCT05773222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472685|NCT05773222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472686|NCT05773222|Anticoagulants|anticoagulants|mesh-ancestor
83472687|NCT05638594|Carboplatin|carboplatin|mesh-list
83472688|NCT05638594|Docetaxel|docetaxel|mesh-list
83472689|NCT05638594|Trastuzumab|trastuzumab|mesh-list
83472690|NCT05638594|Letrozole|letrozole|mesh-list
83472691|NCT05638594|Pertuzumab|pertuzumab|mesh-list
83472692|NCT05638594|Hormones|hormones|mesh-list
83472693|NCT05638594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472694|NCT05638594|Tubulin Modulators|tubulin modulators|mesh-ancestor
83472695|NCT05638594|Antimitotic Agents|antimitotic agents|mesh-ancestor
83472696|NCT05638594|Mitosis Modulators|mitosis modulators|mesh-ancestor
83472697|NCT05638594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477329|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
83472698|NCT05638594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83472699|NCT05638594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83472700|NCT05638594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472701|NCT05638594|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83472702|NCT05638594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83472703|NCT05638594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472704|NCT05638594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83472705|NCT05638594|Hormone Antagonists|hormone antagonists|mesh-ancestor
83472706|NCT05635227|Dexamethasone|dexamethasone|mesh-list
83472707|NCT05635227|Olanzapine|olanzapine|mesh-list
83472708|NCT05635227|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83472709|NCT05635227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83472710|NCT05635227|Antiemetics|antiemetics|mesh-ancestor
83472711|NCT05635227|Autonomic Agents|autonomic agents|mesh-ancestor
83472712|NCT05635227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472713|NCT05635227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472714|NCT05635227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83472715|NCT05635227|Glucocorticoids|glucocorticoids|mesh-ancestor
83472716|NCT05635227|Hormones|hormones|mesh-ancestor
83472717|NCT05635227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83472718|NCT05635227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83472719|NCT05635227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472720|NCT05635227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83472721|NCT05635227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83472722|NCT05635227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83472723|NCT05635227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83472724|NCT05635227|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83472725|NCT05635227|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83472726|NCT05635227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83472727|NCT05635227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472728|NCT05635227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83472729|NCT05635227|Serotonin Agents|serotonin agents|mesh-ancestor
83472730|NCT05607147|Antibodies|antibodies|mesh-list
83472731|NCT05607147|Immunologic Factors|immunologic factors|mesh-ancestor
83472732|NCT05607147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472733|NCT05519254|Lactoferrin|lactoferrin|mesh-list
83472734|NCT05519254|Muramidase|muramidase|mesh-list
82766351|NCT00896402|Iodine|iodine|mesh-list
83472735|NCT05519254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472736|NCT05493475|Fentanyl|fentanyl|mesh-list
83472737|NCT05493475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83472738|NCT05493475|Narcotics|narcotics|mesh-ancestor
83472739|NCT05493475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83472740|NCT05493475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472741|NCT05493475|Analgesics|analgesics|mesh-ancestor
83472742|NCT05493475|Sensory System Agents|sensory system agents|mesh-ancestor
83472743|NCT05493475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472744|NCT05493475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83472745|NCT05493475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83472746|NCT05493475|Anesthetics, General|anesthetics, general|mesh-ancestor
83472747|NCT05493475|Anesthetics|anesthetics|mesh-ancestor
83472748|NCT05463341|Fentanyl|fentanyl|mesh-list
83472749|NCT05463341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83472750|NCT05463341|Narcotics|narcotics|mesh-ancestor
83472751|NCT05463341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83472752|NCT05463341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472754|NCT05463341|Sensory System Agents|sensory system agents|mesh-ancestor
83472755|NCT05463341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472756|NCT05463341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83472757|NCT05463341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83472758|NCT05463341|Anesthetics, General|anesthetics, general|mesh-ancestor
83472759|NCT05463341|Anesthetics|anesthetics|mesh-ancestor
83472760|NCT05446298|Pembrolizumab|pembrolizumab|mesh-list
83472761|NCT05446298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83472762|NCT05446298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472763|NCT05446298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83472764|NCT05446298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472765|NCT05429970|Etodolac|etodolac|mesh-list
83472766|NCT05429970|Propofol|propofol|mesh-list
83472767|NCT05429970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83472768|NCT05429970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83472769|NCT05429970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472770|NCT05429970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83472771|NCT05429970|Anesthetics, General|anesthetics, general|mesh-ancestor
83472772|NCT05429970|Anesthetics|anesthetics|mesh-ancestor
83472773|NCT05429970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83472774|NCT05429970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83472775|NCT05429970|Analgesics|analgesics|mesh-ancestor
83472776|NCT05429970|Sensory System Agents|sensory system agents|mesh-ancestor
83472777|NCT05429970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472778|NCT05429970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83472779|NCT05429970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83472780|NCT05429970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83472781|NCT05429970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83472782|NCT05429970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472783|NCT05429970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472784|NCT05376904|Ropivacaine|ropivacaine|mesh-list
83472785|NCT05376904|Anesthetics, Local|anesthetics, local|mesh-ancestor
83472786|NCT05376904|Anesthetics|anesthetics|mesh-ancestor
83472787|NCT05376904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83472788|NCT05376904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472789|NCT05376904|Sensory System Agents|sensory system agents|mesh-ancestor
83472790|NCT05376904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472791|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
83472792|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83472793|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83472794|NCT05329740|Prednisolone|prednisolone|mesh-list
83472795|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
83472796|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83472797|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
83472798|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83472799|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
83472800|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
83472801|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472802|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472803|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83472804|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
83472805|NCT05329740|Hormones|hormones|mesh-ancestor
83472806|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83472807|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83472808|NCT05329740|Protective Agents|protective agents|mesh-ancestor
83472809|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83472810|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472811|NCT05298670|Metformin|metformin|mesh-list
83472812|NCT05298670|Interferons|interferons|mesh-list
83472813|NCT05298670|Interferon-beta|interferon-beta|mesh-list
83472814|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
83472815|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83472816|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472817|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472818|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
83472819|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472820|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
82766489|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
83472821|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83472822|NCT05297851|Riboflavin|riboflavin|mesh-list
83472823|NCT05297851|Niacinamide|niacinamide|mesh-list
83472824|NCT05297851|Niacin|niacin|mesh-list
83472825|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
83472826|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
83472827|NCT05297851|Vitamins|vitamins|mesh-ancestor
83472828|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
83472829|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472830|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83472831|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
83472832|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83472833|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
83472834|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472835|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83472836|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
83472837|NCT05295589|Paclitaxel|paclitaxel|mesh-list
83472838|NCT05295589|Doxorubicin|doxorubicin|mesh-list
83472839|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83472840|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83472841|NCT05295589|Topotecan|topotecan|mesh-list
83472842|NCT05295589|Olaparib|olaparib|mesh-list
83472843|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83472844|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83472845|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472846|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
83472847|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
83472848|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
83472849|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472850|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83472851|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83472852|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472853|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472854|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83472855|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
83472856|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83472857|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472858|NCT05271318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83472859|NCT05271318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472860|NCT05252598|Psilocybin|psilocybin|mesh-list
83472861|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
83472862|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472863|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82766560|NCT01076491|Mannitol|mannitol|mesh-list
83472864|NCT05223829|Brexanolone|brexanolone|mesh-list
83472865|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
83472866|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83472867|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472868|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472869|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
83472870|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
83472871|NCT05180006|Bevacizumab|bevacizumab|mesh-list
83472872|NCT05180006|Trastuzumab|trastuzumab|mesh-list
83472873|NCT05180006|Atezolizumab|atezolizumab|mesh-list
83472874|NCT05180006|Pertuzumab|pertuzumab|mesh-list
83472875|NCT05180006|Ipatasertib|ipatasertib|mesh-list
83472876|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83472877|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472878|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83472879|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83472880|NCT05180006|Growth Substances|growth substances|mesh-ancestor
83472881|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472882|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
83472883|NCT05180006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83472884|NCT05180006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472885|NCT05180006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83472886|NCT05180006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472887|NCT05148884|Befiradol|befiradol|mesh-list
83472888|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83472889|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83472890|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
83472891|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83472892|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472893|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472894|NCT05144854|Capecitabine|capecitabine|mesh-list
83472895|NCT05144854|Tegafur|tegafur|mesh-list
83472896|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
83472897|NCT05144854|Nivolumab|nivolumab|mesh-list
83472898|NCT05144854|Ipilimumab|ipilimumab|mesh-list
83472899|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83472900|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
83472901|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472902|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472903|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83472904|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83472905|NCT05099666|Doxorubicin|doxorubicin|mesh-list
83472906|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83472907|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472908|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83472909|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83472910|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472911|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472912|NCT05042817|Sufentanil|sufentanil|mesh-list
83472913|NCT05042817|Morphine|morphine|mesh-list
83472914|NCT05042817|Prilocaine|prilocaine|mesh-list
83472915|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83472916|NCT05042817|Narcotics|narcotics|mesh-ancestor
83472917|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83472918|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472919|NCT05042817|Analgesics|analgesics|mesh-ancestor
83472920|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
83472921|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472922|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83472923|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83472924|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
83472925|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
83472926|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
83472927|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83472928|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
83472929|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83472930|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472931|NCT05042505|Incretins|incretins|mesh-ancestor
83472932|NCT05042505|Hormones|hormones|mesh-ancestor
83472933|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83472934|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83472935|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
83472936|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472937|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472938|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83472939|NCT04914234|Metoprolol|metoprolol|mesh-list
83472940|NCT04914234|Atenolol|atenolol|mesh-list
83472941|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83472942|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83472943|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
83472944|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
82766740|NCT00944424|Vitamin D|vitamin d|mesh-list
83472945|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472946|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472947|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83472948|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83472950|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
83472951|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83472952|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472953|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83472954|NCT04895566|Antibodies|antibodies|mesh-list
83472956|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83472957|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
83472958|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472959|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472960|NCT04820309|Xanomeline|xanomeline|mesh-list
83472961|NCT04820309|Trospium chloride|trospium chloride|mesh-list
83472962|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
83472963|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
83472964|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83472965|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472966|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83472967|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83472968|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
83472969|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83472970|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472971|NCT04820309|Urological Agents|urological agents|mesh-ancestor
83472972|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83472973|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83472974|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83472975|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83472976|NCT04779320|Vedolizumab|vedolizumab|mesh-list
83472977|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83472978|NCT04779307|Vedolizumab|vedolizumab|mesh-list
83472979|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83472980|NCT04762199|Osimertinib|osimertinib|mesh-list
83472981|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472982|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83472983|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472984|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472985|NCT04737187|Trifluridine|trifluridine|mesh-list
83472986|NCT04737187|Bevacizumab|bevacizumab|mesh-list
83472987|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83472988|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83472989|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83472990|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83472991|NCT04737187|Growth Substances|growth substances|mesh-ancestor
83472992|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83472993|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
83472994|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
83472995|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472996|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
83472997|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83472998|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
83472999|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83473000|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83477330|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83473001|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473002|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
83473003|NCT04733157|Coagulants|coagulants|mesh-ancestor
83473004|NCT04723147|Levodopa|levodopa|mesh-list
83473005|NCT04723147|Carbidopa|carbidopa|mesh-list
83473006|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83473007|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83473008|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83473009|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
83473010|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83473011|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473012|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473013|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83473014|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473015|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83473016|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
83473017|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
83473019|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
83473020|NCT04662710|Capecitabine|capecitabine|mesh-list
83473021|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
83473022|NCT04662710|Lenvatinib|lenvatinib|mesh-list
83473023|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
83473024|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473025|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473026|NCT04662710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83473027|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473028|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473029|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
83473030|NCT04662710|Antidotes|antidotes|mesh-ancestor
83473031|NCT04662710|Protective Agents|protective agents|mesh-ancestor
83473032|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473033|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
83473034|NCT04662710|Vitamins|vitamins|mesh-ancestor
83473035|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
83473036|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83473037|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473038|NCT04659174|Xanomeline|xanomeline|mesh-list
83473039|NCT04659174|Trospium chloride|trospium chloride|mesh-list
83473040|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
83473041|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
83473042|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473043|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473044|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83473045|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83473046|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
83473047|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83473048|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473049|NCT04659174|Urological Agents|urological agents|mesh-ancestor
83473051|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83473052|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83473053|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83473054|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
83473055|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83473056|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473057|NCT04643405|Paclitaxel|paclitaxel|mesh-list
83473058|NCT04643405|Gemcitabine|gemcitabine|mesh-list
83473059|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473060|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473061|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473062|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473063|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473064|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473065|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473066|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
83473067|NCT04633122|Sunitinib|sunitinib|mesh-list
83473068|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473069|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83473070|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83473071|NCT04633122|Growth Substances|growth substances|mesh-ancestor
83473072|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473073|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
83473074|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83473075|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473076|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473077|NCT04569747|Tamoxifen|tamoxifen|mesh-list
83473078|NCT04569747|Trastuzumab|trastuzumab|mesh-list
83473079|NCT04569747|Pertuzumab|pertuzumab|mesh-list
83473080|NCT04569747|Letrozole|letrozole|mesh-list
83473081|NCT04569747|Anastrozole|anastrozole|mesh-list
83473082|NCT04569747|Leuprolide|leuprolide|mesh-list
83473083|NCT04569747|Exemestane|exemestane|mesh-list
83473084|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473085|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473086|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83473087|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83473088|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473089|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473090|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83473091|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
83473092|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473093|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473094|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83473095|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83473096|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83473097|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83473098|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83473099|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
83473100|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83473101|NCT04543942|Ethanol|ethanol|mesh-list
83473102|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83473103|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473104|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83473105|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473106|NCT04538950|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
82767295|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
83473107|NCT04538950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473108|NCT04531046|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83473109|NCT04531046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473110|NCT04531046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473112|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
83473113|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
83473114|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83473115|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473116|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
83473117|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473118|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83473119|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83473120|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83473121|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83473122|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473123|NCT04439279|Trametinib|trametinib|mesh-list
83473124|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83473125|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473126|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83473127|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473128|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473129|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83473131|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473132|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83473133|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
83473134|NCT04439201|Palbociclib|palbociclib|mesh-list
83473135|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473136|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83473137|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473138|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473139|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
83473140|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82767408|NCT02577965|Everolimus|everolimus|mesh-list
83473141|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473142|NCT04273165|Etravirine|etravirine|mesh-list
83473143|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83473144|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83473145|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473146|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473147|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
83473148|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473149|NCT04236414|Olaparib|olaparib|mesh-list
83473150|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83473151|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473152|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473153|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473154|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83473155|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83473156|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473157|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
83473158|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473159|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473160|NCT04140526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83473161|NCT04140526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473162|NCT04041128|Olaparib|olaparib|mesh-list
83473163|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83473164|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477405|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83473165|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473166|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473167|NCT04030962|Lifitegrast|lifitegrast|mesh-list
83473168|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83473169|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83473170|NCT03951753|Tirzepatide|tirzepatide|mesh-list
83473171|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83473172|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473173|NCT03951753|Incretins|incretins|mesh-ancestor
83473174|NCT03951753|Hormones|hormones|mesh-ancestor
83473175|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473176|NCT03947671|Acetaminophen|acetaminophen|mesh-list
83473177|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83473178|NCT03947671|Analgesics|analgesics|mesh-ancestor
83473179|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
83473180|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473181|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473182|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
83473183|NCT03941964|Azacitidine|azacitidine|mesh-list
83473185|NCT03941964|Venetoclax|venetoclax|mesh-list
83473186|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473187|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
83473188|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473189|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473190|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473191|NCT03837509|Daratumumab|daratumumab|mesh-list
83473192|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473193|NCT03808077|Rocuronium|rocuronium|mesh-list
83473194|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83473195|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83473196|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83473197|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473198|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473200|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
83473201|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473202|NCT03603184|Paclitaxel|paclitaxel|mesh-list
83473203|NCT03603184|Carboplatin|carboplatin|mesh-list
83473204|NCT03603184|Atezolizumab|atezolizumab|mesh-list
83473205|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473206|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473207|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473208|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473209|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473210|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473211|NCT03603184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83473212|NCT03603184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473213|NCT03586999|Nivolumab|nivolumab|mesh-list
83473214|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473215|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473216|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83473217|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473218|NCT03507452|BAY 2287411|bay 2287411|mesh-list
83473219|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83473220|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473221|NCT03493490|Diclofenac|diclofenac|mesh-list
83473222|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83473223|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83473224|NCT03493490|Analgesics|analgesics|mesh-ancestor
83473225|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
83473226|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473227|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473228|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83473229|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83473230|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83473231|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473232|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767618|NCT02577497|Hormones|hormones|mesh-ancestor
83473234|NCT03414658|Avelumab|avelumab|mesh-list
83473235|NCT03414658|Vinorelbine|vinorelbine|mesh-list
83473236|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473237|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473238|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473239|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473240|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473241|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473242|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473243|NCT03377491|Paclitaxel|paclitaxel|mesh-list
83473244|NCT03377491|Gemcitabine|gemcitabine|mesh-list
83473245|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473246|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473247|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473248|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473249|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473250|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473251|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473252|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
83473253|NCT03298087|Leuprolide|leuprolide|mesh-list
83473254|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83473255|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
83473256|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83473257|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473258|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83473259|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473261|NCT03297359|Tinzaparin|tinzaparin|mesh-list
83473262|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83473263|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
83473264|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83473265|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83473266|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473267|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
83473268|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473269|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473270|NCT03189719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83473271|NCT03189719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473272|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
83473273|NCT03126630|Maytansine|maytansine|mesh-list
83473274|NCT03126630|Anetumab ravtansine|anetumab ravtansine|mesh-list
83473275|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473276|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473277|NCT03126630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83473278|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473279|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473280|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473281|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473282|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473283|NCT03126630|Immunoconjugates|immunoconjugates|mesh-ancestor
83473284|NCT03126630|Immunologic Factors|immunologic factors|mesh-ancestor
83473285|NCT03126630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473286|NCT02889081|Vitamin D|vitamin d|mesh-list
83473287|NCT02889081|Vitamins|vitamins|mesh-ancestor
83473288|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
83473289|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473290|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83473291|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
83473292|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83473293|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83473294|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473295|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83473296|NCT02856594|Analgesics|analgesics|mesh-ancestor
83473297|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
83473298|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473299|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83473300|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83473301|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83473302|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
83473303|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83473304|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473305|NCT02840539|Cytarabine|cytarabine|mesh-list
83473306|NCT02840539|Dexamethasone|dexamethasone|mesh-list
83473307|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
83473308|NCT02840539|Bortezomib|bortezomib|mesh-list
83473309|NCT02840539|BB 1101|bb 1101|mesh-list
83473310|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83473311|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
83473312|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
83473313|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473314|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473315|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83473316|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
83473317|NCT02840539|Hormones|hormones|mesh-ancestor
83473318|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473319|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83473320|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473321|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
83473322|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473323|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473324|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473325|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
83473326|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
83473327|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473328|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473329|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
83473330|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
83490178|NCT03637400|Trimethoprim|trimethoprim|mesh-list
83473331|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473332|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473333|NCT02453594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83473334|NCT02453594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473335|NCT02342782|Cytarabine|cytarabine|mesh-list
83473336|NCT02342782|Etoposide|etoposide|mesh-list
83473337|NCT02342782|Melphalan|melphalan|mesh-list
83473338|NCT02342782|Carmustine|carmustine|mesh-list
83473339|NCT02342782|Basiliximab|basiliximab|mesh-list
83473340|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473341|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473342|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83473343|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473344|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473345|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473346|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473347|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
83473348|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
83473349|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473350|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82767960|NCT00709553|Midazolam|midazolam|mesh-list
83473351|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
83473352|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473353|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83473354|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
83473355|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83473356|NCT02291055|Durvalumab|durvalumab|mesh-list
83473357|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473358|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473359|NCT02112864|Dexamethasone|dexamethasone|mesh-list
83473360|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83473361|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
83473362|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
83473363|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473364|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473365|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83473366|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
83473367|NCT02112864|Hormones|hormones|mesh-ancestor
83473368|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473369|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83473370|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473371|NCT02106988|Dexamethasone|dexamethasone|mesh-list
83473372|NCT02106988|Carboplatin|carboplatin|mesh-list
83473374|NCT02106988|Ifosfamide|ifosfamide|mesh-list
83473375|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
83473376|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83473377|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
83473378|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
83473379|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473380|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473381|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83473382|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
83473383|NCT02106988|Hormones|hormones|mesh-ancestor
83473384|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473385|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83473386|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473387|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473388|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83473389|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473390|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473391|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473392|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83473393|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
83473394|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83473395|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83473396|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473397|NCT00723697|Buprenorphine|buprenorphine|mesh-list
83473398|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83473399|NCT00723697|Narcotics|narcotics|mesh-ancestor
83473400|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83473401|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473402|NCT00723697|Analgesics|analgesics|mesh-ancestor
83473403|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
83473404|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473405|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83473406|NCT00684073|Buprenorphine|buprenorphine|mesh-list
83473407|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83473409|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83473410|NCT00684073|Narcotics|narcotics|mesh-ancestor
83473411|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83473412|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473413|NCT00684073|Analgesics|analgesics|mesh-ancestor
83473414|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
83473415|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473416|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83473417|NCT00603109|Rimonabant|rimonabant|mesh-list
83473418|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83473419|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83473420|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83473421|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83473422|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473423|NCT00603109|Hormones|hormones|mesh-ancestor
83473424|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473425|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473426|NCT00199095|Cytarabine|cytarabine|mesh-list
83473427|NCT00199095|Dexamethasone|dexamethasone|mesh-list
83473428|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
83473429|NCT00199095|Ifosfamide|ifosfamide|mesh-list
83473430|NCT00199095|Methotrexate|methotrexate|mesh-list
83473431|NCT00199095|Vincristine|vincristine|mesh-list
83473432|NCT00199095|Doxorubicin|doxorubicin|mesh-list
83473433|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
83473434|NCT00199095|Idarubicin|idarubicin|mesh-list
83473435|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473436|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
83473437|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473438|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83473439|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83473440|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
83473441|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473442|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473443|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83473444|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83473445|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
83473446|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
83473447|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473448|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83473449|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
83473450|NCT00199095|Hormones|hormones|mesh-ancestor
83473451|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473452|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83473453|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83473454|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
83473455|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83473456|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473457|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
83473458|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
83473459|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473460|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83473461|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83473462|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
83473463|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473464|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473465|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473466|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473467|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473468|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83473469|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83473470|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473471|NCT00199056|Cytarabine|cytarabine|mesh-list
83473472|NCT00199056|Dexamethasone|dexamethasone|mesh-list
83473473|NCT00199056|Prednisolone|prednisolone|mesh-list
83473474|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
83473475|NCT00199056|Ifosfamide|ifosfamide|mesh-list
83473476|NCT00199056|Methotrexate|methotrexate|mesh-list
83473477|NCT00199056|Fludarabine|fludarabine|mesh-list
83473478|NCT00199056|Vincristine|vincristine|mesh-list
83473479|NCT00199056|Doxorubicin|doxorubicin|mesh-list
83473480|NCT00199056|Daunorubicin|daunorubicin|mesh-list
83473481|NCT00199056|Asparaginase|asparaginase|mesh-list
83473482|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
83473483|NCT00199056|Idarubicin|idarubicin|mesh-list
83473484|NCT00199056|Thioguanine|thioguanine|mesh-list
83473485|NCT00199056|Vindesine|vindesine|mesh-list
83473486|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473487|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
83473488|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473489|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83473490|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83473491|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
83473492|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473493|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473494|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83473495|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83473496|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
83473497|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
83473498|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473499|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83473500|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
83473501|NCT00199056|Hormones|hormones|mesh-ancestor
83473502|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473503|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83473504|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83473505|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
83473506|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83473507|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473508|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
83473509|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
83473510|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473511|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83473512|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83473513|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
83473514|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473515|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473516|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473517|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473518|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473519|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83473520|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83473521|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473522|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
83473523|NCT00199030|Cladribine|cladribine|mesh-list
83473524|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473525|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473526|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473527|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
83473528|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473529|NCT00198978|Cytarabine|cytarabine|mesh-list
83473530|NCT00198978|Dexamethasone|dexamethasone|mesh-list
83473531|NCT00198978|Prednisolone|prednisolone|mesh-list
83473532|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
83473533|NCT00198978|Rituximab|rituximab|mesh-list
83473534|NCT00198978|Methotrexate|methotrexate|mesh-list
83473535|NCT00198978|Vincristine|vincristine|mesh-list
83473536|NCT00198978|Asparaginase|asparaginase|mesh-list
83473537|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
83473538|NCT00198978|Idarubicin|idarubicin|mesh-list
83473539|NCT00198978|Lenograstim|lenograstim|mesh-list
83473540|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473541|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
83473542|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473543|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83473544|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83473545|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
83473546|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473547|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473548|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83473549|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473550|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83473551|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
83473552|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
83473553|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473554|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83473555|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
83473557|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473558|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83473559|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83473560|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
83473561|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83473562|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473563|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
83473564|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
83473565|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473566|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83473567|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83473568|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
83473569|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473570|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473571|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473572|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473573|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473574|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83473575|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83473576|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83473577|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473578|NCT00109395|Midazolam|midazolam|mesh-list
83473579|NCT00109395|Lorazepam|lorazepam|mesh-list
83473580|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83473581|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83473582|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83473583|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473584|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83473585|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83473586|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83473587|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83473588|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
83473589|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
83473590|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
83473591|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
83473592|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83473593|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473594|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
83473595|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
83473596|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
83473597|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473598|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83473599|NCT01215643|Ribavirin|ribavirin|mesh-list
83473600|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83473601|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
83473602|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473603|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
83473604|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473605|NCT00004924|Paclitaxel|paclitaxel|mesh-list
83473606|NCT00004924|Irinotecan|irinotecan|mesh-list
83473607|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473608|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473609|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473610|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473611|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473612|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473613|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83473614|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473615|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473616|NCT00004144|Gemcitabine|gemcitabine|mesh-list
83473617|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
83473618|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473619|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
83473620|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473621|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473622|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83473623|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
83473624|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473625|NCT00004150|Leucovorin|leucovorin|mesh-list
83473626|NCT00004150|Fluorouracil|fluorouracil|mesh-list
83473627|NCT00004150|Calcium|calcium|mesh-list
83473628|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
83473629|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83473630|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473631|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
83473632|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473633|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473634|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473635|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473636|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
83473638|NCT00004150|Protective Agents|protective agents|mesh-ancestor
83473639|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
83473640|NCT00004150|Vitamins|vitamins|mesh-ancestor
83473641|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
83473642|NCT00004930|Doxorubicin|doxorubicin|mesh-list
83473643|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83473644|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83473645|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473646|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83473647|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473648|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473649|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473650|NCT00003928|Gemcitabine|gemcitabine|mesh-list
83473651|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473652|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473653|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
83473654|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473655|NCT00004162|Doxorubicin|doxorubicin|mesh-list
83473656|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83473657|NCT00004162|Methotrexate|methotrexate|mesh-list
83473658|NCT00004162|Vincristine|vincristine|mesh-list
83473659|NCT00004162|Sargramostim|sargramostim|mesh-list
83473660|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83473661|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473662|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83473663|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473664|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473665|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473666|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83473667|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
83473668|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83473669|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473670|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473671|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
83473672|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
83473673|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83473674|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473675|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
83473676|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83473677|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83473678|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473679|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473680|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473681|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473682|NCT00004984|Insulin|insulin|mesh-list
83473683|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83473684|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83473685|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473686|NCT00004174|Paclitaxel|paclitaxel|mesh-list
83473687|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
83473688|NCT00004174|Thiotepa|thiotepa|mesh-list
83473689|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473690|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473691|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473692|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473693|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473694|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473695|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473696|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
83473697|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473698|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83473699|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83473700|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
83473701|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82768599|NCT04036526|Vaccines|vaccines|mesh-list
83473702|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83473703|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83473704|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83473705|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83473706|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473707|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83473708|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83473709|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83473710|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83473711|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
83473712|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83473713|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473714|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83473715|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83473717|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83473718|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83473719|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
83473720|NCT00004990|Dexamethasone|dexamethasone|mesh-list
83473721|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83473722|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
83473723|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
83473724|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473725|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768644|NCT05300334|Adenosine|adenosine|mesh-list
83473726|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83473727|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
83473728|NCT00004990|Hormones|hormones|mesh-ancestor
83473729|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473730|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83473731|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473732|NCT01216735|Fluticasone|fluticasone|mesh-list
83473733|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83473734|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83473735|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
83473736|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473737|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473738|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83473739|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
83473740|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
83473741|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83473742|NCT00004186|Carboplatin|carboplatin|mesh-list
83473743|NCT00004186|Etoposide|etoposide|mesh-list
83473744|NCT00004186|Topotecan|topotecan|mesh-list
83473745|NCT00004186|Ifosfamide|ifosfamide|mesh-list
83473746|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473747|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473748|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83473749|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473750|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473751|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473752|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83473753|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83473754|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
83473755|NCT00004192|Cytarabine|cytarabine|mesh-list
82768689|NCT01009593|Sorafenib|sorafenib|mesh-list
83473756|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
83473757|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83473758|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83473759|NCT00004192|Prednisolone|prednisolone|mesh-list
83473760|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
83473761|NCT00004192|Etoposide|etoposide|mesh-list
83473762|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83473763|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
83473764|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473765|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473766|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83473767|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473768|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473769|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473770|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473771|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
83473772|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
83473773|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473774|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473775|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
83473776|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768740|NCT05352126|Disinfectants|disinfectants|mesh-list
83473777|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83473778|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
83473779|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
83473780|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83473781|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83473782|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
83473783|NCT00004192|Hormones|hormones|mesh-ancestor
83473784|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473785|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83473786|NCT00004192|Protective Agents|protective agents|mesh-ancestor
83473787|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83473788|NCT00005002|Lamivudine|lamivudine|mesh-list
83473789|NCT00005002|Zidovudine|zidovudine|mesh-list
83473790|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83473791|NCT00005002|Nelfinavir|nelfinavir|mesh-list
83473792|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83473793|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83473794|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473795|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473796|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
83473797|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473798|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83473799|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83473800|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
83473801|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83473802|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83473803|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
83473804|NCT00004198|Sargramostim|sargramostim|mesh-list
83473805|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83473806|NCT00004198|Vaccines|vaccines|mesh-list
83473807|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
83473808|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473809|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83473810|NCT01264705|Sorafenib|sorafenib|mesh-list
83473811|NCT01264705|Bavituximab|bavituximab|mesh-list
83473812|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83473813|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473814|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83473815|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473816|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473817|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83473818|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
83473819|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473820|NCT00004204|Temozolomide|temozolomide|mesh-list
83473821|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83473822|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
83473823|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473824|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473825|NCT01217515|Diltiazem|diltiazem|mesh-list
83473826|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83473827|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83473828|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83473829|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473830|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83473831|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473832|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
82768913|NCT04070495|Rifampin|rifampin|mesh-list
83473833|NCT00005014|Risperidone|risperidone|mesh-list
83473834|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83473835|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
83473836|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83473837|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473838|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473839|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83473840|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83473841|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83473842|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83473843|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83473844|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
83473845|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83473846|NCT03009799|Laxatives|laxatives|mesh-ancestor
83473847|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83473848|NCT00005026|Paclitaxel|paclitaxel|mesh-list
83473849|NCT00005026|Carboplatin|carboplatin|mesh-list
83473850|NCT00005026|Topotecan|topotecan|mesh-list
83473851|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473852|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473853|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473854|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473855|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473856|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473857|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83473858|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473859|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473860|NCT00016718|Emtricitabine|emtricitabine|mesh-list
83473861|NCT00016718|Efavirenz|efavirenz|mesh-list
83473862|NCT00016718|Didanosine|didanosine|mesh-list
83473863|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
83473864|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473865|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83490179|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
83473866|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83473867|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473868|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473869|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83473870|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83473871|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83473872|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83473873|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83473874|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83473875|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83473876|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83473877|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
83473878|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
83473879|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
83473880|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83473881|NCT00004216|Cefixime|cefixime|mesh-list
83473882|NCT00004216|Trimethoprim|trimethoprim|mesh-list
83473883|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
83473884|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83473885|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473886|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83473887|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473888|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473889|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473890|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473891|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83473892|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83473893|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83473894|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
83473895|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83473896|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83473897|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83473898|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83473899|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83473900|NCT00005032|Paclitaxel|paclitaxel|mesh-list
83473901|NCT00005032|Oblimersen|oblimersen|mesh-list
83473902|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473903|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473904|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473905|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473906|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473907|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473908|NCT00005038|Aldesleukin|aldesleukin|mesh-list
83473909|NCT00005038|Histamine|histamine|mesh-list
83473910|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
83473911|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473912|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83473913|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83473914|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
83473915|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473916|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
83473917|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
83473918|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83473919|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769155|NCT01026376|Decitabine|decitabine|mesh-list
83473920|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473921|NCT00019682|Aldesleukin|aldesleukin|mesh-list
83473922|NCT00019682|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83473923|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473924|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83473925|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83473926|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
83473927|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473928|NCT00019682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83473929|NCT00019682|Immunologic Factors|immunologic factors|mesh-ancestor
83473930|NCT00019682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473931|NCT00005050|Fluorouracil|fluorouracil|mesh-list
83473932|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
83473933|NCT00005050|Eniluracil|eniluracil|mesh-list
83473934|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
83473935|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473936|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473937|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473938|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473939|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
83473940|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473941|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473942|NCT00005578|Prednisone|prednisone|mesh-list
83473943|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
83473944|NCT00005578|Doxorubicin|doxorubicin|mesh-list
83473945|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83473946|NCT00005578|Etoposide|etoposide|mesh-list
83473947|NCT00005578|Vincristine|vincristine|mesh-list
83473948|NCT00005578|Bleomycin|bleomycin|mesh-list
83473949|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
83473950|NCT00005578|Razoxane|razoxane|mesh-list
83473951|NCT00005578|Lenograstim|lenograstim|mesh-list
83473952|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473953|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
83473954|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473955|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83473956|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83473957|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
83473958|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473959|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473960|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83473961|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83473962|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83473963|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83473964|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473965|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83473966|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
83473967|NCT00005578|Hormones|hormones|mesh-ancestor
83490484|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
83473968|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83473969|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83473970|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83473971|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83473972|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
83473973|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
83473974|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
83473975|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83473976|NCT00005578|Protective Agents|protective agents|mesh-ancestor
83473977|NCT00022490|Cytarabine|cytarabine|mesh-list
83473978|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
83473979|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83473980|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
83473981|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473982|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473983|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
83473984|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473985|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83473986|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
83473987|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83473988|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83473989|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473990|NCT00386230|Zidovudine|zidovudine|mesh-list
83473991|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473992|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
83473993|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83473994|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83473995|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83473996|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
83473997|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83473998|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83473999|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83474000|NCT00097448|Prednisone|prednisone|mesh-list
83474001|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
83474002|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83474003|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83474004|NCT00097448|Prednisolone|prednisolone|mesh-list
83474005|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
83474006|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83474007|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
83474008|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83474010|NCT00097448|Hormones|hormones|mesh-ancestor
83474011|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83474012|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474013|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83474014|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474015|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
83474016|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
83474017|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474018|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83474019|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83474020|NCT00097448|Protective Agents|protective agents|mesh-ancestor
83474021|NCT00004246|Fludarabine|fludarabine|mesh-list
83474022|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
83474023|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474024|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83474025|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
83477551|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474026|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474027|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474028|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
83474029|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474031|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83474032|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474033|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
83474034|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83474035|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
83474036|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474037|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474038|NCT00004252|Leucovorin|leucovorin|mesh-list
83474039|NCT00004252|Fluorouracil|fluorouracil|mesh-list
83474040|NCT00004252|Calcium|calcium|mesh-list
83474041|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
83474042|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83474043|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474044|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
83474045|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474046|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83474047|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474048|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474049|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
83474050|NCT00004252|Antidotes|antidotes|mesh-ancestor
83474051|NCT00004252|Protective Agents|protective agents|mesh-ancestor
83474052|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
83474053|NCT00004252|Vitamins|vitamins|mesh-ancestor
83474054|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
83474055|NCT00005590|Levofloxacin|levofloxacin|mesh-list
83474056|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83474057|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474058|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83474059|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83474060|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83474061|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474062|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474063|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474064|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83474065|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83474066|NCT00005596|Leucovorin|leucovorin|mesh-list
83474067|NCT00005596|Cytarabine|cytarabine|mesh-list
83474068|NCT00005596|Dexamethasone|dexamethasone|mesh-list
83474069|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
83474070|NCT00005596|Methotrexate|methotrexate|mesh-list
83474071|NCT00005596|Vincristine|vincristine|mesh-list
83474072|NCT00005596|Daunorubicin|daunorubicin|mesh-list
83474073|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
83474074|NCT00005596|Pegaspargase|pegaspargase|mesh-list
83474075|NCT00005596|Thioguanine|thioguanine|mesh-list
83474076|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
83474077|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474078|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
83474079|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474080|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83474081|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83474082|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
83474083|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474084|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474085|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83474086|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83474087|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
83474088|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
83474089|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474090|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83474091|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
83474092|NCT00005596|Hormones|hormones|mesh-ancestor
83474093|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83474094|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83474095|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83474096|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
83474097|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83474098|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83474100|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
83474101|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474102|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83474103|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83474104|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
83474105|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474106|NCT00005596|Antidotes|antidotes|mesh-ancestor
83474107|NCT00005596|Protective Agents|protective agents|mesh-ancestor
83474108|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
83474109|NCT00005596|Vitamins|vitamins|mesh-ancestor
83474110|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
83474111|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83474112|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
83474113|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
83474114|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
83474115|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83474116|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83474117|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83474118|NCT00005068|Leucovorin|leucovorin|mesh-list
83474119|NCT00005068|Fluorouracil|fluorouracil|mesh-list
83474120|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
83474121|NCT00005068|Irinotecan|irinotecan|mesh-list
83474122|NCT00005068|Calcium|calcium|mesh-list
83474123|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
83474124|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83474125|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474126|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
83474127|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474128|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83474129|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474130|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474131|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
83474132|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83474133|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83474134|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474135|NCT00005068|Antidotes|antidotes|mesh-ancestor
83474136|NCT00005068|Protective Agents|protective agents|mesh-ancestor
83474137|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
83474138|NCT00005068|Vitamins|vitamins|mesh-ancestor
83474139|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
83474140|NCT00004264|Docetaxel|docetaxel|mesh-list
83474141|NCT00004264|Amifostine|amifostine|mesh-list
83474142|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474143|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
83474144|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
83474145|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
83474146|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474147|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83474148|NCT00004264|Protective Agents|protective agents|mesh-ancestor
83474149|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474150|NCT00005074|Alvocidib|alvocidib|mesh-list
83474151|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474152|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
82769794|NCT01074697|Dexamethasone|dexamethasone|mesh-list
83474153|NCT00005074|Growth Substances|growth substances|mesh-ancestor
83474154|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474155|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83474156|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474157|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474158|NCT00005602|Carboplatin|carboplatin|mesh-list
83474159|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474160|NCT00004276|Thalidomide|thalidomide|mesh-list
83474161|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474162|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
83474163|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474164|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
83474165|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83474166|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474167|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83474168|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83474170|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
83474171|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474172|NCT00004288|Olsalazine|olsalazine|mesh-list
83474173|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83474174|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83474175|NCT00004288|Analgesics|analgesics|mesh-ancestor
83474176|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
83474177|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474178|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474179|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83474180|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83474181|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83474182|NCT00005086|Gemcitabine|gemcitabine|mesh-list
83474183|NCT00005086|Docetaxel|docetaxel|mesh-list
83474184|NCT00005086|Methotrexate|methotrexate|mesh-list
83474185|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769916|NCT00725777|Artemether|artemether|mesh-list
83474186|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83474187|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
83474188|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474189|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
83474190|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
83474191|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
83474192|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83474193|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
83474194|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83474195|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474196|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
83474197|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474198|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83474199|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474200|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
83474201|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83474202|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83474203|NCT00005614|Gemcitabine|gemcitabine|mesh-list
83474204|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83474205|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
83474206|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474207|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474208|NCT00101036|Lapatinib|lapatinib|mesh-list
83474209|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474210|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83474211|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474212|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474213|NCT00004300|Bromocriptine|bromocriptine|mesh-list
83474214|NCT00004300|Sertraline|sertraline|mesh-list
83474215|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
83474216|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83474217|NCT00004300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83474218|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83474219|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83474220|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474221|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474222|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
83474223|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474224|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83474225|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83474226|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
83474227|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83474228|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
83474229|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
83474230|NCT00005626|Irinotecan|irinotecan|mesh-list
83474231|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83474232|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83474233|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474234|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474235|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474236|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
83474237|NCT00005092|Thiotepa|thiotepa|mesh-list
83474238|NCT00005092|Methoxsalen|methoxsalen|mesh-list
83474239|NCT00005092|Furocoumarins|furocoumarins|mesh-list
83474240|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474241|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
83474242|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474243|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83474244|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83474245|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
83474246|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474247|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474248|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83474249|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83474250|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
83474251|NCT00005638|Irinotecan|irinotecan|mesh-list
83474252|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474253|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83474254|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83474255|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474256|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474257|NCT00005104|Metformin|metformin|mesh-list
83474258|NCT00005104|Clomiphene|clomiphene|mesh-list
83474259|NCT00005104|Enclomiphene|enclomiphene|mesh-list
83474260|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
83474261|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83474262|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474263|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83474264|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
83474265|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83474266|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83474267|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
83474268|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83474269|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83474270|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83474271|NCT00005110|Albuterol|albuterol|mesh-list
83474272|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83474273|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83474274|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
83474275|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474276|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474277|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83474278|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
83474279|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83474280|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83474281|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83474282|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
83474283|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474284|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474285|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
83474286|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83474287|NCT00004330|Hormones|hormones|mesh-list
83474288|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83474289|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474290|NCT00005668|Itraconazole|itraconazole|mesh-list
83474291|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
83474292|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474293|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83474294|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83474295|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474296|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474297|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83474298|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
83474299|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83474300|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474301|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83474302|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
83474303|NCT00030992|Promethazine|promethazine|mesh-list
83474304|NCT00030992|Ranitidine|ranitidine|mesh-list
83474305|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83474306|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83474307|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83474308|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83474309|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474310|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
83474311|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
83474312|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
83474313|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474314|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
83474315|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
83474316|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83474317|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83474318|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
83474319|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
83474320|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477627|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
83474321|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474322|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83474323|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
83474324|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
83474325|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83474326|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83474328|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83474329|NCT00004360|Diuretics|diuretics|mesh-ancestor
83474330|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
83474331|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474332|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83474333|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83474334|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474335|NCT00385450|Nelfinavir|nelfinavir|mesh-list
83474336|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83474337|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83474338|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
83474339|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474340|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474341|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83474342|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83474343|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
83474344|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474345|NCT00004390|Morphine|morphine|mesh-list
83474346|NCT00004390|Methadone|methadone|mesh-list
83474347|NCT00004390|Nortriptyline|nortriptyline|mesh-list
83474348|NCT00004390|Desipramine|desipramine|mesh-list
83474349|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83474350|NCT00004390|Narcotics|narcotics|mesh-ancestor
83474351|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83474352|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474353|NCT00004390|Analgesics|analgesics|mesh-ancestor
83474354|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
83474355|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474356|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
83474357|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
83474358|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83474359|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
83474360|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83474361|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83474362|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83474363|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83474364|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474366|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474367|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474368|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
83474369|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474370|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474371|NCT00004402|Calcitriol|calcitriol|mesh-list
83474372|NCT00004402|Interferons|interferons|mesh-list
83474373|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
83474374|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474375|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
83474376|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474377|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83474378|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474379|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83474380|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83474381|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474382|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83474383|NCT00004402|Vitamins|vitamins|mesh-ancestor
83474384|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
83474385|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83474386|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
83474387|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83474388|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83474389|NCT00004420|Analgesics|analgesics|mesh-ancestor
83474390|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
83474391|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474392|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474393|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83474394|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83474395|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83474396|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
83474397|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474398|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83474399|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
83474400|NCT00004426|Leuprolide|leuprolide|mesh-list
83474401|NCT00004426|Hormones|hormones|mesh-list
83474402|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83474403|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474404|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83474405|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
83474406|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83474407|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83474408|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474409|NCT00004438|Leuprolide|leuprolide|mesh-list
83474410|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83474411|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
83474412|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83474413|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474414|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83474415|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474416|NCT01217749|Ofatumumab|ofatumumab|mesh-list
83474417|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474418|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83474419|NCT02197273|Epinephrine|epinephrine|mesh-list
83474420|NCT02197273|Fentanyl|fentanyl|mesh-list
83474421|NCT02197273|Morphine|morphine|mesh-list
83474422|NCT02197273|Bupivacaine|bupivacaine|mesh-list
83474423|NCT02197273|Ropivacaine|ropivacaine|mesh-list
83474424|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
83474425|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
83474426|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83474427|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474428|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
83474429|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474430|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83474431|NCT02197273|Narcotics|narcotics|mesh-ancestor
83474432|NCT02197273|Analgesics|analgesics|mesh-ancestor
83474433|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83474434|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83474435|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
83474436|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83474437|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83474438|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
83474439|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474440|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474441|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83474442|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83474443|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
83474444|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83474445|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
83474446|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
83474447|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
83474448|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83474449|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83474450|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
83474451|NCT02197273|Hormones|hormones|mesh-ancestor
83474452|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83474453|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83474454|NCT02197273|Protective Agents|protective agents|mesh-ancestor
83474455|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83474456|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474457|NCT00004444|Paromomycin|paromomycin|mesh-list
83474458|NCT00004444|Streptomycin|streptomycin|mesh-list
83474459|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83474460|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474461|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83474462|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83474463|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83474464|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490485|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83474465|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474468|NCT00004450|Thalidomide|thalidomide|mesh-list
83474469|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474470|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
83474471|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474472|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474473|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
83474474|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474475|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
83474476|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83474477|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83474478|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83474479|NCT00004450|Growth Substances|growth substances|mesh-ancestor
83474480|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
83474481|NCT00004468|Calcitriol|calcitriol|mesh-list
83474482|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83474483|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474484|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83474485|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83474486|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474487|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83474488|NCT00004468|Vitamins|vitamins|mesh-ancestor
83474489|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
83474490|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83474491|NCT01288807|Milnacipran|milnacipran|mesh-list
83474492|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83474493|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83474494|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83474495|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474496|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474497|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474498|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83474499|NCT01288807|Analgesics|analgesics|mesh-ancestor
83474501|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474502|NCT00005764|Lamivudine|lamivudine|mesh-list
83474503|NCT00005764|Zidovudine|zidovudine|mesh-list
83474504|NCT00005764|Abacavir|abacavir|mesh-list
83474505|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83474506|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83474507|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83474508|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474509|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474510|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
83474511|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474512|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83474513|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83474514|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
83474515|NCT01289275|Nicotine|nicotine|mesh-list
83474516|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83474517|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
83474518|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474519|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474520|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83474521|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83474522|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
83474523|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474524|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474525|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
83474526|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83474527|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474528|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
83474529|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474530|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83474531|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83474532|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
83474533|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474534|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474535|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83474536|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
83474537|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83474538|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83474539|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83474540|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83474541|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474542|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
83474543|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474544|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474545|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83474546|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474548|NCT00004486|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83474549|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83474550|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83474551|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474552|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474553|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
83474554|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474555|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83474557|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83474558|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83474559|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83474560|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474561|NCT00004492|Clotrimazole|clotrimazole|mesh-list
83474562|NCT00004492|Miconazole|miconazole|mesh-list
83474563|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
83474564|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474565|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
83474566|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474567|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474568|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83474569|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83474570|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474571|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
83474572|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83474573|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83474574|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83474575|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
83474576|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83474577|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474578|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83474579|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83474580|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
83474581|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83474582|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
83474583|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474584|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474585|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83474586|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
83474587|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83474588|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
83477853|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83474589|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474591|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83474592|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
83474593|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
83474594|NCT00005776|Protective Agents|protective agents|mesh-ancestor
83474595|NCT01290445|Varenicline|varenicline|mesh-list
83474596|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83474597|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83474598|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
83474599|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474600|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474601|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474602|NCT00005782|Lenograstim|lenograstim|mesh-list
83474603|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83474605|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474606|NCT01290913|Omalizumab|omalizumab|mesh-list
83474607|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83474608|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83474609|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
83474610|NCT00004552|Acamprosate|acamprosate|mesh-list
83474611|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83474612|NCT00101660|Dasatinib|dasatinib|mesh-list
83474613|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474614|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83474615|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474616|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474617|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
83474618|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83474619|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474620|NCT00005800|Docetaxel|docetaxel|mesh-list
83474621|NCT00005800|Doxorubicin|doxorubicin|mesh-list
83474622|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83474623|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474624|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
83474625|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
83474626|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
83474627|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474628|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83474629|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83474630|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83474631|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474632|NCT00004564|Clopidogrel|clopidogrel|mesh-list
83474633|NCT00004564|Atorvastatin|atorvastatin|mesh-list
83474634|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83474635|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83474636|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
83474637|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474638|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83474639|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83474640|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474641|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83474642|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83474643|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83474644|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83474645|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
83474646|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474647|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474648|NCT01268527|Calcipotriene|calcipotriene|mesh-list
83474649|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
83474651|NCT00005806|Carboplatin|carboplatin|mesh-list
83474652|NCT00005806|Gefitinib|gefitinib|mesh-list
83474653|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83474654|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474655|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
83474656|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
83474657|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
83474658|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474659|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83474660|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474661|NCT00005812|Temozolomide|temozolomide|mesh-list
83474662|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83474663|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
83474664|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474665|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474666|NCT01270555|Bupropion|bupropion|mesh-list
83474667|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83474668|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
83474669|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83474670|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83474671|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83474672|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83474673|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474674|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
83474675|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474676|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474677|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83474678|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83474679|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474681|NCT00004582|Lopinavir|lopinavir|mesh-list
83474682|NCT00004582|Efavirenz|efavirenz|mesh-list
83474683|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83474684|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83474685|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
83474686|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474687|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474688|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83474689|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83474690|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
83474691|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474692|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83474693|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83474694|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83474695|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83474696|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83474697|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83474699|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83474700|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83474701|NCT00004690|Monolaurin|monolaurin|mesh-list
83474702|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
83474703|NCT00004690|Protective Agents|protective agents|mesh-ancestor
83474704|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474705|NCT00004696|Morphine|morphine|mesh-list
83474706|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83474707|NCT00004696|Narcotics|narcotics|mesh-ancestor
83474708|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83474709|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474710|NCT00004696|Analgesics|analgesics|mesh-ancestor
83474711|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
83474712|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474713|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
83474714|NCT00004744|Antibodies|antibodies|mesh-list
83474715|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
83474716|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83474717|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83474718|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
83474719|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474720|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
83474721|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83474722|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474723|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474724|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83474725|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83474726|NCT01292005|Protective Agents|protective agents|mesh-ancestor
83474727|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474728|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
83474729|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83474731|NCT00004762|Cladribine|cladribine|mesh-list
83474732|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474733|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474734|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
83474735|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474736|NCT00004786|Iloprost|iloprost|mesh-list
83474737|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83474738|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
83474739|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83474740|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83474741|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474742|NCT01272583|Incretins|incretins|mesh-ancestor
83474743|NCT01272583|Hormones|hormones|mesh-ancestor
83474744|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83474745|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83474746|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
83474747|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474748|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474749|NCT00004804|Interferons|interferons|mesh-list
83474750|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
83474751|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474752|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
83474753|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474754|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
83474755|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474756|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
83474757|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83474758|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
83474759|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
83474760|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474761|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83474762|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
83474763|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83474764|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474765|NCT00004816|Antibodies|antibodies|mesh-list
83474766|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83474767|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
83474768|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474769|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
83474770|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
83474771|NCT01341301|Tacrolimus|tacrolimus|mesh-list
83474772|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474773|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
83474774|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474775|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83474776|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83474777|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
83474778|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474779|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474780|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83474781|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83474782|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474783|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83474784|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83474785|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
83474786|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83474787|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474789|NCT01273207|Cyclosporins|cyclosporins|mesh-list
83474790|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477854|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83474791|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474792|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474793|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
83474794|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474795|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
83474796|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474797|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
83474798|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83474799|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83474801|NCT01342549|Valproic Acid|valproic acid|mesh-list
83474802|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83474803|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83474804|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474805|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
83474806|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474807|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
83474808|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474809|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474810|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
83474811|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474812|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
83474813|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83474814|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83474815|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83474816|NCT01295515|Interferons|interferons|mesh-list
83474817|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
83474818|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
83474819|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83474820|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474821|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
83474822|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474823|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
83474824|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474825|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
83474826|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83474827|NCT00101816|Dasatinib|dasatinib|mesh-list
83474828|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474829|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83474830|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474831|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474832|NCT00102518|Aripiprazole|aripiprazole|mesh-list
83474833|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
83474834|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83474835|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83474836|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83474837|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83474838|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474839|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
83474840|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
83474841|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474842|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474843|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83474844|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83474845|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
83474846|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83474847|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83474848|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83474849|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83474850|NCT00103376|Bortezomib|bortezomib|mesh-list
83474851|NCT00103376|Androgens|androgens|mesh-list
83474852|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
83474853|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474854|NCT00103376|Hormones|hormones|mesh-ancestor
83474855|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83474856|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474857|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
83474858|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
83474859|NCT00042224|Clozapine|clozapine|mesh-list
83474860|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83474861|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
83474862|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474863|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771548|NCT02567981|Vitamin A|vitamin a|mesh-list
83474865|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83474866|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83474867|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83474868|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83474869|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
83474870|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
83474871|NCT01296763|Irinotecan|irinotecan|mesh-list
83474872|NCT01296763|Olaparib|olaparib|mesh-list
83474873|NCT01296763|Mitomycins|mitomycins|mesh-list
83474874|NCT01296763|Mitomycin|mitomycin|mesh-list
83474875|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474876|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83474877|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83474878|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474879|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474880|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83474881|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83474882|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
83474883|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83474884|NCT01349491|Ranolazine|ranolazine|mesh-list
83474885|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83474886|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83474887|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474888|NCT01280695|Pioglitazone|pioglitazone|mesh-list
83474889|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82771614|NCT00700115|Ritonavir|ritonavir|mesh-list
83474890|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474891|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
83474892|NCT00103844|Dasatinib|dasatinib|mesh-list
83474893|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474894|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83474895|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474896|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474897|NCT01402375|Acetaminophen|acetaminophen|mesh-list
83474898|NCT01402375|Oxycodone|oxycodone|mesh-list
83474899|NCT01402375|Hydrocodone|hydrocodone|mesh-list
83474900|NCT01402375|Codeine|codeine|mesh-list
82771663|NCT00936962|Vaccines|vaccines|mesh-list
83474901|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83474902|NCT01402375|Analgesics|analgesics|mesh-ancestor
83474903|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
83474904|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474905|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474906|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
83474907|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83474908|NCT01402375|Narcotics|narcotics|mesh-ancestor
83474909|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83474910|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
83474911|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
83474912|NCT01302379|Metformin|metformin|mesh-list
83474913|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83474914|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474915|NCT01351753|Metformin|metformin|mesh-list
83474916|NCT01351753|Topiramate|topiramate|mesh-list
83474917|NCT01351753|Orlistat|orlistat|mesh-list
83474918|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83474919|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474920|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
83474921|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477855|NCT05266820|Growth Substances|growth substances|mesh-ancestor
83474922|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474924|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83474925|NCT00104858|Cyclosporine|cyclosporine|mesh-list
83474926|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
83474927|NCT00104858|Rituximab|rituximab|mesh-list
83474928|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83474929|NCT00104858|Fludarabine|fludarabine|mesh-list
83474930|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
83474931|NCT00104858|Antibodies|antibodies|mesh-list
83474932|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
83474933|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83474934|NCT00104858|Cyclosporins|cyclosporins|mesh-list
83474935|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
83474936|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477856|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
83474937|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474938|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83474939|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83474940|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
83474941|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474942|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474943|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474944|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
83474945|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474946|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
83474947|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83474948|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83474949|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83474950|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
83474951|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83474952|NCT01407523|Levetiracetam|levetiracetam|mesh-list
83474953|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
83474954|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
83474955|NCT00047060|Cyclosporine|cyclosporine|mesh-list
83474956|NCT00047060|Fludarabine|fludarabine|mesh-list
83474957|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
83474958|NCT00047060|Cyclosporins|cyclosporins|mesh-list
83474959|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474960|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474961|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83474962|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
83474963|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474964|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474965|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
83474966|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83474967|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
83474968|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83474969|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83474970|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83474971|NCT01304407|Calcium|calcium|mesh-list
83474972|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83474973|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474974|NCT00106106|Acamprosate|acamprosate|mesh-list
83474975|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83474976|NCT01304641|Atorvastatin|atorvastatin|mesh-list
83474977|NCT01304641|Simvastatin|simvastatin|mesh-list
83474978|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83474979|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83474980|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
83474981|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474982|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83474983|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83474984|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474985|NCT04753112|Valsartan|valsartan|mesh-list
83474986|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83474987|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83474988|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83474989|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83477857|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83474990|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474992|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83474993|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83474994|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474995|NCT00108524|Orlistat|orlistat|mesh-list
83474996|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474997|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83474998|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83474999|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83475000|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
83475001|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475002|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83475003|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475004|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475005|NCT01410409|Acetaminophen|acetaminophen|mesh-list
83475006|NCT01410409|Pantoprazole|pantoprazole|mesh-list
83475007|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83475008|NCT01410409|Analgesics|analgesics|mesh-ancestor
83475009|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
83475010|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475011|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475012|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
83475013|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83475014|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83475015|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83475016|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475017|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475018|NCT01410565|Apaziquone|apaziquone|mesh-list
83475019|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475020|NCT01357135|Metformin|metformin|mesh-list
83475021|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83475022|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82772003|NCT00446446|Panitumumab|panitumumab|mesh-list
83475023|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475024|NCT01357135|Incretins|incretins|mesh-ancestor
83475025|NCT01357135|Hormones|hormones|mesh-ancestor
83475026|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83475027|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83475028|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
83475029|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475030|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475031|NCT02324335|Brilacidin|brilacidin|mesh-list
83475032|NCT02324335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475033|NCT01411501|Mosapride|mosapride|mesh-list
83475034|NCT01411501|Citric Acid|citric acid|mesh-list
83475035|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
83475036|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
83475037|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83475038|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
83475039|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
83475040|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475041|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83475042|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83475043|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
83475044|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475045|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475046|NCT01310179|Fludarabine|fludarabine|mesh-list
83475047|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
83475048|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475049|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83475050|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
83475051|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475052|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475053|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
83475054|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475055|NCT01412281|Vaccines|vaccines|mesh-list
83475056|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
83475057|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475058|NCT01359007|Leucovorin|leucovorin|mesh-list
83475059|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
83475060|NCT01359007|Irinotecan|irinotecan|mesh-list
83475061|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475062|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83475063|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83475064|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475065|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475066|NCT01359007|Antidotes|antidotes|mesh-ancestor
83475067|NCT01359007|Protective Agents|protective agents|mesh-ancestor
83475068|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475069|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
83475071|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
83475072|NCT01414153|Bevacizumab|bevacizumab|mesh-list
83475073|NCT01414153|Ranibizumab|ranibizumab|mesh-list
83475074|NCT01414153|Aflibercept|aflibercept|mesh-list
83475075|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83475076|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83475077|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475078|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83475079|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83475080|NCT01414153|Growth Substances|growth substances|mesh-ancestor
83475081|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475082|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
83475083|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
83475084|NCT01311895|Hydromorphone|hydromorphone|mesh-list
83475085|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83475086|NCT01311895|Narcotics|narcotics|mesh-ancestor
83475087|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83475088|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475089|NCT01311895|Analgesics|analgesics|mesh-ancestor
83475090|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
83475091|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475092|NCT01362127|Cisplatin|cisplatin|mesh-list
83475093|NCT01362127|Carboplatin|carboplatin|mesh-list
83475094|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
83475095|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475096|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
83475097|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83475098|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83475099|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475100|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83475101|NCT01362205|Analgesics|analgesics|mesh-ancestor
83475102|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
83475103|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475104|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83475105|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83475106|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83475107|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
83475108|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475109|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475110|NCT00052910|Leucovorin|leucovorin|mesh-list
83475111|NCT00052910|Fluorouracil|fluorouracil|mesh-list
83475112|NCT00052910|Epirubicin|epirubicin|mesh-list
83475113|NCT00052910|Calcium|calcium|mesh-list
83475114|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
83475115|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475116|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83475117|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475118|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
83475119|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475120|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83475121|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475122|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
83475123|NCT00052910|Antidotes|antidotes|mesh-ancestor
83475124|NCT00052910|Protective Agents|protective agents|mesh-ancestor
83475125|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
83475126|NCT00052910|Vitamins|vitamins|mesh-ancestor
83475127|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
83475128|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83475129|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83475130|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83475131|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475132|NCT01363843|Leucovorin|leucovorin|mesh-list
83475133|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
83475134|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475135|NCT01363843|Antidotes|antidotes|mesh-ancestor
83475136|NCT01363843|Protective Agents|protective agents|mesh-ancestor
83475137|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475138|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
83475139|NCT01363843|Vitamins|vitamins|mesh-ancestor
83475140|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
83475141|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
83475142|NCT02092298|Cisplatin|cisplatin|mesh-list
83475143|NCT02092298|Mitomycins|mitomycins|mesh-list
83475144|NCT02092298|Mitomycin|mitomycin|mesh-list
83475145|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475146|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83475147|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
83475148|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475149|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83475150|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475151|NCT02092298|Antidotes|antidotes|mesh-ancestor
83475152|NCT02092298|Protective Agents|protective agents|mesh-ancestor
83475153|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475154|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
83475155|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
83475156|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83475157|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475158|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
83475159|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
83475160|NCT02568566|Vaccines|vaccines|mesh-list
83475161|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
83475162|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475163|NCT00151814|Olmesartan|olmesartan|mesh-list
83475164|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83475165|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83475166|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83475167|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83475168|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475169|NCT00153842|Bexarotene|bexarotene|mesh-list
83475170|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475171|NCT01314001|Nicotine|nicotine|mesh-list
83475172|NCT01314001|Varenicline|varenicline|mesh-list
83475173|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83475174|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
83475175|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475176|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475177|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83475178|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83475179|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
83475180|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475181|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475182|NCT01363999|Atorvastatin|atorvastatin|mesh-list
83475183|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
83475184|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83475185|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83475186|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
82772378|NCT00940550|Melatonin|melatonin|mesh-list
83475187|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475188|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83475189|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83475190|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475192|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475193|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83475194|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83475195|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475196|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83475197|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
83475198|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
83475199|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475200|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475201|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83475202|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83475203|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83475204|NCT00258128|Analgesics|analgesics|mesh-ancestor
83475205|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
83475206|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475207|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475208|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83475210|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
83475211|NCT01364623|Testosterone|testosterone|mesh-list
83475212|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
83475213|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
83475214|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83475215|NCT01364623|Androgens|androgens|mesh-ancestor
83475216|NCT01364623|Hormones|hormones|mesh-ancestor
83475217|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83475218|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475219|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83475220|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475221|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
83475222|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
83475223|NCT00258206|Rituximab|rituximab|mesh-list
83475224|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475225|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
83475226|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475227|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475228|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83475229|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
83475230|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475231|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475232|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83475233|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83475234|NCT01063907|Bortezomib|bortezomib|mesh-list
83475235|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475236|NCT01316263|Olaratumab|olaratumab|mesh-list
83475237|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475238|NCT03015857|Phenylephrine|phenylephrine|mesh-list
83475239|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
83475240|NCT03015857|Norepinephrine|norepinephrine|mesh-list
83475241|NCT03015857|Fentanyl|fentanyl|mesh-list
83475242|NCT03015857|Bupivacaine|bupivacaine|mesh-list
83475243|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
83475244|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
83475245|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490486|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83475246|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475247|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
83475248|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475249|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83475250|NCT03015857|Narcotics|narcotics|mesh-ancestor
83475251|NCT03015857|Analgesics|analgesics|mesh-ancestor
83475252|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83475253|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83475254|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
83475255|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83475256|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
83475257|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
83475258|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
83475259|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83475260|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
83475261|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
83475262|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83475263|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83475264|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83475265|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
83475266|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475267|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475268|NCT03015857|Protective Agents|protective agents|mesh-ancestor
83475269|NCT03295487|Estrogens|estrogens|mesh-list
83475270|NCT03295487|Hormones|hormones|mesh-ancestor
83475271|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83475272|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475273|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
83475274|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83475275|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475276|NCT03016091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83475277|NCT03016091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475279|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83475280|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
83475281|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83475282|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475283|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83475284|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83475285|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83475286|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
83475287|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83475288|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83475289|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
83475290|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83475291|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
83475292|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83475293|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83475294|NCT03047135|Olaparib|olaparib|mesh-list
83475295|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83475296|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475297|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475298|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475299|NCT04780061|Vitamin D|vitamin d|mesh-list
83475300|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
83475301|NCT04780061|Vitamins|vitamins|mesh-list
83475302|NCT04780061|Vitamin K|vitamin k|mesh-list
83475303|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
83475304|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
83475305|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475306|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83475307|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83475308|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475309|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83475310|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83475312|NCT04780061|Coagulants|coagulants|mesh-ancestor
83475313|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83475314|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
83475315|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83475316|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83475317|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83475318|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475319|NCT02973737|Capecitabine|capecitabine|mesh-list
83475320|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83475321|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
83490938|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
83475322|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475323|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475325|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83475326|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475327|NCT02872025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83475328|NCT02872025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475329|NCT02762669|Oxytocin|oxytocin|mesh-list
83475330|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
83475331|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83475332|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475333|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
83475334|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83475335|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83475336|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475337|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83475338|NCT01072643|Analgesics|analgesics|mesh-ancestor
83475339|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
82772890|NCT04012268|Aspirin|aspirin|mesh-list
83475340|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475341|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83475342|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83475343|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83475344|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
83475345|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475346|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475347|NCT01076231|Etoposide|etoposide|mesh-list
83475348|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
83475349|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
83475350|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475351|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83475352|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83475353|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83475354|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475355|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475356|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
83475357|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
83475358|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
83475359|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
83475360|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
83475361|NCT00117962|Carboplatin|carboplatin|mesh-list
83475363|NCT00117962|Cetuximab|cetuximab|mesh-list
83475364|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475365|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475366|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475367|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83475368|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83475369|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83475370|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
83475371|NCT00118274|Vaccines|vaccines|mesh-list
83475372|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
83475373|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
83475374|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475375|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475376|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475377|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83475378|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
83475379|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475380|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475381|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83475382|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83475383|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
83475384|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83475385|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475386|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
83475387|NCT00166166|Fluconazole|fluconazole|mesh-list
83475388|NCT00166166|Nitroprusside|nitroprusside|mesh-list
83475389|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
83475390|NCT00166166|Acetylcholine|acetylcholine|mesh-list
83475391|NCT00166166|Bradykinin|bradykinin|mesh-list
83475392|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83475393|NCT00166166|Kininogens|kininogens|mesh-list
83475394|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
83475395|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475396|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83475397|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83475398|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475399|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475400|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83475401|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
83475402|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83475403|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475404|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83475405|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83475406|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83475407|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
83475408|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83475409|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83475410|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
83475411|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475412|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83475413|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
83475414|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83475415|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83475416|NCT00118352|Cyclosporine|cyclosporine|mesh-list
83475417|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
83475418|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83475419|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
83475420|NCT00118352|Fludarabine|fludarabine|mesh-list
83475421|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
83475422|NCT00118352|Antibodies|antibodies|mesh-list
83475423|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
83475424|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83475425|NCT00118352|Cyclosporins|cyclosporins|mesh-list
83475426|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
83490939|NCT01507181|Analgesics|analgesics|mesh-ancestor
83475427|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475428|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475429|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83475430|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
83475431|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475432|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475433|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475434|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
83475435|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475436|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
83475437|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475438|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83475439|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83475440|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83475441|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
83475442|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83475443|NCT01111331|Empagliflozin|empagliflozin|mesh-list
83475445|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
83475446|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83475447|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475448|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83475449|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475450|NCT00167102|Alefacept|alefacept|mesh-list
83475451|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
83475452|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
83475453|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475454|NCT01859819|Cytarabine|cytarabine|mesh-list
83475456|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83475457|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475458|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
83475459|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475460|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475461|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83475462|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
83475463|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475464|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
83475465|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475466|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475467|NCT01795313|Imiquimod|imiquimod|mesh-list
83475468|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83475469|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
83475470|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475471|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475472|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
83475473|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
83475474|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83475475|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83475476|NCT02176031|Prednisolone|prednisolone|mesh-list
83475477|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
83475478|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83475479|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
83475480|NCT02176031|Natalizumab|natalizumab|mesh-list
83475481|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83475482|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
83475483|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
83475484|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475485|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475486|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83475487|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
83475489|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83475490|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83475491|NCT02176031|Protective Agents|protective agents|mesh-ancestor
83475492|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82773418|NCT00949494|Hylan|hylan|mesh-list
83475493|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475494|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
83475495|NCT03013361|Bupivacaine|bupivacaine|mesh-list
83475496|NCT03013361|Ropivacaine|ropivacaine|mesh-list
83475497|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
83475498|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
83475499|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83475500|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475501|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
83475502|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475503|NCT01077401|Ranibizumab|ranibizumab|mesh-list
83475504|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83475505|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82773539|NCT00110305|Rilpivirine|rilpivirine|mesh-list
83475506|NCT01077401|Growth Substances|growth substances|mesh-ancestor
83475507|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475508|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
83475509|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475511|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83475512|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475513|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83475514|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475515|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83475516|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
83475517|NCT01112735|Coagulants|coagulants|mesh-ancestor
83475518|NCT03014297|Everolimus|everolimus|mesh-list
83475519|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
83475520|NCT03014297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83475521|NCT03014297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83475522|NCT03014297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475523|NCT03014297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475524|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773613|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
83475525|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
83475526|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475527|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475528|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83475529|NCT01034111|Metformin|metformin|mesh-list
83475530|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83475531|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83475532|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475533|NCT01034111|Incretins|incretins|mesh-ancestor
83475534|NCT01034111|Hormones|hormones|mesh-ancestor
83475535|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83475536|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83475537|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
83475538|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475539|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475540|NCT01114997|Lidocaine|lidocaine|mesh-list
83475541|NCT01114997|Esmolol|esmolol|mesh-list
83475542|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
83475543|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
83475544|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83475545|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475546|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
83475547|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475548|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83475549|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83475550|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83475551|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83475552|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475553|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83475554|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83475555|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83475556|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
83475557|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475558|NCT00118742|Cyclosporine|cyclosporine|mesh-list
83475559|NCT00118742|Sirolimus|sirolimus|mesh-list
83475560|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
83475561|NCT00118742|Tacrolimus|tacrolimus|mesh-list
83475562|NCT00118742|Cyclosporins|cyclosporins|mesh-list
83475563|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773723|NCT00454636|Cisplatin|cisplatin|mesh-list
83475564|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
83475565|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475566|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83475567|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475568|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475569|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
83475570|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475571|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
83475572|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475573|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83475574|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475575|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83475576|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
83475577|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83475578|NCT01317667|Vaccines|vaccines|mesh-list
83475579|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
83475580|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475581|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
83475582|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475583|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
83475584|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475585|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475586|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83475587|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
83475588|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475589|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475590|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83475592|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83475593|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83475594|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475595|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
83475596|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475597|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475598|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83475599|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
83475600|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475601|NCT03008551|Metformin|metformin|mesh-list
83475602|NCT03008551|Empagliflozin|empagliflozin|mesh-list
83475603|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83475604|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475605|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83475606|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475607|NCT01366885|Vitamin D|vitamin d|mesh-list
83475608|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
83475609|NCT01366885|Vitamins|vitamins|mesh-ancestor
83475610|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
83475611|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475612|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83475613|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83475614|NCT01899170|Carfentanil|carfentanil|mesh-list
83475615|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83475616|NCT01899170|Narcotics|narcotics|mesh-ancestor
83475617|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83475618|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475619|NCT01899170|Analgesics|analgesics|mesh-ancestor
83475620|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
83475621|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475622|NCT01425229|Bosentan|bosentan|mesh-list
83475623|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83475624|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83475625|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475626|NCT00258362|Carboplatin|carboplatin|mesh-list
83475627|NCT00258362|Docetaxel|docetaxel|mesh-list
83475628|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475629|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
83475630|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
83475631|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
83475632|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475634|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
83475635|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475636|NCT02539368|Infliximab|infliximab|mesh-list
83475637|NCT02539368|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83475638|NCT02539368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83475639|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
83475640|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83475641|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475642|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
83475643|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475644|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
83475645|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475646|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475647|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83475648|NCT01035749|Vaccines|vaccines|mesh-list
83475649|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
83475650|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475651|NCT00123110|Metformin|metformin|mesh-list
83475652|NCT00123110|Leuprolide|leuprolide|mesh-list
83475653|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83475654|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475655|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83475656|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
83475657|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83475658|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83475659|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475660|NCT01425853|Celecoxib|celecoxib|mesh-list
83475661|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83475662|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83475663|NCT01425853|Analgesics|analgesics|mesh-ancestor
83475664|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
83475665|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475666|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475667|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83475668|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475669|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83475670|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83475671|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475672|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475673|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83475674|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83475675|NCT01426867|Brinzolamide|brinzolamide|mesh-list
83475676|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83475677|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83475678|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83475679|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83475680|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82774124|NCT00947336|Norfloxacin|norfloxacin|mesh-list
83475681|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
83475682|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475683|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475684|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475685|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83475686|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475687|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
83475688|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83475689|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83475690|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83475691|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83475692|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475693|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
83475694|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475695|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475696|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83475697|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475698|NCT01427881|Cyclosporine|cyclosporine|mesh-list
83475699|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
83475700|NCT01427881|Busulfan|busulfan|mesh-list
83475701|NCT01427881|Fludarabine|fludarabine|mesh-list
83475702|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
83475703|NCT01427881|Cyclosporins|cyclosporins|mesh-list
83475704|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475705|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
83475706|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475707|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475708|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83475709|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
83475710|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475711|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475712|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83475714|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
83475715|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475716|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
83475717|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475718|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
83475719|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83475720|NCT02112734|Vitamin D|vitamin d|mesh-list
83475721|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
83475722|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
83475723|NCT02112734|Vitamins|vitamins|mesh-list
83475724|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
83475725|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475726|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83475727|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83475728|NCT01319773|Cyclosporine|cyclosporine|mesh-list
83475729|NCT01319773|Cyclosporins|cyclosporins|mesh-list
83475730|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475731|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475732|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475733|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
83475734|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475735|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
83475736|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475737|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
83475738|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475739|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83475741|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
83475742|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
83475743|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475744|NCT04351867|Docetaxel|docetaxel|mesh-list
83475745|NCT04351867|Capecitabine|capecitabine|mesh-list
83475746|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
83475747|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475748|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
83475749|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
83475750|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
83475751|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475752|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83475753|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
83475755|NCT00262730|Poly ICLC|poly iclc|mesh-list
83475756|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83475757|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
83475758|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475759|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475760|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
83475761|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
83475762|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475763|NCT04262934|Vitamin D|vitamin d|mesh-list
83475764|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
83475765|NCT04262934|Vitamins|vitamins|mesh-ancestor
83475766|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
83475767|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475768|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83475769|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83475770|NCT00262964|Niacin|niacin|mesh-list
83475771|NCT00262964|Fenofibrate|fenofibrate|mesh-list
83475772|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83475773|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
83475774|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475775|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83475776|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
83475777|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
83475778|NCT00262964|Vitamins|vitamins|mesh-ancestor
83475779|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
83475780|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475781|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83475782|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
83475783|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83475785|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83475786|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475787|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83475788|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83475789|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475790|NCT01899248|Sevoflurane|sevoflurane|mesh-list
83475791|NCT01899248|Desflurane|desflurane|mesh-list
83475792|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83475793|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83475794|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
82774755|NCT00964080|Vitamins|vitamins|mesh-ancestor
83475796|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83475797|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475798|NCT01322815|Leucovorin|leucovorin|mesh-list
83475799|NCT01322815|Fluorouracil|fluorouracil|mesh-list
83475800|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
83475801|NCT01322815|Irinotecan|irinotecan|mesh-list
83475802|NCT01322815|Bevacizumab|bevacizumab|mesh-list
83475803|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
83475804|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
83475805|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475806|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83475807|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475808|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475809|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
83475810|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475811|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83475812|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83475813|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475814|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83475815|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83475816|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83475817|NCT01322815|Growth Substances|growth substances|mesh-ancestor
83475818|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
83475819|NCT01322815|Antidotes|antidotes|mesh-ancestor
83475820|NCT01322815|Protective Agents|protective agents|mesh-ancestor
83475821|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
83475822|NCT01322815|Vitamins|vitamins|mesh-ancestor
83475823|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
83475824|NCT00176228|Lamotrigine|lamotrigine|mesh-list
83475825|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
83475826|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83475827|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83475828|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475829|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83475830|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475831|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83475832|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83475833|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83475834|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83475835|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83475836|NCT00176306|Levofloxacin|levofloxacin|mesh-list
83475837|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83475838|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475839|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83475840|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83475841|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83475842|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475843|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475845|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83475846|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83475847|NCT01429987|Plecanatide|plecanatide|mesh-list
83475848|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83475849|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
83475850|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475851|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83475852|NCT00265616|Pentobarbital|pentobarbital|mesh-list
83475853|NCT00265616|Thiopental|thiopental|mesh-list
83475854|NCT00265616|Propofol|propofol|mesh-list
83475855|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83475856|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83475857|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475858|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83475859|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
83475860|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
83475861|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
83475862|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
82775362|NCT00547118|Rimonabant|rimonabant|mesh-list
83475864|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475865|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475866|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83475867|NCT00176852|Vidarabine|vidarabine|mesh-list
83475868|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
83475869|NCT00176852|Busulfan|busulfan|mesh-list
83475870|NCT00176852|Fludarabine|fludarabine|mesh-list
83475871|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
83475872|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
83475873|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83475874|NCT00176852|Lenograstim|lenograstim|mesh-list
83475875|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475876|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
83475877|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475878|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475879|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83475880|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
83475881|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475882|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475883|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83475884|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83475885|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
83475886|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
83475887|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475888|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83475889|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83475891|NCT01323517|Ipilimumab|ipilimumab|mesh-list
83475892|NCT01323517|Melphalan|melphalan|mesh-list
83475893|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82775931|NCT00966576|Timolol|timolol|mesh-list
83475894|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475895|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83477858|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
83475896|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475897|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83475898|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
83475899|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83475900|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83475901|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
83475902|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776299|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83475903|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83475904|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83475905|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83475906|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83475907|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475908|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83475909|NCT01323595|Celecoxib|celecoxib|mesh-list
83475910|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83475911|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83475912|NCT01323595|Analgesics|analgesics|mesh-ancestor
83475913|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
83475914|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776517|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
83475915|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475916|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83475917|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83475918|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83477859|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
83475919|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83475920|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475921|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475922|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83475923|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83475924|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475925|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83475926|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475927|NCT01431391|Leuprolide|leuprolide|mesh-list
83475928|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83475929|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
83475930|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83475931|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475932|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83475933|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475934|NCT03009097|Atorvastatin|atorvastatin|mesh-list
83475935|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83475936|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83475937|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
83475938|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475939|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83475940|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83475941|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475942|NCT01325311|Vitamin D|vitamin d|mesh-list
83475943|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
83475944|NCT01325311|Genistein|genistein|mesh-list
83475945|NCT01325311|Vitamins|vitamins|mesh-ancestor
83475946|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
83475947|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475948|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83475949|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83475950|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83475951|NCT01325311|Protective Agents|protective agents|mesh-ancestor
83475952|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475953|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83475954|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491470|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
83475955|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475956|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
83475957|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83475958|NCT01325311|Estrogens|estrogens|mesh-ancestor
83475959|NCT01325311|Hormones|hormones|mesh-ancestor
83475960|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83475961|NCT01432015|Aprepitant|aprepitant|mesh-list
83475962|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
83475963|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
83475964|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
83475965|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83475966|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475967|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83475968|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83475969|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475970|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475971|NCT01080677|Propranolol|propranolol|mesh-list
82777228|NCT05919472|Micronutrients|micronutrients|mesh-ancestor
82777229|NCT05919407|Amifampridine|amifampridine|mesh-list
82777230|NCT05919407|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
82777231|NCT05919407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82777232|NCT05919407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777233|NCT05919407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777234|NCT05919407|Cholinergic Agents|cholinergic agents|mesh-ancestor
82777235|NCT05919407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82777236|NCT05919407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777237|NCT05919407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82777238|NCT05919407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777239|NCT05919407|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82777240|NCT05919407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82777245|NCT05919277|Antibodies|antibodies|mesh-list
82777246|NCT05919277|Immunoglobulins|immunoglobulins|mesh-list
82777247|NCT05919277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82777248|NCT05919277|Immunoglobulin G|immunoglobulin g|mesh-list
82777249|NCT05919277|Immunologic Factors|immunologic factors|mesh-ancestor
82777250|NCT05919277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777268|NCT05919147|Pioglitazone|pioglitazone|mesh-list
82777269|NCT05919147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83475972|NCT01080677|Caffeine|caffeine|mesh-list
83475973|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83475974|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475975|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83475976|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475977|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475978|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83475979|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83475980|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
83475981|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82777307|NCT05918822|Antiviral Agents|antiviral agents|mesh-ancestor
83475982|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83475983|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83475985|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83475986|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83475987|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
83475988|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
83475989|NCT01378273|Hematinics|hematinics|mesh-ancestor
82777368|NCT05918328|Trastuzumab|trastuzumab|mesh-list
82777369|NCT05918328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82777370|NCT05918328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777371|NCT05918328|Tubulin Modulators|tubulin modulators|mesh-ancestor
82777372|NCT05918328|Antimitotic Agents|antimitotic agents|mesh-ancestor
82777373|NCT05918328|Mitosis Modulators|mitosis modulators|mesh-ancestor
82777374|NCT05918328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777375|NCT05918328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777376|NCT05918302|Everolimus|everolimus|mesh-list
82777377|NCT05918302|Edotreotide|edotreotide|mesh-list
82777378|NCT05918302|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
82777379|NCT05918302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82777380|NCT05918302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82777444|NCT05917912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777445|NCT05917912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777446|NCT05917912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82777447|NCT05917912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82777448|NCT05917912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82777449|NCT05917912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83475990|NCT01432405|Pioglitazone|pioglitazone|mesh-list
83475991|NCT01432405|Exenatide|exenatide|mesh-list
83475992|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83475993|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475994|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83475995|NCT01432405|Incretins|incretins|mesh-ancestor
83475996|NCT01432405|Hormones|hormones|mesh-ancestor
83475997|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83475998|NCT01432561|Cysteamine|cysteamine|mesh-list
83475999|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83476000|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476001|NCT01116401|Leuprolide|leuprolide|mesh-list
83476002|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83476003|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
83476004|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82777532|NCT05900427|Bupivacaine|bupivacaine|mesh-list
82777533|NCT05900427|Anesthetics, Local|anesthetics, local|mesh-ancestor
82777534|NCT05900427|Anesthetics|anesthetics|mesh-ancestor
82777535|NCT05900427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82777536|NCT05900427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777537|NCT05900427|Sensory System Agents|sensory system agents|mesh-ancestor
82777538|NCT05900427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777551|NCT05888831|Nivolumab|nivolumab|mesh-list
82777552|NCT05888831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777553|NCT05888831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777554|NCT05888831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82777555|NCT05888831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777560|NCT05883241|Diclofenac|diclofenac|mesh-list
82777561|NCT05883241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82777562|NCT05883241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82777563|NCT05883241|Analgesics|analgesics|mesh-ancestor
82777564|NCT05883241|Sensory System Agents|sensory system agents|mesh-ancestor
82777565|NCT05883241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777566|NCT05883241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777567|NCT05883241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82777568|NCT05883241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82777590|NCT05879107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82777591|NCT05879107|Immunologic Factors|immunologic factors|mesh-ancestor
82777592|NCT05879107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777593|NCT05874245|Midazolam|midazolam|mesh-list
82777594|NCT05874245|Dexmedetomidine|dexmedetomidine|mesh-list
82777595|NCT05874245|Ketamine|ketamine|mesh-list
82777596|NCT05874245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82777597|NCT05874245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82777598|NCT05874245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777599|NCT05874245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82777600|NCT05874245|Analgesics|analgesics|mesh-ancestor
82777601|NCT05874245|Sensory System Agents|sensory system agents|mesh-ancestor
82777602|NCT05874245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777603|NCT05874245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83476005|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476006|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83476007|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476008|NCT03008317|Chromium|chromium|mesh-list
83476009|NCT03008317|Trace Elements|trace elements|mesh-ancestor
83476010|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
83476011|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476012|NCT01433107|Terbinafine|terbinafine|mesh-list
83476013|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
83476014|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83476015|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777680|NCT05794230|Vaccines|vaccines|mesh-list
82777681|NCT05794230|Immunologic Factors|immunologic factors|mesh-ancestor
82777682|NCT05794230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777692|NCT05773274|Everolimus|everolimus|mesh-list
82777693|NCT05773274|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
82777694|NCT05773274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82777695|NCT05773274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82777696|NCT05773274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777697|NCT05773274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777698|NCT05773274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82777699|NCT05773274|Immunologic Factors|immunologic factors|mesh-ancestor
82777700|NCT05773274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777701|NCT05773274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777702|NCT05773274|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82777703|NCT05766501|Islatravir|islatravir|mesh-list
82777704|NCT05766501|Antiviral Agents|antiviral agents|mesh-ancestor
82777705|NCT05766501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777706|NCT05766501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777707|NCT05766501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777708|NCT05766501|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82777709|NCT05766501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82777710|NCT05766501|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82777711|NCT05763823|Letermovir|letermovir|mesh-list
82777712|NCT05763823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82777713|NCT05763823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777714|NCT05763823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777727|NCT05730712|Pertuzumab|pertuzumab|mesh-list
83491693|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
83491694|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491695|NCT02684006|Sunitinib|sunitinib|mesh-list
83491696|NCT02684006|Avelumab|avelumab|mesh-list
83491697|NCT02684006|Axitinib|axitinib|mesh-list
83491698|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491699|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83491700|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83491701|NCT02684006|Growth Substances|growth substances|mesh-ancestor
83491702|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491703|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
83491704|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83491705|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777745|NCT05705349|Islatravir|islatravir|mesh-list
82777746|NCT05705349|Antiviral Agents|antiviral agents|mesh-ancestor
82777747|NCT05705349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777748|NCT05705349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777749|NCT05705349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777750|NCT05705349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82777751|NCT05705349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82777752|NCT05705349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82777753|NCT05696080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82777754|NCT05696080|Immunologic Factors|immunologic factors|mesh-ancestor
82777755|NCT05696080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777756|NCT05687136|Peposertib|peposertib|mesh-list
82777757|NCT05687136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82777758|NCT05687136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777760|NCT05687110|Novobiocin|novobiocin|mesh-list
82777808|NCT05630755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777809|NCT05630755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777810|NCT05630755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82777811|NCT05630755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82777812|NCT05630755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82777819|NCT05600894|Decitabine|decitabine|mesh-list
82777820|NCT05600894|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83476016|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476018|NCT01082939|Rituximab|rituximab|mesh-list
83476019|NCT01082939|Fludarabine|fludarabine|mesh-list
83476020|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
83476021|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
83476022|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83476023|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
83476024|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476025|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83476026|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83476027|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
83491854|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
83476028|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476029|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476030|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83476031|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83476032|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83476034|NCT01381471|Fluticasone|fluticasone|mesh-list
83476035|NCT01381471|Xhance|xhance|mesh-list
83476036|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83476037|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83476038|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83476039|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
83476040|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476041|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476042|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83476043|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
83476044|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
83476045|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83476046|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83476047|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83476048|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83476049|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
83476050|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476051|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476052|NCT05422092|Pioglitazone|pioglitazone|mesh-list
83476053|NCT05422092|Canagliflozin|canagliflozin|mesh-list
83476054|NCT05422092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83476055|NCT05422092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476056|NCT05422092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83476057|NCT05422092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476058|NCT05448456|Tranexamic Acid|tranexamic acid|mesh-list
83476059|NCT05448456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83476060|NCT05448456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83476061|NCT05448456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476062|NCT05448456|Hemostatics|hemostatics|mesh-ancestor
83476063|NCT05448456|Coagulants|coagulants|mesh-ancestor
83476064|NCT05448378|Inositol|inositol|mesh-list
83476065|NCT05448378|Vitamin B Complex|vitamin b complex|mesh-ancestor
83476066|NCT05448378|Vitamins|vitamins|mesh-ancestor
83476067|NCT05448378|Micronutrients|micronutrients|mesh-ancestor
83476068|NCT05448378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476069|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
83476070|NCT01434121|Vitamins|vitamins|mesh-ancestor
83476071|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
83476072|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476073|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
83476074|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476075|NCT01434121|Protective Agents|protective agents|mesh-ancestor
83476076|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82778100|NCT05387187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778101|NCT05387187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778102|NCT05387187|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82778103|NCT05387187|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82778104|NCT05387187|Protective Agents|protective agents|mesh-ancestor
82778105|NCT05387187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778106|NCT05387187|Vasodilator Agents|vasodilator agents|mesh-ancestor
82778119|NCT05365893|Losartan|losartan|mesh-list
83476078|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476079|NCT01040819|Pioglitazone|pioglitazone|mesh-list
83476080|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83476081|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476082|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83476084|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83476085|NCT01084265|Hormones|hormones|mesh-list
83476086|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83476087|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476088|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476089|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83476090|NCT01084499|Letrozole|letrozole|mesh-list
83476091|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476092|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83476093|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83476094|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476095|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476096|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83476097|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
83476098|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476099|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476100|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
83476101|NCT01118273|Promethazine|promethazine|mesh-list
83476102|NCT01118273|Ibuprofen|ibuprofen|mesh-list
83476103|NCT01118273|Naproxen|naproxen|mesh-list
83476104|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476105|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83476106|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83476107|NCT01118273|Analgesics|analgesics|mesh-ancestor
83476108|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
83476109|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476110|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476111|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83476112|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83476113|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83476114|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476115|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
83476116|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83476117|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83476118|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82778380|NCT04949256|Tubulin Modulators|tubulin modulators|mesh-ancestor
82778381|NCT04949256|Antimitotic Agents|antimitotic agents|mesh-ancestor
82778382|NCT04949256|Mitosis Modulators|mitosis modulators|mesh-ancestor
82778383|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778463|NCT04880785|Dolutegravir|dolutegravir|mesh-list
82778464|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82778465|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82778466|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778467|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778468|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
82778469|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82778470|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82778471|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82778472|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82778473|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82778474|NCT04874246|Vasopressins|vasopressins|mesh-list
82778475|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
82778476|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
82778477|NCT04874246|Coagulants|coagulants|mesh-ancestor
82778478|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82778479|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82778480|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
82778481|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778483|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82778484|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82778485|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82778486|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778487|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778488|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
82778489|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778490|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778491|NCT04847466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778492|NCT04847466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476120|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
82778539|NCT04777006|Fluoxetine|fluoxetine|mesh-list
83476121|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
83476122|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
83476123|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83476124|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83476125|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
83476126|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
82778679|NCT04600648|Insulin|insulin|mesh-list
82778680|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82778681|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778682|NCT04586023|Teriflunomide|teriflunomide|mesh-list
82778683|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82778685|NCT04586023|Analgesics|analgesics|mesh-ancestor
83476127|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476128|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83476129|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
83476130|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
83476131|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83476132|NCT01085903|Modafinil|modafinil|mesh-list
82778771|NCT04491942|Cisplatin|cisplatin|mesh-list
83476133|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83476134|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476135|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83476136|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83476137|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83476138|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476139|NCT01118741|Disulfiram|disulfiram|mesh-list
83476140|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83476141|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83476142|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476143|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778825|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
82778826|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778827|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778828|NCT04428151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778829|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82778830|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
82778831|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82778832|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778841|NCT04380636|Paclitaxel|paclitaxel|mesh-list
82778842|NCT04380636|Etoposide|etoposide|mesh-list
82778843|NCT04380636|Carboplatin|carboplatin|mesh-list
82778844|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
82778845|NCT04380636|Pemetrexed|pemetrexed|mesh-list
82778846|NCT04380636|Durvalumab|durvalumab|mesh-list
82778847|NCT04380636|Olaparib|olaparib|mesh-list
82778848|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82778849|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778850|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
82778851|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
82778852|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
82778853|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778855|NCT04380636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83476144|NCT01439815|Fluticasone|fluticasone|mesh-list
83476146|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83476147|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83476148|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
83476149|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476150|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476151|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83476152|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
83476153|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
83476154|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82778896|NCT04294810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778897|NCT04294810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778898|NCT04294810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778899|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778900|NCT04266795|Azacitidine|azacitidine|mesh-list
82778901|NCT04266795|Venetoclax|venetoclax|mesh-list
82778902|NCT04266795|Pevonedistat|pevonedistat|mesh-list
82778903|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83476155|NCT01332253|Ibuprofen|ibuprofen|mesh-list
83476156|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83476157|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83476158|NCT01332253|Analgesics|analgesics|mesh-ancestor
83476159|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
83476160|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476161|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476162|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83476163|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83476164|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83476165|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476166|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476167|NCT01332721|Bevacizumab|bevacizumab|mesh-list
83476168|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83476169|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778961|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
82778962|NCT04184609|Albuterol|albuterol|mesh-list
82778963|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82778964|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
82778965|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778966|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778967|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82778968|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
82778969|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
82778970|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82778971|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82778972|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82778973|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82778974|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
82778975|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82778990|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
83476170|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83476171|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83476172|NCT01332721|Growth Substances|growth substances|mesh-ancestor
83476173|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476174|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
83476175|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
83476176|NCT01384591|Losartan|losartan|mesh-list
83476177|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83476178|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83476179|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83476180|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83476181|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83476182|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476183|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
83476184|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83476185|NCT01384591|Expectorants|expectorants|mesh-ancestor
83476186|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
83476187|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83476188|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
83476189|NCT01384591|Protective Agents|protective agents|mesh-ancestor
83476190|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476191|NCT01384591|Antidotes|antidotes|mesh-ancestor
83476192|NCT01086605|Pixantrone|pixantrone|mesh-list
83476193|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83476194|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83476195|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779101|NCT03939897|Fulvestrant|fulvestrant|mesh-list
82779102|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82779103|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779104|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82779105|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82779106|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
83476196|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476198|NCT00265850|Leucovorin|leucovorin|mesh-list
83476199|NCT00265850|Folic Acid|folic acid|mesh-list
83476200|NCT00265850|Bevacizumab|bevacizumab|mesh-list
83476201|NCT00265850|Cetuximab|cetuximab|mesh-list
83476202|NCT00265850|Fluorouracil|fluorouracil|mesh-list
83476203|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
83476204|NCT00265850|Irinotecan|irinotecan|mesh-list
83476205|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
83476206|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83476207|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476208|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83476209|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82779167|NCT03833167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779168|NCT03811002|Cisplatin|cisplatin|mesh-list
82779169|NCT03811002|Carboplatin|carboplatin|mesh-list
82779170|NCT03811002|Etoposide|etoposide|mesh-list
82779171|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
82779172|NCT03811002|Atezolizumab|atezolizumab|mesh-list
82779173|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
82779174|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82779175|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476210|NCT00265850|Growth Substances|growth substances|mesh-ancestor
83476211|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476212|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
83476213|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
83477937|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83476214|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476215|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83476216|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83476217|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
83476218|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83476219|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83476220|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476221|NCT00265850|Antidotes|antidotes|mesh-ancestor
83476222|NCT00265850|Protective Agents|protective agents|mesh-ancestor
83476223|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
83476224|NCT00265850|Vitamins|vitamins|mesh-ancestor
83476225|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
83476227|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83476228|NCT00125372|Bexarotene|bexarotene|mesh-list
83476229|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476230|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83476231|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476232|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476233|NCT00125528|Cycloserine|cycloserine|mesh-list
83476234|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83476235|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83476236|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83476237|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
83476238|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83476239|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
83476240|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476241|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
83476242|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
83476243|NCT01390909|Lactitol|lactitol|mesh-list
83476244|NCT01390909|Cathartics|cathartics|mesh-ancestor
83476245|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83476246|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476247|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83476248|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83476249|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83476250|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83476251|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82779732|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82779733|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
82779734|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
82779735|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779736|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779737|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82779738|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
82779739|NCT02393859|Hormones|hormones|mesh-ancestor
82779740|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476253|NCT01042145|Prednisone|prednisone|mesh-list
83476254|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83476255|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
83476256|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
83476257|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476258|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476259|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83476260|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
83476261|NCT01042145|Hormones|hormones|mesh-ancestor
83477938|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779806|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779807|NCT02233829|Protective Agents|protective agents|mesh-ancestor
82779833|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82779834|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82779835|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779836|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
82779837|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
82779838|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779839|NCT01842386|Rituximab|rituximab|mesh-list
82779840|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779841|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779842|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
82779843|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779844|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82779845|NCT01799538|Albuterol|albuterol|mesh-list
82779846|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82779847|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
82779848|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779849|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779850|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82779851|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
82779852|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
83476355|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476356|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
83476357|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83476358|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83476359|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83476360|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83476361|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476362|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
83476363|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476364|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476365|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83476366|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476367|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
83476368|NCT01089569|Exenatide|exenatide|mesh-list
83476369|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83476370|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476262|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476263|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83476264|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476265|NCT01043393|Desoximetasone|desoximetasone|mesh-list
83476266|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83476267|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
83476268|NCT01043393|Hormones|hormones|mesh-ancestor
83476269|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476270|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476271|NCT01087931|Bupivacaine|bupivacaine|mesh-list
83476272|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
83476273|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
83476274|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82780022|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780023|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
82780024|NCT00353158|Doxycycline|doxycycline|mesh-list
82780025|NCT00353158|Voriconazole|voriconazole|mesh-list
82780026|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82780027|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780028|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
82780029|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82780030|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83476275|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476276|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
83476277|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476278|NCT01336933|Prednisone|prednisone|mesh-list
83476279|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
83476280|NCT01336933|Etoposide|etoposide|mesh-list
83476281|NCT01336933|Vincristine|vincristine|mesh-list
83476282|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
83476283|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83476284|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
83476285|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476286|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83476287|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83476288|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
83476289|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476290|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476291|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83476292|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83476293|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
83476294|NCT01336933|Hormones|hormones|mesh-ancestor
83476295|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476296|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83476297|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83476298|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83476299|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83476300|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476301|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
83476302|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
83476303|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
83476304|NCT03009409|Ketamine|ketamine|mesh-list
83476305|NCT03009409|Analgesics|analgesics|mesh-ancestor
83476306|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
83476307|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476308|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476309|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83476310|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83476311|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
83476312|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
83476313|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476314|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83476315|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83476316|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476317|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476318|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
83476319|NCT00176930|Busulfan|busulfan|mesh-list
83476320|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83476321|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
83476322|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476323|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83476324|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83476325|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
83476326|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476327|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476328|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83476329|NCT01473745|Daminozide|daminozide|mesh-list
83476330|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83476331|NCT01473745|Growth Substances|growth substances|mesh-ancestor
83476332|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476333|NCT00178178|Bupivacaine|bupivacaine|mesh-list
83476334|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
83476335|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
83476336|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476337|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476338|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
83476339|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476340|NCT01441843|Lorazepam|lorazepam|mesh-list
83476374|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476375|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
83476376|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83476377|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83476378|NCT00128180|Prednisolone|prednisolone|mesh-list
83476379|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
83476380|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83476381|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
83476382|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83476383|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
83476384|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
83476385|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476386|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476387|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83476388|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
83476389|NCT00128180|Hormones|hormones|mesh-ancestor
83476390|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476391|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83476392|NCT00128180|Protective Agents|protective agents|mesh-ancestor
83476393|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83476394|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476395|NCT01121939|Bevacizumab|bevacizumab|mesh-list
83476396|NCT01121939|Pertuzumab|pertuzumab|mesh-list
83476397|NCT01121939|Octreotide|octreotide|mesh-list
83476398|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83476399|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476400|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83476401|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83476402|NCT01121939|Growth Substances|growth substances|mesh-ancestor
83476403|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476404|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
83476405|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83476406|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83476407|NCT03013751|Udenafil|udenafil|mesh-list
83476408|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83476409|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83476410|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476411|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476412|NCT01897844|Somatostatin|somatostatin|mesh-list
83476413|NCT01897844|Hormones|hormones|mesh-ancestor
83476414|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476415|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476416|NCT00131378|Hormones|hormones|mesh-list
83476417|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476418|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476419|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
83476420|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83476421|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
83476422|NCT01445821|Fludarabine|fludarabine|mesh-list
83476423|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
83476424|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83476425|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
83476426|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476427|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83476428|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83476429|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
83476430|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476431|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476432|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83476433|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83476434|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
83476435|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
83476436|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476437|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83476438|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
83476439|NCT01445821|Hormones|hormones|mesh-ancestor
83476440|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476441|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83476442|NCT01445821|Protective Agents|protective agents|mesh-ancestor
83476443|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83476444|NCT00182000|Cycloserine|cycloserine|mesh-list
83476445|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83476446|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83476447|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83476480|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476481|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
83476482|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476483|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476484|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83476485|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
83476486|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476488|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
83476489|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83476490|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
83476491|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83476492|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83476493|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
83476494|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83476495|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
83476496|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476497|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476498|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476499|NCT00132002|Vorinostat|vorinostat|mesh-list
83476500|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476501|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83476502|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476503|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476504|NCT00183794|Gemcitabine|gemcitabine|mesh-list
83476505|NCT00183794|Docetaxel|docetaxel|mesh-list
83476506|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83476507|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
83476508|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476509|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476510|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
83476511|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
83476512|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
83476513|NCT00270296|Ritonavir|ritonavir|mesh-list
83476514|NCT00270296|Lopinavir|lopinavir|mesh-list
83476515|NCT00270296|Lamivudine|lamivudine|mesh-list
83476516|NCT00270296|Zidovudine|zidovudine|mesh-list
83476517|NCT00270296|Nevirapine|nevirapine|mesh-list
83476518|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83476519|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83476520|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83476521|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
83476522|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476523|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476524|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83476525|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83476526|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
83476527|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83476528|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83476529|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83476530|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83476531|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83476532|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
83476533|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83476534|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83476535|NCT01047527|Nicotine|nicotine|mesh-list
83476536|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83476537|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
83476538|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476539|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476540|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83476541|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83476542|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
83476543|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476544|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476545|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
83476546|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83476547|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476548|NCT03013127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83476549|NCT03013127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476550|NCT01048697|Ethambutol|ethambutol|mesh-list
83476551|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
83476552|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83476553|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83476554|NCT01049243|Fluocinonide|fluocinonide|mesh-list
83476558|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476559|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476560|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83476561|NCT03013205|Triamcinolone|triamcinolone|mesh-list
83476562|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83476563|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83476564|NCT03013205|Lidocaine|lidocaine|mesh-list
83476565|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83476566|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83476567|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
83476568|NCT03013205|Hormones|hormones|mesh-ancestor
83476569|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476570|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476571|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83476572|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
83476573|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476574|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476575|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
83476576|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
83476577|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476578|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
83476579|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476580|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83476581|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83476582|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83476583|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83476584|NCT01094717|Tazarotene|tazarotene|mesh-list
83476585|NCT01094717|Acitretin|acitretin|mesh-list
83476586|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
83476587|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
83476588|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83476589|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83476590|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83476591|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
83476592|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476593|NCT01095887|Eculizumab|eculizumab|mesh-list
83476594|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83476595|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83476596|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
83476597|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476598|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83476599|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83476600|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476601|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83476602|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
83476603|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476604|NCT03110315|Suvorexant|suvorexant|mesh-list
83476605|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83476606|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83476607|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476608|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476609|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83476610|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476611|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476612|NCT05307341|Sufentanil|sufentanil|mesh-list
83476613|NCT05307341|Dsuvia|dsuvia|mesh-list
83476614|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83476615|NCT05307341|Narcotics|narcotics|mesh-ancestor
83476616|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476617|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476618|NCT05307341|Analgesics|analgesics|mesh-ancestor
83476619|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
83476620|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476621|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83476622|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83476623|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
83476624|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
83476625|NCT01100255|Ketamine|ketamine|mesh-list
83476626|NCT01100255|Analgesics|analgesics|mesh-ancestor
83476627|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
83476628|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476629|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476630|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83476631|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83476638|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476639|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
83476640|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83476641|NCT03012347|Protective Agents|protective agents|mesh-ancestor
83476642|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476643|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
83476644|NCT01100723|Vitamin D|vitamin d|mesh-list
83476645|NCT01100723|Calcitriol|calcitriol|mesh-list
83476646|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83476647|NCT01100723|Cinacalcet|cinacalcet|mesh-list
83476648|NCT01100723|Vitamins|vitamins|mesh-ancestor
83476649|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
83476650|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476651|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83476652|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83476653|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83476654|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83476655|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476656|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83476657|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83476658|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
83476659|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476660|NCT05306405|Misoprostol|misoprostol|mesh-list
83476661|NCT05306405|Estradiol|estradiol|mesh-list
83476662|NCT05306405|Estrogens|estrogens|mesh-ancestor
83476663|NCT05306405|Hormones|hormones|mesh-ancestor
83476664|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476665|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476666|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83476667|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83476668|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
83476669|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83476670|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83476671|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
83476672|NCT04352621|Ketamine|ketamine|mesh-list
83476673|NCT04352621|Analgesics|analgesics|mesh-ancestor
83476674|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
83476675|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476676|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476677|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83476678|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83476679|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
83476680|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
83476681|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476682|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83476683|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83476684|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476685|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476686|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
83476687|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83476688|NCT02246855|Antibodies|antibodies|mesh-list
83476689|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
83476690|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476691|NCT05272397|Methylphenidate|methylphenidate|mesh-list
83476692|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83476693|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476694|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83476695|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83476696|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83476697|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476698|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
83476699|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476700|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
83476701|NCT00185900|Nifedipine|nifedipine|mesh-list
83476702|NCT00185900|Analgesics|analgesics|mesh-ancestor
83476703|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
83476704|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476705|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476706|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
83476707|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476708|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83476709|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
83476710|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83476711|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83476712|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476713|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83476714|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
83476715|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83476716|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
83476717|NCT00186056|Mifepristone|mifepristone|mesh-list
83476718|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83476719|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
83476720|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83476721|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476722|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83476723|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83476724|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83476725|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
83476726|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83476727|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83476728|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
83476729|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476730|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
83476731|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83476732|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83476733|NCT00186446|Bupropion|bupropion|mesh-list
83476734|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83476735|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
83476736|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83476737|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83476738|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83476739|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83476740|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476741|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
83476742|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476743|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476744|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83476745|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83476746|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476747|NCT00136760|Bupropion|bupropion|mesh-list
83476748|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83476749|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
83476750|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83476751|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83476752|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83476753|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83476754|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476755|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
83476756|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476757|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476758|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83476759|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83476760|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476761|NCT00189098|Trimethoprim|trimethoprim|mesh-list
83476762|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83476763|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
83476764|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83476765|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83476766|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
83476767|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83476768|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83476769|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83476770|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476771|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476772|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83476773|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83476774|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83476775|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83476776|NCT00145418|Docetaxel|docetaxel|mesh-list
83476777|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
83476778|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476779|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
83476780|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
83476781|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
83476782|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476784|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83476785|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83476786|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83476787|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476788|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476789|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476790|NCT04751318|Analgesics|analgesics|mesh-ancestor
83476791|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
83476792|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476793|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
83476794|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83476795|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
83476796|NCT01107665|Paclitaxel|paclitaxel|mesh-list
83476797|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83476798|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476799|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
83476800|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
83476801|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
83476802|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476803|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
83476804|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83476805|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476806|NCT01447225|Carboplatin|carboplatin|mesh-list
83476807|NCT01447225|Gemcitabine|gemcitabine|mesh-list
83476808|NCT01447225|Pemetrexed|pemetrexed|mesh-list
83476809|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476810|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83476811|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
83476812|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476813|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476814|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83476815|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83476816|NCT01447849|Lubiprostone|lubiprostone|mesh-list
83476817|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83476818|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83476819|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476820|NCT00277394|Heparin|heparin|mesh-list
83476821|NCT00277394|Tinzaparin|tinzaparin|mesh-list
83476822|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
83476823|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83476824|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83476825|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476826|NCT01450189|Tenofovir|tenofovir|mesh-list
83476827|NCT01450189|Emtricitabine|emtricitabine|mesh-list
83476828|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
83476829|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83476830|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
83476831|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83476832|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83476833|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83476834|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476835|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476836|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83476837|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83476838|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83476839|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83476840|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
83476841|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476842|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83476843|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476844|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476845|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
83476846|NCT01474213|Remifentanil|remifentanil|mesh-list
83476847|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83476848|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476849|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476850|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83476851|NCT01474213|Analgesics|analgesics|mesh-ancestor
83476852|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
83476853|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476854|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83476855|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83476856|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83476859|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476860|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83476862|NCT00147212|Trabectedin|trabectedin|mesh-list
83476863|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83476864|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
83476865|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476866|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476867|NCT01474915|Promethazine|promethazine|mesh-list
83476868|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
83476869|NCT01474915|Dexamethasone|dexamethasone|mesh-list
83476870|NCT01474915|Ondansetron|ondansetron|mesh-list
83476871|NCT01474915|Aprepitant|aprepitant|mesh-list
83476872|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83476873|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
83476874|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
83476875|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476876|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476877|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83476878|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
83476879|NCT01474915|Hormones|hormones|mesh-ancestor
83476880|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476881|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83476882|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476883|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
83476884|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
83476885|NCT01474915|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83476886|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83476887|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
83476888|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476889|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476890|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83476891|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83476892|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
83476893|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
83476894|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83476895|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83476896|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83476897|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476898|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
83476899|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
83476900|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
83476901|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
83476902|NCT01899794|Oxybutynin|oxybutynin|mesh-list
83476903|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
83476904|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
83476905|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476906|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476907|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83476908|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83476909|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
83476910|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476911|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476912|NCT01899794|Urological Agents|urological agents|mesh-ancestor
83476913|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83476914|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83476915|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
83476916|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83476917|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83476918|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83476919|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83476920|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476921|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
83476922|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476923|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476924|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83476925|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476926|NCT02099084|Teduglutide|teduglutide|mesh-list
83476927|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83476928|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83476929|NCT02099084|Protective Agents|protective agents|mesh-ancestor
83476930|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476931|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
83476932|NCT00281918|Rituximab|rituximab|mesh-list
83476933|NCT00281918|Fludarabine|fludarabine|mesh-list
83476941|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476942|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476943|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83476944|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83476945|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83476946|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
83476947|NCT00201734|Paclitaxel|paclitaxel|mesh-list
83476948|NCT00201734|Carboplatin|carboplatin|mesh-list
83476949|NCT00201734|Capecitabine|capecitabine|mesh-list
83476950|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83476951|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476952|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
83476953|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
83476954|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
83476955|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476956|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83476957|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
83476958|NCT00203216|Levetiracetam|levetiracetam|mesh-list
83476959|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
83476960|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
83476961|NCT05156060|Ketamine|ketamine|mesh-list
83476962|NCT05156060|Gabapentin|gabapentin|mesh-list
83476963|NCT05156060|Analgesics|analgesics|mesh-ancestor
83476964|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
83476965|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476966|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476967|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83476968|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83476969|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
83476970|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
83476971|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83476972|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83476973|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83476974|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476975|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476976|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
83476977|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83476978|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83476979|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83476980|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
83476981|NCT00206336|Topiramate|topiramate|mesh-list
83476982|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
83476983|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83476984|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476986|NCT00210470|Indomethacin|indomethacin|mesh-list
83476987|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
83476988|NCT00210470|Omeprazole|omeprazole|mesh-list
83476989|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83476990|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
83476991|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476992|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83476993|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83476994|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
83476995|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476996|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83476997|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83476998|NCT00210470|Trace Elements|trace elements|mesh-ancestor
83476999|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
83477000|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83477001|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83477002|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83477003|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477004|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83477005|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83477006|NCT00210470|Analgesics|analgesics|mesh-ancestor
83477007|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
83477008|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477009|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83477010|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
83477011|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
83477012|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83477013|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83477015|NCT01108445|Sunitinib|sunitinib|mesh-list
83477016|NCT01108445|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83477017|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83477018|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477019|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477020|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83477021|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
83477022|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477023|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477024|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83477025|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83477026|NCT01108445|Growth Substances|growth substances|mesh-ancestor
83477027|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
83477028|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83477029|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83477030|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477031|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83477032|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
83477033|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83477034|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83477036|NCT04352153|Citric Acid|citric acid|mesh-list
83477037|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
83477038|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83477039|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
83477040|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
83477041|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477042|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
83477043|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477044|NCT05215067|Docetaxel|docetaxel|mesh-list
83477045|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477046|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
83477047|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
83477048|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
83477049|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477050|NCT01162733|Vancomycin|vancomycin|mesh-list
83477051|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83477052|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477053|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
83477054|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
83477055|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477056|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
83477057|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477058|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477059|NCT05410860|Etripamil|etripamil|mesh-list
83477060|NCT05410860|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83477061|NCT05410860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83477062|NCT05410860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477063|NCT05410860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83477064|NCT05410860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477065|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
83477066|NCT01131065|Antibodies|antibodies|mesh-list
83477067|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
83477068|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83477069|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83477070|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
83477071|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477072|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83477073|NCT01165541|Mirtazapine|mirtazapine|mesh-list
83477074|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
83477075|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83477076|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83477077|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83477078|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477079|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477080|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83477082|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
83477083|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477084|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477085|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83477086|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83477087|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83477088|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83477089|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
83477090|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83477091|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83477092|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
83477093|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83477098|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83477099|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
83477100|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477101|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83477102|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83477103|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83477104|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83477105|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477106|NCT00287222|Bevacizumab|bevacizumab|mesh-list
83477107|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83477108|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83477109|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477110|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83477111|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83477112|NCT00287222|Growth Substances|growth substances|mesh-ancestor
83477113|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477114|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
83477115|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83477116|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477117|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477118|NCT00218426|Naltrexone|naltrexone|mesh-list
83477119|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83477120|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83477121|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477122|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
83477123|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477124|NCT01134575|Rituximab|rituximab|mesh-list
83477125|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83477126|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83477127|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477128|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
83477129|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477130|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477131|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83477132|NCT01134575|Immunotoxins|immunotoxins|mesh-ancestor
83477133|NCT01134575|Immunoconjugates|immunoconjugates|mesh-ancestor
83477134|NCT01790672|Ethanol|ethanol|mesh-list
83477135|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83477136|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477137|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477138|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477139|NCT00223262|Lamotrigine|lamotrigine|mesh-list
83477140|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
83477141|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83477142|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83477143|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477144|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83477145|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477146|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83477147|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83477148|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477149|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83477150|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83477151|NCT00290654|Tamoxifen|tamoxifen|mesh-list
83477152|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83477153|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
83477154|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83477155|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477156|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83477157|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477158|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83477159|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83477160|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83477161|NCT00290810|Bevacizumab|bevacizumab|mesh-list
83477162|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83477163|NCT00290810|Antibodies|antibodies|mesh-list
83477164|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
83477165|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83477166|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477167|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83477168|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83477169|NCT00290810|Growth Substances|growth substances|mesh-ancestor
83477170|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477176|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83477177|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477178|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
83477179|NCT01138475|Vitamin D|vitamin d|mesh-list
83477180|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83477181|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477182|NCT01138475|Vitamins|vitamins|mesh-ancestor
83477183|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
83477184|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83477185|NCT00293540|Tamoxifen|tamoxifen|mesh-list
83477186|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83477187|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
83477188|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83477189|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477190|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83477191|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477192|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83477193|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83477194|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83477195|NCT03012113|Mirabegron|mirabegron|mesh-list
83477196|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83477197|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83477198|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83477199|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83477200|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477201|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477202|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477203|NCT03012113|Urological Agents|urological agents|mesh-ancestor
83477204|NCT01139801|Misoprostol|misoprostol|mesh-list
83477205|NCT01139801|Oxytocin|oxytocin|mesh-list
83477206|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
83477207|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83477208|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477209|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83477210|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
83477211|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83477212|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83477213|NCT00294632|Rituximab|rituximab|mesh-list
83477214|NCT00294632|Lenalidomide|lenalidomide|mesh-list
83477215|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83477216|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477217|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
83477218|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477219|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477220|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83477221|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83477222|NCT00294632|Growth Substances|growth substances|mesh-ancestor
83477223|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
83477224|NCT01898624|Mirabegron|mirabegron|mesh-list
83477225|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83477226|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83477227|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83477228|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
83477229|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477230|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477231|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477232|NCT01898624|Urological Agents|urological agents|mesh-ancestor
83477233|NCT01140191|Gentamicins|gentamicins|mesh-list
83477234|NCT01140191|Paromomycin|paromomycin|mesh-list
83477235|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83477236|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477237|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83477238|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477239|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477240|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83477241|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83477242|NCT01141049|Gabapentin|gabapentin|mesh-list
83477243|NCT01141049|Analgesics|analgesics|mesh-ancestor
83477244|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
83477245|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477246|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477247|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
83477248|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83477249|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83477255|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477256|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
83477257|NCT01141595|Verapamil|verapamil|mesh-list
83477258|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83477259|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83477260|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83477261|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477262|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83477263|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477264|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
83477265|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
83477266|NCT01167569|Vitamins|vitamins|mesh-ancestor
83477267|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
83477268|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477269|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
83477270|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477271|NCT01167569|Protective Agents|protective agents|mesh-ancestor
83477272|NCT00296192|Rotigotine|rotigotine|mesh-list
83477273|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
83477274|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
83477275|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477276|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477277|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477278|NCT04312139|Lincomycin|lincomycin|mesh-list
83477279|NCT04312139|Calcium|calcium|mesh-list
83477280|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83477281|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477282|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83477283|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477284|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83477285|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477286|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477287|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
83477288|NCT00297596|Trastuzumab|trastuzumab|mesh-list
83477289|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477290|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83477291|NCT01144637|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83477292|NCT01144637|Antiviral Agents|antiviral agents|mesh-ancestor
83477293|NCT01144637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477294|NCT00298610|Artesunate|artesunate|mesh-list
83477295|NCT00298610|Atovaquone|atovaquone|mesh-list
83477296|NCT00298610|Proguanil|proguanil|mesh-list
83477297|NCT00298610|Quinidine|quinidine|mesh-list
83477298|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83477299|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
83477300|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83477301|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83477302|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477303|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477304|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
83477305|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
83477306|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83477307|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
83477308|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477309|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477310|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
83477311|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83477312|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83477313|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
83477314|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477315|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477316|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83477317|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83477318|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83477319|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
83477320|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83477321|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83477322|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83477323|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83477324|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83477325|NCT01144949|Silodosin|silodosin|mesh-list
83477326|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83477327|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83477328|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83477331|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477332|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477333|NCT01144949|Urological Agents|urological agents|mesh-ancestor
83477334|NCT00215930|Carboplatin|carboplatin|mesh-list
83477335|NCT00215930|Gemcitabine|gemcitabine|mesh-list
83477336|NCT00215930|Docetaxel|docetaxel|mesh-list
83477337|NCT00215930|Vinorelbine|vinorelbine|mesh-list
83477338|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477339|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83477340|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
83477341|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477342|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
83477343|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
83477344|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
83477345|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83477346|NCT01145183|Doxazosin|doxazosin|mesh-list
83477347|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83477348|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83477349|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83477350|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83477351|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
83477352|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477353|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477354|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477355|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83477356|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477357|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83477358|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477359|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477360|NCT04128722|Sirolimus|sirolimus|mesh-list
83477361|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83477362|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477363|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83477364|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477365|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
83477366|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83477367|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
83477368|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477369|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
83477370|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
83477371|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83477372|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83477373|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477374|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477375|NCT01169519|Urological Agents|urological agents|mesh-ancestor
83477376|NCT04071977|Antioxidants|antioxidants|mesh-list
83477377|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477378|NCT04071977|Protective Agents|protective agents|mesh-ancestor
83477379|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477380|NCT02101190|Opicapone|opicapone|mesh-list
83477381|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83477382|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477383|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477384|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83477385|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83477386|NCT01170533|Omeprazole|omeprazole|mesh-list
83477387|NCT01170533|Pantoprazole|pantoprazole|mesh-list
83477388|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83477389|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83477390|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83477391|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477392|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477393|NCT01147601|Timolol|timolol|mesh-list
83477394|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83477395|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83477396|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
83477397|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477398|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477399|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477400|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83477401|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83477402|NCT03011645|Ziprasidone|ziprasidone|mesh-list
83477403|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83477404|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
83477406|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477407|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477408|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83477409|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83477410|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477411|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83477412|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83477413|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
83477415|NCT01149785|Crizotinib|crizotinib|mesh-list
83477416|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
83477417|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477418|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83477419|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83477420|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477421|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477422|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83477423|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
83477424|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83477425|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477426|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83477427|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477428|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83477429|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83477430|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477431|NCT03011567|Acetaminophen|acetaminophen|mesh-list
83477432|NCT03011567|Ibuprofen|ibuprofen|mesh-list
83477433|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83477434|NCT03011567|Analgesics|analgesics|mesh-ancestor
83477435|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
83477436|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477437|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477438|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
83477439|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83477440|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83477441|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477442|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83477443|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477444|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477445|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
83477446|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
83477447|NCT01173029|Diuretics|diuretics|mesh-list
83477448|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83477449|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83477450|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83477451|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83477452|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83477453|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477455|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477456|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
83477457|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477458|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83477459|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
83477460|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83477461|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83477462|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
83477463|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83477464|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83477465|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83477466|NCT03886649|Venetoclax|venetoclax|mesh-list
83477467|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477468|NCT01151813|Varenicline|varenicline|mesh-list
83477469|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83477470|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83477471|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
83477472|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477473|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477474|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477475|NCT03877991|Cannabidiol|cannabidiol|mesh-list
83477476|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
83477477|NCT03835949|Atezolizumab|atezolizumab|mesh-list
83477478|NCT03835949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83477479|NCT03835949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477480|NCT03835949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83477481|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477483|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83477484|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477485|NCT01179113|Esmolol|esmolol|mesh-list
83477486|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83477487|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83477488|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83477489|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83477490|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477491|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477492|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477493|NCT01152515|Remifentanil|remifentanil|mesh-list
83477494|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83477495|NCT01152515|Narcotics|narcotics|mesh-ancestor
83477496|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477497|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477498|NCT01152515|Analgesics|analgesics|mesh-ancestor
83477499|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
83477500|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477501|NCT03011177|Linagliptin|linagliptin|mesh-list
83477502|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83477503|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477504|NCT03011177|Incretins|incretins|mesh-ancestor
83477505|NCT03011177|Hormones|hormones|mesh-ancestor
83477506|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83477507|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83477508|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
83477509|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477510|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477511|NCT03465527|Prednisolone|prednisolone|mesh-list
83477512|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83477513|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
83477514|NCT03465527|Hormones|hormones|mesh-ancestor
83477515|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83477516|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477517|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83477518|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477519|NCT03418805|Ibuprofen|ibuprofen|mesh-list
83477520|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83477521|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83477522|NCT03418805|Analgesics|analgesics|mesh-ancestor
83477523|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
83477524|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477525|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477526|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83477527|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477528|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83477529|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477530|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477531|NCT01156571|Clopidogrel|clopidogrel|mesh-list
83477532|NCT01156571|Cangrelor|cangrelor|mesh-list
83477533|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83477534|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83477535|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83477536|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83477537|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
83477538|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477539|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477540|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477541|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
83477542|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83477543|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
83477544|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477545|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477546|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83477547|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
83477548|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83477549|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
83477550|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477552|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83477553|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
83477554|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
83477555|NCT01220687|Protective Agents|protective agents|mesh-ancestor
83477556|NCT03010865|Butyric Acid|butyric acid|mesh-list
83477557|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
83477558|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
83477559|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477560|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477561|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477562|NCT01157429|Cycloserine|cycloserine|mesh-list
83477563|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83477564|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477565|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83477566|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
83477567|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83477568|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
83477569|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477570|NCT00234884|Adalimumab|adalimumab|mesh-list
83477571|NCT00234884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83477572|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83477573|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477574|NCT04388774|Ketamine|ketamine|mesh-list
83477575|NCT04388774|Analgesics|analgesics|mesh-ancestor
83477576|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
83477577|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477578|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477579|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83477580|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83477581|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
83477582|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
83477583|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477584|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83477585|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83477586|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477587|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477588|NCT01602666|Carboplatin|carboplatin|mesh-list
83477589|NCT01602666|Etoposide|etoposide|mesh-list
83477590|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
83477591|NCT01602666|Ifosfamide|ifosfamide|mesh-list
83477592|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
83477593|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
83477594|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477595|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83477596|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83477597|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83477598|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477599|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477600|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83477601|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
83477602|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
83477603|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
83477604|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
83477605|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
83477606|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
83477607|NCT05442060|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83477608|NCT05442060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477609|NCT05442060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83477610|NCT05442060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477611|NCT05442060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477612|NCT05441592|Tranexamic Acid|tranexamic acid|mesh-list
83477613|NCT05441592|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83477614|NCT05441592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83477615|NCT05441592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477616|NCT05441592|Hemostatics|hemostatics|mesh-ancestor
83477617|NCT05441592|Coagulants|coagulants|mesh-ancestor
83477618|NCT05415462|Vaccines|vaccines|mesh-list
83477619|NCT05415462|Immunologic Factors|immunologic factors|mesh-ancestor
83477620|NCT05415462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477621|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83477622|NCT00300482|Calcium|calcium|mesh-list
83477623|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83477624|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477625|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83477626|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83477628|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477629|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83477630|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83477631|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477632|NCT05439876|Melatonin|melatonin|mesh-list
83477633|NCT05439876|Antioxidants|antioxidants|mesh-ancestor
83477634|NCT05439876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477635|NCT05439876|Protective Agents|protective agents|mesh-ancestor
83477636|NCT05439876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477637|NCT05439876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477638|NCT00301028|Paclitaxel|paclitaxel|mesh-list
83477639|NCT00301028|Carboplatin|carboplatin|mesh-list
83477640|NCT00301028|Cetuximab|cetuximab|mesh-list
83477641|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83477642|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477643|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
83477644|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
83477645|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
83477646|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477647|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83477648|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83477649|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477650|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83477651|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477652|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477653|NCT05414838|Vitamin D|vitamin d|mesh-list
83477654|NCT05414838|Curcumin|curcumin|mesh-list
83477655|NCT05414838|Vitamins|vitamins|mesh-ancestor
83477656|NCT05414838|Micronutrients|micronutrients|mesh-ancestor
83477657|NCT05414838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477658|NCT05414838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83477659|NCT05414838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83477660|NCT05414838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83477661|NCT05414838|Analgesics|analgesics|mesh-ancestor
83477662|NCT05414838|Sensory System Agents|sensory system agents|mesh-ancestor
83477663|NCT05414838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477664|NCT05414838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83477665|NCT05414838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477666|NCT05414838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477667|NCT05414838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477668|NCT05414838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477669|NCT05414214|Anesthetics|anesthetics|mesh-list
83477670|NCT05414214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477671|NCT05414214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477672|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
83477673|NCT05014230|Narcotics|narcotics|mesh-ancestor
83477674|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477675|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477676|NCT05014230|Analgesics|analgesics|mesh-ancestor
83477677|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
83477678|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477679|NCT01896284|Aflibercept|aflibercept|mesh-list
83477680|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83477681|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83477682|NCT01896284|Growth Substances|growth substances|mesh-ancestor
83477683|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477684|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
83477685|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477686|NCT05438160|Coal Tar|coal tar|mesh-list
83477687|NCT05438160|Keratolytic Agents|keratolytic agents|mesh-ancestor
83477688|NCT05438160|Dermatologic Agents|dermatologic agents|mesh-ancestor
83477689|NCT03954990|Metronidazole|metronidazole|mesh-list
83477690|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477691|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83477692|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83477693|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83477694|NCT01478581|Dexamethasone|dexamethasone|mesh-list
83477695|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83477696|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
83477697|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
83477698|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477699|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477700|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83477701|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
83477702|NCT01478581|Hormones|hormones|mesh-ancestor
83477939|NCT05265962|Decitabine|decitabine|mesh-list
83477703|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83477704|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83477705|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477706|NCT00239642|Iron|iron|mesh-list
83477707|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83477708|NCT00239642|Trace Elements|trace elements|mesh-ancestor
83477709|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
83477710|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477711|NCT00239642|Hematinics|hematinics|mesh-ancestor
83477712|NCT01351896|Lenalidomide|lenalidomide|mesh-list
83477713|NCT01351896|Vaccines|vaccines|mesh-list
83477714|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83477715|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
83477716|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477717|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83477718|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83477719|NCT01351896|Growth Substances|growth substances|mesh-ancestor
83477720|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
83477721|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477722|NCT00241904|Propranolol|propranolol|mesh-list
83477723|NCT00241904|Metoprolol|metoprolol|mesh-list
83477724|NCT00241904|Atenolol|atenolol|mesh-list
83477725|NCT00241904|Lisinopril|lisinopril|mesh-list
83477726|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83477727|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83477728|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83477729|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83477730|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
83477731|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477732|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477733|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477734|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83477735|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83477736|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
83477737|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
83477738|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
83477739|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477740|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83477741|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
83477742|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477743|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83477744|NCT00241904|Protective Agents|protective agents|mesh-ancestor
83477745|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
83477746|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83477747|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477748|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477749|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83477750|NCT01791296|Analgesics|analgesics|mesh-ancestor
83477751|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
83477752|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477753|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83477754|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83477755|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83477756|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
83477757|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477758|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477759|NCT01479127|Silicon|silicon|mesh-list
83477760|NCT01479127|Levodopa|levodopa|mesh-list
83477761|NCT01479127|Carbidopa|carbidopa|mesh-list
83477762|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83477763|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83477764|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
83477765|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477766|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477767|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477768|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83477769|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477770|NCT01479127|Trace Elements|trace elements|mesh-ancestor
83477771|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
83477772|NCT03917966|Docetaxel|docetaxel|mesh-list
83477773|NCT03917966|Apatinib|apatinib|mesh-list
83477774|NCT03917966|Nedaplatin|nedaplatin|mesh-list
83477775|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477776|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
83477777|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
83477778|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
83478014|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83477779|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477780|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83477781|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477782|NCT00243152|Lamotrigine|lamotrigine|mesh-list
83477783|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
83477784|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83477785|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83477786|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477787|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83477788|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477789|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83477790|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83477791|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477792|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83477793|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83477794|NCT01453075|Valacyclovir|valacyclovir|mesh-list
83477795|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
83477796|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477797|NCT01791374|Rilotumumab|rilotumumab|mesh-list
83477798|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83477799|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83477800|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477801|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
83477802|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477803|NCT03783416|Ixazomib|ixazomib|mesh-list
83477804|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477805|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
83477806|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477807|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477808|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
83477809|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83477810|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83477811|NCT00248534|Prednisolone|prednisolone|mesh-list
83477812|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
83477813|NCT00248534|Rituximab|rituximab|mesh-list
83477814|NCT00248534|Temozolomide|temozolomide|mesh-list
83477815|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83477816|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
83477817|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83477818|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477819|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
83477820|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477821|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477822|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83477823|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
83477824|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477825|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83477826|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
83477827|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
83477828|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477829|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83477830|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
83477832|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83477833|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83477834|NCT00248534|Protective Agents|protective agents|mesh-ancestor
83477835|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83477836|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83477837|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83477838|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83477839|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83477840|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477841|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477842|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477843|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83477844|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
83477845|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83477846|NCT05266820|Thalidomide|thalidomide|mesh-list
83477847|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83477848|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
83477849|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477850|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
83477851|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83477852|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477861|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83477862|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83477863|NCT01454791|Analgesics|analgesics|mesh-ancestor
83477864|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
83477865|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477866|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477867|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83477868|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477869|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83477870|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477871|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477872|NCT02099006|Ketoprofen|ketoprofen|mesh-list
83477873|NCT02099006|Ketamine|ketamine|mesh-list
83477874|NCT02099006|Gabapentin|gabapentin|mesh-list
83477875|NCT02099006|Amitriptyline|amitriptyline|mesh-list
83477876|NCT02099006|Baclofen|baclofen|mesh-list
83477877|NCT02099006|Loperamide|loperamide|mesh-list
83477878|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
83477879|NCT02099006|Analgesics|analgesics|mesh-ancestor
83477880|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
83477881|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477882|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477883|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83477884|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83477885|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
83477886|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
83477887|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477888|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83477889|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83477890|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477891|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477892|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
83477893|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83477894|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83477895|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83477896|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
83477897|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83477898|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83477899|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83477900|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
83477901|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
83477902|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83477903|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83477904|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83477905|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477906|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83477907|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477908|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83477909|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
83477910|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83477911|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83477912|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83477913|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
83477914|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83477915|NCT05266274|Azacitidine|azacitidine|mesh-list
83477916|NCT05266274|Antibodies|antibodies|mesh-list
83477917|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83477918|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
83477919|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477920|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83477921|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
83477922|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477923|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477924|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477925|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
83477926|NCT05266196|Topotecan|topotecan|mesh-list
83477927|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83477928|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
83477929|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477930|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477931|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83477932|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
83477933|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477934|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477935|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83477936|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83477942|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477943|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477945|NCT00324896|Eszopiclone|eszopiclone|mesh-list
83477946|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83477947|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477948|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477949|NCT01479517|Tetracaine|tetracaine|mesh-list
83477950|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
83477951|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
83477952|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83477953|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477954|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
83477955|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477956|NCT01480219|Voriconazole|voriconazole|mesh-list
83477957|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
83477958|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83477959|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83477960|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83477961|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477962|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477963|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83477964|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
83477965|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83477966|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477967|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83477968|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83477969|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
83477970|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83477971|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83477972|NCT01480297|Analgesics|analgesics|mesh-ancestor
83477973|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
83477974|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83477975|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477976|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83477977|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83477978|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83477979|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477980|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477981|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
83477982|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83477983|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477984|NCT01392703|Dasatinib|dasatinib|mesh-list
83477985|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83477986|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83477987|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477988|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477989|NCT01392859|Levocetirizine|levocetirizine|mesh-list
83477990|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83477991|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83477992|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
83477993|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
83477994|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83477995|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83477996|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83477997|NCT01457521|Ibuprofen|ibuprofen|mesh-list
83477998|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83477999|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83478000|NCT01457521|Analgesics|analgesics|mesh-ancestor
83478001|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
83478002|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478003|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478004|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83478005|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83478006|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83478007|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478008|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478009|NCT00325442|Treprostinil|treprostinil|mesh-list
83478010|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83478011|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83478012|NCT01393717|Antibodies|antibodies|mesh-list
83478013|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
83478043|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478044|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83478045|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478046|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
83478047|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83478048|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478050|NCT01481545|Protective Agents|protective agents|mesh-ancestor
83478051|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
83478053|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
83478054|NCT01482091|Fentanyl|fentanyl|mesh-list
83478055|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83478056|NCT01482091|Narcotics|narcotics|mesh-ancestor
83478057|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83478058|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478059|NCT01482091|Analgesics|analgesics|mesh-ancestor
83478060|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
83478061|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478062|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83478063|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83478064|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
83478065|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
83478066|NCT00327392|Fospropofol|fospropofol|mesh-list
83478067|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83478068|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83478069|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478070|NCT01791608|Zinc|zinc|mesh-list
83478071|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
83478072|NCT01791608|Trace Elements|trace elements|mesh-ancestor
83478073|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
83478074|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478075|NCT01791608|Astringents|astringents|mesh-ancestor
83478076|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
83478077|NCT04346030|Triamcinolone|triamcinolone|mesh-list
83478078|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83478079|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83478080|NCT04346030|Lidocaine|lidocaine|mesh-list
83478081|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83478082|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
83478083|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
83478084|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83478085|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478086|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
83478087|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478088|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83478089|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83478090|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83478091|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83478092|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478093|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83478094|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
83478095|NCT04346030|Hormones|hormones|mesh-ancestor
83478096|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83478097|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478098|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
83478099|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478100|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
83478101|NCT05075330|Narcotics|narcotics|mesh-ancestor
83478102|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83478103|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478104|NCT05075330|Analgesics|analgesics|mesh-ancestor
83478105|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
83478106|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478107|NCT02108288|Carteolol|carteolol|mesh-list
83478108|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83478109|NCT02108288|Latanoprost|latanoprost|mesh-list
83478110|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83478111|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83478112|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83478113|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
83478114|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478115|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478116|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478117|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83478118|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83478119|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
83478144|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478145|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83478146|NCT00335504|Sulindac|sulindac|mesh-list
83478147|NCT00335504|Atorvastatin|atorvastatin|mesh-list
83478148|NCT00335504|Calcium|calcium|mesh-list
83478149|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83478150|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478151|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83478152|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83478153|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
83478154|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478155|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83478156|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83478157|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478158|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83478159|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83478160|NCT00335504|Analgesics|analgesics|mesh-ancestor
83478161|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
83478162|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478163|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83478164|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83478165|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478166|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83478167|NCT01183169|Ribavirin|ribavirin|mesh-list
83478168|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83478169|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
83478170|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478171|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
83478172|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478173|NCT01183481|Aprepitant|aprepitant|mesh-list
83478174|NCT01183481|Granisetron|granisetron|mesh-list
83478175|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
83478176|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
83478177|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478178|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478179|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83478180|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83478181|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478182|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478183|NCT01183481|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83478184|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83478185|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
83478186|NCT01183559|Paclitaxel|paclitaxel|mesh-list
83478187|NCT01183559|Carboplatin|carboplatin|mesh-list
83478188|NCT01183559|Fluorouracil|fluorouracil|mesh-list
83478189|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83478190|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478191|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
83478192|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
83478193|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
83478194|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478196|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83478197|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478198|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
83478199|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478200|NCT01184417|Phenobarbital|phenobarbital|mesh-list
83478201|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
83478202|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83478203|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83478204|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478205|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83478206|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83478207|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478208|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478209|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
83478210|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
83478211|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83478212|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83478213|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83478214|NCT01159067|Deferasirox|deferasirox|mesh-list
83478215|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83478216|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
83478217|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
83478218|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478219|NCT01222091|Propranolol|propranolol|mesh-list
83478220|NCT01222091|Remifentanil|remifentanil|mesh-list
83478221|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83478222|NCT01222091|Narcotics|narcotics|mesh-ancestor
83478223|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83478224|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478225|NCT01222091|Analgesics|analgesics|mesh-ancestor
83478226|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
83478227|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478228|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83478229|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83478230|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
83478231|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478232|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478233|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83478234|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83478235|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
83478236|NCT01225055|Teriparatide|teriparatide|mesh-list
83478237|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83478238|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478239|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83478240|NCT01336140|Aminophylline|aminophylline|mesh-list
83478241|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83478242|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
83478243|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478244|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478245|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83478246|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
83478247|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83478248|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83478249|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478250|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478251|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83478252|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83478253|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
83478254|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478255|NCT01336140|Protective Agents|protective agents|mesh-ancestor
83478256|NCT01184885|Sirolimus|sirolimus|mesh-list
83478257|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
83478258|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83478259|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478260|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478261|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83478262|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478263|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
83478264|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478265|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
83478266|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478267|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83478268|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83478269|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
83478270|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83478271|NCT01187381|Trastuzumab|trastuzumab|mesh-list
83478272|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83478273|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478274|NCT01225289|Vitamin A|vitamin a|mesh-list
83478275|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
83478276|NCT01225289|Vitamins|vitamins|mesh-ancestor
83478277|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
83478278|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478279|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
83478280|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478281|NCT01225289|Protective Agents|protective agents|mesh-ancestor
83478282|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83478283|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478284|NCT01161563|Leuprolide|leuprolide|mesh-list
83478285|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83478286|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83478287|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
83478288|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83478289|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478290|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83478291|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478292|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
83478306|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83478307|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478309|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
83478310|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478311|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83478312|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83478313|NCT02191865|Nintedanib|nintedanib|mesh-list
83478314|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478315|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83478316|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478317|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478318|NCT04352465|Methotrexate|methotrexate|mesh-list
83478319|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83478320|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
83478321|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83478322|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478323|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83478324|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
83478325|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478326|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478327|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
83478328|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478329|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83478330|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478331|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
83478332|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83478333|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83478334|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
83478335|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83478336|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478337|NCT00343460|Dexamethasone|dexamethasone|mesh-list
83478338|NCT00343460|Palonosetron|palonosetron|mesh-list
83478339|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83478340|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
83478341|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
83478342|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478343|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478344|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83478345|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
83478346|NCT00343460|Hormones|hormones|mesh-ancestor
83478347|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83478348|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83478349|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478350|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83478351|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83478352|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
83478353|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478354|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478355|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
83478356|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
83478357|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83478358|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478359|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83478360|NCT01192139|Metformin|metformin|mesh-list
83478361|NCT01192139|Saxagliptin|saxagliptin|mesh-list
83478362|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83478363|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478364|NCT01192139|Incretins|incretins|mesh-ancestor
83478365|NCT01192139|Hormones|hormones|mesh-ancestor
83478366|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83478367|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83478368|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
83478369|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478370|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478371|NCT04892186|Inositol|inositol|mesh-list
83478372|NCT04892186|Metformin|metformin|mesh-list
83478373|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83478374|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478375|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
83478376|NCT04892186|Vitamins|vitamins|mesh-ancestor
83478377|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
83478378|NCT01229423|Bimatoprost|bimatoprost|mesh-list
83478379|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83478448|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478449|NCT00305162|Clopidogrel|clopidogrel|mesh-list
83478450|NCT00305162|Cangrelor|cangrelor|mesh-list
83478451|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83478452|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83478453|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83478454|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83478455|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
83478456|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478457|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478458|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478459|NCT00351416|Letrozole|letrozole|mesh-list
83478460|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83478461|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
83478462|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478463|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83478464|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478465|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478466|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83478467|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
83478468|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83478469|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478470|NCT00305942|Carboplatin|carboplatin|mesh-list
83478471|NCT00305942|Topotecan|topotecan|mesh-list
83478472|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478473|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83478474|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83478475|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478476|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478477|NCT02527200|Liraglutide|liraglutide|mesh-list
83478478|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83478479|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478480|NCT02527200|Incretins|incretins|mesh-ancestor
83478481|NCT02527200|Hormones|hormones|mesh-ancestor
83478482|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83478483|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
83478484|NCT00352976|Sirolimus|sirolimus|mesh-list
83478485|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
83478486|NCT00352976|Fludarabine|fludarabine|mesh-list
83478487|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478488|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
83478489|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478490|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83478491|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83478492|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
83478493|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478494|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478495|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83478496|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83478497|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83478498|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
83478499|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83478500|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478501|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478502|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
83478503|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83478505|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83478506|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478507|NCT00306488|Protective Agents|protective agents|mesh-ancestor
83478508|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478509|NCT01793636|Everolimus|everolimus|mesh-list
83478510|NCT01793636|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83478511|NCT01793636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83478512|NCT01793636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478513|NCT01793636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478514|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478515|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
83478516|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478517|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478518|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
83478519|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83478520|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83478522|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478523|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83478524|NCT00310076|Thalidomide|thalidomide|mesh-list
83478525|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478526|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
83478527|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478528|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
83478529|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83478530|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478531|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83478532|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83478533|NCT00310076|Growth Substances|growth substances|mesh-ancestor
83478534|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
83478535|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478536|NCT00353834|Insulin|insulin|mesh-list
83478537|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83478538|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
83478539|NCT00353834|Exenatide|exenatide|mesh-list
83478540|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83478541|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478542|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83478543|NCT00353834|Incretins|incretins|mesh-ancestor
83478544|NCT00353834|Hormones|hormones|mesh-ancestor
83478545|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83478546|NCT05344404|Niacinamide|niacinamide|mesh-list
83478547|NCT05344404|Niacin|niacin|mesh-list
83478548|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
83478549|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
83478550|NCT05344404|Vitamins|vitamins|mesh-ancestor
83478551|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
83478552|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478553|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83478554|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
83478555|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478556|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83478557|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
83478558|NCT00354224|Capecitabine|capecitabine|mesh-list
83478559|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
83478560|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83478561|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
83478562|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478563|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478564|NCT01792388|Vitamin D|vitamin d|mesh-list
83478565|NCT01792388|Vitamins|vitamins|mesh-ancestor
83478566|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
83478567|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478568|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83478569|NCT05395104|Midazolam|midazolam|mesh-list
83478570|NCT05395104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83478571|NCT05395104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83478572|NCT05395104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83478573|NCT05395104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478574|NCT05395104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83478575|NCT05395104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83478576|NCT05395104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83478577|NCT05395104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83478578|NCT05395104|Anesthetics, General|anesthetics, general|mesh-ancestor
83478579|NCT05395104|Anesthetics|anesthetics|mesh-ancestor
83478580|NCT05395104|GABA Modulators|gaba modulators|mesh-ancestor
83478581|NCT05395104|GABA Agents|gaba agents|mesh-ancestor
83478582|NCT05395104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478583|NCT05395104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478584|NCT01793870|Carvedilol|carvedilol|mesh-list
83478585|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83478586|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83478587|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
83478588|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478589|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478590|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478591|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83478592|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
83478593|NCT01793870|Protective Agents|protective agents|mesh-ancestor
83478594|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83478595|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83478596|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83478597|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
83478598|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83478599|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83478600|NCT01793948|Metformin|metformin|mesh-list
83478601|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83478602|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478603|NCT00310466|Immunomodulating Agents|immunomodulating agents|mesh-list
83478604|NCT00310466|Immunologic Factors|immunologic factors|mesh-ancestor
83478605|NCT00310466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478606|NCT00355394|Metoclopramide|metoclopramide|mesh-list
83478607|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
83478608|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
83478609|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478610|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478611|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83478612|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83478613|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83478614|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
83478615|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478616|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478617|NCT00311246|Adalimumab|adalimumab|mesh-list
83478618|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83478619|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83478620|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83478621|NCT02105324|Pancrelipase|pancrelipase|mesh-list
83478622|NCT02105324|Pancreatin|pancreatin|mesh-list
83478623|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83478624|NCT02105558|Anesthetics|anesthetics|mesh-list
83478625|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83478626|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478627|NCT02106962|Bacitracin|bacitracin|mesh-list
83478628|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
83478629|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83478630|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83478631|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478632|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
83478633|NCT02106962|Coagulants|coagulants|mesh-ancestor
83478634|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83478635|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478636|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83478637|NCT00315146|Pioglitazone|pioglitazone|mesh-list
83478638|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83478639|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478640|NCT01792700|Amoxicillin|amoxicillin|mesh-list
83478641|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
83478642|NCT01792700|Metronidazole|metronidazole|mesh-list
83478643|NCT01792700|Tetracycline|tetracycline|mesh-list
83478645|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83478646|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478647|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83478648|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83478649|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478650|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478651|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478652|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83478653|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83478654|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83478655|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83478656|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83478657|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83478658|NCT00315302|Atropine|atropine|mesh-list
83478659|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83478660|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83478661|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83478662|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
83478663|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478664|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478665|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83478666|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
83478667|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
83478668|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
83478669|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83478670|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83478671|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
83478672|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478673|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478674|NCT00316862|Irinotecan|irinotecan|mesh-list
83478822|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83478823|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
83478824|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83478825|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83478826|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83478827|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
83478828|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478829|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
83478830|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478831|NCT05329428|Vitamin D|vitamin d|mesh-list
83478832|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
83478833|NCT05329428|Cholecalciferol|cholecalciferol|mesh-list
83478834|NCT05329428|Vitamins|vitamins|mesh-list
83478835|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
83478836|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478837|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83478838|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83478839|NCT01794572|Melphalan|melphalan|mesh-list
83478840|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83478841|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
83478842|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478843|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478844|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83478845|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478846|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
83478847|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478848|NCT05385432|Mycophenolic Acid|mycophenolic acid|mesh-list
83478849|NCT05385432|Tacrolimus|tacrolimus|mesh-list
83478850|NCT05385432|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83478851|NCT05385432|Basiliximab|basiliximab|mesh-list
83478852|NCT05385432|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83478853|NCT05385432|Thymoglobulin|thymoglobulin|mesh-list
83478854|NCT05385432|Immunologic Factors|immunologic factors|mesh-ancestor
83478855|NCT05385432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478856|NCT05385432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83478857|NCT05385432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478858|NCT05385432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478859|NCT05385432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83478860|NCT05385432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478861|NCT05385432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83478862|NCT05385432|Antitubercular Agents|antitubercular agents|mesh-ancestor
83478863|NCT05385432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83478864|NCT05385432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478865|NCT00392444|Sunitinib|sunitinib|mesh-list
83478866|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478867|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83478868|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83478869|NCT00392444|Growth Substances|growth substances|mesh-ancestor
83478870|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478871|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
83478872|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83478873|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478874|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478875|NCT02528214|Prednisone|prednisone|mesh-list
83478876|NCT02528214|Prednisolone|prednisolone|mesh-list
83478877|NCT02528214|Albuterol|albuterol|mesh-list
83478878|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83478879|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
83478880|NCT02528214|Hormones|hormones|mesh-ancestor
83478881|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83478882|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478883|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83478884|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478885|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
83478886|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478887|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83478888|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83478889|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
83478890|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
83478891|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83478892|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83478893|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83478894|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83478895|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
83478896|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491932|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83478897|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478898|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83478899|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
83478900|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83478901|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83478902|NCT00392678|Analgesics|analgesics|mesh-ancestor
83478903|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
83478904|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478905|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478906|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83478907|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83478908|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83478909|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478910|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478911|NCT05902299|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83478912|NCT05902299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478913|NCT05902260|Immunomodulating Agents|immunomodulating agents|mesh-list
83478914|NCT05902260|Immunologic Factors|immunologic factors|mesh-ancestor
83478915|NCT05902260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478916|NCT05902221|Amoxicillin|amoxicillin|mesh-list
83478917|NCT05902221|Moxifloxacin|moxifloxacin|mesh-list
83478918|NCT05902221|Rifampin|rifampin|mesh-list
83478919|NCT05902221|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83478920|NCT05902221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83478921|NCT05902221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478922|NCT05902221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83478923|NCT05902221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83478924|NCT05902221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478925|NCT05902221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478926|NCT05902221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478927|NCT05902221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83478928|NCT05902221|Contraceptive Agents|contraceptive agents|mesh-ancestor
83478929|NCT05902221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83478930|NCT05902221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478931|NCT05902221|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83478932|NCT05902221|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83478933|NCT05902221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83478934|NCT05902221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83478935|NCT05902221|Antitubercular Agents|antitubercular agents|mesh-ancestor
83478936|NCT05902221|Leprostatic Agents|leprostatic agents|mesh-ancestor
83478937|NCT05902221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83478938|NCT05902221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83478939|NCT05902221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83478940|NCT05902221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83478941|NCT05902221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83478942|NCT05902221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83478943|NCT05902221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83478945|NCT05902208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478946|NCT05902169|Carboplatin|carboplatin|mesh-list
83478947|NCT05902169|Temozolomide|temozolomide|mesh-list
83478948|NCT05902169|Lomustine|lomustine|mesh-list
83478949|NCT05902169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478950|NCT05902169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83478951|NCT05902169|Alkylating Agents|alkylating agents|mesh-ancestor
83478952|NCT05902169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478953|NCT05902117|Arginine Vasopressin|arginine vasopressin|mesh-list
83478954|NCT05902117|Hemostatics|hemostatics|mesh-ancestor
83478955|NCT05902117|Coagulants|coagulants|mesh-ancestor
83478956|NCT05902117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83478957|NCT05902117|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83478958|NCT05902117|Natriuretic Agents|natriuretic agents|mesh-ancestor
83478959|NCT05902117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478960|NCT05902078|Calcitriol|calcitriol|mesh-list
83478961|NCT05902078|Eldecalcitol|eldecalcitol|mesh-list
83478962|NCT05902078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83478963|NCT05902078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478964|NCT05902078|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83478965|NCT05902078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83478966|NCT05902078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478967|NCT05902078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83478968|NCT05902078|Vitamins|vitamins|mesh-ancestor
83478969|NCT05902078|Micronutrients|micronutrients|mesh-ancestor
83479041|NCT05901519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479042|NCT05901519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479043|NCT05901519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83479044|NCT05901519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479046|NCT05901467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479047|NCT05901467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479048|NCT05901454|Vaccines|vaccines|mesh-list
83479049|NCT05901454|Immunologic Factors|immunologic factors|mesh-ancestor
83479050|NCT05901454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479051|NCT05901441|Sufentanil|sufentanil|mesh-list
83479052|NCT05901441|Hydromorphone|hydromorphone|mesh-list
83479053|NCT05901441|Ropivacaine|ropivacaine|mesh-list
83479054|NCT05901441|Anesthetics, Local|anesthetics, local|mesh-ancestor
83479055|NCT05901441|Anesthetics|anesthetics|mesh-ancestor
83479056|NCT05901441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479057|NCT05901441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479058|NCT05901441|Sensory System Agents|sensory system agents|mesh-ancestor
83479059|NCT05901441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479060|NCT05901441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83479061|NCT05901441|Narcotics|narcotics|mesh-ancestor
83479062|NCT05901441|Analgesics|analgesics|mesh-ancestor
83479063|NCT05901441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83479064|NCT05901441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83479065|NCT05901441|Anesthetics, General|anesthetics, general|mesh-ancestor
83479066|NCT05901389|Lidocaine|lidocaine|mesh-list
83479067|NCT05901389|Anesthetics, Local|anesthetics, local|mesh-ancestor
83479068|NCT05901389|Anesthetics|anesthetics|mesh-ancestor
83479069|NCT05901389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479070|NCT05901389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479071|NCT05901389|Sensory System Agents|sensory system agents|mesh-ancestor
83479072|NCT05901389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479073|NCT05901389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83479074|NCT05901389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83479075|NCT05901389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83479076|NCT05901389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83479077|NCT05901389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479078|NCT05901350|Levodopa|levodopa|mesh-list
83479079|NCT05901350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83479080|NCT05901350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83479081|NCT05901350|Dopamine Agents|dopamine agents|mesh-ancestor
83479082|NCT05901350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479083|NCT05901350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479084|NCT05901350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479085|NCT05901194|Lenvatinib|lenvatinib|mesh-list
83479086|NCT05901194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479087|NCT05901194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83479088|NCT05901194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479089|NCT05901194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479090|NCT05901051|Amoxicillin|amoxicillin|mesh-list
83479091|NCT05901051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83479092|NCT05901051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479093|NCT05901012|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83479094|NCT05901012|Hallucinogens|hallucinogens|mesh-ancestor
83479095|NCT05901012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479096|NCT05901012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83479097|NCT05901012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83479098|NCT05901012|Serotonin Agents|serotonin agents|mesh-ancestor
83479099|NCT05901012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479100|NCT05901012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479101|NCT05901012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83479102|NCT05900921|Paclitaxel|paclitaxel|mesh-list
83479103|NCT05900921|Carboplatin|carboplatin|mesh-list
83479104|NCT05900921|Tislelizumab|tislelizumab|mesh-list
83479105|NCT05900921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83479106|NCT05900921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479107|NCT05900921|Tubulin Modulators|tubulin modulators|mesh-ancestor
83479108|NCT05900921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83479109|NCT05900921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83479110|NCT05900921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479111|NCT05900921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479112|NCT05900895|Olaparib|olaparib|mesh-list
83479113|NCT05900895|Estradiol|estradiol|mesh-list
83479114|NCT05900895|Estrogens|estrogens|mesh-ancestor
83479115|NCT05900895|Hormones|hormones|mesh-ancestor
83479116|NCT05900895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479118|NCT05900895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83479119|NCT05900895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479120|NCT05900895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479121|NCT05900895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479122|NCT05900882|Dexamethasone|dexamethasone|mesh-list
83479123|NCT05900882|Lenalidomide|lenalidomide|mesh-list
83479124|NCT05900882|Bortezomib|bortezomib|mesh-list
83479125|NCT05900882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83479126|NCT05900882|Antiemetics|antiemetics|mesh-ancestor
83479127|NCT05900882|Autonomic Agents|autonomic agents|mesh-ancestor
83479128|NCT05900882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479129|NCT05900882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479130|NCT05900882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83479131|NCT05900882|Glucocorticoids|glucocorticoids|mesh-ancestor
83479132|NCT05900882|Hormones|hormones|mesh-ancestor
83479133|NCT05900882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479134|NCT05900882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83479135|NCT05900882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479136|NCT05900882|Immunologic Factors|immunologic factors|mesh-ancestor
83479137|NCT05900882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83479138|NCT05900882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83479139|NCT05900882|Growth Substances|growth substances|mesh-ancestor
83479140|NCT05900882|Growth Inhibitors|growth inhibitors|mesh-ancestor
83479141|NCT05899699|Adapalene|adapalene|mesh-list
83479142|NCT05899699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83479143|NCT05899699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83479144|NCT05899699|Analgesics|analgesics|mesh-ancestor
83479145|NCT05899699|Sensory System Agents|sensory system agents|mesh-ancestor
83479146|NCT05899699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479147|NCT05899699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479148|NCT05899699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83479149|NCT05899699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83479150|NCT05899699|Dermatologic Agents|dermatologic agents|mesh-ancestor
83479151|NCT05899608|Pembrolizumab|pembrolizumab|mesh-list
83479152|NCT05899608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479153|NCT05899608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479154|NCT05899608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479155|NCT05899608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479156|NCT05898919|Neostigmine|neostigmine|mesh-list
83479157|NCT05898919|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83479158|NCT05898919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479159|NCT05898919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479160|NCT05898919|Cholinergic Agents|cholinergic agents|mesh-ancestor
83479161|NCT05898919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479162|NCT05898919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479163|NCT05898919|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83479164|NCT05898919|Autonomic Agents|autonomic agents|mesh-ancestor
83479165|NCT05898919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479166|NCT05898854|FAPI-46|fapi-46|mesh-list
83479167|NCT05898854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83479168|NCT05898854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479169|NCT05897151|Anesthetics|anesthetics|mesh-list
83479170|NCT05897151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479171|NCT05897151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479172|NCT05897138|Lenvatinib|lenvatinib|mesh-list
83479173|NCT05897138|Tislelizumab|tislelizumab|mesh-list
83479174|NCT05897138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479175|NCT05897138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83479176|NCT05897138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479177|NCT05897138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479178|NCT05897138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479179|NCT05895162|Fluconazole|fluconazole|mesh-list
83479180|NCT05895162|Antifungal Agents|antifungal agents|mesh-ancestor
83479181|NCT05895162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479182|NCT05895162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83479183|NCT05895162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83479184|NCT05895162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479185|NCT05895162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479186|NCT05895162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83479187|NCT05895162|Hormone Antagonists|hormone antagonists|mesh-ancestor
83479188|NCT05895162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479189|NCT05895162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479190|NCT05895162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83479191|NCT05895162|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83479192|NCT05894603|Ritonavir|ritonavir|mesh-list
83479193|NCT05894603|Nirmatrelvir|nirmatrelvir|mesh-list
83479194|NCT05894603|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83479195|NCT05894603|Molnupiravir|molnupiravir|mesh-list
83479196|NCT05894603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83479197|NCT05894603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83479198|NCT05894603|Protease Inhibitors|protease inhibitors|mesh-ancestor
83479199|NCT05894603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479200|NCT05894603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479201|NCT05894603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83479202|NCT05894603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83479203|NCT05894603|Antiviral Agents|antiviral agents|mesh-ancestor
83479204|NCT05894603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479205|NCT05894603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83479206|NCT05894603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83479207|NCT05889793|Emetine|emetine|mesh-list
83479208|NCT05889793|Amebicides|amebicides|mesh-ancestor
83479209|NCT05889793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83479210|NCT05889793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83479211|NCT05889793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479212|NCT05889793|Antinematodal Agents|antinematodal agents|mesh-ancestor
83479213|NCT05889793|Anthelmintics|anthelmintics|mesh-ancestor
83479214|NCT05889793|Cathartics|cathartics|mesh-ancestor
83479215|NCT05889793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83479216|NCT05889793|Emetics|emetics|mesh-ancestor
83479217|NCT05889793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479218|NCT05889793|Autonomic Agents|autonomic agents|mesh-ancestor
83479219|NCT05889793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479220|NCT05889793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83479221|NCT05889793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479222|NCT05889793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479223|NCT05886335|Cyclophosphamide|cyclophosphamide|mesh-list
83479224|NCT05886335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83479225|NCT05886335|Immunologic Factors|immunologic factors|mesh-ancestor
83479226|NCT05886335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479227|NCT05886335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83479228|NCT05886335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83479229|NCT05886335|Alkylating Agents|alkylating agents|mesh-ancestor
83479230|NCT05886335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479231|NCT05886335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479232|NCT05886335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83479233|NCT05877326|Anesthetics|anesthetics|mesh-list
83479234|NCT05877326|Propofol|propofol|mesh-list
83479235|NCT05877326|Sevoflurane|sevoflurane|mesh-list
83479236|NCT05877326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479237|NCT05877326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479238|NCT05877326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83479239|NCT05877326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83479240|NCT05877326|Anesthetics, General|anesthetics, general|mesh-ancestor
83479241|NCT05877326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83479242|NCT05877326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83479243|NCT05870956|Nintedanib|nintedanib|mesh-list
83479244|NCT05870956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479245|NCT05870956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83479246|NCT05870956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479247|NCT05870956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479248|NCT05844332|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83479249|NCT05844332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83479250|NCT05844332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479251|NCT05837000|Magnesium Sulfate|magnesium sulfate|mesh-list
83479252|NCT05837000|Dexmedetomidine|dexmedetomidine|mesh-list
83479253|NCT05837000|Ketamine|ketamine|mesh-list
83479254|NCT05837000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83479255|NCT05837000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479256|NCT05837000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479257|NCT05837000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83479258|NCT05837000|Analgesics|analgesics|mesh-ancestor
83479259|NCT05837000|Sensory System Agents|sensory system agents|mesh-ancestor
83479260|NCT05837000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479261|NCT05837000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83479314|NCT05810597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479315|NCT05807139|Spironolactone|spironolactone|mesh-list
83479316|NCT05807139|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83479317|NCT05807139|Hormone Antagonists|hormone antagonists|mesh-ancestor
83479318|NCT05807139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479319|NCT05807139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479320|NCT05807139|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83479321|NCT05807139|Diuretics|diuretics|mesh-ancestor
83479322|NCT05807139|Natriuretic Agents|natriuretic agents|mesh-ancestor
83479323|NCT05786547|Varenicline|varenicline|mesh-list
83479324|NCT05786547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83479325|NCT05786547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83479326|NCT05786547|Cholinergic Agents|cholinergic agents|mesh-ancestor
83479327|NCT05786547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479328|NCT05786547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479329|NCT05786547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479330|NCT05785767|Cemiplimab|cemiplimab|mesh-list
83479331|NCT05785767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479332|NCT05785767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479333|NCT05775289|Paclitaxel|paclitaxel|mesh-list
83479334|NCT05775289|Carboplatin|carboplatin|mesh-list
83479335|NCT05775289|Pembrolizumab|pembrolizumab|mesh-list
83479336|NCT05775289|Pemetrexed|pemetrexed|mesh-list
83479337|NCT05775289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83479338|NCT05775289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479339|NCT05775289|Tubulin Modulators|tubulin modulators|mesh-ancestor
83479340|NCT05775289|Antimitotic Agents|antimitotic agents|mesh-ancestor
83479341|NCT05775289|Mitosis Modulators|mitosis modulators|mesh-ancestor
83479342|NCT05775289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479343|NCT05775289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479344|NCT05775289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479345|NCT05775289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479346|NCT05775289|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83479347|NCT05775289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83479348|NCT05763875|Ezetimibe|ezetimibe|mesh-list
83479349|NCT05763875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83479350|NCT05763875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83479351|NCT05763875|Antimetabolites|antimetabolites|mesh-ancestor
83479352|NCT05763875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479353|NCT05763875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83479354|NCT05736861|Ivermectin|ivermectin|mesh-list
83479355|NCT05736861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83479356|NCT05736861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479357|NCT05728372|Copper|copper|mesh-list
83479358|NCT05728372|Pembrolizumab|pembrolizumab|mesh-list
83479359|NCT05728372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479360|NCT05728372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479361|NCT05728372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479362|NCT05728372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479363|NCT05728372|Trace Elements|trace elements|mesh-ancestor
83479364|NCT05728372|Micronutrients|micronutrients|mesh-ancestor
83479365|NCT05728372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479366|NCT05707273|Cyclophosphamide|cyclophosphamide|mesh-list
83479367|NCT05707273|Fludarabine|fludarabine|mesh-list
83479368|NCT05707273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83479369|NCT05707273|Immunologic Factors|immunologic factors|mesh-ancestor
83479370|NCT05707273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479371|NCT05707273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83479372|NCT05707273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83479373|NCT05707273|Alkylating Agents|alkylating agents|mesh-ancestor
83479374|NCT05707273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479375|NCT05707273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479376|NCT05707273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83479377|NCT05705856|Ustekinumab|ustekinumab|mesh-list
83479378|NCT05705856|Dermatologic Agents|dermatologic agents|mesh-ancestor
83479379|NCT05672173|Cyclophosphamide|cyclophosphamide|mesh-list
83479380|NCT05672173|Nivolumab|nivolumab|mesh-list
83479381|NCT05672173|Fludarabine|fludarabine|mesh-list
83479382|NCT05672173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83479383|NCT05672173|Immunologic Factors|immunologic factors|mesh-ancestor
83479384|NCT05672173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479385|NCT05672173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83479386|NCT05672173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83479387|NCT05672173|Alkylating Agents|alkylating agents|mesh-ancestor
83479388|NCT05672173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479428|NCT05629234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479429|NCT05614739|Pembrolizumab|pembrolizumab|mesh-list
83479430|NCT05614739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479431|NCT05614739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479432|NCT05614739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479433|NCT05614739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479435|NCT05610319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83479436|NCT05610319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83479437|NCT05610319|Growth Substances|growth substances|mesh-ancestor
83479438|NCT05610319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479439|NCT05610319|Growth Inhibitors|growth inhibitors|mesh-ancestor
83479440|NCT05610319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479441|NCT05570825|Pembrolizumab|pembrolizumab|mesh-list
83479442|NCT05570825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479443|NCT05570825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479444|NCT05570825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479445|NCT05570825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479446|NCT05567315|Anesthetics|anesthetics|mesh-list
83479447|NCT05567315|Anesthetics, Local|anesthetics, local|mesh-list
83479448|NCT05567315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479449|NCT05567315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479450|NCT05567315|Sensory System Agents|sensory system agents|mesh-ancestor
83479451|NCT05567315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479452|NCT05556681|Sirolimus|sirolimus|mesh-list
83479453|NCT05556681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83479454|NCT05556681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479455|NCT05556681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83479456|NCT05556681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479457|NCT05556681|Antifungal Agents|antifungal agents|mesh-ancestor
83479458|NCT05556681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83479459|NCT05556681|Immunologic Factors|immunologic factors|mesh-ancestor
83479460|NCT05556681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479461|NCT05547386|Edetic Acid|edetic acid|mesh-list
83479462|NCT05547386|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83479463|NCT05547386|Chelating Agents|chelating agents|mesh-ancestor
83479464|NCT05547386|Sequestering Agents|sequestering agents|mesh-ancestor
83479465|NCT05547386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479466|NCT05547386|Anticoagulants|anticoagulants|mesh-ancestor
83479467|NCT05547386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83479468|NCT05547386|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83479469|NCT05519111|Dronabinol|dronabinol|mesh-list
83479470|NCT05519111|Hallucinogens|hallucinogens|mesh-ancestor
83479471|NCT05519111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479472|NCT05519111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83479473|NCT05519111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83479474|NCT05519111|Analgesics|analgesics|mesh-ancestor
83479475|NCT05519111|Sensory System Agents|sensory system agents|mesh-ancestor
83479476|NCT05519111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479477|NCT05519111|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83479478|NCT05519111|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83479479|NCT05519111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479480|NCT05519111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479481|NCT05519111|Hormones|hormones|mesh-ancestor
83479482|NCT05519111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479483|NCT05519085|Dexamethasone|dexamethasone|mesh-list
83479484|NCT05519085|Bortezomib|bortezomib|mesh-list
83479485|NCT05519085|Pomalidomide|pomalidomide|mesh-list
83479486|NCT05519085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83479487|NCT05519085|Antiemetics|antiemetics|mesh-ancestor
83479488|NCT05519085|Autonomic Agents|autonomic agents|mesh-ancestor
83479489|NCT05519085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479490|NCT05519085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479491|NCT05519085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83479492|NCT05519085|Glucocorticoids|glucocorticoids|mesh-ancestor
83479493|NCT05519085|Hormones|hormones|mesh-ancestor
83479494|NCT05519085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479495|NCT05519085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83479496|NCT05519085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479497|NCT05519085|Immunologic Factors|immunologic factors|mesh-ancestor
83479498|NCT05519085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83479499|NCT05519085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83479500|NCT05519085|Growth Substances|growth substances|mesh-ancestor
83479501|NCT05519085|Growth Inhibitors|growth inhibitors|mesh-ancestor
83479503|NCT05509777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83479504|NCT05509777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83479505|NCT05509777|Analgesics|analgesics|mesh-ancestor
83479506|NCT05509777|Sensory System Agents|sensory system agents|mesh-ancestor
83479507|NCT05509777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479508|NCT05509777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479509|NCT05509777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83479510|NCT05509777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83479511|NCT05509777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83479512|NCT05509777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83479513|NCT05492994|Carbon Monoxide|carbon monoxide|mesh-list
83479514|NCT05492994|Antimetabolites|antimetabolites|mesh-ancestor
83479515|NCT05492994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479516|NCT05492994|Gasotransmitters|gasotransmitters|mesh-ancestor
83479517|NCT05492994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479518|NCT05492994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479520|NCT05463133|Cyclophosphamide|cyclophosphamide|mesh-list
83479521|NCT05463133|Busulfan|busulfan|mesh-list
83479522|NCT05463133|Alemtuzumab|alemtuzumab|mesh-list
83479523|NCT05463133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83479524|NCT05463133|Immunologic Factors|immunologic factors|mesh-ancestor
83479525|NCT05463133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479526|NCT05463133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83479527|NCT05463133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83479528|NCT05463133|Alkylating Agents|alkylating agents|mesh-ancestor
83479529|NCT05463133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479530|NCT05463133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479531|NCT05463133|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83479532|NCT05463133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83479533|NCT05463133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479534|NCT05463133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83479535|NCT05463133|Antifungal Agents|antifungal agents|mesh-ancestor
83479536|NCT05463133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479537|NCT05446129|Pembrolizumab|pembrolizumab|mesh-list
83479538|NCT05446129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479539|NCT05446129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479540|NCT05446129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479541|NCT05446129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479542|NCT05438602|Ritonavir|ritonavir|mesh-list
83479543|NCT05438602|Nirmatrelvir|nirmatrelvir|mesh-list
83479544|NCT05438602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83479545|NCT05438602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83479546|NCT05438602|Protease Inhibitors|protease inhibitors|mesh-ancestor
83479547|NCT05438602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479548|NCT05438602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479549|NCT05438602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83479550|NCT05438602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83479551|NCT05438602|Antiviral Agents|antiviral agents|mesh-ancestor
83479552|NCT05438602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479553|NCT05438602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83479554|NCT05438602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83479555|NCT05436418|Sirolimus|sirolimus|mesh-list
83479556|NCT05436418|Cyclophosphamide|cyclophosphamide|mesh-list
83479557|NCT05436418|Melphalan|melphalan|mesh-list
83479558|NCT05436418|Fludarabine|fludarabine|mesh-list
83479559|NCT05436418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83479560|NCT05436418|Immunologic Factors|immunologic factors|mesh-ancestor
83479561|NCT05436418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479562|NCT05436418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83479563|NCT05436418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83479564|NCT05436418|Alkylating Agents|alkylating agents|mesh-ancestor
83479565|NCT05436418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479566|NCT05436418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479567|NCT05436418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83479568|NCT05436418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83479569|NCT05436418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83479570|NCT05436418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479571|NCT05436418|Antifungal Agents|antifungal agents|mesh-ancestor
83479572|NCT05427474|Propranolol|propranolol|mesh-list
83479573|NCT05427474|Gabapentin|gabapentin|mesh-list
83479574|NCT05427474|Analgesics|analgesics|mesh-ancestor
83479575|NCT05427474|Sensory System Agents|sensory system agents|mesh-ancestor
83479576|NCT05427474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479577|NCT05427474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479606|NCT05415215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479608|NCT05415215|Immunoconjugates|immunoconjugates|mesh-ancestor
83479609|NCT05415215|Immunologic Factors|immunologic factors|mesh-ancestor
83479610|NCT05415215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479611|NCT05396833|Avelumab|avelumab|mesh-list
83479612|NCT05396833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479613|NCT05396833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479614|NCT05383352|Leucovorin|leucovorin|mesh-list
83479615|NCT05383352|Folic Acid|folic acid|mesh-list
83479616|NCT05383352|Fluorouracil|fluorouracil|mesh-list
83479617|NCT05383352|Irinotecan|irinotecan|mesh-list
83479618|NCT05383352|Camptothecin|camptothecin|mesh-list
83479619|NCT05383352|Levoleucovorin|levoleucovorin|mesh-list
83479620|NCT05383352|Antimetabolites|antimetabolites|mesh-ancestor
83479621|NCT05383352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479622|NCT05383352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83479623|NCT05383352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479624|NCT05383352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83479625|NCT05383352|Immunologic Factors|immunologic factors|mesh-ancestor
83479626|NCT05383352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479627|NCT05383352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83479628|NCT05383352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83479629|NCT05383352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479630|NCT05383352|Antidotes|antidotes|mesh-ancestor
83479631|NCT05383352|Protective Agents|protective agents|mesh-ancestor
83479632|NCT05383352|Vitamin B Complex|vitamin b complex|mesh-ancestor
83479633|NCT05383352|Vitamins|vitamins|mesh-ancestor
83479634|NCT05383352|Micronutrients|micronutrients|mesh-ancestor
83479635|NCT05383352|Hematinics|hematinics|mesh-ancestor
83479636|NCT05383352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83479637|NCT05376579|Siponimod|siponimod|mesh-list
83479638|NCT05376579|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83479639|NCT05376579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479640|NCT05376579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83479641|NCT05376579|Immunologic Factors|immunologic factors|mesh-ancestor
83479642|NCT05376579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479643|NCT05340673|Petrolatum|petrolatum|mesh-list
83479644|NCT05340673|Mineral Oil|mineral oil|mesh-list
83479645|NCT05340673|Emollients|emollients|mesh-ancestor
83479646|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
83479647|NCT05320406|Leuprolide|leuprolide|mesh-list
83479648|NCT05320406|Relugolix|relugolix|mesh-list
83479649|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83479650|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
83479651|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83479652|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479653|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83479654|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479655|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
83479656|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
83479657|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479658|NCT05312151|Psilocybin|psilocybin|mesh-list
83479659|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
83479660|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479661|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83479662|NCT05307198|Capecitabine|capecitabine|mesh-list
83479663|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
83479664|NCT05307198|Antibodies|antibodies|mesh-list
83479665|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83479666|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
83479667|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479668|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83479669|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
83479670|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479671|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479672|NCT05299073|Denosumab|denosumab|mesh-list
83479673|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83479674|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479675|NCT05285982|Nintedanib|nintedanib|mesh-list
83479676|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479677|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83479678|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479679|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479680|NCT05282121|Empagliflozin|empagliflozin|mesh-list
83479681|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83491933|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83479682|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479683|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83479684|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479685|NCT05249426|Cetuximab|cetuximab|mesh-list
83479686|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479687|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479688|NCT05243290|Niacinamide|niacinamide|mesh-list
83479689|NCT05243290|Niacin|niacin|mesh-list
83479690|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
83479691|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
83479692|NCT05243290|Vitamins|vitamins|mesh-ancestor
83479693|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
83479694|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479695|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83479696|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
83479697|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479698|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83479699|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
83479700|NCT05227001|Camphor|camphor|mesh-list
83479701|NCT05227001|Menthol|menthol|mesh-list
83479702|NCT05227001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83479703|NCT05227001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479704|NCT05227001|Antipruritics|antipruritics|mesh-ancestor
83479705|NCT05227001|Dermatologic Agents|dermatologic agents|mesh-ancestor
83479706|NCT05226871|Cetuximab|cetuximab|mesh-list
83479707|NCT05226871|Letrozole|letrozole|mesh-list
83479708|NCT05226871|Fulvestrant|fulvestrant|mesh-list
83479709|NCT05226871|Palbociclib|palbociclib|mesh-list
83479710|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479711|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479712|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83479713|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83479714|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479715|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479716|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83479717|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
83479718|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479719|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479720|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83479721|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83479722|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83479723|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83479724|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479725|NCT05221398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479726|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479727|NCT05213221|Lenvatinib|lenvatinib|mesh-list
83479728|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479729|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83479730|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479731|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479732|NCT05213208|Propofol|propofol|mesh-list
83479733|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83479734|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479735|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479736|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83479737|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
83479738|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
83479739|NCT05212337|Denosumab|denosumab|mesh-list
83479740|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83479741|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479742|NCT05189223|Buprenorphine|buprenorphine|mesh-list
83479743|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83479744|NCT05189223|Narcotics|narcotics|mesh-ancestor
83479745|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479746|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479747|NCT05189223|Analgesics|analgesics|mesh-ancestor
83479748|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
83479749|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479750|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83479751|NCT05123040|Prednisone|prednisone|mesh-list
83479752|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
83479753|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83479754|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
83479755|NCT05123040|Hormones|hormones|mesh-ancestor
83479756|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479757|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479779|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479780|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
83479781|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479782|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479783|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
83479784|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83479785|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479786|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83479787|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83479788|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83479789|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83479790|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479791|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479792|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83479793|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83479794|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479795|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
83479796|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479797|NCT04999215|Choline|choline|mesh-list
83479798|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
83479799|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83479800|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
83479801|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479802|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83479803|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83479804|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
83479805|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
83479806|NCT04991025|Carboplatin|carboplatin|mesh-list
83479807|NCT04991025|Gemcitabine|gemcitabine|mesh-list
83479808|NCT04991025|Nivolumab|nivolumab|mesh-list
83479809|NCT04991025|Pemetrexed|pemetrexed|mesh-list
83479810|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479811|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83479812|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
83479813|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479814|NCT04991025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479815|NCT04991025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479816|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479817|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83479818|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83479819|NCT04991025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83479820|NCT04991025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83479821|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83479822|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
83479823|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479824|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83479825|NCT04973163|Midazolam|midazolam|mesh-list
83479826|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83479827|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83479828|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479829|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479830|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83479831|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83479832|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83479833|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83479834|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
83479835|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
83479836|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
83479837|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
83479838|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479839|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479840|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
83479841|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
83479842|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479843|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83479844|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83479845|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83479846|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479847|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
83479848|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479849|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479850|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83479851|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479857|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479858|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83479859|NCT04915729|Tenecteplase|tenecteplase|mesh-list
83479860|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83479861|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83479862|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479863|NCT04887857|Azacitidine|azacitidine|mesh-list
83479864|NCT04887857|Venetoclax|venetoclax|mesh-list
83479865|NCT04887857|Cc-486|cc-486|mesh-list
83479866|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83479867|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
83479868|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479869|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479870|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479871|NCT04879329|Pembrolizumab|pembrolizumab|mesh-list
83479872|NCT04879329|Disitamab vedotin|disitamab vedotin|mesh-list
83479873|NCT04879329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479874|NCT04879329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479875|NCT04879329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479876|NCT04879329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479877|NCT04879329|Immunoconjugates|immunoconjugates|mesh-ancestor
83479878|NCT04879329|Immunologic Factors|immunologic factors|mesh-ancestor
83479879|NCT04879329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479880|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83479881|NCT04855266|Hematinics|hematinics|mesh-ancestor
83479882|NCT04854499|Carboplatin|carboplatin|mesh-list
83479883|NCT04854499|Docetaxel|docetaxel|mesh-list
83479884|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
83479885|NCT04854499|Magrolimab|magrolimab|mesh-list
83479886|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479887|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
83479888|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
83479889|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
83479890|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479891|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479892|NCT04854499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479893|NCT04832399|Natalizumab|natalizumab|mesh-list
83479894|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
83479895|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479896|NCT04821310|Pantoprazole|pantoprazole|mesh-list
83479897|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83479898|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83479899|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83479900|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479901|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479902|NCT04795245|Afatinib|afatinib|mesh-list
83479903|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479904|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83479905|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479906|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479907|NCT04772209|Heparin|heparin|mesh-list
83479908|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
83479909|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83479910|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83479911|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479912|NCT04757662|Tadalafil|tadalafil|mesh-list
83479913|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
83479914|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83479915|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83479916|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479917|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479918|NCT04757662|Urological Agents|urological agents|mesh-ancestor
83479919|NCT04756050|Epinephrine|epinephrine|mesh-list
83479920|NCT04756050|Racepinephrine|racepinephrine|mesh-list
83479921|NCT04756050|Bupivacaine|bupivacaine|mesh-list
83479923|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83479924|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
83479925|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
83479926|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
83479927|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479928|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479929|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
83479930|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479931|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83479932|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83479933|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
83479935|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479936|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83479937|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83479938|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
83479939|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83479940|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
83479941|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
83479942|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
83479943|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83479944|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83479945|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83479946|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83479947|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479948|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
83479949|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479950|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479951|NCT04731103|Lamivudine|lamivudine|mesh-list
83479952|NCT04731103|Zidovudine|zidovudine|mesh-list
83479953|NCT04731103|Abacavir|abacavir|mesh-list
83479954|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
83479955|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83479956|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83479957|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479958|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479959|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
83479960|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479961|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83479962|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83479963|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
83479964|NCT04716712|Azithromycin|azithromycin|mesh-list
83479965|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83479966|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479967|NCT04686305|Carboplatin|carboplatin|mesh-list
83479968|NCT04686305|Trastuzumab|trastuzumab|mesh-list
83479969|NCT04686305|Pemetrexed|pemetrexed|mesh-list
83479970|NCT04686305|Durvalumab|durvalumab|mesh-list
83479971|NCT04686305|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83479972|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479973|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479974|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479975|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479976|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83479977|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83479978|NCT04686305|Immunoconjugates|immunoconjugates|mesh-ancestor
83479979|NCT04686305|Immunologic Factors|immunologic factors|mesh-ancestor
83479980|NCT04686305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479981|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
83479982|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
83479983|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479984|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479985|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479986|NCT04680221|Bupivacaine|bupivacaine|mesh-list
83479987|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
83479988|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
83479989|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479990|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479991|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
83479992|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479993|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83479995|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83479996|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83479997|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83479998|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83479999|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
83480000|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480001|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480002|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480003|NCT04667078|Cangrelor|cangrelor|mesh-list
83480004|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83480005|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83480006|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83480007|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83480008|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
83480010|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480011|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480012|NCT04663997|Docetaxel|docetaxel|mesh-list
83480013|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
83480014|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480015|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
83480016|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
83480017|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
83480018|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480019|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83480020|NCT04650581|Fulvestrant|fulvestrant|mesh-list
83480021|NCT04650581|Ipatasertib|ipatasertib|mesh-list
83480022|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480023|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480024|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83480025|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83480026|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
83480027|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480028|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480029|NCT04650581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480030|NCT04650581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480031|NCT04650581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480032|NCT04644796|Bupivacaine|bupivacaine|mesh-list
83480033|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
83480034|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
83480035|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83480036|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480037|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
83480038|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480039|NCT04639414|Empagliflozin|empagliflozin|mesh-list
83480040|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83480041|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480042|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83480043|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480044|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
83480045|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83480046|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83480047|NCT04623541|Prednisone|prednisone|mesh-list
83480048|NCT04623541|Cyclophosphamide|cyclophosphamide|mesh-list
83480049|NCT04623541|Rituximab|rituximab|mesh-list
83480050|NCT04623541|Doxorubicin|doxorubicin|mesh-list
83480051|NCT04623541|Vincristine|vincristine|mesh-list
83480052|NCT04623541|Lenalidomide|lenalidomide|mesh-list
83480053|NCT04623541|Venetoclax|venetoclax|mesh-list
83480054|NCT04623541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480055|NCT04623541|Immunologic Factors|immunologic factors|mesh-ancestor
83480056|NCT04623541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480057|NCT04623541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480058|NCT04623541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83480059|NCT04623541|Alkylating Agents|alkylating agents|mesh-ancestor
83480060|NCT04623541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480061|NCT04623541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480062|NCT04623541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83480063|NCT04623541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480064|NCT04623541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83480065|NCT04623541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83480066|NCT04623541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83480067|NCT04623541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480068|NCT04623541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480069|NCT04623541|Glucocorticoids|glucocorticoids|mesh-ancestor
83480070|NCT04623541|Hormones|hormones|mesh-ancestor
83480071|NCT04623541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480072|NCT04623541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480073|NCT04623541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83480074|NCT04623541|Tubulin Modulators|tubulin modulators|mesh-ancestor
83480075|NCT04623541|Antimitotic Agents|antimitotic agents|mesh-ancestor
83480076|NCT04623541|Mitosis Modulators|mitosis modulators|mesh-ancestor
83480077|NCT04623541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83480078|NCT04623541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83480079|NCT04623541|Growth Substances|growth substances|mesh-ancestor
83480080|NCT04623541|Growth Inhibitors|growth inhibitors|mesh-ancestor
83480081|NCT04621929|Topiramate|topiramate|mesh-list
83480082|NCT04621929|Phentermine|phentermine|mesh-list
83480083|NCT04621929|Allopurinol|allopurinol|mesh-list
83480161|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83480084|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480085|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
83480086|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83480087|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480088|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
83480089|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480090|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
83480091|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480092|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83480093|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
83480094|NCT04621929|Protective Agents|protective agents|mesh-ancestor
83480095|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83480096|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
83480097|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83480098|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
83480099|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
83480100|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480101|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
83480102|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480103|NCT04593927|Siponimod|siponimod|mesh-list
83480104|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83480105|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480106|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480107|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
83480108|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480109|NCT04572763|Venetoclax|venetoclax|mesh-list
83480110|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480111|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
83480112|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480113|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
83480114|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480115|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480116|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83480117|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
83480118|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480119|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480120|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83480121|NCT04559581|Nintedanib|nintedanib|mesh-list
83480122|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480123|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480124|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480125|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480126|NCT04556370|Norepinephrine|norepinephrine|mesh-list
83480127|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83480128|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83480129|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
83480130|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480131|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480132|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480133|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
83480134|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
83480135|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480136|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83480137|NCT04553692|Leucovorin|leucovorin|mesh-list
83480138|NCT04553692|Bevacizumab|bevacizumab|mesh-list
83480139|NCT04553692|Gemcitabine|gemcitabine|mesh-list
83480141|NCT04553692|Fluorouracil|fluorouracil|mesh-list
83480142|NCT04553692|Irinotecan|irinotecan|mesh-list
83480143|NCT04553692|Azacitidine|azacitidine|mesh-list
83480144|NCT04553692|Venetoclax|venetoclax|mesh-list
83480145|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480146|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480147|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83480148|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83480149|NCT04553692|Growth Substances|growth substances|mesh-ancestor
83480150|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480151|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
83480152|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83480153|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
83480154|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480155|NCT04553692|Tubulin Modulators|tubulin modulators|mesh-ancestor
83480156|NCT04553692|Antimitotic Agents|antimitotic agents|mesh-ancestor
83480157|NCT04553692|Mitosis Modulators|mitosis modulators|mesh-ancestor
83480158|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480159|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
83480160|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83480178|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480180|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83480181|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
83480182|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480183|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83480184|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480185|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
83480186|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83480187|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
83480188|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83480189|NCT04535882|Protective Agents|protective agents|mesh-ancestor
83480190|NCT04535687|Fluzoparib|fluzoparib|mesh-list
83480191|NCT04535687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83480192|NCT04535687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480193|NCT04535687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480194|NCT04535687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480195|NCT04527887|Dexamethasone|dexamethasone|mesh-list
83480196|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480197|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
83480198|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
83480199|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480200|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480201|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83480202|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
83480203|NCT04527887|Hormones|hormones|mesh-ancestor
83480204|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480205|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480206|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480207|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83480208|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
83480209|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83480210|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83480211|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83480212|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83480213|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480214|NCT04474847|Abatacept|abatacept|mesh-list
83480215|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480216|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480217|NCT04474847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480218|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480219|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480220|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
83480221|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480222|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480223|NCT04458831|Dexamethasone|dexamethasone|mesh-list
83480224|NCT04458831|Pomalidomide|pomalidomide|mesh-list
83480225|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480226|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
83480227|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
83480228|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480229|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480230|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83480231|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
83480232|NCT04458831|Hormones|hormones|mesh-ancestor
83480233|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480234|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480235|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480236|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
83480237|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83480238|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83480239|NCT04458831|Growth Substances|growth substances|mesh-ancestor
83480240|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
83480241|NCT04458259|Axitinib|axitinib|mesh-list
83480242|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480243|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480244|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480245|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480246|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
83480247|NCT04436926|Narcotics|narcotics|mesh-ancestor
83480248|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83480249|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480250|NCT04436926|Analgesics|analgesics|mesh-ancestor
83480251|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
83480294|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480295|NCT04379713|Vaccines|vaccines|mesh-list
83480296|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83480297|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
83480298|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480299|NCT04325217|Nintedanib|nintedanib|mesh-list
83480300|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480301|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480302|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480303|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480304|NCT04323280|Dexamethasone|dexamethasone|mesh-list
83480305|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480306|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
83480307|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
83480308|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480309|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480310|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83480311|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
83480312|NCT04323280|Hormones|hormones|mesh-ancestor
83480313|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480314|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480315|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480316|NCT04218773|Phenylephrine|phenylephrine|mesh-list
83480317|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
83480318|NCT04218773|Norepinephrine|norepinephrine|mesh-list
83480319|NCT04218773|Synephrine|synephrine|mesh-list
83480320|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83480321|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
83480322|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
83480323|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480324|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480325|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
83480326|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83480327|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
83480328|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
83480329|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83480330|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83480331|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83480332|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
83480333|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480334|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480335|NCT04218773|Protective Agents|protective agents|mesh-ancestor
83480336|NCT04217447|Aspirin|aspirin|mesh-list
83480337|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83480338|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83480339|NCT04217447|Analgesics|analgesics|mesh-ancestor
83480340|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
83480341|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480342|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480343|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480344|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480345|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83480346|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83480347|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480348|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83480349|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83480350|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480351|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
83480352|NCT04216329|Temozolomide|temozolomide|mesh-list
83480353|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83480354|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
83480355|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480356|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480357|NCT04206787|Afatinib|afatinib|mesh-list
83480358|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480359|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480360|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480361|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480362|NCT04194944|Carboplatin|carboplatin|mesh-list
83480363|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
83480364|NCT04194944|Pemetrexed|pemetrexed|mesh-list
83480365|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480366|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480367|NCT04194944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480368|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480369|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480370|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83480371|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83480373|NCT04191499|Palbociclib|palbociclib|mesh-list
83480375|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480376|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480377|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83480378|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83480379|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
83480380|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480381|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480382|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480383|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480384|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480385|NCT04191499|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83480386|NCT04175431|Prednisone|prednisone|mesh-list
83480387|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
83480388|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480389|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
83480390|NCT04175431|Hormones|hormones|mesh-ancestor
83480391|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480392|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480393|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480394|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480395|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83480396|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480397|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480398|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
83480399|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83480400|NCT04172532|Peposertib|peposertib|mesh-list
83480401|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480402|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480403|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480404|NCT04126031|Ceftazidime|ceftazidime|mesh-list
83480405|NCT04126031|Avibactam|avibactam|mesh-list
83480406|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83480407|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83480408|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83480409|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83480410|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480411|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480412|NCT04111458|Trametinib|trametinib|mesh-list
83480413|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480414|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480415|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480416|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480417|NCT04100824|Nimodipine|nimodipine|mesh-list
83480418|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83480419|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83480420|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83480421|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480422|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83480423|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480424|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
83480425|NCT04088851|Metformin|metformin|mesh-list
83480426|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83480427|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480428|NCT04074265|Ketorolac|ketorolac|mesh-list
83480429|NCT04074265|Epinephrine|epinephrine|mesh-list
83480430|NCT04074265|Ropivacaine|ropivacaine|mesh-list
83480431|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
83480432|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
83480433|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83480434|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480435|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
83480436|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480437|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83480438|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83480439|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
83480440|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480441|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480442|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83480443|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83480445|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83480446|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
83480447|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
83480448|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
83480449|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83480450|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83480451|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83480452|NCT04074265|Analgesics|analgesics|mesh-ancestor
83480453|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480454|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480455|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83480456|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480457|NCT04058067|Aflibercept|aflibercept|mesh-list
83480458|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83480459|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83480460|NCT04058067|Growth Substances|growth substances|mesh-ancestor
83480461|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480462|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
83480463|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480464|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
83480465|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480466|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480467|NCT04007744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480468|NCT04007744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480469|NCT03998735|Lobeline|lobeline|mesh-list
83480470|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83480471|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
83480472|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480473|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480474|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83480475|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83480476|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
83480477|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480478|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480479|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
83480480|NCT03993327|Iodine|iodine|mesh-list
83480481|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83480482|NCT03993327|Antibodies|antibodies|mesh-list
83480483|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
83480484|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83480485|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
83480486|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480487|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480488|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83480489|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83480490|NCT03993327|Trace Elements|trace elements|mesh-ancestor
83480491|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
83480492|NCT03983057|Antibodies|antibodies|mesh-list
83480493|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83480494|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
83480495|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480496|NCT03953300|Benralizumab|benralizumab|mesh-list
83480497|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83480498|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
83480499|NCT03933215|Cladribine|cladribine|mesh-list
83480500|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480501|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480502|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
83480503|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480504|NCT03932643|TIC10 compound|tic10 compound|mesh-list
83480505|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480506|NCT03879135|Factor VIII|factor viii|mesh-list
83480507|NCT03879135|Coagulants|coagulants|mesh-ancestor
83480508|NCT03833154|Durvalumab|durvalumab|mesh-list
83480509|NCT03833154|Osimertinib|osimertinib|mesh-list
83480510|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480511|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480512|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480513|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480514|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480515|NCT03822468|Letrozole|letrozole|mesh-list
83480516|NCT03822468|Anastrozole|anastrozole|mesh-list
83480517|NCT03822468|Goserelin|goserelin|mesh-list
83480522|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480524|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
83480525|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480526|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480527|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480528|NCT03802799|Cannabidiol|cannabidiol|mesh-list
83480529|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
83480530|NCT03789110|Nivolumab|nivolumab|mesh-list
83480531|NCT03789110|Ipilimumab|ipilimumab|mesh-list
83480532|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480533|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480534|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480535|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480536|NCT03778229|Osimertinib|osimertinib|mesh-list
83480537|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480538|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480539|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480540|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480541|NCT03759028|Acetaminophen|acetaminophen|mesh-list
83480542|NCT03759028|Ibuprofen|ibuprofen|mesh-list
83480543|NCT03759028|Oxycodone|oxycodone|mesh-list
83480544|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83480545|NCT03759028|Analgesics|analgesics|mesh-ancestor
83480546|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
83480547|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480548|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480549|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
83480550|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83480551|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480552|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480553|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83480554|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480555|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480556|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83480557|NCT03759028|Narcotics|narcotics|mesh-ancestor
83480558|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83480559|NCT03735121|Atezolizumab|atezolizumab|mesh-list
83480560|NCT03735121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480561|NCT03735121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480562|NCT03735121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480563|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480564|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83480565|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83480566|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83480567|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
83480568|NCT03706365|Prednisone|prednisone|mesh-list
83480569|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
83480570|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480571|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
83480572|NCT03706365|Hormones|hormones|mesh-ancestor
83480573|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480574|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480575|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480576|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480577|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83480578|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480579|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480580|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
83480581|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83480582|NCT03693560|Metformin|metformin|mesh-list
83480583|NCT03693560|Glimepiride|glimepiride|mesh-list
83480584|NCT03693560|Vildagliptin|vildagliptin|mesh-list
83480585|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83480586|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480587|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83480588|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480589|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
83480590|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83480591|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
83480592|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480593|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480594|NCT03675893|Metformin|metformin|mesh-list
83480602|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480604|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
83480605|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480606|NCT03631199|Paclitaxel|paclitaxel|mesh-list
83480607|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83480608|NCT03631199|Carboplatin|carboplatin|mesh-list
83480609|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
83480610|NCT03631199|Pemetrexed|pemetrexed|mesh-list
83480611|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83480612|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83480613|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480614|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
83480615|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
83480616|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
83480617|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480618|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480619|NCT03631199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480620|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480621|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83480622|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83480623|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
83480624|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480625|NCT03624062|Insulin|insulin|mesh-list
83480626|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83480627|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480628|NCT03610724|Tisagenlecleucel|tisagenlecleucel|mesh-list
83480629|NCT03610724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480630|NCT03610724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480631|NCT03574090|Amoxicillin|amoxicillin|mesh-list
83480632|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
83480633|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
83480634|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83480635|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83480636|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83480637|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83480638|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480639|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480640|NCT03554473|Temozolomide|temozolomide|mesh-list
83480641|NCT03554473|Topotecan|topotecan|mesh-list
83480642|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83480643|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
83480644|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480645|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480646|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83480647|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83480648|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480649|NCT03533283|Atezolizumab|atezolizumab|mesh-list
83480650|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
83480651|NCT03533283|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83480652|NCT03533283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480653|NCT03533283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480654|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480655|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480656|NCT03533283|Immunoconjugates|immunoconjugates|mesh-ancestor
83480657|NCT03533283|Immunologic Factors|immunologic factors|mesh-ancestor
83480658|NCT03533283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480659|NCT03522246|Nivolumab|nivolumab|mesh-list
83480660|NCT03522246|Rucaparib|rucaparib|mesh-list
83480661|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480662|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480663|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480664|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480665|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83480666|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480667|NCT03504397|Leucovorin|leucovorin|mesh-list
83480668|NCT03504397|Folic Acid|folic acid|mesh-list
83480669|NCT03504397|Fluorouracil|fluorouracil|mesh-list
83480670|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
83480671|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
83480672|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
83480673|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480674|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83480675|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480730|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83480731|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480732|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83480733|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480734|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
83480735|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480736|NCT03317405|Tamoxifen|tamoxifen|mesh-list
83480737|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83480738|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
83480739|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480740|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480741|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480742|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480743|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83480744|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83480745|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83480747|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
83480748|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
83480749|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
83480750|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480751|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480752|NCT03309878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480753|NCT03309878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480754|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
83480755|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480756|NCT03297606|Nivolumab|nivolumab|mesh-list
83480757|NCT03297606|Trastuzumab|trastuzumab|mesh-list
83480758|NCT03297606|Ipilimumab|ipilimumab|mesh-list
83480759|NCT03297606|Pertuzumab|pertuzumab|mesh-list
83480760|NCT03297606|Sunitinib|sunitinib|mesh-list
83480761|NCT03297606|Dasatinib|dasatinib|mesh-list
83480762|NCT03297606|Olaparib|olaparib|mesh-list
83480763|NCT03297606|Palbociclib|palbociclib|mesh-list
83480764|NCT03297606|Temsirolimus|temsirolimus|mesh-list
83480765|NCT03297606|Axitinib|axitinib|mesh-list
83480766|NCT03297606|Vemurafenib|vemurafenib|mesh-list
83480767|NCT03297606|Crizotinib|crizotinib|mesh-list
83480768|NCT03297606|Tucatinib|tucatinib|mesh-list
83480769|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480770|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480771|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480772|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480773|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480774|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480775|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83480776|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83480777|NCT03297606|Growth Substances|growth substances|mesh-ancestor
83480778|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480779|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
83480780|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83480781|NCT03297606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83480782|NCT03297606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480783|NCT03297606|Immunologic Factors|immunologic factors|mesh-ancestor
83480784|NCT03233204|Olaparib|olaparib|mesh-list
83480785|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83480786|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480787|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480788|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480789|NCT03194893|Crizotinib|crizotinib|mesh-list
83480790|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480791|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480792|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480793|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480794|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
83480795|NCT03179930|Entinostat|entinostat|mesh-list
83480796|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480797|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480798|NCT03179930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480799|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480800|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83480801|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480802|NCT03113851|Molgramostim|molgramostim|mesh-list
83480803|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480804|NCT03043313|Trastuzumab|trastuzumab|mesh-list
83480805|NCT03043313|Tucatinib|tucatinib|mesh-list
83480806|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480810|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480812|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83480813|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
83480814|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480815|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480816|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
83480817|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480818|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480819|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83480820|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
83480821|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480823|NCT02903381|Nivolumab|nivolumab|mesh-list
83480824|NCT02903381|Lenalidomide|lenalidomide|mesh-list
83480825|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480826|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
83480827|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
83480828|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480829|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480830|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83480831|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
83480832|NCT02903381|Hormones|hormones|mesh-ancestor
83480833|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480834|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480835|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480836|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480837|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83480838|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480839|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
83480840|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83480841|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83480842|NCT02903381|Growth Substances|growth substances|mesh-ancestor
83480843|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
83480844|NCT02830724|Aldesleukin|aldesleukin|mesh-list
83480845|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
83480846|NCT02830724|Fludarabine|fludarabine|mesh-list
83480847|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480848|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
83480849|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480850|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480851|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83480852|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
83480853|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480854|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480855|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83480856|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83480857|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83480858|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
83480859|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83480860|NCT02811133|Inositol|inositol|mesh-list
83480861|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
83480862|NCT02811133|Vitamins|vitamins|mesh-ancestor
83480863|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
83480864|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480865|NCT02744391|Levodopa|levodopa|mesh-list
83480866|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83480867|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83480868|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
83480869|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480870|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480871|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480872|NCT02618577|Edoxaban|edoxaban|mesh-list
83480873|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83480874|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
83480875|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83480876|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
83480877|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480878|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480879|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
83480880|NCT02607722|Nintedanib|nintedanib|mesh-list
83480881|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480882|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480883|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480884|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480885|NCT02462837|Mirabegron|mirabegron|mesh-list
83480891|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480892|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480893|NCT02462837|Urological Agents|urological agents|mesh-ancestor
83480894|NCT02436707|Dexamethasone|dexamethasone|mesh-list
83480895|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
83480896|NCT02436707|Rituximab|rituximab|mesh-list
83480897|NCT02436707|Gemcitabine|gemcitabine|mesh-list
83480898|NCT02436707|Etoposide|etoposide|mesh-list
83480899|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480900|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
83480901|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480902|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480903|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83480904|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
83480905|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480906|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480907|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83480908|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480909|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480910|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
83480911|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
83480912|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83480913|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83480914|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
83480915|NCT02436707|Hormones|hormones|mesh-ancestor
83480916|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83480917|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83480918|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83480919|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
83480920|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83480921|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83480922|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83480923|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480924|NCT02346201|Methylphenidate|methylphenidate|mesh-list
83480925|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83480926|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480927|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83480928|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83480929|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83480930|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480931|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
83480932|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480933|NCT02331134|Lenograstim|lenograstim|mesh-list
83480934|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83480935|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
83480936|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480937|NCT02310321|Cytarabine|cytarabine|mesh-list
83480938|NCT02310321|Idarubicin|idarubicin|mesh-list
83480939|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83480940|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
83480941|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480942|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480943|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
83480944|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83480945|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480946|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
83480947|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480948|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83480949|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83480950|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83480951|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480952|NCT02078427|BAX 855|bax 855|mesh-list
83480953|NCT02078427|Coagulants|coagulants|mesh-ancestor
83480954|NCT02042378|Rucaparib|rucaparib|mesh-list
83480955|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83480956|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480957|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480958|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480959|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83480960|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
83480961|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480962|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480963|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480964|NCT01866930|Interferons|interferons|mesh-list
83480970|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480972|NCT01856478|Afatinib|afatinib|mesh-list
83480973|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83480974|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
83480975|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83480976|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480977|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83480978|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
83480979|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480980|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480981|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
83480982|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480983|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83480984|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83480985|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
83480986|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83480987|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83480988|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480989|NCT01853826|Afatinib|afatinib|mesh-list
83480990|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480991|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83480992|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480993|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480994|NCT01682187|Lomustine|lomustine|mesh-list
83480995|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83480996|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
83480997|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83480998|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83480999|NCT01621568|Sunitinib|sunitinib|mesh-list
83481000|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481001|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83481002|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83481003|NCT01621568|Growth Substances|growth substances|mesh-ancestor
83481004|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481005|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
83481006|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83481007|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481008|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481009|NCT01366612|Vidarabine|vidarabine|mesh-list
83481010|NCT01366612|Fludarabine|fludarabine|mesh-list
83481011|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
83481012|NCT01366612|Busulfan|busulfan|mesh-list
83481013|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481014|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83481015|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
83481016|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481017|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83481018|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
83481019|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481020|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
83481021|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83481022|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
83481023|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83481024|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83481025|NCT01196390|Paclitaxel|paclitaxel|mesh-list
83481026|NCT01196390|Carboplatin|carboplatin|mesh-list
83481027|NCT01196390|Trastuzumab|trastuzumab|mesh-list
83481028|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83481029|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83481030|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83481031|NCT01196390|Antibodies|antibodies|mesh-list
83481032|NCT01196390|Immunoglobulins|immunoglobulins|mesh-list
83481033|NCT01196390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83481034|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83481035|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481036|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
83481037|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
83481038|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
83481039|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481040|NCT01196390|Immunologic Factors|immunologic factors|mesh-ancestor
83481041|NCT01196390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481042|NCT00903110|Mecasermin|mecasermin|mesh-list
83481043|NCT00903110|Growth Substances|growth substances|mesh-ancestor
83481049|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481051|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481052|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83481053|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481054|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481055|NCT00481091|Navitoclax|navitoclax|mesh-list
83481056|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481057|NCT00075946|Rituximab|rituximab|mesh-list
83481058|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83481059|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481060|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
83481061|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481062|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83481063|NCT00003641|Interferons|interferons|mesh-list
83481064|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
83481065|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
83481066|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481067|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
83481068|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83481069|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
83481070|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481071|NCT00392834|Leucovorin|leucovorin|mesh-list
83481072|NCT00392834|Cytarabine|cytarabine|mesh-list
83481073|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
83481074|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83481075|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83481076|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83481077|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
83481078|NCT00392834|Ifosfamide|ifosfamide|mesh-list
83481079|NCT00392834|Rituximab|rituximab|mesh-list
83481080|NCT00392834|Doxorubicin|doxorubicin|mesh-list
83481081|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83481082|NCT00392834|Methotrexate|methotrexate|mesh-list
83481083|NCT00392834|Etoposide|etoposide|mesh-list
83481084|NCT00392834|Vincristine|vincristine|mesh-list
83481085|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
83481086|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83481087|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
83481088|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481089|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83481090|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83481091|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
83481092|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481093|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481094|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83481095|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83481096|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83481097|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83481098|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83481099|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481100|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83481101|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
83481102|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83481103|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83481104|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
83481105|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
83481106|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83481107|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83481108|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83481109|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
83481110|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83481111|NCT00392834|Antidotes|antidotes|mesh-ancestor
83481112|NCT00392834|Protective Agents|protective agents|mesh-ancestor
83481113|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
83481114|NCT00392834|Vitamins|vitamins|mesh-ancestor
83481115|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
83481116|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
83481117|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
83481118|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
83481119|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83481120|NCT05363670|Albuterol|albuterol|mesh-list
83481121|NCT05363670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83481122|NCT05363670|Autonomic Agents|autonomic agents|mesh-ancestor
83481123|NCT05363670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481124|NCT05363670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481125|NCT05363670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83481134|NCT05363670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481136|NCT00393380|Hormones|hormones|mesh-list
83481137|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
83481138|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83481139|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481140|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83481141|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83481142|NCT05361642|Lidocaine|lidocaine|mesh-list
83481143|NCT05361642|Dexmedetomidine|dexmedetomidine|mesh-list
83481144|NCT05361642|Bupivacaine|bupivacaine|mesh-list
83481145|NCT05361642|Anesthetics, Local|anesthetics, local|mesh-ancestor
83481146|NCT05361642|Anesthetics|anesthetics|mesh-ancestor
83481147|NCT05361642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83481148|NCT05361642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481149|NCT05361642|Sensory System Agents|sensory system agents|mesh-ancestor
83481150|NCT05361642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481151|NCT05361642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83481152|NCT05361642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83481153|NCT05361642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83481154|NCT05361642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83481155|NCT05361642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481156|NCT05361642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83481157|NCT05361642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83481158|NCT05361642|Analgesics|analgesics|mesh-ancestor
83481159|NCT05361642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83481160|NCT05361642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83481161|NCT05361642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83481162|NCT05361642|Adrenergic Agents|adrenergic agents|mesh-ancestor
83481163|NCT05361642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481164|NCT00395876|Tenecteplase|tenecteplase|mesh-list
83481165|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83481166|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83481167|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481168|NCT02662634|Paclitaxel|paclitaxel|mesh-list
83481169|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83481170|NCT02662634|Cisplatin|cisplatin|mesh-list
83481171|NCT02662634|Carboplatin|carboplatin|mesh-list
83481172|NCT02662634|Pemetrexed|pemetrexed|mesh-list
83481173|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83481174|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481175|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
83481176|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
83481177|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
83481178|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481179|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481180|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83481181|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83481182|NCT00396032|Tenecteplase|tenecteplase|mesh-list
83481183|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83481184|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83481185|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481186|NCT02277782|Fentanyl|fentanyl|mesh-list
83481187|NCT02277782|Hydromorphone|hydromorphone|mesh-list
83481188|NCT02277782|Bupivacaine|bupivacaine|mesh-list
83481189|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
83481190|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
83481191|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83481192|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481193|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
83481194|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481195|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83481196|NCT02277782|Narcotics|narcotics|mesh-ancestor
83481197|NCT02277782|Analgesics|analgesics|mesh-ancestor
83481198|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83481199|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83481200|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
83481202|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
83481203|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
83481204|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481205|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481206|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83481207|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83481208|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83481212|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481213|NCT02271230|Vitamin D|vitamin d|mesh-list
83481214|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
83481215|NCT02271230|Cholecalciferol|cholecalciferol|mesh-list
83481216|NCT02271230|Vitamins|vitamins|mesh-list
83481217|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
83481218|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481219|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83481220|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83481221|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
83481222|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83481223|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481224|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83481225|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481226|NCT05514990|Dexamethasone|dexamethasone|mesh-list
83481227|NCT05514990|Dexamethasone acetate|dexamethasone acetate|mesh-list
83481228|NCT05514990|Pembrolizumab|pembrolizumab|mesh-list
83481229|NCT05514990|Bortezomib|bortezomib|mesh-list
83481230|NCT05514990|Ichthammol|ichthammol|mesh-list
83481231|NCT05514990|BB 1101|bb 1101|mesh-list
83481232|NCT05514990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83481233|NCT05514990|Antiemetics|antiemetics|mesh-ancestor
83481234|NCT05514990|Autonomic Agents|autonomic agents|mesh-ancestor
83481235|NCT05514990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481236|NCT05514990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481237|NCT05514990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83481238|NCT05514990|Glucocorticoids|glucocorticoids|mesh-ancestor
83481239|NCT05514990|Hormones|hormones|mesh-ancestor
83481240|NCT05514990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83481241|NCT05514990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83481242|NCT05514990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481243|NCT05514990|Protease Inhibitors|protease inhibitors|mesh-ancestor
83481244|NCT05514990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481245|NCT05514990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481246|NCT05514990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83481247|NCT05514990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83481248|NCT05514990|Dermatologic Agents|dermatologic agents|mesh-ancestor
83481249|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
83481250|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83481251|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83481252|NCT00396266|Plerixafor|plerixafor|mesh-list
83481253|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83481254|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83481255|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
83481256|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83481257|NCT04271384|Nivolumab|nivolumab|mesh-list
83481258|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83481259|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481260|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83481261|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481262|NCT05610384|Ibuprofen|ibuprofen|mesh-list
83481263|NCT05610384|Ketorolac|ketorolac|mesh-list
83481264|NCT05610384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83481265|NCT05610384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83481267|NCT05610384|Sensory System Agents|sensory system agents|mesh-ancestor
83481268|NCT05610384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481269|NCT05610384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481270|NCT05610384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83481271|NCT05610384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83481272|NCT05610384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83481273|NCT05610384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481274|NCT05610384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481275|NCT03570632|Metformin|metformin|mesh-list
83481276|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83481277|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481278|NCT00397904|Irinotecan|irinotecan|mesh-list
83481279|NCT00397904|Cetuximab|cetuximab|mesh-list
83481280|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481281|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83481282|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83481283|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481284|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481285|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83481286|NCT00398918|Zonisamide|zonisamide|mesh-list
83481287|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
83481288|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83481290|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481291|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83481292|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481293|NCT05380752|Tecovirimat|tecovirimat|mesh-list
83481294|NCT05380752|Antiviral Agents|antiviral agents|mesh-ancestor
83481295|NCT05380752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83481297|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
83481298|NCT00370838|Clonidine|clonidine|mesh-list
83481299|NCT00370838|Levetiracetam|levetiracetam|mesh-list
83481300|NCT00370838|Analgesics|analgesics|mesh-ancestor
83481301|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
83481302|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481303|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481304|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83481305|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
83481306|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
83481307|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83481308|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83481309|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83481310|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
83481311|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481312|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481313|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
83481314|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
83481315|NCT01795430|Etoposide|etoposide|mesh-list
83481316|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
83481317|NCT01795430|Melphalan|melphalan|mesh-list
83481318|NCT01795430|Busulfan|busulfan|mesh-list
83481319|NCT01795430|Topotecan|topotecan|mesh-list
83481320|NCT01795430|Ifosfamide|ifosfamide|mesh-list
83481321|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83481322|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481323|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83481324|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83481325|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481326|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481327|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83481328|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
83481329|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83481330|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83481331|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
83481332|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481333|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83481334|NCT04750382|Gemcitabine|gemcitabine|mesh-list
83481335|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481336|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83481337|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
83481338|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481339|NCT00401882|Metoprolol|metoprolol|mesh-list
83481340|NCT00401882|Epinephrine|epinephrine|mesh-list
83481341|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83481343|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
83481344|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481345|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481346|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481347|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83481348|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83481349|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
83481350|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481351|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83481352|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
83481353|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
83481354|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
83481355|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83481356|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83481357|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83481358|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
83481359|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83481360|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83481361|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83481362|NCT00373334|Nizatidine|nizatidine|mesh-list
83481363|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83481364|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83481365|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83481366|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
83481377|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481378|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83481379|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83481380|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481381|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
83481382|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83481383|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
83481384|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
83481385|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83481386|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
83481387|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481388|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481389|NCT00402194|Losartan|losartan|mesh-list
83481390|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83481391|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83481392|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83481393|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83481394|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481395|NCT05305404|Dexamethasone|dexamethasone|mesh-list
83481396|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
83481397|NCT05305404|BB 1101|bb 1101|mesh-list
83481398|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83481399|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
83481400|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
83481401|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481402|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481403|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83481404|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
83481405|NCT05305404|Hormones|hormones|mesh-ancestor
83481406|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83481407|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83481408|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481409|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
83481410|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481411|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481412|NCT00402896|Mitogens|mitogens|mesh-list
83481413|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
83481414|NCT00402896|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83481415|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
83481416|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481417|NCT00402896|Growth Substances|growth substances|mesh-ancestor
83481418|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481419|NCT00402896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83481420|NCT00402896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481421|NCT05268120|Doxycycline|doxycycline|mesh-list
83481422|NCT05268120|Rifampin|rifampin|mesh-list
83481423|NCT05268120|Trimethoprim|trimethoprim|mesh-list
83481424|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83481425|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83481426|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
83481427|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83481428|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83481429|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83481430|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
83481431|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
83481432|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83481433|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481434|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481435|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83481436|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83481437|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83481438|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83481439|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83481440|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83481441|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83481442|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83481443|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83481444|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83481445|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83481446|NCT00405704|Trimethoprim|trimethoprim|mesh-list
83481447|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83481448|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
83492154|NCT01832948|Leucovorin|leucovorin|mesh-list
83481456|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481457|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83481458|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83481459|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83481460|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83481461|NCT01657266|Nepafenac|nepafenac|mesh-list
83481462|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83481463|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83481464|NCT01657266|Analgesics|analgesics|mesh-ancestor
83481465|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
83481466|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481467|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481468|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83481469|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83481470|NCT00375830|Diphosphonates|diphosphonates|mesh-list
83481471|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
83481472|NCT00375830|Listerine|listerine|mesh-list
83481473|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
83481474|NCT00375830|Fluorides|fluorides|mesh-list
83481475|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
83481476|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83481477|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
83481478|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
83481479|NCT00375830|Protective Agents|protective agents|mesh-ancestor
83481480|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481481|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83481482|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481483|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83481484|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83481485|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
83481486|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
83481487|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83481488|NCT05286008|Dexamethasone|dexamethasone|mesh-list
83481489|NCT05286008|Ropivacaine|ropivacaine|mesh-list
83481490|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83481491|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
83481492|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
83481493|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481494|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481495|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83481496|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
83481497|NCT05286008|Hormones|hormones|mesh-ancestor
83481498|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83481499|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83481500|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481501|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
83481502|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
83481503|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83481504|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
83481505|NCT05302284|Carboplatin|carboplatin|mesh-list
83481506|NCT05302284|Gemcitabine|gemcitabine|mesh-list
83481507|NCT05302284|Disitamab vedotin|disitamab vedotin|mesh-list
83481508|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481509|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83481510|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
83481511|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481512|NCT05302284|Immunoconjugates|immunoconjugates|mesh-ancestor
83481513|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
83481514|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481515|NCT05263284|Venetoclax|venetoclax|mesh-list
83481516|NCT05263284|Adenosine|adenosine|mesh-list
83481517|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481518|NCT05263284|Analgesics|analgesics|mesh-ancestor
83481519|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
83481520|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481521|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481522|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83481523|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
83481524|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83481525|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
83481526|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
83481527|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481528|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481529|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
83481530|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83481531|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83481542|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481543|NCT05299476|Bevacizumab|bevacizumab|mesh-list
83481544|NCT05299476|Tislelizumab|tislelizumab|mesh-list
83481545|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83481546|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481547|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83481548|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83481549|NCT05299476|Growth Substances|growth substances|mesh-ancestor
83481550|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481551|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
83481552|NCT00405938|Bevacizumab|bevacizumab|mesh-list
83481553|NCT00405938|Fulvestrant|fulvestrant|mesh-list
83481554|NCT00405938|Anastrozole|anastrozole|mesh-list
83481555|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83481556|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481557|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83481558|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83481559|NCT00405938|Growth Substances|growth substances|mesh-ancestor
83481560|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481561|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
83481562|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83481563|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83481564|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83481565|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
83481566|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83481567|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83481568|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83481569|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481570|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481571|NCT05299398|Trazodone|trazodone|mesh-list
83481572|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83481573|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83481574|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83481575|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481576|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83481577|NCT05299398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83481578|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83481579|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83481580|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481581|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481582|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
83481583|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83481584|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
83481585|NCT01793480|Methadone|methadone|mesh-list
83481586|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83481587|NCT01793480|Narcotics|narcotics|mesh-ancestor
83481588|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83481589|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481590|NCT01793480|Analgesics|analgesics|mesh-ancestor
83481591|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
83481592|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481593|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
83481594|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
83481595|NCT05299086|Fluticasone|fluticasone|mesh-list
83481596|NCT05299086|Xhance|xhance|mesh-list
83481597|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83481598|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83481599|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
83481600|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481601|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481602|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83481603|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
83481604|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
83481605|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83481606|NCT05299008|Bethanechol|bethanechol|mesh-list
83481607|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83481608|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
83481609|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481610|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481611|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83481612|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83481613|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
83481614|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481615|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481626|NCT05256264|Ketamine|ketamine|mesh-list
83481627|NCT05256264|Analgesics|analgesics|mesh-ancestor
83481628|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
83481629|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481630|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481631|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83481632|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83481633|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
83481634|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
83481635|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83481636|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83481637|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83481638|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481639|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481640|NCT00379574|Prednisolone|prednisolone|mesh-list
83481641|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
83481642|NCT00379574|Doxorubicin|doxorubicin|mesh-list
83481643|NCT00379574|Vincristine|vincristine|mesh-list
83481644|NCT00379574|Bortezomib|bortezomib|mesh-list
83481645|NCT00379574|Lenograstim|lenograstim|mesh-list
83481646|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83481647|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
83481648|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481649|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83481650|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83481651|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
83481652|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481653|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481654|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83481655|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83481656|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83481657|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83481658|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481659|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83481660|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
83481661|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
83481662|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
83481663|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83481664|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
83481665|NCT00379574|Hormones|hormones|mesh-ancestor
83481666|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83481667|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83481668|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83481669|NCT05256108|Oxycodone|oxycodone|mesh-list
83481670|NCT05256108|Tramadol|tramadol|mesh-list
83481671|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83481672|NCT05256108|Narcotics|narcotics|mesh-ancestor
83481673|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83481674|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481675|NCT05256108|Analgesics|analgesics|mesh-ancestor
83481676|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
83481677|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481678|NCT00407654|Aflibercept|aflibercept|mesh-list
83481679|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
83481680|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83481681|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83481682|NCT00407654|Growth Substances|growth substances|mesh-ancestor
83481683|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481684|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
83481685|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481686|NCT05484492|Calcium|calcium|mesh-list
83481687|NCT05484492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83481688|NCT05484492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481689|NCT00407888|Paclitaxel|paclitaxel|mesh-list
83481690|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83481691|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
83481692|NCT00407888|Doxorubicin|doxorubicin|mesh-list
83481693|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83481694|NCT00407888|Trastuzumab|trastuzumab|mesh-list
83481695|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83481696|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481697|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
83481698|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
83481699|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
83481700|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481701|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83481702|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
83481703|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481704|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83481705|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83481706|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
83481707|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83481708|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83481709|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83481710|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83481711|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481712|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83481713|NCT00407966|Cytarabine|cytarabine|mesh-list
83481714|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
83481715|NCT00407966|Alvocidib|alvocidib|mesh-list
83481716|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83481717|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
83481718|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481719|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481720|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
83481721|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83481722|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83481723|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
83481724|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481725|NCT00407966|Analgesics|analgesics|mesh-ancestor
83481726|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
83481727|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481728|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83481729|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83481730|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481731|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
83481732|NCT00407966|Growth Substances|growth substances|mesh-ancestor
83481733|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83481734|NCT00408200|Sotalol|sotalol|mesh-list
83481735|NCT00408200|Flecainide|flecainide|mesh-list
83481736|NCT00408200|Propafenone|propafenone|mesh-list
83481737|NCT00408200|Dofetilide|dofetilide|mesh-list
83481738|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83481739|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83481740|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
83481741|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481742|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481743|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481744|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83481745|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
83481746|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
83481747|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481748|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83481749|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83481750|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83481751|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83481752|NCT05255406|Aflutinib|aflutinib|mesh-list
83481753|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83481754|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481755|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481756|NCT05250050|Amoxicillin|amoxicillin|mesh-list
83481757|NCT05250050|Metronidazole|metronidazole|mesh-list
83481758|NCT05250050|Clarithromycin|clarithromycin|mesh-list
83481759|NCT05250050|Levofloxacin|levofloxacin|mesh-list
83481760|NCT05250050|Tetracycline|tetracycline|mesh-list
83481761|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
83481762|NCT05250050|Esomeprazole|esomeprazole|mesh-list
83481763|NCT05250050|Bismuth|bismuth|mesh-list
83481764|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481765|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83481766|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83481767|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83481768|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83481769|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83481770|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83481771|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83481772|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481773|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83481774|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83481791|NCT05499390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481792|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83481793|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83481794|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83481795|NCT05294328|Aceclidine|aceclidine|mesh-list
83481796|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83481797|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83481798|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83481799|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83481800|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
83481801|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481802|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481803|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481804|NCT05294328|Miotics|miotics|mesh-ancestor
83481805|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
83481806|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481807|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83481808|NCT05254236|Vaccines|vaccines|mesh-list
83481809|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
83481810|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481811|NCT05292690|Caffeine|caffeine|mesh-list
83481812|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83481813|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481814|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83481815|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481816|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481817|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83481818|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83481819|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
83481820|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481821|NCT00382148|Omalizumab|omalizumab|mesh-list
83481822|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83481823|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83481824|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
83481825|NCT05292066|Pregabalin|pregabalin|mesh-list
83481826|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83481827|NCT05292066|Analgesics|analgesics|mesh-ancestor
83481828|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
83481829|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481830|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481831|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
83481832|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83481833|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83481834|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481835|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83481836|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83481837|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83481838|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83481839|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83481840|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83481841|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83481842|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481843|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
83481844|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
83481845|NCT04270994|Misoprostol|misoprostol|mesh-list
83481846|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83481847|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
83481848|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83481849|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481850|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83481851|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83481852|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
83481853|NCT02111798|Bupropion|bupropion|mesh-list
83481854|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83481855|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
83481856|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83481857|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83481858|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83481859|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83481860|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481861|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
83481862|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481863|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481875|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481876|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481877|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83481878|NCT05143502|Fluticasone|fluticasone|mesh-list
83481879|NCT05143502|Xhance|xhance|mesh-list
83481880|NCT05143502|Prednisolone|prednisolone|mesh-list
83481881|NCT05143502|Montelukast|montelukast|mesh-list
83481882|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83481883|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83481884|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
83481885|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481886|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481887|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83481888|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
83481889|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
83481890|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83481891|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
83481892|NCT05143502|Hormones|hormones|mesh-ancestor
83481893|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83481894|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83481895|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481896|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83481897|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
83481898|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83481899|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83481900|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481901|NCT05290116|Apatinib|apatinib|mesh-list
83481902|NCT05290116|Tislelizumab|tislelizumab|mesh-list
83481903|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481904|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83481905|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481906|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481907|NCT05290116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83481908|NCT00409292|Everolimus|everolimus|mesh-list
83481909|NCT00409292|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83481910|NCT00409292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83481911|NCT00409292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481912|NCT00409292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481913|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83481914|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
83481915|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481916|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481917|NCT05246046|Bromides|bromides|mesh-list
83481918|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
83481919|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83481920|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
83481921|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481922|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481923|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83481924|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
83481925|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
83481926|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83481927|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
83481928|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481929|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481930|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
83481931|NCT00383942|Misoprostol|misoprostol|mesh-list
83481932|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83481933|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
83481934|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83481935|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481936|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83481937|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83481939|NCT05288400|Amlodipine|amlodipine|mesh-list
83481940|NCT05288400|Bisoprolol|bisoprolol|mesh-list
83481941|NCT05288400|Perindopril|perindopril|mesh-list
83481942|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83481943|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83481944|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83481945|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481946|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83481947|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481948|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
83481949|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
83481952|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83481953|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83481954|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83481955|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
83481956|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481957|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83481958|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
83481959|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481960|NCT05474040|Morphine|morphine|mesh-list
83481961|NCT05474040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83481962|NCT05474040|Narcotics|narcotics|mesh-ancestor
83481963|NCT05474040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83481964|NCT05474040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481965|NCT05474040|Analgesics|analgesics|mesh-ancestor
83481966|NCT05474040|Sensory System Agents|sensory system agents|mesh-ancestor
83481967|NCT05474040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481968|NCT00410150|Albuterol|albuterol|mesh-list
83481969|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83481970|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
83481971|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83481972|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481973|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83481974|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
83481975|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
83481976|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83481977|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83481978|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83481979|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83481980|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
83481981|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83481982|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481983|NCT00385268|Acamprosate|acamprosate|mesh-list
83481984|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83481985|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
83481986|NCT05287464|Nivolumab|nivolumab|mesh-list
83481987|NCT05287464|Ipilimumab|ipilimumab|mesh-list
83481988|NCT05287464|Atezolizumab|atezolizumab|mesh-list
83481989|NCT05287464|Avelumab|avelumab|mesh-list
83481990|NCT05287464|Lenvatinib|lenvatinib|mesh-list
83481991|NCT05287464|Axitinib|axitinib|mesh-list
83481992|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83481993|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83481994|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83481995|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83481996|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83481997|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83481998|NCT01657500|Gentamicins|gentamicins|mesh-list
83481999|NCT01657500|Dextrans|dextrans|mesh-list
83482000|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83482001|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83482002|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482003|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83482004|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482005|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482006|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
83482007|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
83482008|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
83482009|NCT00411086|Rituximab|rituximab|mesh-list
83482010|NCT00411086|Molgramostim|molgramostim|mesh-list
83482011|NCT00411086|Sargramostim|sargramostim|mesh-list
83482012|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83482013|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482015|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482016|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83482017|NCT01658904|Melphalan|melphalan|mesh-list
83482018|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
83482019|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482020|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83482021|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
83482022|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482023|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482024|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83482025|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83482026|NCT05238948|Midazolam|midazolam|mesh-list
83482027|NCT05238948|CKD-506|ckd-506|mesh-list
83482028|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83482029|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83482041|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482042|NCT05238948|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83482043|NCT05238948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482044|NCT00385580|Dasatinib|dasatinib|mesh-list
83482045|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482046|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83482047|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482048|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482049|NCT05236530|Metformin|metformin|mesh-list
83482050|NCT05236530|Repaglinide|repaglinide|mesh-list
83482051|NCT05236530|Dolutegravir|dolutegravir|mesh-list
83482052|NCT05236530|Lumefantrine|lumefantrine|mesh-list
83482053|NCT05236530|Midazolam|midazolam|mesh-list
83482054|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
83482055|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83482056|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83482057|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482058|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83482059|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83482060|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482061|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83482062|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83482063|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482064|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83482065|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
83482066|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
83482067|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
83482068|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
83482069|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482070|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482071|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83482072|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83482073|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
83482074|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83482075|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83482076|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482077|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83482078|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83482079|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83482080|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83482081|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
83482082|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482083|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
83482084|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83482085|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83482086|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
83482087|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
83482088|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83482089|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83482090|NCT00455702|Cycloserine|cycloserine|mesh-list
83482091|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83482092|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482093|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83482094|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
83482095|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83482096|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
83482097|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482098|NCT00456014|Desipramine|desipramine|mesh-list
83482099|NCT00456014|Escitalopram|escitalopram|mesh-list
83482100|NCT00456014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83482101|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83482102|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83482103|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482104|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482105|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
83482106|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482107|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
83482108|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482109|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83482110|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482111|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83482112|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
83482113|NCT05235516|Cisplatin|cisplatin|mesh-list
83482114|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482115|NCT00411398|Memantine|memantine|mesh-list
83482120|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482122|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83482123|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83482124|NCT05231694|Mitogens|mitogens|mesh-list
83482125|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
83482126|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482127|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83482128|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83482129|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83482130|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83482131|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482132|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482133|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482134|NCT00457730|Analgesics|analgesics|mesh-ancestor
83482135|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
83482136|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482137|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
83482138|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482139|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
83482140|NCT00458822|Dexamethasone|dexamethasone|mesh-list
83482141|NCT00458822|Bortezomib|bortezomib|mesh-list
83482142|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83482143|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
83482144|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
83482145|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482146|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482147|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83482148|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
83482149|NCT00458822|Hormones|hormones|mesh-ancestor
83482150|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83482151|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83482152|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482153|NCT00389168|Atenolol|atenolol|mesh-list
83482154|NCT00389168|Irbesartan|irbesartan|mesh-list
83482155|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83482156|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83482157|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83482158|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482159|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83482160|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
83482161|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
83482162|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482163|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482164|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83482165|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83482166|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83482167|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
83482168|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482169|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83482170|NCT00462020|Metronidazole|metronidazole|mesh-list
83482171|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
83482172|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
83482173|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
83482174|NCT00462020|Ampicillin|ampicillin|mesh-list
83482175|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83482176|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482177|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
83482178|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83482179|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83482180|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482181|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482182|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83482183|NCT05275374|Trametinib|trametinib|mesh-list
83482184|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482185|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83482186|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482187|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482188|NCT05177718|Natalizumab|natalizumab|mesh-list
83482189|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
83482190|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482191|NCT00414206|Mecamylamine|mecamylamine|mesh-list
83482192|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83482201|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482203|NCT05480046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83482204|NCT05480046|Serotonin Agents|serotonin agents|mesh-ancestor
83482205|NCT05480046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482206|NCT05480046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482207|NCT05480046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482208|NCT05480046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83482209|NCT05480046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83482210|NCT05480046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482211|NCT05480046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482212|NCT05480046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83482213|NCT05480046|Dopamine Agents|dopamine agents|mesh-ancestor
83482214|NCT04241640|Nefopam|nefopam|mesh-list
83482215|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83482216|NCT04241640|Analgesics|analgesics|mesh-ancestor
83482217|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
83482218|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482219|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482220|NCT00462332|Vidarabine|vidarabine|mesh-list
83482221|NCT00462332|Fludarabine|fludarabine|mesh-list
83482222|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
83482223|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
83482224|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482225|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83482226|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
83482227|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482228|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83482229|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
83482230|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482231|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
83482232|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482233|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83482234|NCT00462644|Fentanyl|fentanyl|mesh-list
83482235|NCT00462644|Midazolam|midazolam|mesh-list
83482236|NCT00462644|Etomidate|etomidate|mesh-list
83482237|NCT00462644|Succinylcholine|succinylcholine|mesh-list
83482238|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83482239|NCT00462644|Narcotics|narcotics|mesh-ancestor
83482240|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482241|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482242|NCT00462644|Analgesics|analgesics|mesh-ancestor
83482243|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
83482244|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482245|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83482246|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83482247|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
83482248|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
83482249|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83482250|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83482251|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83482252|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482253|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
83482254|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
83482255|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482256|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482257|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83482258|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83482259|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83482260|NCT00462722|Ibuprofen|ibuprofen|mesh-list
83482261|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83482262|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83482263|NCT00462722|Analgesics|analgesics|mesh-ancestor
83482264|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
83482265|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482266|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482267|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83482268|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83482269|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83482270|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482271|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482272|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
83482273|NCT05272254|Povidone|povidone|mesh-list
83482274|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
83482275|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
83482276|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83482282|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482283|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482284|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
83482285|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482286|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83482287|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
83482288|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482289|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83482290|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83482291|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83482292|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482293|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83482294|NCT00528788|Vitamins|vitamins|mesh-ancestor
83482295|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
83482296|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482297|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83482298|NCT00414518|Ritonavir|ritonavir|mesh-list
83482299|NCT00414518|Lopinavir|lopinavir|mesh-list
83482300|NCT00414518|Tenofovir|tenofovir|mesh-list
83482301|NCT00414518|Emtricitabine|emtricitabine|mesh-list
83482302|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83482303|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83482304|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
83482305|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482306|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482307|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83482308|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83482309|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
83482310|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482311|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83482312|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83482313|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83482314|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83482315|NCT01795664|Fluticasone|fluticasone|mesh-list
83482316|NCT01795664|Xhance|xhance|mesh-list
83482317|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83482318|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83482319|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83482320|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83482321|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
83482322|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482323|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482324|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83482325|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
83482326|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
83482327|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83482328|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83482329|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83482330|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83482331|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
83482332|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482333|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482334|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
83482335|NCT01795664|Hormones|hormones|mesh-ancestor
83482336|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83482337|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
83482338|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
83482339|NCT05271084|Dexetimide|dexetimide|mesh-list
83482340|NCT05271084|Citalopram|citalopram|mesh-list
83482341|NCT05271084|Escitalopram|escitalopram|mesh-list
83482342|NCT05271084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83482343|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83482344|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83482345|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482346|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482347|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
83482348|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482349|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83482350|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
83482351|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482352|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83482353|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83482354|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
83482355|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
83482356|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482373|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83482374|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
83482375|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482376|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83482377|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83482378|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83482379|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482380|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
83482381|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482382|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482383|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83482384|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83482385|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482386|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83482387|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83482388|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482389|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
83482390|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83482391|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83482392|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
83482393|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83482394|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83482395|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83482396|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83482397|NCT00531518|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83482398|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
83482399|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83482400|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83482401|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83482402|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83482403|NCT00533546|Protein C|protein c|mesh-list
83482404|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
83482405|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83482406|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83482407|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482408|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482409|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83482410|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83482411|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83482412|NCT00534794|Analgesics|analgesics|mesh-ancestor
83482413|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
83482414|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482415|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482416|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83482417|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83482418|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83482419|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83482420|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83482421|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
83482422|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
83482423|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482424|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482425|NCT01658436|Dactolisib|dactolisib|mesh-list
83482426|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482427|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
83482428|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83482429|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482430|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482431|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83482432|NCT05168280|Analgesics|analgesics|mesh-ancestor
83482433|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
83482434|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482435|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83482436|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83482437|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83482438|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
83482439|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482440|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482441|NCT05053854|Talazoparib|talazoparib|mesh-list
83482442|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83482443|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492155|NCT01832948|Folic Acid|folic acid|mesh-list
83482444|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482445|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482446|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83482447|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
83482448|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
83482449|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
83482450|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
83482451|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83482452|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83482453|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482454|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83482455|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83482456|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482457|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482458|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482459|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83482460|NCT00465530|Gentamicins|gentamicins|mesh-list
83482461|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83482462|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482463|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83482464|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482465|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482466|NCT00466310|Risperidone|risperidone|mesh-list
83482467|NCT00466310|Aripiprazole|aripiprazole|mesh-list
83482468|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83482469|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
83482470|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482471|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482472|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482473|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83482474|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83482475|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482476|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482477|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83482478|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
83482479|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
83482480|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
83482481|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83482482|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83482483|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83482484|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83482485|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
83482487|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83482488|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482489|NCT03463460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83482490|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482491|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83482492|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83482493|NCT03463460|Growth Substances|growth substances|mesh-ancestor
83482494|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482495|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
83482496|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83482497|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482498|NCT00535652|Ertapenem|ertapenem|mesh-list
83482499|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83482500|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482501|NCT00418028|Capecitabine|capecitabine|mesh-list
83482502|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83482503|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
83482504|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482505|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482506|NCT00537290|Rituximab|rituximab|mesh-list
83482507|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83482508|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482509|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
83482510|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482511|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83482512|NCT00537680|Ubiquinone|ubiquinone|mesh-list
83482513|NCT00537680|Idebenone|idebenone|mesh-list
83482514|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
83482515|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482516|NCT00537680|Protective Agents|protective agents|mesh-ancestor
83482517|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482537|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482538|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83482539|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
83482540|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
83482541|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83482542|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83482543|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482544|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
83482545|NCT05157126|Gentamicins|gentamicins|mesh-list
83482546|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83482547|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482548|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83482549|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482550|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482551|NCT00469508|Modafinil|modafinil|mesh-list
83482552|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83482553|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482554|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83482555|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83482556|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83482557|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482558|NCT05096832|Vaccines|vaccines|mesh-list
83482559|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
83482560|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482561|NCT00470600|Ibuprofen|ibuprofen|mesh-list
83482562|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83482563|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83482564|NCT00470600|Analgesics|analgesics|mesh-ancestor
83482565|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
83482566|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482567|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482568|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83482569|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83482570|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83482571|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482572|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482573|NCT00471068|Timolol|timolol|mesh-list
83482574|NCT00471068|Travoprost|travoprost|mesh-list
83482575|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83482576|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83482577|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
83482578|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482579|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482580|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482581|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83482582|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83482583|NCT00471380|Timolol|timolol|mesh-list
83482584|NCT00471380|Travoprost|travoprost|mesh-list
83482585|NCT00471380|Dorzolamide|dorzolamide|mesh-list
83482586|NCT00471380|Brinzolamide|brinzolamide|mesh-list
83482587|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83482588|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83482589|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
83482590|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482591|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482592|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482593|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83482594|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83482595|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83482596|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482597|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
83482598|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83482599|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
83482600|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482601|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83482602|NCT00538850|Fentanyl|fentanyl|mesh-list
83482603|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83482604|NCT00538850|Narcotics|narcotics|mesh-ancestor
83482605|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482606|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482607|NCT00538850|Analgesics|analgesics|mesh-ancestor
83482608|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
83482609|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482610|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83482611|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83482618|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482620|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482621|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482622|NCT00418574|Abagovomab|abagovomab|mesh-list
83482623|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83482624|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482625|NCT00473642|Ranibizumab|ranibizumab|mesh-list
83482626|NCT00473642|Verteporfin|verteporfin|mesh-list
83482627|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83482628|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83482629|NCT00473642|Growth Substances|growth substances|mesh-ancestor
83482630|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482631|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
83482632|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482633|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83482634|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
83482635|NCT00539942|PENTA|penta|mesh-list
83482636|NCT00539942|Fondaparinux|fondaparinux|mesh-list
83482637|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83482638|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
83482639|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83482640|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
83482641|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482642|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482643|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
83482644|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83482645|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83482646|NCT00419666|Calcitriol|calcitriol|mesh-list
83482647|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83482648|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482649|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83482650|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83482651|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482652|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83482653|NCT00419666|Vitamins|vitamins|mesh-ancestor
83482654|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
83482655|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83482656|NCT00540722|Acetic Acid|acetic acid|mesh-list
83482657|NCT00540722|Retinol acetate|retinol acetate|mesh-list
83482658|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
83482659|NCT00540722|Gossypol|gossypol|mesh-list
83482660|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83482661|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482662|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83482663|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
83482664|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482665|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83482666|NCT00540722|Protective Agents|protective agents|mesh-ancestor
83482667|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482668|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83482669|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
83482670|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83482671|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83482672|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83482673|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83482674|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83482675|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
83482676|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83482677|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
83482678|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482679|NCT00542750|Expectorants|expectorants|mesh-ancestor
83482680|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
83482681|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83482682|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
83482683|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482684|NCT00542750|Protective Agents|protective agents|mesh-ancestor
83482685|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482686|NCT00542750|Antidotes|antidotes|mesh-ancestor
83482687|NCT00475904|Gabapentin|gabapentin|mesh-list
83482689|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
83482690|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482691|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482692|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
83482693|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83482694|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83482767|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482768|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
83482769|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482770|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83482771|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83482772|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83482773|NCT00425672|Interleukin-2|interleukin-2|mesh-list
83482774|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
83482775|NCT00425672|Immunotoxins|immunotoxins|mesh-list
83482776|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482777|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83482778|NCT00425672|Analgesics|analgesics|mesh-ancestor
83482779|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
83482780|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482781|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482782|NCT00425672|Immunoconjugates|immunoconjugates|mesh-ancestor
83482783|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
83482784|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
83482785|NCT00544076|Alprostadil|alprostadil|mesh-list
83482786|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482787|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
83482788|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83482789|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83482790|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482791|NCT00544076|Urological Agents|urological agents|mesh-ancestor
83482792|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83482793|NCT00544778|Doxorubicin|doxorubicin|mesh-list
83482794|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83482795|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
83482796|NCT00544778|Irinotecan|irinotecan|mesh-list
83482797|NCT00544778|Ifosfamide|ifosfamide|mesh-list
83482798|NCT00544778|Razoxane|razoxane|mesh-list
83482799|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83482800|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482801|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83482802|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83482803|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482804|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482805|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83482806|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482807|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83482808|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
83482809|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83482810|NCT00544778|Protective Agents|protective agents|mesh-ancestor
83482811|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
83482812|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
83482813|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
83482814|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482815|NCT00486824|Indomethacin|indomethacin|mesh-list
83482816|NCT00486824|Nifedipine|nifedipine|mesh-list
83482817|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83482818|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83482819|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482820|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83482821|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482822|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
83482823|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
83482824|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83482825|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83482826|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83482827|NCT00486824|Analgesics|analgesics|mesh-ancestor
83482828|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
83482829|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482830|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83482831|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83482832|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
83482833|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83482834|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482835|NCT00489086|Tazarotene|tazarotene|mesh-list
83482836|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
83482837|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
83482838|NCT00489866|Aripiprazole|aripiprazole|mesh-list
83482839|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
83482840|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482841|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83482842|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83492156|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
83482848|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482849|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83482850|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83482851|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
83482852|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83482853|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83482854|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83482855|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83482857|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482858|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83482859|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482860|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482861|NCT00546728|Metformin|metformin|mesh-list
83482862|NCT00546728|Exenatide|exenatide|mesh-list
83482863|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83482864|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482865|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83482866|NCT00546728|Incretins|incretins|mesh-ancestor
83482867|NCT00546728|Hormones|hormones|mesh-ancestor
83482868|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83482869|NCT00547586|Bromides|bromides|mesh-list
83482870|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
83482871|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
83482872|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83482873|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482874|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
83482875|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482876|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
83482877|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83482878|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482879|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
83482880|NCT00490100|Mecasermin|mecasermin|mesh-list
83482881|NCT00490100|Growth Substances|growth substances|mesh-ancestor
83482882|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482883|NCT00490802|Oxytocin|oxytocin|mesh-list
83482884|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
83482885|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83482886|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482887|NCT00550394|Topiramate|topiramate|mesh-list
83482888|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83482889|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
83482890|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482891|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83482892|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83482893|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482894|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482895|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
83482896|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83482897|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83482898|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83482899|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83482900|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
83482901|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83482902|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482903|NCT00492206|Cetuximab|cetuximab|mesh-list
83482904|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83482905|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482906|NCT00431132|Estradiol|estradiol|mesh-list
83482907|NCT00431132|Estrogens|estrogens|mesh-ancestor
83482908|NCT00431132|Hormones|hormones|mesh-ancestor
83482909|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83482910|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482911|NCT00493064|Niacin|niacin|mesh-list
83482912|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
83482913|NCT00493064|Niacinamide|niacinamide|mesh-list
83482914|NCT00493064|Prednisolone|prednisolone|mesh-list
83482915|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83482916|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
83482917|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83482918|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
83482919|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83482920|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
83482921|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83482922|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
83482923|NCT00493064|Hormones|hormones|mesh-ancestor
83482924|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83482936|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482937|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83482938|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
83482939|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
83482941|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
83482942|NCT00552422|Domperidone|domperidone|mesh-list
83482943|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
83482944|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
83482945|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482946|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482947|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83482948|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83482949|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
83482950|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482951|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482952|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
83482953|NCT00432458|Thalidomide|thalidomide|mesh-list
83482954|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83482955|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
83482956|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482957|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
83482958|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83482959|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83482960|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83482961|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83482962|NCT00432458|Growth Substances|growth substances|mesh-ancestor
83482963|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
83482964|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482965|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83482966|NCT00433550|Capecitabine|capecitabine|mesh-list
83482967|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
83482968|NCT00433550|Irinotecan|irinotecan|mesh-list
83482969|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83482970|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
83482971|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482972|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482973|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83482974|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83482975|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482976|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
83482977|NCT02208037|Maraviroc|maraviroc|mesh-list
83482978|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
83482979|NCT02208037|Methotrexate|methotrexate|mesh-list
83482980|NCT02208037|Bortezomib|bortezomib|mesh-list
83482981|NCT02208037|Tacrolimus|tacrolimus|mesh-list
83482982|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83482983|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
83482984|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482985|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83482986|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83482987|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
83482988|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482989|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482990|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83482991|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83482992|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
83482993|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83482994|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83482995|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
83482996|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
83482997|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482998|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83482999|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83483000|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83483001|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83483002|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83483003|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
83483004|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83483005|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83483006|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83483007|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83483008|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83483009|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83483010|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
83483011|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83483022|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483023|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83483024|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483025|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
83483026|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
83483027|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483028|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
83483029|NCT05041842|Trastuzumab|trastuzumab|mesh-list
83483030|NCT05041842|Pertuzumab|pertuzumab|mesh-list
83483031|NCT05041842|Tucatinib|tucatinib|mesh-list
83483032|NCT05041842|Hormones|hormones|mesh-list
83483033|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83483034|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483035|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483036|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483037|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83483038|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483039|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483040|NCT05150496|Vaccines|vaccines|mesh-list
83483041|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
83483042|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483043|NCT00496340|Rituximab|rituximab|mesh-list
83483044|NCT00496340|Busulfan|busulfan|mesh-list
83483045|NCT00496340|Pentostatin|pentostatin|mesh-list
83483046|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83483047|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483048|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
83483049|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483050|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483051|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
83483052|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483053|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83483054|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83483055|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83483056|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83483057|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483058|NCT05090358|Canagliflozin|canagliflozin|mesh-list
83483059|NCT05090358|Fulvestrant|fulvestrant|mesh-list
83483060|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83483061|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483062|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83483063|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83483064|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
83483065|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483066|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483067|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83483068|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483069|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83483070|NCT00496808|Trastuzumab|trastuzumab|mesh-list
83483071|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83483072|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483073|NCT05148078|Anesthetics|anesthetics|mesh-list
83483074|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483075|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483076|NCT01795820|Ticagrelor|ticagrelor|mesh-list
83483077|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83483078|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83483079|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83483080|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83483081|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
83483082|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483083|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483084|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483085|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83483086|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83483087|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483088|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483089|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83483090|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
83483091|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483092|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483093|NCT00555152|Lapatinib|lapatinib|mesh-list
83483097|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483098|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83483099|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483100|NCT00555464|Prednisone|prednisone|mesh-list
83483101|NCT00555464|Prednisolone|prednisolone|mesh-list
83483102|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83483103|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
83483104|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83483105|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
83483106|NCT00555464|Vincristine|vincristine|mesh-list
83483107|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83483108|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
83483109|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483110|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
83483111|NCT00555464|Hormones|hormones|mesh-ancestor
83483112|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483113|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483114|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83483115|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483116|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83483117|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
83483118|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
83483119|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
83483120|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483121|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
83483122|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
83483123|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483124|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483125|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83483126|NCT00555464|Protective Agents|protective agents|mesh-ancestor
83483127|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
83483128|NCT01795976|Fludarabine|fludarabine|mesh-list
83483129|NCT01795976|Interleukin-2|interleukin-2|mesh-list
83483130|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83483131|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
83483132|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483133|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483134|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83483135|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
83483136|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483137|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483138|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83483139|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83483140|NCT01795976|Analgesics|analgesics|mesh-ancestor
83483141|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
83483142|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483143|NCT01461733|Amiodarone|amiodarone|mesh-list
83483144|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83483145|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
83483146|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83483147|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83483148|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483149|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83483150|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83483151|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83483152|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483153|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83483154|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83483155|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83483156|NCT01462279|Thiamine|thiamine|mesh-list
83483157|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
83483158|NCT01462279|Vitamins|vitamins|mesh-ancestor
83483159|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
83483160|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483161|NCT00435812|Vaccines|vaccines|mesh-list
83483162|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
83483163|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483164|NCT05081466|Vitamin D|vitamin d|mesh-list
83483165|NCT05081466|Calcium|calcium|mesh-list
83483166|NCT05081466|Vitamins|vitamins|mesh-ancestor
83483167|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
83483168|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483169|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83483170|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83483171|NCT01464229|Iloperidone|iloperidone|mesh-list
83483187|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83483188|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83483189|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83483190|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483191|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83483192|NCT00500240|Insulin|insulin|mesh-list
83483193|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83483194|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
83483195|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
83483196|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83483197|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483198|NCT01469767|Fluocinonide|fluocinonide|mesh-list
83483199|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483200|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
83483201|NCT01469767|Hormones|hormones|mesh-ancestor
83483202|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483203|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483204|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83483205|NCT05029596|Heparin|heparin|mesh-list
83483206|NCT05029596|Calcium heparin|calcium heparin|mesh-list
83483207|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
83483208|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83483209|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83483210|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483211|NCT03246620|Diazepam|diazepam|mesh-list
83483212|NCT03246620|Haloperidol|haloperidol|mesh-list
83483213|NCT03246620|Olanzapine|olanzapine|mesh-list
83483214|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
83483215|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
83483216|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
83483217|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483218|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483219|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483220|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83483221|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83483222|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483223|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83483224|NCT03246620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83483225|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83483226|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83483227|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483228|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483229|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
83483230|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83483231|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
83483232|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83483233|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83483234|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
83483235|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83483236|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83483237|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83483238|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83483239|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83483240|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
83483241|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
83483242|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
83483243|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
83483244|NCT05080218|Adalimumab|adalimumab|mesh-list
83483245|NCT05080218|Golimumab|golimumab|mesh-list
83483246|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83483247|NCT05080218|Etanercept|etanercept|mesh-list
83483248|NCT05080218|Abatacept|abatacept|mesh-list
83483249|NCT05080218|Upadacitinib|upadacitinib|mesh-list
83483250|NCT05080218|Ixekizumab|ixekizumab|mesh-list
83483251|NCT05080218|Tofacitinib|tofacitinib|mesh-list
83483252|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483253|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483254|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83483255|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83483256|NCT05080218|Analgesics|analgesics|mesh-ancestor
83483257|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
83483258|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483259|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483260|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483261|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83483262|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
83483263|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83483340|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483264|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483265|NCT05080218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83483266|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483267|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83483268|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83483269|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483270|NCT05080218|Dermatologic Agents|dermatologic agents|mesh-ancestor
83483271|NCT01470859|Levodopa|levodopa|mesh-list
83483272|NCT01470859|Carbidopa|carbidopa|mesh-list
83483273|NCT01470859|Pramipexole|pramipexole|mesh-list
83483274|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83483275|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83483276|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83483277|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
83483278|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483279|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483280|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483281|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83483282|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483283|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
83483284|NCT01470859|Protective Agents|protective agents|mesh-ancestor
83483285|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
83483286|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83483287|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
83483288|NCT00436046|Interferons|interferons|mesh-list
83483289|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483290|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
83483291|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83483292|NCT01471639|Ketorolac|ketorolac|mesh-list
83483293|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83483294|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83483295|NCT01471639|Analgesics|analgesics|mesh-ancestor
83483296|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
83483297|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483298|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483299|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483300|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483301|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83483302|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483303|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483304|NCT05622656|Dexmedetomidine|dexmedetomidine|mesh-list
83483305|NCT05622656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83483306|NCT05622656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483307|NCT05622656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483308|NCT05622656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83483309|NCT05622656|Analgesics|analgesics|mesh-ancestor
83483310|NCT05622656|Sensory System Agents|sensory system agents|mesh-ancestor
83483311|NCT05622656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483312|NCT05622656|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83483313|NCT05622656|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83483314|NCT05622656|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83483315|NCT05622656|Adrenergic Agents|adrenergic agents|mesh-ancestor
83483316|NCT05622656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483317|NCT05622656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483318|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
83483319|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
83483320|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483321|NCT05079126|Protective Agents|protective agents|mesh-ancestor
83483322|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483323|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83483324|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483325|NCT05140278|Artesunate|artesunate|mesh-list
83483326|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
83483327|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83483328|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83483329|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83483330|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483331|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
83483332|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
83483333|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83483334|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
83483335|NCT00436904|Rituximab|rituximab|mesh-list
83483336|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
83483337|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83483338|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483346|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483347|NCT01485055|Infliximab|infliximab|mesh-list
83483348|NCT01485055|Basiliximab|basiliximab|mesh-list
83483349|NCT01485055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83483350|NCT01485055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483351|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
83483352|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483353|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483354|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83483355|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
83483356|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483357|NCT05028348|Dexamethasone|dexamethasone|mesh-list
83483358|NCT05028348|Pomalidomide|pomalidomide|mesh-list
83483359|NCT05028348|Elotuzumab|elotuzumab|mesh-list
83483360|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483361|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
83483362|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
83483363|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483364|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483365|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483366|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
83483367|NCT05028348|Hormones|hormones|mesh-ancestor
83483368|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483369|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83483370|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483371|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
83483372|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83483373|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83483374|NCT05028348|Growth Substances|growth substances|mesh-ancestor
83483375|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
83483376|NCT01486615|Melatonin|melatonin|mesh-list
83483377|NCT01486615|Alprazolam|alprazolam|mesh-list
83483378|NCT01486615|Azaperone|azaperone|mesh-list
83483379|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
83483380|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483381|NCT01486615|Protective Agents|protective agents|mesh-ancestor
83483382|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483383|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483384|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83483385|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83483386|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83483387|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83483388|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
83483389|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
83483390|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483391|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83483392|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83483393|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
83483394|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83483395|NCT00503750|Vinorelbine|vinorelbine|mesh-list
83483396|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483397|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83483398|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
83483399|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
83483400|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
83483401|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483402|NCT05077332|Celecoxib|celecoxib|mesh-list
83483403|NCT05077332|Famotidine|famotidine|mesh-list
83483404|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83483405|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83483406|NCT05077332|Analgesics|analgesics|mesh-ancestor
83483407|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
83483408|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483409|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483410|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483411|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483412|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83483413|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83483414|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483415|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483416|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83483417|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483418|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83483419|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
83483420|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
83483421|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483422|NCT05076006|PF-06700841|pf-06700841|mesh-list
83483425|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483426|NCT00439946|Treprostinil|treprostinil|mesh-list
83483427|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83483428|NCT04227678|Heparin|heparin|mesh-list
83483429|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
83483430|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83483431|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83483432|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483433|NCT00508118|Nicardipine|nicardipine|mesh-list
83483434|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83483435|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83483436|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83483437|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483438|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83483439|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483440|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
83483441|NCT05139030|Bupivacaine|bupivacaine|mesh-list
83483442|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
83483443|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
83483444|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483445|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483446|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
83483447|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483448|NCT00440180|Anastrozole|anastrozole|mesh-list
83483449|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83483450|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483451|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83483452|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83483453|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483454|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483455|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83483456|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
83483457|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483458|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483459|NCT05021484|Felzartamab|felzartamab|mesh-list
83483460|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483461|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
83483462|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483463|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83483464|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83483465|NCT05021094|Estradiol|estradiol|mesh-list
83483466|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83483467|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
83483468|NCT05021094|Estrogens|estrogens|mesh-ancestor
83483469|NCT05021094|Hormones|hormones|mesh-ancestor
83483470|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483471|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483472|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83483473|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
83483474|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83483475|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83483476|NCT05021094|Progestins|progestins|mesh-ancestor
83483477|NCT01364298|Pregabalin|pregabalin|mesh-list
83483478|NCT01364298|Gabapentin|gabapentin|mesh-list
83483479|NCT01364298|Analgesics|analgesics|mesh-ancestor
83483480|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
83483481|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483482|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483483|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
83483484|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83483485|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83483486|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483487|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83483488|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83483489|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83483490|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483491|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83483492|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83483493|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83483494|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483495|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
83483496|NCT04421742|Beclomethasone|beclomethasone|mesh-list
83483497|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
83483498|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83483509|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483510|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483511|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
83483512|NCT04421742|Hormones|hormones|mesh-ancestor
83483513|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483514|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
83483515|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83483516|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
83483517|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483518|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483519|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83483520|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
83483521|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83483522|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83483523|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83483524|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
83483525|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483526|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483527|NCT01488409|Acipimox|acipimox|mesh-list
83483528|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83483529|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
83483530|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483531|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83483532|NCT01488877|Spironolactone|spironolactone|mesh-list
83483533|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83483534|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
83483535|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483536|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483537|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83483538|NCT01488877|Diuretics|diuretics|mesh-ancestor
83483539|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
83483540|NCT01364922|Acetaminophen|acetaminophen|mesh-list
83483541|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83483542|NCT01364922|Hydrocodone|hydrocodone|mesh-list
83483543|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83483544|NCT01364922|Analgesics|analgesics|mesh-ancestor
83483545|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
83483546|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483547|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483548|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
83483549|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83483550|NCT01364922|Narcotics|narcotics|mesh-ancestor
83483551|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483552|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
83483553|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
83483554|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83483555|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483556|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483557|NCT01489969|Melatonin|melatonin|mesh-list
83483558|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
83483559|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483560|NCT01489969|Protective Agents|protective agents|mesh-ancestor
83483561|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483562|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483563|NCT00509288|Aldesleukin|aldesleukin|mesh-list
83483564|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
83483565|NCT00509288|Fludarabine|fludarabine|mesh-list
83483566|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83483567|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
83483568|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483569|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483570|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83483571|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
83483572|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483573|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483574|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83483575|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83483576|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83483577|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
83483578|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83483579|NCT00442364|Polidocanol|polidocanol|mesh-list
83483580|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83483581|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83483585|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483587|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
83483588|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483589|NCT00511706|Dexamethasone|dexamethasone|mesh-list
83483590|NCT00511706|Ranibizumab|ranibizumab|mesh-list
83483591|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483592|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
83483593|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
83483594|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483595|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483596|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483597|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
83483598|NCT00511706|Hormones|hormones|mesh-ancestor
83483599|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483600|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83483601|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483602|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83483603|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83483604|NCT00511706|Growth Substances|growth substances|mesh-ancestor
83483605|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
83483606|NCT05067894|Vaccines|vaccines|mesh-list
83483607|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
83483608|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483609|NCT01493947|Metronidazole|metronidazole|mesh-list
83483610|NCT01493947|Ivermectin|ivermectin|mesh-list
83483611|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83483612|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83483613|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83483614|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83483615|NCT00445484|Lenalidomide|lenalidomide|mesh-list
83483616|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83483617|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
83483618|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483619|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83483620|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83483621|NCT00445484|Growth Substances|growth substances|mesh-ancestor
83483622|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
83483623|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483624|NCT01495585|Lonafarnib|lonafarnib|mesh-list
83483625|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483626|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483627|NCT00446264|Sirolimus|sirolimus|mesh-list
83483628|NCT00446264|Tacrolimus|tacrolimus|mesh-list
83483629|NCT00446264|Daclizumab|daclizumab|mesh-list
83483630|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83483631|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
83483632|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483633|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83483634|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483635|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483636|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83483637|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83483638|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83483639|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483640|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
83483641|NCT01495819|Nicotine|nicotine|mesh-list
83483642|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83483643|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
83483644|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483645|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483646|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83483647|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83483648|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
83483649|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483650|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483651|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
83483652|NCT04214886|Fludarabine|fludarabine|mesh-list
83483653|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83483654|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
83483655|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483656|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483657|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83483658|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
83483659|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483660|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483661|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83483662|NCT00512876|Bevacizumab|bevacizumab|mesh-list
83483663|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83483664|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483665|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83483666|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83483667|NCT00512876|Growth Substances|growth substances|mesh-ancestor
83483668|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483670|NCT05127876|Ephedrine|ephedrine|mesh-list
83483671|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
83483672|NCT05127876|Ondansetron|ondansetron|mesh-list
83483673|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
83483674|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
83483675|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483676|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483677|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483678|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
83483679|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
83483680|NCT05127876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83483681|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83483682|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
83483683|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483684|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483685|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83483686|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
83483687|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83483688|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
83483689|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83483690|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83483691|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
83483692|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
83483693|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
83483694|NCT01496131|Goserelin|goserelin|mesh-list
83483695|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
83483696|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483697|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83483698|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483699|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83483700|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
83483701|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483702|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483703|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83483704|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83483705|NCT02520726|Sertraline|sertraline|mesh-list
83483706|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
83483707|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83483708|NCT02520726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83483709|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83483710|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83483711|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483712|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483713|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
83483714|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483715|NCT00450242|Lidocaine|lidocaine|mesh-list
83483716|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
83483717|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
83483718|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483719|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483720|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
83483721|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483722|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83483723|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83483724|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83483725|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83483726|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483727|NCT00517010|Ranibizumab|ranibizumab|mesh-list
83483728|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83483729|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83483730|NCT00517010|Growth Substances|growth substances|mesh-ancestor
83483731|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483732|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
83483733|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483734|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
83483735|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
83483736|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83483737|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483738|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83483739|NCT00519584|Bupivacaine|bupivacaine|mesh-list
83483740|NCT00519584|Ropivacaine|ropivacaine|mesh-list
83483741|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
83483742|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
83483743|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483744|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483745|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
83483746|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483748|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83483749|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83483750|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
83483751|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83483752|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83483753|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483754|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483755|NCT05122884|Protective Agents|protective agents|mesh-ancestor
83483756|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483757|NCT00520286|Modafinil|modafinil|mesh-list
83483758|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83483759|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483760|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83483761|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83483762|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83483763|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483764|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83483765|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483766|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83483767|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483768|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483769|NCT01395043|Epinephrine|epinephrine|mesh-list
83483770|NCT01395043|Bupivacaine|bupivacaine|mesh-list
83483771|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
83483772|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
83483773|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483774|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483775|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
83483776|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483777|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83483778|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83483779|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
83483780|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483781|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483782|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83483783|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83483784|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
83483785|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83483786|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
83483787|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
83483788|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
83483789|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83483790|NCT00521456|Ketorolac|ketorolac|mesh-list
83483791|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83483792|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83483793|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83483794|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83483795|NCT00521456|Analgesics|analgesics|mesh-ancestor
83483796|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
83483797|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483798|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483799|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483800|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483801|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83483802|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483803|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483804|NCT01796366|Insulin|insulin|mesh-list
83483805|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83483806|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
83483807|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83483808|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483809|NCT03326180|Bupivacaine|bupivacaine|mesh-list
83483810|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
83483812|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483813|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483814|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
83483815|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483816|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83483817|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83483818|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83483819|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83483820|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483821|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
83483822|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483823|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483824|NCT05119920|Pilocarpine|pilocarpine|mesh-list
83483825|NCT05119920|Miotics|miotics|mesh-ancestor
83483826|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
83483827|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483828|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483829|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83483830|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83483831|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
83483832|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483833|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483834|NCT01796444|Hormones|hormones|mesh-list
83483835|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483836|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483837|NCT01542541|Rifaximin|rifaximin|mesh-list
83483838|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83483839|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83483840|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483841|NCT00524264|Ketorolac|ketorolac|mesh-list
83483842|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83483843|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83483844|NCT00524264|Analgesics|analgesics|mesh-ancestor
83483845|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
83483846|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483847|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483848|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483849|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483850|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83483851|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483852|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483853|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
83483854|NCT00452426|Narcotics|narcotics|mesh-ancestor
83483855|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483856|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483857|NCT00452426|Analgesics|analgesics|mesh-ancestor
83483858|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
83483859|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483860|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
83483861|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483862|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83483863|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483864|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483865|NCT00524342|Oprelvekin|oprelvekin|mesh-list
83483866|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483867|NCT00524576|Vaccines|vaccines|mesh-list
83483868|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
83483869|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483870|NCT04950660|Caffeine|caffeine|mesh-list
83483871|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83483872|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483873|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83483874|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483875|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483876|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83483877|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83483878|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
83483879|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483880|NCT02516202|Estradiol|estradiol|mesh-list
83483881|NCT02516202|Estrogens|estrogens|mesh-ancestor
83483882|NCT02516202|Hormones|hormones|mesh-ancestor
83483883|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483884|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483887|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83483888|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83483889|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
83483890|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83483891|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83483892|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483893|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483894|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83483895|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
83483896|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483897|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483898|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83483899|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83483900|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
83483902|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83483903|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
83483904|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483905|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83483906|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83483907|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
83483908|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483909|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483910|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83483911|NCT04521140|Dexamethasone|dexamethasone|mesh-list
83483912|NCT04521140|Prednisolone|prednisolone|mesh-list
83483913|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83483914|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
83483915|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83483916|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
83483917|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83483918|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
83483919|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83483920|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
83483921|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
83483922|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483923|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483924|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483925|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
83483926|NCT04521140|Hormones|hormones|mesh-ancestor
83483927|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483928|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83483929|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483930|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83483931|NCT04521140|Protective Agents|protective agents|mesh-ancestor
83483932|NCT02124044|Asunaprevir|asunaprevir|mesh-list
83483933|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
83483934|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483935|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483936|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
83483937|NCT01502761|Analgesics|analgesics|mesh-ancestor
83483938|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
83483939|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483940|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483941|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
83483942|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483943|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83483944|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
83483945|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83483946|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83483947|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483948|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83483949|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
83483950|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83483951|NCT01504477|Bortezomib|bortezomib|mesh-list
83483952|NCT01504477|Panitumumab|panitumumab|mesh-list
83483953|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483954|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83483955|NCT02124512|Rifaximin|rifaximin|mesh-list
83483956|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83483957|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83483958|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483959|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
83483960|NCT01504711|Aprepitant|aprepitant|mesh-list
83483963|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83483964|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483965|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83483966|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83483967|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483968|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483969|NCT02209519|Metronidazole|metronidazole|mesh-list
83483970|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83483971|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83483972|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83483973|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83483974|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
83483975|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83483976|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83483977|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83483978|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
83483979|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483980|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483981|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483982|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
83483983|NCT04946370|Androgens|androgens|mesh-list
83483984|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83483985|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83483986|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483987|NCT04946370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83483988|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483989|NCT04946370|Hormones|hormones|mesh-ancestor
83483990|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83483991|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483992|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83483993|NCT01505179|Ranolazine|ranolazine|mesh-list
83483994|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83483995|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83483996|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83483997|NCT01797848|Ribavirin|ribavirin|mesh-list
83483998|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83483999|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
83484000|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484001|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
83484002|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484003|NCT01398943|Antioxidants|antioxidants|mesh-list
83484004|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484005|NCT01398943|Protective Agents|protective agents|mesh-ancestor
83484006|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484007|NCT01550341|Buprenorphine|buprenorphine|mesh-list
83484008|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83484009|NCT01550341|Naloxone|naloxone|mesh-list
83484010|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83484011|NCT01550341|Narcotics|narcotics|mesh-ancestor
83484012|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83484013|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484014|NCT01550341|Analgesics|analgesics|mesh-ancestor
83484015|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
83484016|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484017|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83484018|NCT02125292|Mesalamine|mesalamine|mesh-list
83484019|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83484020|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83484021|NCT02125292|Analgesics|analgesics|mesh-ancestor
83484022|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
83484023|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484024|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484025|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83484026|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484027|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
83484028|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83484029|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484030|NCT01653912|Paclitaxel|paclitaxel|mesh-list
83484031|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83484032|NCT01653912|Carboplatin|carboplatin|mesh-list
83484033|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83484034|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484035|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
83484038|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484039|NCT04132388|Adalimumab|adalimumab|mesh-list
83484040|NCT04132388|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83484041|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83484042|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484043|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
83484044|NCT03693014|Nivolumab|nivolumab|mesh-list
83484045|NCT03693014|Ipilimumab|ipilimumab|mesh-list
83484046|NCT03693014|Atezolizumab|atezolizumab|mesh-list
83484047|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83484048|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484049|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83484050|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484051|NCT02514174|Afatinib|afatinib|mesh-list
83484052|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484053|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83484054|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484055|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484056|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
83484057|NCT02132468|Combretastatin|combretastatin|mesh-list
83484058|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83484059|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484060|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
83484061|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
83484062|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
83484063|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484064|NCT01508455|Fentanyl|fentanyl|mesh-list
83484065|NCT01508455|Midazolam|midazolam|mesh-list
83484066|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
83484067|NCT01508455|Morphine|morphine|mesh-list
83484068|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83484069|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83484070|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484071|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83484072|NCT01508455|Analgesics|analgesics|mesh-ancestor
83484073|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
83484074|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484075|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83484076|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83484077|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83484078|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
83484079|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484080|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484081|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83484082|NCT01508455|Narcotics|narcotics|mesh-ancestor
83484083|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83484084|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83484085|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
83484086|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
83484087|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83484088|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83484089|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83484090|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
83484091|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
83484092|NCT03095612|Docetaxel|docetaxel|mesh-list
83484093|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484094|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83484095|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83484096|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
83484097|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484098|NCT01509625|Fulvestrant|fulvestrant|mesh-list
83484099|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83484100|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484101|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83484102|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83484103|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
83484104|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83484105|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484106|NCT02482428|Imiquimod|imiquimod|mesh-list
83484107|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83484108|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
83484109|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484110|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484111|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
83484112|NCT01510327|Aspirin|aspirin|mesh-list
83484113|NCT01510327|Everolimus|everolimus|mesh-list
83484114|NCT01510327|Ticlopidine|ticlopidine|mesh-list
83484116|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83484117|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83484118|NCT01510327|Analgesics|analgesics|mesh-ancestor
83484119|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
83484120|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484121|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484122|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83484123|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484124|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83484125|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83484126|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484127|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83484128|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83484129|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484130|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
83484131|NCT01510327|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83484132|NCT01510327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83484133|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484134|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
83484135|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484136|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83484137|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83484138|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83484139|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
83484140|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484141|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83484142|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83484143|NCT01401595|Dexetimide|dexetimide|mesh-list
83484144|NCT01401595|Citalopram|citalopram|mesh-list
83484145|NCT01401595|Escitalopram|escitalopram|mesh-list
83484146|NCT01401595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83484147|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83484148|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83484149|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484150|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484151|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
83484152|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484153|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83484154|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83484155|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
83484156|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
83484157|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484158|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83484159|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83484160|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
83484161|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83484162|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
83484163|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83484164|NCT01511809|Ritonavir|ritonavir|mesh-list
83484165|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83484166|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83484167|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83484168|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
83484169|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484170|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484171|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83484172|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83484173|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
83484174|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484175|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83484176|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83484177|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
83484178|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83484179|NCT02480712|Velpatasvir|velpatasvir|mesh-list
83484180|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
83484181|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484182|NCT03916094|Trastuzumab|trastuzumab|mesh-list
83484183|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83484184|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484185|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
83484186|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83484187|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484189|NCT04986852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484190|NCT00115700|Prednisolone|prednisolone|mesh-list
83484194|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484195|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
83484196|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484197|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484198|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83484199|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
83484200|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484201|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484202|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83484203|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83484204|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83484205|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
83484206|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
83484207|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
83484208|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83484209|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
83484210|NCT00115700|Hormones|hormones|mesh-ancestor
83484211|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83484212|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83484213|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83484214|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83484215|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
83484216|NCT03243890|Vitamin D|vitamin d|mesh-list
83484217|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
83484218|NCT03243890|Vitamin K|vitamin k|mesh-list
83484219|NCT03243890|Menaquinone 7|menaquinone 7|mesh-list
83484220|NCT03243890|Vitamins|vitamins|mesh-ancestor
83484221|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
83484222|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484223|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83484224|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83484225|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83484226|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484227|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
83484228|NCT03243890|Coagulants|coagulants|mesh-ancestor
83484229|NCT00560612|Paroxetine|paroxetine|mesh-list
83484230|NCT00560612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83484231|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83484232|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83484233|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484234|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484235|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
83484236|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484237|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83484238|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
83484239|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83484240|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83484241|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83484242|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484243|NCT01556347|Rituximab|rituximab|mesh-list
83484244|NCT01556347|Bortezomib|bortezomib|mesh-list
83484245|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
83484246|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83484247|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83484248|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83484249|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484250|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
83484251|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484252|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484253|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484254|NCT00561002|Vaccines|vaccines|mesh-list
83484255|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
83484256|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484257|NCT03236792|Dexamethasone|dexamethasone|mesh-list
83484258|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
83484259|NCT03236792|Ixazomib|ixazomib|mesh-list
83484260|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484261|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
83484262|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484263|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484264|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83484265|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
83484266|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484267|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484268|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83484269|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83484270|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
83484271|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
83484272|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484273|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83484274|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
83484276|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83484277|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83484278|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
83484279|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484280|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
83484281|NCT03725384|Iron|iron|mesh-list
83484282|NCT03725384|Vitamins|vitamins|mesh-ancestor
83484283|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
83484284|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484285|NCT03725384|Trace Elements|trace elements|mesh-ancestor
83484286|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
83484287|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484288|NCT03725384|Protective Agents|protective agents|mesh-ancestor
83484289|NCT01556425|Naltrexone|naltrexone|mesh-list
83484290|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83484291|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83484292|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484293|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
83484294|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484295|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
83484296|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484297|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83484298|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484299|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484300|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
83484301|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83484302|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484303|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83484304|NCT03143270|Nivolumab|nivolumab|mesh-list
83484305|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83484306|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484307|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83484308|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484309|NCT00562328|Rituximab|rituximab|mesh-list
83484310|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
83484311|NCT00562328|Sargramostim|sargramostim|mesh-list
83484312|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83484313|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484314|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
83484315|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484316|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484317|NCT01514149|Metformin|metformin|mesh-list
83484318|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83484319|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484320|NCT05566093|Ethanol|ethanol|mesh-list
83484321|NCT05566093|Polidocanol|polidocanol|mesh-list
83484322|NCT05566093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83484323|NCT05566093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484324|NCT05566093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83484325|NCT05566093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484326|NCT05566093|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83484327|NCT05566093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83484328|NCT01558063|Ketamine|ketamine|mesh-list
83484329|NCT01558063|Analgesics|analgesics|mesh-ancestor
83484330|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
83484331|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484332|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484333|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83484334|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83484335|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
83484336|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
83484337|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83484338|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83484339|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83484340|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484341|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484342|NCT03641846|Tadalafil|tadalafil|mesh-list
83484343|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
83484344|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83484345|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83484346|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484347|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484348|NCT03641846|Urological Agents|urological agents|mesh-ancestor
83484349|NCT03474458|Doxycycline|doxycycline|mesh-list
83484350|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83484351|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484352|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
83484353|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83484354|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83484355|NCT01516957|Brodalumab|brodalumab|mesh-list
83484356|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83484357|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
83484358|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
83484359|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484360|NCT01519063|Naltrexone|naltrexone|mesh-list
83484361|NCT01519063|Memantine|memantine|mesh-list
83484362|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83484363|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83484364|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484365|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
83484366|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484367|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83484368|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83484369|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
83484370|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484371|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484372|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83484373|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83484374|NCT01559857|Pioglitazone|pioglitazone|mesh-list
83484375|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83484376|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484377|NCT05565625|Sunscreening Agents|sunscreening agents|mesh-list
83484378|NCT05565625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83484379|NCT05565625|Protective Agents|protective agents|mesh-ancestor
83484380|NCT05565625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484381|NCT05565625|Dermatologic Agents|dermatologic agents|mesh-ancestor
83484382|NCT00754208|Methylphenidate|methylphenidate|mesh-list
83484383|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83484384|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484385|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83484386|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83484387|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83484388|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484389|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
83484390|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484391|NCT01562041|Ranolazine|ranolazine|mesh-list
83484392|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83484393|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83484394|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484395|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
83484396|NCT00634166|Amphotericin B|amphotericin b|mesh-list
83484397|NCT00634166|Clotrimazole|clotrimazole|mesh-list
83484398|NCT00634166|Miconazole|miconazole|mesh-list
83484399|NCT00634166|Bacitracin|bacitracin|mesh-list
83484400|NCT00634166|Mafenide|mafenide|mesh-list
83484401|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83484402|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
83484403|NCT00634166|Amebicides|amebicides|mesh-ancestor
83484404|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83484405|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83484406|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83484407|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83484408|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83484409|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484410|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484411|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83484413|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83484414|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484415|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83484416|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83484417|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83484418|NCT00565370|Capecitabine|capecitabine|mesh-list
83484419|NCT00565370|Sorafenib|sorafenib|mesh-list
83484421|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83484422|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
83484423|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484424|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83484425|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484426|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
83484427|NCT03303950|Busulfan|busulfan|mesh-list
83484428|NCT03303950|Fludarabine|fludarabine|mesh-list
83484429|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484430|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
83484431|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484432|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484433|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83484434|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
83484435|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484436|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484437|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83484438|NCT01563055|Ofatumumab|ofatumumab|mesh-list
83484439|NCT01563055|Chlorambucil|chlorambucil|mesh-list
83484440|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484441|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83484442|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
83484443|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484444|NCT00565916|Estradiol|estradiol|mesh-list
83484445|NCT00565916|Estrogens|estrogens|mesh-list
83484446|NCT00565916|Progesterone|progesterone|mesh-list
83484447|NCT00565916|Hormones|hormones|mesh-ancestor
83484448|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83484449|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484450|NCT00565916|Progestins|progestins|mesh-ancestor
83484451|NCT03258320|Docetaxel|docetaxel|mesh-list
83484452|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
83484453|NCT03258320|Satraplatin|satraplatin|mesh-list
83484454|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484455|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
83484456|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
83484457|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
83484458|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484459|NCT03258320|Analgesics|analgesics|mesh-ancestor
83484460|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
83484461|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484462|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484463|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83484464|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83484465|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484466|NCT01797926|Losartan|losartan|mesh-list
83484467|NCT01797926|Amlodipine|amlodipine|mesh-list
83484468|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83484469|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83484470|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83484471|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484472|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83484473|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484474|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
83484475|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83484476|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83484477|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83484478|NCT03008083|Clopidogrel|clopidogrel|mesh-list
83484479|NCT03008083|Ticagrelor|ticagrelor|mesh-list
83484480|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83484481|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83484482|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83484483|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83484484|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
83484485|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484486|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484487|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484488|NCT05559398|Glenzocimab|glenzocimab|mesh-list
83484489|NCT05559398|Anticoagulants|anticoagulants|mesh-ancestor
83484490|NCT00566150|Levetiracetam|levetiracetam|mesh-list
83484491|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
83484492|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
83484493|NCT00566540|Paclitaxel|paclitaxel|mesh-list
83484494|NCT00566540|Cisplatin|cisplatin|mesh-list
83484495|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83484497|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
83484498|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
83484499|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
83484500|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484501|NCT00567008|Varenicline|varenicline|mesh-list
83484502|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83484503|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83484504|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
83484505|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484506|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484507|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484508|NCT00567320|Varenicline|varenicline|mesh-list
83484509|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83484510|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83484511|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
83484512|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484513|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484514|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484515|NCT01522417|Tirofiban|tirofiban|mesh-list
83484516|NCT01522417|Eptifibatide|eptifibatide|mesh-list
83484517|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83484518|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83484519|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484520|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83484521|NCT00568022|Capecitabine|capecitabine|mesh-list
83484522|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83484523|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
83484524|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484525|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484526|NCT01522963|Nicotine|nicotine|mesh-list
83484527|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83484528|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
83484529|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484530|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484531|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83484532|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83484533|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
83484534|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484535|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484536|NCT03094286|Durvalumab|durvalumab|mesh-list
83484537|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83484538|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484539|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
83484540|NCT03071666|Vitamins|vitamins|mesh-ancestor
83484541|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
83484542|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484543|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
83484544|NCT05533580|Sufentanil|sufentanil|mesh-list
83484545|NCT05533580|Dsuvia|dsuvia|mesh-list
83484546|NCT05533580|Propofol|propofol|mesh-list
83484547|NCT05533580|Cisatracurium|cisatracurium|mesh-list
83484548|NCT05533580|Atracurium|atracurium|mesh-list
83484549|NCT05533580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83484550|NCT05533580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83484551|NCT05533580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484552|NCT05533580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83484553|NCT05533580|Anesthetics, General|anesthetics, general|mesh-ancestor
83484554|NCT05533580|Anesthetics|anesthetics|mesh-ancestor
83484555|NCT05533580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83484556|NCT05533580|Narcotics|narcotics|mesh-ancestor
83484557|NCT05533580|Analgesics|analgesics|mesh-ancestor
83484558|NCT05533580|Sensory System Agents|sensory system agents|mesh-ancestor
83484559|NCT05533580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484560|NCT05533580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83484561|NCT05533580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83484563|NCT05533580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83484564|NCT05533580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83484565|NCT05533580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83484566|NCT05533580|Cholinergic Agents|cholinergic agents|mesh-ancestor
83484567|NCT05533580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484568|NCT05533580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484569|NCT02129426|Midazolam|midazolam|mesh-list
83484570|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
83484571|NCT02129426|Ketamine|ketamine|mesh-list
83484572|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83484573|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83484574|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484575|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83484577|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
83484578|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484579|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83484580|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83484581|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83484582|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
83484583|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484584|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484585|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83484586|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83484587|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
83484588|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
83484589|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83484590|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83484591|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83484592|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83484593|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83484594|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83484595|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
83484596|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
83484597|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
83484598|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83484599|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484600|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484601|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83484602|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83484603|NCT05409716|Hemostatics|hemostatics|mesh-list
83484604|NCT05409716|Coagulants|coagulants|mesh-ancestor
83484605|NCT05395910|Paclitaxel|paclitaxel|mesh-list
83484606|NCT05395910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83484607|NCT05395910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484608|NCT05395910|Tubulin Modulators|tubulin modulators|mesh-ancestor
83484609|NCT05395910|Antimitotic Agents|antimitotic agents|mesh-ancestor
83484610|NCT05395910|Mitosis Modulators|mitosis modulators|mesh-ancestor
83484611|NCT05395910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484612|NCT05389046|Dexetimide|dexetimide|mesh-list
83484613|NCT05389046|Aripiprazole|aripiprazole|mesh-list
83484614|NCT05389046|Citalopram|citalopram|mesh-list
83484615|NCT05389046|Escitalopram|escitalopram|mesh-list
83484616|NCT05389046|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83484617|NCT05389046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83484618|NCT05389046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83484619|NCT05389046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484620|NCT05389046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484621|NCT05389046|Serotonin Agents|serotonin agents|mesh-ancestor
83484622|NCT05389046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484623|NCT05389046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83484624|NCT05389046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83484625|NCT05389046|Parasympatholytics|parasympatholytics|mesh-ancestor
83484626|NCT05389046|Autonomic Agents|autonomic agents|mesh-ancestor
83484627|NCT05389046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484628|NCT05389046|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83484629|NCT05389046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83484630|NCT05389046|Cholinergic Agents|cholinergic agents|mesh-ancestor
83484631|NCT05389046|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83484632|NCT05389046|Antidepressive Agents|antidepressive agents|mesh-ancestor
83484633|NCT05389046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83484634|NCT05389046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83484635|NCT05389046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83484636|NCT05389046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83484637|NCT05389046|Dopamine Agonists|dopamine agonists|mesh-ancestor
83484638|NCT05389046|Dopamine Agents|dopamine agents|mesh-ancestor
83484639|NCT05389046|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83484640|NCT05389046|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83484641|NCT05389046|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83484642|NCT05389046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83484643|NCT05389046|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83484644|NCT05389046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83484645|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83484647|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83484648|NCT02184416|Everolimus|everolimus|mesh-list
83484649|NCT02184416|Temsirolimus|temsirolimus|mesh-list
83484650|NCT02184416|Sorafenib|sorafenib|mesh-list
83484651|NCT02184416|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83484652|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83484653|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484654|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484655|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484656|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
83484657|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484658|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484659|NCT01568905|Nicotine|nicotine|mesh-list
83484660|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83484661|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
83484662|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484663|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484664|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83484665|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83484666|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
83484667|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484668|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484669|NCT01569451|Rituximab|rituximab|mesh-list
83484670|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
83484671|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
83484672|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83484673|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484674|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
83484675|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484676|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484677|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83484678|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484679|NCT02132936|Calcipotriene|calcipotriene|mesh-list
83484680|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
83484681|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
83484682|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83484683|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83484684|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484685|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83484686|NCT01528891|Analgesics|analgesics|mesh-ancestor
83484687|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
83484688|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484689|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83484690|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83484691|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83484692|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
83484693|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484694|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484695|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
83484696|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83484697|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83484698|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83484699|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83484700|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484701|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
83484702|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484703|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484704|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83484705|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484706|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
83484707|NCT01529827|Methotrexate|methotrexate|mesh-list
83484708|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
83484709|NCT01529827|Fludarabine|fludarabine|mesh-list
83484710|NCT01529827|Melphalan|melphalan|mesh-list
83484711|NCT01529827|Tacrolimus|tacrolimus|mesh-list
83484712|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83484713|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
83484714|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83484715|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484716|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83484717|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
83484718|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484719|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484720|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
83484721|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484722|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83484723|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484724|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
83484725|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484726|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83484727|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83484728|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83484729|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83484730|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
83484731|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83484732|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484733|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83484734|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
83484735|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83484737|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83484738|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
83484739|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
83484740|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484741|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484742|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83484743|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
83484744|NCT01571557|Hormones|hormones|mesh-ancestor
83484745|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83484746|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83484747|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484748|NCT00569660|Azacitidine|azacitidine|mesh-list
83484749|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83484750|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
83484751|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484752|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484753|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484754|NCT01573273|Oxytocin|oxytocin|mesh-list
83484755|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
83484756|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83484757|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484758|NCT00572234|Bupropion|bupropion|mesh-list
83484759|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83484760|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
83484761|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83484762|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83484763|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83484764|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83484765|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484766|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
83484767|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484768|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484769|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83484770|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83484771|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484772|NCT00572468|Simvastatin|simvastatin|mesh-list
83484773|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83484774|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83484775|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
83484776|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484777|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83484778|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83484779|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484780|NCT02339246|Tacrolimus|tacrolimus|mesh-list
83484781|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484782|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
83484783|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484784|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83484785|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484786|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484787|NCT00572936|Timolol|timolol|mesh-list
83484788|NCT00572936|Dorzolamide|dorzolamide|mesh-list
83484789|NCT00572936|Latanoprost|latanoprost|mesh-list
83484790|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83484791|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83484792|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
83484793|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484794|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484795|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484796|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83484797|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83484798|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83484799|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83484800|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83484801|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484802|NCT05085626|Fluzoparib|fluzoparib|mesh-list
83484803|NCT05085626|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83484804|NCT05085626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484805|NCT05085626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484806|NCT05085626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484807|NCT05041946|Methylphenidate|methylphenidate|mesh-list
83484808|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83484809|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484810|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83484811|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83484812|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83484813|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484814|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
83484815|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484816|NCT05092412|Carboplatin|carboplatin|mesh-list
83484817|NCT05092412|Etoposide|etoposide|mesh-list
83484818|NCT05092412|Durvalumab|durvalumab|mesh-list
83484819|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484820|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83484821|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83484822|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83484823|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484824|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484825|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83484826|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83484827|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484828|NCT05004896|Midazolam|midazolam|mesh-list
83484829|NCT05004896|Ketamine|ketamine|mesh-list
83484830|NCT05004896|Analgesics|analgesics|mesh-ancestor
83484831|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
83484832|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484833|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484834|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83484835|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83484836|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
83484837|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
83484838|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83484839|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83484840|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83484841|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484842|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484843|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83484844|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83484845|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83484846|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83484847|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83484848|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
83484849|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
83484850|NCT00576680|Temozolomide|temozolomide|mesh-list
83484851|NCT00576680|Everolimus|everolimus|mesh-list
83484852|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83484853|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
83484854|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484855|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484856|NCT00576680|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83484857|NCT00576680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83484858|NCT00576680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484859|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484860|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
83484861|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484862|NCT04866602|Atovaquone|atovaquone|mesh-list
83484863|NCT04866602|Proguanil|proguanil|mesh-list
83484864|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83484865|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484866|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
83484867|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83484868|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83484869|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485020|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484870|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484871|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
83484872|NCT04730648|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83484873|NCT04730648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83484874|NCT04730648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83484875|NCT04730648|Antimetabolites|antimetabolites|mesh-ancestor
83484876|NCT04730648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484877|NCT04730648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83484878|NCT04730648|Protease Inhibitors|protease inhibitors|mesh-ancestor
83484879|NCT04730648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484880|NCT04730648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83484881|NCT00578552|Gabapentin|gabapentin|mesh-list
83484882|NCT00578552|Analgesics|analgesics|mesh-ancestor
83484883|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
83484884|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484885|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484886|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
83484887|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83484888|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83484889|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83484890|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83484891|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83484892|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83484893|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83484894|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484895|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
83484896|NCT01532089|Bevacizumab|bevacizumab|mesh-list
83484897|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83484898|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83484899|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
83484900|NCT01532089|Antibodies|antibodies|mesh-list
83484901|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
83484902|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83484903|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
83484904|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484905|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83484906|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83484907|NCT01532089|Growth Substances|growth substances|mesh-ancestor
83484908|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484909|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
83484910|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
83484911|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83484912|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484913|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484914|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
83484915|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
83484916|NCT00579878|Methotrexate|methotrexate|mesh-list
83484917|NCT00579878|Leflunomide|leflunomide|mesh-list
83484918|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83484919|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
83484920|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83484921|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484922|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83484923|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
83484924|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484925|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484926|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
83484927|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484928|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83484929|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484930|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
83484931|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484932|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83484933|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
83484934|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83484935|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83484936|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484937|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83484938|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83484939|NCT00579878|Analgesics|analgesics|mesh-ancestor
83484940|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
83484941|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83484942|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83484943|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485096|NCT05540743|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83484944|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83484945|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83484946|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83484947|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
83484948|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484949|NCT05246072|Ivermectin|ivermectin|mesh-list
83484950|NCT05246072|Colchicine|colchicine|mesh-list
83484951|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
83484952|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484953|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
83484954|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
83484955|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
83484956|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484957|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484958|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83484959|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484960|NCT02135432|Ivacaftor|ivacaftor|mesh-list
83484961|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83484962|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83484963|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484964|NCT05245994|Carboplatin|carboplatin|mesh-list
83484965|NCT05245994|Etoposide|etoposide|mesh-list
83484966|NCT05245994|Durvalumab|durvalumab|mesh-list
83484967|NCT05245994|Olaparib|olaparib|mesh-list
83484968|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484969|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83484970|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83484971|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83484972|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484973|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484974|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83484975|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83484976|NCT05245604|Cyclosporine|cyclosporine|mesh-list
83484977|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83484978|NCT05245604|Cyclosporins|cyclosporins|mesh-list
83484979|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484980|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83484981|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83484982|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
83484983|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83484984|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
83484985|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484986|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
83484987|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83484988|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83484989|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83484990|NCT05245448|Tetrandrine|tetrandrine|mesh-list
83484991|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
83484992|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83484993|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83484994|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83484995|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83484996|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484997|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
83484998|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83484999|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83485000|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485001|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83485002|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485003|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83485004|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
83485005|NCT00581048|Vitamin E|vitamin e|mesh-list
83485006|NCT00581048|Tocopherols|tocopherols|mesh-list
83485007|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
83485008|NCT00581048|Vitamins|vitamins|mesh-ancestor
83485009|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
83485010|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485011|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
83485012|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485013|NCT00581048|Protective Agents|protective agents|mesh-ancestor
83485014|NCT01798472|Cimetidine|cimetidine|mesh-list
83485015|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83485016|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485017|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83485018|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
83485019|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
83485021|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485022|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485023|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83485024|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83485025|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485027|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83485028|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83485029|NCT01579513|Prednisolone|prednisolone|mesh-list
83485030|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
83485031|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83485032|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
83485033|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
83485034|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485035|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
83485036|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
83485037|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485038|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485039|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485040|NCT01579513|Hormones|hormones|mesh-ancestor
83485041|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83485042|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83485043|NCT01579513|Protective Agents|protective agents|mesh-ancestor
83485044|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83485045|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485046|NCT01534897|Dabrafenib|dabrafenib|mesh-list
83485047|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485048|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83485049|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485050|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485051|NCT05121350|Epirubicin|epirubicin|mesh-list
83485052|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83485053|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485054|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83485055|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83485056|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485057|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485058|NCT00583622|Bevacizumab|bevacizumab|mesh-list
83485059|NCT00583622|Carboplatin|carboplatin|mesh-list
83485060|NCT00583622|Gemcitabine|gemcitabine|mesh-list
83485061|NCT00583622|Docetaxel|docetaxel|mesh-list
83485062|NCT00583622|Melphalan|melphalan|mesh-list
83485063|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83485064|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485065|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83485066|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83485067|NCT00583622|Growth Substances|growth substances|mesh-ancestor
83485068|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485069|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
83485070|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83485071|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
83485072|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485073|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
83485074|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
83485075|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
83485076|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83485077|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
83485078|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83485079|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83485080|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
83485081|NCT00583700|Vitamin E|vitamin e|mesh-list
83485082|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
83485083|NCT00583700|Vitamins|vitamins|mesh-ancestor
83485084|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
83485085|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485086|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
83485087|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485088|NCT00583700|Protective Agents|protective agents|mesh-ancestor
83485089|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83485090|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485091|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83485092|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83485093|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
83485094|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83485095|NCT05540743|Adalimumab|adalimumab|mesh-list
83485097|NCT05540743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485098|NCT05540743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485099|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
83485100|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
83485101|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83485102|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83485103|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83485104|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485105|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485106|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485107|NCT04257188|Anesthetics|anesthetics|mesh-list
83485108|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485109|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485110|NCT04224428|Fexofenadine|fexofenadine|mesh-list
83485111|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83485112|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83485113|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83485114|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
83485115|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
83485116|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485117|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485118|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485119|NCT04224194|Adalimumab|adalimumab|mesh-list
83485120|NCT04224194|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83485121|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485122|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485123|NCT00584948|Memantine|memantine|mesh-list
83485124|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83485125|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83485126|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
83485127|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485128|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485129|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485130|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83485131|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83485132|NCT00605072|Metoprolol|metoprolol|mesh-list
83485133|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83485134|NCT00605072|Candesartan|candesartan|mesh-list
83485135|NCT00605072|Lisinopril|lisinopril|mesh-list
83485136|NCT00605072|Nifedipine|nifedipine|mesh-list
83485137|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83485138|NCT00605072|Diuretics|diuretics|mesh-ancestor
83485139|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
83485140|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485141|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83485142|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83485143|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485144|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83485145|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
83485146|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
83485147|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485148|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83485149|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83485150|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83485151|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
83485152|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485153|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83485154|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83485155|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83485156|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83485157|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
83485158|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
83485159|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83485160|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83485161|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
83485162|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485163|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83485164|NCT00605072|Protective Agents|protective agents|mesh-ancestor
83485165|NCT00585104|Simendan|simendan|mesh-list
83485166|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83485167|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
83485168|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83485169|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83485170|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485246|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83485171|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485172|NCT00585104|Protective Agents|protective agents|mesh-ancestor
83485173|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485175|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
83485176|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83485177|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83485178|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485179|NCT00585650|Etanercept|etanercept|mesh-list
83485180|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83485181|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83485182|NCT00585650|Analgesics|analgesics|mesh-ancestor
83485183|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
83485184|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485185|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485186|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485187|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485188|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485189|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83485190|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
83485191|NCT04856228|Lidocaine|lidocaine|mesh-list
83485192|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
83485193|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
83485194|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485195|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485196|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
83485197|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485198|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83485199|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83485200|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83485201|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83485202|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485203|NCT00605384|Tenofovir|tenofovir|mesh-list
83485204|NCT00605384|Lamivudine|lamivudine|mesh-list
83485205|NCT00605384|Entecavir|entecavir|mesh-list
83485206|NCT00605384|Adefovir|adefovir|mesh-list
83485207|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
83485208|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83485209|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83485210|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83485211|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485212|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485213|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83485214|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83485215|NCT00586196|Donepezil|donepezil|mesh-list
83485216|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83485217|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485218|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485219|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
83485220|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485221|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485222|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
83485223|NCT00605696|Insulin|insulin|mesh-list
83485224|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83485225|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485226|NCT00587132|Secretin|secretin|mesh-list
83485227|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485228|NCT00587132|Hormones|hormones|mesh-ancestor
83485229|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83485230|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485231|NCT00587678|Simvastatin|simvastatin|mesh-list
83485232|NCT00587678|Ezetimibe|ezetimibe|mesh-list
83485233|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83485234|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83485235|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
83485236|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485237|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83485238|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83485239|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485240|NCT02138006|Insulin|insulin|mesh-list
83485241|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83485242|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83485243|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485244|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
83485245|NCT04545008|Famotidine|famotidine|mesh-list
83485248|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83485249|NCT04545008|Expectorants|expectorants|mesh-ancestor
83485250|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
83485251|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83485252|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
83485253|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485254|NCT04545008|Protective Agents|protective agents|mesh-ancestor
83485255|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485256|NCT04545008|Antidotes|antidotes|mesh-ancestor
83485257|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83485258|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485259|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83485260|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
83485261|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
83485262|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485263|NCT04527770|Dexamethasone|dexamethasone|mesh-list
83485264|NCT04527770|Midazolam|midazolam|mesh-list
83485265|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485266|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
83485267|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
83485268|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485269|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485270|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485271|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
83485272|NCT04527770|Hormones|hormones|mesh-ancestor
83485273|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83485274|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83485275|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485276|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83485277|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83485278|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485279|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83485280|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83485281|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83485282|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83485283|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
83485284|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
83485285|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
83485286|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
83485287|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485288|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485289|NCT01798940|Pioglitazone|pioglitazone|mesh-list
83485290|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83485291|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485292|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83485293|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83485294|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83485295|NCT00609128|Analgesics|analgesics|mesh-ancestor
83485296|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
83485297|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485298|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485299|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485300|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485301|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83485302|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83485303|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83485304|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
83485305|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
83485306|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485307|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485308|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
83485309|NCT00668564|Busulfan|busulfan|mesh-list
83485310|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
83485311|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83485312|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
83485313|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485314|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485315|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83485316|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
83485317|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485318|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485319|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83485320|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83485321|NCT00610688|Vitamin D|vitamin d|mesh-list
83485322|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
83485323|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
83485326|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485327|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83485328|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83485329|NCT00669578|Pomalidomide|pomalidomide|mesh-list
83485330|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
83485331|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485332|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83485333|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83485334|NCT00669578|Growth Substances|growth substances|mesh-ancestor
83485335|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
83485336|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485337|NCT02137382|Pancrelipase|pancrelipase|mesh-list
83485338|NCT02137382|Pancreatin|pancreatin|mesh-list
83485339|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485340|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83485341|NCT00611468|Topotecan|topotecan|mesh-list
83485342|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485343|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83485344|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485345|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485346|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83485347|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83485348|NCT00670202|Fasudil|fasudil|mesh-list
83485349|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83485350|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83485351|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485352|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83485353|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485354|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
83485355|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83485356|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485357|NCT00670982|Bevacizumab|bevacizumab|mesh-list
83485358|NCT00670982|Trastuzumab|trastuzumab|mesh-list
83485359|NCT00670982|Vinorelbine|vinorelbine|mesh-list
83485360|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83485361|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485362|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83485363|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83485364|NCT00670982|Growth Substances|growth substances|mesh-ancestor
83485365|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485366|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
83485367|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83485368|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
83485369|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
83485370|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
83485371|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485372|NCT00612560|Anastrozole|anastrozole|mesh-list
83485373|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83485374|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485375|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83485376|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83485377|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485378|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485379|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83485380|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
83485381|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83485382|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485383|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
83485384|NCT00612716|Busulfan|busulfan|mesh-list
83485385|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83485386|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
83485387|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485388|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485389|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83485390|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
83485391|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485392|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485393|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83485394|NCT04220684|Cytarabine|cytarabine|mesh-list
83485395|NCT04220684|Fludarabine|fludarabine|mesh-list
83485396|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485397|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83485398|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
83492157|NCT01832948|Endostar protein|endostar protein|mesh-list
83485400|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83485401|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
83485402|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485403|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
83485404|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83485405|NCT00613028|Bevacizumab|bevacizumab|mesh-list
83485406|NCT00613028|Etoposide|etoposide|mesh-list
83485407|NCT00613028|Temozolomide|temozolomide|mesh-list
83485408|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83485409|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485410|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83485411|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83485412|NCT00613028|Growth Substances|growth substances|mesh-ancestor
83485413|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485414|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
83485415|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83485416|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83485417|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83485418|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485419|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485420|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83485421|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
83485422|NCT01799798|Denosumab|denosumab|mesh-list
83485423|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83485424|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485425|NCT00614198|Caseins|caseins|mesh-list
83485426|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
83485427|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
83485428|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485429|NCT00616772|Choline|choline|mesh-list
83485430|NCT00616772|Atorvastatin|atorvastatin|mesh-list
83485431|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
83485432|NCT00616772|Fenofibrate|fenofibrate|mesh-list
83485433|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83485434|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83485435|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
83485436|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485437|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83485438|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83485439|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485440|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
83485441|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485442|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
83485443|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83485444|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83485445|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83485446|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83485447|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
83485448|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83485449|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83485450|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
83485451|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83485452|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83485453|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83485454|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485455|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485456|NCT02513550|Ixekizumab|ixekizumab|mesh-list
83485457|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
83485458|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
83485459|NCT00673712|Narcotics|narcotics|mesh-ancestor
83485460|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485461|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485462|NCT00673712|Analgesics|analgesics|mesh-ancestor
83485463|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
83485464|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485465|NCT04062032|Aspirin|aspirin|mesh-list
83485466|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83485467|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83485468|NCT04062032|Analgesics|analgesics|mesh-ancestor
83485469|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
83485470|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485471|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485472|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485476|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485477|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83485478|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83485479|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485480|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
83485481|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83485482|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
83485483|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83485484|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83485485|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83485486|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485487|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485488|NCT03722966|Nicotine|nicotine|mesh-list
83485489|NCT03722966|Varenicline|varenicline|mesh-list
83485490|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83485491|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
83485492|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485493|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485494|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83485495|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83485496|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
83485497|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485498|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485499|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
83485500|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485501|NCT01582477|Bupivacaine|bupivacaine|mesh-list
83485502|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
83485503|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
83485504|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485505|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485506|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
83485507|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485508|NCT03001687|Vitamin D|vitamin d|mesh-list
83485509|NCT03001687|Vitamins|vitamins|mesh-ancestor
83485510|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
83485511|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485512|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83485513|NCT03001609|Abivertinib|abivertinib|mesh-list
83485514|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83485515|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485516|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485517|NCT03007381|Ketorolac|ketorolac|mesh-list
83485518|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83485519|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83485520|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83485521|NCT03007381|Analgesics|analgesics|mesh-ancestor
83485522|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
83485523|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485524|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485525|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485526|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485527|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83485528|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485529|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485530|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83485531|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83485532|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83485533|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
83485534|NCT01585207|Vigabatrin|vigabatrin|mesh-list
83485535|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
83485536|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485537|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485538|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
83485539|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485540|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485541|NCT03007303|Olanzapine|olanzapine|mesh-list
83485542|NCT03007303|Risperidone|risperidone|mesh-list
83485543|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83485544|NCT03007303|Ziprasidone|ziprasidone|mesh-list
83485545|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
83485546|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83485547|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
83485548|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485549|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485550|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485551|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83485552|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485553|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83485554|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83485555|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
83485556|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
83485557|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
83485558|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485559|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485560|NCT03007303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83485561|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83485562|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83485563|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
83485564|NCT01585441|Finasteride|finasteride|mesh-list
83485565|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83485566|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83485567|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485568|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485569|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
83485570|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83485571|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485572|NCT01585441|Urological Agents|urological agents|mesh-ancestor
83485573|NCT00617942|Paclitaxel|paclitaxel|mesh-list
83485574|NCT00617942|Carboplatin|carboplatin|mesh-list
83485575|NCT00617942|Trastuzumab|trastuzumab|mesh-list
83485576|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83485577|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485578|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
83485579|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
83485580|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
83485581|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485582|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83485583|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
83485584|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485585|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
83485586|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83485587|NCT01588561|Nicotine|nicotine|mesh-list
83485588|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83485589|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
83485590|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485591|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485592|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83485593|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83485594|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
83485595|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485596|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485597|NCT00619190|Aripiprazole|aripiprazole|mesh-list
83485598|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
83485599|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83485600|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83485601|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83485602|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485603|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485604|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
83485605|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
83485606|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485607|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485608|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83485609|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83485610|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
83485611|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83485612|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83485613|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83485614|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83485615|NCT01589263|Tamsulosin|tamsulosin|mesh-list
83485616|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83485617|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83485618|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83485619|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
83485620|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485621|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485623|NCT01589263|Urological Agents|urological agents|mesh-ancestor
83485624|NCT01590979|Ranolazine|ranolazine|mesh-list
83485625|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83485626|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83485627|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485628|NCT00619970|Rifaximin|rifaximin|mesh-list
83485629|NCT00619970|Lactulose|lactulose|mesh-list
83485630|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485631|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83485632|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83485633|NCT01591837|Vaccines|vaccines|mesh-list
83485634|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
83485635|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485636|NCT01592851|Fluorides|fluorides|mesh-list
83485637|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
83485638|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
83485639|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
83485640|NCT01592851|Protective Agents|protective agents|mesh-ancestor
83485641|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485642|NCT00675584|Budesonide|budesonide|mesh-list
83485643|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485644|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83485645|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
83485646|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485647|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485648|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83485649|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
83485650|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
83485651|NCT00675584|Hormones|hormones|mesh-ancestor
83485652|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83485653|NCT03376646|Paclitaxel|paclitaxel|mesh-list
83485654|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83485655|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485656|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
83485657|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
83485658|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
83485659|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485660|NCT00676364|Lidocaine|lidocaine|mesh-list
83485661|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
83485662|NCT00676364|Anesthetics|anesthetics|mesh-list
83485663|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485664|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485665|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
83485666|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485667|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83485668|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83485669|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83485670|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83485671|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485672|NCT00676676|Testosterone|testosterone|mesh-list
83485673|NCT00676676|Androgens|androgens|mesh-ancestor
83485674|NCT00676676|Hormones|hormones|mesh-ancestor
83485675|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83485676|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485677|NCT00677924|Zalutumumab|zalutumumab|mesh-list
83485678|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83485679|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485680|NCT03177122|Inositol|inositol|mesh-list
83485681|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
83485682|NCT03177122|Vitamins|vitamins|mesh-ancestor
83485683|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
83485684|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485685|NCT00621530|Ketorolac|ketorolac|mesh-list
83485686|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83485687|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83485688|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83485689|NCT00621530|Analgesics|analgesics|mesh-ancestor
83485690|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
83485691|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485692|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485693|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485694|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485695|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83485696|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485697|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485698|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
83485699|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83485700|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485701|NCT02513472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83485702|NCT02513472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485703|NCT00621686|Bevacizumab|bevacizumab|mesh-list
83485704|NCT00621686|Sorafenib|sorafenib|mesh-list
83485705|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83485706|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485707|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83485708|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83485709|NCT00621686|Growth Substances|growth substances|mesh-ancestor
83485710|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485711|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
83485712|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83485713|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485714|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485715|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
83485716|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485717|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83485718|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485719|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485720|NCT00678470|Alefacept|alefacept|mesh-list
83485721|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
83485722|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
83485723|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485724|NCT00623012|Sirolimus|sirolimus|mesh-list
83485725|NCT00623012|Tacrolimus|tacrolimus|mesh-list
83485726|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83485727|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
83485728|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485729|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83485730|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485731|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485732|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83485733|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83485734|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83485735|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485736|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
83485737|NCT02592356|Lenvatinib|lenvatinib|mesh-list
83485738|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485739|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83485740|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485741|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485742|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
83485743|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
83485744|NCT02446964|Fludarabine|fludarabine|mesh-list
83485745|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
83485746|NCT02446964|Tacrolimus|tacrolimus|mesh-list
83485747|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83485748|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
83485749|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485750|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485751|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83485752|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
83485753|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485754|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485755|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83485756|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83485757|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
83485758|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83485759|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485760|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83485761|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83485762|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
83485763|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83485764|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83485765|NCT01799954|Vaccines|vaccines|mesh-list
83485766|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
83485767|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485768|NCT00623714|Fluticasone|fluticasone|mesh-list
83485769|NCT00623714|Xhance|xhance|mesh-list
83485770|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485771|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83485773|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485774|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485775|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83485776|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
83485777|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
83485778|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83485779|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83485780|NCT02174822|Paroxetine|paroxetine|mesh-list
83485781|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83485782|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83485783|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83485784|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485785|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485786|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485787|NCT02174822|Analgesics|analgesics|mesh-ancestor
83485788|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
83485789|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485790|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
83485791|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83485792|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
83485793|NCT02174822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83485794|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
83485795|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83485796|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83485797|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83485798|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485799|NCT00624416|Prednisolone|prednisolone|mesh-list
83485800|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83485801|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
83485802|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83485803|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
83485804|NCT00624416|Cortisone|cortisone|mesh-list
83485805|NCT00624416|Isoproterenol|isoproterenol|mesh-list
83485806|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83485807|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
83485808|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485809|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
83485810|NCT00624416|Hormones|hormones|mesh-ancestor
83485811|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83485812|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485813|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83485814|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485815|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
83485816|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
83485817|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485818|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83485819|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83485820|NCT00624416|Protective Agents|protective agents|mesh-ancestor
83485821|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83485822|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83485823|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
83485824|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485825|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485826|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83485827|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83485828|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
83485829|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83485830|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
83485831|NCT01872260|Letrozole|letrozole|mesh-list
83485832|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485833|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83485834|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83485835|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485836|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485837|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83485838|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
83485839|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83485840|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485841|NCT00626210|Modafinil|modafinil|mesh-list
83485842|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83485843|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485844|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83485845|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83485846|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83485847|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485848|NCT00653276|Cyclosporine|cyclosporine|mesh-list
83485849|NCT00653276|Ezetimibe|ezetimibe|mesh-list
83485850|NCT00653276|Cyclosporins|cyclosporins|mesh-list
83485851|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485852|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485853|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83485854|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
83485855|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485856|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
83485857|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83485858|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
83485859|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485860|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83485861|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83485862|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83485863|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
83485864|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83485865|NCT00683852|Aripiprazole|aripiprazole|mesh-list
83485866|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
83485867|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83485868|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83485869|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83485870|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485871|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485872|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
83485873|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
83485874|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485875|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485876|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83485877|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83485878|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
83485879|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83485880|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83485881|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83485882|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83485883|NCT03006835|Clopidogrel|clopidogrel|mesh-list
83485884|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83485885|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83485886|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83485887|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83485888|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
83485889|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485890|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485891|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485892|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
83485893|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
83485894|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83485895|NCT03006757|Protective Agents|protective agents|mesh-ancestor
83485896|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485897|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
83485898|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83485899|NCT05566405|Anesthetics|anesthetics|mesh-list
83485900|NCT05566405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485901|NCT05566405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485902|NCT03000127|Testosterone|testosterone|mesh-list
83485903|NCT03000127|Androgens|androgens|mesh-ancestor
83485904|NCT03000127|Hormones|hormones|mesh-ancestor
83485905|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83485906|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485907|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
83485908|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83485909|NCT02999815|Antibodies|antibodies|mesh-list
83485910|NCT02999815|Antitoxins|antitoxins|mesh-list
83485911|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
83485912|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485913|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
83485914|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83485915|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485916|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485917|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83485918|NCT05134363|Analgesics|analgesics|mesh-ancestor
83485919|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
83485920|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485921|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83485922|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83485923|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83485924|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
83485925|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485926|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485927|NCT03006679|Meropenem|meropenem|mesh-list
83485928|NCT03006679|Tazobactam|tazobactam|mesh-list
83485929|NCT03006679|Piperacillin|piperacillin|mesh-list
83485930|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83485931|NCT03006679|Vaborbactam|vaborbactam|mesh-list
83485932|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83485933|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83485934|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83485935|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485936|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485937|NCT03006445|Dotinurad|dotinurad|mesh-list
83485938|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
83485939|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
83485940|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83485941|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
83485942|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
83485943|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83485944|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
83485945|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
83485946|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83485947|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485948|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83485949|NCT03006211|Analgesics|analgesics|mesh-ancestor
83485950|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
83485951|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83485952|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83485953|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
83485954|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83485955|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
83485956|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83485957|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
83485958|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485959|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485960|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83485961|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
83485962|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
83485963|NCT03006211|Protective Agents|protective agents|mesh-ancestor
83485964|NCT02248051|CXA-10|cxa-10|mesh-list
83485965|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83485966|NCT02247505|Tadalafil|tadalafil|mesh-list
83485967|NCT02247505|Tamsulosin|tamsulosin|mesh-list
83485968|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
83485969|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83485970|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83485971|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83485972|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485973|NCT02247505|Urological Agents|urological agents|mesh-ancestor
83485974|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83485975|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83485976|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83485977|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
83485978|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83485979|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485981|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83485982|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83485983|NCT04707625|Growth Substances|growth substances|mesh-ancestor
83485984|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485985|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
83485986|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83485987|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83485988|NCT02248129|Telmisartan|telmisartan|mesh-list
83485989|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83485990|NCT02248129|Diuretics|diuretics|mesh-ancestor
83485991|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
83485992|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485993|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83485994|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492158|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
83485995|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485996|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83485997|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83485998|NCT02248207|Pramipexole|pramipexole|mesh-list
83485999|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
83486000|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486001|NCT02248207|Protective Agents|protective agents|mesh-ancestor
83486002|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486003|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83486004|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83486005|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
83486006|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
83486007|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486008|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
83486009|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83486010|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486011|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83486012|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
83486013|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83486014|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486015|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486016|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486017|NCT00684242|Lenalidomide|lenalidomide|mesh-list
83486018|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
83486019|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486020|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83486021|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83486022|NCT00684242|Growth Substances|growth substances|mesh-ancestor
83486023|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
83486024|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486025|NCT00651560|Simvastatin|simvastatin|mesh-list
83486026|NCT00651560|Ezetimibe|ezetimibe|mesh-list
83486027|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83486028|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83486029|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
83486030|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486031|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83486032|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83486033|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486034|NCT00684554|Buprenorphine|buprenorphine|mesh-list
83486035|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83486036|NCT00684554|Narcotics|narcotics|mesh-ancestor
83486037|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83486038|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486039|NCT00684554|Analgesics|analgesics|mesh-ancestor
83486040|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
83486041|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486042|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83486043|NCT00551876|Simvastatin|simvastatin|mesh-list
83486044|NCT00551876|Ezetimibe|ezetimibe|mesh-list
83486045|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83486046|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83486047|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
83486048|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486049|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83486050|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83486051|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486052|NCT04451863|Caryophyllene|caryophyllene|mesh-list
83486053|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486054|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83486056|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
83486057|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486058|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83486059|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486060|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83486061|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83486062|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83486063|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83486064|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83486065|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486066|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
83486067|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486068|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486071|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83486073|NCT00251576|Dalteparin|dalteparin|mesh-list
83486074|NCT00251576|Tirofiban|tirofiban|mesh-list
83486075|NCT00251576|Simvastatin|simvastatin|mesh-list
83486076|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
83486077|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83486078|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83486079|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486080|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83486081|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83486082|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
83486083|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83486084|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83486085|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486086|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83486087|NCT04387604|Ranibizumab|ranibizumab|mesh-list
83486088|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83486089|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83486090|NCT04387604|Growth Substances|growth substances|mesh-ancestor
83486091|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486092|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
83486093|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486094|NCT03005665|Acetazolamide|acetazolamide|mesh-list
83486095|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
83486096|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83486097|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486098|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486099|NCT03005665|Diuretics|diuretics|mesh-ancestor
83486100|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
83486101|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486102|NCT00628628|Rasburicase|rasburicase|mesh-list
83486103|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
83486104|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83486105|NCT04386811|Calcitriol|calcitriol|mesh-list
83486106|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83486107|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486108|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83486109|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83486110|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486111|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83486112|NCT04386811|Vitamins|vitamins|mesh-ancestor
83486113|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
83486114|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83486115|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
83486116|NCT04357873|Vorinostat|vorinostat|mesh-list
83486117|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83486118|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486119|NCT04357873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83486120|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486121|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83486122|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486123|NCT05671081|Magnesium Sulfate|magnesium sulfate|mesh-list
83486124|NCT05671081|Dexmedetomidine|dexmedetomidine|mesh-list
83486125|NCT05671081|Analgesics|analgesics|mesh-list
83486126|NCT05671081|Narcotics|narcotics|mesh-list
83486127|NCT05671081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83486128|NCT05671081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83486129|NCT05671081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486130|NCT05671081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83486131|NCT05671081|Sensory System Agents|sensory system agents|mesh-ancestor
83486132|NCT05671081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486133|NCT05671081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83486134|NCT05671081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83486135|NCT05671081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83486136|NCT05671081|Adrenergic Agents|adrenergic agents|mesh-ancestor
83486137|NCT05671081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486138|NCT05671081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486139|NCT05671081|Anesthetics|anesthetics|mesh-ancestor
83486140|NCT05671081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83486141|NCT05671081|Anticonvulsants|anticonvulsants|mesh-ancestor
83486142|NCT05671081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83486143|NCT05671081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83486144|NCT05671081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83486145|NCT05671081|Tocolytic Agents|tocolytic agents|mesh-ancestor
83486146|NCT05671081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83486147|NCT00630734|Ritonavir|ritonavir|mesh-list
83486148|NCT00630734|Darunavir|darunavir|mesh-list
83486149|NCT00630734|Pravastatin|pravastatin|mesh-list
83486150|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83486151|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83486152|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
83486153|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486154|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486155|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83486156|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83486157|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
83486158|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486159|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83486160|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83486161|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83486162|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83486163|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
83486164|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83486165|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83486166|NCT05644249|Doxorubicin|doxorubicin|mesh-list
83486167|NCT05644249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486168|NCT05644249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83486169|NCT05644249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83486170|NCT05644249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83486171|NCT05644249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486172|NCT05644249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486173|NCT00686582|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83486174|NCT00686582|Antiviral Agents|antiviral agents|mesh-ancestor
83486175|NCT00686582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486176|NCT00631358|Dexamethasone|dexamethasone|mesh-list
83486177|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486178|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
83486179|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
83486180|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486181|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486182|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83486183|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
83486184|NCT00631358|Hormones|hormones|mesh-ancestor
83486185|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83486186|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83486187|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486188|NCT02248753|Metoprolol|metoprolol|mesh-list
83486189|NCT02248753|Digoxin|digoxin|mesh-list
83486190|NCT02248753|Amiodarone|amiodarone|mesh-list
83486191|NCT02248753|Verapamil|verapamil|mesh-list
83486192|NCT02248753|Flecainide|flecainide|mesh-list
83486193|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83486194|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83486195|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
83486196|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
83486197|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486198|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486199|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83486200|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83486201|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83486202|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
83486203|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486204|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486205|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83486206|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486207|NCT02248753|Protective Agents|protective agents|mesh-ancestor
83486208|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
83486209|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83486210|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83486211|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83486212|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83486213|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83486214|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83486215|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83486216|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83486217|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83486218|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83492237|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
83486219|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83486220|NCT00687674|Dexamethasone|dexamethasone|mesh-list
83486221|NCT00687674|Lenalidomide|lenalidomide|mesh-list
83486222|NCT00687674|Sorafenib|sorafenib|mesh-list
83486223|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486224|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
83486225|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
83486226|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486227|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486228|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83486229|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
83486230|NCT00687674|Hormones|hormones|mesh-ancestor
83486231|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83486232|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83486233|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486234|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
83486235|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83486236|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83486237|NCT00687674|Growth Substances|growth substances|mesh-ancestor
83486238|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
83486239|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83486240|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486241|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486242|NCT00687908|Adapalene|adapalene|mesh-list
83486243|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83486244|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
83486245|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83486246|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83486247|NCT00687908|Analgesics|analgesics|mesh-ancestor
83486248|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
83486249|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486250|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486251|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486252|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83486253|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83486254|NCT00689078|Prednisolone|prednisolone|mesh-list
83486255|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83486256|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
83486257|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83486258|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
83486259|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
83486260|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83486261|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
83486262|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486263|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
83486264|NCT00689078|Hormones|hormones|mesh-ancestor
83486265|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83486266|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486267|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83486268|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486269|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
83486270|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
83486271|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486272|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83486273|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83486274|NCT00689078|Protective Agents|protective agents|mesh-ancestor
83486275|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83486276|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83486277|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83486278|NCT05568979|Vaccines|vaccines|mesh-list
83486279|NCT05568979|Immunologic Factors|immunologic factors|mesh-ancestor
83486280|NCT05568979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486281|NCT03005353|Clotrimazole|clotrimazole|mesh-list
83486282|NCT03005353|Miconazole|miconazole|mesh-list
83486283|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83486284|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486285|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
83486286|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83486287|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83486288|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486289|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486290|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83486291|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
83486292|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83486293|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486294|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83486295|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83486296|NCT00588536|Leucovorin|leucovorin|mesh-list
83486297|NCT00588536|Methotrexate|methotrexate|mesh-list
83486298|NCT00588536|Thioguanine|thioguanine|mesh-list
83486299|NCT00588536|Calcium|calcium|mesh-list
83486300|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
83486301|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83486302|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486303|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83486304|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
83486305|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83486306|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83486307|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
83486308|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486309|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486310|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
83486311|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486312|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83486313|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83486314|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
83486315|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83486316|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83486317|NCT00588536|Antidotes|antidotes|mesh-ancestor
83486318|NCT00588536|Protective Agents|protective agents|mesh-ancestor
83486319|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
83486320|NCT00588536|Vitamins|vitamins|mesh-ancestor
83486321|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
83486322|NCT03977233|Leucovorin|leucovorin|mesh-list
83486323|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
83486324|NCT03977233|Irinotecan|irinotecan|mesh-list
83486325|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486326|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83486327|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83486328|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486329|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486330|NCT03977233|Antidotes|antidotes|mesh-ancestor
83486331|NCT03977233|Protective Agents|protective agents|mesh-ancestor
83486332|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486333|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
83486334|NCT03977233|Vitamins|vitamins|mesh-ancestor
83486335|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
83486336|NCT03951649|Acetaminophen|acetaminophen|mesh-list
83486337|NCT03951649|Caffeine|caffeine|mesh-list
83486338|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83486339|NCT03951649|Analgesics|analgesics|mesh-ancestor
83486340|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
83486341|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486342|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486343|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
83486344|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83486345|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83486346|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486347|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486348|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83486349|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83486350|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
83486351|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486352|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
83486353|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486354|NCT02219503|Ritonavir|ritonavir|mesh-list
83486355|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83486356|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83486357|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
83486358|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486359|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486360|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83486361|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83486362|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
83486363|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486364|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83486365|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83486366|NCT00592124|Tenofovir|tenofovir|mesh-list
83486367|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
83486368|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486369|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83486370|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83486372|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486374|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83486375|NCT02221219|Indomethacin|indomethacin|mesh-list
83486376|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83486377|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83486378|NCT02221219|Analgesics|analgesics|mesh-ancestor
83486379|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
83486380|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486381|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486382|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486383|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83486384|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
83486385|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
83486386|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83486387|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83486388|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486389|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486390|NCT00593450|Bevacizumab|bevacizumab|mesh-list
83486391|NCT00593450|Ranibizumab|ranibizumab|mesh-list
83486392|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83486393|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486394|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83486395|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83486396|NCT00593450|Growth Substances|growth substances|mesh-ancestor
83486397|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486398|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
83486399|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83486400|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
83486401|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83486402|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83486403|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83486404|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83486405|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486406|NCT00594230|Panobinostat|panobinostat|mesh-list
83486407|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486408|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83486409|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486410|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486411|NCT00594308|Cyclosporine|cyclosporine|mesh-list
83486412|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
83486413|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
83486414|NCT00594308|Fludarabine|fludarabine|mesh-list
83486415|NCT00594308|Cyclosporins|cyclosporins|mesh-list
83486416|NCT00594308|Basiliximab|basiliximab|mesh-list
83486417|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83486418|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
83486419|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486420|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83486421|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83486422|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
83486423|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486424|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486425|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83486426|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486427|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
83486428|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486429|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
83486430|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83486431|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83486432|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83486433|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
83486434|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83486435|NCT02137538|Letrozole|letrozole|mesh-list
83486436|NCT02137538|Anastrozole|anastrozole|mesh-list
83486437|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486438|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83486439|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83486440|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486441|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486442|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83486443|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
83486444|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83486445|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486446|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83486448|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
83486449|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83486450|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83486451|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486452|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83486453|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486454|NCT00595790|Vaccines|vaccines|mesh-list
83486455|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
83486456|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486457|NCT00595946|Lubiprostone|lubiprostone|mesh-list
83486458|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83486459|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83486460|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486461|NCT00597038|Dasatinib|dasatinib|mesh-list
83486462|NCT00597038|Dacarbazine|dacarbazine|mesh-list
83486463|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486464|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83486465|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486466|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486467|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83486468|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
83486469|NCT00597428|Lubiprostone|lubiprostone|mesh-list
83486470|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83486471|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83486472|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486473|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83486474|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83486475|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83486476|NCT00597818|Analgesics|analgesics|mesh-ancestor
83486477|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
83486478|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486479|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486480|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83486481|NCT00597896|Pramipexole|pramipexole|mesh-list
83486482|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
83486483|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486484|NCT00597896|Protective Agents|protective agents|mesh-ancestor
83486485|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486486|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83486487|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83486488|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
83486489|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
83486490|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486491|NCT01790282|Estradiol|estradiol|mesh-list
83486492|NCT01790282|Progesterone|progesterone|mesh-list
83486493|NCT01790282|Estrogens|estrogens|mesh-ancestor
83486494|NCT01790282|Hormones|hormones|mesh-ancestor
83486495|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83486496|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486497|NCT01790282|Progestins|progestins|mesh-ancestor
83486498|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
83486499|NCT03843541|Ambroxol|ambroxol|mesh-list
83486500|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83486502|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486503|NCT03843541|Expectorants|expectorants|mesh-ancestor
83486504|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
83486505|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83486506|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
83486507|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486508|NCT03843541|Protective Agents|protective agents|mesh-ancestor
83486509|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486510|NCT03843541|Antidotes|antidotes|mesh-ancestor
83486511|NCT00639158|Choline|choline|mesh-list
83486512|NCT00639158|Atorvastatin|atorvastatin|mesh-list
83486513|NCT00639158|Ezetimibe|ezetimibe|mesh-list
83486514|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
83486515|NCT00639158|Fenofibrate|fenofibrate|mesh-list
83486516|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83486517|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83486518|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
83486519|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486520|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83486521|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83486529|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486530|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83486531|NCT00692978|Fluticasone|fluticasone|mesh-list
83486532|NCT00692978|Xhance|xhance|mesh-list
83486533|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486534|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83486535|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
83486536|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486537|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486538|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83486539|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
83486540|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
83486541|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83486542|NCT00601718|Rituximab|rituximab|mesh-list
83486543|NCT00601718|Carboplatin|carboplatin|mesh-list
83486544|NCT00601718|Etoposide|etoposide|mesh-list
83486545|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
83486546|NCT00601718|Ifosfamide|ifosfamide|mesh-list
83486547|NCT00601718|Vorinostat|vorinostat|mesh-list
83486548|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83486549|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486550|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
83486551|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486552|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83486553|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83486554|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83486555|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83486556|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486557|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486558|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83486559|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
83486560|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83486561|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
83486562|NCT00601796|Tretinoin|tretinoin|mesh-list
83486563|NCT00601796|Vaccines|vaccines|mesh-list
83486564|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
83486565|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486566|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83486567|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83486568|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83486569|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
83486570|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486571|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486572|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83486573|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
83486574|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
83486575|NCT00693992|Sunitinib|sunitinib|mesh-list
83486576|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486577|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83486578|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83486579|NCT00693992|Growth Substances|growth substances|mesh-ancestor
83486580|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486581|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
83486582|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83486583|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486584|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486585|NCT00645710|Gemcitabine|gemcitabine|mesh-list
83486586|NCT00645710|Floxuridine|floxuridine|mesh-list
83486588|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83486589|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
83486590|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486591|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83486592|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
83486593|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486594|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486595|NCT00603044|Fluticasone|fluticasone|mesh-list
83486596|NCT00603044|Xhance|xhance|mesh-list
83486597|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486598|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83486599|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
83486600|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486601|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486602|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83486603|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
83486604|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
83486605|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83486606|NCT00646646|Midazolam|midazolam|mesh-list
83486609|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83486610|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83486611|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486612|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83486613|NCT00646646|Analgesics|analgesics|mesh-ancestor
83486614|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
83486615|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486616|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83486617|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83486618|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83486619|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
83486620|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486621|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486622|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83486623|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
83486624|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
83486625|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83486626|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83486627|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83486628|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83486629|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
83486630|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
83486631|NCT02998424|Propofol|propofol|mesh-list
83486632|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83486633|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83486634|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486635|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83486636|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
83486637|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
83486638|NCT00696488|Fluorouracil|fluorouracil|mesh-list
83486639|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
83486640|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486641|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83486642|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486643|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83486644|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
83486645|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486646|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
83486647|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83486648|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83486649|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486650|NCT00650078|Prednisone|prednisone|mesh-list
83486651|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486652|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
83486653|NCT00650078|Hormones|hormones|mesh-ancestor
83486654|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83486655|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486656|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83486657|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486658|NCT01799486|Adefovir|adefovir|mesh-list
83486659|NCT01799486|Telbivudine|telbivudine|mesh-list
83486660|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
83486661|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486662|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83486663|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83486664|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486665|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486666|NCT00650546|Exenatide|exenatide|mesh-list
83486667|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83486668|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486669|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83486670|NCT00650546|Incretins|incretins|mesh-ancestor
83486671|NCT00650546|Hormones|hormones|mesh-ancestor
83486672|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83486673|NCT01386710|Bevacizumab|bevacizumab|mesh-list
83486674|NCT01386710|Carboplatin|carboplatin|mesh-list
83486675|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83486676|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486677|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83486678|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83486679|NCT01386710|Growth Substances|growth substances|mesh-ancestor
83486680|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486681|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
83486682|NCT00650858|Plasminogen|plasminogen|mesh-list
83486683|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83486685|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83486686|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486687|NCT00651482|Bevacizumab|bevacizumab|mesh-list
83486688|NCT00651482|Everolimus|everolimus|mesh-list
83486689|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83486690|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486691|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83486692|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83486693|NCT00651482|Growth Substances|growth substances|mesh-ancestor
83486694|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486695|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
83486696|NCT00651482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83486697|NCT00651482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83486698|NCT00651482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486699|NCT00651482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486700|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83486701|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
83486702|NCT00654836|Bevacizumab|bevacizumab|mesh-list
83486703|NCT00654836|Carboplatin|carboplatin|mesh-list
83486704|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83486705|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83486706|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486707|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83486708|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83486709|NCT00654836|Growth Substances|growth substances|mesh-ancestor
83486710|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486711|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
83486712|NCT02997800|Labetalol|labetalol|mesh-list
83486713|NCT02997800|Fentanyl|fentanyl|mesh-list
83486714|NCT02997800|Esmolol|esmolol|mesh-list
83486715|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83486716|NCT02997800|Narcotics|narcotics|mesh-ancestor
83486717|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83486718|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486719|NCT02997800|Analgesics|analgesics|mesh-ancestor
83486720|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
83486721|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486722|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83486723|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83486724|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
83486725|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
83486726|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83486727|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83486728|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83486730|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486731|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486732|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83486733|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
83486734|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
83486735|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83486736|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83486737|NCT00701636|Daptomycin|daptomycin|mesh-list
83486738|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83486739|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486740|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
83486741|NCT00701714|Hematinics|hematinics|mesh-ancestor
83486742|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
83486743|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83486744|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83486745|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
83486746|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486747|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83486748|NCT00656630|Naltrexone|naltrexone|mesh-list
83486749|NCT00656630|Acamprosate|acamprosate|mesh-list
83486750|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83486751|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83486752|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486753|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
83486754|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486755|NCT01362998|Fentanyl|fentanyl|mesh-list
83486756|NCT01362998|Morphine|morphine|mesh-list
83486757|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83486758|NCT01362998|Narcotics|narcotics|mesh-ancestor
83486759|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83486760|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486761|NCT01362998|Analgesics|analgesics|mesh-ancestor
83486762|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
83486763|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486764|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83486765|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83486766|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
83486767|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
83486768|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
83486769|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
83486770|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486771|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83486772|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
83486773|NCT02997332|Docetaxel|docetaxel|mesh-list
83486774|NCT02997332|Fluorouracil|fluorouracil|mesh-list
83486775|NCT02997332|Durvalumab|durvalumab|mesh-list
83486776|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486777|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
83486778|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
83486779|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
83486780|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486781|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
83486782|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83486783|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83486784|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
83486785|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486786|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83486787|NCT04345094|Hydroquinone|hydroquinone|mesh-list
83486788|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
83486789|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486790|NCT04345094|Protective Agents|protective agents|mesh-ancestor
83486791|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486792|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83486793|NCT00702884|Sunitinib|sunitinib|mesh-list
83486794|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486795|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83486796|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83486797|NCT00702884|Growth Substances|growth substances|mesh-ancestor
83486798|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486799|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
83486800|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83486801|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486802|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486803|NCT00703508|Metformin|metformin|mesh-list
83486804|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83486805|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486806|NCT01284335|Gemcitabine|gemcitabine|mesh-list
83486807|NCT01284335|Docetaxel|docetaxel|mesh-list
83486808|NCT01284335|Temozolomide|temozolomide|mesh-list
83486809|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83486810|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486811|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83486812|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
83486813|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486814|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
83486815|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
83486816|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
83486817|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83486818|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
83486819|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83486820|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486821|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
83486822|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83486823|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
83486824|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486825|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486826|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83486827|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
83486828|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83486829|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83486830|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83486831|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
83486832|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486833|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486834|NCT01230593|Tobramycin|tobramycin|mesh-list
83486835|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
83486836|NCT01230593|Dexamethasone|dexamethasone|mesh-list
83486837|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
83486839|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486841|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
83486842|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486843|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486844|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83486845|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
83486846|NCT01230593|Hormones|hormones|mesh-ancestor
83486847|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83486848|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83486849|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486850|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
83486851|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486852|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486853|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83486854|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83486855|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83486856|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83486857|NCT01195025|Chrysarobin|chrysarobin|mesh-list
83486858|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83486859|NCT01195025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83486860|NCT01195025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83486861|NCT01195025|Analgesics|analgesics|mesh-ancestor
83486862|NCT01195025|Sensory System Agents|sensory system agents|mesh-ancestor
83486863|NCT01195025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486864|NCT01195025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486865|NCT01195025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486866|NCT01195025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83486867|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
83486868|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
83486869|NCT00703664|Bortezomib|bortezomib|mesh-list
83486870|NCT00703664|Vorinostat|vorinostat|mesh-list
83486871|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486872|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83486873|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486874|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486875|NCT00658736|Triamcinolone|triamcinolone|mesh-list
83486876|NCT00658736|Bupivacaine|bupivacaine|mesh-list
83486877|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
83486878|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
83486879|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83486880|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486881|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
83486882|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486883|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486884|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
83486885|NCT00658736|Hormones|hormones|mesh-ancestor
83486886|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83486887|NCT00659360|Saracatinib|saracatinib|mesh-list
83486888|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486889|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486890|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486891|NCT01197833|Polidocanol|polidocanol|mesh-list
83486892|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83486893|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83486894|NCT04270370|Atorvastatin|atorvastatin|mesh-list
83486895|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83486896|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83486897|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
83486898|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486899|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83486900|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83486901|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486902|NCT01288781|Acetazolamide|acetazolamide|mesh-list
83486903|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
83486904|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83486905|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486906|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486907|NCT01288781|Diuretics|diuretics|mesh-ancestor
83486908|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
83486909|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486910|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
83486911|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486912|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
83486913|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83486914|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83486915|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486916|NCT02990078|Urological Agents|urological agents|mesh-ancestor
83486917|NCT01288859|Curcumin|curcumin|mesh-list
83486918|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83486919|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83486920|NCT01288859|Analgesics|analgesics|mesh-ancestor
83486921|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
83486922|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486923|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486924|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83486925|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83486926|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486927|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486928|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486929|NCT01235195|Sertraline|sertraline|mesh-list
83486930|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
83486931|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83486932|NCT01235195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83486933|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83486934|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83486935|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486936|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486937|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
83486938|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486939|NCT02996942|Factor VIII|factor viii|mesh-list
83486940|NCT02996942|Coagulants|coagulants|mesh-ancestor
83486941|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
83486942|NCT01199237|Sevoflurane|sevoflurane|mesh-list
83486943|NCT01199237|Desflurane|desflurane|mesh-list
83486944|NCT01199237|Rocuronium|rocuronium|mesh-list
83486945|NCT01199237|Neostigmine|neostigmine|mesh-list
83486946|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83486947|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83486948|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
83486949|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
83486950|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83486951|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486952|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83486953|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83486954|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83486955|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486956|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83486957|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83486958|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486959|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
83486960|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486961|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83486962|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
83486963|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83486964|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83486965|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83486966|NCT01235897|Paclitaxel|paclitaxel|mesh-list
83486967|NCT01235897|Trastuzumab|trastuzumab|mesh-list
83486968|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83486969|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486970|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
83486971|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
83486972|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
83486973|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486974|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83486975|NCT01236053|Gabapentin|gabapentin|mesh-list
83486976|NCT01236053|Analgesics|analgesics|mesh-ancestor
83486977|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
83486978|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83486979|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486980|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
83486981|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83486982|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83486983|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83486984|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83486985|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83486986|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83486987|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83486988|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83486989|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
83486990|NCT00703976|Bevacizumab|bevacizumab|mesh-list
83486991|NCT00703976|Cetuximab|cetuximab|mesh-list
83486992|NCT00703976|Pemetrexed|pemetrexed|mesh-list
83486993|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83486994|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83486995|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83486996|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83486997|NCT00703976|Growth Substances|growth substances|mesh-ancestor
83486998|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486999|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
83487000|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487001|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487002|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83487003|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83487004|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
83487005|NCT00661544|Melphalan|melphalan|mesh-list
83487006|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
83487007|NCT00661544|Vitamins|vitamins|mesh-ancestor
83487008|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
83487009|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487010|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83487011|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
83487012|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487013|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487014|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83487015|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83487016|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
83487017|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
83487018|NCT00661544|Protective Agents|protective agents|mesh-ancestor
83487019|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83487020|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
83487021|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487022|NCT02979392|Paclitaxel|paclitaxel|mesh-list
83487023|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83487024|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487025|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
83487026|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
83487027|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
83487028|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487029|NCT02999906|Treprostinil|treprostinil|mesh-list
83487030|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83487031|NCT01238471|Propranolol|propranolol|mesh-list
83487032|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83487033|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83487034|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
83487035|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487036|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487037|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487038|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83487039|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83487040|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
83487042|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83487043|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487044|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83487045|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83487046|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487047|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83487048|NCT00664430|Vitamins|vitamins|mesh-ancestor
83487049|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
83487050|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83487051|NCT01292447|Lidocaine|lidocaine|mesh-list
83487052|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
83487053|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
83487054|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487055|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487056|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
83487057|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487058|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83487059|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83487060|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83487061|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83487133|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487062|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487063|NCT00704912|Orlistat|orlistat|mesh-list
83487064|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
83487065|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83487066|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
83487067|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83487068|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487069|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83487070|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487071|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487072|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83487073|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83487074|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83487075|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83487076|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83487077|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83487078|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83487079|NCT02195921|Antiemetics|antiemetics|mesh-list
83487080|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
83487081|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487082|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487083|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83487084|NCT02189213|Sertraline|sertraline|mesh-list
83487085|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
83487086|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83487087|NCT02189213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83487088|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83487089|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83487090|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487091|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487092|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
83487093|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487094|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83487095|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83487096|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83487097|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
83487098|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487099|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83487100|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83487101|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487102|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83487103|NCT00666848|Enalapril|enalapril|mesh-list
83487104|NCT00666848|Enalaprilat|enalaprilat|mesh-list
83487105|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83487106|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487107|NCT00666848|Incretins|incretins|mesh-ancestor
83487108|NCT00666848|Hormones|hormones|mesh-ancestor
83487109|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83487110|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83487111|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
83487112|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487113|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487114|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83487115|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83487116|NCT01287377|Nicotine|nicotine|mesh-list
83487117|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83487118|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
83487119|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487120|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487121|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83487122|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83487123|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
83487124|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487125|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487126|NCT01511042|Norepinephrine|norepinephrine|mesh-list
83487127|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
83487128|NCT01511042|Giapreza|giapreza|mesh-list
83487129|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
83487130|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83487131|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83487132|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
83487134|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487135|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487137|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
83487138|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487139|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83487140|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83487141|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
83487142|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487143|NCT00667004|Ecabet|ecabet|mesh-list
83487144|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83487145|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83487146|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487147|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83487148|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83487149|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
83487150|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487151|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487152|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83487153|NCT00667004|Protective Agents|protective agents|mesh-ancestor
83487154|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487155|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487156|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
83487157|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83487158|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487159|NCT01028846|Diazoxide|diazoxide|mesh-list
83487160|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83487161|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
83487162|NCT04386122|Loxoprofen|loxoprofen|mesh-list
83487163|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83487164|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83487165|NCT04386122|Analgesics|analgesics|mesh-ancestor
83487166|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
83487167|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487168|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487169|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83487170|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83487171|NCT03009461|Sorafenib|sorafenib|mesh-list
83487172|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487173|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83487174|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487175|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487176|NCT02990702|Bupivacaine|bupivacaine|mesh-list
83487177|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
83487178|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
83487179|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487180|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487181|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
83487182|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487183|NCT02995304|Midazolam|midazolam|mesh-list
83487184|NCT02995304|Morphine|morphine|mesh-list
83487185|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83487186|NCT02995304|Narcotics|narcotics|mesh-ancestor
83487187|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487188|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487189|NCT02995304|Analgesics|analgesics|mesh-ancestor
83487190|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
83487191|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487192|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83487193|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83487194|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83487195|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83487196|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83487197|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83487198|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
83487199|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
83487200|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
83487201|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
83487202|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487203|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487204|NCT02990858|Leronlimab|leronlimab|mesh-list
83487205|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83487206|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83487207|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487208|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83487209|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83487210|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
83487211|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487212|NCT00725504|Lidocaine|lidocaine|mesh-list
83487213|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
83487214|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
83487215|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487216|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487217|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
83487218|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487219|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83487220|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83487221|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83487222|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83487223|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487224|NCT03830684|Baicalein|baicalein|mesh-list
83487225|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
83487226|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487227|NCT03830684|Protective Agents|protective agents|mesh-ancestor
83487228|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487229|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487230|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
83487231|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
83487232|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83487233|NCT02990546|Midodrine|midodrine|mesh-list
83487234|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
83487235|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
83487236|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487237|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487238|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83487239|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83487240|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83487241|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83487242|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
83487243|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487244|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487245|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83487246|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83487247|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83487248|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83487249|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83487250|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487251|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487252|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487253|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83487254|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
83487255|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83487257|NCT01294163|Sevoflurane|sevoflurane|mesh-list
83487258|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83487259|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487260|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487261|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83487262|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
83487263|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
83487264|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83487265|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83487266|NCT01294319|Dexamethasone|dexamethasone|mesh-list
83487267|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
83487268|NCT01294319|Spironolactone|spironolactone|mesh-list
83487269|NCT01294319|Mifepristone|mifepristone|mesh-list
83487270|NCT01294319|BB 1101|bb 1101|mesh-list
83487271|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83487272|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
83487273|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
83487274|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487275|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487276|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83487277|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
83487278|NCT01294319|Hormones|hormones|mesh-ancestor
83487279|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83487280|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83487281|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487282|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
83487284|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487285|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83487286|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
83487287|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83487288|NCT01294319|Diuretics|diuretics|mesh-ancestor
83487289|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
83487290|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83487291|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
83487292|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83487293|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83487294|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83487295|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83487296|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
83487297|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83487298|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83487299|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
83487300|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83487301|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83487302|NCT00727298|Infliximab|infliximab|mesh-list
83487303|NCT00727298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83487304|NCT00727298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83487305|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
83487306|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83487307|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83487308|NCT02990312|Sirolimus|sirolimus|mesh-list
83487309|NCT02990312|Maraviroc|maraviroc|mesh-list
83487310|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83487311|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487312|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83487313|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487314|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
83487315|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83487316|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
83487317|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487318|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487319|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83487320|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83487321|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83487322|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83487324|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83487325|NCT01295879|Vitamin D|vitamin d|mesh-list
83487326|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
83487327|NCT01295879|Vitamins|vitamins|mesh-ancestor
83487328|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
83487329|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487330|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83487331|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83487332|NCT01244633|Ecopipam|ecopipam|mesh-list
83487333|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83487334|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83487335|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487336|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487337|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83487338|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83487339|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
83487340|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487341|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487342|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
83487343|NCT01296191|Besifloxacin|besifloxacin|mesh-list
83487344|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83487345|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487346|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83487347|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83487348|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487349|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487350|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487351|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83487352|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
83487353|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83487354|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83487355|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83487356|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487357|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487358|NCT01210079|Gabapentin|gabapentin|mesh-list
83487359|NCT01210079|Analgesics|analgesics|mesh-ancestor
83487360|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
83487361|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487362|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487363|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
83487364|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83487365|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83487366|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487367|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83487368|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83487369|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83487370|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487371|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487372|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
83487373|NCT01245647|Naltrexone|naltrexone|mesh-list
83487374|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83487375|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83487376|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487377|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
83487378|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487379|NCT00708110|Dolutegravir|dolutegravir|mesh-list
83487380|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83487381|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83487382|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487383|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487384|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83487385|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83487386|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
83487387|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487388|NCT01296815|Bevacizumab|bevacizumab|mesh-list
83487389|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83487390|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487391|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83487392|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83487393|NCT01296815|Growth Substances|growth substances|mesh-ancestor
83487394|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487395|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
83487396|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
83487397|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83487398|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83487400|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83487401|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487402|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83487403|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83487404|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83487405|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83487406|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83487407|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83487408|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83487409|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83487410|NCT01276496|Paclitaxel|paclitaxel|mesh-list
83487411|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83487412|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83487413|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487414|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
83487415|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
83487416|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
83487417|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487418|NCT01297595|Crizotinib|crizotinib|mesh-list
83487419|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487420|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83487421|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487422|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487423|NCT02992418|Vaccines|vaccines|mesh-list
83487424|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
83487425|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487426|NCT01276730|Interferons|interferons|mesh-list
83487427|NCT01276730|Tretinoin|tretinoin|mesh-list
83487428|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487429|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
83487430|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487431|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
83487432|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
83487433|NCT01298063|Afatinib|afatinib|mesh-list
83487434|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487435|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83487436|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487437|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487438|NCT02999594|Tramadol|tramadol|mesh-list
83487439|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83487440|NCT02999594|Narcotics|narcotics|mesh-ancestor
83487441|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487442|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487443|NCT02999594|Analgesics|analgesics|mesh-ancestor
83487444|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
83487445|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487446|NCT01298219|Lubiprostone|lubiprostone|mesh-list
83487447|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83487448|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83487449|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487450|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83487451|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487452|NCT02322242|Dexamethasone|dexamethasone|mesh-list
83487453|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
83487454|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83487455|NCT02322242|BB 1101|bb 1101|mesh-list
83487456|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83487457|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
83487458|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
83487459|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487460|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487461|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83487462|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
83487463|NCT02322242|Hormones|hormones|mesh-ancestor
83487464|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83487465|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83487466|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487467|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
83487468|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487469|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487470|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83487472|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
83487473|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487474|NCT02993588|Melatonin|melatonin|mesh-list
83487475|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
83487476|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487477|NCT02993588|Protective Agents|protective agents|mesh-ancestor
83487478|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487479|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487480|NCT01270178|Entecavir|entecavir|mesh-list
83487481|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
83487482|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487483|NCT01270412|Mitogens|mitogens|mesh-list
83487484|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
83487485|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
83487486|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487487|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83487488|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
83487489|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487490|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
83487491|NCT01270412|Protective Agents|protective agents|mesh-ancestor
83487492|NCT02992496|Midazolam|midazolam|mesh-list
83487493|NCT02992496|Ketamine|ketamine|mesh-list
83487494|NCT02992496|Analgesics|analgesics|mesh-ancestor
83487495|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
83487496|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487497|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487498|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83487499|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83487500|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
83487501|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
83487502|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487503|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83487504|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83487505|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487506|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487507|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83487508|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83487509|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83487516|NCT00729482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83487517|NCT00729482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487518|NCT00729482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487519|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83487520|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
83487521|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487522|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487524|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
83487525|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487526|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
83487527|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487528|NCT01278056|Deferasirox|deferasirox|mesh-list
83487529|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83487530|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
83487531|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
83487532|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487533|NCT02992652|Allopurinol|allopurinol|mesh-list
83487534|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
83487535|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487536|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487537|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
83487538|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83487539|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83487540|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
83487541|NCT02992652|Protective Agents|protective agents|mesh-ancestor
83487542|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487543|NCT01270724|Paclitaxel|paclitaxel|mesh-list
83487544|NCT01270724|Gemcitabine|gemcitabine|mesh-list
83487545|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
83487546|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83487547|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487548|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
83487549|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
83487550|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
83487551|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487552|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83487553|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
83487554|NCT00709826|Gemcitabine|gemcitabine|mesh-list
83487555|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83487556|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83487557|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
83487558|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487559|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487560|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83487561|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487562|NCT01271114|Terlipressin|terlipressin|mesh-list
83487563|NCT01271114|Norepinephrine|norepinephrine|mesh-list
83487564|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83487565|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83487566|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
83487567|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487568|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487569|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487570|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
83487571|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
83487572|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487573|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83487574|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83487575|NCT02992340|Gemcitabine|gemcitabine|mesh-list
83487576|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487577|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83487578|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
83487579|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487580|NCT00711464|Modafinil|modafinil|mesh-list
83487581|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83487582|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487583|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83487584|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83487585|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83487586|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487587|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83487588|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83487589|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
83487590|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83487591|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
83487592|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83487593|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487594|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83487595|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83487596|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487597|NCT01278290|Hormones|hormones|mesh-ancestor
83487598|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83487599|NCT01278446|Caseins|caseins|mesh-list
83487600|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
83487601|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
83487602|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487603|NCT02339558|Nivolumab|nivolumab|mesh-list
83487604|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83487605|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487606|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83487607|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487608|NCT00731198|Drotaverin|drotaverin|mesh-list
83487609|NCT00731198|Scopolamine|scopolamine|mesh-list
83487610|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83487611|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83487612|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
83487613|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
83487614|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487615|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487616|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83487617|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
83487618|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83487619|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
83487620|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487621|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487622|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83487623|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
83487625|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
83487626|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
83487627|NCT01278602|Rituximab|rituximab|mesh-list
83487628|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83487629|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487630|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
83487631|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487632|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83487633|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
83487634|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83487635|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
83487636|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487637|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
83487638|NCT00712244|Protective Agents|protective agents|mesh-ancestor
83487639|NCT02991950|Parnaparin|parnaparin|mesh-list
83487640|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
83487641|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83487642|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83487643|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487644|NCT01271582|Leucovorin|leucovorin|mesh-list
83487645|NCT01271582|Irinotecan|irinotecan|mesh-list
83487646|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83487647|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83487648|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487649|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487650|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487651|NCT01271582|Antidotes|antidotes|mesh-ancestor
83487652|NCT01271582|Protective Agents|protective agents|mesh-ancestor
83487653|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487654|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
83487655|NCT01271582|Vitamins|vitamins|mesh-ancestor
83487656|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
83487657|NCT01271660|Pregabalin|pregabalin|mesh-list
83487658|NCT01271660|Analgesics|analgesics|mesh-ancestor
83487659|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
83487660|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487661|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487662|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
83487663|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83487664|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83487665|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492238|NCT03219710|Hormones|hormones|mesh-ancestor
83487666|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83487667|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83487668|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83487669|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487670|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83487672|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
83487673|NCT00731588|Vitamins|vitamins|mesh-ancestor
83487674|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
83487675|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487676|NCT01271894|Efavirenz|efavirenz|mesh-list
83487677|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83487678|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83487679|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487680|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487681|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
83487682|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487683|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83487684|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83487685|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83487686|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83487687|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83487688|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83487689|NCT01278758|Vadimezan|vadimezan|mesh-list
83487690|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487691|NCT00717626|Factor VIII|factor viii|mesh-list
83487692|NCT00717626|Coagulants|coagulants|mesh-ancestor
83487693|NCT01272128|Interferons|interferons|mesh-list
83487694|NCT01272128|Interferon-beta|interferon-beta|mesh-list
83487696|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487697|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
83487698|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487699|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
83487700|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487701|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83487702|NCT00719186|Letrozole|letrozole|mesh-list
83487703|NCT00719186|Clomiphene|clomiphene|mesh-list
83487704|NCT00719186|Enclomiphene|enclomiphene|mesh-list
83487705|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
83487706|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487707|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487708|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83487709|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83487710|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487711|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83487712|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
83487713|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83487714|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487715|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83487716|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
83487717|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83487718|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83487719|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83487720|NCT00721136|Heparin|heparin|mesh-list
83487721|NCT00721136|Warfarin|warfarin|mesh-list
83487722|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
83487723|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83487724|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83487725|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487726|NCT00737204|Modafinil|modafinil|mesh-list
83487727|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83487728|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487729|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83487730|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83487731|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83487732|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487733|NCT00722072|Sorafenib|sorafenib|mesh-list
83487734|NCT00722072|Fulvestrant|fulvestrant|mesh-list
83487735|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487736|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83487737|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487738|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487739|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83487740|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83487743|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83487744|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487746|NCT01275170|Relebactam|relebactam|mesh-list
83487747|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
83487748|NCT01275170|Midazolam|midazolam|mesh-list
83487749|NCT01275170|Caffeine|caffeine|mesh-list
83487750|NCT01275170|Omeprazole|omeprazole|mesh-list
83487751|NCT01275170|Cilastatin|cilastatin|mesh-list
83487752|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83487753|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83487754|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487755|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487756|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83487757|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83487758|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83487759|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83487760|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
83487761|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
83487762|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
83487763|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
83487764|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487765|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487766|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83487767|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83487768|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487769|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83487770|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83487771|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
83487772|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83487773|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83487774|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83487775|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83487776|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487777|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
83487778|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83487779|NCT04385654|Axitinib|axitinib|mesh-list
83487780|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487781|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83487782|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487783|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487784|NCT01273064|Interferons|interferons|mesh-list
83487785|NCT01273064|Ribavirin|ribavirin|mesh-list
83487786|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487787|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
83487788|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487789|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
83487790|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487791|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
83487792|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
83487793|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487794|NCT01272908|Rituximab|rituximab|mesh-list
83487795|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83487796|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487797|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
83487798|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487799|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83487800|NCT01271504|Sorafenib|sorafenib|mesh-list
83487801|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487802|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83487803|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487804|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487805|NCT02144714|Adalimumab|adalimumab|mesh-list
83487806|NCT02144714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83487807|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83487808|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83487809|NCT00741026|Olanzapine|olanzapine|mesh-list
83487810|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
83487811|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
83487812|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487813|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487814|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83487815|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83487816|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83487817|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487818|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83487819|NCT00741026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83487820|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83487821|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83487822|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487823|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487824|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
83487825|NCT00741104|Infliximab|infliximab|mesh-list
83487826|NCT00741104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83487827|NCT00741104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83487828|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
83487829|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83487830|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83487831|NCT01273298|Bisoprolol|bisoprolol|mesh-list
83487832|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83487833|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
83487834|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
83487835|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487836|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487837|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83487838|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83487839|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83487840|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
83487841|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487842|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487843|NCT01270802|Tenofovir|tenofovir|mesh-list
83487844|NCT01270802|Emtricitabine|emtricitabine|mesh-list
83487845|NCT01270802|Efavirenz|efavirenz|mesh-list
83487846|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
83487847|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
83487848|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487849|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83487850|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83487851|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487852|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487853|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83487854|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83487855|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83487856|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83487857|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83487858|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83487859|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83487860|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83487861|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83487862|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83487863|NCT01273454|Hydromorphone|hydromorphone|mesh-list
83487864|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83487865|NCT01273454|Narcotics|narcotics|mesh-ancestor
83487866|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487867|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487868|NCT01273454|Analgesics|analgesics|mesh-ancestor
83487869|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
83487870|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487871|NCT01270256|Budesonide|budesonide|mesh-list
83487872|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83487873|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83487874|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
83487875|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487876|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487877|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83487878|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83487879|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
83487880|NCT01270256|Hormones|hormones|mesh-ancestor
83487881|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83487882|NCT01279694|Prednisone|prednisone|mesh-list
83487883|NCT01279694|Melphalan|melphalan|mesh-list
83487884|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83487885|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
83487886|NCT01279694|Hormones|hormones|mesh-ancestor
83487887|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83487888|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487889|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83487890|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487891|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83487892|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
83487893|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487894|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83487895|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83487896|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
83487897|NCT01273532|Tapentadol|tapentadol|mesh-list
83487898|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83487899|NCT01273532|Narcotics|narcotics|mesh-ancestor
83487900|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487901|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487902|NCT01273532|Analgesics|analgesics|mesh-ancestor
83487903|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
83487904|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487905|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83487906|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83487907|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83487908|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487909|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
83487910|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487911|NCT00744380|Midazolam|midazolam|mesh-list
83487912|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
83487913|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83487914|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487915|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487916|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83487917|NCT00744380|Analgesics|analgesics|mesh-ancestor
83487918|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
83487919|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487920|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83487921|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83487922|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83487923|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
83487924|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487925|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487926|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83487927|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83487928|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83487929|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83487930|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83487931|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
83487933|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
83487934|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
83487935|NCT00744692|Fludarabine|fludarabine|mesh-list
83487936|NCT00744692|Melphalan|melphalan|mesh-list
83487937|NCT00744692|Thiotepa|thiotepa|mesh-list
83487938|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
83487939|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487940|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487941|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83487942|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
83487943|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487944|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83487945|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
83487946|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83487947|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
83487948|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487949|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83487950|NCT00744848|Epinephrine|epinephrine|mesh-list
83487951|NCT00744848|Bupivacaine|bupivacaine|mesh-list
83487952|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
83487953|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
83487954|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83487955|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83487956|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
83487957|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83487958|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83487959|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83487960|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
83487961|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83487962|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487963|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83487964|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83487965|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
83487966|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83487967|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
83487968|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
83487970|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83487971|NCT03830606|Paclitaxel|paclitaxel|mesh-list
83487972|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83487973|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83487974|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
83487975|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
83487976|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
83487977|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487978|NCT01278134|Ritonavir|ritonavir|mesh-list
83487979|NCT01278134|Ribavirin|ribavirin|mesh-list
83487980|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83487981|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83487982|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83487983|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
83487984|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83487985|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83487986|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83487987|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83487988|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
83487989|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83487990|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83487991|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83487992|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
83487993|NCT01273844|Bortezomib|bortezomib|mesh-list
83487995|NCT01271348|Etoricoxib|etoricoxib|mesh-list
83487996|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83487997|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83487998|NCT01271348|Analgesics|analgesics|mesh-ancestor
83487999|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
83488000|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488001|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488002|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488003|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488004|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83488005|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83488006|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488007|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488008|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
83488009|NCT04385264|Mannitol|mannitol|mesh-list
83488010|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
83488011|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83488012|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83488013|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488014|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488015|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488016|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488017|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83488018|NCT04385264|Diuretics|diuretics|mesh-ancestor
83488019|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
83488020|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488021|NCT00746954|Acetazolamide|acetazolamide|mesh-list
83488022|NCT00746954|Buspirone|buspirone|mesh-list
83488023|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
83488024|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83488025|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488026|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488027|NCT00746954|Diuretics|diuretics|mesh-ancestor
83488028|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
83488029|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488030|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83488031|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83488032|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83488033|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83488034|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83488035|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
83488036|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488037|NCT00752102|Calcitriol|calcitriol|mesh-list
83488038|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83488039|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488040|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83488041|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83488042|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488043|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83488044|NCT00752102|Vitamins|vitamins|mesh-ancestor
83488045|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
83488046|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83488050|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488051|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
83488052|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488053|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
83488054|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
83488055|NCT01279616|Busulfan|busulfan|mesh-list
83488056|NCT01279616|Rituximab|rituximab|mesh-list
83488057|NCT01279616|Fludarabine|fludarabine|mesh-list
83488058|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
83488059|NCT01279616|Tacrolimus|tacrolimus|mesh-list
83488060|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
83488061|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83488062|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
83488063|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488064|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488065|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83488066|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
83488067|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488068|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488069|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83488070|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83488071|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83488073|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83488074|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488075|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83488076|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83488077|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
83488078|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83488079|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488080|NCT01275638|Prednisolone|prednisolone|mesh-list
83488081|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83488082|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
83488083|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83488084|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
83488085|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83488086|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
83488087|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488088|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
83488089|NCT01275638|Hormones|hormones|mesh-ancestor
83488090|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488091|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488092|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83488093|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488094|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
83488095|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
83488096|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488097|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83488098|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83488099|NCT01275638|Protective Agents|protective agents|mesh-ancestor
83488100|NCT00724568|Dexamethasone|dexamethasone|mesh-list
83488101|NCT00724568|Lenalidomide|lenalidomide|mesh-list
83488102|NCT00724568|Bortezomib|bortezomib|mesh-list
83488103|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488104|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
83488105|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
83488106|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488107|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488108|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83488109|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
83488110|NCT00724568|Hormones|hormones|mesh-ancestor
83488111|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488112|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83488113|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488114|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
83488115|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83488116|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83488117|NCT00724568|Growth Substances|growth substances|mesh-ancestor
83488118|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
83488119|NCT01274000|Ramosetron|ramosetron|mesh-list
83488120|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
83488121|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
83488122|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488123|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488124|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83488125|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83488126|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
83488127|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488128|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488129|NCT04274426|Paclitaxel|paclitaxel|mesh-list
83488130|NCT04274426|Maytansine|maytansine|mesh-list
83488131|NCT04274426|Carboplatin|carboplatin|mesh-list
83488132|NCT04274426|Gemcitabine|gemcitabine|mesh-list
83488133|NCT04274426|Doxorubicin|doxorubicin|mesh-list
83488134|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83488135|NCT04274426|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
83488136|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83488137|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488138|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
83488139|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
83488140|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
83488141|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488142|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83488143|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
83488144|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83488145|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83488146|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83488147|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488148|NCT04274426|Immunoconjugates|immunoconjugates|mesh-ancestor
83488149|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
83488150|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488151|NCT04272320|Bupivacaine|bupivacaine|mesh-list
83488152|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
83488153|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
83488154|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83488155|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488156|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
83488157|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488158|NCT01277744|Cisplatin|cisplatin|mesh-list
83488159|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488160|NCT01277822|Losartan|losartan|mesh-list
83488161|NCT01277822|Amlodipine|amlodipine|mesh-list
83488162|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83488163|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83488164|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83488165|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488166|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83488167|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488168|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
83488169|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83488170|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83488171|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83488172|NCT00249002|Paclitaxel|paclitaxel|mesh-list
83488173|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83488174|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83488175|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488176|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
83488177|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
83488178|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
83488179|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488180|NCT00748826|Infliximab|infliximab|mesh-list
83488181|NCT00748826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83488182|NCT00748826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488183|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
83488184|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83488185|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488186|NCT00246740|Doxycycline|doxycycline|mesh-list
83488187|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83488188|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488189|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
83488190|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83488191|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83488192|NCT01274624|Leucovorin|leucovorin|mesh-list
83488193|NCT01274624|Bevacizumab|bevacizumab|mesh-list
83488194|NCT01274624|Fluorouracil|fluorouracil|mesh-list
83488195|NCT01274624|Irinotecan|irinotecan|mesh-list
83488196|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83488197|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488198|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83488199|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83488200|NCT01274624|Growth Substances|growth substances|mesh-ancestor
83488201|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488202|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
83488203|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
83492385|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
83488204|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488205|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83488206|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83488207|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
83488208|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83488209|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83488210|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488211|NCT01274624|Antidotes|antidotes|mesh-ancestor
83488212|NCT01274624|Protective Agents|protective agents|mesh-ancestor
83488213|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
83488214|NCT01274624|Vitamins|vitamins|mesh-ancestor
83488215|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
83488216|NCT00761930|Listerine|listerine|mesh-list
83488217|NCT00761930|Triclosan|triclosan|mesh-list
83488218|NCT00761930|Fluorides|fluorides|mesh-list
83488219|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
83488220|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
83488221|NCT00761930|Protective Agents|protective agents|mesh-ancestor
83488222|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488223|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83488224|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488225|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83488227|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
83488228|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488229|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83488230|NCT00245102|Sorafenib|sorafenib|mesh-list
83488231|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488232|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83488233|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488234|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488235|NCT01275014|Dexamethasone|dexamethasone|mesh-list
83488236|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488237|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
83488238|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
83488239|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488240|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488241|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83488242|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
83488243|NCT01275014|Hormones|hormones|mesh-ancestor
83488244|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488245|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83488246|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488247|NCT01275248|Ondansetron|ondansetron|mesh-list
83488248|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
83488249|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
83488250|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488251|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488252|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83488253|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
83488254|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
83488255|NCT01275248|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83488256|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83488257|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
83488258|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488259|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488260|NCT00756236|Metoprolol|metoprolol|mesh-list
83488261|NCT00756236|Esmolol|esmolol|mesh-list
83488262|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83488263|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83488264|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
83488265|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
83488266|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488267|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488268|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83488269|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83488270|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83488271|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
83488272|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488273|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488274|NCT00762320|Ritonavir|ritonavir|mesh-list
83488275|NCT00762320|Lopinavir|lopinavir|mesh-list
83488276|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83488277|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83488278|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
83488279|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488280|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488282|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83488284|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488285|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83488286|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83488287|NCT00244712|Tenofovir|tenofovir|mesh-list
83488288|NCT00244712|Lamivudine|lamivudine|mesh-list
83488289|NCT00244712|Emtricitabine|emtricitabine|mesh-list
83488290|NCT00244712|Abacavir|abacavir|mesh-list
83488291|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
83488292|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488293|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83488294|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83488295|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488296|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488297|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83488298|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83488299|NCT00725270|Mifepristone|mifepristone|mesh-list
83488300|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83488301|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
83488302|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83488303|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488304|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83488305|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83488306|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83488307|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
83488308|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83488309|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83488310|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
83488311|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488312|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
83488313|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83488314|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83488315|NCT00243932|Ubiquinone|ubiquinone|mesh-list
83488316|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
83488317|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
83488318|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488319|NCT00243932|Vitamins|vitamins|mesh-ancestor
83488320|NCT00243386|Factor VIII|factor viii|mesh-list
83488321|NCT00243386|Coagulants|coagulants|mesh-ancestor
83488322|NCT03807362|CC-11050|cc-11050|mesh-list
83488323|NCT03807362|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83488324|NCT03807362|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83488325|NCT03807362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488326|NCT03807362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488327|NCT01275560|Metronidazole|metronidazole|mesh-list
83488328|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488329|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83488330|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83488331|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83488332|NCT00762710|Prazosin|prazosin|mesh-list
83488333|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83488334|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83488335|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83488336|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83488337|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
83488338|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488339|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488340|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488341|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83488342|NCT00756548|Laxatives|laxatives|mesh-ancestor
83488343|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83488344|NCT00243074|Cediranib|cediranib|mesh-list
83488345|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488346|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488347|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488348|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83488349|NCT00241358|Plerixafor|plerixafor|mesh-list
83488350|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83488351|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83488352|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
83488353|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488354|NCT00778310|Methylphenidate|methylphenidate|mesh-list
83488355|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83488356|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488357|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83488358|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83488359|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83488360|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488361|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
83488362|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488363|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
83488364|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83488365|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488366|NCT01247285|Fluoxetine|fluoxetine|mesh-list
83488367|NCT01247285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83488368|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83488369|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83488370|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488371|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488372|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
83488373|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488374|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83488375|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
83488376|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83488377|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83488378|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83488379|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488380|NCT03806582|Norepinephrine|norepinephrine|mesh-list
83488381|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83488382|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83488383|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
83488384|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488385|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488386|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488387|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
83488388|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
83488389|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488390|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83488391|NCT00779558|Heparin|heparin|mesh-list
83488392|NCT00779558|Calcium heparin|calcium heparin|mesh-list
83488393|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
83488394|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83488395|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83488396|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488397|NCT00758342|Travoprost|travoprost|mesh-list
83488398|NCT00758342|Brinzolamide|brinzolamide|mesh-list
83488399|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83488400|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83488401|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488402|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488403|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83488404|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83488405|NCT01301183|Estradiol|estradiol|mesh-list
83488406|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83488407|NCT01301183|Mecasermin|mecasermin|mesh-list
83488408|NCT01301183|Estrogens|estrogens|mesh-ancestor
83488409|NCT01301183|Hormones|hormones|mesh-ancestor
83488410|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488411|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488412|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83488413|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
83488414|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83488415|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83488416|NCT01301183|Growth Substances|growth substances|mesh-ancestor
83488417|NCT00758420|Polidocanol|polidocanol|mesh-list
83488418|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83488419|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83488420|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
83488421|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83488422|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488423|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488424|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83488425|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83488426|NCT01213199|Adapalene|adapalene|mesh-list
83488427|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83488428|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83488429|NCT01213199|Analgesics|analgesics|mesh-ancestor
83488430|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
83488431|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488432|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488433|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488434|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488435|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
83488436|NCT03809702|Pregabalin|pregabalin|mesh-list
83488437|NCT03809702|Analgesics|analgesics|mesh-ancestor
83488438|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
83488439|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488440|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488441|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
83488442|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83488443|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83488444|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488445|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83488446|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83488448|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83488449|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83488450|NCT03806036|Vitamin D|vitamin d|mesh-list
83488451|NCT03806036|Clomiphene|clomiphene|mesh-list
83488452|NCT03806036|Enclomiphene|enclomiphene|mesh-list
83488453|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
83488454|NCT03806036|Vitamins|vitamins|mesh-ancestor
83488455|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
83488456|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488457|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83488458|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83488459|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
83488460|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488461|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83488462|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
83488463|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83488464|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83488465|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83488466|NCT00780026|Insulin|insulin|mesh-list
83488467|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83488468|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488469|NCT01214057|Remifentanil|remifentanil|mesh-list
83488470|NCT01214057|Propofol|propofol|mesh-list
83488471|NCT01214057|Sevoflurane|sevoflurane|mesh-list
83488472|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83488473|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83488474|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488475|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83488476|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
83488477|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
83488478|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83488479|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83488480|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83488481|NCT01214057|Narcotics|narcotics|mesh-ancestor
83488482|NCT01214057|Analgesics|analgesics|mesh-ancestor
83488483|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
83488484|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488485|NCT03809546|Dronabinol|dronabinol|mesh-list
83488486|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
83488487|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488488|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83488489|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83488490|NCT03809546|Analgesics|analgesics|mesh-ancestor
83488491|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
83488492|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488493|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83488494|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83488495|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488496|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488497|NCT03809546|Hormones|hormones|mesh-ancestor
83488498|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488499|NCT03809312|Amoxicillin|amoxicillin|mesh-list
83488500|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
83488501|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
83488502|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83488503|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488504|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488505|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488506|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83488507|NCT01247363|Globalagliatin|globalagliatin|mesh-list
83488509|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488511|NCT00780494|Carboplatin|carboplatin|mesh-list
83488512|NCT00780494|Capecitabine|capecitabine|mesh-list
83488513|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83488514|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488515|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83488516|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83488517|NCT00780494|Growth Substances|growth substances|mesh-ancestor
83488518|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488519|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
83488520|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83488521|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
83488522|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488523|NCT00763412|Repaglinide|repaglinide|mesh-list
83488524|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83488525|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488526|NCT01302743|Metformin|metformin|mesh-list
83488527|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83488528|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488529|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
83488530|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83488531|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488532|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83488533|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
83488534|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83488535|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488536|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488537|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488538|NCT01214759|Tenofovir|tenofovir|mesh-list
83488539|NCT01214759|Emtricitabine|emtricitabine|mesh-list
83488540|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
83488541|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83488542|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
83488543|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488544|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83488545|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83488546|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488547|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488548|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83488549|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83488550|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83488551|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83488552|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
83488553|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83488554|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
83488555|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488556|NCT00780962|Expectorants|expectorants|mesh-ancestor
83488557|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
83488558|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83488559|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
83488560|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488561|NCT00780962|Protective Agents|protective agents|mesh-ancestor
83488562|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488563|NCT00780962|Antidotes|antidotes|mesh-ancestor
83488564|NCT00764738|Ranibizumab|ranibizumab|mesh-list
83488565|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83488566|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83488567|NCT00764738|Growth Substances|growth substances|mesh-ancestor
83488568|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488569|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
83488570|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488571|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
83488572|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
83488573|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83488574|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83488575|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488576|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488577|NCT00781508|Urological Agents|urological agents|mesh-ancestor
83488578|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
83488579|NCT03805568|Remifentanil|remifentanil|mesh-list
83488580|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83488581|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83488582|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488583|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83488584|NCT03805568|Analgesics|analgesics|mesh-ancestor
83488585|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
83488586|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488587|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83488588|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83488589|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83488590|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
83488591|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488592|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488593|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83488594|NCT03805568|Narcotics|narcotics|mesh-ancestor
83488595|NCT00781898|Naltrexone|naltrexone|mesh-list
83488596|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83488597|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83488598|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488599|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
83488600|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488601|NCT00765128|Ketorolac|ketorolac|mesh-list
83488602|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83488603|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83488604|NCT00765128|Analgesics|analgesics|mesh-ancestor
83488605|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
83488606|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488607|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488608|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488609|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488610|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83488611|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488612|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488613|NCT00765206|Omeprazole|omeprazole|mesh-list
83488614|NCT00765206|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
83488615|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83488616|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83488617|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83488618|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488619|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488620|NCT03809156|Ambrisentan|ambrisentan|mesh-list
83488621|NCT03809156|Riociguat|riociguat|mesh-list
83488622|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
83488623|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488624|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83488625|NCT03808844|Propofol|propofol|mesh-list
83488626|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83488627|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83488628|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488629|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83488630|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
83488631|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
83488632|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83488633|NCT03809078|Bombesin|bombesin|mesh-list
83488634|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83488635|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488636|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488637|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488638|NCT05316428|Ethanol|ethanol|mesh-list
83488639|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83488640|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488641|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83488642|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488643|NCT03805178|Abatacept|abatacept|mesh-list
83488644|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83488645|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488646|NCT03805178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83488647|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488648|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83488649|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
83488650|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488651|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488652|NCT01303835|Naltrexone|naltrexone|mesh-list
83488653|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83488654|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83488655|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488656|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
83488657|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488659|NCT01250717|Goserelin|goserelin|mesh-list
83488660|NCT01250717|Estramustine|estramustine|mesh-list
83488661|NCT01250717|Docetaxel|docetaxel|mesh-list
83488662|NCT01250717|Bicalutamide|bicalutamide|mesh-list
83488663|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488664|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
83488665|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
83488666|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488667|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488668|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83488669|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
83488670|NCT01250717|Hormones|hormones|mesh-ancestor
83488671|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488672|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83488673|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488674|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
83488675|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
83488676|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
83488677|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488678|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
83488679|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
83488680|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83488681|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
83488682|NCT03804866|Doxorubicin|doxorubicin|mesh-list
83488683|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83488684|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83488685|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488686|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83488687|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83488688|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488689|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488690|NCT01251575|Cyclosporine|cyclosporine|mesh-list
83488691|NCT01251575|Sirolimus|sirolimus|mesh-list
83488692|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
83488693|NCT01251575|Fludarabine|fludarabine|mesh-list
83488694|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
83488695|NCT01251575|Cyclosporins|cyclosporins|mesh-list
83488696|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488697|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83488698|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
83488699|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488700|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83488701|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
83488702|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488703|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488704|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
83488705|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488706|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
83488707|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488708|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83488709|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83488710|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83488711|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
83488712|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83488713|NCT00782756|Bevacizumab|bevacizumab|mesh-list
83488714|NCT00782756|Temozolomide|temozolomide|mesh-list
83488715|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83488716|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488717|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83488718|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83488719|NCT00782756|Growth Substances|growth substances|mesh-ancestor
83488720|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488721|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
83488722|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83488723|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
83488724|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488725|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
83488726|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83488727|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
83488728|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488729|NCT01306175|Empagliflozin|empagliflozin|mesh-list
83488730|NCT01306175|Digoxin|digoxin|mesh-list
83488731|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83488732|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83488734|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488735|NCT01306175|Protective Agents|protective agents|mesh-ancestor
83488736|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488737|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83488738|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83488739|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
83488740|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83488741|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488742|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83488743|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83488744|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83488745|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488746|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
83488747|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488748|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
83488749|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83488750|NCT01216241|Daptomycin|daptomycin|mesh-list
83488751|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83488752|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488753|NCT01216397|Metformin|metformin|mesh-list
83488754|NCT01216397|Linagliptin|linagliptin|mesh-list
83488755|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83488756|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488757|NCT01216397|Incretins|incretins|mesh-ancestor
83488758|NCT01216397|Hormones|hormones|mesh-ancestor
83488759|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488760|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83488761|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
83488762|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488763|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488764|NCT04345406|Chloroquine|chloroquine|mesh-list
83488765|NCT04345406|Enalapril|enalapril|mesh-list
83488766|NCT04345406|Captopril|captopril|mesh-list
83488767|NCT04345406|Amebicides|amebicides|mesh-ancestor
83488768|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83488769|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83488770|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488771|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
83488772|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488773|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83488774|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
83488775|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488776|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488777|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83488778|NCT05621174|Dextroamphetamine|dextroamphetamine|mesh-list
83488779|NCT05621174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83488780|NCT05621174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488781|NCT05621174|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83488782|NCT05621174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83488783|NCT05621174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83488784|NCT05621174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488785|NCT05621174|Dopamine Agents|dopamine agents|mesh-ancestor
83488786|NCT05621174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488787|NCT01216943|Timolol|timolol|mesh-list
83488788|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83488789|NCT01216943|Bimatoprost|bimatoprost|mesh-list
83488790|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83488791|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83488792|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83488793|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83488794|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
83488795|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488796|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488797|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488798|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83488799|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83488800|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83488801|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83488802|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83488803|NCT00783614|Aspirin|aspirin|mesh-list
83488804|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83488805|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83488806|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83488807|NCT00783614|Analgesics|analgesics|mesh-ancestor
83488808|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
83488809|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488810|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488811|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488812|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488813|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83488814|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83488815|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488816|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83488817|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83488818|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488819|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
83488820|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
83488821|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488822|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
83488823|NCT01252745|Testosterone|testosterone|mesh-list
83488824|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
83488825|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
83488826|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83488827|NCT01252745|Androgens|androgens|mesh-ancestor
83488828|NCT01252745|Hormones|hormones|mesh-ancestor
83488829|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488830|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488831|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83488832|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488833|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
83488834|NCT04278872|SJX-653|sjx-653|mesh-list
83488835|NCT04278872|Hormone Antagonists|hormone antagonists|mesh-ancestor
83488836|NCT04278872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488837|NCT04278872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488838|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
83488839|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83488840|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
83488841|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488842|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
83488843|NCT03807596|Protective Agents|protective agents|mesh-ancestor
83488844|NCT01217411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83488845|NCT01217411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83488846|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488847|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488848|NCT01253525|Paclitaxel|paclitaxel|mesh-list
83488849|NCT01253525|Ramucirumab|ramucirumab|mesh-list
83488850|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83488851|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488852|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
83488853|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
83488854|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
83488855|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488856|NCT05310968|Aspirin|aspirin|mesh-list
83488857|NCT05310968|Tirofiban|tirofiban|mesh-list
83488858|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83488859|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83488860|NCT05310968|Analgesics|analgesics|mesh-ancestor
83488861|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
83488862|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488863|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488864|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488865|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488866|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83488867|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83488868|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488869|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83488870|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83488871|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488872|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
83488873|NCT00768716|Acetaminophen|acetaminophen|mesh-list
83488874|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83488875|NCT00768716|Analgesics|analgesics|mesh-ancestor
83488876|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
83488877|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488878|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488879|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
83488880|NCT05743634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83488883|NCT05743634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488884|NCT05743634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488885|NCT05743634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83488886|NCT05743634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83488887|NCT05743634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488889|NCT05743634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488890|NCT05583188|Paclitaxel|paclitaxel|mesh-list
83488891|NCT05583188|Vinorelbine|vinorelbine|mesh-list
83488892|NCT05583188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83488893|NCT05583188|Gemcitabine|gemcitabine|mesh-list
83488894|NCT05583188|Nivolumab|nivolumab|mesh-list
83488895|NCT05583188|Pemetrexed|pemetrexed|mesh-list
83488896|NCT05583188|Carboplatin|carboplatin|mesh-list
83488897|NCT05583188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83488898|NCT05583188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488899|NCT05583188|Tubulin Modulators|tubulin modulators|mesh-ancestor
83488900|NCT05583188|Antimitotic Agents|antimitotic agents|mesh-ancestor
83488901|NCT05583188|Mitosis Modulators|mitosis modulators|mesh-ancestor
83488902|NCT05583188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488903|NCT05583188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83488904|NCT05583188|Antimetabolites|antimetabolites|mesh-ancestor
83488905|NCT05583188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83488906|NCT05583188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83488907|NCT05583188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488908|NCT05583188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83488909|NCT05583188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83488910|NCT01218971|Naltrexone|naltrexone|mesh-list
83488911|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83488912|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83488913|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488914|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
83488915|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488916|NCT05743244|Abrocitinib|abrocitinib|mesh-list
83488917|NCT05743244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83488918|NCT05743244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488919|NCT05743244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488920|NCT01337687|Oxytocin|oxytocin|mesh-list
83488921|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
83488922|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83488923|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488924|NCT04351919|Azithromycin|azithromycin|mesh-list
83488925|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
83488926|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83488927|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488928|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
83488929|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83488930|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83488931|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488932|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488933|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488934|NCT00769886|Ketotifen|ketotifen|mesh-list
83488935|NCT00769886|Naphazoline|naphazoline|mesh-list
83488936|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
83488937|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
83488938|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83488939|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
83488940|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
83488941|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488942|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488943|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488944|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83488945|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83488946|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83488947|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
83488948|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
83488949|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83488950|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
83488951|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83488952|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83488953|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83488954|NCT00794144|Analgesics|analgesics|mesh-ancestor
83488955|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
83488956|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488957|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488958|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488959|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488960|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83488961|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83488962|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83488963|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
83488964|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
83488965|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83488966|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488967|NCT01309451|Dexamethasone|dexamethasone|mesh-list
83488968|NCT01309451|Bevacizumab|bevacizumab|mesh-list
83488969|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83488971|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83488972|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83488973|NCT01309451|Growth Substances|growth substances|mesh-ancestor
83488974|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83488975|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
83488976|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83488977|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
83488978|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
83488979|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488980|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83488981|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
83488982|NCT01309451|Hormones|hormones|mesh-ancestor
83488983|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83488984|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83488985|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
83488986|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
83488987|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83488988|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83488989|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83488990|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83488991|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488992|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83488993|NCT00795002|Cytarabine|cytarabine|mesh-list
83488994|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
83488995|NCT00795002|Alvocidib|alvocidib|mesh-list
83488996|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83488997|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
83488998|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83488999|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489000|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
83489001|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489002|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83489003|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
83489004|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489005|NCT00795002|Analgesics|analgesics|mesh-ancestor
83489006|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
83489007|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489008|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83489009|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83489010|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489011|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
83489012|NCT00795002|Growth Substances|growth substances|mesh-ancestor
83489013|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83489014|NCT05742698|Nabilone|nabilone|mesh-list
83489015|NCT05742698|Antiemetics|antiemetics|mesh-ancestor
83489016|NCT05742698|Autonomic Agents|autonomic agents|mesh-ancestor
83489017|NCT05742698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489018|NCT05742698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489019|NCT05742698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83489020|NCT05742698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83489021|NCT05742698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83489022|NCT05742698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83489023|NCT05742698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83489024|NCT03802838|Amisulpride|amisulpride|mesh-list
83489025|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83489026|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83489027|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83489028|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489029|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83489030|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83489031|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
83489032|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489033|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492386|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
83489034|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83489036|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83489037|NCT00772304|Azelastine|azelastine|mesh-list
83489038|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83489039|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83489040|NCT00772304|Analgesics|analgesics|mesh-ancestor
83489041|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
83489042|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489043|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489044|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83489045|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489046|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83489047|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83489048|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83489049|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
83489050|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
83489051|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489052|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489053|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83489054|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
83489055|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83489056|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
83489057|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83489058|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489059|NCT01310231|Metformin|metformin|mesh-list
83489060|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83489061|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489062|NCT00789074|Varenicline|varenicline|mesh-list
83489063|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83489064|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83489065|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
83489066|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489067|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489068|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489069|NCT01338857|Sorafenib|sorafenib|mesh-list
83489070|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489071|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83489072|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489073|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489074|NCT01339013|Anesthetics|anesthetics|mesh-list
83489075|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83489076|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489077|NCT01339091|Vancomycin|vancomycin|mesh-list
83489078|NCT01339091|Linezolid|linezolid|mesh-list
83489079|NCT01339091|Dalbavancin|dalbavancin|mesh-list
83489080|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83489081|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489082|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83489083|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489084|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489085|NCT01339247|Halofantrine|halofantrine|mesh-list
83489086|NCT01339247|Paroxetine|paroxetine|mesh-list
83489087|NCT01339247|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83489088|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83489089|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83489090|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489091|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489092|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
83489093|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489094|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83489095|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
83489096|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83489097|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83489098|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83489099|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489100|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
83489101|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83489102|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83489103|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489104|NCT00772772|Vitamin D|vitamin d|mesh-list
83489105|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
83489106|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
83489107|NCT00772772|Vitamins|vitamins|mesh-list
83489109|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489110|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83489111|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83489112|NCT00773474|Lonafarnib|lonafarnib|mesh-list
83489113|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489114|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489115|NCT01310855|Gefitinib|gefitinib|mesh-list
83489116|NCT01310855|Cediranib|cediranib|mesh-list
83489117|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489118|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489119|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489120|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83489122|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83489123|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
83489124|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489125|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489126|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83489127|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
83489128|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83489129|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83489130|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83489131|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
83489132|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489133|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489134|NCT01258049|Artemether|artemether|mesh-list
83489135|NCT01258049|Quinine|quinine|mesh-list
83489136|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
83489137|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83489138|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83489139|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489140|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83489141|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489142|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83489143|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489144|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83489145|NCT01258049|Analgesics|analgesics|mesh-ancestor
83489146|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
83489147|NCT03802214|Vedolizumab|vedolizumab|mesh-list
83489148|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83489149|NCT03801746|Cyclosporine|cyclosporine|mesh-list
83489150|NCT03801746|Rifampin|rifampin|mesh-list
83489151|NCT03801746|Probenecid|probenecid|mesh-list
83489152|NCT03801746|Cyclosporins|cyclosporins|mesh-list
83489153|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489154|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489155|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83489156|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
83489157|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489158|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
83489159|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489160|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
83489161|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489162|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83489163|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83489164|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
83489165|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83489166|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
83489167|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83489168|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83489169|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83489170|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83489171|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83489172|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83489173|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83489174|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
83489175|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
83489176|NCT03801668|Paclitaxel|paclitaxel|mesh-list
83489177|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
83489178|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83489179|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83489180|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489181|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
83489182|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
83489183|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
83489184|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489188|NCT05414006|Sensory System Agents|sensory system agents|mesh-ancestor
83489189|NCT05414006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489190|NCT05414006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489191|NCT05414006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83489192|NCT05414006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83489193|NCT05414006|Anesthetics, General|anesthetics, general|mesh-ancestor
83489194|NCT05414006|Anesthetics|anesthetics|mesh-ancestor
83489195|NCT05414006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83489196|NCT05414006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83489197|NCT05414006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83489198|NCT05414006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489199|NCT05414006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489200|NCT05414006|Antidepressive Agents|antidepressive agents|mesh-ancestor
83489201|NCT05414006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83489202|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
83489203|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
83489204|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83489205|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83489206|NCT02199041|Prednisolone|prednisolone|mesh-list
83489207|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
83489208|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
83489209|NCT02199041|Melphalan|melphalan|mesh-list
83489210|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
83489211|NCT02199041|Thiotepa|thiotepa|mesh-list
83489212|NCT02199041|Fludarabine|fludarabine|mesh-list
83489213|NCT02199041|Tacrolimus|tacrolimus|mesh-list
83489214|NCT02199041|Lenograstim|lenograstim|mesh-list
83489215|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83489216|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
83489217|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83489218|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
83489219|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489220|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489221|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83489222|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
83489223|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489224|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489225|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83489226|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83489227|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489228|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83489229|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83489230|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
83489231|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83489232|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489233|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83489234|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
83489235|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
83489236|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489237|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83489238|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
83489239|NCT02199041|Hormones|hormones|mesh-ancestor
83489240|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83489241|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83489242|NCT02199041|Protective Agents|protective agents|mesh-ancestor
83489243|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83489244|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83489245|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
83489246|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
83489247|NCT00789776|Fludarabine|fludarabine|mesh-list
83489248|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
83489249|NCT00789776|Tacrolimus|tacrolimus|mesh-list
83489250|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83489251|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
83489252|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489253|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489254|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83489255|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
83489256|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489257|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489258|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83489259|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83489260|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
83489261|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83489262|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489263|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83489264|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83489265|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
83489266|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83489267|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489268|NCT03801590|Riboflavin|riboflavin|mesh-list
83489269|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
83489270|NCT03801590|Vitamins|vitamins|mesh-ancestor
83489271|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
83489272|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489273|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83489274|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
83489275|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83489276|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83489277|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83489278|NCT00775658|Analgesics|analgesics|mesh-ancestor
83489279|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
83489280|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489281|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489282|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83489283|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489284|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83489285|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83489286|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83489287|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
83489288|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
83489289|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489290|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489291|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83489292|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489293|NCT00799604|Clevidipine|clevidipine|mesh-list
83489294|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83489295|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83489296|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489297|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83489298|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489299|NCT01259063|Gemcitabine|gemcitabine|mesh-list
83489300|NCT01259063|Everolimus|everolimus|mesh-list
83489301|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83489302|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
83489303|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489304|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489305|NCT01259063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83489306|NCT01259063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83489307|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489308|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83489309|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
83489310|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489311|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
83489312|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83489313|NCT04383548|Antibodies|antibodies|mesh-list
83489314|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
83489315|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489316|NCT01313897|Bortezomib|bortezomib|mesh-list
83489317|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489318|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83489319|NCT04351763|Amiodarone|amiodarone|mesh-list
83489320|NCT04351763|Verapamil|verapamil|mesh-list
83489321|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83489322|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
83489323|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83489324|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83489325|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489326|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83489327|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83489328|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83489329|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489330|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83489331|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83489332|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83489333|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83489334|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83489335|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489336|NCT00801398|Oxymorphone|oxymorphone|mesh-list
83489339|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83489340|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489341|NCT00801398|Analgesics|analgesics|mesh-ancestor
83489342|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
83489343|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489344|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83489346|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83489347|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
83489348|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489349|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489350|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83489351|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83489352|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
83489353|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489354|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489355|NCT01342757|Temozolomide|temozolomide|mesh-list
83489356|NCT01342757|Vorinostat|vorinostat|mesh-list
83489357|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83489358|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
83489359|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489360|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489361|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83489362|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489363|NCT02199743|Haloperidol|haloperidol|mesh-list
83489364|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
83489365|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83489366|NCT02199743|Perphenazine|perphenazine|mesh-list
83489367|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
83489368|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
83489369|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489370|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489371|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83489372|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83489373|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83489374|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83489375|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83489376|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83489377|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
83489378|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489379|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489380|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83489381|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83489382|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83489383|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83489384|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
83489385|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83489386|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83489387|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
83489388|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83489389|NCT00776594|Bevacizumab|bevacizumab|mesh-list
83489390|NCT00776594|Bicalutamide|bicalutamide|mesh-list
83489391|NCT00776594|Androgens|androgens|mesh-list
83489392|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83489393|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489394|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83489395|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83489396|NCT00776594|Growth Substances|growth substances|mesh-ancestor
83489397|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489398|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
83489399|NCT00776594|Hormones|hormones|mesh-ancestor
83489400|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83489401|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
83489402|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
83489403|NCT00777062|Naltrexone|naltrexone|mesh-list
83489404|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83489405|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83489406|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489407|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
83489408|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489409|NCT02193347|Temozolomide|temozolomide|mesh-list
83489410|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83489411|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
83489412|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489413|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489414|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83489415|NCT01318967|Furosemide|furosemide|mesh-list
83489416|NCT01318967|Diuretics|diuretics|mesh-ancestor
83489417|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
83489418|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489419|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83489420|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83489421|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489422|NCT01319045|Iloprost|iloprost|mesh-list
83489423|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83489424|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
83489425|NCT01348607|Methylphenidate|methylphenidate|mesh-list
83489426|NCT01348607|Modafinil|modafinil|mesh-list
83489427|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83489428|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489429|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83489430|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83489431|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83489432|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489433|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
83489434|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489435|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83489436|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83489437|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83489438|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
83489439|NCT01268111|Vitamin D|vitamin d|mesh-list
83489440|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83489441|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489442|NCT01268111|Vitamins|vitamins|mesh-ancestor
83489443|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
83489444|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83489445|NCT01349231|Ketamine|ketamine|mesh-list
83489446|NCT01349231|Analgesics|analgesics|mesh-ancestor
83489447|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
83489448|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489449|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489450|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83489451|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83489452|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
83489453|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
83489454|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83489455|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83489456|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83489457|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489458|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489459|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
83489460|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
83489461|NCT01350245|Tacrolimus|tacrolimus|mesh-list
83489462|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83489463|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
83489464|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489465|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489466|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83489467|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
83489468|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489469|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489470|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83489471|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83489472|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489473|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83489474|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83489475|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
83489476|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83489477|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489478|NCT01321151|Resveratrol|resveratrol|mesh-list
83489479|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
83489480|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489481|NCT01321151|Protective Agents|protective agents|mesh-ancestor
83489482|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489483|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489484|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83489485|NCT01350947|Azacitidine|azacitidine|mesh-list
83489486|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83489487|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
83489488|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489489|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489490|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489491|NCT01269047|Exenatide|exenatide|mesh-list
83489492|NCT01269047|Pramlintide|pramlintide|mesh-list
83489493|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83489494|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489495|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83489496|NCT01269047|Incretins|incretins|mesh-ancestor
83489497|NCT01269047|Hormones|hormones|mesh-ancestor
83489498|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83489499|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
83489500|NCT03800264|Bisoprolol|bisoprolol|mesh-list
83489501|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83489502|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83489503|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
83489504|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
83489505|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489506|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489507|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83489508|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83489509|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83489510|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
83489511|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489512|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489513|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
83489514|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83489515|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
83489516|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489517|NCT05287724|Expectorants|expectorants|mesh-ancestor
83489518|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
83489519|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83489520|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
83489521|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489522|NCT05287724|Protective Agents|protective agents|mesh-ancestor
83489523|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489524|NCT05287724|Antidotes|antidotes|mesh-ancestor
83489525|NCT01321541|Rituximab|rituximab|mesh-list
83489526|NCT01321541|Gemcitabine|gemcitabine|mesh-list
83489527|NCT01321541|Pixantrone|pixantrone|mesh-list
83489528|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83489529|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489530|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
83489531|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489532|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489533|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83489534|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
83489535|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489536|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83489537|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83489538|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489539|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83489540|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83489541|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489542|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489543|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
83489544|NCT05201612|Olaparib|olaparib|mesh-list
83489545|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83489546|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489547|NCT05201612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83489548|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489549|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83489550|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489551|NCT01271855|Glycerol|glycerol|mesh-list
83489552|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489553|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83489554|NCT01271855|Protective Agents|protective agents|mesh-ancestor
83489555|NCT04865978|Warfarin|warfarin|mesh-list
83489556|NCT04865978|Apixaban|apixaban|mesh-list
83489557|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
83489558|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83489559|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
83489560|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83489561|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
83489562|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489563|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489565|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83489566|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83489568|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
83489569|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489570|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489571|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83489572|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489573|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83489574|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83489575|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489576|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489577|NCT05168462|Norepinephrine|norepinephrine|mesh-list
83489578|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83489579|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83489580|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
83489581|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489582|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489583|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489584|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
83489585|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
83489586|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489587|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83489588|NCT02196857|Azacitidine|azacitidine|mesh-list
83489589|NCT02196857|Sorafenib|sorafenib|mesh-list
83489590|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83489591|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
83489592|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489593|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489594|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489595|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83489596|NCT01272245|Cytarabine|cytarabine|mesh-list
83489597|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
83489598|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83489599|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
83489600|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489601|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489602|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
83489603|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489604|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83489605|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
83489606|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489607|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83489608|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83489609|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489610|NCT00802100|Metformin|metformin|mesh-list
83489611|NCT00802100|Benztropine|benztropine|mesh-list
83489612|NCT00802100|Olanzapine|olanzapine|mesh-list
83489613|NCT00802100|Aripiprazole|aripiprazole|mesh-list
83489614|NCT00802100|Perphenazine|perphenazine|mesh-list
83489615|NCT00802100|Simvastatin|simvastatin|mesh-list
83489616|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83489617|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489618|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83489619|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83489620|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
83489621|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489622|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83489623|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83489624|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489625|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
83489626|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
83489627|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489628|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83489629|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83489630|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83489631|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83489632|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83489633|NCT00802100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83489634|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83489635|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83489636|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489637|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
83489638|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
83489639|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
83489641|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83489642|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83489643|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83489644|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83489645|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83489646|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83489647|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83489648|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83489649|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
83489650|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83489651|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83489652|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
83489653|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83489654|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
83489655|NCT00809276|Busulfan|busulfan|mesh-list
83489656|NCT00809276|Fludarabine|fludarabine|mesh-list
83489657|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83489658|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
83489659|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489660|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489661|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83489662|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
83489663|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489664|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489665|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83489666|NCT00802412|Topiramate|topiramate|mesh-list
83489667|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
83489668|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83489669|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489670|NCT01355705|Aspirin|aspirin|mesh-list
83489671|NCT01355705|Dexamethasone|dexamethasone|mesh-list
83489672|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
83489673|NCT01355705|Lenalidomide|lenalidomide|mesh-list
83489674|NCT01355705|Amrubicin|amrubicin|mesh-list
83489675|NCT01355705|BB 1101|bb 1101|mesh-list
83489676|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83489677|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
83489678|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
83489679|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489680|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489681|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83489682|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
83489683|NCT01355705|Hormones|hormones|mesh-ancestor
83489684|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83489685|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83489686|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489687|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
83489688|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489689|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489690|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83489691|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83489692|NCT01355705|Analgesics|analgesics|mesh-ancestor
83489693|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
83489694|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489695|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83489696|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83489697|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83489698|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83489699|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
83489700|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
83489701|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83489702|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83489703|NCT01355705|Growth Substances|growth substances|mesh-ancestor
83489704|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
83489705|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
83489706|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489707|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
83489708|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
83489709|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
83489710|NCT00802880|Dacarbazine|dacarbazine|mesh-list
83489711|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83489712|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
83489713|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489714|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489715|NCT05118854|Cisplatin|cisplatin|mesh-list
83489716|NCT05118854|Carboplatin|carboplatin|mesh-list
83489717|NCT05118854|Pemetrexed|pemetrexed|mesh-list
83489719|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489720|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489721|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489722|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83489723|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83489724|NCT05118854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83489725|NCT05118854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83489727|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83489728|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83489729|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83489730|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
83489731|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489732|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489733|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83489734|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
83489735|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
83489736|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
83489737|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83489738|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83489739|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
83489740|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489741|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489742|NCT05089526|Lidocaine|lidocaine|mesh-list
83489743|NCT05089526|Fentanyl|fentanyl|mesh-list
83489744|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
83489745|NCT05089526|Ketamine|ketamine|mesh-list
83489746|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
83489747|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
83489748|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83489749|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489750|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
83489751|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489752|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83489753|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83489754|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83489755|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83489756|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489757|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83489758|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83489759|NCT05089526|Analgesics|analgesics|mesh-ancestor
83489760|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83489761|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83489762|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83489763|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
83489764|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489765|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83489766|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83489767|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
83489768|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83489769|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83489770|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83489771|NCT05089526|Narcotics|narcotics|mesh-ancestor
83489772|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83489773|NCT04645550|Aspirin|aspirin|mesh-list
83489774|NCT04645550|Heparin|heparin|mesh-list
83489775|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83489776|NCT04645550|Tinzaparin|tinzaparin|mesh-list
83489777|NCT04645550|Dalteparin|dalteparin|mesh-list
83489778|NCT04645550|Dipyridamole|dipyridamole|mesh-list
83489779|NCT04645550|Warfarin|warfarin|mesh-list
83489780|NCT04645550|Apixaban|apixaban|mesh-list
83489781|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83489782|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83489783|NCT04645550|Analgesics|analgesics|mesh-ancestor
83489784|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
83489785|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489786|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489787|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83489788|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489789|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83489790|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83489791|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489792|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83489793|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83489799|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83489800|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
83489801|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83489802|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
83489803|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
83489804|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83489805|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489806|NCT05032820|Lenalidomide|lenalidomide|mesh-list
83489807|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
83489808|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489809|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83489810|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83489811|NCT05032820|Growth Substances|growth substances|mesh-ancestor
83489812|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
83489813|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489814|NCT01274897|Lactitol|lactitol|mesh-list
83489815|NCT01274897|Cathartics|cathartics|mesh-ancestor
83489816|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83489817|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
83489818|NCT02323217|Idazoxan|idazoxan|mesh-list
83489819|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83489820|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83489821|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83489822|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
83489823|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489824|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489825|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489826|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
83489827|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83489828|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83489829|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489830|NCT04382768|Ibuprofen|ibuprofen|mesh-list
83489831|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83489832|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83489833|NCT04382768|Analgesics|analgesics|mesh-ancestor
83489834|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
83489835|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489836|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489837|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83489838|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83489839|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83489840|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489841|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489842|NCT03932162|Insulin|insulin|mesh-list
83489843|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83489844|NCT03932162|Mitogens|mitogens|mesh-list
83489845|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83489846|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489847|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
83489848|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489849|NCT04155164|Metformin|metformin|mesh-list
83489850|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83489851|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489852|NCT00806078|Quinine|quinine|mesh-list
83489853|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
83489854|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83489855|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83489856|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489857|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83489858|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489859|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83489860|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489861|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83489862|NCT00806078|Analgesics|analgesics|mesh-ancestor
83489863|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
83489864|NCT00806234|Metformin|metformin|mesh-list
83489865|NCT00806234|Olanzapine|olanzapine|mesh-list
83489866|NCT00806234|Risperidone|risperidone|mesh-list
83489867|NCT00806234|Aripiprazole|aripiprazole|mesh-list
83489868|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83489869|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83489870|NCT00806234|Ziprasidone|ziprasidone|mesh-list
83489871|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83489872|NCT00806234|Asenapine|asenapine|mesh-list
83489873|NCT00806234|Iloperidone|iloperidone|mesh-list
83489874|NCT00806234|Perphenazine|perphenazine|mesh-list
83489875|NCT00806234|Fluoxetine|fluoxetine|mesh-list
83489876|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83489877|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489878|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83489879|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
83489880|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489881|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489882|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83489883|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83489884|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83489885|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83489886|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83489887|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
83489888|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
83489889|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
83489890|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489891|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83489892|NCT00806234|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83489893|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83489894|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83489895|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
83489896|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
83489897|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83489898|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83489899|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83489900|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83489901|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83489902|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83489903|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83489904|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489905|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83489906|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83489907|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83489908|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
83489909|NCT04493138|Azacitidine|azacitidine|mesh-list
83489910|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83489911|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
83489912|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489913|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489914|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489915|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
83489916|NCT01275365|Testosterone|testosterone|mesh-list
83489917|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
83489918|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
83489919|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83489920|NCT01275365|Androgens|androgens|mesh-ancestor
83489921|NCT01275365|Hormones|hormones|mesh-ancestor
83489922|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83489923|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489924|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83489925|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489926|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
83489927|NCT00811850|Timolol|timolol|mesh-list
83489928|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83489929|NCT00811850|Dorzolamide|dorzolamide|mesh-list
83489930|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83489931|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83489932|NCT00811850|Maleic acid|maleic acid|mesh-list
83489933|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489934|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489935|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83489936|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83489937|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
83489938|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489939|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489940|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83489941|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83489942|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83489943|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83489944|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83489945|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83489946|NCT03678506|Apixaban|apixaban|mesh-list
83489947|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83489948|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
83489949|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83489950|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
83489952|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489953|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
83489954|NCT00844298|Cytarabine|cytarabine|mesh-list
83489955|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83489956|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
83489957|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489958|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489959|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
83489960|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489961|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83489962|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
83489963|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489964|NCT01329185|Valganciclovir|valganciclovir|mesh-list
83489965|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
83489966|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83489967|NCT01276301|Empagliflozin|empagliflozin|mesh-list
83489968|NCT01276301|Verapamil|verapamil|mesh-list
83489969|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83489970|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489971|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83489972|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489973|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83489974|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83489975|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83489976|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83489977|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
83489978|NCT00845000|Levodopa|levodopa|mesh-list
83489979|NCT00845000|Carbidopa|carbidopa|mesh-list
83489980|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83489981|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83489982|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
83489983|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489984|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83489985|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489986|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83489987|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83489988|NCT01330043|Bupropion|bupropion|mesh-list
83489989|NCT01330043|Nicotine|nicotine|mesh-list
83489990|NCT01330043|Varenicline|varenicline|mesh-list
83489991|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83489992|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
83489993|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83489994|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83489995|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83489996|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83489997|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
83489998|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83489999|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490000|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83490001|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
83490002|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83490003|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83490004|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83490005|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83490006|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
83490007|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83490008|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83490009|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490010|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
83490011|NCT01330355|Besifloxacin|besifloxacin|mesh-list
83490012|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83490013|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490014|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83490015|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83490016|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83490017|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83490018|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490019|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490020|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490021|NCT02193815|Calcitriol|calcitriol|mesh-list
83490022|NCT02193815|Calcipotriene|calcipotriene|mesh-list
83490023|NCT02193815|Tofacitinib|tofacitinib|mesh-list
83490024|NCT02193815|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83490025|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83490026|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490027|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490028|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
83490029|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83490030|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490031|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83490032|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83490033|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83490034|NCT02193815|Vitamins|vitamins|mesh-ancestor
83490035|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
83490036|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83490037|NCT01277081|Acetaminophen|acetaminophen|mesh-list
83490038|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83490039|NCT01277081|Analgesics|analgesics|mesh-ancestor
83490040|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
83490041|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490042|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490043|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
83490044|NCT01361633|Cycloserine|cycloserine|mesh-list
83490045|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83490046|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490047|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83490048|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
83490049|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83490050|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
83490051|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490052|NCT01331213|Pregabalin|pregabalin|mesh-list
83490053|NCT01331213|Analgesics|analgesics|mesh-ancestor
83490054|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
83490055|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490056|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490057|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
83490058|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83490059|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83490060|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490061|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83490062|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83490063|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83490064|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490065|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83490066|NCT01332071|Metformin|metformin|mesh-list
83490067|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
83490068|NCT01332071|Maleic acid|maleic acid|mesh-list
83490069|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83490070|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490071|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490072|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490073|NCT01277159|Dexamethasone|dexamethasone|mesh-list
83490074|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
83490075|NCT01277159|Buprenorphine|buprenorphine|mesh-list
83490076|NCT01277159|BB 1101|bb 1101|mesh-list
83490077|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83490078|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
83490079|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
83490080|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490081|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490082|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83490083|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
83490084|NCT01277159|Hormones|hormones|mesh-ancestor
83490085|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490086|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83490087|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490088|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
83490089|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490090|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490091|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83490092|NCT01277159|Narcotics|narcotics|mesh-ancestor
83490093|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490094|NCT01277159|Analgesics|analgesics|mesh-ancestor
83490095|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
83490096|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83490097|NCT01362959|Nicotine|nicotine|mesh-list
83490098|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83490099|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
83490100|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490101|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490105|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490106|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490107|NCT01332461|Fluticasone|fluticasone|mesh-list
83490108|NCT01332461|Xhance|xhance|mesh-list
83490109|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83490110|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83490111|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83490112|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
83490113|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490114|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490115|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83490116|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
83490117|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
83490118|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83490119|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83490120|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83490121|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83490122|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
83490123|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490124|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490125|NCT01279187|Teriparatide|teriparatide|mesh-list
83490126|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83490127|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490128|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83490129|NCT01280123|Pioglitazone|pioglitazone|mesh-list
83490130|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83490131|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490132|NCT03608696|Buprenorphine|buprenorphine|mesh-list
83490133|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83490134|NCT03608696|Narcotics|narcotics|mesh-ancestor
83490135|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490136|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490137|NCT03608696|Analgesics|analgesics|mesh-ancestor
83490138|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
83490139|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490140|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83490141|NCT01334723|Finasteride|finasteride|mesh-list
83490142|NCT01334723|Dutasteride|dutasteride|mesh-list
83490143|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
83490144|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83490145|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490146|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490147|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
83490148|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490149|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490150|NCT01334723|Urological Agents|urological agents|mesh-ancestor
83490151|NCT04311710|Nivolumab|nivolumab|mesh-list
83490152|NCT04311710|Ipilimumab|ipilimumab|mesh-list
83490153|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83490154|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490155|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83490156|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490157|NCT01334957|Ibuprofen|ibuprofen|mesh-list
83490158|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83490159|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83490160|NCT01334957|Analgesics|analgesics|mesh-ancestor
83490161|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
83490162|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490163|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490164|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83490165|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83490166|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83490167|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490168|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490169|NCT01402427|Verapamil|verapamil|mesh-list
83490170|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83490171|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83490172|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83490173|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490174|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83490175|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490176|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
83490177|NCT03637400|Doxycycline|doxycycline|mesh-list
83490180|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83490181|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490182|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
83490183|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83490184|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83490185|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83490186|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83490187|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490188|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490189|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83490190|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83490191|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83490192|NCT01365611|Fluticasone|fluticasone|mesh-list
83490194|NCT01365611|Ketorolac|ketorolac|mesh-list
83490195|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83490196|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83490197|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83490198|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
83490199|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490200|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490201|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83490202|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
83490203|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
83490204|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83490205|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83490206|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83490207|NCT01365611|Analgesics|analgesics|mesh-ancestor
83490208|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
83490209|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83490210|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83490211|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490212|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490213|NCT01472549|Ethanol|ethanol|mesh-list
83490214|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
83490215|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83490216|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490217|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490218|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490219|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
83490220|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83490221|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83490222|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490223|NCT01404923|Mebeverine|mebeverine|mesh-list
83490224|NCT01404923|Alverine|alverine|mesh-list
83490225|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
83490226|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
83490227|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490228|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490229|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
83490230|NCT01368263|Letrozole|letrozole|mesh-list
83490231|NCT01368263|Anastrozole|anastrozole|mesh-list
83490232|NCT01368263|Goserelin|goserelin|mesh-list
83490233|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490234|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83490235|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83490236|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490237|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490238|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83490239|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
83490240|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490241|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490242|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83490243|NCT00815360|Triamcinolone|triamcinolone|mesh-list
83490244|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83490245|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83490247|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83490248|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83490249|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83490250|NCT00815360|Growth Substances|growth substances|mesh-ancestor
83490251|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490252|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
83490253|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490254|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83490255|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
83490256|NCT00815360|Hormones|hormones|mesh-ancestor
83492464|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490257|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490258|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83490259|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
83490260|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490261|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490262|NCT01474109|Macitentan|macitentan|mesh-list
83490263|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83490264|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83490265|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490266|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83490267|NCT01405937|Ribavirin|ribavirin|mesh-list
83490268|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
83490269|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490270|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
83490271|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490272|NCT01368653|Nicotine|nicotine|mesh-list
83490273|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83490274|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
83490275|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490276|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490277|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83490278|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83490279|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
83490280|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490281|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490282|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
83490283|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
83490284|NCT01368809|Fentanyl|fentanyl|mesh-list
83490285|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83490286|NCT01368809|Narcotics|narcotics|mesh-ancestor
83490287|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490288|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490289|NCT01368809|Analgesics|analgesics|mesh-ancestor
83490290|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
83490291|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490292|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83490293|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83490294|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
83490295|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
83490296|NCT01369745|Prednisone|prednisone|mesh-list
83490297|NCT01369745|Prednisolone|prednisolone|mesh-list
83490298|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83490299|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
83490300|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83490301|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
83490302|NCT01369745|Dipyridamole|dipyridamole|mesh-list
83490303|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83490304|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
83490305|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83490306|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
83490307|NCT01369745|Hormones|hormones|mesh-ancestor
83490308|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490309|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490310|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83490311|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490312|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
83490313|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
83490314|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490315|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83490316|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83490317|NCT01369745|Protective Agents|protective agents|mesh-ancestor
83490318|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83490319|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490320|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490321|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83490322|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
83490323|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
83490324|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83490325|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83490326|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490327|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83490328|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83490329|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490330|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490331|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490332|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83490333|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
83490334|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83490335|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490336|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83490337|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83490338|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83490339|NCT01407575|Buprenorphine|buprenorphine|mesh-list
83490340|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83490341|NCT01407575|Narcotics|narcotics|mesh-ancestor
83490342|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490343|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490344|NCT01407575|Analgesics|analgesics|mesh-ancestor
83490345|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
83490346|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490347|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83490348|NCT01476449|Ranibizumab|ranibizumab|mesh-list
83490349|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83490350|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83490351|NCT01476449|Growth Substances|growth substances|mesh-ancestor
83490352|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490353|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
83490354|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490355|NCT01370369|Testosterone|testosterone|mesh-list
83490356|NCT01370369|Androgens|androgens|mesh-ancestor
83490357|NCT01370369|Hormones|hormones|mesh-ancestor
83490358|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490359|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490360|NCT01477463|Vitamin D|vitamin d|mesh-list
83490361|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
83490362|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
83490363|NCT01477463|Vitamins|vitamins|mesh-list
83490364|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
83490365|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490366|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83490367|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83490368|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83490369|NCT02203565|Eusol|eusol|mesh-list
83490370|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83490371|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
83490372|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490373|NCT01375127|Tofacitinib|tofacitinib|mesh-list
83490374|NCT01375127|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83490375|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83490376|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490377|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490378|NCT00857714|Lapatinib|lapatinib|mesh-list
83490379|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490380|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83490381|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490382|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490383|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
83490384|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83490385|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83490386|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
83490387|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490388|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83490389|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83490390|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490391|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490392|NCT01376297|Dexamethasone|dexamethasone|mesh-list
83490393|NCT01376297|Aprepitant|aprepitant|mesh-list
83490394|NCT01376297|Palonosetron|palonosetron|mesh-list
83490395|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83490396|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
83490397|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
83490398|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490399|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490400|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83490401|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
83490402|NCT01376297|Hormones|hormones|mesh-ancestor
83490403|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490404|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83490405|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490406|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83490407|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490408|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490409|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83490410|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83490411|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
83490412|NCT00859040|Pasireotide|pasireotide|mesh-list
83490413|NCT00859040|Hormones|hormones|mesh-ancestor
83490414|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490415|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490416|NCT02669186|Fentanyl|fentanyl|mesh-list
83490417|NCT02669186|Bupivacaine|bupivacaine|mesh-list
83490418|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
83490419|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
83490420|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490421|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490422|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
83490423|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490424|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83490425|NCT02669186|Narcotics|narcotics|mesh-ancestor
83490426|NCT02669186|Analgesics|analgesics|mesh-ancestor
83490427|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83490428|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83490429|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
83490430|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83490431|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83490432|NCT00859508|Estradiol|estradiol|mesh-list
83490433|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83490434|NCT00859508|Estrogens|estrogens|mesh-ancestor
83490435|NCT00859508|Hormones|hormones|mesh-ancestor
83490436|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490437|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490438|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83490439|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
83490440|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83490441|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83490442|NCT01377467|Denosumab|denosumab|mesh-list
83490443|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83490444|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490445|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
83490446|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83490447|NCT02348762|Glycine|glycine|mesh-list
83490448|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
83490449|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490450|NCT02348762|Expectorants|expectorants|mesh-ancestor
83490451|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
83490452|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83490453|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
83490454|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490455|NCT02348762|Protective Agents|protective agents|mesh-ancestor
83490456|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490457|NCT02348762|Antidotes|antidotes|mesh-ancestor
83490458|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
83490459|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490460|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
83490461|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83490462|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490463|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490464|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83490465|NCT01377623|Analgesics|analgesics|mesh-ancestor
83490466|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
83490467|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490468|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83490469|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83490470|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83490471|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
83490472|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490473|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490474|NCT01486043|Metformin|metformin|mesh-list
83490475|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83490476|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490477|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
83490478|NCT01490723|Rituximab|rituximab|mesh-list
83490479|NCT01490723|Methotrexate|methotrexate|mesh-list
83490480|NCT01490723|Fludarabine|fludarabine|mesh-list
83490481|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
83490482|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83490483|NCT01490723|Tacrolimus|tacrolimus|mesh-list
83490487|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83490488|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490489|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
83490490|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490491|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83490492|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83490493|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
83490494|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83490495|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83490496|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
83490497|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490498|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
83490499|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490500|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83490501|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83490502|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83490503|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490504|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83490505|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83490506|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83490507|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
83490508|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83490509|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83490510|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
83490511|NCT01491113|Levetiracetam|levetiracetam|mesh-list
83490512|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
83490513|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
83490514|NCT03839498|Axitinib|axitinib|mesh-list
83490515|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490516|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83490517|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490518|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490519|NCT02252432|Ketamine|ketamine|mesh-list
83490520|NCT02252432|Methadone|methadone|mesh-list
83490521|NCT02252432|Analgesics|analgesics|mesh-ancestor
83490522|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
83490523|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490524|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490525|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83490526|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83490527|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
83490528|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
83490529|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490530|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83490531|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83490532|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490533|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490534|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83490535|NCT02252432|Narcotics|narcotics|mesh-ancestor
83490536|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
83490537|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
83490538|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
83490539|NCT01492673|Bevacizumab|bevacizumab|mesh-list
83490540|NCT01492673|Topotecan|topotecan|mesh-list
83490541|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83490542|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
83490543|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490544|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83490545|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83490546|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
83490547|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490548|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490549|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83490550|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83490551|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83490552|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83490553|NCT01492673|Growth Substances|growth substances|mesh-ancestor
83490554|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
83490555|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83490556|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83490557|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490558|NCT00818324|Rebamipide|rebamipide|mesh-list
83490559|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83490560|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83490561|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
83490562|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490563|NCT00818324|Protective Agents|protective agents|mesh-ancestor
83490564|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490565|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490567|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83490568|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
83490569|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
83490570|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490571|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490572|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
83490573|NCT02155010|Bupivacaine|bupivacaine|mesh-list
83490574|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
83490575|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
83490576|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490577|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490578|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
83490579|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490580|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83490581|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83490582|NCT02155010|Analgesics|analgesics|mesh-ancestor
83490583|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83490584|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83490585|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83490586|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
83490587|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490588|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490589|NCT01495481|Adenosine|adenosine|mesh-list
83490590|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
83490591|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83490592|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490593|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490594|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83490595|NCT01495481|Analgesics|analgesics|mesh-ancestor
83490596|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
83490597|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490598|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83490599|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83490600|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83490601|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
83490602|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490603|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490604|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83490605|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
83490606|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83490607|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
83490608|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
83490609|NCT01379183|Erythromycin|erythromycin|mesh-list
83490610|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
83490611|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83490612|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
83490613|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83490614|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490615|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83490616|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83490617|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490618|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490619|NCT01380197|Morphine|morphine|mesh-list
83490620|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83490621|NCT01380197|Narcotics|narcotics|mesh-ancestor
83490622|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490623|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490624|NCT01380197|Analgesics|analgesics|mesh-ancestor
83490625|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
83490626|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490628|NCT00862784|Folic Acid|folic acid|mesh-list
83490629|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
83490630|NCT00862784|Fluorouracil|fluorouracil|mesh-list
83490631|NCT00862784|Ramucirumab|ramucirumab|mesh-list
83490632|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83490633|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
83490634|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490635|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
83490636|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490637|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83490638|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83490639|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
83490640|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490641|NCT00862784|Antidotes|antidotes|mesh-ancestor
83490642|NCT00862784|Protective Agents|protective agents|mesh-ancestor
83490643|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
83490644|NCT00862784|Vitamins|vitamins|mesh-ancestor
83490645|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
83490646|NCT00862784|Hematinics|hematinics|mesh-ancestor
83490647|NCT00864032|Sorafenib|sorafenib|mesh-list
83490648|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490649|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83490650|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490651|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490652|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83490653|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83490654|NCT00820664|Estradiol|estradiol|mesh-list
83490655|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83490656|NCT00820664|Estrogens|estrogens|mesh-ancestor
83490657|NCT00820664|Hormones|hormones|mesh-ancestor
83490658|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490659|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490660|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83490661|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
83490662|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83490663|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83490664|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
83490665|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
83490666|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490667|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490668|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490669|NCT01419977|Dalteparin|dalteparin|mesh-list
83490670|NCT01419977|Tinzaparin|tinzaparin|mesh-list
83490671|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83490672|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
83490673|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83490674|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83490675|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490676|NCT01499147|Vidarabine|vidarabine|mesh-list
83490677|NCT01499147|Fludarabine|fludarabine|mesh-list
83490678|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
83490679|NCT01499147|Melphalan|melphalan|mesh-list
83490680|NCT01499147|Busulfan|busulfan|mesh-list
83490681|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
83490682|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490683|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83490684|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
83490685|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490686|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83490687|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
83490688|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490689|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
83490690|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490691|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83490692|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
83490693|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83490694|NCT00823082|Antithrombins|antithrombins|mesh-list
83490695|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
83490696|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83490697|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
83490698|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490699|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490700|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
83490701|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
83490702|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83490703|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490704|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490705|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83490706|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83490707|NCT01382303|Protective Agents|protective agents|mesh-ancestor
83490708|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490709|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
83490710|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83490711|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
83490712|NCT05236634|Tadalafil|tadalafil|mesh-list
83490713|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
83490714|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83490715|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
83490716|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83490717|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490718|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490719|NCT05236634|Urological Agents|urological agents|mesh-ancestor
83490720|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83490721|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83490722|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490723|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490724|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
83490725|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83490726|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83490727|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83490728|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490729|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
83490730|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490731|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490732|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83490733|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490734|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
83490735|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83490736|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
83490737|NCT00865202|Tryptophan|tryptophan|mesh-list
83490738|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83490739|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
83490740|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83490741|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
83490742|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83490743|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
83490744|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490745|NCT01424033|Expectorants|expectorants|mesh-ancestor
83490746|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
83490747|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83490748|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
83490749|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490750|NCT01424033|Protective Agents|protective agents|mesh-ancestor
83490751|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490752|NCT01424033|Antidotes|antidotes|mesh-ancestor
83490753|NCT01503749|Lenograstim|lenograstim|mesh-list
83490754|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83490755|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
83490756|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490757|NCT00867932|Eculizumab|eculizumab|mesh-list
83490758|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83490759|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83490760|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
83490761|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490762|NCT00825266|Pioglitazone|pioglitazone|mesh-list
83490763|NCT00825266|Bosentan|bosentan|mesh-list
83490764|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83490765|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490766|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83490767|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83490768|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490769|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83490770|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83490771|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
83490772|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490773|NCT01385189|Antacids|antacids|mesh-ancestor
83490774|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490775|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83490776|NCT01386983|Finasteride|finasteride|mesh-list
83490777|NCT01386983|Dutasteride|dutasteride|mesh-list
83490778|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83490779|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83490780|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490781|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490782|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
83490783|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490784|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490785|NCT01386983|Urological Agents|urological agents|mesh-ancestor
83490786|NCT01387139|Ketamine|ketamine|mesh-list
83490787|NCT01387139|Propofol|propofol|mesh-list
83490788|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83490789|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490790|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490791|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83490792|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
83490793|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
83490794|NCT01387139|Analgesics|analgesics|mesh-ancestor
83490795|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
83490796|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490797|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83490798|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83490799|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83490800|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490801|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490802|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
83490803|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83490804|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
83490805|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490806|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490807|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83490808|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
83490809|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
83490810|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83490811|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
83490812|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490813|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490814|NCT00825344|Etanercept|etanercept|mesh-list
83490815|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83490816|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83490817|NCT00825344|Analgesics|analgesics|mesh-ancestor
83490818|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
83490819|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490820|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490821|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83490822|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83490823|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83490824|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83490825|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
83490826|NCT01426763|Complement C1s|complement c1s|mesh-list
83490827|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83490828|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83490829|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
83490830|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490831|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83490832|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83490833|NCT00825500|Loxapine|loxapine|mesh-list
83490834|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83490835|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83490836|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490837|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490838|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83490839|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83490840|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
83490841|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490842|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490843|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
83490844|NCT01505933|Propofol|propofol|mesh-list
83490845|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83490846|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490847|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490848|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83490849|NCT01505933|Analgesics|analgesics|mesh-ancestor
83490850|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
83490851|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490852|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83490853|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83490854|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83490855|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
83490856|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490857|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490858|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83490859|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
83490860|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
83490861|NCT00825734|Sorafenib|sorafenib|mesh-list
83490862|NCT00825734|Epothilones|epothilones|mesh-list
83490863|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490864|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83490865|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490866|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490867|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
83490868|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
83490869|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
83490870|NCT00872534|Aspirin|aspirin|mesh-list
83490871|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83490872|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83490873|NCT00872534|Analgesics|analgesics|mesh-ancestor
83490874|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
83490875|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490876|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490877|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83490878|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83490879|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83490880|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83490881|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490882|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83490883|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83490884|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490885|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
83490886|NCT02513160|Beclomethasone|beclomethasone|mesh-list
83490887|NCT02513160|Albuterol|albuterol|mesh-list
83490888|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83490889|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
83490890|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490891|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490892|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83490893|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
83490894|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
83490895|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83490896|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83490897|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83490898|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83490899|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
83490900|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490901|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490902|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83490903|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
83490904|NCT02513160|Hormones|hormones|mesh-ancestor
83490905|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490906|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
83490907|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83490908|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
83490909|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490910|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83490911|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83490912|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
83490913|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490914|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490915|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83490916|NCT02480010|Pertuzumab|pertuzumab|mesh-list
83490917|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83490918|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490919|NCT00876200|Minoxidil|minoxidil|mesh-list
83490920|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83490921|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
83490922|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
83490923|NCT02512302|Bromides|bromides|mesh-list
83490924|NCT02512302|Charcoal|charcoal|mesh-list
83490925|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
83490926|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83490927|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83490928|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83490929|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
83490930|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490931|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490932|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490933|NCT02512302|Antidotes|antidotes|mesh-ancestor
83490934|NCT02512302|Protective Agents|protective agents|mesh-ancestor
83490935|NCT01507181|Midazolam|midazolam|mesh-list
83490936|NCT01507181|Ketamine|ketamine|mesh-list
83490937|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
83490940|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
83490941|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490942|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490943|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83490944|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83490945|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
83490946|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
83490947|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83490948|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83490949|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490950|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490951|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83490952|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83490953|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83490954|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83490955|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83490956|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
83490957|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
83490958|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83490959|NCT01428245|Estradiol|estradiol|mesh-list
83490960|NCT01428245|Estrogens|estrogens|mesh-list
83490961|NCT01428245|Progesterone|progesterone|mesh-list
83490962|NCT01428245|Hormones|hormones|mesh-ancestor
83490963|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83490964|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490965|NCT01428245|Progestins|progestins|mesh-ancestor
83490966|NCT00877370|Ertapenem|ertapenem|mesh-list
83490967|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83490968|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490969|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83490970|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83490971|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83490972|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
83490973|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490974|NCT01508117|Axitinib|axitinib|mesh-list
83490975|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83490976|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83490977|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83490978|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490979|NCT00878228|Ondansetron|ondansetron|mesh-list
83490980|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
83490981|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
83490982|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83490983|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83490984|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83490985|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
83490986|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
83490987|NCT00878228|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83490988|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83490989|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
83490990|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83490991|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83490992|NCT01391273|Bimatoprost|bimatoprost|mesh-list
83490993|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83490994|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83490995|NCT01429259|Meropenem|meropenem|mesh-list
83490996|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83490997|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83490998|NCT05177198|Clindamycin|clindamycin|mesh-list
83490999|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
83491000|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
83491001|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83491002|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491003|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83491004|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491005|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491006|NCT01392989|Cyclosporine|cyclosporine|mesh-list
83491007|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
83491008|NCT01392989|Cyclosporins|cyclosporins|mesh-list
83491009|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
83491010|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83491011|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491012|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491013|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83491014|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
83491015|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491016|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
83491017|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491018|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
83491019|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83491020|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83491021|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83491022|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491023|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83491024|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
83491025|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83491026|NCT01393457|Levodopa|levodopa|mesh-list
83491027|NCT01393457|Carbidopa|carbidopa|mesh-list
83491028|NCT01393457|Ropinirole|ropinirole|mesh-list
83491029|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83491030|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83491031|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
83491032|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491033|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491034|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491035|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83491036|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491037|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
83491038|NCT02518464|Ticagrelor|ticagrelor|mesh-list
83491039|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83491040|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83491041|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83491042|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83491043|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
83491044|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491045|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491046|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491047|NCT02479230|Gemcitabine|gemcitabine|mesh-list
83491048|NCT02479230|Vaccines|vaccines|mesh-list
83491049|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
83491050|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491051|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83491052|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
83491053|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491054|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491055|NCT04985136|Sorafenib|sorafenib|mesh-list
83491056|NCT04985136|Apatinib|apatinib|mesh-list
83491057|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491058|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83491059|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491060|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491061|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
83491062|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83491063|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83491064|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491065|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
83491066|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491067|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491068|NCT04411446|Vitamin D|vitamin d|mesh-list
83491069|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
83491070|NCT04411446|Vitamins|vitamins|mesh-ancestor
83491071|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
83491072|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491073|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83491074|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83491075|NCT01510379|Promethazine|promethazine|mesh-list
83491076|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
83491077|NCT01510379|Ondansetron|ondansetron|mesh-list
83491078|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
83491079|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
83491080|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491081|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491082|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83491083|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
83491084|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
83491085|NCT01510379|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83491086|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83491087|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
83491088|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491089|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491090|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83491091|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
83491092|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
83491093|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83491094|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83491095|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83491096|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83491097|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
83491098|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
83491099|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
83491100|NCT01363986|Trastuzumab|trastuzumab|mesh-list
83491101|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83491102|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491103|NCT01510457|Milnacipran|milnacipran|mesh-list
83491104|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
83491105|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83491106|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83491107|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83491108|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491109|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491110|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491111|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83491112|NCT01510457|Analgesics|analgesics|mesh-ancestor
83491113|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
83491114|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491115|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
83491116|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83491117|NCT04983966|Desflurane|desflurane|mesh-list
83491118|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83491119|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
83491120|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
83491121|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83491122|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491123|NCT02478372|Bupivacaine|bupivacaine|mesh-list
83491124|NCT02478372|Ropivacaine|ropivacaine|mesh-list
83491125|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
83491126|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
83491127|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
83491128|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83491129|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491130|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
83491131|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491132|NCT01511315|Ustekinumab|ustekinumab|mesh-list
83491133|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
83491134|NCT01654536|Ciclesonide|ciclesonide|mesh-list
83491135|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
83491136|NCT01654536|Hormones|hormones|mesh-ancestor
83491137|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83491138|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491139|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83491140|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
83491141|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83491142|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491143|NCT02509026|Etanercept|etanercept|mesh-list
83491144|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83491145|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83491146|NCT02509026|Analgesics|analgesics|mesh-ancestor
83491147|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
83491148|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491149|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491150|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83491151|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83491152|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83491153|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83491154|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
83491155|NCT03439280|Dexamethasone|dexamethasone|mesh-list
83491156|NCT03439280|Pomalidomide|pomalidomide|mesh-list
83491157|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83491158|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
83491159|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
83491160|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491161|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491162|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83491163|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
83491164|NCT03439280|Hormones|hormones|mesh-ancestor
83491165|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83491166|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83491167|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491168|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
83491169|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83491170|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83491171|NCT03439280|Growth Substances|growth substances|mesh-ancestor
83491172|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
83491173|NCT00828074|Sorafenib|sorafenib|mesh-list
83491174|NCT00828074|Vinorelbine|vinorelbine|mesh-list
83491175|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491176|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83491177|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491178|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491179|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83491180|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
83491181|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
83491182|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
83491183|NCT03434444|Propranolol|propranolol|mesh-list
83491184|NCT03434444|Oxytocin|oxytocin|mesh-list
83491185|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
83491186|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83491187|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491188|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83491189|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83491190|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
83491191|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491192|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491193|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83491194|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83491195|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
83491196|NCT04382300|Thalidomide|thalidomide|mesh-list
83491197|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83491198|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
83491199|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491200|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
83491201|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83491202|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491203|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83491204|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83491205|NCT04382300|Growth Substances|growth substances|mesh-ancestor
83491206|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
83491207|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491208|NCT01430819|Vaccines|vaccines|mesh-list
83491209|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
83491210|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491211|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83491212|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
83491213|NCT00828542|Desogestrel|desogestrel|mesh-list
83491214|NCT00828542|Etonogestrel|etonogestrel|mesh-list
83491215|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83491216|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83491217|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83491218|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
83491219|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83491220|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491221|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83491222|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83491223|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83491224|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83491225|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491226|NCT00828542|Progestins|progestins|mesh-ancestor
83491227|NCT00828542|Hormones|hormones|mesh-ancestor
83491228|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83491229|NCT01395329|Metoprolol|metoprolol|mesh-list
83491230|NCT01395329|Nebivolol|nebivolol|mesh-list
83491231|NCT01395329|Nitroprusside|nitroprusside|mesh-list
83491232|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
83491233|NCT01395329|BQ 788|bq 788|mesh-list
83491234|NCT01395329|Acetylcholine|acetylcholine|mesh-list
83491235|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83491236|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83491237|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
83491238|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
83491239|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491240|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491241|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83491242|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83491243|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83491244|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
83491245|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491246|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491247|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
83491248|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83491249|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83491250|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83491251|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83491252|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83491253|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
83491254|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83491255|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83491256|NCT00882206|Cytarabine|cytarabine|mesh-list
83491257|NCT00882206|Prednisone|prednisone|mesh-list
83491258|NCT00882206|Doxorubicin|doxorubicin|mesh-list
83491259|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83491260|NCT00882206|Methotrexate|methotrexate|mesh-list
83491261|NCT00882206|Vincristine|vincristine|mesh-list
83491262|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
83491263|NCT00882206|Decitabine|decitabine|mesh-list
83491264|NCT00882206|Asparaginase|asparaginase|mesh-list
83491265|NCT00882206|Vorinostat|vorinostat|mesh-list
83491266|NCT00882206|Pegaspargase|pegaspargase|mesh-list
83491267|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83491268|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491269|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83491270|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83491271|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491272|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491273|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83491274|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
83491275|NCT00882206|Hormones|hormones|mesh-ancestor
83491276|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83491277|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491278|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83491279|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83491280|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
83491281|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83491282|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83491283|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
83491284|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
83491285|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83491286|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83491287|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
83491288|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83491289|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83491290|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
83491291|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491292|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83491293|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
83491294|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
83491295|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
83491296|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83491297|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83491298|NCT00831272|Naltrexone|naltrexone|mesh-list
83491299|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83491300|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83491301|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491302|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
83491303|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491304|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83491305|NCT01512251|Vemurafenib|vemurafenib|mesh-list
83491306|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491307|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83491308|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491309|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491310|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83491311|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83491312|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491313|NCT00885638|Incretins|incretins|mesh-ancestor
83491314|NCT00885638|Hormones|hormones|mesh-ancestor
83491315|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83491316|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83491317|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
83491318|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491319|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491320|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83491321|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83491322|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491323|NCT01512797|Incretins|incretins|mesh-ancestor
83491324|NCT01512797|Hormones|hormones|mesh-ancestor
83491325|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83491326|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83491327|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
83491328|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491329|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491330|NCT05620940|Naltrexone|naltrexone|mesh-list
83491331|NCT05620940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83491332|NCT05620940|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83491333|NCT05620940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491334|NCT05620940|Sensory System Agents|sensory system agents|mesh-ancestor
83491335|NCT05620940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491336|NCT01395797|Pioglitazone|pioglitazone|mesh-list
83491337|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83491338|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491339|NCT05124704|Ropivacaine|ropivacaine|mesh-list
83491340|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
83491341|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
83491342|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83491343|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491344|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
83491345|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491346|NCT02203019|Fentanyl|fentanyl|mesh-list
83491347|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
83491348|NCT02203019|Propofol|propofol|mesh-list
83491349|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83491350|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83491351|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491352|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83491353|NCT02203019|Analgesics|analgesics|mesh-ancestor
83491354|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
83491355|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491356|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83491357|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83491358|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83491359|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
83491360|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491361|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491362|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83491363|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
83491364|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
83491365|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83491366|NCT02203019|Narcotics|narcotics|mesh-ancestor
83491367|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83491368|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
83491369|NCT05000450|Fludarabine|fludarabine|mesh-list
83491370|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83491371|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
83491372|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491373|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83491374|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83491375|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
83491376|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491377|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491378|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83491379|NCT00886262|Vasopressins|vasopressins|mesh-list
83491380|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
83491381|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
83491382|NCT00886262|Coagulants|coagulants|mesh-ancestor
83491383|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83491384|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83491385|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
83491386|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491387|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83491388|NCT00887510|Trandolapril|trandolapril|mesh-list
83491389|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83491390|NCT00887510|Diuretics|diuretics|mesh-ancestor
83491391|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
83491392|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491393|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83492540|NCT01561703|Azithromycin|azithromycin|mesh-list
83491394|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83491395|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491396|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83491397|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
83491398|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491399|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
83491400|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83491401|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491402|NCT03313778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83491403|NCT03313778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491404|NCT01431989|Amoxicillin|amoxicillin|mesh-list
83491405|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83491406|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491407|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
83491408|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
83491410|NCT03247088|Fludarabine|fludarabine|mesh-list
83491411|NCT03247088|Sorafenib|sorafenib|mesh-list
83491412|NCT03247088|Tacrolimus|tacrolimus|mesh-list
83491413|NCT03247088|Lenograstim|lenograstim|mesh-list
83491414|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83491415|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
83491416|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491417|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83491418|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83491419|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
83491420|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491421|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491422|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83491423|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83491424|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83491425|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491426|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83491427|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83491428|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
83491429|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83491430|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491431|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83491432|NCT01397591|Bortezomib|bortezomib|mesh-list
83491433|NCT01397591|Ofatumumab|ofatumumab|mesh-list
83491434|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491435|NCT03855332|Cilostazol|cilostazol|mesh-list
83491436|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
83491437|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
83491438|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83491439|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83491440|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491441|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491442|NCT03855332|Urological Agents|urological agents|mesh-ancestor
83491443|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83491444|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
83491445|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491446|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491447|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83491448|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
83491449|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83491450|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83491451|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83491452|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83491453|NCT03855332|Protective Agents|protective agents|mesh-ancestor
83491454|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83491455|NCT02335580|Somatostatin|somatostatin|mesh-list
83491456|NCT02335580|Hormones|hormones|mesh-ancestor
83491457|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83491458|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491459|NCT02476968|Olaparib|olaparib|mesh-list
83491460|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83491461|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491462|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491463|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491464|NCT01514513|Permethrin|permethrin|mesh-list
83491465|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491466|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491467|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
83491468|NCT04981860|Povidone|povidone|mesh-list
83491469|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
83491471|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83491472|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491473|NCT01432145|Methotrexate|methotrexate|mesh-list
83491474|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
83491475|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83491476|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
83491477|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83491478|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491479|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83491480|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
83491481|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491482|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491483|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83491484|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491485|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83491486|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83491487|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
83491488|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83491489|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83491490|NCT04979520|Brodalumab|brodalumab|mesh-list
83491491|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
83491492|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
83491493|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83491494|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83491495|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83491496|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83491497|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491498|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
83491499|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491500|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491501|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83491502|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491503|NCT02504892|Everolimus|everolimus|mesh-list
83491504|NCT02504892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83491505|NCT02504892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83491506|NCT02504892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491507|NCT02504892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491508|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83491509|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
83491510|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491511|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491512|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83491513|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
83491514|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491515|NCT00890162|Omalizumab|omalizumab|mesh-list
83491516|NCT00890162|Epinephrine|epinephrine|mesh-list
83491517|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83491518|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83491519|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
83491520|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491521|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491522|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491523|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83491524|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83491525|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
83491526|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491527|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83491528|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
83491529|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
83491530|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
83491531|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83491532|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83491533|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
83491534|NCT01433081|Analgesics|analgesics|mesh-ancestor
83491535|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
83491536|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491537|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491538|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
83491539|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83491540|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83491541|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
83491542|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83491543|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83491544|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491545|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83491546|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
83491547|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83491548|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
83491549|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491550|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
83491551|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491552|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491553|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83491554|NCT01401023|Tigecycline|tigecycline|mesh-list
83491555|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83491556|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491557|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83491558|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491559|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491560|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
83491561|NCT01515995|Analgesics|analgesics|mesh-ancestor
83491562|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
83491563|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491564|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491565|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
83491566|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83491567|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83491568|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
83491569|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83491570|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83491571|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491572|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83491573|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
83491574|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83491575|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
83491576|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83491577|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491578|NCT01519271|Rivastigmine|rivastigmine|mesh-list
83491579|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83491580|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491581|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491582|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
83491583|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491584|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491585|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83491586|NCT01519271|Protective Agents|protective agents|mesh-ancestor
83491587|NCT01436279|Mifepristone|mifepristone|mesh-list
83491588|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83491589|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
83491590|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83491591|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491592|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83491593|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83491594|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83491595|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
83491596|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83491597|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83491598|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
83491599|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83491601|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83491602|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83491603|NCT02210195|Aprepitant|aprepitant|mesh-list
83491604|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
83491605|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
83491606|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491607|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491608|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83491609|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83491610|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491611|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491612|NCT01437449|Carboplatin|carboplatin|mesh-list
83491613|NCT01437449|Docetaxel|docetaxel|mesh-list
83491614|NCT01437449|Cetuximab|cetuximab|mesh-list
83491615|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491616|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
83491617|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
83491618|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
83491619|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491620|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83491621|NCT00836888|Nivolumab|nivolumab|mesh-list
83491622|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83491623|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491624|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83491625|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491626|NCT02262026|Saracatinib|saracatinib|mesh-list
83491627|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491628|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491629|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491630|NCT00889226|Atorvastatin|atorvastatin|mesh-list
83491631|NCT00889226|Pitavastatin|pitavastatin|mesh-list
83491632|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83491633|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83491634|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
83491635|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491636|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83491637|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83491638|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491639|NCT00837200|Doxorubicin|doxorubicin|mesh-list
83491640|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83491641|NCT00837200|Asparaginase|asparaginase|mesh-list
83491642|NCT00837200|Pegaspargase|pegaspargase|mesh-list
83491643|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83491644|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491645|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83491646|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83491647|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491648|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491649|NCT00837512|Insulin|insulin|mesh-list
83491650|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83491651|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83491652|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491653|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83491654|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
83491655|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83491656|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83491657|NCT00837590|Analgesics|analgesics|mesh-ancestor
83491658|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
83491659|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491660|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491661|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83491662|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83491663|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83491664|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491665|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491666|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83491667|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
83491668|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491669|NCT00839540|Caspofungin|caspofungin|mesh-list
83491670|NCT00839540|Micafungin|micafungin|mesh-list
83491671|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
83491672|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491673|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491674|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491675|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
83491676|NCT02966912|Antacids|antacids|mesh-ancestor
83491677|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491678|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83491679|NCT02964182|Nicotine|nicotine|mesh-list
83491680|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83491681|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
83491682|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491683|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491684|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83491685|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83491686|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
83491687|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491688|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491689|NCT01437605|Poly I-C|poly i-c|mesh-list
83491690|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
83491691|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
83491692|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491706|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491707|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83491708|NCT01541735|Pantoprazole|pantoprazole|mesh-list
83491709|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83491710|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83491711|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83491712|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491713|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491714|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83491715|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83491716|NCT01520207|Mannitol|mannitol|mesh-list
83491717|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83491718|NCT01520207|Diuretics|diuretics|mesh-ancestor
83491719|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
83491720|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491721|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
83491722|NCT01203722|Sirolimus|sirolimus|mesh-list
83491723|NCT01203722|Fludarabine|fludarabine|mesh-list
83491724|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
83491725|NCT01203722|Tacrolimus|tacrolimus|mesh-list
83491726|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491727|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491728|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83491729|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
83491730|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491731|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83491732|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491733|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83491734|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83491735|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
83491736|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83491737|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83491738|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83491739|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
83491740|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83491741|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491742|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
83491743|NCT01520519|Rituximab|rituximab|mesh-list
83491744|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83491745|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491746|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
83491747|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491748|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83491749|NCT03008057|Vitamin D|vitamin d|mesh-list
83491750|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
83491751|NCT03008057|Cholecalciferol|cholecalciferol|mesh-list
83491752|NCT03008057|Vitamins|vitamins|mesh-list
83491753|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
83491754|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491755|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83491756|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83491757|NCT01542125|Lidocaine|lidocaine|mesh-list
83491758|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
83491759|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
83491760|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83491761|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491762|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
83491763|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491764|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83491765|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83491766|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83491767|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83491768|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491769|NCT03216668|Silymarin|silymarin|mesh-list
83491770|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
83491771|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491772|NCT03216668|Protective Agents|protective agents|mesh-ancestor
83491773|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491774|NCT02548832|Bezafibrate|bezafibrate|mesh-list
83491775|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83491776|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
83491777|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491778|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83491779|NCT03216278|Metformin|metformin|mesh-list
83491780|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
83491781|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83491782|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491783|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83491784|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491785|NCT05310344|Paclitaxel|paclitaxel|mesh-list
83491786|NCT05310344|Bevacizumab|bevacizumab|mesh-list
83491787|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83491788|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83491789|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491790|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
83491791|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
83491792|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
83491793|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491794|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83491795|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83491796|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83491797|NCT05310344|Growth Substances|growth substances|mesh-ancestor
83491798|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491799|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
83491800|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
83491801|NCT00837902|Atenolol|atenolol|mesh-list
83491802|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83491803|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83491804|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
83491805|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
83491806|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491807|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491808|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83491809|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83491810|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83491811|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
83491812|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491813|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491814|NCT04382144|Bupivacaine|bupivacaine|mesh-list
83491815|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
83491816|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
83491817|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83491818|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491819|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
83491820|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83491821|NCT03215966|Tadalafil|tadalafil|mesh-list
83491822|NCT03215966|Macitentan|macitentan|mesh-list
83491823|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
83491824|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83491825|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83491826|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491827|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491828|NCT03215966|Urological Agents|urological agents|mesh-ancestor
83491829|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83491830|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83491831|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83491832|NCT03215498|Insulin|insulin|mesh-list
83491833|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83491834|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
83491835|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
83491836|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83491837|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83491838|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491839|NCT01441037|Danazol|danazol|mesh-list
83491840|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83491841|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
83491842|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83491843|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491844|NCT00891878|Capecitabine|capecitabine|mesh-list
83491845|NCT00891878|Sunitinib|sunitinib|mesh-list
83491846|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83491847|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
83491848|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491849|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491850|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83491851|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83491852|NCT00891878|Growth Substances|growth substances|mesh-ancestor
83491853|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491855|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83491856|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491857|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
83491858|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83491859|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491860|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
83491861|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83491862|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83491863|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491864|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
83491865|NCT03838328|Coagulants|coagulants|mesh-ancestor
83491866|NCT01526213|Fexofenadine|fexofenadine|mesh-list
83491867|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83491868|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83491869|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83491870|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
83491871|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
83491872|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491873|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491874|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491875|NCT01549223|Misoprostol|misoprostol|mesh-list
83491876|NCT01549223|Oxytocin|oxytocin|mesh-list
83491877|NCT01549223|Carboprost|carboprost|mesh-list
83491878|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
83491879|NCT01549223|Methylergonovine|methylergonovine|mesh-list
83491880|NCT01549223|Maleic acid|maleic acid|mesh-list
83491881|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
83491882|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83491883|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491884|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83491885|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
83491886|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83491887|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83491888|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491889|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491890|NCT00895934|Azacitidine|azacitidine|mesh-list
83491891|NCT00895934|Vorinostat|vorinostat|mesh-list
83491892|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
83491893|NCT00895934|Calicheamicins|calicheamicins|mesh-list
83491894|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83491895|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
83491896|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491897|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491898|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491899|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83491900|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83491901|NCT00895934|Immunotoxins|immunotoxins|mesh-ancestor
83491902|NCT00895934|Immunoconjugates|immunoconjugates|mesh-ancestor
83491903|NCT00895934|Immunologic Factors|immunologic factors|mesh-ancestor
83491904|NCT00895934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491905|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83491906|NCT01550471|Ciclesonide|ciclesonide|mesh-list
83491907|NCT01550471|Beclomethasone|beclomethasone|mesh-list
83491908|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83491909|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
83491910|NCT01550471|Hormones|hormones|mesh-ancestor
83491911|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83491912|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491913|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83491914|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
83491915|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83491916|NCT00896012|Sirolimus|sirolimus|mesh-list
83491917|NCT00896012|Tacrolimus|tacrolimus|mesh-list
83491918|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83491919|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
83491920|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491921|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83491922|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491923|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491924|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83491925|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491926|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83491927|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491928|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
83491929|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
83491930|NCT03215264|Entinostat|entinostat|mesh-list
83491931|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
83491934|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491935|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491936|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491937|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83491938|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83491939|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83491940|NCT01447511|Rifampin|rifampin|mesh-list
83491941|NCT01447511|Fluconazole|fluconazole|mesh-list
83491942|NCT01447511|Warfarin|warfarin|mesh-list
83491943|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
83491944|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83491945|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
83491946|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83491947|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491948|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
83491949|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83491950|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491951|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491952|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83491953|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83491954|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83491955|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83491956|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83491957|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83491958|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
83491959|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83491960|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83491961|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83491962|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
83491963|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83491964|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491965|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83491966|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83491967|NCT01831622|Methylphenidate|methylphenidate|mesh-list
83491968|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83491969|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83491970|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83491971|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83491972|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83491973|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491974|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
83491975|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83491976|NCT04380818|Ritonavir|ritonavir|mesh-list
83491977|NCT04380818|Lopinavir|lopinavir|mesh-list
83491978|NCT04380818|Azithromycin|azithromycin|mesh-list
83491979|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
83491980|NCT04380818|Heparin|heparin|mesh-list
83491981|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83491982|NCT04380818|Tinzaparin|tinzaparin|mesh-list
83491983|NCT04380818|Dalteparin|dalteparin|mesh-list
83491984|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83491985|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83491986|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
83491987|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83491988|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83491989|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83491990|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83491991|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
83491992|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83491993|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83491994|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83491995|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
83491996|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83491997|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83491998|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83491999|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
83492000|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83492001|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83492002|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492003|NCT05312294|Vaccines|vaccines|mesh-list
83492004|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
83492005|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492006|NCT01550705|Isoniazid|isoniazid|mesh-list
83492007|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
83492009|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492010|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83492011|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83492012|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
83492013|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492014|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83492015|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83492016|NCT01831700|Lisinopril|lisinopril|mesh-list
83492017|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
83492018|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83492019|NCT01831700|Diuretics|diuretics|mesh-ancestor
83492020|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
83492021|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492022|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83492023|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492024|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492025|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83492026|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
83492027|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492028|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83492029|NCT01831700|Protective Agents|protective agents|mesh-ancestor
83492030|NCT01531439|Naloxone|naloxone|mesh-list
83492031|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83492032|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492033|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
83492034|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492035|NCT03214874|Torsemide|torsemide|mesh-list
83492036|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83492037|NCT03214874|Diuretics|diuretics|mesh-ancestor
83492038|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
83492039|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492040|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83492041|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492042|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492043|NCT02504268|Methotrexate|methotrexate|mesh-list
83492044|NCT02504268|Abatacept|abatacept|mesh-list
83492045|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83492046|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
83492047|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83492048|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492049|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83492050|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
83492051|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492052|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492053|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
83492054|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492055|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83492056|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83492057|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
83492058|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492059|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83492060|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83492061|NCT02504268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83492062|NCT00904826|Eculizumab|eculizumab|mesh-list
83492063|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83492064|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83492065|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
83492066|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492067|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83492068|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83492069|NCT01448525|Bimatoprost|bimatoprost|mesh-list
83492070|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83492071|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83492072|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83492073|NCT01654302|Lidocaine|lidocaine|mesh-list
83492074|NCT01654302|Tetracaine|tetracaine|mesh-list
83492075|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
83492076|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
83492077|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492078|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492079|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
83492080|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492081|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83492082|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83492083|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83492084|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492085|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492086|NCT01832558|Eplerenone|eplerenone|mesh-list
83492087|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83492088|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
83492089|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83492090|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492091|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83492092|NCT01832558|Diuretics|diuretics|mesh-ancestor
83492093|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
83492094|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83492095|NCT02476422|Ibuprofen|ibuprofen|mesh-list
83492096|NCT02476422|Diclofenac|diclofenac|mesh-list
83492097|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83492098|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83492099|NCT02476422|Analgesics|analgesics|mesh-ancestor
83492100|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
83492101|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492102|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492103|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83492104|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492105|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83492106|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492107|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492108|NCT01450319|Cetuximab|cetuximab|mesh-list
83492109|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83492110|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492111|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83492112|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
83492113|NCT01552343|Coagulants|coagulants|mesh-ancestor
83492114|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83492115|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
83492116|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492117|NCT02475564|Resveratrol|resveratrol|mesh-list
83492118|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
83492119|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492120|NCT02475564|Protective Agents|protective agents|mesh-ancestor
83492121|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492122|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492123|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83492124|NCT00893984|Nebivolol|nebivolol|mesh-list
83492125|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83492126|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
83492127|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83492128|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83492129|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83492130|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
83492131|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492132|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492133|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492134|NCT01832870|Ipilimumab|ipilimumab|mesh-list
83492135|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83492136|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492137|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83492138|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492139|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
83492140|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83492141|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492142|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492143|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
83492144|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492145|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492146|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
83492147|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83492148|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
83492149|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83492150|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
83492151|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492152|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492153|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
83492159|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492160|NCT01832948|Antidotes|antidotes|mesh-ancestor
83492161|NCT01832948|Protective Agents|protective agents|mesh-ancestor
83492162|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492163|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
83492164|NCT01832948|Vitamins|vitamins|mesh-ancestor
83492165|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
83492166|NCT01832948|Hematinics|hematinics|mesh-ancestor
83492167|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83492168|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83492169|NCT01832948|Growth Substances|growth substances|mesh-ancestor
83492170|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
83492171|NCT01533077|Levodopa|levodopa|mesh-list
83492172|NCT01533077|Carbidopa|carbidopa|mesh-list
83492173|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83492174|NCT01533077|Opicapone|opicapone|mesh-list
83492175|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83492176|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83492177|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
83492178|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492179|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492180|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492181|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83492182|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492183|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83492184|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
83492185|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
83492186|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83492187|NCT01534013|Insulin|insulin|mesh-list
83492188|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83492189|NCT01534013|Pancrelipase|pancrelipase|mesh-list
83492190|NCT01534013|Pancreatin|pancreatin|mesh-list
83492191|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83492192|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492193|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83492194|NCT03211988|Entinostat|entinostat|mesh-list
83492195|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492196|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83492197|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492198|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492199|NCT01833572|Gefitinib|gefitinib|mesh-list
83492200|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492201|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83492202|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492203|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492204|NCT01833728|Acetaminophen|acetaminophen|mesh-list
83492205|NCT01833728|Propacetamol|propacetamol|mesh-list
83492206|NCT01833728|Nefopam|nefopam|mesh-list
83492207|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83492208|NCT01833728|Analgesics|analgesics|mesh-ancestor
83492209|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
83492210|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492211|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492212|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83492213|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83492214|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492215|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
83492216|NCT03213392|Anesthetics|anesthetics|mesh-list
83492217|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492218|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492219|NCT03219788|Remifentanil|remifentanil|mesh-list
83492220|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83492221|NCT03219788|Narcotics|narcotics|mesh-ancestor
83492222|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492223|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492224|NCT03219788|Analgesics|analgesics|mesh-ancestor
83492225|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
83492226|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492227|NCT03219710|Dexamethasone|dexamethasone|mesh-list
83492228|NCT03219710|Ondansetron|ondansetron|mesh-list
83492229|NCT03219710|Olanzapine|olanzapine|mesh-list
83492230|NCT03219710|Aprepitant|aprepitant|mesh-list
83492231|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83492232|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
83492233|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
83492234|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492235|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492236|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83492239|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83492240|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83492241|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492242|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
83492243|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
83492244|NCT03219710|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83492245|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83492246|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
83492247|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492248|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492249|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83492250|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83492251|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492252|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83492253|NCT03219710|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83492254|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83492255|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492256|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83492257|NCT01532141|Opicapone|opicapone|mesh-list
83492258|NCT01532141|Rasagiline|rasagiline|mesh-list
83492259|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83492260|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492261|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492262|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83492263|NCT01532141|Protective Agents|protective agents|mesh-ancestor
83492264|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492265|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83492266|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83492267|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83492268|NCT00899600|Ketamine|ketamine|mesh-list
83492269|NCT00899600|Analgesics|analgesics|mesh-ancestor
83492270|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
83492271|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492272|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492273|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83492274|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83492275|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
83492276|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
83492277|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492278|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83492279|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83492280|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492281|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492282|NCT03219554|Palbociclib|palbociclib|mesh-list
83492283|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492284|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83492285|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492286|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492287|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
83492288|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83492289|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
83492290|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492291|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492292|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83492293|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
83492294|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492295|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492296|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83492297|NCT01451411|Conivaptan|conivaptan|mesh-list
83492298|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83492299|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492300|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
83492301|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492302|NCT03837938|Dipropizine|dipropizine|mesh-list
83492303|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
83492304|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
83492305|NCT01554683|Levetiracetam|levetiracetam|mesh-list
83492306|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
83492307|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
83492308|NCT00905060|Temozolomide|temozolomide|mesh-list
83492309|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83492310|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
83492311|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492313|NCT01535573|Dexetimide|dexetimide|mesh-list
83492314|NCT01535573|Citalopram|citalopram|mesh-list
83492315|NCT01535573|Escitalopram|escitalopram|mesh-list
83492316|NCT01535573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83492317|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83492318|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492319|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492320|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492321|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
83492322|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492323|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83492324|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
83492325|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83492326|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83492327|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83492328|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
83492329|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
83492330|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492331|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83492332|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83492333|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
83492334|NCT01834508|Entecavir|entecavir|mesh-list
83492335|NCT01834508|Adefovir|adefovir|mesh-list
83492336|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
83492337|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492338|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83492339|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83492340|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492341|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492342|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
83492343|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83492344|NCT03213002|Capecitabine|capecitabine|mesh-list
83492345|NCT03213002|Temozolomide|temozolomide|mesh-list
83492346|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83492347|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
83492348|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492349|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492350|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83492351|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
83492352|NCT01556633|Oseltamivir|oseltamivir|mesh-list
83492353|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
83492354|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492355|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492356|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492357|NCT03218852|Prednisone|prednisone|mesh-list
83492358|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
83492359|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83492360|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
83492361|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492362|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492363|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83492364|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
83492365|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492366|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492367|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83492368|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83492369|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
83492370|NCT03218852|Hormones|hormones|mesh-ancestor
83492371|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83492372|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83492373|NCT01834898|Oxycodone|oxycodone|mesh-list
83492374|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83492375|NCT01834898|Narcotics|narcotics|mesh-ancestor
83492376|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492377|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492378|NCT01834898|Analgesics|analgesics|mesh-ancestor
83492379|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
83492380|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492381|NCT01557959|Docetaxel|docetaxel|mesh-list
83492382|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83492383|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492384|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
83492387|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492388|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83492389|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492390|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
83492391|NCT03212456|Ropivacaine|ropivacaine|mesh-list
83492392|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
83492393|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
83492394|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492395|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492396|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
83492397|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492398|NCT03212456|Narcotics|narcotics|mesh-ancestor
83492399|NCT03212456|Analgesics|analgesics|mesh-ancestor
83492400|NCT03217838|Azacitidine|azacitidine|mesh-list
83492401|NCT03217838|Venetoclax|venetoclax|mesh-list
83492402|NCT03217838|Pyrazole|pyrazole|mesh-list
83492403|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83492404|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
83492405|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492406|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492407|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492408|NCT01558661|Axitinib|axitinib|mesh-list
83492409|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492410|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83492411|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492412|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492413|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
83492414|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492415|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
83492416|NCT02502864|Docetaxel|docetaxel|mesh-list
83492417|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83492418|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
83492419|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492420|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492421|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83492422|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
83492423|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492424|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492425|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83492426|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
83492427|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
83492428|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
83492429|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
83492430|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83492431|NCT03217292|Tramadol|tramadol|mesh-list
83492432|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83492433|NCT03217292|Narcotics|narcotics|mesh-ancestor
83492434|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492435|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492436|NCT03217292|Analgesics|analgesics|mesh-ancestor
83492437|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
83492438|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492439|NCT03217448|Warfarin|warfarin|mesh-list
83492440|NCT03217448|Dabigatran|dabigatran|mesh-list
83492441|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
83492442|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
83492443|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83492444|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
83492445|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492446|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492447|NCT01457573|Tamsulosin|tamsulosin|mesh-list
83492448|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
83492449|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83492450|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83492451|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83492452|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
83492453|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492454|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492455|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492456|NCT01457573|Urological Agents|urological agents|mesh-ancestor
83492457|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83492458|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83492459|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
83492460|NCT01560143|Tigecycline|tigecycline|mesh-list
83492461|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83492462|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492463|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83492465|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492466|NCT01836224|Terlipressin|terlipressin|mesh-list
83492467|NCT01836224|Norepinephrine|norepinephrine|mesh-list
83492468|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83492469|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83492470|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83492471|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83492472|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
83492473|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492474|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492475|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492476|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
83492477|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
83492478|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492479|NCT01836536|Bevacizumab|bevacizumab|mesh-list
83492480|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83492481|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492482|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83492483|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83492484|NCT01836536|Growth Substances|growth substances|mesh-ancestor
83492485|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492486|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
83492487|NCT03216980|Antioxidants|antioxidants|mesh-list
83492488|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492489|NCT03216980|Protective Agents|protective agents|mesh-ancestor
83492490|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492491|NCT00895232|Iron|iron|mesh-list
83492492|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83492493|NCT00895232|Trace Elements|trace elements|mesh-ancestor
83492494|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
83492495|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492496|NCT00895232|Hematinics|hematinics|mesh-ancestor
83492497|NCT03211052|Leuprolide|leuprolide|mesh-list
83492498|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83492499|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
83492500|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83492501|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492502|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83492503|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492504|NCT01560923|Tryptophan|tryptophan|mesh-list
83492505|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83492506|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
83492507|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83492508|NCT01839032|Vinorelbine|vinorelbine|mesh-list
83492509|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492510|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83492511|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
83492512|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
83492513|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
83492514|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492515|NCT01457885|Busulfan|busulfan|mesh-list
83492516|NCT01457885|Clofarabine|clofarabine|mesh-list
83492517|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
83492518|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492519|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83492520|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
83492521|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492522|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83492523|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492524|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83492525|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83492526|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
83492527|NCT01460225|Lubiprostone|lubiprostone|mesh-list
83492528|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83492529|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492530|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492531|NCT01561469|Vancomycin|vancomycin|mesh-list
83492532|NCT01561469|Linezolid|linezolid|mesh-list
83492533|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83492534|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492535|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83492536|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492537|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492538|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83492539|NCT01561703|Amoxicillin|amoxicillin|mesh-list
83492543|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83492544|NCT01561703|Cephalexin|cephalexin|mesh-list
83492545|NCT01561703|Cefdinir|cefdinir|mesh-list
83492546|NCT01561703|Cefaclor|cefaclor|mesh-list
83492547|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492548|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83492549|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492550|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492551|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83492552|NCT01839500|Trastuzumab|trastuzumab|mesh-list
83492553|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83492554|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492555|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
83492556|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83492557|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492558|NCT03210662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83492559|NCT03210662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492560|NCT02501928|Fesoterodine|fesoterodine|mesh-list
83492561|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83492562|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83492563|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
83492564|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492565|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492566|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492567|NCT02501928|Urological Agents|urological agents|mesh-ancestor
83492568|NCT01839734|Lubiprostone|lubiprostone|mesh-list
83492569|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83492570|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492571|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492572|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
83492573|NCT01462253|Clofarabine|clofarabine|mesh-list
83492574|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83492575|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
83492576|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492577|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492578|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83492579|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
83492580|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492581|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492582|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83492583|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83492584|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
83492585|NCT01837394|Acetaminophen|acetaminophen|mesh-list
83492586|NCT01837394|Morphine|morphine|mesh-list
83492587|NCT01837394|Ondansetron|ondansetron|mesh-list
83492588|NCT01837394|Metoclopramide|metoclopramide|mesh-list
83492589|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83492590|NCT01837394|Narcotics|narcotics|mesh-ancestor
83492591|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492592|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492593|NCT01837394|Analgesics|analgesics|mesh-ancestor
83492594|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
83492595|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492596|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83492597|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
83492598|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
83492599|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
83492600|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83492601|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
83492602|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
83492603|NCT01837394|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83492604|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83492605|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
83492606|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492607|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492608|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83492609|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83492610|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
83492611|NCT01462565|Epoprostenol|epoprostenol|mesh-list
83492612|NCT01462565|Tezosentan|tezosentan|mesh-list
83492613|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83492614|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83492615|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
83492616|NCT01837628|Lidocaine|lidocaine|mesh-list
83492617|NCT01837628|Mineral Oil|mineral oil|mesh-list
83492618|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
83492621|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492622|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
83492623|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492624|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83492625|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83492626|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83492627|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492628|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492629|NCT01837628|Emollients|emollients|mesh-ancestor
83492630|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
83492631|NCT01462877|Fenofibrate|fenofibrate|mesh-list
83492632|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83492633|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
83492634|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492635|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83492636|NCT04972656|Ambrisentan|ambrisentan|mesh-list
83492637|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83492638|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83492639|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
83492640|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492641|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
83492642|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83492643|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492644|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
83492645|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
83492646|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83492647|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
83492648|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83492649|NCT01839812|Cosyntropin|cosyntropin|mesh-list
83492650|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83492651|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83492652|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
83492654|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83492655|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492656|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492657|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492658|NCT04939272|Venetoclax|venetoclax|mesh-list
83492659|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492660|NCT01839890|Paclitaxel|paclitaxel|mesh-list
83492661|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83492662|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492663|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
83492664|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
83492665|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
83492666|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492667|NCT02205983|Acetaminophen|acetaminophen|mesh-list
83492668|NCT02205983|Hydromorphone|hydromorphone|mesh-list
83492669|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83492670|NCT02205983|Analgesics|analgesics|mesh-ancestor
83492671|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
83492672|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492673|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492674|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
83492675|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83492676|NCT02205983|Narcotics|narcotics|mesh-ancestor
83492677|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492678|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83492679|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83492680|NCT03210038|Lidocaine|lidocaine|mesh-list
83492681|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
83492682|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
83492683|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492684|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492685|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
83492686|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492687|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83492688|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83492689|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83492690|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492691|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492692|NCT02472756|Rituximab|rituximab|mesh-list
83492693|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83492695|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
83492696|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492697|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492698|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
83492699|NCT01464359|Busulfan|busulfan|mesh-list
83492700|NCT01464359|Fludarabine|fludarabine|mesh-list
83492701|NCT01464359|Interleukin-2|interleukin-2|mesh-list
83492702|NCT01464359|Allopurinol|allopurinol|mesh-list
83492703|NCT01464359|Levetiracetam|levetiracetam|mesh-list
83492704|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83492705|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
83492706|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492707|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492708|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83492709|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
83492710|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492711|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492712|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83492713|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
83492714|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83492715|NCT01464359|Analgesics|analgesics|mesh-ancestor
83492716|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
83492717|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492718|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
83492719|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
83492720|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492721|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
83492722|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83492723|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
83492724|NCT01464359|Protective Agents|protective agents|mesh-ancestor
83492725|NCT04969224|Ivacaftor|ivacaftor|mesh-list
83492726|NCT04969224|Elexacaftor|elexacaftor|mesh-list
83492727|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83492728|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492729|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492730|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
83492731|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83492732|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
83492733|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492734|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
83492735|NCT01838252|Protective Agents|protective agents|mesh-ancestor
83492736|NCT01838330|Psyllium|psyllium|mesh-list
83492737|NCT01838330|Cathartics|cathartics|mesh-ancestor
83492738|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83492739|NCT02498652|Allopurinol|allopurinol|mesh-list
83492740|NCT02498652|Verinurad|verinurad|mesh-list
83492741|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
83492742|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492743|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492744|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
83492745|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492746|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83492747|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
83492748|NCT02498652|Protective Agents|protective agents|mesh-ancestor
83492749|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492750|NCT03213158|Ixazomib|ixazomib|mesh-list
83492751|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492752|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
83492753|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492754|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492755|NCT02498418|Rifaximin|rifaximin|mesh-list
83492756|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83492757|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492758|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83492759|NCT03219476|Tamoxifen|tamoxifen|mesh-list
83492760|NCT03219476|Letrozole|letrozole|mesh-list
83492761|NCT03219476|Anastrozole|anastrozole|mesh-list
83492762|NCT03219476|Exemestane|exemestane|mesh-list
83492763|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492764|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83492765|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83492766|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492767|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492768|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83492769|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
83492770|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83492771|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492772|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83492773|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83492774|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83492775|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83492776|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83492777|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83492778|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
83492779|NCT02472366|Hormones|hormones|mesh-ancestor
83492780|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83492781|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492782|NCT01724606|Sorafenib|sorafenib|mesh-list
83492783|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492784|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83492785|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492786|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492787|NCT03219164|Aztreonam|aztreonam|mesh-list
83492788|NCT03219164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83492789|NCT03219164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492790|NCT01720238|Lamivudine|lamivudine|mesh-list
83492791|NCT01720238|Adefovir|adefovir|mesh-list
83492792|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83492793|NCT01720238|Entecavir|entecavir|mesh-list
83492794|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83492795|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83492796|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492797|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492798|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
83492799|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492800|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83492801|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83492802|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
83492803|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83492804|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492805|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492806|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83492807|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83492808|NCT03836222|Protective Agents|protective agents|mesh-ancestor
83492809|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492810|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
83492811|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83492812|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
83492813|NCT01830218|Anesthetics|anesthetics|mesh-list
83492814|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492815|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492816|NCT00910208|Morphine|morphine|mesh-list
83492817|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83492818|NCT00910208|Narcotics|narcotics|mesh-ancestor
83492819|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492820|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492821|NCT00910208|Analgesics|analgesics|mesh-ancestor
83492822|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
83492823|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492824|NCT01566539|Vasopressins|vasopressins|mesh-list
83492825|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
83492826|NCT01566539|Lorazepam|lorazepam|mesh-list
83492827|NCT01566539|Oxytocin|oxytocin|mesh-list
83492828|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
83492829|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83492830|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492831|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
83492832|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
83492833|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
83492834|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492835|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83492836|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83492837|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492838|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83492839|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83492840|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83492841|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
83492842|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
83492843|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492844|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492845|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
83492846|NCT01566539|Coagulants|coagulants|mesh-ancestor
83492847|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83492848|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83492853|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
83492854|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492855|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492856|NCT01725776|Milrinone|milrinone|mesh-list
83492857|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83492858|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83492859|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
83492860|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83492861|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83492862|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492863|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492864|NCT01725776|Protective Agents|protective agents|mesh-ancestor
83492865|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492866|NCT01830296|Morphine|morphine|mesh-list
83492867|NCT01830296|Remifentanil|remifentanil|mesh-list
83492868|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83492869|NCT01830296|Narcotics|narcotics|mesh-ancestor
83492870|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492871|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492872|NCT01830296|Analgesics|analgesics|mesh-ancestor
83492873|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
83492874|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492875|NCT05564819|Acetaminophen|acetaminophen|mesh-list
83492876|NCT05564819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83492877|NCT05564819|Analgesics|analgesics|mesh-ancestor
83492878|NCT05564819|Sensory System Agents|sensory system agents|mesh-ancestor
83492879|NCT05564819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492880|NCT05564819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492881|NCT05564819|Antipyretics|antipyretics|mesh-ancestor
83492882|NCT01720394|Dinoprostone|dinoprostone|mesh-list
83492883|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
83492884|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83492885|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492886|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83492887|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83492888|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83492889|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83492890|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
83492891|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492892|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
83492893|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83492894|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83492895|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83492896|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83492897|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492898|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
83492899|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492900|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492901|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83492902|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492903|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
83492904|NCT01568255|Vitamin D|vitamin d|mesh-list
83492905|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83492906|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492907|NCT01568255|Vitamins|vitamins|mesh-ancestor
83492908|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
83492909|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83492910|NCT01720628|Angiogenin|angiogenin|mesh-list
83492911|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83492912|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83492913|NCT01720628|Growth Substances|growth substances|mesh-ancestor
83492914|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492915|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
83492916|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83492917|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
83492918|NCT01569191|Epinastine|epinastine|mesh-list
83492919|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83492920|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83492921|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
83492922|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
83492923|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83492924|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492925|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492926|NCT03409874|Diclofenac|diclofenac|mesh-list
83492927|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83492928|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83492930|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
83492931|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83492932|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492933|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83492934|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492935|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83492936|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492937|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492938|NCT01726088|Modafinil|modafinil|mesh-list
83492939|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83492940|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492941|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83492942|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83492943|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83492944|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492945|NCT01468337|Interferons|interferons|mesh-list
83492946|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
83492947|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492948|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
83492949|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492950|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83492951|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83492952|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83492953|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
83492954|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492955|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83492956|NCT05562089|Paclitaxel|paclitaxel|mesh-list
83492957|NCT05562089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83492958|NCT05562089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492959|NCT05562089|Tubulin Modulators|tubulin modulators|mesh-ancestor
83492960|NCT05562089|Antimitotic Agents|antimitotic agents|mesh-ancestor
83492961|NCT05562089|Mitosis Modulators|mitosis modulators|mesh-ancestor
83492962|NCT05562089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492963|NCT01726478|Oxytocin|oxytocin|mesh-list
83492964|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
83492965|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83492966|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492967|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
83492968|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
83492969|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83492970|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83492971|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492972|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83492973|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492974|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492975|NCT03409250|Ranibizumab|ranibizumab|mesh-list
83492976|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83492977|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83492978|NCT03409250|Growth Substances|growth substances|mesh-ancestor
83492979|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83492980|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
83492981|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492982|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83492983|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83492984|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492985|NCT01469585|Doxycycline|doxycycline|mesh-list
83492986|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83492987|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492988|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
83492989|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83492990|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83492991|NCT01720940|Vancomycin|vancomycin|mesh-list
83492992|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83492993|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83492994|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83492995|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83492996|NCT01721798|Copper|copper|mesh-list
83492997|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
83492998|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83492999|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
83493000|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83493299|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493001|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493002|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83493003|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83493004|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83493005|NCT01721798|Trace Elements|trace elements|mesh-ancestor
83493006|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
83493007|NCT02497404|Fludarabine|fludarabine|mesh-list
83493008|NCT02497404|Azacitidine|azacitidine|mesh-list
83493009|NCT02497404|Melphalan|melphalan|mesh-list
83493010|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
83493011|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493012|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83493013|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
83493014|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493015|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83493016|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
83493017|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493018|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493019|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83493020|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
83493021|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83493022|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83493023|NCT01573169|Enoxaparin|enoxaparin|mesh-list
83493024|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
83493025|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83493026|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83493027|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493028|NCT04205994|Tolcapone|tolcapone|mesh-list
83493029|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83493030|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83493031|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83493032|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493033|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493034|NCT02218307|Mupirocin|mupirocin|mesh-list
83493035|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83493036|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493037|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83493038|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493039|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493040|NCT01722110|Indomethacin|indomethacin|mesh-list
83493041|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83493042|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83493043|NCT01722110|Analgesics|analgesics|mesh-ancestor
83493044|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
83493045|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493046|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493047|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83493048|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83493049|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
83493050|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
83493051|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83493052|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83493053|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493054|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493055|NCT01573949|Metformin|metformin|mesh-list
83493056|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83493057|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493058|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83493059|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
83493060|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83493061|NCT01574183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83493062|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83493063|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83493064|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493065|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493066|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
83493067|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493068|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83493069|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83493070|NCT01574807|Lidocaine|lidocaine|mesh-list
83493071|NCT01574807|Mepivacaine|mepivacaine|mesh-list
83493072|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
83493073|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
83493074|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493075|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493076|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
83493077|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493078|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83493079|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83493080|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83493081|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83493082|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493083|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83493084|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83493085|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
83493086|NCT01728272|Metoprolol|metoprolol|mesh-list
83493087|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83493088|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83493089|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
83493090|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
83493091|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493092|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493093|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83493094|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83493095|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83493096|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
83493097|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493098|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493099|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
83493100|NCT03835286|Vitamins|vitamins|mesh-ancestor
83493101|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
83493102|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493103|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
83493104|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493105|NCT03835286|Protective Agents|protective agents|mesh-ancestor
83493106|NCT04377386|Vitamin D|vitamin d|mesh-list
83493107|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
83493108|NCT04377386|Cholecalciferol|cholecalciferol|mesh-list
83493109|NCT04377386|Vitamins|vitamins|mesh-list
83493110|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
83493111|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493112|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83493113|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83493114|NCT01728740|Metformin|metformin|mesh-list
83493115|NCT01728740|Acarbose|acarbose|mesh-list
83493116|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83493117|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493118|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83493119|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493120|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493121|NCT01728818|Gemcitabine|gemcitabine|mesh-list
83493122|NCT01728818|Afatinib|afatinib|mesh-list
83493123|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83493124|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
83493125|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493126|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493127|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83493128|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493129|NCT03835520|Immunomodulating Agents|immunomodulating agents|mesh-list
83493130|NCT03835520|Immunologic Factors|immunologic factors|mesh-ancestor
83493131|NCT03835520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493132|NCT01728974|Anesthetics|anesthetics|mesh-list
83493133|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493134|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493135|NCT03407300|Docetaxel|docetaxel|mesh-list
83493136|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493137|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
83493138|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
83493139|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
83493140|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493141|NCT01722968|Paclitaxel|paclitaxel|mesh-list
83493142|NCT01722968|Bevacizumab|bevacizumab|mesh-list
83493143|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83493144|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493145|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
83493146|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
83493147|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
83493148|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493300|NCT03405584|Antacids|antacids|mesh-ancestor
83493149|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83493150|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83493151|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83493152|NCT01722968|Growth Substances|growth substances|mesh-ancestor
83493153|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493154|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
83493155|NCT04379180|Bosentan|bosentan|mesh-list
83493156|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
83493157|NCT04379180|Tadalafil|tadalafil|mesh-list
83493158|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
83493159|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83493160|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83493161|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493162|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493163|NCT04379180|Urological Agents|urological agents|mesh-ancestor
83493164|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83493165|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83493166|NCT01576523|Complement C1s|complement c1s|mesh-list
83493167|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83493168|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83493169|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
83493170|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493171|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83493172|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83493173|NCT03406676|Methylene Blue|methylene blue|mesh-list
83493174|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493175|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493176|NCT03001739|Urapidil|urapidil|mesh-list
83493177|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83493178|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
83493179|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83493180|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
83493181|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493182|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493183|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493184|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83493185|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83493186|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83493187|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
83493188|NCT03001661|Dinoprostone|dinoprostone|mesh-list
83493189|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
83493190|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83493191|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493192|NCT03006965|Factor VIII|factor viii|mesh-list
83493193|NCT03006965|BAX 855|bax 855|mesh-list
83493194|NCT03006965|Coagulants|coagulants|mesh-ancestor
83493195|NCT04379102|Anesthetics|anesthetics|mesh-list
83493196|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
83493197|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493198|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493199|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
83493200|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493201|NCT02469246|Lamivudine|lamivudine|mesh-list
83493202|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83493203|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83493204|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493205|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493206|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
83493207|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493208|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83493209|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83493210|NCT01723202|Trametinib|trametinib|mesh-list
83493211|NCT01723202|Dabrafenib|dabrafenib|mesh-list
83493212|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493213|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83493214|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493215|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493216|NCT01578317|Vaccines|vaccines|mesh-list
83493217|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
83493218|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493219|NCT03830216|Insulin|insulin|mesh-list
83493220|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83493221|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83493222|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493223|NCT01726946|Ribavirin|ribavirin|mesh-list
83493224|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
83493225|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493226|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
83493227|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493228|NCT01723670|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
83493229|NCT01723670|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83493230|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493231|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493233|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83493234|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493235|NCT02469090|Apomorphine|apomorphine|mesh-list
83493236|NCT02469090|Emetics|emetics|mesh-ancestor
83493237|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493238|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
83493239|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493240|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83493241|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
83493242|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
83493243|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493244|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493245|NCT02496000|Insulin|insulin|mesh-list
83493246|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83493247|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493248|NCT02517528|Ritonavir|ritonavir|mesh-list
83493249|NCT02517528|Ribavirin|ribavirin|mesh-list
83493250|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83493251|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83493252|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
83493253|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493254|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493255|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83493256|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83493257|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
83493258|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493259|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83493260|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83493261|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
83493262|NCT01727336|Axitinib|axitinib|mesh-list
83493263|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493264|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83493265|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493266|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493267|NCT01578707|Ofatumumab|ofatumumab|mesh-list
83493268|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493269|NCT03835442|Baclofen|baclofen|mesh-list
83493270|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83493271|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493272|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83493273|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493274|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83493275|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
83493276|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
83493277|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493278|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493279|NCT01722656|Aflibercept|aflibercept|mesh-list
83493280|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83493281|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83493282|NCT01722656|Growth Substances|growth substances|mesh-ancestor
83493283|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493284|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
83493285|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493286|NCT04963764|Amoxicillin|amoxicillin|mesh-list
83493287|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83493288|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493289|NCT03405584|Amoxicillin|amoxicillin|mesh-list
83493290|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
83493291|NCT03405584|Esomeprazole|esomeprazole|mesh-list
83493292|NCT03405584|Bismuth|bismuth|mesh-list
83493293|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493294|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83493295|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493296|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83493297|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83493298|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83493303|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493304|NCT03405584|Expectorants|expectorants|mesh-ancestor
83493305|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
83493306|NCT03007121|Sufentanil|sufentanil|mesh-list
83493307|NCT03007121|Morphine|morphine|mesh-list
83493308|NCT03007121|Dsuvia|dsuvia|mesh-list
83493309|NCT03007121|Bupivacaine|bupivacaine|mesh-list
83493310|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
83493311|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
83493312|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493313|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493314|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
83493315|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493316|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83493317|NCT03007121|Narcotics|narcotics|mesh-ancestor
83493318|NCT03007121|Analgesics|analgesics|mesh-ancestor
83493319|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83493320|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83493321|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
83493322|NCT01725152|Ganaxolone|ganaxolone|mesh-list
83493323|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
83493324|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493325|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493326|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493327|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
83493328|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
83493329|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83493330|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83493331|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
83493332|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83493333|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493334|NCT02981303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83493335|NCT02981303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493336|NCT02981459|Mirabegron|mirabegron|mesh-list
83493337|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83493338|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83493339|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83493340|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
83493341|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493342|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493343|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493344|NCT02981459|Urological Agents|urological agents|mesh-ancestor
83493345|NCT01724138|Deferasirox|deferasirox|mesh-list
83493346|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83493347|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
83493348|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
83493349|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493350|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83493351|NCT03006809|Metronidazole|metronidazole|mesh-list
83493352|NCT03006809|Vancomycin|vancomycin|mesh-list
83493353|NCT03006809|Neomycin|neomycin|mesh-list
83493354|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493355|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83493356|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83493357|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83493358|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493359|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493360|NCT01580423|Aprepitant|aprepitant|mesh-list
83493361|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
83493362|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
83493363|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493364|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493365|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83493366|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83493367|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493368|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493369|NCT01049984|Rasagiline|rasagiline|mesh-list
83493370|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83493371|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493372|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493373|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83493374|NCT01049984|Protective Agents|protective agents|mesh-ancestor
83493375|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493376|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83493377|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83493381|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493382|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83493383|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83493384|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493385|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83493387|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
83493388|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83493389|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493390|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
83493391|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83493392|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
83493393|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493394|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493395|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83493396|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
83493397|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83493398|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83493399|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83493400|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
83493401|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493402|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493403|NCT02494596|Capecitabine|capecitabine|mesh-list
83493404|NCT02494596|Pertuzumab|pertuzumab|mesh-list
83493405|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83493406|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
83493407|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493408|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493409|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83493410|NCT01048502|Fenofibrate|fenofibrate|mesh-list
83493411|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83493412|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
83493413|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493414|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83493415|NCT01583543|Olaparib|olaparib|mesh-list
83493416|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83493417|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493418|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493419|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493420|NCT01724372|Aripiprazole|aripiprazole|mesh-list
83493421|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
83493422|NCT01724372|Fluoxetine|fluoxetine|mesh-list
83493423|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
83493424|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83493425|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83493426|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493427|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493428|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
83493429|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
83493430|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493431|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493432|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83493433|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83493434|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
83493435|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83493436|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83493437|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83493438|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83493439|NCT01724372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83493440|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83493441|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83493442|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83493443|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83493444|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83493445|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493446|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
83493447|NCT02464410|Narcotics|narcotics|mesh-ancestor
83493448|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493449|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493450|NCT02464410|Analgesics|analgesics|mesh-ancestor
83493451|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
83493452|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493456|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493457|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83493458|NCT03405272|Antibodies|antibodies|mesh-list
83493459|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83493460|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
83493461|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493462|NCT03405194|Efavirenz|efavirenz|mesh-list
83493463|NCT03405194|Cobicistat|cobicistat|mesh-list
83493464|NCT03405194|Elvitegravir|elvitegravir|mesh-list
83493465|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83493466|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83493467|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493468|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493469|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
83493470|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493471|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83493472|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83493473|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83493474|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83493475|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83493476|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83493478|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83493479|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83493480|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83493481|NCT03006107|Piroxicam|piroxicam|mesh-list
83493482|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83493483|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83493484|NCT03006107|Analgesics|analgesics|mesh-ancestor
83493485|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
83493486|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493487|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493488|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83493489|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83493490|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83493491|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493492|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493493|NCT01046396|Adapalene|adapalene|mesh-list
83493494|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83493495|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83493496|NCT01046396|Analgesics|analgesics|mesh-ancestor
83493497|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
83493498|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493499|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493500|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83493501|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83493502|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
83493503|NCT01046084|Lansoprazole|lansoprazole|mesh-list
83493504|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
83493505|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83493506|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83493507|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83493508|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493509|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493510|NCT01045694|Triamcinolone|triamcinolone|mesh-list
83493511|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83493512|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83493513|NCT01045694|Lidocaine|lidocaine|mesh-list
83493514|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
83493515|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83493516|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83493517|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83493518|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
83493519|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
83493520|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493521|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493522|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
83493523|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493524|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83493525|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83493526|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83493527|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83493528|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493529|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83493530|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
83493531|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493532|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83493533|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83493534|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
83493535|NCT01045694|Hormones|hormones|mesh-ancestor
83493536|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83493537|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83493538|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
83493539|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493540|NCT01586975|Aspirin|aspirin|mesh-list
83493541|NCT01586975|Clopidogrel|clopidogrel|mesh-list
83493542|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83493543|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83493544|NCT01586975|Analgesics|analgesics|mesh-ancestor
83493545|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
83493546|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493547|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493548|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83493549|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83493550|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83493551|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83493552|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493553|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83493554|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83493555|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493556|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
83493557|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83493558|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83493559|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83493560|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
83493561|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493562|NCT03000413|Fentanyl|fentanyl|mesh-list
83493563|NCT03000413|Ketamine|ketamine|mesh-list
83493564|NCT03000413|Analgesics|analgesics|mesh-ancestor
83493565|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
83493566|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493567|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493568|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83493569|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83493570|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
83493571|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
83493572|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493573|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83493574|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83493575|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493576|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493577|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83493578|NCT03000413|Narcotics|narcotics|mesh-ancestor
83493579|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83493580|NCT01724918|Lacosamide|lacosamide|mesh-list
83493581|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
83493582|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83493583|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83493584|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83493585|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493586|NCT01588457|Lamotrigine|lamotrigine|mesh-list
83493587|NCT01588457|Valproic Acid|valproic acid|mesh-list
83493588|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83493589|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
83493590|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
83493591|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83493592|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83493593|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83493594|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493595|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493596|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493597|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493598|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
83493599|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
83493600|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83493601|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83493602|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83493603|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83493604|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
83493605|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493607|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493608|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83493609|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493610|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493611|NCT01590875|Adenosine|adenosine|mesh-list
83493612|NCT01590875|Analgesics|analgesics|mesh-ancestor
83493613|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
83493614|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493615|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493616|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83493617|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
83493618|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83493619|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
83493620|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
83493621|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493622|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493623|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83493624|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83493625|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493626|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83493627|NCT01725230|Simvastatin|simvastatin|mesh-list
83493628|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83493629|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83493630|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
83493631|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493632|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83493633|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83493634|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493635|NCT01591733|Capecitabine|capecitabine|mesh-list
83493636|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
83493638|NCT01591733|Folfirinox|folfirinox|mesh-list
83493639|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83493640|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
83493641|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493642|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493643|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83493644|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83493645|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493646|NCT03005405|Methamphetamine|methamphetamine|mesh-list
83493647|NCT03005405|Fluorides|fluorides|mesh-list
83493648|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
83493649|NCT03005405|Protective Agents|protective agents|mesh-ancestor
83493650|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493651|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83493652|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
83493653|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
83493654|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493655|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
83493656|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493657|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493658|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
83493659|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83493660|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83493661|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83493662|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83493663|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83493664|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83493665|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
83493666|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493667|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493668|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83493669|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
83493670|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83493671|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83493672|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83493673|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
83493674|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493675|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493676|NCT03005483|Gabapentin|gabapentin|mesh-list
83493677|NCT03005483|Analgesics|analgesics|mesh-ancestor
83493678|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
83493679|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493680|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493681|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
83493684|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493685|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83493686|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83493687|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83493688|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493689|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493691|NCT01593215|Yohimbine|yohimbine|mesh-list
83493692|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
83493693|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
83493694|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493695|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493696|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83493697|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83493698|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83493699|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
83493700|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493701|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493702|NCT01593215|Urological Agents|urological agents|mesh-ancestor
83493703|NCT05404919|Tenofovir|tenofovir|mesh-list
83493704|NCT05404919|Entecavir|entecavir|mesh-list
83493705|NCT05404919|Immunoglobulins|immunoglobulins|mesh-list
83493706|NCT05404919|Antibodies|antibodies|mesh-list
83493707|NCT05404919|gamma-Globulins|gamma-globulins|mesh-list
83493708|NCT05404919|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83493709|NCT05404919|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83493710|NCT05404919|Antiviral Agents|antiviral agents|mesh-ancestor
83493711|NCT05404919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493712|NCT05404919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83493713|NCT05404919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83493714|NCT05404919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493715|NCT05404919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493716|NCT05404919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83493717|NCT05404919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83493718|NCT05404919|Immunologic Factors|immunologic factors|mesh-ancestor
83493719|NCT05404919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493720|NCT03005015|Doxorubicin|doxorubicin|mesh-list
83493721|NCT03005015|Lenvatinib|lenvatinib|mesh-list
83493722|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83493723|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493724|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83493725|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83493726|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493727|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493728|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83493729|NCT03005171|Lidocaine|lidocaine|mesh-list
83493730|NCT03005171|Bupivacaine|bupivacaine|mesh-list
83493731|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
83493732|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
83493733|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493734|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493735|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
83493736|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493737|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83493738|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83493739|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83493740|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83493741|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493742|NCT01041638|Vitamin A|vitamin a|mesh-list
83493743|NCT01041638|Aldesleukin|aldesleukin|mesh-list
83493744|NCT01041638|Interleukin-2|interleukin-2|mesh-list
83493745|NCT01041638|Tretinoin|tretinoin|mesh-list
83493746|NCT01041638|Dinutuximab|dinutuximab|mesh-list
83493747|NCT01041638|Isotretinoin|isotretinoin|mesh-list
83493748|NCT01041638|Sargramostim|sargramostim|mesh-list
83493749|NCT01041638|Vitamins|vitamins|mesh-ancestor
83493750|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
83493751|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493752|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493753|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83493754|NCT01041638|Analgesics|analgesics|mesh-ancestor
83493755|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
83493756|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493757|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
83493758|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83493759|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83493761|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493762|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
83493763|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
83493764|NCT03004625|Ribavirin|ribavirin|mesh-list
83493765|NCT03004625|Asunaprevir|asunaprevir|mesh-list
83493766|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
83493767|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493768|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
83493769|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493770|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
83493771|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493772|NCT05566301|Clopidogrel|clopidogrel|mesh-list
83493773|NCT05566301|Ticagrelor|ticagrelor|mesh-list
83493774|NCT05566301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83493775|NCT05566301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83493776|NCT05566301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83493777|NCT05566301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83493778|NCT05566301|Purinergic Agents|purinergic agents|mesh-ancestor
83493779|NCT05566301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493780|NCT05566301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493781|NCT05566301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493782|NCT03404024|Mitogens|mitogens|mesh-list
83493783|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
83493784|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493785|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
83493786|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83493787|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493788|NCT05131919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83493789|NCT05131919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493790|NCT01725542|Ribavirin|ribavirin|mesh-list
83493791|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83493792|NCT01725542|Asunaprevir|asunaprevir|mesh-list
83493793|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
83493794|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493795|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
83493796|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493797|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
83493798|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493799|NCT01725620|Etanercept|etanercept|mesh-list
83493800|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83493801|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83493802|NCT01725620|Analgesics|analgesics|mesh-ancestor
83493803|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
83493804|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493805|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493806|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83493807|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83493808|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83493809|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83493810|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
83493811|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
83493812|NCT01045460|Melphalan|melphalan|mesh-list
83493813|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83493814|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
83493815|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493816|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83493817|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83493818|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
83493819|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493820|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493821|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83493822|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83493823|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
83493824|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83493825|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83493826|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83493827|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493828|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493829|NCT05014919|Vortioxetine|vortioxetine|mesh-list
83493830|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
83493831|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83493832|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83493833|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83493834|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494056|NCT04374188|Levofloxacin|levofloxacin|mesh-list
83493835|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493836|NCT05014919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83493837|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83493838|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83493839|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493840|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493841|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
83493842|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83493843|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83493844|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83493845|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83493846|NCT05620862|Mitoxantrone|mitoxantrone|mesh-list
83493847|NCT05620862|Analgesics|analgesics|mesh-ancestor
83493848|NCT05620862|Sensory System Agents|sensory system agents|mesh-ancestor
83493849|NCT05620862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493850|NCT05620862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493851|NCT05620862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493852|NCT05620862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83493853|NCT05620862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83493854|NCT05620862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493855|NCT05620862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493856|NCT03406286|Tolvaptan|tolvaptan|mesh-list
83493857|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83493858|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493859|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
83493860|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493861|NCT05672537|Gemcitabine|gemcitabine|mesh-list
83493862|NCT05672537|Durvalumab|durvalumab|mesh-list
83493863|NCT05672537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493864|NCT05672537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83493865|NCT05672537|Antimetabolites|antimetabolites|mesh-ancestor
83493866|NCT05672537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493867|NCT05672537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83493868|NCT03400592|Irinotecan|irinotecan|mesh-list
83493869|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
83493870|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83493871|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83493872|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493873|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493874|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493875|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83493876|NCT02218463|Estradiol|estradiol|mesh-list
83493877|NCT02218463|Estrogens|estrogens|mesh-ancestor
83493878|NCT02218463|Hormones|hormones|mesh-ancestor
83493879|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83493880|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493881|NCT00919802|Oxytocin|oxytocin|mesh-list
83493882|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
83493883|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83493884|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493885|NCT02222129|Bupivacaine|bupivacaine|mesh-list
83493886|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
83493887|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
83493888|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493889|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493890|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
83493891|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493892|NCT03003611|Anesthetics|anesthetics|mesh-list
83493893|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493894|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493895|NCT03401294|Leucovorin|leucovorin|mesh-list
83493896|NCT03401294|Bevacizumab|bevacizumab|mesh-list
83493897|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
83493898|NCT03401294|Irinotecan|irinotecan|mesh-list
83493899|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83493900|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493901|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83493902|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83493903|NCT03401294|Growth Substances|growth substances|mesh-ancestor
83493904|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493905|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
83493906|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83493907|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83493908|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493909|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493911|NCT03401294|Protective Agents|protective agents|mesh-ancestor
83493912|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
83493913|NCT03401294|Vitamins|vitamins|mesh-ancestor
83493914|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
83493915|NCT02980991|Pemetrexed|pemetrexed|mesh-list
83493916|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493917|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493918|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493919|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83493920|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83493921|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
83493922|NCT03402698|Vitamin D|vitamin d|mesh-list
83493923|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83493924|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493925|NCT03402698|Vitamins|vitamins|mesh-ancestor
83493926|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
83493927|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83493928|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
83493929|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83493930|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493931|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
83493932|NCT02248181|Pramipexole|pramipexole|mesh-list
83493933|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
83493934|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493935|NCT02248181|Protective Agents|protective agents|mesh-ancestor
83493936|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493937|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83493938|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83493939|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
83493940|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
83493941|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493942|NCT03003143|Vigabatrin|vigabatrin|mesh-list
83493943|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
83493944|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493945|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493946|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
83493947|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83493948|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493949|NCT02462928|Ranibizumab|ranibizumab|mesh-list
83493950|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83493951|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83493952|NCT02462928|Growth Substances|growth substances|mesh-ancestor
83493953|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493954|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
83493955|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493956|NCT03002831|Tegafur|tegafur|mesh-list
83493957|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83493958|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
83493959|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493960|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83493961|NCT02248259|Itraconazole|itraconazole|mesh-list
83493962|NCT02248259|BI 409306|bi 409306|mesh-list
83493963|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
83493964|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83493965|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83493966|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83493967|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493968|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493969|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83493970|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
83493971|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83493972|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493973|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83493974|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83493975|NCT04526951|Aspirin|aspirin|mesh-list
83493976|NCT04526951|Tenecteplase|tenecteplase|mesh-list
83493977|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83493978|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83493979|NCT04526951|Analgesics|analgesics|mesh-ancestor
83493980|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
83493981|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83493982|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83493983|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83493984|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83493985|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83493986|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83493987|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493988|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83493989|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83493990|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493991|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
83493992|NCT04956432|Allopurinol|allopurinol|mesh-list
83493993|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
83493994|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493995|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83493996|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
83493997|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83493998|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83493999|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
83494000|NCT04956432|Protective Agents|protective agents|mesh-ancestor
83494001|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494002|NCT02248415|Anesthetics|anesthetics|mesh-list
83494003|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494004|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494005|NCT02248571|Bevacizumab|bevacizumab|mesh-list
83494006|NCT02248571|Capecitabine|capecitabine|mesh-list
83494007|NCT02248571|Everolimus|everolimus|mesh-list
83494008|NCT02248571|Exemestane|exemestane|mesh-list
83494009|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83494010|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494011|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83494012|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83494013|NCT02248571|Growth Substances|growth substances|mesh-ancestor
83494014|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494015|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
83494016|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83494017|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
83494018|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494019|NCT02248571|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83494020|NCT02248571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83494021|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494022|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83494023|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
83494024|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83494025|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83494026|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83494027|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
83494028|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83494029|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83494030|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83494031|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494032|NCT03002675|Exenatide|exenatide|mesh-list
83494033|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83494034|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494035|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83494036|NCT03002675|Incretins|incretins|mesh-ancestor
83494037|NCT03002675|Hormones|hormones|mesh-ancestor
83494038|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83494039|NCT02246270|Heparin|heparin|mesh-list
83494040|NCT02246270|Calcium heparin|calcium heparin|mesh-list
83494041|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
83494042|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83494043|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83494044|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494045|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83494046|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83494047|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83494048|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494049|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494050|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83494051|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83494052|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494053|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
83494054|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494055|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
83494057|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83494058|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494059|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83494060|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83494061|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494062|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494063|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494064|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83494065|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83494066|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83494067|NCT04374032|Enkephalin, Methionine|enkephalin, methionine|mesh-list
83494068|NCT04374032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494069|NCT04374032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494070|NCT04374032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494071|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
83494072|NCT03401606|Remifentanil|remifentanil|mesh-list
83494073|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83494074|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494075|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494076|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83494077|NCT03401606|Analgesics|analgesics|mesh-ancestor
83494078|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
83494079|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494080|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83494081|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83494082|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83494083|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
83494084|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494085|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494086|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83494087|NCT03401606|Narcotics|narcotics|mesh-ancestor
83494088|NCT02516592|Fluticasone|fluticasone|mesh-list
83494089|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83494090|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83494091|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83494092|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
83494093|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494094|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494095|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83494096|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
83494097|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
83494098|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83494099|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83494100|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83494101|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83494102|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
83494103|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494104|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494105|NCT03401372|Doxycycline|doxycycline|mesh-list
83494106|NCT03401372|Dexamethasone|dexamethasone|mesh-list
83494107|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
83494108|NCT03401372|Bortezomib|bortezomib|mesh-list
83494109|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83494110|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
83494111|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494112|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83494113|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83494114|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
83494115|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494116|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494117|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83494118|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83494119|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
83494120|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
83494121|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494122|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83494123|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
83494124|NCT03401372|Hormones|hormones|mesh-ancestor
83494125|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83494126|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83494127|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83494128|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494129|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
83494130|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83494142|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494143|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494144|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
83494145|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494146|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83494147|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83494148|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83494149|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83494150|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494151|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83494152|NCT04955574|Metronidazole|metronidazole|mesh-list
83494153|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83494154|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494155|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
83494156|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83494157|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83494158|NCT04716335|Harmine|harmine|mesh-list
83494159|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
83494160|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494161|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83494162|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83494163|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494164|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494165|NCT04283669|Crizotinib|crizotinib|mesh-list
83494166|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494167|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83494168|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494169|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494170|NCT02221349|Listerine|listerine|mesh-list
83494171|NCT02221349|Fluorides|fluorides|mesh-list
83494172|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
83494173|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
83494174|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
83494175|NCT02221349|Protective Agents|protective agents|mesh-ancestor
83494176|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494177|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83494178|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494179|NCT02461758|Vaccines|vaccines|mesh-list
83494180|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
83494181|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494182|NCT02461290|Rituximab|rituximab|mesh-list
83494183|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83494184|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494185|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
83494186|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494187|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83494188|NCT04376528|Cyclosporine|cyclosporine|mesh-list
83494189|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
83494190|NCT04376528|Cyclosporins|cyclosporins|mesh-list
83494191|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494192|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494193|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83494194|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
83494195|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494196|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
83494197|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494198|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
83494199|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83494200|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83494201|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83494202|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494203|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83494204|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
83494205|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83494206|NCT02461134|Ponesimod|ponesimod|mesh-list
83494207|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83494208|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494209|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83494210|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
83494211|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494212|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
83494213|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83494214|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83494215|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83494216|NCT04373018|Eusol|eusol|mesh-list
83494518|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83494217|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83494218|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494219|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
83494220|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
83494221|NCT04934748|Phenylephrine|phenylephrine|mesh-list
83494222|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
83494223|NCT04934748|Norepinephrine|norepinephrine|mesh-list
83494224|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83494225|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
83494226|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
83494227|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494228|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494229|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
83494230|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83494231|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
83494232|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
83494233|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83494234|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83494235|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83494236|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
83494237|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494238|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494239|NCT04934748|Protective Agents|protective agents|mesh-ancestor
83494240|NCT04594733|Minocycline|minocycline|mesh-list
83494241|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83494242|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494243|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
83494244|NCT02223065|Saxagliptin|saxagliptin|mesh-list
83494245|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83494246|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494247|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83494248|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494249|NCT02223065|Incretins|incretins|mesh-ancestor
83494250|NCT02223065|Hormones|hormones|mesh-ancestor
83494251|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83494252|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83494253|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
83494254|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494255|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83494256|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83494257|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
83494258|NCT02241200|Hematinics|hematinics|mesh-ancestor
83494259|NCT02241278|Ketamine|ketamine|mesh-list
83494260|NCT02241278|Analgesics|analgesics|mesh-ancestor
83494261|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
83494262|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494263|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494264|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83494265|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83494266|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
83494267|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
83494268|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494269|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83494270|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83494271|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494272|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494273|NCT04347512|Azithromycin|azithromycin|mesh-list
83494274|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
83494275|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83494276|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494277|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
83494278|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83494279|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83494280|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494281|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494282|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83494283|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
83494284|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83494285|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494286|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83494287|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494288|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
83494289|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
83494290|NCT04372316|Vitamins|vitamins|mesh-ancestor
83494291|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
83494292|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494294|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83494295|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494296|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83494297|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494298|NCT02241356|Methamphetamine|methamphetamine|mesh-list
83494299|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83494300|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494301|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
83494302|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
83494303|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494304|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
83494305|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494306|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494307|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
83494308|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83494309|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83494310|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83494311|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83494312|NCT04365686|Propofol|propofol|mesh-list
83494313|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83494314|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494315|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494316|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83494317|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
83494318|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
83494319|NCT02241590|Entecavir|entecavir|mesh-list
83494320|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
83494321|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494322|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
83494323|NCT04083755|Hematinics|hematinics|mesh-ancestor
83494324|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
83494325|NCT04372082|Niclosamide|niclosamide|mesh-list
83494326|NCT04372082|Diltiazem|diltiazem|mesh-list
83494327|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
83494328|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83494329|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83494330|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494331|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494332|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494333|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83494334|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83494335|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83494336|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83494337|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83494338|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494339|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
83494340|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
83494341|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83494342|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
83494343|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
83494344|NCT05363111|Daratumumab|daratumumab|mesh-list
83494345|NCT05363111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83494346|NCT05363111|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83494347|NCT05363111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494348|NCT05363111|Immunologic Factors|immunologic factors|mesh-ancestor
83494349|NCT05363111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494350|NCT05363111|Chelating Agents|chelating agents|mesh-ancestor
83494351|NCT05363111|Sequestering Agents|sequestering agents|mesh-ancestor
83494352|NCT05363111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494353|NCT02489448|Durvalumab|durvalumab|mesh-list
83494354|NCT02489448|Tremelimumab|tremelimumab|mesh-list
83494355|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83494356|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494357|NCT00926588|Analgesics|analgesics|mesh-list
83494358|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
83494359|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494360|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494361|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
83494362|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
83494363|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83494364|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83494365|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494366|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494367|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494368|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83494369|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
83494370|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83494371|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494372|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83494373|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83494374|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494375|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494376|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494377|NCT04364906|Anesthetics|anesthetics|mesh-list
83494378|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494379|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494380|NCT04134845|Dantrolene|dantrolene|mesh-list
83494381|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83494382|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494383|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83494384|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494385|NCT02488980|Mefloquine|mefloquine|mesh-list
83494386|NCT02488980|Tafenoquine|tafenoquine|mesh-list
83494387|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
83494388|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83494389|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83494390|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494391|NCT02227667|Durvalumab|durvalumab|mesh-list
83494392|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83494393|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494394|NCT02242214|Misoprostol|misoprostol|mesh-list
83494395|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83494396|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
83494397|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83494398|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494399|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83494400|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83494401|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
83494402|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
83494403|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83494404|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494405|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494406|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83494407|NCT02245256|Analgesics|analgesics|mesh-ancestor
83494408|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
83494409|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494410|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83494411|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83494412|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83494413|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
83494414|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494415|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494416|NCT05208983|Vaccines|vaccines|mesh-list
83494417|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
83494418|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494419|NCT02242292|Scopolamine|scopolamine|mesh-list
83494420|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83494421|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83494422|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
83494423|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
83494424|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494425|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494426|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83494427|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
83494428|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83494429|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
83494430|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494431|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494432|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83494433|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
83494434|NCT02242370|Telmisartan|telmisartan|mesh-list
83494435|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83494436|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83494437|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83494438|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494439|NCT04371146|Methylphenidate|methylphenidate|mesh-list
83494440|NCT04371146|Reboxetine|reboxetine|mesh-list
83494441|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83494442|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494443|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83494444|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83494445|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83494446|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494447|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
83494448|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494449|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
83494450|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83494451|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83494452|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
83494453|NCT01623479|Bimatoprost|bimatoprost|mesh-list
83494454|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83494455|NCT03399539|Dexamethasone|dexamethasone|mesh-list
83494456|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
83494458|NCT03399539|Ixazomib|ixazomib|mesh-list
83494459|NCT03399539|Ichthammol|ichthammol|mesh-list
83494460|NCT03399539|BB 1101|bb 1101|mesh-list
83494461|NCT03399539|Glycine|glycine|mesh-list
83494462|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83494463|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
83494464|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
83494465|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494466|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494467|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83494468|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
83494469|NCT03399539|Hormones|hormones|mesh-ancestor
83494470|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83494471|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83494472|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494473|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494474|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
83494475|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494476|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
83494477|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
83494478|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494479|NCT04347200|Anticoagulants|anticoagulants|mesh-list
83494480|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83494481|NCT04364516|Vitamin K|vitamin k|mesh-list
83494482|NCT04364516|Anticoagulants|anticoagulants|mesh-list
83494483|NCT04364516|Vitamins|vitamins|mesh-ancestor
83494484|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
83494485|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494486|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83494487|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83494488|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494489|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
83494490|NCT04364516|Coagulants|coagulants|mesh-ancestor
83494491|NCT01623869|Trebananib|trebananib|mesh-list
83494492|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83494493|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83494494|NCT01623869|Growth Substances|growth substances|mesh-ancestor
83494495|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494496|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
83494497|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494498|NCT02242838|Telmisartan|telmisartan|mesh-list
83494499|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83494500|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83494501|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83494502|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494503|NCT03207347|Niraparib|niraparib|mesh-list
83494504|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83494505|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494506|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494507|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494508|NCT02249039|Clonidine|clonidine|mesh-list
83494509|NCT02249039|Analgesics|analgesics|mesh-ancestor
83494510|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
83494511|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494512|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494513|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83494514|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
83494515|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
83494516|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83494517|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83494558|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494559|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83494560|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494561|NCT03102125|Regadenoson|regadenoson|mesh-list
83494562|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83494563|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83494564|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
83494565|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
83494566|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494567|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494568|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494569|NCT04369586|Meplazumab|meplazumab|mesh-list
83494570|NCT04369586|Antiviral Agents|antiviral agents|mesh-ancestor
83494571|NCT04369586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494572|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
83494573|NCT02231177|Olodaterol|olodaterol|mesh-list
83494574|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83494575|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
83494576|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494577|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494578|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83494579|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
83494580|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
83494581|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83494582|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
83494583|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494584|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494585|NCT03283007|Nintedanib|nintedanib|mesh-list
83494586|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494587|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83494588|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494589|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494590|NCT02244086|Bupivacaine|bupivacaine|mesh-list
83494591|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
83494592|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
83494593|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494594|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494595|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
83494596|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494597|NCT01630109|Metoclopramide|metoclopramide|mesh-list
83494598|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
83494599|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
83494600|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494601|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494602|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83494603|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83494604|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83494605|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
83494606|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494607|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494608|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83494609|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83494610|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494611|NCT01632215|Gabapentin|gabapentin|mesh-list
83494612|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
83494613|NCT01632215|Analgesics|analgesics|mesh-ancestor
83494614|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
83494615|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494616|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494617|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83494618|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83494619|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494620|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83494621|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83494622|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83494623|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494624|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494625|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
83494626|NCT02244242|Tamsulosin|tamsulosin|mesh-list
83494627|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83494628|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83494629|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83494630|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
83494631|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494632|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494633|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494634|NCT02244242|Urological Agents|urological agents|mesh-ancestor
83494635|NCT03127631|Atorvastatin|atorvastatin|mesh-list
83494636|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83494637|NCT03127631|Simvastatin|simvastatin|mesh-list
83494638|NCT03127631|Pravastatin|pravastatin|mesh-list
83494639|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83494640|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83494641|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83494642|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
83494643|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494644|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83494645|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83494646|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494647|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
83494648|NCT02244320|Tamsulosin|tamsulosin|mesh-list
83494649|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83494650|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83494651|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83494652|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
83494653|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494654|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494655|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494656|NCT02244320|Urological Agents|urological agents|mesh-ancestor
83494657|NCT02244632|Bevacizumab|bevacizumab|mesh-list
83494658|NCT02244632|Fluorouracil|fluorouracil|mesh-list
83494659|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
83494660|NCT02244632|Irinotecan|irinotecan|mesh-list
83494661|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83494662|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494663|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83494664|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83494665|NCT02244632|Growth Substances|growth substances|mesh-ancestor
83494666|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494667|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
83494669|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494670|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83494671|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83494672|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
83494673|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83494674|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83494675|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494676|NCT03060083|Nicotine|nicotine|mesh-list
83494677|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83494678|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
83494679|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494680|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494681|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83494682|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83494683|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
83494684|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494685|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494686|NCT02244710|Clopidogrel|clopidogrel|mesh-list
83494687|NCT02244710|Ticagrelor|ticagrelor|mesh-list
83494688|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83494689|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83494690|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83494691|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83494692|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
83494693|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494694|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494695|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494696|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
83494697|NCT04362332|Chloroquine|chloroquine|mesh-list
83494698|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83494699|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
83494700|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83494701|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83494702|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494703|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494704|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494731|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494732|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83494733|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83494734|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
83494735|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494736|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494737|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83494738|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83494739|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
83494740|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83494741|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83494742|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83494744|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494745|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
83494746|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494747|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83494748|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83494749|NCT02245022|Tenofovir|tenofovir|mesh-list
83494750|NCT02245022|Lamivudine|lamivudine|mesh-list
83494751|NCT02245022|Efavirenz|efavirenz|mesh-list
83494752|NCT02245022|Dolutegravir|dolutegravir|mesh-list
83494753|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
83494754|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494755|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83494756|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83494757|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494758|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494759|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83494760|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83494761|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83494762|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83494763|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83494764|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83494765|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83494766|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83494767|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83494768|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83494769|NCT02224313|Estradiol|estradiol|mesh-list
83494770|NCT02224313|Progesterone|progesterone|mesh-list
83494771|NCT02224313|Estrogens|estrogens|mesh-ancestor
83494772|NCT02224313|Hormones|hormones|mesh-ancestor
83494773|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83494774|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494775|NCT02224313|Progestins|progestins|mesh-ancestor
83494776|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83494777|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
83494778|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494779|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
83494780|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83494781|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494782|NCT02460198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83494783|NCT02460198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494784|NCT01633853|Vitamin D|vitamin d|mesh-list
83494785|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
83494786|NCT01633853|Cholecalciferol|cholecalciferol|mesh-list
83494787|NCT01633853|Vitamins|vitamins|mesh-list
83494788|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
83494789|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494790|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83494791|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83494792|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
83494793|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
83494794|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
83494795|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494796|NCT04376216|Prednisone|prednisone|mesh-list
83494797|NCT04376216|Prednisolone|prednisolone|mesh-list
83494798|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83494799|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
83494800|NCT04376216|Hormones|hormones|mesh-ancestor
83494801|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83494802|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494803|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83494804|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494826|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83494827|NCT01635101|Analgesics|analgesics|mesh-ancestor
83494828|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
83494829|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494830|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494831|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
83494832|NCT02087111|Interferons|interferons|mesh-list
83494833|NCT02087111|Ribavirin|ribavirin|mesh-list
83494834|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
83494835|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
83494836|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83494837|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494838|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
83494839|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494840|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
83494841|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494842|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
83494843|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494844|NCT00932438|Leucovorin|leucovorin|mesh-list
83494845|NCT00932438|Bevacizumab|bevacizumab|mesh-list
83494846|NCT00932438|Fluorouracil|fluorouracil|mesh-list
83494847|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
83494848|NCT00932438|Irinotecan|irinotecan|mesh-list
83494849|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83494850|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494851|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83494852|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83494853|NCT00932438|Growth Substances|growth substances|mesh-ancestor
83494854|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494855|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
83494856|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
83494857|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494858|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83494859|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83494860|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
83494861|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83494862|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83494863|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494864|NCT00932438|Antidotes|antidotes|mesh-ancestor
83494865|NCT00932438|Protective Agents|protective agents|mesh-ancestor
83494866|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
83494867|NCT00932438|Vitamins|vitamins|mesh-ancestor
83494868|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
83494869|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
83494870|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83494871|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83494872|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494873|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
83494874|NCT01869413|Coagulants|coagulants|mesh-ancestor
83494875|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
83494876|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83494877|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494878|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494879|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83494880|NCT02982512|Analgesics|analgesics|mesh-ancestor
83494881|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
83494882|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494883|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83494884|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83494885|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83494886|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
83494887|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494888|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494889|NCT01555697|Memantine|memantine|mesh-list
83494890|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83494891|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83494892|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
83494893|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494894|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494895|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494896|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83494897|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83494898|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
83494899|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83494900|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83494901|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494931|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83494932|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
83494933|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494934|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494935|NCT02451696|Everolimus|everolimus|mesh-list
83494936|NCT02451696|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83494937|NCT02451696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83494938|NCT02451696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494939|NCT02451696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494940|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83494941|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
83494942|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494943|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494944|NCT00928772|Midazolam|midazolam|mesh-list
83494945|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83494946|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83494947|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494948|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494949|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83494950|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83494951|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83494952|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83494953|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
83494954|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
83494955|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
83494956|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
83494957|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494958|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494959|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83494960|NCT02459418|Hormones|hormones|mesh-ancestor
83494961|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83494962|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494963|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
83494964|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
83494965|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
83494966|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83494967|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83494968|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494969|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494970|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494971|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83494972|NCT00695279|Vaccines|vaccines|mesh-list
83494973|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
83494974|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494975|NCT04925076|Ethanol|ethanol|mesh-list
83494976|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83494977|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494978|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494979|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494980|NCT01598207|Dronabinol|dronabinol|mesh-list
83494981|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
83494982|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494983|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83494984|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83494985|NCT01598207|Analgesics|analgesics|mesh-ancestor
83494986|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
83494987|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494988|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83494989|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83494990|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494991|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494992|NCT01598207|Hormones|hormones|mesh-ancestor
83494993|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83494994|NCT01640171|Ketorolac|ketorolac|mesh-list
83494995|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83494996|NCT01640171|Lidocaine|lidocaine|mesh-list
83494997|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
83494998|NCT01640171|Anesthetics|anesthetics|mesh-list
83494999|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
83495000|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495001|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495002|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
83495003|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495004|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83495005|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83495006|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83495007|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495008|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495009|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83495010|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83495011|NCT01640171|Analgesics|analgesics|mesh-ancestor
83495012|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83495013|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83495014|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495015|NCT04361474|Budesonide|budesonide|mesh-list
83495016|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83495017|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83495018|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
83495019|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495020|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495021|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83495022|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
83495023|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
83495024|NCT04361474|Hormones|hormones|mesh-ancestor
83495025|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83495026|NCT04366622|Riociguat|riociguat|mesh-list
83495027|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
83495028|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495029|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
83495030|NCT02245334|Povidone|povidone|mesh-list
83495031|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
83495032|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
83495033|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83495034|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495035|NCT04762160|Rituximab|rituximab|mesh-list
83495036|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83495037|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495038|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
83495039|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495040|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83495041|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
83495042|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83495043|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83495044|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83495045|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
83495046|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495047|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495048|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495049|NCT04356872|Doxorubicin|doxorubicin|mesh-list
83495050|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83495051|NCT04356872|Ifosfamide|ifosfamide|mesh-list
83495052|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83495053|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495054|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83495055|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83495056|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495057|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495058|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83495059|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
83495060|NCT02487108|Acetaminophen|acetaminophen|mesh-list
83495061|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83495062|NCT02487108|Hydrocodone|hydrocodone|mesh-list
83495063|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83495064|NCT02487108|Analgesics|analgesics|mesh-ancestor
83495065|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
83495066|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495067|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495068|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
83495069|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83495070|NCT02487108|Narcotics|narcotics|mesh-ancestor
83495071|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495072|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
83495073|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
83495074|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83495075|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83495076|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83495077|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
83495078|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83495079|NCT02487030|Ledipasvir|ledipasvir|mesh-list
83495080|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
83495081|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495082|NCT02486952|Prednisone|prednisone|mesh-list
83495083|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
83495084|NCT02486952|Rituximab|rituximab|mesh-list
83495085|NCT02486952|Vincristine|vincristine|mesh-list
83495086|NCT02486952|Doxorubicin|doxorubicin|mesh-list
83495087|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83495088|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83495089|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
83495090|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495091|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83495092|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83495093|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
83495094|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495095|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495096|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83495097|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83495098|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83495099|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
83495100|NCT02486952|Hormones|hormones|mesh-ancestor
83495101|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83495102|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83495103|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83495104|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
83495105|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
83495106|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
83495107|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83495108|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83495109|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83495110|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495111|NCT02486796|Ubiquinone|ubiquinone|mesh-list
83495112|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
83495113|NCT02486796|Melatonin|melatonin|mesh-list
83495114|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
83495115|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495116|NCT02486796|Protective Agents|protective agents|mesh-ancestor
83495117|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495118|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495119|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
83495120|NCT02486796|Vitamins|vitamins|mesh-ancestor
83495121|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
83495122|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
83495123|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
83495124|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495125|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495126|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
83495127|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495128|NCT01641653|Midazolam|midazolam|mesh-list
83495129|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83495130|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83495131|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495132|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495133|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83495134|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83495135|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83495136|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83495137|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
83495138|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
83495139|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
83495140|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
83495141|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495142|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495143|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83495144|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83495145|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495146|NCT01600703|Incretins|incretins|mesh-ancestor
83495147|NCT01600703|Hormones|hormones|mesh-ancestor
83495148|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83495149|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83495150|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
83495151|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495152|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495153|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
83495154|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83495155|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83495156|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83495157|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495158|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495159|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
83495160|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495161|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495162|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83495163|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495164|NCT01605539|Cannabidiol|cannabidiol|mesh-list
83495165|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
83495166|NCT02458638|Atezolizumab|atezolizumab|mesh-list
83495167|NCT02458638|Antibodies|antibodies|mesh-list
83495168|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
83495169|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495170|NCT02458638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83495171|NCT02458638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495172|NCT02458638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83495173|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495174|NCT01607411|Fluorides|fluorides|mesh-list
83495175|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
83495176|NCT01607411|Protective Agents|protective agents|mesh-ancestor
83495177|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495178|NCT01691339|Vaccines|vaccines|mesh-list
83495179|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
83495180|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495181|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
83495182|NCT02233751|Testosterone|testosterone|mesh-list
83495183|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
83495184|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
83495185|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83495186|NCT02233751|Androgens|androgens|mesh-ancestor
83495187|NCT02233751|Hormones|hormones|mesh-ancestor
83495188|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83495189|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495190|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83495191|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495192|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
83495193|NCT01607645|Cytarabine|cytarabine|mesh-list
83495194|NCT01607645|Decitabine|decitabine|mesh-list
83495195|NCT01607645|Azacitidine|azacitidine|mesh-list
83495196|NCT01607645|Idarubicin|idarubicin|mesh-list
83495197|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83495198|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
83495199|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495200|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495201|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
83495202|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495203|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83495204|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
83495205|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495206|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495207|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83495208|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83495209|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83495210|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83495211|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83495212|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
83495213|NCT01647581|Hormones|hormones|mesh-ancestor
83495214|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83495215|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495216|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495217|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495218|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
83495219|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83495220|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83495221|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83495222|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495223|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495224|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
83495225|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495226|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495227|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83495228|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495229|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
83495230|NCT01649609|Sirolimus|sirolimus|mesh-list
83495231|NCT01649609|Tacrolimus|tacrolimus|mesh-list
83495233|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83495234|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
83495235|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495236|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83495237|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495238|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495239|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83495240|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495241|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83495242|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
83495243|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83495244|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495245|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
83495246|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83495247|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83495249|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83495250|NCT02449902|Estrogens|estrogens|mesh-ancestor
83495251|NCT02449902|Hormones|hormones|mesh-ancestor
83495252|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83495253|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495254|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83495255|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
83495256|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83495257|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83495258|NCT02449044|Tolvaptan|tolvaptan|mesh-list
83495259|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83495260|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495261|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
83495262|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495263|NCT04942626|Capecitabine|capecitabine|mesh-list
83495264|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83495265|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83495266|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
83495267|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495268|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495269|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83495271|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495272|NCT02228681|Tamoxifen|tamoxifen|mesh-list
83495273|NCT02228681|Everolimus|everolimus|mesh-list
83495274|NCT02228681|Letrozole|letrozole|mesh-list
83495275|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83495276|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
83495277|NCT02228681|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83495278|NCT02228681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83495279|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495280|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495281|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83495282|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
83495283|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495284|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495285|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83495286|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83495287|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83495288|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
83495289|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83495290|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83495291|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83495292|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83495293|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83495294|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83495295|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83495296|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83495297|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
83495298|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83495299|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83495300|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83495301|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83495302|NCT00942578|Prednisone|prednisone|mesh-list
83495303|NCT00942578|Bevacizumab|bevacizumab|mesh-list
83495304|NCT00942578|Lenalidomide|lenalidomide|mesh-list
83495305|NCT00942578|Docetaxel|docetaxel|mesh-list
83495453|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
83495306|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83495307|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495308|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83495309|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83495310|NCT00942578|Growth Substances|growth substances|mesh-ancestor
83495311|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495312|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
83495313|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
83495314|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
83495315|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
83495316|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495317|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83495318|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
83495319|NCT00942578|Hormones|hormones|mesh-ancestor
83495320|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83495321|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83495322|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
83495323|NCT02229461|Aspirin|aspirin|mesh-list
83495324|NCT02229461|Naproxen|naproxen|mesh-list
83495325|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83495326|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83495327|NCT02229461|Analgesics|analgesics|mesh-ancestor
83495328|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
83495329|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495330|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495331|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83495332|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83495333|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83495334|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83495335|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495336|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83495337|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83495338|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495339|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
83495340|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
83495341|NCT04641104|Thiamine|thiamine|mesh-list
83495342|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
83495343|NCT04641104|Vitamins|vitamins|mesh-ancestor
83495344|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
83495345|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495346|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
83495347|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83495348|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495349|NCT02237417|Aripiprazole|aripiprazole|mesh-list
83495350|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
83495351|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
83495352|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83495353|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83495354|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495355|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495356|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
83495357|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
83495358|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495359|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495360|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83495361|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83495362|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
83495363|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83495364|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83495365|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83495366|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83495367|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
83495368|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
83495369|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495370|NCT04603898|Protective Agents|protective agents|mesh-ancestor
83495371|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495372|NCT04603898|Vitamins|vitamins|mesh-ancestor
83495373|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
83495374|NCT02245490|Tamsulosin|tamsulosin|mesh-list
83495375|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83495376|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83495377|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83495378|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
83495379|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495380|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495381|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495382|NCT02245490|Urological Agents|urological agents|mesh-ancestor
83495384|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83495385|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83495386|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83495387|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495388|NCT00934934|Anidulafungin|anidulafungin|mesh-list
83495389|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
83495390|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495391|NCT01651793|Caffeine|caffeine|mesh-list
83495392|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83495393|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495394|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83495395|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495396|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495397|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83495398|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83495399|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
83495400|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495401|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
83495402|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83495403|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83495404|NCT01652495|Prednisolone|prednisolone|mesh-list
83495405|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
83495406|NCT01652495|Triamcinolone|triamcinolone|mesh-list
83495407|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83495408|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83495409|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83495410|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
83495411|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83495412|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83495413|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
83495414|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
83495415|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495416|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495417|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83495418|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
83495419|NCT01652495|Hormones|hormones|mesh-ancestor
83495420|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83495421|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83495422|NCT01652495|Protective Agents|protective agents|mesh-ancestor
83495423|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83495424|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495425|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83495426|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
83495427|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495428|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495429|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83495430|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
83495431|NCT00935792|Everolimus|everolimus|mesh-list
83495432|NCT00935792|Antibodies|antibodies|mesh-list
83495433|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
83495434|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83495435|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
83495436|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495437|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495438|NCT00935792|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83495439|NCT00935792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83495440|NCT00935792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495441|NCT00935792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495442|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83495443|NCT01699607|Amphetamine|amphetamine|mesh-list
83495444|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
83495445|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83495446|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495447|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
83495448|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
83495449|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495450|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
83495451|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495452|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495454|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83495455|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83495456|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495457|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83495458|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
83495459|NCT04355468|Anesthetics|anesthetics|mesh-list
83495460|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495461|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495462|NCT04355468|Narcotics|narcotics|mesh-ancestor
83495463|NCT04355468|Analgesics|analgesics|mesh-ancestor
83495464|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
83495465|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495466|NCT01653509|Acyclovir|acyclovir|mesh-list
83495467|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
83495468|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495469|NCT01614509|Triamcinolone|triamcinolone|mesh-list
83495470|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83495471|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83495472|NCT01614509|Bevacizumab|bevacizumab|mesh-list
83495473|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83495474|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83495475|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495476|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83495477|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83495478|NCT01614509|Growth Substances|growth substances|mesh-ancestor
83495479|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495480|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
83495481|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83495482|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
83495483|NCT01614509|Hormones|hormones|mesh-ancestor
83495484|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83495485|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83495486|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
83495487|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495488|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495489|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83495491|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495492|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495493|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83495494|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495495|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495496|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
83495497|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495498|NCT00943202|Vaccines|vaccines|mesh-list
83495499|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
83495500|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495501|NCT01654445|Tenecteplase|tenecteplase|mesh-list
83495502|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83495503|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83495504|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495505|NCT01703039|Riluzole|riluzole|mesh-list
83495506|NCT01703039|Sertraline|sertraline|mesh-list
83495507|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
83495508|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83495509|NCT01703039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83495510|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83495511|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495512|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495513|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495514|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
83495515|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495516|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
83495517|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83495518|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83495519|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83495520|NCT01703039|Protective Agents|protective agents|mesh-ancestor
83495521|NCT01656629|Vitamin D|vitamin d|mesh-list
83495522|NCT01656629|Alendronate|alendronate|mesh-list
83495523|NCT01656629|Teriparatide|teriparatide|mesh-list
83495524|NCT01656629|Calcium|calcium|mesh-list
83495525|NCT01656629|Vitamins|vitamins|mesh-ancestor
83495526|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
83495527|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495528|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83495529|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83495560|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495561|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
83495562|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495563|NCT01617083|Azithromycin|azithromycin|mesh-list
83495564|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83495565|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495566|NCT04359524|Vitamin D|vitamin d|mesh-list
83495567|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
83495568|NCT04359524|Vitamins|vitamins|mesh-ancestor
83495569|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
83495570|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495571|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83495572|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83495573|NCT01658657|Metoprolol|metoprolol|mesh-list
83495574|NCT01658657|Amlodipine|amlodipine|mesh-list
83495575|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83495576|NCT01658657|Lisinopril|lisinopril|mesh-list
83495577|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
83495578|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83495579|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83495580|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495581|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495582|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83495583|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495584|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
83495585|NCT01658657|Diuretics|diuretics|mesh-ancestor
83495586|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
83495587|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83495588|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83495589|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
83495590|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
83495591|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495592|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83495593|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83495594|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83495595|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
83495596|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495597|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83495598|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
83495599|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495600|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83495601|NCT01658657|Protective Agents|protective agents|mesh-ancestor
83495602|NCT04359212|Heparin|heparin|mesh-list
83495603|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83495604|NCT04359212|Tinzaparin|tinzaparin|mesh-list
83495605|NCT04359212|Dalteparin|dalteparin|mesh-list
83495606|NCT04359212|PENTA|penta|mesh-list
83495607|NCT04359212|Fondaparinux|fondaparinux|mesh-list
83495608|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
83495609|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83495610|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83495611|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495612|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83495613|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
83495614|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83495615|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
83495616|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495617|NCT01620047|Fentanyl|fentanyl|mesh-list
83495618|NCT01620047|Ropivacaine|ropivacaine|mesh-list
83495619|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
83495620|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
83495621|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495622|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495623|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
83495624|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495625|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83495626|NCT01620047|Narcotics|narcotics|mesh-ancestor
83495627|NCT01620047|Analgesics|analgesics|mesh-ancestor
83495628|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83495629|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83495630|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
83495631|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83495632|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83495633|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495634|NCT00944450|Incretins|incretins|mesh-ancestor
83495635|NCT00944450|Hormones|hormones|mesh-ancestor
83495711|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
83495636|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83495637|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83495638|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
83495639|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495640|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495643|NCT03875144|Pemetrexed|pemetrexed|mesh-list
83495644|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495645|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83495646|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83495647|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83495648|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495649|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495650|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83495651|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83495652|NCT01661621|Doxazosin|doxazosin|mesh-list
83495653|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83495654|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83495655|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83495656|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83495657|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83495658|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
83495659|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495660|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495661|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495662|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83495663|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83495664|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
83495665|NCT01661621|Urological Agents|urological agents|mesh-ancestor
83495666|NCT01620593|Metformin|metformin|mesh-list
83495667|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83495668|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495669|NCT00939536|Zolpidem|zolpidem|mesh-list
83495670|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83495671|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83495672|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495673|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495674|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83495675|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
83495676|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
83495677|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495678|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495679|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83495680|NCT04358354|Fluorouracil|fluorouracil|mesh-list
83495681|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
83495682|NCT04358354|Irinotecan|irinotecan|mesh-list
83495683|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
83495684|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495685|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83495686|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495687|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83495688|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
83495689|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495690|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83495691|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83495692|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495693|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
83495694|NCT03516968|Vitamin D|vitamin d|mesh-list
83495695|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83495696|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495697|NCT03516968|Vitamins|vitamins|mesh-ancestor
83495698|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
83495699|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83495700|NCT04355156|Axitinib|axitinib|mesh-list
83495701|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495702|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83495703|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495704|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495705|NCT03320018|Minocycline|minocycline|mesh-list
83495706|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83495707|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495708|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
83495709|NCT03032666|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83495710|NCT03032666|Velpatasvir|velpatasvir|mesh-list
83495712|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495713|NCT04354376|Telmisartan|telmisartan|mesh-list
83495714|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
83495715|NCT04354376|Diuretics|diuretics|mesh-list
83495716|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83495717|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83495718|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83495719|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83495720|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83495721|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495722|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
83495723|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495724|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495725|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83495726|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83495727|NCT02777372|Sertraline|sertraline|mesh-list
83495728|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
83495729|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83495730|NCT02777372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83495731|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83495732|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495733|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495734|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495735|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
83495736|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495737|NCT01622543|Leucovorin|leucovorin|mesh-list
83495738|NCT01622543|Bevacizumab|bevacizumab|mesh-list
83495739|NCT01622543|Fluorouracil|fluorouracil|mesh-list
83495740|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
83495741|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83495742|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495743|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83495744|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83495745|NCT01622543|Growth Substances|growth substances|mesh-ancestor
83495746|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495747|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
83495748|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
83495749|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495750|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83495751|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83495752|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
83495753|NCT01622543|Antidotes|antidotes|mesh-ancestor
83495754|NCT01622543|Protective Agents|protective agents|mesh-ancestor
83495755|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
83495756|NCT01622543|Vitamins|vitamins|mesh-ancestor
83495757|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
83495758|NCT03032042|Azithromycin|azithromycin|mesh-list
83495759|NCT03032042|Albendazole|albendazole|mesh-list
83495760|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83495761|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495762|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
83495763|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83495764|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
83495765|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83495766|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83495767|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
83495768|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
83495769|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
83495770|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495771|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495772|NCT01623323|Fluticasone|fluticasone|mesh-list
83495773|NCT01623323|Xhance|xhance|mesh-list
83495774|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83495775|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83495776|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
83495777|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495778|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495779|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83495780|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
83495781|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
83495782|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83495783|NCT01709747|Hydromorphone|hydromorphone|mesh-list
83495784|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83495785|NCT01709747|Narcotics|narcotics|mesh-ancestor
83496233|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
83495786|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495787|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495788|NCT01709747|Analgesics|analgesics|mesh-ancestor
83495789|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
83495790|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495792|NCT03031808|Rocuronium|rocuronium|mesh-list
83495793|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
83495794|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
83495795|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495796|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495797|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
83495798|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495799|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83495800|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83495801|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83495802|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495803|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495804|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83495805|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83495806|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83495807|NCT01662791|Rifaximin|rifaximin|mesh-list
83495808|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83495809|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495810|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83495811|NCT03035084|Vitamin D|vitamin d|mesh-list
83495812|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
83495813|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
83495814|NCT03035084|Vitamins|vitamins|mesh-list
83495815|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
83495816|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495817|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83495818|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83495819|NCT03034850|Doxorubicin|doxorubicin|mesh-list
83495820|NCT03034850|Fluorouracil|fluorouracil|mesh-list
83495821|NCT03034850|Ifosfamide|ifosfamide|mesh-list
83495822|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83495823|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495824|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83495825|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83495826|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495827|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495828|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
83495829|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83495830|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83495831|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
83495832|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495833|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83495834|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
83495835|NCT01663259|Cetuximab|cetuximab|mesh-list
83495836|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83495837|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495838|NCT03031184|Mirtazapine|mirtazapine|mesh-list
83495839|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
83495840|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83495841|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83495842|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
83495843|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
83495844|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495845|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495846|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495847|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83495848|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83495849|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495850|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83495851|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83495852|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83495853|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
83495854|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83495855|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83495856|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
83495857|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83495858|NCT02238977|Bupropion|bupropion|mesh-list
83495859|NCT02238977|Fluoxetine|fluoxetine|mesh-list
83495860|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83495861|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
83495862|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83495863|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83495864|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83495865|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495866|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495867|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
83495868|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495869|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495870|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83495871|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83495872|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495873|NCT02238977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83495874|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
83495875|NCT03034382|Lidocaine|lidocaine|mesh-list
83495876|NCT03034382|Epinephrine|epinephrine|mesh-list
83495877|NCT03034382|Morphine|morphine|mesh-list
83495878|NCT03034382|Nalbuphine|nalbuphine|mesh-list
83495879|NCT03034382|Bupivacaine|bupivacaine|mesh-list
83495880|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
83495881|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
83495882|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495883|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495884|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
83495885|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495886|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83495887|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83495888|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83495889|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83495890|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495891|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83495892|NCT03034382|Narcotics|narcotics|mesh-ancestor
83495893|NCT03034382|Analgesics|analgesics|mesh-ancestor
83495894|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83495895|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83495896|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
83495897|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495898|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83495899|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83495900|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
83495901|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83495902|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
83495903|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
83495904|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
83495905|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83495906|NCT01664741|Nicotine|nicotine|mesh-list
83495907|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83495908|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
83495909|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495910|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495911|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83495912|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83495913|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
83495914|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495915|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495916|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
83495917|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83495918|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83495919|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495920|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
83495921|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83495922|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83495923|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495924|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83495925|NCT03030950|Analgesics|analgesics|mesh-ancestor
83495926|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
83495927|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495928|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83495929|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83495930|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83495931|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
83495932|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83495933|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495934|NCT02022644|Irinotecan|irinotecan|mesh-list
83495935|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83495936|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83495937|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495938|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495939|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495940|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83495941|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495942|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83495943|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495944|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495945|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
83495946|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
83495947|NCT03030716|Procyanidin|procyanidin|mesh-list
83495948|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83495949|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495950|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
83495951|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495952|NCT03030716|Protective Agents|protective agents|mesh-ancestor
83495953|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495954|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83495955|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83495956|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495957|NCT04353362|Amoxicillin|amoxicillin|mesh-list
83495958|NCT04353362|Metronidazole|metronidazole|mesh-list
83495960|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83495961|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495962|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83495963|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83495964|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83495965|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83495966|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83495967|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495968|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495969|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495970|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83495971|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83495972|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
83495973|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83495974|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83495975|NCT00946478|Analgesics|analgesics|mesh-ancestor
83495976|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
83495977|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83495978|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495979|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83495980|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83495981|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
83495982|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83495983|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
83495984|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83495985|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495986|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495987|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
83495988|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83495989|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495990|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83495991|NCT03033836|Dolutegravir|dolutegravir|mesh-list
83495992|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83495993|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83495994|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83495995|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495996|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
83495997|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83495998|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83495999|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83496000|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83496001|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83496002|NCT03030560|Lidocaine|lidocaine|mesh-list
83496003|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
83496004|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
83496005|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83496006|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496007|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
83496008|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496009|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83496010|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83496011|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83496012|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83496013|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496015|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83496016|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83496017|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496018|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496019|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
83496020|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496021|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83496022|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83496023|NCT03031262|Cytarabine|cytarabine|mesh-list
83496024|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83496025|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
83496026|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496027|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496028|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
83496029|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496030|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496031|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
83496032|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496033|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
83496034|NCT03032978|Calcium|calcium|mesh-list
83496035|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83496036|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496037|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83496038|NCT03030248|Vancomycin|vancomycin|mesh-list
83496039|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83496040|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496041|NCT03028532|Clomiphene|clomiphene|mesh-list
83496042|NCT03028532|Enclomiphene|enclomiphene|mesh-list
83496043|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
83496044|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83496045|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
83496046|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496047|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496048|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83496049|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
83496050|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83496051|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83496052|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83496053|NCT03017768|Tryptophan|tryptophan|mesh-list
83496054|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83496055|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
83496056|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83496057|NCT01006538|Ranibizumab|ranibizumab|mesh-list
83496058|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83496059|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83496060|NCT01006538|Growth Substances|growth substances|mesh-ancestor
83496061|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496062|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
83496063|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496064|NCT03017222|Ondansetron|ondansetron|mesh-list
83496065|NCT03017222|Ramosetron|ramosetron|mesh-list
83496066|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
83496067|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
83496068|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496069|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496070|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83496071|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
83496072|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
83496073|NCT03017222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83496074|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83496075|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
83496076|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496077|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496078|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83496079|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83496080|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
83496081|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83496082|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
83496083|NCT01010282|Glycerol|glycerol|mesh-list
83496084|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83496085|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83496086|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83496087|NCT01010282|Protective Agents|protective agents|mesh-ancestor
83496088|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496089|NCT01010282|Laxatives|laxatives|mesh-ancestor
83496090|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83496091|NCT03016988|Cytarabine|cytarabine|mesh-list
83496092|NCT03016988|Fludarabine|fludarabine|mesh-list
83496093|NCT03016988|Bortezomib|bortezomib|mesh-list
83496094|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496095|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83496096|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
83496097|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496098|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496099|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
83496100|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496101|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
83496102|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496103|NCT03017066|Anesthetics|anesthetics|mesh-list
83496104|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83496105|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496106|NCT03016832|Irbesartan|irbesartan|mesh-list
83496107|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83496108|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83496109|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83496110|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496111|NCT00955916|Cytarabine|cytarabine|mesh-list
83496112|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
83496113|NCT00955916|Cladribine|cladribine|mesh-list
83496114|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83496115|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
83496116|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496117|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496118|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
83496119|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496120|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496121|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
83496122|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496123|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83496124|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496125|NCT01668017|Niacinamide|niacinamide|mesh-list
83496126|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
83496127|NCT01668017|Vitamins|vitamins|mesh-ancestor
83496128|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
83496129|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496130|NCT01010984|Doxorubicin|doxorubicin|mesh-list
83496131|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83496132|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496133|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83496134|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83496135|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496136|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496137|NCT05214599|Budesonide|budesonide|mesh-list
83496138|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83496139|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83496140|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
83496141|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496142|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496143|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83496144|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
83496145|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
83496146|NCT05214599|Hormones|hormones|mesh-ancestor
83496147|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496148|NCT01011218|Modafinil|modafinil|mesh-list
83496149|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83496150|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496151|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83496152|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83496153|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83496154|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496155|NCT03023306|Antiemetics|antiemetics|mesh-list
83496156|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
83496157|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496158|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496159|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83496160|NCT05710367|Dapagliflozin|dapagliflozin|mesh-list
83496161|NCT05710367|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83496162|NCT05710367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496163|NCT05710367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83496164|NCT05710367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496165|NCT05184101|Heparin|heparin|mesh-list
83496166|NCT05184101|Calcium heparin|calcium heparin|mesh-list
83496167|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
83496168|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83496169|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83496170|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496171|NCT00957242|Warfarin|warfarin|mesh-list
83496172|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
83496173|NCT01014728|Propofol|propofol|mesh-list
83496174|NCT01014728|Sevoflurane|sevoflurane|mesh-list
83496175|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83496176|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83496177|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496178|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83496179|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
83496180|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
83496181|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83496182|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83496183|NCT01015586|Lamotrigine|lamotrigine|mesh-list
83496184|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
83496185|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83496186|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83496187|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496188|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83496189|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496190|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83496191|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83496192|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83496193|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83496194|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83496195|NCT01680653|Glucagon|glucagon|mesh-list
83496196|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83496197|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83496198|NCT01680653|Hormones|hormones|mesh-ancestor
83496199|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496200|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496201|NCT01680653|Incretins|incretins|mesh-ancestor
83496202|NCT02448810|Fluorouracil|fluorouracil|mesh-list
83496203|NCT02448810|Panitumumab|panitumumab|mesh-list
83496204|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
83496205|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496206|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83496207|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496208|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496209|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
83496210|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496211|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83496212|NCT01680887|Varenicline|varenicline|mesh-list
83496213|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83496214|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83496215|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
83496216|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496217|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496218|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496219|NCT01016678|Naproxen|naproxen|mesh-list
83496220|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83496221|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83496222|NCT01016678|Analgesics|analgesics|mesh-ancestor
83496223|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
83496224|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496225|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496226|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83496227|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83496228|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
83496229|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83496230|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496231|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496232|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83496249|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496250|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
83496251|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496252|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83496253|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
83496254|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83496255|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
83496256|NCT00961532|Coagulants|coagulants|mesh-ancestor
83496257|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83496258|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
83496259|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496260|NCT02447718|Vaccines|vaccines|mesh-list
83496261|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83496262|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
83496263|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496264|NCT03016442|Dinoprostone|dinoprostone|mesh-list
83496265|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
83496266|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83496267|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496268|NCT01682135|Ramucirumab|ramucirumab|mesh-list
83496269|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496270|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
83496271|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83496272|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83496273|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
83496274|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496275|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83496276|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
83496277|NCT00963872|Fludarabine|fludarabine|mesh-list
83496278|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
83496279|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496280|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
83496281|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496282|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83496283|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83496284|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
83496285|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496286|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496287|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83496288|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83496289|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
83496290|NCT00964496|Thalidomide|thalidomide|mesh-list
83496291|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
83496292|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496293|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
83496294|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496295|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
83496296|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83496297|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496298|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83496299|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83496300|NCT00964496|Growth Substances|growth substances|mesh-ancestor
83496301|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
83496302|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496303|NCT00964496|Hematinics|hematinics|mesh-ancestor
83496304|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
83496305|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
83496306|NCT01685411|Busulfan|busulfan|mesh-list
83496307|NCT01685411|Allopurinol|allopurinol|mesh-list
83496308|NCT01685411|Levetiracetam|levetiracetam|mesh-list
83496309|NCT01685411|Tacrolimus|tacrolimus|mesh-list
83496310|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83496312|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496313|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
83496314|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496315|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83496316|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83496317|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
83496318|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496319|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496320|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83496321|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83496322|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83496323|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496324|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83496325|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83496326|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
83496327|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83496328|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496330|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
83496331|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
83496332|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
83496333|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83496334|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
83496335|NCT01685411|Protective Agents|protective agents|mesh-ancestor
83496336|NCT02243813|Psilocybin|psilocybin|mesh-list
83496337|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
83496338|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496339|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83496340|NCT02991209|Testosterone|testosterone|mesh-list
83496341|NCT02991209|Androgens|androgens|mesh-ancestor
83496342|NCT02991209|Hormones|hormones|mesh-ancestor
83496343|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496344|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496345|NCT03019562|Fentanyl|fentanyl|mesh-list
83496346|NCT03019562|Oxycodone|oxycodone|mesh-list
83496347|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83496348|NCT03019562|Narcotics|narcotics|mesh-ancestor
83496349|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83496350|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496351|NCT03019562|Analgesics|analgesics|mesh-ancestor
83496352|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
83496353|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496354|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83496355|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83496356|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
83496357|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
83496358|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83496359|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83496360|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83496361|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
83496362|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496363|NCT00969878|Antacids|antacids|mesh-ancestor
83496364|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496365|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83496366|NCT05677919|Venetoclax|venetoclax|mesh-list
83496367|NCT05677919|Pirtobrutinib|pirtobrutinib|mesh-list
83496368|NCT05677919|Pyrazole|pyrazole|mesh-list
83496369|NCT05677919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496370|NCT05677919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83496371|NCT05677919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496372|NCT05677919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496373|NCT00970814|Levetiracetam|levetiracetam|mesh-list
83496374|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
83496375|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
83496376|NCT02486406|Ritonavir|ritonavir|mesh-list
83496377|NCT02486406|Ribavirin|ribavirin|mesh-list
83496378|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83496379|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83496380|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
83496381|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496382|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496383|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83496384|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83496385|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
83496386|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496387|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83496388|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83496389|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
83496390|NCT01688609|Paclitaxel|paclitaxel|mesh-list
83496391|NCT01688609|Trastuzumab|trastuzumab|mesh-list
83496392|NCT01688609|Lapatinib|lapatinib|mesh-list
83496393|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83496394|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496395|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
83496396|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
83496397|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
83496398|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496399|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83496400|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83496401|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496402|NCT02485158|Dronabinol|dronabinol|mesh-list
83496403|NCT02485158|Amphetamine|amphetamine|mesh-list
83496404|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
83496405|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83496406|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496407|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
83496408|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
83496409|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496410|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
83496411|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496412|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496413|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
83496414|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83496415|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83496416|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83496417|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83496418|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
83496419|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83496420|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83496421|NCT02485158|Analgesics|analgesics|mesh-ancestor
83496422|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
83496423|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83496424|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83496425|NCT02485158|Hormones|hormones|mesh-ancestor
83496426|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496427|NCT02455518|Acetaminophen|acetaminophen|mesh-list
83496428|NCT02455518|Ibuprofen|ibuprofen|mesh-list
83496429|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83496430|NCT02455518|Oxycodone|oxycodone|mesh-list
83496431|NCT02455518|Hydrocodone|hydrocodone|mesh-list
83496432|NCT02455518|Codeine|codeine|mesh-list
83496433|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83496434|NCT02455518|Analgesics|analgesics|mesh-ancestor
83496435|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
83496436|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496437|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496438|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
83496439|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83496440|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83496441|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83496442|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83496443|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496444|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496445|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83496446|NCT02455518|Narcotics|narcotics|mesh-ancestor
83496447|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83496448|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
83496449|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
83496450|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83496451|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83496452|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83496453|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83496454|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83496455|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
83496456|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496457|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496458|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496459|NCT03018626|Prednisone|prednisone|mesh-list
83496460|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
83496461|NCT03018626|Rituximab|rituximab|mesh-list
83496462|NCT03018626|Doxorubicin|doxorubicin|mesh-list
83496463|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83496464|NCT03018626|Etoposide|etoposide|mesh-list
83496465|NCT03018626|Vincristine|vincristine|mesh-list
83496466|NCT03018626|Bleomycin|bleomycin|mesh-list
83496467|NCT03018626|Vindesine|vindesine|mesh-list
83496468|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496469|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
83496470|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496471|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83496472|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83496473|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
83496474|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496475|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496476|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83496477|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83496478|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83496479|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83496480|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83496481|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496482|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83496483|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
83496484|NCT03018626|Hormones|hormones|mesh-ancestor
83496485|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496486|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83496487|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83496488|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
83496489|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
83496490|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
83496491|NCT01689779|Vitamin D|vitamin d|mesh-list
83496492|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
83496493|NCT01689779|Vitamins|vitamins|mesh-ancestor
83496494|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
83496495|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496496|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83496497|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83496498|NCT05388500|Paclitaxel|paclitaxel|mesh-list
83496499|NCT05388500|Trastuzumab|trastuzumab|mesh-list
83496500|NCT05388500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83496501|NCT05388500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496502|NCT05388500|Tubulin Modulators|tubulin modulators|mesh-ancestor
83496503|NCT05388500|Antimitotic Agents|antimitotic agents|mesh-ancestor
83496504|NCT05388500|Mitosis Modulators|mitosis modulators|mesh-ancestor
83496505|NCT05388500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496506|NCT05388500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83496507|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83496508|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83496509|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
83496510|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496511|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496512|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83496513|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
83496514|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
83496515|NCT00974246|Hormones|hormones|mesh-ancestor
83496516|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496517|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
83496518|NCT00974480|Tretinoin|tretinoin|mesh-list
83496519|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496520|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
83496521|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
83496522|NCT00975650|Testosterone|testosterone|mesh-list
83496523|NCT00975650|Androgens|androgens|mesh-ancestor
83496524|NCT00975650|Hormones|hormones|mesh-ancestor
83496525|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496526|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496527|NCT00979940|Atorvastatin|atorvastatin|mesh-list
83496528|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83496529|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83496530|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
83496531|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496532|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83496533|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83496534|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496535|NCT03018236|Ethanol|ethanol|mesh-list
83496536|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
83496537|NCT03018236|Cocaine|cocaine|mesh-list
83496538|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83496539|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83496540|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496541|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83496542|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496543|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
83496544|NCT03018236|Expectorants|expectorants|mesh-ancestor
83496545|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
83496546|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83496547|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
83496548|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496549|NCT03018236|Protective Agents|protective agents|mesh-ancestor
83496550|NCT03018236|Antidotes|antidotes|mesh-ancestor
83496551|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
83496552|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
83496553|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
83496554|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496555|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83496556|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83496557|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83496558|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83496560|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496561|NCT02873195|Bevacizumab|bevacizumab|mesh-list
83496562|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83496563|NCT02873195|Atezolizumab|atezolizumab|mesh-list
83496564|NCT02873195|Capecitabine|capecitabine|mesh-list
83496565|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
83496566|NCT02873195|Antibodies|antibodies|mesh-list
83496567|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
83496568|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83496569|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
83496570|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496571|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83496572|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83496573|NCT02873195|Growth Substances|growth substances|mesh-ancestor
83496574|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496575|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
83496576|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
83496577|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83496578|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
83496579|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496580|NCT02873195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83496581|NCT02817659|Glucagon|glucagon|mesh-list
83496582|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83496583|NCT02817659|Hormones|hormones|mesh-ancestor
83496584|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496585|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496586|NCT02659241|Adavosertib|adavosertib|mesh-list
83496587|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496588|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496589|NCT04337177|Temozolomide|temozolomide|mesh-list
83496590|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83496591|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
83496592|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496593|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496594|NCT00982592|Leucovorin|leucovorin|mesh-list
83496595|NCT00982592|Fluorouracil|fluorouracil|mesh-list
83496596|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
83496597|NCT00982592|Calcium|calcium|mesh-list
83496598|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
83496599|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83496600|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496601|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
83496602|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496603|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83496604|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496605|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496606|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
83496607|NCT00982592|Antidotes|antidotes|mesh-ancestor
83496608|NCT00982592|Protective Agents|protective agents|mesh-ancestor
83496609|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
83496610|NCT00982592|Vitamins|vitamins|mesh-ancestor
83496611|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
83496612|NCT00983216|Ketoconazole|ketoconazole|mesh-list
83496613|NCT00983216|Colchicine|colchicine|mesh-list
83496614|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
83496615|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83496616|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
83496617|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
83496618|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
83496619|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496620|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496621|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
83496622|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496623|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83496624|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83496625|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496626|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83496627|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
83496628|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496629|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497001|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496630|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83496632|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
83496633|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
83496634|NCT01788020|Rituximab|rituximab|mesh-list
83496635|NCT01788020|Bortezomib|bortezomib|mesh-list
83496636|NCT01788020|BB 1101|bb 1101|mesh-list
83496637|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496638|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
83496639|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496640|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83496641|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83496642|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
83496643|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496644|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496645|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83496646|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83496647|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83496648|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
83496649|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
83496650|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496651|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83496652|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
83496653|NCT01788020|Hormones|hormones|mesh-ancestor
83496654|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496655|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83496656|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
83496657|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496658|NCT02435849|Tisagenlecleucel|tisagenlecleucel|mesh-list
83496659|NCT02435849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83496660|NCT02435849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496661|NCT02249585|Iodine|iodine|mesh-list
83496662|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83496663|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496664|NCT02249585|Trace Elements|trace elements|mesh-ancestor
83496665|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
83496666|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496667|NCT05478863|Caffeine|caffeine|mesh-list
83496668|NCT05478863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83496669|NCT05478863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496670|NCT05478863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83496671|NCT05478863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496672|NCT05478863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496673|NCT05478863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83496674|NCT05478863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83496675|NCT05478863|Purinergic Agents|purinergic agents|mesh-ancestor
83496676|NCT05478863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496677|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
83496678|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83496679|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496680|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496681|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83496682|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83496683|NCT01774487|Protective Agents|protective agents|mesh-ancestor
83496684|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496685|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
83496686|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83496687|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
83496688|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
83496689|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83496690|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83496691|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496692|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
83496693|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496694|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496695|NCT02161484|Bupivacaine|bupivacaine|mesh-list
83496696|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
83496697|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
83496698|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83496699|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496700|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
83496701|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496702|NCT00988832|Infliximab|infliximab|mesh-list
83496703|NCT00988832|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83496704|NCT00988832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83496705|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
83496706|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83496707|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83496708|NCT01023776|Vaccines|vaccines|mesh-list
83496709|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
83496710|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496711|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
83496712|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83496713|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83496714|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83496715|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83496716|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496717|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
83496718|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496719|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496720|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83496721|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496722|NCT00990236|Enoxaparin|enoxaparin|mesh-list
83496723|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
83496724|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
83496725|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83496726|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83496727|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496728|NCT01024010|Vidarabine|vidarabine|mesh-list
83496729|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
83496730|NCT01024010|Ofatumumab|ofatumumab|mesh-list
83496731|NCT01024010|Pentostatin|pentostatin|mesh-list
83496732|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83496733|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496734|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
83496735|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496736|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83496737|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83496738|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
83496739|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496740|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496741|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83496742|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83496743|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496744|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
83496745|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
83496746|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496747|NCT02484690|Ranibizumab|ranibizumab|mesh-list
83496748|NCT02484690|Faricimab|faricimab|mesh-list
83496749|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83496750|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83496751|NCT02484690|Growth Substances|growth substances|mesh-ancestor
83496752|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496753|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
83496754|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496755|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83496756|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496757|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83496758|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496759|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496760|NCT01654224|Vaccines|vaccines|mesh-list
83496761|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
83496762|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496763|NCT02447328|Fulvestrant|fulvestrant|mesh-list
83496764|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83496765|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496766|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83496767|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83496768|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
83496769|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496770|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496771|NCT02447250|Albuterol|albuterol|mesh-list
83496772|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83496773|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
83496774|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496775|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496776|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83496777|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
83496778|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
83497153|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
83496779|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83496780|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83496781|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83496782|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83496783|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
83496784|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496785|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496786|NCT00993200|Warfarin|warfarin|mesh-list
83496787|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
83496788|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83496789|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83496790|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83496791|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
83496792|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496793|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83496794|NCT02447172|Gentamicins|gentamicins|mesh-list
83496795|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83496796|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496797|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83496798|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496799|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496800|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83496801|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83496802|NCT04200066|Tamoxifen|tamoxifen|mesh-list
83496803|NCT04200066|Temozolomide|temozolomide|mesh-list
83496804|NCT04200066|Maprotiline|maprotiline|mesh-list
83496805|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83496806|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
83496807|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496808|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496809|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83496810|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
83496811|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83496812|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496813|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83496814|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83496815|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83496816|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83496817|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83496818|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
83496819|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83496820|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83496821|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83496822|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83496823|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
83496824|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496825|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83496826|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83496827|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83496828|NCT02455050|Laxatives|laxatives|mesh-ancestor
83496829|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83496830|NCT00994760|Fentanyl|fentanyl|mesh-list
83496831|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83496832|NCT00994760|Narcotics|narcotics|mesh-ancestor
83496833|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83496834|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496835|NCT00994760|Analgesics|analgesics|mesh-ancestor
83496836|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
83496837|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496838|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83496839|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83496840|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
83496841|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
83496842|NCT00995072|Metoprolol|metoprolol|mesh-list
83496843|NCT00995072|Nebivolol|nebivolol|mesh-list
83496844|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83496845|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83496846|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
83496847|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
83496848|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496849|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496850|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83496851|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83496852|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83496853|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
83496854|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496855|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496856|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
83496857|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83496858|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83496859|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83496860|NCT01027910|Doxorubicin|doxorubicin|mesh-list
83496861|NCT01027910|Abexinostat|abexinostat|mesh-list
83496862|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83496863|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496864|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83496865|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83496866|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496867|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496868|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83496869|NCT01031420|Doxorubicin|doxorubicin|mesh-list
83496870|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83496871|NCT01031420|Methotrexate|methotrexate|mesh-list
83496872|NCT01031420|Vinblastine|vinblastine|mesh-list
83496873|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83496874|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496875|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83496876|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83496877|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496878|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496879|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83496880|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
83496881|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83496882|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496883|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83496884|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
83496885|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
83496886|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83496887|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83496888|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
83496889|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83496890|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83496891|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83496892|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
83496893|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
83496894|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83496895|NCT01031498|Ondansetron|ondansetron|mesh-list
83496896|NCT01031498|Palonosetron|palonosetron|mesh-list
83496897|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
83496898|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
83496899|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496900|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496901|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83496902|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
83496903|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
83496904|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83496905|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83496906|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
83496907|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496908|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496909|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
83496910|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
83496912|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83496913|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496914|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496915|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83496916|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83496917|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83496918|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496919|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
83496920|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83496921|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496922|NCT03425006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83496923|NCT03425006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496924|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
83496925|NCT00998426|Antibodies|antibodies|mesh-list
83496926|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
83496927|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83496928|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83496929|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
83496930|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
83496931|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496932|NCT00998582|Tenofovir|tenofovir|mesh-list
83496933|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
83496934|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83496935|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83496936|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83496937|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83496938|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496939|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83496940|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83496941|NCT02168660|Vitamin D|vitamin d|mesh-list
83496942|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
83496943|NCT02168660|Vitamins|vitamins|mesh-ancestor
83496944|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
83496945|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496946|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83496947|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83496948|NCT01003106|Ranibizumab|ranibizumab|mesh-list
83496949|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83496950|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83496951|NCT01003106|Growth Substances|growth substances|mesh-ancestor
83496952|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496953|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
83496954|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496955|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83496956|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
83496957|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496958|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
83496959|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83496960|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83496961|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83496962|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83496963|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496964|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
83496965|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496966|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496967|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83496968|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496969|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
83496970|NCT01004354|Vitamin D|vitamin d|mesh-list
83496971|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83496972|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496973|NCT01004354|Vitamins|vitamins|mesh-ancestor
83496974|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
83496975|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83496976|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83496977|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83496978|NCT02417064|Sertraline|sertraline|mesh-list
83496979|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
83496980|NCT02417064|Esketamine|esketamine|mesh-list
83496981|NCT02417064|Escitalopram|escitalopram|mesh-list
83496982|NCT02417064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83496983|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83496984|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83496985|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496986|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496987|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
83496988|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496989|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83496990|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83496991|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83496992|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83496993|NCT02417064|Analgesics|analgesics|mesh-ancestor
83496994|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
83496995|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
83496996|NCT01004744|Anastrozole|anastrozole|mesh-list
83496997|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83496998|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83496999|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83497000|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83497002|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497003|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83497004|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
83497005|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83497006|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497007|NCT01005290|Ramipril|ramipril|mesh-list
83497008|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83497009|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
83497010|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497011|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497012|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83497013|NCT04478474|Ganciclovir|ganciclovir|mesh-list
83497014|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83497015|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
83497016|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497017|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83497018|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497019|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497020|NCT05592860|Insulin|insulin|mesh-list
83497021|NCT05592860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83497022|NCT05592860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497023|NCT01051778|Aspirin|aspirin|mesh-list
83497024|NCT01051778|Heparin|heparin|mesh-list
83497025|NCT01051778|Enoxaparin|enoxaparin|mesh-list
83497026|NCT01051778|Calcium heparin|calcium heparin|mesh-list
83497027|NCT01051778|Calcium|calcium|mesh-list
83497028|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83497029|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497030|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83497031|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83497032|NCT01051778|Analgesics|analgesics|mesh-ancestor
83497033|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
83497034|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497035|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83497036|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83497037|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83497038|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83497039|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497040|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83497041|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83497042|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497043|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
83497044|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
83497045|NCT02169440|Opicapone|opicapone|mesh-list
83497046|NCT02169440|Warfarin|warfarin|mesh-list
83497047|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
83497048|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83497049|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497050|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497051|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83497052|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83497053|NCT03015350|Sevoflurane|sevoflurane|mesh-list
83497054|NCT03015350|Desflurane|desflurane|mesh-list
83497055|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83497056|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83497057|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
83497058|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
83497059|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83497060|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497061|NCT01054742|Ribavirin|ribavirin|mesh-list
83497062|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83497063|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
83497064|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497065|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
83497066|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497067|NCT04171466|Metronidazole|metronidazole|mesh-list
83497068|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
83497069|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497070|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83497071|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83497072|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83497073|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83497074|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83497075|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497076|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497077|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497078|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83497079|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83497080|NCT02170376|Levodopa|levodopa|mesh-list
83497081|NCT02170376|Carbidopa|carbidopa|mesh-list
83497082|NCT02170376|Opicapone|opicapone|mesh-list
83497083|NCT02170376|Entacapone|entacapone|mesh-list
83497084|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83497085|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83497086|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
83497087|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497088|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497089|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497090|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83497091|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497092|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83497093|NCT02170532|Albuterol|albuterol|mesh-list
83497094|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83497095|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
83497096|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497097|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497098|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83497099|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
83497100|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
83497101|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83497102|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83497103|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83497104|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83497105|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
83497106|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497107|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497108|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
83497109|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83497110|NCT05509634|Dexamethasone|dexamethasone|mesh-list
83497111|NCT05509634|Dexamethasone acetate|dexamethasone acetate|mesh-list
83497112|NCT05509634|Palonosetron|palonosetron|mesh-list
83497113|NCT05509634|Fosaprepitant|fosaprepitant|mesh-list
83497114|NCT05509634|Aprepitant|aprepitant|mesh-list
83497115|NCT05509634|BB 1101|bb 1101|mesh-list
83497116|NCT05509634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83497117|NCT05509634|Antiemetics|antiemetics|mesh-ancestor
83497118|NCT05509634|Autonomic Agents|autonomic agents|mesh-ancestor
83497119|NCT05509634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497120|NCT05509634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497121|NCT05509634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83497122|NCT05509634|Glucocorticoids|glucocorticoids|mesh-ancestor
83497123|NCT05509634|Hormones|hormones|mesh-ancestor
83497124|NCT05509634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83497125|NCT05509634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83497126|NCT05509634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497127|NCT05509634|Protease Inhibitors|protease inhibitors|mesh-ancestor
83497128|NCT05509634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497129|NCT05509634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497130|NCT05509634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83497131|NCT05509634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83497132|NCT05509634|Serotonin Agents|serotonin agents|mesh-ancestor
83497133|NCT05509634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497134|NCT05509634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83497136|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
83497137|NCT02175212|Androgens|androgens|mesh-list
83497138|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83497139|NCT02175212|Hormones|hormones|mesh-ancestor
83497140|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83497141|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497142|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
83497143|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497144|NCT02175212|Protective Agents|protective agents|mesh-ancestor
83497145|NCT02175212|Vitamins|vitamins|mesh-ancestor
83497146|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
83497147|NCT02175212|Estrogens|estrogens|mesh-ancestor
83497148|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83497149|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497150|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
83497151|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
83497152|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83497154|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497155|NCT03014882|Expectorants|expectorants|mesh-ancestor
83497156|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
83497157|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83497158|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
83497159|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497160|NCT03014882|Protective Agents|protective agents|mesh-ancestor
83497161|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497162|NCT03014882|Antidotes|antidotes|mesh-ancestor
83497163|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83497164|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
83497165|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83497166|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83497167|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83497168|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497169|NCT01061528|Nicotine|nicotine|mesh-list
83497170|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83497171|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
83497172|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497173|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497174|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83497175|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83497176|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
83497177|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497178|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497179|NCT01062230|Bortezomib|bortezomib|mesh-list
83497180|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497181|NCT01064882|Bimatoprost|bimatoprost|mesh-list
83497182|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83497183|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83497184|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83497185|NCT01065506|Nicotine|nicotine|mesh-list
83497186|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83497187|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
83497188|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497189|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497190|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83497191|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83497192|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
83497193|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497194|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497195|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83497196|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497197|NCT03817736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83497198|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497199|NCT03811886|Natalizumab|natalizumab|mesh-list
83497200|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
83497201|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497202|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83497203|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83497204|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83497205|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
83497206|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497207|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83497208|NCT01066520|Diclofenac|diclofenac|mesh-list
83497209|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83497210|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83497211|NCT01066520|Analgesics|analgesics|mesh-ancestor
83497212|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
83497213|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497214|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497215|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83497216|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83497217|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83497218|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497219|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497220|NCT03014804|Nivolumab|nivolumab|mesh-list
83497221|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83497222|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497223|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83497224|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497225|NCT05224388|Heparin|heparin|mesh-list
83497226|NCT05224388|Enoxaparin|enoxaparin|mesh-list
83497227|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
83497238|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497239|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83497240|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
83497241|NCT02416908|Cytarabine|cytarabine|mesh-list
83497242|NCT02416908|Plerixafor|plerixafor|mesh-list
83497243|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
83497244|NCT02416908|Cladribine|cladribine|mesh-list
83497245|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83497246|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
83497247|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497248|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497249|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
83497250|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497251|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83497252|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
83497253|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497254|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83497255|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83497256|NCT01070810|Thiamine|thiamine|mesh-list
83497257|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
83497258|NCT01070810|Vitamins|vitamins|mesh-ancestor
83497259|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
83497260|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497261|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83497262|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83497263|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497264|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83497265|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83497266|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83497267|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497268|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
83497269|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497270|NCT05150756|Lidocaine|lidocaine|mesh-list
83497271|NCT05150756|Morphine|morphine|mesh-list
83497272|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
83497273|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
83497274|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83497275|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497276|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
83497277|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497278|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83497279|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83497280|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83497281|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83497282|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497283|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83497284|NCT05150756|Narcotics|narcotics|mesh-ancestor
83497285|NCT05150756|Analgesics|analgesics|mesh-ancestor
83497286|NCT01072136|Azithromycin|azithromycin|mesh-list
83497287|NCT01072136|Cefixime|cefixime|mesh-list
83497288|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83497289|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497290|NCT05135858|Methotrexate|methotrexate|mesh-list
83497291|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83497292|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
83497293|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83497294|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497295|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83497296|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
83497297|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497298|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497299|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
83497300|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497301|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83497302|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83497303|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
83497304|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83497305|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83497306|NCT05070650|Acetaminophen|acetaminophen|mesh-list
83497307|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
83497308|NCT05070650|Phenylephrine|phenylephrine|mesh-list
83497309|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
83497310|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83497311|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83497312|NCT05070650|Analgesics|analgesics|mesh-ancestor
83497313|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
83497314|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497315|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497316|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
83497317|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
83497318|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497319|NCT05070650|Expectorants|expectorants|mesh-ancestor
83497320|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
83497321|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83497322|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
83497323|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497324|NCT05070650|Protective Agents|protective agents|mesh-ancestor
83497325|NCT05070650|Antidotes|antidotes|mesh-ancestor
83497326|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83497327|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
83497328|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
83497329|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
83497330|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83497331|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
83497332|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83497333|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83497334|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83497335|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
83497336|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497337|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
83497338|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83497339|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497340|NCT03012230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83497341|NCT03012230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497342|NCT03005444|Enoxaparin|enoxaparin|mesh-list
83497343|NCT03005444|Nadroparin|nadroparin|mesh-list
83497344|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
83497345|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83497346|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
83497347|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83497348|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
83497349|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497350|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497351|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
83497352|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83497353|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83497354|NCT01076270|Plerixafor|plerixafor|mesh-list
83497355|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83497356|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83497357|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
83497358|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497359|NCT01076504|Carboplatin|carboplatin|mesh-list
83497360|NCT01076504|Amrubicin|amrubicin|mesh-list
83497362|NCT01076972|Ritonavir|ritonavir|mesh-list
83497363|NCT01076972|Lopinavir|lopinavir|mesh-list
83497364|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83497365|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83497366|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
83497367|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497368|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497369|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83497370|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83497371|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
83497372|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497373|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83497374|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83497375|NCT02174432|Nalbuphine|nalbuphine|mesh-list
83497376|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83497377|NCT02174432|Narcotics|narcotics|mesh-ancestor
83497378|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83497379|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497380|NCT02174432|Analgesics|analgesics|mesh-ancestor
83497381|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
83497382|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497383|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
83497384|NCT02176382|Denosumab|denosumab|mesh-list
83497385|NCT02176382|Teriparatide|teriparatide|mesh-list
83497386|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83497387|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497388|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83497389|NCT01077596|Bupropion|bupropion|mesh-list
83497390|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
83497391|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
83497399|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497400|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
83497401|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497402|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497403|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83497404|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83497405|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497406|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83497407|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
83497408|NCT03013712|Immunomodulating Agents|immunomodulating agents|mesh-list
83497409|NCT03013712|Immunologic Factors|immunologic factors|mesh-ancestor
83497410|NCT03013712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497412|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83497413|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
83497414|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
83497415|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83497416|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497417|NCT02414958|Empagliflozin|empagliflozin|mesh-list
83497418|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83497419|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497420|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83497421|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497422|NCT03016208|Misoprostol|misoprostol|mesh-list
83497423|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83497424|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
83497425|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83497426|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497427|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83497428|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83497429|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
83497430|NCT03013790|Melatonin|melatonin|mesh-list
83497431|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
83497432|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497433|NCT03013790|Protective Agents|protective agents|mesh-ancestor
83497434|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497435|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83497436|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83497437|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83497438|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83497439|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497440|NCT02485184|Propranolol|propranolol|mesh-list
83497441|NCT02485184|Warfarin|warfarin|mesh-list
83497442|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83497443|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
83497444|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83497445|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
83497446|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497447|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497448|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497449|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83497450|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83497451|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
83497452|NCT03015818|Calcium|calcium|mesh-list
83497453|NCT03015818|Fluorides|fluorides|mesh-list
83497454|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83497455|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497456|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
83497457|NCT03015818|Protective Agents|protective agents|mesh-ancestor
83497458|NCT01080248|Gemcitabine|gemcitabine|mesh-list
83497459|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83497460|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
83497461|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497462|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497463|NCT04802876|Spartalizumab|spartalizumab|mesh-list
83497464|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83497465|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497466|NCT04802876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83497467|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497468|NCT02452476|Poractant alfa|poractant alfa|mesh-list
83497469|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83497470|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
83497471|NCT01082588|Pravastatin|pravastatin|mesh-list
83497472|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83497473|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83497475|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497476|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83497477|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83497478|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497479|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
83497480|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83497481|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497482|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83497483|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497484|NCT02441946|Anastrozole|anastrozole|mesh-list
83497485|NCT02441946|Loperamide|loperamide|mesh-list
83497486|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
83497487|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83497488|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497489|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83497490|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83497491|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497492|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497493|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83497494|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
83497495|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83497496|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497497|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83497498|NCT01083368|Sirolimus|sirolimus|mesh-list
83497499|NCT01083368|Bevacizumab|bevacizumab|mesh-list
83497500|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83497501|NCT01083368|Temsirolimus|temsirolimus|mesh-list
83497502|NCT01083368|MTOR Inhibitors|mtor inhibitors|mesh-list
83497503|NCT01083368|Antibodies|antibodies|mesh-list
83497504|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
83497505|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83497506|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497507|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83497508|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83497509|NCT01083368|Growth Substances|growth substances|mesh-ancestor
83497510|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497511|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
83497512|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
83497513|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83497514|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497515|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83497516|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
83497517|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83497518|NCT01083368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83497519|NCT01083368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497520|NCT01083368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497521|NCT02387580|Artefenomel|artefenomel|mesh-list
83497522|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
83497523|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83497524|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83497525|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497526|NCT02440854|Afatinib|afatinib|mesh-list
83497527|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497528|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83497529|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497530|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497531|NCT01084148|V0034CR|v0034cr|mesh-list
83497532|NCT01084148|Emollients|emollients|mesh-ancestor
83497533|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
83497534|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
83497535|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83497536|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83497537|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497538|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
83497539|NCT01085006|Coagulants|coagulants|mesh-ancestor
83497540|NCT01085786|Amoxicillin|amoxicillin|mesh-list
83497541|NCT01085786|Metronidazole|metronidazole|mesh-list
83497542|NCT01085786|Clarithromycin|clarithromycin|mesh-list
83497543|NCT01085786|Esomeprazole|esomeprazole|mesh-list
83497544|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83497545|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497546|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83497547|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83497562|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497563|NCT02170220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83497564|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83497565|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83497566|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497567|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497568|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
83497569|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83497570|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83497571|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83497572|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83497573|NCT01036802|Warfarin|warfarin|mesh-list
83497574|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
83497575|NCT01037192|Vancomycin|vancomycin|mesh-list
83497576|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83497577|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497578|NCT02386098|Ritonavir|ritonavir|mesh-list
83497579|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83497580|NCT02386098|Tenofovir|tenofovir|mesh-list
83497581|NCT02386098|Dolutegravir|dolutegravir|mesh-list
83497582|NCT02386098|BMS-955176|bms-955176|mesh-list
83497583|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83497584|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83497585|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
83497586|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497587|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497588|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83497589|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83497590|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
83497591|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497592|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83497593|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83497594|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83497595|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83497596|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83497597|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83497598|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
83497599|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83497600|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
83497601|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
83497602|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497603|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497604|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497605|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83497606|NCT01089062|Analgesics|analgesics|mesh-ancestor
83497607|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
83497608|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497609|NCT02412618|Misoprostol|misoprostol|mesh-list
83497610|NCT02412618|Mifepristone|mifepristone|mesh-list
83497611|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83497612|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
83497613|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83497614|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497615|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83497616|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83497617|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
83497618|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83497619|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83497620|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83497621|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83497622|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
83497623|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83497624|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83497625|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
83497626|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83497627|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
83497628|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83497629|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83497630|NCT02179892|Acetaminophen|acetaminophen|mesh-list
83497631|NCT02179892|Dexamethasone|dexamethasone|mesh-list
83497632|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
83497633|NCT02179892|Bupivacaine|bupivacaine|mesh-list
83497634|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83497635|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
83497647|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83497648|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
83497649|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83497650|NCT02179892|Analgesics|analgesics|mesh-ancestor
83497651|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
83497652|NCT01092338|Vitamin D|vitamin d|mesh-list
83497653|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
83497654|NCT01092338|Vitamins|vitamins|mesh-ancestor
83497655|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
83497656|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497657|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83497658|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83497659|NCT01110434|Topiramate|topiramate|mesh-list
83497660|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
83497661|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83497662|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497663|NCT01042496|Lamotrigine|lamotrigine|mesh-list
83497664|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
83497665|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83497666|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83497667|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497668|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83497669|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497670|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83497671|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83497672|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83497673|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83497674|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83497675|NCT01111058|Everolimus|everolimus|mesh-list
83497676|NCT01111058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83497677|NCT01111058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83497678|NCT01111058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497679|NCT01111058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497680|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83497681|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
83497682|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497683|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497684|NCT01094522|Morphine|morphine|mesh-list
83497685|NCT01094522|Methadone|methadone|mesh-list
83497686|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83497687|NCT01094522|Narcotics|narcotics|mesh-ancestor
83497688|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83497689|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497690|NCT01094522|Analgesics|analgesics|mesh-ancestor
83497691|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
83497692|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497693|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
83497694|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
83497695|NCT02178800|Cabotegravir|cabotegravir|mesh-list
83497696|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83497697|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83497698|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497699|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497700|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83497701|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83497702|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
83497703|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497704|NCT01044212|Psyllium|psyllium|mesh-list
83497705|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83497706|NCT01044212|Cathartics|cathartics|mesh-ancestor
83497707|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83497708|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
83497709|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83497710|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83497711|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83497712|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83497713|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497714|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83497715|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83497716|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83497717|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83497718|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
83497719|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497720|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497721|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83497722|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83497733|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83497734|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497735|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497736|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83497737|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
83497738|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83497739|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497740|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83497741|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83497742|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
83497743|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83497744|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
83497745|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83497746|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83497747|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83497748|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83497749|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83497750|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83497751|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83497752|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497753|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83497754|NCT01113398|Bevacizumab|bevacizumab|mesh-list
83497755|NCT01113398|Rilotumumab|rilotumumab|mesh-list
83497756|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83497757|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497758|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83497759|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83497760|NCT01113398|Growth Substances|growth substances|mesh-ancestor
83497761|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497762|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
83497763|NCT03013556|Tenofovir|tenofovir|mesh-list
83497764|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83497765|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
83497766|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
83497767|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497768|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83497769|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83497770|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497771|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497772|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83497773|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83497774|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
83497775|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497776|NCT01113632|Ofatumumab|ofatumumab|mesh-list
83497777|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497778|NCT00458835|Ciclesonide|ciclesonide|mesh-list
83497779|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
83497780|NCT00458835|Hormones|hormones|mesh-ancestor
83497781|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83497782|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497783|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83497784|NCT01044758|Levetiracetam|levetiracetam|mesh-list
83497785|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
83497786|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
83497787|NCT01115582|Cholic Acids|cholic acids|mesh-list
83497788|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83497789|NCT03013400|Ebselen|ebselen|mesh-list
83497790|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83497791|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83497792|NCT03013400|Analgesics|analgesics|mesh-ancestor
83497793|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
83497794|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497795|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497796|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83497797|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83497798|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83497799|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83497800|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
83497801|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497802|NCT03013400|Protective Agents|protective agents|mesh-ancestor
83497803|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83497804|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497805|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83497806|NCT02439138|Idelalisib|idelalisib|mesh-list
83497807|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497808|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497809|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497810|NCT01097642|Cetuximab|cetuximab|mesh-list
83497811|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83497812|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497813|NCT01048658|Sevoflurane|sevoflurane|mesh-list
83497814|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83497815|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83497816|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
83497817|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
83497818|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83497819|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497820|NCT04341675|Sirolimus|sirolimus|mesh-list
83497821|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83497822|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497823|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83497824|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497825|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
83497826|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83497827|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
83497828|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497829|NCT02445807|Clobetasol|clobetasol|mesh-list
83497830|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83497831|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
83497832|NCT02445807|Hormones|hormones|mesh-ancestor
83497833|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83497834|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497835|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83497836|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83497837|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497838|NCT01116986|Nicotine|nicotine|mesh-list
83497839|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83497840|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
83497841|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497842|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497843|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83497844|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83497845|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
83497846|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497847|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497848|NCT01098500|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83497849|NCT01098500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83497850|NCT01098500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497851|NCT01098500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497852|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
83497853|NCT01099202|Hematinics|hematinics|mesh-ancestor
83497854|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
83497855|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
83497856|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83497857|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497858|NCT02448303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83497859|NCT02448303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497860|NCT02415855|Dabigatran|dabigatran|mesh-list
83497861|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
83497862|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83497863|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
83497864|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497865|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497866|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
83497867|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
83497868|NCT00363285|Hormones|hormones|mesh-list
83497869|NCT00363285|Cyproterone|cyproterone|mesh-list
83497870|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83497871|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497872|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
83497873|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
83497874|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497875|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83497876|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
83497877|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83497878|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
83497879|NCT02424357|Povidone|povidone|mesh-list
83497880|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83497881|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83497904|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83497905|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497907|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
83497908|NCT02435901|Fludarabine|fludarabine|mesh-list
83497909|NCT02435901|Melphalan|melphalan|mesh-list
83497910|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
83497911|NCT02435901|Tacrolimus|tacrolimus|mesh-list
83497912|NCT02435901|Cyclosporins|cyclosporins|mesh-list
83497913|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497914|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497915|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83497916|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
83497917|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497918|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83497919|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497920|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
83497921|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497922|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
83497923|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83497924|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83497925|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83497926|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
83497927|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83497928|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83497929|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
83497930|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83497931|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83497932|NCT02437383|Propranolol|propranolol|mesh-list
83497933|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83497934|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83497935|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
83497936|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497937|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497938|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497939|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83497940|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83497941|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
83497942|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
83497943|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83497944|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83497945|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497946|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
83497947|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
83497948|NCT01099358|Fluorouracil|fluorouracil|mesh-list
83497949|NCT01099358|Cetuximab|cetuximab|mesh-list
83497950|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497951|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
83497952|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497953|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83497954|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83497955|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
83497956|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497957|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83497958|NCT01118624|Vitamins|vitamins|mesh-list
83497959|NCT01118624|Folic Acid|folic acid|mesh-list
83497960|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
83497961|NCT01118624|Hydroxocobalamin|hydroxocobalamin|mesh-list
83497962|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
83497963|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
83497964|NCT01118624|Aminopterin|aminopterin|mesh-list
83497965|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
83497966|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497967|NCT01118624|Hematinics|hematinics|mesh-ancestor
83497968|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83497969|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497970|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497971|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497972|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
83497973|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
83497974|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497975|NCT02439879|Protective Agents|protective agents|mesh-ancestor
83497976|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497977|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
83497978|NCT02439879|Vitamins|vitamins|mesh-ancestor
83497979|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
83497980|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
83497993|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83497994|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497995|NCT01119794|Bortezomib|bortezomib|mesh-list
83497996|NCT01119794|Ofatumumab|ofatumumab|mesh-list
83497997|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497998|NCT02926196|Avelumab|avelumab|mesh-list
83497999|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83498000|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498001|NCT01103414|Pioglitazone|pioglitazone|mesh-list
83498002|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83498003|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498004|NCT02180828|Fluconazole|fluconazole|mesh-list
83498005|NCT02180828|Clotrimazole|clotrimazole|mesh-list
83498006|NCT02180828|Miconazole|miconazole|mesh-list
83498007|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
83498008|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498009|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83498010|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83498011|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498012|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498013|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83498014|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
83498015|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498016|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498017|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83498018|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83498019|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83498020|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83498021|NCT02525523|Alicaforsen|alicaforsen|mesh-list
83498022|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498023|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83498024|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
83498025|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498026|NCT02528409|Vortioxetine|vortioxetine|mesh-list
83498027|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
83498028|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83498029|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83498030|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83498031|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83498032|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498033|NCT02528409|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83498034|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83498035|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83498036|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498037|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498038|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
83498039|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83498040|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83498041|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83498042|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83498043|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
83498044|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83498045|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83498046|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83498047|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
83498048|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498049|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498050|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498051|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
83498052|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83498053|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83498054|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498055|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83498056|NCT03013634|Analgesics|analgesics|mesh-ancestor
83498057|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
83498058|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498059|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83498060|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83498061|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83498062|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83498063|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498064|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498078|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83498079|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498080|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498081|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
83498082|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498083|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498084|NCT03013322|Miotics|miotics|mesh-ancestor
83498085|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
83498086|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498087|NCT02469597|Furosemide|furosemide|mesh-list
83498088|NCT02469597|Diuretics|diuretics|mesh-ancestor
83498089|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
83498090|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498091|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83498092|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83498093|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498094|NCT02183792|Furosemide|furosemide|mesh-list
83498095|NCT02183792|Tolvaptan|tolvaptan|mesh-list
83498096|NCT02183792|Diuretics|diuretics|mesh-ancestor
83498097|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
83498098|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498099|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83498100|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83498101|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498102|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83498103|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83498104|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83498105|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498106|NCT00363519|Incretins|incretins|mesh-ancestor
83498107|NCT00363519|Hormones|hormones|mesh-ancestor
83498108|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498109|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83498110|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
83498111|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498112|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498113|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
83498114|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498115|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83498116|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498117|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498118|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
83498119|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83498120|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498121|NCT02475837|Vorapaxar|vorapaxar|mesh-list
83498122|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83498123|NCT01124786|Gemcitabine|gemcitabine|mesh-list
83498124|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83498125|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
83498126|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498127|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498128|NCT01125098|Amoxicillin|amoxicillin|mesh-list
83498129|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
83498130|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83498131|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83498132|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498133|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83498134|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498135|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498136|NCT02478489|Naltrexone|naltrexone|mesh-list
83498137|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83498138|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83498139|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498140|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
83498141|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498142|NCT02322320|Lenalidomide|lenalidomide|mesh-list
83498143|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
83498144|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498145|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83498146|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83498147|NCT02322320|Growth Substances|growth substances|mesh-ancestor
83498148|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
83498149|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498150|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
83498151|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83498152|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498153|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83498154|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498155|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
83498156|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83498157|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498158|NCT01127438|Fospropofol|fospropofol|mesh-list
83498159|NCT01127438|Propofol|propofol|mesh-list
83498160|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83498161|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83498162|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498163|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83498164|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
83498165|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
83498166|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
83498167|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83498168|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83498169|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498170|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83498171|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83498172|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498173|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498174|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498175|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83498176|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
83498177|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83498178|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498179|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83498180|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83498181|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83498182|NCT02481219|Erythromycin|erythromycin|mesh-list
83498183|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
83498184|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83498185|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
83498186|NCT02481219|Metoclopramide|metoclopramide|mesh-list
83498187|NCT02481219|Bisacodyl|bisacodyl|mesh-list
83498188|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83498189|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
83498190|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
83498191|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498192|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498193|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498194|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83498195|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83498196|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
83498197|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498198|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498199|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83498200|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498201|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83498202|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498203|NCT02481219|Cathartics|cathartics|mesh-ancestor
83498204|NCT02481219|Laxatives|laxatives|mesh-ancestor
83498205|NCT02481297|Rituximab|rituximab|mesh-list
83498206|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83498207|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498208|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
83498209|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498210|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83498211|NCT02481375|Iron|iron|mesh-list
83498212|NCT02481375|Trace Elements|trace elements|mesh-list
83498213|NCT02481375|Micronutrients|micronutrients|mesh-list
83498214|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498215|NCT01164098|Rituximab|rituximab|mesh-list
83498216|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83498217|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498218|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
83498219|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498220|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83498221|NCT01165112|Rituximab|rituximab|mesh-list
83498222|NCT01165112|Carboplatin|carboplatin|mesh-list
83498223|NCT01165112|Etoposide|etoposide|mesh-list
83498224|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83498225|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83498226|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498227|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
83498228|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498229|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83498230|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83498231|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83498232|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83498233|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498234|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498235|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83498236|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
83498237|NCT01129778|Omeprazole|omeprazole|mesh-list
83498238|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83498239|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
83498240|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83498241|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498242|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498243|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498244|NCT02556333|Tenofovir|tenofovir|mesh-list
83498245|NCT02556333|Emtricitabine|emtricitabine|mesh-list
83498246|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
83498247|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498248|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83498249|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83498250|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498251|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498252|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83498253|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83498254|NCT01166126|Sirolimus|sirolimus|mesh-list
83498255|NCT01166126|Temsirolimus|temsirolimus|mesh-list
83498256|NCT01166126|MTOR Inhibitors|mtor inhibitors|mesh-list
83498257|NCT01166126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83498258|NCT01166126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498259|NCT01166126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498260|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83498261|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
83498262|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498263|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498264|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83498265|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498266|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83498267|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
83498268|NCT05306990|Atorvastatin|atorvastatin|mesh-list
83498269|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83498270|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83498271|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83498272|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
83498273|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498274|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83498275|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83498276|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498277|NCT02557035|Dexamethasone|dexamethasone|mesh-list
83498278|NCT02557035|Palonosetron|palonosetron|mesh-list
83498279|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83498280|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
83498281|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
83498282|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498283|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498284|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498285|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
83498286|NCT02557035|Hormones|hormones|mesh-ancestor
83498287|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498288|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83498289|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498290|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83498291|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83498292|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
83498293|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498294|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498295|NCT04341207|Azithromycin|azithromycin|mesh-list
83498296|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
83498297|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83498298|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498299|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
83498308|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83498309|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498310|NCT02486211|Amantadine|amantadine|mesh-list
83498311|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83498312|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83498313|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
83498314|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498315|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
83498316|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498317|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498318|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498319|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83498320|NCT02486211|Analgesics|analgesics|mesh-ancestor
83498321|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
83498322|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498323|NCT01167452|Trimethoprim|trimethoprim|mesh-list
83498324|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83498325|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
83498326|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83498327|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498328|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
83498329|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83498330|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83498331|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83498332|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498333|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498334|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83498335|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83498336|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83498337|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83498338|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
83498339|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83498340|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498341|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498342|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83498343|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83498344|NCT02487225|Protective Agents|protective agents|mesh-ancestor
83498345|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498346|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
83498347|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83498348|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
83498349|NCT02384850|Leucovorin|leucovorin|mesh-list
83498350|NCT02384850|Folic Acid|folic acid|mesh-list
83498351|NCT02384850|Fluorouracil|fluorouracil|mesh-list
83498352|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
83498353|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
83498354|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
83498355|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498356|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83498357|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498358|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83498359|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
83498360|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498361|NCT02384850|Antidotes|antidotes|mesh-ancestor
83498362|NCT02384850|Protective Agents|protective agents|mesh-ancestor
83498363|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
83498364|NCT02384850|Vitamins|vitamins|mesh-ancestor
83498365|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
83498366|NCT02384850|Hematinics|hematinics|mesh-ancestor
83498367|NCT02558829|Insulin|insulin|mesh-list
83498368|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83498369|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83498370|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498371|NCT02487303|Acetaminophen|acetaminophen|mesh-list
83498372|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83498373|NCT02487303|Analgesics|analgesics|mesh-ancestor
83498374|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
83498375|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498376|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498377|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
83498378|NCT01168934|Crizotinib|crizotinib|mesh-list
83498379|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498380|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83498381|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498382|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498383|NCT05305508|Mannitol|mannitol|mesh-list
83498384|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
83498492|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498493|NCT01138124|Gabapentin|gabapentin|mesh-list
83498494|NCT01138124|Analgesics|analgesics|mesh-ancestor
83498495|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
83498496|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498497|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498498|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
83498499|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83498500|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83498501|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83498502|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83498503|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83498504|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83498505|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498506|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498507|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
83498508|NCT02560779|Sorafenib|sorafenib|mesh-list
83498509|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498510|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83498511|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498512|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498513|NCT01138514|Clindamycin|clindamycin|mesh-list
83498514|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
83498515|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
83498516|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83498517|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83498518|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498519|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83498520|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498521|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498522|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
83498523|NCT02561481|Sulforaphane|sulforaphane|mesh-list
83498524|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83498525|NCT02561481|Protective Agents|protective agents|mesh-ancestor
83498526|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498527|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498528|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
83498529|NCT01173848|Vitamin D|vitamin d|mesh-list
83498530|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
83498531|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83498532|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498533|NCT01173848|Vitamins|vitamins|mesh-ancestor
83498534|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
83498535|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83498536|NCT01174082|Vaccines|vaccines|mesh-list
83498537|NCT01174082|Sargramostim|sargramostim|mesh-list
83498538|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
83498539|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498540|NCT01175798|Vitamin D|vitamin d|mesh-list
83498541|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
83498542|NCT01175798|Vitamins|vitamins|mesh-ancestor
83498543|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
83498544|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498545|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83498546|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83498547|NCT02246894|Factor VIII|factor viii|mesh-list
83498548|NCT02246894|Coagulants|coagulants|mesh-ancestor
83498549|NCT05177510|Mifepristone|mifepristone|mesh-list
83498550|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83498551|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
83498552|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83498553|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498554|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83498555|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83498556|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83498557|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
83498558|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83498559|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83498560|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
83498561|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498562|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
83498563|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83498564|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83498565|NCT03011996|Amoxicillin|amoxicillin|mesh-list
83498566|NCT03011996|Clarithromycin|clarithromycin|mesh-list
83498580|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498581|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
83498582|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498583|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83498584|NCT01178528|Carvedilol|carvedilol|mesh-list
83498585|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83498586|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83498587|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
83498588|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498589|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498590|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498591|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83498592|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
83498593|NCT01178528|Protective Agents|protective agents|mesh-ancestor
83498594|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83498595|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83498596|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83498597|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
83498598|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83498599|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83498600|NCT02980250|Domperidone|domperidone|mesh-list
83498601|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
83498602|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
83498603|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498604|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498605|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498606|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83498607|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
83498608|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498609|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498610|NCT02491437|Progesterone|progesterone|mesh-list
83498611|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
83498612|NCT02491437|Progestins|progestins|mesh-ancestor
83498613|NCT02491437|Hormones|hormones|mesh-ancestor
83498614|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498615|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498616|NCT02383758|Bisacodyl|bisacodyl|mesh-list
83498617|NCT02383758|Glycerol|glycerol|mesh-list
83498618|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83498619|NCT02383758|Protective Agents|protective agents|mesh-ancestor
83498620|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498621|NCT02383758|Cathartics|cathartics|mesh-ancestor
83498622|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498623|NCT02383758|Laxatives|laxatives|mesh-ancestor
83498624|NCT02492451|Progesterone|progesterone|mesh-list
83498625|NCT02492451|Progestins|progestins|mesh-ancestor
83498626|NCT02492451|Hormones|hormones|mesh-ancestor
83498627|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498628|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498629|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83498630|NCT02410278|Montelukast|montelukast|mesh-list
83498631|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83498632|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
83498633|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83498634|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
83498635|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498636|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498637|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83498638|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83498639|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498640|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
83498641|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83498642|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
83498643|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
83498644|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
83498645|NCT01181258|Rituximab|rituximab|mesh-list
83498646|NCT01181258|Fludarabine|fludarabine|mesh-list
83498647|NCT01181258|Interleukin-2|interleukin-2|mesh-list
83498648|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83498649|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
83498650|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498651|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83498652|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83498653|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
83498654|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498655|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498656|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83498657|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83498658|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83498660|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
83498661|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498662|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498663|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
83498664|NCT01181258|Hormones|hormones|mesh-ancestor
83498665|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498666|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83498667|NCT01181258|Protective Agents|protective agents|mesh-ancestor
83498668|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83498669|NCT01181258|Analgesics|analgesics|mesh-ancestor
83498670|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
83498671|NCT02570139|Protective Agents|protective agents|mesh-list
83498672|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498673|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83498674|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
83498675|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83498676|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
83498677|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498678|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83498679|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83498680|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
83498681|NCT02494713|Ketoconazole|ketoconazole|mesh-list
83498682|NCT02494713|Docetaxel|docetaxel|mesh-list
83498683|NCT02494713|Doxorubicin|doxorubicin|mesh-list
83498684|NCT02494713|Estramustine|estramustine|mesh-list
83498685|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498686|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
83498687|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
83498688|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
83498689|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498690|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83498691|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83498692|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83498693|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498694|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
83498695|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498696|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83498697|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83498698|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83498699|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
83498700|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498701|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498702|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83498703|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83498704|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
83498705|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83498706|NCT02495103|Metformin|metformin|mesh-list
83498707|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83498708|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498709|NCT02382276|Nalmefene|nalmefene|mesh-list
83498710|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83498711|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498712|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
83498713|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498715|NCT02571153|Analgesics|analgesics|mesh-ancestor
83498716|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
83498717|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498718|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498719|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83498720|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83498721|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
83498722|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
83498723|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83498724|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83498725|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83498726|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498727|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498728|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
83498729|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
83498730|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498731|NCT04573322|Protective Agents|protective agents|mesh-ancestor
83498732|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498733|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83498734|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498735|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
83498736|NCT01143818|Testosterone|testosterone|mesh-list
83498737|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
83498738|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
83498739|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83498740|NCT01143818|Androgens|androgens|mesh-ancestor
83498742|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498743|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498744|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83498745|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498746|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
83498747|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83498748|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
83498749|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498750|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
83498751|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83498752|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83498753|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83498754|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83498755|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498756|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
83498757|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498758|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498759|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83498760|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498761|NCT01650558|Chloroquine|chloroquine|mesh-list
83498762|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83498763|NCT01650558|Amebicides|amebicides|mesh-ancestor
83498764|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83498765|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83498766|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498767|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
83498768|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83498769|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83498770|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83498771|NCT02579343|Dexetimide|dexetimide|mesh-list
83498772|NCT02579343|Citalopram|citalopram|mesh-list
83498773|NCT02579343|Escitalopram|escitalopram|mesh-list
83498774|NCT02579343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83498775|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83498776|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83498777|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498778|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498779|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
83498780|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498781|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83498782|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83498783|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
83498784|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
83498785|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498786|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83498787|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83498788|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
83498789|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83498790|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
83498791|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83498792|NCT01144442|Paclitaxel|paclitaxel|mesh-list
83498793|NCT01144442|Carboplatin|carboplatin|mesh-list
83498794|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83498795|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498796|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
83498797|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
83498798|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
83498799|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498800|NCT02499081|Ixazomib|ixazomib|mesh-list
83498801|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498802|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
83498803|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498804|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498805|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83498806|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83498808|NCT02501265|Varenicline|varenicline|mesh-list
83498809|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83498810|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
83498811|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498812|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498813|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83498814|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83498815|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
83498816|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498817|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498818|NCT02408016|Aldesleukin|aldesleukin|mesh-list
83498819|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
83498820|NCT02408016|Interleukin-2|interleukin-2|mesh-list
83498821|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83498822|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
83498823|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498824|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83498825|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83498826|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
83498827|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498828|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498829|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83498830|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83498831|NCT02408016|Analgesics|analgesics|mesh-ancestor
83498832|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
83498833|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498834|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83498835|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83498836|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
83498837|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498838|NCT02579421|Progesterone|progesterone|mesh-list
83498839|NCT02579421|Progestins|progestins|mesh-ancestor
83498840|NCT02579421|Hormones|hormones|mesh-ancestor
83498841|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498842|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498843|NCT00422175|Siponimod|siponimod|mesh-list
83498844|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83498845|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498846|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83498847|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
83498848|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498849|NCT01186250|Pioglitazone|pioglitazone|mesh-list
83498850|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83498851|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498852|NCT01186406|Bevacizumab|bevacizumab|mesh-list
83498853|NCT01186406|Temozolomide|temozolomide|mesh-list
83498854|NCT01186406|Carmustine|carmustine|mesh-list
83498855|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83498856|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498857|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83498858|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83498859|NCT01186406|Growth Substances|growth substances|mesh-ancestor
83498860|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498861|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
83498862|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83498863|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
83498864|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498865|NCT02407704|Lorazepam|lorazepam|mesh-list
83498866|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83498867|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83498868|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83498869|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83498870|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498871|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498872|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498873|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83498874|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
83498875|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83498876|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
83498907|NCT02581839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83498908|NCT02581839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83498909|NCT02581839|Serotonin Agents|serotonin agents|mesh-ancestor
83498910|NCT02581839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498911|NCT02504775|Acetaminophen|acetaminophen|mesh-list
83498912|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83498913|NCT02504775|Analgesics|analgesics|mesh-ancestor
83498914|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
83498915|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498916|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498917|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
83498918|NCT02504931|Sertraline|sertraline|mesh-list
83498919|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
83498920|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83498921|NCT02504931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83498922|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83498923|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83498924|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498925|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498926|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
83498927|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498928|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
83498929|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83498930|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83498931|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498932|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
83498933|NCT02584725|Coagulants|coagulants|mesh-ancestor
83498934|NCT04423029|Nivolumab|nivolumab|mesh-list
83498935|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83498936|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498937|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83498938|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498939|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83498940|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83498941|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498942|NCT01186562|Incretins|incretins|mesh-ancestor
83498943|NCT01186562|Hormones|hormones|mesh-ancestor
83498944|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498945|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83498946|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
83498947|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498948|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498949|NCT01187498|Oxybutynin|oxybutynin|mesh-list
83498950|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
83498951|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
83498952|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498953|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498954|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83498955|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83498956|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
83498957|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498958|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498959|NCT01187498|Urological Agents|urological agents|mesh-ancestor
83498960|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83498961|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
83498962|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83498963|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83498964|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83498965|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
83498966|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83498967|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498968|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83498969|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83498970|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83498971|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83498972|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498973|NCT01149434|Everolimus|everolimus|mesh-list
83498974|NCT01149434|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83498975|NCT01149434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83498976|NCT01149434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498977|NCT01149434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498978|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83498979|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
83498980|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498981|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498982|NCT01150760|Alvimopan|alvimopan|mesh-list
83498983|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498984|NCT01150838|Propofol|propofol|mesh-list
83498985|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83498986|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83498987|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498988|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83498989|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
83498990|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
83498991|NCT01189292|Dexamethasone|dexamethasone|mesh-list
83498992|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83498993|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
83498994|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
83498995|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498996|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498997|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498998|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
83498999|NCT01189292|Hormones|hormones|mesh-ancestor
83499000|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499001|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83499002|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499003|NCT01189370|Sorafenib|sorafenib|mesh-list
83499004|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499005|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83499006|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499007|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499008|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83499009|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83499010|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83499011|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499012|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499013|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83499014|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83499015|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499016|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
83499017|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499019|NCT03010202|Rituximab|rituximab|mesh-list
83499020|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499021|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499022|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
83499023|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499024|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83499025|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83499026|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
83499027|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
83499028|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499029|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499030|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
83499031|NCT03010202|Hormones|hormones|mesh-ancestor
83499032|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499033|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83499034|NCT01191320|Enclomiphene|enclomiphene|mesh-list
83499035|NCT01191320|Clomiphene|clomiphene|mesh-list
83499036|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
83499037|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83499038|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
83499039|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499040|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499041|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83499042|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
83499043|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83499044|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83499045|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83499046|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
83499047|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499048|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83499049|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499050|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499051|NCT01191398|Atropine|atropine|mesh-list
83499052|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
83499053|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83499054|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83499055|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83499066|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499067|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499068|NCT01191476|Propofol|propofol|mesh-list
83499069|NCT01191476|Sevoflurane|sevoflurane|mesh-list
83499070|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83499071|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499072|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499073|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83499074|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
83499075|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
83499076|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83499077|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83499078|NCT02508207|Ivacaftor|ivacaftor|mesh-list
83499079|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83499080|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83499081|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499082|NCT02509065|Pancrelipase|pancrelipase|mesh-list
83499083|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499084|NCT01194674|Plasminogen|plasminogen|mesh-list
83499085|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83499086|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83499087|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499088|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83499089|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
83499090|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83499091|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83499092|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83499093|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
83499094|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83499095|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499096|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83499097|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83499098|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83499099|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83499100|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499101|NCT01154192|Dexamethasone|dexamethasone|mesh-list
83499102|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83499103|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83499104|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
83499105|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
83499106|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499107|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499108|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499109|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
83499110|NCT01154192|Hormones|hormones|mesh-ancestor
83499111|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499112|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83499113|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499114|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83499115|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
83499116|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83499117|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83499118|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83499119|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83499120|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499121|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499122|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499123|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83499124|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83499125|NCT01195922|Sirolimus|sirolimus|mesh-list
83499126|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83499127|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83499128|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83499129|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499130|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
83499131|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83499132|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
83499133|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499134|NCT02512575|Prednisolone|prednisolone|mesh-list
83499135|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83499136|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
83499137|NCT02512575|Hormones|hormones|mesh-ancestor
83499138|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499589|NCT05696847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83499139|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499140|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83499141|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499142|NCT01199744|Zanamivir|zanamivir|mesh-list
83499143|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
83499144|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83499145|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499146|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499147|NCT03702374|Antioxidants|antioxidants|mesh-list
83499148|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499149|NCT03702374|Protective Agents|protective agents|mesh-ancestor
83499150|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499151|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
83499152|NCT02512809|Isoflurane|isoflurane|mesh-list
83499153|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83499154|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499155|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499156|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83499157|NCT02512809|Analgesics|analgesics|mesh-ancestor
83499158|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
83499159|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499160|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83499161|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83499162|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83499163|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
83499164|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499165|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499166|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83499167|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
83499168|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
83499169|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83499170|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83499171|NCT01202162|Sevoflurane|sevoflurane|mesh-list
83499172|NCT01202162|Desflurane|desflurane|mesh-list
83499173|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83499174|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83499175|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
83499176|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
83499177|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499178|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499179|NCT01159262|Fentanyl|fentanyl|mesh-list
83499180|NCT01159262|Midazolam|midazolam|mesh-list
83499181|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
83499182|NCT01159262|Morphine|morphine|mesh-list
83499183|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83499184|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499185|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499186|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83499187|NCT01159262|Analgesics|analgesics|mesh-ancestor
83499188|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
83499189|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499190|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83499191|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83499192|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83499193|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
83499194|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499195|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499196|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83499197|NCT01159262|Narcotics|narcotics|mesh-ancestor
83499198|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83499199|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83499200|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
83499201|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
83499202|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83499203|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83499204|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83499205|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
83499206|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
83499207|NCT04378959|Lidocaine|lidocaine|mesh-list
83499208|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
83499209|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
83499210|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499211|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499212|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
83499213|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499214|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83499215|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83499216|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83499217|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83499218|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499219|NCT03011060|Capecitabine|capecitabine|mesh-list
83499220|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83499221|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
83499222|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499223|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499224|NCT03010670|Oxytocin|oxytocin|mesh-list
83499225|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
83499226|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83499227|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499228|NCT04377711|Ciclesonide|ciclesonide|mesh-list
83499229|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
83499230|NCT04377711|Hormones|hormones|mesh-ancestor
83499231|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499232|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499233|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83499234|NCT04366713|Capecitabine|capecitabine|mesh-list
83499235|NCT04366713|Loperamide|loperamide|mesh-list
83499236|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
83499237|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83499238|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
83499239|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499240|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499241|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499242|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
83499243|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83499244|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83499245|NCT02976441|Temozolomide|temozolomide|mesh-list
83499246|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83499247|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
83499248|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499249|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499250|NCT00363753|Aspirin|aspirin|mesh-list
83499251|NCT00363753|Clopidogrel|clopidogrel|mesh-list
83499252|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83499253|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83499254|NCT00363753|Analgesics|analgesics|mesh-ancestor
83499255|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
83499256|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499257|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499258|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83499259|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83499260|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83499261|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83499262|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499263|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83499264|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83499265|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499266|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
83499267|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83499268|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83499269|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83499270|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
83499271|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499272|NCT02434770|Vaccines|vaccines|mesh-list
83499273|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
83499274|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499275|NCT01203644|Bupivacaine|bupivacaine|mesh-list
83499276|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
83499277|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
83499278|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499279|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499280|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
83499281|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499282|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
83499283|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499284|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
83499285|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83499286|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83499287|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83499288|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83499289|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
83499290|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499291|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499292|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499293|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83499294|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
83499295|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499296|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83499297|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
83499298|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83499299|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83499300|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83499301|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
83499302|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
83499303|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83499304|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499305|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83499306|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499307|NCT00363909|Dexetimide|dexetimide|mesh-list
83499308|NCT00363909|Citalopram|citalopram|mesh-list
83499309|NCT00363909|Escitalopram|escitalopram|mesh-list
83499310|NCT00363909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83499311|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83499312|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83499313|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499314|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499315|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
83499316|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499317|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83499318|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
83499319|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83499320|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83499321|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83499322|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
83499323|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
83499324|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499325|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83499326|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83499327|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
83499328|NCT01205828|Temozolomide|temozolomide|mesh-list
83499329|NCT01205828|Veliparib|veliparib|mesh-list
83499330|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83499331|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
83499332|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499333|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499334|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83499335|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499336|NCT02515305|Clindamycin|clindamycin|mesh-list
83499337|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
83499338|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
83499339|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83499340|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83499341|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83499342|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83499343|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499344|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499345|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
83499346|NCT01206452|Prednisone|prednisone|mesh-list
83499347|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83499348|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
83499349|NCT01206452|Hormones|hormones|mesh-ancestor
83499350|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499351|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499352|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83499353|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499354|NCT01206608|Bupivacaine|bupivacaine|mesh-list
83499355|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
83499356|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
83499357|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499358|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499359|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
83499360|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499361|NCT03010436|Benralizumab|benralizumab|mesh-list
83499362|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83499740|NCT05543629|Docetaxel|docetaxel|mesh-list
83499363|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
83499365|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83499366|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83499367|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
83499368|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499369|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83499370|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83499371|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499372|NCT02517021|Dexamethasone|dexamethasone|mesh-list
83499373|NCT02517021|Palonosetron|palonosetron|mesh-list
83499374|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83499375|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
83499376|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
83499377|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499378|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499379|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499380|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
83499381|NCT02517021|Hormones|hormones|mesh-ancestor
83499382|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499383|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83499384|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499385|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83499386|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83499387|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
83499388|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499389|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499390|NCT05859269|Methylprednisolone|methylprednisolone|mesh-list
83499391|NCT05859269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83499392|NCT05859269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83499393|NCT05859269|Prednisolone|prednisolone|mesh-list
83499394|NCT05859269|Prednisolone acetate|prednisolone acetate|mesh-list
83499395|NCT05859269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83499396|NCT05859269|Prednisolone phosphate|prednisolone phosphate|mesh-list
83499397|NCT05859269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83499398|NCT05859269|Antiemetics|antiemetics|mesh-ancestor
83499399|NCT05859269|Autonomic Agents|autonomic agents|mesh-ancestor
83499400|NCT05859269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499401|NCT05859269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499402|NCT05859269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499403|NCT05859269|Glucocorticoids|glucocorticoids|mesh-ancestor
83499404|NCT05859269|Hormones|hormones|mesh-ancestor
83499405|NCT05859269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499406|NCT05859269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83499407|NCT05859269|Protective Agents|protective agents|mesh-ancestor
83499408|NCT05859269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83499409|NCT05859269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499410|NCT05859217|Atezolizumab|atezolizumab|mesh-list
83499411|NCT05859217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83499412|NCT05859217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499413|NCT05859217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499414|NCT05859217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499415|NCT05859126|Choline|choline|mesh-list
83499416|NCT05859126|Lipotropic Agents|lipotropic agents|mesh-ancestor
83499417|NCT05859126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83499418|NCT05859126|Antimetabolites|antimetabolites|mesh-ancestor
83499419|NCT05859126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499420|NCT05859126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499421|NCT05859126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83499422|NCT05859126|Nootropic Agents|nootropic agents|mesh-ancestor
83499423|NCT05858710|Doxorubicin|doxorubicin|mesh-list
83499424|NCT05858710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83499425|NCT05858710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499426|NCT05858710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83499427|NCT05858710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83499428|NCT05858710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499429|NCT05858710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499430|NCT05858671|Fenugreek seed meal|fenugreek seed meal|mesh-list
83499431|NCT05858671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83499432|NCT05858671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499433|NCT05858645|Deucravacitinib|deucravacitinib|mesh-list
83499434|NCT05858645|Dermatologic Agents|dermatologic agents|mesh-ancestor
83499435|NCT05858645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83499436|NCT05858645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499437|NCT05858645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499438|NCT05858216|Chlorpheniramine|chlorpheniramine|mesh-list
83499439|NCT05858216|Antipruritics|antipruritics|mesh-ancestor
83499440|NCT05858216|Dermatologic Agents|dermatologic agents|mesh-ancestor
83499441|NCT05858216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83499442|NCT05858216|Histamine Antagonists|histamine antagonists|mesh-ancestor
83499443|NCT05858216|Histamine Agents|histamine agents|mesh-ancestor
83499444|NCT05858216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499445|NCT05858216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499446|NCT05858216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499447|NCT05858216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83499448|NCT05858177|Temozolomide|temozolomide|mesh-list
83499449|NCT05858177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83499450|NCT05858177|Alkylating Agents|alkylating agents|mesh-ancestor
83499451|NCT05858177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499452|NCT05858177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499454|NCT05857982|Mitoxantrone|mitoxantrone|mesh-list
83499455|NCT05857982|Daratumumab|daratumumab|mesh-list
83499456|NCT05857982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83499457|NCT05857982|Antiemetics|antiemetics|mesh-ancestor
83499458|NCT05857982|Autonomic Agents|autonomic agents|mesh-ancestor
83499459|NCT05857982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499460|NCT05857982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499461|NCT05857982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499462|NCT05857982|Glucocorticoids|glucocorticoids|mesh-ancestor
83499463|NCT05857982|Hormones|hormones|mesh-ancestor
83499464|NCT05857982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499465|NCT05857982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83499466|NCT05857982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499467|NCT05857982|Analgesics|analgesics|mesh-ancestor
83499468|NCT05857982|Sensory System Agents|sensory system agents|mesh-ancestor
83499469|NCT05857982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83499470|NCT05857982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83499471|NCT05857982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499472|NCT05857982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499473|NCT05857891|Epoetin Alfa|epoetin alfa|mesh-list
83499474|NCT05857891|Hematinics|hematinics|mesh-ancestor
83499475|NCT05857748|Lifitegrast|lifitegrast|mesh-list
83499476|NCT05857748|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83499477|NCT05857748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83499478|NCT05844618|Triamcinolone|triamcinolone|mesh-list
83499479|NCT05844618|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83499480|NCT05844618|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83499481|NCT05844618|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83499482|NCT05844618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83499483|NCT05844618|Glucocorticoids|glucocorticoids|mesh-ancestor
83499484|NCT05844618|Hormones|hormones|mesh-ancestor
83499485|NCT05844618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499486|NCT05844618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499487|NCT05844618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83499488|NCT05844618|Immunologic Factors|immunologic factors|mesh-ancestor
83499489|NCT05844618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499490|NCT05844618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499491|NCT05836025|Sirolimus|sirolimus|mesh-list
83499492|NCT05836025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83499493|NCT05836025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83499494|NCT05836025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83499495|NCT05836025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499496|NCT05836025|Antifungal Agents|antifungal agents|mesh-ancestor
83499497|NCT05836025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83499498|NCT05836025|Immunologic Factors|immunologic factors|mesh-ancestor
83499499|NCT05836025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499500|NCT05819853|Metformin|metformin|mesh-list
83499501|NCT05819853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83499502|NCT05819853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499503|NCT05796752|Memantine|memantine|mesh-list
83499504|NCT05796752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83499505|NCT05796752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83499506|NCT05796752|Dopamine Agents|dopamine agents|mesh-ancestor
83499507|NCT05796752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499508|NCT05796752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499509|NCT05796752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499510|NCT05796752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83499511|NCT05796752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83499512|NCT05794971|Irinotecan|irinotecan|mesh-list
83499513|NCT05794971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83499514|NCT05794971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83499515|NCT05794971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499516|NCT05794971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499517|NCT05794971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499518|NCT05785195|Nitric Oxide|nitric oxide|mesh-list
83499519|NCT05785195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83499520|NCT05785195|Autonomic Agents|autonomic agents|mesh-ancestor
83499521|NCT05785195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499522|NCT05785195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499523|NCT05785195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83499524|NCT05785195|Respiratory System Agents|respiratory system agents|mesh-ancestor
83499525|NCT05785195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83499526|NCT05785195|Antioxidants|antioxidants|mesh-ancestor
83499527|NCT05785195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499528|NCT05785195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499529|NCT05785195|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83499530|NCT05785195|Vasodilator Agents|vasodilator agents|mesh-ancestor
83499531|NCT05785195|Gasotransmitters|gasotransmitters|mesh-ancestor
83499532|NCT05785195|Protective Agents|protective agents|mesh-ancestor
83499534|NCT05735717|Fludarabine|fludarabine|mesh-list
83499535|NCT05735717|Melphalan|melphalan|mesh-list
83499536|NCT05735717|Busulfan|busulfan|mesh-list
83499537|NCT05735717|Levetiracetam|levetiracetam|mesh-list
83499538|NCT05735717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499539|NCT05735717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499540|NCT05735717|Immunologic Factors|immunologic factors|mesh-ancestor
83499541|NCT05735717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499542|NCT05735717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83499543|NCT05735717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499544|NCT05735717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83499545|NCT05735717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83499546|NCT05735717|Alkylating Agents|alkylating agents|mesh-ancestor
83499547|NCT05735717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83499548|NCT05735717|Anticonvulsants|anticonvulsants|mesh-ancestor
83499549|NCT05735717|Nootropic Agents|nootropic agents|mesh-ancestor
83499550|NCT05729282|Diazoxide|diazoxide|mesh-list
83499551|NCT05729282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83499552|NCT05729282|Vasodilator Agents|vasodilator agents|mesh-ancestor
83499553|NCT05709977|Histamine Antagonists|histamine antagonists|mesh-list
83499554|NCT05709977|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83499555|NCT05709977|Histamine Agents|histamine agents|mesh-ancestor
83499556|NCT05709977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499557|NCT05709977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499558|NCT05709977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499559|NCT05704985|Paclitaxel|paclitaxel|mesh-list
83499560|NCT05704985|Carboplatin|carboplatin|mesh-list
83499561|NCT05704985|Pembrolizumab|pembrolizumab|mesh-list
83499562|NCT05704985|Fluorouracil|fluorouracil|mesh-list
83499563|NCT05704985|Capecitabine|capecitabine|mesh-list
83499564|NCT05704985|Oxaliplatin|oxaliplatin|mesh-list
83499565|NCT05704985|Nivolumab|nivolumab|mesh-list
83499566|NCT05704985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83499567|NCT05704985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83499568|NCT05704985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499569|NCT05704985|Tubulin Modulators|tubulin modulators|mesh-ancestor
83499570|NCT05704985|Antimitotic Agents|antimitotic agents|mesh-ancestor
83499571|NCT05704985|Mitosis Modulators|mitosis modulators|mesh-ancestor
83499572|NCT05704985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499573|NCT05704985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499574|NCT05704985|Antimetabolites|antimetabolites|mesh-ancestor
83499575|NCT05704985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83499576|NCT05704985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83499577|NCT05704985|Immunologic Factors|immunologic factors|mesh-ancestor
83499578|NCT05704985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499579|NCT05698095|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83499580|NCT05698095|Hallucinogens|hallucinogens|mesh-ancestor
83499581|NCT05698095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499582|NCT05698095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83499583|NCT05698095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83499584|NCT05698095|Serotonin Agents|serotonin agents|mesh-ancestor
83499585|NCT05698095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499586|NCT05698095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499587|NCT05698095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83499588|NCT05696847|Tirzepatide|tirzepatide|mesh-list
83499590|NCT05696847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499591|NCT05696847|Incretins|incretins|mesh-ancestor
83499592|NCT05696847|Hormones|hormones|mesh-ancestor
83499593|NCT05696847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499594|NCT05693675|Methadone|methadone|mesh-list
83499595|NCT05693675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83499596|NCT05693675|Narcotics|narcotics|mesh-ancestor
83499597|NCT05693675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499598|NCT05693675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499599|NCT05693675|Analgesics|analgesics|mesh-ancestor
83499600|NCT05693675|Sensory System Agents|sensory system agents|mesh-ancestor
83499601|NCT05693675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499602|NCT05693675|Antitussive Agents|antitussive agents|mesh-ancestor
83499603|NCT05693675|Respiratory System Agents|respiratory system agents|mesh-ancestor
83499604|NCT05658380|Atropine|atropine|mesh-list
83499605|NCT05658380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83499606|NCT05658380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83499607|NCT05658380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83499608|NCT05658380|Autonomic Agents|autonomic agents|mesh-ancestor
83499609|NCT05658380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499610|NCT05658380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499611|NCT05658380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83499612|NCT05658380|Respiratory System Agents|respiratory system agents|mesh-ancestor
83499613|NCT05658380|Mydriatics|mydriatics|mesh-ancestor
83499614|NCT05658380|Parasympatholytics|parasympatholytics|mesh-ancestor
83499615|NCT05658380|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83499616|NCT05658380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83499617|NCT05658380|Cholinergic Agents|cholinergic agents|mesh-ancestor
83499618|NCT05658380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499619|NCT05658380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499620|NCT05655273|Tacrolimus|tacrolimus|mesh-list
83499621|NCT05655273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83499622|NCT05655273|Immunologic Factors|immunologic factors|mesh-ancestor
83499623|NCT05655273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499624|NCT05655273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83499625|NCT05655273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499626|NCT05655273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499627|NCT05642078|Vaccines|vaccines|mesh-list
83499628|NCT05642078|Immunologic Factors|immunologic factors|mesh-ancestor
83499629|NCT05642078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499630|NCT05640245|Adalimumab|adalimumab|mesh-list
83499631|NCT05640245|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83499632|NCT05640245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83499633|NCT05640245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83499634|NCT05624528|Tolcapone|tolcapone|mesh-list
83499635|NCT05624528|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83499636|NCT05624528|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83499637|NCT05624528|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83499638|NCT05624528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499639|NCT05624528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499640|NCT05624151|Magnesium Sulfate|magnesium sulfate|mesh-list
83499641|NCT05624151|Dexmedetomidine|dexmedetomidine|mesh-list
83499642|NCT05624151|Bupivacaine|bupivacaine|mesh-list
83499643|NCT05624151|Anesthetics, Local|anesthetics, local|mesh-ancestor
83499644|NCT05624151|Anesthetics|anesthetics|mesh-ancestor
83499645|NCT05624151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499646|NCT05624151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499647|NCT05624151|Sensory System Agents|sensory system agents|mesh-ancestor
83499648|NCT05624151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499649|NCT05624151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83499650|NCT05624151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83499651|NCT05624151|Analgesics|analgesics|mesh-ancestor
83499652|NCT05624151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83499653|NCT05624151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83499654|NCT05624151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83499655|NCT05624151|Adrenergic Agents|adrenergic agents|mesh-ancestor
83499656|NCT05624151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499657|NCT05624151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499658|NCT05624151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83499659|NCT05624151|Anticonvulsants|anticonvulsants|mesh-ancestor
83499660|NCT05624151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83499661|NCT05624151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83499662|NCT05624151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83499663|NCT05624151|Tocolytic Agents|tocolytic agents|mesh-ancestor
83499664|NCT05624151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83499665|NCT05620914|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
83499666|NCT05620914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499667|NCT05620914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499668|NCT05588609|Abiraterone Acetate|abiraterone acetate|mesh-list
83499669|NCT05588609|Afatinib|afatinib|mesh-list
83499670|NCT05588609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499671|NCT05588609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83499672|NCT05588609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499673|NCT05588609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499674|NCT05588609|Hormone Antagonists|hormone antagonists|mesh-ancestor
83499675|NCT05588609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499676|NCT05588609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499677|NCT05588609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83499678|NCT05588609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83499679|NCT05584007|Floxacillin|floxacillin|mesh-list
83499680|NCT05584007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83499681|NCT05584007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83499682|NCT05570292|Folic Acid|folic acid|mesh-list
83499683|NCT05570292|Domperidone|domperidone|mesh-list
83499684|NCT05570292|Hematinics|hematinics|mesh-ancestor
83499685|NCT05570292|Vitamin B Complex|vitamin b complex|mesh-ancestor
83499686|NCT05570292|Vitamins|vitamins|mesh-ancestor
83499687|NCT05570292|Micronutrients|micronutrients|mesh-ancestor
83499688|NCT05570292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499689|NCT05570292|Antiemetics|antiemetics|mesh-ancestor
83499690|NCT05570292|Autonomic Agents|autonomic agents|mesh-ancestor
83499691|NCT05570292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499692|NCT05570292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499693|NCT05570292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83499694|NCT05570292|Dopamine Agents|dopamine agents|mesh-ancestor
83499695|NCT05570292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499696|NCT05570292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499697|NCT05559905|Molnupiravir|molnupiravir|mesh-list
83499698|NCT05559905|Antiviral Agents|antiviral agents|mesh-ancestor
83499699|NCT05559905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83499700|NCT05554939|Cyclophosphamide|cyclophosphamide|mesh-list
83499701|NCT05554939|Mechlorethamine|mechlorethamine|mesh-list
83499702|NCT05554939|Doxorubicin|doxorubicin|mesh-list
83499703|NCT05554939|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83499704|NCT05554939|Fludarabine|fludarabine|mesh-list
83499705|NCT05554939|Fludarabine phosphate|fludarabine phosphate|mesh-list
83499706|NCT05554939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83499707|NCT05554939|Immunologic Factors|immunologic factors|mesh-ancestor
83499708|NCT05554939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499709|NCT05554939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83499710|NCT05554939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83499711|NCT05554939|Alkylating Agents|alkylating agents|mesh-ancestor
83499712|NCT05554939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499713|NCT05554939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499714|NCT05554939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83499715|NCT05554939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83499716|NCT05554939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83499717|NCT05554939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83499718|NCT05554939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499719|NCT05554939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83499720|NCT05554939|Antimetabolites|antimetabolites|mesh-ancestor
83499721|NCT05545891|Aripiprazole|aripiprazole|mesh-list
83499722|NCT05545891|Antidepressive Agents|antidepressive agents|mesh-ancestor
83499723|NCT05545891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83499724|NCT05545891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83499725|NCT05545891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83499726|NCT05545891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499727|NCT05545891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499728|NCT05545891|Dopamine Agonists|dopamine agonists|mesh-ancestor
83499729|NCT05545891|Dopamine Agents|dopamine agents|mesh-ancestor
83499730|NCT05545891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499731|NCT05545891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499732|NCT05545891|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83499733|NCT05545891|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83499734|NCT05545891|Serotonin Agents|serotonin agents|mesh-ancestor
83499735|NCT05545891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83499736|NCT05545891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83499737|NCT05545891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83499738|NCT05545891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83499739|NCT05543629|Paclitaxel|paclitaxel|mesh-list
83499750|NCT05543629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499751|NCT05543629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83499752|NCT05535166|Cyclophosphamide|cyclophosphamide|mesh-list
83499753|NCT05535166|Carboplatin|carboplatin|mesh-list
83499754|NCT05535166|Methotrexate|methotrexate|mesh-list
83499755|NCT05535166|Etoposide|etoposide|mesh-list
83499756|NCT05535166|Vincristine|vincristine|mesh-list
83499757|NCT05535166|Topotecan|topotecan|mesh-list
83499758|NCT05535166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83499759|NCT05535166|Immunologic Factors|immunologic factors|mesh-ancestor
83499760|NCT05535166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499761|NCT05535166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83499762|NCT05535166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83499763|NCT05535166|Alkylating Agents|alkylating agents|mesh-ancestor
83499764|NCT05535166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499765|NCT05535166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499766|NCT05535166|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83499767|NCT05535166|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83499768|NCT05535166|Abortifacient Agents|abortifacient agents|mesh-ancestor
83499769|NCT05535166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83499770|NCT05535166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83499771|NCT05535166|Antimetabolites|antimetabolites|mesh-ancestor
83499772|NCT05535166|Dermatologic Agents|dermatologic agents|mesh-ancestor
83499773|NCT05535166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499774|NCT05535166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83499775|NCT05535166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83499776|NCT05535166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83499777|NCT05535166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83499778|NCT05535166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83499779|NCT05535166|Tubulin Modulators|tubulin modulators|mesh-ancestor
83499780|NCT05535166|Antimitotic Agents|antimitotic agents|mesh-ancestor
83499781|NCT05535166|Mitosis Modulators|mitosis modulators|mesh-ancestor
83499782|NCT05535166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83499783|NCT05533697|Pembrolizumab|pembrolizumab|mesh-list
83499784|NCT05533697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499785|NCT05533697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499786|NCT05533697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83499787|NCT05533697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499788|NCT05528458|Osimertinib|osimertinib|mesh-list
83499789|NCT05528458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499790|NCT05528458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83499791|NCT05528458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499792|NCT05528458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499793|NCT05494762|Tislelizumab|tislelizumab|mesh-list
83499794|NCT05494762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499795|NCT05494762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499796|NCT05493215|Imatinib Mesylate|imatinib mesylate|mesh-list
83499797|NCT05493215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499798|NCT05493215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83499799|NCT05493215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499800|NCT05493215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499801|NCT05478278|Moxifloxacin|moxifloxacin|mesh-list
83499802|NCT05478278|Psilocybin|psilocybin|mesh-list
83499803|NCT05478278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83499804|NCT05478278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83499805|NCT05478278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83499806|NCT05478278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83499807|NCT05478278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499808|NCT05478278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499809|NCT05478278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499810|NCT05478278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499811|NCT05478278|Hallucinogens|hallucinogens|mesh-ancestor
83499812|NCT05478278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83499813|NCT05467761|Psilocybin|psilocybin|mesh-list
83499814|NCT05467761|Hallucinogens|hallucinogens|mesh-ancestor
83499815|NCT05467761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499816|NCT05467761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83499817|NCT05440864|Durvalumab|durvalumab|mesh-list
83499818|NCT05440864|Tremelimumab|tremelimumab|mesh-list
83499819|NCT05440864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499820|NCT05440864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499821|NCT05418361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83499822|NCT05418361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83499823|NCT05418361|Protease Inhibitors|protease inhibitors|mesh-ancestor
83499824|NCT05418361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499825|NCT05418361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499826|NCT05399498|Psilocybin|psilocybin|mesh-list
83499827|NCT05399498|Hallucinogens|hallucinogens|mesh-ancestor
83499828|NCT05399498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499829|NCT05399498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83499830|NCT05379530|Anesthetics|anesthetics|mesh-list
83499831|NCT05379530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499832|NCT05379530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499833|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
83499834|NCT05282901|Lenvatinib|lenvatinib|mesh-list
83499835|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499836|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499837|NCT05282901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83499838|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499839|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83499840|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499841|NCT05272605|Vaccines|vaccines|mesh-list
83499842|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
83499843|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499844|NCT05265286|Factor VIII|factor viii|mesh-list
83499845|NCT05265286|Coagulants|coagulants|mesh-ancestor
83499846|NCT05233202|Simendan|simendan|mesh-list
83499847|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83499848|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
83499849|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83499850|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83499851|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499852|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499853|NCT05233202|Protective Agents|protective agents|mesh-ancestor
83499854|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499855|NCT05232123|Cannabidiol|cannabidiol|mesh-list
83499856|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
83499857|NCT05229055|Ketamine|ketamine|mesh-list
83499858|NCT05229055|Analgesics|analgesics|mesh-ancestor
83499859|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
83499860|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499861|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499862|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83499863|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83499864|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
83499865|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
83499866|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83499867|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83499868|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83499869|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499870|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499871|NCT05151471|Edaravone|edaravone|mesh-list
83499872|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83499873|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
83499874|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499875|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83499876|NCT05151471|Protective Agents|protective agents|mesh-ancestor
83499877|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499878|NCT05098210|Poly I-C|poly i-c|mesh-list
83499879|NCT05098210|Nivolumab|nivolumab|mesh-list
83499880|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83499881|NCT05098210|Poly ICLC|poly iclc|mesh-list
83499882|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499883|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499884|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83499885|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499886|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
83499887|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
83499888|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499889|NCT05098210|Laxatives|laxatives|mesh-ancestor
83499890|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499891|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
83499892|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83499893|NCT05056727|Valsartan|valsartan|mesh-list
83499894|NCT05056727|Lisinopril|lisinopril|mesh-list
83499895|NCT05056727|Irbesartan|irbesartan|mesh-list
83499896|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83499897|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83499898|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83499899|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499976|NCT04847453|Venetoclax|venetoclax|mesh-list
83499900|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83499901|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
83499902|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499903|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83499904|NCT05056727|Protective Agents|protective agents|mesh-ancestor
83499905|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499906|NCT05009992|TIC10 compound|tic10 compound|mesh-list
83499907|NCT05009992|Dopamine|dopamine|mesh-list
83499908|NCT05009992|GDC-0084|gdc-0084|mesh-list
83499909|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83499910|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
83499911|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
83499912|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499913|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499914|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
83499915|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499916|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499917|NCT05009992|Protective Agents|protective agents|mesh-ancestor
83499918|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499919|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499920|NCT04992312|Glucagon|glucagon|mesh-list
83499921|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499922|NCT04992312|Hormones|hormones|mesh-ancestor
83499923|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499924|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499925|NCT04986072|Nitroprusside|nitroprusside|mesh-list
83499926|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83499927|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
83499928|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83499929|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499930|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
83499931|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83499932|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499933|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83499934|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499935|NCT04964869|Epinephrine|epinephrine|mesh-list
83499936|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83499937|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83499938|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
83499939|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499940|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499941|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499942|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83499943|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83499944|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
83499945|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499946|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83499947|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
83499948|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
83499949|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
83499950|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83499951|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
83499952|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83499953|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499954|NCT04936841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83499955|NCT04936841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499956|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
83499957|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499958|NCT04893291|Sirolimus|sirolimus|mesh-list
83499959|NCT04893291|Everolimus|everolimus|mesh-list
83499960|NCT04893291|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83499961|NCT04893291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83499962|NCT04893291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499963|NCT04893291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499964|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83499965|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
83499966|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499967|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499968|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83499969|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83499970|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83499971|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
83499972|NCT04864743|Factor VIII|factor viii|mesh-list
83499973|NCT04864743|Coagulants|coagulants|mesh-ancestor
83499974|NCT04847453|Dexamethasone|dexamethasone|mesh-list
83499975|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
83499986|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83499987|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
83499988|NCT04847453|Hormones|hormones|mesh-ancestor
83499989|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83499990|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83499991|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499992|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
83499993|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83499994|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499995|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
83499996|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
83499997|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83499998|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
83499999|NCT04809766|Fludarabine|fludarabine|mesh-list
83500000|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83500001|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
83500002|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500003|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83500004|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83500005|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
83500006|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500007|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500008|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83500009|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83500010|NCT04803422|Amoxicillin|amoxicillin|mesh-list
83500011|NCT04803422|Metronidazole|metronidazole|mesh-list
83500012|NCT04803422|Tazobactam|tazobactam|mesh-list
83500013|NCT04803422|Piperacillin|piperacillin|mesh-list
83500014|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
83500015|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
83500016|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83500017|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500018|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83500019|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83500020|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83500021|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500022|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500023|NCT04791943|Melatonin|melatonin|mesh-list
83500024|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
83500025|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500026|NCT04791943|Protective Agents|protective agents|mesh-ancestor
83500027|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500028|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83500029|NCT04770532|Insulin|insulin|mesh-list
83500030|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83500031|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83500032|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500033|NCT04731779|Cannabidiol|cannabidiol|mesh-list
83500034|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
83500035|NCT04717765|Vitamin E|vitamin e|mesh-list
83500036|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
83500037|NCT04717765|Tocopherols|tocopherols|mesh-list
83500038|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
83500039|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500040|NCT04717765|Protective Agents|protective agents|mesh-ancestor
83500041|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500042|NCT04717765|Vitamins|vitamins|mesh-ancestor
83500043|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
83500044|NCT04715568|Losartan|losartan|mesh-list
83500045|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
83500046|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
83500047|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83500048|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83500049|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83500050|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500051|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83500052|NCT04676646|Spironolactone|spironolactone|mesh-list
83500053|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83500054|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
83500055|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83500056|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500057|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83500058|NCT04676646|Diuretics|diuretics|mesh-ancestor
83500059|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
83500060|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83500122|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500123|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500124|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83500125|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83500126|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
83500127|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500128|NCT04294160|Tislelizumab|tislelizumab|mesh-list
83500129|NCT04294160|Spartalizumab|spartalizumab|mesh-list
83500130|NCT04294160|Trametinib|trametinib|mesh-list
83500131|NCT04294160|Dabrafenib|dabrafenib|mesh-list
83500132|NCT04294160|Naporafenib|naporafenib|mesh-list
83500133|NCT04294160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500134|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500135|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83500136|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500137|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500138|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83500139|NCT04250051|Vidarabine|vidarabine|mesh-list
83500140|NCT04250051|Cytarabine|cytarabine|mesh-list
83500141|NCT04250051|Fludarabine|fludarabine|mesh-list
83500142|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
83500143|NCT04250051|Ivosidenib|ivosidenib|mesh-list
83500144|NCT04250051|Lenograstim|lenograstim|mesh-list
83500145|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500146|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83500147|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
83500148|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500149|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83500150|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
83500151|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500152|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
83500153|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500154|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83500155|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500156|NCT04207060|Indomethacin|indomethacin|mesh-list
83500157|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83500158|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83500159|NCT04207060|Analgesics|analgesics|mesh-ancestor
83500160|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
83500161|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500162|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500163|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83500164|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83500165|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
83500166|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
83500167|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83500168|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83500169|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500170|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500171|NCT04204980|Daratumumab|daratumumab|mesh-list
83500172|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83500173|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500174|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
83500175|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500176|NCT04165824|Edaravone|edaravone|mesh-list
83500177|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83500178|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
83500179|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500180|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83500181|NCT04165824|Protective Agents|protective agents|mesh-ancestor
83500182|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500183|NCT04158258|Bevacizumab|bevacizumab|mesh-list
83500184|NCT04158258|Trastuzumab|trastuzumab|mesh-list
83500185|NCT04158258|Atezolizumab|atezolizumab|mesh-list
83500186|NCT04158258|Pertuzumab|pertuzumab|mesh-list
83500187|NCT04158258|Capecitabine|capecitabine|mesh-list
83500188|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500189|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500190|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83500191|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83500192|NCT04158258|Growth Substances|growth substances|mesh-ancestor
83500193|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500194|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
83500195|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83500196|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
83500197|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500274|NCT03850028|Atezolizumab|atezolizumab|mesh-list
83500198|NCT04158258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83500199|NCT04108039|Cetrorelix|cetrorelix|mesh-list
83500200|NCT04108039|Progesterone|progesterone|mesh-list
83500201|NCT04108039|Ganirelix|ganirelix|mesh-list
83500202|NCT04108039|Progestins|progestins|mesh-ancestor
83500203|NCT04108039|Hormones|hormones|mesh-ancestor
83500204|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83500205|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500206|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
83500207|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83500208|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
83500209|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83500211|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83500212|NCT04086745|Etanercept|etanercept|mesh-list
83500213|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83500214|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83500215|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83500216|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83500217|NCT04086745|Analgesics|analgesics|mesh-ancestor
83500218|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
83500219|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500220|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500221|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83500222|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83500223|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
83500224|NCT04069169|Lidocaine|lidocaine|mesh-list
83500225|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
83500226|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
83500227|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83500228|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500229|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
83500230|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500231|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83500232|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83500233|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83500234|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83500235|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500236|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
83500237|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
83500238|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83500239|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83500240|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500241|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500242|NCT03997097|Urological Agents|urological agents|mesh-ancestor
83500243|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
83500244|NCT03988036|Trastuzumab|trastuzumab|mesh-list
83500245|NCT03988036|Pertuzumab|pertuzumab|mesh-list
83500246|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500247|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500248|NCT03988036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83500249|NCT03988036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500250|NCT03899987|Aspirin|aspirin|mesh-list
83500251|NCT03899987|Interferons|interferons|mesh-list
83500252|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
83500253|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
83500254|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83500255|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500256|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
83500257|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500258|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83500259|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83500260|NCT03899987|Analgesics|analgesics|mesh-ancestor
83500261|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
83500262|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500263|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500264|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83500265|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83500266|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83500267|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83500268|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500269|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83500270|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83500271|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500272|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
83500273|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
83500275|NCT03850028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83500276|NCT03850028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500277|NCT03850028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500278|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500279|NCT03744468|Tislelizumab|tislelizumab|mesh-list
83500280|NCT03744468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500281|NCT03744468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500282|NCT03742895|Olaparib|olaparib|mesh-list
83500283|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83500284|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500285|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500286|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500287|NCT03725436|Paclitaxel|paclitaxel|mesh-list
83500288|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83500289|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83500290|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500291|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
83500292|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
83500293|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
83500294|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500295|NCT03678688|Bedaquiline|bedaquiline|mesh-list
83500296|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
83500297|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
83500298|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83500299|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500300|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
83500301|NCT03602612|Fludarabine|fludarabine|mesh-list
83500302|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83500303|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
83500304|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500305|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83500306|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83500307|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
83500308|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500309|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500310|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83500311|NCT03554044|Tamoxifen|tamoxifen|mesh-list
83500312|NCT03554044|Paclitaxel|paclitaxel|mesh-list
83500313|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83500314|NCT03554044|Carboplatin|carboplatin|mesh-list
83500315|NCT03554044|Gemcitabine|gemcitabine|mesh-list
83500316|NCT03554044|Letrozole|letrozole|mesh-list
83500317|NCT03554044|Fulvestrant|fulvestrant|mesh-list
83500318|NCT03554044|Anastrozole|anastrozole|mesh-list
83500319|NCT03554044|Exemestane|exemestane|mesh-list
83500320|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83500321|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83500322|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500323|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
83500324|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
83500325|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
83500326|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500327|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83500328|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
83500329|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83500330|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83500331|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500332|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83500333|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
83500334|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83500335|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500336|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83500337|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83500338|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83500339|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83500340|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83500341|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500342|NCT03524937|Melatonin|melatonin|mesh-list
83500343|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
83500344|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500345|NCT03524937|Protective Agents|protective agents|mesh-ancestor
83500346|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500347|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83500348|NCT03505710|Trastuzumab|trastuzumab|mesh-list
83500371|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83500372|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500373|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500374|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
83500375|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500376|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83500377|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83500378|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83500379|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
83500380|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83500381|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500382|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500383|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500384|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83500385|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
83500386|NCT03323476|Hormones|hormones|mesh-ancestor
83500387|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83500388|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83500389|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
83500390|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83500391|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
83500392|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500393|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500394|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83500395|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
83500396|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83500397|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
83500398|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500399|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83500400|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83500401|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
83500402|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
83500403|NCT03260569|Protective Agents|protective agents|mesh-ancestor
83500404|NCT03188796|Vitamin D|vitamin d|mesh-list
83500405|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
83500406|NCT03188796|Vitamins|vitamins|mesh-ancestor
83500407|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
83500408|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500409|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83500410|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83500411|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
83500412|NCT03184194|Nivolumab|nivolumab|mesh-list
83500413|NCT03184194|Daratumumab|daratumumab|mesh-list
83500414|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83500415|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83500416|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
83500417|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500418|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83500419|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83500420|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
83500421|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500422|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500423|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83500424|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500425|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83500426|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
83500427|NCT03103971|Fludarabine|fludarabine|mesh-list
83500428|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83500429|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
83500430|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500431|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83500432|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83500433|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
83500434|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500435|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500436|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83500437|NCT03096041|Analgesics|analgesics|mesh-list
83500438|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
83500439|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500440|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500441|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
83500442|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500443|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500444|NCT03092323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83500445|NCT03092323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500446|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83500447|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83500448|NCT03018366|Estradiol|estradiol|mesh-list
83500449|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83500450|NCT03018366|Progesterone|progesterone|mesh-list
83500451|NCT03018366|Estrogens|estrogens|mesh-ancestor
83500452|NCT03018366|Hormones|hormones|mesh-ancestor
83500453|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83500454|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500455|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83500456|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
83500457|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83500458|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83500459|NCT03018366|Progestins|progestins|mesh-ancestor
83500460|NCT03012529|Riboflavin|riboflavin|mesh-list
83500461|NCT03012529|Rifampin|rifampin|mesh-list
83500462|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83500463|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
83500464|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83500465|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500466|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
83500467|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83500468|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500469|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500470|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83500471|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83500472|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83500473|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83500474|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83500475|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83500476|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
83500477|NCT03012529|Vitamins|vitamins|mesh-ancestor
83500478|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
83500479|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500480|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83500481|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
83500482|NCT02889159|Imiquimod|imiquimod|mesh-list
83500483|NCT02889159|Histamine|histamine|mesh-list
83500484|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
83500485|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83500486|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
83500487|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500488|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500489|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
83500490|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
83500491|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
83500492|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83500493|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500494|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
83500495|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83500496|NCT02841280|Diuretics|diuretics|mesh-ancestor
83500497|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
83500498|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500499|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83500500|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83500501|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500502|NCT02813356|Naloxegol|naloxegol|mesh-list
83500503|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83500504|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500505|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
83500506|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500507|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
83500508|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83500509|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
83500510|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500511|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500512|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83500513|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
83500514|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83500515|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
83500516|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500517|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83500518|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83500567|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83500568|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83500569|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83500570|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83500571|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83500572|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500573|NCT02620865|Antidotes|antidotes|mesh-ancestor
83500574|NCT02620865|Protective Agents|protective agents|mesh-ancestor
83500575|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
83500577|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
83500578|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83500579|NCT02620865|Analgesics|analgesics|mesh-ancestor
83500580|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
83500581|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500583|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83500584|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83500585|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
83500586|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500587|NCT02595879|Deoxyglucose|deoxyglucose|mesh-list
83500588|NCT02595879|Cisplatin|cisplatin|mesh-list
83500589|NCT02595879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83500590|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500591|NCT02595879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83500592|NCT02595879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500593|NCT02595879|Antimetabolites|antimetabolites|mesh-ancestor
83500594|NCT02595879|Antiviral Agents|antiviral agents|mesh-ancestor
83500595|NCT02595879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500596|NCT02576574|Paclitaxel|paclitaxel|mesh-list
83500597|NCT02576574|Carboplatin|carboplatin|mesh-list
83500598|NCT02576574|Gemcitabine|gemcitabine|mesh-list
83500599|NCT02576574|Pemetrexed|pemetrexed|mesh-list
83500600|NCT02576574|Avelumab|avelumab|mesh-list
83500601|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83500602|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83500603|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500604|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
83500605|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
83500606|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
83500607|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500608|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83500609|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
83500610|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500611|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83500612|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83500613|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500614|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
83500615|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500616|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
83500617|NCT02550652|Prednisone|prednisone|mesh-list
83500618|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
83500619|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
83500620|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83500621|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
83500622|NCT02550652|Hormones|hormones|mesh-ancestor
83500623|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83500624|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500625|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83500626|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500627|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83500628|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83500629|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
83500630|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83500631|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500632|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500633|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500634|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
83500635|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
83500636|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500637|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83500638|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83500639|NCT02550652|Protective Agents|protective agents|mesh-ancestor
83500640|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500641|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
83500642|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83500643|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
83500644|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500665|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83500666|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
83500667|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500668|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83500669|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83500670|NCT02345330|Growth Substances|growth substances|mesh-ancestor
83500671|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
83500672|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500673|NCT02281084|Azacitidine|azacitidine|mesh-list
83500674|NCT02281084|Durvalumab|durvalumab|mesh-list
83500675|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83500676|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
83500677|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500678|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500679|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500680|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500681|NCT01665677|Atorvastatin|atorvastatin|mesh-list
83500682|NCT01665677|Calcium|calcium|mesh-list
83500683|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83500684|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500685|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83500686|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83500687|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
83500688|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500689|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83500690|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83500691|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500692|NCT01530373|Clonidine|clonidine|mesh-list
83500693|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
83500694|NCT01530373|Analgesics|analgesics|mesh-ancestor
83500695|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
83500696|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500697|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500698|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83500699|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
83500700|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
83500701|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83500702|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83500703|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83500704|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
83500705|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83500706|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500707|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83500708|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83500709|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
83500710|NCT01530373|Urological Agents|urological agents|mesh-ancestor
83500712|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
83500713|NCT01499953|Fondaparinux|fondaparinux|mesh-list
83500714|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83500715|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
83500716|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83500717|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
83500718|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500719|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500720|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
83500721|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83500722|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83500723|NCT01440816|Interleukin-12|interleukin-12|mesh-list
83500724|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83500725|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
83500726|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500727|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83500728|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83500729|NCT01440816|Growth Substances|growth substances|mesh-ancestor
83500730|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
83500731|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500732|NCT01348919|Dexamethasone|dexamethasone|mesh-list
83500733|NCT01348919|Lenalidomide|lenalidomide|mesh-list
83500734|NCT01348919|Delanzomib|delanzomib|mesh-list
83500735|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83500736|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
83500737|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
83500738|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500739|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500740|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83500741|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
83500742|NCT01348919|Hormones|hormones|mesh-ancestor
83500743|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83500744|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83500745|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500746|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
83500747|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83500748|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83500749|NCT01348919|Growth Substances|growth substances|mesh-ancestor
83500750|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
83500751|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
83500752|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
83500753|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500754|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500756|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83500757|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
83500758|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500759|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500760|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500761|NCT01280994|Xenon|xenon|mesh-list
83500762|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83500763|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
83500764|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
83500765|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83500766|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500767|NCT01217970|Ibudilast|ibudilast|mesh-list
83500768|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83500769|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
83500770|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500771|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500772|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83500773|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
83500774|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83500775|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500776|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500777|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83500778|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
83500779|NCT02431806|Milnacipran|milnacipran|mesh-list
83500780|NCT02431806|Fluoxetine|fluoxetine|mesh-list
83500781|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
83500782|NCT02431806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83500783|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83500784|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83500785|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500786|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83500787|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
83500788|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500789|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83500790|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
83500791|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83500792|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83500793|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83500794|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500795|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83500796|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83500797|NCT02431806|Analgesics|analgesics|mesh-ancestor
83500798|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
83500799|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500800|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
83500801|NCT05159193|Carboplatin|carboplatin|mesh-list
83500802|NCT05159193|Docetaxel|docetaxel|mesh-list
83500803|NCT05159193|Doxorubicin|doxorubicin|mesh-list
83500804|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83500805|NCT05159193|Trastuzumab|trastuzumab|mesh-list
83500806|NCT05159193|Pertuzumab|pertuzumab|mesh-list
83500807|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83500808|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
83500809|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500810|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83500811|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83500812|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
83500813|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500814|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500815|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83500834|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83500835|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83500836|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500837|NCT01650246|Lesinurad|lesinurad|mesh-list
83500838|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
83500839|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83500840|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
83500841|NCT01212302|Clopidogrel|clopidogrel|mesh-list
83500842|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500843|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500844|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83500845|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83500846|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83500847|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83500848|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
83500849|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83500850|NCT01284296|Chrysarobin|chrysarobin|mesh-list
83500851|NCT01284296|Lidocaine|lidocaine|mesh-list
83500852|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
83500853|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
83500854|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83500855|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500856|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
83500857|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500858|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83500859|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83500860|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83500861|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83500862|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500863|NCT01284296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83500864|NCT01284296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83500865|NCT01284296|Analgesics|analgesics|mesh-ancestor
83500866|NCT01284296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83500867|NCT01284296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83500868|NCT00364143|Irinotecan|irinotecan|mesh-list
83500869|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83500870|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83500871|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500872|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500873|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500874|NCT01652664|Timolol|timolol|mesh-list
83500875|NCT01652664|Travoprost|travoprost|mesh-list
83500876|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83500877|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83500878|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83500879|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83500880|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
83500881|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83500882|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500883|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500884|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83500885|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83500886|NCT04055649|Paclitaxel|paclitaxel|mesh-list
83500887|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83500888|NCT04055649|TIC10 compound|tic10 compound|mesh-list
83500889|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83500890|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500891|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
83500892|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
83500893|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
83500894|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500895|NCT04899492|Nicotine|nicotine|mesh-list
83500896|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83500897|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
83500898|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500899|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500900|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83500901|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83500902|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
83500903|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83500904|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500905|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
83500906|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83500907|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500909|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83500910|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
83500911|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83500912|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83500913|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83500914|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83500915|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500916|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
83500917|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83500918|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500919|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83500920|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83500921|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500922|NCT01222832|Bacitracin|bacitracin|mesh-list
83500923|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83500924|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500925|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83500926|NCT04297605|Paclitaxel|paclitaxel|mesh-list
83500927|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
83500928|NCT04297605|Pemetrexed|pemetrexed|mesh-list
83500929|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83500930|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500931|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
83500932|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
83500933|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
83500934|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500935|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500936|NCT04297605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83500937|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500938|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83500939|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83500940|NCT02379390|Prednisone|prednisone|mesh-list
83500941|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
83500942|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83500943|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
83500944|NCT02379390|Hormones|hormones|mesh-ancestor
83500945|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83500946|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500947|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83500948|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500949|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83500950|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500951|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500952|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
83500953|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83500954|NCT04932915|Niclosamide|niclosamide|mesh-list
83500955|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
83500956|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83500957|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
83500958|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83500959|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500960|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
83500961|NCT01223378|Latanoprost|latanoprost|mesh-list
83500962|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83500963|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83500964|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
83500965|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83500966|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500967|NCT01224626|Linezolid|linezolid|mesh-list
83500968|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83500969|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500970|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83500971|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500972|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500973|NCT01289522|Cetuximab|cetuximab|mesh-list
83500974|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500975|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500976|NCT01226420|Alefacept|alefacept|mesh-list
83500977|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
83500978|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
83500979|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500980|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
83500981|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83500982|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500983|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83500984|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500985|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
83500986|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83500987|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
83500988|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83500989|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83500990|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
83500991|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
83500992|NCT00365001|Methotrexate|methotrexate|mesh-list
83500993|NCT00365001|Simvastatin|simvastatin|mesh-list
83500994|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83500995|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
83500996|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83500997|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500998|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83500999|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
83501000|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501001|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501002|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
83501003|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501004|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83501005|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83501006|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
83501007|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501008|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83501009|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83501010|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83501011|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83501012|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83501013|NCT01289912|Everolimus|everolimus|mesh-list
83501014|NCT01289912|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83501015|NCT01289912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83501016|NCT01289912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501017|NCT01289912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501018|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83501019|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
83501020|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501021|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501022|NCT03192345|Cemiplimab|cemiplimab|mesh-list
83501023|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83501024|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501025|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
83501026|NCT03069963|Antacids|antacids|mesh-ancestor
83501027|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501028|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83501030|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501031|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83501032|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501033|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501034|NCT01714739|Nivolumab|nivolumab|mesh-list
83501035|NCT01714739|Ipilimumab|ipilimumab|mesh-list
83501036|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
83501037|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83501038|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501039|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83501040|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501041|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
83501042|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501043|NCT05440383|Leuprolide|leuprolide|mesh-list
83501044|NCT05440383|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83501045|NCT05440383|Fertility Agents|fertility agents|mesh-ancestor
83501046|NCT05440383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83501047|NCT05440383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501048|NCT05440383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83501049|NCT05440383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501050|NCT02377479|Letrozole|letrozole|mesh-list
83501051|NCT02377479|Clomiphene|clomiphene|mesh-list
83501052|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501053|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83501054|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83501069|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501070|NCT00609791|Paclitaxel|paclitaxel|mesh-list
83501071|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83501072|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83501073|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501074|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
83501075|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
83501076|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
83501077|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501078|NCT05457959|Poly I-C|poly i-c|mesh-list
83501079|NCT05457959|Nivolumab|nivolumab|mesh-list
83501080|NCT05457959|Ipilimumab|ipilimumab|mesh-list
83501081|NCT05457959|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83501082|NCT05457959|Vaccines|vaccines|mesh-list
83501083|NCT05457959|Poly ICLC|poly iclc|mesh-list
83501084|NCT05457959|Immunologic Factors|immunologic factors|mesh-ancestor
83501085|NCT05457959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501086|NCT05457959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83501087|NCT05457959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501088|NCT05457959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83501089|NCT05457959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501090|NCT05457959|Interferon Inducers|interferon inducers|mesh-ancestor
83501091|NCT05457959|Laxatives|laxatives|mesh-ancestor
83501092|NCT05457959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83501093|NCT05457959|Antiviral Agents|antiviral agents|mesh-ancestor
83501094|NCT05457959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501095|NCT05457647|Riboflavin|riboflavin|mesh-list
83501096|NCT05457647|Vitamin B Complex|vitamin b complex|mesh-ancestor
83501097|NCT05457647|Vitamins|vitamins|mesh-ancestor
83501098|NCT05457647|Micronutrients|micronutrients|mesh-ancestor
83501099|NCT05457647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501100|NCT05457647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83501101|NCT05457647|Dermatologic Agents|dermatologic agents|mesh-ancestor
83501102|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
83501103|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83501104|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83501105|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
83501106|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501107|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83501108|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83501109|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501110|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501111|NCT05439629|Ranibizumab|ranibizumab|mesh-list
83501112|NCT05439629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83501113|NCT05439629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83501114|NCT05439629|Growth Substances|growth substances|mesh-ancestor
83501115|NCT05439629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501116|NCT05439629|Growth Inhibitors|growth inhibitors|mesh-ancestor
83501117|NCT05439629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501118|NCT01229228|Naproxen|naproxen|mesh-list
83501119|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83501120|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83501121|NCT01229228|Analgesics|analgesics|mesh-ancestor
83501122|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
83501123|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501124|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501125|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501126|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501127|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
83501128|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83501129|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501130|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501131|NCT01292252|Teriparatide|teriparatide|mesh-list
83501132|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
83501133|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501134|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83501135|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83501136|NCT02192684|Pioglitazone|pioglitazone|mesh-list
83501137|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83501138|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501139|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
83501140|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83501141|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501142|NCT02243579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83501143|NCT02243579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501144|NCT00003407|Cytarabine|cytarabine|mesh-list
83501179|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83501180|NCT01710839|Growth Substances|growth substances|mesh-ancestor
83501181|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501182|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
83501183|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501184|NCT01215110|Bedaquiline|bedaquiline|mesh-list
83501185|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
83501186|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83501187|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501188|NCT02980757|Gliclazide|gliclazide|mesh-list
83501189|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83501190|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501191|NCT01229462|Timolol|timolol|mesh-list
83501192|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83501193|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83501194|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83501195|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83501196|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83501197|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
83501198|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501199|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501200|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501201|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83501202|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83501203|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83501204|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83501205|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83501206|NCT01292642|Nicotine|nicotine|mesh-list
83501207|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83501208|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
83501209|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501210|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501211|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83501212|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83501213|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
83501214|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501215|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501216|NCT01231334|Clindamycin|clindamycin|mesh-list
83501217|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
83501218|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
83501219|NCT01231334|Dapsone|dapsone|mesh-list
83501220|NCT01231334|Adapalene|adapalene|mesh-list
83501221|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83501222|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83501223|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501224|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83501225|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501226|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501227|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
83501228|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83501229|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83501230|NCT01231334|Analgesics|analgesics|mesh-ancestor
83501231|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
83501232|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501233|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501234|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501235|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501236|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
83501237|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83501238|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83501239|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83501240|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
83501241|NCT04771481|Metoclopramide|metoclopramide|mesh-list
83501242|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
83501243|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
83501244|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501245|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501246|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83501247|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83501248|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83501249|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
83501250|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501251|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501252|NCT01292798|Ranibizumab|ranibizumab|mesh-list
83501253|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83501254|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83501320|NCT01716221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83501322|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83501323|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83501324|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
83501325|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
83501326|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501327|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83501328|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83501329|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
83501330|NCT01215344|Diphosphonates|diphosphonates|mesh-list
83501331|NCT01215344|Dexamethasone|dexamethasone|mesh-list
83501332|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
83501333|NCT01215344|Doxorubicin|doxorubicin|mesh-list
83501334|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83501335|NCT01215344|Lenalidomide|lenalidomide|mesh-list
83501336|NCT01215344|Bortezomib|bortezomib|mesh-list
83501337|NCT01215344|BB 1101|bb 1101|mesh-list
83501338|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501339|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
83501340|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
83501341|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501342|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501343|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83501344|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
83501345|NCT01215344|Hormones|hormones|mesh-ancestor
83501346|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83501347|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83501348|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501349|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
83501350|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501351|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501352|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83501353|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83501354|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83501355|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
83501356|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83501357|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83501358|NCT01215344|Growth Substances|growth substances|mesh-ancestor
83501359|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
83501360|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83501361|NCT01231412|Cyclosporine|cyclosporine|mesh-list
83501362|NCT01231412|Sirolimus|sirolimus|mesh-list
83501363|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
83501364|NCT01231412|Fludarabine|fludarabine|mesh-list
83501365|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
83501366|NCT01231412|Cyclosporins|cyclosporins|mesh-list
83501367|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501368|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83501369|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
83501370|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501371|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83501372|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
83501373|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501374|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501375|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
83501376|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501377|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
83501378|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501379|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83501380|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83501381|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83501382|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
83501383|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83501384|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83501385|NCT01719653|Laxatives|laxatives|mesh-ancestor
83501386|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83501387|NCT04580771|Cisplatin|cisplatin|mesh-list
83501388|NCT04580771|Vaccines|vaccines|mesh-list
83501389|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
83501390|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501391|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501392|NCT01720277|Vaccines|vaccines|mesh-list
83501393|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
83501394|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501395|NCT04514393|Methotrexate|methotrexate|mesh-list
83501396|NCT04514393|Temozolomide|temozolomide|mesh-list
83501397|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83501398|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
83501399|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83501400|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501401|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83501402|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
83501403|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501404|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501405|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
83501406|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501407|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83501408|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83501409|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
83501410|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501411|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83501412|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83501413|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
83501415|NCT01232504|Lenograstim|lenograstim|mesh-list
83501416|NCT01232504|Sargramostim|sargramostim|mesh-list
83501417|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83501418|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
83501419|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501420|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501421|NCT01737593|Acetaminophen|acetaminophen|mesh-list
83501422|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83501423|NCT01737593|Analgesics|analgesics|mesh-ancestor
83501424|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
83501425|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501426|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501427|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
83501428|NCT01217840|Vitamin D|vitamin d|mesh-list
83501429|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
83501430|NCT01217840|Vitamins|vitamins|mesh-ancestor
83501431|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
83501432|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501433|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83501434|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83501435|NCT01721603|Trametinib|trametinib|mesh-list
83501436|NCT01721603|Dabrafenib|dabrafenib|mesh-list
83501437|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501438|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83501439|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501440|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501441|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
83501442|NCT01296542|Besifloxacin|besifloxacin|mesh-list
83501443|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83501444|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501445|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83501446|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83501447|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501448|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501449|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501450|NCT01234766|Rituximab|rituximab|mesh-list
83501451|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83501452|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83501453|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501454|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
83501455|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501456|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501457|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83501458|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
83501459|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501460|NCT01234922|Losartan|losartan|mesh-list
83501461|NCT01234922|Ramipril|ramipril|mesh-list
83501462|NCT01234922|Lisinopril|lisinopril|mesh-list
83501463|NCT01234922|Benazepril|benazepril|mesh-list
83501464|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83501465|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83501466|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83501467|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83501468|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501469|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83501470|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
83501471|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501511|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501512|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
83501514|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83501515|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83501516|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501517|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501518|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83501519|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501520|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501521|NCT01303406|Idebenone|idebenone|mesh-list
83501522|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
83501523|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501524|NCT01303406|Protective Agents|protective agents|mesh-ancestor
83501525|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501526|NCT03619707|Progesterone|progesterone|mesh-list
83501527|NCT03619707|Progestins|progestins|mesh-ancestor
83501528|NCT03619707|Hormones|hormones|mesh-ancestor
83501529|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83501530|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501531|NCT02597907|Aprepitant|aprepitant|mesh-list
83501532|NCT02597907|Palonosetron|palonosetron|mesh-list
83501533|NCT02597907|Ramosetron|ramosetron|mesh-list
83501534|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
83501535|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
83501536|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501537|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501538|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83501539|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83501540|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501541|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501542|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83501543|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83501544|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
83501545|NCT02600325|Grazoprevir|grazoprevir|mesh-list
83501546|NCT02600325|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83501547|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
83501548|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501549|NCT02600715|Morphine|morphine|mesh-list
83501550|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83501551|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83501552|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83501553|NCT02600715|Narcotics|narcotics|mesh-ancestor
83501554|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83501555|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501556|NCT02600715|Analgesics|analgesics|mesh-ancestor
83501557|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
83501558|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501559|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83501560|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83501561|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83501562|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501563|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
83501564|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501565|NCT04743297|Dinoprostone|dinoprostone|mesh-list
83501566|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
83501567|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83501568|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501569|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
83501570|NCT04176783|Narcotics|narcotics|mesh-ancestor
83501571|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83501572|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501573|NCT04176783|Analgesics|analgesics|mesh-ancestor
83501574|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
83501575|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501576|NCT00365313|Celecoxib|celecoxib|mesh-list
83501577|NCT00365313|Esomeprazole|esomeprazole|mesh-list
83501578|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83501579|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83501580|NCT00365313|Analgesics|analgesics|mesh-ancestor
83501581|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
83501582|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501583|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501584|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501585|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501586|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83501587|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83501588|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501589|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501590|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83501591|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83501592|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83501593|NCT02605395|Rabeprazole|rabeprazole|mesh-list
83501594|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83501595|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83501596|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83501597|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501598|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501599|NCT04166721|Atezolizumab|atezolizumab|mesh-list
83501600|NCT04166721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83501601|NCT04166721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501602|NCT04166721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83501603|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501604|NCT04343001|Aspirin|aspirin|mesh-list
83501605|NCT04343001|Losartan|losartan|mesh-list
83501606|NCT04343001|Simvastatin|simvastatin|mesh-list
83501607|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83501608|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83501609|NCT04343001|Analgesics|analgesics|mesh-ancestor
83501610|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
83501611|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501612|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501613|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501614|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501615|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83501616|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83501617|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501618|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83501619|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83501620|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501621|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
83501622|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83501623|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83501624|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
83501625|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83501626|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83501627|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83501628|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83501629|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83501630|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83501631|NCT02865135|Vaccines|vaccines|mesh-list
83501632|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
83501633|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501634|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
83501635|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83501636|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83501637|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501638|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
83501639|NCT04742205|Coagulants|coagulants|mesh-ancestor
83501640|NCT04743063|Losartan|losartan|mesh-list
83501641|NCT04743063|Valsartan|valsartan|mesh-list
83501642|NCT04743063|Telmisartan|telmisartan|mesh-list
83501643|NCT04743063|Candesartan|candesartan|mesh-list
83501644|NCT04743063|Olmesartan|olmesartan|mesh-list
83501645|NCT04743063|Irbesartan|irbesartan|mesh-list
83501646|NCT04743063|Eprosartan|eprosartan|mesh-list
83501647|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
83501648|NCT04743063|Giapreza|giapreza|mesh-list
83501649|NCT04743063|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83501650|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83501651|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
83501652|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83501653|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83501654|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501655|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83501656|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83501657|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83501658|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
83501659|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501660|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
83501662|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83501663|NCT01739699|Analgesics|analgesics|mesh-ancestor
83501664|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
83501665|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501666|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501667|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
83501668|NCT04154787|Rituximab|rituximab|mesh-list
83501669|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83501670|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501671|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
83501672|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501673|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501674|NCT01740713|Deferiprone|deferiprone|mesh-list
83501675|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83501676|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
83501677|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
83501678|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501679|NCT02613117|Fluorides|fluorides|mesh-list
83501680|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
83501681|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
83501682|NCT02613117|Protective Agents|protective agents|mesh-ancestor
83501683|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501684|NCT01742117|Clopidogrel|clopidogrel|mesh-list
83501685|NCT01742117|Ticagrelor|ticagrelor|mesh-list
83501686|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83501687|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83501688|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83501689|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83501690|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
83501691|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501692|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501693|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501694|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
83501695|NCT02613897|Saxagliptin|saxagliptin|mesh-list
83501696|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83501697|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501698|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83501699|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501700|NCT02613897|Incretins|incretins|mesh-ancestor
83501701|NCT02613897|Hormones|hormones|mesh-ancestor
83501702|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83501703|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83501704|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
83501705|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501706|NCT02615535|Alprostadil|alprostadil|mesh-list
83501707|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83501708|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
83501709|NCT02615535|Urological Agents|urological agents|mesh-ancestor
83501710|NCT05732181|Lidocaine|lidocaine|mesh-list
83501711|NCT05732181|Anesthetics, Local|anesthetics, local|mesh-ancestor
83501712|NCT05732181|Anesthetics|anesthetics|mesh-ancestor
83501713|NCT05732181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83501714|NCT05732181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501715|NCT05732181|Sensory System Agents|sensory system agents|mesh-ancestor
83501716|NCT05732181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501717|NCT05732181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83501718|NCT05732181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83501719|NCT05732181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83501720|NCT05732181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83501721|NCT05732181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501722|NCT01342172|Lenalidomide|lenalidomide|mesh-list
83501723|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
83501724|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501725|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83501726|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83501727|NCT01342172|Growth Substances|growth substances|mesh-ancestor
83501728|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
83501729|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501730|NCT01243112|Lidocaine|lidocaine|mesh-list
83501731|NCT01243112|Epinephrine|epinephrine|mesh-list
83501732|NCT01243112|Racepinephrine|racepinephrine|mesh-list
83501733|NCT01243112|Bupivacaine|bupivacaine|mesh-list
83501734|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
83501746|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83501747|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83501748|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
83501749|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501750|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83501751|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83501752|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
83501753|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83501754|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
83501755|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
83501756|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
83501757|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83501758|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
83501759|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
83501760|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83501761|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
83501762|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83501763|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501764|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83501765|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83501766|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501767|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83501768|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83501769|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501770|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501771|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501772|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83501773|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83501774|NCT01743521|Ribavirin|ribavirin|mesh-list
83501775|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
83501776|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501777|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
83501778|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501779|NCT00361803|Topotecan|topotecan|mesh-list
83501780|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83501781|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83501782|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501783|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501784|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501785|NCT00361881|Acyclovir|acyclovir|mesh-list
83501786|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
83501787|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
83501788|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501789|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501790|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
83501791|NCT01743677|Tofacitinib|tofacitinib|mesh-list
83501792|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83501793|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501794|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83501795|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83501796|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501797|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501798|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501799|NCT01743677|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83501800|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83501801|NCT00365937|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83501802|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
83501803|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
83501804|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501805|NCT01246076|Lenalidomide|lenalidomide|mesh-list
83501806|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
83501807|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501808|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83501809|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83501810|NCT01246076|Growth Substances|growth substances|mesh-ancestor
83501811|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
83501812|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501813|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
83501814|NCT00364455|Hematinics|hematinics|mesh-ancestor
83501815|NCT01307462|Fluticasone|fluticasone|mesh-list
83501816|NCT01307462|Xhance|xhance|mesh-list
83501817|NCT01307462|Azithromycin|azithromycin|mesh-list
83501818|NCT01307462|Montelukast|montelukast|mesh-list
83501819|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501820|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83501821|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
83501823|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501824|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83501825|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
83501826|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
83501827|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83501828|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83501829|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501830|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83501831|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
83501832|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83501833|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83501834|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83501835|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501836|NCT05731089|Aflibercept|aflibercept|mesh-list
83501837|NCT05731089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83501838|NCT05731089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83501839|NCT05731089|Growth Substances|growth substances|mesh-ancestor
83501840|NCT05731089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501841|NCT05731089|Growth Inhibitors|growth inhibitors|mesh-ancestor
83501842|NCT05731089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501843|NCT01307618|Interleukin-12|interleukin-12|mesh-list
83501844|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83501845|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
83501846|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501847|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83501848|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83501849|NCT01307618|Growth Substances|growth substances|mesh-ancestor
83501850|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
83501851|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501852|NCT01307930|Anidulafungin|anidulafungin|mesh-list
83501853|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
83501854|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501855|NCT05371197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83501856|NCT05371197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501857|NCT05371197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83501858|NCT05371197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501859|NCT01746095|Vancomycin|vancomycin|mesh-list
83501860|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83501861|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501862|NCT05730777|Paclitaxel|paclitaxel|mesh-list
83501863|NCT05730777|Carboplatin|carboplatin|mesh-list
83501864|NCT05730777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83501865|NCT05730777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501866|NCT05730777|Tubulin Modulators|tubulin modulators|mesh-ancestor
83501867|NCT05730777|Antimitotic Agents|antimitotic agents|mesh-ancestor
83501868|NCT05730777|Mitosis Modulators|mitosis modulators|mesh-ancestor
83501869|NCT05730777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501870|NCT04425239|Leucovorin|leucovorin|mesh-list
83501871|NCT04425239|Folic Acid|folic acid|mesh-list
83501872|NCT04425239|Fluorouracil|fluorouracil|mesh-list
83501873|NCT04425239|Irinotecan|irinotecan|mesh-list
83501874|NCT04425239|Panitumumab|panitumumab|mesh-list
83501875|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
83501876|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
83501877|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501878|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83501879|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501880|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83501881|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
83501882|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501883|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83501884|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83501885|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501886|NCT04425239|Antidotes|antidotes|mesh-ancestor
83501887|NCT04425239|Protective Agents|protective agents|mesh-ancestor
83501888|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
83501889|NCT04425239|Vitamins|vitamins|mesh-ancestor
83501890|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
83501891|NCT04425239|Hematinics|hematinics|mesh-ancestor
83501892|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83501893|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
83501894|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83501895|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83501896|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83501897|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83501898|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501899|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
83501900|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501901|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501902|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83501903|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501904|NCT00366093|Eszopiclone|eszopiclone|mesh-list
83501905|NCT00366093|Zopiclone|zopiclone|mesh-list
83501906|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83501907|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83501908|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501909|NCT04379999|Aspirin|aspirin|mesh-list
83501910|NCT04379999|Atorvastatin|atorvastatin|mesh-list
83501911|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83501912|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83501913|NCT04379999|Analgesics|analgesics|mesh-ancestor
83501914|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
83501915|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501916|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501917|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501918|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501919|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83501920|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83501921|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501922|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83501923|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83501924|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501925|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
83501926|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83501927|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83501928|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
83501929|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83501930|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83501931|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
83501932|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83501933|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83501934|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501936|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83501937|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
83501938|NCT05730621|Aspirin|aspirin|mesh-list
83501939|NCT05730621|Sarpogrelate|sarpogrelate|mesh-list
83501940|NCT05730621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83501941|NCT05730621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83501942|NCT05730621|Analgesics|analgesics|mesh-ancestor
83501943|NCT05730621|Sensory System Agents|sensory system agents|mesh-ancestor
83501944|NCT05730621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501945|NCT05730621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501946|NCT05730621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501947|NCT05730621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83501948|NCT05730621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83501949|NCT05730621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83501950|NCT05730621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501951|NCT05730621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83501952|NCT05730621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83501953|NCT05730621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501954|NCT05730621|Antipyretics|antipyretics|mesh-ancestor
83501955|NCT05730621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83501956|NCT05730621|Serotonin Agents|serotonin agents|mesh-ancestor
83501957|NCT05730621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501958|NCT01346072|Tolvaptan|tolvaptan|mesh-list
83501959|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83501960|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501961|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
83501962|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501963|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
83501964|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83501965|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
83501966|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501967|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501968|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83501969|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
83501970|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83501971|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
83501972|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501973|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501974|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83501975|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
83501976|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
83501977|NCT04292483|Protective Agents|protective agents|mesh-ancestor
83501978|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
83501979|NCT01347008|Citric Acid|citric acid|mesh-list
83501980|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
83501981|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
83501982|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83501983|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
83501984|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
83501985|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501986|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
83501987|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83501988|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83501989|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501990|NCT01347008|Urological Agents|urological agents|mesh-ancestor
83501991|NCT05343429|Aspirin|aspirin|mesh-list
83501992|NCT05343429|Benzydamine|benzydamine|mesh-list
83501993|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83501994|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83501995|NCT05343429|Analgesics|analgesics|mesh-ancestor
83501996|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
83501997|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501998|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501999|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83502000|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83502001|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83502002|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83502003|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502004|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83502005|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83502006|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502007|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
83502008|NCT01310582|Sevoflurane|sevoflurane|mesh-list
83502009|NCT01310582|Desflurane|desflurane|mesh-list
83502010|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83502011|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83502012|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
83502013|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
83502014|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502015|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502016|NCT05193591|Autoantibodies|autoantibodies|mesh-list
83502017|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
83502018|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502019|NCT01311674|Vaccines|vaccines|mesh-list
83502020|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
83502021|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502022|NCT05561751|Propranolol|propranolol|mesh-list
83502023|NCT05561751|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83502024|NCT05561751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83502025|NCT05561751|Adrenergic Agents|adrenergic agents|mesh-ancestor
83502026|NCT05561751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502027|NCT05561751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502028|NCT05561751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502029|NCT05561751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83502030|NCT05561751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83502031|NCT05561751|Vasodilator Agents|vasodilator agents|mesh-ancestor
83502032|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
83502033|NCT05081193|Testosterone|testosterone|mesh-list
83502034|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
83502035|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
83502036|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83502037|NCT05081193|Androgens|androgens|mesh-ancestor
83502038|NCT05081193|Hormones|hormones|mesh-ancestor
83502039|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83502040|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502041|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83502042|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502043|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
83502044|NCT01349972|Cytarabine|cytarabine|mesh-list
83502045|NCT01349972|Daunorubicin|daunorubicin|mesh-list
83502046|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
83502047|NCT01349972|Alvocidib|alvocidib|mesh-list
83502048|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83502066|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83502068|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
83502069|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83502070|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83502071|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502072|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
83502073|NCT01248104|Coagulants|coagulants|mesh-ancestor
83502074|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
83502075|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83502076|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
83502077|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502078|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502079|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83502080|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
83502081|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83502082|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
83502083|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502084|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502085|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83502086|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
83502087|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
83502088|NCT01748045|Protective Agents|protective agents|mesh-ancestor
83502089|NCT01312766|Menotropins|menotropins|mesh-list
83502090|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83502091|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
83502092|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83502093|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502094|NCT01749215|Topiramate|topiramate|mesh-list
83502095|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
83502096|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83502097|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502098|NCT04522167|Aflibercept|aflibercept|mesh-list
83502099|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83502100|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83502101|NCT04522167|Growth Substances|growth substances|mesh-ancestor
83502102|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502103|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
83502104|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502105|NCT01248416|Letrozole|letrozole|mesh-list
83502106|NCT01248416|Anastrozole|anastrozole|mesh-list
83502107|NCT01248416|Hormones|hormones|mesh-list
83502108|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83502109|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83502110|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502111|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502112|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83502113|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502114|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502115|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83502116|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
83502117|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83502118|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
83502119|NCT01749293|Busulfan|busulfan|mesh-list
83502120|NCT01749293|Fludarabine|fludarabine|mesh-list
83502121|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83502122|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
83502123|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502124|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83502125|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83502126|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
83502127|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502128|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502129|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83502130|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
83502131|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83502132|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83502133|NCT01250210|Estradiol|estradiol|mesh-list
83502134|NCT01250210|Estrogens|estrogens|mesh-ancestor
83502135|NCT01250210|Hormones|hormones|mesh-ancestor
83502136|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83502137|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502138|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83502139|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
83502140|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83502142|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83502143|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83502144|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83502145|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83502146|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
83502147|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
83502148|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83502149|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502150|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83502151|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83502152|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502153|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502154|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502155|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83502156|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83502157|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83502158|NCT01312844|Scopolamine|scopolamine|mesh-list
83502159|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83502160|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83502162|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
83502163|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502164|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502165|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83502166|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
83502167|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83502168|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
83502169|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502170|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502171|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83502172|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
83502173|NCT01750931|Meloxicam|meloxicam|mesh-list
83502174|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83502175|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83502176|NCT01750931|Analgesics|analgesics|mesh-ancestor
83502177|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
83502178|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502179|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502180|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83502181|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83502182|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83502183|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83502184|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502185|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502186|NCT01731041|Ticagrelor|ticagrelor|mesh-list
83502187|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83502188|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83502189|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83502190|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83502191|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
83502192|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502193|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502194|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502195|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83502196|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502197|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502198|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502199|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83502200|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
83502201|NCT01752413|Hematinics|hematinics|mesh-ancestor
83502202|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83502203|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83502204|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83502205|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502206|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502207|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83502208|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83502209|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83502210|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83502211|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
83502212|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502288|NCT01315574|Latanoprost|latanoprost|mesh-list
83502213|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502214|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83502215|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83502216|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
83502217|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83502218|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83502219|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
83502220|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
83502221|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502222|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
83502223|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502224|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502225|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83502226|NCT01732445|Danazol|danazol|mesh-list
83502227|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83502228|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83502229|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
83502230|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83502231|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502232|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83502233|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502234|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502236|NCT01250834|Atorvastatin|atorvastatin|mesh-list
83502237|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83502238|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83502239|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
83502240|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502241|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83502242|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83502243|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502244|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83502245|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502246|NCT04387695|Sorafenib|sorafenib|mesh-list
83502247|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502248|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83502249|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502250|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502251|NCT01354652|Lamivudine|lamivudine|mesh-list
83502252|NCT01354652|Entecavir|entecavir|mesh-list
83502253|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83502254|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83502255|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502256|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502257|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
83502258|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502259|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83502260|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83502261|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
83502262|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83502263|NCT01250990|Niacin|niacin|mesh-list
83502264|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83502265|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
83502266|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502267|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83502268|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
83502269|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
83502270|NCT01250990|Vitamins|vitamins|mesh-ancestor
83502271|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
83502272|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502273|NCT02990975|Ketamine|ketamine|mesh-list
83502274|NCT02990975|Analgesics|analgesics|mesh-ancestor
83502275|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
83502276|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502277|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502278|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83502279|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83502280|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
83502281|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
83502282|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502283|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83502284|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83502285|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502286|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502287|NCT01315574|Travoprost|travoprost|mesh-list
83502310|NCT04297995|Carboplatin|carboplatin|mesh-list
83502311|NCT04297995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502312|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
83502313|NCT04340349|Bromhexine|bromhexine|mesh-list
83502314|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
83502315|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83502316|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83502317|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502318|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502319|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502320|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83502321|NCT04340349|Expectorants|expectorants|mesh-ancestor
83502322|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
83502323|NCT04268771|Rituximab|rituximab|mesh-list
83502324|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83502325|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502326|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
83502327|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502328|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83502329|NCT04267809|Vitamin D|vitamin d|mesh-list
83502330|NCT04267809|Metformin|metformin|mesh-list
83502331|NCT04267809|Calcium|calcium|mesh-list
83502332|NCT04267809|Vitamins|vitamins|mesh-ancestor
83502333|NCT04267809|Micronutrients|micronutrients|mesh-ancestor
83502334|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502335|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83502336|NCT04267809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83502337|NCT04267809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83502338|NCT02242409|Paclitaxel|paclitaxel|mesh-list
83502339|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83502340|NCT02242409|Gemcitabine|gemcitabine|mesh-list
83502341|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83502342|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502343|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
83502344|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
83502345|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
83502346|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502347|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83502348|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
83502349|NCT00366873|Calcium|calcium|mesh-list
83502350|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83502351|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502352|NCT05317325|Vaccines|vaccines|mesh-list
83502353|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
83502354|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502355|NCT04182399|Zonisamide|zonisamide|mesh-list
83502356|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
83502357|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83502358|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83502359|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502360|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83502361|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502362|NCT04246619|Pregabalin|pregabalin|mesh-list
83502363|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83502364|NCT04246619|Analgesics|analgesics|mesh-ancestor
83502365|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
83502366|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502367|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502368|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
83502369|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83502370|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83502371|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502372|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83502373|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83502374|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83502375|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502376|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83502377|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83502378|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83502379|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502380|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
83502381|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
83502382|NCT01757561|Propofol|propofol|mesh-list
83502383|NCT01757561|Sevoflurane|sevoflurane|mesh-list
83502384|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83502385|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502386|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502387|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83502388|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
83502389|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
83502390|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83502391|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83502392|NCT02618187|Vancomycin|vancomycin|mesh-list
83502393|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83502394|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502395|NCT05316857|Itraconazole|itraconazole|mesh-list
83502396|NCT05316857|Rifampin|rifampin|mesh-list
83502397|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
83502398|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502399|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83502400|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83502401|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502402|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502403|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83502404|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
83413628|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502405|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83502406|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502407|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83502408|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83502409|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
83502410|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83502411|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
83502412|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83502413|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83502414|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83502415|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83502416|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83502417|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83502418|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83502419|NCT01759277|Anesthetics|anesthetics|mesh-list
83502420|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
83502421|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502422|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502423|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
83502424|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502425|NCT02618343|Ondansetron|ondansetron|mesh-list
83502426|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
83502427|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
83502428|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502429|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502430|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83502431|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
83502432|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
83502433|NCT02618343|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83502434|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83502435|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
83502436|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502437|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502438|NCT02991053|Ketamine|ketamine|mesh-list
83502439|NCT02991053|Analgesics|analgesics|mesh-ancestor
83502440|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
83502441|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502442|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502443|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83502444|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83502445|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
83502446|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
83502447|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502448|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83502449|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83502450|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502451|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502452|NCT01251536|Cetuximab|cetuximab|mesh-list
83502453|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83502454|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502455|NCT02620683|Lidocaine|lidocaine|mesh-list
83502456|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
83502481|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83502482|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83502483|NCT01355588|Analgesics|analgesics|mesh-ancestor
83502484|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83502485|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83502486|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83502487|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502488|NCT02621619|Acetaminophen|acetaminophen|mesh-list
83502489|NCT02621619|Hydromorphone|hydromorphone|mesh-list
83502490|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83502491|NCT02621619|Analgesics|analgesics|mesh-ancestor
83502492|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
83502493|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502494|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502495|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
83502496|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83502497|NCT02621619|Narcotics|narcotics|mesh-ancestor
83502498|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502499|NCT01253642|Docetaxel|docetaxel|mesh-list
83502500|NCT01253642|Phenelzine|phenelzine|mesh-list
83502501|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502502|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
83502503|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
83502504|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
83502505|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502506|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
83502507|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83502508|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83502509|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502510|NCT01357148|Metformin|metformin|mesh-list
83502511|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83502512|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83502513|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502514|NCT01357148|Incretins|incretins|mesh-ancestor
83502515|NCT01357148|Hormones|hormones|mesh-ancestor
83502516|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83502517|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83502518|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
83502519|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502520|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502521|NCT02623803|Lidocaine|lidocaine|mesh-list
83502522|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
83502523|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
83502524|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502525|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502526|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
83502527|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502528|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83502529|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83502530|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83502531|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83502532|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502533|NCT02322788|Terbutaline|terbutaline|mesh-list
83502534|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83502535|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
83502536|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502537|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502538|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83502539|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
83502540|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
83502541|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
83502542|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83502543|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83502544|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83502545|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83502546|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
83502547|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502548|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502549|NCT02625207|Maraviroc|maraviroc|mesh-list
83502550|NCT02625207|Darunavir|darunavir|mesh-list
83502551|NCT02625207|Cobicistat|cobicistat|mesh-list
83502552|NCT02625207|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83502553|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83502554|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83502555|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502589|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83502590|NCT01763645|Growth Substances|growth substances|mesh-ancestor
83502591|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502592|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
83502594|NCT02253173|Estrogens|estrogens|mesh-ancestor
83502595|NCT02253173|Hormones|hormones|mesh-ancestor
83502596|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83502597|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502598|NCT03924791|Dexamethasone|dexamethasone|mesh-list
83502599|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
83502600|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83502601|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83502602|NCT03924791|Prednisolone|prednisolone|mesh-list
83502604|NCT03924791|Lidocaine|lidocaine|mesh-list
83502605|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83502606|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
83502607|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83502608|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
83502609|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
83502610|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502611|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502612|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83502613|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
83502614|NCT03924791|Hormones|hormones|mesh-ancestor
83502615|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83502616|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83502617|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502618|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
83502619|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
83502620|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502621|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
83502622|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83502623|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83502624|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83502625|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83502626|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502627|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83502628|NCT03924791|Protective Agents|protective agents|mesh-ancestor
83502629|NCT01318694|Ribavirin|ribavirin|mesh-list
83502630|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83502631|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
83502632|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502633|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
83502634|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502635|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83502636|NCT03009578|Hematinics|hematinics|mesh-ancestor
83502637|NCT01361048|Metronidazole|metronidazole|mesh-list
83502638|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502639|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83502640|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83502641|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83502642|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
83502643|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
83502644|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502645|NCT01766219|Protective Agents|protective agents|mesh-ancestor
83502646|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502647|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
83502648|NCT01766219|Vitamins|vitamins|mesh-ancestor
83502649|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
83502650|NCT01767155|Doxorubicin|doxorubicin|mesh-list
83502651|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83502652|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83502653|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502654|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83502655|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83502656|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502657|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502658|NCT01362686|Rivastigmine|rivastigmine|mesh-list
83502659|NCT01362686|Donepezil|donepezil|mesh-list
83502660|NCT01362686|Galantamine|galantamine|mesh-list
83502661|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83502662|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502663|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502664|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
83502665|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502666|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502667|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
83502668|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83502669|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
83502670|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502671|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83502672|NCT01362686|Protective Agents|protective agents|mesh-ancestor
83502673|NCT01322048|Propranolol|propranolol|mesh-list
83502674|NCT01322048|Clonidine|clonidine|mesh-list
83502675|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83502676|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83502677|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
83502678|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502679|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502680|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502681|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83502682|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83502683|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
83502685|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
83502686|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502687|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
83502688|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
83502689|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83502690|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83502691|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83502692|NCT01322360|Morphine|morphine|mesh-list
83502693|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83502694|NCT01322360|Narcotics|narcotics|mesh-ancestor
83502695|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502696|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502697|NCT01322360|Analgesics|analgesics|mesh-ancestor
83502698|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
83502699|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502700|NCT04351724|Ritonavir|ritonavir|mesh-list
83502701|NCT04351724|Lopinavir|lopinavir|mesh-list
83502702|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
83502703|NCT04351724|Chloroquine|chloroquine|mesh-list
83502704|NCT04351724|Remdesivir|remdesivir|mesh-list
83502705|NCT04351724|Candesartan|candesartan|mesh-list
83502706|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
83502707|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
83502708|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83502709|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83502710|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
83502711|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502712|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502713|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83502714|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83502715|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
83502716|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502717|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83502718|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83502719|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83502720|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
83502721|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83502722|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
83502723|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
83502724|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83502725|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83502726|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83502727|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83502728|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83502729|NCT04351724|Amebicides|amebicides|mesh-ancestor
83502730|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
83502731|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
83502732|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83502733|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83502734|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
83502735|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502736|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83502737|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83502738|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502739|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502740|NCT04351412|Fluorides|fluorides|mesh-list
83502741|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
83502742|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
83502743|NCT04351412|Protective Agents|protective agents|mesh-ancestor
83502744|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502759|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83502760|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502761|NCT03684785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83502762|NCT03684785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502763|NCT01364558|Diazepam|diazepam|mesh-list
83502764|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83502765|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
83502766|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
83502767|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
83502768|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502769|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502770|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83502771|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83502772|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502773|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83502774|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83502775|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83502776|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83502777|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83502778|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83502779|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
83502780|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
83502781|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
83502782|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
83502783|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502784|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502785|NCT01323140|Testosterone|testosterone|mesh-list
83502786|NCT01323140|Androgens|androgens|mesh-ancestor
83502787|NCT01323140|Hormones|hormones|mesh-ancestor
83502788|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83502789|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502790|NCT03516305|Alprazolam|alprazolam|mesh-list
83502791|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83502792|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502793|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502794|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83502795|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83502796|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83502797|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
83502798|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
83502799|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502800|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502801|NCT03823287|Aflibercept|aflibercept|mesh-list
83502802|NCT03823287|Faricimab|faricimab|mesh-list
83502803|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83502804|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83502805|NCT03823287|Growth Substances|growth substances|mesh-ancestor
83502806|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502807|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
83502808|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502809|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
83502810|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83502811|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83502812|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502813|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
83502814|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502815|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502816|NCT02626611|Omalizumab|omalizumab|mesh-list
83502817|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83502818|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83502819|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
83502820|NCT01260662|Ketamine|ketamine|mesh-list
83502821|NCT01260662|Propofol|propofol|mesh-list
83502822|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83502823|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502824|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502825|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83502826|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
83502827|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
83502828|NCT01260662|Analgesics|analgesics|mesh-ancestor
83502829|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
83502830|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502831|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83502832|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83502833|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83503059|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83502835|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502836|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
83502837|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83502838|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83502839|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502840|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
83502841|NCT02327117|Coagulants|coagulants|mesh-ancestor
83502842|NCT01365650|Fluticasone|fluticasone|mesh-list
83502843|NCT01365650|Xhance|xhance|mesh-list
83502844|NCT01365650|Ketorolac|ketorolac|mesh-list
83502845|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83502846|NCT01365650|Phenylephrine|phenylephrine|mesh-list
83502847|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
83502848|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83502849|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83502850|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
83502851|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502852|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502853|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83502854|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
83502855|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
83502856|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83502857|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83502858|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83502859|NCT01365650|Analgesics|analgesics|mesh-ancestor
83502860|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
83502861|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83502862|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83502863|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502864|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502865|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83502866|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83502867|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
83502868|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502869|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
83502870|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
83502871|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83502872|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83502873|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
83502874|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83502875|NCT01365650|Protective Agents|protective agents|mesh-ancestor
83502876|NCT01324700|Dexetimide|dexetimide|mesh-list
83502877|NCT01324700|Citalopram|citalopram|mesh-list
83502878|NCT01324700|Escitalopram|escitalopram|mesh-list
83502879|NCT01324700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83502880|NCT01324700|Serotonin|serotonin|mesh-list
83502881|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83502882|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83502883|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502884|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502885|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
83502886|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502887|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83502888|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83502889|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
83502890|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
83502891|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502892|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83502893|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83502894|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
83502895|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83502896|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
83502897|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83502898|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83502899|NCT04769297|Ketamine|ketamine|mesh-list
83502900|NCT04769297|Analgesics|analgesics|mesh-ancestor
83502901|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
83502902|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502903|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502904|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83502905|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83502906|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
83502907|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
83502908|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83503060|NCT02251613|Epinastine|epinastine|mesh-list
83502909|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83502910|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83502911|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502912|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502914|NCT02631057|Dabigatran|dabigatran|mesh-list
83502915|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
83502916|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
83502917|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83502918|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
83502919|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502920|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502921|NCT02631525|Propofol|propofol|mesh-list
83502922|NCT02631525|Desflurane|desflurane|mesh-list
83502923|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83502924|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502925|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502926|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83502927|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
83502928|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
83502929|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83502930|NCT03162497|Azithromycin|azithromycin|mesh-list
83502931|NCT03162497|Doxycycline|doxycycline|mesh-list
83502932|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83502933|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502934|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
83502935|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83502936|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83502937|NCT05190315|Temozolomide|temozolomide|mesh-list
83502938|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
83502939|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83502940|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
83502941|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502942|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502943|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
83502944|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
83502945|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502946|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502947|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83502948|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83502949|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83502950|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502951|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83502952|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83502953|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
83502954|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502955|NCT05167643|Anastrozole|anastrozole|mesh-list
83502956|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83502957|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502958|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83502959|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83502960|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502961|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502962|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83502963|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
83502964|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83502965|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502966|NCT01366196|Pregabalin|pregabalin|mesh-list
83502967|NCT01366196|Analgesics|analgesics|mesh-ancestor
83502968|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
83502969|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502970|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502971|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
83502972|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83502973|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83502974|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502975|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83502976|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83502977|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83502978|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502979|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83502980|NCT01366976|Acetaminophen|acetaminophen|mesh-list
83502981|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83502982|NCT01366976|Analgesics|analgesics|mesh-ancestor
83502983|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
83502984|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502985|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502986|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
83502987|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
83502988|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83502989|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83502990|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
83502991|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502992|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502993|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502994|NCT01777217|Urological Agents|urological agents|mesh-ancestor
83502995|NCT02251379|Fluticasone|fluticasone|mesh-list
83502996|NCT02251379|Xhance|xhance|mesh-list
83502997|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83502998|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83502999|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
83503000|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503001|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503002|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83503003|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
83503004|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
83503005|NCT02251379|Hormones|hormones|mesh-ancestor
83503006|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503007|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
83503008|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503009|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
83503010|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83503011|NCT02255513|Methylphenidate|methylphenidate|mesh-list
83503012|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83503013|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503014|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83503015|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83503016|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83503017|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503018|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
83503019|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503020|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
83503021|NCT01778465|Salicylates|salicylates|mesh-list
83503022|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83503023|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503024|NCT01778465|Analgesics|analgesics|mesh-ancestor
83503025|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
83503026|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503027|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503028|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503029|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503030|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83503031|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503032|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503033|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503034|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
83503035|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
83503036|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
83503037|NCT01779167|Thalidomide|thalidomide|mesh-list
83503038|NCT01779167|Rituximab|rituximab|mesh-list
83503039|NCT01779167|Lenalidomide|lenalidomide|mesh-list
83503040|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83503041|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503042|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
83503043|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503044|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503045|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83503046|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83503047|NCT01779167|Growth Substances|growth substances|mesh-ancestor
83503048|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
83503049|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503050|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
83503051|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83503052|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503053|NCT01780337|Oxytocin|oxytocin|mesh-list
83503054|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
83503055|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83503056|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503057|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83503058|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83503061|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83503063|NCT02251613|Analgesics|analgesics|mesh-ancestor
83503064|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
83503065|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503066|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503067|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503068|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503069|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83503070|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83503071|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83503072|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
83503073|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
83503074|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503075|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503076|NCT02865473|Pilocarpine|pilocarpine|mesh-list
83503077|NCT02865473|Miotics|miotics|mesh-ancestor
83503078|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
83503079|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503080|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503081|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83503082|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83503083|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
83503084|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503085|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503086|NCT02850419|Doxorubicin|doxorubicin|mesh-list
83503087|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83503088|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83503089|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503090|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83503091|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83503092|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503093|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503094|NCT02841371|Edetic Acid|edetic acid|mesh-list
83503095|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
83503096|NCT02841371|Antidotes|antidotes|mesh-ancestor
83503097|NCT02841371|Protective Agents|protective agents|mesh-ancestor
83503098|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503099|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
83503100|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
83503101|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503102|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83503103|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
83503104|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83503105|NCT01783847|Prednisolone|prednisolone|mesh-list
83503106|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83503107|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
83503108|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83503109|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
83503110|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
83503111|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83503112|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
83503113|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503114|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
83503115|NCT01783847|Hormones|hormones|mesh-ancestor
83503116|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503117|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503118|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83503119|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503120|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
83503121|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
83503122|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503123|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83503124|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83503125|NCT01783847|Protective Agents|protective agents|mesh-ancestor
83503126|NCT01783847|Hematinics|hematinics|mesh-ancestor
83503127|NCT02585375|Latanoprost|latanoprost|mesh-list
83503128|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83503129|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83503130|NCT02516813|Peposertib|peposertib|mesh-list
83503131|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83503132|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503133|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503135|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83503211|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
83503136|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503137|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503138|NCT01786343|Decitabine|decitabine|mesh-list
83503139|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83503140|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
83503141|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503142|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503143|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503144|NCT03362775|Propofol|propofol|mesh-list
83503145|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83503146|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83503147|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503148|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83503149|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
83503150|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
83503151|NCT01786967|Fesoterodine|fesoterodine|mesh-list
83503152|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83503153|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83503154|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
83503155|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503156|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503157|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503158|NCT01786967|Urological Agents|urological agents|mesh-ancestor
83503159|NCT02392871|Trametinib|trametinib|mesh-list
83503160|NCT02392871|Dabrafenib|dabrafenib|mesh-list
83503161|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503162|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83503163|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503164|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503165|NCT02382575|Rituximab|rituximab|mesh-list
83503166|NCT02382575|Tacrolimus|tacrolimus|mesh-list
83503167|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83503168|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83503169|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503170|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
83503171|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503172|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503173|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503174|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503175|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503176|NCT01807871|Nicotine|nicotine|mesh-list
83503177|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83503178|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
83503179|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503180|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503181|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83503182|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83503183|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
83503184|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503185|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503186|NCT01091831|Dexamethasone|dexamethasone|mesh-list
83503187|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
83503188|NCT01091831|Melphalan|melphalan|mesh-list
83503189|NCT01091831|Lenalidomide|lenalidomide|mesh-list
83503190|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503191|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
83503192|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503193|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503194|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83503195|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
83503196|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503197|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503198|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83503199|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503200|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
83503201|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
83503202|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503203|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83503204|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
83503205|NCT01091831|Hormones|hormones|mesh-ancestor
83503206|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503207|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83503208|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83503209|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83503210|NCT01091831|Growth Substances|growth substances|mesh-ancestor
83503224|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83503225|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
83503226|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503227|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503228|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503229|NCT00367185|Thalidomide|thalidomide|mesh-list
83503230|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503231|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
83503232|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503233|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
83503234|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83503235|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503236|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83503237|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83503238|NCT00367185|Growth Substances|growth substances|mesh-ancestor
83503239|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
83503240|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503241|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83503242|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83503243|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503244|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83503245|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83503246|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83503247|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503248|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
83503249|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503250|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
83503251|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83503252|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503253|NCT03283137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83503254|NCT03283137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503255|NCT01267136|Acetaminophen|acetaminophen|mesh-list
83503256|NCT01267136|Tramadol|tramadol|mesh-list
83503257|NCT01267136|Codeine|codeine|mesh-list
83503258|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503259|NCT01267136|Analgesics|analgesics|mesh-ancestor
83503260|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
83503261|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503262|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503263|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
83503264|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83503265|NCT01267136|Narcotics|narcotics|mesh-ancestor
83503266|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83503267|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
83503268|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
83503269|NCT01370564|Diuretics|diuretics|mesh-list
83503270|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
83503271|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503272|NCT00367263|Ciclesonide|ciclesonide|mesh-list
83503273|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
83503274|NCT00367263|Hormones|hormones|mesh-ancestor
83503275|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503276|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503277|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83503278|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83503279|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
83503280|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
83503281|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503282|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503283|NCT01371110|Midazolam|midazolam|mesh-list
83503284|NCT01371110|Ketamine|ketamine|mesh-list
83503285|NCT01371110|Analgesics|analgesics|mesh-ancestor
83503286|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
83503287|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503288|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503289|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83503290|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83503291|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
83503292|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
83503293|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83503294|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83503295|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83503296|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503297|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503298|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83503299|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83503300|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83503301|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83503302|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83503303|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
83503305|NCT01791491|Abatacept|abatacept|mesh-list
83503306|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83503307|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503308|NCT01791491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83503309|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503310|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503311|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
83503312|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503313|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503314|NCT00367419|Erythromycin|erythromycin|mesh-list
83503315|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
83503316|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83503317|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
83503318|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83503319|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503320|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83503321|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83503322|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503323|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503324|NCT01372202|Paclitaxel|paclitaxel|mesh-list
83503325|NCT01372202|Fluorouracil|fluorouracil|mesh-list
83503326|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
83503327|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83503328|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503329|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
83503330|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
83503331|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
83503332|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503333|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
83503334|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83503335|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503336|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
83503337|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503338|NCT01811147|Norepinephrine|norepinephrine|mesh-list
83503339|NCT01811147|Serotonin|serotonin|mesh-list
83503340|NCT01811147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83503341|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83503342|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83503343|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
83503344|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503345|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503346|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503347|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
83503348|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
83503349|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503350|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83503351|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83503352|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
83503353|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83503354|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83503355|NCT01373450|Liraglutide|liraglutide|mesh-list
83503356|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83503357|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503358|NCT01373450|Incretins|incretins|mesh-ancestor
83503359|NCT01373450|Hormones|hormones|mesh-ancestor
83503360|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503361|NCT01793285|Etanercept|etanercept|mesh-list
83503362|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83503363|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503364|NCT01793285|Analgesics|analgesics|mesh-ancestor
83503365|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
83503366|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503367|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503368|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503369|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503370|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83503371|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503372|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
83503373|NCT05049525|Itraconazole|itraconazole|mesh-list
83503397|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503398|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83503399|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
83503400|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503401|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503402|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83503403|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83503404|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83503405|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83503406|NCT01332188|Cetirizine|cetirizine|mesh-list
83503407|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83503408|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83503409|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83503410|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
83503411|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
83503412|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503413|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503414|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503415|NCT01794455|Candesartan|candesartan|mesh-list
83503416|NCT01794455|Sertraline|sertraline|mesh-list
83503417|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
83503418|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83503419|NCT01794455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83503420|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83503421|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83503422|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503423|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503424|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
83503425|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503426|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83503427|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83503428|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83503429|NCT01332500|Naproxen|naproxen|mesh-list
83503430|NCT01332500|Sumatriptan|sumatriptan|mesh-list
83503431|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83503432|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503433|NCT01332500|Analgesics|analgesics|mesh-ancestor
83503434|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
83503435|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503436|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503437|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503438|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503439|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
83503440|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83503441|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503442|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503443|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83503444|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83503445|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83503446|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
83503447|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503448|NCT01812005|Rituximab|rituximab|mesh-list
83503449|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83503450|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503451|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
83503452|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503453|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503454|NCT01332578|Acetaminophen|acetaminophen|mesh-list
83503455|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
83503456|NCT01332578|Phenylephrine|phenylephrine|mesh-list
83503457|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
83503458|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503459|NCT01332578|Analgesics|analgesics|mesh-ancestor
83503460|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
83503461|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503462|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503463|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
83503464|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
83503465|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503466|NCT01332578|Protective Agents|protective agents|mesh-ancestor
83503467|NCT01332578|Vitamins|vitamins|mesh-ancestor
83503468|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
83503489|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83503490|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503491|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83503492|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83503493|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83503494|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503495|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
83503496|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503497|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83503498|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83503499|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83503500|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83503501|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83503502|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
83503504|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503505|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
83503506|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
83503507|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503508|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503509|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83503510|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
83503511|NCT01734161|Hormones|hormones|mesh-ancestor
83503512|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503513|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83503514|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503515|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83503516|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
83503517|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503518|NCT01797575|Aspirin|aspirin|mesh-list
83503519|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
83503520|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83503521|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83503522|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503523|NCT01797575|Analgesics|analgesics|mesh-ancestor
83503524|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
83503525|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503526|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503527|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503528|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503529|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83503530|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83503531|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503532|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83503533|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83503534|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503535|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
83503536|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
83503537|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503538|NCT01797575|Expectorants|expectorants|mesh-ancestor
83503539|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
83503540|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83503541|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
83503542|NCT01797575|Protective Agents|protective agents|mesh-ancestor
83503543|NCT01797575|Antidotes|antidotes|mesh-ancestor
83503544|NCT02641353|Thalidomide|thalidomide|mesh-list
83503545|NCT02641353|Apremilast|apremilast|mesh-list
83503546|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83503547|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503548|NCT02641353|Analgesics|analgesics|mesh-ancestor
83503549|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
83503550|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503551|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503552|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503553|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503554|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83503555|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83503556|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503557|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503558|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503559|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
83503560|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
83503561|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83503562|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503563|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83503564|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83503565|NCT02641353|Growth Substances|growth substances|mesh-ancestor
83503566|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
83503567|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503568|NCT01378520|Ketoconazole|ketoconazole|mesh-list
83503569|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
83503570|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503571|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83503572|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83503573|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503574|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503575|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83503576|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
83503577|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503578|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503579|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83503580|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
83503581|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83503582|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83503583|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503584|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503585|NCT01378988|Analgesics|analgesics|mesh-ancestor
83503586|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
83503587|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503588|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83503589|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83503590|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83503591|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
83503592|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503593|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503594|NCT01335620|Tenofovir|tenofovir|mesh-list
83503595|NCT01335620|Emtricitabine|emtricitabine|mesh-list
83503596|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
83503597|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
83503598|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503599|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83503600|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83503601|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503602|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503603|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83503604|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83503605|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83503606|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83503607|NCT01335932|Ganciclovir|ganciclovir|mesh-list
83503608|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83503609|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
83503610|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503611|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83503612|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503613|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503614|NCT01273766|Deferasirox|deferasirox|mesh-list
83503615|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83503616|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
83503617|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
83503618|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503619|NCT01403246|Lenalidomide|lenalidomide|mesh-list
83503620|NCT01403246|Chlorambucil|chlorambucil|mesh-list
83503621|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
83503622|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503623|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83503624|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83503625|NCT01403246|Growth Substances|growth substances|mesh-ancestor
83503626|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
83503627|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503628|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83503629|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
83503630|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503631|NCT01734551|Clonidine|clonidine|mesh-list
83503632|NCT01734551|Morphine|morphine|mesh-list
83503633|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83503634|NCT01734551|Narcotics|narcotics|mesh-ancestor
83503635|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83503936|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
83503636|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503637|NCT01734551|Analgesics|analgesics|mesh-ancestor
83503638|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
83503639|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503640|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83503641|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
83503642|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
83503643|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83503644|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83503645|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83503646|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
83503647|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503648|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503649|NCT01404260|Carboplatin|carboplatin|mesh-list
83503650|NCT01404260|Gemcitabine|gemcitabine|mesh-list
83503651|NCT01404260|Gefitinib|gefitinib|mesh-list
83503652|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503653|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83503655|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503656|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83503657|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503658|NCT02235909|Losartan|losartan|mesh-list
83503659|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83503660|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83503661|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83503662|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83503663|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83503664|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503665|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83503666|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83503667|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83503668|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
83503669|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503670|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503671|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83503672|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83503673|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
83503674|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503675|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
83503676|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83503677|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
83503678|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503679|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503680|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83503681|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
83503682|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
83503683|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83503684|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
83503685|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503686|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503687|NCT01799213|Meloxicam|meloxicam|mesh-list
83503688|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83503689|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503690|NCT01799213|Analgesics|analgesics|mesh-ancestor
83503691|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
83503692|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503693|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503694|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503695|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503696|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83503697|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83503698|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503699|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503700|NCT01383200|Lidocaine|lidocaine|mesh-list
83503701|NCT01383200|Tetracaine|tetracaine|mesh-list
83503702|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
83503703|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
83503704|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83503705|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503706|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
83503707|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503708|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83503709|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83503710|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83503711|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83503712|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503713|NCT05588037|Dexamethasone|dexamethasone|mesh-list
83503714|NCT05588037|Dexamethasone acetate|dexamethasone acetate|mesh-list
83503715|NCT05588037|BB 1101|bb 1101|mesh-list
83503716|NCT05588037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503717|NCT05588037|Antiemetics|antiemetics|mesh-ancestor
83503718|NCT05588037|Autonomic Agents|autonomic agents|mesh-ancestor
83503719|NCT05588037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503720|NCT05588037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503721|NCT05588037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83503722|NCT05588037|Glucocorticoids|glucocorticoids|mesh-ancestor
83503723|NCT05588037|Hormones|hormones|mesh-ancestor
83503724|NCT05588037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503725|NCT05588037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83503726|NCT05588037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503727|NCT05588037|Protease Inhibitors|protease inhibitors|mesh-ancestor
83503728|NCT05588037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503729|NCT05588037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503730|NCT02194088|Diclofenac|diclofenac|mesh-list
83503731|NCT02194088|Atropine|atropine|mesh-list
83503732|NCT02194088|Analgesics|analgesics|mesh-list
83503733|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83503734|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503735|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
83503736|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503737|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503738|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503739|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503740|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83503741|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503742|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503743|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83503744|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83503745|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83503746|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
83503747|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83503748|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
83503749|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
83503750|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
83503751|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83503752|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83503753|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
83503754|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503755|NCT02023593|Leucovorin|leucovorin|mesh-list
83503756|NCT02023593|Fluorouracil|fluorouracil|mesh-list
83503757|NCT02023593|Irinotecan|irinotecan|mesh-list
83503758|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
83503759|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503760|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83503761|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503762|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503763|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
83503764|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503765|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83503766|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83503767|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503768|NCT02023593|Antidotes|antidotes|mesh-ancestor
83503769|NCT02023593|Protective Agents|protective agents|mesh-ancestor
83503770|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
83503771|NCT02023593|Vitamins|vitamins|mesh-ancestor
83503772|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
83503773|NCT01978431|Cocaine|cocaine|mesh-list
83503774|NCT01978431|Methylphenidate|methylphenidate|mesh-list
83503775|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83503776|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503777|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83503778|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83503779|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83503780|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503781|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
83503782|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503783|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
83503784|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
83503785|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83503786|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
83503787|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503788|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83503789|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
83503790|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83503791|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83503792|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503793|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83503794|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503795|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83503796|NCT02685267|Prednisone|prednisone|mesh-list
83503797|NCT02685267|Docetaxel|docetaxel|mesh-list
83503798|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503799|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
83503800|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
83503801|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
83503802|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503803|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503804|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
83503805|NCT02685267|Hormones|hormones|mesh-ancestor
83503806|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503807|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503808|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83503809|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
83503810|NCT02257541|Infigratinib|infigratinib|mesh-list
83503811|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503812|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83503813|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503814|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503815|NCT01817855|AZD7624|azd7624|mesh-list
83503816|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83503817|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503818|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503819|NCT00368121|Dexamethasone|dexamethasone|mesh-list
83503820|NCT00368121|Cetuximab|cetuximab|mesh-list
83503821|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503822|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
83503823|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
83503824|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503825|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503826|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83503827|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
83503828|NCT00368121|Hormones|hormones|mesh-ancestor
83503829|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503830|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83503831|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503832|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83503833|NCT00367497|Cytarabine|cytarabine|mesh-list
83503834|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
83503835|NCT00367497|Rituximab|rituximab|mesh-list
83503836|NCT00367497|Etoposide|etoposide|mesh-list
83503837|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83503838|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503839|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
83503840|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503841|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503842|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83503843|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83503844|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83503845|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503846|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503847|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83503848|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
83503849|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
83503850|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503851|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503852|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503853|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
83503854|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
83503855|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503856|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83503857|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
83503858|NCT00367497|Hormones|hormones|mesh-ancestor
83503859|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503860|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83503861|NCT00367497|Protective Agents|protective agents|mesh-ancestor
83503862|NCT01387178|Fluticasone|fluticasone|mesh-list
83503863|NCT01387178|Xhance|xhance|mesh-list
83503864|NCT01387178|Bromides|bromides|mesh-list
83503865|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
83503866|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83503867|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503868|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83503869|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
83503870|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503871|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503872|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83503873|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
83503874|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
83503875|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83503876|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
83503877|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83503878|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
83503879|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503880|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503881|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83503882|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83503883|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83503884|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
83503885|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
83503886|NCT01805297|Aflibercept|aflibercept|mesh-list
83503887|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83503888|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83503889|NCT01805297|Growth Substances|growth substances|mesh-ancestor
83503890|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503891|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
83503892|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503893|NCT01389284|Naproxen|naproxen|mesh-list
83503894|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83503895|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503896|NCT01389284|Analgesics|analgesics|mesh-ancestor
83503897|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
83503898|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503899|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503900|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83503901|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503902|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
83503903|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83503904|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503905|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503906|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83503907|NCT01794143|Liraglutide|liraglutide|mesh-list
83503908|NCT01794143|Glimepiride|glimepiride|mesh-list
83503909|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83503910|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83503911|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503912|NCT01794143|Incretins|incretins|mesh-ancestor
83503913|NCT01794143|Hormones|hormones|mesh-ancestor
83503914|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503915|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
83503916|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503917|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503918|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83503919|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503920|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
83503921|NCT01547741|Paclitaxel|paclitaxel|mesh-list
83503922|NCT01547741|Docetaxel|docetaxel|mesh-list
83503923|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
83503924|NCT01547741|Doxorubicin|doxorubicin|mesh-list
83503925|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83503926|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83503927|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
83503928|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
83503929|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
83503930|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503931|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83503932|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
83503933|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503934|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83503935|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83503937|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83503938|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83503939|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83503940|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83503941|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503942|NCT01390064|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83503943|NCT01390064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83503944|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
83503945|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503946|NCT01473368|Amoxicillin|amoxicillin|mesh-list
83503947|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
83503948|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
83503949|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83503950|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83503951|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503952|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83503953|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503954|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503955|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
83503956|NCT04351490|Vitamin D|vitamin d|mesh-list
83503957|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83503958|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503959|NCT04351490|Vitamins|vitamins|mesh-ancestor
83503960|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
83503961|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83503962|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
83503963|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83503964|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83503965|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83503966|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83503967|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503968|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
83503969|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503970|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503971|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83503972|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503973|NCT03008252|Caseins|caseins|mesh-list
83503974|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
83503975|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
83503976|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503977|NCT05328635|Candesartan|candesartan|mesh-list
83503978|NCT05328635|Gabapentin|gabapentin|mesh-list
83503979|NCT05328635|Analgesics|analgesics|mesh-ancestor
83503980|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
83503981|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83503982|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503983|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
83503984|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83503985|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83503986|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83503987|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83503988|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83503989|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83503990|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503991|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503992|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
83503993|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83503994|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83503995|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83503996|NCT01391858|Pregabalin|pregabalin|mesh-list
83503997|NCT01391858|Analgesics|analgesics|mesh-ancestor
83503998|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
83503999|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504000|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504001|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
83504002|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83504003|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83504004|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504005|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83504006|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83504007|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83504008|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504009|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83504010|NCT05587257|Minoxidil|minoxidil|mesh-list
83504011|NCT05587257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83504012|NCT05587257|Vasodilator Agents|vasodilator agents|mesh-ancestor
83504013|NCT01825655|Cetirizine|cetirizine|mesh-list
83504014|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83504015|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83504016|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83504017|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
83504018|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
83504019|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504020|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504021|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504022|NCT02249663|Fluticasone|fluticasone|mesh-list
83504023|NCT02249663|Xhance|xhance|mesh-list
83504024|NCT02249663|Azelastine|azelastine|mesh-list
83504025|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504026|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83504027|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
83504028|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504029|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504030|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83504031|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
83504032|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
83504033|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83504034|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83504035|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504036|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504037|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83504038|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83504039|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
83504040|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
83504041|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504042|NCT04237623|Sargramostim|sargramostim|mesh-list
83504043|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
83504044|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504045|NCT01825889|Evacetrapib|evacetrapib|mesh-list
83504046|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83504047|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83504048|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
83504049|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504050|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83504051|NCT02692755|Letrozole|letrozole|mesh-list
83504052|NCT02692755|Fulvestrant|fulvestrant|mesh-list
83504053|NCT02692755|Palbociclib|palbociclib|mesh-list
83504054|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504055|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83504056|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83504057|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504058|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504059|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83504060|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
83504061|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83504062|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504063|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83504064|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83504065|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83504066|NCT01829399|Epinephrine|epinephrine|mesh-list
83504067|NCT01829399|Bupivacaine|bupivacaine|mesh-list
83504068|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
83504069|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
83504070|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504071|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504072|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
83504073|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504074|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83504075|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83504076|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
83504077|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504078|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504079|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83504080|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83504081|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
83504082|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83504083|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
83504084|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
83504109|NCT05327309|Bleomycin|bleomycin|mesh-list
83504110|NCT05327309|Propranolol|propranolol|mesh-list
83504111|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83504112|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83504113|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
83504114|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504115|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504116|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504117|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83504118|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83504119|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
83504120|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83504121|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504122|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83504123|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
83504124|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504125|NCT05326841|Vitamin D|vitamin d|mesh-list
83504126|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
83504127|NCT05326841|Vitamins|vitamins|mesh-ancestor
83504128|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
83504129|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504130|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83504131|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83504132|NCT01412372|Mesalamine|mesalamine|mesh-list
83504133|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83504134|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83504135|NCT01412372|Analgesics|analgesics|mesh-ancestor
83504136|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
83504137|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504138|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504139|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504140|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83504141|NCT01414010|Amoxicillin|amoxicillin|mesh-list
83504142|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83504143|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504144|NCT01415960|Leuprolide|leuprolide|mesh-list
83504145|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83504146|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
83504147|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83504148|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504149|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83504150|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504151|NCT01833845|Ribavirin|ribavirin|mesh-list
83504152|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
83504153|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
83504154|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504155|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
83504156|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504157|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
83504158|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83504159|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83504160|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504161|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83504162|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83504163|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
83504164|NCT01416194|Diphosphonates|diphosphonates|mesh-list
83504165|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83504166|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
83504167|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83504168|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504169|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83504170|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83504171|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83504172|NCT01416584|Methadone|methadone|mesh-list
83504173|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83504174|NCT01416584|Narcotics|narcotics|mesh-ancestor
83504175|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504176|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504178|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
83504179|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504180|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
83504181|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
83504182|NCT02698215|Naltrexone|naltrexone|mesh-list
83504183|NCT02698215|Varenicline|varenicline|mesh-list
83504184|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83504199|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83504200|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
83504201|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504202|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
83504203|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504204|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
83504205|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83504206|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83504207|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83504208|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83504209|NCT01480232|Nicotine|nicotine|mesh-list
83504210|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83504211|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
83504212|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504213|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504214|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83504215|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83504216|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
83504217|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504218|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504219|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
83504220|NCT04049799|Narcotics|narcotics|mesh-ancestor
83504221|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504222|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504223|NCT04049799|Analgesics|analgesics|mesh-ancestor
83504224|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
83504225|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504226|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
83504227|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504228|NCT05437575|Fentanyl|fentanyl|mesh-list
83504229|NCT05437575|Ketamine|ketamine|mesh-list
83504230|NCT05437575|Analgesics|analgesics|mesh-ancestor
83504231|NCT05437575|Sensory System Agents|sensory system agents|mesh-ancestor
83504232|NCT05437575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504233|NCT05437575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504234|NCT05437575|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83504235|NCT05437575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83504236|NCT05437575|Anesthetics, General|anesthetics, general|mesh-ancestor
83504237|NCT05437575|Anesthetics|anesthetics|mesh-ancestor
83504238|NCT05437575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504239|NCT05437575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83504240|NCT05437575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83504241|NCT05437575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504242|NCT05437575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504243|NCT05437575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83504244|NCT05437575|Narcotics|narcotics|mesh-ancestor
83504245|NCT05437575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83504246|NCT03008876|Acetaminophen|acetaminophen|mesh-list
83504247|NCT03008876|Ibuprofen|ibuprofen|mesh-list
83504248|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83504249|NCT03008876|Analgesics|analgesics|mesh-ancestor
83504250|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
83504251|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504252|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504253|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
83504254|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83504255|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504256|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83504257|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83504258|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504259|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504260|NCT05414487|Ofatumumab|ofatumumab|mesh-list
83504261|NCT05414487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504262|NCT02701257|Glucagon|glucagon|mesh-list
83504263|NCT02701257|Pancrelipase|pancrelipase|mesh-list
83504264|NCT02701257|Pancreatin|pancreatin|mesh-list
83504265|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83504266|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83504267|NCT02701257|Hormones|hormones|mesh-ancestor
83504268|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83504269|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504270|NCT02701257|Incretins|incretins|mesh-ancestor
83504271|NCT01836029|Carboplatin|carboplatin|mesh-list
83504272|NCT01836029|Fluorouracil|fluorouracil|mesh-list
83504273|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504274|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
83504275|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504276|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83504277|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83504278|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
83504279|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504280|NCT02703909|Rocuronium|rocuronium|mesh-list
83504281|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83504282|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83504283|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83504284|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504285|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504286|NCT01836185|Evacetrapib|evacetrapib|mesh-list
83504287|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83504288|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83504289|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
83504290|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504291|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83504292|NCT02706249|Enoxaparin|enoxaparin|mesh-list
83504293|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
83504294|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83504295|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83504296|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504297|NCT04740021|Carboplatin|carboplatin|mesh-list
83504298|NCT04740021|Etoposide|etoposide|mesh-list
83504299|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504300|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83504301|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83504302|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83504303|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504304|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504305|NCT02708433|Lidocaine|lidocaine|mesh-list
83504306|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
83504307|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
83504308|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504309|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504310|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
83504311|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504312|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83504313|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83504314|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83504315|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83504316|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504317|NCT03575013|Docetaxel|docetaxel|mesh-list
83504318|NCT03575013|Avelumab|avelumab|mesh-list
83504319|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504320|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
83504321|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
83504322|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
83504323|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504324|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83504325|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
83504326|NCT00559637|Hematinics|hematinics|mesh-ancestor
83504327|NCT03349281|Cytarabine|cytarabine|mesh-list
83504328|NCT03349281|Dexamethasone|dexamethasone|mesh-list
83504329|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
83504330|NCT03349281|Doxorubicin|doxorubicin|mesh-list
83504331|NCT03349281|Methotrexate|methotrexate|mesh-list
83504332|NCT03349281|Vincristine|vincristine|mesh-list
83504333|NCT03349281|Asparaginase|asparaginase|mesh-list
83504334|NCT03349281|Pegaspargase|pegaspargase|mesh-list
83504335|NCT03349281|Pevonedistat|pevonedistat|mesh-list
83504336|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504337|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
83504338|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
83504339|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504340|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504341|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83504342|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
83504343|NCT03349281|Hormones|hormones|mesh-ancestor
83504344|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83504345|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83504346|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504347|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83504348|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83504349|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83504350|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504351|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504352|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83504353|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
83504354|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83504355|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83504356|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
83504357|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
83504358|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83504359|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83504360|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
83504361|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83504362|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83504363|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
83504364|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504365|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83504366|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
83504367|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
83504368|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
83504369|NCT03206151|Leucovorin|leucovorin|mesh-list
83504370|NCT03206151|Folic Acid|folic acid|mesh-list
83504371|NCT03206151|Fluorouracil|fluorouracil|mesh-list
83504372|NCT03206151|Irinotecan|irinotecan|mesh-list
83504373|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
83504374|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
83504375|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504376|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83504377|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504378|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83504379|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
83504380|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504381|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83504382|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83504383|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504384|NCT03206151|Antidotes|antidotes|mesh-ancestor
83504385|NCT03206151|Protective Agents|protective agents|mesh-ancestor
83504386|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
83504387|NCT03206151|Vitamins|vitamins|mesh-ancestor
83504388|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
83504389|NCT03206151|Hematinics|hematinics|mesh-ancestor
83504390|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83504391|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
83504392|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83504393|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504394|NCT01841021|Immunotoxins|immunotoxins|mesh-ancestor
83504395|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
83504396|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504397|NCT02714283|Azithromycin|azithromycin|mesh-list
83504398|NCT02714283|Erythromycin|erythromycin|mesh-list
83504399|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83504400|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504401|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83504402|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83504403|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504404|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504405|NCT04814927|Copper|copper|mesh-list
83504406|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83504407|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
83504408|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
83504409|NCT04814927|Etonogestrel|etonogestrel|mesh-list
83504410|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83504411|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
83504412|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83504413|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504414|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83504415|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83504416|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83504417|NCT04814927|Trace Elements|trace elements|mesh-ancestor
83504418|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
83504419|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83504420|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83504421|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83504422|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504423|NCT04810949|Vitamin D|vitamin d|mesh-list
83504424|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
83504425|NCT04810949|Vitamins|vitamins|mesh-ancestor
83504426|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
83504427|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504428|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83504429|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83504430|NCT04795583|Prednisone|prednisone|mesh-list
83504431|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504432|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
83504433|NCT04795583|Hormones|hormones|mesh-ancestor
83504434|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83504435|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504436|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83504437|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504438|NCT02722239|Metformin|metformin|mesh-list
83504439|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
83504440|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83504441|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504442|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83504443|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504444|NCT02578641|Carboplatin|carboplatin|mesh-list
83504445|NCT02578641|Gemcitabine|gemcitabine|mesh-list
83504446|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504447|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83504448|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
83504449|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504450|NCT05084859|Prednisone|prednisone|mesh-list
83504451|NCT05084859|Docetaxel|docetaxel|mesh-list
83504452|NCT05084859|Panitumumab|panitumumab|mesh-list
83504453|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504454|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
83504455|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
83504456|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
83504457|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504458|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504459|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
83504460|NCT05084859|Hormones|hormones|mesh-ancestor
83504461|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83504462|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504463|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83504464|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83504465|NCT01846871|Tivozanib|tivozanib|mesh-list
83504466|NCT01846871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83504467|NCT01846871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504468|NCT01846871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504469|NCT02431260|INCB054329|incb054329|mesh-list
83504470|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504471|NCT02055963|Minocycline|minocycline|mesh-list
83504472|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83504473|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504474|NCT01848041|Phenylephrine|phenylephrine|mesh-list
83504475|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
83504476|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83504477|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83504478|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83504479|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83504480|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
83504481|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504482|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504483|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504484|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
83504485|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
83504486|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504487|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
83504488|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83504489|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
83504490|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83504491|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
83504492|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83504493|NCT01848041|Protective Agents|protective agents|mesh-ancestor
83504494|NCT02724033|Dexamethasone|dexamethasone|mesh-list
83504495|NCT02724033|Ondansetron|ondansetron|mesh-list
83504496|NCT02724033|Antiemetics|antiemetics|mesh-list
83504497|NCT02724033|Bupivacaine|bupivacaine|mesh-list
83504498|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504499|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
83504500|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504501|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504502|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83504503|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
83504581|NCT01852175|Ticagrelor|ticagrelor|mesh-list
83504505|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83504506|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83504507|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504508|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504509|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
83504510|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
83504511|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504512|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
83504513|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
83504514|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
83504515|NCT02724033|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83504516|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83504517|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
83504518|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504519|NCT02724423|Diazepam|diazepam|mesh-list
83504520|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83504521|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
83504522|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
83504523|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
83504524|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504525|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504526|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83504527|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83504528|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504529|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83504530|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83504531|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83504532|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83504533|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83504534|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83504535|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
83504536|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
83504537|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
83504538|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
83504539|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504540|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504541|NCT02989259|Apatinib|apatinib|mesh-list
83504542|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504543|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83504544|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504545|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504546|NCT04950621|Propofol|propofol|mesh-list
83504547|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83504548|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504549|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504550|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83504551|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
83504552|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
83504553|NCT01848899|Bivalirudin|bivalirudin|mesh-list
83504554|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
83504555|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83504556|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
83504557|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504558|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504559|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
83504560|NCT02731833|Fluorides|fluorides|mesh-list
83504561|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
83504562|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
83504563|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
83504564|NCT02731833|Protective Agents|protective agents|mesh-ancestor
83504565|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504566|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83504567|NCT01852019|Cangrelor|cangrelor|mesh-list
83504568|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83504569|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83504570|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83504571|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83504572|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
83504573|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504574|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504575|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504576|NCT04457219|Hemostatics|hemostatics|mesh-list
83504577|NCT04457219|Coagulants|coagulants|mesh-ancestor
83504578|NCT02430480|Goserelin|goserelin|mesh-list
83504579|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83504580|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504582|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83504583|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83504584|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83504585|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83504586|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83504587|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
83504588|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504589|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504590|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504591|NCT02429934|Abatacept|abatacept|mesh-list
83504592|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83504593|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504594|NCT02429934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83504595|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504596|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83504597|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
83504598|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504599|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83504600|NCT01852955|Acetaminophen|acetaminophen|mesh-list
83504601|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83504602|NCT01852955|Analgesics|analgesics|mesh-ancestor
83504603|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
83504604|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504605|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504606|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
83504607|NCT00558467|Pramipexole|pramipexole|mesh-list
83504608|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
83504609|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504610|NCT00558467|Protective Agents|protective agents|mesh-ancestor
83504611|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504612|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83504613|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83504614|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
83504615|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
83504616|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504617|NCT04226495|Sufentanil|sufentanil|mesh-list
83504618|NCT04226495|Dsuvia|dsuvia|mesh-list
83504619|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83504620|NCT04226495|Narcotics|narcotics|mesh-ancestor
83504621|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504622|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504623|NCT04226495|Analgesics|analgesics|mesh-ancestor
83504624|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
83504625|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504626|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83504627|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83504628|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
83504629|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
83504630|NCT02401230|Tenofovir|tenofovir|mesh-list
83504631|NCT02401230|Emtricitabine|emtricitabine|mesh-list
83504632|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83504633|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
83504634|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504635|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83504636|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83504637|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504638|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504639|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83504640|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83504641|NCT01854359|Idebenone|idebenone|mesh-list
83504642|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
83504643|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504644|NCT01854359|Protective Agents|protective agents|mesh-ancestor
83504645|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504646|NCT01854593|Bevacizumab|bevacizumab|mesh-list
83504647|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83504648|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504649|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83504650|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83504651|NCT01854593|Growth Substances|growth substances|mesh-ancestor
83504652|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504653|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
83504654|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83504655|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
83504668|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504669|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504670|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83504671|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
83504672|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
83504673|NCT02734953|Protective Agents|protective agents|mesh-ancestor
83504674|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83504675|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83504676|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504677|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504678|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83504679|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83504680|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504681|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
83504682|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504684|NCT02735187|Vitamins|vitamins|mesh-ancestor
83504685|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
83504686|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504687|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83504688|NCT02428296|Sirolimus|sirolimus|mesh-list
83504689|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83504690|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504691|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83504692|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504693|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
83504694|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83504695|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
83504696|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504697|NCT02643615|Propofol|propofol|mesh-list
83504698|NCT02643615|Desflurane|desflurane|mesh-list
83504699|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83504700|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504701|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504702|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83504703|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
83504704|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
83504705|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83504706|NCT02265341|Ponatinib|ponatinib|mesh-list
83504707|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504708|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83504709|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504710|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504712|NCT05679479|Antiviral Agents|antiviral agents|mesh-ancestor
83504713|NCT05679479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504714|NCT01421186|Dexamethasone|dexamethasone|mesh-list
83504715|NCT01421186|Lenalidomide|lenalidomide|mesh-list
83504716|NCT01421186|Pomalidomide|pomalidomide|mesh-list
83504717|NCT01421186|Felzartamab|felzartamab|mesh-list
83504718|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504719|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
83504720|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
83504721|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504722|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504723|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83504724|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
83504725|NCT01421186|Hormones|hormones|mesh-ancestor
83504726|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83504727|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83504728|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504729|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
83504730|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83504731|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83504732|NCT01421186|Growth Substances|growth substances|mesh-ancestor
83504733|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
83504734|NCT01860287|Buprenorphine|buprenorphine|mesh-list
83504735|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83504736|NCT01860287|Narcotics|narcotics|mesh-ancestor
83504737|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504738|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504739|NCT01860287|Analgesics|analgesics|mesh-ancestor
83504740|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
83504741|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504742|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83504743|NCT01421498|Lifitegrast|lifitegrast|mesh-list
83504744|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83504745|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83504746|NCT01422200|Vaccines|vaccines|mesh-list
83504747|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
83504748|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504749|NCT01860521|Sufentanil|sufentanil|mesh-list
83504750|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
83504751|NCT01860521|Gemeprost|gemeprost|mesh-list
83504752|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83504753|NCT01860521|Narcotics|narcotics|mesh-ancestor
83504754|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504755|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504756|NCT01860521|Analgesics|analgesics|mesh-ancestor
83504757|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
83504758|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504759|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83504760|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83504761|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
83504762|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
83504763|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
83504764|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83504765|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
83504766|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83504767|NCT01400906|Fluticasone|fluticasone|mesh-list
83504768|NCT01400906|Xhance|xhance|mesh-list
83504769|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504770|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83504771|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
83504772|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504773|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504774|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83504775|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
83504776|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
83504777|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83504778|NCT00367653|Azithromycin|azithromycin|mesh-list
83504779|NCT00367653|Chloroquine|chloroquine|mesh-list
83504780|NCT00367653|Mefloquine|mefloquine|mesh-list
83504781|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83504782|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504783|NCT00367653|Amebicides|amebicides|mesh-ancestor
83504784|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83504785|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83504786|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
83504787|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83504788|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
83504789|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83504790|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504791|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504792|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83504793|NCT01485380|Analgesics|analgesics|mesh-ancestor
83504794|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
83504795|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504796|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83504797|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83504798|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83504799|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
83504800|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504801|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504802|NCT05445297|Amiodarone|amiodarone|mesh-list
83504803|NCT05445297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83504804|NCT05445297|Vasodilator Agents|vasodilator agents|mesh-ancestor
83504805|NCT05445297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83504806|NCT05445297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83504807|NCT05445297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504808|NCT05445297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83504809|NCT05445297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83504810|NCT05445297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83504811|NCT05445297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504812|NCT05445297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83504813|NCT05445297|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83504814|NCT05445297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83504815|NCT00556673|Fluticasone|fluticasone|mesh-list
83504816|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
83504817|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83504818|NCT00556673|Maleic acid|maleic acid|mesh-list
83504819|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504820|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83504821|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
83504822|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504823|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504824|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83504825|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
83504826|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
83504827|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83504828|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83504829|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83504830|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83504831|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
83504832|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504833|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504834|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504835|NCT05437029|Plant Lectins|plant lectins|mesh-list
83504836|NCT05437029|Agglutinins|agglutinins|mesh-ancestor
83504837|NCT05437029|Immunologic Factors|immunologic factors|mesh-ancestor
83504838|NCT05437029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504839|NCT05437029|Coagulants|coagulants|mesh-ancestor
83504840|NCT05437029|Hemagglutinins|hemagglutinins|mesh-ancestor
83504841|NCT01422434|Calcitriol|calcitriol|mesh-list
83504842|NCT01422434|Betamethasone|betamethasone|mesh-list
83504843|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
83504844|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83504845|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
83504846|NCT01422434|Calcipotriene|calcipotriene|mesh-list
83504847|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83504848|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504849|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
83504850|NCT01422434|Hormones|hormones|mesh-ancestor
83504851|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83504852|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504853|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83504854|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
83504855|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
83504856|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83504857|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83504858|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83504859|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504860|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83504861|NCT01422434|Vitamins|vitamins|mesh-ancestor
83504862|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
83504863|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83504864|NCT05434065|Celecoxib|celecoxib|mesh-list
83504865|NCT05434065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83504866|NCT05434065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83504867|NCT05434065|Analgesics|analgesics|mesh-ancestor
83504868|NCT05434065|Sensory System Agents|sensory system agents|mesh-ancestor
83504869|NCT05434065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504870|NCT05434065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504871|NCT05434065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504872|NCT05434065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83504873|NCT05434065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83504874|NCT05434065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83504875|NCT05434065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504876|NCT05434065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504877|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83504878|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504879|NCT02270255|Lidocaine|lidocaine|mesh-list
83504880|NCT02270255|Ropivacaine|ropivacaine|mesh-list
83504881|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
83504882|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
83504883|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504884|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504885|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
83504886|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504887|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83504888|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83504889|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83504890|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83504891|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504892|NCT02651259|Vitamins|vitamins|mesh-list
83504893|NCT02651259|Pyridoxine|pyridoxine|mesh-list
83504894|NCT02651259|Pyridoxal|pyridoxal|mesh-list
83504895|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
83504896|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
83504918|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504919|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83504921|NCT05442411|Ropivacaine|ropivacaine|mesh-list
83504922|NCT05442411|Anesthetics, Local|anesthetics, local|mesh-ancestor
83504923|NCT05442411|Anesthetics|anesthetics|mesh-ancestor
83504924|NCT05442411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504925|NCT05442411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504926|NCT05442411|Sensory System Agents|sensory system agents|mesh-ancestor
83504927|NCT05442411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504928|NCT05442411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83504929|NCT05442411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83504930|NCT05442411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504931|NCT05442411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504932|NCT05442411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83504933|NCT05442411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83504934|NCT05442411|Analgesics|analgesics|mesh-ancestor
83504935|NCT05442411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83504936|NCT05442411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83504937|NCT05654363|Morphine|morphine|mesh-list
83504938|NCT05654363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83504939|NCT05654363|Narcotics|narcotics|mesh-ancestor
83504940|NCT05654363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504941|NCT05654363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504942|NCT05654363|Analgesics|analgesics|mesh-ancestor
83504943|NCT05654363|Sensory System Agents|sensory system agents|mesh-ancestor
83504944|NCT05654363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504945|NCT02651415|Perindopril|perindopril|mesh-list
83504946|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83504947|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
83504948|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504949|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504950|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83504951|NCT00555425|Buprenorphine|buprenorphine|mesh-list
83504952|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83504953|NCT00555425|Naloxone|naloxone|mesh-list
83504954|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83504955|NCT00555425|Narcotics|narcotics|mesh-ancestor
83504956|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504957|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504958|NCT00555425|Analgesics|analgesics|mesh-ancestor
83504959|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
83504960|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504961|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83504962|NCT05444751|Anesthetics|anesthetics|mesh-list
83504963|NCT05444751|Anesthetics, General|anesthetics, general|mesh-list
83504964|NCT05444751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504965|NCT05444751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504966|NCT05444673|Cisplatin|cisplatin|mesh-list
83504967|NCT05444673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504968|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
83504969|NCT04338633|Calcium|calcium|mesh-list
83504970|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83504971|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504972|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83504973|NCT01488188|Vaccines|vaccines|mesh-list
83504974|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
83504975|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504976|NCT01489670|Bimatoprost|bimatoprost|mesh-list
83504977|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83504978|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83504979|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83504980|NCT01427504|Etravirine|etravirine|mesh-list
83504981|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83504982|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83504983|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504984|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504985|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
83504986|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504987|NCT03169361|Ixazomib|ixazomib|mesh-list
83504988|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504989|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
83504990|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504991|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505001|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505002|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83505003|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83505004|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
83505005|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
83505006|NCT03000257|Venetoclax|venetoclax|mesh-list
83505007|NCT03000257|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
83505008|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505009|NCT03000257|Immunoconjugates|immunoconjugates|mesh-ancestor
83505010|NCT03000257|Immunologic Factors|immunologic factors|mesh-ancestor
83505011|NCT03000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505012|NCT02945813|Metformin|metformin|mesh-list
83505013|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83505014|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505015|NCT05387811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83505016|NCT05387811|Diuretics|diuretics|mesh-list
83505017|NCT05387811|Natriuretic Agents|natriuretic agents|mesh-ancestor
83505018|NCT05387811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505019|NCT05442801|Tropicamide|tropicamide|mesh-list
83505020|NCT05442801|Cyclopentolate|cyclopentolate|mesh-list
83505021|NCT05442801|Mydriatics|mydriatics|mesh-ancestor
83505022|NCT05442801|Autonomic Agents|autonomic agents|mesh-ancestor
83505023|NCT05442801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505024|NCT05442801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505025|NCT05442801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83505026|NCT05442801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83505027|NCT05442801|Cholinergic Agents|cholinergic agents|mesh-ancestor
83505028|NCT05442801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505029|NCT05442801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505030|NCT05442801|Parasympatholytics|parasympatholytics|mesh-ancestor
83505031|NCT05339373|Aceclofenac|aceclofenac|mesh-list
83505032|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83505033|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83505034|NCT05339373|Analgesics|analgesics|mesh-ancestor
83505035|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
83505036|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505037|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505038|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83505039|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83505040|NCT05439993|Paclitaxel|paclitaxel|mesh-list
83505041|NCT05439993|Tepotinib|tepotinib|mesh-list
83505042|NCT05439993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83505043|NCT05439993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505044|NCT05439993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83505045|NCT05439993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83505046|NCT05439993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83505047|NCT05439993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505048|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83505049|NCT00554099|Mesalamine|mesalamine|mesh-list
83505050|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505051|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83505052|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83505053|NCT00554099|Analgesics|analgesics|mesh-ancestor
83505054|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
83505055|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505056|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505057|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83505058|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83505059|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
83505060|NCT04048161|Tacrolimus|tacrolimus|mesh-list
83505061|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83505062|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
83505063|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505064|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83505065|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505066|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505067|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83505068|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505069|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83505070|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
83505071|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83505072|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505073|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
83505074|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83505075|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83505076|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505085|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83505086|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505087|NCT00553319|Amphetamine|amphetamine|mesh-list
83505088|NCT00553319|Adderall|adderall|mesh-list
83505089|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83505090|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505091|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
83505092|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
83505093|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505094|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
83505095|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505096|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505097|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
83505098|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83505099|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83505100|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83505101|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83505102|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83505103|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83505104|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
83505105|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505106|NCT01868633|Dexamethasone|dexamethasone|mesh-list
83505107|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83505108|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
83505109|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
83505110|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505111|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505112|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83505113|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
83505114|NCT01868633|Hormones|hormones|mesh-ancestor
83505115|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83505116|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83505117|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505118|NCT04738773|Naltrexone|naltrexone|mesh-list
83505119|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83505120|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83505121|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505122|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
83505123|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505124|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
83505125|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83505126|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83505127|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83505128|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83505129|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505130|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
83505131|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505132|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505133|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83505134|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505135|NCT02676375|Bupropion|bupropion|mesh-list
83505136|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83505137|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
83505138|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83505139|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83505140|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83505141|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83505142|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505143|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
83505144|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505145|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505146|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83505147|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83505148|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505149|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
83505150|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
83505151|NCT01871441|Tacrolimus|tacrolimus|mesh-list
83505152|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83505153|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
83505154|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505155|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83505156|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83505164|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83505165|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
83505166|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83505167|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505168|NCT04338711|Tofacitinib|tofacitinib|mesh-list
83505169|NCT04338711|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83505170|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83505171|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505172|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505173|NCT01874951|Naltrexone|naltrexone|mesh-list
83505174|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83505175|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83505176|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505177|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
83505178|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505179|NCT04739241|Insulin|insulin|mesh-list
83505180|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83505181|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83505182|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505183|NCT03024437|Bevacizumab|bevacizumab|mesh-list
83505184|NCT03024437|Atezolizumab|atezolizumab|mesh-list
83505185|NCT03024437|Entinostat|entinostat|mesh-list
83505186|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83505187|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505188|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83505189|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83505190|NCT03024437|Growth Substances|growth substances|mesh-ancestor
83505191|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505192|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
83505193|NCT03024437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83505194|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505195|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83505196|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505197|NCT01489826|HU 211|hu 211|mesh-list
83505198|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83505199|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
83505200|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
83505201|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505202|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505203|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83505204|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83505205|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83505206|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505207|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505208|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83505209|NCT01489826|Protective Agents|protective agents|mesh-ancestor
83505210|NCT02677623|Mannitol|mannitol|mesh-list
83505211|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83505212|NCT02677623|Diuretics|diuretics|mesh-ancestor
83505213|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
83505214|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505215|NCT02677701|Azithromycin|azithromycin|mesh-list
83505216|NCT02677701|Tobramycin|tobramycin|mesh-list
83505217|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83505218|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505219|NCT01543178|Rifaximin|rifaximin|mesh-list
83505220|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83505221|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505222|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83505223|NCT01649856|Rituximab|rituximab|mesh-list
83505224|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83505225|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505226|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
83505227|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505228|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83505229|NCT01543568|Aflibercept|aflibercept|mesh-list
83505230|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83505231|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83505232|NCT01543568|Growth Substances|growth substances|mesh-ancestor
83505233|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505234|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
83505235|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505237|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505238|NCT02375724|Bromides|bromides|mesh-list
83505239|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
83505240|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83505241|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83505242|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
83505243|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505244|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505245|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83505246|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
83505247|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83505248|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83505249|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83505250|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
83505251|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505252|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505253|NCT02425098|Vaccines|vaccines|mesh-list
83505254|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
83505255|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505256|NCT02424630|Ropivacaine|ropivacaine|mesh-list
83505257|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
83505258|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
83505259|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83505260|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505261|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
83505262|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505263|NCT02397408|Choline|choline|mesh-list
83505264|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
83505265|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83505266|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
83505267|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505268|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83505269|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83505270|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
83505271|NCT02397096|Ritonavir|ritonavir|mesh-list
83505272|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83505273|NCT02397096|Tenofovir|tenofovir|mesh-list
83505274|NCT02397096|Lamivudine|lamivudine|mesh-list
83505275|NCT02397096|Cobicistat|cobicistat|mesh-list
83505276|NCT02397096|Elvitegravir|elvitegravir|mesh-list
83505277|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83505278|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
83505279|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83505280|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505281|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505282|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83505283|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83505284|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
83505285|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505286|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83505287|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83505288|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83505289|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83505290|NCT02396316|Aflibercept|aflibercept|mesh-list
83505291|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83505292|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83505293|NCT02396316|Growth Substances|growth substances|mesh-ancestor
83505294|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505295|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
83505296|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505297|NCT02682381|Teduglutide|teduglutide|mesh-list
83505298|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83505299|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83505300|NCT02682381|Protective Agents|protective agents|mesh-ancestor
83505301|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505302|NCT04915950|APD791|apd791|mesh-list
83505303|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83505304|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83505305|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
83505306|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505307|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505308|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505309|NCT04976595|Testosterone|testosterone|mesh-list
83505310|NCT04976595|Androgens|androgens|mesh-ancestor
83505311|NCT04976595|Hormones|hormones|mesh-ancestor
83505312|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83505313|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505314|NCT03033303|Isotretinoin|isotretinoin|mesh-list
83505315|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
83505316|NCT00367965|Eszopiclone|eszopiclone|mesh-list
83505349|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505350|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83505351|NCT02683707|Narcotics|narcotics|mesh-ancestor
83505352|NCT02683707|Analgesics|analgesics|mesh-ancestor
83505353|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83505354|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83505355|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
83505356|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83505357|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83505358|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83505359|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83505360|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
83505361|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
83505362|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505363|NCT02371980|Vortioxetine|vortioxetine|mesh-list
83505364|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
83505365|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83505366|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83505367|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83505368|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83505369|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505370|NCT02371980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83505371|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83505372|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83505373|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505374|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505375|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
83505376|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83505377|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83505378|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83505379|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83505380|NCT02867865|Gemcitabine|gemcitabine|mesh-list
83505381|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505382|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83505383|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
83505384|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505385|NCT02833233|Nivolumab|nivolumab|mesh-list
83505387|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83505388|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505389|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83505390|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505391|NCT05447949|Levobupivacaine|levobupivacaine|mesh-list
83505392|NCT05447949|Anesthetics, Local|anesthetics, local|mesh-ancestor
83505393|NCT05447949|Anesthetics|anesthetics|mesh-ancestor
83505394|NCT05447949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83505395|NCT05447949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505396|NCT05447949|Sensory System Agents|sensory system agents|mesh-ancestor
83505397|NCT05447949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505398|NCT05447871|Bupivacaine|bupivacaine|mesh-list
83505399|NCT05447871|Anesthetics, Local|anesthetics, local|mesh-ancestor
83505400|NCT05447871|Anesthetics|anesthetics|mesh-ancestor
83505401|NCT05447871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83505402|NCT05447871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505403|NCT05447871|Sensory System Agents|sensory system agents|mesh-ancestor
83505404|NCT05447871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505405|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
83505406|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83505407|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505408|NCT00914823|Hormones|hormones|mesh-list
83505409|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83505410|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505411|NCT04772235|Osimertinib|osimertinib|mesh-list
83505412|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505413|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83505414|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505415|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505416|NCT04766463|Morphine|morphine|mesh-list
83505417|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83505418|NCT04766463|Narcotics|narcotics|mesh-ancestor
83505419|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83505420|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505421|NCT04766463|Analgesics|analgesics|mesh-ancestor
83505422|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
83505652|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
83505423|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505424|NCT00823563|Adenosine|adenosine|mesh-list
83505425|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
83505426|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
83505427|NCT00823563|Analgesics|analgesics|mesh-ancestor
83505428|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
83505429|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505430|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505431|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83505432|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83505433|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
83505434|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
83505435|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505436|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505437|NCT05447169|Antibodies|antibodies|mesh-list
83505438|NCT05447169|Immunologic Factors|immunologic factors|mesh-ancestor
83505439|NCT05447169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505440|NCT04704453|Amitriptyline|amitriptyline|mesh-list
83505441|NCT04704453|Capsaicin|capsaicin|mesh-list
83505442|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
83505443|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
83505444|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
83505445|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505446|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505447|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83505448|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
83505449|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83505450|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83505451|NCT04704453|Analgesics|analgesics|mesh-ancestor
83505452|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83505453|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83505454|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83505455|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505456|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
83505457|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505458|NCT04652193|Anesthetics|anesthetics|mesh-list
83505459|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83505460|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505462|NCT05451147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83505463|NCT05451147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505464|NCT04553367|Meropenem|meropenem|mesh-list
83505465|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83505466|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505467|NCT00369837|Clevidipine|clevidipine|mesh-list
83505468|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83505469|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83505470|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505471|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83505472|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505473|NCT05449899|Cyclophosphamide|cyclophosphamide|mesh-list
83505474|NCT05449899|Busulfan|busulfan|mesh-list
83505475|NCT05449899|Fludarabine|fludarabine|mesh-list
83505476|NCT05449899|Decitabine|decitabine|mesh-list
83505477|NCT05449899|Lenograstim|lenograstim|mesh-list
83505478|NCT05449899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83505479|NCT05449899|Immunologic Factors|immunologic factors|mesh-ancestor
83505480|NCT05449899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505481|NCT05449899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83505482|NCT05449899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83505483|NCT05449899|Alkylating Agents|alkylating agents|mesh-ancestor
83505484|NCT05449899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505485|NCT05449899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505486|NCT05449899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83505487|NCT05449899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83505488|NCT05449899|Antimetabolites|antimetabolites|mesh-ancestor
83505489|NCT05449899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505490|NCT05449899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83505491|NCT05441631|Insulin|insulin|mesh-list
83505492|NCT05441631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83505493|NCT05441631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83505494|NCT05441631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505495|NCT01546454|Leuprolide|leuprolide|mesh-list
83505496|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83505497|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83505498|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
83505499|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83505500|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83505501|NCT01546454|Estradiol|estradiol|mesh-list
83505502|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83505503|NCT01546454|Progesterone|progesterone|mesh-list
83505504|NCT01546454|Estrogens|estrogens|mesh-ancestor
83505505|NCT01546454|Hormones|hormones|mesh-ancestor
83505506|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83505507|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505508|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83505509|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
83505510|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83505511|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83505512|NCT01546454|Progestins|progestins|mesh-ancestor
83505513|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83505514|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
83505515|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83505516|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505517|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83505518|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83505519|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83505520|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83505521|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
83505522|NCT00368901|Hematinics|hematinics|mesh-ancestor
83505523|NCT05430867|Memantine|memantine|mesh-list
83505524|NCT05430867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83505525|NCT05430867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83505526|NCT05430867|Dopamine Agents|dopamine agents|mesh-ancestor
83505527|NCT05430867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505528|NCT05430867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505529|NCT05430867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505530|NCT05430867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83505531|NCT05430867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83505532|NCT05448885|Cisplatin|cisplatin|mesh-list
83505533|NCT05448885|Gemcitabine|gemcitabine|mesh-list
83505534|NCT05448885|Tislelizumab|tislelizumab|mesh-list
83505535|NCT05448885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505536|NCT05448885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83505537|NCT05448885|Antimetabolites|antimetabolites|mesh-ancestor
83505538|NCT05448885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505539|NCT05448885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83505540|NCT01547000|Guanfacine|guanfacine|mesh-list
83505541|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83505542|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83505543|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83505544|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83505545|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
83505546|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505547|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505548|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505549|NCT02980016|Isoniazid|isoniazid|mesh-list
83505550|NCT02980016|Rifapentine|rifapentine|mesh-list
83505551|NCT02980016|Rifampin|rifampin|mesh-list
83505552|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
83505553|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83505554|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505555|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83505556|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83505557|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
83505558|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505559|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83505560|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83505561|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
83505562|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83505563|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505564|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83505565|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83505566|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83505567|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83505568|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83505569|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83505570|NCT01493180|Rebamipide|rebamipide|mesh-list
83505571|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83505572|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
83505573|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83505574|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83505575|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
83505576|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505577|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
83505578|NCT01493180|Protective Agents|protective agents|mesh-ancestor
83505579|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83505580|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83505581|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
83505582|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505583|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505584|NCT01431014|Dexamethasone|dexamethasone|mesh-list
83505585|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
83505586|NCT01431014|BB 1101|bb 1101|mesh-list
83505587|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83505588|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
83505589|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
83505590|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505591|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505592|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83505593|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
83505594|NCT01431014|Hormones|hormones|mesh-ancestor
83505595|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83505596|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83505597|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505598|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
83505599|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505600|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505601|NCT04375605|Leucovorin|leucovorin|mesh-list
83505602|NCT04375605|Docetaxel|docetaxel|mesh-list
83505603|NCT04375605|Fluorouracil|fluorouracil|mesh-list
83505604|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
83505605|NCT04375605|Calcium|calcium|mesh-list
83505606|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
83505607|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505608|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
83505609|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
83505610|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
83505611|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505612|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83505613|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505614|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
83505615|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83505616|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83505617|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
83505618|NCT04375605|Antidotes|antidotes|mesh-ancestor
83505619|NCT04375605|Protective Agents|protective agents|mesh-ancestor
83505620|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
83505621|NCT04375605|Vitamins|vitamins|mesh-ancestor
83505622|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
83505623|NCT01431170|Trimethoprim|trimethoprim|mesh-list
83505624|NCT01431170|Polymyxins|polymyxins|mesh-list
83505625|NCT01431170|Polymyxin B|polymyxin b|mesh-list
83505626|NCT01431170|Besifloxacin|besifloxacin|mesh-list
83505627|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
83505628|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83505629|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505630|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
83505631|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83505632|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83505633|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83505634|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505635|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505636|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83505637|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83505638|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83505639|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83505640|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83505641|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83505642|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505643|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83505644|NCT05448183|Gemcitabine|gemcitabine|mesh-list
83505645|NCT05448183|Oxaliplatin|oxaliplatin|mesh-list
83505646|NCT05448183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83505647|NCT05448183|Antimetabolites|antimetabolites|mesh-ancestor
83505648|NCT05448183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505649|NCT05448183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505650|NCT04732455|Lidocaine|lidocaine|mesh-list
83505651|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83505671|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83505672|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83505673|NCT04306965|Analgesics|analgesics|mesh-ancestor
83505674|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
83505675|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505676|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505677|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83505678|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83505679|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83505680|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83505681|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505682|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505683|NCT02371746|Travoprost|travoprost|mesh-list
83505684|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83505685|NCT01431794|Paclitaxel|paclitaxel|mesh-list
83505686|NCT01431794|Gemcitabine|gemcitabine|mesh-list
83505687|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83505688|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505689|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
83505690|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
83505691|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
83505692|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505693|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83505694|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
83505695|NCT01497860|Vinorelbine|vinorelbine|mesh-list
83505696|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83505697|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505698|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
83505699|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
83505700|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
83505701|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505702|NCT02213900|Haloperidol|haloperidol|mesh-list
83505703|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
83505704|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
83505705|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
83505706|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505707|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505708|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83505709|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83505710|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83505711|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83505712|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83505713|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83505714|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
83505715|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505716|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505717|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83505718|NCT02370888|Lenalidomide|lenalidomide|mesh-list
83505719|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
83505720|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505721|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83505722|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83505723|NCT02370888|Growth Substances|growth substances|mesh-ancestor
83505724|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
83505725|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505726|NCT05358873|Antibodies|antibodies|mesh-list
83505727|NCT05358873|Immunologic Factors|immunologic factors|mesh-ancestor
83505728|NCT05358873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505729|NCT02214290|Caffeine|caffeine|mesh-list
83505730|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83505731|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505732|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83505733|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505734|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505735|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83505736|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83505737|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
83505738|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505739|NCT03160911|Hemostatics|hemostatics|mesh-list
83505740|NCT03160911|Coagulants|coagulants|mesh-ancestor
83505741|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
83505742|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83505743|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505744|NCT04685499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83505891|NCT02421120|Ceftolozane|ceftolozane|mesh-list
83505745|NCT04685499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505746|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83505747|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
83505748|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505749|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83505750|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83505751|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505752|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505753|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505754|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83505755|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83505757|NCT00369603|Galantamine|galantamine|mesh-list
83505758|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83505759|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505760|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505761|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
83505762|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505763|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505764|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
83505765|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83505766|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
83505767|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505768|NCT04635189|Dexamethasone|dexamethasone|mesh-list
83505769|NCT04635189|Lenalidomide|lenalidomide|mesh-list
83505770|NCT04635189|Daratumumab|daratumumab|mesh-list
83505771|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83505772|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
83505773|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
83505774|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505775|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505776|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83505777|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
83505779|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83505780|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83505781|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505782|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
83505783|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83505784|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83505785|NCT04635189|Growth Substances|growth substances|mesh-ancestor
83505786|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
83505787|NCT01551056|Cetirizine|cetirizine|mesh-list
83505788|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83505789|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83505790|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83505791|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
83505792|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
83505793|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505794|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505795|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505796|NCT05227131|Capecitabine|capecitabine|mesh-list
83505797|NCT05227131|Tucatinib|tucatinib|mesh-list
83505798|NCT05227131|Margetuximab|margetuximab|mesh-list
83505799|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83505800|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
83505801|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505802|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505803|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83505804|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505805|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
83505806|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
83505807|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83505808|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83505809|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505810|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505811|NCT01499498|Urological Agents|urological agents|mesh-ancestor
83505812|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83505813|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83505814|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505815|NCT02421588|Doxorubicin|doxorubicin|mesh-list
83505816|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83505817|NCT02421588|Topotecan|topotecan|mesh-list
83505818|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83505819|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505820|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83505821|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83505822|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505823|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505824|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83505825|NCT02768727|Xenon|xenon|mesh-list
83505826|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83505827|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
83505828|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
83505829|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83505830|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505831|NCT02688309|Dexamethasone|dexamethasone|mesh-list
83505832|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83505833|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
83505834|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
83505835|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505836|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505837|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83505838|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
83505839|NCT02688309|Hormones|hormones|mesh-ancestor
83505840|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83505841|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83505842|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505843|NCT00370851|Bevacizumab|bevacizumab|mesh-list
83505844|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83505845|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505846|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83505847|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83505848|NCT00370851|Growth Substances|growth substances|mesh-ancestor
83505849|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505850|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
83505851|NCT05124171|Vaccines|vaccines|mesh-list
83505852|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
83505853|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505854|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
83505855|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83505856|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505857|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83505858|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83505859|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505860|NCT00371007|Incretins|incretins|mesh-ancestor
83505861|NCT00371007|Hormones|hormones|mesh-ancestor
83505862|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83505863|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83505864|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
83505865|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505866|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505867|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83505868|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83505869|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505870|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83505871|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505872|NCT00552617|Rocuronium|rocuronium|mesh-list
83505873|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
83505874|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83505875|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83505876|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83505877|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505878|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505879|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83505880|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83505881|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
83505882|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505883|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505884|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
83505885|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83505886|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83505887|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505888|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
83505889|NCT04387305|Coagulants|coagulants|mesh-ancestor
83505890|NCT02421120|Tazobactam|tazobactam|mesh-list
83505892|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83505893|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83505894|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505895|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83505896|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505897|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505898|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83505900|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83505901|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
83505902|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83505903|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83505904|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505905|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505906|NCT03022877|Protective Agents|protective agents|mesh-ancestor
83505907|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505908|NCT02420262|Insulin|insulin|mesh-list
83505909|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83505910|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
83505911|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
83505912|NCT02420262|Liraglutide|liraglutide|mesh-list
83505913|NCT02420262|Xultophy|xultophy|mesh-list
83505914|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83505915|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505916|NCT02420262|Incretins|incretins|mesh-ancestor
83505917|NCT02420262|Hormones|hormones|mesh-ancestor
83505918|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83505919|NCT00369993|Fluticasone|fluticasone|mesh-list
83505920|NCT00369993|Xhance|xhance|mesh-list
83505921|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83505922|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83505923|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83505924|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
83505925|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505926|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505927|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83505928|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
83505929|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
83505930|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83505931|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83505932|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83505933|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83505934|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
83505935|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505936|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505937|NCT00552305|Lacosamide|lacosamide|mesh-list
83505938|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
83505939|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83505940|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83505941|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83505942|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505943|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
83505944|NCT02278887|Fludarabine|fludarabine|mesh-list
83505945|NCT02278887|Ipilimumab|ipilimumab|mesh-list
83505946|NCT02278887|Interleukin-2|interleukin-2|mesh-list
83505947|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83505948|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
83505949|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505950|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83505951|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83505952|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
83505953|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505954|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505955|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83505956|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83505957|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83505958|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83505959|NCT02278887|Analgesics|analgesics|mesh-ancestor
83505960|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
83505961|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505962|NCT04168203|Apixaban|apixaban|mesh-list
83505963|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83505964|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
83505965|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83505966|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
83506045|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83506046|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83506047|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506048|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83506049|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83506050|NCT00370539|Growth Substances|growth substances|mesh-ancestor
83506051|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506052|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
83506053|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506054|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
83506055|NCT00370539|Hormones|hormones|mesh-ancestor
83506056|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506057|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83506058|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
83506059|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506060|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506061|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83506062|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
83506063|NCT03996057|Methenamine|methenamine|mesh-list
83506064|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
83506065|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
83506066|NCT03996057|Estrogens|estrogens|mesh-list
83506067|NCT03996057|Hormones|hormones|mesh-ancestor
83506068|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506069|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506070|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83506071|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506072|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83506073|NCT03150875|Docetaxel|docetaxel|mesh-list
83506074|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506075|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
83506076|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
83506077|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
83506078|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506079|NCT04900623|Paclitaxel|paclitaxel|mesh-list
83506080|NCT04900623|Cisplatin|cisplatin|mesh-list
83506081|NCT04900623|Carboplatin|carboplatin|mesh-list
83506082|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83506083|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506084|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
83506085|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
83506086|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
83506087|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506088|NCT00552071|Octreotide|octreotide|mesh-list
83506089|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83506090|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83506091|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506092|NCT00673335|Letrozole|letrozole|mesh-list
83506093|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506094|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83506095|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83506096|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506097|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506098|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83506099|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
83506100|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506101|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506102|NCT04880889|Pantothenic Acid|pantothenic acid|mesh-list
83506103|NCT04880889|Thiamine|thiamine|mesh-list
83506104|NCT04880889|Vitamin B Complex|vitamin b complex|mesh-ancestor
83506105|NCT04880889|Vitamins|vitamins|mesh-ancestor
83506106|NCT04880889|Micronutrients|micronutrients|mesh-ancestor
83506107|NCT04880889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506108|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
83506109|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83506110|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506111|NCT03833427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83506112|NCT03833427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506113|NCT00551759|Docetaxel|docetaxel|mesh-list
83506114|NCT00551759|Fluorouracil|fluorouracil|mesh-list
83506115|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
83506116|NCT00551759|Cetuximab|cetuximab|mesh-list
83506117|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506118|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
83506119|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
83506120|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
83506121|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506123|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83506124|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83506125|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
83506126|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506127|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83506128|NCT04849377|Cisplatin|cisplatin|mesh-list
83506129|NCT04849377|Carboplatin|carboplatin|mesh-list
83506130|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506131|NCT05511779|Brincidofovir|brincidofovir|mesh-list
83506132|NCT05511779|Antiviral Agents|antiviral agents|mesh-ancestor
83506133|NCT05511779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506134|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
83506135|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83506136|NCT00551525|Analgesics|analgesics|mesh-ancestor
83506137|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
83506138|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506139|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506140|NCT03716349|Anesthetics|anesthetics|mesh-list
83506141|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
83506142|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506143|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506144|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
83506145|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506146|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83506147|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
83506148|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506149|NCT05454345|Moxifloxacin|moxifloxacin|mesh-list
83506150|NCT05454345|Rifampin|rifampin|mesh-list
83506151|NCT05454345|Isoniazid|isoniazid|mesh-list
83506152|NCT05454345|Pyrazinamide|pyrazinamide|mesh-list
83506153|NCT05454345|Ethambutol|ethambutol|mesh-list
83506154|NCT05454345|Rifapentine|rifapentine|mesh-list
83506155|NCT05454345|Sitafloxacin|sitafloxacin|mesh-list
83506156|NCT05454345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83506157|NCT05454345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506158|NCT05454345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83506159|NCT05454345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83506160|NCT05454345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506161|NCT05454345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506162|NCT05454345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506163|NCT05454345|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83506164|NCT05454345|Antitubercular Agents|antitubercular agents|mesh-ancestor
83506165|NCT05454345|Leprostatic Agents|leprostatic agents|mesh-ancestor
83506166|NCT05454345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83506167|NCT05454345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83506168|NCT05454345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83506169|NCT05454345|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83506170|NCT05454345|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83506171|NCT05454345|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83506172|NCT05454345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83506173|NCT05454345|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83506174|NCT05454345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83506175|NCT05454345|Antimetabolites|antimetabolites|mesh-ancestor
83506176|NCT05454345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83506177|NCT04459611|Paclitaxel|paclitaxel|mesh-list
83506178|NCT04459611|Carboplatin|carboplatin|mesh-list
83506179|NCT04459611|Pemetrexed|pemetrexed|mesh-list
83506180|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83506181|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83506182|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506183|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
83506184|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
83506185|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
83506186|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506187|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506188|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83506189|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83506190|NCT00370617|Metformin|metformin|mesh-list
83506191|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83506192|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506193|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
83506194|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83506195|NCT01553708|Mitogens|mitogens|mesh-list
83506196|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
83506197|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506198|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83506199|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506200|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83506201|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83506202|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
83506203|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83506204|NCT02370498|Paclitaxel|paclitaxel|mesh-list
83506205|NCT02370498|Pembrolizumab|pembrolizumab|mesh-list
83506206|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83506207|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506208|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
83506209|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
83506210|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
83506211|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506212|NCT02370498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83506213|NCT02370498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83506214|NCT01554488|Fluticasone|fluticasone|mesh-list
83506215|NCT01554488|Xhance|xhance|mesh-list
83506216|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506217|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83506218|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
83506219|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506220|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506221|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83506222|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
83506223|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
83506224|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83506225|NCT02347332|Methotrexate|methotrexate|mesh-list
83506226|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83506227|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
83506228|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83506229|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506230|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83506231|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
83506232|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506233|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506234|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
83506235|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506236|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83506237|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83506238|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
83506239|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83506240|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83506241|NCT01502306|Nicotine|nicotine|mesh-list
83506242|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83506243|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
83506244|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506245|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506246|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83506247|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83506248|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
83506249|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506250|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506251|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83506252|NCT03325959|Analgesics|analgesics|mesh-ancestor
83506253|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
83506254|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506255|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506256|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83506257|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506258|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83506259|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83506260|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83506261|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506262|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
83506263|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
83506264|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83506265|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
83506266|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506267|NCT05451381|Dexmedetomidine|dexmedetomidine|mesh-list
83506268|NCT05451381|Propofol|propofol|mesh-list
83506269|NCT05451381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83506270|NCT05451381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506271|NCT05451381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506272|NCT05451381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83506274|NCT05451381|Sensory System Agents|sensory system agents|mesh-ancestor
83506275|NCT05451381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506276|NCT05451381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83506277|NCT05451381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83506278|NCT05451381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83506279|NCT05451381|Adrenergic Agents|adrenergic agents|mesh-ancestor
83506280|NCT05451381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506281|NCT05451381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506282|NCT05451381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83506283|NCT05451381|Anesthetics, General|anesthetics, general|mesh-ancestor
83506284|NCT05451381|Anesthetics|anesthetics|mesh-ancestor
83506285|NCT05450913|Lidocaine|lidocaine|mesh-list
83506286|NCT05450913|Anesthetics, Local|anesthetics, local|mesh-list
83506287|NCT05450913|Anesthetics|anesthetics|mesh-list
83506288|NCT05450913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506289|NCT05450913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506290|NCT05450913|Sensory System Agents|sensory system agents|mesh-ancestor
83506291|NCT05450913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506292|NCT05450913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83506293|NCT05450913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83506294|NCT05450913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83506295|NCT05450913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83506296|NCT05450913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506297|NCT05446779|Hydrocortisone|hydrocortisone|mesh-list
83506298|NCT05446779|Epinephrine|epinephrine|mesh-list
83506299|NCT05446779|Racepinephrine|racepinephrine|mesh-list
83506300|NCT05446779|Epinephryl borate|epinephryl borate|mesh-list
83506301|NCT05446779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506302|NCT05446779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83506303|NCT05446779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83506304|NCT05446779|Adrenergic Agents|adrenergic agents|mesh-ancestor
83506305|NCT05446779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506306|NCT05446779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506307|NCT05446779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506308|NCT05446779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83506309|NCT05446779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83506310|NCT05446779|Autonomic Agents|autonomic agents|mesh-ancestor
83506311|NCT05446779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506312|NCT05446779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83506313|NCT05446779|Respiratory System Agents|respiratory system agents|mesh-ancestor
83506314|NCT05446779|Mydriatics|mydriatics|mesh-ancestor
83506315|NCT05446779|Sympathomimetics|sympathomimetics|mesh-ancestor
83506316|NCT05446779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83506317|NCT02215070|Pasireotide|pasireotide|mesh-list
83506318|NCT02215070|Hormones|hormones|mesh-ancestor
83506319|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506320|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506321|NCT04000737|Sorafenib|sorafenib|mesh-list
83506322|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506323|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83506324|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506325|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506326|NCT02347098|Atorvastatin|atorvastatin|mesh-list
83506327|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83506328|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83506329|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83506330|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
83506331|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506332|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83506333|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506334|NCT03708237|Gabapentin|gabapentin|mesh-list
83506335|NCT03708237|Ropinirole|ropinirole|mesh-list
83506336|NCT03708237|Analgesics|analgesics|mesh-ancestor
83506337|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
83506338|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506339|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506340|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
83506341|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83506342|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83506343|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506351|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83506352|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
83506355|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83506356|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83506357|NCT01556594|Hormones|hormones|mesh-ancestor
83506358|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506359|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506360|NCT01556594|Incretins|incretins|mesh-ancestor
83506361|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
83506362|NCT00371319|Tacrolimus|tacrolimus|mesh-list
83506363|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83506364|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
83506365|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506366|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83506367|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506368|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506369|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83506370|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506371|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83506372|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
83506373|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83506374|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506375|NCT01439672|Insulin|insulin|mesh-list
83506376|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83506377|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506378|NCT03465111|Hormones|hormones|mesh-list
83506379|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83506380|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83506381|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
83506382|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506383|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506384|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506385|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506386|NCT01440764|Furosemide|furosemide|mesh-list
83506387|NCT01440764|Diuretics|diuretics|mesh-ancestor
83506388|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
83506389|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506390|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83506391|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83506392|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506393|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
83506394|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83506395|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506396|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506397|NCT05283837|Pertuzumab|pertuzumab|mesh-list
83506398|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83506399|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506400|NCT02209610|Fentanyl|fentanyl|mesh-list
83506401|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83506402|NCT02209610|Narcotics|narcotics|mesh-ancestor
83506403|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506404|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506405|NCT02209610|Analgesics|analgesics|mesh-ancestor
83506406|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
83506407|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506408|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83506409|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83506410|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
83506411|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
83506412|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83506413|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83506414|NCT05244993|Paclitaxel|paclitaxel|mesh-list
83506415|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83506416|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506417|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83506418|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83506419|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83506420|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506421|NCT03289299|Dexamethasone|dexamethasone|mesh-list
83506422|NCT03289299|Lenalidomide|lenalidomide|mesh-list
83506423|NCT03289299|Daratumumab|daratumumab|mesh-list
83506424|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506425|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
83506443|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83506444|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506445|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506446|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506447|NCT01558700|Analgesics|analgesics|mesh-ancestor
83506448|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
83506449|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506450|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
83506451|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83506452|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
83506453|NCT02757105|Ondansetron|ondansetron|mesh-list
83506454|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
83506455|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
83506456|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506457|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506458|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83506459|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
83506460|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
83506461|NCT02757105|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83506462|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83506463|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
83506464|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506465|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506466|NCT05083845|Anesthetics|anesthetics|mesh-list
83506467|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
83506468|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506469|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506470|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
83506471|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506472|NCT00371553|Sunitinib|sunitinib|mesh-list
83506473|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506474|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83506475|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83506476|NCT00371553|Growth Substances|growth substances|mesh-ancestor
83506477|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506478|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
83506479|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83506480|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506481|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506482|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
83506483|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83506484|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506485|NCT02892201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83506486|NCT02892201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506487|NCT01507220|Morphine|morphine|mesh-list
83506488|NCT01507220|Bupivacaine|bupivacaine|mesh-list
83506489|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
83506490|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
83506491|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506492|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506493|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
83506494|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506495|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83506496|NCT01507220|Narcotics|narcotics|mesh-ancestor
83506497|NCT01507220|Analgesics|analgesics|mesh-ancestor
83506498|NCT01509404|Valganciclovir|valganciclovir|mesh-list
83506499|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
83506500|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506501|NCT01562132|Fluconazole|fluconazole|mesh-list
83506502|NCT01562132|Flucytosine|flucytosine|mesh-list
83506503|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
83506504|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506505|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83506506|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83506507|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506508|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506509|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83506510|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
83506511|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506512|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506513|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83506514|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83506515|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
83506528|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83506529|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506530|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
83506531|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
83506532|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
83506533|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506534|NCT01509638|Bupivacaine|bupivacaine|mesh-list
83506535|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
83506536|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
83506537|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506538|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506539|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
83506540|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506541|NCT04336917|Lidocaine|lidocaine|mesh-list
83506542|NCT04336917|Bupivacaine|bupivacaine|mesh-list
83506543|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
83506544|NCT04336917|Anesthetics|anesthetics|mesh-list
83506545|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506546|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506547|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
83506548|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506549|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83506550|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83506551|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83506552|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83506553|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506554|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
83506555|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83506556|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83506557|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
83506558|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506559|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83506560|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83506561|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506562|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506563|NCT01562678|Liraglutide|liraglutide|mesh-list
83506564|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83506565|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506566|NCT01562678|Incretins|incretins|mesh-ancestor
83506567|NCT01562678|Hormones|hormones|mesh-ancestor
83506568|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506569|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
83506570|NCT02767869|Antacids|antacids|mesh-ancestor
83506571|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506572|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83506573|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83506574|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
83506575|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
83506576|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506577|NCT02767947|Luliconazole|luliconazole|mesh-list
83506578|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
83506579|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506580|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83506581|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83506582|NCT02770365|Estradiol|estradiol|mesh-list
83506583|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83506584|NCT02770365|Estrogens|estrogens|mesh-ancestor
83506585|NCT02770365|Hormones|hormones|mesh-ancestor
83506586|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506587|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506588|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83506589|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
83506590|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83506591|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83506592|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
83506593|NCT02770521|Treprostinil|treprostinil|mesh-list
83506594|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83506595|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506596|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83506597|NCT02346240|Etanercept|etanercept|mesh-list
83506598|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
83506599|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83506600|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83506601|NCT02346240|Analgesics|analgesics|mesh-ancestor
83506602|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
83506603|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506604|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506605|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506606|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83506607|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83506608|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83506609|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
83506610|NCT02346240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83506611|NCT01511978|Amifampridine|amifampridine|mesh-list
83506612|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83506613|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506614|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506615|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83506616|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83506617|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506618|NCT02772783|Insulin|insulin|mesh-list
83506619|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83506620|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83506621|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506622|NCT02774343|Pioglitazone|pioglitazone|mesh-list
83506623|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83506624|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506625|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83506626|NCT05349045|Antibodies|antibodies|mesh-list
83506627|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
83506628|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506629|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83506630|NCT05349045|Growth Substances|growth substances|mesh-ancestor
83506631|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
83506632|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506633|NCT02392104|Warfarin|warfarin|mesh-list
83506634|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
83506635|NCT04336605|Analgesics|analgesics|mesh-list
83506636|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
83506637|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506638|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506639|NCT01450826|Ondansetron|ondansetron|mesh-list
83506640|NCT01450826|Aprepitant|aprepitant|mesh-list
83506641|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
83506642|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
83506643|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506644|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506645|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83506646|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
83506647|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
83506648|NCT01450826|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83506649|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83506650|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
83506651|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506652|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506653|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83506654|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83506655|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
83506656|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506657|NCT05349903|Protective Agents|protective agents|mesh-ancestor
83506658|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506659|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83506660|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83506661|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506662|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83506663|NCT05349825|Losartan|losartan|mesh-list
83506664|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83506665|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83506666|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83506667|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83506668|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506669|NCT01451996|Loratadine|loratadine|mesh-list
83506670|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
83506671|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
83506672|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83506673|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83506674|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83506675|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
83506676|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
83506677|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506678|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506679|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506681|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83506682|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506683|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
83506684|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
83506685|NCT04334967|Vitamins|vitamins|mesh-ancestor
83506686|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
83506687|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506688|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
83506689|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83506690|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83506691|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506692|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506693|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506694|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83506695|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
83506696|NCT04334967|Protective Agents|protective agents|mesh-ancestor
83506697|NCT04335123|Losartan|losartan|mesh-list
83506698|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83506699|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83506700|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83506701|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83506702|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506703|NCT05453565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83506704|NCT02742987|Clopidogrel|clopidogrel|mesh-list
83506705|NCT02742987|Ticagrelor|ticagrelor|mesh-list
83506706|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83506707|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83506708|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83506709|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83506710|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
83506711|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506712|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506713|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506714|NCT05450055|Lidocaine|lidocaine|mesh-list
83506715|NCT05450055|Analgesics|analgesics|mesh-list
83506716|NCT05450055|Anesthetics, Local|anesthetics, local|mesh-ancestor
83506717|NCT05450055|Anesthetics|anesthetics|mesh-ancestor
83506718|NCT05450055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506719|NCT05450055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506720|NCT05450055|Sensory System Agents|sensory system agents|mesh-ancestor
83506721|NCT05450055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506722|NCT05450055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83506723|NCT05450055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83506725|NCT05450055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83506726|NCT05450055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506727|NCT02743377|Rolipram|rolipram|mesh-list
83506728|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
83506729|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83506730|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83506731|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83506732|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506733|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506734|NCT05437965|Glucocorticoids|glucocorticoids|mesh-list
83506735|NCT05437965|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83506736|NCT05437965|Hormones|hormones|mesh-ancestor
83506737|NCT05437965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506738|NCT05437965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506739|NCT05437965|Immunologic Factors|immunologic factors|mesh-ancestor
83506740|NCT00372099|Calcitonin|calcitonin|mesh-list
83506741|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
83506742|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83506743|NCT00372099|Katacalcin|katacalcin|mesh-list
83506744|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83506745|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506746|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83506747|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
83506748|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
83506749|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83506750|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83506764|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506765|NCT05013255|Pioglitazone|pioglitazone|mesh-list
83506766|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83506767|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506768|NCT01461668|Retapamulin|retapamulin|mesh-list
83506769|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83506770|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506771|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
83506772|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
83506773|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506774|NCT05177991|Bupivacaine|bupivacaine|mesh-list
83506775|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
83506776|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
83506777|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506778|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506779|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
83506780|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506781|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83506782|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
83506783|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83506784|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83506785|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83506786|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
83506787|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83506788|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506789|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83506790|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83506791|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83506792|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83506793|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506794|NCT04080843|Capecitabine|capecitabine|mesh-list
83506795|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
83506796|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83506797|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
83506798|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506799|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506800|NCT04737837|Lacosamide|lacosamide|mesh-list
83506801|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
83506802|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83506803|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83506804|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83506805|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506806|NCT04826133|Calcitriol|calcitriol|mesh-list
83506807|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83506808|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83506809|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506810|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83506811|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83506812|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506813|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83506814|NCT04826133|Vitamins|vitamins|mesh-ancestor
83506815|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
83506816|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83506817|NCT05456763|Butyric Acid|butyric acid|mesh-list
83506818|NCT05456763|Histamine Antagonists|histamine antagonists|mesh-ancestor
83506819|NCT05456763|Histamine Agents|histamine agents|mesh-ancestor
83506820|NCT05456763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506821|NCT05456763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506822|NCT05456763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506823|NCT05456061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83506824|NCT05456061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83506825|NCT02369874|Durvalumab|durvalumab|mesh-list
83506826|NCT02369874|Tremelimumab|tremelimumab|mesh-list
83506827|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83506828|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83506829|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506830|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
83506831|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506832|NCT00372645|Folic Acid|folic acid|mesh-list
83506833|NCT00372645|Hematinics|hematinics|mesh-ancestor
83506834|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
83506835|NCT00372645|Vitamins|vitamins|mesh-ancestor
83506836|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
83506837|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506838|NCT00372723|Infliximab|infliximab|mesh-list
83506839|NCT00372723|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83506840|NCT00372723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506841|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
83506842|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83506843|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83506844|NCT00372801|Ibuprofen|ibuprofen|mesh-list
83506845|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83506846|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83506847|NCT00372801|Analgesics|analgesics|mesh-ancestor
83506848|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
83506849|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506850|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506851|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506852|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83506853|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83506854|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506855|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506856|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83506857|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506858|NCT05455359|Famotidine|famotidine|mesh-list
83506859|NCT05455359|Prucalopride|prucalopride|mesh-list
83506860|NCT05455359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83506861|NCT05455359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83506862|NCT05455359|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83506863|NCT05455359|Histamine Antagonists|histamine antagonists|mesh-ancestor
83506864|NCT05455359|Histamine Agents|histamine agents|mesh-ancestor
83506865|NCT05455359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506866|NCT05455359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506867|NCT05455359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506868|NCT05455359|Laxatives|laxatives|mesh-ancestor
83506869|NCT05455359|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83506870|NCT05455359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83506871|NCT05455359|Serotonin Agents|serotonin agents|mesh-ancestor
83506872|NCT00373503|Lofexidine|lofexidine|mesh-list
83506873|NCT00373503|Dronabinol|dronabinol|mesh-list
83506874|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
83506875|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506876|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83506877|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83506878|NCT00373503|Analgesics|analgesics|mesh-ancestor
83506879|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
83506880|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506881|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83506882|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83506883|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506884|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506885|NCT00373503|Hormones|hormones|mesh-ancestor
83506886|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506887|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83506888|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83506889|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83506890|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83506891|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83506892|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
83506893|NCT02633397|Riociguat|riociguat|mesh-list
83506894|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
83506895|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506896|NCT01515176|Ofatumumab|ofatumumab|mesh-list
83506897|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83506898|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506899|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
83506900|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506901|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83506902|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83506903|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
83506904|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506905|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83506906|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83506907|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
83506908|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
83506909|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506910|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506911|NCT01515566|Fentanyl|fentanyl|mesh-list
83506912|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83506913|NCT01515566|Narcotics|narcotics|mesh-ancestor
83506914|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506915|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506916|NCT01515566|Analgesics|analgesics|mesh-ancestor
83506917|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
83506918|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506919|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83506920|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83506921|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
83506922|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
83506923|NCT02522715|Prednisone|prednisone|mesh-list
83506924|NCT02522715|Cortisone|cortisone|mesh-list
83506925|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506926|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
83506927|NCT02522715|Hormones|hormones|mesh-ancestor
83506928|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506929|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506930|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83506931|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506932|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
83506933|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
83506934|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506935|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
83506936|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506937|NCT01516268|Sufentanil|sufentanil|mesh-list
83506938|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83506939|NCT01516268|Narcotics|narcotics|mesh-ancestor
83506940|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506941|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506942|NCT01516268|Analgesics|analgesics|mesh-ancestor
83506943|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
83506944|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506945|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83506946|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83506947|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
83506948|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
83506949|NCT05440968|Chrysarobin|chrysarobin|mesh-list
83506950|NCT05440968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83506951|NCT05440968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83506952|NCT05440968|Analgesics|analgesics|mesh-ancestor
83506953|NCT05440968|Sensory System Agents|sensory system agents|mesh-ancestor
83506954|NCT05440968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506955|NCT05440968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506956|NCT05440968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506957|NCT05440968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83506958|NCT01516424|Risperidone|risperidone|mesh-list
83506959|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83506960|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
83506961|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506962|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506963|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506964|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83506965|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83506966|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506967|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83506968|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83506969|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
83506971|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
83506972|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
83506973|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83506974|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83506975|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506976|NCT01463384|Minocycline|minocycline|mesh-list
83506977|NCT01463384|Tetracycline|tetracycline|mesh-list
83506978|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83506979|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506980|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83506981|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506982|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506983|NCT02785185|Clobetasol|clobetasol|mesh-list
83506984|NCT02785185|Halobetasol|halobetasol|mesh-list
83506985|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83506986|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506987|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
83506988|NCT02785185|Hormones|hormones|mesh-ancestor
83506989|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506990|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507019|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507020|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83507022|NCT05062317|Bevacizumab|bevacizumab|mesh-list
83507023|NCT05062317|Fluorouracil|fluorouracil|mesh-list
83507024|NCT05062317|Capecitabine|capecitabine|mesh-list
83507026|NCT05062317|Irinotecan|irinotecan|mesh-list
83507027|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83507028|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507029|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83507030|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83507031|NCT05062317|Growth Substances|growth substances|mesh-ancestor
83507032|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507033|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
83507034|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
83507035|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507036|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83507037|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83507038|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
83507039|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83507040|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83507041|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507042|NCT05062317|Antidotes|antidotes|mesh-ancestor
83507043|NCT05062317|Protective Agents|protective agents|mesh-ancestor
83507044|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
83507045|NCT05062317|Vitamins|vitamins|mesh-ancestor
83507046|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
83507047|NCT01469234|Loratadine|loratadine|mesh-list
83507048|NCT01469234|Fexofenadine|fexofenadine|mesh-list
83507049|NCT01469234|Terfenadine|terfenadine|mesh-list
83507050|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
83507051|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
83507052|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83507053|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83507054|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83507055|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
83507056|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
83507057|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507058|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507059|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507060|NCT05045937|Vitamin D|vitamin d|mesh-list
83507061|NCT05045937|Vitamins|vitamins|mesh-list
83507062|NCT05045937|Ivermectin|ivermectin|mesh-list
83507063|NCT05045937|Remdesivir|remdesivir|mesh-list
83507064|NCT05045937|Ibuprofen|ibuprofen|mesh-list
83507065|NCT05045937|Budesonide|budesonide|mesh-list
83507066|NCT05045937|Melatonin|melatonin|mesh-list
83507067|NCT05045937|Albuterol|albuterol|mesh-list
83507068|NCT05045937|Quercetin|quercetin|mesh-list
83507069|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507070|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
83507071|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83507072|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83507073|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83507074|NCT05045937|Analgesics|analgesics|mesh-ancestor
83507075|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
83507076|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507077|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507078|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83507079|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507080|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83507081|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507082|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83507083|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
83507084|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83507085|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
83507086|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
83507087|NCT05045937|Hormones|hormones|mesh-ancestor
83507088|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83507089|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
83507090|NCT05045937|Protective Agents|protective agents|mesh-ancestor
83507091|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507092|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
83507093|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83507094|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83507095|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83507096|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83507097|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
83507098|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507100|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507101|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
83507102|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
83507104|NCT00373581|Vigabatrin|vigabatrin|mesh-list
83507105|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
83507106|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
83507107|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507108|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507109|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
83507110|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507111|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83507112|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83507113|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83507114|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83507115|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507116|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
83507117|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507118|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
83507119|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507120|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
83507121|NCT01470170|Alfentanil|alfentanil|mesh-list
83507122|NCT01470170|Propofol|propofol|mesh-list
83507123|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83507124|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507125|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507126|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83507127|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
83507128|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
83507129|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83507130|NCT01470170|Narcotics|narcotics|mesh-ancestor
83507131|NCT01470170|Analgesics|analgesics|mesh-ancestor
83507132|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
83507133|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507134|NCT04311567|Methotrexate|methotrexate|mesh-list
83507135|NCT04311567|Tofacitinib|tofacitinib|mesh-list
83507136|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83507137|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
83507138|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83507139|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507140|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83507141|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
83507142|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507143|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507144|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
83507145|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507146|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83507147|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83507148|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
83507149|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83507150|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83507151|NCT04311567|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83507152|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83507153|NCT04259775|Insulin|insulin|mesh-list
83507154|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83507155|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507156|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83507157|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507158|NCT05037825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83507159|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507160|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
83507161|NCT01573052|Gabapentin|gabapentin|mesh-list
83507162|NCT01573052|Analgesics|analgesics|mesh-ancestor
83507163|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
83507164|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507165|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507166|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
83507167|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83507168|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83507169|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507170|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83507171|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83507172|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83507173|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507174|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507175|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
83507176|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83507177|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83507178|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
83507179|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
83507180|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
83507181|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83507182|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507183|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
83507184|NCT01523834|Panobinostat|panobinostat|mesh-list
83507185|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507186|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83507187|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507188|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507189|NCT01472432|Vildagliptin|vildagliptin|mesh-list
83507190|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83507191|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507192|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83507193|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
83507194|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507195|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507196|NCT01524302|Levofloxacin|levofloxacin|mesh-list
83507197|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83507198|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83507199|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507200|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83507201|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83507202|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83507203|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507204|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507205|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507206|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83507207|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83507209|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83507210|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
83507211|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507212|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507213|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83507214|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
83507215|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
83507216|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83507217|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83507218|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83507219|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83507220|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
83507221|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507222|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507223|NCT01576874|Oxytocin|oxytocin|mesh-list
83507224|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
83507225|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83507226|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507227|NCT01576952|Bromfenac|bromfenac|mesh-list
83507228|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83507229|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83507230|NCT01576952|Analgesics|analgesics|mesh-ancestor
83507231|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
83507232|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507233|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507234|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507235|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83507236|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
83507237|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507238|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83507239|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83507240|NCT01577966|Analgesics|analgesics|mesh-ancestor
83507241|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
83507242|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507243|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507244|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507245|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83507246|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83507247|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83507249|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83507250|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507251|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507252|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
83507253|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507254|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83507255|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83507256|NCT02802501|Piperaquine|piperaquine|mesh-list
83507257|NCT02802501|Primaquine|primaquine|mesh-list
83507258|NCT02802501|Artenimol|artenimol|mesh-list
83507259|NCT02802501|Tafenoquine|tafenoquine|mesh-list
83507260|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
83507261|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83507262|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83507263|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507264|NCT01528592|Levodopa|levodopa|mesh-list
83507265|NCT01528592|Carbidopa|carbidopa|mesh-list
83507266|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83507267|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83507268|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83507269|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
83507270|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507271|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507272|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507273|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83507274|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507275|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83507276|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
83507277|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
83507278|NCT01578278|Fluticasone|fluticasone|mesh-list
83507279|NCT01578278|Xhance|xhance|mesh-list
83507280|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
83507281|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507282|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83507283|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
83507284|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507285|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507286|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83507287|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
83507288|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
83507289|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83507290|NCT02803749|Buspirone|buspirone|mesh-list
83507291|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83507292|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83507293|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507294|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507295|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83507296|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83507297|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
83507298|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507299|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507300|NCT01578980|Pancrelipase|pancrelipase|mesh-list
83507301|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83507302|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83507303|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507304|NCT00372879|Vitamin E|vitamin e|mesh-list
83507305|NCT00372879|Vitamins|vitamins|mesh-ancestor
83507306|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
83507307|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507308|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
83507309|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507310|NCT00372879|Protective Agents|protective agents|mesh-ancestor
83507311|NCT02806869|Ibuprofen|ibuprofen|mesh-list
83507312|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83507313|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83507314|NCT02806869|Analgesics|analgesics|mesh-ancestor
83507315|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
83507316|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507317|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507318|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507319|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83507320|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83507321|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507322|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507323|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
83507324|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83507325|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83507326|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507327|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
83507328|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507329|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507330|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83507331|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83507332|NCT05564858|Antibodies|antibodies|mesh-list
83507333|NCT05564858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83507334|NCT05564858|Immunoconjugates|immunoconjugates|mesh-list
83507335|NCT05564858|Immunologic Factors|immunologic factors|mesh-ancestor
83507336|NCT05564858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507337|NCT02814279|Dipyrone|dipyrone|mesh-list
83507338|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
83507339|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83507340|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507341|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
83507342|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83507343|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83507344|NCT02814279|Analgesics|analgesics|mesh-ancestor
83507345|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
83507346|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507347|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507348|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507349|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83507350|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
83507351|NCT00373659|Ranibizumab|ranibizumab|mesh-list
83507352|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83507353|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83507354|NCT00373659|Growth Substances|growth substances|mesh-ancestor
83507355|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507356|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
83507357|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507358|NCT02885025|Fluticasone|fluticasone|mesh-list
83507359|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507360|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83507361|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
83507362|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507363|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507364|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83507365|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
83507366|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
83507367|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83507368|NCT01580618|Tenecteplase|tenecteplase|mesh-list
83507369|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83507370|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83507371|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507372|NCT01581710|Montelukast|montelukast|mesh-list
83507373|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83507374|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
83507375|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83507376|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
83507377|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83507378|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507379|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83507380|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83507381|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507382|NCT01582490|Bupivacaine|bupivacaine|mesh-list
83507383|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
83507384|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
83507385|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507386|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507387|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
83507388|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507389|NCT01582880|Riboflavin|riboflavin|mesh-list
83507390|NCT01582880|Vitamins|vitamins|mesh-ancestor
83507391|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
83507392|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507393|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
83507394|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83507395|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
83507396|NCT02889393|Teduglutide|teduglutide|mesh-list
83507397|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83507398|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83507420|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83507422|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
83507423|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507424|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507425|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507426|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83507427|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83507428|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83507429|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507430|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83507431|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83507432|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507433|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
83507434|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83507435|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83507436|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83507437|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
83507438|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507439|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83507440|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
83507441|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83507442|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
83507443|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
83507444|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83507445|NCT03581409|Protective Agents|protective agents|mesh-ancestor
83507446|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83507447|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83507448|NCT03566667|Metoprolol|metoprolol|mesh-list
83507449|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83507450|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83507451|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
83507452|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
83507453|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507454|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507455|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83507456|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83507457|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83507458|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
83507459|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507460|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507461|NCT01533116|Levodopa|levodopa|mesh-list
83507462|NCT01533116|Carbidopa|carbidopa|mesh-list
83507463|NCT01533116|Opicapone|opicapone|mesh-list
83507464|NCT01533116|Benserazide|benserazide|mesh-list
83507465|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83507466|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83507467|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
83507468|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507469|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507470|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507471|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83507472|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507473|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83507474|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
83507475|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
83507476|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83507477|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
83507478|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507479|NCT03510741|Expectorants|expectorants|mesh-ancestor
83507480|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
83507481|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83507482|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
83507483|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507484|NCT03510741|Protective Agents|protective agents|mesh-ancestor
83507485|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507486|NCT03510741|Antidotes|antidotes|mesh-ancestor
83507487|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
83507488|NCT05556044|Empagliflozin|empagliflozin|mesh-list
83507489|NCT05556044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83507490|NCT05556044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507491|NCT05556044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83507492|NCT05556044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507494|NCT03207945|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83507495|NCT03207945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83507496|NCT03207945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83507497|NCT03207945|Antimetabolites|antimetabolites|mesh-ancestor
83507498|NCT03207945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507499|NCT03207945|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83507500|NCT03207945|Protease Inhibitors|protease inhibitors|mesh-ancestor
83507501|NCT03207945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507502|NCT03207945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83507503|NCT01584518|Furosemide|furosemide|mesh-list
83507504|NCT01584518|Diuretics|diuretics|mesh-ancestor
83507505|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
83507506|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507507|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83507508|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83507509|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507510|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
83507511|NCT02901249|Sertraline|sertraline|mesh-list
83507512|NCT02901249|Nortriptyline|nortriptyline|mesh-list
83507513|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
83507514|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83507515|NCT02901249|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83507516|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83507517|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83507518|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507519|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507520|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
83507521|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507522|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507523|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
83507524|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83507525|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507526|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83507527|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83507528|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
83507529|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83507530|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83507531|NCT00373815|Everolimus|everolimus|mesh-list
83507532|NCT00373815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83507533|NCT00373815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83507534|NCT00373815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507535|NCT00373815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507536|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83507537|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
83507538|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507539|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507540|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
83507541|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83507542|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
83507543|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507544|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
83507545|NCT01586312|Protective Agents|protective agents|mesh-ancestor
83507546|NCT00373893|Lidocaine|lidocaine|mesh-list
83507547|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
83507548|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
83507549|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507550|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507551|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
83507552|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507553|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83507554|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83507555|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83507556|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83507557|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507558|NCT02977299|Aripiprazole|aripiprazole|mesh-list
83507559|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83507560|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
83507561|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83507562|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83507563|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83507564|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507565|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507566|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
83507567|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
83507568|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507569|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507570|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83507571|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83507572|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
83507573|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83507574|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83507575|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83507576|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83507577|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83507578|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83507579|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83507580|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83507581|NCT02212106|Vaccines|vaccines|mesh-list
83507582|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
83507583|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507584|NCT02903121|Tamoxifen|tamoxifen|mesh-list
83507585|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83507586|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
83507587|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83507588|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507589|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83507590|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507591|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83507592|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83507593|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83507594|NCT02638701|Infliximab|infliximab|mesh-list
83507595|NCT02638701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83507596|NCT02638701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507597|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
83507598|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83507599|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83507600|NCT02904915|Lidocaine|lidocaine|mesh-list
83507601|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
83507602|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
83507603|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507604|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507605|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
83507606|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507607|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83507608|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83507609|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83507610|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83507611|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507612|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83507613|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83507614|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507615|NCT01535924|Gemcitabine|gemcitabine|mesh-list
83507616|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83507617|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83507618|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
83507619|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507620|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507621|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83507622|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
83507623|NCT02909439|Neostigmine|neostigmine|mesh-list
83507624|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83507625|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507626|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507627|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
83507628|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507629|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507630|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83507631|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
83507632|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507633|NCT01536938|Calcitriol|calcitriol|mesh-list
83507634|NCT01536938|Betamethasone|betamethasone|mesh-list
83507635|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
83507636|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83507637|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
83507638|NCT01536938|Calcipotriene|calcipotriene|mesh-list
83507639|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83507640|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507641|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
83507642|NCT01536938|Hormones|hormones|mesh-ancestor
83507643|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83507644|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507645|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83507646|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
83507647|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
83507648|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83507649|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83507650|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83507651|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507652|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83507653|NCT01536938|Vitamins|vitamins|mesh-ancestor
83507654|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
83507655|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83507656|NCT01588418|Exenatide|exenatide|mesh-list
83507657|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83507658|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507659|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83507660|NCT01588418|Incretins|incretins|mesh-ancestor
83507661|NCT01588418|Hormones|hormones|mesh-ancestor
83507662|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83507663|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
83507664|NCT03007160|Diuretics|diuretics|mesh-ancestor
83507665|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
83507666|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507667|NCT03007160|Expectorants|expectorants|mesh-ancestor
83507668|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
83507669|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83507670|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
83507671|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83507672|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83507673|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83507674|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83507675|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507676|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
83507677|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507678|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507679|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83507680|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507681|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83507682|NCT02914119|Rocuronium|rocuronium|mesh-list
83507683|NCT02914119|Mivacurium|mivacurium|mesh-list
83507684|NCT02914119|Cisatracurium|cisatracurium|mesh-list
83507685|NCT02914119|Succinylcholine|succinylcholine|mesh-list
83507686|NCT02914119|Neostigmine|neostigmine|mesh-list
83507687|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83507688|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83507689|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83507690|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507691|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507692|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83507693|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507694|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507695|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
83507696|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507697|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83507698|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
83507699|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83507700|NCT01589510|Bimatoprost|bimatoprost|mesh-list
83507701|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83507702|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83507703|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83507704|NCT02914509|Travoprost|travoprost|mesh-list
83507705|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83507706|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
83507707|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83507708|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83507709|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507710|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
83507711|NCT02840097|Coagulants|coagulants|mesh-ancestor
83507712|NCT02841033|Daratumumab|daratumumab|mesh-list
83507713|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507714|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83507715|NCT02988089|Amoxicillin|amoxicillin|mesh-list
83507732|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83507733|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83507734|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83507735|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83507736|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507737|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83507739|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83507740|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83507741|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83507742|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83507743|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
83507744|NCT02430233|Progesterone|progesterone|mesh-list
83507745|NCT02430233|Progestins|progestins|mesh-ancestor
83507746|NCT02430233|Hormones|hormones|mesh-ancestor
83507747|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83507748|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507749|NCT01589978|Aspirin|aspirin|mesh-list
83507750|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
83507751|NCT01589978|Salicylates|salicylates|mesh-list
83507752|NCT01589978|Ticlopidine|ticlopidine|mesh-list
83507753|NCT01589978|Clopidogrel|clopidogrel|mesh-list
83507754|NCT01589978|Ticagrelor|ticagrelor|mesh-list
83507755|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83507756|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83507757|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83507758|NCT01589978|Analgesics|analgesics|mesh-ancestor
83507759|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
83507760|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507761|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507762|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507763|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83507764|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83507765|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83507766|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507767|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83507768|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83507769|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507770|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
83507771|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83507772|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83507773|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83507774|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
83507775|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507776|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507777|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
83507778|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
83507779|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
83507780|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83507781|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83507782|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
83507783|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83507784|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507785|NCT01592006|Ribavirin|ribavirin|mesh-list
83507786|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83507787|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
83507788|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507789|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
83507790|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507791|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
83507792|NCT00551291|Prednisone|prednisone|mesh-list
83507793|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
83507794|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507795|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
83507796|NCT00551291|Hormones|hormones|mesh-ancestor
83507797|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83507798|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507799|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83507800|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507801|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83507802|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83507803|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
83507804|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83507805|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507806|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507807|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507808|NCT00551291|Hematinics|hematinics|mesh-ancestor
83507809|NCT02981264|Lidocaine|lidocaine|mesh-list
83507810|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
83507811|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
83507812|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507813|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507814|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
83507815|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507816|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83507817|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83507818|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83507819|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83507820|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507821|NCT05470985|Ozanimod|ozanimod|mesh-list
83507822|NCT05470985|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83507823|NCT05470985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507824|NCT05470985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83507825|NCT05470985|Immunologic Factors|immunologic factors|mesh-ancestor
83507826|NCT05470985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507827|NCT01593722|Ivermectin|ivermectin|mesh-list
83507828|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
83507829|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83507830|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507831|NCT01593722|Filaricides|filaricides|mesh-ancestor
83507832|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
83507833|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
83507834|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83507835|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507836|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507837|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
83507838|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83507839|NCT01594424|Antibodies|antibodies|mesh-list
83507840|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
83507841|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83507842|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
83507843|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507844|NCT01595282|Ibuprofen|ibuprofen|mesh-list
83507845|NCT01595282|Ketorolac|ketorolac|mesh-list
83507846|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83507847|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83507849|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
83507850|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507851|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507852|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507853|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83507854|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83507855|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507856|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507857|NCT01595516|Metoprolol|metoprolol|mesh-list
83507858|NCT01595516|Nebivolol|nebivolol|mesh-list
83507859|NCT01595516|Bradykinin|bradykinin|mesh-list
83507860|NCT01595516|Kininogens|kininogens|mesh-list
83507861|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507862|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507863|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83507864|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83507865|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
83507866|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
83507867|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507868|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83507869|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83507870|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83507871|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
83507872|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507873|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
83507874|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83507875|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83507876|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83507877|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83507878|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
83507879|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507880|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
83507881|NCT01596842|Vitamin D|vitamin d|mesh-list
83507882|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83507883|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507884|NCT01596842|Vitamins|vitamins|mesh-ancestor
83507885|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
83507886|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83507887|NCT02217800|Octreotide|octreotide|mesh-list
83507888|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83507889|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83507890|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507891|NCT02218190|Alvimopan|alvimopan|mesh-list
83507892|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83507893|NCT03006614|Cisplatin|cisplatin|mesh-list
83507894|NCT03006614|Gemcitabine|gemcitabine|mesh-list
83507895|NCT03006614|Docetaxel|docetaxel|mesh-list
83507896|NCT03006614|Capecitabine|capecitabine|mesh-list
83507897|NCT03006614|Trastuzumab|trastuzumab|mesh-list
83507898|NCT03006614|Vinorelbine|vinorelbine|mesh-list
83507899|NCT03006614|Epirubicin|epirubicin|mesh-list
83507900|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507901|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83507902|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
83507903|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507904|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
83507905|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
83507906|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
83507907|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83507908|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83507909|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83507910|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83507911|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83507912|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507913|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83507914|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83507915|NCT03006380|Oxytocin|oxytocin|mesh-list
83507916|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
83507917|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83507918|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507919|NCT02981030|Misoprostol|misoprostol|mesh-list
83507920|NCT02981030|Mifepristone|mifepristone|mesh-list
83507921|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83507922|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
83507923|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83507924|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507925|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83507926|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83507927|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
83507928|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83507929|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83507930|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83507931|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83507932|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
83507933|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83507934|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83507935|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
83507936|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83507937|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
83507938|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83507939|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83507940|NCT03006146|Molgramostim|molgramostim|mesh-list
83507941|NCT03006146|Sargramostim|sargramostim|mesh-list
83507942|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
83507943|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507944|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507945|NCT00551213|Capecitabine|capecitabine|mesh-list
83507946|NCT00551213|Irinotecan|irinotecan|mesh-list
83507947|NCT00551213|Cetuximab|cetuximab|mesh-list
83507948|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83507949|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
83507950|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507951|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507952|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83507953|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83507954|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507955|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83507956|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
83507957|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83507958|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507959|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83507960|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
83507961|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83507962|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507963|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507964|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507966|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83507967|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507968|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83507969|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507970|NCT01684397|Bevacizumab|bevacizumab|mesh-list
83507971|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83507972|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
83507973|NCT01684397|Antibodies|antibodies|mesh-list
83507974|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
83507975|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83507976|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
83507977|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507978|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83507979|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83507980|NCT01684397|Growth Substances|growth substances|mesh-ancestor
83507981|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507982|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
83507983|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
83507984|NCT03005678|Denosumab|denosumab|mesh-list
83507985|NCT03005678|Alendronate|alendronate|mesh-list
83507986|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83507987|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507988|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
83507989|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83507990|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
83507991|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507992|NCT03008889|Expectorants|expectorants|mesh-ancestor
83507993|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
83507994|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83507995|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
83507996|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507997|NCT03008889|Protective Agents|protective agents|mesh-ancestor
83507998|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507999|NCT03008889|Antidotes|antidotes|mesh-ancestor
83508000|NCT04980482|Interferons|interferons|mesh-list
83508001|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
83508002|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
83508003|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83508004|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508005|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
83508006|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508007|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
83508008|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508009|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83508010|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
83508011|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508012|NCT03000218|Metformin|metformin|mesh-list
83508013|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83508014|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83508015|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508016|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83508017|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83508018|NCT03010683|Metformin|metformin|mesh-list
83508019|NCT03010683|Liraglutide|liraglutide|mesh-list
83508020|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83508021|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508022|NCT03010683|Incretins|incretins|mesh-ancestor
83508023|NCT03010683|Hormones|hormones|mesh-ancestor
83508024|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508025|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
83508026|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83508027|NCT02918097|Risperidone|risperidone|mesh-list
83508028|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
83508029|NCT02918097|Sertraline|sertraline|mesh-list
83508030|NCT02918097|Nortriptyline|nortriptyline|mesh-list
83508031|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83508032|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
83508033|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508034|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508035|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508036|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83508044|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83508045|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83508046|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508047|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
83508048|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83508049|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83508050|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
83508052|NCT05408585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508053|NCT05408585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508054|NCT02999204|Vitamin D|vitamin d|mesh-list
83508055|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
83508056|NCT02999204|Vitamins|vitamins|mesh-ancestor
83508057|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
83508058|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508059|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83508060|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83508061|NCT03012477|Adavosertib|adavosertib|mesh-list
83508062|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508063|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508064|NCT02919111|Edetic Acid|edetic acid|mesh-list
83508065|NCT02919111|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83508066|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
83508067|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
83508068|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508069|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
83508070|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83508071|NCT02919111|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83508072|NCT02999126|Remifentanil|remifentanil|mesh-list
83508073|NCT02999126|Propofol|propofol|mesh-list
83508074|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83508075|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508076|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508077|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83508078|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
83508079|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
83508080|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83508081|NCT02999126|Narcotics|narcotics|mesh-ancestor
83508082|NCT02999126|Analgesics|analgesics|mesh-ancestor
83508083|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
83508084|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508085|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
83508086|NCT03019887|Haloperidol|haloperidol|mesh-list
83508087|NCT03019887|Olanzapine|olanzapine|mesh-list
83508088|NCT03019887|Risperidone|risperidone|mesh-list
83508089|NCT03019887|Aripiprazole|aripiprazole|mesh-list
83508090|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83508091|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83508092|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
83508093|NCT03019887|Perphenazine|perphenazine|mesh-list
83508094|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83508095|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
83508096|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508097|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508098|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508099|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83508100|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83508101|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508102|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83508103|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83508104|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
83508105|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
83508106|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
83508107|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508108|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83508109|NCT03019887|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83508110|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83508111|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83508112|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
83508113|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
83508114|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83508115|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83508116|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83508117|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83508118|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83508119|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83508131|NCT05406752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508132|NCT05406752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508133|NCT05406752|Antipyretics|antipyretics|mesh-ancestor
83508134|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
83508135|NCT02247362|Vaccines|vaccines|mesh-list
83508136|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
83508137|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508138|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
83508139|NCT02247362|Coagulants|coagulants|mesh-ancestor
83508140|NCT02920749|Anesthetics|anesthetics|mesh-list
83508141|NCT02920749|Propofol|propofol|mesh-list
83508142|NCT02920749|Sevoflurane|sevoflurane|mesh-list
83508143|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508144|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508145|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83508146|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83508147|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
83508148|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83508149|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83508150|NCT02248142|Pramipexole|pramipexole|mesh-list
83508151|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
83508152|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508153|NCT02248142|Protective Agents|protective agents|mesh-ancestor
83508154|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508155|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83508156|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83508157|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
83508158|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
83508159|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508160|NCT04667780|Colchicine|colchicine|mesh-list
83508161|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
83508162|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83508163|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
83508164|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
83508165|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
83508166|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508167|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508168|NCT02248220|Pramipexole|pramipexole|mesh-list
83508169|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
83508170|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508171|NCT02248220|Protective Agents|protective agents|mesh-ancestor
83508172|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508173|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83508174|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83508175|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
83508176|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
83508177|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508178|NCT02921061|Cytarabine|cytarabine|mesh-list
83508179|NCT02921061|Decitabine|decitabine|mesh-list
83508180|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83508181|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
83508182|NCT02921061|Cladribine|cladribine|mesh-list
83508183|NCT02921061|Lenograstim|lenograstim|mesh-list
83508184|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83508185|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
83508186|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508187|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508188|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
83508189|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508190|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83508191|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
83508192|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508193|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83508194|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508195|NCT02921061|Analgesics|analgesics|mesh-ancestor
83508196|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
83508197|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508198|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83508199|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83508200|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83508201|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83508202|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83508203|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83508204|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83508205|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
83508206|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83508207|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508208|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
83508209|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
83508210|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508211|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
83508212|NCT04523480|Testosterone|testosterone|mesh-list
83508213|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
83508214|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
83508215|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83508216|NCT04523480|Androgens|androgens|mesh-ancestor
83508218|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508219|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508220|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83508221|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508222|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
83508223|NCT05200442|Cetuximab|cetuximab|mesh-list
83508224|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83508225|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508226|NCT02859441|Ranibizumab|ranibizumab|mesh-list
83508227|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83508228|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83508229|NCT02859441|Growth Substances|growth substances|mesh-ancestor
83508230|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508231|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
83508232|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508233|NCT01880099|Galantamine|galantamine|mesh-list
83508234|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
83508235|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508236|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508237|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
83508238|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508239|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508240|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83508241|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
83508242|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508243|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
83508244|NCT05183204|Metformin|metformin|mesh-list
83508245|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83508246|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508247|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
83508248|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83508249|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
83508250|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
83508251|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508252|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508253|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83508254|NCT02860845|Clindamycin|clindamycin|mesh-list
83508255|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
83508256|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
83508257|NCT02860845|Clotrimazole|clotrimazole|mesh-list
83508258|NCT02860845|Miconazole|miconazole|mesh-list
83508259|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
83508260|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508261|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83508262|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508263|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508264|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83508265|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83508266|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83508267|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83508268|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
83508269|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508270|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508271|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83508272|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83508273|NCT03003884|Propofol|propofol|mesh-list
83508274|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83508275|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508276|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508277|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83508278|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
83508279|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
83508280|NCT01880723|Albuterol|albuterol|mesh-list
83508281|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83508282|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
83508283|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508284|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508285|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83508286|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
83508287|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
83508288|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83508289|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83508290|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83508291|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83508292|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
83508293|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508294|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508296|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83508297|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508298|NCT04466618|Heparin|heparin|mesh-list
83508299|NCT04466618|Calcium heparin|calcium heparin|mesh-list
83508300|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83508301|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
83508302|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83508303|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83508304|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508305|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83508306|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83508308|NCT01881113|Cetirizine|cetirizine|mesh-list
83508309|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83508310|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83508311|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83508312|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
83508313|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
83508314|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508315|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508316|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508317|NCT05140694|Empagliflozin|empagliflozin|mesh-list
83508318|NCT05140694|Dulaglutide|dulaglutide|mesh-list
83508319|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
83508320|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83508321|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508322|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83508323|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508324|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
83508325|NCT02987699|Leucovorin|leucovorin|mesh-list
83508326|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
83508327|NCT02987699|Fluorouracil|fluorouracil|mesh-list
83508328|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
83508329|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508330|NCT02987699|Antidotes|antidotes|mesh-ancestor
83508331|NCT02987699|Protective Agents|protective agents|mesh-ancestor
83508332|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508333|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
83508334|NCT02987699|Vitamins|vitamins|mesh-ancestor
83508335|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
83508336|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
83508337|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508338|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83508339|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83508340|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
83508341|NCT03003728|Melphalan|melphalan|mesh-list
83508342|NCT03003728|Elotuzumab|elotuzumab|mesh-list
83508343|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83508344|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
83508345|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508346|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508347|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83508348|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83508349|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
83508350|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508351|NCT05672810|Fibrin fragment D|fibrin fragment d|mesh-list
83508352|NCT05672810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83508353|NCT05672810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83508354|NCT05672810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508355|NCT05672810|Hemostatics|hemostatics|mesh-ancestor
83508356|NCT05672810|Coagulants|coagulants|mesh-ancestor
83508357|NCT00559247|Asunaprevir|asunaprevir|mesh-list
83508358|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
83508359|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508512|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83508360|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508361|NCT03003416|Dexamethasone|dexamethasone|mesh-list
83508362|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83508363|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
83508364|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
83508365|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508366|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508367|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83508368|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
83508369|NCT03003416|Hormones|hormones|mesh-ancestor
83508370|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508371|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83508372|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508373|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
83508374|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
83508375|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83508376|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
83508377|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508378|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508379|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83508380|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
83508381|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83508382|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83508383|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83508384|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
83508385|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508386|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508387|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
83508388|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83508389|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
83508390|NCT03028467|Folic Acid|folic acid|mesh-list
83508391|NCT03028467|Methotrexate|methotrexate|mesh-list
83508392|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83508393|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
83508394|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83508395|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508396|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83508397|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
83508398|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508399|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508400|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
83508401|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508402|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83508403|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83508404|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
83508405|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83508406|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83508407|NCT03028467|Hematinics|hematinics|mesh-ancestor
83508408|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
83508409|NCT03028467|Vitamins|vitamins|mesh-ancestor
83508410|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
83508411|NCT04327310|Meplazumab|meplazumab|mesh-list
83508412|NCT04327310|Antiviral Agents|antiviral agents|mesh-ancestor
83508413|NCT04327310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508414|NCT02222870|Vaccines|vaccines|mesh-list
83508415|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
83508416|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508417|NCT02223260|Dabigatran|dabigatran|mesh-list
83508418|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
83508419|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83508420|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
83508421|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508422|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508423|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
83508424|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
83508425|NCT02863263|Povidone|povidone|mesh-list
83508426|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
83508427|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
83508428|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83508429|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508430|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
83508431|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83508432|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508433|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83508434|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83508435|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508736|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
83508436|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508437|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508438|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83508439|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83508440|NCT01887587|Dexamethasone|dexamethasone|mesh-list
83508441|NCT01887587|Doxorubicin|doxorubicin|mesh-list
83508442|NCT01887587|Vincristine|vincristine|mesh-list
83508443|NCT01887587|Ixazomib|ixazomib|mesh-list
83508444|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83508445|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
83508446|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
83508447|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508448|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508449|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83508450|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
83508451|NCT01887587|Hormones|hormones|mesh-ancestor
83508452|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508453|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83508454|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508455|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83508456|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83508457|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83508458|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508459|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508460|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83508461|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
83508462|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
83508463|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
83508464|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
83508465|NCT03029091|Losartan|losartan|mesh-list
83508466|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83508467|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83508468|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83508469|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83508470|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508471|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
83508472|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508473|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
83508474|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
83508475|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
83508476|NCT00374205|Artesunate|artesunate|mesh-list
83508477|NCT00374205|Lumefantrine|lumefantrine|mesh-list
83508478|NCT00374205|Artemether|artemether|mesh-list
83508479|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83508480|NCT00374205|Amodiaquine|amodiaquine|mesh-list
83508481|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
83508482|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83508483|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83508484|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508485|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508486|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
83508487|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
83508488|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83508489|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
83508490|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
83508491|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83508492|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83508493|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83508494|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83508495|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508496|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
83508497|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508498|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508499|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83508500|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508501|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
83508502|NCT03029715|Remifentanil|remifentanil|mesh-list
83508503|NCT03029715|Propofol|propofol|mesh-list
83508504|NCT03029715|Desflurane|desflurane|mesh-list
83508505|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83508506|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508507|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508508|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83508509|NCT03029715|Analgesics|analgesics|mesh-ancestor
83508510|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
83508511|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508513|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83508514|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83508515|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
83508516|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508517|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508518|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83508519|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
83508520|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
83508521|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83508522|NCT03029715|Narcotics|narcotics|mesh-ancestor
83508523|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83508524|NCT00555035|Dolutegravir|dolutegravir|mesh-list
83508525|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83508526|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83508527|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508528|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508529|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83508530|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83508531|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
83508532|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508533|NCT03035955|Azelaic acid|azelaic acid|mesh-list
83508534|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508535|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
83508536|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
83508537|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83508538|NCT02927223|Atropine|atropine|mesh-list
83508539|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83508540|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83508541|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83508542|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
83508543|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508544|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508545|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83508546|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
83508547|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
83508548|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
83508549|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83508550|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83508551|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
83508552|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508553|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508554|NCT03002792|Anesthetics|anesthetics|mesh-list
83508555|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508556|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508557|NCT02927457|GSK2646264|gsk2646264|mesh-list
83508558|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83508559|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508560|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508561|NCT01891331|Fluconazole|fluconazole|mesh-list
83508562|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
83508563|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508564|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83508565|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83508566|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508567|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508568|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83508569|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
83508570|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508571|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508572|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83508573|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83508574|NCT02247518|Tadalafil|tadalafil|mesh-list
83508575|NCT02247518|Tamsulosin|tamsulosin|mesh-list
83508576|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
83508577|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83508578|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83508579|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508580|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508581|NCT02247518|Urological Agents|urological agents|mesh-ancestor
83508582|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83508583|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83508584|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83508585|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
83508586|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508587|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508588|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
83508589|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83508590|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83508591|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508592|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
83508593|NCT02867163|Coagulants|coagulants|mesh-ancestor
83508594|NCT04067609|Dexamethasone|dexamethasone|mesh-list
83508595|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83508596|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
83508597|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
83508598|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508599|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508600|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83508601|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
83508602|NCT04067609|Hormones|hormones|mesh-ancestor
83508603|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508604|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83508605|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508606|NCT03022097|Bromides|bromides|mesh-list
83508607|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
83508608|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83508609|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
83508610|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508611|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508612|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83508613|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
83508614|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83508615|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83508616|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83508617|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
83508618|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508619|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508620|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
83508621|NCT03002636|Anesthetics|anesthetics|mesh-list
83508622|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508623|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508624|NCT03039543|Rocuronium|rocuronium|mesh-list
83508625|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83508626|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83508627|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83508628|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508629|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508630|NCT04047875|Norethindrone|norethindrone|mesh-list
83508631|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
83508632|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83508633|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83508634|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83508635|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
83508636|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83508637|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508638|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83508639|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83508640|NCT03002090|Iron|iron|mesh-list
83508641|NCT03002090|Trace Elements|trace elements|mesh-ancestor
83508642|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
83508643|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508644|NCT02328755|Methotrexate|methotrexate|mesh-list
83508645|NCT02328755|Tacrolimus|tacrolimus|mesh-list
83508646|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83508647|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
83508648|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83508649|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508650|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83508651|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
83508652|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508653|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508654|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
83508655|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508656|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83508657|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83508658|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
83508659|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83508660|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83508737|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
83508661|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83508662|NCT02870283|Carbamazepine|carbamazepine|mesh-list
83508663|NCT02870283|Valproic Acid|valproic acid|mesh-list
83508664|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83508665|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508666|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508667|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
83508668|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83508669|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508670|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508671|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
83508672|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
83508673|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508674|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83508675|NCT02870283|Analgesics|analgesics|mesh-ancestor
83508676|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
83508677|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508678|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83508679|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83508680|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83508681|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83508682|NCT02931045|Clopidogrel|clopidogrel|mesh-list
83508683|NCT02931045|Ticagrelor|ticagrelor|mesh-list
83508684|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83508685|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83508686|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83508687|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83508688|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
83508689|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508690|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508691|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508692|NCT03040011|Dexamethasone|dexamethasone|mesh-list
83508693|NCT03040011|Bupivacaine|bupivacaine|mesh-list
83508694|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83508695|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
83508696|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
83508697|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508698|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508699|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83508700|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
83508701|NCT03040011|Hormones|hormones|mesh-ancestor
83508702|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508703|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83508704|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508705|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
83508706|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
83508707|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508708|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
83508709|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
83508710|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508711|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
83508712|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508713|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508714|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83508715|NCT03040479|Lasmiditan|lasmiditan|mesh-list
83508716|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83508717|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
83508718|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508719|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508720|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508721|NCT02872857|Galantamine|galantamine|mesh-list
83508722|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83508723|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508724|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508725|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
83508726|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83508727|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508728|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83508729|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
83508730|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508731|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
83508732|NCT02996318|Sirolimus|sirolimus|mesh-list
83508733|NCT02996318|Paclitaxel|paclitaxel|mesh-list
83508734|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83508735|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508746|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508748|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83508749|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
83508750|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508751|NCT05197751|Antacids|antacids|mesh-ancestor
83508752|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508753|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83508754|NCT02994602|ST 1435|st 1435|mesh-list
83508755|NCT02994602|Testosterone|testosterone|mesh-list
83508756|NCT02994602|Androgens|androgens|mesh-ancestor
83508758|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508759|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508760|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83508761|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
83508762|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83508763|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83508764|NCT03297710|Trifluridine|trifluridine|mesh-list
83508765|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
83508766|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508767|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
83508768|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508769|NCT04350671|Interferons|interferons|mesh-list
83508770|NCT04350671|Ritonavir|ritonavir|mesh-list
83508771|NCT04350671|Lopinavir|lopinavir|mesh-list
83508772|NCT04350671|Interferon-beta|interferon-beta|mesh-list
83508773|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
83508774|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
83508775|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508776|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
83508777|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508778|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83508779|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83508780|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
83508781|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508782|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508783|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83508784|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83508785|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83508786|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83508787|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
83508788|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83508789|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83508790|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83508791|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
83508792|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508793|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83508794|NCT04850846|Metformin|metformin|mesh-list
83508795|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83508796|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508797|NCT05166083|Testosterone|testosterone|mesh-list
83508798|NCT05166083|Androgens|androgens|mesh-ancestor
83508799|NCT05166083|Hormones|hormones|mesh-ancestor
83508800|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508801|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508802|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83508803|NCT04826354|Ezetimibe|ezetimibe|mesh-list
83508804|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83508805|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83508806|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
83508807|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508808|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83508809|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83508810|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508811|NCT04707794|Sevoflurane|sevoflurane|mesh-list
83508812|NCT04707794|Desflurane|desflurane|mesh-list
83508813|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83508814|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83508815|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
83508816|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
83508817|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508818|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508819|NCT04667312|Durvalumab|durvalumab|mesh-list
83508820|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83508821|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508822|NCT02759588|Bevacizumab|bevacizumab|mesh-list
83508823|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83508824|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508825|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83508826|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83508827|NCT02759588|Growth Substances|growth substances|mesh-ancestor
83508828|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508829|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
83508831|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
83508832|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83508834|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
83508835|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508836|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83508837|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83508838|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508839|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508840|NCT02249078|Quetmolimab|quetmolimab|mesh-list
83508841|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83508842|NCT02697344|Acetic Acid|acetic acid|mesh-list
83508843|NCT02697344|Dexamethasone|dexamethasone|mesh-list
83508844|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
83508845|NCT02697344|Lenalidomide|lenalidomide|mesh-list
83508846|NCT02697344|Retinol acetate|retinol acetate|mesh-list
83508847|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
83508848|NCT02697344|Gossypol|gossypol|mesh-list
83508849|NCT02697344|BB 1101|bb 1101|mesh-list
83508850|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83508851|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
83508852|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
83508853|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508854|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508855|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83508856|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
83508857|NCT02697344|Hormones|hormones|mesh-ancestor
83508858|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508859|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83508860|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508861|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
83508862|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83508863|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83508864|NCT02697344|Growth Substances|growth substances|mesh-ancestor
83508865|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
83508866|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
83508867|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508868|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508869|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83508870|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508871|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83508872|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83508873|NCT02697344|Protective Agents|protective agents|mesh-ancestor
83508874|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83508875|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
83508876|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83508877|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83508878|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83508879|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83508880|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83508881|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
83508882|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83508883|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
83508884|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83508885|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83508886|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508887|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83508888|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508889|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83508890|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508891|NCT01907321|Capsaicin|capsaicin|mesh-list
83508892|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
83508893|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
83508894|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
83508895|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508896|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508897|NCT02219516|Verinurad|verinurad|mesh-list
83508898|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
83508899|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83508955|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508956|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83508957|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
83508958|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
83508959|NCT02143466|Durvalumab|durvalumab|mesh-list
83508960|NCT02143466|Osimertinib|osimertinib|mesh-list
83508961|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83508962|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83508963|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508964|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
83508965|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508966|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83508967|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508968|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508969|NCT03050619|Empagliflozin|empagliflozin|mesh-list
83508970|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83508971|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508972|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83508973|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508975|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83508976|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
83508977|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
83508978|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508979|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508980|NCT01911065|Vaccines|vaccines|mesh-list
83508981|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
83508982|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508983|NCT02995772|Tamoxifen|tamoxifen|mesh-list
83508984|NCT02995772|Fluorouracil|fluorouracil|mesh-list
83508985|NCT02995772|Letrozole|letrozole|mesh-list
83508986|NCT02995772|Anastrozole|anastrozole|mesh-list
83508987|NCT02995772|Exemestane|exemestane|mesh-list
83508988|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83508989|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
83508990|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508991|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83508992|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508993|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83508994|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
83508995|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508996|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508997|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83508998|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83508999|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
83509000|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83509001|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83509002|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83509003|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83509004|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83509005|NCT02987465|Norepinephrine|norepinephrine|mesh-list
83509006|NCT02987465|Acetylcholine|acetylcholine|mesh-list
83509007|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
83509008|NCT02987465|Hematinics|hematinics|mesh-ancestor
83509009|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83509010|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83509011|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
83509012|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509013|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509014|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509015|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
83509016|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
83509017|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509018|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83509019|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
83509020|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83509021|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
83509022|NCT04895579|Durvalumab|durvalumab|mesh-list
83509023|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83509024|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509025|NCT02227316|Acetaminophen|acetaminophen|mesh-list
83509026|NCT02227316|Ibuprofen|ibuprofen|mesh-list
83509027|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83509028|NCT02227316|Analgesics|analgesics|mesh-ancestor
83509029|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
83509030|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509181|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
83509031|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509032|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
83509033|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83509034|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509035|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509036|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83509037|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509038|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509039|NCT00555971|Omalizumab|omalizumab|mesh-list
83509040|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83509041|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83509042|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
83509043|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
83509044|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
83509045|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
83509046|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509047|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509048|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83509049|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83509050|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83509051|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509052|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83509053|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83509054|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
83509055|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509056|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509057|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
83509058|NCT01850108|Sirolimus|sirolimus|mesh-list
83509059|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
83509060|NCT01850108|Fludarabine|fludarabine|mesh-list
83509061|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
83509062|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83509063|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
83509064|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509065|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509066|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83509067|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
83509068|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509069|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509070|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83509071|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83509072|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83509073|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
83509074|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83509075|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509076|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509077|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
83509078|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
83509079|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
83509080|NCT01822652|Fludarabine|fludarabine|mesh-list
83509081|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
83509082|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83509083|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
83509084|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509085|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509086|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83509087|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
83509088|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509089|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509090|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83509091|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83509092|NCT01822652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83509093|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83509094|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
83509095|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83509096|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83509097|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509098|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509099|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83509100|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83509101|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509102|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
83509103|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509104|NCT01338740|Adalimumab|adalimumab|mesh-list
83509105|NCT01338740|Infliximab|infliximab|mesh-list
83509106|NCT01338740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83509107|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509108|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509109|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
83509110|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83509112|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509113|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
83509114|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83509115|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83509116|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83509117|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509118|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509119|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
83509120|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83509121|NCT05376722|Prednisone|prednisone|mesh-list
83509122|NCT05376722|Pamiparib|pamiparib|mesh-list
83509123|NCT05376722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509124|NCT05376722|Glucocorticoids|glucocorticoids|mesh-ancestor
83509125|NCT05376722|Hormones|hormones|mesh-ancestor
83509126|NCT05376722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83509127|NCT05376722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509128|NCT05376722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83509129|NCT05376722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509130|NCT05376722|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83509131|NCT05376722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509132|NCT05376722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509133|NCT04737057|Fluorides|fluorides|mesh-list
83509134|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
83509135|NCT04737057|Protective Agents|protective agents|mesh-ancestor
83509136|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509137|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83509138|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83509139|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83509141|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
83509142|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509143|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509144|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509145|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509146|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83509147|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509148|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509149|NCT02946489|Ketamine|ketamine|mesh-list
83509150|NCT02946489|Analgesics|analgesics|mesh-ancestor
83509151|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
83509152|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509153|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509154|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83509155|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83509156|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
83509157|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
83509158|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509159|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83509160|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83509161|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509162|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509163|NCT02949921|Lidocaine|lidocaine|mesh-list
83509164|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
83509165|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
83509166|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509167|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509168|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
83509169|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509170|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83509171|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83509172|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83509173|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83509174|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509175|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83509176|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
83509177|NCT02227706|Coagulants|coagulants|mesh-ancestor
83509178|NCT03112863|Vitamin A|vitamin a|mesh-list
83509179|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
83509180|NCT03112863|Vitamins|vitamins|mesh-ancestor
83509182|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509184|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509185|NCT03112863|Protective Agents|protective agents|mesh-ancestor
83509186|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83509187|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509188|NCT02950467|Psilocybin|psilocybin|mesh-list
83509189|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83509190|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
83509191|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509192|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83509193|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83509194|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
83509195|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509196|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509197|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83509198|NCT01930487|Antioxidants|antioxidants|mesh-list
83509199|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509200|NCT01930487|Protective Agents|protective agents|mesh-ancestor
83509201|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509202|NCT03864068|Inositol|inositol|mesh-list
83509203|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
83509204|NCT03864068|Vitamins|vitamins|mesh-ancestor
83509205|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
83509206|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509207|NCT03063255|Anesthetics|anesthetics|mesh-list
83509208|NCT03063255|Mepivacaine|mepivacaine|mesh-list
83509209|NCT03063255|Rocuronium|rocuronium|mesh-list
83509210|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509211|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509212|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83509213|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83509215|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509216|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
83509217|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
83509218|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83509219|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83509220|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509221|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83509222|NCT05245292|Antibodies|antibodies|mesh-list
83509223|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
83509224|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83509225|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
83509226|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
83509227|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509228|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509229|NCT03115827|Carbidopa|carbidopa|mesh-list
83509230|NCT03115827|Droxidopa|droxidopa|mesh-list
83509231|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83509232|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83509233|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
83509234|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509235|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509236|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509237|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83509238|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509239|NCT01915823|Fluticasone|fluticasone|mesh-list
83509240|NCT01915823|Xhance|xhance|mesh-list
83509241|NCT01915823|Azelastine|azelastine|mesh-list
83509242|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509243|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83509244|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
83509245|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509246|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509247|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83509248|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
83509249|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
83509250|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83509251|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83509252|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509253|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509254|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83509255|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83509256|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
83509257|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
83509258|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509259|NCT05199194|Tenecteplase|tenecteplase|mesh-list
83509260|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83509261|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83509262|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509263|NCT01916681|Misoprostol|misoprostol|mesh-list
83509264|NCT01916681|Oxytocin|oxytocin|mesh-list
83509265|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
83509266|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83509267|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509268|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83509269|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
83509270|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83509271|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83509272|NCT05735951|Stiripentol|stiripentol|mesh-list
83509273|NCT05735951|Anticonvulsants|anticonvulsants|mesh-ancestor
83509274|NCT01917773|Octreotide|octreotide|mesh-list
83509275|NCT01917773|Bisacodyl|bisacodyl|mesh-list
83509276|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83509277|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83509278|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509279|NCT01917773|Cathartics|cathartics|mesh-ancestor
83509280|NCT01917773|Laxatives|laxatives|mesh-ancestor
83509281|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83509282|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509283|NCT01934231|Amoxicillin|amoxicillin|mesh-list
83509284|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
83509285|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
83509286|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83509287|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83509288|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509289|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83509290|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509291|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509292|NCT01935791|Glucagon|glucagon|mesh-list
83509293|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83509294|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83509295|NCT01935791|Hormones|hormones|mesh-ancestor
83509296|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83509297|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509298|NCT01935791|Incretins|incretins|mesh-ancestor
83509299|NCT03074409|Oxytocin|oxytocin|mesh-list
83509300|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
83509301|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83509302|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509303|NCT02955147|Prednisone|prednisone|mesh-list
83509304|NCT02955147|Ustekinumab|ustekinumab|mesh-list
83509305|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509306|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
83509307|NCT02955147|Hormones|hormones|mesh-ancestor
83509308|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83509309|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509310|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83509311|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509312|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
83509313|NCT03119181|Lidocaine|lidocaine|mesh-list
83509314|NCT03119181|Epinephrine|epinephrine|mesh-list
83509315|NCT03119181|Racepinephrine|racepinephrine|mesh-list
83509316|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83509317|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
83509318|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
83509319|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
83509320|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509321|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509322|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
83509323|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509324|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83509325|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83509326|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83509327|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83509328|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509329|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83509330|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83509331|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
83509332|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509333|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83509334|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83509402|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83509403|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509404|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83509405|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83509406|NCT01626092|Cyclosporine|cyclosporine|mesh-list
83509407|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
83509408|NCT01626092|Melphalan|melphalan|mesh-list
83509409|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
83509410|NCT01626092|Clofarabine|clofarabine|mesh-list
83509411|NCT01626092|Cyclosporins|cyclosporins|mesh-list
83509412|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509413|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509414|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83509415|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
83509416|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509417|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
83509418|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509419|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
83509420|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509421|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83509422|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83509423|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509424|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83509425|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
83509426|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83509427|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83509428|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
83509429|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83509430|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83509431|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83509432|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
83509433|NCT01694966|Methylene Blue|methylene blue|mesh-list
83509434|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509435|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509436|NCT01937975|Grazoprevir|grazoprevir|mesh-list
83509437|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
83509438|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509439|NCT01628588|Bimatoprost|bimatoprost|mesh-list
83509440|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83509441|NCT00374985|Docetaxel|docetaxel|mesh-list
83509442|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
83509443|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509444|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
83509445|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
83509446|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
83509447|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509448|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83509449|NCT01695668|Cyclosporine|cyclosporine|mesh-list
83509450|NCT01695668|Cyclosporins|cyclosporins|mesh-list
83509451|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509452|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509453|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83509454|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
83509455|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509456|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
83509457|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509458|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
83509459|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509460|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83509461|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83509462|NCT03270020|Denosumab|denosumab|mesh-list
83509463|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83509464|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509465|NCT01921751|Paclitaxel|paclitaxel|mesh-list
83509466|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83509467|NCT01921751|Gemcitabine|gemcitabine|mesh-list
83509468|NCT01921751|Capecitabine|capecitabine|mesh-list
83509469|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83509470|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509471|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
83509472|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
83509473|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
83509474|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509475|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83509476|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
83509477|NCT02958345|Vaccines|vaccines|mesh-list
83509478|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
83509479|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509480|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
83509481|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83509482|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
83509483|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509484|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
83509485|NCT01629134|Protective Agents|protective agents|mesh-ancestor
83509486|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
83509487|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
83509488|NCT01629290|Protective Agents|protective agents|mesh-ancestor
83509489|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509490|NCT01696760|Aspirin|aspirin|mesh-list
83509491|NCT01696760|Enoxaparin|enoxaparin|mesh-list
83509492|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
83509493|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
83509494|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83509495|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83509496|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509497|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83509498|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83509499|NCT01696760|Analgesics|analgesics|mesh-ancestor
83509500|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
83509501|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509502|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509503|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509504|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509505|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83509506|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83509507|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509508|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
83509509|NCT01924169|Lenalidomide|lenalidomide|mesh-list
83509510|NCT01924169|Vaccines|vaccines|mesh-list
83509511|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
83509512|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509513|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83509514|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83509515|NCT01924169|Growth Substances|growth substances|mesh-ancestor
83509516|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
83509518|NCT02958969|Apixaban|apixaban|mesh-list
83509519|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83509520|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
83509521|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83509522|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
83509523|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509524|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509525|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
83509526|NCT01924871|Remifentanil|remifentanil|mesh-list
83509527|NCT01924871|Desflurane|desflurane|mesh-list
83509528|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83509529|NCT01924871|Narcotics|narcotics|mesh-ancestor
83509530|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509531|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509532|NCT01924871|Analgesics|analgesics|mesh-ancestor
83509533|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
83509534|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509535|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83509536|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
83509537|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
83509538|NCT01698710|Paclitaxel|paclitaxel|mesh-list
83509539|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83509540|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83509541|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509542|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
83509543|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
83509544|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
83509545|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509546|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
83509547|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83509548|NCT01924949|Ledipasvir|ledipasvir|mesh-list
83509549|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
83509550|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509551|NCT01938989|Methamphetamine|methamphetamine|mesh-list
83509552|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
83509553|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83509554|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83509555|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83509556|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509622|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509623|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509624|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509625|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83509626|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
83509627|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83509628|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509629|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83509630|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83509631|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83509632|NCT01928849|Valproic Acid|valproic acid|mesh-list
83509633|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
83509634|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509635|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509636|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
83509637|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509638|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509639|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
83509640|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83509641|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509642|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83509643|NCT01631552|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83509644|NCT01631552|Immunoconjugates|immunoconjugates|mesh-ancestor
83509645|NCT01631552|Immunologic Factors|immunologic factors|mesh-ancestor
83509646|NCT01631552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509647|NCT03081117|Insulin|insulin|mesh-list
83509648|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83509649|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509650|NCT01944293|Midazolam|midazolam|mesh-list
83509651|NCT01944293|Ketamine|ketamine|mesh-list
83509652|NCT01944293|Analgesics|analgesics|mesh-ancestor
83509653|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
83509654|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509655|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509656|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83509657|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83509658|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
83509659|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
83509660|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509661|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83509662|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83509663|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509664|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509665|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83509666|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83509667|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83509668|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83509669|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83509670|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
83509671|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
83509672|NCT01944371|Disulfiram|disulfiram|mesh-list
83509673|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83509674|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83509675|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509676|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509677|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
83509678|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509679|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83509680|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509681|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509682|NCT01631630|Pioglitazone|pioglitazone|mesh-list
83509683|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83509684|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509685|NCT03837860|Oxycodone|oxycodone|mesh-list
83509686|NCT03837860|Risperidone|risperidone|mesh-list
83509687|NCT03837860|Ziprasidone|ziprasidone|mesh-list
83509688|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83509689|NCT03837860|Narcotics|narcotics|mesh-ancestor
83509690|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509691|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509692|NCT03837860|Analgesics|analgesics|mesh-ancestor
83509693|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
83509694|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509695|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83509712|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83509713|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83509714|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
83509715|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509716|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509717|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83509718|NCT03129945|Indomethacin|indomethacin|mesh-list
83509719|NCT03129945|Nifedipine|nifedipine|mesh-list
83509720|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83509721|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83509722|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509723|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83509724|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509725|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
83509726|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
83509727|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83509728|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83509729|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83509730|NCT03129945|Analgesics|analgesics|mesh-ancestor
83509731|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
83509732|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509733|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509734|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509735|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
83509736|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83509737|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509738|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83509739|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
83509740|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83509741|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83509742|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
83509743|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509744|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509745|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
83509746|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83509747|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509748|NCT02971748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83509749|NCT02971748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509750|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83509751|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509752|NCT03093207|Aspirin|aspirin|mesh-list
83509753|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83509754|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83509755|NCT03093207|Analgesics|analgesics|mesh-ancestor
83509756|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
83509757|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509758|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509759|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509760|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509761|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83509762|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83509763|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509764|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83509765|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83509766|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509767|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
83509768|NCT05482451|Nivolumab|nivolumab|mesh-list
83509769|NCT05482451|Tretinoin|tretinoin|mesh-list
83509770|NCT05482451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83509771|NCT05482451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509772|NCT05482451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83509773|NCT05482451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509774|NCT05482451|Keratolytic Agents|keratolytic agents|mesh-ancestor
83509775|NCT05482451|Dermatologic Agents|dermatologic agents|mesh-ancestor
83509776|NCT02228408|Hydralazine|hydralazine|mesh-list
83509777|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83509778|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
83509779|NCT03134703|Morphine|morphine|mesh-list
83509780|NCT03134703|Methadone|methadone|mesh-list
83509781|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83509782|NCT03134703|Narcotics|narcotics|mesh-ancestor
83509783|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509784|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509802|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83509803|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509804|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509805|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509806|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83509807|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
83509808|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
83509809|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83509810|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83509811|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83509812|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83509813|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83509814|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83509815|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83509816|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83509817|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83509819|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83509821|NCT04350281|Interferon-beta|interferon-beta|mesh-list
83509822|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
83509823|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
83509824|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509825|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
83509826|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509827|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
83509828|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83509829|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83509830|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509831|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509832|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83509833|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
83509834|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509835|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83509836|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
83509837|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83509838|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83509839|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83509840|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
83509841|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509842|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509843|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83509844|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
83509845|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
83509846|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
83509847|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83509848|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83509849|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
83509850|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509851|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509852|NCT02389764|Nintedanib|nintedanib|mesh-list
83509853|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509854|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83509855|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509856|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509857|NCT04903470|Bisacodyl|bisacodyl|mesh-list
83509858|NCT04903470|Cathartics|cathartics|mesh-ancestor
83509859|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83509860|NCT04903470|Laxatives|laxatives|mesh-ancestor
83509861|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83509862|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83509863|NCT01647932|Diuretics|diuretics|mesh-ancestor
83509864|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
83509865|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509866|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83509867|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83509868|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509869|NCT04903002|Oxytocin|oxytocin|mesh-list
83509870|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
83509871|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83509872|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509873|NCT02366130|Denosumab|denosumab|mesh-list
83509874|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83509875|NCT02366130|Hormones|hormones|mesh-list
83509876|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83509877|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509878|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83509879|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509880|NCT01635062|Calcitriol|calcitriol|mesh-list
83509881|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83509882|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83509883|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509884|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83509885|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83509886|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509887|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83509888|NCT01635062|Vitamins|vitamins|mesh-ancestor
83509889|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
83509890|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83509892|NCT01637090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83509893|NCT01637090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83509894|NCT01637090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509895|NCT01637090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509896|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83509897|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
83509898|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509899|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509900|NCT02389452|Hylan|hylan|mesh-list
83509901|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
83509902|NCT02389452|Protective Agents|protective agents|mesh-ancestor
83509903|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509904|NCT02365584|Lanreotide|lanreotide|mesh-list
83509905|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509906|NCT02342418|Tedizolid|tedizolid|mesh-list
83509907|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
83509908|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83509909|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509910|NCT04902378|Insulin|insulin|mesh-list
83509911|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83509912|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509913|NCT05727449|Anesthetics|anesthetics|mesh-list
83509914|NCT05727449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509915|NCT05727449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509916|NCT03102645|Imipramine|imipramine|mesh-list
83509917|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83509918|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
83509919|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83509920|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83509921|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83509922|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83509923|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509924|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
83509925|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509926|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509927|NCT01639352|Pasireotide|pasireotide|mesh-list
83509928|NCT01639352|Hormones|hormones|mesh-ancestor
83509929|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83509930|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509931|NCT01705496|Fialuridine|fialuridine|mesh-list
83509932|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
83509933|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509934|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83509935|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509936|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509937|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83509938|NCT02287415|Warfarin|warfarin|mesh-list
83509939|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
83509940|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
83509941|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83509942|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83509943|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83509944|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509945|NCT02312934|Nicotine|nicotine|mesh-list
83509946|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83509947|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
83509948|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509949|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509950|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83509965|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83509966|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509967|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
83509968|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
83509969|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509970|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509971|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83509972|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
83509973|NCT01602068|Hormones|hormones|mesh-ancestor
83509974|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83509975|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83509976|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509977|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
83509978|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83509979|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
83509980|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
83509981|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509982|NCT02978157|Amoxicillin|amoxicillin|mesh-list
83509983|NCT02978157|Levofloxacin|levofloxacin|mesh-list
83509984|NCT02978157|Ofloxacin|ofloxacin|mesh-list
83509985|NCT02978157|Tetracycline|tetracycline|mesh-list
83509986|NCT02978157|Esomeprazole|esomeprazole|mesh-list
83509987|NCT02978157|Bismuth|bismuth|mesh-list
83509988|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83509989|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509990|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83509991|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83509992|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83509993|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509994|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509995|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83509996|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83509997|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83509998|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509999|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83510000|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83510001|NCT02978157|Antacids|antacids|mesh-ancestor
83510002|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83510003|NCT01705964|Epinephrine|epinephrine|mesh-list
83510004|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83510005|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83510006|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
83510007|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510008|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510009|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510010|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83510011|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83510012|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
83510013|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510014|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83510015|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
83510016|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
83510017|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
83510018|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83510019|NCT02341482|Itraconazole|itraconazole|mesh-list
83510020|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
83510021|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83510022|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83510023|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83510024|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510025|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510026|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83510027|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
83510028|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510029|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510030|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83510031|NCT03140631|Protamines|protamines|mesh-list
83510032|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
83510033|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510034|NCT03140631|Coagulants|coagulants|mesh-ancestor
83510035|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
83510036|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
83510037|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510038|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
83510343|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83510039|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83510040|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
83510041|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510042|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
83510043|NCT00422643|Protective Agents|protective agents|mesh-ancestor
83510044|NCT05405907|Hemostatics|hemostatics|mesh-list
83510045|NCT05405907|Coagulants|coagulants|mesh-ancestor
83510047|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83510048|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83510049|NCT01706588|Analgesics|analgesics|mesh-ancestor
83510050|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
83510051|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510052|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510053|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83510054|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83510055|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83510056|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510057|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510058|NCT01602692|Lidocaine|lidocaine|mesh-list
83510059|NCT01602692|Epinephrine|epinephrine|mesh-list
83510060|NCT01602692|Racepinephrine|racepinephrine|mesh-list
83510061|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83510062|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
83510063|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
83510064|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
83510065|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510066|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510067|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
83510068|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510069|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83510070|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83510071|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83510072|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83510073|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510074|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83510075|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83510076|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
83510077|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510078|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83510079|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83510080|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
83510081|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83510082|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
83510083|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
83510084|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
83510085|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83510086|NCT01603940|Losartan|losartan|mesh-list
83510087|NCT01603940|Benazepril|benazepril|mesh-list
83510088|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83510089|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83510090|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83510091|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83510092|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510093|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83510094|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
83510095|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510096|NCT01605032|Bortezomib|bortezomib|mesh-list
83510097|NCT01605032|Melphalan|melphalan|mesh-list
83510098|NCT01605032|Busulfan|busulfan|mesh-list
83510099|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510100|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83510101|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
83510102|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510103|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83510104|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83510105|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
83510106|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510107|NCT01706666|Dexamethasone|dexamethasone|mesh-list
83510108|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
83510109|NCT01706666|Lenalidomide|lenalidomide|mesh-list
83510110|NCT01706666|Bortezomib|bortezomib|mesh-list
83510111|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83510112|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
83510113|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510114|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83510115|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83510116|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
83510117|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510118|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510119|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83510120|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83510121|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
83510122|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
83510123|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510124|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83510125|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
83510126|NCT01706666|Hormones|hormones|mesh-ancestor
83510127|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510128|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83510129|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83510130|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83510131|NCT01706666|Growth Substances|growth substances|mesh-ancestor
83510132|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
83510133|NCT03149991|Ketamine|ketamine|mesh-list
83510134|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
83510135|NCT03149991|Analgesics|analgesics|mesh-ancestor
83510136|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
83510137|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510138|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510139|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83510140|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83510141|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
83510142|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
83510143|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510144|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83510145|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83510146|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510147|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510148|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
83510149|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
83510150|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
83510151|NCT05704439|Antihypertensive Agents|antihypertensive agents|mesh-list
83510152|NCT05400993|Cyclophosphamide|cyclophosphamide|mesh-list
83510153|NCT05400993|Docetaxel|docetaxel|mesh-list
83510154|NCT05400993|Epirubicin|epirubicin|mesh-list
83510155|NCT05400993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83510156|NCT05400993|Immunologic Factors|immunologic factors|mesh-ancestor
83510157|NCT05400993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510158|NCT05400993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83510159|NCT05400993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83510160|NCT05400993|Alkylating Agents|alkylating agents|mesh-ancestor
83510161|NCT05400993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510162|NCT05400993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510163|NCT05400993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83510164|NCT05400993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83510165|NCT05400993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83510166|NCT05400993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83510167|NCT05400993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83510168|NCT05400993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83510169|NCT05400993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83510170|NCT05400993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510171|NCT01605890|Tenofovir|tenofovir|mesh-list
83510172|NCT01605890|Emtricitabine|emtricitabine|mesh-list
83510173|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
83510174|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83510175|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
83510176|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83510177|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83510178|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83510179|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510180|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510181|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83510182|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83510183|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83510184|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83510185|NCT02288273|Exenatide|exenatide|mesh-list
83510186|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83510187|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510188|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83510189|NCT02288273|Incretins|incretins|mesh-ancestor
83510191|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510192|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83510193|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
83510194|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510195|NCT01606124|Protective Agents|protective agents|mesh-ancestor
83510196|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510197|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83510198|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83510199|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510200|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83510201|NCT01607450|Glucagon|glucagon|mesh-list
83510202|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83510203|NCT01607450|Incretins|incretins|mesh-ancestor
83510204|NCT01607450|Hormones|hormones|mesh-ancestor
83510205|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510206|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510207|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83510208|NCT05738993|Pertuzumab|pertuzumab|mesh-list
83510209|NCT05738993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83510210|NCT05738993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510211|NCT01709474|Vitamin D|vitamin d|mesh-list
83510212|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
83510213|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
83510214|NCT01709474|Vitamins|vitamins|mesh-list
83510215|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
83510216|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510217|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83510218|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83510219|NCT02992808|Menotropins|menotropins|mesh-list
83510220|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83510221|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
83510222|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83510223|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510224|NCT02992886|Raltitrexed|raltitrexed|mesh-list
83510225|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83510226|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
83510227|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510228|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510229|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83510230|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510231|NCT02331095|Warfarin|warfarin|mesh-list
83510232|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
83510233|NCT02331095|Atorvastatin|atorvastatin|mesh-list
83510234|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83510235|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83510236|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
83510237|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510238|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83510239|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83510240|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510241|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
83510242|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83510243|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
83510244|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83510245|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
83510246|NCT01640834|Glucagon|glucagon|mesh-list
83510247|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83510248|NCT01640834|Hormones|hormones|mesh-ancestor
83510249|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510250|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510251|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
83510252|NCT03029273|Fludarabine|fludarabine|mesh-list
83510253|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83510254|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
83510255|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510256|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83510257|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83510258|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
83510259|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510260|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510261|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83510262|NCT05316935|Letrozole|letrozole|mesh-list
83510263|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83510264|NCT05316935|Cyproterone|cyproterone|mesh-list
83510265|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
83510266|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510267|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83510268|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83510269|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510270|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510271|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83510272|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
83510273|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510274|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510275|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83510276|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83510277|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83510278|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
83510279|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83510280|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83510282|NCT05316935|Hormones|hormones|mesh-ancestor
83510283|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
83510284|NCT05738759|Anesthetics|anesthetics|mesh-list
83510285|NCT05738759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510286|NCT05738759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510287|NCT05738681|Acetylcysteine|acetylcysteine|mesh-list
83510288|NCT05738681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83510289|NCT05738681|Antiviral Agents|antiviral agents|mesh-ancestor
83510290|NCT05738681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83510291|NCT05738681|Expectorants|expectorants|mesh-ancestor
83510292|NCT05738681|Respiratory System Agents|respiratory system agents|mesh-ancestor
83510293|NCT05738681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83510294|NCT05738681|Antioxidants|antioxidants|mesh-ancestor
83510295|NCT05738681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510296|NCT05738681|Protective Agents|protective agents|mesh-ancestor
83510297|NCT05738681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510298|NCT05738681|Antidotes|antidotes|mesh-ancestor
83510299|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
83510300|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
83510301|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510302|NCT02288819|Diuretics|diuretics|mesh-list
83510303|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83510304|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
83510305|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510306|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83510307|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510308|NCT01642238|Aspirin|aspirin|mesh-list
83510309|NCT01642238|Hirudins|hirudins|mesh-list
83510310|NCT01642238|Bivalirudin|bivalirudin|mesh-list
83510311|NCT01642238|Clopidogrel|clopidogrel|mesh-list
83510312|NCT01642238|Ticagrelor|ticagrelor|mesh-list
83510313|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83510314|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83510315|NCT01642238|Analgesics|analgesics|mesh-ancestor
83510316|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
83510317|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510318|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510319|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83510320|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83510321|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83510322|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83510323|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510324|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83510325|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83510326|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510327|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
83510328|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83510329|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83510330|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83510331|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
83510332|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510333|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
83510334|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83510335|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
83510336|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
83510337|NCT05710874|Fluorides|fluorides|mesh-list
83510338|NCT05710874|Cariostatic Agents|cariostatic agents|mesh-ancestor
83510340|NCT05710874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510341|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
83510342|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83510376|NCT05736419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83510377|NCT05736419|Immunologic Factors|immunologic factors|mesh-ancestor
83510378|NCT05736419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510379|NCT05736419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83510380|NCT05736419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83510381|NCT05736419|Alkylating Agents|alkylating agents|mesh-ancestor
83510382|NCT05736419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510383|NCT05736419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510384|NCT05736419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83510385|NCT05736419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83510386|NCT05736419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83510387|NCT05736419|Antiemetics|antiemetics|mesh-ancestor
83510388|NCT05736419|Autonomic Agents|autonomic agents|mesh-ancestor
83510389|NCT05736419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510390|NCT05736419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83510391|NCT05736419|Glucocorticoids|glucocorticoids|mesh-ancestor
83510392|NCT05736419|Hormones|hormones|mesh-ancestor
83510393|NCT05736419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510394|NCT05736419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83510395|NCT05736419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83510396|NCT05736419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510397|NCT05736419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83510398|NCT05736419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83510399|NCT05736419|Antitubercular Agents|antitubercular agents|mesh-ancestor
83510400|NCT05736419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83510401|NCT05736419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83510402|NCT02986685|Rabeprazole|rabeprazole|mesh-list
83510403|NCT02986685|Trimebutine|trimebutine|mesh-list
83510404|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510405|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510406|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83510407|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83510408|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83510409|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
83510410|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
83510411|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510412|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510413|NCT01610570|Plicamycin|plicamycin|mesh-list
83510414|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83510415|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510416|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83510417|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510418|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83510419|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510420|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510421|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83510422|NCT05736341|Midazolam|midazolam|mesh-list
83510423|NCT05736341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83510424|NCT05736341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83510425|NCT05736341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510426|NCT05736341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510427|NCT05736341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83510428|NCT05736341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83510429|NCT05736341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83510430|NCT05736341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83510431|NCT05736341|Anesthetics, General|anesthetics, general|mesh-ancestor
83510432|NCT05736341|Anesthetics|anesthetics|mesh-ancestor
83510433|NCT05736341|GABA Modulators|gaba modulators|mesh-ancestor
83510434|NCT05736341|GABA Agents|gaba agents|mesh-ancestor
83510435|NCT05736341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510436|NCT05736341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510437|NCT01611662|Gemcitabine|gemcitabine|mesh-list
83510438|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510439|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83510440|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
83510441|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510442|NCT05200481|Carboplatin|carboplatin|mesh-list
83510443|NCT05200481|Pemetrexed|pemetrexed|mesh-list
83510444|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510445|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510446|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510447|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83510448|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83510525|NCT05421416|Dermatologic Agents|dermatologic agents|mesh-ancestor
83510449|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83510450|NCT05139563|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83510451|NCT05139563|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83510452|NCT05139563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83510453|NCT05139563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83510454|NCT01646762|Paclitaxel|paclitaxel|mesh-list
83510455|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83510456|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83510457|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510458|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
83510459|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
83510460|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
83510461|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510462|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83510463|NCT04997525|Estradiol|estradiol|mesh-list
83510464|NCT04997525|Progesterone|progesterone|mesh-list
83510465|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83510466|NCT04997525|Estrogens|estrogens|mesh-ancestor
83510467|NCT04997525|Hormones|hormones|mesh-ancestor
83510468|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510469|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510470|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83510471|NCT04997525|Progestins|progestins|mesh-ancestor
83510472|NCT01649180|Axitinib|axitinib|mesh-list
83510473|NCT01649180|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83510474|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510475|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83510476|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510477|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510478|NCT04408313|Naltrexone|naltrexone|mesh-list
83510479|NCT04408313|Buprenorphine|buprenorphine|mesh-list
83510480|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83510481|NCT04408313|Narcotics|narcotics|mesh-ancestor
83510482|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510483|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510484|NCT04408313|Analgesics|analgesics|mesh-ancestor
83510485|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
83510486|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510487|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83510488|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83510489|NCT01619774|Trametinib|trametinib|mesh-list
83510491|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510492|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83510493|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510494|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510495|NCT01651442|Zolpidem|zolpidem|mesh-list
83510496|NCT01651442|Trazodone|trazodone|mesh-list
83510497|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83510498|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83510499|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510500|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510501|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83510502|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
83510503|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
83510504|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510505|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510506|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83510507|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83510508|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83510509|NCT01651442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83510510|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83510511|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83510512|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
83510513|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83510514|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
83510515|NCT04901975|Spironolactone|spironolactone|mesh-list
83510516|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83510517|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
83510518|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510519|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510520|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83510521|NCT04901975|Diuretics|diuretics|mesh-ancestor
83510522|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
83510523|NCT05421416|Loratadine|loratadine|mesh-list
83510524|NCT05421416|Antipruritics|antipruritics|mesh-ancestor
83510527|NCT05421416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83510528|NCT05421416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83510529|NCT05421416|Histamine Antagonists|histamine antagonists|mesh-ancestor
83510530|NCT05421416|Histamine Agents|histamine agents|mesh-ancestor
83510531|NCT05421416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510532|NCT05421416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510533|NCT05421416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510534|NCT04868045|Hormones|hormones|mesh-list
83510535|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
83510536|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510537|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510538|NCT04803539|Capecitabine|capecitabine|mesh-list
83510539|NCT04803539|Apatinib|apatinib|mesh-list
83510540|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83510541|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
83510542|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510543|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510544|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83510545|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510546|NCT04799015|Dexamethasone|dexamethasone|mesh-list
83510547|NCT04799015|Metoclopramide|metoclopramide|mesh-list
83510548|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83510549|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
83510550|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
83510551|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510552|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510553|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83510554|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
83510555|NCT04799015|Hormones|hormones|mesh-ancestor
83510556|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510557|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83510558|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510559|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83510560|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83510561|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
83510562|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510563|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510564|NCT03141359|Paclitaxel|paclitaxel|mesh-list
83510565|NCT03141359|Etoposide|etoposide|mesh-list
83510566|NCT03141359|Carboplatin|carboplatin|mesh-list
83510567|NCT03141359|Durvalumab|durvalumab|mesh-list
83510568|NCT03141359|Cisplatin|cisplatin|mesh-list
83510569|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83510570|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510571|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
83510572|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
83510573|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
83510574|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510575|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83510576|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83510577|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510578|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83510579|NCT01658228|Donepezil|donepezil|mesh-list
83510580|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83510581|NCT01658228|Citalopram|citalopram|mesh-list
83510582|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83510583|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510584|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510585|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
83510586|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510587|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510588|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
83510589|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83510590|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83510591|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83510592|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83510593|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
83510594|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83510595|NCT01658228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83510596|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
83510597|NCT05709938|Insulin|insulin|mesh-list
83510598|NCT05709938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83510599|NCT05709938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83510600|NCT05709938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510601|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
83510602|NCT01659866|Gentamicins|gentamicins|mesh-list
83510603|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
83510604|NCT01659866|Imipenem|imipenem|mesh-list
83510605|NCT01659866|Amikacin|amikacin|mesh-list
83510606|NCT01659866|Cefuroxime|cefuroxime|mesh-list
83510607|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83510608|NCT01659866|Aztreonam|aztreonam|mesh-list
83510609|NCT01659866|Trimethoprim|trimethoprim|mesh-list
83510610|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
83510611|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83510612|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83510613|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83510614|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83510615|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510616|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510617|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510618|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83510619|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83510620|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83510621|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83510622|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
83510623|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83510624|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83510625|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83510626|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83510627|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83510628|NCT02249702|Gemcitabine|gemcitabine|mesh-list
83510629|NCT02249702|Docetaxel|docetaxel|mesh-list
83510630|NCT02249702|Trabectedin|trabectedin|mesh-list
83510631|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83510632|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
83510633|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510634|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510635|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
83510636|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
83510637|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
83510638|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83510640|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
83510641|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83510642|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83510643|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510644|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
83510645|NCT02947529|Coagulants|coagulants|mesh-ancestor
83510646|NCT01660802|Dexamethasone|dexamethasone|mesh-list
83510647|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83510648|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
83510649|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
83510650|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510651|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510652|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83510653|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
83510654|NCT01660802|Hormones|hormones|mesh-ancestor
83510655|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510656|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83510657|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510658|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83510659|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83510660|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510661|NCT01661114|Gemcitabine|gemcitabine|mesh-list
83510662|NCT01661114|Fluorouracil|fluorouracil|mesh-list
83510663|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510664|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83510665|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
83510666|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510667|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83510668|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
83510669|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510670|NCT02683265|Methylphenidate|methylphenidate|mesh-list
83510671|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83510672|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510673|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83510674|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83510675|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83510676|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510677|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
83510678|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510679|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
83510680|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
83510681|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
83510682|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510683|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510684|NCT02988843|Bevacizumab|bevacizumab|mesh-list
83510685|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83510686|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83510687|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510688|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83510689|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83510690|NCT02988843|Growth Substances|growth substances|mesh-ancestor
83510691|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510692|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
83510693|NCT02988843|Immunotoxins|immunotoxins|mesh-ancestor
83510694|NCT02988843|Immunoconjugates|immunoconjugates|mesh-ancestor
83510695|NCT02988843|Immunologic Factors|immunologic factors|mesh-ancestor
83510696|NCT01661270|Aflibercept|aflibercept|mesh-list
83510697|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83510698|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83510699|NCT01661270|Growth Substances|growth substances|mesh-ancestor
83510700|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510701|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
83510702|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510703|NCT03000309|Apremilast|apremilast|mesh-list
83510704|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83510705|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83510706|NCT03000309|Analgesics|analgesics|mesh-ancestor
83510707|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
83510708|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510709|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510710|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83510712|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83510713|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83510714|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510715|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510716|NCT02992028|Vitamins|vitamins|mesh-list
83510717|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
83510718|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510719|NCT03165981|Vaccines|vaccines|mesh-list
83510720|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83510721|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
83510722|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510723|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
83510724|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83510725|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510726|NCT03170661|Rocuronium|rocuronium|mesh-list
83510727|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83510728|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83510729|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83510730|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510731|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510732|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83510733|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510734|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510735|NCT01662908|Heparin|heparin|mesh-list
83510736|NCT01662908|Enoxaparin|enoxaparin|mesh-list
83510737|NCT01662908|Calcium heparin|calcium heparin|mesh-list
83510738|NCT01662908|Warfarin|warfarin|mesh-list
83510739|NCT01662908|Edoxaban|edoxaban|mesh-list
83510740|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
83510741|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83510742|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83510743|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510744|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83510745|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
83510746|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83510747|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
83510748|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510749|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
83510750|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
83510751|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83510752|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83510753|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510754|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510755|NCT00375297|Urological Agents|urological agents|mesh-ancestor
83510756|NCT02234570|Oxfendazole|oxfendazole|mesh-list
83510757|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
83510758|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83510759|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83510760|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
83510761|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83510762|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
83510763|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510764|NCT02240030|Levodopa|levodopa|mesh-list
83510765|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83510766|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83510767|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
83510768|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510769|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510770|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510771|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
83510772|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83510773|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510774|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83510775|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510776|NCT03471663|Palbociclib|palbociclib|mesh-list
83510777|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510778|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83510779|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510780|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510781|NCT01664858|Calcium|calcium|mesh-list
83510782|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83510783|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510784|NCT04348695|Simvastatin|simvastatin|mesh-list
83510785|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83510786|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83510787|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
83510788|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510789|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83510790|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83510791|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510793|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83510794|NCT04316871|Narcotics|narcotics|mesh-ancestor
83510795|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510796|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510797|NCT04316871|Analgesics|analgesics|mesh-ancestor
83510798|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
83510799|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510800|NCT05364567|Vitamin D|vitamin d|mesh-list
83510801|NCT05364567|Cholecalciferol|cholecalciferol|mesh-list
83510802|NCT05364567|Vitamins|vitamins|mesh-ancestor
83510803|NCT05364567|Micronutrients|micronutrients|mesh-ancestor
83510804|NCT05364567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510805|NCT05364567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83510806|NCT05364567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83510807|NCT00375765|Dutasteride|dutasteride|mesh-list
83510808|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83510809|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83510810|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510811|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510812|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
83510813|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510814|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510815|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
83510816|NCT03325647|Testosterone|testosterone|mesh-list
83510817|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
83510818|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
83510819|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83510820|NCT03325647|Androgens|androgens|mesh-ancestor
83510821|NCT03325647|Hormones|hormones|mesh-ancestor
83510822|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510823|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510824|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83510825|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510826|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
83510827|NCT01665950|Simvastatin|simvastatin|mesh-list
83510828|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83510829|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83510830|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
83510831|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510832|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83510833|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83510834|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510835|NCT01667978|Ritonavir|ritonavir|mesh-list
83510836|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83510837|NCT01667978|Norethindrone|norethindrone|mesh-list
83510838|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
83510839|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
83510840|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83510841|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83510842|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510843|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510844|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83510845|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83510846|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
83510847|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83510848|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83510849|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83510850|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83510851|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83510852|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83510853|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
83510854|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83510855|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510856|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83510857|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83510858|NCT03282669|Morphine|morphine|mesh-list
83510859|NCT03282669|Hydromorphone|hydromorphone|mesh-list
83510860|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83510861|NCT03282669|Narcotics|narcotics|mesh-ancestor
83510862|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510863|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510864|NCT03282669|Analgesics|analgesics|mesh-ancestor
83510865|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
83510866|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510867|NCT00375843|Sertraline|sertraline|mesh-list
83510868|NCT00375843|Escitalopram|escitalopram|mesh-list
83510869|NCT00375843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83510870|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83510871|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83510872|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510873|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510874|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
83510875|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510876|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
83510877|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83510878|NCT03247569|Edoxaban|edoxaban|mesh-list
83510879|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83510880|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
83510881|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83510882|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
83510883|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510884|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510885|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
83510886|NCT01668836|Resveratrol|resveratrol|mesh-list
83510887|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
83510888|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510889|NCT01668836|Protective Agents|protective agents|mesh-ancestor
83510890|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510891|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510892|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83510893|NCT03744663|Buprenorphine|buprenorphine|mesh-list
83510894|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83510895|NCT03744663|Naloxone|naloxone|mesh-list
83510896|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83510897|NCT03744663|Narcotics|narcotics|mesh-ancestor
83510898|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510899|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510901|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
83510902|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510903|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83510904|NCT01669538|Galantamine|galantamine|mesh-list
83510905|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83510906|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510907|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510908|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
83510909|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510910|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510911|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83510912|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
83510913|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510914|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
83510915|NCT00375375|Lactulose|lactulose|mesh-list
83510916|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83510917|NCT04333095|Bupivacaine|bupivacaine|mesh-list
83510918|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
83510919|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
83510920|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510921|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510922|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
83510923|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510924|NCT05045144|Vaccines|vaccines|mesh-list
83510925|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
83510926|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510927|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83510928|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
83510929|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83510930|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
83510931|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83510932|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510933|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83510934|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83510935|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510937|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510938|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83510939|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510940|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510941|NCT01455051|Ofatumumab|ofatumumab|mesh-list
83510942|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510943|NCT01673828|Pregnanolone|pregnanolone|mesh-list
83510944|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83510945|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
83510946|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510947|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510948|NCT05325099|Azacitidine|azacitidine|mesh-list
83510949|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83510950|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
83510951|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510952|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510953|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510954|NCT05293509|Cyclosporine|cyclosporine|mesh-list
83510955|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
83510956|NCT05293509|Dexamethasone|dexamethasone|mesh-list
83510957|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
83510958|NCT05293509|Busulfan|busulfan|mesh-list
83510959|NCT05293509|Rituximab|rituximab|mesh-list
83510960|NCT05293509|Fludarabine|fludarabine|mesh-list
83510961|NCT05293509|Bortezomib|bortezomib|mesh-list
83510962|NCT05293509|Tacrolimus|tacrolimus|mesh-list
83510963|NCT05293509|Cyclosporins|cyclosporins|mesh-list
83510964|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
83510965|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83510966|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
83510967|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510968|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83510969|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83510970|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
83510971|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510972|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510973|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83510974|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83510975|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83510976|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
83510977|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
83510978|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510979|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83510980|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
83510982|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83510983|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83510984|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83510985|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510986|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
83510987|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83510988|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
83510989|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83510990|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83510991|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
83510992|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83510993|NCT04736433|Valsartan|valsartan|mesh-list
83510994|NCT04736433|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83510995|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83510996|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83510997|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83510998|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83510999|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511000|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
83511001|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511002|NCT02296775|Rituximab|rituximab|mesh-list
83511003|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83511004|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511005|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
83511006|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511007|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511008|NCT01675778|Hydromorphone|hydromorphone|mesh-list
83511009|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83511010|NCT01675778|Narcotics|narcotics|mesh-ancestor
83511011|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511012|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511013|NCT01675778|Analgesics|analgesics|mesh-ancestor
83511014|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
83511015|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511016|NCT04736589|Sirolimus|sirolimus|mesh-list
83511017|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83511018|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511019|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83511020|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511021|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
83511022|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83511023|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
83511024|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511025|NCT05201859|Capecitabine|capecitabine|mesh-list
83511026|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83511027|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
83511028|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511029|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511030|NCT02594111|Colchicine|colchicine|mesh-list
83511031|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
83511032|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511033|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
83511034|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
83511035|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
83511036|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511037|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511038|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
83511039|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83511040|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83511041|NCT03186261|Fluorides|fluorides|mesh-list
83511042|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
83511043|NCT03186261|Protective Agents|protective agents|mesh-ancestor
83511044|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511045|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83511046|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511047|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
83511048|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
83511049|NCT02589353|Acarbose|acarbose|mesh-list
83511050|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83511051|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511052|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511053|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83511054|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511055|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
83511056|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83511057|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511058|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83511059|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
83511060|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
83511061|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83511062|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83511063|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83511064|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511065|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83511066|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83511067|NCT04645667|Tacrolimus|tacrolimus|mesh-list
83511068|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83511069|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
83511070|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511071|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83511072|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511073|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511074|NCT02249936|Omeprazole|omeprazole|mesh-list
83511075|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83511076|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83511077|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83511078|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511079|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511080|NCT03190005|Clopidogrel|clopidogrel|mesh-list
83511081|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83511082|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83511083|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83511084|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83511085|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
83511086|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511087|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511088|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511089|NCT04816214|Carboplatin|carboplatin|mesh-list
83511090|NCT04816214|Pemetrexed|pemetrexed|mesh-list
83511091|NCT04816214|Osimertinib|osimertinib|mesh-list
83511092|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511093|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511094|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511095|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83511096|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83511097|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83511098|NCT01461915|Paclitaxel|paclitaxel|mesh-list
83511099|NCT01461915|Gemcitabine|gemcitabine|mesh-list
83511100|NCT01461915|Heparin|heparin|mesh-list
83511101|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83511102|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511103|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
83511104|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
83511105|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
83511106|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511107|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83511108|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
83511109|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
83511110|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83511111|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83511112|NCT01682642|Goserelin|goserelin|mesh-list
83511113|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83511114|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511115|NCT01683422|Gemcitabine|gemcitabine|mesh-list
83511116|NCT01683422|Capecitabine|capecitabine|mesh-list
83511117|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83511118|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83511119|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
83511120|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511121|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511122|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83511127|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83511128|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511129|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511130|NCT05066061|Analgesics|analgesics|mesh-list
83511131|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
83511132|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
83511133|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511134|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511135|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83511136|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511137|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83511138|NCT04781673|Lidocaine|lidocaine|mesh-list
83511139|NCT04781673|Ketamine|ketamine|mesh-list
83511140|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
83511141|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
83511142|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511143|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511144|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
83511145|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511146|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83511147|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83511148|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83511149|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83511150|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511151|NCT04781673|Analgesics|analgesics|mesh-ancestor
83511152|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83511153|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83511155|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83511156|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83511157|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511158|NCT03197025|Aldesleukin|aldesleukin|mesh-list
83511159|NCT03197025|Interleukin-2|interleukin-2|mesh-list
83511160|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511161|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83511162|NCT03197025|Analgesics|analgesics|mesh-ancestor
83511163|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
83511164|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511165|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511166|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83511167|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83511168|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
83511169|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511170|NCT02249546|Amoxicillin|amoxicillin|mesh-list
83511171|NCT02249546|Clarithromycin|clarithromycin|mesh-list
83511172|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
83511173|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83511174|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83511175|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511176|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83511177|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511178|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511179|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83511180|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83511181|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
83511182|NCT02249546|Expectorants|expectorants|mesh-ancestor
83511183|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
83511184|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83511185|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
83511186|NCT02249546|Protective Agents|protective agents|mesh-ancestor
83511187|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511188|NCT02249546|Antidotes|antidotes|mesh-ancestor
83511189|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
83511190|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83511191|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83511192|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
83511193|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511194|NCT04960215|Ubiquinone|ubiquinone|mesh-list
83511195|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
83511196|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
83511197|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511198|NCT04960215|Vitamins|vitamins|mesh-ancestor
83511199|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83511200|NCT02333045|Maraviroc|maraviroc|mesh-list
83511201|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83511202|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83511203|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511204|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511205|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
83511206|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511207|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83511208|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83511209|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83511210|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83511211|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83511212|NCT01684748|Olmesartan|olmesartan|mesh-list
83511213|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83511214|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83511215|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83511216|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83511217|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511218|NCT04028063|Doxorubicin|doxorubicin|mesh-list
83511219|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83511220|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511221|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83511222|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83511223|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511224|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511225|NCT01685684|Oxycodone|oxycodone|mesh-list
83511226|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83511227|NCT01685684|Narcotics|narcotics|mesh-ancestor
83511228|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511229|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511231|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
83511232|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511233|NCT03978767|Acetaminophen|acetaminophen|mesh-list
83511234|NCT03978767|Ibuprofen|ibuprofen|mesh-list
83511235|NCT03978767|Ketorolac|ketorolac|mesh-list
83511236|NCT03978767|Oxycodone|oxycodone|mesh-list
83511237|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83511238|NCT03978767|Analgesics|analgesics|mesh-ancestor
83511239|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
83511240|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511241|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511242|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
83511243|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83511244|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83511245|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511246|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83511247|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511248|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511249|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83511250|NCT03978767|Narcotics|narcotics|mesh-ancestor
83511251|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511252|NCT04436133|Vaccines|vaccines|mesh-list
83511253|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
83511254|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511255|NCT01685996|Zonisamide|zonisamide|mesh-list
83511256|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
83511257|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83511258|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83511259|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511260|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83511261|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511262|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83511263|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
83511264|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511265|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
83511266|NCT04633148|Fludarabine|fludarabine|mesh-list
83511267|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83511268|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
83511269|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511270|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511271|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83511272|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
83511273|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511274|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511275|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83511276|NCT04543409|Benralizumab|benralizumab|mesh-list
83511277|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83511278|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
83511280|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
83511281|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83511282|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83511283|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83511284|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83511285|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511286|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
83511287|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511288|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511289|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83511290|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83511291|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511292|NCT02175173|Rufinamide|rufinamide|mesh-list
83511293|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
83511294|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83511295|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83511296|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83511297|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511298|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
83511299|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83511300|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
83511301|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511302|NCT02124941|Expectorants|expectorants|mesh-ancestor
83511303|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
83511304|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83511305|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
83511306|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511307|NCT02124941|Protective Agents|protective agents|mesh-ancestor
83511308|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511309|NCT02124941|Antidotes|antidotes|mesh-ancestor
83511310|NCT04121403|Rituximab|rituximab|mesh-list
83511311|NCT04121403|Cladribine|cladribine|mesh-list
83511312|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83511313|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511314|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
83511315|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511316|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511317|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83511318|NCT02049515|Ofatumumab|ofatumumab|mesh-list
83511319|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511320|NCT03224403|Acetaminophen|acetaminophen|mesh-list
83511321|NCT03224403|Ibuprofen|ibuprofen|mesh-list
83511322|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83511323|NCT03224403|Analgesics|analgesics|mesh-ancestor
83511324|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
83511325|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511326|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511327|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
83511328|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83511329|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83511330|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511331|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83511332|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511333|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511334|NCT02334059|Ketamine|ketamine|mesh-list
83511335|NCT02334059|Analgesics|analgesics|mesh-ancestor
83511336|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
83511337|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511338|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511339|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83511340|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83511341|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
83511342|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
83511343|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511344|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83511345|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83511346|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511347|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511348|NCT04501523|Capecitabine|capecitabine|mesh-list
83511349|NCT04501523|Tislelizumab|tislelizumab|mesh-list
83511350|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83511351|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
83511352|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511353|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511354|NCT04501523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83511355|NCT04499573|Cytarabine|cytarabine|mesh-list
83511356|NCT04499573|Dexamethasone|dexamethasone|mesh-list
83511357|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
83511358|NCT04499573|Fludarabine|fludarabine|mesh-list
83511359|NCT04499573|Etoposide|etoposide|mesh-list
83511360|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83511361|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
83511362|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511363|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511364|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83511365|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
83511366|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511367|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511368|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83511369|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83511370|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
83511371|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
83511372|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511373|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83511374|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
83511375|NCT04499573|Hormones|hormones|mesh-ancestor
83511376|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83511377|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83511378|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511379|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83511380|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
83511381|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83511382|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83511383|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83511384|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
83511385|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511386|NCT03425097|Fexofenadine|fexofenadine|mesh-list
83511387|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83511388|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83511389|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83511390|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
83511391|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
83511392|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511393|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511394|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511395|NCT01926041|Varenicline|varenicline|mesh-list
83511396|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83511397|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83511398|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
83511399|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511400|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511401|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511402|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83511403|NCT01769027|Azithromycin|azithromycin|mesh-list
83511404|NCT01769027|Penicillins|penicillins|mesh-list
83511405|NCT01769027|Sertraline|sertraline|mesh-list
83511406|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83511407|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511408|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
83511409|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83511410|NCT01769027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83511411|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83511412|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83511413|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511414|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511415|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
83511416|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511417|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
83511418|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
83511419|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83511420|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511421|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83511422|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511423|NCT04706949|Carboplatin|carboplatin|mesh-list
83511424|NCT04706949|Pemetrexed|pemetrexed|mesh-list
83511425|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511427|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511428|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83511429|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83511430|NCT02299349|Epinephrine|epinephrine|mesh-list
83511431|NCT02299349|Racepinephrine|racepinephrine|mesh-list
83511432|NCT02299349|Morphine|morphine|mesh-list
83511433|NCT02299349|Bupivacaine|bupivacaine|mesh-list
83511434|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
83511435|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
83511436|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
83511437|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511438|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511439|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
83511440|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511441|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83511442|NCT02299349|Narcotics|narcotics|mesh-ancestor
83511443|NCT02299349|Analgesics|analgesics|mesh-ancestor
83511444|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83511445|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83511446|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
83511447|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511448|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511449|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83511450|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83511451|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
83511452|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83511453|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
83511454|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
83511455|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
83511456|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83511457|NCT03296163|Paclitaxel|paclitaxel|mesh-list
83511458|NCT03296163|Bevacizumab|bevacizumab|mesh-list
83511459|NCT03296163|Carboplatin|carboplatin|mesh-list
83511460|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83511461|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511462|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
83511463|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
83511464|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
83511465|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511466|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83511467|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83511468|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83511469|NCT03296163|Growth Substances|growth substances|mesh-ancestor
83511470|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511471|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
83511472|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
83511473|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
83511474|NCT00376155|Amodiaquine|amodiaquine|mesh-list
83511475|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
83511476|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83511477|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83511478|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511479|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83511480|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511481|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511482|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83511483|NCT01989221|Granisetron|granisetron|mesh-list
83511484|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
83511485|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
83511486|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511487|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511488|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83511489|NCT01989221|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83511490|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83511491|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
83511492|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511493|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511494|NCT03226899|Colchicine|colchicine|mesh-list
83511495|NCT03226899|Allopurinol|allopurinol|mesh-list
83511496|NCT03226899|Febuxostat|febuxostat|mesh-list
83511497|NCT03226899|Lesinurad|lesinurad|mesh-list
83511498|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
83511499|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511500|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
83511501|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
83511502|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
83511503|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511504|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511505|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
83511506|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511507|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83511508|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
83511509|NCT03226899|Protective Agents|protective agents|mesh-ancestor
83511510|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511511|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
83511512|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
83511513|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83511514|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
83511515|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83511516|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511517|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83511518|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83511519|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83511520|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83511521|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511522|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
83511523|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83511524|NCT01992185|Protective Agents|protective agents|mesh-ancestor
83511525|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511526|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
83511527|NCT04332627|Neostigmine|neostigmine|mesh-list
83511528|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83511529|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511530|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511531|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
83511532|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511533|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511534|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83511535|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
83511536|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511537|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83511538|NCT03440229|Laxatives|laxatives|mesh-ancestor
83511539|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83511540|NCT01963091|Oxytocin|oxytocin|mesh-list
83511541|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
83511542|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83511543|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511544|NCT02306759|Ketamine|ketamine|mesh-list
83511545|NCT02306759|Analgesics|analgesics|mesh-ancestor
83511546|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
83511547|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511548|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511549|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83511550|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83511551|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
83511552|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
83511553|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511554|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83511555|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83511556|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511557|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511558|NCT03298113|Protective Agents|protective agents|mesh-list
83511559|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511560|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
83511561|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83511562|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83511563|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
83511564|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
83511565|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511566|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511567|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83511568|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
83511569|NCT03232749|Hormones|hormones|mesh-ancestor
83511570|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83511571|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83511572|NCT03232749|Protective Agents|protective agents|mesh-ancestor
83511573|NCT01687400|Decitabine|decitabine|mesh-list
83511574|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83511575|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
83511576|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511577|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511578|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511579|NCT01688102|Vitamin D|vitamin d|mesh-list
83511580|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
83511581|NCT01688102|Vitamins|vitamins|mesh-ancestor
83511582|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
83511583|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511584|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83511585|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83511586|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83511587|NCT01994993|Metronidazole|metronidazole|mesh-list
83511588|NCT01994993|Clindamycin|clindamycin|mesh-list
83511589|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
83511590|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
83511591|NCT01994993|Gentamicins|gentamicins|mesh-list
83511592|NCT01994993|Tazobactam|tazobactam|mesh-list
83511593|NCT01994993|Piperacillin|piperacillin|mesh-list
83511594|NCT01994993|Ampicillin|ampicillin|mesh-list
83511595|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83511596|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511597|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83511598|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83511599|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83511600|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511601|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511602|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83511604|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
83511605|NCT01688336|Irinotecan|irinotecan|mesh-list
83511606|NCT01688336|Folfirinox|folfirinox|mesh-list
83511607|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511608|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83511609|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83511610|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511611|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511612|NCT01688336|Antidotes|antidotes|mesh-ancestor
83511613|NCT01688336|Protective Agents|protective agents|mesh-ancestor
83511614|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511615|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
83511616|NCT01688336|Vitamins|vitamins|mesh-ancestor
83511617|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
83511618|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
83511619|NCT01963481|Exemestane|exemestane|mesh-list
83511620|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83511621|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
83511622|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511623|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511624|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83511625|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
83511626|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511627|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511628|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83511629|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83511630|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83511631|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511632|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83511633|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
83511634|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83511635|NCT04436744|Palbociclib|palbociclib|mesh-list
83511636|NCT04436744|Anastrozole|anastrozole|mesh-list
83511637|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511638|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83511639|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511640|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511641|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83511642|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83511643|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83511644|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83511646|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83511647|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511648|NCT01963793|Aprepitant|aprepitant|mesh-list
83511649|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
83511650|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
83511651|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
83511652|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511653|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511654|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83511655|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83511656|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511657|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511658|NCT03449433|Insulin|insulin|mesh-list
83511659|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83511660|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
83511661|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
83511662|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83511663|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
83511664|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83511665|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511666|NCT03241485|Morphine|morphine|mesh-list
83511667|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83511668|NCT03241485|Narcotics|narcotics|mesh-ancestor
83511669|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511670|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511671|NCT03241485|Analgesics|analgesics|mesh-ancestor
83511672|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
83511673|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511674|NCT04313504|Niraparib|niraparib|mesh-list
83511675|NCT04313504|Dostarlimab|dostarlimab|mesh-list
83511676|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83511677|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511678|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511679|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511680|NCT01996943|Ethanol|ethanol|mesh-list
83511681|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83511682|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511683|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511684|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511685|NCT04812626|Triamcinolone|triamcinolone|mesh-list
83511686|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83511687|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83511688|NCT04812626|Fluorouracil|fluorouracil|mesh-list
83511689|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83511690|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
83511691|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511692|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83511693|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511694|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83511695|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
83511696|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511697|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83511698|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
83511699|NCT04812626|Hormones|hormones|mesh-ancestor
83511700|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83511701|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511702|NCT04197986|Infigratinib|infigratinib|mesh-list
83511703|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511704|NCT01997411|Glucagon|glucagon|mesh-list
83511705|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83511706|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83511707|NCT01997411|Hormones|hormones|mesh-ancestor
83511708|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83511709|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511710|NCT01997411|Incretins|incretins|mesh-ancestor
83511711|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
83511712|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83511713|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511714|NCT03534635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83511715|NCT03534635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511716|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
83511717|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
83511718|NCT02657486|Infigratinib|infigratinib|mesh-list
83511719|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511720|NCT02385110|Dexamethasone|dexamethasone|mesh-list
83511724|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83511725|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
83511726|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
83511727|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511728|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511729|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83511730|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
83511731|NCT02385110|Hormones|hormones|mesh-ancestor
83511732|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83511733|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83511734|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511735|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83511736|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
83511737|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83511738|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83511739|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
83511740|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511741|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
83511742|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511743|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83511744|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83511745|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
83511746|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511747|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83511748|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83511749|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83511750|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83511751|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83511752|NCT01999985|Dasatinib|dasatinib|mesh-list
83511753|NCT01999985|Afatinib|afatinib|mesh-list
83511754|NCT01999985|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83511755|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511756|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83511757|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511758|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511759|NCT01968317|Metformin|metformin|mesh-list
83511760|NCT01968317|Megestrol|megestrol|mesh-list
83511761|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
83511762|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83511763|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511764|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83511765|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83511766|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83511767|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
83511768|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83511769|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83511770|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83511771|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83511772|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511773|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
83511774|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83511775|NCT01971593|Eplerenone|eplerenone|mesh-list
83511776|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83511777|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
83511778|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83511779|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511780|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83511781|NCT01971593|Diuretics|diuretics|mesh-ancestor
83511782|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
83511783|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83511784|NCT02986451|Clarithromycin|clarithromycin|mesh-list
83511785|NCT02986451|Dexamethasone|dexamethasone|mesh-list
83511786|NCT02986451|Lenalidomide|lenalidomide|mesh-list
83511787|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83511788|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
83511789|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
83511790|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511791|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511792|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83511793|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
83511794|NCT02986451|Hormones|hormones|mesh-ancestor
83511795|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83511796|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83511797|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511799|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83511800|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83511801|NCT02986451|Growth Substances|growth substances|mesh-ancestor
83511802|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
83511803|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83511804|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511805|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83511806|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511807|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511808|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83511809|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83511810|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
83511811|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83511812|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
83511813|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511814|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
83511815|NCT03245463|Protective Agents|protective agents|mesh-ancestor
83511816|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
83511817|NCT01974245|Vitamin D|vitamin d|mesh-list
83511818|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83511819|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511820|NCT01974245|Vitamins|vitamins|mesh-ancestor
83511821|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
83511822|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83511823|NCT03307005|Zolpidem|zolpidem|mesh-list
83511824|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83511825|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83511826|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511827|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511828|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83511829|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
83511830|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
83511831|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511832|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511833|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83511834|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83511835|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83511836|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83511837|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511838|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511839|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511840|NCT02005601|Analgesics|analgesics|mesh-ancestor
83511841|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
83511842|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511843|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
83511844|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83511845|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
83511846|NCT02007863|Fludarabine|fludarabine|mesh-list
83511847|NCT02007863|Melphalan|melphalan|mesh-list
83511848|NCT02007863|Busulfan|busulfan|mesh-list
83511849|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511850|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511851|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83511852|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
83511853|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511854|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83511855|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
83511856|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83511857|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83511858|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511859|NCT02305277|Opicapone|opicapone|mesh-list
83511860|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83511861|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511862|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511863|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83511864|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83511865|NCT03309657|Tazobactam|tazobactam|mesh-list
83511866|NCT03309657|Ceftolozane|ceftolozane|mesh-list
83511867|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83511868|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83511869|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83511870|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83511871|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512021|NCT03496545|Analgesics|analgesics|mesh-ancestor
83413629|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511872|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511873|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83511874|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
83511875|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83511876|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511877|NCT03463161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83511878|NCT03463161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511879|NCT03467685|Anesthetics|anesthetics|mesh-list
83511880|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511881|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511882|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
83511883|NCT03468075|Gemcitabine|gemcitabine|mesh-list
83511884|NCT03468075|Vitamins|vitamins|mesh-ancestor
83511885|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
83511886|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511887|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83511888|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
83511889|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511890|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511891|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
83511892|NCT03468075|Protective Agents|protective agents|mesh-ancestor
83511893|NCT03468933|Plasminogen|plasminogen|mesh-list
83511894|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83511895|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83511896|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83511897|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511898|NCT03472287|Diacerein|diacerein|mesh-list
83511899|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83511900|NCT02219984|Anticoagulants|anticoagulants|mesh-list
83511901|NCT02067416|Paclitaxel|paclitaxel|mesh-list
83511902|NCT02067416|Docetaxel|docetaxel|mesh-list
83511903|NCT02067416|Epirubicin|epirubicin|mesh-list
83511904|NCT02067416|Taxane|taxane|mesh-list
83511905|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83511906|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511907|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
83511908|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
83511909|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
83511910|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511911|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83511912|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83511913|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83511914|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511915|NCT03258645|Dabigatran|dabigatran|mesh-list
83511916|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
83511917|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83511918|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
83511919|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511920|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511921|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
83511922|NCT03482583|Nicotine|nicotine|mesh-list
83511923|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83511924|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
83511925|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511926|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511927|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83511928|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83511929|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
83511930|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511931|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511932|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
83511933|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83511934|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
83511935|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511936|NCT03261999|Leuprolide|leuprolide|mesh-list
83511937|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83511938|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
83511939|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83511940|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511941|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83511942|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511943|NCT03482973|Bupivacaine|bupivacaine|mesh-list
83511944|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
83511945|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
83511946|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83511947|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511948|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
83511949|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511950|NCT01602380|Fulvestrant|fulvestrant|mesh-list
83511951|NCT01602380|Anastrozole|anastrozole|mesh-list
83511952|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83511953|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511954|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83511955|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83511956|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
83511957|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83511958|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511959|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83511960|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83511961|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511962|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511963|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83511964|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
83511965|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511966|NCT03327051|Omeprazole|omeprazole|mesh-list
83511967|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83511968|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83511969|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83511970|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511971|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83511972|NCT02057939|Leuprolide|leuprolide|mesh-list
83511973|NCT02057939|Androgens|androgens|mesh-list
83511974|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83511975|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
83511976|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83511977|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511978|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83511979|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511980|NCT02057939|Hormones|hormones|mesh-ancestor
83511981|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83511982|NCT03496467|Nepafenac|nepafenac|mesh-list
83511983|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83511984|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83511985|NCT03496467|Analgesics|analgesics|mesh-ancestor
83511986|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
83511987|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511988|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511989|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83511990|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511991|NCT00482690|Nicotine|nicotine|mesh-list
83511992|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83511993|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
83511994|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511995|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511996|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83511997|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83511998|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
83511999|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512000|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512001|NCT02058251|Oxytocin|oxytocin|mesh-list
83512002|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
83512003|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83512004|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512005|NCT03329937|Niraparib|niraparib|mesh-list
83512006|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83512007|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512008|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512009|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512010|NCT01710254|Regadenoson|regadenoson|mesh-list
83512011|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83512012|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83512013|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
83512014|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
83512015|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512016|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512017|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512018|NCT03496545|Acetaminophen|acetaminophen|mesh-list
83512019|NCT03496545|Bromocriptine|bromocriptine|mesh-list
83512020|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83512022|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
83512023|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512024|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512025|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
83512026|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83512027|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83512028|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
83512029|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512030|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
83512031|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
83512032|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512033|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512034|NCT01710332|Aflibercept|aflibercept|mesh-list
83512035|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83512036|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83512037|NCT01710332|Growth Substances|growth substances|mesh-ancestor
83512038|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512039|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
83512040|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512041|NCT02311907|Paclitaxel|paclitaxel|mesh-list
83512042|NCT02311907|Carboplatin|carboplatin|mesh-list
83512043|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83512044|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83512045|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512046|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
83512047|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
83512048|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
83512049|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512050|NCT02013245|Vaccines|vaccines|mesh-list
83512051|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
83512052|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512053|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
83512054|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
83512055|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512056|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
83512057|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512058|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512059|NCT01981967|Vaccines|vaccines|mesh-list
83512060|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
83512061|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512062|NCT01982123|Edetic Acid|edetic acid|mesh-list
83512063|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
83512064|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
83512065|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
83512066|NCT01982123|Antidotes|antidotes|mesh-ancestor
83512067|NCT01982123|Protective Agents|protective agents|mesh-ancestor
83512068|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512069|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
83512070|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
83512071|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512072|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83512073|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
83512074|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83512075|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83512076|NCT02061683|Bimatoprost|bimatoprost|mesh-list
83512077|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83512078|NCT01711658|Lapatinib|lapatinib|mesh-list
83512079|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512080|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83512081|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512082|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512083|NCT01712360|Naftifine|naftifine|mesh-list
83512084|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
83512085|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512086|NCT02396147|Relugolix|relugolix|mesh-list
83512087|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
83512088|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
83512089|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512090|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512091|NCT01713608|Artefenomel|artefenomel|mesh-list
83512092|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
83512093|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83512094|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83512095|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512096|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83512097|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413630|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
83512098|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512099|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512101|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83512102|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83512103|NCT02018627|Hormones|hormones|mesh-ancestor
83512104|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512105|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512106|NCT02018627|Incretins|incretins|mesh-ancestor
83512107|NCT03476330|Quercetin|quercetin|mesh-list
83512108|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
83512109|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512110|NCT03476330|Protective Agents|protective agents|mesh-ancestor
83512111|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512112|NCT04413344|Bromocriptine|bromocriptine|mesh-list
83512113|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83512114|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83512115|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
83512116|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512117|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512118|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
83512119|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
83512120|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512121|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512122|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83512124|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83512125|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83512126|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512127|NCT01717898|Prednisone|prednisone|mesh-list
83512128|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
83512129|NCT01717898|Dactolisib|dactolisib|mesh-list
83512130|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83512131|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
83512132|NCT01717898|Hormones|hormones|mesh-ancestor
83512133|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512134|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512135|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83512136|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512137|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83512138|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512139|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512140|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
83512141|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83512142|NCT01737944|Methotrexate|methotrexate|mesh-list
83512143|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83512144|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
83512145|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83512146|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512147|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83512148|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
83512149|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512150|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512151|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
83512152|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512153|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83512154|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83512155|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
83512156|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83512157|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83512158|NCT01740206|Methylphenidate|methylphenidate|mesh-list
83512159|NCT01740206|Amphetamine|amphetamine|mesh-list
83512160|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83512161|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512162|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83512163|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83512164|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83512165|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512166|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
83512167|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512168|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
83512169|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
83512170|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512172|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83512173|NCT01740362|Tofacitinib|tofacitinib|mesh-list
83512174|NCT01740362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83512175|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83512176|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512177|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512178|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83512179|NCT02068157|Trioxsalen|trioxsalen|mesh-list
83512180|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512181|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
83512182|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83512183|NCT01741454|Tamsulosin|tamsulosin|mesh-list
83512184|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83512185|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83512186|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83512187|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83512188|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
83512189|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512190|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512191|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512192|NCT01741454|Urological Agents|urological agents|mesh-ancestor
83512193|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83512194|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83512195|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
83512196|NCT01720316|Glycine|glycine|mesh-list
83512197|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
83512198|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512199|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512200|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512201|NCT02399345|Ritonavir|ritonavir|mesh-list
83512202|NCT02399345|Ribavirin|ribavirin|mesh-list
83512203|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
83512204|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83512205|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83512206|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
83512207|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512208|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512209|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83512210|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83512211|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
83512212|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512213|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83512214|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83512215|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
83512216|NCT02400437|Dexamethasone|dexamethasone|mesh-list
83512217|NCT02400437|Rituximab|rituximab|mesh-list
83512218|NCT02400437|Ixazomib|ixazomib|mesh-list
83512219|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83512220|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512221|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
83512222|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512223|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83512224|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83512225|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
83512226|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
83512227|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512228|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83512229|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
83512230|NCT02400437|Hormones|hormones|mesh-ancestor
83512231|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512232|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83512233|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
83512234|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512235|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512236|NCT02024477|Saxagliptin|saxagliptin|mesh-list
83512237|NCT02024477|Incretins|incretins|mesh-ancestor
83512238|NCT02024477|Hormones|hormones|mesh-ancestor
83512239|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512240|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512241|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83512242|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
83512243|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512244|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512245|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83512246|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
83512247|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83512248|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
83512249|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512251|NCT02024711|Protective Agents|protective agents|mesh-ancestor
83512252|NCT02071823|Opicapone|opicapone|mesh-list
83512253|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83512254|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512255|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512256|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83512257|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83512258|NCT02029703|Hylan|hylan|mesh-list
83512259|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
83512260|NCT02029703|Protective Agents|protective agents|mesh-ancestor
83512261|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512262|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83512263|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83512264|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512265|NCT02406443|Incretins|incretins|mesh-ancestor
83512267|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512268|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83512269|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
83512270|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512271|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512272|NCT02032433|Naltrexone|naltrexone|mesh-list
83512273|NCT02032433|Buprenorphine|buprenorphine|mesh-list
83512274|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83512275|NCT02032433|Naloxone|naloxone|mesh-list
83512276|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83512277|NCT02032433|Narcotics|narcotics|mesh-ancestor
83512278|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83512279|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512280|NCT02032433|Analgesics|analgesics|mesh-ancestor
83512281|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
83512282|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512283|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83512284|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83512285|NCT02342015|Atorvastatin|atorvastatin|mesh-list
83512286|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83512287|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83512288|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
83512289|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512290|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83512291|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83512292|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512293|NCT02342327|Menthol|menthol|mesh-list
83512294|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
83512295|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
83512296|NCT01721564|Bosentan|bosentan|mesh-list
83512297|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83512298|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83512299|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512300|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
83512301|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83512302|NCT02343575|Valproic Acid|valproic acid|mesh-list
83512303|NCT02343575|Haloperidol|haloperidol|mesh-list
83512304|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
83512305|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
83512306|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
83512307|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512308|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512309|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83512310|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83512311|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83512312|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83512313|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83512314|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83512315|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
83512316|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512317|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512318|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83512319|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
83512320|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512321|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
83512322|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
83512323|NCT01744574|Progesterone|progesterone|mesh-list
83512326|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512327|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512328|NCT01744730|Clindamycin|clindamycin|mesh-list
83512329|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
83512330|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
83512331|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83512332|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512333|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83512334|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512335|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512336|NCT02033993|Paclitaxel|paclitaxel|mesh-list
83512337|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83512338|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83512339|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512340|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83512341|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83512342|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83512343|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512344|NCT00354965|Amoxicillin|amoxicillin|mesh-list
83512345|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
83512346|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
83512347|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83512348|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83512349|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512350|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83512351|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512352|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512353|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83512354|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83512355|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83512356|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512357|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512358|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83512359|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83512360|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512361|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
83512362|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512363|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
83512364|NCT00355043|Astringents|astringents|mesh-ancestor
83512365|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512366|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
83512367|NCT02037893|Antipyrine|antipyrine|mesh-list
83512368|NCT02037893|Benzocaine|benzocaine|mesh-list
83512369|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83512370|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
83512371|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
83512372|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83512373|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512374|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
83512375|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512376|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83512377|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83512378|NCT02037893|Analgesics|analgesics|mesh-ancestor
83512379|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83512380|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83512381|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83512382|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83512383|NCT02041325|Lenalidomide|lenalidomide|mesh-list
83512384|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
83512385|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512386|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83512387|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83512388|NCT02041325|Growth Substances|growth substances|mesh-ancestor
83512389|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
83512390|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512391|NCT01723514|Erenumab|erenumab|mesh-list
83512392|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83512393|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512394|NCT01723514|Analgesics|analgesics|mesh-ancestor
83512395|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
83512396|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512397|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512398|NCT02044367|Dabigatran|dabigatran|mesh-list
83512400|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83512401|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
83512402|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413631|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512403|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512404|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
83512405|NCT01745822|Tenofovir|tenofovir|mesh-list
83512406|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
83512407|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512408|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83512409|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83512410|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512411|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512412|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83512413|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83512414|NCT05718869|Zanubrutinib|zanubrutinib|mesh-list
83512415|NCT05718869|Immunoglobulins|immunoglobulins|mesh-list
83512416|NCT05718869|Immunologic Factors|immunologic factors|mesh-ancestor
83512417|NCT05718869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512418|NCT05718869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512419|NCT05718869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83512420|NCT05718869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512421|NCT05718869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512422|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
83512424|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512425|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83512426|NCT01747850|Ethanol|ethanol|mesh-list
83512427|NCT01747850|Nabiximols|nabiximols|mesh-list
83512428|NCT01747850|Dronabinol|dronabinol|mesh-list
83512429|NCT01747850|Cannabidiol|cannabidiol|mesh-list
83512430|NCT01747850|Peppermint oil|peppermint oil|mesh-list
83512431|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
83512432|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83512433|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512434|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83512435|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512436|NCT01747850|Analgesics|analgesics|mesh-ancestor
83512437|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
83512438|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512439|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
83512440|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83512441|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83512442|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83512443|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83512444|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512445|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512446|NCT01747850|Hormones|hormones|mesh-ancestor
83512447|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512448|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
83512449|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
83512450|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83512451|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
83512452|NCT01727414|Methylphenidate|methylphenidate|mesh-list
83512453|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83512454|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512455|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83512456|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83512457|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83512458|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512459|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
83512460|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512461|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83512462|NCT02048891|Progesterone|progesterone|mesh-list
83512463|NCT02048891|Progestins|progestins|mesh-ancestor
83512464|NCT02048891|Hormones|hormones|mesh-ancestor
83512465|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512466|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512467|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
83512468|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83512469|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
83512470|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83512471|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83512472|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83512473|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512474|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83512476|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
83512477|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83512478|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83512479|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83512480|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83512481|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512482|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
83512483|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512484|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512485|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
83512486|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
83512487|NCT02355821|Bisoprolol|bisoprolol|mesh-list
83512488|NCT02355821|Moxonidine|moxonidine|mesh-list
83512489|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83512490|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
83512491|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
83512492|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512493|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512494|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83512495|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83512496|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83512497|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
83512498|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512499|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512500|NCT01748240|Azacitidine|azacitidine|mesh-list
83512501|NCT01748240|Vorinostat|vorinostat|mesh-list
83512502|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83512503|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
83512504|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512505|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512506|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512507|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83512508|NCT01748942|Dexamethasone|dexamethasone|mesh-list
83512509|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
83512510|NCT01748942|Ichthammol|ichthammol|mesh-list
83512511|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83512512|NCT01748942|BB 1101|bb 1101|mesh-list
83512513|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83512514|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
83512515|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
83512516|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512517|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512518|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83512519|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
83512520|NCT01748942|Hormones|hormones|mesh-ancestor
83512521|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512522|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83512523|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512524|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
83512525|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512526|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512527|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
83512528|NCT02355977|Minocycline|minocycline|mesh-list
83512529|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83512530|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512531|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
83512532|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83512533|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83512534|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83512535|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83512536|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512537|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
83512538|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512539|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512540|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83512541|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512542|NCT01729598|Valproic Acid|valproic acid|mesh-list
83512543|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
83512544|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512545|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512546|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
83512547|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512548|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512549|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
83512550|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83512551|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83512552|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83512553|NCT05718011|Dexmedetomidine|dexmedetomidine|mesh-list
83512554|NCT05718011|Ketamine|ketamine|mesh-list
83512555|NCT05718011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83512556|NCT05718011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83512557|NCT05718011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512558|NCT05718011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83512559|NCT05718011|Analgesics|analgesics|mesh-ancestor
83512560|NCT05718011|Sensory System Agents|sensory system agents|mesh-ancestor
83512561|NCT05718011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512562|NCT05718011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83512564|NCT05718011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83512565|NCT05718011|Adrenergic Agents|adrenergic agents|mesh-ancestor
83512566|NCT05718011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512567|NCT05718011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512568|NCT05718011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83512569|NCT05718011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83512570|NCT05718011|Anesthetics, General|anesthetics, general|mesh-ancestor
83512571|NCT05718011|Anesthetics|anesthetics|mesh-ancestor
83512572|NCT05718011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83512573|NCT05718011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83512574|NCT05717933|Hormones|hormones|mesh-list
83512575|NCT05717933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512576|NCT05717933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512577|NCT01730846|Doxazosin|doxazosin|mesh-list
83512578|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83512579|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83512580|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83512581|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83512582|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
83512583|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512584|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512585|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512586|NCT02314403|Rituximab|rituximab|mesh-list
83512587|NCT02314403|Abatacept|abatacept|mesh-list
83512588|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83512589|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512590|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
83512591|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512592|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83512593|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83512594|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512595|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83512596|NCT02052557|Bupivacaine|bupivacaine|mesh-list
83512597|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
83512598|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
83512599|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83512600|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512601|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
83512602|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512603|NCT02052635|Clopidogrel|clopidogrel|mesh-list
83512604|NCT02052635|Ticagrelor|ticagrelor|mesh-list
83512605|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83512606|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83512607|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83512608|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83512609|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
83512610|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512611|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512612|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512613|NCT01732718|Atorvastatin|atorvastatin|mesh-list
83512614|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83512615|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83512616|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
83512617|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512618|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83512619|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83512620|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512621|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
83512622|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83512623|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
83512624|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83512625|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512626|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83512627|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83512629|NCT02363621|Ranibizumab|ranibizumab|mesh-list
83512630|NCT02363621|Aflibercept|aflibercept|mesh-list
83512631|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83512632|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83512633|NCT02363621|Growth Substances|growth substances|mesh-ancestor
83512634|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512635|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
83512636|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512637|NCT01749956|Leucovorin|leucovorin|mesh-list
83512638|NCT01749956|Fluorouracil|fluorouracil|mesh-list
83512639|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
83512640|NCT01749956|Aflibercept|aflibercept|mesh-list
83512641|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
83512642|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512643|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83512644|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512645|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83512646|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
83512647|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512648|NCT01749956|Antidotes|antidotes|mesh-ancestor
83512649|NCT01749956|Protective Agents|protective agents|mesh-ancestor
83512650|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
83512651|NCT01749956|Vitamins|vitamins|mesh-ancestor
83512652|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
83512653|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83512654|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83512655|NCT01749956|Growth Substances|growth substances|mesh-ancestor
83512656|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
83512657|NCT02365961|Clonidine|clonidine|mesh-list
83512658|NCT02365961|Epinephrine|epinephrine|mesh-list
83512659|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83512660|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83512661|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
83512662|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512663|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512664|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512665|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83512666|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83512667|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
83512668|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512669|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83512670|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
83512671|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
83512672|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
83512673|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83512674|NCT02365961|Analgesics|analgesics|mesh-ancestor
83512675|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
83512676|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83512677|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
83512678|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83512679|NCT05532059|Cisplatin|cisplatin|mesh-list
83512680|NCT05532059|Gemcitabine|gemcitabine|mesh-list
83512681|NCT05532059|Lenvatinib|lenvatinib|mesh-list
83512682|NCT05532059|Tislelizumab|tislelizumab|mesh-list
83512683|NCT05532059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512684|NCT05532059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83512685|NCT05532059|Antimetabolites|antimetabolites|mesh-ancestor
83512686|NCT05532059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512687|NCT05532059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83512688|NCT05532059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512689|NCT05532059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83512690|NCT03809234|Ondansetron|ondansetron|mesh-list
83512691|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
83512692|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
83512693|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512694|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512695|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83512696|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
83512697|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
83512698|NCT03809234|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83512699|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83512700|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
83512701|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512702|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512703|NCT03711188|Nivolumab|nivolumab|mesh-list
83512704|NCT03711188|Ipilimumab|ipilimumab|mesh-list
83512705|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83512706|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512707|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83512708|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512709|NCT02366663|Cytarabine|cytarabine|mesh-list
83512711|NCT02366663|Etoposide|etoposide|mesh-list
83512712|NCT02366663|Melphalan|melphalan|mesh-list
83512713|NCT02366663|Carmustine|carmustine|mesh-list
83512714|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83512715|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512716|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
83512717|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512718|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83512719|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83512720|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83512721|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83512722|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512723|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512724|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83512725|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
83512726|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
83512727|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512728|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83512729|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83512730|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
83512731|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83512732|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83512733|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
83512734|NCT01754480|Coagulants|coagulants|mesh-ancestor
83512735|NCT02367599|Vitamin D|vitamin d|mesh-list
83512736|NCT02367599|Vitamins|vitamins|mesh-ancestor
83512737|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
83512738|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512739|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83512740|NCT02368457|Tocopherols|tocopherols|mesh-list
83512741|NCT02368457|Vitamin E|vitamin e|mesh-list
83512742|NCT02368457|Tocotrienols|tocotrienols|mesh-list
83512743|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
83512744|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
83512745|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83512746|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512747|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512748|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83512749|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83512750|NCT02368457|Protective Agents|protective agents|mesh-ancestor
83512751|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512752|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
83512753|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83512754|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
83512755|NCT02368457|Vitamins|vitamins|mesh-ancestor
83512756|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
83512757|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
83512758|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83512759|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512760|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83512761|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512762|NCT02373137|Ofloxacin|ofloxacin|mesh-list
83512763|NCT02373137|Prednisolone|prednisolone|mesh-list
83512764|NCT02373137|Phenylephrine|phenylephrine|mesh-list
83512765|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
83512766|NCT02373137|Tropicamide|tropicamide|mesh-list
83512767|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83512768|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
83512769|NCT02373137|Hormones|hormones|mesh-ancestor
83512770|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83512771|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512772|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83512773|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512774|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
83512775|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512776|NCT02373137|Protective Agents|protective agents|mesh-ancestor
83512777|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83512780|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83512781|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
83512782|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
83512783|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83512784|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83512785|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83512786|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
83512787|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512788|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512789|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83512790|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83512791|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
83512792|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83512793|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512794|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83512795|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83512796|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83512797|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512798|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83512799|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83512800|NCT05488067|Atorvastatin|atorvastatin|mesh-list
83512801|NCT05488067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83512802|NCT05488067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83512803|NCT05488067|Antimetabolites|antimetabolites|mesh-ancestor
83512804|NCT05488067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512805|NCT05488067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83512806|NCT05488067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83512807|NCT05488067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512808|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83512809|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83512810|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
83512811|NCT00354653|Lamivudine|lamivudine|mesh-list
83512812|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83512813|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83512814|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512815|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512816|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
83512817|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512818|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83512819|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83512820|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
83512821|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83512822|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512823|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512824|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83512825|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83512826|NCT00354731|Protective Agents|protective agents|mesh-ancestor
83512827|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512828|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
83512829|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83512830|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
83512831|NCT00354809|Casopitant|casopitant|mesh-list
83512832|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
83512833|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
83512834|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512835|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512836|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83512837|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83512838|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512839|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512840|NCT04769258|Vaccines|vaccines|mesh-list
83512841|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
83512842|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512843|NCT01762904|Ethanol|ethanol|mesh-list
83512844|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
83512845|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83512846|NCT01762904|Triclosan|triclosan|mesh-list
83512847|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83512848|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512849|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83512850|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512851|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
83512852|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
83512853|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83512854|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83512855|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
83512856|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512857|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83512858|NCT02376257|Cycloserine|cycloserine|mesh-list
83512859|NCT02376257|Modafinil|modafinil|mesh-list
83512860|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83512861|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512862|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83512863|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83512864|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83512865|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512866|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83512867|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512868|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83512869|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
83512870|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83512871|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
83512872|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83512873|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83512874|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512875|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
83512876|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83512877|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83512878|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83512879|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512880|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
83512881|NCT03211286|Coagulants|coagulants|mesh-ancestor
83512882|NCT01763606|Aspirin|aspirin|mesh-list
83512883|NCT01763606|Enoxaparin|enoxaparin|mesh-list
83512884|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83512885|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83512886|NCT01763606|Analgesics|analgesics|mesh-ancestor
83512887|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
83512888|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512889|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512890|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83512891|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83512892|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83512893|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83512894|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512895|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83512896|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83512897|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512898|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
83512899|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
83512900|NCT03161756|Denosumab|denosumab|mesh-list
83512901|NCT03161756|Nivolumab|nivolumab|mesh-list
83512902|NCT03161756|Ipilimumab|ipilimumab|mesh-list
83512903|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83512904|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512905|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83512906|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512907|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83512908|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512909|NCT01766024|Interferons|interferons|mesh-list
83512910|NCT01766024|Interferon-beta|interferon-beta|mesh-list
83512911|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
83512912|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512913|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
83512914|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512915|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
83512916|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512917|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83512918|NCT01767506|Azithromycin|azithromycin|mesh-list
83512919|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83512920|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512921|NCT02383043|Cocaine|cocaine|mesh-list
83512922|NCT02383043|Amphetamine|amphetamine|mesh-list
83512923|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
83512924|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83512925|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512926|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
83512927|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
83513000|NCT02239874|Vitamin D|vitamin d|mesh-list
83512928|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512929|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
83512930|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512931|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512932|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
83512933|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83512934|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83512935|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83512936|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83512937|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
83512938|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
83512939|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83512940|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
83512941|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83512942|NCT01768520|Celecoxib|celecoxib|mesh-list
83512943|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83512944|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83512945|NCT01768520|Analgesics|analgesics|mesh-ancestor
83512946|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
83512947|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83512948|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512949|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83512950|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83512951|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83512952|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83512953|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512954|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512955|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83512956|NCT00355589|Ramipril|ramipril|mesh-list
83512957|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83512958|NCT00355589|Diuretics|diuretics|mesh-ancestor
83512959|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
83512960|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512961|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83512962|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83512963|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512964|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83512965|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
83512966|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512967|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83512968|NCT01769222|Ipilimumab|ipilimumab|mesh-list
83512969|NCT01769222|Antibodies|antibodies|mesh-list
83512970|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
83512971|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83512972|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
83512973|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512974|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83512975|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83512976|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512977|NCT02386319|Melatonin|melatonin|mesh-list
83512978|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
83512979|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512980|NCT02386319|Protective Agents|protective agents|mesh-ancestor
83512981|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512982|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83512983|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83512984|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
83512985|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512986|NCT02387801|Ixekizumab|ixekizumab|mesh-list
83512987|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
83512988|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
83512989|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83512990|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
83512991|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83512992|NCT05284097|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83512993|NCT05284097|Antiviral Agents|antiviral agents|mesh-ancestor
83512994|NCT05284097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83512995|NCT02326844|Talazoparib|talazoparib|mesh-list
83512996|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83512997|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83512998|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512999|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513005|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513006|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83513007|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83513008|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
83513009|NCT01771952|Hylan|hylan|mesh-list
83513010|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83513011|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
83513012|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513013|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
83513014|NCT01771952|Protective Agents|protective agents|mesh-ancestor
83513015|NCT02389361|Acetaminophen|acetaminophen|mesh-list
83513016|NCT02389361|Tramadol|tramadol|mesh-list
83513017|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83513018|NCT02389361|Analgesics|analgesics|mesh-ancestor
83513019|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
83513020|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513021|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513022|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
83513023|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83513024|NCT02389361|Narcotics|narcotics|mesh-ancestor
83513025|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513026|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83513027|NCT02252354|Relugolix|relugolix|mesh-list
83513028|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
83513029|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
83513030|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83513031|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513032|NCT02393339|Acetaminophen|acetaminophen|mesh-list
83513033|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83513034|NCT02393339|Analgesics|analgesics|mesh-ancestor
83513035|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
83513036|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513037|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513038|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
83513039|NCT05235191|Methadone|methadone|mesh-list
83513040|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83513041|NCT05235191|Narcotics|narcotics|mesh-ancestor
83513042|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513043|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513044|NCT05235191|Analgesics|analgesics|mesh-ancestor
83513045|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
83513046|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513047|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
83513048|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
83513049|NCT01774604|Indomethacin|indomethacin|mesh-list
83513050|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83513051|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83513052|NCT01774604|Analgesics|analgesics|mesh-ancestor
83513053|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
83513054|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513055|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513056|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513057|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83513058|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
83513059|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
83513060|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83513061|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83513062|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513063|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513064|NCT01777412|Bevacizumab|bevacizumab|mesh-list
83513065|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83513066|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513067|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83513068|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83513069|NCT01777412|Growth Substances|growth substances|mesh-ancestor
83513070|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513071|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
83513072|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83513073|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83513074|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513075|NCT04873349|Oleuropein|oleuropein|mesh-list
83513076|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513077|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83513078|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
83513079|NCT01780454|Rituximab|rituximab|mesh-list
83513080|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83513081|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513082|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
83513083|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513084|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83513085|NCT04869449|Ketoconazole|ketoconazole|mesh-list
83513086|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
83513087|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513088|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83513089|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83513090|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513091|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513092|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83513093|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
83513094|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83513095|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513096|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83513097|NCT00355901|Visilizumab|visilizumab|mesh-list
83513098|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
83513099|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513100|NCT00355667|Furosemide|furosemide|mesh-list
83513101|NCT00355667|Azosemide|azosemide|mesh-list
83513102|NCT00355667|Diuretics|diuretics|mesh-ancestor
83513103|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
83513104|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513105|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83513106|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83513107|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513108|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83513109|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
83513110|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513111|NCT04419948|Ibuprofen|ibuprofen|mesh-list
83513112|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83513113|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83513114|NCT04419948|Analgesics|analgesics|mesh-ancestor
83513115|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
83513116|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513117|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513118|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513119|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83513120|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83513121|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513122|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513123|NCT01312922|Dexetimide|dexetimide|mesh-list
83513124|NCT01312922|Pipamperone|pipamperone|mesh-list
83513125|NCT01312922|Citalopram|citalopram|mesh-list
83513126|NCT01312922|Escitalopram|escitalopram|mesh-list
83513127|NCT01312922|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83513128|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83513129|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83513130|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513131|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513132|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
83513133|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513134|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83513135|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
83513136|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83513137|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83513138|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83513139|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
83513140|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
83513141|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513142|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83513143|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83513144|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
83513145|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83513146|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83513147|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83513148|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513149|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
83513150|NCT01783574|Testosterone|testosterone|mesh-list
83513151|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
83513152|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
83513153|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83513154|NCT01783574|Androgens|androgens|mesh-ancestor
83513156|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83513157|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513158|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83513159|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513160|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
83513161|NCT03656783|Tenofovir|tenofovir|mesh-list
83513162|NCT03656783|Emtricitabine|emtricitabine|mesh-list
83513163|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83513164|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
83513165|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513166|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83513167|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83513168|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513169|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513170|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83513171|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83513172|NCT01784666|Isradipine|isradipine|mesh-list
83513173|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83513174|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83513175|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83513176|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513177|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83513178|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513179|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
83513180|NCT04362293|Sirolimus|sirolimus|mesh-list
83513181|NCT04362293|Plerixafor|plerixafor|mesh-list
83513182|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
83513183|NCT04362293|Thiotepa|thiotepa|mesh-list
83513184|NCT04362293|Temsirolimus|temsirolimus|mesh-list
83513185|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
83513186|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
83513187|NCT04362293|Azathioprine|azathioprine|mesh-list
83513188|NCT04362293|MTOR Inhibitors|mtor inhibitors|mesh-list
83513189|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83513190|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
83513191|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513192|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83513193|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83513194|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
83513195|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513196|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513197|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83513198|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83513199|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513200|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83513201|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
83513202|NCT04362293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83513203|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513204|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83513205|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
83513206|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83513207|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
83513208|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83513209|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83513210|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83513211|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
83513212|NCT04296695|Tenofovir|tenofovir|mesh-list
83513213|NCT04296695|Efavirenz|efavirenz|mesh-list
83513214|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
83513215|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513216|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83513217|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83513218|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513219|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513220|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83513221|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83513222|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83513223|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83513224|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83513225|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83513226|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83513227|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83513228|NCT04259645|Bupivacaine|bupivacaine|mesh-list
83513231|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513232|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513234|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513235|NCT01787006|Fluorouracil|fluorouracil|mesh-list
83513236|NCT01787006|Cetuximab|cetuximab|mesh-list
83513237|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513238|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
83413632|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83513239|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513240|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83513241|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83513242|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
83513243|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513244|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83513245|NCT02260622|Aspirin|aspirin|mesh-list
83513246|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
83513247|NCT02260622|Clopidogrel|clopidogrel|mesh-list
83513248|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83513249|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83513250|NCT02260622|Analgesics|analgesics|mesh-ancestor
83513251|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
83513252|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513253|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513254|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513255|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83513256|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83513257|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83513258|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513259|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83513260|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83513261|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513262|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
83513263|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83513264|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83513265|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83513266|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
83513267|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513268|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83513269|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
83513270|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83513271|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
83513272|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
83513273|NCT03186209|Benralizumab|benralizumab|mesh-list
83513274|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83513275|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
83513276|NCT02261948|Simendan|simendan|mesh-list
83513277|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83513278|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
83513279|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83513280|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83513281|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513282|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513283|NCT02261948|Protective Agents|protective agents|mesh-ancestor
83513284|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513285|NCT01787240|Escitalopram|escitalopram|mesh-list
83513286|NCT01787240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83513287|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83513288|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83513289|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513290|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513291|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
83513292|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513293|NCT00357149|Cisplatin|cisplatin|mesh-list
83513294|NCT00357149|Docetaxel|docetaxel|mesh-list
83513295|NCT00357149|Fluorouracil|fluorouracil|mesh-list
83513296|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513297|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
83513298|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
83513299|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
83513300|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513301|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
83513302|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83513303|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83513304|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
83513305|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513307|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83513308|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513309|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
83513310|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
83513311|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
83513312|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513313|NCT04071821|Cetirizine|cetirizine|mesh-list
83513314|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83513315|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83513316|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83513317|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
83513318|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
83513319|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513320|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513321|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513322|NCT03064295|Adenosine|adenosine|mesh-list
83513323|NCT03064295|Regadenoson|regadenoson|mesh-list
83513324|NCT03064295|Analgesics|analgesics|mesh-ancestor
83513325|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
83513326|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513327|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513328|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83513329|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
83513330|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83513331|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
83513332|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
83513333|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513334|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513335|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83513336|NCT01789814|Clopidogrel|clopidogrel|mesh-list
83513337|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83513338|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83513339|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83513340|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83513341|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83513342|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
83513343|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513344|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513345|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513346|NCT00356447|Estradiol|estradiol|mesh-list
83513347|NCT00356447|Estrogens|estrogens|mesh-ancestor
83513348|NCT00356447|Hormones|hormones|mesh-ancestor
83513349|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83513350|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513351|NCT01736852|Oxytocin|oxytocin|mesh-list
83513352|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
83513353|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83513354|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513355|NCT01810952|Insulin|insulin|mesh-list
83513356|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83513357|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
83513358|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
83513359|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
83513360|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
83513361|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
83513362|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83513363|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513364|NCT04059887|Atezolizumab|atezolizumab|mesh-list
83513365|NCT04059887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83513366|NCT04059887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513367|NCT04059887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83513368|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513369|NCT01877642|Lorazepam|lorazepam|mesh-list
83513370|NCT01877642|Loxapine|loxapine|mesh-list
83513371|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
83513372|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
83513373|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
83513374|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513375|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513376|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83513377|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83513378|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513379|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83513380|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83513384|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513385|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513386|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83513387|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83513388|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
83513389|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83513390|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83513391|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513392|NCT01878656|Sevoflurane|sevoflurane|mesh-list
83513393|NCT01878656|Desflurane|desflurane|mesh-list
83513394|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83513395|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83513396|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
83513397|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
83513398|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513399|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513400|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
83513401|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83513402|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
83513403|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513404|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
83513405|NCT01811654|Protective Agents|protective agents|mesh-ancestor
83513406|NCT02266472|Metformin|metformin|mesh-list
83513407|NCT02266472|Empagliflozin|empagliflozin|mesh-list
83513408|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83513409|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513410|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83513411|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513412|NCT03500289|Midazolam|midazolam|mesh-list
83513413|NCT03500289|Ketamine|ketamine|mesh-list
83513414|NCT03500289|Analgesics|analgesics|mesh-ancestor
83513415|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
83513416|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513417|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513418|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83513419|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83513420|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
83513421|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
83513422|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513423|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83513424|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83513425|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513426|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513427|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83513428|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83513429|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83513430|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83513431|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83513432|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
83513433|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
83513434|NCT01812044|Lidocaine|lidocaine|mesh-list
83513435|NCT01812044|Bupivacaine|bupivacaine|mesh-list
83513436|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
83513437|NCT01812044|Anesthetics|anesthetics|mesh-list
83513438|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513439|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513440|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
83513441|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513442|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83513443|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83513444|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83513445|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83513446|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513447|NCT03974789|Dexamethasone|dexamethasone|mesh-list
83513448|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513449|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
83513450|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
83513451|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513452|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513453|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83513454|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
83513455|NCT03974789|Hormones|hormones|mesh-ancestor
83513456|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83513457|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83513458|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513462|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513463|NCT02570477|Vancomycin|vancomycin|mesh-list
83513464|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83513465|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513466|NCT04344821|Calcium|calcium|mesh-list
83513467|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83513468|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513469|NCT04351100|Diacerein|diacerein|mesh-list
83513470|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513471|NCT05328674|Mitogens|mitogens|mesh-list
83513472|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
83513473|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513474|NCT01798316|Acetaminophen|acetaminophen|mesh-list
83513475|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83513476|NCT01798316|Analgesics|analgesics|mesh-ancestor
83513477|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
83513478|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513479|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513480|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
83513481|NCT03883763|Bupivacaine|bupivacaine|mesh-list
83513482|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
83513483|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
83513484|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513485|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513486|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
83513487|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513488|NCT01798394|Progesterone|progesterone|mesh-list
83513489|NCT01798394|Progestins|progestins|mesh-ancestor
83513490|NCT01798394|Hormones|hormones|mesh-ancestor
83513491|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83513492|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513493|NCT01798550|Enoxaparin|enoxaparin|mesh-list
83513494|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
83513495|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83513496|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83513497|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513498|NCT00357305|Cytarabine|cytarabine|mesh-list
83513499|NCT00357305|Etoposide|etoposide|mesh-list
83513500|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
83513501|NCT00357305|Vorinostat|vorinostat|mesh-list
83513502|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83513503|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513504|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83513505|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83513506|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513507|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513508|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83513509|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
83513510|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
83513511|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513512|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83513513|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
83513514|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513515|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83513516|NCT02340000|Amoxicillin|amoxicillin|mesh-list
83513517|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
83513518|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
83513519|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83513520|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83513521|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513522|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83513523|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513524|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513525|NCT01813214|Vemurafenib|vemurafenib|mesh-list
83513526|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513527|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83513528|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513529|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513530|NCT01815008|Aspirin|aspirin|mesh-list
83513531|NCT01815008|Clopidogrel|clopidogrel|mesh-list
83513532|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83513533|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83513534|NCT01815008|Analgesics|analgesics|mesh-ancestor
83513535|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
83513536|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513537|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513538|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513539|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83513540|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83513541|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83513542|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513543|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83513544|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83513545|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513546|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
83513547|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83513548|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83513549|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83513550|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
83513551|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513552|NCT01801124|Bupivacaine|bupivacaine|mesh-list
83513553|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
83513554|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
83513555|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513556|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513557|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
83513558|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513559|NCT00357461|Ipilimumab|ipilimumab|mesh-list
83513560|NCT00357461|Vaccines|vaccines|mesh-list
83513561|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
83513562|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
83513563|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513564|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83513565|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513566|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83513567|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513568|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83513569|NCT00357539|Azithromycin|azithromycin|mesh-list
83513570|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83513571|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513572|NCT03331965|Metoclopramide|metoclopramide|mesh-list
83513573|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
83513574|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
83513575|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513576|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513577|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83513578|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83513579|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83513580|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
83513581|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513582|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513583|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83513584|NCT03279237|Leucovorin|leucovorin|mesh-list
83513585|NCT03279237|Paclitaxel|paclitaxel|mesh-list
83513586|NCT03279237|Carboplatin|carboplatin|mesh-list
83513587|NCT03279237|Fluorouracil|fluorouracil|mesh-list
83513588|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
83513589|NCT03279237|Irinotecan|irinotecan|mesh-list
83513590|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83513591|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513592|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
83513593|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
83513594|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
83513595|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513596|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
83513597|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83513598|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83513599|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
83513600|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513601|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83513602|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83513603|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513604|NCT03279237|Antidotes|antidotes|mesh-ancestor
83513605|NCT03279237|Protective Agents|protective agents|mesh-ancestor
83513606|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
83513607|NCT03279237|Vitamins|vitamins|mesh-ancestor
83513608|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
83513609|NCT03282591|Serlopitant|serlopitant|mesh-list
83513610|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83513611|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513612|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513613|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513617|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83513618|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
83513619|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513620|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513621|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
83513622|NCT03336645|Midazolam|midazolam|mesh-list
83513623|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83513624|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83513625|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513626|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513627|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83513628|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83513629|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83513630|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83513631|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
83513632|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
83513633|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
83513634|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
83513635|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513636|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513637|NCT00376311|Calcitonin|calcitonin|mesh-list
83513638|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
83513639|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83513640|NCT00376311|Katacalcin|katacalcin|mesh-list
83513641|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83513642|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513643|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83513644|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
83513645|NCT03511521|Insulin|insulin|mesh-list
83513646|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83513647|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
83513648|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
83513649|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
83513650|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
83513651|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83513652|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513653|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
83513654|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83513655|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83513656|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
83513657|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83513658|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513659|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
83513660|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
83513661|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513662|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513663|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83513664|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
83513665|NCT00376077|Hormones|hormones|mesh-ancestor
83513666|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83513667|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83513668|NCT00376077|Protective Agents|protective agents|mesh-ancestor
83513669|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83513670|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513671|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
83513672|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
83513673|NCT03519243|Hematinics|hematinics|mesh-ancestor
83513674|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
83513675|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83513676|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513677|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83513678|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83513679|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513680|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513681|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513682|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
83513683|NCT03521505|Propofol|propofol|mesh-list
83513684|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83513685|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513686|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513687|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83513689|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
83513690|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513691|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83513692|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83513695|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513696|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513697|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83513698|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
83513699|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
83513700|NCT03522441|Clindamycin|clindamycin|mesh-list
83513701|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
83513702|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
83513703|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83513704|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513705|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83513706|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513707|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513708|NCT03530631|Adderall|adderall|mesh-list
83513709|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83513710|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513711|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83513712|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
83513713|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
83513714|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
83513715|NCT03351933|Antibodies|antibodies|mesh-list
83513716|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
83513717|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83513718|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83513719|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
83513720|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513721|NCT03594045|Apixaban|apixaban|mesh-list
83513722|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83513723|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
83513724|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83513725|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
83513726|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513727|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513728|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
83513729|NCT03595449|Lidocaine|lidocaine|mesh-list
83513730|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
83513731|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
83513732|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513733|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513734|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
83513735|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513736|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83513737|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83513738|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83513739|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83513740|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513741|NCT03597009|Nivolumab|nivolumab|mesh-list
83513742|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83513743|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83513744|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513745|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83513746|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513747|NCT03352323|Phenylephrine|phenylephrine|mesh-list
83513748|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
83513749|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83513750|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83513751|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
83513752|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513753|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513754|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513755|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
83513756|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
83513757|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513758|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
83513759|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83513760|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
83513761|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83513763|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83513764|NCT03352323|Protective Agents|protective agents|mesh-ancestor
83513765|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
83513766|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513767|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513768|NCT03357393|Midazolam|midazolam|mesh-list
83513769|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
83513770|NCT03357393|Scopolamine|scopolamine|mesh-list
83513774|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83513775|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513776|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513777|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83513778|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
83513779|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
83513780|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83513781|NCT03357393|Narcotics|narcotics|mesh-ancestor
83513782|NCT03357393|Analgesics|analgesics|mesh-ancestor
83513783|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
83513784|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513785|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83513786|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83513787|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83513788|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83513789|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
83513790|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
83513791|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513792|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513793|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83513794|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83513795|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
83513796|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
83513797|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
83513798|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83513799|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
83513800|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
83513801|NCT03541941|Bupivacaine|bupivacaine|mesh-list
83513802|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
83513803|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
83513804|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513805|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513806|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
83513807|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513808|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
83513809|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513810|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83513811|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513812|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513813|NCT03556761|Furosemide|furosemide|mesh-list
83513814|NCT03556761|Diuretics|diuretics|mesh-ancestor
83513815|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
83513816|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513817|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83513818|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83513819|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513820|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
83513821|NCT03559179|Narcotics|narcotics|mesh-ancestor
83513822|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513823|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513824|NCT03559179|Analgesics|analgesics|mesh-ancestor
83513825|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
83513826|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513827|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
83513828|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83513829|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513830|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83513831|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83513832|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513833|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513834|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513835|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83513836|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83513837|NCT03368235|Prednisolone|prednisolone|mesh-list
83513838|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513839|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
83513840|NCT03368235|Hormones|hormones|mesh-ancestor
83513841|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83513842|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513843|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83513844|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513845|NCT02310750|PF-06700841|pf-06700841|mesh-list
83513846|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83513848|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513849|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83513850|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513851|NCT02310672|Macitentan|macitentan|mesh-list
83513852|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83513853|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83513854|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513855|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83513856|NCT03626415|Abrocitinib|abrocitinib|mesh-list
83513857|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83513858|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513859|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513860|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
83513861|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83513862|NCT04373421|Benzydamine|benzydamine|mesh-list
83513863|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83513864|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513865|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
83513866|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
83513867|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513868|NCT03632109|Gentamicins|gentamicins|mesh-list
83513869|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83513870|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513871|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83513872|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513873|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513874|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
83513875|NCT02363946|Promethazine|promethazine|mesh-list
83513876|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83513877|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83513878|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513879|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513880|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
83513881|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
83513882|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
83513883|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513884|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
83513885|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
83513886|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83513887|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83513888|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
83513889|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
83513890|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513891|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513892|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83513893|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
83513894|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
83513895|NCT02363478|Buspirone|buspirone|mesh-list
83513896|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83513897|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83513898|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513899|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513900|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83513901|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83513902|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
83513903|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513904|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513905|NCT02338362|Fluticasone|fluticasone|mesh-list
83513906|NCT02338362|Xhance|xhance|mesh-list
83513907|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513908|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83513909|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
83513910|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513911|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513912|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83513913|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
83513914|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
83513915|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83513916|NCT01803074|Ritonavir|ritonavir|mesh-list
83513917|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83513918|NCT01803074|Tenofovir|tenofovir|mesh-list
83513919|NCT01803074|Emtricitabine|emtricitabine|mesh-list
83513920|NCT01803074|BMS-955176|bms-955176|mesh-list
83513921|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83513922|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83513925|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513927|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83513928|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
83513929|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83513930|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83513931|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83513932|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83513933|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83513934|NCT05327894|Blinatumomab|blinatumomab|mesh-list
83513935|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83513936|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513937|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
83513938|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513939|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
83513940|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
83513941|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513942|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
83513943|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513944|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513945|NCT01822886|Gemcitabine|gemcitabine|mesh-list
83513946|NCT01822886|Romidepsin|romidepsin|mesh-list
83513947|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83513948|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
83513949|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513950|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513951|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83513952|NCT01822886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83513953|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513954|NCT01823510|Aspirin|aspirin|mesh-list
83513955|NCT01823510|Clopidogrel|clopidogrel|mesh-list
83513956|NCT01823510|Ticagrelor|ticagrelor|mesh-list
83513957|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83513958|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83513959|NCT01823510|Analgesics|analgesics|mesh-ancestor
83513960|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
83513961|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513962|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513963|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513964|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83513965|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83513966|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83513967|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513968|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83513969|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83513970|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513971|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
83513972|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83513973|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83513974|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83513975|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
83513976|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83513977|NCT05327582|Paclitaxel|paclitaxel|mesh-list
83513978|NCT05327582|Durvalumab|durvalumab|mesh-list
83513979|NCT05327582|Lenvatinib|lenvatinib|mesh-list
83513980|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83513981|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83513982|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83513983|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83513984|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83513985|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83513986|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83513987|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83513988|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513989|NCT02271698|Dexamethasone|dexamethasone|mesh-list
83513990|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
83513991|NCT02271698|BB 1101|bb 1101|mesh-list
83513992|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83513993|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
83513994|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
83513995|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513996|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513997|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83513998|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
83513999|NCT02271698|Hormones|hormones|mesh-ancestor
83514000|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83514001|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83514002|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514003|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
83514004|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514005|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514006|NCT02328404|Vitamin D|vitamin d|mesh-list
83514007|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
83514008|NCT02328404|Vitamins|vitamins|mesh-ancestor
83514009|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
83514010|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514011|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83514012|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83514013|NCT05748236|Lamotrigine|lamotrigine|mesh-list
83514014|NCT05748236|Carbamazepine|carbamazepine|mesh-list
83514015|NCT05748236|Anticonvulsants|anticonvulsants|mesh-ancestor
83514016|NCT05748236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83514017|NCT05748236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83514018|NCT05748236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514019|NCT05748236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83514020|NCT05748236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514021|NCT05748236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83514022|NCT05748236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83514023|NCT05748236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514024|NCT05748236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83514025|NCT05748236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83514026|NCT05748236|Antimanic Agents|antimanic agents|mesh-ancestor
83514027|NCT05748236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83514028|NCT05748236|Analgesics|analgesics|mesh-ancestor
83514029|NCT05748236|Sensory System Agents|sensory system agents|mesh-ancestor
83514030|NCT05748236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514031|NCT05748236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83514032|NCT05748236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83514033|NCT01829516|Oxytocin|oxytocin|mesh-list
83514034|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
83514035|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83514036|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514037|NCT01830140|Bimatoprost|bimatoprost|mesh-list
83514038|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83514039|NCT01830842|Nicotine|nicotine|mesh-list
83514040|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83514041|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
83514042|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514043|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514044|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83514045|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83514046|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
83514047|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514048|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514049|NCT01831232|Cytarabine|cytarabine|mesh-list
83514050|NCT01831232|Idarubicin|idarubicin|mesh-list
83514051|NCT01831232|Pravastatin|pravastatin|mesh-list
83514052|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83514053|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
83514054|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514055|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514056|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
83514057|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514058|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83514059|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
83514060|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514061|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83514062|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83514063|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83514064|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514065|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83514066|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83514067|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83514068|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83514069|NCT01831934|Vaccines|vaccines|mesh-list
83514070|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
83514071|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514072|NCT01833026|Albuterol|albuterol|mesh-list
83514073|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83514075|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514076|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514077|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83514078|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
83514080|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83514081|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83514082|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83514083|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83514084|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
83514085|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514086|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514087|NCT03383523|Praziquantel|praziquantel|mesh-list
83514088|NCT03383523|Emodepside|emodepside|mesh-list
83514089|NCT03383523|Toltrazuril|toltrazuril|mesh-list
83514090|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
83514091|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83514092|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514093|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
83514094|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83514095|NCT00377091|PENTA|penta|mesh-list
83514096|NCT00377091|Fondaparinux|fondaparinux|mesh-list
83514097|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83514098|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
83514099|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83514100|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
83514101|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514102|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514103|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
83514104|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83514105|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83514106|NCT01835912|Citric Acid|citric acid|mesh-list
83514107|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
83514108|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
83514109|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83514110|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
83514111|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
83514112|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514113|NCT05747768|Midazolam|midazolam|mesh-list
83514114|NCT05747768|Dabigatran|dabigatran|mesh-list
83514115|NCT05747768|Atorvastatin|atorvastatin|mesh-list
83514116|NCT05747768|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83514117|NCT05747768|Pitavastatin|pitavastatin|mesh-list
83514118|NCT05747768|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83514119|NCT05747768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83514120|NCT05747768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514121|NCT05747768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514122|NCT05747768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83514123|NCT05747768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83514124|NCT05747768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83514125|NCT05747768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83514126|NCT05747768|Anesthetics, General|anesthetics, general|mesh-ancestor
83514127|NCT05747768|Anesthetics|anesthetics|mesh-ancestor
83514128|NCT05747768|GABA Modulators|gaba modulators|mesh-ancestor
83514129|NCT05747768|GABA Agents|gaba agents|mesh-ancestor
83514130|NCT05747768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514131|NCT05747768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514132|NCT05747768|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83514133|NCT05747768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83514134|NCT05747768|Antimetabolites|antimetabolites|mesh-ancestor
83514135|NCT05747768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83514136|NCT05747768|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83514137|NCT05747768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514138|NCT05747768|Antithrombins|antithrombins|mesh-ancestor
83514139|NCT05747768|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83514140|NCT05747768|Protease Inhibitors|protease inhibitors|mesh-ancestor
83514141|NCT05747768|Anticoagulants|anticoagulants|mesh-ancestor
83514142|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
83514143|NCT04410159|Listerine|listerine|mesh-list
83514144|NCT04410159|Povidone|povidone|mesh-list
83514145|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
83514146|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
83514147|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83514148|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514149|NCT03398421|Itraconazole|itraconazole|mesh-list
83514150|NCT03398421|Nemiralisib|nemiralisib|mesh-list
83514151|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
83514152|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514228|NCT05745974|Coagulants|coagulants|mesh-ancestor
83514153|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83514154|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83514155|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514156|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514157|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83514158|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
83514159|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83514160|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514161|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83514162|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83514163|NCT01839110|Ranolazine|ranolazine|mesh-list
83514164|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83514165|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83514166|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514167|NCT00559754|Bevacizumab|bevacizumab|mesh-list
83514168|NCT00559754|Docetaxel|docetaxel|mesh-list
83514169|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83514170|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514171|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83514172|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83514173|NCT00559754|Growth Substances|growth substances|mesh-ancestor
83514174|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514175|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
83514176|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
83514177|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
83514178|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
83514179|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514180|NCT03402243|Menthol|menthol|mesh-list
83514181|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
83514182|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
83514183|NCT01841606|Ondansetron|ondansetron|mesh-list
83514184|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
83514185|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
83514186|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514187|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514188|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83514189|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
83514190|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
83514191|NCT01841606|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83514192|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83514193|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
83514194|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514195|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514196|NCT04392141|Colchicine|colchicine|mesh-list
83514197|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
83514198|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83514199|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
83514200|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
83514201|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
83514202|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514203|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514204|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
83514205|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
83514206|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
83514207|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514208|NCT00559364|Omeprazole|omeprazole|mesh-list
83514209|NCT00559364|Pancrelipase|pancrelipase|mesh-list
83514210|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83514211|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83514212|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83514213|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514214|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514215|NCT05746676|Hyaluronic Acid|hyaluronic acid|mesh-list
83514216|NCT05746676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514217|NCT05746676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83514218|NCT05746676|Immunologic Factors|immunologic factors|mesh-ancestor
83514219|NCT05746676|Viscosupplements|viscosupplements|mesh-ancestor
83514220|NCT05746676|Protective Agents|protective agents|mesh-ancestor
83514221|NCT05746598|Cisplatin|cisplatin|mesh-list
83514222|NCT05746598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514223|NCT05745974|Fibrin fragment D|fibrin fragment d|mesh-list
83514224|NCT05745974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83514225|NCT05745974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83514226|NCT05745974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514227|NCT05745974|Hemostatics|hemostatics|mesh-ancestor
83514231|NCT05745038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83514232|NCT05745038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514233|NCT05745038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514235|NCT05745038|GABA Agents|gaba agents|mesh-ancestor
83514236|NCT05745038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514237|NCT05745038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514238|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
83514239|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83514240|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514241|NCT02306850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83514242|NCT02306850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514243|NCT02306694|Factor VIII|factor viii|mesh-list
83514244|NCT02306694|Coagulants|coagulants|mesh-ancestor
83514245|NCT01648140|Interferons|interferons|mesh-list
83514246|NCT01648140|Ribavirin|ribavirin|mesh-list
83514247|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
83514248|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
83514249|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83514250|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514251|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
83514252|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514253|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
83514254|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514255|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
83514256|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514257|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
83514258|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
83514259|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83514260|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83514261|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514262|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514263|NCT02335242|Urological Agents|urological agents|mesh-ancestor
83514264|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
83514265|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83514266|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
83514267|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514268|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
83514269|NCT04883892|Protective Agents|protective agents|mesh-ancestor
83514270|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
83514271|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83514272|NCT02305758|Bevacizumab|bevacizumab|mesh-list
83514273|NCT02305758|Fluorouracil|fluorouracil|mesh-list
83514274|NCT02305758|Veliparib|veliparib|mesh-list
83514275|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83514276|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514277|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83514278|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83514279|NCT02305758|Growth Substances|growth substances|mesh-ancestor
83514280|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514281|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
83514282|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
83514283|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514284|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83514285|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83514286|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
83514287|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83514288|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514289|NCT04392219|Molnupiravir|molnupiravir|mesh-list
83514290|NCT04392219|Antiviral Agents|antiviral agents|mesh-ancestor
83514291|NCT04392219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514292|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83514293|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
83514294|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514295|NCT03654417|Lidocaine|lidocaine|mesh-list
83514296|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
83514297|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
83514298|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514299|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514300|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
83514301|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514302|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83514303|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83514304|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83514305|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83514306|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514308|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83514309|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514310|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83514311|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83514312|NCT00376701|Growth Substances|growth substances|mesh-ancestor
83514313|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514314|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
83514315|NCT04358991|Ceftazidime|ceftazidime|mesh-list
83514316|NCT04358991|Avibactam|avibactam|mesh-list
83514317|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83514318|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83514319|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514320|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83514321|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514322|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514323|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83514324|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
83514325|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514326|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514327|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83514328|NCT02354976|Fenofibrate|fenofibrate|mesh-list
83514329|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83514330|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
83514331|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514332|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83514333|NCT02303262|Gemcitabine|gemcitabine|mesh-list
83514334|NCT02303262|Mocetinostat|mocetinostat|mesh-list
83514335|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83514336|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
83514337|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514338|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514339|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83514340|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514341|NCT04889664|Ketamine|ketamine|mesh-list
83514342|NCT04889664|Analgesics|analgesics|mesh-ancestor
83514343|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
83514344|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514345|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514346|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83514347|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83514348|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
83514349|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
83514350|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514351|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83514352|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83514353|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514354|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514355|NCT00558896|Dexamethasone|dexamethasone|mesh-list
83514356|NCT00558896|Pomalidomide|pomalidomide|mesh-list
83514357|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514358|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
83514359|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
83514360|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514361|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514362|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83514363|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
83514365|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83514366|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83514367|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514368|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
83514369|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83514370|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83514371|NCT00558896|Growth Substances|growth substances|mesh-ancestor
83514372|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
83514373|NCT01857362|Nitisinone|nitisinone|mesh-list
83514374|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514375|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514376|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
83514377|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83514378|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
83514379|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514380|NCT02265224|Expectorants|expectorants|mesh-ancestor
83514381|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
83514382|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83514383|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
83514384|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514385|NCT02265224|Protective Agents|protective agents|mesh-ancestor
83514386|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514387|NCT02265224|Antidotes|antidotes|mesh-ancestor
83514388|NCT01859078|Digoxin|digoxin|mesh-list
83514389|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83514390|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83514391|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514392|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514393|NCT01859078|Protective Agents|protective agents|mesh-ancestor
83514394|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514395|NCT00558428|Amlodipine|amlodipine|mesh-list
83514396|NCT00558428|Telmisartan|telmisartan|mesh-list
83514397|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83514398|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83514399|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83514400|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83514401|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514402|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83514403|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514404|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
83514405|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83514406|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83514407|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83514408|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514409|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83514410|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514411|NCT04310085|Lumefantrine|lumefantrine|mesh-list
83514412|NCT04310085|Artemether|artemether|mesh-list
83514413|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83514414|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
83514415|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83514416|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83514417|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514418|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
83514419|NCT00558272|Saracatinib|saracatinib|mesh-list
83514420|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83514421|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514422|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514423|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514424|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514425|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
83514426|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83514427|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514428|NCT03407625|Misoprostol|misoprostol|mesh-list
83514429|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83514430|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
83514431|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83514432|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514433|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83514434|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83514435|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
83514436|NCT03666663|Lidocaine|lidocaine|mesh-list
83514437|NCT03666663|Bupivacaine|bupivacaine|mesh-list
83514438|NCT03666663|Ropivacaine|ropivacaine|mesh-list
83514439|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
83514440|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
83514441|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514442|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514443|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
83514444|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514445|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83514446|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83514447|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83514448|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83514449|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514450|NCT05692154|Fexofenadine|fexofenadine|mesh-list
83514451|NCT05692154|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83514602|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514452|NCT05692154|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83514453|NCT05692154|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83514454|NCT05692154|Histamine Antagonists|histamine antagonists|mesh-ancestor
83514455|NCT05692154|Histamine Agents|histamine agents|mesh-ancestor
83514456|NCT05692154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514457|NCT05692154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514458|NCT05692154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514460|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83514461|NCT03415581|Oxycodone|oxycodone|mesh-list
83514462|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83514463|NCT03415581|Narcotics|narcotics|mesh-ancestor
83514464|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514465|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514466|NCT03415581|Analgesics|analgesics|mesh-ancestor
83514467|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
83514468|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514469|NCT00557492|Bevacizumab|bevacizumab|mesh-list
83514470|NCT00557492|Gemcitabine|gemcitabine|mesh-list
83514471|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83514472|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514473|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83514474|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83514475|NCT00557492|Growth Substances|growth substances|mesh-ancestor
83514476|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514477|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
83514478|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83514479|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
83514480|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514481|NCT01865708|Ethanol|ethanol|mesh-list
83514482|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83514483|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514484|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514485|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514486|NCT04203225|Lidocaine|lidocaine|mesh-list
83514487|NCT04203225|Epinephrine|epinephrine|mesh-list
83514488|NCT04203225|Tetracaine|tetracaine|mesh-list
83514489|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
83514490|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
83514491|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514492|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514493|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
83514494|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514495|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83514496|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83514497|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83514498|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83514499|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514500|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83514501|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83514502|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
83514503|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514504|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83514505|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83514506|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
83514507|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83514508|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
83514509|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
83514510|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
83514511|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83514512|NCT05314257|Granisetron|granisetron|mesh-list
83514513|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
83514514|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
83514515|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514516|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514517|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83514518|NCT05314257|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83514519|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83514520|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
83514521|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514522|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514523|NCT02354586|Niraparib|niraparib|mesh-list
83514524|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83514525|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514526|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514527|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514528|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83514529|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514530|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83514531|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514532|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514533|NCT00377325|Cyclosporine|cyclosporine|mesh-list
83514534|NCT00377325|Cyclosporins|cyclosporins|mesh-list
83514535|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514536|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514537|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83514538|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
83514539|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514540|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
83514541|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514542|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
83514543|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83514544|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83514545|NCT02332824|Candesartan|candesartan|mesh-list
83514546|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
83514547|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
83514548|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83514549|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83514550|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83514551|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514552|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514553|NCT03701061|Vaccines|vaccines|mesh-list
83514554|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
83514555|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514556|NCT03420014|Doxorubicin|doxorubicin|mesh-list
83514557|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83514558|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83514559|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514560|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83514561|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83514562|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514563|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514564|NCT03705273|Dexamethasone|dexamethasone|mesh-list
83514565|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
83514566|NCT03705273|BB 1101|bb 1101|mesh-list
83514567|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514568|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
83514569|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
83514570|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514571|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514572|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83514573|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
83514574|NCT03705273|Hormones|hormones|mesh-ancestor
83514575|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83514576|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83514577|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514578|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
83514579|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514580|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514581|NCT04184271|Fluorides|fluorides|mesh-list
83514582|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
83514583|NCT04184271|Protective Agents|protective agents|mesh-ancestor
83514584|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514586|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
83514587|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
83514588|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514589|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514590|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
83514591|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514592|NCT04173429|Nadroparin|nadroparin|mesh-list
83514593|NCT04173429|Warfarin|warfarin|mesh-list
83514594|NCT04173429|Calcium|calcium|mesh-list
83514595|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83514596|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514597|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
83514598|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83514599|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83514600|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514601|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
83514606|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514607|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514608|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
83514609|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514610|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83514611|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83514612|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83514613|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83514614|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514615|NCT03929367|Oxytocin|oxytocin|mesh-list
83514616|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
83514617|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83514618|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514619|NCT04149405|Diphosphonates|diphosphonates|mesh-list
83514620|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83514621|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514622|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83514623|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514624|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83514625|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514626|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514627|NCT03717051|Nicotine|nicotine|mesh-list
83514628|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83514629|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
83514630|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514631|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514632|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83514633|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83514634|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
83514635|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514636|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514637|NCT04350320|Colchicine|colchicine|mesh-list
83514638|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
83514639|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83514640|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
83514641|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
83514642|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
83514643|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514644|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514645|NCT03920865|Risdiplam|risdiplam|mesh-list
83514646|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83514647|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514648|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514649|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83514650|NCT00556322|Docetaxel|docetaxel|mesh-list
83514651|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514652|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83514653|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514654|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514655|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
83514656|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
83514657|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
83514658|NCT04137627|Melatonin|melatonin|mesh-list
83514659|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
83514660|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514661|NCT04137627|Protective Agents|protective agents|mesh-ancestor
83514662|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514663|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514664|NCT04136145|Belimumab|belimumab|mesh-list
83514665|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83514666|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
83514667|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514668|NCT01869686|Denosumab|denosumab|mesh-list
83514669|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83514670|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514671|NCT03360890|Docetaxel|docetaxel|mesh-list
83514672|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
83514673|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514674|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
83514675|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
83514676|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
83514677|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514678|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83514679|NCT03360890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83514681|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83514682|NCT03862755|Tinzaparin|tinzaparin|mesh-list
83514683|NCT03862755|Dalteparin|dalteparin|mesh-list
83514684|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
83514685|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83514686|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83514687|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514688|NCT02332590|Adalimumab|adalimumab|mesh-list
83514689|NCT02332590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83514690|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514691|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83514692|NCT04076787|Sunitinib|sunitinib|mesh-list
83514693|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514694|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83514695|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83514696|NCT04076787|Growth Substances|growth substances|mesh-ancestor
83514697|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514698|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
83514699|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83514700|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514701|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514702|NCT00554840|Varenicline|varenicline|mesh-list
83514703|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83514704|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83514705|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
83514706|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514707|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514708|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514709|NCT04069221|Cobicistat|cobicistat|mesh-list
83514710|NCT04069221|Artefenomel|artefenomel|mesh-list
83514711|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83514712|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83514713|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
83514714|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514715|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83514716|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83514717|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514718|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514719|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
83514720|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83514721|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83514722|NCT03054038|Afatinib|afatinib|mesh-list
83514723|NCT03054038|Necitumumab|necitumumab|mesh-list
83514724|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514725|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83514726|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514727|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514728|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83514729|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83514730|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514731|NCT03958071|Pirfenidone|pirfenidone|mesh-list
83514732|NCT03958071|Nintedanib|nintedanib|mesh-list
83514733|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514734|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83514735|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514736|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514737|NCT03958071|Analgesics|analgesics|mesh-ancestor
83514738|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
83514739|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514740|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514741|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83514742|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83514743|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514744|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83514745|NCT04066647|Dexamethasone|dexamethasone|mesh-list
83514746|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514747|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
83514748|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
83514749|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514750|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514751|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83514752|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
83514753|NCT04066647|Hormones|hormones|mesh-ancestor
83514754|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83514755|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83514757|NCT04041453|Ivermectin|ivermectin|mesh-list
83514758|NCT04041453|Albendazole|albendazole|mesh-list
83514759|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83514760|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514761|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
83514762|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
83514763|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83514764|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83514765|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
83514766|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
83514767|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
83514768|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514769|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514770|NCT02354508|Pasireotide|pasireotide|mesh-list
83514771|NCT02354508|Hormones|hormones|mesh-ancestor
83514772|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83514773|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514774|NCT00554216|Topiramate|topiramate|mesh-list
83514775|NCT00554216|Phentermine|phentermine|mesh-list
83514776|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
83514777|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83514778|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514779|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83514780|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
83514781|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83514782|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
83514783|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
83514784|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514785|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
83514786|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514787|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514788|NCT02353572|Dexamethasone|dexamethasone|mesh-list
83514789|NCT02353572|Bortezomib|bortezomib|mesh-list
83514790|NCT02353572|Melphalan|melphalan|mesh-list
83514791|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514792|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
83514793|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
83514794|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514795|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514796|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83514797|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
83514798|NCT02353572|Hormones|hormones|mesh-ancestor
83514799|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83514800|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83514801|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514802|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83514803|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
83514804|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514805|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83514806|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83514807|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
83514808|NCT03886701|Isoniazid|isoniazid|mesh-list
83514809|NCT03886701|Rifapentine|rifapentine|mesh-list
83514810|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
83514811|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83514812|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514813|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83514814|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83514815|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
83514816|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514817|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83514818|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83514819|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
83514820|NCT00552578|Buprenorphine|buprenorphine|mesh-list
83514821|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83514822|NCT00552578|Naloxone|naloxone|mesh-list
83514823|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83514824|NCT00552578|Narcotics|narcotics|mesh-ancestor
83514825|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514826|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514827|NCT00552578|Analgesics|analgesics|mesh-ancestor
83514828|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
83514829|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514830|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83514831|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
83514832|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83514833|NCT02301936|Ledipasvir|ledipasvir|mesh-list
83514834|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
83514835|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514836|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
83514837|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83514838|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
83514839|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514840|NCT03881163|Expectorants|expectorants|mesh-ancestor
83514841|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
83514842|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83514843|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
83514844|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514845|NCT03881163|Protective Agents|protective agents|mesh-ancestor
83514846|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514847|NCT03881163|Antidotes|antidotes|mesh-ancestor
83514848|NCT03848871|Betamethasone|betamethasone|mesh-list
83514849|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
83514850|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83514851|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
83514852|NCT03848871|Calcipotriene|calcipotriene|mesh-list
83514853|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83514854|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514855|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
83514856|NCT03848871|Hormones|hormones|mesh-ancestor
83514857|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83514858|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514859|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83514860|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
83514861|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
83514862|NCT04032327|Bupivacaine|bupivacaine|mesh-list
83514863|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
83514864|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
83514865|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83514866|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514867|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
83514868|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514869|NCT04041219|Tacrolimus|tacrolimus|mesh-list
83514870|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83514871|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
83514872|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514873|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83514874|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514875|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514876|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
83514877|NCT00552344|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83514878|NCT00552344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514879|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83514880|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
83514881|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514882|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83514883|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83514884|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83514885|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514886|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83514887|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83514888|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
83514889|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514890|NCT03879603|Antacids|antacids|mesh-ancestor
83514891|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514892|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83514893|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83514894|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83514895|NCT00553514|Hormones|hormones|mesh-ancestor
83514896|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83514897|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514898|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83514899|NCT02813642|Mitogens|mitogens|mesh-list
83514900|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
83514901|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514902|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
83514903|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83514904|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83514905|NCT03852537|Prednisolone|prednisolone|mesh-list
83514906|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
83514907|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83514908|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
83514909|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514910|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
83514911|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
83514912|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514913|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514914|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83514915|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
83514916|NCT03852537|Hormones|hormones|mesh-ancestor
83514917|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83514918|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83514919|NCT03852537|Protective Agents|protective agents|mesh-ancestor
83514920|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83514921|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514922|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
83514923|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
83514924|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514925|NCT00553202|Cyclosporine|cyclosporine|mesh-list
83514926|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
83514927|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83514928|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83514929|NCT00553202|Prednisolone|prednisolone|mesh-list
83514930|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
83514931|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
83514932|NCT00553202|Busulfan|busulfan|mesh-list
83514933|NCT00553202|Methotrexate|methotrexate|mesh-list
83514934|NCT00553202|Tacrolimus|tacrolimus|mesh-list
83514935|NCT00553202|Cyclosporins|cyclosporins|mesh-list
83514936|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
83514937|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83514938|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83514939|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
83514940|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83514941|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
83514942|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514943|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83514944|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83514945|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
83514946|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514947|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83514948|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83514949|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83514950|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
83514951|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83514952|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83514953|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
83514954|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
83514955|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514956|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83514957|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83514958|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83514959|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
83514960|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83514961|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514962|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
83514963|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
83514964|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83514965|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83514966|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
83514967|NCT00553202|Hormones|hormones|mesh-ancestor
83514968|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83514969|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83514970|NCT00553202|Protective Agents|protective agents|mesh-ancestor
83514971|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83514972|NCT00552188|Atreleuton|atreleuton|mesh-list
83514973|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83514974|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514975|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514976|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83514977|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
83514978|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83514979|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83514980|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83514981|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514984|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83514985|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83514986|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
83514987|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514988|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
83514989|NCT00552110|Phenylephrine|phenylephrine|mesh-list
83514990|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
83514991|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83514992|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
83514993|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83514994|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83514995|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83514996|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
83514997|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514998|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514999|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515000|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
83515001|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
83515002|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515003|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
83515004|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83515005|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
83515006|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83515007|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
83515008|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83515009|NCT00552110|Protective Agents|protective agents|mesh-ancestor
83515010|NCT02301624|Eculizumab|eculizumab|mesh-list
83515011|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83515012|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83515013|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
83515014|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515015|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83515016|NCT02007122|Cephalosporins|cephalosporins|mesh-list
83515017|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83515018|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83515019|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
83515020|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
83515021|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83515022|NCT03250520|Protective Agents|protective agents|mesh-ancestor
83515023|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515024|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
83515025|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83515026|NCT03847389|Clobetasol|clobetasol|mesh-list
83515027|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83515028|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
83515029|NCT03847389|Hormones|hormones|mesh-ancestor
83515030|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83515031|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515032|NCT02351934|Celecoxib|celecoxib|mesh-list
83515033|NCT02351934|Furosemide|furosemide|mesh-list
83515034|NCT02351934|Gabapentin|gabapentin|mesh-list
83515035|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83515036|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83515037|NCT02351934|Analgesics|analgesics|mesh-ancestor
83515038|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
83515039|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515040|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515041|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83515042|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83515043|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83515044|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83515045|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515046|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515047|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
83515048|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83515049|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83515050|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515051|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83515052|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83515053|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83515054|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515055|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
83515056|NCT02351934|Diuretics|diuretics|mesh-ancestor
83515057|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
83515058|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83515059|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515065|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515066|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
83515067|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
83515068|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
83515069|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515070|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83515071|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83515072|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83515073|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515074|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
83515075|NCT03026348|Vaccines|vaccines|mesh-list
83515076|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
83515077|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515078|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83515079|NCT03026348|Antacids|antacids|mesh-ancestor
83515080|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515081|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83515082|NCT04763408|Sorafenib|sorafenib|mesh-list
83515083|NCT04763408|Lenvatinib|lenvatinib|mesh-list
83515084|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515085|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83515086|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515087|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515088|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
83515089|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83515090|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83515091|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515092|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
83515093|NCT03825939|Coagulants|coagulants|mesh-ancestor
83515094|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
83515095|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83515096|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515097|NCT03988647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83515098|NCT03988647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515099|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
83515100|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83515101|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
83515102|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515103|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515104|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83515105|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
83515106|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83515107|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
83515108|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515109|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515110|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83515111|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
83515112|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
83515113|NCT00551642|Protective Agents|protective agents|mesh-ancestor
83515114|NCT02799212|Somatostatin|somatostatin|mesh-list
83515115|NCT02799212|Hormones|hormones|mesh-ancestor
83515116|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83515117|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515118|NCT04690322|Factor VIII|factor viii|mesh-list
83515119|NCT04690322|BAX 855|bax 855|mesh-list
83515120|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83515121|NCT04690322|Coagulants|coagulants|mesh-ancestor
83515122|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
83515123|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515124|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
83515125|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
83515126|NCT02648282|Vaccines|vaccines|mesh-list
83515127|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
83515128|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515129|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83515130|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83515131|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83515132|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
83515133|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515134|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515135|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83515136|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83515137|NCT02648282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83515138|NCT04004481|Morphine|morphine|mesh-list
83515139|NCT04004481|Tramadol|tramadol|mesh-list
83515142|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515143|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515144|NCT04004481|Analgesics|analgesics|mesh-ancestor
83515145|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
83515146|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515147|NCT03997851|Acetaminophen|acetaminophen|mesh-list
83515148|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83515149|NCT03997851|Analgesics|analgesics|mesh-ancestor
83515150|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
83515151|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515152|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515153|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
83515154|NCT03989427|Listerine|listerine|mesh-list
83515155|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
83515156|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
83515157|NCT03989427|Protective Agents|protective agents|mesh-ancestor
83515158|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515159|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83515160|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83515161|NCT03007719|Fluorides|fluorides|mesh-list
83515162|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
83515163|NCT03007719|Protective Agents|protective agents|mesh-ancestor
83515164|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515165|NCT02985801|Pancrelipase|pancrelipase|mesh-list
83515166|NCT02985801|Pancreatin|pancreatin|mesh-list
83515167|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83515168|NCT02988362|Amlodipine|amlodipine|mesh-list
83515169|NCT02988362|Candesartan|candesartan|mesh-list
83515170|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83515171|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83515172|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515173|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515174|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83515175|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515176|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
83515177|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83515178|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83515179|NCT02988440|Sorafenib|sorafenib|mesh-list
83515180|NCT02988440|Spartalizumab|spartalizumab|mesh-list
83515181|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515182|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83515183|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515184|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515185|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83515186|NCT02988440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83515187|NCT05405192|Dostarlimab|dostarlimab|mesh-list
83515188|NCT05405192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515189|NCT00550550|Fluticasone|fluticasone|mesh-list
83515190|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
83515191|NCT00550550|Loratadine|loratadine|mesh-list
83515192|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83515193|NCT00550550|Prednisone|prednisone|mesh-list
83515194|NCT00550550|Albuterol|albuterol|mesh-list
83515195|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83515196|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
83515197|NCT00550550|Hormones|hormones|mesh-ancestor
83515198|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83515199|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515200|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83515201|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515202|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83515203|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
83515204|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515205|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83515206|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
83515207|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
83515208|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83515209|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
83515210|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83515211|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83515212|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83515213|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83515214|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
83515215|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515216|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515217|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
83515218|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83515219|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83515220|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
83515221|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
83515222|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83515223|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83515225|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
83515226|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83515227|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83515228|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515229|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515230|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515231|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83515232|NCT02971839|Ivacaftor|ivacaftor|mesh-list
83515233|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83515234|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515235|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515236|NCT02974803|Trametinib|trametinib|mesh-list
83515237|NCT02974803|Dabrafenib|dabrafenib|mesh-list
83515238|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515239|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83515240|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515241|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515242|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83515243|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83515244|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
83515245|NCT00558038|Lactulose|lactulose|mesh-list
83515246|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83515247|NCT01507233|Morphine|morphine|mesh-list
83515248|NCT01507233|Bupivacaine|bupivacaine|mesh-list
83515249|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
83515250|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
83515251|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515252|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515253|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
83515254|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515255|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83515256|NCT01507233|Narcotics|narcotics|mesh-ancestor
83515257|NCT01507233|Analgesics|analgesics|mesh-ancestor
83515258|NCT02301390|Amiodarone|amiodarone|mesh-list
83515259|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83515260|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
83515261|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83515262|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515263|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515264|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83515265|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83515266|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83515267|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515268|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83515269|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83515270|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83515271|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83515272|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83515273|NCT00378417|Vaccines|vaccines|mesh-list
83515274|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
83515275|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515276|NCT01487499|Cisplatin|cisplatin|mesh-list
83515277|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515278|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
83515279|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83515280|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83515281|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83515282|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515283|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515284|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
83515285|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515286|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515287|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83515288|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515289|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83515290|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
83515291|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
83515292|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83515293|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83515294|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515295|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
83515296|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83515297|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83515298|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515299|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515300|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83515301|NCT00378729|Metformin|metformin|mesh-list
83515302|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83515303|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515304|NCT00378495|Miltefosine|miltefosine|mesh-list
83515305|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
83515306|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83515307|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515308|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83515309|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83515310|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83515311|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
83515312|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83515313|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83515314|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515315|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515316|NCT03802227|Oxycodone|oxycodone|mesh-list
83515317|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83515318|NCT03802227|Narcotics|narcotics|mesh-ancestor
83515319|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515320|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515321|NCT03802227|Analgesics|analgesics|mesh-ancestor
83515322|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
83515323|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515324|NCT02749617|Apixaban|apixaban|mesh-list
83515325|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83515326|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
83515327|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83515328|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
83515329|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515330|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515331|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
83515332|NCT02749227|Pasireotide|pasireotide|mesh-list
83515333|NCT02749227|Hormones|hormones|mesh-ancestor
83515334|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83515335|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515336|NCT02746263|Acetaminophen|acetaminophen|mesh-list
83515337|NCT02746263|Morphine|morphine|mesh-list
83515338|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83515339|NCT02746263|Narcotics|narcotics|mesh-ancestor
83515340|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515341|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515342|NCT02746263|Analgesics|analgesics|mesh-ancestor
83515343|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
83515344|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515345|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83515346|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
83515347|NCT01394211|Anastrozole|anastrozole|mesh-list
83515348|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83515349|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515350|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83515351|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83515352|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515353|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515354|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83515355|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
83515356|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83515357|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515358|NCT02717949|Ribavirin|ribavirin|mesh-list
83515359|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
83515360|NCT02717949|Ledipasvir|ledipasvir|mesh-list
83515361|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
83515362|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515363|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
83515364|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83515365|NCT02300610|Cisplatin|cisplatin|mesh-list
83515366|NCT02300610|Gemcitabine|gemcitabine|mesh-list
83515517|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
83515367|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515368|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83515369|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
83515370|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515372|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83515373|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
83515374|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515375|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515376|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83515377|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
83515378|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83515379|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515380|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515381|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83515382|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83515383|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83515384|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
83515385|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
83515386|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515387|NCT01377441|Ibuprofen|ibuprofen|mesh-list
83515388|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83515389|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83515390|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83515391|NCT01377441|Analgesics|analgesics|mesh-ancestor
83515392|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
83515393|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515394|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515395|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83515396|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83515397|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515398|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515399|NCT01882868|Leucovorin|leucovorin|mesh-list
83515400|NCT01882868|Irinotecan|irinotecan|mesh-list
83515401|NCT01882868|Aflibercept|aflibercept|mesh-list
83515402|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
83515403|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83515404|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83515405|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515406|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515407|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515408|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83515409|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83515410|NCT01882868|Growth Substances|growth substances|mesh-ancestor
83515411|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515412|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
83515413|NCT01882868|Antidotes|antidotes|mesh-ancestor
83515414|NCT01882868|Protective Agents|protective agents|mesh-ancestor
83515415|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
83515416|NCT01882868|Vitamins|vitamins|mesh-ancestor
83515417|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
83515418|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
83515419|NCT01383447|Entinostat|entinostat|mesh-list
83515420|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83515421|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515422|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83515423|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515424|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515425|NCT02300298|Docetaxel|docetaxel|mesh-list
83515426|NCT02300298|Nintedanib|nintedanib|mesh-list
83515427|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515428|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
83515429|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
83515430|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
83515431|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515432|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83515433|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515434|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
83515435|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83515436|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83515437|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83515438|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83515439|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515440|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515441|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515442|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83515443|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83515444|NCT01379469|Carbamazepine|carbamazepine|mesh-list
83515445|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
83515446|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
83515447|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83515448|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515449|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515450|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83515451|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83515452|NCT01379469|Analgesics|analgesics|mesh-ancestor
83515453|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
83515454|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515455|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83515456|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515457|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515458|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83515459|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83515460|NCT01309581|Ketamine|ketamine|mesh-list
83515461|NCT01309581|Methohexital|methohexital|mesh-list
83515462|NCT01309581|Analgesics|analgesics|mesh-ancestor
83515463|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
83515464|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515465|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515466|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83515467|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83515468|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
83515469|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
83515470|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515471|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83515472|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83515473|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515474|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515475|NCT05289050|Ketamine|ketamine|mesh-list
83515476|NCT05289050|Esketamine|esketamine|mesh-list
83515477|NCT05289050|Analgesics|analgesics|mesh-ancestor
83515478|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
83515479|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515480|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515481|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83515482|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83515483|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
83515484|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
83515485|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515486|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83515487|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83515488|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515489|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515490|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
83515492|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
83515493|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83515494|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515495|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83515496|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515497|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
83515498|NCT01292265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83515499|NCT01292265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83515500|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83515501|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
83515502|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515503|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83515504|NCT01885910|Doxycycline|doxycycline|mesh-list
83515505|NCT01885910|Dapsone|dapsone|mesh-list
83515506|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83515507|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83515508|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
83515509|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83515510|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83515511|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83515512|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515513|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515514|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
83515515|NCT02658357|Risperidone|risperidone|mesh-list
83515516|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83515518|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515519|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515520|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515521|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83515522|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83515523|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515524|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83515525|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83515526|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
83515527|NCT02988908|Donepezil|donepezil|mesh-list
83515528|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83515529|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515530|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515531|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
83515532|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515533|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515534|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
83515535|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
83515536|NCT02326272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83515537|NCT02326272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83515538|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83515539|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
83515540|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515541|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83515542|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
83515543|NCT02325414|Diphosphonates|diphosphonates|mesh-list
83515544|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83515545|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515546|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
83515547|NCT02349048|Simeprevir|simeprevir|mesh-list
83515548|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
83515549|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83515550|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
83515551|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515552|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515553|NCT01280643|Leucovorin|leucovorin|mesh-list
83515554|NCT01280643|Bevacizumab|bevacizumab|mesh-list
83515555|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83515556|NCT01280643|Cetuximab|cetuximab|mesh-list
83515557|NCT01280643|Fluorouracil|fluorouracil|mesh-list
83515558|NCT01280643|Capecitabine|capecitabine|mesh-list
83515559|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
83515560|NCT01280643|Irinotecan|irinotecan|mesh-list
83515561|NCT01280643|Antibodies|antibodies|mesh-list
83515562|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
83515563|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83515564|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
83515565|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515566|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83515567|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83515568|NCT01280643|Growth Substances|growth substances|mesh-ancestor
83515569|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515570|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
83515571|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
83515572|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
83515573|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515574|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83515575|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83515576|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83515577|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83515578|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515579|NCT01280643|Antidotes|antidotes|mesh-ancestor
83515580|NCT01280643|Protective Agents|protective agents|mesh-ancestor
83515581|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
83515582|NCT01280643|Vitamins|vitamins|mesh-ancestor
83515583|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
83515584|NCT01888952|Prednisone|prednisone|mesh-list
83515585|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83515586|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
83515587|NCT01888952|Hormones|hormones|mesh-ancestor
83515588|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83515589|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515590|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83515591|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515592|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
83515593|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
83515594|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
83515595|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83515597|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515598|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
83515599|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515600|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
83515601|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515602|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515603|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83515604|NCT02298192|Liraglutide|liraglutide|mesh-list
83515605|NCT02298192|Xultophy|xultophy|mesh-list
83515606|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83515607|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515608|NCT02298192|Incretins|incretins|mesh-ancestor
83515609|NCT02298192|Hormones|hormones|mesh-ancestor
83515610|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83515611|NCT01893632|Gabapentin|gabapentin|mesh-list
83515612|NCT01893632|Analgesics|analgesics|mesh-ancestor
83515613|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
83515614|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515615|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515616|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
83515617|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83515618|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83515619|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515620|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83515621|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83515622|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83515623|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515624|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515625|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
83515626|NCT01272141|Everolimus|everolimus|mesh-list
83515627|NCT01272141|Lapatinib|lapatinib|mesh-list
83515628|NCT01272141|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83515629|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83515630|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515631|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515632|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83515633|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
83515634|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515635|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515636|NCT01895036|Naltrexone|naltrexone|mesh-list
83515637|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83515638|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83515639|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515640|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
83515641|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515642|NCT03781479|Amifampridine|amifampridine|mesh-list
83515643|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83515644|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515645|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515646|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83515647|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515648|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515649|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83515650|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83515651|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83515652|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515653|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515654|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515655|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515656|NCT01223001|Analgesics|analgesics|mesh-ancestor
83515657|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
83515658|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515659|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
83515660|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83515661|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
83515662|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
83515663|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83515664|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515665|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83515666|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515667|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
83515668|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83515669|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515672|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83515673|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515674|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83515675|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515676|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515678|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83515679|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83515680|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
83515681|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515682|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515683|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515684|NCT01189071|Urological Agents|urological agents|mesh-ancestor
83515685|NCT02515851|Bupivacaine|bupivacaine|mesh-list
83515686|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
83515687|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
83515688|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515689|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515690|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
83515691|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515692|NCT02492295|Propofol|propofol|mesh-list
83515693|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83515694|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515695|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515696|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83515697|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
83515698|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
83515699|NCT02468583|Triamcinolone|triamcinolone|mesh-list
83515700|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83515701|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83515702|NCT02468583|FX006|fx006|mesh-list
83515703|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83515704|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83515705|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
83515706|NCT02468583|Hormones|hormones|mesh-ancestor
83515707|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83515708|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515709|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83515710|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
83515711|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515712|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515713|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
83515714|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
83515715|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515716|NCT03763929|Protective Agents|protective agents|mesh-ancestor
83515717|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515718|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83515719|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515720|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
83515721|NCT01118013|Methotrexate|methotrexate|mesh-list
83515722|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
83515723|NCT01118013|Fludarabine|fludarabine|mesh-list
83515724|NCT01118013|Busulfan|busulfan|mesh-list
83515725|NCT01118013|Tacrolimus|tacrolimus|mesh-list
83515726|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83515727|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83515728|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
83515729|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83515730|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515731|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83515732|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
83515733|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515734|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515735|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
83515736|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515737|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83515738|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83515739|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
83515740|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83515741|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83515742|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83515743|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83515744|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83515745|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
83515746|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83515747|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83515748|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
83515749|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83515750|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83515751|NCT00378027|PENTA|penta|mesh-list
83515752|NCT00378027|Fondaparinux|fondaparinux|mesh-list
83515753|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83515754|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
83515755|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83515756|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
83515757|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515758|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515759|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
83515760|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83515761|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83515762|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
83515763|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83515764|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
83515765|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83515766|NCT02429583|Vaccines|vaccines|mesh-list
83515767|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
83515768|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515769|NCT02413047|Methotrexate|methotrexate|mesh-list
83515770|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
83515771|NCT02413047|Azathioprine|azathioprine|mesh-list
83515772|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83515773|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
83515774|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83515775|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515776|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83515777|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
83515778|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515779|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515780|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
83515781|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515782|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83515783|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83515784|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
83515785|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83515786|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83515787|NCT02277548|Pregabalin|pregabalin|mesh-list
83515788|NCT02277548|Analgesics|analgesics|mesh-ancestor
83515789|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
83515790|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515791|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515792|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
83515793|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83515794|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515795|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515796|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83515797|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83515798|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83515799|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515800|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83515801|NCT02411643|Calcipotriene|calcipotriene|mesh-list
83515802|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
83515803|NCT01085643|Lubiprostone|lubiprostone|mesh-list
83515804|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83515805|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83515806|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515807|NCT03028766|Adavosertib|adavosertib|mesh-list
83515808|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515809|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515810|NCT01071993|Atorvastatin|atorvastatin|mesh-list
83515811|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83515812|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83515813|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
83515814|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515815|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83515816|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83515817|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515818|NCT02379585|Paclitaxel|paclitaxel|mesh-list
83515819|NCT02379585|Docetaxel|docetaxel|mesh-list
83515820|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
83515824|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83515825|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515826|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
83515827|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
83515828|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
83515829|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515830|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83515831|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
83515832|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515833|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83515834|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83515835|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
83515836|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83515837|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83515838|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83515839|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83515840|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515841|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83515842|NCT03756818|Paclitaxel|paclitaxel|mesh-list
83515843|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83515844|NCT03756818|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83515845|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83515846|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515847|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
83515848|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
83515849|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
83515850|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515851|NCT03756818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83515852|NCT03756818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515853|NCT01065051|Riociguat|riociguat|mesh-list
83515854|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
83515855|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515856|NCT01048125|Nitroprusside|nitroprusside|mesh-list
83515857|NCT01048125|Phenylephrine|phenylephrine|mesh-list
83515858|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
83515859|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83515860|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
83515861|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
83515862|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515863|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515864|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
83515865|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83515866|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
83515867|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
83515868|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83515869|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83515870|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83515871|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
83515872|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515873|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515874|NCT01048125|Protective Agents|protective agents|mesh-ancestor
83515875|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83515876|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
83515877|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83515878|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
83515879|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83515880|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83515881|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515882|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83515883|NCT01901588|Analgesics|analgesics|mesh-ancestor
83515884|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
83515885|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515886|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83515887|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83515888|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83515889|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
83515890|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515891|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515892|NCT03673124|Letrozole|letrozole|mesh-list
83515893|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515894|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83515895|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83515896|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515897|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515900|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83515901|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515902|NCT01025271|Daptomycin|daptomycin|mesh-list
83515903|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83515904|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83515905|NCT01902758|Ambrisentan|ambrisentan|mesh-list
83515906|NCT01902758|Theophylline|theophylline|mesh-list
83515907|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83515908|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
83515909|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515910|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515911|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83515912|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
83515913|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83515914|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515915|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515916|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
83515917|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83515918|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83515919|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
83515920|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515921|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83515922|NCT01020903|Aprepitant|aprepitant|mesh-list
83515923|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
83515924|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
83515925|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515926|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515927|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83515928|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83515929|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515930|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515931|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
83515932|NCT02318901|Trastuzumab|trastuzumab|mesh-list
83515933|NCT02318901|Cetuximab|cetuximab|mesh-list
83515934|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83515935|NCT02318901|Maytansine|maytansine|mesh-list
83515936|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83515937|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515938|NCT02318901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83515939|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515940|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83515942|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
83515943|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
83515944|NCT02318901|Immunotoxins|immunotoxins|mesh-ancestor
83515945|NCT02318901|Immunoconjugates|immunoconjugates|mesh-ancestor
83515946|NCT02318901|Immunologic Factors|immunologic factors|mesh-ancestor
83515947|NCT02318901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515949|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
83515950|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515951|NCT01904864|Trace Elements|trace elements|mesh-ancestor
83515952|NCT01016847|Montelukast|montelukast|mesh-list
83515953|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83515954|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
83515955|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83515956|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
83515957|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83515958|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515959|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83515960|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83515961|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515962|NCT00989937|Oxytocin|oxytocin|mesh-list
83515963|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
83515964|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83515965|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515966|NCT00982995|Palonosetron|palonosetron|mesh-list
83515967|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
83515968|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
83515969|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515970|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515971|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83515972|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83515973|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83515975|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83515976|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515978|NCT00965055|Ezetimibe|ezetimibe|mesh-list
83515979|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83515980|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83515981|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
83515982|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83515983|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83515984|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83515985|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515986|NCT02266797|Dexamethasone|dexamethasone|mesh-list
83515987|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83515988|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
83515989|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
83515990|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515991|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83515992|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83515993|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
83515994|NCT02266797|Hormones|hormones|mesh-ancestor
83515995|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83515996|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83515997|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83515998|NCT00378183|Risperidone|risperidone|mesh-list
83515999|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83516000|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
83516001|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516002|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516003|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516004|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83516005|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83516006|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516007|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83516008|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83516009|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
83516010|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83516011|NCT01906658|Hormones|hormones|mesh-ancestor
83516012|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83516013|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516015|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83516016|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83516017|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516018|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
83516019|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516020|NCT00924807|Sorafenib|sorafenib|mesh-list
83516021|NCT00924807|Leuprolide|leuprolide|mesh-list
83516022|NCT00924807|Bicalutamide|bicalutamide|mesh-list
83516023|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516024|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83516025|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516026|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516027|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83516028|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
83516029|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83516030|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516031|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83516032|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
83516033|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
83516034|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83516035|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
83516036|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83516037|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
83516038|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516039|NCT00896025|Expectorants|expectorants|mesh-ancestor
83516040|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
83516041|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83516042|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
83516043|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516044|NCT00896025|Protective Agents|protective agents|mesh-ancestor
83516045|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516046|NCT00896025|Antidotes|antidotes|mesh-ancestor
83516047|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
83516048|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
83516273|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
83516049|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83516050|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83516051|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516052|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516053|NCT02162979|Urological Agents|urological agents|mesh-ancestor
83516054|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
83516055|NCT03734601|Tacrolimus|tacrolimus|mesh-list
83516056|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83516057|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83516058|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
83516059|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516060|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83516061|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516062|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516063|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83516064|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516065|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83516066|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
83516067|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83516068|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516069|NCT01908842|Buprenorphine|buprenorphine|mesh-list
83516070|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83516071|NCT01908842|Narcotics|narcotics|mesh-ancestor
83516072|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516073|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516074|NCT01908842|Analgesics|analgesics|mesh-ancestor
83516075|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
83516076|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516077|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83516078|NCT00833859|Gemcitabine|gemcitabine|mesh-list
83516079|NCT00833859|Capecitabine|capecitabine|mesh-list
83516080|NCT00833859|Docetaxel|docetaxel|mesh-list
83516081|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83516082|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
83516083|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516084|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516085|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
83516086|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
83516087|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
83516088|NCT00832299|Leucovorin|leucovorin|mesh-list
83516089|NCT00832299|Fluorouracil|fluorouracil|mesh-list
83516090|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
83516091|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
83516092|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516093|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83516094|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516095|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83516096|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
83516097|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516098|NCT00832299|Antidotes|antidotes|mesh-ancestor
83516099|NCT00832299|Protective Agents|protective agents|mesh-ancestor
83516100|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
83516101|NCT00832299|Vitamins|vitamins|mesh-ancestor
83516102|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
83516103|NCT03723447|Dexamethasone|dexamethasone|mesh-list
83516104|NCT03723447|Epinephrine|epinephrine|mesh-list
83516105|NCT03723447|Bupivacaine|bupivacaine|mesh-list
83516106|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83516107|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
83516108|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
83516109|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516110|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516111|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83516112|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
83516113|NCT03723447|Hormones|hormones|mesh-ancestor
83516114|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83516115|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83516116|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516117|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
83516118|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
83516119|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516120|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
83516121|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83516122|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83516123|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
83516124|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516125|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516126|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83516127|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83516128|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83516129|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
83516130|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
83516131|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
83516132|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83516133|NCT00836355|Minocycline|minocycline|mesh-list
83516134|NCT00836355|Enoxaparin|enoxaparin|mesh-list
83516135|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
83516136|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83516137|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83516138|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516139|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83516140|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516141|NCT00816777|Irinotecan|irinotecan|mesh-list
83516142|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83516143|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83516144|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516145|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516146|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516147|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
83516148|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83516149|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
83516150|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516151|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516152|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83516153|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
83516154|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83516155|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
83516156|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516157|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516158|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83516159|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
83516160|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
83516161|NCT00823095|Protective Agents|protective agents|mesh-ancestor
83516162|NCT00803283|Morphine|morphine|mesh-list
83516163|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83516165|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516166|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516167|NCT00803283|Analgesics|analgesics|mesh-ancestor
83516168|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
83516169|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516170|NCT03701295|Azacitidine|azacitidine|mesh-list
83516171|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83516172|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
83516173|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516174|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516175|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516176|NCT00799773|Rituximab|rituximab|mesh-list
83516177|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516178|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516179|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
83516180|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516181|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83516182|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
83516183|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
83516184|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83516185|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83516186|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516187|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516188|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516189|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83516190|NCT00760461|Domperidone|domperidone|mesh-list
83516191|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
83516192|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
83516193|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516194|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516195|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83516196|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83516197|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
83516198|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516199|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516200|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83516201|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516202|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83516203|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516204|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516205|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83516206|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83516207|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83516208|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
83516209|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83516210|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516211|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83516212|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83516213|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83516214|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83516215|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83516216|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83516217|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83516218|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83516219|NCT01901679|Celecoxib|celecoxib|mesh-list
83516220|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83516221|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83516222|NCT01901679|Analgesics|analgesics|mesh-ancestor
83516223|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
83516224|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516225|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516226|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83516227|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83516228|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83516229|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83516230|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516231|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516232|NCT00688935|Melatonin|melatonin|mesh-list
83516233|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
83516234|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516235|NCT00688935|Protective Agents|protective agents|mesh-ancestor
83516236|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516237|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516238|NCT00684255|Fludarabine|fludarabine|mesh-list
83516239|NCT00684255|Busulfan|busulfan|mesh-list
83516240|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
83516241|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516242|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516243|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83516244|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
83516245|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516246|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
83516247|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83516248|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83516249|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516250|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83516251|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
83516252|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83516253|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83516254|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83516255|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516256|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516257|NCT01856361|Ramipril|ramipril|mesh-list
83516258|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83516259|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
83516260|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516261|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516262|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83516263|NCT00642603|Bevacizumab|bevacizumab|mesh-list
83516264|NCT00642603|Capecitabine|capecitabine|mesh-list
83516265|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
83516266|NCT00642603|Irinotecan|irinotecan|mesh-list
83516267|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516268|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516269|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83516270|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83516271|NCT00642603|Growth Substances|growth substances|mesh-ancestor
83516272|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516274|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83516275|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
83516276|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516277|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83516278|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83516279|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516280|NCT01841931|Buprenorphine|buprenorphine|mesh-list
83516281|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83516282|NCT01841931|Naloxone|naloxone|mesh-list
83516283|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83516284|NCT01841931|Narcotics|narcotics|mesh-ancestor
83516285|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516286|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516287|NCT01841931|Analgesics|analgesics|mesh-ancestor
83516288|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
83516289|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516290|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83516291|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
83516292|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
83516293|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516294|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
83516295|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516296|NCT04713891|Atezolizumab|atezolizumab|mesh-list
83516297|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83516298|NCT04713891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83516299|NCT04713891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516300|NCT04713891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516301|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516302|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
83516303|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516304|NCT00379509|Lapatinib|lapatinib|mesh-list
83516305|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516306|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83516307|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516308|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516309|NCT04706247|Anesthetics|anesthetics|mesh-list
83516310|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516311|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516312|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
83516313|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
83516314|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83516315|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
83516316|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516317|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516318|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
83516319|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516320|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
83516321|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83516322|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516323|NCT00588471|Simvastatin|simvastatin|mesh-list
83516324|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83516325|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83516326|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
83516327|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516328|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83516329|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83516330|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516331|NCT05600673|Bimatoprost|bimatoprost|mesh-list
83516332|NCT05600673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83516333|NCT01784991|Morphine|morphine|mesh-list
83516334|NCT01784991|Hydromorphone|hydromorphone|mesh-list
83516335|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83516336|NCT01784991|Narcotics|narcotics|mesh-ancestor
83516337|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516338|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516339|NCT01784991|Analgesics|analgesics|mesh-ancestor
83516340|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
83516341|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516342|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83516343|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83516344|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516345|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83516346|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83516347|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83516348|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516349|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
83516350|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516351|NCT05600517|Fluorides|fluorides|mesh-list
83516352|NCT05600517|Cariostatic Agents|cariostatic agents|mesh-ancestor
83516353|NCT05600517|Protective Agents|protective agents|mesh-ancestor
83516354|NCT05600517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516355|NCT01745913|Fludarabine|fludarabine|mesh-list
83516356|NCT01745913|Melphalan|melphalan|mesh-list
83516357|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
83516358|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516359|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516360|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83516361|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
83516362|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516363|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83516364|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
83516365|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83516366|NCT05600127|Avelumab|avelumab|mesh-list
83516367|NCT05600127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516368|NCT05600127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516369|NCT01691079|Bromides|bromides|mesh-list
83516370|NCT01691079|Ipratropium|ipratropium|mesh-list
83516371|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
83516372|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83516373|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
83516374|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516375|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516376|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83516377|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
83516378|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83516379|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
83516380|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516381|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516382|NCT01673061|Lidocaine|lidocaine|mesh-list
83516383|NCT01673061|Epinephrine|epinephrine|mesh-list
83516384|NCT01673061|Norflurane|norflurane|mesh-list
83516385|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
83516386|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
83516387|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516388|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516389|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
83516390|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516391|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83516392|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83516393|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83516394|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83516395|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516396|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83516397|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83516398|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
83516399|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516400|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83516401|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83516402|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
83516403|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83516404|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
83516405|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
83516406|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
83516407|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83516408|NCT05599347|Azithromycin|azithromycin|mesh-list
83516409|NCT05599347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83516410|NCT05599347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516411|NCT01621737|Oxytocin|oxytocin|mesh-list
83516412|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
83516413|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83516414|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516415|NCT00379665|Cisplatin|cisplatin|mesh-list
83516416|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516417|NCT00357383|Azithromycin|azithromycin|mesh-list
83516418|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83516419|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516420|NCT01598025|Fludarabine|fludarabine|mesh-list
83516421|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
83516422|NCT01598025|Melphalan|melphalan|mesh-list
83516423|NCT01598025|Thiotepa|thiotepa|mesh-list
83516424|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83516425|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516426|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83516427|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
83516428|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516429|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83516430|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
83516431|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516432|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83516433|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
83516434|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83516435|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
83516436|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
83516437|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516438|NCT01587963|Protective Agents|protective agents|mesh-ancestor
83516439|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516440|NCT01587963|Vitamins|vitamins|mesh-ancestor
83516441|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
83516442|NCT01648751|Estrogens|estrogens|mesh-list
83516443|NCT01648751|Hormones|hormones|mesh-ancestor
83516444|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83516445|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516446|NCT05550519|Tenofovir|tenofovir|mesh-list
83516447|NCT05550519|Entecavir|entecavir|mesh-list
83516448|NCT05550519|Antiviral Agents|antiviral agents|mesh-ancestor
83516449|NCT05550519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516450|NCT05550519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83516451|NCT05550519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83516452|NCT05550519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516453|NCT05550519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516454|NCT05550519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83516455|NCT05550519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83516456|NCT01203371|Naftopidil|naftopidil|mesh-list
83516457|NCT01203371|Tamsulosin|tamsulosin|mesh-list
83516458|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83516459|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83516460|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83516461|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
83516462|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516463|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516464|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516465|NCT01203371|Urological Agents|urological agents|mesh-ancestor
83516466|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83516467|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83516468|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83516469|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83516470|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83516471|NCT01549977|Febuxostat|febuxostat|mesh-list
83516472|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
83516473|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83516474|NCT00357617|Celecoxib|celecoxib|mesh-list
83516475|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83516476|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83516477|NCT00357617|Analgesics|analgesics|mesh-ancestor
83516478|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
83516479|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516480|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516481|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83516482|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83516483|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83516484|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83516485|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516486|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516487|NCT01548651|Saxagliptin|saxagliptin|mesh-list
83516488|NCT01548651|Incretins|incretins|mesh-ancestor
83516489|NCT01548651|Hormones|hormones|mesh-ancestor
83516490|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83516491|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516492|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83516493|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
83516494|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516495|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516496|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83516497|NCT01533753|Gabapentin|gabapentin|mesh-list
83516498|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83516500|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
83516501|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516502|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516503|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
83516504|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83516505|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83516506|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516507|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83516508|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83516509|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83516510|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516511|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516512|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
83516513|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83516514|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83516515|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83516516|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83516517|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
83516518|NCT05722301|Methyltestosterone|methyltestosterone|mesh-list
83516519|NCT05722301|Testosterone|testosterone|mesh-list
83516520|NCT05722301|Testosterone undecanoate|testosterone undecanoate|mesh-list
83516521|NCT05722301|Testosterone enanthate|testosterone enanthate|mesh-list
83516522|NCT05722301|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83516523|NCT05722301|Androgens|androgens|mesh-ancestor
83516524|NCT05722301|Hormones|hormones|mesh-ancestor
83516525|NCT05722301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83516526|NCT05722301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516527|NCT05722301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83516528|NCT05722301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516529|NCT05722301|Anabolic Agents|anabolic agents|mesh-ancestor
83516530|NCT01534143|Sirolimus|sirolimus|mesh-list
83516531|NCT01534143|Fludarabine|fludarabine|mesh-list
83516532|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
83516533|NCT01534143|Bortezomib|bortezomib|mesh-list
83516534|NCT01534143|Busulfan|busulfan|mesh-list
83516535|NCT01534143|Tacrolimus|tacrolimus|mesh-list
83516536|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
83516537|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83516538|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
83516539|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516540|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83516541|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
83516542|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516543|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83516544|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
83516545|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516546|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83516547|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516548|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83516549|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516550|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83516551|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
83516552|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
83516553|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83516554|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83516555|NCT05722067|Calcium|calcium|mesh-list
83516556|NCT05722067|Ionophores|ionophores|mesh-list
83516557|NCT05722067|Calcium Ionophores|calcium ionophores|mesh-list
83516558|NCT05722067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83516559|NCT05722067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516560|NCT05722067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83516561|NCT05722067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516562|NCT01692171|Heparin|heparin|mesh-list
83516563|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83516564|NCT01692171|Tinzaparin|tinzaparin|mesh-list
83516565|NCT01692171|Dalteparin|dalteparin|mesh-list
83516566|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
83516567|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83516568|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83516569|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516570|NCT05723315|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83516571|NCT05723315|Natriuretic Agents|natriuretic agents|mesh-ancestor
83516572|NCT05723315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516573|NCT00570531|Paclitaxel|paclitaxel|mesh-list
83516574|NCT00570531|Bevacizumab|bevacizumab|mesh-list
83516575|NCT00570531|Fluorouracil|fluorouracil|mesh-list
83516576|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83516577|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516578|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
83516579|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
83516580|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
83516581|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516582|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516583|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83516584|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83516585|NCT00570531|Growth Substances|growth substances|mesh-ancestor
83516586|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516587|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
83516588|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
83516589|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83516590|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83516591|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
83516592|NCT05258565|Plasminogen|plasminogen|mesh-list
83516593|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83516594|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83516595|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83516596|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516597|NCT05715437|Ketamine|ketamine|mesh-list
83516598|NCT05715437|Bupivacaine|bupivacaine|mesh-list
83516599|NCT05715437|Anesthetics, Local|anesthetics, local|mesh-ancestor
83516600|NCT05715437|Anesthetics|anesthetics|mesh-ancestor
83516601|NCT05715437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516602|NCT05715437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516603|NCT05715437|Sensory System Agents|sensory system agents|mesh-ancestor
83516604|NCT05715437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516605|NCT05715437|Analgesics|analgesics|mesh-ancestor
83516606|NCT05715437|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83516607|NCT05715437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83516608|NCT05715437|Anesthetics, General|anesthetics, general|mesh-ancestor
83516609|NCT05715437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83516610|NCT05715437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83516611|NCT05715437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516612|NCT05715437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516613|NCT05721443|Cetuximab|cetuximab|mesh-list
83516614|NCT05721443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516615|NCT05721443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516616|NCT00523809|Bevacizumab|bevacizumab|mesh-list
83516617|NCT00523809|Fludarabine|fludarabine|mesh-list
83516618|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
83516619|NCT00523809|Melphalan|melphalan|mesh-list
83516620|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
83516621|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83516622|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516623|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516624|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83516625|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83516626|NCT00523809|Growth Substances|growth substances|mesh-ancestor
83516627|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516628|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
83516629|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83516630|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
83516631|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516632|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83516633|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
83516634|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83516635|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
83516636|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83516637|NCT00501345|Aspirin|aspirin|mesh-list
83516638|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83516639|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83516640|NCT00501345|Analgesics|analgesics|mesh-ancestor
83516641|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
83516642|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516643|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516644|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83516645|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83516646|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83516647|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83516648|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516649|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83516650|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83516651|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516652|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
83516653|NCT00357773|Azithromycin|azithromycin|mesh-list
83516654|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83516655|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516656|NCT00487461|Simvastatin|simvastatin|mesh-list
83516657|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83516658|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83516659|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
83516660|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516661|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83516662|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83516663|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516664|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
83516665|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83516666|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
83516667|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516668|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
83516669|NCT04972383|Protective Agents|protective agents|mesh-ancestor
83516670|NCT00356187|Propranolol|propranolol|mesh-list
83516671|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83516672|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83516673|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
83516674|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516675|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516676|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516677|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83516678|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83516679|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
83516680|NCT02224729|Dexamethasone|dexamethasone|mesh-list
83516681|NCT02224729|Bortezomib|bortezomib|mesh-list
83516682|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83516683|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83516684|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
83516685|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
83516686|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516687|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516688|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83516689|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
83516690|NCT02224729|Hormones|hormones|mesh-ancestor
83516691|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83516692|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83516693|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516694|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83516695|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
83516696|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516697|NCT00305643|Celecoxib|celecoxib|mesh-list
83516698|NCT00305643|Capecitabine|capecitabine|mesh-list
83516699|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83516700|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
83516701|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516702|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516703|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83516704|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83516705|NCT00305643|Analgesics|analgesics|mesh-ancestor
83516706|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
83516707|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516708|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516709|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83516710|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83516711|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83516712|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83516713|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516714|NCT03004105|Durvalumab|durvalumab|mesh-list
83516715|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516716|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516717|NCT00271011|Irinotecan|irinotecan|mesh-list
83516718|NCT00271011|Cetuximab|cetuximab|mesh-list
83516719|NCT00271011|Mitomycins|mitomycins|mesh-list
83516720|NCT00271011|Mitomycin|mitomycin|mesh-list
83516721|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83516722|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83516723|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516798|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83516724|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516725|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516726|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516727|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83516728|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
83516729|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83516730|NCT03312530|Atezolizumab|atezolizumab|mesh-list
83516731|NCT03312530|Venetoclax|venetoclax|mesh-list
83516732|NCT03312530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83516733|NCT03312530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516734|NCT03312530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516735|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516736|NCT05697965|Vancomycin|vancomycin|mesh-list
83516737|NCT05697965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83516738|NCT05697965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516739|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
83516740|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83516741|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516742|NCT05720273|Calcitriol|calcitriol|mesh-list
83516743|NCT05720273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83516744|NCT05720273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516745|NCT05720273|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83516746|NCT05720273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83516747|NCT05720273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516748|NCT05720273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83516749|NCT05720273|Vitamins|vitamins|mesh-ancestor
83516750|NCT05720273|Micronutrients|micronutrients|mesh-ancestor
83516751|NCT05720273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83516752|NCT00183963|Tamoxifen|tamoxifen|mesh-list
83516753|NCT00183963|Fulvestrant|fulvestrant|mesh-list
83516754|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83516755|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
83516756|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83516757|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516758|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83516759|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516760|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83516761|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83516762|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83516763|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83516764|NCT00176631|Docetaxel|docetaxel|mesh-list
83516765|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516766|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
83516767|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
83516768|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
83516769|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516770|NCT05719961|Insulin|insulin|mesh-list
83516771|NCT05719961|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83516772|NCT05719961|Insulin Aspart|insulin aspart|mesh-list
83516773|NCT05719961|Insulin, Long-Acting|insulin, long-acting|mesh-list
83516774|NCT05719961|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83516775|NCT05719961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83516776|NCT05719961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516777|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
83516778|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
83516779|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516780|NCT04317807|Levetiracetam|levetiracetam|mesh-list
83516781|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
83516782|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
83516783|NCT00118053|Carboplatin|carboplatin|mesh-list
83516784|NCT00118053|Docetaxel|docetaxel|mesh-list
83516785|NCT00118053|Trastuzumab|trastuzumab|mesh-list
83516786|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516787|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
83516788|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
83516789|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
83516790|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516791|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83516792|NCT04225611|Dexamethasone|dexamethasone|mesh-list
83516793|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83516794|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
83516795|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
83516796|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516797|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516801|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83516802|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83516803|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516804|NCT00379977|Vaccines|vaccines|mesh-list
83516805|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
83516806|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516807|NCT05669885|Sildenafil Citrate|sildenafil citrate|mesh-list
83516808|NCT05669885|Vasodilator Agents|vasodilator agents|mesh-ancestor
83516809|NCT05669885|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83516810|NCT05669885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83516811|NCT05669885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516812|NCT05669885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516813|NCT05669885|Urological Agents|urological agents|mesh-ancestor
83516814|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
83516815|NCT00955929|Alprostadil|alprostadil|mesh-list
83516816|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
83516817|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83516818|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83516819|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516820|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516821|NCT00955929|Urological Agents|urological agents|mesh-ancestor
83516822|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83516823|NCT00357851|Aprotinin|aprotinin|mesh-list
83516824|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
83516825|NCT00357851|Coagulants|coagulants|mesh-ancestor
83516826|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83516827|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83516828|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
83516829|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516830|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516831|NCT05664659|Misoprostol|misoprostol|mesh-list
83516832|NCT05664659|Oxytocin|oxytocin|mesh-list
83516833|NCT05664659|Carbetocin|carbetocin|mesh-list
83516834|NCT05664659|Oxytocics|oxytocics|mesh-ancestor
83516835|NCT05664659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83516836|NCT05664659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516837|NCT05664659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83516838|NCT05664659|Abortifacient Agents|abortifacient agents|mesh-ancestor
83516839|NCT05664659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83516840|NCT05664659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83516841|NCT00358319|Valproic Acid|valproic acid|mesh-list
83516842|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
83516843|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516844|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516845|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
83516846|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516847|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516848|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
83516849|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83516850|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516851|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83516852|NCT05663801|Magnesium Sulfate|magnesium sulfate|mesh-list
83516853|NCT05663801|Ketamine|ketamine|mesh-list
83516854|NCT05663801|Bupivacaine|bupivacaine|mesh-list
83516855|NCT05663801|Anesthetics, Local|anesthetics, local|mesh-ancestor
83516856|NCT05663801|Anesthetics|anesthetics|mesh-ancestor
83516857|NCT05663801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516858|NCT05663801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516859|NCT05663801|Sensory System Agents|sensory system agents|mesh-ancestor
83516860|NCT05663801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516861|NCT05663801|Analgesics|analgesics|mesh-ancestor
83516862|NCT05663801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83516863|NCT05663801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83516864|NCT05663801|Anesthetics, General|anesthetics, general|mesh-ancestor
83516865|NCT05663801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83516866|NCT05663801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83516867|NCT05663801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516868|NCT05663801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516869|NCT05663801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83516870|NCT05663801|Anticonvulsants|anticonvulsants|mesh-ancestor
83516871|NCT05663801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83516872|NCT05663801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83516873|NCT05663801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83516874|NCT05663801|Tocolytic Agents|tocolytic agents|mesh-ancestor
83516875|NCT05663801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83516876|NCT03866499|Gefitinib|gefitinib|mesh-list
83516877|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516878|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83516879|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516880|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516881|NCT00000105|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83516882|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
83516883|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83516884|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
83516885|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516886|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
83516887|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83516888|NCT00000117|Antibodies|antibodies|mesh-list
83516889|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
83516890|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516891|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83516892|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
83516893|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83516894|NCT00000123|Protective Agents|protective agents|mesh-ancestor
83516895|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516896|NCT00380133|Prednisolone|prednisolone|mesh-list
83516897|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83516898|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
83516899|NCT00380133|Hormones|hormones|mesh-ancestor
83516900|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83516901|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516902|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83516903|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83516904|NCT02959229|Lactoferrin|lactoferrin|mesh-list
83516905|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83516906|NCT02953665|Liraglutide|liraglutide|mesh-list
83516907|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83516908|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516909|NCT02953665|Incretins|incretins|mesh-ancestor
83516910|NCT02953665|Hormones|hormones|mesh-ancestor
83516911|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83516912|NCT00000189|Gepirone|gepirone|mesh-list
83516913|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
83516914|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83516915|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83516916|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83516917|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516918|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516919|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83516920|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
83516921|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516922|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516923|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
83516924|NCT02681211|Promethazine|promethazine|mesh-list
83516925|NCT02681211|Ketorolac|ketorolac|mesh-list
83516926|NCT02681211|Metoclopramide|metoclopramide|mesh-list
83516927|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83516928|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83516929|NCT02681211|Analgesics|analgesics|mesh-ancestor
83516930|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
83516931|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516932|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516933|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83516934|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83516935|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83516936|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516937|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516938|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83516939|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83516940|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516941|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
83516942|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
83516943|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
83516944|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
83516945|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83516946|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83516947|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
83516948|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
83516949|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516950|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83516953|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83516954|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83516955|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
83516956|NCT00000195|Naltrexone|naltrexone|mesh-list
83516957|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83516958|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83516959|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516960|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
83516961|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516962|NCT05688371|Dexmedetomidine|dexmedetomidine|mesh-list
83516963|NCT05688371|Morphine|morphine|mesh-list
83516964|NCT05688371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83516965|NCT05688371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516966|NCT05688371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516967|NCT05688371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83516968|NCT05688371|Analgesics|analgesics|mesh-ancestor
83516969|NCT05688371|Sensory System Agents|sensory system agents|mesh-ancestor
83516970|NCT05688371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516971|NCT05688371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83516972|NCT05688371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83516973|NCT05688371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83516974|NCT05688371|Adrenergic Agents|adrenergic agents|mesh-ancestor
83516975|NCT05688371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516976|NCT05688371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516977|NCT05688371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83516978|NCT05688371|Narcotics|narcotics|mesh-ancestor
83516979|NCT00000201|Selegiline|selegiline|mesh-list
83516980|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
83516981|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83516982|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83516983|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83516984|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83516985|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83516986|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83516987|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83516988|NCT00000201|Protective Agents|protective agents|mesh-ancestor
83516989|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516990|NCT00000207|Buprenorphine|buprenorphine|mesh-list
83516991|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83516992|NCT00000207|Narcotics|narcotics|mesh-ancestor
83516993|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83516994|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83516995|NCT00000207|Analgesics|analgesics|mesh-ancestor
83516996|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
83516997|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83516998|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83516999|NCT02295774|Methylene Blue|methylene blue|mesh-list
83517000|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517001|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517002|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
83517003|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
83517004|NCT01807611|Melphalan|melphalan|mesh-list
83517005|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
83517006|NCT01807611|Thiotepa|thiotepa|mesh-list
83517007|NCT01807611|Fludarabine|fludarabine|mesh-list
83517008|NCT01807611|Lenograstim|lenograstim|mesh-list
83517009|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83517010|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
83517011|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517012|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83517013|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83517014|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
83517015|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517016|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517017|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83517018|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83517019|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83517020|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
83517021|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83517022|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517023|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517024|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83517025|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83517026|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83517027|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
83517028|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83517029|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517030|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83517031|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83517032|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83517033|NCT02294682|Gepotidacin|gepotidacin|mesh-list
83517034|NCT02294682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83517035|NCT02294682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517036|NCT02294682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517037|NCT02294682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517038|NCT01692717|Losartan|losartan|mesh-list
83517039|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83517040|NCT01692717|Atorvastatin|atorvastatin|mesh-list
83517041|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83517042|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83517043|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
83517044|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517045|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83517046|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83517047|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517048|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83517049|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83517050|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83517051|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83517052|NCT01692717|Diuretics|diuretics|mesh-ancestor
83517053|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
83517054|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517055|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83517056|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83517057|NCT00355277|Amitriptyline|amitriptyline|mesh-list
83517058|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83517059|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
83517060|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83517061|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83517062|NCT00355277|Analgesics|analgesics|mesh-ancestor
83517063|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
83517064|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517065|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517066|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83517067|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83517068|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83517069|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517070|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
83517071|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517072|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83517073|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
83517074|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517075|NCT00000213|Fluoxetine|fluoxetine|mesh-list
83517076|NCT00000213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83517077|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83517078|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83517079|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517080|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517081|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
83517082|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517083|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83517084|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
83517085|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83517086|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83517087|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83517088|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517089|NCT00000219|Buprenorphine|buprenorphine|mesh-list
83517090|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83517091|NCT00000219|Narcotics|narcotics|mesh-ancestor
83517092|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83517093|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517094|NCT00000219|Analgesics|analgesics|mesh-ancestor
83517095|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
83517096|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517097|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83517098|NCT00000225|Buprenorphine|buprenorphine|mesh-list
83517099|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83517100|NCT00000225|Narcotics|narcotics|mesh-ancestor
83517254|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83517101|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83517102|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517104|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
83517105|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517106|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83517107|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
83517108|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83517109|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
83517110|NCT02294604|Povidone|povidone|mesh-list
83517111|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83517112|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517113|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
83517114|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
83517115|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
83517116|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
83517117|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
83517118|NCT01645176|Atorvastatin|atorvastatin|mesh-list
83517119|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83517120|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83517121|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
83517122|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517123|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83517124|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83517125|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517126|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
83517127|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83517128|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83517129|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517130|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83517131|NCT03465735|Heparin|heparin|mesh-list
83517132|NCT03465735|Enoxaparin|enoxaparin|mesh-list
83517133|NCT03465735|Dalteparin|dalteparin|mesh-list
83517134|NCT03465735|Warfarin|warfarin|mesh-list
83517135|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
83517136|NCT03465735|Dabigatran|dabigatran|mesh-list
83517137|NCT03465735|Apixaban|apixaban|mesh-list
83517138|NCT03465735|Edoxaban|edoxaban|mesh-list
83517139|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
83517140|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83517141|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83517142|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517143|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83517144|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
83517145|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83517146|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
83517147|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517148|NCT05637671|Paroxetine|paroxetine|mesh-list
83517149|NCT05637671|Oxybutynin|oxybutynin|mesh-list
83517150|NCT05637671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83517151|NCT05637671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83517152|NCT05637671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83517153|NCT05637671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517154|NCT05637671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517155|NCT05637671|Serotonin Agents|serotonin agents|mesh-ancestor
83517156|NCT05637671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517157|NCT05637671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83517158|NCT05637671|Antidepressive Agents|antidepressive agents|mesh-ancestor
83517159|NCT05637671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83517160|NCT05637671|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83517161|NCT05637671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83517162|NCT05637671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517163|NCT05637671|Parasympatholytics|parasympatholytics|mesh-ancestor
83517164|NCT05637671|Autonomic Agents|autonomic agents|mesh-ancestor
83517165|NCT05637671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517166|NCT05637671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83517167|NCT05637671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83517168|NCT05637671|Cholinergic Agents|cholinergic agents|mesh-ancestor
83517169|NCT05637671|Urological Agents|urological agents|mesh-ancestor
83517170|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83517171|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83517172|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83517173|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83517174|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83517175|NCT02322216|Analgesics|analgesics|mesh-ancestor
83517176|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
83517177|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517178|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517179|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83517180|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83517181|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83517182|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83517183|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83517184|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
83517185|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
83517186|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517187|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517188|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
83517189|NCT03447639|Povidone|povidone|mesh-list
83517190|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
83517191|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
83517192|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83517193|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517194|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
83517195|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83517196|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83517197|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517198|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
83517199|NCT03425799|Coagulants|coagulants|mesh-ancestor
83517200|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
83517201|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83517202|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83517203|NCT03360903|Caffeine|caffeine|mesh-list
83517204|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83517205|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517206|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83517207|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517208|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517209|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83517210|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83517211|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
83517212|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517213|NCT00000231|Buprenorphine|buprenorphine|mesh-list
83517214|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83517215|NCT00000231|Narcotics|narcotics|mesh-ancestor
83517216|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83517217|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517218|NCT00000231|Analgesics|analgesics|mesh-ancestor
83517219|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
83517220|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517221|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83517222|NCT00000237|Buprenorphine|buprenorphine|mesh-list
83517223|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83517224|NCT00000237|Narcotics|narcotics|mesh-ancestor
83517225|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83517226|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517227|NCT00000237|Analgesics|analgesics|mesh-ancestor
83517228|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
83517229|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517230|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83517231|NCT00000765|Zidovudine|zidovudine|mesh-list
83517232|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
83517233|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517234|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517235|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517236|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517237|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
83517238|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517239|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517240|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517241|NCT00000243|Buprenorphine|buprenorphine|mesh-list
83517242|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83517243|NCT00000243|Narcotics|narcotics|mesh-ancestor
83517244|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83517245|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517246|NCT00000243|Analgesics|analgesics|mesh-ancestor
83517247|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
83517248|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517249|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83517250|NCT00000771|Paromomycin|paromomycin|mesh-list
83517251|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83517252|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517253|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83517256|NCT05575505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83517257|NCT05575505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517258|NCT05575505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517259|NCT05575505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83517260|NCT05575505|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83517261|NCT05575505|Protective Agents|protective agents|mesh-ancestor
83517262|NCT05575505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517263|NCT05575505|Vasodilator Agents|vasodilator agents|mesh-ancestor
83517264|NCT05575505|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83517265|NCT05575505|Antioxidants|antioxidants|mesh-ancestor
83517266|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
83517267|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83517268|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
83517269|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
83517270|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83517271|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517272|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83517273|NCT00000249|Analgesics|analgesics|mesh-ancestor
83517274|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
83517275|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517276|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
83517277|NCT00000261|Sevoflurane|sevoflurane|mesh-list
83517278|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83517279|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83517280|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
83517281|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
83517282|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83517283|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517284|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83517285|NCT00000261|Analgesics|analgesics|mesh-ancestor
83517286|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
83517287|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517288|NCT00000801|Cytarabine|cytarabine|mesh-list
83517289|NCT00000801|Dexamethasone|dexamethasone|mesh-list
83517290|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
83517291|NCT00000801|Doxorubicin|doxorubicin|mesh-list
83517292|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83517293|NCT00000801|Vincristine|vincristine|mesh-list
83517294|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83517295|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
83517296|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517297|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83517298|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83517299|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
83517300|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517301|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517302|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83517303|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83517304|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
83517305|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
83517306|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517307|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83517308|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
83517309|NCT00000801|Hormones|hormones|mesh-ancestor
83517310|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83517311|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83517312|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83517313|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83517314|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83517315|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517316|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83517317|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
83517318|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
83517319|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517320|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83517321|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
83517322|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
83517323|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
83517324|NCT00000267|Risperidone|risperidone|mesh-list
83517325|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83517326|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
83517327|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517328|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517329|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517330|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83517331|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83517332|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83517333|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83517334|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83517335|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
83517336|NCT00000807|Etoposide|etoposide|mesh-list
83517337|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83517338|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517339|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83517340|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83517341|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517342|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517343|NCT00001677|Methotrexate|methotrexate|mesh-list
83517344|NCT00001677|Fludarabine|fludarabine|mesh-list
83517345|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83517346|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
83517347|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83517348|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517349|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83517350|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
83517351|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517352|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517353|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
83517354|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517355|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83517356|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83517357|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
83517358|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83517359|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517360|NCT00001689|Vincristine|vincristine|mesh-list
83517361|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83517362|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517363|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
83517364|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
83517365|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
83517366|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517367|NCT00001713|Heparin|heparin|mesh-list
83517368|NCT00001713|Plasminogen|plasminogen|mesh-list
83517369|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83517370|NCT00001713|Warfarin|warfarin|mesh-list
83517371|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
83517372|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83517373|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83517374|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517375|NCT00000273|Fentanyl|fentanyl|mesh-list
83517376|NCT00000273|Morphine|morphine|mesh-list
83517377|NCT00000273|Oxycodone|oxycodone|mesh-list
83517378|NCT00000273|Buprenorphine|buprenorphine|mesh-list
83517379|NCT00000273|Methadone|methadone|mesh-list
83517380|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83517381|NCT00000273|Narcotics|narcotics|mesh-ancestor
83517382|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83517383|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517384|NCT00000273|Analgesics|analgesics|mesh-ancestor
83517385|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
83517386|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517387|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83517388|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83517389|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
83517390|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
83517391|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83517392|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
83517393|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
83517394|NCT00000819|Prednisone|prednisone|mesh-list
83517395|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83517396|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
83517397|NCT00000819|Hormones|hormones|mesh-ancestor
83517398|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83517399|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517400|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83517401|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517402|NCT00000279|Clonidine|clonidine|mesh-list
83517403|NCT00000279|Analgesics|analgesics|mesh-ancestor
83517404|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
83517405|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517406|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517407|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83517408|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
83517410|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83517411|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83517412|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83517413|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
83517414|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517415|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517416|NCT00000825|Aldesleukin|aldesleukin|mesh-list
83517417|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517418|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517419|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517420|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
83517421|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517422|NCT00000285|Phenytoin|phenytoin|mesh-list
83517423|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
83517424|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83517425|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83517426|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83517427|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517428|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83517429|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83517430|NCT00001737|Cyclosporine|cyclosporine|mesh-list
83517431|NCT00001737|Cyclosporins|cyclosporins|mesh-list
83517432|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517433|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517434|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83517435|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
83517436|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517437|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
83517438|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517439|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
83517440|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83517441|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83517442|NCT00000843|Adefovir|adefovir|mesh-list
83517443|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83517444|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
83517445|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517446|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517447|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517448|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517449|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517450|NCT05362487|Bromides|bromides|mesh-list
83517451|NCT05362487|Tiotropium Bromide|tiotropium bromide|mesh-list
83517452|NCT05362487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83517453|NCT05362487|Autonomic Agents|autonomic agents|mesh-ancestor
83517454|NCT05362487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517455|NCT05362487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517456|NCT05362487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83517457|NCT05362487|Respiratory System Agents|respiratory system agents|mesh-ancestor
83517458|NCT05362487|Parasympatholytics|parasympatholytics|mesh-ancestor
83517459|NCT05362487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83517460|NCT05362487|Cholinergic Agents|cholinergic agents|mesh-ancestor
83517461|NCT05362487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517462|NCT05362487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517463|NCT05362487|Anticonvulsants|anticonvulsants|mesh-ancestor
83517464|NCT00000291|Labetalol|labetalol|mesh-list
83517465|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83517466|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83517467|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
83517468|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517469|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517470|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517471|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83517472|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
83517473|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
83517474|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517475|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83517476|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83517477|NCT00000861|Indinavir|indinavir|mesh-list
83517478|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83517479|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83517480|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
83517481|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517482|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517483|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517484|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517485|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
83517486|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517487|NCT00000297|Labetalol|labetalol|mesh-list
83517488|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83517489|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83517490|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
83517491|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517492|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517493|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517494|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83517495|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
83517496|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
83517497|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517498|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83517499|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83517500|NCT00359879|Exenatide|exenatide|mesh-list
83517501|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83517502|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517503|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83517504|NCT00359879|Incretins|incretins|mesh-ancestor
83517505|NCT00359879|Hormones|hormones|mesh-ancestor
83517506|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83517507|NCT00000303|Baclofen|baclofen|mesh-list
83517508|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83517509|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517510|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83517511|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517512|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83517513|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
83517514|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
83517515|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517516|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517518|NCT00001785|Interferon-beta|interferon-beta|mesh-list
83517519|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
83517520|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517521|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
83517522|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517523|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
83517524|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517525|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83517526|NCT00001827|Aldesleukin|aldesleukin|mesh-list
83517527|NCT00001827|Sargramostim|sargramostim|mesh-list
83517528|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
83517529|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
83517530|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517531|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517532|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517533|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517534|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
83517535|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517536|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83517537|NCT01647516|Ozanimod|ozanimod|mesh-list
83517538|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83517539|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517540|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83517541|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
83517542|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517543|NCT00001839|Cyclosporine|cyclosporine|mesh-list
83517544|NCT00001839|Cyclosporins|cyclosporins|mesh-list
83517545|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83517546|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517547|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517548|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83517549|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
83517550|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517551|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
83517552|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517553|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
83517554|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83517555|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83517556|NCT00000885|Lamivudine|lamivudine|mesh-list
83517557|NCT00000885|Zidovudine|zidovudine|mesh-list
83517558|NCT00000885|Efavirenz|efavirenz|mesh-list
83517559|NCT00000885|Abacavir|abacavir|mesh-list
83517560|NCT00000885|Stavudine|stavudine|mesh-list
83517561|NCT00000885|Didanosine|didanosine|mesh-list
83517562|NCT00000885|Adefovir|adefovir|mesh-list
83517566|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517567|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517568|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517569|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517570|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
83517571|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517572|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517573|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517574|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
83517575|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83517576|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83517577|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83517578|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83517579|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83517580|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83517581|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83517582|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83517583|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
83517584|NCT01647282|Minocycline|minocycline|mesh-list
83517585|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83517586|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517587|NCT00000897|Zidovudine|zidovudine|mesh-list
83517588|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
83517589|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517590|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517591|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517592|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517593|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
83517594|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517595|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517596|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517597|NCT05347979|Dabigatran|dabigatran|mesh-list
83517598|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
83517599|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83517600|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
83517601|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517602|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517603|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
83517604|NCT00000909|Aldesleukin|aldesleukin|mesh-list
83517605|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517606|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517607|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517608|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
83517609|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517610|NCT05444699|Prednisolone|prednisolone|mesh-list
83517611|NCT05444699|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83517612|NCT05444699|Methylprednisolone|methylprednisolone|mesh-list
83517613|NCT05444699|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83517614|NCT05444699|Prednisolone acetate|prednisolone acetate|mesh-list
83517615|NCT05444699|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83517616|NCT05444699|Prednisolone phosphate|prednisolone phosphate|mesh-list
83517617|NCT05444699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83517618|NCT05444699|Glucocorticoids|glucocorticoids|mesh-ancestor
83517619|NCT05444699|Hormones|hormones|mesh-ancestor
83517620|NCT05444699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83517621|NCT05444699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517622|NCT05444699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83517623|NCT05444699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517624|NCT05444699|Antiemetics|antiemetics|mesh-ancestor
83517625|NCT05444699|Autonomic Agents|autonomic agents|mesh-ancestor
83517626|NCT05444699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517627|NCT05444699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83517628|NCT05444699|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83517629|NCT05444699|Protective Agents|protective agents|mesh-ancestor
83517630|NCT00001863|Leflunomide|leflunomide|mesh-list
83517631|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517632|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517633|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83517634|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
83517635|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517636|NCT05530655|Lisinopril|lisinopril|mesh-list
83517637|NCT05530655|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83517638|NCT05530655|Protease Inhibitors|protease inhibitors|mesh-ancestor
83517639|NCT05530655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517640|NCT05530655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517641|NCT05530655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83517642|NCT05530655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83517643|NCT05530655|Protective Agents|protective agents|mesh-ancestor
83517644|NCT05530655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517645|NCT00000921|Prednisone|prednisone|mesh-list
83517646|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83517647|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
83517648|NCT00000921|Hormones|hormones|mesh-ancestor
83517649|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83517650|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517651|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83517652|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517653|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
83517654|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83517655|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83517656|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83517657|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83517658|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517659|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
83517660|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517661|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517662|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83517663|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517664|NCT05325515|Alendronate|alendronate|mesh-list
83517665|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83517666|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517667|NCT00000939|Efavirenz|efavirenz|mesh-list
83517668|NCT00000939|Stavudine|stavudine|mesh-list
83517669|NCT00000939|Didanosine|didanosine|mesh-list
83517670|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
83517671|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517672|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517673|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517674|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517675|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
83517676|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517677|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83517678|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83517679|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83517680|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83517681|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83517682|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83517683|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517684|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
83517685|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
83517686|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517687|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517688|NCT00000945|Cidofovir|cidofovir|mesh-list
83517689|NCT00000945|Probenecid|probenecid|mesh-list
83517690|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
83517691|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
83517692|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83517693|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
83517694|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517695|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517696|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517697|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
83517698|NCT04344041|Vitamin D|vitamin d|mesh-list
83517699|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83517700|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517701|NCT04344041|Vitamins|vitamins|mesh-ancestor
83517702|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
83517703|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83517704|NCT00000963|Didanosine|didanosine|mesh-list
83517705|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
83517706|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517707|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517708|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517709|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517710|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
83517711|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517712|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517713|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517714|NCT05322707|Budesonide|budesonide|mesh-list
83517716|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83517717|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83517718|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83517719|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
83517720|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517721|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517722|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83517723|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
83517724|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
83517725|NCT05322707|Hormones|hormones|mesh-ancestor
83517726|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83517727|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83517728|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83517729|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83517730|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
83517731|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517732|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517733|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
83517734|NCT02319642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83517735|NCT02319642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83517736|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83517737|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
83517738|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517739|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83517740|NCT00001893|Etanercept|etanercept|mesh-list
83517741|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83517742|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83517743|NCT00001893|Analgesics|analgesics|mesh-ancestor
83517744|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
83517745|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517746|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517747|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83517748|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83517749|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83517750|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83517751|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
83517752|NCT00000981|Fiacitabine|fiacitabine|mesh-list
83517753|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517754|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
83517755|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517756|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
83517757|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83517758|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83517759|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517760|NCT00001905|Interferons|interferons|mesh-list
83517761|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
83517762|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517763|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
83517764|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517765|NCT00000987|Zidovudine|zidovudine|mesh-list
83517766|NCT00000987|Doxorubicin|doxorubicin|mesh-list
83517767|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83517768|NCT00000987|Bleomycin|bleomycin|mesh-list
83517769|NCT00000987|Vincristine|vincristine|mesh-list
83517770|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83517771|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517772|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83517773|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83517774|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517775|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517776|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83517777|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
83517778|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
83517779|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
83517780|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
83517781|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517782|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517783|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
83517784|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517785|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517786|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517787|NCT00001911|Interleukin-12|interleukin-12|mesh-list
83517788|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83517789|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
83517790|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517792|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83517793|NCT00001911|Growth Substances|growth substances|mesh-ancestor
83517794|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
83517795|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517796|NCT00001929|Eliprodil|eliprodil|mesh-list
83517797|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83517798|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83517799|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517800|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517801|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517802|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83517803|NCT00001929|Protective Agents|protective agents|mesh-ancestor
83517804|NCT00358553|Insulin|insulin|mesh-list
83517805|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83517806|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517807|NCT00000993|Zidovudine|zidovudine|mesh-list
83517808|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
83517809|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517810|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517811|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517812|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517813|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
83517814|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517815|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517816|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517817|NCT00359177|Casopitant|casopitant|mesh-list
83517818|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
83517819|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
83517820|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517821|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517822|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83517823|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83517824|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517825|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517826|NCT00001017|Fluconazole|fluconazole|mesh-list
83517827|NCT00001017|Amphotericin B|amphotericin b|mesh-list
83517828|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83517829|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
83517830|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517831|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83517832|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83517833|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517834|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517835|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83517836|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
83517837|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83517838|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517839|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83517840|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83517841|NCT00001017|Amebicides|amebicides|mesh-ancestor
83517842|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83517843|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83517844|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83517845|NCT02279862|Ipilimumab|ipilimumab|mesh-list
83517846|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83517847|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517848|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83517849|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517850|NCT00001965|Cyclosporine|cyclosporine|mesh-list
83517851|NCT00001965|Cyclosporins|cyclosporins|mesh-list
83517852|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517853|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517854|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83517855|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
83517856|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517857|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
83517858|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517859|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
83517860|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83517861|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83517862|NCT00001023|Azithromycin|azithromycin|mesh-list
83517863|NCT00001023|Clarithromycin|clarithromycin|mesh-list
83517865|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83517866|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517867|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83517868|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517869|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517870|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83517871|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83517872|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83517873|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
83517874|NCT00001035|Interferons|interferons|mesh-list
83517875|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
83517876|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
83517877|NCT00001035|Zidovudine|zidovudine|mesh-list
83517878|NCT00001035|Didanosine|didanosine|mesh-list
83517879|NCT00001035|Zalcitabine|zalcitabine|mesh-list
83517880|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517881|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
83517882|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517883|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
83517884|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517885|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
83517886|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517887|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517888|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517889|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517890|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517891|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517892|NCT05503901|Timolol|timolol|mesh-list
83517893|NCT05503901|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83517894|NCT05503901|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83517895|NCT05503901|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83517896|NCT05503901|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83517897|NCT05503901|Adrenergic Agents|adrenergic agents|mesh-ancestor
83517898|NCT05503901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83517899|NCT05503901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517900|NCT05503901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517901|NCT05503901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83517902|NCT05503901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83517903|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83517904|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83517905|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
83517906|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517907|NCT00001053|Antacids|antacids|mesh-ancestor
83517908|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517909|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83517910|NCT00001989|Zidovudine|zidovudine|mesh-list
83517911|NCT00001989|Trichosanthin|trichosanthin|mesh-list
83517912|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
83517913|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517914|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517915|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517916|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517917|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
83517918|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517919|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517920|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517921|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83517922|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
83517923|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83517924|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517925|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83517926|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517927|NCT00001059|Doxorubicin|doxorubicin|mesh-list
83517928|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83517929|NCT00001059|Bleomycin|bleomycin|mesh-list
83517930|NCT00001059|Vincristine|vincristine|mesh-list
83517931|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83517932|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83517933|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83517934|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83517935|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517936|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517937|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83517938|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
83517939|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
83517942|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83517943|NCT00001065|Amebicides|amebicides|mesh-ancestor
83517944|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83517945|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83517946|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517947|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83517948|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
83517949|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83517950|NCT02977637|Hematinics|hematinics|mesh-ancestor
83517951|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83517952|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83517953|NCT00001995|Rifabutin|rifabutin|mesh-list
83517954|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83517955|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517956|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83517957|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
83517958|NCT05501483|Pioglitazone|pioglitazone|mesh-list
83517959|NCT05501483|Empagliflozin|empagliflozin|mesh-list
83517960|NCT05501483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83517961|NCT05501483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517962|NCT05501483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83517963|NCT05501483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517964|NCT00002001|Zidovudine|zidovudine|mesh-list
83517965|NCT00002001|Didanosine|didanosine|mesh-list
83517966|NCT00002001|Zalcitabine|zalcitabine|mesh-list
83517967|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
83517968|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517969|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517970|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517971|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517972|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
83517973|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517974|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517975|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517976|NCT00002007|Zidovudine|zidovudine|mesh-list
83517977|NCT00002007|Sargramostim|sargramostim|mesh-list
83517978|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
83517979|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517980|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517981|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517982|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517983|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
83517984|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83517985|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83517986|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83517987|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
83517988|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517989|NCT00001095|Lamivudine|lamivudine|mesh-list
83517990|NCT00001095|Zidovudine|zidovudine|mesh-list
83517991|NCT00001095|Nevirapine|nevirapine|mesh-list
83517992|NCT00001095|Stavudine|stavudine|mesh-list
83517993|NCT00001095|Indinavir|indinavir|mesh-list
83517994|NCT00001095|Amprenavir|amprenavir|mesh-list
83517995|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83517996|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83517997|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517998|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83517999|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
83518000|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518001|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518002|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518003|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
83518004|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83518005|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83518006|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518007|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518008|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518009|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83518010|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
83518011|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518012|NCT02294058|Interferons|interferons|mesh-list
83518013|NCT02294058|Interferon-beta|interferon-beta|mesh-list
83518014|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
83518015|NCT02294058|Ozanimod|ozanimod|mesh-list
83518016|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518017|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
83518018|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518020|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518021|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83518022|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83518023|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518024|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83518025|NCT00002013|Zidovudine|zidovudine|mesh-list
83518026|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
83518027|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518028|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518029|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518030|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518031|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
83518032|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518033|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518034|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518035|NCT00359333|Gemcitabine|gemcitabine|mesh-list
83518036|NCT00359333|Docetaxel|docetaxel|mesh-list
83518037|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83518038|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
83518039|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518040|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518041|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
83518042|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
83518043|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
83518045|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
83518046|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518047|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518048|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
83518049|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83518050|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83518051|NCT00001107|Fluconazole|fluconazole|mesh-list
83518052|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83518053|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
83518054|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518055|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83518056|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83518057|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518058|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518059|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83518060|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
83518061|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83518062|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518063|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83518064|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83518065|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83518066|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83518067|NCT00002019|Amphotericin B|amphotericin b|mesh-list
83518068|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83518069|NCT00002019|Amebicides|amebicides|mesh-ancestor
83518070|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83518071|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83518072|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518073|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518074|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
83518075|NCT00002025|Ganciclovir|ganciclovir|mesh-list
83518076|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83518077|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
83518078|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518079|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518080|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518081|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518082|NCT00001131|Aldesleukin|aldesleukin|mesh-list
83518083|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518084|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518085|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518086|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
83518087|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518088|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
83518089|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83518090|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
83518091|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518092|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83518093|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83518094|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
83518323|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
83518095|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518096|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518097|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83518098|NCT00002037|Trifluridine|trifluridine|mesh-list
83518099|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
83518100|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518101|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
83518102|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518103|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
83518104|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518105|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
83518106|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518107|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518108|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518110|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
83518111|NCT05270057|Rituximab|rituximab|mesh-list
83518112|NCT05270057|Doxorubicin|doxorubicin|mesh-list
83518113|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83518114|NCT05270057|Etoposide|etoposide|mesh-list
83518115|NCT05270057|Vincristine|vincristine|mesh-list
83518116|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83518117|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83518118|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
83518119|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518120|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83518121|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83518122|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
83518123|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518124|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518125|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83518126|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83518127|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83518128|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83518129|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83518130|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518131|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83518133|NCT05270057|Hormones|hormones|mesh-ancestor
83518134|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83518135|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83518136|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83518137|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
83518138|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
83518139|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
83518140|NCT00002043|Dapsone|dapsone|mesh-list
83518141|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518142|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
83518143|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83518144|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83518145|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83518146|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518147|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518148|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
83518149|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518150|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
83518151|NCT00001209|Ifosfamide|ifosfamide|mesh-list
83518152|NCT00001209|Vincristine|vincristine|mesh-list
83518153|NCT00001209|Doxorubicin|doxorubicin|mesh-list
83518154|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83518155|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83518156|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
83518157|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518158|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83518159|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83518160|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
83518161|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518162|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518163|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83518164|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83518165|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
83518166|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
83518167|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
83518168|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83518169|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83518170|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83518171|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518172|NCT00002049|Thymopentin|thymopentin|mesh-list
83518173|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83518174|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
83518175|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518176|NCT05044637|Primaquine|primaquine|mesh-list
83518177|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
83518178|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83518179|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83518180|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518181|NCT05043077|Phenylephrine|phenylephrine|mesh-list
83518182|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
83518183|NCT05043077|Tropicamide|tropicamide|mesh-list
83518184|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83518185|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
83518186|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
83518187|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83518188|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518189|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
83518190|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83518191|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
83518192|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
83518193|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83518194|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83518195|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83518196|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
83518197|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83518198|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518199|NCT05043077|Protective Agents|protective agents|mesh-ancestor
83518200|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83518201|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83518202|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
83518203|NCT00002055|Pentamidine|pentamidine|mesh-list
83518204|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
83518205|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518206|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83518207|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83518208|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83518209|NCT05031455|Aspirin|aspirin|mesh-list
83518210|NCT05031455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83518211|NCT05031455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83518212|NCT05031455|Analgesics|analgesics|mesh-ancestor
83518213|NCT05031455|Sensory System Agents|sensory system agents|mesh-ancestor
83518214|NCT05031455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83518215|NCT05031455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518216|NCT05031455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83518217|NCT05031455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83518218|NCT05031455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83518219|NCT05031455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83518220|NCT05031455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518221|NCT05031455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83518222|NCT05031455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83518223|NCT05031455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518224|NCT05031455|Antipyretics|antipyretics|mesh-ancestor
83518225|NCT05029973|Bevacizumab|bevacizumab|mesh-list
83518226|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83518227|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518228|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83518229|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83518230|NCT05029973|Growth Substances|growth substances|mesh-ancestor
83518231|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518232|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
83518233|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
83518234|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83518235|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
83518236|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518237|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
83518238|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518239|NCT00002067|Megestrol|megestrol|mesh-list
83518240|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
83518241|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83518242|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83518243|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83518244|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
83518245|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83518246|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518247|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83518248|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83518249|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83518250|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518251|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
83518252|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83518253|NCT05442983|Probenecid|probenecid|mesh-list
83518254|NCT05442983|Uricosuric Agents|uricosuric agents|mesh-ancestor
83518255|NCT05442983|Gout Suppressants|gout suppressants|mesh-ancestor
83518256|NCT05442983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83518257|NCT00380835|Amrubicin|amrubicin|mesh-list
83518258|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518259|NCT00001311|Heparin|heparin|mesh-list
83518260|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
83518261|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83518262|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83518263|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518264|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
83518265|NCT05016713|Fluorides|fluorides|mesh-list
83518266|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
83518267|NCT05016713|Protective Agents|protective agents|mesh-ancestor
83518268|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518269|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83518270|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518271|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
83518272|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
83518273|NCT00002073|Hematinics|hematinics|mesh-ancestor
83518274|NCT00001317|Interferons|interferons|mesh-list
83518275|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
83518276|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518277|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
83518278|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518279|NCT00001335|Topotecan|topotecan|mesh-list
83518280|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83518281|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83518282|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518283|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518284|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518285|NCT00002079|Miglustat|miglustat|mesh-list
83518286|NCT00002079|Zidovudine|zidovudine|mesh-list
83518287|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
83518288|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518289|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518290|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518291|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518292|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
83518293|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518294|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518295|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518296|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83518297|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83518298|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518299|NCT00002085|Azithromycin|azithromycin|mesh-list
83518300|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518301|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518302|NCT00001383|Paclitaxel|paclitaxel|mesh-list
83518303|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83518304|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518305|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
83518306|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
83518307|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
83518308|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518309|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
83518310|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83518311|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518312|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518313|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83518314|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83518315|NCT00002091|Protective Agents|protective agents|mesh-ancestor
83518316|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518317|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
83518318|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83518319|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
83518320|NCT00001407|Interferons|interferons|mesh-list
83518321|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
83518322|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518324|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518326|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518327|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518328|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
83518329|NCT00002097|Ionophores|ionophores|mesh-ancestor
83518330|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83518331|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518332|NCT00001431|Gemcitabine|gemcitabine|mesh-list
83518333|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83518334|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
83518335|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518336|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518337|NCT05428007|Nivolumab|nivolumab|mesh-list
83518338|NCT05428007|Ipilimumab|ipilimumab|mesh-list
83518339|NCT05428007|Relatlimab|relatlimab|mesh-list
83518340|NCT05428007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83518341|NCT05428007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518342|NCT05428007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83518343|NCT05428007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518344|NCT00002103|Leucovorin|leucovorin|mesh-list
83518345|NCT00002103|Trimetrexate|trimetrexate|mesh-list
83518346|NCT00002103|Calcium|calcium|mesh-list
83518347|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
83518348|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83518349|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518350|NCT00002103|Antidotes|antidotes|mesh-ancestor
83518351|NCT00002103|Protective Agents|protective agents|mesh-ancestor
83518352|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
83518353|NCT00002103|Vitamins|vitamins|mesh-ancestor
83518354|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
83518355|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
83518356|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518357|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83518358|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
83518359|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518360|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518361|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83518362|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518363|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
83518364|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83518365|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518366|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518367|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83518368|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83518369|NCT00001437|Protective Agents|protective agents|mesh-ancestor
83518370|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518371|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
83518372|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83518373|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
83518374|NCT00360191|Buspirone|buspirone|mesh-list
83518375|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83518376|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83518377|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83518378|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518379|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83518380|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83518381|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
83518382|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83518383|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518384|NCT00001443|Indinavir|indinavir|mesh-list
83518385|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518386|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518387|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518388|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518389|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518390|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518391|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518392|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
83518393|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518394|NCT00001449|Leucovorin|leucovorin|mesh-list
83518395|NCT00001449|Gemcitabine|gemcitabine|mesh-list
83518396|NCT00001449|Floxuridine|floxuridine|mesh-list
83518397|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83518398|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
83518399|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518400|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518401|NCT00001449|Antidotes|antidotes|mesh-ancestor
83518402|NCT00001449|Protective Agents|protective agents|mesh-ancestor
83518403|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518404|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
83518405|NCT00001449|Vitamins|vitamins|mesh-ancestor
83518406|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
83518407|NCT00002109|Zidovudine|zidovudine|mesh-list
83518408|NCT00002109|Stavudine|stavudine|mesh-list
83518409|NCT00002109|Didanosine|didanosine|mesh-list
83518410|NCT00002109|Zalcitabine|zalcitabine|mesh-list
83518411|NCT00002109|Thymopentin|thymopentin|mesh-list
83518412|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
83518413|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518414|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518415|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518416|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518417|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
83518418|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518419|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518420|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518421|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83518422|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
83518423|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518424|NCT00359567|Palonosetron|palonosetron|mesh-list
83518425|NCT00359567|Granisetron|granisetron|mesh-list
83518426|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
83518427|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
83518428|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83518429|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518430|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83518431|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83518432|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83518433|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
83518434|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83518435|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518436|NCT00381147|Clarithromycin|clarithromycin|mesh-list
83518437|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518438|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518439|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83518440|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518441|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518442|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83518443|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83518444|NCT05210465|Dobutamine|dobutamine|mesh-list
83518445|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83518446|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
83518447|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
83518448|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83518449|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518450|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83518451|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83518452|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83518453|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
83518454|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83518455|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518456|NCT05210465|Protective Agents|protective agents|mesh-ancestor
83518457|NCT00002115|Adefovir|adefovir|mesh-list
83518458|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
83518459|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518460|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518461|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518462|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518463|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518464|NCT04983407|Paclitaxel|paclitaxel|mesh-list
83518465|NCT04983407|Gemcitabine|gemcitabine|mesh-list
83518466|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83518467|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518468|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
83518469|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
83518470|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
83518471|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518472|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83518473|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
83518474|NCT00001569|Paclitaxel|paclitaxel|mesh-list
83518476|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83518477|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518478|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
83518479|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
83518480|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
83518481|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518482|NCT00001587|Melphalan|melphalan|mesh-list
83518483|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83518484|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
83518485|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518486|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518487|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83518488|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83518489|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
83518490|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518491|NCT00002127|Thalidomide|thalidomide|mesh-list
83518492|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83518493|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
83518494|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518495|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
83518496|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518497|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518498|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83518499|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83518500|NCT00002127|Growth Substances|growth substances|mesh-ancestor
83518501|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
83518502|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518503|NCT00001599|Thalidomide|thalidomide|mesh-list
83518504|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83518505|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
83518506|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518507|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
83518508|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518509|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518510|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83518511|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83518512|NCT00001599|Growth Substances|growth substances|mesh-ancestor
83518513|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
83518514|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518515|NCT00380913|Nabilone|nabilone|mesh-list
83518516|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
83518517|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
83518518|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83518519|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518520|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83518521|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83518522|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83518523|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83518524|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83518525|NCT00002133|Itraconazole|itraconazole|mesh-list
83518526|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
83518527|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518528|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83518529|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83518530|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518531|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518532|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83518533|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
83518534|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83518535|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518536|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83518537|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
83518538|NCT00001629|Giapreza|giapreza|mesh-list
83518539|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
83518540|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
83518541|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83518542|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83518543|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518544|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518545|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518546|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83518547|NCT00002139|Azithromycin|azithromycin|mesh-list
83518548|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518549|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518551|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83518552|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
83518553|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518555|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518556|NCT00002145|Foscarnet|foscarnet|mesh-list
83518557|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83518558|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
83518559|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518560|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518561|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518562|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518563|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518564|NCT00002301|Foscarnet|foscarnet|mesh-list
83518565|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83518566|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
83518567|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518568|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518569|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518570|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518571|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518572|NCT00002307|Zidovudine|zidovudine|mesh-list
83518573|NCT00002307|Stavudine|stavudine|mesh-list
83518574|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
83518575|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518576|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518577|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518578|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518579|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
83518580|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518581|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518582|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518583|NCT00002313|Didanosine|didanosine|mesh-list
83518584|NCT00002313|Nystatin|nystatin|mesh-list
83518585|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
83518586|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518587|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518588|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518589|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518590|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
83518591|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518592|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518593|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518594|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518595|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
83518596|NCT00002313|Ionophores|ionophores|mesh-ancestor
83518597|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83518598|NCT00002157|Thalidomide|thalidomide|mesh-list
83518599|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83518600|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
83518601|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518602|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
83518603|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518604|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518605|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83518606|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83518607|NCT00002157|Growth Substances|growth substances|mesh-ancestor
83518608|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
83518609|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518610|NCT00002319|Doxorubicin|doxorubicin|mesh-list
83518611|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83518612|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83518613|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518614|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83518615|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83518616|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518617|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518618|NCT00002163|Abacavir|abacavir|mesh-list
83518619|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518620|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518621|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518622|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518623|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
83518624|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518625|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518626|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518627|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
83518628|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83518629|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
83518630|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518631|NCT00002325|Fluconazole|fluconazole|mesh-list
83518632|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
83518633|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518634|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83518635|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83518636|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518637|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518638|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83518639|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
83518640|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83518641|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518642|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83518643|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83518644|NCT00002331|Clarithromycin|clarithromycin|mesh-list
83518645|NCT00002331|Ethambutol|ethambutol|mesh-list
83518646|NCT00002331|Clofazimine|clofazimine|mesh-list
83518647|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518648|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518649|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83518650|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518651|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518652|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83518653|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83518654|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
83518655|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83518656|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
83518657|NCT00002337|Vesnarinone|vesnarinone|mesh-list
83518658|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83518659|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
83518660|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518661|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518662|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
83518663|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518664|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83518665|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83518666|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518667|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518668|NCT00002337|Protective Agents|protective agents|mesh-ancestor
83518669|NCT00002169|Nelfinavir|nelfinavir|mesh-list
83518670|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518671|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518672|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518673|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518674|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518675|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518676|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518677|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
83518678|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518679|NCT02293902|Folic Acid|folic acid|mesh-list
83518680|NCT02293902|Methotrexate|methotrexate|mesh-list
83518681|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83518682|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
83518683|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83518684|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518685|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83518686|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
83518687|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518688|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518689|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
83518690|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518691|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83518692|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83518693|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
83518694|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83518695|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518696|NCT02293902|Hematinics|hematinics|mesh-ancestor
83518697|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
83518698|NCT02293902|Vitamins|vitamins|mesh-ancestor
83518699|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
83518700|NCT00002343|Ethambutol|ethambutol|mesh-list
83518702|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
83518703|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518704|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518705|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83518706|NCT05168735|Ketamine|ketamine|mesh-list
83518707|NCT05168735|Analgesics|analgesics|mesh-ancestor
83518708|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
83518709|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83518710|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518711|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83518712|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83518713|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
83518714|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
83518715|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83518716|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83518717|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83518718|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83518719|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518721|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
83518722|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518723|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518724|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518725|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518726|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
83518727|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518728|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518729|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518730|NCT04706013|Pyridoxal|pyridoxal|mesh-list
83518731|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
83518732|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
83518733|NCT04706013|Vitamins|vitamins|mesh-ancestor
83518734|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
83518735|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518736|NCT00002355|Fomivirsen|fomivirsen|mesh-list
83518737|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
83518738|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518739|NCT02278614|Timolol|timolol|mesh-list
83518740|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83518741|NCT02278614|Latanoprost|latanoprost|mesh-list
83518742|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83518743|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83518744|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83518745|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
83518746|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83518747|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518748|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518749|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83518750|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83518751|NCT00002361|Ritonavir|ritonavir|mesh-list
83518752|NCT00002361|Indinavir|indinavir|mesh-list
83518753|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518754|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518755|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518756|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518757|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518758|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518759|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518760|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
83518761|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518762|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83518763|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83518764|NCT00002181|Cidofovir|cidofovir|mesh-list
83518765|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
83518766|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518767|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518768|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518769|NCT00002367|Lamivudine|lamivudine|mesh-list
83518770|NCT00002367|Zidovudine|zidovudine|mesh-list
83518771|NCT00002367|Saquinavir|saquinavir|mesh-list
83518772|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518773|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518774|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518775|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518776|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
83518777|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518778|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518779|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518780|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
83518781|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518782|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518783|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518784|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83518785|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83518787|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
83518788|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518789|NCT00002373|Maribavir|maribavir|mesh-list
83518790|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
83518791|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518792|NCT00002379|Lamivudine|lamivudine|mesh-list
83518793|NCT00002379|Zidovudine|zidovudine|mesh-list
83518794|NCT00002379|Stavudine|stavudine|mesh-list
83518795|NCT00002379|Adefovir|adefovir|mesh-list
83518796|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83518797|NCT00002379|Indinavir|indinavir|mesh-list
83518798|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518799|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518800|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518801|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518802|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
83518803|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518804|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518805|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518806|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
83518807|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518808|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518809|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518810|NCT00359723|Methylphenidate|methylphenidate|mesh-list
83518811|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83518812|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518813|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83518814|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83518815|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83518816|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518817|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
83518818|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83518819|NCT00002193|Amprenavir|amprenavir|mesh-list
83518820|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83518821|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
83518822|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518823|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518824|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518825|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518826|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518827|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518828|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518829|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518830|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518831|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
83518832|NCT00002391|Lamivudine|lamivudine|mesh-list
83518833|NCT00002391|Zidovudine|zidovudine|mesh-list
83518834|NCT00002391|Abacavir|abacavir|mesh-list
83518835|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518836|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518837|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518838|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518839|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
83518840|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518841|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518842|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518843|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
83518844|NCT00002199|Lamivudine|lamivudine|mesh-list
83518845|NCT00002199|Zidovudine|zidovudine|mesh-list
83518846|NCT00002199|Abacavir|abacavir|mesh-list
83518847|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83518848|NCT00002199|Indinavir|indinavir|mesh-list
83518849|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518850|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518851|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518852|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518853|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
83518854|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518855|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518856|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518857|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
83518858|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518859|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518860|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518862|NCT00002397|Stavudine|stavudine|mesh-list
83518863|NCT00002397|Nelfinavir|nelfinavir|mesh-list
83518864|NCT00002397|Saquinavir|saquinavir|mesh-list
83518865|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518866|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518867|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518868|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518869|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
83518870|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518871|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518872|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518873|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518874|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518875|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518876|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
83518877|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83518878|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83518880|NCT00002205|Amprenavir|amprenavir|mesh-list
83518881|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518882|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518883|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518884|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518885|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
83518886|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518887|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518888|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518889|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83518890|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
83518891|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83518892|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518893|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518894|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518895|NCT02977169|Cisplatin|cisplatin|mesh-list
83518896|NCT02977169|Carboplatin|carboplatin|mesh-list
83518897|NCT02977169|Pemetrexed|pemetrexed|mesh-list
83518898|NCT02977169|Vinorelbine|vinorelbine|mesh-list
83518899|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518900|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518901|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518902|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83518903|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518904|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83518905|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
83518906|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
83518907|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
83518908|NCT00002409|Lamivudine|lamivudine|mesh-list
83518909|NCT00002409|Zidovudine|zidovudine|mesh-list
83518910|NCT00002409|Abacavir|abacavir|mesh-list
83518911|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83518912|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518913|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518914|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518915|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518916|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
83518917|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518918|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518919|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518920|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
83518921|NCT00002211|Nelfinavir|nelfinavir|mesh-list
83518922|NCT00002211|Stavudine|stavudine|mesh-list
83518923|NCT00002211|Didanosine|didanosine|mesh-list
83518924|NCT00002211|Delavirdine|delavirdine|mesh-list
83518925|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518926|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518927|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518928|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518929|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518930|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518931|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518932|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
83518933|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518935|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518936|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518938|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
83518939|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518940|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518941|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518942|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518943|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518944|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518945|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518946|NCT00381537|Carbamazepine|carbamazepine|mesh-list
83518947|NCT00381537|Phenobarbital|phenobarbital|mesh-list
83518948|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
83518949|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
83518950|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83518951|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83518952|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83518953|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83518954|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83518956|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
83518957|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83518958|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83518959|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83518960|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518961|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83518962|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83518963|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83518964|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83518965|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83518966|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83518967|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
83518968|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
83518969|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83518970|NCT00002427|Stavudine|stavudine|mesh-list
83518971|NCT00002427|Didanosine|didanosine|mesh-list
83518972|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
83518973|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518974|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
83518975|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518976|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518977|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83518978|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
83518979|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83518980|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
83518981|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518982|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518983|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518984|NCT00002223|Ritonavir|ritonavir|mesh-list
83518985|NCT00002223|Indinavir|indinavir|mesh-list
83518986|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83518987|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83518988|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
83518989|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83518990|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518991|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83518992|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83518993|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
83518994|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83518995|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83518996|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83518997|NCT00002433|Interferons|interferons|mesh-list
83518998|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
83518999|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519000|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
83519001|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519002|NCT00002439|Alitretinoin|alitretinoin|mesh-list
83519003|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519004|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
83519005|NCT00002229|Saquinavir|saquinavir|mesh-list
83519006|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83519007|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83519008|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
83519009|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519010|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519013|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
83519014|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519015|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83519016|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83519017|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83519018|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519019|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519020|NCT05381909|Paclitaxel|paclitaxel|mesh-list
83519021|NCT05381909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83519022|NCT05381909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519023|NCT05381909|Tubulin Modulators|tubulin modulators|mesh-ancestor
83519024|NCT05381909|Antimitotic Agents|antimitotic agents|mesh-ancestor
83519025|NCT05381909|Mitosis Modulators|mitosis modulators|mesh-ancestor
83519026|NCT05381909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519027|NCT00002451|Ritonavir|ritonavir|mesh-list
83519028|NCT00002451|Indinavir|indinavir|mesh-list
83519029|NCT00002451|Lamivudine|lamivudine|mesh-list
83519030|NCT00002451|Stavudine|stavudine|mesh-list
83519031|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83519032|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83519033|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
83519034|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519035|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519036|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83519037|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83519038|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
83519039|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519040|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83519041|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83519042|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83519043|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519044|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
83519045|NCT00002235|Efavirenz|efavirenz|mesh-list
83519046|NCT00002235|Nelfinavir|nelfinavir|mesh-list
83519047|NCT00002235|Indinavir|indinavir|mesh-list
83519048|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83519049|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519050|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519051|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519052|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
83519053|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519054|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83519055|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83519056|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83519057|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83519058|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83519059|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83519060|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83519061|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83519062|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
83519063|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83519064|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83519065|NCT00002241|Ritonavir|ritonavir|mesh-list
83519066|NCT00002241|Indinavir|indinavir|mesh-list
83519067|NCT00002241|Lamivudine|lamivudine|mesh-list
83519068|NCT00002241|Stavudine|stavudine|mesh-list
83519069|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83519070|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83519071|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
83519072|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519073|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519074|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83519075|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83519076|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
83519077|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519078|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83519079|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83519080|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83519081|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519082|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
83519083|NCT00002463|Leucovorin|leucovorin|mesh-list
83519084|NCT00002463|Prednisone|prednisone|mesh-list
83519085|NCT00002463|Methotrexate|methotrexate|mesh-list
83519086|NCT00002463|Vincristine|vincristine|mesh-list
83519091|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83519092|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519093|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519094|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
83519095|NCT00002463|Hormones|hormones|mesh-ancestor
83519096|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519097|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519098|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519099|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83519100|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
83519101|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83519102|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83519104|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519105|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
83519106|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519107|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83519108|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519109|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
83519110|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519111|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519112|NCT00002463|Antidotes|antidotes|mesh-ancestor
83519113|NCT00002463|Protective Agents|protective agents|mesh-ancestor
83519114|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
83519115|NCT00002463|Vitamins|vitamins|mesh-ancestor
83519116|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
83519117|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83519118|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
83519119|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
83519120|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
83519121|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
83519122|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83519123|NCT04500899|Phenylephrine|phenylephrine|mesh-list
83519124|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83519125|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
83519126|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
83519127|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519128|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519129|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
83519130|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83519131|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
83519132|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
83519133|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83519134|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83519135|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83519136|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
83519137|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83519138|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519139|NCT04500899|Protective Agents|protective agents|mesh-ancestor
83519140|NCT00002247|Ganciclovir|ganciclovir|mesh-list
83519141|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83519142|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
83519143|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519144|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519145|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519146|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519147|NCT00002475|Interferons|interferons|mesh-list
83519148|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
83519149|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
83519150|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
83519151|NCT00002475|Vaccines|vaccines|mesh-list
83519152|NCT00002475|Sargramostim|sargramostim|mesh-list
83519153|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
83519154|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519155|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519156|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519157|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83519158|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
83519159|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519160|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519161|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83519162|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
83519163|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519164|NCT00002481|Cytarabine|cytarabine|mesh-list
83519165|NCT00002481|Dexamethasone|dexamethasone|mesh-list
83519166|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
83519167|NCT00002481|Etoposide|etoposide|mesh-list
83519168|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519170|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519171|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519172|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83519173|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
83519174|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519175|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519176|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83519177|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519178|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
83519179|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
83519180|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519181|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519182|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
83519183|NCT00002481|Hormones|hormones|mesh-ancestor
83519184|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519185|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519186|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83519187|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83519188|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83519189|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519190|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83519191|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
83519192|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
83519193|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519194|NCT00002253|Octreotide|octreotide|mesh-list
83519195|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519196|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519197|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519198|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
83519199|NCT04862585|Promethazine|promethazine|mesh-list
83519200|NCT04862585|Dexamethasone|dexamethasone|mesh-list
83519201|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
83519202|NCT04862585|Paclitaxel|paclitaxel|mesh-list
83519203|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83519204|NCT04862585|Famotidine|famotidine|mesh-list
83519205|NCT04862585|Ranitidine|ranitidine|mesh-list
83519206|NCT04862585|Cimetidine|cimetidine|mesh-list
83519207|NCT04862585|BB 1101|bb 1101|mesh-list
83519208|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83519209|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519210|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
83519211|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
83519212|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
83413633|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519213|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519214|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519215|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
83519216|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
83519217|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519218|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519219|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519220|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
83519221|NCT04862585|Hormones|hormones|mesh-ancestor
83519222|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519223|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519224|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
83519225|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519226|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83519227|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83519228|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83519229|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
83519230|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
83519231|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
83519232|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83519233|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
83519234|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
83519235|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83519236|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83519237|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
83519238|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
83519239|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83519240|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83519241|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83519242|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83519243|NCT00002487|Methotrexate|methotrexate|mesh-list
83519245|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83519246|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
83519247|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83519248|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519249|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83519250|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
83519251|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519252|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519253|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
83519254|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519255|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83519256|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519257|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
83519258|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519259|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519260|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83519261|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83519262|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
83519263|NCT00002493|Doxorubicin|doxorubicin|mesh-list
83519264|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83519265|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519266|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83519267|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83519268|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83519269|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519270|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519271|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
83519272|NCT00002259|Analgesics|analgesics|mesh-ancestor
83519273|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
83519274|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519275|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519276|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519277|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83519278|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83519279|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519280|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519281|NCT00002499|Cytarabine|cytarabine|mesh-list
83519282|NCT00002499|Dexamethasone|dexamethasone|mesh-list
83519283|NCT00002499|Prednisone|prednisone|mesh-list
83519284|NCT00002499|Methotrexate|methotrexate|mesh-list
83519285|NCT00002499|Vincristine|vincristine|mesh-list
83519286|NCT00002499|Daunorubicin|daunorubicin|mesh-list
83519287|NCT00002499|Asparaginase|asparaginase|mesh-list
83519288|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519289|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
83519290|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
83519291|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519292|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519293|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519294|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
83519295|NCT00002499|Hormones|hormones|mesh-ancestor
83519296|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519297|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519298|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519299|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83519300|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
83519301|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83519302|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83519303|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
83519304|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519305|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
83519306|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519307|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83519308|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519309|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
83519310|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519311|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519312|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
83519313|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519314|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83519315|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
83519316|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
83519317|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
83519318|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83519319|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83519320|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83519321|NCT00002505|Interferons|interferons|mesh-list
83519322|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
83519323|NCT00002505|Vaccines|vaccines|mesh-list
83519324|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519325|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
83519326|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519327|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
83519328|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519329|NCT00002265|Zalcitabine|zalcitabine|mesh-list
83519330|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
83519331|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519332|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83519333|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519334|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519335|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
83519336|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519337|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83519338|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83519339|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
83519340|NCT04933331|Fluorides|fluorides|mesh-list
83519341|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
83519342|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
83519343|NCT04933331|Protective Agents|protective agents|mesh-ancestor
83519344|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519345|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83519346|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519347|NCT00002271|Alovudine|alovudine|mesh-list
83519348|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
83519349|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519350|NCT00002517|Cytarabine|cytarabine|mesh-list
83519351|NCT00002517|Dexamethasone|dexamethasone|mesh-list
83519352|NCT00002517|Etoposide|etoposide|mesh-list
83519353|NCT00002517|Daunorubicin|daunorubicin|mesh-list
83519354|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
83519355|NCT00002517|Idarubicin|idarubicin|mesh-list
83519356|NCT00002517|Thioguanine|thioguanine|mesh-list
83519357|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519358|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
83519359|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
83519360|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519361|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519362|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519363|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
83519364|NCT00002517|Hormones|hormones|mesh-ancestor
83519365|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519366|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519367|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519368|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83519369|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83519370|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83519371|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519372|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519373|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83519374|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
83519375|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
83519376|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519377|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519378|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
83519379|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83519380|NCT00002517|Analgesics|analgesics|mesh-ancestor
83519381|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
83519382|NCT00002277|Fluconazole|fluconazole|mesh-list
83519383|NCT00002277|Amphotericin B|amphotericin b|mesh-list
83519384|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83519385|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
83519386|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519387|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83519388|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83519389|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519390|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519391|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83519392|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
83519393|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519394|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519395|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83519396|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83519397|NCT00002277|Amebicides|amebicides|mesh-ancestor
83519398|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83519399|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83519400|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83519401|NCT04469075|Clindamycin|clindamycin|mesh-list
83519402|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
83519403|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
83519404|NCT04469075|Triamcinolone|triamcinolone|mesh-list
83519405|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83519406|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83519407|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83519408|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519409|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
83519410|NCT04469075|Hormones|hormones|mesh-ancestor
83519411|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519412|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519413|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519414|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
83519415|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519416|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519417|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83519418|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519419|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83519420|NCT00002523|Leucovorin|leucovorin|mesh-list
83519421|NCT00002523|Fluorouracil|fluorouracil|mesh-list
83519422|NCT00002523|Calcium|calcium|mesh-list
83519423|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
83519424|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83519425|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519426|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
83519427|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519428|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83519429|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519430|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519431|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
83519432|NCT00002523|Antidotes|antidotes|mesh-ancestor
83519433|NCT00002523|Protective Agents|protective agents|mesh-ancestor
83519434|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
83519435|NCT00002523|Vitamins|vitamins|mesh-ancestor
83519436|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
83519437|NCT00002529|Tamoxifen|tamoxifen|mesh-list
83519438|NCT00002529|Toremifene|toremifene|mesh-list
83519439|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
83519440|NCT00002529|Doxorubicin|doxorubicin|mesh-list
83519441|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83519442|NCT00002529|Epirubicin|epirubicin|mesh-list
83519443|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519444|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
83519445|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519446|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519447|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83519448|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
83519449|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519450|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519451|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83519452|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83519453|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83519454|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83519455|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519456|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83519457|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
83519458|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519459|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519460|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83519461|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83519462|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83519463|NCT04832087|Teduglutide|teduglutide|mesh-list
83519464|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519465|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83519466|NCT04832087|Protective Agents|protective agents|mesh-ancestor
83519467|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519468|NCT00002217|Lamivudine|lamivudine|mesh-list
83519469|NCT00002217|Zidovudine|zidovudine|mesh-list
83519470|NCT00002217|Abacavir|abacavir|mesh-list
83519471|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83519472|NCT00002217|Amprenavir|amprenavir|mesh-list
83519473|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83519474|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519475|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519476|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519477|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
83519478|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519479|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83519480|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83519481|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
83519482|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83519483|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
83519484|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83519485|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83519486|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83519487|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
83519488|NCT00002283|Trimethoprim|trimethoprim|mesh-list
83519489|NCT00002283|Dapsone|dapsone|mesh-list
83519490|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
83519491|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83519492|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519493|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
83519494|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83519495|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83519496|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83519497|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519498|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519499|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83519500|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83519501|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83519502|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
83519503|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83519504|NCT04826237|Dexamethasone|dexamethasone|mesh-list
83519505|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
83519506|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83519507|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83519508|NCT04826237|Prednisolone|prednisolone|mesh-list
83519509|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
83519510|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83519511|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83519512|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
83519513|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519514|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
83519515|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
83519516|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413634|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
83519517|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519518|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519519|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
83519520|NCT04826237|Hormones|hormones|mesh-ancestor
83519521|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519522|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519523|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519524|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83519525|NCT04826237|Protective Agents|protective agents|mesh-ancestor
83519526|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83519527|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83519528|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
83519529|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519530|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519531|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83519532|NCT00002535|Aldesleukin|aldesleukin|mesh-list
83519533|NCT00002535|Indomethacin|indomethacin|mesh-list
83519534|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
83519535|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519536|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
83519537|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519538|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519539|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83519540|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
83519541|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519542|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519543|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83519544|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83519545|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83519546|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
83519547|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519548|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83519549|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83519550|NCT00002535|Analgesics|analgesics|mesh-ancestor
83519551|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
83519552|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519553|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519554|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
83519555|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
83519556|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83519557|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83519558|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519559|NCT00002547|Cytarabine|cytarabine|mesh-list
83519560|NCT00002547|Cyclosporine|cyclosporine|mesh-list
83519561|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
83519562|NCT00002547|Busulfan|busulfan|mesh-list
83519563|NCT00002547|Methotrexate|methotrexate|mesh-list
83519564|NCT00002547|Cyclosporins|cyclosporins|mesh-list
83519565|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519566|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
83519567|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519568|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519569|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83519570|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
83519571|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519572|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519573|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83519574|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83519575|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
83519576|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83519577|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83519578|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
83519579|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
83519580|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519581|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83519582|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519583|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
83519584|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519585|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
83519586|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83519587|NCT00002289|Thymopentin|thymopentin|mesh-list
83519588|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83519589|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
83519590|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519591|NCT00002553|Cobalt|cobalt|mesh-list
83519592|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
83519593|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519594|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
83519595|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519596|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519597|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83519598|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
83519599|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519600|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519601|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83519602|NCT00002553|Trace Elements|trace elements|mesh-ancestor
83519603|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
83519604|NCT00002559|Paclitaxel|paclitaxel|mesh-list
83519605|NCT00002559|Ifosfamide|ifosfamide|mesh-list
83519606|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83519607|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519608|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
83519609|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
83519610|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
83519611|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519612|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83519613|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
83519614|NCT00002565|Cytarabine|cytarabine|mesh-list
83519615|NCT00002565|Prednisone|prednisone|mesh-list
83519616|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
83519617|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
83519618|NCT00002565|Ifosfamide|ifosfamide|mesh-list
83519619|NCT00002565|Doxorubicin|doxorubicin|mesh-list
83519620|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83519621|NCT00002565|Etoposide|etoposide|mesh-list
83519622|NCT00002565|Vincristine|vincristine|mesh-list
83519623|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
83519624|NCT00002565|Idarubicin|idarubicin|mesh-list
83519625|NCT00002565|Bleomycin|bleomycin|mesh-list
83519626|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519628|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519629|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519630|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83519631|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
83519632|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519633|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519634|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83519635|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83519636|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83519637|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83519638|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519639|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519640|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
83519641|NCT00002565|Hormones|hormones|mesh-ancestor
83519642|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519643|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519644|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83519645|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83519646|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
83519647|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
83519648|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519649|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
83519650|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
83519651|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
83519652|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
83519653|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
83519654|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519655|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519656|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83519657|NCT00002565|Protective Agents|protective agents|mesh-ancestor
83519658|NCT00002565|Analgesics|analgesics|mesh-ancestor
83519659|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
83519660|NCT00002571|Leucovorin|leucovorin|mesh-list
83519661|NCT00002571|Cytarabine|cytarabine|mesh-list
83519662|NCT00002571|Trimethoprim|trimethoprim|mesh-list
83519663|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
83519664|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83519665|NCT00002571|Prednisone|prednisone|mesh-list
83519666|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
83519667|NCT00002571|Doxorubicin|doxorubicin|mesh-list
83519668|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83519669|NCT00002571|Methotrexate|methotrexate|mesh-list
83519670|NCT00002571|Etoposide|etoposide|mesh-list
83519671|NCT00002571|Vincristine|vincristine|mesh-list
83519672|NCT00002571|Bleomycin|bleomycin|mesh-list
83519673|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
83519674|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519675|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
83519676|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519677|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519678|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83519679|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
83519680|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519681|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519682|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83519683|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83519684|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83519685|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83519686|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519687|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519688|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
83519689|NCT00002571|Hormones|hormones|mesh-ancestor
83519690|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519691|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519692|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83519693|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
83519694|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83519695|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83519696|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
83519697|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
83519698|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83519699|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519700|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83519701|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
83519702|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519703|NCT00002571|Antidotes|antidotes|mesh-ancestor
83519711|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83519712|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
83519713|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83519714|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83519715|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83519716|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83519717|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83519718|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83519719|NCT00360815|Insulin|insulin|mesh-list
83519720|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83519721|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519722|NCT00002583|Vinorelbine|vinorelbine|mesh-list
83519723|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519724|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83519725|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
83519726|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
83519727|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
83519728|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519729|NCT00002589|Aldesleukin|aldesleukin|mesh-list
83519730|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
83519731|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519732|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83519733|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83519734|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
83519735|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519736|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
83519737|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519738|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519739|NCT02223871|Lumefantrine|lumefantrine|mesh-list
83519740|NCT02223871|Artemether|artemether|mesh-list
83519741|NCT02223871|Primaquine|primaquine|mesh-list
83519742|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
83519743|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83519744|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83519745|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519746|NCT00002595|Toremifene|toremifene|mesh-list
83519747|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519748|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519749|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83519750|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83519751|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
83519752|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519753|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519754|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83519755|NCT03004339|Betamethasone|betamethasone|mesh-list
83519756|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
83519757|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83519758|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
83519759|NCT03004339|Calcipotriene|calcipotriene|mesh-list
83519760|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83519761|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519762|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
83519763|NCT03004339|Hormones|hormones|mesh-ancestor
83519764|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519765|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519766|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83519767|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
83519768|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
83519769|NCT00002619|Carboplatin|carboplatin|mesh-list
83519770|NCT00002619|Thiotepa|thiotepa|mesh-list
83519771|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519772|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
83519773|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519774|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83519775|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
83519776|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519777|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83519778|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519779|NCT00002625|Topotecan|topotecan|mesh-list
83519780|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83519781|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83519782|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519783|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519784|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519785|NCT00360737|Antitoxins|antitoxins|mesh-list
83519786|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
83519788|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519789|NCT05752305|Dexamethasone|dexamethasone|mesh-list
83519790|NCT05752305|Methylprednisolone|methylprednisolone|mesh-list
83519791|NCT05752305|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83519792|NCT05752305|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83519793|NCT05752305|Prednisolone|prednisolone|mesh-list
83519794|NCT05752305|Prednisolone acetate|prednisolone acetate|mesh-list
83519795|NCT05752305|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83519796|NCT05752305|Prednisolone phosphate|prednisolone phosphate|mesh-list
83519797|NCT05752305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519798|NCT05752305|Antiemetics|antiemetics|mesh-ancestor
83519799|NCT05752305|Autonomic Agents|autonomic agents|mesh-ancestor
83519800|NCT05752305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519801|NCT05752305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519802|NCT05752305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519803|NCT05752305|Glucocorticoids|glucocorticoids|mesh-ancestor
83519804|NCT05752305|Hormones|hormones|mesh-ancestor
83519805|NCT05752305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519806|NCT05752305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519807|NCT05752305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519808|NCT05752305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83519809|NCT05752305|Protective Agents|protective agents|mesh-ancestor
83519810|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
83519811|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83519812|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83519813|NCT04343729|Prednisolone|prednisolone|mesh-list
83519814|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
83519815|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83519816|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
83519817|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519818|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
83519819|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
83519820|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519821|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519822|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519823|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
83519824|NCT04343729|Hormones|hormones|mesh-ancestor
83519825|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519826|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83519827|NCT04343729|Protective Agents|protective agents|mesh-ancestor
83519828|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519829|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519830|NCT00002631|Fluorouracil|fluorouracil|mesh-list
83519831|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519832|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
83519833|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519834|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83519835|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83519836|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
83519837|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519838|NCT00002637|Interferons|interferons|mesh-list
83519839|NCT00002637|Aldesleukin|aldesleukin|mesh-list
83519840|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
83519841|NCT00002637|Vaccines|vaccines|mesh-list
83519842|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519843|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
83519844|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519845|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83519846|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83519847|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
83519848|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519849|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83519850|NCT02977013|Dalteparin|dalteparin|mesh-list
83519851|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
83519852|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83519853|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83519854|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519855|NCT05806918|Interferons|interferons|mesh-list
83519856|NCT05806918|Interferon alpha-2|interferon alpha-2|mesh-list
83519857|NCT05806918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519858|NCT05806918|Antiviral Agents|antiviral agents|mesh-ancestor
83519859|NCT05806918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519860|NCT05806853|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83519861|NCT05806853|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83519862|NCT05806853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519863|NCT05806749|Belumosudil|belumosudil|mesh-list
83519864|NCT05806749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83519866|NCT05806749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519868|NCT05806723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83519869|NCT05806723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83519870|NCT05806723|Antimetabolites|antimetabolites|mesh-ancestor
83519871|NCT05806723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519872|NCT05806723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83519873|NCT05806723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83519874|NCT05806723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519875|NCT05806697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83519876|NCT05806697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83519877|NCT05806697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519878|NCT05806671|Fulvestrant|fulvestrant|mesh-list
83519879|NCT05806671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519880|NCT05806671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519881|NCT05806671|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83519882|NCT05806671|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83519883|NCT05806671|Hormone Antagonists|hormone antagonists|mesh-ancestor
83519884|NCT05806671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519885|NCT05806671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519886|NCT05806515|Carboplatin|carboplatin|mesh-list
83519887|NCT05806515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519888|NCT05806476|Caffeine|caffeine|mesh-list
83519889|NCT05806476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83519890|NCT05806476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519891|NCT05806476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83519892|NCT05806476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519893|NCT05806476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519894|NCT05806476|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83519895|NCT05806476|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83519896|NCT05806476|Purinergic Agents|purinergic agents|mesh-ancestor
83519897|NCT05806476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83519898|NCT05806385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83519899|NCT05806385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519900|NCT05806385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83519901|NCT05806385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519902|NCT05806307|Vasopressins|vasopressins|mesh-list
83519903|NCT05806307|Arginine Vasopressin|arginine vasopressin|mesh-list
83519904|NCT05806307|Epinephrine|epinephrine|mesh-list
83519905|NCT05806307|Bupivacaine|bupivacaine|mesh-list
83519906|NCT05806307|Misoprostol|misoprostol|mesh-list
83519907|NCT05806307|Ethamsylate|ethamsylate|mesh-list
83519908|NCT05806307|Oxytocin|oxytocin|mesh-list
83519909|NCT05806307|Carbetocin|carbetocin|mesh-list
83519910|NCT05806307|Anesthetics, Local|anesthetics, local|mesh-ancestor
83519911|NCT05806307|Anesthetics|anesthetics|mesh-ancestor
83519912|NCT05806307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83519913|NCT05806307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519914|NCT05806307|Sensory System Agents|sensory system agents|mesh-ancestor
83519915|NCT05806307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519916|NCT05806307|Oxytocics|oxytocics|mesh-ancestor
83519917|NCT05806307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83519918|NCT05806307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83519919|NCT05806307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83519920|NCT05806307|Adrenergic Agents|adrenergic agents|mesh-ancestor
83519921|NCT05806307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83519922|NCT05806307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519923|NCT05806307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83519924|NCT05806307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83519925|NCT05806307|Autonomic Agents|autonomic agents|mesh-ancestor
83519926|NCT05806307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83519927|NCT05806307|Respiratory System Agents|respiratory system agents|mesh-ancestor
83519929|NCT05806307|Sympathomimetics|sympathomimetics|mesh-ancestor
83519930|NCT05806307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83519931|NCT05806307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83519932|NCT05806307|Abortifacient Agents|abortifacient agents|mesh-ancestor
83519933|NCT05806307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83519934|NCT05806307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519935|NCT05806307|Hemostatics|hemostatics|mesh-ancestor
83519936|NCT05806307|Coagulants|coagulants|mesh-ancestor
83519937|NCT05806307|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83519938|NCT05806307|Natriuretic Agents|natriuretic agents|mesh-ancestor
83519939|NCT05806047|Fulvestrant|fulvestrant|mesh-list
83520013|NCT05804747|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83519940|NCT05806047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519941|NCT05806047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519942|NCT05806047|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83519943|NCT05806047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83519944|NCT05806047|Hormone Antagonists|hormone antagonists|mesh-ancestor
83519945|NCT05806047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519946|NCT05806047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519947|NCT05805930|Prednisone|prednisone|mesh-list
83519948|NCT05805930|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83519949|NCT05805930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519950|NCT05805930|Glucocorticoids|glucocorticoids|mesh-ancestor
83519951|NCT05805930|Hormones|hormones|mesh-ancestor
83519952|NCT05805930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519953|NCT05805930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519954|NCT05805930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519955|NCT05805930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519956|NCT05805930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83519957|NCT05805891|Bortezomib|bortezomib|mesh-list
83519958|NCT05805891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519959|NCT05805839|Corticosterone|corticosterone|mesh-list
83519960|NCT05805839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519961|NCT05805800|Dexamethasone|dexamethasone|mesh-list
83519962|NCT05805800|Olanzapine|olanzapine|mesh-list
83519963|NCT05805800|Serotonin|serotonin|mesh-list
83519964|NCT05805800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83519965|NCT05805800|Antiemetics|antiemetics|mesh-ancestor
83519966|NCT05805800|Autonomic Agents|autonomic agents|mesh-ancestor
83519967|NCT05805800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83519968|NCT05805800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83519969|NCT05805800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83519970|NCT05805800|Glucocorticoids|glucocorticoids|mesh-ancestor
83519971|NCT05805800|Hormones|hormones|mesh-ancestor
83519972|NCT05805800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519973|NCT05805800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83519974|NCT05805800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519975|NCT05805800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83519976|NCT05805800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83519977|NCT05805800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83519978|NCT05805800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83519979|NCT05805800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83519980|NCT05805800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83519981|NCT05805800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83519982|NCT05805800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519983|NCT05805800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83519984|NCT05805800|Serotonin Agents|serotonin agents|mesh-ancestor
83519985|NCT05805800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83519986|NCT05805761|Anti-Infective Agents|anti-infective agents|mesh-list
83519987|NCT05805761|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83519988|NCT05805631|Pemetrexed|pemetrexed|mesh-list
83519989|NCT05805631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83519990|NCT05805631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83519991|NCT05805631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519992|NCT05805631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83519993|NCT05805631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519994|NCT05805553|Nandrolone Decanoate|nandrolone decanoate|mesh-list
83519995|NCT05805553|Propranolol|propranolol|mesh-list
83519996|NCT05805553|Nandrolone|nandrolone|mesh-list
83519997|NCT05805553|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
83519998|NCT05805553|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83519999|NCT05805553|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83520000|NCT05805553|Adrenergic Agents|adrenergic agents|mesh-ancestor
83520001|NCT05805553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520002|NCT05805553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520003|NCT05805553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520004|NCT05805553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83520005|NCT05805553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83520006|NCT05805553|Vasodilator Agents|vasodilator agents|mesh-ancestor
83520007|NCT05805553|Androgens|androgens|mesh-ancestor
83520008|NCT05805553|Hormones|hormones|mesh-ancestor
83520009|NCT05805553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83520010|NCT05805553|Anabolic Agents|anabolic agents|mesh-ancestor
83520011|NCT05805553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83520012|NCT05804747|Edoxaban|edoxaban|mesh-list
83520015|NCT05804747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83520016|NCT05804747|Protease Inhibitors|protease inhibitors|mesh-ancestor
83520017|NCT05804747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520018|NCT05804747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520019|NCT05804747|Anticoagulants|anticoagulants|mesh-ancestor
83520020|NCT05800938|Isosorbide|isosorbide|mesh-list
83520021|NCT05800938|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83520022|NCT05800938|Diuretics|diuretics|mesh-ancestor
83520023|NCT05800938|Natriuretic Agents|natriuretic agents|mesh-ancestor
83520024|NCT05800938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520025|NCT05797935|Dapagliflozin|dapagliflozin|mesh-list
83520026|NCT05797935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83520027|NCT05797935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520028|NCT05797935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83520029|NCT05797935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520030|NCT05775237|Vitamins|vitamins|mesh-list
83520031|NCT05775237|Ascorbic Acid|ascorbic acid|mesh-list
83520032|NCT05775237|Curcumin|curcumin|mesh-list
83520033|NCT05775237|Micronutrients|micronutrients|mesh-ancestor
83520034|NCT05775237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520035|NCT05775237|Antioxidants|antioxidants|mesh-ancestor
83520036|NCT05775237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520037|NCT05775237|Protective Agents|protective agents|mesh-ancestor
83520038|NCT05775237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83520039|NCT05775237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83520040|NCT05775237|Analgesics|analgesics|mesh-ancestor
83520041|NCT05775237|Sensory System Agents|sensory system agents|mesh-ancestor
83520042|NCT05775237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520043|NCT05775237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83520044|NCT05775237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83520045|NCT05775237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520046|NCT05775237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520047|NCT05773365|Anesthetics|anesthetics|mesh-list
83520048|NCT05773365|Anesthetics, Local|anesthetics, local|mesh-list
83520049|NCT05773365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83520050|NCT05773365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520051|NCT05773365|Sensory System Agents|sensory system agents|mesh-ancestor
83520052|NCT05773365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520053|NCT05751044|Cytarabine|cytarabine|mesh-list
83520054|NCT05751044|Dexamethasone|dexamethasone|mesh-list
83520055|NCT05751044|Cyclophosphamide|cyclophosphamide|mesh-list
83520056|NCT05751044|Venetoclax|venetoclax|mesh-list
83520057|NCT05751044|Dasatinib|dasatinib|mesh-list
83520058|NCT05751044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83520059|NCT05751044|Immunologic Factors|immunologic factors|mesh-ancestor
83520060|NCT05751044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520061|NCT05751044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83520062|NCT05751044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83520063|NCT05751044|Alkylating Agents|alkylating agents|mesh-ancestor
83520064|NCT05751044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520065|NCT05751044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520066|NCT05751044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83520067|NCT05751044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83520068|NCT05751044|Antiemetics|antiemetics|mesh-ancestor
83520069|NCT05751044|Autonomic Agents|autonomic agents|mesh-ancestor
83520070|NCT05751044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520071|NCT05751044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83520072|NCT05751044|Glucocorticoids|glucocorticoids|mesh-ancestor
83520073|NCT05751044|Hormones|hormones|mesh-ancestor
83520074|NCT05751044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83520075|NCT05751044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83520076|NCT05751044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83520077|NCT05751044|Antimetabolites|antimetabolites|mesh-ancestor
83520078|NCT05751044|Antiviral Agents|antiviral agents|mesh-ancestor
83520079|NCT05751044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520080|NCT05751044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83520081|NCT05751044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520082|NCT05709093|Azacitidine|azacitidine|mesh-list
83520083|NCT05709093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83520084|NCT05709093|Antimetabolites|antimetabolites|mesh-ancestor
83520085|NCT05709093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520086|NCT05709093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520087|NCT05709093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520088|NCT05690646|Ritonavir|ritonavir|mesh-list
83520089|NCT05690646|Nirmatrelvir|nirmatrelvir|mesh-list
83520090|NCT05690646|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83520092|NCT05690646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83520093|NCT05690646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83520094|NCT05690646|Protease Inhibitors|protease inhibitors|mesh-ancestor
83520095|NCT05690646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520096|NCT05690646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520097|NCT05690646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83520098|NCT05690646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83520099|NCT05690646|Antiviral Agents|antiviral agents|mesh-ancestor
83520100|NCT05690646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520101|NCT05690646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83520102|NCT05690646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83520103|NCT05690646|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83520104|NCT05690646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83520105|NCT05648201|Raltegravir Potassium|raltegravir potassium|mesh-list
83520106|NCT05648201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83520107|NCT05648201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83520108|NCT05648201|Antiviral Agents|antiviral agents|mesh-ancestor
83520109|NCT05648201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520110|NCT05648201|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83520111|NCT05648201|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83520112|NCT05648201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520113|NCT05648201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520114|NCT05627635|Calcium, Dietary|calcium, dietary|mesh-list
83520115|NCT05627635|Leucovorin|leucovorin|mesh-list
83520116|NCT05627635|Folic Acid|folic acid|mesh-list
83520117|NCT05627635|Bevacizumab|bevacizumab|mesh-list
83520118|NCT05627635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83520119|NCT05627635|Fluorouracil|fluorouracil|mesh-list
83520120|NCT05627635|Oxaliplatin|oxaliplatin|mesh-list
83520121|NCT05627635|Endothelial Growth Factors|endothelial growth factors|mesh-list
83520122|NCT05627635|Antibodies|antibodies|mesh-list
83520123|NCT05627635|Immunoglobulins|immunoglobulins|mesh-list
83520124|NCT05627635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83520125|NCT05627635|Immunoglobulin G|immunoglobulin g|mesh-list
83520126|NCT05627635|Calcium|calcium|mesh-list
83520127|NCT05627635|Levoleucovorin|levoleucovorin|mesh-list
83520128|NCT05627635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520129|NCT05627635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83520130|NCT05627635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83520131|NCT05627635|Growth Substances|growth substances|mesh-ancestor
83520132|NCT05627635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520133|NCT05627635|Growth Inhibitors|growth inhibitors|mesh-ancestor
83520134|NCT05627635|Immunologic Factors|immunologic factors|mesh-ancestor
83520135|NCT05627635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83520136|NCT05627635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83520137|NCT05627635|Antimetabolites|antimetabolites|mesh-ancestor
83520138|NCT05627635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520139|NCT05627635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83520140|NCT05627635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83520141|NCT05627635|Antidotes|antidotes|mesh-ancestor
83520142|NCT05627635|Protective Agents|protective agents|mesh-ancestor
83520143|NCT05627635|Vitamin B Complex|vitamin b complex|mesh-ancestor
83520144|NCT05627635|Vitamins|vitamins|mesh-ancestor
83520145|NCT05627635|Micronutrients|micronutrients|mesh-ancestor
83520146|NCT05627635|Hematinics|hematinics|mesh-ancestor
83520147|NCT05607004|Exemestane|exemestane|mesh-list
83520148|NCT05607004|Goserelin|goserelin|mesh-list
83520149|NCT05607004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520150|NCT05607004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83520151|NCT05607004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83520152|NCT05607004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520153|NCT05607004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520154|NCT05607004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83520155|NCT05607004|Hormone Antagonists|hormone antagonists|mesh-ancestor
83520156|NCT05607004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83520157|NCT05607004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520158|NCT05607004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83520160|NCT05604300|Vitamins|vitamins|mesh-ancestor
83520161|NCT05604300|Micronutrients|micronutrients|mesh-ancestor
83520162|NCT05604300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520163|NCT05604300|Antioxidants|antioxidants|mesh-ancestor
83520164|NCT05604300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520165|NCT05604300|Protective Agents|protective agents|mesh-ancestor
83520166|NCT05593497|Abiraterone Acetate|abiraterone acetate|mesh-list
83520167|NCT05593497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520168|NCT05593497|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83520169|NCT05593497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520170|NCT05593497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520171|NCT05593497|Hormone Antagonists|hormone antagonists|mesh-ancestor
83520172|NCT05593497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83520173|NCT05593497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520174|NCT05593497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83520175|NCT05511870|Etripamil|etripamil|mesh-list
83520176|NCT05511870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83520177|NCT05511870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83520178|NCT05511870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520179|NCT05511870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83520180|NCT05511870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520181|NCT05492851|Hylan|hylan|mesh-list
83520182|NCT05492851|Viscosupplements|viscosupplements|mesh-ancestor
83520183|NCT05492851|Protective Agents|protective agents|mesh-ancestor
83520184|NCT05492851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520185|NCT05486104|Hemay005|hemay005|mesh-list
83520186|NCT05486104|Dermatologic Agents|dermatologic agents|mesh-ancestor
83520187|NCT05486104|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83520188|NCT05486104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83520189|NCT05486104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520190|NCT05486104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520191|NCT05434663|Granisetron|granisetron|mesh-list
83520192|NCT05434663|Antiemetics|antiemetics|mesh-ancestor
83520193|NCT05434663|Autonomic Agents|autonomic agents|mesh-ancestor
83520194|NCT05434663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520195|NCT05434663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520196|NCT05434663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83520197|NCT05434663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83520198|NCT05434663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83520199|NCT05434663|Serotonin Agents|serotonin agents|mesh-ancestor
83520200|NCT05434663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520201|NCT05434663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520202|NCT05429762|Maytansine|maytansine|mesh-list
83520203|NCT05429762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83520204|NCT05429762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520205|NCT05429762|Tubulin Modulators|tubulin modulators|mesh-ancestor
83520206|NCT05429762|Antimitotic Agents|antimitotic agents|mesh-ancestor
83520207|NCT05429762|Mitosis Modulators|mitosis modulators|mesh-ancestor
83520208|NCT05429762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520209|NCT05423535|Fibrin Foam|fibrin foam|mesh-list
83520210|NCT05423535|Hemostatics|hemostatics|mesh-ancestor
83520211|NCT05423535|Coagulants|coagulants|mesh-ancestor
83520212|NCT05414409|Metformin|metformin|mesh-list
83520213|NCT05414409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83520214|NCT05414409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520215|NCT05411575|Plerixafor|plerixafor|mesh-list
83520216|NCT05411575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83520217|NCT05411575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83520218|NCT05411575|Antiviral Agents|antiviral agents|mesh-ancestor
83520219|NCT05411575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520220|NCT05367401|Azacitidine|azacitidine|mesh-list
83520221|NCT05367401|Magrolimab|magrolimab|mesh-list
83520222|NCT05367401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83520223|NCT05367401|Antimetabolites|antimetabolites|mesh-ancestor
83520224|NCT05367401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520225|NCT05367401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520226|NCT05367401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520227|NCT05367401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520228|NCT05297448|Rifaximin|rifaximin|mesh-list
83520229|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83520230|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520231|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83520232|NCT05161156|Bromides|bromides|mesh-list
83520233|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
83520234|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83520235|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
83520236|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520237|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520238|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83520239|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
83520240|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
83520241|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83520242|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
83520243|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520244|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520247|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520248|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83520249|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520250|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520252|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83520253|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83520254|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520255|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
83520256|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
83520257|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520258|NCT05045950|Memantine|memantine|mesh-list
83520259|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83520260|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83520261|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
83520262|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520263|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520264|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520265|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83520266|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83520267|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
83520268|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83520269|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83520270|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520271|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
83520272|NCT04947514|Coagulants|coagulants|mesh-ancestor
83520273|NCT04924101|Cisplatin|cisplatin|mesh-list
83520274|NCT04924101|Carboplatin|carboplatin|mesh-list
83520275|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
83520276|NCT04924101|Etoposide|etoposide|mesh-list
83520277|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
83520278|NCT04924101|Lenvatinib|lenvatinib|mesh-list
83520279|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520280|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520281|NCT04924101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83520282|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520283|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83520284|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83520285|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83520286|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520287|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83520288|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
83520289|NCT04860011|Metolazone|metolazone|mesh-list
83520290|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83520291|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520292|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83520293|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520294|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83520295|NCT04860011|Diuretics|diuretics|mesh-ancestor
83520296|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
83520297|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83520298|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83520299|NCT04837014|Acetaminophen|acetaminophen|mesh-list
83520300|NCT04837014|Naproxen|naproxen|mesh-list
83520301|NCT04837014|Hydromorphone|hydromorphone|mesh-list
83520302|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83520303|NCT04837014|Analgesics|analgesics|mesh-ancestor
83520304|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
83520305|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520306|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520307|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
83520308|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83520309|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83520310|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83520311|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
83520312|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83520313|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520314|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520315|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83520316|NCT04837014|Narcotics|narcotics|mesh-ancestor
83520317|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83520318|NCT04827745|Blinatumomab|blinatumomab|mesh-list
83520319|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520320|NCT04735978|Nivolumab|nivolumab|mesh-list
83520321|NCT04735978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520322|NCT04735978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520323|NCT04735978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83520324|NCT04735978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520325|NCT04704050|Dronedarone|dronedarone|mesh-list
83520326|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83520327|NCT04696146|Complement C1s|complement c1s|mesh-list
83520328|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83520329|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83520330|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
83520331|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520332|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83520333|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83520334|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
83520335|NCT04669210|Tacrolimus|tacrolimus|mesh-list
83520336|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83520337|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
83520338|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520339|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83520340|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520341|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520342|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83520343|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520344|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83520345|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
83520346|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83520347|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520348|NCT04655157|Nivolumab|nivolumab|mesh-list
83520349|NCT04655157|Ipilimumab|ipilimumab|mesh-list
83520350|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520351|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520352|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83520353|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520354|NCT04650269|Emtricitabine|emtricitabine|mesh-list
83520355|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
83520356|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520357|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83520358|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83520359|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520360|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520361|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83520362|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83520363|NCT04629196|Ustekinumab|ustekinumab|mesh-list
83520364|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
83520365|NCT04628338|Interferons|interferons|mesh-list
83520366|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
83520367|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520368|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
83413635|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83520369|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520370|NCT04617002|TIC10 compound|tic10 compound|mesh-list
83520371|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520372|NCT04591808|Perindopril|perindopril|mesh-list
83520373|NCT04591808|Atorvastatin|atorvastatin|mesh-list
83520374|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83520375|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83520376|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
83520377|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520378|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83520379|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83520380|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520381|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83520382|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
83520383|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83520384|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83520385|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83520386|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83520387|NCT04587687|Antibodies|antibodies|mesh-list
83520388|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
83520389|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83520390|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
83520391|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
83520392|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520393|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520394|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83520395|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
83520396|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520399|NCT04585750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520400|NCT04585750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520401|NCT04585750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83520402|NCT04585750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520403|NCT04578600|Lenalidomide|lenalidomide|mesh-list
83520404|NCT04578600|Azacitidine|azacitidine|mesh-list
83520405|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
83520406|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
83520407|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520408|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83520409|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83520410|NCT04578600|Growth Substances|growth substances|mesh-ancestor
83520411|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
83520412|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520413|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83520414|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
83520415|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520416|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520417|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520418|NCT04538352|Insulin|insulin|mesh-list
83520419|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83520420|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
83520421|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83520422|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520423|NCT04471987|Interleukin-12|interleukin-12|mesh-list
83520424|NCT04471987|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83520425|NCT04471987|Immunologic Factors|immunologic factors|mesh-ancestor
83520426|NCT04471987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520427|NCT04471987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83520428|NCT04471987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83520429|NCT04471987|Growth Substances|growth substances|mesh-ancestor
83520430|NCT04471987|Growth Inhibitors|growth inhibitors|mesh-ancestor
83520431|NCT04471987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520432|NCT04447768|Venetoclax|venetoclax|mesh-list
83520433|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
83520434|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520435|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520436|NCT04405037|Alvimopan|alvimopan|mesh-list
83520437|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83520438|NCT04389177|Paclitaxel|paclitaxel|mesh-list
83520439|NCT04389177|Cisplatin|cisplatin|mesh-list
83520440|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
83520441|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83520442|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520443|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
83520444|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
83520445|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
83520446|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520447|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520448|NCT04389177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83520449|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83520450|NCT04365257|Prazosin|prazosin|mesh-list
83520451|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
83520452|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
83520453|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83520454|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83520455|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
83520456|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520457|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520458|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520459|NCT04341545|Letrozole|letrozole|mesh-list
83520460|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520461|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83520462|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83520463|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520464|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520465|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83520466|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
83520467|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83520468|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520469|NCT04220021|Metformin|metformin|mesh-list
83520470|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83520471|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520472|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
83520473|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83520475|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520476|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
83520477|NCT04219722|Protective Agents|protective agents|mesh-ancestor
83520478|NCT04191304|Benralizumab|benralizumab|mesh-list
83520479|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83520480|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
83520481|NCT04186299|Clonidine|clonidine|mesh-list
83520482|NCT04186299|Epinephrine|epinephrine|mesh-list
83520483|NCT04186299|Carticaine|carticaine|mesh-list
83520484|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83520485|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83520486|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
83520487|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520488|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520489|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520490|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83520491|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83520492|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
83520493|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520494|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83520495|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
83520496|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
83520497|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
83520498|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83520499|NCT04186299|Analgesics|analgesics|mesh-ancestor
83520500|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
83520501|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83520502|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
83520503|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83520504|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
83520505|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
83520506|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83520507|NCT04165096|Acetaminophen|acetaminophen|mesh-list
83520508|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
83520509|NCT04165096|Promethazine|promethazine|mesh-list
83520510|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
83520511|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520512|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520513|NCT04165096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83520514|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520515|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83520516|NCT04165096|Analgesics|analgesics|mesh-ancestor
83520517|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
83520518|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520519|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520520|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
83520521|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83520522|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83520523|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83520524|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
83520525|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
83520526|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
83520527|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
83520528|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83520529|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83520530|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
83520531|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
83520532|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520533|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83520535|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
83520536|NCT04145700|Gemcitabine|gemcitabine|mesh-list
83520537|NCT04145700|Docetaxel|docetaxel|mesh-list
83520538|NCT04145700|Ramucirumab|ramucirumab|mesh-list
83520539|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83520540|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
83520541|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520542|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520543|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
83520544|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
83520545|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
83520546|NCT04068753|Niraparib|niraparib|mesh-list
83520547|NCT04068753|Dostarlimab|dostarlimab|mesh-list
83520548|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83520549|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520550|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520551|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520552|NCT04005690|Olaparib|olaparib|mesh-list
83520553|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83520556|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520557|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520558|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83520559|NCT03973268|Complement Factor H|complement factor h|mesh-list
83520560|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83520561|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83520562|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
83520563|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520564|NCT03927222|Temozolomide|temozolomide|mesh-list
83520565|NCT03927222|Molgramostim|molgramostim|mesh-list
83520566|NCT03927222|Sargramostim|sargramostim|mesh-list
83520567|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
83520568|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520569|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83520570|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
83520571|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520572|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520573|NCT03869892|Trifluridine|trifluridine|mesh-list
83520574|NCT03869892|Bevacizumab|bevacizumab|mesh-list
83520575|NCT03869892|Capecitabine|capecitabine|mesh-list
83520576|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520577|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520578|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83520579|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83520580|NCT03869892|Growth Substances|growth substances|mesh-ancestor
83520581|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520582|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
83520583|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83520584|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
83520585|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520586|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
83520587|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520588|NCT03822663|Caffeine|caffeine|mesh-list
83520589|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83520590|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520591|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83520592|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520593|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520594|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83520595|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83520596|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
83520597|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520598|NCT03801525|Venetoclax|venetoclax|mesh-list
83520599|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520600|NCT03778957|Bevacizumab|bevacizumab|mesh-list
83520601|NCT03778957|Durvalumab|durvalumab|mesh-list
83520602|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520603|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520604|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83520605|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83520606|NCT03778957|Growth Substances|growth substances|mesh-ancestor
83520607|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520608|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
83520609|NCT03767933|Acetaminophen|acetaminophen|mesh-list
83520610|NCT03767933|Ibuprofen|ibuprofen|mesh-list
83520611|NCT03767933|Hydromorphone|hydromorphone|mesh-list
83520612|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83520613|NCT03767933|Analgesics|analgesics|mesh-ancestor
83520614|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
83520615|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520616|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520617|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
83520618|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83520619|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83520620|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83520621|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83520622|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520623|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520624|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83520625|NCT03767933|Narcotics|narcotics|mesh-ancestor
83520626|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83520627|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
83520628|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83520629|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83520704|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
83520630|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83520631|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520632|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
83520633|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520634|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520635|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83520636|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520637|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
83520638|NCT03636152|Chloroquine|chloroquine|mesh-list
83520639|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
83520640|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83520641|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83520642|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520643|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520644|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520645|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83520646|NCT03636152|Amebicides|amebicides|mesh-ancestor
83520647|NCT03633604|HBOC 201|hboc 201|mesh-list
83520648|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
83520649|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83520650|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83520651|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520652|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520653|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83520654|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83520655|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520656|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
83520657|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520658|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
83520659|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520660|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520661|NCT03474497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83520662|NCT03474497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520663|NCT03395223|Methylene Blue|methylene blue|mesh-list
83520664|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520665|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520666|NCT03289650|Tacrolimus|tacrolimus|mesh-list
83520667|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83520668|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
83520669|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520670|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83520671|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520672|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520673|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
83520674|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
83520675|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520676|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
83520677|NCT03192397|Sirolimus|sirolimus|mesh-list
83520678|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
83520679|NCT03192397|Melphalan|melphalan|mesh-list
83520680|NCT03192397|Fludarabine|fludarabine|mesh-list
83520681|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
83520682|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83520683|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
83520684|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520685|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83520686|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83520687|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
83520688|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520689|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520690|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83520691|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83520692|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
83520693|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83520694|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83520695|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
83520696|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83520697|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520698|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520699|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
83520700|NCT02975492|Vitamin D|vitamin d|mesh-list
83520701|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
83520702|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
83520703|NCT02975492|Vitamins|vitamins|mesh-list
83520705|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520706|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83520707|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83520708|NCT02937818|Carboplatin|carboplatin|mesh-list
83520709|NCT02937818|Durvalumab|durvalumab|mesh-list
83520710|NCT02937818|Olaparib|olaparib|mesh-list
83520711|NCT02937818|Tremelimumab|tremelimumab|mesh-list
83520712|NCT02937818|Adavosertib|adavosertib|mesh-list
83520713|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520714|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520715|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83520716|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520717|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520718|NCT02867267|Thymalfasin|thymalfasin|mesh-list
83520719|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83520720|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
83520721|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520722|NCT02821832|Rifampin|rifampin|mesh-list
83520723|NCT02821832|Isoniazid|isoniazid|mesh-list
83520724|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
83520725|NCT02821832|Ethambutol|ethambutol|mesh-list
83520726|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83520727|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
83520728|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83520729|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520730|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
83520731|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83520732|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520733|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520734|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83520735|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83520736|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83520737|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83520738|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83520739|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83520740|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83520741|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83520742|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
83520743|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83520744|NCT02813148|Naloxegol|naloxegol|mesh-list
83520745|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83520746|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520747|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
83520748|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520749|NCT02756611|Venetoclax|venetoclax|mesh-list
83520750|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520751|NCT02673359|Progesterone|progesterone|mesh-list
83520752|NCT02673359|Progestins|progestins|mesh-ancestor
83520753|NCT02673359|Hormones|hormones|mesh-ancestor
83520754|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83520755|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520756|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
83520757|NCT02629809|Fludarabine|fludarabine|mesh-list
83520758|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
83520759|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
83520760|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83520761|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
83520762|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520763|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83520764|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83520765|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
83520766|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520767|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520768|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83520769|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83520770|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
83520771|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520772|NCT02624518|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
83520773|NCT02624518|Bombesin|bombesin|mesh-list
83520774|NCT02624518|Gastrins|gastrins|mesh-list
83520775|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520776|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520777|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520778|NCT02624518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83520780|NCT02624518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83520781|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
83520782|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
83520783|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83520784|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83520785|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520786|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520787|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520788|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83520789|NCT02542657|Clarithromycin|clarithromycin|mesh-list
83520790|NCT02542657|Dexamethasone|dexamethasone|mesh-list
83520791|NCT02542657|Pomalidomide|pomalidomide|mesh-list
83520792|NCT02542657|Ixazomib|ixazomib|mesh-list
83520793|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83520794|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
83520795|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
83520796|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520797|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520798|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83520799|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
83520800|NCT02542657|Hormones|hormones|mesh-ancestor
83520801|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83520802|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83520803|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520804|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520805|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83520806|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520807|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83520808|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520809|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83520810|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83520811|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
83520812|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83520813|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83520814|NCT02542657|Growth Substances|growth substances|mesh-ancestor
83520815|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
83520816|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
83520817|NCT02303171|Enoxaparin|enoxaparin|mesh-list
83520818|NCT02303171|Warfarin|warfarin|mesh-list
83520819|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
83520820|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83520821|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83520822|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520823|NCT02287623|Bupivacaine|bupivacaine|mesh-list
83520824|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
83520825|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
83520826|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83520827|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520828|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
83520829|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520830|NCT02266329|Prazosin|prazosin|mesh-list
83520831|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83520832|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83520833|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83520834|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83520836|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520837|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520838|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520839|NCT01794520|Dexamethasone|dexamethasone|mesh-list
83520840|NCT01794520|Venetoclax|venetoclax|mesh-list
83520841|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83520842|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
83520843|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
83520844|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520845|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520846|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83520847|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
83520848|NCT01794520|Hormones|hormones|mesh-ancestor
83520849|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83520850|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83520851|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520852|NCT01653678|Vitamin D|vitamin d|mesh-list
83520853|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
83520854|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
83520855|NCT01653678|Vitamins|vitamins|mesh-list
83520857|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520858|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83520859|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83520861|NCT01370811|Clonidine|clonidine|mesh-list
83520862|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83520863|NCT01370811|Oxybutynin|oxybutynin|mesh-list
83520864|NCT01370811|Analgesics|analgesics|mesh-ancestor
83520865|NCT01370811|Sensory System Agents|sensory system agents|mesh-ancestor
83520866|NCT01370811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520867|NCT01370811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520868|NCT01370811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83520869|NCT01370811|Sympatholytics|sympatholytics|mesh-ancestor
83520870|NCT01370811|Autonomic Agents|autonomic agents|mesh-ancestor
83520871|NCT01370811|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83520872|NCT01370811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83520873|NCT01370811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83520874|NCT01370811|Adrenergic Agents|adrenergic agents|mesh-ancestor
83520875|NCT01370811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520876|NCT01370811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520877|NCT01370811|Parasympatholytics|parasympatholytics|mesh-ancestor
83520878|NCT01370811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83520879|NCT01370811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83520880|NCT01370811|Cholinergic Agents|cholinergic agents|mesh-ancestor
83520881|NCT01370811|Urological Agents|urological agents|mesh-ancestor
83520882|NCT01370811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83520883|NCT01370811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520884|NCT01323569|Nabiximols|nabiximols|mesh-list
83520885|NCT01323569|Dronabinol|dronabinol|mesh-list
83520886|NCT01323569|Analgesics|analgesics|mesh-ancestor
83520887|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
83520888|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520889|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520890|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
83520891|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83520892|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83520893|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83520894|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83520895|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83520896|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520897|NCT01323569|Hormones|hormones|mesh-ancestor
83520898|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83520899|NCT01323465|Rifampin|rifampin|mesh-list
83520900|NCT01323465|Ketoconazole|ketoconazole|mesh-list
83520901|NCT01323465|Nabiximols|nabiximols|mesh-list
83520902|NCT01323465|Omeprazole|omeprazole|mesh-list
83520903|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83520904|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83520905|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83520906|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520907|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520908|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83520909|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
83520910|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83520911|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520912|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
83520913|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83520914|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83520915|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83520916|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83520917|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83520918|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83520919|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83520920|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
83520921|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83520922|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83520923|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83520924|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
83520925|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83520926|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520927|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83520928|NCT01323465|Analgesics|analgesics|mesh-ancestor
83520929|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
83520930|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520931|NCT01322464|Nabiximols|nabiximols|mesh-list
83520932|NCT01322464|Analgesics|analgesics|mesh-ancestor
83520933|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
83520934|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520935|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520936|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
83520937|NCT01322139|Nabiximols|nabiximols|mesh-list
83520938|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83520939|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83520940|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83520941|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83520942|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83520943|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520944|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520945|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520946|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83520947|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
83520948|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83520949|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520950|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83520951|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83520952|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83520953|NCT01322139|Analgesics|analgesics|mesh-ancestor
83520954|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
83520955|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83520956|NCT01169259|Vitamin D|vitamin d|mesh-list
83520957|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
83520958|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
83520959|NCT01169259|Vitamins|vitamins|mesh-list
83520960|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
83520961|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520962|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83520963|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83520964|NCT01165632|Fluorides|fluorides|mesh-list
83520965|NCT01165632|Cariostatic Agents|cariostatic agents|mesh-ancestor
83520966|NCT01165632|Protective Agents|protective agents|mesh-ancestor
83520967|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520968|NCT01019850|Vorinostat|vorinostat|mesh-list
83520969|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83520970|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520971|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83520972|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520973|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520974|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83520975|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
83520976|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
83520977|NCT00885326|Bevacizumab|bevacizumab|mesh-list
83520978|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83520979|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
83520980|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520981|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83520982|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83520983|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
83520984|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520985|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520986|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83520987|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83520988|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83520989|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83520990|NCT00885326|Growth Substances|growth substances|mesh-ancestor
83520991|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
83520992|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83520993|NCT00606138|Ranibizumab|ranibizumab|mesh-list
83520994|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83520995|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83520996|NCT00606138|Growth Substances|growth substances|mesh-ancestor
83520997|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83520998|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
83520999|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521000|NCT00390793|Cytarabine|cytarabine|mesh-list
83521001|NCT00390793|Dexamethasone|dexamethasone|mesh-list
83521002|NCT00390793|Prednisone|prednisone|mesh-list
83521003|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
83521004|NCT00390793|Cortisone|cortisone|mesh-list
83521005|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
83521013|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83521014|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
83521015|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521016|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521017|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521018|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
83521019|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521020|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521021|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83521022|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83521023|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
83521024|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
83521025|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521026|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521027|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
83521028|NCT00390793|Hormones|hormones|mesh-ancestor
83521029|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521030|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83521031|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83521032|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83521033|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83521034|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521035|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83521036|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
83521037|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83521038|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83521039|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
83521040|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
83521041|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83521042|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83521043|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
83521044|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521045|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83521046|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
83521047|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
83521048|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
83521049|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83521050|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
83521051|NCT00005835|Melphalan|melphalan|mesh-list
83521052|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
83521053|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
83521054|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521055|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521056|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
83521057|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521058|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521059|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83521060|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83521061|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
83521062|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83521063|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521064|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83521065|NCT00005835|Protective Agents|protective agents|mesh-ancestor
83521067|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83521068|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521069|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83521070|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521071|NCT00002643|Cobalt|cobalt|mesh-list
83521072|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
83521073|NCT00002643|Ifosfamide|ifosfamide|mesh-list
83521074|NCT00002643|Doxorubicin|doxorubicin|mesh-list
83521075|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83521076|NCT00002643|Etoposide|etoposide|mesh-list
83521077|NCT00002643|Vincristine|vincristine|mesh-list
83521078|NCT00002643|Topotecan|topotecan|mesh-list
83521079|NCT00002643|Amifostine|amifostine|mesh-list
83521080|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83521081|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
83521082|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521083|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521084|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521085|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
83521086|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521087|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521088|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83521089|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83521090|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83521091|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83521093|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83521094|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
83521095|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
83521096|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
83521097|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83521098|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83521099|NCT00002643|Protective Agents|protective agents|mesh-ancestor
83521100|NCT00002643|Trace Elements|trace elements|mesh-ancestor
83521101|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
83521102|NCT00002649|Aldesleukin|aldesleukin|mesh-list
83521103|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
83521104|NCT00002649|Etoposide|etoposide|mesh-list
83521105|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
83521106|NCT00002649|Interleukin-2|interleukin-2|mesh-list
83521107|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83521108|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
83521109|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521110|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521111|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521112|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
83521113|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521114|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521115|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83521116|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83521117|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83521118|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83521119|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521120|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83521121|NCT00002649|Analgesics|analgesics|mesh-ancestor
83521122|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
83521123|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521124|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83521125|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83521126|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
83521127|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521128|NCT01151605|Insulin|insulin|mesh-list
83521129|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83521130|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83521131|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521133|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83521134|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83521135|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521136|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
83521137|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
83521138|NCT00995059|Sirolimus|sirolimus|mesh-list
83521139|NCT00995059|Bortezomib|bortezomib|mesh-list
83521140|NCT00995059|Melphalan|melphalan|mesh-list
83521141|NCT00995059|Tacrolimus|tacrolimus|mesh-list
83521142|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
83521143|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83521144|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
83521145|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83521146|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
83521147|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521148|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83521149|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521150|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521151|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521152|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83521153|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521154|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83521155|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
83521156|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521157|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
83521158|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83521159|NCT02249299|Nabiximols|nabiximols|mesh-list
83521160|NCT02249299|Analgesics|analgesics|mesh-ancestor
83521161|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
83521162|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521163|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521164|NCT00002679|Tamoxifen|tamoxifen|mesh-list
83521165|NCT00002679|Paclitaxel|paclitaxel|mesh-list
83521166|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
83521167|NCT00002679|Doxorubicin|doxorubicin|mesh-list
83521169|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83521171|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
83521172|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
83521173|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
83521174|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521175|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83521176|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
83521177|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521178|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521179|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521180|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
83521181|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83521182|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83521183|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83521184|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83521185|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521186|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83521187|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
83521188|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521189|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83521190|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83521191|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83521192|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83521193|NCT00002691|Leucovorin|leucovorin|mesh-list
83521194|NCT00002691|Cytarabine|cytarabine|mesh-list
83521195|NCT00002691|Dexamethasone|dexamethasone|mesh-list
83521196|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
83521197|NCT00002691|Methotrexate|methotrexate|mesh-list
83521198|NCT00002691|Etoposide|etoposide|mesh-list
83521199|NCT00002691|Vincristine|vincristine|mesh-list
83521200|NCT00002691|Daunorubicin|daunorubicin|mesh-list
83521201|NCT00002691|Asparaginase|asparaginase|mesh-list
83521202|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
83521203|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83521204|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
83521205|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521206|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521207|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521208|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
83521209|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521210|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521211|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83521212|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83521213|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
83521214|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
83521215|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521216|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521217|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
83521218|NCT00002691|Hormones|hormones|mesh-ancestor
83521219|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521220|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83521221|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83521222|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
83521223|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83521224|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83521225|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
83521226|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
83521227|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521228|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83521229|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83521230|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83521231|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83521232|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83521233|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
83521234|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521235|NCT00002691|Antidotes|antidotes|mesh-ancestor
83521236|NCT00002691|Protective Agents|protective agents|mesh-ancestor
83521237|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
83521238|NCT00002691|Vitamins|vitamins|mesh-ancestor
83521239|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
83521240|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
83521241|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
83521242|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
83521243|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83521246|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83521247|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521248|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83521249|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521250|NCT04054115|Alprostadil|alprostadil|mesh-list
83521251|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83521252|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
83521253|NCT04054115|Urological Agents|urological agents|mesh-ancestor
83521254|NCT00002697|Carboplatin|carboplatin|mesh-list
83521255|NCT00002697|Etoposide|etoposide|mesh-list
83521256|NCT00002697|Ifosfamide|ifosfamide|mesh-list
83521257|NCT00002697|Sargramostim|sargramostim|mesh-list
83521258|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521259|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83521260|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83521261|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83521262|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521263|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521264|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
83521265|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521266|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521267|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
83521268|NCT04488601|Sirolimus|sirolimus|mesh-list
83521269|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83521270|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521271|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83521272|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521273|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
83521274|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83521275|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
83521276|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521277|NCT05032807|Cannabidiol|cannabidiol|mesh-list
83521278|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
83521279|NCT00002715|Prednisone|prednisone|mesh-list
83521280|NCT00002715|Doxorubicin|doxorubicin|mesh-list
83521281|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83521282|NCT00002715|Bleomycin|bleomycin|mesh-list
83521283|NCT00002715|Etoposide|etoposide|mesh-list
83521284|NCT00002715|Vincristine|vincristine|mesh-list
83521285|NCT00002715|Vinblastine|vinblastine|mesh-list
83521286|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
83521287|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83521288|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521289|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83521290|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83521291|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521292|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521293|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83521294|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
83521296|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521297|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521298|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83521299|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83521300|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
83521301|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
83521302|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
83521303|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
83521304|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521305|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
83521306|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83521307|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
83521308|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521309|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521310|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83521311|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
83521312|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83521313|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
83521314|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521315|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83521316|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83521317|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
83521318|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
83521319|NCT04972513|Protective Agents|protective agents|mesh-ancestor
83521320|NCT02976467|Fulacimstat|fulacimstat|mesh-list
83521321|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521399|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
83521322|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521323|NCT02981095|Bupivacaine|bupivacaine|mesh-list
83521324|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
83521325|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
83521326|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83521327|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521328|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
83521329|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521330|NCT00002721|Doxorubicin|doxorubicin|mesh-list
83521331|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83521332|NCT00002721|Estramustine|estramustine|mesh-list
83521333|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83521334|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521335|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83521336|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83521337|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521338|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521339|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521340|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
83521341|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83521342|NCT04739345|Pentoxifylline|pentoxifylline|mesh-list
83521343|NCT04739345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83521344|NCT04739345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521345|NCT04739345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521346|NCT04739345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83521347|NCT04739345|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83521348|NCT04739345|Protective Agents|protective agents|mesh-ancestor
83521349|NCT04739345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521350|NCT04739345|Vasodilator Agents|vasodilator agents|mesh-ancestor
83521351|NCT04739345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83521352|NCT04739345|Antioxidants|antioxidants|mesh-ancestor
83521353|NCT01625455|Aprepitant|aprepitant|mesh-list
83521354|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
83521355|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
83521356|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521357|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521358|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521359|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83521361|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521362|NCT05751681|Cetrorelix|cetrorelix|mesh-list
83521363|NCT05751681|Dydrogesterone|dydrogesterone|mesh-list
83521364|NCT05751681|Progestins|progestins|mesh-list
83521365|NCT05751681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83521366|NCT05751681|Fertility Agents|fertility agents|mesh-ancestor
83521367|NCT05751681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83521368|NCT05751681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521369|NCT05751681|Hormone Antagonists|hormone antagonists|mesh-ancestor
83521370|NCT05751681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521371|NCT05751681|Hormones|hormones|mesh-ancestor
83521372|NCT02976623|Metronidazole|metronidazole|mesh-list
83521373|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521374|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83521375|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83521376|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83521377|NCT00002733|Interferons|interferons|mesh-list
83521378|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
83521379|NCT00002733|Aldesleukin|aldesleukin|mesh-list
83521380|NCT00002733|Cimetidine|cimetidine|mesh-list
83521381|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521382|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
83521383|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521384|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
83521385|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521386|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83521387|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83521388|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83521389|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521390|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83521391|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
83521392|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
83521393|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83521394|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521395|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83521396|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83521397|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521398|NCT01625923|Olanzapine|olanzapine|mesh-list
83521401|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521402|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521403|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521404|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83521405|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83521406|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83521407|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83521408|NCT01625923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83521409|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83521410|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83521411|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521412|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83521413|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
83521414|NCT00002751|Antibodies|antibodies|mesh-list
83521415|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83521416|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
83521417|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521418|NCT00002757|Cytarabine|cytarabine|mesh-list
83521419|NCT00002757|Prednisone|prednisone|mesh-list
83521420|NCT00002757|Prednisolone|prednisolone|mesh-list
83521421|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
83521422|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83521423|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83521424|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83521425|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
83521426|NCT00002757|Doxorubicin|doxorubicin|mesh-list
83521427|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83521428|NCT00002757|Methotrexate|methotrexate|mesh-list
83521429|NCT00002757|Etoposide|etoposide|mesh-list
83521430|NCT00002757|Vincristine|vincristine|mesh-list
83521431|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83521432|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
83521433|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521434|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521435|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521436|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
83521437|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521438|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521439|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83521440|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83521441|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83521442|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83521443|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521444|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83521445|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
83521446|NCT00002757|Hormones|hormones|mesh-ancestor
83521447|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521448|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83521449|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83521450|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
83521451|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83521452|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83521453|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
83521454|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
83521455|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83521456|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83521457|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83521458|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
83521459|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521460|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
83521461|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
83521462|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
83521463|NCT00002763|Interferons|interferons|mesh-list
83521464|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
83521465|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521466|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
83521467|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521468|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
83521469|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521470|NCT00002775|Docetaxel|docetaxel|mesh-list
83521471|NCT00002775|Estramustine|estramustine|mesh-list
83521472|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521473|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
83521474|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
83521475|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
83521476|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521477|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521478|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
83521479|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83521480|NCT01631149|Rocuronium|rocuronium|mesh-list
83521481|NCT01631149|Atracurium|atracurium|mesh-list
83521482|NCT01631149|Mivacurium|mivacurium|mesh-list
83521483|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83521484|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83521485|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83521486|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521487|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521488|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83521489|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83521490|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
83521491|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83521492|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521493|NCT00002787|Aldesleukin|aldesleukin|mesh-list
83521494|NCT00002787|Interleukin-2|interleukin-2|mesh-list
83521495|NCT00002787|Vaccines|vaccines|mesh-list
83521496|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
83521497|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83521498|NCT00002787|Antibodies|antibodies|mesh-list
83521499|NCT00002787|Sargramostim|sargramostim|mesh-list
83521500|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83521501|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83521502|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
83521503|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521504|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521505|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83521506|NCT00002787|Analgesics|analgesics|mesh-ancestor
83521507|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
83521508|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521509|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83521510|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83521511|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
83521512|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521513|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83521514|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
83521515|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83521516|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
83521517|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83521518|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
83521519|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521520|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521521|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
83521522|NCT00002793|Leucovorin|leucovorin|mesh-list
83521523|NCT00002793|Fluorouracil|fluorouracil|mesh-list
83521524|NCT00002793|Calcium|calcium|mesh-list
83521525|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
83521526|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83521527|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521528|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
83521529|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521530|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83521531|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521532|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83521533|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
83521534|NCT00002793|Antidotes|antidotes|mesh-ancestor
83521535|NCT00002793|Protective Agents|protective agents|mesh-ancestor
83521536|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
83521537|NCT00002793|Vitamins|vitamins|mesh-ancestor
83521538|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
83521539|NCT01632709|Bupivacaine|bupivacaine|mesh-list
83521540|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
83521541|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
83521542|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83521543|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521544|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
83521545|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521546|NCT05751291|Bupivacaine|bupivacaine|mesh-list
83521547|NCT05751291|Anesthetics, Local|anesthetics, local|mesh-ancestor
83521548|NCT05751291|Anesthetics|anesthetics|mesh-ancestor
83521549|NCT05751291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83521550|NCT05751291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521551|NCT05751291|Sensory System Agents|sensory system agents|mesh-ancestor
83521552|NCT05751291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521553|NCT01634191|Apremilast|apremilast|mesh-list
83521554|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83521556|NCT01634191|Analgesics|analgesics|mesh-ancestor
83521557|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
83521558|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521559|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521560|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83521561|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521562|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83521563|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83521564|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521565|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521566|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83521567|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521568|NCT04003649|Nivolumab|nivolumab|mesh-list
83521569|NCT04003649|Ipilimumab|ipilimumab|mesh-list
83521570|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83521571|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521572|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83521573|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521574|NCT05713851|Dapagliflozin|dapagliflozin|mesh-list
83521575|NCT05713851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83521576|NCT05713851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521577|NCT05713851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83521578|NCT05713851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521579|NCT00361907|Insulin|insulin|mesh-list
83521580|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83521581|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83521582|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521583|NCT05710185|Deucravacitinib|deucravacitinib|mesh-list
83521584|NCT05710185|Dermatologic Agents|dermatologic agents|mesh-ancestor
83521585|NCT05710185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83521586|NCT05710185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521587|NCT05710185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521588|NCT04276493|Docetaxel|docetaxel|mesh-list
83521589|NCT04276493|Capecitabine|capecitabine|mesh-list
83521590|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
83521591|NCT04276493|Tislelizumab|tislelizumab|mesh-list
83521592|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521593|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
83521594|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
83521595|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
83521596|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521597|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83521598|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
83521599|NCT04276493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83521600|NCT05670795|Clomiphene|clomiphene|mesh-list
83521601|NCT05670795|Enclomiphene|enclomiphene|mesh-list
83521602|NCT05670795|Zuclomiphene|zuclomiphene|mesh-list
83521603|NCT05670795|Hormones|hormones|mesh-list
83521604|NCT05670795|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83521605|NCT05670795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521606|NCT05670795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521607|NCT05670795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83521608|NCT05670795|Hormone Antagonists|hormone antagonists|mesh-ancestor
83521609|NCT05670795|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83521610|NCT05670795|Fertility Agents|fertility agents|mesh-ancestor
83521611|NCT05670795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83521612|NCT05670795|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83521613|NCT05670795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83521614|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83521615|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
83521616|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83521617|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83521618|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521619|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521620|NCT04266197|Urological Agents|urological agents|mesh-ancestor
83521621|NCT05669313|Rivaroxaban|rivaroxaban|mesh-list
83521622|NCT05669313|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83521623|NCT05669313|Antithrombins|antithrombins|mesh-ancestor
83521624|NCT05669313|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83521625|NCT05669313|Protease Inhibitors|protease inhibitors|mesh-ancestor
83521626|NCT05669313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521627|NCT05669313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521632|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83521633|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521634|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521635|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
83521636|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83521637|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521638|NCT05750199|Immunomodulating Agents|immunomodulating agents|mesh-list
83521639|NCT05750199|Immunologic Factors|immunologic factors|mesh-ancestor
83521640|NCT05750199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521641|NCT04248179|Sufentanil|sufentanil|mesh-list
83521642|NCT04248179|Ropivacaine|ropivacaine|mesh-list
83521643|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
83521644|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
83521645|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83521646|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521647|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
83521648|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521649|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83521650|NCT04248179|Narcotics|narcotics|mesh-ancestor
83521651|NCT04248179|Analgesics|analgesics|mesh-ancestor
83521652|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83521653|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83521654|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
83521655|NCT00361517|Amphotericin B|amphotericin b|mesh-list
83521656|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83521657|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
83521658|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
83521659|NCT00361517|Amebicides|amebicides|mesh-ancestor
83521660|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83521661|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83521662|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521663|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83521664|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
83521665|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83521666|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521667|NCT03920267|Deucravacitinib|deucravacitinib|mesh-list
83521668|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
83521669|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83521670|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521671|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521672|NCT05447507|Dexmedetomidine|dexmedetomidine|mesh-list
83521673|NCT05447507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83521674|NCT05447507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83521675|NCT05447507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521676|NCT05447507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83521677|NCT05447507|Analgesics|analgesics|mesh-ancestor
83521678|NCT05447507|Sensory System Agents|sensory system agents|mesh-ancestor
83521679|NCT05447507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521680|NCT05447507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83521681|NCT05447507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83521682|NCT05447507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83521683|NCT05447507|Adrenergic Agents|adrenergic agents|mesh-ancestor
83521684|NCT05447507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413636|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83521685|NCT05447507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521686|NCT01635439|Dinoprostone|dinoprostone|mesh-list
83521687|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
83521688|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83521689|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521690|NCT01636063|Misoprostol|misoprostol|mesh-list
83521691|NCT01636063|Mifepristone|mifepristone|mesh-list
83521692|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83521693|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
83521694|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83521695|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521696|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83521697|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521698|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
83521699|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83521700|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83521701|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83521702|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83521703|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
83521704|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83521705|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83521706|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
83521707|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521708|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
83521709|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83521710|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83521711|NCT05635305|Zoliflodacin|zoliflodacin|mesh-list
83521712|NCT05635305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83521713|NCT05635305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83521714|NCT05635305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521715|NCT05635305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521716|NCT05635305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521717|NCT05749575|Paclitaxel|paclitaxel|mesh-list
83521718|NCT05749575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83521719|NCT05749575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521720|NCT05749575|Tubulin Modulators|tubulin modulators|mesh-ancestor
83521721|NCT05749575|Antimitotic Agents|antimitotic agents|mesh-ancestor
83521722|NCT05749575|Mitosis Modulators|mitosis modulators|mesh-ancestor
83521723|NCT05749575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521724|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
83521725|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
83521726|NCT04387201|Dulaglutide|dulaglutide|mesh-list
83521727|NCT04387201|Vitamins|vitamins|mesh-ancestor
83521728|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
83521729|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521730|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
83521731|NCT04387201|Hematinics|hematinics|mesh-ancestor
83521732|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83521733|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
83521734|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83521735|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521736|NCT04370587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83521737|NCT04370587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521738|NCT04178005|Cladribine|cladribine|mesh-list
83521739|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521740|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83521741|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
83521742|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521743|NCT05623761|Fluorides|fluorides|mesh-list
83521744|NCT05623761|Cariostatic Agents|cariostatic agents|mesh-ancestor
83521745|NCT05623761|Protective Agents|protective agents|mesh-ancestor
83521746|NCT05623761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521747|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
83521748|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83521749|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521750|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83521751|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521752|NCT00361985|Esomeprazole|esomeprazole|mesh-list
83521753|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83521754|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521755|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83521756|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521757|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521758|NCT00362063|Hormones|hormones|mesh-list
83413637|NCT01451333|Efavirenz|efavirenz|mesh-list
83521759|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521760|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521761|NCT00382239|Exenatide|exenatide|mesh-list
83521762|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83521763|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521764|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83521765|NCT00382239|Incretins|incretins|mesh-ancestor
83521766|NCT00382239|Hormones|hormones|mesh-ancestor
83521767|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521768|NCT04004845|Misoprostol|misoprostol|mesh-list
83521769|NCT04004845|Oxytocin|oxytocin|mesh-list
83521770|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
83521771|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83521772|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521773|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83521774|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
83521775|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83521776|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521777|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
83521778|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83521779|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521780|NCT03968419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83521931|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521781|NCT03968419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521782|NCT01637935|Pioglitazone|pioglitazone|mesh-list
83521783|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83521784|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521785|NCT00382083|Acetaminophen|acetaminophen|mesh-list
83521786|NCT00382083|Ibuprofen|ibuprofen|mesh-list
83521787|NCT00382083|Lidocaine|lidocaine|mesh-list
83521788|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
83521789|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
83521790|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83521791|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521792|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
83521793|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521794|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83521795|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83521796|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83521797|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83521798|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521799|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83521800|NCT00382083|Analgesics|analgesics|mesh-ancestor
83521801|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
83521802|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83521803|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83521804|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521805|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83521806|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521807|NCT01640197|Resveratrol|resveratrol|mesh-list
83521808|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
83521809|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521810|NCT01640197|Protective Agents|protective agents|mesh-ancestor
83521811|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521812|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521813|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83521814|NCT05742399|Hyaluronic Acid|hyaluronic acid|mesh-list
83521815|NCT05742399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83521816|NCT05742399|Immunologic Factors|immunologic factors|mesh-ancestor
83521817|NCT05742399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521818|NCT05742399|Viscosupplements|viscosupplements|mesh-ancestor
83521819|NCT05742399|Protective Agents|protective agents|mesh-ancestor
83521820|NCT01641445|Topiramate|topiramate|mesh-list
83521821|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
83521822|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83521823|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521824|NCT04185311|Nivolumab|nivolumab|mesh-list
83521825|NCT04185311|Ipilimumab|ipilimumab|mesh-list
83521826|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83521827|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83521828|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521829|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83521830|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521831|NCT05513937|Amlodipine|amlodipine|mesh-list
83521832|NCT05513937|Nebivolol|nebivolol|mesh-list
83521833|NCT05513937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83521834|NCT05513937|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83521835|NCT05513937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83521836|NCT05513937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521837|NCT05513937|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83521838|NCT05513937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521839|NCT05513937|Vasodilator Agents|vasodilator agents|mesh-ancestor
83521840|NCT05513937|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83521841|NCT05513937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83521842|NCT05513937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83521843|NCT05513937|Adrenergic Agents|adrenergic agents|mesh-ancestor
83521844|NCT05513937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83521845|NCT01642147|Anesthetics|anesthetics|mesh-list
83521846|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83521847|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521848|NCT04584749|Lidocaine|lidocaine|mesh-list
83521849|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
83521850|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
83521851|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83521852|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521853|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
83521854|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521855|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83521856|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83521857|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83521858|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83521859|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521860|NCT01644331|Tolvaptan|tolvaptan|mesh-list
83521861|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83521862|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521863|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
83521864|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521865|NCT00362141|Levetiracetam|levetiracetam|mesh-list
83521866|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
83521867|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
83521868|NCT05733897|Hydroxychloroquine|hydroxychloroquine|mesh-list
83521869|NCT05733897|Antimalarials|antimalarials|mesh-ancestor
83521870|NCT05733897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83521871|NCT05733897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83521872|NCT05733897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521873|NCT05733897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521874|NCT05733897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521875|NCT05733897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521876|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83521877|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83521878|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521879|NCT03561259|Vorinostat|vorinostat|mesh-list
83521880|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83521881|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521882|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83521883|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521884|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521885|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83521886|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
83521887|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
83521888|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521889|NCT03002935|Vitamins|vitamins|mesh-ancestor
83521890|NCT03788291|Rituximab|rituximab|mesh-list
83521891|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
83521892|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83521893|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521894|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
83521895|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521896|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521897|NCT04593459|Metformin|metformin|mesh-list
83521898|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83521899|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521900|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
83521901|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
83521902|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83521903|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83521904|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521905|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521906|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521907|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521908|NCT03775109|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83521909|NCT03775109|Immunologic Factors|immunologic factors|mesh-ancestor
83521910|NCT03775109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521911|NCT03251924|Nivolumab|nivolumab|mesh-list
83521912|NCT03251924|Ipilimumab|ipilimumab|mesh-list
83521913|NCT03251924|Antibodies|antibodies|mesh-list
83521914|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
83521915|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
83521916|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
83521917|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521918|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83521919|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521920|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83521921|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521922|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
83521923|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83521924|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521925|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521926|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83521927|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83521928|NCT03762317|Clonidine|clonidine|mesh-list
83521929|NCT03762317|Analgesics|analgesics|mesh-ancestor
83521930|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
83521932|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521933|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83521935|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
83521936|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83521937|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83521938|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83521939|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
83521940|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83521941|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521942|NCT04383639|Locust bean gum|locust bean gum|mesh-list
83521943|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
83521944|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521945|NCT03083431|Propranolol|propranolol|mesh-list
83521946|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83521947|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83521948|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
83521949|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83521950|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521951|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521952|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83521953|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83521954|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
83521955|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
83521956|NCT02975921|Povidone|povidone|mesh-list
83521957|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
83521958|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
83521959|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83521960|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521961|NCT05452785|Minocycline|minocycline|mesh-list
83521962|NCT05452785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83521963|NCT05452785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83521964|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
83521965|NCT03002545|Cathartics|cathartics|mesh-ancestor
83521966|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521967|NCT04517747|Ramucirumab|ramucirumab|mesh-list
83521968|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521969|NCT02219581|Dexamethasone|dexamethasone|mesh-list
83521970|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
83521972|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83521973|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
83521974|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
83521975|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521976|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521977|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83521978|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
83521979|NCT02219581|Hormones|hormones|mesh-ancestor
83521980|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521981|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83521982|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521983|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
83521984|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521985|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521986|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83521987|NCT01437709|Ofatumumab|ofatumumab|mesh-list
83521988|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83521989|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83521990|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
83521991|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521992|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521993|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
83521994|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83521995|NCT03740165|Paclitaxel|paclitaxel|mesh-list
83521996|NCT03740165|Docetaxel|docetaxel|mesh-list
83521997|NCT03740165|Bevacizumab|bevacizumab|mesh-list
83521998|NCT03740165|Carboplatin|carboplatin|mesh-list
83521999|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
83522000|NCT03740165|Olaparib|olaparib|mesh-list
83522001|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83522002|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522003|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
83522004|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
83522005|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
83522006|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522007|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83522008|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83522009|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83522010|NCT03740165|Growth Substances|growth substances|mesh-ancestor
83522011|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522012|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
83522013|NCT03740165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83522014|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83522015|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522016|NCT01912274|Azacitidine|azacitidine|mesh-list
83522017|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83522018|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
83522019|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522020|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522021|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522022|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
83522023|NCT01654861|Gemcitabine|gemcitabine|mesh-list
83522024|NCT01654861|Vitamins|vitamins|mesh-ancestor
83522025|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
83522026|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522027|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83522028|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
83522029|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522030|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522031|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
83522032|NCT01654861|Protective Agents|protective agents|mesh-ancestor
83522033|NCT01934582|Treprostinil|treprostinil|mesh-list
83522034|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83522035|NCT05735834|Rituximab|rituximab|mesh-list
83522036|NCT05735834|Zanubrutinib|zanubrutinib|mesh-list
83522037|NCT05735834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83522038|NCT05735834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522039|NCT05735834|Immunologic Factors|immunologic factors|mesh-ancestor
83522040|NCT05735834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522041|NCT05735834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83522042|NCT05735834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83522043|NCT05735834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522044|NCT05735834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522045|NCT05184777|Estradiol|estradiol|mesh-list
83522046|NCT05184777|Progesterone|progesterone|mesh-list
83522047|NCT05184777|Estrogens|estrogens|mesh-ancestor
83522048|NCT05184777|Hormones|hormones|mesh-ancestor
83522049|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522050|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522051|NCT05184777|Progestins|progestins|mesh-ancestor
83522052|NCT01912352|Methylphenidate|methylphenidate|mesh-list
83522053|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83522054|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522055|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83522056|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83522057|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522058|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522059|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
83522060|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522061|NCT02975843|Beclomethasone|beclomethasone|mesh-list
83522062|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
83522063|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
83522064|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83522065|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
83522066|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522067|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522068|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83522069|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
83522070|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83522071|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83522072|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83522073|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
83522074|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522075|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522076|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83522077|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83522078|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83522079|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
83522080|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83522081|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
83522082|NCT02975843|Hormones|hormones|mesh-ancestor
83522083|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522085|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83522086|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
83522087|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522088|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83522089|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522090|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522091|NCT01655719|Pioglitazone|pioglitazone|mesh-list
83522092|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83522093|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522094|NCT05735756|Citalopram|citalopram|mesh-list
83522095|NCT05735756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83522096|NCT05735756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83522097|NCT05735756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522098|NCT05735756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522099|NCT05735756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522100|NCT05735756|Serotonin Agents|serotonin agents|mesh-ancestor
83522101|NCT05735756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522102|NCT05735756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83522103|NCT05735756|Antidepressive Agents|antidepressive agents|mesh-ancestor
83522104|NCT05735756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83522105|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83522106|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83522107|NCT02987348|Insulin|insulin|mesh-list
83522108|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83522109|NCT02987348|Exenatide|exenatide|mesh-list
83522110|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
83522111|NCT02987348|Glucagon|glucagon|mesh-list
83522112|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83522113|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83522114|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522115|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83522116|NCT02987348|Incretins|incretins|mesh-ancestor
83522117|NCT02987348|Hormones|hormones|mesh-ancestor
83522118|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522119|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83522120|NCT01656031|Cytarabine|cytarabine|mesh-list
83522121|NCT01656031|Clofarabine|clofarabine|mesh-list
83522122|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83522123|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
83522124|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522125|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522126|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
83522127|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522128|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83522129|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
83522130|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522131|NCT01656187|Memantine|memantine|mesh-list
83522132|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83522133|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83522134|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
83522135|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522136|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522137|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522138|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83522139|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83522140|NCT01658839|Travoprost|travoprost|mesh-list
83522141|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83522142|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83522143|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83522144|NCT01658995|Doxycycline|doxycycline|mesh-list
83522145|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83522146|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522147|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
83522148|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83522149|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83522150|NCT01350141|Bococizumab|bococizumab|mesh-list
83522151|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83522152|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83522153|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
83522154|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522155|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83522156|NCT01662115|Nicotine|nicotine|mesh-list
83522157|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83522159|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522160|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522161|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83522162|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83522163|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
83522164|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522165|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522166|NCT01598545|Hydromorphone|hydromorphone|mesh-list
83522167|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83522168|NCT01598545|Narcotics|narcotics|mesh-ancestor
83522169|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522170|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522171|NCT01598545|Analgesics|analgesics|mesh-ancestor
83522172|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
83522173|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522174|NCT01598701|Acetaminophen|acetaminophen|mesh-list
83522175|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83522176|NCT01598701|Analgesics|analgesics|mesh-ancestor
83522177|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
83522178|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522179|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522180|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
83522181|NCT00000309|Risperidone|risperidone|mesh-list
83522182|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83522183|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
83522184|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522185|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522186|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522187|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83522188|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83522189|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522190|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83522191|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83522193|NCT00000315|Cocaine|cocaine|mesh-list
83522194|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
83522195|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
83522196|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522197|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522198|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
83522199|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522200|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83522201|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83522202|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83522203|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522204|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522205|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
83522206|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522207|NCT00000321|Desipramine|desipramine|mesh-list
83522208|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83522209|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
83522210|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83522211|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413638|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83522212|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522213|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83522214|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83522215|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522216|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
83522217|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522218|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522219|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
83522220|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83522221|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522222|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522223|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
83522224|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522225|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522226|NCT01940276|Prednisone|prednisone|mesh-list
83522227|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
83522228|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83522229|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
83522230|NCT01940276|Hormones|hormones|mesh-ancestor
83522231|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522232|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522233|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83522234|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522235|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83522236|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522237|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522238|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
83522239|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83522240|NCT00000327|Heroin|heroin|mesh-list
83522241|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83522242|NCT00000327|Narcotics|narcotics|mesh-ancestor
83522243|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522244|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522245|NCT00000327|Analgesics|analgesics|mesh-ancestor
83522246|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
83522247|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522248|NCT01919216|Citalopram|citalopram|mesh-list
83522249|NCT01919216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83522250|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83522251|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522252|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522253|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522254|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
83522255|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522256|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83522257|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
83522258|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83522259|NCT01940510|Rifampin|rifampin|mesh-list
83522260|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83522261|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
83522262|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83522263|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522264|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
83522265|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83522266|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522267|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522268|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83522269|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83522270|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83522271|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83522272|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83522273|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83522274|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83522275|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83522276|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
83522277|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522278|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522279|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522280|NCT05364645|Carboplatin|carboplatin|mesh-list
83522281|NCT05364645|Pemetrexed|pemetrexed|mesh-list
83522282|NCT05364645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522283|NCT05364645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522284|NCT05364645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522285|NCT05364645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83522286|NCT05364645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83522287|NCT01919450|Regadenoson|regadenoson|mesh-list
83522288|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83522289|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83522290|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
83522291|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
83522292|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522293|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522294|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522295|NCT01602679|Progesterone|progesterone|mesh-list
83522296|NCT01602679|Progestins|progestins|mesh-ancestor
83522297|NCT01602679|Hormones|hormones|mesh-ancestor
83522298|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522299|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522300|NCT01919606|Bupivacaine|bupivacaine|mesh-list
83522301|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
83522302|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
83522303|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522304|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522305|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
83522306|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522307|NCT01919996|Azithromycin|azithromycin|mesh-list
83522308|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83522309|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522310|NCT05735132|Lidocaine|lidocaine|mesh-list
83522311|NCT05735132|Anesthetics, Local|anesthetics, local|mesh-ancestor
83522312|NCT05735132|Anesthetics|anesthetics|mesh-ancestor
83522313|NCT05735132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522314|NCT05735132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522315|NCT05735132|Sensory System Agents|sensory system agents|mesh-ancestor
83522316|NCT05735132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522317|NCT05735132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83522318|NCT05735132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83522319|NCT05735132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83522320|NCT05735132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522321|NCT05735132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522322|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
83522323|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522324|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83522325|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83522326|NCT01667029|Analgesics|analgesics|mesh-ancestor
83522327|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
83522328|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522329|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522330|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83522331|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83522332|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83522333|NCT01943864|Trametinib|trametinib|mesh-list
83522334|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522335|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83522336|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522337|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522338|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83522339|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83522340|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
83522341|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83522342|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
83522343|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83522344|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522345|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83522346|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83522347|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522348|NCT00000333|Benztropine|benztropine|mesh-list
83522349|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83522350|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83522351|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
83522352|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
83522353|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522354|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522355|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83522356|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83522357|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
83522358|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522359|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522360|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83522361|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83522362|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522363|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
83522364|NCT00000339|Risperidone|risperidone|mesh-list
83522365|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83522366|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
83522367|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522368|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522369|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522370|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83522371|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83522372|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522373|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83522374|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83522375|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
83522376|NCT00000345|Lofexidine|lofexidine|mesh-list
83522377|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83522379|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522380|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
83522381|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522382|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83522383|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83522384|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83522385|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
83522386|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522387|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522388|NCT00000357|Buprenorphine|buprenorphine|mesh-list
83522389|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83522390|NCT00000357|Narcotics|narcotics|mesh-ancestor
83522391|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522392|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522393|NCT00000357|Analgesics|analgesics|mesh-ancestor
83522394|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
83522395|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522396|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83522397|NCT05095311|Cetirizine|cetirizine|mesh-list
83522398|NCT05095311|Nedocromil|nedocromil|mesh-list
83522399|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83522400|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83522401|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83522402|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
83522403|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
83522404|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522405|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522406|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522407|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83522408|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
83522409|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83522410|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83522411|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
83522412|NCT01922336|Infliximab|infliximab|mesh-list
83522413|NCT01922336|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83522414|NCT01922336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83522415|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
83522416|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83522417|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83522418|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
83522419|NCT04330755|Simendan|simendan|mesh-list
83522420|NCT04330755|Analgesics|analgesics|mesh-ancestor
83522421|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
83522422|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522423|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522424|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
83522425|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522426|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83522427|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
83522428|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83522429|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522430|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522431|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83522432|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
83522433|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83522434|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83522435|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
83522436|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83522437|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83522438|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522439|NCT04330755|Protective Agents|protective agents|mesh-ancestor
83522440|NCT01608295|Paroxetine|paroxetine|mesh-list
83522441|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
83522442|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83522443|NCT01608295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83522444|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83522445|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522446|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522447|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522448|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
83522449|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522450|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83522451|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83522604|NCT02287376|Diclofenac|diclofenac|mesh-list
83522452|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83522453|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83522454|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522455|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83522456|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83522457|NCT04713189|Fentanyl|fentanyl|mesh-list
83522458|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83522459|NCT04713189|Narcotics|narcotics|mesh-ancestor
83522460|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522461|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522462|NCT04713189|Analgesics|analgesics|mesh-ancestor
83522463|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
83522464|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522465|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83522466|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83522467|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
83522468|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
83522469|NCT01610011|Glycine|glycine|mesh-list
83522470|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
83522471|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522472|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522473|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522474|NCT00000399|Hormones|hormones|mesh-list
83522475|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522476|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522477|NCT02237989|Acetaminophen|acetaminophen|mesh-list
83522478|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83522479|NCT02237989|Analgesics|analgesics|mesh-ancestor
83522480|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
83522481|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522482|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522483|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
83522484|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
83522485|NCT00000429|Calcium|calcium|mesh-list
83522486|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83522487|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522488|NCT00000429|Antacids|antacids|mesh-ancestor
83522489|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522490|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83522491|NCT01673191|Dexamethasone|dexamethasone|mesh-list
83522492|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
83522493|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83522494|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83522495|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
83522496|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
83522497|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522498|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522499|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83522500|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
83522501|NCT01673191|Hormones|hormones|mesh-ancestor
83522502|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522503|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83522504|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522505|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83522506|NCT01925144|Omeprazole|omeprazole|mesh-list
83522507|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83522508|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83522509|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83522510|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522511|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522512|NCT00000441|Carbamazepine|carbamazepine|mesh-list
83522513|NCT00000441|Lorazepam|lorazepam|mesh-list
83522514|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
83522515|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
83522516|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
83522517|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522518|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522519|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83522520|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83522521|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522522|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83522523|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83522524|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83522525|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
83522526|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
83522527|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522528|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522529|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
83522530|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83522531|NCT00000441|Analgesics|analgesics|mesh-ancestor
83522532|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
83522533|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83522534|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522535|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83522536|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83522537|NCT00000447|Naltrexone|naltrexone|mesh-list
83522538|NCT00000447|Nicotine|nicotine|mesh-list
83522539|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83522540|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
83522541|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522542|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522543|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83522544|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83522545|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
83522546|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522547|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522548|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83522549|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83522550|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
83522551|NCT01927718|Thalidomide|thalidomide|mesh-list
83522552|NCT01927718|Lenalidomide|lenalidomide|mesh-list
83522553|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
83522554|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522555|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83522556|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83522557|NCT01927718|Growth Substances|growth substances|mesh-ancestor
83522558|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
83522559|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522560|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83522561|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
83522562|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83522563|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522565|NCT05066607|Pomalidomide|pomalidomide|mesh-list
83522566|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83522567|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
83522568|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
83522569|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522570|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522571|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83522572|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
83522573|NCT05066607|Hormones|hormones|mesh-ancestor
83522574|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522575|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83522576|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522577|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
83522578|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83522579|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83522580|NCT05066607|Growth Substances|growth substances|mesh-ancestor
83522581|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
83522582|NCT01948310|Ranolazine|ranolazine|mesh-list
83522583|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83522584|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522585|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522586|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83522587|NCT01948388|Hormones|hormones|mesh-ancestor
83522588|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522589|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522590|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
83522591|NCT01675297|Vitamin D|vitamin d|mesh-list
83522592|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
83522593|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
83522594|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83522595|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522596|NCT01675297|Vitamins|vitamins|mesh-ancestor
83522597|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
83522598|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83522599|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83522600|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522601|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522602|NCT05295537|Liver Extracts|liver extracts|mesh-list
83522603|NCT05295537|Hematinics|hematinics|mesh-ancestor
83522605|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83522606|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83522608|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
83522609|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522610|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522611|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83522612|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83522613|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83522614|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522615|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522616|NCT01928186|Alovudine|alovudine|mesh-list
83522617|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
83522618|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522619|NCT01611571|Teriparatide|teriparatide|mesh-list
83522620|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
83522621|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
83522622|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
83522623|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83522624|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522625|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83522626|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83522627|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522628|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522629|NCT00000477|Lovastatin|lovastatin|mesh-list
83522630|NCT00000477|L 647318|l 647318|mesh-list
83522632|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83522633|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83522634|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
83522635|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522636|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83522637|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83522638|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522639|NCT00000483|Niacin|niacin|mesh-list
83522640|NCT00000483|Clofibrate|clofibrate|mesh-list
83522641|NCT00000483|Estrogens|estrogens|mesh-list
83522642|NCT00000483|Hormones|hormones|mesh-ancestor
83522643|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522644|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522645|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83522646|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
83522647|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522648|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83522649|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
83522650|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
83522651|NCT00000483|Vitamins|vitamins|mesh-ancestor
83522652|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
83522653|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83522654|NCT00000507|Streptokinase|streptokinase|mesh-list
83522655|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83522656|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83522657|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522658|NCT00380445|Vildagliptin|vildagliptin|mesh-list
83522659|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83522660|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522661|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83522662|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
83522663|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522664|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522665|NCT01950260|Hormones|hormones|mesh-list
83522666|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522667|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522668|NCT01676311|Huperzine A|huperzine a|mesh-list
83522669|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83522670|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522671|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522672|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
83522673|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522674|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522675|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83522676|NCT01676311|Protective Agents|protective agents|mesh-ancestor
83522677|NCT01951118|Donepezil|donepezil|mesh-list
83522678|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83522679|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522680|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522682|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522683|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522684|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
83522685|NCT01951820|Lidocaine|lidocaine|mesh-list
83522686|NCT01951820|Tetracaine|tetracaine|mesh-list
83522687|NCT01951820|Carticaine|carticaine|mesh-list
83522688|NCT01951820|Benzocaine|benzocaine|mesh-list
83522689|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
83522690|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
83522691|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522692|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522693|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
83522694|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522695|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83522696|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83522697|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83522698|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522699|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522700|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
83522701|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83522702|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522703|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83522704|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83522705|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522706|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522707|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522708|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83522709|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83522710|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
83522711|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83522712|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83522713|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
83522714|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
83522715|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522716|NCT00382629|Protective Agents|protective agents|mesh-ancestor
83522717|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522718|NCT00000513|Atenolol|atenolol|mesh-list
83522719|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
83522720|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83522721|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83522722|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
83522723|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
83522724|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522725|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522726|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83522727|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83522728|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83522729|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
83522730|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522731|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522732|NCT00000513|Diuretics|diuretics|mesh-ancestor
83522733|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
83522734|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83522735|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522736|NCT00000543|Calcium|calcium|mesh-list
83522737|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83522738|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522739|NCT00000549|Hormones|hormones|mesh-list
83522740|NCT00000549|Estrogens|estrogens|mesh-list
83522741|NCT00000549|Progestins|progestins|mesh-list
83522742|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522743|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522744|NCT01617577|Lenograstim|lenograstim|mesh-list
83522745|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83522746|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
83522747|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522748|NCT01701037|Trametinib|trametinib|mesh-list
83522749|NCT01701037|Dabrafenib|dabrafenib|mesh-list
83522750|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522751|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83522752|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523055|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
83522753|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522754|NCT00000585|Penicillins|penicillins|mesh-list
83522755|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83522756|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522757|NCT01701115|Bupivacaine|bupivacaine|mesh-list
83522758|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
83522759|NCT01701115|Mepivacaine|mepivacaine|mesh-list
83522760|NCT01701115|Anesthetics|anesthetics|mesh-list
83522761|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522762|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522763|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
83522764|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522765|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
83522766|NCT00000597|Nandrolone|nandrolone|mesh-list
83522767|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
83522768|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83522769|NCT00000597|Androgens|androgens|mesh-ancestor
83522770|NCT00000597|Hormones|hormones|mesh-ancestor
83522771|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522772|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522773|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
83522774|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83522775|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
83522776|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83522777|NCT01621009|Bupropion|bupropion|mesh-list
83522778|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83522779|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
83522780|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83522781|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83522782|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83522783|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522784|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522785|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
83522786|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522787|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522788|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83522789|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83522790|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522791|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
83522792|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83522793|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83522794|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522795|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
83522796|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
83522797|NCT01683331|Insulin|insulin|mesh-list
83522798|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83522799|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522800|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
83522801|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83522802|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83522803|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83522804|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83522805|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522806|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
83522807|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522808|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522809|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83522810|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522811|NCT02290106|Pitavastatin|pitavastatin|mesh-list
83522812|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83522813|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83522814|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83522815|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
83522816|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522817|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522818|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83522819|NCT00000621|Tretinoin|tretinoin|mesh-list
83522820|NCT00000621|Isotretinoin|isotretinoin|mesh-list
83522821|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522822|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
83522823|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
83522824|NCT04818957|Vitamin D|vitamin d|mesh-list
83522825|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
83522826|NCT04818957|Vitamins|vitamins|mesh-ancestor
83522827|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
83523056|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83522828|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522829|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83522830|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83522831|NCT01621477|Cytarabine|cytarabine|mesh-list
83522832|NCT01621477|Plerixafor|plerixafor|mesh-list
83522833|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
83522834|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
83522835|NCT01621477|Busulfan|busulfan|mesh-list
83522836|NCT01621477|Clofarabine|clofarabine|mesh-list
83522837|NCT01621477|Tacrolimus|tacrolimus|mesh-list
83522838|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
83522839|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83522840|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83522841|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
83522842|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522843|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83522844|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83522845|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
83522846|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522847|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522848|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83522849|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83522850|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
83522851|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
83522852|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522853|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83522854|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522855|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83522856|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83522857|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
83522858|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83522859|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83522860|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83522861|NCT00000627|Fluconazole|fluconazole|mesh-list
83522862|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
83522863|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522864|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83522865|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83522866|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522867|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522868|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83522869|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
83522870|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522871|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522872|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83522873|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83522874|NCT00000633|Vaccines|vaccines|mesh-list
83522875|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
83522876|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522877|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83522878|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83522879|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522880|NCT05479214|Metformin|metformin|mesh-list
83522881|NCT05479214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83522882|NCT05479214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522883|NCT00000657|Zidovudine|zidovudine|mesh-list
83522884|NCT00000657|Didanosine|didanosine|mesh-list
83522885|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
83522886|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522887|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83522888|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83522889|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522890|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
83522891|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522892|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83522893|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83522894|NCT01701505|Phenylephrine|phenylephrine|mesh-list
83522895|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
83522896|NCT01701505|Tetracaine|tetracaine|mesh-list
83522897|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
83522898|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
83522899|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522900|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522901|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
83522902|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522903|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83522904|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83522905|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
83522906|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522907|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522908|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
83522909|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
83522910|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
83522911|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83522912|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
83522913|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83522914|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
83522915|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83522916|NCT01701505|Protective Agents|protective agents|mesh-ancestor
83522917|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
83522918|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
83522919|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522920|NCT00000669|Didanosine|didanosine|mesh-list
83522921|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
83522922|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522923|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83522924|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83522925|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522926|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
83522927|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522928|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83522929|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83522930|NCT01622257|Metformin|metformin|mesh-list
83522931|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83522932|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522933|NCT04942899|Capecitabine|capecitabine|mesh-list
83522934|NCT04942899|Letrozole|letrozole|mesh-list
83522935|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83522936|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
83522937|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522938|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522939|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83522940|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83522941|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522942|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83522943|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
83522944|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83522945|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522946|NCT00000693|Zidovudine|zidovudine|mesh-list
83522947|NCT00000693|Acyclovir|acyclovir|mesh-list
83522948|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
83522949|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522950|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83522951|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83522952|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83522953|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
83522954|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522955|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83522956|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83522957|NCT04752033|Morphine|morphine|mesh-list
83522958|NCT04752033|Hydromorphone|hydromorphone|mesh-list
83522959|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83522960|NCT04752033|Narcotics|narcotics|mesh-ancestor
83522961|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83522962|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522963|NCT04752033|Analgesics|analgesics|mesh-ancestor
83522964|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
83522965|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522966|NCT02987270|Piperaquine|piperaquine|mesh-list
83522967|NCT02987270|Artenimol|artenimol|mesh-list
83522968|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
83522969|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83522970|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83522971|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522972|NCT00000699|Ribavirin|ribavirin|mesh-list
83522973|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
83522974|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
83522975|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522976|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
83522977|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83522978|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83522979|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
83522980|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522982|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83522983|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83522984|NCT04931979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83522985|NCT04931979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83522986|NCT00000723|Leucovorin|leucovorin|mesh-list
83522987|NCT00000723|Zidovudine|zidovudine|mesh-list
83522988|NCT00000723|Dexamethasone|dexamethasone|mesh-list
83522989|NCT00000723|Methotrexate|methotrexate|mesh-list
83522990|NCT00000723|Calcium|calcium|mesh-list
83522991|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
83522992|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83522993|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
83522994|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
83522995|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83522996|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83522997|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83522998|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
83522999|NCT00000723|Hormones|hormones|mesh-ancestor
83523000|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523001|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83523002|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523003|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83523004|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83523005|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
83523006|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83523007|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83523008|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
83523009|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523010|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
83523011|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523012|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83523013|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523014|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
83523015|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83523016|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83523017|NCT00000723|Antidotes|antidotes|mesh-ancestor
83523018|NCT00000723|Protective Agents|protective agents|mesh-ancestor
83523019|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
83523020|NCT00000723|Vitamins|vitamins|mesh-ancestor
83523021|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
83523022|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83523023|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
83523024|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523025|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83523026|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83523027|NCT02329964|Neostigmine|neostigmine|mesh-list
83523028|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83523029|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83523030|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523031|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523032|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
83523033|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523034|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523035|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83523036|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
83523037|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523038|NCT04750395|Haloperidol|haloperidol|mesh-list
83523039|NCT04750395|Olanzapine|olanzapine|mesh-list
83523040|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
83523041|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
83523042|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
83523043|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523044|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523045|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83523046|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83523047|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83523048|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523049|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83523050|NCT04750395|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83523051|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83523052|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83523053|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523054|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523058|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83523059|NCT00000729|Foscarnet|foscarnet|mesh-list
83523060|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83523061|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
83523062|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523063|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83523064|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83523065|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523066|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523067|NCT03438773|Tacrolimus|tacrolimus|mesh-list
83523068|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523069|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
83523070|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523071|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83523072|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523073|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523074|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
83523075|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83523076|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
83523077|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523078|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
83523079|NCT02974985|Protective Agents|protective agents|mesh-ancestor
83523080|NCT01704781|Lenalidomide|lenalidomide|mesh-list
83523081|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
83523082|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523083|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83523084|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83523085|NCT01704781|Growth Substances|growth substances|mesh-ancestor
83523086|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
83523087|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523089|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
83523090|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
83523091|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
83523092|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523093|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523094|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
83523095|NCT04699383|Allopurinol|allopurinol|mesh-list
83523096|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
83523097|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523098|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523099|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
83523100|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83523101|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83523102|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
83523103|NCT04699383|Protective Agents|protective agents|mesh-ancestor
83523104|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523105|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83523106|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83523107|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523108|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
83523109|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83523110|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
83523111|NCT05700266|Aspirin|aspirin|mesh-list
83523112|NCT05700266|Rivaroxaban|rivaroxaban|mesh-list
83523113|NCT05700266|Clopidogrel|clopidogrel|mesh-list
83523114|NCT05700266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83523115|NCT05700266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83523116|NCT05700266|Analgesics|analgesics|mesh-ancestor
83523117|NCT05700266|Sensory System Agents|sensory system agents|mesh-ancestor
83523118|NCT05700266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523119|NCT05700266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523120|NCT05700266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83523121|NCT05700266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83523122|NCT05700266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83523123|NCT05700266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83523124|NCT05700266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523125|NCT05700266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83523126|NCT05700266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83523127|NCT05700266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523128|NCT05700266|Antipyretics|antipyretics|mesh-ancestor
83523129|NCT05700266|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83523130|NCT05700266|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83523131|NCT05700266|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83523132|NCT05700266|Purinergic Agents|purinergic agents|mesh-ancestor
83523133|NCT05700266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523134|NCT05700266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83523136|NCT05700266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83523137|NCT05700266|Protease Inhibitors|protease inhibitors|mesh-ancestor
83523138|NCT05700266|Anticoagulants|anticoagulants|mesh-ancestor
83523139|NCT05423132|Ropivacaine|ropivacaine|mesh-list
83523140|NCT05423132|Anesthetics, Local|anesthetics, local|mesh-ancestor
83523141|NCT05423132|Anesthetics|anesthetics|mesh-ancestor
83523142|NCT05423132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523143|NCT05423132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523144|NCT05423132|Sensory System Agents|sensory system agents|mesh-ancestor
83523145|NCT05423132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523146|NCT02975219|Bevacizumab|bevacizumab|mesh-list
83523147|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83523148|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523149|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83523150|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83523151|NCT02975219|Growth Substances|growth substances|mesh-ancestor
83523152|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523153|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
83523154|NCT01686451|Simvastatin|simvastatin|mesh-list
83523155|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83523156|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83523157|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
83523158|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523159|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83523160|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83523161|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523162|NCT00361751|Fenofibrate|fenofibrate|mesh-list
83523163|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83523164|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
83523165|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523166|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83523167|NCT05681702|Aspirin|aspirin|mesh-list
83523168|NCT05681702|Clopidogrel|clopidogrel|mesh-list
83523169|NCT05681702|Ticagrelor|ticagrelor|mesh-list
83523170|NCT05681702|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83523171|NCT05681702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83523172|NCT05681702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83523173|NCT05681702|Analgesics|analgesics|mesh-ancestor
83523174|NCT05681702|Sensory System Agents|sensory system agents|mesh-ancestor
83523175|NCT05681702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523176|NCT05681702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523177|NCT05681702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83523178|NCT05681702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83523179|NCT05681702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83523180|NCT05681702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83523181|NCT05681702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523182|NCT05681702|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83523183|NCT05681702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83523184|NCT05681702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523185|NCT05681702|Antipyretics|antipyretics|mesh-ancestor
83523186|NCT05681702|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83523187|NCT05681702|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83523188|NCT05681702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83523189|NCT05681702|Purinergic Agents|purinergic agents|mesh-ancestor
83523190|NCT05681702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523191|NCT04675983|Fluorouracil|fluorouracil|mesh-list
83523192|NCT04675983|Capecitabine|capecitabine|mesh-list
83523193|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
83523194|NCT04675983|Ramucirumab|ramucirumab|mesh-list
83523195|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523196|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
83523197|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523198|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83523199|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523200|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
83523201|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523202|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
83523203|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83523204|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523205|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523206|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83523207|NCT03668951|Analgesics|analgesics|mesh-ancestor
83523208|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
83523209|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523210|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83523211|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83523212|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83523213|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
83523214|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523215|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523216|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
83523217|NCT04889703|Salicylates|salicylates|mesh-list
83523218|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523219|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
83523220|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
83523221|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
83523222|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83523223|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83523224|NCT04889703|Analgesics|analgesics|mesh-ancestor
83523225|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
83523226|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523227|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523228|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83523229|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83523230|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83523231|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523232|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523234|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83523235|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
83523236|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523237|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523238|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83523239|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523240|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
83523241|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523242|NCT05676476|Antihypertensive Agents|antihypertensive agents|mesh-list
83523243|NCT03363893|Fulvestrant|fulvestrant|mesh-list
83523244|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83523245|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523246|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83523247|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83523248|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
83523249|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523250|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523251|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83523252|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
83523253|NCT01706263|Salicylates|salicylates|mesh-list
83523254|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523255|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
83523256|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
83523257|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
83523258|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83523259|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83523260|NCT01706263|Analgesics|analgesics|mesh-ancestor
83523261|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
83523262|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523263|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523264|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83523265|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83523266|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83523267|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523268|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523269|NCT05738798|Immunomodulating Agents|immunomodulating agents|mesh-list
83523270|NCT05738798|Immunologic Factors|immunologic factors|mesh-ancestor
83523271|NCT05738798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523272|NCT05641298|Fusidic Acid|fusidic acid|mesh-list
83523273|NCT05641298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83523274|NCT05641298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523275|NCT05641298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83523276|NCT05641298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523277|NCT05641298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523278|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
83523279|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83523280|NCT04342247|Testosterone|testosterone|mesh-list
83523281|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
83523282|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
83523283|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83523284|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523287|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523288|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523289|NCT04342247|Androgens|androgens|mesh-ancestor
83523290|NCT05738642|Thrombin|thrombin|mesh-list
83523291|NCT05738642|Hemostatics|hemostatics|mesh-ancestor
83523292|NCT05738642|Coagulants|coagulants|mesh-ancestor
83523293|NCT01690663|Dexamethasone|dexamethasone|mesh-list
83523294|NCT01690663|Bupivacaine|bupivacaine|mesh-list
83523295|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83523296|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
83523297|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
83523298|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523299|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523300|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83523301|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
83523302|NCT01690663|Hormones|hormones|mesh-ancestor
83523303|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523304|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83523305|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523306|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
83523308|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523309|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
83523310|NCT05738564|Lidocaine|lidocaine|mesh-list
83523311|NCT05738564|Epinephrine|epinephrine|mesh-list
83523312|NCT05738564|Oxymetazoline|oxymetazoline|mesh-list
83523313|NCT05738564|Anesthetics, Local|anesthetics, local|mesh-ancestor
83523314|NCT05738564|Anesthetics|anesthetics|mesh-ancestor
83523315|NCT05738564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523316|NCT05738564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523317|NCT05738564|Sensory System Agents|sensory system agents|mesh-ancestor
83523318|NCT05738564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523319|NCT05738564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83523320|NCT05738564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83523321|NCT05738564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83523322|NCT05738564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83523323|NCT05738564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523324|NCT05738564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83523325|NCT05738564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83523326|NCT05738564|Adrenergic Agents|adrenergic agents|mesh-ancestor
83523327|NCT05738564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523328|NCT05738564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83523329|NCT05738564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83523330|NCT05738564|Autonomic Agents|autonomic agents|mesh-ancestor
83523331|NCT05738564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83523332|NCT05738564|Respiratory System Agents|respiratory system agents|mesh-ancestor
83523333|NCT05738564|Mydriatics|mydriatics|mesh-ancestor
83523334|NCT05738564|Sympathomimetics|sympathomimetics|mesh-ancestor
83523335|NCT05738564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83523336|NCT05738564|Nasal Decongestants|nasal decongestants|mesh-ancestor
83523337|NCT05343572|Plerixafor|plerixafor|mesh-list
83523338|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83523339|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83523340|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
83523341|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523342|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
83523343|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83523344|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523345|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523346|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83523347|NCT04350086|Analgesics|analgesics|mesh-ancestor
83523348|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
83523349|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523350|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83523351|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83523352|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83523353|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
83523354|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523355|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523356|NCT05738408|Nicotine|nicotine|mesh-list
83523357|NCT05738408|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83523358|NCT05738408|Autonomic Agents|autonomic agents|mesh-ancestor
83523359|NCT05738408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523360|NCT05738408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523361|NCT05738408|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83523362|NCT05738408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83523365|NCT05738408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523366|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
83523367|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83523368|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523369|NCT03414229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83523370|NCT03414229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523371|NCT01352117|Tenofovir|tenofovir|mesh-list
83523372|NCT01352117|Emtricitabine|emtricitabine|mesh-list
83523373|NCT01352117|Efavirenz|efavirenz|mesh-list
83523374|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83523375|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83523376|NCT01352117|Etoposide|etoposide|mesh-list
83523377|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83523378|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523379|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83523380|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83523381|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523382|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523383|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
83523384|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523385|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83523386|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83523387|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83523388|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83523389|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83523390|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83523391|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83523392|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83523393|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83523394|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83523395|NCT03379207|Dimercaprol|dimercaprol|mesh-list
83523396|NCT03379207|Chelating Agents|chelating agents|mesh-ancestor
83523397|NCT03379207|Sequestering Agents|sequestering agents|mesh-ancestor
83523398|NCT03379207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523399|NCT02974439|Amlodipine|amlodipine|mesh-list
83523400|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83523401|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83523402|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83523403|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523404|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83523405|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523406|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
83523407|NCT03340727|Caffeine|caffeine|mesh-list
83523408|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
83523409|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523410|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83523411|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523412|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83523413|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523414|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83523415|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83523416|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
83523417|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523418|NCT04612179|Sirolimus|sirolimus|mesh-list
83523419|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83523420|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523421|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83523422|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523423|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
83523424|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523425|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
83523426|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523427|NCT05578820|Ganciclovir|ganciclovir|mesh-list
83523428|NCT05578820|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83523429|NCT05578820|Antiviral Agents|antiviral agents|mesh-ancestor
83523430|NCT05578820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523431|NCT05578820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83523432|NCT05578820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523433|NCT05578820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523437|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83523438|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
83523439|NCT01707043|Calcipotriene|calcipotriene|mesh-list
83523440|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83523441|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83523442|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
83523444|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523445|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523446|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83523447|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
83523448|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
83523449|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83523451|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83523452|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523453|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83523454|NCT01707043|Vitamins|vitamins|mesh-ancestor
83523455|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
83523456|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83523457|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
83523458|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
83523459|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523460|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523461|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523462|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
83523463|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
83523464|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
83523465|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523466|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83523467|NCT01708525|Protective Agents|protective agents|mesh-ancestor
83523468|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523469|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
83523470|NCT03634917|Acamprosate|acamprosate|mesh-list
83523471|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
83523472|NCT03634917|Calcium|calcium|mesh-list
83523473|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83523474|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523475|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83523476|NCT03634917|Antacids|antacids|mesh-ancestor
83523477|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523478|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83523479|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83523480|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
83523481|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83523482|NCT05058872|Estradiol|estradiol|mesh-list
83523483|NCT05058872|Estrogens|estrogens|mesh-ancestor
83523484|NCT05058872|Hormones|hormones|mesh-ancestor
83523485|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523486|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523487|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83523488|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
83523489|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83523490|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83523491|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83523492|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83523493|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83523494|NCT04595565|Carboplatin|carboplatin|mesh-list
83523495|NCT04595565|Capecitabine|capecitabine|mesh-list
83523496|NCT04595565|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83523497|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523498|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83523499|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
83523500|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523501|NCT04595565|Immunoconjugates|immunoconjugates|mesh-ancestor
83523502|NCT04595565|Immunologic Factors|immunologic factors|mesh-ancestor
83523503|NCT04595565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523504|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83523505|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
83523506|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83523507|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83523508|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83523509|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523510|NCT03538899|Busulfan|busulfan|mesh-list
83523511|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
83523512|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523513|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523514|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
83523515|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523516|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83523517|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523518|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83523519|NCT04230681|Fentanyl|fentanyl|mesh-list
83523520|NCT04230681|Hydromorphone|hydromorphone|mesh-list
83523521|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83523522|NCT04230681|Narcotics|narcotics|mesh-ancestor
83523523|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523524|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523525|NCT04230681|Analgesics|analgesics|mesh-ancestor
83523526|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
83523527|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523528|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83523529|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83523530|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
83523531|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
83523532|NCT02324543|Gemcitabine|gemcitabine|mesh-list
83523534|NCT02324543|Capecitabine|capecitabine|mesh-list
83523535|NCT02324543|Irinotecan|irinotecan|mesh-list
83523536|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523537|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83523538|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
83523539|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523540|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
83523541|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
83523542|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
83523543|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83523544|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83523545|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523546|NCT01708603|Ustekinumab|ustekinumab|mesh-list
83523547|NCT01708603|Brodalumab|brodalumab|mesh-list
83523548|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83523549|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
83523550|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
83523551|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523552|NCT03523221|Dexamethasone|dexamethasone|mesh-list
83523553|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83523554|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
83523555|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
83523556|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523557|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523558|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83523559|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
83523560|NCT03523221|Hormones|hormones|mesh-ancestor
83523561|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523562|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83523563|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523564|NCT03590171|Bortezomib|bortezomib|mesh-list
83523565|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523566|NCT00362765|Metformin|metformin|mesh-list
83523567|NCT00362765|Fenofibrate|fenofibrate|mesh-list
83523568|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83523569|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523570|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83523571|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
83523572|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523573|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83523574|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83523575|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83523576|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
83523577|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
83523578|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523579|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523580|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523581|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
83523582|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
83523583|NCT03300947|Lorazepam|lorazepam|mesh-list
83523584|NCT03300947|Psilocybin|psilocybin|mesh-list
83523585|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
83523586|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523587|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83523588|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
83523589|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
83523590|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
83523591|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523592|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83523593|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83523594|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523595|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83523596|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83523597|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
83523598|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
83523599|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523600|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523601|NCT03543839|Belimumab|belimumab|mesh-list
83523602|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523603|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
83523604|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523606|NCT04173507|Talazoparib|talazoparib|mesh-list
83523607|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83523608|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83523609|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523610|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83523611|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523612|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523613|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
83523614|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523615|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
83523616|NCT05033756|Olaparib|olaparib|mesh-list
83523617|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83523618|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523619|NCT05033756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83523620|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523621|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83523622|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523623|NCT03532295|Bevacizumab|bevacizumab|mesh-list
83523624|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83523625|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523626|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83523627|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83523628|NCT03532295|Growth Substances|growth substances|mesh-ancestor
83523629|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523630|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
83523631|NCT03522077|Hemostatics|hemostatics|mesh-list
83523632|NCT03522077|Coagulants|coagulants|mesh-ancestor
83523633|NCT02980562|Bisacodyl|bisacodyl|mesh-list
83523634|NCT02980562|Cathartics|cathartics|mesh-ancestor
83523635|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83523636|NCT02980562|Laxatives|laxatives|mesh-ancestor
83523637|NCT03266393|Tacrolimus|tacrolimus|mesh-list
83523638|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523639|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
83523640|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523641|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83523642|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523643|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523644|NCT03246347|Docetaxel|docetaxel|mesh-list
83523645|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523646|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
83523647|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
83523648|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
83523649|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523650|NCT00421967|Ketorolac|ketorolac|mesh-list
83523651|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83523652|NCT00421967|Epinephrine|epinephrine|mesh-list
83523653|NCT00421967|Racepinephrine|racepinephrine|mesh-list
83523654|NCT00421967|Ropivacaine|ropivacaine|mesh-list
83523655|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
83523656|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
83523657|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
83523658|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523659|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523660|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
83523661|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523662|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83523663|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83523664|NCT00421967|Analgesics|analgesics|mesh-ancestor
83523665|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83523666|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83523667|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83523669|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523670|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83523671|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83523672|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
83523673|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523674|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83523675|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83523676|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
83523677|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83523678|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
83523679|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
83523680|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
83523681|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83523682|NCT03209687|Menotropins|menotropins|mesh-list
83523683|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83523684|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
83523685|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83523686|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523687|NCT04997798|Trastuzumab|trastuzumab|mesh-list
83523688|NCT04997798|Exemestane|exemestane|mesh-list
83523689|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83523690|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523691|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83523692|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83523693|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523694|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523695|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83523696|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
83523697|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523698|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523699|NCT00362531|Prednisone|prednisone|mesh-list
83523700|NCT00362531|Tacrolimus|tacrolimus|mesh-list
83523701|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83523702|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
83523703|NCT00362531|Hormones|hormones|mesh-ancestor
83523704|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523705|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523706|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83523707|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523708|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523709|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
83523710|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83523711|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523712|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523713|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83523714|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
83523715|NCT04330677|Oxytocin|oxytocin|mesh-list
83523716|NCT04330677|Estrogens|estrogens|mesh-list
83523717|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
83523718|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83523719|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523720|NCT04330677|Hormones|hormones|mesh-ancestor
83523721|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523722|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
83523723|NCT04965116|Progestins|progestins|mesh-list
83523724|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83523725|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523726|NCT04965116|Hormones|hormones|mesh-ancestor
83413639|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83523727|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523728|NCT04964960|Paclitaxel|paclitaxel|mesh-list
83523729|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83523730|NCT04964960|Carboplatin|carboplatin|mesh-list
83523731|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
83523732|NCT04964960|Pemetrexed|pemetrexed|mesh-list
83523733|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83523734|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523735|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
83523736|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
83523737|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
83523738|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523739|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83523740|NCT04964960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83523741|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523742|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83523743|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83523744|NCT05114486|Pilocarpine|pilocarpine|mesh-list
83523745|NCT05114486|Miotics|miotics|mesh-ancestor
83523746|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
83523747|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523748|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523749|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83523750|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83523751|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
83523752|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523753|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523754|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
83523755|NCT03200847|Tretinoin|tretinoin|mesh-list
83523756|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83523757|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523758|NCT03200847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83523759|NCT03200847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523760|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
83523761|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
83523762|NCT02259517|Guanfacine|guanfacine|mesh-list
83523763|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83523764|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83523765|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523766|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83523767|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83523768|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83523769|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523770|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
83523771|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523772|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83523773|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83523774|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83523775|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83523776|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
83523777|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
83523778|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83523779|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
83523780|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523781|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523782|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83523783|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
83523784|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83523785|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
83523786|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523787|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523788|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83523789|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
83523790|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
83523791|NCT04358588|Protective Agents|protective agents|mesh-ancestor
83523792|NCT03166761|Dexamethasone|dexamethasone|mesh-list
83523793|NCT03166761|Triamcinolone|triamcinolone|mesh-list
83523794|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83523795|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83523796|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83523797|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83523798|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
83523799|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
83523800|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523801|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523802|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83523803|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
83523804|NCT03166761|Hormones|hormones|mesh-ancestor
83523805|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523806|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83523807|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523808|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523809|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
83523810|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523811|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523812|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
83523813|NCT04042155|Apixaban|apixaban|mesh-list
83523814|NCT04042155|Edoxaban|edoxaban|mesh-list
83523815|NCT04042155|Dabigatran|dabigatran|mesh-list
83523816|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83523817|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
83523818|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83523819|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
83523820|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523821|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523823|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
83523824|NCT04195256|Ketamine|ketamine|mesh-list
83523825|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83523826|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523827|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523828|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83523829|NCT04195256|Analgesics|analgesics|mesh-ancestor
83523830|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
83523831|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523832|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83523833|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83523834|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83523835|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
83523836|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523837|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523838|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83523839|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83523840|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
83523841|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
83523842|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83523843|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83523844|NCT00002901|Docetaxel|docetaxel|mesh-list
83523845|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523846|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
83523847|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
83523848|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
83523849|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523850|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
83523851|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83523852|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
83523853|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523854|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523855|NCT01710787|Phenylephrine|phenylephrine|mesh-list
83523856|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
83523857|NCT01710787|Tetracaine|tetracaine|mesh-list
83523858|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
83523859|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
83523860|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523861|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523862|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
83523863|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523864|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83523865|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83523866|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
83523867|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523868|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523869|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
83523870|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
83523871|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
83523872|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83523873|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
83523874|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83523875|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
83523876|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83523877|NCT01710787|Protective Agents|protective agents|mesh-ancestor
83523878|NCT01711177|Travoprost|travoprost|mesh-list
83523879|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83523880|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83523881|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523882|NCT01715233|Leucovorin|leucovorin|mesh-list
83523883|NCT01715233|Carboplatin|carboplatin|mesh-list
83523884|NCT01715233|Docetaxel|docetaxel|mesh-list
83523885|NCT01715233|Fluorouracil|fluorouracil|mesh-list
83523886|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523887|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
83523888|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
83523889|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
83523890|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523891|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
83523892|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83523893|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523895|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523896|NCT01715233|Antidotes|antidotes|mesh-ancestor
83523897|NCT01715233|Protective Agents|protective agents|mesh-ancestor
83523898|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
83523899|NCT01715233|Vitamins|vitamins|mesh-ancestor
83523900|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
83523901|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83523902|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83523903|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83523904|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
83523905|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523906|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
83523907|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83523908|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83523909|NCT04826588|Prednisolone|prednisolone|mesh-list
83523910|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
83523911|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83523912|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
83523913|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
83523914|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83523915|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
83523916|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
83523917|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523918|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523919|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83523920|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
83523921|NCT04826588|Hormones|hormones|mesh-ancestor
83523922|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83523923|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83523924|NCT04826588|Protective Agents|protective agents|mesh-ancestor
83523925|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83523926|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523927|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
83523928|NCT01719367|Atenolol|atenolol|mesh-list
83523929|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83523930|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83523931|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
83523932|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
83523933|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523934|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523935|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83523936|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83523937|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83523938|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
83523939|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523940|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523941|NCT02276040|Bupivacaine|bupivacaine|mesh-list
83523942|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
83523943|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
83523944|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523945|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523946|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
83523947|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523948|NCT02250703|Midazolam|midazolam|mesh-list
83523949|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
83523950|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83523951|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83523952|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523953|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83523954|NCT02250703|Analgesics|analgesics|mesh-ancestor
83523955|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
83523956|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523957|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83523958|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83523959|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83523960|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
83523961|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523962|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523963|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83523964|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83523965|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83523966|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83523967|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83523968|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
83523969|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
83523970|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
83523975|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83523976|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523977|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83523978|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
83523979|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83523980|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83523981|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
83523982|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83523983|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
83523984|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83523985|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523986|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83523987|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
83523988|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83523989|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
83523990|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83523991|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523992|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83523993|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
83523994|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
83523995|NCT03135860|Protective Agents|protective agents|mesh-ancestor
83523996|NCT02275338|Lanreotide|lanreotide|mesh-list
83523997|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523998|NCT01646268|Rotigotine|rotigotine|mesh-list
83523999|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
83524000|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
83524001|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83524002|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524003|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524004|NCT03988634|Valsartan|valsartan|mesh-list
83524005|NCT03988634|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83524006|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83524007|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83524008|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83524009|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524010|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83524011|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
83524012|NCT01722487|Chlorambucil|chlorambucil|mesh-list
83524013|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83524014|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
83524015|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524016|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524017|NCT02795858|Octreotide|octreotide|mesh-list
83524018|NCT02795858|Ramucirumab|ramucirumab|mesh-list
83524019|NCT02795858|Lanreotide|lanreotide|mesh-list
83524020|NCT02795858|Somatostatin|somatostatin|mesh-list
83524021|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83524022|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83524023|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524024|NCT02795858|Hormones|hormones|mesh-ancestor
83524025|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83524026|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524027|NCT02730962|Vancomycin|vancomycin|mesh-list
83524028|NCT02730962|Clindamycin|clindamycin|mesh-list
83524029|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
83524030|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
83524031|NCT02730962|Neomycin|neomycin|mesh-list
83524032|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83524033|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83524034|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83524035|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524036|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524037|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83524038|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83524039|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
83524040|NCT02296346|Prednisolone|prednisolone|mesh-list
83524041|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
83524042|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83524043|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
83524044|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83524045|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
83524046|NCT02296346|Hormones|hormones|mesh-ancestor
83524047|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83524197|NCT02975141|Afatinib|afatinib|mesh-list
83524048|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524049|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83524050|NCT02296346|Protective Agents|protective agents|mesh-ancestor
83524051|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83524052|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524053|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
83524054|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
83524055|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83524056|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83524057|NCT01726621|Insulin|insulin|mesh-list
83524058|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83524059|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524060|NCT02372630|Linagliptin|linagliptin|mesh-list
83524061|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83524062|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524063|NCT02372630|Incretins|incretins|mesh-ancestor
83524064|NCT02372630|Hormones|hormones|mesh-ancestor
83524065|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83524066|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83524067|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
83524068|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524069|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524070|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83524071|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
83524072|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
83524073|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83524074|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524075|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
83524076|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83524077|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83524078|NCT04349930|Cannabidiol|cannabidiol|mesh-list
83524079|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
83524080|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
83524081|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83524082|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524083|NCT02303990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83524084|NCT02303990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524085|NCT04585958|Trastuzumab|trastuzumab|mesh-list
83524086|NCT04585958|Olaparib|olaparib|mesh-list
83524087|NCT04585958|Camptothecin|camptothecin|mesh-list
83524088|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83524089|NCT04585958|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83524090|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
83524091|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83524092|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524093|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524094|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524095|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
83524096|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524097|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524098|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83524099|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524100|NCT01727089|Bevacizumab|bevacizumab|mesh-list
83524101|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83524102|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
83524103|NCT01727089|Antibodies|antibodies|mesh-list
83524104|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
83524105|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83524106|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
83524107|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524108|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83524109|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83524110|NCT01727089|Growth Substances|growth substances|mesh-ancestor
83524111|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524112|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
83524113|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
83524114|NCT01727791|Pregabalin|pregabalin|mesh-list
83524115|NCT01727791|Analgesics|analgesics|mesh-ancestor
83524116|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
83524117|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83524118|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524119|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
83524120|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83524121|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83524196|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83524122|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524123|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83524124|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83524125|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83524126|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83524127|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83524128|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
83524129|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83524130|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83524131|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83524132|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83524133|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524134|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
83524135|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83524136|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524137|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83524138|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83524139|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
83524140|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83524141|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83524142|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83524143|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83524144|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524145|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
83524146|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83524147|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524148|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83524149|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83524150|NCT02245087|Atorvastatin|atorvastatin|mesh-list
83524151|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83524152|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83524153|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
83524154|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524155|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83524156|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83524157|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524158|NCT04726969|Ivermectin|ivermectin|mesh-list
83524159|NCT04726969|Albendazole|albendazole|mesh-list
83524160|NCT04726969|Moxidectin|moxidectin|mesh-list
83524161|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83524162|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83524163|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
83524164|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
83524165|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83524166|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83524167|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524168|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524169|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524170|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524171|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524172|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
83524173|NCT03174275|Paclitaxel|paclitaxel|mesh-list
83524174|NCT03174275|Carboplatin|carboplatin|mesh-list
83524175|NCT03174275|Durvalumab|durvalumab|mesh-list
83524176|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524177|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524178|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524179|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524180|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524181|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524182|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83524183|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
83524184|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83524185|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524186|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524187|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83524188|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83524189|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83524190|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83524191|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524192|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
83524193|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524194|NCT02975141|Paclitaxel|paclitaxel|mesh-list
83524195|NCT02975141|Gemcitabine|gemcitabine|mesh-list
83524198|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524199|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524200|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524201|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524202|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524203|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524204|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524206|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83524207|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524208|NCT03452891|Simvastatin|simvastatin|mesh-list
83524209|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83524210|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83524211|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
83524212|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524213|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83524214|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83524215|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524216|NCT04341935|Linagliptin|linagliptin|mesh-list
83524217|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83524218|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524219|NCT04341935|Incretins|incretins|mesh-ancestor
83524220|NCT04341935|Hormones|hormones|mesh-ancestor
83524221|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83524222|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83524223|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
83524224|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524225|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524226|NCT05317039|Calcium|calcium|mesh-list
83524227|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83524228|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524229|NCT05316883|Clozapine|clozapine|mesh-list
83524230|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83524231|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
83524232|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83524233|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524234|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524235|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83524236|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83524237|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83524238|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83524239|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
83524240|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
83524241|NCT05316649|Chrysarobin|chrysarobin|mesh-list
83524242|NCT05316649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83524243|NCT05316649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83524244|NCT05316649|Analgesics|analgesics|mesh-ancestor
83524245|NCT05316649|Sensory System Agents|sensory system agents|mesh-ancestor
83524246|NCT05316649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83524247|NCT05316649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524248|NCT05316649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83524249|NCT05316649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83524250|NCT03990363|Allopurinol|allopurinol|mesh-list
83524251|NCT03990363|Verinurad|verinurad|mesh-list
83524252|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
83524253|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524254|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524255|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
83524256|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83524257|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83524258|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
83524259|NCT03990363|Protective Agents|protective agents|mesh-ancestor
83524260|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524261|NCT04341857|Antibodies|antibodies|mesh-list
83524262|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83524263|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
83524264|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524265|NCT00002913|Paclitaxel|paclitaxel|mesh-list
83524266|NCT00002913|Topotecan|topotecan|mesh-list
83524267|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524268|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524269|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524270|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524271|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524272|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524273|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83524274|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524275|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524276|NCT00002919|Doxorubicin|doxorubicin|mesh-list
83524277|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83524278|NCT00002919|Methotrexate|methotrexate|mesh-list
83524279|NCT00002919|Vinblastine|vinblastine|mesh-list
83524280|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524281|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83524282|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524283|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524284|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524285|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524286|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83524287|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
83524288|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83524289|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524290|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524291|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
83524292|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
83524293|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83524294|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524295|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
83524296|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83524297|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83524298|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524299|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524300|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524301|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524302|NCT03083405|Opipramol|opipramol|mesh-list
83524303|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83524304|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
83524305|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83524306|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83524307|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83524308|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83524309|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524310|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
83524311|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83524312|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524313|NCT00383799|Amiodarone|amiodarone|mesh-list
83524314|NCT00383799|Procainamide|procainamide|mesh-list
83524315|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83524316|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
83524317|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83524318|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83524319|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524320|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83524321|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83524322|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83524323|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524324|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83524325|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83524326|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83524327|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83524328|NCT04635241|Heparin|heparin|mesh-list
83524329|NCT04635241|Calcium heparin|calcium heparin|mesh-list
83524330|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
83524331|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83524332|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83524333|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524334|NCT03954483|Triazolam|triazolam|mesh-list
83524335|NCT03954483|Buspirone|buspirone|mesh-list
83524336|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83524337|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83524338|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83524339|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524340|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83524341|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83524342|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
83524343|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83524344|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524345|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83524346|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
83524347|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
83524348|NCT04545541|Heparin|heparin|mesh-list
83524349|NCT04545541|Calcium heparin|calcium heparin|mesh-list
83524350|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
83524351|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83524352|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83524353|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524354|NCT00002925|Aldesleukin|aldesleukin|mesh-list
83524355|NCT00002925|Etoposide|etoposide|mesh-list
83524356|NCT00002925|Daunorubicin|daunorubicin|mesh-list
83524357|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524358|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524359|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524360|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524361|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524362|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524363|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83524364|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83524365|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83524366|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
83524367|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83524368|NCT00002937|Paclitaxel|paclitaxel|mesh-list
83524369|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524370|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524371|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524372|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524373|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524374|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524375|NCT02922777|Docetaxel|docetaxel|mesh-list
83524376|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524377|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524378|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524379|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524380|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524381|NCT02918955|Cisplatin|cisplatin|mesh-list
83524382|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524383|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
83524384|NCT00002943|Carboplatin|carboplatin|mesh-list
83524385|NCT00002943|Etoposide|etoposide|mesh-list
83524386|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524387|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
83524388|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524389|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83524390|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83524391|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
83524392|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524393|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524394|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83524395|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524396|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524397|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524398|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524399|NCT00002949|Paclitaxel|paclitaxel|mesh-list
83524400|NCT00002949|Vinorelbine|vinorelbine|mesh-list
83524401|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524402|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524403|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524404|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524405|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524406|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524407|NCT05315557|Terlipressin|terlipressin|mesh-list
83524408|NCT05315557|Vasopressins|vasopressins|mesh-list
83524409|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
83524410|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
83524411|NCT05315557|Coagulants|coagulants|mesh-ancestor
83524412|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83524413|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83524414|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
83524415|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524416|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83524417|NCT00002955|Leucovorin|leucovorin|mesh-list
83524418|NCT00002955|Trimetrexate|trimetrexate|mesh-list
83524419|NCT00002955|Fluorouracil|fluorouracil|mesh-list
83524420|NCT00002955|Calcium|calcium|mesh-list
83524421|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
83524422|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83524423|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524424|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
83524425|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524426|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524427|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524428|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524429|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
83524430|NCT00002955|Antidotes|antidotes|mesh-ancestor
83524431|NCT00002955|Protective Agents|protective agents|mesh-ancestor
83524432|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
83524433|NCT00002955|Vitamins|vitamins|mesh-ancestor
83524434|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
83524435|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
83524436|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83524437|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83524438|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524439|NCT00002961|Cyclosporine|cyclosporine|mesh-list
83524440|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
83524441|NCT00002961|Busulfan|busulfan|mesh-list
83524442|NCT00002961|Methotrexate|methotrexate|mesh-list
83524443|NCT00002961|Etoposide|etoposide|mesh-list
83524444|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
83524445|NCT00002961|Cyclosporins|cyclosporins|mesh-list
83524446|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524447|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
83524448|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524449|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83524450|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83524451|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
83524452|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524453|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524454|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83524455|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83524456|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
83524457|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83524458|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524459|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
83524460|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
83524461|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524462|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83524463|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83524464|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524465|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524466|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524467|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
83524468|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83524469|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83524470|NCT00002967|Tamoxifen|tamoxifen|mesh-list
83524471|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
83524472|NCT00002967|Doxorubicin|doxorubicin|mesh-list
83524473|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83524474|NCT00002967|Octreotide|octreotide|mesh-list
83524475|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524476|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
83524477|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524478|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83524479|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83524480|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
83524481|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524482|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524483|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83524484|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83524485|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524486|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524487|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524488|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83524489|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
83524490|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83524491|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83524492|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83524493|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83524494|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83524495|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83524498|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83524499|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524500|NCT04246177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83524501|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524502|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83524503|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524504|NCT00002973|Melphalan|melphalan|mesh-list
83524505|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83524506|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
83524507|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524508|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524509|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83524510|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524511|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
83524512|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524513|NCT00002985|Doxorubicin|doxorubicin|mesh-list
83524514|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83524515|NCT00002985|Daunorubicin|daunorubicin|mesh-list
83524516|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83524517|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524518|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524519|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524520|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524521|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524522|NCT02767557|Paclitaxel|paclitaxel|mesh-list
83524523|NCT02767557|Gemcitabine|gemcitabine|mesh-list
83524524|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524525|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524526|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524527|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524528|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524529|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524530|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524531|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
83524532|NCT00363389|Misoprostol|misoprostol|mesh-list
83524533|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83524534|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
83524535|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83524536|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524537|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83524538|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83524539|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
83524540|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83524541|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83524542|NCT03057431|Diuretics|diuretics|mesh-ancestor
83524543|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
83524544|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524545|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83524546|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83524547|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524548|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
83524549|NCT00003003|Mitomycins|mitomycins|mesh-list
83524550|NCT00003003|Mitomycin|mitomycin|mesh-list
83524551|NCT00003003|Sargramostim|sargramostim|mesh-list
83524552|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
83524553|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524554|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524555|NCT00003003|Analgesics|analgesics|mesh-ancestor
83524556|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
83524557|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83524558|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524559|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524560|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524561|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524562|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83524563|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
83524564|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83524565|NCT00003009|Aldesleukin|aldesleukin|mesh-list
83524566|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524567|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83524568|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83524569|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
83524570|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83524571|NCT00003015|Carboplatin|carboplatin|mesh-list
83524572|NCT00003015|Vincristine|vincristine|mesh-list
83524573|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524574|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524575|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524577|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524578|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524579|NCT04204837|Nivolumab|nivolumab|mesh-list
83524580|NCT04204837|Relatlimab|relatlimab|mesh-list
83524581|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83524582|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524583|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83524584|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524585|NCT00003021|Bizelesin|bizelesin|mesh-list
83524586|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83524587|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524588|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83524589|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
83524590|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524591|NCT00003039|Alvocidib|alvocidib|mesh-list
83524592|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524593|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
83524594|NCT00003039|Growth Substances|growth substances|mesh-ancestor
83524595|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524596|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83524597|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524598|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524599|NCT00383877|Insulin|insulin|mesh-list
83524600|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83524601|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
83524602|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
83524603|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
83524604|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
83524605|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83524606|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524607|NCT00003063|Leucovorin|leucovorin|mesh-list
83524608|NCT00003063|Interferons|interferons|mesh-list
83524609|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
83524610|NCT00003063|Levamisole|levamisole|mesh-list
83524611|NCT00003063|Fluorouracil|fluorouracil|mesh-list
83524612|NCT00003063|Calcium|calcium|mesh-list
83524613|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
83524614|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83524615|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524616|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
83524617|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524618|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524619|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524620|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524621|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
83524622|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
83524623|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83524624|NCT00003063|Antidotes|antidotes|mesh-ancestor
83524625|NCT00003063|Protective Agents|protective agents|mesh-ancestor
83524626|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
83524627|NCT00003063|Vitamins|vitamins|mesh-ancestor
83524628|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
83524629|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83524630|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
83524631|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
83524632|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83524633|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83524634|NCT00003075|Fenretinide|fenretinide|mesh-list
83524635|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524636|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83524637|NCT00003075|Protective Agents|protective agents|mesh-ancestor
83524638|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524639|NCT00003081|Melphalan|melphalan|mesh-list
83524640|NCT00003081|Busulfan|busulfan|mesh-list
83524641|NCT00003081|Thiotepa|thiotepa|mesh-list
83524642|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
83524643|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524644|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83524645|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
83524646|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524647|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524648|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83524649|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524650|NCT02348385|Amphetamine|amphetamine|mesh-list
83524651|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
83524652|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83524653|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524655|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
83524656|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83524657|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
83524658|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83524659|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524660|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
83524661|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83524662|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83524663|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83524664|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83524665|NCT00003087|Paclitaxel|paclitaxel|mesh-list
83524666|NCT00003087|Cisplatin|cisplatin|mesh-list
83524667|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524668|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524669|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524670|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524671|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524672|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524673|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
83524674|NCT00003093|Carboplatin|carboplatin|mesh-list
83524675|NCT00003093|Doxorubicin|doxorubicin|mesh-list
83524676|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83524677|NCT00003093|Etoposide|etoposide|mesh-list
83524678|NCT00003093|Molgramostim|molgramostim|mesh-list
83524679|NCT00003093|Lenograstim|lenograstim|mesh-list
83524680|NCT00003093|Sargramostim|sargramostim|mesh-list
83524681|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524682|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
83524683|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524684|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83524685|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83524686|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
83524687|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524688|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524689|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83524690|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83524691|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524692|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524693|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524694|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524695|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83524696|NCT00003099|Tamoxifen|tamoxifen|mesh-list
83524697|NCT00003099|Fenretinide|fenretinide|mesh-list
83524698|NCT00003099|Retinamide|retinamide|mesh-list
83524699|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83524700|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
83524701|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83524702|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524703|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83524704|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524705|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83524706|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83524707|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83524708|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83524709|NCT00003099|Protective Agents|protective agents|mesh-ancestor
83524710|NCT00003105|Paclitaxel|paclitaxel|mesh-list
83524711|NCT00003105|Gemcitabine|gemcitabine|mesh-list
83524712|NCT00003105|Doxorubicin|doxorubicin|mesh-list
83524713|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83524714|NCT00003105|Ifosfamide|ifosfamide|mesh-list
83524715|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524716|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524717|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524718|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524719|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524720|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524721|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524722|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
83524723|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83524724|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524725|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524726|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524727|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83524728|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
83524729|NCT00003111|Paclitaxel|paclitaxel|mesh-list
83524730|NCT00003111|Carboplatin|carboplatin|mesh-list
83524731|NCT00003111|Irinotecan|irinotecan|mesh-list
83524732|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524733|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524734|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524735|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524736|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524737|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524738|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83524739|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524740|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524741|NCT05709301|Donepezil|donepezil|mesh-list
83524742|NCT05709301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83524743|NCT05709301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524744|NCT05709301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524745|NCT05709301|Cholinergic Agents|cholinergic agents|mesh-ancestor
83524746|NCT05709301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83524747|NCT05709301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524748|NCT05709301|Nootropic Agents|nootropic agents|mesh-ancestor
83524749|NCT00003117|Paclitaxel|paclitaxel|mesh-list
83524750|NCT00003117|Carboplatin|carboplatin|mesh-list
83524751|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524752|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524753|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524754|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524755|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524756|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524757|NCT02240329|Capsaicin|capsaicin|mesh-list
83524758|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
83524759|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
83524760|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
83524761|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83524762|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524763|NCT00003123|Amifostine|amifostine|mesh-list
83524764|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83524765|NCT00003123|Protective Agents|protective agents|mesh-ancestor
83524766|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524767|NCT03981523|Benzonidazole|benzonidazole|mesh-list
83524768|NCT03981523|Nifurtimox|nifurtimox|mesh-list
83524769|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524770|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
83524771|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524772|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83524773|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83524774|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83524775|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83524776|NCT03965923|Tenofovir|tenofovir|mesh-list
83524777|NCT03965923|Emtricitabine|emtricitabine|mesh-list
83524778|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83524779|NCT03965923|Dapivirine|dapivirine|mesh-list
83524780|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
83524781|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83524782|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83524783|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83524784|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524785|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524786|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83524787|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83524788|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
83524789|NCT03962725|Ketamine|ketamine|mesh-list
83524790|NCT03962725|Propofol|propofol|mesh-list
83524791|NCT03962725|Anesthetics|anesthetics|mesh-list
83524792|NCT03962725|Rocuronium|rocuronium|mesh-list
83524793|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83524794|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83524795|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83524796|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524797|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83524798|NCT03962725|Analgesics|analgesics|mesh-ancestor
83524799|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
83524800|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83524801|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83524802|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83524803|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83524805|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83524806|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524807|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83524808|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
83524809|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83524810|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83524811|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83524812|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83524813|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83524814|NCT05699473|Calcium, Dietary|calcium, dietary|mesh-list
83524815|NCT05699473|Tetrahydrofolates|tetrahydrofolates|mesh-list
83524816|NCT05699473|Calcium|calcium|mesh-list
83524817|NCT05699473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83524818|NCT05699473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524819|NCT05699473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83524820|NCT05699473|Vitamin B Complex|vitamin b complex|mesh-ancestor
83524821|NCT05699473|Vitamins|vitamins|mesh-ancestor
83524822|NCT05699473|Micronutrients|micronutrients|mesh-ancestor
83524823|NCT02210559|Paclitaxel|paclitaxel|mesh-list
83524824|NCT02210559|Gemcitabine|gemcitabine|mesh-list
83524825|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524826|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524827|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524828|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524829|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524830|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524831|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524832|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
83524833|NCT00003135|Doxorubicin|doxorubicin|mesh-list
83524834|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83524835|NCT00003135|Fluorouracil|fluorouracil|mesh-list
83524836|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83524837|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524838|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524839|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524840|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524841|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524842|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
83524843|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524844|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524845|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
83524846|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524847|NCT03669133|Vitamin E|vitamin e|mesh-list
83524848|NCT03669133|Vitamins|vitamins|mesh-ancestor
83524849|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
83524850|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524851|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
83524852|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524853|NCT03669133|Protective Agents|protective agents|mesh-ancestor
83524854|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
83524855|NCT02114229|Carboplatin|carboplatin|mesh-list
83524856|NCT02114229|Methotrexate|methotrexate|mesh-list
83524857|NCT02114229|Etoposide|etoposide|mesh-list
83524858|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
83524859|NCT02114229|Vincristine|vincristine|mesh-list
83524860|NCT02114229|Topotecan|topotecan|mesh-list
83524861|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524862|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
83524863|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524864|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83524865|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83524866|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
83524867|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524868|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524869|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83524870|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83524871|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
83524872|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83524873|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524874|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
83524875|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
83524876|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524877|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83524878|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83524879|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524880|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524881|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524882|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524883|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524884|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524885|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83524886|NCT03439891|Nivolumab|nivolumab|mesh-list
83524887|NCT03439891|Sorafenib|sorafenib|mesh-list
83524888|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83524889|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524890|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83524891|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524892|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83524893|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524894|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
83524895|NCT00003141|Thiotepa|thiotepa|mesh-list
83524896|NCT00003141|Cisplatin|cisplatin|mesh-list
83524897|NCT00003141|Carboplatin|carboplatin|mesh-list
83524898|NCT00003141|Etoposide|etoposide|mesh-list
83524899|NCT00003141|Vincristine|vincristine|mesh-list
83524900|NCT00003141|Lenograstim|lenograstim|mesh-list
83524901|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83524902|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
83524903|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524904|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83524905|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83524906|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
83524907|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524908|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524909|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83524910|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524911|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83524912|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83524913|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524914|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83524915|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524916|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524917|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524918|NCT04867135|Amikacin|amikacin|mesh-list
83524919|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83524920|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83524921|NCT04860661|Esketamine|esketamine|mesh-list
83524922|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
83524923|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83524924|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83524925|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83524926|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83524927|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83524928|NCT04728217|Factor VIII|factor viii|mesh-list
83524929|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
83524930|NCT04728217|Coagulants|coagulants|mesh-ancestor
83524931|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
83524932|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524933|NCT04581343|Paclitaxel|paclitaxel|mesh-list
83524934|NCT04581343|Gemcitabine|gemcitabine|mesh-list
83524935|NCT04581343|Spartalizumab|spartalizumab|mesh-list
83524936|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83524937|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524938|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
83524939|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524940|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
83524941|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524942|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524943|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
83524944|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83524945|NCT04581343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83524946|NCT01743859|Lenalidomide|lenalidomide|mesh-list
83524947|NCT01743859|Azacitidine|azacitidine|mesh-list
83524948|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
83524949|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524950|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83524951|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83524952|NCT01743859|Growth Substances|growth substances|mesh-ancestor
83524953|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
83524954|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83524955|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524956|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
83524957|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524960|NCT01746043|Modafinil|modafinil|mesh-list
83524961|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83524962|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83524963|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83524964|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524965|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83524966|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83524967|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83524968|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524969|NCT05635903|Diazepam|diazepam|mesh-list
83524970|NCT05635903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83524971|NCT05635903|Anticonvulsants|anticonvulsants|mesh-ancestor
83524972|NCT05635903|Antiemetics|antiemetics|mesh-ancestor
83524973|NCT05635903|Autonomic Agents|autonomic agents|mesh-ancestor
83524974|NCT05635903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83524975|NCT05635903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524976|NCT05635903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83524977|NCT05635903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83524978|NCT05635903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83524979|NCT05635903|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83524980|NCT05635903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83524981|NCT05635903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83524982|NCT05635903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83524983|NCT05635903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83524984|NCT05635903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83524985|NCT05635903|Anesthetics, General|anesthetics, general|mesh-ancestor
83524986|NCT05635903|Anesthetics|anesthetics|mesh-ancestor
83524987|NCT05635903|GABA Modulators|gaba modulators|mesh-ancestor
83524988|NCT05635903|GABA Agents|gaba agents|mesh-ancestor
83524989|NCT05635903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83524990|NCT05635903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524991|NCT01746511|Glycerol|glycerol|mesh-list
83524992|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83524993|NCT01746511|Protective Agents|protective agents|mesh-ancestor
83524994|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83524995|NCT01746979|Gemcitabine|gemcitabine|mesh-list
83524996|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83524997|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
83524998|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83524999|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525000|NCT05614453|Tislelizumab|tislelizumab|mesh-list
83525001|NCT05614453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525002|NCT05614453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525003|NCT01754389|Sirolimus|sirolimus|mesh-list
83525004|NCT01754389|Methotrexate|methotrexate|mesh-list
83525005|NCT01754389|Bortezomib|bortezomib|mesh-list
83525006|NCT01754389|Tacrolimus|tacrolimus|mesh-list
83525007|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83525008|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
83525009|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83525010|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525011|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83525012|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
83525013|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525014|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525015|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
83525016|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525017|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83525018|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83525019|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
83525020|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525021|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83525022|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83525023|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83525024|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525025|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83525026|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
83525027|NCT01754623|Gemcitabine|gemcitabine|mesh-list
83525028|NCT01754623|Fluorouracil|fluorouracil|mesh-list
83525029|NCT01754623|Capecitabine|capecitabine|mesh-list
83525030|NCT01754623|Docetaxel|docetaxel|mesh-list
83525032|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
83525033|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525035|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
83525036|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
83525037|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
83525038|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83525039|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
83525040|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525041|NCT01755169|Ketamine|ketamine|mesh-list
83525042|NCT01755169|Analgesics|analgesics|mesh-ancestor
83525043|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
83525044|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525045|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525046|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83525047|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83525048|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
83525049|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
83525050|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525051|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83525052|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83525053|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525054|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525055|NCT01755949|Colchicine|colchicine|mesh-list
83525056|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
83525057|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525058|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
83525059|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
83525060|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
83525061|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525062|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525063|NCT01756885|Varenicline|varenicline|mesh-list
83525064|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83525065|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83525066|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
83525067|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525068|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525069|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525070|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
83525071|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
83525072|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525073|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525074|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525075|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83525076|NCT01760785|Valproic Acid|valproic acid|mesh-list
83525077|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
83525078|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525079|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525080|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
83525081|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525082|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525083|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
83525084|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83525085|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525086|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83525087|NCT04062097|Vitamin K|vitamin k|mesh-list
83525088|NCT04062097|Dabigatran|dabigatran|mesh-list
83525089|NCT04062097|Vitamins|vitamins|mesh-ancestor
83525090|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
83525091|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525092|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
83525093|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83525094|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
83525095|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525096|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525097|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
83525098|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83525099|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83525101|NCT04062097|Coagulants|coagulants|mesh-ancestor
83525103|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525104|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525105|NCT04005079|Ofloxacin|ofloxacin|mesh-list
83525106|NCT04005079|Prednisolone|prednisolone|mesh-list
83525107|NCT04005079|Pilocarpine|pilocarpine|mesh-list
83525108|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525109|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
83525110|NCT04005079|Hormones|hormones|mesh-ancestor
83525111|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525112|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525113|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83525114|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525115|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
83525116|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525117|NCT04005079|Miotics|miotics|mesh-ancestor
83525118|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83525119|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83525120|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
83525121|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525122|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525123|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83525124|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525125|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83525126|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83525127|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83525128|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525129|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83525130|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83525131|NCT01762501|Amlodipine|amlodipine|mesh-list
83525132|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83525133|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83525134|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83525135|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83525136|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525137|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83525138|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525139|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
83525140|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83525141|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83525142|NCT01764607|Sirolimus|sirolimus|mesh-list
83525143|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83525144|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525145|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83525146|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525147|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
83525148|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83525149|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
83525150|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525151|NCT01764685|Topiramate|topiramate|mesh-list
83525152|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
83525153|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83525154|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525155|NCT05115409|Rituximab|rituximab|mesh-list
83525156|NCT05115409|Antibodies|antibodies|mesh-list
83525157|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
83525158|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525159|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525160|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525161|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525162|NCT01766713|Ezetimibe|ezetimibe|mesh-list
83525163|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83525164|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83525165|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
83525166|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525167|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83525168|NCT01767103|Deferiprone|deferiprone|mesh-list
83525169|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83525170|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
83525172|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525173|NCT01769209|Cytarabine|cytarabine|mesh-list
83525174|NCT01769209|Dexamethasone|dexamethasone|mesh-list
83525175|NCT01769209|Doxorubicin|doxorubicin|mesh-list
83525176|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83525177|NCT01769209|Methotrexate|methotrexate|mesh-list
83525178|NCT01769209|Vincristine|vincristine|mesh-list
83525179|NCT01769209|Bortezomib|bortezomib|mesh-list
83525182|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525183|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
83525184|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
83525185|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525186|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525187|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83525188|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
83525189|NCT01769209|Hormones|hormones|mesh-ancestor
83525190|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525191|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83525192|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525193|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83525194|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83525195|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83525196|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525197|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525198|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83525199|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
83525200|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83525201|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83525202|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
83525203|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
83525204|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83525205|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83525206|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
83525207|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525208|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83525209|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
83525210|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525211|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83525212|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
83525213|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
83525214|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
83525215|NCT01769365|Amoxicillin|amoxicillin|mesh-list
83525216|NCT01769365|Metronidazole|metronidazole|mesh-list
83525217|NCT01769365|Clarithromycin|clarithromycin|mesh-list
83525218|NCT01769365|Pantoprazole|pantoprazole|mesh-list
83525219|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83525220|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525221|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83525222|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83525223|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83525224|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525225|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525226|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83525227|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83525228|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83525229|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83525230|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83525231|NCT01771627|Nicotine|nicotine|mesh-list
83525232|NCT01771627|Varenicline|varenicline|mesh-list
83525233|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83525234|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
83525235|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525236|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525237|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83525238|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83525239|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
83525240|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525241|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525242|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
83525243|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
83525244|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525245|NCT03499483|Tenofovir|tenofovir|mesh-list
83525246|NCT03499483|Emtricitabine|emtricitabine|mesh-list
83525247|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83525248|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
83525249|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525250|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83525251|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83525252|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525253|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525254|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83525255|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83525257|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83525258|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
83525259|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525260|NCT01673867|Docetaxel|docetaxel|mesh-list
83525261|NCT01673867|Nivolumab|nivolumab|mesh-list
83525262|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525263|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
83525264|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
83525265|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
83525266|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525267|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525268|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83525269|NCT01777945|Docetaxel|docetaxel|mesh-list
83525270|NCT01777945|Capecitabine|capecitabine|mesh-list
83525271|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525272|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
83525273|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
83525274|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
83525275|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525276|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83525277|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
83525278|NCT03012581|Nivolumab|nivolumab|mesh-list
83525279|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525280|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525281|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83525282|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525283|NCT05473273|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83525284|NCT05473273|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83525285|NCT05473273|Estradiol|estradiol|mesh-list
83525286|NCT05473273|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83525287|NCT05473273|Progesterone|progesterone|mesh-list
83525288|NCT05473273|Estrogens|estrogens|mesh-ancestor
83525289|NCT05473273|Hormones|hormones|mesh-ancestor
83525290|NCT05473273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525291|NCT05473273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525292|NCT05473273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83525293|NCT05473273|Contraceptive Agents|contraceptive agents|mesh-ancestor
83525294|NCT05473273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83525295|NCT05473273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83525296|NCT05473273|Progestins|progestins|mesh-ancestor
83525297|NCT05451043|Paclitaxel|paclitaxel|mesh-list
83525298|NCT05451043|Gemcitabine|gemcitabine|mesh-list
83525299|NCT05451043|Durvalumab|durvalumab|mesh-list
83525300|NCT05451043|Tremelimumab|tremelimumab|mesh-list
83525301|NCT05451043|Propranolol|propranolol|mesh-list
83525302|NCT05451043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83525303|NCT05451043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525304|NCT05451043|Tubulin Modulators|tubulin modulators|mesh-ancestor
83525305|NCT05451043|Antimitotic Agents|antimitotic agents|mesh-ancestor
83525306|NCT05451043|Mitosis Modulators|mitosis modulators|mesh-ancestor
83525307|NCT05451043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525308|NCT05451043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83525309|NCT05451043|Antimetabolites|antimetabolites|mesh-ancestor
83525310|NCT05451043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525311|NCT05451043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83525312|NCT05451043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83525313|NCT05451043|Adrenergic Agents|adrenergic agents|mesh-ancestor
83525314|NCT05451043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525315|NCT05451043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525316|NCT05451043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83525317|NCT05451043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83525318|NCT05451043|Vasodilator Agents|vasodilator agents|mesh-ancestor
83525319|NCT02652169|Amikacin|amikacin|mesh-list
83525320|NCT02652169|Teicoplanin|teicoplanin|mesh-list
83525321|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83525322|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525323|NCT02478775|Cetrorelix|cetrorelix|mesh-list
83525324|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83525325|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
83525326|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83525327|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525328|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
83525329|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525330|NCT01783561|Caffeine|caffeine|mesh-list
83525331|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
83525332|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525333|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83525334|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525335|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83525336|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525337|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83525338|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83525339|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
83525340|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525341|NCT02452931|Leuprolide|leuprolide|mesh-list
83525342|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83525343|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
83525344|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83525345|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525346|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83525347|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525348|NCT04744727|Acetaminophen|acetaminophen|mesh-list
83525349|NCT04744727|Meperidine|meperidine|mesh-list
83525350|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83525351|NCT04744727|Analgesics|analgesics|mesh-ancestor
83525352|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
83525353|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525354|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525355|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
83525356|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83525357|NCT04744727|Narcotics|narcotics|mesh-ancestor
83525358|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525359|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83525360|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
83525361|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
83525362|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525363|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525364|NCT02454179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83525365|NCT02454179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525366|NCT02041533|Paclitaxel|paclitaxel|mesh-list
83525367|NCT02041533|Carboplatin|carboplatin|mesh-list
83525368|NCT02041533|Gemcitabine|gemcitabine|mesh-list
83525369|NCT02041533|Nivolumab|nivolumab|mesh-list
83525370|NCT02041533|Pemetrexed|pemetrexed|mesh-list
83525371|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83525372|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525373|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
83525374|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
83525375|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
83525376|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525377|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83525378|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
83525379|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525380|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83525381|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525382|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83525383|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83525384|NCT02260531|Trastuzumab|trastuzumab|mesh-list
83525385|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525386|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525387|NCT02458235|Azacitidine|azacitidine|mesh-list
83525388|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83525389|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
83525390|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525391|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525392|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525393|NCT02115997|Prednisone|prednisone|mesh-list
83525394|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
83525395|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83525396|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83525397|NCT02115997|Prednisolone|prednisolone|mesh-list
83525398|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
83525399|NCT02115997|Rituximab|rituximab|mesh-list
83525400|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83525401|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
83525402|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525403|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525404|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
83525405|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525406|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525407|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525408|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
83525409|NCT02115997|Hormones|hormones|mesh-ancestor
83525410|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525411|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83525412|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
83525413|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
83525414|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525415|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83525416|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83525417|NCT02115997|Protective Agents|protective agents|mesh-ancestor
83525418|NCT01805323|Dexamethasone|dexamethasone|mesh-list
83525419|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525420|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
83525421|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
83525422|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525423|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525424|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83525425|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
83525426|NCT01805323|Hormones|hormones|mesh-ancestor
83525427|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525428|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83525429|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525430|NCT01641055|Caseins|caseins|mesh-list
83525431|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
83525432|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
83525433|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525434|NCT01788631|Regadenoson|regadenoson|mesh-list
83525435|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83525436|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83525437|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
83525438|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
83525439|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525440|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525441|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525442|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83525443|NCT00907283|Deferiprone|deferiprone|mesh-list
83525444|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83525445|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
83525446|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
83525447|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525448|NCT01789255|Cyclosporine|cyclosporine|mesh-list
83525449|NCT01789255|Methotrexate|methotrexate|mesh-list
83525450|NCT01789255|Vorinostat|vorinostat|mesh-list
83525451|NCT01789255|Tacrolimus|tacrolimus|mesh-list
83525452|NCT01789255|Cyclosporins|cyclosporins|mesh-list
83525453|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83525454|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
83525455|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83525456|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525457|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83525458|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
83525459|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525460|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525461|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
83525462|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525463|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83525464|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83525465|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
83525466|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525467|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83525468|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83525469|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
83525470|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525471|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83525472|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
83525473|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
83525474|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
83525475|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525476|NCT02464163|Coagulants|coagulants|mesh-ancestor
83525477|NCT01808755|Trimethoprim|trimethoprim|mesh-list
83525478|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
83525479|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83525480|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525481|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
83525482|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83525483|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83525484|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83525485|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525486|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525487|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83525488|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83525489|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83525490|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
83525491|NCT02694809|Estrogens|estrogens|mesh-list
83525492|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83525493|NCT02694809|Hormones|hormones|mesh-ancestor
83525494|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525495|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525496|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83525497|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83525498|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
83525499|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83525500|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
83525501|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83525502|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83525503|NCT00568997|Analgesics|analgesics|mesh-ancestor
83525504|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
83525505|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525506|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525507|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525508|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525509|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
83525510|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83525511|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
83525512|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83525513|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525514|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525515|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83525516|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83525517|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83525518|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525519|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525520|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
83525521|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525522|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83525523|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83525524|NCT01790659|Gentamicins|gentamicins|mesh-list
83525525|NCT01790659|Paromomycin|paromomycin|mesh-list
83525526|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83525527|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525528|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83525529|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525530|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525531|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83525532|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83525533|NCT02469701|Nivolumab|nivolumab|mesh-list
83525534|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525535|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525536|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83525537|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525538|NCT01733953|Atorvastatin|atorvastatin|mesh-list
83525539|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83525540|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83525541|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
83525542|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525543|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83525544|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83525545|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525546|NCT00362921|Carmustine|carmustine|mesh-list
83525547|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83525548|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83525549|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
83525550|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525551|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525552|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525553|NCT01734889|Nitisinone|nitisinone|mesh-list
83525554|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525555|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525556|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83525557|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83525562|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83525563|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525564|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83525565|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525566|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525567|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
83525568|NCT01798225|Doxycycline|doxycycline|mesh-list
83525569|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83525570|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525571|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
83525572|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83525573|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83525574|NCT02581085|Tocotrienols|tocotrienols|mesh-list
83525575|NCT02581085|Vitamin E|vitamin e|mesh-list
83525576|NCT02581085|Tocopherols|tocopherols|mesh-list
83525577|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
83525578|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525579|NCT02581085|Protective Agents|protective agents|mesh-ancestor
83525580|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525581|NCT02581085|Vitamins|vitamins|mesh-ancestor
83525582|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
83525583|NCT01800877|Phenylephrine|phenylephrine|mesh-list
83525584|NCT01800877|Dopamine|dopamine|mesh-list
83525585|NCT01800877|Vasopressins|vasopressins|mesh-list
83525586|NCT01800877|Epinephrine|epinephrine|mesh-list
83525587|NCT01800877|Norepinephrine|norepinephrine|mesh-list
83525588|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83525589|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83525590|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83525591|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
83525592|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525593|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525594|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525595|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83525596|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83525597|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
83525598|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525599|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83525600|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
83525601|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
83525602|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
83525603|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83525604|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
83525605|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83525606|NCT01800877|Protective Agents|protective agents|mesh-ancestor
83525607|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
83525608|NCT01800877|Coagulants|coagulants|mesh-ancestor
83525609|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83525610|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
83525611|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
83525612|NCT02471651|Dexamethasone|dexamethasone|mesh-list
83525613|NCT02471651|Ranibizumab|ranibizumab|mesh-list
83525614|NCT02471651|Aflibercept|aflibercept|mesh-list
83525615|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525616|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83525617|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83525618|NCT02471651|Growth Substances|growth substances|mesh-ancestor
83525619|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525620|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
83525621|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525622|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
83525623|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
83525624|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525625|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83525626|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
83525627|NCT02471651|Hormones|hormones|mesh-ancestor
83525628|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525629|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83525630|NCT02477423|Gentamicins|gentamicins|mesh-list
83525631|NCT02477423|Ampicillin|ampicillin|mesh-list
83525632|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83525633|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525634|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83525635|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525636|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525637|NCT00363701|Esomeprazole|esomeprazole|mesh-list
83525638|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83525639|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83525640|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83525642|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525643|NCT04744571|Aspirin|aspirin|mesh-list
83525644|NCT04744571|Metoprolol|metoprolol|mesh-list
83525645|NCT04744571|Clopidogrel|clopidogrel|mesh-list
83525646|NCT04744571|Ticagrelor|ticagrelor|mesh-list
83525647|NCT04744571|Atorvastatin|atorvastatin|mesh-list
83525648|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83525649|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83525650|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83525651|NCT04744571|Analgesics|analgesics|mesh-ancestor
83525652|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
83525653|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525654|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525655|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525656|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525657|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83525658|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83525659|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525660|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83525661|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83525662|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525663|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
83525664|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83525665|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83525666|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
83525667|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83525668|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83525669|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83525670|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83525671|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83525672|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
83525673|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525674|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83525675|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83525676|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
83525677|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
83525678|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83525679|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83525680|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83525681|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
83525682|NCT00363155|KRN 7000|krn 7000|mesh-list
83525683|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83525684|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
83525685|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525686|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525687|NCT02519387|Buprenorphine|buprenorphine|mesh-list
83525688|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83525689|NCT02519387|Narcotics|narcotics|mesh-ancestor
83525690|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525691|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525692|NCT02519387|Analgesics|analgesics|mesh-ancestor
83525693|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
83525694|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525695|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83525696|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83525697|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
83525698|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83525699|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83525700|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
83525701|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525702|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
83525703|NCT02257957|Protective Agents|protective agents|mesh-ancestor
83525704|NCT02524769|Estrogens|estrogens|mesh-list
83525705|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83525706|NCT02524769|Hormones|hormones|mesh-ancestor
83525707|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525708|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525709|NCT02525549|Adapalene|adapalene|mesh-list
83525710|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83525711|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
83525712|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83525713|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83525714|NCT02525549|Analgesics|analgesics|mesh-ancestor
83525715|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
83525716|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525717|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525718|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525719|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525721|NCT01878799|Ledipasvir|ledipasvir|mesh-list
83525722|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
83525723|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525724|NCT02527265|Insulin|insulin|mesh-list
83525725|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83525726|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525727|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83525728|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
83525729|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83525730|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83525731|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83525732|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525733|NCT01804075|Morphine|morphine|mesh-list
83525734|NCT01804075|Methadone|methadone|mesh-list
83525735|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83525736|NCT01804075|Narcotics|narcotics|mesh-ancestor
83525737|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525738|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525739|NCT01804075|Analgesics|analgesics|mesh-ancestor
83525740|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
83525741|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525742|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
83525743|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
83525744|NCT02416193|Vitamin D|vitamin d|mesh-list
83525745|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
83525746|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
83525747|NCT02416193|Vitamins|vitamins|mesh-list
83525748|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
83525749|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525750|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83525751|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83525752|NCT02530151|Clonidine|clonidine|mesh-list
83525753|NCT02530151|Morphine|morphine|mesh-list
83525754|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83525755|NCT02530151|Narcotics|narcotics|mesh-ancestor
83525756|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525757|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525758|NCT02530151|Analgesics|analgesics|mesh-ancestor
83525759|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
83525760|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525761|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83525762|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
83525763|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
83525764|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83525765|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83525766|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83525767|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
83525768|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525769|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525770|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
83525771|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83525772|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83525773|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525774|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
83525775|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
83525776|NCT01804465|Ipilimumab|ipilimumab|mesh-list
83525777|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525778|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525779|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83525780|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525781|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
83525782|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83525783|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83525784|NCT02531321|Estradiol|estradiol|mesh-list
83525785|NCT02531321|Estrogens|estrogens|mesh-ancestor
83525786|NCT02531321|Hormones|hormones|mesh-ancestor
83525787|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525788|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525789|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83525790|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
83525791|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83525792|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83525793|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83525795|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83525796|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83525797|NCT01805089|Melatonin|melatonin|mesh-list
83525798|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
83525799|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525800|NCT01805089|Protective Agents|protective agents|mesh-ancestor
83525801|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525802|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525803|NCT02417129|Rituximab|rituximab|mesh-list
83525804|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525805|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525806|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
83525807|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525808|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525809|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
83525810|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83525811|NCT02417831|Tamsulosin|tamsulosin|mesh-list
83525812|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83525813|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83525814|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83525815|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
83525816|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525817|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525818|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525819|NCT02417831|Urological Agents|urological agents|mesh-ancestor
83525820|NCT02419547|Fentanyl|fentanyl|mesh-list
83525821|NCT02419547|Midazolam|midazolam|mesh-list
83525822|NCT02419547|Propofol|propofol|mesh-list
83525823|NCT02419547|Sevoflurane|sevoflurane|mesh-list
83525824|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83525825|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525826|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525827|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83525828|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
83525829|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
83525830|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83525831|NCT02419547|Narcotics|narcotics|mesh-ancestor
83525832|NCT02419547|Analgesics|analgesics|mesh-ancestor
83525833|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
83525834|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525835|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83525836|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83525837|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83525838|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83525839|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
83525840|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
83525841|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525842|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525843|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83525844|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83525845|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83525846|NCT02533427|Norgestimate|norgestimate|mesh-list
83525847|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83525848|NCT02533427|Estradiol|estradiol|mesh-list
83525849|NCT02533427|Estrogens|estrogens|mesh-ancestor
83525850|NCT02533427|Hormones|hormones|mesh-ancestor
83525851|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525852|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525853|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83525854|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
83525855|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83525856|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83525857|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83525858|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83525859|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83525860|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83525861|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83525862|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83525863|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525864|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
83525865|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
83525866|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
83525867|NCT05328427|Protective Agents|protective agents|mesh-ancestor
83525868|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525869|NCT02533505|Budesonide|budesonide|mesh-list
83525871|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525872|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83525873|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
83525874|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413640|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525875|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525876|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83525877|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
83525878|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
83525879|NCT02533505|Hormones|hormones|mesh-ancestor
83525880|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525881|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83525882|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83525883|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83525884|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
83525885|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525886|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525887|NCT02420015|Bupropion|bupropion|mesh-list
83525888|NCT02420015|Nicotine|nicotine|mesh-list
83525889|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83525890|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
83525891|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525892|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525893|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83525894|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83525895|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
83525896|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525897|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525898|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83525899|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
83525900|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83525901|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83525902|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83525903|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83525904|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
83525905|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83525906|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83525907|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525908|NCT05326867|Lidocaine|lidocaine|mesh-list
83525909|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
83525910|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
83525911|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525912|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525913|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
83525914|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525915|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83525916|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83525917|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83525918|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83525919|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525920|NCT05324995|Celecoxib|celecoxib|mesh-list
83525921|NCT05324995|Epinephrine|epinephrine|mesh-list
83525922|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83525923|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83525924|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
83525925|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525926|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525927|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525928|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83525929|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83525930|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
83525931|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525932|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83525933|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
83525934|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
83525935|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
83525936|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83525937|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83525938|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83525939|NCT05324995|Analgesics|analgesics|mesh-ancestor
83525940|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
83525941|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525942|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525943|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83525944|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83525945|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525946|NCT05318521|Ibuprofen|ibuprofen|mesh-list
83525947|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83525948|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83525949|NCT05318521|Analgesics|analgesics|mesh-ancestor
83525950|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
83525951|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525952|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525953|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83525954|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83525955|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83525956|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525957|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525958|NCT02420873|Maytansine|maytansine|mesh-list
83525959|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
83525960|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83525961|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525962|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
83525963|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
83525964|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
83525965|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525966|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83525967|NCT02420873|Immunotoxins|immunotoxins|mesh-ancestor
83525968|NCT02420873|Immunoconjugates|immunoconjugates|mesh-ancestor
83525969|NCT02420873|Immunologic Factors|immunologic factors|mesh-ancestor
83525970|NCT02420873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525971|NCT02534129|Petrolatum|petrolatum|mesh-list
83525972|NCT02534129|Emollients|emollients|mesh-ancestor
83525973|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
83525974|NCT02420951|Bupivacaine|bupivacaine|mesh-list
83525975|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
83525976|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
83525977|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525978|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83525979|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
83525980|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525981|NCT02267083|Doxorubicin|doxorubicin|mesh-list
83525982|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83525983|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83525984|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83525985|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83525986|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525987|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525988|NCT05748145|Metronidazole|metronidazole|mesh-list
83525989|NCT05748145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83525990|NCT05748145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83525991|NCT05748145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83525992|NCT05748145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83525993|NCT02535611|Memantine|memantine|mesh-list
83525994|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83525995|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83525996|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
83525997|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83525998|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83525999|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526000|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83526001|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83526002|NCT01823497|Morphine|morphine|mesh-list
83526003|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83526004|NCT01823497|Narcotics|narcotics|mesh-ancestor
83526005|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526006|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526007|NCT01823497|Analgesics|analgesics|mesh-ancestor
83526008|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
83526009|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526010|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
83526011|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83526012|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526013|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526014|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83526015|NCT00363935|Analgesics|analgesics|mesh-ancestor
83526016|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
83526017|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526018|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83526019|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83526020|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83526021|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
83526022|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526023|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526024|NCT05747521|Doxorubicin|doxorubicin|mesh-list
83526025|NCT05747521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83526026|NCT05747521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83526027|NCT05747521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526028|NCT05747521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83526029|NCT05747521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83526030|NCT05747521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526031|NCT05747521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526032|NCT02537873|Cocaine|cocaine|mesh-list
83526033|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
83526034|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
83526035|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526036|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526037|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
83526038|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526039|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83526040|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83526041|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83526042|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83526043|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526044|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
83526045|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526046|NCT02537951|Lidocaine|lidocaine|mesh-list
83526047|NCT02537951|Prilocaine|prilocaine|mesh-list
83526048|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83526049|NCT02537951|Capsaicin|capsaicin|mesh-list
83526050|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
83526051|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
83526052|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526053|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526054|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
83526055|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526056|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83526057|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83526058|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83526059|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83526060|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526061|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
83526062|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
83526063|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83526064|NCT02487485|Sirolimus|sirolimus|mesh-list
83526065|NCT02487485|Ketamine|ketamine|mesh-list
83526066|NCT02487485|Analgesics|analgesics|mesh-ancestor
83526067|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
83526068|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526069|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526070|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83526071|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83526072|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
83526073|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
83526074|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526075|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83526076|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83526077|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526078|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526079|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83526080|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526081|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83526082|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526083|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
83526084|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83526085|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
83526086|NCT02487563|Decitabine|decitabine|mesh-list
83526087|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83526088|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
83526089|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526090|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526091|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526393|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
83526092|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83526093|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526094|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526095|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
83526096|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83526097|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526098|NCT02489357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83526099|NCT02489357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526100|NCT02490293|Cephalosporins|cephalosporins|mesh-list
83526101|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83526102|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526103|NCT02539511|Ketamine|ketamine|mesh-list
83526104|NCT02539511|Analgesics|analgesics|mesh-ancestor
83526105|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
83526106|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526107|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526108|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83526109|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83526110|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
83526111|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
83526112|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526113|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83526114|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83526115|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526116|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526117|NCT02493257|Ethanol|ethanol|mesh-list
83526118|NCT02493257|Capsaicin|capsaicin|mesh-list
83526119|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83526120|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526121|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526122|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526123|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
83526124|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
83526125|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
83526126|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526127|NCT02430389|Remifentanil|remifentanil|mesh-list
83526128|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83526129|NCT02430389|Narcotics|narcotics|mesh-ancestor
83526130|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526131|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526132|NCT02430389|Analgesics|analgesics|mesh-ancestor
83526133|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
83526134|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526135|NCT02431637|Piperaquine|piperaquine|mesh-list
83526136|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
83526137|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83526138|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83526139|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526140|NCT02545907|Thalidomide|thalidomide|mesh-list
83526141|NCT02545907|Dexamethasone|dexamethasone|mesh-list
83526142|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526143|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
83526144|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
83526145|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526146|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526147|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83526148|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
83526149|NCT02545907|Hormones|hormones|mesh-ancestor
83526150|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83526151|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83526152|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526153|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83526154|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
83526155|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
83526156|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83526157|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526158|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83526159|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83526160|NCT02545907|Growth Substances|growth substances|mesh-ancestor
83526161|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
83526162|NCT02495831|Diclofenac|diclofenac|mesh-list
83526163|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83526164|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83526165|NCT02495831|Analgesics|analgesics|mesh-ancestor
83526166|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
83526394|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
83526167|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526168|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526169|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526170|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83526171|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83526172|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526173|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526174|NCT02498483|Acetaminophen|acetaminophen|mesh-list
83526175|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83526176|NCT02498483|Analgesics|analgesics|mesh-ancestor
83526177|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
83526178|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526179|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526180|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
83526181|NCT02547623|Dexamethasone|dexamethasone|mesh-list
83526182|NCT02547623|Prednisolone|prednisolone|mesh-list
83526183|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526184|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
83526185|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
83526186|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526187|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526188|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83526189|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
83526190|NCT02547623|Hormones|hormones|mesh-ancestor
83526191|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83526192|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83526193|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526194|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
83526195|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83526196|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83526197|NCT00559585|Abatacept|abatacept|mesh-list
83526198|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83526199|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526200|NCT00559585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83526201|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526202|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83526203|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
83526204|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526205|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83526206|NCT01824901|Docetaxel|docetaxel|mesh-list
83526207|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526208|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
83526209|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
83526210|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
83526211|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526212|NCT00559507|Saracatinib|saracatinib|mesh-list
83526213|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526214|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526215|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526216|NCT04969627|Metformin|metformin|mesh-list
83526217|NCT04969627|Exenatide|exenatide|mesh-list
83526218|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83526219|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526220|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83526221|NCT04969627|Incretins|incretins|mesh-ancestor
83526222|NCT04969627|Hormones|hormones|mesh-ancestor
83526223|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83526224|NCT04953325|Vaccines|vaccines|mesh-list
83526225|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83526226|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
83526227|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526228|NCT01826851|Bupivacaine|bupivacaine|mesh-list
83526229|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
83526230|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
83526231|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526232|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526233|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
83526234|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526235|NCT02499497|Androgens|androgens|mesh-list
83526236|NCT02499497|Hormones|hormones|mesh-ancestor
83526237|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83526238|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526239|NCT01827475|Acetaminophen|acetaminophen|mesh-list
83526240|NCT01827475|Ibuprofen|ibuprofen|mesh-list
83526241|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83526242|NCT01827475|Analgesics|analgesics|mesh-ancestor
83526243|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
83526244|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526245|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526246|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
83526247|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83526248|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526249|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83526250|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83526251|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526252|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526253|NCT02434523|Amitriptyline|amitriptyline|mesh-list
83526254|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83526255|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
83526256|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83526257|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83526258|NCT02434523|Analgesics|analgesics|mesh-ancestor
83526259|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
83526260|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526261|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526262|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83526263|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83526264|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83526265|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526266|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
83526267|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526268|NCT02501135|Bupivacaine|bupivacaine|mesh-list
83526269|NCT02501135|Ropivacaine|ropivacaine|mesh-list
83526270|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
83526271|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
83526272|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526273|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526274|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
83526275|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526276|NCT02550743|Capecitabine|capecitabine|mesh-list
83526277|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83526278|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
83526279|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526280|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526281|NCT02437253|Adalimumab|adalimumab|mesh-list
83526282|NCT02437253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83526283|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526284|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83526285|NCT01829503|Cytarabine|cytarabine|mesh-list
83526286|NCT01829503|Decitabine|decitabine|mesh-list
83526287|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83526288|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
83526289|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526290|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526291|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
83526292|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526293|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83526294|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
83526295|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526296|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526297|NCT04654507|Dexamethasone|dexamethasone|mesh-list
83526298|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526299|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
83526300|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
83526301|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526302|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526303|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83526304|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
83526305|NCT04654507|Hormones|hormones|mesh-ancestor
83526306|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83526307|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83526308|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526309|NCT05742763|Acetaminophen|acetaminophen|mesh-list
83526310|NCT05742763|Ibuprofen|ibuprofen|mesh-list
83526311|NCT05742763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83526312|NCT05742763|Analgesics|analgesics|mesh-ancestor
83526313|NCT05742763|Sensory System Agents|sensory system agents|mesh-ancestor
83526314|NCT05742763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526315|NCT05742763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526316|NCT05742763|Antipyretics|antipyretics|mesh-ancestor
83526317|NCT05742763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83526318|NCT05742763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526319|NCT05742763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83526320|NCT05742763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83526321|NCT05742763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526322|NCT05742763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526323|NCT02504723|Carvedilol|carvedilol|mesh-list
83526324|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83526325|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83526326|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
83526327|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526328|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526329|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526330|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83526331|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
83526332|NCT02504723|Protective Agents|protective agents|mesh-ancestor
83526333|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83526334|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83526335|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83526336|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
83526337|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83526338|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83526339|NCT02439281|Clonidine|clonidine|mesh-list
83526340|NCT02439281|Ropivacaine|ropivacaine|mesh-list
83526341|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
83526342|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
83526343|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526344|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526345|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
83526346|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526347|NCT02439281|Analgesics|analgesics|mesh-ancestor
83526348|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83526349|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
83526350|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
83526351|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83526352|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83526353|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83526354|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
83526355|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526356|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526357|NCT02505269|Doxorubicin|doxorubicin|mesh-list
83526358|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83526359|NCT02505269|Dacarbazine|dacarbazine|mesh-list
83526360|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83526361|NCT02505269|Imidazole|imidazole|mesh-list
83526362|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83526363|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526364|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83526365|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83526366|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526367|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526368|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83526369|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
83526370|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83526371|NCT02505269|Immunotoxins|immunotoxins|mesh-ancestor
83526372|NCT02505269|Immunoconjugates|immunoconjugates|mesh-ancestor
83526373|NCT02505269|Immunologic Factors|immunologic factors|mesh-ancestor
83526374|NCT02505269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526375|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83526376|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
83526377|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83526378|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83526379|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83526380|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526381|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526382|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
83526383|NCT00559273|Hematinics|hematinics|mesh-ancestor
83526384|NCT02506673|Midazolam|midazolam|mesh-list
83526385|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83526386|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83526387|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526388|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526389|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83526390|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83526391|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83526392|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83526397|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526398|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526399|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
83526400|NCT02508077|Leucovorin|leucovorin|mesh-list
83526401|NCT02508077|Folic Acid|folic acid|mesh-list
83526402|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83526403|NCT02508077|Panitumumab|panitumumab|mesh-list
83526404|NCT02508077|Fluorouracil|fluorouracil|mesh-list
83526405|NCT02508077|Irinotecan|irinotecan|mesh-list
83526406|NCT02508077|Camptothecin|camptothecin|mesh-list
83526407|NCT02508077|Antibodies|antibodies|mesh-list
83526408|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
83526409|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83526410|NCT02508077|Calcium|calcium|mesh-list
83526411|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
83526412|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
83526413|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526414|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526415|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83526416|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83526417|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
83526418|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526419|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83526420|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83526421|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83526422|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83526423|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526424|NCT02508077|Antidotes|antidotes|mesh-ancestor
83526425|NCT02508077|Protective Agents|protective agents|mesh-ancestor
83526426|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
83526427|NCT02508077|Vitamins|vitamins|mesh-ancestor
83526428|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
83526429|NCT02508077|Hematinics|hematinics|mesh-ancestor
83526430|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83526431|NCT00558259|Dabigatran|dabigatran|mesh-list
83526432|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
83526433|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83526434|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
83526435|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526436|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526437|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
83526438|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
83526439|NCT02508389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83526440|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
83526441|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526442|NCT02508389|Protective Agents|protective agents|mesh-ancestor
83526443|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526444|NCT02509481|Ivermectin|ivermectin|mesh-list
83526445|NCT02509481|Albendazole|albendazole|mesh-list
83526446|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83526447|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526448|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
83526449|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
83526450|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83526451|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83526452|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
83526453|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
83526454|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
83526455|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526456|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526458|NCT04341077|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83526459|NCT04341077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526460|NCT04341077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526461|NCT04341077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526462|NCT02561897|Warfarin|warfarin|mesh-list
83526463|NCT02561897|Edoxaban|edoxaban|mesh-list
83526464|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
83526465|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83526466|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
83526467|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83526468|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
83526469|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526470|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526471|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
83526472|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83526473|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
83526474|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526475|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83526476|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83526477|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
83526478|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526479|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526480|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83526481|NCT02562521|Nicotine|nicotine|mesh-list
83526482|NCT02562521|Varenicline|varenicline|mesh-list
83526483|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83526484|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
83526485|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526486|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526487|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83526488|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83526489|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
83526490|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526491|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526492|NCT02562755|Sorafenib|sorafenib|mesh-list
83526493|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526494|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83526495|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526496|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526497|NCT05446883|Paclitaxel|paclitaxel|mesh-list
83526498|NCT05446883|Carboplatin|carboplatin|mesh-list
83526499|NCT05446883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83526500|NCT05446883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526501|NCT05446883|Tubulin Modulators|tubulin modulators|mesh-ancestor
83526502|NCT05446883|Antimitotic Agents|antimitotic agents|mesh-ancestor
83526503|NCT05446883|Mitosis Modulators|mitosis modulators|mesh-ancestor
83526504|NCT05446883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526505|NCT00363857|Ropinirole|ropinirole|mesh-list
83526506|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83526507|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83526508|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
83526509|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
83526510|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526511|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526512|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526513|NCT04563923|Avdoralimab|avdoralimab|mesh-list
83526514|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526515|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
83526516|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526517|NCT00558103|Lapatinib|lapatinib|mesh-list
83526518|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526519|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83526520|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526521|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526522|NCT02974361|Ibuprofen|ibuprofen|mesh-list
83526523|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83526524|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83526525|NCT02974361|Analgesics|analgesics|mesh-ancestor
83526526|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
83526527|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526528|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526529|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526530|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83526531|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83526532|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526533|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526534|NCT05690815|Tenofovir|tenofovir|mesh-list
83526535|NCT05690815|Emtricitabine|emtricitabine|mesh-list
83526536|NCT05690815|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83526537|NCT05690815|Antiviral Agents|antiviral agents|mesh-ancestor
83526538|NCT05690815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526539|NCT05690815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83526540|NCT05690815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83526541|NCT05690815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526542|NCT05690815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526543|NCT05690815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83526544|NCT05690815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83526545|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
83526546|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83526547|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526548|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83526549|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526848|NCT02596451|Diclofenac|diclofenac|mesh-list
83526550|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526551|NCT04477733|Butorphanol|butorphanol|mesh-list
83526552|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83526553|NCT04477733|Narcotics|narcotics|mesh-ancestor
83526554|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526555|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526556|NCT04477733|Analgesics|analgesics|mesh-ancestor
83526557|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
83526558|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526559|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
83526560|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
83526561|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83526562|NCT00558025|Pramipexole|pramipexole|mesh-list
83526563|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
83526564|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526565|NCT00558025|Protective Agents|protective agents|mesh-ancestor
83526566|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526567|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83526568|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83526569|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
83526570|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
83526571|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526572|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
83526573|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83526574|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83526575|NCT02576249|Prednisolone|prednisolone|mesh-list
83526576|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
83526577|NCT02576249|Ropivacaine|ropivacaine|mesh-list
83526578|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83526579|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
83526580|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
83526581|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
83526582|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526583|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526584|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
83526585|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526586|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526587|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
83526588|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
83526589|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83526590|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
83526591|NCT02576249|Hormones|hormones|mesh-ancestor
83526592|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83526593|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83526594|NCT02576249|Protective Agents|protective agents|mesh-ancestor
83526595|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83526596|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526597|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
83526598|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83526599|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526600|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83526601|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83526602|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526603|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526604|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526605|NCT01834261|Oxytocin|oxytocin|mesh-list
83526606|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
83526607|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83526608|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526609|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
83526610|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83526611|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83526612|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526613|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
83526614|NCT02578901|Coagulants|coagulants|mesh-ancestor
83526615|NCT02579057|Furosemide|furosemide|mesh-list
83526616|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83526617|NCT02579057|Diuretics|diuretics|mesh-ancestor
83526618|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
83526619|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526620|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83526621|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83526622|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526623|NCT00557245|Tenofovir|tenofovir|mesh-list
83526624|NCT00557245|Emtricitabine|emtricitabine|mesh-list
83526773|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83413641|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526625|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83526626|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
83526627|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526628|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83526629|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83526630|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526631|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526632|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83526633|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83526634|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83526635|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83526636|NCT04743011|Heparin|heparin|mesh-list
83526637|NCT04743011|Calcium heparin|calcium heparin|mesh-list
83526638|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83526639|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
83526640|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83526641|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83526642|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526643|NCT03528941|Lamivudine|lamivudine|mesh-list
83526644|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83526645|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83526646|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526647|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526648|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
83526649|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526650|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83526651|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83526652|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83526653|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526654|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83526655|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526656|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526657|NCT00365183|Pemetrexed|pemetrexed|mesh-list
83526658|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
83526659|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526660|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526661|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526662|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83526663|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83526664|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83526665|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
83526666|NCT01837069|Metoprolol|metoprolol|mesh-list
83526667|NCT01837069|Lisinopril|lisinopril|mesh-list
83526668|NCT01837069|Atorvastatin|atorvastatin|mesh-list
83526669|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83526670|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83526671|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83526672|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
83526673|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526674|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83526675|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83526676|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526677|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83526678|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83526679|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
83526680|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
83526681|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526682|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526683|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83526684|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83526685|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83526686|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
83526687|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526688|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
83526689|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83526690|NCT01837069|Protective Agents|protective agents|mesh-ancestor
83526691|NCT02289690|Carboplatin|carboplatin|mesh-list
83526692|NCT02289690|Etoposide|etoposide|mesh-list
83526693|NCT02289690|Veliparib|veliparib|mesh-list
83526694|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526695|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83526696|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83526697|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83526698|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526699|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526700|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83526702|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83526703|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83526704|NCT02268955|Analgesics|analgesics|mesh-ancestor
83526705|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
83526706|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526707|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526708|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526709|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83526710|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83526711|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526712|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526713|NCT02585843|Spironolactone|spironolactone|mesh-list
83526714|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83526715|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
83526716|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83526717|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526718|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83526719|NCT02585843|Diuretics|diuretics|mesh-ancestor
83526720|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
83526721|NCT01838317|Pioglitazone|pioglitazone|mesh-list
83526722|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83526723|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526724|NCT05249231|Fluorides|fluorides|mesh-list
83526725|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
83526726|NCT05249231|Protective Agents|protective agents|mesh-ancestor
83526727|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526728|NCT05249153|Sufentanil|sufentanil|mesh-list
83526729|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
83526730|NCT05249153|Dsuvia|dsuvia|mesh-list
83526731|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83526732|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526733|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526734|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83526735|NCT05249153|Analgesics|analgesics|mesh-ancestor
83526736|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
83526737|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526738|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83526739|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83526740|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83526741|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
83526742|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526743|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526744|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83526745|NCT05249153|Narcotics|narcotics|mesh-ancestor
83526746|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83526747|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83526748|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
83526749|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
83526750|NCT02961257|Prednisone|prednisone|mesh-list
83526751|NCT02961257|Lenograstim|lenograstim|mesh-list
83526752|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526753|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
83526754|NCT02961257|Hormones|hormones|mesh-ancestor
83526755|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83526756|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526757|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83526758|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526759|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83526760|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
83526761|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
83526762|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83526763|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83526764|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526765|NCT02989519|Progesterone|progesterone|mesh-list
83526766|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
83526767|NCT02989519|Progestins|progestins|mesh-ancestor
83526768|NCT02989519|Hormones|hormones|mesh-ancestor
83526769|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83526770|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526771|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83526772|NCT02429375|Mocetinostat|mocetinostat|mesh-list
83526774|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526775|NCT02429375|Immunotoxins|immunotoxins|mesh-ancestor
83526776|NCT02429375|Immunoconjugates|immunoconjugates|mesh-ancestor
83526777|NCT02429375|Immunologic Factors|immunologic factors|mesh-ancestor
83526778|NCT02429375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526779|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83526780|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526781|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526782|NCT02289456|Paclitaxel|paclitaxel|mesh-list
83526783|NCT02289456|Carboplatin|carboplatin|mesh-list
83526784|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83526785|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526786|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
83526787|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
83526788|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
83526789|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526790|NCT02589977|Regadenoson|regadenoson|mesh-list
83526791|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83526792|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83526793|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
83526794|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
83526795|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526796|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526797|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526798|NCT02274948|Metformin|metformin|mesh-list
83526799|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83526800|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526801|NCT02274792|Etanercept|etanercept|mesh-list
83526802|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83526803|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83526804|NCT02274792|Analgesics|analgesics|mesh-ancestor
83526805|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
83526806|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526807|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526808|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526809|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83526810|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83526811|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83526812|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
83526813|NCT05432466|Celiprolol|celiprolol|mesh-list
83526814|NCT05432466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83526815|NCT05432466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83526816|NCT05432466|Sympathomimetics|sympathomimetics|mesh-ancestor
83526817|NCT05432466|Autonomic Agents|autonomic agents|mesh-ancestor
83526818|NCT05432466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526819|NCT05432466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526820|NCT05432466|Vasodilator Agents|vasodilator agents|mesh-ancestor
83526821|NCT05432466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83526822|NCT05432466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83526823|NCT05432466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83526824|NCT05432466|Adrenergic Agents|adrenergic agents|mesh-ancestor
83526825|NCT05432466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526826|NCT05432466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526827|NCT02592629|Triamcinolone|triamcinolone|mesh-list
83526828|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83526829|NCT02592629|Lidocaine|lidocaine|mesh-list
83526830|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
83526831|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
83526832|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
83526833|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526834|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526835|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
83526836|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526837|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83526838|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83526839|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83526840|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83526841|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526842|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526843|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
83526844|NCT02592629|Hormones|hormones|mesh-ancestor
83526845|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83526846|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83526847|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
83526849|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83526850|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83526851|NCT02596451|Analgesics|analgesics|mesh-ancestor
83526852|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
83526853|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526854|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526855|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526856|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83526857|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83526858|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526859|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526860|NCT01839799|Paclitaxel|paclitaxel|mesh-list
83526861|NCT01839799|Gemcitabine|gemcitabine|mesh-list
83526862|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83526863|NCT01839799|Folfirinox|folfirinox|mesh-list
83526864|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83526865|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526866|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
83526867|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
83526868|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
83526869|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526870|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83526871|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
83526872|NCT03062059|Gemcitabine|gemcitabine|mesh-list
83526873|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83526874|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
83526875|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526876|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526877|NCT02597543|Regadenoson|regadenoson|mesh-list
83526878|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83526879|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83526880|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
83526881|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
83526882|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526883|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526884|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526885|NCT00553501|Rituximab|rituximab|mesh-list
83526886|NCT00553501|Epratuzumab|epratuzumab|mesh-list
83526887|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83526888|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526889|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
83526890|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526891|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83526892|NCT02599649|Nivolumab|nivolumab|mesh-list
83526893|NCT02599649|Azacitidine|azacitidine|mesh-list
83526894|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83526895|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83526896|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83526897|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526898|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83526899|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
83526900|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526901|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
83526902|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83526903|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
83526904|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526905|NCT01840345|Expectorants|expectorants|mesh-ancestor
83526906|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
83526907|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83526908|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
83526909|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526910|NCT01840345|Protective Agents|protective agents|mesh-ancestor
83526911|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526912|NCT01840345|Antidotes|antidotes|mesh-ancestor
83526913|NCT00364481|Omeprazole|omeprazole|mesh-list
83526914|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83526915|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83526916|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83526917|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526918|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526919|NCT02601833|Fluorides|fluorides|mesh-list
83526920|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
83526921|NCT02601833|Protective Agents|protective agents|mesh-ancestor
83526922|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526923|NCT00553267|Amlodipine|amlodipine|mesh-list
83526924|NCT00553267|Telmisartan|telmisartan|mesh-list
83526925|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83526926|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83526927|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83526928|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83526929|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526930|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83526931|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526932|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
83526933|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83526934|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83526935|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83526936|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83526937|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83526938|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
83526939|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526940|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83526941|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83526942|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526943|NCT02271984|Praziquantel|praziquantel|mesh-list
83526944|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
83526945|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83526946|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526947|NCT02604173|Budesonide|budesonide|mesh-list
83526948|NCT02604173|Acetazolamide|acetazolamide|mesh-list
83526949|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83526950|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83526951|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
83526952|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83526953|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526954|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83526955|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
83526956|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
83526957|NCT02604173|Hormones|hormones|mesh-ancestor
83526958|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83526959|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
83526960|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83526961|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526962|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526963|NCT02604173|Diuretics|diuretics|mesh-ancestor
83526964|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
83526965|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83526966|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83526967|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83526968|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83526969|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526970|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
83526971|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83526972|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526973|NCT00365339|Ritonavir|ritonavir|mesh-list
83526974|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83526975|NCT00365339|Tenofovir|tenofovir|mesh-list
83526976|NCT00365339|Aripiprazole|aripiprazole|mesh-list
83526977|NCT00365339|Famotidine|famotidine|mesh-list
83526978|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83526979|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83526980|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
83526981|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83526982|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83526983|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83526984|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83526985|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
83526986|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83526987|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83526988|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83526989|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83526990|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83526991|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
83526992|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83526993|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83526994|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83526995|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83526996|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83526997|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
83526998|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
83526999|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527000|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83527001|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83527002|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
83527003|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83527004|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83527005|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83527006|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83527007|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83527008|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83527009|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83527010|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
83527011|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
83527012|NCT02815033|Choline|choline|mesh-list
83527013|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
83527014|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83527015|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
83527016|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527017|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83527018|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83527019|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
83527020|NCT00366119|Ramipril|ramipril|mesh-list
83527021|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83527022|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
83527023|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527024|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527025|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83527026|NCT05371301|Paclitaxel|paclitaxel|mesh-list
83527027|NCT05371301|Carboplatin|carboplatin|mesh-list
83527028|NCT05371301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83527029|NCT05371301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527030|NCT05371301|Tubulin Modulators|tubulin modulators|mesh-ancestor
83527031|NCT05371301|Antimitotic Agents|antimitotic agents|mesh-ancestor
83527032|NCT05371301|Mitosis Modulators|mitosis modulators|mesh-ancestor
83527033|NCT05371301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527034|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
83527035|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
83527036|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527037|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83527038|NCT02605187|Acetaminophen|acetaminophen|mesh-list
83527039|NCT02605187|Ibuprofen|ibuprofen|mesh-list
83527040|NCT02605187|Morphine|morphine|mesh-list
83527041|NCT02605187|Gabapentin|gabapentin|mesh-list
83527042|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83527043|NCT02605187|Narcotics|narcotics|mesh-ancestor
83527044|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527045|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527046|NCT02605187|Analgesics|analgesics|mesh-ancestor
83527047|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
83527048|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527049|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83527051|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83527052|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83527053|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527054|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83527055|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527056|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527057|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
83527058|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83527059|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83527060|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83527061|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83527062|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83527063|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527064|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
83527065|NCT05592197|Lenvatinib|lenvatinib|mesh-list
83527066|NCT05592197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527067|NCT05592197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83527068|NCT05592197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527069|NCT05592197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527070|NCT02989207|Mitomycins|mitomycins|mesh-list
83527071|NCT02989207|Mitomycin|mitomycin|mesh-list
83527072|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83527073|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527074|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
83527075|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527076|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83527077|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527079|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83527080|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83527081|NCT02647099|Analgesics|analgesics|mesh-ancestor
83527082|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
83527083|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527084|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527085|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83527086|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527087|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83527088|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83527089|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527090|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83527091|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83527092|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527093|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
83527094|NCT01843621|Vaccines|vaccines|mesh-list
83527095|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
83527096|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527097|NCT02608229|Paclitaxel|paclitaxel|mesh-list
83527098|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83527099|NCT02608229|Gemcitabine|gemcitabine|mesh-list
83527100|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83527101|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527102|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
83527103|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
83527104|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
83527105|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527106|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83527107|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
83527108|NCT00555061|Retapamulin|retapamulin|mesh-list
83527109|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83527110|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527111|NCT01642212|Budesonide|budesonide|mesh-list
83527112|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83527113|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83527114|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
83527115|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527116|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527117|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83527118|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
83527119|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
83527120|NCT01642212|Hormones|hormones|mesh-ancestor
83527121|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83527122|NCT05649618|Cyclophosphamide|cyclophosphamide|mesh-list
83527123|NCT05649618|Fludarabine|fludarabine|mesh-list
83527124|NCT05649618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83527125|NCT05649618|Immunologic Factors|immunologic factors|mesh-ancestor
83527126|NCT05649618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527127|NCT05649618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527128|NCT05649618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83527129|NCT05649618|Alkylating Agents|alkylating agents|mesh-ancestor
83527130|NCT05649618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527131|NCT05649618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527132|NCT05649618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83527133|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83527134|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83527135|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83527136|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83527137|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527138|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527139|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527140|NCT00552175|Analgesics|analgesics|mesh-ancestor
83527141|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
83527142|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527143|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
83527149|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83527150|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83527151|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
83527152|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527153|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83527154|NCT01644474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83527155|NCT01644474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83527156|NCT01644474|Protease Inhibitors|protease inhibitors|mesh-ancestor
83527157|NCT01644474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527158|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
83527159|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527161|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
83527162|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527163|NCT02989129|Protective Agents|protective agents|mesh-ancestor
83527164|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527165|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
83527166|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83527167|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83527168|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527169|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
83527170|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527171|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527172|NCT01847131|Phenylephrine|phenylephrine|mesh-list
83527173|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
83527174|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83527175|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83527176|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
83527177|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527178|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527179|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527180|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
83527181|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
83527182|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527183|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
83527184|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83527185|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
83527186|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83527187|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
83527188|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83527189|NCT01847131|Protective Agents|protective agents|mesh-ancestor
83527190|NCT02285010|Pregabalin|pregabalin|mesh-list
83527191|NCT02285010|Analgesics|analgesics|mesh-ancestor
83527192|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
83527193|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527194|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527195|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
83527196|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83527197|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83527198|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527199|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83527200|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83527201|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83527202|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527203|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83527204|NCT02617667|Cyclosporine|cyclosporine|mesh-list
83527205|NCT02617667|Cyclosporins|cyclosporins|mesh-list
83527206|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527207|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527208|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83527209|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
83527210|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527211|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
83527212|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527213|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
83527214|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527215|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83527216|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
83527217|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83527218|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
83527219|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527220|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527221|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83527222|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
83527223|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83527224|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
83527225|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527226|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527227|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83527228|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
83527229|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
83527230|NCT03023449|Protective Agents|protective agents|mesh-ancestor
83527231|NCT01848067|Prednisone|prednisone|mesh-list
83527232|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
83527233|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83527234|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
83527235|NCT01848067|Hormones|hormones|mesh-ancestor
83527236|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83527237|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527238|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83527239|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527240|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83527241|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527242|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527243|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
83527244|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83527245|NCT05731973|Sufentanil|sufentanil|mesh-list
83527246|NCT05731973|Oxycodone|oxycodone|mesh-list
83527247|NCT05731973|Analgesics, Opioid|analgesics, opioid|mesh-list
83527248|NCT05731973|Bupivacaine|bupivacaine|mesh-list
83527249|NCT05731973|Anesthetics, Local|anesthetics, local|mesh-ancestor
83527250|NCT05731973|Anesthetics|anesthetics|mesh-ancestor
83527251|NCT05731973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527252|NCT05731973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527253|NCT05731973|Sensory System Agents|sensory system agents|mesh-ancestor
83527254|NCT05731973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527255|NCT05731973|Narcotics|narcotics|mesh-ancestor
83527256|NCT05731973|Analgesics|analgesics|mesh-ancestor
83527257|NCT05731973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83527258|NCT05731973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83527259|NCT05731973|Anesthetics, General|anesthetics, general|mesh-ancestor
83527260|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
83527261|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83527262|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83527263|NCT05068349|Protective Agents|protective agents|mesh-ancestor
83527264|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527265|NCT05452577|Estazolam|estazolam|mesh-list
83527266|NCT05452577|Anticonvulsants|anticonvulsants|mesh-ancestor
83527267|NCT05452577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83527268|NCT05452577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83527269|NCT05452577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527270|NCT05452577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527271|NCT05452577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83527272|NCT05452577|GABA Modulators|gaba modulators|mesh-ancestor
83527273|NCT05452577|GABA Agents|gaba agents|mesh-ancestor
83527274|NCT05452577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527275|NCT05452577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527276|NCT05464615|Amoxicillin|amoxicillin|mesh-list
83527277|NCT05464615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83527278|NCT05464615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527279|NCT00364871|Naltrexone|naltrexone|mesh-list
83527280|NCT00364871|Bupropion|bupropion|mesh-list
83527281|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83527282|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83527283|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527284|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
83527285|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527286|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83527287|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
83527288|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83527289|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83527290|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83527291|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83527292|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527293|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
83527294|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527295|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83527296|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83527300|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83527301|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
83527302|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527303|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527304|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527305|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83527306|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83527307|NCT00550771|Paclitaxel|paclitaxel|mesh-list
83527308|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83527309|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
83527310|NCT00550771|Doxorubicin|doxorubicin|mesh-list
83527311|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83527312|NCT00550771|Trastuzumab|trastuzumab|mesh-list
83527313|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83527314|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527315|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
83527316|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
83527317|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
83527318|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527319|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83527320|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
83527321|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527322|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527323|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83527324|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
83527325|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83527326|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83527327|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83527328|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83527329|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527330|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527331|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83527332|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83527333|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83527334|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527335|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527336|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83527337|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83527338|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527339|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
83527340|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527341|NCT01852669|Furosemide|furosemide|mesh-list
83527342|NCT01852669|Diuretics|diuretics|mesh-ancestor
83527343|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
83527344|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527345|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83527346|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83527347|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527349|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83527350|NCT04741295|Tinzaparin|tinzaparin|mesh-list
83527351|NCT04741295|Dalteparin|dalteparin|mesh-list
83527352|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
83527353|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83527354|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83527355|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527356|NCT00550537|Paclitaxel|paclitaxel|mesh-list
83527357|NCT00550537|Bevacizumab|bevacizumab|mesh-list
83527358|NCT00550537|Carboplatin|carboplatin|mesh-list
83527359|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83527360|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83527361|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527362|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
83527363|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
83527364|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
83527365|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527366|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527367|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83527368|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83527369|NCT00550537|Growth Substances|growth substances|mesh-ancestor
83527370|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527371|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
83527372|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83527373|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527374|NCT04801043|Imipenem|imipenem|mesh-list
83527376|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83527377|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527378|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
83527379|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527380|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527381|NCT05706701|Nicotine|nicotine|mesh-list
83527382|NCT05706701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83527383|NCT05706701|Autonomic Agents|autonomic agents|mesh-ancestor
83527384|NCT05706701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527385|NCT05706701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527386|NCT05706701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83527387|NCT05706701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83527388|NCT05706701|Cholinergic Agents|cholinergic agents|mesh-ancestor
83527389|NCT05706701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527390|NCT05706701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527391|NCT04734197|Cyclosporine|cyclosporine|mesh-list
83527392|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
83527393|NCT04734197|Betamethasone|betamethasone|mesh-list
83527394|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
83527395|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83527396|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
83527397|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83527398|NCT04734197|Lifitegrast|lifitegrast|mesh-list
83527399|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83527400|NCT04734197|Cyclosporins|cyclosporins|mesh-list
83527401|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83527402|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527403|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527404|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83527405|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
83527406|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527407|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
83527408|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527409|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
83527410|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527411|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83527412|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83527413|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
83527414|NCT04734197|Hormones|hormones|mesh-ancestor
83527415|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83527416|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83527417|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
83527418|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83527419|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527420|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83527421|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
83527422|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83527423|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83527424|NCT00550147|Methylphenidate|methylphenidate|mesh-list
83527425|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83527426|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527427|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83527428|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83527429|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83527430|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527431|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
83527432|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527433|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
83527434|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83527435|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83527436|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83527437|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527438|NCT05688215|Calcium, Dietary|calcium, dietary|mesh-list
83527439|NCT05688215|Leucovorin|leucovorin|mesh-list
83527440|NCT05688215|Folic Acid|folic acid|mesh-list
83527441|NCT05688215|Fluorouracil|fluorouracil|mesh-list
83527442|NCT05688215|Oxaliplatin|oxaliplatin|mesh-list
83527443|NCT05688215|Irinotecan|irinotecan|mesh-list
83527444|NCT05688215|Quemliclustat|quemliclustat|mesh-list
83527445|NCT05688215|Calcium|calcium|mesh-list
83527446|NCT05688215|Levoleucovorin|levoleucovorin|mesh-list
83527447|NCT05688215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83527448|NCT05688215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527449|NCT05688215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83527450|NCT05688215|Antimetabolites|antimetabolites|mesh-ancestor
83527451|NCT05688215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527452|NCT05688215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83527453|NCT05688215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527454|NCT05688215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83527455|NCT05688215|Immunologic Factors|immunologic factors|mesh-ancestor
83527456|NCT05688215|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83527457|NCT05688215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83527458|NCT05688215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527459|NCT05688215|Antidotes|antidotes|mesh-ancestor
83527460|NCT05688215|Protective Agents|protective agents|mesh-ancestor
83527461|NCT05688215|Vitamin B Complex|vitamin b complex|mesh-ancestor
83527463|NCT05688215|Micronutrients|micronutrients|mesh-ancestor
83527464|NCT05688215|Hematinics|hematinics|mesh-ancestor
83527465|NCT05688215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83527466|NCT05688215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527467|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
83527468|NCT00557401|Baclofen|baclofen|mesh-list
83527469|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83527470|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527471|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83527472|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527473|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83527474|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
83527475|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
83527476|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527477|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527478|NCT02264353|Donepezil|donepezil|mesh-list
83527479|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83527480|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527481|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527482|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
83527483|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527484|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527485|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
83527486|NCT02265913|Acyclovir|acyclovir|mesh-list
83527487|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
83527488|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527489|NCT02624843|Ethanol|ethanol|mesh-list
83527490|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
83527491|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83527492|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527493|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527494|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527495|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
83527496|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
83527497|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
83527498|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527500|NCT02279641|Verinurad|verinurad|mesh-list
83527501|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
83527502|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527503|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527504|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
83527505|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527506|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83527507|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
83527508|NCT02279641|Protective Agents|protective agents|mesh-ancestor
83527509|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527510|NCT02629991|Oxytocin|oxytocin|mesh-list
83527511|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
83527512|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83527513|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527514|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83527515|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83527516|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83527517|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
83527518|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527519|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527520|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527521|NCT00553657|Urological Agents|urological agents|mesh-ancestor
83527522|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83527523|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83527524|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527525|NCT05142709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527526|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527527|NCT04992143|Sorafenib|sorafenib|mesh-list
83527528|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527529|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83527530|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527531|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527532|NCT04485065|Azacitidine|azacitidine|mesh-list
83527533|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83527534|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
83527535|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527536|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527537|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527538|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
83527539|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527540|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527541|NCT03769129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83527542|NCT03769129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527543|NCT00367445|Insulin|insulin|mesh-list
83527544|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83527545|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
83527546|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83527547|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527548|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
83527549|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83527550|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83527551|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527552|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
83527553|NCT01866943|Coagulants|coagulants|mesh-ancestor
83527554|NCT01868425|Acetaminophen|acetaminophen|mesh-list
83527555|NCT01868425|Ketamine|ketamine|mesh-list
83527556|NCT01868425|Gabapentin|gabapentin|mesh-list
83527557|NCT01868425|Bupivacaine|bupivacaine|mesh-list
83527558|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
83527559|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
83527560|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527561|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527562|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
83527563|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527564|NCT01868425|Analgesics|analgesics|mesh-ancestor
83527565|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83527566|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83527567|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
83527568|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83527569|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83527570|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527571|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527572|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83527573|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
83527574|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
83527575|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83527576|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83527577|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83527578|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
83527580|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83527581|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527582|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
83527583|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527584|NCT01871077|Ketorolac|ketorolac|mesh-list
83527585|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83527586|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83527587|NCT01871077|Analgesics|analgesics|mesh-ancestor
83527588|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
83527589|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527590|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527591|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83527592|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527593|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83527594|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527595|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527596|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
83527597|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83527598|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
83527599|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527600|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527601|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
83527602|NCT01874119|Aprepitant|aprepitant|mesh-list
83527605|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527606|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527607|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83527608|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83527609|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527610|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527612|NCT02823145|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83527613|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83527614|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83527615|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527616|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527617|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
83527618|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527619|NCT02280811|Aldesleukin|aldesleukin|mesh-list
83527620|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
83527621|NCT02280811|Fludarabine|fludarabine|mesh-list
83527622|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83527623|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
83527624|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527625|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527626|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83527627|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
83527628|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527629|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527630|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83527631|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83527632|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83527633|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
83527634|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527635|NCT01930747|Remifentanil|remifentanil|mesh-list
83527636|NCT01930747|Sevoflurane|sevoflurane|mesh-list
83527637|NCT01930747|Rocuronium|rocuronium|mesh-list
83527638|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83527639|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83527640|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
83527641|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
83527642|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527643|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527644|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83527645|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83527646|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83527647|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527648|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83527650|NCT01930747|Analgesics|analgesics|mesh-ancestor
83527651|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
83527652|NCT01931527|Rasburicase|rasburicase|mesh-list
83527653|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
83527654|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527655|NCT02639429|Misoprostol|misoprostol|mesh-list
83527656|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83527657|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
83527658|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83527659|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527660|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83527661|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83527662|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
83527663|NCT01936363|Niacinamide|niacinamide|mesh-list
83527664|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
83527665|NCT01936363|Vitamins|vitamins|mesh-ancestor
83527666|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
83527667|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527668|NCT04893629|Digoxin|digoxin|mesh-list
83527669|NCT04893629|Captopril|captopril|mesh-list
83527670|NCT04893629|Furosemide|furosemide|mesh-list
83527671|NCT04893629|Diuretics|diuretics|mesh-ancestor
83527672|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
83527673|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527674|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83527675|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83527676|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527677|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83527678|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83527679|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527680|NCT04893629|Protective Agents|protective agents|mesh-ancestor
83527681|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83527682|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
83527683|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83527684|NCT04891991|Infliximab|infliximab|mesh-list
83527685|NCT04891991|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83527686|NCT04891991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83527687|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
83527688|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83527689|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527690|NCT01936519|Cyclosporine|cyclosporine|mesh-list
83527691|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
83527692|NCT01936519|Everolimus|everolimus|mesh-list
83527693|NCT01936519|Tacrolimus|tacrolimus|mesh-list
83527694|NCT01936519|Cyclosporins|cyclosporins|mesh-list
83527695|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83527696|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83527697|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
83527698|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527699|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527700|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527701|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
83527702|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527703|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
83527704|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527705|NCT01936519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83527706|NCT01936519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83527707|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527708|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83527709|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83527710|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
83527711|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83527712|NCT04507841|Niraparib|niraparib|mesh-list
83527713|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83527714|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527715|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527716|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527717|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83527718|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527719|NCT01938079|Ketamine|ketamine|mesh-list
83527720|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83527721|NCT01938079|Analgesics|analgesics|mesh-ancestor
83527722|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
83527723|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527724|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527725|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83527726|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83527727|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
83527728|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
83527729|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527730|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83527731|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83527732|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527733|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527734|NCT02641691|Leucovorin|leucovorin|mesh-list
83527735|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
83527736|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83527737|NCT02641691|Fluorouracil|fluorouracil|mesh-list
83527738|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
83527739|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
83527740|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
83527741|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527742|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83527743|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527744|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83527745|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
83527746|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527747|NCT02641691|Antidotes|antidotes|mesh-ancestor
83527748|NCT02641691|Protective Agents|protective agents|mesh-ancestor
83527749|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
83527750|NCT02641691|Vitamins|vitamins|mesh-ancestor
83527751|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
83527752|NCT04047251|Topotecan|topotecan|mesh-list
83527753|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83527754|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83527755|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527756|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527757|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527758|NCT04045613|Atezolizumab|atezolizumab|mesh-list
83527759|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83527760|NCT04045613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83527761|NCT04045613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527762|NCT04045613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527763|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527764|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
83527765|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527766|NCT05588999|Salicylic Acid|salicylic acid|mesh-list
83527767|NCT05588999|Salicylates|salicylates|mesh-list
83527768|NCT05588999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527769|NCT05588999|Antifungal Agents|antifungal agents|mesh-ancestor
83527770|NCT05588999|Keratolytic Agents|keratolytic agents|mesh-ancestor
83527771|NCT05588999|Dermatologic Agents|dermatologic agents|mesh-ancestor
83527772|NCT05588999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83527773|NCT05588999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83527774|NCT05588999|Analgesics|analgesics|mesh-ancestor
83527775|NCT05588999|Sensory System Agents|sensory system agents|mesh-ancestor
83527776|NCT05588999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527777|NCT05588999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527778|NCT05588999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83527779|NCT05588999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527780|NCT05588999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83527781|NCT05588999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527782|NCT05588999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527783|NCT01643928|Rituximab|rituximab|mesh-list
83527784|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527785|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527786|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
83527787|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527788|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527789|NCT04234997|Suvorexant|suvorexant|mesh-list
83527790|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83527791|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83527792|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527793|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527794|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83527795|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527796|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527797|NCT03750071|Avelumab|avelumab|mesh-list
83527798|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527799|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527800|NCT03635567|Paclitaxel|paclitaxel|mesh-list
83527801|NCT03635567|Bevacizumab|bevacizumab|mesh-list
83527802|NCT03635567|Carboplatin|carboplatin|mesh-list
83527803|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
83527804|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83527805|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527806|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
83527807|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
83527808|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
83527809|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527810|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527811|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83527812|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83527813|NCT03635567|Growth Substances|growth substances|mesh-ancestor
83527814|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527815|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
83527816|NCT03635567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83527817|NCT05588531|Cefepime|cefepime|mesh-list
83527818|NCT05588531|Avibactam|avibactam|mesh-list
83527819|NCT05588531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83527820|NCT05588531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527821|NCT05588531|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83527822|NCT05588531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527823|NCT05588531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527824|NCT05588297|Bevacizumab|bevacizumab|mesh-list
83527825|NCT05588297|Nivolumab|nivolumab|mesh-list
83527826|NCT05588297|Capecitabine|capecitabine|mesh-list
83527827|NCT05588297|Oxaliplatin|oxaliplatin|mesh-list
83527828|NCT05588297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527829|NCT05588297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527830|NCT05588297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83527831|NCT05588297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83527832|NCT05588297|Growth Substances|growth substances|mesh-ancestor
83527833|NCT05588297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527834|NCT05588297|Growth Inhibitors|growth inhibitors|mesh-ancestor
83527835|NCT05588297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83527836|NCT05588297|Antimetabolites|antimetabolites|mesh-ancestor
83527837|NCT05588297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527838|NCT05588297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83527839|NCT05588219|Cisplatin|cisplatin|mesh-list
83527840|NCT05588219|Tislelizumab|tislelizumab|mesh-list
83527841|NCT05588219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83527842|NCT05588219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527843|NCT05588219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527844|NCT05588219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527845|NCT02303405|Pioglitazone|pioglitazone|mesh-list
83527846|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
83527847|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83527848|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527849|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
83527850|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83527851|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83527852|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83527853|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527854|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527855|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527856|NCT02164955|Pomalidomide|pomalidomide|mesh-list
83527857|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
83527858|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527859|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83527860|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83527861|NCT02164955|Growth Substances|growth substances|mesh-ancestor
83527862|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
83527863|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527864|NCT05587361|Propranolol|propranolol|mesh-list
83527865|NCT05587361|Nicotine|nicotine|mesh-list
83527866|NCT05587361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83527867|NCT05587361|Autonomic Agents|autonomic agents|mesh-ancestor
83527868|NCT05587361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527869|NCT05587361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527870|NCT05587361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83527871|NCT05587361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83527872|NCT05587361|Cholinergic Agents|cholinergic agents|mesh-ancestor
83527873|NCT05587361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527874|NCT05587361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527875|NCT05587361|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83527876|NCT05587361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83527877|NCT05587361|Adrenergic Agents|adrenergic agents|mesh-ancestor
83527878|NCT05587361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83527879|NCT05587361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83527880|NCT05587361|Vasodilator Agents|vasodilator agents|mesh-ancestor
83527881|NCT01943461|Avelumab|avelumab|mesh-list
83527882|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83527883|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527884|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527885|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
83527886|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527887|NCT00422435|Paclitaxel|paclitaxel|mesh-list
83527888|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83527889|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527890|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
83527891|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
83527892|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
83527893|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527894|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
83527895|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527896|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527897|NCT03559049|Carboplatin|carboplatin|mesh-list
83527898|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
83527899|NCT03559049|Pemetrexed|pemetrexed|mesh-list
83527900|NCT03559049|Rucaparib|rucaparib|mesh-list
83527901|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527902|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83527903|NCT03559049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83527904|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527906|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83527907|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83527908|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83527909|NCT05559437|Bupivacaine|bupivacaine|mesh-list
83527910|NCT05559437|Levobupivacaine|levobupivacaine|mesh-list
83527911|NCT05559437|Anesthetics, Local|anesthetics, local|mesh-ancestor
83527912|NCT05559437|Anesthetics|anesthetics|mesh-ancestor
83527913|NCT05559437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527914|NCT05559437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527915|NCT05559437|Sensory System Agents|sensory system agents|mesh-ancestor
83527916|NCT05559437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527918|NCT00367211|Omeprazole|omeprazole|mesh-list
83527919|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83527920|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83527921|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83527922|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527923|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527924|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83527925|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83527926|NCT00367211|Analgesics|analgesics|mesh-ancestor
83527927|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
83527928|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527929|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527930|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83527931|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83527932|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
83527933|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83527934|NCT02646449|Mirtazapine|mirtazapine|mesh-list
83527935|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
83527936|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83527937|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83527938|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
83527939|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
83527940|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527941|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527942|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527943|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83527944|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83527945|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527946|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83527947|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83527948|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83527949|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
83527950|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83527951|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83527952|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
83527953|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83527954|NCT04339361|Lidocaine|lidocaine|mesh-list
83527955|NCT04339361|Dinoprostone|dinoprostone|mesh-list
83527956|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
83527957|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
83527958|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527959|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527960|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
83527961|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527962|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83527963|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83527964|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83527965|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83527966|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527967|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
83527968|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83527969|NCT05369351|Mirabegron|mirabegron|mesh-list
83527970|NCT05369351|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83527971|NCT05369351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83527972|NCT05369351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83527973|NCT05369351|Adrenergic Agents|adrenergic agents|mesh-ancestor
83527974|NCT05369351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83527975|NCT05369351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527976|NCT05369351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527977|NCT05369351|Urological Agents|urological agents|mesh-ancestor
83527978|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83527982|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83527983|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83527984|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527985|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83527986|NCT05303987|Analgesics|analgesics|mesh-ancestor
83527987|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
83527988|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527989|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83527990|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83527991|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83527992|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
83527993|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413642|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
83527994|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527995|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83527996|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
83527997|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
83527998|NCT02654483|Serlopitant|serlopitant|mesh-list
83527999|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83528000|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528001|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528002|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528003|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
83528004|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
83528005|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83528006|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83528007|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528008|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
83528009|NCT02655653|Coagulants|coagulants|mesh-ancestor
83528010|NCT03081143|Paclitaxel|paclitaxel|mesh-list
83528011|NCT03081143|Ramucirumab|ramucirumab|mesh-list
83528012|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83528013|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528014|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
83528015|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
83528016|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
83528017|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528018|NCT02658461|Trastuzumab|trastuzumab|mesh-list
83528019|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83528020|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528021|NCT00367913|Clarithromycin|clarithromycin|mesh-list
83528022|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
83528023|NCT00367913|Rifampin|rifampin|mesh-list
83528024|NCT00367913|Ethambutol|ethambutol|mesh-list
83528025|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83528026|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528027|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83528028|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528029|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528030|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83528031|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83528032|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83528033|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83528034|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528035|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83528036|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83528037|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
83528038|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
83528039|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83528040|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83528041|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83528042|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83528043|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83528044|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83528045|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83528046|NCT02659787|Buprenorphine|buprenorphine|mesh-list
83528047|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83528048|NCT02659787|Narcotics|narcotics|mesh-ancestor
83528049|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528050|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528051|NCT02659787|Analgesics|analgesics|mesh-ancestor
83528052|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
83528053|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528054|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83528055|NCT05044871|Paclitaxel|paclitaxel|mesh-list
83528056|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83528058|NCT05044871|Tislelizumab|tislelizumab|mesh-list
83528059|NCT05044871|Pamiparib|pamiparib|mesh-list
83528060|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83528061|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528062|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
83528063|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
83528064|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
83528065|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528066|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83528067|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83528068|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83528069|NCT05044871|Growth Substances|growth substances|mesh-ancestor
83528070|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528071|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
83528072|NCT05044871|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83528073|NCT05044871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528074|NCT04931693|Acetaminophen|acetaminophen|mesh-list
83528075|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83528076|NCT04931693|Analgesics|analgesics|mesh-ancestor
83528077|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
83528078|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528079|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528080|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
83528081|NCT02271594|Insulin|insulin|mesh-list
83528082|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83528083|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528084|NCT04817969|Cimetidine|cimetidine|mesh-list
83528085|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83528086|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83528087|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83528088|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
83528089|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
83528090|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528091|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528092|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528093|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83528094|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83528095|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528096|NCT05649228|Capsaicin|capsaicin|mesh-list
83528097|NCT05649228|Antipruritics|antipruritics|mesh-ancestor
83528098|NCT05649228|Dermatologic Agents|dermatologic agents|mesh-ancestor
83528099|NCT05649228|Sensory System Agents|sensory system agents|mesh-ancestor
83528100|NCT05649228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528101|NCT05649228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528102|NCT02350517|Paclitaxel|paclitaxel|mesh-list
83528103|NCT02350517|Endostar protein|endostar protein|mesh-list
83528104|NCT02350517|Endostatins|endostatins|mesh-list
83528105|NCT02350517|Nedaplatin|nedaplatin|mesh-list
83528106|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83528107|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528108|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
83528109|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
83528110|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
83528111|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528112|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83528113|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83528114|NCT02350517|Growth Substances|growth substances|mesh-ancestor
83528115|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528116|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
83528117|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
83528118|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83528119|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83528120|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83528121|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83528122|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83528123|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528124|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
83528125|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528126|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528127|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83528128|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528129|NCT02205047|Fluorouracil|fluorouracil|mesh-list
83528130|NCT02205047|Capecitabine|capecitabine|mesh-list
83528133|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528134|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
83528135|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528136|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83528137|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83528138|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
83528139|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528140|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83528141|NCT01585805|Cisplatin|cisplatin|mesh-list
83528142|NCT01585805|Gemcitabine|gemcitabine|mesh-list
83528143|NCT01585805|Veliparib|veliparib|mesh-list
83528144|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528145|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83528146|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
83528147|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528148|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83528149|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528150|NCT04878198|Melatonin|melatonin|mesh-list
83528151|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
83528152|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528153|NCT04878198|Protective Agents|protective agents|mesh-ancestor
83528154|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528155|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528156|NCT04651595|Morphine|morphine|mesh-list
83528157|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83528158|NCT04651595|Narcotics|narcotics|mesh-ancestor
83528159|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528160|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528161|NCT04651595|Analgesics|analgesics|mesh-ancestor
83528162|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
83528163|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528164|NCT02669615|Melphalan|melphalan|mesh-list
83528165|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83528166|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
83528167|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528168|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528169|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83528170|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83528171|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
83528172|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528173|NCT02672111|Buprenorphine|buprenorphine|mesh-list
83528174|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83528175|NCT02672111|Narcotics|narcotics|mesh-ancestor
83528176|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528177|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528178|NCT02672111|Analgesics|analgesics|mesh-ancestor
83528179|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
83528180|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528181|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83528182|NCT00586391|Ipilimumab|ipilimumab|mesh-list
83528183|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83528184|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528185|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83528186|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528187|NCT05432843|Pregabalin|pregabalin|mesh-list
83528188|NCT05432843|Analgesics|analgesics|mesh-ancestor
83528189|NCT05432843|Sensory System Agents|sensory system agents|mesh-ancestor
83528190|NCT05432843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528191|NCT05432843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528192|NCT05432843|Anticonvulsants|anticonvulsants|mesh-ancestor
83528193|NCT05432843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83528194|NCT05432843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83528195|NCT05432843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528196|NCT05432843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83528197|NCT05432843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83528198|NCT05432843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83528199|NCT05432843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528200|NCT05432843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83528201|NCT05411471|Vaccines|vaccines|mesh-list
83528202|NCT05411471|Immunologic Factors|immunologic factors|mesh-ancestor
83528203|NCT05411471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528204|NCT02677493|Vaccines|vaccines|mesh-list
83528205|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
83528206|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528210|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528211|NCT02680301|Triamcinolone|triamcinolone|mesh-list
83528212|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83528213|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83528214|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83528215|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528216|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
83528217|NCT02680301|Hormones|hormones|mesh-ancestor
83528218|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83528219|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528220|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83528221|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
83528222|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528223|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528224|NCT02680457|Insulin|insulin|mesh-list
83528225|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83528226|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
83528227|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83528228|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528229|NCT02283762|Riociguat|riociguat|mesh-list
83528230|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
83528231|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528232|NCT02692391|Indomethacin|indomethacin|mesh-list
83528233|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83528234|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83528235|NCT02692391|Analgesics|analgesics|mesh-ancestor
83528236|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
83528237|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528238|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528239|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528240|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83528241|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
83528242|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
83528243|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83528244|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83528245|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528246|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528247|NCT05407961|Dulaglutide|dulaglutide|mesh-list
83528248|NCT05407961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83528249|NCT05407961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528250|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83528251|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
83528252|NCT02682563|Gliclazide|gliclazide|mesh-list
83528253|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83528254|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528255|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83528256|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528257|NCT02697071|Ketamine|ketamine|mesh-list
83528258|NCT02697071|Analgesics|analgesics|mesh-ancestor
83528259|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
83528260|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528261|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528262|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83528263|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83528264|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
83528265|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
83528266|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528267|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83528268|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83528269|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528270|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528271|NCT02283294|Warfarin|warfarin|mesh-list
83528272|NCT02283294|Apixaban|apixaban|mesh-list
83528273|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
83528274|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83528275|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
83528276|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83528277|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
83528278|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528279|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528280|NCT05648994|Paclitaxel|paclitaxel|mesh-list
83528281|NCT05648994|Cyclophosphamide|cyclophosphamide|mesh-list
83528282|NCT05648994|Fludarabine|fludarabine|mesh-list
83528283|NCT05648994|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83528284|NCT05648994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83528285|NCT05648994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528286|NCT05648994|Tubulin Modulators|tubulin modulators|mesh-ancestor
83528287|NCT05648994|Antimitotic Agents|antimitotic agents|mesh-ancestor
83528288|NCT05648994|Mitosis Modulators|mitosis modulators|mesh-ancestor
83528289|NCT05648994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528290|NCT05648994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83528291|NCT05648994|Immunologic Factors|immunologic factors|mesh-ancestor
83528292|NCT05648994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528293|NCT05648994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83528294|NCT05648994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83528295|NCT05648994|Alkylating Agents|alkylating agents|mesh-ancestor
83528296|NCT05648994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83528297|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
83528298|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83528299|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
83528300|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528301|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
83528302|NCT04869306|Protective Agents|protective agents|mesh-ancestor
83528304|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
83528305|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528306|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
83528307|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528308|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528309|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
83528310|NCT04859946|Busulfan|busulfan|mesh-list
83528311|NCT04859946|Thiotepa|thiotepa|mesh-list
83528312|NCT04859946|Fludarabine|fludarabine|mesh-list
83528313|NCT04859946|Tacrolimus|tacrolimus|mesh-list
83528314|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83528315|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
83528316|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528317|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83528318|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83528319|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
83528320|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528321|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528322|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83528323|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83528324|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528325|NCT02703779|Plerixafor|plerixafor|mesh-list
83528326|NCT02703779|Bortezomib|bortezomib|mesh-list
83528327|NCT02703779|Lenograstim|lenograstim|mesh-list
83528328|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83528329|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
83528330|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528331|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528332|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83528333|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83528334|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
83528335|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528336|NCT04738955|Micafungin|micafungin|mesh-list
83528337|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
83528338|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528339|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
83528340|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
83528341|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83528342|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
83528343|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528344|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528345|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83528346|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
83528347|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83528348|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83528349|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83528350|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
83528351|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528352|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528353|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83528354|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83528355|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83528356|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
83528357|NCT05648526|Ketamine|ketamine|mesh-list
83528358|NCT05648526|Analgesics|analgesics|mesh-ancestor
83528359|NCT05648526|Sensory System Agents|sensory system agents|mesh-ancestor
83528360|NCT05648526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528361|NCT05648526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528362|NCT05648526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83528363|NCT05648526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83528364|NCT05648526|Anesthetics, General|anesthetics, general|mesh-ancestor
83528365|NCT05648526|Anesthetics|anesthetics|mesh-ancestor
83528366|NCT05648526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528367|NCT05648526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83528368|NCT05648526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83528369|NCT05648526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528370|NCT05648526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528371|NCT02705807|Epoprostenol|epoprostenol|mesh-list
83528372|NCT02705807|Tezosentan|tezosentan|mesh-list
83528373|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83528374|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83528375|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
83528376|NCT01643772|Oxycodone|oxycodone|mesh-list
83528377|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83528378|NCT01643772|Narcotics|narcotics|mesh-ancestor
83528379|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528380|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528381|NCT01643772|Analgesics|analgesics|mesh-ancestor
83528382|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
83528383|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528384|NCT02707523|Azithromycin|azithromycin|mesh-list
83528385|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83528386|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528387|NCT05278715|Carboplatin|carboplatin|mesh-list
83528388|NCT05278715|Vincristine|vincristine|mesh-list
83528389|NCT05278715|Endostatins|endostatins|mesh-list
83528390|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528391|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83528392|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
83528393|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
83528394|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
83528395|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528396|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83528397|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83528398|NCT05278715|Growth Substances|growth substances|mesh-ancestor
83528399|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528400|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
83528402|NCT02712047|Xhance|xhance|mesh-list
83528403|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528404|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83528405|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
83528406|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528407|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528408|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83528409|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
83528410|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
83528411|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83528412|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83528413|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83528414|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528415|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
83528416|NCT00369239|Risperidone|risperidone|mesh-list
83528417|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83528418|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
83528419|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528420|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528421|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528422|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83528423|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83528424|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528425|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83528426|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83528427|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
83528428|NCT03833921|Prednisone|prednisone|mesh-list
83528429|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
83528430|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528431|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
83528432|NCT03833921|Hormones|hormones|mesh-ancestor
83528433|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83528434|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528435|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83528436|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528437|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83528438|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528439|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528441|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83528442|NCT05215925|Carboplatin|carboplatin|mesh-list
83528443|NCT05215925|Docetaxel|docetaxel|mesh-list
83528444|NCT05215925|Pemetrexed|pemetrexed|mesh-list
83528445|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528446|NCT05215925|Tubulin Modulators|tubulin modulators|mesh-ancestor
83528447|NCT05215925|Antimitotic Agents|antimitotic agents|mesh-ancestor
83528448|NCT05215925|Mitosis Modulators|mitosis modulators|mesh-ancestor
83528449|NCT05215925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528450|NCT05215925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528451|NCT05215925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83528452|NCT05215925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83528453|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83528454|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83528455|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83528456|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83528457|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528458|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
83528459|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528460|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528461|NCT02721017|Fentanyl|fentanyl|mesh-list
83528462|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83528463|NCT02721017|Narcotics|narcotics|mesh-ancestor
83528464|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528465|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528466|NCT02721017|Analgesics|analgesics|mesh-ancestor
83528467|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
83528468|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528469|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83528470|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83528471|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
83528472|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
83528473|NCT02721641|Trastuzumab|trastuzumab|mesh-list
83528474|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83528475|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528476|NCT03649061|Etanercept|etanercept|mesh-list
83528477|NCT03649061|Leflunomide|leflunomide|mesh-list
83528478|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83528479|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83528480|NCT03649061|Analgesics|analgesics|mesh-ancestor
83528481|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
83528482|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528483|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528484|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528485|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83528486|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83528487|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83528488|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
83528489|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528490|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528491|NCT02265744|Antibodies|antibodies|mesh-list
83528492|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
83528493|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528494|NCT05109143|Indomethacin|indomethacin|mesh-list
83528495|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83528496|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83528497|NCT05109143|Analgesics|analgesics|mesh-ancestor
83528498|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
83528499|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528500|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528501|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528502|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83528503|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
83528504|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
83528505|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83528506|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83528507|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528508|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528509|NCT03614663|Cannabidiol|cannabidiol|mesh-list
83528510|NCT03614663|Anticonvulsants|anticonvulsants|mesh-ancestor
83528511|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
83528512|NCT00085735|Lomustine|lomustine|mesh-list
83528513|NCT00085735|Cisplatin|cisplatin|mesh-list
83528515|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83528516|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
83528517|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528518|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83528519|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83528520|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
83528521|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528522|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528523|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83528524|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83528525|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
83528526|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
83528527|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
83528528|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83528529|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
83528531|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528532|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528533|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
83528534|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528535|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83528536|NCT03538457|Acetaminophen|acetaminophen|mesh-list
83528537|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83528538|NCT03538457|Analgesics|analgesics|mesh-ancestor
83528539|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
83528540|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528541|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528542|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
83528543|NCT05544786|Ritonavir|ritonavir|mesh-list
83528544|NCT05544786|Nirmatrelvir|nirmatrelvir|mesh-list
83528545|NCT05544786|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83528546|NCT05544786|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83528547|NCT05544786|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83528548|NCT05544786|Protease Inhibitors|protease inhibitors|mesh-ancestor
83528549|NCT05544786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528550|NCT05544786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528551|NCT05544786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83528552|NCT05544786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83528553|NCT05544786|Antiviral Agents|antiviral agents|mesh-ancestor
83528554|NCT05544786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528555|NCT05544786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83528556|NCT05544786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83528557|NCT02726789|Interferons|interferons|mesh-list
83528558|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
83528559|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
83528560|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83528561|NCT02726789|Entecavir|entecavir|mesh-list
83528562|NCT02726789|REP 2139|rep 2139|mesh-list
83528563|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528564|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
83528565|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528566|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
83528567|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528568|NCT02731313|Trastuzumab|trastuzumab|mesh-list
83528569|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83528570|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528571|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83528572|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
83528573|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83528574|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83528575|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83528576|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528577|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
83528578|NCT02731469|Hematinics|hematinics|mesh-ancestor
83528579|NCT03445949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83528580|NCT01944319|Meropenem|meropenem|mesh-list
83528581|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83528582|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528583|NCT00368303|Paroxetine|paroxetine|mesh-list
83528584|NCT00368303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83528585|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83528586|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83528587|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528588|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528590|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528591|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83528592|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
83528593|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83528594|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83528595|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83528596|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528597|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
83528598|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528599|NCT05020145|Vaccines|vaccines|mesh-list
83528600|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
83528601|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528602|NCT02734355|Amlodipine|amlodipine|mesh-list
83528603|NCT02734355|Telmisartan|telmisartan|mesh-list
83528604|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83528605|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83528606|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83528607|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83528608|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528609|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83528610|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528611|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
83528612|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83528613|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83528614|NCT00369395|Volociximab|volociximab|mesh-list
83528615|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83528616|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83528617|NCT00369395|Growth Substances|growth substances|mesh-ancestor
83528618|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528619|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
83528620|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528621|NCT01947907|Hormones|hormones|mesh-list
83528622|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83528623|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528624|NCT01948141|Nintedanib|nintedanib|mesh-list
83528625|NCT01948141|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83528626|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528627|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83528628|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528629|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528630|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
83528631|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83528632|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
83528633|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528634|NCT05446493|Tadalafil|tadalafil|mesh-list
83528635|NCT05446493|Vasodilator Agents|vasodilator agents|mesh-ancestor
83528636|NCT05446493|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83528637|NCT05446493|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83528638|NCT05446493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528639|NCT05446493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528640|NCT05446493|Urological Agents|urological agents|mesh-ancestor
83528641|NCT02863055|Nintedanib|nintedanib|mesh-list
83528642|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528643|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83528644|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528645|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528646|NCT05445479|Doxycycline|doxycycline|mesh-list
83528647|NCT05445479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83528648|NCT05445479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528649|NCT05445479|Antimalarials|antimalarials|mesh-ancestor
83528650|NCT05445479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83528651|NCT05445479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83528652|NCT02711735|Vaccines|vaccines|mesh-list
83528653|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
83528654|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528655|NCT05445011|Cyclophosphamide|cyclophosphamide|mesh-list
83528656|NCT05445011|Fludarabine|fludarabine|mesh-list
83528657|NCT05445011|Fludarabine phosphate|fludarabine phosphate|mesh-list
83528658|NCT05445011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83528659|NCT05445011|Immunologic Factors|immunologic factors|mesh-ancestor
83528660|NCT05445011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528661|NCT05445011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83528662|NCT05445011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83528663|NCT05445011|Alkylating Agents|alkylating agents|mesh-ancestor
83528664|NCT05445011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528666|NCT05445011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83528667|NCT05445011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83528668|NCT05445011|Antimetabolites|antimetabolites|mesh-ancestor
83528669|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
83528670|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83528671|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528672|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83528673|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528674|NCT04770155|Bosentan|bosentan|mesh-list
83528675|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
83528676|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
83528677|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83528678|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83528679|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528680|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528681|NCT04770155|Urological Agents|urological agents|mesh-ancestor
83528682|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83528683|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83528684|NCT04744181|Folic Acid|folic acid|mesh-list
83528685|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
83528686|NCT04744181|Vitamins|vitamins|mesh-ancestor
83528687|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
83528688|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528689|NCT04744181|Hematinics|hematinics|mesh-ancestor
83528690|NCT05444543|Fluticasone|fluticasone|mesh-list
83528691|NCT05444543|Xhance|xhance|mesh-list
83528692|NCT05444543|Budesonide|budesonide|mesh-list
83528693|NCT05444543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528694|NCT05444543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83528695|NCT05444543|Autonomic Agents|autonomic agents|mesh-ancestor
83528696|NCT05444543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528697|NCT05444543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528698|NCT05444543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83528699|NCT05444543|Respiratory System Agents|respiratory system agents|mesh-ancestor
83528700|NCT05444543|Dermatologic Agents|dermatologic agents|mesh-ancestor
83528701|NCT05444543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83528702|NCT05444543|Glucocorticoids|glucocorticoids|mesh-ancestor
83528703|NCT05444543|Hormones|hormones|mesh-ancestor
83528704|NCT05444543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83528705|NCT01970345|Mecasermin|mecasermin|mesh-list
83528706|NCT01970345|Growth Substances|growth substances|mesh-ancestor
83528707|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528708|NCT00619931|APD791|apd791|mesh-list
83528709|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83528710|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83528711|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
83528712|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528713|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528714|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528715|NCT04739111|Antibodies|antibodies|mesh-list
83528716|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
83528717|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83528718|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
83528719|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528720|NCT04768231|Rifampin|rifampin|mesh-list
83528721|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83528722|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
83528723|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83528724|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528725|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
83528726|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83528727|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528728|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528729|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83528730|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83528731|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83528732|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83528733|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83528734|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83528735|NCT05452187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83528736|NCT05452187|Immunologic Factors|immunologic factors|mesh-ancestor
83528737|NCT05452187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528740|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83528741|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528742|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
83528743|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528744|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83528746|NCT00369551|Bevacizumab|bevacizumab|mesh-list
83528747|NCT00369551|Carboplatin|carboplatin|mesh-list
83528748|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83528749|NCT00369551|Antibodies|antibodies|mesh-list
83528750|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
83528751|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83528752|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83528753|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528754|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
83528755|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
83528756|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
83528757|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528758|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83528759|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83528760|NCT00369551|Growth Substances|growth substances|mesh-ancestor
83528761|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528762|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
83528763|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
83528764|NCT04537793|Ivacaftor|ivacaftor|mesh-list
83528765|NCT04537793|Elexacaftor|elexacaftor|mesh-list
83528766|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83528767|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83528768|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528769|NCT05451173|Durvalumab|durvalumab|mesh-list
83528770|NCT05451173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83528771|NCT05451173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528772|NCT05437601|Carotenoids|carotenoids|mesh-list
83528773|NCT05437601|Antioxidants|antioxidants|mesh-ancestor
83528774|NCT05437601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528775|NCT05437601|Protective Agents|protective agents|mesh-ancestor
83528776|NCT05437601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528777|NCT05449145|Vitamin D|vitamin d|mesh-list
83528778|NCT05449145|Vitamins|vitamins|mesh-ancestor
83528779|NCT05449145|Micronutrients|micronutrients|mesh-ancestor
83528780|NCT05449145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528781|NCT05449145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83528782|NCT05447039|Montelukast|montelukast|mesh-list
83528783|NCT05447039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83528784|NCT05447039|Respiratory System Agents|respiratory system agents|mesh-ancestor
83528785|NCT05447039|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83528786|NCT05447039|Hormone Antagonists|hormone antagonists|mesh-ancestor
83528787|NCT05447039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83528788|NCT05447039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528789|NCT05447039|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83528790|NCT05447039|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83528791|NCT05447039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528792|NCT05446805|Corticosterone|corticosterone|mesh-list
83528793|NCT05446805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528794|NCT05446415|Glucagon|glucagon|mesh-list
83528795|NCT05446415|Incretins|incretins|mesh-list
83528796|NCT05446415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83528797|NCT05446415|Hormones|hormones|mesh-ancestor
83528798|NCT05446415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83528799|NCT05446415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528800|NCT05448365|Vitamin D|vitamin d|mesh-list
83528801|NCT05448365|Vitamins|vitamins|mesh-list
83528802|NCT05448365|Inositol|inositol|mesh-list
83528803|NCT05448365|Vitamin B 6|vitamin b 6|mesh-list
83528804|NCT05448365|Pyridoxal|pyridoxal|mesh-list
83528805|NCT05448365|Pyridoxine|pyridoxine|mesh-list
83528806|NCT05448365|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83528807|NCT05448365|Micronutrients|micronutrients|mesh-ancestor
83528808|NCT05448365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528809|NCT05448365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83528810|NCT05448365|Vitamin B Complex|vitamin b complex|mesh-ancestor
83528811|NCT05448365|Antioxidants|antioxidants|mesh-ancestor
83528812|NCT05448365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528813|NCT05448365|Protective Agents|protective agents|mesh-ancestor
83528814|NCT05448365|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83528815|NCT05448365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83528816|NCT05448365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528817|NCT05448365|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83528819|NCT03137771|Docetaxel|docetaxel|mesh-list
83528820|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
83528821|NCT03137771|Pemetrexed|pemetrexed|mesh-list
83528822|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83528823|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83528824|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
83528825|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528826|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528827|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
83528828|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
83528829|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
83528830|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83528831|NCT03137771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83528832|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528833|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83528834|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83528835|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83528836|NCT00370799|Betamethasone|betamethasone|mesh-list
83528837|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
83528838|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83528839|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
83528840|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83528841|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83528842|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528843|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
83528844|NCT00370799|Hormones|hormones|mesh-ancestor
83528845|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83528846|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528847|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83528848|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
83528849|NCT05444777|Ketamine|ketamine|mesh-list
83528850|NCT05444777|Analgesics|analgesics|mesh-ancestor
83528851|NCT05444777|Sensory System Agents|sensory system agents|mesh-ancestor
83528852|NCT05444777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528853|NCT05444777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528854|NCT05444777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83528855|NCT05444777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83528856|NCT05444777|Anesthetics, General|anesthetics, general|mesh-ancestor
83528857|NCT05444777|Anesthetics|anesthetics|mesh-ancestor
83528858|NCT05444777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528859|NCT05444777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83528860|NCT05444777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83528861|NCT05444777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528862|NCT05444777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528863|NCT02661971|Leucovorin|leucovorin|mesh-list
83528864|NCT02661971|Docetaxel|docetaxel|mesh-list
83528865|NCT02661971|Fluorouracil|fluorouracil|mesh-list
83528866|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
83528867|NCT02661971|Ramucirumab|ramucirumab|mesh-list
83528868|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528869|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
83528870|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
83528871|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
83528872|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528873|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
83528874|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83528875|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83528876|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
83528877|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528878|NCT02661971|Antidotes|antidotes|mesh-ancestor
83528879|NCT02661971|Protective Agents|protective agents|mesh-ancestor
83528880|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
83528881|NCT02661971|Vitamins|vitamins|mesh-ancestor
83528882|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
83528883|NCT05442905|Anesthetics|anesthetics|mesh-list
83528884|NCT05442905|Propofol|propofol|mesh-list
83528885|NCT05442905|Sevoflurane|sevoflurane|mesh-list
83528886|NCT05442905|Atracurium|atracurium|mesh-list
83528887|NCT05442905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83528888|NCT05442905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528889|NCT05442905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83528890|NCT05442905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83528891|NCT05442905|Anesthetics, General|anesthetics, general|mesh-ancestor
83529040|NCT01951963|Narcotics|narcotics|mesh-ancestor
83528892|NCT05442905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83528893|NCT05442905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83528894|NCT05442905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83528895|NCT05442905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83528896|NCT05442905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83528897|NCT05442905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528898|NCT05442905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83528899|NCT05442905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83528900|NCT05442905|Cholinergic Agents|cholinergic agents|mesh-ancestor
83528901|NCT05442905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528902|NCT05442905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528903|NCT00369863|Triamcinolone|triamcinolone|mesh-list
83528904|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83528905|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83528906|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83528907|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528908|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
83528909|NCT00369863|Hormones|hormones|mesh-ancestor
83528910|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83528911|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528912|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83528913|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
83528914|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528915|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528916|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83528917|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83528918|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528919|NCT02588027|Ibuprofen|ibuprofen|mesh-list
83528920|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83528921|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83528922|NCT02588027|Analgesics|analgesics|mesh-ancestor
83528923|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
83528924|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528925|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528926|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528927|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83528928|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83528929|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528930|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528931|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
83528932|NCT04449965|Povidone|povidone|mesh-list
83528933|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
83528934|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
83528935|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83528936|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528937|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83528938|NCT01951339|Glimepiride|glimepiride|mesh-list
83528939|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83528940|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528941|NCT01951339|Incretins|incretins|mesh-ancestor
83528942|NCT01951339|Hormones|hormones|mesh-ancestor
83528943|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83528944|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83528945|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
83528946|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528947|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528948|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83528949|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83528950|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
83528951|NCT05431673|Doxycycline|doxycycline|mesh-list
83528952|NCT05431673|Ciprofloxacin|ciprofloxacin|mesh-list
83528953|NCT05431673|Rifampin|rifampin|mesh-list
83528954|NCT05431673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83528955|NCT05431673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83528956|NCT05431673|Antimalarials|antimalarials|mesh-ancestor
83528957|NCT05431673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83528958|NCT05431673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83528959|NCT05431673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83528960|NCT05431673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83528961|NCT05431673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83528962|NCT05431673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83528963|NCT05431673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528964|NCT05431673|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83529041|NCT02377271|Bosentan|bosentan|mesh-list
83528965|NCT05431673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83528966|NCT05431673|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83528967|NCT05431673|Antitubercular Agents|antitubercular agents|mesh-ancestor
83528968|NCT05431673|Leprostatic Agents|leprostatic agents|mesh-ancestor
83528969|NCT05431673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83528970|NCT05431673|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83528971|NCT05431673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83528972|NCT05431673|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83528973|NCT05431673|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83528974|NCT05431673|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83528975|NCT05431673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83528976|NCT01951651|Exenatide|exenatide|mesh-list
83528977|NCT01951651|Glipizide|glipizide|mesh-list
83528978|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83528979|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83528980|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83528981|NCT01951651|Incretins|incretins|mesh-ancestor
83528982|NCT01951651|Hormones|hormones|mesh-ancestor
83528983|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83528984|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
83528985|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
83528986|NCT02466581|Prednisolone|prednisolone|mesh-list
83528987|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83528988|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
83528989|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83528990|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
83528991|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
83528992|NCT02466581|Abatacept|abatacept|mesh-list
83528993|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83528994|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
83528995|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83528996|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
83528997|NCT02466581|Hormones|hormones|mesh-ancestor
83528998|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83528999|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529000|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83529001|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529002|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
83529003|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
83529004|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529005|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83529006|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83529007|NCT02466581|Protective Agents|protective agents|mesh-ancestor
83529008|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
83529009|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83529010|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83529011|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529012|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529013|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529014|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83529015|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83529016|NCT02466581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83529017|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83529018|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
83529019|NCT02466581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83529020|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83529021|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83529022|NCT02466581|Analgesics|analgesics|mesh-ancestor
83529023|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
83529024|NCT01951963|Ketamine|ketamine|mesh-list
83529025|NCT01951963|Morphine|morphine|mesh-list
83529026|NCT01951963|Analgesics|analgesics|mesh-ancestor
83529027|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
83529028|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529029|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529030|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83529031|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83529032|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
83529033|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
83529034|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529035|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83529036|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83529037|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529038|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529039|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83529042|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83529043|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83529044|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529045|NCT01894555|Aspirin|aspirin|mesh-list
83529046|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83529047|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83529048|NCT01894555|Analgesics|analgesics|mesh-ancestor
83529049|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
83529050|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529051|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529052|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83529053|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83529054|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83529055|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83529056|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529057|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83529058|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83529059|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529060|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
83529061|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
83529062|NCT02344355|Temozolomide|temozolomide|mesh-list
83529063|NCT02344355|Vitamins|vitamins|mesh-ancestor
83529064|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
83529065|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529066|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83529067|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
83529068|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529069|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529070|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
83529071|NCT02344355|Protective Agents|protective agents|mesh-ancestor
83529072|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
83529073|NCT01953211|Norinyl|norinyl|mesh-list
83529074|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
83529075|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83529076|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83529077|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529078|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83529079|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83529080|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83529081|NCT02028221|Metformin|metformin|mesh-list
83529082|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83529083|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529084|NCT05735197|Dapagliflozin|dapagliflozin|mesh-list
83529085|NCT05735197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83529086|NCT05735197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529087|NCT05735197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83529088|NCT05735197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529089|NCT00370097|Fluticasone|fluticasone|mesh-list
83529090|NCT00370097|Xhance|xhance|mesh-list
83529091|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83529092|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83529093|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
83529094|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529095|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529096|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83529097|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
83529098|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
83529099|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83529100|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83529101|NCT01897285|Laxatives|laxatives|mesh-ancestor
83529102|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83529103|NCT00370253|Terlipressin|terlipressin|mesh-list
83529104|NCT00370253|Norepinephrine|norepinephrine|mesh-list
83529105|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83529106|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83529107|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83529108|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83529109|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83529110|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529111|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529112|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529113|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
83529114|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
83529115|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529116|NCT01491815|Abatacept|abatacept|mesh-list
83529117|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83529118|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529119|NCT01491815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83529120|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529121|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83529122|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
83529123|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529124|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83529125|NCT04359953|Azithromycin|azithromycin|mesh-list
83529126|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
83529127|NCT04359953|Telmisartan|telmisartan|mesh-list
83529128|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83529129|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529130|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
83529131|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83529132|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83529133|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529134|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529135|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83529136|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83529137|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83529138|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83529140|NCT05364515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83529141|NCT05364515|Glucocorticoids|glucocorticoids|mesh-ancestor
83529142|NCT05364515|Hormones|hormones|mesh-ancestor
83529143|NCT05364515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529144|NCT05364515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529145|NCT01438073|Hormones|hormones|mesh-list
83529146|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529147|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529148|NCT04338191|Leucovorin|leucovorin|mesh-list
83529149|NCT04338191|Fluorouracil|fluorouracil|mesh-list
83529150|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
83529151|NCT04338191|Irinotecan|irinotecan|mesh-list
83529152|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
83529153|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
83529154|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529155|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83529156|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529157|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83529158|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
83529159|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529160|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83529161|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83529162|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529163|NCT04338191|Antidotes|antidotes|mesh-ancestor
83529164|NCT04338191|Protective Agents|protective agents|mesh-ancestor
83529165|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
83529166|NCT04338191|Vitamins|vitamins|mesh-ancestor
83529167|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
83529168|NCT00371033|Pregabalin|pregabalin|mesh-list
83529169|NCT00371033|Analgesics|analgesics|mesh-ancestor
83529170|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
83529171|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529172|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529173|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
83529174|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83529175|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83529176|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529177|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83529178|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83529179|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83529180|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529181|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83529182|NCT00371111|Triamcinolone|triamcinolone|mesh-list
83529183|NCT00371111|Bevacizumab|bevacizumab|mesh-list
83529184|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83529185|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529186|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83529187|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83529188|NCT00371111|Growth Substances|growth substances|mesh-ancestor
83529189|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529190|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
83529191|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83529192|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
83529194|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529195|NCT05454683|Melatonin|melatonin|mesh-list
83529196|NCT05454683|Antioxidants|antioxidants|mesh-ancestor
83529197|NCT05454683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529198|NCT05454683|Protective Agents|protective agents|mesh-ancestor
83529199|NCT05454683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529200|NCT05454683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529201|NCT05193071|Aspirin|aspirin|mesh-list
83529202|NCT05193071|Clopidogrel|clopidogrel|mesh-list
83529203|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83529204|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83529205|NCT05193071|Analgesics|analgesics|mesh-ancestor
83529206|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
83529207|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529208|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529209|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83529210|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83529211|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83529212|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83529213|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529214|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83529215|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83529216|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529217|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
83529218|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83529219|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83529220|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83529221|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
83529222|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529223|NCT05180825|Trametinib|trametinib|mesh-list
83529224|NCT05180825|Vinblastine|vinblastine|mesh-list
83529225|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529226|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83529227|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529228|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529229|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83529230|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
83529231|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
83529232|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83529233|NCT05139095|Apatinib|apatinib|mesh-list
83529234|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529235|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83529236|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529237|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529238|NCT04108247|Fluzoparib|fluzoparib|mesh-list
83529239|NCT04108247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83529240|NCT04108247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529241|NCT04108247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529242|NCT04108247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529243|NCT05453435|Entecavir|entecavir|mesh-list
83529244|NCT05453435|Antiviral Agents|antiviral agents|mesh-ancestor
83529245|NCT05453435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529246|NCT03029845|Propranolol|propranolol|mesh-list
83529247|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83529248|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83529249|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
83529250|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529251|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529252|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529253|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83529254|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83529255|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
83529256|NCT05451719|Capecitabine|capecitabine|mesh-list
83529257|NCT05451719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83529258|NCT05451719|Antimetabolites|antimetabolites|mesh-ancestor
83529259|NCT05451719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529260|NCT05451719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529261|NCT01955629|Capecitabine|capecitabine|mesh-list
83529262|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
83529263|NCT01955629|Aflibercept|aflibercept|mesh-list
83529264|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83529266|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529267|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529268|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83529269|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83529270|NCT01955629|Growth Substances|growth substances|mesh-ancestor
83529271|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529272|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
83529274|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
83529275|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
83529276|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529277|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529278|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
83529279|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529280|NCT04021121|Linezolid|linezolid|mesh-list
83529281|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83529282|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529283|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83529284|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529285|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529286|NCT05062577|Buprenorphine|buprenorphine|mesh-list
83529287|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83529288|NCT05062577|ASP8062|asp8062|mesh-list
83529289|NCT05062577|Naloxone|naloxone|mesh-list
83529290|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83529291|NCT05062577|Narcotics|narcotics|mesh-ancestor
83529292|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529293|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529294|NCT05062577|Analgesics|analgesics|mesh-ancestor
83529295|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
83529296|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529297|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83529298|NCT05062577|GABA Modulators|gaba modulators|mesh-ancestor
83529299|NCT05062577|GABA Agents|gaba agents|mesh-ancestor
83529300|NCT05062577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529301|NCT05062577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529302|NCT05448989|Atropine|atropine|mesh-list
83529303|NCT05448989|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83529304|NCT05448989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83529305|NCT05448989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83529306|NCT05448989|Autonomic Agents|autonomic agents|mesh-ancestor
83529307|NCT05448989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529308|NCT05448989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529309|NCT05448989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83529310|NCT05448989|Respiratory System Agents|respiratory system agents|mesh-ancestor
83529311|NCT05448989|Mydriatics|mydriatics|mesh-ancestor
83529312|NCT05448989|Parasympatholytics|parasympatholytics|mesh-ancestor
83529313|NCT05448989|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83529314|NCT05448989|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83529315|NCT05448989|Cholinergic Agents|cholinergic agents|mesh-ancestor
83529316|NCT05448989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529317|NCT05448989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529318|NCT00370565|Insulin|insulin|mesh-list
83529319|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83529320|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83529321|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529322|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83529323|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83529324|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529325|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529326|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83529327|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83529328|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529329|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
83529330|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529331|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83529332|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
83529333|NCT00370019|Estradiol|estradiol|mesh-list
83529334|NCT00370019|Estrogens|estrogens|mesh-ancestor
83529335|NCT00370019|Hormones|hormones|mesh-ancestor
83529336|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529337|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529338|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83529339|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
83529340|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83529341|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83529342|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83529343|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83529344|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83529345|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83529346|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83529347|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529348|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83529349|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83529350|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
83529351|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83529352|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83529353|NCT04969211|Iloperidone|iloperidone|mesh-list
83529354|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83529355|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83529356|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529357|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529358|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83529359|NCT01901575|Remifentanil|remifentanil|mesh-list
83529360|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83529361|NCT01901575|Narcotics|narcotics|mesh-ancestor
83529362|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529363|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529364|NCT01901575|Analgesics|analgesics|mesh-ancestor
83529365|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
83529366|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529367|NCT03754049|Dexamethasone|dexamethasone|mesh-list
83529368|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
83529369|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83529370|NCT03754049|BB 1101|bb 1101|mesh-list
83529371|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83529372|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
83529373|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
83529374|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529375|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529376|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83529377|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
83529378|NCT03754049|Hormones|hormones|mesh-ancestor
83529379|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529380|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83529381|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529382|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
83529383|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529384|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529385|NCT01901809|Dopamine|dopamine|mesh-list
83529386|NCT01901809|Furosemide|furosemide|mesh-list
83529387|NCT01901809|Diuretics|diuretics|mesh-ancestor
83529388|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
83529389|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529390|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83529391|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83529392|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529393|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83529394|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
83529395|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
83529396|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529397|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
83529398|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529399|NCT01901809|Protective Agents|protective agents|mesh-ancestor
83529400|NCT04947527|Fluorides|fluorides|mesh-list
83529401|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
83529402|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
83529403|NCT04947527|Protective Agents|protective agents|mesh-ancestor
83529404|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529405|NCT05005403|Pembrolizumab|pembrolizumab|mesh-list
83529406|NCT05005403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83529407|NCT05005403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529408|NCT05005403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83529409|NCT05005403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529410|NCT03029533|Leuprolide|leuprolide|mesh-list
83529411|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83529412|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
83529413|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83529414|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529415|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83529416|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529418|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
83529419|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
83529420|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529421|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529422|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
83529423|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529424|NCT01904071|Morphine|morphine|mesh-list
83529425|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83529426|NCT01904071|Narcotics|narcotics|mesh-ancestor
83529427|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529428|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529429|NCT01904071|Analgesics|analgesics|mesh-ancestor
83529430|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
83529431|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529432|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83529433|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83529434|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83529435|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
83529436|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529437|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83529438|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83529439|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529440|NCT01907113|Empagliflozin|empagliflozin|mesh-list
83529441|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83529442|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529443|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83529444|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529445|NCT00370643|Insulin|insulin|mesh-list
83529446|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83529447|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83529448|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529449|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
83529450|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529451|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
83529452|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
83529453|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
83529454|NCT04679831|Praziquantel|praziquantel|mesh-list
83529455|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
83529456|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83529457|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529458|NCT01908751|Vitamin D|vitamin d|mesh-list
83529459|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
83529460|NCT01908751|Cholecalciferol|cholecalciferol|mesh-list
83529461|NCT01908751|Vitamins|vitamins|mesh-list
83529462|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
83529463|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529464|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83529465|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83529466|NCT00370721|Bevacizumab|bevacizumab|mesh-list
83529467|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83529468|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529469|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83529470|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83529471|NCT00370721|Growth Substances|growth substances|mesh-ancestor
83529472|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529473|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
83529474|NCT01909141|Metformin|metformin|mesh-list
83529475|NCT01909141|Pioglitazone|pioglitazone|mesh-list
83529476|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
83529477|NCT01909141|Letrozole|letrozole|mesh-list
83529478|NCT01909141|Clomiphene|clomiphene|mesh-list
83529479|NCT01909141|Enclomiphene|enclomiphene|mesh-list
83529480|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
83529481|NCT01909141|Hormones|hormones|mesh-list
83529482|NCT01909141|Estradiol|estradiol|mesh-list
83529483|NCT01909141|Testosterone|testosterone|mesh-list
83529484|NCT01909141|Progesterone|progesterone|mesh-list
83529485|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83529486|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83529487|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529488|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529489|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529490|NCT01909141|Estrogens|estrogens|mesh-ancestor
83529491|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83529493|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83529494|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83529495|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529496|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83529497|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
83529498|NCT01909141|Androgens|androgens|mesh-ancestor
83529499|NCT01909141|Progestins|progestins|mesh-ancestor
83529500|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83529501|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529502|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83529503|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
83529504|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83529505|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83529506|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
83529507|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83529508|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
83529509|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83529510|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
83529511|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529512|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529513|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
83529514|NCT01910311|Rifampin|rifampin|mesh-list
83529515|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83529516|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
83529517|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83529518|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529519|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
83529520|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83529521|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529522|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529523|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83529524|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83529525|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83529526|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83529527|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83529528|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83529529|NCT04404959|Ropivacaine|ropivacaine|mesh-list
83529530|NCT04404959|Anesthetics|anesthetics|mesh-list
83529531|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
83529532|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529533|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529534|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
83529535|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529536|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
83529537|NCT04403711|Anesthetics|anesthetics|mesh-list
83529538|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
83529539|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83529540|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529541|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529542|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83529543|NCT04403711|Analgesics|analgesics|mesh-ancestor
83529544|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
83529545|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529546|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83529547|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83529548|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83529549|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
83529550|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529551|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529552|NCT01911169|Vitamin D|vitamin d|mesh-list
83529553|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
83529554|NCT01911169|Vitamins|vitamins|mesh-list
83529555|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
83529556|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529557|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83529558|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83529559|NCT04403087|Trimebutine|trimebutine|mesh-list
83529560|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83529561|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
83529562|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
83529563|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529564|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529565|NCT04358393|Azacitidine|azacitidine|mesh-list
83529566|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83529567|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
83529568|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529569|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529570|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529571|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
83529572|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83529573|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
83529574|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529575|NCT04748887|Protective Agents|protective agents|mesh-ancestor
83529576|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529577|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
83529578|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83529579|NCT01916629|Protective Agents|protective agents|mesh-ancestor
83529580|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529581|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
83529582|NCT01916941|Prazosin|prazosin|mesh-list
83529583|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83529584|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83529585|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83529586|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83529587|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
83529588|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529589|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529590|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529591|NCT05732701|Oxymetazoline|oxymetazoline|mesh-list
83529592|NCT05732701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83529593|NCT05732701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83529594|NCT05732701|Adrenergic Agents|adrenergic agents|mesh-ancestor
83529595|NCT05732701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529596|NCT05732701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529597|NCT05732701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529598|NCT05732701|Sympathomimetics|sympathomimetics|mesh-ancestor
83529599|NCT05732701|Autonomic Agents|autonomic agents|mesh-ancestor
83529600|NCT05732701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529601|NCT05732701|Nasal Decongestants|nasal decongestants|mesh-ancestor
83529602|NCT05732701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83529603|NCT05732701|Respiratory System Agents|respiratory system agents|mesh-ancestor
83529604|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
83529605|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529606|NCT04210037|Paclitaxel|paclitaxel|mesh-list
83529607|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83529608|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529609|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
83529610|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
83529611|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
83529612|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529613|NCT03273023|Chromium|chromium|mesh-list
83529614|NCT03273023|Everolimus|everolimus|mesh-list
83529615|NCT03273023|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83529616|NCT03273023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83529617|NCT03273023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529618|NCT03273023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529619|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83529620|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
83529621|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529622|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529623|NCT03273023|Trace Elements|trace elements|mesh-ancestor
83529624|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
83529625|NCT00371501|Aspirin|aspirin|mesh-list
83529626|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83529627|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83529628|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83529629|NCT00371501|Analgesics|analgesics|mesh-ancestor
83529630|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
83529631|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529632|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529633|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83529634|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83529635|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83529636|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83529637|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529638|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83529639|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83529643|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83529644|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
83529645|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83529646|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83529647|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
83529648|NCT03251651|Propofol|propofol|mesh-list
83529649|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83529650|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529651|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529652|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83529653|NCT03251651|Analgesics|analgesics|mesh-ancestor
83529654|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
83529655|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529656|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83529657|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83529658|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83529659|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
83529660|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529661|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529662|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83529663|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
83529664|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
83529665|NCT05738707|Vaccines|vaccines|mesh-list
83529666|NCT05738707|Immunologic Factors|immunologic factors|mesh-ancestor
83529667|NCT05738707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529668|NCT05738629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83529669|NCT05738629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83529670|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
83529671|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83529672|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83529673|NCT05349071|Prednisolone|prednisolone|mesh-list
83529674|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
83529675|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83529676|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
83529677|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83529678|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
83529679|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
83529680|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529681|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529682|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83529683|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
83529684|NCT05349071|Hormones|hormones|mesh-ancestor
83529685|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529686|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83529687|NCT05349071|Protective Agents|protective agents|mesh-ancestor
83529688|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83529689|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529690|NCT01929889|Iloperidone|iloperidone|mesh-list
83529691|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83529692|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83529693|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529694|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529695|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83529696|NCT05738473|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83529697|NCT05738473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529698|NCT04335461|Anesthetics|anesthetics|mesh-list
83529699|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
83529700|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529701|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529702|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
83529703|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529704|NCT05725135|Propofol|propofol|mesh-list
83529705|NCT05725135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83529706|NCT05725135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83529707|NCT05725135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529708|NCT05725135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83529709|NCT05725135|Anesthetics, General|anesthetics, general|mesh-ancestor
83529710|NCT05725135|Anesthetics|anesthetics|mesh-ancestor
83529711|NCT05738317|Paclitaxel|paclitaxel|mesh-list
83529712|NCT05738317|Bevacizumab|bevacizumab|mesh-list
83529713|NCT05738317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83529714|NCT05738317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529715|NCT05738317|Tubulin Modulators|tubulin modulators|mesh-ancestor
83529716|NCT05738317|Antimitotic Agents|antimitotic agents|mesh-ancestor
83529718|NCT05738317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529719|NCT05738317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83529721|NCT05738317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83529722|NCT05738317|Growth Substances|growth substances|mesh-ancestor
83529723|NCT05738317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529724|NCT05738317|Growth Inhibitors|growth inhibitors|mesh-ancestor
83529725|NCT02284555|Mupirocin|mupirocin|mesh-list
83529726|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83529727|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529728|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83529729|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529730|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529731|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
83529732|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83529733|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83529734|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
83529735|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529736|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83529737|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83529738|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529739|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529740|NCT02287909|Clopidogrel|clopidogrel|mesh-list
83529741|NCT02287909|Ticagrelor|ticagrelor|mesh-list
83529742|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83529743|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83529744|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83529745|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83529746|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
83529747|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529748|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529749|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529751|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
83529752|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529753|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83529754|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83529755|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83529756|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
83529757|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529758|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83529759|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83529760|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529761|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
83529762|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
83529763|NCT02833805|Fludarabine|fludarabine|mesh-list
83529764|NCT02833805|Tacrolimus|tacrolimus|mesh-list
83529765|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
83529766|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83529767|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83529768|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
83529769|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529770|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83529771|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83529772|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
83529773|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529774|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529775|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83529776|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83529777|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529778|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83529779|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83529780|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
83529781|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83529782|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529783|NCT02327195|Methylphenidate|methylphenidate|mesh-list
83529784|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83529785|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529786|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83529787|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83529788|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83529789|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529790|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
83529791|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529792|NCT04768465|Prednisone|prednisone|mesh-list
83529793|NCT04768465|Bromides|bromides|mesh-list
83529794|NCT04768465|Tacrolimus|tacrolimus|mesh-list
83529795|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83529796|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83529797|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
83529798|NCT04768465|Hormones|hormones|mesh-ancestor
83529799|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529800|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529801|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83529802|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529803|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83529804|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
83529805|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83529806|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529807|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529808|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
83529809|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83529810|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
83529811|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529812|NCT05448547|Hormones|hormones|mesh-list
83529813|NCT05448547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529814|NCT05448547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529815|NCT01614665|Tacrolimus|tacrolimus|mesh-list
83529816|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83529817|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
83529818|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529819|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83529820|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529821|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529822|NCT05691829|Pembrolizumab|pembrolizumab|mesh-list
83529823|NCT05691829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83529824|NCT05691829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529825|NCT05691829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83529826|NCT05691829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529827|NCT00371735|Artesunate|artesunate|mesh-list
83529828|NCT00371735|Dapsone|dapsone|mesh-list
83529829|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
83529830|NCT00371735|Proguanil|proguanil|mesh-list
83529831|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
83529832|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83529833|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83529834|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529835|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529836|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
83529837|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
83529838|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83529839|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
83529840|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83529841|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529842|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529843|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
83529844|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83529845|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
83529846|NCT05052307|Vaccines|vaccines|mesh-list
83529847|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
83529848|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529849|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83529850|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83529851|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
83529852|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529853|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529854|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529855|NCT05417659|Niacin|niacin|mesh-list
83529856|NCT05417659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83529857|NCT05417659|Antimetabolites|antimetabolites|mesh-ancestor
83529858|NCT05417659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529859|NCT05417659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83529860|NCT05417659|Vasodilator Agents|vasodilator agents|mesh-ancestor
83529861|NCT05417659|Vitamin B Complex|vitamin b complex|mesh-ancestor
83529862|NCT05417659|Vitamins|vitamins|mesh-ancestor
83529863|NCT05417659|Micronutrients|micronutrients|mesh-ancestor
83529864|NCT05417659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529865|NCT02762513|Axitinib|axitinib|mesh-list
83529866|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529945|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529867|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83529868|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529869|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529870|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
83529871|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83529872|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
83529873|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529874|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
83529875|NCT02958761|Protective Agents|protective agents|mesh-ancestor
83529876|NCT05215535|Liver Extracts|liver extracts|mesh-list
83529877|NCT05215535|Hematinics|hematinics|mesh-ancestor
83529878|NCT02767271|Luliconazole|luliconazole|mesh-list
83529879|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
83529880|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529881|NCT05647993|Azithromycin|azithromycin|mesh-list
83529882|NCT05647993|Cefazolin|cefazolin|mesh-list
83529883|NCT05647993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83529884|NCT05647993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529885|NCT02741687|Insulin|insulin|mesh-list
83529886|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83529887|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
83529888|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83529889|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
83529890|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
83529891|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
83529892|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83529893|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529894|NCT02741687|Incretins|incretins|mesh-ancestor
83529895|NCT02741687|Hormones|hormones|mesh-ancestor
83529896|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529897|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83529898|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
83529899|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529900|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529901|NCT05361499|Amoxicillin|amoxicillin|mesh-list
83529902|NCT05361499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83529903|NCT05361499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529904|NCT04337099|Tempol|tempol|mesh-list
83529905|NCT04337099|TEMPO|tempo|mesh-list
83529906|NCT04337099|TEMPOL-H|tempol-h|mesh-list
83529907|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
83529908|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529909|NCT04337099|Protective Agents|protective agents|mesh-ancestor
83529910|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529911|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83529912|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529913|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83529914|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83529915|NCT05630677|Rabeprazole|rabeprazole|mesh-list
83529916|NCT05630677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83529917|NCT05630677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83529918|NCT05630677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83529919|NCT05630677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529920|NCT05630677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529921|NCT05627791|Oxytocin|oxytocin|mesh-list
83529922|NCT05627791|Oxytocics|oxytocics|mesh-ancestor
83529923|NCT05627791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83529924|NCT05627791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529925|NCT02771093|Alogliptin|alogliptin|mesh-list
83529926|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83529927|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529928|NCT02771093|Incretins|incretins|mesh-ancestor
83529929|NCT02771093|Hormones|hormones|mesh-ancestor
83529930|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529931|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83529932|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
83529933|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529934|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529935|NCT05306587|Daratumumab|daratumumab|mesh-list
83529936|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529937|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
83529938|NCT04337879|Irinotecan|irinotecan|mesh-list
83529939|NCT04337879|Calcium|calcium|mesh-list
83529940|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83529941|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529942|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529943|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83529944|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83529946|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529947|NCT02745353|Naloxegol|naloxegol|mesh-list
83529948|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83529949|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529950|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
83529951|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83529952|NCT04778839|Paclitaxel|paclitaxel|mesh-list
83529953|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83529954|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83529955|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529956|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
83529957|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
83529958|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
83529959|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529960|NCT05602207|Abrocitinib|abrocitinib|mesh-list
83529961|NCT05602207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83529962|NCT05602207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529963|NCT05602207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529964|NCT05598619|Ascorbic Acid|ascorbic acid|mesh-list
83529965|NCT05598619|Vitamins|vitamins|mesh-ancestor
83529966|NCT05598619|Micronutrients|micronutrients|mesh-ancestor
83529967|NCT05598619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529968|NCT05598619|Antioxidants|antioxidants|mesh-ancestor
83529969|NCT05598619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529971|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83529972|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83529973|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
83529974|NCT02746991|Hormones|hormones|mesh-ancestor
83529975|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83529976|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529977|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
83529978|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83529979|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83529980|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529981|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
83529982|NCT02747615|Coagulants|coagulants|mesh-ancestor
83529983|NCT02775617|Azithromycin|azithromycin|mesh-list
83529984|NCT02775617|Ivermectin|ivermectin|mesh-list
83529985|NCT02775617|Permethrin|permethrin|mesh-list
83529986|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83529987|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83529988|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83529989|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529990|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529991|NCT00371813|Varenicline|varenicline|mesh-list
83529992|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83529993|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83529994|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
83529995|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529996|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83529997|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83529998|NCT02748785|Methotrexate|methotrexate|mesh-list
83529999|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83530000|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
83530001|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83530002|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530003|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83530004|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
83530005|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530006|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530007|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83530008|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530009|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83530010|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83530011|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
83530012|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530013|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83530014|NCT02295553|Ketamine|ketamine|mesh-list
83530015|NCT02295553|Propofol|propofol|mesh-list
83530016|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83530017|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530018|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530019|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83530020|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
83530021|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
83530023|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
83530024|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530025|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83530026|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83530027|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83530028|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530029|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530031|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
83530032|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
83530033|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530034|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530035|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
83530036|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530037|NCT05455073|Folic Acid|folic acid|mesh-list
83530038|NCT05455073|Hematinics|hematinics|mesh-ancestor
83530039|NCT05455073|Vitamin B Complex|vitamin b complex|mesh-ancestor
83530040|NCT05455073|Vitamins|vitamins|mesh-ancestor
83530041|NCT05455073|Micronutrients|micronutrients|mesh-ancestor
83530042|NCT05455073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530043|NCT04334993|Blinatumomab|blinatumomab|mesh-list
83530044|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530045|NCT05349929|Ibuprofen|ibuprofen|mesh-list
83530046|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83530047|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83530048|NCT05349929|Analgesics|analgesics|mesh-ancestor
83530049|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
83530050|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530051|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530052|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83530053|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530054|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83530055|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530056|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530057|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83530058|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83530059|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530060|NCT05559931|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83530061|NCT05559931|Hallucinogens|hallucinogens|mesh-ancestor
83530062|NCT05559931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530063|NCT05559931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83530064|NCT05559931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83530065|NCT05559931|Serotonin Agents|serotonin agents|mesh-ancestor
83530066|NCT05559931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530067|NCT05559931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530068|NCT05559931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83530069|NCT04669171|Rituximab|rituximab|mesh-list
83530070|NCT04669171|Lenalidomide|lenalidomide|mesh-list
83530071|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83530072|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530073|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
83530074|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530075|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530076|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83530077|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83530078|NCT04669171|Growth Substances|growth substances|mesh-ancestor
83530079|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
83530080|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
83530081|NCT04757675|Ketamine|ketamine|mesh-list
83530082|NCT04757675|Esketamine|esketamine|mesh-list
83530083|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83530084|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530085|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530086|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83530087|NCT04757675|Analgesics|analgesics|mesh-ancestor
83530088|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
83530089|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530090|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83530091|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83530092|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83530093|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
83530094|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530095|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530096|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83530097|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83530098|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
83530099|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
83530100|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83530101|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83530102|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
83530103|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83530104|NCT04611529|Ibuprofen|ibuprofen|mesh-list
83530105|NCT04611529|Diclofenac|diclofenac|mesh-list
83530106|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83530107|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83530108|NCT04611529|Analgesics|analgesics|mesh-ancestor
83530109|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
83530110|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530111|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530112|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83530113|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530114|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83530115|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530116|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530117|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
83530118|NCT05323721|Piperaquine|piperaquine|mesh-list
83530119|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
83530120|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83530121|NCT05323721|Amodiaquine|amodiaquine|mesh-list
83530122|NCT05323721|Artenimol|artenimol|mesh-list
83530123|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
83530124|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83530125|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83530126|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530127|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83530128|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530129|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530130|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83530131|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
83530132|NCT05288075|Charcoal|charcoal|mesh-list
83530133|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83530134|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83530135|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83530136|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
83530137|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530138|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530139|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530140|NCT05288075|Antidotes|antidotes|mesh-ancestor
83530141|NCT05288075|Protective Agents|protective agents|mesh-ancestor
83530142|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
83530143|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83530144|NCT05272787|Protective Agents|protective agents|mesh-ancestor
83530145|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530146|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
83530147|NCT05145569|Paclitaxel|paclitaxel|mesh-list
83530148|NCT05145569|Carboplatin|carboplatin|mesh-list
83530149|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83530150|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530151|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
83530152|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
83530153|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
83530154|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530155|NCT04566991|Deferoxamine|deferoxamine|mesh-list
83530156|NCT04566991|Siderophores|siderophores|mesh-ancestor
83530157|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83530158|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
83530159|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
83530160|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530161|NCT04645823|Lidocaine|lidocaine|mesh-list
83530162|NCT04645823|Fentanyl|fentanyl|mesh-list
83530163|NCT04645823|Citric Acid|citric acid|mesh-list
83530164|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
83530165|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
83530166|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
83530167|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530168|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530169|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
83530170|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530171|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83530172|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83530173|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83530174|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83530175|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530176|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83530177|NCT04645823|Narcotics|narcotics|mesh-ancestor
83530178|NCT04645823|Analgesics|analgesics|mesh-ancestor
83530179|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83530180|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83530181|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
83530182|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
83530183|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83530184|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
83530185|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
83530186|NCT03763175|Lovastatin|lovastatin|mesh-list
83530187|NCT03763175|L 647318|l 647318|mesh-list
83530188|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
83530189|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83530190|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83530191|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
83530192|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530193|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83530194|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83530195|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530197|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83530198|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530199|NCT04365049|Paclitaxel|paclitaxel|mesh-list
83530200|NCT04365049|Gemcitabine|gemcitabine|mesh-list
83530201|NCT04365049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83530202|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530203|NCT04365049|Tubulin Modulators|tubulin modulators|mesh-ancestor
83530204|NCT04365049|Antimitotic Agents|antimitotic agents|mesh-ancestor
83530205|NCT04365049|Mitosis Modulators|mitosis modulators|mesh-ancestor
83530206|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530207|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83530208|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
83530209|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
83530210|NCT04606901|Neostigmine|neostigmine|mesh-list
83530211|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83530212|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530213|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530214|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
83530215|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530216|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530217|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83530218|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
83530219|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530220|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83530221|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83530222|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83530223|NCT03092011|Clonidine|clonidine|mesh-list
83530224|NCT03092011|Morphine|morphine|mesh-list
83530225|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83530226|NCT03092011|Narcotics|narcotics|mesh-ancestor
83530227|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530228|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530229|NCT03092011|Analgesics|analgesics|mesh-ancestor
83530230|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
83530231|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530232|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83530233|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
83530234|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
83530235|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83530236|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83530237|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83530238|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
83530239|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530240|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530241|NCT00372515|Gefitinib|gefitinib|mesh-list
83530242|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530243|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83530244|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530245|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530246|NCT04448119|Favipiravir|favipiravir|mesh-list
83530247|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
83530248|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530249|NCT04706507|Ganciclovir|ganciclovir|mesh-list
83530250|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83530251|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
83530252|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530253|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83530254|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530255|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530256|NCT03047473|Avelumab|avelumab|mesh-list
83530257|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83530258|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530259|NCT03069131|Rifaximin|rifaximin|mesh-list
83530260|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83530261|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530262|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83530263|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
83530264|NCT02990845|Leuprolide|leuprolide|mesh-list
83530265|NCT02990845|Exemestane|exemestane|mesh-list
83530266|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83530267|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530268|NCT02990845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83530269|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530270|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83530271|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
83530272|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83530273|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530274|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83530275|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83530276|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83530277|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530278|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83530279|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
83530280|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83530281|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
83530282|NCT04438213|Metolazone|metolazone|mesh-list
83530283|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83530284|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530285|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83530286|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530287|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83530288|NCT04438213|Diuretics|diuretics|mesh-ancestor
83530289|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
83530290|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83530291|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83530292|NCT01987219|Bromides|bromides|mesh-list
83530293|NCT01987219|Albuterol|albuterol|mesh-list
83530294|NCT01987219|Ipratropium|ipratropium|mesh-list
83530295|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
83530296|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83530297|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
83530298|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530299|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530300|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83530301|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
83530302|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
83530303|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83530304|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83530305|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83530306|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83530307|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
83530308|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530309|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530310|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83530311|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
83530312|NCT02917993|Osimertinib|osimertinib|mesh-list
83530313|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530314|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83530315|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530316|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530317|NCT04405349|Atezolizumab|atezolizumab|mesh-list
83530318|NCT04405349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83530319|NCT04405349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530320|NCT04405349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83530321|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530322|NCT04265053|Ketorolac|ketorolac|mesh-list
83530329|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83530330|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530331|NCT04265053|Androgens|androgens|mesh-ancestor
83530332|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83530333|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83530334|NCT04265053|Analgesics|analgesics|mesh-ancestor
83530335|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
83530336|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530337|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83530338|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530339|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83530340|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530341|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530342|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
83530343|NCT04332497|Ibuprofen|ibuprofen|mesh-list
83530344|NCT04332497|Fentanyl|fentanyl|mesh-list
83530345|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83530346|NCT04332497|Narcotics|narcotics|mesh-ancestor
83530347|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530348|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530349|NCT04332497|Analgesics|analgesics|mesh-ancestor
83530350|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
83530351|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530352|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83530353|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83530354|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
83530355|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
83530356|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83530357|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83530358|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83530359|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530360|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83530361|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530362|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530363|NCT02633137|Cytarabine|cytarabine|mesh-list
83530364|NCT02633137|Lenalidomide|lenalidomide|mesh-list
83530365|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83530366|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
83530367|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530368|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530369|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
83530370|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530371|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83530372|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
83530373|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530374|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83530375|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83530376|NCT02633137|Growth Substances|growth substances|mesh-ancestor
83530377|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
83530378|NCT04258397|Pirfenidone|pirfenidone|mesh-list
83530379|NCT04258397|Analgesics|analgesics|mesh-ancestor
83530380|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
83530381|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530382|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530383|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83530384|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83530385|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83530386|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530387|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530388|NCT04707209|Sirolimus|sirolimus|mesh-list
83530389|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83530390|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530391|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83530392|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530393|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
83530394|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83530395|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
83530396|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530397|NCT01989793|Losartan|losartan|mesh-list
83530398|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83530399|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83530400|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83530401|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83530402|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530404|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83530405|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83530406|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83530407|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83530408|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
83530409|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530410|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530411|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530412|NCT04188665|Lectins|lectins|mesh-list
83530413|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
83530414|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
83530415|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530416|NCT04188665|Coagulants|coagulants|mesh-ancestor
83530417|NCT04186247|Azithromycin|azithromycin|mesh-list
83530418|NCT04186247|Metronidazole|metronidazole|mesh-list
83530419|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83530420|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530421|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83530422|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83530423|NCT04181255|Poractant alfa|poractant alfa|mesh-list
83530424|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83530425|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
83530426|NCT00373373|Sorafenib|sorafenib|mesh-list
83530427|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530428|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83530429|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530430|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530431|NCT00373451|Heparin|heparin|mesh-list
83530432|NCT00373451|Calcium heparin|calcium heparin|mesh-list
83530433|NCT00373451|Bivalirudin|bivalirudin|mesh-list
83530434|NCT00373451|Abciximab|abciximab|mesh-list
83530435|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
83530436|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83530437|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83530438|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530439|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
83530440|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83530441|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
83530442|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530443|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83530444|NCT01387763|Interferons|interferons|mesh-list
83530445|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
83530446|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
83530447|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83530448|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83530449|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
83530450|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530451|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
83530452|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530453|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
83530454|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530455|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
83530456|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530457|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530458|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83530459|NCT00373061|Omalizumab|omalizumab|mesh-list
83530460|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83530461|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83530462|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
83530463|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
83530464|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
83530465|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530466|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
83530467|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530468|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
83530469|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83530470|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
83530471|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530472|NCT01993849|Expectorants|expectorants|mesh-ancestor
83530473|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
83530474|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83530475|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
83530476|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530477|NCT01993849|Protective Agents|protective agents|mesh-ancestor
83530478|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530479|NCT01993849|Antidotes|antidotes|mesh-ancestor
83530480|NCT02778113|Glucagon|glucagon|mesh-list
83530481|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83530482|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83530483|NCT02778113|Hormones|hormones|mesh-ancestor
83530484|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83530485|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530486|NCT02778113|Incretins|incretins|mesh-ancestor
83530487|NCT04982237|Paclitaxel|paclitaxel|mesh-list
83530488|NCT04982237|Bevacizumab|bevacizumab|mesh-list
83530489|NCT04982237|Carboplatin|carboplatin|mesh-list
83530490|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83530491|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530492|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
83530493|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
83530494|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
83530495|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530496|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83530497|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83530498|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83530499|NCT04982237|Growth Substances|growth substances|mesh-ancestor
83530500|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530501|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
83530502|NCT01996657|Warfarin|warfarin|mesh-list
83530503|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
83530504|NCT02316379|Xenon|xenon|mesh-list
83530505|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83530506|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
83530507|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
83530508|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530509|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530510|NCT02303977|Gemcitabine|gemcitabine|mesh-list
83530511|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83530512|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83530513|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
83530514|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530515|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530516|NCT01997515|Ketamine|ketamine|mesh-list
83530517|NCT01997515|Analgesics|analgesics|mesh-ancestor
83530518|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
83530519|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530520|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530521|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83530522|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83530523|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
83530524|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
83530525|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530526|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83530527|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83530528|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530529|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530530|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
83530531|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83530532|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530533|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83530534|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530535|NCT01997905|Protein S|protein s|mesh-list
83530536|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
83530537|NCT02788019|Ropivacaine|ropivacaine|mesh-list
83530538|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
83530539|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
83530540|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530541|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530542|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
83530543|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530544|NCT02788097|Progesterone|progesterone|mesh-list
83530545|NCT02788097|Progestins|progestins|mesh-ancestor
83530546|NCT02788097|Hormones|hormones|mesh-ancestor
83530547|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83530548|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530549|NCT02789033|Isosorbide|isosorbide|mesh-list
83530550|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83530551|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83530552|NCT02789033|Chitosan|chitosan|mesh-list
83530553|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83530554|NCT02789033|Diuretics|diuretics|mesh-ancestor
83530555|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
83530556|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530557|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
83530559|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530560|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83530561|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83530562|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
83530563|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83530564|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
83530565|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
83530566|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
83530567|NCT02789033|Coagulants|coagulants|mesh-ancestor
83530568|NCT00372827|Travoprost|travoprost|mesh-list
83530569|NCT00372827|Brinzolamide|brinzolamide|mesh-list
83530570|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83530571|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83530572|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530573|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530574|NCT02278315|Dexamethasone|dexamethasone|mesh-list
83530575|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83530577|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
83530578|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530579|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530580|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83530581|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
83530582|NCT02278315|Hormones|hormones|mesh-ancestor
83530583|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83530584|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83530585|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530586|NCT02795117|Ivermectin|ivermectin|mesh-list
83530587|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83530588|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530589|NCT02882633|Bupivacaine|bupivacaine|mesh-list
83530590|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
83530591|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
83530592|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530593|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530594|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
83530595|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530596|NCT00373607|Artesunate|artesunate|mesh-list
83530597|NCT00373607|Piperaquine|piperaquine|mesh-list
83530598|NCT00373607|Mefloquine|mefloquine|mesh-list
83530599|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
83530600|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83530601|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83530602|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530603|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530604|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
83530605|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
83530606|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83530607|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
83530608|NCT02882711|Ketamine|ketamine|mesh-list
83530609|NCT02882711|Analgesics|analgesics|mesh-ancestor
83530610|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
83530611|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530612|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530613|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83530614|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83530615|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
83530616|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
83530617|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530618|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83530619|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83530620|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530621|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530622|NCT02794337|Sorafenib|sorafenib|mesh-list
83530623|NCT02794337|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83530624|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530625|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83530626|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530627|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530628|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
83530629|NCT02590523|Vancomycin|vancomycin|mesh-list
83530630|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83530631|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530632|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83530633|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83530634|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530635|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530712|NCT02003911|Azithromycin|azithromycin|mesh-list
83530636|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530637|NCT02895035|Ketorolac|ketorolac|mesh-list
83530638|NCT02895035|Phenylephrine|phenylephrine|mesh-list
83530639|NCT02895035|Epinephrine|epinephrine|mesh-list
83530640|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
83530641|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83530642|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83530643|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
83530644|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530645|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530646|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530647|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83530648|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83530649|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
83530650|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530651|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83530652|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
83530653|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
83530654|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
83530655|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83530656|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83530657|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83530658|NCT02895035|Analgesics|analgesics|mesh-ancestor
83530659|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
83530660|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83530661|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530662|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83530663|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530664|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83530665|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
83530666|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83530667|NCT02895035|Protective Agents|protective agents|mesh-ancestor
83530668|NCT02802449|Vitamin D|vitamin d|mesh-list
83530669|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
83530670|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
83530671|NCT02802449|Calcifediol|calcifediol|mesh-list
83530672|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83530673|NCT02802449|Vitamins|vitamins|mesh-list
83530674|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
83530675|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530676|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83530677|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83530678|NCT02803229|Amphetamine|amphetamine|mesh-list
83530679|NCT02803229|Adderall|adderall|mesh-list
83530680|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83530681|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530682|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
83530683|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
83530684|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530685|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
83530686|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530687|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530688|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
83530689|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83530690|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83530691|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83530692|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83530693|NCT01938001|Rituximab|rituximab|mesh-list
83530694|NCT01938001|Lenalidomide|lenalidomide|mesh-list
83530695|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83530696|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530697|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
83530698|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530699|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530700|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83530701|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83530702|NCT01938001|Growth Substances|growth substances|mesh-ancestor
83530703|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
83530704|NCT02805179|Temozolomide|temozolomide|mesh-list
83530705|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83530706|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
83530707|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530708|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530709|NCT02896595|Anesthetics|anesthetics|mesh-list
83530710|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530711|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530713|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83530714|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530715|NCT04147351|Bevacizumab|bevacizumab|mesh-list
83530716|NCT04147351|Atezolizumab|atezolizumab|mesh-list
83530717|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83530718|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530719|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83530720|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83530721|NCT04147351|Growth Substances|growth substances|mesh-ancestor
83530722|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530723|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
83530724|NCT04147351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83530725|NCT04147351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530726|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
83530727|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83530728|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530729|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530730|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83530731|NCT02004613|Analgesics|analgesics|mesh-ancestor
83530732|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
83530733|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530734|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83530735|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83530736|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83530737|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
83530738|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530739|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530740|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
83530741|NCT01754779|Citric Acid|citric acid|mesh-list
83530742|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
83530743|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
83530744|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83530745|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
83530746|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
83530747|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530748|NCT01754779|Diuretics|diuretics|mesh-ancestor
83530749|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
83530750|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530751|NCT01754779|Expectorants|expectorants|mesh-ancestor
83530752|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
83530753|NCT02149277|Lenograstim|lenograstim|mesh-list
83530754|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83530755|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
83530756|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530757|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
83530758|NCT02896907|Vitamins|vitamins|mesh-list
83530759|NCT02896907|Leucovorin|leucovorin|mesh-list
83530760|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
83530761|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
83530762|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83530763|NCT02896907|Fluorouracil|fluorouracil|mesh-list
83530764|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
83530765|NCT02896907|Irinotecan|irinotecan|mesh-list
83530766|NCT02896907|Camptothecin|camptothecin|mesh-list
83530767|NCT02896907|Calcium|calcium|mesh-list
83530768|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
83530769|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
83530770|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530771|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83530772|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83530773|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
83530774|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530775|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83530776|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530777|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83530778|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
83530779|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83530780|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83530781|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530782|NCT02896907|Antidotes|antidotes|mesh-ancestor
83530783|NCT02896907|Protective Agents|protective agents|mesh-ancestor
83530784|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
83530785|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
83530786|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83530787|NCT02005549|Bevacizumab|bevacizumab|mesh-list
83530788|NCT02005549|Docetaxel|docetaxel|mesh-list
83530789|NCT02005549|Capecitabine|capecitabine|mesh-list
83530790|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83530791|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530792|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83530793|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83530794|NCT02005549|Growth Substances|growth substances|mesh-ancestor
83530795|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530796|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
83530797|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
83530798|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
83530799|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
83530800|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530801|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83530802|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
83530803|NCT04349696|Mitiglinide|mitiglinide|mesh-list
83530804|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83530805|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530807|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
83530808|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83530809|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83530810|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530811|NCT02810873|Trace Elements|trace elements|mesh-ancestor
83530812|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
83530813|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530814|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
83530815|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
83530816|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530817|NCT04492358|Prednisone|prednisone|mesh-list
83530818|NCT04492358|Colchicine|colchicine|mesh-list
83530819|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83530820|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
83530821|NCT04492358|Hormones|hormones|mesh-ancestor
83530822|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83530823|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530824|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83530825|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530826|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
83530827|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530828|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
83530829|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
83530830|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
83530831|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530832|NCT03488420|Edoxaban|edoxaban|mesh-list
83530833|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83530834|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
83530835|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83530836|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
83530837|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530838|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530839|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
83530840|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
83530841|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
83530842|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83530843|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83530844|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530845|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83530846|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530847|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530848|NCT01959685|Enclomiphene|enclomiphene|mesh-list
83530849|NCT01959685|Clomiphene|clomiphene|mesh-list
83530850|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
83530851|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83530852|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
83530853|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83530854|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530855|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83530856|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
83530857|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83530858|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83530859|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83530860|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
83530861|NCT02901899|Guadecitabine|guadecitabine|mesh-list
83530862|NCT02901899|Azacitidine|azacitidine|mesh-list
83530863|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83530864|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530865|NCT02901899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83530866|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530867|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83530869|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530870|NCT04333589|Favipiravir|favipiravir|mesh-list
83530871|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
83530872|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530873|NCT02902913|Ibuprofen|ibuprofen|mesh-list
83530874|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83530875|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83530876|NCT02902913|Analgesics|analgesics|mesh-ancestor
83530877|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
83530878|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530879|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530880|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83530881|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530882|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83530883|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530884|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530885|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
83530887|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
83530888|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530889|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530890|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83530891|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83530892|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
83530893|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530894|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530895|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
83530896|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
83530897|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83530898|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83530899|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530900|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530901|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530902|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530903|NCT02301416|Topiramate|topiramate|mesh-list
83530904|NCT02301416|Phentermine|phentermine|mesh-list
83530905|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
83530906|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83530907|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530908|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83530909|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
83530910|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83530911|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
83530912|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
83530913|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530914|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
83530915|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530916|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530917|NCT02815709|Morphine|morphine|mesh-list
83530918|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83530919|NCT02815709|Narcotics|narcotics|mesh-ancestor
83530920|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530921|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530922|NCT02815709|Analgesics|analgesics|mesh-ancestor
83530923|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
83530924|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530925|NCT02912195|Lidocaine|lidocaine|mesh-list
83530926|NCT02912195|Morphine|morphine|mesh-list
83530927|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
83530928|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
83530929|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530930|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530931|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
83530932|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530933|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83530934|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83530935|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83530936|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83530937|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530938|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83530939|NCT02912195|Narcotics|narcotics|mesh-ancestor
83530940|NCT02912195|Analgesics|analgesics|mesh-ancestor
83530941|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
83530947|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530948|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
83530949|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83530950|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530951|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
83530952|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83530953|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530954|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83530955|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83530956|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83530957|NCT01988246|Aflibercept|aflibercept|mesh-list
83530958|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83530959|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83530960|NCT01988246|Growth Substances|growth substances|mesh-ancestor
83530961|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530962|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
83530963|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530964|NCT01990898|Cyclosporine|cyclosporine|mesh-list
83530965|NCT01990898|Cyclosporins|cyclosporins|mesh-list
83530966|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530967|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530968|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83530969|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
83530970|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530971|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
83530972|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530973|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
83530974|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83530975|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83530976|NCT01960387|Cytarabine|cytarabine|mesh-list
83530977|NCT01960387|Clofarabine|clofarabine|mesh-list
83530978|NCT01960387|Antimetabolites|antimetabolites|mesh-list
83530979|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83530980|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530981|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83530982|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
83530983|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83530984|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83530985|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
83530986|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530987|NCT02823431|Lidocaine|lidocaine|mesh-list
83530988|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
83530989|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
83530990|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83530991|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83530992|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
83530993|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83530994|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83530995|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83530996|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83530997|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83530998|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83530999|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83531000|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83531001|NCT03008213|Palonosetron|palonosetron|mesh-list
83531002|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
83531003|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
83531004|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531005|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531006|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531007|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83531008|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83531009|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
83531010|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531011|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531012|NCT02059070|Bupivacaine|bupivacaine|mesh-list
83531013|NCT02059070|Ropivacaine|ropivacaine|mesh-list
83531014|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
83531015|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
83531016|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531017|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531018|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
83531019|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531020|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
83531023|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531024|NCT01962961|Expectorants|expectorants|mesh-ancestor
83531025|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
83531026|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83531027|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
83531028|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531029|NCT01962961|Protective Agents|protective agents|mesh-ancestor
83531030|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531032|NCT03010631|Lubiprostone|lubiprostone|mesh-list
83531033|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83531034|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83531035|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531036|NCT00374621|Isosorbide|isosorbide|mesh-list
83531037|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83531038|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83531039|NCT00374621|Misoprostol|misoprostol|mesh-list
83531040|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83531041|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
83531042|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83531043|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531044|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83531045|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531046|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
83531047|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83531048|NCT00374621|Diuretics|diuretics|mesh-ancestor
83531049|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
83531050|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
83531051|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83531052|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531053|NCT03012191|Gentamicins|gentamicins|mesh-list
83531054|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83531055|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531056|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83531057|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531058|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531059|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
83531060|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
83531061|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531062|NCT01967641|Buprenorphine|buprenorphine|mesh-list
83531063|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83531064|NCT01967641|Naloxone|naloxone|mesh-list
83531065|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83531066|NCT01967641|Narcotics|narcotics|mesh-ancestor
83531067|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531068|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531069|NCT01967641|Analgesics|analgesics|mesh-ancestor
83531070|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
83531071|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531072|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83531073|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
83531074|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83531075|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
83531076|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531077|NCT02913521|Diclofenac|diclofenac|mesh-list
83531078|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83531079|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83531080|NCT02913521|Analgesics|analgesics|mesh-ancestor
83531081|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
83531082|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531083|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531084|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531085|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83531086|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83531087|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531088|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531089|NCT01969201|Hormones|hormones|mesh-list
83531090|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531091|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531092|NCT01962428|Ticagrelor|ticagrelor|mesh-list
83531093|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83531094|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83531095|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83531096|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83531098|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531099|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531100|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531102|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83531103|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83531104|NCT01999400|Analgesics|analgesics|mesh-ancestor
83531105|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
83531106|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531107|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531108|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531109|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83531110|NCT01969435|Cytarabine|cytarabine|mesh-list
83531111|NCT01969435|Etoposide|etoposide|mesh-list
83531112|NCT01969435|Melphalan|melphalan|mesh-list
83531113|NCT01969435|Carmustine|carmustine|mesh-list
83531114|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
83531115|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83531116|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531117|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83531118|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83531119|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531120|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531121|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83531122|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
83531123|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
83531124|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531125|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83531126|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
83531127|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531128|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83531129|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
83531130|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83531131|NCT01965002|Aspirin|aspirin|mesh-list
83531132|NCT01965002|Enoxaparin|enoxaparin|mesh-list
83531133|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83531134|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83531135|NCT01965002|Analgesics|analgesics|mesh-ancestor
83531136|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
83531137|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531138|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531139|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531140|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83531141|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83531142|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83531143|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531144|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83531145|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83531146|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531147|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
83531148|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
83531149|NCT02304757|Alendronate|alendronate|mesh-list
83531150|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
83531151|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83531152|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531153|NCT01969747|Empagliflozin|empagliflozin|mesh-list
83531154|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83531155|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531156|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83531157|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531158|NCT02002832|Risperidone|risperidone|mesh-list
83531159|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83531160|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83531161|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
83531162|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531163|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531164|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531165|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83531166|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83531167|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531168|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83531169|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83531170|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
83531171|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83531172|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83531173|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83531174|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
83531175|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83531176|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83531177|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83531178|NCT01966718|Hormones|hormones|mesh-ancestor
83531179|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531180|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531181|NCT02308501|Alcaftadine|alcaftadine|mesh-list
83531182|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83531183|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
83531184|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
83531185|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531186|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531187|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531188|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83531189|NCT02006108|Hematinics|hematinics|mesh-ancestor
83531190|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83531191|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83531192|NCT02006342|Insulin|insulin|mesh-list
83531193|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83531194|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
83531195|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83531196|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531197|NCT01968356|Ethanol|ethanol|mesh-list
83531198|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
83531199|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83531200|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83531201|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531202|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531203|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531204|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
83531205|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
83531206|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83531207|NCT02008682|Liraglutide|liraglutide|mesh-list
83531208|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83531209|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531210|NCT02008682|Incretins|incretins|mesh-ancestor
83531211|NCT02008682|Hormones|hormones|mesh-ancestor
83531212|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531213|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83531214|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
83531215|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531216|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531217|NCT01969916|Regadenoson|regadenoson|mesh-list
83531218|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83531219|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83531220|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
83531221|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
83531222|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531223|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531224|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531225|NCT00373919|Erythromycin|erythromycin|mesh-list
83531226|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
83531227|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83531228|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
83531229|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83531230|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531231|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531232|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83531233|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531234|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531235|NCT02916407|Sevoflurane|sevoflurane|mesh-list
83531236|NCT02916407|Desflurane|desflurane|mesh-list
83531237|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83531238|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83531239|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
83531240|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
83531241|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531242|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531243|NCT02918357|Edetic Acid|edetic acid|mesh-list
83531244|NCT02918357|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83531245|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
83531247|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531248|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
83531249|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83531250|NCT02918357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83531252|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83531253|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531254|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83531255|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531256|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531257|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83531258|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83531259|NCT02012192|Paclitaxel|paclitaxel|mesh-list
83531260|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83531261|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531262|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
83531263|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
83531264|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
83531265|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531266|NCT02066792|Cycloserine|cycloserine|mesh-list
83531267|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83531268|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531269|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83531270|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
83531271|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83531272|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
83531273|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531274|NCT02922959|Naloxone|naloxone|mesh-list
83531275|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531276|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
83531277|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531278|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83531279|NCT02014363|Amitriptyline|amitriptyline|mesh-list
83531280|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83531281|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
83531282|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83531283|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83531284|NCT02014363|Analgesics|analgesics|mesh-ancestor
83531285|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
83531286|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531287|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531288|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83531289|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83531290|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83531291|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531292|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
83531293|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531294|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
83531295|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
83531296|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
83531297|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531298|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531299|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
83531300|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531301|NCT02833415|Empagliflozin|empagliflozin|mesh-list
83531302|NCT02833415|Glycerol|glycerol|mesh-list
83531303|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83531304|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531305|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83531306|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531307|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83531308|NCT02833415|Protective Agents|protective agents|mesh-ancestor
83531309|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83531310|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83531311|NCT02012348|Triclocarban|triclocarban|mesh-list
83531312|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531313|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83531314|NCT02834663|Ranibizumab|ranibizumab|mesh-list
83531315|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83531316|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83531317|NCT02834663|Growth Substances|growth substances|mesh-ancestor
83531318|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531319|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
83531320|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531322|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
83531323|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83531324|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531326|NCT02017327|Latanoprost|latanoprost|mesh-list
83531327|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83531328|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83531329|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83531330|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83531331|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
83531332|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
83531333|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531334|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531335|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83531336|NCT02837237|Diuretics|diuretics|mesh-ancestor
83531337|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
83531338|NCT02837237|Hormones|hormones|mesh-ancestor
83531339|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83531340|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83531341|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531342|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
83531343|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
83531344|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
83531345|NCT02018653|Calcium|calcium|mesh-list
83531346|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83531347|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531348|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83531349|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531350|NCT02923895|Fluorides|fluorides|mesh-list
83531351|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
83531352|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
83531353|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
83531354|NCT02923895|Protective Agents|protective agents|mesh-ancestor
83531355|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531356|NCT01973348|Methamphetamine|methamphetamine|mesh-list
83531357|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83531358|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531359|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
83531360|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
83531361|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531362|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
83531363|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531364|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531365|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
83531366|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83531367|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83531368|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83531369|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83531370|NCT02839889|Naloxegol|naloxegol|mesh-list
83531371|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83531372|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531373|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
83531374|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531375|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83531376|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
83531377|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83531378|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
83531379|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531380|NCT02925611|Desflurane|desflurane|mesh-list
83531381|NCT02925611|Isoflurane|isoflurane|mesh-list
83531382|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83531383|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
83531384|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
83531385|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531386|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531387|NCT01973335|Spironolactone|spironolactone|mesh-list
83531388|NCT01973335|Acetazolamide|acetazolamide|mesh-list
83531389|NCT01973335|Bumetanide|bumetanide|mesh-list
83531390|NCT01973335|Diuretics|diuretics|mesh-list
83531391|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83531392|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83531393|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
83531394|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531395|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531396|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83531397|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
83531398|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
83531399|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83531400|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531401|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531402|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83531403|NCT01973413|Insulin|insulin|mesh-list
83531404|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83531405|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531406|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83531407|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
83531408|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83531409|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83531410|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83531411|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531412|NCT02929667|Fluoxetine|fluoxetine|mesh-list
83531413|NCT02929667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83531414|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83531415|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83531416|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531417|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531418|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
83531419|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531420|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83531421|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
83531422|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83531423|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83531424|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83531425|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531426|NCT02021929|Sorafenib|sorafenib|mesh-list
83531427|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531428|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83531429|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531430|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531431|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83531432|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83531433|NCT02023411|Teriparatide|teriparatide|mesh-list
83531434|NCT02023411|Hormones|hormones|mesh-list
83531435|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
83531436|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531437|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531438|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83531439|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83531440|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
83531441|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
83531442|NCT02068820|Protective Agents|protective agents|mesh-ancestor
83531443|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531444|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83531445|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
83531446|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531447|NCT02934191|Acetaminophen|acetaminophen|mesh-list
83531448|NCT02934191|Celecoxib|celecoxib|mesh-list
83531449|NCT02934191|Oxycodone|oxycodone|mesh-list
83531450|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
83531451|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531452|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83531453|NCT02934191|Analgesics|analgesics|mesh-ancestor
83531454|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
83531455|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531456|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
83531457|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83531458|NCT02934191|Narcotics|narcotics|mesh-ancestor
83531459|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531460|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83531461|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531462|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83531463|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83531464|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83531465|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531466|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531467|NCT02934191|Antacids|antacids|mesh-ancestor
83531468|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531469|NCT02937623|Calcium|calcium|mesh-list
83531470|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83531471|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531472|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
83531473|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83531474|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83531475|NCT01977781|Prednisolone|prednisolone|mesh-list
83531476|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
83531477|NCT01977781|Tacrolimus|tacrolimus|mesh-list
83531478|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83531479|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
83531480|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83531481|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
83531482|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531483|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83531484|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531485|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531486|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531487|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
83531488|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
83531489|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531490|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531491|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
83531492|NCT01977781|Hormones|hormones|mesh-ancestor
83531493|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531494|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83531495|NCT01977781|Protective Agents|protective agents|mesh-ancestor
83531496|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83531497|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531498|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
83531499|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83531500|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83531501|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83531502|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83531503|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531504|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
83531505|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531506|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531507|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83531508|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531509|NCT02938949|Alirocumab|alirocumab|mesh-list
83531510|NCT02938949|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83531511|NCT02938949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83531512|NCT02938949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83531513|NCT02938949|Antimetabolites|antimetabolites|mesh-ancestor
83531514|NCT02938949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531515|NCT02938949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83531516|NCT02938949|Protease Inhibitors|protease inhibitors|mesh-ancestor
83531517|NCT02938949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531518|NCT02938949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83531519|NCT02025439|Amantadine|amantadine|mesh-list
83531520|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83531521|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83531522|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
83531523|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531524|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
83531525|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531526|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531527|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531528|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83531529|NCT02025439|Analgesics|analgesics|mesh-ancestor
83531530|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
83531531|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531532|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
83531533|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83531534|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531535|NCT02939651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83531536|NCT02939651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531537|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
83531538|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83531539|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83531540|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531541|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
83531542|NCT02026297|Coagulants|coagulants|mesh-ancestor
83531546|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531547|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531548|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83531549|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531550|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83531551|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83531552|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83531553|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
83531554|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83531555|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
83531556|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83531557|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83531558|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531559|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83531560|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531561|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83531562|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531563|NCT02869451|Bupropion|bupropion|mesh-list
83531564|NCT02869451|Nicotine|nicotine|mesh-list
83531565|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83531566|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
83531567|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531568|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531569|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83531570|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83531571|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
83531572|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531573|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531574|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83531575|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
83531576|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83531577|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83531578|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83531579|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83531580|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
83531581|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83531582|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83531583|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531584|NCT02305316|Opicapone|opicapone|mesh-list
83531585|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83531586|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531587|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531588|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83531589|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83531590|NCT02944565|Daratumumab|daratumumab|mesh-list
83531591|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531592|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83531593|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83531594|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83531595|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
83531596|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531597|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531598|NCT01979276|Dexamethasone|dexamethasone|mesh-list
83531599|NCT01979276|Pomalidomide|pomalidomide|mesh-list
83531600|NCT01979276|Romidepsin|romidepsin|mesh-list
83531601|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531602|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
83531603|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
83531604|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531605|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531606|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531607|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
83531608|NCT01979276|Hormones|hormones|mesh-ancestor
83531609|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531610|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83531611|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531612|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
83531613|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83531614|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83531615|NCT01979276|Growth Substances|growth substances|mesh-ancestor
83531616|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
83531617|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83531618|NCT01979276|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83531619|NCT01979276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531620|NCT01979276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531621|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
83531622|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83531623|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
83531624|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531625|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531626|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83531627|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
83531628|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83531629|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
83531630|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531631|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531632|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83531633|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
83531634|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
83531635|NCT02871011|Protective Agents|protective agents|mesh-ancestor
83531637|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
83531638|NCT02344238|Vitamins|vitamins|mesh-ancestor
83531639|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
83531640|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531641|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83531642|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
83531643|NCT02344316|Melatonin|melatonin|mesh-list
83531644|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
83531645|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531646|NCT02344316|Protective Agents|protective agents|mesh-ancestor
83531647|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531648|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531649|NCT02344628|Azithromycin|azithromycin|mesh-list
83531650|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83531651|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531652|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
83531653|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83531654|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83531655|NCT02019758|Fluticasone|fluticasone|mesh-list
83531656|NCT02019758|Budesonide|budesonide|mesh-list
83531657|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531658|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83531659|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
83531660|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531661|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531662|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83531663|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
83531664|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
83531665|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83531666|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
83531667|NCT02019758|Hormones|hormones|mesh-ancestor
83531668|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531669|NCT01980589|Dexamethasone|dexamethasone|mesh-list
83531670|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
83531671|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83531672|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
83531673|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531674|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83531675|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83531676|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
83531677|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531678|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531679|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83531680|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531681|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
83531682|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
83531683|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531684|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531685|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
83531686|NCT01980589|Hormones|hormones|mesh-ancestor
83531687|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531688|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83531689|NCT02021942|Pasireotide|pasireotide|mesh-list
83531690|NCT02021942|Hormones|hormones|mesh-ancestor
83531691|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531692|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531694|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83531695|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531696|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83531697|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
83531698|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83531699|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
83531700|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531701|NCT01980524|Acipimox|acipimox|mesh-list
83531702|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83531703|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
83531704|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531705|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83531706|NCT01982539|Diclofenac|diclofenac|mesh-list
83531707|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83531708|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83531709|NCT01982539|Analgesics|analgesics|mesh-ancestor
83531710|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
83531711|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531712|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531713|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531714|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83531715|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83531716|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531717|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531718|NCT01982695|Losartan|losartan|mesh-list
83531719|NCT01982695|Lisinopril|lisinopril|mesh-list
83531720|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83531721|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83531722|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83531723|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83531724|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531725|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83531726|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
83531727|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531728|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83531729|NCT01982695|Protective Agents|protective agents|mesh-ancestor
83531730|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531731|NCT01981772|Lidocaine|lidocaine|mesh-list
83531732|NCT01981772|Epinephrine|epinephrine|mesh-list
83531733|NCT01981772|Racepinephrine|racepinephrine|mesh-list
83531734|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
83531735|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
83531736|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
83531737|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531738|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531739|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
83531740|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531741|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83531742|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83531743|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83531744|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83531745|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531746|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83531747|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83531748|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
83531749|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531750|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83531751|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83531752|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
83531753|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83531754|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
83531755|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
83531756|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
83531757|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83531758|NCT01982240|Bisacodyl|bisacodyl|mesh-list
83531759|NCT01982240|Plecanatide|plecanatide|mesh-list
83531760|NCT01982240|Cathartics|cathartics|mesh-ancestor
83531761|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531762|NCT01982240|Laxatives|laxatives|mesh-ancestor
83531763|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83531764|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
83531765|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531766|NCT02029495|Brodalumab|brodalumab|mesh-list
83531768|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
83531769|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
83531770|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531772|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
83531773|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83531774|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
83531775|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
83531776|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
83531777|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531778|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531779|NCT02348918|Bevacizumab|bevacizumab|mesh-list
83531780|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83531781|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531782|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83531783|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83531784|NCT02348918|Growth Substances|growth substances|mesh-ancestor
83531785|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531786|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
83531787|NCT01985581|Guanfacine|guanfacine|mesh-list
83531788|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83531789|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83531790|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83531791|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83531792|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
83531793|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531794|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531795|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531796|NCT02024204|Fluticasone|fluticasone|mesh-list
83531797|NCT02024204|Xhance|xhance|mesh-list
83531798|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83531799|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83531800|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531801|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83531802|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
83531803|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531804|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531805|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83531806|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
83531807|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
83531808|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83531809|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83531810|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83531811|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83531812|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
83531813|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531814|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531815|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
83531816|NCT02024204|Hormones|hormones|mesh-ancestor
83531817|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531818|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
83531819|NCT03930745|TOL-463|tol-463|mesh-list
83531820|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531821|NCT02034019|Dexamethasone|dexamethasone|mesh-list
83531822|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531823|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
83531824|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
83531825|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531826|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531827|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531828|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
83531829|NCT02034019|Hormones|hormones|mesh-ancestor
83531830|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531831|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83531832|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531833|NCT02349152|Fentanyl|fentanyl|mesh-list
83531834|NCT02349152|Remifentanil|remifentanil|mesh-list
83531835|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83531836|NCT02349152|Narcotics|narcotics|mesh-ancestor
83531837|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531838|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531839|NCT02349152|Analgesics|analgesics|mesh-ancestor
83531840|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
83531841|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531842|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83531843|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83531847|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531848|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
83531849|NCT01986361|Analgesics|analgesics|mesh-ancestor
83531850|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
83531851|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531852|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531853|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83531854|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83531855|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531856|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83531857|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83531858|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531859|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531860|NCT01983020|Lidocaine|lidocaine|mesh-list
83531861|NCT01983020|Ketamine|ketamine|mesh-list
83531862|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
83531863|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
83531864|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531865|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531866|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
83531867|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531868|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83531869|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83531870|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83531871|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83531872|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531873|NCT01983020|Analgesics|analgesics|mesh-ancestor
83531874|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83531875|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83531876|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
83531877|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83531878|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83531879|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531880|NCT02058511|Anesthetics|anesthetics|mesh-list
83531881|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531882|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531883|NCT01983566|Omeprazole|omeprazole|mesh-list
83531884|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83531885|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531886|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83531887|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531888|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531889|NCT01983878|Ramucirumab|ramucirumab|mesh-list
83531890|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531891|NCT02396732|Aspirin|aspirin|mesh-list
83531892|NCT02396732|Enoxaparin|enoxaparin|mesh-list
83531893|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83531894|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83531895|NCT02396732|Analgesics|analgesics|mesh-ancestor
83531896|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
83531897|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531898|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531899|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83531900|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83531901|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83531902|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83531903|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531904|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83531905|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83531906|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531907|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
83531908|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
83531909|NCT02352974|Vitamin D|vitamin d|mesh-list
83531910|NCT02352974|Vitamins|vitamins|mesh-ancestor
83531911|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
83531912|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531913|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83531914|NCT02353754|Morphine|morphine|mesh-list
83531915|NCT02353754|Bupivacaine|bupivacaine|mesh-list
83531916|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
83531917|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
83531918|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531919|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531920|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
83531921|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531926|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83531927|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531928|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531929|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83531931|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
83531932|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531933|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83531934|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83531935|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83531936|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
83531937|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531938|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531939|NCT02059213|Palbociclib|palbociclib|mesh-list
83531940|NCT02059213|Leuprolide|leuprolide|mesh-list
83531941|NCT02059213|Goserelin|goserelin|mesh-list
83531942|NCT02059213|Bicalutamide|bicalutamide|mesh-list
83531943|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531944|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83531945|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531946|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531947|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83531948|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
83531949|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83531950|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531951|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83531952|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
83531953|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
83531954|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83531955|NCT02037061|Bupivacaine|bupivacaine|mesh-list
83531956|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
83531957|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
83531958|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531959|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531960|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
83531961|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531962|NCT02354534|Artesunate|artesunate|mesh-list
83531963|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
83531964|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83531965|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83531966|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83531967|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531968|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
83531969|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
83531970|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83531971|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
83531972|NCT02355158|Clonidine|clonidine|mesh-list
83531973|NCT02355158|Analgesics|analgesics|mesh-ancestor
83531974|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
83531975|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531976|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531977|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83531978|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
83531979|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
83531980|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83531981|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83531982|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83531983|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
83531984|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531985|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531986|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83531987|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83531988|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83531989|NCT02061397|Sirolimus|sirolimus|mesh-list
83531990|NCT02061397|Everolimus|everolimus|mesh-list
83531991|NCT02061397|Simvastatin|simvastatin|mesh-list
83531992|NCT02061397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83531993|NCT02061397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83531994|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531995|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83531996|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83531997|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
83531998|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83531999|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532000|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83532001|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532002|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83532003|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
83532004|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83532005|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83532006|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
83532007|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83532008|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83532009|NCT02062177|Midazolam|midazolam|mesh-list
83532010|NCT02062177|Propofol|propofol|mesh-list
83532011|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83532012|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532013|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532014|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83532015|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
83532016|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
83532017|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83532018|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83532019|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83532020|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83532021|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
83532022|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
83532023|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532024|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532025|NCT02034578|Apixaban|apixaban|mesh-list
83532026|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83532027|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
83532028|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83532029|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
83532030|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532031|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532032|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
83532033|NCT02403830|Morphine|morphine|mesh-list
83532034|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
83532035|NCT02403830|Ticagrelor|ticagrelor|mesh-list
83532036|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83532037|NCT02403830|Narcotics|narcotics|mesh-ancestor
83532038|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532039|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532040|NCT02403830|Analgesics|analgesics|mesh-ancestor
83532041|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
83532042|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532043|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83532044|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83532045|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83532046|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83532047|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
83532048|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532049|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532050|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83532051|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83532052|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532053|NCT02951195|Ivacaftor|ivacaftor|mesh-list
83532054|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83532055|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532056|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532057|NCT02037230|Gemcitabine|gemcitabine|mesh-list
83532058|NCT02037230|Adavosertib|adavosertib|mesh-list
83532059|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83532060|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
83532061|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532062|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532063|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532064|NCT02312882|Tofacitinib|tofacitinib|mesh-list
83532065|NCT02312882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83532066|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83532068|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532069|NCT02877095|Furosemide|furosemide|mesh-list
83532070|NCT02877095|Diuretics|diuretics|mesh-ancestor
83532071|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
83532072|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532073|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83532074|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532075|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532077|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83532078|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83532079|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83532080|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532081|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
83532082|NCT02877485|Hormones|hormones|mesh-ancestor
83532083|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83532084|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532085|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83532086|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
83532087|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532088|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532089|NCT00374387|NuvaRing|nuvaring|mesh-list
83532090|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83532091|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
83532092|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83532093|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532094|NCT03023891|Prednisone|prednisone|mesh-list
83532095|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532096|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
83532097|NCT03023891|Hormones|hormones|mesh-ancestor
83532098|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83532099|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532100|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83532101|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532102|NCT03028025|Hemostatics|hemostatics|mesh-list
83532103|NCT03028025|Coagulants|coagulants|mesh-ancestor
83532104|NCT02955329|Nicotine|nicotine|mesh-list
83532105|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83532106|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
83532107|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532108|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532109|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83532110|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83532111|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
83532112|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532113|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532114|NCT02359058|Capecitabine|capecitabine|mesh-list
83532115|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
83532116|NCT02359058|Ramucirumab|ramucirumab|mesh-list
83532117|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532118|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83532119|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
83532120|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532121|NCT02404610|Propofol|propofol|mesh-list
83532122|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83532123|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532124|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532125|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83532126|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
83532127|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
83532128|NCT03110003|Bupivacaine|bupivacaine|mesh-list
83532129|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
83532130|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
83532131|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532132|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532133|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
83532134|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532135|NCT03114995|Tirofiban|tirofiban|mesh-list
83532136|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83532137|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83532138|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532139|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83532140|NCT02959853|Anastrozole|anastrozole|mesh-list
83532141|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83532142|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532143|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83532144|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83532145|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532146|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532147|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83532148|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
83532149|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83532150|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532153|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83532154|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83532155|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
83532156|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532157|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532158|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532159|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83532160|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
83532161|NCT00374465|Protective Agents|protective agents|mesh-ancestor
83532162|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83532163|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532164|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83532165|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
83532166|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83532167|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83532168|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83532169|NCT02040116|Rituximab|rituximab|mesh-list
83532170|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83532171|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532172|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
83532173|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532174|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83532175|NCT02360774|Canagliflozin|canagliflozin|mesh-list
83532176|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83532177|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532178|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83532179|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532180|NCT02361476|Clonidine|clonidine|mesh-list
83532181|NCT02361476|Analgesics|analgesics|mesh-ancestor
83532182|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
83532183|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532184|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532185|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83532186|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
83532187|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
83532188|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83532189|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83532190|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83532191|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
83532192|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532193|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532194|NCT02363270|Ketamine|ketamine|mesh-list
83532195|NCT02363270|Analgesics|analgesics|mesh-ancestor
83532196|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
83532197|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532198|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532199|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83532200|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83532201|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
83532202|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
83532203|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532204|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83532205|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83532206|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532207|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532208|NCT02042534|Warfarin|warfarin|mesh-list
83532209|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
83532210|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
83532211|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83532212|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
83532213|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83532214|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
83532215|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532216|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532217|NCT02043704|Acetaminophen|acetaminophen|mesh-list
83532218|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83532219|NCT02043704|Analgesics|analgesics|mesh-ancestor
83532220|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
83532221|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532222|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532223|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
83532224|NCT02410382|Dexamethasone|dexamethasone|mesh-list
83532225|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532228|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532229|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532231|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
83532232|NCT02410382|Hormones|hormones|mesh-ancestor
83532233|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83532234|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83532235|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532236|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83532237|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83532238|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83532239|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532240|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532241|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532242|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532243|NCT03038867|Analgesics|analgesics|mesh-ancestor
83532244|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
83532245|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532246|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
83532247|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83532248|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
83532249|NCT03119831|Ethanol|ethanol|mesh-list
83532250|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
83532251|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83532252|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83532253|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532254|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532255|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532256|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
83532257|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
83532258|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
83532259|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83532260|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
83532261|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532262|NCT03124121|Golimumab|golimumab|mesh-list
83532263|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83532264|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532265|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83532266|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
83532267|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532268|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83532269|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83532270|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83532271|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532272|NCT00374699|Bortezomib|bortezomib|mesh-list
83532273|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532274|NCT00374777|Nitrazepam|nitrazepam|mesh-list
83532275|NCT00374777|Zolpidem|zolpidem|mesh-list
83532276|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83532277|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83532278|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532279|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532280|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83532281|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
83532282|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
83532283|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532284|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532285|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
83532286|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83532287|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83532288|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83532289|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
83532290|NCT02044796|Cytarabine|cytarabine|mesh-list
83532291|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83532292|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
83532293|NCT02044796|Cladribine|cladribine|mesh-list
83532294|NCT02044796|Lenograstim|lenograstim|mesh-list
83532295|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83532296|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
83532297|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532298|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532299|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
83532300|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532301|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83532303|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532305|NCT02044796|Analgesics|analgesics|mesh-ancestor
83532306|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
83532307|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532308|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83532309|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83532310|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532311|NCT02973503|Grazoprevir|grazoprevir|mesh-list
83532312|NCT02973503|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83532313|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
83532314|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532315|NCT03127943|Lidocaine|lidocaine|mesh-list
83532316|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
83532317|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
83532318|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532319|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532320|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
83532321|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532322|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83532323|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83532324|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83532325|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532326|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532327|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83532328|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83532329|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83532330|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532331|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532332|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83532333|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532334|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532335|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
83532336|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532337|NCT02045264|Icatibant|icatibant|mesh-list
83532338|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83532339|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83532340|NCT02045264|Analgesics|analgesics|mesh-ancestor
83532341|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
83532342|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532343|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532344|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532345|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83532346|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83532347|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83532348|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532349|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83532350|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83532351|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
83532352|NCT02975297|Exenatide|exenatide|mesh-list
83532353|NCT02975297|Nicotine|nicotine|mesh-list
83532354|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83532355|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
83532356|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532357|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532358|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83532359|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83532360|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
83532361|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532362|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532363|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83532364|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83532365|NCT02975297|Incretins|incretins|mesh-ancestor
83532366|NCT02975297|Hormones|hormones|mesh-ancestor
83532367|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83532368|NCT02046200|Ethanol|ethanol|mesh-list
83532369|NCT02046200|Ivermectin|ivermectin|mesh-list
83532370|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83532371|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532372|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532373|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532374|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83532375|NCT02978339|Curcumin|curcumin|mesh-list
83532376|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83532377|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83532378|NCT02978339|Analgesics|analgesics|mesh-ancestor
83532379|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
83532380|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532381|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532382|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532383|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83532384|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532385|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532386|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532387|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
83532388|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532389|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532390|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83532391|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83532392|NCT00374855|Diuretics|diuretics|mesh-ancestor
83532393|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
83532394|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532395|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83532396|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532397|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532398|NCT02412644|Apremilast|apremilast|mesh-list
83532399|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83532400|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83532401|NCT02412644|Analgesics|analgesics|mesh-ancestor
83532402|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
83532403|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532404|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532405|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532406|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83532407|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83532408|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83532409|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532410|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532411|NCT02413034|Vancomycin|vancomycin|mesh-list
83532412|NCT02413034|Cefazolin|cefazolin|mesh-list
83532413|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83532414|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532415|NCT04737473|Anesthetics|anesthetics|mesh-list
83532416|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532417|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532418|NCT02369900|Esmolol|esmolol|mesh-list
83532419|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83532420|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83532421|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
83532422|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532423|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532424|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532425|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83532426|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
83532427|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83532428|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532429|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532430|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83532431|NCT03054857|Analgesics|analgesics|mesh-ancestor
83532432|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
83532433|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532434|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83532435|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83532437|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
83532438|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532439|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532440|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
83532441|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
83532442|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83532443|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83532444|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532445|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532446|NCT02414204|Urological Agents|urological agents|mesh-ancestor
83532447|NCT02989493|Doxazosin|doxazosin|mesh-list
83532448|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83532449|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83532450|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83532451|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83532452|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
83532453|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532454|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532455|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532456|NCT02050334|Caffeic acid|caffeic acid|mesh-list
83532457|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
83532458|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532459|NCT02050334|Protective Agents|protective agents|mesh-ancestor
83532460|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532461|NCT02371850|Nicotine|nicotine|mesh-list
83532462|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83532463|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
83532464|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532465|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532466|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83532467|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83532468|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
83532469|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532470|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532471|NCT03144635|Grazoprevir|grazoprevir|mesh-list
83532472|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
83532473|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532474|NCT03145259|Diclofenac|diclofenac|mesh-list
83532475|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83532476|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83532477|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83532478|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83532479|NCT03145259|Analgesics|analgesics|mesh-ancestor
83532480|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
83532481|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532482|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532483|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532484|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83532485|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83532486|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532487|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532488|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83532489|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
83532490|NCT00354692|Hematinics|hematinics|mesh-ancestor
83532491|NCT02989727|Lamotrigine|lamotrigine|mesh-list
83532492|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
83532493|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83532494|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532495|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532496|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83532497|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532498|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83532499|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83532500|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532501|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83532502|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83532503|NCT02039947|Trametinib|trametinib|mesh-list
83532504|NCT02039947|Dabrafenib|dabrafenib|mesh-list
83532505|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532506|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83532508|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532509|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83532510|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
83532511|NCT02996591|Dexamethasone|dexamethasone|mesh-list
83532512|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
83532513|NCT02996591|Midazolam|midazolam|mesh-list
83532514|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
83532515|NCT02996591|Ketamine|ketamine|mesh-list
83532516|NCT02996591|Bupivacaine|bupivacaine|mesh-list
83532517|NCT02996591|Mepivacaine|mepivacaine|mesh-list
83532518|NCT02996591|Anesthetics|anesthetics|mesh-list
83532519|NCT02996591|Propofol|propofol|mesh-list
83532520|NCT02996591|Sevoflurane|sevoflurane|mesh-list
83532521|NCT02996591|BB 1101|bb 1101|mesh-list
83532522|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532523|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
83532524|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
83532525|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532526|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532527|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83532528|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
83532530|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83532531|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83532532|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532533|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
83532534|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532535|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532536|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
83532537|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532538|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
83532539|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83532540|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83532541|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
83532542|NCT02996591|Analgesics|analgesics|mesh-ancestor
83532543|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83532544|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83532545|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83532546|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532547|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83532548|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83532549|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83532550|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83532551|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
83532552|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
83532553|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83532554|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83532555|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83532556|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83532557|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
83532558|NCT03066947|Interferons|interferons|mesh-list
83532559|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
83532560|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
83532561|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
83532562|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83532563|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
83532564|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532565|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83532566|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83532567|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
83532568|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532569|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532570|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83532571|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
83532572|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532573|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
83532574|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83532575|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83532576|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83532577|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532578|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532579|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
83532580|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532581|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532582|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83532583|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532585|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83532586|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532587|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
83532588|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
83532589|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532590|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83532591|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
83532592|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532593|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532594|NCT03152591|Licogliflozin|licogliflozin|mesh-list
83532595|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83532596|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532597|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83532598|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532599|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
83532600|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83532601|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83532602|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532603|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
83532604|NCT02063035|Coagulants|coagulants|mesh-ancestor
83532605|NCT00375245|Sirolimus|sirolimus|mesh-list
83532606|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83532607|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532608|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83532609|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532610|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
83532611|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83532612|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
83532613|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532614|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83532615|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
83532616|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532617|NCT02054156|Azithromycin|azithromycin|mesh-list
83532618|NCT02054156|Tobramycin|tobramycin|mesh-list
83532619|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83532620|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532621|NCT03159143|Docetaxel|docetaxel|mesh-list
83532622|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
83532623|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532624|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
83532625|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
83532626|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
83532627|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532628|NCT03068897|Ibuprofen|ibuprofen|mesh-list
83532629|NCT03068897|Tizanidine|tizanidine|mesh-list
83532630|NCT03068897|Baclofen|baclofen|mesh-list
83532631|NCT03068897|Metaxalone|metaxalone|mesh-list
83532632|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83532633|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83532634|NCT03068897|Analgesics|analgesics|mesh-ancestor
83532635|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
83532636|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532637|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532638|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532639|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83532640|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83532641|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532642|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532643|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83532644|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83532645|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83532646|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
83532647|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
83532648|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532649|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
83532650|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
83532651|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
83532652|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83532653|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83532654|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83532655|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
83532656|NCT02049476|Dexamethasone|dexamethasone|mesh-list
83532657|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532658|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
83532659|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
83532660|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532661|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532662|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83532663|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
83532664|NCT02049476|Hormones|hormones|mesh-ancestor
83413643|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532665|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83532666|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83532667|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532668|NCT02299297|Tofacitinib|tofacitinib|mesh-list
83532669|NCT02299297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83532670|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83532671|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532672|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532673|NCT03069677|Midazolam|midazolam|mesh-list
83532674|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83532675|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83532676|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532677|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532678|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83532679|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83532680|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83532681|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83532682|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
83532683|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
83532684|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
83532685|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
83532686|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532687|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532688|NCT02055638|SRX246|srx246|mesh-list
83532689|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83532690|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532691|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
83532692|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532693|NCT02044393|Itraconazole|itraconazole|mesh-list
83532694|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
83532695|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532696|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83532697|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83532698|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532699|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532700|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83532701|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
83532702|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83532703|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532704|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83532705|NCT05405465|Golimumab|golimumab|mesh-list
83532706|NCT05405465|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83532707|NCT05405465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532708|NCT05405465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83532709|NCT05405465|Immunologic Factors|immunologic factors|mesh-ancestor
83532710|NCT05405465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532711|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
83532712|NCT02064907|Lansoprazole|lansoprazole|mesh-list
83532713|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83532714|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83532715|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83532716|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532717|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532718|NCT02064985|Ticagrelor|ticagrelor|mesh-list
83532719|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83532720|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83532721|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83532722|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83532723|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
83532724|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532725|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532726|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532727|NCT03170219|Furosemide|furosemide|mesh-list
83532728|NCT03170219|Diuretics|diuretics|mesh-ancestor
83532729|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
83532730|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532731|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83532732|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532733|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532735|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83532736|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
83532737|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83532738|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83532739|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83532740|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532741|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532742|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
83532743|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532744|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532745|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
83532746|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532747|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
83532748|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
83532749|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83532750|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
83532751|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532752|NCT03177395|Expectorants|expectorants|mesh-ancestor
83532753|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
83532754|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83532755|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
83532756|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532757|NCT03177395|Protective Agents|protective agents|mesh-ancestor
83532758|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532759|NCT03177395|Antidotes|antidotes|mesh-ancestor
83532760|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
83532761|NCT05282069|DA-8010|da-8010|mesh-list
83532762|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83532763|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83532764|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
83532765|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532766|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532767|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532768|NCT05282069|Urological Agents|urological agents|mesh-ancestor
83532769|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
83532770|NCT03179345|Pregabalin|pregabalin|mesh-list
83532771|NCT03179345|Gabapentin|gabapentin|mesh-list
83532772|NCT03179345|Analgesics|analgesics|mesh-ancestor
83532773|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
83532774|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532775|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532776|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
83532777|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83532778|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532779|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532780|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83532781|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83532782|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83532783|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532784|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83532785|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83532786|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83532787|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532788|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
83532789|NCT03086213|Lidocaine|lidocaine|mesh-list
83532790|NCT03086213|Sufentanil|sufentanil|mesh-list
83532791|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
83532792|NCT03086213|Dsuvia|dsuvia|mesh-list
83532793|NCT03086213|Ropivacaine|ropivacaine|mesh-list
83532794|NCT03086213|Propofol|propofol|mesh-list
83532795|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
83532796|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
83532797|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532798|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532799|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
83532800|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532801|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83532802|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83532803|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83532804|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532805|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532806|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83532807|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83532808|NCT03086213|Analgesics|analgesics|mesh-ancestor
83532809|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83532810|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83532811|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83532812|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
83532813|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532814|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83532815|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
83532816|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83532817|NCT03086213|Narcotics|narcotics|mesh-ancestor
83532818|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83532819|NCT02378714|Varenicline|varenicline|mesh-list
83532820|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83532821|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83532822|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
83532823|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532824|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532825|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532826|NCT03091673|Glucagon|glucagon|mesh-list
83532827|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83532828|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83532829|NCT03091673|Hormones|hormones|mesh-ancestor
83532830|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83532831|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532832|NCT03091673|Incretins|incretins|mesh-ancestor
83532833|NCT02382848|Prazosin|prazosin|mesh-list
83532834|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83532835|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83532836|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83532837|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83532838|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
83532839|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532840|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532841|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532842|NCT02065687|Metformin|metformin|mesh-list
83532843|NCT02065687|Paclitaxel|paclitaxel|mesh-list
83532844|NCT02065687|Carboplatin|carboplatin|mesh-list
83532845|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83532846|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83532847|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532848|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
83532849|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
83532850|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
83532851|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532852|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83532853|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532854|NCT03096353|Naloxone|naloxone|mesh-list
83532855|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83532856|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532857|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
83532858|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532859|NCT03098615|Efinaconazole|efinaconazole|mesh-list
83532860|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
83532861|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532862|NCT05363501|Naloxone|naloxone|mesh-list
83532863|NCT05363501|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83532864|NCT05363501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532865|NCT05363501|Sensory System Agents|sensory system agents|mesh-ancestor
83532866|NCT05363501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532867|NCT04736927|Midazolam|midazolam|mesh-list
83532868|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83532869|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83532870|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83532871|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532872|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83532873|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83532874|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83532875|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83532876|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
83532877|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
83532878|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
83532879|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
83532880|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532881|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532882|NCT03810703|Amphetamine|amphetamine|mesh-list
83532883|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
83532884|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83532885|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532886|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
83532887|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
83532888|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532889|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
83532890|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532891|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532892|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
83532893|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83532894|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83532895|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532896|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83532897|NCT05304455|Heparin|heparin|mesh-list
83532898|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83532899|NCT05304455|Tinzaparin|tinzaparin|mesh-list
83532900|NCT05304455|Dalteparin|dalteparin|mesh-list
83532901|NCT05304455|Dipyridamole|dipyridamole|mesh-list
83532902|NCT05304455|Apixaban|apixaban|mesh-list
83532916|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532917|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83532918|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83532919|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532920|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532921|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83532922|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
83532923|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83532924|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532925|NCT02068027|Clonidine|clonidine|mesh-list
83532926|NCT02068027|Analgesics|analgesics|mesh-ancestor
83532927|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
83532928|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532929|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532930|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83532931|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
83532932|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
83532933|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83532934|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83532935|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83532936|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
83532937|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532938|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532939|NCT02392208|Telavancin|telavancin|mesh-list
83532940|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83532941|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532942|NCT05185583|Methylphenidate|methylphenidate|mesh-list
83532943|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83532944|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532945|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83532946|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83532947|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532948|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532949|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
83532950|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532951|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
83532952|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
83532953|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532954|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
83532955|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83532956|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532957|NCT04603937|Aflibercept|aflibercept|mesh-list
83532958|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83532959|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83532960|NCT04603937|Growth Substances|growth substances|mesh-ancestor
83532961|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532962|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
83532963|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532964|NCT02392286|Prednisone|prednisone|mesh-list
83532965|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
83532966|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83532967|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
83532968|NCT02392286|Hormones|hormones|mesh-ancestor
83532969|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83532970|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532971|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83532972|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532973|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
83532975|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83532976|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83532977|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83532978|NCT02392286|Protective Agents|protective agents|mesh-ancestor
83532979|NCT04586153|Meplazumab|meplazumab|mesh-list
83532980|NCT04586153|Antiviral Agents|antiviral agents|mesh-ancestor
83532981|NCT04586153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83532982|NCT05717738|Bevacizumab|bevacizumab|mesh-list
83532983|NCT05717738|Atezolizumab|atezolizumab|mesh-list
83532984|NCT05717738|Sorafenib|sorafenib|mesh-list
83532985|NCT05717738|Apatinib|apatinib|mesh-list
83532986|NCT05717738|Lenvatinib|lenvatinib|mesh-list
83532987|NCT05717738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83532988|NCT05717738|Antibodies|antibodies|mesh-list
83532989|NCT05717738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83532990|NCT05717738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83532991|NCT05717738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83532992|NCT05717738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83532993|NCT05717738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83532994|NCT05717738|Growth Substances|growth substances|mesh-ancestor
83532995|NCT05717738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83532996|NCT05717738|Growth Inhibitors|growth inhibitors|mesh-ancestor
83532997|NCT05717738|Immunologic Factors|immunologic factors|mesh-ancestor
83532998|NCT05717738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83532999|NCT05717738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533000|NCT05717738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533001|NCT02393378|Folic Acid|folic acid|mesh-list
83533002|NCT02393378|Adalimumab|adalimumab|mesh-list
83533003|NCT02393378|Methotrexate|methotrexate|mesh-list
83533004|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83533005|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
83533006|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83533007|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533008|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83533009|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
83533010|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533011|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533012|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
83533013|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533014|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83533015|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83533016|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
83533017|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83533018|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83533019|NCT02393378|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83533020|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83533021|NCT02393378|Hematinics|hematinics|mesh-ancestor
83533022|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
83533023|NCT02393378|Vitamins|vitamins|mesh-ancestor
83533024|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
83533025|NCT04949477|Acetaminophen|acetaminophen|mesh-list
83533026|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
83533027|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83533028|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533029|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533030|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83533031|NCT04949477|Analgesics|analgesics|mesh-ancestor
83533032|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
83533033|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533034|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83533035|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83533036|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83533037|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
83533038|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533039|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533040|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
83533041|NCT05437796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83533042|NCT05437796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533043|NCT05437796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533044|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
83533045|NCT04873895|Axitinib|axitinib|mesh-list
83533046|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
83533047|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83533048|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83533049|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533050|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533051|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533053|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533054|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83533055|NCT05717582|Androgens|androgens|mesh-list
83533056|NCT05717582|Hormones|hormones|mesh-ancestor
83533057|NCT05717582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533058|NCT05717582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533059|NCT03101033|Betamethasone|betamethasone|mesh-list
83533060|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
83533061|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83533062|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
83533063|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83533064|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83533065|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
83533066|NCT03101033|Hormones|hormones|mesh-ancestor
83533067|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533068|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533069|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83533070|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
83533071|NCT02069041|Leucovorin|leucovorin|mesh-list
83533072|NCT02069041|Fluorouracil|fluorouracil|mesh-list
83533073|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
83533074|NCT02069041|Ramucirumab|ramucirumab|mesh-list
83533075|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
83533076|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533077|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83533078|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533079|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83533080|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
83533081|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533082|NCT02069041|Antidotes|antidotes|mesh-ancestor
83533083|NCT02069041|Protective Agents|protective agents|mesh-ancestor
83533084|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
83533085|NCT02069041|Vitamins|vitamins|mesh-ancestor
83533086|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
83533087|NCT04920344|Cisplatin|cisplatin|mesh-list
83533088|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533089|NCT03101111|Vaccines|vaccines|mesh-list
83533090|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
83533091|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533092|NCT05423834|Tenofovir|tenofovir|mesh-list
83533093|NCT05423834|Entecavir|entecavir|mesh-list
83533094|NCT05423834|Antiviral Agents|antiviral agents|mesh-ancestor
83533095|NCT05423834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533096|NCT05423834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83533097|NCT05423834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83533098|NCT05423834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533099|NCT05423834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533100|NCT05423834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83533101|NCT05423834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83533102|NCT03103061|Regadenoson|regadenoson|mesh-list
83533103|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83533104|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83533105|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
83533106|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
83533107|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533108|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533109|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533110|NCT03105479|Vancomycin|vancomycin|mesh-list
83533111|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83533112|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533113|NCT00355862|Cyclosporine|cyclosporine|mesh-list
83533114|NCT00355862|Sirolimus|sirolimus|mesh-list
83533115|NCT00355862|Prednisolone|prednisolone|mesh-list
83533116|NCT00355862|Temsirolimus|temsirolimus|mesh-list
83533117|NCT00355862|Azathioprine|azathioprine|mesh-list
83533118|NCT00355862|MTOR Inhibitors|mtor inhibitors|mesh-list
83533119|NCT00355862|Tacrolimus|tacrolimus|mesh-list
83533120|NCT00355862|Cyclosporins|cyclosporins|mesh-list
83533121|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83533122|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
83533123|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533124|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83533125|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533126|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533127|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
83533128|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533129|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
83533130|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83533131|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83533132|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83533133|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533134|NCT00355862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83533135|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83533136|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
83533137|NCT00355862|Hormones|hormones|mesh-ancestor
83533138|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533139|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83533140|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
83533141|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83533142|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
83533143|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83533144|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
83533145|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533146|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83533147|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83533148|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
83533149|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533150|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533151|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83533152|NCT02049307|Losartan|losartan|mesh-list
83533153|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83533154|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83533155|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83533156|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83533157|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533158|NCT00355628|Fentanyl|fentanyl|mesh-list
83533159|NCT00355628|Citric Acid|citric acid|mesh-list
83533160|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
83533161|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83533162|NCT00355628|Narcotics|narcotics|mesh-ancestor
83533163|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533164|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533165|NCT00355628|Analgesics|analgesics|mesh-ancestor
83533166|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
83533167|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533168|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83533169|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83533170|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
83533172|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
83533173|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83533174|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
83533175|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
83533176|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533177|NCT02049385|Diazoxide|diazoxide|mesh-list
83533178|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83533179|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
83533180|NCT03717155|Carboplatin|carboplatin|mesh-list
83533181|NCT03717155|Gemcitabine|gemcitabine|mesh-list
83533182|NCT03717155|Cetuximab|cetuximab|mesh-list
83533183|NCT03717155|Avelumab|avelumab|mesh-list
83533184|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533185|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83533186|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
83533187|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533188|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83533189|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
83533190|NCT03789097|Poly ICLC|poly iclc|mesh-list
83533191|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83533192|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533193|NCT03789097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83533194|NCT03789097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533195|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
83533196|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
83533197|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533198|NCT03655613|Nivolumab|nivolumab|mesh-list
83533199|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83533200|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533201|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83533202|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533203|NCT04820036|Insulin|insulin|mesh-list
83533204|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83533205|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533206|NCT03286829|Metoprolol|metoprolol|mesh-list
83533208|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83533209|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
83533210|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
83533211|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533212|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533213|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83533214|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83533215|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83533216|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
83533217|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533218|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533219|NCT02051335|Scopolamine|scopolamine|mesh-list
83533220|NCT02051335|Donepezil|donepezil|mesh-list
83533221|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83533222|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83533223|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533224|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533225|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
83533226|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533227|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533228|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
83533229|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83533230|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
83533231|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
83533232|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533233|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83533234|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
83533235|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83533236|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83533237|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
83533238|NCT03290027|Tazarotene|tazarotene|mesh-list
83533239|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
83533240|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
83533241|NCT02300077|Fentanyl|fentanyl|mesh-list
83533242|NCT02300077|Morphine|morphine|mesh-list
83533243|NCT02300077|Methadone|methadone|mesh-list
83533245|NCT02300077|Narcotics|narcotics|mesh-ancestor
83533246|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533247|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533248|NCT02300077|Analgesics|analgesics|mesh-ancestor
83533249|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
83533250|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533251|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83533252|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83533253|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
83533254|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
83533255|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
83533256|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
83533257|NCT05272826|Dexamethasone|dexamethasone|mesh-list
83533258|NCT05272826|Bortezomib|bortezomib|mesh-list
83533259|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83533260|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
83533261|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
83533262|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533263|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533264|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83533265|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
83533266|NCT05272826|Hormones|hormones|mesh-ancestor
83533267|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533268|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83533269|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533270|NCT03458429|Lenograstim|lenograstim|mesh-list
83533271|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83533272|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
83533273|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533274|NCT03291197|Bupivacaine|bupivacaine|mesh-list
83533275|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
83533276|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
83533277|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533278|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533279|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
83533280|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533281|NCT05638880|Empagliflozin|empagliflozin|mesh-list
83533282|NCT05638880|Valsartan|valsartan|mesh-list
83533283|NCT05638880|Levocetirizine|levocetirizine|mesh-list
83533284|NCT05638880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83533285|NCT05638880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83533286|NCT05638880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83533287|NCT05638880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533288|NCT05638880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83533289|NCT05638880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83533290|NCT05638880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533291|NCT05638880|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83533292|NCT05638880|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83533293|NCT05638880|Histamine Antagonists|histamine antagonists|mesh-ancestor
83533294|NCT05638880|Histamine Agents|histamine agents|mesh-ancestor
83533295|NCT05638880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533296|NCT00356096|Pramipexole|pramipexole|mesh-list
83533297|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
83533298|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533299|NCT00356096|Protective Agents|protective agents|mesh-ancestor
83533300|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533301|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83533302|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83533303|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
83533304|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
83533305|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533306|NCT05637086|Phenytoin|phenytoin|mesh-list
83533307|NCT05637086|Pentoxifylline|pentoxifylline|mesh-list
83533308|NCT05637086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83533309|NCT05637086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533310|NCT05637086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533311|NCT05637086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83533312|NCT05637086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83533313|NCT05637086|Protective Agents|protective agents|mesh-ancestor
83533314|NCT05637086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533315|NCT05637086|Vasodilator Agents|vasodilator agents|mesh-ancestor
83533316|NCT05637086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83533317|NCT05637086|Antioxidants|antioxidants|mesh-ancestor
83533318|NCT05637086|Anticonvulsants|anticonvulsants|mesh-ancestor
83533319|NCT05637086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83533320|NCT05637086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83533321|NCT05637086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83533322|NCT05637086|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83533323|NCT05637086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83533324|NCT03243461|Temozolomide|temozolomide|mesh-list
83533325|NCT03243461|Valproic Acid|valproic acid|mesh-list
83533326|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83533327|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
83533328|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533329|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533330|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
83533331|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533332|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
83533333|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533334|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533335|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
83533336|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83533337|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533338|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83533339|NCT03296345|Ketamine|ketamine|mesh-list
83533340|NCT03296345|Analgesics|analgesics|mesh-ancestor
83533341|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
83533342|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533343|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533344|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83533345|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83533346|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
83533347|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
83533348|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533349|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83533350|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83533351|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533352|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533353|NCT00421694|Bicalutamide|bicalutamide|mesh-list
83533354|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
83533355|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
83533356|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533357|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533358|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533360|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83533361|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83533362|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533363|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83533364|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83533365|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533366|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
83533367|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83533368|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83533369|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533370|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83533371|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
83533372|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533373|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83533374|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83533375|NCT04652414|Prednisone|prednisone|mesh-list
83533376|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83533377|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
83533378|NCT04652414|Hormones|hormones|mesh-ancestor
83533379|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533380|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533381|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83533382|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533383|NCT04630964|Niacin|niacin|mesh-list
83533384|NCT04630964|Psilocybin|psilocybin|mesh-list
83533385|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83533386|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
83533387|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533388|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83533389|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
83533390|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
83533391|NCT04630964|Vitamins|vitamins|mesh-ancestor
83533392|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
83533393|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533394|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
83533395|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83533396|NCT05595044|Vitamin D|vitamin d|mesh-list
83533397|NCT05595044|Vitamins|vitamins|mesh-ancestor
83533398|NCT05595044|Micronutrients|micronutrients|mesh-ancestor
83533399|NCT05595044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533400|NCT05595044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83533401|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
83533402|NCT04736381|Abatacept|abatacept|mesh-list
83533403|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83533404|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533405|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83533406|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
83533407|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83533408|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533409|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533410|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533411|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83533412|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
83533413|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533414|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83533415|NCT04736381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83533416|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83533417|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
83533418|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83533419|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83533420|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533421|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
83533422|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533423|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533424|NCT02792465|Fulvestrant|fulvestrant|mesh-list
83533425|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83533426|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533427|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83533428|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83533429|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
83533430|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533431|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533432|NCT05573828|Parathyroid Hormone|parathyroid hormone|mesh-list
83533433|NCT05573828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83533434|NCT05573828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533435|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
83533436|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533437|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533438|NCT04525820|Vitamin D|vitamin d|mesh-list
83533439|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
83533440|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
83533441|NCT04525820|Vitamins|vitamins|mesh-list
83533442|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83533443|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
83533444|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533445|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83533446|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83533447|NCT05570708|Psilocybin|psilocybin|mesh-list
83533448|NCT05570708|Hallucinogens|hallucinogens|mesh-ancestor
83533449|NCT05570708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533450|NCT05570708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83533451|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
83533452|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83533453|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
83533454|NCT03305159|Povidone|povidone|mesh-list
83533455|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83533456|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533457|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
83533458|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
83533459|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
83533460|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
83533461|NCT05552144|Listerine|listerine|mesh-list
83533462|NCT05552144|Sodium Fluoride|sodium fluoride|mesh-list
83533463|NCT05552144|Cariostatic Agents|cariostatic agents|mesh-ancestor
83533464|NCT05552144|Protective Agents|protective agents|mesh-ancestor
83533465|NCT05552144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533466|NCT05552144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83533467|NCT05552144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533469|NCT03308669|Lasmiditan|lasmiditan|mesh-list
83533470|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
83533471|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83533472|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533473|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83533474|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
83533475|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533476|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533477|NCT00356252|Carotenoids|carotenoids|mesh-list
83533478|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
83533479|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533480|NCT00356252|Protective Agents|protective agents|mesh-ancestor
83533481|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533482|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83533483|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
83533484|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83533485|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83533486|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83533487|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533488|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533489|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
83533490|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83533491|NCT03312023|Ledipasvir|ledipasvir|mesh-list
83533492|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
83533493|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533494|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83533495|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
83533496|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83533497|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
83533498|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83533499|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533500|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83533501|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83533502|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533503|NCT02344225|Ibuprofen|ibuprofen|mesh-list
83533504|NCT02344225|Ketorolac|ketorolac|mesh-list
83533505|NCT02344225|Caffeine|caffeine|mesh-list
83533506|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
83533507|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533508|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83533509|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83533510|NCT02344225|Analgesics|analgesics|mesh-ancestor
83533511|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
83533512|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533513|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533514|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83533515|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83533516|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83533517|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533518|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83533519|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83533520|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83533521|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83533522|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
83533523|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533524|NCT04319588|Anesthetics|anesthetics|mesh-list
83533525|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
83533526|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533527|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533528|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
83533529|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533530|NCT05065736|Clofarabine|clofarabine|mesh-list
83533531|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83533532|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
83533533|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533534|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533535|NCT04298606|Vaccines|vaccines|mesh-list
83533536|NCT04298606|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83533537|NCT04298606|Mitogens|mitogens|mesh-list
83533538|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
83533539|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533540|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
83533541|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533542|NCT04298606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83533543|NCT03769844|Molgramostim|molgramostim|mesh-list
83533544|NCT03769844|Sargramostim|sargramostim|mesh-list
83533545|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
83533546|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533547|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533548|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
83533549|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83533550|NCT02347345|Ledipasvir|ledipasvir|mesh-list
83533551|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
83533552|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533553|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
83533554|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83533555|NCT03319277|Narcotics|narcotics|mesh-ancestor
83533556|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533557|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533558|NCT03319277|Analgesics|analgesics|mesh-ancestor
83533559|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
83533560|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533561|NCT03768440|Ropivacaine|ropivacaine|mesh-list
83533562|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
83533563|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
83533564|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533565|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533566|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
83533567|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533568|NCT04624295|Aspirin|aspirin|mesh-list
83533569|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83533570|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83533571|NCT04624295|Analgesics|analgesics|mesh-ancestor
83533572|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
83533573|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533574|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533575|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83533576|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83533577|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83533578|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83533579|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533580|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83533581|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83533582|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533583|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
83533586|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533587|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
83533588|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
83533589|NCT04450355|Nefopam|nefopam|mesh-list
83533590|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83533591|NCT04450355|Analgesics|analgesics|mesh-ancestor
83533592|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
83533593|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533594|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533595|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
83533596|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83533597|NCT02352259|Bleomycin|bleomycin|mesh-list
83533598|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83533599|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533600|NCT03326999|Bupivacaine|bupivacaine|mesh-list
83533601|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
83533602|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
83533603|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533604|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533605|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
83533606|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533607|NCT02397265|Insulin|insulin|mesh-list
83533608|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83533609|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533610|NCT00356720|Azithromycin|azithromycin|mesh-list
83533611|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83533612|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533613|NCT04121780|Hormones|hormones|mesh-list
83533614|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533615|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533616|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
83533617|NCT00375869|Hematinics|hematinics|mesh-ancestor
83533618|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
83533619|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
83533620|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83533621|NCT03198221|Citric Acid|citric acid|mesh-list
83533622|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
83533623|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83533624|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
83533625|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
83533626|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533627|NCT03198221|Cathartics|cathartics|mesh-ancestor
83533628|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83533630|NCT03198221|Laxatives|laxatives|mesh-ancestor
83533631|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
83533632|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83533633|NCT03203681|Testosterone|testosterone|mesh-list
83533634|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
83533635|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
83533636|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83533637|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533638|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
83533639|NCT03203681|Hormones|hormones|mesh-ancestor
83533640|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533641|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533642|NCT03203681|Androgens|androgens|mesh-ancestor
83533643|NCT02399917|Azacitidine|azacitidine|mesh-list
83533644|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83533645|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
83533646|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533647|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533648|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533649|NCT00356486|Ribavirin|ribavirin|mesh-list
83533650|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83533651|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
83533652|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
83533653|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533654|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
83533655|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533656|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
83533657|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533658|NCT03331835|Brodalumab|brodalumab|mesh-list
83533659|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
83533660|NCT02403895|Paclitaxel|paclitaxel|mesh-list
83533661|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83533662|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533663|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
83533664|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
83533666|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533668|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
83533669|NCT03994874|Diuretics|diuretics|mesh-list
83533670|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83533671|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
83533672|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533673|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83533674|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533675|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83533676|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83533677|NCT05722340|Anesthetics|anesthetics|mesh-list
83533678|NCT05722340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533679|NCT05722340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533680|NCT02354833|Phenylephrine|phenylephrine|mesh-list
83533681|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
83533682|NCT02354833|Norepinephrine|norepinephrine|mesh-list
83533683|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83533684|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
83533685|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
83533686|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533687|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533688|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
83533689|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83533690|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
83533691|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
83533692|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83533693|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83533694|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83533695|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
83533696|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533697|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533698|NCT02354833|Protective Agents|protective agents|mesh-ancestor
83533699|NCT03337724|Paclitaxel|paclitaxel|mesh-list
83533700|NCT03337724|Ipatasertib|ipatasertib|mesh-list
83533701|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83533702|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533703|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
83533704|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
83533705|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
83533706|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533707|NCT03337724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83533708|NCT03337724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533709|NCT03838484|Nicotine|nicotine|mesh-list
83533710|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83533711|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
83533712|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533713|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533714|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83533715|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83533716|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
83533717|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533718|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533719|NCT03307616|Nivolumab|nivolumab|mesh-list
83533720|NCT03307616|Ipilimumab|ipilimumab|mesh-list
83533721|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83533722|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533723|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83533724|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533725|NCT05721872|Arsenic Trioxide|arsenic trioxide|mesh-list
83533726|NCT05721872|Isoascorbic acid|isoascorbic acid|mesh-list
83533727|NCT05721872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533728|NCT05721872|Antioxidants|antioxidants|mesh-ancestor
83533729|NCT05721872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533730|NCT05721872|Protective Agents|protective agents|mesh-ancestor
83533731|NCT05721872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533732|NCT02408965|Methylergonovine|methylergonovine|mesh-list
83533733|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
83533734|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83533735|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533736|NCT03299426|Vaccines|vaccines|mesh-list
83533737|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
83533738|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533739|NCT03220022|Prednisone|prednisone|mesh-list
83533740|NCT03220022|Cortisone|cortisone|mesh-list
83533750|NCT03220022|Antibodies|antibodies|mesh-list
83533751|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
83533752|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83533753|NCT03220022|Lenograstim|lenograstim|mesh-list
83533754|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83533755|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
83533756|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533757|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83533758|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83533759|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
83533760|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533761|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533762|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83533763|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83533764|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83533765|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83533766|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533767|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83533768|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
83533769|NCT03220022|Hormones|hormones|mesh-ancestor
83533770|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533771|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83533772|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83533773|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83533774|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
83533775|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
83533776|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
83533777|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
83533778|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
83533780|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83533781|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533782|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83533783|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
83533784|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83533785|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
83533786|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533787|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
83533788|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83533789|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533790|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83533791|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533792|NCT05721404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83533793|NCT05721404|Icodextrin|icodextrin|mesh-list
83533794|NCT05721404|Dialysis Solutions|dialysis solutions|mesh-list
83533795|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
83533796|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
83533797|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533798|NCT00356954|Protective Agents|protective agents|mesh-ancestor
83533799|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533800|NCT00356954|Vitamins|vitamins|mesh-ancestor
83533801|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
83533802|NCT02358889|Ranibizumab|ranibizumab|mesh-list
83533803|NCT02358889|hI-con1|hi-con1|mesh-list
83533804|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
83533805|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83533806|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83533807|NCT02358889|Growth Substances|growth substances|mesh-ancestor
83533808|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533809|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
83533810|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533811|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
83533812|NCT05721170|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83533813|NCT05721170|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83533814|NCT05721170|Adrenergic Agents|adrenergic agents|mesh-ancestor
83533815|NCT05721170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533816|NCT05721170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533817|NCT05721170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533818|NCT03038672|Nivolumab|nivolumab|mesh-list
83533819|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
83533820|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
83533821|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83533822|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83533823|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533824|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83533825|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533826|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
83533827|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533828|NCT00358124|Metformin|metformin|mesh-list
83533829|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
83533830|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
83533831|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83533832|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533833|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
83533834|NCT00358202|Cefepime|cefepime|mesh-list
83533835|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83533836|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533837|NCT02802566|Vitamins|vitamins|mesh-list
83533838|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
83533839|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533840|NCT04736225|Insulin|insulin|mesh-list
83533841|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83533842|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533843|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83533844|NCT03344861|Trioxsalen|trioxsalen|mesh-list
83533845|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533846|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
83533847|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83533848|NCT03348683|Propranolol|propranolol|mesh-list
83533849|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83533850|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83533851|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
83533852|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533853|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533854|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533855|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83533856|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83533857|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
83533858|NCT04344782|Bevacizumab|bevacizumab|mesh-list
83533859|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83533860|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533861|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83533862|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83533863|NCT04344782|Growth Substances|growth substances|mesh-ancestor
83533864|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533865|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
83533866|NCT00357188|Ritonavir|ritonavir|mesh-list
83533867|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83533868|NCT00357188|Efavirenz|efavirenz|mesh-list
83533869|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83533870|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83533871|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
83533872|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533873|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533874|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83533875|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83533876|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
83533877|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533878|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83533879|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83533880|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83533881|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83533882|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83533883|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83533884|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83533885|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83533886|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83533887|NCT02360215|Memantine|memantine|mesh-list
83533888|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83533889|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83533890|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
83533891|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533892|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533893|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533894|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83533895|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83533896|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
83533897|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83533898|NCT01349192|Minocycline|minocycline|mesh-list
83533904|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533905|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
83533906|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
83533907|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83533908|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83533909|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
83533910|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
83533911|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83533912|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83533913|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533914|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83533915|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83533916|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83533917|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83533918|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83533919|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83533920|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83533921|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
83533922|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83533923|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83533924|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83533925|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83533926|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83533927|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83533928|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83533929|NCT02362321|Dexamethasone|dexamethasone|mesh-list
83533930|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83533931|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
83533932|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
83533933|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533934|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533935|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83533936|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
83533937|NCT02362321|Hormones|hormones|mesh-ancestor
83533938|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83533939|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83533940|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533941|NCT00354991|Losartan|losartan|mesh-list
83533942|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83533943|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83533944|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83533945|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83533946|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83533947|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533948|NCT00354991|Diuretics|diuretics|mesh-ancestor
83533949|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
83533950|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533951|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83533952|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83533953|NCT00357890|Insulin|insulin|mesh-list
83533954|NCT00357890|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83533955|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
83533956|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83533957|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533958|NCT02112578|Meclizine|meclizine|mesh-list
83533959|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
83533960|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
83533961|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
83533962|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533963|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533964|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83533965|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83533966|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
83533967|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
83533968|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83533969|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533970|NCT02112578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83533971|NCT02112578|Cholinergic Agents|cholinergic agents|mesh-ancestor
83533972|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83533973|NCT00358280|Bupivacaine|bupivacaine|mesh-list
83533974|NCT00358280|Ropivacaine|ropivacaine|mesh-list
83533975|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
83533978|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533979|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
83533980|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533981|NCT05719285|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83533982|NCT05719285|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83533983|NCT05719285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83533984|NCT05719285|Antitubercular Agents|antitubercular agents|mesh-ancestor
83533985|NCT02363803|Lidocaine|lidocaine|mesh-list
83533986|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
83533987|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
83533988|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83533989|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533990|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
83533991|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533992|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83533993|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83533994|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83533995|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83533996|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83533997|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
83533998|NCT03417193|Anesthetics|anesthetics|mesh-list
83533999|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534000|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534001|NCT03417193|Narcotics|narcotics|mesh-ancestor
83534002|NCT03417193|Analgesics|analgesics|mesh-ancestor
83534003|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
83534004|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534005|NCT02367859|Trametinib|trametinib|mesh-list
83534006|NCT02367859|Dabrafenib|dabrafenib|mesh-list
83534007|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534008|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83534009|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534010|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534011|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
83534012|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
83534013|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
83534014|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83534015|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83534016|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534017|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534018|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534019|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
83534020|NCT03342937|Capecitabine|capecitabine|mesh-list
83534021|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
83534022|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83534023|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534024|NCT03342937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83534025|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534026|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83534027|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
83534028|NCT05718661|Methamphetamine|methamphetamine|mesh-list
83534029|NCT05718661|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83534030|NCT05718661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534031|NCT05718661|Sympathomimetics|sympathomimetics|mesh-ancestor
83534032|NCT05718661|Autonomic Agents|autonomic agents|mesh-ancestor
83534033|NCT05718661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534034|NCT05718661|Dopamine Agents|dopamine agents|mesh-ancestor
83534035|NCT05718661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534036|NCT05718661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534037|NCT05718661|Adrenergic Agents|adrenergic agents|mesh-ancestor
83534038|NCT05718661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83534039|NCT05718661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83534040|NCT05718661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83534041|NCT05718661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83534042|NCT00354757|Rabeprazole|rabeprazole|mesh-list
83534043|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83534044|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83534045|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83534046|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534047|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534048|NCT02376283|Clopidogrel|clopidogrel|mesh-list
83534050|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83534051|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83534052|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83534053|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83534054|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83534055|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
83534056|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534057|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534058|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534059|NCT00425347|Elotuzumab|elotuzumab|mesh-list
83534060|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534061|NCT05718037|Vaccines|vaccines|mesh-list
83534062|NCT05718037|Immunologic Factors|immunologic factors|mesh-ancestor
83534063|NCT05718037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534064|NCT05717881|Propolis|propolis|mesh-list
83534065|NCT05717881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534066|NCT00355303|Misoprostol|misoprostol|mesh-list
83534067|NCT00355303|Dinoprostone|dinoprostone|mesh-list
83534068|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83534069|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
83534070|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83534071|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534072|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83534073|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83534074|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
83534075|NCT05717569|Vitamin D|vitamin d|mesh-list
83534076|NCT05717569|Vitamins|vitamins|mesh-ancestor
83534077|NCT05717569|Micronutrients|micronutrients|mesh-ancestor
83534078|NCT05717569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534079|NCT05717569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83534080|NCT02385097|Ropivacaine|ropivacaine|mesh-list
83534081|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
83534082|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
83534083|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
83534084|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534085|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534086|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
83534087|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534088|NCT02387359|Plecanatide|plecanatide|mesh-list
83534089|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83534090|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
83534091|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534092|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83534093|NCT00355459|Doxycycline|doxycycline|mesh-list
83534094|NCT00355459|Tetracycline|tetracycline|mesh-list
83534095|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83534096|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534097|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
83534098|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83534099|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83534100|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83534101|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534102|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534103|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
83534104|NCT02393677|Ropivacaine|ropivacaine|mesh-list
83534105|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83534106|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534107|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534108|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83534109|NCT02393677|Analgesics|analgesics|mesh-ancestor
83534110|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
83534111|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534112|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83534113|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83534114|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83534115|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
83534116|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534117|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534118|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
83534119|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
83534120|NCT02394457|Cosyntropin|cosyntropin|mesh-list
83534121|NCT02394457|Hormones|hormones|mesh-ancestor
83534122|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534123|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534124|NCT00355771|Levocetirizine|levocetirizine|mesh-list
83534352|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534125|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83534126|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83534127|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
83534128|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
83534129|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534130|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534131|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534132|NCT05664139|Paclitaxel|paclitaxel|mesh-list
83534133|NCT05664139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83534134|NCT05664139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534135|NCT05664139|Tubulin Modulators|tubulin modulators|mesh-ancestor
83534136|NCT05664139|Antimitotic Agents|antimitotic agents|mesh-ancestor
83534137|NCT05664139|Mitosis Modulators|mitosis modulators|mesh-ancestor
83534138|NCT05664139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534139|NCT03224351|Ivacaftor|ivacaftor|mesh-list
83534140|NCT03224351|VX-659|vx-659|mesh-list
83534141|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83534142|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83534143|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534144|NCT05658055|Amoxicillin|amoxicillin|mesh-list
83534145|NCT05658055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83534146|NCT05658055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534147|NCT05642923|Thiamine|thiamine|mesh-list
83534148|NCT05642923|Vitamins|vitamins|mesh-ancestor
83534149|NCT05642923|Micronutrients|micronutrients|mesh-ancestor
83534150|NCT05642923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534151|NCT05642923|Vitamin B Complex|vitamin b complex|mesh-ancestor
83534152|NCT03906071|Docetaxel|docetaxel|mesh-list
83534153|NCT03906071|Nivolumab|nivolumab|mesh-list
83534154|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534155|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
83534156|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
83534157|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
83534158|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534159|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83534160|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83534161|NCT01721876|Cytarabine|cytarabine|mesh-list
83534162|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83534163|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
83534164|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534165|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534166|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
83534167|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534168|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83534169|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
83534170|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534171|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83534172|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83534173|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
83534174|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534175|NCT01112072|Riboflavin|riboflavin|mesh-list
83534176|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
83534177|NCT01112072|Vitamins|vitamins|mesh-ancestor
83534178|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
83534179|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534180|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83534181|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
83534182|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83534183|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
83534184|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534185|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534186|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83534187|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534188|NCT05662202|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83534189|NCT05662202|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83534190|NCT05662202|Dermatologic Agents|dermatologic agents|mesh-ancestor
83534191|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
83534192|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534193|NCT03226223|Methamphetamine|methamphetamine|mesh-list
83534194|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83534195|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534196|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
83534197|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
83534198|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534199|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
83534200|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534201|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534203|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83534204|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83534205|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83534206|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83534207|NCT05620771|Bevacizumab|bevacizumab|mesh-list
83534208|NCT05620771|Atezolizumab|atezolizumab|mesh-list
83534209|NCT05620771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83534210|NCT05620771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534211|NCT05620771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83534212|NCT05620771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83534213|NCT05620771|Growth Substances|growth substances|mesh-ancestor
83534214|NCT05620771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534215|NCT05620771|Growth Inhibitors|growth inhibitors|mesh-ancestor
83534216|NCT05620771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83534217|NCT05620771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534218|NCT05419297|Buprenorphine|buprenorphine|mesh-list
83534219|NCT05419297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83534220|NCT05419297|Narcotics|narcotics|mesh-ancestor
83534221|NCT05419297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534222|NCT05419297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534223|NCT05419297|Analgesics|analgesics|mesh-ancestor
83534224|NCT05419297|Sensory System Agents|sensory system agents|mesh-ancestor
83534225|NCT05419297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534226|NCT05419297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83534227|NCT03226457|Empagliflozin|empagliflozin|mesh-list
83534228|NCT03226457|Furosemide|furosemide|mesh-list
83534229|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83534230|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534231|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83534232|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534233|NCT03226457|Diuretics|diuretics|mesh-ancestor
83534234|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
83534235|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83534236|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83534237|NCT03226691|Plerixafor|plerixafor|mesh-list
83534238|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83534239|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83534240|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
83534241|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534242|NCT00003159|Paclitaxel|paclitaxel|mesh-list
83534243|NCT00003159|Vinorelbine|vinorelbine|mesh-list
83534244|NCT00003159|Vinblastine|vinblastine|mesh-list
83534245|NCT00003159|Docetaxel|docetaxel|mesh-list
83534246|NCT00003159|Carboplatin|carboplatin|mesh-list
83534247|NCT00003159|Gemcitabine|gemcitabine|mesh-list
83534248|NCT00003159|Ifosfamide|ifosfamide|mesh-list
83534249|NCT00003159|Mitomycins|mitomycins|mesh-list
83534250|NCT00003159|Mitomycin|mitomycin|mesh-list
83534251|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83534252|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534253|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
83534254|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
83534255|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
83534256|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534257|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83534258|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
83534259|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83534260|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
83534261|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83534262|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83534263|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534264|NCT03228017|Aspirin|aspirin|mesh-list
83534265|NCT03228017|Atorvastatin|atorvastatin|mesh-list
83534266|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83534267|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83534268|NCT03228017|Analgesics|analgesics|mesh-ancestor
83534269|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
83534270|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534271|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534272|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83534273|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83534274|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83534275|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83534276|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534277|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83534278|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83534279|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534280|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
83534281|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83534282|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83534283|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
83534284|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83534285|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83534286|NCT00355927|Propofol|propofol|mesh-list
83534287|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83534288|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534289|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534290|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83534291|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
83534292|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
83534293|NCT00357422|Ethanol|ethanol|mesh-list
83534294|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83534295|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534296|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534297|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534298|NCT00356005|Azithromycin|azithromycin|mesh-list
83534299|NCT00356005|Artesunate|artesunate|mesh-list
83534300|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83534301|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534302|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
83534303|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83534304|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83534305|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534306|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
83534307|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
83534308|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83534309|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
83534310|NCT00376337|Micafungin|micafungin|mesh-list
83534311|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
83534312|NCT00376337|Clotrimazole|clotrimazole|mesh-list
83534313|NCT00376337|Miconazole|miconazole|mesh-list
83534314|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534315|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83534316|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83534317|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83534318|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534319|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534320|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83534321|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
83534322|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534323|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534324|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83534325|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83534326|NCT00003165|Doxorubicin|doxorubicin|mesh-list
83534327|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83534328|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534329|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83534330|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83534331|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534332|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534333|NCT05723510|Rivaroxaban|rivaroxaban|mesh-list
83534334|NCT05723510|Apixaban|apixaban|mesh-list
83534335|NCT05723510|Edoxaban|edoxaban|mesh-list
83534336|NCT05723510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83534337|NCT05723510|Antithrombins|antithrombins|mesh-ancestor
83534338|NCT05723510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83534339|NCT05723510|Protease Inhibitors|protease inhibitors|mesh-ancestor
83534340|NCT05723510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534341|NCT05723510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534342|NCT05723510|Anticoagulants|anticoagulants|mesh-ancestor
83534343|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
83534344|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83534345|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
83534346|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534347|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534348|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
83534349|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534350|NCT00003183|Analgesics|analgesics|mesh-ancestor
83534351|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
83534353|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534354|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83534355|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83534356|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534357|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534358|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
83534359|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
83534360|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
83534361|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534362|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
83534363|NCT02979223|Protective Agents|protective agents|mesh-ancestor
83534364|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534365|NCT02979223|Vitamins|vitamins|mesh-ancestor
83534366|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
83534367|NCT02979223|Cathartics|cathartics|mesh-ancestor
83534368|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83534369|NCT01805271|Everolimus|everolimus|mesh-list
83534370|NCT01805271|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83534371|NCT01805271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83534372|NCT01805271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534373|NCT01805271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534374|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83534375|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
83534376|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534377|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534378|NCT05723276|Psilocybin|psilocybin|mesh-list
83534379|NCT05723276|Hallucinogens|hallucinogens|mesh-ancestor
83534380|NCT05723276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534381|NCT05723276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83534382|NCT01768767|Ketamine|ketamine|mesh-list
83534383|NCT01768767|Analgesics|analgesics|mesh-ancestor
83534384|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
83534385|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534386|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534387|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83534388|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83534389|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
83534390|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
83534391|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534392|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83534393|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83534394|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534395|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534396|NCT00376493|Metronidazole|metronidazole|mesh-list
83534397|NCT00376493|Doxycycline|doxycycline|mesh-list
83534398|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534399|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83534400|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83534401|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83534402|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
83534403|NCT00003195|Interferons|interferons|mesh-list
83534404|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
83534405|NCT00003195|Busulfan|busulfan|mesh-list
83534406|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534407|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
83534408|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534409|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
83534410|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534411|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
83534412|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534413|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83534414|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83534415|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83534416|NCT03671109|Piperaquine|piperaquine|mesh-list
83534417|NCT03671109|Artenimol|artenimol|mesh-list
83534418|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
83534419|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83534420|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83534421|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534422|NCT05716256|Urinastatin|urinastatin|mesh-list
83534423|NCT05716256|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83534424|NCT05716256|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83534425|NCT05716256|Protease Inhibitors|protease inhibitors|mesh-ancestor
83534426|NCT05716256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534427|NCT05716256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534428|NCT00356083|Methadone|methadone|mesh-list
83534429|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83534430|NCT00356083|Narcotics|narcotics|mesh-ancestor
83534431|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534432|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534433|NCT00356083|Analgesics|analgesics|mesh-ancestor
83534434|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
83534435|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534436|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
83534437|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
83534439|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83534440|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83534441|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83534442|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
83534443|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534444|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534445|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534446|NCT02977832|Urological Agents|urological agents|mesh-ancestor
83534447|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
83534448|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
83534449|NCT04344236|Povidone|povidone|mesh-list
83534450|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83534451|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534453|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
83534454|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
83534455|NCT00355537|Testosterone|testosterone|mesh-list
83534456|NCT00355537|Androgens|androgens|mesh-ancestor
83534457|NCT00355537|Hormones|hormones|mesh-ancestor
83534458|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534459|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534460|NCT00003207|Doxorubicin|doxorubicin|mesh-list
83534461|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83534462|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83534463|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534464|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83534465|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83534466|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534467|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534468|NCT00003387|Paclitaxel|paclitaxel|mesh-list
83534469|NCT00003387|Carboplatin|carboplatin|mesh-list
83534470|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83534471|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534472|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
83534473|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
83534474|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
83534475|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534476|NCT01542021|Androgens|androgens|mesh-list
83534477|NCT01542021|Hormones|hormones|mesh-ancestor
83534478|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534479|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534480|NCT04706897|Lidocaine|lidocaine|mesh-list
83534481|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
83534482|NCT04706897|Ketamine|ketamine|mesh-list
83534483|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
83534484|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
83534485|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534486|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534487|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
83534488|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534489|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83534490|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83534491|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83534492|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83534493|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534494|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83534495|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83534496|NCT04706897|Analgesics|analgesics|mesh-ancestor
83534497|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83534498|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83534499|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83534500|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
83534501|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534502|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83534503|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83534504|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
83534505|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83534506|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83534507|NCT00003213|Dexamethasone|dexamethasone|mesh-list
83534508|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
83534509|NCT00003213|Metoclopramide|metoclopramide|mesh-list
83534510|NCT00003213|Granisetron|granisetron|mesh-list
83534511|NCT00003213|BB 1101|bb 1101|mesh-list
83534512|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83534513|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
83534514|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
83534515|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534516|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534517|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83534518|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
83534519|NCT00003213|Hormones|hormones|mesh-ancestor
83413644|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83534520|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534521|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83534522|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534523|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
83534524|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534525|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534526|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83534527|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83534528|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
83534529|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534530|NCT00003213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83534531|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83534532|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
83534533|NCT01445067|Calcitonin|calcitonin|mesh-list
83534534|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83534535|NCT01445067|Katacalcin|katacalcin|mesh-list
83534536|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
83534537|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83534538|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534539|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83534540|NCT02978066|Anesthetics|anesthetics|mesh-list
83534541|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534542|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534543|NCT00003399|Dexamethasone|dexamethasone|mesh-list
83534544|NCT00003399|Paclitaxel|paclitaxel|mesh-list
83534545|NCT00003399|Etoposide|etoposide|mesh-list
83534546|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
83534547|NCT00003399|Melphalan|melphalan|mesh-list
83534548|NCT00003399|Carmustine|carmustine|mesh-list
83534549|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83534550|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534551|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
83534552|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
83534553|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
83534554|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534555|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83534556|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
83534557|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534558|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83534559|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83534560|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
83534561|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83534562|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83534563|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
83534564|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
83534565|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534566|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83534567|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
83534568|NCT00003399|Hormones|hormones|mesh-ancestor
83534569|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534570|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83534571|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83534572|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83534573|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534574|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
83534575|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83534576|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83534577|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534578|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
83534579|NCT03376061|Coagulants|coagulants|mesh-ancestor
83534580|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
83534581|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83534582|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
83534583|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534584|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534585|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83534586|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
83534587|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
83534588|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83534589|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
83534590|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534591|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534592|NCT04735523|Warfarin|warfarin|mesh-list
83534593|NCT04735523|Dabigatran|dabigatran|mesh-list
83534594|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
83534595|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
83534596|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83534597|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
83534598|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534599|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534600|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
83534601|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534602|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534603|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534604|NCT05715788|Nitric Oxide|nitric oxide|mesh-list
83534605|NCT05715788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83534606|NCT05715788|Autonomic Agents|autonomic agents|mesh-ancestor
83534607|NCT05715788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534608|NCT05715788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534609|NCT05715788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83534610|NCT05715788|Respiratory System Agents|respiratory system agents|mesh-ancestor
83534611|NCT05715788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83534612|NCT05715788|Antioxidants|antioxidants|mesh-ancestor
83534613|NCT05715788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534614|NCT05715788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534615|NCT05715788|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83534616|NCT05715788|Vasodilator Agents|vasodilator agents|mesh-ancestor
83534617|NCT05715788|Gasotransmitters|gasotransmitters|mesh-ancestor
83534618|NCT05715788|Protective Agents|protective agents|mesh-ancestor
83534619|NCT00003225|Irinotecan|irinotecan|mesh-list
83534620|NCT00003225|Amifostine|amifostine|mesh-list
83534621|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83534622|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83534623|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534624|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534625|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534626|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83534627|NCT00003225|Protective Agents|protective agents|mesh-ancestor
83534628|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534629|NCT05372588|Vaccines|vaccines|mesh-list
83534630|NCT05372588|Immunologic Factors|immunologic factors|mesh-ancestor
83534631|NCT05372588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534632|NCT03838094|Calcium|calcium|mesh-list
83534633|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83534634|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534635|NCT03441269|Ibuprofen|ibuprofen|mesh-list
83534636|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83534637|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83534638|NCT03441269|Analgesics|analgesics|mesh-ancestor
83534639|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
83534640|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534641|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534642|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83534643|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83534644|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83534645|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534646|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534647|NCT03252353|Octreotide|octreotide|mesh-list
83534648|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83534649|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83534650|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534651|NCT05355272|Hormones|hormones|mesh-list
83534652|NCT05355272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534653|NCT05355272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534654|NCT00358358|Fluticasone|fluticasone|mesh-list
83534655|NCT00358358|Xhance|xhance|mesh-list
83534656|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83534808|NCT00003405|Analgesics|analgesics|mesh-ancestor
83534657|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83534659|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83534660|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
83534661|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534662|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534663|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83534664|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
83534665|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
83534666|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83534667|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83534668|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83534669|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83534670|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
83534671|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534672|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534673|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
83534674|NCT00358358|Hormones|hormones|mesh-ancestor
83534675|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534676|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
83534677|NCT03441581|Eluxadoline|eluxadoline|mesh-list
83534678|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83534679|NCT02265510|Dexamethasone|dexamethasone|mesh-list
83534680|NCT02265510|Paclitaxel|paclitaxel|mesh-list
83534681|NCT02265510|Gemcitabine|gemcitabine|mesh-list
83534682|NCT02265510|Lenalidomide|lenalidomide|mesh-list
83534683|NCT02265510|Azacitidine|azacitidine|mesh-list
83534684|NCT02265510|Bortezomib|bortezomib|mesh-list
83534685|NCT02265510|Pomalidomide|pomalidomide|mesh-list
83534686|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83534687|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534688|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
83534689|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
83534690|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
83534691|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534692|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83534693|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
83534694|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
83534695|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534696|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534697|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83534698|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
83534699|NCT02265510|Hormones|hormones|mesh-ancestor
83534700|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534701|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83534702|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83534703|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
83534704|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
83534705|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83534706|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83534707|NCT02265510|Growth Substances|growth substances|mesh-ancestor
83534708|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
83534709|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534710|NCT03254147|Warfarin|warfarin|mesh-list
83534711|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
83534712|NCT03254147|Dabigatran|dabigatran|mesh-list
83534713|NCT03254147|Apixaban|apixaban|mesh-list
83534714|NCT03254147|Edoxaban|edoxaban|mesh-list
83534715|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
83534716|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83534717|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
83534718|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83534719|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
83534720|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534721|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534722|NCT03384329|Resveratrol|resveratrol|mesh-list
83534723|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
83534724|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534725|NCT03384329|Protective Agents|protective agents|mesh-ancestor
83534726|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534727|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534728|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83534729|NCT03443063|Lemborexant|lemborexant|mesh-list
83534730|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83534731|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534732|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534734|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83534735|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534736|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534737|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83534738|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83534739|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534740|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534741|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83534742|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83534743|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534744|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
83534745|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534746|NCT03256253|Pregabalin|pregabalin|mesh-list
83534747|NCT03256253|Analgesics|analgesics|mesh-ancestor
83534748|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
83534749|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534750|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534751|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
83534752|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83534753|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83534754|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534755|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83534756|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83534757|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83534758|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534759|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83534760|NCT03256799|Ivacaftor|ivacaftor|mesh-list
83534761|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83534762|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83534763|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534764|NCT01238211|Cytarabine|cytarabine|mesh-list
83534765|NCT01238211|Daunorubicin|daunorubicin|mesh-list
83534766|NCT01238211|Dasatinib|dasatinib|mesh-list
83534767|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83534768|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
83534769|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534770|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534771|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
83534772|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534773|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83534774|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
83534775|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534776|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83534777|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83534778|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83534779|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534780|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83534781|NCT04735445|Liver Extracts|liver extracts|mesh-list
83534782|NCT04735445|Hematinics|hematinics|mesh-ancestor
83534783|NCT00003231|Docetaxel|docetaxel|mesh-list
83534784|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534785|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
83534786|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
83534787|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
83534788|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534789|NCT00003405|Interferons|interferons|mesh-list
83534790|NCT00003405|Cytarabine|cytarabine|mesh-list
83534791|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
83534792|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
83534793|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
83534794|NCT00003405|Idoxuridine|idoxuridine|mesh-list
83534795|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
83534796|NCT00003405|Idarubicin|idarubicin|mesh-list
83534797|NCT00003405|Isotretinoin|isotretinoin|mesh-list
83534798|NCT00003405|Amifostine|amifostine|mesh-list
83534799|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534800|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
83534801|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534802|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83534803|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
83534804|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534805|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83534806|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
83534807|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534810|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534811|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83534812|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83534813|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534814|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83534815|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
83534816|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83534817|NCT00003405|Protective Agents|protective agents|mesh-ancestor
83534818|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83534819|NCT05131646|Axitinib|axitinib|mesh-list
83534820|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534821|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83534822|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534823|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534824|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
83534825|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534826|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83534827|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
83534829|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
83534830|NCT00003243|Doxorubicin|doxorubicin|mesh-list
83534831|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83534832|NCT00003243|Etoposide|etoposide|mesh-list
83534833|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83534834|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
83534835|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534836|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83534837|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83534838|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
83534839|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534840|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534841|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83534842|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83534843|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83534844|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83534845|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534846|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83534847|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83534848|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83534849|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
83534850|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534851|NCT04344158|Sorafenib|sorafenib|mesh-list
83534852|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534853|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83534854|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534855|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534856|NCT00003249|Ketoconazole|ketoconazole|mesh-list
83534857|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
83534858|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
83534859|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534860|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83534861|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83534862|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534863|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534864|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83534865|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
83534866|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534867|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534868|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83534869|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534870|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83534871|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83534872|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83534873|NCT00003255|Carboplatin|carboplatin|mesh-list
83534874|NCT00003255|Topotecan|topotecan|mesh-list
83534875|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534876|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83534877|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83534878|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534879|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534880|NCT03269435|Metoclopramide|metoclopramide|mesh-list
83534881|NCT03269435|Bupivacaine|bupivacaine|mesh-list
83534882|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
83534884|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534885|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534886|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
83534887|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534888|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
83534889|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
83534890|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83534891|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83534892|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83534893|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
83534894|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83534895|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534896|NCT00003261|Zidovudine|zidovudine|mesh-list
83534897|NCT00003261|Methotrexate|methotrexate|mesh-list
83534898|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83534899|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
83534900|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83534901|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534902|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83534903|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
83534904|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534905|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534906|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
83534907|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534908|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83534909|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83534910|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
83534911|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83534912|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83534913|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83534914|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
83534915|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534916|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83534917|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83534918|NCT03279731|Liraglutide|liraglutide|mesh-list
83534919|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83534920|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534921|NCT03279731|Incretins|incretins|mesh-ancestor
83534922|NCT03279731|Hormones|hormones|mesh-ancestor
83534923|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534924|NCT04530409|Dexamethasone|dexamethasone|mesh-list
83534925|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
83534926|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83534927|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
83534928|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
83534929|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534930|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534931|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83534932|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
83534933|NCT04530409|Hormones|hormones|mesh-ancestor
83534934|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83534935|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83534936|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534937|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83534938|NCT04530409|Protective Agents|protective agents|mesh-ancestor
83534939|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
83534940|NCT04477837|Apixaban|apixaban|mesh-list
83534941|NCT04477837|Edoxaban|edoxaban|mesh-list
83534942|NCT04477837|Dabigatran|dabigatran|mesh-list
83534943|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83534944|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
83534945|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83534946|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
83534947|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534948|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534949|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
83534950|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83534951|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83534952|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
83534953|NCT02264574|Chlorambucil|chlorambucil|mesh-list
83534954|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83534955|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534956|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83534957|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
83534958|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534959|NCT04412863|Interferons|interferons|mesh-list
83534963|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534964|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
83534965|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83534966|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
83534967|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534968|NCT03400475|Simvastatin|simvastatin|mesh-list
83534969|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83534970|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83534971|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
83534972|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534973|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83534974|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83534975|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83534976|NCT01641900|Eszopiclone|eszopiclone|mesh-list
83534977|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83534978|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534979|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534980|NCT03834571|Paclitaxel|paclitaxel|mesh-list
83534981|NCT03834571|Cisplatin|cisplatin|mesh-list
83534982|NCT03834571|Carboplatin|carboplatin|mesh-list
83534983|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83534984|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83534985|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83534986|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
83534987|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
83534988|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
83534989|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83534990|NCT05088980|Lidocaine|lidocaine|mesh-list
83534991|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
83534992|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
83534993|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534994|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83534995|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
83534996|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83534997|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83534998|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83534999|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83535000|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83535001|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535002|NCT00376727|Cetuximab|cetuximab|mesh-list
83535003|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535004|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535005|NCT05468606|Imiquimod|imiquimod|mesh-list
83535006|NCT05468606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83535007|NCT05468606|Immunologic Factors|immunologic factors|mesh-ancestor
83535008|NCT05468606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535009|NCT05468606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535010|NCT05468606|Interferon Inducers|interferon inducers|mesh-ancestor
83535011|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
83535012|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83535013|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
83535014|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535015|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535016|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83535017|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
83535018|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83535019|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
83535020|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535021|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535022|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83535023|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
83535024|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
83535025|NCT04290871|Protective Agents|protective agents|mesh-ancestor
83535026|NCT03501979|Capecitabine|capecitabine|mesh-list
83535027|NCT03501979|Trastuzumab|trastuzumab|mesh-list
83535028|NCT03501979|Tucatinib|tucatinib|mesh-list
83535029|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83535030|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
83535031|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535032|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535033|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535034|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83535035|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535036|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83535037|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83535038|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
83535039|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83535040|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83535041|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83535042|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535043|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535044|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83535045|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83535046|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83535047|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
83535048|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535049|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535050|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83535051|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83535052|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
83535053|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83535054|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83535055|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
83535056|NCT05071352|Nefopam|nefopam|mesh-list
83535057|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83535058|NCT05071352|Analgesics|analgesics|mesh-ancestor
83535059|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
83535060|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535061|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535062|NCT00376025|Antioxidants|antioxidants|mesh-list
83535063|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535064|NCT00376025|Protective Agents|protective agents|mesh-ancestor
83535065|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535066|NCT00376103|Temozolomide|temozolomide|mesh-list
83535067|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83535068|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
83535069|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535070|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535071|NCT03836287|Bromides|bromides|mesh-list
83535072|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
83535073|NCT03403517|Dexamethasone|dexamethasone|mesh-list
83535074|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
83535075|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83535076|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83535077|NCT03403517|Prednisolone|prednisolone|mesh-list
83535078|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
83535079|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83535080|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
83535081|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83535082|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
83535083|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
83535084|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535085|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535086|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83535087|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
83535088|NCT03403517|Hormones|hormones|mesh-ancestor
83535089|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83535090|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83535091|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535092|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83535093|NCT03403517|Protective Agents|protective agents|mesh-ancestor
83535094|NCT05247788|Ethanol|ethanol|mesh-list
83535095|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83535096|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535097|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535098|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535099|NCT02263326|Lamivudine|lamivudine|mesh-list
83535100|NCT02263326|Dolutegravir|dolutegravir|mesh-list
83535101|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83535102|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83535103|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83535104|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535105|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535106|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
83535107|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535108|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83535109|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83535110|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83535111|NCT05463848|Pembrolizumab|pembrolizumab|mesh-list
83535112|NCT05463848|Temozolomide|temozolomide|mesh-list
83535113|NCT05463848|Olaparib|olaparib|mesh-list
83535114|NCT05463848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535115|NCT05463848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535116|NCT05463848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83535117|NCT05463848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535118|NCT05463848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83535119|NCT05463848|Alkylating Agents|alkylating agents|mesh-ancestor
83535120|NCT05463848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83535121|NCT05463848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535122|NCT05647512|Dexamethasone|dexamethasone|mesh-list
83535123|NCT05647512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83535124|NCT05647512|Antiemetics|antiemetics|mesh-ancestor
83535125|NCT05647512|Autonomic Agents|autonomic agents|mesh-ancestor
83535126|NCT05647512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535127|NCT05647512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535128|NCT05647512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83535129|NCT05647512|Glucocorticoids|glucocorticoids|mesh-ancestor
83535131|NCT05647512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83535132|NCT05647512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83535133|NCT05647512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535134|NCT00356395|Candesartan|candesartan|mesh-list
83535135|NCT00356395|Ramipril|ramipril|mesh-list
83535136|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83535137|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83535138|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83535139|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535140|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83535141|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
83535142|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535143|NCT00356473|Atorvastatin|atorvastatin|mesh-list
83535144|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83535145|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83535146|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
83535147|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535148|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83535149|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83535150|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535151|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
83535152|NCT03410875|Vemurafenib|vemurafenib|mesh-list
83535153|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535154|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535155|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83535156|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535157|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535158|NCT05461508|Amoxicillin|amoxicillin|mesh-list
83535159|NCT05461508|Fucoidan|fucoidan|mesh-list
83535160|NCT05461508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83535161|NCT05461508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535162|NCT05461508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83535163|NCT05461508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83535164|NCT05461508|Anticoagulants|anticoagulants|mesh-ancestor
83535165|NCT05461508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535166|NCT00356941|Docetaxel|docetaxel|mesh-list
83535167|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
83535168|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535169|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
83535170|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
83535171|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
83535172|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535173|NCT03450083|Benralizumab|benralizumab|mesh-list
83535174|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83535175|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
83535176|NCT03580343|Tofacitinib|tofacitinib|mesh-list
83535177|NCT03580343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83535178|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83535179|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535180|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535181|NCT05445440|Leucovorin|leucovorin|mesh-list
83535182|NCT05445440|Sulfasalazine|sulfasalazine|mesh-list
83535183|NCT05445440|Methotrexate|methotrexate|mesh-list
83535184|NCT05445440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83535185|NCT05445440|Abortifacient Agents|abortifacient agents|mesh-ancestor
83535186|NCT05445440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83535187|NCT05445440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535188|NCT05445440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83535189|NCT05445440|Antimetabolites|antimetabolites|mesh-ancestor
83535190|NCT05445440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535191|NCT05445440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535192|NCT05445440|Dermatologic Agents|dermatologic agents|mesh-ancestor
83535193|NCT05445440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535194|NCT05445440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83535195|NCT05445440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83535196|NCT05445440|Immunologic Factors|immunologic factors|mesh-ancestor
83535197|NCT05445440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83535198|NCT05445440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83535199|NCT05445440|Antidotes|antidotes|mesh-ancestor
83535200|NCT05445440|Protective Agents|protective agents|mesh-ancestor
83535201|NCT05445440|Vitamin B Complex|vitamin b complex|mesh-ancestor
83535202|NCT05445440|Vitamins|vitamins|mesh-ancestor
83535203|NCT05445440|Micronutrients|micronutrients|mesh-ancestor
83535204|NCT05445440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535205|NCT05445440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83535206|NCT05445440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83535207|NCT05445440|Analgesics|analgesics|mesh-ancestor
83535208|NCT05445440|Sensory System Agents|sensory system agents|mesh-ancestor
83535209|NCT05445440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535210|NCT05445440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83535211|NCT05445440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83535212|NCT05041322|Buspirone|buspirone|mesh-list
83535213|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83535214|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83535215|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535216|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535217|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83535218|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83535219|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
83535220|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535221|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535222|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
83535223|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535224|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83535225|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535226|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535227|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
83535228|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535229|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535230|NCT05229614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83535231|NCT05229614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535232|NCT05445128|Plerixafor|plerixafor|mesh-list
83535233|NCT05445128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83535234|NCT05445128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83535235|NCT05445128|Antiviral Agents|antiviral agents|mesh-ancestor
83535236|NCT05445128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535237|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83535238|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
83535239|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535240|NCT05483010|Atorvastatin|atorvastatin|mesh-list
83535241|NCT05483010|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83535242|NCT05483010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83535243|NCT05483010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83535244|NCT05483010|Antimetabolites|antimetabolites|mesh-ancestor
83535245|NCT05483010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535246|NCT05483010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83535247|NCT05483010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83535248|NCT05483010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535249|NCT05210582|Afamelanotide|afamelanotide|mesh-list
83535250|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
83535251|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
83535252|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83535253|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
83535254|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535255|NCT05647356|Bicalutamide|bicalutamide|mesh-list
83535256|NCT05647356|Androgen Antagonists|androgen antagonists|mesh-ancestor
83535257|NCT05647356|Hormone Antagonists|hormone antagonists|mesh-ancestor
83535258|NCT05647356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83535259|NCT05647356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535260|NCT05647356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535261|NCT05647278|Esomeprazole|esomeprazole|mesh-list
83535262|NCT05647278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83535264|NCT05647278|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83535265|NCT05647278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535266|NCT05647278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535267|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
83535268|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83535269|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
83535270|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
83535271|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535272|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
83535273|NCT00359840|Hematinics|hematinics|mesh-ancestor
83535274|NCT02259582|Carboplatin|carboplatin|mesh-list
83535275|NCT02259582|Pemetrexed|pemetrexed|mesh-list
83535276|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535277|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535278|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535279|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83535280|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83535282|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83535283|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83535284|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83535285|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83535286|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
83535287|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535288|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535289|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535290|NCT02977208|Gabapentin|gabapentin|mesh-list
83535291|NCT02977208|Analgesics|analgesics|mesh-ancestor
83535292|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
83535293|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535294|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535295|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
83535296|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83535297|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83535298|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535299|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83535300|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83535301|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83535302|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535303|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535304|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
83535305|NCT04866108|Capecitabine|capecitabine|mesh-list
83535306|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83535307|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
83535308|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535309|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535310|NCT04343768|Interferons|interferons|mesh-list
83535311|NCT04343768|Ritonavir|ritonavir|mesh-list
83535312|NCT04343768|Lopinavir|lopinavir|mesh-list
83535313|NCT04343768|Interferon-beta|interferon-beta|mesh-list
83535314|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
83535315|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
83535316|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
83535317|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535318|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
83535319|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535320|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83535321|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83535322|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
83535323|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535324|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535325|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83535326|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83535327|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83535328|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83535329|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
83535330|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83535331|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83535332|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83535333|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
83535334|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535335|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83535336|NCT05925894|Anesthetics|anesthetics|mesh-list
83535337|NCT05925894|Mydriatics|mydriatics|mesh-list
83535415|NCT05925166|Etanercept|etanercept|mesh-list
83535338|NCT05925894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535339|NCT05925894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535340|NCT05925894|Autonomic Agents|autonomic agents|mesh-ancestor
83535341|NCT05925894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535342|NCT05925803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83535343|NCT05925803|Immunologic Factors|immunologic factors|mesh-ancestor
83535344|NCT05925803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535345|NCT05925790|Antibodies|antibodies|mesh-list
83535346|NCT05925790|Immunologic Factors|immunologic factors|mesh-ancestor
83535347|NCT05925790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535348|NCT05925686|Tramadol|tramadol|mesh-list
83535349|NCT05925686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83535350|NCT05925686|Narcotics|narcotics|mesh-ancestor
83535351|NCT05925686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535352|NCT05925686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535353|NCT05925686|Analgesics|analgesics|mesh-ancestor
83535354|NCT05925686|Sensory System Agents|sensory system agents|mesh-ancestor
83535355|NCT05925686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535356|NCT05925530|Durvalumab|durvalumab|mesh-list
83535357|NCT05925530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535358|NCT05925530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535359|NCT05925504|Luspatercept|luspatercept|mesh-list
83535360|NCT05925504|Hematinics|hematinics|mesh-ancestor
83535361|NCT05925491|Pembrolizumab|pembrolizumab|mesh-list
83535362|NCT05925491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535363|NCT05925491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535364|NCT05925491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83535365|NCT05925491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535366|NCT05925309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83535367|NCT05925309|Meropenem|meropenem|mesh-list
83535368|NCT05925309|Imipenem|imipenem|mesh-list
83535369|NCT05925309|Cefaclor|cefaclor|mesh-list
83535370|NCT05925309|Sulfamethoxazole|sulfamethoxazole|mesh-list
83535371|NCT05925309|Sulperazone|sulperazone|mesh-list
83535372|NCT05925309|Methylprednisolone|methylprednisolone|mesh-list
83535373|NCT05925309|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
83535374|NCT05925309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83535375|NCT05925309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535376|NCT05925309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535377|NCT05925309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83535378|NCT05925309|Antiemetics|antiemetics|mesh-ancestor
83535379|NCT05925309|Autonomic Agents|autonomic agents|mesh-ancestor
83535380|NCT05925309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535381|NCT05925309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83535382|NCT05925309|Glucocorticoids|glucocorticoids|mesh-ancestor
83535383|NCT05925309|Hormones|hormones|mesh-ancestor
83535384|NCT05925309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83535385|NCT05925309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83535386|NCT05925309|Protective Agents|protective agents|mesh-ancestor
83535387|NCT05925309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83535388|NCT05925309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83535389|NCT05925283|Midazolam|midazolam|mesh-list
83535390|NCT05925283|Esketamine|esketamine|mesh-list
83535391|NCT05925283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83535392|NCT05925283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83535393|NCT05925283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535394|NCT05925283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535395|NCT05925283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83535396|NCT05925283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83535397|NCT05925283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83535398|NCT05925283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83535399|NCT05925283|Anesthetics, General|anesthetics, general|mesh-ancestor
83535400|NCT05925283|Anesthetics|anesthetics|mesh-ancestor
83535401|NCT05925283|GABA Modulators|gaba modulators|mesh-ancestor
83535402|NCT05925283|GABA Agents|gaba agents|mesh-ancestor
83535403|NCT05925283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535404|NCT05925283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535405|NCT05925283|Antidepressive Agents|antidepressive agents|mesh-ancestor
83535406|NCT05925179|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83535407|NCT05925179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83535408|NCT05925179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535409|NCT05925179|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83535410|NCT05925179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535411|NCT05925179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535412|NCT05925166|Triamcinolone|triamcinolone|mesh-list
83535413|NCT05925166|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83535414|NCT05925166|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83535416|NCT05925166|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83535417|NCT05925166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83535418|NCT05925166|Glucocorticoids|glucocorticoids|mesh-ancestor
83535419|NCT05925166|Hormones|hormones|mesh-ancestor
83535420|NCT05925166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83535421|NCT05925166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535422|NCT05925166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83535423|NCT05925166|Immunologic Factors|immunologic factors|mesh-ancestor
83535424|NCT05925166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535425|NCT05925166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535426|NCT05925166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83535427|NCT05925166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83535428|NCT05925166|Analgesics|analgesics|mesh-ancestor
83535429|NCT05925166|Sensory System Agents|sensory system agents|mesh-ancestor
83535430|NCT05925166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535431|NCT05925166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83535432|NCT05925166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83535433|NCT05925140|Ritonavir|ritonavir|mesh-list
83535434|NCT05925140|Lopinavir|lopinavir|mesh-list
83535435|NCT05925140|Remdesivir|remdesivir|mesh-list
83535436|NCT05925140|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83535437|NCT05925140|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83535438|NCT05925140|Protease Inhibitors|protease inhibitors|mesh-ancestor
83535439|NCT05925140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535440|NCT05925140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535441|NCT05925140|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83535442|NCT05925140|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83535443|NCT05925140|Antiviral Agents|antiviral agents|mesh-ancestor
83535444|NCT05925140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535445|NCT05925140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83535446|NCT05925140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83535447|NCT05925140|Antimetabolites|antimetabolites|mesh-ancestor
83535448|NCT05925127|Vaccines|vaccines|mesh-list
83535449|NCT05925127|Immunologic Factors|immunologic factors|mesh-ancestor
83535450|NCT05925127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535451|NCT05925049|Natalizumab|natalizumab|mesh-list
83535452|NCT05925049|Immunologic Factors|immunologic factors|mesh-ancestor
83535453|NCT05925049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535454|NCT05925023|Sirolimus|sirolimus|mesh-list
83535455|NCT05925023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83535456|NCT05925023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535457|NCT05925023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83535458|NCT05925023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535459|NCT05925023|Antifungal Agents|antifungal agents|mesh-ancestor
83535460|NCT05925023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83535461|NCT05925023|Immunologic Factors|immunologic factors|mesh-ancestor
83535462|NCT05925023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535463|NCT05924997|Apatinib|apatinib|mesh-list
83535464|NCT05924997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535465|NCT05924997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83535466|NCT05924997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535467|NCT05924997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535468|NCT05924971|Aspirin|aspirin|mesh-list
83535469|NCT05924971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83535470|NCT05924971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83535471|NCT05924971|Analgesics|analgesics|mesh-ancestor
83535472|NCT05924971|Sensory System Agents|sensory system agents|mesh-ancestor
83535473|NCT05924971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535474|NCT05924971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535475|NCT05924971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83535476|NCT05924971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83535477|NCT05924971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83535478|NCT05924971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83535479|NCT05924971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535480|NCT05924971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83535481|NCT05924971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83535482|NCT05924971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535483|NCT05924971|Antipyretics|antipyretics|mesh-ancestor
83535484|NCT05924893|Naltrexone|naltrexone|mesh-list
83535485|NCT05924893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83535486|NCT05924893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83535487|NCT05924893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535488|NCT05924893|Sensory System Agents|sensory system agents|mesh-ancestor
83535489|NCT05924893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535490|NCT05924880|Durvalumab|durvalumab|mesh-list
83535565|NCT05923996|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83535491|NCT05924880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535492|NCT05924880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535493|NCT05924815|Moxifloxacin|moxifloxacin|mesh-list
83535494|NCT05924815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83535495|NCT05924815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535496|NCT05924815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83535497|NCT05924815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83535498|NCT05924815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535499|NCT05924815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535500|NCT05924815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535501|NCT05924776|Immunomodulating Agents|immunomodulating agents|mesh-list
83535502|NCT05924776|Immunologic Factors|immunologic factors|mesh-ancestor
83535503|NCT05924776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535504|NCT05924672|Diphosphonates|diphosphonates|mesh-list
83535505|NCT05924672|Methylene diphosphonate|methylene diphosphonate|mesh-list
83535506|NCT05924672|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83535507|NCT05924672|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
83535508|NCT05924672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535509|NCT05924672|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83535510|NCT05924672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535511|NCT05924672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83535512|NCT05924672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535513|NCT05924594|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83535514|NCT05924594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83535515|NCT05924594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535516|NCT05924594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83535517|NCT05924594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83535518|NCT05924594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83535519|NCT05924594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535520|NCT05924594|Dopamine Agents|dopamine agents|mesh-ancestor
83535521|NCT05924594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535522|NCT05924321|Moxifloxacin|moxifloxacin|mesh-list
83535523|NCT05924321|Carbetocin|carbetocin|mesh-list
83535524|NCT05924321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83535525|NCT05924321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535526|NCT05924321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83535527|NCT05924321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83535528|NCT05924321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535529|NCT05924321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535530|NCT05924321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535531|NCT05924321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83535532|NCT05924321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535533|NCT05924321|Oxytocics|oxytocics|mesh-ancestor
83535534|NCT05924256|Leuprolide|leuprolide|mesh-list
83535535|NCT05924256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83535536|NCT05924256|Fertility Agents|fertility agents|mesh-ancestor
83535537|NCT05924256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83535538|NCT05924256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535539|NCT05924256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83535540|NCT05924256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535541|NCT05924165|Ketorolac|ketorolac|mesh-list
83535542|NCT05924165|Oxycodone|oxycodone|mesh-list
83535543|NCT05924165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83535544|NCT05924165|Narcotics|narcotics|mesh-ancestor
83535545|NCT05924165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535546|NCT05924165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535547|NCT05924165|Analgesics|analgesics|mesh-ancestor
83535548|NCT05924165|Sensory System Agents|sensory system agents|mesh-ancestor
83535549|NCT05924165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535550|NCT05924165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83535551|NCT05924165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83535552|NCT05924165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83535553|NCT05924165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83535554|NCT05924165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83535555|NCT05924165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535556|NCT05924165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535557|NCT05924152|Adagrasib|adagrasib|mesh-list
83535558|NCT05924152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535559|NCT05924126|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83535560|NCT05924126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535561|NCT05924100|Luspatercept|luspatercept|mesh-list
83535562|NCT05924100|Hematinics|hematinics|mesh-ancestor
83535563|NCT05923996|Botulinum Toxins|botulinum toxins|mesh-list
83535564|NCT05923996|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83535566|NCT05923996|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83535567|NCT05923996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83535568|NCT05923996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535569|NCT05923996|Cholinergic Agents|cholinergic agents|mesh-ancestor
83535570|NCT05923996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535571|NCT05923996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535572|NCT05923996|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83535573|NCT05923996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535574|NCT05923970|Vaccines|vaccines|mesh-list
83535575|NCT05923970|Antibodies|antibodies|mesh-list
83535576|NCT05923970|Immunoglobulins|immunoglobulins|mesh-list
83535577|NCT05923970|Immunologic Factors|immunologic factors|mesh-ancestor
83535578|NCT05923970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535579|NCT05923879|Rituximab|rituximab|mesh-list
83535580|NCT05923879|Lenalidomide|lenalidomide|mesh-list
83535581|NCT05923879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535582|NCT05923879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535583|NCT05923879|Immunologic Factors|immunologic factors|mesh-ancestor
83535584|NCT05923879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535585|NCT05923879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83535586|NCT05923879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83535587|NCT05923879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83535588|NCT05923879|Growth Substances|growth substances|mesh-ancestor
83535589|NCT05923879|Growth Inhibitors|growth inhibitors|mesh-ancestor
83535590|NCT05923476|Lithium Carbonate|lithium carbonate|mesh-list
83535591|NCT05923476|Antidepressive Agents|antidepressive agents|mesh-ancestor
83535592|NCT05923476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83535593|NCT05923476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535594|NCT05923476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535595|NCT05923476|Antimanic Agents|antimanic agents|mesh-ancestor
83535596|NCT05923476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83535597|NCT05923476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535598|NCT05923476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535599|NCT05923411|Rabeprazole|rabeprazole|mesh-list
83535600|NCT05923411|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83535601|NCT05923411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83535602|NCT05923411|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83535603|NCT05923411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535604|NCT05923411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535605|NCT05923190|Pembrolizumab|pembrolizumab|mesh-list
83535606|NCT05923190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535607|NCT05923190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535608|NCT05923190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83535609|NCT05923190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535610|NCT05923086|Lidocaine|lidocaine|mesh-list
83535611|NCT05923086|Anesthetics, Local|anesthetics, local|mesh-ancestor
83535612|NCT05923086|Anesthetics|anesthetics|mesh-ancestor
83535613|NCT05923086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535614|NCT05923086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535615|NCT05923086|Sensory System Agents|sensory system agents|mesh-ancestor
83535616|NCT05923086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535617|NCT05923086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83535618|NCT05923086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83535619|NCT05923086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83535620|NCT05923086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83535621|NCT05923086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535622|NCT05923060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83535623|NCT05923060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83535624|NCT05923060|Dermatologic Agents|dermatologic agents|mesh-ancestor
83535625|NCT05923021|Sertraline|sertraline|mesh-list
83535626|NCT05923021|Antidepressive Agents|antidepressive agents|mesh-ancestor
83535627|NCT05923021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83535628|NCT05923021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83535629|NCT05923021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83535630|NCT05923021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83535631|NCT05923021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535632|NCT05923021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535633|NCT05923021|Serotonin Agents|serotonin agents|mesh-ancestor
83535634|NCT05923021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535635|NCT05922982|Norepinephrine|norepinephrine|mesh-list
83535636|NCT05922982|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83535637|NCT05922982|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83535639|NCT05922982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535640|NCT05922982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535641|NCT05922982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535642|NCT05922982|Sympathomimetics|sympathomimetics|mesh-ancestor
83535643|NCT05922982|Autonomic Agents|autonomic agents|mesh-ancestor
83535644|NCT05922982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535645|NCT05922982|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83535646|NCT05922930|Cyclophosphamide|cyclophosphamide|mesh-list
83535647|NCT05922930|Fludarabine|fludarabine|mesh-list
83535648|NCT05922930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83535649|NCT05922930|Immunologic Factors|immunologic factors|mesh-ancestor
83535650|NCT05922930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535651|NCT05922930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83535652|NCT05922930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83535653|NCT05922930|Alkylating Agents|alkylating agents|mesh-ancestor
83535654|NCT05922930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535655|NCT05922930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535656|NCT05922930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83535657|NCT05922904|Doxorubicin|doxorubicin|mesh-list
83535658|NCT05922904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83535659|NCT05922904|Pembrolizumab|pembrolizumab|mesh-list
83535660|NCT05922904|Dacarbazine|dacarbazine|mesh-list
83535661|NCT05922904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83535662|NCT05922904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83535663|NCT05922904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535664|NCT05922904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83535665|NCT05922904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83535666|NCT05922904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535667|NCT05922904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535668|NCT05922904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535669|NCT05922904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83535670|NCT05922904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83535671|NCT05922904|Alkylating Agents|alkylating agents|mesh-ancestor
83535672|NCT05922904|Immunotoxins|immunotoxins|mesh-ancestor
83535673|NCT05922904|Immunoconjugates|immunoconjugates|mesh-ancestor
83535674|NCT05922904|Immunologic Factors|immunologic factors|mesh-ancestor
83535675|NCT05922904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535676|NCT05922839|Zanubrutinib|zanubrutinib|mesh-list
83535677|NCT05922839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535678|NCT05922839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83535679|NCT05922839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535680|NCT05922839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535681|NCT05922800|Gamma-oryzanol|gamma-oryzanol|mesh-list
83535682|NCT05922800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83535683|NCT05922800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83535684|NCT05922800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83535685|NCT05922800|Antimetabolites|antimetabolites|mesh-ancestor
83535686|NCT05922800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535687|NCT05922800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83535688|NCT05922761|Fluticasone|fluticasone|mesh-list
83535689|NCT05922761|Xhance|xhance|mesh-list
83535690|NCT05922761|Azithromycin|azithromycin|mesh-list
83535691|NCT05922761|Prednisone|prednisone|mesh-list
83535692|NCT05922761|Montelukast|montelukast|mesh-list
83535693|NCT05922761|Belumosudil|belumosudil|mesh-list
83535694|NCT05922761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83535695|NCT05922761|Glucocorticoids|glucocorticoids|mesh-ancestor
83535696|NCT05922761|Hormones|hormones|mesh-ancestor
83535697|NCT05922761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83535698|NCT05922761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535699|NCT05922761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83535700|NCT05922761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535701|NCT05922761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83535702|NCT05922761|Autonomic Agents|autonomic agents|mesh-ancestor
83535703|NCT05922761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535704|NCT05922761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83535705|NCT05922761|Respiratory System Agents|respiratory system agents|mesh-ancestor
83535706|NCT05922761|Dermatologic Agents|dermatologic agents|mesh-ancestor
83535707|NCT05922761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83535708|NCT05922761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83535709|NCT05922761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535710|NCT05922761|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83535711|NCT05922761|Hormone Antagonists|hormone antagonists|mesh-ancestor
83535712|NCT05922761|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83535713|NCT05922761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83535789|NCT05922306|Interferons|interferons|mesh-list
83535714|NCT05922761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535715|NCT05922761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83535716|NCT05922761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535717|NCT05922696|Vitamin D|vitamin d|mesh-list
83535718|NCT05922696|Cholecalciferol|cholecalciferol|mesh-list
83535719|NCT05922696|Vitamins|vitamins|mesh-ancestor
83535720|NCT05922696|Micronutrients|micronutrients|mesh-ancestor
83535721|NCT05922696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535722|NCT05922696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83535723|NCT05922696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83535724|NCT05922605|Ketamine|ketamine|mesh-list
83535725|NCT05922605|Ropivacaine|ropivacaine|mesh-list
83535726|NCT05922605|Esketamine|esketamine|mesh-list
83535727|NCT05922605|Analgesics|analgesics|mesh-ancestor
83535728|NCT05922605|Sensory System Agents|sensory system agents|mesh-ancestor
83535729|NCT05922605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535730|NCT05922605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535731|NCT05922605|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83535732|NCT05922605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83535733|NCT05922605|Anesthetics, General|anesthetics, general|mesh-ancestor
83535734|NCT05922605|Anesthetics|anesthetics|mesh-ancestor
83535735|NCT05922605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535736|NCT05922605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83535737|NCT05922605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83535738|NCT05922605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535739|NCT05922605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535740|NCT05922605|Anesthetics, Local|anesthetics, local|mesh-ancestor
83535741|NCT05922605|Antidepressive Agents|antidepressive agents|mesh-ancestor
83535742|NCT05922605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83535743|NCT05922501|Dexamethasone|dexamethasone|mesh-list
83535744|NCT05922501|Pomalidomide|pomalidomide|mesh-list
83535745|NCT05922501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83535746|NCT05922501|Antiemetics|antiemetics|mesh-ancestor
83535747|NCT05922501|Autonomic Agents|autonomic agents|mesh-ancestor
83535748|NCT05922501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535749|NCT05922501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535750|NCT05922501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83535751|NCT05922501|Glucocorticoids|glucocorticoids|mesh-ancestor
83535752|NCT05922501|Hormones|hormones|mesh-ancestor
83535753|NCT05922501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83535754|NCT05922501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83535755|NCT05922501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535756|NCT05922501|Immunologic Factors|immunologic factors|mesh-ancestor
83535757|NCT05922501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83535758|NCT05922501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83535759|NCT05922501|Growth Substances|growth substances|mesh-ancestor
83535760|NCT05922501|Growth Inhibitors|growth inhibitors|mesh-ancestor
83535761|NCT05922436|Clevidipine|clevidipine|mesh-list
83535762|NCT05922436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83535763|NCT05922436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83535764|NCT05922436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535765|NCT05922436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83535766|NCT05922436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535767|NCT05922384|Etoposide|etoposide|mesh-list
83535768|NCT05922384|Melphalan|melphalan|mesh-list
83535769|NCT05922384|Carmustine|carmustine|mesh-list
83535770|NCT05922384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83535771|NCT05922384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535772|NCT05922384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83535773|NCT05922384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83535774|NCT05922384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535775|NCT05922384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535776|NCT05922384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83535777|NCT05922384|Alkylating Agents|alkylating agents|mesh-ancestor
83535778|NCT05922384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83535779|NCT05922384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83535780|NCT05922384|Immunologic Factors|immunologic factors|mesh-ancestor
83535781|NCT05922384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535782|NCT05922358|Anti-Allergic Agents|anti-allergic agents|mesh-list
83535783|NCT05922345|Docetaxel|docetaxel|mesh-list
83535784|NCT05922345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535785|NCT05922345|Tubulin Modulators|tubulin modulators|mesh-ancestor
83535786|NCT05922345|Antimitotic Agents|antimitotic agents|mesh-ancestor
83535787|NCT05922345|Mitosis Modulators|mitosis modulators|mesh-ancestor
83535788|NCT05922345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535792|NCT05922306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535793|NCT05922306|Antiviral Agents|antiviral agents|mesh-ancestor
83535794|NCT05922306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535795|NCT05922306|Immunologic Factors|immunologic factors|mesh-ancestor
83535796|NCT05922306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535797|NCT05922176|Immunomodulating Agents|immunomodulating agents|mesh-list
83535798|NCT05922176|Immunologic Factors|immunologic factors|mesh-list
83535799|NCT05922176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535800|NCT05922124|Meropenem|meropenem|mesh-list
83535801|NCT05922124|Colistin|colistin|mesh-list
83535802|NCT05922124|Ampicillin|ampicillin|mesh-list
83535803|NCT05922124|Sulbactam|sulbactam|mesh-list
83535804|NCT05922124|Sultamicillin|sultamicillin|mesh-list
83535805|NCT05922124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83535806|NCT05922124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535807|NCT05922124|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83535808|NCT05922124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535809|NCT05922124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535810|NCT05922033|Insulin|insulin|mesh-list
83535811|NCT05922033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83535812|NCT05922033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83535813|NCT05922033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535814|NCT05921968|Iron|iron|mesh-list
83535815|NCT05921968|Lactoferrin|lactoferrin|mesh-list
83535816|NCT05921968|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83535817|NCT05921968|Trace Elements|trace elements|mesh-ancestor
83535818|NCT05921968|Micronutrients|micronutrients|mesh-ancestor
83535819|NCT05921968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535820|NCT05921968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535821|NCT05921968|Hematinics|hematinics|mesh-ancestor
83535822|NCT05921942|Metformin|metformin|mesh-list
83535823|NCT05921942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83535824|NCT05921942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535825|NCT05921760|Nivolumab|nivolumab|mesh-list
83535826|NCT05921760|Ipilimumab|ipilimumab|mesh-list
83535827|NCT05921760|Ivosidenib|ivosidenib|mesh-list
83535828|NCT05921760|Glycine|glycine|mesh-list
83535829|NCT05921760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535830|NCT05921760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535831|NCT05921760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83535832|NCT05921760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535833|NCT05921760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535834|NCT05921760|Glycine Agents|glycine agents|mesh-ancestor
83535835|NCT05921760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535836|NCT05921760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535837|NCT05921604|Gabapentin|gabapentin|mesh-list
83535838|NCT05921604|Baclofen|baclofen|mesh-list
83535839|NCT05921604|Analgesics|analgesics|mesh-ancestor
83535840|NCT05921604|Sensory System Agents|sensory system agents|mesh-ancestor
83535841|NCT05921604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535842|NCT05921604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535843|NCT05921604|Anticonvulsants|anticonvulsants|mesh-ancestor
83535844|NCT05921604|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83535845|NCT05921604|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83535846|NCT05921604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535847|NCT05921604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83535848|NCT05921604|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83535849|NCT05921604|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83535850|NCT05921604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535851|NCT05921604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535852|NCT05921604|Antimanic Agents|antimanic agents|mesh-ancestor
83535853|NCT05921604|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83535854|NCT05921604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83535855|NCT05921604|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83535856|NCT05921604|GABA Agonists|gaba agonists|mesh-ancestor
83535857|NCT05921604|GABA Agents|gaba agents|mesh-ancestor
83535858|NCT05921370|Silodosin|silodosin|mesh-list
83535859|NCT05921370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83535860|NCT05921370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83535861|NCT05921370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83535862|NCT05921370|Adrenergic Agents|adrenergic agents|mesh-ancestor
83535863|NCT05921370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535864|NCT05921370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535865|NCT05921370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535866|NCT05921370|Urological Agents|urological agents|mesh-ancestor
83535867|NCT05921292|Lidocaine|lidocaine|mesh-list
83535868|NCT05921292|Anesthetics, Local|anesthetics, local|mesh-ancestor
83535869|NCT05921292|Anesthetics|anesthetics|mesh-ancestor
83536019|NCT05920343|Anticoagulants|anticoagulants|mesh-ancestor
83535870|NCT05921292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535871|NCT05921292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535872|NCT05921292|Sensory System Agents|sensory system agents|mesh-ancestor
83535873|NCT05921292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535874|NCT05921292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83535875|NCT05921292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83535876|NCT05921292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83535877|NCT05921292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83535878|NCT05921292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535879|NCT05921149|Paclitaxel|paclitaxel|mesh-list
83535880|NCT05921149|Carboplatin|carboplatin|mesh-list
83535881|NCT05921149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83535882|NCT05921149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535883|NCT05921149|Tubulin Modulators|tubulin modulators|mesh-ancestor
83535884|NCT05921149|Antimitotic Agents|antimitotic agents|mesh-ancestor
83535885|NCT05921149|Mitosis Modulators|mitosis modulators|mesh-ancestor
83535886|NCT05921149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535887|NCT05921097|Histamine|histamine|mesh-list
83535888|NCT05921097|Histamine Agonists|histamine agonists|mesh-ancestor
83535889|NCT05921097|Histamine Agents|histamine agents|mesh-ancestor
83535890|NCT05921097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83535891|NCT05921097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535892|NCT05921097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535893|NCT05921071|Tranexamic Acid|tranexamic acid|mesh-list
83535894|NCT05921071|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83535895|NCT05921071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83535896|NCT05921071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535897|NCT05921071|Hemostatics|hemostatics|mesh-ancestor
83535898|NCT05921071|Coagulants|coagulants|mesh-ancestor
83535899|NCT05920980|Lidocaine|lidocaine|mesh-list
83535900|NCT05920980|Anesthetics, Local|anesthetics, local|mesh-ancestor
83535901|NCT05920980|Anesthetics|anesthetics|mesh-ancestor
83535902|NCT05920980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535903|NCT05920980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535904|NCT05920980|Sensory System Agents|sensory system agents|mesh-ancestor
83535905|NCT05920980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535906|NCT05920980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83535907|NCT05920980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83535908|NCT05920980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83535909|NCT05920980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83535910|NCT05920980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535911|NCT05920967|Dexamethasone|dexamethasone|mesh-list
83535912|NCT05920967|Dexamethasone acetate|dexamethasone acetate|mesh-list
83535913|NCT05920967|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83535914|NCT05920967|BB 1101|bb 1101|mesh-list
83535915|NCT05920967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83535916|NCT05920967|Antiemetics|antiemetics|mesh-ancestor
83535917|NCT05920967|Autonomic Agents|autonomic agents|mesh-ancestor
83535918|NCT05920967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535919|NCT05920967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535920|NCT05920967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83535921|NCT05920967|Glucocorticoids|glucocorticoids|mesh-ancestor
83535922|NCT05920967|Hormones|hormones|mesh-ancestor
83535923|NCT05920967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83535924|NCT05920967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83535925|NCT05920967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535926|NCT05920967|Protease Inhibitors|protease inhibitors|mesh-ancestor
83535927|NCT05920967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535928|NCT05920967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535929|NCT05920928|Capecitabine|capecitabine|mesh-list
83535930|NCT05920928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83535931|NCT05920928|Antimetabolites|antimetabolites|mesh-ancestor
83535932|NCT05920928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535933|NCT05920928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535934|NCT05920876|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83535935|NCT05920876|Immunologic Factors|immunologic factors|mesh-ancestor
83535936|NCT05920876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535937|NCT05920863|Lenvatinib|lenvatinib|mesh-list
83535938|NCT05920863|Tislelizumab|tislelizumab|mesh-list
83535939|NCT05920863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535940|NCT05920863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83535941|NCT05920863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535942|NCT05920863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535943|NCT05920863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535944|NCT05920798|Pembrolizumab|pembrolizumab|mesh-list
83535945|NCT05920798|Vaccines|vaccines|mesh-list
83535946|NCT05920798|Immunologic Factors|immunologic factors|mesh-ancestor
83535947|NCT05920798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535948|NCT05920798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83535949|NCT05920798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535950|NCT05920798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83535951|NCT05920798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535952|NCT05920707|Vasopressins|vasopressins|mesh-list
83535953|NCT05920707|Arginine Vasopressin|arginine vasopressin|mesh-list
83535954|NCT05920707|Oxytocin|oxytocin|mesh-list
83535955|NCT05920707|Oxytocics|oxytocics|mesh-ancestor
83535956|NCT05920707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83535957|NCT05920707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535958|NCT05920707|Hemostatics|hemostatics|mesh-ancestor
83535959|NCT05920707|Coagulants|coagulants|mesh-ancestor
83535960|NCT05920707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83535961|NCT05920707|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83535962|NCT05920707|Natriuretic Agents|natriuretic agents|mesh-ancestor
83535963|NCT05920642|Morphine|morphine|mesh-list
83535964|NCT05920642|Analgesics|analgesics|mesh-list
83535965|NCT05920642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83535966|NCT05920642|Narcotics|narcotics|mesh-ancestor
83535967|NCT05920642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83535968|NCT05920642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535969|NCT05920642|Sensory System Agents|sensory system agents|mesh-ancestor
83535970|NCT05920642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83535971|NCT05920538|Nicardipine|nicardipine|mesh-list
83535972|NCT05920538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83535973|NCT05920538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83535974|NCT05920538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83535975|NCT05920538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535976|NCT05920538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83535977|NCT05920538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535978|NCT05920538|Vasodilator Agents|vasodilator agents|mesh-ancestor
83535979|NCT05920512|Calcitriol|calcitriol|mesh-list
83535980|NCT05920512|Sirolimus|sirolimus|mesh-list
83535981|NCT05920512|Valproic Acid|valproic acid|mesh-list
83535982|NCT05920512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83535983|NCT05920512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83535984|NCT05920512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83535985|NCT05920512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83535986|NCT05920512|Antifungal Agents|antifungal agents|mesh-ancestor
83535987|NCT05920512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83535988|NCT05920512|Immunologic Factors|immunologic factors|mesh-ancestor
83535989|NCT05920512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83535990|NCT05920512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83535991|NCT05920512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83535992|NCT05920512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83535993|NCT05920512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83535994|NCT05920512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83535995|NCT05920512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83535996|NCT05920512|Vitamins|vitamins|mesh-ancestor
83535997|NCT05920512|Micronutrients|micronutrients|mesh-ancestor
83535998|NCT05920512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83535999|NCT05920512|Anticonvulsants|anticonvulsants|mesh-ancestor
83536000|NCT05920512|GABA Agents|gaba agents|mesh-ancestor
83536001|NCT05920512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536002|NCT05920512|Antimanic Agents|antimanic agents|mesh-ancestor
83536003|NCT05920512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83536004|NCT05920512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536005|NCT05920512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83536006|NCT05920356|Pembrolizumab|pembrolizumab|mesh-list
83536007|NCT05920356|Sotorasib|sotorasib|mesh-list
83536008|NCT05920356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536009|NCT05920356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536010|NCT05920356|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83536011|NCT05920356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536012|NCT05920343|Rivaroxaban|rivaroxaban|mesh-list
83536013|NCT05920343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83536014|NCT05920343|Antithrombins|antithrombins|mesh-ancestor
83536015|NCT05920343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83536016|NCT05920343|Protease Inhibitors|protease inhibitors|mesh-ancestor
83536017|NCT05920343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536018|NCT05920343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536022|NCT05920213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83536023|NCT05920213|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83536024|NCT05920213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83536025|NCT05920213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536026|NCT05920213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536027|NCT05920213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536028|NCT05920187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83536029|NCT05920122|Chlorhexidine|chlorhexidine|mesh-list
83536030|NCT05920122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83536031|NCT05920122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83536032|NCT05920122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83536033|NCT05920122|Disinfectants|disinfectants|mesh-ancestor
83536034|NCT05920122|Dermatologic Agents|dermatologic agents|mesh-ancestor
83536035|NCT05920005|Amlodipine|amlodipine|mesh-list
83536036|NCT05920005|Valsartan|valsartan|mesh-list
83536037|NCT05920005|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83536038|NCT05920005|Candesartan|candesartan|mesh-list
83536039|NCT05920005|Candesartan cilexetil|candesartan cilexetil|mesh-list
83536040|NCT05920005|Chlorthalidone|chlorthalidone|mesh-list
83536041|NCT05920005|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83536042|NCT05920005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83536043|NCT05920005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83536044|NCT05920005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83536045|NCT05920005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536046|NCT05920005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83536047|NCT05920005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536048|NCT05920005|Vasodilator Agents|vasodilator agents|mesh-ancestor
83536049|NCT05920005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83536050|NCT05920005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83536051|NCT05920005|Diuretics|diuretics|mesh-ancestor
83536052|NCT05920005|Natriuretic Agents|natriuretic agents|mesh-ancestor
83536053|NCT05920005|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83536054|NCT05919992|Hydrocortisone|hydrocortisone|mesh-list
83536055|NCT05919992|Metyrapone|metyrapone|mesh-list
83536056|NCT05919992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83536057|NCT05919992|Antimetabolites|antimetabolites|mesh-ancestor
83536058|NCT05919992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536059|NCT05919992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536060|NCT05919966|Chlorhexidine|chlorhexidine|mesh-list
83536061|NCT05919966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83536062|NCT05919966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83536063|NCT05919966|Disinfectants|disinfectants|mesh-ancestor
83536064|NCT05919823|Xanomeline|xanomeline|mesh-list
83536065|NCT05919823|Trospium chloride|trospium chloride|mesh-list
83536066|NCT05919823|Parasympatholytics|parasympatholytics|mesh-ancestor
83536067|NCT05919823|Autonomic Agents|autonomic agents|mesh-ancestor
83536068|NCT05919823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536069|NCT05919823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536070|NCT05919823|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83536071|NCT05919823|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83536072|NCT05919823|Cholinergic Agents|cholinergic agents|mesh-ancestor
83536073|NCT05919823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536074|NCT05919823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536075|NCT05919823|Urological Agents|urological agents|mesh-ancestor
83536076|NCT05919823|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83536077|NCT05919823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83536078|NCT05919823|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83536079|NCT05919823|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83536080|NCT05919745|Acetaminophen|acetaminophen|mesh-list
83536081|NCT05919745|Ibuprofen|ibuprofen|mesh-list
83536082|NCT05919745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83536083|NCT05919745|Analgesics|analgesics|mesh-ancestor
83536084|NCT05919745|Sensory System Agents|sensory system agents|mesh-ancestor
83536085|NCT05919745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536086|NCT05919745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536087|NCT05919745|Antipyretics|antipyretics|mesh-ancestor
83536088|NCT05919745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83536089|NCT05919745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83536090|NCT05919745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536091|NCT05919745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83536092|NCT05919745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536093|NCT05919745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536094|NCT05919316|Mometasone Furoate|mometasone furoate|mesh-list
83536095|NCT05919316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83536096|NCT05919316|Dermatologic Agents|dermatologic agents|mesh-ancestor
83536097|NCT05919316|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83536102|NCT05919173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536103|NCT05919173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536104|NCT05919173|Sensory System Agents|sensory system agents|mesh-ancestor
83536105|NCT05919173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536106|NCT05919173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83536107|NCT05919173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83536108|NCT05919173|Analgesics|analgesics|mesh-ancestor
83536109|NCT05919173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83536110|NCT05919173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83536111|NCT05919173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83536112|NCT05919173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83536113|NCT05919173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536114|NCT05919173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536115|NCT05918133|Paclitaxel|paclitaxel|mesh-list
83536116|NCT05918133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83536117|NCT05918133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536118|NCT05918133|Tubulin Modulators|tubulin modulators|mesh-ancestor
83536119|NCT05918133|Antimitotic Agents|antimitotic agents|mesh-ancestor
83536120|NCT05918133|Mitosis Modulators|mitosis modulators|mesh-ancestor
83536121|NCT05918133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536122|NCT05918107|Carboplatin|carboplatin|mesh-list
83536123|NCT05918107|Pemetrexed|pemetrexed|mesh-list
83536124|NCT05918107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536125|NCT05918107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536126|NCT05918107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536127|NCT05918107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83536128|NCT05918107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83536129|NCT05918055|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83536130|NCT05918055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83536131|NCT05918055|Antimetabolites|antimetabolites|mesh-ancestor
83536132|NCT05918055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536133|NCT05918055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536134|NCT05916950|Calcium|calcium|mesh-list
83536135|NCT05916950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83536136|NCT05916950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536137|NCT05907759|Daratumumab|daratumumab|mesh-list
83536138|NCT05907759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536139|NCT05907746|Mycophenolic Acid|mycophenolic acid|mesh-list
83536140|NCT05907746|Cyclophosphamide|cyclophosphamide|mesh-list
83536141|NCT05907746|Fludarabine|fludarabine|mesh-list
83536142|NCT05907746|Tacrolimus|tacrolimus|mesh-list
83536143|NCT05907746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83536144|NCT05907746|Immunologic Factors|immunologic factors|mesh-ancestor
83536145|NCT05907746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536146|NCT05907746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536147|NCT05907746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83536148|NCT05907746|Alkylating Agents|alkylating agents|mesh-ancestor
83536149|NCT05907746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536150|NCT05907746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536151|NCT05907746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83536152|NCT05907746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83536153|NCT05907746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536154|NCT05907746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83536155|NCT05907746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83536156|NCT05907746|Antitubercular Agents|antitubercular agents|mesh-ancestor
83536157|NCT05907746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83536158|NCT05907746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83536159|NCT05904743|Insulin|insulin|mesh-list
83536160|NCT05904743|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83536161|NCT05904743|Insulin, Short-Acting|insulin, short-acting|mesh-list
83536162|NCT05904743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83536163|NCT05904743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536164|NCT05900466|Metformin|metformin|mesh-list
83536165|NCT05900466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83536166|NCT05900466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536167|NCT05898828|Nivolumab|nivolumab|mesh-list
83536168|NCT05898828|Entinostat|entinostat|mesh-list
83536169|NCT05898828|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83536170|NCT05898828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536171|NCT05898828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536172|NCT05898828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83536173|NCT05898828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536174|NCT05898828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83536176|NCT05898828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536177|NCT05898828|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83536178|NCT05898828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536180|NCT05898646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536181|NCT05897268|Lenvatinib|lenvatinib|mesh-list
83536182|NCT05897268|Tislelizumab|tislelizumab|mesh-list
83536183|NCT05897268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536184|NCT05897268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83536185|NCT05897268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536186|NCT05897268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536187|NCT05897268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536188|NCT05895773|Povidone-Iodine|povidone-iodine|mesh-list
83536189|NCT05895773|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
83536190|NCT05895773|Povidone|povidone|mesh-list
83536191|NCT05895773|Plasma Substitutes|plasma substitutes|mesh-ancestor
83536192|NCT05895773|Blood Substitutes|blood substitutes|mesh-ancestor
83536193|NCT05895773|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83536194|NCT05895773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83536195|NCT05895773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83536196|NCT05895266|Midazolam|midazolam|mesh-list
83536197|NCT05895266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83536198|NCT05895266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83536199|NCT05895266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536200|NCT05895266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536201|NCT05895266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83536202|NCT05895266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83536203|NCT05895266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83536204|NCT05895266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83536205|NCT05895266|Anesthetics, General|anesthetics, general|mesh-ancestor
83536206|NCT05895266|Anesthetics|anesthetics|mesh-ancestor
83536207|NCT05895266|GABA Modulators|gaba modulators|mesh-ancestor
83536208|NCT05895266|GABA Agents|gaba agents|mesh-ancestor
83536209|NCT05895266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536210|NCT05895266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536211|NCT05895019|Propofol|propofol|mesh-list
83536212|NCT05895019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83536213|NCT05895019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536214|NCT05895019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536215|NCT05895019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83536216|NCT05895019|Anesthetics, General|anesthetics, general|mesh-ancestor
83536217|NCT05895019|Anesthetics|anesthetics|mesh-ancestor
83536218|NCT05893056|Lenvatinib|lenvatinib|mesh-list
83536219|NCT05893056|Tislelizumab|tislelizumab|mesh-list
83536220|NCT05893056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536221|NCT05893056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83536222|NCT05893056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536223|NCT05893056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536224|NCT05893056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536225|NCT05891548|Aflibercept|aflibercept|mesh-list
83536226|NCT05891548|Axitinib|axitinib|mesh-list
83536227|NCT05891548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83536228|NCT05891548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83536229|NCT05891548|Growth Substances|growth substances|mesh-ancestor
83536230|NCT05891548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536231|NCT05891548|Growth Inhibitors|growth inhibitors|mesh-ancestor
83536232|NCT05891548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536233|NCT05891548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83536234|NCT05891548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536235|NCT05891548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536236|NCT05891379|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83536237|NCT05891379|Immunologic Factors|immunologic factors|mesh-ancestor
83536238|NCT05891379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536239|NCT05889182|Upadacitinib|upadacitinib|mesh-list
83536240|NCT05889182|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83536241|NCT05889182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83536242|NCT05889182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536243|NCT05889182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536244|NCT05889182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536245|NCT05888311|Charcoal|charcoal|mesh-list
83536246|NCT05888311|Antidotes|antidotes|mesh-ancestor
83536247|NCT05888311|Protective Agents|protective agents|mesh-ancestor
83536248|NCT05888311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536249|NCT05888207|Fluvoxamine|fluvoxamine|mesh-list
83536250|NCT05888207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83536251|NCT05888207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83536252|NCT05888207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536253|NCT05888207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536254|NCT05888207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83536255|NCT05888207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83536256|NCT05888207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83536257|NCT05888207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83536258|NCT05888207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536259|NCT05888207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536261|NCT05888207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83536262|NCT05888207|Antidepressive Agents|antidepressive agents|mesh-ancestor
83536263|NCT05888207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83536264|NCT05888207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83536265|NCT05888207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536266|NCT05888207|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83536267|NCT05884398|Androgens|androgens|mesh-list
83536268|NCT05884398|Hormones|hormones|mesh-ancestor
83536269|NCT05884398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83536270|NCT05884398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536271|NCT05883852|Cyclophosphamide|cyclophosphamide|mesh-list
83536272|NCT05883852|Carboplatin|carboplatin|mesh-list
83536273|NCT05883852|Docetaxel|docetaxel|mesh-list
83536274|NCT05883852|Trastuzumab|trastuzumab|mesh-list
83536275|NCT05883852|Epirubicin|epirubicin|mesh-list
83536276|NCT05883852|Pertuzumab|pertuzumab|mesh-list
83536277|NCT05883852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83536278|NCT05883852|Immunologic Factors|immunologic factors|mesh-ancestor
83536279|NCT05883852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536280|NCT05883852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536281|NCT05883852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83536282|NCT05883852|Alkylating Agents|alkylating agents|mesh-ancestor
83536283|NCT05883852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536284|NCT05883852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536285|NCT05883852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83536286|NCT05883852|Tubulin Modulators|tubulin modulators|mesh-ancestor
83536287|NCT05883852|Antimitotic Agents|antimitotic agents|mesh-ancestor
83536288|NCT05883852|Mitosis Modulators|mitosis modulators|mesh-ancestor
83536289|NCT05883852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536290|NCT05883852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83536291|NCT05883852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83536292|NCT05883852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83536293|NCT05883852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536294|NCT05879484|Pembrolizumab|pembrolizumab|mesh-list
83536295|NCT05879484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536296|NCT05879484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536297|NCT05879484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83536298|NCT05879484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536299|NCT05871606|Nitrous Oxide|nitrous oxide|mesh-list
83536300|NCT05871606|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83536301|NCT05871606|Anesthetics, General|anesthetics, general|mesh-ancestor
83536302|NCT05871606|Anesthetics|anesthetics|mesh-ancestor
83536303|NCT05871606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536304|NCT05871606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536305|NCT05871606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83536306|NCT05871606|Analgesics|analgesics|mesh-ancestor
83536307|NCT05871606|Sensory System Agents|sensory system agents|mesh-ancestor
83536308|NCT05871606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536309|NCT05862545|Budesonide|budesonide|mesh-list
83536310|NCT05862545|Glycopyrrolate|glycopyrrolate|mesh-list
83536311|NCT05862545|Formoterol Fumarate|formoterol fumarate|mesh-list
83536312|NCT05862545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83536313|NCT05862545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83536314|NCT05862545|Autonomic Agents|autonomic agents|mesh-ancestor
83536315|NCT05862545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536316|NCT05862545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536317|NCT05862545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83536318|NCT05862545|Respiratory System Agents|respiratory system agents|mesh-ancestor
83536319|NCT05862545|Glucocorticoids|glucocorticoids|mesh-ancestor
83536320|NCT05862545|Hormones|hormones|mesh-ancestor
83536321|NCT05862545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83536322|NCT05862545|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83536323|NCT05862545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83536324|NCT05862545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83536325|NCT05862545|Adrenergic Agents|adrenergic agents|mesh-ancestor
83536326|NCT05862545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536700|NCT05749926|Vaccines|vaccines|mesh-list
83536327|NCT05862545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536328|NCT05862545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83536329|NCT05862545|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83536330|NCT05862545|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83536331|NCT05862545|Cholinergic Agents|cholinergic agents|mesh-ancestor
83536333|NCT05857514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83536334|NCT05857514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83536335|NCT05857514|Analgesics|analgesics|mesh-ancestor
83536336|NCT05857514|Sensory System Agents|sensory system agents|mesh-ancestor
83536337|NCT05857514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536338|NCT05857514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536339|NCT05857514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83536340|NCT05857514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536341|NCT05857514|Gout Suppressants|gout suppressants|mesh-ancestor
83536342|NCT05857514|Tocolytic Agents|tocolytic agents|mesh-ancestor
83536343|NCT05857514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83536344|NCT05857514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83536345|NCT05857514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536346|NCT05857514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536347|NCT05857007|Glucocorticoids|glucocorticoids|mesh-list
83536348|NCT05857007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536349|NCT05857007|Hormones|hormones|mesh-ancestor
83536350|NCT05857007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83536351|NCT05853367|Pembrolizumab|pembrolizumab|mesh-list
83536352|NCT05853367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536353|NCT05853367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536354|NCT05853367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83536355|NCT05853367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536356|NCT05849480|Capecitabine|capecitabine|mesh-list
83536357|NCT05849480|Oxaliplatin|oxaliplatin|mesh-list
83536358|NCT05849480|Pembrolizumab|pembrolizumab|mesh-list
83536359|NCT05849480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83536360|NCT05849480|Antimetabolites|antimetabolites|mesh-ancestor
83536361|NCT05849480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536362|NCT05849480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536363|NCT05849480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536364|NCT05849480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83536365|NCT05846789|Carboplatin|carboplatin|mesh-list
83536366|NCT05846789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536367|NCT05846646|Pembrolizumab|pembrolizumab|mesh-list
83536368|NCT05846646|Nivolumab|nivolumab|mesh-list
83536369|NCT05846646|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83536370|NCT05846646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536371|NCT05846646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536372|NCT05846646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536373|NCT05845645|Esomeprazole|esomeprazole|mesh-list
83536374|NCT05845645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83536375|NCT05845645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83536376|NCT05845645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83536377|NCT05845645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536378|NCT05845645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536379|NCT05839951|Trifluridine|trifluridine|mesh-list
83536380|NCT05839951|Bevacizumab|bevacizumab|mesh-list
83536381|NCT05839951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536382|NCT05839951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536383|NCT05839951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83536384|NCT05839951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83536385|NCT05839951|Growth Substances|growth substances|mesh-ancestor
83536386|NCT05839951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536387|NCT05839951|Growth Inhibitors|growth inhibitors|mesh-ancestor
83536388|NCT05839951|Antimetabolites|antimetabolites|mesh-ancestor
83536389|NCT05839951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536390|NCT05839951|Antiviral Agents|antiviral agents|mesh-ancestor
83536391|NCT05839951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83536392|NCT05838287|Pioglitazone|pioglitazone|mesh-list
83536393|NCT05838287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83536394|NCT05838287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536395|NCT05832892|Paclitaxel|paclitaxel|mesh-list
83536396|NCT05832892|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83536397|NCT05832892|Gemcitabine|gemcitabine|mesh-list
83536398|NCT05832892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83536399|NCT05832892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536400|NCT05832892|Tubulin Modulators|tubulin modulators|mesh-ancestor
83536401|NCT05832892|Antimitotic Agents|antimitotic agents|mesh-ancestor
83536403|NCT05832892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536404|NCT05832892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83536405|NCT05832892|Antimetabolites|antimetabolites|mesh-ancestor
83536406|NCT05832398|Leucovorin|leucovorin|mesh-list
83536407|NCT05832398|Fluorouracil|fluorouracil|mesh-list
83536408|NCT05832398|Oxaliplatin|oxaliplatin|mesh-list
83536409|NCT05832398|Irinotecan|irinotecan|mesh-list
83536410|NCT05832398|Antimetabolites|antimetabolites|mesh-ancestor
83536411|NCT05832398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536412|NCT05832398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83536413|NCT05832398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536414|NCT05832398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83536415|NCT05832398|Immunologic Factors|immunologic factors|mesh-ancestor
83536416|NCT05832398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536417|NCT05832398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83536418|NCT05832398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83536419|NCT05832398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536420|NCT05832398|Antidotes|antidotes|mesh-ancestor
83536421|NCT05832398|Protective Agents|protective agents|mesh-ancestor
83536422|NCT05832398|Vitamin B Complex|vitamin b complex|mesh-ancestor
83536423|NCT05832398|Vitamins|vitamins|mesh-ancestor
83536424|NCT05832398|Micronutrients|micronutrients|mesh-ancestor
83536425|NCT05829356|Vaccines|vaccines|mesh-list
83536426|NCT05829356|Immunologic Factors|immunologic factors|mesh-ancestor
83536427|NCT05829356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536428|NCT05828459|Paclitaxel|paclitaxel|mesh-list
83536429|NCT05828459|Bevacizumab|bevacizumab|mesh-list
83536430|NCT05828459|Lenalidomide|lenalidomide|mesh-list
83536431|NCT05828459|Pomalidomide|pomalidomide|mesh-list
83536432|NCT05828459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83536433|NCT05828459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536434|NCT05828459|Tubulin Modulators|tubulin modulators|mesh-ancestor
83536435|NCT05828459|Antimitotic Agents|antimitotic agents|mesh-ancestor
83536436|NCT05828459|Mitosis Modulators|mitosis modulators|mesh-ancestor
83536437|NCT05828459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536438|NCT05828459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536439|NCT05828459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83536440|NCT05828459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83536441|NCT05828459|Growth Substances|growth substances|mesh-ancestor
83536442|NCT05828459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536443|NCT05828459|Growth Inhibitors|growth inhibitors|mesh-ancestor
83536444|NCT05828459|Immunologic Factors|immunologic factors|mesh-ancestor
83536445|NCT05828147|Rituximab|rituximab|mesh-list
83536446|NCT05828147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536447|NCT05828147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536448|NCT05828147|Immunologic Factors|immunologic factors|mesh-ancestor
83536449|NCT05828147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536450|NCT05828147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536451|NCT05827874|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83536452|NCT05827874|Immunologic Factors|immunologic factors|mesh-ancestor
83536453|NCT05827874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536454|NCT05824559|Bevacizumab|bevacizumab|mesh-list
83536455|NCT05824559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536456|NCT05824559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536457|NCT05824559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83536458|NCT05824559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83536459|NCT05824559|Growth Substances|growth substances|mesh-ancestor
83536460|NCT05824559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536461|NCT05824559|Growth Inhibitors|growth inhibitors|mesh-ancestor
83536462|NCT05823987|Lenvatinib|lenvatinib|mesh-list
83536463|NCT05823987|Tislelizumab|tislelizumab|mesh-list
83536464|NCT05823987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536465|NCT05823987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83536466|NCT05823987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536467|NCT05823987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536468|NCT05823987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536469|NCT05823467|Trimethoprim|trimethoprim|mesh-list
83536470|NCT05823467|Sulfamethoxazole|sulfamethoxazole|mesh-list
83536471|NCT05823467|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83536472|NCT05823467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83536473|NCT05823467|Antimalarials|antimalarials|mesh-ancestor
83536474|NCT05823467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83536475|NCT05823467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83536476|NCT05823467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83536477|NCT05823467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536478|NCT05823467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536479|NCT05823467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83536480|NCT05823467|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83536481|NCT05823467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83536482|NCT05823337|Selenium|selenium|mesh-list
83536483|NCT05823337|Antioxidants|antioxidants|mesh-ancestor
83536484|NCT05823337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536485|NCT05823337|Protective Agents|protective agents|mesh-ancestor
83536486|NCT05823337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536487|NCT05823337|Trace Elements|trace elements|mesh-ancestor
83536488|NCT05823337|Micronutrients|micronutrients|mesh-ancestor
83536489|NCT05822752|Sorafenib|sorafenib|mesh-list
83536490|NCT05822752|Lenvatinib|lenvatinib|mesh-list
83536491|NCT05822752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536492|NCT05822752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83536493|NCT05822752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536494|NCT05822752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536495|NCT05822440|Itraconazole|itraconazole|mesh-list
83536496|NCT05822440|Antifungal Agents|antifungal agents|mesh-ancestor
83536497|NCT05822440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83536498|NCT05822440|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83536499|NCT05822440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83536500|NCT05822440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536501|NCT05822440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536502|NCT05822440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83536503|NCT05822440|Hormone Antagonists|hormone antagonists|mesh-ancestor
83536504|NCT05822440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83536505|NCT05822440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536506|NCT05822440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83536507|NCT05820841|Acalabrutinib|acalabrutinib|mesh-list
83536508|NCT05820841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536509|NCT05817591|Capsaicin|capsaicin|mesh-list
83536510|NCT05817591|Antipruritics|antipruritics|mesh-ancestor
83536511|NCT05817591|Dermatologic Agents|dermatologic agents|mesh-ancestor
83536512|NCT05817591|Sensory System Agents|sensory system agents|mesh-ancestor
83536513|NCT05817591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536514|NCT05817591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536515|NCT05815160|Carboplatin|carboplatin|mesh-list
83536516|NCT05815160|Etoposide|etoposide|mesh-list
83536517|NCT05815160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536518|NCT05815160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83536519|NCT05815160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83536520|NCT05815160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83536521|NCT05815160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536522|NCT05815160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536523|NCT05814627|Adalimumab|adalimumab|mesh-list
83536524|NCT05814627|Upadacitinib|upadacitinib|mesh-list
83536525|NCT05814627|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83536526|NCT05814627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83536527|NCT05814627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536528|NCT05814627|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83536529|NCT05814627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83536530|NCT05814627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536531|NCT05814627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536532|NCT05811351|Prednisone|prednisone|mesh-list
83536533|NCT05811351|Triamcinolone|triamcinolone|mesh-list
83536534|NCT05811351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83536535|NCT05811351|Glucocorticoids|glucocorticoids|mesh-ancestor
83536536|NCT05811351|Hormones|hormones|mesh-ancestor
83536537|NCT05811351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83536538|NCT05811351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536539|NCT05811351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83536540|NCT05811351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536541|NCT05803551|Ketamine|ketamine|mesh-list
83536542|NCT05803551|Analgesics|analgesics|mesh-ancestor
83536543|NCT05803551|Sensory System Agents|sensory system agents|mesh-ancestor
83536544|NCT05803551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536545|NCT05803551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536546|NCT05803551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83536547|NCT05803551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83536548|NCT05803551|Anesthetics, General|anesthetics, general|mesh-ancestor
83536549|NCT05803551|Anesthetics|anesthetics|mesh-ancestor
83536550|NCT05803551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536551|NCT05803551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83536552|NCT05803551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83536553|NCT05803551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536554|NCT05803551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536556|NCT05797246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536557|NCT05797246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536558|NCT05797246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83536559|NCT05797246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83536560|NCT05797246|Growth Substances|growth substances|mesh-ancestor
83536561|NCT05797246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536562|NCT05797246|Growth Inhibitors|growth inhibitors|mesh-ancestor
83536563|NCT05797233|Cyclophosphamide|cyclophosphamide|mesh-list
83536564|NCT05797233|Fludarabine|fludarabine|mesh-list
83536565|NCT05797233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83536566|NCT05797233|Immunologic Factors|immunologic factors|mesh-ancestor
83536567|NCT05797233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536568|NCT05797233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536569|NCT05797233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83536570|NCT05797233|Alkylating Agents|alkylating agents|mesh-ancestor
83536571|NCT05797233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536572|NCT05797233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536573|NCT05797233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83536574|NCT05796791|Ketamine|ketamine|mesh-list
83536575|NCT05796791|Analgesics|analgesics|mesh-ancestor
83536576|NCT05796791|Sensory System Agents|sensory system agents|mesh-ancestor
83536577|NCT05796791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536578|NCT05796791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536579|NCT05796791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83536580|NCT05796791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83536581|NCT05796791|Anesthetics, General|anesthetics, general|mesh-ancestor
83536582|NCT05796791|Anesthetics|anesthetics|mesh-ancestor
83536583|NCT05796791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536584|NCT05796791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83536585|NCT05796791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83536586|NCT05796791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536587|NCT05796791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536588|NCT05784844|Meropenem|meropenem|mesh-list
83536589|NCT05784844|Micafungin|micafungin|mesh-list
83536590|NCT05784844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83536591|NCT05784844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83536592|NCT05784844|Antifungal Agents|antifungal agents|mesh-ancestor
83536593|NCT05784363|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83536594|NCT05784363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83536595|NCT05784363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536596|NCT05784363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536597|NCT05784363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83536598|NCT05784363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83536599|NCT05784363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536600|NCT05784363|Cholinergic Agents|cholinergic agents|mesh-ancestor
83536601|NCT05784363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536602|NCT05782244|Sildenafil Citrate|sildenafil citrate|mesh-list
83536603|NCT05782244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536604|NCT05782244|Vasodilator Agents|vasodilator agents|mesh-ancestor
83536605|NCT05782244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83536606|NCT05782244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83536607|NCT05782244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536608|NCT05782244|Urological Agents|urological agents|mesh-ancestor
83536609|NCT05777603|Vancomycin|vancomycin|mesh-list
83536610|NCT05777603|Aztreonam|aztreonam|mesh-list
83536611|NCT05777603|Pembrolizumab|pembrolizumab|mesh-list
83536612|NCT05777603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536613|NCT05777603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536614|NCT05777603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83536615|NCT05777603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536616|NCT05777603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83536617|NCT05777603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83536618|NCT05773066|Lidocaine|lidocaine|mesh-list
83536619|NCT05773066|Anesthetics, Local|anesthetics, local|mesh-ancestor
83536620|NCT05773066|Anesthetics|anesthetics|mesh-ancestor
83536621|NCT05773066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536622|NCT05773066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536623|NCT05773066|Sensory System Agents|sensory system agents|mesh-ancestor
83536624|NCT05773066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536625|NCT05773066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83536626|NCT05773066|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83536627|NCT05773066|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83536628|NCT05773066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83536629|NCT05773066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536630|NCT05773053|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83536631|NCT05773053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83536632|NCT05773053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83536633|NCT05773053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536634|NCT05773053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536635|NCT05773053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83536636|NCT05773053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83536637|NCT05773053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536638|NCT05773053|Cholinergic Agents|cholinergic agents|mesh-ancestor
83536639|NCT05773053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536641|NCT05770102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83536642|NCT05770102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536643|NCT05770102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536644|NCT05770102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536645|NCT05768139|Fulvestrant|fulvestrant|mesh-list
83536646|NCT05768139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83536647|NCT05768139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536648|NCT05768139|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83536649|NCT05768139|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83536650|NCT05768139|Hormone Antagonists|hormone antagonists|mesh-ancestor
83536651|NCT05768139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83536652|NCT05768139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536653|NCT05765812|Temozolomide|temozolomide|mesh-list
83536654|NCT05765812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83536655|NCT05765812|Alkylating Agents|alkylating agents|mesh-ancestor
83536656|NCT05765812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536657|NCT05765812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536658|NCT05764733|Diphosphonates|diphosphonates|mesh-list
83536659|NCT05764733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83536660|NCT05764733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536661|NCT05760313|Linaclotide|linaclotide|mesh-list
83536662|NCT05760313|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83536663|NCT05760313|Enzyme Activators|enzyme activators|mesh-ancestor
83536664|NCT05760313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536665|NCT05760313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83536666|NCT05759364|Papaverine|papaverine|mesh-list
83536667|NCT05759364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83536668|NCT05759364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536669|NCT05759364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536670|NCT05759364|Vasodilator Agents|vasodilator agents|mesh-ancestor
83536671|NCT05759364|Urological Agents|urological agents|mesh-ancestor
83536672|NCT05757869|Apixaban|apixaban|mesh-list
83536673|NCT05757869|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83536674|NCT05757869|Antithrombins|antithrombins|mesh-ancestor
83536675|NCT05757869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83536676|NCT05757869|Protease Inhibitors|protease inhibitors|mesh-ancestor
83536677|NCT05757869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536678|NCT05757869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536679|NCT05757869|Anticoagulants|anticoagulants|mesh-ancestor
83536680|NCT05755035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83536681|NCT05755035|Immunoglobulins|immunoglobulins|mesh-list
83536682|NCT05755035|Antibodies|antibodies|mesh-list
83536683|NCT05755035|gamma-Globulins|gamma-globulins|mesh-list
83536684|NCT05755035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83536685|NCT05755035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83536686|NCT05755035|Immunoglobulin G|immunoglobulin g|mesh-list
83536687|NCT05755035|Immunologic Factors|immunologic factors|mesh-ancestor
83536688|NCT05755035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536689|NCT05753735|Amoxicillin|amoxicillin|mesh-list
83536690|NCT05753735|Tazobactam|tazobactam|mesh-list
83536691|NCT05753735|Piperacillin|piperacillin|mesh-list
83536692|NCT05753735|Clavulanic Acids|clavulanic acids|mesh-list
83536693|NCT05753735|Clavulanic Acid|clavulanic acid|mesh-list
83536694|NCT05753735|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83536695|NCT05753735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83536696|NCT05753735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83536697|NCT05753735|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83536698|NCT05753735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536699|NCT05753735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536702|NCT05749926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536703|NCT05740566|Topotecan|topotecan|mesh-list
83536704|NCT05740566|Amrubicin|amrubicin|mesh-list
83536705|NCT05740566|AMG 757|amg 757|mesh-list
83536706|NCT05740566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83536707|NCT05740566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83536708|NCT05740566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536709|NCT05740566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536710|NCT05740566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536711|NCT05739981|Paclitaxel|paclitaxel|mesh-list
83536712|NCT05739981|Bevacizumab|bevacizumab|mesh-list
83536713|NCT05739981|Carboplatin|carboplatin|mesh-list
83536714|NCT05739981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83536715|NCT05739981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536716|NCT05739981|Tubulin Modulators|tubulin modulators|mesh-ancestor
83536717|NCT05739981|Antimitotic Agents|antimitotic agents|mesh-ancestor
83536718|NCT05739981|Mitosis Modulators|mitosis modulators|mesh-ancestor
83536719|NCT05739981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536720|NCT05739981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536721|NCT05739981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83536722|NCT05739981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83536723|NCT05739981|Growth Substances|growth substances|mesh-ancestor
83536724|NCT05739981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536725|NCT05739981|Growth Inhibitors|growth inhibitors|mesh-ancestor
83536726|NCT05736562|Vitamins|vitamins|mesh-list
83536727|NCT05736562|Micronutrients|micronutrients|mesh-ancestor
83536728|NCT05736562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536729|NCT05734625|Methylprednisolone|methylprednisolone|mesh-list
83536730|NCT05734625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83536731|NCT05734625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83536732|NCT05734625|Prednisolone|prednisolone|mesh-list
83536733|NCT05734625|Prednisolone acetate|prednisolone acetate|mesh-list
83536734|NCT05734625|Bupivacaine|bupivacaine|mesh-list
83536735|NCT05734625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83536736|NCT05734625|Prednisolone phosphate|prednisolone phosphate|mesh-list
83536737|NCT05734625|Anesthetics, Local|anesthetics, local|mesh-ancestor
83536738|NCT05734625|Anesthetics|anesthetics|mesh-ancestor
83536739|NCT05734625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536740|NCT05734625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536741|NCT05734625|Sensory System Agents|sensory system agents|mesh-ancestor
83536742|NCT05734625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536743|NCT05734625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83536744|NCT05734625|Antiemetics|antiemetics|mesh-ancestor
83536745|NCT05734625|Autonomic Agents|autonomic agents|mesh-ancestor
83536746|NCT05734625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83536747|NCT05734625|Glucocorticoids|glucocorticoids|mesh-ancestor
83536748|NCT05734625|Hormones|hormones|mesh-ancestor
83536749|NCT05734625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83536750|NCT05734625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83536751|NCT05734625|Protective Agents|protective agents|mesh-ancestor
83536752|NCT05734625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83536753|NCT05734625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536754|NCT05731492|Macitentan|macitentan|mesh-list
83536755|NCT05731492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83536756|NCT05731492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83536757|NCT05731492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536758|NCT05731492|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83536759|NCT05730205|Etonogestrel|etonogestrel|mesh-list
83536760|NCT05730205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83536761|NCT05730205|Contraceptive Agents|contraceptive agents|mesh-ancestor
83536762|NCT05730205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83536763|NCT05730205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536764|NCT05730205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83536765|NCT05728736|Lemborexant|lemborexant|mesh-list
83536766|NCT05728736|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83536767|NCT05728736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536768|NCT05728736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536769|NCT05728736|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83536770|NCT05728736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83536771|NCT05728736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536772|NCT05728736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536773|NCT05725837|Fluoxetine|fluoxetine|mesh-list
83536774|NCT05725837|Paroxetine|paroxetine|mesh-list
83536775|NCT05725837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83536776|NCT05725837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83536777|NCT05725837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83536778|NCT05725837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536779|NCT05725837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536780|NCT05725837|Serotonin Agents|serotonin agents|mesh-ancestor
83536781|NCT05725837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536782|NCT05725837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83536783|NCT05725837|Antidepressive Agents|antidepressive agents|mesh-ancestor
83536784|NCT05725837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83536785|NCT05725837|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83536786|NCT05725837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83536787|NCT05725837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536788|NCT05724108|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83536789|NCT05724108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536790|NCT05724108|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83536791|NCT05717140|Nivolumab|nivolumab|mesh-list
83536792|NCT05717140|Sargramostim|sargramostim|mesh-list
83536793|NCT05717140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536794|NCT05717140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536795|NCT05717140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83536796|NCT05717140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536797|NCT05717140|Immunologic Factors|immunologic factors|mesh-ancestor
83536798|NCT05717140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536799|NCT05714865|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83536800|NCT05714865|Respiratory System Agents|respiratory system agents|mesh-ancestor
83536801|NCT05714345|Cyclophosphamide|cyclophosphamide|mesh-list
83536802|NCT05714345|Fludarabine|fludarabine|mesh-list
83536803|NCT05714345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83536804|NCT05714345|Immunologic Factors|immunologic factors|mesh-ancestor
83536805|NCT05714345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536806|NCT05714345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536807|NCT05714345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83536808|NCT05714345|Alkylating Agents|alkylating agents|mesh-ancestor
83536809|NCT05714345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536810|NCT05714345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536811|NCT05714345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83536812|NCT05713799|Thioctic Acid|thioctic acid|mesh-list
83536813|NCT05713799|Mirabegron|mirabegron|mesh-list
83536814|NCT05713799|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83536815|NCT05713799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83536816|NCT05713799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83536817|NCT05713799|Adrenergic Agents|adrenergic agents|mesh-ancestor
83536818|NCT05713799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536819|NCT05713799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536820|NCT05713799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536821|NCT05713799|Urological Agents|urological agents|mesh-ancestor
83536822|NCT05713799|Antioxidants|antioxidants|mesh-ancestor
83536823|NCT05713799|Protective Agents|protective agents|mesh-ancestor
83536824|NCT05713799|Vitamin B Complex|vitamin b complex|mesh-ancestor
83536825|NCT05713799|Vitamins|vitamins|mesh-ancestor
83536826|NCT05713799|Micronutrients|micronutrients|mesh-ancestor
83536827|NCT05711615|Doxorubicin|doxorubicin|mesh-list
83536828|NCT05711615|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83536829|NCT05711615|Peposertib|peposertib|mesh-list
83536830|NCT05711615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83536831|NCT05711615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536832|NCT05711615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83536833|NCT05711615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83536834|NCT05711615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536835|NCT05711615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536836|NCT05711615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83536837|NCT05707208|Lidocaine|lidocaine|mesh-list
83536838|NCT05707208|Anesthetics, Local|anesthetics, local|mesh-ancestor
83536839|NCT05707208|Anesthetics|anesthetics|mesh-ancestor
83536840|NCT05707208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536841|NCT05707208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536842|NCT05707208|Sensory System Agents|sensory system agents|mesh-ancestor
83536843|NCT05707208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536844|NCT05707208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83536845|NCT05707208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83536846|NCT05707208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83536847|NCT05707208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83536848|NCT05707208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536849|NCT05706753|Drospirenone|drospirenone|mesh-list
83536850|NCT05706753|Midazolam|midazolam|mesh-list
83536852|NCT05706753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83536853|NCT05706753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83536854|NCT05706753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536855|NCT05706753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536856|NCT05706753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83536857|NCT05706753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83536858|NCT05706753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83536859|NCT05706753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83536860|NCT05706753|Anesthetics, General|anesthetics, general|mesh-ancestor
83536861|NCT05706753|Anesthetics|anesthetics|mesh-ancestor
83536862|NCT05706753|GABA Modulators|gaba modulators|mesh-ancestor
83536863|NCT05706753|GABA Agents|gaba agents|mesh-ancestor
83536864|NCT05706753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536865|NCT05706753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536866|NCT05706753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83536867|NCT05706753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83536868|NCT05706753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83536869|NCT05706753|Contraceptive Agents|contraceptive agents|mesh-ancestor
83536870|NCT05706753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83536871|NCT05706753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83536872|NCT05706753|Estrogens|estrogens|mesh-ancestor
83536873|NCT05706753|Hormones|hormones|mesh-ancestor
83536874|NCT05706753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83536875|NCT05706753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83536876|NCT05706753|Hormone Antagonists|hormone antagonists|mesh-ancestor
83536877|NCT05706753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83536878|NCT05706753|Diuretics|diuretics|mesh-ancestor
83536879|NCT05706753|Natriuretic Agents|natriuretic agents|mesh-ancestor
83536880|NCT05706233|Analgesics|analgesics|mesh-list
83536881|NCT05706233|Sensory System Agents|sensory system agents|mesh-ancestor
83536882|NCT05706233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536883|NCT05706233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536884|NCT05705050|Aminophylline|aminophylline|mesh-list
83536885|NCT05705050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83536886|NCT05705050|Autonomic Agents|autonomic agents|mesh-ancestor
83536887|NCT05705050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536888|NCT05705050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536889|NCT05705050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83536890|NCT05705050|Respiratory System Agents|respiratory system agents|mesh-ancestor
83536891|NCT05705050|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83536892|NCT05705050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83536893|NCT05705050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536894|NCT05705050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536895|NCT05705050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83536896|NCT05705050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83536897|NCT05705050|Purinergic Agents|purinergic agents|mesh-ancestor
83536898|NCT05705050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83536899|NCT05705050|Protective Agents|protective agents|mesh-ancestor
83536900|NCT05693454|Tramadol|tramadol|mesh-list
83536901|NCT05693454|Levobupivacaine|levobupivacaine|mesh-list
83536902|NCT05693454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83536903|NCT05693454|Narcotics|narcotics|mesh-ancestor
83536904|NCT05693454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83536905|NCT05693454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536906|NCT05693454|Analgesics|analgesics|mesh-ancestor
83536907|NCT05693454|Sensory System Agents|sensory system agents|mesh-ancestor
83536908|NCT05693454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536909|NCT05693454|Anesthetics, Local|anesthetics, local|mesh-ancestor
83536910|NCT05693454|Anesthetics|anesthetics|mesh-ancestor
83536911|NCT05691478|Cisplatin|cisplatin|mesh-list
83536912|NCT05691478|Doxorubicin|doxorubicin|mesh-list
83536913|NCT05691478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83536914|NCT05691478|Methotrexate|methotrexate|mesh-list
83536915|NCT05691478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536916|NCT05691478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83536917|NCT05691478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83536918|NCT05691478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83536919|NCT05691478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536920|NCT05691478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536921|NCT05691478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83536922|NCT05691478|Abortifacient Agents|abortifacient agents|mesh-ancestor
83536923|NCT05691478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83536924|NCT05691478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536925|NCT05691478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83536928|NCT05691478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83536929|NCT05691478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83536930|NCT05691478|Immunologic Factors|immunologic factors|mesh-ancestor
83536931|NCT05691478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536932|NCT05691478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83536933|NCT05681650|Paclitaxel|paclitaxel|mesh-list
83536934|NCT05681650|Cyclophosphamide|cyclophosphamide|mesh-list
83536935|NCT05681650|Fludarabine|fludarabine|mesh-list
83536936|NCT05681650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83536937|NCT05681650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83536938|NCT05681650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536939|NCT05681650|Tubulin Modulators|tubulin modulators|mesh-ancestor
83536940|NCT05681650|Antimitotic Agents|antimitotic agents|mesh-ancestor
83536941|NCT05681650|Mitosis Modulators|mitosis modulators|mesh-ancestor
83536942|NCT05681650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536943|NCT05681650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83536944|NCT05681650|Immunologic Factors|immunologic factors|mesh-ancestor
83536945|NCT05681650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536946|NCT05681650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536947|NCT05681650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83536948|NCT05681650|Alkylating Agents|alkylating agents|mesh-ancestor
83536949|NCT05681650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83536950|NCT05675410|Deoxyglucose|deoxyglucose|mesh-list
83536951|NCT05675410|Prednisone|prednisone|mesh-list
83536952|NCT05675410|Prednisolone|prednisolone|mesh-list
83536953|NCT05675410|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83536954|NCT05675410|Methylprednisolone|methylprednisolone|mesh-list
83536955|NCT05675410|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83536956|NCT05675410|Prednisolone acetate|prednisolone acetate|mesh-list
83536957|NCT05675410|Hydrocortisone|hydrocortisone|mesh-list
83536958|NCT05675410|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83536959|NCT05675410|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83536960|NCT05675410|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83536961|NCT05675410|Cortisone|cortisone|mesh-list
83536962|NCT05675410|Cyclophosphamide|cyclophosphamide|mesh-list
83536963|NCT05675410|Dacarbazine|dacarbazine|mesh-list
83536964|NCT05675410|Doxorubicin|doxorubicin|mesh-list
83536965|NCT05675410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83536966|NCT05675410|Nivolumab|nivolumab|mesh-list
83536967|NCT05675410|Etoposide|etoposide|mesh-list
83536968|NCT05675410|Etoposide phosphate|etoposide phosphate|mesh-list
83536969|NCT05675410|Vincristine|vincristine|mesh-list
83536970|NCT05675410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83536971|NCT05675410|Bleomycin|bleomycin|mesh-list
83536972|NCT05675410|Vinblastine|vinblastine|mesh-list
83536973|NCT05675410|Podophyllotoxin|podophyllotoxin|mesh-list
83536974|NCT05675410|Procarbazine|procarbazine|mesh-list
83536975|NCT05675410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83536976|NCT05675410|Antibodies|antibodies|mesh-list
83536977|NCT05675410|Immunoglobulins|immunoglobulins|mesh-list
83536978|NCT05675410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83536979|NCT05675410|Imidazole|imidazole|mesh-list
83536980|NCT05675410|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83536981|NCT05675410|Prednisolone phosphate|prednisolone phosphate|mesh-list
83536982|NCT05675410|Immunoconjugates|immunoconjugates|mesh-list
83536983|NCT05675410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83536984|NCT05675410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83536985|NCT05675410|Immunologic Factors|immunologic factors|mesh-ancestor
83536986|NCT05675410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536987|NCT05675410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83536988|NCT05675410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83536989|NCT05675410|Alkylating Agents|alkylating agents|mesh-ancestor
83536990|NCT05675410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83536991|NCT05675410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83536992|NCT05675410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83536993|NCT05675410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83536994|NCT05675410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83536995|NCT05675410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83536996|NCT05675410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83536997|NCT05675410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83536998|NCT05675410|Glucocorticoids|glucocorticoids|mesh-ancestor
83536999|NCT05675410|Hormones|hormones|mesh-ancestor
83537000|NCT05675410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537001|NCT05675410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537002|NCT05675410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537003|NCT05675410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537004|NCT05675410|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537005|NCT05675410|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537006|NCT05675410|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537009|NCT05675410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537010|NCT05675410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83537011|NCT05675410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83537012|NCT05675410|Protective Agents|protective agents|mesh-ancestor
83537013|NCT05675410|Immunotoxins|immunotoxins|mesh-ancestor
83537014|NCT05675410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83537015|NCT05675410|Keratolytic Agents|keratolytic agents|mesh-ancestor
83537016|NCT05675410|Dermatologic Agents|dermatologic agents|mesh-ancestor
83537017|NCT05675410|Antimetabolites|antimetabolites|mesh-ancestor
83537018|NCT05675410|Antiviral Agents|antiviral agents|mesh-ancestor
83537019|NCT05675410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83537020|NCT05673200|Paclitaxel|paclitaxel|mesh-list
83537021|NCT05673200|Pembrolizumab|pembrolizumab|mesh-list
83537022|NCT05673200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83537023|NCT05673200|Decitabine|decitabine|mesh-list
83537024|NCT05673200|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83537025|NCT05673200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537026|NCT05673200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537027|NCT05673200|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537028|NCT05673200|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537029|NCT05673200|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537030|NCT05673200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537031|NCT05673200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537032|NCT05673200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537033|NCT05673200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83537034|NCT05673200|Antimetabolites|antimetabolites|mesh-ancestor
83537035|NCT05673200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537036|NCT05672108|Mitomycins|mitomycins|mesh-list
83537037|NCT05672108|Mitomycin|mitomycin|mesh-list
83537038|NCT05672108|Ethiodized Oil|ethiodized oil|mesh-list
83537039|NCT05672108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83537040|NCT05672108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537041|NCT05672108|Alkylating Agents|alkylating agents|mesh-ancestor
83537042|NCT05672108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537043|NCT05672108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83537044|NCT05672108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537045|NCT05670106|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83537046|NCT05670106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83537047|NCT05670106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537048|NCT05668429|Ibrexafungerp|ibrexafungerp|mesh-list
83537049|NCT05668429|Antifungal Agents|antifungal agents|mesh-ancestor
83537050|NCT05668429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83537051|NCT05663866|Dexamethasone|dexamethasone|mesh-list
83537052|NCT05663866|Methotrexate|methotrexate|mesh-list
83537053|NCT05663866|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83537054|NCT05663866|Montelukast|montelukast|mesh-list
83537055|NCT05663866|Lazertinib|lazertinib|mesh-list
83537056|NCT05663866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83537057|NCT05663866|Antiemetics|antiemetics|mesh-ancestor
83537058|NCT05663866|Autonomic Agents|autonomic agents|mesh-ancestor
83537059|NCT05663866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537060|NCT05663866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537061|NCT05663866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83537062|NCT05663866|Glucocorticoids|glucocorticoids|mesh-ancestor
83537063|NCT05663866|Hormones|hormones|mesh-ancestor
83537064|NCT05663866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537065|NCT05663866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537066|NCT05663866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537067|NCT05663866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83537068|NCT05663866|Abortifacient Agents|abortifacient agents|mesh-ancestor
83537069|NCT05663866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83537070|NCT05663866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83537071|NCT05663866|Antimetabolites|antimetabolites|mesh-ancestor
83537072|NCT05663866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537073|NCT05663866|Dermatologic Agents|dermatologic agents|mesh-ancestor
83537074|NCT05663866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537075|NCT05663866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83537076|NCT05663866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83537078|NCT05663866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83537079|NCT05663866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83537080|NCT05663866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83537081|NCT05663866|Respiratory System Agents|respiratory system agents|mesh-ancestor
83537082|NCT05663866|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83537083|NCT05663866|Hormone Antagonists|hormone antagonists|mesh-ancestor
83537084|NCT05663866|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83537085|NCT05663866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83537086|NCT05663866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537087|NCT05663866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537088|NCT05655598|Palbociclib|palbociclib|mesh-list
83537089|NCT05655598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537090|NCT05655598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537091|NCT05655598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537092|NCT05655598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537093|NCT05652478|Tenofovir|tenofovir|mesh-list
83537094|NCT05652478|Dolutegravir|dolutegravir|mesh-list
83537095|NCT05652478|Antiviral Agents|antiviral agents|mesh-ancestor
83537096|NCT05652478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83537097|NCT05652478|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83537098|NCT05652478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83537099|NCT05652478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537100|NCT05652478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537101|NCT05652478|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83537102|NCT05652478|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83537103|NCT05652478|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83537104|NCT05652478|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83537105|NCT05651711|KHK4083|khk4083|mesh-list
83537106|NCT05651711|Dermatologic Agents|dermatologic agents|mesh-ancestor
83537107|NCT05648591|Iloperidone|iloperidone|mesh-list
83537108|NCT05648591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83537109|NCT05648591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83537110|NCT05648591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83537111|NCT05648591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537112|NCT05648591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83537113|NCT05647889|Lidocaine|lidocaine|mesh-list
83537114|NCT05647889|Anesthetics, Local|anesthetics, local|mesh-ancestor
83537115|NCT05647889|Anesthetics|anesthetics|mesh-ancestor
83537116|NCT05647889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83537117|NCT05647889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537118|NCT05647889|Sensory System Agents|sensory system agents|mesh-ancestor
83537119|NCT05647889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537120|NCT05647889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83537121|NCT05647889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83537122|NCT05647889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83537123|NCT05647889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83537124|NCT05647889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537125|NCT05646862|Fulvestrant|fulvestrant|mesh-list
83537126|NCT05646862|Inavolisib|inavolisib|mesh-list
83537127|NCT05646862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537128|NCT05646862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537129|NCT05646862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83537130|NCT05646862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83537131|NCT05646862|Hormone Antagonists|hormone antagonists|mesh-ancestor
83537132|NCT05646862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537133|NCT05646862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537134|NCT05646862|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83537135|NCT05646862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537136|NCT05646862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537137|NCT05642195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83537138|NCT05642195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83537139|NCT05642195|Immunologic Factors|immunologic factors|mesh-ancestor
83537140|NCT05642195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537141|NCT05635916|Bupivacaine|bupivacaine|mesh-list
83537142|NCT05635916|Anesthetics, Local|anesthetics, local|mesh-ancestor
83537143|NCT05635916|Anesthetics|anesthetics|mesh-ancestor
83537144|NCT05635916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83537145|NCT05635916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537146|NCT05635916|Sensory System Agents|sensory system agents|mesh-ancestor
83537147|NCT05635916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537148|NCT05633654|Pembrolizumab|pembrolizumab|mesh-list
83537149|NCT05633654|Capecitabine|capecitabine|mesh-list
83537150|NCT05633654|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83537151|NCT05633654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537152|NCT05633654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537153|NCT05633654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537154|NCT05633654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537155|NCT05633654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83537156|NCT05633654|Antimetabolites|antimetabolites|mesh-ancestor
83537157|NCT05633654|Immunoconjugates|immunoconjugates|mesh-ancestor
83537159|NCT05633654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537161|NCT05630781|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83537162|NCT05630781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83537163|NCT05630781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83537164|NCT05630781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537165|NCT05630781|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83537166|NCT05630781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83537167|NCT05630781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537168|NCT05624957|Lidocaine|lidocaine|mesh-list
83537169|NCT05624957|Epinephrine|epinephrine|mesh-list
83537170|NCT05624957|Racepinephrine|racepinephrine|mesh-list
83537171|NCT05624957|Epinephryl borate|epinephryl borate|mesh-list
83537172|NCT05624957|Anesthetics, Local|anesthetics, local|mesh-ancestor
83537173|NCT05624957|Anesthetics|anesthetics|mesh-ancestor
83537174|NCT05624957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83537175|NCT05624957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537176|NCT05624957|Sensory System Agents|sensory system agents|mesh-ancestor
83537177|NCT05624957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537178|NCT05624957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83537179|NCT05624957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83537180|NCT05624957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83537181|NCT05624957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83537182|NCT05624957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537183|NCT05624957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83537184|NCT05624957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83537185|NCT05624957|Adrenergic Agents|adrenergic agents|mesh-ancestor
83537186|NCT05624957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83537187|NCT05624957|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83537188|NCT05624957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83537189|NCT05624957|Autonomic Agents|autonomic agents|mesh-ancestor
83537190|NCT05624957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83537191|NCT05624957|Respiratory System Agents|respiratory system agents|mesh-ancestor
83537192|NCT05624957|Mydriatics|mydriatics|mesh-ancestor
83537193|NCT05624957|Sympathomimetics|sympathomimetics|mesh-ancestor
83537194|NCT05624957|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83537195|NCT05624554|Cyclophosphamide|cyclophosphamide|mesh-list
83537196|NCT05624554|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83537197|NCT05624554|Rituximab|rituximab|mesh-list
83537198|NCT05624554|Fludarabine|fludarabine|mesh-list
83537199|NCT05624554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83537200|NCT05624554|Immunologic Factors|immunologic factors|mesh-ancestor
83537201|NCT05624554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537202|NCT05624554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83537203|NCT05624554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83537204|NCT05624554|Alkylating Agents|alkylating agents|mesh-ancestor
83537205|NCT05624554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537206|NCT05624554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537207|NCT05624554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83537208|NCT05624554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537209|NCT05617677|Deucravacitinib|deucravacitinib|mesh-list
83537210|NCT05617677|Dermatologic Agents|dermatologic agents|mesh-ancestor
83537211|NCT05617677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537212|NCT05617677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537213|NCT05617677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537214|NCT05613426|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83537215|NCT05613426|Evolocumab|evolocumab|mesh-list
83537216|NCT05613426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83537217|NCT05613426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83537218|NCT05613426|Antimetabolites|antimetabolites|mesh-ancestor
83537219|NCT05613426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537220|NCT05613426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83537221|NCT05613426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83537223|NCT05613426|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83537224|NCT05613426|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83537225|NCT05613426|Protease Inhibitors|protease inhibitors|mesh-ancestor
83537226|NCT05610657|Mitapivat|mitapivat|mesh-list
83537227|NCT05610657|Enzyme Activators|enzyme activators|mesh-ancestor
83537228|NCT05610657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537229|NCT05605899|Prednisone|prednisone|mesh-list
83537230|NCT05605899|Cyclophosphamide|cyclophosphamide|mesh-list
83537231|NCT05605899|Rituximab|rituximab|mesh-list
83537232|NCT05605899|Doxorubicin|doxorubicin|mesh-list
83537233|NCT05605899|Fludarabine|fludarabine|mesh-list
83537234|NCT05605899|Etoposide|etoposide|mesh-list
83537235|NCT05605899|Vincristine|vincristine|mesh-list
83537310|NCT05600426|Alkylating Agents|alkylating agents|mesh-ancestor
83537236|NCT05605899|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83537237|NCT05605899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83537238|NCT05605899|Immunologic Factors|immunologic factors|mesh-ancestor
83537239|NCT05605899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537240|NCT05605899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83537241|NCT05605899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83537242|NCT05605899|Alkylating Agents|alkylating agents|mesh-ancestor
83537243|NCT05605899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537244|NCT05605899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537245|NCT05605899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83537246|NCT05605899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537247|NCT05605899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83537248|NCT05605899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83537249|NCT05605899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83537250|NCT05605899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537251|NCT05605899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83537253|NCT05605899|Hormones|hormones|mesh-ancestor
83537254|NCT05605899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537255|NCT05605899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537256|NCT05605899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537257|NCT05605899|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537258|NCT05605899|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537259|NCT05605899|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537260|NCT05603065|Paclitaxel|paclitaxel|mesh-list
83537261|NCT05603065|Tislelizumab|tislelizumab|mesh-list
83537262|NCT05603065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537263|NCT05603065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537264|NCT05603065|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537265|NCT05603065|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537266|NCT05603065|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537267|NCT05603065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537268|NCT05603065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537269|NCT05601973|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83537270|NCT05601973|Lazertinib|lazertinib|mesh-list
83537271|NCT05601973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537272|NCT05601973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537273|NCT05601973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537274|NCT05601973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537275|NCT05601973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537276|NCT05601882|Upadacitinib|upadacitinib|mesh-list
83537277|NCT05601882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83537278|NCT05601882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537279|NCT05601882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537280|NCT05601882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537281|NCT05601882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83537282|NCT05601700|Paclitaxel|paclitaxel|mesh-list
83537283|NCT05601700|Carboplatin|carboplatin|mesh-list
83537284|NCT05601700|Letrozole|letrozole|mesh-list
83537285|NCT05601700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537286|NCT05601700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537287|NCT05601700|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537288|NCT05601700|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537289|NCT05601700|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537290|NCT05601700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537291|NCT05601700|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83537292|NCT05601700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83537293|NCT05601700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537294|NCT05601700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83537295|NCT05601700|Hormone Antagonists|hormone antagonists|mesh-ancestor
83537296|NCT05601700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537297|NCT05601700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537298|NCT05600426|Cyclosporine|cyclosporine|mesh-list
83537299|NCT05600426|Cyclophosphamide|cyclophosphamide|mesh-list
83537300|NCT05600426|Methotrexate|methotrexate|mesh-list
83537301|NCT05600426|Fludarabine|fludarabine|mesh-list
83537302|NCT05600426|Cyclosporins|cyclosporins|mesh-list
83537303|NCT05600426|Thymoglobulin|thymoglobulin|mesh-list
83537304|NCT05600426|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83537305|NCT05600426|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83537306|NCT05600426|Immunologic Factors|immunologic factors|mesh-ancestor
83537307|NCT05600426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537308|NCT05600426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83537309|NCT05600426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83537311|NCT05600426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537312|NCT05600426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537313|NCT05600426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83537314|NCT05600426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83537315|NCT05600426|Abortifacient Agents|abortifacient agents|mesh-ancestor
83537316|NCT05600426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83537317|NCT05600426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83537318|NCT05600426|Antimetabolites|antimetabolites|mesh-ancestor
83537319|NCT05600426|Dermatologic Agents|dermatologic agents|mesh-ancestor
83537320|NCT05600426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537321|NCT05600426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83537322|NCT05600426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83537323|NCT05600426|Antifungal Agents|antifungal agents|mesh-ancestor
83537324|NCT05600426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83537325|NCT05600426|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83537326|NCT05592418|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83537327|NCT05592418|Poly I-C|poly i-c|mesh-list
83537328|NCT05592418|Antiviral Agents|antiviral agents|mesh-ancestor
83537329|NCT05592418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83537330|NCT05592418|Interferon Inducers|interferon inducers|mesh-ancestor
83537331|NCT05592418|Immunologic Factors|immunologic factors|mesh-ancestor
83537332|NCT05592418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537333|NCT05590585|Emollients|emollients|mesh-list
83537334|NCT05590585|Dermatologic Agents|dermatologic agents|mesh-ancestor
83537335|NCT05585125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83537336|NCT05585125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83537337|NCT05585125|Adrenergic Agents|adrenergic agents|mesh-ancestor
83537338|NCT05585125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83537339|NCT05585125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537340|NCT05585125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537341|NCT05583552|Imetelstat|imetelstat|mesh-list
83537342|NCT05583552|Motesanib diphosphate|motesanib diphosphate|mesh-list
83537343|NCT05583552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537344|NCT05583552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537345|NCT05583552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537346|NCT05582694|UB-421|ub-421|mesh-list
83537347|NCT05582694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83537348|NCT05582694|Antiviral Agents|antiviral agents|mesh-ancestor
83537349|NCT05582694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83537350|NCT05578976|Prednisone|prednisone|mesh-list
83537351|NCT05578976|Cyclophosphamide|cyclophosphamide|mesh-list
83537352|NCT05578976|Rituximab|rituximab|mesh-list
83537353|NCT05578976|Doxorubicin|doxorubicin|mesh-list
83537354|NCT05578976|Vincristine|vincristine|mesh-list
83537355|NCT05578976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83537356|NCT05578976|Immunologic Factors|immunologic factors|mesh-ancestor
83537357|NCT05578976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537358|NCT05578976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83537359|NCT05578976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83537360|NCT05578976|Alkylating Agents|alkylating agents|mesh-ancestor
83537361|NCT05578976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537362|NCT05578976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537363|NCT05578976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83537364|NCT05578976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537365|NCT05578976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83537366|NCT05578976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83537367|NCT05578976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83537368|NCT05578976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537369|NCT05578976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83537370|NCT05578976|Glucocorticoids|glucocorticoids|mesh-ancestor
83537371|NCT05578976|Hormones|hormones|mesh-ancestor
83537372|NCT05578976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537373|NCT05578976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537374|NCT05578976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537375|NCT05578976|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537376|NCT05578976|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537377|NCT05578976|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537379|NCT05578872|Ipilimumab|ipilimumab|mesh-list
83537380|NCT05578872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537381|NCT05578872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537382|NCT05578872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537383|NCT05578872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537384|NCT05577715|Farletuzumab|farletuzumab|mesh-list
83537385|NCT05577715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537387|NCT05575063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83537388|NCT05575063|Immunologic Factors|immunologic factors|mesh-ancestor
83537389|NCT05575063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537390|NCT05575063|Viscosupplements|viscosupplements|mesh-ancestor
83537391|NCT05575063|Protective Agents|protective agents|mesh-ancestor
83537392|NCT05572684|Pembrolizumab|pembrolizumab|mesh-list
83537393|NCT05572684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537394|NCT05572684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537395|NCT05572684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537396|NCT05572684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537397|NCT05572515|Dexamethasone|dexamethasone|mesh-list
83537398|NCT05572515|Bortezomib|bortezomib|mesh-list
83537399|NCT05572515|Pomalidomide|pomalidomide|mesh-list
83537400|NCT05572515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83537401|NCT05572515|Antiemetics|antiemetics|mesh-ancestor
83537402|NCT05572515|Autonomic Agents|autonomic agents|mesh-ancestor
83537403|NCT05572515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537404|NCT05572515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537405|NCT05572515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83537406|NCT05572515|Glucocorticoids|glucocorticoids|mesh-ancestor
83537407|NCT05572515|Hormones|hormones|mesh-ancestor
83537408|NCT05572515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537409|NCT05572515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537410|NCT05572515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537411|NCT05572515|Immunologic Factors|immunologic factors|mesh-ancestor
83537412|NCT05572515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83537413|NCT05572515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83537414|NCT05572515|Growth Substances|growth substances|mesh-ancestor
83537415|NCT05572515|Growth Inhibitors|growth inhibitors|mesh-ancestor
83537416|NCT05566756|Ofatumumab|ofatumumab|mesh-list
83537417|NCT05566756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537418|NCT05564377|Leucovorin|leucovorin|mesh-list
83537419|NCT05564377|Paclitaxel|paclitaxel|mesh-list
83537420|NCT05564377|Fluorouracil|fluorouracil|mesh-list
83537421|NCT05564377|Oxaliplatin|oxaliplatin|mesh-list
83537422|NCT05564377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83537423|NCT05564377|Fulvestrant|fulvestrant|mesh-list
83537424|NCT05564377|Olaparib|olaparib|mesh-list
83537425|NCT05564377|Palbociclib|palbociclib|mesh-list
83537426|NCT05564377|Panitumumab|panitumumab|mesh-list
83537427|NCT05564377|Ipatasertib|ipatasertib|mesh-list
83537428|NCT05564377|Sotorasib|sotorasib|mesh-list
83537429|NCT05564377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83537430|NCT05564377|Antibodies|antibodies|mesh-list
83537431|NCT05564377|Immunoglobulins|immunoglobulins|mesh-list
83537432|NCT05564377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83537433|NCT05564377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537434|NCT05564377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537435|NCT05564377|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537436|NCT05564377|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537437|NCT05564377|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537438|NCT05564377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537439|NCT05564377|Immunologic Factors|immunologic factors|mesh-ancestor
83537440|NCT05564377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537441|NCT05564377|Antimetabolites|antimetabolites|mesh-ancestor
83537442|NCT05564377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83537443|NCT05564377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83537444|NCT05564377|Antidotes|antidotes|mesh-ancestor
83537445|NCT05564377|Protective Agents|protective agents|mesh-ancestor
83537446|NCT05564377|Vitamin B Complex|vitamin b complex|mesh-ancestor
83537447|NCT05564377|Vitamins|vitamins|mesh-ancestor
83537448|NCT05564377|Micronutrients|micronutrients|mesh-ancestor
83537449|NCT05564377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537450|NCT05564377|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83537451|NCT05564377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83537452|NCT05564377|Hormone Antagonists|hormone antagonists|mesh-ancestor
83537453|NCT05564377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537454|NCT05564377|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83537455|NCT05564377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537456|NCT05564377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537457|NCT05564377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537458|NCT05558150|Aceclofenac|aceclofenac|mesh-list
83537459|NCT05558150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83537460|NCT05558150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83537461|NCT05558150|Analgesics|analgesics|mesh-ancestor
83537462|NCT05558150|Sensory System Agents|sensory system agents|mesh-ancestor
83537463|NCT05558150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537464|NCT05558150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537465|NCT05558150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83537466|NCT05558150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83537467|NCT05554380|Paclitaxel|paclitaxel|mesh-list
83537468|NCT05554380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83537469|NCT05554380|Ipatasertib|ipatasertib|mesh-list
83537470|NCT05554380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537471|NCT05554380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537472|NCT05554380|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537473|NCT05554380|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537474|NCT05554380|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537475|NCT05554380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537476|NCT05554380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537477|NCT05554380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537478|NCT05552859|Insulin|insulin|mesh-list
83537479|NCT05552859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83537480|NCT05552859|Insulin Glargine|insulin glargine|mesh-list
83537481|NCT05552859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83537482|NCT05552859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537483|NCT05550532|Aticaprant|aticaprant|mesh-list
83537484|NCT05550532|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83537485|NCT05550532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537486|NCT05550532|Sensory System Agents|sensory system agents|mesh-ancestor
83537487|NCT05550532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537488|NCT05537740|Pembrolizumab|pembrolizumab|mesh-list
83537489|NCT05537740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537490|NCT05537740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537491|NCT05537740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537492|NCT05537740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537493|NCT05536791|Dabigatran|dabigatran|mesh-list
83537494|NCT05536791|Antithrombins|antithrombins|mesh-ancestor
83537495|NCT05536791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83537496|NCT05536791|Protease Inhibitors|protease inhibitors|mesh-ancestor
83537497|NCT05536791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537498|NCT05536791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537499|NCT05536791|Anticoagulants|anticoagulants|mesh-ancestor
83537500|NCT05528510|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83537501|NCT05528510|Immunologic Factors|immunologic factors|mesh-ancestor
83537502|NCT05528510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537503|NCT05521997|Cisplatin|cisplatin|mesh-list
83537504|NCT05521997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537505|NCT05521087|Cytarabine|cytarabine|mesh-list
83537506|NCT05521087|Dexamethasone|dexamethasone|mesh-list
83537507|NCT05521087|Fludarabine|fludarabine|mesh-list
83537508|NCT05521087|Vincristine|vincristine|mesh-list
83537509|NCT05521087|Pegaspargase|pegaspargase|mesh-list
83537510|NCT05521087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83537511|NCT05521087|Antiemetics|antiemetics|mesh-ancestor
83537512|NCT05521087|Autonomic Agents|autonomic agents|mesh-ancestor
83537513|NCT05521087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537514|NCT05521087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537515|NCT05521087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83537516|NCT05521087|Glucocorticoids|glucocorticoids|mesh-ancestor
83537517|NCT05521087|Hormones|hormones|mesh-ancestor
83537518|NCT05521087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537519|NCT05521087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537520|NCT05521087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537521|NCT05521087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83537522|NCT05521087|Antimetabolites|antimetabolites|mesh-ancestor
83537523|NCT05521087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537524|NCT05521087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83537525|NCT05521087|Immunologic Factors|immunologic factors|mesh-ancestor
83537526|NCT05521087|Antiviral Agents|antiviral agents|mesh-ancestor
83537527|NCT05521087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83537528|NCT05521087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537529|NCT05521087|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537530|NCT05521087|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537531|NCT05521087|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537532|NCT05518149|Aticaprant|aticaprant|mesh-list
83537533|NCT05518149|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83537534|NCT05518149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537535|NCT05518149|Sensory System Agents|sensory system agents|mesh-ancestor
83537536|NCT05518149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537537|NCT05514912|Paclitaxel|paclitaxel|mesh-list
83537538|NCT05514912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83537539|NCT05514912|Cisplatin|cisplatin|mesh-list
83537540|NCT05514912|Gemcitabine|gemcitabine|mesh-list
83537541|NCT05514912|Infigratinib|infigratinib|mesh-list
83537542|NCT05514912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537543|NCT05514912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537544|NCT05514912|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537545|NCT05514912|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537546|NCT05514912|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537547|NCT05514912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537548|NCT05514912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83537549|NCT05514912|Antimetabolites|antimetabolites|mesh-ancestor
83537550|NCT05514444|Pembrolizumab|pembrolizumab|mesh-list
83537551|NCT05514444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537552|NCT05514444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537553|NCT05514444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537554|NCT05514444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537555|NCT05507580|Upadacitinib|upadacitinib|mesh-list
83537556|NCT05507580|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83537557|NCT05507580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537558|NCT05507580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537559|NCT05507580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537560|NCT05507580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83537561|NCT05506943|Paclitaxel|paclitaxel|mesh-list
83537562|NCT05506943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537563|NCT05506943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537564|NCT05506943|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537565|NCT05506943|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537566|NCT05506943|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537567|NCT05506943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537568|NCT05502237|Paclitaxel|paclitaxel|mesh-list
83537569|NCT05502237|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83537570|NCT05502237|Carboplatin|carboplatin|mesh-list
83537571|NCT05502237|Pembrolizumab|pembrolizumab|mesh-list
83537572|NCT05502237|Pemetrexed|pemetrexed|mesh-list
83537573|NCT05502237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537574|NCT05502237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537575|NCT05502237|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537576|NCT05502237|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537577|NCT05502237|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537578|NCT05502237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537579|NCT05502237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537580|NCT05502237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537581|NCT05502237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537582|NCT05502237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83537583|NCT05502237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83537584|NCT05498428|Carboplatin|carboplatin|mesh-list
83537585|NCT05498428|Pemetrexed|pemetrexed|mesh-list
83537586|NCT05498428|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83537587|NCT05498428|Heparin|heparin|mesh-list
83537588|NCT05498428|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83537589|NCT05498428|Tinzaparin|tinzaparin|mesh-list
83537590|NCT05498428|Dalteparin|dalteparin|mesh-list
83537591|NCT05498428|Anticoagulants|anticoagulants|mesh-list
83537592|NCT05498428|Lazertinib|lazertinib|mesh-list
83537593|NCT05498428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537594|NCT05498428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537595|NCT05498428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537596|NCT05498428|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83537597|NCT05498428|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83537598|NCT05498428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83537599|NCT05498428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83537600|NCT05498428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537601|NCT05498428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537602|NCT05488314|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83537603|NCT05488314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537604|NCT05488314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537605|NCT05480384|Nivolumab|nivolumab|mesh-list
83537606|NCT05480384|Trastuzumab|trastuzumab|mesh-list
83537607|NCT05480384|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83537608|NCT05480384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537609|NCT05480384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537610|NCT05480384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537611|NCT05480384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537612|NCT05480384|Immunoconjugates|immunoconjugates|mesh-ancestor
83537613|NCT05480384|Immunologic Factors|immunologic factors|mesh-ancestor
83537614|NCT05480384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537615|NCT05467748|Pembrolizumab|pembrolizumab|mesh-list
83537616|NCT05467748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537617|NCT05467748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537618|NCT05467748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537619|NCT05467748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537620|NCT05460871|Pregabalin|pregabalin|mesh-list
83537621|NCT05460871|Analgesics|analgesics|mesh-ancestor
83537622|NCT05460871|Sensory System Agents|sensory system agents|mesh-ancestor
83537623|NCT05460871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537624|NCT05460871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537625|NCT05460871|Anticonvulsants|anticonvulsants|mesh-ancestor
83537626|NCT05460871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83537627|NCT05460871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83537628|NCT05460871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537629|NCT05460871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83537630|NCT05460871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83537631|NCT05460871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83537632|NCT05460871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83537633|NCT05460871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83537634|NCT05457998|Flutemetamol|flutemetamol|mesh-list
83537635|NCT05457998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83537636|NCT05457998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537637|NCT05455684|Aticaprant|aticaprant|mesh-list
83537638|NCT05455684|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83537639|NCT05455684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537640|NCT05455684|Sensory System Agents|sensory system agents|mesh-ancestor
83537641|NCT05455684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537642|NCT05455424|Niraparib|niraparib|mesh-list
83537643|NCT05455424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83537644|NCT05455424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537645|NCT05455424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537646|NCT05455424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537647|NCT05455320|Dexamethasone|dexamethasone|mesh-list
83537648|NCT05455320|Daratumumab|daratumumab|mesh-list
83537649|NCT05455320|Pomalidomide|pomalidomide|mesh-list
83537650|NCT05455320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83537651|NCT05455320|Antiemetics|antiemetics|mesh-ancestor
83537652|NCT05455320|Autonomic Agents|autonomic agents|mesh-ancestor
83537653|NCT05455320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537654|NCT05455320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537655|NCT05455320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83537656|NCT05455320|Glucocorticoids|glucocorticoids|mesh-ancestor
83537657|NCT05455320|Hormones|hormones|mesh-ancestor
83537658|NCT05455320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537659|NCT05455320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537660|NCT05455320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537661|NCT05455320|Immunologic Factors|immunologic factors|mesh-ancestor
83537662|NCT05455320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83537663|NCT05455320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83537664|NCT05455320|Growth Substances|growth substances|mesh-ancestor
83537665|NCT05455320|Growth Inhibitors|growth inhibitors|mesh-ancestor
83537666|NCT05453903|Cytarabine|cytarabine|mesh-list
83537667|NCT05453903|Azacitidine|azacitidine|mesh-list
83537668|NCT05453903|Daunorubicin|daunorubicin|mesh-list
83537669|NCT05453903|Venetoclax|venetoclax|mesh-list
83537670|NCT05453903|Idarubicin|idarubicin|mesh-list
83537671|NCT05453903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83537672|NCT05453903|Antimetabolites|antimetabolites|mesh-ancestor
83537673|NCT05453903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537674|NCT05453903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537675|NCT05453903|Antiviral Agents|antiviral agents|mesh-ancestor
83537677|NCT05453903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83537678|NCT05453903|Immunologic Factors|immunologic factors|mesh-ancestor
83537679|NCT05453903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537680|NCT05453903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537681|NCT05453903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83537682|NCT05453903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83537683|NCT05453903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83537684|NCT05444530|Ipilimumab|ipilimumab|mesh-list
83537685|NCT05444530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537686|NCT05444530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537687|NCT05444530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537688|NCT05444530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537689|NCT05438316|Ramipril|ramipril|mesh-list
83537690|NCT05438316|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83537691|NCT05438316|Protease Inhibitors|protease inhibitors|mesh-ancestor
83537692|NCT05438316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537693|NCT05438316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537694|NCT05438316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83537695|NCT05438043|Dexamethasone|dexamethasone|mesh-list
83537696|NCT05438043|Lenalidomide|lenalidomide|mesh-list
83537697|NCT05438043|Daratumumab|daratumumab|mesh-list
83537698|NCT05438043|Pomalidomide|pomalidomide|mesh-list
83537699|NCT05438043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83537700|NCT05438043|Antiemetics|antiemetics|mesh-ancestor
83537701|NCT05438043|Autonomic Agents|autonomic agents|mesh-ancestor
83537702|NCT05438043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537703|NCT05438043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537704|NCT05438043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83537705|NCT05438043|Glucocorticoids|glucocorticoids|mesh-ancestor
83537706|NCT05438043|Hormones|hormones|mesh-ancestor
83537707|NCT05438043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537708|NCT05438043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537709|NCT05438043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537710|NCT05438043|Immunologic Factors|immunologic factors|mesh-ancestor
83537711|NCT05438043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83537712|NCT05438043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83537713|NCT05438043|Growth Substances|growth substances|mesh-ancestor
83537714|NCT05438043|Growth Inhibitors|growth inhibitors|mesh-ancestor
83537715|NCT05429268|Lenalidomide|lenalidomide|mesh-list
83537716|NCT05429268|Immunologic Factors|immunologic factors|mesh-ancestor
83537717|NCT05429268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537718|NCT05429268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83537719|NCT05429268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83537720|NCT05429268|Growth Substances|growth substances|mesh-ancestor
83537721|NCT05429268|Growth Inhibitors|growth inhibitors|mesh-ancestor
83537722|NCT05429268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537723|NCT05426525|Empagliflozin|empagliflozin|mesh-list
83537724|NCT05426525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83537725|NCT05426525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537726|NCT05426525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83537727|NCT05426525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537728|NCT05425940|Atezolizumab|atezolizumab|mesh-list
83537729|NCT05425940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537730|NCT05425940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537731|NCT05425940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537732|NCT05425940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537733|NCT05413018|Azacitidine|azacitidine|mesh-list
83537734|NCT05413018|Cc-486|cc-486|mesh-list
83537735|NCT05413018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83537736|NCT05413018|Antimetabolites|antimetabolites|mesh-ancestor
83537737|NCT05413018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537738|NCT05413018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537739|NCT05413018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537740|NCT05403580|Olanzapine|olanzapine|mesh-list
83537741|NCT05403580|Antiemetics|antiemetics|mesh-ancestor
83537742|NCT05403580|Autonomic Agents|autonomic agents|mesh-ancestor
83537743|NCT05403580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537744|NCT05403580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537745|NCT05403580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83537746|NCT05403580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83537747|NCT05403580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83537748|NCT05403580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83537749|NCT05403580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83537750|NCT05403580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83537751|NCT05403580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83537752|NCT05403580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83537753|NCT05403580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537754|NCT05403580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83537755|NCT05403580|Serotonin Agents|serotonin agents|mesh-ancestor
83537756|NCT05403138|Daratumumab|daratumumab|mesh-list
83537757|NCT05403138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537758|NCT05389423|Prednisone|prednisone|mesh-list
83537759|NCT05389423|Cyclophosphamide|cyclophosphamide|mesh-list
83537760|NCT05389423|Rituximab|rituximab|mesh-list
83537761|NCT05389423|Doxorubicin|doxorubicin|mesh-list
83537762|NCT05389423|Etoposide|etoposide|mesh-list
83537763|NCT05389423|Vincristine|vincristine|mesh-list
83537764|NCT05389423|Pomalidomide|pomalidomide|mesh-list
83537765|NCT05389423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83537766|NCT05389423|Immunologic Factors|immunologic factors|mesh-ancestor
83537767|NCT05389423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537768|NCT05389423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83537769|NCT05389423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83537770|NCT05389423|Alkylating Agents|alkylating agents|mesh-ancestor
83537771|NCT05389423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537772|NCT05389423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537773|NCT05389423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83537774|NCT05389423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537775|NCT05389423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83537776|NCT05389423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83537777|NCT05389423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83537778|NCT05389423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537779|NCT05389423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83537780|NCT05389423|Glucocorticoids|glucocorticoids|mesh-ancestor
83537781|NCT05389423|Hormones|hormones|mesh-ancestor
83537782|NCT05389423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537783|NCT05389423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537784|NCT05389423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537785|NCT05389423|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537786|NCT05389423|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537787|NCT05389423|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537788|NCT05389423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83537789|NCT05389423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83537790|NCT05389423|Growth Substances|growth substances|mesh-ancestor
83537791|NCT05389423|Growth Inhibitors|growth inhibitors|mesh-ancestor
83537792|NCT05388669|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83537793|NCT05388669|Lazertinib|lazertinib|mesh-list
83537794|NCT05388669|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83537795|NCT05388669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537796|NCT05388669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537797|NCT05388669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537798|NCT05388669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537799|NCT05388669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537800|NCT05388669|Immunologic Factors|immunologic factors|mesh-ancestor
83537801|NCT05388669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537802|NCT05386888|Paclitaxel|paclitaxel|mesh-list
83537803|NCT05386888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83537804|NCT05386888|Carboplatin|carboplatin|mesh-list
83537805|NCT05386888|Pemetrexed|pemetrexed|mesh-list
83537806|NCT05386888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83537807|NCT05386888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537808|NCT05386888|Tubulin Modulators|tubulin modulators|mesh-ancestor
83537809|NCT05386888|Antimitotic Agents|antimitotic agents|mesh-ancestor
83537810|NCT05386888|Mitosis Modulators|mitosis modulators|mesh-ancestor
83537811|NCT05386888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537812|NCT05386888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537813|NCT05386888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83537814|NCT05386888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83537815|NCT05379595|Leucovorin|leucovorin|mesh-list
83537816|NCT05379595|Fluorouracil|fluorouracil|mesh-list
83537817|NCT05379595|Oxaliplatin|oxaliplatin|mesh-list
83537818|NCT05379595|Irinotecan|irinotecan|mesh-list
83537819|NCT05379595|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83537820|NCT05379595|Antimetabolites|antimetabolites|mesh-ancestor
83537821|NCT05379595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537822|NCT05379595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83537823|NCT05379595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537824|NCT05379595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83537825|NCT05379595|Immunologic Factors|immunologic factors|mesh-ancestor
83537826|NCT05379595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537827|NCT05379595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83537828|NCT05379595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83537829|NCT05379595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537830|NCT05379595|Antidotes|antidotes|mesh-ancestor
83537831|NCT05379595|Protective Agents|protective agents|mesh-ancestor
83537832|NCT05379595|Vitamin B Complex|vitamin b complex|mesh-ancestor
83537833|NCT05379595|Vitamins|vitamins|mesh-ancestor
83537834|NCT05379595|Micronutrients|micronutrients|mesh-ancestor
83537835|NCT05379595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537836|NCT05375994|Adagrasib|adagrasib|mesh-list
83537837|NCT05375994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537838|NCT05375929|Abrocitinib|abrocitinib|mesh-list
83537839|NCT05375929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537840|NCT05375929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537841|NCT05375929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537842|NCT05375825|LMB-100|lmb-100|mesh-list
83537843|NCT05375825|Immunoconjugates|immunoconjugates|mesh-ancestor
83537844|NCT05375825|Immunologic Factors|immunologic factors|mesh-ancestor
83537845|NCT05375825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537846|NCT05371054|Prednisone|prednisone|mesh-list
83537847|NCT05371054|Venetoclax|venetoclax|mesh-list
83537848|NCT05371054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83537849|NCT05371054|Glucocorticoids|glucocorticoids|mesh-ancestor
83537850|NCT05371054|Hormones|hormones|mesh-ancestor
83537851|NCT05371054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537852|NCT05371054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537853|NCT05371054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537854|NCT05371054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537855|NCT05367440|Abiraterone Acetate|abiraterone acetate|mesh-list
83537856|NCT05367440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537857|NCT05367440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83537858|NCT05367440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537859|NCT05367440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537860|NCT05367440|Hormone Antagonists|hormone antagonists|mesh-ancestor
83413645|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83537861|NCT05367440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537862|NCT05367440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537863|NCT05367440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83537864|NCT05364944|Octreotide|octreotide|mesh-list
83537865|NCT05364944|Lanreotide|lanreotide|mesh-list
83537866|NCT05364944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83537867|NCT05364944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83537868|NCT05364944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537869|NCT05353140|Aspirin|aspirin|mesh-list
83537870|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
83537871|NCT05353140|Clopidogrel|clopidogrel|mesh-list
83537872|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83537873|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83537874|NCT05353140|Analgesics|analgesics|mesh-ancestor
83537875|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
83537876|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537877|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537878|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83537879|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83537880|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83537881|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83537882|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537883|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83537884|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83537885|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537886|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
83537887|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83537888|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83537889|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83537890|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
83537891|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83537892|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83537893|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
83537894|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83537895|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
83537896|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
83537897|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83537898|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83537899|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83537900|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83537901|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537902|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
83537903|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83537904|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537906|NCT05351801|Nabiximols|nabiximols|mesh-list
83537907|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
83537908|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537909|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83537910|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83537911|NCT05351801|Analgesics|analgesics|mesh-ancestor
83537912|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
83537913|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83537914|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83537915|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83537916|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83537917|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537918|NCT05351801|Hormones|hormones|mesh-ancestor
83538069|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
83537919|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83537920|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
83537921|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83537922|NCT05350774|Antibodies|antibodies|mesh-list
83537923|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
83537924|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83537925|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
83537926|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537927|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
83537928|NCT05347485|Fludarabine|fludarabine|mesh-list
83537929|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83537930|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
83537931|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537932|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83537933|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83537934|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
83537935|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537936|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537937|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83537938|NCT05346393|Terlipressin|terlipressin|mesh-list
83537939|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83537940|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83537941|NCT05340465|Iron|iron|mesh-list
83537942|NCT05340465|Dextrans|dextrans|mesh-list
83537943|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
83537944|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83537945|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
83537946|NCT05340465|Trace Elements|trace elements|mesh-ancestor
83537947|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
83537948|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537949|NCT05340465|Hematinics|hematinics|mesh-ancestor
83537950|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83537951|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83537952|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
83537953|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
83537954|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
83537955|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83537956|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537957|NCT05338775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537958|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537959|NCT05337137|Bevacizumab|bevacizumab|mesh-list
83537960|NCT05337137|Nivolumab|nivolumab|mesh-list
83537961|NCT05337137|Relatlimab|relatlimab|mesh-list
83537962|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537963|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537964|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83537965|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83537966|NCT05337137|Growth Substances|growth substances|mesh-ancestor
83537967|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537968|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
83537969|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537970|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537971|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
83537972|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
83537973|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83537974|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83537975|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
83537976|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83537977|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537978|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537979|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
83537980|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83537981|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537982|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83537983|NCT05308446|Nivolumab|nivolumab|mesh-list
83537984|NCT05308446|Cetuximab|cetuximab|mesh-list
83537985|NCT05308446|Antibodies|antibodies|mesh-list
83537986|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
83537987|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83537988|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
83537989|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83537990|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537991|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83537992|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537993|NCT05303090|Lenvatinib|lenvatinib|mesh-list
83537994|NCT05303090|Tislelizumab|tislelizumab|mesh-list
83537995|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83537996|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83537997|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537998|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537999|NCT05303090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538000|NCT05303064|Olanzapine|olanzapine|mesh-list
83538001|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
83538002|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
83538003|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538004|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538005|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83538006|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83538007|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83538008|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83538009|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83538010|NCT05303064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83538011|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83538012|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83538013|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538014|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83538015|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
83538016|NCT05296798|Paclitaxel|paclitaxel|mesh-list
83538017|NCT05296798|Docetaxel|docetaxel|mesh-list
83538018|NCT05296798|Trastuzumab|trastuzumab|mesh-list
83538019|NCT05296798|Pertuzumab|pertuzumab|mesh-list
83538020|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83538021|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538022|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
83538023|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
83538024|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
83538025|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538026|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538027|NCT05286827|Olaparib|olaparib|mesh-list
83538028|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83538029|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538030|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538031|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538032|NCT05284747|Evolocumab|evolocumab|mesh-list
83538033|NCT05284747|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83538034|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83538035|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83538036|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
83538037|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538038|NCT05284747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83538039|NCT05284747|Protease Inhibitors|protease inhibitors|mesh-ancestor
83538040|NCT05284747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538041|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83538042|NCT05283304|Buprenorphine|buprenorphine|mesh-list
83538043|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83538044|NCT05283304|Narcotics|narcotics|mesh-ancestor
83538045|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83538046|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538047|NCT05283304|Analgesics|analgesics|mesh-ancestor
83538048|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
83538049|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538050|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83538051|NCT05275023|Tenofovir|tenofovir|mesh-list
83538052|NCT05275023|Entecavir|entecavir|mesh-list
83538053|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83538054|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
83538055|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83538056|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83538057|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83538058|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538059|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538060|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83538061|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83538062|NCT05275023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538063|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538064|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83538065|NCT05263388|Hormones|hormones|mesh-ancestor
83538066|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538067|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538068|NCT05259943|Psilocybin|psilocybin|mesh-list
83538070|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538071|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83538072|NCT05255991|Treprostinil|treprostinil|mesh-list
83538073|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83538074|NCT05252533|Ustekinumab|ustekinumab|mesh-list
83538075|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
83538076|NCT05251948|Capecitabine|capecitabine|mesh-list
83538077|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
83538078|NCT05251948|Atezolizumab|atezolizumab|mesh-list
83538079|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83538080|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
83538081|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538082|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538083|NCT05251948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538084|NCT05251948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538085|NCT05250973|Dexamethasone|dexamethasone|mesh-list
83538086|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
83538087|NCT05250973|Bortezomib|bortezomib|mesh-list
83538088|NCT05250973|Daratumumab|daratumumab|mesh-list
83538089|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538090|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
83538091|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538092|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83538093|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83538094|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
83538095|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538096|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538097|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83538098|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538099|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
83538100|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
83538101|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538102|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83538103|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
83538104|NCT05250973|Hormones|hormones|mesh-ancestor
83538105|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538106|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83538107|NCT05243329|Psilocybin|psilocybin|mesh-list
83538108|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
83538109|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538110|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83538111|NCT05242484|Golimumab|golimumab|mesh-list
83538112|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83538113|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538114|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538115|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
83538116|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538117|NCT05242471|Golimumab|golimumab|mesh-list
83538118|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83538119|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538120|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538121|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
83538122|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538123|NCT05237297|Celecoxib|celecoxib|mesh-list
83538124|NCT05237297|Naproxen|naproxen|mesh-list
83538125|NCT05237297|Aceclofenac|aceclofenac|mesh-list
83538126|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83538127|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83538128|NCT05237297|Analgesics|analgesics|mesh-ancestor
83538129|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
83538130|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538131|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538132|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538133|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83538134|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83538135|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83538136|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538137|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538138|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
83538139|NCT05224102|Faricimab|faricimab|mesh-list
83538140|NCT05224102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83538141|NCT05224102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83538142|NCT05224102|Growth Substances|growth substances|mesh-ancestor
83538143|NCT05224102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538144|NCT05224102|Growth Inhibitors|growth inhibitors|mesh-ancestor
83538145|NCT05224102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538148|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538149|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83538150|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83538151|NCT05222555|Growth Substances|growth substances|mesh-ancestor
83538152|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
83538153|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538154|NCT05218499|Doxorubicin|doxorubicin|mesh-list
83538155|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83538156|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538157|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83538158|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83538159|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538160|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538161|NCT05216952|Misoprostol|misoprostol|mesh-list
83538162|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
83538163|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83538164|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
83538165|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83538166|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538167|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83538168|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83538169|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
83538170|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83538171|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
83538172|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83538173|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
83538174|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538175|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538176|NCT05215340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538177|NCT05215340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538178|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
83538179|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83538180|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
83538181|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538182|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538183|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83538184|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
83538185|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83538186|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
83538187|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538188|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83538189|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83538190|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
83538191|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
83538192|NCT05213676|Protective Agents|protective agents|mesh-ancestor
83538193|NCT05206110|Ketorolac|ketorolac|mesh-list
83538194|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83538195|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83538196|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83538197|NCT05206110|Analgesics|analgesics|mesh-ancestor
83538198|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
83538199|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538200|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538201|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538202|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83538203|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83538204|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538205|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538206|NCT05201183|Fludarabine|fludarabine|mesh-list
83538207|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538208|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83538209|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
83538210|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538211|NCT05190770|Triamcinolone|triamcinolone|mesh-list
83538212|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83538213|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83538214|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83538215|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538216|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
83538218|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538219|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538220|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538221|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
83538222|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538223|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538224|NCT05185947|Paclitaxel|paclitaxel|mesh-list
83538225|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83538226|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538227|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
83538228|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
83538229|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
83538230|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538231|NCT05183412|Methamphetamine|methamphetamine|mesh-list
83538232|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83538233|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538234|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
83538235|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
83538236|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538237|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
83538238|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83538239|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538240|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
83538241|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83538242|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83538243|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83538244|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83538245|NCT05179876|Selexipag|selexipag|mesh-list
83538246|NCT05179876|Tadalafil|tadalafil|mesh-list
83538247|NCT05179876|Macitentan|macitentan|mesh-list
83538248|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
83538249|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83538250|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83538251|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538252|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538253|NCT05179876|Urological Agents|urological agents|mesh-ancestor
83538254|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83538255|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83538256|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83538257|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83538258|NCT05176483|Nivolumab|nivolumab|mesh-list
83538259|NCT05176483|Ipilimumab|ipilimumab|mesh-list
83538260|NCT05176483|Relatlimab|relatlimab|mesh-list
83538261|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538262|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538263|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538264|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538265|NCT05176288|Palbociclib|palbociclib|mesh-list
83538266|NCT05176288|Avelumab|avelumab|mesh-list
83538267|NCT05176288|Axitinib|axitinib|mesh-list
83538268|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538269|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83538270|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538271|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538272|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538273|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
83538274|NCT05172258|Ipatasertib|ipatasertib|mesh-list
83538275|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538276|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538277|NCT05172258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538278|NCT05172258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538279|NCT05172258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83538280|NCT05172258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538281|NCT05172245|Cisplatin|cisplatin|mesh-list
83538282|NCT05172245|Ipatasertib|ipatasertib|mesh-list
83538283|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538284|NCT05172245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83538285|NCT05172245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538286|NCT05172245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538287|NCT05171777|Atezolizumab|atezolizumab|mesh-list
83538288|NCT05171777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538289|NCT05171777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538290|NCT05171777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538291|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538292|NCT05170204|Durvalumab|durvalumab|mesh-list
83538293|NCT05170204|Pralsetinib|pralsetinib|mesh-list
83538294|NCT05170204|Entrectinib|entrectinib|mesh-list
83538295|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538296|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538297|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83538298|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538299|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538301|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83538302|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83538303|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538304|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83538305|NCT05155709|Azacitidine|azacitidine|mesh-list
83538306|NCT05155709|Venetoclax|venetoclax|mesh-list
83538307|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83538308|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
83538309|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538310|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538311|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538312|NCT05155293|Aflibercept|aflibercept|mesh-list
83538313|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83538314|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83538315|NCT05155293|Growth Substances|growth substances|mesh-ancestor
83538316|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538317|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
83538318|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538319|NCT05154747|Rilpivirine|rilpivirine|mesh-list
83538320|NCT05154747|Cabotegravir|cabotegravir|mesh-list
83538321|NCT05154747|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
83538322|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83538323|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83538324|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538325|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538326|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
83538327|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83538328|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83538329|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83538330|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83538331|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83538332|NCT05151640|Nintedanib|nintedanib|mesh-list
83538333|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538334|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83538335|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538336|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538337|NCT05146739|Leucovorin|leucovorin|mesh-list
83538338|NCT05146739|Cytarabine|cytarabine|mesh-list
83538339|NCT05146739|Fludarabine|fludarabine|mesh-list
83538340|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538341|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83538342|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
83538343|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538344|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538345|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
83538346|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538347|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
83538348|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83538349|NCT05146739|Antidotes|antidotes|mesh-ancestor
83538350|NCT05146739|Protective Agents|protective agents|mesh-ancestor
83538351|NCT05146739|Vitamin B Complex|vitamin b complex|mesh-ancestor
83538352|NCT05146739|Vitamins|vitamins|mesh-ancestor
83538353|NCT05146739|Micronutrients|micronutrients|mesh-ancestor
83538354|NCT05144243|Azacitidine|azacitidine|mesh-list
83538355|NCT05144243|Venetoclax|venetoclax|mesh-list
83538356|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83538357|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
83538358|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538359|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538360|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538361|NCT05143281|Dexamethasone|dexamethasone|mesh-list
83538362|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
83538363|NCT05143281|BB 1101|bb 1101|mesh-list
83538364|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538365|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
83538366|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
83538367|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538368|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538369|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83538370|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
83538371|NCT05143281|Hormones|hormones|mesh-ancestor
83538446|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
83538372|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538373|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83538374|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538375|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
83538376|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538377|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538378|NCT05139238|Labetalol|labetalol|mesh-list
83538379|NCT05139238|Nifedipine|nifedipine|mesh-list
83538380|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83538381|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83538382|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538383|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83538384|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538385|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
83538386|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
83538387|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83538388|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83538389|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83538390|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
83538391|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83538392|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83538393|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
83538394|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
83538395|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538396|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83538397|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83538398|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
83538399|NCT05138614|Narcotics|narcotics|mesh-ancestor
83538400|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83538401|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538402|NCT05138614|Analgesics|analgesics|mesh-ancestor
83538403|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
83538404|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538405|NCT05132439|Metformin|metformin|mesh-list
83538406|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83538407|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538408|NCT05123599|Tenofovir|tenofovir|mesh-list
83538409|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
83538410|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83538411|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83538412|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83538413|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538414|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538415|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83538416|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83538417|NCT05120141|Listerine|listerine|mesh-list
83538418|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83538419|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83538420|NCT05119907|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83538421|NCT05119907|Immunoconjugates|immunoconjugates|mesh-ancestor
83538422|NCT05119907|Immunologic Factors|immunologic factors|mesh-ancestor
83538423|NCT05119907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538424|NCT05111626|Nivolumab|nivolumab|mesh-list
83538425|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
83538426|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538427|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538428|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538429|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538430|NCT05103904|Lenvatinib|lenvatinib|mesh-list
83538431|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538432|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83538433|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538434|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538435|NCT05093582|Cromakalim|cromakalim|mesh-list
83538436|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83538437|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83538438|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
83538439|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538440|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538441|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83538442|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
83538443|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
83538444|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
83538445|NCT05092269|Ustekinumab|ustekinumab|mesh-list
83538448|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538449|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
83538450|NCT05090384|Hormones|hormones|mesh-ancestor
83538451|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538452|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538453|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83538454|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538455|NCT05089734|Docetaxel|docetaxel|mesh-list
83538456|NCT05089734|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83538457|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538458|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
83538459|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
83538460|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
83538461|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538462|NCT05089734|Immunoconjugates|immunoconjugates|mesh-ancestor
83538463|NCT05089734|Immunologic Factors|immunologic factors|mesh-ancestor
83538464|NCT05089734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538465|NCT05087992|Bevacizumab|bevacizumab|mesh-list
83538466|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538467|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538468|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83538469|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83538470|NCT05087992|Growth Substances|growth substances|mesh-ancestor
83538471|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538472|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
83538473|NCT05086692|Pembrolizumab|pembrolizumab|mesh-list
83538474|NCT05086692|Interleukin-2|interleukin-2|mesh-list
83538475|NCT05086692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538476|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538477|NCT05086692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538478|NCT05086692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538479|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83538480|NCT05086692|Analgesics|analgesics|mesh-ancestor
83538481|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
83538482|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538483|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538484|NCT05083182|Ustekinumab|ustekinumab|mesh-list
83538485|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
83538486|NCT05083169|Dexamethasone|dexamethasone|mesh-list
83538487|NCT05083169|Bortezomib|bortezomib|mesh-list
83538488|NCT05083169|Daratumumab|daratumumab|mesh-list
83538489|NCT05083169|Pomalidomide|pomalidomide|mesh-list
83538490|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538491|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
83538492|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
83538493|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538494|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538495|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83538496|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
83538497|NCT05083169|Hormones|hormones|mesh-ancestor
83538498|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538499|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83538500|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538501|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
83538502|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83538503|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83538504|NCT05083169|Growth Substances|growth substances|mesh-ancestor
83538505|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
83538506|NCT05071664|Golimumab|golimumab|mesh-list
83538507|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83538508|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538509|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538510|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
83538511|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538512|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
83538513|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538514|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83538515|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538516|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538517|NCT05067283|Leucovorin|leucovorin|mesh-list
83538518|NCT05067283|Carboplatin|carboplatin|mesh-list
83538519|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
83538520|NCT05067283|Fluorouracil|fluorouracil|mesh-list
83538521|NCT05067283|Oxaliplatin|oxaliplatin|mesh-list
83538522|NCT05067283|Pemetrexed|pemetrexed|mesh-list
83538523|NCT05067283|Cetuximab|cetuximab|mesh-list
83538524|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538525|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538526|NCT05067283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538527|NCT05067283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538528|NCT05067283|Antimetabolites|antimetabolites|mesh-ancestor
83538529|NCT05067283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83538530|NCT05067283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538531|NCT05067283|Immunologic Factors|immunologic factors|mesh-ancestor
83538532|NCT05067283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538533|NCT05067283|Antidotes|antidotes|mesh-ancestor
83538534|NCT05067283|Protective Agents|protective agents|mesh-ancestor
83538535|NCT05067283|Vitamin B Complex|vitamin b complex|mesh-ancestor
83538536|NCT05067283|Vitamins|vitamins|mesh-ancestor
83538537|NCT05067283|Micronutrients|micronutrients|mesh-ancestor
83538538|NCT05067283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538539|NCT05067283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83538540|NCT05067283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83538541|NCT05065190|Nintedanib|nintedanib|mesh-list
83538542|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538543|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83538544|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538545|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538546|NCT05062889|Leucovorin|leucovorin|mesh-list
83538547|NCT05062889|Trifluridine|trifluridine|mesh-list
83538548|NCT05062889|Fluorouracil|fluorouracil|mesh-list
83538549|NCT05062889|Capecitabine|capecitabine|mesh-list
83538550|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
83538551|NCT05062889|Irinotecan|irinotecan|mesh-list
83538552|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
83538553|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
83538554|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538555|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83538556|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538557|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538558|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
83538559|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538560|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83538561|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83538562|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538563|NCT05062889|Antidotes|antidotes|mesh-ancestor
83538564|NCT05062889|Protective Agents|protective agents|mesh-ancestor
83538565|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
83538566|NCT05062889|Vitamins|vitamins|mesh-ancestor
83538567|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
83538568|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
83538569|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83538570|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
83538571|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538572|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538573|NCT05050097|Lenalidomide|lenalidomide|mesh-list
83538574|NCT05050097|Pomalidomide|pomalidomide|mesh-list
83538575|NCT05050097|Daratumumab|daratumumab|mesh-list
83538576|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
83538577|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538578|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83538579|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83538580|NCT05050097|Growth Substances|growth substances|mesh-ancestor
83538581|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
83538582|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538583|NCT05045703|Vitamin A|vitamin a|mesh-list
83538584|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
83538585|NCT05045703|Vitamins|vitamins|mesh-ancestor
83538586|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
83538587|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538588|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
83538589|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538590|NCT05045703|Protective Agents|protective agents|mesh-ancestor
83538591|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83538592|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538593|NCT05029921|Ustekinumab|ustekinumab|mesh-list
83538594|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
83538595|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
83538596|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83538597|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83538598|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83538599|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83538600|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538601|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
83538602|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83538603|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538604|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83538605|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538606|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
83538607|NCT05027945|Sirolimus|sirolimus|mesh-list
83538608|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
83538609|NCT05027945|Busulfan|busulfan|mesh-list
83538610|NCT05027945|Fludarabine|fludarabine|mesh-list
83538611|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538612|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
83538613|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538614|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83538615|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83538616|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
83538617|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538618|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538619|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83538620|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83538621|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83538622|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
83538623|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83538624|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83538625|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538626|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
83538627|NCT05024773|Paclitaxel|paclitaxel|mesh-list
83538628|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
83538629|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83538630|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538631|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
83538632|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
83538633|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
83538634|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538635|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83538636|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
83538637|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538638|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
83538639|NCT05024773|Protective Agents|protective agents|mesh-ancestor
83538640|NCT05020236|Dexamethasone|dexamethasone|mesh-list
83538641|NCT05020236|Daratumumab|daratumumab|mesh-list
83538642|NCT05020236|Pomalidomide|pomalidomide|mesh-list
83538643|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538644|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
83538645|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
83538646|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538647|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538648|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83538649|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
83538650|NCT05020236|Hormones|hormones|mesh-ancestor
83538651|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538652|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83538653|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538654|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
83538655|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83538656|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83538657|NCT05020236|Growth Substances|growth substances|mesh-ancestor
83538658|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
83538659|NCT05019716|Cisplatin|cisplatin|mesh-list
83538660|NCT05019716|Etoposide|etoposide|mesh-list
83538661|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
83538662|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
83538663|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538664|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83538665|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83538666|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83538667|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538668|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538669|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
83538670|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
83538671|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
83538672|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
83538673|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
83538674|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83538675|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83538676|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538677|NCT05005728|Carboplatin|carboplatin|mesh-list
83538678|NCT05005728|Docetaxel|docetaxel|mesh-list
83538680|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538681|NCT05005728|Tubulin Modulators|tubulin modulators|mesh-ancestor
83538682|NCT05005728|Antimitotic Agents|antimitotic agents|mesh-ancestor
83538683|NCT05005728|Mitosis Modulators|mitosis modulators|mesh-ancestor
83538684|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538685|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83538686|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538687|NCT05001880|Bevacizumab|bevacizumab|mesh-list
83538688|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83538689|NCT05001880|Atezolizumab|atezolizumab|mesh-list
83538690|NCT05001880|Carboplatin|carboplatin|mesh-list
83538691|NCT05001880|Pemetrexed|pemetrexed|mesh-list
83538692|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
83538693|NCT05001880|Antibodies|antibodies|mesh-list
83538694|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
83538695|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83538696|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
83538697|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538698|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83538699|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83538700|NCT05001880|Growth Substances|growth substances|mesh-ancestor
83538701|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538702|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
83538703|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
83538704|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538705|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538706|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83538707|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83538708|NCT05001880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538709|NCT04994717|Blinatumomab|blinatumomab|mesh-list
83538710|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538711|NCT04992507|Anesthetics|anesthetics|mesh-list
83538712|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83538713|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538714|NCT04990037|Folfirinox|folfirinox|mesh-list
83538715|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538716|NCT04989816|Trastuzumab|trastuzumab|mesh-list
83538717|NCT04989816|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83538718|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538719|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538720|NCT04989816|Immunoconjugates|immunoconjugates|mesh-ancestor
83538721|NCT04989816|Immunologic Factors|immunologic factors|mesh-ancestor
83538722|NCT04989816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538723|NCT04987203|Nivolumab|nivolumab|mesh-list
83538724|NCT04987203|Tivozanib|tivozanib|mesh-list
83538725|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538726|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538727|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538728|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538729|NCT04987203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83538730|NCT04987203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538731|NCT04973254|Rilpivirine|rilpivirine|mesh-list
83538732|NCT04973254|Cabotegravir|cabotegravir|mesh-list
83538733|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83538734|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83538735|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538736|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538737|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
83538738|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83538739|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83538740|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83538741|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83538742|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83538743|NCT04956640|Carboplatin|carboplatin|mesh-list
83538744|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
83538745|NCT04956640|Pemetrexed|pemetrexed|mesh-list
83538746|NCT04956640|Cetuximab|cetuximab|mesh-list
83538747|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538748|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538749|NCT04956640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538750|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538751|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538752|NCT04956640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83538753|NCT04956640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83538754|NCT04949828|Pancrelipase|pancrelipase|mesh-list
83538755|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83538757|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538758|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538759|NCT04949191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538760|NCT04949191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538762|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83538763|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83538764|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
83538765|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83538766|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538767|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538768|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83538769|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83538770|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83538771|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83538772|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83538773|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
83538774|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83538775|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83538776|NCT04928846|Docetaxel|docetaxel|mesh-list
83538777|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538778|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
83538779|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
83538780|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
83538781|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538782|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
83538783|NCT04927884|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83538784|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538785|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
83538786|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538787|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83538788|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83538789|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
83538790|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538791|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538792|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83538793|NCT04927884|Immunoconjugates|immunoconjugates|mesh-ancestor
83538794|NCT04923893|Dexamethasone|dexamethasone|mesh-list
83538795|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
83538796|NCT04923893|Fludarabine|fludarabine|mesh-list
83538797|NCT04923893|Lenalidomide|lenalidomide|mesh-list
83538798|NCT04923893|Bortezomib|bortezomib|mesh-list
83538799|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538800|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
83538801|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538802|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83538803|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83538804|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
83538805|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538806|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538807|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83538808|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83538810|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
83538811|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83538812|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83538813|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
83538814|NCT04923893|Hormones|hormones|mesh-ancestor
83538815|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538816|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83538817|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83538818|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83538819|NCT04923893|Growth Substances|growth substances|mesh-ancestor
83538820|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
83538821|NCT04915183|Atorvastatin|atorvastatin|mesh-list
83538822|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83538823|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83538824|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
83538825|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538826|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83538827|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83538828|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538829|NCT04910386|Cisplatin|cisplatin|mesh-list
83538830|NCT04910386|Gemcitabine|gemcitabine|mesh-list
83538831|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538832|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83538834|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538835|NCT04905693|Treprostinil|treprostinil|mesh-list
83538836|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83538837|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
83538838|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538839|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538840|NCT04895722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538841|NCT04895722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538842|NCT04895709|Docetaxel|docetaxel|mesh-list
83538843|NCT04895709|Nivolumab|nivolumab|mesh-list
83538844|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538845|NCT04895709|Tubulin Modulators|tubulin modulators|mesh-ancestor
83538846|NCT04895709|Antimitotic Agents|antimitotic agents|mesh-ancestor
83538847|NCT04895709|Mitosis Modulators|mitosis modulators|mesh-ancestor
83538848|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538849|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538850|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538851|NCT04895436|Venetoclax|venetoclax|mesh-list
83538852|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
83538853|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538854|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538855|NCT04890093|Vincristine|vincristine|mesh-list
83538856|NCT04890093|Temozolomide|temozolomide|mesh-list
83538857|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83538858|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538859|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
83538860|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
83538861|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
83538862|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538863|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83538864|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
83538865|NCT04882072|Ustekinumab|ustekinumab|mesh-list
83538866|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
83538867|NCT04873362|Trastuzumab|trastuzumab|mesh-list
83538868|NCT04873362|Atezolizumab|atezolizumab|mesh-list
83538869|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83538870|NCT04873362|Maytansine|maytansine|mesh-list
83538871|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538872|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538873|NCT04873362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538874|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538875|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83538876|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
83538877|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
83538878|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
83538879|NCT04873362|Immunotoxins|immunotoxins|mesh-ancestor
83538880|NCT04873362|Immunoconjugates|immunoconjugates|mesh-ancestor
83538881|NCT04873362|Immunologic Factors|immunologic factors|mesh-ancestor
83538882|NCT04873362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538884|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
83538885|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538886|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
83538887|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83538888|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83538889|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83538890|NCT04865029|Estradiol|estradiol|mesh-list
83538891|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83538892|NCT04865029|Progesterone|progesterone|mesh-list
83538893|NCT04865029|Estrogens|estrogens|mesh-ancestor
83538894|NCT04865029|Hormones|hormones|mesh-ancestor
83538895|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538896|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538897|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83538898|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
83538899|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83538900|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83538901|NCT04865029|Progestins|progestins|mesh-ancestor
83538902|NCT04859660|Tamsulosin|tamsulosin|mesh-list
83538903|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83538904|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83538905|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83538906|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
83538907|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83538908|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538909|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538910|NCT04859660|Urological Agents|urological agents|mesh-ancestor
83538911|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
83538912|NCT04847063|Doxorubicin|doxorubicin|mesh-list
83538913|NCT04847063|Fluorouracil|fluorouracil|mesh-list
83538914|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
83538916|NCT04847063|Mitomycin|mitomycin|mesh-list
83538917|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538918|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83538919|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83538920|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83538921|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538922|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538923|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
83538924|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83538925|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83538926|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
83538927|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538928|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
83538929|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83538930|NCT04847063|Antidotes|antidotes|mesh-ancestor
83538931|NCT04847063|Protective Agents|protective agents|mesh-ancestor
83538932|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
83538933|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
83538934|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83538935|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83538936|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
83538937|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
83538938|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83538939|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
83538940|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83538941|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
83538942|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83538943|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538944|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538945|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83538946|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538947|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
83538948|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538949|NCT04829318|Esketamine|esketamine|mesh-list
83538950|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
83538951|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83538952|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
83538953|NCT04828486|Futibatinib|futibatinib|mesh-list
83538954|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538955|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538956|NCT04828486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538957|NCT04828486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538958|NCT04826341|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83538959|NCT04826341|Immunoconjugates|immunoconjugates|mesh-ancestor
83538960|NCT04826341|Immunologic Factors|immunologic factors|mesh-ancestor
83538961|NCT04826341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538962|NCT04807517|Buspirone|buspirone|mesh-list
83538963|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83538964|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83538965|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83538966|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538967|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83538968|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83538969|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
83538970|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83538971|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538972|NCT04806919|Progesterone|progesterone|mesh-list
83538973|NCT04806919|Progestins|progestins|mesh-ancestor
83538974|NCT04806919|Hormones|hormones|mesh-ancestor
83538975|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538976|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538977|NCT04805957|Sulforaphane|sulforaphane|mesh-list
83538978|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83538979|NCT04805957|Protective Agents|protective agents|mesh-ancestor
83538980|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538981|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538982|NCT04797780|Azacitidine|azacitidine|mesh-list
83538983|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83538984|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
83538985|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538986|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538987|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83538988|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
83538989|NCT04796779|Trace Elements|trace elements|mesh-ancestor
83538990|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
83538991|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83538992|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
83538993|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83538994|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83538995|NCT04793815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83538996|NCT04793815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83538997|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
83538998|NCT04789408|Fludarabine|fludarabine|mesh-list
83538999|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83539000|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
83539001|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539002|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539003|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83539004|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
83539005|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539006|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539007|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83539008|NCT04775082|Liraglutide|liraglutide|mesh-list
83539009|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83539010|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539011|NCT04775082|Incretins|incretins|mesh-ancestor
83539012|NCT04775082|Hormones|hormones|mesh-ancestor
83539013|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539014|NCT04762888|Edetic Acid|edetic acid|mesh-list
83539015|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83539016|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
83539017|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
83539018|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539019|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
83539020|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83539021|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83539022|NCT04762134|Doxycycline|doxycycline|mesh-list
83539023|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83539024|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539025|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
83539026|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83539027|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83539028|NCT04759586|Prednisone|prednisone|mesh-list
83539029|NCT04759586|Prednisolone|prednisolone|mesh-list
83539030|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83539031|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
83539032|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83539033|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
83539034|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
83539035|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83539036|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83539037|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83539038|NCT04759586|Cortisone|cortisone|mesh-list
83539039|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
83539040|NCT04759586|Rituximab|rituximab|mesh-list
83539041|NCT04759586|Doxorubicin|doxorubicin|mesh-list
83539042|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83539043|NCT04759586|Nivolumab|nivolumab|mesh-list
83539044|NCT04759586|Etoposide|etoposide|mesh-list
83539045|NCT04759586|Vincristine|vincristine|mesh-list
83539046|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
83539047|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83539048|NCT04759586|Antibodies|antibodies|mesh-list
83539049|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
83539050|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83539051|NCT04759586|Lenograstim|lenograstim|mesh-list
83539052|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83539053|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
83539054|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83539055|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
83539056|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539057|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539058|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83539059|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
83539060|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539061|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539062|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83539063|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83539064|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83539065|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83539066|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539067|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83539069|NCT04759586|Hormones|hormones|mesh-ancestor
83539070|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539071|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83539072|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539073|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83539074|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83539075|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
83539076|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
83539077|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
83539078|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
83539079|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
83539080|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539081|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83539082|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83539083|NCT04759586|Protective Agents|protective agents|mesh-ancestor
83539084|NCT04743934|Androgens|androgens|mesh-list
83539085|NCT04743934|Hormones|hormones|mesh-ancestor
83539086|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539087|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539088|NCT04739813|Prednisone|prednisone|mesh-list
83539089|NCT04739813|Lenalidomide|lenalidomide|mesh-list
83539090|NCT04739813|Venetoclax|venetoclax|mesh-list
83539091|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
83539092|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83539093|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
83539094|NCT04739813|Hormones|hormones|mesh-ancestor
83539095|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539096|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539097|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83539098|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539099|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
83539100|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83539101|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83539102|NCT04739813|Growth Substances|growth substances|mesh-ancestor
83539103|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
83539104|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539105|NCT04736329|Telmisartan|telmisartan|mesh-list
83539106|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83539107|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83539108|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83539109|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539111|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
83539112|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83539113|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83539114|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539115|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539116|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539117|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539118|NCT04730544|Nivolumab|nivolumab|mesh-list
83539119|NCT04730544|Ipilimumab|ipilimumab|mesh-list
83539120|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539121|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539122|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539123|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539124|NCT04729959|Atezolizumab|atezolizumab|mesh-list
83539125|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
83539126|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83539127|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
83539128|NCT04729959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539129|NCT04729959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539130|NCT04729959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539131|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539132|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
83539133|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539134|NCT04721548|Minoxidil|minoxidil|mesh-list
83539135|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83539136|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
83539137|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83539138|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
83539139|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83539140|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539141|NCT04717414|Luspatercept|luspatercept|mesh-list
83539142|NCT04717414|Hematinics|hematinics|mesh-ancestor
83539143|NCT04717089|Anesthetics|anesthetics|mesh-list
83539144|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83539145|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539146|NCT04712799|Xylometazoline|xylometazoline|mesh-list
83539147|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
83539148|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83539149|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
83539150|NCT04712734|Iloperidone|iloperidone|mesh-list
83539151|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83539152|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83539153|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83539154|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539155|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83539157|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539158|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539159|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539160|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539161|NCT04687098|Idarubicin|idarubicin|mesh-list
83539162|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83539163|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539164|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83539165|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83539166|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539167|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539168|NCT04685135|Docetaxel|docetaxel|mesh-list
83539169|NCT04685135|Adagrasib|adagrasib|mesh-list
83539170|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539171|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
83539172|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
83539173|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
83539174|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539175|NCT04683406|Oseltamivir|oseltamivir|mesh-list
83539176|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
83539177|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539178|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539179|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539180|NCT04680052|Rituximab|rituximab|mesh-list
83539181|NCT04680052|Lenalidomide|lenalidomide|mesh-list
83539182|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539183|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539184|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
83539185|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539186|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539187|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83539188|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83539189|NCT04680052|Growth Substances|growth substances|mesh-ancestor
83539190|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
83539191|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
83539192|NCT04678401|Thiotepa|thiotepa|mesh-list
83539193|NCT04678401|Fludarabine|fludarabine|mesh-list
83539194|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83539195|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
83539196|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539197|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539198|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83539199|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
83539200|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539201|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539202|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83539203|NCT04677504|Bevacizumab|bevacizumab|mesh-list
83539204|NCT04677504|Atezolizumab|atezolizumab|mesh-list
83539205|NCT04677504|Gemcitabine|gemcitabine|mesh-list
83539206|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539207|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539208|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83539209|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83539210|NCT04677504|Growth Substances|growth substances|mesh-ancestor
83539211|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539212|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
83539213|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83539214|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
83539215|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539216|NCT04677504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539217|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
83539218|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
83539219|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
83539220|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
83539221|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539222|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539223|NCT04673357|Ustekinumab|ustekinumab|mesh-list
83539224|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
83539225|NCT04662086|Camostat|camostat|mesh-list
83539226|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
83539227|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539228|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539229|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83539230|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83539231|NCT04662073|Camostat|camostat|mesh-list
83539232|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
83539233|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539234|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539235|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83539236|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83539237|NCT04658862|Gemcitabine|gemcitabine|mesh-list
83539238|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539239|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83539240|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
83539241|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539242|NCT04647877|Phenytoin|phenytoin|mesh-list
83539243|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
83539244|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83539245|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83539246|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83539247|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539248|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83539249|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83539250|NCT04633252|Prednisone|prednisone|mesh-list
83539251|NCT04633252|Docetaxel|docetaxel|mesh-list
83539252|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539253|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
83539254|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
83539255|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
83539256|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539257|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83539258|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
83539259|NCT04633252|Hormones|hormones|mesh-ancestor
83539260|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539261|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539262|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83539263|NCT04632992|Maytansine|maytansine|mesh-list
83539264|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83539265|NCT04632992|Trastuzumab|trastuzumab|mesh-list
83539266|NCT04632992|Atezolizumab|atezolizumab|mesh-list
83539267|NCT04632992|Pertuzumab|pertuzumab|mesh-list
83539268|NCT04632992|Ipatasertib|ipatasertib|mesh-list
83539269|NCT04632992|Tucatinib|tucatinib|mesh-list
83539270|NCT04632992|Pralsetinib|pralsetinib|mesh-list
83539271|NCT04632992|Entrectinib|entrectinib|mesh-list
83539272|NCT04632992|Inavolisib|inavolisib|mesh-list
83539273|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83539274|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539275|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
83539276|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
83539277|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
83539278|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539279|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539280|NCT04632992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539281|NCT04632992|Immunotoxins|immunotoxins|mesh-ancestor
83539282|NCT04632992|Immunoconjugates|immunoconjugates|mesh-ancestor
83539283|NCT04632992|Immunologic Factors|immunologic factors|mesh-ancestor
83539284|NCT04632992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539285|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83539286|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539287|NCT04632992|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83539289|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
83539290|NCT04629547|Suvorexant|suvorexant|mesh-list
83539291|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83539292|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83539293|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83539294|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539295|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83539296|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83539297|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539298|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
83539299|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83539300|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
83539301|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539302|NCT04627922|Expectorants|expectorants|mesh-ancestor
83539303|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
83539304|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83539305|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
83539306|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539307|NCT04627922|Protective Agents|protective agents|mesh-ancestor
83539308|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539309|NCT04627922|Antidotes|antidotes|mesh-ancestor
83539310|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
83539311|NCT04617938|Narcotics|narcotics|mesh-ancestor
83539312|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83539313|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539314|NCT04617938|Analgesics|analgesics|mesh-ancestor
83539315|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
83539316|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539317|NCT04615403|Travoprost|travoprost|mesh-list
83539318|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83539319|NCT04609020|Lidocaine|lidocaine|mesh-list
83539320|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
83539321|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
83539322|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83539323|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539324|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
83539325|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539326|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83539327|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83539328|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83539329|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83539330|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539331|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83539332|NCT04608539|Hematinics|hematinics|mesh-ancestor
83539333|NCT04606381|Lazertinib|lazertinib|mesh-list
83539334|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83539335|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539336|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539338|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
83539339|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83539340|NCT04597437|Zanamivir|zanamivir|mesh-list
83539341|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
83539342|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539343|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539344|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539345|NCT04586660|Denosumab|denosumab|mesh-list
83539346|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83539347|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539348|NCT04586166|Imidacloprid|imidacloprid|mesh-list
83539349|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
83539350|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83539351|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539352|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539353|NCT04585789|Tenofovir|tenofovir|mesh-list
83539354|NCT04585789|Entecavir|entecavir|mesh-list
83539355|NCT04585789|JNJ-56136379|jnj-56136379|mesh-list
83539356|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83539357|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
83539358|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539359|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83539360|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83539361|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539515|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
83539362|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539363|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83539364|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83539366|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83539367|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83539368|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83539369|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539370|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83539371|NCT04577833|Prednisone|prednisone|mesh-list
83539372|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
83539373|NCT04577833|Niraparib|niraparib|mesh-list
83539374|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83539375|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
83539376|NCT04577833|Hormones|hormones|mesh-ancestor
83539377|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539378|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539379|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83539380|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539381|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83539382|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539383|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539384|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
83539385|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83539386|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83539387|NCT04576117|Vinblastine|vinblastine|mesh-list
83539388|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83539389|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539390|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
83539391|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
83539392|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
83539393|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539394|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
83539395|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539396|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539397|NCT04576091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539398|NCT04576091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539399|NCT04575597|Molnupiravir|molnupiravir|mesh-list
83539400|NCT04575597|Antiviral Agents|antiviral agents|mesh-ancestor
83539401|NCT04575597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539402|NCT04564755|Abrocitinib|abrocitinib|mesh-list
83539403|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83539404|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539405|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539406|NCT04562792|Daunorubicin|daunorubicin|mesh-list
83539407|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83539408|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539409|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83539410|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83539411|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539412|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539414|NCT04551521|Atezolizumab|atezolizumab|mesh-list
83539415|NCT04551521|Pertuzumab|pertuzumab|mesh-list
83539416|NCT04551521|Vemurafenib|vemurafenib|mesh-list
83539417|NCT04551521|Ipatasertib|ipatasertib|mesh-list
83539418|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83539419|NCT04551521|Inavolisib|inavolisib|mesh-list
83539420|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539421|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539422|NCT04551521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539423|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539424|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
83539425|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539426|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83539427|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539428|NCT04551521|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83539429|NCT04550377|Cannabidiol|cannabidiol|mesh-list
83539430|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
83539431|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83539432|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539433|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
83539434|NCT04539366|Fludarabine|fludarabine|mesh-list
83539435|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
83539436|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
83539437|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539438|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83539439|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539440|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83539441|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
83539442|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539443|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539444|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83539445|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83539446|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
83539447|NCT04538664|Carboplatin|carboplatin|mesh-list
83539448|NCT04538664|Pemetrexed|pemetrexed|mesh-list
83539449|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83539450|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539451|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539452|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539453|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83539454|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83539455|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539456|NCT04535544|Tenofovir|tenofovir|mesh-list
83539457|NCT04535544|Entecavir|entecavir|mesh-list
83539458|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
83539459|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539460|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83539461|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83539462|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539463|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539464|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83539465|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83539466|NCT04530565|Cytarabine|cytarabine|mesh-list
83539467|NCT04530565|Dexamethasone|dexamethasone|mesh-list
83539468|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
83539469|NCT04530565|Prednisone|prednisone|mesh-list
83539470|NCT04530565|Cortisone|cortisone|mesh-list
83539471|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
83539472|NCT04530565|Doxorubicin|doxorubicin|mesh-list
83539473|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83539474|NCT04530565|Methotrexate|methotrexate|mesh-list
83539475|NCT04530565|Vincristine|vincristine|mesh-list
83539476|NCT04530565|Dasatinib|dasatinib|mesh-list
83539477|NCT04530565|Blinatumomab|blinatumomab|mesh-list
83539478|NCT04530565|Ponatinib|ponatinib|mesh-list
83539479|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83539480|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
83539481|NCT04530565|Antibodies|antibodies|mesh-list
83539482|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
83539483|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83539484|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83539485|NCT04530565|BB 1101|bb 1101|mesh-list
83539486|NCT04530565|Mesna|mesna|mesh-list
83539487|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83539488|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
83539489|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539490|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539491|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83539492|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
83539493|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539494|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539495|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83539496|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83539497|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
83539498|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
83539499|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539500|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83539501|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
83539502|NCT04530565|Hormones|hormones|mesh-ancestor
83539503|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539504|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83539505|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
83539506|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539507|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83539508|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83539509|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83539510|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83539511|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
83539512|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83539513|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83539514|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
83539516|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83539517|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83539518|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
83539519|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539520|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83539521|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
83539522|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
83539523|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
83539524|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83539525|NCT04530565|Protective Agents|protective agents|mesh-ancestor
83539526|NCT04524871|Bevacizumab|bevacizumab|mesh-list
83539527|NCT04524871|Atezolizumab|atezolizumab|mesh-list
83539528|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539529|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539530|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83539531|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83539532|NCT04524871|Growth Substances|growth substances|mesh-ancestor
83539533|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539534|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
83539535|NCT04524871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539536|NCT04524871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539538|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
83539539|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
83539540|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539541|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539542|NCT04521231|Blinatumomab|blinatumomab|mesh-list
83539543|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539544|NCT04519619|Aflibercept|aflibercept|mesh-list
83539545|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83539546|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83539547|NCT04519619|Growth Substances|growth substances|mesh-ancestor
83539548|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539549|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
83539550|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539551|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83539552|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
83539553|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83539554|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83539555|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83539556|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83539557|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539558|NCT04511702|Methotrexate|methotrexate|mesh-list
83539559|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83539560|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
83539561|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83539562|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539563|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83539564|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
83539565|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539566|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539567|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
83539568|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539569|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83539570|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83539571|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
83539572|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539573|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83539574|NCT04511039|Trifluridine|trifluridine|mesh-list
83539575|NCT04511039|Talazoparib|talazoparib|mesh-list
83539576|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83539577|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539578|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539579|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539580|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
83539581|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
83539582|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539583|NCT04501367|Dexamethasone|dexamethasone|mesh-list
83539584|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
83539585|NCT04501367|Prednisone|prednisone|mesh-list
83539586|NCT04501367|BB 1101|bb 1101|mesh-list
83539587|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83539588|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
83539589|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
83539590|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539591|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539592|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83539593|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
83539594|NCT04501367|Hormones|hormones|mesh-ancestor
83539595|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539596|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83539597|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539598|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
83539599|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539600|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539601|NCT04497844|Prednisone|prednisone|mesh-list
83539602|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
83539603|NCT04497844|Niraparib|niraparib|mesh-list
83539604|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83539605|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
83539606|NCT04497844|Hormones|hormones|mesh-ancestor
83539607|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539608|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539609|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83539610|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539611|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83539612|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539613|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539614|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
83539615|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83539616|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83539617|NCT04496960|Tofacitinib|tofacitinib|mesh-list
83539618|NCT04496960|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83539619|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83539620|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539621|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539622|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
83539623|NCT04491617|Narcotics|narcotics|mesh-ancestor
83539624|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83539625|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539626|NCT04491617|Analgesics|analgesics|mesh-ancestor
83539627|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
83539628|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539629|NCT04490057|Bupropion|bupropion|mesh-list
83539630|NCT04490057|Nicotine|nicotine|mesh-list
83539631|NCT04490057|Varenicline|varenicline|mesh-list
83539632|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83539633|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
83539634|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539635|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539637|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83539638|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
83539639|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83539640|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539641|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83539642|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
83539643|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83539644|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83539645|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83539646|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83539647|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
83539648|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83539649|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83539650|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539651|NCT04487392|Estrogens|estrogens|mesh-list
83539652|NCT04487392|Hormones|hormones|mesh-ancestor
83539653|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539654|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539655|NCT04487080|Osimertinib|osimertinib|mesh-list
83539656|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83539657|NCT04487080|Lazertinib|lazertinib|mesh-list
83539658|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539659|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83539660|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539661|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539662|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539663|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83539664|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83539666|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
83539667|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83539668|NCT04472416|Analgesics|analgesics|mesh-list
83539669|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
83539670|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539671|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539672|NCT04468984|Navitoclax|navitoclax|mesh-list
83539673|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539674|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
83539675|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
83539676|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539677|NCT04439539|Tenofovir|tenofovir|mesh-list
83539678|NCT04439539|JNJ-56136379|jnj-56136379|mesh-list
83539679|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83539680|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
83539681|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539682|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83539683|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83539684|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539685|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539686|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83539687|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83539688|NCT04439136|Afatinib|afatinib|mesh-list
83539689|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539690|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83539691|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539692|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539693|NCT04439110|Trastuzumab|trastuzumab|mesh-list
83539694|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83539695|NCT04439110|Maytansine|maytansine|mesh-list
83539696|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
83539697|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539698|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539699|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83539700|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
83539701|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
83539702|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
83539703|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539704|NCT04439110|Immunotoxins|immunotoxins|mesh-ancestor
83539705|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
83539706|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539707|NCT04435782|Selexipag|selexipag|mesh-list
83539708|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83539709|NCT04432831|Faricimab|faricimab|mesh-list
83539710|NCT04432831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83539711|NCT04432831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83539712|NCT04432831|Growth Substances|growth substances|mesh-ancestor
83539713|NCT04432831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539714|NCT04432831|Growth Inhibitors|growth inhibitors|mesh-ancestor
83539715|NCT04432831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539716|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
83539717|NCT04427293|Lenvatinib|lenvatinib|mesh-list
83539718|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539719|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539720|NCT04427293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539721|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539722|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83539723|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539724|NCT04402788|Atezolizumab|atezolizumab|mesh-list
83539725|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83539726|NCT04402788|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539727|NCT04402788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539728|NCT04402788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539729|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539730|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
83539731|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539732|NCT04391842|Diclofenac|diclofenac|mesh-list
83539733|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83539734|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83539735|NCT04391842|Analgesics|analgesics|mesh-ancestor
83539736|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
83539737|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539738|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539739|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83539740|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539891|NCT04297592|Cefadroxil|cefadroxil|mesh-list
83539741|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83539742|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539743|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539744|NCT04383262|Fosamprenavir|fosamprenavir|mesh-list
83539745|NCT04383262|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83539746|NCT04383262|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83539747|NCT04383262|Protease Inhibitors|protease inhibitors|mesh-ancestor
83539748|NCT04383262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539749|NCT04383262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539750|NCT04383262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83539751|NCT04383262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83539752|NCT04383262|Antiviral Agents|antiviral agents|mesh-ancestor
83539753|NCT04383262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539754|NCT04372108|Ustekinumab|ustekinumab|mesh-list
83539755|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
83539756|NCT04370795|Sirolimus|sirolimus|mesh-list
83539757|NCT04370795|Busulfan|busulfan|mesh-list
83539758|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83539759|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539760|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83539761|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539762|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
83539763|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83539764|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
83539765|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539766|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539767|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
83539768|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83539769|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83539770|NCT04360681|Lofexidine|lofexidine|mesh-list
83539771|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83539772|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83539773|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539774|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
83539775|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539776|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83539777|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83539778|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83539779|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
83539780|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83539781|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539782|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
83539783|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539784|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539785|NCT04344795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539786|NCT04344795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539787|NCT04339751|Vorinostat|vorinostat|mesh-list
83539788|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539789|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83539790|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539791|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539792|NCT04334759|Cisplatin|cisplatin|mesh-list
83539793|NCT04334759|Carboplatin|carboplatin|mesh-list
83539794|NCT04334759|Nivolumab|nivolumab|mesh-list
83539795|NCT04334759|Pemetrexed|pemetrexed|mesh-list
83539796|NCT04334759|Ipilimumab|ipilimumab|mesh-list
83539797|NCT04334759|Durvalumab|durvalumab|mesh-list
83539798|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539799|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539800|NCT04334759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539801|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539802|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539803|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83539804|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83539805|NCT04330248|Carbamazepine|carbamazepine|mesh-list
83539806|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
83539807|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
83539808|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83539809|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83539810|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539811|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83539812|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83539813|NCT04330248|Analgesics|analgesics|mesh-ancestor
83539814|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
83539815|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539816|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83539817|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83539818|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539819|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83539820|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83539821|NCT04328844|Pemetrexed|pemetrexed|mesh-list
83539822|NCT04328844|Avelumab|avelumab|mesh-list
83539823|NCT04328844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539824|NCT04328844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539825|NCT04328844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539826|NCT04328844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83539827|NCT04328844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83539828|NCT04328844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539829|NCT04327024|Allopurinol|allopurinol|mesh-list
83539830|NCT04327024|Verinurad|verinurad|mesh-list
83539831|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
83539832|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539833|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539834|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
83539835|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539836|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83539837|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
83539838|NCT04327024|Protective Agents|protective agents|mesh-ancestor
83539839|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539840|NCT04315272|Azithromycin|azithromycin|mesh-list
83539841|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83539842|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539843|NCT04312659|Infliximab|infliximab|mesh-list
83539844|NCT04312659|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83539845|NCT04312659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83539846|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
83539847|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83539848|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539849|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
83539850|NCT04304352|Capecitabine|capecitabine|mesh-list
83539851|NCT04304352|Vinorelbine|vinorelbine|mesh-list
83539852|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83539853|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
83539854|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539855|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539856|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83539857|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
83539858|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539859|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539860|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83539861|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83539862|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
83539863|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83539864|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
83539865|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
83539866|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
83539867|NCT04298567|Aspirin|aspirin|mesh-list
83539868|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
83539869|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83539870|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
83539871|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83539872|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
83539873|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539874|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539875|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
83539876|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83539877|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83539878|NCT04298567|Analgesics|analgesics|mesh-ancestor
83539879|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
83539880|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539881|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539882|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83539883|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83539884|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83539885|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83539886|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83539887|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83539888|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
83539889|NCT04297592|Doxycycline|doxycycline|mesh-list
83539890|NCT04297592|Cephalexin|cephalexin|mesh-list
83539892|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83539893|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539894|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
83539895|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83539896|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83539897|NCT04294459|Acetaminophen|acetaminophen|mesh-list
83539898|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
83539899|NCT04294459|Promethazine|promethazine|mesh-list
83539900|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
83539901|NCT04294459|Ranitidine|ranitidine|mesh-list
83539902|NCT04294459|Montelukast|montelukast|mesh-list
83539903|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83539904|NCT04294459|Analgesics|analgesics|mesh-ancestor
83539905|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
83539906|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539907|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539908|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
83539909|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83539910|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
83539911|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
83539912|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83539913|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
83539914|NCT04294459|Hormones|hormones|mesh-ancestor
83539915|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83539916|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83539917|NCT04294459|Protective Agents|protective agents|mesh-ancestor
83539918|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83539919|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
83539920|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83539921|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
83539922|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83539923|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83539924|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539925|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83539926|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83539927|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83539928|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
83539929|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
83539930|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83539931|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
83539932|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
83539933|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83539934|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83539935|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
83539936|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
83539937|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83539938|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83539939|NCT04291105|Cemiplimab|cemiplimab|mesh-list
83539940|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539941|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539942|NCT04273945|Macitentan|macitentan|mesh-list
83539943|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83539944|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83539945|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539946|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83539947|NCT04271475|Macitentan|macitentan|mesh-list
83539948|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83539949|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83539950|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539951|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83539952|NCT04269902|Venetoclax|venetoclax|mesh-list
83539953|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
83539954|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539955|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539956|NCT04268121|Cisplatin|cisplatin|mesh-list
83539957|NCT04268121|Etoposide|etoposide|mesh-list
83539958|NCT04268121|Etoposide phosphate|etoposide phosphate|mesh-list
83539959|NCT04268121|Carboplatin|carboplatin|mesh-list
83539960|NCT04268121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539961|NCT04268121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83539962|NCT04268121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83539963|NCT04268121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83539964|NCT04268121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539965|NCT04268121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539966|NCT04267848|Paclitaxel|paclitaxel|mesh-list
83539967|NCT04267848|Cisplatin|cisplatin|mesh-list
83539968|NCT04267848|Carboplatin|carboplatin|mesh-list
83539972|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83539973|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83539974|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83539975|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
83539976|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
83539977|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
83539978|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539979|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83539980|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
83539981|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83539982|NCT04267848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83539983|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539984|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83539985|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83539986|NCT04252742|Erenumab|erenumab|mesh-list
83539987|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83539988|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83539989|NCT04252742|Analgesics|analgesics|mesh-ancestor
83539990|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
83539991|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83539992|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539993|NCT04252612|Pramlintide|pramlintide|mesh-list
83539994|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83539995|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539996|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83539997|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
83539998|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83539999|NCT04221477|Acetaminophen|acetaminophen|mesh-list
83540000|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
83540001|NCT04221477|Promethazine|promethazine|mesh-list
83540002|NCT04221477|Prednisone|prednisone|mesh-list
83540003|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
83540004|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
83540005|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540006|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
83540007|NCT04221477|Hormones|hormones|mesh-ancestor
83540008|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540009|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540010|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83540011|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540012|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83540013|NCT04221477|Analgesics|analgesics|mesh-ancestor
83540014|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
83540015|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540016|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
83540017|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
83540018|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
83540019|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83540020|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83540021|NCT04221477|Protective Agents|protective agents|mesh-ancestor
83540022|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540023|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83540024|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83540025|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83540026|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
83540027|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
83540028|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83540029|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
83540030|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
83540031|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83540032|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540033|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83540034|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
83540035|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
83540036|NCT04214288|Fulvestrant|fulvestrant|mesh-list
83540037|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83540038|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540039|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83540040|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83540041|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
83540042|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540043|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540044|NCT04214262|Atezolizumab|atezolizumab|mesh-list
83540045|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83540046|NCT04214262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540047|NCT04214262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540048|NCT04214262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540049|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540050|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
83540051|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540052|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
83540053|NCT04210505|Povidone|povidone|mesh-list
83540054|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
83540055|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
83540056|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83540057|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83540058|NCT04209595|Rucaparib|rucaparib|mesh-list
83540059|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83540060|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540061|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540062|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540063|NCT04195698|Upadacitinib|upadacitinib|mesh-list
83540064|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83540065|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83540066|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540067|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540068|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540069|NCT04194528|Acetaminophen|acetaminophen|mesh-list
83540070|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83540071|NCT04194528|Oxycodone|oxycodone|mesh-list
83540072|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83540073|NCT04194528|Analgesics|analgesics|mesh-ancestor
83540074|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
83540075|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540076|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540077|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
83540078|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83540079|NCT04194528|Narcotics|narcotics|mesh-ancestor
83540080|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83540081|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83540082|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540083|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540084|NCT04189614|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
83540085|NCT04189614|Immunoconjugates|immunoconjugates|mesh-ancestor
83540086|NCT04189614|Immunologic Factors|immunologic factors|mesh-ancestor
83540087|NCT04189614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540088|NCT04182204|Rituximab|rituximab|mesh-list
83540089|NCT04182204|Gemcitabine|gemcitabine|mesh-list
83540090|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
83540091|NCT04182204|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83540092|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540093|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540094|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
83540095|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540096|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540097|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540098|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
83540099|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540100|NCT04182204|Immunoconjugates|immunoconjugates|mesh-ancestor
83540101|NCT04181827|Dexamethasone|dexamethasone|mesh-list
83540102|NCT04181827|Bortezomib|bortezomib|mesh-list
83540103|NCT04181827|Daratumumab|daratumumab|mesh-list
83540104|NCT04181827|Pomalidomide|pomalidomide|mesh-list
83540105|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540106|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
83540107|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
83540108|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540109|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540110|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83540111|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
83540112|NCT04181827|Hormones|hormones|mesh-ancestor
83540113|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540114|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83540115|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540116|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
83540117|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83540118|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83540119|NCT04181827|Growth Substances|growth substances|mesh-ancestor
83540120|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
83540121|NCT04179396|Rucaparib|rucaparib|mesh-list
83540122|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83540124|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540125|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540127|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83540128|NCT04172675|Gemcitabine|gemcitabine|mesh-list
83540129|NCT04172675|Mitomycins|mitomycins|mesh-list
83540130|NCT04172675|Mitomycin|mitomycin|mesh-list
83540131|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540132|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
83540133|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540134|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540135|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83540136|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
83540137|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83540138|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540139|NCT04170348|Vitamin D|vitamin d|mesh-list
83540140|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
83540141|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
83540142|NCT04170348|Vitamins|vitamins|mesh-list
83540143|NCT04170348|Trientine|trientine|mesh-list
83540144|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
83540145|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540146|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83540147|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83540148|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
83540149|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
83540150|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540151|NCT04166487|Paclitaxel|paclitaxel|mesh-list
83540152|NCT04166487|Carboplatin|carboplatin|mesh-list
83540153|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
83540154|NCT04166487|Pemetrexed|pemetrexed|mesh-list
83540155|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83540156|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540157|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
83540158|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
83540159|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
83540160|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540161|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540162|NCT04166487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540163|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540164|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83540165|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83540166|NCT04164199|Capecitabine|capecitabine|mesh-list
83540167|NCT04164199|Pemetrexed|pemetrexed|mesh-list
83540168|NCT04164199|Temozolomide|temozolomide|mesh-list
83540169|NCT04164199|Tislelizumab|tislelizumab|mesh-list
83540170|NCT04164199|Pamiparib|pamiparib|mesh-list
83540171|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540172|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
83540173|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540174|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540175|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540176|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83540177|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83540178|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83540179|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
83540180|NCT04164199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540181|NCT04164199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83540182|NCT04158440|Paclitaxel|paclitaxel|mesh-list
83540183|NCT04158440|Docetaxel|docetaxel|mesh-list
83540184|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83540185|NCT04158440|Cisplatin|cisplatin|mesh-list
83540186|NCT04158440|Carboplatin|carboplatin|mesh-list
83540187|NCT04158440|Pemetrexed|pemetrexed|mesh-list
83540188|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83540189|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540190|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
83540191|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
83540192|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
83540193|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540194|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540195|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83540196|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83540197|NCT04150887|Azacitidine|azacitidine|mesh-list
83540198|NCT04150887|Venetoclax|venetoclax|mesh-list
83540199|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540200|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
83540201|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540202|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540203|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540204|NCT04140162|Dexamethasone|dexamethasone|mesh-list
83540205|NCT04140162|Lenalidomide|lenalidomide|mesh-list
83540206|NCT04140162|Bortezomib|bortezomib|mesh-list
83540207|NCT04140162|Daratumumab|daratumumab|mesh-list
83540208|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540209|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
83540210|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
83540211|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540212|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540213|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83540214|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
83540215|NCT04140162|Hormones|hormones|mesh-ancestor
83540216|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540217|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83540218|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540219|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
83540220|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83540221|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83540222|NCT04140162|Growth Substances|growth substances|mesh-ancestor
83540223|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
83540224|NCT04133636|Dexamethasone|dexamethasone|mesh-list
83540225|NCT04133636|Lenalidomide|lenalidomide|mesh-list
83540226|NCT04133636|Bortezomib|bortezomib|mesh-list
83540227|NCT04133636|Daratumumab|daratumumab|mesh-list
83540228|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540229|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
83540230|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
83540231|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540232|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540233|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83540234|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
83540235|NCT04133636|Hormones|hormones|mesh-ancestor
83540236|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540237|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83540238|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540239|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
83540240|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83540241|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83540242|NCT04133636|Growth Substances|growth substances|mesh-ancestor
83540243|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
83540244|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
83540245|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540246|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540247|NCT04129515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540248|NCT04129515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540249|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83540250|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83540251|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83540252|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540253|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540254|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83540255|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83540256|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540257|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
83540258|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83540259|NCT04111978|Letrozole|letrozole|mesh-list
83540260|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540261|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83540262|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83540263|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540264|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540265|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83540266|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
83540267|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540268|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540269|NCT04109066|Paclitaxel|paclitaxel|mesh-list
83540270|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
83540271|NCT04109066|Nivolumab|nivolumab|mesh-list
83540272|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83540273|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540274|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
83540277|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540278|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540279|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
83540280|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540281|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540282|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83540283|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
83540284|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83540285|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540286|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540287|NCT04108208|Androgens|androgens|mesh-list
83540288|NCT04108208|Hormones|hormones|mesh-ancestor
83540289|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540290|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540291|NCT04108195|Daratumumab|daratumumab|mesh-list
83540292|NCT04108195|Pomalidomide|pomalidomide|mesh-list
83540293|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540294|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
83540295|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540296|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83540297|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83540298|NCT04108195|Growth Substances|growth substances|mesh-ancestor
83540299|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
83540300|NCT04102436|Aldesleukin|aldesleukin|mesh-list
83540301|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
83540302|NCT04102436|Fludarabine|fludarabine|mesh-list
83540303|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540304|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
83540305|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540306|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540307|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83540308|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
83540309|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540310|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540311|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83540312|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83540313|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83540314|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
83540315|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83540316|NCT04092283|Paclitaxel|paclitaxel|mesh-list
83540317|NCT04092283|Etoposide|etoposide|mesh-list
83540318|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
83540319|NCT04092283|Cisplatin|cisplatin|mesh-list
83540320|NCT04092283|Carboplatin|carboplatin|mesh-list
83540321|NCT04092283|Pemetrexed|pemetrexed|mesh-list
83540322|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83540323|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
83540324|NCT04092283|Durvalumab|durvalumab|mesh-list
83540325|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
83540326|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83540327|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
83540328|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83540329|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540330|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
83540331|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
83540332|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
83540333|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540334|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83540335|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83540336|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540337|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83540338|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83540339|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540340|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
83540341|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540342|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
83540343|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
83540344|NCT04085458|Factor VIII|factor viii|mesh-list
83540345|NCT04085458|Coagulants|coagulants|mesh-ancestor
83540346|NCT04077580|Methenamine|methenamine|mesh-list
83540347|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
83540348|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
83540349|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83540350|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83540351|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83540352|NCT04077463|Carboplatin|carboplatin|mesh-list
83540353|NCT04077463|Pemetrexed|pemetrexed|mesh-list
83540354|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83540356|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540357|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540358|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540359|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83540360|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83540361|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83540362|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540363|NCT04065399|Cobicistat|cobicistat|mesh-list
83540364|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83540365|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83540366|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
83540367|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83540368|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83540369|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83540370|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540371|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540372|NCT04056910|Nivolumab|nivolumab|mesh-list
83540373|NCT04056910|Ivosidenib|ivosidenib|mesh-list
83540374|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540375|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540376|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540377|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540378|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540379|NCT04054752|Vaccines|vaccines|mesh-list
83540380|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
83540381|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540382|NCT04037527|Gemcitabine|gemcitabine|mesh-list
83540383|NCT04037527|Docetaxel|docetaxel|mesh-list
83540384|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540385|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
83540386|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540387|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540388|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
83540389|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
83540390|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
83540391|NCT04034095|Prednisolone|prednisolone|mesh-list
83540392|NCT04034095|Docetaxel|docetaxel|mesh-list
83540394|NCT04034095|Androgens|androgens|mesh-list
83540395|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540396|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83540397|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83540398|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83540399|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540400|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540401|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
83540402|NCT04034095|Hormones|hormones|mesh-ancestor
83540403|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540404|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540405|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83540406|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
83540407|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
83540408|NCT04026113|Linaclotide|linaclotide|mesh-list
83540409|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83540410|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
83540411|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540412|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83540413|NCT04023526|Azacitidine|azacitidine|mesh-list
83540414|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540415|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
83540416|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540417|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540418|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540419|NCT04008030|Leucovorin|leucovorin|mesh-list
83540420|NCT04008030|Bevacizumab|bevacizumab|mesh-list
83540421|NCT04008030|Nivolumab|nivolumab|mesh-list
83540422|NCT04008030|Cetuximab|cetuximab|mesh-list
83540423|NCT04008030|Ipilimumab|ipilimumab|mesh-list
83540424|NCT04008030|Fluorouracil|fluorouracil|mesh-list
83540425|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
83540426|NCT04008030|Irinotecan|irinotecan|mesh-list
83540427|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540428|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540429|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83540430|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83540431|NCT04008030|Growth Substances|growth substances|mesh-ancestor
83540432|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540435|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540436|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540437|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540438|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
83540439|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540440|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83540441|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83540442|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540444|NCT04008030|Protective Agents|protective agents|mesh-ancestor
83540445|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
83540446|NCT04008030|Vitamins|vitamins|mesh-ancestor
83540447|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
83540448|NCT03989414|Dexamethasone|dexamethasone|mesh-list
83540449|NCT03989414|Bortezomib|bortezomib|mesh-list
83540450|NCT03989414|Daratumumab|daratumumab|mesh-list
83540451|NCT03989414|Elotuzumab|elotuzumab|mesh-list
83540452|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540453|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
83540454|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
83540455|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540456|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540457|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83540458|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
83540459|NCT03989414|Hormones|hormones|mesh-ancestor
83540460|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540461|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83540462|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540463|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
83540464|NCT03978624|Entinostat|entinostat|mesh-list
83540465|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540466|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540467|NCT03978624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540468|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540469|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83540470|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540472|NCT03974217|Talazoparib|talazoparib|mesh-list
83540473|NCT03974217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540474|NCT03974217|Antimetabolites|antimetabolites|mesh-ancestor
83540475|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540476|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540477|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540478|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83540479|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
83540480|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
83540481|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540482|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
83540483|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540484|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540485|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83540486|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
83540487|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540488|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540489|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83540490|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540491|NCT03971045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540492|NCT03968653|Carboplatin|carboplatin|mesh-list
83540493|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540494|NCT03952585|Deoxyglucose|deoxyglucose|mesh-list
83540495|NCT03952585|Cisplatin|cisplatin|mesh-list
83540496|NCT03952585|Nivolumab|nivolumab|mesh-list
83540497|NCT03952585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83540498|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540499|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540500|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540501|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540502|NCT03952585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83540503|NCT03952585|Antimetabolites|antimetabolites|mesh-ancestor
83540504|NCT03952585|Antiviral Agents|antiviral agents|mesh-ancestor
83540505|NCT03952585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83540506|NCT03946800|Durvalumab|durvalumab|mesh-list
83540507|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540508|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540509|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83540510|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83540511|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540512|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540513|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
83540514|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540515|NCT03940235|Androgens|androgens|mesh-list
83540516|NCT03940235|Hormones|hormones|mesh-ancestor
83540517|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540518|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540519|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
83540520|NCT03935893|Fludarabine|fludarabine|mesh-list
83540521|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540522|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
83540523|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540524|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540525|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83540526|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
83540527|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540528|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540529|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83540530|NCT03932201|Factor VIII|factor viii|mesh-list
83540531|NCT03932201|Coagulants|coagulants|mesh-ancestor
83540532|NCT03916510|Capecitabine|capecitabine|mesh-list
83540533|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540534|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
83540535|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540536|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540537|NCT03912428|Celecoxib|celecoxib|mesh-list
83540538|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83540539|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83540540|NCT03912428|Analgesics|analgesics|mesh-ancestor
83540541|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
83540542|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540543|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540544|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540545|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540546|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83540547|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83540548|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540549|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540550|NCT03905798|Lorazepam|lorazepam|mesh-list
83540551|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
83540552|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
83540553|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
83540554|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540555|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540556|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83540557|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83540558|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83540559|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83540560|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83540561|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83540562|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
83540563|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
83540564|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83540565|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540566|NCT03901963|Lenalidomide|lenalidomide|mesh-list
83540567|NCT03901963|Daratumumab|daratumumab|mesh-list
83540568|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
83540569|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540570|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83540571|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83540572|NCT03901963|Growth Substances|growth substances|mesh-ancestor
83540573|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
83540574|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540575|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
83540576|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83540577|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
83540578|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
83540579|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83540580|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540581|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540582|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83540583|NCT03901482|Analgesics|analgesics|mesh-ancestor
83540584|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
83540585|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540586|NCT03900377|Rituximab|rituximab|mesh-list
83540587|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540588|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540589|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
83540590|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540591|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540592|NCT03868124|Travoprost|travoprost|mesh-list
83540593|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83540594|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83540595|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83540596|NCT03860844|Cytarabine|cytarabine|mesh-list
83540597|NCT03860844|Dexamethasone|dexamethasone|mesh-list
83540598|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
83540599|NCT03860844|Doxorubicin|doxorubicin|mesh-list
83540600|NCT03860844|Methotrexate|methotrexate|mesh-list
83540601|NCT03860844|Fludarabine|fludarabine|mesh-list
83540602|NCT03860844|Etoposide|etoposide|mesh-list
83540603|NCT03860844|Vincristine|vincristine|mesh-list
83540604|NCT03860844|Daunorubicin|daunorubicin|mesh-list
83540605|NCT03860844|Asparaginase|asparaginase|mesh-list
83540606|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
83540607|NCT03860844|Idarubicin|idarubicin|mesh-list
83540608|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
83540609|NCT03860844|Pegaspargase|pegaspargase|mesh-list
83540610|NCT03860844|Montelukast|montelukast|mesh-list
83540611|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540612|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
83540613|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540614|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540615|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83540616|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
83540617|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540618|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540619|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83540620|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540621|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
83540622|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
83540623|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540624|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83540625|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
83540626|NCT03860844|Hormones|hormones|mesh-ancestor
83540627|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540628|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83540629|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83540630|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83540631|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83540632|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540633|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83540634|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
83540635|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83540636|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540637|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
83540638|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
83540639|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83540640|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83540641|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83540642|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
83540643|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83540644|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
83540645|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
83540646|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
83540647|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83540648|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
83540649|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83540650|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
83540651|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83540652|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83540653|NCT03860844|Analgesics|analgesics|mesh-ancestor
83540654|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
83540655|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
83540656|NCT03853317|Avelumab|avelumab|mesh-list
83540657|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540658|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540659|NCT03848676|Immunomodulating Agents|immunomodulating agents|mesh-list
83540660|NCT03848676|Immunologic Factors|immunologic factors|mesh-ancestor
83540661|NCT03848676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540662|NCT03845010|Verapamil|verapamil|mesh-list
83540663|NCT03845010|Sotalol|sotalol|mesh-list
83540665|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83540666|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83540667|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83540668|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540669|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83540670|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540671|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
83540672|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83540673|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83540674|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
83540675|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83540676|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
83540677|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
83540678|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540679|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83540680|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83540681|NCT03841617|Hormones|hormones|mesh-list
83540682|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540683|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540684|NCT03829371|Dexamethasone|dexamethasone|mesh-list
83540685|NCT03829371|Prednisone|prednisone|mesh-list
83540686|NCT03829371|Lenalidomide|lenalidomide|mesh-list
83540687|NCT03829371|Melphalan|melphalan|mesh-list
83540688|NCT03829371|Bortezomib|bortezomib|mesh-list
83540689|NCT03829371|Daratumumab|daratumumab|mesh-list
83540690|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540691|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
83540692|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
83540693|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540694|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540695|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83540696|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
83540697|NCT03829371|Hormones|hormones|mesh-ancestor
83540698|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540699|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83540700|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540701|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
83540702|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83540703|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83540704|NCT03829371|Growth Substances|growth substances|mesh-ancestor
83540705|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
83540706|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83540707|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
83540708|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540709|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83540710|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540711|NCT03828227|Bevacizumab|bevacizumab|mesh-list
83540712|NCT03828227|Fluorouracil|fluorouracil|mesh-list
83540713|NCT03828227|Capecitabine|capecitabine|mesh-list
83540714|NCT03828227|Oxaliplatin|oxaliplatin|mesh-list
83540715|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540716|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540717|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83540718|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83540719|NCT03828227|Growth Substances|growth substances|mesh-ancestor
83540720|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540721|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
83540722|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
83540723|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540724|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540725|NCT03828227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540726|NCT03828227|Immunologic Factors|immunologic factors|mesh-ancestor
83540727|NCT03816358|Gemcitabine|gemcitabine|mesh-list
83540728|NCT03816358|Nivolumab|nivolumab|mesh-list
83540729|NCT03816358|Ipilimumab|ipilimumab|mesh-list
83540730|NCT03816358|Maytansine|maytansine|mesh-list
83540731|NCT03816358|Anetumab ravtansine|anetumab ravtansine|mesh-list
83540732|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540733|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
83540734|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540735|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540736|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540737|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540738|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83540739|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
83540744|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540746|NCT03816332|Cortisone|cortisone|mesh-list
83540747|NCT03816332|Nivolumab|nivolumab|mesh-list
83540748|NCT03816332|Ipilimumab|ipilimumab|mesh-list
83540749|NCT03816332|Tacrolimus|tacrolimus|mesh-list
83540750|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540751|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
83540752|NCT03816332|Hormones|hormones|mesh-ancestor
83540753|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540754|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540755|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83540756|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540757|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540758|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540759|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540760|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540761|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
83540762|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83540763|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540764|NCT03793179|Carboplatin|carboplatin|mesh-list
83540765|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
83540766|NCT03793179|Pemetrexed|pemetrexed|mesh-list
83540767|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540768|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540769|NCT03793179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540770|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540771|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540772|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83540773|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83540774|NCT03793166|Nivolumab|nivolumab|mesh-list
83540775|NCT03793166|Ipilimumab|ipilimumab|mesh-list
83540776|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540777|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540778|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540779|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540780|NCT03785964|Nirogacestat|nirogacestat|mesh-list
83540781|NCT03785964|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83540782|NCT03785964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540783|NCT03785964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540784|NCT03775265|Cisplatin|cisplatin|mesh-list
83540785|NCT03775265|Gemcitabine|gemcitabine|mesh-list
83540786|NCT03775265|Fluorouracil|fluorouracil|mesh-list
83540787|NCT03775265|Atezolizumab|atezolizumab|mesh-list
83540788|NCT03775265|Mitomycins|mitomycins|mesh-list
83540789|NCT03775265|Mitomycin|mitomycin|mesh-list
83540790|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83540791|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540792|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540793|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
83540794|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540795|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540796|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
83540797|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540798|NCT03775265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540799|NCT03775265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540800|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83540801|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
83540802|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83540803|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540804|NCT03767244|Androgens|androgens|mesh-list
83540805|NCT03767244|Hormones|hormones|mesh-ancestor
83540806|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540807|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540808|NCT03743428|Bevacizumab|bevacizumab|mesh-list
83540809|NCT03743428|Apatinib|apatinib|mesh-list
83540810|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540811|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540812|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83540813|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83540814|NCT03743428|Growth Substances|growth substances|mesh-ancestor
83540815|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540816|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
83540817|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83540818|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540819|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540820|NCT03739710|Docetaxel|docetaxel|mesh-list
83540821|NCT03739710|Ipilimumab|ipilimumab|mesh-list
83540822|NCT03739710|Dostarlimab|dostarlimab|mesh-list
83540823|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540824|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
83540825|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
83540826|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
83540827|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540828|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540829|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540830|NCT03733067|Abatacept|abatacept|mesh-list
83540831|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540832|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540833|NCT03733067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540834|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540835|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540836|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
83540837|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540838|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540839|NCT03729869|Progesterone|progesterone|mesh-list
83540840|NCT03729869|Progestins|progestins|mesh-ancestor
83540841|NCT03729869|Hormones|hormones|mesh-ancestor
83540842|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83540843|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540844|NCT03729349|Golimumab|golimumab|mesh-list
83540845|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83540846|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83540847|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540848|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
83540849|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540851|NCT03723551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83540852|NCT03723551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83540853|NCT03715933|Carboplatin|carboplatin|mesh-list
83540854|NCT03715933|Fluorouracil|fluorouracil|mesh-list
83540855|NCT03715933|Irinotecan|irinotecan|mesh-list
83540856|NCT03715933|Pemetrexed|pemetrexed|mesh-list
83540857|NCT03715933|Temozolomide|temozolomide|mesh-list
83540858|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540859|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
83540860|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540861|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540862|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540863|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
83540864|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540865|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83540866|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83540867|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540868|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83540869|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83540870|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83540871|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
83540872|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83540873|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83540874|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540875|NCT03690921|Cisplatin|cisplatin|mesh-list
83540876|NCT03690921|Fluorouracil|fluorouracil|mesh-list
83540877|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540878|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
83540879|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540880|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540881|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83540882|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
83540883|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540884|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
83540885|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540886|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540887|NCT03666273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540888|NCT03666273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540889|NCT03660826|Durvalumab|durvalumab|mesh-list
83540890|NCT03660826|Olaparib|olaparib|mesh-list
83540891|NCT03660826|Cediranib|cediranib|mesh-list
83540892|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83540893|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
83540897|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540898|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540899|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
83540900|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540901|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540902|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540903|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83540904|NCT03656536|Gemcitabine|gemcitabine|mesh-list
83540905|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540906|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83540907|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
83540908|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540909|NCT03637660|Penicillins|penicillins|mesh-list
83540910|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83540911|NCT03637660|Penicillin G|penicillin g|mesh-list
83540912|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
83540913|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83540914|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83540916|NCT03635489|Bevacizumab|bevacizumab|mesh-list
83540917|NCT03635489|Carboplatin|carboplatin|mesh-list
83540918|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83540919|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540920|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
83540921|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
83540922|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
83540923|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540924|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540925|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83540926|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83540927|NCT03635489|Growth Substances|growth substances|mesh-ancestor
83540928|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540929|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
83540931|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83540932|NCT03631784|Carboplatin|carboplatin|mesh-list
83540933|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
83540934|NCT03631784|Pemetrexed|pemetrexed|mesh-list
83540935|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83540936|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540937|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
83540938|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
83540939|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
83540940|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540941|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540942|NCT03631784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540943|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540944|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83540945|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83540946|NCT03617705|Ethanol|ethanol|mesh-list
83540947|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83540948|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83540949|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83540950|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540951|NCT03607422|Upadacitinib|upadacitinib|mesh-list
83540952|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83540953|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83540954|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540955|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540956|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83540957|NCT03604978|Nivolumab|nivolumab|mesh-list
83540958|NCT03604978|Ipilimumab|ipilimumab|mesh-list
83540959|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540960|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540961|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540962|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540963|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
83540964|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83540965|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
83540966|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83540967|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540968|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83540969|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
83540970|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83540971|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
83540972|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540973|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83540974|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83540975|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
83540976|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
83540977|NCT03576885|Protective Agents|protective agents|mesh-ancestor
83540979|NCT03576612|Acyclovir|acyclovir|mesh-list
83540980|NCT03576612|Nivolumab|nivolumab|mesh-list
83540981|NCT03576612|Temozolomide|temozolomide|mesh-list
83540982|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83540983|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540984|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83540985|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540986|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83540987|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
83540988|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
83540989|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83540990|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
83540991|NCT03576105|Methylene Blue|methylene blue|mesh-list
83540992|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540993|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83540994|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
83540995|NCT03568318|Upadacitinib|upadacitinib|mesh-list
83540996|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83540997|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83540998|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83540999|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541000|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541001|NCT03550794|Thiamine|thiamine|mesh-list
83541002|NCT03550794|Vitamins|vitamins|mesh-ancestor
83541003|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
83541004|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541005|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
83541006|NCT03539614|Prazosin|prazosin|mesh-list
83541007|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83541008|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83541009|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83541010|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83541011|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
83541012|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83541013|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541014|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541015|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
83541016|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
83541017|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541018|NCT03519386|Travoprost|travoprost|mesh-list
83541019|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83541020|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83541021|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83541022|NCT03495713|Nivolumab|nivolumab|mesh-list
83541023|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541024|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541025|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541026|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541027|NCT03491059|Nicotine|nicotine|mesh-list
83541028|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83541029|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
83541030|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541031|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541032|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83541033|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83541034|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
83541035|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83541036|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541037|NCT03485209|Carboplatin|carboplatin|mesh-list
83541038|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
83541039|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
83541040|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541041|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541042|NCT03485209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541043|NCT03485209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541044|NCT03459846|Durvalumab|durvalumab|mesh-list
83541045|NCT03459846|Olaparib|olaparib|mesh-list
83541186|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83541046|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541047|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541048|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83541049|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541050|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541051|NCT03456102|Pravastatin|pravastatin|mesh-list
83541052|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83541053|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83541054|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
83541055|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541056|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83541057|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83541058|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541059|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
83541060|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541061|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541062|NCT03448666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541063|NCT03448666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541064|NCT03440385|Ozanimod|ozanimod|mesh-list
83541065|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83541066|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541067|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541068|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
83541069|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541070|NCT03439865|Ivacaftor|ivacaftor|mesh-list
83541071|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83541072|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83541073|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541074|NCT03436654|Prednisone|prednisone|mesh-list
83541075|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
83541076|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541077|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
83541078|NCT03436654|Hormones|hormones|mesh-ancestor
83541079|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541080|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541081|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541082|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541083|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83541084|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541085|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541086|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
83541087|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83541088|NCT03427125|Sevelamer|sevelamer|mesh-list
83541089|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
83541090|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
83541091|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541092|NCT03412773|Sorafenib|sorafenib|mesh-list
83541093|NCT03412773|Tislelizumab|tislelizumab|mesh-list
83541094|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541095|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541096|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541097|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541098|NCT03412773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541099|NCT03393884|Paclitaxel|paclitaxel|mesh-list
83541100|NCT03393884|Carboplatin|carboplatin|mesh-list
83541101|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541102|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541103|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541104|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541105|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541106|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541107|NCT03359863|Pirfenidone|pirfenidone|mesh-list
83541108|NCT03359863|Analgesics|analgesics|mesh-ancestor
83541109|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
83541110|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541111|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541112|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83541113|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83541114|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541115|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541116|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541117|NCT03341273|Azithromycin|azithromycin|mesh-list
83541118|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83541119|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83541120|NCT03334617|Trastuzumab|trastuzumab|mesh-list
83541121|NCT03334617|Durvalumab|durvalumab|mesh-list
83541122|NCT03334617|Olaparib|olaparib|mesh-list
83541123|NCT03334617|Cediranib|cediranib|mesh-list
83541124|NCT03334617|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83541125|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541126|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541127|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83541128|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541129|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541130|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541131|NCT03334617|Immunoconjugates|immunoconjugates|mesh-ancestor
83541132|NCT03334617|Immunologic Factors|immunologic factors|mesh-ancestor
83541133|NCT03334617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541134|NCT03332797|Palbociclib|palbociclib|mesh-list
83541135|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541136|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541138|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541139|NCT03319901|Venetoclax|venetoclax|mesh-list
83541140|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541141|NCT03307785|Paclitaxel|paclitaxel|mesh-list
83541142|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83541143|NCT03307785|Bevacizumab|bevacizumab|mesh-list
83541144|NCT03307785|Carboplatin|carboplatin|mesh-list
83541145|NCT03307785|Pemetrexed|pemetrexed|mesh-list
83541146|NCT03307785|Niraparib|niraparib|mesh-list
83541147|NCT03307785|Dostarlimab|dostarlimab|mesh-list
83541148|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541149|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541150|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541151|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541152|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541153|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541154|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541155|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83541156|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83541157|NCT03307785|Growth Substances|growth substances|mesh-ancestor
83541158|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541159|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
83541160|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541161|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83541162|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83541163|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83541164|NCT03301766|Lidocaine|lidocaine|mesh-list
83541165|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
83541166|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
83541167|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83541168|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541169|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
83541170|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541171|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83541172|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83541173|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83541174|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83541175|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541176|NCT03248167|Cannabidiol|cannabidiol|mesh-list
83541177|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
83541178|NCT03243552|Levodopa|levodopa|mesh-list
83541179|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83541180|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83541181|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
83541182|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83541183|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541184|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541185|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
83541188|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83541189|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
83541190|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541191|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541192|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
83541193|NCT03198728|Testosterone|testosterone|mesh-list
83541194|NCT03198728|Androgens|androgens|mesh-ancestor
83541195|NCT03198728|Hormones|hormones|mesh-ancestor
83541196|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541197|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541198|NCT03151811|Dexamethasone|dexamethasone|mesh-list
83541199|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
83541200|NCT03151811|Melphalan|melphalan|mesh-list
83541201|NCT03151811|Pomalidomide|pomalidomide|mesh-list
83541202|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541203|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
83541204|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
83541205|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541206|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541207|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83541208|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
83541209|NCT03151811|Hormones|hormones|mesh-ancestor
83541210|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541211|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541212|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541213|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541214|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
83541215|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541216|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83541217|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541218|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
83541219|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83541220|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83541221|NCT03151811|Growth Substances|growth substances|mesh-ancestor
83541222|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
83541223|NCT03148418|Atezolizumab|atezolizumab|mesh-list
83541224|NCT03148418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541225|NCT03148418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541226|NCT03148418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541227|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541228|NCT03144804|Lamivudine|lamivudine|mesh-list
83541229|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83541230|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83541231|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541232|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541233|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
83541234|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83541235|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83541236|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83541237|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
83541238|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541239|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541240|NCT03142334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541241|NCT03142334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541242|NCT03141034|Irinotecan|irinotecan|mesh-list
83541243|NCT03141034|Ramucirumab|ramucirumab|mesh-list
83541244|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83541245|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83541246|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541247|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541248|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541249|NCT03126539|Sulforaphane|sulforaphane|mesh-list
83541250|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83541251|NCT03126539|Protective Agents|protective agents|mesh-ancestor
83541252|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541253|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541254|NCT03114319|Nazartinib|nazartinib|mesh-list
83541255|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541256|NCT03107923|Dobutamine|dobutamine|mesh-list
83541257|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83541258|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
83541259|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
83541260|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541261|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541262|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83541263|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83541264|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83541265|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
83541266|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83541267|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541268|NCT03107923|Protective Agents|protective agents|mesh-ancestor
83541269|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
83541270|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
83541272|NCT03096782|Busulfan|busulfan|mesh-list
83541273|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
83541274|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83541275|NCT03096782|Rituximab|rituximab|mesh-list
83541276|NCT03096782|Fludarabine|fludarabine|mesh-list
83541277|NCT03096782|Clofarabine|clofarabine|mesh-list
83541278|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83541279|NCT03096782|Tacrolimus|tacrolimus|mesh-list
83541280|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
83541281|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83541282|NCT03096782|Antibodies|antibodies|mesh-list
83541283|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
83541284|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83541285|NCT03096782|Lenograstim|lenograstim|mesh-list
83541286|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541287|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
83541288|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541289|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541290|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541291|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
83541292|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541293|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541294|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83541295|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83541296|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
83541297|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83541298|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83541299|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541300|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83541301|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83541302|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
83541303|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83541304|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83541306|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541307|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
83541308|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
83541309|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541310|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541311|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83541312|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
83541313|NCT03092817|Hormones|hormones|mesh-ancestor
83541314|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541315|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541316|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541317|NCT03078010|Tazobactam|tazobactam|mesh-list
83541318|NCT03078010|Piperacillin|piperacillin|mesh-list
83541319|NCT03078010|Cefepime|cefepime|mesh-list
83541320|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83541321|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83541322|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83541323|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83541324|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541325|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541326|NCT03065387|Everolimus|everolimus|mesh-list
83541327|NCT03065387|Palbociclib|palbociclib|mesh-list
83541328|NCT03065387|Trametinib|trametinib|mesh-list
83541329|NCT03065387|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83541330|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541331|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541332|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541333|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541334|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
83541335|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541336|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541337|NCT03064126|Paclitaxel|paclitaxel|mesh-list
83541338|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83541339|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541341|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541342|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541343|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541344|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541345|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
83541346|NCT03043664|Lanreotide|lanreotide|mesh-list
83541347|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541348|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541349|NCT03043664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541350|NCT03043664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541351|NCT03006068|Upadacitinib|upadacitinib|mesh-list
83541352|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83541353|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541354|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541355|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541356|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541357|NCT02992522|Lenalidomide|lenalidomide|mesh-list
83541358|NCT02992522|Venetoclax|venetoclax|mesh-list
83541359|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
83541360|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
83541361|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541362|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83541363|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83541364|NCT02992522|Growth Substances|growth substances|mesh-ancestor
83541365|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
83541366|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541367|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541368|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
83541369|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541370|NCT02969681|Vitamins|vitamins|mesh-ancestor
83541371|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
83541372|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
83541373|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541374|NCT02969681|Protective Agents|protective agents|mesh-ancestor
83541375|NCT02956590|Pitavastatin|pitavastatin|mesh-list
83541376|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83541377|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83541378|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83541379|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
83541380|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541381|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541382|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83541383|NCT02949700|Metformin|metformin|mesh-list
83541384|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83541385|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541386|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83541387|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83541388|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83541389|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
83541390|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541391|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541392|NCT02944071|Paclitaxel|paclitaxel|mesh-list
83541393|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541394|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541395|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541396|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541397|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541398|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541399|NCT02941783|Factor VIII|factor viii|mesh-list
83541400|NCT02941783|Coagulants|coagulants|mesh-ancestor
83541401|NCT02864550|Doxycycline|doxycycline|mesh-list
83541402|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83541403|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83541404|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
83541405|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83541406|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83541407|NCT02841995|Belumosudil|belumosudil|mesh-list
83541408|NCT02841995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541409|NCT02841995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541410|NCT02841995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541411|NCT02773030|Dexamethasone|dexamethasone|mesh-list
83541412|NCT02773030|Bortezomib|bortezomib|mesh-list
83541413|NCT02773030|Daratumumab|daratumumab|mesh-list
83541414|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541415|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
83541417|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541418|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541419|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83541420|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
83541421|NCT02773030|Hormones|hormones|mesh-ancestor
83541422|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541423|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541424|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541425|NCT02754596|Timolol|timolol|mesh-list
83541426|NCT02754596|Travoprost|travoprost|mesh-list
83541427|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83541428|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83541429|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541430|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83541431|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83541432|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
83541433|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83541434|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541435|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83541436|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83541437|NCT02752035|Azacitidine|azacitidine|mesh-list
83541438|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83541439|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
83541440|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541441|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541442|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541443|NCT02728050|Cytarabine|cytarabine|mesh-list
83541444|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83541445|NCT02728050|Sorafenib|sorafenib|mesh-list
83541446|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
83541447|NCT02728050|Cladribine|cladribine|mesh-list
83541448|NCT02728050|Lenograstim|lenograstim|mesh-list
83541449|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83541450|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
83541451|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541452|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541453|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
83541454|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83541455|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541456|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
83541457|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541458|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83541459|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541460|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541461|NCT02728050|Analgesics|analgesics|mesh-ancestor
83541462|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
83541463|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541464|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83541465|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83541466|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
83541467|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541468|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541469|NCT02702414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541470|NCT02702414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541471|NCT02667587|Nivolumab|nivolumab|mesh-list
83541472|NCT02667587|Temozolomide|temozolomide|mesh-list
83541473|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541474|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541475|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541476|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541477|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541478|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
83541479|NCT02640534|Metformin|metformin|mesh-list
83541480|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83541481|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541482|NCT02632409|Nivolumab|nivolumab|mesh-list
83541483|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541484|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541485|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541486|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541487|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
83541488|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83541489|NCT02626455|Prednisone|prednisone|mesh-list
83541490|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
83541491|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83541495|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541496|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
83541497|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541498|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541499|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541500|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
83541501|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541502|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541503|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83541504|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541505|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83541506|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83541507|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83541508|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541509|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541510|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
83541511|NCT02626455|Hormones|hormones|mesh-ancestor
83541512|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541513|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541514|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541515|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541516|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541517|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541518|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
83541519|NCT02625480|Fludarabine|fludarabine|mesh-list
83541520|NCT02625480|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
83541521|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541522|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
83541523|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541524|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541525|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541526|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
83541527|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541528|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541529|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83541530|NCT02625480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541531|NCT02598726|Curcumin|curcumin|mesh-list
83541532|NCT02598726|Piperine|piperine|mesh-list
83541533|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83541534|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83541535|NCT02598726|Analgesics|analgesics|mesh-ancestor
83541536|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
83541537|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541538|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541539|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541540|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541541|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541542|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541543|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541544|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83541545|NCT02586038|Thalidomide|thalidomide|mesh-list
83541546|NCT02586038|Dexamethasone|dexamethasone|mesh-list
83541547|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
83541548|NCT02586038|Ixazomib|ixazomib|mesh-list
83541549|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541550|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
83541551|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541552|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541553|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541554|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
83541555|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541556|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541557|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83541558|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541559|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
83541560|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
83541561|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541562|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83541563|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
83541564|NCT02586038|Hormones|hormones|mesh-ancestor
83541565|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541566|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541567|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
83541568|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83541569|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83541570|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83541571|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83541572|NCT02586038|Growth Substances|growth substances|mesh-ancestor
83541573|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
83541574|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
83541575|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541576|NCT02579811|Axitinib|axitinib|mesh-list
83541577|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541578|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541579|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541580|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541581|NCT02554383|Amoxicillin|amoxicillin|mesh-list
83541582|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
83541583|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
83541584|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83541585|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83541586|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83541587|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83541588|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541589|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541590|NCT02531516|Bicalutamide|bicalutamide|mesh-list
83541591|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
83541592|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
83541593|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541594|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541595|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541596|NCT02519439|Ganaxolone|ganaxolone|mesh-list
83541597|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
83541598|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83541599|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541600|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541601|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
83541602|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
83541603|NCT02500797|Nivolumab|nivolumab|mesh-list
83541604|NCT02500797|Ipilimumab|ipilimumab|mesh-list
83541605|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541606|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541607|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541608|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541609|NCT02404870|Canagliflozin|canagliflozin|mesh-list
83541610|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83541611|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541612|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83541613|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541614|NCT02359175|Acetaminophen|acetaminophen|mesh-list
83541615|NCT02359175|Fentanyl|fentanyl|mesh-list
83541616|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
83541617|NCT02359175|Bupivacaine|bupivacaine|mesh-list
83541618|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
83541619|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
83541620|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83541621|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541622|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
83541623|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541624|NCT02359175|Narcotics|narcotics|mesh-ancestor
83541625|NCT02359175|Analgesics|analgesics|mesh-ancestor
83541626|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83541627|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83541628|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
83541629|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83541630|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
83541631|NCT02339571|Nivolumab|nivolumab|mesh-list
83541632|NCT02339571|Ipilimumab|ipilimumab|mesh-list
83541633|NCT02339571|Sargramostim|sargramostim|mesh-list
83541634|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541635|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541636|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541637|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541638|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
83541639|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541640|NCT02215980|Dexamethasone|dexamethasone|mesh-list
83541641|NCT02215980|Lenalidomide|lenalidomide|mesh-list
83541642|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541643|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
83541644|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
83541645|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541646|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541647|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83541648|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
83541649|NCT02215980|Hormones|hormones|mesh-ancestor
83541650|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541651|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541652|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541653|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
83541654|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83541655|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83541656|NCT02215980|Growth Substances|growth substances|mesh-ancestor
83541657|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
83541658|NCT02194738|Paclitaxel|paclitaxel|mesh-list
83541659|NCT02194738|Cisplatin|cisplatin|mesh-list
83541660|NCT02194738|Carboplatin|carboplatin|mesh-list
83541661|NCT02194738|Gemcitabine|gemcitabine|mesh-list
83541662|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
83541663|NCT02194738|Nivolumab|nivolumab|mesh-list
83541664|NCT02194738|Pemetrexed|pemetrexed|mesh-list
83541665|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83541666|NCT02194738|Crizotinib|crizotinib|mesh-list
83541667|NCT02194738|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83541668|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541669|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541670|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541671|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541672|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541673|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541674|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83541675|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
83541676|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541677|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541678|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541679|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83541680|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83541681|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541682|NCT02185560|Sorafenib|sorafenib|mesh-list
83541683|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541684|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541685|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541686|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541687|NCT02101021|Paclitaxel|paclitaxel|mesh-list
83541688|NCT02101021|Gemcitabine|gemcitabine|mesh-list
83541689|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83541690|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541691|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541692|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541693|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541694|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541695|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541696|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83541697|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
83541698|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541699|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541700|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83541701|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83541702|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541703|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541704|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83541705|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83541706|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541707|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
83541708|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83541709|NCT02031536|Everolimus|everolimus|mesh-list
83541710|NCT02031536|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83541711|NCT02031536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83541712|NCT02031536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541713|NCT02031536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541714|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541715|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
83541716|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541717|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541718|NCT02023996|Trastuzumab|trastuzumab|mesh-list
83541719|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541720|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541721|NCT02020720|Fluorides|fluorides|mesh-list
83541722|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
83541723|NCT02020720|Protective Agents|protective agents|mesh-ancestor
83541724|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541725|NCT02020707|Paclitaxel|paclitaxel|mesh-list
83541726|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83541727|NCT02020707|Bevacizumab|bevacizumab|mesh-list
83541728|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83541729|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
83541730|NCT02020707|Antibodies|antibodies|mesh-list
83541731|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
83541732|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83541733|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
83541734|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541735|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541736|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541737|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541738|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541739|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541740|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83541741|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83541742|NCT02020707|Growth Substances|growth substances|mesh-ancestor
83541743|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541744|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
83541745|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
83541746|NCT01968200|Enalapril|enalapril|mesh-list
83541747|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83541748|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
83541749|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541750|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541751|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83541752|NCT01964430|Paclitaxel|paclitaxel|mesh-list
83541753|NCT01964430|Gemcitabine|gemcitabine|mesh-list
83541754|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541755|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541756|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541757|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541758|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541759|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541760|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83541761|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
83541762|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83541763|NCT01928394|Nivolumab|nivolumab|mesh-list
83541764|NCT01928394|Ipilimumab|ipilimumab|mesh-list
83541765|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541766|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541767|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83541768|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541769|NCT01898494|Cisplatin|cisplatin|mesh-list
83541770|NCT01898494|Carboplatin|carboplatin|mesh-list
83541771|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541772|NCT01841359|Pramlintide|pramlintide|mesh-list
83541773|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83541774|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541775|NCT01824875|Capecitabine|capecitabine|mesh-list
83541776|NCT01824875|Temozolomide|temozolomide|mesh-list
83541777|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83541778|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
83541779|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541780|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541781|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541782|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
83541783|NCT01724346|Chlorambucil|chlorambucil|mesh-list
83541784|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541785|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
83541786|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541787|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541788|NCT01579734|Tamoxifen|tamoxifen|mesh-list
83541789|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83541790|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
83541791|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541792|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541793|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541794|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541795|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83541796|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83541797|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83541798|NCT01566240|Paclitaxel|paclitaxel|mesh-list
83541799|NCT01566240|Carboplatin|carboplatin|mesh-list
83541800|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541801|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541802|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541803|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541804|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541805|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541806|NCT01390584|Prednisone|prednisone|mesh-list
83541807|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
83541808|NCT01390584|Dacarbazine|dacarbazine|mesh-list
83541809|NCT01390584|Doxorubicin|doxorubicin|mesh-list
83541810|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83541811|NCT01390584|Etoposide|etoposide|mesh-list
83541812|NCT01390584|Vincristine|vincristine|mesh-list
83541813|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
83541814|NCT01390584|Bleomycin|bleomycin|mesh-list
83541815|NCT01390584|Vinblastine|vinblastine|mesh-list
83541816|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
83541817|NCT01390584|Procarbazine|procarbazine|mesh-list
83541818|NCT01390584|Imidazole|imidazole|mesh-list
83541819|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541820|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
83541821|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541822|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541823|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541824|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
83541825|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541826|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541827|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83541828|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83541829|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83541830|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83541831|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541832|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541833|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
83541834|NCT01390584|Hormones|hormones|mesh-ancestor
83541835|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541836|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541837|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541838|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541839|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541840|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541841|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
83541842|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
83541843|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
83541844|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541845|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
83541846|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541847|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541848|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541849|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
83541850|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541851|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541852|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83541853|NCT01319565|Aldesleukin|aldesleukin|mesh-list
83541854|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
83541855|NCT01319565|Fludarabine|fludarabine|mesh-list
83541856|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541857|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
83541858|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541859|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541860|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541861|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
83541862|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541863|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541864|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83541865|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83541866|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83541867|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
83541868|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83541869|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
83541870|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
83541871|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541872|NCT01216683|Rituximab|rituximab|mesh-list
83541873|NCT01216683|Lenalidomide|lenalidomide|mesh-list
83541874|NCT01216683|Bortezomib|bortezomib|mesh-list
83541875|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83541876|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541877|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541878|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
83541879|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541880|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541881|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83541882|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83541883|NCT01216683|Growth Substances|growth substances|mesh-ancestor
83541884|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
83541885|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541886|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
83541887|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541888|NCT01166113|Prednisone|prednisone|mesh-list
83541889|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
83541890|NCT01166113|Pomalidomide|pomalidomide|mesh-list
83541891|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541892|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
83541893|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541894|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541895|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541896|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
83541897|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541898|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541899|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83541900|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541901|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
83541902|NCT01166113|Hormones|hormones|mesh-ancestor
83541903|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541904|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541905|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83541906|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83541907|NCT01166113|Growth Substances|growth substances|mesh-ancestor
83541908|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
83541909|NCT01160107|Prednisone|prednisone|mesh-list
83541910|NCT01160107|Melphalan|melphalan|mesh-list
83541911|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541912|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
83541913|NCT01160107|Hormones|hormones|mesh-ancestor
83541914|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541915|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541916|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541917|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541918|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541919|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
83541920|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541921|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83541922|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541923|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
83541924|NCT01145495|Rituximab|rituximab|mesh-list
83541925|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83541926|NCT01145495|Lenalidomide|lenalidomide|mesh-list
83541927|NCT01145495|Antibodies|antibodies|mesh-list
83541928|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
83541929|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83541930|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
83541931|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541932|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541933|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541934|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83541935|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83541936|NCT01145495|Growth Substances|growth substances|mesh-ancestor
83541937|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
83541938|NCT01124695|Tamoxifen|tamoxifen|mesh-list
83541939|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83541940|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
83541941|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541942|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541943|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541944|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542020|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83541945|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83541946|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83541947|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83541948|NCT01084083|Paclitaxel|paclitaxel|mesh-list
83541949|NCT01084083|Cetuximab|cetuximab|mesh-list
83541950|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83541951|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541952|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
83541953|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
83541954|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83541955|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541956|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541957|NCT01079780|Irinotecan|irinotecan|mesh-list
83541958|NCT01079780|Cetuximab|cetuximab|mesh-list
83541959|NCT01079780|Ramucirumab|ramucirumab|mesh-list
83541960|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83541961|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83541962|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541963|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541964|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541965|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541966|NCT01063179|Thalidomide|thalidomide|mesh-list
83541967|NCT01063179|Prednisone|prednisone|mesh-list
83541968|NCT01063179|Bortezomib|bortezomib|mesh-list
83541969|NCT01063179|Melphalan|melphalan|mesh-list
83541970|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83541971|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
83541972|NCT01063179|Hormones|hormones|mesh-ancestor
83541973|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83541974|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541975|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83541976|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541977|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83541978|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
83541979|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83541980|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83541981|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83541982|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
83541983|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
83541984|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83541985|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83541986|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83541987|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83541988|NCT01063179|Growth Substances|growth substances|mesh-ancestor
83541989|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
83541990|NCT01013961|Rituximab|rituximab|mesh-list
83541991|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
83541992|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83541993|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83541994|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
83541995|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83541996|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83541997|NCT00834093|Immunomodulating Agents|immunomodulating agents|mesh-list
83541998|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
83541999|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542000|NCT00783510|Adalimumab|adalimumab|mesh-list
83542001|NCT00783510|Methotrexate|methotrexate|mesh-list
83542002|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83542003|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
83542004|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83542005|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542006|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83542007|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
83542008|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542009|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542010|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
83542011|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542012|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83542013|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542014|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
83542015|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542016|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83542017|NCT00783510|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83542018|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542019|NCT00779194|Sirolimus|sirolimus|mesh-list
83542021|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542022|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83542023|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542024|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
83542025|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542026|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
83542027|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542028|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83542030|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83542031|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
83542032|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542033|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542034|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83542035|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
83542036|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
83542037|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83542038|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83542039|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83542040|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83542041|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
83542042|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83542043|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542044|NCT00606294|Misonidazole|misonidazole|mesh-list
83542045|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542046|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83542047|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83542048|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542050|NCT00551928|Lenalidomide|lenalidomide|mesh-list
83542051|NCT00551928|Melphalan|melphalan|mesh-list
83542052|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542053|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
83542054|NCT00551928|Hormones|hormones|mesh-ancestor
83542055|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83542056|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542057|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83542058|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542059|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
83542060|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83542061|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83542062|NCT00551928|Growth Substances|growth substances|mesh-ancestor
83542063|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
83542064|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542065|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
83542066|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542067|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83542068|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542069|NCT00330564|Sunitinib|sunitinib|mesh-list
83542070|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542071|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83542072|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83542073|NCT00330564|Growth Substances|growth substances|mesh-ancestor
83542074|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542075|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
83542076|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83542077|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542078|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542079|NCT00316888|Cisplatin|cisplatin|mesh-list
83542080|NCT00316888|Fluorouracil|fluorouracil|mesh-list
83542081|NCT00316888|Cetuximab|cetuximab|mesh-list
83542082|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542083|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
83542084|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542085|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83542086|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542087|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
83542088|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542089|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542090|NCT00309478|Tamoxifen|tamoxifen|mesh-list
83542091|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
83542092|NCT00309478|Fluorouracil|fluorouracil|mesh-list
83542093|NCT00309478|Methotrexate|methotrexate|mesh-list
83542094|NCT00309478|Goserelin|goserelin|mesh-list
83542095|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542103|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83542104|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
83542105|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83542106|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83542107|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
83542108|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83542109|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
83542110|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542111|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83542112|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83542113|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83542114|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
83542115|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83542116|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83542117|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83542118|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83542119|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83542120|NCT00295646|Tamoxifen|tamoxifen|mesh-list
83542121|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
83542122|NCT00295646|Anastrozole|anastrozole|mesh-list
83542123|NCT00295646|Goserelin|goserelin|mesh-list
83542124|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83542125|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
83542126|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83542127|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542128|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83542129|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542130|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83542131|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83542132|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83542133|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83542134|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83542135|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542136|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542137|NCT00274924|Prednisone|prednisone|mesh-list
83542138|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
83542139|NCT00274924|Ifosfamide|ifosfamide|mesh-list
83542140|NCT00274924|Rituximab|rituximab|mesh-list
83542141|NCT00274924|Carboplatin|carboplatin|mesh-list
83542142|NCT00274924|Doxorubicin|doxorubicin|mesh-list
83542143|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83542144|NCT00274924|Etoposide|etoposide|mesh-list
83542145|NCT00274924|Vincristine|vincristine|mesh-list
83542146|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
83542147|NCT00274924|Lenograstim|lenograstim|mesh-list
83542148|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542149|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
83542150|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542151|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542152|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542153|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
83542154|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542155|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542156|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83542157|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542158|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83542159|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83542160|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83542161|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542162|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542163|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
83542164|NCT00274924|Hormones|hormones|mesh-ancestor
83542165|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83542166|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83542167|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83542168|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83542169|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
83542170|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
83542171|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
83542172|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
83542173|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
83542174|NCT00104884|Romidepsin|romidepsin|mesh-list
83542175|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83542176|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542177|NCT00104884|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83542203|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
83542204|NCT00078949|Hormones|hormones|mesh-ancestor
83542205|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83542206|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83542207|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83542208|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
83542209|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542210|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
83542211|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542212|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542213|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
83542214|NCT00074282|Rituximab|rituximab|mesh-list
83542215|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
83542216|NCT00074282|Pentostatin|pentostatin|mesh-list
83542217|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542218|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
83542219|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542220|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542221|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542222|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
83542223|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542224|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542225|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83542226|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542227|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83542228|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542229|NCT00071981|Molgramostim|molgramostim|mesh-list
83542230|NCT00071981|Vaccines|vaccines|mesh-list
83542231|NCT00071981|Sargramostim|sargramostim|mesh-list
83542232|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
83542233|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
83542234|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542235|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542236|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83542237|NCT00070291|Cyclosporine|cyclosporine|mesh-list
83542238|NCT00070291|Cyclosporins|cyclosporins|mesh-list
83542239|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542240|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542241|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542242|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
83542243|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542244|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
83542245|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542246|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
83542247|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542248|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83542249|NCT00064350|Sorafenib|sorafenib|mesh-list
83542250|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542251|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83542252|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542253|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542254|NCT00060346|Prednisone|prednisone|mesh-list
83542255|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
83542256|NCT00060346|Rituximab|rituximab|mesh-list
83542257|NCT00060346|Doxorubicin|doxorubicin|mesh-list
83542258|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83542259|NCT00060346|Vincristine|vincristine|mesh-list
83542260|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542261|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
83542262|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542263|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542264|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542265|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
83542266|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542267|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542268|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83542269|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542270|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83542271|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83542272|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83542273|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542274|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542275|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
83542354|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83542277|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83542278|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83542279|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83542280|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
83542281|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
83542282|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
83542283|NCT00057954|Cyclosporine|cyclosporine|mesh-list
83542284|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
83542285|NCT00057954|Methotrexate|methotrexate|mesh-list
83542286|NCT00057954|Pentostatin|pentostatin|mesh-list
83542287|NCT00057954|Cyclosporins|cyclosporins|mesh-list
83542288|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83542289|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
83542290|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83542291|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542292|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83542293|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
83542294|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542295|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542296|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
83542297|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542298|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83542299|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542300|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
83542301|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542302|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83542303|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
83542304|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542305|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83542306|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83542307|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83542308|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
83542309|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83542310|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83542311|NCT00049530|Interferons|interferons|mesh-list
83542312|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
83542313|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
83542314|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83542315|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542316|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
83542317|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542318|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
83542319|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542320|NCT00045305|Cyclosporine|cyclosporine|mesh-list
83542321|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
83542322|NCT00045305|Methotrexate|methotrexate|mesh-list
83542323|NCT00045305|Pentostatin|pentostatin|mesh-list
83542324|NCT00045305|Methoxsalen|methoxsalen|mesh-list
83542325|NCT00045305|Cyclosporins|cyclosporins|mesh-list
83542326|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83542327|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
83542328|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83542329|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542330|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83542331|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
83542332|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542333|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542334|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
83542335|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542336|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83542337|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542338|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
83542339|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542340|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83542341|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
83542342|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542343|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83542344|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83542345|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83542346|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
83542347|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83542348|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83542349|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83542350|NCT00033657|Paclitaxel|paclitaxel|mesh-list
83542351|NCT00033657|Camptothecin|camptothecin|mesh-list
83542352|NCT00033657|Cisplatin|cisplatin|mesh-list
83542353|NCT00033657|Irinotecan|irinotecan|mesh-list
83542355|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542356|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
83542357|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
83542358|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
83542359|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542360|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83542361|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83542362|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542363|NCT00006421|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83542364|NCT00006421|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83542365|NCT00006421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542366|NCT00003389|Prednisone|prednisone|mesh-list
83542367|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
83542368|NCT00003389|Dacarbazine|dacarbazine|mesh-list
83542369|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
83542370|NCT00003389|Doxorubicin|doxorubicin|mesh-list
83542371|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83542372|NCT00003389|Etoposide|etoposide|mesh-list
83542373|NCT00003389|Vincristine|vincristine|mesh-list
83542374|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
83542375|NCT00003389|Bleomycin|bleomycin|mesh-list
83542376|NCT00003389|Vinblastine|vinblastine|mesh-list
83542377|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
83542378|NCT00003389|Imidazole|imidazole|mesh-list
83542379|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542380|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
83542381|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542382|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542383|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542384|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
83542385|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542386|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542387|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83542388|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83542389|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83542390|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83542391|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542392|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542393|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
83542394|NCT00003389|Hormones|hormones|mesh-ancestor
83542395|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83542396|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83542397|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83542398|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
83542399|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
83542400|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
83542401|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
83542402|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
83542403|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
83542404|NCT00003138|Lenograstim|lenograstim|mesh-list
83542405|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83542406|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
83542407|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542408|NCT00003138|Hematinics|hematinics|mesh-ancestor
83542409|NCT00002525|Leucovorin|leucovorin|mesh-list
83542410|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
83542411|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83542412|NCT00002525|Fluorouracil|fluorouracil|mesh-list
83542413|NCT00002525|Calcium|calcium|mesh-list
83542414|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
83542415|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83542416|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542417|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
83542418|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542419|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83542420|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542421|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542422|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
83542423|NCT00002525|Antidotes|antidotes|mesh-ancestor
83542424|NCT00002525|Protective Agents|protective agents|mesh-ancestor
83542425|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
83542426|NCT00002525|Vitamins|vitamins|mesh-ancestor
83542427|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
83542428|NCT00001379|Interferons|interferons|mesh-list
83542429|NCT00001379|Rituximab|rituximab|mesh-list
83542430|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542431|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
83542432|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542433|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542434|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
83542435|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542436|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389744|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389745|NCT05013060|Butyric Acid|butyric acid|mesh-list
83389746|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
83389747|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
83389748|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389749|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389750|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389751|NCT05008068|Simvastatin|simvastatin|mesh-list
83389752|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83389753|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83389754|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
83389755|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389756|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83389757|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83389758|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389759|NCT00925119|Atenolol|atenolol|mesh-list
83389760|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83389761|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83389762|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
83389763|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
83389764|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389765|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389766|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83389767|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83389768|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83389769|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
83389770|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389771|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389772|NCT04020809|Atezolizumab|atezolizumab|mesh-list
83389773|NCT04020809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83389774|NCT04020809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389775|NCT04020809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83389776|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389777|NCT04027751|Tropisetron|tropisetron|mesh-list
83389778|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
83389779|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
83389780|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389781|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389782|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83389783|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83389784|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83389785|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
83389786|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389787|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389788|NCT05018988|Vitamin D|vitamin d|mesh-list
83389789|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
83389790|NCT05018988|Cholecalciferol|cholecalciferol|mesh-list
83389791|NCT05018988|Vitamins|vitamins|mesh-list
83389792|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
83389793|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389794|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83389795|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83389796|NCT04028765|Misoprostol|misoprostol|mesh-list
83389797|NCT04028765|Oxytocin|oxytocin|mesh-list
83389798|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
83389799|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83389800|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389801|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83389802|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
83389803|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83389804|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83389805|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
83389806|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83389807|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389808|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83389809|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83389810|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389811|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389812|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389827|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389828|NCT04027283|Erythritol|erythritol|mesh-list
83389829|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
83389830|NCT04028141|Ketamine|ketamine|mesh-list
83389831|NCT04028141|Propofol|propofol|mesh-list
83389832|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83389833|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389834|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389835|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83389836|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
83389837|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
83389838|NCT04028141|Analgesics|analgesics|mesh-ancestor
83389839|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
83389840|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389841|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83389842|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83389843|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83389844|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389845|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389846|NCT03401541|Vitamin D|vitamin d|mesh-list
83389847|NCT03401541|Calcifediol|calcifediol|mesh-list
83389848|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
83389849|NCT03401541|Vitamins|vitamins|mesh-ancestor
83389850|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
83389851|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389852|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83389853|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83389854|NCT03953261|Curcumin|curcumin|mesh-list
83389855|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83389856|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83389857|NCT03953261|Analgesics|analgesics|mesh-ancestor
83389858|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
83389859|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389860|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389861|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83389862|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389863|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389864|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389865|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389866|NCT02242149|Diacerein|diacerein|mesh-list
83389867|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83389868|NCT03022565|Vorinostat|vorinostat|mesh-list
83389869|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389870|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83389871|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389872|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389873|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
83389874|NCT03079050|Lansoprazole|lansoprazole|mesh-list
83389875|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83389876|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83389877|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83389878|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389879|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389880|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
83389881|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83389882|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389883|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389884|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83389885|NCT03834129|Analgesics|analgesics|mesh-ancestor
83389886|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
83389887|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389888|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83389889|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83389890|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83389891|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
83389892|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389893|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389894|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
83389895|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83389896|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389897|NCT03022409|Olaparib|olaparib|mesh-list
83389898|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83389899|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389900|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389901|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389902|NCT03833895|Phenylephrine|phenylephrine|mesh-list
83389903|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
83389904|NCT03833895|Norepinephrine|norepinephrine|mesh-list
83389905|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83389906|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
83389907|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
83389908|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389909|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389910|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
83389911|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83389912|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
83389913|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
83389914|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83389915|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83389916|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83389917|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
83389918|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389919|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389920|NCT03833895|Protective Agents|protective agents|mesh-ancestor
83389921|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83389922|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83389923|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
83389924|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389925|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389926|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83389927|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
83389928|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83389929|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83389930|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83389931|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
83389932|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389933|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389934|NCT05000892|Paclitaxel|paclitaxel|mesh-list
83389935|NCT05000892|Carboplatin|carboplatin|mesh-list
83389936|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83389937|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389938|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
83389939|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
83389940|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
83389941|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389942|NCT04372407|Itraconazole|itraconazole|mesh-list
83389943|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
83389944|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389945|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83389946|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83389947|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389948|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389949|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83389950|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
83389951|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389952|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389953|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83389954|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83389955|NCT02242383|Telmisartan|telmisartan|mesh-list
83389956|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83389957|NCT02242383|Diuretics|diuretics|mesh-ancestor
83389958|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
83389959|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389960|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83389961|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83389962|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389963|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83389964|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83389965|NCT04366089|Azithromycin|azithromycin|mesh-list
83389966|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
83389967|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83389968|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389969|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
83389970|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83389971|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83389972|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389973|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390003|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83390004|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83390005|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390006|NCT04999878|Dexamethasone|dexamethasone|mesh-list
83390007|NCT04999878|Gemcitabine|gemcitabine|mesh-list
83390008|NCT04999878|Etoposide|etoposide|mesh-list
83390009|NCT04999878|Cisplatin|cisplatin|mesh-list
83390010|NCT04999878|Pegaspargase|pegaspargase|mesh-list
83390011|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83390012|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
83390013|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
83390014|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390015|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390016|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83390017|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
83390018|NCT04999878|Hormones|hormones|mesh-ancestor
83390019|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83390020|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83390021|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390022|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83390023|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
83390024|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390025|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83390026|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83390027|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83390028|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390029|NCT02242929|Imiquimod|imiquimod|mesh-list
83390030|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83390031|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
83390032|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390033|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390034|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
83390035|NCT04457856|Plonmarlimab|plonmarlimab|mesh-list
83390036|NCT04457856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83390037|NCT04457856|Antiviral Agents|antiviral agents|mesh-ancestor
83390038|NCT04457856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390039|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83390041|NCT05006898|Pilocarpine|pilocarpine|mesh-list
83390042|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83390043|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83390044|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83390045|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83390046|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
83390047|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390048|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390049|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390050|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
83390051|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
83390052|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390053|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
83390054|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83390055|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
83390056|NCT05006898|Miotics|miotics|mesh-ancestor
83390057|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83390058|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83390059|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
83390060|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
83390061|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83390062|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83390063|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390064|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83390065|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83390066|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390067|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390068|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390069|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83390070|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
83390071|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83390072|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390073|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83390074|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83390075|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83390076|NCT03076320|Adapalene|adapalene|mesh-list
83390091|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
83390092|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390093|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390094|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83390095|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390096|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83390097|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83390098|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390099|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83390100|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83390101|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390102|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
83390103|NCT02243553|Vitamin K|vitamin k|mesh-list
83390104|NCT02243553|Ritonavir|ritonavir|mesh-list
83390105|NCT02243553|Tipranavir|tipranavir|mesh-list
83390106|NCT02243553|Digoxin|digoxin|mesh-list
83390107|NCT02243553|Midazolam|midazolam|mesh-list
83390108|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
83390109|NCT02243553|Caffeine|caffeine|mesh-list
83390110|NCT02243553|Omeprazole|omeprazole|mesh-list
83390111|NCT02243553|Warfarin|warfarin|mesh-list
83390112|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83390113|NCT02243553|Vitamins|vitamins|mesh-ancestor
83390114|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
83390115|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390116|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83390117|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83390118|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390119|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83390120|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83390121|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83390122|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83390123|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
83390124|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
83390125|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
83390126|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
83390127|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390128|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390129|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83390130|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83390131|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
83390132|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390133|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83390134|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83390135|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
83390136|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390137|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83390138|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83390139|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
83390140|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83390141|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83390142|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83390143|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83390144|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
83390145|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83390146|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83390147|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83390148|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83390149|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83390150|NCT02243553|Protective Agents|protective agents|mesh-ancestor
83390151|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83390152|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83390153|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
83390154|NCT02243553|Coagulants|coagulants|mesh-ancestor
83390155|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
83390156|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
83390157|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83390158|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83390159|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
83390160|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83390161|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
83390162|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83390163|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390164|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83390165|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83390166|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83390167|NCT05006664|Prednisone|prednisone|mesh-list
83390168|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
83390185|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83390186|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390187|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83390188|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
83390189|NCT05006664|Hormones|hormones|mesh-ancestor
83390190|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83390191|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83390192|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83390193|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83390194|NCT05006664|Immunotoxins|immunotoxins|mesh-ancestor
83390195|NCT05006664|Immunoconjugates|immunoconjugates|mesh-ancestor
83390196|NCT04346901|Methimazole|methimazole|mesh-list
83390197|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
83390198|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
83390199|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83390200|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390201|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83390202|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83390203|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390204|NCT02244021|Immunotoxins|immunotoxins|mesh-ancestor
83390205|NCT02244021|Immunoconjugates|immunoconjugates|mesh-ancestor
83390206|NCT02244021|Immunologic Factors|immunologic factors|mesh-ancestor
83390207|NCT02244021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390208|NCT04364451|Asparaginase|asparaginase|mesh-list
83390209|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390210|NCT02245269|Ritonavir|ritonavir|mesh-list
83390211|NCT02245269|Tipranavir|tipranavir|mesh-list
83390212|NCT02245269|Atorvastatin|atorvastatin|mesh-list
83390213|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83390214|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83390215|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
83390216|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390217|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83390218|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83390219|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390220|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83390221|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83390222|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
83390223|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83390224|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83390225|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
83390226|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390227|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83390228|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83390229|NCT04364139|Metoprolol|metoprolol|mesh-list
83390230|NCT04364139|Amlodipine|amlodipine|mesh-list
83390231|NCT04364139|Ramipril|ramipril|mesh-list
83390232|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83390233|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83390234|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83390235|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390236|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83390237|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390238|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
83390239|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83390240|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
83390241|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
83390242|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390243|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83390244|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83390245|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83390246|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
83390247|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390248|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83390249|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
83390250|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390251|NCT02244255|Tamsulosin|tamsulosin|mesh-list
83390252|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83390253|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83390254|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83390255|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
83390256|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390257|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390258|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390266|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390268|NCT00923949|Pioglitazone|pioglitazone|mesh-list
83390269|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83390270|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390271|NCT04376541|Fentanyl|fentanyl|mesh-list
83390272|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83390273|NCT04376541|Narcotics|narcotics|mesh-ancestor
83390274|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390275|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390276|NCT04376541|Analgesics|analgesics|mesh-ancestor
83390277|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
83390278|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390279|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83390280|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83390281|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
83390282|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
83390283|NCT04376307|Anesthetics|anesthetics|mesh-list
83390284|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390285|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390286|NCT02244489|Capecitabine|capecitabine|mesh-list
83390287|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
83390288|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83390289|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83390290|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
83390291|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390292|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390293|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83390294|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390295|NCT02244567|Metformin|metformin|mesh-list
83390296|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390297|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83390298|NCT04376073|Niraparib|niraparib|mesh-list
83390299|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83390300|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390301|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390302|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390303|NCT04999176|Enoxaparin|enoxaparin|mesh-list
83390304|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
83390305|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83390306|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
83390307|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83390308|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
83390309|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390310|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390311|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
83390312|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83390313|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83390314|NCT04363203|Azithromycin|azithromycin|mesh-list
83390315|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
83390316|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83390317|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390318|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
83390319|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83390320|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83390321|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390322|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390323|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390324|NCT04363359|Vaccines|vaccines|mesh-list
83390325|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
83390326|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390327|NCT02244879|Resveratrol|resveratrol|mesh-list
83390328|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
83390329|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390330|NCT02244879|Protective Agents|protective agents|mesh-ancestor
83390331|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390332|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390333|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83390334|NCT04362735|Vedolizumab|vedolizumab|mesh-list
83390335|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83390336|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
83390337|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83390338|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
83390339|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390340|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390341|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83390342|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
83390343|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83390344|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
83390345|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390346|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390347|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83390348|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
83390349|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
83390350|NCT04375995|Protective Agents|protective agents|mesh-ancestor
83390351|NCT04365231|Azithromycin|azithromycin|mesh-list
83390352|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
83390353|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83390354|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390355|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
83390356|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83390357|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83390358|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390359|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390360|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390361|NCT04993014|Trastuzumab|trastuzumab|mesh-list
83390362|NCT04993014|Pertuzumab|pertuzumab|mesh-list
83390363|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83390364|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390365|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
83390366|NCT05005494|Analgesics|analgesics|mesh-ancestor
83390367|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
83390368|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390369|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390370|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
83390371|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390372|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83390373|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
83390374|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83390375|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83390376|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390377|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83390378|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
83390379|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83390380|NCT04025567|Vancomycin|vancomycin|mesh-list
83390381|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83390382|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390383|NCT03074994|Anesthetics|anesthetics|mesh-list
83390384|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
83390385|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390386|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390387|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
83390388|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390389|NCT04025177|Indomethacin|indomethacin|mesh-list
83390390|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83390391|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83390392|NCT04025177|Analgesics|analgesics|mesh-ancestor
83390393|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
83390394|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390395|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390396|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83390397|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390398|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
83390399|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
83390400|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83390401|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83390402|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390403|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390404|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
83390405|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83390406|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
83390407|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390408|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
83390409|NCT04358055|Protective Agents|protective agents|mesh-ancestor
83390410|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83390411|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
83390412|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390413|NCT02985281|Ribavirin|ribavirin|mesh-list
83390414|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
83390415|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
83390416|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390461|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390462|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390463|NCT04912596|Miotics|miotics|mesh-ancestor
83390464|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83390465|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83390466|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83390467|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83390468|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
83390469|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
83390470|NCT00936741|Mifepristone|mifepristone|mesh-list
83390471|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83390472|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
83390473|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83390474|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390475|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83390476|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83390477|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83390478|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
83390479|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83390480|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83390481|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
83390482|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83390483|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
83390484|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83390485|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83390486|NCT04024865|Domperidone|domperidone|mesh-list
83390487|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
83390488|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
83390489|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390490|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390491|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83390492|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83390493|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
83390494|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390495|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390496|NCT04024241|Cytarabine|cytarabine|mesh-list
83390497|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
83390498|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83390499|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
83390500|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390501|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390502|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
83390503|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390504|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83390505|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
83390506|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390507|NCT04024241|Analgesics|analgesics|mesh-ancestor
83390508|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
83390509|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390510|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83390511|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83390512|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390513|NCT04024163|Benzonidazole|benzonidazole|mesh-list
83390514|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83390515|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
83390516|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390517|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83390518|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83390519|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83390520|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390521|NCT04996290|Ropivacaine|ropivacaine|mesh-list
83390522|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
83390523|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
83390524|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390525|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390526|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
83390527|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390528|NCT04023617|Docetaxel|docetaxel|mesh-list
83390529|NCT04023617|Nivolumab|nivolumab|mesh-list
83390530|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390531|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
83390532|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
83390533|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
83390534|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390535|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83390536|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83390537|NCT04023149|Aldesleukin|aldesleukin|mesh-list
83390538|NCT04023149|Interleukin-2|interleukin-2|mesh-list
83390539|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390540|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83390541|NCT04023149|Analgesics|analgesics|mesh-ancestor
83390542|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
83390543|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390544|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390545|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83390546|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83390547|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
83390548|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390549|NCT04023305|Sevoflurane|sevoflurane|mesh-list
83390550|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83390551|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83390552|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
83390553|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
83390554|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390555|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390556|NCT04149275|Nivolumab|nivolumab|mesh-list
83390557|NCT04149275|Ipilimumab|ipilimumab|mesh-list
83390558|NCT04149275|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83390559|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83390560|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390561|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83390562|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390563|NCT04149275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83390564|NCT04149275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390565|NCT04148963|Loxapine|loxapine|mesh-list
83390566|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83390567|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83390568|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390569|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390570|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83390571|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83390573|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390574|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390575|NCT04022837|Pantoprazole|pantoprazole|mesh-list
83390576|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83390577|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83390578|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83390579|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390580|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390581|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
83390582|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83390583|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83390584|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390585|NCT04148885|Paclitaxel|paclitaxel|mesh-list
83390586|NCT04148885|Carboplatin|carboplatin|mesh-list
83390587|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83390588|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390589|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
83390590|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
83390591|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
83390592|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390593|NCT04022525|Leflunomide|leflunomide|mesh-list
83390594|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390595|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390596|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83390597|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
83390598|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390599|NCT04022291|Insulin|insulin|mesh-list
83390600|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83390601|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83390602|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390603|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
83390604|NCT03074448|Cathartics|cathartics|mesh-ancestor
83390605|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83390606|NCT04021433|Ketamine|ketamine|mesh-list
83390607|NCT04021433|Analgesics|analgesics|mesh-ancestor
83390608|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
83390609|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390610|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390611|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83390612|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83390622|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390623|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390624|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
83390625|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390626|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
83390627|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83390628|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83390629|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83390630|NCT04148261|Epinephrine|epinephrine|mesh-list
83390631|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83390632|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83390633|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
83390634|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390635|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390636|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390637|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83390638|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83390639|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
83390640|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390641|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83390642|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
83390643|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
83390644|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
83390645|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83390646|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83390647|NCT03072264|Fluoxetine|fluoxetine|mesh-list
83390648|NCT03072264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83390649|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83390650|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83390651|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390652|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390653|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
83390654|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390655|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83390656|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
83390657|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83390658|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83390659|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83390660|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390661|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
83390662|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
83390663|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83390664|NCT04991064|Protective Agents|protective agents|mesh-ancestor
83390665|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390666|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
83390667|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83390668|NCT00928083|Artefenomel|artefenomel|mesh-list
83390669|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
83390670|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83390671|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83390672|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390673|NCT04996446|Tislelizumab|tislelizumab|mesh-list
83390674|NCT04996446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83390675|NCT04996446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390676|NCT04361721|Erenumab|erenumab|mesh-list
83390677|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83390678|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390679|NCT04361721|Analgesics|analgesics|mesh-ancestor
83390680|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
83390681|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390682|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390683|NCT04361643|Lenalidomide|lenalidomide|mesh-list
83390684|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
83390685|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390686|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83390687|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83390688|NCT04361643|Growth Substances|growth substances|mesh-ancestor
83390689|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
83390690|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390691|NCT04406051|Norepinephrine|norepinephrine|mesh-list
83390692|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83390693|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83390694|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
83390695|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390697|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390698|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
83390699|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
83390700|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390701|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83390702|NCT04991298|Fentanyl|fentanyl|mesh-list
83390703|NCT04991298|Midazolam|midazolam|mesh-list
83390704|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83390705|NCT04991298|Narcotics|narcotics|mesh-ancestor
83390706|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390707|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390708|NCT04991298|Analgesics|analgesics|mesh-ancestor
83390709|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
83390710|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390711|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83390712|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83390713|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
83390714|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
83390715|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83390716|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83390717|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83390718|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83390719|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
83390720|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
83390721|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390722|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390723|NCT04361175|Letrozole|letrozole|mesh-list
83390724|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390725|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390726|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83390727|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83390728|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390729|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83390730|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
83390731|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83390732|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390733|NCT04368819|Allopurinol|allopurinol|mesh-list
83390734|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
83390735|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390736|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390737|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
83390738|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390739|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83390740|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
83390741|NCT04368819|Protective Agents|protective agents|mesh-ancestor
83390742|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390743|NCT04368585|Simethicone|simethicone|mesh-list
83390744|NCT04368585|Omeprazole|omeprazole|mesh-list
83390745|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83390746|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83390747|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
83390748|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
83390749|NCT04368585|TEMPO|tempo|mesh-list
83390750|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83390751|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83390752|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83390753|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390754|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390755|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
83390756|NCT04368585|Emollients|emollients|mesh-ancestor
83390757|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
83390758|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83390759|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
83390760|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390761|NCT04368585|Antacids|antacids|mesh-ancestor
83390762|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
83390763|NCT04368585|Protective Agents|protective agents|mesh-ancestor
83390764|NCT04361331|Lenvatinib|lenvatinib|mesh-list
83390765|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390766|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83390767|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390768|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390769|NCT04990830|Heparin|heparin|mesh-list
83390770|NCT04990830|Enoxaparin|enoxaparin|mesh-list
83390771|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83390773|NCT04990830|Dalteparin|dalteparin|mesh-list
83390774|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
83390775|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
83390776|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83390777|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83390778|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390779|NCT04361409|Rituximab|rituximab|mesh-list
83390780|NCT04361409|Gemcitabine|gemcitabine|mesh-list
83390781|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83390782|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390783|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
83390784|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390785|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390786|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83390787|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
83390788|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390789|NCT04368273|Antibodies|antibodies|mesh-list
83390790|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
83390791|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390792|NCT04995354|Mitogens|mitogens|mesh-list
83390793|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
83390794|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390795|NCT04368351|Azithromycin|azithromycin|mesh-list
83390796|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
83390797|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83390798|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390799|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
83390800|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83390801|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83390802|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390803|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390804|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390805|NCT05620641|Gabapentin|gabapentin|mesh-list
83390806|NCT05620641|Ondansetron|ondansetron|mesh-list
83390807|NCT05620641|Analgesics|analgesics|mesh-ancestor
83390808|NCT05620641|Sensory System Agents|sensory system agents|mesh-ancestor
83390809|NCT05620641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390810|NCT05620641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390811|NCT05620641|Anticonvulsants|anticonvulsants|mesh-ancestor
83390812|NCT05620641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83390813|NCT05620641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83390814|NCT05620641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390815|NCT05620641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83390816|NCT05620641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83390817|NCT05620641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83390818|NCT05620641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390819|NCT05620641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390820|NCT05620641|Antimanic Agents|antimanic agents|mesh-ancestor
83390821|NCT05620641|Antiemetics|antiemetics|mesh-ancestor
83390822|NCT05620641|Autonomic Agents|autonomic agents|mesh-ancestor
83390823|NCT05620641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83390824|NCT05620641|Antipruritics|antipruritics|mesh-ancestor
83390825|NCT05620641|Dermatologic Agents|dermatologic agents|mesh-ancestor
83390826|NCT05620641|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83390827|NCT05620641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83390828|NCT05620641|Serotonin Agents|serotonin agents|mesh-ancestor
83390829|NCT04360785|Methotrexate|methotrexate|mesh-list
83390830|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83390831|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
83390832|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83390833|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390834|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83390835|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
83390836|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390837|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390838|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83390839|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390840|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83390841|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83390842|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
83390843|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390844|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83390845|NCT04360317|Docetaxel|docetaxel|mesh-list
83390846|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390874|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390875|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390877|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83390878|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
83390879|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
83390880|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83390881|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83390882|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83390883|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
83390884|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390885|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390886|NCT02245191|Protective Agents|protective agents|mesh-ancestor
83390887|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83390888|NCT04145921|Tacrine|tacrine|mesh-list
83390889|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83390890|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390891|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390892|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
83390893|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390894|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390895|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83390896|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
83390897|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390898|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
83390899|NCT04145687|Metformin|metformin|mesh-list
83390900|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83390901|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390902|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
83390903|NCT04359615|Favipiravir|favipiravir|mesh-list
83390904|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
83390905|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83390906|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83390907|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390908|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390909|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390910|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390911|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
83390912|NCT02635386|Metformin|metformin|mesh-list
83390913|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
83390914|NCT02635386|Exenatide|exenatide|mesh-list
83390915|NCT02635386|Topiramate|topiramate|mesh-list
83390916|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83390917|NCT02635386|Phentermine|phentermine|mesh-list
83390918|NCT02635386|Glucagon|glucagon|mesh-list
83390919|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83390920|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83390921|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390922|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390923|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83390924|NCT02635386|Incretins|incretins|mesh-ancestor
83390925|NCT02635386|Hormones|hormones|mesh-ancestor
83390926|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83390927|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
83390928|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83390929|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83390930|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
83390931|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
83390932|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
83390933|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390934|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
83390935|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390936|NCT03924947|Pancrelipase|pancrelipase|mesh-list
83390937|NCT03924947|Pancreatin|pancreatin|mesh-list
83390938|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83390939|NCT00934635|Risperidone|risperidone|mesh-list
83390940|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83390941|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83390942|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
83390943|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390944|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390945|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390946|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83390947|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83390948|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390949|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83390960|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390961|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390962|NCT03922997|Atezolizumab|atezolizumab|mesh-list
83390963|NCT03922997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83390964|NCT03922997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390965|NCT03922997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83390966|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390967|NCT04356417|Antimalarials|antimalarials|mesh-list
83390968|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83390969|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83390970|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390971|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83390972|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83390973|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390975|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
83390976|NCT04355949|Cholecalciferol|cholecalciferol|mesh-list
83390977|NCT04355949|Vitamins|vitamins|mesh-list
83390978|NCT04355949|Folic Acid|folic acid|mesh-list
83390979|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
83390980|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
83390981|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
83390982|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
83390983|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390984|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83390985|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83390986|NCT04355949|Hematinics|hematinics|mesh-ancestor
83390987|NCT05580887|Paclitaxel|paclitaxel|mesh-list
83390988|NCT05580887|Cyclophosphamide|cyclophosphamide|mesh-list
83390989|NCT05580887|Carboplatin|carboplatin|mesh-list
83390990|NCT05580887|Doxorubicin|doxorubicin|mesh-list
83390991|NCT05580887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83390992|NCT05580887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390993|NCT05580887|Tubulin Modulators|tubulin modulators|mesh-ancestor
83390994|NCT05580887|Antimitotic Agents|antimitotic agents|mesh-ancestor
83390995|NCT05580887|Mitosis Modulators|mitosis modulators|mesh-ancestor
83390996|NCT05580887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390997|NCT05580887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83390998|NCT05580887|Immunologic Factors|immunologic factors|mesh-ancestor
83390999|NCT05580887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391000|NCT05580887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83391001|NCT05580887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83391002|NCT05580887|Alkylating Agents|alkylating agents|mesh-ancestor
83391003|NCT05580887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83391004|NCT05580887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83391005|NCT05580887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83391006|NCT05580887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83391007|NCT05580887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391008|NCT04994262|Menthol|menthol|mesh-list
83391009|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
83391010|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
83391011|NCT00939159|Panobinostat|panobinostat|mesh-list
83391012|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391013|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83391014|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391015|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391016|NCT04144439|Butyric Acid|butyric acid|mesh-list
83391017|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
83391018|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
83391019|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391020|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391021|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391022|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
83391023|NCT04994574|Olodaterol|olodaterol|mesh-list
83391024|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83391025|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
83391026|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391027|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391028|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83391029|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
83391030|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
83391031|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83391032|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
83391033|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391034|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391035|NCT04355637|Budesonide|budesonide|mesh-list
83391036|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83391037|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83391038|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
83391039|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391040|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391041|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83391042|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
83391043|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
83391044|NCT04355637|Hormones|hormones|mesh-ancestor
83391045|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391046|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
83391047|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391048|NCT03076710|Bupivacaine|bupivacaine|mesh-list
83391049|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
83391050|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
83391051|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83391052|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391053|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
83391054|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391055|NCT04143581|Empagliflozin|empagliflozin|mesh-list
83391056|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83391057|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391058|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83391059|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391060|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83391061|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83391062|NCT03071172|Progesterone|progesterone|mesh-list
83391063|NCT03071172|Hormones|hormones|mesh-ancestor
83391064|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391065|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391066|NCT03071172|Progestins|progestins|mesh-ancestor
83391067|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
83391068|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83391069|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
83391070|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83391071|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83391072|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83391073|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391074|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
83391075|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83391076|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
83391077|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83391078|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83391079|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83391080|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83391081|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391082|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
83391083|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391084|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391085|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83391086|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391087|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
83391088|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83391089|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83391090|NCT04355247|Prednisolone|prednisolone|mesh-list
83391091|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
83391092|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83391093|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
83391094|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83391095|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
83391096|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
83391097|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391098|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391099|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83391100|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
83391101|NCT04355247|Hormones|hormones|mesh-ancestor
83391102|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391103|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83391104|NCT04355247|Protective Agents|protective agents|mesh-ancestor
83391105|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83391106|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391107|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
83391108|NCT03903809|Hematinics|hematinics|mesh-ancestor
83391109|NCT04987554|Immunoferon|immunoferon|mesh-list
83391110|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83391111|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
83391112|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391113|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
83391114|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83391115|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83391116|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391117|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83391119|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
83391120|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391121|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83391122|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83391123|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83391124|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
83391125|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391126|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391127|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
83391128|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
83391129|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391130|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83391131|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83391132|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391133|NCT00936663|Incretins|incretins|mesh-ancestor
83391134|NCT00936663|Hormones|hormones|mesh-ancestor
83391135|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391136|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83391137|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
83391138|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391139|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391140|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
83391141|NCT03903185|Ledipasvir|ledipasvir|mesh-list
83391142|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83391143|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
83391144|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391145|NCT03917303|Adalimumab|adalimumab|mesh-list
83391146|NCT03917303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83391147|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83391148|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83391149|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83391150|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83391151|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391152|NCT05583149|Cyclophosphamide|cyclophosphamide|mesh-list
83391153|NCT05583149|Fludarabine|fludarabine|mesh-list
83391154|NCT05583149|Acalabrutinib|acalabrutinib|mesh-list
83391155|NCT05583149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83391156|NCT05583149|Immunologic Factors|immunologic factors|mesh-ancestor
83391157|NCT05583149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391158|NCT05583149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83391159|NCT05583149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83391160|NCT05583149|Alkylating Agents|alkylating agents|mesh-ancestor
83391161|NCT05583149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391162|NCT05583149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391163|NCT05583149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83391164|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
83391165|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391166|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
83391167|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
83391168|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
83391169|NCT04989270|Anesthetics|anesthetics|mesh-list
83391170|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83391171|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391172|NCT04989348|Hormones|hormones|mesh-list
83391173|NCT04989348|Progestins|progestins|mesh-list
83391174|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
83391175|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391176|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391177|NCT04346823|Sevoflurane|sevoflurane|mesh-list
83391178|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83391179|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83391180|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
83391181|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
83391182|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83391183|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391184|NCT05582837|Topiramate|topiramate|mesh-list
83391185|NCT05582837|Nortriptyline|nortriptyline|mesh-list
83391186|NCT05582837|Anticonvulsants|anticonvulsants|mesh-ancestor
83391217|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83391218|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83391219|NCT04661007|Growth Substances|growth substances|mesh-ancestor
83391220|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
83391221|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391222|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83391223|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83391224|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391225|NCT04461288|Nicotine|nicotine|mesh-list
83391226|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83391227|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
83391228|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391229|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391230|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83391231|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83391232|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
83391233|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391234|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391235|NCT05582135|Morphine|morphine|mesh-list
83391236|NCT05582135|Esketamine|esketamine|mesh-list
83391237|NCT05582135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83391238|NCT05582135|Narcotics|narcotics|mesh-ancestor
83391239|NCT05582135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83391240|NCT05582135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391241|NCT05582135|Analgesics|analgesics|mesh-ancestor
83391242|NCT05582135|Sensory System Agents|sensory system agents|mesh-ancestor
83391243|NCT05582135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391244|NCT05582135|Antidepressive Agents|antidepressive agents|mesh-ancestor
83391245|NCT05582135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83391246|NCT03070704|Liraglutide|liraglutide|mesh-list
83391247|NCT03070704|Xultophy|xultophy|mesh-list
83391248|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83391249|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391250|NCT03070704|Incretins|incretins|mesh-ancestor
83391251|NCT03070704|Hormones|hormones|mesh-ancestor
83391252|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391253|NCT03069768|Varenicline|varenicline|mesh-list
83391254|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83391255|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83391256|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
83391257|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391258|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391259|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391260|NCT04141553|Diltiazem|diltiazem|mesh-list
83391261|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83391262|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83391263|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83391264|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391265|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83391266|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391267|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
83391268|NCT04141163|Metformin|metformin|mesh-list
83391269|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83391270|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391271|NCT00942825|Cisplatin|cisplatin|mesh-list
83391272|NCT00942825|Pemetrexed|pemetrexed|mesh-list
83391273|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391274|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391275|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391276|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83391277|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83391278|NCT04544943|Gentamicins|gentamicins|mesh-list
83391279|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83391280|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391281|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83391282|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391283|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391284|NCT04140461|Amphotericin B|amphotericin b|mesh-list
83391285|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83391286|NCT04140461|Flucytosine|flucytosine|mesh-list
83391287|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391288|NCT04140461|Amebicides|amebicides|mesh-ancestor
83391289|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83391290|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83391291|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83391371|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83391372|NCT03068442|Flutemetamol|flutemetamol|mesh-list
83391373|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83391374|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391375|NCT00939705|Topiramate|topiramate|mesh-list
83391376|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
83391377|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83391378|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391379|NCT05001672|Tenofovir|tenofovir|mesh-list
83391380|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
83391381|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391382|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83391383|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83391384|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391385|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391386|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83391387|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83391388|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83391389|NCT04354545|Lifitegrast|lifitegrast|mesh-list
83391390|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83391391|NCT03587285|Goserelin|goserelin|mesh-list
83391392|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
83391393|NCT03587285|Bicalutamide|bicalutamide|mesh-list
83391394|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83391395|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391396|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83391397|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391398|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391399|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
83391400|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391401|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391402|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83391403|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
83391404|NCT03587129|Apatinib|apatinib|mesh-list
83391405|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391406|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83391407|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391408|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391409|NCT02245503|Tamsulosin|tamsulosin|mesh-list
83391410|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83391411|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83391412|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83391413|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
83391414|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391415|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391416|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391417|NCT02245503|Urological Agents|urological agents|mesh-ancestor
83391418|NCT03586817|Palonosetron|palonosetron|mesh-list
83391419|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
83391420|NCT03586817|Aprepitant|aprepitant|mesh-list
83391421|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
83391422|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
83391423|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391424|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391425|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83391426|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83391427|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83391428|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
83391429|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391430|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391431|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83391432|NCT03891173|Vinorelbine|vinorelbine|mesh-list
83391433|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391434|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83391435|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
83391436|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
83391437|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
83391438|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391439|NCT03585725|Ribavirin|ribavirin|mesh-list
83391440|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
83391441|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391442|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
83391443|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391444|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83391445|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83391446|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83391447|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83391448|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391449|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
83391450|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391451|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391452|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83391453|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391455|NCT03585179|Hydroquinone|hydroquinone|mesh-list
83391456|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83391457|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83391458|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391459|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
83391460|NCT03585179|Coagulants|coagulants|mesh-ancestor
83391461|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
83391462|NCT03585179|Protective Agents|protective agents|mesh-ancestor
83391463|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391464|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83391465|NCT03585101|Grazoprevir|grazoprevir|mesh-list
83391466|NCT03585101|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83391467|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
83391468|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391470|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83391471|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83391472|NCT03834363|Fentanyl|fentanyl|mesh-list
83391473|NCT03834363|Morphine|morphine|mesh-list
83391474|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83391475|NCT03834363|Narcotics|narcotics|mesh-ancestor
83391476|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83391477|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391478|NCT03834363|Analgesics|analgesics|mesh-ancestor
83391479|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
83391480|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391481|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83391482|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83391483|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
83391484|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
83391485|NCT03031353|Misoprostol|misoprostol|mesh-list
83391486|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83391487|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
83391488|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83391489|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391490|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83391491|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83391492|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
83391493|NCT05702957|Letrozole|letrozole|mesh-list
83391494|NCT05702957|Clomiphene|clomiphene|mesh-list
83391495|NCT05702957|Enclomiphene|enclomiphene|mesh-list
83391496|NCT05702957|Zuclomiphene|zuclomiphene|mesh-list
83391497|NCT05702957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391498|NCT05702957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391499|NCT05702957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83391500|NCT05702957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83391501|NCT05702957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391502|NCT05702957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83391503|NCT05702957|Hormone Antagonists|hormone antagonists|mesh-ancestor
83391504|NCT05702957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391505|NCT05702957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391506|NCT05702957|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83391507|NCT05702957|Fertility Agents|fertility agents|mesh-ancestor
83391508|NCT05702957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83391509|NCT05702957|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83391510|NCT05702957|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83391511|NCT04405505|Paclitaxel|paclitaxel|mesh-list
83391512|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83391513|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391514|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
83391515|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
83391516|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
83391517|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391518|NCT03580733|Caspofungin|caspofungin|mesh-list
83391519|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
83391520|NCT03580733|Clotrimazole|clotrimazole|mesh-list
83391521|NCT03580733|Miconazole|miconazole|mesh-list
83391522|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391523|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391524|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391525|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83391526|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83391527|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83391528|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83391529|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
83391530|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391531|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391532|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83391533|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83391535|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83391536|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
83391537|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391538|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83391539|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391540|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391541|NCT04939662|Bevacizumab|bevacizumab|mesh-list
83391542|NCT04939662|Olaparib|olaparib|mesh-list
83391543|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83391544|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391545|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83391546|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83391547|NCT04939662|Growth Substances|growth substances|mesh-ancestor
83391548|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391549|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
83391550|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83391551|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391552|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391553|NCT05581979|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83391554|NCT05581979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83391555|NCT05581979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391557|NCT05331144|Amlodipine|amlodipine|mesh-list
83391558|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
83391559|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
83391560|NCT05331144|Giapreza|giapreza|mesh-list
83391561|NCT05331144|Calcium|calcium|mesh-list
83391562|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83391563|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
83391564|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83391565|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391566|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83391567|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83391568|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391569|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
83391570|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83391571|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83391572|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83391573|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83391574|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
83391575|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391576|NCT03580499|Vitamins|vitamins|mesh-list
83391577|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
83391578|NCT03580499|Pyridoxal|pyridoxal|mesh-list
83391579|NCT03580499|Pyridoxine|pyridoxine|mesh-list
83391580|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
83391581|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
83391582|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391583|NCT00951561|Ibuprofen|ibuprofen|mesh-list
83391584|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83391585|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83391586|NCT00951561|Analgesics|analgesics|mesh-ancestor
83391587|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
83391588|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391589|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391590|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83391591|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83391592|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83391593|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391594|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391595|NCT03031119|Atorvastatin|atorvastatin|mesh-list
83391596|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83391597|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83391598|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
83391599|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391600|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83391601|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83391602|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391604|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83391605|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83391606|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391607|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391608|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391609|NCT02943057|Ganciclovir|ganciclovir|mesh-list
83391610|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83391611|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
83391612|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391613|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83391614|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391615|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391616|NCT03581903|Vaccines|vaccines|mesh-list
83391617|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
83391618|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391619|NCT02783547|Azacitidine|azacitidine|mesh-list
83391620|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83391621|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
83391622|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391623|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391624|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391625|NCT02555007|Vinorelbine|vinorelbine|mesh-list
83391626|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83391627|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391628|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
83391629|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
83391630|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
83391631|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391633|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83391634|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391635|NCT04982874|Furosemide|furosemide|mesh-list
83391636|NCT04982874|Diuretics|diuretics|mesh-ancestor
83391637|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
83391638|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391639|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83391640|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83391641|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391642|NCT03584711|Panitumumab|panitumumab|mesh-list
83391643|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83391644|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391645|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83391646|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83391647|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
83391648|NCT03068208|Methylene Blue|methylene blue|mesh-list
83391649|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391650|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391651|NCT03067974|Ketamine|ketamine|mesh-list
83391652|NCT03067974|Analgesics|analgesics|mesh-ancestor
83391653|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
83391654|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391655|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391656|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83391657|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83391658|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
83391659|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
83391660|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83391661|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83391662|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83391663|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391664|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391665|NCT05104866|Gemcitabine|gemcitabine|mesh-list
83391666|NCT05104866|Capecitabine|capecitabine|mesh-list
83391667|NCT05104866|Vinorelbine|vinorelbine|mesh-list
83391668|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83391669|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
83391670|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391671|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391672|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83391673|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
83391674|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
83391675|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
83391676|NCT03582137|Cannabidiol|cannabidiol|mesh-list
83391677|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
83391678|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
83391679|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83391680|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
83391681|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391682|NCT04405193|Expectorants|expectorants|mesh-ancestor
83391683|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
83391684|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83391685|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
83391686|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391687|NCT04405193|Protective Agents|protective agents|mesh-ancestor
83391688|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391689|NCT04405193|Antidotes|antidotes|mesh-ancestor
83391690|NCT05227833|Pantoprazole|pantoprazole|mesh-list
83391691|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83391692|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83391693|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83391694|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391695|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391696|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
83391697|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83391698|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83391699|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391700|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83391701|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83391702|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
83391703|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391704|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391705|NCT05701475|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83391706|NCT05701475|Dermatologic Agents|dermatologic agents|mesh-ancestor
83391707|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83391708|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
83391709|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391710|NCT04405271|Tenofovir|tenofovir|mesh-list
83391711|NCT04405271|Emtricitabine|emtricitabine|mesh-list
83391712|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83391713|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
83391714|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391715|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83391716|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83391717|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391718|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391719|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83391720|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83391721|NCT03034941|Metformin|metformin|mesh-list
83391722|NCT03034941|Liraglutide|liraglutide|mesh-list
83391723|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83391724|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391725|NCT03034941|Incretins|incretins|mesh-ancestor
83391726|NCT03034941|Hormones|hormones|mesh-ancestor
83391727|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391728|NCT03030105|Scopolamine|scopolamine|mesh-list
83391729|NCT03030105|Donepezil|donepezil|mesh-list
83391730|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83391731|NCT03030105|BPN14770|bpn14770|mesh-list
83391732|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83391733|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391734|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391735|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
83391736|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391737|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391738|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
83391739|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83391740|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
83391741|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
83391742|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391743|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83391744|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
83391745|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83391822|NCT04801797|Daunorubicin|daunorubicin|mesh-list
83391746|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83391747|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
83391748|NCT03030105|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83391749|NCT03030105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83391750|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
83391751|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
83391752|NCT03067896|Bupivacaine|bupivacaine|mesh-list
83391753|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
83391754|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
83391755|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83391756|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391757|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
83391758|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391759|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83391760|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83391761|NCT03067896|Analgesics|analgesics|mesh-ancestor
83391762|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83391763|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83391764|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83391765|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
83391766|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391767|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391768|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83391769|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
83391770|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83391771|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83391772|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83391773|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
83391774|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83391775|NCT03034707|Biotin|biotin|mesh-list
83391776|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
83391777|NCT03034707|Vitamins|vitamins|mesh-ancestor
83391778|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
83391779|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391780|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
83391781|NCT03067740|Bupivacaine|bupivacaine|mesh-list
83391782|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
83391783|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
83391784|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83391785|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391786|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
83391787|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391788|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83391789|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83391790|NCT03067740|Analgesics|analgesics|mesh-ancestor
83391791|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83391792|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83391793|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83391794|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
83391795|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391796|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391797|NCT05730114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83391798|NCT05634174|Mirabegron|mirabegron|mesh-list
83391799|NCT05634174|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83391800|NCT05634174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83391801|NCT05634174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83391802|NCT05634174|Adrenergic Agents|adrenergic agents|mesh-ancestor
83391803|NCT05634174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391804|NCT05634174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391805|NCT05634174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391806|NCT05634174|Urological Agents|urological agents|mesh-ancestor
83391807|NCT03027843|Hormones|hormones|mesh-list
83391808|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391809|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391810|NCT03068832|Poly I-C|poly i-c|mesh-list
83391811|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83391812|NCT03068832|Poly ICLC|poly iclc|mesh-list
83391813|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
83391814|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
83391815|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391816|NCT03068832|Laxatives|laxatives|mesh-ancestor
83391817|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83391818|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
83391819|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391820|NCT04801797|Cytarabine|cytarabine|mesh-list
83391821|NCT04801797|Azacitidine|azacitidine|mesh-list
83391844|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391845|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
83391846|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
83391847|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83391848|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391849|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83391850|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83391851|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391852|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391853|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391854|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83391855|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83391856|NCT03069144|Calcitriol|calcitriol|mesh-list
83391857|NCT03069144|Calcipotriene|calcipotriene|mesh-list
83391858|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
83391859|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83391860|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391861|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83391862|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83391863|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391864|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83391865|NCT03069144|Vitamins|vitamins|mesh-ancestor
83391866|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
83391867|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83391868|NCT03017703|Eplerenone|eplerenone|mesh-list
83391869|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83391870|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
83391871|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391872|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391873|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83391874|NCT03017703|Diuretics|diuretics|mesh-ancestor
83391875|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
83391876|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83391877|NCT01670669|Prucalopride|prucalopride|mesh-list
83391878|NCT01670669|Laxatives|laxatives|mesh-ancestor
83391879|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83391880|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83391881|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83391882|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
83391883|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391884|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391885|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391886|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
83391887|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
83391888|NCT00946023|Rituximab|rituximab|mesh-list
83391889|NCT00946023|Fludarabine|fludarabine|mesh-list
83391890|NCT00946023|Tacrolimus|tacrolimus|mesh-list
83391891|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83391892|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
83391893|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391894|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83391895|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83391896|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
83391897|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391898|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391899|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83391900|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83391901|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83391902|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391903|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83391904|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83391905|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
83391906|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83391907|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391908|NCT01672151|Sirolimus|sirolimus|mesh-list
83391909|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83391910|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391911|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83391912|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391913|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
83391914|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83391915|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
83391916|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391917|NCT05729646|Oxaliplatin|oxaliplatin|mesh-list
83391920|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391921|NCT01672307|Minoxidil|minoxidil|mesh-list
83391922|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83391923|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
83391924|NCT03067194|Celecoxib|celecoxib|mesh-list
83391925|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83391926|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83391927|NCT03067194|Analgesics|analgesics|mesh-ancestor
83391928|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
83391929|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391930|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391931|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83391932|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83391933|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83391934|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83391935|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391936|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391937|NCT05629494|Ibuprofen|ibuprofen|mesh-list
83391938|NCT05629494|Naproxen|naproxen|mesh-list
83391939|NCT05629494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83391940|NCT05629494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83391941|NCT05629494|Analgesics|analgesics|mesh-ancestor
83391942|NCT05629494|Sensory System Agents|sensory system agents|mesh-ancestor
83391943|NCT05629494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391944|NCT05629494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391945|NCT05629494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83391946|NCT05629494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83391947|NCT05629494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83391948|NCT05629494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391949|NCT05629494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391950|NCT05629494|Gout Suppressants|gout suppressants|mesh-ancestor
83391951|NCT00952653|Midazolam|midazolam|mesh-list
83391952|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83391953|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83391954|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83391955|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83391956|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391957|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83391958|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83391959|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83391960|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83391961|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
83391962|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
83391963|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
83391964|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
83391965|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391966|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391967|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83391968|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83391969|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83391970|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
83391971|NCT01673087|Dexamethasone|dexamethasone|mesh-list
83391972|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83391973|NCT01673087|Cosyntropin|cosyntropin|mesh-list
83391974|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
83391975|NCT01673087|Metyrapone|metyrapone|mesh-list
83391976|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83391977|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
83391978|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
83391979|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391980|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391981|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83391982|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
83391983|NCT01673087|Hormones|hormones|mesh-ancestor
83391984|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391985|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83391986|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391987|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
83391988|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391989|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391990|NCT02299505|Ceritinib|ceritinib|mesh-list
83391991|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391992|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83392009|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83392010|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392011|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83392012|NCT01674257|Fluorides|fluorides|mesh-list
83392013|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
83392014|NCT01674257|Protective Agents|protective agents|mesh-ancestor
83392015|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392016|NCT01674257|Hematinics|hematinics|mesh-ancestor
83392017|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83392018|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83392019|NCT01674413|Adalimumab|adalimumab|mesh-list
83392020|NCT01674413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83392021|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83392022|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392023|NCT00953121|Bevacizumab|bevacizumab|mesh-list
83392024|NCT00953121|Carboplatin|carboplatin|mesh-list
83392025|NCT00953121|Irinotecan|irinotecan|mesh-list
83392026|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83392027|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392028|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83392029|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83392030|NCT00953121|Growth Substances|growth substances|mesh-ancestor
83392031|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392032|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
83392033|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83392034|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83392035|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392036|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392037|NCT03017391|Dexamethasone|dexamethasone|mesh-list
83392038|NCT03017391|Metoclopramide|metoclopramide|mesh-list
83392039|NCT03017391|Granisetron|granisetron|mesh-list
83392040|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83392041|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
83392042|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
83392043|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392044|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392045|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83392046|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
83392047|NCT03017391|Hormones|hormones|mesh-ancestor
83392048|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83392049|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83392050|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392051|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83392052|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83392053|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
83392054|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392055|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392056|NCT03017391|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83392057|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83392058|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
83392059|NCT00953199|Lidocaine|lidocaine|mesh-list
83392060|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
83392061|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
83392062|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392063|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392064|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
83392065|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392066|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83392067|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83392068|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83392069|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83392070|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392072|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
83392073|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
83392074|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83392075|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83392076|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392077|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83392078|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392079|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392080|NCT01675895|Lidocaine|lidocaine|mesh-list
83392081|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
83392082|NCT01675895|Anesthetics|anesthetics|mesh-list
83392083|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
83392084|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392085|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392086|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
83392087|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392088|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83392089|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83392090|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83392091|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83392092|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392093|NCT01675973|Ranolazine|ranolazine|mesh-list
83392094|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83392095|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83392096|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392097|NCT04764851|Ecopipam|ecopipam|mesh-list
83392098|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83392099|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83392100|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392101|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392102|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83392103|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83392104|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
83392105|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392106|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392107|NCT00956085|Memantine|memantine|mesh-list
83392108|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83392109|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83392110|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
83392111|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392112|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392113|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392114|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83392115|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83392116|NCT01005459|Bupivacaine|bupivacaine|mesh-list
83392117|NCT01005459|Tetracaine|tetracaine|mesh-list
83392118|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
83392119|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
83392120|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392121|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392122|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
83392123|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392124|NCT01676285|Metoprolol|metoprolol|mesh-list
83392125|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83392126|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83392127|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
83392128|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
83392129|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392130|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392131|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83392132|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83392133|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83392134|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
83392135|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392136|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392137|NCT01676363|Diflunisal|diflunisal|mesh-list
83392138|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83392139|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83392140|NCT01676363|Analgesics|analgesics|mesh-ancestor
83392141|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
83392142|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392143|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392144|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83392145|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392146|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83392147|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392148|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392149|NCT00956709|Ropivacaine|ropivacaine|mesh-list
83392150|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
83392151|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
83392152|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
83392153|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392154|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392155|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
83392156|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392157|NCT00957333|Ketamine|ketamine|mesh-list
83392159|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
83392160|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392161|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392162|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83392163|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83392164|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
83392165|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
83392166|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392167|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83392168|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83392169|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392170|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392171|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83392172|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83392173|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83392174|NCT02159547|Analgesics|analgesics|mesh-ancestor
83392175|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
83392176|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392177|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392178|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83392179|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392180|NCT00958035|Bimatoprost|bimatoprost|mesh-list
83392181|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83392182|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83392183|NCT01011075|Paclitaxel|paclitaxel|mesh-list
83392184|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
83392185|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83392186|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392187|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
83392188|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
83392189|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
83392190|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392191|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83392192|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392193|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
83392194|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
83392195|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83392196|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83392197|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392198|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
83392199|NCT00958581|Coagulants|coagulants|mesh-ancestor
83392200|NCT01012089|Daptomycin|daptomycin|mesh-list
83392201|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83392202|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392203|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83392204|NCT04422431|Choline|choline|mesh-list
83392205|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
83392206|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83392207|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
83392208|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392209|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83392210|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83392211|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
83392212|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
83392213|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
83392214|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392215|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83392216|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83392217|NCT04422431|Growth Substances|growth substances|mesh-ancestor
83392218|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392219|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
83392220|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392221|NCT04265651|Infigratinib|infigratinib|mesh-list
83392222|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392223|NCT04055753|Doxorubicin|doxorubicin|mesh-list
83392224|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83392225|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392226|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83392227|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83392228|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392229|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392230|NCT03871361|Abatacept|abatacept|mesh-list
83392231|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83392232|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392233|NCT03871361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83392234|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392235|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83392236|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
83392237|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392238|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392239|NCT04764227|Paclitaxel|paclitaxel|mesh-list
83392240|NCT04764227|Carboplatin|carboplatin|mesh-list
83392241|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83392242|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392243|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83392244|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83392245|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83392246|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392247|NCT03589547|Durvalumab|durvalumab|mesh-list
83392248|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83392249|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392250|NCT04764383|Histamine|histamine|mesh-list
83392251|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
83392252|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
83392253|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392254|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392255|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392256|NCT03016611|Ticagrelor|ticagrelor|mesh-list
83392257|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83392258|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83392259|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83392260|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83392261|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83392262|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
83392263|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392264|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392265|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392266|NCT00961233|Budesonide|budesonide|mesh-list
83392267|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83392268|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83392269|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
83392270|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392271|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392272|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83392273|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
83392274|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
83392275|NCT00961233|Hormones|hormones|mesh-ancestor
83392276|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83392277|NCT00962871|Tenofovir|tenofovir|mesh-list
83392278|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83392279|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
83392280|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392281|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83392282|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83392283|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392284|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392285|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83392286|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83392287|NCT01014351|Paclitaxel|paclitaxel|mesh-list
83392288|NCT01014351|Carboplatin|carboplatin|mesh-list
83392290|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83392291|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392292|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
83392293|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
83392294|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
83392295|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392296|NCT01014351|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83392297|NCT01014351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83392298|NCT01014351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392299|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83392300|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
83392301|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392302|NCT01014741|Ibutilide|ibutilide|mesh-list
83392303|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83392304|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
83392305|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83392306|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
83392307|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392308|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392309|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83392311|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392312|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392313|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83392314|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
83392315|NCT00962949|Giapreza|giapreza|mesh-list
83392316|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
83392317|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83392318|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83392319|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
83392320|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392321|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392322|NCT01695941|Rituximab|rituximab|mesh-list
83392323|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83392324|NCT01695941|Bortezomib|bortezomib|mesh-list
83392325|NCT01695941|Antibodies|antibodies|mesh-list
83392326|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
83392327|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83392328|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
83392329|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392330|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392331|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392332|NCT01244789|Paclitaxel|paclitaxel|mesh-list
83392333|NCT01244789|Carboplatin|carboplatin|mesh-list
83392334|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83392335|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392336|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
83392337|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
83392338|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
83392339|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392340|NCT02631876|Paclitaxel|paclitaxel|mesh-list
83392341|NCT02631876|Maytansine|maytansine|mesh-list
83392342|NCT02631876|Doxorubicin|doxorubicin|mesh-list
83392343|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83392344|NCT02631876|Topotecan|topotecan|mesh-list
83392345|NCT02631876|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
83392346|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83392347|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392348|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
83392349|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
83392350|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
83392351|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392352|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83392353|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83392354|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83392355|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392356|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83392357|NCT02631876|Immunoconjugates|immunoconjugates|mesh-ancestor
83392358|NCT02631876|Immunologic Factors|immunologic factors|mesh-ancestor
83392359|NCT02631876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392360|NCT03156179|Calcium|calcium|mesh-list
83392361|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83392362|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392363|NCT04436796|Pancrelipase|pancrelipase|mesh-list
83392364|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83392365|NCT02081963|Amikacin|amikacin|mesh-list
83392366|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83392367|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392368|NCT04765085|Aripiprazole|aripiprazole|mesh-list
83392369|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
83392370|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83392371|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83392372|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83392373|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392374|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392375|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
83392376|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
83392377|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392378|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392379|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83392380|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83392381|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
83392382|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83392383|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83392384|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83392385|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83392386|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83392387|NCT02633046|Hormones|hormones|mesh-ancestor
83392388|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83392389|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392390|NCT03881345|Anticoagulants|anticoagulants|mesh-list
83392391|NCT01676597|Rifaximin|rifaximin|mesh-list
83392392|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
83392393|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83392394|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392395|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83392396|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83392397|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392398|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392399|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83392400|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83392401|NCT01676597|Protective Agents|protective agents|mesh-ancestor
83392402|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392403|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
83392404|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83392405|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
83392406|NCT04374630|Paclitaxel|paclitaxel|mesh-list
83392407|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83392408|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392409|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
83392410|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
83392411|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
83392412|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392413|NCT05540964|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83392414|NCT05540964|Antiviral Agents|antiviral agents|mesh-ancestor
83392415|NCT05540964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392417|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
83392418|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
83392419|NCT04364802|Povidone|povidone|mesh-list
83392420|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83392421|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392422|NCT04364802|Trace Elements|trace elements|mesh-ancestor
83392423|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
83392424|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392425|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
83392426|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
83392427|NCT03155087|Metformin|metformin|mesh-list
83392428|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83392429|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392430|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83392431|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
83392432|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392433|NCT00963105|Lenalidomide|lenalidomide|mesh-list
83392434|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
83392435|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392436|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83392437|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83392438|NCT00963105|Growth Substances|growth substances|mesh-ancestor
83392439|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
83392440|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392441|NCT04879992|Amoxicillin|amoxicillin|mesh-list
83392442|NCT04879992|Metronidazole|metronidazole|mesh-list
83392443|NCT04879992|Tetracycline|tetracycline|mesh-list
83392444|NCT04879992|Rifabutin|rifabutin|mesh-list
83392445|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
83392446|NCT04879992|Esomeprazole|esomeprazole|mesh-list
83392447|NCT04879992|Bismuth|bismuth|mesh-list
83392448|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392449|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83392450|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392451|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83392452|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83392453|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83392454|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83392455|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83392456|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392457|NCT04879992|Antacids|antacids|mesh-ancestor
83392458|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83392459|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83392460|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
83392461|NCT04879992|Diuretics|diuretics|mesh-ancestor
83392462|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
83392463|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392464|NCT04879992|Expectorants|expectorants|mesh-ancestor
83392465|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
83392467|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83392468|NCT04181736|Guanfacine|guanfacine|mesh-list
83392469|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83392470|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83392471|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83392472|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83392473|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
83392474|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392475|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392476|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392477|NCT04404491|Capecitabine|capecitabine|mesh-list
83392478|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83392479|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
83392480|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392481|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392482|NCT03861299|Anesthetics|anesthetics|mesh-list
83392483|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392484|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392485|NCT05573568|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83392486|NCT05573568|Hallucinogens|hallucinogens|mesh-ancestor
83392487|NCT05573568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392488|NCT05573568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83392489|NCT05573568|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83392490|NCT05573568|Serotonin Agents|serotonin agents|mesh-ancestor
83392491|NCT05573568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392492|NCT05573568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392493|NCT05573568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83392494|NCT03858491|Cobicistat|cobicistat|mesh-list
83392495|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83392496|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83392497|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
83392498|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392499|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83392500|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83392501|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392502|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392503|NCT01672788|Metformin|metformin|mesh-list
83392504|NCT01672788|Empagliflozin|empagliflozin|mesh-list
83392505|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83392506|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392507|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83392508|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392509|NCT02705963|Trametinib|trametinib|mesh-list
83392510|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83392511|NCT02705963|Norethindrone|norethindrone|mesh-list
83392512|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
83392513|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
83392514|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
83392515|NCT02705963|Estradiol|estradiol|mesh-list
83392516|NCT02705963|Estrogens|estrogens|mesh-ancestor
83392517|NCT02705963|Hormones|hormones|mesh-ancestor
83392518|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83392519|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392520|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83392521|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83392522|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83392523|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392524|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83392525|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392526|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392527|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83392528|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83392529|NCT03065868|Clarithromycin|clarithromycin|mesh-list
83392530|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83392531|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392532|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83392533|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392534|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392535|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83392536|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83392537|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
83392538|NCT03844061|Rituximab|rituximab|mesh-list
83392539|NCT03844061|Belimumab|belimumab|mesh-list
83392694|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
83392540|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83392541|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392542|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
83392543|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392544|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392545|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83392546|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83392547|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
83392548|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83392549|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392550|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392551|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392552|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83392553|NCT03840239|Capecitabine|capecitabine|mesh-list
83392554|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
83392555|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83392556|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
83392557|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392558|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392559|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83392560|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83392561|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
83392562|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83392563|NCT03830723|Hormones|hormones|mesh-ancestor
83392564|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83392565|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392566|NCT03829319|Carboplatin|carboplatin|mesh-list
83392567|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
83392568|NCT03829319|Pemetrexed|pemetrexed|mesh-list
83392569|NCT03829319|Lenvatinib|lenvatinib|mesh-list
83392570|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392571|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83392572|NCT03829319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83392573|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392574|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392575|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83392576|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83392577|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83392578|NCT03814109|Niacin|niacin|mesh-list
83392579|NCT03814109|Indapamide|indapamide|mesh-list
83392580|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83392581|NCT03814109|Diuretics|diuretics|mesh-ancestor
83392582|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
83392583|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392584|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83392585|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83392586|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392587|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83392588|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
83392589|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83392590|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
83392591|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
83392592|NCT03814109|Vitamins|vitamins|mesh-ancestor
83392593|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
83392594|NCT01016769|Sirolimus|sirolimus|mesh-list
83392595|NCT01016769|Paclitaxel|paclitaxel|mesh-list
83392596|NCT01016769|Carboplatin|carboplatin|mesh-list
83392597|NCT01016769|Temsirolimus|temsirolimus|mesh-list
83392598|NCT01016769|MTOR Inhibitors|mtor inhibitors|mesh-list
83392599|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83392600|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392601|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
83392602|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
83392603|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
83392604|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392605|NCT01016769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83392606|NCT01016769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392607|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83392608|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
83392609|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392610|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83392611|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392612|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83392613|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
83392614|NCT03807479|Ponatinib|ponatinib|mesh-list
83392615|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392616|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83392617|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392618|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392619|NCT03019809|Plerixafor|plerixafor|mesh-list
83392620|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83392621|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83392622|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
83392623|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392624|NCT00964353|Warfarin|warfarin|mesh-list
83392625|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
83392626|NCT00964431|Celecoxib|celecoxib|mesh-list
83392627|NCT00964431|Indomethacin|indomethacin|mesh-list
83392628|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83392629|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83392630|NCT00964431|Analgesics|analgesics|mesh-ancestor
83392631|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
83392632|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392633|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392634|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83392635|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392636|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83392637|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83392638|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392639|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392640|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
83392641|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
83392642|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83392643|NCT05475054|Liver Extracts|liver extracts|mesh-list
83392644|NCT05475054|Hematinics|hematinics|mesh-ancestor
83392645|NCT01017003|Colchicine|colchicine|mesh-list
83392646|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
83392647|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392648|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
83392649|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
83392650|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
83392651|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392652|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392653|NCT01017237|Midazolam|midazolam|mesh-list
83392654|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
83392655|NCT01017237|Ketamine|ketamine|mesh-list
83392656|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83392657|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392658|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392659|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83392660|NCT01017237|Analgesics|analgesics|mesh-ancestor
83392661|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
83392662|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392663|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83392664|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83392665|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83392666|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
83392667|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392668|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392669|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83392670|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83392671|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
83392672|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
83392673|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83392674|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83392675|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83392676|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83392677|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83392678|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83392679|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
83392680|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
83392681|NCT04442412|Vitamin D|vitamin d|mesh-list
83392682|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
83392683|NCT04442412|Vitamins|vitamins|mesh-ancestor
83392684|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
83392685|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392686|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83392687|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83392688|NCT01018095|Metronidazole|metronidazole|mesh-list
83392689|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392690|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83392691|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83392692|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83392693|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
83392695|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392696|NCT03788759|Protective Agents|protective agents|mesh-ancestor
83392697|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392698|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
83392700|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
83392701|NCT00967551|Zinc|zinc|mesh-list
83392702|NCT00967551|Trace Elements|trace elements|mesh-list
83392703|NCT00967551|Micronutrients|micronutrients|mesh-list
83392704|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392705|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83392706|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83392707|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83392708|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
83392709|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392710|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392711|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
83392712|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392713|NCT00970203|Vaccines|vaccines|mesh-list
83392714|NCT00970203|Androgens|androgens|mesh-list
83392715|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
83392716|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392717|NCT00970203|Hormones|hormones|mesh-ancestor
83392718|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83392719|NCT00971295|Metformin|metformin|mesh-list
83392720|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83392721|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83392722|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392723|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
83392724|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83392725|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83392726|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83392727|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392728|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83392729|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
83392730|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83392731|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83392732|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83392733|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392734|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392735|NCT00971841|Paclitaxel|paclitaxel|mesh-list
83392736|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83392737|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392738|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
83392739|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
83392740|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
83392741|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392742|NCT04913220|Cemiplimab|cemiplimab|mesh-list
83392743|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83392744|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392745|NCT05395299|Ethylene|ethylene|mesh-list
83392746|NCT05395299|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83392747|NCT05395299|Growth Substances|growth substances|mesh-ancestor
83392748|NCT05395299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392750|NCT02246049|Bevacizumab|bevacizumab|mesh-list
83392751|NCT02246049|Fluorouracil|fluorouracil|mesh-list
83392752|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
83392753|NCT02246049|Irinotecan|irinotecan|mesh-list
83392754|NCT02246049|Calcium|calcium|mesh-list
83392755|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
83392756|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83392757|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392758|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83392759|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83392760|NCT02246049|Growth Substances|growth substances|mesh-ancestor
83392761|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392762|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
83392763|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83392764|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
83392765|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392766|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83392767|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83392768|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
83392769|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83392770|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83392780|NCT05395143|Dermatologic Agents|dermatologic agents|mesh-ancestor
83392781|NCT05394909|Methylprednisolone|methylprednisolone|mesh-list
83392782|NCT05394909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83392783|NCT05394909|Antiemetics|antiemetics|mesh-ancestor
83392784|NCT05394909|Autonomic Agents|autonomic agents|mesh-ancestor
83392785|NCT05394909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392786|NCT05394909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392787|NCT05394909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83392788|NCT05394909|Glucocorticoids|glucocorticoids|mesh-ancestor
83392789|NCT05394909|Hormones|hormones|mesh-ancestor
83392790|NCT05394909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83392791|NCT05394909|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83392792|NCT05394909|Protective Agents|protective agents|mesh-ancestor
83392793|NCT05694858|Lidocaine|lidocaine|mesh-list
83392794|NCT05694858|Anesthetics, Local|anesthetics, local|mesh-ancestor
83392795|NCT05694858|Anesthetics|anesthetics|mesh-ancestor
83392796|NCT05694858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392797|NCT05694858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392798|NCT05694858|Sensory System Agents|sensory system agents|mesh-ancestor
83392799|NCT05694858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392800|NCT05694858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83392801|NCT05694858|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83392802|NCT05694858|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83392803|NCT05694858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83392804|NCT05694858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392805|NCT02159859|Ertapenem|ertapenem|mesh-list
83392806|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83392807|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392808|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83392809|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83392810|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392811|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
83392812|NCT02083679|Paclitaxel|paclitaxel|mesh-list
83392813|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83392814|NCT02083679|Cisplatin|cisplatin|mesh-list
83392815|NCT02083679|Carboplatin|carboplatin|mesh-list
83392816|NCT02083679|Gemcitabine|gemcitabine|mesh-list
83392817|NCT02083679|Pemetrexed|pemetrexed|mesh-list
83392818|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83392819|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83392820|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392821|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
83392822|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
83392823|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
83392824|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392825|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83392826|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
83392827|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392828|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83392829|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83392830|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
83392831|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392832|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83392833|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83392835|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392836|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392837|NCT03769025|Analgesics|analgesics|mesh-ancestor
83392838|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
83392839|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392840|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83392841|NCT01672710|Niacin|niacin|mesh-list
83392842|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83392843|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
83392844|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392845|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83392846|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
83392847|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
83392848|NCT01672710|Vitamins|vitamins|mesh-ancestor
83392849|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
83392850|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392851|NCT03766763|Venetoclax|venetoclax|mesh-list
83392852|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392853|NCT04790448|Irinotecan|irinotecan|mesh-list
83392854|NCT04790448|Camptothecin|camptothecin|mesh-list
83392855|NCT04790448|Cetuximab|cetuximab|mesh-list
83392857|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83392858|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83392859|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392860|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392861|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392862|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83392863|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83392864|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83392865|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
83392866|NCT04784052|Rituximab|rituximab|mesh-list
83392867|NCT04784052|Fludarabine|fludarabine|mesh-list
83392868|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
83392869|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83392870|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83392871|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
83392872|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392873|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392874|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83392875|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
83392876|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392877|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392878|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83392879|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83392880|NCT05319756|Oxycodone|oxycodone|mesh-list
83392881|NCT05319756|Gabapentin|gabapentin|mesh-list
83392882|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83392883|NCT05319756|Narcotics|narcotics|mesh-ancestor
83392884|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392885|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392886|NCT05319756|Analgesics|analgesics|mesh-ancestor
83392887|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
83392888|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392889|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
83392890|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83392891|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83392892|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83392893|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83392894|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83392895|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392896|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392897|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
83392898|NCT00976521|Abciximab|abciximab|mesh-list
83392899|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
83392900|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83392901|NCT04410588|Fentanyl|fentanyl|mesh-list
83392902|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
83392903|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83392904|NCT04410588|Narcotics|narcotics|mesh-ancestor
83392905|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392906|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392907|NCT04410588|Analgesics|analgesics|mesh-ancestor
83392908|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
83392909|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392910|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83392911|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83392912|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
83392913|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
83392914|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
83392915|NCT05303220|Branebrutinib|branebrutinib|mesh-list
83392916|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83392917|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392918|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392919|NCT04444830|Ketorolac|ketorolac|mesh-list
83392920|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83392921|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83392922|NCT04444830|Analgesics|analgesics|mesh-ancestor
83392923|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
83392924|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392925|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392926|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83392927|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392928|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83392929|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392930|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392931|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83392932|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83392933|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
83392934|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392935|NCT03738917|Bromides|bromides|mesh-list
83392936|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
83392937|NCT03738917|Ipratropium|ipratropium|mesh-list
83392938|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83392939|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
83392940|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
83392941|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
83392942|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83392943|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83392944|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83392945|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392946|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392947|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83392948|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
83392949|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392950|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83392951|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
83392952|NCT00976599|Methotrexate|methotrexate|mesh-list
83392953|NCT00976599|Tofacitinib|tofacitinib|mesh-list
83392954|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83392955|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
83392956|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83392957|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392958|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83392959|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
83392960|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392961|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392962|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
83392963|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83392964|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83392965|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83392966|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
83392967|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392968|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83392969|NCT00976599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83392970|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83392971|NCT02630472|Quinine|quinine|mesh-list
83392972|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
83392973|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83392974|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83392975|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392976|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83392977|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392978|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83392979|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392980|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83392981|NCT02630472|Analgesics|analgesics|mesh-ancestor
83392982|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
83392984|NCT03729011|Sevoflurane|sevoflurane|mesh-list
83392985|NCT03729011|Desflurane|desflurane|mesh-list
83392986|NCT03729011|Isoflurane|isoflurane|mesh-list
83392987|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83392988|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83392989|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83392990|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83392991|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
83392992|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
83392993|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83392994|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83392995|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83392996|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
83392997|NCT05264922|Coagulants|coagulants|mesh-ancestor
83392998|NCT00977769|Oxytocin|oxytocin|mesh-list
83392999|NCT00977769|Carbetocin|carbetocin|mesh-list
83393000|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
83393001|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83393002|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393003|NCT03725501|Ranibizumab|ranibizumab|mesh-list
83393004|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83393005|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83393006|NCT03725501|Growth Substances|growth substances|mesh-ancestor
83393007|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393008|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
83393009|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393013|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83393014|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393015|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83393016|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83393017|NCT00979017|Growth Substances|growth substances|mesh-ancestor
83393018|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393019|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
83393020|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83393021|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83393022|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393023|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393024|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83393025|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
83393026|NCT01670526|Rivastigmine|rivastigmine|mesh-list
83393027|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
83393028|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393029|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393030|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
83393031|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393032|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393033|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83393034|NCT01670526|Protective Agents|protective agents|mesh-ancestor
83393035|NCT00945035|Etoricoxib|etoricoxib|mesh-list
83393036|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83393037|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83393038|NCT00945035|Analgesics|analgesics|mesh-ancestor
83393039|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
83393040|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393041|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393042|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393043|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393044|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83393045|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83393046|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393047|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393048|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
83393049|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83393050|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393051|NCT03720431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83393052|NCT03720431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393053|NCT05386953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83393054|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83393055|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
83393057|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
83393058|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393059|NCT03719105|Dexamethasone|dexamethasone|mesh-list
83393060|NCT03719105|Prednisone|prednisone|mesh-list
83393061|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
83393062|NCT03719105|Ifosfamide|ifosfamide|mesh-list
83393063|NCT03719105|Doxorubicin|doxorubicin|mesh-list
83393064|NCT03719105|Methotrexate|methotrexate|mesh-list
83393065|NCT03719105|Etoposide|etoposide|mesh-list
83393066|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83393067|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83393068|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
83393069|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393070|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393071|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83393072|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
83393073|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393074|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393075|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83393076|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393077|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
83393078|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
83393079|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393080|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83393081|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
83393082|NCT03719105|Hormones|hormones|mesh-ancestor
83393083|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83393084|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83393085|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83393086|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83393087|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83393089|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83393090|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
83393091|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83393092|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83393093|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
83393094|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
83393095|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83393096|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83393097|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83393098|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83393099|NCT03719105|Immunotoxins|immunotoxins|mesh-ancestor
83393100|NCT03719105|Immunoconjugates|immunoconjugates|mesh-ancestor
83393101|NCT00979875|Insulin|insulin|mesh-list
83393102|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83393103|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
83393104|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
83393105|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
83393106|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83393107|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393108|NCT03710603|Dexamethasone|dexamethasone|mesh-list
83393109|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
83393110|NCT03710603|Lenalidomide|lenalidomide|mesh-list
83393111|NCT03710603|Bortezomib|bortezomib|mesh-list
83393112|NCT03710603|Daratumumab|daratumumab|mesh-list
83393113|NCT03710603|BB 1101|bb 1101|mesh-list
83393114|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393115|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
83393116|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
83393117|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393118|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393119|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83393120|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
83393121|NCT03710603|Hormones|hormones|mesh-ancestor
83393122|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83393123|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83393124|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393125|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
83393126|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393127|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393128|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
83393129|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83393130|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83393131|NCT03710603|Growth Substances|growth substances|mesh-ancestor
83393132|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
83393133|NCT02630706|Metformin|metformin|mesh-list
83393134|NCT02630706|Glimepiride|glimepiride|mesh-list
83393135|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
83393136|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83393137|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393138|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83393139|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83393140|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
83393141|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83393142|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393143|NCT03709043|Ethanol|ethanol|mesh-list
83393144|NCT03709043|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83393145|NCT03709043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393146|NCT03709043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83393147|NCT03709043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393148|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
83393149|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83393150|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
83393151|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393152|NCT03707951|Expectorants|expectorants|mesh-ancestor
83393153|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
83393154|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83393155|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
83393156|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393157|NCT03707951|Protective Agents|protective agents|mesh-ancestor
83393158|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393159|NCT03707951|Antidotes|antidotes|mesh-ancestor
83393160|NCT04763057|Calcium|calcium|mesh-list
83393161|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83393162|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393163|NCT03702179|Durvalumab|durvalumab|mesh-list
83393164|NCT03702179|Tremelimumab|tremelimumab|mesh-list
83393165|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83393166|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393167|NCT01677143|Bupivacaine|bupivacaine|mesh-list
83393168|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
83393169|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
83393170|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83393171|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393172|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
83393173|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393174|NCT03692663|Cyclophosphamide|cyclophosphamide|mesh-list
83393175|NCT03692663|Fludarabine|fludarabine|mesh-list
83393176|NCT03692663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83393177|NCT03692663|Immunologic Factors|immunologic factors|mesh-ancestor
83393178|NCT03692663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393179|NCT03692663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393180|NCT03692663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83393181|NCT03692663|Alkylating Agents|alkylating agents|mesh-ancestor
83393182|NCT03692663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393183|NCT03692663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393184|NCT03692663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83393185|NCT02084069|Atorvastatin|atorvastatin|mesh-list
83393186|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83393187|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83393188|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
83393189|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393190|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83393191|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83393192|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393193|NCT03685331|Fulvestrant|fulvestrant|mesh-list
83393194|NCT03685331|Olaparib|olaparib|mesh-list
83393195|NCT03685331|Palbociclib|palbociclib|mesh-list
83393196|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83393197|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393198|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83393199|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83393200|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
83393201|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83393202|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393203|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83393204|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393205|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393206|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83393207|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
83393209|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393210|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83393211|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393212|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393213|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83393214|NCT00981045|Hematinics|hematinics|mesh-ancestor
83393215|NCT00981435|Prednisolone|prednisolone|mesh-list
83393216|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
83393217|NCT00981435|Ketorolac|ketorolac|mesh-list
83393218|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
83393219|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393220|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
83393221|NCT00981435|Hormones|hormones|mesh-ancestor
83393222|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83393223|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393224|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83393225|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393226|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393227|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83393228|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83393229|NCT00981435|Analgesics|analgesics|mesh-ancestor
83393230|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
83393231|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393232|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83393233|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393234|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393235|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83393236|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83393237|NCT04571580|Reteplase|reteplase|mesh-list
83393238|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83393239|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83393240|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83393241|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393243|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
83393244|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393245|NCT00981825|Listerine|listerine|mesh-list
83393246|NCT00981825|Triclosan|triclosan|mesh-list
83393247|NCT00981825|Fluorides|fluorides|mesh-list
83393248|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
83393249|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
83393250|NCT00981825|Protective Agents|protective agents|mesh-ancestor
83393251|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393252|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83393253|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393254|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83393255|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83393256|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
83393257|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393258|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83393259|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83393260|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393261|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83393262|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393263|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393264|NCT04762745|Thalidomide|thalidomide|mesh-list
83393265|NCT04762745|Dexamethasone|dexamethasone|mesh-list
83393266|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
83393267|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83393268|NCT04762745|Pomalidomide|pomalidomide|mesh-list
83393269|NCT04762745|BB 1101|bb 1101|mesh-list
83393270|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393271|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
83393272|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
83393273|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393274|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393275|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83393276|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
83393277|NCT04762745|Hormones|hormones|mesh-ancestor
83393278|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83393279|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83393280|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393281|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
83393282|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393283|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393284|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83393285|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
83393286|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
83393287|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83393288|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83393289|NCT04762745|Growth Substances|growth substances|mesh-ancestor
83393290|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
83393291|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83393292|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
83393293|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83393294|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393295|NCT00983541|Gemcitabine|gemcitabine|mesh-list
83393296|NCT00983541|Fluorouracil|fluorouracil|mesh-list
83393297|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83393298|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
83393299|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393300|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393301|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83393302|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
83393303|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393304|NCT03667703|Famotidine|famotidine|mesh-list
83393305|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83393306|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83393307|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83393308|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
83393309|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
83393310|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393311|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393312|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393313|NCT05074056|Ketorolac|ketorolac|mesh-list
83393314|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83393315|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83393328|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393329|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83393330|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83393331|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
83393332|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
83393334|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
83393335|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393336|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393337|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83393338|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83393339|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
83393340|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83393341|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83393342|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
83393343|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393344|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393345|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83393346|NCT00986583|Succinylcholine|succinylcholine|mesh-list
83393347|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83393348|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83393349|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83393350|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393352|NCT05056974|UB-421|ub-421|mesh-list
83393353|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83393354|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
83393355|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393356|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83393357|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83393358|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393359|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393360|NCT04762511|Vaccines|vaccines|mesh-list
83393361|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
83393362|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393363|NCT04762901|Paclitaxel|paclitaxel|mesh-list
83393364|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
83393365|NCT04762901|Carboplatin|carboplatin|mesh-list
83393366|NCT04762901|Doxorubicin|doxorubicin|mesh-list
83393367|NCT04762901|Niraparib|niraparib|mesh-list
83393368|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83393369|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393370|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
83393371|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
83393372|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
83393373|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393374|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83393375|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
83393376|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393377|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393378|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83393379|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
83393380|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83393381|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83393382|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83393383|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83393384|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393385|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83393386|NCT00988143|Vaccines|vaccines|mesh-list
83393387|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
83393388|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393389|NCT03018171|Clonidine|clonidine|mesh-list
83393390|NCT03018171|Sufentanil|sufentanil|mesh-list
83393391|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83393392|NCT03018171|Narcotics|narcotics|mesh-ancestor
83393393|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83393394|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393395|NCT03018171|Analgesics|analgesics|mesh-ancestor
83393396|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
83393397|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393398|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83393399|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83393400|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
83393401|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
83393402|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83393403|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
83393404|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
83393405|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83393406|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83393407|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83393408|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
83393409|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393410|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393411|NCT03638375|Interferons|interferons|mesh-list
83393412|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
83393413|NCT03638375|Nivolumab|nivolumab|mesh-list
83393414|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83393415|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393416|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83393417|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393418|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
83393419|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393420|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
83393421|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393422|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83393423|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83393424|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83393425|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83393426|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393427|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393428|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393429|NCT00989157|Analgesics|analgesics|mesh-ancestor
83393430|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
83393431|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393432|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
83393433|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83393434|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
83393435|NCT00990561|Clobetasol|clobetasol|mesh-list
83393436|NCT00990561|Halobetasol|halobetasol|mesh-list
83393437|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83393438|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393439|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
83393440|NCT00990561|Hormones|hormones|mesh-ancestor
83393441|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83393442|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393443|NCT03018015|Ibuprofen|ibuprofen|mesh-list
83393444|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83393445|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83393446|NCT03018015|Analgesics|analgesics|mesh-ancestor
83393447|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
83393448|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393449|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393450|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393451|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393452|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83393453|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393454|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393455|NCT03614741|Tinzaparin|tinzaparin|mesh-list
83393456|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83393457|NCT03614741|Dalteparin|dalteparin|mesh-list
83393458|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
83393459|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83393460|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83393461|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393462|NCT03609593|Rituximab|rituximab|mesh-list
83393463|NCT03609593|Venetoclax|venetoclax|mesh-list
83393464|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83393465|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83393466|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393467|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
83393468|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393469|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393470|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83393471|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
83393472|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393473|NCT00004547|Paclitaxel|paclitaxel|mesh-list
83393474|NCT00004547|Cisplatin|cisplatin|mesh-list
83393475|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83393476|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393477|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
83393478|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
83393480|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393481|NCT00005669|Metformin|metformin|mesh-list
83393482|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83393483|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393484|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
83393485|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83393486|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83393487|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393488|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83393489|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393490|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83393491|NCT01363661|Molsidomine|molsidomine|mesh-list
83393492|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
83393493|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83393494|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393495|NCT02628600|Amikacin|amikacin|mesh-list
83393496|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83393497|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393498|NCT00006101|Eflornithine|eflornithine|mesh-list
83393499|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393500|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83393502|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83393503|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393504|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83393505|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393506|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393507|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
83393508|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83393509|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
83393510|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393511|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393512|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393513|NCT04437888|Ketamine|ketamine|mesh-list
83393514|NCT04437888|Analgesics|analgesics|mesh-ancestor
83393515|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
83393516|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393517|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393518|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83393519|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83393520|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
83393521|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
83393522|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83393523|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83393524|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83393525|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393526|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393527|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
83393528|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83393529|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393530|NCT00991029|Clopidogrel|clopidogrel|mesh-list
83393531|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83393532|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83393533|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83393534|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83393535|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
83393536|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393537|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393538|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393539|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
83393540|NCT00991809|Promethazine|promethazine|mesh-list
83393541|NCT00991809|Alfentanil|alfentanil|mesh-list
83393542|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83393543|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83393544|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83393545|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393546|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
83393547|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
83393548|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
83393549|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393550|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
83393551|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
83393552|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83393553|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83393554|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
83393555|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
83393556|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393557|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393558|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83393559|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
83393560|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
83393561|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83393562|NCT00991809|Narcotics|narcotics|mesh-ancestor
83393563|NCT00991809|Analgesics|analgesics|mesh-ancestor
83393564|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83393565|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
83393566|NCT02627274|Trastuzumab|trastuzumab|mesh-list
83393567|NCT02627274|Cetuximab|cetuximab|mesh-list
83393568|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83393569|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393570|NCT04982016|Methamphetamine|methamphetamine|mesh-list
83393571|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83393572|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393573|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
83393574|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
83393575|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393576|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
83393577|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393578|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393579|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
83393580|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83393581|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83393582|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83393583|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83393585|NCT04436250|Esketamine|esketamine|mesh-list
83393586|NCT04436250|Analgesics|analgesics|mesh-ancestor
83393587|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
83393588|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393589|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393590|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83393591|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83393592|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
83393593|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
83393594|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83393595|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83393596|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83393597|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393598|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393599|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
83393600|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83393601|NCT00994929|Oprelvekin|oprelvekin|mesh-list
83393602|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393603|NCT00929253|Buprenorphine|buprenorphine|mesh-list
83393604|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83393605|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83393606|NCT00929253|Narcotics|narcotics|mesh-ancestor
83393607|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83393608|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393609|NCT00929253|Analgesics|analgesics|mesh-ancestor
83393610|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
83393611|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393612|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83393613|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
83393614|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
83393615|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83393616|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83393617|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393618|NCT04374903|Sirolimus|sirolimus|mesh-list
83393619|NCT04374903|Azithromycin|azithromycin|mesh-list
83393620|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
83393621|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83393622|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393623|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83393624|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393625|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
83393626|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83393627|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
83393628|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393629|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393705|NCT04974060|Remifentanil|remifentanil|mesh-list
83393630|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393631|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
83393632|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83393633|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83393634|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393635|NCT03062982|Fluzoparib|fluzoparib|mesh-list
83393636|NCT03062982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83393637|NCT03062982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393638|NCT03062982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393639|NCT03062982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393640|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
83393641|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
83393642|NCT03062436|Protective Agents|protective agents|mesh-ancestor
83393643|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393644|NCT03500874|Leucovorin|leucovorin|mesh-list
83393645|NCT03500874|Fluorouracil|fluorouracil|mesh-list
83393646|NCT03500874|Floxuridine|floxuridine|mesh-list
83393647|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
83393648|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
83393649|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393650|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83393651|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393652|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83393653|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
83393654|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393655|NCT03500874|Antidotes|antidotes|mesh-ancestor
83393656|NCT03500874|Protective Agents|protective agents|mesh-ancestor
83393657|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
83393658|NCT03500874|Vitamins|vitamins|mesh-ancestor
83393659|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
83393660|NCT00997113|Alfentanil|alfentanil|mesh-list
83393661|NCT00997113|Propofol|propofol|mesh-list
83393662|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83393663|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83393664|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393665|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83393666|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
83393667|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
83393668|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83393669|NCT00997113|Narcotics|narcotics|mesh-ancestor
83393670|NCT00997113|Analgesics|analgesics|mesh-ancestor
83393671|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
83393672|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393673|NCT04981704|Itraconazole|itraconazole|mesh-list
83393674|NCT04981704|Phenytoin|phenytoin|mesh-list
83393675|NCT04981704|Paroxetine|paroxetine|mesh-list
83393676|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
83393677|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393678|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83393679|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83393680|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393681|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393682|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83393683|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
83393684|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83393685|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393686|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83393687|NCT04981704|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83393688|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83393689|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83393690|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393691|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
83393692|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83393693|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
83393694|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83393695|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83393696|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
83393697|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83393698|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83393699|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83393700|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83393701|NCT02163837|Rifaximin|rifaximin|mesh-list
83393702|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83393703|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393704|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83393709|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393711|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
83393712|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393713|NCT01021761|Ketorolac|ketorolac|mesh-list
83393714|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83393715|NCT01021761|Nepafenac|nepafenac|mesh-list
83393716|NCT01021761|Bromfenac|bromfenac|mesh-list
83393717|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83393718|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83393719|NCT01021761|Analgesics|analgesics|mesh-ancestor
83393720|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
83393721|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393722|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393723|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393724|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393725|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83393726|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393727|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393728|NCT04973904|Paclitaxel|paclitaxel|mesh-list
83393729|NCT04973904|Bevacizumab|bevacizumab|mesh-list
83393730|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83393731|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393732|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
83393733|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
83393734|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
83393735|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393736|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83393737|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83393738|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83393739|NCT04973904|Growth Substances|growth substances|mesh-ancestor
83393740|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393741|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
83393742|NCT00998049|Plerixafor|plerixafor|mesh-list
83393743|NCT00998049|Lenograstim|lenograstim|mesh-list
83393744|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83393745|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
83393746|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393747|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83393748|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83393749|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
83393750|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393751|NCT00998205|Atropine|atropine|mesh-list
83393752|NCT00998205|Dobutamine|dobutamine|mesh-list
83393753|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83393754|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83393755|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83393756|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
83393757|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393758|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393759|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83393760|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
83393761|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
83393762|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
83393763|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83393764|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83393765|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
83393766|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393767|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393768|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83393769|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
83393770|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83393771|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83393772|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83393773|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
83393774|NCT00998205|Protective Agents|protective agents|mesh-ancestor
83393775|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
83393776|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
83393777|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83393778|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83393779|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393780|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393781|NCT02626182|Urological Agents|urological agents|mesh-ancestor
83393782|NCT01023477|Chloroquine|chloroquine|mesh-list
83393783|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83393784|NCT01023477|Amebicides|amebicides|mesh-ancestor
83393796|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393797|NCT01023477|Filaricides|filaricides|mesh-ancestor
83393798|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
83393799|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
83393800|NCT01023711|Vaccines|vaccines|mesh-list
83393801|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
83393802|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393803|NCT01001403|Nafamostat|nafamostat|mesh-list
83393804|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83393805|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83393806|NCT01001403|Analgesics|analgesics|mesh-ancestor
83393807|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
83393808|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393809|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393810|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393811|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393812|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
83393813|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
83393814|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393815|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393816|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83393817|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83393818|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83393819|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83393820|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
83393821|NCT01024335|Naltrexone|naltrexone|mesh-list
83393822|NCT01024335|Dronabinol|dronabinol|mesh-list
83393823|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83393824|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83393825|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393826|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
83393827|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393828|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
83393829|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83393830|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83393831|NCT01024335|Analgesics|analgesics|mesh-ancestor
83393832|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83393833|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83393834|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393835|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393836|NCT01024335|Hormones|hormones|mesh-ancestor
83393837|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83393838|NCT01001559|Norepinephrine|norepinephrine|mesh-list
83393839|NCT01001559|Serotonin|serotonin|mesh-list
83393840|NCT01001559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83393841|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
83393842|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83393843|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83393844|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
83393845|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393846|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393847|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393848|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
83393849|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
83393850|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393851|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83393852|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83393853|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
83393854|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83393855|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83393856|NCT01025427|Tenofovir|tenofovir|mesh-list
83393857|NCT01025427|Emtricitabine|emtricitabine|mesh-list
83393858|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
83393859|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
83393860|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393861|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83393862|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83393863|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393864|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393865|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83393866|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83393867|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83393868|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83393869|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
83393870|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83393871|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83393872|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393873|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83393874|NCT02162433|Analgesics|analgesics|mesh-ancestor
83393875|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
83393876|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393877|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83393878|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83393879|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83393880|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
83393881|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393882|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393883|NCT01004991|Prednisone|prednisone|mesh-list
83393884|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
83393885|NCT01004991|Rituximab|rituximab|mesh-list
83393886|NCT01004991|Doxorubicin|doxorubicin|mesh-list
83393887|NCT01004991|Vincristine|vincristine|mesh-list
83393888|NCT01004991|Azacitidine|azacitidine|mesh-list
83393889|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83393890|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
83393891|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393892|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393893|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83393894|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
83393895|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393896|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393897|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83393898|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83393899|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83393900|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83393901|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83393902|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393903|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393904|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
83393905|NCT01004991|Hormones|hormones|mesh-ancestor
83393906|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83393907|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83393908|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83393909|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
83393910|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
83393911|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
83393912|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83393913|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
83393914|NCT03063060|Vitamin D|vitamin d|mesh-list
83393915|NCT03063060|Calcium|calcium|mesh-list
83393916|NCT03063060|Vitamins|vitamins|mesh-ancestor
83393917|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
83393918|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393919|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83393920|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83393921|NCT03115047|Meperidine|meperidine|mesh-list
83393922|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
83393923|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83393924|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83393925|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393926|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83393927|NCT03115047|Analgesics|analgesics|mesh-ancestor
83393928|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
83393929|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393930|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83393931|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83393932|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83393933|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
83393934|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393935|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393936|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83393937|NCT03115047|Narcotics|narcotics|mesh-ancestor
83393938|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83393939|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83393940|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393941|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
83393942|NCT03015519|Incretins|incretins|mesh-ancestor
83393943|NCT03015519|Hormones|hormones|mesh-ancestor
83393944|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83393945|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393978|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393979|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393980|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83393981|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83393982|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393983|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83393984|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83393985|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393986|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
83393987|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
83393988|NCT04358133|Morphine|morphine|mesh-list
83393989|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83393990|NCT04358133|Narcotics|narcotics|mesh-ancestor
83393991|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83393992|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393993|NCT04358133|Analgesics|analgesics|mesh-ancestor
83393994|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
83393995|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393996|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
83393997|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83393998|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
83393999|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394000|NCT04291209|Expectorants|expectorants|mesh-ancestor
83394001|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
83394002|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83394003|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
83394004|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394005|NCT04291209|Protective Agents|protective agents|mesh-ancestor
83394006|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394007|NCT04291209|Antidotes|antidotes|mesh-ancestor
83394008|NCT01032759|Memantine|memantine|mesh-list
83394009|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83394010|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83394011|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
83394012|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394013|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394014|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394015|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83394016|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83394017|NCT01032993|Ubiquinone|ubiquinone|mesh-list
83394018|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
83394019|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
83394020|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394021|NCT01032993|Vitamins|vitamins|mesh-ancestor
83394022|NCT01033773|Metformin|metformin|mesh-list
83394023|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83394024|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394025|NCT01053507|Naproxen|naproxen|mesh-list
83394026|NCT01053507|Sumatriptan|sumatriptan|mesh-list
83394027|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83394028|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394029|NCT01053507|Analgesics|analgesics|mesh-ancestor
83394030|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
83394031|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394032|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394033|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83394034|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83394035|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
83394036|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83394037|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394038|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394039|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83394040|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83394041|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83394042|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
83394043|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394044|NCT01053819|Etanercept|etanercept|mesh-list
83394045|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83394046|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394047|NCT01053819|Analgesics|analgesics|mesh-ancestor
83394048|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
83394049|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394050|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394051|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83394069|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83394070|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
83394071|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83394072|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394073|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83394074|NCT01055223|Diuretics|diuretics|mesh-ancestor
83394075|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
83394076|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83394077|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83394078|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83394079|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394080|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83394081|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83394082|NCT02168361|Interferons|interferons|mesh-list
83394083|NCT02168361|Ribavirin|ribavirin|mesh-list
83394084|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
83394085|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
83394086|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
83394087|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83394088|NCT02168361|Simeprevir|simeprevir|mesh-list
83394089|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394090|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
83394091|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394092|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
83394093|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394094|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
83394095|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394096|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
83394097|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394098|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83394099|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394100|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83394102|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394103|NCT01055769|Linezolid|linezolid|mesh-list
83394104|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83394105|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394106|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83394107|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394108|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394109|NCT01057017|Panitumumab|panitumumab|mesh-list
83394110|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83394111|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394112|NCT04972032|Estrogens|estrogens|mesh-list
83394113|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
83394114|NCT04972032|Hormones|hormones|mesh-ancestor
83394115|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83394116|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394117|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83394118|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
83394119|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
83394120|NCT04972032|Protective Agents|protective agents|mesh-ancestor
83394121|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
83394122|NCT04432662|Hematinics|hematinics|mesh-ancestor
83394123|NCT02918370|Aripiprazole|aripiprazole|mesh-list
83394124|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
83394125|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83394126|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83394127|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83394128|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394129|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394130|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
83394131|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
83394132|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394133|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394134|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83394135|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83394136|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
83394137|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83394138|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83394139|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83394140|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83394141|NCT04152564|Bupivacaine|bupivacaine|mesh-list
83394142|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
83394143|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
83394144|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
83394145|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394146|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394147|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
83394148|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394149|NCT04977960|Canrenone|canrenone|mesh-list
83394150|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
83394151|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83394152|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
83394153|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83394154|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394155|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83394156|NCT04977960|Diuretics|diuretics|mesh-ancestor
83394157|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
83394158|NCT05593809|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
83394159|NCT05593809|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83394160|NCT05593809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394161|NCT05593731|Melatonin|melatonin|mesh-list
83394162|NCT05593731|Antioxidants|antioxidants|mesh-ancestor
83394163|NCT05593731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394164|NCT05593731|Protective Agents|protective agents|mesh-ancestor
83394165|NCT05593731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394166|NCT05593731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394167|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
83394168|NCT01062009|Astringents|astringents|mesh-ancestor
83394169|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394170|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
83394171|NCT01062165|Caspofungin|caspofungin|mesh-list
83394172|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
83394173|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394174|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394175|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394176|NCT05592951|Methamphetamine|methamphetamine|mesh-list
83394177|NCT05592951|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83394178|NCT05592951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394179|NCT05592951|Sympathomimetics|sympathomimetics|mesh-ancestor
83394180|NCT05592951|Autonomic Agents|autonomic agents|mesh-ancestor
83394181|NCT05592951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394182|NCT05592951|Dopamine Agents|dopamine agents|mesh-ancestor
83394183|NCT05592951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394184|NCT05592951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394185|NCT05592951|Adrenergic Agents|adrenergic agents|mesh-ancestor
83394186|NCT05592951|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83394187|NCT05592951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83394188|NCT05592951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83394189|NCT05592951|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83394190|NCT04041843|Apixaban|apixaban|mesh-list
83394191|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83394192|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
83394193|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83394194|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
83394195|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394196|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394197|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
83394198|NCT01068873|Ritonavir|ritonavir|mesh-list
83394199|NCT01068873|Lopinavir|lopinavir|mesh-list
83394200|NCT01068873|Maraviroc|maraviroc|mesh-list
83394201|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83394202|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83394203|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
83394204|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394205|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394206|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83394207|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83394208|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
83394209|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394210|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83394211|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83394212|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83394213|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83394214|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83394215|NCT01072773|Dexamethasone|dexamethasone|mesh-list
83394216|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
83394217|NCT01072773|Bortezomib|bortezomib|mesh-list
83394218|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83394220|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394221|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83394222|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83394223|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
83394224|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394225|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394226|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83394227|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83394228|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
83394229|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
83394230|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394231|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83394232|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
83394233|NCT01072773|Hormones|hormones|mesh-ancestor
83394234|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83394235|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83394236|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83394237|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83394238|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83394239|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
83394240|NCT01074177|Afatinib|afatinib|mesh-list
83394241|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394242|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83394243|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394244|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394245|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
83394246|NCT01076283|Baclofen|baclofen|mesh-list
83394247|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83394248|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394249|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83394250|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394251|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83394252|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
83394253|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
83394254|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394255|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394256|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
83394257|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
83394258|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83394259|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83394260|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
83394261|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
83394262|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83394263|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
83394264|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83394265|NCT03805581|Defibrotide|defibrotide|mesh-list
83394266|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83394267|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83394268|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394269|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83394270|NCT01076985|Ritonavir|ritonavir|mesh-list
83394271|NCT01076985|Lopinavir|lopinavir|mesh-list
83394272|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83394273|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83394274|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
83394275|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394276|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394277|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83394278|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83394279|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
83394280|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394281|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83394282|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83394283|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
83394284|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83394285|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394286|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83394287|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83394288|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394289|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394290|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394291|NCT05539911|Fentanyl|fentanyl|mesh-list
83394292|NCT05539911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83394293|NCT05539911|Narcotics|narcotics|mesh-ancestor
83394294|NCT05539911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394295|NCT05539911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394296|NCT05539911|Analgesics|analgesics|mesh-ancestor
83394297|NCT05539911|Sensory System Agents|sensory system agents|mesh-ancestor
83394298|NCT05539911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394299|NCT05539911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83394300|NCT05539911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83394301|NCT05539911|Anesthetics, General|anesthetics, general|mesh-ancestor
83394302|NCT05539911|Anesthetics|anesthetics|mesh-ancestor
83394303|NCT03589833|Methotrexate|methotrexate|mesh-list
83394304|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83394305|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
83394306|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83394307|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394308|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83394309|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
83394310|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394311|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394312|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
83394313|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394314|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83394315|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83394316|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
83394317|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83394318|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83394319|NCT01077921|Propranolol|propranolol|mesh-list
83394320|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83394321|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83394322|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
83394323|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394324|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394325|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394326|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83394327|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83394328|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
83394330|NCT05498181|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83394331|NCT05498181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83394332|NCT05498181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83394333|NCT05498181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83394334|NCT05498181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394335|NCT04970238|Simendan|simendan|mesh-list
83394336|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83394337|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
83394338|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83394339|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83394340|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394341|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394342|NCT04970238|Protective Agents|protective agents|mesh-ancestor
83394343|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394344|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83394345|NCT02169453|Opicapone|opicapone|mesh-list
83394346|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83394347|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
83394348|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394349|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83394350|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83394351|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
83394352|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
83394353|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394354|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394355|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83394356|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394357|NCT01822314|Paclitaxel|paclitaxel|mesh-list
83394358|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83394359|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83394360|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394361|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
83394362|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
83394363|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
83394364|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394365|NCT01765296|Celecoxib|celecoxib|mesh-list
83394366|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83394367|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394368|NCT01765296|Analgesics|analgesics|mesh-ancestor
83394370|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394371|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394372|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83394373|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83394374|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83394375|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83394376|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394377|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394378|NCT01081041|Carboplatin|carboplatin|mesh-list
83394379|NCT01081041|Fluorouracil|fluorouracil|mesh-list
83394380|NCT01081041|Cetuximab|cetuximab|mesh-list
83394381|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394382|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
83394383|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394384|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83394385|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83394386|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
83394387|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394388|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83394389|NCT03022617|Apremilast|apremilast|mesh-list
83394390|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83394391|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394392|NCT03022617|Analgesics|analgesics|mesh-ancestor
83394393|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
83394394|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394395|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394396|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83394397|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83394398|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83394399|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83394400|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394401|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394403|NCT05427981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83394404|NCT05427981|Narcotics|narcotics|mesh-ancestor
83394405|NCT05427981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394406|NCT05427981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394407|NCT05427981|Analgesics|analgesics|mesh-ancestor
83394408|NCT05427981|Sensory System Agents|sensory system agents|mesh-ancestor
83394409|NCT05427981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394410|NCT05427981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83394411|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
83394412|NCT02089685|Ipilimumab|ipilimumab|mesh-list
83394413|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83394414|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394415|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83394416|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394417|NCT01088295|Telmisartan|telmisartan|mesh-list
83394418|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83394419|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83394420|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83394421|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394422|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
83394423|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83394424|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394425|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394426|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394427|NCT04730609|Analgesics|analgesics|mesh-ancestor
83394428|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
83394429|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394430|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83394431|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83394432|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83394433|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
83394434|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394435|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394436|NCT03013335|Nivolumab|nivolumab|mesh-list
83394437|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83394438|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394439|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83394440|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394449|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83394450|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83394451|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
83394452|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394453|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394454|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83394455|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83394456|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
83394457|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83394458|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
83394459|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
83394460|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
83394461|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83394462|NCT05569733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83394463|NCT05569733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83394464|NCT05569733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394465|NCT05853575|Adagrasib|adagrasib|mesh-list
83394466|NCT05853575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394467|NCT05853458|Hydroxyurea|hydroxyurea|mesh-list
83394468|NCT05853458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394469|NCT05853458|Antisickling Agents|antisickling agents|mesh-ancestor
83394470|NCT05853458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394471|NCT05853458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394472|NCT05853458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83394473|NCT05853354|Denosumab|denosumab|mesh-list
83394474|NCT05853354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83394475|NCT05853354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394476|NCT05853341|Rivastigmine|rivastigmine|mesh-list
83394477|NCT05853341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83394478|NCT05853341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394479|NCT05853341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394480|NCT05853341|Cholinergic Agents|cholinergic agents|mesh-ancestor
83394481|NCT05853341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394482|NCT05853341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394483|NCT05853341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83394484|NCT05853341|Protective Agents|protective agents|mesh-ancestor
83394485|NCT05853289|Analgesics, Opioid|analgesics, opioid|mesh-list
83394486|NCT05853289|Narcotics|narcotics|mesh-ancestor
83394487|NCT05853289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394488|NCT05853289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394489|NCT05853289|Analgesics|analgesics|mesh-ancestor
83394490|NCT05853289|Sensory System Agents|sensory system agents|mesh-ancestor
83394491|NCT05853289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394492|NCT05853224|Lidocaine|lidocaine|mesh-list
83394493|NCT05853224|Hyaluronic Acid|hyaluronic acid|mesh-list
83394494|NCT05853224|Anesthetics, Local|anesthetics, local|mesh-ancestor
83394495|NCT05853224|Anesthetics|anesthetics|mesh-ancestor
83394496|NCT05853224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394497|NCT05853224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394498|NCT05853224|Sensory System Agents|sensory system agents|mesh-ancestor
83394499|NCT05853224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394500|NCT05853224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83394501|NCT05853224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83394502|NCT05853224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83394503|NCT05853224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83394504|NCT05853224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394505|NCT05853224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83394506|NCT05853224|Immunologic Factors|immunologic factors|mesh-ancestor
83394507|NCT05853224|Viscosupplements|viscosupplements|mesh-ancestor
83394508|NCT05853224|Protective Agents|protective agents|mesh-ancestor
83394509|NCT05853172|Paclitaxel|paclitaxel|mesh-list
83394510|NCT05853172|Apatinib|apatinib|mesh-list
83394511|NCT05853172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83394512|NCT05853172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394513|NCT05853172|Tubulin Modulators|tubulin modulators|mesh-ancestor
83394514|NCT05853172|Antimitotic Agents|antimitotic agents|mesh-ancestor
83394515|NCT05853172|Mitosis Modulators|mitosis modulators|mesh-ancestor
83394516|NCT05853172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394517|NCT05853172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83394518|NCT05853172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394519|NCT05853263|Acetaminophen|acetaminophen|mesh-list
83394520|NCT05853263|Morphine|morphine|mesh-list
83394521|NCT05853263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83394522|NCT05853263|Narcotics|narcotics|mesh-ancestor
83394523|NCT05853263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394524|NCT05853263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394526|NCT05853263|Sensory System Agents|sensory system agents|mesh-ancestor
83394527|NCT05853263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394528|NCT05853263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394529|NCT05853263|Antipyretics|antipyretics|mesh-ancestor
83394530|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83394531|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83394532|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394533|NCT05852873|Ritonavir|ritonavir|mesh-list
83394534|NCT05852873|Nirmatrelvir|nirmatrelvir|mesh-list
83394535|NCT05852873|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83394536|NCT05852873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83394537|NCT05852873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83394538|NCT05852873|Protease Inhibitors|protease inhibitors|mesh-ancestor
83394539|NCT05852873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394540|NCT05852873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394541|NCT05852873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83394542|NCT05852873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83394543|NCT05852873|Antiviral Agents|antiviral agents|mesh-ancestor
83394544|NCT05852873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394545|NCT05852873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83394546|NCT05852873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83394547|NCT05852847|Danazol|danazol|mesh-list
83394548|NCT05852847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83394549|NCT05852847|Hormone Antagonists|hormone antagonists|mesh-ancestor
83394550|NCT05852847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83394551|NCT05852847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394552|NCT05852769|Flurbiprofen|flurbiprofen|mesh-list
83394553|NCT05852769|Digoxin|digoxin|mesh-list
83394554|NCT05852769|Midazolam|midazolam|mesh-list
83394555|NCT05852769|Caffeine|caffeine|mesh-list
83394556|NCT05852769|Omeprazole|omeprazole|mesh-list
83394557|NCT05852769|Pravastatin|pravastatin|mesh-list
83394558|NCT05852769|Montelukast|montelukast|mesh-list
83394559|NCT05852769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83394560|NCT05852769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83394561|NCT05852769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394562|NCT05852769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394563|NCT05852769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83394564|NCT05852769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83394565|NCT05852769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83394566|NCT05852769|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83394567|NCT05852769|Anesthetics, General|anesthetics, general|mesh-ancestor
83394568|NCT05852769|Anesthetics|anesthetics|mesh-ancestor
83394569|NCT05852769|GABA Modulators|gaba modulators|mesh-ancestor
83394570|NCT05852769|GABA Agents|gaba agents|mesh-ancestor
83394571|NCT05852769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394572|NCT05852769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394573|NCT05852769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83394574|NCT05852769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83394575|NCT05852769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394576|NCT05852769|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83394577|NCT05852769|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83394578|NCT05852769|Purinergic Agents|purinergic agents|mesh-ancestor
83394579|NCT05852769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83394580|NCT05852769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83394581|NCT05852769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83394582|NCT05852769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83394583|NCT05852769|Respiratory System Agents|respiratory system agents|mesh-ancestor
83394584|NCT05852769|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83394585|NCT05852769|Hormone Antagonists|hormone antagonists|mesh-ancestor
83394586|NCT05852769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83394587|NCT05852769|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83394588|NCT05852769|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83394589|NCT05852769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83394590|NCT05852769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83394591|NCT05852769|Protective Agents|protective agents|mesh-ancestor
83394592|NCT05852769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83394593|NCT05852769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83394594|NCT05852769|Antimetabolites|antimetabolites|mesh-ancestor
83394595|NCT05852769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83394596|NCT05852769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83394597|NCT05852769|Analgesics|analgesics|mesh-ancestor
83394598|NCT05852769|Sensory System Agents|sensory system agents|mesh-ancestor
83394599|NCT05852769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394600|NCT05852769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83394601|NCT05852769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394602|NCT05852769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83394603|NCT05852769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83394604|NCT05852769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83394605|NCT05852704|Dapagliflozin|dapagliflozin|mesh-list
83394606|NCT05852704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83394607|NCT05852704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394608|NCT05852704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83394609|NCT05852704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394610|NCT05852496|Vitamin D|vitamin d|mesh-list
83394611|NCT05852496|Vitamins|vitamins|mesh-ancestor
83394612|NCT05852496|Micronutrients|micronutrients|mesh-ancestor
83394613|NCT05852496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394614|NCT05852496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83394615|NCT05852223|Pembrolizumab|pembrolizumab|mesh-list
83394616|NCT05852223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83394617|NCT05852223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394618|NCT05852223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83394619|NCT05852223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394620|NCT05852197|Anticoagulants|anticoagulants|mesh-list
83394621|NCT05852197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83394622|NCT05852119|Anticoagulants|anticoagulants|mesh-list
83394623|NCT05852093|Celecoxib|celecoxib|mesh-list
83394624|NCT05852093|Buprenorphine|buprenorphine|mesh-list
83394625|NCT05852093|Tizanidine|tizanidine|mesh-list
83394626|NCT05852093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83394627|NCT05852093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394628|NCT05852093|Analgesics|analgesics|mesh-ancestor
83394629|NCT05852093|Sensory System Agents|sensory system agents|mesh-ancestor
83394630|NCT05852093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394631|NCT05852093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394632|NCT05852093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83394633|NCT05852093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83394634|NCT05852093|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83394635|NCT05852093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83394636|NCT05852093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394637|NCT05852093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394638|NCT05852093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83394639|NCT05852093|Narcotics|narcotics|mesh-ancestor
83394640|NCT05852093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394641|NCT05852093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83394642|NCT05852093|Anticonvulsants|anticonvulsants|mesh-ancestor
83394643|NCT05852093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83394644|NCT05852093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83394645|NCT05852093|Parasympatholytics|parasympatholytics|mesh-ancestor
83394646|NCT05852093|Autonomic Agents|autonomic agents|mesh-ancestor
83394647|NCT05852093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83394648|NCT05852093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83394649|NCT05852093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83394650|NCT05852093|Adrenergic Agents|adrenergic agents|mesh-ancestor
83394651|NCT05852093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394652|NCT05852002|Hyaluronic Acid|hyaluronic acid|mesh-list
83394653|NCT05852002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83394654|NCT05852002|Immunologic Factors|immunologic factors|mesh-ancestor
83394655|NCT05852002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394656|NCT05852002|Viscosupplements|viscosupplements|mesh-ancestor
83394657|NCT05852002|Protective Agents|protective agents|mesh-ancestor
83394658|NCT05851976|Naproxen|naproxen|mesh-list
83394659|NCT05851976|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83394660|NCT05851976|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83394661|NCT05851976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83394662|NCT05851976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83394663|NCT05851976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394664|NCT05851976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394665|NCT05851976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394666|NCT05851976|Analgesics|analgesics|mesh-ancestor
83394667|NCT05851976|Sensory System Agents|sensory system agents|mesh-ancestor
83394668|NCT05851976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394669|NCT05851976|Antidepressive Agents|antidepressive agents|mesh-ancestor
83394670|NCT05851976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83394671|NCT05851976|Dopamine Agents|dopamine agents|mesh-ancestor
83394672|NCT05851976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83394673|NCT05851976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394674|NCT05851976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83394675|NCT05851976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83394676|NCT05851976|Gout Suppressants|gout suppressants|mesh-ancestor
83394677|NCT05851976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83394678|NCT05851976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394679|NCT05851898|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83394680|NCT05851898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83394681|NCT05851898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83394682|NCT05851898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83394683|NCT05851898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394684|NCT05851898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394685|NCT05851898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394687|NCT05851898|Sensory System Agents|sensory system agents|mesh-ancestor
83394688|NCT05851898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394689|NCT05851898|Antidepressive Agents|antidepressive agents|mesh-ancestor
83394690|NCT05851898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83394691|NCT05851898|Dopamine Agents|dopamine agents|mesh-ancestor
83394692|NCT05851781|Lacosamide|lacosamide|mesh-list
83394693|NCT05851781|Anticonvulsants|anticonvulsants|mesh-ancestor
83394694|NCT05851781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83394695|NCT05851781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83394696|NCT05851781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83394697|NCT05851781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394698|NCT05849129|Ascorbic Acid|ascorbic acid|mesh-list
83394699|NCT05849129|Vitamins|vitamins|mesh-ancestor
83394700|NCT05849129|Micronutrients|micronutrients|mesh-ancestor
83394701|NCT05849129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394702|NCT05849129|Antioxidants|antioxidants|mesh-ancestor
83394703|NCT05849129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394704|NCT05849129|Protective Agents|protective agents|mesh-ancestor
83394705|NCT05848843|Durvalumab|durvalumab|mesh-list
83394706|NCT05848843|Adagrasib|adagrasib|mesh-list
83394707|NCT05848843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83394708|NCT05848843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394709|NCT05845762|Obinutuzumab|obinutuzumab|mesh-list
83394710|NCT05845762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83394711|NCT05845762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394712|NCT05830396|Ambroxol|ambroxol|mesh-list
83394713|NCT05830396|Expectorants|expectorants|mesh-ancestor
83394714|NCT05830396|Respiratory System Agents|respiratory system agents|mesh-ancestor
83394715|NCT05817656|Sucralfate|sucralfate|mesh-list
83394716|NCT05817656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83394717|NCT05817656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83394718|NCT05810311|Darbepoetin alfa|darbepoetin alfa|mesh-list
83394719|NCT05810311|Hematinics|hematinics|mesh-ancestor
83394720|NCT05809297|Ciclopirox|ciclopirox|mesh-list
83394721|NCT05809297|Chitosan|chitosan|mesh-list
83394722|NCT05809297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83394723|NCT05809297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83394724|NCT05809297|Antimetabolites|antimetabolites|mesh-ancestor
83394725|NCT05809297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394726|NCT05809297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83394727|NCT05809297|Chelating Agents|chelating agents|mesh-ancestor
83394728|NCT05809297|Sequestering Agents|sequestering agents|mesh-ancestor
83394729|NCT05809297|Hemostatics|hemostatics|mesh-ancestor
83394730|NCT05809297|Coagulants|coagulants|mesh-ancestor
83394731|NCT05809297|Antifungal Agents|antifungal agents|mesh-ancestor
83394732|NCT05809297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394733|NCT05807412|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83394734|NCT05807412|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83394735|NCT05807412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83394736|NCT05807412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394737|NCT05807412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394738|NCT05807412|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83394739|NCT05807412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83394740|NCT05807412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394741|NCT05807412|Cholinergic Agents|cholinergic agents|mesh-ancestor
83394742|NCT05807412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394743|NCT05778591|Buprenorphine|buprenorphine|mesh-list
83394744|NCT05778591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83394745|NCT05778591|Narcotics|narcotics|mesh-ancestor
83394746|NCT05778591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394747|NCT05778591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394748|NCT05778591|Analgesics|analgesics|mesh-ancestor
83394749|NCT05778591|Sensory System Agents|sensory system agents|mesh-ancestor
83394750|NCT05778591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394751|NCT05778591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83394752|NCT05770375|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83394753|NCT05770375|Hallucinogens|hallucinogens|mesh-ancestor
83394754|NCT05770375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394755|NCT05770375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83394756|NCT05770375|Serotonin Agents|serotonin agents|mesh-ancestor
83394757|NCT05770375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394758|NCT05770375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394759|NCT05770375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83394760|NCT05770375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83394761|NCT05770375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83394762|NCT05770375|Adrenergic Agents|adrenergic agents|mesh-ancestor
83394763|NCT05768191|Insulin|insulin|mesh-list
83394764|NCT05768191|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83394765|NCT05768191|Isophane Insulin, Human|isophane insulin, human|mesh-list
83394766|NCT05768191|Insulin, Isophane|insulin, isophane|mesh-list
83394767|NCT05768191|Isophane insulin, beef|isophane insulin, beef|mesh-list
83394768|NCT05768191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83394769|NCT05768191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394770|NCT05745987|Vaccines|vaccines|mesh-list
83394771|NCT05745987|Immunologic Factors|immunologic factors|mesh-ancestor
83394772|NCT05745987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394773|NCT05736198|Dexmedetomidine|dexmedetomidine|mesh-list
83394774|NCT05736198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83394775|NCT05736198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394776|NCT05736198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394777|NCT05736198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394778|NCT05736198|Analgesics|analgesics|mesh-ancestor
83394779|NCT05736198|Sensory System Agents|sensory system agents|mesh-ancestor
83394780|NCT05736198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394781|NCT05736198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83394782|NCT05736198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83394783|NCT05736198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83394784|NCT05736198|Adrenergic Agents|adrenergic agents|mesh-ancestor
83394785|NCT05736198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394786|NCT05736198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394787|NCT05734495|Venetoclax|venetoclax|mesh-list
83394788|NCT05734495|Pirtobrutinib|pirtobrutinib|mesh-list
83394789|NCT05734495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394790|NCT05734495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83394791|NCT05734495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394792|NCT05734495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394793|NCT05729503|Lidocaine|lidocaine|mesh-list
83394794|NCT05729503|Anesthetics, Local|anesthetics, local|mesh-ancestor
83394795|NCT05729503|Anesthetics|anesthetics|mesh-ancestor
83394796|NCT05729503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394797|NCT05729503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394798|NCT05729503|Sensory System Agents|sensory system agents|mesh-ancestor
83394799|NCT05729503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394800|NCT05729503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83394801|NCT05729503|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83394802|NCT05729503|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83394803|NCT05729503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83394804|NCT05729503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394805|NCT05725876|Ustekinumab|ustekinumab|mesh-list
83394806|NCT05725876|Dermatologic Agents|dermatologic agents|mesh-ancestor
83394807|NCT05720390|Quinine|quinine|mesh-list
83394808|NCT05720390|Antimalarials|antimalarials|mesh-ancestor
83394809|NCT05720390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83394810|NCT05720390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83394811|NCT05720390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394812|NCT05720390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83394813|NCT05720390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394814|NCT05720390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83394815|NCT05720390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394816|NCT05720390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394817|NCT05720390|Analgesics|analgesics|mesh-ancestor
83394818|NCT05720390|Sensory System Agents|sensory system agents|mesh-ancestor
83394819|NCT05711641|Lidocaine|lidocaine|mesh-list
83394820|NCT05711641|Anesthetics, Local|anesthetics, local|mesh-ancestor
83394821|NCT05711641|Anesthetics|anesthetics|mesh-ancestor
83394822|NCT05711641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394823|NCT05711641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394824|NCT05711641|Sensory System Agents|sensory system agents|mesh-ancestor
83394825|NCT05711641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394826|NCT05711641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83394827|NCT05711641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83394828|NCT05711641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83394829|NCT05711641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83394830|NCT05711641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394831|NCT05702970|Vitamin D|vitamin d|mesh-list
83394832|NCT05702970|Vitamins|vitamins|mesh-ancestor
83394833|NCT05702970|Micronutrients|micronutrients|mesh-ancestor
83394834|NCT05702970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394835|NCT05702970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83394836|NCT05693467|Dexamethasone|dexamethasone|mesh-list
83394837|NCT05693467|Ropivacaine|ropivacaine|mesh-list
83394838|NCT05693467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83394839|NCT05693467|Antiemetics|antiemetics|mesh-ancestor
83394840|NCT05693467|Autonomic Agents|autonomic agents|mesh-ancestor
83394841|NCT05693467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394842|NCT05693467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394843|NCT05693467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83394844|NCT05693467|Glucocorticoids|glucocorticoids|mesh-ancestor
83394845|NCT05693467|Hormones|hormones|mesh-ancestor
83394846|NCT05693467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83394847|NCT05693467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83394848|NCT05693467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394849|NCT05693467|Anesthetics, Local|anesthetics, local|mesh-ancestor
83394850|NCT05693467|Anesthetics|anesthetics|mesh-ancestor
83394851|NCT05693467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394852|NCT05693467|Sensory System Agents|sensory system agents|mesh-ancestor
83394853|NCT05682339|Quinine|quinine|mesh-list
83394854|NCT05682339|Antimalarials|antimalarials|mesh-ancestor
83394855|NCT05682339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83394856|NCT05682339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83394857|NCT05682339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394858|NCT05682339|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83394859|NCT05682339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394860|NCT05682339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83394861|NCT05682339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394862|NCT05682339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83394863|NCT05682339|Analgesics|analgesics|mesh-ancestor
83394864|NCT05682339|Sensory System Agents|sensory system agents|mesh-ancestor
83394865|NCT05676931|Docetaxel|docetaxel|mesh-list
83394866|NCT05676931|Quemliclustat|quemliclustat|mesh-list
83394867|NCT05676931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394868|NCT05676931|Tubulin Modulators|tubulin modulators|mesh-ancestor
83394869|NCT05676931|Antimitotic Agents|antimitotic agents|mesh-ancestor
83394870|NCT05676931|Mitosis Modulators|mitosis modulators|mesh-ancestor
83394871|NCT05676931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394872|NCT05676931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83394873|NCT05676931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83394874|NCT05658887|Gabapentin|gabapentin|mesh-list
83394875|NCT05658887|Analgesics|analgesics|mesh-ancestor
83394876|NCT05658887|Sensory System Agents|sensory system agents|mesh-ancestor
83394877|NCT05658887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394878|NCT05658887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394879|NCT05658887|Anticonvulsants|anticonvulsants|mesh-ancestor
83394880|NCT05658887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83394881|NCT05658887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83394882|NCT05658887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394883|NCT05658887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83394884|NCT05658887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83394885|NCT05658887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83394886|NCT05658887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394887|NCT05658887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394888|NCT05658887|Antimanic Agents|antimanic agents|mesh-ancestor
83394889|NCT05652283|Pamiparib|pamiparib|mesh-list
83394890|NCT05652283|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83394891|NCT05652283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394892|NCT05652283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394893|NCT05652283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394894|NCT05651282|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83394895|NCT05651282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83394896|NCT05651282|Contraceptive Agents|contraceptive agents|mesh-ancestor
83394897|NCT05651282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83395275|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
83394898|NCT05651282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394899|NCT05651282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83394900|NCT05651282|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83394901|NCT05651282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83394902|NCT05651282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394903|NCT05627115|Tislelizumab|tislelizumab|mesh-list
83394904|NCT05627115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83394905|NCT05627115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394906|NCT05626920|Disulfiram|disulfiram|mesh-list
83394907|NCT05626920|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83394908|NCT05626920|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83394909|NCT05626920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394910|NCT05626920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394911|NCT05605366|Minocycline|minocycline|mesh-list
83394912|NCT05605366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83394913|NCT05605366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83394914|NCT05591118|Anticoagulants|anticoagulants|mesh-list
83394915|NCT05572255|Cenobamate|cenobamate|mesh-list
83394916|NCT05572255|Anticonvulsants|anticonvulsants|mesh-ancestor
83394917|NCT05531123|Gemcitabine|gemcitabine|mesh-list
83394918|NCT05531123|Tislelizumab|tislelizumab|mesh-list
83394919|NCT05531123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394920|NCT05531123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83394921|NCT05531123|Antimetabolites|antimetabolites|mesh-ancestor
83394922|NCT05531123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394923|NCT05531123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83394924|NCT05523609|Vitamin D|vitamin d|mesh-list
83394925|NCT05523609|Letrozole|letrozole|mesh-list
83394926|NCT05523609|Vitamins|vitamins|mesh-ancestor
83394927|NCT05523609|Micronutrients|micronutrients|mesh-ancestor
83394928|NCT05523609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394929|NCT05523609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83394930|NCT05523609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394931|NCT05523609|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83394932|NCT05523609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83394933|NCT05523609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394934|NCT05523609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394935|NCT05523609|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83394936|NCT05523609|Hormone Antagonists|hormone antagonists|mesh-ancestor
83394937|NCT05523609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83394938|NCT05488366|Pembrolizumab|pembrolizumab|mesh-list
83394939|NCT05488366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83394940|NCT05488366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394941|NCT05488366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83394942|NCT05488366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394943|NCT05483465|Niacinamide|niacinamide|mesh-list
83394944|NCT05483465|Niacin|niacin|mesh-list
83394945|NCT05483465|Nicotinic Acids|nicotinic acids|mesh-list
83394946|NCT05483465|Vitamin B Complex|vitamin b complex|mesh-ancestor
83394947|NCT05483465|Vitamins|vitamins|mesh-ancestor
83394948|NCT05483465|Micronutrients|micronutrients|mesh-ancestor
83394949|NCT05483465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394950|NCT05483465|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83394951|NCT05483465|Antimetabolites|antimetabolites|mesh-ancestor
83394952|NCT05483465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394953|NCT05483465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83394954|NCT05483465|Vasodilator Agents|vasodilator agents|mesh-ancestor
83394955|NCT05477108|Budesonide|budesonide|mesh-list
83394956|NCT05477108|Formoterol Fumarate|formoterol fumarate|mesh-list
83394957|NCT05477108|Charcoal|charcoal|mesh-list
83394958|NCT05477108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83394959|NCT05477108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83394960|NCT05477108|Autonomic Agents|autonomic agents|mesh-ancestor
83394961|NCT05477108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394962|NCT05477108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394963|NCT05477108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83394964|NCT05477108|Respiratory System Agents|respiratory system agents|mesh-ancestor
83394965|NCT05477108|Glucocorticoids|glucocorticoids|mesh-ancestor
83394966|NCT05477108|Hormones|hormones|mesh-ancestor
83394967|NCT05477108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83394968|NCT05477108|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83394969|NCT05477108|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83394970|NCT05477108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83394971|NCT05477108|Adrenergic Agents|adrenergic agents|mesh-ancestor
83394972|NCT05477108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395425|NCT04851301|Naloxone|naloxone|mesh-list
83394973|NCT05477108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394975|NCT05477108|Protective Agents|protective agents|mesh-ancestor
83394976|NCT05464979|Fentanyl|fentanyl|mesh-list
83394977|NCT05464979|Midazolam|midazolam|mesh-list
83394978|NCT05464979|Ketamine|ketamine|mesh-list
83394979|NCT05464979|Esketamine|esketamine|mesh-list
83394980|NCT05464979|Analgesics|analgesics|mesh-ancestor
83394981|NCT05464979|Sensory System Agents|sensory system agents|mesh-ancestor
83394982|NCT05464979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394983|NCT05464979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394984|NCT05464979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83394985|NCT05464979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83394986|NCT05464979|Anesthetics, General|anesthetics, general|mesh-ancestor
83394987|NCT05464979|Anesthetics|anesthetics|mesh-ancestor
83394988|NCT05464979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394989|NCT05464979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83394990|NCT05464979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83394991|NCT05464979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83394992|NCT05464979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394993|NCT05464979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83394994|NCT05464979|Narcotics|narcotics|mesh-ancestor
83394995|NCT05464979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83394996|NCT05464979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83394997|NCT05464979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83394998|NCT05464979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83394999|NCT05464979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83395000|NCT05464979|GABA Modulators|gaba modulators|mesh-ancestor
83395001|NCT05464979|GABA Agents|gaba agents|mesh-ancestor
83395002|NCT05464979|Antidepressive Agents|antidepressive agents|mesh-ancestor
83395003|NCT05444582|Levonorgestrel|levonorgestrel|mesh-list
83395004|NCT05444582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83395005|NCT05444582|Contraceptive Agents|contraceptive agents|mesh-ancestor
83395006|NCT05444582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83395007|NCT05444582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395008|NCT05444582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83395009|NCT05444582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83395010|NCT05444582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83395011|NCT05442463|Captopril|captopril|mesh-list
83395012|NCT05442463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83395013|NCT05442463|Protease Inhibitors|protease inhibitors|mesh-ancestor
83395014|NCT05442463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395015|NCT05442463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395016|NCT05442463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83395017|NCT05435222|Psychotropic Drugs|psychotropic drugs|mesh-list
83395018|NCT05402319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83395019|NCT05402319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83395020|NCT05402319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395021|NCT05402319|Antitubercular Agents|antitubercular agents|mesh-ancestor
83395022|NCT05398289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83395023|NCT05398289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83395024|NCT05398289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395025|NCT05398289|Antitubercular Agents|antitubercular agents|mesh-ancestor
83395026|NCT05384938|Benralizumab|benralizumab|mesh-list
83395027|NCT05384938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83395028|NCT05384938|Respiratory System Agents|respiratory system agents|mesh-ancestor
83395029|NCT05381948|Aflibercept|aflibercept|mesh-list
83395030|NCT05381948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83395031|NCT05381948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83395032|NCT05381948|Growth Substances|growth substances|mesh-ancestor
83395033|NCT05381948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395034|NCT05381948|Growth Inhibitors|growth inhibitors|mesh-ancestor
83395035|NCT05381948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395036|NCT05373108|Macitentan|macitentan|mesh-list
83395037|NCT05373108|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83395038|NCT05373108|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83395039|NCT05373108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395040|NCT05373108|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83395041|NCT05368753|Lidocaine|lidocaine|mesh-list
83395042|NCT05368753|Ropivacaine|ropivacaine|mesh-list
83395043|NCT05368753|Anesthetics, Local|anesthetics, local|mesh-ancestor
83395044|NCT05368753|Anesthetics|anesthetics|mesh-ancestor
83395045|NCT05368753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395046|NCT05368753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395047|NCT05368753|Sensory System Agents|sensory system agents|mesh-ancestor
83395048|NCT05368753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395049|NCT05368753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83395050|NCT05368753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83395051|NCT05368753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83395052|NCT05368753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83395053|NCT05368753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395054|NCT05363514|Naltrexone|naltrexone|mesh-list
83395055|NCT05363514|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83395056|NCT05363514|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83395057|NCT05363514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395058|NCT05363514|Sensory System Agents|sensory system agents|mesh-ancestor
83395059|NCT05363514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395060|NCT05359653|Clemastine|clemastine|mesh-list
83395061|NCT05359653|Antipruritics|antipruritics|mesh-ancestor
83395062|NCT05359653|Dermatologic Agents|dermatologic agents|mesh-ancestor
83395063|NCT05359653|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83395064|NCT05359653|Histamine Antagonists|histamine antagonists|mesh-ancestor
83395065|NCT05359653|Histamine Agents|histamine agents|mesh-ancestor
83395066|NCT05359653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395067|NCT05359653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395068|NCT05359653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395069|NCT05359653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83395070|NCT05345691|Denosumab|denosumab|mesh-list
83395071|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83395072|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395073|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
83395074|NCT05325073|Hematinics|hematinics|mesh-ancestor
83395075|NCT05314998|Leucovorin|leucovorin|mesh-list
83395076|NCT05314998|Folic Acid|folic acid|mesh-list
83395077|NCT05314998|Gemcitabine|gemcitabine|mesh-list
83395078|NCT05314998|Fluorouracil|fluorouracil|mesh-list
83395079|NCT05314998|Capecitabine|capecitabine|mesh-list
83395080|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
83395081|NCT05314998|Irinotecan|irinotecan|mesh-list
83395082|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
83395083|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83395084|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
83395085|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395086|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395087|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83395088|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
83395089|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395090|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83395091|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83395092|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395093|NCT05314998|Antidotes|antidotes|mesh-ancestor
83395094|NCT05314998|Protective Agents|protective agents|mesh-ancestor
83395095|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
83395096|NCT05314998|Vitamins|vitamins|mesh-ancestor
83395097|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
83395098|NCT05314998|Hematinics|hematinics|mesh-ancestor
83395099|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83395100|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395101|NCT05275439|Azacitidine|azacitidine|mesh-list
83395102|NCT05275439|Venetoclax|venetoclax|mesh-list
83395103|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83395104|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
83395105|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395106|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395107|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395108|NCT05269615|Valsartan|valsartan|mesh-list
83395109|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83395110|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83395111|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83395112|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395113|NCT05250895|Misonidazole|misonidazole|mesh-list
83395114|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395115|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83395116|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83395117|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395118|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
83395119|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83395120|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395121|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83395122|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395123|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83395124|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83395125|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395126|NCT05219409|Incretins|incretins|mesh-ancestor
83395127|NCT05219409|Hormones|hormones|mesh-ancestor
83395128|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395129|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83395130|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
83395131|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395132|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395133|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83395134|NCT05209295|Azacitidine|azacitidine|mesh-list
83395135|NCT05209295|Cc-486|cc-486|mesh-list
83395136|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83395137|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
83395138|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395139|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395140|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395141|NCT05196932|Antibodies|antibodies|mesh-list
83395142|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
83395143|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395144|NCT05194111|Valsartan|valsartan|mesh-list
83395145|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83395146|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83395147|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83395148|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83395149|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395150|NCT05189756|Aprepitant|aprepitant|mesh-list
83395151|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
83395152|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
83395153|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
83395154|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395155|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395156|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83395157|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83395158|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395159|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395160|NCT05181150|Glucagon|glucagon|mesh-list
83395161|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83395162|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83395163|NCT05181150|Hormones|hormones|mesh-ancestor
83395164|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395165|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395166|NCT05181150|Incretins|incretins|mesh-ancestor
83395167|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
83395168|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
83395169|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395170|NCT05168657|Pancrelipase|pancrelipase|mesh-list
83395171|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83395172|NCT05151159|Antibodies|antibodies|mesh-list
83395173|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
83395174|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395175|NCT05144529|Nivolumab|nivolumab|mesh-list
83395176|NCT05144529|Ipilimumab|ipilimumab|mesh-list
83395177|NCT05144529|Evolocumab|evolocumab|mesh-list
83395178|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395179|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395180|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83395181|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395182|NCT05144529|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83395183|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83395184|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83395185|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
83395186|NCT05144529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83395187|NCT05144529|Protease Inhibitors|protease inhibitors|mesh-ancestor
83395188|NCT05144529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395189|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83395190|NCT05132920|Dexamethasone|dexamethasone|mesh-list
83395191|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83395192|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
83395193|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
83395194|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395195|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395196|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83395197|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
83395198|NCT05132920|Hormones|hormones|mesh-ancestor
83395199|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395200|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83395201|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395202|NCT05129085|Dexamethasone|dexamethasone|mesh-list
83395203|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83395204|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
83395205|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
83395206|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395207|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395208|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83395209|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
83395210|NCT05129085|Hormones|hormones|mesh-ancestor
83395211|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395212|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83395213|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395214|NCT05118399|Bupivacaine|bupivacaine|mesh-list
83395215|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
83395216|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
83395217|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395218|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395219|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
83395220|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395221|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
83395222|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395223|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395224|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395225|NCT05099471|Dexamethasone|dexamethasone|mesh-list
83395226|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
83395227|NCT05099471|Rituximab|rituximab|mesh-list
83395228|NCT05099471|Venetoclax|venetoclax|mesh-list
83395229|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83395230|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
83395231|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395232|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83395233|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83395234|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
83395235|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395236|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395237|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83395238|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395239|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83395240|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
83395241|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
83395242|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395243|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83395244|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
83395245|NCT05099471|Hormones|hormones|mesh-ancestor
83395246|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395247|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83395248|NCT05087693|Albuterol|albuterol|mesh-list
83395249|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83395250|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
83395251|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395252|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395253|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83395254|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
83395255|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
83395256|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83395257|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83395258|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83395259|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83395260|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
83395261|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395262|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395263|NCT05081583|Midazolam|midazolam|mesh-list
83395264|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83395265|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83395266|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395267|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395268|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83395269|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83395270|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83395271|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83395272|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
83395273|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
83395274|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
83395276|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395277|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395278|NCT05070754|Cantharidin|cantharidin|mesh-list
83395279|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395280|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395281|NCT05067387|Dronabinol|dronabinol|mesh-list
83395282|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
83395283|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395284|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83395285|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83395286|NCT05067387|Analgesics|analgesics|mesh-ancestor
83395287|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
83395288|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395289|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83395290|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83395291|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395292|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395293|NCT05067387|Hormones|hormones|mesh-ancestor
83395294|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395295|NCT05060731|Iron|iron|mesh-list
83395296|NCT05060731|Trace Elements|trace elements|mesh-ancestor
83395297|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
83395298|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395299|NCT05057806|Empagliflozin|empagliflozin|mesh-list
83395300|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83395301|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395302|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83395303|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395304|NCT05052099|Bevacizumab|bevacizumab|mesh-list
83395305|NCT05052099|Atezolizumab|atezolizumab|mesh-list
83395306|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395307|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395308|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83395309|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83395310|NCT05052099|Growth Substances|growth substances|mesh-ancestor
83395311|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395312|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
83395313|NCT05052099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83395314|NCT05052099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395315|NCT05050253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83395316|NCT05044819|Cannabidiol|cannabidiol|mesh-list
83395317|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
83395318|NCT05037487|Dronabinol|dronabinol|mesh-list
83395319|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
83395320|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395321|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83395322|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83395323|NCT05037487|Analgesics|analgesics|mesh-ancestor
83395324|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
83395325|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395326|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83395327|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83395328|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395329|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395330|NCT05037487|Hormones|hormones|mesh-ancestor
83395331|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395332|NCT05030441|Ivosidenib|ivosidenib|mesh-list
83395333|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395334|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395335|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395336|NCT05011266|Buprenorphine|buprenorphine|mesh-list
83395337|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83395338|NCT05011266|Naloxone|naloxone|mesh-list
83395339|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83395340|NCT05011266|Narcotics|narcotics|mesh-ancestor
83395341|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395342|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395343|NCT05011266|Analgesics|analgesics|mesh-ancestor
83395344|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
83395345|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395346|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83395347|NCT05001074|Tacrolimus|tacrolimus|mesh-list
83395348|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83395349|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
83395350|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395351|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83395352|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395353|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395354|NCT04985890|UB-421|ub-421|mesh-list
83395355|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83395356|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
83395357|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395358|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
83395359|NCT04977453|Lenvatinib|lenvatinib|mesh-list
83395360|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395361|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395362|NCT04977453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83395363|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395364|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83395365|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395366|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83395367|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
83395368|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83395369|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395370|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83395371|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83395372|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83395373|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395374|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
83395375|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395376|NCT04928664|Bupivacaine|bupivacaine|mesh-list
83395377|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
83395378|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
83395379|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395380|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395381|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
83395382|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395383|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
83395384|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83395385|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395386|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83395387|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
83395388|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83395389|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395390|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395391|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395392|NCT04916392|Bupivacaine|bupivacaine|mesh-list
83395393|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
83395394|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
83395395|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395396|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395397|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
83395398|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395399|NCT04903119|Trametinib|trametinib|mesh-list
83395400|NCT04903119|Dabrafenib|dabrafenib|mesh-list
83395401|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395402|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83395403|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395404|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395405|NCT04899115|Vancomycin|vancomycin|mesh-list
83395406|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83395407|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395408|NCT04892875|Cisplatin|cisplatin|mesh-list
83395409|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395410|NCT04871594|Nivolumab|nivolumab|mesh-list
83395411|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395412|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395413|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83395414|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395415|NCT04868903|Vitamin D|vitamin d|mesh-list
83395416|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
83395417|NCT04868903|Vitamins|vitamins|mesh-ancestor
83395418|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
83395419|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395420|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83395421|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83395422|NCT04859530|Lugol's solution|lugol's solution|mesh-list
83395423|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
83395424|NCT04859530|Coagulants|coagulants|mesh-ancestor
83395428|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
83395429|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395430|NCT04843982|Esketamine|esketamine|mesh-list
83395431|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
83395432|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83395433|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
83395434|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395435|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395436|NCT04811027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83395437|NCT04811027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395438|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
83395439|NCT04801966|Nivolumab|nivolumab|mesh-list
83395440|NCT04801966|Atezolizumab|atezolizumab|mesh-list
83395441|NCT04801966|Olaparib|olaparib|mesh-list
83395442|NCT04801966|Palbociclib|palbociclib|mesh-list
83395443|NCT04801966|Trametinib|trametinib|mesh-list
83395444|NCT04801966|Vemurafenib|vemurafenib|mesh-list
83395445|NCT04801966|Dabrafenib|dabrafenib|mesh-list
83395446|NCT04801966|Talazoparib|talazoparib|mesh-list
83395447|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395448|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395449|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83395450|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395451|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83395452|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395453|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83395454|NCT04789915|Memantine|memantine|mesh-list
83395455|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83395456|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83395457|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
83395458|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395459|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395460|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395461|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83395462|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83395463|NCT04771299|Cariprazine|cariprazine|mesh-list
83395464|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83395465|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83395466|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395467|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395468|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83395469|NCT04736173|Paclitaxel|paclitaxel|mesh-list
83395470|NCT04736173|Carboplatin|carboplatin|mesh-list
83395471|NCT04736173|Pembrolizumab|pembrolizumab|mesh-list
83395472|NCT04736173|Pemetrexed|pemetrexed|mesh-list
83395473|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83395474|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395475|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
83395476|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
83395477|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
83395478|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395479|NCT04736173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395480|NCT04736173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83395481|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395482|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83395483|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83395484|NCT04725656|Nicotine|nicotine|mesh-list
83395485|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83395486|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
83395487|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395488|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395489|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83395490|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83395491|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
83395492|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395493|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395494|NCT04704063|Vitamin E|vitamin e|mesh-list
83395495|NCT04704063|Tocopherols|tocopherols|mesh-list
83395496|NCT04704063|Tocotrienols|tocotrienols|mesh-list
83395497|NCT04704063|Tocovid|tocovid|mesh-list
83395498|NCT04704063|Vitamins|vitamins|mesh-ancestor
83395499|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
83395500|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395501|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
83395502|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395515|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395516|NCT04703036|Antidotes|antidotes|mesh-ancestor
83395517|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
83395518|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395519|NCT04636255|Calcium|calcium|mesh-list
83395520|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83395521|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395522|NCT04635176|Dexamethasone|dexamethasone|mesh-list
83395523|NCT04635176|Epinephrine|epinephrine|mesh-list
83395524|NCT04635176|Bupivacaine|bupivacaine|mesh-list
83395525|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83395527|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
83395528|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395529|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395530|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83395531|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
83395532|NCT04635176|Hormones|hormones|mesh-ancestor
83395533|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395534|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83395535|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395536|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
83395537|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
83395538|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395539|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
83395540|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83395541|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83395542|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
83395543|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395544|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395545|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83395546|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83395547|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83395548|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
83395549|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
83395550|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
83395551|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83395552|NCT04625907|Dactinomycin|dactinomycin|mesh-list
83395553|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
83395554|NCT04625907|Temozolomide|temozolomide|mesh-list
83395555|NCT04625907|Ifosfamide|ifosfamide|mesh-list
83395556|NCT04625907|Doxorubicin|doxorubicin|mesh-list
83395557|NCT04625907|Irinotecan|irinotecan|mesh-list
83395558|NCT04625907|Vincristine|vincristine|mesh-list
83395559|NCT04625907|Vinorelbine|vinorelbine|mesh-list
83395560|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83395561|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
83395562|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395563|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83395564|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83395565|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
83395566|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395567|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395568|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83395569|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83395570|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83395571|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83395572|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395573|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83395574|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83395575|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
83395576|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
83395577|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
83395578|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83395579|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395580|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83395581|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83395582|NCT04623086|Insulin|insulin|mesh-list
83395583|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83395584|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
83395585|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83395586|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395587|NCT04574713|Candesartan|candesartan|mesh-list
83395588|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
83395589|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83395590|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83395591|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83395822|NCT03889743|Hormones|hormones|mesh-ancestor
83395592|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395594|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83395595|NCT04569877|Sargramostim|sargramostim|mesh-list
83395596|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395597|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
83395598|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395599|NCT04550234|Allopurinol|allopurinol|mesh-list
83395600|NCT04550234|Verinurad|verinurad|mesh-list
83395601|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
83395602|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395603|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395604|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
83395605|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83395606|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83395607|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
83395608|NCT04550234|Protective Agents|protective agents|mesh-ancestor
83395609|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395610|NCT04542070|Rilpivirine|rilpivirine|mesh-list
83395611|NCT04542070|Cabotegravir|cabotegravir|mesh-list
83395612|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83395613|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83395614|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395615|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395616|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
83395617|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395618|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83395619|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83395620|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83395621|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83395622|NCT04541797|Empagliflozin|empagliflozin|mesh-list
83395623|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83395624|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395625|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83395626|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395628|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83395629|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395630|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395631|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83395632|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
83395633|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
83395634|NCT04530383|Metformin|metformin|mesh-list
83395635|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83395636|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395637|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
83395638|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83395639|NCT04495621|Cetuximab|cetuximab|mesh-list
83395640|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395641|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395642|NCT04485130|Disulfiram|disulfiram|mesh-list
83395643|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83395644|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83395645|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395646|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395647|NCT04485104|Cannabidiol|cannabidiol|mesh-list
83395648|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
83395649|NCT04469491|Interferons|interferons|mesh-list
83395650|NCT04469491|Interferon Type I|interferon type i|mesh-list
83395651|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395652|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
83395653|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395654|NCT04431245|Entecavir|entecavir|mesh-list
83395655|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
83395656|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395657|NCT04421248|Methylphenidate|methylphenidate|mesh-list
83395658|NCT04421248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83395659|NCT04421248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395660|NCT04421248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83395661|NCT04421248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83395662|NCT04421248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83395663|NCT04421248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395664|NCT04421248|Dopamine Agents|dopamine agents|mesh-ancestor
83395665|NCT04421248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395666|NCT04355572|Vitamin D|vitamin d|mesh-list
83395667|NCT04355572|Vitamins|vitamins|mesh-ancestor
83395668|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
83395669|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395670|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83395672|NCT04310059|Hematinics|hematinics|mesh-ancestor
83395673|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
83395674|NCT04310059|Vitamins|vitamins|mesh-ancestor
83395675|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
83395676|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395677|NCT04303780|Docetaxel|docetaxel|mesh-list
83395678|NCT04303780|Sotorasib|sotorasib|mesh-list
83395679|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395680|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
83395681|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
83395682|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
83395683|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395684|NCT04303780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83395685|NCT04303780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395686|NCT04303689|Colchicine|colchicine|mesh-list
83395687|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
83395688|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83395689|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
83395690|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
83395691|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
83395692|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395693|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395694|NCT04270409|Dexamethasone|dexamethasone|mesh-list
83395695|NCT04270409|Lenalidomide|lenalidomide|mesh-list
83395696|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83395697|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
83395698|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
83395699|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395700|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395701|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83395702|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
83395703|NCT04270409|Hormones|hormones|mesh-ancestor
83395704|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395705|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83395706|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395707|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
83395708|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83395709|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83395710|NCT04270409|Growth Substances|growth substances|mesh-ancestor
83395711|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
83395712|NCT04217278|Cytarabine|cytarabine|mesh-list
83395713|NCT04217278|Fludarabine|fludarabine|mesh-list
83395714|NCT04217278|Busulfan|busulfan|mesh-list
83395715|NCT04217278|Thiotepa|thiotepa|mesh-list
83395716|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395717|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83395718|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
83395719|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395720|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83395721|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
83395722|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395723|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
83395724|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395725|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
83395726|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83395727|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83395728|NCT04202809|Durvalumab|durvalumab|mesh-list
83395729|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395730|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395731|NCT04177953|Carboplatin|carboplatin|mesh-list
83395732|NCT04177953|Nivolumab|nivolumab|mesh-list
83395733|NCT04177953|Pemetrexed|pemetrexed|mesh-list
83395734|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395735|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395736|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83395737|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395738|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395739|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83395740|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83395741|NCT04143061|Vaccines|vaccines|mesh-list
83395742|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
83395743|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395744|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83395745|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
83395746|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83395748|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83395749|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395750|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83395751|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83395752|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395753|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83395754|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
83395755|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395757|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
83395758|NCT04061512|Rituximab|rituximab|mesh-list
83395759|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83395760|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
83395761|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395762|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83395763|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83395764|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
83395765|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395766|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395767|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83395768|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395769|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83395770|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
83395771|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
83395772|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395773|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83395774|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
83395775|NCT04061512|Hormones|hormones|mesh-ancestor
83395776|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395777|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83395778|NCT04036461|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
83395779|NCT04036461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395780|NCT04036461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395781|NCT04019548|Cisplatin|cisplatin|mesh-list
83395782|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395783|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
83395784|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83395785|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83395786|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
83395787|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
83395788|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395789|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395790|NCT04002271|Propofol|propofol|mesh-list
83395791|NCT04002271|Sevoflurane|sevoflurane|mesh-list
83395792|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
83395793|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395794|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395795|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83395796|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83395797|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
83395798|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83395799|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83395800|NCT03998488|Psyllium|psyllium|mesh-list
83395801|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
83395802|NCT03998488|Cathartics|cathartics|mesh-ancestor
83395803|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83395804|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
83395805|NCT03972592|Sirolimus|sirolimus|mesh-list
83395806|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83395807|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395808|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83395809|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395810|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
83395811|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83395812|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
83395813|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395814|NCT03889743|Dexamethasone|dexamethasone|mesh-list
83395815|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83395816|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
83395817|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
83395818|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395819|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395820|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83395821|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
83395823|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395824|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83395825|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395826|NCT03875872|Propofol|propofol|mesh-list
83395827|NCT03875872|Anesthetics|anesthetics|mesh-list
83395828|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
83395829|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83395830|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395831|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395832|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83395833|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
83395834|NCT03871036|Paclitaxel|paclitaxel|mesh-list
83395835|NCT03871036|Durvalumab|durvalumab|mesh-list
83395836|NCT03871036|Tremelimumab|tremelimumab|mesh-list
83395837|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83395838|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395839|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
83395840|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
83395841|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
83395842|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395843|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395844|NCT03859908|Ethanol|ethanol|mesh-list
83395845|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
83395846|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83395847|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83395848|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395849|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395850|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395851|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
83395852|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
83395853|NCT03825536|Methamphetamine|methamphetamine|mesh-list
83395854|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83395855|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395856|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
83395857|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
83395858|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395859|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
83395860|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395861|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395862|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
83395863|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83395864|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83395865|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83395866|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83395867|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
83395868|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395869|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395870|NCT03799003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83395871|NCT03799003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395872|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
83395873|NCT03797196|Everolimus|everolimus|mesh-list
83395874|NCT03797196|Tacrolimus|tacrolimus|mesh-list
83395875|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83395876|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
83395877|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395878|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83395879|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395880|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395881|NCT03797196|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83395882|NCT03797196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83395883|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395884|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83395885|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83395886|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
83395887|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83395888|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395889|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
83395890|NCT03775382|Vitamins|vitamins|mesh-ancestor
83395891|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
83395892|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395893|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
83395894|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395895|NCT03775382|Protective Agents|protective agents|mesh-ancestor
83395896|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
83395897|NCT03747432|Propofol|propofol|mesh-list
83395898|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83395899|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395900|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395901|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83395902|NCT03747432|Analgesics|analgesics|mesh-ancestor
83395903|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
83395904|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395905|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83395906|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83395907|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83395908|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
83395909|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395910|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395911|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83395912|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
83395914|NCT03724019|Ketamine|ketamine|mesh-list
83395915|NCT03724019|Analgesics|analgesics|mesh-ancestor
83395916|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
83395917|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395918|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395919|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83395920|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83395921|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
83395922|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
83395923|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83395924|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83395925|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83395926|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83395927|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395928|NCT03697512|Rituximab|rituximab|mesh-list
83395929|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395930|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395931|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
83395932|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395933|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83395934|NCT03691610|Vaccines|vaccines|mesh-list
83395935|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
83395936|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395937|NCT03686332|Atezolizumab|atezolizumab|mesh-list
83395938|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83395939|NCT03686332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83395940|NCT03686332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395941|NCT03686332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395942|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395943|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
83395944|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395945|NCT03683069|Amlodipine|amlodipine|mesh-list
83395946|NCT03683069|Eplerenone|eplerenone|mesh-list
83395947|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83395948|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83395949|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83395950|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395951|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83395952|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395953|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
83395954|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83395955|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
83395956|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83395957|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83395958|NCT03683069|Diuretics|diuretics|mesh-ancestor
83395959|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
83395960|NCT03667651|Decanoic acid|decanoic acid|mesh-list
83395961|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
83395962|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395963|NCT03649633|Vitamins|vitamins|mesh-list
83395964|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
83395965|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
83395966|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395967|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83395968|NCT03620903|Rituximab|rituximab|mesh-list
83395969|NCT03620903|Bortezomib|bortezomib|mesh-list
83395970|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83395971|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395972|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
83395973|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395974|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83395975|NCT03497156|Lercanidipine|lercanidipine|mesh-list
83395976|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83395977|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83395978|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83395979|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395980|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83395981|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395982|NCT03471117|Pioglitazone|pioglitazone|mesh-list
83395983|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83395984|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395985|NCT03464292|Capsaicin|capsaicin|mesh-list
83395986|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
83395987|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
83395988|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
83395989|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83395990|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395991|NCT03448718|Olaparib|olaparib|mesh-list
83395992|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83395993|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83395994|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395995|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83395996|NCT03435939|Losartan|losartan|mesh-list
83395997|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83395998|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83395999|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83396000|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83396001|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396002|NCT03422393|Venetoclax|venetoclax|mesh-list
83396003|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396004|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
83396005|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396006|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396007|NCT03385226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83396008|NCT03385226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396009|NCT03377543|Aspirin|aspirin|mesh-list
83396010|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83396011|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83396012|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83396013|NCT03377543|Analgesics|analgesics|mesh-ancestor
83396014|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
83396015|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396016|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396017|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396018|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83396019|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83396020|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396021|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83396022|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83396023|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396024|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
83396025|NCT03365908|Ropivacaine|ropivacaine|mesh-list
83396026|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
83396027|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
83396028|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396029|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396030|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
83396031|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396032|NCT03362047|Macitentan|macitentan|mesh-list
83396033|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83396034|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83396035|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396036|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83396037|NCT03337919|Nivolumab|nivolumab|mesh-list
83396038|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396039|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396040|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83396041|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396042|NCT03334305|Vaccines|vaccines|mesh-list
83396043|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
83396044|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396053|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83396054|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83396055|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
83396056|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396057|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396058|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83396059|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83396060|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
83396061|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83396062|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
83396063|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
83396064|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
83396065|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83396066|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
83396067|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83396068|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396069|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
83396070|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83396071|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83396072|NCT03229538|Prednisolone|prednisolone|mesh-list
83396073|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
83396074|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83396075|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
83396076|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83396077|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
83396078|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
83396079|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396080|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396081|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83396082|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
83396083|NCT03229538|Hormones|hormones|mesh-ancestor
83396084|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83396085|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83396086|NCT03229538|Protective Agents|protective agents|mesh-ancestor
83396087|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83396088|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396089|NCT03198351|Teriflunomide|teriflunomide|mesh-list
83396090|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83396091|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83396092|NCT03198351|Analgesics|analgesics|mesh-ancestor
83396093|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
83396094|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396095|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396096|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83396097|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396098|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83396099|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
83396100|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83396101|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83396102|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83396103|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83396104|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396105|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
83396106|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396107|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396108|NCT03148795|Talazoparib|talazoparib|mesh-list
83396109|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83396110|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396111|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396112|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396113|NCT03070054|Epinephrine|epinephrine|mesh-list
83396114|NCT03070054|Bupivacaine|bupivacaine|mesh-list
83396115|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
83396116|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
83396117|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396118|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396119|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
83396120|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396121|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83396122|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83396123|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
83396124|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396125|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396126|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83396127|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83396128|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
83396129|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83396130|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
83396131|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
83396132|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
83396133|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83396134|NCT03040778|Vitamin E|vitamin e|mesh-list
83396135|NCT03040778|Tocopherols|tocopherols|mesh-list
83396136|NCT03040778|Tocotrienols|tocotrienols|mesh-list
83396137|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
83396138|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
83396139|NCT03040778|Vitamins|vitamins|mesh-ancestor
83396140|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
83396141|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396142|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
83396143|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396144|NCT03040778|Protective Agents|protective agents|mesh-ancestor
83396145|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83396146|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396147|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83396148|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83396149|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
83396150|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83396151|NCT03025256|Nivolumab|nivolumab|mesh-list
83396152|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396153|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396154|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83396155|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396156|NCT02962414|Everolimus|everolimus|mesh-list
83396157|NCT02962414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83396158|NCT02962414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83396159|NCT02962414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396160|NCT02962414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396161|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83396162|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
83396163|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396164|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396165|NCT02959047|Alirocumab|alirocumab|mesh-list
83396166|NCT02959047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83396167|NCT02959047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83396168|NCT02959047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83396169|NCT02959047|Antimetabolites|antimetabolites|mesh-ancestor
83396170|NCT02959047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396171|NCT02959047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83396172|NCT02959047|Protease Inhibitors|protease inhibitors|mesh-ancestor
83396173|NCT02959047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396174|NCT02959047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83396175|NCT02913313|Nivolumab|nivolumab|mesh-list
83396176|NCT02913313|Ipilimumab|ipilimumab|mesh-list
83396177|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396178|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396179|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83396180|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396181|NCT02895750|Metformin|metformin|mesh-list
83396182|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83396183|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396184|NCT02895360|Lisavanbulin|lisavanbulin|mesh-list
83396185|NCT02895360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83396186|NCT02895360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396187|NCT02895360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396188|NCT02895360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396189|NCT02890784|Dasatinib|dasatinib|mesh-list
83396190|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396191|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83396192|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396193|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396194|NCT02863809|Riboflavin|riboflavin|mesh-list
83396195|NCT02863809|Dextrans|dextrans|mesh-list
83396196|NCT02863809|Vitamins|vitamins|mesh-ancestor
83396197|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
83396198|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396199|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
83396200|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83396201|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
83396202|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
83396203|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
83396231|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396232|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396233|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83396234|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83396235|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
83396236|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396237|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83396238|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
83396239|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
83396240|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
83396241|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83396242|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
83396243|NCT02785224|Coagulants|coagulants|mesh-ancestor
83396244|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83396245|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
83396246|NCT02768363|Valacyclovir|valacyclovir|mesh-list
83396247|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
83396248|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83396249|NCT02729805|Ketamine|ketamine|mesh-list
83396250|NCT02729805|Analgesics|analgesics|mesh-ancestor
83396251|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
83396252|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396253|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396254|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83396255|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83396256|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
83396257|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
83396258|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396259|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83396260|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83396261|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396262|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396263|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
83396264|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396265|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
83396266|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83396267|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396268|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83396269|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396270|NCT02584478|Paclitaxel|paclitaxel|mesh-list
83396271|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83396272|NCT02584478|Carboplatin|carboplatin|mesh-list
83396273|NCT02584478|Doxorubicin|doxorubicin|mesh-list
83396274|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83396275|NCT02584478|Topotecan|topotecan|mesh-list
83396276|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83396277|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396278|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
83396279|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
83396280|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
83396281|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396282|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83396283|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83396284|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83396285|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396286|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83396287|NCT02582905|Choline|choline|mesh-list
83396288|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83396289|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
83396290|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83396291|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
83396292|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396293|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83396294|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83396295|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
83396296|NCT02521311|Clemastine|clemastine|mesh-list
83396297|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
83396298|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
83396299|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83396300|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
83396301|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
83396302|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396303|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396304|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396354|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83396355|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396356|NCT02308072|Olaparib|olaparib|mesh-list
83396357|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396358|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83396359|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396360|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396361|NCT02289079|Bupivacaine|bupivacaine|mesh-list
83396362|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
83396363|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
83396364|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396365|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396366|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
83396367|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396368|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
83396369|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396370|NCT02131753|Cladribine|cladribine|mesh-list
83396371|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396372|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83396373|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
83396374|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396375|NCT02101788|Tamoxifen|tamoxifen|mesh-list
83396376|NCT02101788|Paclitaxel|paclitaxel|mesh-list
83396377|NCT02101788|Doxorubicin|doxorubicin|mesh-list
83396378|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83396379|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83396380|NCT02101788|Letrozole|letrozole|mesh-list
83396381|NCT02101788|Topotecan|topotecan|mesh-list
83396382|NCT02101788|Trametinib|trametinib|mesh-list
83396383|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83396384|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83396385|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396386|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
83396387|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
83396388|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
83396389|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396390|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83396391|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83396392|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83396393|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396394|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83396395|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83396396|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83396397|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
83396398|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83396399|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396400|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83396401|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83396402|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83396403|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83396404|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83396405|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83396406|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83396407|NCT02101788|Protective Agents|protective agents|mesh-ancestor
83396408|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83396409|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
83396410|NCT02095132|Irinotecan|irinotecan|mesh-list
83396411|NCT02095132|Camptothecin|camptothecin|mesh-list
83396412|NCT02095132|Adavosertib|adavosertib|mesh-list
83396413|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83396414|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83396415|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396416|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396417|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396418|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83396419|NCT02079740|Trametinib|trametinib|mesh-list
83396420|NCT02079740|Navitoclax|navitoclax|mesh-list
83396421|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396422|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83396423|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396424|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396425|NCT02058706|Leuprolide|leuprolide|mesh-list
83396426|NCT02058706|Goserelin|goserelin|mesh-list
83396427|NCT02058706|Bicalutamide|bicalutamide|mesh-list
83396428|NCT02058706|Androgens|androgens|mesh-list
83396429|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83396430|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
83396431|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83396432|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396433|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83396434|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396435|NCT02058706|Hormones|hormones|mesh-ancestor
83396436|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83396437|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
83396438|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
83396439|NCT02015117|Trametinib|trametinib|mesh-list
83396440|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396441|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83396442|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396443|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396444|NCT01644110|Pomalidomide|pomalidomide|mesh-list
83396445|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
83396446|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396447|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83396448|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83396449|NCT01644110|Growth Substances|growth substances|mesh-ancestor
83396450|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
83396451|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396452|NCT01478542|Rituximab|rituximab|mesh-list
83396453|NCT01478542|Vincristine|vincristine|mesh-list
83396454|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396455|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396456|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
83396457|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396458|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396459|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83396460|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
83396461|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
83396462|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
83396463|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396464|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83396465|NCT01407263|Hemostatics|hemostatics|mesh-list
83396466|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83396467|NCT01407263|Coagulants|coagulants|mesh-ancestor
83396468|NCT01406678|Sufentanil|sufentanil|mesh-list
83396469|NCT01406678|Dsuvia|dsuvia|mesh-list
83396470|NCT01406678|Isoflurane|isoflurane|mesh-list
83396471|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
83396472|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396473|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396474|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83396475|NCT01406678|Narcotics|narcotics|mesh-ancestor
83396476|NCT01406678|Analgesics|analgesics|mesh-ancestor
83396477|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
83396478|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396479|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83396480|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83396481|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
83396482|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83396483|NCT01397929|Lisavanbulin|lisavanbulin|mesh-list
83396484|NCT01397929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83396485|NCT01397929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396486|NCT01397929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396487|NCT01397929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396488|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83396489|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396490|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396491|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396492|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83396493|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83396494|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83396495|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
83396496|NCT00715611|Carboplatin|carboplatin|mesh-list
83396497|NCT00715611|Pemetrexed|pemetrexed|mesh-list
83396498|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396499|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396500|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396501|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83396502|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83396503|NCT00695214|Propofol|propofol|mesh-list
83396504|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83396505|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396583|NCT00569127|Octreotide|octreotide|mesh-list
83396507|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83396508|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
83396509|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
83396510|NCT00678327|Prednisolone|prednisolone|mesh-list
83396511|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
83396512|NCT00678327|Dacarbazine|dacarbazine|mesh-list
83396513|NCT00678327|Doxorubicin|doxorubicin|mesh-list
83396514|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83396515|NCT00678327|Etoposide|etoposide|mesh-list
83396516|NCT00678327|Vincristine|vincristine|mesh-list
83396517|NCT00678327|Bleomycin|bleomycin|mesh-list
83396518|NCT00678327|Vinblastine|vinblastine|mesh-list
83396519|NCT00678327|Procarbazine|procarbazine|mesh-list
83396520|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83396521|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
83396522|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396523|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396524|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83396525|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
83396526|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396527|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396528|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83396529|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83396530|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83396531|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83396532|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396533|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83396534|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
83396535|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
83396536|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
83396537|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83396538|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
83396539|NCT00678327|Hormones|hormones|mesh-ancestor
83396540|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83396541|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83396542|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
83396543|NCT00602667|Cisplatin|cisplatin|mesh-list
83396544|NCT00602667|Carboplatin|carboplatin|mesh-list
83396545|NCT00602667|Methotrexate|methotrexate|mesh-list
83396546|NCT00602667|Etoposide|etoposide|mesh-list
83396547|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
83396548|NCT00602667|Vincristine|vincristine|mesh-list
83396549|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83396550|NCT00602667|Topotecan|topotecan|mesh-list
83396551|NCT00602667|Vinblastine|vinblastine|mesh-list
83396552|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83396553|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
83396554|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396555|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396556|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83396557|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
83396558|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396559|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396560|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83396561|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83396562|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
83396563|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83396564|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83396565|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
83396566|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
83396567|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396568|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83396569|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83396570|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83396571|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83396572|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83396573|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
83396574|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
83396575|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
83396576|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83396577|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83396578|NCT00569127|Interferons|interferons|mesh-list
83396579|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
83396580|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
83396581|NCT00569127|Bevacizumab|bevacizumab|mesh-list
83396582|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83396584|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
83396585|NCT00569127|Antibodies|antibodies|mesh-list
83396586|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
83396587|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83396588|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
83396589|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396590|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83396591|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83396592|NCT00569127|Growth Substances|growth substances|mesh-ancestor
83396593|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396594|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
83396595|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
83396596|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
83396597|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83396598|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83396599|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83396600|NCT00544466|Fludarabine|fludarabine|mesh-list
83396601|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
83396602|NCT00544466|Melphalan|melphalan|mesh-list
83396603|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396604|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83396605|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
83396606|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396607|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83396608|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
83396609|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396610|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83396611|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
83396612|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83396613|NCT00544115|Cyclosporine|cyclosporine|mesh-list
83396614|NCT00544115|Sirolimus|sirolimus|mesh-list
83396615|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
83396616|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
83396617|NCT00544115|Melphalan|melphalan|mesh-list
83396618|NCT00544115|Busulfan|busulfan|mesh-list
83396619|NCT00544115|Methotrexate|methotrexate|mesh-list
83396620|NCT00544115|Fludarabine|fludarabine|mesh-list
83396621|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
83396622|NCT00544115|Etoposide|etoposide|mesh-list
83396623|NCT00544115|Tacrolimus|tacrolimus|mesh-list
83396624|NCT00544115|Cyclosporins|cyclosporins|mesh-list
83396625|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83396626|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
83396627|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396628|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396629|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83396630|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
83396631|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396632|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396633|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83396634|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83396635|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
83396636|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83396637|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83396638|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
83396639|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
83396640|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396641|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83396642|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83396643|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83396644|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83396645|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83396646|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83396647|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
83396648|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83396649|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83396650|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83396651|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
83396652|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83396653|NCT00519675|Alitretinoin|alitretinoin|mesh-list
83396654|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396655|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
83396656|NCT00492999|Leucovorin|leucovorin|mesh-list
83396657|NCT00492999|Dexamethasone|dexamethasone|mesh-list
83396658|NCT00492999|Fluorouracil|fluorouracil|mesh-list
83396659|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
83396660|NCT00492999|Irinotecan|irinotecan|mesh-list
83396661|NCT00492999|Floxuridine|floxuridine|mesh-list
83396662|NCT00492999|Calcium|calcium|mesh-list
83396672|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83396673|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83396674|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396675|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83396676|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
83396677|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396678|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83396679|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83396680|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
83396681|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83396682|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83396683|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396684|NCT00492999|Antidotes|antidotes|mesh-ancestor
83396685|NCT00492999|Protective Agents|protective agents|mesh-ancestor
83396686|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
83396687|NCT00492999|Vitamins|vitamins|mesh-ancestor
83396688|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
83396689|NCT00413439|Isavuconazole|isavuconazole|mesh-list
83396690|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
83396691|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83396692|NCT00374075|Valproic Acid|valproic acid|mesh-list
83396693|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
83396694|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396695|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396696|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
83396697|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396698|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396699|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
83396700|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83396701|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396702|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83396703|NCT00309621|Alitretinoin|alitretinoin|mesh-list
83396704|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396705|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
83396706|NCT00124475|Alitretinoin|alitretinoin|mesh-list
83396707|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396708|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
83396709|NCT00124436|Alitretinoin|alitretinoin|mesh-list
83396710|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396711|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
83396712|NCT00112931|Rituximab|rituximab|mesh-list
83396713|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396714|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396715|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
83396716|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396717|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396718|NCT00110110|Cyclosporine|cyclosporine|mesh-list
83396719|NCT00110110|Carboplatin|carboplatin|mesh-list
83396720|NCT00110110|Etoposide|etoposide|mesh-list
83396721|NCT00110110|Vincristine|vincristine|mesh-list
83396722|NCT00110110|Cyclosporins|cyclosporins|mesh-list
83396723|NCT00110110|Lenograstim|lenograstim|mesh-list
83396724|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396725|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83396726|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83396727|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83396728|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396729|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396730|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83396731|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
83396732|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396733|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
83396734|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
83396735|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
83396736|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83396737|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
83396738|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83396739|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
83396740|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396741|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83396742|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83396743|NCT05307003|Trazodone|trazodone|mesh-list
83396744|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
83396745|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83396746|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83396747|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83396748|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83397498|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
83396749|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396750|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83396751|NCT05307003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83396752|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83396753|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83396754|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396755|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396756|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
83396757|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83396759|NCT03153917|Melatonin|melatonin|mesh-list
83396760|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
83396761|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396762|NCT03153917|Protective Agents|protective agents|mesh-ancestor
83396763|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396764|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396765|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83396766|NCT01096875|Atorvastatin|atorvastatin|mesh-list
83396767|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83396768|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83396769|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
83396770|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396771|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83396772|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83396773|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396774|NCT01097343|Clopidogrel|clopidogrel|mesh-list
83396775|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83396776|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83396777|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83396778|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83396779|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
83396780|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396781|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396782|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396783|NCT03580187|Morphine|morphine|mesh-list
83396784|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83396785|NCT03580187|Narcotics|narcotics|mesh-ancestor
83396786|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396787|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396788|NCT03580187|Analgesics|analgesics|mesh-ancestor
83396789|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
83396790|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396791|NCT01098747|Ibuprofen|ibuprofen|mesh-list
83396792|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83396793|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83396794|NCT01098747|Analgesics|analgesics|mesh-ancestor
83396795|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
83396796|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396797|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396798|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83396799|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396800|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83396801|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396802|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396803|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
83396804|NCT02085161|Olodaterol|olodaterol|mesh-list
83396805|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83396806|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
83396807|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396808|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396809|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83396810|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
83396811|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
83396812|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83396813|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
83396814|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396815|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396817|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396818|NCT01035333|Orlistat|orlistat|mesh-list
83396819|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396820|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396821|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83396823|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
83396824|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83396825|NCT03152981|Remifentanil|remifentanil|mesh-list
83396826|NCT03152981|Propofol|propofol|mesh-list
83396827|NCT03152981|Desflurane|desflurane|mesh-list
83396828|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83396829|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396830|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396831|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83396832|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
83396833|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
83396834|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83396835|NCT03152981|Narcotics|narcotics|mesh-ancestor
83396836|NCT03152981|Analgesics|analgesics|mesh-ancestor
83396837|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
83396838|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396839|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83396840|NCT03576755|Spironolactone|spironolactone|mesh-list
83396841|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83396842|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
83396843|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83396844|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396845|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83396846|NCT03576755|Diuretics|diuretics|mesh-ancestor
83396847|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
83396848|NCT05384015|Carboplatin|carboplatin|mesh-list
83396849|NCT05384015|Pembrolizumab|pembrolizumab|mesh-list
83396850|NCT05384015|Etoposide|etoposide|mesh-list
83396851|NCT05384015|Etoposide phosphate|etoposide phosphate|mesh-list
83396852|NCT05384015|Lenvatinib|lenvatinib|mesh-list
83396853|NCT05384015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396854|NCT05384015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396855|NCT05384015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83396856|NCT05384015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396857|NCT05384015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83396858|NCT05384015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83396859|NCT05384015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83396860|NCT05384015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396861|NCT05384015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83396862|NCT03572387|Azacitidine|azacitidine|mesh-list
83396863|NCT03572387|Tretinoin|tretinoin|mesh-list
83396864|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83396865|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
83396866|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396867|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396868|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396869|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
83396870|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
83396871|NCT04728971|Caspofungin|caspofungin|mesh-list
83396872|NCT04728971|Micafungin|micafungin|mesh-list
83396873|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
83396874|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83396875|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396876|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396877|NCT03568643|Amoxicillin|amoxicillin|mesh-list
83396878|NCT03568643|Azithromycin|azithromycin|mesh-list
83396879|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83396880|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83396881|NCT01100931|Paclitaxel|paclitaxel|mesh-list
83396882|NCT01100931|Carboplatin|carboplatin|mesh-list
83396883|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83396884|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396885|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
83396886|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
83396887|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
83396888|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396889|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
83396890|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
83396891|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83396892|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83396893|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396895|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83396896|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83396897|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
83396898|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
83396899|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396900|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396901|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83396902|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
83396903|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83396904|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
83396905|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396906|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396907|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83396908|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
83396909|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
83396910|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83396911|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83396912|NCT03013959|Analgesics|analgesics|mesh-ancestor
83396913|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
83396914|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396915|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396916|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83396917|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396918|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
83396919|NCT02246595|Vilobelimab|vilobelimab|mesh-list
83396920|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83396921|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83396922|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
83396923|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396924|NCT01106859|Zolpidem|zolpidem|mesh-list
83396925|NCT01106859|Zopiclone|zopiclone|mesh-list
83396926|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83396927|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83396928|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396929|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396930|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83396931|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
83396932|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
83396933|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396934|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396935|NCT01042509|Rituximab|rituximab|mesh-list
83396936|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
83396937|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396938|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396939|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
83396940|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396941|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396942|NCT04814355|Celecoxib|celecoxib|mesh-list
83396943|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83396944|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83396945|NCT04814355|Analgesics|analgesics|mesh-ancestor
83396946|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
83396947|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396948|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396949|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83396950|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396951|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83396952|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83396953|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396954|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396955|NCT02179671|Docetaxel|docetaxel|mesh-list
83396956|NCT02179671|Gefitinib|gefitinib|mesh-list
83396957|NCT02179671|Tremelimumab|tremelimumab|mesh-list
83396958|NCT02179671|Osimertinib|osimertinib|mesh-list
83396959|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396960|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
83396961|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
83396962|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
83396963|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396964|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83396965|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396966|NCT01110135|Dexamethasone|dexamethasone|mesh-list
83396967|NCT01110135|Etoposide|etoposide|mesh-list
83396968|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
83396969|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83396970|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83396971|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
83396972|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
83396973|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396974|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396976|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
83396977|NCT01110135|Hormones|hormones|mesh-ancestor
83396978|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83396979|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83396980|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396981|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83396982|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83396983|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83396984|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396985|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396986|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83396987|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
83396988|NCT01112241|Albuterol|albuterol|mesh-list
83396989|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
83396990|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83396991|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
83396992|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396993|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396994|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83396995|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
83396996|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
83396997|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83396998|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
83396999|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397000|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397001|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
83397002|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83397003|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83397004|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83397005|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83397006|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
83397007|NCT03013881|Trastuzumab|trastuzumab|mesh-list
83397008|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83397009|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397010|NCT02174913|Fentanyl|fentanyl|mesh-list
83397011|NCT02174913|Propofol|propofol|mesh-list
83397012|NCT02174913|Atracurium|atracurium|mesh-list
83397013|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83397014|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83397015|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397016|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83397017|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
83397018|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
83397019|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83397020|NCT02174913|Narcotics|narcotics|mesh-ancestor
83397021|NCT02174913|Analgesics|analgesics|mesh-ancestor
83397022|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
83397023|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397024|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83397025|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83397026|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83397027|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83397028|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83397029|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83397030|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
83397031|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397032|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397033|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
83397034|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83397035|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83397036|NCT01114503|Prednisolone|prednisolone|mesh-list
83397037|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
83397038|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83397039|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
83397040|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83397041|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
83397042|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
83397043|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397044|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397045|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83397046|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
83397047|NCT01114503|Hormones|hormones|mesh-ancestor
83397048|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397049|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83397050|NCT01114503|Protective Agents|protective agents|mesh-ancestor
83397051|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83397052|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397053|NCT03015831|Colchicine|colchicine|mesh-list
83397054|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
83397055|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397056|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
83397057|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
83397058|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
83397059|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397060|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397061|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
83397062|NCT01114581|Guaifenesin|guaifenesin|mesh-list
83397063|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83397064|NCT01114581|Expectorants|expectorants|mesh-ancestor
83397065|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
83397066|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83397067|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83397068|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
83397069|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397070|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397071|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397072|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
83397073|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83397074|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
83397075|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
83397076|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397077|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
83397078|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83397079|NCT01114893|Travoprost|travoprost|mesh-list
83397080|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83397081|NCT01114971|Labetalol|labetalol|mesh-list
83397082|NCT01114971|Fentanyl|fentanyl|mesh-list
83397083|NCT01114971|Esmolol|esmolol|mesh-list
83397084|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83397085|NCT01114971|Narcotics|narcotics|mesh-ancestor
83397086|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83397087|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397088|NCT01114971|Analgesics|analgesics|mesh-ancestor
83397089|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
83397090|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397091|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83397092|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83397093|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
83397094|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
83397095|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83397096|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83397097|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83397098|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
83397099|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397100|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397101|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83397102|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
83397103|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
83397104|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83397105|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83397106|NCT01044693|Metoprolol|metoprolol|mesh-list
83397107|NCT01044693|Nebivolol|nebivolol|mesh-list
83397108|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
83397109|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
83397110|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83397111|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83397112|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397113|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397114|NCT01044693|Urological Agents|urological agents|mesh-ancestor
83397115|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83397116|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83397117|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
83397118|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
83397119|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397120|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397121|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83397122|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83397123|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83397124|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
83397125|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397126|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83397127|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83397128|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83397129|NCT01115517|Bevacizumab|bevacizumab|mesh-list
83397130|NCT01115517|Mitomycins|mitomycins|mesh-list
83397131|NCT01115517|Mitomycin|mitomycin|mesh-list
83397132|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83397133|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397134|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83397135|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83397136|NCT01115517|Growth Substances|growth substances|mesh-ancestor
83397137|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397138|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
83397139|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83397140|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
83397141|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397142|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83397143|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397144|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
83397145|NCT03015675|Vitamins|vitamins|mesh-ancestor
83397146|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
83397147|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397148|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
83397149|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397150|NCT03015675|Protective Agents|protective agents|mesh-ancestor
83397151|NCT01044771|Tenofovir|tenofovir|mesh-list
83397152|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
83397153|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
83397154|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397155|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83397156|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83397157|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397158|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397159|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83397160|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83397161|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83397162|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83397163|NCT01115673|Acetaminophen|acetaminophen|mesh-list
83397164|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83397165|NCT01115673|Analgesics|analgesics|mesh-ancestor
83397166|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
83397167|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397168|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397169|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
83397170|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83397171|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
83397172|NCT04582383|Doxycycline|doxycycline|mesh-list
83397173|NCT04582383|Spironolactone|spironolactone|mesh-list
83397174|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83397175|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397176|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
83397177|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83397178|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83397179|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83397180|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
83397181|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397182|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397183|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83397184|NCT04582383|Diuretics|diuretics|mesh-ancestor
83397185|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
83397186|NCT01118091|Aldesleukin|aldesleukin|mesh-list
83397187|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397188|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83397189|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83397190|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
83397191|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397192|NCT01045551|Apremilast|apremilast|mesh-list
83397193|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83397194|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83397195|NCT01045551|Analgesics|analgesics|mesh-ancestor
83397196|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
83397197|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397198|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397199|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83397200|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397201|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83397202|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83397203|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397204|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397205|NCT01047189|Clindamycin|clindamycin|mesh-list
83397206|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
83397207|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
83397208|NCT01047189|Tretinoin|tretinoin|mesh-list
83397209|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83397210|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397211|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83397212|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397213|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397214|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397215|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
83397216|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
83397217|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
83397218|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83397219|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83397220|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397221|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
83397222|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397223|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397224|NCT03012945|Anesthetics|anesthetics|mesh-list
83397225|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83397226|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397227|NCT01121211|Testosterone|testosterone|mesh-list
83397228|NCT01121211|Androgens|androgens|mesh-ancestor
83397229|NCT01121211|Hormones|hormones|mesh-ancestor
83397230|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397231|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397232|NCT01162551|Sirolimus|sirolimus|mesh-list
83397233|NCT01162551|Methotrexate|methotrexate|mesh-list
83397234|NCT01162551|Temsirolimus|temsirolimus|mesh-list
83397235|NCT01162551|MTOR Inhibitors|mtor inhibitors|mesh-list
83397236|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83397237|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
83397238|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83397239|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397240|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83397241|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
83397242|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397243|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397244|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
83397245|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397246|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83397247|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83397248|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
83397249|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397250|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83397251|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83397252|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397253|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83397254|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
83397255|NCT01162551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83397256|NCT01163097|Heparin|heparin|mesh-list
83397257|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
83397258|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83397259|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83397260|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397261|NCT03013101|Antibodies|antibodies|mesh-list
83397262|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83397263|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
83397264|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397265|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83397266|NCT03088137|Hormones|hormones|mesh-ancestor
83397267|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397268|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397269|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
83397270|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83397271|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
83397272|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397273|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397274|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83397275|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
83397276|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83397278|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397279|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397280|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83397281|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
83397282|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
83397283|NCT01165047|Protective Agents|protective agents|mesh-ancestor
83397284|NCT01166997|Heparin|heparin|mesh-list
83397285|NCT01166997|Calcium heparin|calcium heparin|mesh-list
83397286|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
83397287|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83397288|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83397289|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397290|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
83397291|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83397292|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397293|NCT01170117|Olanzapine|olanzapine|mesh-list
83397294|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
83397295|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
83397296|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397297|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397298|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83397299|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83397300|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83397301|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83397302|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83397303|NCT01170117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83397304|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83397305|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83397306|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397307|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397308|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
83397309|NCT01172145|Modafinil|modafinil|mesh-list
83397310|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83397311|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397312|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83397313|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83397314|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83397315|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397316|NCT01175343|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83397317|NCT01175343|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
83397318|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397319|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397320|NCT01176435|Levodopa|levodopa|mesh-list
83397321|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83397322|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83397323|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
83397324|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397325|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397326|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397327|NCT01176591|Aprepitant|aprepitant|mesh-list
83397328|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
83397329|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
83397330|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
83397331|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397332|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397333|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83397334|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83397335|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397336|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397337|NCT01176981|Methotrexate|methotrexate|mesh-list
83397338|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83397339|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
83397340|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83397341|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397342|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83397343|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
83397344|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397345|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397346|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
83397347|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397348|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83397349|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83397350|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
83397351|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397352|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83397353|NCT01126593|Bupivacaine|bupivacaine|mesh-list
83397354|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
83397355|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
83397356|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83397357|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397358|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
83397359|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397360|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83397361|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83397362|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397363|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397364|NCT01126671|Vitamin D|vitamin d|mesh-list
83397365|NCT01126671|Vitamins|vitamins|mesh-ancestor
83397366|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
83397367|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397368|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83397369|NCT01182675|Plerixafor|plerixafor|mesh-list
83397370|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
83397371|NCT01182675|Lenograstim|lenograstim|mesh-list
83397372|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83397373|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
83397374|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397375|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83397376|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397377|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83397378|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83397379|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
83397380|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397381|NCT01129245|Celecoxib|celecoxib|mesh-list
83397382|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83397383|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83397384|NCT01129245|Analgesics|analgesics|mesh-ancestor
83397385|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
83397386|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397387|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397388|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83397389|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397390|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83397391|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83397392|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397393|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397394|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83397395|NCT01183533|Plasminogen|plasminogen|mesh-list
83397396|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83397397|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83397398|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397399|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83397400|NCT01188369|Simendan|simendan|mesh-list
83397401|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83397402|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
83397403|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83397404|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83397405|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397406|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397407|NCT01188369|Protective Agents|protective agents|mesh-ancestor
83397408|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397409|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
83397410|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
83397411|NCT01135329|Busulfan|busulfan|mesh-list
83397412|NCT01135329|Fludarabine|fludarabine|mesh-list
83397413|NCT01135329|Tacrolimus|tacrolimus|mesh-list
83397414|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83397415|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
83397416|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397417|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397418|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83397419|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
83397420|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397421|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397422|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83397423|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83397424|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397425|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83397426|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83397427|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
83397428|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83397429|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397430|NCT03012009|Lidocaine|lidocaine|mesh-list
83397431|NCT03012009|Epinephrine|epinephrine|mesh-list
83397432|NCT03012009|Racepinephrine|racepinephrine|mesh-list
83397433|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
83397434|NCT03012009|Anesthetics|anesthetics|mesh-list
83397435|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83397436|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
83397437|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83397438|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397439|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
83397440|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397441|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83397442|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83397443|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83397444|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83397445|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397446|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83397447|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83397448|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
83397449|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397450|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83397451|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83397452|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
83397453|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83397454|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
83397455|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
83397456|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
83397457|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83397458|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83397459|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
83397460|NCT04403555|Ivermectin|ivermectin|mesh-list
83397461|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83397462|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397463|NCT03565835|Prednisone|prednisone|mesh-list
83397464|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
83397465|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83397466|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
83397467|NCT03565835|Hormones|hormones|mesh-ancestor
83397468|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397469|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397470|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83397471|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397472|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83397473|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397474|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397475|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
83397476|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83397477|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
83397478|NCT03563729|Nivolumab|nivolumab|mesh-list
83397479|NCT03563729|Ipilimumab|ipilimumab|mesh-list
83397480|NCT03563729|Trametinib|trametinib|mesh-list
83397481|NCT03563729|Dabrafenib|dabrafenib|mesh-list
83397482|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83397483|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397484|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83397485|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397486|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83397487|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397488|NCT01624259|Metformin|metformin|mesh-list
83397489|NCT01624259|Liraglutide|liraglutide|mesh-list
83397490|NCT01624259|Dulaglutide|dulaglutide|mesh-list
83397491|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83397492|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397493|NCT01624259|Incretins|incretins|mesh-ancestor
83397494|NCT01624259|Hormones|hormones|mesh-ancestor
83397495|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397496|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
83397497|NCT02081183|Prednisone|prednisone|mesh-list
83397499|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83397500|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
83397501|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397502|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397503|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83397504|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
83397505|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397506|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397507|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83397508|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83397509|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
83397510|NCT02081183|Hormones|hormones|mesh-ancestor
83397511|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397512|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83397513|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83397514|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83397515|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
83397516|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83397517|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397518|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397519|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
83397520|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83397521|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83397522|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397523|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
83397524|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
83397525|NCT02079077|Aspirin|aspirin|mesh-list
83397526|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
83397527|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
83397528|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83397529|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83397530|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397531|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397532|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397533|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397534|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83397535|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83397536|NCT02079077|Analgesics|analgesics|mesh-ancestor
83397537|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
83397538|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397539|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397540|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83397541|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83397542|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83397543|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83397544|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83397545|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
83397546|NCT03547271|Vaccines|vaccines|mesh-list
83397547|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83397548|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
83397549|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397550|NCT03547115|Venetoclax|venetoclax|mesh-list
83397551|NCT03547115|Voruciclib|voruciclib|mesh-list
83397552|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397553|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83397554|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397555|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397556|NCT01191255|Sevelamer|sevelamer|mesh-list
83397557|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
83397558|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
83397559|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397560|NCT02078219|Allopurinol|allopurinol|mesh-list
83397561|NCT02078219|Verinurad|verinurad|mesh-list
83397562|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
83397563|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397564|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397565|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
83397566|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397567|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83397568|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
83397569|NCT02078219|Protective Agents|protective agents|mesh-ancestor
83397570|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397571|NCT03536039|Prednisone|prednisone|mesh-list
83397572|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
83397573|NCT03536039|Rituximab|rituximab|mesh-list
83397574|NCT03536039|Doxorubicin|doxorubicin|mesh-list
83397575|NCT03536039|Vincristine|vincristine|mesh-list
83397576|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83397577|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
83397578|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397579|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397580|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83397581|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
83397582|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397583|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397584|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83397585|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83397586|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83397587|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83397588|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83397589|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397590|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83397591|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
83397593|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397594|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83397595|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83397596|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
83397597|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
83397598|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
83397599|NCT02075255|Benralizumab|benralizumab|mesh-list
83397600|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83397601|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
83397602|NCT03532217|Nivolumab|nivolumab|mesh-list
83397603|NCT03532217|Ipilimumab|ipilimumab|mesh-list
83397604|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83397605|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397606|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83397607|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397608|NCT03529487|Phenylephrine|phenylephrine|mesh-list
83397609|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
83397610|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83397611|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83397612|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
83397613|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397614|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397615|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397616|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
83397617|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
83397618|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397619|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
83397620|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83397621|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
83397622|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83397623|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
83397624|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83397625|NCT03529487|Protective Agents|protective agents|mesh-ancestor
83397626|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
83397627|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
83397628|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397629|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397630|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397631|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83397632|NCT03527147|Rituximab|rituximab|mesh-list
83397633|NCT03527147|Magrolimab|magrolimab|mesh-list
83397634|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
83397635|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83397636|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397637|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
83397638|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397639|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397640|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83397641|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83397642|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83397643|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
83397644|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397645|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83397646|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83397647|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397648|NCT01677611|Resveratrol|resveratrol|mesh-list
83397649|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
83397650|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397651|NCT01677611|Protective Agents|protective agents|mesh-ancestor
83397652|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397653|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397654|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83397655|NCT03518801|Cannabidiol|cannabidiol|mesh-list
83397656|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
83397657|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
83397658|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83397659|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397660|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83397661|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83397662|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397663|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397664|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397665|NCT01193049|Prednisone|prednisone|mesh-list
83397666|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83397667|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
83397668|NCT01193049|Hormones|hormones|mesh-ancestor
83397669|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397670|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397671|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83397672|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397673|NCT01679951|Methotrexate|methotrexate|mesh-list
83397674|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83397675|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
83397676|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83397677|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397678|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83397679|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
83397680|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397681|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397682|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
83397683|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397684|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83397685|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83397686|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
83397687|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83397688|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83397689|NCT03514589|Cosyntropin|cosyntropin|mesh-list
83397690|NCT03514589|Hormones|hormones|mesh-ancestor
83397691|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397692|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397693|NCT01194297|Vaccines|vaccines|mesh-list
83397694|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
83397695|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397696|NCT01194453|Folic Acid|folic acid|mesh-list
83397697|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
83397698|NCT01194453|Hydroxocobalamin|hydroxocobalamin|mesh-list
83397699|NCT01194453|Dexamethasone|dexamethasone|mesh-list
83397700|NCT01194453|Cisplatin|cisplatin|mesh-list
83397701|NCT01194453|Gemcitabine|gemcitabine|mesh-list
83397702|NCT01194453|Vitamins|vitamins|mesh-ancestor
83397703|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
83397704|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397705|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83397706|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
83397707|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
83397708|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397709|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83397710|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
83397711|NCT01194453|Hormones|hormones|mesh-ancestor
83397712|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397713|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83397714|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397715|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83397716|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
83397717|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397718|NCT01194453|Hematinics|hematinics|mesh-ancestor
83397719|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
83397720|NCT03507413|Metformin|metformin|mesh-list
83397721|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83397722|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397723|NCT01195467|Tenofovir|tenofovir|mesh-list
83397724|NCT01195467|Emtricitabine|emtricitabine|mesh-list
83397725|NCT01195467|Efavirenz|efavirenz|mesh-list
83397726|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
83397727|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83397728|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
83397729|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397730|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83397731|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83397732|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397733|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397734|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83397735|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83397736|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83397737|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83397738|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83397739|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83397740|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83397741|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83397742|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83397743|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83397744|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83397745|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
83397746|NCT03492437|Tepotinib|tepotinib|mesh-list
83397747|NCT03492437|Dabigatran|dabigatran|mesh-list
83397748|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
83397749|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83397750|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
83397751|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397752|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397753|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
83397754|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397755|NCT01195779|Vaccines|vaccines|mesh-list
83397756|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
83397757|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397758|NCT02405585|Leucovorin|leucovorin|mesh-list
83397759|NCT02405585|Gemcitabine|gemcitabine|mesh-list
83397760|NCT02405585|Fluorouracil|fluorouracil|mesh-list
83397761|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
83397762|NCT02405585|Irinotecan|irinotecan|mesh-list
83397763|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83397764|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
83397765|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397766|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397767|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83397768|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
83397769|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397770|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83397771|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83397772|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397773|NCT02405585|Antidotes|antidotes|mesh-ancestor
83397774|NCT02405585|Protective Agents|protective agents|mesh-ancestor
83397775|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
83397776|NCT02405585|Vitamins|vitamins|mesh-ancestor
83397777|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
83397778|NCT03491345|Avelumab|avelumab|mesh-list
83397779|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83397780|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397781|NCT00089999|Lapatinib|lapatinib|mesh-list
83397782|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397783|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83397784|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397785|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397786|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
83397787|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83397788|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397789|NCT03454451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83397790|NCT03454451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397791|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
83397792|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
83397793|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
83397794|NCT00089843|Testosterone|testosterone|mesh-list
83397795|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
83397796|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
83397797|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83397799|NCT00089843|Hormones|hormones|mesh-ancestor
83397800|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397801|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397802|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83397803|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397804|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
83397805|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83397806|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83397807|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397808|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83397809|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83397810|NCT03485417|Aripiprazole|aripiprazole|mesh-list
83397811|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83397812|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
83397813|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83397814|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83397815|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83397816|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83397817|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397818|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
83397819|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
83397820|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397821|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397822|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83397823|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83397824|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
83397825|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83397826|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83397827|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83397828|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83397829|NCT01677923|Metformin|metformin|mesh-list
83397830|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83397831|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397832|NCT00089297|Paclitaxel|paclitaxel|mesh-list
83397833|NCT00089297|Carboplatin|carboplatin|mesh-list
83397834|NCT00089297|Cetuximab|cetuximab|mesh-list
83397835|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83397836|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397837|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
83397838|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
83397839|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
83397840|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397841|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83397842|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83397843|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83397844|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397845|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397846|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83397847|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83397848|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397849|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
83397850|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397851|NCT03482297|Midodrine|midodrine|mesh-list
83397852|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
83397853|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
83397854|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83397855|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397856|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83397857|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83397858|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83397859|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83397860|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
83397861|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397862|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397863|NCT00088907|Docetaxel|docetaxel|mesh-list
83397864|NCT00088907|Gefitinib|gefitinib|mesh-list
83397865|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397866|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
83397867|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
83397868|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
83397869|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397870|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83397871|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397872|NCT00088829|Paclitaxel|paclitaxel|mesh-list
83397873|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83397874|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83397875|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397876|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
83397919|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
83397920|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83397921|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83397922|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
83397923|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
83397924|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83397925|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397926|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397927|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83397928|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83397929|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83397930|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83397931|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83397932|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83397933|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
83397934|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83397935|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83397936|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
83397937|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83397938|NCT00085709|Cytarabine|cytarabine|mesh-list
83397939|NCT00085709|Daunorubicin|daunorubicin|mesh-list
83397940|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
83397941|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83397942|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
83397943|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397944|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397945|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
83397946|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397947|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83397948|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
83397949|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397950|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83397951|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83397952|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83397953|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397954|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83397955|NCT00085709|Immunotoxins|immunotoxins|mesh-ancestor
83397956|NCT00085709|Immunoconjugates|immunoconjugates|mesh-ancestor
83397957|NCT01201863|Testosterone|testosterone|mesh-list
83397958|NCT01201863|Androgens|androgens|mesh-ancestor
83397959|NCT01201863|Hormones|hormones|mesh-ancestor
83397960|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397961|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397962|NCT01202253|Anidulafungin|anidulafungin|mesh-list
83397963|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
83397964|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83397965|NCT01678703|Misoprostol|misoprostol|mesh-list
83397966|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83397967|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
83397968|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83397969|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397970|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83397971|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83397972|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
83397973|NCT00085631|Cisplatin|cisplatin|mesh-list
83397974|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397975|NCT01141491|Vaccines|vaccines|mesh-list
83397976|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
83397977|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
83397978|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397979|NCT01141569|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83397980|NCT01141569|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
83397981|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397982|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397983|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83397984|NCT01141725|Idarubicin|idarubicin|mesh-list
83397985|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83397986|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
83397987|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397988|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83397989|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83397990|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83397991|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83398027|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83398029|NCT04270175|Hormones|hormones|mesh-ancestor
83398030|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398031|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83398032|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398033|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
83398034|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83398035|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83398036|NCT04270175|Growth Substances|growth substances|mesh-ancestor
83398037|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
83398038|NCT01203189|Ketoconazole|ketoconazole|mesh-list
83398039|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
83398040|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398041|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83398042|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83398043|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398044|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398045|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83398046|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
83398047|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398048|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398049|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83398050|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
83398051|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83398052|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398053|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
83398054|NCT01679327|Leucovorin|leucovorin|mesh-list
83398055|NCT01679327|Bevacizumab|bevacizumab|mesh-list
83398056|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
83398057|NCT01679327|Calcium|calcium|mesh-list
83398058|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
83398059|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83398060|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398061|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83398062|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83398063|NCT01679327|Growth Substances|growth substances|mesh-ancestor
83398064|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398065|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
83398066|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83398067|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83398068|NCT01679327|Antidotes|antidotes|mesh-ancestor
83398069|NCT01679327|Protective Agents|protective agents|mesh-ancestor
83398070|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
83398071|NCT01679327|Vitamins|vitamins|mesh-ancestor
83398072|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
83398073|NCT01206387|Desoximetasone|desoximetasone|mesh-list
83398074|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83398075|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
83398076|NCT01206387|Hormones|hormones|mesh-ancestor
83398077|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398078|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398079|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83398080|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83398081|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83398082|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83398083|NCT01679639|Rifampin|rifampin|mesh-list
83398084|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83398085|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
83398086|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83398087|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398088|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
83398089|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83398091|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398092|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83398093|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83398094|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83398095|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83398096|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83398097|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83398098|NCT01679795|Tibolone|tibolone|mesh-list
83398099|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
83398100|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
83398101|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398102|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398103|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83398104|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83398105|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398106|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83398107|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
83398109|NCT01206465|Fluorouracil|fluorouracil|mesh-list
83398110|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
83398111|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398112|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83398113|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398114|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398115|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
83398116|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398117|NCT01207401|Lidocaine|lidocaine|mesh-list
83398118|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
83398119|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
83398120|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398121|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398122|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
83398123|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398124|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83398125|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83398126|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83398127|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83398128|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398129|NCT04761731|Tacrolimus|tacrolimus|mesh-list
83398130|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398131|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
83398132|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398133|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83398134|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398135|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398136|NCT03419897|Tislelizumab|tislelizumab|mesh-list
83398137|NCT03419897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83398138|NCT03419897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398139|NCT03087539|Abciximab|abciximab|mesh-list
83398140|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
83398141|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83398142|NCT03087149|Vitamin D|vitamin d|mesh-list
83398143|NCT03087149|Vitamins|vitamins|mesh-ancestor
83398144|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
83398145|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398146|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83398147|NCT03086681|Cisplatin|cisplatin|mesh-list
83398148|NCT03086681|Endostar protein|endostar protein|mesh-list
83398149|NCT03086681|Endostatins|endostatins|mesh-list
83398150|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398151|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83398152|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83398153|NCT03086681|Growth Substances|growth substances|mesh-ancestor
83398154|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398155|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
83398156|NCT03086759|Triamcinolone|triamcinolone|mesh-list
83398157|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83398158|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83398159|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83398160|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83398161|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
83398162|NCT03086759|Hormones|hormones|mesh-ancestor
83398163|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398164|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398165|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398166|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
83398167|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398168|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398169|NCT03086291|Simvastatin|simvastatin|mesh-list
83398170|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83398171|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83398172|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
83398173|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398174|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83398175|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83398176|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398177|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83398178|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83398179|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398180|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398181|NCT01209195|Paclitaxel|paclitaxel|mesh-list
83398182|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83398183|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398184|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
83398185|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
83398186|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
83398187|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398188|NCT03084809|Leucovorin|leucovorin|mesh-list
83398189|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
83398190|NCT03084809|Fluorouracil|fluorouracil|mesh-list
83398191|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
83398192|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398193|NCT03084809|Antidotes|antidotes|mesh-ancestor
83398194|NCT03084809|Protective Agents|protective agents|mesh-ancestor
83398195|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398196|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
83398197|NCT03084809|Vitamins|vitamins|mesh-ancestor
83398198|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
83398199|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
83398200|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398201|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83398202|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398203|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
83398204|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
83398205|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83398206|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83398207|NCT01144143|Prednisolone|prednisolone|mesh-list
83398208|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
83398209|NCT01144143|Infliximab|infliximab|mesh-list
83398210|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83398211|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
83398212|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83398213|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
83398214|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
83398215|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398216|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398217|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83398218|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
83398219|NCT01144143|Hormones|hormones|mesh-ancestor
83398220|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398221|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83398222|NCT01144143|Protective Agents|protective agents|mesh-ancestor
83398223|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83398224|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398225|NCT01144143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83398226|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
83398227|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83398228|NCT03084575|Glycerol|glycerol|mesh-list
83398229|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83398230|NCT03084575|Protective Agents|protective agents|mesh-ancestor
83398231|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398232|NCT01212471|Bromfenac|bromfenac|mesh-list
83398233|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83398234|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83398235|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83398236|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83398237|NCT01212471|Analgesics|analgesics|mesh-ancestor
83398238|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
83398239|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398240|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398241|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83398242|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83398244|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83398245|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398246|NCT03084419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83398247|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398248|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398249|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
83398250|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398251|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83398278|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83398279|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83398280|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83398281|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398282|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83398283|NCT00083915|Thalidomide|thalidomide|mesh-list
83398284|NCT00083915|Dexamethasone|dexamethasone|mesh-list
83398285|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
83398286|NCT00083915|Melphalan|melphalan|mesh-list
83398287|NCT00083915|Cisplatin|cisplatin|mesh-list
83398288|NCT00083915|Doxorubicin|doxorubicin|mesh-list
83398289|NCT00083915|Etoposide|etoposide|mesh-list
83398290|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83398291|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398292|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
83398293|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398294|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83398295|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83398296|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
83398297|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398298|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398299|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83398300|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83398301|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
83398302|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
83398303|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398304|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83398305|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
83398306|NCT00083915|Hormones|hormones|mesh-ancestor
83398307|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398308|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83398309|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83398310|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83398311|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83398312|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398313|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83398314|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
83398315|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83398316|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398317|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83398318|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83398319|NCT00083915|Growth Substances|growth substances|mesh-ancestor
83398320|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
83398321|NCT04401839|Oxytocin|oxytocin|mesh-list
83398322|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
83398323|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83398324|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398325|NCT04761185|Raltitrexed|raltitrexed|mesh-list
83398326|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83398327|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
83398328|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398329|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398330|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83398331|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398332|NCT01144455|Gemcitabine|gemcitabine|mesh-list
83398333|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
83398334|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83398335|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
83398336|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398337|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398338|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83398339|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
83398340|NCT03080675|Vitamins|vitamins|mesh-list
83398341|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
83398342|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398343|NCT03080363|Lidocaine|lidocaine|mesh-list
83398344|NCT03080363|Bupivacaine|bupivacaine|mesh-list
83398345|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
83398346|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
83398347|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398348|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398349|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
83398350|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398351|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83398352|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83398353|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83398354|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83398355|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398356|NCT01145001|Nicotine|nicotine|mesh-list
83398357|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83398358|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
83398359|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398360|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398361|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83398362|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83398363|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
83398364|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83398365|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398366|NCT03011463|Clarithromycin|clarithromycin|mesh-list
83398367|NCT03011463|Ranitidine|ranitidine|mesh-list
83398368|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83398369|NCT03011463|Trospium chloride|trospium chloride|mesh-list
83398370|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83398371|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398372|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83398373|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398374|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398375|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83398376|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83398377|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83398378|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83398379|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83398380|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
83398381|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
83398382|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83398383|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398384|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
83398385|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
83398386|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398387|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83398388|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83398389|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
83398390|NCT03011463|Urological Agents|urological agents|mesh-ancestor
83398391|NCT01214109|Pramipexole|pramipexole|mesh-list
83398392|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
83398393|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398394|NCT01214109|Protective Agents|protective agents|mesh-ancestor
83398395|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398396|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83398397|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83398398|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
83398399|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
83398400|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83398401|NCT05688761|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83398402|NCT05688761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398403|NCT05688761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398404|NCT01215123|Bevacizumab|bevacizumab|mesh-list
83398405|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83398406|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398407|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83398408|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83398409|NCT01215123|Growth Substances|growth substances|mesh-ancestor
83398410|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398411|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
83398412|NCT05688449|Fentanyl|fentanyl|mesh-list
83398413|NCT05688449|Bupivacaine|bupivacaine|mesh-list
83398414|NCT05688449|Anesthetics, Local|anesthetics, local|mesh-ancestor
83398415|NCT05688449|Anesthetics|anesthetics|mesh-ancestor
83398416|NCT05688449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398417|NCT05688449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398418|NCT05688449|Sensory System Agents|sensory system agents|mesh-ancestor
83398419|NCT05688449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398420|NCT05688449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83398421|NCT05688449|Narcotics|narcotics|mesh-ancestor
83398422|NCT05688449|Analgesics|analgesics|mesh-ancestor
83398423|NCT05688449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83398424|NCT05688449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83398425|NCT05688449|Anesthetics, General|anesthetics, general|mesh-ancestor
83398426|NCT04401137|Topiramate|topiramate|mesh-list
83398427|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
83398428|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83398429|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398457|NCT05687981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83398458|NCT05687981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398459|NCT05687981|Anesthetics, Local|anesthetics, local|mesh-ancestor
83398460|NCT05687981|Anesthetics|anesthetics|mesh-ancestor
83398461|NCT05687981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398462|NCT05687981|Sensory System Agents|sensory system agents|mesh-ancestor
83398463|NCT05687747|FAPI-46|fapi-46|mesh-list
83398464|NCT05687747|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83398465|NCT05687747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398466|NCT05687669|Phentolamine|phentolamine|mesh-list
83398467|NCT05687669|Nitroglycerin|nitroglycerin|mesh-list
83398468|NCT05687669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83398470|NCT05687669|Adrenergic Agents|adrenergic agents|mesh-ancestor
83398471|NCT05687669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83398472|NCT05687669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398473|NCT05687669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398474|NCT05687669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83398475|NCT05687669|Vasodilator Agents|vasodilator agents|mesh-ancestor
83398476|NCT04400747|Vitamin D|vitamin d|mesh-list
83398477|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
83398478|NCT04400747|Vitamins|vitamins|mesh-ancestor
83398479|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
83398480|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398481|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83398482|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83398483|NCT02190903|Anesthetics|anesthetics|mesh-list
83398484|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398485|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398486|NCT03369041|Irinotecan|irinotecan|mesh-list
83398487|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83398488|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83398489|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398490|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398491|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398492|NCT01149759|Cyclosporine|cyclosporine|mesh-list
83398493|NCT01149759|Cyclosporins|cyclosporins|mesh-list
83398494|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398495|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398496|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398497|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
83398498|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398499|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
83398500|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398501|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
83398502|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83398503|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83398504|NCT01216761|Iodine|iodine|mesh-list
83398505|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
83398506|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83398507|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
83398508|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
83398509|NCT01216761|Povidone|povidone|mesh-list
83398510|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83398511|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398512|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
83398513|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
83398514|NCT01216761|Trace Elements|trace elements|mesh-ancestor
83398515|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
83398516|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398517|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
83398518|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
83398519|NCT04279379|Decitabine|decitabine|mesh-list
83398520|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83398521|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
83398522|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398523|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398524|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398525|NCT05685719|Itraconazole|itraconazole|mesh-list
83398526|NCT05685719|Rifampin|rifampin|mesh-list
83398527|NCT05685719|Antifungal Agents|antifungal agents|mesh-ancestor
83398528|NCT05685719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398529|NCT05685719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83398530|NCT05685719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83398531|NCT05685719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398532|NCT05685719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398533|NCT05685719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83398534|NCT05685719|Hormone Antagonists|hormone antagonists|mesh-ancestor
83398535|NCT05685719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398537|NCT05685719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83398538|NCT05685719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83398539|NCT05685719|Antitubercular Agents|antitubercular agents|mesh-ancestor
83398540|NCT05685719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83398541|NCT05685719|Leprostatic Agents|leprostatic agents|mesh-ancestor
83398542|NCT05685719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83398543|NCT05685719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83398544|NCT05685719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83398545|NCT05685719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83398546|NCT05685719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83398547|NCT05685719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83398548|NCT05685719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83398550|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
83398551|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83398552|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83398553|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83398554|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83398555|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398556|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83398557|NCT01218399|Budesonide|budesonide|mesh-list
83398558|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83398559|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83398560|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83398561|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
83398562|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398563|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398564|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83398565|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
83398566|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
83398567|NCT01218399|Hormones|hormones|mesh-ancestor
83398568|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398569|NCT01219881|Sevoflurane|sevoflurane|mesh-list
83398570|NCT01219881|Desflurane|desflurane|mesh-list
83398571|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83398572|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83398573|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
83398574|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
83398575|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398576|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398577|NCT01220973|Celecoxib|celecoxib|mesh-list
83398578|NCT01220973|Atorvastatin|atorvastatin|mesh-list
83398579|NCT01220973|Calcium|calcium|mesh-list
83398580|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83398581|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398582|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83398583|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83398584|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
83398585|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398586|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83398587|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83398588|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398589|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83398590|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83398591|NCT01220973|Analgesics|analgesics|mesh-ancestor
83398592|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
83398593|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398594|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83398595|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83398596|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83398597|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83398598|NCT05375747|Propofol|propofol|mesh-list
83398599|NCT05375747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83398600|NCT05375747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398601|NCT05375747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398602|NCT05375747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83398603|NCT05375747|Anesthetics, General|anesthetics, general|mesh-ancestor
83398604|NCT05375747|Anesthetics|anesthetics|mesh-ancestor
83398605|NCT01221207|Calpastatin|calpastatin|mesh-list
83398606|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83398614|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398615|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83398616|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83398617|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398618|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83398619|NCT05338619|Lazertinib|lazertinib|mesh-list
83398620|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83398621|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398622|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398623|NCT03289949|Ketanserin|ketanserin|mesh-list
83398624|NCT03289949|Psilocybin|psilocybin|mesh-list
83398625|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
83398626|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398627|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83398628|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83398629|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83398630|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83398631|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
83398632|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83398633|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398634|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
83398635|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83398636|NCT04400045|Treosulfan|treosulfan|mesh-list
83398637|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83398638|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
83398639|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398640|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398641|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83398642|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398643|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83398644|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398645|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398646|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83398647|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83398648|NCT01153581|Estradiol|estradiol|mesh-list
83398649|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83398650|NCT01153581|Progesterone|progesterone|mesh-list
83398651|NCT01153581|Ganirelix|ganirelix|mesh-list
83398652|NCT01153581|Estrogens|estrogens|mesh-ancestor
83398653|NCT01153581|Hormones|hormones|mesh-ancestor
83398654|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398655|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398656|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83398657|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
83398658|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83398659|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83398660|NCT01153581|Progestins|progestins|mesh-ancestor
83398661|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
83398662|NCT04278599|Zinc|zinc|mesh-list
83398663|NCT04278599|Trace Elements|trace elements|mesh-ancestor
83398664|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
83398665|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398666|NCT05277623|Mannitol|mannitol|mesh-list
83398667|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83398668|NCT05277623|Diuretics|diuretics|mesh-ancestor
83398669|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
83398670|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398671|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83398672|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83398673|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83398674|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398675|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398676|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83398677|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83398678|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398679|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
83398680|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83398681|NCT04760327|Cisplatin|cisplatin|mesh-list
83398682|NCT04760327|Bleomycin|bleomycin|mesh-list
83398683|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398684|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83398685|NCT01225263|Vitamin D|vitamin d|mesh-list
83398686|NCT01225263|Simvastatin|simvastatin|mesh-list
83398687|NCT01225263|Vitamins|vitamins|mesh-ancestor
83398688|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
83398689|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398690|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83398691|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83398692|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83398693|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
83398694|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398695|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83398696|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83398697|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398698|NCT04278287|Paclitaxel|paclitaxel|mesh-list
83398699|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83398700|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83398701|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398702|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
83398703|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
83398704|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
83398705|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398706|NCT05162027|Erenumab|erenumab|mesh-list
83398707|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83398708|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398709|NCT05162027|Analgesics|analgesics|mesh-ancestor
83398710|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
83398711|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398712|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398713|NCT03278717|Olaparib|olaparib|mesh-list
83398714|NCT03278717|Cediranib|cediranib|mesh-list
83398715|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83398716|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398717|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398718|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398719|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83398720|NCT01227993|Finasteride|finasteride|mesh-list
83398721|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83398722|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83398723|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398724|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398725|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
83398726|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398727|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398728|NCT01227993|Urological Agents|urological agents|mesh-ancestor
83398729|NCT01155999|Tobramycin|tobramycin|mesh-list
83398730|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83398731|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398732|NCT03275597|Durvalumab|durvalumab|mesh-list
83398733|NCT03275597|Tremelimumab|tremelimumab|mesh-list
83398734|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83398735|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398736|NCT01228149|Acetazolamide|acetazolamide|mesh-list
83398737|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
83398738|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83398739|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398740|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398741|NCT01228149|Diuretics|diuretics|mesh-ancestor
83398742|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
83398743|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398744|NCT04989413|Dronabinol|dronabinol|mesh-list
83398745|NCT04989413|Cannabidiol|cannabidiol|mesh-list
83398746|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
83398747|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
83398748|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398749|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83398750|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83398751|NCT04989413|Analgesics|analgesics|mesh-ancestor
83398752|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
83398753|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398754|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83398755|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83398756|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83398757|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398758|NCT04989413|Hormones|hormones|mesh-ancestor
83398759|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83398760|NCT04986839|Acetaminophen|acetaminophen|mesh-list
83398761|NCT04986839|Ibuprofen|ibuprofen|mesh-list
83398762|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83398763|NCT04986839|Analgesics|analgesics|mesh-ancestor
83398764|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
83398765|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398766|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398767|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
83398768|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83398769|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83398770|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83398771|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83398772|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398773|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398774|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
83398775|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83398776|NCT02192541|Aflibercept|aflibercept|mesh-list
83398777|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83398778|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83398779|NCT02192541|Growth Substances|growth substances|mesh-ancestor
83398780|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398781|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
83398782|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398783|NCT01156701|Zanamivir|zanamivir|mesh-list
83398784|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
83398785|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398786|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398787|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398788|NCT03266081|Bupivacaine|bupivacaine|mesh-list
83398789|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
83398790|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
83398791|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398792|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398793|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
83398794|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398795|NCT03010995|Prazosin|prazosin|mesh-list
83398796|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83398797|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83398798|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83398799|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83398800|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
83398801|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83398802|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398803|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398804|NCT01230177|Etanercept|etanercept|mesh-list
83398805|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83398806|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83398807|NCT01230177|Analgesics|analgesics|mesh-ancestor
83398808|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
83398809|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398810|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398811|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83398812|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83398813|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83398814|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398815|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
83398816|NCT02984657|Anesthetics|anesthetics|mesh-list
83398817|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398818|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398819|NCT01158651|Everolimus|everolimus|mesh-list
83398820|NCT01158651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83398821|NCT01158651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83398822|NCT01158651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398823|NCT01158651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398824|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398825|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
83398826|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398827|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398828|NCT04852679|Lanreotide|lanreotide|mesh-list
83398829|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398830|NCT04826393|Cemiplimab|cemiplimab|mesh-list
83398831|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83398832|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398833|NCT03262103|Poly I-C|poly i-c|mesh-list
83398834|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83398835|NCT03262103|Poly ICLC|poly iclc|mesh-list
83398836|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
83398837|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
83398838|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398867|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398868|NCT04731467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83398869|NCT04731467|Antimetabolites|antimetabolites|mesh-ancestor
83398870|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83398871|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83398872|NCT04731467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398873|NCT04731467|Immunologic Factors|immunologic factors|mesh-ancestor
83398874|NCT04731467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398875|NCT04685915|Acalabrutinib|acalabrutinib|mesh-list
83398876|NCT04685915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398877|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83398878|NCT04399187|Eusol|eusol|mesh-list
83398879|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
83398880|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398881|NCT03240809|Brodalumab|brodalumab|mesh-list
83398882|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83398883|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
83398884|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
83398885|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398886|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
83398887|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83398888|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398889|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
83398890|NCT04746365|Ivermectin|ivermectin|mesh-list
83398891|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
83398892|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83398893|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83398894|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398895|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398896|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398897|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83398898|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
83398899|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83398900|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398901|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398902|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83398903|NCT04399343|Analgesics|analgesics|mesh-ancestor
83398904|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
83398905|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398906|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83398907|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83398908|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83398909|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
83398910|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83398911|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398912|NCT03676049|Cannabidiol|cannabidiol|mesh-list
83398913|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
83398914|NCT03233633|Cannabidiol|cannabidiol|mesh-list
83398915|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
83398916|NCT02984345|Caseins|caseins|mesh-list
83398917|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
83398918|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
83398919|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398920|NCT01232205|Micronutrients|micronutrients|mesh-list
83398921|NCT01232205|Trace Elements|trace elements|mesh-list
83398922|NCT01232205|Antioxidants|antioxidants|mesh-list
83398923|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398924|NCT01232205|Protective Agents|protective agents|mesh-ancestor
83398925|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398926|NCT04584125|Riboflavin|riboflavin|mesh-list
83398927|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
83398928|NCT04584125|Dextrans|dextrans|mesh-list
83398929|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83398930|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83398931|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
83398932|NCT04584125|Vitamins|vitamins|mesh-ancestor
83398933|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
83398934|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398935|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83398936|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
83398937|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
83398938|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
83398939|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
83398940|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
83398941|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83398942|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398943|NCT01158885|Cytarabine|cytarabine|mesh-list
83398944|NCT01158885|Methotrexate|methotrexate|mesh-list
83398945|NCT01158885|Clofarabine|clofarabine|mesh-list
83398946|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83398947|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
83398948|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83398949|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398950|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83398951|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
83398952|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398953|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398954|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
83398955|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398956|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83398957|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398958|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
83398959|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83398960|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83398961|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
83398962|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398963|NCT01232829|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83398964|NCT01232829|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83398965|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398966|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398967|NCT01233921|Mitogens|mitogens|mesh-list
83398968|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83398969|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398970|NCT03367013|Lactoferrin|lactoferrin|mesh-list
83398971|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398972|NCT03226301|Venetoclax|venetoclax|mesh-list
83398973|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398974|NCT01236105|Charcoal|charcoal|mesh-list
83398975|NCT01236105|Antidotes|antidotes|mesh-ancestor
83398976|NCT01236105|Protective Agents|protective agents|mesh-ancestor
83398977|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398978|NCT04533347|Tafenoquine|tafenoquine|mesh-list
83398979|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
83398980|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83398981|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83398982|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398983|NCT01160445|Aldesleukin|aldesleukin|mesh-list
83398984|NCT01160445|Zanolimumab|zanolimumab|mesh-list
83398985|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398986|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83398987|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83398988|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
83398989|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398990|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83398992|NCT01237041|Niacinamide|niacinamide|mesh-list
83398993|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
83398994|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83398995|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
83398996|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398997|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83398998|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
83398999|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
83399000|NCT01237041|Vitamins|vitamins|mesh-ancestor
83399001|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
83399002|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399003|NCT01237197|Exenatide|exenatide|mesh-list
83399004|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83399005|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399006|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83399007|NCT01237197|Incretins|incretins|mesh-ancestor
83399008|NCT01237197|Hormones|hormones|mesh-ancestor
83399009|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83399010|NCT01237353|Rabeprazole|rabeprazole|mesh-list
83399011|NCT01237353|Betaine|betaine|mesh-list
83399012|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83399013|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83399014|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83399015|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399016|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399017|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
83399018|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83399019|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
83399020|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83399021|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
83399023|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399024|NCT03634241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83399025|NCT03634241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399026|NCT04410341|Vildagliptin|vildagliptin|mesh-list
83399027|NCT04410341|Escitalopram|escitalopram|mesh-list
83399028|NCT04410341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83399029|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83399030|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83399031|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399032|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399033|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
83399034|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399035|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83399036|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83399037|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
83399038|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399039|NCT03010761|Moclobemide|moclobemide|mesh-list
83399040|NCT03010761|Escitalopram|escitalopram|mesh-list
83399041|NCT03010761|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83399042|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83399043|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83399044|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399045|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399046|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
83399047|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399048|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
83399049|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83399050|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83399051|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399052|NCT01243593|Anesthetics|anesthetics|mesh-list
83399053|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399054|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399055|NCT04362761|Ivacaftor|ivacaftor|mesh-list
83399056|NCT04362761|Elexacaftor|elexacaftor|mesh-list
83399057|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83399058|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83399059|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399060|NCT01162005|Tacrolimus|tacrolimus|mesh-list
83399061|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83399062|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
83399063|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399064|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83399065|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399066|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399067|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
83399068|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83399069|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
83399070|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399071|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
83399072|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
83399073|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83399074|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83399075|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399076|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399077|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399078|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83399079|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83399080|NCT01244451|Ofatumumab|ofatumumab|mesh-list
83399081|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83399082|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
83399083|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399084|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399085|NCT05632211|Golimumab|golimumab|mesh-list
83399086|NCT05632211|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83399087|NCT05632211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83399088|NCT05632211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83399089|NCT05632211|Immunologic Factors|immunologic factors|mesh-ancestor
83399090|NCT05632211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399091|NCT01246401|Naltrexone|naltrexone|mesh-list
83399092|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83399093|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83399095|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
83399096|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399097|NCT05627375|Anticoagulants|anticoagulants|mesh-list
83399098|NCT01281501|Scopolamine|scopolamine|mesh-list
83399099|NCT01281501|Pantoprazole|pantoprazole|mesh-list
83399100|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
83399101|NCT01281501|Antacids|antacids|mesh-list
83399102|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83399103|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83399104|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83399105|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399106|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399107|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83399108|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
83399109|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
83399110|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399111|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399112|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
83399113|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83399114|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
83399115|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399116|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83399117|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
83399118|NCT03353831|Bevacizumab|bevacizumab|mesh-list
83399119|NCT03353831|Atezolizumab|atezolizumab|mesh-list
83399120|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83399121|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399122|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83399123|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83399124|NCT03353831|Growth Substances|growth substances|mesh-ancestor
83399125|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399126|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
83399127|NCT03353831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83399128|NCT03353831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399129|NCT01246713|Acetaminophen|acetaminophen|mesh-list
83399130|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83399131|NCT01246713|Analgesics|analgesics|mesh-ancestor
83399132|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
83399133|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399134|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399135|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
83399136|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83399137|NCT01246791|Norethindrone|norethindrone|mesh-list
83399138|NCT01246791|Norinyl|norinyl|mesh-list
83399139|NCT01246791|Estradiol|estradiol|mesh-list
83399140|NCT01246791|Estrogens|estrogens|mesh-ancestor
83399141|NCT01246791|Hormones|hormones|mesh-ancestor
83399142|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83399143|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399144|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83399145|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
83399146|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83399147|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83399148|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83399149|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83399150|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83399151|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83399152|NCT04319081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83399153|NCT04319081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83399154|NCT04319081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83399155|NCT04319081|Antimetabolites|antimetabolites|mesh-ancestor
83399156|NCT04319081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399157|NCT04319081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83399158|NCT04319081|Protease Inhibitors|protease inhibitors|mesh-ancestor
83399159|NCT04319081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399160|NCT04319081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83399161|NCT05345639|Ropivacaine|ropivacaine|mesh-list
83399162|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
83399163|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399164|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399165|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
83399166|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
83399167|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399168|NCT05617313|Pembrolizumab|pembrolizumab|mesh-list
83399169|NCT05617313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83399170|NCT05617313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399171|NCT05617313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83399172|NCT05617313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399173|NCT04303325|Esketamine|esketamine|mesh-list
83399174|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
83399175|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83399176|NCT04248335|Midazolam|midazolam|mesh-list
83399177|NCT04248335|Pantoprazole|pantoprazole|mesh-list
83399178|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83399179|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83399180|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399181|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399182|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83399183|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83399184|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83399185|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83399186|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
83399187|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
83399188|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
83399189|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
83399190|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399191|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399192|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83399193|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83399194|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83399195|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399196|NCT04746209|Blinatumomab|blinatumomab|mesh-list
83399197|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399198|NCT04176419|Acetaminophen|acetaminophen|mesh-list
83399199|NCT04176419|Celecoxib|celecoxib|mesh-list
83399200|NCT04176419|Lidocaine|lidocaine|mesh-list
83399201|NCT04176419|Ketamine|ketamine|mesh-list
83399202|NCT04176419|Gabapentin|gabapentin|mesh-list
83399203|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
83399204|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
83399205|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399206|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399207|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
83399208|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399209|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83399210|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83399211|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83399212|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83399213|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399214|NCT04176419|Analgesics|analgesics|mesh-ancestor
83399215|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83399216|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83399217|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
83399218|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83399219|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83399220|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399221|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83399222|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
83399223|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83399224|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83399225|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83399226|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83399227|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83399228|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399229|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
83399230|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83399231|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83399232|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83399233|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
83399234|NCT04168931|Trastuzumab|trastuzumab|mesh-list
83399235|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83399236|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399237|NCT04165967|Nivolumab|nivolumab|mesh-list
83399238|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83399239|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399240|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83399241|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399242|NCT03211949|Mepivacaine|mepivacaine|mesh-list
83399243|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
83399244|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
83399841|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83399245|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399246|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399247|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
83399248|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399249|NCT01285635|Docetaxel|docetaxel|mesh-list
83399250|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399251|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
83399252|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
83399253|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
83399254|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399255|NCT01286259|Disulfiram|disulfiram|mesh-list
83399256|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83399257|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83399258|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399259|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399260|NCT01286805|Bupivacaine|bupivacaine|mesh-list
83399261|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
83399262|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
83399263|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399264|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399265|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
83399266|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399267|NCT01288521|Ketoconazole|ketoconazole|mesh-list
83399268|NCT01288521|Tacrolimus|tacrolimus|mesh-list
83399269|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83399270|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
83399271|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399272|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83399273|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399274|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399275|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
83399276|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399277|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83399278|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83399279|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83399280|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
83399281|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83399282|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83399283|NCT00632749|Cytarabine|cytarabine|mesh-list
83399284|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83399285|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
83399286|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399287|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399288|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
83399289|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399290|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83399291|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
83399292|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399293|NCT01289067|Satraplatin|satraplatin|mesh-list
83399294|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399295|NCT01248585|Dexamethasone|dexamethasone|mesh-list
83399296|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83399297|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
83399298|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
83399299|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399300|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399301|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83399302|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
83399303|NCT01248585|Hormones|hormones|mesh-ancestor
83399304|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83399305|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83399306|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399307|NCT00632359|Lenalidomide|lenalidomide|mesh-list
83399308|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
83399309|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399310|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83399311|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83399312|NCT00632359|Growth Substances|growth substances|mesh-ancestor
83399313|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
83399314|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399315|NCT03954899|Melatonin|melatonin|mesh-list
83399316|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
83399317|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399318|NCT03954899|Protective Agents|protective agents|mesh-ancestor
83399319|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399320|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399322|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83399323|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83399324|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83399325|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399326|NCT03924635|Budesonide|budesonide|mesh-list
83399327|NCT03924635|Albuterol|albuterol|mesh-list
83399328|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
83399329|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83399330|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83399331|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83399332|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
83399333|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399334|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399335|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83399336|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
83399337|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
83399338|NCT03924635|Hormones|hormones|mesh-ancestor
83399339|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83399340|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83399341|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83399342|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83399343|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
83399344|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399345|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399346|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
83399347|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83399348|NCT04398251|Febuxostat|febuxostat|mesh-list
83399349|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
83399350|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83399351|NCT00632203|Temozolomide|temozolomide|mesh-list
83399352|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83399353|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
83399354|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399355|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399356|NCT01289457|Cytarabine|cytarabine|mesh-list
83399357|NCT01289457|Fludarabine|fludarabine|mesh-list
83399358|NCT01289457|Idarubicin|idarubicin|mesh-list
83399359|NCT01289457|Clofarabine|clofarabine|mesh-list
83399360|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399361|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83399362|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
83399363|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399364|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83399365|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
83399366|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399367|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
83399368|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399369|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83399370|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83399371|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83399372|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399373|NCT03830333|Metronidazole|metronidazole|mesh-list
83399374|NCT03830333|Meropenem|meropenem|mesh-list
83399375|NCT03830333|Tazobactam|tazobactam|mesh-list
83399376|NCT03830333|Ceftolozane|ceftolozane|mesh-list
83399377|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83399378|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399379|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83399380|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83399381|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83399382|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83399383|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399384|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399385|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83399386|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
83399387|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83399388|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
83399389|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399390|NCT01251315|Expectorants|expectorants|mesh-ancestor
83399391|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
83399392|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83399393|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
83399394|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399395|NCT01251315|Protective Agents|protective agents|mesh-ancestor
83399396|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399397|NCT01251315|Antidotes|antidotes|mesh-ancestor
83399398|NCT03810287|Domperidone|domperidone|mesh-list
83399399|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
83399400|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
83399401|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399402|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399403|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83399404|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83399405|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
83399406|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399407|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399408|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
83399409|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83399410|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
83399411|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83399412|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
83399413|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399414|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399415|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
83399416|NCT01290237|Vancomycin|vancomycin|mesh-list
83399417|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83399418|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399419|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
83399420|NCT03613727|Vitamins|vitamins|mesh-ancestor
83399421|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
83399422|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399423|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
83399424|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399425|NCT03613727|Protective Agents|protective agents|mesh-ancestor
83399426|NCT01251393|Biperiden|biperiden|mesh-list
83399427|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83399428|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83399429|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
83399430|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
83399431|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399432|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399433|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83399434|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83399435|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
83399436|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399437|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399438|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83399439|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
83399440|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83399441|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83399442|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399443|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399444|NCT00631969|Urological Agents|urological agents|mesh-ancestor
83399445|NCT01255137|Axitinib|axitinib|mesh-list
83399446|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399447|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83399448|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399449|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399450|NCT01255449|Albuterol|albuterol|mesh-list
83399451|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83399452|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
83399453|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399454|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399455|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83399456|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
83399457|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
83399458|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83399459|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83399460|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83399461|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83399462|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
83399463|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399464|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399465|NCT00631657|Mirtazapine|mirtazapine|mesh-list
83399466|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
83399467|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83399468|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83399470|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
83399471|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399472|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399473|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399474|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83399475|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83399476|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399477|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83399478|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83399479|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83399480|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
83399481|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83399482|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83399483|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
83399484|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83399485|NCT01257087|Insulin|insulin|mesh-list
83399486|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83399487|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
83399488|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83399489|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399490|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
83399491|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83399492|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399493|NCT03106415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83399494|NCT03106415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399495|NCT00631189|Atorvastatin|atorvastatin|mesh-list
83399496|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83399497|NCT00631189|Pravastatin|pravastatin|mesh-list
83399498|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83399499|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83399500|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
83399501|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399502|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83399503|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83399504|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399505|NCT00630877|Aspirin|aspirin|mesh-list
83399506|NCT00630877|Niacin|niacin|mesh-list
83399507|NCT00630877|Niacinamide|niacinamide|mesh-list
83399508|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
83399509|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83399510|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83399511|NCT00630877|Analgesics|analgesics|mesh-ancestor
83399512|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
83399513|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399514|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399515|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83399516|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83399517|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83399518|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83399519|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399520|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83399521|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83399522|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399523|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
83399524|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83399525|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
83399526|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83399527|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
83399528|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
83399529|NCT00630877|Vitamins|vitamins|mesh-ancestor
83399530|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
83399531|NCT04557163|Itraconazole|itraconazole|mesh-list
83399532|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
83399533|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399534|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83399535|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83399536|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399537|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399538|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83399539|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
83399540|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83399541|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399543|NCT02915783|Everolimus|everolimus|mesh-list
83399544|NCT02915783|Lenvatinib|lenvatinib|mesh-list
83399545|NCT02915783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83399546|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83399547|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399548|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399549|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83399550|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
83399551|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399552|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399553|NCT02736149|Ubenimex|ubenimex|mesh-list
83399554|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83399555|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
83399556|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399557|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83399558|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399559|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83399560|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399561|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
83399562|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399563|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399564|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83399565|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83399566|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
83399567|NCT02307149|Ipilimumab|ipilimumab|mesh-list
83399568|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83399569|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399570|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83399571|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399572|NCT02134301|Oritavancin|oritavancin|mesh-list
83399573|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83399574|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399575|NCT04397393|Midazolam|midazolam|mesh-list
83399576|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83399577|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83399578|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399579|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399580|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83399581|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83399582|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83399583|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83399584|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
83399585|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
83399586|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
83399587|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
83399588|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399589|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399590|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
83399591|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83399592|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399594|NCT01176461|Vaccines|vaccines|mesh-list
83399595|NCT01176461|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83399596|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
83399597|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399598|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83399599|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399600|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83399601|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399602|NCT01176461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83399603|NCT00630331|Vaccines|vaccines|mesh-list
83399604|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
83399605|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399606|NCT04555291|Ropivacaine|ropivacaine|mesh-list
83399607|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
83399608|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
83399609|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399610|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399611|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
83399612|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399613|NCT04275115|Midazolam|midazolam|mesh-list
83399614|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83399615|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83399616|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399617|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399618|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83399619|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83399620|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83399621|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83399622|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
83399623|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
83399624|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
83399625|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
83399626|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399627|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399628|NCT00633997|Vildagliptin|vildagliptin|mesh-list
83399629|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83399630|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399631|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83399632|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
83399633|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399634|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399635|NCT04559347|Bupivacaine|bupivacaine|mesh-list
83399636|NCT04559347|Ropivacaine|ropivacaine|mesh-list
83399637|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
83399638|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
83399639|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399640|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399641|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
83399642|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399643|NCT00631111|Aspirin|aspirin|mesh-list
83399644|NCT00631111|Ibuprofen|ibuprofen|mesh-list
83399645|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399646|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83399647|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83399648|NCT00631111|Analgesics|analgesics|mesh-ancestor
83399649|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
83399650|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399651|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83399652|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83399653|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83399654|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83399655|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399656|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83399657|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83399658|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399659|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
83399660|NCT00630799|Leuprolide|leuprolide|mesh-list
83399661|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83399662|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
83399663|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83399664|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399665|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83399666|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399667|NCT01925287|Curcumin|curcumin|mesh-list
83399668|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83399669|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83399670|NCT01925287|Analgesics|analgesics|mesh-ancestor
83399671|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
83399672|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399673|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399674|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83399675|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83399676|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399677|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399678|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399679|NCT01924273|Talaporfin|talaporfin|mesh-list
83399680|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399681|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83399682|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
83399683|NCT00667121|Tamoxifen|tamoxifen|mesh-list
83399684|NCT00667121|Gabapentin|gabapentin|mesh-list
83399685|NCT00667121|Dexetimide|dexetimide|mesh-list
83399686|NCT00667121|Citalopram|citalopram|mesh-list
83399687|NCT00667121|Sertraline|sertraline|mesh-list
83399688|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83399689|NCT00667121|Escitalopram|escitalopram|mesh-list
83399690|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399691|NCT00667121|Analgesics|analgesics|mesh-ancestor
83399692|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
83399693|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399694|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399695|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
83399696|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83399697|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83399698|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399699|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83399700|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83399701|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83399702|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399703|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
83399704|NCT00667121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83399705|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83399706|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83399707|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
83399708|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83399709|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83399710|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
83399711|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
83399712|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83399713|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83399714|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
83399715|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83399716|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
83399717|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83399718|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
83399719|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83399720|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83399721|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399722|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83399723|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83399724|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83399725|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83399726|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
83399727|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83399728|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
83399729|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399730|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
83399731|NCT04276649|Antacids|antacids|mesh-ancestor
83399732|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399733|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83399734|NCT04553419|Cephalexin|cephalexin|mesh-list
83399735|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83399736|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399737|NCT03097783|Lidocaine|lidocaine|mesh-list
83399738|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
83399739|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
83399740|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399741|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399742|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
83399743|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399744|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83399745|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83399746|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83399747|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83399748|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399749|NCT04346407|Dronabinol|dronabinol|mesh-list
83399750|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
83399751|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399752|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83399753|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83399754|NCT04346407|Analgesics|analgesics|mesh-ancestor
83399755|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
83399756|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399757|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83399758|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83399759|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399760|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399761|NCT04346407|Hormones|hormones|mesh-ancestor
83399762|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83399763|NCT04397549|Morphine|morphine|mesh-list
83399764|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83399765|NCT04397549|Narcotics|narcotics|mesh-ancestor
83399842|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83399766|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399767|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399768|NCT04397549|Analgesics|analgesics|mesh-ancestor
83399769|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
83399770|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399771|NCT03080441|Midodrine|midodrine|mesh-list
83399772|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
83399773|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
83399774|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399775|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399776|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83399777|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83399778|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83399779|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83399780|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
83399781|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399782|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399783|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
83399784|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83399785|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
83399786|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83399787|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
83399788|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399789|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399790|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
83399791|NCT01920919|Dexamethasone|dexamethasone|mesh-list
83399792|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83399793|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
83399794|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
83399795|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399796|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399797|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83399798|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
83399799|NCT01920919|Hormones|hormones|mesh-ancestor
83399800|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83399801|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83399802|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399803|NCT01925911|Midazolam|midazolam|mesh-list
83399804|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83399805|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83399806|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399807|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399808|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83399809|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83399810|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83399811|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83399812|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
83399813|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
83399814|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
83399815|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
83399816|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399817|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399818|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83399819|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399820|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83399821|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399822|NCT01921231|Bupivacaine|bupivacaine|mesh-list
83399823|NCT01921231|Prilocaine|prilocaine|mesh-list
83399824|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
83399825|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
83399826|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399827|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399828|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
83399829|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399830|NCT03056833|Paclitaxel|paclitaxel|mesh-list
83399831|NCT03056833|Carboplatin|carboplatin|mesh-list
83399832|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83399833|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399834|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
83399835|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
83399836|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
83399837|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399838|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83399839|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
83399840|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83399843|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399844|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399845|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
83399846|NCT03148457|Apixaban|apixaban|mesh-list
83399847|NCT03148457|Edoxaban|edoxaban|mesh-list
83399848|NCT03148457|Dabigatran|dabigatran|mesh-list
83399849|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83399850|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
83399851|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83399852|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
83399853|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399854|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399855|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
83399856|NCT01926379|Isoniazid|isoniazid|mesh-list
83399857|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
83399858|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83399859|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399860|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83399861|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83399862|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
83399863|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399864|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83399865|NCT05249309|Ketamine|ketamine|mesh-list
83399866|NCT05249309|Analgesics|analgesics|mesh-ancestor
83399867|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
83399868|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399869|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399870|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83399871|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83399872|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
83399873|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
83399874|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399875|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83399876|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83399877|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399878|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399879|NCT02393183|Selenium|selenium|mesh-list
83399880|NCT02393183|Antioxidants|antioxidants|mesh-list
83399881|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399882|NCT02393183|Protective Agents|protective agents|mesh-ancestor
83399883|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399884|NCT02393183|Trace Elements|trace elements|mesh-ancestor
83399885|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
83399886|NCT05599295|Oritavancin|oritavancin|mesh-list
83399887|NCT05599295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83399888|NCT05599295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399889|NCT03351647|Ustekinumab|ustekinumab|mesh-list
83399890|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
83399892|NCT05601271|Antimetabolites|antimetabolites|mesh-ancestor
83399893|NCT05601271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399894|NCT05601271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399895|NCT05601271|Gout Suppressants|gout suppressants|mesh-ancestor
83399896|NCT05601271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83399897|NCT05601271|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83399898|NCT05601271|Antioxidants|antioxidants|mesh-ancestor
83399899|NCT05601271|Protective Agents|protective agents|mesh-ancestor
83399900|NCT05601271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399901|NCT02392637|Paclitaxel|paclitaxel|mesh-list
83399902|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83399903|NCT02392637|Cisplatin|cisplatin|mesh-list
83399904|NCT02392637|Gemcitabine|gemcitabine|mesh-list
83399905|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83399906|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399907|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
83399908|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
83399909|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
83399910|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399911|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83399912|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
83399913|NCT05600881|Methylphenidate|methylphenidate|mesh-list
83399914|NCT05600881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83399915|NCT05600881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399916|NCT05600881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83399917|NCT05600881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83399918|NCT05600881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83399995|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399919|NCT05600881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399920|NCT05600881|Dopamine Agents|dopamine agents|mesh-ancestor
83399921|NCT05600881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83399922|NCT01926769|Metformin|metformin|mesh-list
83399923|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83399924|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399925|NCT04394143|Mannitol|mannitol|mesh-list
83399926|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83399927|NCT04394143|Diuretics|diuretics|mesh-ancestor
83399928|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
83399929|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399930|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83399931|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
83399932|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399933|NCT01926847|Riociguat|riociguat|mesh-list
83399934|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
83399935|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399936|NCT05586815|Minocycline|minocycline|mesh-list
83399937|NCT05586815|Colistin|colistin|mesh-list
83399938|NCT05586815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83399939|NCT05586815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83399940|NCT05607901|Hydrocortisone|hydrocortisone|mesh-list
83399941|NCT05607901|Tacrolimus|tacrolimus|mesh-list
83399942|NCT05607901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83399943|NCT05607901|Immunologic Factors|immunologic factors|mesh-ancestor
83399944|NCT05607901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399945|NCT05607901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83399946|NCT05607901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83399947|NCT05607901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399948|NCT05607901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83399949|NCT05604859|Methylprednisolone|methylprednisolone|mesh-list
83399950|NCT05604859|Heparin|heparin|mesh-list
83399951|NCT05604859|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83399952|NCT05604859|Tinzaparin|tinzaparin|mesh-list
83399953|NCT05604859|Dalteparin|dalteparin|mesh-list
83399954|NCT05604859|Immunoglobulins|immunoglobulins|mesh-list
83399955|NCT05604859|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83399956|NCT05604859|gamma-Globulins|gamma-globulins|mesh-list
83399957|NCT05604859|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83399958|NCT05604859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83399959|NCT05604859|Antiemetics|antiemetics|mesh-ancestor
83399960|NCT05604859|Autonomic Agents|autonomic agents|mesh-ancestor
83399961|NCT05604859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399962|NCT05604859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399963|NCT05604859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83399964|NCT05604859|Glucocorticoids|glucocorticoids|mesh-ancestor
83399965|NCT05604859|Hormones|hormones|mesh-ancestor
83399966|NCT05604859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83399967|NCT05604859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83399968|NCT05604859|Protective Agents|protective agents|mesh-ancestor
83399969|NCT05604859|Anticoagulants|anticoagulants|mesh-ancestor
83399970|NCT05604859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83399971|NCT05604859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83399972|NCT05604859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399973|NCT05604859|Immunologic Factors|immunologic factors|mesh-ancestor
83399974|NCT03133325|Lidocaine|lidocaine|mesh-list
83399975|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
83399976|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
83399977|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399978|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399979|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
83399980|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83399981|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83399982|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83399983|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83399984|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83399985|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399986|NCT00638963|Temozolomide|temozolomide|mesh-list
83399987|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83399988|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
83399989|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399990|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399991|NCT04278677|Melatonin|melatonin|mesh-list
83399992|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
83399993|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83399994|NCT04278677|Protective Agents|protective agents|mesh-ancestor
83399996|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83399998|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83399999|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83400000|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
83400001|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400002|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400003|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400004|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83400005|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83400006|NCT03342911|Paclitaxel|paclitaxel|mesh-list
83400007|NCT03342911|Carboplatin|carboplatin|mesh-list
83400008|NCT03342911|Nivolumab|nivolumab|mesh-list
83400009|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83400010|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400011|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
83400012|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
83400013|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
83400014|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400015|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83400016|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83400017|NCT05607199|Calcium|calcium|mesh-list
83400018|NCT05607199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83400019|NCT05607199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400020|NCT01927315|Fenofibrate|fenofibrate|mesh-list
83400021|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83400022|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
83400023|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400024|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83400025|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
83400026|NCT00636155|Rituximab|rituximab|mesh-list
83400027|NCT00636155|Fludarabine|fludarabine|mesh-list
83400028|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83400029|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
83400030|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400031|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400032|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83400033|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
83400034|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400035|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400036|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83400037|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83400038|NCT00634907|Warfarin|warfarin|mesh-list
83400039|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
83400041|NCT04124497|Daratumumab|daratumumab|mesh-list
83400042|NCT04124497|Pomalidomide|pomalidomide|mesh-list
83400043|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83400044|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
83400045|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
83400046|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400047|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400048|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83400049|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
83400050|NCT04124497|Hormones|hormones|mesh-ancestor
83400051|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400052|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83400053|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400054|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
83400055|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83400056|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83400057|NCT04124497|Growth Substances|growth substances|mesh-ancestor
83400058|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
83400059|NCT04127851|Cyclosporine|cyclosporine|mesh-list
83400060|NCT04127851|Cyclosporins|cyclosporins|mesh-list
83400061|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400062|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400063|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83400064|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
83400065|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400066|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
83400067|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400068|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
83400069|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400070|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83400071|NCT04394533|Bupivacaine|bupivacaine|mesh-list
83400083|NCT05602129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83400084|NCT05602129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400085|NCT05609929|Omeprazole|omeprazole|mesh-list
83400086|NCT05609929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83400087|NCT05609929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83400088|NCT05609929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83400089|NCT05609929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400090|NCT05609929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400091|NCT01928563|Udenafil|udenafil|mesh-list
83400092|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83400093|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83400094|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400095|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400096|NCT04129255|Octreotide|octreotide|mesh-list
83400097|NCT04129255|Somatostatin|somatostatin|mesh-list
83400098|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83400099|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83400100|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400101|NCT04129255|Hormones|hormones|mesh-ancestor
83400102|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400103|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400104|NCT03044977|Octreotide|octreotide|mesh-list
83400105|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83400106|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83400107|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400108|NCT03422731|Alovudine|alovudine|mesh-list
83400109|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
83400110|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400111|NCT04129489|Cannabidiol|cannabidiol|mesh-list
83400112|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
83400113|NCT04128787|Omeprazole|omeprazole|mesh-list
83400114|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83400115|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83400116|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83400117|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400118|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400119|NCT04394377|Heparin|heparin|mesh-list
83400120|NCT04394377|Enoxaparin|enoxaparin|mesh-list
83400121|NCT04394377|Calcium heparin|calcium heparin|mesh-list
83400122|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
83400123|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
83400124|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
83400125|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83400126|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83400127|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400128|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83400129|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
83400130|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83400131|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
83400132|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400133|NCT02984293|Atorvastatin|atorvastatin|mesh-list
83400134|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83400135|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83400136|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
83400137|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400138|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83400139|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83400140|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400141|NCT01929187|Amorolfine|amorolfine|mesh-list
83400142|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
83400143|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400144|NCT00634751|Capecitabine|capecitabine|mesh-list
83400145|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
83400146|NCT00634751|Sorafenib|sorafenib|mesh-list
83400147|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83400148|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
83400149|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400150|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400151|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83400152|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400153|NCT04396223|Methotrexate|methotrexate|mesh-list
83400154|NCT04396223|Avelumab|avelumab|mesh-list
83400155|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83400156|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
83400157|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83400158|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400159|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83400162|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400163|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
83400164|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400165|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83400166|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83400167|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
83400168|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400169|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83400170|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83400171|NCT04396067|Tretinoin|tretinoin|mesh-list
83400172|NCT04396067|Isotretinoin|isotretinoin|mesh-list
83400173|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400174|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
83400175|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
83400176|NCT05608213|Lenvatinib|lenvatinib|mesh-list
83400177|NCT05608213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400178|NCT05608213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83400179|NCT05608213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400180|NCT05608213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400181|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83400182|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83400183|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400184|NCT03015259|Budesonide|budesonide|mesh-list
83400185|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
83400186|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83400187|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83400188|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83400189|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
83400190|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400191|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400192|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83400193|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
83400194|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
83400195|NCT03015259|Hormones|hormones|mesh-ancestor
83400196|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400197|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83400198|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83400199|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83400200|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
83400201|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400202|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400203|NCT03236545|Estradiol|estradiol|mesh-list
83400204|NCT03236545|Estrogens|estrogens|mesh-list
83400205|NCT03236545|Hormones|hormones|mesh-ancestor
83400206|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400207|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400208|NCT04126993|Apatinib|apatinib|mesh-list
83400209|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400210|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83400211|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400212|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400213|NCT04127227|Gemcitabine|gemcitabine|mesh-list
83400214|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
83400215|NCT04127227|Pegaspargase|pegaspargase|mesh-list
83400216|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83400217|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
83400218|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400219|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400220|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83400221|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83400222|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83400223|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83400224|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
83400225|NCT03292861|Sirolimus|sirolimus|mesh-list
83400226|NCT03292861|Tacrolimus|tacrolimus|mesh-list
83400227|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
83400228|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83400229|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
83400230|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400231|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83400232|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400233|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400234|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83400236|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83400237|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
83400238|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83400239|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400240|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
83400241|NCT03828175|Anesthetics|anesthetics|mesh-list
83400242|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400243|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400244|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
83400245|NCT04392973|Favipiravir|favipiravir|mesh-list
83400246|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
83400247|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83400248|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83400249|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400250|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400251|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400252|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400253|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
83400254|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
83400255|NCT03267277|Antidotes|antidotes|mesh-ancestor
83400256|NCT03267277|Protective Agents|protective agents|mesh-ancestor
83400257|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400258|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
83400259|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400260|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
83400261|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83400262|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400263|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
83400264|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
83400265|NCT00634049|Isavuconazole|isavuconazole|mesh-list
83400266|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
83400267|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400268|NCT04123249|Propofol|propofol|mesh-list
83400269|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
83400270|NCT04123249|Anesthetics|anesthetics|mesh-list
83400271|NCT04123249|Sevoflurane|sevoflurane|mesh-list
83400272|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83400273|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400274|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400275|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
83400276|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83400277|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83400278|NCT04758871|Progesterone|progesterone|mesh-list
83400279|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
83400280|NCT04758871|Progestins|progestins|mesh-ancestor
83400281|NCT04758871|Hormones|hormones|mesh-ancestor
83400282|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400283|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400284|NCT03336203|Allopurinol|allopurinol|mesh-list
83400285|NCT03336203|Febuxostat|febuxostat|mesh-list
83400286|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
83400287|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400288|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400289|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
83400290|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400291|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83400292|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
83400293|NCT03336203|Protective Agents|protective agents|mesh-ancestor
83400294|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400295|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
83400296|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400297|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400298|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400299|NCT04274257|Rituximab|rituximab|mesh-list
83400300|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83400301|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400302|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
83400303|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400304|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400305|NCT03128879|Venetoclax|venetoclax|mesh-list
83400306|NCT03128879|Acalabrutinib|acalabrutinib|mesh-list
83400307|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400308|NCT03831815|Rocuronium|rocuronium|mesh-list
83400309|NCT03831815|Cisatracurium|cisatracurium|mesh-list
83400310|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83400311|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83400312|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83400313|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400314|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400315|NCT00632099|Progesterone|progesterone|mesh-list
83400316|NCT00632099|Progestins|progestins|mesh-ancestor
83400317|NCT00632099|Hormones|hormones|mesh-ancestor
83400318|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400319|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400320|NCT03827629|Naloxone|naloxone|mesh-list
83400321|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83400322|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400323|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
83400324|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400325|NCT00631475|Bosentan|bosentan|mesh-list
83400326|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83400327|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83400328|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400329|NCT03826615|Gabapentin|gabapentin|mesh-list
83400330|NCT03826615|Analgesics|analgesics|mesh-ancestor
83400331|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
83400332|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400333|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400334|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
83400335|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83400336|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83400337|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400338|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83400339|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83400340|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83400341|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400342|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400343|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
83400344|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
83400345|NCT04124887|Listerine|listerine|mesh-list
83400346|NCT04124887|Calcium|calcium|mesh-list
83400347|NCT04124887|Fluorides|fluorides|mesh-list
83400348|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
83400349|NCT04124887|Caseins|caseins|mesh-list
83400350|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83400351|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400352|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83400353|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
83400354|NCT04124887|Protective Agents|protective agents|mesh-ancestor
83400355|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83400356|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400357|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
83400358|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
83400359|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400360|NCT04121767|Warfarin|warfarin|mesh-list
83400361|NCT04121767|Edoxaban|edoxaban|mesh-list
83400362|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
83400363|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83400364|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
83400365|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83400366|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
83400367|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400368|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400369|NCT04121689|Caseins|caseins|mesh-list
83400370|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
83400371|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
83400372|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400373|NCT03830827|Vortioxetine|vortioxetine|mesh-list
83400374|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
83400375|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83400376|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83400377|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83400378|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400379|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400380|NCT03830827|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83400381|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83400382|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83400383|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400384|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400385|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
83400386|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83400387|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83400388|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83400389|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83400390|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83400391|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400393|NCT03098485|Levofloxacin|levofloxacin|mesh-list
83400394|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
83400395|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
83400396|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83400397|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400398|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83400399|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83400400|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83400401|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400402|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400403|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400404|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83400405|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83400406|NCT04121533|Vitamin D|vitamin d|mesh-list
83400407|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
83400408|NCT04121533|Vitamins|vitamins|mesh-ancestor
83400409|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
83400410|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400411|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83400412|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83400413|NCT03822169|Choline|choline|mesh-list
83400414|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
83400415|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83400416|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
83400417|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400418|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83400419|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83400421|NCT03825601|Flumazenil|flumazenil|mesh-list
83400422|NCT03825601|Antidotes|antidotes|mesh-ancestor
83400423|NCT03825601|Protective Agents|protective agents|mesh-ancestor
83400424|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400425|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
83400426|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
83400427|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400428|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400429|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83400430|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83400431|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400432|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83400433|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83400434|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400435|NCT03064867|Rituximab|rituximab|mesh-list
83400436|NCT03064867|Carboplatin|carboplatin|mesh-list
83400437|NCT03064867|Etoposide|etoposide|mesh-list
83400438|NCT03064867|Venetoclax|venetoclax|mesh-list
83400439|NCT03064867|Ifosfamide|ifosfamide|mesh-list
83400440|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83400441|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400442|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
83400443|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400444|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400445|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83400446|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83400447|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83400448|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400449|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400450|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83400451|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
83400452|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83400453|NCT04120987|Lifitegrast|lifitegrast|mesh-list
83400454|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83400455|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
83400456|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83400457|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83400458|NCT03824665|Fentanyl|fentanyl|mesh-list
83400459|NCT03824665|Nalbuphine|nalbuphine|mesh-list
83400460|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83400461|NCT03824665|Narcotics|narcotics|mesh-ancestor
83400462|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400463|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400464|NCT03824665|Analgesics|analgesics|mesh-ancestor
83400465|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
83400466|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400467|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83400468|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83400469|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
83400470|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
83400471|NCT04120831|Abatacept|abatacept|mesh-list
83400472|NCT04120831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83400473|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400474|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
83400475|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400476|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400477|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83400478|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400479|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83400480|NCT00631163|Deferasirox|deferasirox|mesh-list
83400481|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83400482|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
83400483|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
83400484|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400485|NCT02677051|Sulforaphane|sulforaphane|mesh-list
83400486|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83400487|NCT02677051|Protective Agents|protective agents|mesh-ancestor
83400488|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400489|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400490|NCT04120519|Thalidomide|thalidomide|mesh-list
83400491|NCT04120519|Dexamethasone|dexamethasone|mesh-list
83400492|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
83400493|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83400494|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
83400495|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400496|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400497|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83400498|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
83400499|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400500|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400501|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83400502|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83400503|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
83400504|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
83400505|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400506|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83400507|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
83400508|NCT04120519|Hormones|hormones|mesh-ancestor
83400509|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400510|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83400511|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
83400512|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83400513|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400514|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83400515|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83400516|NCT04120519|Growth Substances|growth substances|mesh-ancestor
83400517|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
83400518|NCT00631007|Pioglitazone|pioglitazone|mesh-list
83400519|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83400520|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400521|NCT03014167|Albendazole|albendazole|mesh-list
83400522|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
83400523|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83400524|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400525|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
83400526|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83400527|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83400528|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
83400529|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
83400530|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
83400531|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400532|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400533|NCT00630539|Tamoxifen|tamoxifen|mesh-list
83400534|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83400535|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
83400536|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400537|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400538|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83400539|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400540|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83400541|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83400542|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83400543|NCT00634829|Albuterol|albuterol|mesh-list
83400544|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83400545|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
83400546|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400547|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400548|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83400549|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
83400550|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
83400551|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83400552|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83400553|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83400554|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83400555|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
83400556|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400557|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400558|NCT00634517|Albuterol|albuterol|mesh-list
83400559|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83400560|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
83400561|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400562|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400563|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83400564|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
83400565|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
83400566|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83400567|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83400569|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83400570|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
83400571|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400572|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400573|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83400574|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
83400575|NCT01920113|Remifentanil|remifentanil|mesh-list
83400576|NCT01920113|Propofol|propofol|mesh-list
83400577|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83400578|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400579|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400580|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83400581|NCT01920113|Analgesics|analgesics|mesh-ancestor
83400582|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
83400583|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400584|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83400585|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83400586|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83400587|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83400588|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400589|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400590|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83400591|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
83400592|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
83400593|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83400594|NCT01920113|Narcotics|narcotics|mesh-ancestor
83400595|NCT01920191|Poly ICLC|poly iclc|mesh-list
83400596|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
83400597|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
83400598|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400599|NCT01920269|Mitomycins|mitomycins|mesh-list
83400600|NCT01920269|Mitomycin|mitomycin|mesh-list
83400601|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83400602|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400603|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
83400604|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400605|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83400606|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400607|NCT02921893|Dexamethasone|dexamethasone|mesh-list
83400608|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
83400609|NCT02921893|Lenalidomide|lenalidomide|mesh-list
83400610|NCT02921893|Ixazomib|ixazomib|mesh-list
83400611|NCT02921893|Ichthammol|ichthammol|mesh-list
83400612|NCT02921893|BB 1101|bb 1101|mesh-list
83400613|NCT02921893|Glycine|glycine|mesh-list
83400614|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83400615|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
83400616|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
83400617|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400618|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400619|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83400620|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
83400621|NCT02921893|Hormones|hormones|mesh-ancestor
83400622|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400623|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83400624|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400625|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
83400626|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400627|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400628|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
83400629|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83400630|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83400631|NCT02921893|Growth Substances|growth substances|mesh-ancestor
83400632|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
83400633|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
83400634|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
83400635|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400636|NCT01920503|Doxorubicin|doxorubicin|mesh-list
83400637|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83400638|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400639|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83400640|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83400641|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400642|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400643|NCT01293825|Ziprasidone|ziprasidone|mesh-list
83400644|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83400645|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
83400646|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400647|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400648|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400649|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83400650|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83400651|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400652|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83400653|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83400654|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
83400655|NCT03009513|Glimepiride|glimepiride|mesh-list
83400656|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83400657|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83400658|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400659|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83400660|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
83400661|NCT02983591|Misoprostol|misoprostol|mesh-list
83400662|NCT02983591|Oxytocin|oxytocin|mesh-list
83400663|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
83400664|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83400665|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400666|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83400667|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
83400668|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83400669|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83400670|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
83400671|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83400672|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400673|NCT03115151|Fentanyl|fentanyl|mesh-list
83400674|NCT03115151|Hydromorphone|hydromorphone|mesh-list
83400675|NCT03115151|Bupivacaine|bupivacaine|mesh-list
83400676|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
83400677|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
83400678|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400679|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400680|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
83400681|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400682|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83400683|NCT03115151|Narcotics|narcotics|mesh-ancestor
83400684|NCT03115151|Analgesics|analgesics|mesh-ancestor
83400685|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83400686|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83400687|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
83400688|NCT01263717|Hormones|hormones|mesh-list
83400689|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
83400690|NCT01263717|Tesamorelin|tesamorelin|mesh-list
83400691|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400693|NCT01263717|Growth Substances|growth substances|mesh-ancestor
83400694|NCT04120753|Amlodipine|amlodipine|mesh-list
83400695|NCT04120753|Olmesartan|olmesartan|mesh-list
83400696|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83400697|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83400698|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83400699|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400700|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83400701|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400702|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
83400703|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83400704|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83400705|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
83400706|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
83400707|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83400708|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400709|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400710|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83400711|NCT01921361|Analgesics|analgesics|mesh-ancestor
83400712|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
83400713|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400714|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83400715|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83400716|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83400717|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
83400718|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413646|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83400719|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400720|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
83400721|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
83400722|NCT01921673|Docetaxel|docetaxel|mesh-list
83400723|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400724|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
83400725|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
83400726|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
83400727|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400728|NCT01921985|Terlipressin|terlipressin|mesh-list
83400729|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83400730|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83400731|NCT02943733|Temozolomide|temozolomide|mesh-list
83400732|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83400733|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
83400734|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400735|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400736|NCT01922141|Amlodipine|amlodipine|mesh-list
83400737|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83400738|NCT01922141|Ramipril|ramipril|mesh-list
83400739|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83400740|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83400741|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83400742|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400743|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83400744|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400745|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
83400746|NCT01922141|Diuretics|diuretics|mesh-ancestor
83400747|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
83400748|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83400749|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83400750|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
83400751|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400752|NCT03828019|Cyclosporine|cyclosporine|mesh-list
83400753|NCT03828019|Adalimumab|adalimumab|mesh-list
83400754|NCT03828019|Methotrexate|methotrexate|mesh-list
83400755|NCT03828019|Azathioprine|azathioprine|mesh-list
83400756|NCT03828019|Tacrolimus|tacrolimus|mesh-list
83400757|NCT03828019|Cyclosporins|cyclosporins|mesh-list
83400758|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83400759|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
83400760|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83400761|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400762|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83400763|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
83400764|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400765|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400766|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
83400767|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400768|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83400769|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83400770|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
83400771|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400772|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83400773|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83400774|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
83400775|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400776|NCT03828019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83400777|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83400779|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83400780|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83400781|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83400782|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
83400783|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400784|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400785|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400786|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83400787|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
83400788|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
83400789|NCT02856295|Enoxaparin|enoxaparin|mesh-list
83400790|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
83400791|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83400792|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83400793|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400795|NCT01266447|Veliparib|veliparib|mesh-list
83400796|NCT01266447|Lenograstim|lenograstim|mesh-list
83400797|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83400798|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
83400799|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400800|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83400801|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83400802|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400803|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400804|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400805|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83400806|NCT01922375|Naftopidil|naftopidil|mesh-list
83400807|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83400808|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83400809|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
83400810|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400811|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400812|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400813|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83400814|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83400815|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83400816|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83400817|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83400818|NCT03823339|Liraglutide|liraglutide|mesh-list
83400819|NCT03823339|Xultophy|xultophy|mesh-list
83400820|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83400821|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400822|NCT03823339|Incretins|incretins|mesh-ancestor
83400823|NCT03823339|Hormones|hormones|mesh-ancestor
83400824|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400825|NCT01922687|Amlodipine|amlodipine|mesh-list
83400826|NCT01922687|Atorvastatin|atorvastatin|mesh-list
83400827|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83400828|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83400829|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
83400830|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400831|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83400832|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83400833|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400834|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83400835|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83400836|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83400837|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83400838|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400839|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
83400840|NCT01268553|Treprostinil|treprostinil|mesh-list
83400841|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83400842|NCT01922999|Melatonin|melatonin|mesh-list
83400843|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
83400844|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400845|NCT01922999|Protective Agents|protective agents|mesh-ancestor
83400846|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400847|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400848|NCT01268943|Capecitabine|capecitabine|mesh-list
83400849|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83400850|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
83400851|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400852|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400853|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83400854|NCT01923077|Simvastatin|simvastatin|mesh-list
83400855|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83400856|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83400857|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
83400858|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400859|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83400860|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83400861|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400862|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
83400863|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83400864|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83400865|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83400866|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83400867|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400868|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
83400869|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400870|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400871|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83400872|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400873|NCT01297335|Clonidine|clonidine|mesh-list
83400874|NCT01297335|Analgesics|analgesics|mesh-ancestor
83400875|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
83400876|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400877|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400878|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83400879|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
83400880|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
83400881|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83400882|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83400883|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83400884|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
83400885|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83400886|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400887|NCT05498129|Micronutrients|micronutrients|mesh-list
83400888|NCT05498129|Trace Elements|trace elements|mesh-list
83400889|NCT05498129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400890|NCT01270659|Acetaminophen|acetaminophen|mesh-list
83400891|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83400892|NCT01270659|Fentanyl|fentanyl|mesh-list
83400893|NCT01270659|Oxycodone|oxycodone|mesh-list
83400894|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83400895|NCT01270659|Narcotics|narcotics|mesh-ancestor
83400896|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400897|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400898|NCT01270659|Analgesics|analgesics|mesh-ancestor
83400899|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
83400900|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400901|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83400902|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83400903|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
83400904|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
83400905|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83400906|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
83400907|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83400908|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83400909|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400910|NCT01271907|Aldesleukin|aldesleukin|mesh-list
83400911|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
83400912|NCT01271907|Fludarabine|fludarabine|mesh-list
83400913|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83400915|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400916|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400917|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83400918|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
83400919|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400920|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400921|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83400922|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83400923|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83400924|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
83400925|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400926|NCT01929941|Paclitaxel|paclitaxel|mesh-list
83400927|NCT01929941|Gemcitabine|gemcitabine|mesh-list
83400928|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83400929|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400930|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
83400931|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
83400932|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
83400933|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400934|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83400935|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
83400936|NCT01920737|Leucovorin|leucovorin|mesh-list
83400937|NCT01920737|Cytarabine|cytarabine|mesh-list
83400938|NCT01920737|Dexamethasone|dexamethasone|mesh-list
83400939|NCT01920737|Prednisone|prednisone|mesh-list
83400940|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
83400941|NCT01920737|Methotrexate|methotrexate|mesh-list
83400942|NCT01920737|Vincristine|vincristine|mesh-list
83400943|NCT01920737|Daunorubicin|daunorubicin|mesh-list
83400944|NCT01920737|Asparaginase|asparaginase|mesh-list
83400945|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
83400946|NCT01920737|Pegaspargase|pegaspargase|mesh-list
83400947|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83400948|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
83400949|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400950|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83400951|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83400952|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
83400953|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400954|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400955|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83400956|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83400957|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
83400958|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
83400959|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400960|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83400961|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
83400962|NCT01920737|Hormones|hormones|mesh-ancestor
83400963|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83400964|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83400965|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83400966|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
83400967|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83400968|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83400969|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
83400970|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
83400971|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400972|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83400973|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83400974|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
83400975|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83400976|NCT01920737|Antidotes|antidotes|mesh-ancestor
83400977|NCT01920737|Protective Agents|protective agents|mesh-ancestor
83400978|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
83400979|NCT01920737|Vitamins|vitamins|mesh-ancestor
83400980|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
83400981|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83400982|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
83400983|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
83400984|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
83400985|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83400986|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83400987|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83400988|NCT01922843|Calcitriol|calcitriol|mesh-list
83400989|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83400990|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400991|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83400992|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83400993|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400994|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83400996|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
83400997|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83400998|NCT01302483|Lidocaine|lidocaine|mesh-list
83400999|NCT01302483|Phenylephrine|phenylephrine|mesh-list
83401000|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
83401001|NCT01302483|Tetracaine|tetracaine|mesh-list
83401002|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
83401003|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
83401004|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401005|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401006|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
83401007|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401008|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83401009|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83401010|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83401011|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83401012|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401013|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83401014|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83401015|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
83401016|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83401017|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
83401018|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
83401019|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
83401020|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83401021|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
83401022|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83401023|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
83401024|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83401025|NCT01302483|Protective Agents|protective agents|mesh-ancestor
83401026|NCT04769583|Metronidazole|metronidazole|mesh-list
83401027|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401028|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83401029|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83401030|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83401031|NCT01279317|Acetic Acid|acetic acid|mesh-list
83401032|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83401033|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401034|NCT01304589|Milnacipran|milnacipran|mesh-list
83401035|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
83401036|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83401037|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83401038|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83401039|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401040|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83401041|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401042|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83401043|NCT01304589|Analgesics|analgesics|mesh-ancestor
83401044|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
83401045|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401046|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
83401047|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83401048|NCT01280409|Metformin|metformin|mesh-list
83401049|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83401050|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401051|NCT01926197|Leucovorin|leucovorin|mesh-list
83401052|NCT01926197|Fluorouracil|fluorouracil|mesh-list
83401053|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
83401054|NCT01926197|Irinotecan|irinotecan|mesh-list
83401055|NCT01926197|Camptothecin|camptothecin|mesh-list
83401056|NCT01926197|Antimetabolites|antimetabolites|mesh-ancestor
83401057|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401058|NCT01926197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83401059|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401060|NCT01926197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83401061|NCT01926197|Immunologic Factors|immunologic factors|mesh-ancestor
83401062|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401063|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83401064|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83401065|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401066|NCT01926197|Antidotes|antidotes|mesh-ancestor
83401067|NCT01926197|Protective Agents|protective agents|mesh-ancestor
83401071|NCT01926197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83401073|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83401074|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
83401075|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401076|NCT01925027|Sirolimus|sirolimus|mesh-list
83401077|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83401078|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401079|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83401080|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401081|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
83401082|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83401083|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
83401084|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401085|NCT01305213|Bevacizumab|bevacizumab|mesh-list
83401086|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83401087|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
83401088|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
83401089|NCT01305213|Antibodies|antibodies|mesh-list
83401090|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
83401091|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83401092|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
83401093|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401094|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83401095|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83401096|NCT01305213|Growth Substances|growth substances|mesh-ancestor
83401097|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401098|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
83401099|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
83401100|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83401101|NCT00989963|Beraprost|beraprost|mesh-list
83401102|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83401103|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
83401104|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83401105|NCT01339299|Hormones|hormones|mesh-list
83401106|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401107|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401108|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83401109|NCT01307007|Dextrans|dextrans|mesh-list
83401110|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
83401111|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
83401112|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
83401113|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
83401114|NCT01307007|Hematinics|hematinics|mesh-ancestor
83401115|NCT02197455|Tofacitinib|tofacitinib|mesh-list
83401116|NCT02197455|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83401117|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83401118|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401119|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401120|NCT03101501|Mitomycins|mitomycins|mesh-list
83401121|NCT03101501|Mitomycin|mitomycin|mesh-list
83401122|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83401123|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401124|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
83401125|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401126|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83401127|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401128|NCT01923623|Ropivacaine|ropivacaine|mesh-list
83401129|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
83401130|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
83401131|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401132|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401133|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
83401134|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401135|NCT01923857|Enclomiphene|enclomiphene|mesh-list
83401136|NCT01923857|Clomiphene|clomiphene|mesh-list
83401137|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
83401138|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83401139|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
83401140|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401141|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401142|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83401143|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
83401144|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83401145|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83401224|NCT01925729|Phenylephrine|phenylephrine|mesh-list
83401146|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83401147|NCT03100253|Adalimumab|adalimumab|mesh-list
83401148|NCT03100253|Infliximab|infliximab|mesh-list
83401149|NCT03100253|Golimumab|golimumab|mesh-list
83401150|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
83401151|NCT03100253|Etanercept|etanercept|mesh-list
83401152|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83401153|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401154|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83401155|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
83401156|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83401157|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83401158|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83401159|NCT03100253|Analgesics|analgesics|mesh-ancestor
83401160|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
83401161|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401162|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401163|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83401164|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
83401165|NCT01924091|Dapivirine|dapivirine|mesh-list
83401166|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83401167|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83401168|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
83401169|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401170|NCT03485729|TIC10 compound|tic10 compound|mesh-list
83401171|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401172|NCT01924325|Aspirin|aspirin|mesh-list
83401173|NCT01924325|Apixaban|apixaban|mesh-list
83401174|NCT01924325|Clopidogrel|clopidogrel|mesh-list
83401175|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83401176|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83401177|NCT01924325|Analgesics|analgesics|mesh-ancestor
83401178|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
83401179|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401180|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401181|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401182|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83401183|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83401184|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83401185|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401186|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83401187|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83401188|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401189|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
83401190|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83401191|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83401192|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83401193|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
83401194|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83401195|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83401196|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
83401197|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83401198|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
83401199|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
83401200|NCT01924481|Theobromine|theobromine|mesh-list
83401202|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83401203|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401204|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83401205|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401206|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401207|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83401208|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83401209|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
83401210|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83401211|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83401212|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
83401213|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401214|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83401215|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
83401216|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
83401217|NCT01924637|Insulin|insulin|mesh-list
83401218|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83401219|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
83401220|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
83401221|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83401222|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83401223|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401230|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
83401231|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401232|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401233|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83401234|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
83401235|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
83401236|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83401237|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83401238|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
83401239|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
83401240|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83401241|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401242|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83401243|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83401244|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83401245|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
83401246|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83401247|NCT01925729|Protective Agents|protective agents|mesh-ancestor
83401248|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
83401249|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
83401250|NCT01926587|Azacitidine|azacitidine|mesh-list
83401252|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83401253|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
83401254|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401255|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401256|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401257|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83401258|NCT01922765|Amoxicillin|amoxicillin|mesh-list
83401259|NCT01922765|Metronidazole|metronidazole|mesh-list
83401260|NCT01922765|Clarithromycin|clarithromycin|mesh-list
83401261|NCT01922765|Rabeprazole|rabeprazole|mesh-list
83401262|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83401263|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401264|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83401265|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83401266|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83401267|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401268|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401269|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83401270|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83401271|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83401272|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83401273|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83401274|NCT01926665|Dexamethasone|dexamethasone|mesh-list
83401275|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401276|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
83401277|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
83401278|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401279|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401280|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83401281|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
83401282|NCT01926665|Hormones|hormones|mesh-ancestor
83401283|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401284|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83401285|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401286|NCT01926821|Sizofiran|sizofiran|mesh-list
83401287|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83401288|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
83401289|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401290|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83401291|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401292|NCT01926899|Bortezomib|bortezomib|mesh-list
83401293|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401294|NCT03430661|Clopidogrel|clopidogrel|mesh-list
83401295|NCT03430661|Ticagrelor|ticagrelor|mesh-list
83401296|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83401297|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83401298|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83401299|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83401300|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83401301|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
83401302|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83401303|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401304|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401306|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
83401307|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401308|NCT01927913|Deferasirox|deferasirox|mesh-list
83401309|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83401310|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
83401311|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
83401312|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401313|NCT01928069|Montelukast|montelukast|mesh-list
83401314|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83401315|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
83401316|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83401317|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
83401318|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401319|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401320|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83401321|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83401322|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401323|NCT01928459|Infigratinib|infigratinib|mesh-list
83401324|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401325|NCT01928537|ON 01910|on 01910|mesh-list
83401326|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401327|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83401328|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401329|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401330|NCT01307397|Vemurafenib|vemurafenib|mesh-list
83401331|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401332|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83401333|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401334|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401335|NCT01929161|Oxytocin|oxytocin|mesh-list
83401336|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
83401337|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83401338|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401339|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
83401340|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401341|NCT04552535|Afatinib|afatinib|mesh-list
83401342|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401343|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83401344|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401345|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401346|NCT02197767|Rituximab|rituximab|mesh-list
83401347|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83401348|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401349|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
83401350|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401351|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83401352|NCT01342029|Ranolazine|ranolazine|mesh-list
83401353|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83401354|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83401355|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401356|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83401357|NCT05601479|Acetylcarnitine|acetylcarnitine|mesh-list
83401358|NCT05601479|Vitamin B Complex|vitamin b complex|mesh-ancestor
83401359|NCT05601479|Vitamins|vitamins|mesh-ancestor
83401360|NCT05601479|Micronutrients|micronutrients|mesh-ancestor
83401361|NCT05601479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401362|NCT05601479|Nootropic Agents|nootropic agents|mesh-ancestor
83401363|NCT04275245|Meplazumab|meplazumab|mesh-list
83401364|NCT04275245|Antiviral Agents|antiviral agents|mesh-ancestor
83401365|NCT04275245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401366|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
83401367|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
83401368|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401369|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83401370|NCT04394897|Remifentanil|remifentanil|mesh-list
83401371|NCT04394897|Propofol|propofol|mesh-list
83401372|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83401373|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401374|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401375|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83401376|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
83401377|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
83401381|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
83401382|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401383|NCT05607641|Ketorolac|ketorolac|mesh-list
83401384|NCT05607641|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83401385|NCT05607641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83401386|NCT05607641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83401387|NCT05607641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83401388|NCT05607641|Analgesics|analgesics|mesh-ancestor
83401389|NCT05607641|Sensory System Agents|sensory system agents|mesh-ancestor
83401390|NCT05607641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401391|NCT05607641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401392|NCT05607641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401393|NCT05607641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83401394|NCT05607641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83401395|NCT05607641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401396|NCT05607641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401397|NCT05607017|Losartan|losartan|mesh-list
83401398|NCT05607017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83401399|NCT05607017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83401400|NCT05607017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83401401|NCT05607017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83401402|NCT05607017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401403|NCT05603039|Bevacizumab|bevacizumab|mesh-list
83401404|NCT05603039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83401405|NCT05603039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401406|NCT05603039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83401407|NCT05603039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83401408|NCT05603039|Growth Substances|growth substances|mesh-ancestor
83401409|NCT05603039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401410|NCT05603039|Growth Inhibitors|growth inhibitors|mesh-ancestor
83401411|NCT05609903|Paclitaxel|paclitaxel|mesh-list
83401412|NCT05609903|Atezolizumab|atezolizumab|mesh-list
83401413|NCT05609903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83401414|NCT05609903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401415|NCT05609903|Tubulin Modulators|tubulin modulators|mesh-ancestor
83401416|NCT05609903|Antimitotic Agents|antimitotic agents|mesh-ancestor
83401417|NCT05609903|Mitosis Modulators|mitosis modulators|mesh-ancestor
83401418|NCT05609903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401419|NCT05609903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83401420|NCT05609903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83401421|NCT03045029|Treprostinil|treprostinil|mesh-list
83401422|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83401423|NCT04161599|Metronidazole|metronidazole|mesh-list
83401424|NCT04161599|Cefuroxime|cefuroxime|mesh-list
83401425|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
83401426|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
83401427|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
83401428|NCT04161599|Citric Acid|citric acid|mesh-list
83401429|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
83401430|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401431|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83401432|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83401433|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83401434|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
83401435|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83401436|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
83401437|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
83401438|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401439|NCT04161599|Cathartics|cathartics|mesh-ancestor
83401440|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83401441|NCT04161599|Antacids|antacids|mesh-ancestor
83401442|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83401443|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83401444|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401445|NCT05608499|Clobetasol|clobetasol|mesh-list
83401446|NCT05608499|Halobetasol|halobetasol|mesh-list
83401447|NCT05608499|Tazarotene|tazarotene|mesh-list
83401448|NCT05608499|Dermatologic Agents|dermatologic agents|mesh-ancestor
83401449|NCT05608499|Keratolytic Agents|keratolytic agents|mesh-ancestor
83401450|NCT05608499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83401451|NCT05608499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401452|NCT05608499|Glucocorticoids|glucocorticoids|mesh-ancestor
83401453|NCT05608499|Hormones|hormones|mesh-ancestor
83401454|NCT05608499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401455|NCT05608499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401456|NCT05601167|Ritonavir|ritonavir|mesh-list
83401457|NCT05601167|Nirmatrelvir|nirmatrelvir|mesh-list
83401458|NCT05601167|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83401459|NCT05601167|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83401460|NCT05601167|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83401461|NCT05601167|Protease Inhibitors|protease inhibitors|mesh-ancestor
83401462|NCT05601167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401463|NCT05601167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401464|NCT05601167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83401465|NCT05601167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83401466|NCT05601167|Antiviral Agents|antiviral agents|mesh-ancestor
83401467|NCT05601167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401468|NCT05601167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83401469|NCT05601167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83401470|NCT05605613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83401471|NCT05605613|Antibodies|antibodies|mesh-list
83401472|NCT05605613|Immunologic Factors|immunologic factors|mesh-ancestor
83401473|NCT05605613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401474|NCT05605613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401475|NCT05605613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83401476|NCT05605613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401477|NCT05602259|Dimercaprol|dimercaprol|mesh-list
83401478|NCT05602259|Chelating Agents|chelating agents|mesh-ancestor
83401479|NCT05602259|Sequestering Agents|sequestering agents|mesh-ancestor
83401480|NCT05602259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401481|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
83401482|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83401483|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401484|NCT04393883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83401485|NCT04393883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401486|NCT05603975|Esketamine|esketamine|mesh-list
83401487|NCT05603975|Antidepressive Agents|antidepressive agents|mesh-ancestor
83401488|NCT05603975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83401489|NCT03029429|Theophylline|theophylline|mesh-list
83401490|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83401491|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
83401492|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401493|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401494|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83401495|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
83401496|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83401497|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401498|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401499|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
83401500|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83401501|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83401502|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
83401503|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83401504|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
83401505|NCT04120363|Testosterone|testosterone|mesh-list
83401506|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
83401507|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
83401508|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83401509|NCT04120363|Androgens|androgens|mesh-ancestor
83401510|NCT04120363|Hormones|hormones|mesh-ancestor
83401511|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401512|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401513|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83401514|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401515|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
83401516|NCT04125745|CXA-10|cxa-10|mesh-list
83401517|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401518|NCT04393805|Heparin|heparin|mesh-list
83401519|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83401520|NCT04393805|Tinzaparin|tinzaparin|mesh-list
83401521|NCT04393805|Dalteparin|dalteparin|mesh-list
83401522|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
83401523|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83401524|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83401525|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401526|NCT04122755|Buprenorphine|buprenorphine|mesh-list
83401527|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83401528|NCT04122755|Narcotics|narcotics|mesh-ancestor
83401529|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401530|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401531|NCT04122755|Analgesics|analgesics|mesh-ancestor
83401532|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
83401533|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401534|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83401535|NCT04129697|Dexamethasone|dexamethasone|mesh-list
83401536|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
83401537|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83401538|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83401539|NCT04129697|Prednisolone|prednisolone|mesh-list
83401540|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
83401541|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83401542|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
83401543|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401544|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
83401545|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
83401546|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401547|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401548|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83401549|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
83401550|NCT04129697|Hormones|hormones|mesh-ancestor
83401551|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401552|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83401553|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401554|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83401555|NCT04129697|Protective Agents|protective agents|mesh-ancestor
83401556|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
83401557|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401559|NCT05793892|Tetracaine|tetracaine|mesh-list
83401560|NCT05793892|Anesthetics, Local|anesthetics, local|mesh-ancestor
83401561|NCT05793892|Anesthetics|anesthetics|mesh-ancestor
83401562|NCT05793892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401563|NCT05793892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401564|NCT05793892|Sensory System Agents|sensory system agents|mesh-ancestor
83401565|NCT05793892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401566|NCT05793892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83401567|NCT05793892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83401568|NCT05793892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83401569|NCT05793892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83401570|NCT05793892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401571|NCT05793632|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83401572|NCT05793632|Antidepressive Agents|antidepressive agents|mesh-ancestor
83401573|NCT05793632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83401574|NCT05793632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83401575|NCT05793632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83401576|NCT05793632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401577|NCT05793632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401578|NCT05793359|Methylprednisolone|methylprednisolone|mesh-list
83401579|NCT05793359|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83401580|NCT05793359|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83401581|NCT05793359|Prednisolone|prednisolone|mesh-list
83401582|NCT05793359|Prednisolone acetate|prednisolone acetate|mesh-list
83401583|NCT05793359|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83401584|NCT05793359|Prednisolone phosphate|prednisolone phosphate|mesh-list
83401585|NCT05793359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401586|NCT05793359|Antiemetics|antiemetics|mesh-ancestor
83401587|NCT05793359|Autonomic Agents|autonomic agents|mesh-ancestor
83401588|NCT05793359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401589|NCT05793359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401590|NCT05793359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83401591|NCT05793359|Glucocorticoids|glucocorticoids|mesh-ancestor
83401592|NCT05793359|Hormones|hormones|mesh-ancestor
83401593|NCT05793359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401594|NCT05793359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83401595|NCT05793359|Protective Agents|protective agents|mesh-ancestor
83401596|NCT05793359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83401597|NCT05793359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401598|NCT05793268|Tenofovir|tenofovir|mesh-list
83401599|NCT05793268|Entecavir|entecavir|mesh-list
83401600|NCT05793268|Antiviral Agents|antiviral agents|mesh-ancestor
83401601|NCT05793268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401602|NCT05793268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83401603|NCT05793268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83401604|NCT05793268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401605|NCT05793268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401606|NCT05793268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83401607|NCT05793268|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83401608|NCT05793099|Propolis|propolis|mesh-list
83401687|NCT05792111|Anesthetics, Local|anesthetics, local|mesh-ancestor
83401609|NCT05793099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401610|NCT05793060|Dexamethasone|dexamethasone|mesh-list
83401611|NCT05793060|Dexamethasone acetate|dexamethasone acetate|mesh-list
83401612|NCT05793060|Dexmedetomidine|dexmedetomidine|mesh-list
83401613|NCT05793060|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83401614|NCT05793060|BB 1101|bb 1101|mesh-list
83401615|NCT05793060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401616|NCT05793060|Antiemetics|antiemetics|mesh-ancestor
83401617|NCT05793060|Autonomic Agents|autonomic agents|mesh-ancestor
83401618|NCT05793060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401619|NCT05793060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401620|NCT05793060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83401621|NCT05793060|Glucocorticoids|glucocorticoids|mesh-ancestor
83401622|NCT05793060|Hormones|hormones|mesh-ancestor
83401623|NCT05793060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401624|NCT05793060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83401625|NCT05793060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401627|NCT05793060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401628|NCT05793060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401629|NCT05793060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83401630|NCT05793060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401631|NCT05793060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83401632|NCT05793060|Analgesics|analgesics|mesh-ancestor
83401633|NCT05793060|Sensory System Agents|sensory system agents|mesh-ancestor
83401634|NCT05793060|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83401635|NCT05793060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83401636|NCT05793060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83401637|NCT05793060|Adrenergic Agents|adrenergic agents|mesh-ancestor
83401638|NCT05793060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83401639|NCT05792995|Pembrolizumab|pembrolizumab|mesh-list
83401640|NCT05792995|Nivolumab|nivolumab|mesh-list
83401641|NCT05792995|Durvalumab|durvalumab|mesh-list
83401642|NCT05792995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83401643|NCT05792995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401644|NCT05792995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83401645|NCT05792995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401646|NCT05792878|Interferons|interferons|mesh-list
83401647|NCT05792878|Interferon-alpha|interferon-alpha|mesh-list
83401648|NCT05792878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401649|NCT05792878|Antiviral Agents|antiviral agents|mesh-ancestor
83401650|NCT05792878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401651|NCT05792878|Immunologic Factors|immunologic factors|mesh-ancestor
83401652|NCT05792878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401653|NCT05792865|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83401654|NCT05792865|Antiviral Agents|antiviral agents|mesh-ancestor
83401655|NCT05792865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401656|NCT05792761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83401657|NCT05792761|Antiviral Agents|antiviral agents|mesh-ancestor
83401658|NCT05792761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401659|NCT05792748|Hemostatics|hemostatics|mesh-list
83401660|NCT05792748|Coagulants|coagulants|mesh-ancestor
83401661|NCT05792644|Crizotinib|crizotinib|mesh-list
83401662|NCT05792644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401663|NCT05792644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83401664|NCT05792644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401665|NCT05792644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401666|NCT05792410|Bevacizumab|bevacizumab|mesh-list
83401667|NCT05792410|Fulvestrant|fulvestrant|mesh-list
83401668|NCT05792410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83401669|NCT05792410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401670|NCT05792410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83401671|NCT05792410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83401672|NCT05792410|Growth Substances|growth substances|mesh-ancestor
83401673|NCT05792410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401674|NCT05792410|Growth Inhibitors|growth inhibitors|mesh-ancestor
83401675|NCT05792410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83401676|NCT05792410|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83401677|NCT05792410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83401678|NCT05792410|Hormone Antagonists|hormone antagonists|mesh-ancestor
83401679|NCT05792410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401680|NCT05792319|Copper|copper|mesh-list
83401681|NCT05792319|Trace Elements|trace elements|mesh-ancestor
83401682|NCT05792319|Micronutrients|micronutrients|mesh-ancestor
83401683|NCT05792319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401684|NCT05792111|Triamcinolone|triamcinolone|mesh-list
83401685|NCT05792111|Lidocaine|lidocaine|mesh-list
83401686|NCT05792111|Bupivacaine|bupivacaine|mesh-list
83401689|NCT05792111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401690|NCT05792111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401691|NCT05792111|Sensory System Agents|sensory system agents|mesh-ancestor
83401692|NCT05792111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401693|NCT05792111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83401694|NCT05792111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83401695|NCT05792111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83401696|NCT05792111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83401697|NCT05792111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401698|NCT05792111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401699|NCT05792111|Glucocorticoids|glucocorticoids|mesh-ancestor
83401700|NCT05792111|Hormones|hormones|mesh-ancestor
83401701|NCT05792111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401702|NCT05789732|Tadalafil|tadalafil|mesh-list
83401703|NCT05789732|Silodosin|silodosin|mesh-list
83401704|NCT05789732|Vasodilator Agents|vasodilator agents|mesh-ancestor
83401705|NCT05789732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83401706|NCT05789732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83401707|NCT05789732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401708|NCT05789732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401709|NCT05789732|Urological Agents|urological agents|mesh-ancestor
83401710|NCT05789732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83401711|NCT05789732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83401712|NCT05789732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83401713|NCT05789732|Adrenergic Agents|adrenergic agents|mesh-ancestor
83401714|NCT05789732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83401715|NCT05789732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401716|NCT05789615|Letermovir|letermovir|mesh-list
83401717|NCT05789615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83401718|NCT05789615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401719|NCT05789615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401720|NCT05789615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401721|NCT05789615|Antiviral Agents|antiviral agents|mesh-ancestor
83401722|NCT05789615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401723|NCT05783817|Methamphetamine|methamphetamine|mesh-list
83401724|NCT05783817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83401725|NCT05783817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401726|NCT05783817|Sympathomimetics|sympathomimetics|mesh-ancestor
83401727|NCT05783817|Autonomic Agents|autonomic agents|mesh-ancestor
83401728|NCT05783817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401729|NCT05783817|Dopamine Agents|dopamine agents|mesh-ancestor
83401730|NCT05783817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83401731|NCT05783817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401732|NCT05783817|Adrenergic Agents|adrenergic agents|mesh-ancestor
83401733|NCT05783817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83401734|NCT05783817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83401735|NCT05783817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83401736|NCT05783817|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83401737|NCT05761080|Amoxicillin|amoxicillin|mesh-list
83401738|NCT05761080|Clavulanic Acids|clavulanic acids|mesh-list
83401739|NCT05761080|Clavulanic Acid|clavulanic acid|mesh-list
83401740|NCT05761080|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83401741|NCT05761080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83401742|NCT05761080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401743|NCT05761080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401744|NCT05761080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401745|NCT05761080|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83401746|NCT05743764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83401747|NCT05743764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83401748|NCT05737186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83401749|NCT05737186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401750|NCT05737186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83401751|NCT05737186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401752|NCT05708638|Anesthetics|anesthetics|mesh-list
83401753|NCT05708638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401754|NCT05708638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401755|NCT05700669|Olaparib|olaparib|mesh-list
83401756|NCT05700669|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83401757|NCT05700669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401758|NCT05700669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401759|NCT05700669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401761|NCT05652660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83401762|NCT05652660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83401763|NCT05652660|Antimetabolites|antimetabolites|mesh-ancestor
83401764|NCT05652660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401765|NCT05652660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83401766|NCT05652660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83401767|NCT05652660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401768|NCT05642026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83401769|NCT05642026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83401770|NCT05642026|Ropivacaine|ropivacaine|mesh-list
83401771|NCT05642026|Anesthetics, Local|anesthetics, local|mesh-ancestor
83401772|NCT05642026|Anesthetics|anesthetics|mesh-ancestor
83401773|NCT05642026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401774|NCT05642026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401775|NCT05642026|Sensory System Agents|sensory system agents|mesh-ancestor
83401776|NCT05642026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401777|NCT05642026|Analgesics|analgesics|mesh-ancestor
83401778|NCT05642026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83401779|NCT05642026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83401780|NCT05617742|FAPI-46|fapi-46|mesh-list
83401781|NCT05617742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83401782|NCT05617742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401783|NCT05605535|Paclitaxel|paclitaxel|mesh-list
83401784|NCT05605535|Carboplatin|carboplatin|mesh-list
83401785|NCT05605535|Oregovomab|oregovomab|mesh-list
83401786|NCT05605535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83401787|NCT05605535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401788|NCT05605535|Tubulin Modulators|tubulin modulators|mesh-ancestor
83401789|NCT05605535|Antimitotic Agents|antimitotic agents|mesh-ancestor
83401790|NCT05605535|Mitosis Modulators|mitosis modulators|mesh-ancestor
83401791|NCT05605535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401792|NCT05605535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83401793|NCT05593575|Valsartan|valsartan|mesh-list
83401794|NCT05593575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83401795|NCT05593575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83401796|NCT05593575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83401797|NCT05593575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401798|NCT05558137|Mivacurium|mivacurium|mesh-list
83401799|NCT05558137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83401800|NCT05558137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83401801|NCT05558137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83401802|NCT05558137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401803|NCT05558137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401804|NCT05521828|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83401805|NCT05521828|Dydrogesterone|dydrogesterone|mesh-list
83401806|NCT05521828|Hormones|hormones|mesh-ancestor
83401807|NCT05521828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401808|NCT05521828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401809|NCT05521828|Progestins|progestins|mesh-ancestor
83401810|NCT05505214|Mometasone Furoate|mometasone furoate|mesh-list
83401811|NCT05505214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401812|NCT05505214|Dermatologic Agents|dermatologic agents|mesh-ancestor
83401813|NCT05505214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83401814|NCT05501769|Everolimus|everolimus|mesh-list
83401815|NCT05501769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83401816|NCT05501769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83401817|NCT05501769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401818|NCT05501769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401819|NCT05501769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83401820|NCT05501769|Immunologic Factors|immunologic factors|mesh-ancestor
83401821|NCT05501769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401822|NCT05501769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401823|NCT05463224|Lazertinib|lazertinib|mesh-list
83401824|NCT05463224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83401825|NCT05463224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401826|NCT05463224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401827|NCT05456932|Iron|iron|mesh-list
83401828|NCT05456932|Ferrous fumarate|ferrous fumarate|mesh-list
83401829|NCT05456932|Ferric maltol|ferric maltol|mesh-list
83401830|NCT05456932|Trace Elements|trace elements|mesh-ancestor
83401831|NCT05456932|Micronutrients|micronutrients|mesh-ancestor
83401832|NCT05456932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401833|NCT05456932|Hematinics|hematinics|mesh-ancestor
83401834|NCT05447780|Anesthetics|anesthetics|mesh-list
83401835|NCT05447780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401836|NCT05447780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401837|NCT05437289|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83401838|NCT05437289|Antiviral Agents|antiviral agents|mesh-ancestor
83401839|NCT05437289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401840|NCT05419011|Vaccines|vaccines|mesh-list
83401841|NCT05419011|Immunologic Factors|immunologic factors|mesh-ancestor
83401842|NCT05419011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401843|NCT05413343|Ceftazidime|ceftazidime|mesh-list
83401844|NCT05413343|Avibactam|avibactam|mesh-list
83401845|NCT05413343|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83401846|NCT05413343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83401847|NCT05413343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401848|NCT05413343|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83401850|NCT05413343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401851|NCT05403502|Insulin|insulin|mesh-list
83401852|NCT05403502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83401853|NCT05403502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401854|NCT05389930|Ethanol|ethanol|mesh-list
83401855|NCT05389930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83401856|NCT05389930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401857|NCT05389930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401858|NCT05389930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401859|NCT05382546|Ketorolac|ketorolac|mesh-list
83401860|NCT05382546|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83401861|NCT05382546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83401862|NCT05382546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83401863|NCT05382546|Analgesics|analgesics|mesh-ancestor
83401864|NCT05382546|Sensory System Agents|sensory system agents|mesh-ancestor
83401865|NCT05382546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401866|NCT05382546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401867|NCT05382546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401868|NCT05382546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83401869|NCT05382546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83401870|NCT05382546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401871|NCT05382546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401872|NCT05372133|Morphine|morphine|mesh-list
83401873|NCT05372133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83401874|NCT05372133|Narcotics|narcotics|mesh-ancestor
83401875|NCT05372133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401876|NCT05372133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401877|NCT05372133|Analgesics|analgesics|mesh-ancestor
83401878|NCT05372133|Sensory System Agents|sensory system agents|mesh-ancestor
83401879|NCT05372133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401880|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83401881|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
83401882|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401883|NCT05341115|Leuprolide|leuprolide|mesh-list
83401884|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83401885|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
83401886|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83401887|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401888|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83401889|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401890|NCT05292664|Leucovorin|leucovorin|mesh-list
83401891|NCT05292664|Cytarabine|cytarabine|mesh-list
83401892|NCT05292664|Dexamethasone|dexamethasone|mesh-list
83401893|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
83401894|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
83401895|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83401896|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83401897|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83401898|NCT05292664|Cortisone|cortisone|mesh-list
83401899|NCT05292664|Doxorubicin|doxorubicin|mesh-list
83401900|NCT05292664|Methotrexate|methotrexate|mesh-list
83401901|NCT05292664|Vincristine|vincristine|mesh-list
83401902|NCT05292664|Azacitidine|azacitidine|mesh-list
83401903|NCT05292664|Venetoclax|venetoclax|mesh-list
83401904|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
83401905|NCT05292664|Razoxane|razoxane|mesh-list
83401906|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83401907|NCT05292664|BB 1101|bb 1101|mesh-list
83401908|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
83401909|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83401910|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
83401911|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
83401912|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401913|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401914|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83401917|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401918|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83401919|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401920|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
83401921|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401922|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401923|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83401924|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83401925|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83401926|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83401927|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
83401928|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83401929|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83401930|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
83401931|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
83401932|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83401933|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83401934|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
83401935|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83401936|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83401937|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
83401938|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401939|NCT05292664|Antidotes|antidotes|mesh-ancestor
83401940|NCT05292664|Protective Agents|protective agents|mesh-ancestor
83401941|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
83401942|NCT05292664|Vitamins|vitamins|mesh-ancestor
83401943|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
83401944|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83401945|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
83401946|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
83401947|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
83401948|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83401949|NCT05283109|Vaccines|vaccines|mesh-list
83401950|NCT05283109|Poly ICLC|poly iclc|mesh-list
83401951|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
83401952|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401953|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
83401954|NCT05278975|Thiostrepton|thiostrepton|mesh-list
83401955|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83401956|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83401957|NCT05278351|Irinotecan|irinotecan|mesh-list
83401958|NCT05278351|Cetuximab|cetuximab|mesh-list
83401959|NCT05278351|Tislelizumab|tislelizumab|mesh-list
83401960|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83401961|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83401962|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401963|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401964|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83401965|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83401966|NCT05275907|Amlodipine|amlodipine|mesh-list
83401967|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
83401968|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83401969|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83401970|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83401971|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401972|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83401973|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401974|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
83401975|NCT05275907|Diuretics|diuretics|mesh-ancestor
83401976|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
83401977|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83401978|NCT05269628|Dronabinol|dronabinol|mesh-list
83401979|NCT05269628|Cannabidiol|cannabidiol|mesh-list
83401980|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
83401981|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
83401982|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401983|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83401984|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83401985|NCT05269628|Analgesics|analgesics|mesh-ancestor
83401986|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
83401987|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401988|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83401989|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83401990|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83401991|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401992|NCT05269628|Hormones|hormones|mesh-ancestor
83401993|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83401994|NCT05263700|FAPI-46|fapi-46|mesh-list
83401995|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83401996|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83401997|NCT05257447|Baclofen|baclofen|mesh-list
83401998|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
83401999|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83402000|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402001|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83402002|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402003|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83402004|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
83402005|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
83402006|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83402007|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402008|NCT05211154|Diclofenac|diclofenac|mesh-list
83402009|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83402010|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83402011|NCT05211154|Analgesics|analgesics|mesh-ancestor
83402012|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
83402013|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402014|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402015|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83402016|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83402017|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83402018|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402019|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402020|NCT05128344|Vigabatrin|vigabatrin|mesh-list
83402021|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
83402022|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402023|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402024|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
83402025|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83402026|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402027|NCT05093296|Naltrexone|naltrexone|mesh-list
83402028|NCT05093296|Oxytocin|oxytocin|mesh-list
83402029|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
83402030|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83402031|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402032|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83402033|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83402034|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
83402035|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402036|NCT05071833|Peppermint oil|peppermint oil|mesh-list
83402037|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
83402038|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
83402039|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402040|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402041|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83402042|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
83402043|NCT05023369|Dexamethasone|dexamethasone|mesh-list
83402044|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83402045|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
83402046|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
83402047|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402048|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402049|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83402050|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
83402051|NCT05023369|Hormones|hormones|mesh-ancestor
83402052|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402053|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83402054|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402055|NCT04818632|Everolimus|everolimus|mesh-list
83402056|NCT04818632|Palbociclib|palbociclib|mesh-list
83402057|NCT04818632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83402058|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83402059|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402060|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402061|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83402062|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
83402063|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402064|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402065|NCT04749628|Cannabidiol|cannabidiol|mesh-list
83402066|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
83402067|NCT04729101|Lansoprazole|lansoprazole|mesh-list
83402068|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
83402070|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83402071|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83402072|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402073|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402075|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83402076|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83402077|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83402078|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402079|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402080|NCT04707872|Antibodies|antibodies|mesh-list
83402081|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
83402082|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402083|NCT04673448|Niraparib|niraparib|mesh-list
83402084|NCT04673448|Dostarlimab|dostarlimab|mesh-list
83402085|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
83402086|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
83402087|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
83402088|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402089|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83402090|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402091|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402092|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402093|NCT04670081|Niacinamide|niacinamide|mesh-list
83402094|NCT04670081|Niacin|niacin|mesh-list
83402095|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
83402096|NCT04670081|Psilocybin|psilocybin|mesh-list
83402097|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
83402098|NCT04670081|Vitamins|vitamins|mesh-ancestor
83402099|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
83402100|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402101|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83402102|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
83402103|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402104|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83402105|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
83402106|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
83402107|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83402108|NCT04648280|Fostemsavir|fostemsavir|mesh-list
83402109|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83402110|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83402111|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
83402112|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402113|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83402114|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83402115|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402116|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
83402117|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402118|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402119|NCT04602377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83402120|NCT04602377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402121|NCT04601961|Propofol|propofol|mesh-list
83402122|NCT04601961|Sevoflurane|sevoflurane|mesh-list
83402123|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83402124|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83402125|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402126|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83402127|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
83402128|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
83402129|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83402130|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83402131|NCT04551430|Nivolumab|nivolumab|mesh-list
83402132|NCT04551430|Ipilimumab|ipilimumab|mesh-list
83402133|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402134|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402135|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83402136|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402137|NCT04513314|Valproic Acid|valproic acid|mesh-list
83402138|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83402139|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
83402140|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83402141|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83402142|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83402143|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83402144|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402145|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
83402147|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402148|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
83402149|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83402150|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
83402151|NCT04485559|Everolimus|everolimus|mesh-list
83402152|NCT04485559|Trametinib|trametinib|mesh-list
83402153|NCT04485559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83402154|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83402155|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402156|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402158|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
83402159|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402160|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402161|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
83402162|NCT04469868|Narcotics|narcotics|mesh-ancestor
83402163|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83402164|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402165|NCT04469868|Analgesics|analgesics|mesh-ancestor
83402166|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
83402167|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402168|NCT04451187|Zopiclone|zopiclone|mesh-list
83402169|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83402170|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83402171|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402172|NCT04446117|Prednisone|prednisone|mesh-list
83402173|NCT04446117|Atezolizumab|atezolizumab|mesh-list
83402174|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
83402175|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83402176|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
83402177|NCT04446117|Hormones|hormones|mesh-ancestor
83402178|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402179|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402180|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83402181|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402182|NCT04446117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83402183|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402184|NCT04446117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402185|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83402186|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402187|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
83402188|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83402189|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
83402190|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83402191|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402192|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83402193|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402194|NCT04318405|Iron|iron|mesh-list
83402195|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83402196|NCT04318405|Trace Elements|trace elements|mesh-ancestor
83402197|NCT04318405|Micronutrients|micronutrients|mesh-ancestor
83402198|NCT04318405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402199|NCT04318405|Hematinics|hematinics|mesh-ancestor
83402200|NCT04301778|Durvalumab|durvalumab|mesh-list
83402201|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402202|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402203|NCT04287049|Azithromycin|azithromycin|mesh-list
83402204|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83402205|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402206|NCT04282629|Milrinone|milrinone|mesh-list
83402207|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83402208|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83402209|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
83402210|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83402211|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83402212|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402213|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402214|NCT04282629|Protective Agents|protective agents|mesh-ancestor
83402215|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402216|NCT04275492|Pramipexole|pramipexole|mesh-list
83402217|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
83402218|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402219|NCT04275492|Protective Agents|protective agents|mesh-ancestor
83402220|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402221|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83402222|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83402225|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83402227|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83402228|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83402229|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
83402230|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402231|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402232|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83402233|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
83402234|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
83402235|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83402236|NCT04246229|Bilirubin|bilirubin|mesh-list
83402237|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
83402238|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402239|NCT04246229|Protective Agents|protective agents|mesh-ancestor
83402240|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402241|NCT04239703|Antibodies|antibodies|mesh-list
83402242|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
83402243|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402244|NCT04208178|Trastuzumab|trastuzumab|mesh-list
83402245|NCT04208178|Pertuzumab|pertuzumab|mesh-list
83402246|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402247|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402248|NCT04031833|Amphotericin B|amphotericin b|mesh-list
83402249|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83402250|NCT04031833|Amebicides|amebicides|mesh-ancestor
83402251|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83402252|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83402253|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402254|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83402255|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
83402256|NCT03943875|Vaccines|vaccines|mesh-list
83402257|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
83402258|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402259|NCT03933202|Cladribine|cladribine|mesh-list
83402260|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402261|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83402262|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
83402263|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402264|NCT03908307|Dexamethasone|dexamethasone|mesh-list
83402265|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
83402266|NCT03908307|BB 1101|bb 1101|mesh-list
83402267|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83402268|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
83402269|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
83402270|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402271|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402272|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83402273|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
83402274|NCT03908307|Hormones|hormones|mesh-ancestor
83402275|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402276|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83402277|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402278|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
83402279|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402280|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402281|NCT03841058|Abaloparatide|abaloparatide|mesh-list
83402282|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83402283|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402284|NCT03731923|Liver Extracts|liver extracts|mesh-list
83402285|NCT03731923|Hematinics|hematinics|mesh-ancestor
83402286|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83402287|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
83402288|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83402289|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
83402290|NCT03684590|Narcotics|narcotics|mesh-ancestor
83402291|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83402292|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402293|NCT03684590|Analgesics|analgesics|mesh-ancestor
83402294|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
83402295|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402296|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83402297|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
83402298|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83402299|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
83402300|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402301|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402302|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402303|NCT03385304|Iodine|iodine|mesh-list
83402304|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
83402305|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83402306|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
83402307|NCT03385304|Povidone|povidone|mesh-list
83402308|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83402309|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402310|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
83402311|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
83402312|NCT03385304|Trace Elements|trace elements|mesh-ancestor
83402313|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
83402314|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402315|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
83402316|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
83402317|NCT03351998|Atorvastatin|atorvastatin|mesh-list
83402318|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83402319|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83402320|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
83402321|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402322|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83402323|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83402324|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402325|NCT03331198|Venetoclax|venetoclax|mesh-list
83402326|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402327|NCT03285568|Palbociclib|palbociclib|mesh-list
83402328|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402329|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83402330|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402331|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402332|NCT03152786|Propranolol|propranolol|mesh-list
83402333|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83402334|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83402335|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
83402336|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83402337|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402338|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402339|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83402340|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83402341|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
83402342|NCT03117816|Interferons|interferons|mesh-list
83402343|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
83402344|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
83402345|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402346|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
83402347|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402348|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
83402349|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402350|NCT03038802|Vaccines|vaccines|mesh-list
83402351|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
83402352|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402353|NCT02938793|Durvalumab|durvalumab|mesh-list
83402354|NCT02938793|Tremelimumab|tremelimumab|mesh-list
83402355|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402356|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402357|NCT02837094|Insulin|insulin|mesh-list
83402358|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83402359|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402360|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
83402361|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83402362|NCT02836925|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83402363|NCT02836925|Ledipasvir|ledipasvir|mesh-list
83402364|NCT02836925|Velpatasvir|velpatasvir|mesh-list
83402365|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
83402366|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402367|NCT02756962|Cytarabine|cytarabine|mesh-list
83402368|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83402369|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
83402370|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402371|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402372|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
83402373|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402374|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83402375|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
83402376|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402377|NCT02728037|Lidocaine|lidocaine|mesh-list
83402378|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
83402379|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
83402381|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83402382|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402383|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
83402384|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402385|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83402386|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83402387|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83402388|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83402389|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402391|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
83402392|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83402393|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83402394|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
83402395|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83402396|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83402397|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
83402398|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83402399|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
83402400|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402401|NCT02392572|TIC10 compound|tic10 compound|mesh-list
83402402|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402403|NCT02275780|Ritonavir|ritonavir|mesh-list
83402404|NCT02275780|Darunavir|darunavir|mesh-list
83402405|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83402406|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83402407|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83402408|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
83402409|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402410|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402411|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83402412|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83402413|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
83402414|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402415|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83402416|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83402417|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83402418|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83402419|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
83402420|NCT02158091|Rituximab|rituximab|mesh-list
83402421|NCT02158091|Fludarabine|fludarabine|mesh-list
83402422|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83402423|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
83402424|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402425|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83402426|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83402427|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
83402428|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402429|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402430|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83402431|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402432|NCT01828112|Docetaxel|docetaxel|mesh-list
83402433|NCT01828112|Pemetrexed|pemetrexed|mesh-list
83402434|NCT01828112|Ceritinib|ceritinib|mesh-list
83402435|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402436|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
83402437|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
83402438|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
83402439|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402440|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402441|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83402442|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83402443|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83402444|NCT01746836|Ponatinib|ponatinib|mesh-list
83402445|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402446|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83402447|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402448|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402449|NCT00545077|Bevacizumab|bevacizumab|mesh-list
83402450|NCT00545077|Letrozole|letrozole|mesh-list
83402451|NCT00545077|Fulvestrant|fulvestrant|mesh-list
83402452|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402453|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402454|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83402455|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83402457|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402458|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
83402459|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83402460|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83402461|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402462|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402463|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83402464|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
83402465|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402466|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83402467|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83402468|NCT00251433|Docetaxel|docetaxel|mesh-list
83402469|NCT00251433|Trastuzumab|trastuzumab|mesh-list
83402470|NCT00251433|Lapatinib|lapatinib|mesh-list
83402471|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402472|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
83402473|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
83402474|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
83402475|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402476|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402477|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83402478|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402479|NCT00130533|Capecitabine|capecitabine|mesh-list
83402480|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83402481|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
83402482|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402483|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402484|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
83402485|NCT00129935|Docetaxel|docetaxel|mesh-list
83402486|NCT00129935|Capecitabine|capecitabine|mesh-list
83402487|NCT00129935|Epirubicin|epirubicin|mesh-list
83402488|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83402489|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
83402490|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402491|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83402492|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83402493|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
83402494|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402495|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402496|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83402497|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
83402498|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
83402499|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
83402500|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83402501|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
83402502|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83402503|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83402504|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83402505|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402506|NCT02760667|Cisplatin|cisplatin|mesh-list
83402507|NCT02760667|Carboplatin|carboplatin|mesh-list
83402508|NCT02760667|Docetaxel|docetaxel|mesh-list
83402509|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402510|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
83402511|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
83402512|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
83402513|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402514|NCT04127357|Fluorides|fluorides|mesh-list
83402515|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
83402516|NCT04127357|Protective Agents|protective agents|mesh-ancestor
83402517|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402518|NCT01450111|Lacosamide|lacosamide|mesh-list
83402519|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
83402520|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83402521|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83402522|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83402523|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402524|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83402525|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83402526|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402527|NCT02697253|Incretins|incretins|mesh-ancestor
83402528|NCT02697253|Hormones|hormones|mesh-ancestor
83402529|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402530|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83402531|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
83402533|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402535|NCT02660905|Emtricitabine|emtricitabine|mesh-list
83402536|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
83402537|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83402538|NCT02660905|Rilpivirine|rilpivirine|mesh-list
83402539|NCT02660905|Ledipasvir|ledipasvir|mesh-list
83402540|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
83402541|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402542|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83402543|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83402544|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402545|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402546|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83402547|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83402548|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83402549|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83402550|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402551|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402552|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83402553|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
83402554|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402555|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402556|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
83402557|NCT03825289|Trametinib|trametinib|mesh-list
83402558|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
83402559|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83402560|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83402561|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402562|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402563|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402564|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83402565|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402566|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83402567|NCT01450345|Pregabalin|pregabalin|mesh-list
83402568|NCT01450345|Analgesics|analgesics|mesh-ancestor
83402569|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
83402570|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402571|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402572|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
83402573|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83402574|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83402575|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402576|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83402577|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83402578|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83402579|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83402580|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83402581|NCT03822559|Timolol|timolol|mesh-list
83402582|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83402583|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83402584|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83402585|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83402586|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
83402587|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83402588|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402589|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402590|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83402591|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83402592|NCT01647828|Paclitaxel|paclitaxel|mesh-list
83402593|NCT01647828|Gemcitabine|gemcitabine|mesh-list
83402594|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83402595|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402596|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
83402597|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
83402598|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
83402599|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402600|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83402601|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
83402602|NCT03825367|Nivolumab|nivolumab|mesh-list
83402603|NCT03825367|Azacitidine|azacitidine|mesh-list
83402604|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402605|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402606|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83402607|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402608|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83402610|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402611|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
83402612|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83402613|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83402614|NCT04273321|Prednisolone|prednisolone|mesh-list
83402615|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
83402616|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83402617|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
83402618|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83402619|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
83402620|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
83402621|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402622|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402623|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83402624|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
83402625|NCT04273321|Hormones|hormones|mesh-ancestor
83402626|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402627|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83402628|NCT04273321|Protective Agents|protective agents|mesh-ancestor
83402629|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83402630|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402631|NCT02654119|Paclitaxel|paclitaxel|mesh-list
83402632|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
83402633|NCT02654119|Trastuzumab|trastuzumab|mesh-list
83402634|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83402635|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83402636|NCT02654119|Antibodies|antibodies|mesh-list
83402637|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
83402638|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83402639|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83402640|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402641|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
83402642|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
83402643|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
83402644|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402645|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83402646|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
83402647|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402648|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83402649|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83402650|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
83402651|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83402652|NCT01243476|Lenalidomide|lenalidomide|mesh-list
83402653|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
83402654|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402655|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83402656|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83402657|NCT01243476|Growth Substances|growth substances|mesh-ancestor
83402658|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
83402659|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402660|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
83402661|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83402662|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83402663|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
83402664|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402665|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83402666|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83402667|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402668|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402669|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
83402670|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402671|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402672|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
83402673|NCT01454011|Testosterone|testosterone|mesh-list
83402674|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
83402675|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
83402676|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83402677|NCT01454011|Androgens|androgens|mesh-ancestor
83402678|NCT01454011|Hormones|hormones|mesh-ancestor
83402679|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402680|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402681|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83402682|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402685|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
83402686|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
83402687|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402688|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402689|NCT04976088|Diclofenac|diclofenac|mesh-list
83402690|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83402691|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83402692|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83402693|NCT04976088|Analgesics|analgesics|mesh-ancestor
83402694|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
83402695|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402696|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402697|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83402698|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83402699|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83402700|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402701|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402702|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
83402703|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83402704|NCT04975932|Estrogens|estrogens|mesh-ancestor
83402705|NCT04975932|Hormones|hormones|mesh-ancestor
83402706|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402707|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402708|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83402709|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402710|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
83402711|NCT04968132|Narcotics|narcotics|mesh-ancestor
83402712|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83402713|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402714|NCT04968132|Analgesics|analgesics|mesh-ancestor
83402715|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
83402716|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402717|NCT03829111|Nivolumab|nivolumab|mesh-list
83402718|NCT03829111|Ipilimumab|ipilimumab|mesh-list
83402719|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402720|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402721|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83402722|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402723|NCT01454479|Lapatinib|lapatinib|mesh-list
83402724|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402725|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83402726|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402727|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402728|NCT03061032|Ribavirin|ribavirin|mesh-list
83402729|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
83402730|NCT03061032|Ledipasvir|ledipasvir|mesh-list
83402731|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
83402732|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402733|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
83402734|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402735|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
83402736|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83402737|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83402738|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402739|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
83402740|NCT02911831|Coagulants|coagulants|mesh-ancestor
83402741|NCT03061734|Acetaminophen|acetaminophen|mesh-list
83402742|NCT03061734|Naltrexone|naltrexone|mesh-list
83402743|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83402744|NCT03061734|Analgesics|analgesics|mesh-ancestor
83402745|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
83402746|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402747|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402748|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
83402749|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83402750|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83402751|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
83402752|NCT03061656|Melphalan|melphalan|mesh-list
83402753|NCT03061656|Thiotepa|thiotepa|mesh-list
83402754|NCT03061656|Carboplatin|carboplatin|mesh-list
83402755|NCT03061656|Etoposide|etoposide|mesh-list
83402756|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83402757|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
83402758|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402759|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83402760|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83402761|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
83402762|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402763|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402764|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83402765|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83402766|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83402767|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83402768|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402769|NCT02906761|Aspirin|aspirin|mesh-list
83402770|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83402771|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83402772|NCT02906761|Analgesics|analgesics|mesh-ancestor
83402773|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
83402774|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83402775|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402776|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83402777|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83402778|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83402779|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83402780|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402781|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83402782|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83402783|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402784|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
83402785|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
83402786|NCT02905591|Paclitaxel|paclitaxel|mesh-list
83402787|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83402788|NCT02905591|Carboplatin|carboplatin|mesh-list
83402789|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83402790|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402791|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
83402792|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
83402793|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
83402794|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402795|NCT02905591|Vitamins|vitamins|mesh-ancestor
83402796|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
83402797|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402798|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
83402799|NCT02905591|Protective Agents|protective agents|mesh-ancestor
83402800|NCT01455025|Plerixafor|plerixafor|mesh-list
83402801|NCT01455025|Lenograstim|lenograstim|mesh-list
83402802|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83402803|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
83402804|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402805|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83402806|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83402807|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
83402808|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402809|NCT03060798|Desflurane|desflurane|mesh-list
83402810|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83402811|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
83402812|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
83402813|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83402814|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402815|NCT01451593|Phenytoin|phenytoin|mesh-list
83402816|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
83402817|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83402818|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83402819|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83402820|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402821|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83402822|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83402823|NCT01455103|BMS-936559|bms-936559|mesh-list
83402824|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83402825|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402826|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402827|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
83402828|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402829|NCT04975074|Iron|iron|mesh-list
83402830|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
83402831|NCT04975074|Trace Elements|trace elements|mesh-ancestor
83402832|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
83402833|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402834|NCT04975074|Hematinics|hematinics|mesh-ancestor
83402835|NCT04963998|Copper|copper|mesh-list
83402836|NCT04963998|Trace Elements|trace elements|mesh-ancestor
83402838|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402839|NCT03148327|Durvalumab|durvalumab|mesh-list
83402840|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402841|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402842|NCT01451905|Liraglutide|liraglutide|mesh-list
83402843|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83402844|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402845|NCT01451905|Incretins|incretins|mesh-ancestor
83402846|NCT01451905|Hormones|hormones|mesh-ancestor
83402847|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402848|NCT01455649|Cyclosporine|cyclosporine|mesh-list
83402849|NCT01455649|Everolimus|everolimus|mesh-list
83402850|NCT01455649|Tacrolimus|tacrolimus|mesh-list
83402851|NCT01455649|Cyclosporins|cyclosporins|mesh-list
83402852|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83402853|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83402854|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
83402855|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402856|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402857|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402858|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
83402859|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83402860|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
83402861|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83402862|NCT01455649|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83402863|NCT01455649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83402864|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402865|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83402866|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
83402867|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402868|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83402869|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83402870|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
83402871|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83402872|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83402873|NCT01455883|Glimepiride|glimepiride|mesh-list
83402874|NCT01455883|Exenatide|exenatide|mesh-list
83402875|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83402876|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83402877|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402878|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83402879|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
83402880|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83402881|NCT01455883|Incretins|incretins|mesh-ancestor
83402882|NCT01455883|Hormones|hormones|mesh-ancestor
83402883|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402884|NCT01452217|Secretin|secretin|mesh-list
83402885|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83402886|NCT01452217|Hormones|hormones|mesh-ancestor
83402887|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402888|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402889|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83402890|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83402891|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402892|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402893|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83402894|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
83402895|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402896|NCT04954560|Losartan|losartan|mesh-list
83402897|NCT04954560|Eprosartan|eprosartan|mesh-list
83402898|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83402899|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83402900|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83402901|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83402902|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402903|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
83402904|NCT01456117|Pioglitazone|pioglitazone|mesh-list
83402905|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83402906|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402907|NCT04962672|Anesthetics|anesthetics|mesh-list
83402908|NCT04962672|Propofol|propofol|mesh-list
83402909|NCT04962672|Sevoflurane|sevoflurane|mesh-list
83402910|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83402911|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402912|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83402914|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
83402915|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83402916|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83402917|NCT03829345|Olaparib|olaparib|mesh-list
83402918|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83402919|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402920|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402921|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402922|NCT01456351|Rituximab|rituximab|mesh-list
83402923|NCT01456351|Fludarabine|fludarabine|mesh-list
83402924|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83402925|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402926|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402927|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
83402928|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402929|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83402930|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402931|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83402932|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
83402933|NCT02541955|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83402934|NCT02541955|Hormones|hormones|mesh-ancestor
83402935|NCT02541955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402936|NCT02541955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402937|NCT01452685|Leuprolide|leuprolide|mesh-list
83402938|NCT01452685|Relugolix|relugolix|mesh-list
83402939|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83402940|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
83402941|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83402942|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402943|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83402944|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402945|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
83402946|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
83402947|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402948|NCT01452763|Lansoprazole|lansoprazole|mesh-list
83402949|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
83402950|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83402951|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83402952|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83402953|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402954|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402955|NCT04954014|Bevacizumab|bevacizumab|mesh-list
83402956|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402957|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402958|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83402959|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83402960|NCT04954014|Growth Substances|growth substances|mesh-ancestor
83402961|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402962|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
83402963|NCT00988559|Imiquimod|imiquimod|mesh-list
83402964|NCT00988559|Vaccines|vaccines|mesh-list
83402965|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
83402966|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83402967|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83402968|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402969|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
83402970|NCT02967289|Irinotecan|irinotecan|mesh-list
83402971|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83402972|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83402973|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402974|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402975|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402976|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83402977|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402978|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83402979|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402980|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402981|NCT02967133|Paclitaxel|paclitaxel|mesh-list
83402982|NCT02967133|Nivolumab|nivolumab|mesh-list
83402983|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83402984|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402985|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
83402988|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402989|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83402990|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83402992|NCT04961970|Gemcitabine|gemcitabine|mesh-list
83402993|NCT04961970|Fluorouracil|fluorouracil|mesh-list
83402994|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
83402995|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83402996|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83402997|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
83402998|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83402999|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83403000|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
83403001|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403002|NCT04961970|Antidotes|antidotes|mesh-ancestor
83403003|NCT04961970|Protective Agents|protective agents|mesh-ancestor
83403004|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
83403005|NCT04961970|Vitamins|vitamins|mesh-ancestor
83403006|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
83403007|NCT01311687|Dexamethasone|dexamethasone|mesh-list
83403008|NCT01311687|Pomalidomide|pomalidomide|mesh-list
83403009|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403010|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
83403011|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
83403012|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403013|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403014|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83403015|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
83403016|NCT01311687|Hormones|hormones|mesh-ancestor
83403017|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83403018|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83403019|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403020|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
83403021|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83403022|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83403023|NCT01311687|Growth Substances|growth substances|mesh-ancestor
83403024|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
83403025|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
83403026|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83403027|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
83403028|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403029|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
83403030|NCT00988091|Protective Agents|protective agents|mesh-ancestor
83403031|NCT04965324|Anesthetics|anesthetics|mesh-list
83403032|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403033|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403034|NCT04961268|Acetaminophen|acetaminophen|mesh-list
83403035|NCT04961268|Ibuprofen|ibuprofen|mesh-list
83403036|NCT04961268|Tramadol|tramadol|mesh-list
83403037|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83403038|NCT04961268|Analgesics|analgesics|mesh-ancestor
83403039|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
83403040|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403041|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403042|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
83403043|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83403044|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403045|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403046|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83403047|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403048|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403049|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83403050|NCT04961268|Narcotics|narcotics|mesh-ancestor
83403051|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403052|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83403053|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
83403054|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403055|NCT01346397|Cyclosporine|cyclosporine|mesh-list
83403056|NCT01346397|Tacrolimus|tacrolimus|mesh-list
83403057|NCT01346397|Cyclosporins|cyclosporins|mesh-list
83403058|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83403059|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
83403060|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403061|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83403062|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403063|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403064|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
83403065|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403070|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83403071|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
83403072|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83403073|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403074|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
83403075|NCT01347255|Hormones|hormones|mesh-ancestor
83403076|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83403077|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403078|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83403079|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
83403080|NCT02908477|Docetaxel|docetaxel|mesh-list
83403081|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403082|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
83403083|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
83403084|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
83403085|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403086|NCT04392427|Ribavirin|ribavirin|mesh-list
83403087|NCT04392427|Ivermectin|ivermectin|mesh-list
83403088|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
83403089|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
83403090|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403091|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
83403092|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403093|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83403094|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
83403095|NCT01457131|Fludarabine|fludarabine|mesh-list
83403096|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83403097|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
83403098|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403099|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403100|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83403101|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
83403102|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403103|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403104|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83403105|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
83403106|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
83403107|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83403108|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83403109|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403110|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83403111|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403112|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403113|NCT01455337|Prednisolone|prednisolone|mesh-list
83403114|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
83403115|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403116|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
83403117|NCT01455337|Hormones|hormones|mesh-ancestor
83403118|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83403119|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403120|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83403121|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403122|NCT01455337|Protective Agents|protective agents|mesh-ancestor
83403123|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83403124|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403125|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403126|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83403127|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83403128|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
83403129|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83403130|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
83403131|NCT03059316|Labetalol|labetalol|mesh-list
83403132|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
83403133|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
83403134|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83403135|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83403136|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
83403137|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403138|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403139|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403140|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83403141|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
83403142|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
83403143|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403144|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83403145|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83403147|NCT01312389|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83403148|NCT01312389|Immunologic Factors|immunologic factors|mesh-ancestor
83403149|NCT01312389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403150|NCT01312389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83403151|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
83403152|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403153|NCT04943952|Asparaginase|asparaginase|mesh-list
83403154|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403155|NCT04410978|Teriflunomide|teriflunomide|mesh-list
83403156|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83403157|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83403158|NCT04410978|Analgesics|analgesics|mesh-ancestor
83403159|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
83403160|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403161|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403162|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403163|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403164|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83403165|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
83403166|NCT01352637|Cycloserine|cycloserine|mesh-list
83403167|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83403168|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403169|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83403170|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
83403171|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83403172|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
83403173|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403174|NCT03058536|Progesterone|progesterone|mesh-list
83403175|NCT03058536|Progestins|progestins|mesh-ancestor
83403177|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83403178|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403179|NCT01314417|Methotrexate|methotrexate|mesh-list
83403180|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83403181|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
83403182|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83403183|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403184|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83403185|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
83413647|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83403186|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403187|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403188|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
83403189|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403190|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83403191|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83403192|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
83403193|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403194|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83403195|NCT01457911|Metformin|metformin|mesh-list
83403196|NCT01457911|Glimepiride|glimepiride|mesh-list
83403197|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83403198|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403199|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83403200|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83403201|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
83403202|NCT02893423|Ropivacaine|ropivacaine|mesh-list
83403203|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
83403204|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
83403205|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403206|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403207|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
83403208|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403209|NCT05586919|Ethanol|ethanol|mesh-list
83403210|NCT05586919|Polidocanol|polidocanol|mesh-list
83403211|NCT05586919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83403212|NCT05586919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403213|NCT05586919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403214|NCT05586919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403215|NCT05586919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83403216|NCT05586919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83403217|NCT01890889|Ezetimibe|ezetimibe|mesh-list
83403218|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83403219|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83403220|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
83403221|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403222|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83403223|NCT04951752|Ropivacaine|ropivacaine|mesh-list
83403224|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
83403225|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
83403226|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403227|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403228|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
83403229|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403230|NCT01315665|Sulforaphane|sulforaphane|mesh-list
83403231|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83403232|NCT01315665|Protective Agents|protective agents|mesh-ancestor
83403233|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403234|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403235|NCT01454089|Carboplatin|carboplatin|mesh-list
83403236|NCT01454089|Gemcitabine|gemcitabine|mesh-list
83403237|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403238|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83403239|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
83403240|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403241|NCT01457989|Ezogabine|ezogabine|mesh-list
83403242|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
83403243|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83403244|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403245|NCT01458067|GSK2636771|gsk2636771|mesh-list
83403246|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403247|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83403248|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403249|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403250|NCT04942860|Methotrexate|methotrexate|mesh-list
83403251|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83403252|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
83403253|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83403254|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403255|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83403256|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
83403257|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403258|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403259|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
83403260|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403261|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83403262|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83403263|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
83403264|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403265|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83403266|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83403267|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83403268|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403269|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
83403270|NCT04959786|Ribavirin|ribavirin|mesh-list
83403271|NCT04959786|Ivermectin|ivermectin|mesh-list
83403272|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
83403273|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
83403274|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403275|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
83403276|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403277|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83403278|NCT01452451|Exenatide|exenatide|mesh-list
83403279|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83403280|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403281|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83403282|NCT01452451|Incretins|incretins|mesh-ancestor
83403283|NCT01452451|Hormones|hormones|mesh-ancestor
83403284|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83403285|NCT04951128|Anesthetics|anesthetics|mesh-list
83403286|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
83403287|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
83403288|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403289|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403290|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83403291|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83403292|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403293|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
83403294|NCT04951128|Coagulants|coagulants|mesh-ancestor
83403295|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
83403296|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403297|NCT01458301|Leuprolide|leuprolide|mesh-list
83403298|NCT01458301|Relugolix|relugolix|mesh-list
83403299|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83403300|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
83403301|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83403302|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403303|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83403304|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403305|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
83403306|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
83403307|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83403308|NCT03059238|Celecoxib|celecoxib|mesh-list
83403309|NCT03059238|Parecoxib|parecoxib|mesh-list
83403310|NCT03059238|Oxycodone|oxycodone|mesh-list
83403311|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83403312|NCT03059238|Narcotics|narcotics|mesh-ancestor
83403313|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403314|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403315|NCT03059238|Analgesics|analgesics|mesh-ancestor
83403316|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
83403317|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403318|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83403319|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83403320|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403321|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403322|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83403323|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83403324|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403325|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403326|NCT01891201|Oxytocin|oxytocin|mesh-list
83403327|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
83403328|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83403329|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403330|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
83403331|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83403332|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83403333|NCT04942002|Prednisolone|prednisolone|mesh-list
83403334|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
83403335|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83403336|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
83403337|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403338|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
83403339|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
83403340|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403341|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403342|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83403343|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
83403344|NCT04942002|Hormones|hormones|mesh-ancestor
83403345|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83403346|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83403347|NCT04942002|Protective Agents|protective agents|mesh-ancestor
83403348|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83403349|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403350|NCT01891435|Acetaminophen|acetaminophen|mesh-list
83403351|NCT01891435|Diclofenac|diclofenac|mesh-list
83403352|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83403353|NCT01891435|Analgesics|analgesics|mesh-ancestor
83403354|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
83403355|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403356|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403357|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
83403358|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83403359|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403360|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403361|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83403362|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403363|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403364|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83403365|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83403366|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83403367|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
83403368|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403369|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403370|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83403371|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83403373|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403374|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83403375|NCT04941846|Nimodipine|nimodipine|mesh-list
83403376|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83403377|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83403378|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83403379|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403380|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83403381|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403382|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
83403383|NCT01891513|Losartan|losartan|mesh-list
83403384|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83403385|NCT01891513|Perindopril|perindopril|mesh-list
83403386|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83403387|NCT01891513|Diuretics|diuretics|mesh-list
83403388|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83403389|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83403390|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83403391|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83403392|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83403393|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403394|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
83403395|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403396|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83403397|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
83403398|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403399|NCT04843423|Cariprazine|cariprazine|mesh-list
83403400|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83403401|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83403402|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403403|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403404|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83403405|NCT01459081|Zanamivir|zanamivir|mesh-list
83403406|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
83403407|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403408|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403409|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403410|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
83403411|NCT04421196|Analgesics|analgesics|mesh-list
83403412|NCT04421196|Narcotics|narcotics|mesh-ancestor
83403413|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403414|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403415|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
83403416|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403417|NCT01459315|Dolutegravir|dolutegravir|mesh-list
83403418|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83403419|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83403420|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403421|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403422|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83403423|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83403424|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
83403425|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403426|NCT04948788|Gemcitabine|gemcitabine|mesh-list
83403427|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
83403428|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83403429|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
83403430|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403431|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403432|NCT02865811|Doxorubicin|doxorubicin|mesh-list
83403433|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83403434|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
83403435|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83403436|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403437|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83403438|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83403439|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403440|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403441|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83403442|NCT02865811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83403443|NCT03058224|Acetaminophen|acetaminophen|mesh-list
83403444|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83403445|NCT03058224|Analgesics|analgesics|mesh-ancestor
83403446|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
83403521|NCT04937946|Fentanyl|fentanyl|mesh-list
83403447|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403448|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403450|NCT04957212|Carboplatin|carboplatin|mesh-list
83403451|NCT04957212|Docetaxel|docetaxel|mesh-list
83403452|NCT04957212|Trastuzumab|trastuzumab|mesh-list
83403453|NCT04957212|Pertuzumab|pertuzumab|mesh-list
83403454|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403455|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
83403456|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
83403457|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
83403458|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403459|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83403460|NCT02879617|Durvalumab|durvalumab|mesh-list
83403461|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83403462|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403463|NCT04390789|Calcium|calcium|mesh-list
83403464|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83403465|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403466|NCT04947774|Immunomodulating Agents|immunomodulating agents|mesh-list
83403467|NCT04947774|Immunologic Factors|immunologic factors|mesh-ancestor
83403468|NCT04947774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403469|NCT04948164|Naproxen|naproxen|mesh-list
83403470|NCT04948164|Sumatriptan|sumatriptan|mesh-list
83403471|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83403472|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83403473|NCT04948164|Analgesics|analgesics|mesh-ancestor
83403474|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
83403475|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403476|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403477|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403478|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403479|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
83403480|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83403481|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403482|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403483|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83403484|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83403485|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83403486|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
83403487|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403488|NCT02808871|Pirfenidone|pirfenidone|mesh-list
83403489|NCT02808871|Analgesics|analgesics|mesh-ancestor
83403490|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
83403491|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403492|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403493|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83403494|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83403495|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403496|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403497|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403498|NCT01892683|Propofol|propofol|mesh-list
83403499|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
83403500|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403501|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403502|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83403503|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83403504|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
83403505|NCT01459627|Ticagrelor|ticagrelor|mesh-list
83403506|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83403507|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83403508|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83403509|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83403510|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83403511|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
83403512|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403513|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403514|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403515|NCT02467621|Pantoprazole|pantoprazole|mesh-list
83403516|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83403517|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83403518|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83403519|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403520|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403524|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403525|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403526|NCT04937946|Analgesics|analgesics|mesh-ancestor
83403527|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
83403528|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403529|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83403530|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83403531|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
83403532|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
83403533|NCT05160987|Midazolam|midazolam|mesh-list
83403534|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83403535|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83403536|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403537|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403538|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83403539|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83403540|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83403541|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83403542|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
83403543|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
83403544|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
83403545|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
83403546|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403547|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403548|NCT01892995|Ketamine|ketamine|mesh-list
83403549|NCT01892995|Analgesics|analgesics|mesh-ancestor
83403550|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
83403551|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403552|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403553|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83403554|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83403555|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
83403556|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
83403557|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403558|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83403559|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83403560|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403561|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403562|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
83403563|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83403564|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83403565|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83403566|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83403567|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403568|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
83403569|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403570|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403571|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83403572|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403573|NCT02181075|Doxorubicin|doxorubicin|mesh-list
83403574|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83403575|NCT02181075|Liver Extracts|liver extracts|mesh-list
83403576|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83403577|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403578|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83403579|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83403580|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403581|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403582|NCT02181075|Hematinics|hematinics|mesh-ancestor
83403583|NCT01359735|Bacitracin|bacitracin|mesh-list
83403584|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83403585|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403586|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83403587|NCT01361217|Midazolam|midazolam|mesh-list
83403588|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
83403589|NCT01361217|Caffeine|caffeine|mesh-list
83403590|NCT01361217|Fluoxetine|fluoxetine|mesh-list
83403591|NCT01361217|Omeprazole|omeprazole|mesh-list
83403592|NCT01361217|Lovastatin|lovastatin|mesh-list
83403593|NCT01361217|L 647318|l 647318|mesh-list
83403594|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
83403595|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83403596|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83403597|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403598|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403599|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83403600|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83403602|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83403603|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
83403604|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
83403605|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
83403606|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
83403607|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403608|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403609|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83403610|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83403611|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403612|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83403613|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83403614|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
83403615|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83403616|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83403617|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83403618|NCT01361217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83403619|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83403620|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83403621|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
83403622|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83403623|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
83403624|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83403625|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83403626|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
83403627|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
83403628|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83403629|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83403630|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83403631|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83403632|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
83403633|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83403634|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83403635|NCT04271839|Fluticasone|fluticasone|mesh-list
83403636|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
83403637|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403638|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83403639|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
83403640|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403641|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403642|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83403643|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
83403644|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
83403645|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83403646|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83403647|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83403648|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83403649|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
83403650|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403651|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403652|NCT04945434|Methamphetamine|methamphetamine|mesh-list
83403653|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83403654|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403655|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
83403656|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
83403657|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403658|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
83403659|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403660|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403662|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83403663|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83403664|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83403665|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83403666|NCT04411758|Propolis|propolis|mesh-list
83403667|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403668|NCT04408560|Acetaminophen|acetaminophen|mesh-list
83403669|NCT04408560|Analgesics|analgesics|mesh-list
83403670|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83403671|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
83403672|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403673|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403674|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
83403675|NCT04844905|Ivermectin|ivermectin|mesh-list
83403679|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403681|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83403682|NCT04418856|Methamphetamine|methamphetamine|mesh-list
83403683|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83403684|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403685|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
83403686|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
83403687|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403688|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
83403689|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403690|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403691|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
83403692|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83403693|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83403694|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83403695|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83403696|NCT01454635|Sertraline|sertraline|mesh-list
83403697|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
83403698|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83403699|NCT01454635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83403700|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83403701|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83403702|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403703|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403704|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
83403705|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403706|NCT02196831|Tesamorelin|tesamorelin|mesh-list
83403707|NCT02196831|Growth Substances|growth substances|mesh-ancestor
83403708|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403709|NCT04944966|Lumefantrine|lumefantrine|mesh-list
83403710|NCT04944966|Artemether|artemether|mesh-list
83403711|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83403712|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
83403713|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83403714|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83403715|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403716|NCT04955262|Nivolumab|nivolumab|mesh-list
83403717|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83403718|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403719|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83403720|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403721|NCT01363479|Dexamethasone|dexamethasone|mesh-list
83403722|NCT01363479|Palonosetron|palonosetron|mesh-list
83403723|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403724|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
83403725|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
83403726|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403727|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403728|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83403729|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
83403730|NCT01363479|Hormones|hormones|mesh-ancestor
83403731|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83403732|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83403733|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403734|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83403735|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83403736|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
83403737|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403738|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403739|NCT01893385|Vitamin D|vitamin d|mesh-list
83403740|NCT01893385|Vitamins|vitamins|mesh-ancestor
83403741|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
83403742|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403743|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83403744|NCT04935450|Dimercaprol|dimercaprol|mesh-list
83403745|NCT04935450|Chelating Agents|chelating agents|mesh-ancestor
83403746|NCT04935450|Sequestering Agents|sequestering agents|mesh-ancestor
83403747|NCT04935450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403748|NCT02181231|Buprenorphine|buprenorphine|mesh-list
83403749|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83403750|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83403751|NCT02181231|Narcotics|narcotics|mesh-ancestor
83403752|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83403754|NCT02181231|Analgesics|analgesics|mesh-ancestor
83403755|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
83403756|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403757|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83403758|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83403759|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83403760|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83403761|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403762|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403763|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83403764|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
83403765|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83403766|NCT04922034|Amoxicillin|amoxicillin|mesh-list
83403767|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83403768|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403769|NCT01364259|Amifostine|amifostine|mesh-list
83403770|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83403771|NCT01364259|Protective Agents|protective agents|mesh-ancestor
83403772|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403773|NCT01321437|Axitinib|axitinib|mesh-list
83403774|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403775|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83403776|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403777|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403778|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
83403779|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403780|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
83403781|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83403782|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83403783|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403784|NCT01365585|Urological Agents|urological agents|mesh-ancestor
83403785|NCT02664181|Nivolumab|nivolumab|mesh-list
83403786|NCT02664181|Decitabine|decitabine|mesh-list
83403787|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
83403788|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83403789|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403790|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83403791|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403792|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83403793|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
83403794|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403795|NCT04407390|Niacinamide|niacinamide|mesh-list
83403796|NCT04407390|Niacin|niacin|mesh-list
83403797|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
83403798|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
83403799|NCT04407390|Vitamins|vitamins|mesh-ancestor
83403800|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
83403801|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403802|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83403803|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
83403804|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403805|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83403806|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
83403807|NCT02181387|Acetaminophen|acetaminophen|mesh-list
83403808|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83403809|NCT02181387|Analgesics|analgesics|mesh-ancestor
83403810|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
83403811|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403812|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403813|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
83403814|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
83403815|NCT04921878|Analgesics|analgesics|mesh-ancestor
83403816|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
83403817|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403818|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403819|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403820|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83403821|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83403822|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403823|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403824|NCT04351347|Ivermectin|ivermectin|mesh-list
83403825|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83403826|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403829|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403831|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
83403832|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403833|NCT04921566|Torsemide|torsemide|mesh-list
83403834|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83403835|NCT04921566|Diuretics|diuretics|mesh-ancestor
83403836|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
83403837|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403838|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83403839|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83403840|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403841|NCT02655601|Manganese|manganese|mesh-list
83403842|NCT02655601|Temozolomide|temozolomide|mesh-list
83403843|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83403844|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
83403845|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403846|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403847|NCT02655601|Trace Elements|trace elements|mesh-ancestor
83403848|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
83403849|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403850|NCT02652247|Dimercaprol|dimercaprol|mesh-list
83403851|NCT02652247|Chelating Agents|chelating agents|mesh-ancestor
83403852|NCT02652247|Sequestering Agents|sequestering agents|mesh-ancestor
83403853|NCT02652247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403854|NCT04934514|Gemcitabine|gemcitabine|mesh-list
83403855|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403856|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83403857|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
83403858|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403859|NCT01365819|Varenicline|varenicline|mesh-list
83403860|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83403861|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83403862|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
83403863|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403864|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403865|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403866|NCT02635555|Phenylephrine|phenylephrine|mesh-list
83403867|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
83403868|NCT02635555|Ephedrine|ephedrine|mesh-list
83403869|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83403870|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
83403871|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
83403872|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403873|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403874|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
83403875|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83403876|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
83403877|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
83403878|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83403879|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83403880|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83403881|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
83403882|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403883|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403884|NCT02635555|Protective Agents|protective agents|mesh-ancestor
83403885|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83403886|NCT01893541|Propranolol|propranolol|mesh-list
83403887|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83403888|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83403889|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
83403890|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83403891|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403892|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403893|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83403894|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83403895|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
83403896|NCT02849899|Vildagliptin|vildagliptin|mesh-list
83403897|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83403898|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403899|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83403900|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
83403901|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403902|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403904|NCT02771197|Fludarabine|fludarabine|mesh-list
83403905|NCT02771197|Melphalan|melphalan|mesh-list
83403906|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83403907|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403908|NCT02771197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83403909|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403910|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83403911|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
83403912|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403913|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83403914|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
83403915|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83403916|NCT01369875|Aldesleukin|aldesleukin|mesh-list
83403917|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
83403918|NCT01369875|Fludarabine|fludarabine|mesh-list
83403919|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83403920|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
83403921|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403922|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403923|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83403924|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
83403925|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403926|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403927|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83403928|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83403929|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83403930|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
83403931|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403932|NCT02620189|Adalimumab|adalimumab|mesh-list
83403933|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
83403934|NCT02620189|Etanercept|etanercept|mesh-list
83403935|NCT02620189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83403936|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403937|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403938|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83403939|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83403940|NCT02620189|Analgesics|analgesics|mesh-ancestor
83403941|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
83403942|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403943|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403944|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83403945|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83403946|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
83403947|NCT02763319|Rituximab|rituximab|mesh-list
83403948|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83403949|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83403950|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403951|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
83403952|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403953|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403954|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83403955|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
83403956|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403957|NCT02755597|Dexamethasone|dexamethasone|mesh-list
83403959|NCT02755597|Venetoclax|venetoclax|mesh-list
83403960|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83403961|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
83403962|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
83403963|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403964|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403965|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83403966|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
83403967|NCT02755597|Hormones|hormones|mesh-ancestor
83403968|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83403969|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83403970|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403971|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
83403972|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83403973|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83403974|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
83403975|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403976|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83403979|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83403980|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83403981|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
83403982|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
83403983|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
83403984|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403985|NCT02197065|Atorvastatin|atorvastatin|mesh-list
83403986|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83403987|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83403988|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
83403989|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403990|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83403991|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83403992|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83403993|NCT04405596|Ambroxol|ambroxol|mesh-list
83403994|NCT04405596|Expectorants|expectorants|mesh-ancestor
83403995|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
83403996|NCT01375491|Doxycycline|doxycycline|mesh-list
83403997|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83403998|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403999|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
83404000|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83404001|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83404002|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
83404003|NCT02591251|Povidone|povidone|mesh-list
83404004|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83404005|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
83404006|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
83404007|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83404008|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404009|NCT01325181|Ranibizumab|ranibizumab|mesh-list
83404010|NCT01325181|Verteporfin|verteporfin|mesh-list
83404011|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83404012|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83404013|NCT01325181|Growth Substances|growth substances|mesh-ancestor
83404014|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404015|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
83404016|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404017|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83404018|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
83404019|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83404020|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83404021|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404022|NCT04238637|Durvalumab|durvalumab|mesh-list
83404023|NCT04238637|Tremelimumab|tremelimumab|mesh-list
83404024|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83404025|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404026|NCT02588443|Paclitaxel|paclitaxel|mesh-list
83404027|NCT02588443|Gemcitabine|gemcitabine|mesh-list
83404028|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83404029|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404030|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
83404031|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
83404032|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
83404033|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404034|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83404035|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
83404036|NCT02741323|Maraviroc|maraviroc|mesh-list
83404037|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83404038|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83404039|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404040|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83404041|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83404042|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
83404043|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404044|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83404045|NCT02582359|Cytarabine|cytarabine|mesh-list
83404046|NCT02582359|Daunorubicin|daunorubicin|mesh-list
83404047|NCT02582359|Ixazomib|ixazomib|mesh-list
83404048|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83404049|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
83404050|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404051|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404052|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
83404053|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404054|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83404055|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
83404056|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404057|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83404058|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83404059|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83404060|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404061|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
83404062|NCT00227253|Hormones|hormones|mesh-list
83404063|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404064|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404065|NCT05021809|Calcium|calcium|mesh-list
83404066|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83404067|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404068|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
83404069|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83404070|NCT02730715|Basiliximab|basiliximab|mesh-list
83404071|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
83404072|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404073|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83404074|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
83404075|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
83404076|NCT04919460|Coagulants|coagulants|mesh-ancestor
83404077|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
83404078|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404079|NCT04037241|Leucovorin|leucovorin|mesh-list
83404080|NCT04037241|Paclitaxel|paclitaxel|mesh-list
83404081|NCT04037241|Gemcitabine|gemcitabine|mesh-list
83404082|NCT04037241|Capecitabine|capecitabine|mesh-list
83404083|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83404084|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404085|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
83404086|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
83404087|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
83404088|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404089|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83404090|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
83404091|NCT04037241|Antidotes|antidotes|mesh-ancestor
83404092|NCT04037241|Protective Agents|protective agents|mesh-ancestor
83404093|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404094|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
83404095|NCT04037241|Vitamins|vitamins|mesh-ancestor
83404096|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
83404097|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83404098|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83404099|NCT04912128|Growth Substances|growth substances|mesh-ancestor
83404100|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404101|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
83404102|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404103|NCT01327677|Fentanyl|fentanyl|mesh-list
83404104|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83404105|NCT01327677|Narcotics|narcotics|mesh-ancestor
83404106|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83404107|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404108|NCT01327677|Analgesics|analgesics|mesh-ancestor
83404109|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
83404110|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404111|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83404112|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83404113|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
83404114|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
83404115|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
83404116|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83404117|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83404118|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83404119|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83404120|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404121|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
83404122|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83404123|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404124|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83404125|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404126|NCT04918914|Dapsone|dapsone|mesh-list
83404127|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404128|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
83404129|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83404130|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83404132|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404133|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404134|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
83404135|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83404136|NCT04918524|Aspirin|aspirin|mesh-list
83404137|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
83404138|NCT04918524|Prednisone|prednisone|mesh-list
83404139|NCT04918524|Heparin|heparin|mesh-list
83404140|NCT04918524|Enoxaparin|enoxaparin|mesh-list
83404141|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83404142|NCT04918524|Tinzaparin|tinzaparin|mesh-list
83404143|NCT04918524|Dalteparin|dalteparin|mesh-list
83404144|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83404145|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
83404146|NCT04918524|Hormones|hormones|mesh-ancestor
83404147|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404148|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404149|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83404150|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404151|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83404152|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83404153|NCT04918524|Analgesics|analgesics|mesh-ancestor
83404154|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
83404155|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404156|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83404157|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83404158|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83404159|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404160|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83404161|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83404162|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404163|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
83404164|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
83404165|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
83404166|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83404167|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83404168|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404169|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
83404170|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83404171|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83404172|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404173|NCT05586763|Promethazine|promethazine|mesh-list
83404174|NCT05586763|Diphenhydramine|diphenhydramine|mesh-list
83404175|NCT05586763|Metoclopramide|metoclopramide|mesh-list
83404176|NCT05586763|Antiemetics|antiemetics|mesh-ancestor
83404177|NCT05586763|Autonomic Agents|autonomic agents|mesh-ancestor
83404178|NCT05586763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404179|NCT05586763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404180|NCT05586763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83404181|NCT05586763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83404182|NCT05586763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83404183|NCT05586763|Dopamine Agents|dopamine agents|mesh-ancestor
83404184|NCT05586763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83404185|NCT05586763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404186|NCT05586763|Antipruritics|antipruritics|mesh-ancestor
83404187|NCT05586763|Dermatologic Agents|dermatologic agents|mesh-ancestor
83404188|NCT05586763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83404189|NCT05586763|Histamine Antagonists|histamine antagonists|mesh-ancestor
83404190|NCT05586763|Histamine Agents|histamine agents|mesh-ancestor
83404191|NCT05586763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83404192|NCT05586763|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83404193|NCT05586763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83404194|NCT05586763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83404195|NCT05586763|Anesthetics, Local|anesthetics, local|mesh-ancestor
83404196|NCT05586763|Anesthetics|anesthetics|mesh-ancestor
83404197|NCT05586763|Sensory System Agents|sensory system agents|mesh-ancestor
83404198|NCT01328769|Febuxostat|febuxostat|mesh-list
83404199|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
83404200|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83404201|NCT02552641|Amoxicillin|amoxicillin|mesh-list
83404202|NCT02552641|Clarithromycin|clarithromycin|mesh-list
83404203|NCT02552641|Esomeprazole|esomeprazole|mesh-list
83404204|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83404205|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404206|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83404207|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83404208|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83404209|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404210|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404211|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83404212|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83404213|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83404214|NCT02620020|Fasinumab|fasinumab|mesh-list
83404215|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83404216|NCT02620020|Analgesics|analgesics|mesh-ancestor
83404217|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
83404218|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404219|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404220|NCT02551237|Capecitabine|capecitabine|mesh-list
83404221|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83404222|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
83404223|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404224|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404225|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
83404226|NCT01378299|Testosterone|testosterone|mesh-list
83404227|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
83404228|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
83404229|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83404230|NCT01378299|Androgens|androgens|mesh-ancestor
83404231|NCT01378299|Hormones|hormones|mesh-ancestor
83404232|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404233|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404234|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83404235|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404236|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
83404237|NCT04929522|Anesthetics|anesthetics|mesh-list
83404238|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83404239|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404240|NCT02549833|Poly I-C|poly i-c|mesh-list
83404241|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83404242|NCT02549833|Poly ICLC|poly iclc|mesh-list
83404243|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
83404244|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
83404245|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404246|NCT02549833|Laxatives|laxatives|mesh-ancestor
83404247|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83404248|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
83404249|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404250|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83404251|NCT02542969|Simvastatin|simvastatin|mesh-list
83404252|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83404253|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83404254|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
83404255|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404256|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83404257|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83404258|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404259|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
83404260|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
83404261|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83404262|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
83404263|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404265|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83404266|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
83404267|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404268|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404269|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83404270|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83404271|NCT02414269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83404272|NCT04928586|Pirfenidone|pirfenidone|mesh-list
83404273|NCT04928586|Analgesics|analgesics|mesh-ancestor
83404274|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
83404275|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404276|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404277|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83404278|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83404279|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83404280|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83404281|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404282|NCT03054168|Goserelin|goserelin|mesh-list
83404283|NCT03054168|Testosterone|testosterone|mesh-list
83404285|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404286|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404287|NCT03054168|Androgens|androgens|mesh-ancestor
83404288|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83404289|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404290|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
83404291|NCT02518945|Liraglutide|liraglutide|mesh-list
83404292|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83404293|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404294|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83404295|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404296|NCT02518945|Incretins|incretins|mesh-ancestor
83404297|NCT02518945|Hormones|hormones|mesh-ancestor
83404298|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404299|NCT02390869|Rituximab|rituximab|mesh-list
83404300|NCT02390869|Lenalidomide|lenalidomide|mesh-list
83404301|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83404302|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404303|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
83404304|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404305|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83404306|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83404307|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83404308|NCT02390869|Growth Substances|growth substances|mesh-ancestor
83404309|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
83404310|NCT04757779|Docetaxel|docetaxel|mesh-list
83404311|NCT04757779|Irinotecan|irinotecan|mesh-list
83404312|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404313|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
83404314|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
83404315|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
83404316|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404317|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83404318|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83404319|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404320|NCT03053856|Paclitaxel|paclitaxel|mesh-list
83404321|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
83404322|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83404323|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404324|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
83404325|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
83404326|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
83404327|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404328|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83404329|NCT03053856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83404330|NCT02389309|Sirolimus|sirolimus|mesh-list
83404331|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
83404332|NCT02389309|Temsirolimus|temsirolimus|mesh-list
83404333|NCT02389309|Dasatinib|dasatinib|mesh-list
83404334|NCT02389309|MTOR Inhibitors|mtor inhibitors|mesh-list
83404335|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83404336|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
83404337|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404338|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83404339|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83404340|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
83404341|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404342|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404343|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83404344|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83404345|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404346|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83404347|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
83404348|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83404349|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404350|NCT02489695|Axitinib|axitinib|mesh-list
83404351|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404352|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83404353|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404354|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404355|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
83404356|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83404357|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
83404358|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404359|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404360|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83404361|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
83404362|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83404363|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
83404364|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404365|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83404366|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83404367|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
83404368|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
83404369|NCT03053388|Protective Agents|protective agents|mesh-ancestor
83404370|NCT03053544|Metformin|metformin|mesh-list
83404371|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83404372|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404373|NCT02384083|Dexamethasone|dexamethasone|mesh-list
83404374|NCT02384083|Pomalidomide|pomalidomide|mesh-list
83404375|NCT02384083|Filanesib|filanesib|mesh-list
83404376|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83404377|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
83404378|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
83404379|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404380|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404381|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83404382|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
83404383|NCT02384083|Hormones|hormones|mesh-ancestor
83404384|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404385|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83404386|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404387|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
83404388|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83404389|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83404390|NCT02384083|Growth Substances|growth substances|mesh-ancestor
83404391|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
83404392|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
83404393|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83404394|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404395|NCT04926480|Anesthetics|anesthetics|mesh-list
83404396|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83404397|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404398|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
83404399|NCT02484391|Cytarabine|cytarabine|mesh-list
83404400|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
83404401|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83404402|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
83404403|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404404|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404405|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
83404406|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404407|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83404408|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
83404409|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404410|NCT02484391|Analgesics|analgesics|mesh-ancestor
83404411|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
83404412|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404413|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83404414|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83404415|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404416|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
83404417|NCT02484391|Protective Agents|protective agents|mesh-ancestor
83404418|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
83404419|NCT02484391|Vitamins|vitamins|mesh-ancestor
83404420|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
83404421|NCT03053622|Mirikizumab|mirikizumab|mesh-list
83404422|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83404423|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83404424|NCT03053622|Analgesics|analgesics|mesh-ancestor
83404425|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
83404426|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404427|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404428|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83404429|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83404430|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83404431|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83404432|NCT02380573|Methylene Blue|methylene blue|mesh-list
83404433|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404434|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404435|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
83404436|NCT02461537|Analgesics|analgesics|mesh-ancestor
83404437|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
83404438|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404439|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404440|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404441|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83404442|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83404443|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404444|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404445|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83404446|NCT05028673|Antacids|antacids|mesh-list
83404447|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83404448|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83404449|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
83404450|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404451|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404452|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83404453|NCT04916574|Antibodies|antibodies|mesh-list
83404454|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
83404455|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404456|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
83404457|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83404458|NCT02460445|Cyproterone|cyproterone|mesh-list
83404459|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83404460|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83404461|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83404462|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
83404463|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83404464|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404465|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83404466|NCT02460445|Estrogens|estrogens|mesh-ancestor
83404467|NCT02460445|Hormones|hormones|mesh-ancestor
83404468|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404469|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
83404470|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
83404471|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404472|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83404473|NCT02455687|Budesonide|budesonide|mesh-list
83404474|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
83404475|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83404476|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83404477|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
83404478|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404479|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404480|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83404481|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
83404482|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
83404483|NCT02455687|Hormones|hormones|mesh-ancestor
83404484|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404485|NCT02455687|Analgesics|analgesics|mesh-ancestor
83404486|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
83404487|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
83404488|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83404489|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83404490|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
83404491|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83404492|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83404493|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404494|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83404495|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
83404496|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83404497|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
83404498|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83404499|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404500|NCT05023837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83404501|NCT05023837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404502|NCT02358967|Vitamin E|vitamin e|mesh-list
83404503|NCT02358967|Tocopherols|tocopherols|mesh-list
83404504|NCT02358967|Tocotrienols|tocotrienols|mesh-list
83404505|NCT02358967|Vitamins|vitamins|mesh-ancestor
83404506|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
83404507|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404508|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
83404509|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404510|NCT02358967|Protective Agents|protective agents|mesh-ancestor
83404511|NCT03052998|Ivermectin|ivermectin|mesh-list
83404515|NCT05586061|Tislelizumab|tislelizumab|mesh-list
83404516|NCT05586061|Disitamab vedotin|disitamab vedotin|mesh-list
83404517|NCT05586061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83404518|NCT05586061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404519|NCT05586061|Immunoconjugates|immunoconjugates|mesh-ancestor
83404520|NCT05586061|Immunologic Factors|immunologic factors|mesh-ancestor
83404521|NCT05586061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404522|NCT02354131|Bevacizumab|bevacizumab|mesh-list
83404523|NCT02354131|Niraparib|niraparib|mesh-list
83404524|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83404525|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404526|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83404527|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83404528|NCT02354131|Growth Substances|growth substances|mesh-ancestor
83404529|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404530|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
83404531|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83404532|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404533|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404534|NCT02352337|Gemcitabine|gemcitabine|mesh-list
83404535|NCT02352337|Folfirinox|folfirinox|mesh-list
83404536|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83404537|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
83404538|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404539|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404540|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
83404541|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83404542|NCT02827201|Paclitaxel|paclitaxel|mesh-list
83404543|NCT02827201|Gemcitabine|gemcitabine|mesh-list
83404544|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83404545|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404546|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
83404547|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
83404548|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
83404549|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404550|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83404551|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
83404552|NCT02346253|Leuprolide|leuprolide|mesh-list
83404553|NCT02346253|Goserelin|goserelin|mesh-list
83404554|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83404555|NCT02346253|Bicalutamide|bicalutamide|mesh-list
83404556|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83404557|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
83404558|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83404559|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404560|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83404561|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404562|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
83404563|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
83404564|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404565|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
83404566|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83404567|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
83404568|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83404569|NCT01378377|Niacinamide|niacinamide|mesh-list
83404570|NCT01378377|Sirolimus|sirolimus|mesh-list
83404571|NCT01378377|Temsirolimus|temsirolimus|mesh-list
83404572|NCT01378377|MTOR Inhibitors|mtor inhibitors|mesh-list
83404573|NCT01378377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83404574|NCT01378377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404575|NCT01378377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404576|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83404577|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
83404578|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404579|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404580|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83404581|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404582|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83404583|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
83404584|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
83404585|NCT01378377|Vitamins|vitamins|mesh-ancestor
83404586|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
83404587|NCT03012321|Prednisone|prednisone|mesh-list
83404588|NCT03012321|Olaparib|olaparib|mesh-list
83404589|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
83404590|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83404591|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
83404593|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404594|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404595|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83404596|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404597|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83404598|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404599|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404600|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83404601|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
83404602|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83404603|NCT03009045|Tedizolid|tedizolid|mesh-list
83404604|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
83404605|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
83404606|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83404607|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404608|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83404609|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404610|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404611|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
83404613|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83404614|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83404615|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404616|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83404617|NCT03056274|Metformin|metformin|mesh-list
83404618|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83404619|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83404620|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404621|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83404622|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83404623|NCT03056118|Aspirin|aspirin|mesh-list
83404624|NCT03056118|Clopidogrel|clopidogrel|mesh-list
83404625|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83404626|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83404627|NCT03056118|Analgesics|analgesics|mesh-ancestor
83404628|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
83404629|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404630|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404631|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83404632|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83404633|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83404634|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83404635|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404636|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83404637|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83404638|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404639|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
83404640|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83404641|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83404642|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83404643|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
83404644|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83404645|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83404646|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83404647|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
83404648|NCT00987935|Sorafenib|sorafenib|mesh-list
83404649|NCT00987935|Nintedanib|nintedanib|mesh-list
83404650|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404651|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83404652|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404653|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404654|NCT00987467|Cyclosporine|cyclosporine|mesh-list
83404655|NCT00987467|Cyclosporins|cyclosporins|mesh-list
83404656|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404657|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404658|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83404659|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
83404660|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404661|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
83404662|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404663|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
83404666|NCT05874440|Tenofovir|tenofovir|mesh-list
83404667|NCT05874440|Antiviral Agents|antiviral agents|mesh-ancestor
83404668|NCT05874440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404669|NCT05874440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83404670|NCT05874440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83404671|NCT05874440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404672|NCT05874440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404673|NCT05874440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83404674|NCT05874440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83404675|NCT05874219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83404676|NCT05874219|Mupirocin|mupirocin|mesh-list
83404677|NCT05874219|Neomycin|neomycin|mesh-list
83404678|NCT05874219|Bacitracin|bacitracin|mesh-list
83404679|NCT05874219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404680|NCT05874219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83404681|NCT05874219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404682|NCT05874219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404683|NCT05874219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83404684|NCT05874180|Metformin|metformin|mesh-list
83404685|NCT05874180|Linagliptin|linagliptin|mesh-list
83404686|NCT05874180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83404687|NCT05874180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404688|NCT05874180|Incretins|incretins|mesh-ancestor
83404689|NCT05874180|Hormones|hormones|mesh-ancestor
83404690|NCT05874180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404691|NCT05874180|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83404692|NCT05874180|Protease Inhibitors|protease inhibitors|mesh-ancestor
83404693|NCT05874180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404694|NCT05874180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404695|NCT05874167|Metformin|metformin|mesh-list
83404696|NCT05874167|Linagliptin|linagliptin|mesh-list
83404697|NCT05874167|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83404698|NCT05874167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404699|NCT05874167|Incretins|incretins|mesh-ancestor
83404700|NCT05874167|Hormones|hormones|mesh-ancestor
83404701|NCT05874167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404702|NCT05874167|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83404703|NCT05874167|Protease Inhibitors|protease inhibitors|mesh-ancestor
83404704|NCT05874167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404705|NCT05874167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404706|NCT05874154|Botulinum Toxins|botulinum toxins|mesh-list
83404707|NCT05874154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83404708|NCT05874154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83404709|NCT05874154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404710|NCT05874154|Cholinergic Agents|cholinergic agents|mesh-ancestor
83404711|NCT05874154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83404712|NCT05874154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404714|NCT05874141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404715|NCT05874141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404716|NCT05873972|Cetuximab|cetuximab|mesh-list
83404717|NCT05873972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83404718|NCT05873972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404719|NCT05873881|Thiamine|thiamine|mesh-list
83404720|NCT05873881|Colchicine|colchicine|mesh-list
83404721|NCT05873881|Gout Suppressants|gout suppressants|mesh-ancestor
83404722|NCT05873881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83404723|NCT05873881|Tubulin Modulators|tubulin modulators|mesh-ancestor
83404724|NCT05873881|Antimitotic Agents|antimitotic agents|mesh-ancestor
83404725|NCT05873881|Mitosis Modulators|mitosis modulators|mesh-ancestor
83404726|NCT05873881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404727|NCT05873881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404728|NCT05873881|Vitamin B Complex|vitamin b complex|mesh-ancestor
83404729|NCT05873881|Vitamins|vitamins|mesh-ancestor
83404730|NCT05873881|Micronutrients|micronutrients|mesh-ancestor
83404731|NCT05873881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404732|NCT05873751|Vaccines|vaccines|mesh-list
83404733|NCT05873751|Immunologic Factors|immunologic factors|mesh-ancestor
83404734|NCT05873751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404735|NCT05873738|Nicotine|nicotine|mesh-list
83404736|NCT05873738|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83404737|NCT05873738|Autonomic Agents|autonomic agents|mesh-ancestor
83404738|NCT05873738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404739|NCT05873738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404743|NCT05873738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83404744|NCT05873738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404745|NCT05873712|Cyclophosphamide|cyclophosphamide|mesh-list
83404746|NCT05873712|Fludarabine|fludarabine|mesh-list
83404747|NCT05873712|Zanubrutinib|zanubrutinib|mesh-list
83404748|NCT05873712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83404749|NCT05873712|Immunologic Factors|immunologic factors|mesh-ancestor
83404750|NCT05873712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404751|NCT05873712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83404752|NCT05873712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83404753|NCT05873712|Alkylating Agents|alkylating agents|mesh-ancestor
83404754|NCT05873712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404755|NCT05873712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404756|NCT05873712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83404757|NCT05873712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83404758|NCT05873712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404759|NCT05873673|Ubiquinone|ubiquinone|mesh-list
83404760|NCT05873673|Coenzyme Q10|coenzyme q10|mesh-list
83404761|NCT05873673|Micronutrients|micronutrients|mesh-ancestor
83404762|NCT05873673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404763|NCT05873673|Vitamins|vitamins|mesh-ancestor
83404764|NCT05873465|Fentanyl|fentanyl|mesh-list
83404765|NCT05873465|Midazolam|midazolam|mesh-list
83404766|NCT05873465|Propofol|propofol|mesh-list
83404767|NCT05873465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83404768|NCT05873465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83404769|NCT05873465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404770|NCT05873465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83404771|NCT05873465|Anesthetics, General|anesthetics, general|mesh-ancestor
83404772|NCT05873465|Anesthetics|anesthetics|mesh-ancestor
83404773|NCT05873465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83404774|NCT05873465|Narcotics|narcotics|mesh-ancestor
83404775|NCT05873465|Analgesics|analgesics|mesh-ancestor
83404776|NCT05873465|Sensory System Agents|sensory system agents|mesh-ancestor
83404777|NCT05873465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404778|NCT05873465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83404779|NCT05873465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83404780|NCT05873465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83404781|NCT05873465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83404782|NCT05873465|GABA Modulators|gaba modulators|mesh-ancestor
83404783|NCT05873465|GABA Agents|gaba agents|mesh-ancestor
83404784|NCT05873465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83404785|NCT05873465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404786|NCT05873244|Sorafenib|sorafenib|mesh-list
83404787|NCT05873244|Lenvatinib|lenvatinib|mesh-list
83404788|NCT05873244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404789|NCT05873244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83404790|NCT05873244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404791|NCT05873244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404793|NCT05873218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83404794|NCT05873218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404795|NCT05873218|Sympathomimetics|sympathomimetics|mesh-ancestor
83404796|NCT05873218|Autonomic Agents|autonomic agents|mesh-ancestor
83404797|NCT05873218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404798|NCT05873218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83404799|NCT05873218|Adrenergic Agents|adrenergic agents|mesh-ancestor
83404800|NCT05873218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413648|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83404801|NCT05873218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404802|NCT05873192|Talazoparib|talazoparib|mesh-list
83404803|NCT05873192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83404804|NCT05873192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404805|NCT05873192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404806|NCT05873192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404807|NCT05872932|Botulinum Toxins|botulinum toxins|mesh-list
83404808|NCT05872932|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83404809|NCT05872932|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83404810|NCT05872932|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83404811|NCT05872932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83404812|NCT05872932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404813|NCT05872932|Cholinergic Agents|cholinergic agents|mesh-ancestor
83404814|NCT05872932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83404815|NCT05872932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404816|NCT05872932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83404817|NCT05872932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404818|NCT05872893|Dexamethasone|dexamethasone|mesh-list
83404819|NCT05872893|Ondansetron|ondansetron|mesh-list
83404820|NCT05872893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83404821|NCT05872893|Antiemetics|antiemetics|mesh-ancestor
83404822|NCT05872893|Autonomic Agents|autonomic agents|mesh-ancestor
83404823|NCT05872893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404824|NCT05872893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404825|NCT05872893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83404826|NCT05872893|Glucocorticoids|glucocorticoids|mesh-ancestor
83404827|NCT05872893|Hormones|hormones|mesh-ancestor
83404828|NCT05872893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404829|NCT05872893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83404830|NCT05872893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404831|NCT05872893|Antipruritics|antipruritics|mesh-ancestor
83404832|NCT05872893|Dermatologic Agents|dermatologic agents|mesh-ancestor
83404833|NCT05872893|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83404834|NCT05872893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83404835|NCT05872893|Serotonin Agents|serotonin agents|mesh-ancestor
83404836|NCT05872893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83404837|NCT05872893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404838|NCT05872867|Pembrolizumab|pembrolizumab|mesh-list
83404839|NCT05872867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83404840|NCT05872867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404841|NCT05872867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83404842|NCT05872867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404843|NCT05872698|Carvedilol|carvedilol|mesh-list
83404844|NCT05872698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83404845|NCT05872698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83404846|NCT05872698|Adrenergic Agents|adrenergic agents|mesh-ancestor
83404847|NCT05872698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83404848|NCT05872698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404849|NCT05872698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404850|NCT05872698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83404851|NCT05872698|Antioxidants|antioxidants|mesh-ancestor
83404852|NCT05872698|Protective Agents|protective agents|mesh-ancestor
83404853|NCT05872698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83404854|NCT05872698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83404855|NCT05872698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83404856|NCT05872698|Vasodilator Agents|vasodilator agents|mesh-ancestor
83404857|NCT05872698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83404858|NCT05872698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83404859|NCT05872685|Oxaliplatin|oxaliplatin|mesh-list
83404860|NCT05872685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404861|NCT05872568|Mycophenolic Acid|mycophenolic acid|mesh-list
83404862|NCT05872568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83404863|NCT05872568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404864|NCT05872568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83404865|NCT05872568|Antitubercular Agents|antitubercular agents|mesh-ancestor
83404866|NCT05872568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83404867|NCT05872568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404868|NCT05872568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404869|NCT05872568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404870|NCT05872555|Antipsychotic Agents|antipsychotic agents|mesh-list
83404871|NCT05872555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83404872|NCT05872555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83404873|NCT05872555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404874|NCT05872555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83404875|NCT05872451|Bromides|bromides|mesh-list
83404876|NCT05872451|Rocuronium|rocuronium|mesh-list
83404877|NCT05872451|Anticonvulsants|anticonvulsants|mesh-ancestor
83404878|NCT05872451|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83404879|NCT05872451|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83404880|NCT05872451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83404881|NCT05872451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404882|NCT05872451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404883|NCT05872386|Buprenorphine|buprenorphine|mesh-list
83404884|NCT05872386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83404885|NCT05872386|Narcotics|narcotics|mesh-ancestor
83404886|NCT05872386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83404887|NCT05872386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404888|NCT05872386|Analgesics|analgesics|mesh-ancestor
83404889|NCT05872386|Sensory System Agents|sensory system agents|mesh-ancestor
83404890|NCT05872386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404891|NCT05872386|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83404892|NCT05872256|Halobetasol|halobetasol|mesh-list
83404893|NCT05872256|Tazarotene|tazarotene|mesh-list
83404896|NCT05872256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83404898|NCT05872204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404899|NCT05872204|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83404900|NCT05872204|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83404901|NCT05872204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404902|NCT05872204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404903|NCT05872204|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83404904|NCT05872204|Hormone Antagonists|hormone antagonists|mesh-ancestor
83404905|NCT05872204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83404906|NCT05872204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404907|NCT05872087|Midazolam|midazolam|mesh-list
83404908|NCT05872087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83404909|NCT05872087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83404910|NCT05872087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83404911|NCT05872087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404912|NCT05872087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83404913|NCT05872087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83404914|NCT05872087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83404915|NCT05872087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83404916|NCT05872087|Anesthetics, General|anesthetics, general|mesh-ancestor
83404917|NCT05872087|Anesthetics|anesthetics|mesh-ancestor
83404918|NCT05872087|GABA Modulators|gaba modulators|mesh-ancestor
83404919|NCT05872087|GABA Agents|gaba agents|mesh-ancestor
83404920|NCT05872087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83404921|NCT05872087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404922|NCT05871619|Fluorides|fluorides|mesh-list
83404923|NCT05871619|Fluorides, Topical|fluorides, topical|mesh-list
83404924|NCT05871619|Cariostatic Agents|cariostatic agents|mesh-ancestor
83404925|NCT05871619|Protective Agents|protective agents|mesh-ancestor
83404926|NCT05871619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404927|NCT05871177|Hyaluronic Acid|hyaluronic acid|mesh-list
83404928|NCT05871177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83404929|NCT05871177|Immunologic Factors|immunologic factors|mesh-ancestor
83404930|NCT05871177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404931|NCT05871177|Viscosupplements|viscosupplements|mesh-ancestor
83404932|NCT05871177|Protective Agents|protective agents|mesh-ancestor
83404933|NCT05870800|Leucovorin|leucovorin|mesh-list
83404934|NCT05870800|Fluorouracil|fluorouracil|mesh-list
83404935|NCT05870800|Capecitabine|capecitabine|mesh-list
83404936|NCT05870800|Oxaliplatin|oxaliplatin|mesh-list
83404937|NCT05870800|Atezolizumab|atezolizumab|mesh-list
83404938|NCT05870800|Antimetabolites|antimetabolites|mesh-ancestor
83404939|NCT05870800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404940|NCT05870800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83404941|NCT05870800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404942|NCT05870800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83404943|NCT05870800|Immunologic Factors|immunologic factors|mesh-ancestor
83404944|NCT05870800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404945|NCT05870800|Antidotes|antidotes|mesh-ancestor
83404946|NCT05870800|Protective Agents|protective agents|mesh-ancestor
83404947|NCT05870800|Vitamin B Complex|vitamin b complex|mesh-ancestor
83404949|NCT05870800|Micronutrients|micronutrients|mesh-ancestor
83404950|NCT05870800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83404951|NCT05870800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83404952|NCT05870319|Carboplatin|carboplatin|mesh-list
83404953|NCT05870319|Pemetrexed|pemetrexed|mesh-list
83404954|NCT05870319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404955|NCT05870319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83404956|NCT05870319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404957|NCT05870319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83404958|NCT05870319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83404959|NCT05869357|Turmeric extract|turmeric extract|mesh-list
83404960|NCT05869357|Antioxidants|antioxidants|mesh-ancestor
83404961|NCT05869357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404962|NCT05869357|Protective Agents|protective agents|mesh-ancestor
83404963|NCT05869357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404964|NCT05869188|Isotretinoin|isotretinoin|mesh-list
83404965|NCT05869188|Dermatologic Agents|dermatologic agents|mesh-ancestor
83404966|NCT05868889|Trabectedin|trabectedin|mesh-list
83404967|NCT05868889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83404968|NCT05868889|Alkylating Agents|alkylating agents|mesh-ancestor
83404969|NCT05868889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404970|NCT05868889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404971|NCT05868174|Peposertib|peposertib|mesh-list
83404972|NCT05868174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83404974|NCT05868174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404976|NCT05865457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83404977|NCT05865379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83404978|NCT05865379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83404979|NCT05855967|Ixekizumab|ixekizumab|mesh-list
83404980|NCT05855967|Dermatologic Agents|dermatologic agents|mesh-ancestor
83404981|NCT05849740|Daratumumab|daratumumab|mesh-list
83404982|NCT05849740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83404983|NCT05813587|Meplazumab|meplazumab|mesh-list
83404984|NCT05813587|Antiviral Agents|antiviral agents|mesh-ancestor
83404985|NCT05813587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404986|NCT05811676|Tranexamic Acid|tranexamic acid|mesh-list
83404987|NCT05811676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83404988|NCT05811676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83404989|NCT05811676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83404990|NCT05811676|Hemostatics|hemostatics|mesh-ancestor
83404991|NCT05811676|Coagulants|coagulants|mesh-ancestor
83404992|NCT05803421|Insulin Glargine|insulin glargine|mesh-list
83404993|NCT05803421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83404994|NCT05803421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83404995|NCT05799326|Levofloxacin|levofloxacin|mesh-list
83404996|NCT05799326|Ofloxacin|ofloxacin|mesh-list
83404997|NCT05799326|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83404998|NCT05799326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404999|NCT05799326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83405000|NCT05799326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83405001|NCT05799326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83405002|NCT05799326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405003|NCT05799326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405004|NCT05799326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405005|NCT05799326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83405006|NCT05799326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83405007|NCT05797467|Bevacizumab|bevacizumab|mesh-list
83405008|NCT05797467|Cetuximab|cetuximab|mesh-list
83405009|NCT05797467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405010|NCT05797467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405011|NCT05797467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83405012|NCT05797467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83405013|NCT05797467|Growth Substances|growth substances|mesh-ancestor
83405014|NCT05797467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405015|NCT05797467|Growth Inhibitors|growth inhibitors|mesh-ancestor
83405016|NCT05796973|Atorvastatin|atorvastatin|mesh-list
83405017|NCT05796973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83405018|NCT05796973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83405019|NCT05796973|Antimetabolites|antimetabolites|mesh-ancestor
83405020|NCT05796973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405021|NCT05796973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83405022|NCT05796973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83405023|NCT05796973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405024|NCT05795153|Remibrutinib|remibrutinib|mesh-list
83405025|NCT05795153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83405026|NCT05795153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405027|NCT05795153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405028|NCT05766553|Nicotine|nicotine|mesh-list
83405029|NCT05766553|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83405030|NCT05766553|Autonomic Agents|autonomic agents|mesh-ancestor
83405031|NCT05766553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405032|NCT05766553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405033|NCT05766553|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83405034|NCT05766553|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83405035|NCT05766553|Cholinergic Agents|cholinergic agents|mesh-ancestor
83405036|NCT05766553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405037|NCT05766553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405038|NCT05756777|Ivosidenib|ivosidenib|mesh-list
83405039|NCT05756777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405040|NCT05756777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405041|NCT05756777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405042|NCT05742841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83405043|NCT05742841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83405044|NCT05742841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83405045|NCT05742841|Antimetabolites|antimetabolites|mesh-ancestor
83405046|NCT05742841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405047|NCT05742841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83405048|NCT05742841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83405050|NCT05741905|Levofloxacin|levofloxacin|mesh-list
83405051|NCT05741905|Ofloxacin|ofloxacin|mesh-list
83405052|NCT05741905|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83405053|NCT05741905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405054|NCT05741905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83405055|NCT05741905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83405056|NCT05741905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83405057|NCT05741905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405058|NCT05741905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405059|NCT05741905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405060|NCT05741905|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83405061|NCT05741905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83405062|NCT05741658|Dapagliflozin|dapagliflozin|mesh-list
83405063|NCT05741658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83405064|NCT05741658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405065|NCT05741658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405066|NCT05741658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405067|NCT05739123|Relugolix|relugolix|mesh-list
83405068|NCT05739123|Androgen Antagonists|androgen antagonists|mesh-ancestor
83405069|NCT05739123|Hormone Antagonists|hormone antagonists|mesh-ancestor
83405070|NCT05739123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405071|NCT05739123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405072|NCT05733923|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83405073|NCT05733923|Eusol|eusol|mesh-list
83405074|NCT05733923|Disinfectants|disinfectants|mesh-ancestor
83405075|NCT05733923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405076|NCT05733741|Benoxinate|benoxinate|mesh-list
83405077|NCT05733741|Hyaluronic Acid|hyaluronic acid|mesh-list
83405078|NCT05733741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83405079|NCT05733741|Immunologic Factors|immunologic factors|mesh-ancestor
83405080|NCT05733741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405081|NCT05733741|Viscosupplements|viscosupplements|mesh-ancestor
83405082|NCT05733741|Protective Agents|protective agents|mesh-ancestor
83405083|NCT05733741|Anesthetics, Local|anesthetics, local|mesh-ancestor
83405084|NCT05733741|Anesthetics|anesthetics|mesh-ancestor
83405085|NCT05733741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83405086|NCT05733741|Sensory System Agents|sensory system agents|mesh-ancestor
83405087|NCT05733741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405088|NCT05711082|Dopamine|dopamine|mesh-list
83405089|NCT05711082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83405090|NCT05711082|Sympathomimetics|sympathomimetics|mesh-ancestor
83405091|NCT05711082|Autonomic Agents|autonomic agents|mesh-ancestor
83405092|NCT05711082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405093|NCT05711082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405094|NCT05711082|Dopamine Agents|dopamine agents|mesh-ancestor
83405095|NCT05711082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405096|NCT05711082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405097|NCT05711082|Protective Agents|protective agents|mesh-ancestor
83405098|NCT05708950|Pembrolizumab|pembrolizumab|mesh-list
83405099|NCT05708950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405100|NCT05708950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405101|NCT05708950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83405102|NCT05708950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405103|NCT05706506|Tirzepatide|tirzepatide|mesh-list
83405104|NCT05706506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405105|NCT05706506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405106|NCT05706506|Incretins|incretins|mesh-ancestor
83405107|NCT05706506|Hormones|hormones|mesh-ancestor
83405108|NCT05706506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405109|NCT05694637|Varenicline|varenicline|mesh-list
83405110|NCT05694637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83405111|NCT05694637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83405112|NCT05694637|Cholinergic Agents|cholinergic agents|mesh-ancestor
83405113|NCT05694637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405114|NCT05694637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405115|NCT05694637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405116|NCT05689463|Immunoglobulins|immunoglobulins|mesh-list
83405117|NCT05689463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83405118|NCT05689463|Antibodies|antibodies|mesh-list
83405119|NCT05689463|Immunologic Factors|immunologic factors|mesh-ancestor
83405120|NCT05689463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405121|NCT05686993|Nifedipine|nifedipine|mesh-list
83405124|NCT05686993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83405125|NCT05686993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405126|NCT05686993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83405127|NCT05686993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405128|NCT05686993|Vasodilator Agents|vasodilator agents|mesh-ancestor
83405129|NCT05686993|Tocolytic Agents|tocolytic agents|mesh-ancestor
83405130|NCT05686993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83405131|NCT05686993|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83405132|NCT05686993|Histamine Antagonists|histamine antagonists|mesh-ancestor
83405133|NCT05686993|Histamine Agents|histamine agents|mesh-ancestor
83405134|NCT05686993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405135|NCT05673577|Cetuximab|cetuximab|mesh-list
83405136|NCT05673577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405137|NCT05673577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405138|NCT05658146|Sulconazole|sulconazole|mesh-list
83405139|NCT05658146|Antifungal Agents|antifungal agents|mesh-ancestor
83405140|NCT05658146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405141|NCT05591755|Ketotifen|ketotifen|mesh-list
83405142|NCT05591755|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83405143|NCT05591755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83405144|NCT05591755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83405145|NCT05591755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83405146|NCT05591755|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83405147|NCT05591755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83405148|NCT05591755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83405149|NCT05591755|Adrenergic Agents|adrenergic agents|mesh-ancestor
83405150|NCT05591755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405151|NCT05591755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405152|NCT05591755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405153|NCT05591755|Antipruritics|antipruritics|mesh-ancestor
83405154|NCT05591755|Dermatologic Agents|dermatologic agents|mesh-ancestor
83405155|NCT05591755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83405156|NCT05591755|Histamine Antagonists|histamine antagonists|mesh-ancestor
83405157|NCT05591755|Histamine Agents|histamine agents|mesh-ancestor
83405158|NCT05591755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83405159|NCT05579730|Ketotifen|ketotifen|mesh-list
83405160|NCT05579730|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83405161|NCT05579730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83405162|NCT05579730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83405163|NCT05579730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83405164|NCT05579730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83405165|NCT05579730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83405166|NCT05579730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83405167|NCT05579730|Adrenergic Agents|adrenergic agents|mesh-ancestor
83405168|NCT05579730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405169|NCT05579730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405170|NCT05579730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405171|NCT05579730|Antipruritics|antipruritics|mesh-ancestor
83405172|NCT05579730|Dermatologic Agents|dermatologic agents|mesh-ancestor
83405173|NCT05579730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83405174|NCT05579730|Histamine Antagonists|histamine antagonists|mesh-ancestor
83405175|NCT05579730|Histamine Agents|histamine agents|mesh-ancestor
83405176|NCT05579730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83405177|NCT05540223|Sirolimus|sirolimus|mesh-list
83405178|NCT05540223|Everolimus|everolimus|mesh-list
83405179|NCT05540223|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83405180|NCT05540223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83405181|NCT05540223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405182|NCT05540223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405183|NCT05540223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83405184|NCT05540223|Immunologic Factors|immunologic factors|mesh-ancestor
83405185|NCT05540223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405186|NCT05540223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405187|NCT05540223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83405188|NCT05540223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405189|NCT05540223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83405190|NCT05540223|Antifungal Agents|antifungal agents|mesh-ancestor
83405191|NCT05536804|Tirzepatide|tirzepatide|mesh-list
83405192|NCT05536804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405193|NCT05536804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405194|NCT05536804|Incretins|incretins|mesh-ancestor
83405195|NCT05536804|Hormones|hormones|mesh-ancestor
83405196|NCT05536804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405197|NCT05533164|Rituximab|rituximab|mesh-list
83405198|NCT05533164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405199|NCT05533164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405201|NCT05533164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405202|NCT05533164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83405203|NCT05533125|Rituximab|rituximab|mesh-list
83405204|NCT05533125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405205|NCT05533125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405206|NCT05533125|Immunologic Factors|immunologic factors|mesh-ancestor
83405207|NCT05533125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405208|NCT05533125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83405209|NCT05525455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83405210|NCT05525455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405211|NCT05525455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405212|NCT05525455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405213|NCT05520567|Azacitidine|azacitidine|mesh-list
83405214|NCT05520567|Venetoclax|venetoclax|mesh-list
83405215|NCT05520567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83405216|NCT05520567|Antimetabolites|antimetabolites|mesh-ancestor
83405217|NCT05520567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405218|NCT05520567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405219|NCT05520567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405220|NCT05498155|Durvalumab|durvalumab|mesh-list
83405221|NCT05498155|Olaparib|olaparib|mesh-list
83405222|NCT05498155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405223|NCT05498155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405224|NCT05498155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83405225|NCT05498155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405226|NCT05498155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405227|NCT05463744|Insulin|insulin|mesh-list
83405228|NCT05463744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83405229|NCT05463744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405230|NCT05463744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405231|NCT05462756|Insulin|insulin|mesh-list
83405232|NCT05462756|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83405233|NCT05462756|Insulin Glargine|insulin glargine|mesh-list
83405234|NCT05462756|Insulin Lispro|insulin lispro|mesh-list
83405235|NCT05462756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405236|NCT05462756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405237|NCT05433584|Tirzepatide|tirzepatide|mesh-list
83405238|NCT05433584|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83405239|NCT05433584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405240|NCT05433584|Incretins|incretins|mesh-ancestor
83405241|NCT05433584|Hormones|hormones|mesh-ancestor
83405242|NCT05433584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405243|NCT05407584|Paclitaxel|paclitaxel|mesh-list
83405244|NCT05407584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83405245|NCT05407584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405246|NCT05407584|Tubulin Modulators|tubulin modulators|mesh-ancestor
83405247|NCT05407584|Antimitotic Agents|antimitotic agents|mesh-ancestor
83405248|NCT05407584|Mitosis Modulators|mitosis modulators|mesh-ancestor
83405249|NCT05407584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405250|NCT05370885|Vancomycin|vancomycin|mesh-list
83405251|NCT05370885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83405252|NCT05370885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405253|NCT05362058|Insulin|insulin|mesh-list
83405254|NCT05362058|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83405255|NCT05362058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405256|NCT05362058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405257|NCT05335122|Bimatoprost|bimatoprost|mesh-list
83405258|NCT05335122|Travoprost|travoprost|mesh-list
83405259|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83405260|NCT05321251|Insulin|insulin|mesh-list
83405261|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405262|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405263|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
83405264|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83405265|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
83405266|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
83405267|NCT05294588|Cefixime|cefixime|mesh-list
83405268|NCT05294588|Vaccines|vaccines|mesh-list
83405269|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
83405270|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405271|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83405272|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405273|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83405426|NCT04977986|Cannabidiol|cannabidiol|mesh-list
83405274|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83405275|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405276|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405277|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405278|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83405279|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83405281|NCT05288166|Prednisolone|prednisolone|mesh-list
83405282|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83405283|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
83405284|NCT05288166|Hormones|hormones|mesh-ancestor
83405285|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405286|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405287|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83405288|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405289|NCT05287906|Cardiac Glycosides|cardiac glycosides|mesh-list
83405290|NCT05287906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83405291|NCT05287906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83405292|NCT05287906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405293|NCT05287906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405294|NCT05287906|Protective Agents|protective agents|mesh-ancestor
83405295|NCT05287906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405296|NCT05286814|Leucovorin|leucovorin|mesh-list
83405297|NCT05286814|Dexamethasone|dexamethasone|mesh-list
83405298|NCT05286814|Gemcitabine|gemcitabine|mesh-list
83405299|NCT05286814|Fluorouracil|fluorouracil|mesh-list
83405300|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
83405301|NCT05286814|Irinotecan|irinotecan|mesh-list
83405302|NCT05286814|Floxuridine|floxuridine|mesh-list
83405303|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83405304|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
83405305|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
83405306|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405307|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405308|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83405309|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
83405310|NCT05286814|Hormones|hormones|mesh-ancestor
83405311|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405312|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83405313|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405314|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83405315|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
83405316|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405318|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
83405319|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83405320|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83405321|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405322|NCT05286814|Antidotes|antidotes|mesh-ancestor
83405323|NCT05286814|Protective Agents|protective agents|mesh-ancestor
83405324|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
83405325|NCT05286814|Vitamins|vitamins|mesh-ancestor
83405326|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
83405327|NCT05260021|Tirzepatide|tirzepatide|mesh-list
83405328|NCT05260021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405329|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405330|NCT05260021|Incretins|incretins|mesh-ancestor
83405331|NCT05260021|Hormones|hormones|mesh-ancestor
83405332|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405333|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
83405334|NCT05188508|Temozolomide|temozolomide|mesh-list
83405335|NCT05188508|Olaparib|olaparib|mesh-list
83405336|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405337|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405338|NCT05188508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83405339|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405340|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83405341|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
83405342|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83405343|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405344|NCT05170139|Caffeine|caffeine|mesh-list
83405345|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83405346|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405347|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83405348|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405349|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405350|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83405351|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83405352|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
83405353|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405354|NCT05169567|Fulvestrant|fulvestrant|mesh-list
83405355|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83405356|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405357|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83405358|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83405359|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
83405360|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405361|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405362|NCT05140811|Azacitidine|azacitidine|mesh-list
83405363|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83405364|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
83405365|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405366|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405367|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405368|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83405369|NCT05117398|Dalbavancin|dalbavancin|mesh-list
83405370|NCT05117398|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83405371|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405372|NCT05117398|Antitubercular Agents|antitubercular agents|mesh-ancestor
83405373|NCT05096169|Citric Acid|citric acid|mesh-list
83405374|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
83405375|NCT05096169|Clomiphene|clomiphene|mesh-list
83405376|NCT05096169|Enclomiphene|enclomiphene|mesh-list
83405377|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
83405378|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
83405379|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83405380|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
83405381|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
83405382|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405383|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83405384|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
83405385|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405386|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405387|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83405388|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
83405389|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83405390|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83405391|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83405392|NCT05079841|Oxytocin|oxytocin|mesh-list
83405393|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
83405394|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83405395|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405396|NCT05046184|Midazolam|midazolam|mesh-list
83405397|NCT05046184|Ketamine|ketamine|mesh-list
83405398|NCT05046184|Analgesics|analgesics|mesh-ancestor
83405399|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
83405400|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405401|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405402|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83405403|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83405404|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
83405405|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
83405406|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83405407|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83405408|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83405409|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405410|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405411|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83405412|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83405413|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83405414|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83405415|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83405416|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
83405417|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
83405418|NCT05033522|Sorafenib|sorafenib|mesh-list
83405419|NCT05033522|Lenvatinib|lenvatinib|mesh-list
83405420|NCT05033522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405421|NCT05033522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83405422|NCT05033522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405423|NCT05033522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405424|NCT05020028|Cannabidiol|cannabidiol|mesh-list
83405425|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
83405429|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83405430|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83405431|NCT04976868|Analgesics|analgesics|mesh-ancestor
83405432|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
83405433|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405434|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405435|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83405436|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83405437|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
83405438|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83405439|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
83405440|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83405441|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405442|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405443|NCT04976855|Buprenorphine|buprenorphine|mesh-list
83405444|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83405445|NCT04976855|Naloxone|naloxone|mesh-list
83405446|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83405447|NCT04976855|Narcotics|narcotics|mesh-ancestor
83405448|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83405449|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405450|NCT04976855|Analgesics|analgesics|mesh-ancestor
83405451|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
83405452|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405453|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83405454|NCT04975308|Fulvestrant|fulvestrant|mesh-list
83405455|NCT04975308|Exemestane|exemestane|mesh-list
83405456|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83405457|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405458|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83405459|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83405460|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
83405461|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405462|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405463|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83405464|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83405465|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405466|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405467|NCT04944654|Emtricitabine|emtricitabine|mesh-list
83405468|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
83405469|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405470|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83405471|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83405472|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405473|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405474|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83405475|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83405476|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
83405477|NCT04939623|Probenecid|probenecid|mesh-list
83405478|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
83405479|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
83405480|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83405481|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
83405482|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405483|NCT04939597|Memantine|memantine|mesh-list
83405484|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83405485|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83405486|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
83405487|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405488|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405489|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405490|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83405491|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83405492|NCT04933227|Capecitabine|capecitabine|mesh-list
83405493|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
83405494|NCT04933227|Atezolizumab|atezolizumab|mesh-list
83405495|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83405496|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
83405497|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405498|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405499|NCT04933227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83405500|NCT04933227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405501|NCT04886232|Lidocaine|lidocaine|mesh-list
83405502|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
83405503|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
83405504|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83405505|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405506|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
83405507|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405508|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83405509|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83405510|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83405511|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83405512|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405514|NCT04885712|Pioglitazone|pioglitazone|mesh-list
83405515|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
83405516|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405517|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405518|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83405519|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405520|NCT04843046|Pioglitazone|pioglitazone|mesh-list
83405521|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405522|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405523|NCT04789499|Theophylline|theophylline|mesh-list
83405524|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83405525|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
83405526|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405527|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405528|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83405529|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
83405530|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83405531|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405532|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405533|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
83405534|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83405535|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83405536|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
83405537|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405538|NCT04774380|Carboplatin|carboplatin|mesh-list
83405539|NCT04774380|Etoposide|etoposide|mesh-list
83405540|NCT04774380|Durvalumab|durvalumab|mesh-list
83405541|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405542|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83405543|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83405544|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83405545|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405546|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405547|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405548|NCT04706130|Artesunate|artesunate|mesh-list
83405549|NCT04706130|Primaquine|primaquine|mesh-list
83405550|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
83405551|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83405552|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83405553|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405554|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405555|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
83405556|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
83405557|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83405558|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
83405559|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
83405560|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83405561|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
83405562|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405563|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
83405564|NCT04697823|Protective Agents|protective agents|mesh-ancestor
83405565|NCT04675827|Trastuzumab|trastuzumab|mesh-list
83405566|NCT04675827|Pertuzumab|pertuzumab|mesh-list
83405567|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83405568|NCT04675827|Maytansine|maytansine|mesh-list
83405569|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405570|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405571|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83405572|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
83405573|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
83405574|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
83405575|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405576|NCT04675827|Immunotoxins|immunotoxins|mesh-ancestor
83405577|NCT04675827|Immunoconjugates|immunoconjugates|mesh-ancestor
83405578|NCT04675827|Immunologic Factors|immunologic factors|mesh-ancestor
83405580|NCT04674683|Nivolumab|nivolumab|mesh-list
83405581|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405582|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405583|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83405584|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405585|NCT04674462|Vaccines|vaccines|mesh-list
83405586|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
83405587|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405588|NCT04670679|Pembrolizumab|pembrolizumab|mesh-list
83405589|NCT04670679|Cetuximab|cetuximab|mesh-list
83405590|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405591|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405592|NCT04670679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83405593|NCT04670679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405594|NCT04665843|Atezolizumab|atezolizumab|mesh-list
83405595|NCT04665843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83405596|NCT04665843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405597|NCT04665843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405598|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405599|NCT04657016|Tirzepatide|tirzepatide|mesh-list
83405600|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405601|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405602|NCT04657016|Incretins|incretins|mesh-ancestor
83405603|NCT04657016|Hormones|hormones|mesh-ancestor
83405604|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405605|NCT04641871|Irinotecan|irinotecan|mesh-list
83405606|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83405607|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83405608|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405609|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405610|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405611|NCT04638036|Cetuximab|cetuximab|mesh-list
83405612|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405613|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405615|NCT04598074|Narcotics|narcotics|mesh-ancestor
83405616|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83405617|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405618|NCT04598074|Analgesics|analgesics|mesh-ancestor
83405619|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
83405620|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405621|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
83405622|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
83405623|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83405624|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83405625|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405626|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405627|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405628|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83405629|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
83405630|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83405631|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83405632|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405633|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
83405634|NCT04560010|Coagulants|coagulants|mesh-ancestor
83405635|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
83405636|NCT04558866|Testosterone|testosterone|mesh-list
83405637|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
83405638|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
83405639|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83405640|NCT04558866|Androgens|androgens|mesh-ancestor
83405641|NCT04558866|Hormones|hormones|mesh-ancestor
83405642|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405643|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405644|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83405645|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405646|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
83405647|NCT04557020|Gemcitabine|gemcitabine|mesh-list
83405648|NCT04557020|Cisplatin|cisplatin|mesh-list
83405649|NCT04557020|Antibodies|antibodies|mesh-list
83405650|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
83405651|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405652|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83405653|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
83405654|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405655|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405656|NCT04457258|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83405657|NCT04457258|FAPI-46|fapi-46|mesh-list
83405658|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83405659|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405660|NCT04430452|Durvalumab|durvalumab|mesh-list
83405661|NCT04430452|Ipilimumab|ipilimumab|mesh-list
83405662|NCT04430452|Tremelimumab|tremelimumab|mesh-list
83405663|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
83405664|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83405665|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
83405666|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405667|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405668|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
83405669|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405670|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83405671|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405672|NCT04402073|Vincristine|vincristine|mesh-list
83405673|NCT04402073|Lomustine|lomustine|mesh-list
83405674|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405675|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83405676|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
83405677|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
83405678|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
83405679|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405680|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83405681|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
83405682|NCT04397679|Chloroquine|chloroquine|mesh-list
83405683|NCT04397679|Temozolomide|temozolomide|mesh-list
83405684|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83405685|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
83405686|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405687|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405688|NCT04397679|Amebicides|amebicides|mesh-ancestor
83405689|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83405690|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83405691|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405692|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
83405693|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83405694|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
83405695|NCT04363164|Testosterone|testosterone|mesh-list
83405696|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
83405697|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
83405698|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83405699|NCT04363164|Androgens|androgens|mesh-ancestor
83405700|NCT04363164|Hormones|hormones|mesh-ancestor
83405701|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405702|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405703|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83405704|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405705|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
83405706|NCT04293393|Paclitaxel|paclitaxel|mesh-list
83405707|NCT04293393|Docetaxel|docetaxel|mesh-list
83405708|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
83405709|NCT04293393|Doxorubicin|doxorubicin|mesh-list
83405710|NCT04293393|Letrozole|letrozole|mesh-list
83405711|NCT04293393|Leuprolide|leuprolide|mesh-list
83405712|NCT04293393|Goserelin|goserelin|mesh-list
83405714|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83405715|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405716|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
83405717|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
83405718|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
83405719|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405720|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83405721|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
83405722|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405723|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83405724|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83405725|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
83405726|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83405727|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83405728|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83405729|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83405730|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405732|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83405733|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83405734|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
83405735|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405736|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83405738|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83405739|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83405740|NCT04258423|Everolimus|everolimus|mesh-list
83405741|NCT04258423|Tacrolimus|tacrolimus|mesh-list
83405742|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83405743|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
83405744|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405745|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83405746|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405747|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405748|NCT04258423|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83405749|NCT04258423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83405750|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405751|NCT04255433|Dulaglutide|dulaglutide|mesh-list
83405752|NCT04255433|Tirzepatide|tirzepatide|mesh-list
83405753|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405754|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405755|NCT04255433|Incretins|incretins|mesh-ancestor
83405756|NCT04255433|Hormones|hormones|mesh-ancestor
83405757|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405758|NCT04211987|Cytarabine|cytarabine|mesh-list
83405759|NCT04211987|Methotrexate|methotrexate|mesh-list
83405760|NCT04211987|Etoposide|etoposide|mesh-list
83405761|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83405762|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
83405763|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405764|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405765|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
83405766|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405767|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83405768|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
83405769|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405770|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83405771|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83405772|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83405773|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405774|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83405775|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
83405776|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83405777|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
83405778|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83405779|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83405780|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83405781|NCT04190433|Carvedilol|carvedilol|mesh-list
83405782|NCT04190433|Lisinopril|lisinopril|mesh-list
83405783|NCT04190433|Spironolactone|spironolactone|mesh-list
83405784|NCT04190433|Pravastatin|pravastatin|mesh-list
83405785|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83405786|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
83405787|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405788|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405789|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83405790|NCT04190433|Diuretics|diuretics|mesh-ancestor
83405791|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
83405792|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83405793|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83405794|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
83405795|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405796|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405797|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83405798|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
83405799|NCT04190433|Protective Agents|protective agents|mesh-ancestor
83405800|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83405801|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83405802|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83405803|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
83405804|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83405805|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83405806|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83405807|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83405808|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
83405809|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83405810|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83405811|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405812|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83405813|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
83405814|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83405816|NCT04177810|Cemiplimab|cemiplimab|mesh-list
83405817|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83405818|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83405819|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
83405820|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405821|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405822|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405823|NCT04166773|Tirzepatide|tirzepatide|mesh-list
83405824|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83405825|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405826|NCT04166773|Incretins|incretins|mesh-ancestor
83405827|NCT04166773|Hormones|hormones|mesh-ancestor
83405828|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405829|NCT04163900|Gemcitabine|gemcitabine|mesh-list
83405830|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405831|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83405832|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
83405833|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405834|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83405835|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
83405836|NCT04146038|Azacitidine|azacitidine|mesh-list
83405837|NCT04146038|Decitabine|decitabine|mesh-list
83405838|NCT04146038|Venetoclax|venetoclax|mesh-list
83405839|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83405840|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
83405841|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405842|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405843|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405844|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83405845|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83405846|NCT04146038|Analgesics|analgesics|mesh-ancestor
83405847|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
83405848|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405849|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405850|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83405851|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83405852|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83405853|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
83405854|NCT04145349|Vinorelbine|vinorelbine|mesh-list
83405855|NCT04145349|Ramucirumab|ramucirumab|mesh-list
83405856|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83405857|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
83405858|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405859|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83405860|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83405861|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
83405862|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405863|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405864|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83405865|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83405866|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
83405867|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
83405868|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
83405869|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
83405870|NCT04109885|Promethazine|promethazine|mesh-list
83405871|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
83405872|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83405873|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83405874|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83405875|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405876|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
83405877|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
83405878|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
83405879|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405880|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
83405881|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
83405882|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83405883|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83405884|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
83405885|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
83405886|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405887|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405888|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83405889|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
83405890|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
83405891|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83405892|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83405893|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83405894|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83405895|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
83405896|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
83405897|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405898|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405899|NCT04098068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83405900|NCT04098068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405901|NCT04087668|Anesthetics|anesthetics|mesh-list
83405902|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83405903|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405904|NCT04025372|Bicalutamide|bicalutamide|mesh-list
83405905|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
83405906|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
83405907|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405908|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405909|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405910|NCT04006873|Ivacaftor|ivacaftor|mesh-list
83405911|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83405912|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83405913|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405914|NCT03984448|Prednisone|prednisone|mesh-list
83405915|NCT03984448|Cortisone|cortisone|mesh-list
83405916|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
83405917|NCT03984448|Rituximab|rituximab|mesh-list
83405918|NCT03984448|Doxorubicin|doxorubicin|mesh-list
83405920|NCT03984448|Etoposide|etoposide|mesh-list
83405921|NCT03984448|Vincristine|vincristine|mesh-list
83405922|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
83405923|NCT03984448|Venetoclax|venetoclax|mesh-list
83405924|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
83405925|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83405926|NCT03984448|Antibodies|antibodies|mesh-list
83405927|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
83405928|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83405929|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83405930|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
83405931|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405932|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83405933|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83405934|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
83405935|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405936|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405937|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83405938|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83405939|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83405940|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83405941|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405942|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83405943|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
83405944|NCT03984448|Hormones|hormones|mesh-ancestor
83405945|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83405946|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83405947|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83405948|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
83405949|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
83405950|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
83405951|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
83405952|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
83405953|NCT03972488|Octreotide|octreotide|mesh-list
83405954|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83405955|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83405956|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83405957|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405958|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83405959|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405961|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83405962|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83405963|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83405964|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83405965|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83405966|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
83405967|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83405968|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405969|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83405970|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
83405971|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
83405972|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
83405973|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83405974|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83405975|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
83405976|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83405977|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405978|NCT03878095|Olaparib|olaparib|mesh-list
83405979|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83405980|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405981|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405982|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405983|NCT03824483|Venetoclax|venetoclax|mesh-list
83405984|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
83405985|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
83405986|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83405987|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83405988|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83405989|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405990|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83405991|NCT03820310|Immunomodulating Agents|immunomodulating agents|mesh-list
83405992|NCT03820310|Immunologic Factors|immunologic factors|mesh-ancestor
83405993|NCT03820310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405995|NCT03780673|Simvastatin|simvastatin|mesh-list
83405996|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83405997|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83405998|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
83405999|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406000|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83406001|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83406002|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406003|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83406004|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83406005|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83406006|NCT03779334|Risdiplam|risdiplam|mesh-list
83406007|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83406008|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406009|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406010|NCT03769311|Cetuximab|cetuximab|mesh-list
83406011|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406012|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406013|NCT03767335|Trastuzumab|trastuzumab|mesh-list
83406014|NCT03767335|Fulvestrant|fulvestrant|mesh-list
83406015|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406016|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406017|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83406018|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83406019|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83406020|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
83406021|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406022|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406023|NCT03746106|Thiamine|thiamine|mesh-list
83406024|NCT03746106|Metformin|metformin|mesh-list
83406025|NCT03746106|Trimethoprim|trimethoprim|mesh-list
83406026|NCT03746106|Vitamins|vitamins|mesh-ancestor
83406027|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
83406028|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406029|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83406030|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
83406031|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83406032|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83406033|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
83406036|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83406038|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406039|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83406040|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83406041|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83406042|NCT03745430|Ramucirumab|ramucirumab|mesh-list
83406043|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406044|NCT03692052|Mitapivat|mitapivat|mesh-list
83406045|NCT03692052|Enzyme Activators|enzyme activators|mesh-ancestor
83406046|NCT03692052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406047|NCT03651882|Oxytocin|oxytocin|mesh-list
83406048|NCT03651882|Carbetocin|carbetocin|mesh-list
83406049|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
83406050|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83406051|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406052|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
83406053|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83406054|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
83406055|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83406056|NCT03636932|Expectorants|expectorants|mesh-ancestor
83406057|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
83406058|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83406059|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
83406060|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406061|NCT03636932|Protective Agents|protective agents|mesh-ancestor
83406062|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406063|NCT03636932|Antidotes|antidotes|mesh-ancestor
83406064|NCT05910554|Metformin|metformin|mesh-list
83406065|NCT05910554|Glyburide|glyburide|mesh-list
83406066|NCT05910554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83406067|NCT05910554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406068|NCT05910476|Ezetimibe|ezetimibe|mesh-list
83406069|NCT05910476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83406070|NCT05910476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83406071|NCT05910476|Antimetabolites|antimetabolites|mesh-ancestor
83406072|NCT05910476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406073|NCT05910476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83406074|NCT05910450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83406075|NCT05910190|Buprenorphine|buprenorphine|mesh-list
83406076|NCT05910190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83406077|NCT05910190|Narcotics|narcotics|mesh-ancestor
83406078|NCT05910190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406079|NCT05910190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406080|NCT05910190|Analgesics|analgesics|mesh-ancestor
83406081|NCT05910190|Sensory System Agents|sensory system agents|mesh-ancestor
83406082|NCT05910190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406083|NCT05910190|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83406084|NCT05910177|Etoposide|etoposide|mesh-list
83406085|NCT05910177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406086|NCT05910177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83406087|NCT05910177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83406088|NCT05910177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83406089|NCT05910177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406090|NCT05910177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406091|NCT05910125|Aspirin|aspirin|mesh-list
83406092|NCT05910125|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83406093|NCT05910125|Clopidogrel|clopidogrel|mesh-list
83406094|NCT05910125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83406095|NCT05910125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83406096|NCT05910125|Analgesics|analgesics|mesh-ancestor
83406097|NCT05910125|Sensory System Agents|sensory system agents|mesh-ancestor
83406098|NCT05910125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406099|NCT05910125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406100|NCT05910125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83406101|NCT05910125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83406102|NCT05910125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83406103|NCT05910125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83406104|NCT05910125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406105|NCT05910125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83406106|NCT05910125|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83406107|NCT05910125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406108|NCT05910125|Antipyretics|antipyretics|mesh-ancestor
83406109|NCT05910125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83406110|NCT05910125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83406111|NCT05910125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83406112|NCT05910125|Purinergic Agents|purinergic agents|mesh-ancestor
83406113|NCT05910125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406114|NCT05910034|Docetaxel|docetaxel|mesh-list
83406115|NCT05910034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406116|NCT05910034|Tubulin Modulators|tubulin modulators|mesh-ancestor
83406117|NCT05910034|Antimitotic Agents|antimitotic agents|mesh-ancestor
83406118|NCT05910034|Mitosis Modulators|mitosis modulators|mesh-ancestor
83406119|NCT05910034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406120|NCT05909995|Ipilimumab|ipilimumab|mesh-list
83406121|NCT05909995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406122|NCT05909995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406123|NCT05909995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83406124|NCT05909995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406125|NCT05909904|Tislelizumab|tislelizumab|mesh-list
83406126|NCT05909904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406127|NCT05909904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406128|NCT05909852|Adalimumab|adalimumab|mesh-list
83406129|NCT05909852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83406130|NCT05909852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83406131|NCT05909852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83406132|NCT05909826|Dexamethasone|dexamethasone|mesh-list
83406133|NCT05909826|Cyclophosphamide|cyclophosphamide|mesh-list
83406134|NCT05909826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83406135|NCT05909826|Immunologic Factors|immunologic factors|mesh-ancestor
83406136|NCT05909826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406137|NCT05909826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83406138|NCT05909826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83406139|NCT05909826|Alkylating Agents|alkylating agents|mesh-ancestor
83406140|NCT05909826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406141|NCT05909826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406142|NCT05909826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83406143|NCT05909826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83406144|NCT05909826|Antiemetics|antiemetics|mesh-ancestor
83406145|NCT05909826|Autonomic Agents|autonomic agents|mesh-ancestor
83406146|NCT05909826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406147|NCT05909826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83406148|NCT05909826|Glucocorticoids|glucocorticoids|mesh-ancestor
83406149|NCT05909826|Hormones|hormones|mesh-ancestor
83406150|NCT05909826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406151|NCT05909826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83406152|NCT05909800|Fenofibrate|fenofibrate|mesh-list
83406153|NCT05909800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83406154|NCT05909800|Antimetabolites|antimetabolites|mesh-ancestor
83406155|NCT05909800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406156|NCT05909800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83406157|NCT05909696|Rocuronium|rocuronium|mesh-list
83406158|NCT05909696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83406159|NCT05909696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83406160|NCT05909696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83406161|NCT05909696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406162|NCT05909696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406163|NCT05909618|Nivolumab|nivolumab|mesh-list
83406164|NCT05909618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83406165|NCT05909618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406166|NCT05909618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406167|NCT05909618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83406168|NCT05909618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406169|NCT05909462|Triamcinolone|triamcinolone|mesh-list
83406170|NCT05909462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83406171|NCT05909462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83406172|NCT05909462|Lidocaine|lidocaine|mesh-list
83406173|NCT05909462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83406174|NCT05909462|Anesthetics, Local|anesthetics, local|mesh-ancestor
83406175|NCT05909462|Anesthetics|anesthetics|mesh-ancestor
83406176|NCT05909462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406177|NCT05909462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406178|NCT05909462|Sensory System Agents|sensory system agents|mesh-ancestor
83406179|NCT05909462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406180|NCT05909462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83406181|NCT05909462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83406182|NCT05909462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83406183|NCT05909462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83406257|NCT05909072|Viscosupplements|viscosupplements|mesh-ancestor
83406184|NCT05909462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406185|NCT05909462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83406187|NCT05909462|Hormones|hormones|mesh-ancestor
83406188|NCT05909462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406189|NCT05909462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83406190|NCT05909462|Immunologic Factors|immunologic factors|mesh-ancestor
83406191|NCT05909462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406192|NCT05909423|Pembrolizumab|pembrolizumab|mesh-list
83406193|NCT05909423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406194|NCT05909423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406195|NCT05909423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83406196|NCT05909423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406197|NCT05909397|Letrozole|letrozole|mesh-list
83406198|NCT05909397|Palbociclib|palbociclib|mesh-list
83406199|NCT05909397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406200|NCT05909397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83406201|NCT05909397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83406202|NCT05909397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406203|NCT05909397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406204|NCT05909397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83406205|NCT05909397|Hormone Antagonists|hormone antagonists|mesh-ancestor
83406206|NCT05909397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406207|NCT05909397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406208|NCT05909397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83406209|NCT05909293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83406210|NCT05909293|Venetoclax|venetoclax|mesh-list
83406211|NCT05909293|Antiemetics|antiemetics|mesh-list
83406212|NCT05909293|Lenograstim|lenograstim|mesh-list
83406213|NCT05909293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83406214|NCT05909293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83406215|NCT05909293|Immunologic Factors|immunologic factors|mesh-ancestor
83406216|NCT05909293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406217|NCT05909293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406218|NCT05909293|Autonomic Agents|autonomic agents|mesh-ancestor
83406219|NCT05909293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406220|NCT05909293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83406221|NCT05909267|Carbidopa|carbidopa|mesh-list
83406222|NCT05909267|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83406223|NCT05909267|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83406224|NCT05909267|Dopamine Agents|dopamine agents|mesh-ancestor
83406225|NCT05909267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406226|NCT05909267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406227|NCT05909267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406228|NCT05909267|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83406229|NCT05909267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406230|NCT05909215|Dexmedetomidine|dexmedetomidine|mesh-list
83406231|NCT05909215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83406232|NCT05909215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406233|NCT05909215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406234|NCT05909215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83406235|NCT05909215|Analgesics|analgesics|mesh-ancestor
83406236|NCT05909215|Sensory System Agents|sensory system agents|mesh-ancestor
83406237|NCT05909215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406238|NCT05909215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83406239|NCT05909215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83406240|NCT05909215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83406241|NCT05909215|Adrenergic Agents|adrenergic agents|mesh-ancestor
83406242|NCT05909215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406243|NCT05909215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406244|NCT05909137|Immunomodulating Agents|immunomodulating agents|mesh-list
83406245|NCT05909137|Immunologic Factors|immunologic factors|mesh-ancestor
83406246|NCT05909137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406247|NCT05909072|Tranexamic Acid|tranexamic acid|mesh-list
83406248|NCT05909072|Hyaluronic Acid|hyaluronic acid|mesh-list
83406249|NCT05909072|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83406250|NCT05909072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83406251|NCT05909072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406252|NCT05909072|Hemostatics|hemostatics|mesh-ancestor
83406253|NCT05909072|Coagulants|coagulants|mesh-ancestor
83406254|NCT05909072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83406255|NCT05909072|Immunologic Factors|immunologic factors|mesh-ancestor
83406256|NCT05909072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406261|NCT05909059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83406262|NCT05909059|Immunologic Factors|immunologic factors|mesh-ancestor
83406263|NCT05909059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406264|NCT05909059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83406265|NCT05909059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83406266|NCT05909059|Alkylating Agents|alkylating agents|mesh-ancestor
83406267|NCT05909059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406268|NCT05909059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406269|NCT05909059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83406270|NCT05908864|Magnesium Sulfate|magnesium sulfate|mesh-list
83406271|NCT05908864|Analgesics|analgesics|mesh-ancestor
83406272|NCT05908864|Sensory System Agents|sensory system agents|mesh-ancestor
83406273|NCT05908864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406274|NCT05908864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406275|NCT05908864|Anesthetics|anesthetics|mesh-ancestor
83406276|NCT05908864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406277|NCT05908864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83406278|NCT05908864|Anticonvulsants|anticonvulsants|mesh-ancestor
83406279|NCT05908864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83406280|NCT05908864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83406281|NCT05908864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406282|NCT05908864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83406283|NCT05908864|Tocolytic Agents|tocolytic agents|mesh-ancestor
83406284|NCT05908864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83406285|NCT05908851|Ketorolac|ketorolac|mesh-list
83406286|NCT05908851|Epinephrine|epinephrine|mesh-list
83406287|NCT05908851|Morphine|morphine|mesh-list
83406288|NCT05908851|Ropivacaine|ropivacaine|mesh-list
83406289|NCT05908851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83406290|NCT05908851|Narcotics|narcotics|mesh-ancestor
83406291|NCT05908851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406292|NCT05908851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406294|NCT05908851|Sensory System Agents|sensory system agents|mesh-ancestor
83406295|NCT05908851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406296|NCT05908851|Anesthetics, Local|anesthetics, local|mesh-ancestor
83406297|NCT05908851|Anesthetics|anesthetics|mesh-ancestor
83406298|NCT05908851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83406299|NCT05908851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83406300|NCT05908851|Adrenergic Agents|adrenergic agents|mesh-ancestor
83406301|NCT05908851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406302|NCT05908851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406303|NCT05908851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83406304|NCT05908851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83406305|NCT05908851|Autonomic Agents|autonomic agents|mesh-ancestor
83406306|NCT05908851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83406307|NCT05908851|Respiratory System Agents|respiratory system agents|mesh-ancestor
83406308|NCT05908851|Mydriatics|mydriatics|mesh-ancestor
83406309|NCT05908851|Sympathomimetics|sympathomimetics|mesh-ancestor
83406310|NCT05908851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83406311|NCT05908851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83406312|NCT05908851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83406313|NCT05908851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83406314|NCT05908851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83406315|NCT05908851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83406316|NCT05908851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406317|NCT05908799|Pembrolizumab|pembrolizumab|mesh-list
83406318|NCT05908799|Pemetrexed|pemetrexed|mesh-list
83406319|NCT05908799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406320|NCT05908799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406321|NCT05908799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83406322|NCT05908799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406323|NCT05908799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406324|NCT05908799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83406325|NCT05908799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83406326|NCT05908786|Bevacizumab|bevacizumab|mesh-list
83406327|NCT05908786|Atezolizumab|atezolizumab|mesh-list
83406328|NCT05908786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406329|NCT05908786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406330|NCT05908786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83406331|NCT05908786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83406332|NCT05908786|Growth Substances|growth substances|mesh-ancestor
83406333|NCT05908786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406334|NCT05908786|Growth Inhibitors|growth inhibitors|mesh-ancestor
83406335|NCT05908786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83406559|NCT05903716|Dermatologic Agents|dermatologic agents|mesh-ancestor
83406336|NCT05908786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406338|NCT05908747|Gemcitabine|gemcitabine|mesh-list
83406339|NCT05908747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83406340|NCT05908747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406341|NCT05908747|Tubulin Modulators|tubulin modulators|mesh-ancestor
83406342|NCT05908747|Antimitotic Agents|antimitotic agents|mesh-ancestor
83406343|NCT05908747|Mitosis Modulators|mitosis modulators|mesh-ancestor
83406344|NCT05908747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406345|NCT05908747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83406346|NCT05908747|Antimetabolites|antimetabolites|mesh-ancestor
83406347|NCT05908734|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83406348|NCT05908734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406349|NCT05908734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406350|NCT05906732|Dofetilide|dofetilide|mesh-list
83406351|NCT05906732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83406352|NCT05906732|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83406353|NCT05906732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83406354|NCT05906732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406355|NCT05906121|Lidocaine|lidocaine|mesh-list
83406356|NCT05906121|Ketamine|ketamine|mesh-list
83406357|NCT05906121|Anesthetics, Local|anesthetics, local|mesh-ancestor
83406358|NCT05906121|Anesthetics|anesthetics|mesh-ancestor
83406359|NCT05906121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406360|NCT05906121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406361|NCT05906121|Sensory System Agents|sensory system agents|mesh-ancestor
83406362|NCT05906121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406363|NCT05906121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83406364|NCT05906121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83406365|NCT05906121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83406366|NCT05906121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83406367|NCT05906121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406368|NCT05906121|Analgesics|analgesics|mesh-ancestor
83406369|NCT05906121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83406370|NCT05906121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83406371|NCT05906121|Anesthetics, General|anesthetics, general|mesh-ancestor
83406372|NCT05906121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83406373|NCT05906121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83406374|NCT05906121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406375|NCT05904587|Imidacloprid|imidacloprid|mesh-list
83406376|NCT05904587|Cholinergic Agents|cholinergic agents|mesh-ancestor
83406377|NCT05904587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406378|NCT05904587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406379|NCT05904587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406380|NCT05904496|Tislelizumab|tislelizumab|mesh-list
83406381|NCT05904496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406382|NCT05904496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406383|NCT05904470|Ruzasvir|ruzasvir|mesh-list
83406384|NCT05904470|Antiviral Agents|antiviral agents|mesh-ancestor
83406385|NCT05904470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83406386|NCT05904457|Bevacizumab|bevacizumab|mesh-list
83406387|NCT05904457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83406388|NCT05904457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406389|NCT05904457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406390|NCT05904457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83406391|NCT05904457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83406392|NCT05904457|Growth Substances|growth substances|mesh-ancestor
83406393|NCT05904457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406394|NCT05904457|Growth Inhibitors|growth inhibitors|mesh-ancestor
83406395|NCT05904457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83406396|NCT05904457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406397|NCT05904457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406398|NCT05904379|Paclitaxel|paclitaxel|mesh-list
83406399|NCT05904379|Docetaxel|docetaxel|mesh-list
83406400|NCT05904379|Pemetrexed|pemetrexed|mesh-list
83406401|NCT05904379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83406402|NCT05904379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406403|NCT05904379|Tubulin Modulators|tubulin modulators|mesh-ancestor
83406404|NCT05904379|Antimitotic Agents|antimitotic agents|mesh-ancestor
83406405|NCT05904379|Mitosis Modulators|mitosis modulators|mesh-ancestor
83406406|NCT05904379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406407|NCT05904379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406408|NCT05904379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83406409|NCT05904379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83406410|NCT05904275|Dexamethasone|dexamethasone|mesh-list
83406411|NCT05904275|Ropivacaine|ropivacaine|mesh-list
83406412|NCT05904275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83406413|NCT05904275|Antiemetics|antiemetics|mesh-ancestor
83406414|NCT05904275|Autonomic Agents|autonomic agents|mesh-ancestor
83406415|NCT05904275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406416|NCT05904275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406417|NCT05904275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83406418|NCT05904275|Glucocorticoids|glucocorticoids|mesh-ancestor
83406419|NCT05904275|Hormones|hormones|mesh-ancestor
83406420|NCT05904275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406421|NCT05904275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83406422|NCT05904275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406423|NCT05904275|Anesthetics, Local|anesthetics, local|mesh-ancestor
83406424|NCT05904275|Anesthetics|anesthetics|mesh-ancestor
83406425|NCT05904275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406426|NCT05904275|Sensory System Agents|sensory system agents|mesh-ancestor
83406427|NCT05904184|Calcium, Dietary|calcium, dietary|mesh-list
83406428|NCT05904184|Calcium|calcium|mesh-list
83406429|NCT05904184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83406430|NCT05904184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406431|NCT05904184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83406432|NCT05904119|Lomustine|lomustine|mesh-list
83406433|NCT05904119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83406434|NCT05904119|Alkylating Agents|alkylating agents|mesh-ancestor
83406435|NCT05904119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406436|NCT05904119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406437|NCT05904106|Azacitidine|azacitidine|mesh-list
83406438|NCT05904106|Venetoclax|venetoclax|mesh-list
83406439|NCT05904106|Gemtuzumab|gemtuzumab|mesh-list
83406440|NCT05904106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83406441|NCT05904106|Antimetabolites|antimetabolites|mesh-ancestor
83406442|NCT05904106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406443|NCT05904106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406444|NCT05904106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406445|NCT05904106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406446|NCT05904106|Immunotoxins|immunotoxins|mesh-ancestor
83406447|NCT05904106|Immunoconjugates|immunoconjugates|mesh-ancestor
83406448|NCT05904106|Immunologic Factors|immunologic factors|mesh-ancestor
83406449|NCT05904106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406450|NCT05904080|Nivolumab|nivolumab|mesh-list
83406451|NCT05904080|Ipilimumab|ipilimumab|mesh-list
83406452|NCT05904080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406453|NCT05904080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406454|NCT05904080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83406455|NCT05904080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406456|NCT05904028|Faricimab|faricimab|mesh-list
83406457|NCT05904028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83406458|NCT05904028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83406459|NCT05904028|Growth Substances|growth substances|mesh-ancestor
83406460|NCT05904028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406461|NCT05904028|Growth Inhibitors|growth inhibitors|mesh-ancestor
83406462|NCT05904028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406463|NCT05904002|Budesonide|budesonide|mesh-list
83406464|NCT05904002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83406465|NCT05904002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83406466|NCT05904002|Autonomic Agents|autonomic agents|mesh-ancestor
83406467|NCT05904002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406468|NCT05904002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406469|NCT05904002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83406470|NCT05904002|Respiratory System Agents|respiratory system agents|mesh-ancestor
83406471|NCT05904002|Glucocorticoids|glucocorticoids|mesh-ancestor
83406472|NCT05904002|Hormones|hormones|mesh-ancestor
83406473|NCT05904002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406474|NCT05903963|Midazolam|midazolam|mesh-list
83406475|NCT05903963|Dexmedetomidine|dexmedetomidine|mesh-list
83406476|NCT05903963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83406477|NCT05903963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406478|NCT05903963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406479|NCT05903963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83406480|NCT05903963|Analgesics|analgesics|mesh-ancestor
83406481|NCT05903963|Sensory System Agents|sensory system agents|mesh-ancestor
83406482|NCT05903963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406483|NCT05903963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83406484|NCT05903963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83406485|NCT05903963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83406486|NCT05903963|Adrenergic Agents|adrenergic agents|mesh-ancestor
83406487|NCT05903963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406488|NCT05903963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406489|NCT05903963|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83406490|NCT05903963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83406491|NCT05903963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83406492|NCT05903963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83406493|NCT05903963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83406494|NCT05903963|Anesthetics, General|anesthetics, general|mesh-ancestor
83406495|NCT05903963|Anesthetics|anesthetics|mesh-ancestor
83406496|NCT05903963|GABA Modulators|gaba modulators|mesh-ancestor
83406497|NCT05903963|GABA Agents|gaba agents|mesh-ancestor
83406498|NCT05903937|Melphalan|melphalan|mesh-list
83406499|NCT05903937|Interleukin-2|interleukin-2|mesh-list
83406500|NCT05903937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83406501|NCT05903937|Alkylating Agents|alkylating agents|mesh-ancestor
83406502|NCT05903937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406503|NCT05903937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406504|NCT05903937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83406505|NCT05903937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83406506|NCT05903937|Immunologic Factors|immunologic factors|mesh-ancestor
83406507|NCT05903937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406508|NCT05903937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83406509|NCT05903937|Analgesics|analgesics|mesh-ancestor
83406510|NCT05903937|Sensory System Agents|sensory system agents|mesh-ancestor
83406511|NCT05903937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406512|NCT05903859|Probenecid|probenecid|mesh-list
83406513|NCT05903859|Uricosuric Agents|uricosuric agents|mesh-ancestor
83406514|NCT05903859|Gout Suppressants|gout suppressants|mesh-ancestor
83406515|NCT05903859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83406516|NCT05903833|Pembrolizumab|pembrolizumab|mesh-list
83406517|NCT05903833|Lenvatinib|lenvatinib|mesh-list
83406518|NCT05903833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406519|NCT05903833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406520|NCT05903833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83406521|NCT05903833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406522|NCT05903833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83406523|NCT05903833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406524|NCT05903820|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83406525|NCT05903820|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83406526|NCT05903820|Estradiol|estradiol|mesh-list
83406527|NCT05903820|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83406528|NCT05903820|Progesterone|progesterone|mesh-list
83406529|NCT05903820|Estrogens|estrogens|mesh-ancestor
83406530|NCT05903820|Hormones|hormones|mesh-ancestor
83406531|NCT05903820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406532|NCT05903820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406533|NCT05903820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83406534|NCT05903820|Contraceptive Agents|contraceptive agents|mesh-ancestor
83406535|NCT05903820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83406536|NCT05903820|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83406537|NCT05903820|Progestins|progestins|mesh-ancestor
83406538|NCT05903807|FAPI-46|fapi-46|mesh-list
83406539|NCT05903807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83406540|NCT05903807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406541|NCT05903755|Methamphetamine|methamphetamine|mesh-list
83406542|NCT05903755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83406543|NCT05903755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406544|NCT05903755|Sympathomimetics|sympathomimetics|mesh-ancestor
83406545|NCT05903755|Autonomic Agents|autonomic agents|mesh-ancestor
83406546|NCT05903755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406547|NCT05903755|Dopamine Agents|dopamine agents|mesh-ancestor
83406548|NCT05903755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406549|NCT05903755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406550|NCT05903755|Adrenergic Agents|adrenergic agents|mesh-ancestor
83406551|NCT05903755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83406552|NCT05903755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83406553|NCT05903755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83406554|NCT05903755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83406555|NCT05903716|Isotretinoin|isotretinoin|mesh-list
83406556|NCT05903716|Hormones|hormones|mesh-list
83406557|NCT05903716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406558|NCT05903716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406562|NCT05903703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83406563|NCT05903703|Antimetabolites|antimetabolites|mesh-ancestor
83406564|NCT05903703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406565|NCT05903703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406566|NCT05903703|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83406567|NCT05903703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83406568|NCT05903703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406569|NCT05903456|Lenvatinib|lenvatinib|mesh-list
83406570|NCT05903456|Immunologic Factors|immunologic factors|mesh-list
83406571|NCT05903456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406572|NCT05903456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83406573|NCT05903456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406574|NCT05903456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406575|NCT05903456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406576|NCT05903352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83406577|NCT05903352|Anti-Infective Agents|anti-infective agents|mesh-list
83406578|NCT05903339|MEDI9197|medi9197|mesh-list
83406579|NCT05903339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83406580|NCT05903339|Immunologic Factors|immunologic factors|mesh-ancestor
83406581|NCT05903339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406582|NCT05903326|Dexmedetomidine|dexmedetomidine|mesh-list
83406583|NCT05903326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83406584|NCT05903326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406585|NCT05903326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406586|NCT05903326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83406587|NCT05903326|Analgesics|analgesics|mesh-ancestor
83406588|NCT05903326|Sensory System Agents|sensory system agents|mesh-ancestor
83406589|NCT05903326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406590|NCT05903326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83406591|NCT05903326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83406592|NCT05903326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83406593|NCT05903326|Adrenergic Agents|adrenergic agents|mesh-ancestor
83406594|NCT05903326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406595|NCT05903326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406596|NCT05903131|Levonorgestrel|levonorgestrel|mesh-list
83406597|NCT05903131|Progestins|progestins|mesh-list
83406598|NCT05903131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83406599|NCT05903131|Contraceptive Agents|contraceptive agents|mesh-ancestor
83406600|NCT05903131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83406601|NCT05903131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406602|NCT05903131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83406603|NCT05903131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83406604|NCT05903131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83406605|NCT05903131|Hormones|hormones|mesh-ancestor
83406606|NCT05903131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406607|NCT05903092|Carboplatin|carboplatin|mesh-list
83406608|NCT05903092|Etoposide|etoposide|mesh-list
83406609|NCT05903092|Durvalumab|durvalumab|mesh-list
83406610|NCT05903092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406611|NCT05903092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83406612|NCT05903092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83406613|NCT05903092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83406614|NCT05903092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406615|NCT05903092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406616|NCT05903092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406617|NCT05903040|Lasmiditan|lasmiditan|mesh-list
83406618|NCT05903040|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83406619|NCT05903040|Serotonin Agents|serotonin agents|mesh-ancestor
83406620|NCT05903040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406621|NCT05903040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406622|NCT05903040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406623|NCT05902819|Minocycline|minocycline|mesh-list
83406624|NCT05902819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83406625|NCT05902819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83406626|NCT05902780|Dexmedetomidine|dexmedetomidine|mesh-list
83406627|NCT05902780|Bupivacaine|bupivacaine|mesh-list
83406628|NCT05902780|Anesthetics, Local|anesthetics, local|mesh-ancestor
83406629|NCT05902780|Anesthetics|anesthetics|mesh-ancestor
83406630|NCT05902780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406631|NCT05902780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406632|NCT05902780|Sensory System Agents|sensory system agents|mesh-ancestor
83406633|NCT05902780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406634|NCT05902780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83406635|NCT05902780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83406637|NCT05902780|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83406638|NCT05902780|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83406639|NCT05902780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83406640|NCT05902780|Adrenergic Agents|adrenergic agents|mesh-ancestor
83406641|NCT05902780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406642|NCT05902780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406643|NCT05902754|Sulforaphane|sulforaphane|mesh-list
83406644|NCT05902754|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83406645|NCT05902754|Protective Agents|protective agents|mesh-ancestor
83406646|NCT05902754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406647|NCT05902754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406648|NCT05902728|Itraconazole|itraconazole|mesh-list
83406649|NCT05902728|Rifampin|rifampin|mesh-list
83406650|NCT05902728|Antifungal Agents|antifungal agents|mesh-ancestor
83406651|NCT05902728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83406652|NCT05902728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83406653|NCT05902728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83406654|NCT05902728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406655|NCT05902728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406656|NCT05902728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83406657|NCT05902728|Hormone Antagonists|hormone antagonists|mesh-ancestor
83406658|NCT05902728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406659|NCT05902728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406660|NCT05902728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83406661|NCT05902728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83406662|NCT05902728|Antitubercular Agents|antitubercular agents|mesh-ancestor
83406663|NCT05902728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83406664|NCT05902728|Leprostatic Agents|leprostatic agents|mesh-ancestor
83406665|NCT05902728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83406666|NCT05902728|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83406667|NCT05902728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83406668|NCT05902728|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83406669|NCT05902728|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83406670|NCT05902728|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83406671|NCT05902728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83406672|NCT05902533|Capecitabine|capecitabine|mesh-list
83406674|NCT05902533|Mitomycin|mitomycin|mesh-list
83406675|NCT05902533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83406676|NCT05902533|Antimetabolites|antimetabolites|mesh-ancestor
83406677|NCT05902533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406678|NCT05902533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406679|NCT05902533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83406680|NCT05902533|Alkylating Agents|alkylating agents|mesh-ancestor
83406681|NCT05902533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83406682|NCT05902533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406683|NCT05902468|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83406684|NCT05902468|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83406685|NCT05902468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83406686|NCT05902429|Cladribine|cladribine|mesh-list
83406687|NCT05902429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406688|NCT05902429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83406689|NCT05902429|Immunologic Factors|immunologic factors|mesh-ancestor
83406690|NCT05902429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406691|NCT05901428|Cyclophosphamide|cyclophosphamide|mesh-list
83406692|NCT05901428|Carboplatin|carboplatin|mesh-list
83406693|NCT05901428|Docetaxel|docetaxel|mesh-list
83406694|NCT05901428|Epirubicin|epirubicin|mesh-list
83406695|NCT05901428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83406696|NCT05901428|Immunologic Factors|immunologic factors|mesh-ancestor
83406697|NCT05901428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406698|NCT05901428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83406699|NCT05901428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83406700|NCT05901428|Alkylating Agents|alkylating agents|mesh-ancestor
83406701|NCT05901428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406702|NCT05901428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406703|NCT05901428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83406704|NCT05901428|Tubulin Modulators|tubulin modulators|mesh-ancestor
83406705|NCT05901428|Antimitotic Agents|antimitotic agents|mesh-ancestor
83406706|NCT05901428|Mitosis Modulators|mitosis modulators|mesh-ancestor
83406707|NCT05901428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83406708|NCT05901428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83406709|NCT05901428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83406710|NCT05901428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406715|NCT05899140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83406716|NCT05899140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83406717|NCT05899140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406718|NCT05899140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406719|NCT05895838|Dexamethasone|dexamethasone|mesh-list
83406720|NCT05895838|Olanzapine|olanzapine|mesh-list
83406721|NCT05895838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83406722|NCT05895838|Antiemetics|antiemetics|mesh-ancestor
83406723|NCT05895838|Autonomic Agents|autonomic agents|mesh-ancestor
83406724|NCT05895838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406725|NCT05895838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406726|NCT05895838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83406727|NCT05895838|Glucocorticoids|glucocorticoids|mesh-ancestor
83406728|NCT05895838|Hormones|hormones|mesh-ancestor
83406729|NCT05895838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406730|NCT05895838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83406731|NCT05895838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406732|NCT05895838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83406733|NCT05895838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83406734|NCT05895838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406735|NCT05895838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83406736|NCT05895838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83406737|NCT05895838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83406738|NCT05895838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83406739|NCT05895838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406740|NCT05895838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406741|NCT05895838|Serotonin Agents|serotonin agents|mesh-ancestor
83406742|NCT05895383|Nitrous Oxide|nitrous oxide|mesh-list
83406743|NCT05895383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83406744|NCT05895383|Anesthetics, General|anesthetics, general|mesh-ancestor
83406745|NCT05895383|Anesthetics|anesthetics|mesh-ancestor
83406746|NCT05895383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406747|NCT05895383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406748|NCT05895383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83406749|NCT05895383|Analgesics|analgesics|mesh-ancestor
83406750|NCT05895383|Sensory System Agents|sensory system agents|mesh-ancestor
83406751|NCT05895383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406752|NCT05893030|Anesthetics|anesthetics|mesh-list
83406753|NCT05893030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406754|NCT05893030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406755|NCT05887843|Mometasone Furoate|mometasone furoate|mesh-list
83406756|NCT05887843|Azelastine|azelastine|mesh-list
83406757|NCT05887843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83406758|NCT05887843|Dermatologic Agents|dermatologic agents|mesh-ancestor
83406759|NCT05887843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83406760|NCT05887843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83406761|NCT05887843|Autonomic Agents|autonomic agents|mesh-ancestor
83406762|NCT05887843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406763|NCT05887843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406764|NCT05887843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83406765|NCT05887843|Respiratory System Agents|respiratory system agents|mesh-ancestor
83406766|NCT05887843|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83406767|NCT05887843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406768|NCT05887843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406769|NCT05887843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83406770|NCT05887843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83406771|NCT05887843|Histamine Antagonists|histamine antagonists|mesh-ancestor
83406772|NCT05887843|Histamine Agents|histamine agents|mesh-ancestor
83406773|NCT05887843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406774|NCT05885685|Nabilone|nabilone|mesh-list
83406775|NCT05885685|Antiemetics|antiemetics|mesh-ancestor
83406776|NCT05885685|Autonomic Agents|autonomic agents|mesh-ancestor
83406777|NCT05885685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406778|NCT05885685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406779|NCT05885685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83406780|NCT05885685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83406781|NCT05885685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83406782|NCT05885685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406783|NCT05885685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83406784|NCT05880394|Copper|copper|mesh-list
83406785|NCT05880394|Trace Elements|trace elements|mesh-ancestor
83406786|NCT05880394|Micronutrients|micronutrients|mesh-ancestor
83406787|NCT05880394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406789|NCT05878093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83406790|NCT05878093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83406791|NCT05878093|Autonomic Agents|autonomic agents|mesh-ancestor
83406792|NCT05878093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406793|NCT05878093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406794|NCT05878093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83406795|NCT05878093|Respiratory System Agents|respiratory system agents|mesh-ancestor
83406796|NCT05878093|Glucocorticoids|glucocorticoids|mesh-ancestor
83406797|NCT05878093|Hormones|hormones|mesh-ancestor
83406798|NCT05878093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406799|NCT05875961|MF59 oil emulsion|mf59 oil emulsion|mesh-list
83406800|NCT05875961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83406801|NCT05875961|Immunologic Factors|immunologic factors|mesh-ancestor
83406802|NCT05875961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406803|NCT05866471|Psilocybin|psilocybin|mesh-list
83406804|NCT05866471|Hallucinogens|hallucinogens|mesh-ancestor
83406805|NCT05866471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406806|NCT05866471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83406807|NCT05864625|Propofol|propofol|mesh-list
83406808|NCT05864625|Sevoflurane|sevoflurane|mesh-list
83406809|NCT05864625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83406810|NCT05864625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406811|NCT05864625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406812|NCT05864625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83406813|NCT05864625|Anesthetics, General|anesthetics, general|mesh-ancestor
83406814|NCT05864625|Anesthetics|anesthetics|mesh-ancestor
83406815|NCT05864625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83406816|NCT05864625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83406817|NCT05861570|Triamcinolone|triamcinolone|mesh-list
83406818|NCT05861570|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83406819|NCT05861570|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83406820|NCT05861570|Lidocaine|lidocaine|mesh-list
83406821|NCT05861570|Hyaluronic Acid|hyaluronic acid|mesh-list
83406822|NCT05861570|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83406823|NCT05861570|Anesthetics, Local|anesthetics, local|mesh-ancestor
83406824|NCT05861570|Anesthetics|anesthetics|mesh-ancestor
83406825|NCT05861570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406826|NCT05861570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406827|NCT05861570|Sensory System Agents|sensory system agents|mesh-ancestor
83406828|NCT05861570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406829|NCT05861570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83406830|NCT05861570|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83406831|NCT05861570|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83406832|NCT05861570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83406833|NCT05861570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406834|NCT05861570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83406835|NCT05861570|Glucocorticoids|glucocorticoids|mesh-ancestor
83406836|NCT05861570|Hormones|hormones|mesh-ancestor
83406837|NCT05861570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83406838|NCT05861570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83406839|NCT05861570|Immunologic Factors|immunologic factors|mesh-ancestor
83406840|NCT05861570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406841|NCT05861570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83406842|NCT05861570|Viscosupplements|viscosupplements|mesh-ancestor
83406843|NCT05861570|Protective Agents|protective agents|mesh-ancestor
83406844|NCT05857163|Amoxicillin|amoxicillin|mesh-list
83406845|NCT05857163|Clarithromycin|clarithromycin|mesh-list
83406846|NCT05857163|Potassium Citrate|potassium citrate|mesh-list
83406847|NCT05857163|Rabeprazole|rabeprazole|mesh-list
83406848|NCT05857163|Bismuth|bismuth|mesh-list
83406849|NCT05857163|Citric Acid|citric acid|mesh-list
83406850|NCT05857163|Sodium Citrate|sodium citrate|mesh-list
83406851|NCT05857163|Anticoagulants|anticoagulants|mesh-ancestor
83406852|NCT05857163|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83406853|NCT05857163|Chelating Agents|chelating agents|mesh-ancestor
83406854|NCT05857163|Sequestering Agents|sequestering agents|mesh-ancestor
83406855|NCT05857163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406856|NCT05857163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83406857|NCT05857163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83406858|NCT05857163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83406859|NCT05857163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406860|NCT05857163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83406861|NCT05857163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83406862|NCT05857163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83406863|NCT05857163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83406864|NCT05857163|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83406865|NCT05857163|Antacids|antacids|mesh-ancestor
83406868|NCT05857163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406869|NCT05857163|Expectorants|expectorants|mesh-ancestor
83406870|NCT05857163|Respiratory System Agents|respiratory system agents|mesh-ancestor
83406871|NCT05856851|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83406872|NCT05856851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83406873|NCT05856851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83406874|NCT05856851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406875|NCT05856526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83406876|NCT05840510|Sirolimus|sirolimus|mesh-list
83406877|NCT05840510|Adagrasib|adagrasib|mesh-list
83406878|NCT05840510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83406879|NCT05840510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83406880|NCT05840510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83406881|NCT05840510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406882|NCT05840510|Antifungal Agents|antifungal agents|mesh-ancestor
83406883|NCT05840510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83406884|NCT05840510|Immunologic Factors|immunologic factors|mesh-ancestor
83406885|NCT05840510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406886|NCT05839301|Vaccines|vaccines|mesh-list
83406887|NCT05839301|Immunologic Factors|immunologic factors|mesh-ancestor
83406888|NCT05839301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406890|NCT05826574|Esomeprazole|esomeprazole|mesh-list
83406891|NCT05826574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83406892|NCT05826574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83406893|NCT05826574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83406894|NCT05826574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406895|NCT05826574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406896|NCT05826574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83406897|NCT05826574|Antitubercular Agents|antitubercular agents|mesh-ancestor
83406898|NCT05826574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83406899|NCT05826574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83406900|NCT05826574|Leprostatic Agents|leprostatic agents|mesh-ancestor
83406901|NCT05826574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83406902|NCT05826574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83406903|NCT05826574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83406904|NCT05826574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83406905|NCT05826574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83406906|NCT05826574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83406907|NCT05826574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83406908|NCT05821556|Paclitaxel|paclitaxel|mesh-list
83406909|NCT05821556|Gemcitabine|gemcitabine|mesh-list
83406910|NCT05821556|Capecitabine|capecitabine|mesh-list
83406911|NCT05821556|Valproic Acid|valproic acid|mesh-list
83406912|NCT05821556|Simvastatin|simvastatin|mesh-list
83406913|NCT05821556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83406914|NCT05821556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406915|NCT05821556|Tubulin Modulators|tubulin modulators|mesh-ancestor
83406916|NCT05821556|Antimitotic Agents|antimitotic agents|mesh-ancestor
83406917|NCT05821556|Mitosis Modulators|mitosis modulators|mesh-ancestor
83406918|NCT05821556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406919|NCT05821556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83406920|NCT05821556|Antimetabolites|antimetabolites|mesh-ancestor
83406921|NCT05821556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83406922|NCT05821556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83406923|NCT05821556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83406924|NCT05821556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83406925|NCT05821556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406926|NCT05821556|Anticonvulsants|anticonvulsants|mesh-ancestor
83406927|NCT05821556|GABA Agents|gaba agents|mesh-ancestor
83406928|NCT05821556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406929|NCT05821556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406930|NCT05821556|Antimanic Agents|antimanic agents|mesh-ancestor
83406931|NCT05821556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83406932|NCT05821556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406933|NCT05821556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83406934|NCT05819892|Paclitaxel|paclitaxel|mesh-list
83406935|NCT05819892|Cisplatin|cisplatin|mesh-list
83406936|NCT05819892|Carboplatin|carboplatin|mesh-list
83406937|NCT05819892|Dostarlimab|dostarlimab|mesh-list
83406938|NCT05819892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83406939|NCT05819892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406940|NCT05819892|Tubulin Modulators|tubulin modulators|mesh-ancestor
83406941|NCT05819892|Antimitotic Agents|antimitotic agents|mesh-ancestor
83406942|NCT05819892|Mitosis Modulators|mitosis modulators|mesh-ancestor
83406943|NCT05819892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406944|NCT05815173|Sotorasib|sotorasib|mesh-list
83406946|NCT05815173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406947|NCT05815173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83406948|NCT05815173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406949|NCT05797376|Rivaroxaban|rivaroxaban|mesh-list
83406950|NCT05797376|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83406951|NCT05797376|Antithrombins|antithrombins|mesh-ancestor
83406952|NCT05797376|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83406953|NCT05797376|Protease Inhibitors|protease inhibitors|mesh-ancestor
83406954|NCT05797376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406955|NCT05797376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406956|NCT05797376|Anticoagulants|anticoagulants|mesh-ancestor
83406957|NCT05776979|Lenalidomide|lenalidomide|mesh-list
83406958|NCT05776979|Immunologic Factors|immunologic factors|mesh-ancestor
83406959|NCT05776979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406960|NCT05776979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83406961|NCT05776979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83406962|NCT05776979|Growth Substances|growth substances|mesh-ancestor
83406963|NCT05776979|Growth Inhibitors|growth inhibitors|mesh-ancestor
83406964|NCT05776979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406965|NCT05774717|Tranexamic Acid|tranexamic acid|mesh-list
83406966|NCT05774717|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83406967|NCT05774717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83406968|NCT05774717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406969|NCT05774717|Hemostatics|hemostatics|mesh-ancestor
83406970|NCT05774717|Coagulants|coagulants|mesh-ancestor
83406971|NCT05767359|Cyclophosphamide|cyclophosphamide|mesh-list
83406972|NCT05767359|Fludarabine|fludarabine|mesh-list
83406973|NCT05767359|Fludarabine phosphate|fludarabine phosphate|mesh-list
83406974|NCT05767359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83406975|NCT05767359|Immunologic Factors|immunologic factors|mesh-ancestor
83406976|NCT05767359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406977|NCT05767359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83406978|NCT05767359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83406979|NCT05767359|Alkylating Agents|alkylating agents|mesh-ancestor
83406980|NCT05767359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406981|NCT05767359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406982|NCT05767359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83406983|NCT05767359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83406984|NCT05767359|Antimetabolites|antimetabolites|mesh-ancestor
83406985|NCT05733286|Suvorexant|suvorexant|mesh-list
83406986|NCT05733286|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83406987|NCT05733286|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83406988|NCT05733286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406989|NCT05733286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83406990|NCT05733286|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83406991|NCT05733286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83406992|NCT05733286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83406993|NCT05722327|Irinotecan|irinotecan|mesh-list
83406994|NCT05722327|Cetuximab|cetuximab|mesh-list
83406995|NCT05722327|Adagrasib|adagrasib|mesh-list
83406996|NCT05722327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83406997|NCT05722327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83406998|NCT05722327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406999|NCT05722327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407000|NCT05722327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407001|NCT05722327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407002|NCT05718843|BI 425809|bi 425809|mesh-list
83407003|NCT05718843|Nootropic Agents|nootropic agents|mesh-ancestor
83407004|NCT05708755|Valganciclovir|valganciclovir|mesh-list
83407005|NCT05708755|Antiviral Agents|antiviral agents|mesh-ancestor
83407006|NCT05708755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83407007|NCT05704647|Nivolumab|nivolumab|mesh-list
83407008|NCT05704647|Relatlimab|relatlimab|mesh-list
83407009|NCT05704647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407010|NCT05704647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407011|NCT05704647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83407012|NCT05704647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407013|NCT05698524|Temozolomide|temozolomide|mesh-list
83407014|NCT05698524|Abexinostat|abexinostat|mesh-list
83407015|NCT05698524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83407016|NCT05698524|Alkylating Agents|alkylating agents|mesh-ancestor
83407017|NCT05698524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407018|NCT05698524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407019|NCT05698524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83407021|NCT05689424|Insulin Lispro|insulin lispro|mesh-list
83407022|NCT05689424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83407023|NCT05689424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407024|NCT05689047|Artesunate|artesunate|mesh-list
83407025|NCT05689047|Pyronaridine|pyronaridine|mesh-list
83407026|NCT05689047|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83407027|NCT05689047|Antimalarials|antimalarials|mesh-ancestor
83407028|NCT05689047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83407029|NCT05689047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83407030|NCT05689047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83407031|NCT05689047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407032|NCT05689047|Antiviral Agents|antiviral agents|mesh-ancestor
83407033|NCT05689047|Schistosomicides|schistosomicides|mesh-ancestor
83407034|NCT05689047|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83407035|NCT05689047|Anthelmintics|anthelmintics|mesh-ancestor
83407036|NCT05683171|Rituximab|rituximab|mesh-list
83407037|NCT05683171|Lenalidomide|lenalidomide|mesh-list
83407038|NCT05683171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407039|NCT05683171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407040|NCT05683171|Immunologic Factors|immunologic factors|mesh-ancestor
83407041|NCT05683171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407042|NCT05683171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407043|NCT05683171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83407044|NCT05683171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83407045|NCT05683171|Growth Substances|growth substances|mesh-ancestor
83407046|NCT05683171|Growth Inhibitors|growth inhibitors|mesh-ancestor
83407047|NCT05679024|Apixaban|apixaban|mesh-list
83407048|NCT05679024|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83407049|NCT05679024|Antithrombins|antithrombins|mesh-ancestor
83407050|NCT05679024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83407051|NCT05679024|Protease Inhibitors|protease inhibitors|mesh-ancestor
83407052|NCT05679024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407053|NCT05679024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407054|NCT05679024|Anticoagulants|anticoagulants|mesh-ancestor
83407055|NCT05678257|Leucovorin|leucovorin|mesh-list
83407056|NCT05678257|Bevacizumab|bevacizumab|mesh-list
83407057|NCT05678257|Fluorouracil|fluorouracil|mesh-list
83407058|NCT05678257|Irinotecan|irinotecan|mesh-list
83407059|NCT05678257|Levoleucovorin|levoleucovorin|mesh-list
83407060|NCT05678257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407061|NCT05678257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407062|NCT05678257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83407063|NCT05678257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83407064|NCT05678257|Growth Substances|growth substances|mesh-ancestor
83407065|NCT05678257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407066|NCT05678257|Growth Inhibitors|growth inhibitors|mesh-ancestor
83407067|NCT05678257|Antimetabolites|antimetabolites|mesh-ancestor
83407068|NCT05678257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407069|NCT05678257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83407070|NCT05678257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83407071|NCT05678257|Immunologic Factors|immunologic factors|mesh-ancestor
83407072|NCT05678257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83407073|NCT05678257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83407074|NCT05678257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407075|NCT05678257|Antidotes|antidotes|mesh-ancestor
83407076|NCT05678257|Protective Agents|protective agents|mesh-ancestor
83407077|NCT05678257|Vitamin B Complex|vitamin b complex|mesh-ancestor
83407078|NCT05678257|Vitamins|vitamins|mesh-ancestor
83407079|NCT05678257|Micronutrients|micronutrients|mesh-ancestor
83407080|NCT05677633|Sargramostim|sargramostim|mesh-list
83407081|NCT05677633|Immunologic Factors|immunologic factors|mesh-ancestor
83407082|NCT05677633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407083|NCT05669625|Vaccines|vaccines|mesh-list
83407084|NCT05669625|Immunologic Factors|immunologic factors|mesh-ancestor
83407085|NCT05669625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407086|NCT05669339|Irinotecan|irinotecan|mesh-list
83407087|NCT05669339|Sorafenib|sorafenib|mesh-list
83407088|NCT05669339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83407089|NCT05669339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83407090|NCT05669339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407091|NCT05669339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407092|NCT05669339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407093|NCT05669339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407094|NCT05665088|Dexmedetomidine|dexmedetomidine|mesh-list
83407095|NCT05665088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83407317|NCT05489731|Osimertinib|osimertinib|mesh-list
83407096|NCT05665088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83407097|NCT05665088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407098|NCT05665088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83407099|NCT05665088|Analgesics|analgesics|mesh-ancestor
83407100|NCT05665088|Sensory System Agents|sensory system agents|mesh-ancestor
83407101|NCT05665088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407102|NCT05665088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83407103|NCT05665088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83407104|NCT05665088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83407105|NCT05665088|Adrenergic Agents|adrenergic agents|mesh-ancestor
83407106|NCT05665088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83407107|NCT05665088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407108|NCT05663411|Cinacalcet|cinacalcet|mesh-list
83407109|NCT05663411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83407110|NCT05663411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407111|NCT05663411|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83407112|NCT05663411|Hormone Antagonists|hormone antagonists|mesh-ancestor
83407113|NCT05663411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83407114|NCT05654506|Daratumumab|daratumumab|mesh-list
83407115|NCT05654506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407116|NCT05649722|Treprostinil|treprostinil|mesh-list
83407117|NCT05649722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83407118|NCT05647122|Osimertinib|osimertinib|mesh-list
83407119|NCT05647122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407120|NCT05647122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407121|NCT05647122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407122|NCT05647122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407123|NCT05640674|Acetaminophen|acetaminophen|mesh-list
83407124|NCT05640674|Ibuprofen|ibuprofen|mesh-list
83407125|NCT05640674|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83407126|NCT05640674|Hydrocodone|hydrocodone|mesh-list
83407127|NCT05640674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83407128|NCT05640674|Analgesics|analgesics|mesh-ancestor
83407129|NCT05640674|Sensory System Agents|sensory system agents|mesh-ancestor
83407130|NCT05640674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407131|NCT05640674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407132|NCT05640674|Antipyretics|antipyretics|mesh-ancestor
83407133|NCT05640674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83407134|NCT05640674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83407135|NCT05640674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407136|NCT05640674|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83407137|NCT05640674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407138|NCT05640674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407139|NCT05640674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83407140|NCT05640674|Narcotics|narcotics|mesh-ancestor
83407141|NCT05640674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83407142|NCT05640674|Antitussive Agents|antitussive agents|mesh-ancestor
83407143|NCT05640674|Respiratory System Agents|respiratory system agents|mesh-ancestor
83407144|NCT05640180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83407145|NCT05640180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407146|NCT05640180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83407147|NCT05640180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407148|NCT05634785|Cyclophosphamide|cyclophosphamide|mesh-list
83407149|NCT05634785|Fludarabine|fludarabine|mesh-list
83407150|NCT05634785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83407151|NCT05634785|Immunologic Factors|immunologic factors|mesh-ancestor
83407152|NCT05634785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407153|NCT05634785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407154|NCT05634785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83407155|NCT05634785|Alkylating Agents|alkylating agents|mesh-ancestor
83407156|NCT05634785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407157|NCT05634785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407158|NCT05634785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83407159|NCT05627232|Diphenhydramine|diphenhydramine|mesh-list
83407160|NCT05627232|Promethazine|promethazine|mesh-list
83407161|NCT05627232|Cytarabine|cytarabine|mesh-list
83407162|NCT05627232|Daunorubicin|daunorubicin|mesh-list
83407163|NCT05627232|Palbociclib|palbociclib|mesh-list
83407164|NCT05627232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83407165|NCT05627232|Antimetabolites|antimetabolites|mesh-ancestor
83407166|NCT05627232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407167|NCT05627232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407168|NCT05627232|Antiviral Agents|antiviral agents|mesh-ancestor
83407169|NCT05627232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83407170|NCT05627232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83407171|NCT05627232|Immunologic Factors|immunologic factors|mesh-ancestor
83407172|NCT05627232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407173|NCT05627232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83407174|NCT05627232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83407175|NCT05627232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83407176|NCT05627232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407177|NCT05627232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407178|NCT05627232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83407179|NCT05627232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83407180|NCT05627232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83407181|NCT05627232|Anesthetics, Local|anesthetics, local|mesh-ancestor
83407183|NCT05627232|Sensory System Agents|sensory system agents|mesh-ancestor
83407184|NCT05627232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407185|NCT05627232|Antiemetics|antiemetics|mesh-ancestor
83407186|NCT05627232|Autonomic Agents|autonomic agents|mesh-ancestor
83407187|NCT05627232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83407188|NCT05627232|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83407189|NCT05627232|Histamine Antagonists|histamine antagonists|mesh-ancestor
83407190|NCT05627232|Histamine Agents|histamine agents|mesh-ancestor
83407191|NCT05627232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83407192|NCT05627232|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83407193|NCT05627232|Antipruritics|antipruritics|mesh-ancestor
83407194|NCT05627232|Dermatologic Agents|dermatologic agents|mesh-ancestor
83407195|NCT05625399|Nivolumab|nivolumab|mesh-list
83407196|NCT05625399|Relatlimab|relatlimab|mesh-list
83407197|NCT05625399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407198|NCT05625399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407199|NCT05625399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83407200|NCT05625399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407201|NCT05613777|BI 425809|bi 425809|mesh-list
83407202|NCT05613777|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83407203|NCT05613777|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83407204|NCT05613777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83407205|NCT05613777|Contraceptive Agents|contraceptive agents|mesh-ancestor
83407206|NCT05613777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83407207|NCT05613777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407208|NCT05613777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83407209|NCT05613777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83407210|NCT05613777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83407211|NCT05613777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83407212|NCT05613777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83407213|NCT05613777|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83407214|NCT05613777|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83407215|NCT05613777|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83407216|NCT05613777|Nootropic Agents|nootropic agents|mesh-ancestor
83407217|NCT05612594|Ertugliflozin|ertugliflozin|mesh-list
83407218|NCT05612594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83407219|NCT05612594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407220|NCT05612594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83407221|NCT05612594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407222|NCT05600231|Listerine|listerine|mesh-list
83407223|NCT05600231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83407224|NCT05600231|Sodium Fluoride|sodium fluoride|mesh-list
83407225|NCT05600231|Cariostatic Agents|cariostatic agents|mesh-ancestor
83407226|NCT05600231|Protective Agents|protective agents|mesh-ancestor
83407227|NCT05600231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407228|NCT05600231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83407229|NCT05590793|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83407230|NCT05590793|Luteolytic Agents|luteolytic agents|mesh-ancestor
83407231|NCT05590793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83407232|NCT05590793|Contraceptive Agents|contraceptive agents|mesh-ancestor
83407233|NCT05590793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83407234|NCT05590793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407235|NCT05590793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83407236|NCT05590793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83407237|NCT05590793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407238|NCT05564650|Azacitidine|azacitidine|mesh-list
83407239|NCT05564650|Decitabine|decitabine|mesh-list
83407240|NCT05564650|Venetoclax|venetoclax|mesh-list
83407241|NCT05564650|Navitoclax|navitoclax|mesh-list
83407242|NCT05564650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83407243|NCT05564650|Antimetabolites|antimetabolites|mesh-ancestor
83407244|NCT05564650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407246|NCT05564650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407247|NCT05554627|Aripiprazole|aripiprazole|mesh-list
83407248|NCT05554627|Esketamine|esketamine|mesh-list
83407249|NCT05554627|Antidepressive Agents|antidepressive agents|mesh-ancestor
83407250|NCT05554627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83407251|NCT05554627|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83407252|NCT05554627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83407253|NCT05554627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83407254|NCT05554627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407255|NCT05554627|Dopamine Agonists|dopamine agonists|mesh-ancestor
83407256|NCT05554627|Dopamine Agents|dopamine agents|mesh-ancestor
83407257|NCT05554627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83407258|NCT05554627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407259|NCT05554627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83407260|NCT05554627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83407261|NCT05554627|Serotonin Agents|serotonin agents|mesh-ancestor
83407262|NCT05554627|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83407263|NCT05554627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83407264|NCT05554627|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83407265|NCT05554627|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83407266|NCT05554341|Paclitaxel|paclitaxel|mesh-list
83407267|NCT05554341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83407268|NCT05554341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83407269|NCT05554341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407270|NCT05554341|Tubulin Modulators|tubulin modulators|mesh-ancestor
83407271|NCT05554341|Antimitotic Agents|antimitotic agents|mesh-ancestor
83407272|NCT05554341|Mitosis Modulators|mitosis modulators|mesh-ancestor
83407273|NCT05554341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407274|NCT05542381|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83407275|NCT05542381|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83407276|NCT05542381|Lubricant Eye Drops|lubricant eye drops|mesh-list
83407277|NCT05542381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83407278|NCT05542381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83407279|NCT05538897|Megestrol|megestrol|mesh-list
83407280|NCT05538897|Megestrol Acetate|megestrol acetate|mesh-list
83407281|NCT05538897|Ipatasertib|ipatasertib|mesh-list
83407282|NCT05538897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83407283|NCT05538897|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83407284|NCT05538897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83407285|NCT05538897|Contraceptive Agents|contraceptive agents|mesh-ancestor
83407286|NCT05538897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83407287|NCT05538897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407288|NCT05538897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83407289|NCT05538897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83407290|NCT05538897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83407291|NCT05538897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407292|NCT05538897|Appetite Stimulants|appetite stimulants|mesh-ancestor
83407293|NCT05538897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83407294|NCT05538897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407295|NCT05538897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407296|NCT05538897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407297|NCT05526157|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83407298|NCT05526157|Glucagon|glucagon|mesh-list
83407299|NCT05526157|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83407300|NCT05526157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83407301|NCT05526157|Hormones|hormones|mesh-ancestor
83407302|NCT05526157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83407303|NCT05526157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407304|NCT05526157|Incretins|incretins|mesh-ancestor
83407305|NCT05526157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407306|NCT05526157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83407307|NCT05511025|Acetaminophen|acetaminophen|mesh-list
83407308|NCT05511025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83407309|NCT05511025|Analgesics|analgesics|mesh-ancestor
83407310|NCT05511025|Sensory System Agents|sensory system agents|mesh-ancestor
83407311|NCT05511025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407312|NCT05511025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407313|NCT05511025|Antipyretics|antipyretics|mesh-ancestor
83407314|NCT05510895|Cetuximab|cetuximab|mesh-list
83407315|NCT05510895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407316|NCT05510895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407318|NCT05489731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407319|NCT05489731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407320|NCT05489731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407321|NCT05489731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407323|NCT05478291|Vitamins|vitamins|mesh-ancestor
83407324|NCT05478291|Micronutrients|micronutrients|mesh-ancestor
83407325|NCT05478291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407326|NCT05478291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83407327|NCT05472792|Tamoxifen|tamoxifen|mesh-list
83407328|NCT05472792|Toremifene|toremifene|mesh-list
83407329|NCT05472792|Letrozole|letrozole|mesh-list
83407330|NCT05472792|Fulvestrant|fulvestrant|mesh-list
83407331|NCT05472792|Anastrozole|anastrozole|mesh-list
83407332|NCT05472792|Exemestane|exemestane|mesh-list
83407333|NCT05472792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407334|NCT05472792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83407335|NCT05472792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83407336|NCT05472792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407337|NCT05472792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407338|NCT05472792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83407339|NCT05472792|Hormone Antagonists|hormone antagonists|mesh-ancestor
83407340|NCT05472792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83407341|NCT05472792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407342|NCT05472792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83407343|NCT05472792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83407344|NCT05472792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83407345|NCT05472792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83407346|NCT05472792|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83407347|NCT05467293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83407348|NCT05467293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83407349|NCT05464836|Venetoclax|venetoclax|mesh-list
83407350|NCT05464836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407351|NCT05463367|Acetaminophen|acetaminophen|mesh-list
83407352|NCT05463367|Naproxen|naproxen|mesh-list
83407353|NCT05463367|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83407354|NCT05463367|Oxymorphone|oxymorphone|mesh-list
83407355|NCT05463367|Morphine|morphine|mesh-list
83407356|NCT05463367|Oxycodone|oxycodone|mesh-list
83407357|NCT05463367|Tramadol|tramadol|mesh-list
83407358|NCT05463367|Hydrocodone|hydrocodone|mesh-list
83407359|NCT05463367|Codeine|codeine|mesh-list
83407360|NCT05463367|Levodopa|levodopa|mesh-list
83407361|NCT05463367|Carbidopa|carbidopa|mesh-list
83407362|NCT05463367|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83407363|NCT05463367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83407364|NCT05463367|Narcotics|narcotics|mesh-ancestor
83407365|NCT05463367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83407366|NCT05463367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407367|NCT05463367|Analgesics|analgesics|mesh-ancestor
83407368|NCT05463367|Sensory System Agents|sensory system agents|mesh-ancestor
83407369|NCT05463367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407370|NCT05463367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83407371|NCT05463367|Antipyretics|antipyretics|mesh-ancestor
83407372|NCT05463367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83407373|NCT05463367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83407374|NCT05463367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407375|NCT05463367|Gout Suppressants|gout suppressants|mesh-ancestor
83407376|NCT05463367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83407377|NCT05463367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407378|NCT05463367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407379|NCT05463367|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83407380|NCT05463367|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83407381|NCT05463367|Dopamine Agents|dopamine agents|mesh-ancestor
83407382|NCT05463367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83407383|NCT05463367|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83407384|NCT05463367|Antitussive Agents|antitussive agents|mesh-ancestor
83407385|NCT05463367|Respiratory System Agents|respiratory system agents|mesh-ancestor
83407386|NCT05463367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83407387|NCT05463367|Immunologic Factors|immunologic factors|mesh-ancestor
83407388|NCT05463367|Dopamine Agonists|dopamine agonists|mesh-ancestor
83407389|NCT05463367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83407390|NCT05460533|Tisagenlecleucel|tisagenlecleucel|mesh-list
83407391|NCT05460533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407392|NCT05460533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407393|NCT05436535|Triamcinolone|triamcinolone|mesh-list
83407394|NCT05436535|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83407395|NCT05436535|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83407396|NCT05436535|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83407397|NCT05436535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83407398|NCT05436535|Glucocorticoids|glucocorticoids|mesh-ancestor
83407399|NCT05436535|Hormones|hormones|mesh-ancestor
83407400|NCT05436535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83407401|NCT05436535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407402|NCT05436535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83407403|NCT05436535|Immunologic Factors|immunologic factors|mesh-ancestor
83407404|NCT05436535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407405|NCT05436535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407406|NCT05411081|Atezolizumab|atezolizumab|mesh-list
83407407|NCT05411081|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83407408|NCT05411081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83407409|NCT05411081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407410|NCT05411081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407411|NCT05411081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407412|NCT05411081|Immunologic Factors|immunologic factors|mesh-ancestor
83407413|NCT05411081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407414|NCT05405114|Decitabine|decitabine|mesh-list
83407415|NCT05405114|Hydroxyurea|hydroxyurea|mesh-list
83407416|NCT05405114|Tetrahydrouridine|tetrahydrouridine|mesh-list
83407417|NCT05405114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83407418|NCT05405114|Antimetabolites|antimetabolites|mesh-ancestor
83407419|NCT05405114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407420|NCT05405114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407421|NCT05405114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407422|NCT05405114|Antisickling Agents|antisickling agents|mesh-ancestor
83407423|NCT05405114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83407424|NCT05401097|Azacitidine|azacitidine|mesh-list
83407425|NCT05401097|Venetoclax|venetoclax|mesh-list
83407426|NCT05401097|Ivosidenib|ivosidenib|mesh-list
83407427|NCT05401097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83407428|NCT05401097|Antimetabolites|antimetabolites|mesh-ancestor
83407429|NCT05401097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407430|NCT05401097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407431|NCT05401097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407432|NCT05395091|Denosumab|denosumab|mesh-list
83407433|NCT05395091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83407434|NCT05395091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407435|NCT05392946|Dexamethasone|dexamethasone|mesh-list
83407436|NCT05392946|Dexamethasone acetate|dexamethasone acetate|mesh-list
83407437|NCT05392946|Bortezomib|bortezomib|mesh-list
83407438|NCT05392946|Daratumumab|daratumumab|mesh-list
83407439|NCT05392946|Ichthammol|ichthammol|mesh-list
83407440|NCT05392946|BB 1101|bb 1101|mesh-list
83407441|NCT05392946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83407442|NCT05392946|Antiemetics|antiemetics|mesh-ancestor
83407443|NCT05392946|Autonomic Agents|autonomic agents|mesh-ancestor
83407444|NCT05392946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407445|NCT05392946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407446|NCT05392946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83407447|NCT05392946|Glucocorticoids|glucocorticoids|mesh-ancestor
83407448|NCT05392946|Hormones|hormones|mesh-ancestor
83407449|NCT05392946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83407450|NCT05392946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83407451|NCT05392946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407452|NCT05392946|Protease Inhibitors|protease inhibitors|mesh-ancestor
83407453|NCT05392946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407454|NCT05392946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407455|NCT05392946|Dermatologic Agents|dermatologic agents|mesh-ancestor
83407456|NCT05391828|Cimetidine|cimetidine|mesh-list
83407457|NCT05391828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83407458|NCT05391828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83407459|NCT05391828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83407460|NCT05391828|Histamine Antagonists|histamine antagonists|mesh-ancestor
83407461|NCT05391828|Histamine Agents|histamine agents|mesh-ancestor
83407462|NCT05391828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83407463|NCT05391828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407464|NCT05391828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407465|NCT05391828|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83407466|NCT05391828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83407467|NCT05391828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407468|NCT05384119|Palbociclib|palbociclib|mesh-list
83407469|NCT05384119|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83407618|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83407470|NCT05384119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407471|NCT05384119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407472|NCT05384119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407473|NCT05384119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407474|NCT05384119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83407475|NCT05384119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83407476|NCT05384119|Hormone Antagonists|hormone antagonists|mesh-ancestor
83407477|NCT05384119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83407478|NCT05384119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407480|NCT05382871|Immunologic Factors|immunologic factors|mesh-ancestor
83407481|NCT05382871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407482|NCT05377905|Doxorubicin|doxorubicin|mesh-list
83407483|NCT05377905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83407484|NCT05377905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83407485|NCT05377905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407486|NCT05377905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83407487|NCT05377905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83407488|NCT05377905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407489|NCT05377905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407490|NCT05377242|Curcumin|curcumin|mesh-list
83407491|NCT05377242|Resveratrol|resveratrol|mesh-list
83407492|NCT05377242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83407493|NCT05377242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83407494|NCT05377242|Analgesics|analgesics|mesh-ancestor
83407495|NCT05377242|Sensory System Agents|sensory system agents|mesh-ancestor
83407496|NCT05377242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407497|NCT05377242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407498|NCT05377242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83407499|NCT05377242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407500|NCT05377242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407501|NCT05377242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407502|NCT05377242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407503|NCT05377242|Antioxidants|antioxidants|mesh-ancestor
83407504|NCT05377242|Protective Agents|protective agents|mesh-ancestor
83407505|NCT05377242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83407506|NCT05374954|Vaccines|vaccines|mesh-list
83407507|NCT05374954|Immunologic Factors|immunologic factors|mesh-ancestor
83407508|NCT05374954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407509|NCT05363007|Leucovorin|leucovorin|mesh-list
83407510|NCT05363007|Irinotecan|irinotecan|mesh-list
83407511|NCT05363007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83407512|NCT05363007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83407513|NCT05363007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407514|NCT05363007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407515|NCT05363007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407516|NCT05363007|Antidotes|antidotes|mesh-ancestor
83407517|NCT05363007|Protective Agents|protective agents|mesh-ancestor
83407518|NCT05363007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407519|NCT05363007|Vitamin B Complex|vitamin b complex|mesh-ancestor
83407520|NCT05363007|Vitamins|vitamins|mesh-ancestor
83407521|NCT05363007|Micronutrients|micronutrients|mesh-ancestor
83407522|NCT05360160|Venetoclax|venetoclax|mesh-list
83407523|NCT05360160|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83407524|NCT05360160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407525|NCT05360160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83407526|NCT05360160|Antimetabolites|antimetabolites|mesh-ancestor
83407527|NCT05360160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407528|NCT05351606|Bupropion|bupropion|mesh-list
83407529|NCT05351606|Nicotine|nicotine|mesh-list
83407530|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83407531|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
83407532|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407533|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407534|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83407535|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83407536|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
83407537|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83407538|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407539|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83407540|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
83407541|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83407542|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83407543|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83407544|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83407545|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
83407546|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83407547|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83407548|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407550|NCT05350371|Analgesics|analgesics|mesh-ancestor
83407551|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
83407552|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407553|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407554|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83407555|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83407556|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83407557|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407558|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407559|NCT05348577|Docetaxel|docetaxel|mesh-list
83407560|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407561|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
83407562|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
83407563|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
83407564|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407566|NCT05347212|Relatlimab|relatlimab|mesh-list
83407567|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407568|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407569|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83407570|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407571|NCT05346159|Androgens|androgens|mesh-list
83407572|NCT05346159|Hormones|hormones|mesh-ancestor
83407573|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83407574|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407575|NCT05345171|Prednisolone|prednisolone|mesh-list
83407576|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83407577|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
83407578|NCT05345171|Hormones|hormones|mesh-ancestor
83407579|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83407580|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407581|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83407582|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407583|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83407584|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83407585|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83407586|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
83407587|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407588|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83407589|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83407590|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407591|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
83407592|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
83407593|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407594|NCT05329090|Rituximab|rituximab|mesh-list
83407595|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407596|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407597|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
83407598|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407599|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407600|NCT05328154|Diphosphonates|diphosphonates|mesh-list
83407601|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83407602|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407603|NCT05324059|Pregabalin|pregabalin|mesh-list
83407604|NCT05324059|Tramadol|tramadol|mesh-list
83407605|NCT05324059|Analgesics|analgesics|mesh-ancestor
83407606|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
83407607|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407608|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407609|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
83407610|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83407611|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83407612|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407613|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83407614|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83407615|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83407616|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83407617|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83407631|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407632|NCT05319730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83407633|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83407634|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83407635|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407636|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
83407637|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407638|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407640|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
83407641|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83407642|NCT05312970|Polidocanol|polidocanol|mesh-list
83407643|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83407644|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83407645|NCT05303636|Drospirenone|drospirenone|mesh-list
83407646|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83407647|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
83407648|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83407649|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407650|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83407651|NCT05303636|Diuretics|diuretics|mesh-ancestor
83407652|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
83407653|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
83407654|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83407655|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83407656|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407657|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83407658|NCT05271552|Analgesics|analgesics|mesh-ancestor
83407659|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
83407660|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407661|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83407662|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83407663|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83407664|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
83407665|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83407666|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407667|NCT05268003|Venetoclax|venetoclax|mesh-list
83407668|NCT05268003|Ponatinib|ponatinib|mesh-list
83407669|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407670|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407671|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407672|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407673|NCT05256225|Paclitaxel|paclitaxel|mesh-list
83407674|NCT05256225|Carboplatin|carboplatin|mesh-list
83407675|NCT05256225|Trastuzumab|trastuzumab|mesh-list
83407676|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83407677|NCT05256225|Pertuzumab|pertuzumab|mesh-list
83407678|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83407679|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407680|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
83407681|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
83407682|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
83407683|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407684|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407685|NCT05253651|Leucovorin|leucovorin|mesh-list
83407686|NCT05253651|Bevacizumab|bevacizumab|mesh-list
83407687|NCT05253651|Trastuzumab|trastuzumab|mesh-list
83407688|NCT05253651|Cetuximab|cetuximab|mesh-list
83407689|NCT05253651|Fluorouracil|fluorouracil|mesh-list
83407690|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
83407691|NCT05253651|Tucatinib|tucatinib|mesh-list
83407692|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
83407693|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407694|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407695|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83407696|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83407697|NCT05253651|Growth Substances|growth substances|mesh-ancestor
83407698|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407699|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
83407700|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
83407701|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407702|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83407703|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83407704|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
83407705|NCT05253651|Antidotes|antidotes|mesh-ancestor
83407706|NCT05253651|Protective Agents|protective agents|mesh-ancestor
83407711|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407712|NCT05238142|Insulin|insulin|mesh-list
83407713|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83407714|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407715|NCT05236673|Empagliflozin|empagliflozin|mesh-list
83407716|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83407717|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407718|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83407719|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407720|NCT05232071|Empagliflozin|empagliflozin|mesh-list
83407721|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83407722|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407723|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83407724|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407725|NCT05226429|Vaccines|vaccines|mesh-list
83407726|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
83407727|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407728|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
83407729|NCT05217446|Cetuximab|cetuximab|mesh-list
83407730|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407731|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407732|NCT05217446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83407733|NCT05217446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407734|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
83407735|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83407736|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83407737|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83407738|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83407739|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407740|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
83407741|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83407742|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407743|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83407744|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407745|NCT05212012|Methadone|methadone|mesh-list
83407746|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83407747|NCT05212012|Narcotics|narcotics|mesh-ancestor
83407748|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83407749|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407750|NCT05212012|Analgesics|analgesics|mesh-ancestor
83407751|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
83407752|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407753|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
83407754|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
83407755|NCT05198804|Niraparib|niraparib|mesh-list
83407756|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83407757|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407758|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407759|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407760|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
83407761|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83407762|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83407763|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407764|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83407765|NCT05197439|Analgesics|analgesics|mesh-ancestor
83407766|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
83407767|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407768|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83407769|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83407770|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83407771|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
83407772|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83407773|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407774|NCT05195918|Pirfenidone|pirfenidone|mesh-list
83407775|NCT05195918|Nintedanib|nintedanib|mesh-list
83407776|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83407777|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407778|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407779|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407780|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407781|NCT05195918|Analgesics|analgesics|mesh-ancestor
83407782|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
83407783|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407784|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407785|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83407786|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83407787|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83407788|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407789|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
83407790|NCT05195918|Protective Agents|protective agents|mesh-ancestor
83407791|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83407792|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83407793|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83407794|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83407795|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83407796|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407797|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83407798|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83407799|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83407800|NCT05169060|Analgesics|analgesics|mesh-ancestor
83407801|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
83407802|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407803|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407804|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83407805|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407806|NCT05153408|Carboplatin|carboplatin|mesh-list
83407808|NCT05153408|Osimertinib|osimertinib|mesh-list
83407809|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407810|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407811|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407812|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83407813|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83407814|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407815|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
83407816|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83407817|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83407818|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83407819|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83407820|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407821|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
83407822|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83407823|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407824|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83407825|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407826|NCT05136196|Nivolumab|nivolumab|mesh-list
83407827|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407828|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407829|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83407830|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407831|NCT05132582|Trastuzumab|trastuzumab|mesh-list
83407832|NCT05132582|Pertuzumab|pertuzumab|mesh-list
83407833|NCT05132582|Tucatinib|tucatinib|mesh-list
83407834|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407835|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407836|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407837|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407838|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407839|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
83407840|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83407841|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407842|NCT05113251|Paclitaxel|paclitaxel|mesh-list
83407843|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
83407844|NCT05113251|Doxorubicin|doxorubicin|mesh-list
83407845|NCT05113251|Trastuzumab|trastuzumab|mesh-list
83407846|NCT05113251|Pertuzumab|pertuzumab|mesh-list
83407847|NCT05113251|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83407848|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83407849|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407850|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
83407851|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
83407852|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
83407853|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407854|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83407855|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
83407856|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407857|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407858|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83407859|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
83407860|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83407861|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83407862|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83407863|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83407864|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407865|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407867|NCT05111574|Nivolumab|nivolumab|mesh-list
83407868|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407869|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407870|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83407871|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407872|NCT05107674|Paclitaxel|paclitaxel|mesh-list
83407873|NCT05107674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83407874|NCT05107674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407875|NCT05107674|Tubulin Modulators|tubulin modulators|mesh-ancestor
83407876|NCT05107674|Antimitotic Agents|antimitotic agents|mesh-ancestor
83407877|NCT05107674|Mitosis Modulators|mitosis modulators|mesh-ancestor
83407878|NCT05107674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407879|NCT05100628|Doxorubicin|doxorubicin|mesh-list
83407880|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83407881|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407882|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83407883|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83407884|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407885|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407886|NCT05093959|Metformin|metformin|mesh-list
83407887|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83407888|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407889|NCT05091619|Vaccines|vaccines|mesh-list
83407890|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
83407891|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407892|NCT05089916|Osimertinib|osimertinib|mesh-list
83407893|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407894|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407895|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407896|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407897|NCT05089370|Nivolumab|nivolumab|mesh-list
83407898|NCT05089370|Decitabine|decitabine|mesh-list
83407899|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407900|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407901|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83407902|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407903|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83407904|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
83407905|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407906|NCT05086250|Ketamine|ketamine|mesh-list
83407907|NCT05086250|Analgesics|analgesics|mesh-ancestor
83407908|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
83407909|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407910|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407911|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83407912|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83407913|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
83407914|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
83407915|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83407916|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83407917|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83407918|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83407919|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407920|NCT05084911|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83407921|NCT05084911|Antiviral Agents|antiviral agents|mesh-ancestor
83407922|NCT05084911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83407923|NCT05081388|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83407924|NCT05081388|Antiviral Agents|antiviral agents|mesh-ancestor
83407925|NCT05081388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83407926|NCT05076149|Ivacaftor|ivacaftor|mesh-list
83407927|NCT05076149|Elexacaftor|elexacaftor|mesh-list
83407928|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83407929|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83407930|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407931|NCT05075993|Paclitaxel|paclitaxel|mesh-list
83407932|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83407933|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
83407934|NCT05075993|Bevacizumab|bevacizumab|mesh-list
83407935|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83407936|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407937|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83407938|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83407939|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83407940|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407941|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83407942|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
83407943|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407944|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407945|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83407946|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
83407947|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83407948|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407949|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83407950|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83407951|NCT05075993|Growth Substances|growth substances|mesh-ancestor
83407952|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
83407953|NCT05054374|Fulvestrant|fulvestrant|mesh-list
83407954|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83407955|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407956|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83407957|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83407958|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
83407959|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83407960|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407961|NCT05048797|Carboplatin|carboplatin|mesh-list
83407962|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
83407963|NCT05048797|Trastuzumab|trastuzumab|mesh-list
83407964|NCT05048797|Pemetrexed|pemetrexed|mesh-list
83407965|NCT05048797|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83407966|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407967|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407968|NCT05048797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83407969|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407970|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407971|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83407972|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83407973|NCT05048797|Immunoconjugates|immunoconjugates|mesh-ancestor
83407974|NCT05048797|Immunologic Factors|immunologic factors|mesh-ancestor
83407975|NCT05048797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407976|NCT05039177|Cetuximab|cetuximab|mesh-list
83407977|NCT05039177|Palbociclib|palbociclib|mesh-list
83407978|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83407979|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407980|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407981|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407982|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407983|NCT05027308|Teduglutide|teduglutide|mesh-list
83407984|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83407985|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83407986|NCT05027308|Protective Agents|protective agents|mesh-ancestor
83407987|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407988|NCT05025800|Rituximab|rituximab|mesh-list
83407989|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83407990|NCT05025800|Lenalidomide|lenalidomide|mesh-list
83407991|NCT05025800|Antibodies|antibodies|mesh-list
83407992|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
83407993|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83407994|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
83407995|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83407996|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407997|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83407998|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83407999|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83408000|NCT05025800|Growth Substances|growth substances|mesh-ancestor
83408001|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
83408002|NCT05022342|Fulvestrant|fulvestrant|mesh-list
83408003|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83408004|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408005|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83408006|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83408007|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
83408008|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83408009|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408010|NCT05020899|Nicotine|nicotine|mesh-list
83408011|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83408012|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
83408013|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408014|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408015|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83408016|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83408017|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
83408018|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83408019|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408020|NCT05017246|Lidocaine|lidocaine|mesh-list
83408021|NCT05017246|Morphine|morphine|mesh-list
83408022|NCT05017246|Bupivacaine|bupivacaine|mesh-list
83408023|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
83408024|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
83408025|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83408026|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408027|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
83408028|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408029|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83408030|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83408031|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83408032|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83408033|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408034|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83408035|NCT05017246|Narcotics|narcotics|mesh-ancestor
83408036|NCT05017246|Analgesics|analgesics|mesh-ancestor
83408037|NCT05017025|Osimertinib|osimertinib|mesh-list
83408038|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408039|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408040|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408041|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408042|NCT05007041|Vaccines|vaccines|mesh-list
83408043|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
83408044|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408045|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83408046|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408047|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83408048|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83408049|NCT05001555|Analgesics|analgesics|mesh-ancestor
83408050|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
83408051|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408052|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83408053|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83408054|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
83408055|NCT04995003|Nivolumab|nivolumab|mesh-list
83408056|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83408057|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408058|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408059|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408060|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
83408061|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408062|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408063|NCT04978675|Fluorides|fluorides|mesh-list
83408064|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
83408065|NCT04978675|Protective Agents|protective agents|mesh-ancestor
83408066|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408067|NCT04977024|Vaccines|vaccines|mesh-list
83408068|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
83408069|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408070|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
83408071|NCT04971226|Dasatinib|dasatinib|mesh-list
83408072|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408073|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408074|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408075|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408076|NCT04960709|Durvalumab|durvalumab|mesh-list
83408077|NCT04960709|Tremelimumab|tremelimumab|mesh-list
83408078|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408079|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408080|NCT04939935|Metformin|metformin|mesh-list
83408081|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83408082|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408083|NCT04935177|Antibodies|antibodies|mesh-list
83408084|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
83408085|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83408086|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
83408087|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83408088|NCT04935177|Eculizumab|eculizumab|mesh-list
83408089|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
83408090|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408091|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83408092|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408093|NCT04933539|Dexamethasone|dexamethasone|mesh-list
83408094|NCT04933539|Daratumumab|daratumumab|mesh-list
83408095|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83408096|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
83408097|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
83408098|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408099|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408100|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83408101|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
83408102|NCT04933539|Hormones|hormones|mesh-ancestor
83408103|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83408104|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83408105|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408106|NCT04884360|Olaparib|olaparib|mesh-list
83408107|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83408108|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408109|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408110|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408111|NCT04883255|Dronabinol|dronabinol|mesh-list
83408112|NCT04883255|Cannabidiol|cannabidiol|mesh-list
83408113|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
83408114|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
83408115|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408116|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83408117|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83408118|NCT04883255|Analgesics|analgesics|mesh-ancestor
83408119|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
83408120|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408121|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83408122|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83408123|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83408124|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408125|NCT04883255|Hormones|hormones|mesh-ancestor
83408126|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83408127|NCT04880850|Insulin|insulin|mesh-list
83408128|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83408129|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
83408130|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
83408131|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83408132|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408133|NCT04874194|Venetoclax|venetoclax|mesh-list
83408134|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
83408135|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408136|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83408137|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83408138|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408139|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408140|NCT04868838|Daratumumab|daratumumab|mesh-list
83408141|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408142|NCT04863638|Vaccines|vaccines|mesh-list
83408143|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
83408144|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408145|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
83408146|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
83408147|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408148|NCT04840602|Rituximab|rituximab|mesh-list
83408149|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83408150|NCT04840602|Venetoclax|venetoclax|mesh-list
83408151|NCT04840602|Antibodies|antibodies|mesh-list
83408152|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
83408153|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83408154|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
83408155|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408156|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408171|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408172|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408173|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
83408174|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408175|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83408176|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
83408177|NCT04786210|Hormones|hormones|mesh-ancestor
83408178|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83408179|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408180|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
83408181|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83408182|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
83408183|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83408184|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408185|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83408186|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83408187|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83408188|NCT04781855|Nivolumab|nivolumab|mesh-list
83408189|NCT04781855|Ipilimumab|ipilimumab|mesh-list
83408190|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408191|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408192|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408193|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408194|NCT04774393|Decitabine|decitabine|mesh-list
83408195|NCT04774393|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83408196|NCT04774393|Venetoclax|venetoclax|mesh-list
83408197|NCT04774393|Ivosidenib|ivosidenib|mesh-list
83408198|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83408199|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
83408200|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408201|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408202|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408203|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83408204|NCT04760288|Pralsetinib|pralsetinib|mesh-list
83408205|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408206|NCT04743505|Osimertinib|osimertinib|mesh-list
83408207|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408208|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408209|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408210|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408211|NCT04742777|Sirolimus|sirolimus|mesh-list
83408212|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83408213|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408214|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83408215|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408216|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
83408217|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408218|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
83408219|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408220|NCT04740918|Trastuzumab|trastuzumab|mesh-list
83408221|NCT04740918|Atezolizumab|atezolizumab|mesh-list
83408222|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83408223|NCT04740918|Maytansine|maytansine|mesh-list
83408224|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408225|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408226|NCT04740918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408227|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408228|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83408229|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
83408230|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
83408231|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
83408232|NCT04740918|Immunotoxins|immunotoxins|mesh-ancestor
83408233|NCT04740918|Immunoconjugates|immunoconjugates|mesh-ancestor
83408234|NCT04740918|Immunologic Factors|immunologic factors|mesh-ancestor
83408235|NCT04740918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408236|NCT04729322|Metronidazole|metronidazole|mesh-list
83408237|NCT04729322|Vancomycin|vancomycin|mesh-list
83408238|NCT04729322|Neomycin|neomycin|mesh-list
83408239|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
83408240|NCT04729322|Nivolumab|nivolumab|mesh-list
83408241|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408242|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408243|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408244|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408245|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408246|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83408247|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83408248|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83408249|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83408250|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408251|NCT04724252|Gabapentin|gabapentin|mesh-list
83408252|NCT04724252|Analgesics|analgesics|mesh-ancestor
83408253|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
83408254|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408255|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408256|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
83408257|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83408258|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83408259|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83408260|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83408261|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83408262|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83408263|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83408264|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408265|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
83408266|NCT04723394|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83408267|NCT04723394|Antiviral Agents|antiviral agents|mesh-ancestor
83408268|NCT04723394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408269|NCT04712643|Atezolizumab|atezolizumab|mesh-list
83408270|NCT04712643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408271|NCT04712643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408272|NCT04712643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408273|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408274|NCT04704934|Paclitaxel|paclitaxel|mesh-list
83408275|NCT04704934|Trastuzumab|trastuzumab|mesh-list
83408276|NCT04704934|Ramucirumab|ramucirumab|mesh-list
83408277|NCT04704934|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83408278|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83408279|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408280|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
83408281|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
83408282|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
83408283|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408284|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408285|NCT04704934|Immunoconjugates|immunoconjugates|mesh-ancestor
83408286|NCT04704934|Immunologic Factors|immunologic factors|mesh-ancestor
83408287|NCT04704934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408288|NCT04697628|Gemcitabine|gemcitabine|mesh-list
83408289|NCT04697628|Irinotecan|irinotecan|mesh-list
83408290|NCT04697628|Pemetrexed|pemetrexed|mesh-list
83408291|NCT04697628|Topotecan|topotecan|mesh-list
83408292|NCT04697628|Vinorelbine|vinorelbine|mesh-list
83408293|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
83408294|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83408295|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
83408296|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408297|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408298|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83408299|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83408300|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408301|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83408302|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83408303|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83408304|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
83408305|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
83408306|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
83408307|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408308|NCT04683939|Paclitaxel|paclitaxel|mesh-list
83408309|NCT04683939|Gemcitabine|gemcitabine|mesh-list
83408310|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83408311|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408312|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
83408314|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
83408315|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408316|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83408317|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
83408318|NCT04677569|Azithromycin|azithromycin|mesh-list
83408319|NCT04677569|Amikacin|amikacin|mesh-list
83408320|NCT04677569|Ethambutol|ethambutol|mesh-list
83408321|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83408322|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408323|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
83408324|NCT04671667|Cisplatin|cisplatin|mesh-list
83408325|NCT04671667|Carboplatin|carboplatin|mesh-list
83408326|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
83408327|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408328|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408329|NCT04671667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408330|NCT04671667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408331|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
83408332|NCT04670068|Fludarabine|fludarabine|mesh-list
83408333|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408334|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
83408335|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408336|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83408337|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83408338|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
83408339|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408340|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408341|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83408342|NCT04660344|Atezolizumab|atezolizumab|mesh-list
83408343|NCT04660344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408344|NCT04660344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408345|NCT04660344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408346|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408347|NCT04645160|Tivozanib|tivozanib|mesh-list
83408348|NCT04645160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408349|NCT04645160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408350|NCT04645160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408351|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
83408352|NCT04626518|Lenvatinib|lenvatinib|mesh-list
83408353|NCT04626518|Belzutifan|belzutifan|mesh-list
83408354|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408355|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408356|NCT04626518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408357|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408358|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408359|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408360|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
83408361|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83408362|NCT04618289|Vitamin D|vitamin d|mesh-list
83408363|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
83408364|NCT04618289|Vitamins|vitamins|mesh-ancestor
83408365|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
83408366|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408367|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83408368|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83408369|NCT04617795|Insulin|insulin|mesh-list
83408370|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83408371|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408372|NCT04599634|Venetoclax|venetoclax|mesh-list
83408373|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
83408374|NCT04599634|Magrolimab|magrolimab|mesh-list
83408375|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408376|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408377|NCT04592237|Carboplatin|carboplatin|mesh-list
83408378|NCT04592237|Niraparib|niraparib|mesh-list
83408379|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408380|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83408381|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408382|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408383|NCT04588441|Adenosine|adenosine|mesh-list
83408384|NCT04588441|Analgesics|analgesics|mesh-ancestor
83408385|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
83408386|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408387|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408388|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83408389|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
83408390|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83408391|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
83408392|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
83408393|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83408394|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408395|NCT04586010|Teriflunomide|teriflunomide|mesh-list
83408396|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83408397|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83408398|NCT04586010|Analgesics|analgesics|mesh-ancestor
83408399|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
83408400|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408401|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408402|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83408403|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83408404|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408405|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
83408406|NCT04578015|Metronidazole|metronidazole|mesh-list
83408407|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408408|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83408409|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83408410|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83408411|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83408412|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83408413|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83408414|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83408415|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
83408416|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
83408417|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408419|NCT04538378|Olaparib|olaparib|mesh-list
83408420|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408421|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408422|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83408423|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408424|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408425|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
83408426|NCT04535401|Leucovorin|leucovorin|mesh-list
83408427|NCT04535401|Folic Acid|folic acid|mesh-list
83408428|NCT04535401|Fluorouracil|fluorouracil|mesh-list
83408429|NCT04535401|Irinotecan|irinotecan|mesh-list
83408430|NCT04535401|Camptothecin|camptothecin|mesh-list
83408431|NCT04535401|Calcium|calcium|mesh-list
83408432|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
83408433|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83408434|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408435|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83408436|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
83408437|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408438|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83408439|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408440|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408441|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
83408442|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83408443|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83408444|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408445|NCT04535401|Antidotes|antidotes|mesh-ancestor
83408446|NCT04535401|Protective Agents|protective agents|mesh-ancestor
83408447|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
83408448|NCT04535401|Vitamins|vitamins|mesh-ancestor
83408449|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
83408450|NCT04535401|Hematinics|hematinics|mesh-ancestor
83408451|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83408452|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
83408453|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408454|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408455|NCT04534205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408456|NCT04534205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408457|NCT04522323|Lenvatinib|lenvatinib|mesh-list
83408458|NCT04522323|Axitinib|axitinib|mesh-list
83408459|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408460|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408461|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408462|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408463|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
83408464|NCT04520451|Hormones|hormones|mesh-ancestor
83408465|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83408466|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408467|NCT04510207|Vaccines|vaccines|mesh-list
83408468|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
83408469|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408470|NCT04494425|Paclitaxel|paclitaxel|mesh-list
83408471|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83408472|NCT04494425|Capecitabine|capecitabine|mesh-list
83408473|NCT04494425|Trastuzumab|trastuzumab|mesh-list
83408475|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83408476|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408477|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
83408478|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
83408479|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
83408480|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408481|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83408482|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
83408483|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408484|NCT04494425|Immunoconjugates|immunoconjugates|mesh-ancestor
83408485|NCT04494425|Immunologic Factors|immunologic factors|mesh-ancestor
83408486|NCT04494425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408487|NCT04454658|Navitoclax|navitoclax|mesh-list
83408488|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408489|NCT04445519|Latanoprost|latanoprost|mesh-list
83408490|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83408491|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83408492|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83408493|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
83408494|NCT04420585|Coagulants|coagulants|mesh-ancestor
83408495|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83408496|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
83408497|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408498|NCT04396860|Nivolumab|nivolumab|mesh-list
83408499|NCT04396860|Ipilimumab|ipilimumab|mesh-list
83408500|NCT04396860|Temozolomide|temozolomide|mesh-list
83408501|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408502|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408503|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408504|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408505|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83408506|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
83408507|NCT04396496|Daratumumab|daratumumab|mesh-list
83408508|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408509|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83408510|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83408511|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83408512|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83408513|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408514|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
83408515|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83408516|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408517|NCT04338204|Tofacitinib|tofacitinib|mesh-list
83408518|NCT04338204|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83408519|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408520|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408521|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408522|NCT04334941|Atezolizumab|atezolizumab|mesh-list
83408523|NCT04334941|Talazoparib|talazoparib|mesh-list
83408524|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83408525|NCT04334941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408526|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408527|NCT04334941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408528|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408529|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
83408530|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408531|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83408532|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408533|NCT04317105|Nivolumab|nivolumab|mesh-list
83408534|NCT04317105|Ipilimumab|ipilimumab|mesh-list
83408535|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408536|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408537|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408538|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408539|NCT04294225|Letrozole|letrozole|mesh-list
83408540|NCT04294225|Anastrozole|anastrozole|mesh-list
83408541|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408542|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83408543|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83408544|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408545|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408546|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83408547|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
83408548|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83408549|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408550|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83408552|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83408553|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408554|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
83408555|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83408556|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83408557|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408558|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83408559|NCT04268303|Analgesics|analgesics|mesh-ancestor
83408560|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
83408561|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408562|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83408563|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83408564|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83408565|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
83408566|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83408567|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408568|NCT04267497|Amphotericin B|amphotericin b|mesh-list
83408569|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83408570|NCT04267497|Amebicides|amebicides|mesh-ancestor
83408571|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83408572|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83408573|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408574|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83408575|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
83408576|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
83408577|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408578|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408579|NCT04266730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408580|NCT04266730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408581|NCT04263831|Aldesleukin|aldesleukin|mesh-list
83408582|NCT04263831|Interleukin-2|interleukin-2|mesh-list
83408583|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408584|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83408585|NCT04263831|Analgesics|analgesics|mesh-ancestor
83408586|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
83408587|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408588|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408589|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83408590|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83408591|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
83408592|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408593|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
83408594|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408595|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408596|NCT04260529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408597|NCT04260529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408598|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
83408599|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83408600|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83408601|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408602|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
83408603|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83408604|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408605|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
83408606|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83408607|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83408608|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408609|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
83408610|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83408611|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408612|NCT04249401|Warfarin|warfarin|mesh-list
83408613|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
83408614|NCT04249401|Dabigatran|dabigatran|mesh-list
83408615|NCT04249401|Apixaban|apixaban|mesh-list
83408616|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
83408617|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83408618|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
83408619|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83408620|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
83408621|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408697|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83408622|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408623|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
83408624|NCT04239092|Temozolomide|temozolomide|mesh-list
83408625|NCT04239092|Irinotecan|irinotecan|mesh-list
83408626|NCT04239092|Topotecan|topotecan|mesh-list
83408627|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408628|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
83408629|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408630|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83408631|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83408632|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
83408633|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408634|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408635|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83408636|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83408637|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83408638|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408639|NCT04237649|Spartalizumab|spartalizumab|mesh-list
83408640|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408641|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408642|NCT04237649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408643|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408644|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
83408645|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
83408646|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83408647|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83408648|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408649|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
83408650|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408651|NCT04224740|Cisplatin|cisplatin|mesh-list
83408652|NCT04224740|Carboplatin|carboplatin|mesh-list
83408653|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
83408654|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408655|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408656|NCT04224740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408657|NCT04224740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408658|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
83408659|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83408660|NCT04223765|Fludarabine|fludarabine|mesh-list
83408661|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408662|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
83408663|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408664|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83408665|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83408666|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
83408667|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408668|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408669|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83408670|NCT04222972|Paclitaxel|paclitaxel|mesh-list
83408671|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83408672|NCT04222972|Carboplatin|carboplatin|mesh-list
83408673|NCT04222972|Gemcitabine|gemcitabine|mesh-list
83408674|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
83408675|NCT04222972|Pemetrexed|pemetrexed|mesh-list
83408676|NCT04222972|Pralsetinib|pralsetinib|mesh-list
83408677|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83408678|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408679|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
83408680|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
83408681|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
83408682|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408683|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83408684|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
83408685|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408686|NCT04222972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408688|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83408689|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83408690|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
83408691|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408692|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408693|NCT04205227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408694|NCT04205227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408695|NCT04204941|Doxorubicin|doxorubicin|mesh-list
83408696|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83408698|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408699|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83408700|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83408701|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408702|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408703|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
83408704|NCT04189757|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83408705|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408706|NCT04189757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408707|NCT04189757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408708|NCT04189757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408709|NCT04175912|Paclitaxel|paclitaxel|mesh-list
83408710|NCT04175912|Carboplatin|carboplatin|mesh-list
83408711|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83408712|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83408713|NCT04175912|Pevonedistat|pevonedistat|mesh-list
83408714|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83408715|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408716|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
83408717|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
83408718|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
83408719|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408720|NCT04161898|Prednisolone|prednisolone|mesh-list
83408721|NCT04161898|Upadacitinib|upadacitinib|mesh-list
83408722|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83408723|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
83408724|NCT04161898|Hormones|hormones|mesh-ancestor
83408725|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83408726|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408727|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83408728|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408729|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83408730|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408731|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408732|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408733|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83408734|NCT04159155|Paclitaxel|paclitaxel|mesh-list
83408735|NCT04159155|Carboplatin|carboplatin|mesh-list
83408736|NCT04159155|Niraparib|niraparib|mesh-list
83408737|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83408738|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408739|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
83408740|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
83408741|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
83408742|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408743|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83408744|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408745|NCT04145115|Nivolumab|nivolumab|mesh-list
83408746|NCT04145115|Ipilimumab|ipilimumab|mesh-list
83408747|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408748|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408749|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408750|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408751|NCT04141696|Midazolam|midazolam|mesh-list
83408752|NCT04141696|Ketamine|ketamine|mesh-list
83408753|NCT04141696|Analgesics|analgesics|mesh-ancestor
83408754|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
83408755|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408756|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408757|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83408758|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83408759|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
83408760|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
83408761|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83408762|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83408763|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83408764|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83408765|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408766|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83408767|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83408768|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83408769|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83408770|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83408771|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
83408772|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
83408776|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83408777|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408778|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
83408779|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408780|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
83408781|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408782|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408783|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408784|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408785|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83408786|NCT04108858|Trastuzumab|trastuzumab|mesh-list
83408787|NCT04108858|Pertuzumab|pertuzumab|mesh-list
83408788|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83408789|NCT04108858|Antibodies|antibodies|mesh-list
83408790|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
83408791|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83408792|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
83408793|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408794|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408795|NCT04094675|Sirolimus|sirolimus|mesh-list
83408796|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83408797|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408798|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83408799|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408800|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
83408801|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408802|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
83408803|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408804|NCT04092452|PF-06700841|pf-06700841|mesh-list
83408805|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408806|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408807|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408808|NCT04090398|Paclitaxel|paclitaxel|mesh-list
83408809|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83408810|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83408811|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83408812|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408813|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
83408814|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
83408815|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
83408816|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408817|NCT04074746|Vidarabine|vidarabine|mesh-list
83408818|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
83408819|NCT04074746|Fludarabine|fludarabine|mesh-list
83408820|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
83408821|NCT04074746|Antibodies|antibodies|mesh-list
83408822|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83408823|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408824|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
83408825|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408826|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83408827|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83408828|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
83408829|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408830|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408831|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83408832|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83408833|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
83408834|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
83408835|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408836|NCT04047641|Cytarabine|cytarabine|mesh-list
83408837|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83408838|NCT04047641|Idarubicin|idarubicin|mesh-list
83408839|NCT04047641|Cladribine|cladribine|mesh-list
83408840|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83408841|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
83408842|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408843|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408844|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
83408845|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408846|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408847|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
83408848|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408849|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83408850|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83408851|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83408855|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408856|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408857|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408858|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408859|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408860|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408861|NCT04029688|Cytarabine|cytarabine|mesh-list
83408862|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
83408863|NCT04029688|Fludarabine|fludarabine|mesh-list
83408864|NCT04029688|Topotecan|topotecan|mesh-list
83408865|NCT04029688|Venetoclax|venetoclax|mesh-list
83408866|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408867|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
83408868|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408869|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83408870|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83408871|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
83408872|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408873|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408874|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83408875|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83408876|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
83408877|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
83408878|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408879|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83408880|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83408881|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408882|NCT04029116|Fluconazole|fluconazole|mesh-list
83408883|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
83408884|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
83408885|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408886|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83408887|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83408888|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408889|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408890|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83408891|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
83408892|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83408893|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408894|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83408895|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83408896|NCT04025489|Vitamin D|vitamin d|mesh-list
83408897|NCT04025489|Vitamins|vitamins|mesh-ancestor
83408898|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
83408899|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408900|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83408901|NCT04002947|Rituximab|rituximab|mesh-list
83408902|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
83408903|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408904|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408905|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
83408906|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408907|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83408908|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
83408909|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
83408910|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83408911|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
83408912|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83408913|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83408914|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408915|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83408916|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408917|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408918|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83408919|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
83408920|NCT03983850|Sirolimus|sirolimus|mesh-list
83408921|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
83408922|NCT03983850|Busulfan|busulfan|mesh-list
83408923|NCT03983850|Fludarabine|fludarabine|mesh-list
83408924|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83408925|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
83408926|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408927|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83408928|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83408929|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
83409004|NCT03907488|Imidazole|imidazole|mesh-list
83408930|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408932|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83408933|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83408934|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83408935|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
83408936|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83408937|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408938|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408939|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
83408940|NCT03962894|Prednisolone|prednisolone|mesh-list
83408941|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83408942|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
83408943|NCT03962894|Hormones|hormones|mesh-ancestor
83408944|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83408945|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408946|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83408947|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408948|NCT03959488|Palivizumab|palivizumab|mesh-list
83408949|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
83408950|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408951|NCT03946878|Venetoclax|venetoclax|mesh-list
83408952|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
83408953|NCT03946878|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83408954|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408955|NCT03946878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83408956|NCT03946878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408957|NCT03946878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408958|NCT03926026|Fluticasone|fluticasone|mesh-list
83408959|NCT03926026|Xhance|xhance|mesh-list
83408960|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83408961|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83408962|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
83408963|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83408964|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408965|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83408966|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
83408967|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
83408968|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83408969|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
83408970|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408971|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408972|NCT03924895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408973|NCT03924895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408974|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
83408975|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408976|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408977|NCT03924869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408978|NCT03924869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408979|NCT03917082|Tamoxifen|tamoxifen|mesh-list
83408980|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83408981|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408982|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83408983|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
83408984|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83408985|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83408986|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83408987|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83408988|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83408989|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83408990|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83408991|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83408992|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408993|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83408994|NCT03907488|Nivolumab|nivolumab|mesh-list
83408995|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83408996|NCT03907488|Doxorubicin|doxorubicin|mesh-list
83408997|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83408998|NCT03907488|Dacarbazine|dacarbazine|mesh-list
83408999|NCT03907488|Vinblastine|vinblastine|mesh-list
83409000|NCT03907488|Antibodies|antibodies|mesh-list
83409001|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
83409002|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83409003|NCT03907488|Lenograstim|lenograstim|mesh-list
83409007|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409008|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409009|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83409010|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83409011|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83409012|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409013|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409014|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409015|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83409016|NCT03907488|Immunotoxins|immunotoxins|mesh-ancestor
83409017|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83409018|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
83409019|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83409020|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
83409021|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
83409022|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
83409023|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
83409024|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83409025|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83409026|NCT03875690|Prednisolone|prednisolone|mesh-list
83409027|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
83409028|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83409029|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
83409030|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83409031|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
83409032|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
83409033|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409034|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409035|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83409036|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
83409037|NCT03875690|Hormones|hormones|mesh-ancestor
83409038|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83409039|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83409040|NCT03875690|Protective Agents|protective agents|mesh-ancestor
83409041|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83409042|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409043|NCT03856216|Rituximab|rituximab|mesh-list
83409044|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83409045|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83409046|NCT03856216|Methotrexate|methotrexate|mesh-list
83409047|NCT03856216|Fludarabine|fludarabine|mesh-list
83409048|NCT03856216|Melphalan|melphalan|mesh-list
83409049|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83409050|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
83409051|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83409052|NCT03856216|Antibodies|antibodies|mesh-list
83409053|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
83409054|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83409055|NCT03856216|Lenograstim|lenograstim|mesh-list
83409056|NCT03856216|Tacrolimus|tacrolimus|mesh-list
83409057|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83409058|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
83409059|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409060|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409061|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409062|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83409063|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
83409064|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83409065|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409067|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409068|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
83409069|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409070|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83409071|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409072|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83409073|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83409074|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83409075|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83409076|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
83409077|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83409078|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83409079|NCT03856216|Immunotoxins|immunotoxins|mesh-ancestor
83409080|NCT03856216|Immunoconjugates|immunoconjugates|mesh-ancestor
83409081|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
83409082|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409083|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409085|NCT03834493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409086|NCT03829254|Pembrolizumab|pembrolizumab|mesh-list
83409087|NCT03829254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409088|NCT03829254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409089|NCT03829254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409090|NCT03829254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409091|NCT03808610|Cytarabine|cytarabine|mesh-list
83409092|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
83409093|NCT03808610|Dexamethasone|dexamethasone|mesh-list
83409094|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
83409095|NCT03808610|Prednisone|prednisone|mesh-list
83409096|NCT03808610|Cortisone|cortisone|mesh-list
83409097|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
83409098|NCT03808610|Rituximab|rituximab|mesh-list
83409099|NCT03808610|Methotrexate|methotrexate|mesh-list
83409100|NCT03808610|Vincristine|vincristine|mesh-list
83409101|NCT03808610|Venetoclax|venetoclax|mesh-list
83409102|NCT03808610|Asparaginase|asparaginase|mesh-list
83409103|NCT03808610|Pegaspargase|pegaspargase|mesh-list
83409104|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83409105|NCT03808610|Antibodies|antibodies|mesh-list
83409106|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
83409107|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83409108|NCT03808610|BB 1101|bb 1101|mesh-list
83409109|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409110|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
83409111|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409112|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409113|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83409114|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
83409115|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409116|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409117|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83409118|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83409119|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
83409120|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
83409121|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409122|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83409123|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
83409124|NCT03808610|Hormones|hormones|mesh-ancestor
83409125|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83409126|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83409127|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
83409128|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409129|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83409130|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
83409131|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83409132|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409133|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
83409134|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
83409135|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83409136|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83409137|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
83409138|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409139|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83409140|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
83409141|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
83409142|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
83409144|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83409145|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
83409146|NCT03774446|Roscovitine|roscovitine|mesh-list
83409147|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409148|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
83409149|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409150|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83409151|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409152|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409153|NCT03770416|Nivolumab|nivolumab|mesh-list
83409154|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409155|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409156|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409157|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409158|NCT03765918|Cisplatin|cisplatin|mesh-list
83409159|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
83409160|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409161|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409162|NCT03765918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409163|NCT03765918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409164|NCT03739996|Cabotegravir|cabotegravir|mesh-list
83409165|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83409166|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83409167|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83409168|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409169|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409170|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83409171|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83409172|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
83409173|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409174|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83409175|NCT03734029|Paclitaxel|paclitaxel|mesh-list
83409176|NCT03734029|Camptothecin|camptothecin|mesh-list
83409177|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83409178|NCT03734029|Gemcitabine|gemcitabine|mesh-list
83409179|NCT03734029|Capecitabine|capecitabine|mesh-list
83409180|NCT03734029|Trastuzumab|trastuzumab|mesh-list
83409181|NCT03734029|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83409182|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
83409183|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83409184|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409185|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
83409186|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
83409187|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
83409188|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409189|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409190|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
83409191|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409192|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
83409193|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409194|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83409195|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83409196|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409197|NCT03732820|Olaparib|olaparib|mesh-list
83409198|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
83409199|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83409200|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409201|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409202|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409203|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83409204|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
83409205|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83409206|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409207|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83409208|NCT03732677|Gemcitabine|gemcitabine|mesh-list
83409209|NCT03732677|Durvalumab|durvalumab|mesh-list
83409210|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409211|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409212|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
83409213|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409214|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409215|NCT03728673|Dexetimide|dexetimide|mesh-list
83409216|NCT03728673|Citalopram|citalopram|mesh-list
83409217|NCT03728673|Escitalopram|escitalopram|mesh-list
83409218|NCT03728673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83409219|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83409220|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83409221|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409222|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83409223|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
83409224|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409225|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83409226|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83409227|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
83409228|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
83409229|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409230|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83409231|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83409232|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
83409233|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83409234|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
83409235|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83409236|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
83409237|NCT03721068|Fludarabine|fludarabine|mesh-list
83409238|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409239|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
83409240|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409241|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409242|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83409243|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
83409244|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409245|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409246|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83409247|NCT03711058|Nivolumab|nivolumab|mesh-list
83409248|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409249|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409250|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409251|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409252|NCT03710772|Cytarabine|cytarabine|mesh-list
83409253|NCT03710772|Dexamethasone|dexamethasone|mesh-list
83409254|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
83409255|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
83409256|NCT03710772|Rituximab|rituximab|mesh-list
83409257|NCT03710772|Doxorubicin|doxorubicin|mesh-list
83409258|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83409259|NCT03710772|Methotrexate|methotrexate|mesh-list
83409260|NCT03710772|Vincristine|vincristine|mesh-list
83409261|NCT03710772|Venetoclax|venetoclax|mesh-list
83409262|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83409263|NCT03710772|Antibodies|antibodies|mesh-list
83409264|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
83409265|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83409266|NCT03710772|BB 1101|bb 1101|mesh-list
83409267|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409268|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
83409269|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409270|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409271|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83409272|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
83409273|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409274|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409275|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83409276|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83409277|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
83409278|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
83409279|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409280|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83409281|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
83409282|NCT03710772|Hormones|hormones|mesh-ancestor
83409283|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83409284|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83409285|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
83409286|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409287|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83409288|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83409289|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83409290|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83409291|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
83409292|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83409293|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409294|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
83409295|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
83409296|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83409297|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83409298|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
83409299|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409300|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83409301|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
83409302|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
83409303|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
83409304|NCT03705962|Tobramycin|tobramycin|mesh-list
83409305|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83409306|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409307|NCT03701308|Cytarabine|cytarabine|mesh-list
83409308|NCT03701308|Daunorubicin|daunorubicin|mesh-list
83409309|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409310|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
83409311|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409312|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409313|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
83409314|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409315|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409316|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
83409317|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409318|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83409319|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83409320|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83409321|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409322|NCT03693183|Ketorolac|ketorolac|mesh-list
83409323|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83409324|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83409325|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83409326|NCT03693183|Analgesics|analgesics|mesh-ancestor
83409327|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
83409328|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409329|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409330|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83409331|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409332|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83409333|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409334|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409335|NCT03687957|Temozolomide|temozolomide|mesh-list
83409336|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83409337|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
83409338|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409339|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409340|NCT03679650|Decitabine|decitabine|mesh-list
83409341|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409342|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
83409343|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409344|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409345|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409346|NCT03672539|Cytarabine|cytarabine|mesh-list
83409347|NCT03672539|Daunorubicin|daunorubicin|mesh-list
83409348|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
83409349|NCT03672539|Calicheamicins|calicheamicins|mesh-list
83409350|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409351|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
83409352|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409353|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409354|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
83409355|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409356|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409357|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
83409358|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409359|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83409360|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83409361|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83409362|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409363|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409364|NCT03672539|Immunotoxins|immunotoxins|mesh-ancestor
83409365|NCT03672539|Immunoconjugates|immunoconjugates|mesh-ancestor
83409366|NCT03661307|Decitabine|decitabine|mesh-list
83409367|NCT03661307|Venetoclax|venetoclax|mesh-list
83409368|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409369|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
83409370|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409371|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409372|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409373|NCT03657797|Latanoprost|latanoprost|mesh-list
83409374|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83409375|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83409376|NCT03631043|Lenalidomide|lenalidomide|mesh-list
83409377|NCT03631043|Vaccines|vaccines|mesh-list
83409378|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
83409379|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409380|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83409381|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83409382|NCT03631043|Growth Substances|growth substances|mesh-ancestor
83409383|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
83409384|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409385|NCT03616886|Paclitaxel|paclitaxel|mesh-list
83409386|NCT03616886|Carboplatin|carboplatin|mesh-list
83409388|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83409389|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409390|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
83409391|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
83409392|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
83409393|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409394|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409395|NCT03610711|Nivolumab|nivolumab|mesh-list
83409396|NCT03610711|Relatlimab|relatlimab|mesh-list
83409397|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409398|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409399|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409400|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409401|NCT03595124|Nivolumab|nivolumab|mesh-list
83409402|NCT03595124|Axitinib|axitinib|mesh-list
83409403|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409404|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409405|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409406|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409407|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83409408|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409409|NCT03594110|Empagliflozin|empagliflozin|mesh-list
83409410|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83409411|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409412|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83409413|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409414|NCT03579446|Oxymorphone|oxymorphone|mesh-list
83409415|NCT03579446|Morphine|morphine|mesh-list
83409416|NCT03579446|Oxycodone|oxycodone|mesh-list
83409417|NCT03579446|Hydromorphone|hydromorphone|mesh-list
83409418|NCT03579446|Hydrocodone|hydrocodone|mesh-list
83409419|NCT03579446|Levorphanol|levorphanol|mesh-list
83409420|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83409421|NCT03579446|Narcotics|narcotics|mesh-ancestor
83409422|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83409423|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409424|NCT03579446|Analgesics|analgesics|mesh-ancestor
83409425|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
83409426|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409427|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
83409428|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
83409429|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83409430|NCT03547973|Carboplatin|carboplatin|mesh-list
83409431|NCT03547973|Gemcitabine|gemcitabine|mesh-list
83409432|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
83409433|NCT03547973|Avelumab|avelumab|mesh-list
83409434|NCT03547973|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83409435|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409436|NCT03547973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409437|NCT03547973|Antimetabolites|antimetabolites|mesh-ancestor
83409438|NCT03547973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409439|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409440|NCT03547973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409441|NCT03547973|Immunoconjugates|immunoconjugates|mesh-ancestor
83409442|NCT03547973|Immunologic Factors|immunologic factors|mesh-ancestor
83409443|NCT03547973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409444|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
83409445|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409446|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409447|NCT03546361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409448|NCT03546361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409449|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
83409450|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409451|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409452|NCT03534804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409453|NCT03534804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409454|NCT03473574|Gemcitabine|gemcitabine|mesh-list
83409455|NCT03473574|Durvalumab|durvalumab|mesh-list
83409456|NCT03473574|Tremelimumab|tremelimumab|mesh-list
83409457|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409458|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409459|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
83409460|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409461|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409462|NCT03472040|Berotralstat|berotralstat|mesh-list
83409463|NCT03472040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83409464|NCT03472040|Protease Inhibitors|protease inhibitors|mesh-ancestor
83409465|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409466|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409467|NCT03452137|Atezolizumab|atezolizumab|mesh-list
83409468|NCT03452137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409469|NCT03452137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409470|NCT03452137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409471|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409472|NCT03428126|Durvalumab|durvalumab|mesh-list
83409473|NCT03428126|Trametinib|trametinib|mesh-list
83409474|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409475|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409476|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83409477|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409478|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409479|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
83409480|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
83409481|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409482|NCT03416530|TIC10 compound|tic10 compound|mesh-list
83409483|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409484|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
83409485|NCT03414502|Minocycline|minocycline|mesh-list
83409486|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
83409487|NCT03414502|Adalimumab|adalimumab|mesh-list
83409488|NCT03414502|Infliximab|infliximab|mesh-list
83409489|NCT03414502|Golimumab|golimumab|mesh-list
83409490|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
83409491|NCT03414502|Etanercept|etanercept|mesh-list
83409492|NCT03414502|Rituximab|rituximab|mesh-list
83409493|NCT03414502|Abatacept|abatacept|mesh-list
83409494|NCT03414502|Methotrexate|methotrexate|mesh-list
83409495|NCT03414502|Azathioprine|azathioprine|mesh-list
83409496|NCT03414502|Leflunomide|leflunomide|mesh-list
83409497|NCT03414502|Tofacitinib|tofacitinib|mesh-list
83409498|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409499|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409500|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
83409501|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409502|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409503|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83409504|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
83409505|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83409506|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409507|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
83409508|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409509|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
83409510|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409511|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83409512|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409513|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83409514|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83409515|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83409516|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
83409517|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83409518|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83409519|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409520|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83409521|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83409522|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83409523|NCT03414502|Analgesics|analgesics|mesh-ancestor
83409524|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
83409525|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409526|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83409527|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409528|NCT03414502|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83409529|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83409530|NCT03367871|Paclitaxel|paclitaxel|mesh-list
83409531|NCT03367871|Bevacizumab|bevacizumab|mesh-list
83409532|NCT03367871|Carboplatin|carboplatin|mesh-list
83409533|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
83409534|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83409535|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409536|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
83409537|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
83409538|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
83409539|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409540|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409541|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83409542|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83409544|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409545|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
83409546|NCT03367871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409547|NCT03366142|Ustekinumab|ustekinumab|mesh-list
83409548|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
83409549|NCT03345810|Paclitaxel|paclitaxel|mesh-list
83409550|NCT03345810|Vinorelbine|vinorelbine|mesh-list
83409551|NCT03345810|Carboplatin|carboplatin|mesh-list
83409552|NCT03345810|Gemcitabine|gemcitabine|mesh-list
83409553|NCT03345810|Durvalumab|durvalumab|mesh-list
83409554|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83409555|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409556|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
83409557|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
83409558|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
83409559|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409560|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409561|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
83409562|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409563|NCT03344965|Olaparib|olaparib|mesh-list
83409564|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83409565|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409566|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409567|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409568|NCT03323385|Meloxicam|meloxicam|mesh-list
83409569|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83409570|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83409571|NCT03323385|Analgesics|analgesics|mesh-ancestor
83409572|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
83409573|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409574|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409575|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83409576|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409577|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83409578|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83409579|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409580|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409581|NCT03298451|Sorafenib|sorafenib|mesh-list
83409582|NCT03298451|Durvalumab|durvalumab|mesh-list
83409583|NCT03298451|Tremelimumab|tremelimumab|mesh-list
83409584|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83409585|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409586|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83409587|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409588|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409589|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409590|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
83409591|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409592|NCT03295396|TIC10 compound|tic10 compound|mesh-list
83409593|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409594|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83409595|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
83409596|NCT03278782|Romidepsin|romidepsin|mesh-list
83409597|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409598|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409599|NCT03278782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409600|NCT03278782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409601|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409602|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83409603|NCT03278782|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83409604|NCT03278782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409605|NCT03263572|Cytarabine|cytarabine|mesh-list
83409606|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83409607|NCT03263572|Methotrexate|methotrexate|mesh-list
83409608|NCT03263572|Blinatumomab|blinatumomab|mesh-list
83409609|NCT03263572|Ponatinib|ponatinib|mesh-list
83409610|NCT03263572|Antibodies|antibodies|mesh-list
83409611|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
83409612|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83409613|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
83409614|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83409615|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
83409616|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409617|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409618|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83409619|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
83409620|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83409621|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409622|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
83409623|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409624|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83409625|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409626|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83409627|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409628|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409629|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83409630|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
83409631|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409632|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83409633|NCT03248479|Azacitidine|azacitidine|mesh-list
83409634|NCT03248479|Magrolimab|magrolimab|mesh-list
83409635|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409636|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
83409637|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409638|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409639|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409640|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409641|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
83409642|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409643|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409644|NCT03244384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409645|NCT03244384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409646|NCT03233711|Nivolumab|nivolumab|mesh-list
83409647|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409648|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409649|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409650|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409651|NCT03223610|Prednisone|prednisone|mesh-list
83409652|NCT03223610|Lenalidomide|lenalidomide|mesh-list
83409653|NCT03223610|Venetoclax|venetoclax|mesh-list
83409654|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
83409655|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83409656|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
83409657|NCT03223610|Hormones|hormones|mesh-ancestor
83409658|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83409659|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409660|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83409661|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409662|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
83409663|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83409664|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83409665|NCT03223610|Growth Substances|growth substances|mesh-ancestor
83409666|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
83409667|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409668|NCT03217747|Avelumab|avelumab|mesh-list
83409669|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83409670|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
83409671|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409672|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409673|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
83409674|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409676|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409677|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83409678|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83409679|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409680|NCT03202628|Dexamethasone|dexamethasone|mesh-list
83409681|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
83409682|NCT03202628|Pomalidomide|pomalidomide|mesh-list
83409683|NCT03202628|Ixazomib|ixazomib|mesh-list
83409684|NCT03202628|Ichthammol|ichthammol|mesh-list
83409685|NCT03202628|BB 1101|bb 1101|mesh-list
83409686|NCT03202628|Glycine|glycine|mesh-list
83409687|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83409688|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
83409689|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
83409690|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409691|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409692|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83409695|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83409697|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409698|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409699|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
83409700|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409701|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
83409702|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83409703|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83409704|NCT03202628|Growth Substances|growth substances|mesh-ancestor
83409705|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
83409706|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
83409707|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
83409708|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83409709|NCT03199885|Paclitaxel|paclitaxel|mesh-list
83409710|NCT03199885|Docetaxel|docetaxel|mesh-list
83409711|NCT03199885|Trastuzumab|trastuzumab|mesh-list
83409712|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83409713|NCT03199885|Atezolizumab|atezolizumab|mesh-list
83409714|NCT03199885|Pertuzumab|pertuzumab|mesh-list
83409715|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83409716|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83409717|NCT03199885|Antibodies|antibodies|mesh-list
83409718|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
83409719|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83409720|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83409721|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409722|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
83409723|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
83409724|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
83409725|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409726|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
83409727|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409728|NCT03199885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409729|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
83409730|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409731|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409732|NCT03197467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409733|NCT03197467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409734|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83409735|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83409736|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409737|NCT03176134|Tedizolid|tedizolid|mesh-list
83409738|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
83409739|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83409740|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409741|NCT03172299|Aflibercept|aflibercept|mesh-list
83409742|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83409743|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83409744|NCT03172299|Growth Substances|growth substances|mesh-ancestor
83409745|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409746|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
83409747|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409748|NCT03164616|Cisplatin|cisplatin|mesh-list
83409749|NCT03164616|Carboplatin|carboplatin|mesh-list
83409750|NCT03164616|Gemcitabine|gemcitabine|mesh-list
83409751|NCT03164616|Pemetrexed|pemetrexed|mesh-list
83409752|NCT03164616|Durvalumab|durvalumab|mesh-list
83409753|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83409754|NCT03164616|Tremelimumab|tremelimumab|mesh-list
83409755|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409756|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409757|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
83409758|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409759|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409760|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83409761|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83409762|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409763|NCT03132636|Cemiplimab|cemiplimab|mesh-list
83409764|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409765|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409766|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
83409767|NCT03131908|GSK2636771|gsk2636771|mesh-list
83409768|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409769|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409771|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409772|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83409773|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409774|NCT03089983|Isoniazid|isoniazid|mesh-list
83409775|NCT03089983|Rifapentine|rifapentine|mesh-list
83409776|NCT03089983|Buprenorphine|buprenorphine|mesh-list
83409777|NCT03089983|Methadone|methadone|mesh-list
83409778|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83409779|NCT03089983|Naloxone|naloxone|mesh-list
83409780|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83409781|NCT03089983|Narcotics|narcotics|mesh-ancestor
83409782|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83409783|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409784|NCT03089983|Analgesics|analgesics|mesh-ancestor
83409785|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
83409786|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409787|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83409788|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
83409789|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
83409790|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
83409791|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83409792|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409793|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83409794|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83409795|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
83409796|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409797|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83409798|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83409799|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
83409800|NCT03079999|Aspirin|aspirin|mesh-list
83409801|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83409802|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83409803|NCT03079999|Analgesics|analgesics|mesh-ancestor
83409804|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
83409805|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409806|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409807|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83409808|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409809|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83409810|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83409811|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409812|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83409813|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83409814|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409815|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
83409816|NCT03070184|Metoprolol|metoprolol|mesh-list
83409817|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83409818|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83409819|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
83409820|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
83409821|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409822|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409823|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83409824|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83409825|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83409826|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
83409827|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83409828|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409829|NCT03047993|Azacitidine|azacitidine|mesh-list
83409830|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409831|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
83409832|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409833|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409834|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409835|NCT03044587|Leucovorin|leucovorin|mesh-list
83409836|NCT03044587|Gemcitabine|gemcitabine|mesh-list
83409837|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409838|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409839|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
83409840|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409841|NCT03044587|Antidotes|antidotes|mesh-ancestor
83409842|NCT03044587|Protective Agents|protective agents|mesh-ancestor
83409843|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409849|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409850|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
83409851|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409852|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409853|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83409854|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
83409855|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409856|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409857|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83409858|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409859|NCT03029403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409861|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409862|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409863|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409864|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
83409865|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
83409866|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83409867|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83409868|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83409869|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409870|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409871|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409872|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
83409873|NCT03016377|Fludarabine|fludarabine|mesh-list
83409874|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409875|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
83409876|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409877|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409878|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83409879|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
83409880|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409881|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409882|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83409883|NCT03003962|Paclitaxel|paclitaxel|mesh-list
83409884|NCT03003962|Cisplatin|cisplatin|mesh-list
83409885|NCT03003962|Carboplatin|carboplatin|mesh-list
83409886|NCT03003962|Gemcitabine|gemcitabine|mesh-list
83409887|NCT03003962|Pemetrexed|pemetrexed|mesh-list
83409888|NCT03003962|Durvalumab|durvalumab|mesh-list
83409889|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83409890|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409891|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
83409892|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
83409893|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
83409894|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409895|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409896|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
83409897|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409898|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83409899|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83409900|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409901|NCT02947620|Metformin|metformin|mesh-list
83409902|NCT02947620|Atorvastatin|atorvastatin|mesh-list
83409903|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83409904|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409905|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83409906|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83409907|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
83409908|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409909|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83409910|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83409911|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409912|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
83409913|NCT02912559|Leucovorin|leucovorin|mesh-list
83409914|NCT02912559|Folic Acid|folic acid|mesh-list
83409915|NCT02912559|Fluorouracil|fluorouracil|mesh-list
83409916|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
83409917|NCT02912559|Atezolizumab|atezolizumab|mesh-list
83409918|NCT02912559|Calcium|calcium|mesh-list
83409919|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83409920|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
83409921|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83409922|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409923|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83409924|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
83409925|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409926|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409927|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409928|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409929|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
83409930|NCT02912559|Antidotes|antidotes|mesh-ancestor
83409931|NCT02912559|Protective Agents|protective agents|mesh-ancestor
83409932|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
83409933|NCT02912559|Vitamins|vitamins|mesh-ancestor
83409934|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
83409935|NCT02912559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409936|NCT02912559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83409937|NCT02912559|Hematinics|hematinics|mesh-ancestor
83409938|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
83409939|NCT02890355|Leucovorin|leucovorin|mesh-list
83409940|NCT02890355|Folic Acid|folic acid|mesh-list
83409941|NCT02890355|Fluorouracil|fluorouracil|mesh-list
83409942|NCT02890355|Irinotecan|irinotecan|mesh-list
83409943|NCT02890355|Veliparib|veliparib|mesh-list
83409944|NCT02890355|Camptothecin|camptothecin|mesh-list
83409945|NCT02890355|Calcium|calcium|mesh-list
83409946|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
83409947|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83409948|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409949|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83409950|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
83409951|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409952|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83409953|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409954|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409955|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
83409956|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83409957|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83409958|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409959|NCT02890355|Antidotes|antidotes|mesh-ancestor
83409960|NCT02890355|Protective Agents|protective agents|mesh-ancestor
83409961|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
83409962|NCT02890355|Vitamins|vitamins|mesh-ancestor
83409963|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
83409964|NCT02890355|Hematinics|hematinics|mesh-ancestor
83409965|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83409966|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83409967|NCT02877303|Cytarabine|cytarabine|mesh-list
83409968|NCT02877303|Dexamethasone|dexamethasone|mesh-list
83409969|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
83409970|NCT02877303|Prednisone|prednisone|mesh-list
83409971|NCT02877303|Cortisone|cortisone|mesh-list
83409972|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
83409973|NCT02877303|Rituximab|rituximab|mesh-list
83409974|NCT02877303|Doxorubicin|doxorubicin|mesh-list
83409975|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83409976|NCT02877303|Methotrexate|methotrexate|mesh-list
83409978|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
83409979|NCT02877303|Ofatumumab|ofatumumab|mesh-list
83409980|NCT02877303|Blinatumomab|blinatumomab|mesh-list
83409981|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83409982|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83409983|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
83409984|NCT02877303|Antibodies|antibodies|mesh-list
83409985|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
83409986|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83409987|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83409988|NCT02877303|BB 1101|bb 1101|mesh-list
83409989|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83409990|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
83409991|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83409992|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83409993|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83409994|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
83409995|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83409996|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409997|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83409998|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83409999|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
83410000|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
83410001|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83410002|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83410003|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
83410004|NCT02877303|Hormones|hormones|mesh-ancestor
83410005|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83410006|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83410007|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
83410009|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83410010|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83410011|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83410012|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83410013|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
83410014|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83410015|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410016|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
83410017|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
83410018|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83410019|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83410020|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
83410021|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410022|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410023|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410024|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410025|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410026|NCT02877303|Immunotoxins|immunotoxins|mesh-ancestor
83410027|NCT02877303|Immunoconjugates|immunoconjugates|mesh-ancestor
83410028|NCT02869789|Nivolumab|nivolumab|mesh-list
83410029|NCT02869789|Ipilimumab|ipilimumab|mesh-list
83410030|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410031|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410032|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410033|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410034|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
83410035|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83410036|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
83410037|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83410038|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410039|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83410040|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83410041|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83410042|NCT02839707|Bevacizumab|bevacizumab|mesh-list
83410043|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83410044|NCT02839707|Atezolizumab|atezolizumab|mesh-list
83410045|NCT02839707|Doxorubicin|doxorubicin|mesh-list
83410046|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83410047|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
83410048|NCT02839707|Antibodies|antibodies|mesh-list
83410049|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
83410050|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83410051|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
83410052|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410053|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83410054|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83410055|NCT02839707|Growth Substances|growth substances|mesh-ancestor
83410056|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410057|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
83410058|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
83410059|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83410060|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83410061|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83410062|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410063|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410064|NCT02839707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410065|NCT02834013|Nivolumab|nivolumab|mesh-list
83410066|NCT02834013|Ipilimumab|ipilimumab|mesh-list
83410067|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410068|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410069|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410070|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410071|NCT02769962|Olaparib|olaparib|mesh-list
83410072|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83410073|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410074|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410075|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410076|NCT02696993|Nivolumab|nivolumab|mesh-list
83410077|NCT02696993|Ipilimumab|ipilimumab|mesh-list
83410078|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410079|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410080|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410081|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410082|NCT02671890|Gemcitabine|gemcitabine|mesh-list
83410083|NCT02671890|Disulfiram|disulfiram|mesh-list
83410085|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
83410086|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410087|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410088|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83410089|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83410090|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410091|NCT02661282|Temozolomide|temozolomide|mesh-list
83410092|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83410093|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
83410094|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410095|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410096|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83410097|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83410098|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410099|NCT02634333|Aflibercept|aflibercept|mesh-list
83410100|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
83410101|NCT02634333|Mitogens|mitogens|mesh-list
83410102|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83410103|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83410104|NCT02634333|Growth Substances|growth substances|mesh-ancestor
83410105|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410106|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
83410107|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410108|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410109|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410110|NCT02595944|Nivolumab|nivolumab|mesh-list
83410111|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410112|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410113|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410114|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410115|NCT02595905|Cisplatin|cisplatin|mesh-list
83410116|NCT02595905|Veliparib|veliparib|mesh-list
83410117|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410118|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83410119|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410120|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410121|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
83410122|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410123|NCT02567435|Sirolimus|sirolimus|mesh-list
83410124|NCT02567435|Dactinomycin|dactinomycin|mesh-list
83410125|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
83410126|NCT02567435|Irinotecan|irinotecan|mesh-list
83410127|NCT02567435|Vincristine|vincristine|mesh-list
83410128|NCT02567435|Temsirolimus|temsirolimus|mesh-list
83410129|NCT02567435|Vinorelbine|vinorelbine|mesh-list
83410130|NCT02567435|Camptothecin|camptothecin|mesh-list
83410131|NCT02567435|MTOR Inhibitors|mtor inhibitors|mesh-list
83410132|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410133|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
83410134|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410135|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83410136|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83410137|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
83410138|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410139|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410140|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83410141|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83410142|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83410143|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410144|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410145|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410146|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410147|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410148|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83410149|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410150|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83410151|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
83410152|NCT02567435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83410153|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83410154|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83410155|NCT02530463|Nivolumab|nivolumab|mesh-list
83410156|NCT02530463|Ipilimumab|ipilimumab|mesh-list
83410157|NCT02530463|Azacitidine|azacitidine|mesh-list
83410538|NCT01950390|Antibodies|antibodies|mesh-list
83410158|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410159|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410160|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410161|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410162|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410163|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
83410164|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410165|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83410166|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83410167|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410168|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410169|NCT02506153|Interferons|interferons|mesh-list
83410170|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
83410171|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
83410172|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
83410173|NCT02506153|Ipilimumab|ipilimumab|mesh-list
83410174|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410175|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410176|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410177|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410178|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
83410179|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410180|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
83410181|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410182|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83410183|NCT02465060|Nivolumab|nivolumab|mesh-list
83410184|NCT02465060|Trastuzumab|trastuzumab|mesh-list
83410185|NCT02465060|Pertuzumab|pertuzumab|mesh-list
83410186|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83410187|NCT02465060|Relatlimab|relatlimab|mesh-list
83410188|NCT02465060|Sunitinib|sunitinib|mesh-list
83410189|NCT02465060|Dasatinib|dasatinib|mesh-list
83410190|NCT02465060|Palbociclib|palbociclib|mesh-list
83410191|NCT02465060|Trametinib|trametinib|mesh-list
83410192|NCT02465060|Osimertinib|osimertinib|mesh-list
83410193|NCT02465060|Afatinib|afatinib|mesh-list
83410194|NCT02465060|Dabrafenib|dabrafenib|mesh-list
83410195|NCT02465060|Crizotinib|crizotinib|mesh-list
83410196|NCT02465060|Maytansine|maytansine|mesh-list
83410197|NCT02465060|Ipatasertib|ipatasertib|mesh-list
83410198|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83410199|NCT02465060|GSK2636771|gsk2636771|mesh-list
83410200|NCT02465060|Antibodies|antibodies|mesh-list
83410201|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
83410202|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83410203|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
83410204|NCT02465060|Adavosertib|adavosertib|mesh-list
83410205|NCT02465060|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83410206|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
83410207|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
83410208|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410209|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410210|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410211|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410212|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83410213|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83410214|NCT02465060|Growth Substances|growth substances|mesh-ancestor
83410215|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
83410216|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83410217|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410218|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410219|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410220|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410221|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410222|NCT02465060|Immunotoxins|immunotoxins|mesh-ancestor
83410223|NCT02450331|Atezolizumab|atezolizumab|mesh-list
83410224|NCT02450331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410225|NCT02450331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410226|NCT02450331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410227|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410228|NCT02443077|Cytarabine|cytarabine|mesh-list
83410229|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
83410230|NCT02443077|Melphalan|melphalan|mesh-list
83410231|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
83410232|NCT02443077|Carmustine|carmustine|mesh-list
83410233|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83410234|NCT02443077|Etoposide|etoposide|mesh-list
83410235|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
83410236|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
83410237|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410238|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
83410239|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410240|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83410241|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83410242|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
83410243|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410244|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410245|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83410246|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410247|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83410248|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83410249|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410250|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410252|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
83410253|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410254|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
83410255|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
83410256|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410257|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410258|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410259|NCT02428985|Riociguat|riociguat|mesh-list
83410260|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
83410261|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410262|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
83410263|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410264|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410265|NCT02411656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410266|NCT02411656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410267|NCT02397720|Nivolumab|nivolumab|mesh-list
83410268|NCT02397720|Ipilimumab|ipilimumab|mesh-list
83410269|NCT02397720|Azacitidine|azacitidine|mesh-list
83410270|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410271|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410272|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410273|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410274|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410275|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
83410276|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410277|NCT02391025|Citric Acid|citric acid|mesh-list
83410278|NCT02391025|Sodium Citrate|sodium citrate|mesh-list
83410279|NCT02391025|Anticoagulants|anticoagulants|mesh-ancestor
83410280|NCT02391025|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83410281|NCT02391025|Chelating Agents|chelating agents|mesh-ancestor
83410282|NCT02391025|Sequestering Agents|sequestering agents|mesh-ancestor
83410283|NCT02391025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410284|NCT02386800|Panobinostat|panobinostat|mesh-list
83410285|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410286|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83410287|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410288|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410289|NCT02335944|Nazartinib|nazartinib|mesh-list
83410290|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410291|NCT02326974|Pertuzumab|pertuzumab|mesh-list
83410292|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410293|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410294|NCT02299518|Cytarabine|cytarabine|mesh-list
83410295|NCT02299518|Etoposide|etoposide|mesh-list
83410296|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
83410297|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
83410298|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410299|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410300|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83410301|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83410302|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410303|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410304|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410305|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
83410306|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
83410307|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410308|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410309|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
83410310|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410311|NCT02299518|Analgesics|analgesics|mesh-ancestor
83410313|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83410314|NCT02275533|Nivolumab|nivolumab|mesh-list
83410315|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410316|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410317|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410318|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410319|NCT02257138|Decitabine|decitabine|mesh-list
83410320|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410321|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
83410322|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410323|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410324|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410325|NCT02246621|Letrozole|letrozole|mesh-list
83410326|NCT02246621|Anastrozole|anastrozole|mesh-list
83410327|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410328|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83410329|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83410330|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410331|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410332|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83410333|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
83410334|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83410335|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410336|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83410337|NCT02224781|Nivolumab|nivolumab|mesh-list
83410338|NCT02224781|Ipilimumab|ipilimumab|mesh-list
83410339|NCT02224781|Trametinib|trametinib|mesh-list
83410340|NCT02224781|Dabrafenib|dabrafenib|mesh-list
83410341|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83410342|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410343|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410344|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410345|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410346|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83410347|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410348|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83410349|NCT02224781|Protective Agents|protective agents|mesh-ancestor
83410350|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410351|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83410352|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
83410353|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83410354|NCT02214550|Norinyl|norinyl|mesh-list
83410355|NCT02214550|Mestranol|mestranol|mesh-list
83410356|NCT02214550|Norethindrone|norethindrone|mesh-list
83410357|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83410358|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83410359|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83410360|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
83410361|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83410362|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410363|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83410364|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83410365|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83410366|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83410367|NCT02214550|Estrogens|estrogens|mesh-ancestor
83410368|NCT02214550|Hormones|hormones|mesh-ancestor
83410369|NCT02214550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83410370|NCT02200445|Aldesleukin|aldesleukin|mesh-list
83410371|NCT02200445|Interleukin-2|interleukin-2|mesh-list
83410372|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410373|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83410374|NCT02200445|Analgesics|analgesics|mesh-ancestor
83410375|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
83410376|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83410377|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410378|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83410379|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83410380|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
83410381|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410382|NCT02199236|Capecitabine|capecitabine|mesh-list
83410383|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410384|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
83410539|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
83410385|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410386|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410388|NCT02196181|Dabrafenib|dabrafenib|mesh-list
83410389|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83410390|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410391|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83410392|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410393|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410394|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83410395|NCT02196181|Protective Agents|protective agents|mesh-ancestor
83410396|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410397|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83410398|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
83410399|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83410400|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410401|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83410402|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410403|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410404|NCT02180711|Rituximab|rituximab|mesh-list
83410405|NCT02180711|Lenalidomide|lenalidomide|mesh-list
83410406|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
83410407|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410408|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410409|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
83410410|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410411|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83410412|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83410413|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83410414|NCT02180711|Growth Substances|growth substances|mesh-ancestor
83410415|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
83410416|NCT02152982|Temozolomide|temozolomide|mesh-list
83410417|NCT02152982|Veliparib|veliparib|mesh-list
83410418|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83410419|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
83410420|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410421|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410422|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83410423|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410424|NCT02151084|Gemcitabine|gemcitabine|mesh-list
83410425|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410426|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410427|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
83410428|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410429|NCT02120352|Rilpivirine|rilpivirine|mesh-list
83410430|NCT02120352|Cabotegravir|cabotegravir|mesh-list
83410431|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83410432|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83410433|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410434|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410435|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
83410436|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410437|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83410438|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83410439|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83410440|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83410441|NCT02058693|Amphetamine|amphetamine|mesh-list
83410443|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83410444|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410445|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
83410446|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
83410447|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83410448|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
83410449|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83410450|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410451|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
83410452|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83410453|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83410454|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83410455|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83410456|NCT02047513|Paclitaxel|paclitaxel|mesh-list
83410457|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83410458|NCT02047513|Gemcitabine|gemcitabine|mesh-list
83410459|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410460|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410461|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410462|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410463|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410464|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410465|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410466|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
83410467|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
83410468|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410469|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410470|NCT02954874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410471|NCT02954874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410472|NCT02007044|Rituximab|rituximab|mesh-list
83410473|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83410474|NCT02007044|Antibodies|antibodies|mesh-list
83410475|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
83410476|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83410477|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
83410478|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410479|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410480|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83410481|NCT01991873|Leucovorin|leucovorin|mesh-list
83410482|NCT01991873|Folic Acid|folic acid|mesh-list
83410483|NCT01991873|Fluorouracil|fluorouracil|mesh-list
83410484|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
83410485|NCT01991873|Panitumumab|panitumumab|mesh-list
83410486|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
83410487|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
83410488|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410489|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410490|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410491|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410492|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
83410493|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410494|NCT01991873|Antidotes|antidotes|mesh-ancestor
83410495|NCT01991873|Protective Agents|protective agents|mesh-ancestor
83410496|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
83410497|NCT01991873|Vitamins|vitamins|mesh-ancestor
83410498|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
83410499|NCT01991873|Hematinics|hematinics|mesh-ancestor
83410500|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410501|NCT01955460|Aldesleukin|aldesleukin|mesh-list
83410502|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
83410503|NCT01955460|Fludarabine|fludarabine|mesh-list
83410504|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
83410505|NCT01955460|Interleukin-2|interleukin-2|mesh-list
83410506|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410507|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
83410508|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410509|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83410510|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83410511|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
83410512|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410513|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410514|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83410515|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410516|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
83410517|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83410519|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
83410520|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83410521|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83410522|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83410523|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
83410524|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410525|NCT01954979|Abatacept|abatacept|mesh-list
83410526|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410527|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410528|NCT01954979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410529|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410530|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410531|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
83410532|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410533|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83410534|NCT01950390|Bevacizumab|bevacizumab|mesh-list
83410535|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83410536|NCT01950390|Ipilimumab|ipilimumab|mesh-list
83410537|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
83410542|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410543|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83410544|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83410545|NCT01950390|Growth Substances|growth substances|mesh-ancestor
83410546|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410547|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
83410548|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
83410549|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410550|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410552|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83410553|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410554|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410555|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410556|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410557|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410558|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83410559|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410560|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
83410561|NCT01878617|Gemcitabine|gemcitabine|mesh-list
83410562|NCT01878617|Vincristine|vincristine|mesh-list
83410563|NCT01878617|Pemetrexed|pemetrexed|mesh-list
83410564|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410565|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
83410566|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410567|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83410568|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83410569|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
83410570|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410571|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410572|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83410573|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410574|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
83410575|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410576|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410577|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410578|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410579|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410580|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83410581|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83410582|NCT01843556|Donepezil|donepezil|mesh-list
83410583|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83410584|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410585|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410586|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
83410587|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83410588|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410589|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
83410590|NCT01787487|Azacitidine|azacitidine|mesh-list
83410591|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410592|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
83410593|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410594|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410595|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410596|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
83410597|NCT01751425|Dasatinib|dasatinib|mesh-list
83410598|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83410599|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410600|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83410601|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410602|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410603|NCT01664910|Rituximab|rituximab|mesh-list
83410604|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83410605|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83410606|NCT01664910|Methotrexate|methotrexate|mesh-list
83410607|NCT01664910|Fludarabine|fludarabine|mesh-list
83410608|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
83410609|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83410610|NCT01664910|Antibodies|antibodies|mesh-list
83410611|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
83410612|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83410613|NCT01664910|Tacrolimus|tacrolimus|mesh-list
83410614|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
83410615|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83410616|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
83410617|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410618|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410619|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83410620|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83410621|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
83410622|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83410623|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410624|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
83410625|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410626|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
83410627|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410628|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83410629|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410630|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83410631|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83410632|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83410633|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
83410634|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83410635|NCT01664910|Immunotoxins|immunotoxins|mesh-ancestor
83410636|NCT01664910|Immunoconjugates|immunoconjugates|mesh-ancestor
83410638|NCT01618136|Carboplatin|carboplatin|mesh-list
83410639|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410640|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410641|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410642|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410643|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410644|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410645|NCT01539031|Donepezil|donepezil|mesh-list
83410646|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83410647|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410648|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410649|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
83410650|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83410651|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410652|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
83410653|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83410654|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83410655|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410656|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410657|NCT01508312|Immunotoxins|immunotoxins|mesh-ancestor
83410658|NCT01508312|Immunoconjugates|immunoconjugates|mesh-ancestor
83410659|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
83410660|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410661|NCT01386385|Paclitaxel|paclitaxel|mesh-list
83410662|NCT01386385|Carboplatin|carboplatin|mesh-list
83410663|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83410664|NCT01386385|Veliparib|veliparib|mesh-list
83410665|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410666|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410667|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410668|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410669|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410670|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410671|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83410672|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410673|NCT01375140|Prednisone|prednisone|mesh-list
83410674|NCT01375140|Lenalidomide|lenalidomide|mesh-list
83410675|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83410676|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
83410677|NCT01375140|Hormones|hormones|mesh-ancestor
83410678|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83410679|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410680|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83410681|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410682|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
83410683|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83410684|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83410685|NCT01375140|Growth Substances|growth substances|mesh-ancestor
83410686|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
83410687|NCT01328171|Folic Acid|folic acid|mesh-list
83410688|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
83410689|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
83410690|NCT01328171|Irinotecan|irinotecan|mesh-list
83410691|NCT01328171|Panitumumab|panitumumab|mesh-list
83410692|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410693|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83410694|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83410695|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410696|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410697|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410699|NCT01328171|Vitamins|vitamins|mesh-ancestor
83410700|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
83410701|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410702|NCT01288963|Aldesleukin|aldesleukin|mesh-list
83410703|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410704|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83410705|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83410706|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
83410707|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410708|NCT01269190|Proflavine|proflavine|mesh-list
83410709|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83410710|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410711|NCT01248715|Oseltamivir|oseltamivir|mesh-list
83410712|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
83410713|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410714|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410715|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410716|NCT01167712|Paclitaxel|paclitaxel|mesh-list
83410717|NCT01167712|Bevacizumab|bevacizumab|mesh-list
83410718|NCT01167712|Carboplatin|carboplatin|mesh-list
83410719|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83410720|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83410721|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
83410722|NCT01167712|Antibodies|antibodies|mesh-list
83410723|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
83410724|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83410725|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
83410726|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410727|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410728|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410729|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410730|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410731|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410732|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83410733|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83410734|NCT01167712|Growth Substances|growth substances|mesh-ancestor
83410735|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410736|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
83410737|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
83410738|NCT01065454|Riociguat|riociguat|mesh-list
83410739|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
83410740|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410741|NCT01064466|Etoposide|etoposide|mesh-list
83410742|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
83410743|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410744|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410745|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83410746|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83410747|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410748|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410749|NCT01013649|Gemcitabine|gemcitabine|mesh-list
83410750|NCT01013649|Fluorouracil|fluorouracil|mesh-list
83410751|NCT01013649|Capecitabine|capecitabine|mesh-list
83410752|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83410753|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410754|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
83410755|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410756|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410757|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410758|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
83410759|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410760|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83410761|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410762|NCT00963040|Oxytocin|oxytocin|mesh-list
83410763|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
83410764|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83410765|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410766|NCT00941109|Decitabine|decitabine|mesh-list
83410767|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410768|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
83410769|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410770|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410771|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410772|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
83410773|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83410774|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83410775|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83410776|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83410777|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410778|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
83410779|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83410780|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410781|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83410782|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83410783|NCT00812214|Eszopiclone|eszopiclone|mesh-list
83410784|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83410785|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83410786|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410787|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
83410788|NCT00792948|Leucovorin|leucovorin|mesh-list
83410789|NCT00792948|Folic Acid|folic acid|mesh-list
83410790|NCT00792948|Cytarabine|cytarabine|mesh-list
83410791|NCT00792948|Sirolimus|sirolimus|mesh-list
83410792|NCT00792948|Dexamethasone|dexamethasone|mesh-list
83410793|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
83410794|NCT00792948|Prednisone|prednisone|mesh-list
83410795|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
83410796|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83410797|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83410798|NCT00792948|Prednisolone|prednisolone|mesh-list
83410799|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
83410800|NCT00792948|Cortisone|cortisone|mesh-list
83410801|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
83410802|NCT00792948|Doxorubicin|doxorubicin|mesh-list
83410803|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83410804|NCT00792948|Methotrexate|methotrexate|mesh-list
83410805|NCT00792948|Etoposide|etoposide|mesh-list
83410806|NCT00792948|Vincristine|vincristine|mesh-list
83410807|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
83410808|NCT00792948|Dasatinib|dasatinib|mesh-list
83410809|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
83410810|NCT00792948|Tacrolimus|tacrolimus|mesh-list
83410811|NCT00792948|Lenograstim|lenograstim|mesh-list
83410812|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83410813|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
83410814|NCT00792948|BB 1101|bb 1101|mesh-list
83410815|NCT00792948|Calcium|calcium|mesh-list
83410816|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
83410817|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410818|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
83410819|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410820|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83410821|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83410822|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
83410823|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410824|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410825|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83410826|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83410827|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
83410828|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
83410829|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83410830|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83410831|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
83410832|NCT00792948|Hormones|hormones|mesh-ancestor
83410833|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83410834|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83410835|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
83410836|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410837|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83410838|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83410839|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83410840|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83410841|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83410842|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83410843|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
83410844|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83410845|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410846|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
83410847|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
83410848|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83410849|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83410850|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410851|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
83410852|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83410853|NCT00792948|Antidotes|antidotes|mesh-ancestor
83410854|NCT00792948|Protective Agents|protective agents|mesh-ancestor
83410855|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
83410856|NCT00792948|Vitamins|vitamins|mesh-ancestor
83410857|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
83410858|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83410859|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83410860|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410861|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410862|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410863|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83410864|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
83410865|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83410866|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83410867|NCT00792948|Hematinics|hematinics|mesh-ancestor
83410868|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
83410869|NCT00658814|Azacitidine|azacitidine|mesh-list
83410870|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
83410871|NCT00658814|Calicheamicins|calicheamicins|mesh-list
83410872|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410873|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
83410874|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410875|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410876|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410877|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83410878|NCT00658814|Immunotoxins|immunotoxins|mesh-ancestor
83410879|NCT00658814|Immunoconjugates|immunoconjugates|mesh-ancestor
83410880|NCT00658814|Immunologic Factors|immunologic factors|mesh-ancestor
83410881|NCT00658814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410882|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83410883|NCT00601900|Tamoxifen|tamoxifen|mesh-list
83410884|NCT00601900|Bevacizumab|bevacizumab|mesh-list
83410885|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83410886|NCT00601900|Letrozole|letrozole|mesh-list
83410887|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
83410888|NCT00601900|Antibodies|antibodies|mesh-list
83410889|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
83410890|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83410891|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
83410892|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410893|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83410894|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83410895|NCT00601900|Growth Substances|growth substances|mesh-ancestor
83410896|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410897|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
83410898|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
83410899|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410900|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83410901|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83410902|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410903|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83410904|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
83410905|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83410906|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83410907|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83410908|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83410909|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83410911|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83410912|NCT00588770|Cisplatin|cisplatin|mesh-list
83410913|NCT00588770|Carboplatin|carboplatin|mesh-list
83410914|NCT00588770|Docetaxel|docetaxel|mesh-list
83410915|NCT00588770|Fluorouracil|fluorouracil|mesh-list
83410916|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
83410917|NCT00588770|Antibodies|antibodies|mesh-list
83410918|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
83410919|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83410920|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
83410921|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410922|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83410923|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83410924|NCT00588770|Growth Substances|growth substances|mesh-ancestor
83410925|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410926|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
83410927|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
83410931|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410932|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
83410933|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410934|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410935|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
83410936|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
83410937|NCT00444613|Vitamins|vitamins|mesh-ancestor
83410938|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
83410939|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410940|NCT00433511|Paclitaxel|paclitaxel|mesh-list
83410941|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
83410942|NCT00433511|Bevacizumab|bevacizumab|mesh-list
83410943|NCT00433511|Doxorubicin|doxorubicin|mesh-list
83410944|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83410945|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83410946|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83410947|NCT00433511|Antibodies|antibodies|mesh-list
83410948|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
83410949|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83410950|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
83410951|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
83410952|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83410953|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410954|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410955|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
83410956|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
83410957|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410958|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83410959|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
83410960|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410961|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83410962|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83410963|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
83410964|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83410965|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83410966|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83410967|NCT00433511|Growth Substances|growth substances|mesh-ancestor
83410968|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
83410969|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83410970|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83410971|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83410972|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410974|NCT00359684|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83410975|NCT00359684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410976|NCT00324805|Bevacizumab|bevacizumab|mesh-list
83410977|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83410978|NCT00324805|Cisplatin|cisplatin|mesh-list
83410979|NCT00324805|Gemcitabine|gemcitabine|mesh-list
83410980|NCT00324805|Docetaxel|docetaxel|mesh-list
83410981|NCT00324805|Pemetrexed|pemetrexed|mesh-list
83410982|NCT00324805|Vinorelbine|vinorelbine|mesh-list
83410983|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
83410984|NCT00324805|Antibodies|antibodies|mesh-list
83410985|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
83410986|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83410987|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
83410988|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83410989|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83410990|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83410991|NCT00324805|Growth Substances|growth substances|mesh-ancestor
83410992|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83410993|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
83410994|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
83410995|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410996|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
83410997|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83410998|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
83410999|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
83411000|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
83411001|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411002|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83411003|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83411004|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83411005|NCT00310180|Tamoxifen|tamoxifen|mesh-list
83411006|NCT00310180|Letrozole|letrozole|mesh-list
83411007|NCT00310180|Anastrozole|anastrozole|mesh-list
83411008|NCT00310180|Exemestane|exemestane|mesh-list
83411009|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411010|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411011|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83411012|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83411013|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411014|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83411015|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
83411016|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411017|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411018|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83411019|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83411020|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83411021|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83411022|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
83411024|NCT00217737|Folic Acid|folic acid|mesh-list
83411025|NCT00217737|Bevacizumab|bevacizumab|mesh-list
83411026|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83411027|NCT00217737|Fluorouracil|fluorouracil|mesh-list
83411028|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
83411029|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
83411030|NCT00217737|Antibodies|antibodies|mesh-list
83411031|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
83411032|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83411033|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
83411034|NCT00217737|Calcium|calcium|mesh-list
83411035|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
83411036|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411037|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83411038|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83411039|NCT00217737|Growth Substances|growth substances|mesh-ancestor
83411040|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411041|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
83411042|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
83411043|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83411044|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83411045|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
83411046|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411047|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83411048|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411049|NCT00217737|Antidotes|antidotes|mesh-ancestor
83411050|NCT00217737|Protective Agents|protective agents|mesh-ancestor
83411051|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
83411052|NCT00217737|Vitamins|vitamins|mesh-ancestor
83411053|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
83411054|NCT00217737|Hematinics|hematinics|mesh-ancestor
83411055|NCT00217425|Prednisone|prednisone|mesh-list
83411056|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
83411057|NCT00217425|Bevacizumab|bevacizumab|mesh-list
83411058|NCT00217425|Doxorubicin|doxorubicin|mesh-list
83411059|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83411060|NCT00217425|Vincristine|vincristine|mesh-list
83411061|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411062|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
83411063|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411064|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411065|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83411066|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
83411067|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411068|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411069|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83411070|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411071|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83411072|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83411073|NCT00217425|Growth Substances|growth substances|mesh-ancestor
83411074|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
83411075|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83411076|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83411077|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83411078|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411079|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83411080|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
83411081|NCT00217425|Hormones|hormones|mesh-ancestor
83411082|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411083|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83411084|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83411085|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
83411089|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83411090|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83411091|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411092|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
83411093|NCT00070499|Dasatinib|dasatinib|mesh-list
83411094|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411095|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83411096|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411097|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411098|NCT00060567|Irinotecan|irinotecan|mesh-list
83411099|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
83411100|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83411101|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83411102|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411103|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411104|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411105|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83411106|NCT00049348|Gemcitabine|gemcitabine|mesh-list
83411107|NCT00049348|Fluorouracil|fluorouracil|mesh-list
83411108|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
83411109|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411110|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83411111|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
83411112|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411113|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411114|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
83411115|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411116|NCT00049348|Hematinics|hematinics|mesh-ancestor
83411117|NCT00024622|Levodopa|levodopa|mesh-list
83411118|NCT00024622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83411119|NCT00024622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83411120|NCT00024622|Dopamine Agents|dopamine agents|mesh-ancestor
83411121|NCT00024622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411122|NCT00024622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411123|NCT00024622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411124|NCT00004125|Tamoxifen|tamoxifen|mesh-list
83411125|NCT00004125|Paclitaxel|paclitaxel|mesh-list
83411126|NCT00004125|Docetaxel|docetaxel|mesh-list
83411127|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
83411128|NCT00004125|Doxorubicin|doxorubicin|mesh-list
83411129|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83411130|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83411131|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411132|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
83411133|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
83411134|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
83411135|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411136|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411137|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
83411138|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411139|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411140|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83411141|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
83411142|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83411143|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83411144|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83411145|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83411146|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411147|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83411148|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
83411149|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411150|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83411151|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83411152|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83411153|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83411154|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83411155|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83411156|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411157|NCT03452865|Esomeprazole|esomeprazole|mesh-list
83411158|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83411159|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83411160|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83411161|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411162|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411169|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411171|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411172|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411173|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83411174|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
83411175|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411176|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411177|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83411178|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411179|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83411180|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83411181|NCT03449108|Analgesics|analgesics|mesh-ancestor
83411182|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
83411183|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411184|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83411185|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83411186|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
83411187|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411188|NCT03446001|Methylene Blue|methylene blue|mesh-list
83411189|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411190|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411191|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83411192|NCT03390296|Avelumab|avelumab|mesh-list
83411193|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
83411194|NCT03390296|Azacitidine|azacitidine|mesh-list
83411195|NCT03390296|Venetoclax|venetoclax|mesh-list
83411196|NCT03390296|Calicheamicins|calicheamicins|mesh-list
83411197|NCT03390296|Antibodies|antibodies|mesh-list
83411198|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
83411199|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83411200|NCT03390296|Maleic acid|maleic acid|mesh-list
83411201|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
83411202|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411203|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411204|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83411205|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
83411206|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411207|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411208|NCT03390296|Immunotoxins|immunotoxins|mesh-ancestor
83411209|NCT03390296|Immunoconjugates|immunoconjugates|mesh-ancestor
83411210|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83411211|NCT03345095|Temozolomide|temozolomide|mesh-list
83411212|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83411213|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
83411214|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411215|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411216|NCT03315910|Nicotine|nicotine|mesh-list
83411217|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83411218|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
83411219|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411220|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411221|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83411222|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83411223|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
83411224|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411225|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411226|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
83411227|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411228|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411229|NCT03248570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83411230|NCT03248570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411231|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83411232|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
83411233|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411234|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83411235|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83411236|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
83411237|NCT03152058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83411238|NCT03152058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83411239|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411240|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
83411241|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411242|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411243|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
83411245|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411246|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411247|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411248|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83411249|NCT03102242|Atezolizumab|atezolizumab|mesh-list
83411250|NCT03102242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83411251|NCT03102242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411252|NCT03102242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411253|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411254|NCT03090776|Ketamine|ketamine|mesh-list
83411255|NCT03090776|Analgesics|analgesics|mesh-ancestor
83411256|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
83411257|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411258|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411259|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83411260|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83411261|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
83411262|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
83411263|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83411264|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83411265|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83411266|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411267|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411268|NCT02994784|Melphalan|melphalan|mesh-list
83411269|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83411270|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
83411271|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411272|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411273|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83411274|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411275|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
83411276|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411277|NCT02966847|Anesthetics|anesthetics|mesh-list
83411278|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83411279|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411280|NCT02908685|Risdiplam|risdiplam|mesh-list
83411281|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83411282|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411283|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411284|NCT02891824|Bevacizumab|bevacizumab|mesh-list
83411285|NCT02891824|Atezolizumab|atezolizumab|mesh-list
83411286|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411287|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411288|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83411289|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83411290|NCT02891824|Growth Substances|growth substances|mesh-ancestor
83411291|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411292|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
83411293|NCT02891824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83411294|NCT02891824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411295|NCT02884440|Ropivacaine|ropivacaine|mesh-list
83411296|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
83411297|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83411298|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411299|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
83411300|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
83411301|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411302|NCT02851303|Morphine|morphine|mesh-list
83411303|NCT02851303|Methadone|methadone|mesh-list
83411304|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83411305|NCT02851303|Narcotics|narcotics|mesh-ancestor
83411306|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83411307|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411308|NCT02851303|Analgesics|analgesics|mesh-ancestor
83411309|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
83411310|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411311|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
83411312|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
83411313|NCT02775500|Apremilast|apremilast|mesh-list
83411314|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83411315|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83411316|NCT02775500|Analgesics|analgesics|mesh-ancestor
83411317|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
83411539|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
83411319|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411320|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83411321|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411322|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83411323|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83411324|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411325|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411326|NCT02689440|Venetoclax|venetoclax|mesh-list
83411327|NCT02689440|Dasatinib|dasatinib|mesh-list
83411328|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411329|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83411330|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411331|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411332|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
83411333|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83411334|NCT02549170|Antibodies|antibodies|mesh-list
83411335|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
83411336|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
83411337|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83411338|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
83411339|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411340|NCT02476916|Mitapivat|mitapivat|mesh-list
83411341|NCT02476916|Enzyme Activators|enzyme activators|mesh-ancestor
83411342|NCT02476916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411343|NCT02384122|Octreotide|octreotide|mesh-list
83411344|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83411345|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83411346|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411347|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83411348|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83411349|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411350|NCT02363335|Incretins|incretins|mesh-ancestor
83411351|NCT02363335|Hormones|hormones|mesh-ancestor
83411352|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411353|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83411354|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
83411355|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411356|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411357|NCT02271919|Nicotine|nicotine|mesh-list
83411358|NCT02271919|Varenicline|varenicline|mesh-list
83411359|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83411360|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
83411361|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411362|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411363|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83411364|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83411365|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
83411366|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411367|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411368|NCT02103361|Ustekinumab|ustekinumab|mesh-list
83411369|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
83411370|NCT01918397|Levofloxacin|levofloxacin|mesh-list
83411371|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83411372|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411373|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83411374|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83411375|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83411376|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411377|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411378|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411379|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83411380|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83411381|NCT01883024|Insulin|insulin|mesh-list
83411382|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83411383|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411384|NCT01611116|Sirolimus|sirolimus|mesh-list
83411385|NCT01611116|Temsirolimus|temsirolimus|mesh-list
83411386|NCT01611116|MTOR Inhibitors|mtor inhibitors|mesh-list
83411387|NCT01611116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83411388|NCT01611116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411389|NCT01611116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411390|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411391|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
83411392|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411393|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411394|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83411395|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411396|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83411397|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
83411398|NCT01576315|Itraconazole|itraconazole|mesh-list
83411399|NCT01576315|Voriconazole|voriconazole|mesh-list
83411400|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
83411401|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411402|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83411403|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83411404|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411405|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411406|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83411407|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
83411408|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411409|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411410|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83411411|NCT01388387|Tacrolimus|tacrolimus|mesh-list
83411412|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411413|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
83411414|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411415|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83411416|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411417|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411418|NCT01039090|Dopamine|dopamine|mesh-list
83411419|NCT01039090|Apomorphine|apomorphine|mesh-list
83411420|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
83411421|NCT01039090|Emetics|emetics|mesh-ancestor
83411422|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411423|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
83411424|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411425|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83411426|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
83411427|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411428|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411429|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83411430|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
83411431|NCT01039090|Protective Agents|protective agents|mesh-ancestor
83411432|NCT00819637|Albuterol|albuterol|mesh-list
83411433|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
83411434|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83411435|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
83411436|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411437|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411438|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83411439|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
83411440|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83411441|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83411442|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83411443|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
83411444|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411445|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411446|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
83411447|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83411448|NCT00593060|Sirolimus|sirolimus|mesh-list
83411449|NCT00593060|Cetuximab|cetuximab|mesh-list
83411450|NCT00593060|Temsirolimus|temsirolimus|mesh-list
83411451|NCT00593060|MTOR Inhibitors|mtor inhibitors|mesh-list
83411452|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411453|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411454|NCT00593060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83411455|NCT00593060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411456|NCT00593060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411457|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411458|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
83411459|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411460|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83411461|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411462|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83411463|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
83411464|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
83411465|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411617|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
83411467|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411468|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411469|NCT01332357|Fluticasone|fluticasone|mesh-list
83411470|NCT01332357|Xhance|xhance|mesh-list
83411471|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83411472|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83411473|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83411474|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83411475|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
83411476|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411477|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411478|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83411479|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
83411480|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
83411481|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83411482|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83411483|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83411484|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83411485|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
83411486|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411487|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411488|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
83411489|NCT01332357|Hormones|hormones|mesh-ancestor
83411490|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411491|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
83411492|NCT04914936|Rifampin|rifampin|mesh-list
83411493|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
83411494|NCT04914936|Omeprazole|omeprazole|mesh-list
83411495|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
83411496|NCT04914936|Calcium|calcium|mesh-list
83411497|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83411498|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411499|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83411500|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83411501|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83411502|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411503|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411504|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83411505|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
83411506|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83411507|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411508|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
83411509|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83411510|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83411511|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83411512|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83411513|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83411514|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83411515|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83411516|NCT04914936|Antacids|antacids|mesh-ancestor
83411517|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411518|NCT04914390|Paclitaxel|paclitaxel|mesh-list
83411519|NCT04914390|Tislelizumab|tislelizumab|mesh-list
83411520|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83411521|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411522|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
83411523|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
83411524|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
83411525|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411526|NCT04914390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411527|NCT03054948|SMOFlipid|smoflipid|mesh-list
83411528|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83411529|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83411530|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83411531|NCT00986921|Mifepristone|mifepristone|mesh-list
83411532|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83411533|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
83411534|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83411535|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411536|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83411537|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83411538|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83411540|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83411541|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83411542|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
83411543|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411544|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
83411545|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83411546|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83411548|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
83411549|NCT01383759|Bortezomib|bortezomib|mesh-list
83411550|NCT01383759|BB 1101|bb 1101|mesh-list
83411551|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83411552|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
83411553|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
83411554|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411555|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411556|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83411557|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
83411558|NCT01383759|Hormones|hormones|mesh-ancestor
83411559|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411560|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83411561|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411562|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
83411563|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411564|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411565|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
83411566|NCT01384539|Vitamin D|vitamin d|mesh-list
83411567|NCT01384539|Calcitriol|calcitriol|mesh-list
83411568|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83411569|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411571|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
83411572|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83411573|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83411574|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83411575|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411576|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83411577|NCT03399981|Natalizumab|natalizumab|mesh-list
83411578|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
83411579|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411580|NCT04902222|Morphine|morphine|mesh-list
83411581|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83411582|NCT04902222|Narcotics|narcotics|mesh-ancestor
83411583|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83411584|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411585|NCT04902222|Analgesics|analgesics|mesh-ancestor
83411586|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
83411587|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411588|NCT04904406|Lamivudine|lamivudine|mesh-list
83411589|NCT04904406|Abacavir|abacavir|mesh-list
83411590|NCT04904406|Dolutegravir|dolutegravir|mesh-list
83411591|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83411592|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83411593|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411594|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411595|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
83411596|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411597|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83411598|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83411599|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83411600|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83411601|NCT00985751|Vaccines|vaccines|mesh-list
83411602|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83411603|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
83411604|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411605|NCT02337985|Prednisone|prednisone|mesh-list
83411606|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
83411607|NCT02337985|Rituximab|rituximab|mesh-list
83411608|NCT02337985|Doxorubicin|doxorubicin|mesh-list
83411609|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83411610|NCT02337985|Etoposide|etoposide|mesh-list
83411611|NCT02337985|Vincristine|vincristine|mesh-list
83411612|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411613|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
83411614|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411615|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411616|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83411618|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411620|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83411621|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411622|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83411623|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83411624|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83411625|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411626|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83411627|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
83411628|NCT02337985|Hormones|hormones|mesh-ancestor
83411629|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411630|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83411631|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83411632|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
83411633|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
83411634|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
83411635|NCT02429557|Midodrine|midodrine|mesh-list
83411636|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
83411637|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
83411638|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411639|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411640|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83411641|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83411642|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83411643|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83411644|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
83411645|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411646|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411647|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83411648|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83411649|NCT04884516|Vitamin A|vitamin a|mesh-list
83411650|NCT04884516|Vitamins|vitamins|mesh-ancestor
83411651|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
83411652|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411653|NCT04884282|Docetaxel|docetaxel|mesh-list
83411654|NCT04884282|Nivolumab|nivolumab|mesh-list
83411655|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411656|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
83411657|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
83411658|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
83411659|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411660|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411661|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83411662|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
83411663|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
83411664|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83411665|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83411666|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411667|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411668|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411669|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411670|NCT02422381|Gemcitabine|gemcitabine|mesh-list
83411671|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
83411672|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83411673|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
83411674|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411675|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411676|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411677|NCT02422381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83411678|NCT04883736|Tretinoin|tretinoin|mesh-list
83411679|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411680|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
83411681|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
83411682|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
83411683|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411684|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411685|NCT02312557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83411686|NCT02312557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411687|NCT01387815|Adalimumab|adalimumab|mesh-list
83411688|NCT01387815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83411689|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83411690|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411691|NCT04883034|Analgesics|analgesics|mesh-list
83411692|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
83411693|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411694|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411696|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
83411697|NCT01596504|Liraglutide|liraglutide|mesh-list
83411698|NCT01596504|Lixisenatide|lixisenatide|mesh-list
83411699|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83411700|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411701|NCT01596504|Incretins|incretins|mesh-ancestor
83411702|NCT01596504|Hormones|hormones|mesh-ancestor
83411703|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411704|NCT02394769|Aspirin|aspirin|mesh-list
83411705|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83411706|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83411707|NCT02394769|Analgesics|analgesics|mesh-ancestor
83411708|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
83411709|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411710|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411711|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83411712|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411713|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83411714|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83411715|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411716|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83411717|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83411718|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411719|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
83411720|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83411721|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83411722|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411723|NCT01334229|Incretins|incretins|mesh-ancestor
83411724|NCT01334229|Hormones|hormones|mesh-ancestor
83411725|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411726|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83411727|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
83411728|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411729|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411730|NCT01390077|Nitisinone|nitisinone|mesh-list
83411731|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411732|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411733|NCT02292979|Doxorubicin|doxorubicin|mesh-list
83411734|NCT02292979|Bleomycin|bleomycin|mesh-list
83411735|NCT02292979|Dacarbazine|dacarbazine|mesh-list
83411736|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83411737|NCT02292979|Vinblastine|vinblastine|mesh-list
83411738|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83411739|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411740|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83411741|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83411742|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411743|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411744|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83411745|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
83411746|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411747|NCT02292979|Immunotoxins|immunotoxins|mesh-ancestor
83411748|NCT02292979|Immunoconjugates|immunoconjugates|mesh-ancestor
83411749|NCT02292979|Immunologic Factors|immunologic factors|mesh-ancestor
83411750|NCT02292979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411751|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83411752|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
83411753|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
83411754|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
83411755|NCT02394535|Paclitaxel|paclitaxel|mesh-list
83411756|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83411757|NCT02394535|Capecitabine|capecitabine|mesh-list
83411758|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83411759|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411760|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
83411761|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
83411762|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
83411763|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411764|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83411765|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
83411766|NCT02285959|Bevacizumab|bevacizumab|mesh-list
83411767|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411768|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411769|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83411770|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83411771|NCT02285959|Growth Substances|growth substances|mesh-ancestor
83411772|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411773|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
83411774|NCT01404429|Methotrexate|methotrexate|mesh-list
83411775|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83411776|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
83411777|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83411778|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411779|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83411780|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
83411781|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411782|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411783|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
83411784|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411785|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83411786|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411787|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
83411788|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411789|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83411790|NCT03051906|Cetuximab|cetuximab|mesh-list
83411791|NCT03051906|Durvalumab|durvalumab|mesh-list
83411792|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411793|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411794|NCT01390233|Dinoprostone|dinoprostone|mesh-list
83411796|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83411797|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411798|NCT03051360|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83411799|NCT03051360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83411800|NCT03051360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83411801|NCT03051360|Antimetabolites|antimetabolites|mesh-ancestor
83411802|NCT03051360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411803|NCT03051360|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83411804|NCT03051360|Protease Inhibitors|protease inhibitors|mesh-ancestor
83411805|NCT03051360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411806|NCT03051360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83411807|NCT05026567|Midazolam|midazolam|mesh-list
83411808|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83411809|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83411810|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83411811|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411812|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83411813|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83411814|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83411815|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83411816|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
83411817|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
83411818|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
83411819|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
83411820|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411821|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411822|NCT01391013|Ritonavir|ritonavir|mesh-list
83411823|NCT01391013|Darunavir|darunavir|mesh-list
83411824|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83411825|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83411826|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83411827|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
83411828|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411829|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411830|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83411831|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83411832|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
83411833|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411834|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83411835|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83411836|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83411837|NCT01891747|Bevacizumab|bevacizumab|mesh-list
83411838|NCT01891747|Temozolomide|temozolomide|mesh-list
83411839|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411840|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411841|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83411842|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83411845|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
83411846|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83411847|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
83411848|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411849|NCT04899570|Prednisone|prednisone|mesh-list
83411850|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
83411851|NCT04899570|Rituximab|rituximab|mesh-list
83411852|NCT04899570|Epirubicin|epirubicin|mesh-list
83411853|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
83411854|NCT04899570|Vindesine|vindesine|mesh-list
83411855|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411856|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
83411857|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411858|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411859|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83411860|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
83411861|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411862|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411863|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83411864|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411865|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83411866|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
83411867|NCT04899570|Hormones|hormones|mesh-ancestor
83411868|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411869|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83411870|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83411871|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83411872|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83411873|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411874|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83411875|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83411876|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
83411877|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
83411878|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
83411879|NCT02274415|Vaccines|vaccines|mesh-list
83411880|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83411881|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
83411882|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411883|NCT03049878|Acetaminophen|acetaminophen|mesh-list
83411884|NCT03049878|Codeine|codeine|mesh-list
83411885|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83411886|NCT03049878|Analgesics|analgesics|mesh-ancestor
83411887|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
83411888|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411889|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411890|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
83411891|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83411892|NCT03049878|Narcotics|narcotics|mesh-ancestor
83411893|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83411894|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
83411895|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
83411896|NCT01391325|Allopurinol|allopurinol|mesh-list
83411897|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
83411898|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411899|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411900|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
83411901|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411902|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83411903|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
83411904|NCT01391325|Protective Agents|protective agents|mesh-ancestor
83411905|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411906|NCT01980823|Metformin|metformin|mesh-list
83411907|NCT01980823|Atorvastatin|atorvastatin|mesh-list
83411908|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83411909|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411910|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83411911|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83411912|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
83411913|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411914|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83411915|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83411916|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411917|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83411918|NCT01976065|Metronidazole|metronidazole|mesh-list
83411921|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411922|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83411923|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83411924|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83411925|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83411926|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411927|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411928|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411929|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83411930|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83411931|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
83411932|NCT04891458|Anesthetics|anesthetics|mesh-list
83411934|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83411935|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411936|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83411937|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83411938|NCT04891458|Analgesics|analgesics|mesh-ancestor
83411939|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
83411940|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411941|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83411942|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83411943|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83411944|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
83411945|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411946|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411947|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83411948|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
83411949|NCT04899414|Dexamethasone|dexamethasone|mesh-list
83411950|NCT04899414|Azacitidine|azacitidine|mesh-list
83411951|NCT04899414|Tislelizumab|tislelizumab|mesh-list
83411952|NCT04899414|Pegaspargase|pegaspargase|mesh-list
83411953|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83411954|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
83411955|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
83411956|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411957|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411958|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83411959|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
83411960|NCT04899414|Hormones|hormones|mesh-ancestor
83411961|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83411962|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83411963|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411964|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83411965|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
83411966|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411967|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83411968|NCT04899414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83411969|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
83411970|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83411971|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83411972|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411973|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
83411974|NCT03008655|Coagulants|coagulants|mesh-ancestor
83411975|NCT01894633|Chloroquine|chloroquine|mesh-list
83411976|NCT01894633|Amebicides|amebicides|mesh-ancestor
83411977|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83411978|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83411979|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83411980|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
83411981|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83411982|NCT05585671|Belimumab|belimumab|mesh-list
83411983|NCT05585671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83411984|NCT05585671|Immunologic Factors|immunologic factors|mesh-ancestor
83411985|NCT05585671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411986|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83411987|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
83411988|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83411989|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
83411990|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411991|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411992|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83411993|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
83411994|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83411995|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83411998|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83411999|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412000|NCT01335789|Oxytocin|oxytocin|mesh-list
83412001|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
83412002|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83412003|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412004|NCT02202135|Vancomycin|vancomycin|mesh-list
83412005|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83412006|NCT02202135|Aztreonam|aztreonam|mesh-list
83412007|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83412008|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412009|NCT05585281|Fluzoparib|fluzoparib|mesh-list
83412010|NCT05585281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83412011|NCT05585281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412012|NCT05585281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412013|NCT05585281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412014|NCT01335867|Vigabatrin|vigabatrin|mesh-list
83412015|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
83412016|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412017|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412018|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
83412019|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412020|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412022|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412023|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412024|NCT00985439|Celecoxib|celecoxib|mesh-list
83412025|NCT00985439|Diclofenac|diclofenac|mesh-list
83412026|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83412027|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83412028|NCT00985439|Analgesics|analgesics|mesh-ancestor
83412029|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
83412030|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412031|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412032|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412033|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83412034|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83412035|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83412036|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412037|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412038|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
83412039|NCT02984111|Hematinics|hematinics|mesh-ancestor
83412040|NCT04412148|Triamcinolone|triamcinolone|mesh-list
83412041|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83412042|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83412043|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83412044|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412045|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
83412046|NCT04412148|Hormones|hormones|mesh-ancestor
83412047|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83412048|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412049|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83412050|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
83412051|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412052|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412053|NCT04890522|Gemcitabine|gemcitabine|mesh-list
83412054|NCT04890522|Fluorouracil|fluorouracil|mesh-list
83412055|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412056|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83412057|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
83412058|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412059|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83412060|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
83412061|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412062|NCT01525069|Dexamethasone|dexamethasone|mesh-list
83412063|NCT01525069|Gemcitabine|gemcitabine|mesh-list
83412064|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
83412065|NCT01525069|Floxuridine|floxuridine|mesh-list
83412066|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412067|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
83412068|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
83412069|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412070|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412071|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83412072|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
83412073|NCT01525069|Hormones|hormones|mesh-ancestor
83412074|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83412076|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412077|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83412078|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
83412079|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412080|NCT04898946|Vaccines|vaccines|mesh-list
83412081|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
83412082|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412083|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83412084|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83412085|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83412086|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83412087|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83412088|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
83412089|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412090|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412091|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412092|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
83412093|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83412094|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83412095|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
83412096|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83412097|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412098|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83412099|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83412100|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83412101|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83412102|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412103|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83412104|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83412105|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412106|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412107|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412108|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
83412109|NCT01894867|Antacids|antacids|mesh-ancestor
83412110|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412111|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83412112|NCT01521403|Metronidazole|metronidazole|mesh-list
83412113|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412114|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83412115|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83412116|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83412117|NCT04881942|Menthol|menthol|mesh-list
83412118|NCT04881942|Nicotine|nicotine|mesh-list
83412119|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83412120|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
83412121|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412122|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412123|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83412124|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83412125|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
83412126|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412127|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412128|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
83412129|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
83412130|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
83412131|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412132|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
83412133|NCT03071861|Hematinics|hematinics|mesh-ancestor
83412134|NCT04126811|Apatinib|apatinib|mesh-list
83412135|NCT04126811|Ifosfamide|ifosfamide|mesh-list
83412136|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
83412137|NCT04126811|Pirarubicin|pirarubicin|mesh-list
83412138|NCT04126811|Doxorubicin|doxorubicin|mesh-list
83412139|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412140|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83412141|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412142|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412143|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83412144|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
83412145|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83412146|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83412147|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83412148|NCT01406223|Bupropion|bupropion|mesh-list
83412151|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83412152|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
83412153|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412154|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412155|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83412156|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83412157|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
83412158|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412159|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412160|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83412161|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
83412162|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83412163|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83412164|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83412165|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83412166|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
83412167|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83412168|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83412169|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412170|NCT02230969|Interferons|interferons|mesh-list
83412171|NCT02230969|Interferon-beta|interferon-beta|mesh-list
83412172|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
83412173|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412174|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
83412175|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412176|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
83412177|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412178|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83412179|NCT04881474|Ibuprofen|ibuprofen|mesh-list
83412180|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83412181|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83412182|NCT04881474|Analgesics|analgesics|mesh-ancestor
83412183|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
83412184|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412185|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412186|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412187|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83412188|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83412189|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412190|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412191|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83412192|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83412193|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83412194|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83412195|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412196|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412197|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412198|NCT00981149|Analgesics|analgesics|mesh-ancestor
83412199|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
83412200|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412201|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
83412202|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83412203|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
83412204|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
83412205|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83412206|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412207|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83412208|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412209|NCT01595646|Insulin|insulin|mesh-list
83412210|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83412211|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
83412212|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83412213|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412214|NCT01907191|Bupivacaine|bupivacaine|mesh-list
83412215|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
83412216|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
83412217|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83412218|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412219|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
83412220|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412221|NCT01395537|Paclitaxel|paclitaxel|mesh-list
83412222|NCT01395537|Carboplatin|carboplatin|mesh-list
83412223|NCT01395537|Lapatinib|lapatinib|mesh-list
83412371|NCT02177071|Methotrexate|methotrexate|mesh-list
83412225|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412226|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
83412227|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
83412228|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
83412229|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412230|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83412231|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412232|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
83412233|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83412234|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83412235|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412236|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
83412237|NCT04898712|Coagulants|coagulants|mesh-ancestor
83412238|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83412239|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83412240|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
83412241|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412242|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
83412243|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83412244|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83412245|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412247|NCT02317549|Coagulants|coagulants|mesh-ancestor
83412248|NCT05583643|Calcium, Dietary|calcium, dietary|mesh-list
83412249|NCT05583643|Atorvastatin|atorvastatin|mesh-list
83412250|NCT05583643|Calcium|calcium|mesh-list
83412251|NCT05583643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83412252|NCT05583643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412253|NCT05583643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83412254|NCT05583643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83412255|NCT05583643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83412256|NCT05583643|Antimetabolites|antimetabolites|mesh-ancestor
83412257|NCT05583643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412258|NCT05583643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83412259|NCT05583643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83412260|NCT05583643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412261|NCT02225275|Lenalidomide|lenalidomide|mesh-list
83412262|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
83412263|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
83412264|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412265|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83412266|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83412267|NCT02225275|Growth Substances|growth substances|mesh-ancestor
83412268|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
83412269|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412270|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412271|NCT01897441|Paclitaxel|paclitaxel|mesh-list
83412272|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
83412273|NCT01897441|Doxorubicin|doxorubicin|mesh-list
83412274|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83412275|NCT01897441|Trastuzumab|trastuzumab|mesh-list
83412276|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83412277|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83412278|NCT01897441|Antibodies|antibodies|mesh-list
83412279|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
83412280|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83412281|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83412282|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412283|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
83412284|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
83412285|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
83412286|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412287|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83412288|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
83412289|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412290|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83412291|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83412292|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
83412293|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83412294|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83412295|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83412296|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83412297|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412298|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83412300|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
83412301|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412302|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83412303|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83412304|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
83412305|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
83412306|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412307|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412308|NCT04430556|Sertraline|sertraline|mesh-list
83412309|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
83412310|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83412311|NCT04430556|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83412312|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83412313|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83412314|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412315|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412316|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
83412317|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412318|NCT04897854|Folfirinox|folfirinox|mesh-list
83412319|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412320|NCT01892527|Cetuximab|cetuximab|mesh-list
83412321|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412322|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412323|NCT01399827|Methylphenidate|methylphenidate|mesh-list
83412324|NCT01399827|Amphetamine|amphetamine|mesh-list
83412325|NCT01399827|Adderall|adderall|mesh-list
83412326|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83412327|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
83412328|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83412329|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83412330|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412331|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83412332|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83412333|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83412334|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412335|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
83412336|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412337|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83412338|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
83412339|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
83412340|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
83412341|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412342|NCT04897386|Pemetrexed|pemetrexed|mesh-list
83412343|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412344|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412345|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412346|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83412347|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83412348|NCT02213107|Dutasteride|dutasteride|mesh-list
83412349|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83412350|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83412351|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412352|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412353|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
83412354|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83412355|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412356|NCT04879446|Mitogens|mitogens|mesh-list
83412357|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
83412358|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412359|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
83412360|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83412361|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83412362|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412363|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
83412364|NCT02618382|Coagulants|coagulants|mesh-ancestor
83412365|NCT02196961|Nivolumab|nivolumab|mesh-list
83412366|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412367|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412368|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83412369|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412370|NCT02177071|Infliximab|infliximab|mesh-list
83412385|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83412386|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
83412387|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83412388|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83412389|NCT02177071|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83412390|NCT02177071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412391|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83412392|NCT04889196|Fluorides|fluorides|mesh-list
83412393|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
83412394|NCT04889196|Protective Agents|protective agents|mesh-ancestor
83412395|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412396|NCT03049176|Tenofovir|tenofovir|mesh-list
83412397|NCT03049176|Emtricitabine|emtricitabine|mesh-list
83412398|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83412399|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83412400|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
83412401|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412402|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83412403|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83412404|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412405|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412406|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83412407|NCT01895023|Midazolam|midazolam|mesh-list
83412408|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
83412409|NCT01895023|GABA Modulators|gaba modulators|mesh-list
83412410|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83412411|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83412412|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412413|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83412414|NCT01895023|Analgesics|analgesics|mesh-ancestor
83412415|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
83412416|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412417|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83412418|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83412419|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83412420|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
83412421|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412422|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412423|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83412424|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83412425|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83412426|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83412427|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83412428|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
83412429|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
83412430|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
83412431|NCT04888728|Nebivolol|nebivolol|mesh-list
83412432|NCT04888728|Paroxetine|paroxetine|mesh-list
83412433|NCT04888728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83412434|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83412435|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83412436|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412437|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412438|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
83412439|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412440|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83412441|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
83412442|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83412443|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83412444|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83412445|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412446|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83412447|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
83412448|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83412449|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83412450|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83412451|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
83412452|NCT04125719|Nivolumab|nivolumab|mesh-list
83412453|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412454|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412455|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83412456|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412457|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
83412458|NCT01428973|Sirolimus|sirolimus|mesh-list
83412459|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83412460|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412461|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83412462|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
83412463|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83412464|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412465|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412466|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412467|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
83412468|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83412469|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
83412470|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412472|NCT01421797|Cosyntropin|cosyntropin|mesh-list
83412473|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412474|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
83412475|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
83412476|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412477|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412478|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83412479|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
83412480|NCT01421797|Hormones|hormones|mesh-ancestor
83412481|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83412482|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83412483|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412484|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83412485|NCT01475643|Prednisolone|prednisolone|mesh-list
83412486|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83412487|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
83412488|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83412489|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
83412490|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83412491|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
83412492|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412493|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
83412494|NCT01475643|Hormones|hormones|mesh-ancestor
83412495|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83412496|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412497|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83412498|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412499|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
83412500|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
83412501|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412502|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83412503|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83412504|NCT01475643|Protective Agents|protective agents|mesh-ancestor
83412505|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83412506|NCT01846663|Rifaximin|rifaximin|mesh-list
83412507|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83412508|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412509|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83412510|NCT03004001|Atorvastatin|atorvastatin|mesh-list
83412511|NCT03004001|Alirocumab|alirocumab|mesh-list
83412512|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83412513|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83412514|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83412515|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
83412516|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412517|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83412518|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83412519|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412520|NCT03004001|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83412521|NCT03004001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83412522|NCT03004001|Protease Inhibitors|protease inhibitors|mesh-ancestor
83412523|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
83412524|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412525|NCT04395222|Fludarabine|fludarabine|mesh-list
83412526|NCT04395222|Melphalan|melphalan|mesh-list
83412527|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
83412528|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83412529|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412530|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412531|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83412532|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
83412533|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412534|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83412535|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
83412537|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83412538|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83412539|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83412540|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
83412541|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412542|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83412543|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83412544|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412545|NCT03237377|Durvalumab|durvalumab|mesh-list
83412546|NCT03237377|Tremelimumab|tremelimumab|mesh-list
83412547|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412548|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412549|NCT04124081|Entecavir|entecavir|mesh-list
83412550|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
83412551|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412552|NCT04123925|Nivolumab|nivolumab|mesh-list
83412553|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412554|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412555|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83412556|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412557|NCT04759079|Antiemetics|antiemetics|mesh-list
83412558|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
83412559|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412560|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412561|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83412562|NCT03048942|Paclitaxel|paclitaxel|mesh-list
83412563|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83412564|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412565|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
83412566|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
83412567|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
83412568|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412569|NCT04393025|Clopidogrel|clopidogrel|mesh-list
83412570|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412571|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412572|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83412573|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83412574|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83412575|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83412576|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
83412577|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412578|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83412579|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83412580|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412581|NCT05580445|Gemcitabine|gemcitabine|mesh-list
83412582|NCT05580445|Conteltinib|conteltinib|mesh-list
83412583|NCT05580445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83412584|NCT05580445|Antimetabolites|antimetabolites|mesh-ancestor
83412585|NCT05580445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412586|NCT05580445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412587|NCT05580445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83412588|NCT05580445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412589|NCT05257902|Choline|choline|mesh-list
83412590|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
83412591|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83412592|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
83412593|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412594|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83412595|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83412596|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
83412597|NCT02143219|Leucovorin|leucovorin|mesh-list
83412598|NCT02143219|Folic Acid|folic acid|mesh-list
83412599|NCT02143219|Irinotecan|irinotecan|mesh-list
83412600|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
83412601|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
83412602|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83412603|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83412604|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412605|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412606|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412607|NCT02143219|Antidotes|antidotes|mesh-ancestor
83412608|NCT02143219|Protective Agents|protective agents|mesh-ancestor
83412609|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412615|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83412617|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412618|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412620|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
83412621|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412622|NCT04122599|Protective Agents|protective agents|mesh-ancestor
83412623|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412624|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83412625|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83412626|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83412627|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
83412628|NCT03048474|Nivolumab|nivolumab|mesh-list
83412629|NCT03048474|Ipilimumab|ipilimumab|mesh-list
83412630|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412631|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412632|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83412633|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412634|NCT04121975|Endostar protein|endostar protein|mesh-list
83412635|NCT04121975|Endostatins|endostatins|mesh-list
83412636|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412637|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83412638|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83412639|NCT04121975|Growth Substances|growth substances|mesh-ancestor
83412640|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412641|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
83412642|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
83412643|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83412644|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83412645|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412646|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
83412647|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412648|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412649|NCT03830957|Metoprolol|metoprolol|mesh-list
83412650|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83412651|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83412652|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
83412653|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
83412654|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412655|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412656|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83412657|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83412658|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83412659|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
83412660|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412661|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412662|NCT04121819|Cytarabine|cytarabine|mesh-list
83412663|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83412664|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
83412665|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412666|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412667|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
83412668|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412669|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83412670|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
83412671|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412672|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
83412673|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83412674|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83412675|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
83412676|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412677|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83412678|NCT05189730|Paclitaxel|paclitaxel|mesh-list
83412679|NCT05189730|Carboplatin|carboplatin|mesh-list
83412680|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83412681|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412682|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
83412683|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
83412684|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
83412685|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412686|NCT04121273|Immunomodulating Agents|immunomodulating agents|mesh-list
83412687|NCT04121273|Immunologic Factors|immunologic factors|mesh-ancestor
83412688|NCT04121273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412691|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412692|NCT04121039|Apatinib|apatinib|mesh-list
83412693|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412694|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83412695|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412696|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412697|NCT01401543|Tadalafil|tadalafil|mesh-list
83412698|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
83412699|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83412700|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83412701|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412702|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412703|NCT01401543|Urological Agents|urological agents|mesh-ancestor
83412704|NCT02985749|Oxytocin|oxytocin|mesh-list
83412705|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
83412706|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83412707|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412708|NCT04120259|Metformin|metformin|mesh-list
83412709|NCT04120259|Acetic Acid|acetic acid|mesh-list
83412710|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83412711|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412712|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83412713|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412714|NCT04392102|Niraparib|niraparib|mesh-list
83412715|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83412716|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412717|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412718|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412719|NCT02127073|Oxytocin|oxytocin|mesh-list
83412720|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
83412721|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83412722|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412723|NCT02124421|Paclitaxel|paclitaxel|mesh-list
83412724|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83412725|NCT02124421|Carboplatin|carboplatin|mesh-list
83412726|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83412727|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412728|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
83412729|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
83412730|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
83412731|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412732|NCT05256342|Etoricoxib|etoricoxib|mesh-list
83412733|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83412734|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83412735|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83412736|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83412737|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412738|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412739|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412740|NCT05256342|Analgesics|analgesics|mesh-ancestor
83412741|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
83412742|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412743|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
83412744|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83412745|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
83412746|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83412747|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83412748|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412749|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83412750|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83412751|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83412752|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412753|NCT02117167|Pemetrexed|pemetrexed|mesh-list
83412754|NCT02117167|Durvalumab|durvalumab|mesh-list
83412755|NCT02117167|Olaparib|olaparib|mesh-list
83412756|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412757|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412758|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412759|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83412760|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83412761|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412762|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83412763|NCT04123379|Nivolumab|nivolumab|mesh-list
83412764|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412765|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412766|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83412767|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412768|NCT01895881|Estradiol|estradiol|mesh-list
83412769|NCT01895881|Estrogens|estrogens|mesh-ancestor
83412770|NCT01895881|Hormones|hormones|mesh-ancestor
83412771|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83412772|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412773|NCT04537962|Listerine|listerine|mesh-list
83412774|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
83412775|NCT04537962|Fluorides|fluorides|mesh-list
83412776|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
83412777|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
83412778|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
83412779|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
83412780|NCT04537962|Protective Agents|protective agents|mesh-ancestor
83412781|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412782|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83412783|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412784|NCT04126733|Nivolumab|nivolumab|mesh-list
83412785|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412786|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412787|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83412788|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412789|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
83412790|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
83412791|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412792|NCT04885764|Vaccines|vaccines|mesh-list
83412793|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
83412794|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412795|NCT04311606|Aflibercept|aflibercept|mesh-list
83412796|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83412797|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83412798|NCT04311606|Growth Substances|growth substances|mesh-ancestor
83412799|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412800|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
83412801|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412802|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
83412803|NCT02981069|Exenatide|exenatide|mesh-list
83412804|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83412805|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412806|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83412807|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412808|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83412809|NCT02981069|Incretins|incretins|mesh-ancestor
83412810|NCT02981069|Hormones|hormones|mesh-ancestor
83412811|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83412812|NCT02980835|Dexamethasone|dexamethasone|mesh-list
83412813|NCT02980835|Epinephrine|epinephrine|mesh-list
83412814|NCT02980835|Ropivacaine|ropivacaine|mesh-list
83412815|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412816|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
83412817|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
83412818|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412819|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412820|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83412821|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
83412822|NCT02980835|Hormones|hormones|mesh-ancestor
83412823|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83412824|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83412825|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412826|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
83412827|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
83412828|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83412829|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
83412830|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83412831|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83412832|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
83412833|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412834|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412835|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83412836|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83412837|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83412838|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
83412839|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
83412840|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
83412841|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83412842|NCT03824327|Papaverine|papaverine|mesh-list
83412843|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83412844|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412845|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412846|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
83412847|NCT03824327|Urological Agents|urological agents|mesh-ancestor
83412848|NCT04871724|Fluconazole|fluconazole|mesh-list
83412849|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
83412850|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412851|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83412852|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83412853|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412854|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412855|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83412856|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
83412857|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83412858|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412859|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83412860|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83412861|NCT04871802|Taxifolin|taxifolin|mesh-list
83412862|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83412863|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83412864|NCT04871802|Analgesics|analgesics|mesh-ancestor
83412865|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
83412866|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412867|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412868|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412869|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83412870|NCT04871646|Nafamostat|nafamostat|mesh-list
83412871|NCT04871646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83412872|NCT04871646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83412873|NCT04871646|Analgesics|analgesics|mesh-ancestor
83412874|NCT04871646|Sensory System Agents|sensory system agents|mesh-ancestor
83412875|NCT04871646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412876|NCT04871646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412877|NCT04871646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412878|NCT04871646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83412879|NCT04871646|Anticoagulants|anticoagulants|mesh-ancestor
83412880|NCT04871646|Protease Inhibitors|protease inhibitors|mesh-ancestor
83412881|NCT04871646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412882|NCT04871646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412883|NCT04871646|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83412884|NCT04871646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83412885|NCT04871646|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83412886|NCT04871646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83412887|NCT04871646|Immunologic Factors|immunologic factors|mesh-ancestor
83412888|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
83412889|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412890|NCT03589014|Propranolol|propranolol|mesh-list
83412891|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83412892|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83412893|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
83412894|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412895|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412896|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412897|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83412898|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83412899|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
83412900|NCT04884906|Paclitaxel|paclitaxel|mesh-list
83412901|NCT04884906|Cisplatin|cisplatin|mesh-list
83412902|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83412903|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412904|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
83412905|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
83412906|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
83412907|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412908|NCT03826589|Avelumab|avelumab|mesh-list
83412909|NCT03826589|Axitinib|axitinib|mesh-list
83412910|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412911|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412912|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83412913|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412992|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
83412914|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412917|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83412918|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83412919|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83412920|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83412921|NCT04382664|Nivolumab|nivolumab|mesh-list
83412922|NCT04382664|Ipilimumab|ipilimumab|mesh-list
83412923|NCT04382664|Sargramostim|sargramostim|mesh-list
83412924|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83412925|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412926|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83412927|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412928|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
83412929|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412930|NCT04392479|Aflibercept|aflibercept|mesh-list
83412931|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83412932|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83412933|NCT04392479|Growth Substances|growth substances|mesh-ancestor
83412934|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412935|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
83412936|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412937|NCT03825887|Morphine|morphine|mesh-list
83412938|NCT03825887|Nalbuphine|nalbuphine|mesh-list
83412939|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83412940|NCT03825887|Narcotics|narcotics|mesh-ancestor
83412941|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83412942|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412943|NCT03825887|Analgesics|analgesics|mesh-ancestor
83412944|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
83412945|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412946|NCT03825809|Acetaminophen|acetaminophen|mesh-list
83412947|NCT03825809|Celecoxib|celecoxib|mesh-list
83412948|NCT03825809|Ketorolac|ketorolac|mesh-list
83412949|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83412950|NCT03825809|Diazepam|diazepam|mesh-list
83412951|NCT03825809|Gabapentin|gabapentin|mesh-list
83412952|NCT03825809|Hydrocodone|hydrocodone|mesh-list
83412953|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83412954|NCT03825809|Analgesics|analgesics|mesh-ancestor
83412955|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
83412956|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412957|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412958|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
83412959|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83412960|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83412961|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83412962|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83412963|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83412964|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412965|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412966|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
83412967|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83412968|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83412969|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83412970|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83412971|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83412972|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83412973|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83412974|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
83412975|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83412976|NCT03825809|Narcotics|narcotics|mesh-ancestor
83412977|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
83412978|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
83412979|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83412980|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
83412981|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
83412982|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83412983|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83412984|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83412985|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83412986|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83412987|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
83412988|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
83412989|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
83412990|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
83412991|NCT03824717|Ropivacaine|ropivacaine|mesh-list
83412994|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83412995|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412996|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
83412997|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412999|NCT04392557|Pioglitazone|pioglitazone|mesh-list
83413000|NCT04392557|Alogliptin|alogliptin|mesh-list
83413001|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83413002|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413003|NCT04392557|Incretins|incretins|mesh-ancestor
83413004|NCT04392557|Hormones|hormones|mesh-ancestor
83413005|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413006|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83413007|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
83413008|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413009|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413010|NCT02115373|Tepotinib|tepotinib|mesh-list
83413011|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413012|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
83413013|NCT03824171|Vitamin D|vitamin d|mesh-list
83413014|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83413015|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83413016|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413017|NCT03824171|Vitamins|vitamins|mesh-ancestor
83413018|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
83413019|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83413020|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83413021|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
83413022|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413023|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83413024|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83413025|NCT02079181|Fluorides|fluorides|mesh-list
83413026|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
83413027|NCT02079181|Protective Agents|protective agents|mesh-ancestor
83413028|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413029|NCT02946125|Phenylephrine|phenylephrine|mesh-list
83413030|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
83413031|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83413032|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83413033|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
83413034|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
83413035|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413036|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413037|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
83413038|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83413039|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
83413040|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
83413041|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83413042|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83413043|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83413044|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
83413045|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413046|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413047|NCT02946125|Protective Agents|protective agents|mesh-ancestor
83413048|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83413049|NCT01895257|Leucovorin|leucovorin|mesh-list
83413050|NCT01895257|Fluorouracil|fluorouracil|mesh-list
83413051|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
83413052|NCT01895257|Antidotes|antidotes|mesh-ancestor
83413053|NCT01895257|Protective Agents|protective agents|mesh-ancestor
83413054|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413055|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
83413056|NCT01895257|Vitamins|vitamins|mesh-ancestor
83413057|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
83413058|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
83413059|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413060|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83413061|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413062|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83413063|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
83413064|NCT02064673|Curcumin|curcumin|mesh-list
83413065|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83413066|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83413067|NCT02064673|Analgesics|analgesics|mesh-ancestor
83413068|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
83413368|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83413069|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413070|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413072|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83413073|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413074|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413075|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413076|NCT04392713|Ivermectin|ivermectin|mesh-list
83413077|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83413078|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83413079|NCT03823625|Nivolumab|nivolumab|mesh-list
83413080|NCT03823625|Ipilimumab|ipilimumab|mesh-list
83413081|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83413082|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413083|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83413084|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413085|NCT02053909|Aspirin|aspirin|mesh-list
83413086|NCT02053909|Ticagrelor|ticagrelor|mesh-list
83413087|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83413088|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83413089|NCT02053909|Analgesics|analgesics|mesh-ancestor
83413090|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
83413091|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413092|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413093|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83413094|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83413095|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83413096|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83413097|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413098|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83413099|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83413100|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413101|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
83413102|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83413103|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83413104|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83413105|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
83413106|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413107|NCT02863991|TIC10 compound|tic10 compound|mesh-list
83413108|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413109|NCT02860091|Ropivacaine|ropivacaine|mesh-list
83413110|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
83413111|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
83413112|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83413113|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413114|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
83413115|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413116|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
83413117|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83413118|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83413119|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83413120|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83413121|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413122|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
83413123|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413124|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413125|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83413126|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413127|NCT03823781|Milrinone|milrinone|mesh-list
83413128|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83413129|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83413130|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
83413131|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83413132|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83413133|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413134|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413135|NCT03823781|Protective Agents|protective agents|mesh-ancestor
83413136|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413137|NCT02935361|Atezolizumab|atezolizumab|mesh-list
83413139|NCT02935361|Azacitidine|azacitidine|mesh-list
83413140|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83413141|NCT02935361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83413142|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413143|NCT02935361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83413145|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
83413146|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413147|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83413148|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
83413149|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413150|NCT02614794|Capecitabine|capecitabine|mesh-list
83413151|NCT02614794|Trastuzumab|trastuzumab|mesh-list
83413152|NCT02614794|Tucatinib|tucatinib|mesh-list
83413153|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83413154|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
83413155|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413156|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413157|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83413158|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83413159|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413160|NCT03823079|Irinotecan|irinotecan|mesh-list
83413161|NCT03823079|Raltitrexed|raltitrexed|mesh-list
83413162|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83413163|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83413164|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413165|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413166|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413167|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83413168|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
83413169|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83413170|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
83413171|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83413172|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
83413173|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413174|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83413175|NCT02839265|Protective Agents|protective agents|mesh-ancestor
83413176|NCT00988247|Beclomethasone|beclomethasone|mesh-list
83413177|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83413178|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
83413179|NCT00988247|Hormones|hormones|mesh-ancestor
83413180|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413181|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413182|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83413183|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
83413184|NCT02832401|Caffeine|caffeine|mesh-list
83413185|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83413186|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413187|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83413188|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413189|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413190|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83413191|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83413192|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
83413193|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413194|NCT03044808|Lidocaine|lidocaine|mesh-list
83413195|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
83413196|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
83413197|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83413198|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413199|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
83413200|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413201|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83413202|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83413203|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83413204|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83413205|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413206|NCT04430166|Antibodies|antibodies|mesh-list
83413207|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83413208|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
83413209|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413210|NCT04877106|Metformin|metformin|mesh-list
83413211|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83413212|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83413213|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413214|NCT04877106|Incretins|incretins|mesh-ancestor
83413216|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413217|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83413218|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
83413219|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413220|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413221|NCT00981617|ALKS-33|alks-33|mesh-list
83413222|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83413223|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413224|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
83413225|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413226|NCT04876716|Voriconazole|voriconazole|mesh-list
83413227|NCT04876716|Posaconazole|posaconazole|mesh-list
83413228|NCT04876716|Isavuconazole|isavuconazole|mesh-list
83413229|NCT04876716|Anidulafungin|anidulafungin|mesh-list
83413230|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
83413231|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83413232|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83413233|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83413234|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413235|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413236|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83413237|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
83413238|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413239|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413240|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83413241|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83413242|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83413243|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83413244|NCT04865250|Paclitaxel|paclitaxel|mesh-list
83413245|NCT04865250|Carboplatin|carboplatin|mesh-list
83413246|NCT04865250|Atezolizumab|atezolizumab|mesh-list
83413247|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83413248|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413249|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
83413250|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
83413251|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
83413252|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413253|NCT04865250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83413254|NCT04865250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83413255|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
83413256|NCT04865562|Testosterone|testosterone|mesh-list
83413257|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
83413258|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
83413259|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83413260|NCT04865562|Androgens|androgens|mesh-ancestor
83413261|NCT04865562|Hormones|hormones|mesh-ancestor
83413262|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413263|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413264|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83413265|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413266|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
83413267|NCT04864782|Paclitaxel|paclitaxel|mesh-list
83413268|NCT04864782|Carboplatin|carboplatin|mesh-list
83413269|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83413270|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413271|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
83413272|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
83413273|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
83413274|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413275|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83413276|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
83413277|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413278|NCT04385940|Vitamin D|vitamin d|mesh-list
83413279|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
83413280|NCT04385940|Vitamins|vitamins|mesh-ancestor
83413281|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
83413282|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413283|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83413284|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83413285|NCT00984659|Fluticasone|fluticasone|mesh-list
83413286|NCT00984659|Xhance|xhance|mesh-list
83413287|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83413288|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83413289|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83413290|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
83413291|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413292|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413293|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83413294|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
83413295|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
83413296|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83413297|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83413298|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83413299|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83413300|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
83413301|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413302|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413303|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
83413304|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83413305|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
83413306|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413307|NCT04864314|Protective Agents|protective agents|mesh-ancestor
83413308|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413310|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83413311|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
83413312|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413313|NCT03046290|Lidocaine|lidocaine|mesh-list
83413314|NCT03046290|Ropivacaine|ropivacaine|mesh-list
83413315|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
83413316|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
83413317|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83413318|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413319|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
83413320|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413321|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83413322|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83413323|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83413324|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83413325|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413326|NCT04874688|Provitamins|provitamins|mesh-list
83413327|NCT04874688|Beta Carotene|beta carotene|mesh-list
83413328|NCT04874688|Vitamins|vitamins|mesh-ancestor
83413329|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
83413330|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413331|NCT02612064|Fluorides|fluorides|mesh-list
83413332|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
83413333|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
83413334|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
83413335|NCT02612064|Protective Agents|protective agents|mesh-ancestor
83413336|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413337|NCT04553003|Prednisone|prednisone|mesh-list
83413338|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
83413339|NCT04553003|Choline|choline|mesh-list
83413340|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
83413341|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
83413342|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83413343|NCT04553003|Hormones|hormones|mesh-ancestor
83413344|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413345|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413346|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83413347|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413348|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
83413349|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
83413350|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413351|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83413352|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83413353|NCT04553003|Protective Agents|protective agents|mesh-ancestor
83413354|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
83413355|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83413356|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
83413357|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413358|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83413359|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
83413360|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
83413361|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
83413362|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83413363|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83413364|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413365|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
83413366|NCT03044184|Coagulants|coagulants|mesh-ancestor
83413367|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
83413369|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83413370|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413371|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83413372|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83413373|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83413374|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413375|NCT03047772|Atorvastatin|atorvastatin|mesh-list
83413376|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83413377|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83413378|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
83413379|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413380|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83413381|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83413382|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413383|NCT03047538|Amlodipine|amlodipine|mesh-list
83413384|NCT03047538|Perindopril|perindopril|mesh-list
83413385|NCT03047538|Atorvastatin|atorvastatin|mesh-list
83413386|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83413387|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83413388|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
83413389|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413390|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83413391|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83413392|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413393|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83413394|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83413395|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83413396|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83413397|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413398|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
83413399|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83413400|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
83413401|NCT01728805|Vorinostat|vorinostat|mesh-list
83413402|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
83413403|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413404|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83413405|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413406|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413407|NCT02043457|Hormones|hormones|mesh-list
83413408|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413409|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413410|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83413411|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83413412|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83413413|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83413414|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413415|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413416|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413417|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
83413418|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83413419|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
83413420|NCT03821987|Busulfan|busulfan|mesh-list
83413421|NCT03821987|Fludarabine|fludarabine|mesh-list
83413422|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
83413423|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83413424|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
83413425|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413426|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83413427|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83413428|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
83413429|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413430|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413431|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83413432|NCT04273763|Interferons|interferons|mesh-list
83413433|NCT04273763|Bromhexine|bromhexine|mesh-list
83413434|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413435|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
83413436|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83413437|NCT04273763|Expectorants|expectorants|mesh-ancestor
83413438|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
83413439|NCT01712815|Clevudine|clevudine|mesh-list
83413440|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
83413441|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83413442|NCT03820193|Acetaminophen|acetaminophen|mesh-list
83413445|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83413446|NCT03820193|Diazepam|diazepam|mesh-list
83413447|NCT03820193|Gabapentin|gabapentin|mesh-list
83413448|NCT03820193|Hydrocodone|hydrocodone|mesh-list
83413449|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83413450|NCT03820193|Analgesics|analgesics|mesh-ancestor
83413451|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
83413452|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413453|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413454|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
83413455|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83413456|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83413457|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83413458|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83413459|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83413460|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413461|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413462|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
83413463|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83413464|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83413465|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83413466|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83413467|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83413468|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83413469|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413470|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
83413471|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83413472|NCT03820193|Narcotics|narcotics|mesh-ancestor
83413473|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
83413474|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
83413475|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83413476|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
83413477|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
83413478|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83413479|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83413480|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83413481|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83413482|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83413483|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
83413484|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
83413485|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
83413486|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
83413487|NCT03820037|Opicapone|opicapone|mesh-list
83413488|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83413489|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413490|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413491|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83413492|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83413493|NCT03829007|Durvalumab|durvalumab|mesh-list
83413494|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83413495|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83413496|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413497|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
83413498|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413499|NCT02614560|Fludarabine|fludarabine|mesh-list
83413500|NCT02614560|Melphalan|melphalan|mesh-list
83413501|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413502|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413503|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83413504|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
83413505|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413506|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83413507|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
83413508|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83413509|NCT03828929|Thiamine|thiamine|mesh-list
83413510|NCT03828929|Vitamins|vitamins|mesh-ancestor
83413511|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
83413512|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413513|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
83413514|NCT04873440|Manganese|manganese|mesh-list
83413515|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413516|NCT04873440|Trace Elements|trace elements|mesh-ancestor
83413517|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
83413518|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
83413519|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
83413520|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83413521|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83413672|NCT01451879|Rituximab|rituximab|mesh-list
83413522|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83413523|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83413524|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413525|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413526|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413527|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83413528|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83413529|NCT04391621|Triamcinolone|triamcinolone|mesh-list
83413530|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83413531|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83413532|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83413533|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83413534|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
83413535|NCT04391621|Hormones|hormones|mesh-ancestor
83413536|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413537|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413538|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83413539|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
83413540|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413541|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413542|NCT01669122|Nicotine|nicotine|mesh-list
83413543|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83413544|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
83413545|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413546|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413547|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83413548|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83413549|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
83413550|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413551|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413552|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
83413553|NCT03629483|Ropivacaine|ropivacaine|mesh-list
83413554|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83413555|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83413556|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413557|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83413558|NCT03629483|Analgesics|analgesics|mesh-ancestor
83413559|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
83413560|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413561|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83413562|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83413563|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83413564|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
83413565|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413566|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413567|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
83413568|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
83413569|NCT04873284|Dexamethasone|dexamethasone|mesh-list
83413570|NCT04873284|Aprepitant|aprepitant|mesh-list
83413571|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
83413572|NCT04873284|Granisetron|granisetron|mesh-list
83413573|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83413574|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
83413575|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
83413576|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413577|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413578|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83413579|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
83413580|NCT04873284|Hormones|hormones|mesh-ancestor
83413581|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413582|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83413583|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413584|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83413662|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413663|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83413664|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83413666|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83413667|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
83413668|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413669|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413670|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413671|NCT01451879|Miglustat|miglustat|mesh-list
83413673|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83413674|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413675|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
83413676|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413677|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83413678|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413679|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413680|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83413681|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83413682|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
83413683|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83413684|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83413685|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83413686|NCT03045198|Azithromycin|azithromycin|mesh-list
83413687|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83413688|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83413689|NCT01452113|Vildagliptin|vildagliptin|mesh-list
83413690|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83413691|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413692|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83413693|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
83413694|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413695|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413696|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
83413697|NCT02022709|Sertraline|sertraline|mesh-list
83413698|NCT02022709|Fluoxetine|fluoxetine|mesh-list
83413699|NCT02022709|Paroxetine|paroxetine|mesh-list
83413700|NCT02022709|Citalopram|citalopram|mesh-list
83413701|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
83413702|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83413703|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83413704|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83413705|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83413706|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413707|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413708|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
83413709|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413710|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83413711|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83413712|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83413713|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413714|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83413715|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83413716|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83413717|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83413718|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83413719|NCT02635841|Deferiprone|deferiprone|mesh-list
83413720|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83413721|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
83413722|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
83413723|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413724|NCT00608725|Propranolol|propranolol|mesh-list
83413725|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83413726|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83413727|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
83413728|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413729|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413730|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413731|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83413732|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83413733|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
83413734|NCT01452659|Relugolix|relugolix|mesh-list
83413735|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
83413736|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
83413737|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413738|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413739|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83413740|NCT01896349|Amitriptyline|amitriptyline|mesh-list
83413741|NCT01896349|Risperidone|risperidone|mesh-list
83413742|NCT01896349|Sulpiride|sulpiride|mesh-list
83413743|NCT01896349|Mirtazapine|mirtazapine|mesh-list
83413744|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
83413745|NCT01896349|Trazodone|trazodone|mesh-list
83413746|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
83413747|NCT01896349|Citalopram|citalopram|mesh-list
83413758|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83413759|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
83413760|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413761|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413762|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413763|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83413764|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83413765|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83413766|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83413767|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83413768|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
83413769|NCT01896349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83413770|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83413771|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83413772|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413773|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83413774|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83413775|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83413776|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83413777|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413778|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83413779|NCT01896349|Analgesics|analgesics|mesh-ancestor
83413780|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
83413781|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83413782|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
83413783|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
83413784|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83413785|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83413786|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83413787|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83413788|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
83413789|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83413790|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83413791|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83413792|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83413793|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83413794|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83413795|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83413796|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83413798|NCT01452737|Cathartics|cathartics|mesh-ancestor
83413799|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83413800|NCT01452737|Laxatives|laxatives|mesh-ancestor
83413801|NCT00595933|Muramidase|muramidase|mesh-list
83413802|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83413803|NCT00580489|Fentanyl|fentanyl|mesh-list
83413804|NCT00580489|Morphine|morphine|mesh-list
83413805|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83413806|NCT00580489|Narcotics|narcotics|mesh-ancestor
83413807|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83413808|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413809|NCT00580489|Analgesics|analgesics|mesh-ancestor
83413810|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
83413811|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413812|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83413813|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83413814|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
83413815|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
83413816|NCT01659307|Aspirin|aspirin|mesh-list
83413817|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83413818|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83413819|NCT01659307|Analgesics|analgesics|mesh-ancestor
83413820|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
83413821|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413822|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413823|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83413824|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83413825|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83413826|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83413827|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413828|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83413829|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83413830|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413833|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83413834|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
83413835|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83413836|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413837|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83413838|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83413839|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83413840|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
83413841|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83413842|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413843|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413844|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83413845|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83413846|NCT04391231|Protective Agents|protective agents|mesh-ancestor
83413847|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413848|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
83413849|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83413850|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
83413851|NCT04872270|Caffeine|caffeine|mesh-list
83413852|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83413853|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413854|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83413855|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413856|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413857|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83413858|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83413859|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
83413860|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413861|NCT04872192|Anesthetics|anesthetics|mesh-list
83413862|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83413863|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413864|NCT01624285|Sorafenib|sorafenib|mesh-list
83413865|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413866|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83413867|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413868|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413869|NCT01454609|Clonidine|clonidine|mesh-list
83413870|NCT01454609|Bupivacaine|bupivacaine|mesh-list
83413871|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
83413872|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
83413873|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83413874|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413875|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
83413876|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413877|NCT01454609|Analgesics|analgesics|mesh-ancestor
83413878|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83413879|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
83413880|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
83413881|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83413882|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83413883|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83413884|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
83413885|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413886|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413888|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83413889|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83413890|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413891|NCT02905799|Resveratrol|resveratrol|mesh-list
83413892|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
83413893|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413894|NCT02905799|Protective Agents|protective agents|mesh-ancestor
83413895|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413896|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413897|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83413898|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83413899|NCT00469183|Tretinoin|tretinoin|mesh-list
83413900|NCT00469183|Hydroquinone|hydroquinone|mesh-list
83413901|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413902|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
83413903|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
83413904|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83413905|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
83413906|NCT00469183|Hormones|hormones|mesh-ancestor
83413907|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413908|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413909|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
83413910|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413911|NCT00469183|Protective Agents|protective agents|mesh-ancestor
83413912|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83413913|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83413914|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83413915|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83413916|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413917|NCT00468715|Bicalutamide|bicalutamide|mesh-list
83413918|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
83413919|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
83413920|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413921|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413922|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413923|NCT01456247|Lansoprazole|lansoprazole|mesh-list
83413924|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
83413925|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83413926|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83413927|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83413928|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413929|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413930|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83413931|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413932|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83413933|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413934|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413935|NCT04866498|Analgesics|analgesics|mesh-list
83413936|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
83413937|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413938|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413939|NCT04866654|Nivolumab|nivolumab|mesh-list
83413940|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83413941|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413942|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83413943|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413944|NCT01456715|Vaccines|vaccines|mesh-list
83413945|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
83413946|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413947|NCT01895569|Metformin|metformin|mesh-list
83413948|NCT01895569|Pioglitazone|pioglitazone|mesh-list
83413949|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83413950|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83413951|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413952|NCT01895569|Incretins|incretins|mesh-ancestor
83413953|NCT01895569|Hormones|hormones|mesh-ancestor
83413954|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413955|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83413956|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
83413957|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413958|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413959|NCT01457261|Albuterol|albuterol|mesh-list
83413960|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83413961|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
83413962|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413963|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413964|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83413965|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
83413966|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
83413967|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83413968|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83413969|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83413970|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83413971|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
83413972|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413973|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413974|NCT01457495|Edetic Acid|edetic acid|mesh-list
83413975|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
83413976|NCT01457495|Antidotes|antidotes|mesh-ancestor
83413977|NCT01457495|Protective Agents|protective agents|mesh-ancestor
83413978|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413979|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
83413980|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
83414058|NCT01458977|Emtricitabine|emtricitabine|mesh-list
83413981|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413982|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83413983|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
83413984|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83413985|NCT04778137|Omalizumab|omalizumab|mesh-list
83413986|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83413987|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83413988|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
83413989|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83413990|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83413991|NCT03815929|Estradiol|estradiol|mesh-list
83413992|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83413993|NCT03815929|Estrogens|estrogens|mesh-ancestor
83413994|NCT03815929|Hormones|hormones|mesh-ancestor
83413995|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83413996|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413997|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83413998|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
83413999|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83414000|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83414001|NCT00394147|Gemcitabine|gemcitabine|mesh-list
83414002|NCT00394147|Pemetrexed|pemetrexed|mesh-list
83414003|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83414004|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
83414005|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414006|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414007|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414008|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83414009|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83414010|NCT01458041|Iloprost|iloprost|mesh-list
83414011|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83414012|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
83414013|NCT02610816|Fluticasone|fluticasone|mesh-list
83414014|NCT02610816|Xhance|xhance|mesh-list
83414015|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83414016|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83414017|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
83414018|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414019|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414020|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83414021|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
83414022|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
83414023|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83414024|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
83414025|NCT00332605|Naltrexone|naltrexone|mesh-list
83414026|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83414027|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83414028|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83414029|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414030|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
83414031|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414032|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
83414033|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414034|NCT00332605|Expectorants|expectorants|mesh-ancestor
83414035|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
83414036|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83414037|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
83414038|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414039|NCT00332605|Protective Agents|protective agents|mesh-ancestor
83414040|NCT00332605|Antidotes|antidotes|mesh-ancestor
83414041|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83414042|NCT01458743|Cephalosporins|cephalosporins|mesh-list
83414043|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83414044|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414045|NCT01415583|Dexamethasone|dexamethasone|mesh-list
83414046|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83414047|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
83414048|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
83414049|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414050|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414051|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83414052|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
83414053|NCT01415583|Hormones|hormones|mesh-ancestor
83414054|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83414055|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83414056|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414057|NCT01458977|Tenofovir|tenofovir|mesh-list
83414059|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83414061|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414062|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83414063|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83414064|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414065|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414066|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83414067|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83414069|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83414070|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
83414071|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414072|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414073|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83414074|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
83414075|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
83414076|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83414077|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83414078|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83414079|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83414080|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
83414081|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414082|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414083|NCT00256399|Alfuzosin|alfuzosin|mesh-list
83414084|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83414085|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83414086|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83414087|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
83414088|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414089|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414090|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414091|NCT00256399|Urological Agents|urological agents|mesh-ancestor
83414092|NCT01459133|Insulin|insulin|mesh-list
83414093|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83414094|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414095|NCT01459211|Dexamethasone|dexamethasone|mesh-list
83414096|NCT01459211|Lenalidomide|lenalidomide|mesh-list
83414097|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83414098|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
83414099|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
83414100|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414101|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414102|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83414103|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
83414104|NCT01459211|Hormones|hormones|mesh-ancestor
83414105|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83414106|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83414107|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414108|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
83414109|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83414110|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83414111|NCT01459211|Growth Substances|growth substances|mesh-ancestor
83414112|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
83414113|NCT00198991|Cytarabine|cytarabine|mesh-list
83414114|NCT00198991|Dexamethasone|dexamethasone|mesh-list
83414115|NCT00198991|Prednisolone|prednisolone|mesh-list
83414116|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
83414117|NCT00198991|Methotrexate|methotrexate|mesh-list
83414118|NCT00198991|Fludarabine|fludarabine|mesh-list
83414119|NCT00198991|Etoposide|etoposide|mesh-list
83414120|NCT00198991|Etoposide phosphate|etoposide phosphate|mesh-list
83414121|NCT00198991|Vincristine|vincristine|mesh-list
83414122|NCT00198991|Doxorubicin|doxorubicin|mesh-list
83414123|NCT00198991|Daunorubicin|daunorubicin|mesh-list
83414124|NCT00198991|Asparaginase|asparaginase|mesh-list
83414125|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
83414126|NCT00198991|Idarubicin|idarubicin|mesh-list
83414127|NCT00198991|Thioguanine|thioguanine|mesh-list
83414128|NCT00198991|Cladribine|cladribine|mesh-list
83414129|NCT00198991|Vindesine|vindesine|mesh-list
83414130|NCT00198991|Pegaspargase|pegaspargase|mesh-list
83414131|NCT00198991|Teniposide|teniposide|mesh-list
83414132|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83414133|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
83414134|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414135|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83414136|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83414137|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
83414138|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414139|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414140|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83414141|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83414142|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
83414143|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
83414144|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414145|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83414146|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
83414148|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83414149|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83414150|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83414151|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
83414152|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83414153|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83414154|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
83414155|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
83414156|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414157|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83414158|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83414159|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83414160|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83414161|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83414162|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
83414163|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414164|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
83414165|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
83414166|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
83414167|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83414168|NCT01459367|Lansoprazole|lansoprazole|mesh-list
83414169|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
83414170|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83414171|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83414172|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83414173|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414174|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414175|NCT04777591|Bupivacaine|bupivacaine|mesh-list
83414176|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
83414177|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
83414178|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414179|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414180|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
83414181|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414182|NCT01459601|Cabergoline|cabergoline|mesh-list
83414183|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83414184|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83414185|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
83414186|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
83414187|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414188|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414189|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414190|NCT01418001|Gemcitabine|gemcitabine|mesh-list
83414192|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83414193|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
83414194|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414195|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414196|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
83414197|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
83414198|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
83414199|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83414200|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83414201|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83414202|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
83414203|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414204|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83414205|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83414206|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414207|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
83414208|NCT01542255|Dacarbazine|dacarbazine|mesh-list
83414209|NCT01542255|Vinblastine|vinblastine|mesh-list
83414210|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83414212|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414213|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83414214|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83414215|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
83414216|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414217|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414218|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83414219|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83414220|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
83414221|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
83414222|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
83414224|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
83414225|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
83414226|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414227|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414228|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83414229|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83414230|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83414231|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83414232|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
83414233|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414234|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414235|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
83414236|NCT02872259|Trametinib|trametinib|mesh-list
83414237|NCT02872259|Dabrafenib|dabrafenib|mesh-list
83414238|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83414239|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414240|NCT02872259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83414241|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414242|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83414243|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414244|NCT04776655|Leucovorin|leucovorin|mesh-list
83414245|NCT04776655|Bevacizumab|bevacizumab|mesh-list
83414246|NCT04776655|Cetuximab|cetuximab|mesh-list
83414247|NCT04776655|Fluorouracil|fluorouracil|mesh-list
83414248|NCT04776655|Irinotecan|irinotecan|mesh-list
83414249|NCT04776655|Calcium|calcium|mesh-list
83414250|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
83414251|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83414252|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414253|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83414254|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83414255|NCT04776655|Growth Substances|growth substances|mesh-ancestor
83414256|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414257|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
83414258|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83414259|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
83414260|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414261|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83414262|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83414263|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
83414264|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83414265|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83414266|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414267|NCT04776655|Antidotes|antidotes|mesh-ancestor
83414268|NCT04776655|Protective Agents|protective agents|mesh-ancestor
83414269|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
83414270|NCT04776655|Vitamins|vitamins|mesh-ancestor
83414271|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
83414272|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
83414273|NCT01455233|Besifloxacin|besifloxacin|mesh-list
83414274|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83414275|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83414276|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83414277|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83414278|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414279|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83414280|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83414281|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414282|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414283|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414284|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83414285|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
83414286|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83414287|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414288|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83414289|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83414290|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83414292|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83414293|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83414294|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
83414295|NCT01459679|Vitamins|vitamins|mesh-ancestor
83414296|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
83414297|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414298|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83414299|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
83414300|NCT00048295|Alicaforsen|alicaforsen|mesh-list
83414301|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83414302|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83414303|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
83414304|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414305|NCT01455857|Exenatide|exenatide|mesh-list
83414306|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83414307|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414308|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83414309|NCT01455857|Incretins|incretins|mesh-ancestor
83414310|NCT01455857|Hormones|hormones|mesh-ancestor
83414311|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83414312|NCT03043248|Digoxin|digoxin|mesh-list
83414313|NCT03043248|Midazolam|midazolam|mesh-list
83414314|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83414315|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83414316|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414317|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414318|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83414319|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83414320|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83414321|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83414322|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
83414323|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
83414324|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
83414325|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
83414326|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414327|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414328|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83414329|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83414330|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414331|NCT03043248|Protective Agents|protective agents|mesh-ancestor
83414332|NCT04843631|Ustekinumab|ustekinumab|mesh-list
83414333|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
83414334|NCT03043326|Tenofovir|tenofovir|mesh-list
83414335|NCT03043326|Emtricitabine|emtricitabine|mesh-list
83414336|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
83414337|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414338|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83414339|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83414340|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414341|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414342|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83414343|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83414344|NCT04845737|Vitamin D|vitamin d|mesh-list
83414345|NCT04845737|Vitamins|vitamins|mesh-ancestor
83414346|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
83414347|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414348|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83414349|NCT04849715|Rituximab|rituximab|mesh-list
83414350|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83414351|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83414352|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414353|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
83414354|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414355|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83414356|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83414357|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
83414358|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414359|NCT03044964|Ranolazine|ranolazine|mesh-list
83414360|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83414361|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83414362|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414363|NCT01419639|Everolimus|everolimus|mesh-list
83414366|NCT01419639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414367|NCT01419639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414368|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83414369|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
83414370|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414371|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414372|NCT02856893|Gefitinib|gefitinib|mesh-list
83414373|NCT02856893|Osimertinib|osimertinib|mesh-list
83414374|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414375|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83414376|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414377|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414378|NCT01419795|Rituximab|rituximab|mesh-list
83414379|NCT01419795|Lenalidomide|lenalidomide|mesh-list
83414380|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83414381|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414382|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
83414383|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414384|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83414385|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83414386|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83414387|NCT01419795|Growth Substances|growth substances|mesh-ancestor
83414388|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
83414389|NCT04783753|Itraconazole|itraconazole|mesh-list
83414390|NCT04783753|Quinidine|quinidine|mesh-list
83414391|NCT04783753|Carbamazepine|carbamazepine|mesh-list
83414392|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
83414393|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414394|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83414395|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83414396|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414397|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414398|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83414399|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
83414400|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83414401|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414402|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83414403|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
83414404|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
83414405|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83414406|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414407|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83414408|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83414409|NCT04783753|Analgesics|analgesics|mesh-ancestor
83414410|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
83414411|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414412|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83414413|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83414414|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83414415|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83414416|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83414417|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83414418|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
83414419|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414420|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83414421|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
83414422|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83414423|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83414424|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83414425|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83414426|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
83414427|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83414428|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83414429|NCT02856581|Varenicline|varenicline|mesh-list
83414430|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83414431|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83414432|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
83414433|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414434|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414435|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414436|NCT03042000|Capecitabine|capecitabine|mesh-list
83414437|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
83414438|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83414439|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
83414440|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414441|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414442|NCT01039285|Poractant alfa|poractant alfa|mesh-list
83414443|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83414444|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
83414445|NCT03043482|Calcitriol|calcitriol|mesh-list
83414446|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83414447|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414448|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83414449|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83414450|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414451|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83414452|NCT03043482|Vitamins|vitamins|mesh-ancestor
83414453|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
83414454|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83414455|NCT04775563|Vaccines|vaccines|mesh-list
83414456|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
83414457|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414458|NCT01480089|Ropivacaine|ropivacaine|mesh-list
83414459|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
83414460|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
83414461|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414462|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414463|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
83414464|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414465|NCT03523975|Rituximab|rituximab|mesh-list
83414466|NCT03523975|Lenalidomide|lenalidomide|mesh-list
83414467|NCT03523975|Venetoclax|venetoclax|mesh-list
83414468|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83414469|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414470|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
83414471|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414472|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83414473|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83414474|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83414475|NCT03523975|Growth Substances|growth substances|mesh-ancestor
83414476|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
83414477|NCT01542645|Fentanyl|fentanyl|mesh-list
83414478|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
83414479|NCT01542645|Methadone|methadone|mesh-list
83414480|NCT01542645|Narcotics|narcotics|mesh-ancestor
83414481|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414482|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414483|NCT01542645|Analgesics|analgesics|mesh-ancestor
83414484|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
83414485|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414486|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83414487|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83414488|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
83414489|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
83414490|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
83414491|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
83414492|NCT04857450|Ketamine|ketamine|mesh-list
83414493|NCT04857450|Etomidate|etomidate|mesh-list
83414495|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
83414496|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414497|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414498|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83414499|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83414500|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
83414501|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
83414502|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414503|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83414504|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83414505|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414506|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414507|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83414508|NCT01420653|Acetaminophen|acetaminophen|mesh-list
83414509|NCT01420653|Ibuprofen|ibuprofen|mesh-list
83414510|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83414511|NCT01420653|Analgesics|analgesics|mesh-ancestor
83414512|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
83414513|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414514|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414516|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83414517|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83414518|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83414519|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83414520|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414521|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414523|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83414524|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414525|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83414526|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83414527|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83414528|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
83414529|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414530|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414531|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83414532|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83414533|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
83414534|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414535|NCT04844957|Vitamin D|vitamin d|mesh-list
83414536|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
83414537|NCT04844957|Cholecalciferol|cholecalciferol|mesh-list
83414538|NCT04844957|Vitamins|vitamins|mesh-list
83414539|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
83414540|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414541|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83414542|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83414543|NCT04782115|RC28-E protein|rc28-e protein|mesh-list
83414544|NCT04782115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83414545|NCT04782115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83414546|NCT04782115|Growth Substances|growth substances|mesh-ancestor
83414547|NCT04782115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414548|NCT04782115|Growth Inhibitors|growth inhibitors|mesh-ancestor
83414549|NCT04782115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414550|NCT01421589|Hormones|hormones|mesh-list
83414551|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83414552|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414553|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
83414554|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83414555|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414556|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
83414557|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
83414558|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83414559|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83414560|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414561|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414562|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414563|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83414564|NCT04390685|Tacrolimus|tacrolimus|mesh-list
83414565|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83414566|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
83414567|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414568|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83414569|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414570|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414571|NCT04848246|Bupropion|bupropion|mesh-list
83414572|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83414573|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
83414574|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83414575|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83414576|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83414577|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83414578|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414579|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
83414580|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414581|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414582|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83414583|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83414584|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414585|NCT04842071|Listerine|listerine|mesh-list
83414586|NCT04842071|Fluorides|fluorides|mesh-list
83414587|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
83414588|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
83414589|NCT04842071|Protective Agents|protective agents|mesh-ancestor
83414590|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414591|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83414592|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414593|NCT04038619|Loperamide|loperamide|mesh-list
83414594|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
83414595|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83414596|NCT04774627|Olaparib|olaparib|mesh-list
83414597|NCT04774627|Niraparib|niraparib|mesh-list
83414598|NCT04774627|Talazoparib|talazoparib|mesh-list
83414599|NCT04774627|Veliparib|veliparib|mesh-list
83414600|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83414601|NCT04774627|Rucaparib|rucaparib|mesh-list
83414602|NCT04774627|Pamiparib|pamiparib|mesh-list
83414603|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414604|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414605|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414606|NCT01545141|Interferons|interferons|mesh-list
83414607|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
83414608|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
83414609|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83414610|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83414611|NCT01545141|Poly I-C|poly i-c|mesh-list
83414612|NCT01545141|Celecoxib|celecoxib|mesh-list
83414613|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414614|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
83414615|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414616|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
83414617|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414618|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83414619|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83414620|NCT01545141|Analgesics|analgesics|mesh-ancestor
83414621|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
83414622|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414623|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83414624|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83414625|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83414626|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83414627|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414628|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414629|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
83414630|NCT02849639|Scopolamine|scopolamine|mesh-list
83414631|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83414632|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83414633|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
83414634|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
83414635|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414636|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414637|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83414638|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
83414639|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83414640|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
83414641|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414642|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414643|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83414644|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
83414645|NCT04855968|Analgesics|analgesics|mesh-list
83414646|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
83414647|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414648|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414649|NCT01545765|Lidocaine|lidocaine|mesh-list
83414650|NCT01545765|Tetracaine|tetracaine|mesh-list
83414651|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
83414652|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
83414653|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414654|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414655|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
83414656|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414657|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83414658|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83414659|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83414660|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83414661|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414662|NCT04856124|Ketamine|ketamine|mesh-list
83414663|NCT04856124|Esketamine|esketamine|mesh-list
83414664|NCT04856124|Analgesics|analgesics|mesh-ancestor
83414665|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
83414666|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414667|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414668|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83414669|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83414670|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
83414672|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414673|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83414674|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83414675|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414676|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414677|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
83414678|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83414679|NCT04028479|Immunomodulating Agents|immunomodulating agents|mesh-list
83414680|NCT04028479|Immunologic Factors|immunologic factors|mesh-ancestor
83414681|NCT04028479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414682|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83414683|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83414684|NCT04847622|Remdesivir|remdesivir|mesh-list
83414685|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
83414686|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414687|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
83414688|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414689|NCT04781803|Cyclosporine|cyclosporine|mesh-list
83414690|NCT04781803|Cyclosporins|cyclosporins|mesh-list
83414691|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414692|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414693|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83414694|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
83414695|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414696|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
83414697|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414698|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
83414699|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83414700|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83414701|NCT01422369|Ritonavir|ritonavir|mesh-list
83414702|NCT01422369|Darunavir|darunavir|mesh-list
83414703|NCT01422369|Pitavastatin|pitavastatin|mesh-list
83414704|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83414705|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83414706|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
83414707|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414708|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414709|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83414710|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83414711|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
83414712|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414713|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83414714|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83414715|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83414716|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83414717|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83414718|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
83414719|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83414720|NCT05023343|Ropivacaine|ropivacaine|mesh-list
83414721|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
83414722|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
83414723|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414724|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414725|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
83414726|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414727|NCT04859556|Dipivefrin|dipivefrin|mesh-list
83414728|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83414729|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
83414730|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414731|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414732|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414733|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83414734|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83414735|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414736|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83414737|NCT04773301|Ropivacaine|ropivacaine|mesh-list
83414738|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
83414739|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
83414740|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
83414741|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414742|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414744|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414745|NCT04780945|Olaparib|olaparib|mesh-list
83414746|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83414747|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414748|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414749|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414750|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
83414751|NCT05021315|Povidone|povidone|mesh-list
83414752|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
83414753|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
83414754|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83414755|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414756|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
83414757|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83414758|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
83414759|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414760|NCT01427517|Expectorants|expectorants|mesh-ancestor
83414761|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
83414762|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83414763|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
83414764|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414765|NCT01427517|Protective Agents|protective agents|mesh-ancestor
83414766|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414767|NCT01427517|Antidotes|antidotes|mesh-ancestor
83414768|NCT02835131|Pasireotide|pasireotide|mesh-list
83414769|NCT02835131|Hormones|hormones|mesh-ancestor
83414770|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83414771|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414772|NCT00840853|Acetaminophen|acetaminophen|mesh-list
83414773|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
83414774|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83414775|NCT00840853|Analgesics|analgesics|mesh-ancestor
83414776|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
83414777|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414778|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414779|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
83414780|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83414781|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83414782|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414783|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
83414784|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
83414785|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
83414786|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
83414787|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83414788|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83414789|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
83414790|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
83414791|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414792|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414793|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83414794|NCT04846452|Paclitaxel|paclitaxel|mesh-list
83414795|NCT04846452|Carboplatin|carboplatin|mesh-list
83414796|NCT04846452|Pemetrexed|pemetrexed|mesh-list
83414797|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83414798|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414799|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
83414800|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
83414801|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
83414802|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414803|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414804|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83414805|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83414806|NCT04859244|Remdesivir|remdesivir|mesh-list
83414807|NCT04859244|GS-441524|gs-441524|mesh-list
83414808|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
83414809|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414810|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
83414811|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414812|NCT05028725|Lugol's solution|lugol's solution|mesh-list
83414813|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
83414814|NCT05028725|Coagulants|coagulants|mesh-ancestor
83414815|NCT04779853|Antibodies|antibodies|mesh-list
83414816|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
83414817|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414818|NCT04855110|Warfarin|warfarin|mesh-list
83414819|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
83414823|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414824|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414825|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83414826|NCT01485393|Analgesics|analgesics|mesh-ancestor
83414827|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
83414828|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414829|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83414830|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83414831|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83414832|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
83414833|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414834|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414835|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83414836|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83414837|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
83414838|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
83414839|NCT04772521|Nicotine|nicotine|mesh-list
83414840|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83414841|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
83414842|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414843|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414844|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83414845|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83414846|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
83414847|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414848|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414849|NCT04772287|Paclitaxel|paclitaxel|mesh-list
83414850|NCT04772287|Vinorelbine|vinorelbine|mesh-list
83414851|NCT04772287|Docetaxel|docetaxel|mesh-list
83414852|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83414853|NCT04772287|Cisplatin|cisplatin|mesh-list
83414854|NCT04772287|Carboplatin|carboplatin|mesh-list
83414855|NCT04772287|Gemcitabine|gemcitabine|mesh-list
83414856|NCT04772287|Pemetrexed|pemetrexed|mesh-list
83414857|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83414858|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414859|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
83414860|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
83414861|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
83414862|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414863|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83414864|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
83414865|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414866|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83414867|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83414868|NCT01890005|Aspirin|aspirin|mesh-list
83414869|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83414870|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83414871|NCT01890005|Analgesics|analgesics|mesh-ancestor
83414872|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
83414873|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414874|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414875|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83414876|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83414877|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83414878|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83414879|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414880|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83414881|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83414882|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414883|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
83414884|NCT02822573|Donepezil|donepezil|mesh-list
83414885|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83414886|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414887|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414888|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
83414889|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414890|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414891|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
83414892|NCT04854252|Fentanyl|fentanyl|mesh-list
83414893|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83414894|NCT04854252|Narcotics|narcotics|mesh-ancestor
83414895|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83414896|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414899|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414900|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83414901|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83414902|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
83414903|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
83414904|NCT03040830|Progesterone|progesterone|mesh-list
83414905|NCT03040830|Progestins|progestins|mesh-ancestor
83414906|NCT03040830|Hormones|hormones|mesh-ancestor
83414907|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83414908|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414909|NCT04390295|Metformin|metformin|mesh-list
83414910|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83414911|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414912|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
83414913|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83414914|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414915|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83414916|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414917|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
83414918|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83414919|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83414920|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414921|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
83414922|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
83414923|NCT01890629|Metformin|metformin|mesh-list
83414924|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83414925|NCT01890629|Glimepiride|glimepiride|mesh-list
83414926|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83414927|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414928|NCT01890629|Incretins|incretins|mesh-ancestor
83414929|NCT01890629|Hormones|hormones|mesh-ancestor
83414930|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83414931|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83414932|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
83414933|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414934|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414935|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83414936|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83414937|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
83414938|NCT01890863|Fluticasone|fluticasone|mesh-list
83414939|NCT01890863|Xhance|xhance|mesh-list
83414940|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83414941|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83414942|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83414943|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83414944|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
83414945|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414946|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414947|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83414948|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
83414949|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
83414950|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83414951|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83414952|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83414953|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83414954|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
83414955|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83414956|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414957|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
83414958|NCT01890863|Hormones|hormones|mesh-ancestor
83414959|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83414960|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
83414961|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
83414962|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
83414963|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
83414964|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
83414965|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83414966|NCT02950051|Rituximab|rituximab|mesh-list
83414967|NCT02950051|Fludarabine|fludarabine|mesh-list
83414968|NCT02950051|Venetoclax|venetoclax|mesh-list
83414969|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
83414970|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83414971|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
83414972|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414973|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83414974|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83414975|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
83414976|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414977|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414978|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83414979|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83414980|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83414981|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83414982|NCT01891019|Thalidomide|thalidomide|mesh-list
83414983|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83414984|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
83414985|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83414986|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
83414987|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83414988|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83414989|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83414990|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83414991|NCT01891019|Growth Substances|growth substances|mesh-ancestor
83414992|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
83414993|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83414994|NCT04374474|Budesonide|budesonide|mesh-list
83414995|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83414996|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83414997|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
83414998|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83414999|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415000|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83415001|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
83415002|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
83415003|NCT04374474|Hormones|hormones|mesh-ancestor
83415004|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415005|NCT02983097|Cytarabine|cytarabine|mesh-list
83415006|NCT02983097|Dexamethasone|dexamethasone|mesh-list
83415007|NCT02983097|Rituximab|rituximab|mesh-list
83415008|NCT02983097|Carboplatin|carboplatin|mesh-list
83415009|NCT02983097|Lenalidomide|lenalidomide|mesh-list
83415010|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83415011|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415012|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
83415013|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415014|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83415015|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83415016|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
83415017|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
83415018|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415019|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83415020|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
83415021|NCT02983097|Hormones|hormones|mesh-ancestor
83415022|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415023|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83415024|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83415025|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
83415026|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415027|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
83415028|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415029|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83415030|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83415031|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83415032|NCT02983097|Growth Substances|growth substances|mesh-ancestor
83415033|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
83415034|NCT01891175|Anesthetics|anesthetics|mesh-list
83415035|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415036|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415037|NCT02347865|Denosumab|denosumab|mesh-list
83415038|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83415039|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415040|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
83415041|NCT01550367|Aldesleukin|aldesleukin|mesh-list
83415042|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
83415043|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83415044|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83415045|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415046|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415047|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415048|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83415275|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415049|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415050|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83415051|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83415052|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
83415054|NCT01427595|Progesterone|progesterone|mesh-list
83415055|NCT01427595|Estradiol|estradiol|mesh-list
83415056|NCT01427595|Estrogens|estrogens|mesh-list
83415057|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83415058|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415059|NCT01427595|Progestins|progestins|mesh-ancestor
83415060|NCT01427595|Hormones|hormones|mesh-ancestor
83415061|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415062|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
83415063|NCT04390061|Tofacitinib|tofacitinib|mesh-list
83415064|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
83415065|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83415066|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83415067|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415068|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415069|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415070|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83415071|NCT04390061|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83415072|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83415073|NCT01892813|Bupropion|bupropion|mesh-list
83415074|NCT01892813|Nicotine|nicotine|mesh-list
83415075|NCT01892813|Varenicline|varenicline|mesh-list
83415076|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83415077|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
83415078|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415079|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415080|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83415081|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83415082|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
83415083|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415084|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415085|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83415086|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
83415087|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83415088|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83415089|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83415090|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83415091|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
83415092|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83415093|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83415094|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415095|NCT00716443|Lidocaine|lidocaine|mesh-list
83415096|NCT00716443|Tetracaine|tetracaine|mesh-list
83415097|NCT00716443|Benzocaine|benzocaine|mesh-list
83415098|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
83415099|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
83415100|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415101|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415102|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
83415103|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415104|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83415105|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83415106|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83415107|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83415108|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415109|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83415110|NCT00650143|Lenograstim|lenograstim|mesh-list
83415111|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83415112|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415113|NCT00650143|Incretins|incretins|mesh-ancestor
83415114|NCT00650143|Hormones|hormones|mesh-ancestor
83415115|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415116|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83415117|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
83415118|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415119|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415120|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83415121|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
83415122|NCT04770961|Ropivacaine|ropivacaine|mesh-list
83415123|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
83415124|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
83415125|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415126|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415127|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
83415128|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415129|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
83415130|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83415131|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
83415132|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83415133|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
83415134|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415135|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415136|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
83415137|NCT04769557|Acetaminophen|acetaminophen|mesh-list
83415138|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83415139|NCT04769557|Analgesics|analgesics|mesh-ancestor
83415140|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
83415141|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415142|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415143|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
83415144|NCT05606497|Dexamethasone|dexamethasone|mesh-list
83415145|NCT05606497|Betamethasone|betamethasone|mesh-list
83415146|NCT05606497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83415147|NCT05606497|Antiemetics|antiemetics|mesh-ancestor
83415148|NCT05606497|Autonomic Agents|autonomic agents|mesh-ancestor
83415149|NCT05606497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415150|NCT05606497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415151|NCT05606497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83415152|NCT05606497|Glucocorticoids|glucocorticoids|mesh-ancestor
83415153|NCT05606497|Hormones|hormones|mesh-ancestor
83415154|NCT05606497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415155|NCT05606497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83415156|NCT05606497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415157|NCT05606497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83415158|NCT05606497|Respiratory System Agents|respiratory system agents|mesh-ancestor
83415159|NCT04778917|Heparin|heparin|mesh-list
83415160|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83415161|NCT04778917|Tinzaparin|tinzaparin|mesh-list
83415162|NCT04778917|Dalteparin|dalteparin|mesh-list
83415163|NCT04778917|Calcium heparin|calcium heparin|mesh-list
83415164|NCT04778917|Calcium|calcium|mesh-list
83415165|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83415166|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415167|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
83415168|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83415169|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83415170|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415171|NCT02213289|Nivolumab|nivolumab|mesh-list
83415172|NCT02213289|Trastuzumab|trastuzumab|mesh-list
83415173|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
83415174|NCT02213289|Ramucirumab|ramucirumab|mesh-list
83415175|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83415176|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415177|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83415178|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415179|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
83415180|NCT02779751|Anastrozole|anastrozole|mesh-list
83415181|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83415182|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415183|NCT02779751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83415184|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415185|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83415186|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83415187|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83415188|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415189|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83415190|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
83415191|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415192|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415193|NCT05606107|Tofacitinib|tofacitinib|mesh-list
83415194|NCT05606107|Glucocorticoids|glucocorticoids|mesh-list
83415195|NCT05606107|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83415196|NCT05606107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83415197|NCT05606107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415198|NCT05606107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415199|NCT05606107|Hormones|hormones|mesh-ancestor
83415731|NCT02298257|Vinblastine|vinblastine|mesh-list
83415200|NCT05606107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415201|NCT05606107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415202|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
83415203|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
83415204|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
83415205|NCT00053989|Fludarabine|fludarabine|mesh-list
83415206|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
83415207|NCT00053989|Tacrolimus|tacrolimus|mesh-list
83415208|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83415209|NCT00053989|Sargramostim|sargramostim|mesh-list
83415210|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83415211|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
83415212|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415213|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83415214|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83415215|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
83415216|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415217|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415218|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83415219|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83415220|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
83415221|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83415222|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415223|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83415224|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83415225|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
83415226|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83415227|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415228|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83415229|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
83415230|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
83415231|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415232|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83415233|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
83415234|NCT00053989|Hormones|hormones|mesh-ancestor
83415235|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415236|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83415237|NCT00053989|Protective Agents|protective agents|mesh-ancestor
83415238|NCT02752685|Paclitaxel|paclitaxel|mesh-list
83415239|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
83415240|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83415241|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415242|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
83415243|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
83415244|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
83415245|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415246|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83415247|NCT02752685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83415248|NCT02740595|Nicotine|nicotine|mesh-list
83415249|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83415250|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
83415251|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415252|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415253|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83415254|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83415255|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
83415256|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415257|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415258|NCT02713997|Etanercept|etanercept|mesh-list
83415259|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83415260|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
83415261|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83415262|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83415263|NCT02713997|Analgesics|analgesics|mesh-ancestor
83415264|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
83415265|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415266|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415267|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83415268|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83415269|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83415270|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83415271|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
83415272|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83415273|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83415274|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
83415276|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415277|NCT02697227|Nicotine|nicotine|mesh-list
83415278|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83415279|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
83415280|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415281|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415282|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83415283|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83415284|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
83415285|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415286|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415287|NCT02214615|Carbamazepine|carbamazepine|mesh-list
83415288|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
83415289|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
83415290|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83415291|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415292|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415293|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83415294|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83415295|NCT02214615|Analgesics|analgesics|mesh-ancestor
83415296|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
83415297|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415298|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83415299|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83415300|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415301|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83415302|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83415303|NCT02661503|Dexamethasone|dexamethasone|mesh-list
83415304|NCT02661503|Prednisone|prednisone|mesh-list
83415305|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
83415306|NCT02661503|Dacarbazine|dacarbazine|mesh-list
83415307|NCT02661503|Doxorubicin|doxorubicin|mesh-list
83415308|NCT02661503|Etoposide|etoposide|mesh-list
83415309|NCT02661503|Vincristine|vincristine|mesh-list
83415310|NCT02661503|Bleomycin|bleomycin|mesh-list
83415311|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83415312|NCT02661503|Procarbazine|procarbazine|mesh-list
83415313|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83415314|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
83415315|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415316|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83415317|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83415318|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
83415319|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415320|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415321|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83415322|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83415323|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
83415324|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
83415325|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415326|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83415327|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
83415328|NCT02661503|Hormones|hormones|mesh-ancestor
83415329|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415330|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83415331|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83415332|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83415333|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83415334|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415335|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83415336|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
83415337|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
83415338|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
83415339|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83415340|NCT02661503|Immunotoxins|immunotoxins|mesh-ancestor
83415341|NCT02661503|Immunoconjugates|immunoconjugates|mesh-ancestor
83415342|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83415343|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83415344|NCT02647385|Lidocaine|lidocaine|mesh-list
83415345|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
83415346|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
83415347|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415348|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415349|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
83415350|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415351|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83415352|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83415353|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83415354|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83415355|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415356|NCT03040752|Nifedipine|nifedipine|mesh-list
83415357|NCT03040752|Ritodrine|ritodrine|mesh-list
83415358|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83415359|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83415360|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415361|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83415362|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415363|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
83415364|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
83415365|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83415366|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
83415367|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
83415368|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415369|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83415370|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83415371|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83415372|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
83415373|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415374|NCT01668654|Ezogabine|ezogabine|mesh-list
83415375|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
83415376|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83415377|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415378|NCT01431105|Atorvastatin|atorvastatin|mesh-list
83415379|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83415380|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83415381|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
83415382|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415383|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83415384|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83415385|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415386|NCT03038958|Prilocaine|prilocaine|mesh-list
83415387|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
83415388|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
83415389|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
83415390|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415391|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415392|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
83415393|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415394|NCT04840290|Paclitaxel|paclitaxel|mesh-list
83415395|NCT04840290|Carboplatin|carboplatin|mesh-list
83415396|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83415397|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415398|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
83415399|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
83415400|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
83415401|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415402|NCT02630069|Choline|choline|mesh-list
83415403|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83415404|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
83415405|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83415406|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
83415407|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415408|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83415409|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83415410|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
83415411|NCT01431339|Vancomycin|vancomycin|mesh-list
83415412|NCT01431339|Linezolid|linezolid|mesh-list
83415413|NCT01431339|Dalbavancin|dalbavancin|mesh-list
83415414|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83415415|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415416|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83415417|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415418|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415419|NCT02596685|Nicotine|nicotine|mesh-list
83415420|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83415421|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
83415422|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415423|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415424|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83415425|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83415426|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
83415427|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415428|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415429|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
83415430|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
83415431|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83415432|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415433|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415434|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
83415435|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83415436|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415437|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415438|NCT04843644|Propolis|propolis|mesh-list
83415439|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415440|NCT02588105|Leucovorin|leucovorin|mesh-list
83415441|NCT02588105|Folic Acid|folic acid|mesh-list
83415442|NCT02588105|Fluorouracil|fluorouracil|mesh-list
83415443|NCT02588105|Irinotecan|irinotecan|mesh-list
83415444|NCT02588105|Olaparib|olaparib|mesh-list
83415445|NCT02588105|AZD0156|azd0156|mesh-list
83415446|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
83415447|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
83415448|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415449|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83415450|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415451|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83415452|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
83415453|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415454|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83415455|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83415456|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415457|NCT02588105|Antidotes|antidotes|mesh-ancestor
83415458|NCT02588105|Protective Agents|protective agents|mesh-ancestor
83415459|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
83415460|NCT02588105|Vitamins|vitamins|mesh-ancestor
83415461|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
83415462|NCT02588105|Hematinics|hematinics|mesh-ancestor
83415463|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83415464|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83415465|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83415466|NCT01488279|Dexamethasone|dexamethasone|mesh-list
83415467|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
83415468|NCT01488279|BB 1101|bb 1101|mesh-list
83415469|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83415470|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
83415471|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
83415472|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415473|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415474|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83415475|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
83415476|NCT01488279|Hormones|hormones|mesh-ancestor
83415477|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415478|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83415479|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415480|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
83415481|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415482|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415483|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83415485|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83415486|NCT02586623|Droxidopa|droxidopa|mesh-list
83415487|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83415488|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83415489|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
83415490|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
83415491|NCT03008109|Endostatins|endostatins|mesh-list
83415492|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415493|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83415494|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83415495|NCT03008109|Growth Substances|growth substances|mesh-ancestor
83415496|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415497|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
83415498|NCT02562443|ON 01910|on 01910|mesh-list
83415499|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415500|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83415501|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415502|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415503|NCT04843098|Paclitaxel|paclitaxel|mesh-list
83415504|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83415732|NCT02298257|Antibodies|antibodies|mesh-list
83415505|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415506|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
83415507|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
83415508|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
83415509|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415510|NCT01490931|Ketorolac|ketorolac|mesh-list
83415511|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83415512|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83415513|NCT01490931|Analgesics|analgesics|mesh-ancestor
83415514|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
83415515|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415516|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415517|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83415518|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83415519|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83415520|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415521|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415522|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
83415523|NCT02562365|Carboplatin|carboplatin|mesh-list
83415524|NCT02562365|Etoposide|etoposide|mesh-list
83415525|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83415526|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
83415527|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415528|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83415529|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83415530|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
83415531|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415532|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415533|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83415534|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83415535|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83415536|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83415537|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415538|NCT01491633|Dasatinib|dasatinib|mesh-list
83415539|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415540|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83415541|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415542|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415543|NCT01433913|Metformin|metformin|mesh-list
83415544|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83415545|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415546|NCT02535533|Selenium|selenium|mesh-list
83415547|NCT02535533|Axitinib|axitinib|mesh-list
83415548|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415549|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83415550|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415551|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415552|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
83415553|NCT02535533|Protective Agents|protective agents|mesh-ancestor
83415554|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415555|NCT02535533|Trace Elements|trace elements|mesh-ancestor
83415556|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
83415557|NCT04839198|Nicotine|nicotine|mesh-list
83415558|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83415559|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
83415560|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415561|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415562|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83415563|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83415564|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
83415565|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415566|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415567|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
83415568|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83415569|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83415570|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83415571|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415572|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
83415573|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415574|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415575|NCT02508467|Fisogatinib|fisogatinib|mesh-list
83415576|NCT02508467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415577|NCT05586347|Nicardipine|nicardipine|mesh-list
83415578|NCT05586347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83415579|NCT05586347|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83415580|NCT05586347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83415581|NCT05586347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415582|NCT05586347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83415583|NCT05586347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415584|NCT05586347|Vasodilator Agents|vasodilator agents|mesh-ancestor
83415585|NCT01436799|Alfentanil|alfentanil|mesh-list
83415586|NCT01436799|Propofol|propofol|mesh-list
83415587|NCT01436799|Desflurane|desflurane|mesh-list
83415588|NCT01436799|Rocuronium|rocuronium|mesh-list
83415589|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83415590|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415591|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415592|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83415593|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
83415594|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
83415595|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83415596|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83415597|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83415598|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415599|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83415600|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83415601|NCT01436799|Narcotics|narcotics|mesh-ancestor
83415602|NCT01436799|Analgesics|analgesics|mesh-ancestor
83415603|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
83415604|NCT04851132|Durvalumab|durvalumab|mesh-list
83415605|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83415606|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415607|NCT02504489|Docetaxel|docetaxel|mesh-list
83415608|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415609|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
83415610|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
83415611|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
83415612|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415613|NCT02479451|Theophylline|theophylline|mesh-list
83415614|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83415615|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
83415616|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415617|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415618|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83415619|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
83415620|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83415621|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415622|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415623|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
83415624|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83415625|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83415626|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
83415627|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415628|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83415629|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415630|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83415631|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415632|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415633|NCT02415413|Dexamethasone|dexamethasone|mesh-list
83415634|NCT02415413|Lenalidomide|lenalidomide|mesh-list
83415635|NCT02415413|Melphalan|melphalan|mesh-list
83415636|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83415637|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
83415638|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
83415639|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415640|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415641|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83415642|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
83415643|NCT02415413|Hormones|hormones|mesh-ancestor
83415644|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415645|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83415646|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415647|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
83415648|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83415649|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83415650|NCT02415413|Growth Substances|growth substances|mesh-ancestor
83415651|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
83415652|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83415653|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
83415654|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415655|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83415656|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83415657|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83415659|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83415660|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415661|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
83415662|NCT02379377|Protective Agents|protective agents|mesh-ancestor
83415663|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415664|NCT01894061|Bevacizumab|bevacizumab|mesh-list
83415665|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83415666|NCT01894061|Antibodies|antibodies|mesh-list
83415667|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
83415668|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83415669|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415670|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83415671|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83415672|NCT01894061|Growth Substances|growth substances|mesh-ancestor
83415673|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415674|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
83415675|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
83415676|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
83415677|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83415678|NCT01561053|Antibodies|antibodies|mesh-list
83415679|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
83415680|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415681|NCT01561833|Sorafenib|sorafenib|mesh-list
83415682|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415683|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83415684|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415685|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415686|NCT02607306|Insulin|insulin|mesh-list
83415687|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83415688|NCT02607306|Liraglutide|liraglutide|mesh-list
83415689|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
83415690|NCT02607306|Xultophy|xultophy|mesh-list
83415691|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83415692|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415693|NCT02607306|Incretins|incretins|mesh-ancestor
83415694|NCT02607306|Hormones|hormones|mesh-ancestor
83415695|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415696|NCT03040128|Minocycline|minocycline|mesh-list
83415697|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83415698|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415699|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
83415700|NCT04850040|Apatinib|apatinib|mesh-list
83415701|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415702|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83415703|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415704|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415705|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
83415706|NCT03038334|Analgesics|analgesics|mesh-ancestor
83415707|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
83415708|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415709|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415710|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
83415711|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415712|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83415713|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
83415714|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83415715|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83415716|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415717|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83415718|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
83415719|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83415720|NCT01441245|Furosemide|furosemide|mesh-list
83415721|NCT01441245|Diuretics|diuretics|mesh-ancestor
83415722|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
83415723|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415724|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83415725|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83415726|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415727|NCT02298257|Doxorubicin|doxorubicin|mesh-list
83415728|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83415729|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83415730|NCT02298257|Dacarbazine|dacarbazine|mesh-list
83415737|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415738|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83415739|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415740|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83415741|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83415742|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415743|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415744|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83415745|NCT02298257|Immunotoxins|immunotoxins|mesh-ancestor
83415746|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83415747|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
83415748|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83415749|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
83415750|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
83415751|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
83415752|NCT01563081|Cetirizine|cetirizine|mesh-list
83415753|NCT01563081|Levocetirizine|levocetirizine|mesh-list
83415754|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83415755|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83415756|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
83415757|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
83415758|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415759|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415760|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415761|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83415762|NCT02278601|Fentanyl|fentanyl|mesh-list
83415763|NCT02278601|Ropivacaine|ropivacaine|mesh-list
83415764|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
83415765|NCT02278601|Anesthetics|anesthetics|mesh-list
83415766|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415767|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415768|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
83415769|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415770|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83415771|NCT02278601|Narcotics|narcotics|mesh-ancestor
83415772|NCT02278601|Analgesics|analgesics|mesh-ancestor
83415773|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83415774|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83415775|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
83415776|NCT04833738|Triamcinolone|triamcinolone|mesh-list
83415777|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83415778|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83415779|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
83415780|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83415781|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83415782|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
83415783|NCT04833738|Hormones|hormones|mesh-ancestor
83415784|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415785|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415786|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83415787|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
83415788|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415789|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415790|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83415791|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
83415792|NCT04833738|Protective Agents|protective agents|mesh-ancestor
83415793|NCT01441401|Gabapentin|gabapentin|mesh-list
83415794|NCT01441401|Analgesics|analgesics|mesh-ancestor
83415795|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
83415796|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415797|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415798|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
83415799|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83415800|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83415801|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415802|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83415803|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83415804|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83415805|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415806|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415807|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
83415808|NCT02268695|Docetaxel|docetaxel|mesh-list
83415809|NCT02268695|Cetuximab|cetuximab|mesh-list
83415810|NCT02268695|Lenograstim|lenograstim|mesh-list
83415811|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415812|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
83415815|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415816|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83415817|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83415818|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
83415819|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415821|NCT01495923|Analgesics|analgesics|mesh-ancestor
83415822|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
83415823|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415824|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415825|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
83415826|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83415827|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83415828|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415829|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83415830|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83415831|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83415832|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415833|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415834|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
83415835|NCT03037944|Drospirenone|drospirenone|mesh-list
83415836|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
83415837|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83415838|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83415839|NCT03037944|Estradiol|estradiol|mesh-list
83415840|NCT03037944|Estrogens|estrogens|mesh-ancestor
83415841|NCT03037944|Hormones|hormones|mesh-ancestor
83415842|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415843|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415844|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83415845|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
83415846|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83415847|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83415848|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83415849|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83415850|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83415851|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83415852|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
83415853|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83415854|NCT03037944|Diuretics|diuretics|mesh-ancestor
83415855|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
83415856|NCT03060473|Amoxicillin|amoxicillin|mesh-list
83415858|NCT03060473|Erythromycin|erythromycin|mesh-list
83415859|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
83415860|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83415861|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
83415862|NCT03060473|Ampicillin|ampicillin|mesh-list
83415863|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83415864|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415865|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83415866|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83415867|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415868|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415869|NCT03039426|Diclofenac|diclofenac|mesh-list
83415870|NCT03039426|Bupivacaine|bupivacaine|mesh-list
83415871|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
83415872|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
83415873|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83415874|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415875|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
83415876|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415877|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83415878|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83415879|NCT03039426|Analgesics|analgesics|mesh-ancestor
83415880|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83415881|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83415882|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83415883|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415884|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415885|NCT02205515|Everolimus|everolimus|mesh-list
83415886|NCT02205515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83415887|NCT02205515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83415888|NCT02205515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415889|NCT02205515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415890|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83415891|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
83415892|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415893|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415894|NCT04833036|Irinotecan|irinotecan|mesh-list
83415895|NCT04833036|Cetuximab|cetuximab|mesh-list
83415896|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83415897|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83415898|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415899|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415900|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415901|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83415902|NCT04832880|Remdesivir|remdesivir|mesh-list
83415903|NCT04832880|Dexamethasone|dexamethasone|mesh-list
83415904|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83415905|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
83415906|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
83415907|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415908|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415909|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83415910|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
83415911|NCT04832880|Hormones|hormones|mesh-ancestor
83415912|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415913|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83415914|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415915|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
83415916|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415917|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
83415918|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415919|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
83415920|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83415921|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415922|NCT01894295|Vitamin D|vitamin d|mesh-list
83415923|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83415924|NCT01894295|Vitamins|vitamins|mesh-ancestor
83415925|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
83415926|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415927|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83415928|NCT02169089|Spironolactone|spironolactone|mesh-list
83415929|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83415930|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
83415931|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83415932|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415933|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83415935|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
83415936|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83415937|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83415938|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
83415939|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83415940|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415941|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415942|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
83415943|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
83415944|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83415945|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415946|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83415947|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83415948|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83415949|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415950|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415951|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
83415952|NCT04824924|Venetoclax|venetoclax|mesh-list
83415953|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415954|NCT04553705|Quinine|quinine|mesh-list
83415955|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
83415956|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83415957|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83415958|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83415959|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83415960|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415961|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83415962|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415963|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83415964|NCT04553705|Analgesics|analgesics|mesh-ancestor
83415965|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
83415968|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83415969|NCT02140151|Growth Substances|growth substances|mesh-ancestor
83415970|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415971|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
83415972|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415973|NCT02135315|Isosorbide|isosorbide|mesh-list
83415974|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83415975|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83415976|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83415977|NCT02135315|Diuretics|diuretics|mesh-ancestor
83415978|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
83415979|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415980|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
83415981|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83415982|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415983|NCT01894373|Immunomodulating Agents|immunomodulating agents|mesh-list
83415984|NCT01894373|Immunologic Factors|immunologic factors|mesh-ancestor
83415985|NCT01894373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415986|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
83415987|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83415988|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83415989|NCT02117297|Immunotoxins|immunotoxins|mesh-ancestor
83415990|NCT02117297|Immunoconjugates|immunoconjugates|mesh-ancestor
83415991|NCT02117297|Immunologic Factors|immunologic factors|mesh-ancestor
83415992|NCT02117297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415993|NCT04837170|Ketamine|ketamine|mesh-list
83415994|NCT04837170|Esketamine|esketamine|mesh-list
83415995|NCT04837170|Analgesics|analgesics|mesh-ancestor
83415996|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
83415997|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83415998|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83415999|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83416000|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83416001|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
83416002|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
83416003|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416004|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83416005|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83416006|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416007|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416008|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
83416009|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83416010|NCT04824612|Triamcinolone|triamcinolone|mesh-list
83416011|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83416012|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83416013|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83416014|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83416015|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
83416016|NCT04824612|Hormones|hormones|mesh-ancestor
83416017|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83416018|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416019|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83416020|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
83416021|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416022|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416023|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83416024|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
83416025|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83416026|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
83416027|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83416028|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416029|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83416030|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83416031|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416032|NCT02101775|Gemcitabine|gemcitabine|mesh-list
83416033|NCT02101775|Adavosertib|adavosertib|mesh-list
83416034|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83416035|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
83416036|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416037|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416038|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416039|NCT02099591|Naloxegol|naloxegol|mesh-list
83416040|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83416041|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416042|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
83416043|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416044|NCT01568073|Levodopa|levodopa|mesh-list
83416045|NCT01568073|Carbidopa|carbidopa|mesh-list
83416046|NCT01568073|Opicapone|opicapone|mesh-list
83416047|NCT01568073|Entacapone|entacapone|mesh-list
83416048|NCT01568073|Benserazide|benserazide|mesh-list
83416049|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83416050|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83416051|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
83416052|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416053|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416054|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416055|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83416056|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416057|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83416058|NCT04274933|Capecitabine|capecitabine|mesh-list
83416059|NCT04274933|Venetoclax|venetoclax|mesh-list
83416060|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83416061|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
83416062|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416063|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416064|NCT02603952|Oseltamivir|oseltamivir|mesh-list
83416065|NCT02603952|MEDI8852|medi8852|mesh-list
83416066|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
83416067|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416068|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416069|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416070|NCT02062463|Budesonide|budesonide|mesh-list
83416071|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
83416072|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83416073|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83416074|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83416075|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
83416076|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416077|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416078|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83416079|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
83416080|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
83416081|NCT02062463|Hormones|hormones|mesh-ancestor
83416082|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83416083|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83416084|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83416085|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83416086|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
83416087|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416088|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416090|NCT01501929|Nebivolol|nebivolol|mesh-list
83416091|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83416092|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83416093|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
83416094|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
83416095|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416096|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416097|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83416098|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83416099|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83416100|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
83416101|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416102|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416103|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
83416104|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83416105|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83416106|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83416107|NCT05618496|Hyaluronic Acid|hyaluronic acid|mesh-list
83416108|NCT05618496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83416109|NCT05618496|Immunologic Factors|immunologic factors|mesh-ancestor
83416110|NCT05618496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416111|NCT05618496|Viscosupplements|viscosupplements|mesh-ancestor
83416112|NCT05618496|Protective Agents|protective agents|mesh-ancestor
83416113|NCT02049593|Irinotecan|irinotecan|mesh-list
83416114|NCT02049593|Temozolomide|temozolomide|mesh-list
83416115|NCT02049593|Talazoparib|talazoparib|mesh-list
83416116|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83416117|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83416118|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83416119|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416120|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416121|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416122|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83416123|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
83416124|NCT02049047|Everolimus|everolimus|mesh-list
83416125|NCT02049047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83416126|NCT02049047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83416127|NCT02049047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416128|NCT02049047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416129|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83416130|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
83416131|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416132|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416133|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83416134|NCT04778358|Hormones|hormones|mesh-ancestor
83416135|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83416136|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416137|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83416138|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83416139|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416140|NCT01449747|Incretins|incretins|mesh-ancestor
83416141|NCT01449747|Hormones|hormones|mesh-ancestor
83416142|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83416143|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83416144|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
83416145|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416146|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416147|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
83416148|NCT03035838|Aprepitant|aprepitant|mesh-list
83416149|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
83416150|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
83416151|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416152|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416153|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83416154|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83416155|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416156|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416157|NCT01569087|Lenograstim|lenograstim|mesh-list
83416158|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83416159|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
83416160|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416161|NCT02024087|Sorafenib|sorafenib|mesh-list
83416162|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416163|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83416164|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416165|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416166|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
83416167|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
83416168|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416169|NCT01895621|Protective Agents|protective agents|mesh-ancestor
83416170|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416171|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
83416172|NCT01895621|Vitamins|vitamins|mesh-ancestor
83416173|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
83416174|NCT01517711|Tramadol|tramadol|mesh-list
83416175|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83416176|NCT01517711|Narcotics|narcotics|mesh-ancestor
83416177|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416178|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416179|NCT01517711|Analgesics|analgesics|mesh-ancestor
83416180|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
83416181|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416182|NCT04836078|Chitosan|chitosan|mesh-list
83416183|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83416184|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83416185|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
83416186|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416187|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83416188|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
83416189|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
83416190|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
83416191|NCT04836078|Coagulants|coagulants|mesh-ancestor
83416196|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416197|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83416198|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83416199|NCT01517243|Growth Substances|growth substances|mesh-ancestor
83416200|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416201|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
83416202|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83416203|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416204|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416205|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83416206|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
83416207|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83416208|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416209|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83416210|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
83416211|NCT00055237|Bevacizumab|bevacizumab|mesh-list
83416212|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83416213|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416214|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83416215|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83416216|NCT00055237|Growth Substances|growth substances|mesh-ancestor
83416217|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416218|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
83416219|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
83416220|NCT04836156|Carboplatin|carboplatin|mesh-list
83416221|NCT04836156|Docetaxel|docetaxel|mesh-list
83416222|NCT04836156|Epirubicin|epirubicin|mesh-list
83416223|NCT04836156|Phenobarbital|phenobarbital|mesh-list
83416224|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83416225|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
83416226|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416227|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83416228|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83416229|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
83416230|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416231|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416232|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83416233|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
83416234|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
83416235|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
83416236|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83416237|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83416238|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83416239|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416240|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
83416241|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83416242|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416243|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83416244|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83416245|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416246|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
83416247|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
83416248|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83416249|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83416250|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83416251|NCT01502787|Metoprolol|metoprolol|mesh-list
83416252|NCT01502787|Nebivolol|nebivolol|mesh-list
83416253|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
83416254|NCT01502787|Giapreza|giapreza|mesh-list
83416255|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
83416256|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83416257|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83416258|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
83416259|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
83416260|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416261|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416262|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83416263|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83416264|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83416265|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
83416266|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416267|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416268|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
83416269|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83416270|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83416272|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83416273|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83416274|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
83416275|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416276|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83416278|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416279|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416280|NCT00153985|Fludarabine|fludarabine|mesh-list
83416281|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
83416282|NCT00153985|Busulfan|busulfan|mesh-list
83416283|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416284|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416285|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83416286|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
83416287|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416288|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83416289|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
83416290|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83416291|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83416292|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
83416293|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83416294|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83416295|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
83416296|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83416297|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83416298|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83416299|NCT02318303|Analgesics|analgesics|mesh-ancestor
83416300|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
83416301|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416302|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416303|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83416304|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83416305|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83416306|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
83416308|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416309|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416310|NCT01451775|Empagliflozin|empagliflozin|mesh-list
83416311|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83416312|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416313|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83416314|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416315|NCT04304040|Antibodies|antibodies|mesh-list
83416316|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83416317|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
83416318|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416319|NCT00156013|Clofarabine|clofarabine|mesh-list
83416320|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83416321|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
83416322|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416323|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416324|NCT01358669|Denosumab|denosumab|mesh-list
83416325|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83416326|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416327|NCT00156247|Acitretin|acitretin|mesh-list
83416328|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
83416329|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
83416330|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83416331|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
83416332|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83416333|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83416334|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83416335|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416336|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416337|NCT01573533|Rituximab|rituximab|mesh-list
83416338|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83416339|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416340|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
83416341|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416342|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83416343|NCT01455519|Hydromorphone|hydromorphone|mesh-list
83416344|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83416345|NCT01455519|Narcotics|narcotics|mesh-ancestor
83416346|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416348|NCT01455519|Analgesics|analgesics|mesh-ancestor
83416349|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
83416350|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416351|NCT00157573|Sargramostim|sargramostim|mesh-list
83416352|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
83416353|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416354|NCT04822038|Vitamin D|vitamin d|mesh-list
83416355|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
83416356|NCT04822038|Vitamins|vitamins|mesh-ancestor
83416357|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
83416358|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416359|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83416360|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83416361|NCT01576809|Acetaminophen|acetaminophen|mesh-list
83416362|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
83416363|NCT01576809|Phenylephrine|phenylephrine|mesh-list
83416364|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
83416365|NCT01576809|Guaifenesin|guaifenesin|mesh-list
83416366|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83416367|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83416368|NCT01576809|Analgesics|analgesics|mesh-ancestor
83416369|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
83416370|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416371|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416372|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
83416373|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83416374|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
83416375|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
83416376|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
83416377|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83416378|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
83416379|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
83416380|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83416381|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83416382|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83416383|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
83416384|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416385|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416386|NCT01576809|Protective Agents|protective agents|mesh-ancestor
83416388|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
83416389|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83416390|NCT01456143|Proflavine|proflavine|mesh-list
83416391|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83416392|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416393|NCT01456299|Remifentanil|remifentanil|mesh-list
83416394|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83416395|NCT01456299|Narcotics|narcotics|mesh-ancestor
83416396|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416397|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416398|NCT01456299|Analgesics|analgesics|mesh-ancestor
83416399|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
83416400|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416401|NCT00158743|Digoxin|digoxin|mesh-list
83416402|NCT00158743|Antibodies|antibodies|mesh-list
83416403|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
83416404|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
83416405|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416406|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83416407|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83416408|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416409|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416410|NCT00158743|Protective Agents|protective agents|mesh-ancestor
83416411|NCT00161473|Prazosin|prazosin|mesh-list
83416412|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83416413|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83416414|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83416415|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83416416|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
83416417|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416418|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416419|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416420|NCT01319981|Cytarabine|cytarabine|mesh-list
83416421|NCT01319981|Dexamethasone|dexamethasone|mesh-list
83416422|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
83416423|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83416424|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83416425|NCT01319981|Prednisolone|prednisolone|mesh-list
83416426|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
83416427|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
83416429|NCT01319981|Doxorubicin|doxorubicin|mesh-list
83416430|NCT01319981|Methotrexate|methotrexate|mesh-list
83416431|NCT01319981|Vincristine|vincristine|mesh-list
83416432|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
83416433|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83416434|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
83416435|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83416436|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
83416437|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416438|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83416439|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83416440|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
83416441|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416442|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416443|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83416444|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83416445|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83416446|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
83416447|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
83416448|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416449|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83416450|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
83416451|NCT01319981|Hormones|hormones|mesh-ancestor
83416452|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83416453|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83416454|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83416455|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83416456|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83416457|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416458|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83416459|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
83416460|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83416461|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83416462|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
83416463|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
83416464|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83416465|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83416466|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
83416467|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416468|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83416469|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
83416470|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
83416471|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
83416472|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83416473|NCT01319981|Protective Agents|protective agents|mesh-ancestor
83416474|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83416475|NCT01458561|Thrombin|thrombin|mesh-list
83416476|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83416477|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
83416478|NCT01458561|Coagulants|coagulants|mesh-ancestor
83416479|NCT00065611|Dexamethasone|dexamethasone|mesh-list
83416480|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83416481|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
83416482|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
83416483|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416484|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416485|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83416486|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
83416487|NCT00065611|Hormones|hormones|mesh-ancestor
83416488|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83416489|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83416490|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416491|NCT00066781|Gemcitabine|gemcitabine|mesh-list
83416492|NCT00066781|Irinotecan|irinotecan|mesh-list
83416493|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83416494|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
83416495|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416496|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416497|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83416498|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83416499|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416504|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416505|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83416506|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83416507|NCT01189643|Growth Substances|growth substances|mesh-ancestor
83416508|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416509|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
83416510|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83416511|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83416512|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416513|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416514|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83416515|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
83416516|NCT01431755|Lidocaine|lidocaine|mesh-list
83416517|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
83416518|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
83416519|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
83416520|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416521|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416522|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
83416523|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416524|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83416525|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83416526|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83416527|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83416528|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416529|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83416530|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
83416532|NCT01431755|Protective Agents|protective agents|mesh-ancestor
83416533|NCT00066937|Benztropine|benztropine|mesh-list
83416534|NCT00066937|Nortriptyline|nortriptyline|mesh-list
83416535|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83416536|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
83416537|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83416538|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83416539|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83416540|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83416541|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416542|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
83416543|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416544|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416545|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83416546|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83416547|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
83416548|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
83416549|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416550|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83416551|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83416552|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
83416553|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83416554|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
83416555|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
83416556|NCT01064375|Molgramostim|molgramostim|mesh-list
83416557|NCT01064375|Sargramostim|sargramostim|mesh-list
83416558|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83416559|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
83416560|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416561|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83416562|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83416563|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
83416564|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416565|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416566|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83416567|NCT01061411|Sunitinib|sunitinib|mesh-list
83416568|NCT01061411|Dalteparin|dalteparin|mesh-list
83416569|NCT01061411|Tinzaparin|tinzaparin|mesh-list
83416570|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83416571|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416572|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83416573|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83416574|NCT01061411|Growth Substances|growth substances|mesh-ancestor
83416575|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416576|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
83416577|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83416578|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416579|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416580|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
83416581|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83416582|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83416583|NCT01505673|Liraglutide|liraglutide|mesh-list
83416584|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83416585|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416586|NCT01505673|Incretins|incretins|mesh-ancestor
83416587|NCT01505673|Hormones|hormones|mesh-ancestor
83416588|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83416589|NCT04834986|Lenvatinib|lenvatinib|mesh-list
83416590|NCT04834986|Tislelizumab|tislelizumab|mesh-list
83416591|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416592|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83416593|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416594|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416595|NCT04834986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83416596|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
83416597|NCT04827966|Listerine|listerine|mesh-list
83416598|NCT04827966|Calcium|calcium|mesh-list
83416599|NCT04827966|Fluorides|fluorides|mesh-list
83416600|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
83416601|NCT04827966|Caseins|caseins|mesh-list
83416602|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83416603|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416604|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83416605|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
83416606|NCT04827966|Protective Agents|protective agents|mesh-ancestor
83416607|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83416608|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416609|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
83416610|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
83416611|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416612|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
83416613|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83416614|NCT02247141|Antibodies|antibodies|mesh-list
83416615|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
83416616|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416617|NCT01896245|Sevoflurane|sevoflurane|mesh-list
83416618|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83416619|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83416620|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
83416621|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
83416622|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416623|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416624|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
83416625|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83416626|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
83416627|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416628|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
83416629|NCT04821804|Protective Agents|protective agents|mesh-ancestor
83416630|NCT04835064|Paclitaxel|paclitaxel|mesh-list
83416631|NCT04835064|Gemcitabine|gemcitabine|mesh-list
83416632|NCT04835064|Folfirinox|folfirinox|mesh-list
83416633|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83416634|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416635|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
83416636|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
83416637|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
83416638|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416639|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83416640|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
83416641|NCT00819221|Doxorubicin|doxorubicin|mesh-list
83416642|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83416643|NCT00819221|Olaparib|olaparib|mesh-list
83416644|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83416645|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416646|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83416647|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83416648|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416649|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416650|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83416651|NCT01507779|Vaccines|vaccines|mesh-list
83416652|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
83416653|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416656|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416657|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83416658|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83416659|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416660|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416661|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83416662|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
83416663|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83416664|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416665|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83416666|NCT00068341|Carboplatin|carboplatin|mesh-list
83416667|NCT00068341|Docetaxel|docetaxel|mesh-list
83416668|NCT00068341|Trastuzumab|trastuzumab|mesh-list
83416669|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416670|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
83416671|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
83416672|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
83416673|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416674|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83416675|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
83416676|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83416677|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
83416678|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416679|NCT02605824|Expectorants|expectorants|mesh-ancestor
83416680|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
83416681|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83416682|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
83416683|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416684|NCT02605824|Protective Agents|protective agents|mesh-ancestor
83416685|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416686|NCT02605824|Antidotes|antidotes|mesh-ancestor
83416687|NCT01896661|Amlodipine|amlodipine|mesh-list
83416688|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
83416689|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
83416690|NCT01896661|Amiloride|amiloride|mesh-list
83416691|NCT01896661|Calcium|calcium|mesh-list
83416692|NCT01896661|Diuretics|diuretics|mesh-list
83416693|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83416694|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416695|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83416696|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83416697|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416698|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
83416699|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
83416700|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83416701|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83416702|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83416703|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83416704|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83416705|NCT01462773|Interferons|interferons|mesh-list
83416706|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
83416707|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
83416708|NCT01462773|Bortezomib|bortezomib|mesh-list
83416709|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416710|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
83416711|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416712|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
83416713|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416714|NCT02096029|Nicotine|nicotine|mesh-list
83416715|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83416716|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
83416717|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416718|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416719|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83416720|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83416721|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
83416722|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416723|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416724|NCT02205801|Bupivacaine|bupivacaine|mesh-list
83416725|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
83416726|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
83416727|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416728|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416729|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
83416730|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416733|NCT02096107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83416734|NCT02096107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416735|NCT02096107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416736|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83416737|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
83416738|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416739|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416740|NCT04834440|Ropivacaine|ropivacaine|mesh-list
83416741|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
83416742|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
83416743|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416744|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416745|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
83416746|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416747|NCT00068575|Interferons|interferons|mesh-list
83416748|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
83416749|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
83416750|NCT00068575|Cisplatin|cisplatin|mesh-list
83416751|NCT00068575|Fluorouracil|fluorouracil|mesh-list
83416752|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416753|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
83416754|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416755|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83416756|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83416757|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
83416758|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416759|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
83416760|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416761|NCT00784823|Bortezomib|bortezomib|mesh-list
83416762|NCT00784823|Melphalan|melphalan|mesh-list
83416763|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416764|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83416765|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
83416766|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416767|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83416768|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83416769|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
83416770|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416771|NCT04428684|Goserelin|goserelin|mesh-list
83416772|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83416773|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416774|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83416775|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
83416776|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416777|NCT00773357|Guanfacine|guanfacine|mesh-list
83416778|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83416779|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83416780|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83416781|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83416782|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
83416783|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416784|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416785|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416786|NCT05617950|Salicylic Acid|salicylic acid|mesh-list
83416787|NCT05617950|Salicylates|salicylates|mesh-list
83416788|NCT05617950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416789|NCT05617950|Antifungal Agents|antifungal agents|mesh-ancestor
83416790|NCT05617950|Keratolytic Agents|keratolytic agents|mesh-ancestor
83416791|NCT05617950|Dermatologic Agents|dermatologic agents|mesh-ancestor
83416792|NCT05617950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83416793|NCT05617950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83416794|NCT05617950|Analgesics|analgesics|mesh-ancestor
83416795|NCT05617950|Sensory System Agents|sensory system agents|mesh-ancestor
83416796|NCT05617950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416797|NCT05617950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416798|NCT05617950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83416799|NCT05617950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83416800|NCT05617950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83416801|NCT05617950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416802|NCT05617950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416803|NCT04834752|Esomeprazole|esomeprazole|mesh-list
83416804|NCT04834752|Omeprazole|omeprazole|mesh-list
83416805|NCT04834752|Rabeprazole|rabeprazole|mesh-list
83416806|NCT04834752|Pantoprazole|pantoprazole|mesh-list
83416807|NCT04834752|Lansoprazole|lansoprazole|mesh-list
83416808|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
83416814|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83416815|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83416816|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416817|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416818|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83416819|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
83416820|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
83416821|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416822|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416823|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83416824|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83416825|NCT04834674|Apatinib|apatinib|mesh-list
83416826|NCT04834674|Antibodies|antibodies|mesh-list
83416827|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
83416828|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416829|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416830|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83416831|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416832|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416833|NCT04318938|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83416834|NCT04318938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83416835|NCT04318938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416836|NCT04318938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416837|NCT04826406|Apatinib|apatinib|mesh-list
83416838|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416839|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83416840|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416841|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416842|NCT05617872|Acetic Acid|acetic acid|mesh-list
83416843|NCT05617872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83416844|NCT05617872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416845|NCT04198727|Capecitabine|capecitabine|mesh-list
83416846|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83416847|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
83416848|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416849|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416850|NCT00437255|Betamethasone|betamethasone|mesh-list
83416851|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
83416852|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83416853|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
83416854|NCT00437255|Clobetasol|clobetasol|mesh-list
83416855|NCT00437255|Calcipotriene|calcipotriene|mesh-list
83416856|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83416857|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83416858|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
83416859|NCT00437255|Hormones|hormones|mesh-ancestor
83416860|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83416861|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416862|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83416863|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
83416864|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
83416865|NCT02324673|Cannabidiol|cannabidiol|mesh-list
83416866|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
83416867|NCT00373217|Paclitaxel|paclitaxel|mesh-list
83416868|NCT00373217|Carboplatin|carboplatin|mesh-list
83416869|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83416870|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416871|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
83416872|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
83416873|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
83416874|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416875|NCT02605122|Amoxicillin|amoxicillin|mesh-list
83416876|NCT02605122|Azithromycin|azithromycin|mesh-list
83416877|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
83416878|NCT02605122|Erythromycin|erythromycin|mesh-list
83416879|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
83416880|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83416881|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
83416882|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
83416883|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
83416884|NCT02605122|Ampicillin|ampicillin|mesh-list
83416885|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83416886|NCT02605122|Solithromycin|solithromycin|mesh-list
83416887|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
83416888|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83416889|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83416890|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83416891|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83416892|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416893|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416894|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83416896|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
83416897|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
83416898|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416899|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416900|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
83416901|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416902|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83416903|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83416904|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83416905|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83416906|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416907|NCT00212147|Nitrous Oxide|nitrous oxide|mesh-list
83416908|NCT00212147|Anesthetics|anesthetics|mesh-list
83416909|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416910|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416911|NCT00212147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83416912|NCT00212147|Anesthetics, General|anesthetics, general|mesh-ancestor
83416913|NCT00212147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83416915|NCT00212147|Sensory System Agents|sensory system agents|mesh-ancestor
83416916|NCT00212147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416917|NCT04820010|Insulin|insulin|mesh-list
83416918|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83416919|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416920|NCT04819776|Iloperidone|iloperidone|mesh-list
83416921|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83416922|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83416923|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416924|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416925|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83416926|NCT01454102|Paclitaxel|paclitaxel|mesh-list
83416927|NCT01454102|Bevacizumab|bevacizumab|mesh-list
83416928|NCT01454102|Carboplatin|carboplatin|mesh-list
83416929|NCT01454102|Gemcitabine|gemcitabine|mesh-list
83416930|NCT01454102|Nivolumab|nivolumab|mesh-list
83416931|NCT01454102|Pemetrexed|pemetrexed|mesh-list
83416932|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83416933|NCT01454102|Ipilimumab|ipilimumab|mesh-list
83416934|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83416935|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416936|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
83416937|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
83416938|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
83416939|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416940|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83416941|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83416942|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83416943|NCT01454102|Growth Substances|growth substances|mesh-ancestor
83416944|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416945|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
83416946|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83416947|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
83416948|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83416949|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416950|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83416951|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83416952|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83416953|NCT04192253|Paclitaxel|paclitaxel|mesh-list
83416954|NCT04192253|Carboplatin|carboplatin|mesh-list
83416955|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83416956|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416957|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
83416958|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
83416959|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
83416960|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416961|NCT04825938|Paclitaxel|paclitaxel|mesh-list
83416962|NCT04825938|Carboplatin|carboplatin|mesh-list
83416963|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83416964|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416965|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
83416968|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416970|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83416971|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416972|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
83416973|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
83416974|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
83416975|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416976|NCT01509807|Morphine|morphine|mesh-list
83416977|NCT01509807|Bupivacaine|bupivacaine|mesh-list
83416978|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
83416979|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
83416980|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83416981|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416982|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
83416983|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83416984|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83416985|NCT01509807|Narcotics|narcotics|mesh-ancestor
83416986|NCT01509807|Analgesics|analgesics|mesh-ancestor
83416987|NCT00070135|Methotrexate|methotrexate|mesh-list
83416988|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
83416990|NCT00070135|Busulfan|busulfan|mesh-list
83416991|NCT00070135|Tacrolimus|tacrolimus|mesh-list
83416992|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83416993|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83416994|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
83416995|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83416996|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416997|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83416998|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
83416999|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417000|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417001|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
83417002|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417003|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83417004|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83417005|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
83417006|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417007|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83417008|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83417009|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
83417010|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83417011|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83417012|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
83417013|NCT01583985|Narcotics|narcotics|mesh-ancestor
83417014|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417015|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417016|NCT01583985|Analgesics|analgesics|mesh-ancestor
83417017|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
83417018|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417019|NCT04816344|Anesthetics|anesthetics|mesh-list
83417020|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417021|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417022|NCT01467999|Guanfacine|guanfacine|mesh-list
83417023|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83417024|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83417025|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83417026|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83417027|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
83417028|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417029|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417030|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417031|NCT05617482|Anesthetics|anesthetics|mesh-list
83417032|NCT05617482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417033|NCT05617482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417034|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
83417035|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83417036|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
83417037|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417038|NCT01470027|Expectorants|expectorants|mesh-ancestor
83417039|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
83417040|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83417041|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
83417042|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417043|NCT01470027|Protective Agents|protective agents|mesh-ancestor
83417045|NCT01470027|Antidotes|antidotes|mesh-ancestor
83417046|NCT01470651|Modafinil|modafinil|mesh-list
83417047|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83417048|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417049|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83417050|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83417051|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83417052|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417053|NCT01512225|Domperidone|domperidone|mesh-list
83417054|NCT01512225|Maleic acid|maleic acid|mesh-list
83417055|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417056|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417057|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
83417058|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
83417059|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417060|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417061|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83417062|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83417063|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
83417064|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417065|NCT01472445|Vitamin D|vitamin d|mesh-list
83417066|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
83417067|NCT01472445|Vitamins|vitamins|mesh-ancestor
83417068|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
83417069|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417070|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83417071|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83417072|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83417073|NCT04782089|Fluzoparib|fluzoparib|mesh-list
83417074|NCT04782089|Antibodies|antibodies|mesh-list
83417075|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
83417076|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417077|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417078|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417079|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417080|NCT02604342|Docetaxel|docetaxel|mesh-list
83417081|NCT02604342|Pemetrexed|pemetrexed|mesh-list
83417082|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417083|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
83417084|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
83417085|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
83417086|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417087|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417088|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83417089|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83417090|NCT04781777|Insulin|insulin|mesh-list
83417091|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83417092|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417093|NCT04781075|Bupivacaine|bupivacaine|mesh-list
83417094|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
83417095|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
83417096|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417097|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417098|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
83417099|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417100|NCT01586091|Fexofenadine|fexofenadine|mesh-list
83417101|NCT01586091|Levocetirizine|levocetirizine|mesh-list
83417102|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83417103|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83417104|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
83417105|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
83417106|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417107|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417108|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417109|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83417110|NCT05565573|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83417111|NCT05565573|Levonorgestrel|levonorgestrel|mesh-list
83417112|NCT05565573|Medroxyprogesterone|medroxyprogesterone|mesh-list
83417113|NCT05565573|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83417114|NCT05565573|Contraceptive Agents|contraceptive agents|mesh-ancestor
83417115|NCT05565573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83417116|NCT05565573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417117|NCT05565573|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83417118|NCT05565573|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83417119|NCT05565573|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83417120|NCT05565573|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83417121|NCT05565573|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83417122|NCT05565573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83417123|NCT05565573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417124|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
83417125|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
83417126|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83417127|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83417128|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417129|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417130|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417131|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417132|NCT01587027|Aminophylline|aminophylline|mesh-list
83417133|NCT01587027|Methazolamide|methazolamide|mesh-list
83417134|NCT01587027|Theophylline|theophylline|mesh-list
83417135|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83417136|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
83417137|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417138|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417139|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83417140|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
83417141|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83417142|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417143|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417144|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
83417145|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83417146|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83417147|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
83417148|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417149|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83417150|NCT01587027|Protective Agents|protective agents|mesh-ancestor
83417151|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83417152|NCT01587027|Diuretics|diuretics|mesh-ancestor
83417153|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
83417154|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
83417156|NCT01471340|Prednisolone|prednisolone|mesh-list
83417157|NCT01471340|Albuterol|albuterol|mesh-list
83417158|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
83417159|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
83417160|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83417161|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
83417162|NCT01471340|Hormones|hormones|mesh-ancestor
83417163|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83417164|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417165|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83417166|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417167|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
83417168|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417169|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83417170|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83417171|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
83417172|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83417173|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83417174|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83417175|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
83417176|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417177|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417178|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
83417179|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83417180|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
83417181|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83417182|NCT04754789|Aspirin|aspirin|mesh-list
83417183|NCT04754789|Ticagrelor|ticagrelor|mesh-list
83417184|NCT04754789|Atorvastatin|atorvastatin|mesh-list
83417185|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83417186|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83417187|NCT04754789|Analgesics|analgesics|mesh-ancestor
83417188|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
83417189|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417190|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417191|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83417192|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417194|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83417195|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417196|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83417197|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83417198|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417199|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
83417200|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83417201|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83417202|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
83417203|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83417204|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83417205|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83417206|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83417207|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83417208|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
83417209|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417210|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83417211|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83417212|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83417214|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417215|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83417216|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83417217|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417218|NCT04815408|Paclitaxel|paclitaxel|mesh-list
83417219|NCT04815408|Carboplatin|carboplatin|mesh-list
83417220|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83417221|NCT04815408|Tislelizumab|tislelizumab|mesh-list
83417222|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83417223|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417224|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
83417225|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
83417226|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
83417227|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417228|NCT04815408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83417229|NCT04778813|Artesunate|artesunate|mesh-list
83417230|NCT04778813|Lumefantrine|lumefantrine|mesh-list
83417231|NCT04778813|Artemether|artemether|mesh-list
83417232|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83417233|NCT04778813|Artenimol|artenimol|mesh-list
83417234|NCT04778813|Pyronaridine|pyronaridine|mesh-list
83417235|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
83417236|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83417237|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83417238|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417239|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417240|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
83417241|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
83417242|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83417243|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
83417244|NCT04817982|Dexamethasone|dexamethasone|mesh-list
83417245|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
83417246|NCT04817982|Lidocaine|lidocaine|mesh-list
83417247|NCT04817982|BB 1101|bb 1101|mesh-list
83417248|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83417249|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
83417250|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
83417251|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417252|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417253|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83417254|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
83417255|NCT04817982|Hormones|hormones|mesh-ancestor
83417256|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83417257|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83417258|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417259|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
83417260|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417261|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417262|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
83417263|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
83417264|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417265|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
83417266|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83417267|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83417268|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83417269|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83417270|NCT04779047|Ritonavir|ritonavir|mesh-list
83417275|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83417276|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83417277|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
83417278|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417279|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417281|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83417282|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
83417283|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417284|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83417285|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83417286|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
83417287|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83417288|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83417289|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417290|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
83417291|NCT04427826|Morphine|morphine|mesh-list
83417292|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83417293|NCT04427826|Narcotics|narcotics|mesh-ancestor
83417294|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417295|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417296|NCT04427826|Analgesics|analgesics|mesh-ancestor
83417297|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
83417298|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417299|NCT03699995|Lidocaine|lidocaine|mesh-list
83417300|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
83417301|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
83417302|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417303|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417304|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
83417305|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417306|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83417307|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83417308|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83417309|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83417310|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417311|NCT01515345|Clopidogrel|clopidogrel|mesh-list
83417312|NCT01515345|Ticagrelor|ticagrelor|mesh-list
83417313|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83417314|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83417315|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83417316|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83417317|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83417318|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
83417319|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417320|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417321|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417322|NCT01492400|Dexamethasone|dexamethasone|mesh-list
83417323|NCT01492400|Ranibizumab|ranibizumab|mesh-list
83417324|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83417325|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
83417326|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
83417327|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417328|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417329|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83417330|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
83417331|NCT01492400|Hormones|hormones|mesh-ancestor
83417332|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83417333|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83417334|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417335|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83417336|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83417337|NCT01492400|Growth Substances|growth substances|mesh-ancestor
83417338|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
83417339|NCT00168337|Dexamethasone|dexamethasone|mesh-list
83417340|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83417341|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
83417342|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
83417343|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417344|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417345|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83417346|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
83417347|NCT00168337|Hormones|hormones|mesh-ancestor
83417348|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83417349|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83417350|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417352|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83417353|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83417354|NCT01515657|Analgesics|analgesics|mesh-ancestor
83417355|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
83417356|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417357|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417358|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83417359|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417360|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83417361|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83417362|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417363|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83417364|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83417365|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417366|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
83417367|NCT01515891|Opicapone|opicapone|mesh-list
83417368|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83417369|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417370|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417371|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83417372|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83417373|NCT00073957|Cytarabine|cytarabine|mesh-list
83417374|NCT00073957|Rituximab|rituximab|mesh-list
83417375|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83417376|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417377|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
83417378|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417379|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417380|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83417381|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
83417382|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417383|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
83417384|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417385|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83417386|NCT04354428|Folic Acid|folic acid|mesh-list
83417387|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
83417388|NCT04354428|Ritonavir|ritonavir|mesh-list
83417389|NCT04354428|Lopinavir|lopinavir|mesh-list
83417390|NCT04354428|Azithromycin|azithromycin|mesh-list
83417391|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
83417392|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83417393|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83417394|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
83417395|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417396|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417397|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83417398|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83417399|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
83417400|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417401|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83417402|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83417403|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83417404|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
83417405|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83417406|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83417407|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417408|NCT04354428|Hematinics|hematinics|mesh-ancestor
83417409|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
83417410|NCT04354428|Vitamins|vitamins|mesh-ancestor
83417411|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
83417412|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417413|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
83417414|NCT04354428|Protective Agents|protective agents|mesh-ancestor
83417415|NCT02090075|Warfarin|warfarin|mesh-list
83417416|NCT02090075|Apixaban|apixaban|mesh-list
83417417|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
83417418|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83417419|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
83417420|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83417421|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
83417422|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417423|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417424|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83417425|NCT04817202|Antibodies|antibodies|mesh-list
83417429|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417430|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417432|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83417433|NCT04775303|Cyclosporins|cyclosporins|mesh-list
83417434|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417435|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417436|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83417437|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
83417438|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417439|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
83417440|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417441|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
83417442|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417443|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83417444|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83417445|NCT04816968|Vancomycin|vancomycin|mesh-list
83417446|NCT04816968|Meropenem|meropenem|mesh-list
83417447|NCT04816968|Tazobactam|tazobactam|mesh-list
83417448|NCT04816968|Piperacillin|piperacillin|mesh-list
83417449|NCT04816968|Cefepime|cefepime|mesh-list
83417450|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83417451|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83417452|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417453|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83417454|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417455|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417456|NCT02210247|Bupivacaine|bupivacaine|mesh-list
83417457|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
83417458|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
83417459|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417460|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417461|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
83417462|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417463|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83417464|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
83417465|NCT04806438|Lidocaine|lidocaine|mesh-list
83417466|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
83417467|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
83417468|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417469|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417470|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
83417471|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417472|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83417473|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83417474|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83417475|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83417476|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417477|NCT00074035|Pentostatin|pentostatin|mesh-list
83417478|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417479|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83417480|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417481|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417482|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83417483|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83417484|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
83417485|NCT00074815|Citalopram|citalopram|mesh-list
83417486|NCT00074815|Fluoxetine|fluoxetine|mesh-list
83417487|NCT00074815|Paroxetine|paroxetine|mesh-list
83417488|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83417489|NCT00074815|Sertraline|sertraline|mesh-list
83417490|NCT00074815|Clomipramine|clomipramine|mesh-list
83417491|NCT00074815|Escitalopram|escitalopram|mesh-list
83417492|NCT00074815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83417493|NCT00074815|Serotonin|serotonin|mesh-list
83417494|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83417495|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83417496|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417497|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417498|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
83417499|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417500|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83417501|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
83417502|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83417503|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83417504|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83417505|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417506|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83417507|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83417508|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83417509|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417510|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83417511|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83417512|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83417513|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83417514|NCT04772729|Insulin|insulin|mesh-list
83417515|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83417516|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
83417517|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83417518|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417519|NCT05562375|Tolonium Chloride|tolonium chloride|mesh-list
83417520|NCT05562375|Hemostatics|hemostatics|mesh-ancestor
83417521|NCT05562375|Coagulants|coagulants|mesh-ancestor
83417522|NCT05562375|Heparin Antagonists|heparin antagonists|mesh-ancestor
83417523|NCT05562375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417524|NCT00075829|Thalidomide|thalidomide|mesh-list
83417525|NCT00075829|Dexamethasone|dexamethasone|mesh-list
83417526|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83417527|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
83417528|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
83417529|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417530|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417531|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83417532|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
83417533|NCT00075829|Hormones|hormones|mesh-ancestor
83417534|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83417535|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83417536|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417537|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83417538|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
83417539|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
83417540|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83417541|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417542|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83417543|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83417544|NCT00075829|Growth Substances|growth substances|mesh-ancestor
83417545|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
83417546|NCT02218203|Lidocaine|lidocaine|mesh-list
83417547|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
83417548|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
83417549|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
83417550|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417551|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417552|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
83417553|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417554|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83417555|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83417556|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83417557|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83417558|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417559|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
83417560|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
83417561|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83417562|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83417563|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417564|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
83417565|NCT04771715|Nivolumab|nivolumab|mesh-list
83417566|NCT04771715|Tislelizumab|tislelizumab|mesh-list
83417567|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83417568|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417569|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83417570|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417571|NCT04771559|Antibodies|antibodies|mesh-list
83417572|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
83417573|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417574|NCT02592876|Rituximab|rituximab|mesh-list
83417575|NCT02592876|Carboplatin|carboplatin|mesh-list
83417576|NCT02592876|Etoposide|etoposide|mesh-list
83417577|NCT02592876|Ifosfamide|ifosfamide|mesh-list
83417578|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83417579|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417580|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
83417581|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417582|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417583|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83417584|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83417585|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83417586|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417587|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417588|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83417589|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
83417590|NCT00585559|Acetaminophen|acetaminophen|mesh-list
83417591|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
83417592|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83417593|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83417594|NCT00585559|Analgesics|analgesics|mesh-ancestor
83417595|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
83417596|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417597|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417598|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
83417599|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
83417600|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417601|NCT00585559|Expectorants|expectorants|mesh-ancestor
83417602|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
83417603|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83417604|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
83417605|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417606|NCT00585559|Protective Agents|protective agents|mesh-ancestor
83417607|NCT00585559|Antidotes|antidotes|mesh-ancestor
83417608|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83417610|NCT02763137|Levodopa|levodopa|mesh-list
83417611|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83417612|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
83417613|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417614|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83417615|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83417616|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
83417617|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
83417618|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417619|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417620|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83417621|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417622|NCT01896739|Vaccines|vaccines|mesh-list
83417623|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
83417624|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417625|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
83417626|NCT00176839|Melphalan|melphalan|mesh-list
83417627|NCT00176839|Busulfan|busulfan|mesh-list
83417628|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83417629|NCT00176839|Lenograstim|lenograstim|mesh-list
83417630|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83417631|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
83417632|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417633|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417634|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83417635|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
83417636|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417637|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417638|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83417639|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83417640|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
83417641|NCT00176917|Busulfan|busulfan|mesh-list
83417642|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
83417643|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83417644|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
83417645|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417646|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417647|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83417648|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
83417649|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417650|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417651|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83417652|NCT02664155|Vitamin K|vitamin k|mesh-list
83417653|NCT02664155|Heparin|heparin|mesh-list
83417654|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
83417655|NCT02664155|Apixaban|apixaban|mesh-list
83417656|NCT02664155|Vitamins|vitamins|mesh-ancestor
83417658|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417659|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
83417660|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83417661|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83417662|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417663|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83417664|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
83417665|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83417666|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
83417667|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417668|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83417669|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
83417670|NCT02664155|Coagulants|coagulants|mesh-ancestor
83417671|NCT04770389|Ezetimibe|ezetimibe|mesh-list
83417672|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
83417673|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83417674|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
83417675|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417676|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83417677|NCT04753619|Niclosamide|niclosamide|mesh-list
83417678|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
83417679|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83417680|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
83417681|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83417682|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417683|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
83417684|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83417685|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83417686|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417687|NCT01492088|Immunotoxins|immunotoxins|mesh-ancestor
83417688|NCT01492088|Immunoconjugates|immunoconjugates|mesh-ancestor
83417689|NCT01492088|Immunologic Factors|immunologic factors|mesh-ancestor
83417690|NCT01492088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417691|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
83417692|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83417693|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83417694|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417695|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
83417696|NCT04753151|Coagulants|coagulants|mesh-ancestor
83417697|NCT05606315|Midazolam|midazolam|mesh-list
83417698|NCT05606315|Propofol|propofol|mesh-list
83417699|NCT05606315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83417700|NCT05606315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417701|NCT05606315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417702|NCT05606315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83417703|NCT05606315|Anesthetics, General|anesthetics, general|mesh-ancestor
83417704|NCT05606315|Anesthetics|anesthetics|mesh-ancestor
83417705|NCT05606315|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83417706|NCT05606315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83417707|NCT05606315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83417708|NCT05606315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83417709|NCT05606315|GABA Modulators|gaba modulators|mesh-ancestor
83417710|NCT05606315|GABA Agents|gaba agents|mesh-ancestor
83417711|NCT05606315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417712|NCT05606315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417713|NCT05605925|Ivermectin|ivermectin|mesh-list
83417714|NCT05605925|Lumefantrine|lumefantrine|mesh-list
83417715|NCT05605925|Artemether|artemether|mesh-list
83417716|NCT05605925|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83417717|NCT05605925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83417718|NCT05605925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417719|NCT05605925|Antimalarials|antimalarials|mesh-ancestor
83417720|NCT05605925|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83417721|NCT01520727|Opicapone|opicapone|mesh-list
83417722|NCT01520727|Entacapone|entacapone|mesh-list
83417723|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83417724|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417725|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417726|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83417727|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83417728|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
83417729|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83417730|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417731|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417732|NCT01855607|Menthol|menthol|mesh-list
83417733|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
83417734|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
83417735|NCT01596699|Fludarabine|fludarabine|mesh-list
83417739|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417740|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83417741|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
83417742|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417743|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83417744|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
83417745|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417746|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
83417747|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83417748|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83417749|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83417751|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417752|NCT05605301|Deoxyglucose|deoxyglucose|mesh-list
83417753|NCT05605301|Antimetabolites|antimetabolites|mesh-ancestor
83417754|NCT05605301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417755|NCT05605301|Antiviral Agents|antiviral agents|mesh-ancestor
83417756|NCT05605301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417757|NCT05566743|Capecitabine|capecitabine|mesh-list
83417758|NCT05566743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83417759|NCT05566743|Antimetabolites|antimetabolites|mesh-ancestor
83417760|NCT05566743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417761|NCT05566743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417762|NCT05596721|Azithromycin|azithromycin|mesh-list
83417763|NCT05596721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83417764|NCT05596721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417765|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
83417766|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83417767|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83417768|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83417769|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83417770|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417771|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
83417772|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417773|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417774|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83417775|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417776|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83417777|NCT01525173|Bimatoprost|bimatoprost|mesh-list
83417778|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83417779|NCT01525173|Latanoprost|latanoprost|mesh-list
83417780|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83417781|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
83417782|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83417783|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83417784|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83417785|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83417786|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83417787|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417788|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417789|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417790|NCT03007563|Bilirubin|bilirubin|mesh-list
83417791|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
83417792|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417793|NCT03007563|Protective Agents|protective agents|mesh-ancestor
83417794|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417795|NCT05331131|Ketamine|ketamine|mesh-list
83417796|NCT05331131|Analgesics|analgesics|mesh-ancestor
83417797|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
83417798|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417799|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417800|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83417801|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83417802|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
83417803|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
83417804|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417805|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83417806|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83417807|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417808|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417809|NCT01526577|Ticagrelor|ticagrelor|mesh-list
83417810|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83417811|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83417812|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83417813|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83417814|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
83417815|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417816|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417817|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417819|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
83417820|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83417821|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417822|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83417823|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83417824|NCT01894451|Growth Substances|growth substances|mesh-ancestor
83417825|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417826|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
83417827|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83417828|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417829|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
83417830|NCT01527045|Cyclosporine|cyclosporine|mesh-list
83417831|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
83417832|NCT01527045|Fludarabine|fludarabine|mesh-list
83417833|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
83417834|NCT01527045|Atorvastatin|atorvastatin|mesh-list
83417835|NCT01527045|Calcium|calcium|mesh-list
83417836|NCT01527045|Cyclosporins|cyclosporins|mesh-list
83417837|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83417838|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417839|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83417840|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417841|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83417842|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
83417843|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417844|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83417845|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
83417846|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417847|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
83417848|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417849|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
83417850|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417851|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83417852|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83417853|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83417854|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83417855|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83417856|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83417857|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83417858|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
83417859|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83417860|NCT00078403|Ribavirin|ribavirin|mesh-list
83417861|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83417862|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
83417863|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417864|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
83417865|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417866|NCT01976585|Poly ICLC|poly iclc|mesh-list
83417867|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
83417868|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
83417869|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417870|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83417871|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
83417872|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83417873|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83417874|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83417875|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417876|NCT03001635|Oxytocin|oxytocin|mesh-list
83417877|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
83417878|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83417879|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417880|NCT02592798|Abatacept|abatacept|mesh-list
83417881|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83417882|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417883|NCT02592798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83417884|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417885|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83417886|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
83417887|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417888|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83417889|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83417890|NCT01530243|Terazosin|terazosin|mesh-list
83417891|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83417892|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83417893|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
83417894|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417895|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417896|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417897|NCT01530243|Urological Agents|urological agents|mesh-ancestor
83417898|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83417899|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83417900|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83417901|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
83417902|NCT04797546|Morphine|morphine|mesh-list
83417903|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83417904|NCT04797546|Narcotics|narcotics|mesh-ancestor
83417905|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417906|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417907|NCT04797546|Analgesics|analgesics|mesh-ancestor
83417908|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
83417909|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417910|NCT02980809|Apatinib|apatinib|mesh-list
83417911|NCT02980809|Topotecan|topotecan|mesh-list
83417912|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417913|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83417914|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417915|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417916|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83417917|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83417918|NCT00078559|Acetaminophen|acetaminophen|mesh-list
83417919|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
83417920|NCT00078559|Promethazine|promethazine|mesh-list
83417921|NCT00078559|Sirolimus|sirolimus|mesh-list
83417922|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83417923|NCT00078559|Nystatin|nystatin|mesh-list
83417924|NCT00078559|Clotrimazole|clotrimazole|mesh-list
83417925|NCT00078559|Miconazole|miconazole|mesh-list
83417926|NCT00078559|Pentamidine|pentamidine|mesh-list
83417927|NCT00078559|Trimethoprim|trimethoprim|mesh-list
83417928|NCT00078559|Acyclovir|acyclovir|mesh-list
83417929|NCT00078559|Valganciclovir|valganciclovir|mesh-list
83417930|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
83417931|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
83417932|NCT00078559|Tacrolimus|tacrolimus|mesh-list
83417933|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83417934|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
83417935|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417936|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83417937|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83417938|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83417939|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83417940|NCT00078559|Analgesics|analgesics|mesh-ancestor
83417941|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
83417942|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417943|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
83417944|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83417945|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83417946|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83417947|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83417948|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
83417949|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83417950|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
83417951|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
83417952|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83417953|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
83417954|NCT00078559|Hormones|hormones|mesh-ancestor
83417955|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83417956|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83417957|NCT00078559|Protective Agents|protective agents|mesh-ancestor
83417958|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83417959|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83417960|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83417961|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83417962|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
83417963|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
83417964|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83417965|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
83417966|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
83417967|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417968|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83417969|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
83417970|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
83417971|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83417972|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
83417973|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83417974|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83417975|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83417976|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83417977|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83417978|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83417979|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
83417980|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83417981|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83417982|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83417983|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
83417984|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83417985|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83417986|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83417987|NCT00078559|Ionophores|ionophores|mesh-ancestor
83417988|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83417989|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
83417990|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83417991|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417992|NCT00078715|Yohimbine|yohimbine|mesh-list
83417993|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
83417994|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
83417995|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83417996|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417997|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83417998|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83417999|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83418000|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
83418001|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418002|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418003|NCT00078715|Urological Agents|urological agents|mesh-ancestor
83418004|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
83418005|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418006|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
83418007|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83418008|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83418009|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418010|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
83418011|NCT01530399|Coagulants|coagulants|mesh-ancestor
83418012|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83418013|NCT02596620|Amoxicillin|amoxicillin|mesh-list
83418014|NCT02596620|Metronidazole|metronidazole|mesh-list
83418015|NCT02596620|Levofloxacin|levofloxacin|mesh-list
83418016|NCT02596620|Esomeprazole|esomeprazole|mesh-list
83418017|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83418018|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418019|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83418020|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83418021|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83418022|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83418023|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83418024|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418025|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418026|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83418027|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83418028|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83418029|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418030|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83418031|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83418032|NCT01531959|Midodrine|midodrine|mesh-list
83418033|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
83418034|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
83418035|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418036|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418037|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83418038|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83418039|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83418043|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418044|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
83418045|NCT01532349|Vitamin D|vitamin d|mesh-list
83418047|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
83418048|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418049|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83418050|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83418051|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
83418052|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83418053|NCT01533207|Gemcitabine|gemcitabine|mesh-list
83418054|NCT01533207|Docetaxel|docetaxel|mesh-list
83418055|NCT01533207|Doxorubicin|doxorubicin|mesh-list
83418056|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83418057|NCT01533207|Lenograstim|lenograstim|mesh-list
83418058|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83418059|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
83418060|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418061|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418062|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
83418063|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
83418064|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
83418065|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83418066|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83418067|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83418068|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418069|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83418070|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
83418071|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418072|NCT00182767|Doxorubicin|doxorubicin|mesh-list
83418073|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83418074|NCT00182767|Epothilone B|epothilone b|mesh-list
83418075|NCT00182767|Epothilones|epothilones|mesh-list
83418076|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83418077|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418078|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83418079|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83418080|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418081|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418082|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
83418083|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
83418084|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
83418085|NCT01533597|Tamsulosin|tamsulosin|mesh-list
83418086|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
83418087|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83418088|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83418089|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83418090|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
83418091|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418092|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418093|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418094|NCT01533597|Urological Agents|urological agents|mesh-ancestor
83418095|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83418096|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83418097|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
83418098|NCT03006627|Morphine|morphine|mesh-list
83418099|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83418100|NCT03006627|Narcotics|narcotics|mesh-ancestor
83418101|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418102|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418103|NCT03006627|Analgesics|analgesics|mesh-ancestor
83418104|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
83418105|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418106|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
83418107|NCT04796688|Fludarabine|fludarabine|mesh-list
83418108|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83418109|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
83418110|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418111|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83418112|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83418113|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
83418114|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418115|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418116|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83418117|NCT01535001|Acetaminophen|acetaminophen|mesh-list
83418119|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83418120|NCT01535001|Analgesics|analgesics|mesh-ancestor
83418121|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
83418122|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418123|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418124|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
83418125|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83418126|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83418127|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83418128|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418129|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418130|NCT03000777|Melatonin|melatonin|mesh-list
83418131|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
83418132|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418133|NCT03000777|Protective Agents|protective agents|mesh-ancestor
83418134|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418135|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418136|NCT03006003|Alendronate|alendronate|mesh-list
83418137|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83418138|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83418139|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418140|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83418141|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
83418142|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83418143|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83418144|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83418145|NCT04426734|Dexamethasone|dexamethasone|mesh-list
83418146|NCT04426734|Prednisolone|prednisolone|mesh-list
83418147|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83418148|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
83418149|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83418150|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
83418151|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83418152|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
83418153|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83418154|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
83418155|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
83418156|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418157|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418158|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83418159|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
83418160|NCT04426734|Hormones|hormones|mesh-ancestor
83418161|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83418162|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83418163|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418164|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83418165|NCT04426734|Protective Agents|protective agents|mesh-ancestor
83418166|NCT03006081|Aflibercept|aflibercept|mesh-list
83418167|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83418168|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83418169|NCT03006081|Growth Substances|growth substances|mesh-ancestor
83418170|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418171|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
83418172|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418173|NCT01535937|Midazolam|midazolam|mesh-list
83418174|NCT01535937|Ketamine|ketamine|mesh-list
83418175|NCT01535937|Analgesics|analgesics|mesh-ancestor
83418176|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
83418177|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418178|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418179|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83418180|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83418181|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
83418182|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
83418183|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418184|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83418185|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83418186|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418187|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418188|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83418189|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83418190|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83418191|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83418192|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83418193|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
83418199|NCT02999841|Vildagliptin|vildagliptin|mesh-list
83418200|NCT02999841|Acarbose|acarbose|mesh-list
83418201|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83418202|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418203|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83418204|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
83418205|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418206|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418207|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83418208|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
83418209|NCT01537029|Doxorubicin|doxorubicin|mesh-list
83418210|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83418211|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
83418212|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418213|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83418214|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83418215|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
83418216|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418217|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418218|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83418219|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83418220|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83418221|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83418222|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418223|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83418224|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418225|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83418226|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418227|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418228|NCT04803318|Everolimus|everolimus|mesh-list
83418229|NCT04803318|Lenvatinib|lenvatinib|mesh-list
83418230|NCT04803318|Trametinib|trametinib|mesh-list
83418231|NCT04803318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83418232|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83418233|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418234|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418235|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83418236|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
83418237|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418238|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418239|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
83418240|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83418241|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
83418242|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418243|NCT04803162|Omeprazole|omeprazole|mesh-list
83418244|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83418245|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83418246|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83418247|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418248|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418249|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83418250|NCT02999217|Hematinics|hematinics|mesh-ancestor
83418251|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83418252|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83418253|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
83418254|NCT02980965|Docetaxel|docetaxel|mesh-list
83418255|NCT02980965|Fluorouracil|fluorouracil|mesh-list
83418256|NCT02980965|Letrozole|letrozole|mesh-list
83418257|NCT02980965|Epirubicin|epirubicin|mesh-list
83418258|NCT02980965|Leuprolide|leuprolide|mesh-list
83418259|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83418260|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
83418261|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418262|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83418263|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83418264|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
83418265|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418266|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418267|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83418268|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
83418269|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
83418270|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
83418271|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
83418272|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83418275|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418276|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83418277|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
83418278|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83418279|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83418280|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83418281|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83418282|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83418283|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
83418284|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83418285|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83418286|NCT01538745|Ketamine|ketamine|mesh-list
83418287|NCT01538745|Morphine|morphine|mesh-list
83418288|NCT01538745|Analgesics|analgesics|mesh-ancestor
83418289|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
83418290|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418291|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418292|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83418293|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83418294|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
83418295|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
83418296|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418297|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83418298|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83418299|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418300|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418301|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83418302|NCT01538745|Narcotics|narcotics|mesh-ancestor
83418303|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
83418304|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83418305|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
83418306|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418307|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
83418308|NCT04803240|Protective Agents|protective agents|mesh-ancestor
83418309|NCT04803474|Hormones|hormones|mesh-list
83418310|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83418311|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418312|NCT01539135|Methylene Blue|methylene blue|mesh-list
83418313|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418314|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418315|NCT04426578|Perhexiline|perhexiline|mesh-list
83418316|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83418317|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83418318|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418319|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83418320|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418321|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
83418322|NCT04802928|Isoniazid|isoniazid|mesh-list
83418323|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
83418324|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83418325|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418326|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83418327|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83418328|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
83418329|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418330|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83418331|NCT05365425|Choline|choline|mesh-list
83418332|NCT05365425|Policosanol|policosanol|mesh-list
83418333|NCT05365425|Fenofibrate|fenofibrate|mesh-list
83418334|NCT05365425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83418335|NCT05365425|Antimetabolites|antimetabolites|mesh-ancestor
83418336|NCT05365425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418337|NCT05365425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83418338|NCT05365425|Lipotropic Agents|lipotropic agents|mesh-ancestor
83418339|NCT05365425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83418340|NCT05365425|Nootropic Agents|nootropic agents|mesh-ancestor
83418341|NCT05365425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83418342|NCT05365425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83418343|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83418344|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418345|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83418346|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418347|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418348|NCT04794738|Morphine|morphine|mesh-list
83418349|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83418350|NCT04794738|Narcotics|narcotics|mesh-ancestor
83418351|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418352|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418353|NCT04794738|Analgesics|analgesics|mesh-ancestor
83418354|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
83418355|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418356|NCT04794426|Fluorides|fluorides|mesh-list
83418357|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
83418358|NCT04794426|Protective Agents|protective agents|mesh-ancestor
83418359|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418360|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83418361|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83418362|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418363|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418364|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83418365|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83418366|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418367|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
83418368|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418369|NCT05073315|Adalimumab|adalimumab|mesh-list
83418370|NCT05073315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83418371|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83418372|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83418373|NCT02591238|Melatonin|melatonin|mesh-list
83418374|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
83418375|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418376|NCT02591238|Protective Agents|protective agents|mesh-ancestor
83418377|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418378|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418379|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
83418380|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83418381|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
83418382|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418383|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418384|NCT04793256|Listerine|listerine|mesh-list
83418385|NCT04793256|Fluorides|fluorides|mesh-list
83418386|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
83418387|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
83418388|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
83418389|NCT04793256|Protective Agents|protective agents|mesh-ancestor
83418390|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418391|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83418392|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418393|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83418394|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
83418395|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83418396|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83418397|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83418398|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418399|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418400|NCT04792710|Metronidazole|metronidazole|mesh-list
83418401|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418402|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83418403|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83418404|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83418405|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83418406|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83418407|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418408|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418409|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83418410|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83418411|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418412|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
83418413|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418414|NCT04814433|Lidocaine|lidocaine|mesh-list
83418415|NCT04814433|Epinephrine|epinephrine|mesh-list
83418416|NCT04814433|Racepinephrine|racepinephrine|mesh-list
83418417|NCT04814433|Bupivacaine|bupivacaine|mesh-list
83418418|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
83418419|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
83418420|NCT04814433|Thrombin|thrombin|mesh-list
83418421|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
83418422|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
83418575|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
83418424|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418425|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418426|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
83418427|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418428|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83418429|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83418430|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83418431|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83418432|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418433|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83418434|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83418435|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
83418436|NCT04814433|Coagulants|coagulants|mesh-ancestor
83418437|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83418438|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83418439|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
83418440|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418441|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83418442|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83418443|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
83418444|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83418445|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
83418446|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
83418447|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
83418448|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83418449|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
83418450|NCT03004209|Hematinics|hematinics|mesh-ancestor
83418451|NCT04800978|Durvalumab|durvalumab|mesh-list
83418452|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83418453|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418454|NCT04791774|Caseins|caseins|mesh-list
83418455|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
83418456|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
83418457|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418458|NCT00183469|Lamotrigine|lamotrigine|mesh-list
83418459|NCT00183469|Valproic Acid|valproic acid|mesh-list
83418460|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
83418461|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83418462|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83418463|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418464|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83418465|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418466|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83418467|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83418468|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418469|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83418470|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83418471|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418472|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
83418473|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418474|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
83418475|NCT02248155|Pramipexole|pramipexole|mesh-list
83418476|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
83418477|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418478|NCT02248155|Protective Agents|protective agents|mesh-ancestor
83418479|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418480|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83418481|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83418482|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
83418483|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
83418484|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418485|NCT02597946|Paclitaxel|paclitaxel|mesh-list
83418486|NCT02597946|Afatinib|afatinib|mesh-list
83418487|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83418488|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418489|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
83418490|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
83418491|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
83418492|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418493|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83418494|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418495|NCT02248233|Nimodipine|nimodipine|mesh-list
83418496|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83418497|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
83418498|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83418499|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83418501|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418502|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83418503|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418504|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
83418505|NCT04790838|Fluticasone|fluticasone|mesh-list
83418506|NCT04790838|Xhance|xhance|mesh-list
83418507|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83418508|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83418509|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83418510|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83418511|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
83418512|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418513|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418514|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83418515|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
83418516|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
83418517|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83418518|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83418519|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83418520|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83418521|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
83418522|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418523|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418524|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
83418525|NCT04790838|Hormones|hormones|mesh-ancestor
83418526|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83418527|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
83418528|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83418529|NCT03003273|Amoxicillin|amoxicillin|mesh-list
83418530|NCT03003273|Levofloxacin|levofloxacin|mesh-list
83418531|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
83418532|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
83418533|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418534|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83418535|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83418536|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83418537|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418538|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418539|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418540|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83418541|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83418542|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83418543|NCT05571345|Oxycodone|oxycodone|mesh-list
83418544|NCT05571345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83418545|NCT05571345|Narcotics|narcotics|mesh-ancestor
83418546|NCT05571345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418547|NCT05571345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418548|NCT05571345|Analgesics|analgesics|mesh-ancestor
83418549|NCT05571345|Sensory System Agents|sensory system agents|mesh-ancestor
83418550|NCT05571345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418551|NCT02981121|Metformin|metformin|mesh-list
83418552|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83418553|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418554|NCT02597478|Fentanyl|fentanyl|mesh-list
83418555|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83418556|NCT02597478|Narcotics|narcotics|mesh-ancestor
83418557|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418558|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418559|NCT02597478|Analgesics|analgesics|mesh-ancestor
83418560|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
83418561|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418562|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83418563|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83418564|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
83418565|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
83418566|NCT04811274|Dimercaprol|dimercaprol|mesh-list
83418567|NCT04811274|Chelating Agents|chelating agents|mesh-ancestor
83418568|NCT04811274|Sequestering Agents|sequestering agents|mesh-ancestor
83418569|NCT04811274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418570|NCT04799184|Epinephrine|epinephrine|mesh-list
83418571|NCT04799184|Racepinephrine|racepinephrine|mesh-list
83418572|NCT04799184|Bupivacaine|bupivacaine|mesh-list
83418573|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
83418574|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
83418578|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418579|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
83418580|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418581|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83418582|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83418583|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
83418584|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418585|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418586|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83418587|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83418588|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
83418589|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83418590|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
83418591|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
83418592|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
83418593|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83418594|NCT05562297|Paclitaxel|paclitaxel|mesh-list
83418595|NCT05562297|Gemcitabine|gemcitabine|mesh-list
83418596|NCT05562297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83418597|NCT05562297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418598|NCT05562297|Tubulin Modulators|tubulin modulators|mesh-ancestor
83418599|NCT05562297|Antimitotic Agents|antimitotic agents|mesh-ancestor
83418600|NCT05562297|Mitosis Modulators|mitosis modulators|mesh-ancestor
83418601|NCT05562297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418602|NCT05562297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83418603|NCT05562297|Antimetabolites|antimetabolites|mesh-ancestor
83418604|NCT03003195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83418605|NCT03003195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83418606|NCT03003195|Immunologic Factors|immunologic factors|mesh-ancestor
83418607|NCT03003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418608|NCT04790136|Cannabidiol|cannabidiol|mesh-list
83418609|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
83418610|NCT04339101|Sirolimus|sirolimus|mesh-list
83418611|NCT04339101|Fludarabine|fludarabine|mesh-list
83418612|NCT04339101|Melphalan|melphalan|mesh-list
83418613|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
83418614|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83418615|NCT04339101|Tacrolimus|tacrolimus|mesh-list
83418616|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418617|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418618|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83418619|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
83418620|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418621|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83418622|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418623|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83418624|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418625|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83418626|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
83418627|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83418628|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
83418629|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83418630|NCT03003039|Rituximab|rituximab|mesh-list
83418631|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83418632|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418633|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
83418634|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418635|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83418636|NCT03002961|Buprenorphine|buprenorphine|mesh-list
83418637|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83418638|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83418639|NCT03002961|Narcotics|narcotics|mesh-ancestor
83418640|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418641|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418642|NCT03002961|Analgesics|analgesics|mesh-ancestor
83418643|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
83418644|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418645|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83418646|NCT03002805|Doxorubicin|doxorubicin|mesh-list
83418647|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83418648|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418649|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83418650|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83418651|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418652|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418654|NCT05401227|Analgesics|analgesics|mesh-ancestor
83418655|NCT05401227|Sensory System Agents|sensory system agents|mesh-ancestor
83418656|NCT05401227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418657|NCT05401227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418658|NCT05401227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83418659|NCT05401227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83418660|NCT05401227|Anesthetics, General|anesthetics, general|mesh-ancestor
83418661|NCT05401227|Anesthetics|anesthetics|mesh-ancestor
83418662|NCT05401227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418663|NCT05401227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83418664|NCT05401227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83418665|NCT05401227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418666|NCT05401227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418667|NCT04214691|Acetaminophen|acetaminophen|mesh-list
83418668|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83418669|NCT04214691|Analgesics|analgesics|mesh-ancestor
83418670|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
83418671|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418672|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418673|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
83418674|NCT04786158|Apomorphine|apomorphine|mesh-list
83418675|NCT04786158|Emetics|emetics|mesh-ancestor
83418676|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418677|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
83418678|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418679|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83418680|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
83418681|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
83418682|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418683|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418684|NCT05367687|Apatinib|apatinib|mesh-list
83418685|NCT05367687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418686|NCT05367687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83418687|NCT05367687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418688|NCT05367687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418689|NCT03002493|Rifampin|rifampin|mesh-list
83418690|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83418691|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
83418692|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83418693|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418694|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
83418695|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83418696|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418697|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418698|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83418699|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83418700|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83418701|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83418702|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83418703|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83418704|NCT04786470|Ropivacaine|ropivacaine|mesh-list
83418705|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
83418706|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
83418707|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418708|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418709|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
83418710|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418711|NCT02219997|Methamphetamine|methamphetamine|mesh-list
83418712|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
83418713|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83418714|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83418715|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83418716|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418717|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
83418718|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
83418719|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418720|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
83418721|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418722|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418723|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
83418724|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83418800|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
83418725|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83418726|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83418727|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83418729|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83418730|NCT04786002|Busulfan|busulfan|mesh-list
83418731|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
83418732|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418733|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83418734|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
83418735|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418736|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83418737|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418738|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83418739|NCT04788654|Acetaminophen|acetaminophen|mesh-list
83418740|NCT04788654|Dexamethasone|dexamethasone|mesh-list
83418741|NCT04788654|Celecoxib|celecoxib|mesh-list
83418742|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83418743|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
83418744|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
83418745|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418746|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418747|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83418748|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
83418749|NCT04788654|Hormones|hormones|mesh-ancestor
83418750|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83418751|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83418752|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418753|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83418754|NCT04788654|Analgesics|analgesics|mesh-ancestor
83418755|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
83418756|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
83418757|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83418758|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83418759|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83418760|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83418761|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418762|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418763|NCT04785768|Morphine|morphine|mesh-list
83418764|NCT04785768|Hydromorphone|hydromorphone|mesh-list
83418765|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83418766|NCT04785768|Narcotics|narcotics|mesh-ancestor
83418767|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418768|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418769|NCT04785768|Analgesics|analgesics|mesh-ancestor
83418770|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
83418771|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418772|NCT02223351|Ritonavir|ritonavir|mesh-list
83418773|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83418774|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83418775|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
83418776|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418777|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418778|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83418779|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83418780|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
83418781|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418782|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83418783|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83418784|NCT02223429|Vasopressins|vasopressins|mesh-list
83418785|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
83418786|NCT02223429|Oxytocin|oxytocin|mesh-list
83418787|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418788|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
83418789|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83418790|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
83418791|NCT02223429|Coagulants|coagulants|mesh-ancestor
83418792|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83418793|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83418794|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
83418795|NCT03002649|Tofacitinib|tofacitinib|mesh-list
83418796|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418797|NCT03002649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83418798|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83418799|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418804|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418805|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418806|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
83418807|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418808|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83418809|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83418810|NCT04785222|Analgesics|analgesics|mesh-ancestor
83418811|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83418812|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83418813|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83418814|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
83418815|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418816|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418817|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
83418818|NCT04808856|Hormones|hormones|mesh-list
83418819|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83418820|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83418821|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
83418822|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83418823|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418824|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83418825|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
83418826|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
83418827|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418828|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83418829|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
83418830|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83418831|NCT04808856|Protective Agents|protective agents|mesh-ancestor
83418832|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418833|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418834|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
83418835|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
83418836|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418837|NCT04808622|Protective Agents|protective agents|mesh-ancestor
83418838|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418839|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83418840|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418841|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
83418842|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83418843|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
83418844|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83418845|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83418846|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
83418847|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418848|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83418849|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83418850|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418851|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418852|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83418853|NCT04784988|BAX 855|bax 855|mesh-list
83418854|NCT04784988|Coagulants|coagulants|mesh-ancestor
83418855|NCT04784910|Lansoprazole|lansoprazole|mesh-list
83418856|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
83418857|NCT04784910|Fexuprazan|fexuprazan|mesh-list
83418858|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83418859|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83418860|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83418861|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418862|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418864|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
83418865|NCT01625013|Protective Agents|protective agents|mesh-ancestor
83418866|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418867|NCT00083551|Interferons|interferons|mesh-list
83418868|NCT00083551|Cytarabine|cytarabine|mesh-list
83418869|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
83418870|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
83418871|NCT00083551|Thalidomide|thalidomide|mesh-list
83418872|NCT00083551|Dexamethasone|dexamethasone|mesh-list
83418873|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
83418874|NCT00083551|Melphalan|melphalan|mesh-list
83418875|NCT00083551|Carmustine|carmustine|mesh-list
83418876|NCT00083551|Cisplatin|cisplatin|mesh-list
83418877|NCT00083551|Doxorubicin|doxorubicin|mesh-list
83418878|NCT00083551|Etoposide|etoposide|mesh-list
83418879|NCT00083551|Vincristine|vincristine|mesh-list
83418880|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83418881|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
83418882|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418883|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83418884|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83418885|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
83418886|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418887|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418888|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83418889|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83418890|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
83418891|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
83418892|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418893|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83418894|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
83418895|NCT00083551|Hormones|hormones|mesh-ancestor
83418896|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83418897|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83418898|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83418899|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83418900|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83418901|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418902|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83418903|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
83418904|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418905|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83418906|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
83418907|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
83418908|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
83418909|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
83418910|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
83418911|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83418912|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83418913|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83418914|NCT00083551|Growth Substances|growth substances|mesh-ancestor
83418915|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
83418916|NCT01625169|Etravirine|etravirine|mesh-list
83418917|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83418918|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83418919|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418920|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418921|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
83418922|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418923|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83418924|NCT03933813|Hematinics|hematinics|mesh-ancestor
83418925|NCT01628601|Timolol|timolol|mesh-list
83418926|NCT01628601|Bimatoprost|bimatoprost|mesh-list
83418927|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83418928|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83418929|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
83418930|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418931|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418932|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418933|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83418934|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83418935|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
83418936|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418937|NCT04091022|Eflornithine|eflornithine|mesh-list
83418938|NCT04091022|Diclofenac|diclofenac|mesh-list
83418939|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83418940|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83418941|NCT04091022|Analgesics|analgesics|mesh-ancestor
83418942|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
83418943|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418944|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418945|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83418946|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83418947|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83418948|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418949|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418950|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418951|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83418952|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83418953|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83418954|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83418955|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83418956|NCT01490918|Metformin|metformin|mesh-list
83418961|NCT01490918|Incretins|incretins|mesh-ancestor
83418962|NCT01490918|Hormones|hormones|mesh-ancestor
83418963|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83418964|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83418965|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
83418966|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83418967|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418968|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83418969|NCT02230995|Metformin|metformin|mesh-list
83418970|NCT02230995|Empagliflozin|empagliflozin|mesh-list
83418971|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83418972|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418973|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83418974|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418975|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
83418976|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83418977|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83418978|NCT02995083|Prednisolone|prednisolone|mesh-list
83418979|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
83418980|NCT02995083|Lidocaine|lidocaine|mesh-list
83418981|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83418982|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
83418983|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
83418984|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
83418985|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418986|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418987|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
83418988|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83418989|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83418990|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83418991|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83418992|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83418993|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418994|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83418995|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
83418996|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
83418997|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83418998|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
83418999|NCT02995083|Hormones|hormones|mesh-ancestor
83419000|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83419001|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83419002|NCT02995083|Protective Agents|protective agents|mesh-ancestor
83419003|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83419004|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419005|NCT03794388|Pregabalin|pregabalin|mesh-list
83419006|NCT03794388|Capsaicin|capsaicin|mesh-list
83419007|NCT03794388|Analgesics|analgesics|mesh-ancestor
83419008|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
83419009|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419010|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419011|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
83419012|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83419013|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83419014|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419015|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83419016|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83419017|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83419018|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419019|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83419020|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
83419021|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
83419022|NCT04426422|Metformin|metformin|mesh-list
83419023|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83419024|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419025|NCT05471700|Azacitidine|azacitidine|mesh-list
83419026|NCT05471700|Venetoclax|venetoclax|mesh-list
83419027|NCT05471700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419028|NCT05471700|Antimetabolites|antimetabolites|mesh-ancestor
83419029|NCT05471700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419030|NCT05471700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419031|NCT05471700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419032|NCT01632423|Bimatoprost|bimatoprost|mesh-list
83419033|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83419035|NCT05466318|Gemcitabine|gemcitabine|mesh-list
83419036|NCT05466318|Etoposide|etoposide|mesh-list
83419037|NCT05466318|Melphalan|melphalan|mesh-list
83419038|NCT05466318|Busulfan|busulfan|mesh-list
83419039|NCT05466318|Carmustine|carmustine|mesh-list
83419040|NCT05466318|Cladribine|cladribine|mesh-list
83419041|NCT05466318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419042|NCT05466318|Antimetabolites|antimetabolites|mesh-ancestor
83419043|NCT05466318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419044|NCT05466318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419045|NCT05466318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83419046|NCT05466318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83419047|NCT05466318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83419048|NCT05466318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419049|NCT05466318|Antiviral Agents|antiviral agents|mesh-ancestor
83419050|NCT05466318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419051|NCT05466318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419052|NCT05466318|Immunologic Factors|immunologic factors|mesh-ancestor
83419053|NCT05466318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419054|NCT05466318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83419055|NCT05466318|Alkylating Agents|alkylating agents|mesh-ancestor
83419056|NCT05466318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83419057|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83419058|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419059|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419060|NCT01469546|Axitinib|axitinib|mesh-list
83419061|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419062|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83419063|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419064|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419065|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
83419066|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83419067|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419068|NCT03325101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83419069|NCT03325101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419070|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83419071|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83419072|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
83419073|NCT05613894|177Lu-PSMA-617|177lu-psma-617|mesh-list
83419074|NCT05613894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83419075|NCT05613894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419076|NCT00081263|Celecoxib|celecoxib|mesh-list
83419077|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
83419078|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83419079|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83419080|NCT00081263|Analgesics|analgesics|mesh-ancestor
83419081|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
83419082|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419083|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419084|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83419085|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83419086|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83419087|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83419088|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419089|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419090|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83419091|NCT03138603|Metoprolol|metoprolol|mesh-list
83419092|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83419093|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83419094|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
83419095|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
83419096|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419097|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419098|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83419099|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83419100|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83419101|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
83419102|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419103|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419105|NCT05087381|Niclosamide|niclosamide|mesh-list
83419106|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
83419107|NCT05087381|Bromhexine|bromhexine|mesh-list
83419108|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419109|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419110|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83419111|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83419112|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419113|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419114|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83419115|NCT05087381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83419116|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83419117|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83419118|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419119|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
83419120|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83419121|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
83419122|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83419123|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83419124|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83419125|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
83419126|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83419127|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
83419128|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83419129|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419130|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
83419131|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
83419132|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
83419133|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83419134|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83419135|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
83419136|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
83419137|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83419138|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83419139|NCT05087381|Expectorants|expectorants|mesh-ancestor
83419140|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
83419141|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
83419142|NCT00080483|Testosterone|testosterone|mesh-list
83419143|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
83419144|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
83419145|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83419146|NCT00080483|Androgens|androgens|mesh-ancestor
83419147|NCT00080483|Hormones|hormones|mesh-ancestor
83419148|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83419149|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419150|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83419151|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419152|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
83419153|NCT05248620|Amoxicillin|amoxicillin|mesh-list
83419154|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83419155|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419156|NCT01639599|Dexamethasone|dexamethasone|mesh-list
83419157|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
83419158|NCT01639599|Haloperidol|haloperidol|mesh-list
83419159|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
83419160|NCT01639599|BB 1101|bb 1101|mesh-list
83419161|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83419162|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
83419163|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
83419164|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419165|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419166|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83419167|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
83419168|NCT01639599|Hormones|hormones|mesh-ancestor
83419169|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83419170|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83419171|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419172|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
83419173|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419174|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419175|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83419176|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83419177|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419178|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83419179|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83419180|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
83419181|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419182|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83419183|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
83419184|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83419185|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419186|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83419187|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
83419188|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83419189|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419190|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419191|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419192|NCT02227329|Ethanol|ethanol|mesh-list
83419193|NCT02227329|Heparin|heparin|mesh-list
83419194|NCT02227329|Calcium heparin|calcium heparin|mesh-list
83419195|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
83419196|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83419197|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83419198|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419199|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83419200|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419201|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419202|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419203|NCT05611242|Cangrelor|cangrelor|mesh-list
83419204|NCT05611242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83419205|NCT05611242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83419206|NCT05611242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83419207|NCT05611242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83419208|NCT05611242|Purinergic Agents|purinergic agents|mesh-ancestor
83419209|NCT05611242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419210|NCT05611242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419211|NCT05611242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419212|NCT05615142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83419213|NCT05615142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419214|NCT05615142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83419215|NCT05615142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419216|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
83419217|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83419218|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419219|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
83419220|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
83419221|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83419222|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419223|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419224|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83419225|NCT03172897|Analgesics|analgesics|mesh-ancestor
83419226|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
83419227|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419228|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83419229|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83419230|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83419231|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
83419232|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419233|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419234|NCT00086723|Captopril|captopril|mesh-list
83419235|NCT00086723|Plasminogen|plasminogen|mesh-list
83419236|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83419237|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83419238|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83419239|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419240|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83419241|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
83419242|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419243|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83419244|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
83419245|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419246|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
83419247|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
83419248|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
83419249|NCT05346419|Vitamin D|vitamin d|mesh-list
83419250|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
83419251|NCT05346419|Vitamins|vitamins|mesh-ancestor
83419252|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
83419253|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419254|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83419255|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83419256|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83419484|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
83419257|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419258|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83419259|NCT00084409|Iloprost|iloprost|mesh-list
83419260|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83419261|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
83419262|NCT03831165|Acyclovir|acyclovir|mesh-list
83419263|NCT03831165|Melatonin|melatonin|mesh-list
83419264|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
83419265|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419266|NCT03831165|Protective Agents|protective agents|mesh-ancestor
83419267|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419268|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419269|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
83419270|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419271|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83419272|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83419273|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83419274|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419275|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419276|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83419277|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83419278|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83419279|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83419280|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
83419281|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419282|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419283|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83419284|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83419285|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
83419286|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83419287|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83419288|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
83419289|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
83419290|NCT03849651|Melphalan|melphalan|mesh-list
83419291|NCT03849651|Thiotepa|thiotepa|mesh-list
83419292|NCT03849651|Fludarabine|fludarabine|mesh-list
83419293|NCT03849651|Blinatumomab|blinatumomab|mesh-list
83419294|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
83419295|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419296|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
83419297|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419298|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83419299|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83419300|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
83419301|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419302|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419303|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83419304|NCT05574985|Vaccines|vaccines|mesh-list
83419305|NCT05574985|Immunologic Factors|immunologic factors|mesh-ancestor
83419306|NCT05574985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419307|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
83419308|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83419309|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419310|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83419311|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419312|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83419313|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83419314|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419315|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419316|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419317|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83419318|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
83419319|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83419320|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83419321|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83419322|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83419323|NCT04773366|Cytarabine|cytarabine|mesh-list
83419324|NCT04773366|Prednisone|prednisone|mesh-list
83419325|NCT04773366|Vincristine|vincristine|mesh-list
83419326|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
83419327|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83419328|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
83419329|NCT04773366|Hormones|hormones|mesh-ancestor
83419330|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83419331|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419332|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83419333|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419334|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419335|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
83419336|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419337|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
83419338|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419339|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419340|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
83419341|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83419342|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
83419343|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
83419344|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
83419345|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83419346|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419347|NCT04714541|Ketamine|ketamine|mesh-list
83419348|NCT04714541|Analgesics|analgesics|mesh-ancestor
83419349|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
83419350|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419351|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419352|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83419353|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83419354|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
83419355|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
83419356|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419357|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83419358|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83419359|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419360|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419361|NCT02414724|Gemcitabine|gemcitabine|mesh-list
83419362|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419363|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
83419364|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419365|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419366|NCT00187681|Metformin|metformin|mesh-list
83419367|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83419368|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419369|NCT00083759|Natalizumab|natalizumab|mesh-list
83419370|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
83419371|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419372|NCT02412228|Dexamethasone|dexamethasone|mesh-list
83419373|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
83419374|NCT02412228|Ixazomib|ixazomib|mesh-list
83419375|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419376|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
83419377|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419378|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83419379|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83419380|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
83419381|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419382|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419383|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83419384|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83419385|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
83419386|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
83419387|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419388|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83419389|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
83419390|NCT02412228|Hormones|hormones|mesh-ancestor
83419391|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83419392|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83419393|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
83419394|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419395|NCT03693807|Gemcitabine|gemcitabine|mesh-list
83419396|NCT03693807|Fluorouracil|fluorouracil|mesh-list
83419397|NCT03693807|Floxuridine|floxuridine|mesh-list
83419398|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
83419399|NCT03693807|Irinotecan|irinotecan|mesh-list
83419400|NCT03693807|Cetuximab|cetuximab|mesh-list
83419401|NCT03693807|Panitumumab|panitumumab|mesh-list
83419402|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419403|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
83419404|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419405|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419406|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419407|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
83419408|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419409|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83419410|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83419411|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419412|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83419413|NCT01646151|Bimatoprost|bimatoprost|mesh-list
83419414|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83419415|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83419416|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83419417|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419418|NCT03692403|Quinagolide|quinagolide|mesh-list
83419419|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
83419420|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
83419421|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419422|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419423|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419424|NCT01828710|Folic Acid|folic acid|mesh-list
83419425|NCT01828710|Inositol|inositol|mesh-list
83419426|NCT01828710|Hematinics|hematinics|mesh-ancestor
83419427|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
83419428|NCT01828710|Vitamins|vitamins|mesh-ancestor
83419429|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
83419430|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419431|NCT00088699|Ketamine|ketamine|mesh-list
83419432|NCT00088699|Analgesics|analgesics|mesh-ancestor
83419433|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
83419434|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419435|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419436|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83419437|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83419438|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
83419439|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
83419440|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419441|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83419442|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83419443|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419444|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419445|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
83419446|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83419447|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83419448|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419449|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
83419450|NCT02233101|Coagulants|coagulants|mesh-ancestor
83419451|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
83419452|NCT00089011|Fludarabine|fludarabine|mesh-list
83419453|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
83419454|NCT00089011|Tacrolimus|tacrolimus|mesh-list
83419455|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419456|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419457|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
83419458|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419459|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419460|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
83419461|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419462|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83419463|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419464|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83419465|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83419466|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
83419467|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83419468|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419469|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
83419470|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
83419471|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83419472|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419473|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83419474|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
83419475|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83419476|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419477|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419478|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419479|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83419480|NCT00347412|Paclitaxel|paclitaxel|mesh-list
83419481|NCT00347412|Carboplatin|carboplatin|mesh-list
83419482|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83419483|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419487|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419489|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83419490|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
83419491|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83419492|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
83419493|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83419494|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419495|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83419496|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83419497|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419498|NCT00091273|Sargramostim|sargramostim|mesh-list
83419499|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
83419500|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
83419501|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419502|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83419503|NCT00193375|Bevacizumab|bevacizumab|mesh-list
83419504|NCT00193375|Carboplatin|carboplatin|mesh-list
83419505|NCT00193375|Irinotecan|irinotecan|mesh-list
83419506|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83419507|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419508|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83419509|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83419510|NCT00193375|Growth Substances|growth substances|mesh-ancestor
83419511|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419512|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
83419513|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83419514|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83419515|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419516|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419517|NCT05475210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83419518|NCT05475210|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
83419519|NCT05475210|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83419520|NCT05475210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419521|NCT00193453|Gemcitabine|gemcitabine|mesh-list
83419522|NCT00193453|Docetaxel|docetaxel|mesh-list
83419523|NCT00193453|Cetuximab|cetuximab|mesh-list
83419524|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419525|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
83419526|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419527|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419528|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
83419529|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
83419530|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
83419531|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83419532|NCT05614518|Methylene diphosphonate|methylene diphosphonate|mesh-list
83419533|NCT05614518|Listerine|listerine|mesh-list
83419534|NCT05614518|Fluorides|fluorides|mesh-list
83419535|NCT05614518|Sodium Fluoride|sodium fluoride|mesh-list
83419536|NCT05614518|Cariostatic Agents|cariostatic agents|mesh-ancestor
83419537|NCT05614518|Protective Agents|protective agents|mesh-ancestor
83419538|NCT05614518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419539|NCT05614518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83419540|NCT05614518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419541|NCT05614518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83419542|NCT00091507|Insulin|insulin|mesh-list
83419543|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83419544|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419545|NCT05611086|Acetylcysteine|acetylcysteine|mesh-list
83419546|NCT05611086|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83419547|NCT05611086|Antiviral Agents|antiviral agents|mesh-ancestor
83419548|NCT05611086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419549|NCT05611086|Expectorants|expectorants|mesh-ancestor
83419550|NCT05611086|Respiratory System Agents|respiratory system agents|mesh-ancestor
83419551|NCT05611086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83419552|NCT05611086|Antioxidants|antioxidants|mesh-ancestor
83419553|NCT05611086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419554|NCT05611086|Protective Agents|protective agents|mesh-ancestor
83419555|NCT05611086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419556|NCT05611086|Antidotes|antidotes|mesh-ancestor
83419557|NCT05614440|Tramadol|tramadol|mesh-list
83419558|NCT05614440|Anesthetics|anesthetics|mesh-list
83419559|NCT05614440|Anesthetics, Local|anesthetics, local|mesh-list
83419560|NCT05614440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419561|NCT05614440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419566|NCT05614440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419567|NCT05613192|Vitamin D|vitamin d|mesh-list
83419568|NCT05613192|Cholecalciferol|cholecalciferol|mesh-list
83419569|NCT05613192|Vitamins|vitamins|mesh-ancestor
83419570|NCT05613192|Micronutrients|micronutrients|mesh-ancestor
83419571|NCT05613192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419572|NCT05613192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83419573|NCT05613192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83419574|NCT00194779|Tamoxifen|tamoxifen|mesh-list
83419575|NCT00194779|Vinorelbine|vinorelbine|mesh-list
83419576|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
83419577|NCT00194779|Doxorubicin|doxorubicin|mesh-list
83419578|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83419579|NCT00194779|Capecitabine|capecitabine|mesh-list
83419580|NCT00194779|Methotrexate|methotrexate|mesh-list
83419581|NCT00194779|Trastuzumab|trastuzumab|mesh-list
83419582|NCT00194779|Letrozole|letrozole|mesh-list
83419583|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83419584|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419585|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
83419586|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
83419587|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
83419588|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419589|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419590|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
83419591|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419592|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83419593|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83419594|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
83419595|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83419596|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83419597|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83419598|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83419599|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419600|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419601|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
83419602|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83419603|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
83419604|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83419605|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
83419606|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83419607|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83419608|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83419609|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83419610|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83419611|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83419612|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
83419613|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83419614|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83419615|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83419616|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83419617|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83419618|NCT05474664|Camostat|camostat|mesh-list
83419619|NCT05474664|Protease Inhibitors|protease inhibitors|mesh-ancestor
83419620|NCT05474664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419621|NCT05474664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419622|NCT05474664|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83419623|NCT05474664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83419624|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
83419625|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83419626|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
83419627|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
83419628|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419629|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419630|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83419631|NCT02096575|Analgesics|analgesics|mesh-ancestor
83419632|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
83419633|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419634|NCT04338984|Fentanyl|fentanyl|mesh-list
83419635|NCT04338984|Ropivacaine|ropivacaine|mesh-list
83419636|NCT04338984|Anesthetics|anesthetics|mesh-list
83419637|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
83419638|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
83419639|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419640|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419641|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
83419642|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419643|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83419645|NCT04338984|Analgesics|analgesics|mesh-ancestor
83419646|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83419647|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83419648|NCT00095563|Lapatinib|lapatinib|mesh-list
83419649|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419650|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83419651|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419652|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419653|NCT05473806|Pioglitazone|pioglitazone|mesh-list
83419654|NCT05473806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83419655|NCT05473806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419656|NCT00089609|Thalidomide|thalidomide|mesh-list
83419657|NCT00089609|Prednisone|prednisone|mesh-list
83419658|NCT00089609|Bevacizumab|bevacizumab|mesh-list
83419659|NCT00089609|Docetaxel|docetaxel|mesh-list
83419660|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83419661|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419662|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83419663|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83419664|NCT00089609|Growth Substances|growth substances|mesh-ancestor
83419665|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419666|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
83419667|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
83419668|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
83419669|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
83419670|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419671|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83419672|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
83419673|NCT00089609|Hormones|hormones|mesh-ancestor
83419674|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83419675|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83419676|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419677|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
83419678|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
83419679|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83419680|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419681|NCT04661514|Psilocybin|psilocybin|mesh-list
83419682|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
83419683|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419684|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83419685|NCT00195403|Etanercept|etanercept|mesh-list
83419686|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83419687|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83419688|NCT00195403|Analgesics|analgesics|mesh-ancestor
83419689|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
83419690|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419691|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419692|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83419693|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83419694|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83419695|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419696|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
83419697|NCT04643327|Levetiracetam|levetiracetam|mesh-list
83419698|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
83419699|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
83419700|NCT00095875|Carboplatin|carboplatin|mesh-list
83419701|NCT00095875|Docetaxel|docetaxel|mesh-list
83419703|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419704|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
83419705|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
83419706|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
83419707|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419708|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
83419709|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419710|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419711|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
83419712|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419713|NCT03086993|Gemcitabine|gemcitabine|mesh-list
83419714|NCT03086993|Melphalan|melphalan|mesh-list
83419715|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419716|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419717|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
83419718|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419719|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83419720|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
83419721|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83419722|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419723|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
83419724|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419725|NCT03704363|Infliximab|infliximab|mesh-list
83419726|NCT03704363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83419727|NCT03704363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83419728|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
83419729|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83419730|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83419731|NCT04089072|Phenylephrine|phenylephrine|mesh-list
83419732|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
83419733|NCT04089072|Methylene Blue|methylene blue|mesh-list
83419734|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83419735|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
83419736|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
83419737|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419738|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419739|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
83419740|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83419741|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
83419742|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
83419743|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83419744|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83419745|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83419746|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
83419747|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419748|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419749|NCT04089072|Protective Agents|protective agents|mesh-ancestor
83419750|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419751|NCT00006227|Paclitaxel|paclitaxel|mesh-list
83419752|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83419753|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419754|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83419755|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83419756|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83419757|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419758|NCT00097669|Folic Acid|folic acid|mesh-list
83419759|NCT00097669|Hematinics|hematinics|mesh-ancestor
83419760|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
83419761|NCT00097669|Vitamins|vitamins|mesh-ancestor
83419762|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
83419763|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419764|NCT05612880|Androgens|androgens|mesh-list
83419765|NCT05612880|Hormones|hormones|mesh-ancestor
83419766|NCT05612880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83419767|NCT05612880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419768|NCT00010439|Alendronate|alendronate|mesh-list
83419769|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83419770|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419771|NCT03908736|Picolinic acid|picolinic acid|mesh-list
83419772|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83419773|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
83419774|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
83419775|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419776|NCT05468892|Trifluridine|trifluridine|mesh-list
83419777|NCT05468892|Panitumumab|panitumumab|mesh-list
83419778|NCT05468892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83419779|NCT05468892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419780|NCT05468892|Antimetabolites|antimetabolites|mesh-ancestor
83419781|NCT05468892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419782|NCT05468892|Antiviral Agents|antiviral agents|mesh-ancestor
83419783|NCT05468892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419784|NCT00200161|Temozolomide|temozolomide|mesh-list
83419785|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83419786|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
83419787|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419788|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419789|NCT00016913|Paclitaxel|paclitaxel|mesh-list
83419790|NCT00016913|Carboplatin|carboplatin|mesh-list
83419791|NCT00016913|Leuprolide|leuprolide|mesh-list
83419792|NCT00016913|Goserelin|goserelin|mesh-list
83419793|NCT00016913|Estramustine|estramustine|mesh-list
83419794|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83419795|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419796|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
83419797|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
83419798|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
83419799|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419800|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83419801|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
83419802|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83419803|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419804|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83419805|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83419806|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
83419807|NCT00023309|Lamivudine|lamivudine|mesh-list
83419808|NCT00023309|Adefovir|adefovir|mesh-list
83419809|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83419810|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83419811|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83419812|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419813|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419814|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
83419815|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419816|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83419817|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83419818|NCT00098059|Famciclovir|famciclovir|mesh-list
83419819|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
83419820|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419821|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83419822|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419823|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419824|NCT02440581|Alendronate|alendronate|mesh-list
83419825|NCT02440581|Teriparatide|teriparatide|mesh-list
83419826|NCT02440581|Cinacalcet|cinacalcet|mesh-list
83419827|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83419828|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419829|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83419830|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83419831|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
83419832|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83419833|NCT01359150|Tofacitinib|tofacitinib|mesh-list
83419834|NCT01359150|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83419835|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83419836|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419837|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419838|NCT00098371|Alvocidib|alvocidib|mesh-list
83419839|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419840|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
83419841|NCT00098371|Growth Substances|growth substances|mesh-ancestor
83419842|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419843|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83419844|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419845|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419846|NCT04745988|Leucovorin|leucovorin|mesh-list
83419847|NCT04745988|Docetaxel|docetaxel|mesh-list
83419848|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
83419849|NCT04745988|Fluorouracil|fluorouracil|mesh-list
83419850|NCT04745988|Oxaliplatin|oxaliplatin|mesh-list
83419851|NCT04745988|Lenvatinib|lenvatinib|mesh-list
83419852|NCT04745988|Levoleucovorin|levoleucovorin|mesh-list
83419853|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419854|NCT04745988|Tubulin Modulators|tubulin modulators|mesh-ancestor
83419855|NCT04745988|Antimitotic Agents|antimitotic agents|mesh-ancestor
83419856|NCT04745988|Mitosis Modulators|mitosis modulators|mesh-ancestor
83419857|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419858|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83419859|NCT04745988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83419860|NCT04745988|Antimetabolites|antimetabolites|mesh-ancestor
83419861|NCT04745988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419862|NCT04745988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419863|NCT04745988|Immunologic Factors|immunologic factors|mesh-ancestor
83419864|NCT04745988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419865|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83419866|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419867|NCT04745988|Antidotes|antidotes|mesh-ancestor
83419868|NCT04745988|Protective Agents|protective agents|mesh-ancestor
83419869|NCT04745988|Vitamin B Complex|vitamin b complex|mesh-ancestor
83419870|NCT04745988|Vitamins|vitamins|mesh-ancestor
83419874|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
83419875|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419876|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83419877|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419878|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419879|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
83419880|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83419881|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83419882|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
83419883|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419884|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419885|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419886|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
83419887|NCT04351191|Chloroquine|chloroquine|mesh-list
83419888|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
83419889|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83419890|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83419891|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419892|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419893|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419894|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83419895|NCT04351191|Amebicides|amebicides|mesh-ancestor
83419896|NCT01469000|Pemetrexed|pemetrexed|mesh-list
83419897|NCT01469000|Gefitinib|gefitinib|mesh-list
83419898|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419899|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419900|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419901|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83419902|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83419903|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83419904|NCT05557578|Gemcitabine|gemcitabine|mesh-list
83419905|NCT05557578|Oxaliplatin|oxaliplatin|mesh-list
83419906|NCT05557578|Tislelizumab|tislelizumab|mesh-list
83419907|NCT05557578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419908|NCT05557578|Antimetabolites|antimetabolites|mesh-ancestor
83419909|NCT05557578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419910|NCT05557578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419911|NCT05557578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83419912|NCT00201877|Rituximab|rituximab|mesh-list
83419913|NCT00201877|Bortezomib|bortezomib|mesh-list
83419914|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83419915|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419916|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
83419917|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419918|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83419919|NCT05399628|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83419920|NCT05399628|Respiratory System Agents|respiratory system agents|mesh-ancestor
83419921|NCT01490060|Dexamethasone|dexamethasone|mesh-list
83419922|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
83419923|NCT01490060|Doxorubicin|doxorubicin|mesh-list
83419924|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83419925|NCT01490060|Vincristine|vincristine|mesh-list
83419926|NCT01490060|Ifosfamide|ifosfamide|mesh-list
83419927|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
83419928|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
83419929|NCT01490060|Aprepitant|aprepitant|mesh-list
83419930|NCT01490060|BB 1101|bb 1101|mesh-list
83419931|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83419932|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
83419933|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
83419934|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419935|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419936|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83419937|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
83419938|NCT01490060|Hormones|hormones|mesh-ancestor
83419939|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83419940|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83419941|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419942|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
83419943|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419944|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419945|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83419946|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83419947|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83420023|NCT03085680|Curcumin|curcumin|mesh-list
83419949|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
83419950|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
83419951|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
83419952|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83419953|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
83419954|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83419955|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419956|NCT04090736|Azacitidine|azacitidine|mesh-list
83419957|NCT04090736|Pevonedistat|pevonedistat|mesh-list
83419958|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83419959|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
83419960|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419961|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419962|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419963|NCT05557344|Acetaminophen|acetaminophen|mesh-list
83419964|NCT05557344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83419965|NCT05557344|Analgesics|analgesics|mesh-ancestor
83419966|NCT05557344|Sensory System Agents|sensory system agents|mesh-ancestor
83419967|NCT05557344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83419968|NCT05557344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419969|NCT05557344|Antipyretics|antipyretics|mesh-ancestor
83419970|NCT00101413|Sorafenib|sorafenib|mesh-list
83419971|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83419972|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83419973|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419974|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419975|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
83419976|NCT01246869|Imidazole|imidazole|mesh-list
83419977|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419978|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419979|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
83419980|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
83419981|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83419982|NCT01452152|Clopidogrel|clopidogrel|mesh-list
83419983|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83419984|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83419985|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83419986|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83419987|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83419988|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
83419989|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83419990|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83419991|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419992|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
83419993|NCT01451762|Promethazine|promethazine|mesh-list
83419994|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83419995|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83419996|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83419997|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419998|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
83419999|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
83420000|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
83420001|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420002|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
83420003|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
83420004|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83420005|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83420006|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
83420008|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420009|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420010|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83420011|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
83420012|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
83420013|NCT01654107|Nicotine|nicotine|mesh-list
83420014|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83420015|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
83420016|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420017|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420018|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83420019|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83420020|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
83420021|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420022|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420024|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83420025|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83420027|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
83420028|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420029|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420030|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420031|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420032|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420033|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420034|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420035|NCT01468844|Minocycline|minocycline|mesh-list
83420036|NCT01468844|Bevacizumab|bevacizumab|mesh-list
83420037|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83420038|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420039|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83420040|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83420041|NCT01468844|Growth Substances|growth substances|mesh-ancestor
83420042|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420043|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
83420044|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83420045|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420046|NCT03029598|Carboplatin|carboplatin|mesh-list
83420047|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
83420048|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420049|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83420050|NCT03029598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83420051|NCT03029598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420052|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83420053|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83420054|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83420055|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83420056|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420057|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420058|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420059|NCT01451606|Analgesics|analgesics|mesh-ancestor
83420060|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
83420061|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420062|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
83420063|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83420064|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
83420065|NCT00204373|Lansoprazole|lansoprazole|mesh-list
83420066|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
83420067|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83420068|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83420069|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83420070|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420071|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420072|NCT01655043|Regadenoson|regadenoson|mesh-list
83420073|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83420074|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83420075|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
83420076|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
83420077|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420078|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420079|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420080|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83420081|NCT00473343|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83420082|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83420083|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
83420084|NCT00003927|Paclitaxel|paclitaxel|mesh-list
83420085|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
83420086|NCT00003927|Doxorubicin|doxorubicin|mesh-list
83420087|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83420088|NCT00003927|Amifostine|amifostine|mesh-list
83420089|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83420090|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420091|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
83420092|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
83420093|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
83420094|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420095|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420096|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
83420097|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420098|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420099|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83420100|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
83420101|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83420102|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83420103|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83420104|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83420105|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420106|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83420107|NCT00003927|Protective Agents|protective agents|mesh-ancestor
83420108|NCT00032591|Thrombin|thrombin|mesh-list
83420109|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
83420110|NCT00032591|Coagulants|coagulants|mesh-ancestor
83420111|NCT01660191|Atorvastatin|atorvastatin|mesh-list
83420112|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83420113|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83420114|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83420115|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
83420116|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420117|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83420118|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83420119|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420120|NCT00033917|Indomethacin|indomethacin|mesh-list
83420121|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83420122|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83420123|NCT00033917|Analgesics|analgesics|mesh-ancestor
83420124|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
83420125|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420126|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420127|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420128|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420129|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
83420130|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
83420131|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83420132|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83420133|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420134|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420135|NCT00036569|Interferons|interferons|mesh-list
83420136|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
83420137|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420138|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
83420139|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420140|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
83420141|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420142|NCT01660893|Phenylephrine|phenylephrine|mesh-list
83420143|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
83420144|NCT01660893|Tetracaine|tetracaine|mesh-list
83420145|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
83420146|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
83420147|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420148|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420149|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
83420150|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420151|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83420152|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83420153|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
83420154|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420155|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420156|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
83420157|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
83420158|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
83420159|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83420160|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
83420161|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83420162|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
83420163|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83420164|NCT01660893|Protective Agents|protective agents|mesh-ancestor
83420165|NCT01661283|Bevacizumab|bevacizumab|mesh-list
83420166|NCT01661283|Everolimus|everolimus|mesh-list
83420167|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83420168|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420169|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83420170|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83420171|NCT01661283|Growth Substances|growth substances|mesh-ancestor
83420172|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420175|NCT01661283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83420176|NCT01661283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420177|NCT01661283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420178|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420179|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
83420180|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
83420181|NCT01946373|Fludarabine|fludarabine|mesh-list
83420182|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
83420183|NCT01946373|Interleukin-2|interleukin-2|mesh-list
83420184|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420185|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
83420186|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420187|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420188|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83420189|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
83420190|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420191|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420192|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83420193|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83420194|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
83420195|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83420196|NCT01946373|Analgesics|analgesics|mesh-ancestor
83420197|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
83420198|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420199|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83420200|NCT01662297|Trazodone|trazodone|mesh-list
83420201|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
83420202|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83420203|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83420204|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83420205|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420206|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420207|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83420208|NCT01662297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83420209|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83420210|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83420211|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420212|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420213|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
83420214|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83420215|NCT01600287|Propofol|propofol|mesh-list
83420216|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83420217|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420218|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420219|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83420220|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
83420221|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
83420222|NCT00040937|Thalidomide|thalidomide|mesh-list
83420223|NCT00040937|Dexamethasone|dexamethasone|mesh-list
83420224|NCT00040937|Prednisone|prednisone|mesh-list
83420225|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
83420226|NCT00040937|Melphalan|melphalan|mesh-list
83420227|NCT00040937|Sargramostim|sargramostim|mesh-list
83420228|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420229|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
83420230|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420231|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420232|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83420233|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
83420234|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420235|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420236|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83420237|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420238|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
83420239|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
83420240|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420241|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83420242|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
83420243|NCT00040937|Hormones|hormones|mesh-ancestor
83420244|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83420245|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83420246|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
83420247|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83420248|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420249|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83420251|NCT00040937|Growth Substances|growth substances|mesh-ancestor
83420252|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
83420253|NCT04756895|Vancomycin|vancomycin|mesh-list
83420254|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83420255|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420256|NCT02234115|Leuprolide|leuprolide|mesh-list
83420257|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83420258|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
83420259|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83420260|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420261|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83420262|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420263|NCT02234427|Aspirin|aspirin|mesh-list
83420264|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83420265|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83420266|NCT02234427|Analgesics|analgesics|mesh-ancestor
83420267|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
83420268|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420269|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420270|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420271|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420272|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83420273|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83420274|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420275|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83420276|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83420277|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420278|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
83420279|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
83420280|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83420281|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83420282|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420283|NCT01663935|Levodopa|levodopa|mesh-list
83420284|NCT01663935|Carbidopa|carbidopa|mesh-list
83420285|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83420286|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83420287|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
83420288|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420289|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420290|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420291|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83420292|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420293|NCT01664559|Ketorolac|ketorolac|mesh-list
83420294|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83420295|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83420296|NCT01664559|Analgesics|analgesics|mesh-ancestor
83420297|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
83420298|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420299|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420300|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420301|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420302|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83420303|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420304|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420305|NCT00046475|Midodrine|midodrine|mesh-list
83420306|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
83420307|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
83420308|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420309|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420310|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83420311|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83420312|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83420313|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83420314|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
83420315|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420316|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420317|NCT01894685|Mesalamine|mesalamine|mesh-list
83420318|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83420319|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83420320|NCT01894685|Analgesics|analgesics|mesh-ancestor
83420321|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
83420322|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420323|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420324|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420325|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420326|NCT01695291|Minocycline|minocycline|mesh-list
83420327|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83420328|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420329|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
83420330|NCT00048737|Rituximab|rituximab|mesh-list
83420331|NCT00048737|Fludarabine|fludarabine|mesh-list
83420332|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
83420333|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420334|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
83420335|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420336|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420337|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83420338|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
83420339|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420340|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420341|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83420342|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83420343|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83420344|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
83420345|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
83420346|NCT01604109|Caseins|caseins|mesh-list
83420347|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83420348|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
83420349|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420350|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420351|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420352|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
83420353|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
83420354|NCT01666197|Diclofenac|diclofenac|mesh-list
83420355|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83420356|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83420357|NCT01666197|Analgesics|analgesics|mesh-ancestor
83420358|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
83420359|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420360|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420361|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420362|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420363|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83420364|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420365|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420366|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83420367|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
83420368|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83420369|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83420370|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83420371|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420372|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420373|NCT00048815|Citalopram|citalopram|mesh-list
83420374|NCT00048815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83420375|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83420376|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83420377|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420378|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420379|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
83420380|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420381|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83420382|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
83420383|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83420384|NCT01605903|Acetaminophen|acetaminophen|mesh-list
83420385|NCT01605903|Ibuprofen|ibuprofen|mesh-list
83420386|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83420387|NCT01605903|Analgesics|analgesics|mesh-ancestor
83420388|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
83420389|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420390|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420391|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
83420392|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83420393|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420394|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420395|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83420396|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420397|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420399|NCT00048893|Paclitaxel|paclitaxel|mesh-list
83420400|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
83420401|NCT00048893|Doxorubicin|doxorubicin|mesh-list
83420402|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83420403|NCT00048893|Fludarabine|fludarabine|mesh-list
83420404|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
83420405|NCT00048893|Vaccines|vaccines|mesh-list
83420406|NCT00048893|Sargramostim|sargramostim|mesh-list
83420407|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
83420408|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420409|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83420410|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420411|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
83420412|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
83420413|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
83420414|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420415|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420416|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420417|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83420418|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
83420419|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83420420|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83420421|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83420422|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83420423|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420424|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83420425|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
83420426|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420427|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83420428|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83420429|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83420430|NCT01607853|Calcitriol|calcitriol|mesh-list
83420431|NCT01607853|Betamethasone|betamethasone|mesh-list
83420432|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420433|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
83420434|NCT01607853|Hormones|hormones|mesh-ancestor
83420435|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83420436|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420437|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83420438|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
83420439|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83420440|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83420441|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83420442|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420443|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83420444|NCT01607853|Vitamins|vitamins|mesh-ancestor
83420445|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
83420446|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83420447|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83420448|NCT01700517|Anesthetics|anesthetics|mesh-list
83420449|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420450|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420451|NCT00101647|Dasatinib|dasatinib|mesh-list
83420452|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420453|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83420454|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420455|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420456|NCT01669785|Listerine|listerine|mesh-list
83420457|NCT01669785|Fluorides|fluorides|mesh-list
83420458|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
83420459|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
83420460|NCT01669785|Protective Agents|protective agents|mesh-ancestor
83420461|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420462|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83420463|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420464|NCT05327491|Sotorasib|sotorasib|mesh-list
83420465|NCT05327491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83420466|NCT05327491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420467|NCT05327491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83420468|NCT05327491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420469|NCT03089645|Docetaxel|docetaxel|mesh-list
83420470|NCT03089645|Durvalumab|durvalumab|mesh-list
83420471|NCT03089645|Tremelimumab|tremelimumab|mesh-list
83420472|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83420474|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
83420475|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
83420476|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
83420477|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420478|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83420479|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
83420480|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420481|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
83420482|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83420483|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420484|NCT02587962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83420485|NCT02587962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420486|NCT01931033|Oxytocin|oxytocin|mesh-list
83420487|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
83420488|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83420489|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420490|NCT01671423|Prednisone|prednisone|mesh-list
83420491|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420492|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
83420493|NCT01671423|Hormones|hormones|mesh-ancestor
83420494|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83420495|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420496|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83420497|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420498|NCT02092181|Mirabegron|mirabegron|mesh-list
83420499|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83420500|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83420501|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83420502|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
83420503|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420504|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420505|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420506|NCT02092181|Urological Agents|urological agents|mesh-ancestor
83420507|NCT01672827|Flutemetamol|flutemetamol|mesh-list
83420508|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83420509|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420510|NCT01700907|Sevoflurane|sevoflurane|mesh-list
83420511|NCT01700907|Desflurane|desflurane|mesh-list
83420512|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83420513|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83420514|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
83420515|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
83420516|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420517|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420518|NCT03089567|Listerine|listerine|mesh-list
83420519|NCT03089567|Fluorides|fluorides|mesh-list
83420520|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
83420521|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
83420522|NCT03089567|Protective Agents|protective agents|mesh-ancestor
83420523|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420524|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83420525|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420527|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83420528|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420529|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420530|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420531|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
83420532|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83420533|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
83420534|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420535|NCT01612221|Expectorants|expectorants|mesh-ancestor
83420536|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
83420537|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83420538|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
83420539|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420540|NCT01612221|Protective Agents|protective agents|mesh-ancestor
83420541|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420542|NCT01612221|Antidotes|antidotes|mesh-ancestor
83420543|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
83420544|NCT00105001|Sirolimus|sirolimus|mesh-list
83420545|NCT00105001|Fludarabine|fludarabine|mesh-list
83420546|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
83420547|NCT00105001|Tacrolimus|tacrolimus|mesh-list
83420548|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420549|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83420550|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
83420551|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420552|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420553|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
83420554|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420555|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83420556|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420557|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83420558|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83420559|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
83420560|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83420561|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420562|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
83420564|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
83420565|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420566|NCT02642640|Protective Agents|protective agents|mesh-ancestor
83420567|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420568|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420569|NCT01701375|Palbociclib|palbociclib|mesh-list
83420570|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420571|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83420572|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420573|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420574|NCT05556408|Propofol|propofol|mesh-list
83420575|NCT05556408|Succinylcholine|succinylcholine|mesh-list
83420576|NCT05556408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83420577|NCT05556408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420578|NCT05556408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420579|NCT05556408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83420580|NCT05556408|Anesthetics, General|anesthetics, general|mesh-ancestor
83420581|NCT05556408|Anesthetics|anesthetics|mesh-ancestor
83420582|NCT05556408|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83420583|NCT05556408|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83420584|NCT05556408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83420585|NCT05556408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420586|NCT00054353|Cyclosporine|cyclosporine|mesh-list
83420587|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
83420588|NCT00054353|Fludarabine|fludarabine|mesh-list
83420589|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
83420590|NCT00054353|Melphalan|melphalan|mesh-list
83420591|NCT00054353|Cyclosporins|cyclosporins|mesh-list
83420592|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420593|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83420594|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
83420595|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420596|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420597|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
83420598|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420599|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420600|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
83420601|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420602|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
83420603|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420604|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83420605|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83420606|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83420607|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
83420608|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83420609|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83420610|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
83420611|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83420612|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
83420613|NCT00208975|Rituximab|rituximab|mesh-list
83420614|NCT00208975|Fludarabine|fludarabine|mesh-list
83420615|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
83420616|NCT00208975|Sargramostim|sargramostim|mesh-list
83420617|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420618|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
83420619|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420620|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420621|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83420622|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
83420623|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420624|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420625|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83420626|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83420627|NCT00208975|Analgesics|analgesics|mesh-ancestor
83420628|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
83420629|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420630|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83420631|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83420632|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420633|NCT01702233|Dexamethasone|dexamethasone|mesh-list
83420634|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
83420635|NCT01702233|BB 1101|bb 1101|mesh-list
83420636|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420637|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
83420638|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
83420639|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420640|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420641|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83420642|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
83420643|NCT01702233|Hormones|hormones|mesh-ancestor
83420644|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83420645|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83420646|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420647|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
83420648|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420649|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420650|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
83420651|NCT01852890|Gemcitabine|gemcitabine|mesh-list
83420652|NCT01852890|Vitamins|vitamins|mesh-ancestor
83420653|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
83420654|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420655|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83420656|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
83420657|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420658|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420659|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
83420660|NCT01852890|Protective Agents|protective agents|mesh-ancestor
83420661|NCT05555628|Salicylic Acid|salicylic acid|mesh-list
83420662|NCT05555628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420663|NCT05555628|Antifungal Agents|antifungal agents|mesh-ancestor
83420664|NCT05555628|Keratolytic Agents|keratolytic agents|mesh-ancestor
83420665|NCT05555628|Dermatologic Agents|dermatologic agents|mesh-ancestor
83420666|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
83420667|NCT01757418|Antibodies|antibodies|mesh-list
83420668|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
83420669|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83420670|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83420671|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
83420672|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420673|NCT00217399|Sorafenib|sorafenib|mesh-list
83420674|NCT00217399|Anastrozole|anastrozole|mesh-list
83420675|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420676|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83420677|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420678|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420679|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83420680|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83420681|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83420682|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83420683|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
83420684|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83420685|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420686|NCT04739670|Bevacizumab|bevacizumab|mesh-list
83420687|NCT04739670|Atezolizumab|atezolizumab|mesh-list
83420688|NCT04739670|Carboplatin|carboplatin|mesh-list
83420689|NCT04739670|Gemcitabine|gemcitabine|mesh-list
83420690|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83420691|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420692|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83420693|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83420694|NCT04739670|Growth Substances|growth substances|mesh-ancestor
83420695|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420696|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
83420697|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83420698|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
83420699|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420700|NCT04739670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83420702|NCT05549778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83420703|NCT05549778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83420704|NCT05286619|Carboplatin|carboplatin|mesh-list
83420705|NCT05286619|Gemcitabine|gemcitabine|mesh-list
83420706|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
83420707|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420708|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83420709|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
83420710|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420711|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83420712|NCT05286619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83420713|NCT04329624|Simendan|simendan|mesh-list
83420714|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83420715|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
83420716|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83420717|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83420718|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420719|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420720|NCT04329624|Protective Agents|protective agents|mesh-ancestor
83420721|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420722|NCT00559182|Omeprazole|omeprazole|mesh-list
83420723|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83420724|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83420725|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83420726|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420727|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420728|NCT00218023|Naltrexone|naltrexone|mesh-list
83420729|NCT00218023|Levodopa|levodopa|mesh-list
83420730|NCT00218023|Carbidopa|carbidopa|mesh-list
83420731|NCT00218023|Modafinil|modafinil|mesh-list
83420732|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83420733|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83420734|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420735|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
83420736|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420737|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83420738|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83420739|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
83420740|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420741|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420742|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83420743|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420744|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83420745|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83420746|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83420747|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83420748|NCT00054665|Prednisone|prednisone|mesh-list
83420749|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
83420750|NCT00054665|Doxorubicin|doxorubicin|mesh-list
83420751|NCT00054665|Etoposide|etoposide|mesh-list
83420752|NCT00054665|Vincristine|vincristine|mesh-list
83420753|NCT00054665|Bortezomib|bortezomib|mesh-list
83420754|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420755|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
83420756|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420757|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420758|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83420759|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
83420760|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420761|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420762|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83420763|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83420764|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83420765|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83420766|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420767|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420768|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
83420769|NCT00054665|Hormones|hormones|mesh-ancestor
83420770|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83420771|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83420772|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83420773|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
83420774|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
83420779|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83420780|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83420781|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83420782|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
83420783|NCT00476190|Doxorubicin|doxorubicin|mesh-list
83420784|NCT00476190|Methotrexate|methotrexate|mesh-list
83420785|NCT00476190|Etoposide|etoposide|mesh-list
83420786|NCT00476190|Vincristine|vincristine|mesh-list
83420787|NCT00476190|Asparaginase|asparaginase|mesh-list
83420788|NCT00476190|Pegaspargase|pegaspargase|mesh-list
83420789|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420790|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
83420791|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420792|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420793|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83420794|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
83420795|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420796|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420797|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83420798|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420799|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
83420800|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
83420801|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420802|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83420803|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
83420804|NCT00476190|Hormones|hormones|mesh-ancestor
83420805|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83420806|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83420807|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83420808|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83420809|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83420810|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420811|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83420812|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
83420813|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83420814|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83420815|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
83420816|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
83420817|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83420818|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83420819|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83420820|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
83420821|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420822|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
83420823|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
83420824|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
83420825|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
83420826|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83420827|NCT05555316|Lenvatinib|lenvatinib|mesh-list
83420828|NCT05555316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420829|NCT05555316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83420830|NCT05555316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420831|NCT05555316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420832|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
83420833|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83420834|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
83420835|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83420836|NCT00218491|Expectorants|expectorants|mesh-ancestor
83420837|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
83420838|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83420839|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
83420840|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420841|NCT00218491|Protective Agents|protective agents|mesh-ancestor
83420842|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420843|NCT00218491|Antidotes|antidotes|mesh-ancestor
83420844|NCT05700864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83420845|NCT05700864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83420846|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
83420847|NCT00221299|Hormones|hormones|mesh-list
83420848|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
83420849|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83420850|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420851|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83420852|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83420853|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420854|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83420855|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83420857|NCT05554848|Dexmedetomidine|dexmedetomidine|mesh-list
83420858|NCT05554848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83420859|NCT05554848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420860|NCT05554848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420861|NCT05554848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83420862|NCT05554848|Analgesics|analgesics|mesh-ancestor
83420863|NCT05554848|Sensory System Agents|sensory system agents|mesh-ancestor
83420864|NCT05554848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420865|NCT05554848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83420866|NCT05554848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83420867|NCT05554848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83420868|NCT05554848|Adrenergic Agents|adrenergic agents|mesh-ancestor
83420869|NCT05554848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420870|NCT05554848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420871|NCT05554848|Anesthetics|anesthetics|mesh-ancestor
83420872|NCT05554848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83420873|NCT05554848|Anticonvulsants|anticonvulsants|mesh-ancestor
83420874|NCT05554848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83420875|NCT05554848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83420876|NCT05554848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83420877|NCT05554848|Tocolytic Agents|tocolytic agents|mesh-ancestor
83420878|NCT05554848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83420879|NCT00057785|Fluorouracil|fluorouracil|mesh-list
83420880|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420881|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
83420882|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420883|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83420884|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83420885|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
83420886|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420887|NCT05554224|Liver Extracts|liver extracts|mesh-list
83420888|NCT05554224|Hematinics|hematinics|mesh-ancestor
83420889|NCT05548998|Anesthetics|anesthetics|mesh-list
83420890|NCT05548998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420891|NCT05548998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420892|NCT01666782|Vaccines|vaccines|mesh-list
83420893|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
83420894|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420895|NCT00058019|Epothilones|epothilones|mesh-list
83420896|NCT00058019|Epothilone B|epothilone b|mesh-list
83420897|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
83420898|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
83420899|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
83420900|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420901|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420902|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83420903|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
83420904|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420905|NCT00110461|Aripiprazole|aripiprazole|mesh-list
83420906|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
83420907|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83420908|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83420909|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83420910|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83420911|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420912|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
83420913|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
83420914|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420915|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420916|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83420917|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83420918|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
83420919|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83420920|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83420921|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83420922|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83420923|NCT00061373|Aspirin|aspirin|mesh-list
83420924|NCT00061373|Tinzaparin|tinzaparin|mesh-list
83420925|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83420926|NCT00061373|Dalteparin|dalteparin|mesh-list
83420927|NCT00061373|Eptifibatide|eptifibatide|mesh-list
83420935|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83420936|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83420937|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83420938|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420939|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83420940|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83420941|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420943|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
83420944|NCT01897337|Aprepitant|aprepitant|mesh-list
83420945|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
83420946|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
83420947|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420948|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420949|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83420950|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83420951|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83420952|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420953|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
83420954|NCT03089333|Glyburide|glyburide|mesh-list
83420955|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83420956|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420957|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83420958|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420959|NCT00112723|Alvocidib|alvocidib|mesh-list
83420960|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420961|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
83420962|NCT00112723|Growth Substances|growth substances|mesh-ancestor
83420963|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420964|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83420965|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420966|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83420967|NCT04327206|Vaccines|vaccines|mesh-list
83420968|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
83420969|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
83420970|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420971|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83420972|NCT05700006|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83420973|NCT05700006|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83420974|NCT05700006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420975|NCT05700006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712749|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
82712886|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713044|NCT02589158|Darunavir|darunavir|mesh-list
82714429|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82714430|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82714654|NCT00771147|Sorafenib|sorafenib|mesh-list
82714934|NCT00667251|Paclitaxel|paclitaxel|mesh-list
82715754|NCT00664209|Omeprazole|omeprazole|mesh-list
82715837|NCT02430194|Ritonavir|ritonavir|mesh-list
82716039|NCT00427921|Adalimumab|adalimumab|mesh-list
82716189|NCT02598960|Nivolumab|nivolumab|mesh-list
82716413|NCT01937468|Interleukin-2|interleukin-2|mesh-list
82716657|NCT00581828|Vitamin D|vitamin d|mesh-list
82716698|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82717131|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
82717364|NCT00794859|Sorafenib|sorafenib|mesh-list
82717811|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
82717881|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
82718105|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
82718499|NCT00128856|Paclitaxel|paclitaxel|mesh-list
82718554|NCT00709644|Hematinics|hematinics|mesh-ancestor
82718705|NCT05810792|Interleukin-2|interleukin-2|mesh-list
82718933|NCT05696938|Vitamins|vitamins|mesh-ancestor
82719010|NCT05648435|Antimanic Agents|antimanic agents|mesh-ancestor
82719239|NCT05438082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82720075|NCT04067726|Vitamin D|vitamin d|mesh-list
82720524|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
82720918|NCT02573220|Vitamins|vitamins|mesh-ancestor
82721151|NCT04018768|Ibuprofen|ibuprofen|mesh-list
82721289|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
82721513|NCT05373134|Antioxidants|antioxidants|mesh-ancestor
82722341|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
82723019|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
82723333|NCT00728546|Isoniazid|isoniazid|mesh-list
82723465|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82723918|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82723993|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
82724067|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82724142|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82724510|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
82724599|NCT00879892|Xenon|xenon|mesh-list
82724744|NCT00710606|Estrogens|estrogens|mesh-ancestor
82725193|NCT05741502|Dopamine Agents|dopamine agents|mesh-ancestor
82725274|NCT05500170|Niacin|niacin|mesh-list
82726093|NCT00889642|Lidocaine|lidocaine|mesh-list
82726397|NCT00818415|Naproxen|naproxen|mesh-list
82726614|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
82726691|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
82726777|NCT00626925|Topiramate|topiramate|mesh-list
82727218|NCT00400153|Ipratropium|ipratropium|mesh-list
82727361|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
82728113|NCT00882232|Protective Agents|protective agents|mesh-ancestor
82728338|NCT02538172|Valganciclovir|valganciclovir|mesh-list
82728783|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82729080|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729607|NCT00365365|Growth Substances|growth substances|mesh-ancestor
82729679|NCT00936676|Rasagiline|rasagiline|mesh-list
82729829|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730283|NCT00835107|Ziprasidone|ziprasidone|mesh-list
82730353|NCT00621153|Candesartan|candesartan|mesh-list
82730499|NCT00738452|Antibodies|antibodies|mesh-list
82730874|NCT00697112|Sirolimus|sirolimus|mesh-list
82730951|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82731189|NCT00749502|Niraparib|niraparib|mesh-list
82731322|NCT00855777|Etoricoxib|etoricoxib|mesh-list
82731478|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82732159|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
82732308|NCT00756990|Naltrexone|naltrexone|mesh-list
82732391|NCT00696020|Bromides|bromides|mesh-list
82733893|NCT00760968|Methotrexate|methotrexate|mesh-list
82734037|NCT00676338|Metformin|metformin|mesh-list
82734787|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82735010|NCT00765024|Ivermectin|ivermectin|mesh-list
82735161|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82735230|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82738157|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82738233|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
82738540|NCT05709574|Tadalafil|tadalafil|mesh-list
82738612|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82738846|NCT04004572|Pegaspargase|pegaspargase|mesh-list
82738921|NCT00329641|Paclitaxel|paclitaxel|mesh-list
82739071|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
82739374|NCT00689390|Ribavirin|ribavirin|mesh-list
82739673|NCT04060550|Omalizumab|omalizumab|mesh-list
82740580|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741043|NCT00754910|Trioxsalen|trioxsalen|mesh-list
82741100|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741406|NCT00326209|Analgesics|analgesics|mesh-ancestor
82741907|NCT00801606|Zinc|zinc|mesh-list
82742442|NCT01055431|Iron|iron|mesh-list
82742534|NCT00323557|Molgramostim|molgramostim|mesh-list
82742757|NCT05589454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82743142|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
82743207|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82743655|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
82743731|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82744104|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
82744252|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
82744330|NCT00768404|Phentermine|phentermine|mesh-list
82744857|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
82745004|NCT01066195|Pemetrexed|pemetrexed|mesh-list
82745231|NCT00812760|Levodopa|levodopa|mesh-list
82745308|NCT00815022|Fentanyl|fentanyl|mesh-list
82745460|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
82745535|NCT00815646|Urological Agents|urological agents|mesh-ancestor
82746060|NCT00816426|Kanamycin|kanamycin|mesh-list
82746509|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
82746660|NCT01008592|Levocetirizine|levocetirizine|mesh-list
82747261|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
82747787|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
82747865|NCT03521830|Nivolumab|nivolumab|mesh-list
82748020|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
82748388|NCT00635154|Hormones|hormones|mesh-ancestor
82748994|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
82749134|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
82749206|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82749503|NCT04094597|Lactoferrin|lactoferrin|mesh-list
82749585|NCT04093895|Taurolidine|taurolidine|mesh-list
82749730|NCT04089605|Hormones|hormones|mesh-ancestor
82749876|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82750630|NCT00269113|Rituximab|rituximab|mesh-list
82751170|NCT00967707|Gabapentin|gabapentin|mesh-list
82751539|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
82751993|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
82752516|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
82752668|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
82753123|NCT00286429|Insulin|insulin|mesh-list
82753208|NCT00864240|Clobetasol|clobetasol|mesh-list
82753345|NCT00984633|Bromides|bromides|mesh-list
82753952|NCT00802568|Fludarabine|fludarabine|mesh-list
82754172|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82754694|NCT00797810|Dexamethasone|dexamethasone|mesh-list
82754847|NCT00613938|Analgesics|analgesics|mesh-ancestor
82755070|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
82755240|NCT00652028|Fentanyl|fentanyl|mesh-list
82755910|NCT00883506|Lisinopril|lisinopril|mesh-list
82756059|NCT00730847|Vaccines|vaccines|mesh-list
82756509|NCT00642746|Irinotecan|irinotecan|mesh-list
82756815|NCT00736385|Metformin|metformin|mesh-list
82757048|NCT04397406|Narcotics|narcotics|mesh-ancestor
82757117|NCT05278728|Irinotecan|irinotecan|mesh-list
82757944|NCT02540070|Analgesics|analgesics|mesh-ancestor
82758089|NCT00819572|Antibodies|antibodies|mesh-list
82758241|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82758389|NCT00720941|Sunitinib|sunitinib|mesh-list
82758841|NCT00907608|Hematinics|hematinics|mesh-ancestor
82759076|NCT00827216|Erythromycin|erythromycin|mesh-list
82759811|NCT04043702|Topiramate|topiramate|mesh-list
82760336|NCT01813227|Dexamethasone|dexamethasone|mesh-list
82760861|NCT02547896|Narcotics|narcotics|mesh-ancestor
82760936|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
82761235|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761611|NCT02544698|Vaccines|vaccines|mesh-list
82761765|NCT00865436|Metformin|metformin|mesh-list
82761998|NCT00513682|Pancreatin|pancreatin|mesh-list
82762229|NCT00866684|Sirolimus|sirolimus|mesh-list
82762294|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
82762966|NCT02585765|Pioglitazone|pioglitazone|mesh-list
82763564|NCT02044497|Narcotics|narcotics|mesh-ancestor
82763869|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
82763939|NCT03739931|Durvalumab|durvalumab|mesh-list
82764396|NCT00880178|Simvastatin|simvastatin|mesh-list
82764705|NCT00617084|Everolimus|everolimus|mesh-list
82764774|NCT01020136|Axitinib|axitinib|mesh-list
82765231|NCT00875030|Artesunate|artesunate|mesh-list
82766995|NCT04073537|Paclitaxel|paclitaxel|mesh-list
82767311|NCT02576327|Aprepitant|aprepitant|mesh-list
82767586|NCT00485758|Niacin|niacin|mesh-list
82769787|NCT05206877|Insulin|insulin|mesh-list
82769960|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82776300|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82776531|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
82776750|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
82777425|NCT05918068|Vitamin B Complex|vitamin b complex|mesh-ancestor
82778482|NCT04865731|Esomeprazole|esomeprazole|mesh-list
82778704|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778777|NCT04484623|Dexamethasone|dexamethasone|mesh-list
82778927|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
82779150|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
82779374|NCT03407144|Etoposide|etoposide|mesh-list
82779602|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82710631|NCT04063839|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82710632|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
82710633|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82710634|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
82710635|NCT00785213|Quinine|quinine|mesh-list
82710636|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82710637|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710638|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
82710639|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82710640|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82710641|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82710642|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82710643|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82710644|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82710645|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82710646|NCT00785213|Analgesics|analgesics|mesh-ancestor
82710647|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
82710648|NCT02583594|Loratadine|loratadine|mesh-list
82710649|NCT02583594|Acyclovir|acyclovir|mesh-list
82710650|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
82710651|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
82710652|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
82710653|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82710654|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
82710655|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
82710656|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82710657|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710658|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82710659|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
82710660|NCT02583594|Hormones|hormones|mesh-ancestor
82710661|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82710662|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82710663|NCT02583594|Protective Agents|protective agents|mesh-ancestor
82710664|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710665|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82710666|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
82710667|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82710668|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
82710669|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
82710670|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82710671|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82710672|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82710673|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
82710674|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
82710675|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82710676|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710677|NCT00740415|Dexamethasone|dexamethasone|mesh-list
82710678|NCT00740415|Rituximab|rituximab|mesh-list
82710679|NCT00740415|Bortezomib|bortezomib|mesh-list
82710680|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82710681|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82710682|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710683|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
82710684|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710685|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82710686|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82710687|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
82710688|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
82710689|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82710690|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82710691|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
82710692|NCT00740415|Hormones|hormones|mesh-ancestor
82710693|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82710694|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82710695|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82710696|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
82710697|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710698|NCT00734162|Tenofovir|tenofovir|mesh-list
82710699|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
82710700|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82710701|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82710702|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82710703|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82710704|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710705|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82710706|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82710707|NCT00740493|Warfarin|warfarin|mesh-list
82710709|NCT00740571|Pregabalin|pregabalin|mesh-list
82710710|NCT00740571|Amitriptyline|amitriptyline|mesh-list
82710711|NCT00740571|Analgesics|analgesics|mesh-ancestor
82710712|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
82710713|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82710714|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710715|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
82710716|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82710717|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82710718|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710719|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82710720|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82710721|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82710722|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82710723|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82710724|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82710725|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
82710726|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82710727|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82710728|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82710729|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
82710730|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82710731|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
82710732|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
82710733|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710734|NCT02595242|Prednisone|prednisone|mesh-list
82710735|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
82710736|NCT02595242|Vincristine|vincristine|mesh-list
82710737|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82710738|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
82710739|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710740|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82710741|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82710742|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
82710743|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710744|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710745|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82710746|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82710747|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
82710748|NCT02595242|Hormones|hormones|mesh-ancestor
82710749|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82710750|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82710751|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82710752|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
82710753|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
82710754|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
82710755|NCT04487106|Azacitidine|azacitidine|mesh-list
82710756|NCT04487106|Venetoclax|venetoclax|mesh-list
82710757|NCT04487106|Trametinib|trametinib|mesh-list
82710758|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82710759|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
82710760|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710761|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710762|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82710763|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82710764|NCT00740883|Warfarin|warfarin|mesh-list
82710765|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
82710766|NCT02568033|Paclitaxel|paclitaxel|mesh-list
82710767|NCT02568033|Docetaxel|docetaxel|mesh-list
82710768|NCT02568033|Carboplatin|carboplatin|mesh-list
82710769|NCT02568033|Pemetrexed|pemetrexed|mesh-list
82710770|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82710771|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710772|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
82710773|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
82710774|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
82710775|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710776|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82710777|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82710778|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82710779|NCT00582972|Omeprazole|omeprazole|mesh-list
82710780|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82710781|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82710782|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82710783|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82710784|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710785|NCT05224401|Amoxicillin|amoxicillin|mesh-list
82710786|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
82710787|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82710788|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
82710789|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
82710790|NCT05224401|Ertapenem|ertapenem|mesh-list
82710791|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
82710792|NCT05224401|Trimethoprim|trimethoprim|mesh-list
82710793|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
82710794|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82710795|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82710796|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82710797|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82710798|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82710799|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710800|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710801|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82710802|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82710803|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82710804|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
82710805|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82710806|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82710807|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82710808|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82710809|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82710810|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82710812|NCT00918086|Vitamins|vitamins|mesh-ancestor
82710813|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
82710814|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710815|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82710816|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
82710817|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
82710818|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
82710819|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82710820|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710821|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
82710822|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82710823|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
82710824|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82710825|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710826|NCT04317066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82710827|NCT04317066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710828|NCT04366908|Calcifediol|calcifediol|mesh-list
82710829|NCT04366908|Vitamins|vitamins|mesh-ancestor
82710830|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
82710831|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710832|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82710833|NCT00711243|Docetaxel|docetaxel|mesh-list
82710834|NCT00711243|Fluorouracil|fluorouracil|mesh-list
82710835|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
82710836|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710837|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
82710838|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
82710839|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
82710840|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710841|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
82710842|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82710843|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82710844|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
82710845|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710846|NCT04366518|Scopolamine|scopolamine|mesh-list
82710847|NCT04366518|Rivastigmine|rivastigmine|mesh-list
82710848|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82710849|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82710850|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82710851|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710852|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
82710853|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82710854|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710855|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82710856|NCT04366518|Protective Agents|protective agents|mesh-ancestor
82710857|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82710858|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
82710859|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
82710860|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82710861|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82710862|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
82710863|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82710864|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82710865|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
82710866|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
82710867|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82710868|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
82710869|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710870|NCT04076436|Fosfomycin|fosfomycin|mesh-list
82710871|NCT04076436|Lactams|lactams|mesh-list
82710872|NCT04076436|beta-Lactams|beta-lactams|mesh-list
82710873|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82710874|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82710875|NCT05526417|Coal Tar|coal tar|mesh-list
82710876|NCT05526417|Keratolytic Agents|keratolytic agents|mesh-ancestor
82710877|NCT05526417|Dermatologic Agents|dermatologic agents|mesh-ancestor
82710878|NCT04096170|Lidocaine|lidocaine|mesh-list
82710879|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
82710880|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
82710881|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82710882|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710883|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
82710884|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82710885|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82710886|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82710887|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82710888|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82710889|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710890|NCT00741117|Bilirubin|bilirubin|mesh-list
82710891|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
82710892|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710893|NCT00741117|Protective Agents|protective agents|mesh-ancestor
82710894|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710895|NCT00732992|Pemetrexed|pemetrexed|mesh-list
82710896|NCT00732992|Sunitinib|sunitinib|mesh-list
82710897|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710898|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82710899|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710900|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82710901|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82710902|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82710903|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82710904|NCT00732992|Growth Substances|growth substances|mesh-ancestor
82710905|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710906|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
82710907|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82710908|NCT00741195|Bevacizumab|bevacizumab|mesh-list
82710909|NCT00741195|Docetaxel|docetaxel|mesh-list
82710910|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82710911|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710912|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82710913|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82710914|NCT00741195|Growth Substances|growth substances|mesh-ancestor
82710915|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710916|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
82710917|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
82710918|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
82710919|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
82710920|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710921|NCT05338632|Naloxone|naloxone|mesh-list
82710922|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82710923|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710924|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
82710925|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82710926|NCT00732758|Vitamin D|vitamin d|mesh-list
82710927|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
82710928|NCT00732758|Vitamins|vitamins|mesh-ancestor
82710929|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
82710930|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710931|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82710932|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82710933|NCT00741351|Fentanyl|fentanyl|mesh-list
82710934|NCT00741351|Remifentanil|remifentanil|mesh-list
82710935|NCT00741351|Propofol|propofol|mesh-list
82710936|NCT00741351|Sevoflurane|sevoflurane|mesh-list
82710937|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82710938|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82710939|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710940|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82710941|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
82710942|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
82710943|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82710945|NCT00741351|Analgesics|analgesics|mesh-ancestor
82710946|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
82710947|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82710948|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82710949|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82710950|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82710951|NCT02582190|Colchicine|colchicine|mesh-list
82710952|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
82710953|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82710954|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
82710955|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
82710956|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
82710957|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710958|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710959|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
82710960|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82710961|NCT04277442|Nivolumab|nivolumab|mesh-list
82710962|NCT04277442|Decitabine|decitabine|mesh-list
82710963|NCT04277442|Venetoclax|venetoclax|mesh-list
82710964|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82710965|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710966|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82710967|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710968|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82710969|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
82710970|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82710971|NCT05742243|Insulin|insulin|mesh-list
82710972|NCT05742243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82710973|NCT05742243|Abatacept|abatacept|mesh-list
82710974|NCT05742243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82710975|NCT05742243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710976|NCT05742243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82710977|NCT05742243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82710978|NCT05742243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82710979|NCT05742243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82710980|NCT05742243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82710981|NCT05742243|Immunologic Factors|immunologic factors|mesh-ancestor
82710982|NCT05742243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82710983|NCT04076748|Sufentanil|sufentanil|mesh-list
82710984|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82710985|NCT04076748|Narcotics|narcotics|mesh-ancestor
82710986|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82710987|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82710988|NCT04076748|Analgesics|analgesics|mesh-ancestor
82710989|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
82710990|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82710991|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82710992|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82710993|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
82710994|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
82710995|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
82710996|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82710997|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82710998|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82710999|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711000|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711001|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
82711002|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711003|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711004|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82711005|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711006|NCT04262466|Pembrolizumab|pembrolizumab|mesh-list
82711007|NCT04262466|Atezolizumab|atezolizumab|mesh-list
82711008|NCT04262466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711009|NCT04262466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711010|NCT04262466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82711011|NCT04262466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711012|NCT04255602|Ticagrelor|ticagrelor|mesh-list
82711013|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82711014|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82711092|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
82711015|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82711016|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82711017|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
82711018|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711019|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711020|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711022|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
82711023|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
82711024|NCT00738530|Bevacizumab|bevacizumab|mesh-list
82711025|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711026|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711027|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82711028|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82711029|NCT00738530|Growth Substances|growth substances|mesh-ancestor
82711030|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711031|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
82711032|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
82711033|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711034|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
82711035|NCT04077684|Interleukin-2|interleukin-2|mesh-list
82711036|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711037|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82711038|NCT04077684|Analgesics|analgesics|mesh-ancestor
82711039|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
82711040|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711041|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711042|NCT00711009|Ritonavir|ritonavir|mesh-list
82711043|NCT00711009|Lopinavir|lopinavir|mesh-list
82711044|NCT00711009|Tenofovir|tenofovir|mesh-list
82711045|NCT00711009|Emtricitabine|emtricitabine|mesh-list
82711046|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
82711047|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82711048|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82711049|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82711050|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
82711051|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711052|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711053|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82711054|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82711055|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
82711056|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711057|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82711058|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82711059|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82711060|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82711061|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82711062|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82711063|NCT02567799|Paclitaxel|paclitaxel|mesh-list
82711064|NCT02567799|Carboplatin|carboplatin|mesh-list
82711065|NCT02567799|Genistein|genistein|mesh-list
82711066|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82711067|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711068|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
82711069|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
82711070|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
82711071|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711072|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82711073|NCT02567799|Protective Agents|protective agents|mesh-ancestor
82711074|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711075|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82711076|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711077|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
82711078|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82711079|NCT02567799|Estrogens|estrogens|mesh-ancestor
82711080|NCT02567799|Hormones|hormones|mesh-ancestor
82711081|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82711082|NCT00921219|Ivermectin|ivermectin|mesh-list
82711083|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82711084|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711085|NCT02567331|Capecitabine|capecitabine|mesh-list
82711086|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82711087|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
82711088|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711089|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711090|NCT00577005|Levetiracetam|levetiracetam|mesh-list
82711091|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
82711093|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
82711094|NCT02581566|Bupivacaine|bupivacaine|mesh-list
82711095|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
82711096|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
82711097|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711098|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711099|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
82711100|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711101|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82711102|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82711104|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82711105|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82711106|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82711107|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
82711108|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711109|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711110|NCT04003506|Bupivacaine|bupivacaine|mesh-list
82711111|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
82711112|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
82711113|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711114|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711115|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
82711116|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711118|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711119|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711120|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
82711121|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82711122|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711123|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711124|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82711125|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711126|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82711127|NCT04062357|Lidocaine|lidocaine|mesh-list
82711128|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
82711129|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
82711130|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711131|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711132|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
82711133|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711134|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82711135|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82711136|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82711137|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711138|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711139|NCT04482309|Trastuzumab|trastuzumab|mesh-list
82711140|NCT04482309|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82711141|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711142|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711143|NCT04482309|Immunoconjugates|immunoconjugates|mesh-ancestor
82711144|NCT04482309|Immunologic Factors|immunologic factors|mesh-ancestor
82711145|NCT04482309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711146|NCT05190120|Ropivacaine|ropivacaine|mesh-list
82711147|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
82711148|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
82711149|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711150|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711151|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
82711152|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711153|NCT00738374|Rituximab|rituximab|mesh-list
82711154|NCT00738374|Chlorambucil|chlorambucil|mesh-list
82711155|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711156|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711157|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
82711158|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711159|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82711160|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82711161|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
82711162|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711163|NCT02581176|Apixaban|apixaban|mesh-list
82711164|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82711165|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
82711166|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82711167|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
82711169|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711170|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
82711171|NCT00697593|Antibodies|antibodies|mesh-list
82711172|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82711173|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
82711174|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711175|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
82711176|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
82711177|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82711178|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
82711179|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82711180|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711181|NCT04183452|Progestins|progestins|mesh-ancestor
82711182|NCT04183452|Hormones|hormones|mesh-ancestor
82711183|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82711184|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82711185|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82711186|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711187|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711188|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82711189|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711190|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711191|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
82711192|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711193|NCT04445025|Leuprolide|leuprolide|mesh-list
82711194|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82711195|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
82711196|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82711197|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711198|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82711199|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711200|NCT02580474|Asunaprevir|asunaprevir|mesh-list
82711201|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
82711202|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711203|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711204|NCT04166604|Trifluridine|trifluridine|mesh-list
82711205|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
82711206|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711207|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
82711208|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711209|NCT00738062|Droxidopa|droxidopa|mesh-list
82711210|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82711211|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82711212|NCT04156074|Vitamin D|vitamin d|mesh-list
82711213|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
82711214|NCT04156074|Cholecalciferol|cholecalciferol|mesh-list
82711215|NCT04156074|Vitamins|vitamins|mesh-list
82711216|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
82711217|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711218|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82711219|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82711220|NCT04062045|Ropivacaine|ropivacaine|mesh-list
82711221|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
82711222|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
82711223|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711224|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711225|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
82711226|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711227|NCT03733314|Quetmolimab|quetmolimab|mesh-list
82711228|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82711229|NCT04064073|Metformin|metformin|mesh-list
82711230|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82711231|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711232|NCT04137354|Vitamins|vitamins|mesh-list
82711233|NCT04137354|Vitamin A|vitamin a|mesh-list
82711235|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
82711236|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
82711237|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711239|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
82711240|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711241|NCT04137354|Protective Agents|protective agents|mesh-ancestor
82711242|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82711243|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711244|NCT04902729|Oxytocin|oxytocin|mesh-list
82711245|NCT04902729|Carbetocin|carbetocin|mesh-list
82711246|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
82711247|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82711248|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711249|NCT03498378|Cetuximab|cetuximab|mesh-list
82711250|NCT03498378|Avelumab|avelumab|mesh-list
82711251|NCT03498378|Palbociclib|palbociclib|mesh-list
82711252|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711253|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711254|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82711255|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711256|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711257|NCT03493932|Nivolumab|nivolumab|mesh-list
82711258|NCT03493932|Relatlimab|relatlimab|mesh-list
82711259|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711260|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711261|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82711262|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711263|NCT04211259|Loratadine|loratadine|mesh-list
82711264|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
82711265|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
82711266|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82711267|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82711268|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82711269|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
82711270|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
82711271|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711272|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711273|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711274|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
82711275|NCT00698685|Pentostatin|pentostatin|mesh-list
82711276|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711277|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711278|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82711279|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711280|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711281|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
82711282|NCT04972968|Hormones|hormones|mesh-ancestor
82711283|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82711284|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711285|NCT00737438|Bevacizumab|bevacizumab|mesh-list
82711286|NCT00737438|Docetaxel|docetaxel|mesh-list
82711287|NCT00737438|Capecitabine|capecitabine|mesh-list
82711288|NCT00737438|Irinotecan|irinotecan|mesh-list
82711289|NCT00737438|Epirubicin|epirubicin|mesh-list
82711290|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711291|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711292|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82711293|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82711294|NCT00737438|Growth Substances|growth substances|mesh-ancestor
82711295|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711296|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
82711297|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
82711298|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
82711299|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
82711300|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711301|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82711302|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
82711303|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82711304|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82711305|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711306|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82711307|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82711309|NCT00737048|Tramadol|tramadol|mesh-list
82711310|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82711311|NCT00737048|Analgesics|analgesics|mesh-ancestor
82711312|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
82711313|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711314|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711315|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
82711316|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82711317|NCT00737048|Narcotics|narcotics|mesh-ancestor
82711318|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711319|NCT02593448|Anesthetics|anesthetics|mesh-list
82711320|NCT02593448|Propofol|propofol|mesh-list
82711321|NCT02593448|Sevoflurane|sevoflurane|mesh-list
82711322|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711323|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711324|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82711325|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82711326|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
82711327|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82711328|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82711329|NCT02592746|Capecitabine|capecitabine|mesh-list
82711330|NCT02592746|Palbociclib|palbociclib|mesh-list
82711331|NCT02592746|Leuprolide|leuprolide|mesh-list
82711332|NCT02592746|Exemestane|exemestane|mesh-list
82711333|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82711334|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
82711335|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711336|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711337|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82711338|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711339|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82711340|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
82711341|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82711342|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711343|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82711344|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82711345|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82711346|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82711347|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
82711348|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82711349|NCT03365622|Acetaminophen|acetaminophen|mesh-list
82711350|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82711351|NCT03365622|Analgesics|analgesics|mesh-ancestor
82711352|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
82711353|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711354|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711355|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
82711356|NCT00731120|Vortioxetine|vortioxetine|mesh-list
82711357|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
82711358|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82711359|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82711360|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82711361|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711362|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711363|NCT00731120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82711364|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82711365|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711366|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711367|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711368|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
82711369|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82711370|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82711371|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82711372|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82711373|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
82711374|NCT02580006|Hematinics|hematinics|mesh-ancestor
82711375|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82711376|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82711377|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711378|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
82711379|NCT02787642|Olaparib|olaparib|mesh-list
82711380|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82711381|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711382|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711383|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711384|NCT04075188|Aflibercept|aflibercept|mesh-list
82711385|NCT04075188|Verteporfin|verteporfin|mesh-list
82711386|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82711387|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82711388|NCT04075188|Growth Substances|growth substances|mesh-ancestor
82711389|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711390|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
82711391|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711392|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82711393|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
82711394|NCT00726986|Etoposide|etoposide|mesh-list
82711395|NCT00726986|Sorafenib|sorafenib|mesh-list
82711396|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711397|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82711398|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82711399|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82711400|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711401|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711402|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82711403|NCT00696657|Liraglutide|liraglutide|mesh-list
82711404|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82711405|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711406|NCT00696657|Incretins|incretins|mesh-ancestor
82711407|NCT00696657|Hormones|hormones|mesh-ancestor
82711408|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82711409|NCT00726752|Axitinib|axitinib|mesh-list
82711410|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711411|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82711412|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711413|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711414|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
82711415|NCT02594462|Etonogestrel|etonogestrel|mesh-list
82711416|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82711417|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711418|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82711419|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82711420|NCT02664558|Ubenimex|ubenimex|mesh-list
82711421|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82711422|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
82711423|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711424|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82711425|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711426|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82711427|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711428|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
82711429|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711430|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711431|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82711432|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82711433|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
82711434|NCT02566707|Lamivudine|lamivudine|mesh-list
82711435|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82711436|NCT02566707|Dolutegravir|dolutegravir|mesh-list
82711437|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82711438|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82711439|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711440|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711441|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
82711442|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711443|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82711444|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82711445|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82711446|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82711447|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
82711448|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82711449|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82711450|NCT04063683|Paclitaxel|paclitaxel|mesh-list
82711451|NCT04063683|Cisplatin|cisplatin|mesh-list
82711452|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82711453|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711454|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
82711455|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
82711457|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711458|NCT00921531|Thalidomide|thalidomide|mesh-list
82711459|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82711460|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
82711461|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711462|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
82711463|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82711464|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711465|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82711466|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82711467|NCT00921531|Growth Substances|growth substances|mesh-ancestor
82711468|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
82711469|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711470|NCT00730028|Clindamycin|clindamycin|mesh-list
82711471|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
82711472|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
82711473|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82711474|NCT00730028|Trimethoprim|trimethoprim|mesh-list
82711475|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
82711476|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82711477|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711478|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82711479|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711480|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711481|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82711482|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
82711483|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82711484|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82711485|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82711486|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82711487|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82711488|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82711489|NCT04088084|Palmidrol|palmidrol|mesh-list
82711490|NCT04088084|Analgesics|analgesics|mesh-ancestor
82711491|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
82711492|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711493|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711494|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82711495|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82711496|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82711497|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82711498|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
82711499|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711500|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82711501|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82711502|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711503|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711504|NCT04088084|Hormones|hormones|mesh-ancestor
82711505|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82711506|NCT02593370|Lidocaine|lidocaine|mesh-list
82711507|NCT02593370|Epinephrine|epinephrine|mesh-list
82711508|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
82711509|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
82711510|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
82711511|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711512|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711513|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
82711514|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711515|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82711516|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82711517|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82711518|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711519|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711520|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82711521|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82711522|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
82711523|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711524|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82711525|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82711526|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
82711527|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82711528|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
82711529|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
82711530|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
82711531|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82711532|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
82711533|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
82711534|NCT00918320|Temozolomide|temozolomide|mesh-list
82711535|NCT00918320|Topotecan|topotecan|mesh-list
82711536|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82711537|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
82711538|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711539|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711540|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82711541|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82711542|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711543|NCT00729560|Flutamide|flutamide|mesh-list
82711544|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
82711545|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
82711546|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82711547|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711775|NCT03543813|Immunologic Factors|immunologic factors|mesh-ancestor
82711548|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82711549|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711550|NCT00736190|Tenofovir|tenofovir|mesh-list
82711551|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
82711552|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711553|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82711554|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82711555|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711556|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711557|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82711558|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82711559|NCT04686279|Tenofovir|tenofovir|mesh-list
82711560|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
82711561|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711562|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82711563|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82711564|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711565|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711566|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82711567|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82711568|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82711569|NCT00729326|Exenatide|exenatide|mesh-list
82711570|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82711571|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711572|NCT00729326|Incretins|incretins|mesh-ancestor
82711573|NCT00729326|Hormones|hormones|mesh-ancestor
82711574|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82711575|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82711576|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
82711577|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711578|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711579|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82711580|NCT02565303|Ropivacaine|ropivacaine|mesh-list
82711581|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
82711582|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
82711583|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711584|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711585|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
82711586|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711587|NCT00698451|Bevacizumab|bevacizumab|mesh-list
82711588|NCT00698451|Carboplatin|carboplatin|mesh-list
82711589|NCT00698451|Doxorubicin|doxorubicin|mesh-list
82711590|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82711591|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711592|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711593|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82711594|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82711595|NCT00698451|Growth Substances|growth substances|mesh-ancestor
82711596|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711597|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
82711598|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82711599|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82711600|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82711601|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711602|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711603|NCT03980925|Carboplatin|carboplatin|mesh-list
82711604|NCT03980925|Nivolumab|nivolumab|mesh-list
82711605|NCT03980925|Etoposide|etoposide|mesh-list
82711606|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711607|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711608|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82711609|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711610|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82711611|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82711612|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82711613|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711614|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
82711615|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82711616|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82711617|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82711618|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
82711619|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82711620|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
82711621|NCT03966807|Nicotine|nicotine|mesh-list
82711926|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
82711622|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82711623|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
82711624|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711625|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711626|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82711627|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82711628|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
82711629|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711630|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711631|NCT02565693|Aspirin|aspirin|mesh-list
82711632|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
82711633|NCT02565693|Dipyridamole|dipyridamole|mesh-list
82711634|NCT02565693|Apixaban|apixaban|mesh-list
82711635|NCT02565693|Clopidogrel|clopidogrel|mesh-list
82711636|NCT02565693|Calcium|calcium|mesh-list
82711637|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82711638|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711639|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82711640|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82711641|NCT02565693|Analgesics|analgesics|mesh-ancestor
82711642|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
82711643|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711644|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82711645|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82711646|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82711647|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82711648|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711649|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82711650|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82711651|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711652|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
82711653|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82711654|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82711655|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82711656|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
82711657|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711658|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82711659|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
82711660|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82711661|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
82711662|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
82711663|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82711664|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
82711666|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82711667|NCT04061655|Trace Elements|trace elements|mesh-ancestor
82711668|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
82711669|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711670|NCT04061655|Hematinics|hematinics|mesh-ancestor
82711671|NCT04061265|Lidocaine|lidocaine|mesh-list
82711672|NCT04061265|Epinephrine|epinephrine|mesh-list
82711673|NCT04061265|Carticaine|carticaine|mesh-list
82711674|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
82711675|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
82711676|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711677|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711678|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
82711679|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711680|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82711681|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82711682|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82711683|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711684|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711685|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82711686|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82711687|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
82711688|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711689|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82711690|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82711691|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
82711692|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82711693|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
82711694|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
82711695|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
82711696|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82711697|NCT02592980|Warfarin|warfarin|mesh-list
82711698|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
82711699|NCT00727844|Linezolid|linezolid|mesh-list
82711700|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82711701|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711702|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82711703|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711704|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711705|NCT00735878|Carboplatin|carboplatin|mesh-list
82711706|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711707|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82711708|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
82711709|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
82711710|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82711711|NCT00695955|Diuretics|diuretics|mesh-ancestor
82711712|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
82711713|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711714|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82711715|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711716|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711717|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82711718|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82711719|NCT00693225|Omeprazole|omeprazole|mesh-list
82711720|NCT00693225|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
82711721|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82711722|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82711723|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82711724|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711725|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711726|NCT00735644|Vaccines|vaccines|mesh-list
82711727|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
82711728|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711729|NCT02591888|Bupivacaine|bupivacaine|mesh-list
82711730|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
82711731|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
82711732|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711733|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711734|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
82711735|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711736|NCT00724958|Infliximab|infliximab|mesh-list
82711737|NCT00724958|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82711738|NCT00724958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82711739|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
82711740|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82711741|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82711742|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
82711743|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82711744|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
82711745|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711746|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
82711747|NCT04088006|Protective Agents|protective agents|mesh-ancestor
82711748|NCT00695565|Clonidine|clonidine|mesh-list
82711749|NCT00695565|Analgesics|analgesics|mesh-ancestor
82711750|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
82711751|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711752|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711753|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82711754|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
82711755|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
82711756|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82711757|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82711758|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82711759|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
82711760|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711761|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711762|NCT00727532|Sorafenib|sorafenib|mesh-list
82711763|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711764|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82711765|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711766|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711767|NCT00721214|Azacitidine|azacitidine|mesh-list
82711768|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82711769|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
82711770|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711771|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711772|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711773|NCT03543813|CX-2029|cx-2029|mesh-list
82711774|NCT03543813|Immunoconjugates|immunoconjugates|mesh-ancestor
82711776|NCT03543813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711777|NCT00720902|Hormones|hormones|mesh-list
82711778|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
82711779|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82711780|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711781|NCT02592278|Listerine|listerine|mesh-list
82711782|NCT02592278|Fluorides|fluorides|mesh-list
82711783|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
82711784|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
82711785|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
82711786|NCT02592278|Protective Agents|protective agents|mesh-ancestor
82711787|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711788|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82711789|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711790|NCT00695019|Interferons|interferons|mesh-list
82711791|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
82711792|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
82711793|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82711794|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711795|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
82711796|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711797|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
82711798|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711799|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82711800|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
82711801|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711803|NCT00742911|Disulfiram|disulfiram|mesh-list
82711804|NCT00742911|Trace Elements|trace elements|mesh-ancestor
82711805|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
82711806|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711807|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82711808|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82711809|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711810|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711811|NCT00694707|Risperidone|risperidone|mesh-list
82711812|NCT00694707|Cariprazine|cariprazine|mesh-list
82711813|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82711814|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
82711815|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711816|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711817|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711818|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82711819|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82711820|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711821|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82711822|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82711823|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
82711824|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
82711825|NCT00692913|Vitamin D|vitamin d|mesh-list
82711826|NCT00692913|Alendronate|alendronate|mesh-list
82711827|NCT00692913|Calcium|calcium|mesh-list
82711828|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82711829|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711830|NCT00692913|Vitamins|vitamins|mesh-ancestor
82711831|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
82711832|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82711833|NCT00694551|Poly I-C|poly i-c|mesh-list
82711834|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82711835|NCT00694551|Vaccines|vaccines|mesh-list
82711836|NCT00694551|Poly ICLC|poly iclc|mesh-list
82711837|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
82711838|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711839|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
82711840|NCT00694551|Laxatives|laxatives|mesh-ancestor
82711841|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82711842|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
82711843|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711844|NCT02603705|Oxycodone|oxycodone|mesh-list
82711845|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82711846|NCT02603705|Narcotics|narcotics|mesh-ancestor
82711847|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711848|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711849|NCT02603705|Analgesics|analgesics|mesh-ancestor
82711850|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
82711851|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711852|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82711853|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
82711854|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82711855|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711856|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82711857|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82711858|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711859|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711860|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
82711861|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711862|NCT00915785|Azacitidine|azacitidine|mesh-list
82711863|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82711864|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
82711865|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711866|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711867|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711868|NCT00776009|Methylphenidate|methylphenidate|mesh-list
82711869|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
82711870|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82711871|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711872|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82711873|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82711874|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711875|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711876|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
82711877|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711878|NCT00720356|Bevacizumab|bevacizumab|mesh-list
82711879|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82711880|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82711881|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711882|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82711883|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82711884|NCT00720356|Growth Substances|growth substances|mesh-ancestor
82711885|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711886|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
82711887|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82711888|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711889|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711890|NCT00745953|Valsartan|valsartan|mesh-list
82711891|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82711892|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82711893|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82711894|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82711895|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711896|NCT00745953|Diuretics|diuretics|mesh-ancestor
82711897|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
82711898|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711899|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82711900|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711901|NCT00720278|Azelastine|azelastine|mesh-list
82711902|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82711903|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
82711904|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711905|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711906|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82711907|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
82711908|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82711909|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711910|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711911|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82711912|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82711913|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82711914|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
82711915|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
82711916|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711917|NCT00746031|Goserelin|goserelin|mesh-list
82711918|NCT00746031|Cetrorelix|cetrorelix|mesh-list
82711919|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82711920|NCT00746031|Hormones|hormones|mesh-ancestor
82711921|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82711922|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711923|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82711924|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711925|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82711927|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82711928|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
82711929|NCT00720122|Insulin|insulin|mesh-list
82711930|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82711931|NCT00720122|Mitogens|mitogens|mesh-list
82711932|NCT00720122|Mecasermin|mecasermin|mesh-list
82711933|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82711934|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711935|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
82711936|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711937|NCT00720122|Growth Substances|growth substances|mesh-ancestor
82711938|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
82711939|NCT04085744|Lidocaine|lidocaine|mesh-list
82711940|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
82711941|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
82711942|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82711943|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711944|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
82711945|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711946|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82711947|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82711948|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82711949|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82711950|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711951|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82711952|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
82711953|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82711954|NCT00743847|Varenicline|varenicline|mesh-list
82711955|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82711956|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82711957|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
82711958|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711959|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711960|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711961|NCT00717860|Caspofungin|caspofungin|mesh-list
82711962|NCT00717860|Micafungin|micafungin|mesh-list
82711963|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
82711964|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711965|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711966|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711967|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
82711968|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82711969|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82711970|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
82711971|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82711972|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82711973|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82711974|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711975|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711976|NCT02592122|Bromides|bromides|mesh-list
82711977|NCT02592122|Albuterol|albuterol|mesh-list
82711978|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
82711979|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82711980|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
82711981|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82711982|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82711983|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82711984|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
82711985|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
82711986|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82711987|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82711988|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82711989|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82711990|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
82711991|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82711992|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711993|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
82711994|NCT00923637|Pemetrexed|pemetrexed|mesh-list
82711995|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82711996|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711997|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82711998|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82711999|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82712000|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
82712001|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82712079|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
82712002|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712003|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82712004|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
82712005|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82712006|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712007|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712008|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712009|NCT01090089|Dexamethasone|dexamethasone|mesh-list
82712010|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
82712011|NCT01090089|Lenalidomide|lenalidomide|mesh-list
82712012|NCT01090089|BB 1101|bb 1101|mesh-list
82712013|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712014|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
82712015|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
82712016|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712017|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712018|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82712019|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
82712020|NCT01090089|Hormones|hormones|mesh-ancestor
82712021|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712022|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82712023|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712024|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
82712025|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712026|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712027|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
82712028|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82712029|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82712030|NCT01090089|Growth Substances|growth substances|mesh-ancestor
82712031|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
82712032|NCT00689793|Iron|iron|mesh-list
82712033|NCT00689793|Trace Elements|trace elements|mesh-ancestor
82712034|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
82712035|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712036|NCT04086290|Androgens|androgens|mesh-list
82712037|NCT04086290|Hormones|hormones|mesh-ancestor
82712038|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712039|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712040|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
82712041|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82712042|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82712043|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
82712044|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
82712045|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82712046|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712047|NCT02563353|Teriparatide|teriparatide|mesh-list
82712048|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82712049|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712050|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82712051|NCT00688701|Lixisenatide|lixisenatide|mesh-list
82712052|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82712053|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712054|NCT00744549|Vitamin D|vitamin d|mesh-list
82712055|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
82712056|NCT00744549|Vitamins|vitamins|mesh-list
82712057|NCT00744549|Vitamin E|vitamin e|mesh-list
82712058|NCT00744549|Selenium|selenium|mesh-list
82712059|NCT00744549|Lycopene|lycopene|mesh-list
82712060|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
82712061|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712062|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82712063|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82712064|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
82712065|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712066|NCT00744549|Protective Agents|protective agents|mesh-ancestor
82712067|NCT00744549|Trace Elements|trace elements|mesh-ancestor
82712068|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712069|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82712070|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82712071|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712072|NCT00746655|Cisplatin|cisplatin|mesh-list
82712073|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712074|NCT04060719|Rifampin|rifampin|mesh-list
82712075|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82712076|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
82712077|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82712078|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712080|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82712081|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712082|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712083|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82712084|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82712085|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82712086|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82712087|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82712088|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82712089|NCT00741429|Insulin|insulin|mesh-list
82712090|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82712091|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712092|NCT00741507|Ethanol|ethanol|mesh-list
82712093|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82712094|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712095|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82712096|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712097|NCT00688623|Everolimus|everolimus|mesh-list
82712098|NCT00688623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82712099|NCT00688623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82712100|NCT00688623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712101|NCT00688623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712102|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82712103|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
82712104|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712105|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712106|NCT02563821|Clonidine|clonidine|mesh-list
82712107|NCT02563821|Sufentanil|sufentanil|mesh-list
82712108|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
82712109|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82712110|NCT02563821|Narcotics|narcotics|mesh-ancestor
82712111|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82712112|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712113|NCT02563821|Analgesics|analgesics|mesh-ancestor
82712114|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
82712115|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712116|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82712117|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82712118|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
82712119|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
82712120|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82712121|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
82712122|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
82712123|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82712124|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82712125|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82712126|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
82712127|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82712128|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712129|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
82712130|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
82712131|NCT00717236|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82712132|NCT00717236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712133|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82712134|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
82712135|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712136|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712137|NCT04085354|Vitamins|vitamins|mesh-list
82712138|NCT04085354|Folic Acid|folic acid|mesh-list
82712139|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
82712140|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
82712141|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
82712142|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712143|NCT04085354|Hematinics|hematinics|mesh-ancestor
82712144|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
82712145|NCT00719810|Tigecycline|tigecycline|mesh-list
82712146|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
82712147|NCT00719810|Delafloxacin|delafloxacin|mesh-list
82712148|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82712149|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712150|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82712151|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712152|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712153|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82712154|NCT00723710|Interferons|interferons|mesh-list
82712155|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
82712156|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
82712157|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712158|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
82712159|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712160|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
82712161|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712162|NCT00688545|Celecoxib|celecoxib|mesh-list
82712163|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82712164|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82712165|NCT00688545|Analgesics|analgesics|mesh-ancestor
82712166|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
82712167|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712168|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712169|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712170|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712171|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82712172|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82712173|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712174|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712175|NCT04060407|Nivolumab|nivolumab|mesh-list
82712176|NCT04060407|Ipilimumab|ipilimumab|mesh-list
82712177|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82712178|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712179|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82712180|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712181|NCT00741585|Atenolol|atenolol|mesh-list
82712182|NCT00741585|Amlodipine|amlodipine|mesh-list
82712183|NCT00741585|Valsartan|valsartan|mesh-list
82712184|NCT00741585|Telmisartan|telmisartan|mesh-list
82712185|NCT00741585|Carvedilol|carvedilol|mesh-list
82712186|NCT00741585|Candesartan|candesartan|mesh-list
82712187|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
82712188|NCT00741585|Ramipril|ramipril|mesh-list
82712189|NCT00741585|Olmesartan|olmesartan|mesh-list
82712190|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82712191|NCT00741585|Enalapril|enalapril|mesh-list
82712192|NCT00741585|Enalaprilat|enalaprilat|mesh-list
82712193|NCT00741585|Lisinopril|lisinopril|mesh-list
82712194|NCT00741585|Irbesartan|irbesartan|mesh-list
82712195|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
82712196|NCT00741585|Quinapril|quinapril|mesh-list
82712197|NCT00741585|Lercanidipine|lercanidipine|mesh-list
82712198|NCT00741585|Manidipine|manidipine|mesh-list
82712199|NCT00741585|Doxazosin|doxazosin|mesh-list
82712200|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82712201|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82712202|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712203|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82712204|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712205|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
82712206|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82712207|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82712208|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82712209|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82712210|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
82712211|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82712212|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
82712213|NCT00741585|Protective Agents|protective agents|mesh-ancestor
82712214|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82712215|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82712216|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82712217|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
82712218|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712219|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82712220|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82712221|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
82712222|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
82712223|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712224|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82712225|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
82712226|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
82712227|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82712228|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82712229|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712230|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712231|NCT00746967|Urological Agents|urological agents|mesh-ancestor
82712232|NCT02563041|Heparin|heparin|mesh-list
82712233|NCT02563041|Calcium heparin|calcium heparin|mesh-list
82712235|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712236|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82712237|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82712238|NCT00741663|Furosemide|furosemide|mesh-list
82712239|NCT00741663|Spironolactone|spironolactone|mesh-list
82712240|NCT00741663|Diuretics|diuretics|mesh-ancestor
82712241|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
82712242|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712243|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82712244|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82712245|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712246|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82712247|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
82712248|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712249|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82712250|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
82712251|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82712252|NCT00741741|Rilpivirine|rilpivirine|mesh-list
82712253|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82712254|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82712255|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712256|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712257|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
82712258|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712259|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82712260|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82712261|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82712262|NCT00745173|Estrogens|estrogens|mesh-ancestor
82712263|NCT00745173|Hormones|hormones|mesh-ancestor
82712264|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712265|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712266|NCT04060095|Anesthetics|anesthetics|mesh-list
82712267|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82712268|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712269|NCT00741897|Fexofenadine|fexofenadine|mesh-list
82712270|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82712271|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82712272|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82712273|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
82712274|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
82712275|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82712276|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712277|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712278|NCT00745407|Fenofibrate|fenofibrate|mesh-list
82712279|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82712280|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
82712281|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712282|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82712283|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
82712284|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82712285|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712286|NCT00747279|Insulin|insulin|mesh-list
82712287|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82712288|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712289|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
82712290|NCT00742287|Procyanidin|procyanidin|mesh-list
82712291|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
82712292|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712293|NCT00742287|Protective Agents|protective agents|mesh-ancestor
82712294|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712295|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82712296|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82712297|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712298|NCT00747669|Lidocaine|lidocaine|mesh-list
82712299|NCT00747669|Tetracaine|tetracaine|mesh-list
82712300|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
82712301|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
82712302|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82712303|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712304|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
82712305|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712306|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82712307|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82712308|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82712309|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82712310|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712311|NCT00690573|Adalimumab|adalimumab|mesh-list
82712312|NCT00690573|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82712313|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712314|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712315|NCT00719264|Interferons|interferons|mesh-list
82712316|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
82712317|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
82712318|NCT00719264|Bevacizumab|bevacizumab|mesh-list
82712319|NCT00719264|Everolimus|everolimus|mesh-list
82712320|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82712321|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712322|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82712323|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82712324|NCT00719264|Growth Substances|growth substances|mesh-ancestor
82712325|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712326|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
82712327|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
82712328|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712329|NCT00719264|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82712330|NCT00719264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82712331|NCT00719264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712332|NCT00719264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712333|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82712334|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
82712335|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82712336|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82712337|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82712338|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82712339|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712340|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
82712341|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82712342|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712343|NCT00751959|Poractant alfa|poractant alfa|mesh-list
82712344|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
82712345|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
82712346|NCT00723554|Iloprost|iloprost|mesh-list
82712347|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82712348|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
82712349|NCT00687219|Ribavirin|ribavirin|mesh-list
82712350|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82712351|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
82712352|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712353|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
82712354|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712355|NCT04085120|Dexamethasone|dexamethasone|mesh-list
82712356|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
82712357|NCT04085120|Lidocaine|lidocaine|mesh-list
82712358|NCT04085120|Ropivacaine|ropivacaine|mesh-list
82712359|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712360|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
82712361|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
82712362|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712363|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712364|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82712365|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
82712367|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712368|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82712369|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712370|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
82712371|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
82712372|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82712373|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
82712374|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82712375|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82712376|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82712377|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82712378|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712379|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82712380|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82712381|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
82712382|NCT02562183|Kallikreins|kallikreins|mesh-list
82712383|NCT02562183|Coagulants|coagulants|mesh-ancestor
82712384|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
82712385|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
82712386|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82712387|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712388|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82712389|NCT00723398|Pitavastatin|pitavastatin|mesh-list
82712390|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82712391|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82712392|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82712393|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
82712394|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712395|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712396|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82712397|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82712398|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
82712399|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712400|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712401|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82712402|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82712403|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82712405|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82712406|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82712407|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712408|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82712409|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712410|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712411|NCT00684645|Sunitinib|sunitinib|mesh-list
82712412|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712413|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82712414|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82712415|NCT00684645|Growth Substances|growth substances|mesh-ancestor
82712416|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712417|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
82712418|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82712419|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712420|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712421|NCT00752037|Ritonavir|ritonavir|mesh-list
82712422|NCT00752037|Lopinavir|lopinavir|mesh-list
82712423|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
82712424|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82712425|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82712426|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
82712427|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712428|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712429|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82712430|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82712431|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
82712432|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712433|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82712434|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82712435|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82712436|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82712437|NCT00716144|R 115866|r 115866|mesh-list
82712438|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82712439|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712440|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712441|NCT00752115|Paclitaxel|paclitaxel|mesh-list
82712442|NCT00752115|Carboplatin|carboplatin|mesh-list
82712443|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
82712444|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82712445|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712446|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
82712447|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
82712448|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
82712449|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712450|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
82712451|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82712452|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82712453|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712454|NCT00752115|Urological Agents|urological agents|mesh-ancestor
82712455|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
82712456|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
82712457|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82712458|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712459|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82712461|NCT00749385|Esomeprazole|esomeprazole|mesh-list
82712462|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82712463|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82712464|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82712465|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712466|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712467|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82712468|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82712469|NCT00749385|Analgesics|analgesics|mesh-ancestor
82712470|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
82712471|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712472|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712473|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712474|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712475|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
82712476|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82712477|NCT00748059|Propranolol|propranolol|mesh-list
82712478|NCT00748059|Atropine|atropine|mesh-list
82712479|NCT00748059|Clonidine|clonidine|mesh-list
82712480|NCT00748059|Nitroprusside|nitroprusside|mesh-list
82712481|NCT00748059|Methyldopa|methyldopa|mesh-list
82712482|NCT00748059|Phenylephrine|phenylephrine|mesh-list
82712483|NCT00748059|Isoproterenol|isoproterenol|mesh-list
82712484|NCT00748059|Metoclopramide|metoclopramide|mesh-list
82712485|NCT00748059|Yohimbine|yohimbine|mesh-list
82712486|NCT00748059|Tyramine|tyramine|mesh-list
82712487|NCT00748059|Edrophonium|edrophonium|mesh-list
82712488|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82712489|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82712490|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
82712491|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82712492|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712493|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712494|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82712495|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82712496|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
82712497|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82712499|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
82712500|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712501|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
82712502|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82712503|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
82712504|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
82712505|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82712506|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82712507|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82712508|NCT00748059|Protective Agents|protective agents|mesh-ancestor
82712509|NCT00748059|Analgesics|analgesics|mesh-ancestor
82712510|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
82712511|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
82712512|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82712513|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82712514|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82712515|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82712516|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
82712517|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82712518|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82712519|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
82712520|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
82712521|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82712522|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82712523|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82712524|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
82712525|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82712526|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82712527|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82712528|NCT00748059|Urological Agents|urological agents|mesh-ancestor
82712529|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82712530|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82712531|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82712532|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82712533|NCT00748059|Antidotes|antidotes|mesh-ancestor
82712534|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82712535|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712536|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
82712537|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82712538|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82712539|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712540|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82712541|NCT00576381|Analgesics|analgesics|mesh-ancestor
82712542|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
82712543|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712544|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82712545|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82712546|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82712547|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
82712548|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82712549|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712550|NCT02562417|Dexamethasone|dexamethasone|mesh-list
82712551|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712552|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
82712553|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
82712554|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712555|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712556|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82712557|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
82712558|NCT02562417|Hormones|hormones|mesh-ancestor
82712559|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712560|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82712561|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712562|NCT00749619|Taurolidine|taurolidine|mesh-list
82712563|NCT00749619|Heparin|heparin|mesh-list
82712564|NCT00749619|Calcium heparin|calcium heparin|mesh-list
82712565|NCT00749619|Citric Acid|citric acid|mesh-list
82712566|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
82712567|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82712568|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
82712569|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82712570|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
82712571|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
82712572|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712573|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82712574|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82712575|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712576|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82712577|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712578|NCT00748371|Aspirin|aspirin|mesh-list
82712579|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82712580|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82712581|NCT00748371|Analgesics|analgesics|mesh-ancestor
82712582|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
82712583|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712584|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712585|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712586|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712587|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82712588|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82712589|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712590|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82712591|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82712592|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712593|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
82712594|NCT00749853|Buserelin|buserelin|mesh-list
82712595|NCT00749853|Hormones|hormones|mesh-list
82712596|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82712597|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712598|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712599|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82712600|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
82712602|NCT00684567|Temozolomide|temozolomide|mesh-list
82712603|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82712604|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
82712605|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712606|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712607|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82712608|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82712609|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82712610|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82712611|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712612|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82712613|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82712614|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82712615|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
82712616|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82712617|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712618|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82712619|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82712620|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
82712621|NCT04053621|Thiamine|thiamine|mesh-list
82712622|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
82712623|NCT04053621|Metformin|metformin|mesh-list
82712624|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82712625|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712626|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
82712627|NCT04053621|Vitamins|vitamins|mesh-ancestor
82712628|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
82712629|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
82712630|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712631|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82712632|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712633|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712634|NCT02562651|Doxycycline|doxycycline|mesh-list
82712635|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82712636|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712637|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
82712638|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82712639|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82712640|NCT00748527|Carboplatin|carboplatin|mesh-list
82712641|NCT00748527|Decitabine|decitabine|mesh-list
82712642|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712643|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82712644|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
82712645|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712646|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712647|NCT00686829|Maleic acid|maleic acid|mesh-list
82712648|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712649|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712650|NCT00687297|Carboplatin|carboplatin|mesh-list
82712651|NCT00687297|Docetaxel|docetaxel|mesh-list
82712652|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712653|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
82712654|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
82712655|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
82712656|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712657|NCT00684177|Retapamulin|retapamulin|mesh-list
82712658|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82712659|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712660|NCT00686595|Infliximab|infliximab|mesh-list
82712661|NCT00686595|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82712662|NCT00686595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712663|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
82712664|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82712665|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712666|NCT00752661|Tramadol|tramadol|mesh-list
82712667|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82712668|NCT00752661|Narcotics|narcotics|mesh-ancestor
82712669|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82712670|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712671|NCT00752661|Analgesics|analgesics|mesh-ancestor
82712672|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
82712673|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712674|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
82712675|NCT00576303|Hematinics|hematinics|mesh-ancestor
82712676|NCT00752739|Selenium|selenium|mesh-list
82712677|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
82712678|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712679|NCT00752739|Protective Agents|protective agents|mesh-ancestor
82712680|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712681|NCT00752739|Trace Elements|trace elements|mesh-ancestor
82712682|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
82712683|NCT00755781|Cyclosporine|cyclosporine|mesh-list
82712684|NCT00755781|Cyclosporins|cyclosporins|mesh-list
82712685|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712686|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712687|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82712688|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
82712689|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712690|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
82712691|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712692|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
82712693|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712694|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82712695|NCT00755859|Prednisone|prednisone|mesh-list
82712696|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82712697|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82712698|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
82712699|NCT00755859|Prednisolone|prednisolone|mesh-list
82712700|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
82712701|NCT00755859|Azathioprine|azathioprine|mesh-list
82712702|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82712703|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
82712704|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
82712705|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712706|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82712707|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712708|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82712709|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
82712710|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712711|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712712|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712713|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
82712714|NCT00755859|Hormones|hormones|mesh-ancestor
82712715|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712716|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82712717|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82712718|NCT00755859|Protective Agents|protective agents|mesh-ancestor
82712719|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
82712720|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
82712721|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712722|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82712723|NCT00686517|Interferons|interferons|mesh-list
82712724|NCT00686517|Ribavirin|ribavirin|mesh-list
82712725|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
82712726|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
82712727|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82712728|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712729|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
82712730|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712731|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
82712732|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712733|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
82712734|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712735|NCT00571701|Celecoxib|celecoxib|mesh-list
82712736|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82712737|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82712738|NCT00571701|Analgesics|analgesics|mesh-ancestor
82712739|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
82712740|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712741|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712742|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712743|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712744|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82712745|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82712746|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712747|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712748|NCT00686127|Lidocaine|lidocaine|mesh-list
82712750|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
82712751|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82712752|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712753|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
82712754|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712755|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82712756|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82712757|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82712758|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82712759|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712760|NCT00718718|Methotrexate|methotrexate|mesh-list
82712761|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82712762|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82712763|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
82712764|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82712765|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712766|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82712767|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
82712768|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712769|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712770|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
82712771|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712772|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82712773|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82712774|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
82712775|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712776|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82712777|NCT00683787|Docetaxel|docetaxel|mesh-list
82712778|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712779|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
82712780|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
82712781|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
82712782|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712783|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
82712784|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712785|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
82712786|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712787|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712788|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82712789|NCT00750399|Ranibizumab|ranibizumab|mesh-list
82712790|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82712791|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82712792|NCT00750399|Growth Substances|growth substances|mesh-ancestor
82712793|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712794|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
82712795|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712796|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
82712797|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82712798|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82712799|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
82712800|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712801|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82712802|NCT00718640|Dexamethasone|dexamethasone|mesh-list
82712803|NCT00718640|Bortezomib|bortezomib|mesh-list
82712804|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712805|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
82712806|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
82712807|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712808|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712809|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82712810|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
82712811|NCT00718640|Hormones|hormones|mesh-ancestor
82712812|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712813|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82712814|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712815|NCT00753051|Haloperidol|haloperidol|mesh-list
82712816|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
82712817|NCT00753051|Clozapine|clozapine|mesh-list
82712818|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
82712819|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
82712820|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712821|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712822|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82712823|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82712824|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82712825|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82712826|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82712827|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82712828|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
82712829|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82712830|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712831|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82712832|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82712833|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
82712834|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
82712835|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
82712836|NCT00753207|Epirubicin|epirubicin|mesh-list
82712837|NCT00753207|Lapatinib|lapatinib|mesh-list
82712838|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82712839|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712840|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82712841|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82712842|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712843|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712844|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82712845|NCT00715910|Vaccines|vaccines|mesh-list
82712846|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
82712847|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712848|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
82712849|NCT00715676|Vitamins|vitamins|mesh-ancestor
82712850|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
82712851|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712852|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82712853|NCT00718328|Simvastatin|simvastatin|mesh-list
82712854|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82712855|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82712856|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
82712857|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712858|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82712859|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82712860|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712861|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82712862|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82712863|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82712864|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82712865|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712866|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82712867|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712868|NCT02590874|Analgesics|analgesics|mesh-ancestor
82712869|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
82712870|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712871|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
82712872|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82712873|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
82712874|NCT00715520|Levodopa|levodopa|mesh-list
82712875|NCT00715520|Carbidopa|carbidopa|mesh-list
82712876|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82712877|NCT00715520|Methylphenidate|methylphenidate|mesh-list
82712878|NCT00715520|Amphetamine|amphetamine|mesh-list
82712879|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82712880|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712881|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82712882|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82712883|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82712884|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712885|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
82712887|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82712888|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82712889|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82712890|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712891|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
82712892|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
82712893|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712894|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
82712895|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82712896|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82712897|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
82712898|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
82712900|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82712901|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82712902|NCT00756873|Analgesics|analgesics|mesh-ancestor
82712903|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
82712904|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712905|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712906|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712907|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712908|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82712909|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82712910|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712911|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712912|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82712913|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82712914|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712915|NCT00790205|Incretins|incretins|mesh-ancestor
82712916|NCT00790205|Hormones|hormones|mesh-ancestor
82712917|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712918|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82712919|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
82712920|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712921|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712922|NCT04056039|Colchicine|colchicine|mesh-list
82712923|NCT04056039|Atorvastatin|atorvastatin|mesh-list
82712924|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82712925|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82712926|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
82712927|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712928|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82712929|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82712930|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712931|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
82712932|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712933|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
82712934|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
82712935|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
82712936|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712937|NCT00715208|Prednisone|prednisone|mesh-list
82712938|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
82712939|NCT00715208|Rituximab|rituximab|mesh-list
82712940|NCT00715208|Doxorubicin|doxorubicin|mesh-list
82712941|NCT00715208|Bortezomib|bortezomib|mesh-list
82712942|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82712943|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
82712944|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712945|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82712946|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82712947|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
82712948|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712949|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712950|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82712951|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82712952|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82712953|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82712954|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82712955|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712956|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712957|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
82712958|NCT00715208|Hormones|hormones|mesh-ancestor
82712959|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82712960|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82712961|NCT00919178|Vaccines|vaccines|mesh-list
82712962|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
82712963|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712964|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
82712965|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82712966|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82712967|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82712968|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82712969|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712970|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
82712971|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82712972|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712973|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82712974|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82712975|NCT00775463|Treprostinil|treprostinil|mesh-list
82712976|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82712977|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
82712978|NCT02589782|Linezolid|linezolid|mesh-list
82712979|NCT02589782|Bedaquiline|bedaquiline|mesh-list
82712980|NCT02589782|Clofazimine|clofazimine|mesh-list
82712981|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82712982|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82712983|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82712984|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82712985|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82712986|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82712987|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82712988|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82712989|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
82712990|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82712991|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
82712992|NCT00918554|Methotrexate|methotrexate|mesh-list
82712993|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82712994|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
82712995|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82712996|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82712997|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82712998|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
82712999|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713000|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713001|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
82713002|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713003|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82713004|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713005|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
82713006|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713007|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82713008|NCT02590016|Insulin|insulin|mesh-list
82713009|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
82713010|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82713011|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713012|NCT00768053|Etanercept|etanercept|mesh-list
82713013|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82713014|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82713015|NCT00768053|Analgesics|analgesics|mesh-ancestor
82713016|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
82713017|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713018|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713019|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713020|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713021|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82713022|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713023|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
82713024|NCT00683475|Prednisone|prednisone|mesh-list
82713025|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
82713026|NCT00683475|Ramucirumab|ramucirumab|mesh-list
82713027|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82713028|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713029|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
82713030|NCT00683475|Hormones|hormones|mesh-ancestor
82713031|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713032|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713033|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82713034|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713035|NCT00683475|Analgesics|analgesics|mesh-ancestor
82713036|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
82713037|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713038|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82713039|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82713040|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713041|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713042|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
82713043|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82713045|NCT02589158|Cobicistat|cobicistat|mesh-list
82713046|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82713047|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82713048|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
82713049|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713050|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713051|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82713052|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82713053|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
82713054|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713055|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82713056|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82713057|NCT00916253|Modafinil|modafinil|mesh-list
82713058|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82713059|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713060|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82713061|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82713062|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82713063|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713064|NCT00757029|Norepinephrine|norepinephrine|mesh-list
82713065|NCT00757029|Methylphenidate|methylphenidate|mesh-list
82713366|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
82713066|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82713067|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713068|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82713069|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82713070|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82713071|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713072|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
82713073|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713074|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82713075|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82713076|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
82713077|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
82713078|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
82713079|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713080|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82713081|NCT04101929|Irinotecan|irinotecan|mesh-list
82713082|NCT04101929|Apatinib|apatinib|mesh-list
82713083|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82713084|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82713085|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713086|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713087|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713088|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82713089|NCT00918632|Axitinib|axitinib|mesh-list
82713090|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713091|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82713092|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713093|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713094|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
82713095|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82713096|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
82713097|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713098|NCT00751257|Expectorants|expectorants|mesh-ancestor
82713099|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
82713100|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82713101|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
82713102|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713103|NCT00751257|Protective Agents|protective agents|mesh-ancestor
82713104|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713105|NCT00751257|Antidotes|antidotes|mesh-ancestor
82713106|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
82713107|NCT00757185|Testosterone|testosterone|mesh-list
82713108|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
82713109|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
82713110|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82713111|NCT00757185|Ganirelix|ganirelix|mesh-list
82713112|NCT00757185|Androgens|androgens|mesh-ancestor
82713113|NCT00757185|Hormones|hormones|mesh-ancestor
82713114|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713115|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713116|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82713117|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713118|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
82713119|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
82713120|NCT00751491|Clopidogrel|clopidogrel|mesh-list
82713121|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82713122|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82713123|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82713124|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82713125|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
82713126|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713127|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713128|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713129|NCT02561169|Oseltamivir|oseltamivir|mesh-list
82713130|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
82713131|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
82713132|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713133|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713134|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713135|NCT02561169|Antacids|antacids|mesh-ancestor
82713136|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82713137|NCT00753597|Rituximab|rituximab|mesh-list
82713138|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82713139|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713140|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
82713141|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713142|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713143|NCT00757419|Lesogaberan|lesogaberan|mesh-list
82713144|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82713145|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82713146|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
82713147|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
82713148|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713149|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713150|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713151|NCT00757731|Milnacipran|milnacipran|mesh-list
82713152|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
82713153|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82713154|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82713155|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82713156|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713157|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713158|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713159|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82713160|NCT00757731|Analgesics|analgesics|mesh-ancestor
82713161|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
82713162|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713163|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
82713164|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82713165|NCT00753909|Paclitaxel|paclitaxel|mesh-list
82713166|NCT00753909|Bevacizumab|bevacizumab|mesh-list
82713167|NCT00753909|Carboplatin|carboplatin|mesh-list
82713168|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82713169|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713170|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
82713171|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
82713172|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
82713173|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713174|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82713175|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82713176|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82713177|NCT00753909|Growth Substances|growth substances|mesh-ancestor
82713178|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713179|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
82713180|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
82713181|NCT02560155|Mupirocin|mupirocin|mesh-list
82713182|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82713183|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713184|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
82713185|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82713186|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82713187|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713188|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713189|NCT02559921|Vaccines|vaccines|mesh-list
82713190|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
82713191|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713192|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82713193|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
82713194|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713195|NCT05266040|Valacyclovir|valacyclovir|mesh-list
82713196|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
82713197|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713198|NCT00773747|Bortezomib|bortezomib|mesh-list
82713199|NCT00773747|Vorinostat|vorinostat|mesh-list
82713200|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713201|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82713202|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713203|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713204|NCT00784277|Oxycodone|oxycodone|mesh-list
82713205|NCT00784277|Tapentadol|tapentadol|mesh-list
82713206|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82713207|NCT00784277|Narcotics|narcotics|mesh-ancestor
82713208|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82713209|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713210|NCT00784277|Analgesics|analgesics|mesh-ancestor
82713211|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
82713212|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713213|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82713214|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82713215|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82713216|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713217|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
82713218|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713219|NCT05113784|Meplazumab|meplazumab|mesh-list
82713220|NCT05113784|Antiviral Agents|antiviral agents|mesh-ancestor
82713221|NCT05113784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713222|NCT02588534|Etanercept|etanercept|mesh-list
82713223|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82713224|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82713225|NCT02588534|Analgesics|analgesics|mesh-ancestor
82713226|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
82713227|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713228|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713229|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713230|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713231|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82713232|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713233|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
82713234|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
82713235|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82713236|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82713237|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713238|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
82713239|NCT05099276|Coagulants|coagulants|mesh-ancestor
82713240|NCT00682929|Dronabinol|dronabinol|mesh-list
82713241|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
82713242|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713243|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82713244|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82713245|NCT00682929|Analgesics|analgesics|mesh-ancestor
82713246|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
82713247|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713248|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82713249|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82713250|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713251|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713252|NCT00682929|Hormones|hormones|mesh-ancestor
82713253|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713254|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
82713255|NCT00758199|Prednisolone|prednisolone|mesh-list
82713256|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82713257|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
82713258|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82713259|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
82713260|NCT00758199|Bromfenac|bromfenac|mesh-list
82713261|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82713262|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82713263|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
82713264|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713265|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
82713266|NCT00758199|Hormones|hormones|mesh-ancestor
82713267|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713268|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713269|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82713270|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713271|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
82713272|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
82713273|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713274|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82713275|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82713276|NCT00758199|Protective Agents|protective agents|mesh-ancestor
82713277|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82713278|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713279|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82713280|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82713281|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713282|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713283|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82713284|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
82713285|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82713286|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82713287|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82713288|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82713289|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82713290|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82713291|NCT00758199|Analgesics|analgesics|mesh-ancestor
82713292|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
82713293|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713294|NCT05683808|Apixaban|apixaban|mesh-list
82713295|NCT05683808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82713296|NCT05683808|Antithrombins|antithrombins|mesh-ancestor
82713297|NCT05683808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82713298|NCT05683808|Protease Inhibitors|protease inhibitors|mesh-ancestor
82713299|NCT05683808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713300|NCT05683808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713301|NCT05683808|Anticoagulants|anticoagulants|mesh-ancestor
82713302|NCT00680745|Metformin|metformin|mesh-list
82713303|NCT00680745|Pioglitazone|pioglitazone|mesh-list
82713304|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
82713305|NCT00680745|Glimepiride|glimepiride|mesh-list
82713306|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
82713307|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82713308|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713309|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82713310|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713311|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82713312|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713313|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
82713314|NCT05434377|Vitamin D|vitamin d|mesh-list
82713315|NCT05434377|Ergocalciferols|ergocalciferols|mesh-list
82713316|NCT05434377|Vitamins|vitamins|mesh-ancestor
82713317|NCT05434377|Micronutrients|micronutrients|mesh-ancestor
82713318|NCT05434377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713319|NCT05434377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82713320|NCT05434377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82713321|NCT05428293|Acetaminophen|acetaminophen|mesh-list
82713322|NCT05428293|Ibuprofen|ibuprofen|mesh-list
82713323|NCT05428293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82713324|NCT05428293|Analgesics|analgesics|mesh-ancestor
82713325|NCT05428293|Sensory System Agents|sensory system agents|mesh-ancestor
82713326|NCT05428293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713327|NCT05428293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713328|NCT05428293|Antipyretics|antipyretics|mesh-ancestor
82713329|NCT05428293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82713330|NCT05428293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713331|NCT05428293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713332|NCT05428293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82713333|NCT05428293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713334|NCT05428293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713335|NCT05427825|Anesthetics|anesthetics|mesh-list
82713336|NCT05427825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82713337|NCT05427825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713338|NCT00680121|Benphothiamine|benphothiamine|mesh-list
82713339|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82713340|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
82713341|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713342|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
82713343|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
82713344|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713345|NCT00754689|Metformin|metformin|mesh-list
82713346|NCT00754689|Rimonabant|rimonabant|mesh-list
82713347|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82713348|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713349|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82713350|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
82713351|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82713352|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713353|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713354|NCT00754689|Hormones|hormones|mesh-ancestor
82713355|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713356|NCT00767819|Everolimus|everolimus|mesh-list
82713357|NCT00767819|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82713358|NCT00767819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82713359|NCT00767819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713360|NCT00767819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713361|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713362|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
82713363|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713364|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713365|NCT00758277|Levetiracetam|levetiracetam|mesh-list
82713367|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
82713368|NCT00584870|Naproxen|naproxen|mesh-list
82713369|NCT00584870|Tanezumab|tanezumab|mesh-list
82713370|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82713371|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82713372|NCT00584870|Analgesics|analgesics|mesh-ancestor
82713373|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
82713374|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713375|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713376|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713377|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713378|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
82713379|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82713380|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713381|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713382|NCT00679341|Docetaxel|docetaxel|mesh-list
82713383|NCT00679341|Trastuzumab|trastuzumab|mesh-list
82713384|NCT00679341|Maytansine|maytansine|mesh-list
82713385|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82713386|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713387|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
82713388|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
82713389|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
82713390|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713391|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82713392|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82713393|NCT00679341|Immunotoxins|immunotoxins|mesh-ancestor
82713394|NCT00679341|Immunoconjugates|immunoconjugates|mesh-ancestor
82713395|NCT00679341|Immunologic Factors|immunologic factors|mesh-ancestor
82713396|NCT00679341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713397|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
82713398|NCT00680043|Hematinics|hematinics|mesh-ancestor
82713399|NCT05436093|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82713400|NCT05436093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82713401|NCT05436093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713402|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82713403|NCT00682539|Triamcinolone|triamcinolone|mesh-list
82713404|NCT00682539|Bevacizumab|bevacizumab|mesh-list
82713405|NCT00682539|Ranibizumab|ranibizumab|mesh-list
82713406|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82713407|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713408|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82713409|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82713410|NCT00682539|Growth Substances|growth substances|mesh-ancestor
82713411|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713412|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
82713413|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713414|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
82713415|NCT00682539|Hormones|hormones|mesh-ancestor
82713416|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713417|NCT00682461|Nicotine|nicotine|mesh-list
82713418|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82713419|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
82713420|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713421|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713422|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82713423|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82713424|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
82713425|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713426|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713427|NCT00921765|Ketamine|ketamine|mesh-list
82713428|NCT00921765|Naloxone|naloxone|mesh-list
82713429|NCT00921765|Analgesics|analgesics|mesh-ancestor
82713430|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
82713431|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713432|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713433|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82713434|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82713435|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
82713436|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
82713437|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82713438|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82713439|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82713440|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713441|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713442|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82713443|NCT05435781|Hydrocortisone|hydrocortisone|mesh-list
82713444|NCT05435781|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82713445|NCT05435781|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82713446|NCT05435781|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82713447|NCT05435781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713448|NCT00755157|Bevacizumab|bevacizumab|mesh-list
82713449|NCT00755157|Docetaxel|docetaxel|mesh-list
82713450|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82713451|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713452|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82713453|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82713454|NCT00755157|Growth Substances|growth substances|mesh-ancestor
82713455|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713456|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
82713457|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
82713458|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
82713459|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
82713460|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713461|NCT00919880|Paclitaxel|paclitaxel|mesh-list
82713462|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82713463|NCT00919880|Carboplatin|carboplatin|mesh-list
82713464|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82713465|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713466|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
82713467|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
82713468|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
82713469|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713470|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
82713471|NCT00755313|Carboplatin|carboplatin|mesh-list
82713472|NCT00755313|Docetaxel|docetaxel|mesh-list
82713473|NCT00755313|Doxorubicin|doxorubicin|mesh-list
82713474|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82713475|NCT00755313|Trastuzumab|trastuzumab|mesh-list
82713476|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82713477|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82713478|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713479|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
82713480|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713481|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713482|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82713483|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
82713484|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713485|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713486|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82713487|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
82713488|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
82713489|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
82713490|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82713491|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82713492|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82713493|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713494|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82713495|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82713496|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82713497|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82713498|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
82713499|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713500|NCT04082858|Midazolam|midazolam|mesh-list
82713501|NCT04082858|Ketamine|ketamine|mesh-list
82713502|NCT04082858|Analgesics|analgesics|mesh-ancestor
82713503|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
82713504|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713505|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713506|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82713507|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82713508|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
82713509|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
82713510|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82713511|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82713512|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82713513|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713514|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713515|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82713516|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82713517|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82713518|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82713519|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82713520|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
82713521|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
82713522|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
82713523|NCT00679029|Bevacizumab|bevacizumab|mesh-list
82713524|NCT00679029|Gemcitabine|gemcitabine|mesh-list
82713525|NCT00679029|Doxorubicin|doxorubicin|mesh-list
82713526|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82713527|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82713528|NCT00679029|Antibodies|antibodies|mesh-list
82713529|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
82713530|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82713531|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713532|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713533|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713534|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
82713535|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713536|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713537|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82713538|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
82713539|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82713540|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82713541|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82713542|NCT00679029|Growth Substances|growth substances|mesh-ancestor
82713543|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
82713544|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82713545|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
82713546|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82713547|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82713548|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82713549|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713550|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
82713551|NCT00919022|Cyproterone|cyproterone|mesh-list
82713552|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
82713553|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
82713554|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713555|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713556|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713557|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82713558|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
82713559|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82713560|NCT05004350|Fluorouracil|fluorouracil|mesh-list
82713561|NCT05004350|Irinotecan|irinotecan|mesh-list
82713562|NCT05004350|Cetuximab|cetuximab|mesh-list
82713563|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
82713564|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713565|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82713566|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713567|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713568|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
82713569|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713570|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82713571|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82713572|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713573|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82713574|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
82713575|NCT05122221|Fludarabine|fludarabine|mesh-list
82713576|NCT05122221|Interleukin-2|interleukin-2|mesh-list
82713577|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713578|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
82713579|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713580|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713581|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82713582|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
82713583|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713584|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713585|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82713586|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82713587|NCT05122221|Analgesics|analgesics|mesh-ancestor
82713588|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
82713589|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713590|NCT03802305|Anesthetics|anesthetics|mesh-list
82713591|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82713592|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713593|NCT02587052|Tacrolimus|tacrolimus|mesh-list
82713594|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713595|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
82713596|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713597|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82713598|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713599|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713600|NCT02587130|Ketamine|ketamine|mesh-list
82713601|NCT02587130|Analgesics|analgesics|mesh-ancestor
82713602|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
82713603|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713604|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713605|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82713606|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82713607|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
82713608|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
82713609|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82713610|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82713611|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82713612|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713613|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713614|NCT02559141|Dobutamine|dobutamine|mesh-list
82713615|NCT02559141|Norepinephrine|norepinephrine|mesh-list
82713616|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82713617|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82713618|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
82713619|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713620|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713621|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713622|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
82713623|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
82713624|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713625|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82713626|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82713627|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82713628|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82713629|NCT02559141|Protective Agents|protective agents|mesh-ancestor
82713630|NCT02561013|Monensin|monensin|mesh-list
82713631|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
82713632|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713633|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82713634|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82713635|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
82713636|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
82713637|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
82713638|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713639|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713640|NCT02561013|Ionophores|ionophores|mesh-ancestor
82713641|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82713642|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
82713643|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
82713644|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82713645|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713646|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82713647|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82713648|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713649|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713650|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713651|NCT00678795|Nabiximols|nabiximols|mesh-list
82713652|NCT00678795|Analgesics|analgesics|mesh-ancestor
82713653|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
82713654|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713655|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713656|NCT03417687|Xenon|xenon|mesh-list
82713657|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82713658|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
82713659|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
82713660|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82713661|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713662|NCT04767698|Belimumab|belimumab|mesh-list
82713663|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
82713664|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713665|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
82713666|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713667|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82713668|NCT03205137|Amlodipine|amlodipine|mesh-list
82713669|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82713670|NCT03205137|Telmisartan|telmisartan|mesh-list
82713671|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
82713672|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
82713673|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82713674|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82713675|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82713676|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713677|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82713678|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713679|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
82713680|NCT03205137|Diuretics|diuretics|mesh-ancestor
82713681|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
82713682|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82713683|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82713684|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82713685|NCT00678561|Tofacitinib|tofacitinib|mesh-list
82713686|NCT00678561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82713687|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82713689|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713691|NCT04732286|Atezolizumab|atezolizumab|mesh-list
82713692|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82713693|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713694|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82713695|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82713696|NCT04732286|Growth Substances|growth substances|mesh-ancestor
82713697|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713698|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
82713699|NCT04732286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82713700|NCT04732286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713703|NCT04939142|Dexamethasone|dexamethasone|mesh-list
82713704|NCT04939142|Dexamethasone acetate|dexamethasone acetate|mesh-list
82713705|NCT04939142|Bortezomib|bortezomib|mesh-list
82713706|NCT04939142|BB 1101|bb 1101|mesh-list
82713707|NCT04939142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713708|NCT04939142|Antiemetics|antiemetics|mesh-ancestor
82713709|NCT04939142|Autonomic Agents|autonomic agents|mesh-ancestor
82713710|NCT04939142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713711|NCT04939142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713712|NCT04939142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82713713|NCT04939142|Glucocorticoids|glucocorticoids|mesh-ancestor
82713714|NCT04939142|Hormones|hormones|mesh-ancestor
82713715|NCT04939142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713716|NCT04939142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82713717|NCT04939142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713718|NCT04939142|Protease Inhibitors|protease inhibitors|mesh-ancestor
82713719|NCT04939142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713720|NCT04939142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713721|NCT05683340|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
82713722|NCT05683340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82713723|NCT05683340|Antimetabolites|antimetabolites|mesh-ancestor
82713724|NCT05683340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713725|NCT05683340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82713726|NCT05683340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713727|NCT05683340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82713728|NCT05683340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713729|NCT04081376|Hydromorphone|hydromorphone|mesh-list
82713730|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82713731|NCT04081376|Narcotics|narcotics|mesh-ancestor
82713732|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82713733|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713734|NCT04081376|Analgesics|analgesics|mesh-ancestor
82713735|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
82713736|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713737|NCT02584400|Imidazole|imidazole|mesh-list
82713738|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713739|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713740|NCT04585022|Cimetidine|cimetidine|mesh-list
82713741|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82713742|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82713743|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82713744|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
82713745|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
82713746|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713747|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713748|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713749|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82713750|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82713751|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713753|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713754|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713755|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713756|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
82713757|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713758|NCT00761241|Interferons|interferons|mesh-list
82713759|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
82713760|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82713761|NCT00761241|Gemcitabine|gemcitabine|mesh-list
82713762|NCT00761241|Docetaxel|docetaxel|mesh-list
82713763|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
82713764|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82713765|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
82713766|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713767|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713768|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
82713769|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
82713770|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
82713771|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
82713772|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713773|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
82713774|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713775|NCT02981979|Prednisone|prednisone|mesh-list
82713776|NCT02981979|Leflunomide|leflunomide|mesh-list
82713777|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713778|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
82713779|NCT02981979|Hormones|hormones|mesh-ancestor
82713780|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713781|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713782|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82713783|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713784|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713785|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713786|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713787|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
82713788|NCT04049409|Trastuzumab|trastuzumab|mesh-list
82713789|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82713790|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713791|NCT00920660|Prednisolone|prednisolone|mesh-list
82713792|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713793|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
82713794|NCT00920660|Hormones|hormones|mesh-ancestor
82713795|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713796|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713797|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82713798|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713799|NCT02583464|Tenofovir|tenofovir|mesh-list
82713800|NCT02583464|Emtricitabine|emtricitabine|mesh-list
82713801|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
82713802|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713803|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82713804|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82713805|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713806|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713807|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82713808|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82713809|NCT00675597|Bevacizumab|bevacizumab|mesh-list
82713810|NCT00675597|Docetaxel|docetaxel|mesh-list
82713811|NCT00675597|Vinorelbine|vinorelbine|mesh-list
82713812|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82713813|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713814|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82713815|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82713816|NCT00675597|Growth Substances|growth substances|mesh-ancestor
82713817|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713818|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
82713819|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
82713820|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
82713821|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
82713822|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713823|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82713825|NCT02677545|Clopidogrel|clopidogrel|mesh-list
82713827|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82713828|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82713829|NCT02677545|Analgesics|analgesics|mesh-ancestor
82713830|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
82713831|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713832|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713833|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713834|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713835|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82713836|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82713837|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713838|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82713839|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82713840|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713841|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
82713842|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82713843|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82713844|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82713845|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
82713846|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713847|NCT04079426|Dimercaprol|dimercaprol|mesh-list
82713848|NCT04079426|Chelating Agents|chelating agents|mesh-ancestor
82713849|NCT04079426|Sequestering Agents|sequestering agents|mesh-ancestor
82713850|NCT04079426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713851|NCT00675441|Lenalidomide|lenalidomide|mesh-list
82713852|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
82713853|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713854|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82713855|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82713856|NCT00675441|Growth Substances|growth substances|mesh-ancestor
82713857|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
82713858|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713859|NCT02559297|Sevoflurane|sevoflurane|mesh-list
82713860|NCT02559297|Desflurane|desflurane|mesh-list
82713861|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82713862|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82713863|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
82713864|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
82713865|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82713866|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713867|NCT02558517|Prednisone|prednisone|mesh-list
82713868|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82713869|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
82713870|NCT02558517|Hormones|hormones|mesh-ancestor
82713871|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82713872|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713873|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82713874|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713875|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82713876|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713877|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82713878|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713879|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713880|NCT00673179|Leucovorin|leucovorin|mesh-list
82713881|NCT00673179|Gemcitabine|gemcitabine|mesh-list
82713882|NCT00673179|Doxorubicin|doxorubicin|mesh-list
82713883|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82713884|NCT00673179|Methotrexate|methotrexate|mesh-list
82713885|NCT00673179|Ifosfamide|ifosfamide|mesh-list
82713886|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
82713887|NCT00673179|Razoxane|razoxane|mesh-list
82713888|NCT00673179|Sargramostim|sargramostim|mesh-list
82713889|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713890|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82713891|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
82713892|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713893|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82713894|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82713895|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82713896|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713897|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82713898|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
82713899|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82713900|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713901|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
82713902|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82713903|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82713904|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
82713905|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82713906|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82713907|NCT00673179|Antidotes|antidotes|mesh-ancestor
82713908|NCT00673179|Protective Agents|protective agents|mesh-ancestor
82713909|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
82713910|NCT00673179|Vitamins|vitamins|mesh-ancestor
82713911|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
82713912|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82713913|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
82713914|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82713915|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
82713916|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
82713917|NCT00758433|Capsaicin|capsaicin|mesh-list
82713918|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
82713919|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
82713920|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
82713921|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713922|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713923|NCT00584012|Docetaxel|docetaxel|mesh-list
82713924|NCT00584012|Lovastatin|lovastatin|mesh-list
82713925|NCT00584012|L 647318|l 647318|mesh-list
82713926|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
82713927|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713928|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
82713929|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
82713930|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
82713931|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713932|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82713933|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82713934|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
82713935|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82713936|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82713937|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713938|NCT05435846|Trametinib|trametinib|mesh-list
82713939|NCT05435846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82713940|NCT05435846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82713941|NCT05435846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713942|NCT05435846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713943|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82713944|NCT00920270|Colistin|colistin|mesh-list
82713945|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82713946|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
82713947|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82713948|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
82713949|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82713950|NCT02585882|Fluorides|fluorides|mesh-list
82713951|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
82713952|NCT02585882|Protective Agents|protective agents|mesh-ancestor
82713953|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713954|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82713955|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82713956|NCT02584010|Silicon|silicon|mesh-list
82713957|NCT02584010|Trace Elements|trace elements|mesh-ancestor
82713958|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
82713959|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713960|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
82713961|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82713962|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713963|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82713964|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713965|NCT02582996|Acetaminophen|acetaminophen|mesh-list
82713966|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
82713967|NCT02582996|Metoclopramide|metoclopramide|mesh-list
82713968|NCT02582996|Caffeine|caffeine|mesh-list
82713969|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82713970|NCT02582996|Analgesics|analgesics|mesh-ancestor
82713971|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
82713972|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713973|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713974|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
82713975|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82713976|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82713977|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82713978|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82713979|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82713980|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82713981|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
82713982|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82713983|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
82713984|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
82713985|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82713986|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82713987|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82713988|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
82713989|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82713990|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
82713991|NCT02585570|Phenylephrine|phenylephrine|mesh-list
82713992|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
82713993|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82713994|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
82713995|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
82713996|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82713997|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82713998|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
82713999|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82714000|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
82714001|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
82714002|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82714003|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82714004|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82714005|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
82714006|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714007|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714008|NCT02585570|Protective Agents|protective agents|mesh-ancestor
82714009|NCT02583854|Hemostatics|hemostatics|mesh-list
82714010|NCT02583854|Coagulants|coagulants|mesh-ancestor
82714011|NCT00764907|Leucovorin|leucovorin|mesh-list
82714012|NCT00764907|Cytarabine|cytarabine|mesh-list
82714013|NCT00764907|Dexamethasone|dexamethasone|mesh-list
82714014|NCT00764907|Prednisone|prednisone|mesh-list
82714015|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
82714016|NCT00764907|Ifosfamide|ifosfamide|mesh-list
82714017|NCT00764907|Doxorubicin|doxorubicin|mesh-list
82714018|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82714019|NCT00764907|Methotrexate|methotrexate|mesh-list
82714020|NCT00764907|Etoposide|etoposide|mesh-list
82714021|NCT00764907|Vincristine|vincristine|mesh-list
82714022|NCT00764907|Daunorubicin|daunorubicin|mesh-list
82714023|NCT00764907|Asparaginase|asparaginase|mesh-list
82714024|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
82714025|NCT00764907|Thioguanine|thioguanine|mesh-list
82714026|NCT00764907|Vindesine|vindesine|mesh-list
82714027|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
82714028|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82714029|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
82714030|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714031|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82714032|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82714033|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
82714034|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714035|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714036|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82714037|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82714038|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
82714039|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
82714040|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714041|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82714042|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
82714043|NCT00764907|Hormones|hormones|mesh-ancestor
82714044|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82714045|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82714046|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82714047|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82714048|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82714049|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714050|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82714051|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
82714052|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82714053|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82714054|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
82714055|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
82714056|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82714057|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82714058|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82714059|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
82714060|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82714061|NCT00764907|Antidotes|antidotes|mesh-ancestor
82714062|NCT00764907|Protective Agents|protective agents|mesh-ancestor
82714063|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
82714065|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
82714066|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
82714067|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
82714068|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
82714069|NCT02583698|Carvedilol|carvedilol|mesh-list
82714070|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82714071|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82714072|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
82714073|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714074|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714075|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714076|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82714077|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
82714078|NCT02583698|Protective Agents|protective agents|mesh-ancestor
82714079|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82714080|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82714081|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82714082|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
82714083|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82714084|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82714085|NCT00762099|Pregabalin|pregabalin|mesh-list
82714086|NCT00762099|Analgesics|analgesics|mesh-ancestor
82714087|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
82714088|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714089|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714090|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
82714091|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82714092|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82714093|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714094|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82714095|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82714096|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82714097|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714098|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82714099|NCT00762255|Bevacizumab|bevacizumab|mesh-list
82714100|NCT00762255|Irinotecan|irinotecan|mesh-list
82714101|NCT00762255|Vorinostat|vorinostat|mesh-list
82714102|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82714103|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714104|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82714105|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82714106|NCT00762255|Growth Substances|growth substances|mesh-ancestor
82714107|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714108|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
82714109|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82714110|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82714111|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714112|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714113|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82714114|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
82714115|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82714116|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82714117|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
82714118|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82714119|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82714120|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82714121|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82714122|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714123|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
82714124|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714125|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714126|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82714127|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714128|NCT05332730|Golimumab|golimumab|mesh-list
82714129|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82714130|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82714131|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82714132|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82714133|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
82714134|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714135|NCT02581826|Silodosin|silodosin|mesh-list
82714136|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82714137|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82714138|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82714139|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
82714140|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714141|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714142|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714143|NCT02581826|Urological Agents|urological agents|mesh-ancestor
82714144|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82714145|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
82714146|NCT04340882|Docetaxel|docetaxel|mesh-list
82714147|NCT04340882|Ramucirumab|ramucirumab|mesh-list
82714148|NCT04340882|Antibodies|antibodies|mesh-list
82714149|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
82714150|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82714151|NCT04340882|Lexatumumab|lexatumumab|mesh-list
82714152|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
82714153|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714154|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714155|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
82714156|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
82714157|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
82714158|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714159|NCT04340882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82714160|NCT00765921|Ranibizumab|ranibizumab|mesh-list
82714161|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82714162|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82714163|NCT00765921|Growth Substances|growth substances|mesh-ancestor
82714164|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714165|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
82714166|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714167|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
82714168|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82714169|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82714170|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
82714171|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82714172|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714173|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
82714174|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714175|NCT00766155|Capecitabine|capecitabine|mesh-list
82714176|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
82714177|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82714178|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
82714179|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714180|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714181|NCT02585258|Prednisolone|prednisolone|mesh-list
82714182|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82714183|NCT02585258|Glucocorticoids|glucocorticoids|mesh-ancestor
82714184|NCT02585258|Hormones|hormones|mesh-ancestor
82714185|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82714186|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714187|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82714188|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714189|NCT00762567|Phenylephrine|phenylephrine|mesh-list
82714190|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
82714191|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
82714192|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82714193|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
82714194|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
82714195|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714196|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714197|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
82714198|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82714199|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
82714200|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82714201|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82714202|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82714203|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
82714204|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714205|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714206|NCT00762567|Protective Agents|protective agents|mesh-ancestor
82714207|NCT04338620|Paclitaxel|paclitaxel|mesh-list
82714208|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82714209|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82714210|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714211|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
82714212|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
82714213|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
82714214|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714215|NCT00923234|Lenalidomide|lenalidomide|mesh-list
82714216|NCT00923234|Azacitidine|azacitidine|mesh-list
82714217|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
82714218|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714219|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82714220|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82714221|NCT00923234|Growth Substances|growth substances|mesh-ancestor
82714222|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
82714223|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714224|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82714225|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
82714226|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714227|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714228|NCT00674661|Riboflavin|riboflavin|mesh-list
82714229|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82714230|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82714231|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
82714232|NCT00674661|Vitamins|vitamins|mesh-ancestor
82714233|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
82714234|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714235|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82714236|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
82714237|NCT00766545|Cilostazol|cilostazol|mesh-list
82714238|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82714239|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
82714240|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714241|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714242|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82714243|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
82714244|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82714245|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82714246|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714247|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82714248|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
82714249|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82714250|NCT00766545|Protective Agents|protective agents|mesh-ancestor
82714251|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82714252|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82714253|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714254|NCT02558205|Liver Extracts|liver extracts|mesh-list
82714255|NCT02558205|Hematinics|hematinics|mesh-ancestor
82714256|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
82714257|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82714258|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82714259|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82714260|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82714261|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714262|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
82714263|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714264|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714265|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82714266|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714267|NCT00766857|Insulin|insulin|mesh-list
82714268|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82714269|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
82714270|NCT00766857|Exenatide|exenatide|mesh-list
82714271|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82714272|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714273|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82714274|NCT00766857|Incretins|incretins|mesh-ancestor
82714275|NCT00766857|Hormones|hormones|mesh-ancestor
82714276|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82714277|NCT02558283|Lidocaine|lidocaine|mesh-list
82714278|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
82714279|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
82714280|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714281|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714282|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
82714283|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714284|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82714285|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82714286|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82714287|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82714288|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714289|NCT00767091|Rivastigmine|rivastigmine|mesh-list
82714290|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
82714291|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714292|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714293|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
82714294|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714295|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714296|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82714297|NCT00767091|Protective Agents|protective agents|mesh-ancestor
82714298|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
82714299|NCT00767169|Pamidronate|pamidronate|mesh-list
82714300|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82714301|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714302|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
82714303|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82714304|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714305|NCT05256381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82714306|NCT05256381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714307|NCT00767481|Travoprost|travoprost|mesh-list
82714308|NCT00767481|Brinzolamide|brinzolamide|mesh-list
82714309|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82714310|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82714311|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714312|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714313|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
82714314|NCT00671931|Propofol|propofol|mesh-list
82714315|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82714316|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714317|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714318|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82714319|NCT00671931|Analgesics|analgesics|mesh-ancestor
82714320|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
82714321|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714322|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82714323|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82714324|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82714325|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
82714326|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714327|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714328|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82714329|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
82714330|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
82714332|NCT00767559|Warfarin|warfarin|mesh-list
82714333|NCT00767559|Fondaparinux|fondaparinux|mesh-list
82714334|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
82714335|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82714336|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
82714337|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82714338|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
82714339|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714340|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714341|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82714342|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82714343|NCT00767715|Haloperidol|haloperidol|mesh-list
82714344|NCT00767715|Olanzapine|olanzapine|mesh-list
82714345|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
82714346|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
82714347|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
82714348|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714349|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714350|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82714351|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82714352|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82714353|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714354|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82714355|NCT00767715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82714356|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82714357|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82714358|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714359|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714360|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
82714361|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82714362|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
82714363|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82714364|NCT00762957|Metformin|metformin|mesh-list
82714365|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82714366|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714367|NCT00759993|Chromium|chromium|mesh-list
82714368|NCT00759993|Trace Elements|trace elements|mesh-ancestor
82714369|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
82714370|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714371|NCT00673881|Choline|choline|mesh-list
82714372|NCT00673881|Fenofibrate|fenofibrate|mesh-list
82714373|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82714374|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
82714375|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714376|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82714377|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
82714378|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82714379|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
82714380|NCT00763347|Alogliptin|alogliptin|mesh-list
82714381|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82714382|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714383|NCT00763347|Incretins|incretins|mesh-ancestor
82714384|NCT00763347|Hormones|hormones|mesh-ancestor
82714385|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82714386|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82714387|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
82714388|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714389|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714390|NCT00767871|Escitalopram|escitalopram|mesh-list
82714391|NCT00767871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82714392|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82714393|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82714394|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714395|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714396|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
82714397|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714398|NCT00760149|Rifampin|rifampin|mesh-list
82714399|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82714400|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
82714401|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82714402|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82714403|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
82714404|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82714405|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714406|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714407|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82714408|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82714409|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82714410|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82714411|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82714412|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82714413|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82714414|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
82714415|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82714416|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82714417|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82714418|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714419|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714420|NCT00768183|Ethanol|ethanol|mesh-list
82714421|NCT00768183|Morphine|morphine|mesh-list
82714422|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82714423|NCT00768183|Narcotics|narcotics|mesh-ancestor
82714424|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714425|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714426|NCT00768183|Analgesics|analgesics|mesh-ancestor
82714427|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
82714428|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714432|NCT02557581|Clenbuterol|clenbuterol|mesh-list
82714433|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82714434|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
82714435|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714436|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714437|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82714438|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
82714439|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
82714440|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
82714441|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82714442|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82714443|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82714444|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82714445|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
82714446|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714447|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714448|NCT04077944|Trace Elements|trace elements|mesh-list
82714449|NCT04077944|Micronutrients|micronutrients|mesh-list
82714450|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714451|NCT02558751|Vaccines|vaccines|mesh-list
82714452|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82714453|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
82714454|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714455|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
82714456|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
82714457|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82714458|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82714459|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714460|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714461|NCT00768573|Urological Agents|urological agents|mesh-ancestor
82714462|NCT02558361|Apremilast|apremilast|mesh-list
82714463|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82714464|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82714465|NCT02558361|Analgesics|analgesics|mesh-ancestor
82714466|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
82714467|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714468|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714469|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82714470|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82714471|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82714472|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82714473|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714474|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714475|NCT02558595|Niacinamide|niacinamide|mesh-list
82714476|NCT02558595|Niacin|niacin|mesh-list
82714477|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
82714478|NCT02558595|Vitamins|vitamins|mesh-ancestor
82714479|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
82714480|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714481|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
82714482|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82714483|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
82714484|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714485|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82714486|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
82714487|NCT00760695|Dronabinol|dronabinol|mesh-list
82714488|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
82714489|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714490|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82714491|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82714492|NCT00760695|Analgesics|analgesics|mesh-ancestor
82714493|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
82714494|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714495|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82714496|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82714497|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714498|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714499|NCT00760695|Hormones|hormones|mesh-ancestor
82714500|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82714501|NCT02582372|Fentanyl|fentanyl|mesh-list
82714502|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
82714503|NCT02582372|Bupivacaine|bupivacaine|mesh-list
82714504|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
82714505|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
82714506|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714507|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714508|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
82714509|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714510|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82714511|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82714512|NCT02582372|Analgesics|analgesics|mesh-ancestor
82714513|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82714514|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82714515|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82714516|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
82714517|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714518|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714519|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82714520|NCT02582372|Narcotics|narcotics|mesh-ancestor
82714521|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82714522|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82714523|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
82714525|NCT00768729|Azathioprine|azathioprine|mesh-list
82714526|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82714527|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82714528|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82714529|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714530|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
82714531|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82714532|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
82714533|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714534|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714535|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
82714536|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82714537|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82714538|NCT00768963|Ranibizumab|ranibizumab|mesh-list
82714539|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82714540|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82714541|NCT00768963|Growth Substances|growth substances|mesh-ancestor
82714542|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714543|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
82714544|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714546|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82714547|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82714548|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82714549|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82714550|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714551|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714552|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714553|NCT00770445|Insulin|insulin|mesh-list
82714554|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82714555|NCT00770445|Metformin|metformin|mesh-list
82714556|NCT00770445|Pioglitazone|pioglitazone|mesh-list
82714557|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82714558|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714559|NCT04077398|Ropivacaine|ropivacaine|mesh-list
82714560|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
82714561|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
82714562|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714563|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714564|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
82714565|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714566|NCT04239716|Anesthetics|anesthetics|mesh-list
82714567|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714568|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714569|NCT04048707|Octreotide|octreotide|mesh-list
82714570|NCT04048707|Midodrine|midodrine|mesh-list
82714571|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
82714572|NCT04048707|Giapreza|giapreza|mesh-list
82714573|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
82714574|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82714575|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82714576|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714577|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
82714578|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
82714579|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714580|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714581|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82714582|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82714583|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82714584|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82714585|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
82714586|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714587|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714588|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82714589|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
82714590|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714591|NCT00763893|Losartan|losartan|mesh-list
82714592|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82714593|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82714594|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82714595|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82714596|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714597|NCT00770835|Metformin|metformin|mesh-list
82714598|NCT00770835|Pioglitazone|pioglitazone|mesh-list
82714599|NCT00770835|Glyburide|glyburide|mesh-list
82714600|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82714601|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714602|NCT00769587|Thalidomide|thalidomide|mesh-list
82714603|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82714604|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
82714605|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714606|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
82714607|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82714608|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82714609|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82714610|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82714611|NCT00769587|Growth Substances|growth substances|mesh-ancestor
82714612|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
82714613|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714614|NCT00570921|Everolimus|everolimus|mesh-list
82714615|NCT00570921|Fulvestrant|fulvestrant|mesh-list
82714616|NCT00570921|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82714617|NCT00570921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82714618|NCT00570921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714619|NCT00570921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714620|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82714621|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
82714622|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714623|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714624|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82714625|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82714626|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82714627|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
82714628|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82714629|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82714630|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82714631|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82714632|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714633|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
82714634|NCT04048317|Doxorubicin|doxorubicin|mesh-list
82714635|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82714636|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
82714637|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82714638|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714639|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82714640|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82714641|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714642|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714643|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
82714644|NCT04353986|Ledipasvir|ledipasvir|mesh-list
82714645|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
82714646|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
82714647|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82714648|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82714649|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82714650|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714651|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82714652|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
82714653|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714655|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714656|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82714657|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714658|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714659|NCT04155710|Interleukin-2|interleukin-2|mesh-list
82714660|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714661|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82714662|NCT04155710|Analgesics|analgesics|mesh-ancestor
82714663|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
82714664|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714665|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714666|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82714667|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
82714668|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82714669|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
82714670|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82714671|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714672|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82714673|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82714674|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82714675|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714676|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82714677|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82714678|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82714679|NCT00775125|Ritonavir|ritonavir|mesh-list
82714680|NCT00775125|Darunavir|darunavir|mesh-list
82714681|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
82714682|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82714683|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82714684|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
82714685|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714686|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714687|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82714688|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82714689|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
82714690|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82714691|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82714692|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82714693|NCT02557503|Fluorouracil|fluorouracil|mesh-list
82714694|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
82714695|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
82714696|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714697|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82714698|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714699|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82714700|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
82714701|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714702|NCT00764439|Nicotine|nicotine|mesh-list
82714703|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82714704|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
82714705|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714706|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714707|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82714708|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82714709|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
82714710|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714711|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714712|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
82714713|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82714714|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82714715|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714716|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
82714717|NCT00771303|Coagulants|coagulants|mesh-ancestor
82714718|NCT05674526|Cetuximab|cetuximab|mesh-list
82714719|NCT05674526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82714720|NCT05674526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714721|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
82714722|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82714723|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714724|NCT00771459|Ropivacaine|ropivacaine|mesh-list
82714725|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
82714726|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
82714727|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714728|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714729|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
82714730|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714731|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
82714732|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714733|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82714734|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714735|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714736|NCT00775359|Fenofibrate|fenofibrate|mesh-list
82714737|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82714738|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
82714739|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714740|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82714741|NCT05338502|Omeprazole|omeprazole|mesh-list
82714742|NCT05338502|Ranitidine|ranitidine|mesh-list
82714743|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
82714744|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82714745|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82714746|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82714747|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714748|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714749|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82714750|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
82714751|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
82714752|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714753|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714754|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
82714755|NCT02557269|Azelastine|azelastine|mesh-list
82714756|NCT02557269|Prednisolone|prednisolone|mesh-list
82714757|NCT02557269|Xylometazoline|xylometazoline|mesh-list
82714758|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82714759|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
82714760|NCT02557269|Hormones|hormones|mesh-ancestor
82714761|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82714762|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714763|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82714764|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714765|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
82714766|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714767|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
82714768|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82714769|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82714770|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82714771|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
82714772|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82714773|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714774|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714775|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82714776|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82714777|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
82714778|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
82714779|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714780|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
82714781|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82714782|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
82714783|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82714784|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82714785|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
82714786|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82714787|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714788|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82714789|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82714790|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82714791|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82714792|NCT02556411|Estrogens|estrogens|mesh-ancestor
82714793|NCT02556411|Hormones|hormones|mesh-ancestor
82714794|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82714795|NCT04085276|Paclitaxel|paclitaxel|mesh-list
82714796|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82714797|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82714798|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714799|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
82714800|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
82714801|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
82714802|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714803|NCT00775827|Fenofibrate|fenofibrate|mesh-list
82714804|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82714805|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
82714806|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714807|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82714808|NCT00775905|Amlodipine|amlodipine|mesh-list
82714809|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82714810|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82714811|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82714812|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714813|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82714814|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714815|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
82714816|NCT00772161|Methylphenidate|methylphenidate|mesh-list
82714817|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82714818|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714819|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82714820|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82714821|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82714822|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714823|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
82714824|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714825|NCT00776139|Cetirizine|cetirizine|mesh-list
82714826|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82714827|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82714828|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82714829|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
82714830|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
82714831|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714832|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714833|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714834|NCT00779493|Curcumin|curcumin|mesh-list
82714835|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714836|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82714837|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82714838|NCT00779493|Analgesics|analgesics|mesh-ancestor
82714839|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
82714840|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714841|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82714842|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82714843|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714844|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714845|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714846|NCT02580344|Ibuprofen|ibuprofen|mesh-list
82714847|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82714848|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82714849|NCT02580344|Analgesics|analgesics|mesh-ancestor
82714850|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
82714851|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714852|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714853|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82714854|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82714855|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82714856|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714857|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714858|NCT00779649|Bisacodyl|bisacodyl|mesh-list
82714859|NCT00779649|Cathartics|cathartics|mesh-ancestor
82714860|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82714861|NCT00779649|Laxatives|laxatives|mesh-ancestor
82714862|NCT00776217|Loratadine|loratadine|mesh-list
82714863|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
82714864|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
82714865|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82714866|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82714867|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82714868|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
82714869|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
82714870|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714871|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714872|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714873|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82714874|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82714875|NCT00667875|Naltrexone|naltrexone|mesh-list
82714876|NCT00667875|Aripiprazole|aripiprazole|mesh-list
82714877|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82714878|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82714879|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714880|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
82714881|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714882|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
82714883|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82714884|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82714885|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82714886|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714887|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
82714888|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
82714889|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714890|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714891|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82714892|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82714893|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
82714894|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82714895|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82714896|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82714897|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82714899|NCT02579642|Analgesics|analgesics|mesh-ancestor
82714900|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
82714901|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714902|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714903|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82714904|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82714905|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
82714906|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
82714907|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82714908|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82714909|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82714910|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714911|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714912|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
82714913|NCT00779805|Ephedrine|ephedrine|mesh-list
82714914|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82714915|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
82714916|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82714917|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714918|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82714919|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
82714920|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
82714921|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82714922|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82714923|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
82714924|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
82714925|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714926|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714927|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
82714928|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82714929|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82714930|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714931|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82714932|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714933|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82714935|NCT00667251|Docetaxel|docetaxel|mesh-list
82714936|NCT00667251|Trastuzumab|trastuzumab|mesh-list
82714937|NCT00667251|Lapatinib|lapatinib|mesh-list
82714938|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82714939|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714940|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
82714941|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
82714942|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
82714943|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714944|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82714945|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82714946|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714947|NCT04063124|Dasatinib|dasatinib|mesh-list
82714948|NCT04063124|Quercetin|quercetin|mesh-list
82714949|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714950|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82714951|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714952|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714953|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
82714954|NCT04063124|Protective Agents|protective agents|mesh-ancestor
82714955|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714956|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
82714957|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82714958|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
82714959|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82714960|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714961|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714962|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82714963|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82714964|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714965|NCT00780039|Carboplatin|carboplatin|mesh-list
82714966|NCT00780039|Doxorubicin|doxorubicin|mesh-list
82714967|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82714968|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714969|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82714970|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82714971|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82714972|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714973|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714974|NCT00776763|Bevacizumab|bevacizumab|mesh-list
82714975|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82714976|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714977|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82714978|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82714979|NCT00776763|Growth Substances|growth substances|mesh-ancestor
82714980|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82714981|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
82714982|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
82714983|NCT00772551|Ezetimibe|ezetimibe|mesh-list
82714984|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82714985|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82714986|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
82714987|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82714988|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82714989|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82714990|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82714991|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
82714992|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82714993|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82714994|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82714995|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82714996|NCT00776841|Cholic Acids|cholic acids|mesh-list
82714997|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
82714998|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82714999|NCT02556879|Liver Extracts|liver extracts|mesh-list
82715000|NCT02556879|Antibodies|antibodies|mesh-list
82715001|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
82715002|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715003|NCT02556879|Hematinics|hematinics|mesh-ancestor
82715004|NCT00772863|Docetaxel|docetaxel|mesh-list
82715005|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715006|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
82715007|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
82715008|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
82715009|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715010|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82715011|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82715012|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
82715013|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715014|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715015|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715016|NCT00667719|Amlodipine|amlodipine|mesh-list
82715017|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82715018|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82715019|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82715020|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82715021|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715022|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82715023|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715024|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
82715025|NCT00667719|Diuretics|diuretics|mesh-ancestor
82715026|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
82715027|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82715028|NCT00669669|Plerixafor|plerixafor|mesh-list
82715029|NCT00669669|Temozolomide|temozolomide|mesh-list
82715030|NCT00669669|Carmustine|carmustine|mesh-list
82715031|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
82715032|NCT00669669|Lenograstim|lenograstim|mesh-list
82715033|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82715034|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
82715035|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715036|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82715037|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
82715038|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715039|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715040|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82715041|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82715042|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
82715043|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715044|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715045|NCT02579564|Paclitaxel|paclitaxel|mesh-list
82715046|NCT02579564|Vinorelbine|vinorelbine|mesh-list
82715047|NCT02579564|Gemcitabine|gemcitabine|mesh-list
82715048|NCT02579564|Pemetrexed|pemetrexed|mesh-list
82715049|NCT02579564|Endostar protein|endostar protein|mesh-list
82715050|NCT02579564|Endostatins|endostatins|mesh-list
82715051|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82715052|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715053|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
82715054|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
82715055|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
82715056|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715057|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82715058|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
82715059|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715060|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82715061|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82715062|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82715063|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82715064|NCT02579564|Growth Substances|growth substances|mesh-ancestor
82715065|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715066|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
82715067|NCT00467779|Midazolam|midazolam|mesh-list
82715068|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
82715069|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82715070|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82715071|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82715072|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715073|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82715074|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82715075|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82715076|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82715077|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
82715078|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
82715079|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
82715080|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
82715081|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715082|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715083|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
82715084|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
82715085|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82715086|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82715087|NCT03704480|Durvalumab|durvalumab|mesh-list
82715088|NCT03704480|Tremelimumab|tremelimumab|mesh-list
82715089|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715090|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715091|NCT03699254|Valganciclovir|valganciclovir|mesh-list
82715092|NCT03699254|Ganciclovir|ganciclovir|mesh-list
82715093|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
82715094|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
82715095|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715096|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82715097|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715098|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715099|NCT00570687|Insulin|insulin|mesh-list
82715100|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82715101|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715102|NCT01021891|Insulin|insulin|mesh-list
82715103|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82715104|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715105|NCT01029223|Metoprolol|metoprolol|mesh-list
82715106|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82715107|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82715108|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
82715109|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
82715110|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715111|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715112|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82715113|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82715114|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82715115|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
82715116|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715117|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715118|NCT02556723|Aflibercept|aflibercept|mesh-list
82715119|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82715120|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82715121|NCT02556723|Growth Substances|growth substances|mesh-ancestor
82715122|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715123|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
82715124|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715125|NCT00777543|Ferulic acid|ferulic acid|mesh-list
82715126|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82715127|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82715128|NCT00777543|Analgesics|analgesics|mesh-ancestor
82715129|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
82715130|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715131|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715132|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82715133|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82715134|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
82715135|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82715136|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82715137|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82715138|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82715139|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
82715140|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715141|NCT00777543|Protective Agents|protective agents|mesh-ancestor
82715142|NCT03410654|Tacrolimus|tacrolimus|mesh-list
82715143|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82715144|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
82715145|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715146|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82715147|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715148|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715149|NCT04006262|Nivolumab|nivolumab|mesh-list
82715150|NCT04006262|Ipilimumab|ipilimumab|mesh-list
82715151|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715152|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715153|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82715154|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715155|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
82715156|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82715157|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715158|NCT01022047|Budesonide|budesonide|mesh-list
82715159|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82715160|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82715161|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
82715162|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715163|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715164|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82715165|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
82715166|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
82715167|NCT01022047|Hormones|hormones|mesh-ancestor
82715168|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82715169|NCT01022125|Simeprevir|simeprevir|mesh-list
82715170|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
82715171|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715172|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
82715173|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715174|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715175|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
82715176|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82715177|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82715178|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715179|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
82715180|NCT03385928|Coagulants|coagulants|mesh-ancestor
82715181|NCT05673980|Vitamin D|vitamin d|mesh-list
82715182|NCT05673980|Cholecalciferol|cholecalciferol|mesh-list
82715183|NCT05673980|Ergocalciferols|ergocalciferols|mesh-list
82715184|NCT05673980|Vitamins|vitamins|mesh-ancestor
82715185|NCT05673980|Micronutrients|micronutrients|mesh-ancestor
82715186|NCT05673980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715187|NCT05673980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82715188|NCT05673980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82715189|NCT02581124|Lapatinib|lapatinib|mesh-list
82715190|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715191|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82715192|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715193|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715194|NCT02580968|Flunarizine|flunarizine|mesh-list
82715195|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
82715196|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82715197|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82715198|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715199|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82715200|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715201|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82715202|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
82715203|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
82715204|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715205|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
82715206|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
82715207|NCT00441103|Interferon-beta|interferon-beta|mesh-list
82715208|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82715209|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
82715210|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715211|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715212|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
82715213|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715214|NCT01029613|Adalimumab|adalimumab|mesh-list
82715215|NCT01029613|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82715216|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82715217|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82715218|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
82715219|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
82715220|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715221|NCT03268057|Avelumab|avelumab|mesh-list
82715222|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715223|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715224|NCT01033903|Misoprostol|misoprostol|mesh-list
82715225|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82715226|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
82715227|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82715228|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715229|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82715230|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82715232|NCT03281954|Atezolizumab|atezolizumab|mesh-list
82715233|NCT03281954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82715234|NCT03281954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715235|NCT03281954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715236|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715237|NCT00433537|Dexamethasone|dexamethasone|mesh-list
82715238|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
82715239|NCT00433537|Rituximab|rituximab|mesh-list
82715240|NCT00433537|Doxorubicin|doxorubicin|mesh-list
82715241|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82715242|NCT00433537|Vincristine|vincristine|mesh-list
82715243|NCT00433537|Bortezomib|bortezomib|mesh-list
82715244|NCT00433537|Lenograstim|lenograstim|mesh-list
82715245|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82715246|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
82715247|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715248|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82715249|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82715250|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
82715251|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715252|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715253|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82715254|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715255|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82715256|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
82715257|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
82715258|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715259|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82715260|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
82715261|NCT00433537|Hormones|hormones|mesh-ancestor
82715262|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82715263|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82715264|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82715265|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82715266|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82715267|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715268|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82715269|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82715270|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
82715271|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
82715272|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
82715273|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
82715274|NCT00570765|Cathartics|cathartics|mesh-ancestor
82715275|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82715276|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82715277|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715278|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82715279|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715280|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715281|NCT05118477|Caffeine|caffeine|mesh-list
82715282|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82715283|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715284|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82715285|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715286|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715287|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82715288|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82715289|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
82715290|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715291|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82715292|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
82715293|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82715294|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715295|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715296|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82715297|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82715298|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715299|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
82715300|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715301|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82715302|NCT00667095|Protective Agents|protective agents|mesh-ancestor
82715303|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82715304|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
82715305|NCT00777933|Cyclosporine|cyclosporine|mesh-list
82715306|NCT00777933|Tacrolimus|tacrolimus|mesh-list
82715307|NCT00777933|Cyclosporins|cyclosporins|mesh-list
82715308|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82715309|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
82715310|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715311|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82715312|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715313|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715314|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
82715315|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715316|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
82715317|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82715318|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
82715319|NCT00773331|Hematinics|hematinics|mesh-ancestor
82715320|NCT00778011|Ondansetron|ondansetron|mesh-list
82715321|NCT00778011|Metoclopramide|metoclopramide|mesh-list
82715322|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
82715323|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
82715324|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715325|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715326|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82715327|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
82715328|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
82715329|NCT00778011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82715330|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82715331|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
82715332|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715333|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715334|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82715335|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82715336|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
82715337|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
82715338|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
82715339|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82715340|NCT00778089|Protective Agents|protective agents|mesh-ancestor
82715341|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715342|NCT00433381|Bevacizumab|bevacizumab|mesh-list
82715343|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82715344|NCT00433381|Irinotecan|irinotecan|mesh-list
82715345|NCT00433381|Temozolomide|temozolomide|mesh-list
82715346|NCT00433381|Camptothecin|camptothecin|mesh-list
82715347|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
82715348|NCT00433381|Antibodies|antibodies|mesh-list
82715349|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
82715350|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82715351|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
82715352|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715353|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82715354|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82715355|NCT00433381|Growth Substances|growth substances|mesh-ancestor
82715356|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715357|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
82715358|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
82715359|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82715360|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82715361|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715362|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715363|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82715364|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
82715365|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82715366|NCT00667017|Immunotoxins|immunotoxins|mesh-list
82715367|NCT00667017|Immunoconjugates|immunoconjugates|mesh-ancestor
82715368|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
82715369|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715370|NCT00781131|Pregabalin|pregabalin|mesh-list
82715371|NCT00781131|Analgesics|analgesics|mesh-ancestor
82715372|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
82715373|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715374|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715375|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
82715376|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82715377|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82715378|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715379|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82715380|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82715381|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82715382|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82715383|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82715384|NCT00778245|Cefprozil|cefprozil|mesh-list
82715385|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82715386|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715387|NCT00778401|Gabapentin|gabapentin|mesh-list
82715388|NCT00778401|Analgesics|analgesics|mesh-ancestor
82715389|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
82715390|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715391|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715392|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
82715393|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82715394|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82715395|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82715396|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82715397|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82715398|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82715399|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715400|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715401|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
82715402|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
82715403|NCT00666705|Maraviroc|maraviroc|mesh-list
82715404|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82715405|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82715406|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
82715407|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715408|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82715409|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82715410|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715560|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
82715411|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715412|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82715413|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82715414|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82715415|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82715416|NCT04047849|Amoxicillin|amoxicillin|mesh-list
82715417|NCT04047849|Azithromycin|azithromycin|mesh-list
82715418|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715419|NCT00778557|Cefprozil|cefprozil|mesh-list
82715420|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82715421|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715422|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82715423|NCT00778713|Fosinopril|fosinopril|mesh-list
82715424|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82715425|NCT00778713|Diuretics|diuretics|mesh-ancestor
82715426|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
82715427|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715428|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82715429|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82715430|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715431|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82715432|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
82715433|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715434|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
82715435|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82715436|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82715437|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
82715438|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715439|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82715440|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82715441|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715442|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715443|NCT00774111|Dolutegravir|dolutegravir|mesh-list
82715444|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82715445|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82715446|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715447|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715449|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82715450|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
82715451|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715452|NCT00778791|Metformin|metformin|mesh-list
82715453|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82715454|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715455|NCT00774189|Clarithromycin|clarithromycin|mesh-list
82715456|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82715457|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715458|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82715459|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715460|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715461|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82715462|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82715463|NCT00774423|Riluzole|riluzole|mesh-list
82715464|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
82715465|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82715466|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82715467|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715468|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715469|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715470|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82715471|NCT00774423|Protective Agents|protective agents|mesh-ancestor
82715472|NCT00781521|Ofloxacin|ofloxacin|mesh-list
82715473|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82715474|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715475|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82715476|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82715477|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82715478|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715479|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715480|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715481|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82715482|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82715483|NCT00774501|Anesthetics|anesthetics|mesh-list
82715484|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82715711|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
82715485|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715486|NCT00784485|Omalizumab|omalizumab|mesh-list
82715487|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82715488|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82715489|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
82715490|NCT00781755|Varenicline|varenicline|mesh-list
82715491|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82715492|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82715493|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
82715494|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715495|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715496|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715497|NCT00774735|Dolutegravir|dolutegravir|mesh-list
82715498|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82715499|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82715500|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715501|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715502|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82715503|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82715504|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
82715505|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715506|NCT00666237|Mitomycins|mitomycins|mesh-list
82715507|NCT00666237|Mitomycin|mitomycin|mesh-list
82715508|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82715509|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715510|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
82715511|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715512|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82715513|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715514|NCT00774813|Citalopram|citalopram|mesh-list
82715515|NCT00774813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82715516|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82715517|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82715518|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715519|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715520|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
82715521|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715522|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82715523|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
82715524|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82715525|NCT00784797|Oxytocin|oxytocin|mesh-list
82715526|NCT00784797|Mifepristone|mifepristone|mesh-list
82715527|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
82715528|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82715529|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715530|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82715531|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
82715532|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82715533|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82715534|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82715535|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
82715536|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82715537|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82715538|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
82715539|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82715540|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
82715541|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82715542|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82715543|NCT00774969|Metronidazole|metronidazole|mesh-list
82715544|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715545|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82715546|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82715547|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82715548|NCT00785109|Vitamin K|vitamin k|mesh-list
82715549|NCT00785109|Vitamins|vitamins|mesh-ancestor
82715550|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
82715551|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715552|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82715553|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82715554|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715555|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
82715556|NCT00785109|Coagulants|coagulants|mesh-ancestor
82715557|NCT00662025|Capecitabine|capecitabine|mesh-list
82715558|NCT00662025|Sunitinib|sunitinib|mesh-list
82715559|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82715561|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715562|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715563|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82715564|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82715565|NCT00662025|Growth Substances|growth substances|mesh-ancestor
82715566|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715567|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
82715568|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82715569|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715570|NCT00789945|Insulin|insulin|mesh-list
82715571|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82715572|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82715573|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715574|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
82715575|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82715576|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82715577|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82715578|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715579|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82715580|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715581|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82715582|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82715583|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
82715584|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82715585|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82715586|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82715587|NCT00782301|Maraviroc|maraviroc|mesh-list
82715588|NCT00782301|Etravirine|etravirine|mesh-list
82715589|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82715590|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82715591|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715592|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82715593|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82715594|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
82715595|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715596|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82715597|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82715598|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82715599|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715600|NCT00785421|Leucovorin|leucovorin|mesh-list
82715601|NCT00785421|Folic Acid|folic acid|mesh-list
82715602|NCT00785421|Cisplatin|cisplatin|mesh-list
82715603|NCT00785421|Gemcitabine|gemcitabine|mesh-list
82715604|NCT00785421|Enoxaparin|enoxaparin|mesh-list
82715605|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
82715606|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
82715607|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715608|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82715609|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
82715610|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715611|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715612|NCT00785421|Antidotes|antidotes|mesh-ancestor
82715613|NCT00785421|Protective Agents|protective agents|mesh-ancestor
82715614|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
82715615|NCT00785421|Vitamins|vitamins|mesh-ancestor
82715616|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
82715617|NCT00785421|Hematinics|hematinics|mesh-ancestor
82715618|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
82715619|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82715620|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82715621|NCT00790179|Ropivacaine|ropivacaine|mesh-list
82715622|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
82715623|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
82715624|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82715625|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715626|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
82715627|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715628|NCT00790413|Rituximab|rituximab|mesh-list
82715629|NCT00790413|Fludarabine|fludarabine|mesh-list
82715630|NCT00790413|Thiotepa|thiotepa|mesh-list
82715631|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82715632|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715633|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715634|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
82715635|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715636|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82715637|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715638|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82715639|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82715640|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
82715641|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82715642|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715643|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82715644|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
82715645|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
82715646|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82715647|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715648|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715649|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715650|NCT00440947|Ritonavir|ritonavir|mesh-list
82715651|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82715652|NCT00440947|Lamivudine|lamivudine|mesh-list
82715653|NCT00440947|Abacavir|abacavir|mesh-list
82715654|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
82715655|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82715656|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82715657|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
82715658|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715659|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715660|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82715661|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82715662|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
82715663|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715664|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82715665|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82715666|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82715667|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82715668|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
82715669|NCT00790881|Lumefantrine|lumefantrine|mesh-list
82715670|NCT00790881|Artemether|artemether|mesh-list
82715671|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82715672|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
82715673|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82715674|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82715675|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715676|NCT01029769|Olanzapine|olanzapine|mesh-list
82715677|NCT01029769|Amisulpride|amisulpride|mesh-list
82715678|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
82715679|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
82715680|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715681|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715682|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82715683|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82715684|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82715685|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82715686|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82715687|NCT01029769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82715688|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82715689|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82715690|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715691|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715692|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
82715693|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82715694|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
82715695|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82715696|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
82715697|NCT02557945|Gabapentin|gabapentin|mesh-list
82715698|NCT02557945|Analgesics|analgesics|mesh-ancestor
82715699|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
82715700|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715701|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715702|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
82715703|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82715704|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82715705|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82715706|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82715707|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82715708|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82715709|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715710|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715712|NCT03929666|Leucovorin|leucovorin|mesh-list
82715713|NCT03929666|Bevacizumab|bevacizumab|mesh-list
82715714|NCT03929666|Gemcitabine|gemcitabine|mesh-list
82715715|NCT03929666|Fluorouracil|fluorouracil|mesh-list
82715716|NCT03929666|Capecitabine|capecitabine|mesh-list
82715717|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
82715718|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715719|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715720|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82715721|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82715722|NCT03929666|Growth Substances|growth substances|mesh-ancestor
82715723|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715724|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
82715725|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82715726|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
82715727|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715728|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82715729|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
82715730|NCT03929666|Antidotes|antidotes|mesh-ancestor
82715731|NCT03929666|Protective Agents|protective agents|mesh-ancestor
82715732|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
82715733|NCT03929666|Vitamins|vitamins|mesh-ancestor
82715734|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
82715735|NCT00664521|Rituximab|rituximab|mesh-list
82715736|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715737|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715738|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
82715739|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715740|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82715741|NCT02581046|Dexamethasone|dexamethasone|mesh-list
82715742|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82715743|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
82715744|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
82715745|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715746|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715747|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82715748|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
82715749|NCT02581046|Hormones|hormones|mesh-ancestor
82715750|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82715751|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82715752|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715753|NCT00664209|Amoxicillin|amoxicillin|mesh-list
82715755|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82715756|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715757|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82715758|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82715759|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82715760|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715761|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715762|NCT03192332|Plasminogen|plasminogen|mesh-list
82715763|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82715764|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82715765|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82715766|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715767|NCT02555943|Ritonavir|ritonavir|mesh-list
82715768|NCT02555943|Tenofovir|tenofovir|mesh-list
82715769|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
82715770|NCT02555943|Entecavir|entecavir|mesh-list
82715771|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
82715772|NCT02555943|Ledipasvir|ledipasvir|mesh-list
82715773|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82715774|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82715775|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
82715776|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715777|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715778|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82715779|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82715780|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
82715781|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715782|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82715783|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82715784|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82715785|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82715786|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
82715787|NCT00782847|Cyproterone|cyproterone|mesh-list
82715788|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
82715789|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
82715790|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82715791|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715792|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715793|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82715794|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
82715795|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82715796|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82715797|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
82715798|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715799|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
82715800|NCT00440557|Hematinics|hematinics|mesh-ancestor
82715801|NCT05673590|Docetaxel|docetaxel|mesh-list
82715802|NCT05673590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715803|NCT05673590|Tubulin Modulators|tubulin modulators|mesh-ancestor
82715804|NCT05673590|Antimitotic Agents|antimitotic agents|mesh-ancestor
82715805|NCT05673590|Mitosis Modulators|mitosis modulators|mesh-ancestor
82715806|NCT05673590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715807|NCT01029847|Adalimumab|adalimumab|mesh-list
82715808|NCT01029847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82715809|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82715810|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82715811|NCT02452268|Spartalizumab|spartalizumab|mesh-list
82715812|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82715813|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715814|NCT02452268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715815|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715816|NCT02524249|Caffeine|caffeine|mesh-list
82715817|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82715818|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715819|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82715820|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715821|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715822|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82715823|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82715824|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
82715825|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715826|NCT01033981|Sunitinib|sunitinib|mesh-list
82715827|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715828|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82715829|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82715830|NCT01033981|Growth Substances|growth substances|mesh-ancestor
82715831|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715832|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
82715833|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82715834|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715835|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715836|NCT02430194|Interferons|interferons|mesh-list
82715838|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
82715839|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
82715840|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82715841|NCT02430194|Lonafarnib|lonafarnib|mesh-list
82715842|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715843|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
82715844|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715845|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82715846|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82715847|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
82715848|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715849|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715850|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82715851|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82715852|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82715853|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82715854|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
82715855|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715856|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
82715857|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82715858|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715859|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715860|NCT02400242|Dexamethasone|dexamethasone|mesh-list
82715861|NCT02400242|Pomalidomide|pomalidomide|mesh-list
82715862|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82715863|NCT02400242|Immunomodulating Agents|immunomodulating agents|mesh-list
82715864|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82715865|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
82715866|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
82715867|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715868|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715869|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82715870|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
82715871|NCT02400242|Hormones|hormones|mesh-ancestor
82715872|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82715873|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82715874|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715875|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
82715876|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82715877|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82715878|NCT02400242|Growth Substances|growth substances|mesh-ancestor
82715879|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
82715880|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715881|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715882|NCT03087656|Levofloxacin|levofloxacin|mesh-list
82715883|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
82715884|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82715885|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715886|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82715887|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82715888|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82715889|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715890|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715891|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715892|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82715893|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82715894|NCT03068624|Aldesleukin|aldesleukin|mesh-list
82715895|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
82715896|NCT03068624|Ipilimumab|ipilimumab|mesh-list
82715897|NCT03068624|Interleukin-2|interleukin-2|mesh-list
82715898|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82715899|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
82715900|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715901|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82715902|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82715903|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
82715904|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715905|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715906|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82715907|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715908|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82715909|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82715910|NCT03068624|Analgesics|analgesics|mesh-ancestor
82715911|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
82715912|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715913|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82715914|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82715915|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
82715916|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82715917|NCT03005366|Flecainide|flecainide|mesh-list
82715918|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82715919|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82715920|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82715921|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82715922|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715923|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
82715924|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715925|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715926|NCT04076228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82715927|NCT04076228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715928|NCT02580734|Melatonin|melatonin|mesh-list
82715929|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
82715930|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715931|NCT02580734|Protective Agents|protective agents|mesh-ancestor
82715932|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715933|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82715934|NCT00427999|Pioglitazone|pioglitazone|mesh-list
82715935|NCT00427999|Dexamethasone|dexamethasone|mesh-list
82715936|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
82715937|NCT00427999|Etoricoxib|etoricoxib|mesh-list
82715938|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
82715939|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82715940|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
82715941|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
82715942|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82715943|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715944|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82715945|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
82715947|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82715948|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82715949|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715950|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82715951|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82715952|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715953|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715954|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82715955|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82715956|NCT00427999|Analgesics|analgesics|mesh-ancestor
82715957|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
82715958|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82715959|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82715960|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82715961|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
82715962|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82715963|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715964|NCT00661713|Vaccines|vaccines|mesh-list
82715965|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
82715966|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715967|NCT02578472|Zolpidem|zolpidem|mesh-list
82715968|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82715969|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82715970|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82715971|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715972|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82715973|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
82715974|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
82715975|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82715976|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715977|NCT03840902|Paclitaxel|paclitaxel|mesh-list
82715978|NCT03840902|Etoposide|etoposide|mesh-list
82715979|NCT03840902|Carboplatin|carboplatin|mesh-list
82715980|NCT03840902|Pemetrexed|pemetrexed|mesh-list
82715981|NCT03840902|Durvalumab|durvalumab|mesh-list
82715982|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82715983|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82715984|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
82715985|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
82715986|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
82715987|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82715988|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82715989|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82715990|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82715991|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82715992|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82715993|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82715994|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82715995|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
82715996|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82715997|NCT04038086|Insulin|insulin|mesh-list
82715998|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82715999|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716000|NCT04072640|Voriconazole|voriconazole|mesh-list
82716001|NCT04072640|Amphotericin B|amphotericin b|mesh-list
82716002|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82716003|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
82716004|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
82716005|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
82716006|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716007|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82716008|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82716009|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716010|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716011|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82716012|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
82716013|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82716014|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716015|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82716016|NCT04072640|Amebicides|amebicides|mesh-ancestor
82716017|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82716018|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82716019|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82716020|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82716021|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82716022|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82716023|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
82716024|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82716025|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82716026|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82716027|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82716028|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716029|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82716030|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82716031|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716032|NCT02576288|Incretins|incretins|mesh-ancestor
82716033|NCT02576288|Hormones|hormones|mesh-ancestor
82716034|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82716035|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82716036|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
82716037|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716038|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716040|NCT00427921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82716041|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82716042|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82716043|NCT00432991|Ephedrine|ephedrine|mesh-list
82716044|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82716045|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716046|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
82716047|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
82716048|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716049|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82716050|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
82716051|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716052|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716053|NCT00580970|Lovastatin|lovastatin|mesh-list
82716054|NCT00580970|L 647318|l 647318|mesh-list
82716055|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
82716056|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82716057|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82716058|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
82716059|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716060|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82716061|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82716062|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716063|NCT01030081|Amlodipine|amlodipine|mesh-list
82716064|NCT01030081|Nifedipine|nifedipine|mesh-list
82716065|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82716066|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82716067|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82716068|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716069|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82716070|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716071|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
82716072|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
82716073|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82716074|NCT00426751|Abciximab|abciximab|mesh-list
82716075|NCT00426751|Eptifibatide|eptifibatide|mesh-list
82716076|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
82716077|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82716078|NCT02576366|Rifampin|rifampin|mesh-list
82716079|NCT02576366|Voriconazole|voriconazole|mesh-list
82716080|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82716081|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
82716082|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82716083|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716084|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
82716085|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82716086|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716087|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716088|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82716089|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82716090|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82716091|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82716092|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82716093|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82716094|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
82716095|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82716096|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82716097|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82716098|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
82716099|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82716100|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716101|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82716102|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82716103|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
82716104|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82716105|NCT04046679|Bleomycin|bleomycin|mesh-list
82716106|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82716107|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716108|NCT00786279|Ethanol|ethanol|mesh-list
82716109|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82716110|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716111|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82716112|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716113|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82716114|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82716115|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82716116|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82716117|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716118|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82716119|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82716120|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82716121|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
82716122|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716123|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716124|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82716125|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82716126|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
82716127|NCT00791271|Interferons|interferons|mesh-list
82716128|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
82716129|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
82716130|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82716131|NCT00791271|Decitabine|decitabine|mesh-list
82716132|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716133|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
82716134|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716135|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
82716136|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716137|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82716138|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
82716139|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716140|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716141|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82716142|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82716143|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82716144|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82716145|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716146|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82716147|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82716148|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82716149|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
82716150|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716151|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716152|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82716153|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82716154|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
82716155|NCT00440401|Thrombin|thrombin|mesh-list
82716156|NCT00440401|Hemostatics|hemostatics|mesh-list
82716157|NCT00440401|Coagulants|coagulants|mesh-ancestor
82716158|NCT00791427|Ranibizumab|ranibizumab|mesh-list
82716159|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82716160|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82716161|NCT00791427|Growth Substances|growth substances|mesh-ancestor
82716162|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716163|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
82716164|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716165|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
82716166|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82716167|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
82716168|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82716169|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
82716170|NCT00791505|Trimethoprim|trimethoprim|mesh-list
82716171|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
82716172|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82716173|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716174|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82716175|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82716176|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716177|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716178|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716179|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82716180|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82716181|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82716182|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
82716183|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82716184|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82716185|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82716186|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82716187|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82716188|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82716190|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82716191|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716192|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82716193|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716194|NCT00426361|Vaccines|vaccines|mesh-list
82716195|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
82716196|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716197|NCT00665847|Etravirine|etravirine|mesh-list
82716198|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82716199|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82716200|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716201|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716202|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
82716203|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716204|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82716205|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82716206|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716207|NCT00783081|Cilostazol|cilostazol|mesh-list
82716208|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82716209|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
82716210|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716211|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716212|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82716213|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
82716214|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82716215|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82716216|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716217|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82716218|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
82716219|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82716220|NCT00783081|Protective Agents|protective agents|mesh-ancestor
82716221|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82716222|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82716223|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716224|NCT00426127|Docetaxel|docetaxel|mesh-list
82716225|NCT00426127|Doxorubicin|doxorubicin|mesh-list
82716226|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82716227|NCT00426127|Enoxaparin|enoxaparin|mesh-list
82716228|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716229|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
82716230|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
82716231|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
82716232|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716233|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82716234|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82716235|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82716236|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716237|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
82716238|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82716239|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82716240|NCT02535078|Durvalumab|durvalumab|mesh-list
82716241|NCT02535078|Tremelimumab|tremelimumab|mesh-list
82716242|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82716243|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716244|NCT00425503|Bortezomib|bortezomib|mesh-list
82716245|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716246|NCT00786669|Cefixime|cefixime|mesh-list
82716247|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
82716248|NCT00786669|Bevacizumab|bevacizumab|mesh-list
82716249|NCT00786669|Irinotecan|irinotecan|mesh-list
82716250|NCT00786669|Vincristine|vincristine|mesh-list
82716251|NCT00786669|Temozolomide|temozolomide|mesh-list
82716252|NCT00786669|Camptothecin|camptothecin|mesh-list
82716253|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82716254|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716255|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82716256|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82716257|NCT00786669|Growth Substances|growth substances|mesh-ancestor
82716258|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716259|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
82716260|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82716261|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82716262|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716263|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716264|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82716265|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
82716266|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
82716267|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
82716268|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82716269|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
82716270|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82716271|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716272|NCT00791739|Pregabalin|pregabalin|mesh-list
82716273|NCT00791739|Trazodone|trazodone|mesh-list
82716274|NCT00791739|Analgesics|analgesics|mesh-ancestor
82716275|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
82716276|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716277|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716278|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
82716279|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82716280|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82716281|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716282|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82716283|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82716284|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82716285|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82716286|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82716287|NCT00791739|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82716288|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82716289|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716290|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
82716291|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82716292|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
82716293|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
82716294|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
82716295|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82716296|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82716297|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716298|NCT02503722|Osimertinib|osimertinib|mesh-list
82716299|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716300|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82716301|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716302|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716303|NCT00430573|Cycloserine|cycloserine|mesh-list
82716304|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82716305|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716306|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82716307|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
82716308|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82716309|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
82716310|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716311|NCT00783393|Temozolomide|temozolomide|mesh-list
82716312|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82716313|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
82716314|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716315|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716316|NCT00783471|Docetaxel|docetaxel|mesh-list
82716317|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82716318|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716319|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
82716320|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
82716321|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
82716322|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716323|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82716324|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716325|NCT02460900|Varenicline|varenicline|mesh-list
82716326|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82716327|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82716328|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
82716329|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716330|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716331|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716332|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82716333|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
82716334|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
82716335|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716336|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
82716337|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716338|NCT02075840|Crizotinib|crizotinib|mesh-list
82716339|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716340|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82716341|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716342|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716343|NCT02554695|Denosumab|denosumab|mesh-list
82716344|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82716345|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716346|NCT00792363|Irinotecan|irinotecan|mesh-list
82716347|NCT00792363|Panitumumab|panitumumab|mesh-list
82716348|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82716349|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82716350|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716351|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716352|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716353|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82716354|NCT00425113|Metronidazole|metronidazole|mesh-list
82716355|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716356|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82716357|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82716358|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82716359|NCT04895280|Triamcinolone|triamcinolone|mesh-list
82716360|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82716361|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82716362|NCT04895280|Ketorolac|ketorolac|mesh-list
82716363|NCT04895280|Bupivacaine|bupivacaine|mesh-list
82716364|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82716365|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
82716366|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
82716367|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82716368|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716369|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
82716370|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716371|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82716372|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
82716373|NCT04895280|Hormones|hormones|mesh-ancestor
82716374|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82716375|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82716376|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
82716377|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716378|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716379|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82716380|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82716381|NCT04895280|Analgesics|analgesics|mesh-ancestor
82716382|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82716383|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82716384|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
82716385|NCT03994783|Rituximab|rituximab|mesh-list
82716386|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
82716540|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82716387|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82716388|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
82716389|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82716390|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82716391|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716392|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
82716393|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716394|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82716395|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82716396|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
82716397|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
82716398|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716399|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82716400|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
82716401|NCT03994783|Hormones|hormones|mesh-ancestor
82716402|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82716403|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82716404|NCT03994783|Protective Agents|protective agents|mesh-ancestor
82716405|NCT00440011|Bimatoprost|bimatoprost|mesh-list
82716406|NCT00440011|Travoprost|travoprost|mesh-list
82716407|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82716408|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82716409|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82716410|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82716411|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
82716412|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716414|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716415|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82716416|NCT01937468|Analgesics|analgesics|mesh-ancestor
82716417|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
82716418|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716419|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716420|NCT00663117|Naltrexone|naltrexone|mesh-list
82716421|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82716422|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82716423|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716424|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
82716425|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716426|NCT04072328|Midazolam|midazolam|mesh-list
82716427|NCT04072328|Propofol|propofol|mesh-list
82716428|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82716429|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82716430|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716431|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82716432|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
82716433|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
82716434|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82716435|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82716436|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82716437|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82716438|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
82716439|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
82716440|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716441|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716442|NCT00495716|Acyclovir|acyclovir|mesh-list
82716443|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
82716444|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716445|NCT00784017|Asparaginase|asparaginase|mesh-list
82716446|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716447|NCT04074122|Adenosine|adenosine|mesh-list
82716448|NCT04074122|Isoproterenol|isoproterenol|mesh-list
82716449|NCT04074122|Epinephrine|epinephrine|mesh-list
82716450|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82716451|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82716452|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
82716453|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716454|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716455|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716456|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82716457|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82716458|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
82716459|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716460|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82716461|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
82716462|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
82716463|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
82716464|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82716465|NCT04074122|Analgesics|analgesics|mesh-ancestor
82716466|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
82716467|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82716468|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
82716469|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82716470|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
82716471|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
82716472|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82716473|NCT04074122|Protective Agents|protective agents|mesh-ancestor
82716475|NCT02578550|Emtricitabine|emtricitabine|mesh-list
82716477|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82716478|NCT02578550|Cobicistat|cobicistat|mesh-list
82716479|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
82716480|NCT02578550|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
82716481|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
82716482|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716483|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82716484|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82716485|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716486|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716487|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82716488|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82716489|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82716490|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82716491|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
82716492|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82716493|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82716494|NCT00788463|Beclomethasone|beclomethasone|mesh-list
82716495|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82716496|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
82716497|NCT00788463|Hormones|hormones|mesh-ancestor
82716498|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82716499|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716500|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82716501|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
82716502|NCT00579254|Amlodipine|amlodipine|mesh-list
82716503|NCT00579254|Atorvastatin|atorvastatin|mesh-list
82716504|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82716505|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82716506|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
82716507|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716508|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82716509|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82716510|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716511|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82716512|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82716513|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82716514|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82716515|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716516|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
82716517|NCT00793221|Sirolimus|sirolimus|mesh-list
82716518|NCT00793221|Everolimus|everolimus|mesh-list
82716519|NCT00793221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82716520|NCT00793221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82716521|NCT00793221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716522|NCT00793221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716523|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82716524|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
82716525|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716526|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716527|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82716528|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716529|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82716530|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
82716531|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
82716532|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82716533|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82716534|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82716535|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82716536|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716537|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
82716538|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716539|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716541|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716542|NCT01773278|Antioxidants|antioxidants|mesh-list
82716543|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716544|NCT01773278|Protective Agents|protective agents|mesh-ancestor
82716545|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716546|NCT00788931|Paclitaxel|paclitaxel|mesh-list
82716547|NCT00788931|Trastuzumab|trastuzumab|mesh-list
82716548|NCT00788931|Panobinostat|panobinostat|mesh-list
82716549|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82716550|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716551|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
82716552|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
82716553|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
82716554|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716555|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82716556|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82716557|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716558|NCT02577848|Liraglutide|liraglutide|mesh-list
82716559|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82716560|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716561|NCT02577848|Incretins|incretins|mesh-ancestor
82716562|NCT02577848|Hormones|hormones|mesh-ancestor
82716563|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82716564|NCT00582426|Octreotide|octreotide|mesh-list
82716565|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82716566|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82716567|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716568|NCT00709982|Folic Acid|folic acid|mesh-list
82716569|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82716570|NCT00709982|Norgestimate|norgestimate|mesh-list
82716571|NCT00709982|Estradiol|estradiol|mesh-list
82716572|NCT00709982|Estrogens|estrogens|mesh-ancestor
82716573|NCT00709982|Hormones|hormones|mesh-ancestor
82716574|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82716575|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716576|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82716577|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
82716578|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82716579|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82716580|NCT00709982|Hematinics|hematinics|mesh-ancestor
82716581|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
82716582|NCT00709982|Vitamins|vitamins|mesh-ancestor
82716583|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
82716584|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82716585|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82716586|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82716587|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
82716588|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82716589|NCT00710138|Vitamins|vitamins|mesh-list
82716590|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
82716591|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
82716592|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
82716593|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
82716594|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716595|NCT00710138|Hematinics|hematinics|mesh-ancestor
82716596|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
82716597|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82716598|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716599|NCT00710216|Lamivudine|lamivudine|mesh-list
82716600|NCT00710216|Telbivudine|telbivudine|mesh-list
82716601|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82716602|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82716603|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716604|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716605|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
82716606|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716607|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82716608|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82716609|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
82716610|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
82716611|NCT00773513|Hematinics|hematinics|mesh-ancestor
82716612|NCT00710528|Idelalisib|idelalisib|mesh-list
82716613|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716614|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716615|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716616|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
82716617|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82716618|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716619|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82716620|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82716621|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
82716622|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716623|NCT00711308|Vitamin K|vitamin k|mesh-list
82716624|NCT00711308|Tinzaparin|tinzaparin|mesh-list
82716625|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82716626|NCT00711308|Dalteparin|dalteparin|mesh-list
82716627|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
82716628|NCT00711308|Vitamins|vitamins|mesh-ancestor
82716629|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
82716630|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716631|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82716632|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82716633|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716634|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
82716635|NCT00711308|Coagulants|coagulants|mesh-ancestor
82716636|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
82716637|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82716638|NCT02601911|Acetaminophen|acetaminophen|mesh-list
82716639|NCT02601911|Ketorolac|ketorolac|mesh-list
82716640|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82716641|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82716642|NCT02601911|Analgesics|analgesics|mesh-ancestor
82716643|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
82716644|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716645|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716646|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
82716647|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82716648|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82716649|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82716650|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82716651|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716652|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716653|NCT00711620|Thymalfasin|thymalfasin|mesh-list
82716654|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82716655|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
82716656|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716658|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
82716659|NCT00581828|Cholecalciferol|cholecalciferol|mesh-list
82716660|NCT00581828|Vitamins|vitamins|mesh-list
82716661|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
82716662|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716663|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82716664|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82716665|NCT02577614|Coagulants|coagulants|mesh-list
82716666|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
82716667|NCT02577458|Everolimus|everolimus|mesh-list
82716668|NCT02577458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82716669|NCT02577458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82716670|NCT02577458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716671|NCT02577458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716672|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82716673|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
82716674|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716675|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716676|NCT00767039|Poractant alfa|poractant alfa|mesh-list
82716677|NCT00767039|Beractant|beractant|mesh-list
82716678|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
82716679|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
82716680|NCT01572506|Biotin|biotin|mesh-list
82716681|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
82716682|NCT01572506|Vitamins|vitamins|mesh-ancestor
82716683|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
82716684|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716685|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82716686|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82716687|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716688|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82716689|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
82716690|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716691|NCT02577770|Caffeine|caffeine|mesh-list
82716692|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82716693|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716694|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82716695|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716696|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716697|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82716699|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
82716700|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716701|NCT00129896|Docetaxel|docetaxel|mesh-list
82716702|NCT00129896|Doxorubicin|doxorubicin|mesh-list
82716703|NCT00129896|Trastuzumab|trastuzumab|mesh-list
82716704|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716705|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
82716706|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
82716707|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
82716708|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716709|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82716710|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82716711|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82716712|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716713|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82716714|NCT02574338|Alprostadil|alprostadil|mesh-list
82716715|NCT02574338|Misoprostol|misoprostol|mesh-list
82716716|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82716717|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
82716718|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82716719|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716720|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82716721|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82716722|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
82716723|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82716724|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
82716725|NCT02574338|Urological Agents|urological agents|mesh-ancestor
82716726|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
82716727|NCT03070392|Ipilimumab|ipilimumab|mesh-list
82716728|NCT03070392|Dacarbazine|dacarbazine|mesh-list
82716729|NCT03070392|Imidazole|imidazole|mesh-list
82716730|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82716731|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716732|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82716733|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716734|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82716735|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
82716736|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716737|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
82716738|NCT00711698|Narcotics|narcotics|mesh-ancestor
82716739|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82716740|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716741|NCT00711698|Analgesics|analgesics|mesh-ancestor
82716742|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
82716743|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716744|NCT00795171|Docetaxel|docetaxel|mesh-list
82716745|NCT00795171|Sunitinib|sunitinib|mesh-list
82716746|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716747|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
82716748|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
82716749|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
82716750|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716751|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82716752|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82716753|NCT00795171|Growth Substances|growth substances|mesh-ancestor
82716754|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716755|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
82716756|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82716757|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716758|NCT00711854|Rifampin|rifampin|mesh-list
82716759|NCT00711854|Linezolid|linezolid|mesh-list
82716760|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82716761|NCT00711854|Trimethoprim|trimethoprim|mesh-list
82716762|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
82716763|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82716764|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
82716765|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82716766|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716767|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
82716768|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82716769|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716770|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716771|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82716772|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82716773|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82716774|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82716775|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82716776|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82716777|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82716778|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82716779|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
82716780|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82716781|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82716782|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82716783|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82716784|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82716785|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82716786|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
82716787|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82716788|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716789|NCT00712400|Latanoprost|latanoprost|mesh-list
82716790|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82716791|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82716792|NCT00712478|Insulin|insulin|mesh-list
82716793|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82716794|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716795|NCT03015792|Dexamethasone|dexamethasone|mesh-list
82716796|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
82716797|NCT03015792|Lenalidomide|lenalidomide|mesh-list
82716798|NCT03015792|Ichthammol|ichthammol|mesh-list
82716799|NCT03015792|BB 1101|bb 1101|mesh-list
82716800|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82716801|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
82716802|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
82716803|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716804|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716805|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82716806|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
82716807|NCT03015792|Hormones|hormones|mesh-ancestor
82716808|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82716809|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82716810|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716811|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
82716812|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716813|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716814|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
82716815|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82716816|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82716817|NCT03015792|Growth Substances|growth substances|mesh-ancestor
82716818|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
82716819|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
82716820|NCT00789165|Quinidine|quinidine|mesh-list
82716821|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82716822|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82716823|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
82716824|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716825|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716826|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716827|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82716828|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
82716829|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82716830|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82716831|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716832|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716833|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82716834|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82716835|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
82716836|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82716837|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82716838|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82716839|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82716840|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82716841|NCT00712556|Fluorides|fluorides|mesh-list
82716842|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
82716843|NCT00712556|Protective Agents|protective agents|mesh-ancestor
82716844|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716845|NCT00772967|Naproxen|naproxen|mesh-list
82716846|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82716847|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82716848|NCT00772967|Analgesics|analgesics|mesh-ancestor
82716849|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
82716850|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716851|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716852|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82716853|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82716854|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
82716855|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82716856|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716857|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716858|NCT00793377|Tamoxifen|tamoxifen|mesh-list
82716859|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
82716860|NCT00793377|Docetaxel|docetaxel|mesh-list
82716861|NCT00793377|Doxorubicin|doxorubicin|mesh-list
82716862|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82716863|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82716864|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
82716865|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716866|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82716867|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82716868|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
82716869|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716870|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716871|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82716872|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
82716873|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
82716874|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
82716875|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82716876|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82716877|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82716878|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716879|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82716880|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
82716881|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82716882|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82716883|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82716884|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82716885|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82716886|NCT00662259|Alprazolam|alprazolam|mesh-list
82716887|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82716888|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82716889|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716890|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82716891|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82716892|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82716893|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
82716894|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
82716895|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716896|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716897|NCT00712790|Sorafenib|sorafenib|mesh-list
82716898|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716899|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82716900|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716901|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716902|NCT00660699|Gemcitabine|gemcitabine|mesh-list
82716903|NCT00660699|Docetaxel|docetaxel|mesh-list
82716904|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82716905|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
82716906|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716907|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716908|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
82716909|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
82716910|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
82716911|NCT02577068|Propacetamol|propacetamol|mesh-list
82716912|NCT02577068|Nefopam|nefopam|mesh-list
82716913|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82716914|NCT02577068|Analgesics|analgesics|mesh-ancestor
82716915|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
82716916|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716917|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716918|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82716919|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82716920|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82716921|NCT00582114|Atenolol|atenolol|mesh-list
82716922|NCT00582114|Lisinopril|lisinopril|mesh-list
82716923|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82716924|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
82716925|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716926|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716927|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82716928|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82716929|NCT00582114|Protective Agents|protective agents|mesh-ancestor
82716930|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716931|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82716932|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
82716933|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
82716934|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716935|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82716936|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82716937|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82716938|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
82716939|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716940|NCT00582036|Insulin|insulin|mesh-list
82716941|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82716942|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82716943|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716944|NCT00581360|Doxorubicin|doxorubicin|mesh-list
82716945|NCT00581360|Bortezomib|bortezomib|mesh-list
82716946|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82716947|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716948|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82716949|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82716950|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716951|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716952|NCT01650792|Aspirin|aspirin|mesh-list
82716953|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82716954|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82716955|NCT01650792|Analgesics|analgesics|mesh-ancestor
82716956|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
82716957|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82716958|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716959|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82716960|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82716961|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82716962|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82716963|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716964|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82716965|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82716966|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716967|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
82716968|NCT00660387|Levodopa|levodopa|mesh-list
82716969|NCT00660387|Carbidopa|carbidopa|mesh-list
82716970|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82716971|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82716972|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82716973|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
82716974|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82716975|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716976|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716977|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82716978|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716979|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82716980|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
82716981|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
82716982|NCT00582738|Everolimus|everolimus|mesh-list
82716983|NCT00582738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82716984|NCT00582738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82716985|NCT00582738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716986|NCT00582738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716987|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82716988|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
82716989|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82716990|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82716991|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
82716992|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82716993|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82716994|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82716995|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82716996|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82716997|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82716998|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82716999|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717000|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82717001|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
82717002|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82717003|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717004|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82717005|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82717006|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82717007|NCT00789711|Insulin|insulin|mesh-list
82717008|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82717009|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
82717010|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
82717011|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
82717012|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82717013|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82717014|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717015|NCT00713726|Fentanyl|fentanyl|mesh-list
82717016|NCT00713726|Tramadol|tramadol|mesh-list
82717017|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82717018|NCT00713726|Narcotics|narcotics|mesh-ancestor
82717019|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717020|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717021|NCT00713726|Analgesics|analgesics|mesh-ancestor
82717022|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
82717023|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717024|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82717025|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82717026|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
82717027|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
82717028|NCT00800553|Donepezil|donepezil|mesh-list
82717029|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82717030|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717031|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717032|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
82717033|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717034|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717035|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
82717036|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
82717037|NCT00793767|Hematinics|hematinics|mesh-ancestor
82717038|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82717039|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82717040|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82717041|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717042|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717043|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82717044|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82717045|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82717046|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
82717047|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717048|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717049|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82717050|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82717051|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
82717052|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
82717053|NCT00793845|Melphalan|melphalan|mesh-list
82717054|NCT00793845|Thiotepa|thiotepa|mesh-list
82717055|NCT00793845|Carboplatin|carboplatin|mesh-list
82717056|NCT00793845|Etoposide|etoposide|mesh-list
82717057|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82717058|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
82717059|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717060|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82717061|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82717062|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
82717063|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717064|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717065|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82717066|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82717067|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82717068|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82717069|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717070|NCT00800709|Memantine|memantine|mesh-list
82717071|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82717072|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82717073|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
82717074|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717075|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717076|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717077|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82717078|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82717079|NCT00793923|Dexamethasone|dexamethasone|mesh-list
82717080|NCT00793923|Ranibizumab|ranibizumab|mesh-list
82717081|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82717082|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
82717083|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
82717084|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717085|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717086|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82717087|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
82717088|NCT00793923|Hormones|hormones|mesh-ancestor
82717089|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717090|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82717091|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717092|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82717093|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82717094|NCT00793923|Growth Substances|growth substances|mesh-ancestor
82717095|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
82717096|NCT01247324|Interferons|interferons|mesh-list
82717097|NCT01247324|Interferon-beta|interferon-beta|mesh-list
82717098|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
82717099|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
82717100|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717101|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
82717102|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82717103|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
82717104|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717105|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82717106|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82717107|NCT00772577|Ramipril|ramipril|mesh-list
82717108|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82717109|NCT00772577|Diuretics|diuretics|mesh-ancestor
82717110|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
82717111|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717112|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82717113|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82717114|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717115|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82717116|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
82717117|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717118|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
82717119|NCT02345850|Methotrexate|methotrexate|mesh-list
82717120|NCT02345850|Tacrolimus|tacrolimus|mesh-list
82717121|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82717122|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
82717123|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717124|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82717125|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82717126|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
82717127|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717128|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717129|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82717130|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82717132|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82717133|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82717134|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
82717135|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
82717136|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717137|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82717138|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82717139|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82717140|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
82717141|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
82717142|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717143|NCT04073550|Topotecan|topotecan|mesh-list
82717144|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82717145|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82717146|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717147|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717148|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717149|NCT02576600|Remifentanil|remifentanil|mesh-list
82717150|NCT02576600|Propofol|propofol|mesh-list
82717151|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82717152|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717153|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717154|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82717155|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
82717156|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
82717157|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82717158|NCT02576600|Narcotics|narcotics|mesh-ancestor
82717159|NCT02576600|Analgesics|analgesics|mesh-ancestor
82717160|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
82717161|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717162|NCT02863770|Pancrelipase|pancrelipase|mesh-list
82717163|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82717164|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82717165|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82717166|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82717167|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717168|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717169|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82717170|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82717171|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82717172|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
82717173|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717174|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717175|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82717176|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82717177|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
82717178|NCT00660309|Irbesartan|irbesartan|mesh-list
82717179|NCT00660309|Captopril|captopril|mesh-list
82717180|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82717181|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82717182|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82717183|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717184|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82717185|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
82717186|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717187|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
82717188|NCT04046133|Capecitabine|capecitabine|mesh-list
82717189|NCT04046133|Mitomycins|mitomycins|mesh-list
82717190|NCT04046133|Mitomycin|mitomycin|mesh-list
82717191|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82717192|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717193|NCT04046133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82717194|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717195|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82717196|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
82717197|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82717198|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
82717199|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82717200|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717201|NCT02573714|Ketamine|ketamine|mesh-list
82717202|NCT02573714|Analgesics|analgesics|mesh-ancestor
82717203|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
82717204|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717205|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717206|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82717207|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82717208|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
82717209|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
82717210|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717211|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82717212|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82717213|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717214|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717215|NCT00794235|Sorafenib|sorafenib|mesh-list
82717216|NCT00794235|Dacarbazine|dacarbazine|mesh-list
82717217|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717218|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82717219|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717220|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717221|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82717222|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
82717223|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
82717224|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82717225|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717226|NCT02575664|Buprenorphine|buprenorphine|mesh-list
82717227|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82717228|NCT02575664|Narcotics|narcotics|mesh-ancestor
82717229|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717230|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717231|NCT02575664|Analgesics|analgesics|mesh-ancestor
82717232|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
82717233|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717234|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82717235|NCT00796497|Ondansetron|ondansetron|mesh-list
82717236|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
82717237|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
82717238|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717239|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717240|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82717241|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
82717242|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
82717243|NCT00796497|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82717244|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82717245|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
82717246|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717247|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717248|NCT04330820|Venetoclax|venetoclax|mesh-list
82717249|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717250|NCT00801177|Necitumumab|necitumumab|mesh-list
82717251|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82717252|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82717253|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717254|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
82717255|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717256|NCT00581100|Etanercept|etanercept|mesh-list
82717257|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82717258|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82717259|NCT00581100|Analgesics|analgesics|mesh-ancestor
82717260|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
82717261|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717262|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717263|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82717264|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82717265|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82717266|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82717267|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
82717268|NCT00579098|Atorvastatin|atorvastatin|mesh-list
82717269|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82717270|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82717271|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
82717272|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717273|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82717274|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82717275|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717276|NCT00772109|Vaccines|vaccines|mesh-list
82717277|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
82717278|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717279|NCT00801255|Lactams|lactams|mesh-list
82717280|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82717281|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82717282|NCT00794625|Valproic Acid|valproic acid|mesh-list
82717283|NCT00794625|Risperidone|risperidone|mesh-list
82717284|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
82717285|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82717286|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
82717287|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717288|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717289|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717290|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82717291|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82717292|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717293|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82717294|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82717295|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
82717296|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
82717297|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717298|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
82717299|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
82717300|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82717301|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82717302|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82717303|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82717304|NCT02577432|Fentanyl|fentanyl|mesh-list
82717305|NCT02577432|Bupivacaine|bupivacaine|mesh-list
82717306|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
82717307|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
82717308|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717309|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717310|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
82717311|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717312|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82717313|NCT02577432|Narcotics|narcotics|mesh-ancestor
82717314|NCT02577432|Analgesics|analgesics|mesh-ancestor
82717315|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82717316|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82717317|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
82717318|NCT00794703|Itraconazole|itraconazole|mesh-list
82717319|NCT00794703|Micafungin|micafungin|mesh-list
82717320|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
82717321|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82717322|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82717323|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82717324|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717325|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717326|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82717327|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
82717328|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717329|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717330|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82717332|NCT00772031|Propranolol|propranolol|mesh-list
82717333|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82717334|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82717335|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
82717336|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717337|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717338|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717339|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82717340|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82717341|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
82717342|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
82717343|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82717344|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
82717345|NCT00801411|Docetaxel|docetaxel|mesh-list
82717346|NCT00801411|Doxorubicin|doxorubicin|mesh-list
82717347|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82717348|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82717349|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
82717350|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717351|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82717352|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82717353|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
82717354|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717355|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717356|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82717357|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
82717358|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
82717359|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
82717360|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82717361|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82717362|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82717363|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717365|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717366|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82717367|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717368|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717369|NCT04940013|Misoprostol|misoprostol|mesh-list
82717370|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82717371|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
82717372|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82717373|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717374|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82717375|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82717376|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
82717377|NCT00771953|Docetaxel|docetaxel|mesh-list
82717378|NCT00771953|Pemetrexed|pemetrexed|mesh-list
82717379|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717380|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
82717381|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
82717382|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
82717383|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717384|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717385|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82717386|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82717387|NCT00714584|Naltrexone|naltrexone|mesh-list
82717388|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82717389|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82717390|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717391|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
82717392|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717393|NCT00621244|Panobinostat|panobinostat|mesh-list
82717394|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717395|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82717396|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717397|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717398|NCT00916409|Temozolomide|temozolomide|mesh-list
82717399|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82717400|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
82717401|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717402|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717403|NCT00714740|Acetazolamide|acetazolamide|mesh-list
82717404|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
82717405|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82717406|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717407|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717408|NCT00714740|Diuretics|diuretics|mesh-ancestor
82717409|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
82717410|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717411|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
82717412|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
82717413|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82717414|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82717415|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717416|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717417|NCT00659529|Urological Agents|urological agents|mesh-ancestor
82717418|NCT02575508|Fluorouracil|fluorouracil|mesh-list
82717419|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
82717420|NCT02575508|Irinotecan|irinotecan|mesh-list
82717421|NCT02575508|Camptothecin|camptothecin|mesh-list
82717422|NCT02575508|Infigratinib|infigratinib|mesh-list
82717423|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
82717424|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717425|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82717426|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717427|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82717428|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
82717429|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717430|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82717431|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82717432|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717433|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82717434|NCT00795015|Insulin|insulin|mesh-list
82717435|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82717436|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82717437|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717438|NCT00796887|Niacin|niacin|mesh-list
82717439|NCT00796887|Niacinamide|niacinamide|mesh-list
82717440|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
82717441|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82717442|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
82717443|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717444|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82717445|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
82717446|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
82717447|NCT00796887|Vitamins|vitamins|mesh-ancestor
82717448|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
82717449|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717450|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
82717451|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82717755|NCT00655863|Pioglitazone|pioglitazone|mesh-list
82717452|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717453|NCT00843934|Epirubicin|epirubicin|mesh-list
82717454|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717455|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82717456|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82717457|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82717458|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717459|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717460|NCT00805701|Dutasteride|dutasteride|mesh-list
82717461|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82717462|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82717463|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717464|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717465|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
82717466|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717467|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717469|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82717470|NCT04042948|Analgesics|analgesics|mesh-ancestor
82717471|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
82717472|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717473|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717474|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
82717475|NCT00765245|Rituximab|rituximab|mesh-list
82717476|NCT00765245|Lenalidomide|lenalidomide|mesh-list
82717477|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82717478|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717479|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
82717480|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717481|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82717482|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82717483|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82717484|NCT00765245|Growth Substances|growth substances|mesh-ancestor
82717485|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
82717486|NCT00801879|Mupirocin|mupirocin|mesh-list
82717487|NCT00801879|Calcium|calcium|mesh-list
82717488|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82717489|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717490|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82717491|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82717492|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82717493|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717494|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717495|NCT00718484|Doxorubicin|doxorubicin|mesh-list
82717496|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82717497|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
82717498|NCT00718484|Ifosfamide|ifosfamide|mesh-list
82717499|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82717500|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717501|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82717502|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82717503|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717504|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717505|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82717506|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
82717507|NCT00841126|Iron|iron|mesh-list
82717508|NCT00841126|Trace Elements|trace elements|mesh-ancestor
82717509|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
82717510|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717511|NCT00805857|Tipranavir|tipranavir|mesh-list
82717512|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82717513|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82717514|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
82717515|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82717516|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
82717517|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82717518|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82717519|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82717520|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
82717521|NCT00801957|Tacrolimus|tacrolimus|mesh-list
82717522|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82717523|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
82717524|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717525|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82717526|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717527|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717528|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82717529|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
82717530|NCT00836134|Bupivacaine|bupivacaine|mesh-list
82717531|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
82717532|NCT00836134|Anesthetics|anesthetics|mesh-list
82717533|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717534|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717535|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
82717536|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717537|NCT00782795|Pioglitazone|pioglitazone|mesh-list
82717538|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82717539|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717540|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
82717541|NCT02573558|Propofol|propofol|mesh-list
82717542|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82717543|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717544|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717545|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82717546|NCT02573558|Analgesics|analgesics|mesh-ancestor
82717547|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
82717548|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717549|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82717550|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82717551|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82717552|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
82717553|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717554|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717555|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82717556|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
82717557|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
82717558|NCT00656799|Bromides|bromides|mesh-list
82717559|NCT00656799|Rocuronium|rocuronium|mesh-list
82717560|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
82717561|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82717562|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82717563|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82717564|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717565|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717566|NCT00764699|Mecasermin|mecasermin|mesh-list
82717567|NCT00764699|Growth Substances|growth substances|mesh-ancestor
82717568|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717569|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82717570|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82717571|NCT00844012|Estradiol|estradiol|mesh-list
82717572|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82717573|NCT00844012|Estrogens|estrogens|mesh-ancestor
82717574|NCT00844012|Hormones|hormones|mesh-ancestor
82717575|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717576|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717577|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82717578|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
82717579|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82717580|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82717581|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82717582|NCT02574962|Hormones|hormones|mesh-ancestor
82717583|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717584|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717585|NCT00802035|Baclofen|baclofen|mesh-list
82717586|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82717587|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717588|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82717589|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717590|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82717591|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
82717592|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
82717593|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717594|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717595|NCT00836212|Efavirenz|efavirenz|mesh-list
82717596|NCT00836212|Lopinavir|lopinavir|mesh-list
82717597|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82717598|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82717599|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717600|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717601|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
82717602|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82717603|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82717604|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82717605|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82717606|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82717607|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82717608|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82717609|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82717610|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82717611|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
82717612|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82717613|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82717614|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82717616|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82717617|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
82717618|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82717619|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
82717620|NCT00782717|Nepafenac|nepafenac|mesh-list
82717621|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82717622|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
82717623|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82717624|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
82717625|NCT00782717|Hormones|hormones|mesh-ancestor
82717626|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717627|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717628|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82717629|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717630|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
82717631|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
82717632|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717633|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82717634|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82717635|NCT00782717|Protective Agents|protective agents|mesh-ancestor
82717636|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82717637|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82717638|NCT00782717|Analgesics|analgesics|mesh-ancestor
82717639|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
82717640|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82717641|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
82717642|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82717643|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82717644|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
82717645|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82717646|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82717647|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82717648|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717649|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717650|NCT02601677|Fluoxetine|fluoxetine|mesh-list
82717651|NCT02601677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82717652|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82717653|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82717654|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717655|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717656|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
82717657|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717658|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82717659|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
82717660|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82717661|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82717662|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82717663|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717664|NCT04558112|Levodopa|levodopa|mesh-list
82717665|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82717666|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82717667|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
82717668|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717669|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717670|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717671|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82717672|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82717673|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82717674|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82717675|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717676|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717677|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717678|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82717679|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
82717680|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82717681|NCT05479097|Antihypertensive Agents|antihypertensive agents|mesh-list
82717682|NCT00656019|Vitamin D|vitamin d|mesh-list
82717683|NCT00656019|Calcipotriene|calcipotriene|mesh-list
82717684|NCT00656019|Vitamins|vitamins|mesh-ancestor
82717685|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
82717686|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717687|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82717688|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
82717689|NCT00841438|Abciximab|abciximab|mesh-list
82717690|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
82717691|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82717692|NCT00841516|Immunomodulating Agents|immunomodulating agents|mesh-list
82717693|NCT00841516|Immunologic Factors|immunologic factors|mesh-ancestor
82717694|NCT00841516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717695|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
82717696|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
82717697|NCT04068974|Apatinib|apatinib|mesh-list
82717698|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717699|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82717700|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717701|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717702|NCT00836368|Vitamin E|vitamin e|mesh-list
82717703|NCT00836368|Tocopherols|tocopherols|mesh-list
82717704|NCT00836368|Tocotrienols|tocotrienols|mesh-list
82717705|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
82717706|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
82717707|NCT00836368|Vitamins|vitamins|mesh-ancestor
82717708|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
82717709|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717710|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
82717711|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717712|NCT00836368|Protective Agents|protective agents|mesh-ancestor
82717713|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
82717714|NCT00718796|Ubiquinone|ubiquinone|mesh-list
82717715|NCT00718796|Atorvastatin|atorvastatin|mesh-list
82717716|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82717717|NCT00718796|Simvastatin|simvastatin|mesh-list
82717718|NCT00718796|Pravastatin|pravastatin|mesh-list
82717719|NCT00718796|Lovastatin|lovastatin|mesh-list
82717720|NCT00718796|L 647318|l 647318|mesh-list
82717721|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
82717722|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
82717723|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82717724|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
82717725|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717726|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82717727|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82717728|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717729|NCT00718796|Vitamins|vitamins|mesh-ancestor
82717730|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
82717731|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717732|NCT00844168|Sorafenib|sorafenib|mesh-list
82717733|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717734|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82717735|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717736|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717737|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
82717738|NCT00764465|Ritonavir|ritonavir|mesh-list
82717739|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
82717740|NCT00764465|Maraviroc|maraviroc|mesh-list
82717741|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82717742|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82717743|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
82717744|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717745|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717746|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82717747|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82717748|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
82717749|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82717750|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82717751|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82717752|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82717753|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82717754|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82717756|NCT00655863|Alogliptin|alogliptin|mesh-list
82717757|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82717758|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717759|NCT00655863|Incretins|incretins|mesh-ancestor
82717760|NCT00655863|Hormones|hormones|mesh-ancestor
82717761|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717762|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82717763|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
82717764|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717765|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717766|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82717767|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
82717768|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82717769|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82717770|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717771|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717772|NCT00718952|Urological Agents|urological agents|mesh-ancestor
82717773|NCT00781937|Liraglutide|liraglutide|mesh-list
82717774|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82717775|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717776|NCT00781937|Incretins|incretins|mesh-ancestor
82717777|NCT00781937|Hormones|hormones|mesh-ancestor
82717778|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717779|NCT00802581|Anesthetics|anesthetics|mesh-list
82717780|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
82717781|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717782|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717783|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
82717784|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717785|NCT00719108|Insulin|insulin|mesh-list
82717786|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82717787|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82717788|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717789|NCT00842140|Metformin|metformin|mesh-list
82717790|NCT00842140|Spironolactone|spironolactone|mesh-list
82717791|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
82717792|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
82717793|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82717794|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717795|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82717796|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82717797|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
82717798|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717799|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82717800|NCT00842140|Diuretics|diuretics|mesh-ancestor
82717801|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
82717802|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82717803|NCT00806169|Triamcinolone|triamcinolone|mesh-list
82717804|NCT00806169|Bevacizumab|bevacizumab|mesh-list
82717805|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82717806|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717807|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82717808|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82717809|NCT00806169|Growth Substances|growth substances|mesh-ancestor
82717810|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717812|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82717813|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
82717814|NCT00806169|Hormones|hormones|mesh-ancestor
82717815|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717816|NCT00844324|Candesartan|candesartan|mesh-list
82717817|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
82717818|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82717819|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82717820|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82717821|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717822|NCT00802815|Etanercept|etanercept|mesh-list
82717823|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82717824|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82717825|NCT00802815|Analgesics|analgesics|mesh-ancestor
82717826|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
82717827|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717828|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717829|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82717830|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82717831|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82717832|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82717833|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
82717834|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
82717835|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
82717836|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82717837|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82717838|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717839|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717840|NCT04100759|Urological Agents|urological agents|mesh-ancestor
82717842|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717843|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717844|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717845|NCT00844402|Atorvastatin|atorvastatin|mesh-list
82717846|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82717847|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82717848|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
82717849|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717850|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82717851|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82717852|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717853|NCT00806247|Tapentadol|tapentadol|mesh-list
82717854|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82717855|NCT00806247|Narcotics|narcotics|mesh-ancestor
82717856|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717857|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717858|NCT00806247|Analgesics|analgesics|mesh-ancestor
82717859|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
82717860|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717861|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82717862|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82717863|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82717864|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717865|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
82717866|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717867|NCT00797745|Ritonavir|ritonavir|mesh-list
82717868|NCT00797745|Ribavirin|ribavirin|mesh-list
82717869|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82717870|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82717871|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82717872|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
82717873|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717874|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717875|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82717876|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82717877|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
82717878|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82717879|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82717880|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82717882|NCT00659373|Tamoxifen|tamoxifen|mesh-list
82717883|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82717884|NCT00659373|Exemestane|exemestane|mesh-list
82717885|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82717886|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
82717887|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717888|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717889|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82717890|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717891|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82717892|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82717893|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82717894|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82717895|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82717896|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717897|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717898|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
82717899|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82717900|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
82717901|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82717902|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82717903|NCT00842452|Topotecan|topotecan|mesh-list
82717904|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82717905|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82717906|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717907|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717908|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717909|NCT02552745|Parecoxib|parecoxib|mesh-list
82717910|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82717911|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82717912|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717913|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717914|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82717915|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82717916|NCT02552745|Analgesics|analgesics|mesh-ancestor
82717917|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
82717918|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717919|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717920|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82717921|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82717922|NCT02547844|Tenofovir|tenofovir|mesh-list
82717923|NCT02547844|Efavirenz|efavirenz|mesh-list
82717924|NCT02547844|Emtricitabine|emtricitabine|mesh-list
82717925|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
82717926|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82717927|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82717928|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82717929|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717930|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717931|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82717932|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82717933|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82717934|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82717935|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82717936|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82717937|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82717938|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82717939|NCT00439777|Enoxaparin|enoxaparin|mesh-list
82717940|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
82717941|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82717942|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
82717943|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82717944|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
82717945|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82717946|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717947|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
82717948|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82717949|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82717950|NCT00842686|Bevacizumab|bevacizumab|mesh-list
82717951|NCT00842686|Capecitabine|capecitabine|mesh-list
82717952|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82717953|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82717954|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82717955|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82717956|NCT00842686|Growth Substances|growth substances|mesh-ancestor
82717957|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717958|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
82717959|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82717960|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
82717961|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717962|NCT04045821|Plerixafor|plerixafor|mesh-list
82717963|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82717964|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82717965|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
82717966|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82717967|NCT00803439|Clobetasol|clobetasol|mesh-list
82717968|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82717969|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
82717970|NCT00803439|Hormones|hormones|mesh-ancestor
82717971|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82717972|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717973|NCT00806481|Sevelamer|sevelamer|mesh-list
82717974|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
82717975|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
82717976|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717977|NCT00709436|Ketamine|ketamine|mesh-list
82717978|NCT00709436|Analgesics|analgesics|mesh-ancestor
82717979|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
82717980|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82717981|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717982|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82717983|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82717984|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
82717985|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
82717986|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82717987|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82717988|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82717989|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82717990|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82717991|NCT00844792|Vitamin D|vitamin d|mesh-list
82717992|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
82717993|NCT00844792|Vitamins|vitamins|mesh-list
82717994|NCT00844792|Vitamin E|vitamin e|mesh-list
82717995|NCT00844792|Selenium|selenium|mesh-list
82717996|NCT00844792|Lycopene|lycopene|mesh-list
82717997|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
82717998|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82717999|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82718000|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82718001|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
82718002|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718003|NCT00844792|Protective Agents|protective agents|mesh-ancestor
82718004|NCT00844792|Trace Elements|trace elements|mesh-ancestor
82718005|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82718006|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82718007|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82718008|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718009|NCT00719420|Amoxicillin|amoxicillin|mesh-list
82718010|NCT00719420|Metronidazole|metronidazole|mesh-list
82718011|NCT00719420|Clarithromycin|clarithromycin|mesh-list
82718012|NCT00719420|Omeprazole|omeprazole|mesh-list
82718013|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82718014|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718015|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82718016|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82718017|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82718018|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82718019|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82718020|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718021|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718022|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82718023|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82718024|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82718025|NCT00803829|Sulfalene|sulfalene|mesh-list
82718026|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718027|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82718028|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
82718029|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82718030|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82718031|NCT00716612|Ubiquinone|ubiquinone|mesh-list
82718032|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
82718033|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
82718034|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718035|NCT00716612|Vitamins|vitamins|mesh-ancestor
82718036|NCT00842920|Simvastatin|simvastatin|mesh-list
82718037|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82718038|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82718039|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
82718040|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718041|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82718042|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82718043|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718044|NCT00842998|Trastuzumab|trastuzumab|mesh-list
82718046|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82718047|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718048|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82718049|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718050|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718051|NCT00716846|Atorvastatin|atorvastatin|mesh-list
82718052|NCT00716846|Simvastatin|simvastatin|mesh-list
82718053|NCT00716846|Pitavastatin|pitavastatin|mesh-list
82718054|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82718055|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82718056|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
82718057|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718058|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82718059|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82718060|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718062|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
82718063|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
82718064|NCT00620854|Katacalcin|katacalcin|mesh-list
82718065|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82718066|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718067|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82718068|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
82718069|NCT00716924|Clopidogrel|clopidogrel|mesh-list
82718070|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82718071|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82718072|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82718073|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82718074|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
82718075|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718076|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718077|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718078|NCT00430027|Capecitabine|capecitabine|mesh-list
82718079|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
82718080|NCT00430027|Cetuximab|cetuximab|mesh-list
82718081|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82718082|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
82718083|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718084|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718085|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82718086|NCT04766229|Gabapentin|gabapentin|mesh-list
82718087|NCT04766229|Citalopram|citalopram|mesh-list
82718088|NCT04766229|Analgesics|analgesics|mesh-ancestor
82718089|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
82718090|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718091|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718092|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
82718093|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82718094|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82718095|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82718096|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82718097|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82718098|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82718099|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718100|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718101|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
82718102|NCT04766229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82718103|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82718104|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82718106|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82718107|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
82718108|NCT04068506|Gabapentin|gabapentin|mesh-list
82718109|NCT04068506|Analgesics|analgesics|mesh-ancestor
82718110|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
82718111|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718112|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718113|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
82718114|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82718115|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82718116|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82718117|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82718118|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82718119|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82718120|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718121|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718122|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
82718123|NCT00803907|Imiquimod|imiquimod|mesh-list
82718124|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
82718125|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82718126|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718127|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718128|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
82718129|NCT00843154|Candesartan|candesartan|mesh-list
82718130|NCT00843154|Candesartan cilexetil|candesartan cilexetil|mesh-list
82718131|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82718132|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82718133|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82718134|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718135|NCT00429793|Sirolimus|sirolimus|mesh-list
82718136|NCT00429793|Temsirolimus|temsirolimus|mesh-list
82718137|NCT00429793|MTOR Inhibitors|mtor inhibitors|mesh-list
82718138|NCT00429793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82718139|NCT00429793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718140|NCT00429793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718141|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82718142|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
82718143|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718144|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718145|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82718146|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718147|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82718148|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
82718149|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
82718150|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82718151|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82718152|NCT00806871|Prednisolone|prednisolone|mesh-list
82718153|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
82718154|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82718155|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
82718156|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82718157|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
82718158|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
82718159|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718160|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718161|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82718162|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
82718163|NCT00806871|Hormones|hormones|mesh-ancestor
82718164|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82718165|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82718166|NCT00806871|Protective Agents|protective agents|mesh-ancestor
82718167|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82718168|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718169|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
82718170|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82718171|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718172|NCT00798213|Immunotoxins|immunotoxins|mesh-ancestor
82718173|NCT00798213|Immunoconjugates|immunoconjugates|mesh-ancestor
82718174|NCT00798213|Immunologic Factors|immunologic factors|mesh-ancestor
82718175|NCT00798213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718176|NCT04069208|Cytarabine|cytarabine|mesh-list
82718177|NCT04069208|Idarubicin|idarubicin|mesh-list
82718178|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82718179|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
82718180|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718181|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718182|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
82718183|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718184|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82718185|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
82718186|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718187|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82718188|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82718189|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82718190|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718191|NCT00845104|Bevacizumab|bevacizumab|mesh-list
82718192|NCT00845104|Rituximab|rituximab|mesh-list
82718193|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82718194|NCT00845104|Fludarabine|fludarabine|mesh-list
82718195|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
82718196|NCT00845104|Antibodies|antibodies|mesh-list
82718197|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
82718198|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82718199|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718200|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82718201|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82718202|NCT00845104|Growth Substances|growth substances|mesh-ancestor
82718203|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718204|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
82718205|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
82718206|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82718207|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82718208|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
82718287|NCT00717470|Hormones|hormones|mesh-ancestor
82718209|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718210|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82718211|NCT00763451|Metformin|metformin|mesh-list
82718212|NCT00763451|Lixisenatide|lixisenatide|mesh-list
82718213|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82718214|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718215|NCT00762762|Triclosan|triclosan|mesh-list
82718216|NCT00762762|Fluorides|fluorides|mesh-list
82718217|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
82718218|NCT00762762|Protective Agents|protective agents|mesh-ancestor
82718219|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718220|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82718221|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718222|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82718223|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82718224|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
82718225|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718226|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82718227|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
82718228|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82718229|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82718230|NCT00424489|Prednisolone|prednisolone|mesh-list
82718231|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
82718232|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
82718233|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82718234|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
82718235|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82718236|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
82718237|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718238|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82718239|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82718240|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
82718241|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718242|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718243|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82718244|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82718245|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
82718246|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
82718247|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718248|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82718249|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
82718250|NCT00424489|Hormones|hormones|mesh-ancestor
82718251|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82718252|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82718253|NCT00424489|Protective Agents|protective agents|mesh-ancestor
82718254|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82718255|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
82718256|NCT00578864|Doxorubicin|doxorubicin|mesh-list
82718257|NCT00578864|Etoposide|etoposide|mesh-list
82718258|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
82718259|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82718260|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
82718261|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718262|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82718263|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82718264|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
82718265|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718266|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718267|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82718268|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82718269|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82718270|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82718271|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718272|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82718274|NCT01034683|Antidotes|antidotes|mesh-ancestor
82718275|NCT01034683|Protective Agents|protective agents|mesh-ancestor
82718276|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718277|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
82718278|NCT01034683|Vitamins|vitamins|mesh-ancestor
82718279|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
82718280|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
82718281|NCT00717470|Prednisone|prednisone|mesh-list
82718282|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
82718283|NCT00717470|Tacrolimus|tacrolimus|mesh-list
82718284|NCT00717470|Basiliximab|basiliximab|mesh-list
82718285|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82718286|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
82718288|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82718289|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718290|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82718291|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718292|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82718293|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
82718294|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82718295|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718296|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718297|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82718298|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82718299|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
82718300|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82718301|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718302|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
82718303|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
82718304|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718305|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82718306|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82718307|NCT00717470|Protective Agents|protective agents|mesh-ancestor
82718308|NCT00631566|Mupirocin|mupirocin|mesh-list
82718309|NCT00631566|Triclosan|triclosan|mesh-list
82718310|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
82718311|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82718312|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718313|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82718314|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718315|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718316|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82718317|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82718318|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82718319|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
82718320|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82718321|NCT00722852|Ketoprofen|ketoprofen|mesh-list
82718322|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82718323|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82718324|NCT00722852|Analgesics|analgesics|mesh-ancestor
82718325|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
82718326|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718327|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718328|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82718329|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82718330|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82718331|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718332|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718333|NCT05657444|Tenecteplase|tenecteplase|mesh-list
82718334|NCT05657444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82718335|NCT05657444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82718336|NCT05657444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718337|NCT01410942|Methylphenidate|methylphenidate|mesh-list
82718338|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82718339|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718340|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82718341|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82718342|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82718343|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718344|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
82718345|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718346|NCT04833426|Testosterone|testosterone|mesh-list
82718347|NCT04833426|Androgens|androgens|mesh-ancestor
82718348|NCT04833426|Hormones|hormones|mesh-ancestor
82718349|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82718350|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718351|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82718352|NCT02576964|Capecitabine|capecitabine|mesh-list
82718353|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82718354|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
82718355|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718356|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718357|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
82718358|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718359|NCT00763139|Pioglitazone|pioglitazone|mesh-list
82718360|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82718361|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718362|NCT01366092|Interleukin-2|interleukin-2|mesh-list
82718363|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718364|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82718365|NCT01366092|Analgesics|analgesics|mesh-ancestor
82718366|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
82718367|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718368|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718369|NCT00781859|Plasminogen|plasminogen|mesh-list
82718370|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82718371|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82718372|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718373|NCT01344252|Lidocaine|lidocaine|mesh-list
82718374|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
82718375|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
82718376|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82718377|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718378|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
82718379|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718380|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82718381|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82718382|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82718383|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82718384|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718385|NCT04101383|Insulin|insulin|mesh-list
82718386|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82718387|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
82718388|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82718389|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718390|NCT02576808|Loratadine|loratadine|mesh-list
82718391|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
82718392|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
82718393|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82718394|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82718395|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82718396|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
82718397|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
82718398|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718399|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718400|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718401|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
82718402|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
82718403|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718404|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82718406|NCT04073160|Tremelimumab|tremelimumab|mesh-list
82718407|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82718408|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718409|NCT00417079|Prednisone|prednisone|mesh-list
82718410|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
82718411|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82718412|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
82718413|NCT00417079|Hormones|hormones|mesh-ancestor
82718414|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82718415|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718416|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82718417|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718418|NCT00417079|Analgesics|analgesics|mesh-ancestor
82718419|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
82718420|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718421|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82718422|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82718423|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718424|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718425|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82718426|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82718427|NCT00429169|Bupropion|bupropion|mesh-list
82718428|NCT00429169|Paroxetine|paroxetine|mesh-list
82718429|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82718430|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
82718431|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82718432|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82718433|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82718434|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82718590|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
82718435|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718436|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
82718437|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718438|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718439|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82718440|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82718441|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718442|NCT00429169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82718443|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
82718444|NCT01037491|Aspirin|aspirin|mesh-list
82718445|NCT01037491|Rabeprazole|rabeprazole|mesh-list
82718446|NCT01037491|Clopidogrel|clopidogrel|mesh-list
82718447|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82718448|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82718449|NCT01037491|Analgesics|analgesics|mesh-ancestor
82718450|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
82718451|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718452|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718453|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82718454|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82718455|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82718456|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82718457|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718458|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82718459|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82718460|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718461|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
82718462|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82718463|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82718464|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82718465|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
82718466|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718467|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82718468|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82718469|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82718470|NCT01033279|Warfarin|warfarin|mesh-list
82718471|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
82718472|NCT02576340|Octylonium|octylonium|mesh-list
82718473|NCT02576340|Bromides|bromides|mesh-list
82718474|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
82718475|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82718476|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82718477|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718478|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82718479|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718480|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82718481|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
82718482|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
82718483|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718484|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82718485|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82718486|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
82718487|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718488|NCT02578602|Edetic Acid|edetic acid|mesh-list
82718489|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
82718490|NCT02578602|Antidotes|antidotes|mesh-ancestor
82718491|NCT02578602|Protective Agents|protective agents|mesh-ancestor
82718492|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718493|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
82718494|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
82718495|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718496|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82718497|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
82718498|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82718500|NCT00128856|Gemcitabine|gemcitabine|mesh-list
82718501|NCT00128856|Doxorubicin|doxorubicin|mesh-list
82718502|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82718503|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718504|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
82718505|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
82718506|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
82718507|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718508|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82718509|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
82718510|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82718511|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82718512|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82718513|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718514|NCT00128778|Doxorubicin|doxorubicin|mesh-list
82718515|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82718516|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82718517|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718518|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82718519|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82718520|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718521|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718522|NCT00709488|Talaporfin|talaporfin|mesh-list
82718523|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718524|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82718525|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
82718526|NCT00714246|Carboplatin|carboplatin|mesh-list
82718527|NCT00714246|Docetaxel|docetaxel|mesh-list
82718528|NCT00714246|Bortezomib|bortezomib|mesh-list
82718529|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718530|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
82718531|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
82718532|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
82718533|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718534|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82718535|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82718536|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718537|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
82718538|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718539|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82718540|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718541|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718542|NCT00709644|Folic Acid|folic acid|mesh-list
82718543|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82718544|NCT00709644|Norgestimate|norgestimate|mesh-list
82718545|NCT00709644|Estradiol|estradiol|mesh-list
82718546|NCT00709644|Estrogens|estrogens|mesh-ancestor
82718547|NCT00709644|Hormones|hormones|mesh-ancestor
82718548|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82718549|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718550|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82718551|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
82718552|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82718553|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82718555|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
82718556|NCT00709644|Vitamins|vitamins|mesh-ancestor
82718557|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
82718558|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82718559|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82718560|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82718561|NCT00415597|Naltrexone|naltrexone|mesh-list
82718562|NCT00415597|Morphine|morphine|mesh-list
82718563|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82718564|NCT00415597|Narcotics|narcotics|mesh-ancestor
82718565|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82718566|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718567|NCT00415597|Analgesics|analgesics|mesh-ancestor
82718568|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
82718569|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718570|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82718571|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82718572|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
82718573|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82718574|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
82718575|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718576|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82718577|NCT00714558|Fentanyl|fentanyl|mesh-list
82718578|NCT00714558|Naltrexone|naltrexone|mesh-list
82718579|NCT00714558|Naloxone|naloxone|mesh-list
82718580|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82718581|NCT00714558|Narcotics|narcotics|mesh-ancestor
82718582|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82718583|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718584|NCT00714558|Analgesics|analgesics|mesh-ancestor
82718585|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
82718586|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718587|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82718588|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82718589|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
82718591|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82718592|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82718593|NCT02575638|Camptothecin|camptothecin|mesh-list
82718594|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82718595|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718596|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82718597|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82718598|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718599|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718600|NCT02573610|Levofloxacin|levofloxacin|mesh-list
82718601|NCT02573610|Ofloxacin|ofloxacin|mesh-list
82718602|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82718603|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718604|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82718605|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82718606|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82718607|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718608|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718609|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718610|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82718611|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82718612|NCT02574468|Dexamethasone|dexamethasone|mesh-list
82718613|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
82718614|NCT02574468|BB 1101|bb 1101|mesh-list
82718615|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82718616|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
82718617|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
82718618|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718619|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718620|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82718621|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
82718622|NCT02574468|Hormones|hormones|mesh-ancestor
82718623|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82718624|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82718625|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718626|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
82718627|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718628|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718629|NCT00710268|Bevacizumab|bevacizumab|mesh-list
82718630|NCT00710268|Olaparib|olaparib|mesh-list
82718631|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82718632|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718633|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82718634|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82718635|NCT00710268|Growth Substances|growth substances|mesh-ancestor
82718636|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718637|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
82718638|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82718639|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718640|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718641|NCT02575248|Dienogest|dienogest|mesh-list
82718642|NCT02575248|Clomiphene|clomiphene|mesh-list
82718643|NCT02575248|Enclomiphene|enclomiphene|mesh-list
82718644|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
82718645|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82718646|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
82718647|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82718648|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718649|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82718650|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
82718651|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82718652|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82718653|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82718654|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82718655|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
82718656|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82718657|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82718658|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82718659|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82718660|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82718661|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718662|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82718663|NCT00710736|Fluorouracil|fluorouracil|mesh-list
82718664|NCT00710736|Capecitabine|capecitabine|mesh-list
82718665|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
82718666|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718667|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82718668|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718669|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82718670|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
82718671|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718672|NCT00620542|Atorvastatin|atorvastatin|mesh-list
82718673|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82718674|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82718675|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82718676|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
82718677|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718678|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82718679|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82718680|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718681|NCT04070742|Minocycline|minocycline|mesh-list
82718682|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82718683|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718684|NCT00851344|Cetirizine|cetirizine|mesh-list
82718685|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82718686|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82718687|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82718688|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
82718689|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
82718690|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718691|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718692|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718693|NCT04523922|Oxytocin|oxytocin|mesh-list
82718694|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
82718695|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82718696|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718697|NCT00711204|Donepezil|donepezil|mesh-list
82718698|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82718699|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718700|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718701|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
82718702|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718703|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718704|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
82718706|NCT05810792|Histamine|histamine|mesh-list
82718707|NCT05810792|Histamine phosphate|histamine phosphate|mesh-list
82718708|NCT05810792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718709|NCT05810792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82718710|NCT05810792|Analgesics|analgesics|mesh-ancestor
82718711|NCT05810792|Sensory System Agents|sensory system agents|mesh-ancestor
82718712|NCT05810792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718713|NCT05810792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718714|NCT05810792|Histamine Agonists|histamine agonists|mesh-ancestor
82718715|NCT05810792|Histamine Agents|histamine agents|mesh-ancestor
82718716|NCT05810792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718717|NCT05810792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718718|NCT05810571|Morphine|morphine|mesh-list
82718719|NCT05810571|Remifentanil|remifentanil|mesh-list
82718720|NCT05810571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82718721|NCT05810571|Narcotics|narcotics|mesh-ancestor
82718722|NCT05810571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82718723|NCT05810571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718725|NCT05810571|Sensory System Agents|sensory system agents|mesh-ancestor
82718726|NCT05810571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718727|NCT05810558|Glycine|glycine|mesh-list
82718728|NCT05810558|Glycine Agents|glycine agents|mesh-ancestor
82718729|NCT05810558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718730|NCT05810558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718731|NCT05810558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718732|NCT05810389|Fluorides|fluorides|mesh-list
82718733|NCT05810389|Cariostatic Agents|cariostatic agents|mesh-ancestor
82718734|NCT05810389|Protective Agents|protective agents|mesh-ancestor
82718735|NCT05810389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718736|NCT05809986|Ofatumumab|ofatumumab|mesh-list
82718737|NCT05809986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718738|NCT05809895|Paclitaxel|paclitaxel|mesh-list
82718739|NCT05809895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82718740|NCT05809895|Carboplatin|carboplatin|mesh-list
82718741|NCT05809895|Gemcitabine|gemcitabine|mesh-list
82718742|NCT05809895|Pembrolizumab|pembrolizumab|mesh-list
82718743|NCT05809895|Tislelizumab|tislelizumab|mesh-list
82718744|NCT05809895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82718745|NCT05809895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718746|NCT05809895|Tubulin Modulators|tubulin modulators|mesh-ancestor
82718747|NCT05809895|Antimitotic Agents|antimitotic agents|mesh-ancestor
82718748|NCT05809895|Mitosis Modulators|mitosis modulators|mesh-ancestor
82718749|NCT05809895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718750|NCT05809895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82718751|NCT05809895|Antimetabolites|antimetabolites|mesh-ancestor
82718752|NCT05809895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82718753|NCT05809895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82718754|NCT05809869|Durvalumab|durvalumab|mesh-list
82718755|NCT05809869|Tremelimumab|tremelimumab|mesh-list
82718756|NCT05809869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82718757|NCT05809869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718758|NCT05809843|Pancrelipase|pancrelipase|mesh-list
82718759|NCT05809843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82718760|NCT05809804|Esketamine|esketamine|mesh-list
82718761|NCT05809804|Antidepressive Agents|antidepressive agents|mesh-ancestor
82718762|NCT05809804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82718763|NCT05809609|Ketamine|ketamine|mesh-list
82718764|NCT05809609|Analgesics|analgesics|mesh-ancestor
82718765|NCT05809609|Sensory System Agents|sensory system agents|mesh-ancestor
82718766|NCT05809609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718767|NCT05809609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718768|NCT05809609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82718769|NCT05809609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82718770|NCT05809609|Anesthetics, General|anesthetics, general|mesh-ancestor
82718771|NCT05809609|Anesthetics|anesthetics|mesh-ancestor
82718772|NCT05809609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82718773|NCT05809609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82718774|NCT05809609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82718775|NCT05809609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718776|NCT05809609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718777|NCT05809518|Dexmedetomidine|dexmedetomidine|mesh-list
82718778|NCT05809518|Propofol|propofol|mesh-list
82718779|NCT05809518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82718780|NCT05809518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82718781|NCT05809518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718782|NCT05809518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82718783|NCT05809518|Analgesics|analgesics|mesh-ancestor
82718784|NCT05809518|Sensory System Agents|sensory system agents|mesh-ancestor
82718785|NCT05809518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718786|NCT05809518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82718787|NCT05809518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82718788|NCT05809518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82718789|NCT05809518|Adrenergic Agents|adrenergic agents|mesh-ancestor
82718790|NCT05809518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718791|NCT05809518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718792|NCT05809518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82718793|NCT05809518|Anesthetics, General|anesthetics, general|mesh-ancestor
82718794|NCT05809518|Anesthetics|anesthetics|mesh-ancestor
82718796|NCT05809414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82718797|NCT05809414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82718798|NCT05809414|Antiviral Agents|antiviral agents|mesh-ancestor
82718799|NCT05809414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718800|NCT05809414|Dopamine Agents|dopamine agents|mesh-ancestor
82718801|NCT05809414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718802|NCT05809414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718803|NCT05809414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718804|NCT05809414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82718805|NCT05809414|Analgesics|analgesics|mesh-ancestor
82718806|NCT05809414|Sensory System Agents|sensory system agents|mesh-ancestor
82718807|NCT05809414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718808|NCT05809336|Pembrolizumab|pembrolizumab|mesh-list
82718809|NCT05809336|Atezolizumab|atezolizumab|mesh-list
82718810|NCT05809336|Tislelizumab|tislelizumab|mesh-list
82718811|NCT05809336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82718812|NCT05809336|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82718813|NCT05809336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82718814|NCT05809336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718815|NCT05809336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718816|NCT05809336|Immunologic Factors|immunologic factors|mesh-ancestor
82718817|NCT05809336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719527|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
82718818|NCT05809271|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82718819|NCT05809271|Hallucinogens|hallucinogens|mesh-ancestor
82718820|NCT05809271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718821|NCT05809271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82718822|NCT05809271|Serotonin Agents|serotonin agents|mesh-ancestor
82718823|NCT05809271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718824|NCT05809271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718825|NCT05809271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82718826|NCT05809271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82718827|NCT05809271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82718828|NCT05809271|Adrenergic Agents|adrenergic agents|mesh-ancestor
82718829|NCT05809024|Letrozole|letrozole|mesh-list
82718830|NCT05809024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718831|NCT05809024|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82718832|NCT05809024|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82718833|NCT05809024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718834|NCT05809024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718835|NCT05809024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82718836|NCT05809024|Hormone Antagonists|hormone antagonists|mesh-ancestor
82718837|NCT05809024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82718838|NCT05809024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718839|NCT05808985|Butyric Acid|butyric acid|mesh-list
82718840|NCT05808985|Histamine Antagonists|histamine antagonists|mesh-ancestor
82718841|NCT05808985|Histamine Agents|histamine agents|mesh-ancestor
82718842|NCT05808985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82718843|NCT05808985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718844|NCT05808985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718845|NCT05808972|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82718846|NCT05808946|Thioctic Acid|thioctic acid|mesh-list
82718847|NCT05808946|Antioxidants|antioxidants|mesh-ancestor
82718848|NCT05808946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718849|NCT05808946|Protective Agents|protective agents|mesh-ancestor
82718850|NCT05808946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718851|NCT05808946|Vitamin B Complex|vitamin b complex|mesh-ancestor
82718852|NCT05808946|Vitamins|vitamins|mesh-ancestor
82718853|NCT05808946|Micronutrients|micronutrients|mesh-ancestor
82718854|NCT05806567|Belumosudil|belumosudil|mesh-list
82718855|NCT05806567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82718856|NCT05806567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718857|NCT05806567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718858|NCT05764876|Azithromycin|azithromycin|mesh-list
82718859|NCT05764876|Linezolid|linezolid|mesh-list
82718860|NCT05764876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82718861|NCT05764876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718862|NCT05764876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82718863|NCT05764876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718864|NCT05764876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718865|NCT05737576|Insulin Aspart|insulin aspart|mesh-list
82718866|NCT05737576|Insulin, Long-Acting|insulin, long-acting|mesh-list
82718867|NCT05737576|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82718868|NCT05737576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82718869|NCT05737576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718870|NCT05734560|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
82718871|NCT05734560|Immunoconjugates|immunoconjugates|mesh-ancestor
82718872|NCT05734560|Immunologic Factors|immunologic factors|mesh-ancestor
82718873|NCT05734560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718874|NCT05720988|Azacitidine|azacitidine|mesh-list
82718875|NCT05720988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82718876|NCT05720988|Antimetabolites|antimetabolites|mesh-ancestor
82718877|NCT05720988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82718878|NCT05720988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718879|NCT05720988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82718880|NCT05716763|Tramadol|tramadol|mesh-list
82718881|NCT05716763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82718882|NCT05716763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82718883|NCT05716763|Narcotics|narcotics|mesh-ancestor
82718884|NCT05716763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82718885|NCT05716763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82718886|NCT05716763|Analgesics|analgesics|mesh-ancestor
82718887|NCT05716763|Sensory System Agents|sensory system agents|mesh-ancestor
82718888|NCT05716763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82718889|NCT05716503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82718890|NCT05716503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82718891|NCT05716009|Gemtuzumab|gemtuzumab|mesh-list
82718892|NCT05716009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82718893|NCT05716009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82718894|NCT05716009|Immunotoxins|immunotoxins|mesh-ancestor
82718895|NCT05716009|Immunoconjugates|immunoconjugates|mesh-ancestor
82718896|NCT05716009|Immunologic Factors|immunologic factors|mesh-ancestor
82718897|NCT05716009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719005|NCT05648435|Lithium Carbonate|lithium carbonate|mesh-list
82719006|NCT05648435|Antidepressive Agents|antidepressive agents|mesh-ancestor
82719007|NCT05648435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82719008|NCT05648435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719009|NCT05648435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719011|NCT05648435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82719012|NCT05648435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719013|NCT05648435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719014|NCT05642767|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82719015|NCT05642767|Cetrimonium|cetrimonium|mesh-list
82719016|NCT05642767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719017|NCT05642767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82719018|NCT05624138|Leucovorin|leucovorin|mesh-list
82719019|NCT05624138|Ketotifen|ketotifen|mesh-list
82719020|NCT05624138|Fluorouracil|fluorouracil|mesh-list
82719021|NCT05624138|Oxaliplatin|oxaliplatin|mesh-list
82719022|NCT05624138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719023|NCT05624138|Antimetabolites|antimetabolites|mesh-ancestor
82719024|NCT05624138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719025|NCT05624138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82719026|NCT05624138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719027|NCT05624138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82719028|NCT05624138|Immunologic Factors|immunologic factors|mesh-ancestor
82719029|NCT05624138|Antidotes|antidotes|mesh-ancestor
82719030|NCT05624138|Protective Agents|protective agents|mesh-ancestor
82719031|NCT05624138|Vitamin B Complex|vitamin b complex|mesh-ancestor
82719032|NCT05624138|Vitamins|vitamins|mesh-ancestor
82719033|NCT05624138|Micronutrients|micronutrients|mesh-ancestor
82719034|NCT05624138|Antipruritics|antipruritics|mesh-ancestor
82719035|NCT05624138|Dermatologic Agents|dermatologic agents|mesh-ancestor
82719036|NCT05624138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82719037|NCT05624138|Histamine Antagonists|histamine antagonists|mesh-ancestor
82719038|NCT05624138|Histamine Agents|histamine agents|mesh-ancestor
82719039|NCT05624138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82719040|NCT05624138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82719041|NCT05610800|Exenatide|exenatide|mesh-list
82719042|NCT05610800|Nicotine|nicotine|mesh-list
82719043|NCT05610800|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82719044|NCT05610800|Autonomic Agents|autonomic agents|mesh-ancestor
82719045|NCT05610800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719046|NCT05610800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719047|NCT05610800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82719048|NCT05610800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82719049|NCT05610800|Cholinergic Agents|cholinergic agents|mesh-ancestor
82719050|NCT05610800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82719051|NCT05610800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719052|NCT05610800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82719053|NCT05610800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82719054|NCT05610800|Incretins|incretins|mesh-ancestor
82719055|NCT05610800|Hormones|hormones|mesh-ancestor
82719056|NCT05610800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82719057|NCT05605080|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
82719058|NCT05605080|Hemostatics|hemostatics|mesh-ancestor
82719059|NCT05605080|Coagulants|coagulants|mesh-ancestor
82719060|NCT05596383|Vitamin D|vitamin d|mesh-list
82719061|NCT05596383|Vitamins|vitamins|mesh-ancestor
82719062|NCT05596383|Micronutrients|micronutrients|mesh-ancestor
82719063|NCT05596383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719064|NCT05596383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82719065|NCT05594745|Lifitegrast|lifitegrast|mesh-list
82719066|NCT05594745|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82719067|NCT05594745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82719068|NCT05568953|Vaccines|vaccines|mesh-list
82719069|NCT05568953|Immunologic Factors|immunologic factors|mesh-ancestor
82719070|NCT05568953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719071|NCT05564052|Rituximab|rituximab|mesh-list
82719072|NCT05564052|Lenalidomide|lenalidomide|mesh-list
82719073|NCT05564052|Bortezomib|bortezomib|mesh-list
82719074|NCT05564052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719075|NCT05564052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719076|NCT05564052|Immunologic Factors|immunologic factors|mesh-ancestor
82719077|NCT05564052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719078|NCT05564052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82719079|NCT05564052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82719080|NCT05564052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82719081|NCT05564052|Growth Substances|growth substances|mesh-ancestor
82719082|NCT05564052|Growth Inhibitors|growth inhibitors|mesh-ancestor
82719084|NCT05556200|Antibodies|antibodies|mesh-list
82719085|NCT05556200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82719113|NCT05536154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82719115|NCT05536154|Antiviral Agents|antiviral agents|mesh-ancestor
82719116|NCT05536154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719117|NCT05536154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82719118|NCT05536154|Immunologic Factors|immunologic factors|mesh-ancestor
82719119|NCT05536154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719120|NCT05532215|Misoprostol|misoprostol|mesh-list
82719121|NCT05532215|Oxytocin|oxytocin|mesh-list
82719122|NCT05532215|Oxytocics|oxytocics|mesh-ancestor
82719123|NCT05532215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82719124|NCT05532215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719125|NCT05532215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82719126|NCT05532215|Abortifacient Agents|abortifacient agents|mesh-ancestor
82719127|NCT05532215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82719128|NCT05532215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82719159|NCT05516654|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82719160|NCT05516654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719161|NCT05510089|Cytarabine|cytarabine|mesh-list
82719175|NCT05510089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719176|NCT05505552|Vitamin K|vitamin k|mesh-list
82719177|NCT05505552|Vitamin K 1|vitamin k 1|mesh-list
82719178|NCT05505552|Vitamins|vitamins|mesh-ancestor
82719179|NCT05505552|Micronutrients|micronutrients|mesh-ancestor
82719180|NCT05505552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719181|NCT05505552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82719182|NCT05505552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82719183|NCT05505552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719184|NCT05505552|Hemostatics|hemostatics|mesh-ancestor
82719185|NCT05505552|Coagulants|coagulants|mesh-ancestor
82719189|NCT05473520|Doxycycline|doxycycline|mesh-list
82719190|NCT05473520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82719191|NCT05473520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719192|NCT05473520|Antimalarials|antimalarials|mesh-ancestor
82719193|NCT05473520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82719194|NCT05473520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82719195|NCT05471947|Glycolic acid|glycolic acid|mesh-list
82719196|NCT05471947|Keratolytic Agents|keratolytic agents|mesh-ancestor
82719197|NCT05471947|Dermatologic Agents|dermatologic agents|mesh-ancestor
82719198|NCT05463601|Tamoxifen|tamoxifen|mesh-list
82719199|NCT05463601|Letrozole|letrozole|mesh-list
82719200|NCT05463601|Fulvestrant|fulvestrant|mesh-list
82719201|NCT05463601|Exemestane|exemestane|mesh-list
82719202|NCT05463601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719203|NCT05463601|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82719204|NCT05463601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82719205|NCT05463601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719206|NCT05463601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719207|NCT05463601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82719208|NCT05463601|Hormone Antagonists|hormone antagonists|mesh-ancestor
82719209|NCT05463601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82719210|NCT05463601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719211|NCT05463601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82719212|NCT05463601|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82719213|NCT05463601|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82719214|NCT05463601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82719215|NCT05463601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82719226|NCT05441280|Pimavanserin|pimavanserin|mesh-list
82719227|NCT05441280|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82719228|NCT05441280|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82719229|NCT05441280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82719250|NCT05396014|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82719251|NCT05396014|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82719252|NCT05396014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82719253|NCT05396014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82719254|NCT05396014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719255|NCT05396014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82719256|NCT05396014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719258|NCT05396014|Sensory System Agents|sensory system agents|mesh-ancestor
82719259|NCT05396014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719260|NCT05396014|Antidepressive Agents|antidepressive agents|mesh-ancestor
82719261|NCT05396014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82719262|NCT05396014|Dopamine Agents|dopamine agents|mesh-ancestor
82719263|NCT05395195|Epoetin Alfa|epoetin alfa|mesh-list
82719264|NCT05395195|Hematinics|hematinics|mesh-ancestor
82719265|NCT05391360|Entecavir|entecavir|mesh-list
82719266|NCT05391360|Antiviral Agents|antiviral agents|mesh-ancestor
82719267|NCT05391360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719299|NCT05372887|Cyclobenzaprine|cyclobenzaprine|mesh-list
82719300|NCT05372887|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82719301|NCT05372887|Antidepressive Agents|antidepressive agents|mesh-ancestor
82719302|NCT05372887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82719303|NCT05372887|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82719304|NCT05372887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719305|NCT05372887|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82719306|NCT05372887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719307|NCT05372887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82719308|NCT05372887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719309|NCT05366764|Albuterol|albuterol|mesh-list
82719310|NCT05366764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82719311|NCT05366764|Autonomic Agents|autonomic agents|mesh-ancestor
82719312|NCT05366764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719313|NCT05366764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719314|NCT05366764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82719315|NCT05366764|Respiratory System Agents|respiratory system agents|mesh-ancestor
82719316|NCT05366764|Tocolytic Agents|tocolytic agents|mesh-ancestor
82719317|NCT05366764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82719318|NCT05366764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82719319|NCT05366764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82719320|NCT05366764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82719321|NCT05366764|Adrenergic Agents|adrenergic agents|mesh-ancestor
82719322|NCT05366764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82719323|NCT05366764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719324|NCT05366166|Cisplatin|cisplatin|mesh-list
82719325|NCT05366166|Pembrolizumab|pembrolizumab|mesh-list
82719326|NCT05366166|Olaparib|olaparib|mesh-list
82719327|NCT05366166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719328|NCT05366166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719329|NCT05366166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82719330|NCT05366166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719331|NCT05366166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82719332|NCT05366166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719333|NCT05359835|Edetic Acid|edetic acid|mesh-list
82719334|NCT05359835|Calcium|calcium|mesh-list
82719335|NCT05359835|Pentetic Acid|pentetic acid|mesh-list
82719336|NCT05359835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82719337|NCT05359835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719338|NCT05359835|Antidotes|antidotes|mesh-ancestor
82719339|NCT05359835|Protective Agents|protective agents|mesh-ancestor
82719340|NCT05359835|Chelating Agents|chelating agents|mesh-ancestor
82719341|NCT05359835|Sequestering Agents|sequestering agents|mesh-ancestor
82719342|NCT05359835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719343|NCT05359835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82719344|NCT05359835|Anticoagulants|anticoagulants|mesh-ancestor
82719345|NCT05359835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82719346|NCT05355051|Pembrolizumab|pembrolizumab|mesh-list
82719347|NCT05355051|Azacitidine|azacitidine|mesh-list
82719348|NCT05355051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719349|NCT05355051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719350|NCT05355051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82719351|NCT05355051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719352|NCT05355051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82719353|NCT05355051|Antimetabolites|antimetabolites|mesh-ancestor
82719354|NCT05355051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719359|NCT05335148|Colchicine|colchicine|mesh-list
82719360|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
82719361|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82719362|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
82719363|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
82719364|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
82719365|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719366|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719367|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
82719368|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
82719369|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719370|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
82719371|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719373|NCT05303844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719374|NCT05303844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719449|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82719453|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82719454|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
82719455|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719461|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
82719462|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82719463|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719464|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82719465|NCT05117034|Morphine|morphine|mesh-list
82719466|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82719467|NCT05117034|Narcotics|narcotics|mesh-ancestor
82719468|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719469|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719470|NCT05117034|Analgesics|analgesics|mesh-ancestor
82719471|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
82719472|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719473|NCT05115838|Islatravir|islatravir|mesh-list
82719474|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
82719475|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719476|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719477|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719478|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82719479|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82719480|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82719481|NCT05112939|Cabotegravir|cabotegravir|mesh-list
82719482|NCT05112939|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82719483|NCT05112939|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82719484|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719485|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719486|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82719487|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82719488|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
82719489|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719490|NCT05093920|Doxorubicin|doxorubicin|mesh-list
82719491|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82719492|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82719493|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719494|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82719495|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82719496|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719497|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719498|NCT05080946|Aspirin|aspirin|mesh-list
82719499|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82719500|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82719501|NCT05080946|Analgesics|analgesics|mesh-ancestor
82719502|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
82719503|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719504|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719505|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82719506|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82719507|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82719508|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82719509|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719510|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82719511|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82719512|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719513|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
82719514|NCT05068752|Sorafenib|sorafenib|mesh-list
82719515|NCT05068752|Vemurafenib|vemurafenib|mesh-list
82719516|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719517|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82719518|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719519|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719520|NCT05052879|Tadalafil|tadalafil|mesh-list
82719521|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
82719522|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82719523|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82719524|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719525|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719526|NCT05052879|Urological Agents|urological agents|mesh-ancestor
82719529|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
82719530|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719531|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719532|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
82719533|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719534|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82719535|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
82719536|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82719537|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82719538|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719539|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82719540|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
82719541|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82719542|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
82719543|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
82719544|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
82719545|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82719546|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82719547|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82719548|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719549|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719550|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
82719551|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82719552|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719553|NCT05036109|Aspirin|aspirin|mesh-list
82719554|NCT05036109|Vitamin D|vitamin d|mesh-list
82719555|NCT05036109|Vitamins|vitamins|mesh-ancestor
82719556|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
82719557|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719558|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82719559|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82719560|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82719561|NCT05036109|Analgesics|analgesics|mesh-ancestor
82719562|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
82719563|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719564|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82719565|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82719566|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82719567|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82719568|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719569|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82719570|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82719571|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719572|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
82719573|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
82719574|NCT05033483|Trace Elements|trace elements|mesh-ancestor
82719575|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
82719576|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719577|NCT04999969|Paclitaxel|paclitaxel|mesh-list
82719578|NCT04999969|Gemcitabine|gemcitabine|mesh-list
82719579|NCT04999969|Durvalumab|durvalumab|mesh-list
82719580|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82719581|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719582|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
82719583|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
82719584|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
82719585|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719586|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82719587|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
82719588|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719589|NCT04982913|Oseltamivir|oseltamivir|mesh-list
82719590|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
82719591|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719592|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719593|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719594|NCT04981899|Carboplatin|carboplatin|mesh-list
82719595|NCT04981899|Nivolumab|nivolumab|mesh-list
82719596|NCT04981899|Etoposide|etoposide|mesh-list
82719597|NCT04981899|Ifosfamide|ifosfamide|mesh-list
82719598|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719599|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719600|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82719601|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719602|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82719603|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82719604|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82719605|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719606|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82719607|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
82719609|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82719610|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
82719611|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
82719612|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719613|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719614|NCT04929600|Amlodipine|amlodipine|mesh-list
82719615|NCT04929600|Valsartan|valsartan|mesh-list
82719616|NCT04929600|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82719617|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82719618|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82719619|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82719620|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719621|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82719622|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719623|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
82719624|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82719625|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82719626|NCT04925648|Dasatinib|dasatinib|mesh-list
82719627|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719628|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82719629|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719630|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719631|NCT04904536|Atorvastatin|atorvastatin|mesh-list
82719632|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82719633|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82719634|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
82719635|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719636|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82719637|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82719638|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719639|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82719640|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719641|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82719642|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719643|NCT04852367|Doxorubicin|doxorubicin|mesh-list
82719644|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82719645|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719646|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82719647|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82719648|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719649|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719650|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
82719651|NCT04848337|Lenvatinib|lenvatinib|mesh-list
82719652|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719653|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719654|NCT04848337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82719655|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719656|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82719657|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719658|NCT04824417|Itraconazole|itraconazole|mesh-list
82719659|NCT04824417|Voriconazole|voriconazole|mesh-list
82719660|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
82719661|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719662|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82719663|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82719664|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719665|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719666|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82719667|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
82719668|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82719669|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719670|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82719672|NCT04727996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719673|NCT04727996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719674|NCT04720781|Esomeprazole|esomeprazole|mesh-list
82719675|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82719676|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82719677|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82719678|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719679|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719680|NCT04692623|Insulin|insulin|mesh-list
82719681|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82719682|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
82719683|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
82719684|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82719685|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719686|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82719687|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719688|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82719689|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82719690|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719691|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719692|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719693|NCT04690608|Triamcinolone|triamcinolone|mesh-list
82719694|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82719695|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82719696|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82719697|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82719698|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
82719699|NCT04690608|Hormones|hormones|mesh-ancestor
82719700|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82719701|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719702|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82719703|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
82719704|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719705|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719706|NCT04684238|Midazolam|midazolam|mesh-list
82719707|NCT04684238|Isoflurane|isoflurane|mesh-list
82719708|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82719709|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82719710|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719711|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719712|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82719713|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82719714|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82719715|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82719716|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
82719717|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
82719718|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
82719719|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
82719720|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82719721|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719722|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82719724|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
82719725|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82719726|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719727|NCT04586348|Trace Elements|trace elements|mesh-ancestor
82719728|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
82719729|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719730|NCT04577001|Letrozole|letrozole|mesh-list
82719731|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719732|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82719733|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82719734|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719735|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719736|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82719737|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
82719738|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82719739|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719740|NCT04576078|Nefopam|nefopam|mesh-list
82719741|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82719742|NCT04576078|Analgesics|analgesics|mesh-ancestor
82719743|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
82719744|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719745|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719746|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
82719747|NCT04561557|Fludarabine|fludarabine|mesh-list
82719748|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82719749|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
82719750|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719751|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82719752|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82719753|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
82719754|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719755|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719756|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82719757|NCT04561375|Fentanyl|fentanyl|mesh-list
82719758|NCT04561375|Sufentanil|sufentanil|mesh-list
82719759|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82719760|NCT04561375|Narcotics|narcotics|mesh-ancestor
82719761|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719762|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719763|NCT04561375|Analgesics|analgesics|mesh-ancestor
82719764|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
82719765|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719766|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82719767|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82719768|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
82719769|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
82719770|NCT04560127|Apatinib|apatinib|mesh-list
82719771|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719772|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82719773|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719774|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719775|NCT04553536|Sufentanil|sufentanil|mesh-list
82719776|NCT04553536|Remifentanil|remifentanil|mesh-list
82719777|NCT04553536|Dsuvia|dsuvia|mesh-list
82719778|NCT04553536|Bromides|bromides|mesh-list
82719779|NCT04553536|Propofol|propofol|mesh-list
82719780|NCT04553536|Esketamine|esketamine|mesh-list
82719781|NCT04553536|Rocuronium|rocuronium|mesh-list
82719782|NCT04553536|Cisatracurium|cisatracurium|mesh-list
82719783|NCT04553536|Atracurium|atracurium|mesh-list
82719784|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82719785|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719786|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719787|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82719788|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
82719789|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
82719790|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82719791|NCT04553536|Narcotics|narcotics|mesh-ancestor
82719792|NCT04553536|Analgesics|analgesics|mesh-ancestor
82719793|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
82719794|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719795|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
82719796|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82719797|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82719798|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82719799|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
82719800|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82719801|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82719802|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82719803|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
82719804|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82719805|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719806|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82719807|NCT04540211|Paclitaxel|paclitaxel|mesh-list
82719809|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82719810|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82719811|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719812|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
82719813|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
82719814|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
82719815|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719816|NCT04540211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82719817|NCT04540211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719818|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
82719819|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719820|NCT04536532|Entecavir|entecavir|mesh-list
82719821|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
82719822|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719823|NCT04513145|Ropivacaine|ropivacaine|mesh-list
82719824|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
82719825|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
82719826|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719827|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719828|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
82719829|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719830|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
82719831|NCT04509115|Narcotics|narcotics|mesh-ancestor
82719832|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82719833|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719834|NCT04509115|Analgesics|analgesics|mesh-ancestor
82719835|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
82719836|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719837|NCT04508634|Metformin|metformin|mesh-list
82719838|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82719839|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719840|NCT04489771|Belzutifan|belzutifan|mesh-list
82719841|NCT04489771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719842|NCT04480502|Ipilimumab|ipilimumab|mesh-list
82719843|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719844|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719845|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82719846|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719847|NCT04447092|Leucovorin|leucovorin|mesh-list
82719848|NCT04447092|Paclitaxel|paclitaxel|mesh-list
82719849|NCT04447092|Gemcitabine|gemcitabine|mesh-list
82719850|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
82719851|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
82719852|NCT04447092|Irinotecan|irinotecan|mesh-list
82719853|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82719854|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719855|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
82719856|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
82719857|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
82719858|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719859|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82719860|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
82719861|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719862|NCT04447092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82719863|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82719864|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82719865|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719866|NCT04447092|Antidotes|antidotes|mesh-ancestor
82719867|NCT04447092|Protective Agents|protective agents|mesh-ancestor
82719868|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719869|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
82719870|NCT04447092|Vitamins|vitamins|mesh-ancestor
82719871|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
82719872|NCT04433780|Tenofovir|tenofovir|mesh-list
82719873|NCT04433780|Lamivudine|lamivudine|mesh-list
82719874|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
82719875|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719876|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82719877|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82719878|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719879|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719880|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82719881|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82719882|NCT04398524|Cemiplimab|cemiplimab|mesh-list
82719883|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719884|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719885|NCT04371224|Leucovorin|leucovorin|mesh-list
82719886|NCT04371224|Fluorouracil|fluorouracil|mesh-list
82719887|NCT04371224|Capecitabine|capecitabine|mesh-list
82719888|NCT04371224|Irinotecan|irinotecan|mesh-list
82719889|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
82719890|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719891|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82719892|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719893|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82719894|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
82719895|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719896|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82719897|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82719898|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719899|NCT04371224|Antidotes|antidotes|mesh-ancestor
82719900|NCT04371224|Protective Agents|protective agents|mesh-ancestor
82719901|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
82719902|NCT04371224|Vitamins|vitamins|mesh-ancestor
82719903|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
82719904|NCT04306900|Paclitaxel|paclitaxel|mesh-list
82719905|NCT04306900|Docetaxel|docetaxel|mesh-list
82719906|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82719908|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
82719909|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82719910|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719911|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
82719912|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
82719913|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
82719914|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719915|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82719916|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
82719917|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82719918|NCT04306900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82719919|NCT04288687|Niraparib|niraparib|mesh-list
82719920|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82719921|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719922|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719923|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719924|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
82719925|NCT04231708|Yohimbine|yohimbine|mesh-list
82719926|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82719927|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
82719928|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
82719929|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719930|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719931|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82719932|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82719933|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82719934|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
82719935|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82719936|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719937|NCT04231708|Urological Agents|urological agents|mesh-ancestor
82719938|NCT04218786|Colchicine|colchicine|mesh-list
82719939|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
82719940|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82719941|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
82719942|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
82719943|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
82719944|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719945|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719946|NCT04216524|Cytarabine|cytarabine|mesh-list
82719947|NCT04216524|Dexamethasone|dexamethasone|mesh-list
82719948|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
82719949|NCT04216524|Prednisone|prednisone|mesh-list
82719950|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
82719951|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82719952|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82719953|NCT04216524|Prednisolone|prednisolone|mesh-list
82719954|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
82719955|NCT04216524|Cortisone|cortisone|mesh-list
82719956|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
82719957|NCT04216524|Rituximab|rituximab|mesh-list
82719958|NCT04216524|Doxorubicin|doxorubicin|mesh-list
82719959|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82719960|NCT04216524|Methotrexate|methotrexate|mesh-list
82719961|NCT04216524|Vincristine|vincristine|mesh-list
82719962|NCT04216524|Daunorubicin|daunorubicin|mesh-list
82719963|NCT04216524|Venetoclax|venetoclax|mesh-list
82719964|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
82719965|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82719966|NCT04216524|Antibodies|antibodies|mesh-list
82719967|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
82719968|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82719969|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82719970|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
82719971|NCT04216524|BB 1101|bb 1101|mesh-list
82719972|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82719973|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
82719974|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82719975|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82719976|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82719977|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
82719978|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82719979|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82719980|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82719981|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82719982|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
82719983|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
82719984|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82719985|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82719986|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
82719987|NCT04216524|Hormones|hormones|mesh-ancestor
82719988|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82719989|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82719990|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
82719991|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82719992|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82719993|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82719994|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82719995|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82719996|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
82719997|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82719998|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82719999|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
82720000|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
82720001|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82720002|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82720003|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
82720004|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720005|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82720006|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
82720007|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
82720008|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
82720009|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82720010|NCT04216524|Protective Agents|protective agents|mesh-ancestor
82720011|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
82720012|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
82720013|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82720014|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
82720015|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720016|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
82720017|NCT04202692|Protective Agents|protective agents|mesh-ancestor
82720018|NCT04202692|Antacids|antacids|mesh-ancestor
82720019|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720020|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82720021|NCT04177758|Vitamin D|vitamin d|mesh-list
82720022|NCT04177758|Vitamins|vitamins|mesh-ancestor
82720023|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
82720024|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720025|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82720026|NCT04168112|Dexamethasone|dexamethasone|mesh-list
82720027|NCT04168112|Prednisolone|prednisolone|mesh-list
82720028|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82720029|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
82720030|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82720031|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
82720032|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82720033|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
82720034|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82720035|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
82720036|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
82720037|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720038|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720039|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82720040|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
82720041|NCT04168112|Hormones|hormones|mesh-ancestor
82720042|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82720043|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82720044|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720045|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82720046|NCT04168112|Protective Agents|protective agents|mesh-ancestor
82720047|NCT04150458|Choline|choline|mesh-list
82720048|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
82720049|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82720050|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
82720051|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720052|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82720053|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82720054|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
82720055|NCT04147208|Ritonavir|ritonavir|mesh-list
82720056|NCT04147208|Entecavir|entecavir|mesh-list
82720057|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82720058|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82720059|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
82720060|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720135|NCT03941587|Growth Substances|growth substances|mesh-ancestor
82720061|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720062|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82720063|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82720064|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
82720065|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720066|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82720067|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82720068|NCT04140487|Azacitidine|azacitidine|mesh-list
82720069|NCT04140487|Venetoclax|venetoclax|mesh-list
82720070|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720071|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
82720072|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720073|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720074|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720076|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
82720077|NCT04067726|Denosumab|denosumab|mesh-list
82720078|NCT04067726|Calcium|calcium|mesh-list
82720079|NCT04067726|Vitamins|vitamins|mesh-ancestor
82720080|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
82720081|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720082|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82720083|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82720084|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
82720085|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720086|NCT04003103|Islatravir|islatravir|mesh-list
82720087|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
82720088|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720089|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720090|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720091|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82720092|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82720093|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82720094|NCT03999216|Diuretics|diuretics|mesh-list
82720095|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
82720096|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
82720097|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
82720098|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720099|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82720100|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720101|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
82720102|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82720103|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720104|NCT03978611|Ipilimumab|ipilimumab|mesh-list
82720105|NCT03978611|Relatlimab|relatlimab|mesh-list
82720106|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720107|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720108|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82720109|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720110|NCT03945448|Fluconazole|fluconazole|mesh-list
82720111|NCT03945448|Amphotericin B|amphotericin b|mesh-list
82720112|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82720113|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
82720114|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720115|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82720116|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82720117|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720118|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720119|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82720120|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
82720121|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82720122|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720123|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82720124|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82720125|NCT03945448|Amebicides|amebicides|mesh-ancestor
82720126|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82720127|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82720128|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82720129|NCT03941873|Tislelizumab|tislelizumab|mesh-list
82720130|NCT03941873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720131|NCT03941873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720132|NCT03941587|Aflibercept|aflibercept|mesh-list
82720133|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82720134|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82720136|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720137|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
82720138|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720140|NCT03917420|Emtricitabine|emtricitabine|mesh-list
82720141|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82720142|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
82720143|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720144|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82720145|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82720146|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720147|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720148|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82720149|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82720150|NCT03913195|Ibalizumab|ibalizumab|mesh-list
82720151|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82720152|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82720153|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
82720154|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720155|NCT03913104|Mifepristone|mifepristone|mesh-list
82720156|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82720157|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
82720158|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82720159|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720160|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82720161|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82720162|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82720163|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
82720164|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82720165|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82720166|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
82720167|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82720168|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
82720169|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82720170|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82720171|NCT03884556|Paclitaxel|paclitaxel|mesh-list
82720172|NCT03884556|Gemcitabine|gemcitabine|mesh-list
82720173|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
82720174|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82720175|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720176|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
82720177|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
82720178|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
82720179|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720180|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720181|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
82720182|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720183|NCT03884556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82720184|NCT03720119|Lidocaine|lidocaine|mesh-list
82720185|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
82720186|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
82720187|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82720188|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720189|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
82720190|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720191|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82720192|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82720193|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82720194|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82720195|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720196|NCT03713528|Vancomycin|vancomycin|mesh-list
82720197|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82720198|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720199|NCT03705845|Tocotrienols|tocotrienols|mesh-list
82720200|NCT03705845|Vitamin E|vitamin e|mesh-list
82720201|NCT03705845|Tocopherols|tocopherols|mesh-list
82720202|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
82720203|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720204|NCT03705845|Protective Agents|protective agents|mesh-ancestor
82720205|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720206|NCT03705845|Vitamins|vitamins|mesh-ancestor
82720207|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
82720208|NCT03669718|Cemiplimab|cemiplimab|mesh-list
82720209|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720210|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720211|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82720212|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720214|NCT03642990|Niacin|niacin|mesh-list
82720215|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
82720216|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
82720217|NCT03642990|Vitamins|vitamins|mesh-ancestor
82720218|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
82720219|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720220|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82720221|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
82720222|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720223|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82720224|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
82720225|NCT03582475|Cisplatin|cisplatin|mesh-list
82720226|NCT03582475|Carboplatin|carboplatin|mesh-list
82720227|NCT03582475|Docetaxel|docetaxel|mesh-list
82720228|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
82720229|NCT03582475|Etoposide|etoposide|mesh-list
82720230|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
82720231|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
82720232|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720233|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
82720234|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
82720235|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
82720236|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720237|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720238|NCT03582475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82720239|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82720240|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82720241|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82720242|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720243|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
82720244|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
82720245|NCT03579784|Paclitaxel|paclitaxel|mesh-list
82720246|NCT03579784|Durvalumab|durvalumab|mesh-list
82720247|NCT03579784|Olaparib|olaparib|mesh-list
82720248|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82720249|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720250|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
82720251|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
82720252|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
82720253|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720254|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720255|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82720256|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720257|NCT03564678|Folic Acid|folic acid|mesh-list
82720258|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
82720259|NCT03564678|Vitamins|vitamins|mesh-ancestor
82720260|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
82720261|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720262|NCT03564678|Hematinics|hematinics|mesh-ancestor
82720263|NCT03553563|Esomeprazole|esomeprazole|mesh-list
82720264|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82720265|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82720266|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82720267|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720268|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720269|NCT03542760|Methylene Blue|methylene blue|mesh-list
82720270|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720271|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720272|NCT03530397|Paclitaxel|paclitaxel|mesh-list
82720273|NCT03530397|Carboplatin|carboplatin|mesh-list
82720274|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
82720275|NCT03530397|Pemetrexed|pemetrexed|mesh-list
82720276|NCT03530397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82720277|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720278|NCT03530397|Tubulin Modulators|tubulin modulators|mesh-ancestor
82720279|NCT03530397|Antimitotic Agents|antimitotic agents|mesh-ancestor
82720280|NCT03530397|Mitosis Modulators|mitosis modulators|mesh-ancestor
82720281|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720282|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720283|NCT03530397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82720284|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720285|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82720286|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82720287|NCT03515304|Evolocumab|evolocumab|mesh-list
82720288|NCT03515304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82720289|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82720290|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82720291|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
82720292|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720293|NCT03515304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82720294|NCT03515304|Protease Inhibitors|protease inhibitors|mesh-ancestor
82720295|NCT03515304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720296|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82720297|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
82720298|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82720299|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720300|NCT03465540|Dexamethasone|dexamethasone|mesh-list
82720301|NCT03465540|Azacitidine|azacitidine|mesh-list
82720302|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82720303|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
82720304|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
82720305|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720306|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720307|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82720308|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
82720309|NCT03465540|Hormones|hormones|mesh-ancestor
82720310|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82720311|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82720312|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720313|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720314|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
82720315|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720316|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720317|NCT03368547|Edetic Acid|edetic acid|mesh-list
82720318|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82720319|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
82720320|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
82720321|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720322|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
82720323|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82720324|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82720325|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82720326|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720327|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720328|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720329|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82720330|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
82720331|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82720332|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
82720333|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720334|NCT03152890|Insulin|insulin|mesh-list
82720335|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82720336|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720337|NCT03125811|Ethanol|ethanol|mesh-list
82720338|NCT03125811|Ondansetron|ondansetron|mesh-list
82720339|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82720340|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720341|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82720342|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720343|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
82720344|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
82720345|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720346|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82720347|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
82720348|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
82720349|NCT03125811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82720350|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82720351|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
82720352|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720353|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720354|NCT03123029|Venetoclax|venetoclax|mesh-list
82720355|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720356|NCT03117933|Paclitaxel|paclitaxel|mesh-list
82720357|NCT03117933|Olaparib|olaparib|mesh-list
82720358|NCT03117933|Cediranib|cediranib|mesh-list
82720359|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82720360|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720361|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
82720362|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
82720363|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
82720440|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
82720364|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720365|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82720366|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720367|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82720368|NCT03077243|Cisplatin|cisplatin|mesh-list
82720369|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720370|NCT03048877|Apatinib|apatinib|mesh-list
82720371|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720372|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82720373|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720374|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720375|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
82720376|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
82720377|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
82720378|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82720379|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720380|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
82720381|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720382|NCT02940925|Cisplatin|cisplatin|mesh-list
82720383|NCT02940925|Fluorouracil|fluorouracil|mesh-list
82720384|NCT02940925|Capecitabine|capecitabine|mesh-list
82720385|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720386|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
82720387|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720388|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720389|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82720390|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
82720391|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720392|NCT02915705|Vitamin D|vitamin d|mesh-list
82720393|NCT02915705|Vitamins|vitamins|mesh-ancestor
82720394|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
82720395|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720396|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82720397|NCT02891278|Cytarabine|cytarabine|mesh-list
82720398|NCT02891278|Sertraline|sertraline|mesh-list
82720399|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720400|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
82720401|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720402|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720403|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
82720404|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720405|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82720406|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
82720407|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720408|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
82720409|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82720410|NCT02891278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82720411|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82720412|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82720413|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720414|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
82720415|NCT02807181|Cisplatin|cisplatin|mesh-list
82720416|NCT02807181|Gemcitabine|gemcitabine|mesh-list
82720417|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720418|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720419|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
82720420|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720421|NCT02454543|Androgens|androgens|mesh-list
82720422|NCT02454543|Hormones|hormones|mesh-ancestor
82720423|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82720424|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720425|NCT02384512|Rasagiline|rasagiline|mesh-list
82720426|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82720427|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720428|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720429|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82720430|NCT02384512|Protective Agents|protective agents|mesh-ancestor
82720431|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720432|NCT02366494|Docetaxel|docetaxel|mesh-list
82720433|NCT02366494|Leuprolide|leuprolide|mesh-list
82720434|NCT02366494|Goserelin|goserelin|mesh-list
82720435|NCT02366494|Bicalutamide|bicalutamide|mesh-list
82720436|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82720437|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720438|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
82720439|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
82720441|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720442|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82720443|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
82720444|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82720445|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720446|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82720447|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
82720448|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
82720449|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82720450|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
82720451|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82720452|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
82720453|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82720454|NCT02311933|Tamoxifen|tamoxifen|mesh-list
82720455|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82720456|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
82720457|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82720458|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720459|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82720460|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720461|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82720462|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82720463|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82720464|NCT02157610|Nicotine|nicotine|mesh-list
82720465|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82720466|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
82720467|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720468|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720469|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82720470|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82720471|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
82720472|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720473|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720474|NCT02138617|Leucovorin|leucovorin|mesh-list
82720475|NCT02138617|Bevacizumab|bevacizumab|mesh-list
82720476|NCT02138617|Fluorouracil|fluorouracil|mesh-list
82720477|NCT02138617|Irinotecan|irinotecan|mesh-list
82720478|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
82720479|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720480|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720481|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82720482|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82720483|NCT02138617|Growth Substances|growth substances|mesh-ancestor
82720484|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720485|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
82720486|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
82720487|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720488|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720489|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82720490|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
82720491|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82720492|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82720493|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720494|NCT02138617|Antidotes|antidotes|mesh-ancestor
82720495|NCT02138617|Protective Agents|protective agents|mesh-ancestor
82720496|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
82720497|NCT02138617|Vitamins|vitamins|mesh-ancestor
82720498|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
82720499|NCT02078869|Progesterone|progesterone|mesh-list
82720500|NCT02078869|Progestins|progestins|mesh-ancestor
82720501|NCT02078869|Hormones|hormones|mesh-ancestor
82720502|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82720503|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720504|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
82720505|NCT02070705|Hematinics|hematinics|mesh-ancestor
82720506|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82720507|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82720508|NCT01946815|Atorvastatin|atorvastatin|mesh-list
82720509|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82720510|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82720511|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
82720512|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720513|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82720514|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82720515|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720516|NCT01937156|Granisetron|granisetron|mesh-list
82720517|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
82720518|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
82720519|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720520|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720521|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82720522|NCT01937156|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82720523|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82720525|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720526|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720527|NCT01805804|Valsartan|valsartan|mesh-list
82720528|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82720529|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82720530|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82720531|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720532|NCT01718873|Leucovorin|leucovorin|mesh-list
82720533|NCT01718873|Folic Acid|folic acid|mesh-list
82720534|NCT01718873|Bevacizumab|bevacizumab|mesh-list
82720535|NCT01718873|Fluorouracil|fluorouracil|mesh-list
82720536|NCT01718873|Capecitabine|capecitabine|mesh-list
82720537|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
82720538|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
82720539|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720540|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720541|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82720542|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82720543|NCT01718873|Growth Substances|growth substances|mesh-ancestor
82720544|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720545|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
82720546|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
82720547|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720548|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720549|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82720550|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
82720551|NCT01718873|Antidotes|antidotes|mesh-ancestor
82720552|NCT01718873|Protective Agents|protective agents|mesh-ancestor
82720553|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
82720554|NCT01718873|Vitamins|vitamins|mesh-ancestor
82720555|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
82720556|NCT01718873|Hematinics|hematinics|mesh-ancestor
82720557|NCT01612351|Paclitaxel|paclitaxel|mesh-list
82720558|NCT01612351|Cisplatin|cisplatin|mesh-list
82720559|NCT01612351|Carboplatin|carboplatin|mesh-list
82720560|NCT01612351|Lapatinib|lapatinib|mesh-list
82720561|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82720562|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720563|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
82720564|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
82720565|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
82720566|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720567|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82720568|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720569|NCT01424566|Nabiximols|nabiximols|mesh-list
82720570|NCT01424566|Analgesics|analgesics|mesh-ancestor
82720571|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
82720572|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720573|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720574|NCT01367561|Naloxone|naloxone|mesh-list
82720575|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
82720576|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82720577|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720578|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
82720579|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720580|NCT01361607|Nabiximols|nabiximols|mesh-list
82720581|NCT01361607|Analgesics|analgesics|mesh-ancestor
82720582|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
82720583|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720584|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720585|NCT01337089|Nabiximols|nabiximols|mesh-list
82720586|NCT01337089|Analgesics|analgesics|mesh-ancestor
82720587|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
82720588|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720589|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720590|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
82720591|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
82720592|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82720593|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720594|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82720595|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82720596|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
82720597|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82720598|NCT01276587|Vitamin D|vitamin d|mesh-list
82720599|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
82720600|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
82720601|NCT01276587|Vitamins|vitamins|mesh-list
82720602|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
82720603|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720604|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82720605|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82720606|NCT01217580|Ropivacaine|ropivacaine|mesh-list
82720607|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
82720608|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
82720609|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82720610|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720611|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
82720612|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720613|NCT00802646|Epinephrine|epinephrine|mesh-list
82720614|NCT00802646|Fentanyl|fentanyl|mesh-list
82720615|NCT00802646|Bupivacaine|bupivacaine|mesh-list
82720616|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
82720617|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
82720618|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82720619|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720620|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
82720621|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720622|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82720623|NCT00802646|Narcotics|narcotics|mesh-ancestor
82720624|NCT00802646|Analgesics|analgesics|mesh-ancestor
82720625|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82720626|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82720627|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
82720628|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82720629|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82720630|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
82720631|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720632|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720633|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82720634|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82720635|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
82720636|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82720637|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
82720638|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
82720639|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
82720640|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82720641|NCT00473707|Oxytocin|oxytocin|mesh-list
82720642|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
82720643|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82720644|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720645|NCT00233675|Tiagabine|tiagabine|mesh-list
82720646|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
82720647|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
82720648|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82720649|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82720650|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720651|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
82720652|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720653|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720654|NCT00202774|Fluorouracil|fluorouracil|mesh-list
82720655|NCT00202774|Capecitabine|capecitabine|mesh-list
82720656|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
82720657|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
82720658|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720659|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720660|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720661|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82720662|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
82720663|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720664|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
82720665|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82720666|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
82720667|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720668|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82720669|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82720670|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
82720671|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720672|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720673|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82720674|NCT00107744|Caseins|caseins|mesh-list
82720675|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
82720676|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
82720677|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720678|NCT00845338|Darifenacin|darifenacin|mesh-list
82720679|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82720680|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82720681|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
82720682|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720683|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720684|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720685|NCT00845338|Urological Agents|urological agents|mesh-ancestor
82720686|NCT00923962|Adenosine|adenosine|mesh-list
82720687|NCT00923962|Glucagon|glucagon|mesh-list
82720688|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82720689|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82720690|NCT00923962|Hormones|hormones|mesh-ancestor
82720691|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82720692|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720693|NCT00923962|Incretins|incretins|mesh-ancestor
82720694|NCT00923962|Analgesics|analgesics|mesh-ancestor
82720695|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
82720696|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720697|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82720698|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
82720699|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82720700|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
82720701|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
82720702|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720703|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720704|NCT02575092|Folic Acid|folic acid|mesh-list
82720705|NCT02575092|Enalapril|enalapril|mesh-list
82720706|NCT02575092|Enalaprilat|enalaprilat|mesh-list
82720707|NCT02575092|Maleic acid|maleic acid|mesh-list
82720708|NCT02575092|Hematinics|hematinics|mesh-ancestor
82720709|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
82720710|NCT02575092|Vitamins|vitamins|mesh-ancestor
82720711|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
82720712|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720713|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720714|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720715|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82720716|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
82720717|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82720718|NCT04097470|Decitabine|decitabine|mesh-list
82720719|NCT04097470|Midostaurin|midostaurin|mesh-list
82720720|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720721|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
82720722|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720723|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720724|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720725|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82720726|NCT04041934|Tryptophan|tryptophan|mesh-list
82720727|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82720728|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
82720729|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82720730|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82720731|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82720732|NCT00845572|Risperidone|risperidone|mesh-list
82720733|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82720734|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
82720735|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720736|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720737|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720738|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82720739|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82720740|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82720741|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82720742|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82720743|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
82720744|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
82720745|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
82720746|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82720747|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82720749|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82720750|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82720751|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720752|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82720753|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720754|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720755|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82720756|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82720757|NCT04502550|Propofol|propofol|mesh-list
82720758|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82720759|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82720760|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720761|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82720762|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
82720763|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
82720764|NCT04227184|Trospium chloride|trospium chloride|mesh-list
82720765|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
82720766|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
82720767|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720768|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720769|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82720770|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82720771|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
82720772|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720773|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720774|NCT04227184|Urological Agents|urological agents|mesh-ancestor
82720775|NCT04018950|Durlobactam|durlobactam|mesh-list
82720776|NCT04018950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82720777|NCT04018950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720778|NCT04018950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720779|NCT04018950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82720780|NCT04018950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720781|NCT02545972|Tacrolimus|tacrolimus|mesh-list
82720782|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82720783|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
82720784|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720785|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82720786|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720787|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720788|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
82720789|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82720790|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82720791|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720792|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82720793|NCT00852046|Analgesics|analgesics|mesh-ancestor
82720794|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
82720795|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720796|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82720797|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82720798|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82720799|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
82720800|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720801|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720802|NCT02573064|Vancomycin|vancomycin|mesh-list
82720803|NCT02573064|Colistin|colistin|mesh-list
82720804|NCT02573064|Tigecycline|tigecycline|mesh-list
82720805|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82720806|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720807|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82720808|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720809|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720810|NCT00845884|Bevacizumab|bevacizumab|mesh-list
82720811|NCT00845884|Cisplatin|cisplatin|mesh-list
82720812|NCT00845884|Docetaxel|docetaxel|mesh-list
82720813|NCT00845884|Capecitabine|capecitabine|mesh-list
82720814|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720815|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720816|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82720817|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82720818|NCT00845884|Growth Substances|growth substances|mesh-ancestor
82720819|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720820|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
82720821|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
82720822|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
82720823|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
82720824|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720825|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720826|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
82720827|NCT00923806|Aldesleukin|aldesleukin|mesh-list
82720828|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720829|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82720830|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82720831|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
82720832|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720833|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82720834|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
82720835|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82720836|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
82720837|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82720838|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82720839|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
82720840|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720841|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82720842|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82720843|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720844|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720845|NCT00712062|Pemetrexed|pemetrexed|mesh-list
82720846|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720847|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720848|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720849|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82720850|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82720851|NCT00712140|Trastuzumab|trastuzumab|mesh-list
82720852|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720853|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720854|NCT02545738|Liraglutide|liraglutide|mesh-list
82720855|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82720856|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720857|NCT02545738|Incretins|incretins|mesh-ancestor
82720858|NCT02545738|Hormones|hormones|mesh-ancestor
82720859|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82720860|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
82720861|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82720862|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
82720863|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720864|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720865|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82720866|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
82720867|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82720868|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
82720869|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720870|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720871|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82720872|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
82720873|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
82720874|NCT00848302|Protective Agents|protective agents|mesh-ancestor
82720875|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
82720876|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82720877|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
82720878|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720879|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82720880|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82720881|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
82720882|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720883|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720884|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82720885|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
82720886|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
82720887|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82720888|NCT00712374|Amodiaquine|amodiaquine|mesh-list
82720889|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
82720890|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82720891|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82720892|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720893|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82720894|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720895|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720896|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82720897|NCT02573220|Leucovorin|leucovorin|mesh-list
82720898|NCT02573220|Fluorouracil|fluorouracil|mesh-list
82720899|NCT02573220|Irinotecan|irinotecan|mesh-list
82720900|NCT02573220|Cetuximab|cetuximab|mesh-list
82720901|NCT02573220|Camptothecin|camptothecin|mesh-list
82720902|NCT02573220|Calcium|calcium|mesh-list
82720903|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
82720904|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82720905|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720906|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
82720907|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720908|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82720909|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720910|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82720911|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
82720912|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82720913|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82720914|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720915|NCT02573220|Antidotes|antidotes|mesh-ancestor
82720916|NCT02573220|Protective Agents|protective agents|mesh-ancestor
82720917|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
82720919|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
82720920|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82720921|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82720922|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
82720923|NCT00712452|Vinblastine|vinblastine|mesh-list
82720924|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82720925|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
82720926|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720927|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82720928|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82720929|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
82720930|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720931|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720932|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82720933|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82720934|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
82720935|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
82720936|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
82720937|NCT00618982|Sorafenib|sorafenib|mesh-list
82720938|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720939|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82720940|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720941|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720942|NCT02544880|Tadalafil|tadalafil|mesh-list
82720943|NCT02544880|Vaccines|vaccines|mesh-list
82720944|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
82720945|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720946|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
82720947|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82720948|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82720949|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82720950|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720951|NCT02544880|Urological Agents|urological agents|mesh-ancestor
82720952|NCT00856570|Warfarin|warfarin|mesh-list
82720953|NCT00856570|Mirabegron|mirabegron|mesh-list
82720954|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
82720955|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82720956|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82720957|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82720958|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
82720959|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82720960|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720961|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720962|NCT00856570|Urological Agents|urological agents|mesh-ancestor
82720963|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
82720964|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82720965|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720966|NCT00856804|Ribavirin|ribavirin|mesh-list
82720967|NCT00856804|Thalidomide|thalidomide|mesh-list
82720968|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
82720969|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720970|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
82720971|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82720972|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82720973|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
82720974|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720975|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
82720976|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82720977|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82720978|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82720979|NCT00856804|Growth Substances|growth substances|mesh-ancestor
82720980|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
82720981|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82720983|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
82720984|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
82720985|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82720986|NCT00712686|Olanzapine|olanzapine|mesh-list
82720987|NCT00712686|Aripiprazole|aripiprazole|mesh-list
82720988|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
82720989|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
82720990|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82720991|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82720992|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82720993|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82720994|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82720995|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82720996|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82720997|NCT00712686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82720998|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82720999|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82721000|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721001|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721002|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
82721003|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
82721004|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
82721005|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
82721006|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82721007|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82721008|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82721009|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82721010|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82721011|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82721012|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
82721013|NCT04041856|Povidone|povidone|mesh-list
82721014|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
82721015|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
82721016|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82721017|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721018|NCT00856960|Losartan|losartan|mesh-list
82721019|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82721020|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82721021|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82721022|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82721023|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721024|NCT00712764|Adenosine|adenosine|mesh-list
82721025|NCT00712764|Analgesics|analgesics|mesh-ancestor
82721026|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
82721027|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721028|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721029|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82721030|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
82721031|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82721032|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
82721033|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
82721034|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721035|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721036|NCT00848458|Azelaic acid|azelaic acid|mesh-list
82721037|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721038|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
82721039|NCT00578786|Ambrisentan|ambrisentan|mesh-list
82721040|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82721042|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721043|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82721044|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721045|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721046|NCT02574156|Insulin|insulin|mesh-list
82721047|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82721048|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721049|NCT00848692|Rituximab|rituximab|mesh-list
82721050|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82721051|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721052|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
82721053|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721054|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82721055|NCT00848770|Norepinephrine|norepinephrine|mesh-list
82721056|NCT00848770|Esmolol|esmolol|mesh-list
82721057|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82721058|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82721059|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
82721060|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721061|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721062|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721063|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
82721064|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
82721065|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721066|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82721067|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82721068|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82721069|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82721070|NCT00717704|Dasatinib|dasatinib|mesh-list
82721071|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721072|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82721073|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721074|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721075|NCT00620074|Voriconazole|voriconazole|mesh-list
82721076|NCT00620074|Anidulafungin|anidulafungin|mesh-list
82721077|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
82721078|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721079|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82721080|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82721081|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721082|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721083|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82721084|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
82721085|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82721086|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721087|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82721088|NCT02571296|Progesterone|progesterone|mesh-list
82721089|NCT02571296|Progestins|progestins|mesh-ancestor
82721090|NCT02571296|Hormones|hormones|mesh-ancestor
82721091|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82721092|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721093|NCT00857038|Doxycycline|doxycycline|mesh-list
82721094|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82721095|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721096|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
82721097|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82721098|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82721099|NCT00857116|Albendazole|albendazole|mesh-list
82721100|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
82721101|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82721102|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721103|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
82721104|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82721105|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82721106|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
82721107|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
82721108|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
82721109|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721110|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721111|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
82721112|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82721113|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82721114|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721115|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
82721116|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721117|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721118|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
82721119|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
82721120|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82721121|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82721122|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721123|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721124|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721125|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82721127|NCT00717938|Etoposide|etoposide|mesh-list
82721128|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
82721129|NCT00717938|Cisplatin|cisplatin|mesh-list
82721130|NCT00717938|Enoxaparin|enoxaparin|mesh-list
82721131|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
82721132|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721133|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82721134|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82721135|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82721136|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721137|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721138|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
82721139|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82721140|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82721141|NCT00857428|Oxymorphone|oxymorphone|mesh-list
82721142|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82721143|NCT00857428|Narcotics|narcotics|mesh-ancestor
82721144|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721145|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721146|NCT00857428|Analgesics|analgesics|mesh-ancestor
82721147|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
82721148|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721149|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82721150|NCT04018768|Acetaminophen|acetaminophen|mesh-list
82721152|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82721153|NCT04018768|Oxycodone|oxycodone|mesh-list
82721154|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82721155|NCT04018768|Analgesics|analgesics|mesh-ancestor
82721156|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
82721157|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721158|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721159|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
82721160|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82721161|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82721162|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82721163|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82721164|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721165|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721166|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82721167|NCT04018768|Narcotics|narcotics|mesh-ancestor
82721168|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721169|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
82721170|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82721171|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82721172|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
82721173|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721174|NCT00848848|Vaccines|vaccines|mesh-list
82721175|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
82721176|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721177|NCT02573922|Oxycodone|oxycodone|mesh-list
82721178|NCT02573922|Naloxone|naloxone|mesh-list
82721179|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82721180|NCT02573922|Narcotics|narcotics|mesh-ancestor
82721181|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721182|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721183|NCT02573922|Analgesics|analgesics|mesh-ancestor
82721184|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
82721185|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721186|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82721187|NCT00852436|Pregabalin|pregabalin|mesh-list
82721188|NCT00852436|Analgesics|analgesics|mesh-ancestor
82721189|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
82721190|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721191|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721192|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
82721193|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82721194|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82721195|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721196|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82721197|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82721198|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82721199|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721200|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82721201|NCT00720512|Leucovorin|leucovorin|mesh-list
82721202|NCT00720512|Bevacizumab|bevacizumab|mesh-list
82721203|NCT00720512|Fluorouracil|fluorouracil|mesh-list
82721204|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
82721205|NCT00720512|Irinotecan|irinotecan|mesh-list
82721206|NCT00720512|Calcium|calcium|mesh-list
82721207|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
82721208|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82721209|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721210|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82721211|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82721212|NCT00720512|Growth Substances|growth substances|mesh-ancestor
82721213|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721214|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
82721215|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82721216|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
82721217|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721218|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82721219|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721220|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
82721221|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82721222|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82721223|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721224|NCT00720512|Antidotes|antidotes|mesh-ancestor
82721225|NCT00720512|Protective Agents|protective agents|mesh-ancestor
82721226|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
82721227|NCT00720512|Vitamins|vitamins|mesh-ancestor
82721228|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
82721229|NCT04069286|Amoxicillin|amoxicillin|mesh-list
82721230|NCT04069286|Omeprazole|omeprazole|mesh-list
82721231|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82721232|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721233|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82721234|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82721235|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82721236|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721237|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721238|NCT00713622|Zonisamide|zonisamide|mesh-list
82721239|NCT00713622|Valproic Acid|valproic acid|mesh-list
82721240|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
82721241|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721242|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721243|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
82721244|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721245|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721246|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
82721247|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82721248|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721249|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82721250|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82721251|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82721252|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82721253|NCT00718172|Ribavirin|ribavirin|mesh-list
82721254|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
82721255|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721256|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
82721257|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721258|NCT00720018|Sumatriptan|sumatriptan|mesh-list
82721259|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82721260|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82721261|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82721262|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
82721263|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721264|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721265|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721266|NCT03992456|Trifluridine|trifluridine|mesh-list
82721267|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82721268|NCT03992456|Panitumumab|panitumumab|mesh-list
82721269|NCT03992456|Antibodies|antibodies|mesh-list
82721270|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
82721271|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82721272|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
82721273|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721274|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721275|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
82721276|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721277|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
82721278|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721279|NCT00618826|Paclitaxel|paclitaxel|mesh-list
82721280|NCT00618826|Gemcitabine|gemcitabine|mesh-list
82721281|NCT00618826|Bevacizumab|bevacizumab|mesh-list
82721282|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82721283|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721284|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
82721285|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
82721286|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
82721287|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721288|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82721290|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82721291|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82721292|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82721293|NCT00618826|Growth Substances|growth substances|mesh-ancestor
82721294|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721295|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
82721296|NCT00720174|Doxorubicin|doxorubicin|mesh-list
82721297|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82721298|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82721299|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82721300|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721301|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82721302|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82721303|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721304|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721305|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
82721306|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721307|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82721308|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
82721309|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721310|NCT03834740|Everolimus|everolimus|mesh-list
82721311|NCT03834740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82721312|NCT03834740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82721313|NCT03834740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721314|NCT03834740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721315|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721316|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
82721317|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721318|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721319|NCT00849082|Goserelin|goserelin|mesh-list
82721320|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
82721321|NCT00849082|Cyproterone|cyproterone|mesh-list
82721322|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82721323|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721324|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
82721325|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
82721326|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82721327|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721328|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82721329|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
82721330|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82721331|NCT00849160|Darunavir|darunavir|mesh-list
82721332|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82721333|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82721334|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
82721335|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721336|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721337|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82721338|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82721339|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
82721340|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721341|NCT00720590|Ritonavir|ritonavir|mesh-list
82721342|NCT00720590|Lopinavir|lopinavir|mesh-list
82721343|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82721344|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82721345|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82721346|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
82721347|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721348|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721349|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82721350|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82721351|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
82721352|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721353|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82721354|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82721355|NCT00718406|Metoprolol|metoprolol|mesh-list
82721356|NCT00718406|Morphine|morphine|mesh-list
82721357|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82721358|NCT00718406|Narcotics|narcotics|mesh-ancestor
82721359|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721360|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721361|NCT00718406|Analgesics|analgesics|mesh-ancestor
82721362|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
82721363|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721364|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82721365|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82721366|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
82721367|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
82721368|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82721369|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82721370|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82721371|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
82721372|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721373|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721374|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
82721375|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82721376|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721377|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82721378|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
82721379|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82721380|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721381|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721382|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721383|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
82721384|NCT00720408|Tacrolimus|tacrolimus|mesh-list
82721385|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721386|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
82721387|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721388|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82721389|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721390|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721391|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82721392|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721393|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82721394|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
82721395|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82721396|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721397|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
82721398|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82721399|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721400|NCT00852670|Ponesimod|ponesimod|mesh-list
82721401|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82721402|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721403|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721404|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
82721405|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721406|NCT00717210|Temozolomide|temozolomide|mesh-list
82721407|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82721408|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
82721409|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721410|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721411|NCT00723086|Docetaxel|docetaxel|mesh-list
82721412|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721413|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
82721414|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
82721415|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
82721416|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721417|NCT04018378|Varenicline|varenicline|mesh-list
82721418|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82721419|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82721420|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
82721421|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721422|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721423|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721424|NCT00849550|Bevacizumab|bevacizumab|mesh-list
82721425|NCT00849550|Capecitabine|capecitabine|mesh-list
82721426|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
82721427|NCT00849550|Everolimus|everolimus|mesh-list
82721428|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82721429|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721430|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82721431|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82721432|NCT00849550|Growth Substances|growth substances|mesh-ancestor
82721433|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721434|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
82721435|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82721436|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
82721437|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721438|NCT00849550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82721439|NCT00849550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82721440|NCT00849550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721441|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721442|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
82721444|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
82721445|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82721446|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721447|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82721448|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82721449|NCT03816488|Analgesics|analgesics|mesh-ancestor
82721450|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
82721451|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721452|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82721453|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82721454|NCT00858676|Acarbose|acarbose|mesh-list
82721455|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82721456|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721457|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721458|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82721459|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721460|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
82721461|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82721462|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721463|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
82721464|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721465|NCT00723164|Fentanyl|fentanyl|mesh-list
82721466|NCT00723164|Midazolam|midazolam|mesh-list
82721467|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82721468|NCT00723164|Narcotics|narcotics|mesh-ancestor
82721469|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721470|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721471|NCT00723164|Analgesics|analgesics|mesh-ancestor
82721472|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
82721473|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721474|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82721475|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82721476|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
82721477|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
82721478|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82721479|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82721480|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82721481|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82721482|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
82721483|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
82721484|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721485|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721486|NCT00723242|Ribavirin|ribavirin|mesh-list
82721487|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
82721488|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721489|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
82721490|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721491|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
82721492|NCT02545426|Calcium|calcium|mesh-list
82721493|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82721494|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721495|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82721496|NCT00720824|Anesthetics|anesthetics|mesh-list
82721497|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82721498|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
82721499|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721500|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721501|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
82721502|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721503|NCT05373134|Pentoxifylline|pentoxifylline|mesh-list
82721504|NCT05373134|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82721505|NCT05373134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721654|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
82721506|NCT05373134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721507|NCT05373134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82721508|NCT05373134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82721509|NCT05373134|Protective Agents|protective agents|mesh-ancestor
82721510|NCT05373134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721511|NCT05373134|Vasodilator Agents|vasodilator agents|mesh-ancestor
82721512|NCT05373134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82721514|NCT00723320|Atorvastatin|atorvastatin|mesh-list
82721515|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82721516|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82721517|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
82721518|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721519|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82721520|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82721521|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721522|NCT00578448|Abatacept|abatacept|mesh-list
82721523|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82721524|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721525|NCT00578448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82721526|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721527|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721528|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
82721529|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721530|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82721531|NCT00720564|Temozolomide|temozolomide|mesh-list
82721532|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
82721533|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82721534|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
82721535|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721536|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721537|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82721538|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82721539|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82721540|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82721541|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721542|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721543|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721544|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82721545|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
82721546|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82721547|NCT04067024|Anesthetics|anesthetics|mesh-list
82721548|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721549|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721550|NCT00618748|Olanzapine|olanzapine|mesh-list
82721551|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
82721552|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
82721553|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721554|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721555|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82721556|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82721557|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82721558|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721559|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82721560|NCT00618748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82721561|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82721562|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82721563|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721564|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721565|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
82721566|NCT04067102|Paclitaxel|paclitaxel|mesh-list
82721567|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82721568|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
82721569|NCT04067102|Carboplatin|carboplatin|mesh-list
82721570|NCT04067102|Epirubicin|epirubicin|mesh-list
82721571|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82721572|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721573|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
82721574|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
82721575|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
82721576|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721577|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721578|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
82721579|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721580|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82721581|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82721582|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
82721583|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82721584|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82721585|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82721586|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82721587|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721588|NCT05659290|Bevacizumab|bevacizumab|mesh-list
82721589|NCT05659290|Capecitabine|capecitabine|mesh-list
82721590|NCT05659290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82721591|NCT05659290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721592|NCT05659290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82721593|NCT05659290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82721594|NCT05659290|Growth Substances|growth substances|mesh-ancestor
82721595|NCT05659290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721596|NCT05659290|Growth Inhibitors|growth inhibitors|mesh-ancestor
82721597|NCT05659290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82721598|NCT05659290|Antimetabolites|antimetabolites|mesh-ancestor
82721599|NCT05659290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721600|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
82721601|NCT00717678|Tacrolimus|tacrolimus|mesh-list
82721602|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721603|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
82721604|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721605|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82721606|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721607|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721608|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82721609|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721610|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82721611|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
82721612|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82721613|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721615|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
82721616|NCT02571842|Prednisolone|prednisolone|mesh-list
82721617|NCT02571842|Rituximab|rituximab|mesh-list
82721618|NCT02571842|Enalapril|enalapril|mesh-list
82721619|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82721620|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721621|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
82721622|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721623|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82721624|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82721625|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
82721626|NCT02571842|Hormones|hormones|mesh-ancestor
82721627|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82721628|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82721629|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82721630|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
82721631|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721632|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721633|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82721634|NCT02546284|Lenzilumab|lenzilumab|mesh-list
82721635|NCT02546284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82721636|NCT00721448|Ticagrelor|ticagrelor|mesh-list
82721637|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82721638|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82721639|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82721640|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82721641|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
82721642|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721643|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721644|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721645|NCT00853216|Oxycodone|oxycodone|mesh-list
82721646|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82721647|NCT00853216|Narcotics|narcotics|mesh-ancestor
82721648|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721649|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721650|NCT00853216|Analgesics|analgesics|mesh-ancestor
82721651|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
82721652|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721653|NCT04961528|Terlipressin|terlipressin|mesh-list
82721655|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82721656|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82721657|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721658|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
82721659|NCT04961528|Coagulants|coagulants|mesh-ancestor
82721660|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82721661|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82721662|NCT00721032|Amiodarone|amiodarone|mesh-list
82721663|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82721664|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
82721665|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82721666|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82721667|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721668|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82721669|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82721670|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82721671|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721672|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82721673|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82721674|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82721675|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82721676|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82721677|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82721678|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721679|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721680|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82721681|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82721682|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721683|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
82721684|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721685|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
82721686|NCT00853294|Hydrocodone|hydrocodone|mesh-list
82721687|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721688|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82721689|NCT00853294|Narcotics|narcotics|mesh-ancestor
82721690|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721691|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721692|NCT00853294|Analgesics|analgesics|mesh-ancestor
82721693|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
82721694|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721695|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
82721696|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
82721697|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
82721698|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
82721699|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82721700|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
82721701|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
82721702|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721703|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82721704|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
82721705|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82721706|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
82721707|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721708|NCT00717834|Formaldehyde|formaldehyde|mesh-list
82721709|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
82721710|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721711|NCT00658359|Cyclosporine|cyclosporine|mesh-list
82721712|NCT00658359|Cyclosporins|cyclosporins|mesh-list
82721713|NCT00658359|Tofacitinib|tofacitinib|mesh-list
82721714|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721715|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721716|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721717|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
82721718|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721719|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
82721720|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721721|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
82721722|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82721723|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82721724|NCT00658359|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82721725|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82721726|NCT00853450|Clopidogrel|clopidogrel|mesh-list
82721727|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82721728|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82721729|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82721730|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82721731|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
82721732|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721733|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721734|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721735|NCT04066790|Paclitaxel|paclitaxel|mesh-list
82721736|NCT04066790|Trastuzumab|trastuzumab|mesh-list
82721737|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82721738|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721739|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
82721740|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
82721741|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
82721742|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721743|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82721744|NCT00721526|Disulfiram|disulfiram|mesh-list
82721745|NCT00721526|Lorazepam|lorazepam|mesh-list
82721746|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
82721747|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
82721748|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
82721749|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721750|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721751|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82721752|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82721753|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82721754|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82721755|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82721756|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82721757|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
82721758|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
82721759|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721760|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721761|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82721762|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82721763|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721764|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
82721765|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
82721766|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
82721767|NCT02571192|Volixibat|volixibat|mesh-list
82721768|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82721769|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
82721770|NCT00724022|Prednisolone|prednisolone|mesh-list
82721771|NCT00724022|Tacrolimus|tacrolimus|mesh-list
82721772|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
82721773|NCT00724022|Basiliximab|basiliximab|mesh-list
82721774|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721775|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
82721776|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721777|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82721778|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721779|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721780|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82721781|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
82721782|NCT00724022|Hormones|hormones|mesh-ancestor
82721783|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82721784|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82721785|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721786|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82721787|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82721788|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
82721789|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82721790|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721791|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
82721792|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82721793|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721794|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82721795|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82721796|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721797|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721798|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721799|NCT00717990|Bevacizumab|bevacizumab|mesh-list
82721800|NCT00717990|Capecitabine|capecitabine|mesh-list
82721801|NCT00717990|Irinotecan|irinotecan|mesh-list
82721802|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82721803|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721804|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82721805|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82721806|NCT00717990|Growth Substances|growth substances|mesh-ancestor
82721807|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721808|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
82721809|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82721810|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
82721811|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721812|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82721813|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82721814|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721815|NCT02572986|Permethrin|permethrin|mesh-list
82721816|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721817|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721819|NCT00853684|Endostar protein|endostar protein|mesh-list
82721820|NCT00853684|Endostatins|endostatins|mesh-list
82721821|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82721822|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
82721823|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721824|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721825|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82721826|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82721827|NCT00853684|Growth Substances|growth substances|mesh-ancestor
82721828|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721829|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
82721830|NCT00723060|Escitalopram|escitalopram|mesh-list
82721831|NCT00723060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82721832|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82721833|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82721834|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721835|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721836|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
82721837|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721838|NCT02571140|Teriparatide|teriparatide|mesh-list
82721839|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
82721840|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82721841|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721842|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82721843|NCT00723216|Enoxaparin|enoxaparin|mesh-list
82721844|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
82721845|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82721846|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82721847|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721848|NCT00724178|Vitamin D|vitamin d|mesh-list
82721849|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
82721850|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
82721851|NCT00724178|Calcium|calcium|mesh-list
82721852|NCT00724178|Vitamins|vitamins|mesh-ancestor
82721853|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
82721854|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721855|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82721856|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82721857|NCT00724178|Antacids|antacids|mesh-ancestor
82721858|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721859|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82721860|NCT02546050|Metformin|metformin|mesh-list
82721861|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82721862|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721863|NCT04800224|Propolis|propolis|mesh-list
82721864|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721865|NCT00718146|Vaccines|vaccines|mesh-list
82721866|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
82721867|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721868|NCT00860626|Interferons|interferons|mesh-list
82721869|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721870|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
82721871|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721872|NCT00724256|Ceftibuten|ceftibuten|mesh-list
82721873|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82721874|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721875|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
82721876|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82721877|NCT01005914|Cytarabine|cytarabine|mesh-list
82721878|NCT01005914|Dexamethasone|dexamethasone|mesh-list
82721879|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
82721880|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82721881|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82721882|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
82721883|NCT01005914|Doxorubicin|doxorubicin|mesh-list
82721884|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82721885|NCT01005914|Methotrexate|methotrexate|mesh-list
82721886|NCT01005914|Vincristine|vincristine|mesh-list
82721887|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
82721888|NCT01005914|Asparaginase|asparaginase|mesh-list
82721889|NCT01005914|Pegaspargase|pegaspargase|mesh-list
82721890|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721891|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
82721892|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721893|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82721894|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82721895|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
82721896|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721897|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721898|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82721899|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82721900|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
82721901|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
82721902|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721903|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82721904|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
82721905|NCT01005914|Hormones|hormones|mesh-ancestor
82721906|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82721907|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82721908|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82721909|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82721910|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82721911|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82721912|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82721913|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
82721914|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82721915|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82721916|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
82721917|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
82721918|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82721919|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82721920|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
82721921|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721922|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82721923|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
82721924|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
82721925|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
82721926|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82721927|NCT01005914|Protective Agents|protective agents|mesh-ancestor
82721928|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82721929|NCT00854230|Naltrexone|naltrexone|mesh-list
82721930|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82721931|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82721932|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721933|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
82721934|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721935|NCT00861016|Metoprolol|metoprolol|mesh-list
82721936|NCT00861016|Felodipine|felodipine|mesh-list
82721937|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82721938|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82721939|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
82721940|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
82721941|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721942|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721943|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82721944|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82721945|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82721946|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
82721947|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82721948|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721949|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82721950|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82721951|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82721952|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
82721953|NCT00721916|Leucovorin|leucovorin|mesh-list
82721954|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
82721955|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721956|NCT00721916|Antidotes|antidotes|mesh-ancestor
82721957|NCT00721916|Protective Agents|protective agents|mesh-ancestor
82721958|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721959|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
82721960|NCT00721916|Vitamins|vitamins|mesh-ancestor
82721961|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
82721962|NCT00861250|Dexamethasone|dexamethasone|mesh-list
82721963|NCT00861250|Bortezomib|bortezomib|mesh-list
82721964|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82721965|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
82721966|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
82721967|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82721968|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721969|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82721970|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
82721971|NCT00861250|Hormones|hormones|mesh-ancestor
82721972|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82721973|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82721974|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721975|NCT00722150|Artesunate|artesunate|mesh-list
82721976|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
82721977|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82721978|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82721979|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82721980|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721981|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
82721982|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
82721983|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82721984|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
82721985|NCT00861094|Leucovorin|leucovorin|mesh-list
82721986|NCT00861094|Folic Acid|folic acid|mesh-list
82721987|NCT00861094|Fluorouracil|fluorouracil|mesh-list
82721988|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
82721989|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
82721990|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82721991|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
82721992|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82721993|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82721994|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82721995|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
82721996|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82721997|NCT00861094|Antidotes|antidotes|mesh-ancestor
82721998|NCT00861094|Protective Agents|protective agents|mesh-ancestor
82721999|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
82722000|NCT00861094|Vitamins|vitamins|mesh-ancestor
82722001|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
82722002|NCT00861094|Hematinics|hematinics|mesh-ancestor
82722003|NCT00807261|Gemcitabine|gemcitabine|mesh-list
82722004|NCT00807261|Docetaxel|docetaxel|mesh-list
82722005|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82722006|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
82722007|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722008|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722009|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
82722010|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
82722011|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
82722012|NCT04019106|Budesonide|budesonide|mesh-list
82722013|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82722014|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82722015|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82722016|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
82722017|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722018|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722019|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82722020|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
82722021|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
82722022|NCT04019106|Hormones|hormones|mesh-ancestor
82722023|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82722024|NCT02571608|Metformin|metformin|mesh-list
82722025|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82722026|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722027|NCT00865072|Metformin|metformin|mesh-list
82722028|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82722029|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722030|NCT00804297|Octreotide|octreotide|mesh-list
82722031|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722032|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82722033|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722034|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
82722035|NCT00861328|Irinotecan|irinotecan|mesh-list
82722036|NCT00861328|Camptothecin|camptothecin|mesh-list
82722037|NCT00861328|ON 01910|on 01910|mesh-list
82722038|NCT00861328|Glycine|glycine|mesh-list
82722039|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722040|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82722041|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82722042|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722043|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722044|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82722045|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82722046|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
82722047|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722048|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722049|NCT00861406|Interferons|interferons|mesh-list
82722050|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
82722051|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
82722052|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82722053|NCT00861406|Vaccines|vaccines|mesh-list
82722054|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
82722055|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722056|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722057|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
82722058|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722059|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
82722060|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
82722061|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722062|NCT00865384|Mirtazapine|mirtazapine|mesh-list
82722063|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
82722064|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82722065|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82722066|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
82722067|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
82722068|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722069|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722070|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722071|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82722072|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82722073|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82722074|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82722075|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82722076|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82722077|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
82722078|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82722079|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82722080|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
82722081|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82722082|NCT00724724|Aspirin|aspirin|mesh-list
82722083|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
82722084|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82722085|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82722086|NCT00724724|Analgesics|analgesics|mesh-ancestor
82722087|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
82722088|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722089|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722090|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82722091|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82722092|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82722093|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82722094|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722095|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82722096|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82722097|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722098|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
82722099|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82722100|NCT00724724|Protective Agents|protective agents|mesh-ancestor
82722101|NCT00865462|Bupropion|bupropion|mesh-list
82722102|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82722103|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
82722104|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82722105|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82722106|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82722107|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82722108|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722109|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
82722110|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722111|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722112|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82722113|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82722114|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722115|NCT04042558|Bevacizumab|bevacizumab|mesh-list
82722116|NCT04042558|Atezolizumab|atezolizumab|mesh-list
82722117|NCT04042558|Carboplatin|carboplatin|mesh-list
82722118|NCT04042558|Pemetrexed|pemetrexed|mesh-list
82722119|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82722120|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82722121|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722122|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82722123|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82722124|NCT04042558|Growth Substances|growth substances|mesh-ancestor
82722125|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722126|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
82722127|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722128|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722129|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82722130|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82722131|NCT04042558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82722132|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
82722133|NCT04130204|Colchicine|colchicine|mesh-list
82722134|NCT04130204|Gout Suppressants|gout suppressants|mesh-ancestor
82722135|NCT04130204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82722136|NCT04130204|Tubulin Modulators|tubulin modulators|mesh-ancestor
82722137|NCT04130204|Antimitotic Agents|antimitotic agents|mesh-ancestor
82722138|NCT04130204|Mitosis Modulators|mitosis modulators|mesh-ancestor
82722139|NCT04130204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722140|NCT04130204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722141|NCT00723918|Methadone|methadone|mesh-list
82722142|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82722143|NCT00723918|Narcotics|narcotics|mesh-ancestor
82722144|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82722145|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722146|NCT00723918|Analgesics|analgesics|mesh-ancestor
82722147|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
82722148|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722149|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
82722150|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
82722151|NCT00865540|Prednisolone|prednisolone|mesh-list
82722152|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82722153|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
82722154|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82722155|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
82722156|NCT00865540|Ketorolac|ketorolac|mesh-list
82722157|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82722158|NCT00865540|Nepafenac|nepafenac|mesh-list
82722159|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82722160|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
82722161|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82722162|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
82722163|NCT00865540|Hormones|hormones|mesh-ancestor
82722164|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82722165|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722166|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82722167|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722168|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
82722169|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
82722170|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722171|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722172|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82722173|NCT00865540|Protective Agents|protective agents|mesh-ancestor
82722174|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82722175|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82722176|NCT00865540|Analgesics|analgesics|mesh-ancestor
82722177|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
82722178|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82722179|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82722180|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722181|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722182|NCT00865618|Eplerenone|eplerenone|mesh-list
82722183|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82722184|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
82722185|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82722186|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722187|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82722188|NCT00865618|Diuretics|diuretics|mesh-ancestor
82722189|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
82722190|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82722191|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82722192|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
82722193|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82722194|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82722195|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722196|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722197|NCT00655629|Urological Agents|urological agents|mesh-ancestor
82722198|NCT00865696|Mirtazapine|mirtazapine|mesh-list
82722199|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
82722200|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82722201|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82722202|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
82722203|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
82722204|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722205|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722206|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722207|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82722208|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82722209|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82722210|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82722211|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82722212|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82722213|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
82722214|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82722215|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82722216|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
82722217|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82722218|NCT00724802|Triacetin|triacetin|mesh-list
82722219|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
82722220|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722221|NCT02545114|Tolvaptan|tolvaptan|mesh-list
82722222|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82722223|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722224|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
82722225|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722226|NCT00724880|Clopidogrel|clopidogrel|mesh-list
82722227|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82722228|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82722229|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82722230|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82722231|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
82722232|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722233|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722234|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722235|NCT00724074|Bupivacaine|bupivacaine|mesh-list
82722236|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
82722237|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
82722238|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82722239|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722240|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
82722241|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722242|NCT00854776|Lansoprazole|lansoprazole|mesh-list
82722243|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
82722244|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82722245|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82722246|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722247|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82722248|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722249|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722250|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82722251|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
82722252|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722253|NCT00854776|Antacids|antacids|mesh-ancestor
82722254|NCT00798525|Lepirudin|lepirudin|mesh-list
82722255|NCT00798525|Argatroban|argatroban|mesh-list
82722256|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
82722257|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82722258|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
82722259|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722260|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722261|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
82722262|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82722263|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82722264|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82722265|NCT00861640|Omeprazole|omeprazole|mesh-list
82722266|NCT00861640|Rabeprazole|rabeprazole|mesh-list
82722267|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82722268|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722269|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82722270|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722271|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722272|NCT00724230|Ribavirin|ribavirin|mesh-list
82722273|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82722274|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
82722275|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
82722276|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722277|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
82722278|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722279|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
82722280|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722281|NCT00725036|Insulin|insulin|mesh-list
82722282|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82722283|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
82722284|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
82722285|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
82722286|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
82722287|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82722288|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722289|NCT00724386|Paclitaxel|paclitaxel|mesh-list
82722290|NCT00724386|Vinorelbine|vinorelbine|mesh-list
82722291|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82722292|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722293|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
82722294|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
82722295|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
82722296|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722297|NCT00865852|Metformin|metformin|mesh-list
82722298|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82722299|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722300|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
82722301|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
82722302|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
82722303|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82722304|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722305|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
82722306|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722307|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82722308|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82722309|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722310|NCT00724542|Voglibose|voglibose|mesh-list
82722311|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82722312|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722313|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82722314|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722315|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722316|NCT00724620|Ribavirin|ribavirin|mesh-list
82722317|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82722318|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
82722319|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722320|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
82722321|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722322|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82722323|NCT00866008|Ganirelix|ganirelix|mesh-list
82722324|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
82722325|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82722326|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
82722327|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82722328|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722329|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82722330|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82722331|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722332|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
82722333|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82722334|NCT02571426|Propofol|propofol|mesh-list
82722335|NCT02571426|Sevoflurane|sevoflurane|mesh-list
82722336|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82722337|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82722338|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722339|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82722340|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
82722342|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82722343|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82722344|NCT03491540|Gentamicins|gentamicins|mesh-list
82722345|NCT03491540|Ornidazole|ornidazole|mesh-list
82722346|NCT03491540|Sennosides|sennosides|mesh-list
82722347|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82722348|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722349|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82722350|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722351|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722352|NCT03491540|Laxatives|laxatives|mesh-ancestor
82722353|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722354|NCT03491540|Amebicides|amebicides|mesh-ancestor
82722355|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82722356|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82722357|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82722358|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82722359|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722360|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
82722361|NCT00578292|Busulfan|busulfan|mesh-list
82722362|NCT00578292|Fludarabine|fludarabine|mesh-list
82722363|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
82722364|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82722365|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
82722366|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722367|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82722368|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82722369|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
82722370|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722371|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722372|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82722373|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82722374|NCT00861874|Sirolimus|sirolimus|mesh-list
82722375|NCT00861874|Decitabine|decitabine|mesh-list
82722376|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82722377|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
82722378|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722379|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722380|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722381|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82722382|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722383|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82722384|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
82722385|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82722386|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
82722387|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722388|NCT05372874|Antiviral Agents|antiviral agents|mesh-list
82722389|NCT05372874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722390|NCT04067856|Dexamethasone|dexamethasone|mesh-list
82722391|NCT04067856|Bevacizumab|bevacizumab|mesh-list
82722392|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82722393|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722394|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82722395|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82722396|NCT04067856|Growth Substances|growth substances|mesh-ancestor
82722397|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722398|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
82722399|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82722400|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
82722401|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
82722402|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722403|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722404|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
82722405|NCT04067856|Hormones|hormones|mesh-ancestor
82722406|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82722407|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82722408|NCT04042714|Trifluridine|trifluridine|mesh-list
82722409|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
82722410|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722411|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
82722412|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722413|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82722414|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722415|NCT00725348|R 115866|r 115866|mesh-list
82722416|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82722417|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722418|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722419|NCT00577772|Rifaximin|rifaximin|mesh-list
82722420|NCT00577772|Lactulose|lactulose|mesh-list
82722421|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82722422|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722423|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722424|NCT00578136|Bupivacaine|bupivacaine|mesh-list
82722425|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
82722426|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
82722427|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82722428|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722429|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
82722430|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722431|NCT00861952|Mineral Oil|mineral oil|mesh-list
82722432|NCT00861952|Emollients|emollients|mesh-ancestor
82722433|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
82722434|NCT00655551|Lacosamide|lacosamide|mesh-list
82722435|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
82722436|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82722437|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82722438|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82722439|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722440|NCT00855088|Ritonavir|ritonavir|mesh-list
82722441|NCT00855088|Darunavir|darunavir|mesh-list
82722442|NCT00855088|Etravirine|etravirine|mesh-list
82722443|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82722444|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82722445|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
82722446|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722447|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722448|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82722449|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82722450|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
82722451|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722452|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82722453|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82722454|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82722455|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82722456|NCT02553603|Hormones|hormones|mesh-list
82722457|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
82722458|NCT02553603|Tesamorelin|tesamorelin|mesh-list
82722459|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82722460|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722461|NCT02553603|Growth Substances|growth substances|mesh-ancestor
82722462|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82722463|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
82722464|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82722466|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
82722467|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82722468|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
82722469|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82722470|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
82722471|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
82722472|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722473|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722474|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722475|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
82722476|NCT00804531|Hormones|hormones|mesh-ancestor
82722477|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82722478|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82722479|NCT00804531|Protective Agents|protective agents|mesh-ancestor
82722480|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82722481|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722482|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
82722483|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82722484|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
82722485|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722486|NCT00866866|Expectorants|expectorants|mesh-ancestor
82722487|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
82722488|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82722489|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
82722490|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722491|NCT00866866|Protective Agents|protective agents|mesh-ancestor
82722492|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722493|NCT00866866|Antidotes|antidotes|mesh-ancestor
82722494|NCT00312728|Bevacizumab|bevacizumab|mesh-list
82722495|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82722496|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722497|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82722498|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82722499|NCT00312728|Growth Substances|growth substances|mesh-ancestor
82722500|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722501|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
82722502|NCT00804921|Bevacizumab|bevacizumab|mesh-list
82722503|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82722504|NCT00804921|Acetazolamide|acetazolamide|mesh-list
82722505|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82722506|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722507|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82722508|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82722509|NCT00804921|Growth Substances|growth substances|mesh-ancestor
82722510|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722511|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
82722512|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82722513|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82722514|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82722515|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82722516|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
82722517|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722518|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722519|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
82722520|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82722521|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722522|NCT00804921|Diuretics|diuretics|mesh-ancestor
82722523|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
82722524|NCT00866944|Leucovorin|leucovorin|mesh-list
82722525|NCT00866944|Fluorouracil|fluorouracil|mesh-list
82722526|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
82722527|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82722528|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
82722529|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722530|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82722531|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722532|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82722533|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
82722534|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722535|NCT00866944|Antidotes|antidotes|mesh-ancestor
82722536|NCT00866944|Protective Agents|protective agents|mesh-ancestor
82722537|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
82722538|NCT00866944|Vitamins|vitamins|mesh-ancestor
82722539|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
82722540|NCT00577824|Exenatide|exenatide|mesh-list
82722541|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82722542|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722543|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82722544|NCT00577824|Incretins|incretins|mesh-ancestor
82722545|NCT00577824|Hormones|hormones|mesh-ancestor
82722546|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82722547|NCT02632448|Gemcitabine|gemcitabine|mesh-list
82722548|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82722549|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
82722550|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722551|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722552|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
82722553|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
82722554|NCT04046289|Calcium|calcium|mesh-list
82722555|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82722556|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722557|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82722558|NCT04046289|Antacids|antacids|mesh-ancestor
82722559|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722560|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722561|NCT00807807|Folic Acid|folic acid|mesh-list
82722562|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
82722563|NCT00807807|Hematinics|hematinics|mesh-ancestor
82722564|NCT00807807|Vitamins|vitamins|mesh-ancestor
82722565|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
82722566|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722567|NCT03011814|Lenalidomide|lenalidomide|mesh-list
82722568|NCT03011814|Durvalumab|durvalumab|mesh-list
82722569|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
82722570|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82722571|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
82722572|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
82722573|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722574|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82722575|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82722576|NCT03011814|Growth Substances|growth substances|mesh-ancestor
82722577|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
82722578|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722579|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82722580|NCT00870298|Trimethoprim|trimethoprim|mesh-list
82722581|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
82722582|NCT00870298|Warfarin|warfarin|mesh-list
82722583|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
82722584|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82722585|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722586|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
82722587|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82722588|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82722589|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82722590|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722591|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722592|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82722593|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82722594|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82722595|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
82722596|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82722597|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
82722598|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82722599|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
82722600|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82722601|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722602|NCT00730418|Doxazosin|doxazosin|mesh-list
82722603|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82722604|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82722605|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82722606|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82722607|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
82722608|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722609|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722610|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722612|NCT00805233|Ranibizumab|ranibizumab|mesh-list
82722613|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82722614|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82722615|NCT00805233|Growth Substances|growth substances|mesh-ancestor
82722616|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722617|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
82722618|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722619|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82722620|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82722621|NCT00805233|Analgesics|analgesics|mesh-ancestor
82722622|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
82722623|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722624|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82722625|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82722626|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
82722627|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82722628|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82722629|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722630|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82722631|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82722632|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
82722633|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722634|NCT03906136|Adalimumab|adalimumab|mesh-list
82722635|NCT03906136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82722636|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82722637|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82722638|NCT00725400|Cetuximab|cetuximab|mesh-list
82722639|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82722640|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722641|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
82722642|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722643|NCT00798915|Incretins|incretins|mesh-ancestor
82722644|NCT00798915|Hormones|hormones|mesh-ancestor
82722645|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82722646|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722647|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
82722648|NCT00798993|Vitamin D|vitamin d|mesh-list
82722649|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82722650|NCT00798993|Calcifediol|calcifediol|mesh-list
82722651|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82722652|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722653|NCT00798993|Vitamins|vitamins|mesh-ancestor
82722654|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
82722655|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82722656|NCT00862108|Methylphenidate|methylphenidate|mesh-list
82722657|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82722658|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722659|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82722660|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82722661|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82722662|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722663|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
82722664|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722665|NCT00862264|Beclomethasone|beclomethasone|mesh-list
82722666|NCT00862264|Norflurane|norflurane|mesh-list
82722667|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
82722668|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82722669|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
82722670|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722671|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722672|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82722673|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
82722674|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82722675|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82722676|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82722677|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
82722678|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722679|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722680|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82722681|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
82722683|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82722684|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
82722685|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82722686|NCT00730574|Vitamins|vitamins|mesh-list
82722687|NCT00730574|Folic Acid|folic acid|mesh-list
82722688|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
82722689|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
82722690|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
82722691|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
82722692|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722693|NCT00730574|Hematinics|hematinics|mesh-ancestor
82722694|NCT00870532|Sorafenib|sorafenib|mesh-list
82722695|NCT00870532|Vinorelbine|vinorelbine|mesh-list
82722696|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722697|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82722698|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722699|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722700|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82722701|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
82722702|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
82722703|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
82722704|NCT00725478|Piribedil|piribedil|mesh-list
82722705|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82722706|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82722707|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
82722708|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
82722709|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722710|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722711|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722712|NCT01951274|Serlopitant|serlopitant|mesh-list
82722713|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82722714|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722715|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722716|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722717|NCT03355794|Everolimus|everolimus|mesh-list
82722718|NCT03355794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82722719|NCT03355794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82722720|NCT03355794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722721|NCT03355794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722722|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82722723|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
82722724|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722725|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722726|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82722727|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722728|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82722729|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722730|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722731|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82722732|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82722733|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722734|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82722735|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722736|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722737|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
82722738|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722739|NCT00617344|Vaccines|vaccines|mesh-list
82722740|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
82722741|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722742|NCT00862342|Bevacizumab|bevacizumab|mesh-list
82722743|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82722744|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722745|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82722746|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82722747|NCT00862342|Growth Substances|growth substances|mesh-ancestor
82722748|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722749|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
82722750|NCT00732212|Hemostatics|hemostatics|mesh-list
82722751|NCT00732212|Coagulants|coagulants|mesh-ancestor
82722752|NCT02544724|Interleukin-12|interleukin-12|mesh-list
82722753|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82722754|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
82722755|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722756|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82722757|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82722758|NCT02544724|Growth Substances|growth substances|mesh-ancestor
82722759|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
82722760|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722761|NCT00862420|Ticlopidine|ticlopidine|mesh-list
82722762|NCT00862420|Clopidogrel|clopidogrel|mesh-list
82722763|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82722764|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82722765|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82722766|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82722767|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
82722768|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722769|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722770|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722771|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82722772|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82722773|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82722774|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82722775|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722776|NCT00321698|Docetaxel|docetaxel|mesh-list
82722777|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722778|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
82722779|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
82722780|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
82722781|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722782|NCT02569970|Fluoxetine|fluoxetine|mesh-list
82722783|NCT02569970|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82722784|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82722785|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82722786|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722787|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722788|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
82722789|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722790|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82722791|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
82722792|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82722793|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82722794|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82722795|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723096|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
82722796|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82722797|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
82722798|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82722799|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82722800|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722801|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722802|NCT00725790|Urological Agents|urological agents|mesh-ancestor
82722803|NCT00731276|Irinotecan|irinotecan|mesh-list
82722804|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82722805|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82722806|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722807|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722808|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722809|NCT00725946|Iodine|iodine|mesh-list
82722810|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
82722811|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82722812|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722813|NCT00725946|Trace Elements|trace elements|mesh-ancestor
82722814|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
82722815|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722816|NCT02569346|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
82722817|NCT02569346|Lamivudine|lamivudine|mesh-list
82722818|NCT02569346|Abacavir|abacavir|mesh-list
82722819|NCT02569346|Dolutegravir|dolutegravir|mesh-list
82722820|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82722821|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82722822|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
82722823|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722824|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82722825|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82722826|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722827|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722828|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82722829|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82722830|NCT00726804|Adalimumab|adalimumab|mesh-list
82722831|NCT00726804|Etanercept|etanercept|mesh-list
82722832|NCT00726804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82722833|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82722834|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82722835|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82722836|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82722837|NCT00726804|Analgesics|analgesics|mesh-ancestor
82722838|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
82722839|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722840|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722841|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722842|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82722843|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
82722844|NCT00726960|Buprenorphine|buprenorphine|mesh-list
82722845|NCT00726960|Aprepitant|aprepitant|mesh-list
82722846|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82722847|NCT00726960|Narcotics|narcotics|mesh-ancestor
82722848|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82722849|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722850|NCT00726960|Analgesics|analgesics|mesh-ancestor
82722851|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
82722852|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722853|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82722854|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
82722855|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
82722856|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722857|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82722858|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722859|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722860|NCT00727038|Ranibizumab|ranibizumab|mesh-list
82722861|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82722862|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82722863|NCT00727038|Growth Substances|growth substances|mesh-ancestor
82722864|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722865|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
82722866|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722867|NCT00726258|Ketamine|ketamine|mesh-list
82722868|NCT00726258|Analgesics|analgesics|mesh-ancestor
82722869|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
82722870|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722871|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722872|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82722873|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82722874|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
82722875|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
82722876|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82722877|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82722878|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82722879|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722880|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722881|NCT02950766|Ipilimumab|ipilimumab|mesh-list
82722882|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82722883|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82722884|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82722885|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722886|NCT02569814|Amlodipine|amlodipine|mesh-list
82722887|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82722888|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82722889|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82722890|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82722891|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722892|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82722893|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722894|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
82722895|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82722896|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82722897|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
82722898|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82722899|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82722900|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722901|NCT00726570|Heparin|heparin|mesh-list
82722902|NCT00726570|Calcium heparin|calcium heparin|mesh-list
82722903|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82722904|NCT00726570|Tinzaparin|tinzaparin|mesh-list
82722905|NCT00726570|Dalteparin|dalteparin|mesh-list
82722906|NCT00726570|Anticoagulants|anticoagulants|mesh-list
82722907|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82722908|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82722909|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722910|NCT00726726|Vitamin K|vitamin k|mesh-list
82722911|NCT00726726|Midazolam|midazolam|mesh-list
82722912|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
82722913|NCT00726726|Caffeine|caffeine|mesh-list
82722914|NCT00726726|Omeprazole|omeprazole|mesh-list
82722915|NCT00726726|Warfarin|warfarin|mesh-list
82722916|NCT00726726|BMS 708163|bms 708163|mesh-list
82722917|NCT00726726|Vitamins|vitamins|mesh-ancestor
82722918|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
82722919|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722920|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82722921|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82722922|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82722923|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82722924|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82722925|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82722926|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82722927|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
82722928|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
82722929|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
82722930|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
82722931|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82722932|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722933|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
82722934|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82722935|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82722936|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722937|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82722938|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82722939|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
82722940|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82722941|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82722942|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82722943|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82722944|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82722945|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
82722946|NCT00726726|Coagulants|coagulants|mesh-ancestor
82722947|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
82722948|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
82722949|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82722950|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82722951|NCT00726726|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82722952|NCT00654381|Inositol|inositol|mesh-list
82722953|NCT00654381|Linagliptin|linagliptin|mesh-list
82722954|NCT00654381|Voglibose|voglibose|mesh-list
82722955|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82722956|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722957|NCT00654381|Incretins|incretins|mesh-ancestor
82722958|NCT00654381|Hormones|hormones|mesh-ancestor
82722959|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82722960|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82722961|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
82722962|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722963|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722964|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82722965|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
82722966|NCT00654381|Vitamins|vitamins|mesh-ancestor
82722967|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
82722968|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
82722969|NCT04018482|Povidone|povidone|mesh-list
82722970|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
82722971|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
82722972|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82722973|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82722974|NCT00805311|Aspirin|aspirin|mesh-list
82722975|NCT00805311|Losartan|losartan|mesh-list
82722976|NCT00805311|Amlodipine|amlodipine|mesh-list
82722977|NCT00805311|Atorvastatin|atorvastatin|mesh-list
82722978|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82722979|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82722980|NCT00805311|Analgesics|analgesics|mesh-ancestor
82722981|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
82722982|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82722983|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82722984|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82722985|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82722986|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82722987|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82722988|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82722989|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82722990|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82722991|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82722992|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
82722993|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82722994|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82722995|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
82722996|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82722997|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82722998|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82722999|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82723000|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82723001|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82723002|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
82723003|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82723004|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82723005|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82723006|NCT00732290|Fluoxetine|fluoxetine|mesh-list
82723007|NCT00732290|Clopidogrel|clopidogrel|mesh-list
82723008|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82723009|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82723010|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82723011|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82723012|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
82723013|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723014|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723015|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723016|NCT00732290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82723017|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82723018|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82723020|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82723021|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
82723022|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82723249|NCT04066452|Antibodies|antibodies|mesh-list
82723023|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82723024|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82723025|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723026|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82723027|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
82723028|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723029|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
82723030|NCT00732446|Dexamethasone|dexamethasone|mesh-list
82723031|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
82723032|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82723033|NCT00732446|BB 1101|bb 1101|mesh-list
82723034|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723035|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
82723036|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
82723037|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723038|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723039|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82723040|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
82723041|NCT00732446|Hormones|hormones|mesh-ancestor
82723042|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82723043|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82723044|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723045|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
82723046|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723047|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723048|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82723049|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723050|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82723051|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82723052|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82723053|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
82723054|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82723055|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82723056|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82723057|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82723058|NCT00732524|Glipizide|glipizide|mesh-list
82723059|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82723060|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723061|NCT00657267|Temozolomide|temozolomide|mesh-list
82723062|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82723063|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
82723064|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723065|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723066|NCT00733850|Gemcitabine|gemcitabine|mesh-list
82723067|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82723068|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
82723069|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723070|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723071|NCT00727766|Clofarabine|clofarabine|mesh-list
82723072|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82723073|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
82723074|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723075|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723076|NCT00799071|Posaconazole|posaconazole|mesh-list
82723077|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
82723078|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723079|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82723080|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82723081|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82723082|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82723083|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82723084|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723085|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723086|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82723087|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
82723088|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82723089|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723090|NCT00732836|Paclitaxel|paclitaxel|mesh-list
82723091|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82723092|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82723093|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723094|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
82723095|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
82723097|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723098|NCT00799149|Etoricoxib|etoricoxib|mesh-list
82723099|NCT00799149|Gabapentin|gabapentin|mesh-list
82723100|NCT00799149|Analgesics|analgesics|mesh-ancestor
82723101|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
82723102|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723103|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723104|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
82723105|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82723106|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82723107|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82723108|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82723109|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82723110|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82723111|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723112|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723113|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
82723114|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82723115|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82723116|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723117|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82723118|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82723119|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82723120|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723121|NCT00732914|Sorafenib|sorafenib|mesh-list
82723122|NCT00732914|Sunitinib|sunitinib|mesh-list
82723123|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723124|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82723125|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723126|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723127|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82723128|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82723129|NCT00732914|Growth Substances|growth substances|mesh-ancestor
82723130|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723131|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
82723132|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
82723133|NCT00808275|Calcium|calcium|mesh-list
82723134|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82723135|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723136|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82723137|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
82723138|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82723139|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723140|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82723141|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82723142|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723143|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723144|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723145|NCT00728000|Gemcitabine|gemcitabine|mesh-list
82723146|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
82723147|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82723148|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82723149|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
82723150|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723151|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723152|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82723153|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723154|NCT04065230|Tenofovir|tenofovir|mesh-list
82723155|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
82723156|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723157|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82723158|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82723159|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723160|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723161|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82723162|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82723163|NCT00728078|Thalidomide|thalidomide|mesh-list
82723164|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82723165|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
82723166|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723167|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
82723168|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82723169|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723170|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82723171|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82723172|NCT00728078|Growth Substances|growth substances|mesh-ancestor
82723173|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
82723174|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723175|NCT04066088|Guanfacine|guanfacine|mesh-list
82723176|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82723177|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82723178|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82723179|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82723180|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
82723181|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723182|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723183|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723184|NCT00733148|Insulin|insulin|mesh-list
82723185|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82723186|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723187|NCT00730392|Etanercept|etanercept|mesh-list
82723188|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82723189|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82723190|NCT00730392|Analgesics|analgesics|mesh-ancestor
82723191|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
82723192|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723193|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723194|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723195|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82723196|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82723197|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82723198|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
82723199|NCT01528046|Metformin|metformin|mesh-list
82723200|NCT01528046|Irinotecan|irinotecan|mesh-list
82723201|NCT01528046|Camptothecin|camptothecin|mesh-list
82723202|NCT01528046|Vincristine|vincristine|mesh-list
82723203|NCT01528046|Temozolomide|temozolomide|mesh-list
82723204|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82723205|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723206|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82723207|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82723208|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723209|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723210|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723211|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82723212|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
82723213|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
82723214|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
82723215|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82723216|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
82723217|NCT00652899|Aldesleukin|aldesleukin|mesh-list
82723218|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
82723219|NCT00652899|Fludarabine|fludarabine|mesh-list
82723220|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
82723221|NCT00652899|Interleukin-2|interleukin-2|mesh-list
82723222|NCT00652899|Allopurinol|allopurinol|mesh-list
82723223|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82723224|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
82723225|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723226|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82723227|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82723228|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
82723229|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723230|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723231|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82723232|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82723234|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
82723235|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723236|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82723237|NCT00652899|Analgesics|analgesics|mesh-ancestor
82723238|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
82723239|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723240|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82723241|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82723242|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723243|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
82723244|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82723245|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
82723246|NCT00652899|Protective Agents|protective agents|mesh-ancestor
82723247|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
82723248|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82723250|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
82723251|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723252|NCT00728520|Azacitidine|azacitidine|mesh-list
82723253|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82723254|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
82723255|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723256|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723257|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723258|NCT04065308|Daratumumab|daratumumab|mesh-list
82723259|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723260|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
82723261|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82723262|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723263|NCT00728156|Clopidogrel|clopidogrel|mesh-list
82723264|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82723265|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82723266|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82723267|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82723268|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
82723269|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723270|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723271|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723272|NCT02569554|Rabeprazole|rabeprazole|mesh-list
82723273|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82723274|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82723275|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82723276|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723277|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723278|NCT00734318|Fluticasone|fluticasone|mesh-list
82723280|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
82723281|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82723282|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
82723283|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723284|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723285|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82723286|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
82723287|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82723288|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82723289|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82723290|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
82723291|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723292|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723293|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723294|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
82723295|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82723296|NCT00733616|Docetaxel|docetaxel|mesh-list
82723297|NCT00733616|Capecitabine|capecitabine|mesh-list
82723298|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
82723299|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723300|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
82723301|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
82723302|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
82723303|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723304|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82723305|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
82723306|NCT00728832|Morphine|morphine|mesh-list
82723307|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82723308|NCT00728832|Narcotics|narcotics|mesh-ancestor
82723309|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82723310|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723311|NCT00728832|Analgesics|analgesics|mesh-ancestor
82723312|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
82723313|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723314|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82723315|NCT00728312|Aripiprazole|aripiprazole|mesh-list
82723316|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
82723317|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82723318|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82723319|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82723320|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82723321|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723322|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
82723323|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
82723324|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723325|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723326|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82723327|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82723328|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
82723329|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82723330|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82723331|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82723332|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82723334|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
82723335|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82723336|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723337|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82723338|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82723339|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
82723340|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723341|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82723342|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82723343|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
82723344|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723345|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82723346|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82723347|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82723348|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
82723349|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723350|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82723351|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82723352|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723353|NCT04066296|Bupivacaine|bupivacaine|mesh-list
82723354|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
82723355|NCT04066296|Anesthetics|anesthetics|mesh-list
82723356|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82723357|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723358|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
82723359|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723360|NCT02341014|Lenalidomide|lenalidomide|mesh-list
82723361|NCT02341014|Romidepsin|romidepsin|mesh-list
82723362|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
82723363|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723364|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82723365|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82723366|NCT02341014|Growth Substances|growth substances|mesh-ancestor
82723367|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
82723368|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723369|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82723370|NCT02341014|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82723371|NCT02341014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723372|NCT02341014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723373|NCT00868426|Budesonide|budesonide|mesh-list
82723374|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
82723375|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82723376|NCT00868426|Charcoal|charcoal|mesh-list
82723377|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723378|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82723379|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
82723380|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723381|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723382|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82723383|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
82723384|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
82723385|NCT00868426|Hormones|hormones|mesh-ancestor
82723386|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82723387|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82723388|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82723389|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82723390|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
82723391|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723392|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723394|NCT00868426|Protective Agents|protective agents|mesh-ancestor
82723395|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
82723396|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
82723397|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723398|NCT00868738|Vitamin D|vitamin d|mesh-list
82723399|NCT00868738|Vitamins|vitamins|mesh-ancestor
82723400|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
82723401|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723402|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82723403|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
82723404|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723405|NCT02569866|Cephalexin|cephalexin|mesh-list
82723406|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82723407|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723408|NCT00868894|Latanoprost|latanoprost|mesh-list
82723409|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82723410|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82723411|NCT00730938|Cefuroxime|cefuroxime|mesh-list
82723412|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
82723413|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82723414|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723415|NCT00712010|Caseins|caseins|mesh-list
82723416|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
82723417|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
82723418|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723419|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
82723420|NCT00731016|Pravastatin|pravastatin|mesh-list
82723421|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82723422|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723423|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82723424|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82723425|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
82723426|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723427|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82723428|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82723429|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723430|NCT00799539|Prednisone|prednisone|mesh-list
82723431|NCT00799539|Bortezomib|bortezomib|mesh-list
82723432|NCT00799539|Melphalan|melphalan|mesh-list
82723433|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723434|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
82723435|NCT00799539|Hormones|hormones|mesh-ancestor
82723436|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82723437|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723438|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82723439|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723440|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82723441|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
82723442|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723443|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82723444|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82723445|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
82723446|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
82723447|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
82723448|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82723449|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
82723450|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723451|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82723452|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82723454|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82723455|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82723456|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82723457|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82723458|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
82723459|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723460|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723461|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723462|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
82723463|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82723464|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723466|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82723467|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723468|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723469|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723470|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82723471|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82723472|NCT00729222|Rolofylline|rolofylline|mesh-list
82723473|NCT00729222|Diuretics|diuretics|mesh-ancestor
82723474|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
82723475|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723476|NCT00729300|Disulfiram|disulfiram|mesh-list
82723477|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82723478|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82723479|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723480|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723481|NCT00808743|Celecoxib|celecoxib|mesh-list
82723482|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82723483|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82723484|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82723485|NCT00808743|Analgesics|analgesics|mesh-ancestor
82723486|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
82723487|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723488|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723489|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723490|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82723491|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82723492|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82723493|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723494|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723495|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82723496|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82723497|NCT00869596|Fluticasone|fluticasone|mesh-list
82723498|NCT00869596|Xhance|xhance|mesh-list
82723499|NCT00869596|Albuterol|albuterol|mesh-list
82723500|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723501|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82723502|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
82723503|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723504|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723505|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82723506|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
82723507|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
82723508|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82723509|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
82723510|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82723511|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82723512|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82723513|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82723514|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
82723515|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723516|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723517|NCT03743376|UB-421|ub-421|mesh-list
82723518|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82723519|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
82723520|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723521|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
82723522|NCT03728478|Etanercept|etanercept|mesh-list
82723523|NCT03728478|Methotrexate|methotrexate|mesh-list
82723524|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82723525|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
82723526|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82723527|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723528|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82723529|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
82723530|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723531|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723532|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
82723533|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723534|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82723535|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82723536|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
82723537|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82723538|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82723539|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82723540|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82723541|NCT03728478|Analgesics|analgesics|mesh-ancestor
82723542|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
82723543|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723544|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723545|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82723546|NCT00653523|Simvastatin|simvastatin|mesh-list
82723547|NCT00653523|Ezetimibe|ezetimibe|mesh-list
82723548|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82723549|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82723550|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
82723551|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723552|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82723553|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82723554|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723556|NCT00869752|Antibodies|antibodies|mesh-list
82723557|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82723558|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
82723559|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723560|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723561|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82723562|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82723563|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82723564|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723565|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723566|NCT00808977|Mesalamine|mesalamine|mesh-list
82723567|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82723568|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82723569|NCT00808977|Analgesics|analgesics|mesh-ancestor
82723570|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
82723571|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723572|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723573|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723574|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82723575|NCT00735020|Vaccines|vaccines|mesh-list
82723576|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
82723577|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723578|NCT04065906|Methylphenidate|methylphenidate|mesh-list
82723579|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82723580|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82723581|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723582|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82723583|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82723584|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82723585|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723586|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
82723587|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723588|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82723589|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
82723590|NCT00739388|Azacitidine|azacitidine|mesh-list
82723591|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82723592|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
82723593|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723594|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723595|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723596|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
82723597|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
82723598|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82723599|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82723600|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723601|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723602|NCT00862888|Urological Agents|urological agents|mesh-ancestor
82723603|NCT00729170|Calcium|calcium|mesh-list
82723604|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82723605|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723606|NCT00862966|Heparin|heparin|mesh-list
82723607|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
82723608|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723609|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82723610|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82723611|NCT02569320|Dexamethasone|dexamethasone|mesh-list
82723612|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
82723613|NCT02569320|Pomalidomide|pomalidomide|mesh-list
82723614|NCT02569320|Ichthammol|ichthammol|mesh-list
82723615|NCT02569320|BB 1101|bb 1101|mesh-list
82723616|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82723617|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723618|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
82723619|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
82723620|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723621|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723622|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82723623|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
82723624|NCT02569320|Hormones|hormones|mesh-ancestor
82723625|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82723626|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82723627|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723628|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
82723629|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723630|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723631|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
82723632|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82723633|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82723634|NCT02569320|Growth Substances|growth substances|mesh-ancestor
82723635|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
82723636|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
82723637|NCT00739466|Alendronate|alendronate|mesh-list
82723638|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82723639|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723640|NCT00869908|Insulin|insulin|mesh-list
82723641|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82723642|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
82723643|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
82723644|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82723645|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
82723646|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
82723647|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82723648|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723649|NCT00739622|Rilpivirine|rilpivirine|mesh-list
82723650|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82723651|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82723652|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723653|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723654|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
82723655|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723656|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82723657|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82723658|NCT00731562|Varenicline|varenicline|mesh-list
82723659|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82723660|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82723661|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
82723662|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723663|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723664|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723665|NCT00870142|Amlodipine|amlodipine|mesh-list
82723666|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82723667|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82723668|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82723669|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723670|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82723671|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723672|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
82723673|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82723674|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82723675|NCT00870220|Estradiol|estradiol|mesh-list
82723676|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82723677|NCT00870220|Estrogens|estrogens|mesh-ancestor
82723678|NCT00870220|Hormones|hormones|mesh-ancestor
82723679|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82723680|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723681|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82723682|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
82723683|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82723684|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82723685|NCT00729768|Cyclosporine|cyclosporine|mesh-list
82723686|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
82723687|NCT00729768|Cyclosporins|cyclosporins|mesh-list
82723688|NCT00729768|Basiliximab|basiliximab|mesh-list
82723689|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723690|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723691|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82723692|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
82723693|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723694|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
82723695|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723696|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
82723697|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82723698|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82723699|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82723700|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723701|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82723702|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
82723703|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82723704|NCT00871156|Chloroquine|chloroquine|mesh-list
82723705|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
82723706|NCT00871156|Tafenoquine|tafenoquine|mesh-list
82723707|NCT00871156|Amebicides|amebicides|mesh-ancestor
82723708|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82723709|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82723710|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723711|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
82723712|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82723713|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82723714|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82723715|NCT00871156|Analgesics|analgesics|mesh-ancestor
82723716|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
82723717|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723718|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723719|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723720|NCT00871156|Filaricides|filaricides|mesh-ancestor
82723721|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
82723722|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
82723724|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
82723725|NCT00734448|Vitamins|vitamins|mesh-ancestor
82723726|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
82723727|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723728|NCT00876226|Citalopram|citalopram|mesh-list
82723729|NCT00876226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82723730|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82723731|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82723732|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723733|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723734|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
82723735|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723736|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82723737|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
82723738|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82723739|NCT00734526|Temozolomide|temozolomide|mesh-list
82723740|NCT00734526|Sorafenib|sorafenib|mesh-list
82723741|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82723742|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
82723743|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723744|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723745|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82723746|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723747|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82723748|NCT00729404|Gestodene|gestodene|mesh-list
82723749|NCT00729404|Femovan|femovan|mesh-list
82723750|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82723751|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82723752|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82723753|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
82723754|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82723755|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723756|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82723757|NCT00729404|Estrogens|estrogens|mesh-ancestor
82723758|NCT00729404|Hormones|hormones|mesh-ancestor
82723759|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82723760|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82723761|NCT00729404|Progestins|progestins|mesh-ancestor
82723762|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82723763|NCT00731952|Bortezomib|bortezomib|mesh-list
82723764|NCT00731952|Vorinostat|vorinostat|mesh-list
82723765|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723766|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82723767|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723768|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723769|NCT04065932|Deucravacitinib|deucravacitinib|mesh-list
82723770|NCT04065932|Famotidine|famotidine|mesh-list
82723771|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82723772|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82723773|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82723774|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
82723775|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
82723776|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723777|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723778|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723779|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
82723780|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82723781|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723782|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82723783|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82723784|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
82723785|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723786|NCT00740090|Antacids|antacids|mesh-ancestor
82723787|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723788|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82723789|NCT00738660|Telmisartan|telmisartan|mesh-list
82723790|NCT00738660|Ramipril|ramipril|mesh-list
82723791|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82723792|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82723793|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82723794|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723795|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82723796|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
82723797|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723798|NCT00740168|Bevacizumab|bevacizumab|mesh-list
82723799|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82723800|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723801|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82723802|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82723803|NCT00740168|Growth Substances|growth substances|mesh-ancestor
82723804|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723805|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
82723806|NCT05225974|Liraglutide|liraglutide|mesh-list
82723807|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82723808|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723809|NCT05225974|Incretins|incretins|mesh-ancestor
82723810|NCT05225974|Hormones|hormones|mesh-ancestor
82723811|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82723812|NCT01139970|Temozolomide|temozolomide|mesh-list
82723813|NCT01139970|Veliparib|veliparib|mesh-list
82723814|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82723815|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
82723816|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723817|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723818|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82723819|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723820|NCT00729638|Lenalidomide|lenalidomide|mesh-list
82723821|NCT00729638|Everolimus|everolimus|mesh-list
82723822|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
82723823|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723824|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82723825|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82723826|NCT00729638|Growth Substances|growth substances|mesh-ancestor
82723827|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
82723828|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723829|NCT00729638|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82723830|NCT00729638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82723831|NCT00729638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723832|NCT00729638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723833|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82723834|NCT00734682|Irinotecan|irinotecan|mesh-list
82723835|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82723836|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82723837|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723838|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723839|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723841|NCT00732108|Lactulose|lactulose|mesh-list
82723842|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
82723843|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82723844|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723845|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82723846|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
82723847|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
82723848|NCT00876616|Tacrolimus|tacrolimus|mesh-list
82723849|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82723850|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
82723851|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723852|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82723853|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82723854|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
82723855|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723856|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723857|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82723858|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82723859|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723860|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82723861|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82723862|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
82723863|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82723864|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723866|NCT05575440|Cariostatic Agents|cariostatic agents|mesh-ancestor
82723867|NCT05575440|Protective Agents|protective agents|mesh-ancestor
82723868|NCT05575440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723869|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
82723870|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
82723871|NCT00729794|Vasopressins|vasopressins|mesh-list
82723872|NCT00729794|Epinephrine|epinephrine|mesh-list
82723873|NCT00729794|Racepinephrine|racepinephrine|mesh-list
82723874|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
82723875|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723876|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
82723877|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
82723878|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723879|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723880|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82723881|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
82723882|NCT00729794|Hormones|hormones|mesh-ancestor
82723883|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82723884|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82723885|NCT00729794|Protective Agents|protective agents|mesh-ancestor
82723886|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82723887|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82723888|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
82723889|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723890|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723891|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82723892|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82723893|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82723894|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
82723895|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
82723896|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
82723897|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82723898|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
82723899|NCT00729794|Coagulants|coagulants|mesh-ancestor
82723900|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82723901|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
82723902|NCT00871546|Bortezomib|bortezomib|mesh-list
82723903|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
82723904|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723905|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82723906|NCT03778294|Temozolomide|temozolomide|mesh-list
82723907|NCT03778294|Levodopa|levodopa|mesh-list
82723908|NCT03778294|Fluorides|fluorides|mesh-list
82723909|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82723910|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
82723911|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723912|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723913|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
82723914|NCT03778294|Protective Agents|protective agents|mesh-ancestor
82723915|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723916|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
82723917|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723919|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82723920|NCT00732186|Ipilimumab|ipilimumab|mesh-list
82723921|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82723922|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723923|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82723924|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723925|NCT04039828|Zinc|zinc|mesh-list
82723926|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
82723927|NCT04039828|Trace Elements|trace elements|mesh-ancestor
82723928|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
82723929|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723930|NCT04039828|Astringents|astringents|mesh-ancestor
82723931|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
82723932|NCT00876772|Olanzapine|olanzapine|mesh-list
82723933|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
82723934|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
82723935|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723936|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723937|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82723938|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82723939|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82723940|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82723941|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82723942|NCT00876772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82723943|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82723944|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82723945|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723946|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82723947|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
82723948|NCT00729950|Ipilimumab|ipilimumab|mesh-list
82723949|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82723950|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723951|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82723952|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723953|NCT00616018|Acetaminophen|acetaminophen|mesh-list
82723954|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82723955|NCT00616018|Analgesics|analgesics|mesh-ancestor
82723956|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
82723957|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82723958|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723959|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
82723960|NCT00740948|Rituximab|rituximab|mesh-list
82723961|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82723962|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723963|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
82723964|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723965|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82723974|NCT00876850|Linezolid|linezolid|mesh-list
82723975|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82723976|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82723977|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82723978|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82723979|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82723980|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82723981|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82723982|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82723983|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82723984|NCT05157412|Doxycycline|doxycycline|mesh-list
82723985|NCT05157412|Prednisolone|prednisolone|mesh-list
82723986|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82723987|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
82723988|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82723989|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
82723990|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82723991|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
82723992|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82723994|NCT05157412|Hormones|hormones|mesh-ancestor
82723995|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82723996|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723997|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82723998|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82723999|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
82724000|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
82724001|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724002|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82724003|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82724004|NCT05157412|Protective Agents|protective agents|mesh-ancestor
82724005|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82724006|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724007|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
82724008|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82724009|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82724010|NCT00732420|Topotecan|topotecan|mesh-list
82724011|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82724012|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82724013|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724014|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724015|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724016|NCT00735228|Pancrelipase|pancrelipase|mesh-list
82724017|NCT00735228|Pancreatin|pancreatin|mesh-list
82724018|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82724019|NCT00739128|Vaccines|vaccines|mesh-list
82724020|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
82724021|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724022|NCT00863668|Tenofovir|tenofovir|mesh-list
82724023|NCT00863668|Emtricitabine|emtricitabine|mesh-list
82724024|NCT00863668|Efavirenz|efavirenz|mesh-list
82724025|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
82724026|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82724027|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
82724028|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
82724029|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
82724030|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724031|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82724032|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724033|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724034|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82724035|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82724036|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82724037|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82724038|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82724039|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82724040|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82724041|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82724042|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82724043|NCT00872248|Anesthetics|anesthetics|mesh-list
82724044|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724045|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724046|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
82724047|NCT00732576|Vitamin K|vitamin k|mesh-list
82724048|NCT00732576|Menaquinone 7|menaquinone 7|mesh-list
82724049|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82724050|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82724051|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724052|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
82724053|NCT00732576|Coagulants|coagulants|mesh-ancestor
82724054|NCT00732576|Vitamins|vitamins|mesh-ancestor
82724055|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
82724056|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724057|NCT00863902|Cetirizine|cetirizine|mesh-list
82724058|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82724059|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82724060|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82724061|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
82724062|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
82724063|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724064|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724065|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724066|NCT00732810|Capecitabine|capecitabine|mesh-list
82724068|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82724069|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
82724070|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724071|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724072|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82724073|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724074|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
82724075|NCT00732888|Calcium|calcium|mesh-list
82724076|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82724077|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724078|NCT00732888|Antacids|antacids|mesh-ancestor
82724079|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724080|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82724081|NCT00732966|Losartan|losartan|mesh-list
82724082|NCT00732966|Valsartan|valsartan|mesh-list
82724083|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82724084|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82724085|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82724086|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724087|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82724088|NCT02568618|Analgesics|analgesics|mesh-list
82724089|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
82724090|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724238|NCT00428389|Protective Agents|protective agents|mesh-ancestor
82724091|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724092|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82724093|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
82724094|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82724095|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
82724096|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82724097|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724098|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82724099|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82724100|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724102|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82724103|NCT00735930|Lenalidomide|lenalidomide|mesh-list
82724104|NCT00735930|Alvocidib|alvocidib|mesh-list
82724105|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
82724106|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724107|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82724108|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82724109|NCT00735930|Growth Substances|growth substances|mesh-ancestor
82724110|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
82724111|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724112|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82724113|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724114|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724115|NCT00617734|Cetuximab|cetuximab|mesh-list
82724116|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82724117|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82724118|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724119|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
82724120|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724121|NCT00577460|Pramipexole|pramipexole|mesh-list
82724122|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
82724123|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724124|NCT00577460|Protective Agents|protective agents|mesh-ancestor
82724125|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724126|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82724127|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82724128|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
82724129|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
82724130|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724131|NCT00863980|Telmisartan|telmisartan|mesh-list
82724132|NCT00863980|Candesartan|candesartan|mesh-list
82724133|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
82724134|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82724135|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82724136|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82724137|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724138|NCT00415519|Edaravone|edaravone|mesh-list
82724139|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82724140|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
82724141|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724143|NCT00415519|Protective Agents|protective agents|mesh-ancestor
82724144|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724145|NCT05741294|Tirbanibulin|tirbanibulin|mesh-list
82724146|NCT05741294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724147|NCT05741294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724148|NCT02568176|Midazolam|midazolam|mesh-list
82724149|NCT02568176|Bupropion|bupropion|mesh-list
82724150|NCT02568176|Esketamine|esketamine|mesh-list
82724151|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82724152|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82724153|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724154|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724155|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82724156|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82724157|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82724158|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82724159|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
82724160|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
82724161|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
82724162|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
82724163|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724164|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724165|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82724166|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
82724167|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82724168|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82724169|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82724170|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
82724171|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82724172|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82724173|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724174|NCT00741182|Teriparatide|teriparatide|mesh-list
82724175|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82724176|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724177|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82724178|NCT00423943|Modafinil|modafinil|mesh-list
82724179|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82724180|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724181|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82724182|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82724183|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82724184|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724185|NCT00736346|Paroxetine|paroxetine|mesh-list
82724186|NCT00736346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82724187|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82724188|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82724189|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724190|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724191|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
82724192|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724193|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82724194|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
82724195|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82724196|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82724197|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82724198|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724199|NCT00864058|Gabapentin|gabapentin|mesh-list
82724200|NCT00864058|Analgesics|analgesics|mesh-ancestor
82724201|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
82724202|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724203|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724204|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
82724205|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82724206|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82724207|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724208|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82724209|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82724210|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82724211|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724212|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724213|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
82724214|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
82724215|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82724216|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
82724217|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82724218|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724219|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82724220|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82724221|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82724222|NCT00864214|Hormones|hormones|mesh-list
82724223|NCT00864214|Estradiol|estradiol|mesh-list
82724224|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82724225|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724226|NCT00864214|Estrogens|estrogens|mesh-ancestor
82724227|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
82724228|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82724229|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724230|NCT00428389|Rivastigmine|rivastigmine|mesh-list
82724231|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82724232|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724233|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724234|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
82724235|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724236|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724237|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82724239|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
82724240|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82724241|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724243|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82724244|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724245|NCT01324063|Cytarabine|cytarabine|mesh-list
82724246|NCT01324063|Daunorubicin|daunorubicin|mesh-list
82724247|NCT01324063|Amsacrine|amsacrine|mesh-list
82724248|NCT01324063|Sargramostim|sargramostim|mesh-list
82724249|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82724250|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
82724251|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724252|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724253|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
82724254|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724255|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82724256|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
82724257|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724258|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82724259|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82724260|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82724261|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724262|NCT00864448|Ramipril|ramipril|mesh-list
82724263|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82724264|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
82724265|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724266|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724267|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82724268|NCT00406315|Ziprasidone|ziprasidone|mesh-list
82724269|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82724270|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
82724271|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724272|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724273|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724274|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82724275|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82724276|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724277|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82724278|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82724279|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
82724280|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82724281|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
82724282|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82724283|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82724284|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82724285|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724286|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724288|NCT00864526|Oxycodone|oxycodone|mesh-list
82724289|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82724290|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82724291|NCT00864526|Analgesics|analgesics|mesh-ancestor
82724292|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
82724293|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724294|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724295|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82724296|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82724297|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82724298|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724299|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724300|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82724301|NCT00864526|Narcotics|narcotics|mesh-ancestor
82724302|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724303|NCT00864604|Nabumetone|nabumetone|mesh-list
82724304|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82724305|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82724307|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
82724308|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724309|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724310|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82724311|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82724312|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82724313|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82724314|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724315|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724316|NCT04064138|Anesthetics|anesthetics|mesh-list
82724317|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724318|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724319|NCT01323751|Ricolinostat|ricolinostat|mesh-list
82724320|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724321|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82724322|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724323|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724324|NCT00711594|Afatinib|afatinib|mesh-list
82724325|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724326|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82724327|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724328|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724329|NCT00864760|Gabapentin|gabapentin|mesh-list
82724330|NCT00864760|Analgesics|analgesics|mesh-ancestor
82724331|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
82724332|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724333|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724334|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
82724335|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82724336|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82724337|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724338|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82724339|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82724340|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82724341|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724342|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724343|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
82724344|NCT03743662|Bevacizumab|bevacizumab|mesh-list
82724345|NCT03743662|Nivolumab|nivolumab|mesh-list
82724346|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82724347|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724348|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82724349|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82724350|NCT03743662|Growth Substances|growth substances|mesh-ancestor
82724351|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724352|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
82724353|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82724354|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724355|NCT00710762|Nintedanib|nintedanib|mesh-list
82724356|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724357|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82724358|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724359|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724360|NCT05137912|Immunomodulating Agents|immunomodulating agents|mesh-list
82724361|NCT05137912|Immunologic Factors|immunologic factors|mesh-ancestor
82724362|NCT05137912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724363|NCT00736814|Carboplatin|carboplatin|mesh-list
82724364|NCT00736814|Gemcitabine|gemcitabine|mesh-list
82724365|NCT00736814|Docetaxel|docetaxel|mesh-list
82724366|NCT00736814|Vinorelbine|vinorelbine|mesh-list
82724367|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724368|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82724369|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
82724370|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724371|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
82724372|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
82724373|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
82724374|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82724375|NCT04063904|Misoprostol|misoprostol|mesh-list
82724376|NCT04063904|Mifepristone|mifepristone|mesh-list
82724377|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82724378|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
82724379|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82724380|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724381|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82724382|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82724383|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
82724384|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82724385|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82724386|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82724387|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82724388|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
82724389|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82724390|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82724391|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
82724392|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82724393|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
82724394|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82724395|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82724396|NCT00573430|Candesartan|candesartan|mesh-list
82724397|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
82724398|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82724399|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82724400|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82724401|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724402|NCT00711516|Modafinil|modafinil|mesh-list
82724403|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82724404|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724405|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82724406|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82724407|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82724408|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724409|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82724410|NCT00864838|Acetazolamide|acetazolamide|mesh-list
82724411|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82724412|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82724413|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82724414|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82724415|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
82724416|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724417|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724418|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724419|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
82724420|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82724421|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724422|NCT00864838|Diuretics|diuretics|mesh-ancestor
82724423|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
82724424|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
82724425|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82724426|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724427|NCT00615550|Progesterone|progesterone|mesh-list
82724428|NCT00615550|Progestins|progestins|mesh-ancestor
82724429|NCT00615550|Hormones|hormones|mesh-ancestor
82724430|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82724431|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724432|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
82724433|NCT00186888|Carboplatin|carboplatin|mesh-list
82724434|NCT00186888|Doxorubicin|doxorubicin|mesh-list
82724435|NCT00186888|Etoposide|etoposide|mesh-list
82724436|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
82724437|NCT00186888|Vincristine|vincristine|mesh-list
82724438|NCT00186888|Topotecan|topotecan|mesh-list
82724439|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82724440|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
82724441|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724442|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82724443|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82724444|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
82724445|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724446|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724447|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82724448|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82724449|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82724450|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82724451|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724452|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82724453|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
82724454|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
82724455|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
82724456|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82724457|NCT00736164|Selenium|selenium|mesh-list
82724458|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
82724459|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724460|NCT00736164|Protective Agents|protective agents|mesh-ancestor
82724461|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724462|NCT00736164|Trace Elements|trace elements|mesh-ancestor
82724463|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
82724464|NCT00739830|Sirolimus|sirolimus|mesh-list
82724465|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82724466|NCT00739830|Megestrol|megestrol|mesh-list
82724467|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
82724468|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
82724469|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82724470|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82724471|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82724472|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
82724473|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82724474|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724475|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82724476|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82724477|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82724478|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82724479|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724480|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
82724481|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82724482|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82724483|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724484|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82724485|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
82724486|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82724487|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
82724488|NCT00577382|Sunitinib|sunitinib|mesh-list
82724489|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724490|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82724491|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82724492|NCT00577382|Growth Substances|growth substances|mesh-ancestor
82724493|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724494|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
82724495|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82724496|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724497|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724498|NCT00733434|Alprostadil|alprostadil|mesh-list
82724499|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82724500|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
82724501|NCT00733434|Urological Agents|urological agents|mesh-ancestor
82724502|NCT00736320|Vincristine|vincristine|mesh-list
82724503|NCT00736320|Doxorubicin|doxorubicin|mesh-list
82724504|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82724505|NCT00736320|Dacarbazine|dacarbazine|mesh-list
82724506|NCT00736320|Bleomycin|bleomycin|mesh-list
82724507|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82724508|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724509|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
82724511|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
82724512|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724513|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82724514|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82724515|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82724516|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724517|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82724518|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
82724519|NCT04065282|Capecitabine|capecitabine|mesh-list
82724520|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
82724521|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82724522|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
82724523|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724524|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724525|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82724526|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82724527|NCT00873262|Estropipate|estropipate|mesh-list
82724529|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82724530|NCT00873262|Estrone|estrone|mesh-list
82724531|NCT00873262|Progesterone|progesterone|mesh-list
82724532|NCT00873262|Estrogens|estrogens|mesh-ancestor
82724533|NCT00873262|Hormones|hormones|mesh-ancestor
82724534|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82724535|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724536|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82724537|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
82724538|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82724539|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82724540|NCT00873262|Progestins|progestins|mesh-ancestor
82724541|NCT00739986|Semapimod|semapimod|mesh-list
82724618|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724542|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82724543|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82724544|NCT00739986|Analgesics|analgesics|mesh-ancestor
82724545|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
82724546|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724547|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724548|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82724549|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82724550|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82724551|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
82724552|NCT00736970|Sirolimus|sirolimus|mesh-list
82724553|NCT00736970|Trastuzumab|trastuzumab|mesh-list
82724554|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82724555|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724556|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82724557|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724558|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82724559|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
82724560|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82724561|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
82724562|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724563|NCT00873340|Interferons|interferons|mesh-list
82724564|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
82724565|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724566|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
82724567|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724568|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82724569|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
82724570|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724571|NCT00740064|Lamivudine|lamivudine|mesh-list
82724572|NCT00740064|Abacavir|abacavir|mesh-list
82724573|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
82724574|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82724575|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82724576|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724577|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724578|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
82724579|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724580|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82724581|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82724582|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82724583|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82724584|NCT00614926|Modafinil|modafinil|mesh-list
82724585|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82724586|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724587|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82724588|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82724589|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82724590|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724591|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
82724592|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
82724593|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82724594|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82724595|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724596|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724597|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724598|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82724600|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82724601|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
82724602|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
82724603|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724604|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724605|NCT00095784|Decitabine|decitabine|mesh-list
82724606|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82724607|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
82724608|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724609|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724610|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724611|NCT00740142|Lactulose|lactulose|mesh-list
82724612|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
82724613|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82724614|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
82724615|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82724616|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724617|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724619|NCT00873652|Vaccines|vaccines|mesh-list
82724620|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
82724621|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724622|NCT00423319|Enoxaparin|enoxaparin|mesh-list
82724623|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
82724624|NCT00423319|Apixaban|apixaban|mesh-list
82724625|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
82724626|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82724627|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82724628|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724629|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82724630|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
82724631|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82724632|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
82724633|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724634|NCT05224492|Sulforaphane|sulforaphane|mesh-list
82724635|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82724636|NCT05224492|Protective Agents|protective agents|mesh-ancestor
82724637|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724638|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724639|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82724640|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
82724641|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82724642|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82724643|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82724644|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724645|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724646|NCT04039126|Iodine|iodine|mesh-list
82724647|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
82724648|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
82724649|NCT04039126|Tetracycline|tetracycline|mesh-list
82724650|NCT04039126|Povidone|povidone|mesh-list
82724651|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82724652|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724653|NCT04039126|Trace Elements|trace elements|mesh-ancestor
82724654|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
82724655|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724656|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
82724657|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
82724658|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82724659|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82724660|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724661|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724662|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
82724663|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
82724664|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
82724665|NCT00873808|Tetracycline|tetracycline|mesh-list
82724666|NCT00873808|Demeclocycline|demeclocycline|mesh-list
82724667|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82724668|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724669|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82724670|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724671|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82724672|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724673|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724674|NCT04064190|Durvalumab|durvalumab|mesh-list
82724675|NCT04064190|Vactosertib|vactosertib|mesh-list
82724676|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82724677|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724678|NCT04064190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82724679|NCT04064190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724680|NCT04064190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724681|NCT00873886|Oseltamivir|oseltamivir|mesh-list
82724682|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
82724683|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724684|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724685|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724686|NCT00880282|Sirolimus|sirolimus|mesh-list
82724687|NCT00880282|Temsirolimus|temsirolimus|mesh-list
82724688|NCT00880282|MTOR Inhibitors|mtor inhibitors|mesh-list
82724689|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82724690|NCT00880282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82724691|NCT00880282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724692|NCT00880282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724693|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82724694|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
82724695|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724696|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724697|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82724698|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724699|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82724700|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
82724701|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82724702|NCT00874042|Gemcitabine|gemcitabine|mesh-list
82724703|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82724704|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
82724705|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724706|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724707|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
82724708|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82724709|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
82724710|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724711|NCT00736866|Expectorants|expectorants|mesh-ancestor
82724712|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
82724713|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82724714|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
82724715|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724716|NCT00736866|Protective Agents|protective agents|mesh-ancestor
82724717|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724718|NCT00736866|Antidotes|antidotes|mesh-ancestor
82724719|NCT00879424|Vitamin D|vitamin d|mesh-list
82724720|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
82724721|NCT00879424|Vitamins|vitamins|mesh-ancestor
82724722|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
82724723|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724724|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82724725|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82724726|NCT00710684|Donepezil|donepezil|mesh-list
82724727|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82724728|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724729|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724730|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
82724731|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724732|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724733|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
82724734|NCT00710606|NuvaRing|nuvaring|mesh-list
82724735|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82724736|NCT00710606|Desogestrel|desogestrel|mesh-list
82724737|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82724738|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
82724739|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82724740|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724741|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82724742|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82724743|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82724745|NCT00710606|Hormones|hormones|mesh-ancestor
82724746|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82724747|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82724748|NCT00710606|Progestins|progestins|mesh-ancestor
82724749|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
82724750|NCT00713544|Etanercept|etanercept|mesh-list
82724751|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82724752|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82724753|NCT00713544|Analgesics|analgesics|mesh-ancestor
82724754|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
82724755|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724756|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724757|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82724758|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82724759|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82724760|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82724761|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
82724762|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82724763|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724764|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82724765|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82724766|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
82724767|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724768|NCT00737126|Folic Acid|folic acid|mesh-list
82724769|NCT00737126|Hematinics|hematinics|mesh-ancestor
82724770|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
82724771|NCT00737126|Vitamins|vitamins|mesh-ancestor
82724772|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
82724773|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724774|NCT04063046|Anesthetics|anesthetics|mesh-list
82724775|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724776|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724777|NCT05529056|Atropine|atropine|mesh-list
82724778|NCT05529056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82724779|NCT05529056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82724780|NCT05529056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82724781|NCT05529056|Autonomic Agents|autonomic agents|mesh-ancestor
82724782|NCT05529056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724783|NCT05529056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724784|NCT05529056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82724785|NCT05529056|Respiratory System Agents|respiratory system agents|mesh-ancestor
82724786|NCT05529056|Mydriatics|mydriatics|mesh-ancestor
82724787|NCT05529056|Parasympatholytics|parasympatholytics|mesh-ancestor
82724788|NCT05529056|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82724789|NCT05529056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82724790|NCT05529056|Cholinergic Agents|cholinergic agents|mesh-ancestor
82724791|NCT05529056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724792|NCT05529056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724793|NCT00740922|Becaplermin|becaplermin|mesh-list
82724794|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
82724795|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
82724796|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82724797|NCT00740922|Growth Substances|growth substances|mesh-ancestor
82724798|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724799|NCT05523440|Bevacizumab|bevacizumab|mesh-list
82724800|NCT05523440|Niraparib|niraparib|mesh-list
82724801|NCT05523440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82724802|NCT05523440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724803|NCT05523440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82724804|NCT05523440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82724805|NCT05523440|Growth Substances|growth substances|mesh-ancestor
82724806|NCT05523440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724807|NCT05523440|Growth Inhibitors|growth inhibitors|mesh-ancestor
82724808|NCT05523440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82724809|NCT05523440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724810|NCT05523440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724811|NCT00741078|Amlodipine|amlodipine|mesh-list
82724812|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82724813|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82724814|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82724815|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724816|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82724817|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724818|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
82724819|NCT02568800|Cefepime|cefepime|mesh-list
82724820|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82724821|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82724822|NCT00741234|Azacitidine|azacitidine|mesh-list
82724823|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82724824|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
82724825|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724826|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724827|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724828|NCT00713258|Alendronate|alendronate|mesh-list
82724829|NCT00713258|Hormones|hormones|mesh-list
82724830|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
82724831|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82724832|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724833|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82724834|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82724835|NCT00710034|Nicotine|nicotine|mesh-list
82724836|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82724837|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
82724838|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724839|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724840|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82724841|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82724842|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
82724843|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724844|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724845|NCT02567942|Propofol|propofol|mesh-list
82724846|NCT02567942|Sevoflurane|sevoflurane|mesh-list
82724847|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82724848|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724849|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724850|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82724851|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
82724852|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
82724853|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82724854|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82724855|NCT00414973|Teriparatide|teriparatide|mesh-list
82724856|NCT00414973|Calcitonin|calcitonin|mesh-list
82724857|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
82724858|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
82724859|NCT00414973|Katacalcin|katacalcin|mesh-list
82724860|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82724861|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724862|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82724863|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
82724864|NCT00423085|Rivastigmine|rivastigmine|mesh-list
82724865|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82724866|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724867|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724868|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
82724869|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724870|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724871|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82724872|NCT00423085|Protective Agents|protective agents|mesh-ancestor
82724874|NCT00414661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82724875|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82724876|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724877|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724878|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
82724879|NCT01608451|Vitamin D|vitamin d|mesh-list
82724880|NCT01608451|Progesterone|progesterone|mesh-list
82724881|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82724882|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724883|NCT01608451|Vitamins|vitamins|mesh-ancestor
82724884|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
82724885|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82724886|NCT01608451|Progestins|progestins|mesh-ancestor
82724887|NCT01608451|Hormones|hormones|mesh-ancestor
82724888|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82724889|NCT00405067|Ezetimibe|ezetimibe|mesh-list
82724890|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82724891|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82724892|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
82724893|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724894|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82724895|NCT00708708|Etanercept|etanercept|mesh-list
82724896|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82724897|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82724898|NCT00708708|Analgesics|analgesics|mesh-ancestor
82724899|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
82724900|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724901|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724902|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82724903|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82724904|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82724905|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82724906|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
82724907|NCT00404755|Bupropion|bupropion|mesh-list
82724908|NCT00404755|Imipramine|imipramine|mesh-list
82724909|NCT00404755|Escitalopram|escitalopram|mesh-list
82724910|NCT00404755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82724911|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82724912|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82724913|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724914|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724915|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
82724916|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724917|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82724918|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
82724919|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82724920|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82724921|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
82725069|NCT05736744|Analgesics|analgesics|mesh-ancestor
82724922|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82724923|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82724924|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724925|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82724926|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82724927|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
82724928|NCT03904381|Fluorouracil|fluorouracil|mesh-list
82724929|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
82724930|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724931|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82724932|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82724933|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82724934|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
82724935|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724936|NCT00737256|Aripiprazole|aripiprazole|mesh-list
82724937|NCT00737256|Perphenazine|perphenazine|mesh-list
82724938|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
82724939|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82724940|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82724941|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82724942|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82724943|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724944|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
82724945|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
82724946|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724947|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724948|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82724949|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82724950|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
82724951|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82724952|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82724953|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82724954|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82724955|NCT00614614|Vaccines|vaccines|mesh-list
82724956|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
82724957|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724958|NCT00713310|Mesalamine|mesalamine|mesh-list
82724959|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82724960|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82724961|NCT00713310|Analgesics|analgesics|mesh-ancestor
82724962|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
82724963|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724964|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724965|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82724966|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82724968|NCT05740488|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82724969|NCT05740488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82724970|NCT05740488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724971|NCT05742126|Heparin|heparin|mesh-list
82724972|NCT05742126|Calcium heparin|calcium heparin|mesh-list
82724973|NCT05742126|Anticoagulants|anticoagulants|mesh-ancestor
82724974|NCT05742126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82724975|NCT05742126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82724976|NCT05742126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724977|NCT00882856|Bisoprolol|bisoprolol|mesh-list
82724978|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82724979|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
82724980|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
82724981|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82724982|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724983|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82724984|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82724985|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82724986|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
82724987|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82724988|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724989|NCT00880672|Dutasteride|dutasteride|mesh-list
82724990|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82724991|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82724992|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82724993|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82724994|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
82725070|NCT05736744|Sensory System Agents|sensory system agents|mesh-ancestor
82724995|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82724996|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82724997|NCT00737724|Efavirenz|efavirenz|mesh-list
82724998|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82724999|NCT00737724|Isoniazid|isoniazid|mesh-list
82725000|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82725001|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82725002|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725003|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725004|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
82725005|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725006|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82725007|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82725008|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82725009|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82725010|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82725011|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82725012|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82725013|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82725014|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
82725015|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82725016|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82725017|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82725018|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
82725019|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82725020|NCT00880828|Acetaminophen|acetaminophen|mesh-list
82725021|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82725022|NCT00880828|Analgesics|analgesics|mesh-ancestor
82725023|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
82725024|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725025|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725026|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
82725027|NCT00712920|Azelastine|azelastine|mesh-list
82725028|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82725029|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
82725030|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725031|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725032|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82725033|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
82725034|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82725035|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725036|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725037|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82725038|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82725039|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82725040|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
82725041|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
82725042|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725043|NCT00874744|Triamcinolone|triamcinolone|mesh-list
82725044|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82725045|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82725046|NCT00874744|Bevacizumab|bevacizumab|mesh-list
82725047|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82725048|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82725049|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725050|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82725051|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82725052|NCT00874744|Growth Substances|growth substances|mesh-ancestor
82725053|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725054|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
82725055|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82725056|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
82725057|NCT00874744|Hormones|hormones|mesh-ancestor
82725058|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82725059|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82725060|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
82725061|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725062|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725063|NCT05736744|Magnesium Sulfate|magnesium sulfate|mesh-list
82725064|NCT05736744|Bromides|bromides|mesh-list
82725065|NCT05736744|Rocuronium|rocuronium|mesh-list
82725066|NCT05736744|Atracurium|atracurium|mesh-list
82725067|NCT05736744|Cisatracurium|cisatracurium|mesh-list
82725068|NCT05736744|Anticonvulsants|anticonvulsants|mesh-ancestor
82725071|NCT05736744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725072|NCT05736744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725073|NCT05736744|Anesthetics|anesthetics|mesh-ancestor
82725074|NCT05736744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725075|NCT05736744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82725076|NCT05736744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82725077|NCT05736744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82725078|NCT05736744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725079|NCT05736744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82725080|NCT05736744|Tocolytic Agents|tocolytic agents|mesh-ancestor
82725081|NCT05736744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82725082|NCT05736744|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82725083|NCT05736744|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82725084|NCT05736744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82725085|NCT05736744|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82725086|NCT05736744|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82725087|NCT05736744|Cholinergic Agents|cholinergic agents|mesh-ancestor
82725088|NCT05736744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725089|NCT00920868|Bevacizumab|bevacizumab|mesh-list
82725090|NCT00920868|Capecitabine|capecitabine|mesh-list
82725091|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
82725092|NCT00920868|Dasatinib|dasatinib|mesh-list
82725093|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82725094|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725095|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82725096|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82725097|NCT00920868|Growth Substances|growth substances|mesh-ancestor
82725098|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725099|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
82725100|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82725101|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
82725102|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725103|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82725104|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725105|NCT05741814|Propofol|propofol|mesh-list
82725106|NCT05741814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82725107|NCT05741814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725108|NCT05741814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725109|NCT05741814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82725110|NCT05741814|Anesthetics, General|anesthetics, general|mesh-ancestor
82725111|NCT05741814|Anesthetics|anesthetics|mesh-ancestor
82725112|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
82725113|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82725114|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
82725115|NCT04721626|Tetracycline|tetracycline|mesh-list
82725116|NCT04721626|Doxycycline|doxycycline|mesh-list
82725117|NCT04721626|Povidone|povidone|mesh-list
82725118|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82725119|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725120|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
82725121|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
82725122|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
82725123|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
82725124|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82725125|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82725126|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725127|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725128|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
82725129|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82725130|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82725131|NCT00881140|Mifepristone|mifepristone|mesh-list
82725132|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82725133|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
82725134|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82725135|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725136|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82725137|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82725138|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82725139|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
82725140|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82725141|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82725142|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
82725143|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82725144|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
82725222|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
82725145|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82725146|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82725147|NCT05733078|Vitamins|vitamins|mesh-list
82725148|NCT05733078|Ascorbic Acid|ascorbic acid|mesh-list
82725149|NCT05733078|Micronutrients|micronutrients|mesh-ancestor
82725150|NCT05733078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725151|NCT05733078|Antioxidants|antioxidants|mesh-ancestor
82725152|NCT05733078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725153|NCT05733078|Protective Agents|protective agents|mesh-ancestor
82725154|NCT00874978|Lenalidomide|lenalidomide|mesh-list
82725155|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
82725156|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725157|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82725158|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82725159|NCT00874978|Growth Substances|growth substances|mesh-ancestor
82725160|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
82725161|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725162|NCT00737880|Pancrelipase|pancrelipase|mesh-list
82725163|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82725164|NCT05728632|Nebivolol|nebivolol|mesh-list
82725165|NCT05728632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82725166|NCT05728632|Vasodilator Agents|vasodilator agents|mesh-ancestor
82725167|NCT05728632|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82725168|NCT05728632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82725169|NCT05728632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82725170|NCT05728632|Adrenergic Agents|adrenergic agents|mesh-ancestor
82725171|NCT05728632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725172|NCT05728632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725173|NCT05728632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725174|NCT05741502|Olanzapine|olanzapine|mesh-list
82725175|NCT05741502|Risperidone|risperidone|mesh-list
82725176|NCT05741502|Aripiprazole|aripiprazole|mesh-list
82725177|NCT05741502|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82725178|NCT05741502|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82725179|NCT05741502|Ziprasidone|ziprasidone|mesh-list
82725180|NCT05741502|Antipsychotic Agents|antipsychotic agents|mesh-list
82725181|NCT05741502|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82725182|NCT05741502|Clozapine|clozapine|mesh-list
82725183|NCT05741502|Cariprazine|cariprazine|mesh-list
82725184|NCT05741502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82725185|NCT05741502|Serotonin Agents|serotonin agents|mesh-ancestor
82725186|NCT05741502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725187|NCT05741502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725188|NCT05741502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725189|NCT05741502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82725190|NCT05741502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725191|NCT05741502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82725192|NCT05741502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82725194|NCT05741502|Antiemetics|antiemetics|mesh-ancestor
82725195|NCT05741502|Autonomic Agents|autonomic agents|mesh-ancestor
82725196|NCT05741502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725197|NCT05741502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82725198|NCT05741502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82725199|NCT05741502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82725200|NCT05741502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82725201|NCT05741502|Antidepressive Agents|antidepressive agents|mesh-ancestor
82725202|NCT05741502|Dopamine Agonists|dopamine agonists|mesh-ancestor
82725203|NCT05741502|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82725204|NCT05741502|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82725205|NCT05741502|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82725206|NCT05741502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82725207|NCT05741502|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82725208|NCT05741502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82725209|NCT05741502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82725210|NCT05741502|Adrenergic Agents|adrenergic agents|mesh-ancestor
82725211|NCT05741502|GABA Antagonists|gaba antagonists|mesh-ancestor
82725212|NCT05741502|GABA Agents|gaba agents|mesh-ancestor
82725213|NCT00612586|Leucovorin|leucovorin|mesh-list
82725214|NCT00612586|Bevacizumab|bevacizumab|mesh-list
82725215|NCT00612586|Fluorouracil|fluorouracil|mesh-list
82725216|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82725217|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725218|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82725219|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82725220|NCT00612586|Growth Substances|growth substances|mesh-ancestor
82725221|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725223|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
82725224|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725225|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82725226|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82725227|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
82725228|NCT00612586|Antidotes|antidotes|mesh-ancestor
82725229|NCT00612586|Protective Agents|protective agents|mesh-ancestor
82725230|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
82725231|NCT00612586|Vitamins|vitamins|mesh-ancestor
82725232|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
82725233|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
82725234|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82725235|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82725236|NCT00614380|Amlodipine|amlodipine|mesh-list
82725237|NCT00614380|Telmisartan|telmisartan|mesh-list
82725238|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
82725239|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82725240|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82725241|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82725242|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725243|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82725244|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725245|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
82725246|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82725247|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82725248|NCT00738192|Fentanyl|fentanyl|mesh-list
82725249|NCT00738192|Sufentanil|sufentanil|mesh-list
82725251|NCT00738192|Butorphanol|butorphanol|mesh-list
82725252|NCT00738192|Citric Acid|citric acid|mesh-list
82725253|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
82725254|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82725255|NCT00738192|Narcotics|narcotics|mesh-ancestor
82725256|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725257|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725258|NCT00738192|Analgesics|analgesics|mesh-ancestor
82725259|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
82725260|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725261|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82725262|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82725263|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
82725264|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
82725265|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
82725266|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82725267|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
82725268|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
82725269|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725270|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
82725271|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
82725272|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82725273|NCT05500170|Niacinamide|niacinamide|mesh-list
82725275|NCT05500170|Nicotinic Acids|nicotinic acids|mesh-list
82725276|NCT05500170|Vitamins|vitamins|mesh-ancestor
82725277|NCT05500170|Micronutrients|micronutrients|mesh-ancestor
82725278|NCT05500170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725279|NCT05500170|Vitamin B Complex|vitamin b complex|mesh-ancestor
82725280|NCT05500170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82725281|NCT05500170|Antimetabolites|antimetabolites|mesh-ancestor
82725282|NCT05500170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725283|NCT05500170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82725284|NCT05500170|Vasodilator Agents|vasodilator agents|mesh-ancestor
82725285|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
82725286|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82725287|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82725288|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
82725289|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725290|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725291|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725292|NCT00884104|Urological Agents|urological agents|mesh-ancestor
82725293|NCT04140214|Carbocysteine|carbocysteine|mesh-list
82725294|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82725295|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725296|NCT04140214|Expectorants|expectorants|mesh-ancestor
82725297|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
82725298|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82725299|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82725300|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82725301|NCT00612508|Etonogestrel|etonogestrel|mesh-list
82725756|NCT00811785|Copper|copper|mesh-list
82725303|NCT00612508|NuvaRing|nuvaring|mesh-list
82725304|NCT00612508|Estradiol|estradiol|mesh-list
82725305|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82725306|NCT00612508|Estrogens|estrogens|mesh-ancestor
82725307|NCT00612508|Hormones|hormones|mesh-ancestor
82725308|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82725309|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725310|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82725311|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
82725312|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82725313|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82725314|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82725315|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82725316|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82725317|NCT00612508|Progestins|progestins|mesh-ancestor
82725318|NCT00881218|Regadenoson|regadenoson|mesh-list
82725319|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
82725320|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82725321|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
82725322|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
82725323|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725324|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725325|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725326|NCT00613834|Lidocaine|lidocaine|mesh-list
82725327|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
82725328|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
82725329|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725330|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725331|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
82725332|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725333|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82725334|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82725335|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82725336|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82725337|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725338|NCT00875368|Maraviroc|maraviroc|mesh-list
82725339|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82725340|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82725341|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725342|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82725343|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82725344|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
82725345|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725346|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82725347|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
82725348|NCT03912298|Narcotics|narcotics|mesh-ancestor
82725349|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725350|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725351|NCT03912298|Analgesics|analgesics|mesh-ancestor
82725352|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
82725353|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725354|NCT02543710|Taxane|taxane|mesh-list
82725355|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725356|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
82725357|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82725358|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
82725359|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82725360|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725361|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82725362|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82725363|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82725364|NCT00881296|Carboplatin|carboplatin|mesh-list
82725365|NCT00881296|Gemcitabine|gemcitabine|mesh-list
82725366|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725367|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82725368|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
82725369|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725370|NCT00613366|Misoprostol|misoprostol|mesh-list
82725371|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
82725372|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82725373|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
82725374|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82725375|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725376|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82725377|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82725378|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
82725379|NCT00613366|Antacids|antacids|mesh-ancestor
82725380|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725381|NCT00612352|Ethanol|ethanol|mesh-list
82725382|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82725383|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725384|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725385|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725386|NCT00884416|Sorafenib|sorafenib|mesh-list
82725387|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725388|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82725389|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725390|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725391|NCT00884494|Insulin|insulin|mesh-list
82725392|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82725393|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725394|NCT00881686|Adenosine|adenosine|mesh-list
82725395|NCT00881686|Analgesics|analgesics|mesh-ancestor
82725396|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
82725397|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725398|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725399|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82725400|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
82725401|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82725402|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
82725403|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
82725404|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725405|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725406|NCT00885508|Lenalidomide|lenalidomide|mesh-list
82725407|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
82725408|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725409|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82725410|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82725411|NCT00885508|Growth Substances|growth substances|mesh-ancestor
82725412|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
82725413|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725414|NCT02543086|Piperaquine|piperaquine|mesh-list
82725415|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
82725416|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82725417|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82725418|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725420|NCT00885586|Analgesics|analgesics|mesh-ancestor
82725421|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
82725422|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725423|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725424|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
82725425|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82725426|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82725427|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725428|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82725429|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82725430|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82725431|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725432|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725433|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
82725434|NCT02542930|Thymalfasin|thymalfasin|mesh-list
82725435|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82725436|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
82725437|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725438|NCT00881764|Anesthetics|anesthetics|mesh-list
82725439|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725440|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725441|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
82725442|NCT04038034|Vitamins|vitamins|mesh-ancestor
82725443|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
82725444|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725445|NCT04037878|Tramadol|tramadol|mesh-list
82725446|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82725447|NCT04037878|Narcotics|narcotics|mesh-ancestor
82725448|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725449|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725450|NCT04037878|Analgesics|analgesics|mesh-ancestor
82725451|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
82725452|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725454|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82725455|NCT02542852|Dolutegravir|dolutegravir|mesh-list
82725456|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82725457|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82725458|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
82725459|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725460|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725461|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82725462|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82725463|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
82725464|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725465|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82725466|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82725467|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82725468|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82725469|NCT00651261|Cytarabine|cytarabine|mesh-list
82725470|NCT00651261|Dexamethasone|dexamethasone|mesh-list
82725471|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
82725472|NCT00651261|Daunorubicin|daunorubicin|mesh-list
82725473|NCT00651261|Midostaurin|midostaurin|mesh-list
82725474|NCT00651261|BB 1101|bb 1101|mesh-list
82725475|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82725476|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
82725477|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
82725478|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725479|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725480|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82725481|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
82725482|NCT00651261|Hormones|hormones|mesh-ancestor
82725483|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82725484|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82725485|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725486|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82725487|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
82725488|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725489|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
82725490|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725491|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82725492|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
82725493|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82725494|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82725495|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82725496|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725497|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82725498|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
82725499|NCT00885820|Prednisone|prednisone|mesh-list
82725500|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
82725501|NCT00885820|Tacrolimus|tacrolimus|mesh-list
82725502|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82725503|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
82725504|NCT00885820|Hormones|hormones|mesh-ancestor
82725505|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82725506|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725507|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82725508|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725509|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82725510|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
82725511|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82725512|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725513|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725514|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
82725515|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
82725516|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725517|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82725518|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82725519|NCT00885820|Protective Agents|protective agents|mesh-ancestor
82725520|NCT02567838|Lidocaine|lidocaine|mesh-list
82725521|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
82725522|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
82725523|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725524|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725525|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
82725526|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725527|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82725528|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82725529|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82725530|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82725531|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725532|NCT00651183|Pramipexole|pramipexole|mesh-list
82725533|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
82725534|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725535|NCT00651183|Protective Agents|protective agents|mesh-ancestor
82725536|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725537|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82725538|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82725539|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
82725540|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
82725541|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725542|NCT00810381|Nitroprusside|nitroprusside|mesh-list
82725544|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
82725545|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
82725546|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
82725547|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
82725548|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82725549|NCT00810381|Diuretics|diuretics|mesh-ancestor
82725550|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
82725551|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725552|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82725553|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725554|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82725555|NCT00800319|ALKS-33|alks-33|mesh-list
82725556|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82725557|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725558|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
82725559|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725560|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82725561|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
82725562|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725563|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
82725564|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82725565|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
82725566|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725567|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82725568|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82725569|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82725570|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725571|NCT00810849|Prednisolone|prednisolone|mesh-list
82725572|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82725573|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
82725574|NCT00810849|Hormones|hormones|mesh-ancestor
82725575|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82725576|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725577|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82725578|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725579|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
82725580|NCT00811005|Methoxsalen|methoxsalen|mesh-list
82725581|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82725582|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
82725583|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82725584|NCT00813735|Dexetimide|dexetimide|mesh-list
82725585|NCT00813735|Eszopiclone|eszopiclone|mesh-list
82725586|NCT00813735|Citalopram|citalopram|mesh-list
82725587|NCT00813735|Escitalopram|escitalopram|mesh-list
82725588|NCT00813735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82725589|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82725590|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82725591|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725592|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725593|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
82725594|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725595|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82725596|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82725597|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
82725598|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
82725599|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725600|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82725601|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82725602|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
82725603|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82725604|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
82725605|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82725606|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82725607|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725608|NCT00811083|Succimer|succimer|mesh-list
82725609|NCT00811083|Antidotes|antidotes|mesh-ancestor
82725610|NCT00811083|Protective Agents|protective agents|mesh-ancestor
82725611|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725612|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
82725613|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
82725614|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725615|NCT00642759|Paclitaxel|paclitaxel|mesh-list
82725616|NCT00642759|Bevacizumab|bevacizumab|mesh-list
82725617|NCT00642759|Carboplatin|carboplatin|mesh-list
82725618|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82725619|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725620|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
82725621|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
82725622|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
82725623|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725624|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82725625|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82725626|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82725627|NCT00642759|Growth Substances|growth substances|mesh-ancestor
82725628|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725629|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
82725631|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82725632|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82725633|NCT00813891|Growth Substances|growth substances|mesh-ancestor
82725634|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725635|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
82725636|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725637|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
82725638|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82725639|NCT00611026|Fesoterodine|fesoterodine|mesh-list
82725640|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82725641|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82725642|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82725643|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
82725644|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725645|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725646|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725647|NCT00611026|Urological Agents|urological agents|mesh-ancestor
82725648|NCT02552589|Fluorides|fluorides|mesh-list
82725649|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
82725650|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
82725651|NCT02552589|Protective Agents|protective agents|mesh-ancestor
82725652|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725653|NCT00811239|Antivenins|antivenins|mesh-list
82725654|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
82725655|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725656|NCT00814047|Yohimbine|yohimbine|mesh-list
82725657|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
82725658|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
82725659|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725660|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725661|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82725662|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82725663|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82725664|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
82725665|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725666|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725667|NCT00814047|Urological Agents|urological agents|mesh-ancestor
82725668|NCT00814125|Tamoxifen|tamoxifen|mesh-list
82725669|NCT00814125|Anastrozole|anastrozole|mesh-list
82725670|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82725671|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
82725672|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82725673|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725674|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82725675|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725676|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82725677|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82725678|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82725679|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82725680|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82725681|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725682|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725683|NCT00817713|Ivermectin|ivermectin|mesh-list
82725684|NCT00817713|Albendazole|albendazole|mesh-list
82725685|NCT00817713|Praziquantel|praziquantel|mesh-list
82725686|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82725687|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725688|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
82725689|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
82725690|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82725691|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82725692|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
82725693|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
82725694|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
82725695|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725696|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725697|NCT00422383|Rituximab|rituximab|mesh-list
82725698|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82725699|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725700|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
82725701|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725702|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82725703|NCT00814281|Montelukast|montelukast|mesh-list
82725704|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82725705|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
82725706|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82725707|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
82725708|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82725709|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725710|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82725711|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82725712|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725713|NCT00814359|Benzydamine|benzydamine|mesh-list
82725714|NCT00814359|Sucralfate|sucralfate|mesh-list
82725715|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82725716|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82725717|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82725718|NCT00612040|Insulin|insulin|mesh-list
82725719|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82725720|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
82725721|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
82725722|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
82725723|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82725724|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725725|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
82725726|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
82725727|NCT00422227|Etanercept|etanercept|mesh-list
82725728|NCT00422227|Methotrexate|methotrexate|mesh-list
82725729|NCT00422227|Leflunomide|leflunomide|mesh-list
82725730|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82725731|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
82725732|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82725733|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725734|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82725735|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
82725736|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725737|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725738|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
82725739|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725740|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82725741|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82725742|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
82725743|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82725744|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82725745|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
82725746|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82725747|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82725748|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725749|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82725750|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82725751|NCT00422227|Analgesics|analgesics|mesh-ancestor
82725752|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
82725753|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725754|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82725755|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82725757|NCT00811785|Trace Elements|trace elements|mesh-ancestor
82725758|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
82725759|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725760|NCT00814515|Cyclosporine|cyclosporine|mesh-list
82725761|NCT00814515|Cyclosporins|cyclosporins|mesh-list
82725762|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725763|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725764|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82725765|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
82725766|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725767|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
82725768|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725769|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
82725770|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82725771|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82725773|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82725774|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
82725775|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725776|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725777|NCT00421993|Adapalene|adapalene|mesh-list
82725778|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
82725779|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82725780|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
82725781|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82725782|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82725783|NCT00421993|Analgesics|analgesics|mesh-ancestor
82725784|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
82725785|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725786|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725787|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82725788|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82725789|NCT00884884|Topiramate|topiramate|mesh-list
82725790|NCT00884884|Aripiprazole|aripiprazole|mesh-list
82725791|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
82725792|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82725793|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82725794|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82725795|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725796|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725797|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
82725798|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
82725799|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725800|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725801|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82725802|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82725803|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
82725804|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82725805|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82725806|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82725807|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82725808|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
82725809|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82725810|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
82725811|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725812|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82725813|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725814|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725815|NCT02551029|Capsaicin|capsaicin|mesh-list
82725816|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
82725817|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
82725818|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
82725819|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725820|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725821|NCT00812019|Vaccines|vaccines|mesh-list
82725822|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
82725823|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
82725824|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725825|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82725826|NCT00413959|Dexamethasone|dexamethasone|mesh-list
82725827|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
82725828|NCT00413959|Rituximab|rituximab|mesh-list
82725829|NCT00413959|Bortezomib|bortezomib|mesh-list
82725830|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82725831|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
82725832|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725833|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82725834|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82725835|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
82725836|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725837|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725838|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82725839|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82725840|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82725841|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
82725842|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
82725843|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725844|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82725845|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
82725846|NCT00413959|Hormones|hormones|mesh-ancestor
82725847|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82725848|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82725849|NCT00814905|Clindamycin|clindamycin|mesh-list
82725850|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
82725851|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
82725852|NCT00814905|Gentamicins|gentamicins|mesh-list
82725853|NCT00814905|Ampicillin|ampicillin|mesh-list
82725854|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82725855|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725856|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82725857|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725858|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725859|NCT00611884|Insulin|insulin|mesh-list
82725860|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82725861|NCT00611884|Metformin|metformin|mesh-list
82725862|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
82725863|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
82725864|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82725865|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725866|NCT00611806|Folic Acid|folic acid|mesh-list
82725867|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
82725868|NCT00611806|Hematinics|hematinics|mesh-ancestor
82725869|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
82725870|NCT00611806|Vitamins|vitamins|mesh-ancestor
82725871|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
82725872|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725873|NCT00413413|Amlodipine|amlodipine|mesh-list
82725874|NCT00413413|Valsartan|valsartan|mesh-list
82725875|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82725876|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82725877|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82725878|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725879|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82725880|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725881|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
82725882|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82725883|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82725884|NCT00886132|Sunitinib|sunitinib|mesh-list
82725885|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725886|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82725887|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82725888|NCT00886132|Growth Substances|growth substances|mesh-ancestor
82725889|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725890|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
82725891|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82725892|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725893|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725894|NCT01040455|Lansoprazole|lansoprazole|mesh-list
82725895|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
82725896|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82725897|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82725898|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82725899|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725900|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725902|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725903|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
82725904|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
82725905|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
82725906|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725907|NCT01041313|Memantine|memantine|mesh-list
82725908|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82725909|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82725910|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
82725911|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725912|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725913|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725914|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82725915|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82725917|NCT00610714|Carboplatin|carboplatin|mesh-list
82725918|NCT00610714|Saracatinib|saracatinib|mesh-list
82725919|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82725920|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725921|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
82725922|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
82725923|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
82725924|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725925|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725926|NCT00403585|Adefovir|adefovir|mesh-list
82725927|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82725928|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
82725929|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725930|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82725931|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82725932|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725933|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725934|NCT00645411|Vaccines|vaccines|mesh-list
82725935|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
82725936|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725937|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
82725938|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82725939|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82725940|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82725941|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82725942|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725943|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
82725944|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725945|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725946|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82725947|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725948|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
82725949|NCT00885274|Citric Acid|citric acid|mesh-list
82725950|NCT00885274|Antacids|antacids|mesh-ancestor
82725951|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725952|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82725953|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
82725954|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82725955|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
82725956|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
82725957|NCT00402727|Amoxicillin|amoxicillin|mesh-list
82725958|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
82725959|NCT00402727|Tazobactam|tazobactam|mesh-list
82725960|NCT00402727|Piperacillin|piperacillin|mesh-list
82725961|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
82725962|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
82725963|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82725964|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82725965|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82725966|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82725967|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82725968|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82725969|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82725970|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725971|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82725972|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82725973|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
82725974|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82725975|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725976|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82725977|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82725978|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82725979|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82725980|NCT00923494|Ropivacaine|ropivacaine|mesh-list
82725981|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
82725982|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
82725983|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82725984|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725985|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
82725986|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82725987|NCT00888784|Propranolol|propranolol|mesh-list
82725988|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82725989|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82725990|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
82725991|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82725992|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82725993|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82725994|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82725995|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82725996|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
82725997|NCT00886678|Carboplatin|carboplatin|mesh-list
82725998|NCT00886678|Pemetrexed|pemetrexed|mesh-list
82725999|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726000|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726001|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726002|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82726003|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82726004|NCT00402337|Linaclotide|linaclotide|mesh-list
82726005|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
82726006|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
82726007|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726008|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82726009|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82726010|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82726011|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82726012|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726013|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726014|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726015|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726016|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
82726017|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82726018|NCT00886990|Ritonavir|ritonavir|mesh-list
82726019|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82726020|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82726021|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
82726022|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726023|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726024|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82726025|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82726026|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
82726027|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726028|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82726029|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82726030|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
82726031|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82726032|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
82726033|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726035|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
82726036|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82726037|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
82726038|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726039|NCT00650091|Protective Agents|protective agents|mesh-ancestor
82726040|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726041|NCT00650091|Antidotes|antidotes|mesh-ancestor
82726042|NCT00889018|Carboplatin|carboplatin|mesh-list
82726043|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726044|NCT00889096|Propranolol|propranolol|mesh-list
82726045|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82726046|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82726047|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
82726048|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726049|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726050|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726051|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82726052|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82726053|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
82726054|NCT00818103|Interferons|interferons|mesh-list
82726055|NCT00818103|Atorvastatin|atorvastatin|mesh-list
82726056|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726057|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
82726058|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726059|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82726060|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82726061|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
82726062|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726063|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82726064|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82726065|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726066|NCT00642369|Haloperidol|haloperidol|mesh-list
82726067|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82726068|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
82726069|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
82726070|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82726071|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82726072|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82726073|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82726074|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726075|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
82726076|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
82726077|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726078|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82726079|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82726080|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
82726081|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726082|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726083|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82726084|NCT01154335|Everolimus|everolimus|mesh-list
82726085|NCT01154335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82726086|NCT01154335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82726087|NCT01154335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726088|NCT01154335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726089|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726090|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
82726091|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726092|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726094|NCT00889642|Epinephrine|epinephrine|mesh-list
82726095|NCT00889642|Racepinephrine|racepinephrine|mesh-list
82726096|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
82726097|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
82726098|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
82726099|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82726100|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726101|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
82726102|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726103|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82726104|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82726105|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82726106|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726107|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726108|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82726109|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82726110|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
82726111|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726112|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82726113|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82726114|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
82726115|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82726116|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
82726117|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
82726118|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
82726119|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82726120|NCT02541526|Mirtazapine|mirtazapine|mesh-list
82726121|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
82726122|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82726123|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82726124|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
82726125|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
82726126|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726127|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726128|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726129|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82726130|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82726131|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82726132|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82726133|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82726134|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82726135|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
82726136|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82726137|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82726138|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
82726139|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82726140|NCT01037959|Norfloxacin|norfloxacin|mesh-list
82726141|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82726142|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726143|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82726144|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82726145|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726146|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726147|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726148|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82726149|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82726150|NCT01038037|Carboplatin|carboplatin|mesh-list
82726151|NCT01038037|Vinorelbine|vinorelbine|mesh-list
82726152|NCT01038037|Panitumumab|panitumumab|mesh-list
82726153|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726154|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82726155|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
82726156|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
82726157|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
82726158|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726159|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82726160|NCT00645099|Olanzapine|olanzapine|mesh-list
82726161|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82726162|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
82726163|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
82726164|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726165|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726166|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82726167|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82726168|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82726169|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82726170|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82726171|NCT00645099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82726172|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82726173|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726174|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726175|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726176|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
82726177|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82726178|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82726179|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82726180|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82726181|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
82726182|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82726183|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82726184|NCT01038349|Methotrexate|methotrexate|mesh-list
82726185|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82726186|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
82726187|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82726188|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726189|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82726190|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
82726191|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726192|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726193|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
82726194|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726195|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82726196|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726197|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
82726198|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82726199|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82726200|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
82726201|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
82726202|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82726203|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726204|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82726205|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82726206|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726207|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726208|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726209|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82726210|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82726211|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82726212|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
82726213|NCT01038505|Sirolimus|sirolimus|mesh-list
82726214|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
82726215|NCT01038505|Tacrolimus|tacrolimus|mesh-list
82726216|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726217|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
82726218|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726219|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82726220|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726221|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726222|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82726223|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726224|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82726225|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726226|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
82726227|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82726228|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
82726229|NCT01038583|Aspirin|aspirin|mesh-list
82726230|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82726231|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82726232|NCT01038583|Analgesics|analgesics|mesh-ancestor
82726233|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
82726234|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726235|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726236|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82726237|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82726238|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82726239|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82726240|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726241|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82726242|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82726243|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726244|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
82726245|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
82726246|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82726247|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
82726248|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726249|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726250|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82726251|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
82726252|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82726253|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
82726254|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726255|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726256|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82726257|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
82726258|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
82726259|NCT02551107|Protective Agents|protective agents|mesh-ancestor
82726260|NCT01038661|Docetaxel|docetaxel|mesh-list
82726261|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726262|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
82726263|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
82726264|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
82726265|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726266|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
82726267|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
82726268|NCT01038817|Protective Agents|protective agents|mesh-ancestor
82726269|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726270|NCT00420511|Metformin|metformin|mesh-list
82726271|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82726272|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82726273|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726274|NCT00420511|Incretins|incretins|mesh-ancestor
82726275|NCT00420511|Hormones|hormones|mesh-ancestor
82726276|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82726277|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82726278|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
82726279|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726280|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726281|NCT01038895|Ramipril|ramipril|mesh-list
82726282|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82726283|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
82726284|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726285|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726286|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82726287|NCT00420199|Abatacept|abatacept|mesh-list
82726288|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82726289|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726290|NCT00420199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82726291|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726292|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726293|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
82726294|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726295|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82726296|NCT00649389|Amlodipine|amlodipine|mesh-list
82726297|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82726298|NCT00649389|Olmesartan|olmesartan|mesh-list
82726299|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82726300|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82726301|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82726302|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726303|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726304|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82726305|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726306|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
82726307|NCT00649389|Diuretics|diuretics|mesh-ancestor
82726308|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
82726309|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82726310|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82726311|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82726312|NCT00402103|Amlodipine|amlodipine|mesh-list
82726313|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82726314|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82726315|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82726316|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726317|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726318|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82726319|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726320|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
82726321|NCT00402103|Diuretics|diuretics|mesh-ancestor
82726322|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
82726323|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82726324|NCT00812175|Sorafenib|sorafenib|mesh-list
82726325|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726326|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82726327|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726328|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726329|NCT00815373|Timolol|timolol|mesh-list
82726330|NCT00815373|Dorzolamide|dorzolamide|mesh-list
82726331|NCT00815373|Latanoprost|latanoprost|mesh-list
82726332|NCT00815373|Maleic acid|maleic acid|mesh-list
82726333|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726334|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726335|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82726336|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82726337|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
82726338|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726339|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726340|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82726341|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82726342|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82726343|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82726344|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82726345|NCT00641667|Fentanyl|fentanyl|mesh-list
82726346|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82726347|NCT00641667|Narcotics|narcotics|mesh-ancestor
82726348|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82726349|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726350|NCT00641667|Analgesics|analgesics|mesh-ancestor
82726351|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
82726352|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726353|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82726354|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82726355|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
82726356|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
82726357|NCT00704184|Interferons|interferons|mesh-list
82726358|NCT00704184|Ribavirin|ribavirin|mesh-list
82726359|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726360|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
82726361|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726362|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
82726363|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726364|NCT00641043|Pioglitazone|pioglitazone|mesh-list
82726365|NCT00641043|Linagliptin|linagliptin|mesh-list
82726366|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82726367|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726368|NCT00641043|Incretins|incretins|mesh-ancestor
82726369|NCT00641043|Hormones|hormones|mesh-ancestor
82726370|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82726371|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82726372|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
82726373|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726374|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726375|NCT02567916|Propofol|propofol|mesh-list
82726376|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82726377|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82726378|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726379|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82726380|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
82726381|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
82726382|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
82726383|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82726384|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726385|NCT00609622|Bevacizumab|bevacizumab|mesh-list
82726386|NCT00609622|Sunitinib|sunitinib|mesh-list
82726387|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82726388|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726389|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82726390|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82726391|NCT00609622|Growth Substances|growth substances|mesh-ancestor
82726392|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726393|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
82726394|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82726395|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726396|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726398|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82726399|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82726400|NCT00818415|Analgesics|analgesics|mesh-ancestor
82726401|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
82726402|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726403|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726404|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82726405|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82726406|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
82726407|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82726408|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726409|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726410|NCT00815841|Methylphenidate|methylphenidate|mesh-list
82726411|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82726412|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726413|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82726414|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82726415|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726416|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726417|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
82726418|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726420|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82726421|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726422|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82726423|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82726424|NCT03897192|Growth Substances|growth substances|mesh-ancestor
82726425|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726426|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
82726427|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
82726428|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
82726429|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82726430|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
82726431|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726432|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726433|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82726434|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
82726435|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
82726436|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82726437|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
82726438|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726439|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726440|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82726441|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82726442|NCT00890110|Sunitinib|sunitinib|mesh-list
82726443|NCT00890110|Vaccines|vaccines|mesh-list
82726444|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
82726445|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726446|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726447|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82726448|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82726449|NCT00890110|Growth Substances|growth substances|mesh-ancestor
82726450|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
82726451|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82726452|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726453|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726454|NCT02566824|Methylphenidate|methylphenidate|mesh-list
82726455|NCT02566824|Amphetamine|amphetamine|mesh-list
82726456|NCT02566824|Adderall|adderall|mesh-list
82726457|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
82726458|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82726459|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726460|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82726461|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82726462|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726463|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726464|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
82726465|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726466|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
82726467|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
82726468|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726469|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
82726470|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82726471|NCT00890188|Thalidomide|thalidomide|mesh-list
82726472|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726473|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
82726474|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726475|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
82726476|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82726477|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726478|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82726479|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82726480|NCT00890188|Growth Substances|growth substances|mesh-ancestor
82726481|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
82726482|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726483|NCT05388942|Nitrous Oxide|nitrous oxide|mesh-list
82726484|NCT05388942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82726485|NCT05388942|Anesthetics, General|anesthetics, general|mesh-ancestor
82726486|NCT05388942|Anesthetics|anesthetics|mesh-ancestor
82726487|NCT05388942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82726488|NCT05388942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726489|NCT05388942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82726490|NCT05388942|Analgesics|analgesics|mesh-ancestor
82726491|NCT05388942|Sensory System Agents|sensory system agents|mesh-ancestor
82726492|NCT05388942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726493|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
82726494|NCT04037566|Fludarabine|fludarabine|mesh-list
82726495|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726496|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
82726497|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726498|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82726499|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82726500|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
82726501|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726502|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726503|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82726504|NCT00888082|Goserelin|goserelin|mesh-list
82726505|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82726506|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726507|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
82726508|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82726509|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
82726510|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726511|NCT00627705|Expectorants|expectorants|mesh-ancestor
82726512|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
82726513|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82726514|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
82726515|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726516|NCT00627705|Protective Agents|protective agents|mesh-ancestor
82726517|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726518|NCT00627705|Antidotes|antidotes|mesh-ancestor
82726520|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
82726521|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726522|NCT00921102|Atropine|atropine|mesh-list
82726523|NCT00921102|Morphine|morphine|mesh-list
82726524|NCT00921102|Bupivacaine|bupivacaine|mesh-list
82726525|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
82726526|NCT00921102|Anesthetics|anesthetics|mesh-list
82726527|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82726528|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726529|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
82726530|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726531|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82726532|NCT00921102|Narcotics|narcotics|mesh-ancestor
82726533|NCT00921102|Analgesics|analgesics|mesh-ancestor
82726534|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82726535|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82726536|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82726537|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
82726538|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82726539|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
82726540|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
82726541|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
82726542|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82726543|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82726544|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
82726545|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726546|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726547|NCT00890500|Sirolimus|sirolimus|mesh-list
82726548|NCT00890500|Fludarabine|fludarabine|mesh-list
82726549|NCT00890500|Melphalan|melphalan|mesh-list
82726550|NCT00890500|Tacrolimus|tacrolimus|mesh-list
82726551|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82726552|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726553|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726554|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726555|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
82726556|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726557|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82726558|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726559|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82726560|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726561|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82726562|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
82726563|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82726564|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
82726565|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82726566|NCT04061772|Prednisone|prednisone|mesh-list
82726567|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
82726568|NCT04061772|Etoposide|etoposide|mesh-list
82726569|NCT04061772|Bortezomib|bortezomib|mesh-list
82726570|NCT04061772|Epirubicin|epirubicin|mesh-list
82726571|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726572|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
82726573|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726574|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82726575|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82726576|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
82726577|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726578|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726579|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82726580|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82726581|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
82726582|NCT04061772|Hormones|hormones|mesh-ancestor
82726583|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82726584|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82726585|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82726586|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82726587|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82726588|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726589|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82726590|NCT00644787|Fentanyl|fentanyl|mesh-list
82726591|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82726592|NCT00644787|Narcotics|narcotics|mesh-ancestor
82726593|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82726594|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726595|NCT00644787|Analgesics|analgesics|mesh-ancestor
82726596|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
82726597|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726598|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82726599|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82726600|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
82726601|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
82726602|NCT00821301|Fluphenazine|fluphenazine|mesh-list
82726603|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
82726604|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
82726605|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82726606|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82726607|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82726608|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726609|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82726610|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82726611|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
82726612|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726613|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726615|NCT00699348|Hematinics|hematinics|mesh-ancestor
82726616|NCT00643851|Metformin|metformin|mesh-list
82726617|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
82726618|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82726619|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726620|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82726621|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726622|NCT00821457|Mitogens|mitogens|mesh-list
82726623|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
82726624|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726625|NCT03667690|Fluconazole|fluconazole|mesh-list
82726626|NCT03667690|Caspofungin|caspofungin|mesh-list
82726627|NCT03667690|Rezafungin|rezafungin|mesh-list
82726628|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
82726629|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726630|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82726631|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82726632|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726633|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726634|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82726635|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
82726636|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82726637|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726638|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82726639|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82726640|NCT00821535|Maraviroc|maraviroc|mesh-list
82726641|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82726642|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82726643|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726644|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82726645|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82726646|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
82726647|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726648|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82726649|NCT04062006|Aldesleukin|aldesleukin|mesh-list
82726650|NCT04062006|Interleukin-2|interleukin-2|mesh-list
82726651|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726652|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82726653|NCT04062006|Analgesics|analgesics|mesh-ancestor
82726654|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
82726655|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726656|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726657|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82726658|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82726659|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
82726660|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726661|NCT04872582|Bevacizumab|bevacizumab|mesh-list
82726662|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82726663|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82726664|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726665|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82726666|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82726667|NCT04872582|Growth Substances|growth substances|mesh-ancestor
82726668|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726669|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
82726670|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726672|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
82726673|NCT04061538|Trace Elements|trace elements|mesh-ancestor
82726674|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
82726675|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726676|NCT04061538|Astringents|astringents|mesh-ancestor
82726677|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
82726678|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
82726679|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
82726680|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82726681|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82726682|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726683|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726684|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726685|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82726686|NCT00888394|Imidacloprid|imidacloprid|mesh-list
82726687|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
82726688|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726689|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726690|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726692|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82726693|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
82726694|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82726695|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
82726696|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82726697|NCT00627393|Dexamethasone|dexamethasone|mesh-list
82726698|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82726699|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
82726700|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
82726701|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726702|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726703|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82726704|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
82726705|NCT00627393|Hormones|hormones|mesh-ancestor
82726706|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82726707|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82726708|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726709|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
82726710|NCT00577122|Methotrexate|methotrexate|mesh-list
82726711|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82726712|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
82726713|NCT00577122|Progesterone|progesterone|mesh-list
82726714|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726715|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
82726716|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726717|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82726718|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82726719|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
82726720|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726721|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726722|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82726723|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82726724|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
82726725|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82726726|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82726727|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
82726728|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
82726729|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726730|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82726731|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82726732|NCT00577122|Progestins|progestins|mesh-ancestor
82726733|NCT00577122|Hormones|hormones|mesh-ancestor
82726734|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82726735|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82726736|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82726737|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82726738|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
82726739|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82726740|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82726741|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82726742|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82726744|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82726745|NCT00822081|Dorzolamide|dorzolamide|mesh-list
82726746|NCT00822081|Maleic acid|maleic acid|mesh-list
82726747|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
82726748|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726749|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726750|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82726751|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82726752|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
82726753|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726754|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726755|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82726756|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82726757|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82726758|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82726759|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82726760|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82726761|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82726762|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82726763|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82726764|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726765|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726766|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726767|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726768|NCT00696774|Analgesics|analgesics|mesh-ancestor
82726769|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
82726770|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726771|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
82726772|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82726773|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
82726774|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
82726775|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82726776|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82726778|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
82726779|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82726780|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726781|NCT00816543|Docetaxel|docetaxel|mesh-list
82726782|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
82726783|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726784|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
82726785|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
82726786|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
82726787|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726788|NCT00698646|Valsartan|valsartan|mesh-list
82726789|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82726790|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82726791|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82726792|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82726793|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726794|NCT00698646|Diuretics|diuretics|mesh-ancestor
82726795|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
82726796|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726797|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82726798|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726799|NCT02565888|Ritonavir|ritonavir|mesh-list
82726800|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82726801|NCT02565888|Cobicistat|cobicistat|mesh-list
82726802|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82726803|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82726804|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
82726805|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726806|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726807|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82726808|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82726809|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
82726810|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726811|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82726812|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82726813|NCT00609466|Morphine|morphine|mesh-list
82726814|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82726815|NCT00609466|Narcotics|narcotics|mesh-ancestor
82726816|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82726817|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726818|NCT00609466|Analgesics|analgesics|mesh-ancestor
82726819|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
82726820|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726821|NCT00822315|Efavirenz|efavirenz|mesh-list
82726822|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
82726823|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82726824|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82726825|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726826|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726827|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
82726828|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726829|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82726830|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82726831|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82726832|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82726833|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82726834|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82726835|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82726836|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82726837|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82726838|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82726839|NCT00696696|Gemcitabine|gemcitabine|mesh-list
82726840|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82726841|NCT00696696|Sorafenib|sorafenib|mesh-list
82726842|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82726843|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
82726844|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726845|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726846|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82726847|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726848|NCT00822393|Busulfan|busulfan|mesh-list
82726849|NCT00822393|Treosulfan|treosulfan|mesh-list
82726850|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
82726851|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726852|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726853|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
82726854|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726855|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82726856|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726857|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82726858|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
82726859|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
82726860|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82726861|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
82726862|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726863|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726864|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82726865|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
82726866|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
82726867|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82726868|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82726869|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82726870|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726871|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82726872|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82726873|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726874|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726875|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726876|NCT02551185|Citarinostat|citarinostat|mesh-list
82726877|NCT02551185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82726878|NCT02551185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726879|NCT02551185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726880|NCT00892996|Dexamethasone|dexamethasone|mesh-list
82726881|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
82726882|NCT00892996|BB 1101|bb 1101|mesh-list
82726883|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82726884|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
82726885|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
82726886|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726887|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726888|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82726889|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
82726890|NCT00892996|Hormones|hormones|mesh-ancestor
82726891|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82726892|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82726893|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82726894|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
82726895|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726896|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726897|NCT00891670|Aspirin|aspirin|mesh-list
82726898|NCT00891670|Cilostazol|cilostazol|mesh-list
82726899|NCT00891670|Clopidogrel|clopidogrel|mesh-list
82726900|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82726901|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82726902|NCT00891670|Analgesics|analgesics|mesh-ancestor
82726903|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
82726904|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726905|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726906|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82726907|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82726908|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82726909|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82726910|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726911|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82726912|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82726913|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726914|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
82726915|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82726916|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82726917|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82726918|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
82726919|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726920|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82726921|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
82726922|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82726923|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
82726924|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
82726925|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82726926|NCT00891670|Protective Agents|protective agents|mesh-ancestor
82726927|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82726928|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82726929|NCT00699192|Amlodipine|amlodipine|mesh-list
82726930|NCT00699192|Valsartan|valsartan|mesh-list
82726931|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82726932|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82726933|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726934|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726935|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82726936|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726937|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
82726938|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82726939|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82726940|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82726941|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
82726942|NCT00921180|Entecavir|entecavir|mesh-list
82726943|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
82726944|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726945|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
82726946|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726947|NCT04161066|Psilocybin|psilocybin|mesh-list
82726948|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
82726949|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726950|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82726951|NCT04671810|Eculizumab|eculizumab|mesh-list
82726952|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82726953|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82726954|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
82726955|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726956|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
82726957|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82726958|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727708|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
82726959|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82726960|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
82726961|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82726962|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82726963|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726964|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726965|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82726966|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82726967|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82726968|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726969|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726970|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726971|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726972|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
82726973|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82726974|NCT04661280|Donepezil|donepezil|mesh-list
82726975|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82726976|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82726977|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726978|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
82726979|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82726980|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726981|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
82726982|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
82726983|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
82726984|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
82726985|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82726986|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82726987|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82726988|NCT00696384|Diuretics|diuretics|mesh-ancestor
82726989|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
82726990|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82726991|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82726992|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82726993|NCT01041625|Apremilast|apremilast|mesh-list
82726994|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82726995|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82726996|NCT01041625|Analgesics|analgesics|mesh-ancestor
82726997|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
82726998|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82726999|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727000|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727001|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727002|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82727003|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82727004|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727005|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727006|NCT02566356|Oxytocin|oxytocin|mesh-list
82727007|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
82727008|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82727009|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727010|NCT00892450|Oxybutynin|oxybutynin|mesh-list
82727011|NCT00892450|Darifenacin|darifenacin|mesh-list
82727012|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
82727013|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
82727014|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727015|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727016|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82727017|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82727018|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
82727019|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727020|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727021|NCT00892450|Urological Agents|urological agents|mesh-ancestor
82727022|NCT01566565|Theophylline|theophylline|mesh-list
82727023|NCT01566565|Bambuterol|bambuterol|mesh-list
82727024|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82727025|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
82727026|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727027|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727028|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82727029|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
82727030|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82727031|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727032|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727033|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
82727034|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82727035|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82727036|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
82727037|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727038|NCT01039363|Cytarabine|cytarabine|mesh-list
82727039|NCT01039363|Vorinostat|vorinostat|mesh-list
82727040|NCT01039363|Idarubicin|idarubicin|mesh-list
82727041|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
82727042|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82727043|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
82727044|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727045|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727046|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
82727047|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727048|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82727049|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
82727050|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727051|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82727052|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727053|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82727054|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82727055|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82727056|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82727057|NCT01039363|Immunotoxins|immunotoxins|mesh-ancestor
82727058|NCT01039363|Immunoconjugates|immunoconjugates|mesh-ancestor
82727059|NCT01039441|Bupivacaine|bupivacaine|mesh-list
82727060|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
82727061|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
82727062|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727063|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727064|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
82727065|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727066|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82727067|NCT01034917|Etravirine|etravirine|mesh-list
82727068|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
82727069|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727070|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82727071|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82727072|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727073|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727074|NCT00816699|Anesthetics|anesthetics|mesh-list
82727075|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727076|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727077|NCT00822549|Morphine|morphine|mesh-list
82727078|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82727079|NCT00822549|Narcotics|narcotics|mesh-ancestor
82727080|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727081|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727082|NCT00822549|Analgesics|analgesics|mesh-ancestor
82727083|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
82727084|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727085|NCT00819351|Asparaginase|asparaginase|mesh-list
82727086|NCT00819351|Pegaspargase|pegaspargase|mesh-list
82727087|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727088|NCT00699998|Aspirin|aspirin|mesh-list
82727089|NCT00699998|Clopidogrel|clopidogrel|mesh-list
82727090|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82727091|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82727092|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82727093|NCT00699998|Analgesics|analgesics|mesh-ancestor
82727094|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
82727095|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727096|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727097|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727098|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727099|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82727100|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82727101|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727102|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82727103|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82727104|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727105|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
82727106|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82727786|NCT00819975|Caseins|caseins|mesh-list
82727107|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82727108|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82727109|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
82727110|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727111|NCT00696072|Letrozole|letrozole|mesh-list
82727112|NCT00696072|Dasatinib|dasatinib|mesh-list
82727113|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727114|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82727115|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82727116|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727117|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727118|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82727119|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
82727120|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82727121|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727122|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82727123|NCT00816855|Docetaxel|docetaxel|mesh-list
82727124|NCT00816855|Fluorouracil|fluorouracil|mesh-list
82727125|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727126|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
82727127|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
82727128|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
82727129|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727130|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
82727131|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82727132|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82727133|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
82727134|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727135|NCT00822783|Omalizumab|omalizumab|mesh-list
82727136|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82727137|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82727138|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
82727139|NCT00634647|Prednisone|prednisone|mesh-list
82727140|NCT00634647|Satraplatin|satraplatin|mesh-list
82727141|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727142|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
82727143|NCT00634647|Hormones|hormones|mesh-ancestor
82727144|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82727145|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727146|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82727147|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727148|NCT00576732|Risperidone|risperidone|mesh-list
82727149|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82727150|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
82727151|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727152|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727153|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727154|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82727155|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82727156|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727157|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82727158|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82727159|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
82727160|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82727161|NCT00817011|Mirtazapine|mirtazapine|mesh-list
82727162|NCT00817011|Trazodone|trazodone|mesh-list
82727163|NCT00817011|Bupropion|bupropion|mesh-list
82727164|NCT00817011|Fluoxetine|fluoxetine|mesh-list
82727165|NCT00817011|Paroxetine|paroxetine|mesh-list
82727166|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82727167|NCT00817011|Citalopram|citalopram|mesh-list
82727168|NCT00817011|Sertraline|sertraline|mesh-list
82727169|NCT00817011|Nortriptyline|nortriptyline|mesh-list
82727170|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82727171|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
82727172|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82727173|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82727174|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82727175|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82727176|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727177|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
82727178|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727179|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727180|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82727181|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82727182|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727183|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82727185|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
82727186|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727187|NCT00817011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82727188|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
82727189|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82727190|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
82727191|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
82727192|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82727193|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82727194|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727195|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82727196|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82727197|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82727198|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
82727199|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82727200|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82727201|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82727202|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82727203|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82727204|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
82727205|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82727206|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727207|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727208|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82727210|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
82727211|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727212|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82727213|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82727214|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82727215|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
82727216|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727217|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727219|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82727220|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
82727221|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727222|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727223|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82727224|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
82727225|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82727226|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
82727227|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727228|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727229|NCT04062890|Vigabatrin|vigabatrin|mesh-list
82727230|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
82727231|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727232|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727233|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
82727234|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727235|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727236|NCT00817245|Amoxicillin|amoxicillin|mesh-list
82727237|NCT00817245|Metronidazole|metronidazole|mesh-list
82727238|NCT00817245|Omeprazole|omeprazole|mesh-list
82727239|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82727240|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727241|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82727242|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82727243|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82727244|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82727245|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82727246|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727247|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727248|NCT02550483|Beta Carotene|beta carotene|mesh-list
82727249|NCT02550483|Lycopene|lycopene|mesh-list
82727250|NCT02550483|Carotenoids|carotenoids|mesh-list
82727251|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727252|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
82727253|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727254|NCT02550483|Protective Agents|protective agents|mesh-ancestor
82727255|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727256|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82727257|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82727258|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727259|NCT02550483|Provitamins|provitamins|mesh-ancestor
82727261|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
82727262|NCT04608318|Venetoclax|venetoclax|mesh-list
82727263|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
82727264|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727265|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82727266|NCT04063358|Ranibizumab|ranibizumab|mesh-list
82727267|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82727268|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82727269|NCT04063358|Growth Substances|growth substances|mesh-ancestor
82727270|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727271|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
82727272|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727273|NCT00631917|Ramipril|ramipril|mesh-list
82727274|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82727275|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
82727276|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727277|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727278|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82727279|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
82727280|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82727281|NCT00419341|Antibodies|antibodies|mesh-list
82727282|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
82727283|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727284|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
82727285|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82727286|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727287|NCT03922620|Bupivacaine|bupivacaine|mesh-list
82727288|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
82727289|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
82727290|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727291|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727292|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
82727293|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727294|NCT00419263|Peramivir|peramivir|mesh-list
82727295|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
82727296|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727297|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727298|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727299|NCT01034995|Escitalopram|escitalopram|mesh-list
82727300|NCT01034995|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82727301|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82727302|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82727303|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727304|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727305|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
82727306|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727307|NCT00921414|Rituximab|rituximab|mesh-list
82727308|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82727309|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727310|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
82727311|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727312|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727313|NCT04060914|Clopidogrel|clopidogrel|mesh-list
82727314|NCT04060914|Ticagrelor|ticagrelor|mesh-list
82727315|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82727316|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82727317|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82727318|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82727319|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
82727320|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727321|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727322|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727323|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
82727324|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727325|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82727326|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82727327|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82727328|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82727329|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727330|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
82727331|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727332|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727333|NCT05324904|Vitamin D|vitamin d|mesh-list
82727334|NCT05324904|Acyclovir|acyclovir|mesh-list
82727335|NCT05324904|Vitamins|vitamins|mesh-ancestor
82727336|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
82727337|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727338|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82727339|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
82727340|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727341|NCT02085265|Telmisartan|telmisartan|mesh-list
82727342|NCT02085265|Perindopril|perindopril|mesh-list
82727343|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82727344|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82727345|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82727346|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727347|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82727348|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
82727349|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727350|NCT00699842|Lenalidomide|lenalidomide|mesh-list
82727351|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
82727352|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727353|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82727354|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82727355|NCT00699842|Growth Substances|growth substances|mesh-ancestor
82727356|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
82727357|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727358|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
82727359|NCT00399529|Trastuzumab|trastuzumab|mesh-list
82727360|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82727362|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727363|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727364|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82727365|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
82727366|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727367|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727368|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82727369|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82727370|NCT05403086|Ketamine|ketamine|mesh-list
82727371|NCT05403086|Psilocybin|psilocybin|mesh-list
82727372|NCT05403086|Hallucinogens|hallucinogens|mesh-list
82727373|NCT05403086|Analgesics|analgesics|mesh-ancestor
82727374|NCT05403086|Sensory System Agents|sensory system agents|mesh-ancestor
82727375|NCT05403086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727376|NCT05403086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727377|NCT05403086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82727378|NCT05403086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82727379|NCT05403086|Anesthetics, General|anesthetics, general|mesh-ancestor
82727380|NCT05403086|Anesthetics|anesthetics|mesh-ancestor
82727381|NCT05403086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727382|NCT05403086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82727383|NCT05403086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82727384|NCT05403086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727385|NCT05403086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727386|NCT05403086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82727387|NCT00712712|Acetaminophen|acetaminophen|mesh-list
82727388|NCT00712712|Morphine|morphine|mesh-list
82727389|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82727390|NCT00712712|Narcotics|narcotics|mesh-ancestor
82727391|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727392|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727393|NCT00712712|Analgesics|analgesics|mesh-ancestor
82727394|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
82727395|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727396|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82727397|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
82727398|NCT00411151|Sunitinib|sunitinib|mesh-list
82727399|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727400|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82727401|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82727402|NCT00411151|Growth Substances|growth substances|mesh-ancestor
82727403|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727404|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
82727405|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82727406|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727407|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727408|NCT00607048|Paclitaxel|paclitaxel|mesh-list
82727409|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82727410|NCT00607048|Carboplatin|carboplatin|mesh-list
82727411|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82727412|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82727413|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727414|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
82727415|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
82727416|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
82727417|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727418|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
82727419|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727420|NCT03592576|Venetoclax|venetoclax|mesh-list
82727421|NCT03592576|Navitoclax|navitoclax|mesh-list
82727422|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727423|NCT04035850|Vortioxetine|vortioxetine|mesh-list
82727424|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
82727425|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82727426|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82727427|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82727428|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727429|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727430|NCT04035850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82727431|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82727432|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82727433|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727434|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727435|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
82727436|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82727437|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82727438|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82727439|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82727440|NCT00699608|Zopiclone|zopiclone|mesh-list
82727441|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82727442|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727443|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727444|NCT00895570|Modafinil|modafinil|mesh-list
82727445|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82727446|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727447|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82727448|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82727449|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82727450|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727451|NCT00895648|Pemetrexed|pemetrexed|mesh-list
82727452|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727453|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727454|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727455|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82727456|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82727457|NCT00893854|Triamcinolone|triamcinolone|mesh-list
82727458|NCT00893854|Diclofenac|diclofenac|mesh-list
82727459|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727460|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
82727461|NCT00893854|Hormones|hormones|mesh-ancestor
82727462|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82727463|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727464|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727465|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727466|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82727467|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82727468|NCT00893854|Analgesics|analgesics|mesh-ancestor
82727469|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
82727470|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727471|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727472|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82727473|NCT00895804|Pindolol|pindolol|mesh-list
82727474|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82727475|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82727476|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
82727477|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727478|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727479|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727480|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82727481|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82727482|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
82727483|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
82727484|NCT00895882|Interferons|interferons|mesh-list
82727485|NCT00895882|Ribavirin|ribavirin|mesh-list
82727486|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727487|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
82727488|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727489|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
82727490|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727491|NCT00706706|Sunitinib|sunitinib|mesh-list
82727492|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727493|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82727494|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82727495|NCT00706706|Growth Substances|growth substances|mesh-ancestor
82727496|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727497|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
82727498|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82727499|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727500|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727501|NCT00894010|Carbamazepine|carbamazepine|mesh-list
82727502|NCT00894010|Levetiracetam|levetiracetam|mesh-list
82727503|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
82727504|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
82727505|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
82727506|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82727507|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727508|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727509|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82727510|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82727511|NCT00894010|Analgesics|analgesics|mesh-ancestor
82727512|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
82727513|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727514|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82727515|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82727516|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727517|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82727518|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82727519|NCT00895960|Temozolomide|temozolomide|mesh-list
82727520|NCT00895960|Dasatinib|dasatinib|mesh-list
82727521|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82727522|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
82727523|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727524|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727525|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82727526|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727527|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
82727528|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82727529|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727530|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82727531|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
82727532|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82727533|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727534|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727535|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727536|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82727537|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82727538|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82727539|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82727540|NCT00921128|Muscimol|muscimol|mesh-list
82727541|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82727542|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
82727543|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
82727544|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727545|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727546|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727547|NCT05508776|Moxifloxacin|moxifloxacin|mesh-list
82727548|NCT05508776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82727549|NCT05508776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727550|NCT05508776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82727551|NCT05508776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82727552|NCT05508776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727553|NCT05508776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727554|NCT05508776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727555|NCT00896428|Gallopamil|gallopamil|mesh-list
82727556|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82727557|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82727558|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727559|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82727560|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727562|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
82727563|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
82727564|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
82727565|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727566|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727567|NCT04486716|Ofatumumab|ofatumumab|mesh-list
82727568|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727569|NCT00410605|Dexamethasone|dexamethasone|mesh-list
82727570|NCT00410605|Bevacizumab|bevacizumab|mesh-list
82727571|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82727572|NCT00410605|Lenalidomide|lenalidomide|mesh-list
82727573|NCT00410605|Antibodies|antibodies|mesh-list
82727574|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
82727575|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82727576|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727577|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82727578|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82727579|NCT00410605|Growth Substances|growth substances|mesh-ancestor
82727580|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727581|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
82727582|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
82727583|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727584|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
82727585|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
82727586|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727587|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82727588|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
82727589|NCT00410605|Hormones|hormones|mesh-ancestor
82727590|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82727591|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82727592|NCT00742638|Valproic Acid|valproic acid|mesh-list
82727593|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82727594|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
82727595|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82727596|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82727597|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82727598|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727599|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727600|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
82727601|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727602|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727603|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
82727604|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727605|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
82727606|NCT00418717|Etanercept|etanercept|mesh-list
82727607|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82727608|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82727609|NCT00418717|Analgesics|analgesics|mesh-ancestor
82727610|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
82727611|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727612|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727613|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727614|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727615|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82727616|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82727617|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
82727618|NCT00572572|Aprepitant|aprepitant|mesh-list
82727619|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
82727620|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
82727621|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727622|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727623|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82727624|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82727625|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727626|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727627|NCT00897130|Azacitidine|azacitidine|mesh-list
82727628|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82727629|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
82727630|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727631|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727632|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727633|NCT00398047|Mitogens|mitogens|mesh-list
82727634|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
82727635|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727636|NCT00631371|Interferons|interferons|mesh-list
82727637|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
82727638|NCT00631371|Sirolimus|sirolimus|mesh-list
82727639|NCT00631371|Bevacizumab|bevacizumab|mesh-list
82727640|NCT00631371|Temsirolimus|temsirolimus|mesh-list
82727641|NCT00631371|MTOR Inhibitors|mtor inhibitors|mesh-list
82727642|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82727643|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727644|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82727645|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82727646|NCT00631371|Growth Substances|growth substances|mesh-ancestor
82727647|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727648|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
82727649|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
82727650|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727651|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
82727652|NCT00631371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82727653|NCT00631371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727654|NCT00631371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727655|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82727656|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82727657|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82727658|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
82727659|NCT00409747|Minocycline|minocycline|mesh-list
82727660|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82727661|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727662|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
82727663|NCT04016740|Ketamine|ketamine|mesh-list
82727664|NCT04016740|Remifentanil|remifentanil|mesh-list
82727665|NCT04016740|Propofol|propofol|mesh-list
82727666|NCT04016740|Ropivacaine|ropivacaine|mesh-list
82727667|NCT04016740|Sevoflurane|sevoflurane|mesh-list
82727668|NCT04016740|Rocuronium|rocuronium|mesh-list
82727669|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82727670|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727671|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727672|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82727673|NCT04016740|Analgesics|analgesics|mesh-ancestor
82727674|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
82727675|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727676|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82727677|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82727678|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82727679|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
82727680|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727681|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727682|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82727683|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
82727684|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
82727685|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82727686|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82727687|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82727688|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
82727689|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82727690|NCT04016740|Narcotics|narcotics|mesh-ancestor
82727691|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82727692|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82727693|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82727694|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82727695|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82727696|NCT02540512|Acetaminophen|acetaminophen|mesh-list
82727697|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82727698|NCT02540512|Hydrocodone|hydrocodone|mesh-list
82727699|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82727700|NCT02540512|Analgesics|analgesics|mesh-ancestor
82727701|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
82727702|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727703|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727704|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
82727705|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82727706|NCT02540512|Narcotics|narcotics|mesh-ancestor
82727707|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727709|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
82727710|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82727711|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727712|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727713|NCT00897520|Interferons|interferons|mesh-list
82727714|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
82727715|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727716|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
82727717|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727718|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
82727719|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727720|NCT00894634|Brompheniramine|brompheniramine|mesh-list
82727721|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727722|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82727723|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
82727724|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
82727725|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727726|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727727|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82727728|NCT00894712|Sulforaphane|sulforaphane|mesh-list
82727729|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82727730|NCT00894712|Protective Agents|protective agents|mesh-ancestor
82727731|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727732|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727733|NCT00823641|Infliximab|infliximab|mesh-list
82727734|NCT00823641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82727735|NCT00823641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727736|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
82727737|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82727738|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727739|NCT00823875|Cilostazol|cilostazol|mesh-list
82727740|NCT00823875|Probucol|probucol|mesh-list
82727741|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82727742|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
82727743|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727744|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727745|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82727746|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
82727747|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82727748|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82727749|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727750|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82727751|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
82727752|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82727753|NCT00823875|Protective Agents|protective agents|mesh-ancestor
82727754|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82727755|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82727756|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727757|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82727758|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82727759|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
82727760|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82727761|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
82727762|NCT00397189|Melatonin|melatonin|mesh-list
82727763|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
82727764|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727765|NCT00397189|Protective Agents|protective agents|mesh-ancestor
82727766|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727767|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727768|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
82727769|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82727771|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
82727772|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82727773|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727774|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
82727775|NCT04044651|Nivolumab|nivolumab|mesh-list
82727776|NCT04044651|Lenvatinib|lenvatinib|mesh-list
82727777|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82727778|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727779|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82727780|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727781|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82727782|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727783|NCT00606034|Insulin|insulin|mesh-list
82727784|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82727785|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727787|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
82727788|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
82727789|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727790|NCT04044417|Curcumin|curcumin|mesh-list
82727791|NCT04044417|Simvastatin|simvastatin|mesh-list
82727792|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82727793|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82727794|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
82727795|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727796|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82727797|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82727798|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727799|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82727800|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82727801|NCT04044417|Analgesics|analgesics|mesh-ancestor
82727802|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
82727803|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727804|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727805|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727806|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727807|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727808|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82727809|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82727810|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82727811|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727812|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727813|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82727814|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82727815|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82727816|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
82727817|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727818|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727819|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82727820|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82727821|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
82727822|NCT00820053|Epirubicin|epirubicin|mesh-list
82727823|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
82727824|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82727825|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727826|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82727827|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82727828|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727829|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727830|NCT00572728|Alovudine|alovudine|mesh-list
82727831|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
82727832|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
82727833|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727834|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
82727835|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727836|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82727837|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82727838|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727840|NCT00699374|Sunitinib|sunitinib|mesh-list
82727841|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727842|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82727843|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727844|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727845|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82727846|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82727847|NCT00699374|Growth Substances|growth substances|mesh-ancestor
82727848|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727849|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
82727850|NCT00898534|Chrysarobin|chrysarobin|mesh-list
82727851|NCT00898534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82727852|NCT00898534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82727853|NCT00898534|Analgesics|analgesics|mesh-ancestor
82727854|NCT00898534|Sensory System Agents|sensory system agents|mesh-ancestor
82727855|NCT00898534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727856|NCT00898534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727857|NCT00898534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727858|NCT00898534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727859|NCT00606892|Nicotine|nicotine|mesh-list
82727860|NCT00606892|Varenicline|varenicline|mesh-list
82727861|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82727862|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
82727863|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727864|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727865|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82727866|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82727867|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
82727868|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727869|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727870|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
82727871|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727872|NCT01042561|Vitamin D|vitamin d|mesh-list
82727873|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
82727874|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
82727875|NCT01042561|Vitamins|vitamins|mesh-list
82727876|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
82727877|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727878|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82727879|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82727880|NCT01035853|Colistin|colistin|mesh-list
82727881|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82727882|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727883|NCT05268614|Cisplatin|cisplatin|mesh-list
82727884|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727885|NCT01042717|Plerixafor|plerixafor|mesh-list
82727886|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82727887|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82727888|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
82727889|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727890|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
82727891|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82727892|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
82727893|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727894|NCT00898846|Tegafur|tegafur|mesh-list
82727895|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82727896|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
82727897|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727898|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727899|NCT00826371|Ranibizumab|ranibizumab|mesh-list
82727900|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82727901|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82727902|NCT00826371|Growth Substances|growth substances|mesh-ancestor
82727903|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727904|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
82727905|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727906|NCT02540824|Apatinib|apatinib|mesh-list
82727907|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727908|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82727909|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727910|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727911|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
82727912|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82727913|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82727914|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
82727915|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727916|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727917|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727918|NCT00826527|Urological Agents|urological agents|mesh-ancestor
82727919|NCT02550717|Aspirin|aspirin|mesh-list
82727920|NCT02550717|Anticoagulants|anticoagulants|mesh-list
82727921|NCT02550717|Clopidogrel|clopidogrel|mesh-list
82727922|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82727923|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82727924|NCT02550717|Analgesics|analgesics|mesh-ancestor
82727925|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
82727926|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82727927|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727928|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727929|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727930|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82727931|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82727932|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727933|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82727934|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82727935|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727936|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
82727937|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82727938|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82727939|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82727940|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
82727941|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727943|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82727944|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727945|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82727946|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727947|NCT00824811|Fluorometholone|fluorometholone|mesh-list
82727948|NCT00824811|Cyclosporine|cyclosporine|mesh-list
82727949|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82727950|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
82727951|NCT00824811|Cyclosporins|cyclosporins|mesh-list
82727952|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82727953|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727954|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82727955|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
82727956|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727957|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
82727958|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727959|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
82727960|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727961|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82727962|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82727963|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82727964|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
82727965|NCT00824811|Hormones|hormones|mesh-ancestor
82727966|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82727967|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82727968|NCT00606580|Paromomycin|paromomycin|mesh-list
82727969|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82727970|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82727971|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82727972|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82727973|NCT02550327|Paclitaxel|paclitaxel|mesh-list
82727974|NCT02550327|Gemcitabine|gemcitabine|mesh-list
82727975|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82727976|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82727977|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82727978|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
82727979|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
82727980|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
82727981|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727982|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82727983|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
82727984|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82727985|NCT00825045|Risperidone|risperidone|mesh-list
82727986|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82727987|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
82727988|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82727989|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82727990|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82727991|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82727992|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82727993|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82727994|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82727995|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82727996|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
82727997|NCT00606502|Vitamins|vitamins|mesh-list
82727998|NCT00606502|Folic Acid|folic acid|mesh-list
82727999|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
82728000|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
82728001|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82728002|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
82728003|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
82728004|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728005|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728006|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82728007|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728008|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728009|NCT00606502|Hematinics|hematinics|mesh-ancestor
82728010|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82728011|NCT00825123|Metoprolol|metoprolol|mesh-list
82728012|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82728013|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82728014|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
82728015|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
82728016|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728017|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728018|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82728019|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82728020|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82728021|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
82728022|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728023|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728024|NCT00826839|Leuprolide|leuprolide|mesh-list
82728025|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
82728026|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
82728027|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82728028|NCT00826839|Ganirelix|ganirelix|mesh-list
82728029|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82728030|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728031|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82728032|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
82728033|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82728034|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728035|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82728036|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
82728037|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82728038|NCT04017988|Ethanol|ethanol|mesh-list
82728039|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82728040|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728041|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728042|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728043|NCT00825201|Paclitaxel|paclitaxel|mesh-list
82728044|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82728045|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82728046|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728047|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
82728048|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
82728049|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
82728050|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728051|NCT00820911|Cyclosporine|cyclosporine|mesh-list
82728052|NCT00820911|Everolimus|everolimus|mesh-list
82728053|NCT00820911|Cyclosporins|cyclosporins|mesh-list
82728054|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728055|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728056|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82728057|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
82728058|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728059|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
82728060|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728061|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
82728062|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82728063|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82728064|NCT00820911|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82728065|NCT00820911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82728066|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728068|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82728069|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82728070|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728071|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82728072|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82728073|NCT00605722|Growth Substances|growth substances|mesh-ancestor
82728074|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728075|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
82728076|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82728077|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728078|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728079|NCT00882076|Etoposide|etoposide|mesh-list
82728080|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
82728081|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
82728082|NCT00882076|Clofarabine|clofarabine|mesh-list
82728083|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82728084|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728085|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82728086|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82728087|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728088|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728089|NCT00882076|Analgesics|analgesics|mesh-ancestor
82728090|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
82728091|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728092|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728093|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82728094|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
82728095|NCT00827151|Estrogens|estrogens|mesh-list
82728096|NCT00827151|Hormones|hormones|mesh-ancestor
82728097|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82728098|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728099|NCT00882154|Cefdinir|cefdinir|mesh-list
82728100|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82728101|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728102|NCT00825591|Melatonin|melatonin|mesh-list
82728103|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
82728104|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728105|NCT00825591|Protective Agents|protective agents|mesh-ancestor
82728106|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728107|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728108|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
82728109|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82728110|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
82728111|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728112|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
82728114|NCT00900172|Paclitaxel|paclitaxel|mesh-list
82728115|NCT00900172|Bevacizumab|bevacizumab|mesh-list
82728116|NCT00900172|Carboplatin|carboplatin|mesh-list
82728117|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82728118|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728119|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
82728120|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
82728121|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
82728122|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728123|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82728124|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82728125|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82728126|NCT00900172|Growth Substances|growth substances|mesh-ancestor
82728127|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728128|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
82728129|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
82728130|NCT00605566|Sorafenib|sorafenib|mesh-list
82728131|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82728132|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
82728133|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728134|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82728135|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82728136|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
82728137|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728138|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728139|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82728140|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82728141|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728143|NCT00882388|Celecoxib|celecoxib|mesh-list
82728144|NCT00882388|Clopidogrel|clopidogrel|mesh-list
82728145|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82728146|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82728147|NCT00882388|Analgesics|analgesics|mesh-ancestor
82728148|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
82728149|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728150|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728151|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82728152|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82728153|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82728154|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82728155|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728156|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82728157|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82728158|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728159|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
82728160|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82728161|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82728162|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82728163|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
82728164|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728387|NCT00902512|Urological Agents|urological agents|mesh-ancestor
82728165|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82728166|NCT00396877|Clopidogrel|clopidogrel|mesh-list
82728167|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82728168|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82728169|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82728170|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82728171|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
82728172|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728173|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728174|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728175|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
82728176|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
82728177|NCT00882466|Hematinics|hematinics|mesh-ancestor
82728178|NCT00901498|BMS 708163|bms 708163|mesh-list
82728179|NCT00901498|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82728180|NCT00901498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728181|NCT00901498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728182|NCT00628251|Doxorubicin|doxorubicin|mesh-list
82728183|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82728184|NCT00628251|Olaparib|olaparib|mesh-list
82728185|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82728186|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728187|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82728188|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82728189|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728190|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728191|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82728192|NCT01036399|Lenalidomide|lenalidomide|mesh-list
82728193|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
82728194|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728195|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82728196|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82728197|NCT01036399|Growth Substances|growth substances|mesh-ancestor
82728198|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
82728199|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728200|NCT00901654|Vaccines|vaccines|mesh-list
82728201|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
82728202|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728203|NCT00625131|Bupropion|bupropion|mesh-list
82728204|NCT00625131|Nicotine|nicotine|mesh-list
82728205|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82728206|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
82728207|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728208|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728209|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82728210|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82728211|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
82728212|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728213|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728214|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82728215|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
82728216|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82728217|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82728218|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82728219|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82728220|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
82728221|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82728222|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82728223|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728224|NCT00901732|Calcium|calcium|mesh-list
82728225|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82728226|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728227|NCT00882700|Cefdinir|cefdinir|mesh-list
82728228|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82728229|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728230|NCT00408499|Cetuximab|cetuximab|mesh-list
82728231|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82728232|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82728233|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728234|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82728235|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728236|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728237|NCT00837369|Regadenoson|regadenoson|mesh-list
82728238|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
82728239|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82728240|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
82728241|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
82728242|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728243|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728244|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728246|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
82728247|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82728248|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
82728249|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728250|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728251|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82728252|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
82728253|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82728254|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82728255|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82728256|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
82728257|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728258|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728259|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
82728260|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82728261|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
82728262|NCT00901888|Nitroprusside|nitroprusside|mesh-list
82728263|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82728264|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
82728265|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82728266|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728267|NCT00908362|Fluticasone|fluticasone|mesh-list
82728268|NCT00908362|Xhance|xhance|mesh-list
82728269|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82728270|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82728271|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82728272|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82728273|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
82728274|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728275|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728276|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82728277|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
82728278|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
82728279|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82728280|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82728281|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82728282|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82728283|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
82728284|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728285|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728286|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
82728287|NCT00908362|Hormones|hormones|mesh-ancestor
82728288|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82728289|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
82728290|NCT02549469|Naproxen|naproxen|mesh-list
82728291|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82728292|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82728293|NCT02549469|Analgesics|analgesics|mesh-ancestor
82728294|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
82728295|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728296|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728297|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82728298|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82728299|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
82728300|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82728301|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728302|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728303|NCT02548533|Lidocaine|lidocaine|mesh-list
82728304|NCT02548533|Epinephrine|epinephrine|mesh-list
82728305|NCT02548533|Prilocaine|prilocaine|mesh-list
82728306|NCT02548533|Carticaine|carticaine|mesh-list
82728307|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82728308|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
82728309|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
82728310|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728311|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728312|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
82728313|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728314|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82728315|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82728316|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82728317|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82728318|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728319|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82728320|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82728321|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
82728322|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728323|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82728324|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82728325|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
82728326|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82728327|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
82728328|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
82728329|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
82728330|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82728331|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82728332|NCT02549391|Cinacalcet|cinacalcet|mesh-list
82728333|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82728334|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728335|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82728336|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
82728337|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82728339|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
82728340|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728341|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
82728342|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
82728343|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
82728344|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82728345|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
82728346|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
82728347|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728348|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728349|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728350|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82728351|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
82728352|NCT00908674|Cyproterone|cyproterone|mesh-list
82728353|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
82728354|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
82728355|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82728356|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728357|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728358|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82728359|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
82728360|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82728361|NCT00621777|Varenicline|varenicline|mesh-list
82728362|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82728363|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82728364|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
82728365|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728366|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728367|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728368|NCT02538718|Ritodrine|ritodrine|mesh-list
82728369|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
82728370|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
82728371|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728372|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728373|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
82728374|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82728375|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82728376|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82728377|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82728378|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
82728379|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728380|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728381|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
82728382|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
82728383|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82728384|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82728385|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728386|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728388|NCT00827307|Tamoxifen|tamoxifen|mesh-list
82728389|NCT00827307|Goserelin|goserelin|mesh-list
82728390|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82728391|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
82728392|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82728393|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728394|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82728395|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728396|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82728397|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82728398|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82728399|NCT00837915|Loratadine|loratadine|mesh-list
82728400|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
82728401|NCT00837915|Ephedrine|ephedrine|mesh-list
82728402|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
82728403|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
82728404|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82728405|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82728406|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82728407|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
82728408|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
82728409|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728410|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728411|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728412|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82728413|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
82728414|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728415|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82728416|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
82728417|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
82728418|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82728419|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82728420|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
82728421|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
82728422|NCT00908986|Rituximab|rituximab|mesh-list
82728423|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82728424|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728425|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
82728426|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728427|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82728428|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
82728429|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82728430|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728431|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
82728432|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82728433|NCT00838071|Antibodies|antibodies|mesh-list
82728434|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
82728435|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728436|NCT02547519|Insulin|insulin|mesh-list
82728437|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82728438|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728439|NCT00909454|Vitamin D|vitamin d|mesh-list
82728440|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
82728441|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
82728442|NCT00909454|Vitamins|vitamins|mesh-list
82728443|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
82728444|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728445|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82728446|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82728447|NCT04035070|Clindamycin|clindamycin|mesh-list
82728448|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
82728449|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
82728450|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82728451|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82728453|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82728454|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728455|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82728456|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728457|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728458|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
82728459|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82728460|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82728461|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82728462|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82728463|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82728464|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728465|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728466|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728467|NCT00408421|Analgesics|analgesics|mesh-ancestor
82728468|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
82728469|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728470|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
82728471|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82728472|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
82728473|NCT00604786|Omalizumab|omalizumab|mesh-list
82728474|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82728475|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82728476|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
82728478|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82728479|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
82728480|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
82728481|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728482|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728483|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82728484|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82728485|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82728486|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
82728487|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728488|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728489|NCT01042873|Protective Agents|protective agents|mesh-ancestor
82728490|NCT01042951|Vaccines|vaccines|mesh-list
82728491|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
82728492|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728493|NCT01037023|Topotecan|topotecan|mesh-list
82728494|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82728495|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82728496|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728497|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728498|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728499|NCT00604708|Vaccines|vaccines|mesh-list
82728500|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
82728501|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728502|NCT00909688|BLI-489|bli-489|mesh-list
82728503|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82728504|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728505|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728506|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82728507|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728508|NCT00903214|Riluzole|riluzole|mesh-list
82728509|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
82728510|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82728511|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82728512|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728513|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728514|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728515|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82728516|NCT00903214|Protective Agents|protective agents|mesh-ancestor
82728517|NCT04034836|Parecoxib|parecoxib|mesh-list
82728518|NCT04034836|Ropivacaine|ropivacaine|mesh-list
82728519|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
82728520|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
82728521|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728522|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728523|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
82728524|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728525|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82728526|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82728527|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728528|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728529|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82728530|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82728531|NCT04034836|Analgesics|analgesics|mesh-ancestor
82728532|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82728533|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82728534|NCT00407797|Pregabalin|pregabalin|mesh-list
82728535|NCT00407797|Analgesics|analgesics|mesh-ancestor
82728536|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
82728537|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728687|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82728538|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728539|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
82728540|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82728541|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82728542|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728543|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82728544|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82728545|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82728546|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728547|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82728548|NCT00903292|Pemetrexed|pemetrexed|mesh-list
82728549|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82728550|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728551|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728552|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728553|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82728554|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82728555|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82728556|NCT00903838|Pramipexole|pramipexole|mesh-list
82728557|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
82728558|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728559|NCT00903838|Protective Agents|protective agents|mesh-ancestor
82728560|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728561|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82728562|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82728563|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
82728564|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
82728565|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728566|NCT00924430|Simvastatin|simvastatin|mesh-list
82728567|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82728568|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82728569|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
82728570|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728571|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82728572|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82728573|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728574|NCT00924586|Landiolol|landiolol|mesh-list
82728575|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82728576|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82728577|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
82728578|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728579|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728580|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728581|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82728582|NCT00903994|Ketoprofen|ketoprofen|mesh-list
82728583|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82728584|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82728585|NCT00903994|Analgesics|analgesics|mesh-ancestor
82728586|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
82728587|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728588|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728589|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82728590|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82728591|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82728592|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728593|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728594|NCT00924742|Tazobactam|tazobactam|mesh-list
82728595|NCT00924742|Piperacillin|piperacillin|mesh-list
82728596|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82728597|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728598|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82728599|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728600|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728601|NCT00407563|Paclitaxel|paclitaxel|mesh-list
82728602|NCT00407563|Bevacizumab|bevacizumab|mesh-list
82728603|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82728604|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82728605|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728606|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
82728607|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
82728608|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
82728609|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728610|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82728611|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82728612|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82728613|NCT00407563|Growth Substances|growth substances|mesh-ancestor
82728614|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728615|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
82728617|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82728618|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728619|NCT01037101|Cycloserine|cycloserine|mesh-list
82728620|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82728621|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728622|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82728623|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
82728624|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82728625|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
82728626|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728627|NCT00904306|Chromium|chromium|mesh-list
82728628|NCT00904306|Picolinic acid|picolinic acid|mesh-list
82728629|NCT00904306|Trace Elements|trace elements|mesh-ancestor
82728630|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
82728631|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728632|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82728633|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
82728634|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
82728635|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728636|NCT00623103|Rivastigmine|rivastigmine|mesh-list
82728637|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82728638|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728639|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728640|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
82728641|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728642|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728643|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82728644|NCT00623103|Protective Agents|protective agents|mesh-ancestor
82728645|NCT01043341|Vaccines|vaccines|mesh-list
82728646|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
82728647|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728648|NCT01043419|Xenon|xenon|mesh-list
82728649|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82728650|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
82728651|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
82728652|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728653|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728654|NCT01037335|Morphine|morphine|mesh-list
82728655|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82728656|NCT01037335|Narcotics|narcotics|mesh-ancestor
82728657|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728658|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728659|NCT01037335|Analgesics|analgesics|mesh-ancestor
82728660|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
82728661|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728662|NCT04015492|Factor VIII|factor viii|mesh-list
82728663|NCT04015492|BAX 855|bax 855|mesh-list
82728664|NCT04015492|Coagulants|coagulants|mesh-ancestor
82728665|NCT00904462|Lidocaine|lidocaine|mesh-list
82728666|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
82728667|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
82728668|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728669|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728670|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
82728671|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728672|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82728673|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82728674|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82728675|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82728676|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728677|NCT00396565|Olanzapine|olanzapine|mesh-list
82728678|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82728679|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
82728680|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
82728681|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728682|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728683|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82728684|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82728685|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82728686|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728688|NCT00396565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82728689|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82728690|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82728691|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728692|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728693|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
82728694|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82728695|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82728696|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82728697|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82728698|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
82728699|NCT00904540|Lidocaine|lidocaine|mesh-list
82728700|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
82728701|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
82728702|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728703|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728704|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
82728705|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728706|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82728707|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82728708|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82728709|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82728710|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728711|NCT00906880|Eflornithine|eflornithine|mesh-list
82728712|NCT00906880|Nifurtimox|nifurtimox|mesh-list
82728713|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728714|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82728715|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82728716|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82728717|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728718|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
82728719|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728720|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728721|NCT00904852|Bevacizumab|bevacizumab|mesh-list
82728722|NCT00904852|Temozolomide|temozolomide|mesh-list
82728723|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82728724|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728725|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82728726|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82728727|NCT00904852|Growth Substances|growth substances|mesh-ancestor
82728728|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728729|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
82728730|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82728731|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
82728732|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728733|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82728734|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82728735|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
82728736|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82728737|NCT00394771|Estradiol|estradiol|mesh-list
82728738|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82728739|NCT00394771|Estrogens|estrogens|mesh-ancestor
82728740|NCT00394771|Hormones|hormones|mesh-ancestor
82728741|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82728742|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728743|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82728744|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
82728745|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82728746|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82728747|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82728748|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82728749|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82728750|NCT00396409|Omalizumab|omalizumab|mesh-list
82728751|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82728752|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82728753|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
82728754|NCT03653832|Clonidine|clonidine|mesh-list
82728755|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
82728756|NCT03653832|Propofol|propofol|mesh-list
82728757|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82728758|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728759|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728760|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82728761|NCT03653832|Analgesics|analgesics|mesh-ancestor
82728762|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
82728763|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728764|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82728765|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82728766|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82728767|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
82728768|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728769|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728770|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82728771|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
82728772|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
82728773|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82728774|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
82728775|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
82728776|NCT04060836|Factor VIII|factor viii|mesh-list
82728777|NCT04060836|Coagulants|coagulants|mesh-ancestor
82728778|NCT00693420|Bimatoprost|bimatoprost|mesh-list
82728779|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82728780|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82728781|NCT04034524|Insulin|insulin|mesh-list
82728782|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82728784|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728785|NCT00925912|Bupivacaine|bupivacaine|mesh-list
82728786|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
82728787|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
82728788|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728789|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728790|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
82728791|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728792|NCT00695136|Donepezil|donepezil|mesh-list
82728793|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82728794|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728795|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728796|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
82728797|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728798|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728799|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
82728800|NCT00921570|Amlodipine|amlodipine|mesh-list
82728801|NCT00921570|Valsartan|valsartan|mesh-list
82728802|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82728803|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82728804|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82728805|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728806|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82728807|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728808|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
82728809|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82728810|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82728811|NCT02710890|Lacosamide|lacosamide|mesh-list
82728812|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
82728813|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82728814|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82728815|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82728816|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728817|NCT00605176|Imiquimod|imiquimod|mesh-list
82728818|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82728819|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
82728820|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728821|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728822|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
82728823|NCT00743028|Navitoclax|navitoclax|mesh-list
82728824|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728825|NCT00926302|Levetiracetam|levetiracetam|mesh-list
82728826|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
82728827|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
82728828|NCT00907036|Cyclosporine|cyclosporine|mesh-list
82728829|NCT00907036|Fludarabine|fludarabine|mesh-list
82728830|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
82728831|NCT00907036|Melphalan|melphalan|mesh-list
82728832|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
82728833|NCT00907036|Cyclosporins|cyclosporins|mesh-list
82728834|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728835|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82728836|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
82728837|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728838|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82728839|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
82728840|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728841|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728842|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
82728843|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728844|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
82728845|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82728846|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82728847|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82728848|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
82728849|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82728850|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82728851|NCT00926614|Pioglitazone|pioglitazone|mesh-list
82728852|NCT00926614|Atorvastatin|atorvastatin|mesh-list
82728853|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82728854|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82728855|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
82728856|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728857|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82728858|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82728859|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728860|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82728861|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728862|NCT00907114|Ketorolac|ketorolac|mesh-list
82728863|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82728864|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82728865|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82728866|NCT00907114|Analgesics|analgesics|mesh-ancestor
82728867|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
82728868|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728869|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728870|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82728871|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82728872|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82728873|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728874|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728875|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
82728876|NCT02564094|Hematinics|hematinics|mesh-ancestor
82728877|NCT00745914|Pioglitazone|pioglitazone|mesh-list
82728878|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82728879|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728880|NCT00746070|Spironolactone|spironolactone|mesh-list
82728881|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82728882|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
82728883|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82728884|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728885|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82728886|NCT00746070|Diuretics|diuretics|mesh-ancestor
82728887|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
82728888|NCT00396331|Plerixafor|plerixafor|mesh-list
82728889|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82728890|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82728891|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
82728892|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728893|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
82728894|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
82728895|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82728896|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728897|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728898|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
82728899|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82728900|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82728901|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728902|NCT00926926|Oxybutynin|oxybutynin|mesh-list
82728903|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
82728904|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
82728905|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728906|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728907|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82728908|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82728909|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
82728910|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82728911|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728912|NCT00926926|Urological Agents|urological agents|mesh-ancestor
82728913|NCT00396253|Tenecteplase|tenecteplase|mesh-list
82728914|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82728915|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82728916|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728917|NCT00927004|Etoricoxib|etoricoxib|mesh-list
82728918|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82728919|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82728920|NCT00927004|Analgesics|analgesics|mesh-ancestor
82728921|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
82728922|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82728923|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728924|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82728925|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82728926|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82728927|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82728928|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728929|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728931|NCT00931450|Exemestane|exemestane|mesh-list
82728932|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728933|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82728934|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82728935|NCT00931450|Growth Substances|growth substances|mesh-ancestor
82728936|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728937|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
82728938|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82728939|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728940|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728941|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82728942|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82728943|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82728944|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
82728945|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82728946|NCT00928330|Trastuzumab|trastuzumab|mesh-list
82728947|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82728948|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82728949|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728950|NCT00928330|Immunotoxins|immunotoxins|mesh-ancestor
82728951|NCT00928330|Immunoconjugates|immunoconjugates|mesh-ancestor
82728952|NCT00928330|Immunologic Factors|immunologic factors|mesh-ancestor
82728953|NCT00928330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728954|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
82728955|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
82728956|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
82728957|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728958|NCT00928798|Sirolimus|sirolimus|mesh-list
82728959|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82728960|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728961|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82728962|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728963|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
82728964|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82728965|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
82728966|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728967|NCT00931840|Irinotecan|irinotecan|mesh-list
82728968|NCT00931840|Cetuximab|cetuximab|mesh-list
82728969|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82728970|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82728971|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728972|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728973|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728974|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82728975|NCT04034368|Tenofovir|tenofovir|mesh-list
82728976|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
82728977|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82728978|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82728979|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82728980|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82728981|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82728982|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82728983|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82728984|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
82728985|NCT00907270|Vitamin D|vitamin d|mesh-list
82728986|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82728987|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728988|NCT00907270|Vitamins|vitamins|mesh-ancestor
82728989|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
82728990|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82728991|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
82728992|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82728993|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82728994|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82728995|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82728996|NCT00907504|Cisplatin|cisplatin|mesh-list
82728997|NCT00907504|Gemcitabine|gemcitabine|mesh-list
82728998|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82728999|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82729000|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
82729001|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729002|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
82729003|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82729004|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82729005|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729006|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82729008|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
82729009|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729010|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82729011|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82729012|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82729013|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
82729014|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729015|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729016|NCT00932542|Lidocaine|lidocaine|mesh-list
82729017|NCT00932542|Prilocaine|prilocaine|mesh-list
82729018|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
82729019|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
82729020|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82729021|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729022|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
82729023|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729024|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82729025|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82729026|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82729027|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82729028|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729029|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
82729030|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82729031|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729032|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
82729033|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82729034|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82729035|NCT04014634|Prednisolone|prednisolone|mesh-list
82729036|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
82729037|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82729038|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
82729039|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82729040|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
82729041|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
82729042|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729043|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729044|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82729045|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
82729046|NCT04014634|Hormones|hormones|mesh-ancestor
82729047|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82729048|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82729049|NCT04014634|Protective Agents|protective agents|mesh-ancestor
82729050|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82729051|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729052|NCT01043575|Rifampin|rifampin|mesh-list
82729053|NCT01043575|Rifapentine|rifapentine|mesh-list
82729054|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82729055|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
82729056|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82729057|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729058|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
82729059|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82729060|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729061|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729062|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82729063|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82729064|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82729065|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82729066|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82729067|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82729068|NCT01045837|Prednisolone|prednisolone|mesh-list
82729069|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82729070|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
82729071|NCT01045837|Hormones|hormones|mesh-ancestor
82729072|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82729073|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729074|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82729075|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729076|NCT00567268|Gabapentin|gabapentin|mesh-list
82729077|NCT00567268|Analgesics|analgesics|mesh-ancestor
82729078|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
82729079|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729081|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
82729082|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82729083|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82729084|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82729085|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82729086|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82729087|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82729088|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729089|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729090|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
82729091|NCT00907894|Telbivudine|telbivudine|mesh-list
82729092|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
82729093|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729094|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82729095|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729096|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729097|NCT04014556|Aflibercept|aflibercept|mesh-list
82729098|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82729099|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82729100|NCT04014556|Growth Substances|growth substances|mesh-ancestor
82729101|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729102|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
82729103|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729104|NCT00929812|Glucagon|glucagon|mesh-list
82729105|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82729106|NCT00929812|Hormones|hormones|mesh-ancestor
82729107|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82729108|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729109|NCT00907972|Vitamin D|vitamin d|mesh-list
82729110|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
82729111|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
82729112|NCT00907972|Vitamins|vitamins|mesh-list
82729113|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
82729114|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729115|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82729116|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82729117|NCT03799744|Durvalumab|durvalumab|mesh-list
82729118|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82729119|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729120|NCT00933634|Propafenone|propafenone|mesh-list
82729121|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82729122|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82729123|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82729124|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82729125|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729126|NCT00933790|Rifampin|rifampin|mesh-list
82729127|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
82729128|NCT00933790|Ethambutol|ethambutol|mesh-list
82729129|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82729130|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
82729131|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82729132|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729133|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
82729134|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82729135|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729136|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729137|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82729138|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82729139|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82729140|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82729141|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82729142|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82729143|NCT00566254|Zonisamide|zonisamide|mesh-list
82729144|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
82729145|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82729146|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82729147|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729148|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82729149|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729150|NCT00930202|Conivaptan|conivaptan|mesh-list
82729151|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82729152|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729153|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
82729154|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729155|NCT00393367|Prednisone|prednisone|mesh-list
82729156|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
82729157|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82729158|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82729159|NCT00393367|Prednisolone|prednisolone|mesh-list
82729160|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
82729161|NCT00393367|Budesonide|budesonide|mesh-list
82729162|NCT00393367|Bromides|bromides|mesh-list
82729163|NCT00393367|Albuterol|albuterol|mesh-list
82729164|NCT00393367|Ipratropium|ipratropium|mesh-list
82729165|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82729166|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
82729167|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82729168|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
82729169|NCT00393367|Hormones|hormones|mesh-ancestor
82729170|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82729171|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729172|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82729173|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729174|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
82729175|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
82729176|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729177|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82729178|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82729179|NCT00393367|Protective Agents|protective agents|mesh-ancestor
82729180|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82729181|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82729182|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
82729183|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
82729184|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
82729185|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82729186|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82729187|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82729188|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82729189|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
82729190|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729191|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729192|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82729193|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
82729194|NCT00395629|Deferasirox|deferasirox|mesh-list
82729195|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82729196|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
82729197|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
82729198|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729199|NCT00392665|Sulindac|sulindac|mesh-list
82729200|NCT00392665|Bevacizumab|bevacizumab|mesh-list
82729201|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82729202|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82729203|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729204|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82729205|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82729206|NCT00392665|Growth Substances|growth substances|mesh-ancestor
82729207|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729208|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
82729209|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82729210|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729211|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729212|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82729213|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82729214|NCT00392665|Analgesics|analgesics|mesh-ancestor
82729215|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
82729216|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729217|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82729218|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729219|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82729220|NCT01043965|Metformin|metformin|mesh-list
82729221|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82729222|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729223|NCT00622869|Everolimus|everolimus|mesh-list
82729224|NCT00622869|Tacrolimus|tacrolimus|mesh-list
82729225|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82729226|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
82729227|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729228|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82729229|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729230|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729231|NCT00622869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82729232|NCT00622869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82729233|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729234|NCT00366457|Bevacizumab|bevacizumab|mesh-list
82729235|NCT00366457|Gemcitabine|gemcitabine|mesh-list
82729236|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82729237|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82729238|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729239|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82729240|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82729241|NCT00366457|Growth Substances|growth substances|mesh-ancestor
82729242|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729243|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
82729244|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82729245|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
82729246|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729247|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82729248|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729249|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82729250|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
82729251|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729252|NCT01049347|Amitriptyline|amitriptyline|mesh-list
82729253|NCT01049347|Paroxetine|paroxetine|mesh-list
82729254|NCT01049347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82729255|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82729256|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82729257|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729258|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729259|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
82729260|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729261|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82729262|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
82729263|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82729264|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82729265|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82729266|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729267|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82729268|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82729269|NCT01049347|Analgesics|analgesics|mesh-ancestor
82729270|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
82729271|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729272|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82729273|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
82729274|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
82729275|NCT01049425|Docetaxel|docetaxel|mesh-list
82729276|NCT01049425|Epirubicin|epirubicin|mesh-list
82729277|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82729278|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
82729279|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729280|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729281|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82729282|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
82729283|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729284|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729285|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82729286|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
82729287|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
82729288|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
82729289|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82729290|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82729291|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82729292|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729293|NCT00838227|Modafinil|modafinil|mesh-list
82729294|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82729295|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729296|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82729297|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82729298|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82729299|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729300|NCT00366301|Metformin|metformin|mesh-list
82729301|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
82729302|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82729303|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729304|NCT00838305|Citalopram|citalopram|mesh-list
82729305|NCT00838305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82729306|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82729307|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82729308|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729309|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729310|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
82729311|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729312|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82729313|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
82729314|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82729315|NCT00622713|Rivastigmine|rivastigmine|mesh-list
82729316|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82729317|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729318|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729319|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
82729320|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729321|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729322|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82729323|NCT00622713|Protective Agents|protective agents|mesh-ancestor
82729324|NCT01046227|Vaccines|vaccines|mesh-list
82729325|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
82729326|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729327|NCT00392197|Aripiprazole|aripiprazole|mesh-list
82729328|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
82729329|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82729330|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82729331|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82729332|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82729333|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729334|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
82729335|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
82729336|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729337|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729338|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82729339|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82729340|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
82729341|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82729342|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82729343|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82729344|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82729345|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82729346|NCT00391807|Norethindrone|norethindrone|mesh-list
82729347|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
82729348|NCT00391807|Estradiol|estradiol|mesh-list
82729349|NCT00391807|Estrogens|estrogens|mesh-ancestor
82729350|NCT00391807|Hormones|hormones|mesh-ancestor
82729351|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82729352|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729353|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82729354|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
82729355|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82729356|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82729357|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82729358|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82729359|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82729360|NCT00624585|Dasatinib|dasatinib|mesh-list
82729361|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729362|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82729363|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729364|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729365|NCT01046383|Caseins|caseins|mesh-list
82729366|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
82729367|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
82729368|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729369|NCT00831597|Rituximab|rituximab|mesh-list
82729370|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82729371|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82729372|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729373|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
82729374|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729375|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729376|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82729377|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
82729378|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729379|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82729380|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82729381|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
82729382|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729383|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729384|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82729385|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
82729386|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82729387|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82729388|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82729389|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
82729390|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729391|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729392|NCT00391027|Insulin|insulin|mesh-list
82729393|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82729394|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
82729395|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82729396|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729397|NCT00622401|Interleukin-12|interleukin-12|mesh-list
82729398|NCT00622401|Vaccines|vaccines|mesh-list
82729399|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
82729400|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729401|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82729402|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82729403|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82729404|NCT00622401|Growth Substances|growth substances|mesh-ancestor
82729405|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
82729406|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729407|NCT04018365|Empagliflozin|empagliflozin|mesh-list
82729408|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82729409|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729410|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82729411|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729412|NCT00828087|Cobalt|cobalt|mesh-list
82729413|NCT00828087|Chromium|chromium|mesh-list
82729414|NCT00828087|Everolimus|everolimus|mesh-list
82729415|NCT00828087|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82729416|NCT00828087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82729417|NCT00828087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729418|NCT00828087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729419|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82729420|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
82729421|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729422|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729423|NCT00828087|Trace Elements|trace elements|mesh-ancestor
82729424|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
82729425|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
82729426|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
82729427|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
82729428|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729429|NCT00839085|Protective Agents|protective agents|mesh-ancestor
82729430|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729431|NCT00839085|Vitamins|vitamins|mesh-ancestor
82729432|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
82729433|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82729434|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729435|NCT00839163|Vitamin K|vitamin k|mesh-list
82729436|NCT00839163|Enoxaparin|enoxaparin|mesh-list
82729437|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
82729438|NCT00839163|Vitamins|vitamins|mesh-ancestor
82729439|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
82729440|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729441|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82729442|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
82729443|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82729444|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
82729445|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729446|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729447|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
82729448|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82729449|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82729450|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82729451|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
82729452|NCT00839163|Coagulants|coagulants|mesh-ancestor
82729453|NCT02549001|Amorolfine|amorolfine|mesh-list
82729454|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
82729455|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729456|NCT00621543|Copper|copper|mesh-list
82729457|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
82729458|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82729459|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
82729460|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82729461|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729462|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82729463|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82729464|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82729465|NCT00621543|Trace Elements|trace elements|mesh-ancestor
82729466|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
82729467|NCT00623805|Bevacizumab|bevacizumab|mesh-list
82729468|NCT00623805|Capecitabine|capecitabine|mesh-list
82729469|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
82729470|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82729471|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729472|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82729473|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82729474|NCT00623805|Growth Substances|growth substances|mesh-ancestor
82729475|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729476|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
82729477|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82729479|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729480|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
82729481|NCT02548923|Propofol|propofol|mesh-list
82729482|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82729483|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82729484|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729485|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82729486|NCT02548923|Analgesics|analgesics|mesh-ancestor
82729487|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
82729488|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729489|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82729490|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82729491|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82729492|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
82729493|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729494|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729495|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82729496|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
82729497|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
82729498|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82729499|NCT00832221|Raclopride|raclopride|mesh-list
82729500|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
82729501|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82729502|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82729503|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82729504|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82729505|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729506|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82729507|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
82729508|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729509|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729510|NCT00839397|Paroxetine|paroxetine|mesh-list
82729511|NCT00839397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82729512|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82729740|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82729513|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82729514|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729515|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729517|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729518|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82729519|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
82729520|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82729521|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82729522|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82729523|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729524|NCT00828477|Nepafenac|nepafenac|mesh-list
82729525|NCT00828477|Bromfenac|bromfenac|mesh-list
82729526|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82729527|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82729528|NCT00828477|Analgesics|analgesics|mesh-ancestor
82729529|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
82729530|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729531|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729532|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82729533|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729534|NCT00621309|Rifampin|rifampin|mesh-list
82729535|NCT00621309|Rifamycins|rifamycins|mesh-list
82729536|NCT00621309|Sulforaphane|sulforaphane|mesh-list
82729537|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82729538|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
82729539|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82729540|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729541|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
82729542|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82729543|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729544|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729545|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82729546|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82729547|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82729548|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82729549|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82729550|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82729551|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82729552|NCT00621309|Protective Agents|protective agents|mesh-ancestor
82729553|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729554|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729555|NCT00839553|Minocycline|minocycline|mesh-list
82729556|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82729557|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729558|NCT00832689|Gemcitabine|gemcitabine|mesh-list
82729559|NCT00832689|Irinotecan|irinotecan|mesh-list
82729560|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82729561|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
82729562|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729563|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729564|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82729565|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82729566|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729567|NCT00567190|Docetaxel|docetaxel|mesh-list
82729568|NCT00567190|Trastuzumab|trastuzumab|mesh-list
82729569|NCT00567190|Pertuzumab|pertuzumab|mesh-list
82729570|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729571|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
82729572|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
82729573|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
82729574|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729575|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82729576|NCT00922389|Lenograstim|lenograstim|mesh-list
82729577|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82729578|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
82729579|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729580|NCT00691938|Decitabine|decitabine|mesh-list
82729581|NCT00691938|Panobinostat|panobinostat|mesh-list
82729582|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82729583|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
82729584|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729585|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729586|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729587|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82729588|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
82729590|NCT00365365|Carboplatin|carboplatin|mesh-list
82729591|NCT00365365|Docetaxel|docetaxel|mesh-list
82729592|NCT00365365|Doxorubicin|doxorubicin|mesh-list
82729593|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82729594|NCT00365365|Trastuzumab|trastuzumab|mesh-list
82729595|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82729596|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
82729597|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729598|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729599|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82729600|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
82729601|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729602|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729603|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82729604|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82729605|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82729606|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82729608|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
82729609|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
82729610|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
82729611|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
82729612|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82729613|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82729614|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82729615|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729616|NCT01046461|Dexamethasone|dexamethasone|mesh-list
82729617|NCT01046461|Aprepitant|aprepitant|mesh-list
82729618|NCT01046461|Ramosetron|ramosetron|mesh-list
82729619|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82729620|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
82729621|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
82729622|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729623|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729624|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82729625|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
82729626|NCT01046461|Hormones|hormones|mesh-ancestor
82729627|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82729628|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82729629|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729630|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82729631|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729632|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729633|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82729634|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
82729635|NCT00623727|Factor VIII|factor viii|mesh-list
82729636|NCT00623727|Coagulants|coagulants|mesh-ancestor
82729637|NCT01046539|Buprenorphine|buprenorphine|mesh-list
82729638|NCT01046539|ALKS-33|alks-33|mesh-list
82729639|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82729640|NCT01046539|Narcotics|narcotics|mesh-ancestor
82729641|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82729642|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729643|NCT01046539|Analgesics|analgesics|mesh-ancestor
82729644|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
82729645|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729646|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82729647|NCT01044199|Vaccines|vaccines|mesh-list
82729648|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
82729649|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729650|NCT00828789|Tenofovir|tenofovir|mesh-list
82729651|NCT00828789|Efavirenz|efavirenz|mesh-list
82729652|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
82729653|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729654|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82729655|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82729656|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729657|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729658|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82729659|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82729660|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82729661|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82729662|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82729663|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82729664|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82729665|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82729666|NCT00930358|Anesthetics|anesthetics|mesh-list
82729667|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82729668|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729669|NCT00372775|Sunitinib|sunitinib|mesh-list
82729670|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729671|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82729672|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82729673|NCT00372775|Growth Substances|growth substances|mesh-ancestor
82729674|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729675|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
82729676|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82729677|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729678|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729680|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82729681|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729682|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729683|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82729684|NCT00936676|Protective Agents|protective agents|mesh-ancestor
82729685|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729686|NCT00839787|Morphine|morphine|mesh-list
82729687|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82729688|NCT00839787|Narcotics|narcotics|mesh-ancestor
82729689|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82729690|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729691|NCT00839787|Analgesics|analgesics|mesh-ancestor
82729692|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
82729693|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729694|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82729695|NCT00934258|Fenofibrate|fenofibrate|mesh-list
82729696|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82729697|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82729698|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
82729699|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729700|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82729701|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82729702|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729703|NCT00372697|Octreotide|octreotide|mesh-list
82729704|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82729705|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82729706|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729707|NCT00934414|Insulin|insulin|mesh-list
82729708|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82729709|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729710|NCT00930514|Rituximab|rituximab|mesh-list
82729711|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82729712|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729713|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
82729714|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729715|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729716|NCT00936988|Cinacalcet|cinacalcet|mesh-list
82729717|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82729718|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729719|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82729720|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
82729721|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82729722|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82729723|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82729724|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729725|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82729726|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
82729727|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82729728|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82729729|NCT00934570|Metformin|metformin|mesh-list
82729730|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82729731|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729732|NCT00930670|Esomeprazole|esomeprazole|mesh-list
82729733|NCT00930670|Omeprazole|omeprazole|mesh-list
82729734|NCT00930670|Pantoprazole|pantoprazole|mesh-list
82729735|NCT00930670|Ranitidine|ranitidine|mesh-list
82729736|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
82729737|NCT00930670|Atorvastatin|atorvastatin|mesh-list
82729738|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82729739|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82729741|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
82729742|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729743|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82729744|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82729745|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729746|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82729747|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82729748|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82729749|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82729750|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
82729751|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
82729752|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729753|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729754|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
82729755|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
82729756|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82729757|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82729758|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729759|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729760|NCT00937144|Urological Agents|urological agents|mesh-ancestor
82729761|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
82729763|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
82729764|NCT00937300|Interleukin-2|interleukin-2|mesh-list
82729765|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82729766|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
82729767|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729768|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729769|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82729770|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
82729771|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729772|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729773|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82729774|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82729775|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
82729776|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82729777|NCT00937300|Analgesics|analgesics|mesh-ancestor
82729778|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
82729779|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729780|NCT02226276|Copper|copper|mesh-list
82729781|NCT02226276|Trastuzumab|trastuzumab|mesh-list
82729782|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82729783|NCT02226276|Maytansine|maytansine|mesh-list
82729784|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82729785|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
82729786|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82729787|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729788|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729789|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82729790|NCT02226276|Trace Elements|trace elements|mesh-ancestor
82729791|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
82729792|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729793|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82729794|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
82729795|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
82729796|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
82729797|NCT02226276|Immunotoxins|immunotoxins|mesh-ancestor
82729798|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
82729799|NCT00935116|Etoricoxib|etoricoxib|mesh-list
82729800|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82729801|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82729802|NCT00935116|Analgesics|analgesics|mesh-ancestor
82729803|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
82729804|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729805|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729806|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82729807|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729808|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82729809|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82729810|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729811|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729812|NCT00931138|Cytarabine|cytarabine|mesh-list
82729813|NCT00931138|Daunorubicin|daunorubicin|mesh-list
82729814|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82729815|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729816|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82729817|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82729818|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729819|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729820|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82729821|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
82729822|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
82729823|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729824|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82729825|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
82729826|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729827|NCT00935194|Oseltamivir|oseltamivir|mesh-list
82729828|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
82729830|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729831|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729832|NCT00690378|Imipenem|imipenem|mesh-list
82729833|NCT00690378|Ceftazidime|ceftazidime|mesh-list
82729834|NCT00690378|Avibactam|avibactam|mesh-list
82729835|NCT00690378|Cilastatin|cilastatin|mesh-list
82729836|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82729837|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729838|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
82729839|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729840|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729841|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82729842|NCT00574275|Gemcitabine|gemcitabine|mesh-list
82729843|NCT00574275|Aflibercept|aflibercept|mesh-list
82729844|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82729845|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
82729846|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729847|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729848|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82729849|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82729850|NCT00574275|Growth Substances|growth substances|mesh-ancestor
82729851|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729852|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
82729853|NCT01742832|Citalopram|citalopram|mesh-list
82729854|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
82729855|NCT01742832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82729856|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82729857|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82729858|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729859|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729860|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
82729861|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729862|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82729863|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
82729864|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82729865|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82729866|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82729867|NCT00833079|Tacrolimus|tacrolimus|mesh-list
82729868|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82729869|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
82729870|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729871|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82729872|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729873|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729874|NCT00935506|Aspirin|aspirin|mesh-list
82729875|NCT00935506|Clopidogrel|clopidogrel|mesh-list
82729876|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82729877|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82729878|NCT00935506|Analgesics|analgesics|mesh-ancestor
82729879|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
82729880|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729881|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729882|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82729883|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729884|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82729885|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82729886|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729887|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82729888|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82729889|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730115|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
82729891|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82729892|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82729893|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82729894|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
82729895|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729897|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82729898|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82729899|NCT00833157|Analgesics|analgesics|mesh-ancestor
82729900|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
82729901|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729902|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729903|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82729904|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729905|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82729906|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729907|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729908|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
82729909|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82729910|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82729911|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82729912|NCT04285671|Trastuzumab|trastuzumab|mesh-list
82729913|NCT04285671|Necitumumab|necitumumab|mesh-list
82729914|NCT04285671|Osimertinib|osimertinib|mesh-list
82729915|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
82729916|NCT04285671|Antibodies|antibodies|mesh-list
82729917|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
82729918|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82729919|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
82729920|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729921|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729922|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729923|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82729924|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729925|NCT00931372|Lixisenatide|lixisenatide|mesh-list
82729926|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82729927|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729928|NCT00829257|Fluticasone|fluticasone|mesh-list
82729929|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82729930|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82729931|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82729932|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
82729933|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82729934|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729935|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82729936|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
82729937|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
82729938|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82729939|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
82729940|NCT00829257|Hormones|hormones|mesh-ancestor
82729941|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82729942|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
82729943|NCT03978832|Risperidone|risperidone|mesh-list
82729944|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82729945|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
82729946|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729947|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729948|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729949|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82729950|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82729951|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82729952|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82729953|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82729954|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
82729955|NCT00840333|Levofloxacin|levofloxacin|mesh-list
82729956|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82729957|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729958|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82729959|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82729960|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82729961|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729962|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729963|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729964|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82729965|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82729966|NCT00840489|Ribavirin|ribavirin|mesh-list
82729967|NCT00840489|Colchicine|colchicine|mesh-list
82729968|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
82729969|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729970|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
82729971|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82729972|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
82729973|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729974|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
82729975|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
82729976|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
82729977|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82729978|NCT00743496|Antibodies|antibodies|mesh-list
82729979|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
82729980|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729981|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82729982|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82729983|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82729984|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82729985|NCT00840645|Mirabegron|mirabegron|mesh-list
82729986|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82729987|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82729988|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82729989|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
82729990|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82729991|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82729992|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82729993|NCT00840645|Urological Agents|urological agents|mesh-ancestor
82729994|NCT00566722|Adalimumab|adalimumab|mesh-list
82729995|NCT00566722|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82729996|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82729997|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82729998|NCT00691704|Prednisone|prednisone|mesh-list
82729999|NCT00691704|Lenalidomide|lenalidomide|mesh-list
82730000|NCT00691704|Bortezomib|bortezomib|mesh-list
82730001|NCT00691704|Melphalan|melphalan|mesh-list
82730002|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730003|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
82730004|NCT00691704|Hormones|hormones|mesh-ancestor
82730005|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730006|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730007|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82730008|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730009|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730010|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
82730011|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82730012|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82730013|NCT00691704|Growth Substances|growth substances|mesh-ancestor
82730014|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
82730015|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82730016|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
82730017|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82730018|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82730019|NCT00829647|Lenalidomide|lenalidomide|mesh-list
82730020|NCT00829647|Dasatinib|dasatinib|mesh-list
82730021|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
82730022|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730023|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82730024|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82730025|NCT00829647|Growth Substances|growth substances|mesh-ancestor
82730026|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
82730027|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730028|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82730029|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730030|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730031|NCT00939328|Rituximab|rituximab|mesh-list
82730032|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82730033|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82730034|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730035|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
82730036|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730037|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82730038|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82730039|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
82730268|NCT00835029|Clotrimazole|clotrimazole|mesh-list
82730040|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730041|NCT00829881|Betahistine|betahistine|mesh-list
82730042|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
82730043|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
82730044|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
82730045|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730046|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730047|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730048|NCT04014244|Triamcinolone|triamcinolone|mesh-list
82730049|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82730050|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82730051|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82730052|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730053|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
82730054|NCT04014244|Hormones|hormones|mesh-ancestor
82730055|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730056|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730057|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82730058|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
82730059|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730060|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730061|NCT02548611|Clopidogrel|clopidogrel|mesh-list
82730062|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82730063|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82730064|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82730065|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82730066|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82730067|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
82730068|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730069|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730070|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730071|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
82730072|NCT00937924|Promethazine|promethazine|mesh-list
82730073|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82730074|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82730075|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82730076|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730077|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
82730078|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
82730079|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
82730080|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730081|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
82730082|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
82730083|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82730084|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82730085|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
82730086|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
82730087|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730088|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730089|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82730090|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
82730091|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
82730093|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
82730094|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730095|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
82730096|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82730097|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
82730098|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730099|NCT00830193|Expectorants|expectorants|mesh-ancestor
82730100|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
82730101|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82730102|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
82730103|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730104|NCT00830193|Protective Agents|protective agents|mesh-ancestor
82730105|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730106|NCT00830193|Antidotes|antidotes|mesh-ancestor
82730107|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
82730108|NCT00938158|Incretins|incretins|mesh-ancestor
82730109|NCT00938158|Hormones|hormones|mesh-ancestor
82730110|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730111|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730112|NCT00840957|Infliximab|infliximab|mesh-list
82730113|NCT00840957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82730114|NCT00840957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730116|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82730117|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82730118|NCT00743964|Capecitabine|capecitabine|mesh-list
82730119|NCT00743964|Epirubicin|epirubicin|mesh-list
82730120|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730121|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82730122|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
82730123|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730124|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82730125|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82730126|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82730127|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730128|NCT00830349|Risperidone|risperidone|mesh-list
82730129|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82730130|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
82730131|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730132|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730133|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730134|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82730135|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82730136|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82730137|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82730138|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82730139|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
82730140|NCT00841113|Goserelin|goserelin|mesh-list
82730141|NCT00841113|Bicalutamide|bicalutamide|mesh-list
82730142|NCT00841113|Abarelix|abarelix|mesh-list
82730143|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82730144|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730145|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
82730146|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
82730147|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730148|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730149|NCT00830505|Fluticasone|fluticasone|mesh-list
82730150|NCT00830505|Xhance|xhance|mesh-list
82730151|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82730152|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82730153|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730154|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82730155|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
82730156|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730157|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730158|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82730159|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
82730160|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
82730161|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82730162|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82730163|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82730164|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82730165|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
82730166|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730167|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730169|NCT00830505|Hormones|hormones|mesh-ancestor
82730170|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730171|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
82730172|NCT00566020|Lamotrigine|lamotrigine|mesh-list
82730173|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
82730174|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82730175|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82730176|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730177|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82730178|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730179|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82730180|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82730181|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82730182|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82730183|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82730184|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
82730185|NCT02563782|Tacrolimus|tacrolimus|mesh-list
82730186|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82730187|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
82730188|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730189|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82730190|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730269|NCT00835029|Miconazole|miconazole|mesh-list
82730191|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730192|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82730193|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730194|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82730195|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
82730196|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82730197|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730198|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82730199|NCT00841191|Siltuximab|siltuximab|mesh-list
82730200|NCT00841191|Antibodies|antibodies|mesh-list
82730201|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
82730202|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82730203|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
82730204|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730205|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730206|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
82730207|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
82730208|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
82730209|NCT00843453|Vitamins|vitamins|mesh-ancestor
82730210|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
82730211|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730212|NCT00843453|Hematinics|hematinics|mesh-ancestor
82730213|NCT00921726|Oseltamivir|oseltamivir|mesh-list
82730214|NCT00921726|Zanamivir|zanamivir|mesh-list
82730215|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
82730216|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730217|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730218|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730219|NCT00938236|Cyclosporine|cyclosporine|mesh-list
82730220|NCT00938236|Cyclosporins|cyclosporins|mesh-list
82730221|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730222|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730223|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82730224|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
82730225|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730226|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
82730227|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730228|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
82730229|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82730230|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82730231|NCT00741780|Plerixafor|plerixafor|mesh-list
82730232|NCT00741780|Lenograstim|lenograstim|mesh-list
82730233|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82730234|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
82730235|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730236|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82730237|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82730238|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
82730239|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730240|NCT00936442|Anastrozole|anastrozole|mesh-list
82730241|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82730242|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730243|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82730244|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82730245|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730246|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730247|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82730248|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
82730249|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730250|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730251|NCT00744354|Doxorubicin|doxorubicin|mesh-list
82730252|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82730253|NCT00744354|Bortezomib|bortezomib|mesh-list
82730254|NCT00744354|Vorinostat|vorinostat|mesh-list
82730255|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82730256|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730257|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82730258|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82730259|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730260|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730261|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82730262|NCT04043325|Antibodies|antibodies|mesh-list
82730263|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
82730264|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730265|NCT00936520|Lifitegrast|lifitegrast|mesh-list
82730266|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82730267|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82730270|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82730271|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730272|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
82730273|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82730274|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82730275|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730276|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730277|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82730278|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
82730279|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730280|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730281|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82730282|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82730284|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82730285|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
82730286|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730287|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730288|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730289|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82730290|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82730291|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82730292|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82730293|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82730294|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
82730295|NCT00690612|Candesartan|candesartan|mesh-list
82730296|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
82730297|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82730298|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82730299|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82730300|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730301|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
82730302|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
82730303|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82730304|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82730305|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730306|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730307|NCT00742014|Urological Agents|urological agents|mesh-ancestor
82730308|NCT00742092|Miglustat|miglustat|mesh-list
82730309|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730310|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730311|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82730312|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82730313|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
82730314|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730315|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82730316|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82730317|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730318|NCT00841581|Ranibizumab|ranibizumab|mesh-list
82730319|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82730320|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82730321|NCT00841581|Growth Substances|growth substances|mesh-ancestor
82730322|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730323|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
82730324|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730325|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
82730326|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82730327|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
82730328|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730329|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730330|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82730331|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
82730332|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82730333|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82730334|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82730335|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
82730336|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730337|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730338|NCT04249167|Paclitaxel|paclitaxel|mesh-list
82730339|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82730340|NCT04249167|Atezolizumab|atezolizumab|mesh-list
82730341|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82730342|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82730343|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730344|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
82730345|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
82730346|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
82730347|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730348|NCT04249167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82730349|NCT04249167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82730350|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
82730351|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730352|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82730354|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
82730355|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82730356|NCT00621153|Diuretics|diuretics|mesh-ancestor
82730357|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
82730358|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730359|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82730360|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82730361|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730362|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82730363|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82730364|NCT05447910|Letrozole|letrozole|mesh-list
82730365|NCT05447910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730366|NCT05447910|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82730367|NCT05447910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82730368|NCT05447910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730369|NCT05447910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730370|NCT05447910|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82730371|NCT05447910|Hormone Antagonists|hormone antagonists|mesh-ancestor
82730372|NCT05447910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730373|NCT05447910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730374|NCT00574119|Spironolactone|spironolactone|mesh-list
82730375|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82730376|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
82730377|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730378|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730379|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82730380|NCT00574119|Diuretics|diuretics|mesh-ancestor
82730381|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
82730382|NCT00705614|Infliximab|infliximab|mesh-list
82730383|NCT00705614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82730384|NCT00705614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730385|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
82730386|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82730387|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82730388|NCT00844155|Oseltamivir|oseltamivir|mesh-list
82730389|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
82730390|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730391|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730392|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730393|NCT05669924|Methylphenidate|methylphenidate|mesh-list
82730394|NCT05669924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82730395|NCT05669924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730396|NCT05669924|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82730397|NCT05669924|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82730398|NCT05669924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82730399|NCT05669924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730400|NCT05669924|Dopamine Agents|dopamine agents|mesh-ancestor
82730401|NCT05669924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730402|NCT00844233|Irinotecan|irinotecan|mesh-list
82730403|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82730404|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82730405|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730406|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730407|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730408|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
82730409|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
82730410|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730411|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82730412|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730413|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82730414|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82730415|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730416|NCT00840801|Vaccines|vaccines|mesh-list
82730417|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
82730418|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730419|NCT02547597|Atenolol|atenolol|mesh-list
82730420|NCT02547597|Carvedilol|carvedilol|mesh-list
82730421|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82730422|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82730423|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
82730424|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730425|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730426|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730427|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82730428|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
82730429|NCT02547597|Protective Agents|protective agents|mesh-ancestor
82730430|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82730431|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82730432|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82730433|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
82730434|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82730435|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82730436|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82730437|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
82730438|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
82730439|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730440|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82730441|NCT00842127|Methylphenidate|methylphenidate|mesh-list
82730442|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82730443|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730444|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82730445|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82730446|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82730447|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730448|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
82730449|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730450|NCT00835965|Dexamethasone|dexamethasone|mesh-list
82730451|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
82730452|NCT00835965|Aprepitant|aprepitant|mesh-list
82730453|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
82730454|NCT00835965|BB 1101|bb 1101|mesh-list
82730455|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730456|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
82730457|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
82730458|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730459|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730460|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82730461|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
82730462|NCT00835965|Hormones|hormones|mesh-ancestor
82730463|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730464|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82730465|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730466|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
82730467|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730468|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730469|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82730470|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730471|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
82730472|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82730473|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82730474|NCT05667740|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82730475|NCT05667740|Immunologic Factors|immunologic factors|mesh-ancestor
82730476|NCT05667740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730477|NCT00842205|Interferons|interferons|mesh-list
82730478|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730479|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
82730480|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730481|NCT00738296|Simvastatin|simvastatin|mesh-list
82730482|NCT00738296|Ezetimibe|ezetimibe|mesh-list
82730483|NCT00738296|Pravastatin|pravastatin|mesh-list
82730484|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82730485|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82730486|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
82730487|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730488|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82730569|NCT00842595|Analgesics|analgesics|mesh-ancestor
82730489|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82730490|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730491|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
82730492|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82730493|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730494|NCT02567396|Talazoparib|talazoparib|mesh-list
82730495|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82730496|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730497|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730498|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730500|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82730501|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
82730502|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730503|NCT05667428|Leuprolide|leuprolide|mesh-list
82730504|NCT05667428|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82730505|NCT05667428|Fertility Agents|fertility agents|mesh-ancestor
82730506|NCT05667428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82730507|NCT05667428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730508|NCT05667428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82730509|NCT05667428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730510|NCT05664542|Dexmedetomidine|dexmedetomidine|mesh-list
82730511|NCT05664542|Ropivacaine|ropivacaine|mesh-list
82730512|NCT05664542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82730513|NCT05664542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82730514|NCT05664542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730515|NCT05664542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82730516|NCT05664542|Analgesics|analgesics|mesh-ancestor
82730517|NCT05664542|Sensory System Agents|sensory system agents|mesh-ancestor
82730518|NCT05664542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730519|NCT05664542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82730520|NCT05664542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82730521|NCT05664542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82730522|NCT05664542|Adrenergic Agents|adrenergic agents|mesh-ancestor
82730523|NCT05664542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730524|NCT05664542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730525|NCT05664542|Anesthetics, Local|anesthetics, local|mesh-ancestor
82730526|NCT05664542|Anesthetics|anesthetics|mesh-ancestor
82730532|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
82730533|NCT00562978|Etoposide|etoposide|mesh-list
82730534|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82730535|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
82730536|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730537|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82730538|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82730539|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
82730540|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730541|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730542|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82730543|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82730544|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82730545|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82730546|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730547|NCT00842595|Prednisone|prednisone|mesh-list
82730548|NCT00842595|Rituximab|rituximab|mesh-list
82730549|NCT00842595|Vinorelbine|vinorelbine|mesh-list
82730550|NCT00842595|Ifosfamide|ifosfamide|mesh-list
82730551|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
82730552|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82730553|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730554|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
82730555|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730556|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82730557|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730558|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
82730559|NCT00842595|Hormones|hormones|mesh-ancestor
82730560|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730561|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82730562|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82730563|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
82730564|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
82730565|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
82730566|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730567|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82730568|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
82730570|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
82730571|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730572|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82730573|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82730574|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730575|NCT00938626|Antibodies|antibodies|mesh-list
82730576|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82730577|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
82730578|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730579|NCT00836199|Vaccines|vaccines|mesh-list
82730580|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
82730581|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730582|NCT04013386|Dexamethasone|dexamethasone|mesh-list
82730583|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
82730584|NCT04013386|Aprepitant|aprepitant|mesh-list
82730585|NCT04013386|Mirtazapine|mirtazapine|mesh-list
82730586|NCT04013386|BB 1101|bb 1101|mesh-list
82730587|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730588|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
82730589|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
82730590|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730591|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730592|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82730593|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
82730594|NCT04013386|Hormones|hormones|mesh-ancestor
82730595|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730596|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82730597|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730598|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
82730599|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730600|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730601|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82730602|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730603|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
82730604|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82730605|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82730606|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
82730607|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
82730608|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82730609|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82730610|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82730611|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82730612|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82730613|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82730614|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
82730615|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82730616|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82730617|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
82730618|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82730619|NCT00940420|Ribavirin|ribavirin|mesh-list
82730620|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82730621|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
82730622|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
82730623|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730624|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
82730625|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730626|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
82730627|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730628|NCT00842907|Tretinoin|tretinoin|mesh-list
82730629|NCT00842907|Isotretinoin|isotretinoin|mesh-list
82730630|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730631|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
82730632|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
82730633|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
82730634|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82730635|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730636|NCT00940654|Acetaminophen|acetaminophen|mesh-list
82730637|NCT00940654|Antipyretics|antipyretics|mesh-list
82730638|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82730639|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82730640|NCT00940654|Analgesics|analgesics|mesh-ancestor
82730641|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
82730642|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730643|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730644|NCT00843063|Pantoprazole|pantoprazole|mesh-list
82730645|NCT00843063|Famotidine|famotidine|mesh-list
82730646|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82730647|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82730648|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82730649|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730650|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730651|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82730652|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
82730653|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
82730654|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730655|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730656|NCT04013464|Escitalopram|escitalopram|mesh-list
82730657|NCT04013464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82730658|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82730659|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82730660|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730661|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730662|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
82730663|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730664|NCT04012918|Capecitabine|capecitabine|mesh-list
82730665|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82730666|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82730667|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
82730668|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730669|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730670|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82730671|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730672|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82730673|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
82730674|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730675|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730676|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
82730677|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
82730678|NCT00939718|Vitamins|vitamins|mesh-ancestor
82730679|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
82730680|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730681|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
82730682|NCT00939718|Hematinics|hematinics|mesh-ancestor
82730683|NCT00836667|Sertraline|sertraline|mesh-list
82730684|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
82730685|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82730686|NCT00836667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82730687|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82730688|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82730689|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730690|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730691|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
82730692|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730693|NCT00845559|Exenatide|exenatide|mesh-list
82730694|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82730695|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730696|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82730697|NCT00845559|Incretins|incretins|mesh-ancestor
82730698|NCT00845559|Hormones|hormones|mesh-ancestor
82730699|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730700|NCT00836823|Alfuzosin|alfuzosin|mesh-list
82730701|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82730702|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82730703|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82730704|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
82730705|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730706|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730707|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730708|NCT00836823|Urological Agents|urological agents|mesh-ancestor
82730709|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
82730710|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
82730711|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730712|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
82730713|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730714|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730715|NCT05107778|Entecavir|entecavir|mesh-list
82730716|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
82730717|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730718|NCT00372619|Cytarabine|cytarabine|mesh-list
82730719|NCT00372619|Methotrexate|methotrexate|mesh-list
82730720|NCT00372619|Clofarabine|clofarabine|mesh-list
82730721|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82730722|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
82730723|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82730724|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730725|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82730726|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
82730727|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730728|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730729|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
82730730|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730731|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82730732|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82730733|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
82730734|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82730735|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82730736|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
82730737|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730738|NCT00851175|Caffeine|caffeine|mesh-list
82730739|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82730740|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82730741|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82730742|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
82730743|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730744|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82730745|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82730746|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730747|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82730748|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730749|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82730750|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82730751|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82730752|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
82730753|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730754|NCT02566226|Morphine|morphine|mesh-list
82730755|NCT02566226|Bupivacaine|bupivacaine|mesh-list
82730756|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
82730757|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
82730758|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82730759|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730760|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
82730761|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730762|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82730763|NCT02566226|Narcotics|narcotics|mesh-ancestor
82730764|NCT02566226|Analgesics|analgesics|mesh-ancestor
82730765|NCT00837135|Vaccines|vaccines|mesh-list
82730766|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
82730767|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730768|NCT00562588|Dipyridamole|dipyridamole|mesh-list
82730769|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
82730770|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82730771|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730772|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730773|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82730774|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
82730775|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
82730776|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82730777|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
82730778|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82730779|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
82730780|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730781|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730782|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
82730783|NCT02546349|Fluticasone|fluticasone|mesh-list
82730784|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
82730785|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82730786|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82730787|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730788|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82730789|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
82730790|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730791|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730792|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82730793|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
82730794|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
82730795|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82730796|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
82730797|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82730798|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
82730799|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730800|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730801|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82730802|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82730803|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82730804|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
82730805|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
82730807|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730808|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
82730809|NCT00851487|Amoxicillin|amoxicillin|mesh-list
82730810|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82730811|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730812|NCT00372385|Interferons|interferons|mesh-list
82730813|NCT00372385|Ribavirin|ribavirin|mesh-list
82730814|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
82730815|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
82730816|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82730817|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730818|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
82730819|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730820|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
82730821|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730822|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
82730823|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730824|NCT03830281|Insulin|insulin|mesh-list
82730825|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82730826|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
82730827|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82730828|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730829|NCT00563368|Topiramate|topiramate|mesh-list
82730830|NCT00563368|Phentermine|phentermine|mesh-list
82730831|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
82730832|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82730833|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730834|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82730835|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
82730836|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82730837|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
82730838|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
82730839|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730840|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
82730841|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730842|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730843|NCT00390013|Gabapentin|gabapentin|mesh-list
82730844|NCT00390013|Analgesics|analgesics|mesh-ancestor
82730845|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
82730846|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730847|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730848|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
82730849|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82730850|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82730851|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82730852|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82730853|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82730854|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82730855|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730856|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730857|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
82730858|NCT00562120|Fexofenadine|fexofenadine|mesh-list
82730859|NCT00562120|Terfenadine|terfenadine|mesh-list
82730860|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82730861|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82730862|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82730863|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
82730864|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
82730865|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730866|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730867|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730868|NCT00561730|Pantoprazole|pantoprazole|mesh-list
82730869|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82730870|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82730871|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82730872|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730873|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730875|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82730876|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730877|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82730878|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730879|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
82730880|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82730881|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
82730882|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730883|NCT00621855|Dabigatran|dabigatran|mesh-list
82730884|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
82730885|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82730886|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
82730887|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730888|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730889|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
82730890|NCT00851565|Infliximab|infliximab|mesh-list
82730891|NCT00851565|Antibodies|antibodies|mesh-list
82730892|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
82730893|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730894|NCT00851565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82730895|NCT00851565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730896|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
82730897|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82730898|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82730899|NCT04222088|Chloroquine|chloroquine|mesh-list
82730900|NCT04222088|Lumefantrine|lumefantrine|mesh-list
82730901|NCT04222088|Primaquine|primaquine|mesh-list
82730902|NCT04222088|Amebicides|amebicides|mesh-ancestor
82730903|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82730904|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82730905|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730906|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
82730907|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82730908|NCT00561574|Mirtazapine|mirtazapine|mesh-list
82730909|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
82730910|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82730911|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82730912|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
82730913|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
82730914|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730915|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730916|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730917|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82730918|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82730919|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82730920|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82730921|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82730922|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82730923|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
82730924|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82730925|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82730926|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
82730927|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82730928|NCT00619827|Immunomodulating Agents|immunomodulating agents|mesh-list
82730929|NCT00619827|Immunologic Factors|immunologic factors|mesh-ancestor
82730930|NCT00619827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730931|NCT00687804|Ranibizumab|ranibizumab|mesh-list
82730932|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82730933|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82730934|NCT00687804|Growth Substances|growth substances|mesh-ancestor
82730935|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730936|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
82730937|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730938|NCT02563704|Artesunate|artesunate|mesh-list
82730939|NCT02563704|Quinine|quinine|mesh-list
82730940|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
82730941|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82730942|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82730943|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82730944|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730945|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
82730946|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
82730947|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82730948|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
82730949|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82730950|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730952|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730953|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82730954|NCT02563704|Analgesics|analgesics|mesh-ancestor
82730955|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
82730956|NCT00848523|Panobinostat|panobinostat|mesh-list
82730957|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730958|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82730959|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730960|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730961|NCT05604170|Ganaxolone|ganaxolone|mesh-list
82730962|NCT05604170|Neurosteroids|neurosteroids|mesh-ancestor
82730963|NCT05604170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82730964|NCT05604170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730965|NCT05604170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730966|NCT05604170|GABA Modulators|gaba modulators|mesh-ancestor
82730967|NCT05604170|GABA Agents|gaba agents|mesh-ancestor
82730968|NCT00742404|Dexamethasone|dexamethasone|mesh-list
82730969|NCT00742404|Doxorubicin|doxorubicin|mesh-list
82730970|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82730971|NCT00742404|Bortezomib|bortezomib|mesh-list
82730972|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730973|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
82730974|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
82730975|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82730976|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730977|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82730978|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
82730979|NCT00742404|Hormones|hormones|mesh-ancestor
82730980|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730981|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82730982|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730983|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82730984|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82730985|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82730986|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82730987|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82730988|NCT00744666|Prednisolone|prednisolone|mesh-list
82730989|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82730990|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82730991|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
82730992|NCT00744666|Hormones|hormones|mesh-ancestor
82730993|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82730994|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82730995|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82730996|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82730997|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82730998|NCT04013620|Abatacept|abatacept|mesh-list
82730999|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82731000|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731001|NCT04013620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82731002|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731003|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82731004|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
82731005|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731006|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731007|NCT00749112|Rituximab|rituximab|mesh-list
82731008|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
82731009|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82731010|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731011|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
82731012|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731013|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731014|NCT00848679|Lidocaine|lidocaine|mesh-list
82731015|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
82731016|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
82731017|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731018|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731019|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
82731020|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731021|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82731022|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82731023|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82731024|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82731025|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731026|NCT04012606|Carboplatin|carboplatin|mesh-list
82731027|NCT04012606|Etoposide|etoposide|mesh-list
82731028|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731029|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82731030|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82731031|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82731032|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731033|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731034|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
82731035|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82731036|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82731037|NCT02545959|Prednisolone|prednisolone|mesh-list
82731038|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
82731039|NCT02545959|Rituximab|rituximab|mesh-list
82731040|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82731041|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
82731042|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82731043|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731044|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
82731045|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731046|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731047|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82731048|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
82731049|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
82731050|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731051|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82731052|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
82731053|NCT02545959|Hormones|hormones|mesh-ancestor
82731054|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82731055|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82731056|NCT02545959|Protective Agents|protective agents|mesh-ancestor
82731057|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82731058|NCT00744900|Pemetrexed|pemetrexed|mesh-list
82731059|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731060|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731061|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731062|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82731063|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82731064|NCT00727090|Conivaptan|conivaptan|mesh-list
82731065|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82731066|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731067|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
82731068|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731069|NCT00689052|Pramipexole|pramipexole|mesh-list
82731070|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
82731071|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731072|NCT00689052|Protective Agents|protective agents|mesh-ancestor
82731073|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731074|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82731075|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82731076|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
82731077|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
82731078|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731079|NCT04012450|Anesthetics|anesthetics|mesh-list
82731080|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731081|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731082|NCT00945022|Anesthetics|anesthetics|mesh-list
82731083|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731084|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731085|NCT02565212|Montelukast|montelukast|mesh-list
82731086|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82731087|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
82731088|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82731089|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
82731090|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82731091|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731092|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82731093|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82731094|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731095|NCT00747708|Lenograstim|lenograstim|mesh-list
82731096|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82731097|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
82731098|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731099|NCT05602064|Acetaminophen|acetaminophen|mesh-list
82731100|NCT05602064|Ibuprofen|ibuprofen|mesh-list
82731101|NCT05602064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82731102|NCT05602064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82731103|NCT05602064|Analgesics|analgesics|mesh-ancestor
82731104|NCT05602064|Sensory System Agents|sensory system agents|mesh-ancestor
82731105|NCT05602064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731106|NCT05602064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731107|NCT05602064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82731108|NCT05602064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731109|NCT05602064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82731110|NCT05602064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731111|NCT05602064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731112|NCT05602064|Antipyretics|antipyretics|mesh-ancestor
82731113|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82731114|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
82731115|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731116|NCT02562144|Lidocaine|lidocaine|mesh-list
82731117|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
82731118|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
82731119|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731120|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731121|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
82731122|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731123|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82731124|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82731125|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82731126|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82731127|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731128|NCT02562300|Misoprostol|misoprostol|mesh-list
82731129|NCT02562300|Oxytocin|oxytocin|mesh-list
82731130|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
82731131|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82731132|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731133|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82731134|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
82731135|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82731136|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82731137|NCT00945178|Naproxen|naproxen|mesh-list
82731138|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82731139|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82731140|NCT00945178|Analgesics|analgesics|mesh-ancestor
82731141|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
82731142|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731143|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731144|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82731145|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731146|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
82731147|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82731148|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731149|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731150|NCT00749346|Pemetrexed|pemetrexed|mesh-list
82731151|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731152|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731153|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731154|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82731155|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82731156|NCT02562690|Thrombin|thrombin|mesh-list
82731157|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
82731158|NCT02562690|Coagulants|coagulants|mesh-ancestor
82731159|NCT00576758|Rituximab|rituximab|mesh-list
82731160|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
82731161|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82731162|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731163|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
82731164|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731165|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731166|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82731167|NCT00923676|Fenofibrate|fenofibrate|mesh-list
82731168|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82731169|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82731170|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
82731171|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731172|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82731173|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82731174|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731175|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
82731176|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82731177|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731178|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731179|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82731180|NCT00921284|Analgesics|analgesics|mesh-ancestor
82731181|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
82731182|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731183|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82731184|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82731185|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82731186|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
82731187|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731188|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731190|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82731191|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731192|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731193|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731194|NCT00560794|Blinatumomab|blinatumomab|mesh-list
82731195|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82731196|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731197|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
82731198|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731199|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
82731200|NCT00749736|Vitamin D|vitamin d|mesh-list
82731201|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
82731202|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82731203|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731204|NCT00749736|Vitamins|vitamins|mesh-ancestor
82731205|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
82731206|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82731207|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
82731208|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
82731209|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82731210|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82731211|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731212|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731213|NCT00950404|Urological Agents|urological agents|mesh-ancestor
82731214|NCT00749814|Melatonin|melatonin|mesh-list
82731215|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
82731216|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731217|NCT00749814|Protective Agents|protective agents|mesh-ancestor
82731218|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731219|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731220|NCT00748176|Anesthetics|anesthetics|mesh-list
82731221|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731222|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731223|NCT00619359|Dexamethasone|dexamethasone|mesh-list
82731224|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
82731225|NCT00619359|Ondansetron|ondansetron|mesh-list
82731226|NCT00619359|Aprepitant|aprepitant|mesh-list
82731227|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
82731228|NCT00619359|BB 1101|bb 1101|mesh-list
82731229|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82731230|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
82731231|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
82731232|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731233|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731234|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82731235|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
82731236|NCT00619359|Hormones|hormones|mesh-ancestor
82731237|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82731238|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82731239|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731240|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
82731241|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731242|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731243|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
82731244|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
82731245|NCT00619359|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82731246|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82731247|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
82731248|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731405|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
82731249|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82731250|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
82731251|NCT00848991|Propofol|propofol|mesh-list
82731252|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82731253|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731254|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731255|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82731256|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
82731257|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
82731258|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82731259|NCT00848991|Analgesics|analgesics|mesh-ancestor
82731260|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
82731261|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731262|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82731263|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82731264|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82731265|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
82731266|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731267|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731268|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82731269|NCT00950794|Tulobuterol|tulobuterol|mesh-list
82731270|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82731271|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
82731272|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731273|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731274|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82731275|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
82731276|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82731277|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82731278|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82731279|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
82731280|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731281|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731282|NCT00852189|Folic Acid|folic acid|mesh-list
82731283|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
82731284|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
82731285|NCT00852189|Hematinics|hematinics|mesh-ancestor
82731286|NCT00852189|Vitamins|vitamins|mesh-ancestor
82731287|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
82731288|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731289|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731290|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
82731291|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
82731292|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
82731293|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731294|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
82731295|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82731296|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
82731297|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82731298|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82731299|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731300|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82731301|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731302|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731303|NCT00372229|Valganciclovir|valganciclovir|mesh-list
82731304|NCT00372229|Ganciclovir|ganciclovir|mesh-list
82731305|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
82731306|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
82731307|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731308|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82731309|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731310|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731311|NCT05301010|Docetaxel|docetaxel|mesh-list
82731312|NCT05301010|Trastuzumab|trastuzumab|mesh-list
82731313|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731314|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
82731315|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
82731316|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
82731317|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731318|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82731319|NCT00855699|Acamprosate|acamprosate|mesh-list
82731320|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82731321|NCT00855777|Ibuprofen|ibuprofen|mesh-list
82731323|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82731324|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82731325|NCT00855777|Analgesics|analgesics|mesh-ancestor
82731326|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
82731327|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731328|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731329|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82731330|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731331|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82731332|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731333|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731334|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82731335|NCT04012294|Allopurinol|allopurinol|mesh-list
82731336|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
82731337|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731338|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731339|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
82731340|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731341|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82731342|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
82731343|NCT04012294|Protective Agents|protective agents|mesh-ancestor
82731344|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731345|NCT00849459|Interleukin-12|interleukin-12|mesh-list
82731346|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82731347|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
82731348|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731349|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82731350|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82731351|NCT00849459|Growth Substances|growth substances|mesh-ancestor
82731352|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
82731353|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731354|NCT00852345|Clofazimine|clofazimine|mesh-list
82731355|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82731356|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
82731357|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82731358|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731359|NCT00852423|Artesunate|artesunate|mesh-list
82731360|NCT00852423|Lumefantrine|lumefantrine|mesh-list
82731361|NCT00852423|Artemether|artemether|mesh-list
82731362|NCT00852423|Piperaquine|piperaquine|mesh-list
82731363|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82731364|NCT00852423|Amodiaquine|amodiaquine|mesh-list
82731365|NCT00852423|Artenimol|artenimol|mesh-list
82731366|NCT00852423|Mefloquine|mefloquine|mesh-list
82731367|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
82731368|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82731369|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82731370|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731371|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731372|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
82731373|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
82731374|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82731375|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
82731376|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
82731377|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82731378|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731379|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82731380|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
82731381|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82731382|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731383|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731384|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731385|NCT00849537|Triamcinolone|triamcinolone|mesh-list
82731386|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82731387|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
82731388|NCT00849537|Hormones|hormones|mesh-ancestor
82731389|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82731390|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731391|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
82731392|NCT01049815|Calcium|calcium|mesh-list
82731393|NCT01049815|Sevelamer|sevelamer|mesh-list
82731394|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82731395|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731396|NCT01049815|Antacids|antacids|mesh-ancestor
82731397|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731398|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82731399|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
82731400|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
82731402|NCT00849615|Folic Acid|folic acid|mesh-list
82731403|NCT00849615|Docetaxel|docetaxel|mesh-list
82731404|NCT00849615|Fluorouracil|fluorouracil|mesh-list
82731406|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
82731407|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731408|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
82731409|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
82731410|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
82731411|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731412|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
82731413|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82731414|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82731415|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
82731416|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731417|NCT00849615|Antidotes|antidotes|mesh-ancestor
82731418|NCT00849615|Protective Agents|protective agents|mesh-ancestor
82731419|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
82731420|NCT00849615|Vitamins|vitamins|mesh-ancestor
82731421|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
82731422|NCT00849615|Hematinics|hematinics|mesh-ancestor
82731423|NCT00946036|Sertraline|sertraline|mesh-list
82731424|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
82731425|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82731426|NCT00946036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82731427|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82731428|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82731429|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731430|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731431|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
82731432|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731433|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
82731434|NCT00688740|Docetaxel|docetaxel|mesh-list
82731435|NCT00688740|Doxorubicin|doxorubicin|mesh-list
82731436|NCT00688740|Fluorouracil|fluorouracil|mesh-list
82731437|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82731438|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
82731439|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731440|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731441|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82731442|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
82731443|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731444|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731445|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82731446|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
82731447|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
82731448|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
82731449|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82731450|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82731451|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82731452|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731453|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
82731454|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82731455|NCT05323058|Benzydamine|benzydamine|mesh-list
82731456|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82731457|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
82731458|NCT01046773|Vitamin D|vitamin d|mesh-list
82731459|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82731460|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731461|NCT01046773|Vitamins|vitamins|mesh-ancestor
82731462|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
82731463|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82731464|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
82731465|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82731466|NCT00850005|Antibodies|antibodies|mesh-list
82731467|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
82731468|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82731469|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
82731470|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731471|NCT00852579|Azithromycin|azithromycin|mesh-list
82731472|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82731473|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731474|NCT00942136|Dolutegravir|dolutegravir|mesh-list
82731475|NCT00942136|Omeprazole|omeprazole|mesh-list
82731476|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82731477|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82731479|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731480|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731481|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82731482|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82731483|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82731484|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82731485|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
82731486|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731487|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
82731488|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82731489|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
82731490|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731491|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731492|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82731493|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
82731494|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731495|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731496|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82731497|NCT00942214|Natalizumab|natalizumab|mesh-list
82731498|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
82731499|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731500|NCT00850161|Insulin|insulin|mesh-list
82731501|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82731502|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
82731503|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82731504|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731505|NCT00951574|Nadroparin|nadroparin|mesh-list
82731506|NCT00951574|Calcium|calcium|mesh-list
82731507|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82731508|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731509|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
82731510|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82731511|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82731512|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731513|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82731514|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
82731515|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
82731516|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731517|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
82731518|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731519|NCT00856089|Retapamulin|retapamulin|mesh-list
82731520|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82731521|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731522|NCT00686712|Insulin|insulin|mesh-list
82731523|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82731524|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
82731525|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
82731526|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
82731527|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
82731528|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82731529|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731530|NCT00748644|Rituximab|rituximab|mesh-list
82731531|NCT00748644|Azathioprine|azathioprine|mesh-list
82731532|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82731533|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731534|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
82731535|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731536|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731537|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
82731538|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731539|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82731540|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82731541|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82731542|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82731543|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731544|NCT00686634|Incretins|incretins|mesh-ancestor
82731545|NCT00686634|Hormones|hormones|mesh-ancestor
82731546|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82731547|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82731548|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
82731549|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731550|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731551|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
82731552|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731553|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82731554|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
82731555|NCT00560404|Hematinics|hematinics|mesh-ancestor
82731556|NCT00942526|Nystatin|nystatin|mesh-list
82731557|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82731558|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731559|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
82731560|NCT00942526|Ionophores|ionophores|mesh-ancestor
82731713|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
82731561|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82731562|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731563|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
82731564|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82731565|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
82731566|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731567|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
82731568|NCT03967444|Protective Agents|protective agents|mesh-ancestor
82731569|NCT05300854|Anesthetics|anesthetics|mesh-list
82731570|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731571|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731572|NCT00946504|Glipizide|glipizide|mesh-list
82731573|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82731574|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731575|NCT00619983|Gabapentin|gabapentin|mesh-list
82731576|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82731577|NCT00619983|Donepezil|donepezil|mesh-list
82731578|NCT00619983|Analgesics|analgesics|mesh-ancestor
82731579|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
82731580|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731581|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731582|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
82731583|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82731584|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82731585|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731586|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82731587|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82731588|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82731589|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731590|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731591|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
82731592|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82731593|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82731594|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82731595|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
82731596|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
82731597|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82731598|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731599|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
82731600|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
82731601|NCT00942682|Sorafenib|sorafenib|mesh-list
82731602|NCT00942682|Everolimus|everolimus|mesh-list
82731603|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731604|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82731605|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731606|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731607|NCT00942682|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82731608|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82731609|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
82731610|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731611|NCT04144023|Molgramostim|molgramostim|mesh-list
82731613|NCT04144023|Sargramostim|sargramostim|mesh-list
82731614|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
82731615|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731616|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731617|NCT00853983|Saracatinib|saracatinib|mesh-list
82731618|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731619|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731620|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731621|NCT00750048|Acetaminophen|acetaminophen|mesh-list
82731622|NCT00750048|Naloxone|naloxone|mesh-list
82731623|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82731624|NCT00750048|Analgesics|analgesics|mesh-ancestor
82731625|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
82731626|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731627|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731628|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
82731629|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82731631|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731632|NCT04057014|Amoxicillin|amoxicillin|mesh-list
82731633|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82731634|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731635|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82731636|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731637|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82731638|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731639|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731640|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
82731641|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731642|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82731643|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731644|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731645|NCT00854139|Cyclosporine|cyclosporine|mesh-list
82731646|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
82731647|NCT00854139|Cyclosporins|cyclosporins|mesh-list
82731648|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82731649|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82731650|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
82731651|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731652|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731653|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82731654|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
82731655|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731656|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731657|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82731658|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731659|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
82731660|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731661|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
82731662|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82731663|NCT00755820|Cycloserine|cycloserine|mesh-list
82731664|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82731665|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731666|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82731667|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
82731668|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82731669|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
82731670|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731671|NCT00752154|Curcumin|curcumin|mesh-list
82731672|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82731673|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82731674|NCT00752154|Analgesics|analgesics|mesh-ancestor
82731675|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
82731676|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731677|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731678|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82731679|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731680|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731681|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731682|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731683|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
82731684|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82731685|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731686|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82731687|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
82731688|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82731689|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731690|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731691|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731692|NCT00755898|Amantadine|amantadine|mesh-list
82731693|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82731694|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82731695|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
82731696|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731697|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
82731698|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731699|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731700|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731701|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82731702|NCT00755898|Analgesics|analgesics|mesh-ancestor
82731703|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
82731704|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731705|NCT00750126|Fludarabine|fludarabine|mesh-list
82731706|NCT00750126|Busulfan|busulfan|mesh-list
82731707|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
82731708|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731709|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731710|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82731711|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
82731712|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731714|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82731715|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82731717|NCT00755976|Epirubicin|epirubicin|mesh-list
82731718|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82731719|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731720|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82731721|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82731722|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731723|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731724|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82731725|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82731726|NCT00755976|Analgesics|analgesics|mesh-ancestor
82731727|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
82731728|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731729|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731730|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82731731|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82731732|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82731733|NCT00752310|Darunavir|darunavir|mesh-list
82731734|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82731735|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82731736|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
82731737|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731738|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731739|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82731740|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82731741|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
82731742|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731743|NCT00943462|Temozolomide|temozolomide|mesh-list
82731744|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82731745|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
82731746|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731747|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731748|NCT02560974|Capecitabine|capecitabine|mesh-list
82731749|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
82731750|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82731751|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
82731752|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731753|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731754|NCT00854451|Amoxicillin|amoxicillin|mesh-list
82731755|NCT00854451|Omeprazole|omeprazole|mesh-list
82731756|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82731757|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731758|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82731759|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82731760|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82731761|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731762|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731763|NCT00854529|Bevacizumab|bevacizumab|mesh-list
82731764|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82731765|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731766|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82731767|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82731768|NCT00854529|Growth Substances|growth substances|mesh-ancestor
82731769|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731770|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
82731771|NCT00952432|Carbamazepine|carbamazepine|mesh-list
82731772|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
82731773|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
82731774|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82731775|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731776|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731777|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82731778|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82731779|NCT00952432|Analgesics|analgesics|mesh-ancestor
82731780|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
82731781|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731782|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82731783|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82731784|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731785|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82731786|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82731787|NCT00861315|Amikacin|amikacin|mesh-list
82731788|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82731789|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731790|NCT00943540|Lamivudine|lamivudine|mesh-list
82731791|NCT00943540|Emtricitabine|emtricitabine|mesh-list
82731792|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
82731793|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82731794|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82731795|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82731796|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731797|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731798|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
82731799|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731800|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82731801|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82731802|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82731803|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82731804|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82731805|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82731806|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
82731807|NCT00861627|Paclitaxel|paclitaxel|mesh-list
82731808|NCT00861627|Carboplatin|carboplatin|mesh-list
82731809|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82731810|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731811|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
82731812|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
82731813|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
82731814|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731815|NCT00943930|Dronabinol|dronabinol|mesh-list
82731816|NCT00943930|Amphetamine|amphetamine|mesh-list
82731817|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
82731818|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82731819|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731820|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
82731821|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
82731822|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731823|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
82731824|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731825|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731826|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
82731827|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82731828|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82731829|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82731830|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82731831|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
82731832|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82731833|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82731834|NCT00943930|Analgesics|analgesics|mesh-ancestor
82731835|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
82731836|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82731837|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82731838|NCT00943930|Hormones|hormones|mesh-ancestor
82731839|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82731840|NCT00854763|Olmesartan|olmesartan|mesh-list
82731841|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82731842|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82731843|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82731844|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731845|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
82731846|NCT00854841|Dasatinib|dasatinib|mesh-list
82731847|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731848|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82731849|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731850|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731851|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
82731852|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82731853|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82731854|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731855|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82731856|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
82731857|NCT00861783|Irinotecan|irinotecan|mesh-list
82731858|NCT00861783|Camptothecin|camptothecin|mesh-list
82731859|NCT00861783|ON 01910|on 01910|mesh-list
82731860|NCT00861783|Glycine|glycine|mesh-list
82731861|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731862|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82731863|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82731864|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731865|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731866|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82731867|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82731868|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
82731869|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731870|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731871|NCT00947128|Ondansetron|ondansetron|mesh-list
82731872|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
82731873|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
82731874|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731875|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731876|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82731877|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
82731878|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
82731879|NCT00947128|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82731880|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82731881|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
82731882|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731883|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731884|NCT00861861|Atorvastatin|atorvastatin|mesh-list
82731885|NCT00861861|Pitavastatin|pitavastatin|mesh-list
82731886|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82731887|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82731888|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
82731889|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731890|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82731891|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82731892|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731893|NCT00686166|Capecitabine|capecitabine|mesh-list
82731894|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
82731895|NCT00686166|Cetuximab|cetuximab|mesh-list
82731896|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82731897|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
82731898|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731899|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731900|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82731901|NCT03963375|Cladribine|cladribine|mesh-list
82731902|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731903|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82731904|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
82731905|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731906|NCT04280536|Trifluridine|trifluridine|mesh-list
82731907|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
82731908|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731909|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
82731910|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731911|NCT00944242|Sertraline|sertraline|mesh-list
82731912|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
82731913|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82731914|NCT00944242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82731915|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82731916|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82731917|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731918|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731919|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
82731920|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731921|NCT00363649|Interferons|interferons|mesh-list
82731922|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
82731923|NCT00363649|Sargramostim|sargramostim|mesh-list
82731924|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82731925|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
82731926|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731927|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
82731928|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731930|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82731931|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82731932|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82731933|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
82731934|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82731935|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
82731936|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731937|NCT00952978|Omeprazole|omeprazole|mesh-list
82731938|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82732016|NCT00862095|Amitriptyline|amitriptyline|mesh-list
82731939|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82731940|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82731941|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731942|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731943|NCT00861939|Bupropion|bupropion|mesh-list
82731944|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82731945|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
82731946|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82731947|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82731948|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82731949|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82731950|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731951|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
82731952|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731953|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731954|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82731955|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82731956|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82731957|NCT00953134|Folic Acid|folic acid|mesh-list
82731958|NCT00953134|Micronutrients|micronutrients|mesh-list
82731959|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
82731960|NCT00953134|Trace Elements|trace elements|mesh-list
82731961|NCT00953134|Hematinics|hematinics|mesh-ancestor
82731962|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
82731963|NCT00953134|Vitamins|vitamins|mesh-ancestor
82731964|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731965|NCT00944398|Vitamins|vitamins|mesh-list
82731966|NCT00944398|Zinc|zinc|mesh-list
82731967|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
82731968|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
82731969|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
82731970|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731971|NCT00944398|Trace Elements|trace elements|mesh-ancestor
82731972|NCT00944398|Astringents|astringents|mesh-ancestor
82731973|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
82731974|NCT00855387|Pancrelipase|pancrelipase|mesh-list
82731975|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82731976|NCT00947596|Atropine|atropine|mesh-list
82731977|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82731978|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82731979|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82731980|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
82731981|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731982|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731983|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82731984|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
82731985|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
82731986|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
82731987|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82731988|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82731989|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
82731990|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82731991|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731992|NCT00865059|Gabapentin|gabapentin|mesh-list
82731993|NCT00865059|Analgesics|analgesics|mesh-ancestor
82731994|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
82731995|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82731996|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82731997|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
82731998|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82731999|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82732000|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82732001|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82732002|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82732003|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82732004|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732005|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732006|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
82732007|NCT00865137|Tacrolimus|tacrolimus|mesh-list
82732008|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82732009|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
82732010|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732011|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82732012|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732013|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732014|NCT00862095|Topiramate|topiramate|mesh-list
82732015|NCT00862095|Propranolol|propranolol|mesh-list
82732017|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82732018|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82732019|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
82732020|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732021|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732022|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732023|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82732024|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82732025|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
82732026|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
82732027|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82732028|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82732029|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
82732030|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82732031|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82732032|NCT00862095|Analgesics|analgesics|mesh-ancestor
82732033|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
82732034|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732035|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82732036|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82732037|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82732038|NCT04054128|Heparin|heparin|mesh-list
82732039|NCT04054128|Calcium heparin|calcium heparin|mesh-list
82732040|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
82732041|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82732042|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82732043|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732044|NCT00865215|Propranolol|propranolol|mesh-list
82732045|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82732046|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82732047|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
82732048|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732049|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732050|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732051|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82732052|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82732053|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
82732054|NCT00865371|Bupropion|bupropion|mesh-list
82732055|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82732056|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
82732057|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82732058|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82732059|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82732060|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82732061|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732062|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
82732063|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732064|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732065|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82732066|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82732067|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732068|NCT00865449|Spironolactone|spironolactone|mesh-list
82732069|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82732070|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
82732071|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82732072|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732073|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82732074|NCT00865449|Diuretics|diuretics|mesh-ancestor
82732075|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
82732076|NCT00858195|Indomethacin|indomethacin|mesh-list
82732077|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82732078|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82732079|NCT00858195|Analgesics|analgesics|mesh-ancestor
82732080|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
82732081|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732082|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732083|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82732084|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82732085|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
82732086|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
82732087|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82732088|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82732089|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732090|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732091|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
82732092|NCT00618813|Ifosfamide|ifosfamide|mesh-list
82732093|NCT00618813|Doxorubicin|doxorubicin|mesh-list
82732094|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82732095|NCT00618813|Etoposide|etoposide|mesh-list
82732096|NCT00618813|Vincristine|vincristine|mesh-list
82732097|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
82732098|NCT00618813|Topotecan|topotecan|mesh-list
82732099|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82732100|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
82732101|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732102|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82732103|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82732104|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
82732105|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732106|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732107|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82732108|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82732109|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82732110|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82732111|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732112|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82732113|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
82732114|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
82732115|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
82732116|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82732117|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
82732118|NCT00554788|Thiotepa|thiotepa|mesh-list
82732119|NCT00554788|Cisplatin|cisplatin|mesh-list
82732120|NCT00554788|Carboplatin|carboplatin|mesh-list
82732121|NCT00554788|Etoposide|etoposide|mesh-list
82732122|NCT00554788|Vincristine|vincristine|mesh-list
82732123|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
82732124|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
82732125|NCT00554788|Lenograstim|lenograstim|mesh-list
82732126|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82732127|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
82732128|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732129|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82732130|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82732131|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
82732132|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732133|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732134|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82732135|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82732136|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82732137|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82732138|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732139|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82732140|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
82732141|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
82732142|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
82732143|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
82732144|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
82732145|NCT00685698|Nemonoxacin|nemonoxacin|mesh-list
82732146|NCT00685698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82732147|NCT00685698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732148|NCT00858429|Capecitabine|capecitabine|mesh-list
82732149|NCT00858429|Doxifluridine|doxifluridine|mesh-list
82732150|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82732151|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
82732152|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732153|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732154|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82732155|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
82732156|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732157|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
82732158|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82732160|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82732161|NCT02566928|Bacitracin|bacitracin|mesh-list
82732162|NCT02566928|Mupirocin|mupirocin|mesh-list
82732163|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82732164|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732165|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
82732166|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
82732167|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82732168|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82732169|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732170|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732171|NCT00865605|Clobetasol|clobetasol|mesh-list
82732172|NCT00865605|Halobetasol|halobetasol|mesh-list
82732173|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82732174|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82732175|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
82732176|NCT00865605|Hormones|hormones|mesh-ancestor
82732177|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82732178|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732179|NCT00956644|Amlodipine|amlodipine|mesh-list
82732180|NCT00956644|Irbesartan|irbesartan|mesh-list
82732181|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82732182|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82732183|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82732184|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732185|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82732186|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732187|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
82732188|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82732189|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82732190|NCT00858663|Everolimus|everolimus|mesh-list
82732191|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732192|NCT00858663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82732193|NCT00858663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82732194|NCT00858663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732195|NCT00858663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732196|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82732197|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
82732198|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732199|NCT02544789|Clofarabine|clofarabine|mesh-list
82732200|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82732201|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
82732202|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732203|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732204|NCT02565836|Thrombin|thrombin|mesh-list
82732205|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
82732206|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
82732207|NCT02565836|Coagulants|coagulants|mesh-ancestor
82732208|NCT00865761|Alprazolam|alprazolam|mesh-list
82732209|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82732210|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82732211|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732212|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82732213|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82732214|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82732215|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
82732216|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
82732217|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732218|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732219|NCT00865839|Metformin|metformin|mesh-list
82732220|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82732221|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732222|NCT00865917|Metoprolol|metoprolol|mesh-list
82732223|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82732224|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82732225|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82732226|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
82732227|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
82732228|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732229|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732230|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82732231|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82732232|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
82732233|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732234|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732235|NCT00696410|Zinc|zinc|mesh-list
82732236|NCT00696410|Trace Elements|trace elements|mesh-ancestor
82732237|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
82732238|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732239|NCT00858897|Insulin|insulin|mesh-list
82732240|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82732241|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82732242|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732243|NCT00683904|Carboplatin|carboplatin|mesh-list
82732244|NCT00683904|Epothilones|epothilones|mesh-list
82732245|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732246|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
82732247|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
82732248|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
82732249|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732250|NCT00862329|Caseins|caseins|mesh-list
82732251|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
82732252|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
82732253|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732254|NCT00866073|Decitabine|decitabine|mesh-list
82732255|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82732256|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
82732257|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732258|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732259|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732260|NCT00752466|Topiramate|topiramate|mesh-list
82732261|NCT00752466|Flunarizine|flunarizine|mesh-list
82732262|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
82732263|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82732264|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732265|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82732266|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82732267|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732268|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82732269|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82732270|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
82732271|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
82732272|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732273|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
82732274|NCT00957190|Timolol|timolol|mesh-list
82732275|NCT00957190|Dorzolamide|dorzolamide|mesh-list
82732276|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82732277|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82732278|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
82732279|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732280|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732281|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732282|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82732283|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82732284|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82732285|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732286|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82732287|NCT00866229|Simvastatin|simvastatin|mesh-list
82732288|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82732289|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82732290|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
82732291|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732292|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82732293|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82732294|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732295|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
82732296|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82732297|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732298|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732299|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
82732300|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732301|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732302|NCT00948220|Ribavirin|ribavirin|mesh-list
82732303|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82732304|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
82732305|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732306|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
82732307|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732309|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82732310|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82732311|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732312|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
82732313|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732314|NCT00957346|Misoprostol|misoprostol|mesh-list
82732315|NCT00957346|Mifepristone|mifepristone|mesh-list
82732316|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82732317|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
82732318|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82732319|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732320|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82732321|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82732322|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
82732323|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82732324|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82732325|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82732326|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82732327|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
82732328|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82732329|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82732330|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
82732331|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82732332|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
82732333|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82732334|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82732335|NCT00752544|Simeprevir|simeprevir|mesh-list
82732336|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
82732337|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732338|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
82732339|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732340|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732341|NCT00751062|Timolol|timolol|mesh-list
82732342|NCT00751062|Latanoprost|latanoprost|mesh-list
82732343|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82732344|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82732345|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
82732346|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732347|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732348|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732349|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82732350|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82732351|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82732352|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82732353|NCT04030052|Factor VIII|factor viii|mesh-list
82732354|NCT04030052|Coagulants|coagulants|mesh-ancestor
82732355|NCT00751374|Gentamicins|gentamicins|mesh-list
82732356|NCT00751374|Mupirocin|mupirocin|mesh-list
82732357|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82732358|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732359|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82732360|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732361|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732362|NCT00954304|Loperamide|loperamide|mesh-list
82732363|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
82732364|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82732365|NCT00363415|Carboplatin|carboplatin|mesh-list
82732366|NCT00363415|Etoposide|etoposide|mesh-list
82732367|NCT00363415|Pemetrexed|pemetrexed|mesh-list
82732368|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732369|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82732370|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82732371|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82732372|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732373|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732374|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82732375|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82732376|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
82732377|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82732378|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82732379|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732380|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82732381|NCT00752934|Baclofen|baclofen|mesh-list
82732382|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82732383|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732384|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82732385|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732386|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82732387|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
82732388|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
82732389|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732390|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732392|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
82732393|NCT00696020|Olodaterol|olodaterol|mesh-list
82732394|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82732395|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
82732396|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732397|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732398|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82732399|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
82732400|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
82732401|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82732402|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
82732403|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732404|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732405|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
82732406|NCT00576576|Atorvastatin|atorvastatin|mesh-list
82732407|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82732408|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82732409|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
82732410|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732411|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82732412|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82732413|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732414|NCT00751764|Moxidectin|moxidectin|mesh-list
82732415|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
82732416|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82732417|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732418|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
82732419|NCT00757458|Propofol|propofol|mesh-list
82732420|NCT00757458|Edetic Acid|edetic acid|mesh-list
82732421|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
82732422|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82732423|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82732424|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732425|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82732426|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
82732427|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
82732428|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
82732429|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82732430|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
82732431|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
82732432|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732433|NCT00757458|Antidotes|antidotes|mesh-ancestor
82732434|NCT00757458|Protective Agents|protective agents|mesh-ancestor
82732435|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82732436|NCT00923247|Bortezomib|bortezomib|mesh-list
82732437|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732438|NCT02866136|Carboplatin|carboplatin|mesh-list
82732439|NCT02866136|Etoposide|etoposide|mesh-list
82732440|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
82732441|NCT02866136|Melphalan|melphalan|mesh-list
82732442|NCT02866136|Vincristine|vincristine|mesh-list
82732443|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732444|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82732445|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82732446|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82732447|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732448|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732449|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82732450|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
82732451|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82732452|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82732453|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
82732454|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732455|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
82732456|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
82732457|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
82732458|NCT00757692|Bicalutamide|bicalutamide|mesh-list
82732459|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
82732460|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
82732461|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82732462|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732463|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732464|NCT00753168|Timolol|timolol|mesh-list
82732465|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82732466|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82732467|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732468|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82732469|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82732470|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
82732471|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732472|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732473|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82732474|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82732476|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
82732477|NCT02565602|Vitamins|vitamins|mesh-ancestor
82732478|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
82732479|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732480|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82732481|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82732482|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
82732483|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
82732484|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82732485|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82732486|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732487|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732488|NCT00866463|Urological Agents|urological agents|mesh-ancestor
82732489|NCT00695864|Ondansetron|ondansetron|mesh-list
82732490|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
82732491|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
82732492|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732493|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732494|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82732495|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
82732496|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
82732497|NCT00695864|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82732498|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82732499|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
82732500|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732501|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732502|NCT00684996|Bevacizumab|bevacizumab|mesh-list
82732503|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82732504|NCT00684996|Antibodies|antibodies|mesh-list
82732505|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
82732506|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82732507|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732508|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82732509|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82732510|NCT00684996|Growth Substances|growth substances|mesh-ancestor
82732511|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732512|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
82732513|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
82732514|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
82732515|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82732516|NCT05325008|Antibodies|antibodies|mesh-list
82732517|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
82732518|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82732519|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
82732520|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732521|NCT00684762|Cilostazol|cilostazol|mesh-list
82732522|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82732523|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
82732524|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732525|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732526|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82732527|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
82732528|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82732529|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82732530|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732531|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82732532|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
82732533|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82732534|NCT00684762|Protective Agents|protective agents|mesh-ancestor
82732535|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82732536|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82732537|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732538|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
82732539|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82732540|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732541|NCT00695786|Rituximab|rituximab|mesh-list
82732542|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82732543|NCT00695786|Lenalidomide|lenalidomide|mesh-list
82732544|NCT00695786|Antibodies|antibodies|mesh-list
82732545|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
82732546|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82732547|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
82732548|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732549|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732550|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82732551|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82732552|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82732553|NCT00695786|Growth Substances|growth substances|mesh-ancestor
82732554|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
82732555|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82732556|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
82732557|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732558|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82732559|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82732560|NCT00387127|Lapatinib|lapatinib|mesh-list
82732561|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732562|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82732563|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732564|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732565|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
82732566|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
82732567|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82732568|NCT00683592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82732569|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82732570|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82732571|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732572|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732573|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
82732574|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732575|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82732576|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82732577|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
82732578|NCT00695396|Hematinics|hematinics|mesh-ancestor
82732579|NCT00753402|Epinephrine|epinephrine|mesh-list
82732580|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82732581|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82732582|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
82732583|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732584|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732585|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732586|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82732587|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82732588|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
82732589|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732590|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82732591|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
82732592|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
82732593|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
82732594|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82732595|NCT05434884|Salicylic Acid|salicylic acid|mesh-list
82732596|NCT05434884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732597|NCT05434884|Antifungal Agents|antifungal agents|mesh-ancestor
82732598|NCT05434884|Keratolytic Agents|keratolytic agents|mesh-ancestor
82732599|NCT05434884|Dermatologic Agents|dermatologic agents|mesh-ancestor
82732600|NCT00758004|Atorvastatin|atorvastatin|mesh-list
82732601|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82732602|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82732603|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
82732604|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732605|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82732606|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82732607|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732608|NCT05388006|Durvalumab|durvalumab|mesh-list
82732609|NCT05388006|Venetoclax|venetoclax|mesh-list
82732610|NCT05388006|Acalabrutinib|acalabrutinib|mesh-list
82732611|NCT05388006|Immunoglobulins|immunoglobulins|mesh-list
82732612|NCT05388006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82732613|NCT05388006|Immunoglobulin G|immunoglobulin g|mesh-list
82732614|NCT05388006|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82732615|NCT05388006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82732616|NCT05388006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732617|NCT05388006|Immunologic Factors|immunologic factors|mesh-ancestor
82732618|NCT05388006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732619|NCT05388006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82732620|NCT05388006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732621|NCT05388006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732622|NCT02656706|Nivolumab|nivolumab|mesh-list
82732623|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82732624|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732625|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82732626|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732628|NCT04049916|Piperaquine|piperaquine|mesh-list
82732629|NCT04049916|Primaquine|primaquine|mesh-list
82732630|NCT04049916|Artenimol|artenimol|mesh-list
82732631|NCT04049916|Pyronaridine|pyronaridine|mesh-list
82732632|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
82732633|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82732634|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82732635|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732636|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732637|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
82732638|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
82732639|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82732640|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
82732641|NCT00753558|Gentamicins|gentamicins|mesh-list
82732642|NCT00753558|Polymyxins|polymyxins|mesh-list
82732643|NCT00753558|Colistin|colistin|mesh-list
82732644|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82732645|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732646|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82732647|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732648|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732649|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
82732650|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82732651|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82732652|NCT00753792|Prednisolone|prednisolone|mesh-list
82732653|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
82732654|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82732655|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
82732656|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82732657|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
82732658|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
82732659|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732660|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732661|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82732662|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
82732663|NCT00753792|Hormones|hormones|mesh-ancestor
82732664|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82732665|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82732666|NCT00753792|Protective Agents|protective agents|mesh-ancestor
82732667|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82732668|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732669|NCT00575094|Tigecycline|tigecycline|mesh-list
82732670|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82732671|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732672|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82732673|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732674|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732675|NCT00553696|Sunitinib|sunitinib|mesh-list
82732676|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732677|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82732678|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82732679|NCT00553696|Growth Substances|growth substances|mesh-ancestor
82732680|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732681|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
82732682|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82732683|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732684|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732685|NCT05430126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
82732686|NCT05430126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732687|NCT05430126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732688|NCT00958204|Fluoxetine|fluoxetine|mesh-list
82732689|NCT00958204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82732690|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82732691|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82732692|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732693|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732694|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
82732695|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732696|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82732697|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
82732698|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82732699|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82732700|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82732701|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732702|NCT00617409|Paclitaxel|paclitaxel|mesh-list
82732703|NCT00617409|Tretinoin|tretinoin|mesh-list
82732704|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82732705|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732706|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
82732707|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
82732708|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
82732709|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732710|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
82732711|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
82732712|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
82732713|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82732714|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
82732715|NCT00695318|Hormones|hormones|mesh-ancestor
82732716|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82732717|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732718|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82732719|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732720|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82732721|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732722|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732723|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
82732724|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732725|NCT03529448|Temozolomide|temozolomide|mesh-list
82732726|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82732727|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
82732728|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732729|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732731|NCT05396898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82732732|NCT05396898|Immunologic Factors|immunologic factors|mesh-ancestor
82732733|NCT05396898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732734|NCT05396898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82732735|NCT05396898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732736|NCT05396898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732737|NCT00694304|Vortioxetine|vortioxetine|mesh-list
82732738|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
82732739|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82732740|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82732741|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82732742|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82732743|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732744|NCT00694304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82732745|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82732746|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82732747|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732748|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732749|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
82732750|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82732751|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82732752|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82732753|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82732754|NCT00866853|Simeprevir|simeprevir|mesh-list
82732755|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
82732756|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732757|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
82732758|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732759|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732761|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
82732762|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
82732763|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82732764|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732765|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
82732766|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732767|NCT00682890|Metformin|metformin|mesh-list
82732768|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82732769|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732770|NCT02565368|Metformin|metformin|mesh-list
82732771|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82732772|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732773|NCT03992365|Bisacodyl|bisacodyl|mesh-list
82732774|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
82732775|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82732776|NCT03992365|Cathartics|cathartics|mesh-ancestor
82732777|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82732778|NCT03992365|Laxatives|laxatives|mesh-ancestor
82732779|NCT00921804|Risperidone|risperidone|mesh-list
82732780|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82732781|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
82732782|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732783|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732784|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732785|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82732786|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82732787|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82732788|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82732789|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82732790|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
82732791|NCT00859911|Micronutrients|micronutrients|mesh-list
82732792|NCT00859911|Trace Elements|trace elements|mesh-list
82732793|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732794|NCT00698516|Bevacizumab|bevacizumab|mesh-list
82732795|NCT00698516|Topotecan|topotecan|mesh-list
82732796|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82732797|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732798|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82732799|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82732800|NCT00698516|Growth Substances|growth substances|mesh-ancestor
82732801|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732802|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
82732803|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82732804|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82732805|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732806|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732807|NCT00679302|Trimethoprim|trimethoprim|mesh-list
82732808|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82732809|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
82732810|NCT00679302|Simethicone|simethicone|mesh-list
82732811|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82732812|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732813|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
82732814|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82732815|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82732816|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82732817|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732818|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732819|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82732820|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82732821|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82732822|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
82732823|NCT00679302|Emollients|emollients|mesh-ancestor
82732824|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
82732825|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82732826|NCT04011124|Rifampin|rifampin|mesh-list
82732827|NCT04011124|Fluzoparib|fluzoparib|mesh-list
82732828|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82732829|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
82732830|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82732831|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732832|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
82732833|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82732834|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732835|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732836|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82732837|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82732838|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82732839|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82732840|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82732841|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82732842|NCT04011124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82732843|NCT04011124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732844|NCT00862875|Insulin|insulin|mesh-list
82732845|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82732846|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
82732847|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
82732848|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82732849|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732850|NCT02544165|Caffeine|caffeine|mesh-list
82732851|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82732852|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732853|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82732854|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732855|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732856|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82732857|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82732858|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
82732859|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732860|NCT05343156|Dexamethasone|dexamethasone|mesh-list
82732861|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82732862|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82732863|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
82732864|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
82732865|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732866|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732867|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82732868|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
82732870|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82732871|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82732872|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732873|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82732874|NCT00955162|Buprenorphine|buprenorphine|mesh-list
82732875|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82732876|NCT00955162|Naloxone|naloxone|mesh-list
82732877|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82732878|NCT00955162|Narcotics|narcotics|mesh-ancestor
82732879|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82732880|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732881|NCT00955162|Analgesics|analgesics|mesh-ancestor
82732882|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
82732883|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732884|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82732885|NCT00949546|Etanercept|etanercept|mesh-list
82732886|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82732887|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82732888|NCT00949546|Analgesics|analgesics|mesh-ancestor
82732889|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
82732890|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732891|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732892|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82732893|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82732894|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82732895|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82732896|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
82732897|NCT05291364|Ethanol|ethanol|mesh-list
82732898|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
82732899|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82732900|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82732901|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732902|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82732903|NCT05291364|Analgesics|analgesics|mesh-ancestor
82732904|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
82732905|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732906|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82732907|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82732908|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82732909|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
82732910|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732911|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732912|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82732913|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82732914|NCT00949624|Docetaxel|docetaxel|mesh-list
82732915|NCT00949624|Axitinib|axitinib|mesh-list
82732916|NCT00949624|Crenolanib|crenolanib|mesh-list
82732917|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732918|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
82732919|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
82732920|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
82732921|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732922|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82732923|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732924|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
82732925|NCT04019379|Calcium|calcium|mesh-list
82732926|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82732927|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732928|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82732929|NCT05351788|Carboplatin|carboplatin|mesh-list
82732930|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732931|NCT04005339|Leucovorin|leucovorin|mesh-list
82732932|NCT04005339|Fluorouracil|fluorouracil|mesh-list
82732933|NCT04005339|Irinotecan|irinotecan|mesh-list
82732934|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
82732935|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732936|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82732937|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732938|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82732939|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
82732940|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732941|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82732942|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82732943|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732944|NCT04005339|Antidotes|antidotes|mesh-ancestor
82732945|NCT04005339|Protective Agents|protective agents|mesh-ancestor
82732946|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
82732947|NCT04005339|Vitamins|vitamins|mesh-ancestor
82732948|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
82732949|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
82732950|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82732951|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82732952|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732953|NCT02544243|Gemcitabine|gemcitabine|mesh-list
82732954|NCT02544243|Vinorelbine|vinorelbine|mesh-list
82732955|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82732956|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82732957|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
82732958|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732959|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82732960|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
82732961|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
82732962|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
82732963|NCT04011670|Caffeine|caffeine|mesh-list
82732964|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82732965|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732966|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82732967|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82732968|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732969|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82732970|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82732971|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
82732972|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82732973|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
82732974|NCT01581073|Hematinics|hematinics|mesh-ancestor
82732975|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
82732976|NCT00742820|Calcium|calcium|mesh-list
82732977|NCT00742820|Calcium acetate|calcium acetate|mesh-list
82732978|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82732979|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732980|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82732981|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
82732982|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
82732983|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82732984|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82732985|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
82732986|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
82732987|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82732988|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82732989|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
82732990|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82732991|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82732992|NCT00742976|Insulin|insulin|mesh-list
82732993|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82732994|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
82732995|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
82732996|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
82732997|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
82732998|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82732999|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733000|NCT00571662|Cyclosporine|cyclosporine|mesh-list
82733001|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
82733002|NCT00571662|Pentostatin|pentostatin|mesh-list
82733003|NCT00571662|Cyclosporins|cyclosporins|mesh-list
82733004|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733005|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733006|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82733007|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
82733008|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733009|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
82733010|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733011|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
82733012|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733013|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82733014|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82733015|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733016|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82733017|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
82733018|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82733019|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82733020|NCT00955240|Fluorouracil|fluorouracil|mesh-list
82733021|NCT00955240|Cetuximab|cetuximab|mesh-list
82733022|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733023|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
82733024|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733025|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82733026|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82733027|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
82733028|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733029|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82733030|NCT03387085|Leucovorin|leucovorin|mesh-list
82733031|NCT03387085|Paclitaxel|paclitaxel|mesh-list
82733032|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
82733033|NCT03387085|Bevacizumab|bevacizumab|mesh-list
82733034|NCT03387085|Fluorouracil|fluorouracil|mesh-list
82733035|NCT03387085|Capecitabine|capecitabine|mesh-list
82733036|NCT03387085|Avelumab|avelumab|mesh-list
82733037|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82733038|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733039|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
82733040|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
82733041|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
82733042|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733043|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82733044|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
82733045|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733046|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733047|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82733048|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
82733049|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82733050|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82733051|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82733052|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82733053|NCT03387085|Growth Substances|growth substances|mesh-ancestor
82733054|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
82733055|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
82733056|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82733057|NCT03387085|Antidotes|antidotes|mesh-ancestor
82733058|NCT03387085|Protective Agents|protective agents|mesh-ancestor
82733059|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
82733060|NCT03387085|Vitamins|vitamins|mesh-ancestor
82733061|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
82733062|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
82733063|NCT00867867|Trace Elements|trace elements|mesh-ancestor
82733064|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
82733065|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733066|NCT00955318|Apomorphine|apomorphine|mesh-list
82733067|NCT00955318|Emetics|emetics|mesh-ancestor
82733068|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733069|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
82733070|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733071|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82733072|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
82733073|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
82733074|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733075|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733076|NCT00860223|Digoxin|digoxin|mesh-list
82733077|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82733078|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82733079|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733080|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733081|NCT00860223|Protective Agents|protective agents|mesh-ancestor
82733082|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733083|NCT00698204|Celecoxib|celecoxib|mesh-list
82733084|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82733085|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82733086|NCT00698204|Analgesics|analgesics|mesh-ancestor
82733087|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
82733088|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733089|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733090|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82733091|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733092|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82733093|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82733094|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733095|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733096|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82733097|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82733098|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82733099|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82733100|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733101|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82733102|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82733103|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82733104|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82733105|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
82733106|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733107|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733108|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82733109|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82733110|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
82733111|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82733112|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82733113|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
82733114|NCT00863187|Rituximab|rituximab|mesh-list
82733115|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82733116|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733117|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
82733118|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733119|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733120|NCT00754884|Calcitonin|calcitonin|mesh-list
82733121|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
82733122|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
82733123|NCT00754884|Glycerol|glycerol|mesh-list
82733124|NCT00754884|Katacalcin|katacalcin|mesh-list
82733125|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82733126|NCT00754884|Protective Agents|protective agents|mesh-ancestor
82733127|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733128|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82733129|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82733130|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
82733131|NCT00371761|Interferons|interferons|mesh-list
82733132|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
82733133|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
82733134|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82733135|NCT00371761|Adefovir|adefovir|mesh-list
82733136|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82733137|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733138|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
82733139|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733140|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
82733141|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733142|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82733143|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82733144|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733145|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733146|NCT00754962|Protriptyline|protriptyline|mesh-list
82733147|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82733148|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
82733149|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82733150|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82733151|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82733152|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733153|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733154|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
82733155|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733156|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733157|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
82733158|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82733159|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
82733160|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733161|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733162|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82733163|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
82733164|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82733165|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82733166|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82733167|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
82733168|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733169|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733170|NCT05300386|Escitalopram|escitalopram|mesh-list
82733171|NCT05300386|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82733172|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82733173|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733174|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733175|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733176|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
82733177|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733178|NCT00863499|Methylphenidate|methylphenidate|mesh-list
82733179|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82733180|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733181|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82733182|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82733183|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733184|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733185|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
82733186|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733187|NCT00755118|Leucovorin|leucovorin|mesh-list
82733188|NCT00755118|Bevacizumab|bevacizumab|mesh-list
82733189|NCT00755118|Cetuximab|cetuximab|mesh-list
82733190|NCT00755118|Fluorouracil|fluorouracil|mesh-list
82733191|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
82733192|NCT00755118|Irinotecan|irinotecan|mesh-list
82733193|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82733194|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733195|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82733196|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82733197|NCT00755118|Growth Substances|growth substances|mesh-ancestor
82733198|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733199|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
82733200|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
82733201|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733202|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82733203|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82733204|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
82733205|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82733206|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82733207|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733208|NCT00755118|Antidotes|antidotes|mesh-ancestor
82733209|NCT00755118|Protective Agents|protective agents|mesh-ancestor
82733210|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
82733211|NCT00755118|Vitamins|vitamins|mesh-ancestor
82733212|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
82733213|NCT00755352|Pravastatin|pravastatin|mesh-list
82733214|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
82733215|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82733216|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82733217|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
82733218|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733219|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82733220|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82733221|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733222|NCT00549640|Methylphenidate|methylphenidate|mesh-list
82733223|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82733224|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733225|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82733226|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82733227|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733228|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733229|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
82733230|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733231|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
82733232|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82733233|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
82733234|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
82733235|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82733236|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
82733237|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82733238|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
82733239|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733240|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733241|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
82733242|NCT00863577|Bemiparin|bemiparin|mesh-list
82733243|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
82733244|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
82733245|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82733246|NCT00868413|Rituximab|rituximab|mesh-list
82733247|NCT00868413|Fludarabine|fludarabine|mesh-list
82733248|NCT00868413|Navitoclax|navitoclax|mesh-list
82733249|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82733250|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
82733251|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733252|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733253|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82733254|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
82733255|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733256|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733257|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82733258|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82733259|NCT03897348|Lacosamide|lacosamide|mesh-list
82733260|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
82733261|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82733262|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82733263|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733264|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733265|NCT04010578|Vitamin D|vitamin d|mesh-list
82733266|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
82733267|NCT04010578|Vitamins|vitamins|mesh-ancestor
82733268|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
82733269|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733270|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82733271|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82733272|NCT00868491|Cisplatin|cisplatin|mesh-list
82733273|NCT00868491|Docetaxel|docetaxel|mesh-list
82733274|NCT00868491|Fluorouracil|fluorouracil|mesh-list
82733275|NCT00868491|Cetuximab|cetuximab|mesh-list
82733276|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733277|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
82733278|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
82733279|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
82733280|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733281|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
82733282|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82733283|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82733284|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
82733285|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733286|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82733287|NCT00955630|Ranibizumab|ranibizumab|mesh-list
82733288|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82733289|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82733290|NCT00955630|Growth Substances|growth substances|mesh-ancestor
82733291|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733292|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
82733293|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733294|NCT00868569|Leucovorin|leucovorin|mesh-list
82733295|NCT00868569|Fluorouracil|fluorouracil|mesh-list
82733296|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
82733297|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
82733298|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733299|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82733300|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733301|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82733302|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
82733303|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733304|NCT00868569|Antidotes|antidotes|mesh-ancestor
82733305|NCT00868569|Protective Agents|protective agents|mesh-ancestor
82733306|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
82733307|NCT00868569|Vitamins|vitamins|mesh-ancestor
82733308|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
82733309|NCT00863733|Acetic Acid|acetic acid|mesh-list
82733310|NCT00863733|Vadimezan|vadimezan|mesh-list
82733311|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82733312|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733313|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733314|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82733315|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82733316|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82733317|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82733318|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733319|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82733320|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82733321|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82733322|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
82733323|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733324|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733325|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82733326|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82733327|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
82733328|NCT00860925|Clonidine|clonidine|mesh-list
82733329|NCT00860925|Analgesics|analgesics|mesh-ancestor
82733330|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
82733331|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733332|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733333|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82733334|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
82733335|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
82733336|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82733337|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82733338|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82733339|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
82733340|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733341|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733342|NCT04237012|Dexamethasone|dexamethasone|mesh-list
82733343|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
82733344|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82733345|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
82733346|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
82733347|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733348|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733349|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82733350|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
82733351|NCT04237012|Hormones|hormones|mesh-ancestor
82733352|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82733353|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82733354|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733355|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82733356|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82733357|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82733358|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
82733359|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82733360|NCT00863889|Prednisolone|prednisolone|mesh-list
82733361|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
82733362|NCT00863889|Lidocaine|lidocaine|mesh-list
82733363|NCT00863889|Bupivacaine|bupivacaine|mesh-list
82733364|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82733365|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
82733366|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
82733367|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
82733368|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82733369|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733370|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
82733371|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733372|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82733373|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82733374|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82733375|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733376|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733377|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82733378|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
82733379|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
82733380|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82733381|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
82733382|NCT00863889|Hormones|hormones|mesh-ancestor
82733383|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82733384|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82733385|NCT00863889|Protective Agents|protective agents|mesh-ancestor
82733386|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82733387|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733388|NCT00677352|Sertraline|sertraline|mesh-list
82733389|NCT00677352|Paroxetine|paroxetine|mesh-list
82733390|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
82733391|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82733392|NCT00677352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82733393|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82733394|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733395|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733396|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733397|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
82733398|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733399|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82733400|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82733401|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82733402|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733403|NCT00864045|Olanzapine|olanzapine|mesh-list
82733404|NCT00864045|Sertindole|sertindole|mesh-list
82733405|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
82733406|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
82733407|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733408|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733409|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82733410|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82733411|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82733412|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82733413|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82733414|NCT00864045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82733415|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82733416|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733417|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733418|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733419|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
82733420|NCT00755508|Gabapentin|gabapentin|mesh-list
82733421|NCT00755508|Analgesics|analgesics|mesh-ancestor
82733422|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
82733423|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733424|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733425|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
82733426|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82733427|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82733428|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82733429|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82733430|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82733431|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82733432|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733433|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733434|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
82733435|NCT03680352|Cefepime|cefepime|mesh-list
82733436|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
82733437|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82733438|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733439|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82733440|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733441|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733442|NCT00864201|Bosentan|bosentan|mesh-list
82733443|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82733444|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82733445|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733446|NCT00864279|Cetirizine|cetirizine|mesh-list
82733447|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82733448|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82733449|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82733450|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
82733451|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
82734054|NCT02534623|Propofol|propofol|mesh-list
82733452|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733453|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733454|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733456|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82733457|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733458|NCT00864357|Ibuprofen|ibuprofen|mesh-list
82733459|NCT00864357|Oxycodone|oxycodone|mesh-list
82733460|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82733461|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82733462|NCT00864357|Analgesics|analgesics|mesh-ancestor
82733463|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
82733464|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733465|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733466|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82733467|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733468|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82733469|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733470|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733471|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82733472|NCT00864357|Narcotics|narcotics|mesh-ancestor
82733473|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82733474|NCT00864435|Carvedilol|carvedilol|mesh-list
82733475|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82733476|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82733477|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
82733478|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733479|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733480|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733481|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82733482|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
82733483|NCT00864435|Protective Agents|protective agents|mesh-ancestor
82733484|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82733485|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733486|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82733487|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
82733488|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82733489|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82733490|NCT00755664|Vitamins|vitamins|mesh-list
82733491|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
82733492|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
82733493|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733494|NCT00956098|Oltipraz|oltipraz|mesh-list
82733495|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
82733496|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733497|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
82733498|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82733499|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
82733500|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82733501|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82733502|NCT00956098|Protective Agents|protective agents|mesh-ancestor
82733503|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733504|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733505|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82733506|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82733507|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733508|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733509|NCT00864591|Adenosine|adenosine|mesh-list
82733510|NCT00864591|Analgesics|analgesics|mesh-ancestor
82733511|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
82733512|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733513|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733514|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82733515|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
82733516|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82733517|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
82733518|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
82733519|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733520|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733521|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
82733522|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82733523|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82733524|NCT05350384|Prednisolone|prednisolone|mesh-list
82733525|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
82733526|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82733527|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
82733528|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82733529|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
82733530|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
82733531|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733532|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733533|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82733534|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
82733535|NCT05350384|Hormones|hormones|mesh-ancestor
82733536|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82733537|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82733538|NCT05350384|Protective Agents|protective agents|mesh-ancestor
82733539|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82733540|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733541|NCT00870441|Valacyclovir|valacyclovir|mesh-list
82733542|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
82733543|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733544|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
82733545|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
82733546|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733547|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82733548|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82733549|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733550|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733551|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82733552|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82733553|NCT00864669|Metformin|metformin|mesh-list
82733554|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82733555|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733556|NCT00864747|Propranolol|propranolol|mesh-list
82733557|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82733558|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82733559|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
82733560|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733561|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733562|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733563|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82733564|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82733565|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
82733566|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82733567|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82733568|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
82733569|NCT02559102|Anesthetics|anesthetics|mesh-list
82733570|NCT02559102|Sevoflurane|sevoflurane|mesh-list
82733571|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82733572|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733573|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82733574|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82733575|NCT02559102|Analgesics|analgesics|mesh-ancestor
82733576|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
82733577|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733578|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82733579|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82733580|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82733581|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
82733582|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733583|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733584|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82733585|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82733586|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
82733587|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82733588|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733589|NCT05348668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82733590|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733591|NCT00864825|Allopurinol|allopurinol|mesh-list
82733592|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
82733593|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733594|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733595|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
82733596|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733597|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82733598|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
82733599|NCT00864825|Protective Agents|protective agents|mesh-ancestor
82733600|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733601|NCT00956176|Cidofovir|cidofovir|mesh-list
82733602|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
82733603|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733604|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733605|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733607|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82733608|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
82733609|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82733610|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82733611|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82733612|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733613|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733614|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
82733615|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733616|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733617|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82733618|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82733619|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733620|NCT00371683|Enoxaparin|enoxaparin|mesh-list
82733621|NCT00371683|Apixaban|apixaban|mesh-list
82733622|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
82733623|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82733624|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82733625|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733626|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82733627|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
82733628|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82733629|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
82733630|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733631|NCT00876135|Albuterol|albuterol|mesh-list
82733632|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82733633|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
82733634|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733635|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733636|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82733637|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
82733638|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
82733639|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82733640|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82733641|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82733642|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82733643|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
82733644|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733645|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733646|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
82733647|NCT04039815|Thiamine|thiamine|mesh-list
82733648|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
82733649|NCT04039815|Vitamins|vitamins|mesh-ancestor
82733650|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
82733651|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733652|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82733653|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
82733654|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
82733655|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733656|NCT04039815|Protective Agents|protective agents|mesh-ancestor
82733657|NCT00870987|Vaccines|vaccines|mesh-list
82733658|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
82733659|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733660|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
82733661|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733662|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
82733663|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82733664|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82733665|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733666|NCT00871065|Urological Agents|urological agents|mesh-ancestor
82733667|NCT00962026|Rilonacept|rilonacept|mesh-list
82733668|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82733669|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
82733670|NCT00616239|Salicylates|salicylates|mesh-list
82733671|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733672|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
82733673|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
82733674|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
82733675|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82734055|NCT02534623|Sevoflurane|sevoflurane|mesh-list
82733676|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82733677|NCT00616239|Analgesics|analgesics|mesh-ancestor
82733678|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
82733679|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733680|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733681|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82733682|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733683|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82733684|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733685|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733686|NCT00547534|Rituximab|rituximab|mesh-list
82733687|NCT00547534|Bortezomib|bortezomib|mesh-list
82733688|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82733689|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82733690|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733691|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
82733692|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733693|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733694|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82733695|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
82733696|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733697|NCT00871455|Baclofen|baclofen|mesh-list
82733698|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82733699|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733700|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82733701|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733702|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82733703|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
82733704|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
82733705|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733706|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733707|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
82733708|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
82733709|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82733710|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82733711|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
82733712|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733713|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
82733714|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733715|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733716|NCT00877149|Telbivudine|telbivudine|mesh-list
82733717|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
82733718|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733719|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82733720|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733721|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733722|NCT00877227|Leucovorin|leucovorin|mesh-list
82733723|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
82733724|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
82733725|NCT00877227|Antidotes|antidotes|mesh-ancestor
82733726|NCT00877227|Protective Agents|protective agents|mesh-ancestor
82733727|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733728|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
82733729|NCT00877227|Vitamins|vitamins|mesh-ancestor
82733730|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
82733731|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
82733732|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82733733|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733734|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82733735|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82733736|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
82733737|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733738|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82733739|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
82733740|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733741|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
82733742|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
82733743|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733744|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733745|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733746|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
82733747|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
82733748|NCT00877539|Fluticasone|fluticasone|mesh-list
82733750|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82733751|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82733752|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
82733753|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733754|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733755|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82733756|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
82733757|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
82733758|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82733759|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82733760|NCT00872235|Quinapril|quinapril|mesh-list
82733761|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82733762|NCT00872235|Diuretics|diuretics|mesh-ancestor
82733763|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
82733764|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733765|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82733766|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733767|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733768|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82733769|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
82733770|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733771|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
82733772|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82733773|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82733774|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733775|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
82733776|NCT00872469|Coagulants|coagulants|mesh-ancestor
82733777|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
82733778|NCT00872625|Docetaxel|docetaxel|mesh-list
82733779|NCT00872625|Fluorouracil|fluorouracil|mesh-list
82733780|NCT00872625|Epirubicin|epirubicin|mesh-list
82733781|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82733782|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
82733783|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733784|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733785|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82733786|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
82733787|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733788|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733789|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82733790|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
82733791|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
82733792|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
82733793|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
82733794|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82733795|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82733796|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82733797|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82733798|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733799|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82733800|NCT00872781|Quinapril|quinapril|mesh-list
82733801|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82733802|NCT00872781|Diuretics|diuretics|mesh-ancestor
82733803|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
82733804|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733805|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82733806|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733807|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733808|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82733809|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
82733810|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733811|NCT00384085|Insulin|insulin|mesh-list
82733812|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82733813|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
82733814|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
82733815|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82733816|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733817|NCT00361231|Bevacizumab|bevacizumab|mesh-list
82733818|NCT00361231|Gemcitabine|gemcitabine|mesh-list
82733819|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
82733820|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82733821|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733822|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82733823|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82733824|NCT00361231|Growth Substances|growth substances|mesh-ancestor
82733825|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733826|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
82733827|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82733828|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
82733829|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733831|NCT00676650|Sunitinib|sunitinib|mesh-list
82733832|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82733833|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
82733834|NCT00676650|Hormones|hormones|mesh-ancestor
82733835|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82733836|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733837|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82733838|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733839|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82733840|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82733841|NCT00676650|Growth Substances|growth substances|mesh-ancestor
82733842|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
82733843|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82733844|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733845|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733846|NCT01045369|Etravirine|etravirine|mesh-list
82733847|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82733848|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82733849|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733850|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733851|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
82733852|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733853|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
82733854|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82733855|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
82733856|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733857|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733858|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82733859|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
82733860|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
82733861|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82733862|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
82733863|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733864|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733865|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82733866|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733867|NCT00383149|Cetuximab|cetuximab|mesh-list
82733868|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82733869|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733870|NCT00878631|Dextrans|dextrans|mesh-list
82733871|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
82733872|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
82733873|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
82733874|NCT00382993|Naproxen|naproxen|mesh-list
82733875|NCT00382993|Sumatriptan|sumatriptan|mesh-list
82733876|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82733877|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82733878|NCT00382993|Analgesics|analgesics|mesh-ancestor
82733879|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
82733880|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733881|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733882|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82733883|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733884|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
82733885|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82733886|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733887|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733888|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82733889|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82733890|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82733891|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
82733892|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733894|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82733895|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
82733896|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82733897|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733898|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82733899|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
82733900|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733901|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733902|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
82733903|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733904|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82733905|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82733906|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
82733907|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82733908|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82733909|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
82733911|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82733912|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733913|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82733914|NCT00878865|Alprazolam|alprazolam|mesh-list
82733915|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82733916|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82733917|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733918|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82733919|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82733920|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82733921|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
82733923|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82733924|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733925|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82733926|NCT00873483|Gestodene|gestodene|mesh-list
82733927|NCT00873483|Femovan|femovan|mesh-list
82733928|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82733929|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82733930|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82733931|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
82733932|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82733933|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733934|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82733935|NCT00873483|Estrogens|estrogens|mesh-ancestor
82733936|NCT00873483|Hormones|hormones|mesh-ancestor
82733937|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82733938|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82733939|NCT00873483|Progestins|progestins|mesh-ancestor
82733940|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82733941|NCT01050517|Ivermectin|ivermectin|mesh-list
82733942|NCT01050517|Albendazole|albendazole|mesh-list
82733943|NCT01050517|Praziquantel|praziquantel|mesh-list
82733944|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82733945|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82733946|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
82733947|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
82733948|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82733949|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82733950|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
82733951|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
82733952|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
82733953|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733954|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82733955|NCT02534467|Montelukast|montelukast|mesh-list
82733956|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82733957|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
82733958|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82733959|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
82733960|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82733961|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733962|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82733963|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82733964|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733965|NCT01050595|Naltrexone|naltrexone|mesh-list
82733966|NCT01050595|Bromides|bromides|mesh-list
82733967|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
82733968|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
82733969|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82733970|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733971|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
82733972|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733973|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82733974|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
82733975|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733976|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
82733977|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82733978|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82733979|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82733980|NCT00878943|Urological Agents|urological agents|mesh-ancestor
82733981|NCT00873639|Insulin|insulin|mesh-list
82733982|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82733983|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
82733984|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
82733985|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82733986|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733987|NCT00879021|Pregabalin|pregabalin|mesh-list
82733988|NCT00879021|Analgesics|analgesics|mesh-ancestor
82733989|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
82733990|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82733991|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82733992|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
82733993|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82733994|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82733995|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82733996|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82733997|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82733998|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82733999|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734000|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82734001|NCT00879099|Timolol|timolol|mesh-list
82734002|NCT00879099|Paroxetine|paroxetine|mesh-list
82734003|NCT00879099|Maleic acid|maleic acid|mesh-list
82734004|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734005|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734006|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82734007|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82734008|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
82734009|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734010|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734011|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82734012|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82734013|NCT00879099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82734014|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82734015|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734016|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
82734017|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82734018|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
82734019|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82734020|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82734021|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82734022|NCT00369655|Aflibercept|aflibercept|mesh-list
82734023|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
82734024|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82734025|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82734026|NCT00369655|Growth Substances|growth substances|mesh-ancestor
82734027|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734028|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
82734029|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734030|NCT00879177|Varenicline|varenicline|mesh-list
82734031|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82734032|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82734033|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
82734034|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734035|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734036|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734038|NCT00676338|Pioglitazone|pioglitazone|mesh-list
82734039|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82734040|NCT00676338|Exenatide|exenatide|mesh-list
82734041|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82734042|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734043|NCT00676338|Incretins|incretins|mesh-ancestor
82734044|NCT00676338|Hormones|hormones|mesh-ancestor
82734045|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82734046|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82734047|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
82734048|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734049|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734050|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82734052|NCT02534623|Bupivacaine|bupivacaine|mesh-list
82734053|NCT02534623|Anesthetics|anesthetics|mesh-list
82734056|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
82734057|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734058|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734059|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
82734060|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734061|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82734062|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82734063|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
82734064|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82734065|NCT02534623|Narcotics|narcotics|mesh-ancestor
82734066|NCT02534623|Analgesics|analgesics|mesh-ancestor
82734067|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82734068|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82734069|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82734070|NCT00873795|Aripiprazole|aripiprazole|mesh-list
82734071|NCT00873795|Sertraline|sertraline|mesh-list
82734072|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
82734073|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82734074|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82734075|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82734076|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734077|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734078|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
82734079|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
82734080|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734081|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734082|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82734083|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82734084|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
82734085|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82734086|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82734087|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82734088|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82734089|NCT00873795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82734090|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82734091|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734092|NCT00873951|Caseins|caseins|mesh-list
82734093|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
82734094|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
82734095|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734096|NCT00874107|Paclitaxel|paclitaxel|mesh-list
82734097|NCT00874107|Bevacizumab|bevacizumab|mesh-list
82734098|NCT00874107|Carboplatin|carboplatin|mesh-list
82734099|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82734100|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734101|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
82734102|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
82734103|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
82734104|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734105|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82734106|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82734107|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82734108|NCT00874107|Growth Substances|growth substances|mesh-ancestor
82734109|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734110|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
82734111|NCT00761358|Z 338|z 338|mesh-list
82734112|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82734113|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734114|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734115|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
82734116|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734117|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734118|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82734120|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
82734121|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734122|NCT00874419|Carboplatin|carboplatin|mesh-list
82734123|NCT00874419|Gemcitabine|gemcitabine|mesh-list
82734124|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82734125|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734126|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82734127|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
82734128|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734129|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82734130|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734131|NCT00381043|Acamprosate|acamprosate|mesh-list
82734132|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82734133|NCT01050985|Sirolimus|sirolimus|mesh-list
82734134|NCT01050985|Capecitabine|capecitabine|mesh-list
82734135|NCT01050985|Temsirolimus|temsirolimus|mesh-list
82734136|NCT01050985|MTOR Inhibitors|mtor inhibitors|mesh-list
82734137|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82734138|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
82734139|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734140|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734141|NCT01050985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82734142|NCT01050985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734143|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82734144|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
82734145|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734146|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82734147|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734148|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82734149|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
82734150|NCT00614991|Ritonavir|ritonavir|mesh-list
82734151|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
82734152|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
82734153|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82734154|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82734155|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
82734156|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734157|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734158|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82734159|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82734160|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
82734161|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734162|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82734163|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82734164|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82734165|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82734166|NCT00874575|Vitamin D|vitamin d|mesh-list
82734167|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
82734168|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
82734169|NCT00874575|Vitamins|vitamins|mesh-list
82734170|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
82734171|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734172|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82734173|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82734174|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
82734175|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82734176|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734177|NCT03083808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82734178|NCT03083808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734179|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
82734180|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82734181|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
82734182|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82734183|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734184|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82734185|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82734186|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82734188|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82734189|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82734190|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734191|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734192|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82734193|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82734194|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
82734195|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734196|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734197|NCT00879957|Heparin|heparin|mesh-list
82734198|NCT00879957|Calcium heparin|calcium heparin|mesh-list
82734199|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
82734200|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82734201|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82734202|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734203|NCT00874809|Insulin|insulin|mesh-list
82734204|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
82734205|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82734206|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734207|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
82734208|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82734209|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82734210|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734211|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
82734212|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
82734213|NCT00875355|Temozolomide|temozolomide|mesh-list
82734214|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82734215|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
82734216|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734217|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734218|NCT00678288|Interferons|interferons|mesh-list
82734219|NCT00678288|Sorafenib|sorafenib|mesh-list
82734220|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734221|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
82734222|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734223|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82734224|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734225|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734226|NCT00880815|Rituximab|rituximab|mesh-list
82734227|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82734228|NCT00880815|Methotrexate|methotrexate|mesh-list
82734229|NCT00880815|Fludarabine|fludarabine|mesh-list
82734230|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82734231|NCT00880815|Antibodies|antibodies|mesh-list
82734232|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
82734233|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82734234|NCT00880815|Lenograstim|lenograstim|mesh-list
82734235|NCT00880815|Tacrolimus|tacrolimus|mesh-list
82734236|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
82734237|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82734238|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
82734239|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734240|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734241|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82734242|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82734243|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
82734244|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82734245|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82734246|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
82734247|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734248|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
82734249|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734250|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82734251|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82734252|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82734253|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82734254|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82734255|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82734256|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
82734257|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82734258|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82734259|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82734260|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734261|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734262|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734263|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734264|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
82734265|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82734267|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734268|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82734269|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734270|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734271|NCT00881127|Cetirizine|cetirizine|mesh-list
82734272|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
82734273|NCT00881127|Ephedrine|ephedrine|mesh-list
82734274|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82734275|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82734276|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82734277|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
82734278|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
82734279|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734280|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734281|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734282|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82734283|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
82734284|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734285|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82734286|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
82734287|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
82734288|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82734289|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82734290|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
82734291|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
82734292|NCT00369265|Lansoprazole|lansoprazole|mesh-list
82734293|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
82734294|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82734295|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82734296|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82734297|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734298|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734299|NCT00875745|Sorafenib|sorafenib|mesh-list
82734300|NCT00875745|Vorinostat|vorinostat|mesh-list
82734301|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734302|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82734303|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734304|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734305|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82734306|NCT00368875|Paclitaxel|paclitaxel|mesh-list
82734307|NCT00368875|Bevacizumab|bevacizumab|mesh-list
82734308|NCT00368875|Vorinostat|vorinostat|mesh-list
82734309|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82734310|NCT00368875|Antibodies|antibodies|mesh-list
82734311|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
82734312|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82734313|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82734314|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734315|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
82734316|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
82734317|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
82734318|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734319|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82734320|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82734321|NCT00368875|Growth Substances|growth substances|mesh-ancestor
82734322|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734323|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
82734324|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
82734325|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82734326|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734327|NCT00614055|Insulin|insulin|mesh-list
82734328|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82734329|NCT00614055|Metformin|metformin|mesh-list
82734330|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
82734331|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
82734332|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
82734333|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82734334|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82734335|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734336|NCT00613821|Lidocaine|lidocaine|mesh-list
82734337|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
82734338|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
82734339|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734340|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734341|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
82734342|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734343|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82734344|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82734345|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82734346|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734347|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734348|NCT00882765|Genistein|genistein|mesh-list
82734349|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82734350|NCT00882765|Protective Agents|protective agents|mesh-ancestor
82734351|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734352|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734353|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82734354|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734355|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734356|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
82734357|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82734358|NCT00882765|Estrogens|estrogens|mesh-ancestor
82734359|NCT00882765|Hormones|hormones|mesh-ancestor
82734360|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82734361|NCT00548548|Bevacizumab|bevacizumab|mesh-list
82734362|NCT00548548|Fluorouracil|fluorouracil|mesh-list
82734363|NCT00548548|Capecitabine|capecitabine|mesh-list
82734364|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82734365|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734366|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82734367|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82734368|NCT00548548|Growth Substances|growth substances|mesh-ancestor
82734369|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734370|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
82734371|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
82734372|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734373|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82734374|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82734375|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
82734376|NCT00613509|Interferons|interferons|mesh-list
82734377|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
82734378|NCT00613509|Vaccines|vaccines|mesh-list
82734379|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734380|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
82734381|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734382|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
82734383|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734384|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
82734385|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
82734386|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734387|NCT00881595|Temozolomide|temozolomide|mesh-list
82734388|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82734389|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
82734390|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734391|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734392|NCT00883155|Bupropion|bupropion|mesh-list
82734393|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82734394|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
82734395|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82734396|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82734397|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82734398|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734399|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734400|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
82734401|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734402|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734403|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82734404|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82734405|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734406|NCT00881673|Dexamethasone|dexamethasone|mesh-list
82734407|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82734408|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82734409|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82734410|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
82734411|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
82734412|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734413|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734414|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82734415|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
82734416|NCT00881673|Hormones|hormones|mesh-ancestor
82734417|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82734418|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82734419|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734420|NCT04638465|Cisplatin|cisplatin|mesh-list
82734421|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734422|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82734423|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82734424|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734425|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
82734426|NCT04487925|Hormones|hormones|mesh-list
82734427|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82734428|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82734429|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734430|NCT00547300|Metoprolol|metoprolol|mesh-list
82734431|NCT00547300|Nebivolol|nebivolol|mesh-list
82734432|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82734433|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82734434|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
82734435|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
82734436|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734437|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734438|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82734439|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82734440|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82734441|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
82734442|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734443|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734444|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
82734445|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82734446|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82734447|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82734448|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
82734449|NCT00612807|Bupropion|bupropion|mesh-list
82734450|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82734451|NCT00612807|Sertraline|sertraline|mesh-list
82734452|NCT00612807|Nortriptyline|nortriptyline|mesh-list
82734453|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82734454|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
82734455|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82734456|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82734457|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82734458|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734459|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734460|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
82734461|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734462|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734463|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82734464|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82734465|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734466|NCT00612807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82734467|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
82734468|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82734469|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734470|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82734471|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82734472|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82734473|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
82734474|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82734475|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82734476|NCT00958750|Minoxidil|minoxidil|mesh-list
82734477|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82734478|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
82734479|NCT00958906|Infliximab|infliximab|mesh-list
82734480|NCT00958906|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82734481|NCT00958906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82734482|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
82734483|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82734484|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82734485|NCT00959062|Clonidine|clonidine|mesh-list
82734486|NCT00959062|Analgesics|analgesics|mesh-ancestor
82734487|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
82734488|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734489|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734490|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82734491|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
82734492|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
82734493|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82734494|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82734495|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82734496|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
82734497|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734498|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734499|NCT04038411|Etoposide|etoposide|mesh-list
82734500|NCT04038411|Lenalidomide|lenalidomide|mesh-list
82734501|NCT04038411|Antibodies|antibodies|mesh-list
82734502|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
82734503|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734504|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82734505|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734506|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82734507|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82734508|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734509|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734510|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82734511|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82734512|NCT04038411|Growth Substances|growth substances|mesh-ancestor
82734513|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
82734514|NCT04155424|Eculizumab|eculizumab|mesh-list
82734515|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82734516|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82734517|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
82734518|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734519|NCT00882375|Nicotine|nicotine|mesh-list
82734520|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82734521|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
82734522|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734523|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734524|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82734525|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82734526|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
82734527|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734528|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734529|NCT00882453|Interferons|interferons|mesh-list
82734530|NCT00882453|Interferon-beta|interferon-beta|mesh-list
82734531|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
82734532|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734533|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
82734534|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734535|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
82734536|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734537|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82734538|NCT00882531|Isotretinoin|isotretinoin|mesh-list
82734539|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
82734540|NCT00963274|Bortezomib|bortezomib|mesh-list
82734541|NCT00963274|Romidepsin|romidepsin|mesh-list
82734542|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734543|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82734544|NCT00963274|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82734545|NCT00963274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734546|NCT00963274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734547|NCT00882609|Fluorides|fluorides|mesh-list
82734548|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
82734549|NCT00882609|Protective Agents|protective agents|mesh-ancestor
82734550|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734551|NCT00883623|Lenalidomide|lenalidomide|mesh-list
82734552|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
82734553|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734554|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82734555|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82734556|NCT00883623|Growth Substances|growth substances|mesh-ancestor
82734557|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
82734558|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734559|NCT00959218|Dronabinol|dronabinol|mesh-list
82734560|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
82734561|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734562|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82734563|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82734564|NCT00959218|Analgesics|analgesics|mesh-ancestor
82734565|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
82734566|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734567|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82734568|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82734569|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734570|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734571|NCT00959218|Hormones|hormones|mesh-ancestor
82734572|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82734573|NCT00678210|Tofacitinib|tofacitinib|mesh-list
82734574|NCT00678210|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82734575|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82734576|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734577|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734578|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82734579|NCT00611715|Letrozole|letrozole|mesh-list
82734580|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734581|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82734582|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734659|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
82734583|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734584|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82734585|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82734586|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82734587|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
82734588|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82734589|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734590|NCT04722718|Paclitaxel|paclitaxel|mesh-list
82734591|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82734592|NCT04722718|Carboplatin|carboplatin|mesh-list
82734593|NCT04722718|Apatinib|apatinib|mesh-list
82734594|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82734595|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734596|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
82734597|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
82734598|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
82734599|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734600|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82734601|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734602|NCT00761670|Risperidone|risperidone|mesh-list
82734603|NCT00761670|Amisulpride|amisulpride|mesh-list
82734604|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82734605|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
82734606|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734607|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734608|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734609|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82734610|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82734611|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734612|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82734613|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82734614|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
82734615|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82734616|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
82734617|NCT00963664|Interferons|interferons|mesh-list
82734618|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
82734619|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
82734620|NCT00963664|Lovastatin|lovastatin|mesh-list
82734621|NCT00963664|L 647318|l 647318|mesh-list
82734622|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
82734623|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734624|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
82734625|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734626|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
82734627|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734628|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82734629|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82734630|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
82734631|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734632|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82734633|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82734634|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734636|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
82734637|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82734638|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82734639|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734640|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82734641|NCT00761904|Simvastatin|simvastatin|mesh-list
82734642|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82734643|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82734644|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
82734645|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734646|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82734647|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82734648|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734649|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82734650|NCT00761904|Diuretics|diuretics|mesh-ancestor
82734651|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
82734652|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734653|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82734654|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734655|NCT00963976|Enalapril|enalapril|mesh-list
82734656|NCT00963976|Labetalol|labetalol|mesh-list
82734657|NCT00963976|Hydralazine|hydralazine|mesh-list
82734658|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82734660|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734661|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734662|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82734663|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82734664|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82734665|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
82734666|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734667|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734668|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
82734669|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
82734670|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734671|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82734672|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82734673|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
82734674|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
82734676|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734677|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82734678|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82734679|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734680|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734681|NCT00611247|Temozolomide|temozolomide|mesh-list
82734682|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82734683|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
82734684|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734685|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734686|NCT00883935|Ritonavir|ritonavir|mesh-list
82734687|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82734688|NCT00883935|Dolutegravir|dolutegravir|mesh-list
82734689|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82734690|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82734691|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
82734692|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734693|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734694|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82734695|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82734696|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
82734697|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734698|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82734699|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82734700|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82734701|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82734702|NCT00675948|Nabiximols|nabiximols|mesh-list
82734703|NCT00675948|Analgesics|analgesics|mesh-ancestor
82734704|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
82734705|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734706|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734707|NCT00885885|Panitumumab|panitumumab|mesh-list
82734708|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82734709|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734710|NCT00610935|Peramivir|peramivir|mesh-list
82734711|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
82734712|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734713|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734714|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734715|NCT02303028|Topotecan|topotecan|mesh-list
82734716|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82734717|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82734718|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734719|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734720|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734721|NCT02287818|Febuxostat|febuxostat|mesh-list
82734722|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
82734723|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82734724|NCT00762060|Anesthetics|anesthetics|mesh-list
82734725|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
82734726|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734727|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734728|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
82734729|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734730|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82734731|NCT00610857|Antibodies|antibodies|mesh-list
82734732|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
82734733|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82734734|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
82734735|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734736|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734738|NCT00672984|Guanfacine|guanfacine|mesh-list
82734739|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82734740|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734741|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82734742|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82734743|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734744|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734745|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734746|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734747|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82734748|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82734749|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82734750|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82734751|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
82734752|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734753|NCT02543697|Epinephrine|epinephrine|mesh-list
82734754|NCT02543697|Racepinephrine|racepinephrine|mesh-list
82734755|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
82734756|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82734757|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82734758|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
82734759|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734760|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734761|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734762|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82734763|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82734764|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
82734765|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734766|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82734767|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
82734768|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
82734769|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
82734770|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82734771|NCT00886275|Midazolam|midazolam|mesh-list
82734772|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
82734773|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82734774|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734775|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734776|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82734777|NCT00886275|Analgesics|analgesics|mesh-ancestor
82734778|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
82734779|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734780|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82734781|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82734782|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82734783|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
82734784|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734785|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734786|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82734788|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82734789|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82734790|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82734791|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
82734792|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
82734793|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
82734794|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
82734795|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
82734796|NCT04017897|Nivolumab|nivolumab|mesh-list
82734797|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82734798|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734799|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82734800|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734801|NCT02542137|Thymalfasin|thymalfasin|mesh-list
82734802|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82734803|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
82734804|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734805|NCT00886509|Lenograstim|lenograstim|mesh-list
82734806|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82734807|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
82734808|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734809|NCT02543385|Ketamine|ketamine|mesh-list
82734810|NCT02543385|Esketamine|esketamine|mesh-list
82734811|NCT02543385|Analgesics|analgesics|mesh-ancestor
82734812|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
82734813|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734814|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734815|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82734816|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82734817|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
82734818|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
82734819|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734820|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82734821|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82734822|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734823|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734824|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
82734825|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82734826|NCT00884481|Natalizumab|natalizumab|mesh-list
82734827|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
82734828|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734829|NCT02543229|Ranibizumab|ranibizumab|mesh-list
82734830|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82734831|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82734832|NCT02543229|Growth Substances|growth substances|mesh-ancestor
82734833|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734834|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
82734835|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734836|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
82734837|NCT02543073|Hormones|hormones|mesh-ancestor
82734838|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82734839|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734840|NCT00546364|Docetaxel|docetaxel|mesh-list
82734841|NCT00546364|Capecitabine|capecitabine|mesh-list
82734842|NCT00546364|Epothilones|epothilones|mesh-list
82734843|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734844|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
82734845|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
82734846|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
82734847|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734848|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82734849|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
82734850|NCT00887211|Sirolimus|sirolimus|mesh-list
82734851|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82734852|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734853|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82734854|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734855|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
82734856|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82734857|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
82734858|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734860|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82734861|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734862|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734863|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734864|NCT00964288|Lidocaine|lidocaine|mesh-list
82734865|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
82734866|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
82734867|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734868|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734869|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
82734870|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734871|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82734872|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82734873|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82734874|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734875|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734876|NCT00964756|Ganciclovir|ganciclovir|mesh-list
82734877|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
82734878|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
82734879|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734880|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82734881|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734882|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734883|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82734884|NCT00964834|Doxycycline|doxycycline|mesh-list
82734885|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82734886|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82734887|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
82734888|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
82734889|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82734890|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82734891|NCT00612105|Ezogabine|ezogabine|mesh-list
82734892|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
82734893|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734894|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734895|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
82734896|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82734897|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82734898|NCT04017741|Prednisolone|prednisolone|mesh-list
82734899|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
82734900|NCT04017741|Lidocaine|lidocaine|mesh-list
82734901|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82734902|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
82734903|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
82734904|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
82734905|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82734906|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734907|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
82734908|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82734909|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82734910|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82734911|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82734912|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734913|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734914|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82734915|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
82734916|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
82734917|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82734918|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
82734919|NCT04017741|Hormones|hormones|mesh-ancestor
82734920|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82734921|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82734922|NCT04017741|Protective Agents|protective agents|mesh-ancestor
82734923|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82734924|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734925|NCT00546052|Losartan|losartan|mesh-list
82734926|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82734927|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82734928|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82734929|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82734930|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82734931|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734932|NCT00546052|Diuretics|diuretics|mesh-ancestor
82734933|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
82734934|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734935|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82734936|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734937|NCT00887601|Donepezil|donepezil|mesh-list
82734938|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82734939|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734940|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734941|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
82734942|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734943|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734944|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
82734945|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
82734946|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82734947|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734948|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734949|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
82734950|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82734951|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734952|NCT00887757|Gemcitabine|gemcitabine|mesh-list
82734953|NCT00887757|Navitoclax|navitoclax|mesh-list
82734954|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82734955|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
82734956|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734957|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734958|NCT00965224|Immunomodulating Agents|immunomodulating agents|mesh-list
82734959|NCT00965224|Immunologic Factors|immunologic factors|mesh-ancestor
82734960|NCT00965224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734962|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82734963|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
82734964|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82734965|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82734966|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734967|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82734968|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82734969|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82734970|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734971|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82734972|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82734973|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82734974|NCT00673920|Methotrexate|methotrexate|mesh-list
82734975|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
82734976|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82734977|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
82734978|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82734979|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82734980|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82734981|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
82734982|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734983|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734984|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
82734985|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82734986|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82734987|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82734988|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
82734989|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82734990|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82734991|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82734992|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82734993|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
82734994|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82734995|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82734996|NCT00379795|Ranibizumab|ranibizumab|mesh-list
82734997|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82734998|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82734999|NCT00379795|Growth Substances|growth substances|mesh-ancestor
82735000|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735001|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
82735002|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735003|NCT04588948|Aflibercept|aflibercept|mesh-list
82735004|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82735005|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82735006|NCT04588948|Growth Substances|growth substances|mesh-ancestor
82735007|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735008|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
82735009|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735011|NCT00765024|Albendazole|albendazole|mesh-list
82735012|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82735013|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735014|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
82735015|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
82735016|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82735017|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82735018|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
82735019|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
82735020|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
82735021|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735022|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735023|NCT02557932|Bismuth|bismuth|mesh-list
82735024|NCT02557932|Antacids|antacids|mesh-ancestor
82735025|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735026|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82735027|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
82735028|NCT00960232|Vitamin D|vitamin d|mesh-list
82735029|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82735030|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735031|NCT00960232|Vitamins|vitamins|mesh-ancestor
82735032|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
82735033|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82735034|NCT04577014|Gemcitabine|gemcitabine|mesh-list
82735035|NCT04577014|Docetaxel|docetaxel|mesh-list
82735036|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82735037|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
82735038|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735039|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735040|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
82735041|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
82735042|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
82735043|NCT05282550|Trazodone|trazodone|mesh-list
82735044|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82735045|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82735046|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82735047|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735048|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82735049|NCT05282550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82735050|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82735051|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82735052|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735053|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735054|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
82735055|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82735056|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
82735057|NCT00960310|Bicalutamide|bicalutamide|mesh-list
82735058|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
82735059|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
82735060|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735061|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735062|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735063|NCT00610155|Pregabalin|pregabalin|mesh-list
82735064|NCT00610155|Tramadol|tramadol|mesh-list
82735065|NCT00610155|Analgesics|analgesics|mesh-ancestor
82735066|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
82735067|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735068|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735069|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
82735070|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82735071|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82735072|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735073|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82735074|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82735075|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82735076|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82735077|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82735078|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82735079|NCT00610155|Narcotics|narcotics|mesh-ancestor
82735080|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
82735081|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735082|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
82735083|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735084|NCT00960544|Capecitabine|capecitabine|mesh-list
82735085|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82735086|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
82735087|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735088|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735089|NCT04488952|Anesthetics|anesthetics|mesh-list
82735090|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82735091|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735092|NCT00888303|Dexamethasone|dexamethasone|mesh-list
82735093|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735094|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
82735095|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
82735096|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735097|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735098|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82735099|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
82735100|NCT00888303|Hormones|hormones|mesh-ancestor
82735101|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735102|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82735103|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735104|NCT00967642|Insulin|insulin|mesh-list
82735105|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82735106|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735107|NCT00674700|Immunomodulating Agents|immunomodulating agents|mesh-list
82735108|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
82735109|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735111|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
82735112|NCT00762918|Vitamins|vitamins|mesh-ancestor
82735113|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
82735114|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735115|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82735116|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82735117|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82735118|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82735119|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82735120|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82735121|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735122|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
82735123|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735124|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735125|NCT00759720|Glyburide|glyburide|mesh-list
82735126|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82735127|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735128|NCT00379639|Gemcitabine|gemcitabine|mesh-list
82735129|NCT00379639|Romidepsin|romidepsin|mesh-list
82735130|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82735131|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
82735132|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735133|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735134|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82735135|NCT00379639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82735136|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735137|NCT00609765|Dexamethasone|dexamethasone|mesh-list
82735138|NCT00609765|Bevacizumab|bevacizumab|mesh-list
82735139|NCT00609765|Doxorubicin|doxorubicin|mesh-list
82735140|NCT00609765|Fluorouracil|fluorouracil|mesh-list
82735141|NCT00609765|Streptozocin|streptozocin|mesh-list
82735142|NCT00609765|Ondansetron|ondansetron|mesh-list
82735143|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82735144|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735145|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82735146|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82735147|NCT00609765|Growth Substances|growth substances|mesh-ancestor
82735148|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735149|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
82735150|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735151|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
82735152|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
82735153|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735154|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82735155|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
82735156|NCT00609765|Hormones|hormones|mesh-ancestor
82735157|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735158|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82735159|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82735160|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82735162|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735163|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735164|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
82735165|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82735166|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82735167|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
82735168|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
82735169|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
82735170|NCT00609765|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82735171|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82735172|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
82735173|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735174|NCT01051219|Losartan|losartan|mesh-list
82735175|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82735176|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82735177|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82735178|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82735179|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735180|NCT00961324|Insulin|insulin|mesh-list
82735181|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82735182|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
82735183|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82735184|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735185|NCT00766350|Amitriptyline|amitriptyline|mesh-list
82735186|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82735187|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
82735188|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82735189|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82735190|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82735191|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82735192|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735193|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82735194|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82735195|NCT00766350|Analgesics|analgesics|mesh-ancestor
82735196|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
82735197|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735198|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82735199|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82735200|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82735201|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735202|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
82735203|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735204|NCT00889161|Curcumin|curcumin|mesh-list
82735205|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82735206|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82735207|NCT00889161|Analgesics|analgesics|mesh-ancestor
82735208|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
82735209|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735210|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735211|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735212|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82735213|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735214|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735215|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735216|NCT03992755|Treprostinil|treprostinil|mesh-list
82735217|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82735218|NCT01563328|Dolutegravir|dolutegravir|mesh-list
82735219|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82735220|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82735221|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735222|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735223|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82735224|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82735225|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
82735226|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735227|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
82735228|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82735229|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735231|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82735232|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735233|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735234|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735235|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82735236|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82735237|NCT00961480|Metformin|metformin|mesh-list
82735238|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82735239|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82735240|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735241|NCT00961480|Incretins|incretins|mesh-ancestor
82735242|NCT00961480|Hormones|hormones|mesh-ancestor
82735243|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735244|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82735245|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
82735246|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735247|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735248|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
82735249|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
82735250|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82735251|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
82735252|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82735253|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82735254|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735255|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82735256|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735257|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735258|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82735259|NCT00965926|Mirabegron|mirabegron|mesh-list
82735483|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
82735260|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82735261|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82735262|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82735263|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
82735264|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735265|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735266|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735267|NCT00965926|Urological Agents|urological agents|mesh-ancestor
82735268|NCT00966004|Mirabegron|mirabegron|mesh-list
82735269|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82735270|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82735271|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82735272|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82735273|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
82735274|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735275|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735276|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735277|NCT00966004|Urological Agents|urological agents|mesh-ancestor
82735278|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82735279|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82735280|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
82735281|NCT00966082|Propranolol|propranolol|mesh-list
82735282|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82735283|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82735284|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
82735285|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735286|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735287|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735288|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82735289|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82735290|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
82735291|NCT00889629|Vitamin D|vitamin d|mesh-list
82735292|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
82735293|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
82735294|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
82735295|NCT00889629|Vitamins|vitamins|mesh-ancestor
82735296|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
82735297|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735298|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82735299|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82735300|NCT00966160|Ritonavir|ritonavir|mesh-list
82735301|NCT00966160|Lopinavir|lopinavir|mesh-list
82735302|NCT00966160|Lamivudine|lamivudine|mesh-list
82735303|NCT00966160|Zidovudine|zidovudine|mesh-list
82735304|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
82735305|NCT00966160|Efavirenz|efavirenz|mesh-list
82735306|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82735307|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82735308|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
82735309|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735310|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735311|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82735312|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82735313|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
82735314|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735315|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82735316|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82735317|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82735318|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82735319|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
82735320|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82735321|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82735322|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82735323|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82735324|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82735326|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82735327|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82735328|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
82735329|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735330|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735331|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82735332|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82735333|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
82735334|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735335|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82735336|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82735337|NCT00966316|Aspirin|aspirin|mesh-list
82735338|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82735339|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82735340|NCT00966316|Analgesics|analgesics|mesh-ancestor
82735341|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
82735342|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735343|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735344|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735345|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82735346|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82735347|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82735348|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735349|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82735350|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82735351|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735352|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
82735353|NCT00892827|Rituximab|rituximab|mesh-list
82735354|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82735355|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735356|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
82735357|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735358|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82735359|NCT00766896|Aspirin|aspirin|mesh-list
82735360|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82735361|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82735362|NCT00766896|Analgesics|analgesics|mesh-ancestor
82735363|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
82735364|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735365|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735366|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735367|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82735368|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82735369|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82735370|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735371|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82735372|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82735373|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735374|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
82735375|NCT00763620|Dimercaprol|dimercaprol|mesh-list
82735376|NCT00763620|Chelating Agents|chelating agents|mesh-ancestor
82735377|NCT00763620|Sequestering Agents|sequestering agents|mesh-ancestor
82735378|NCT00763620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735379|NCT00973804|Sirolimus|sirolimus|mesh-list
82735380|NCT00973804|Tacrolimus|tacrolimus|mesh-list
82735381|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82735382|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
82735383|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735384|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82735385|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735386|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735387|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82735388|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735389|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82735390|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735391|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
82735392|NCT04018131|Cimetidine|cimetidine|mesh-list
82735393|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82735394|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82735395|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82735396|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
82735397|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
82735398|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735399|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735400|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735401|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82735402|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82735403|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735404|NCT00973882|Carboplatin|carboplatin|mesh-list
82735405|NCT00973882|Etoposide|etoposide|mesh-list
82735406|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735407|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82735408|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82735409|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82735410|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735411|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735412|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82735413|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82735414|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
82735415|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735416|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735417|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82735418|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
82735419|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82735420|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82735421|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82735422|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
82735423|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735424|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735425|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
82735426|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82735427|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82735428|NCT05279482|Prednisolone|prednisolone|mesh-list
82735429|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
82735430|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82735431|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
82735432|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735433|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
82735434|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
82735435|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735436|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735437|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82735438|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
82735439|NCT05279482|Hormones|hormones|mesh-ancestor
82735440|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735441|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82735442|NCT05279482|Protective Agents|protective agents|mesh-ancestor
82735443|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82735444|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735445|NCT00890175|Loxapine|loxapine|mesh-list
82735446|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82735447|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82735448|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82735449|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735450|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82735451|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82735452|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
82735453|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735454|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735455|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82735456|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82735457|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735458|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82735459|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735460|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735461|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82735462|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82735463|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
82735464|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82735465|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82735466|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
82735467|NCT00890253|Prednisone|prednisone|mesh-list
82735468|NCT00890253|Prednisolone|prednisolone|mesh-list
82735469|NCT00890253|Everolimus|everolimus|mesh-list
82735470|NCT00890253|Basiliximab|basiliximab|mesh-list
82735471|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735472|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
82735473|NCT00890253|Hormones|hormones|mesh-ancestor
82735474|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735475|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735476|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82735477|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735478|NCT00890253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82735479|NCT00890253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82735480|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735481|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735482|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82735484|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82735485|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82735486|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
82735487|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82735488|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735489|NCT00674154|Vitamin D|vitamin d|mesh-list
82735490|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
82735491|NCT00674154|Vitamins|vitamins|mesh-ancestor
82735492|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
82735493|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735494|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82735495|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82735496|NCT00967954|Hormones|hormones|mesh-list
82735497|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
82735498|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735499|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735500|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
82735502|NCT00767286|Goserelin|goserelin|mesh-list
82735503|NCT00767286|Flutamide|flutamide|mesh-list
82735504|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82735505|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735506|NCT00767286|Trace Elements|trace elements|mesh-ancestor
82735507|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
82735508|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735509|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
82735510|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
82735511|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735512|NCT00968110|Omalizumab|omalizumab|mesh-list
82735513|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82735514|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82735515|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
82735516|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
82735517|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
82735518|NCT00608517|Fludarabine|fludarabine|mesh-list
82735519|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
82735520|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82735521|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82735522|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
82735523|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735524|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82735525|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82735526|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
82735527|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735528|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735529|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82735530|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82735531|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
82735532|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735533|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
82735534|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
82735535|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735536|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82735537|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
82735538|NCT00608517|Hormones|hormones|mesh-ancestor
82735539|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735540|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82735541|NCT00608517|Protective Agents|protective agents|mesh-ancestor
82735542|NCT00966706|Gemcitabine|gemcitabine|mesh-list
82735543|NCT00966706|Docetaxel|docetaxel|mesh-list
82735544|NCT00966706|Capecitabine|capecitabine|mesh-list
82735545|NCT00966706|Epirubicin|epirubicin|mesh-list
82735546|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735547|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82735548|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
82735549|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735550|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
82735551|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
82735552|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
82735553|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82735554|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82735555|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82735556|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735557|NCT00893061|Tamoxifen|tamoxifen|mesh-list
82735558|NCT00893061|Letrozole|letrozole|mesh-list
82735559|NCT00893061|Anastrozole|anastrozole|mesh-list
82735560|NCT00893061|Exemestane|exemestane|mesh-list
82735561|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735562|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735563|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82735564|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82735565|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735566|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82735567|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
82735568|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735569|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735570|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82735571|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82735572|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82735573|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82735574|NCT00974272|Exenatide|exenatide|mesh-list
82735575|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82735576|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735577|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82735578|NCT00974272|Incretins|incretins|mesh-ancestor
82735579|NCT00974272|Hormones|hormones|mesh-ancestor
82735580|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735581|NCT00974428|Wobenzym|wobenzym|mesh-list
82735582|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82735583|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
82735584|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735585|NCT00974584|Paclitaxel|paclitaxel|mesh-list
82735586|NCT00974584|Bevacizumab|bevacizumab|mesh-list
82735587|NCT00974584|Carboplatin|carboplatin|mesh-list
82735588|NCT00974584|Pemetrexed|pemetrexed|mesh-list
82735589|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82735590|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735591|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
82735592|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
82735593|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
82735594|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735595|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82735596|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82735597|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82735598|NCT00974584|Growth Substances|growth substances|mesh-ancestor
82735599|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735600|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
82735601|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735602|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82735603|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82735605|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735606|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
82735607|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735608|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82735609|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82735610|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
82735611|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735612|NCT00974740|Atorvastatin|atorvastatin|mesh-list
82735613|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82735614|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82735615|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
82735616|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735617|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82735618|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82735619|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735620|NCT00967096|Rifaximin|rifaximin|mesh-list
82735621|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82735622|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735623|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82735624|NCT05227300|Lidocaine|lidocaine|mesh-list
82735625|NCT05227300|Epinephrine|epinephrine|mesh-list
82735626|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
82735627|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
82735628|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82735629|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735630|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
82735631|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735632|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82735633|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82735634|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82735635|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82735785|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
82735636|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735637|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82735638|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82735639|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
82735640|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735641|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82735642|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82735643|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
82735644|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82735645|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
82735646|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
82735647|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
82735648|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82735649|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
82735650|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82735651|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
82735652|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735653|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
82735654|NCT00890487|Protective Agents|protective agents|mesh-ancestor
82735655|NCT00890565|Granisetron|granisetron|mesh-list
82735656|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
82735657|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
82735658|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735659|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735660|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82735661|NCT00890565|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82735662|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82735663|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
82735664|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735665|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735666|NCT00890643|Prazosin|prazosin|mesh-list
82735667|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82735668|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82735669|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82735670|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82735671|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
82735672|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735673|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735674|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735676|NCT00893217|Interferon-beta|interferon-beta|mesh-list
82735677|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
82735678|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735679|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
82735680|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735681|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
82735682|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735683|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82735684|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
82735685|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82735686|NCT00767598|Udenafil|udenafil|mesh-list
82735687|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
82735688|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
82735689|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82735690|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735691|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735692|NCT00767598|Urological Agents|urological agents|mesh-ancestor
82735693|NCT00670800|Metformin|metformin|mesh-list
82735694|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82735695|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735696|NCT00764166|Docetaxel|docetaxel|mesh-list
82735697|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82735698|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735699|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
82735700|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
82735701|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
82735702|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735703|NCT00764166|Hormones|hormones|mesh-ancestor
82735704|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735705|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735706|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
82735707|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82735708|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82735709|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82735710|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82735786|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82735711|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735712|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
82735713|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735714|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735715|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82735716|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735717|NCT02557542|Polidocanol|polidocanol|mesh-list
82735718|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
82735719|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
82735720|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82735721|NCT00767754|Paroxetine|paroxetine|mesh-list
82735722|NCT00767754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82735723|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82735724|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82735725|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735726|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735727|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
82735728|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735729|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82735730|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
82735731|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82735732|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82735733|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82735734|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735735|NCT00764244|Triamcinolone|triamcinolone|mesh-list
82735736|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82735737|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82735738|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82735739|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735740|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
82735741|NCT00764244|Hormones|hormones|mesh-ancestor
82735742|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735743|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735744|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82735745|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
82735746|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735747|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735748|NCT00770640|Insulin|insulin|mesh-list
82735749|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82735750|NCT00770640|Pioglitazone|pioglitazone|mesh-list
82735751|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82735752|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735753|NCT00770718|Thrombin|thrombin|mesh-list
82735754|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
82735755|NCT00770718|Coagulants|coagulants|mesh-ancestor
82735756|NCT00770796|Atorvastatin|atorvastatin|mesh-list
82735757|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82735758|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82735759|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
82735760|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735761|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82735762|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82735763|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735764|NCT00545740|Mesalamine|mesalamine|mesh-list
82735765|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82735766|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82735767|NCT00545740|Analgesics|analgesics|mesh-ancestor
82735768|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
82735769|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735770|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735771|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735772|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82735773|NCT05208190|Clozapine|clozapine|mesh-list
82735774|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82735775|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
82735776|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735777|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735778|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735779|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82735780|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82735781|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82735782|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82735783|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
82735784|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
82735787|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82735788|NCT00609609|Prednisolone|prednisolone|mesh-list
82735789|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
82735790|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82735791|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
82735792|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735793|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
82735794|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
82735795|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735796|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735797|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82735798|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
82735799|NCT00609609|Hormones|hormones|mesh-ancestor
82735800|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735801|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82735802|NCT00609609|Protective Agents|protective agents|mesh-ancestor
82735803|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82735804|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735805|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82735806|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82735807|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82735808|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82735809|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735810|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735811|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735812|NCT00673452|Analgesics|analgesics|mesh-ancestor
82735813|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
82735814|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735815|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
82735816|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82735817|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
82735818|NCT00967174|Nicotine|nicotine|mesh-list
82735819|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82735820|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
82735821|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735822|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735823|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82735824|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82735825|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
82735826|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735827|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735828|NCT00967252|Atorvastatin|atorvastatin|mesh-list
82735829|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82735830|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82735831|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
82735832|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735833|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82735834|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82735835|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735836|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
82735838|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82735839|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
82735840|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735841|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82735842|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82735843|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
82735844|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735845|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735846|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82735847|NCT00975052|Metformin|metformin|mesh-list
82735848|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82735849|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82735850|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735851|NCT00975052|Incretins|incretins|mesh-ancestor
82735852|NCT00975052|Hormones|hormones|mesh-ancestor
82735853|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735854|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82735855|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
82735856|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735857|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735858|NCT00891033|Bortezomib|bortezomib|mesh-list
82735859|NCT00891033|Panobinostat|panobinostat|mesh-list
82735860|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735937|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
82735861|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82735862|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735863|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735864|NCT00770952|Pioglitazone|pioglitazone|mesh-list
82735865|NCT00770952|Glimepiride|glimepiride|mesh-list
82735866|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82735867|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735868|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82735869|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82735870|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
82735872|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82735873|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735874|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
82735875|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82735876|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82735878|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
82735879|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82735880|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
82735881|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82735882|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
82735883|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
82735884|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82735885|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735886|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82735887|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
82735888|NCT00968578|Hormones|hormones|mesh-ancestor
82735889|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735890|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82735891|NCT00968578|Protective Agents|protective agents|mesh-ancestor
82735892|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82735893|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735894|NCT00893373|Sorafenib|sorafenib|mesh-list
82735895|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735896|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82735897|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735898|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735899|NCT00891267|Amlodipine|amlodipine|mesh-list
82735900|NCT00891267|Olmesartan|olmesartan|mesh-list
82735901|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82735902|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82735903|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82735904|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82735905|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735906|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82735907|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735908|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
82735909|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82735910|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82735911|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82735912|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82735913|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735914|NCT00545584|Incretins|incretins|mesh-ancestor
82735915|NCT00545584|Hormones|hormones|mesh-ancestor
82735916|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735917|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82735918|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
82735919|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735920|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735921|NCT00378703|Sirolimus|sirolimus|mesh-list
82735922|NCT00378703|Bevacizumab|bevacizumab|mesh-list
82735923|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82735924|NCT00378703|Sorafenib|sorafenib|mesh-list
82735925|NCT00378703|Temsirolimus|temsirolimus|mesh-list
82735926|NCT00378703|MTOR Inhibitors|mtor inhibitors|mesh-list
82735927|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
82735928|NCT00378703|Antibodies|antibodies|mesh-list
82735929|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
82735930|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82735931|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
82735932|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735933|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82735934|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82735935|NCT00378703|Growth Substances|growth substances|mesh-ancestor
82735936|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735938|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
82735939|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82735940|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735941|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735942|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82735943|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735944|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82735945|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
82735946|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82735948|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
82735949|NCT00893451|Vitamins|vitamins|mesh-ancestor
82735950|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
82735951|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735952|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82735953|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82735954|NCT00967408|Escitalopram|escitalopram|mesh-list
82735955|NCT00967408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82735956|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82735957|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82735958|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735959|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82735960|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
82735961|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735962|NCT00891423|Meropenem|meropenem|mesh-list
82735963|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82735964|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82735965|NCT04035382|Misoprostol|misoprostol|mesh-list
82735966|NCT04035382|Oxytocin|oxytocin|mesh-list
82735967|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
82735968|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82735969|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735970|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82735971|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
82735972|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82735973|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82735974|NCT02541045|Metadoxine|metadoxine|mesh-list
82735975|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82735976|NCT00891579|Pemetrexed|pemetrexed|mesh-list
82735977|NCT00891579|Gefitinib|gefitinib|mesh-list
82735978|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735979|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82735980|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82735981|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82735982|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82735983|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82735984|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
82735985|NCT00968734|Vitamin D|vitamin d|mesh-list
82735986|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82735987|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82735988|NCT00968734|Vitamins|vitamins|mesh-ancestor
82735989|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
82735990|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82735991|NCT03620643|Fulvestrant|fulvestrant|mesh-list
82735992|NCT03620643|Crizotinib|crizotinib|mesh-list
82735993|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82735994|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82735995|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82735996|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82735997|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
82735998|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82735999|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736000|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82736001|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736002|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736003|NCT04008316|Colchicine|colchicine|mesh-list
82736004|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
82736005|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82736006|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
82736007|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
82736008|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
82736009|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736010|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736011|NCT00893607|Methoxamine|methoxamine|mesh-list
82736012|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
82736013|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
82736014|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736015|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736016|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82736017|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82736018|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82736019|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82736020|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
82736021|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736022|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736023|NCT00969046|Epothilone B|epothilone b|mesh-list
82736024|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736025|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
82736026|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
82736027|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
82736028|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736029|NCT05008354|Pyridoxine|pyridoxine|mesh-list
82736030|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
82736031|NCT05008354|Vitamins|vitamins|mesh-ancestor
82736032|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
82736033|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736034|NCT00975754|Budesonide|budesonide|mesh-list
82736035|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82736036|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82736037|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
82736038|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736039|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736040|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82736041|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
82736042|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
82736043|NCT00975754|Hormones|hormones|mesh-ancestor
82736044|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736045|NCT01045681|Dexamethasone|dexamethasone|mesh-list
82736046|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
82736047|NCT01045681|Bortezomib|bortezomib|mesh-list
82736048|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82736049|NCT01045681|BB 1101|bb 1101|mesh-list
82736050|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82736051|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
82736052|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
82736053|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736054|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736055|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82736056|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
82736057|NCT01045681|Hormones|hormones|mesh-ancestor
82736058|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736059|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82736060|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736061|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
82736062|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736063|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736064|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82736065|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
82736066|NCT00975910|Lidocaine|lidocaine|mesh-list
82736067|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
82736068|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
82736069|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736070|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736071|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
82736072|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736073|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82736074|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82736075|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82736076|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82736077|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736078|NCT03617913|Cisplatin|cisplatin|mesh-list
82736079|NCT03617913|Fluorouracil|fluorouracil|mesh-list
82736080|NCT03617913|Mitomycins|mitomycins|mesh-list
82736081|NCT03617913|Mitomycin|mitomycin|mesh-list
82736082|NCT03617913|Avelumab|avelumab|mesh-list
82736083|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82736084|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736085|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
82736086|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736087|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82736239|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
82736088|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82736089|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
82736090|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736091|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82736092|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
82736093|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82736094|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736095|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82736097|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736098|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82736099|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736100|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736101|NCT00976066|Naltrexone|naltrexone|mesh-list
82736102|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82736103|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82736104|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736105|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
82736106|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736107|NCT03557619|Venetoclax|venetoclax|mesh-list
82736108|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
82736109|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82736110|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82736111|NCT03557619|Estradiol|estradiol|mesh-list
82736112|NCT03557619|Estrogens|estrogens|mesh-ancestor
82736113|NCT03557619|Hormones|hormones|mesh-ancestor
82736114|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736115|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736116|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82736117|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
82736118|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82736119|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82736120|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736121|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82736122|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82736123|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82736124|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82736125|NCT00969592|Insulin|insulin|mesh-list
82736126|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82736127|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
82736128|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
82736129|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82736130|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
82736131|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82736132|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736133|NCT00368641|Icodextrin|icodextrin|mesh-list
82736134|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
82736135|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82736136|NCT00976222|Ranibizumab|ranibizumab|mesh-list
82736137|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82736138|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82736139|NCT00976222|Growth Substances|growth substances|mesh-ancestor
82736140|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736141|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
82736142|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736143|NCT00976300|Cyclosporine|cyclosporine|mesh-list
82736144|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
82736145|NCT00976300|Cyclosporins|cyclosporins|mesh-list
82736146|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82736147|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
82736148|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736149|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82736150|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82736151|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
82736152|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736153|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736154|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82736155|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736156|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
82736157|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736158|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
82736159|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82736160|NCT00979966|Sirolimus|sirolimus|mesh-list
82736161|NCT00979966|Sunitinib|sunitinib|mesh-list
82736162|NCT00979966|Temsirolimus|temsirolimus|mesh-list
82736163|NCT00979966|MTOR Inhibitors|mtor inhibitors|mesh-list
82736164|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736165|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82736166|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82736167|NCT00979966|Growth Substances|growth substances|mesh-ancestor
82736168|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736169|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
82736170|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82736171|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736172|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736173|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82736174|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
82736175|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82736176|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736177|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82736178|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
82736179|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
82736180|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82736181|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
82736182|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736183|NCT00969904|Expectorants|expectorants|mesh-ancestor
82736184|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
82736185|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82736186|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
82736187|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736188|NCT00969904|Protective Agents|protective agents|mesh-ancestor
82736189|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736190|NCT00969904|Antidotes|antidotes|mesh-ancestor
82736191|NCT00976690|Mesalamine|mesalamine|mesh-list
82736192|NCT00976690|Azathioprine|azathioprine|mesh-list
82736193|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
82736194|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736195|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82736196|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736197|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82736198|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
82736199|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736200|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82736201|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82736202|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82736203|NCT00976690|Analgesics|analgesics|mesh-ancestor
82736204|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
82736205|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736206|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82736207|NCT00976768|Fluorouracil|fluorouracil|mesh-list
82736208|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
82736209|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
82736210|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736211|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82736212|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736213|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82736214|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
82736215|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736216|NCT00608985|Zolpidem|zolpidem|mesh-list
82736217|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82736218|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82736219|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736220|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736221|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82736222|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
82736223|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
82736224|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736225|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736226|NCT00969982|Misoprostol|misoprostol|mesh-list
82736227|NCT00969982|Mifepristone|mifepristone|mesh-list
82736228|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82736229|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
82736230|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82736231|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736232|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82736233|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82736234|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
82736235|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82736236|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82736237|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82736238|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82736240|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82736241|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82736242|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
82736243|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736244|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
82736245|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82736246|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82736247|NCT00970138|Apatinib|apatinib|mesh-list
82736248|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736249|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82736250|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736251|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736252|NCT00892125|Carbamazepine|carbamazepine|mesh-list
82736253|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82736254|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82736255|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82736256|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736257|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736258|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82736259|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82736260|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82736261|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
82736262|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736263|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736264|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82736265|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82736266|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
82736267|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
82736268|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
82736269|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82736270|NCT00892125|Analgesics|analgesics|mesh-ancestor
82736271|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
82736272|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736273|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82736274|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82736275|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82736276|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82736277|NCT00980356|Vildagliptin|vildagliptin|mesh-list
82736278|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82736279|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736280|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82736281|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
82736282|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736283|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736284|NCT00368251|Brivaracetam|brivaracetam|mesh-list
82736285|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
82736286|NCT00893841|Pramipexole|pramipexole|mesh-list
82736287|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82736288|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
82736289|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82736290|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82736291|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82736292|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736293|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736294|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
82736295|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736296|NCT00893841|Protective Agents|protective agents|mesh-ancestor
82736297|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82736298|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82736299|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
82736300|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
82736301|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736302|NCT00378079|Methadone|methadone|mesh-list
82736303|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82736304|NCT00378079|Narcotics|narcotics|mesh-ancestor
82736305|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736306|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736307|NCT00378079|Analgesics|analgesics|mesh-ancestor
82736308|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
82736309|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736310|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
82736311|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
82736312|NCT00970450|Acetaminophen|acetaminophen|mesh-list
82736313|NCT00970450|Tropisetron|tropisetron|mesh-list
82736314|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82736315|NCT00970450|Analgesics|analgesics|mesh-ancestor
82736316|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
82736317|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736318|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736319|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
82736320|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
82736321|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
82736322|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82736323|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82736324|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82736325|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
82736326|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736327|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736328|NCT00970528|Acarbose|acarbose|mesh-list
82736329|NCT00970528|Voglibose|voglibose|mesh-list
82736330|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82736331|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736332|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736333|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82736334|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736335|NCT00970762|Rocuronium|rocuronium|mesh-list
82736336|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
82736337|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82736338|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82736339|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82736340|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736341|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736342|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82736343|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82736344|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
82736345|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736346|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736347|NCT00978172|Artesunate|artesunate|mesh-list
82736348|NCT00978172|Mefloquine|mefloquine|mesh-list
82736349|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
82736350|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82736351|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82736352|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736353|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736354|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
82736355|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
82736356|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82736357|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
82736358|NCT03923530|Eplerenone|eplerenone|mesh-list
82736359|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82736360|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
82736361|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736362|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736363|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82736364|NCT03923530|Diuretics|diuretics|mesh-ancestor
82736365|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
82736366|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82736367|NCT00608907|Rifampin|rifampin|mesh-list
82736368|NCT00608907|Dexamethasone|dexamethasone|mesh-list
82736369|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
82736370|NCT00608907|Bortezomib|bortezomib|mesh-list
82736371|NCT00608907|BB 1101|bb 1101|mesh-list
82736372|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82736373|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
82736374|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
82736375|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736376|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736377|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82736378|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
82736379|NCT00608907|Hormones|hormones|mesh-ancestor
82736380|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736381|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82736382|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736383|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
82736384|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736385|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736386|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82736387|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
82736388|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82736389|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736390|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
82736391|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82736392|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82736393|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82736394|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82736395|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82736396|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82736397|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82736398|NCT00970996|Interferons|interferons|mesh-list
82736399|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
82736400|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
82736401|NCT00970996|Paclitaxel|paclitaxel|mesh-list
82736402|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82736403|NCT00970996|Cisplatin|cisplatin|mesh-list
82736404|NCT00970996|Temozolomide|temozolomide|mesh-list
82736405|NCT00970996|Interleukin-2|interleukin-2|mesh-list
82736406|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82736407|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736408|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
82736409|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
82736410|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
82736411|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736412|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
82736413|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736414|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82736415|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
82736416|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
82736417|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736418|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82736419|NCT00970996|Analgesics|analgesics|mesh-ancestor
82736420|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
82736421|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736422|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
82736423|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82736424|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736425|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
82736426|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736427|NCT00869193|Protective Agents|protective agents|mesh-ancestor
82736428|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736429|NCT04009018|Anesthetics|anesthetics|mesh-list
82736430|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736431|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736432|NCT00869271|Leucovorin|leucovorin|mesh-list
82736433|NCT00869271|Fluorouracil|fluorouracil|mesh-list
82736434|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
82736435|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
82736436|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736437|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82736438|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736439|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82736440|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
82736441|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736442|NCT00869271|Antidotes|antidotes|mesh-ancestor
82736443|NCT00869271|Protective Agents|protective agents|mesh-ancestor
82736444|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
82736445|NCT00869271|Vitamins|vitamins|mesh-ancestor
82736446|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
82736448|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
82736449|NCT00971074|Protective Agents|protective agents|mesh-ancestor
82736450|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736451|NCT00971152|Menotropins|menotropins|mesh-list
82736452|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82736453|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
82736454|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82736455|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736456|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
82736457|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82736458|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736459|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82736460|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
82736461|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82736462|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736463|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736464|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736465|NCT00978328|Oxycodone|oxycodone|mesh-list
82736466|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82736467|NCT00978328|Narcotics|narcotics|mesh-ancestor
82736468|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736469|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736470|NCT00978328|Analgesics|analgesics|mesh-ancestor
82736471|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
82736472|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736473|NCT00892359|Anidulafungin|anidulafungin|mesh-list
82736474|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
82736475|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736476|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82736477|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82736478|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82736479|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736480|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736481|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82736482|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82736483|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82736484|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
82736485|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736486|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736487|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82736488|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82736489|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
82736490|NCT03992911|Carboplatin|carboplatin|mesh-list
82736491|NCT03992911|Etoposide|etoposide|mesh-list
82736492|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
82736493|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736494|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82736495|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82736496|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82736497|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736498|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736499|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
82736500|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82736501|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
82736502|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736503|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736504|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82736505|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
82736506|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82736507|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82736508|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82736509|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
82736510|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736511|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736512|NCT00377455|Bosentan|bosentan|mesh-list
82736513|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82736514|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82736515|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736516|NCT00895557|Varenicline|varenicline|mesh-list
82736517|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82736518|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82736519|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
82736520|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736521|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736522|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736523|NCT00869973|Dexamethasone|dexamethasone|mesh-list
82736524|NCT00869973|Aprepitant|aprepitant|mesh-list
82736525|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82736526|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
82736527|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
82736528|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736529|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736530|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82736531|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
82736532|NCT00869973|Hormones|hormones|mesh-ancestor
82736533|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736534|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82736535|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736536|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82736537|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736538|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736539|NCT04008784|Triamcinolone|triamcinolone|mesh-list
82736540|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82736541|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82736542|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82736543|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82736544|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
82736545|NCT04008784|Hormones|hormones|mesh-ancestor
82736546|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736547|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736548|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82736549|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
82736550|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736551|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736552|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
82736553|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82736554|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82736555|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82736556|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82736557|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736558|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
82736559|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736560|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736561|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82736562|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736563|NCT00978718|Selenium|selenium|mesh-list
82736564|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
82736565|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736566|NCT00978718|Protective Agents|protective agents|mesh-ancestor
82736567|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736568|NCT00978718|Trace Elements|trace elements|mesh-ancestor
82736569|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
82736570|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
82736571|NCT00895713|Antibodies|antibodies|mesh-list
82736572|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
82736573|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82736574|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82736575|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
82736576|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736577|NCT01051765|Irinotecan|irinotecan|mesh-list
82736578|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736579|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82736580|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82736581|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736582|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736583|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82736584|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82736585|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736586|NCT00978796|Incretins|incretins|mesh-ancestor
82736587|NCT00978796|Hormones|hormones|mesh-ancestor
82736588|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736589|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82736590|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
82736591|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736592|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736593|NCT00894231|Levocetirizine|levocetirizine|mesh-list
82736594|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82736595|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82736596|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
82736597|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
82736598|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736599|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736600|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736601|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
82736602|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
82736603|NCT03472365|Capecitabine|capecitabine|mesh-list
82736604|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
82736605|NCT03472365|Apatinib|apatinib|mesh-list
82736606|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82736607|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
82736608|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736609|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736610|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82736611|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736612|NCT00894621|Norepinephrine|norepinephrine|mesh-list
82736613|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82736614|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82736615|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
82736616|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736617|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736618|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736619|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
82736620|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
82736621|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736622|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82736623|NCT00376675|Methylphenidate|methylphenidate|mesh-list
82736624|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82736625|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736626|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82736627|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82736628|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82736629|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736630|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
82736631|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736632|NCT00979186|Hemostatics|hemostatics|mesh-list
82736633|NCT00979186|Coagulants|coagulants|mesh-ancestor
82736634|NCT05178628|Paclitaxel|paclitaxel|mesh-list
82736635|NCT05178628|Gemcitabine|gemcitabine|mesh-list
82736636|NCT05178628|Tinzaparin|tinzaparin|mesh-list
82736637|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82736638|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736639|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
82736640|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
82736641|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
82736642|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736643|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82736644|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
82736645|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
82736646|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82736647|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82736648|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82736649|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82736650|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82736651|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82736652|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
82736653|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82736654|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736655|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82736656|NCT00896571|Estrogens|estrogens|mesh-ancestor
82736657|NCT00896571|Hormones|hormones|mesh-ancestor
82736658|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736659|NCT00896727|Antibodies|antibodies|mesh-list
82736660|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
82736661|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736662|NCT00981838|Rituximab|rituximab|mesh-list
82736663|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82736664|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736665|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
82736666|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736667|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82736668|NCT02533765|Olaparib|olaparib|mesh-list
82736669|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82736670|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736671|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736672|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736673|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82736674|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736675|NCT00367237|Infliximab|infliximab|mesh-list
82736676|NCT00367237|Methotrexate|methotrexate|mesh-list
82736677|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82736678|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
82736679|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82736680|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736681|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82736682|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
82736683|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736684|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736685|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
82736686|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736687|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82736688|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82736689|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
82736690|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82736691|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82736692|NCT00367237|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82736693|NCT00367237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82736694|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82736695|NCT00901407|Lamotrigine|lamotrigine|mesh-list
82736696|NCT00901407|Paroxetine|paroxetine|mesh-list
82736697|NCT00901407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82736698|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82736699|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82736700|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736701|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736702|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
82736703|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736704|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82736705|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
82736706|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82736707|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82736708|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82736709|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736710|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
82736711|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82736712|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82736713|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82736714|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82736715|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736716|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82736717|NCT00984724|Nicotine|nicotine|mesh-list
82736718|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82736719|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
82736720|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736721|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736722|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82736723|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82736724|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
82736725|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736726|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736728|NCT00901719|Acetylcholine|acetylcholine|mesh-list
82736729|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82736730|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
82736731|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82736732|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736733|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82736734|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
82736735|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736736|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736737|NCT00972712|Bortezomib|bortezomib|mesh-list
82736738|NCT00972712|Tipifarnib|tipifarnib|mesh-list
82736739|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736740|NCT02539641|Hormones|hormones|mesh-list
82736741|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736742|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736743|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82736744|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82736745|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82736746|NCT00544882|Desogestrel|desogestrel|mesh-list
82736748|NCT00544882|Estradiol|estradiol|mesh-list
82736749|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82736750|NCT00544882|Estrogens|estrogens|mesh-ancestor
82736751|NCT00544882|Hormones|hormones|mesh-ancestor
82736752|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736753|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736754|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82736755|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
82736756|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82736757|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82736758|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82736759|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82736760|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82736761|NCT00544882|Progestins|progestins|mesh-ancestor
82736762|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82736763|NCT04035603|Cycloserine|cycloserine|mesh-list
82736764|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82736765|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736766|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82736767|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
82736768|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82736769|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
82736770|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736771|NCT00606801|Galantamine|galantamine|mesh-list
82736772|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82736773|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736774|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736775|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
82736776|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736777|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736778|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82736779|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
82736780|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736781|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
82736782|NCT00972790|Bupivacaine|bupivacaine|mesh-list
82736783|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
82736784|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
82736785|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736786|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736787|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
82736788|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736789|NCT00901875|Buprenorphine|buprenorphine|mesh-list
82736790|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82736791|NCT00901875|Naloxone|naloxone|mesh-list
82736792|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82736793|NCT00901875|Narcotics|narcotics|mesh-ancestor
82736794|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736795|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736796|NCT00901875|Analgesics|analgesics|mesh-ancestor
82736797|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
82736798|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736799|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82736800|NCT00972946|Dextrans|dextrans|mesh-list
82736801|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
82736802|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
82736804|NCT00606177|Aripiprazole|aripiprazole|mesh-list
82736805|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
82736806|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82736807|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82736808|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82736809|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736810|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736811|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
82736812|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
82736813|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736814|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736815|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82736816|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82736817|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
82736818|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82736819|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82736820|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82736821|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82736822|NCT00985270|Rifampin|rifampin|mesh-list
82736823|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82736824|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
82736825|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82736826|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736827|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
82736828|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82736829|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736830|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736831|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82736832|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82736833|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82736834|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82736835|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82736836|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82736837|NCT00359281|Niacin|niacin|mesh-list
82736838|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
82736839|NCT00359281|Atorvastatin|atorvastatin|mesh-list
82736840|NCT00359281|Simvastatin|simvastatin|mesh-list
82736841|NCT00359281|Ezetimibe|ezetimibe|mesh-list
82736842|NCT00359281|Fenofibrate|fenofibrate|mesh-list
82736843|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82736844|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82736845|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
82736846|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736847|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82736848|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82736849|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736850|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
82736851|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
82736852|NCT00359281|Vitamins|vitamins|mesh-ancestor
82736853|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
82736854|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736855|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
82736856|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
82736857|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82736858|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82736859|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736860|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
82736861|NCT00902031|Sennosides|sennosides|mesh-list
82736862|NCT00902031|Senna Extract|senna extract|mesh-list
82736863|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
82736864|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82736865|NCT00902031|Laxatives|laxatives|mesh-ancestor
82736866|NCT00902031|Cathartics|cathartics|mesh-ancestor
82736867|NCT00985348|Levetiracetam|levetiracetam|mesh-list
82736868|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
82736869|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
82736870|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
82736871|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82736872|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736873|NCT03990961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82736874|NCT03990961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736875|NCT00973336|Vitamin D|vitamin d|mesh-list
82736876|NCT00973336|Calcium|calcium|mesh-list
82736877|NCT00973336|Vitamins|vitamins|mesh-ancestor
82736878|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
82736879|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736880|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82736881|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82736882|NCT00902187|Fesoterodine|fesoterodine|mesh-list
82736883|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82736884|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82736885|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
82736886|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736887|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736888|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736889|NCT00902187|Urological Agents|urological agents|mesh-ancestor
82736891|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82736892|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
82736893|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736894|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82736895|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
82736896|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
82736897|NCT01052311|Vitamins|vitamins|mesh-ancestor
82736898|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
82736899|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736900|NCT00988078|Metformin|metformin|mesh-list
82736901|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82736902|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736903|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
82736904|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
82736905|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82736906|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82736907|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736908|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82736909|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82736910|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736911|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736912|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736913|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82736914|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
82736915|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82736916|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736917|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82736918|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82736919|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82736920|NCT00982540|Caspofungin|caspofungin|mesh-list
82736921|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
82736922|NCT00982540|Clotrimazole|clotrimazole|mesh-list
82736923|NCT00982540|Miconazole|miconazole|mesh-list
82736924|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82736925|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736926|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736927|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82736928|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82736929|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82736930|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82736931|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
82736932|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736933|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736934|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82736935|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82736936|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82736937|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82736938|NCT00366535|Neurotropin|neurotropin|mesh-list
82736939|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82736940|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
82736941|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736942|NCT00366535|Analgesics|analgesics|mesh-ancestor
82736943|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
82736944|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736945|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
82736946|NCT00982618|Lidocaine|lidocaine|mesh-list
82736947|NCT00982618|Morphine|morphine|mesh-list
82736948|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
82736949|NCT00982618|Anesthetics|anesthetics|mesh-list
82736950|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82736951|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736952|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
82736953|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736954|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82736955|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82736956|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82736957|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82736958|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736959|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82736961|NCT00982618|Analgesics|analgesics|mesh-ancestor
82736962|NCT00895167|Curcumin|curcumin|mesh-list
82736963|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82736964|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82736965|NCT00895167|Analgesics|analgesics|mesh-ancestor
82736966|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
82736967|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82736968|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736969|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82736970|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82736971|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82736972|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82736973|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736974|NCT00902421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
82736975|NCT00902421|Serotonin|serotonin|mesh-list
82736976|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
82736977|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82736978|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82736979|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736980|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82736981|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
82736982|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736983|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82736984|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82736985|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
82736986|NCT00985660|Nisoldipine|nisoldipine|mesh-list
82736987|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82736988|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82736989|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82736990|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82736991|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82736992|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82736993|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
82736994|NCT00350545|Cyclosporine|cyclosporine|mesh-list
82736996|NCT00350545|Rituximab|rituximab|mesh-list
82736997|NCT00350545|Tacrolimus|tacrolimus|mesh-list
82736998|NCT00350545|Cyclosporins|cyclosporins|mesh-list
82736999|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82737000|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737001|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
82737002|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737003|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82737004|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82737005|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
82737006|NCT00350545|Hormones|hormones|mesh-ancestor
82737007|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737008|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82737009|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82737010|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82737011|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737012|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737013|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
82737014|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737015|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
82737016|NCT04006054|Midazolam|midazolam|mesh-list
82737017|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
82737018|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82737019|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737020|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737021|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82737022|NCT04006054|Analgesics|analgesics|mesh-ancestor
82737023|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
82737024|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737025|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82737026|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82737027|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82737028|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
82737029|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737030|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737031|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82737032|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82737033|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82737034|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82737035|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82737036|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
82737037|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
82737038|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
82737039|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
82737040|NCT00897975|Red yeast rice|red yeast rice|mesh-list
82737041|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82737042|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82737043|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82737044|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
82737045|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737046|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737047|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82737048|NCT01052389|Haloperidol|haloperidol|mesh-list
82737049|NCT01052389|Olanzapine|olanzapine|mesh-list
82737050|NCT01052389|Aripiprazole|aripiprazole|mesh-list
82737051|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
82737052|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
82737053|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
82737054|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737055|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737056|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82737057|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82737058|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82737059|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737060|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82737061|NCT01052389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82737062|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82737063|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82737064|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737065|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737066|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
82737067|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
82737068|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
82737069|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
82737070|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82737071|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82737072|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82737073|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82737074|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82737075|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82737076|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82737077|NCT00895323|Antibodies|antibodies|mesh-list
82737078|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82737079|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82737080|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
82737081|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737082|NCT00349921|Adenosine|adenosine|mesh-list
82737083|NCT00349921|Clonidine|clonidine|mesh-list
82737084|NCT00349921|Analgesics|analgesics|mesh-ancestor
82737085|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
82737086|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737087|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737088|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82737089|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
82737090|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
82737091|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82737092|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82737093|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82737094|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
82737095|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737096|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737097|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82737098|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
82737099|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82737100|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
82737101|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
82737102|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82737104|NCT00902655|Coagulants|coagulants|mesh-ancestor
82737105|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82737106|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
82737107|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737108|NCT01052623|Clonidine|clonidine|mesh-list
82737109|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82737110|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82737111|NCT01052623|Estradiol|estradiol|mesh-list
82737112|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82737113|NCT01052623|Hormones|hormones|mesh-ancestor
82737114|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737115|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737116|NCT01052623|Estrogens|estrogens|mesh-ancestor
82737117|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82737118|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
82737119|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82737120|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82737121|NCT01052623|Analgesics|analgesics|mesh-ancestor
82737122|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
82737123|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737124|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82737125|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
82737126|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
82737127|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82737128|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82737129|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82737130|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
82737131|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737132|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737133|NCT00902811|Artesunate|artesunate|mesh-list
82737134|NCT00902811|Amodiaquine|amodiaquine|mesh-list
82737135|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
82737136|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82737137|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82737138|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737139|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737140|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
82737141|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
82737142|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82737143|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
82737144|NCT00898287|Gemcitabine|gemcitabine|mesh-list
82737145|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82737146|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
82737147|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737148|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737149|NCT04034823|Docetaxel|docetaxel|mesh-list
82737150|NCT04034823|Trastuzumab|trastuzumab|mesh-list
82737151|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737152|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
82737153|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
82737154|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
82737155|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737156|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82737157|NCT00606021|Pemetrexed|pemetrexed|mesh-list
82737158|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737159|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737160|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737161|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82737162|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82737163|NCT00337675|Montelukast|montelukast|mesh-list
82737164|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82737165|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
82737166|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82737167|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
82737168|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737169|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737170|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82737171|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82737172|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737173|NCT00902967|Atorvastatin|atorvastatin|mesh-list
82737174|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82737175|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82737176|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
82737177|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737178|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82737179|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82737180|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737181|NCT00903045|Propiverine|propiverine|mesh-list
82737182|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
82737183|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
82737184|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737185|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737186|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82737187|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82737188|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
82737189|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737190|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737191|NCT00903045|Urological Agents|urological agents|mesh-ancestor
82737192|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82737193|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82737194|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737195|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82737196|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82737197|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82737198|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737199|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
82737200|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737201|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
82737202|NCT04035525|Ubiquinone|ubiquinone|mesh-list
82737203|NCT04035525|Vitamins|vitamins|mesh-ancestor
82737204|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
82737205|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737206|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
82737207|NCT00905853|Amiodarone|amiodarone|mesh-list
82737208|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
82737209|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82737210|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82737211|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737212|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82737213|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82737214|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82737215|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737216|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82737217|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82737218|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82737220|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82737221|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
82737222|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737223|NCT00905931|Protective Agents|protective agents|mesh-ancestor
82737224|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737225|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82737226|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82737227|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737228|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
82737229|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82737230|NCT04035135|Antibodies|antibodies|mesh-list
82737231|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
82737232|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82737233|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
82737234|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737235|NCT00903279|Retapamulin|retapamulin|mesh-list
82737236|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82737237|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737238|NCT02539017|Immunomodulating Agents|immunomodulating agents|mesh-list
82737239|NCT02539017|Immunologic Factors|immunologic factors|mesh-ancestor
82737240|NCT02539017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737241|NCT00605865|Sertraline|sertraline|mesh-list
82737242|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
82737243|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82737244|NCT00605865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82737245|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82737246|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82737247|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737248|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737249|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
82737250|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737251|NCT00922467|Esmolol|esmolol|mesh-list
82737252|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82737253|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82737254|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82737255|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
82737256|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737257|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737258|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737259|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
82737260|NCT00903747|Prucalopride|prucalopride|mesh-list
82737261|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82737262|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737263|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82737264|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82737265|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737266|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737267|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737268|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737269|NCT00903747|Laxatives|laxatives|mesh-ancestor
82737270|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82737271|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82737272|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82737273|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
82737274|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737275|NCT02538627|Trametinib|trametinib|mesh-list
82737276|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737277|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82737278|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737279|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737280|NCT00903825|Lidocaine|lidocaine|mesh-list
82737281|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
82737282|NCT00903825|Anesthetics|anesthetics|mesh-list
82737283|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737284|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737285|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
82737286|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737287|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82737288|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82737289|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82737290|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82737291|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737292|NCT00904059|Asunaprevir|asunaprevir|mesh-list
82737293|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
82737294|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737295|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737296|NCT00337207|Bevacizumab|bevacizumab|mesh-list
82737297|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82737298|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737299|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82737300|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82737301|NCT00337207|Growth Substances|growth substances|mesh-ancestor
82737302|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737303|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
82737304|NCT01055743|Fluorouracil|fluorouracil|mesh-list
82737305|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
82737306|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737307|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82737308|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737309|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82737310|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
82737311|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737312|NCT00604695|Tenecteplase|tenecteplase|mesh-list
82737313|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82737314|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82737315|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737316|NCT01055821|Interferons|interferons|mesh-list
82737318|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737319|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
82737320|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737321|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
82737322|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737323|NCT00904293|Warfarin|warfarin|mesh-list
82737324|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
82737325|NCT00904449|Oxymorphone|oxymorphone|mesh-list
82737326|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82737327|NCT00904449|Narcotics|narcotics|mesh-ancestor
82737328|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737329|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737330|NCT00904449|Analgesics|analgesics|mesh-ancestor
82737331|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
82737332|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737333|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82737334|NCT00348595|Lenalidomide|lenalidomide|mesh-list
82737335|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
82737336|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737337|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82737338|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82737339|NCT00348595|Growth Substances|growth substances|mesh-ancestor
82737340|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
82737341|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737342|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
82737343|NCT02538939|Antidotes|antidotes|mesh-ancestor
82737344|NCT02538939|Protective Agents|protective agents|mesh-ancestor
82737345|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737346|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
82737347|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737348|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
82737349|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82737350|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737351|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
82737352|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
82737353|NCT00904605|Celecoxib|celecoxib|mesh-list
82737354|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82737355|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82737356|NCT00904605|Analgesics|analgesics|mesh-ancestor
82737357|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
82737358|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737359|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737360|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82737361|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82737362|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82737363|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82737364|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737365|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737366|NCT00905073|Cyclosporine|cyclosporine|mesh-list
82737367|NCT00905073|Methotrexate|methotrexate|mesh-list
82737368|NCT00905073|Cyclosporins|cyclosporins|mesh-list
82737369|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82737370|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
82737371|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82737372|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737373|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82737374|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
82737375|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737376|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737377|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
82737378|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737379|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82737380|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82737381|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
82737382|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82737383|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82737384|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
82737385|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737386|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82737387|NCT00905229|Vitamins|vitamins|mesh-list
82737388|NCT00905229|Vitamin K|vitamin k|mesh-list
82737389|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
82737390|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
82737391|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737392|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82737393|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82737394|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737395|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
82737396|NCT00905229|Coagulants|coagulants|mesh-ancestor
82737397|NCT00905541|Simvastatin|simvastatin|mesh-list
82737398|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82737399|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82737400|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
82737401|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737402|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82737403|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82737404|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737405|NCT00348283|Adalimumab|adalimumab|mesh-list
82737406|NCT00348283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82737407|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82737408|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82737409|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
82737410|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82737411|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737412|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82737413|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
82737414|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82737415|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737416|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737417|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737418|NCT00336583|Cytarabine|cytarabine|mesh-list
82737419|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
82737420|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
82737421|NCT00336583|Etoposide|etoposide|mesh-list
82737422|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737423|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82737424|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82737425|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82737426|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737427|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737428|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82737429|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
82737430|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
82737431|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737432|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82737433|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
82737434|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737435|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82737436|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
82737437|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
82737438|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737439|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82737440|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
82737441|NCT00336583|Hormones|hormones|mesh-ancestor
82737442|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737443|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82737444|NCT00336583|Protective Agents|protective agents|mesh-ancestor
82737445|NCT00336505|Clarithromycin|clarithromycin|mesh-list
82737446|NCT00336505|Cethromycin|cethromycin|mesh-list
82737447|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82737448|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737449|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82737450|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737451|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737452|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82737453|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82737454|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
82737455|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82737456|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82737457|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737458|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
82737459|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
82737460|NCT03987529|Propofol|propofol|mesh-list
82737461|NCT03987529|Sevoflurane|sevoflurane|mesh-list
82737462|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82737463|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737464|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737465|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82737466|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
82737467|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
82737468|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82737469|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82737470|NCT00335959|Capecitabine|capecitabine|mesh-list
82737471|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
82737472|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82737473|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
82737474|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737475|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737476|NCT01053169|Thrombin|thrombin|mesh-list
82737477|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
82737478|NCT01053169|Coagulants|coagulants|mesh-ancestor
82737479|NCT01059331|Pregabalin|pregabalin|mesh-list
82737480|NCT01059331|Analgesics|analgesics|mesh-ancestor
82737481|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
82737482|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737483|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737484|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
82737485|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82737486|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82737487|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737488|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82737489|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82737490|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82737491|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737492|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82737493|NCT01059955|Dexamethasone|dexamethasone|mesh-list
82737494|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
82737495|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82737496|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82737497|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82737498|NCT01059955|BB 1101|bb 1101|mesh-list
82737499|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82737500|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
82737501|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
82737502|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737503|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737504|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82737505|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
82737506|NCT01059955|Hormones|hormones|mesh-ancestor
82737507|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737508|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82737509|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737510|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
82737511|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737512|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737513|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
82737514|NCT01060189|Urinastatin|urinastatin|mesh-list
82737515|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82737516|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82737517|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737518|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
82737519|NCT01060189|Coagulants|coagulants|mesh-ancestor
82737520|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82737521|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82737522|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
82737523|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737524|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82737525|NCT01060267|Erythromycin|erythromycin|mesh-list
82737526|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
82737527|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82737528|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
82737529|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737530|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82737531|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82737532|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737533|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737534|NCT01060423|Irinotecan|irinotecan|mesh-list
82737535|NCT01060423|Cetuximab|cetuximab|mesh-list
82737536|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82737537|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82737538|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737539|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737540|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737541|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82737542|NCT01060501|Leucovorin|leucovorin|mesh-list
82737543|NCT01060501|Folic Acid|folic acid|mesh-list
82737544|NCT01060501|Interferons|interferons|mesh-list
82737545|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
82737546|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
82737547|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737548|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
82737549|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737550|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
82737551|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737552|NCT01060501|Antidotes|antidotes|mesh-ancestor
82737553|NCT01060501|Protective Agents|protective agents|mesh-ancestor
82737554|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
82737555|NCT01060501|Vitamins|vitamins|mesh-ancestor
82737556|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
82737557|NCT01060501|Hematinics|hematinics|mesh-ancestor
82737558|NCT00671658|Cytarabine|cytarabine|mesh-list
82737559|NCT00671658|Dexamethasone|dexamethasone|mesh-list
82737560|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
82737561|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82737562|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82737564|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
82737565|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
82737566|NCT00671658|Rituximab|rituximab|mesh-list
82737567|NCT00671658|Doxorubicin|doxorubicin|mesh-list
82737568|NCT00671658|Methotrexate|methotrexate|mesh-list
82737569|NCT00671658|Vincristine|vincristine|mesh-list
82737570|NCT00671658|Asparaginase|asparaginase|mesh-list
82737571|NCT00671658|Pegaspargase|pegaspargase|mesh-list
82737572|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82737573|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
82737574|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82737575|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
82737576|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737577|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82737578|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82737579|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
82737580|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737581|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737582|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82737583|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82737584|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82737585|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
82737586|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
82737587|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737588|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82737589|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
82737590|NCT00671658|Hormones|hormones|mesh-ancestor
82737591|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737592|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82737593|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82737594|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82737595|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82737596|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737597|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82737598|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
82737599|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82737600|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82737601|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
82737602|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
82737603|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82737604|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82737605|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
82737606|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737607|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82737608|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
82737609|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
82737610|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
82737611|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82737612|NCT00671658|Protective Agents|protective agents|mesh-ancestor
82737613|NCT00764712|Insulin|insulin|mesh-list
82737614|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82737615|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737616|NCT00768456|Ropivacaine|ropivacaine|mesh-list
82737617|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
82737618|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
82737619|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737620|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737621|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
82737622|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737623|NCT00768612|Risperidone|risperidone|mesh-list
82737624|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82737625|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
82737626|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737627|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737628|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737629|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82737631|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737632|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82737633|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82737634|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
82737635|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
82737636|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737637|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737638|NCT04048200|Fentanyl|fentanyl|mesh-list
82737639|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
82737640|NCT04048200|Ketamine|ketamine|mesh-list
82737641|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
82737642|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82737643|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737644|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737645|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82737646|NCT04048200|Analgesics|analgesics|mesh-ancestor
82737647|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
82737648|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737649|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82737650|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82737651|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82737652|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
82737653|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737654|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737655|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82737656|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82737657|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
82737658|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
82737659|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82737660|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82737661|NCT04048200|Narcotics|narcotics|mesh-ancestor
82737662|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82737663|NCT04034589|Fulvestrant|fulvestrant|mesh-list
82737664|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82737665|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737666|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82737667|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82737668|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
82737669|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737670|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737671|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
82737672|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
82737673|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737674|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
82737676|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
82737677|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737678|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737679|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82737680|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
82737681|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
82737682|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82737683|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82737684|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
82737685|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737686|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737687|NCT00768690|Ketoconazole|ketoconazole|mesh-list
82737688|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
82737689|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737690|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82737691|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82737692|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737693|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737694|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82737695|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
82737696|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737697|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737698|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82737699|NCT00768768|Terbinafine|terbinafine|mesh-list
82737700|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
82737701|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737702|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737703|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737705|NCT00775086|Norelgestromin|norelgestromin|mesh-list
82737706|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
82737707|NCT00775086|Estradiol|estradiol|mesh-list
82737708|NCT00775086|Estrogens|estrogens|mesh-ancestor
82737709|NCT00775086|Hormones|hormones|mesh-ancestor
82737710|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737711|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737712|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82737713|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82737714|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82737715|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82737716|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82737717|NCT02557854|Doxorubicin|doxorubicin|mesh-list
82737718|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82737719|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82737720|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737721|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82737722|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82737723|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737724|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737725|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
82737726|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
82737727|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
82737728|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737729|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737730|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
82737731|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737732|NCT00986050|Sirolimus|sirolimus|mesh-list
82737733|NCT00986050|Abciximab|abciximab|mesh-list
82737734|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82737735|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737736|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82737737|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737738|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
82737739|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82737740|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
82737741|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737742|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
82737743|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82737744|NCT00986128|Topiramate|topiramate|mesh-list
82737745|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
82737746|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82737747|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737748|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
82737749|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82737750|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
82737751|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737752|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737753|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82737754|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
82737755|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82737756|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
82737757|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737758|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737759|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82737760|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
82737761|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
82737762|NCT00771342|Protective Agents|protective agents|mesh-ancestor
82737763|NCT00775164|Metformin|metformin|mesh-list
82737764|NCT00775164|Pioglitazone|pioglitazone|mesh-list
82737765|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82737766|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737767|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
82737768|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82737769|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82737770|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
82737771|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737772|NCT04767256|Dexamethasone|dexamethasone|mesh-list
82737773|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
82737774|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82737775|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
82737776|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
82737777|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737778|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737779|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82737780|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
82737781|NCT04767256|Hormones|hormones|mesh-ancestor
82737782|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737783|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82737784|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737785|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82737786|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737787|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82737788|NCT04767256|Analgesics|analgesics|mesh-ancestor
82737789|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
82737790|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82737791|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82737792|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82737793|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
82737794|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737795|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737796|NCT00771498|Lopinavir|lopinavir|mesh-list
82737797|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82737798|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82737799|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
82737800|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737801|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737802|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82737803|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82737804|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
82737805|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737806|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82737807|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82737808|NCT00986284|Gefitinib|gefitinib|mesh-list
82737809|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737810|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82737811|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737812|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737813|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82737815|NCT00988780|Maraviroc|maraviroc|mesh-list
82737816|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82737817|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82737818|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737819|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737820|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
82737821|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737822|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82737823|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82737824|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82737825|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82737826|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82737827|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82737828|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82737829|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82737830|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82737831|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82737832|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82737833|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82737834|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82737835|NCT00775242|Estradiol|estradiol|mesh-list
82737836|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82737837|NCT00775242|Estrogens|estrogens|mesh-list
82737838|NCT00775242|Progesterone|progesterone|mesh-list
82737839|NCT00775242|Progestins|progestins|mesh-list
82737840|NCT00775242|Hormones|hormones|mesh-ancestor
82737841|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737842|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737843|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82737844|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
82737845|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82737846|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82737847|NCT00986518|Immunomodulating Agents|immunomodulating agents|mesh-list
82737848|NCT00986518|Immunologic Factors|immunologic factors|mesh-ancestor
82737849|NCT00986518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737850|NCT00769158|Topiramate|topiramate|mesh-list
82737851|NCT00769158|Naltrexone|naltrexone|mesh-list
82737852|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82737853|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82737854|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737855|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
82737856|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737857|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
82737858|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82737859|NCT00983164|Antioxidants|antioxidants|mesh-list
82737860|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737861|NCT00983164|Protective Agents|protective agents|mesh-ancestor
82737862|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737863|NCT00333775|Bevacizumab|bevacizumab|mesh-list
82737864|NCT00333775|Docetaxel|docetaxel|mesh-list
82737865|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82737866|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737867|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82737868|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82737869|NCT00333775|Growth Substances|growth substances|mesh-ancestor
82737870|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737871|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
82737872|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
82737873|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
82737874|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
82737875|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737876|NCT03860428|Acetaminophen|acetaminophen|mesh-list
82737877|NCT03860428|Ibuprofen|ibuprofen|mesh-list
82737878|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
82737879|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82737880|NCT03860428|Analgesics|analgesics|mesh-ancestor
82737881|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
82737882|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82737883|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737884|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
82737885|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82737886|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82737887|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82737888|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737889|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737890|NCT00771888|Lanreotide|lanreotide|mesh-list
82737891|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737892|NCT00605475|Metformin|metformin|mesh-list
82737893|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82737894|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737895|NCT00986596|Vitamin D|vitamin d|mesh-list
82737896|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
82737897|NCT00986596|Vitamins|vitamins|mesh-ancestor
82737898|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
82737899|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737900|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82737901|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82737902|NCT00769470|Carboplatin|carboplatin|mesh-list
82737904|NCT00769470|Trastuzumab|trastuzumab|mesh-list
82737905|NCT00769470|Lapatinib|lapatinib|mesh-list
82737906|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737907|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
82737908|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
82737909|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
82737910|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737911|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82737912|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82737913|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737914|NCT00605319|Fesoterodine|fesoterodine|mesh-list
82737915|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82737916|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82737917|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
82737918|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82737919|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737920|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737921|NCT00605319|Urological Agents|urological agents|mesh-ancestor
82737922|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82737923|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
82737924|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82737925|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82737926|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82737927|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82737928|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737929|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
82737930|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
82737931|NCT00908661|Coagulants|coagulants|mesh-ancestor
82737932|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
82737933|NCT00983398|Carboplatin|carboplatin|mesh-list
82737934|NCT00983398|Melphalan|melphalan|mesh-list
82737935|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
82737936|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
82737937|NCT00983398|Mannitol|mannitol|mesh-list
82737938|NCT00983398|Antidotes|antidotes|mesh-list
82737939|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737940|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82737941|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
82737942|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737943|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82737944|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82737945|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
82737946|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737947|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82737948|NCT00983398|Diuretics|diuretics|mesh-ancestor
82737949|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
82737950|NCT00983398|Protective Agents|protective agents|mesh-ancestor
82737951|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
82737952|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
82737953|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82737954|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82737955|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
82737956|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
82737957|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
82737958|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82737959|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737960|NCT00769548|Goserelin|goserelin|mesh-list
82737961|NCT00769548|Flutamide|flutamide|mesh-list
82737962|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82737963|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737964|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
82737965|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
82737966|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737967|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737968|NCT05277675|Bevacizumab|bevacizumab|mesh-list
82737969|NCT05277675|Tislelizumab|tislelizumab|mesh-list
82737970|NCT05277675|Lenvatinib|lenvatinib|mesh-list
82737971|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82737972|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737973|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82737974|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82737975|NCT05277675|Growth Substances|growth substances|mesh-ancestor
82737976|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737977|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
82737978|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82737979|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737980|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737981|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
82737982|NCT03984409|Diuretics|diuretics|mesh-ancestor
82737983|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
82737984|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737985|NCT03984409|Expectorants|expectorants|mesh-ancestor
82737986|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
82737987|NCT00983554|Anastrozole|anastrozole|mesh-list
82737988|NCT00983554|Testosterone|testosterone|mesh-list
82737989|NCT00983554|Dutasteride|dutasteride|mesh-list
82737990|NCT00983554|Androgens|androgens|mesh-ancestor
82737991|NCT00983554|Hormones|hormones|mesh-ancestor
82737992|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82737993|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82737994|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82737995|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737996|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82737997|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82737998|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82737999|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738000|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
82738001|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82738002|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82738003|NCT05004987|Dexetimide|dexetimide|mesh-list
82738004|NCT05004987|Citalopram|citalopram|mesh-list
82738005|NCT05004987|Escitalopram|escitalopram|mesh-list
82738006|NCT05004987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82738007|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82738008|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82738009|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738010|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738011|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
82738012|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738013|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82738014|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82738015|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
82738016|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
82738017|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738018|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82738019|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82738020|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
82738021|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82738022|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
82738023|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82738024|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
82738025|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82738026|NCT00908817|Triamcinolone|triamcinolone|mesh-list
82738027|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82738028|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82738029|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82738030|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82738031|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738032|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
82738033|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
82738034|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82738035|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
82738037|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82738038|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738039|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82738040|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
82738041|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738042|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738043|NCT00332839|Cyclosporine|cyclosporine|mesh-list
82738044|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
82738045|NCT00332839|Everolimus|everolimus|mesh-list
82738046|NCT00332839|Tacrolimus|tacrolimus|mesh-list
82738047|NCT00332839|Cyclosporins|cyclosporins|mesh-list
82738048|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82738049|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
82738050|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738051|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82738052|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738053|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738054|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
82738055|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738056|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
82738057|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82738058|NCT00332839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82738059|NCT00332839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82738060|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738061|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82738062|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82738063|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
82738064|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82738065|NCT00927147|Cetuximab|cetuximab|mesh-list
82738066|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82738067|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738068|NCT05712616|Strontium ranelate|strontium ranelate|mesh-list
82738069|NCT05712616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82738070|NCT05712616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738071|NCT00927225|Ropivacaine|ropivacaine|mesh-list
82738072|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
82738073|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
82738074|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82738075|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738076|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
82738077|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738078|NCT00357097|Ropinirole|ropinirole|mesh-list
82738079|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82738080|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82738081|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
82738082|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
82738083|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738084|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738085|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738086|NCT00983788|Bezafibrate|bezafibrate|mesh-list
82738087|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82738088|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
82738089|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738090|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82738091|NCT00983944|Prednisone|prednisone|mesh-list
82738092|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
82738093|NCT00983944|Rituximab|rituximab|mesh-list
82738094|NCT00983944|Doxorubicin|doxorubicin|mesh-list
82738095|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82738096|NCT00983944|Etoposide|etoposide|mesh-list
82738097|NCT00983944|Vincristine|vincristine|mesh-list
82738098|NCT00983944|Bleomycin|bleomycin|mesh-list
82738099|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82738100|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
82738101|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738102|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82738103|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82738104|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
82738105|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738106|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738107|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82738108|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82738109|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82738110|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82738111|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82738112|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738113|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82738114|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
82738115|NCT00983944|Hormones|hormones|mesh-ancestor
82738116|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82738117|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82738118|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82738119|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
82738120|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
82738121|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
82738122|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82738123|NCT00927537|Telmisartan|telmisartan|mesh-list
82738124|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82738125|NCT00927537|Diuretics|diuretics|mesh-ancestor
82738126|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
82738127|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738128|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82738129|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82738130|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738131|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82738132|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82738133|NCT02538003|Delpazolid|delpazolid|mesh-list
82738134|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
82738135|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82738136|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738137|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82738138|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738139|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738140|NCT00909129|Interferons|interferons|mesh-list
82738141|NCT00909129|Ribavirin|ribavirin|mesh-list
82738142|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
82738143|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82738144|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738145|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
82738146|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738147|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
82738148|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738149|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
82738150|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738151|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82738152|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
82738153|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82738154|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82738155|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738156|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82738158|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82738159|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
82738160|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738161|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82738162|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
82738163|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738164|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738165|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82738166|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82738167|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82738168|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
82738169|NCT00927615|Abciximab|abciximab|mesh-list
82738170|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
82738171|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82738172|NCT03990103|Paclitaxel|paclitaxel|mesh-list
82738173|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82738174|NCT03990103|Bevacizumab|bevacizumab|mesh-list
82738175|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
82738176|NCT03990103|Tegafur|tegafur|mesh-list
82738177|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82738178|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738179|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
82738180|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
82738181|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
82738182|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738183|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82738184|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82738185|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82738186|NCT03990103|Growth Substances|growth substances|mesh-ancestor
82738187|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738188|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
82738189|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82738190|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
82738191|NCT00927693|Calcium|calcium|mesh-list
82738192|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82738193|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738194|NCT00987220|Donepezil|donepezil|mesh-list
82738195|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82738196|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738197|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738198|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
82738199|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738200|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738201|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
82738202|NCT01581151|Dexamethasone|dexamethasone|mesh-list
82738203|NCT01581151|Ranibizumab|ranibizumab|mesh-list
82738204|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82738205|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
82738206|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
82738207|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738208|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738209|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82738210|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
82738211|NCT01581151|Hormones|hormones|mesh-ancestor
82738212|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82738213|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82738214|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738215|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82738216|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82738217|NCT01581151|Growth Substances|growth substances|mesh-ancestor
82738218|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
82738219|NCT01053481|Vitamin D|vitamin d|mesh-list
82738220|NCT01053481|Vitamins|vitamins|mesh-ancestor
82738221|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
82738222|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738223|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82738224|NCT00927771|Azelaic acid|azelaic acid|mesh-list
82738225|NCT00927771|Hydroquinone|hydroquinone|mesh-list
82738226|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738227|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
82738228|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
82738229|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738230|NCT00927771|Protective Agents|protective agents|mesh-ancestor
82738231|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738232|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82738234|NCT01053559|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82738235|NCT01053559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82738236|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82738237|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
82738238|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738239|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82738240|NCT01053637|Acetaminophen|acetaminophen|mesh-list
82738241|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82738242|NCT01053637|Hydrocodone|hydrocodone|mesh-list
82738243|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82738244|NCT01053637|Analgesics|analgesics|mesh-ancestor
82738245|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
82738246|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738247|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738248|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
82738249|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82738250|NCT01053637|Narcotics|narcotics|mesh-ancestor
82738251|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82738252|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
82738253|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
82738254|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82738255|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82738256|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82738257|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
82738258|NCT00928161|Lansoprazole|lansoprazole|mesh-list
82738259|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82738260|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82738261|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82738262|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738263|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738264|NCT00909519|Naproxen|naproxen|mesh-list
82738265|NCT00909519|Furosemide|furosemide|mesh-list
82738266|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
82738267|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82738268|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82738269|NCT00909519|Analgesics|analgesics|mesh-ancestor
82738270|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
82738271|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738272|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738273|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82738274|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82738275|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
82738276|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82738277|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738278|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738279|NCT00909519|Diuretics|diuretics|mesh-ancestor
82738280|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
82738281|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82738282|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82738283|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82738284|NCT05014815|Tislelizumab|tislelizumab|mesh-list
82738285|NCT05014815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82738286|NCT05014815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738287|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82738288|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82738289|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82738290|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
82738291|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738292|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82738293|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82738294|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738296|NCT00907179|Panobinostat|panobinostat|mesh-list
82738297|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738298|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738299|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738300|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82738301|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82738302|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82738303|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
82738304|NCT00544648|Paclitaxel|paclitaxel|mesh-list
82738305|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82738306|NCT00544648|Carboplatin|carboplatin|mesh-list
82738307|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82738308|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738309|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
82738310|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
82738311|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
82738312|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738313|NCT01053871|Fentanyl|fentanyl|mesh-list
82738314|NCT01053871|Midazolam|midazolam|mesh-list
82738315|NCT01053871|Propofol|propofol|mesh-list
82738316|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82738317|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82738318|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738319|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82738320|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
82738321|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
82738322|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82738323|NCT01053871|Narcotics|narcotics|mesh-ancestor
82738324|NCT01053871|Analgesics|analgesics|mesh-ancestor
82738325|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
82738326|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738327|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82738328|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82738329|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82738330|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82738331|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
82738332|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
82738333|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738334|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738335|NCT01053949|Thalidomide|thalidomide|mesh-list
82738336|NCT01053949|Pomalidomide|pomalidomide|mesh-list
82738337|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
82738338|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738339|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82738340|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82738341|NCT01053949|Growth Substances|growth substances|mesh-ancestor
82738342|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
82738343|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738344|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82738345|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
82738346|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82738347|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738348|NCT00987376|Choline|choline|mesh-list
82738349|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
82738350|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82738351|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
82738352|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738353|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82738354|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82738355|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
82738356|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
82738357|NCT00987454|Hematinics|hematinics|mesh-ancestor
82738358|NCT04005664|Phenylephrine|phenylephrine|mesh-list
82738359|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
82738360|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82738361|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
82738362|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
82738363|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738364|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738365|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
82738366|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82738367|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
82738368|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
82738369|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82738370|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82738371|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82738372|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
82738373|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738374|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738375|NCT04005664|Protective Agents|protective agents|mesh-ancestor
82738376|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82738377|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82738378|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82738379|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82738380|NCT00924573|Metformin|metformin|mesh-list
82738381|NCT00924573|Glimepiride|glimepiride|mesh-list
82738382|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82738383|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738384|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82738385|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82738386|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
82738387|NCT01054027|Phenylephrine|phenylephrine|mesh-list
82738388|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
82738389|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
82738390|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82738391|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
82738392|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
82738393|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738394|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738395|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
82738396|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82738397|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
82738398|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
82738399|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82738400|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82738401|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82738402|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
82738403|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738404|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738405|NCT01054027|Protective Agents|protective agents|mesh-ancestor
82738406|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
82738407|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82738408|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82738409|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
82738410|NCT01054105|Iloprost|iloprost|mesh-list
82738411|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82738412|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
82738413|NCT00330343|Naloxone|naloxone|mesh-list
82738414|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82738415|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738416|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
82738417|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738418|NCT00987766|Gemcitabine|gemcitabine|mesh-list
82738419|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
82738420|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82738421|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82738422|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
82738423|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738424|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738425|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82738426|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738427|NCT04005430|Dexamethasone|dexamethasone|mesh-list
82738428|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
82738429|NCT04005430|BB 1101|bb 1101|mesh-list
82738430|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82738431|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
82738432|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
82738433|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738434|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738435|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82738436|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
82738437|NCT04005430|Hormones|hormones|mesh-ancestor
82738438|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82738439|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82738440|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738441|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
82738442|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738443|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738444|NCT00330187|Bupropion|bupropion|mesh-list
82738445|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82738446|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
82738447|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82738448|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82738449|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82738450|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82738451|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738452|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
82738453|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738454|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738455|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82738456|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82738457|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738458|NCT00987844|Prucalopride|prucalopride|mesh-list
82738459|NCT00987844|Laxatives|laxatives|mesh-ancestor
82738460|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82738461|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82738462|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82738463|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
82738464|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738465|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738466|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738467|NCT03986905|Scopolamine|scopolamine|mesh-list
82738468|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82738469|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82738470|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
82738471|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
82738472|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738473|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738474|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82738476|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82738477|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
82738478|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738479|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738480|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82738481|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
82738482|NCT04864444|Piperaquine|piperaquine|mesh-list
82738483|NCT04864444|Primaquine|primaquine|mesh-list
82738484|NCT04864444|Artenimol|artenimol|mesh-list
82738485|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
82738486|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82738487|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82738488|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738489|NCT00329797|Vitamin D|vitamin d|mesh-list
82738490|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
82738491|NCT00329797|Calcium|calcium|mesh-list
82738492|NCT00329797|Vitamins|vitamins|mesh-ancestor
82738493|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
82738494|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738495|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82738496|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82738497|NCT00541450|Metformin|metformin|mesh-list
82738498|NCT00541450|Pioglitazone|pioglitazone|mesh-list
82738499|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82738500|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82738501|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738502|NCT00541450|Incretins|incretins|mesh-ancestor
82738503|NCT00541450|Hormones|hormones|mesh-ancestor
82738504|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82738505|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82738506|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
82738507|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738508|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738509|NCT01056679|Doxorubicin|doxorubicin|mesh-list
82738510|NCT01056679|Lenalidomide|lenalidomide|mesh-list
82738511|NCT01056679|Vinblastine|vinblastine|mesh-list
82738512|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82738513|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738514|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82738515|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82738516|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738517|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738518|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
82738519|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738520|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82738521|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82738522|NCT01056679|Growth Substances|growth substances|mesh-ancestor
82738523|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
82738524|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82738525|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
82738526|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
82738527|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
82738528|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82738529|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82738530|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
82738531|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738532|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738533|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738534|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82738535|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
82738536|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738537|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738538|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82738539|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738541|NCT05709574|Vasodilator Agents|vasodilator agents|mesh-ancestor
82738542|NCT05709574|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82738543|NCT05709574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82738544|NCT05709574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738545|NCT05709574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738546|NCT05709574|Urological Agents|urological agents|mesh-ancestor
82738547|NCT05546242|Dolutegravir|dolutegravir|mesh-list
82738548|NCT05546242|Cabotegravir|cabotegravir|mesh-list
82738549|NCT05546242|Rilpivirine|rilpivirine|mesh-list
82738550|NCT05546242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82738551|NCT05546242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82738552|NCT05546242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82738553|NCT05546242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738554|NCT05546242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738555|NCT05546242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82738556|NCT05546242|Antiviral Agents|antiviral agents|mesh-ancestor
82738557|NCT05546242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738558|NCT05546242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82738559|NCT05546242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82738560|NCT04690504|Melatonin|melatonin|mesh-list
82738561|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
82738562|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738563|NCT04690504|Protective Agents|protective agents|mesh-ancestor
82738564|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738565|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82738566|NCT00540124|Tadalafil|tadalafil|mesh-list
82738567|NCT00540124|Tamsulosin|tamsulosin|mesh-list
82738568|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
82738569|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82738570|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82738571|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738572|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738573|NCT00540124|Urological Agents|urological agents|mesh-ancestor
82738574|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82738575|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82738576|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82738577|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
82738578|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738579|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738581|NCT00540046|Trace Elements|trace elements|mesh-ancestor
82738582|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
82738583|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738584|NCT05677126|Copper|copper|mesh-list
82738585|NCT05677126|Trace Elements|trace elements|mesh-list
82738586|NCT05677126|Selenious Acid|selenious acid|mesh-list
82738587|NCT05677126|Micronutrients|micronutrients|mesh-list
82738588|NCT05677126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738589|NCT04613830|Tramadol|tramadol|mesh-list
82738590|NCT04613830|Bupivacaine|bupivacaine|mesh-list
82738591|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
82738592|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
82738593|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82738594|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738595|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
82738596|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738597|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82738598|NCT04613830|Narcotics|narcotics|mesh-ancestor
82738599|NCT04613830|Analgesics|analgesics|mesh-ancestor
82738600|NCT00689936|Thalidomide|thalidomide|mesh-list
82738601|NCT00689936|Dexamethasone|dexamethasone|mesh-list
82738602|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
82738603|NCT00689936|Prednisone|prednisone|mesh-list
82738604|NCT00689936|Lenalidomide|lenalidomide|mesh-list
82738605|NCT00689936|Melphalan|melphalan|mesh-list
82738606|NCT00689936|BB 1101|bb 1101|mesh-list
82738607|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82738608|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
82738609|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
82738610|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738611|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738613|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
82738614|NCT00689936|Hormones|hormones|mesh-ancestor
82738615|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82738616|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82738617|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738618|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
82738619|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738620|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738626|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82738627|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
82738628|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82738629|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82738630|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
82738631|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82738632|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738633|NCT05661682|Zinc|zinc|mesh-list
82738634|NCT05661682|Copper|copper|mesh-list
82738635|NCT05661682|Manganese|manganese|mesh-list
82738636|NCT05661682|Trace Elements|trace elements|mesh-list
82738637|NCT05661682|Selenious Acid|selenious acid|mesh-list
82738638|NCT05661682|Micronutrients|micronutrients|mesh-list
82738639|NCT05661682|Copper Sulfate|copper sulfate|mesh-list
82738640|NCT05661682|Zinc Sulfate|zinc sulfate|mesh-list
82738641|NCT05661682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738642|NCT05661682|Astringents|astringents|mesh-ancestor
82738643|NCT05661682|Dermatologic Agents|dermatologic agents|mesh-ancestor
82738644|NCT05661682|Antidotes|antidotes|mesh-ancestor
82738645|NCT05661682|Protective Agents|protective agents|mesh-ancestor
82738646|NCT05661682|Emetics|emetics|mesh-ancestor
82738647|NCT05661682|Autonomic Agents|autonomic agents|mesh-ancestor
82738648|NCT05661682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738649|NCT05661682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82738650|NCT01563718|Naltrexone|naltrexone|mesh-list
82738651|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82738652|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82738653|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738654|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
82738655|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738661|NCT05473234|Amoxicillin|amoxicillin|mesh-list
82738662|NCT05473234|Azithromycin|azithromycin|mesh-list
82738663|NCT05473234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82738664|NCT05473234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738665|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
82738666|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82738667|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738668|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82738669|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82738670|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
82738671|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738672|NCT00671034|Cytarabine|cytarabine|mesh-list
82738673|NCT00671034|Dexamethasone|dexamethasone|mesh-list
82738674|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
82738675|NCT00671034|Prednisone|prednisone|mesh-list
82738676|NCT00671034|Cortisone|cortisone|mesh-list
82738677|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
82738678|NCT00671034|Doxorubicin|doxorubicin|mesh-list
82738679|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82738680|NCT00671034|Methotrexate|methotrexate|mesh-list
82738681|NCT00671034|Vincristine|vincristine|mesh-list
82738682|NCT00671034|Daunorubicin|daunorubicin|mesh-list
82738683|NCT00671034|Asparaginase|asparaginase|mesh-list
82738684|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
82738685|NCT00671034|Pegaspargase|pegaspargase|mesh-list
82738686|NCT00671034|Thioguanine|thioguanine|mesh-list
82738687|NCT00671034|BB 1101|bb 1101|mesh-list
82738688|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
82738689|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82738690|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
82738691|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738692|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82738693|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82738694|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
82738695|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738696|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738697|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82738698|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82738699|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
82738700|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
82738701|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738702|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82738703|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
82738704|NCT00671034|Hormones|hormones|mesh-ancestor
82738705|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82738706|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82738707|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
82738708|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738709|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82738710|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82738711|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82738712|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82738713|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
82738714|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82738715|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82738716|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
82738717|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
82738718|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82738719|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82738720|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
82738721|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738722|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82738723|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
82738724|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
82738725|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
82738726|NCT04425070|Carboplatin|carboplatin|mesh-list
82738727|NCT04425070|Gemcitabine|gemcitabine|mesh-list
82738728|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
82738729|NCT04425070|Etoposide|etoposide|mesh-list
82738730|NCT04425070|Ifosfamide|ifosfamide|mesh-list
82738731|NCT04425070|Tislelizumab|tislelizumab|mesh-list
82738732|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738733|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82738734|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
82738735|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738736|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82738737|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82738738|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82738739|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738740|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82738741|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
82738742|NCT04425070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82738743|NCT04607954|Durvalumab|durvalumab|mesh-list
82738744|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
82738745|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82738746|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
82738747|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82738748|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738749|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
82738750|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738751|NCT00743678|Cetuximab|cetuximab|mesh-list
82738752|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82738753|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738754|NCT02679508|Lansoprazole|lansoprazole|mesh-list
82738755|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
82738756|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82738757|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82738758|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82738759|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738760|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738761|NCT00775632|Cyclosporine|cyclosporine|mesh-list
82738762|NCT00775632|Methotrexate|methotrexate|mesh-list
82738763|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
82738764|NCT00775632|Cyclosporins|cyclosporins|mesh-list
82738765|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82738766|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
82738767|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82738768|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738769|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82738770|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
82738771|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738772|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738773|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
82738774|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738775|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82738776|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82738777|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
82738778|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82738779|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82738780|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
82738781|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738782|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82738783|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82738784|NCT04047654|Anticoagulants|anticoagulants|mesh-list
82738786|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82738787|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82738788|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738789|NCT04394182|Ritonavir|ritonavir|mesh-list
82738790|NCT04394182|Lopinavir|lopinavir|mesh-list
82738791|NCT04394182|Azithromycin|azithromycin|mesh-list
82738792|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
82738793|NCT04394182|Tazobactam|tazobactam|mesh-list
82738794|NCT04394182|Piperacillin|piperacillin|mesh-list
82738795|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82738796|NCT04394182|Heparin|heparin|mesh-list
82738797|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82738798|NCT04394182|Tinzaparin|tinzaparin|mesh-list
82738799|NCT04394182|Dalteparin|dalteparin|mesh-list
82738800|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82738801|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82738802|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
82738803|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738804|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738805|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82738806|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82738807|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
82738808|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738809|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82738810|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82738811|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
82738812|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82738813|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82738814|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82738815|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
82738816|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82738817|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82738818|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82738819|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82738820|NCT05386576|Venetoclax|venetoclax|mesh-list
82738821|NCT05386576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738822|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
82738823|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82738824|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
82738825|NCT05325580|Analgesics|analgesics|mesh-ancestor
82738826|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
82738827|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738828|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738829|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
82738830|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82738831|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82738832|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
82738833|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82738834|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82739060|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82738835|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738836|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82738837|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
82738838|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82738839|NCT00539734|Ranibizumab|ranibizumab|mesh-list
82738840|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82738841|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82738842|NCT00539734|Growth Substances|growth substances|mesh-ancestor
82738843|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738844|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
82738845|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738847|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738849|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82738850|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738851|NCT01093976|Dronabinol|dronabinol|mesh-list
82738852|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
82738853|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738854|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82738855|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82738856|NCT01093976|Analgesics|analgesics|mesh-ancestor
82738857|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
82738858|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738859|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82738860|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82738861|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738862|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738863|NCT01093976|Hormones|hormones|mesh-ancestor
82738864|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82738865|NCT00329719|Sirolimus|sirolimus|mesh-list
82738866|NCT00329719|Sorafenib|sorafenib|mesh-list
82738867|NCT00329719|Temsirolimus|temsirolimus|mesh-list
82738868|NCT00329719|MTOR Inhibitors|mtor inhibitors|mesh-list
82738869|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738870|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82738871|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738872|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738873|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82738874|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738875|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82738876|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
82738877|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82738878|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
82738879|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738880|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
82738881|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82738882|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
82738883|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
82738884|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82738885|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738886|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82738887|NCT04008628|Analgesics|analgesics|mesh-ancestor
82738888|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
82738889|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738890|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
82738891|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82738892|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82738893|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82738894|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738895|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82738896|NCT00743834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82738897|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82738898|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82738899|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738900|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738901|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
82738902|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82738903|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
82738904|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82738905|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82738906|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738907|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82738908|NCT00743912|Rifaximin|rifaximin|mesh-list
82738909|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82738910|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738911|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82738912|NCT04060472|Paclitaxel|paclitaxel|mesh-list
82738913|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
82738914|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82738915|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82738916|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738917|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
82738918|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
82738919|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
82738920|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738922|NCT00329641|Carboplatin|carboplatin|mesh-list
82738923|NCT00329641|Sorafenib|sorafenib|mesh-list
82738924|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82738925|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738926|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
82738927|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
82738928|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
82738929|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738930|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82738931|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738932|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
82738933|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
82738934|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82738935|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738936|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738937|NCT00743990|Camphor|camphor|mesh-list
82738938|NCT00743990|Menthol|menthol|mesh-list
82738939|NCT00743990|Petrolatum|petrolatum|mesh-list
82738940|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
82738941|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
82738942|NCT00743990|Emollients|emollients|mesh-ancestor
82738943|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82738944|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738945|NCT00329407|Topiramate|topiramate|mesh-list
82738946|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
82738947|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82738948|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738949|NCT01056757|Ribavirin|ribavirin|mesh-list
82738950|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
82738951|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738952|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
82738953|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82738954|NCT01056835|Epoprostenol|epoprostenol|mesh-list
82738955|NCT01056835|Tezosentan|tezosentan|mesh-list
82738956|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82738957|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82738958|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
82738959|NCT03986515|Apatinib|apatinib|mesh-list
82738960|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738961|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82738962|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738963|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738964|NCT00567489|Icodextrin|icodextrin|mesh-list
82738965|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
82738966|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82738967|NCT02538393|Sorafenib|sorafenib|mesh-list
82738968|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82738969|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82738970|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82738971|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738972|NCT00924963|Lidocaine|lidocaine|mesh-list
82738973|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
82738974|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
82738975|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82738976|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738977|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
82738978|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82738979|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82738980|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82738981|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82738982|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82738983|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82738984|NCT00669864|Metformin|metformin|mesh-list
82738985|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
82738986|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
82738987|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82738988|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82738989|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738990|NCT00770172|Lenograstim|lenograstim|mesh-list
82738991|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82738992|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
82738993|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82738994|NCT00776022|Cetirizine|cetirizine|mesh-list
82738995|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82738996|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82738997|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82738998|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
82738999|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
82739000|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739001|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739002|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739003|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82739004|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82739005|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82739006|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739007|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739008|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
82739009|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739010|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82739011|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82739012|NCT00779220|Methotrexate|methotrexate|mesh-list
82739013|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
82739014|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82739015|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
82739016|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82739017|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739018|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82739019|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
82739020|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739021|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739022|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
82739023|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739024|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82739025|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82739026|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
82739027|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739028|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82739029|NCT00779376|Zidovudine|zidovudine|mesh-list
82739030|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
82739031|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739032|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82739033|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82739034|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739035|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
82739036|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739037|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82739038|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82739039|NCT00779454|Gemcitabine|gemcitabine|mesh-list
82739040|NCT00779454|Capecitabine|capecitabine|mesh-list
82739041|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
82739042|NCT00779454|Panitumumab|panitumumab|mesh-list
82739043|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82739044|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
82739045|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739046|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739047|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82739048|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
82739049|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
82739050|NCT00773058|Hormones|hormones|mesh-ancestor
82739051|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739052|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739053|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739054|NCT00776334|Fosinopril|fosinopril|mesh-list
82739055|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82739056|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
82739057|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739058|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739059|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82739061|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
82739062|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739063|NCT00667992|Budesonide|budesonide|mesh-list
82739064|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739065|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82739066|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
82739067|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739068|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739069|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82739070|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
82739072|NCT00667992|Hormones|hormones|mesh-ancestor
82739073|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739074|NCT00776490|Glimepiride|glimepiride|mesh-list
82739075|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82739076|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82739077|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739078|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82739079|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
82739080|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
82739081|NCT00779922|Lenalidomide|lenalidomide|mesh-list
82739082|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
82739083|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739084|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82739085|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82739086|NCT00779922|Growth Substances|growth substances|mesh-ancestor
82739087|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
82739088|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739089|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82739090|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82739091|NCT00776646|Diuretics|diuretics|mesh-ancestor
82739092|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
82739093|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739094|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82739095|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82739096|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739098|NCT00776724|Epirubicin|epirubicin|mesh-list
82739099|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739100|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
82739101|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
82739102|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
82739103|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739104|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82739105|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82739106|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82739107|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739108|NCT00776802|Dexamethasone|dexamethasone|mesh-list
82739109|NCT00776802|Etoposide|etoposide|mesh-list
82739110|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739111|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
82739112|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
82739113|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739114|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739115|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82739116|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
82739117|NCT00776802|Hormones|hormones|mesh-ancestor
82739118|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739119|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82739120|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739121|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82739122|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82739123|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82739124|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739125|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739126|NCT00773916|Methylphenidate|methylphenidate|mesh-list
82739127|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82739128|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739129|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82739130|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82739131|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82739132|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739133|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
82739134|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739135|NCT00774072|Tobramycin|tobramycin|mesh-list
82739136|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82739137|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739138|NCT00780780|Triamcinolone|triamcinolone|mesh-list
82739139|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82739140|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82739141|NCT00780780|Nepafenac|nepafenac|mesh-list
82739142|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82739143|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739144|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
82739145|NCT00780780|Hormones|hormones|mesh-ancestor
82739146|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739147|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739148|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82739149|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
82739150|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739151|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739152|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82739153|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82739154|NCT00780780|Analgesics|analgesics|mesh-ancestor
82739155|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
82739156|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739157|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739158|NCT00780858|Ganirelix|ganirelix|mesh-list
82739159|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
82739160|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739161|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739162|NCT00777114|Bortezomib|bortezomib|mesh-list
82739163|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739164|NCT00669396|Copper|copper|mesh-list
82739166|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82739167|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
82739168|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82739169|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739170|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82739171|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82739172|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82739173|NCT00669396|Trace Elements|trace elements|mesh-ancestor
82739174|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
82739175|NCT00774462|Rituximab|rituximab|mesh-list
82739176|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82739177|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739178|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
82739179|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739180|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739181|NCT00669318|Rituximab|rituximab|mesh-list
82739182|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
82739183|NCT00669318|Pentostatin|pentostatin|mesh-list
82739184|NCT00669318|Sargramostim|sargramostim|mesh-list
82739185|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82739186|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739187|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
82739188|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739189|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739190|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82739191|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739192|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739193|NCT00774540|Ketorolac|ketorolac|mesh-list
82739194|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82739195|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82739196|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82739197|NCT00774540|Analgesics|analgesics|mesh-ancestor
82739198|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
82739199|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739200|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739201|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739202|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739203|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82739204|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739205|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739206|NCT00669240|Varenicline|varenicline|mesh-list
82739207|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82739208|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82739209|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
82739210|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739211|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739212|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739213|NCT00669162|Docetaxel|docetaxel|mesh-list
82739214|NCT00669162|Leuprolide|leuprolide|mesh-list
82739215|NCT00669162|Goserelin|goserelin|mesh-list
82739216|NCT00669162|Bicalutamide|bicalutamide|mesh-list
82739217|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739218|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
82739219|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
82739220|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
82739221|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739222|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82739223|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
82739224|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82739225|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739226|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82739227|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
82739228|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
82739229|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739230|NCT00774696|Clarithromycin|clarithromycin|mesh-list
82739231|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82739232|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739233|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82739234|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739235|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739236|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82739237|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82739238|NCT02556060|Lamotrigine|lamotrigine|mesh-list
82739239|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
82739240|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82739241|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82739242|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739243|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82739244|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739245|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82739246|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82739247|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82739248|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82739249|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82739250|NCT00400946|Leucovorin|leucovorin|mesh-list
82739251|NCT00400946|Cytarabine|cytarabine|mesh-list
82739252|NCT00400946|Dexamethasone|dexamethasone|mesh-list
82739253|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
82739254|NCT00400946|Prednisolone|prednisolone|mesh-list
82739255|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
82739256|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82739257|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82739258|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82739259|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
82739260|NCT00400946|Doxorubicin|doxorubicin|mesh-list
82739261|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82739262|NCT00400946|Methotrexate|methotrexate|mesh-list
82739263|NCT00400946|Etoposide|etoposide|mesh-list
82739264|NCT00400946|Vincristine|vincristine|mesh-list
82739265|NCT00400946|Asparaginase|asparaginase|mesh-list
82739266|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
82739267|NCT00400946|Pegaspargase|pegaspargase|mesh-list
82739268|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
82739269|NCT00400946|Razoxane|razoxane|mesh-list
82739270|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
82739271|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82739272|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
82739273|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739274|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739275|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82739276|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
82739277|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739278|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739279|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82739280|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739281|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
82739282|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
82739283|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739284|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82739285|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
82739286|NCT00400946|Hormones|hormones|mesh-ancestor
82739287|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739288|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82739289|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82739290|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82739291|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82739292|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739293|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82739294|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
82739295|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82739296|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82739297|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
82739298|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
82739299|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82739300|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82739301|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82739302|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
82739303|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739304|NCT00400946|Antidotes|antidotes|mesh-ancestor
82739305|NCT00400946|Protective Agents|protective agents|mesh-ancestor
82739306|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
82739307|NCT00400946|Vitamins|vitamins|mesh-ancestor
82739308|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
82739309|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
82739310|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
82739311|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
82739312|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82739313|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82739314|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
82739315|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82739316|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
82739317|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739318|NCT00354770|Expectorants|expectorants|mesh-ancestor
82739319|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
82739320|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82739321|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
82739322|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739323|NCT00354770|Protective Agents|protective agents|mesh-ancestor
82739324|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739325|NCT00354770|Antidotes|antidotes|mesh-ancestor
82739326|NCT00744224|Exenatide|exenatide|mesh-list
82739327|NCT00744224|Prednisolone|prednisolone|mesh-list
82739328|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82739329|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
82739330|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82739331|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
82739332|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82739333|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
82739334|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739335|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
82739336|NCT00744224|Hormones|hormones|mesh-ancestor
82739337|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739338|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739339|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82739340|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739341|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
82739342|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
82739343|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739344|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82739345|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82739346|NCT00744224|Protective Agents|protective agents|mesh-ancestor
82739347|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82739348|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82739349|NCT00744224|Incretins|incretins|mesh-ancestor
82739350|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
82739351|NCT00744302|Calcium|calcium|mesh-list
82739352|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82739353|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739354|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82739355|NCT00666588|Cytarabine|cytarabine|mesh-list
82739356|NCT00666588|Etoposide|etoposide|mesh-list
82739357|NCT00666588|Idarubicin|idarubicin|mesh-list
82739358|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
82739359|NCT00666588|Bortezomib|bortezomib|mesh-list
82739360|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82739361|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739362|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82739363|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82739364|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739365|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739366|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82739367|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
82739368|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
82739369|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739370|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82739371|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
82739372|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739373|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82739375|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82739376|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
82739377|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739378|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
82739379|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739380|NCT00567879|Trastuzumab|trastuzumab|mesh-list
82739381|NCT00567879|Panobinostat|panobinostat|mesh-list
82739382|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82739383|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739384|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82739385|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739386|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739387|NCT00781404|Adenosine|adenosine|mesh-list
82739388|NCT00781404|Analgesics|analgesics|mesh-ancestor
82739389|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
82739390|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739391|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739392|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82739393|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
82739394|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82739395|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
82739396|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
82739397|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739398|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739399|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
82739400|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82739401|NCT00777504|Growth Substances|growth substances|mesh-ancestor
82739402|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739403|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
82739404|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739405|NCT00781482|Zolpidem|zolpidem|mesh-list
82739406|NCT00781482|Eszopiclone|eszopiclone|mesh-list
82739407|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82739408|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82739409|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82739410|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739411|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82739412|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
82739413|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
82739414|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739415|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739416|NCT00603915|Carboplatin|carboplatin|mesh-list
82739417|NCT00603915|Gemcitabine|gemcitabine|mesh-list
82739418|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82739419|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739420|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82739421|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
82739422|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739423|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82739424|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739425|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82739426|NCT00925977|Insulin|insulin|mesh-list
82739427|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82739428|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
82739429|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
82739430|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
82739431|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
82739432|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
82739433|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82739434|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739435|NCT00926055|Simvastatin|simvastatin|mesh-list
82739436|NCT00926055|Ezetimibe|ezetimibe|mesh-list
82739437|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
82739438|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82739439|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82739440|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
82739441|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739442|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82739443|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82739444|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739445|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
82739447|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82739448|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739449|NCT02538237|Ibuprofen|ibuprofen|mesh-list
82739450|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82739451|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82739452|NCT02538237|Analgesics|analgesics|mesh-ancestor
82739453|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
82739454|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739455|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739456|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739457|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739458|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82739459|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739460|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739461|NCT00691028|Infliximab|infliximab|mesh-list
82739462|NCT00691028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82739463|NCT00691028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739464|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
82739465|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82739466|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739467|NCT00690794|Travoprost|travoprost|mesh-list
82739468|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82739469|NCT00690794|Latanoprost|latanoprost|mesh-list
82739470|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82739471|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82739472|NCT00666276|Linezolid|linezolid|mesh-list
82739473|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82739474|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739475|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82739476|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739477|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739478|NCT00567255|Naltrexone|naltrexone|mesh-list
82739479|NCT00567255|Bupropion|bupropion|mesh-list
82739480|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82739481|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82739482|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739483|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
82739484|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739485|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82739486|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
82739487|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82739488|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82739489|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82739490|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82739491|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739492|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
82739493|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739494|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82739495|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82739496|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739497|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
82739498|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82739499|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739500|NCT00784446|Bevacizumab|bevacizumab|mesh-list
82739501|NCT00784446|Capecitabine|capecitabine|mesh-list
82739502|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
82739504|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82739505|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739506|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82739507|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82739508|NCT00784446|Growth Substances|growth substances|mesh-ancestor
82739509|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739510|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
82739511|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82739512|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
82739513|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739514|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82739515|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739516|NCT00744536|Lenalidomide|lenalidomide|mesh-list
82739517|NCT00744536|Melphalan|melphalan|mesh-list
82739518|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
82739519|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739520|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82739521|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82739522|NCT00744536|Growth Substances|growth substances|mesh-ancestor
82739523|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
82739524|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739525|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82739526|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
82739527|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739528|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82739529|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82739530|NCT00929799|Hormones|hormones|mesh-list
82739531|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739532|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739533|NCT00777738|Bortezomib|bortezomib|mesh-list
82739534|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739535|NCT00744770|Rilpivirine|rilpivirine|mesh-list
82739536|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82739537|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82739538|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739539|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739540|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
82739541|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739542|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82739543|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82739544|NCT00784680|Tamoxifen|tamoxifen|mesh-list
82739545|NCT00784680|Anastrozole|anastrozole|mesh-list
82739546|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82739547|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
82739548|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739549|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739550|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82739551|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739552|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82739553|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82739554|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82739555|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82739556|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82739557|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739558|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739559|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
82739560|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82739561|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739562|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82739563|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739564|NCT02556840|Insulin|insulin|mesh-list
82739565|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82739566|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739567|NCT00929877|Ketoprofen|ketoprofen|mesh-list
82739568|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82739569|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82739570|NCT00929877|Analgesics|analgesics|mesh-ancestor
82739571|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
82739572|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739573|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739574|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739575|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739576|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82739577|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739578|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739580|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82739581|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82739582|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
82739583|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739584|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739585|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739586|NCT00931437|Vitamin K|vitamin k|mesh-list
82739587|NCT00931437|Vitamins|vitamins|mesh-ancestor
82739588|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
82739589|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739590|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82739591|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82739592|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739594|NCT00931437|Coagulants|coagulants|mesh-ancestor
82739595|NCT00742040|Captopril|captopril|mesh-list
82739596|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82739597|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
82739598|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739599|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739600|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82739601|NCT00926757|Entecavir|entecavir|mesh-list
82739602|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
82739603|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739604|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
82739605|NCT00782106|Antibodies|antibodies|mesh-list
82739606|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
82739607|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82739608|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82739609|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
82739610|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
82739611|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739612|NCT00929955|Ondansetron|ondansetron|mesh-list
82739613|NCT00929955|Simvastatin|simvastatin|mesh-list
82739614|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82739615|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82739616|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
82739617|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739618|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82739619|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82739620|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739621|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
82739622|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
82739623|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739624|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739625|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82739626|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
82739627|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
82739628|NCT00929955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82739629|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82739630|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
82739631|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739632|NCT00784914|Sirolimus|sirolimus|mesh-list
82739633|NCT00784914|Temsirolimus|temsirolimus|mesh-list
82739634|NCT00784914|MTOR Inhibitors|mtor inhibitors|mesh-list
82739635|NCT00784914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82739636|NCT00784914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739637|NCT00784914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739638|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82739639|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
82739640|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739641|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739642|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82739643|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739644|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82739645|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
82739646|NCT00745004|Ondansetron|ondansetron|mesh-list
82739647|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
82739648|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
82739649|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739650|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739651|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82739652|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
82739653|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
82739654|NCT00745004|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82739655|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82739656|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
82739657|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739658|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739659|NCT05450978|Lamotrigine|lamotrigine|mesh-list
82739660|NCT05450978|Levetiracetam|levetiracetam|mesh-list
82739661|NCT05450978|Anticonvulsants|anticonvulsants|mesh-list
82739662|NCT05450978|Nootropic Agents|nootropic agents|mesh-ancestor
82739663|NCT05450978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82739664|NCT05450978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82739665|NCT05450978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739666|NCT05450978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82739667|NCT05450978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739668|NCT05450978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82739669|NCT05450978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82739670|NCT05450978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82739671|NCT05450978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82739672|NCT05450978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82739674|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82739675|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82739676|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
82739677|NCT00921674|Ivermectin|ivermectin|mesh-list
82739678|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82739679|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739680|NCT00667446|Leuprolide|leuprolide|mesh-list
82739681|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82739682|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
82739683|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82739684|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739685|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82739686|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739687|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82739688|NCT00777972|Fosinopril|fosinopril|mesh-list
82739689|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82739690|NCT00777972|Diuretics|diuretics|mesh-ancestor
82739691|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
82739692|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739693|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82739694|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82739695|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739696|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82739697|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
82739698|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739699|NCT00778050|Amoxicillin|amoxicillin|mesh-list
82739700|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82739701|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739702|NCT00746486|Budesonide|budesonide|mesh-list
82739703|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739704|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82739705|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
82739706|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739707|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739708|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82739709|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
82739710|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
82739711|NCT00746486|Hormones|hormones|mesh-ancestor
82739712|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739713|NCT00778128|Gemcitabine|gemcitabine|mesh-list
82739714|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82739715|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
82739716|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739717|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739718|NCT00778284|Amoxicillin|amoxicillin|mesh-list
82739719|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82739720|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739721|NCT00749138|Tamoxifen|tamoxifen|mesh-list
82739722|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82739723|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
82739724|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739725|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739726|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82739727|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739728|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82739729|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82739730|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82739731|NCT02563340|Rituximab|rituximab|mesh-list
82739732|NCT02563340|Bortezomib|bortezomib|mesh-list
82739733|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82739734|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739735|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
82739736|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739737|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739738|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
82739739|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82739740|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
82739741|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739742|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739743|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82739744|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
82739745|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82739747|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739748|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739749|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82739750|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
82739751|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
82739752|NCT00782652|Protective Agents|protective agents|mesh-ancestor
82739753|NCT00785382|Pregabalin|pregabalin|mesh-list
82739754|NCT00785382|Analgesics|analgesics|mesh-ancestor
82739755|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
82739756|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739757|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739758|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
82739759|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82739760|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82739761|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739762|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82739763|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82739764|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82739765|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82739766|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82739767|NCT00667368|Metronidazole|metronidazole|mesh-list
82739768|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82739769|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82739770|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82739771|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82739772|NCT00785460|Benphothiamine|benphothiamine|mesh-list
82739773|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82739774|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
82739775|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739776|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
82739777|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
82739778|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739779|NCT00567567|Vitamin A|vitamin a|mesh-list
82739780|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
82739781|NCT00567567|Melphalan|melphalan|mesh-list
82739782|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
82739783|NCT00567567|Thiotepa|thiotepa|mesh-list
82739784|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
82739785|NCT00567567|Cisplatin|cisplatin|mesh-list
82739786|NCT00567567|Carboplatin|carboplatin|mesh-list
82739787|NCT00567567|Doxorubicin|doxorubicin|mesh-list
82739788|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82739789|NCT00567567|Etoposide|etoposide|mesh-list
82739790|NCT00567567|Vincristine|vincristine|mesh-list
82739791|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
82739792|NCT00567567|Topotecan|topotecan|mesh-list
82739793|NCT00567567|Tretinoin|tretinoin|mesh-list
82739794|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
82739795|NCT00567567|Isotretinoin|isotretinoin|mesh-list
82739796|NCT00567567|Lenograstim|lenograstim|mesh-list
82739797|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82739798|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
82739799|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739800|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739801|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82739802|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
82739803|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739804|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739805|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82739806|NCT00567567|Vitamins|vitamins|mesh-ancestor
82739807|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
82739808|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82739809|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82739810|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82739811|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739812|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82739813|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82739814|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
82739815|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
82739816|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
82739817|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82739818|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
82739819|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
82739820|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
82739821|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
82739822|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82739823|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82739824|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739825|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739826|NCT00666198|Urological Agents|urological agents|mesh-ancestor
82739828|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739829|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
82739830|NCT00778596|Hormones|hormones|mesh-ancestor
82739831|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739832|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739833|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82739834|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739835|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82739836|NCT00778674|Benazepril|benazepril|mesh-list
82739837|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82739838|NCT00778674|Diuretics|diuretics|mesh-ancestor
82739839|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
82739840|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739841|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82739842|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82739843|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739844|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82739845|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
82739846|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739847|NCT00778752|Lenalidomide|lenalidomide|mesh-list
82739848|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
82739849|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739850|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82739851|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82739852|NCT00778752|Growth Substances|growth substances|mesh-ancestor
82739853|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
82739854|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739855|NCT00926835|Lamotrigine|lamotrigine|mesh-list
82739856|NCT00926835|Dexetimide|dexetimide|mesh-list
82739857|NCT00926835|Aripiprazole|aripiprazole|mesh-list
82739858|NCT00926835|Mirtazapine|mirtazapine|mesh-list
82739859|NCT00926835|Citalopram|citalopram|mesh-list
82739860|NCT00926835|Bupropion|bupropion|mesh-list
82739861|NCT00926835|Paroxetine|paroxetine|mesh-list
82739862|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82739863|NCT00926835|Escitalopram|escitalopram|mesh-list
82739864|NCT00926835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82739865|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82739866|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82739867|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739868|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739869|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
82739870|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739871|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82739872|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82739873|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
82739874|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
82739875|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739876|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82739877|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82739878|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
82739879|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82739880|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
82739881|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82739882|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82739883|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
82739884|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82739885|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82739886|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739887|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82739888|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82739889|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82739890|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
82739891|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82739892|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82739893|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82739894|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82739895|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82739896|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82739897|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82739899|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82739900|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82739901|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82739902|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82739903|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
82739904|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
82739905|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82739906|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82739907|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82739908|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82739909|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
82739910|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82739911|NCT00930033|Sunitinib|sunitinib|mesh-list
82739912|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739913|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82739914|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82739915|NCT00930033|Growth Substances|growth substances|mesh-ancestor
82739916|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739917|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
82739918|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82739919|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739920|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739921|NCT00664560|Celecoxib|celecoxib|mesh-list
82739922|NCT00664560|Antacids|antacids|mesh-list
82739923|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82739924|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82739925|NCT00664560|Analgesics|analgesics|mesh-ancestor
82739926|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
82739927|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739928|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739929|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739930|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82739931|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82739932|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82739933|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739934|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739935|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82739936|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82739937|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82739938|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82739939|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
82739940|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739941|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82739942|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82739943|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739944|NCT00688688|Mirabegron|mirabegron|mesh-list
82739945|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82739946|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82739947|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82739948|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82739949|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
82739950|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82739951|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739952|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739953|NCT00688688|Urological Agents|urological agents|mesh-ancestor
82739954|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82739955|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82739956|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
82739957|NCT00930189|Triamcinolone|triamcinolone|mesh-list
82739958|NCT00930189|Ranibizumab|ranibizumab|mesh-list
82739959|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82739960|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82739961|NCT00930189|Growth Substances|growth substances|mesh-ancestor
82739962|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739963|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
82739964|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739965|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82739966|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
82739967|NCT00930189|Hormones|hormones|mesh-ancestor
82739968|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82739969|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
82739970|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82739971|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82739972|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
82739973|NCT00931827|Etonogestrel|etonogestrel|mesh-list
82739974|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82739975|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
82739976|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82739977|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739978|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82739979|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82739980|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82739982|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739983|NCT02561468|Nefopam|nefopam|mesh-list
82739984|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82739985|NCT02561468|Analgesics|analgesics|mesh-ancestor
82739986|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
82739987|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82739988|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739989|NCT02555748|Sunitinib|sunitinib|mesh-list
82739990|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82739991|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82739992|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82739993|NCT02555748|Growth Substances|growth substances|mesh-ancestor
82739994|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82739995|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
82739996|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82739997|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82739998|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82739999|NCT00930345|Sunitinib|sunitinib|mesh-list
82740000|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740001|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82740002|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82740003|NCT00930345|Growth Substances|growth substances|mesh-ancestor
82740004|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740005|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
82740006|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82740007|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740008|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740009|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
82740010|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82740011|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740012|NCT00746720|Etoricoxib|etoricoxib|mesh-list
82740013|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82740014|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82740015|NCT00746720|Analgesics|analgesics|mesh-ancestor
82740016|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
82740017|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740018|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740019|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740020|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82740021|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82740022|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82740023|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740024|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740025|NCT00686972|Glucagon|glucagon|mesh-list
82740026|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82740027|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82740028|NCT00686972|Hormones|hormones|mesh-ancestor
82740029|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82740030|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740031|NCT00686972|Incretins|incretins|mesh-ancestor
82740032|NCT00665652|Lenalidomide|lenalidomide|mesh-list
82740033|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
82740034|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740035|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82740036|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82740037|NCT00665652|Growth Substances|growth substances|mesh-ancestor
82740038|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
82740039|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740040|NCT00752024|Hemostatics|hemostatics|mesh-list
82740041|NCT00752024|Coagulants|coagulants|mesh-ancestor
82740042|NCT00937677|Natalizumab|natalizumab|mesh-list
82740043|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
82740044|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740045|NCT00786240|Fesoterodine|fesoterodine|mesh-list
82740046|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82740047|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82740048|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
82740049|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740050|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740051|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740052|NCT00786240|Urological Agents|urological agents|mesh-ancestor
82740053|NCT04498923|Dexamethasone|dexamethasone|mesh-list
82740054|NCT04498923|Epinephrine|epinephrine|mesh-list
82740055|NCT04498923|Bupivacaine|bupivacaine|mesh-list
82740056|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740057|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
82740058|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
82740059|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740060|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740061|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82740062|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
82740064|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82740065|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82740066|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740067|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
82740068|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
82740069|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740070|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
82740071|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82740072|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82740073|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
82740074|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740075|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740076|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82740077|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82740078|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82740079|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
82740080|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
82740081|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
82740082|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82740083|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
82740084|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82740085|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
82740086|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82740087|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
82740088|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740089|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740090|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
82740091|NCT04046874|Analgesics|analgesics|mesh-list
82740092|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
82740093|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740094|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740095|NCT00932217|Lenograstim|lenograstim|mesh-list
82740096|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82740097|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
82740098|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740099|NCT00786318|Ziprasidone|ziprasidone|mesh-list
82740100|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82740101|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
82740102|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740103|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740104|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740105|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82740106|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82740107|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740108|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82740109|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82740110|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
82740111|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82740112|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82740113|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82740114|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740115|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740116|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82740117|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82740118|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82740119|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
82740120|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740121|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740350|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
82740122|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82740123|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82740124|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
82740125|NCT00937911|Darexaban|darexaban|mesh-list
82740126|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82740127|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
82740128|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82740129|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
82740130|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740131|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740132|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
82740133|NCT00930891|Bevacizumab|bevacizumab|mesh-list
82740134|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82740135|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740136|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82740137|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82740138|NCT00930891|Growth Substances|growth substances|mesh-ancestor
82740139|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740140|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
82740141|NCT00938379|Insect Repellents|insect repellents|mesh-list
82740142|NCT00938379|Protective Agents|protective agents|mesh-ancestor
82740143|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740144|NCT00661830|Gemcitabine|gemcitabine|mesh-list
82740145|NCT00661830|Sorafenib|sorafenib|mesh-list
82740146|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82740147|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
82740148|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740149|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740150|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82740151|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740152|NCT00932529|Olanzapine|olanzapine|mesh-list
82740153|NCT00932529|Risperidone|risperidone|mesh-list
82740154|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82740155|NCT00932529|Ziprasidone|ziprasidone|mesh-list
82740156|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82740157|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
82740158|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740159|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740160|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740161|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82740162|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82740163|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740164|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82740165|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82740166|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
82740167|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
82740168|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
82740169|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740170|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82740171|NCT00932529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82740172|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82740173|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82740174|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
82740175|NCT00783744|Insulin|insulin|mesh-list
82740176|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82740177|NCT00783744|Metformin|metformin|mesh-list
82740178|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
82740179|NCT00783744|Glimepiride|glimepiride|mesh-list
82740180|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
82740181|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
82740182|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
82740183|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82740184|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740185|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82740186|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82740187|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
82740188|NCT00932607|Immunomodulating Agents|immunomodulating agents|mesh-list
82740189|NCT00932607|Immunologic Factors|immunologic factors|mesh-ancestor
82740190|NCT00932607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740191|NCT00932685|Midazolam|midazolam|mesh-list
82740192|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82740193|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82740194|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740195|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740196|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82740197|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82740198|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82740199|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82740200|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
82740201|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
82740202|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
82740203|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
82740204|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740205|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740206|NCT00931125|Ranibizumab|ranibizumab|mesh-list
82740207|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82740208|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82740209|NCT00931125|Growth Substances|growth substances|mesh-ancestor
82740210|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740211|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
82740212|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740213|NCT00932763|Amlodipine|amlodipine|mesh-list
82740214|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82740215|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82740216|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82740217|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740218|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82740219|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740220|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
82740221|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82740222|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
82740223|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740224|NCT00783900|Metoprolol|metoprolol|mesh-list
82740225|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82740226|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82740227|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
82740228|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
82740229|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740230|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740231|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82740232|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82740233|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82740234|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
82740235|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740236|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740237|NCT00938613|Budesonide|budesonide|mesh-list
82740238|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740239|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82740240|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
82740241|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740242|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740243|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82740244|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
82740245|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
82740246|NCT00938613|Hormones|hormones|mesh-ancestor
82740247|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82740248|NCT00786552|Paclitaxel|paclitaxel|mesh-list
82740249|NCT00786552|Pemetrexed|pemetrexed|mesh-list
82740250|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82740251|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740252|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
82740253|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
82740254|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
82740255|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740256|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740257|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82740258|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82740259|NCT04047186|Nivolumab|nivolumab|mesh-list
82740260|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82740261|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740262|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82740263|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740264|NCT00931203|Celecoxib|celecoxib|mesh-list
82740265|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82740266|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82740267|NCT00931203|Analgesics|analgesics|mesh-ancestor
82740268|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
82740269|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740270|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740271|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740272|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82740273|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82740274|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82740275|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740276|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740277|NCT00565773|Sirolimus|sirolimus|mesh-list
82740278|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
82740279|NCT00565773|Abatacept|abatacept|mesh-list
82740280|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82740281|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740282|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82740283|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740284|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
82740285|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82740286|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
82740287|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740288|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740289|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82740290|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82740291|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82740292|NCT00570492|Fluticasone|fluticasone|mesh-list
82740293|NCT00570492|Xhance|xhance|mesh-list
82740294|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740295|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82740296|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
82740297|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740298|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740299|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82740300|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
82740301|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
82740302|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82740304|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82740305|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82740306|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
82740307|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740308|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740309|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82740310|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82740311|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
82740312|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740313|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82740314|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82740315|NCT04014855|Lactoferrin|lactoferrin|mesh-list
82740316|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740317|NCT00571922|Acamprosate|acamprosate|mesh-list
82740318|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82740319|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
82740320|NCT00933231|Prednisone|prednisone|mesh-list
82740321|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
82740322|NCT00933231|Ramipril|ramipril|mesh-list
82740323|NCT00933231|Irbesartan|irbesartan|mesh-list
82740324|NCT00933231|Tacrolimus|tacrolimus|mesh-list
82740325|NCT00933231|Basiliximab|basiliximab|mesh-list
82740326|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740327|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
82740328|NCT00933231|Hormones|hormones|mesh-ancestor
82740329|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82740330|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740331|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82740332|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740333|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82740334|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
82740335|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82740336|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740337|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740338|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
82740339|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
82740340|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740341|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82740342|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82740343|NCT00933231|Protective Agents|protective agents|mesh-ancestor
82740344|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82740345|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82740346|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
82740347|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82740348|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740349|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82740351|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82740352|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82740353|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82740354|NCT03489525|Antibodies|antibodies|mesh-list
82740355|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
82740356|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
82740357|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
82740358|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740359|NCT00752180|Insulin|insulin|mesh-list
82740360|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82740361|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82740362|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740363|NCT00784290|Orantinib|orantinib|mesh-list
82740364|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82740365|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740366|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740367|NCT00752414|Levofloxacin|levofloxacin|mesh-list
82740368|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82740369|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740370|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82740371|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82740372|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82740373|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740374|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740375|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740376|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82740377|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82740378|NCT04059224|Trametinib|trametinib|mesh-list
82740379|NCT04059224|Dabrafenib|dabrafenib|mesh-list
82740380|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740381|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82740382|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740383|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740384|NCT00686894|Infliximab|infliximab|mesh-list
82740385|NCT00686894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82740386|NCT00686894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740387|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
82740388|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82740389|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82740390|NCT00328627|Pioglitazone|pioglitazone|mesh-list
82740391|NCT00328627|Alogliptin|alogliptin|mesh-list
82740392|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82740393|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740394|NCT00328627|Incretins|incretins|mesh-ancestor
82740395|NCT00328627|Hormones|hormones|mesh-ancestor
82740396|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82740397|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82740398|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
82740399|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740400|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740401|NCT03374956|Liraglutide|liraglutide|mesh-list
82740402|NCT03374956|Topiramate|topiramate|mesh-list
82740403|NCT03374956|Phentermine|phentermine|mesh-list
82740404|NCT03374956|Naltrexone|naltrexone|mesh-list
82740405|NCT03374956|Bupropion|bupropion|mesh-list
82740406|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82740407|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82740408|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740409|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
82740410|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740411|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82740412|NCT03374956|Incretins|incretins|mesh-ancestor
82740413|NCT03374956|Hormones|hormones|mesh-ancestor
82740414|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82740415|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82740416|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
82740417|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82740418|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82740419|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82740420|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82740421|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740422|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
82740423|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740424|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82740425|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82740426|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740427|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
82740428|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82740429|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
82740430|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82740431|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
82740432|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
82740433|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
82740434|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
82740435|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82740436|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740438|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82740439|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
82740440|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82740441|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740442|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
82740443|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82740444|NCT05223400|Clindamycin|clindamycin|mesh-list
82740445|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
82740446|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
82740447|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82740448|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740449|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82740450|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740451|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740452|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
82740453|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82740454|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
82740455|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740456|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740457|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82740458|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
82740459|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82740460|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
82740461|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740462|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740463|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82740464|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
82740465|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
82740466|NCT00790608|Protective Agents|protective agents|mesh-ancestor
82740467|NCT00749450|Fluorouracil|fluorouracil|mesh-list
82740468|NCT00749450|Capecitabine|capecitabine|mesh-list
82740469|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
82740470|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
82740471|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740472|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82740473|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740474|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82740475|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
82740476|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740477|NCT00795444|Maraviroc|maraviroc|mesh-list
82740478|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82740479|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82740480|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740481|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82740482|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82740483|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
82740484|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740485|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82740486|NCT02561936|Rilpivirine|rilpivirine|mesh-list
82740487|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82740488|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82740489|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740490|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740491|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
82740492|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740493|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82740494|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82740495|NCT00752648|Simeprevir|simeprevir|mesh-list
82740496|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
82740497|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740498|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
82740499|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740500|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740501|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
82740502|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82740503|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82740504|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740505|NCT00752882|Ceftazidime|ceftazidime|mesh-list
82740506|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82740507|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740508|NCT01060735|Vitamin D|vitamin d|mesh-list
82740509|NCT01060735|Vitamins|vitamins|mesh-ancestor
82740510|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
82740511|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740512|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82740513|NCT02555358|Docetaxel|docetaxel|mesh-list
82740514|NCT02555358|Capecitabine|capecitabine|mesh-list
82740515|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
82740516|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740517|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
82740518|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
82740519|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
82740520|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740521|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82740522|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
82740523|NCT00683774|Diazoxide|diazoxide|mesh-list
82740524|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82740525|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
82740526|NCT00787410|Gefitinib|gefitinib|mesh-list
82740527|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740528|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82740529|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740530|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740531|NCT03989557|Aspirin|aspirin|mesh-list
82740532|NCT03989557|Clopidogrel|clopidogrel|mesh-list
82740533|NCT03989557|Ticagrelor|ticagrelor|mesh-list
82740534|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82740535|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82740536|NCT03989557|Analgesics|analgesics|mesh-ancestor
82740537|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
82740538|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740539|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740540|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740541|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82740542|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82740543|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82740544|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740545|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82740546|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82740547|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740548|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
82740549|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82740550|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82740551|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82740552|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
82740553|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740554|NCT00790998|Ivermectin|ivermectin|mesh-list
82740555|NCT00790998|Moxidectin|moxidectin|mesh-list
82740556|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82740557|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740558|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
82740559|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
82740560|NCT02555046|Anesthetics|anesthetics|mesh-list
82740568|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82740569|NCT00354679|Growth Substances|growth substances|mesh-ancestor
82740570|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740571|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
82740572|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82740573|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82740574|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740575|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740576|NCT00540514|Paclitaxel|paclitaxel|mesh-list
82740577|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82740578|NCT00540514|Carboplatin|carboplatin|mesh-list
82740579|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82740581|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
82740582|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
82740583|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
82740584|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740585|NCT00663702|Abatacept|abatacept|mesh-list
82740586|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82740587|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740588|NCT00663702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82740589|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740590|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82740591|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
82740592|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740593|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82740594|NCT02022592|Midazolam|midazolam|mesh-list
82740595|NCT02022592|Lormetazepam|lormetazepam|mesh-list
82740596|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82740597|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82740598|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740599|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740600|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82740601|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82740602|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82740603|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82740604|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
82740605|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
82740606|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
82740607|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
82740608|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740609|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740610|NCT00683618|Atorvastatin|atorvastatin|mesh-list
82740611|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82740612|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82740613|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82740614|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
82740615|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740616|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82740617|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82740618|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740648|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740649|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
82740650|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
82740651|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
82740652|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740653|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82740654|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
82740655|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740656|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82740657|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82740658|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
82740659|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82740660|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82740661|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
82740662|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82740663|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82740664|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82740665|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740666|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82740667|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82740669|NCT00753038|Carboplatin|carboplatin|mesh-list
82740670|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82740671|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740672|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
82740673|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
82740674|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
82740675|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740676|NCT00795756|Cytarabine|cytarabine|mesh-list
82740677|NCT00795756|Methotrexate|methotrexate|mesh-list
82740678|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82740679|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
82740680|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82740681|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740682|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82740683|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
82740684|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740685|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740686|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
82740687|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740688|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82740689|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82740690|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
82740691|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82740692|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82740693|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
82740694|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740696|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740697|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
82740698|NCT04058522|Hormones|hormones|mesh-ancestor
82740699|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82740700|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740701|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82740702|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82740703|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82740704|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740705|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740706|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82740707|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82740708|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82740709|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
82740710|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740711|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740712|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82740713|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82740714|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
82740715|NCT01563952|Sirolimus|sirolimus|mesh-list
82740716|NCT01563952|Umirolimus|umirolimus|mesh-list
82740717|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82740718|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740719|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82740720|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740721|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
82740722|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82740723|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
82740724|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740725|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740726|NCT00795912|Atorvastatin|atorvastatin|mesh-list
82740727|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82740728|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82740729|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
82740730|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740731|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82740732|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82740733|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740734|NCT00788034|Vortioxetine|vortioxetine|mesh-list
82740735|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
82740736|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82740737|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82740738|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82740739|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740740|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740741|NCT00788034|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82740742|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82740743|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82740744|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740745|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740746|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
82740747|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82740748|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82740749|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82740750|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82740751|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
82740752|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82740753|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
82740754|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82740755|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740756|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82740757|NCT00688064|Doxycycline|doxycycline|mesh-list
82740758|NCT00688064|Adapalene|adapalene|mesh-list
82740759|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82740760|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740761|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
82740762|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82740763|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82740764|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82740765|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82740766|NCT00688064|Analgesics|analgesics|mesh-ancestor
82740767|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
82740768|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740769|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740770|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740771|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82740772|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
82740773|NCT00788112|Vorinostat|vorinostat|mesh-list
82740774|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740775|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82740776|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740777|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740778|NCT03112174|Venetoclax|venetoclax|mesh-list
82740779|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740780|NCT00749918|Vitamin D|vitamin d|mesh-list
82740781|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
82740782|NCT00749918|Vitamins|vitamins|mesh-ancestor
82740783|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
82740784|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740785|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82740786|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82740787|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
82740788|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740789|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
82740790|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82740791|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82740792|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740793|NCT04058132|Urological Agents|urological agents|mesh-ancestor
82740794|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82740795|NCT00791544|Sorafenib|sorafenib|mesh-list
82740796|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740797|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82740798|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740799|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740800|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82740801|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
82740802|NCT05171686|Torsemide|torsemide|mesh-list
82740803|NCT05171686|Furosemide|furosemide|mesh-list
82740804|NCT05171686|Bumetanide|bumetanide|mesh-list
82740805|NCT05171686|Diuretics|diuretics|mesh-list
82740806|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82740807|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
82740808|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740809|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82740810|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82740811|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740812|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82740813|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82740814|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82740815|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82740816|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
82740817|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740818|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82740819|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82740820|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740821|NCT00663234|Atorvastatin|atorvastatin|mesh-list
82740822|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82740823|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82740824|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
82740825|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740826|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82740827|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82740828|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740829|NCT00683384|Etanercept|etanercept|mesh-list
82740830|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82740831|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82740832|NCT00683384|Analgesics|analgesics|mesh-ancestor
82740833|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
82740834|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740835|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740836|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740837|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82740838|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82740839|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82740840|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
82740841|NCT00753740|Camptothecin|camptothecin|mesh-list
82740842|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82740843|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740844|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82740845|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82740846|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740847|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740848|NCT00326911|Bevacizumab|bevacizumab|mesh-list
82740849|NCT00326911|Cetuximab|cetuximab|mesh-list
82740850|NCT00326911|Gemcitabine|gemcitabine|mesh-list
82740851|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82740852|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740853|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82740854|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82740855|NCT00326911|Growth Substances|growth substances|mesh-ancestor
82740856|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740857|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
82740858|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82740859|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
82740860|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740861|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82740862|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82740863|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82740864|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740865|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740866|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82740867|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82740868|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82740869|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
82740870|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740871|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740872|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82740873|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82740874|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
82740875|NCT00747110|Budesonide|budesonide|mesh-list
82740876|NCT00747110|Mesalamine|mesalamine|mesh-list
82740877|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82740878|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82740879|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
82740880|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740881|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740882|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82740883|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
82740884|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
82740885|NCT00747110|Hormones|hormones|mesh-ancestor
82740886|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82740887|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82740888|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82740889|NCT00747110|Analgesics|analgesics|mesh-ancestor
82740890|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
82740891|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82740892|NCT00796458|Docetaxel|docetaxel|mesh-list
82740893|NCT00796458|Hormones|hormones|mesh-list
82740894|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740895|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
82740896|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
82740897|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
82740898|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740899|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82740900|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740901|NCT04046016|Paclitaxel|paclitaxel|mesh-list
82740902|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82740903|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740904|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
82740905|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
82740906|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
82740907|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740908|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
82740909|NCT01057615|Vitamins|vitamins|mesh-ancestor
82740910|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
82740911|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740912|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
82740913|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740914|NCT01057615|Protective Agents|protective agents|mesh-ancestor
82740915|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
82740916|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82740917|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
82740918|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740919|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740920|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82740921|NCT00788424|Protective Agents|protective agents|mesh-ancestor
82740922|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82740923|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82740924|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740925|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740926|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
82740927|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740928|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
82740929|NCT00791856|Testosterone|testosterone|mesh-list
82740930|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
82740931|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
82740932|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82740933|NCT00791856|Androgens|androgens|mesh-ancestor
82740934|NCT00791856|Hormones|hormones|mesh-ancestor
82740935|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82740936|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740937|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82740938|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740939|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
82740940|NCT00796692|Heparin|heparin|mesh-list
82740941|NCT00796692|Calcium heparin|calcium heparin|mesh-list
82740942|NCT00796692|Nadroparin|nadroparin|mesh-list
82740943|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
82740944|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82740945|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82740946|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740947|NCT00540436|Ambrisentan|ambrisentan|mesh-list
82740948|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82740949|NCT00788580|Sirolimus|sirolimus|mesh-list
82740950|NCT00788580|Temsirolimus|temsirolimus|mesh-list
82740951|NCT00788580|MTOR Inhibitors|mtor inhibitors|mesh-list
82740952|NCT00788580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82740953|NCT00788580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82740954|NCT00788580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740955|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82740956|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
82740957|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740958|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740959|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82740960|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82740961|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82740962|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
82740963|NCT00792012|Temozolomide|temozolomide|mesh-list
82740964|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82740965|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
82740966|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740967|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82740968|NCT00990418|Fentanyl|fentanyl|mesh-list
82740969|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82740970|NCT00990418|Narcotics|narcotics|mesh-ancestor
82740971|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740972|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740973|NCT00990418|Analgesics|analgesics|mesh-ancestor
82740974|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
82740975|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82740976|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82740977|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82740978|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
82740979|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
82740980|NCT02562950|Midazolam|midazolam|mesh-list
82740981|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82740982|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82740983|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82740984|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82740985|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82740986|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82740987|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82740988|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82740989|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
82740990|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
82740991|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
82740992|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
82740993|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82740994|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740995|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82740996|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82740997|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82740998|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82740999|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741000|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741001|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741002|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82741003|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
82741004|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82741005|NCT00687440|Docetaxel|docetaxel|mesh-list
82741006|NCT00687440|Doxorubicin|doxorubicin|mesh-list
82741007|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82741008|NCT00687440|Trastuzumab|trastuzumab|mesh-list
82741009|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741010|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
82741011|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
82741012|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
82741013|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741014|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82741015|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82741016|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82741017|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741018|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82741019|NCT02554734|Levodopa|levodopa|mesh-list
82741020|NCT02554734|Carbidopa|carbidopa|mesh-list
82741021|NCT02554734|Entacapone|entacapone|mesh-list
82741022|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82741023|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82741024|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
82741025|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741026|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741027|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741028|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82741029|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741030|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82741031|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
82741032|NCT00990496|Fludarabine|fludarabine|mesh-list
82741033|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741034|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
82741035|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741036|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82741037|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82741038|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
82741039|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741040|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741041|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82741042|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
82741044|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741045|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
82741046|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82741047|NCT00755066|Fluticasone|fluticasone|mesh-list
82741049|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741050|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82741051|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
82741052|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741053|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741054|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82741055|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
82741056|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
82741057|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82741058|NCT00990574|Anesthetics|anesthetics|mesh-list
82741059|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741060|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741061|NCT00659490|Naproxen|naproxen|mesh-list
82741062|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82741063|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82741064|NCT00659490|Analgesics|analgesics|mesh-ancestor
82741065|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
82741066|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741067|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741068|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741069|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82741070|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
82741071|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82741072|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741073|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741074|NCT00792246|Voriconazole|voriconazole|mesh-list
82741075|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
82741076|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741077|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82741078|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82741079|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741080|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741081|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82741082|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
82741083|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82741084|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741085|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82741086|NCT00539500|Carboplatin|carboplatin|mesh-list
82741087|NCT00539500|Etoposide|etoposide|mesh-list
82741088|NCT00539500|Melphalan|melphalan|mesh-list
82741089|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741090|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82741091|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82741092|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82741093|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741094|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741095|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82741096|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
82741097|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82741098|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741099|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
82741101|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82741102|NCT00662532|Minocycline|minocycline|mesh-list
82741103|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741105|NCT00792324|Etravirine|etravirine|mesh-list
82741106|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82741107|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82741108|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741109|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741110|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
82741111|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741112|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82741113|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82741114|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82741115|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82741116|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82741117|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82741118|NCT00990808|Atorvastatin|atorvastatin|mesh-list
82741119|NCT00990808|Anacetrapib|anacetrapib|mesh-list
82741120|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82741121|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82741122|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
82741123|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741124|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82741125|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82741126|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741127|NCT00797160|Propofol|propofol|mesh-list
82741128|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82741129|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741130|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741131|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82741132|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
82741133|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
82741134|NCT00682448|Metformin|metformin|mesh-list
82741135|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82741136|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741137|NCT04003792|Bevacizumab|bevacizumab|mesh-list
82741138|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
82741139|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82741140|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741141|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82741142|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82741143|NCT04003792|Growth Substances|growth substances|mesh-ancestor
82741144|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741145|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
82741146|NCT00990886|Oxybutynin|oxybutynin|mesh-list
82741147|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
82741148|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
82741149|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741150|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741151|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82741152|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82741153|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
82741154|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741155|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741156|NCT00990886|Urological Agents|urological agents|mesh-ancestor
82741157|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
82741158|NCT00797394|Urological Agents|urological agents|mesh-ancestor
82741159|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82741160|NCT00681824|Thrombin|thrombin|mesh-list
82741161|NCT00681824|Aprotinin|aprotinin|mesh-list
82741162|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
82741163|NCT00681824|Coagulants|coagulants|mesh-ancestor
82741164|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82741165|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82741166|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
82741167|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741168|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741169|NCT00797472|Bleomycin|bleomycin|mesh-list
82741170|NCT00797472|Dacarbazine|dacarbazine|mesh-list
82741171|NCT00797472|Vinblastine|vinblastine|mesh-list
82741172|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82741173|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741174|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741175|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82741176|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
82741177|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82741178|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
82741179|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
82741180|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
82741181|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82741182|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
82741183|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82741184|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82741185|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82741186|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741187|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741189|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82741190|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
82741191|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741192|NCT00539188|Expectorants|expectorants|mesh-ancestor
82741193|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
82741194|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82741195|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
82741196|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741197|NCT00539188|Protective Agents|protective agents|mesh-ancestor
82741198|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741199|NCT00539188|Antidotes|antidotes|mesh-ancestor
82741200|NCT00681590|Vitamin D|vitamin d|mesh-list
82741201|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
82741202|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
82741203|NCT00681590|Vitamins|vitamins|mesh-list
82741204|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
82741205|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741206|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82741207|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82741208|NCT05359432|Empagliflozin|empagliflozin|mesh-list
82741209|NCT05359432|Vildagliptin|vildagliptin|mesh-list
82741210|NCT05359432|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82741211|NCT05359432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741212|NCT05359432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82741213|NCT05359432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741214|NCT05359432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82741215|NCT05359432|Protease Inhibitors|protease inhibitors|mesh-ancestor
82741216|NCT05359432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741217|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82741218|NCT00755534|Capecitabine|capecitabine|mesh-list
82741219|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
82741220|NCT00755534|Irinotecan|irinotecan|mesh-list
82741221|NCT00755534|Cetuximab|cetuximab|mesh-list
82741222|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82741223|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
82741224|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741225|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741226|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82741227|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82741228|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741229|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82741230|NCT00326599|Carboplatin|carboplatin|mesh-list
82741231|NCT00326599|Gemcitabine|gemcitabine|mesh-list
82741232|NCT00326599|Cediranib|cediranib|mesh-list
82741233|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741234|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82741235|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
82741236|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741237|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741238|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82741239|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
82741240|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82741241|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
82741242|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741243|NCT00750386|Paclitaxel|paclitaxel|mesh-list
82741244|NCT00750386|Carboplatin|carboplatin|mesh-list
82741245|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82741246|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741247|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
82741248|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
82741249|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
82741250|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741251|NCT00539032|Vaccines|vaccines|mesh-list
82741252|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
82741253|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741254|NCT00685802|Cilostazol|cilostazol|mesh-list
82741255|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82741256|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
82741257|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741258|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741259|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82741260|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
82741261|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82741262|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82741263|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741264|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82741265|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
82741266|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82741267|NCT00685802|Protective Agents|protective agents|mesh-ancestor
82741268|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82741269|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82741270|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741271|NCT01054651|Artesunate|artesunate|mesh-list
82741272|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
82741273|NCT01054651|Sulfalene|sulfalene|mesh-list
82741274|NCT01054651|Praziquantel|praziquantel|mesh-list
82741275|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
82741276|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82741277|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82741278|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741279|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741280|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
82741281|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
82741282|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82741283|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
82741284|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82741285|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741286|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741287|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82741288|NCT00792714|Mannitol|mannitol|mesh-list
82741289|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82741290|NCT00792714|Diuretics|diuretics|mesh-ancestor
82741291|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
82741292|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741293|NCT04961554|Anesthetics|anesthetics|mesh-list
82741294|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741295|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741296|NCT00354601|Docetaxel|docetaxel|mesh-list
82741297|NCT00354601|Capecitabine|capecitabine|mesh-list
82741298|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741299|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
82741300|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
82741301|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
82741302|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741303|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82741304|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
82741305|NCT01563640|Permethrin|permethrin|mesh-list
82741306|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741307|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741308|NCT00750620|Mirabegron|mirabegron|mesh-list
82741309|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82741310|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82741311|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82741312|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
82741313|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741314|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741315|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741316|NCT00750620|Urological Agents|urological agents|mesh-ancestor
82741317|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
82741318|NCT03827473|Prednisone|prednisone|mesh-list
82741319|NCT03827473|Cortisone|cortisone|mesh-list
82741320|NCT03827473|Docetaxel|docetaxel|mesh-list
82741321|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
82741322|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
82741323|NCT03827473|Hormones|hormones|mesh-list
82741324|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82741325|NCT03827473|Androgens|androgens|mesh-list
82741326|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
82741327|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741328|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
82741329|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
82741330|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
82741331|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741332|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741333|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
82741334|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82741335|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741336|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82741337|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82741338|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741339|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
82741340|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82741341|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
82741342|NCT03827473|Protective Agents|protective agents|mesh-ancestor
82741343|NCT03827473|Vitamins|vitamins|mesh-ancestor
82741344|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
82741345|NCT03827473|Estrogens|estrogens|mesh-ancestor
82741346|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
82741347|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
82741348|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
82741349|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82741350|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82741351|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741352|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741353|NCT00800592|Urological Agents|urological agents|mesh-ancestor
82741354|NCT00797784|Etanercept|etanercept|mesh-list
82741355|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82741356|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82741357|NCT00797784|Analgesics|analgesics|mesh-ancestor
82741358|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
82741359|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741360|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741361|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741362|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82741363|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82741364|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741365|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
82741366|NCT00747968|Exenatide|exenatide|mesh-list
82741367|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82741368|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741369|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82741370|NCT00747968|Incretins|incretins|mesh-ancestor
82741371|NCT00747968|Hormones|hormones|mesh-ancestor
82741372|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82741373|NCT00755924|Acetic Acid|acetic acid|mesh-list
82741374|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82741375|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741376|NCT00800748|Ribavirin|ribavirin|mesh-list
82741377|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82741378|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
82741379|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741380|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
82741381|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741382|NCT05426174|Vaccines|vaccines|mesh-list
82741383|NCT05426174|Immunologic Factors|immunologic factors|mesh-ancestor
82741384|NCT05426174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741385|NCT00798252|Paclitaxel|paclitaxel|mesh-list
82741386|NCT00798252|Docetaxel|docetaxel|mesh-list
82741387|NCT00798252|Doxorubicin|doxorubicin|mesh-list
82741388|NCT00798252|Capecitabine|capecitabine|mesh-list
82741389|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82741390|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741391|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
82741392|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
82741393|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
82741394|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741395|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82741396|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82741397|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82741398|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741399|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82741400|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
82741401|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
82741402|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741403|NCT00326209|Mesalamine|mesalamine|mesh-list
82741404|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82741405|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82741407|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
82741408|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741409|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741410|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741411|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82741412|NCT00537940|Pregabalin|pregabalin|mesh-list
82741413|NCT00537940|Gabapentin|gabapentin|mesh-list
82741414|NCT00537940|Analgesics|analgesics|mesh-ancestor
82741415|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
82741416|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741417|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741418|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
82741419|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82741420|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82741421|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741422|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82741423|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82741424|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82741425|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741426|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82741427|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82741428|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82741429|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741430|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
82741431|NCT00661362|Metformin|metformin|mesh-list
82741432|NCT00661362|Saxagliptin|saxagliptin|mesh-list
82741433|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82741434|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741435|NCT00661362|Incretins|incretins|mesh-ancestor
82741436|NCT00661362|Hormones|hormones|mesh-ancestor
82741437|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82741438|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82741439|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
82741440|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741441|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741442|NCT00748202|Complement C1s|complement c1s|mesh-list
82741443|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
82741444|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
82741445|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
82741823|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
82741446|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741447|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82741448|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741449|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82741451|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741452|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
82741453|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82741454|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741455|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741456|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82741457|NCT00800826|Analgesics|analgesics|mesh-ancestor
82741458|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
82741459|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741460|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82741461|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82741462|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82741463|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
82741464|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741465|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741466|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
82741467|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82741468|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741469|NCT03989089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82741470|NCT03989089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741471|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
82741472|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
82741473|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82741474|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82741475|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741476|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741477|NCT00793338|Urological Agents|urological agents|mesh-ancestor
82741478|NCT05406856|Cisplatin|cisplatin|mesh-list
82741479|NCT05406856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741480|NCT00344773|Gefitinib|gefitinib|mesh-list
82741481|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741482|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82741483|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741484|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741485|NCT02554344|Curcumin|curcumin|mesh-list
82741486|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82741487|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82741488|NCT02554344|Analgesics|analgesics|mesh-ancestor
82741489|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
82741490|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741491|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741492|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741493|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82741494|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741495|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741496|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741497|NCT01055041|Budesonide|budesonide|mesh-list
82741498|NCT01055041|Doxofylline|doxofylline|mesh-list
82741499|NCT01055041|Montelukast|montelukast|mesh-list
82741500|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741501|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82741502|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
82741503|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741504|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741505|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82741506|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
82741507|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
82741508|NCT01055041|Hormones|hormones|mesh-ancestor
82741509|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82741510|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82741511|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
82741512|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82741513|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82741514|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741515|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
82741516|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82741517|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741518|NCT00325819|Acetaminophen|acetaminophen|mesh-list
82741519|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82741520|NCT00325819|Analgesics|analgesics|mesh-ancestor
82741521|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
82741522|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741523|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741524|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
82741526|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741527|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82741528|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82741529|NCT00748358|Growth Substances|growth substances|mesh-ancestor
82741530|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741531|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
82741532|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82741533|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741534|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741535|NCT00748436|Betahistine|betahistine|mesh-list
82741536|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
82741537|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
82741538|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
82741539|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741540|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741541|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741542|NCT00756860|Sevelamer|sevelamer|mesh-list
82741543|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
82741544|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
82741545|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741546|NCT00757016|Triamcinolone|triamcinolone|mesh-list
82741547|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82741548|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82741549|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82741550|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741551|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
82741552|NCT00757016|Hormones|hormones|mesh-ancestor
82741553|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82741554|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741555|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741556|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
82741557|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741558|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741559|NCT00687362|Infliximab|infliximab|mesh-list
82741560|NCT00687362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82741561|NCT00687362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741562|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
82741563|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82741564|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82741565|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
82741566|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82741567|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
82741568|NCT00751478|Naltrexone|naltrexone|mesh-list
82741569|NCT00751478|Morphine|morphine|mesh-list
82741570|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82741571|NCT00751478|Narcotics|narcotics|mesh-ancestor
82741572|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741573|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741574|NCT00751478|Analgesics|analgesics|mesh-ancestor
82741575|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
82741576|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741577|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82741578|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82741579|NCT00751556|Naproxen|naproxen|mesh-list
82741580|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82741581|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82741582|NCT00751556|Analgesics|analgesics|mesh-ancestor
82741583|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
82741584|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741585|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741586|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741587|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82741588|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
82741589|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82741590|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741591|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741592|NCT00685334|Olanzapine|olanzapine|mesh-list
82741593|NCT00685334|Aripiprazole|aripiprazole|mesh-list
82741594|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
82741595|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
82741596|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741597|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741598|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82741599|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82741600|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82741601|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741602|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82741603|NCT00685334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82741604|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82741605|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82741606|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741607|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741608|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
82741609|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
82741610|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
82741611|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
82741612|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82741613|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82741614|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82741615|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82741616|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82741617|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82741618|NCT00801294|Nintedanib|nintedanib|mesh-list
82741619|NCT00801294|Afatinib|afatinib|mesh-list
82741620|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741621|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82741622|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741623|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741624|NCT04013919|Insulin|insulin|mesh-list
82741625|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82741626|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82741627|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741628|NCT00344461|Tenofovir|tenofovir|mesh-list
82741629|NCT00344461|Nevirapine|nevirapine|mesh-list
82741630|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
82741631|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741632|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82741633|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82741634|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741635|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741636|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82741637|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82741638|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82741639|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82741640|NCT00685178|Topiramate|topiramate|mesh-list
82741641|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
82741642|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82741643|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741644|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
82741646|NCT00537394|Darunavir|darunavir|mesh-list
82741647|NCT00537394|Tipranavir|tipranavir|mesh-list
82741648|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
82741649|NCT00537394|Etravirine|etravirine|mesh-list
82741650|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82741651|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82741652|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
82741653|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741654|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82741655|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82741656|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741657|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741658|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82741659|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82741660|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82741661|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82741662|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82741663|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
82741664|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82741665|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82741666|NCT00933309|Metformin|metformin|mesh-list
82741667|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
82741668|NCT00933309|Exemestane|exemestane|mesh-list
82741669|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82741670|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741671|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741672|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82741673|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82741674|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741675|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741676|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82741677|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
82741678|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82741679|NCT00352885|Escitalopram|escitalopram|mesh-list
82741680|NCT00352885|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82741681|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82741682|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82741683|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741684|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741685|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
82741686|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741687|NCT00933387|Paclitaxel|paclitaxel|mesh-list
82741688|NCT00933387|Cetuximab|cetuximab|mesh-list
82741689|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82741690|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741691|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
82741692|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
82741693|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
82741694|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741695|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82741696|NCT00660660|Esomeprazole|esomeprazole|mesh-list
82741697|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82741698|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82741699|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82741700|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741701|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741702|NCT02560766|Gabapentin|gabapentin|mesh-list
82741703|NCT02560766|Analgesics|analgesics|mesh-ancestor
82741704|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
82741705|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741706|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741707|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
82741708|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82741709|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82741710|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741711|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82741712|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82741713|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82741714|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741715|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741716|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
82741717|NCT00933465|Loperamide|loperamide|mesh-list
82741718|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
82741719|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82741720|NCT00757874|Clobetasol|clobetasol|mesh-list
82741721|NCT00757874|Tacrolimus|tacrolimus|mesh-list
82741722|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741723|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
82741724|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741725|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82741726|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741727|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741728|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741729|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
82741730|NCT00757874|Hormones|hormones|mesh-ancestor
82741731|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82741732|NCT00344305|Vaccines|vaccines|mesh-list
82741733|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
82741734|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741735|NCT00933777|Everolimus|everolimus|mesh-list
82741736|NCT00933777|Sorafenib|sorafenib|mesh-list
82741737|NCT00933777|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82741738|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82741739|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741740|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741741|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741742|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
82741743|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741744|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741745|NCT00801450|Triamcinolone|triamcinolone|mesh-list
82741746|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82741747|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82741748|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82741749|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741750|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
82741751|NCT00801450|Hormones|hormones|mesh-ancestor
82741752|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82741753|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741754|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741755|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
82741756|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741757|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741758|NCT00660816|Docetaxel|docetaxel|mesh-list
82741759|NCT00660816|Pemetrexed|pemetrexed|mesh-list
82741760|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82741761|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741762|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
82741763|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
82741764|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
82741765|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741766|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741767|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82741768|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82741769|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82741770|NCT00801528|Diclofenac|diclofenac|mesh-list
82741771|NCT00801528|Ropivacaine|ropivacaine|mesh-list
82741772|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
82741773|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
82741774|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741775|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741776|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
82741777|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741778|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82741779|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82741780|NCT00801528|Analgesics|analgesics|mesh-ancestor
82741781|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741782|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82741783|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82741784|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741785|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741786|NCT01060891|Colistin|colistin|mesh-list
82741787|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82741788|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741789|NCT04003402|Ethanol|ethanol|mesh-list
82741790|NCT04003402|ASP8062|asp8062|mesh-list
82741791|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82741792|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741793|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741794|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741795|NCT04003402|Analgesics|analgesics|mesh-ancestor
82741796|NCT04003402|Sensory System Agents|sensory system agents|mesh-ancestor
82741797|NCT04003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741798|NCT04003402|GABA Modulators|gaba modulators|mesh-ancestor
82741799|NCT04003402|GABA Agents|gaba agents|mesh-ancestor
82741800|NCT04003402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741801|NCT04003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741802|NCT00576056|Sorafenib|sorafenib|mesh-list
82741803|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741804|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82741805|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741806|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741807|NCT05360602|Thioctic Acid|thioctic acid|mesh-list
82741808|NCT05360602|Antioxidants|antioxidants|mesh-ancestor
82741809|NCT05360602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741810|NCT05360602|Protective Agents|protective agents|mesh-ancestor
82741811|NCT05360602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741812|NCT05360602|Vitamin B Complex|vitamin b complex|mesh-ancestor
82741813|NCT05360602|Vitamins|vitamins|mesh-ancestor
82741814|NCT05360602|Micronutrients|micronutrients|mesh-ancestor
82741815|NCT00991744|Cytarabine|cytarabine|mesh-list
82741816|NCT00991744|Cortisone|cortisone|mesh-list
82741817|NCT00991744|Prednisolone|prednisolone|mesh-list
82741818|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82741819|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
82741820|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82741821|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
82741822|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82741824|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82741825|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
82741826|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741827|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741828|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
82741829|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741830|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741831|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
82741832|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741833|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82741834|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
82741835|NCT00991744|Hormones|hormones|mesh-ancestor
82741836|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82741837|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82741838|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
82741839|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
82741840|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741841|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82741842|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82741843|NCT00991744|Protective Agents|protective agents|mesh-ancestor
82741844|NCT00798876|Vitamin E|vitamin e|mesh-list
82741845|NCT00798876|Vitamins|vitamins|mesh-ancestor
82741846|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
82741847|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741848|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
82741849|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741850|NCT00798876|Protective Agents|protective agents|mesh-ancestor
82741851|NCT00989404|Zanamivir|zanamivir|mesh-list
82741852|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
82741853|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741854|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741855|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741856|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82741857|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82741858|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82741859|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741860|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741861|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82741862|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82741863|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82741864|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
82741865|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741866|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741867|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82741868|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82741869|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
82741870|NCT00991822|Timolol|timolol|mesh-list
82741871|NCT00991822|Dorzolamide|dorzolamide|mesh-list
82741872|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82741873|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82741874|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
82741875|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741876|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741877|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741878|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82741879|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82741880|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82741881|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741882|NCT00798954|Sirolimus|sirolimus|mesh-list
82741883|NCT00798954|Paclitaxel|paclitaxel|mesh-list
82741884|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82741885|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741886|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
82741887|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
82741888|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
82741889|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741890|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82741891|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741892|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82741893|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
82741894|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741895|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
82741896|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741897|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82741898|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82741899|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82741900|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
82741901|NCT00934167|Heparin|heparin|mesh-list
82741902|NCT00934167|Calcium heparin|calcium heparin|mesh-list
82741903|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
82741904|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82741905|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82741906|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741908|NCT00801606|Trace Elements|trace elements|mesh-list
82741909|NCT00801606|Micronutrients|micronutrients|mesh-list
82741910|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741911|NCT00934245|Vaccines|vaccines|mesh-list
82741912|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
82741913|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741914|NCT02560688|Clopidogrel|clopidogrel|mesh-list
82741915|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82741916|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82741917|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82741918|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82741919|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
82741920|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82741921|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741922|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741923|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
82741924|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
82741925|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
82741926|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741927|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
82741928|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741929|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82741930|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82741931|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
82741932|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741933|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741934|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82741935|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82741936|NCT00934323|Metformin|metformin|mesh-list
82741937|NCT00934323|Glimepiride|glimepiride|mesh-list
82741938|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82741939|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741940|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82741941|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741942|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
82741943|NCT00575666|Insulin|insulin|mesh-list
82741944|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82741945|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741946|NCT00934479|Lubiprostone|lubiprostone|mesh-list
82741947|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82741948|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82741949|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741950|NCT00658632|Esomeprazole|esomeprazole|mesh-list
82741951|NCT00658632|Rabeprazole|rabeprazole|mesh-list
82741952|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82741953|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82741954|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82741955|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82741956|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82741957|NCT00677534|Vitamin D|vitamin d|mesh-list
82741958|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
82741959|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
82741960|NCT00677534|Vitamins|vitamins|mesh-ancestor
82741961|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
82741962|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741963|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82741964|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82741965|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
82741966|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
82741967|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
82741968|NCT00660348|Morphine|morphine|mesh-list
82741969|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82741970|NCT00660348|Narcotics|narcotics|mesh-ancestor
82741971|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82741972|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741974|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
82741975|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82741976|NCT03734198|Daratumumab|daratumumab|mesh-list
82741977|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82741978|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741979|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
82741980|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741981|NCT01564108|Ranibizumab|ranibizumab|mesh-list
82741982|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82741983|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82741984|NCT01564108|Growth Substances|growth substances|mesh-ancestor
82741985|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741986|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
82741987|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82741988|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
82741989|NCT00801918|Ifosfamide|ifosfamide|mesh-list
82741990|NCT00801918|Etoposide|etoposide|mesh-list
82741991|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
82741992|NCT00801918|Interleukin-2|interleukin-2|mesh-list
82741993|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82741994|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
82741995|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82741996|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82741997|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82741998|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
82741999|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742000|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742001|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82742002|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82742003|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82742004|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82742005|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742006|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82742007|NCT00801918|Analgesics|analgesics|mesh-ancestor
82742008|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
82742009|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742010|NCT00799188|Everolimus|everolimus|mesh-list
82742011|NCT00799188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82742012|NCT00799188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82742013|NCT00799188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742014|NCT00799188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742015|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82742016|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
82742017|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742018|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742019|NCT00571688|Risperidone|risperidone|mesh-list
82742020|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82742021|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
82742022|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742023|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742024|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742025|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82742026|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82742027|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82742028|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82742029|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82742030|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
82742031|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
82742032|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
82742033|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742034|NCT05408104|Tolvaptan|tolvaptan|mesh-list
82742035|NCT05408104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82742036|NCT05408104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742037|NCT05408104|Natriuretic Agents|natriuretic agents|mesh-ancestor
82742038|NCT05408104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742039|NCT04837716|Bevacizumab|bevacizumab|mesh-list
82742040|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82742041|NCT04837716|Carboplatin|carboplatin|mesh-list
82742042|NCT04837716|Pemetrexed|pemetrexed|mesh-list
82742043|NCT04837716|Ensartinib|ensartinib|mesh-list
82742044|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
82742045|NCT04837716|Antibodies|antibodies|mesh-list
82742046|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
82742047|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82742048|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
82742049|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742050|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82742051|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82742052|NCT04837716|Growth Substances|growth substances|mesh-ancestor
82742053|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742054|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
82742055|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
82742056|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742057|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742058|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82742059|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82742060|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82742061|NCT00343291|Paclitaxel|paclitaxel|mesh-list
82742062|NCT00343291|Bevacizumab|bevacizumab|mesh-list
82742063|NCT00343291|Carboplatin|carboplatin|mesh-list
82742064|NCT00343291|Cetuximab|cetuximab|mesh-list
82742065|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82742066|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742067|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
82742068|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
82742069|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
82742070|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742071|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82742072|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82742073|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82742074|NCT00343291|Growth Substances|growth substances|mesh-ancestor
82742075|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742076|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
82742077|NCT05407870|Propofol|propofol|mesh-list
82742078|NCT05407870|Etomidate|etomidate|mesh-list
82742079|NCT05407870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82742080|NCT05407870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82742081|NCT05407870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742082|NCT05407870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82742083|NCT05407870|Anesthetics, General|anesthetics, general|mesh-ancestor
82742084|NCT05407870|Anesthetics|anesthetics|mesh-ancestor
82742085|NCT03988231|Enoxaparin|enoxaparin|mesh-list
82742086|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
82742087|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82742088|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82742089|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742090|NCT00658788|Calcitriol|calcitriol|mesh-list
82742091|NCT00658788|Clobetasol|clobetasol|mesh-list
82742092|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82742093|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742094|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82742095|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82742096|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742097|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82742098|NCT00658788|Vitamins|vitamins|mesh-ancestor
82742099|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
82742100|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82742101|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742102|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
82742103|NCT00658788|Hormones|hormones|mesh-ancestor
82742104|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742105|NCT01060969|Acetazolamide|acetazolamide|mesh-list
82742107|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
82742108|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82742109|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82742110|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742111|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742112|NCT01060969|Urological Agents|urological agents|mesh-ancestor
82742113|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
82742114|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82742115|NCT01060969|Diuretics|diuretics|mesh-ancestor
82742116|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
82742117|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742118|NCT05407246|Hemay005|hemay005|mesh-list
82742119|NCT05407246|Dermatologic Agents|dermatologic agents|mesh-ancestor
82742120|NCT05407246|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82742121|NCT05407246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82742122|NCT05407246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742123|NCT05407246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742124|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82742125|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
82742126|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742127|NCT00799890|Protective Agents|protective agents|mesh-ancestor
82742653|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742128|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742129|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82742130|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82742131|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742132|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82742133|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
82742134|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82742135|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742137|NCT05590312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82742138|NCT05590312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742139|NCT00802230|Terbutaline|terbutaline|mesh-list
82742140|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82742141|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
82742142|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742143|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742144|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82742145|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
82742146|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
82742147|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
82742148|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82742149|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82742150|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82742151|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82742152|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
82742153|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742154|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742155|NCT00802308|Morphine|morphine|mesh-list
82742156|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82742157|NCT00802308|Narcotics|narcotics|mesh-ancestor
82742158|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82742159|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742160|NCT00802308|Analgesics|analgesics|mesh-ancestor
82742161|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
82742162|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742163|NCT00562965|Dexamethasone|dexamethasone|mesh-list
82742164|NCT00562965|Prednisone|prednisone|mesh-list
82742165|NCT00562965|Prednisolone|prednisolone|mesh-list
82742166|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
82742167|NCT00562965|Rituximab|rituximab|mesh-list
82742168|NCT00562965|Fludarabine|fludarabine|mesh-list
82742169|NCT00562965|Vincristine|vincristine|mesh-list
82742170|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
82742171|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82742172|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82742173|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
82742174|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742175|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82742176|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82742177|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
82742178|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742179|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742180|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82742181|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82742182|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742183|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
82742184|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
82742185|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742186|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742187|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
82742188|NCT00562965|Hormones|hormones|mesh-ancestor
82742189|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742190|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82742191|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82742192|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
82742193|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
82742194|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
82742195|NCT00562965|Analgesics|analgesics|mesh-ancestor
82742196|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
82742197|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82742198|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82742199|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742200|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82742201|NCT00562965|Immunotoxins|immunotoxins|mesh-ancestor
82742202|NCT00562965|Immunoconjugates|immunoconjugates|mesh-ancestor
82742203|NCT05406934|Infliximab|infliximab|mesh-list
82742204|NCT05406934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82742205|NCT05406934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742206|NCT05406934|Dermatologic Agents|dermatologic agents|mesh-ancestor
82742207|NCT05406934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742208|NCT05406934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82742210|NCT00794898|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82742211|NCT00794898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742212|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
82742213|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742214|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82742215|NCT00800280|Cimetidine|cimetidine|mesh-list
82742216|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82742217|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742218|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82742219|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
82742220|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
82742221|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742222|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742223|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742224|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82742225|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82742226|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742227|NCT00800358|Calcitriol|calcitriol|mesh-list
82742228|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82742229|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742230|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82742231|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82742232|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742233|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82742234|NCT00800358|Vitamins|vitamins|mesh-ancestor
82742235|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
82742236|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82742237|NCT00934713|Montelukast|montelukast|mesh-list
82742238|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82742239|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
82742240|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82742241|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
82742242|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742243|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742244|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82742245|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82742246|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742247|NCT01057849|Olanzapine|olanzapine|mesh-list
82742248|NCT01057849|Risperidone|risperidone|mesh-list
82742249|NCT01057849|Aripiprazole|aripiprazole|mesh-list
82742250|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82742251|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
82742252|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742253|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742254|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742255|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82742256|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82742257|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82742258|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82742259|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82742260|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
82742261|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
82742262|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
82742263|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742264|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742265|NCT01057849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82742266|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82742267|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82742268|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
82742269|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
82742270|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82742271|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82742272|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82742273|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82742274|NCT00794976|Dexamethasone|dexamethasone|mesh-list
82742275|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
82742276|NCT00794976|BB 1101|bb 1101|mesh-list
82742277|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742278|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
82742279|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
82742280|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742281|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742282|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742283|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
82742284|NCT00794976|Hormones|hormones|mesh-ancestor
82742285|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742286|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82742287|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742288|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
82742289|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742290|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742291|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82742292|NCT00939939|Glimepiride|glimepiride|mesh-list
82742293|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82742294|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742295|NCT00939939|Incretins|incretins|mesh-ancestor
82742296|NCT00939939|Hormones|hormones|mesh-ancestor
82742297|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742298|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82742299|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
82742300|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742301|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742302|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82742303|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82742304|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
82742305|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82742306|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82742307|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742308|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82742309|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
82742310|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742311|NCT00805662|Oxytocin|oxytocin|mesh-list
82742312|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
82742313|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82742314|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742315|NCT04978012|Fluzoparib|fluzoparib|mesh-list
82742316|NCT04978012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82742317|NCT04978012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742318|NCT04978012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742319|NCT04978012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742320|NCT00803166|Clobetasol|clobetasol|mesh-list
82742321|NCT00803166|Halobetasol|halobetasol|mesh-list
82742322|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82742323|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742324|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
82742325|NCT00803166|Hormones|hormones|mesh-ancestor
82742326|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742327|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742328|NCT00324961|Adefovir|adefovir|mesh-list
82742329|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82742330|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
82742331|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82742332|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82742333|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82742334|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742335|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742336|NCT00935415|Montelukast|montelukast|mesh-list
82742337|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82742338|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
82742339|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82742340|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
82742341|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742342|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742343|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82742344|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82742345|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742346|NCT00935571|Remifentanil|remifentanil|mesh-list
82742347|NCT00935571|Propofol|propofol|mesh-list
82742348|NCT00935571|Sevoflurane|sevoflurane|mesh-list
82742349|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82742350|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82742351|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742352|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82742353|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
82742354|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
82742355|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82742356|NCT00935571|Narcotics|narcotics|mesh-ancestor
82742357|NCT00935571|Analgesics|analgesics|mesh-ancestor
82742358|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
82742359|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742360|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82742361|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82742362|NCT00324649|Lamivudine|lamivudine|mesh-list
82742363|NCT00324649|Zidovudine|zidovudine|mesh-list
82742364|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82742365|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82742366|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82742367|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742368|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742369|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
82742370|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82742371|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82742372|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82742373|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
82742374|NCT03743259|Charcoal|charcoal|mesh-list
82742375|NCT03743259|Antidotes|antidotes|mesh-ancestor
82742376|NCT03743259|Protective Agents|protective agents|mesh-ancestor
82742377|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742378|NCT03983239|Efavirenz|efavirenz|mesh-list
82742379|NCT03983239|Rifampin|rifampin|mesh-list
82742380|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82742381|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82742382|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742383|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742384|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
82742385|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82742386|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82742387|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82742388|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82742389|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82742390|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82742391|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82742392|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82742393|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
82742394|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82742395|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
82742396|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82742397|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82742398|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82742399|NCT00935805|Insulin|insulin|mesh-list
82742400|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82742401|NCT00935805|Metformin|metformin|mesh-list
82742402|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
82742403|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
82742404|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
82742405|NCT00935805|Glyburide|glyburide|mesh-list
82742406|NCT00935805|Propranolol|propranolol|mesh-list
82742407|NCT00935805|Amlodipine|amlodipine|mesh-list
82742408|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82742409|NCT00935805|Captopril|captopril|mesh-list
82742410|NCT00935805|Diuretics|diuretics|mesh-list
82742411|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82742412|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742413|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82742414|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82742415|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82742416|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742417|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82742418|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
82742419|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
82742420|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82742421|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82742422|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82742423|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
82742424|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742425|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82742426|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82742427|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
82742428|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742429|NCT00935961|Docetaxel|docetaxel|mesh-list
82742430|NCT00935961|Everolimus|everolimus|mesh-list
82742431|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742432|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
82742433|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
82742434|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
82742435|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742436|NCT00935961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82742437|NCT00935961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82742438|NCT00935961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742439|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82742440|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
82742441|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742443|NCT01055431|Trace Elements|trace elements|mesh-ancestor
82742444|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
82742445|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742446|NCT00803556|Paclitaxel|paclitaxel|mesh-list
82742447|NCT00803556|Trastuzumab|trastuzumab|mesh-list
82742448|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82742449|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742450|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
82742451|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
82742452|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
82742453|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742454|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82742455|NCT00936195|Ritonavir|ritonavir|mesh-list
82742456|NCT00936195|Lopinavir|lopinavir|mesh-list
82742457|NCT00936195|Tenofovir|tenofovir|mesh-list
82742458|NCT00936195|Lamivudine|lamivudine|mesh-list
82742459|NCT00936195|Emtricitabine|emtricitabine|mesh-list
82742460|NCT00936195|Zidovudine|zidovudine|mesh-list
82742461|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
82742462|NCT00936195|Efavirenz|efavirenz|mesh-list
82742463|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82742464|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82742465|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
82742466|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742467|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742468|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82742469|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82742470|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
82742471|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82742472|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82742473|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82742474|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82742475|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82742476|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
82742477|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82742478|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82742479|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82742480|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82742481|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82742482|NCT00680186|Warfarin|warfarin|mesh-list
82742483|NCT00680186|Dabigatran|dabigatran|mesh-list
82742484|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
82742485|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
82742486|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82742487|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
82742488|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742489|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742490|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82742491|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82742492|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
82742493|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742494|NCT00936429|Antacids|antacids|mesh-ancestor
82742495|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742496|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742497|NCT00656292|Simvastatin|simvastatin|mesh-list
82742498|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82742499|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82742500|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
82742501|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742502|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82742503|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82742504|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742506|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82742507|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742508|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742509|NCT00944541|Maraviroc|maraviroc|mesh-list
82742510|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82742511|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82742512|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742513|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82742514|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82742515|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
82742516|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82742517|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82742518|NCT00944619|Insulin|insulin|mesh-list
82742519|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82742520|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742521|NCT00323869|Bevacizumab|bevacizumab|mesh-list
82742522|NCT00323869|Carboplatin|carboplatin|mesh-list
82742523|NCT00323869|Gemcitabine|gemcitabine|mesh-list
82742524|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82742525|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742526|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82742527|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82742528|NCT00323869|Growth Substances|growth substances|mesh-ancestor
82742529|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742530|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
82742531|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82742532|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
82742533|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742535|NCT00323557|Sargramostim|sargramostim|mesh-list
82742536|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82742537|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
82742538|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742539|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742540|NCT00558363|Dutasteride|dutasteride|mesh-list
82742541|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82742542|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82742543|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742544|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742545|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
82742546|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742547|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742548|NCT00323479|Anastrozole|anastrozole|mesh-list
82742549|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82742550|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742551|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82742552|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82742553|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742554|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742555|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82742556|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
82742557|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742558|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742559|NCT00352105|Fluorouracil|fluorouracil|mesh-list
82742560|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742561|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
82742562|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742563|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82742564|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82742565|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
82742566|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742567|NCT03988075|Acetaminophen|acetaminophen|mesh-list
82742568|NCT03988075|Ibuprofen|ibuprofen|mesh-list
82742569|NCT03988075|Hydrocodone|hydrocodone|mesh-list
82742570|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82742571|NCT03988075|Analgesics|analgesics|mesh-ancestor
82742572|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
82742573|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742574|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742575|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
82742576|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82742577|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742578|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82742579|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82742580|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742581|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742582|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82742583|NCT03988075|Narcotics|narcotics|mesh-ancestor
82742584|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82742585|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
82742586|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
82742588|NCT00944853|Trace Elements|trace elements|mesh-ancestor
82742589|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
82742590|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742591|NCT03985891|Antibodies|antibodies|mesh-list
82742592|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82742593|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
82742594|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742595|NCT00350779|Metformin|metformin|mesh-list
82742596|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82742597|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
82742598|NCT00350779|Glipizide|glipizide|mesh-list
82742599|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82742600|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742601|NCT00350779|Incretins|incretins|mesh-ancestor
82742602|NCT00350779|Hormones|hormones|mesh-ancestor
82742603|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742604|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82742605|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
82742606|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742607|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742608|NCT00656136|Afatinib|afatinib|mesh-list
82742609|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742610|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82742611|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742612|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742613|NCT00676520|Everolimus|everolimus|mesh-list
82742614|NCT00676520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82742615|NCT00676520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82742616|NCT00676520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742617|NCT00676520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742618|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82742619|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
82742620|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742621|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742622|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
82742623|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82742624|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
82742625|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742626|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
82742627|NCT02559908|Protective Agents|protective agents|mesh-ancestor
82742628|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82742629|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82742630|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82742631|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82742632|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742633|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742634|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742635|NCT00322621|Analgesics|analgesics|mesh-ancestor
82742636|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
82742637|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742638|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
82742639|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82742640|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
82742641|NCT02558972|Droxidopa|droxidopa|mesh-list
82742642|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82742643|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82742644|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
82742645|NCT00809718|Rifapentine|rifapentine|mesh-list
82742646|NCT00809718|Rifampin|rifampin|mesh-list
82742647|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82742648|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82742649|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
82742650|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82742651|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82742652|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82742654|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742655|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82742656|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
82742657|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82742658|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
82742659|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82742660|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82742661|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82742662|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82742663|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82742664|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82742665|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82742666|NCT05427266|Bupivacaine|bupivacaine|mesh-list
82742667|NCT05427266|Anesthetics, Local|anesthetics, local|mesh-ancestor
82742668|NCT05427266|Anesthetics|anesthetics|mesh-ancestor
82742669|NCT05427266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82742670|NCT05427266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742671|NCT05427266|Sensory System Agents|sensory system agents|mesh-ancestor
82742672|NCT05427266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742674|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82742675|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
82742676|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742677|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82742678|NCT00656058|Montelukast|montelukast|mesh-list
82742679|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82742680|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
82742681|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82742682|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
82742683|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742684|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742685|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82742686|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82742687|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742688|NCT00537316|Infliximab|infliximab|mesh-list
82742689|NCT00537316|Azathioprine|azathioprine|mesh-list
82742690|NCT00537316|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82742691|NCT00537316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742692|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
82742693|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742694|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82742695|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
82742696|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742697|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82742698|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742699|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82742700|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
82742701|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742702|NCT00803868|Varenicline|varenicline|mesh-list
82742703|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82742704|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82742705|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
82742706|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742707|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742708|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742709|NCT00655980|Folic Acid|folic acid|mesh-list
82742710|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
82742711|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
82742712|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
82742713|NCT00655980|Vitamins|vitamins|mesh-ancestor
82742714|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
82742715|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742716|NCT00655980|Hematinics|hematinics|mesh-ancestor
82742717|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
82742718|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82742719|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
82742720|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
82742721|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82742722|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82742723|NCT00655980|Analgesics|analgesics|mesh-ancestor
82742724|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
82742725|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742726|NCT01063621|Apomorphine|apomorphine|mesh-list
82742727|NCT01063621|Emetics|emetics|mesh-ancestor
82742728|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742729|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
82742730|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742731|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742732|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
82742733|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
82742734|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742735|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742736|NCT02533141|Simvastatin|simvastatin|mesh-list
82742737|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82742738|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82742739|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
82742740|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742741|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82742742|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82742743|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742744|NCT00809796|Pentamidine|pentamidine|mesh-list
82742745|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
82742746|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82742747|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82742748|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82742749|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82742750|NCT05589454|Calcium, Dietary|calcium, dietary|mesh-list
82742751|NCT05589454|Atorvastatin|atorvastatin|mesh-list
82742752|NCT05589454|Calcium|calcium|mesh-list
82742753|NCT05589454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82742754|NCT05589454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742755|NCT05589454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82742756|NCT05589454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82742758|NCT05589454|Antimetabolites|antimetabolites|mesh-ancestor
82742759|NCT05589454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742760|NCT05589454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82742761|NCT05589454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82742762|NCT05589454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742763|NCT00803946|Ibuprofen|ibuprofen|mesh-list
82742764|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82742765|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82742766|NCT00803946|Analgesics|analgesics|mesh-ancestor
82742767|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
82742768|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742769|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742770|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742771|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82742772|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82742773|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742774|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742775|NCT00676130|Trimethoprim|trimethoprim|mesh-list
82742776|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82742777|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
82742778|NCT00676130|Cephalexin|cephalexin|mesh-list
82742779|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82742780|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82742781|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
82742782|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82742783|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82742784|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82742785|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742786|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742787|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82742788|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82742789|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82742790|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82742791|NCT00809874|Caseins|caseins|mesh-list
82742792|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
82742793|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
82742794|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742795|NCT05436002|Hyaluronic Acid|hyaluronic acid|mesh-list
82742796|NCT05436002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82742797|NCT05436002|Immunologic Factors|immunologic factors|mesh-ancestor
82742798|NCT05436002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742800|NCT05436002|Protective Agents|protective agents|mesh-ancestor
82742801|NCT02560376|Exenatide|exenatide|mesh-list
82742802|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82742803|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742804|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82742805|NCT02560376|Incretins|incretins|mesh-ancestor
82742806|NCT02560376|Hormones|hormones|mesh-ancestor
82742807|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742808|NCT00535288|Mirtazapine|mirtazapine|mesh-list
82742809|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742810|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
82742811|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82742812|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82742813|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
82742814|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
82742815|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742816|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742817|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82742818|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82742819|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82742820|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82742821|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82742822|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82742823|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
82742824|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82742825|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82742826|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
82742827|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82742828|NCT00921830|Ibuprofen|ibuprofen|mesh-list
82742829|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82742830|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82742831|NCT00921830|Analgesics|analgesics|mesh-ancestor
82742832|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
82742833|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742834|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742835|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742836|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82742837|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82742838|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742839|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742840|NCT02560220|Mitomycins|mitomycins|mesh-list
82742841|NCT02560220|Mitomycin|mitomycin|mesh-list
82742842|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82742843|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742844|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
82742845|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742846|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82742847|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742848|NCT05356078|Antidepressive Agents|antidepressive agents|mesh-list
82742849|NCT05356078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82742850|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
82742851|NCT04836832|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82742852|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742853|NCT04836832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82742854|NCT04836832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742855|NCT04836832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742856|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
82742857|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82742858|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742859|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
82742860|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
82742861|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82742862|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742863|NCT02783300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82742864|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742865|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742867|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
82742868|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742869|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742870|NCT05435378|Vitamins|vitamins|mesh-list
82742871|NCT05435378|Folic Acid|folic acid|mesh-list
82742872|NCT05435378|Niacinamide|niacinamide|mesh-list
82742873|NCT05435378|Vitamin B Complex|vitamin b complex|mesh-list
82742874|NCT05435378|Micronutrients|micronutrients|mesh-ancestor
82742875|NCT05435378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742876|NCT05435378|Hematinics|hematinics|mesh-ancestor
82742877|NCT05589220|Nicotine|nicotine|mesh-list
82742878|NCT05589220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82742879|NCT05589220|Autonomic Agents|autonomic agents|mesh-ancestor
82742880|NCT05589220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742881|NCT05589220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742882|NCT05589220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82742883|NCT05589220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82742884|NCT05589220|Cholinergic Agents|cholinergic agents|mesh-ancestor
82742885|NCT05589220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742886|NCT05589220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742887|NCT03895840|Triamcinolone|triamcinolone|mesh-list
82742888|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82742889|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82742890|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82742891|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742892|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
82742893|NCT03895840|Hormones|hormones|mesh-ancestor
82742894|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742895|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742896|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82742897|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
82742898|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742899|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742900|NCT00310375|Ezogabine|ezogabine|mesh-list
82742901|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
82742902|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82742903|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742904|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
82742905|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82742906|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82742907|NCT00309907|Prednisolone|prednisolone|mesh-list
82742908|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
82742909|NCT00309907|Etanercept|etanercept|mesh-list
82742910|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82742911|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
82742912|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742913|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
82742914|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
82742915|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742916|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742917|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742918|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
82742919|NCT00309907|Hormones|hormones|mesh-ancestor
82742920|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742921|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82742922|NCT00309907|Protective Agents|protective agents|mesh-ancestor
82742923|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82742924|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742925|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82742926|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82742927|NCT00309907|Analgesics|analgesics|mesh-ancestor
82742928|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
82742929|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82742930|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82742931|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
82742932|NCT00655824|Ofatumumab|ofatumumab|mesh-list
82742933|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742934|NCT03985969|Indomethacin|indomethacin|mesh-list
82742935|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82742936|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82742937|NCT03985969|Analgesics|analgesics|mesh-ancestor
82742938|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
82742939|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742940|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742941|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82742942|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82742943|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
82742944|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
82742945|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82742946|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82742947|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742948|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742949|NCT01061437|Lansoprazole|lansoprazole|mesh-list
82742950|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
82742951|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82742952|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742953|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82742954|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742955|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742957|NCT00575588|Saxagliptin|saxagliptin|mesh-list
82742958|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82742959|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742960|NCT00575588|Incretins|incretins|mesh-ancestor
82742961|NCT00575588|Hormones|hormones|mesh-ancestor
82742962|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82742963|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82742964|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
82742965|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82742966|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742967|NCT01058317|Propranolol|propranolol|mesh-list
82742968|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82742969|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82742970|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
82742971|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742972|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742973|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742974|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82742975|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82742976|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
82742977|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82742978|NCT00810030|Hematinics|hematinics|mesh-ancestor
82742979|NCT00675428|Natalizumab|natalizumab|mesh-list
82742980|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
82742981|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742982|NCT00760916|Treprostinil|treprostinil|mesh-list
82742983|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82742984|NCT00761228|Apomorphine|apomorphine|mesh-list
82742985|NCT00761228|Emetics|emetics|mesh-ancestor
82742986|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82742987|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
82742988|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82742989|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82742990|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
82742991|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
82742992|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82742993|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82742994|NCT00758732|Carboplatin|carboplatin|mesh-list
82742995|NCT00758732|Docetaxel|docetaxel|mesh-list
82742996|NCT00758732|Doxorubicin|doxorubicin|mesh-list
82742997|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82742998|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82742999|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
82743000|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
82743001|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
82743002|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743003|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82743004|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82743005|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82743006|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743007|NCT02559674|Paclitaxel|paclitaxel|mesh-list
82743008|NCT02559674|Gemcitabine|gemcitabine|mesh-list
82743009|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82743010|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743011|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
82743012|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
82743013|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
82743014|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743015|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82743016|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
82743017|NCT00761540|Liraglutide|liraglutide|mesh-list
82743018|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82743019|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743020|NCT00761540|Incretins|incretins|mesh-ancestor
82743021|NCT00761540|Hormones|hormones|mesh-ancestor
82743022|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82743023|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82743024|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82743025|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82743026|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82743027|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743028|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743029|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743030|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82743031|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
82743032|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82743033|NCT00759200|Interferons|interferons|mesh-list
82743034|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
82743035|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
82743036|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743037|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
82743038|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743039|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
82743040|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743041|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
82743043|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82743044|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743045|NCT01299753|Propranolol|propranolol|mesh-list
82743046|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82743047|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82743048|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
82743049|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743050|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743051|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743052|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82743053|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82743054|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
82743055|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
82743056|NCT02559440|Phenylephrine|phenylephrine|mesh-list
82743057|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
82743058|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82743059|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
82743060|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82743061|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82743062|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82743063|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
82743064|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743065|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743066|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743067|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
82743068|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
82743069|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743070|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
82743071|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82743072|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
82743073|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82743074|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
82743075|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82743076|NCT02559440|Protective Agents|protective agents|mesh-ancestor
82743077|NCT00674570|Cycloserine|cycloserine|mesh-list
82743078|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
82743079|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82743080|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82743081|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743082|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82743083|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
82743084|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82743085|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
82743086|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743087|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
82743088|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743089|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82743090|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743091|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743092|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
82743093|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743094|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743095|NCT00940719|Vitamin D|vitamin d|mesh-list
82743096|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
82743097|NCT00940719|Vitamins|vitamins|mesh-ancestor
82743098|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
82743099|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743100|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82743101|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82743102|NCT00940953|Azelastine|azelastine|mesh-list
82743103|NCT00940953|Budesonide|budesonide|mesh-list
82743104|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82743105|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82743106|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
82743107|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743108|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743109|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82743110|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
82743111|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
82743112|NCT00940953|Hormones|hormones|mesh-ancestor
82743113|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82743114|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82743115|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743116|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743117|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82743118|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82743119|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82743120|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
82743121|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
82743122|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743123|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
82743124|NCT00759824|Doxorubicin|doxorubicin|mesh-list
82743125|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82743126|NCT00759824|Vindesine|vindesine|mesh-list
82743127|NCT00759824|Valproic Acid|valproic acid|mesh-list
82743128|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743129|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
82743130|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743131|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82743132|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82743133|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
82743134|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743135|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743136|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82743137|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82743138|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82743139|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82743140|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743141|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
82743143|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743144|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
82743145|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82743146|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743147|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82743148|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82743149|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
82743150|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
82743151|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
82743153|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82743154|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82743155|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
82743156|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743157|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743158|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743159|NCT00561951|Urological Agents|urological agents|mesh-ancestor
82743160|NCT00762398|Chrysarobin|chrysarobin|mesh-list
82743161|NCT00762398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82743162|NCT00762398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82743163|NCT00762398|Analgesics|analgesics|mesh-ancestor
82743164|NCT00762398|Sensory System Agents|sensory system agents|mesh-ancestor
82743165|NCT00762398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743166|NCT00762398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743167|NCT00762398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82743168|NCT00762398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82743169|NCT04552886|Immunomodulating Agents|immunomodulating agents|mesh-list
82743170|NCT04552886|Immunologic Factors|immunologic factors|mesh-ancestor
82743171|NCT04552886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743172|NCT00762632|Everolimus|everolimus|mesh-list
82743173|NCT00762632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82743174|NCT00762632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82743175|NCT00762632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743176|NCT00762632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743177|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743178|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
82743179|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743180|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743181|NCT00322387|Plerixafor|plerixafor|mesh-list
82743182|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82743183|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82743184|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
82743185|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743186|NCT00561015|Ribavirin|ribavirin|mesh-list
82743187|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
82743188|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82743189|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
82743190|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743191|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
82743192|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743193|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743194|NCT04012047|Cromakalim|cromakalim|mesh-list
82743195|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82743196|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82743197|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
82743198|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743199|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743200|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82743201|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
82743202|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
82743203|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
82743204|NCT00941265|Levodopa|levodopa|mesh-list
82743205|NCT00941265|Benserazide|benserazide|mesh-list
82743206|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82743208|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
82743209|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743210|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743211|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743212|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743213|NCT00941343|Alfuzosin|alfuzosin|mesh-list
82743214|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82743215|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82743216|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82743217|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
82743218|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743219|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743220|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743221|NCT00941343|Urological Agents|urological agents|mesh-ancestor
82743223|NCT00561795|Carboplatin|carboplatin|mesh-list
82743224|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82743225|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743226|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
82743227|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
82743228|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
82743229|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743230|NCT00652626|Azacitidine|azacitidine|mesh-list
82743231|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82743232|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
82743233|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743234|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743235|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743236|NCT00560703|Doxycycline|doxycycline|mesh-list
82743237|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82743238|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743239|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
82743240|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82743241|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82743242|NCT00308737|Insulin|insulin|mesh-list
82743243|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82743244|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743245|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82743246|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
82743247|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743248|NCT00941499|Leucovorin|leucovorin|mesh-list
82743249|NCT00941499|Bevacizumab|bevacizumab|mesh-list
82743250|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82743251|NCT00941499|Cetuximab|cetuximab|mesh-list
82743252|NCT00941499|Fluorouracil|fluorouracil|mesh-list
82743253|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
82743254|NCT00941499|Antibodies|antibodies|mesh-list
82743255|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
82743256|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82743257|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743258|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82743259|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82743260|NCT00941499|Growth Substances|growth substances|mesh-ancestor
82743261|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743262|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
82743263|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
82743264|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
82743265|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743266|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82743267|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743268|NCT00941499|Antidotes|antidotes|mesh-ancestor
82743269|NCT00941499|Protective Agents|protective agents|mesh-ancestor
82743270|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
82743271|NCT00941499|Vitamins|vitamins|mesh-ancestor
82743272|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
82743273|NCT04752384|Buprenorphine|buprenorphine|mesh-list
82743274|NCT04752384|Tramadol|tramadol|mesh-list
82743275|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82743276|NCT04752384|Narcotics|narcotics|mesh-ancestor
82743277|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743278|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743279|NCT04752384|Analgesics|analgesics|mesh-ancestor
82743280|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
82743281|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743282|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82743283|NCT04743804|Ravulizumab|ravulizumab|mesh-list
82743284|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82743285|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743286|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
82743287|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743288|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
82743289|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
82743290|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82743291|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
82743292|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743293|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743294|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82743295|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
82743296|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82743297|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
82743298|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743299|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743300|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82743301|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
82743302|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
82743303|NCT00945789|Protective Agents|protective agents|mesh-ancestor
82743304|NCT00945789|Hematinics|hematinics|mesh-ancestor
82743305|NCT00941811|Imiquimod|imiquimod|mesh-list
82743306|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82743307|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
82743308|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743309|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743310|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
82743311|NCT02553018|Methotrexate|methotrexate|mesh-list
82743312|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82743313|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
82743314|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82743315|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743316|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82743317|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
82743318|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743319|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743320|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
82743321|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743322|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82743323|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743324|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
82743325|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82743326|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82743327|NCT00941967|Gemcitabine|gemcitabine|mesh-list
82743328|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
82743330|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82743331|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
82743332|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743333|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743334|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82743335|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743336|NCT00655746|Dasatinib|dasatinib|mesh-list
82743337|NCT00655746|Omeprazole|omeprazole|mesh-list
82743338|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82743339|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82743340|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82743341|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743342|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743343|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743344|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82743345|NCT00338455|Dobutamine|dobutamine|mesh-list
82743346|NCT00338455|Milrinone|milrinone|mesh-list
82743347|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82743348|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82743349|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
82743350|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
82743351|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743352|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743353|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82743354|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82743355|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82743356|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
82743357|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743358|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743359|NCT00338455|Protective Agents|protective agents|mesh-ancestor
82743360|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82743361|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
82743362|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82743363|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82743364|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743365|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
82743367|NCT00678392|Axitinib|axitinib|mesh-list
82743368|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743369|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82743370|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743371|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743372|NCT00950391|Tacrolimus|tacrolimus|mesh-list
82743373|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743374|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
82743375|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743376|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82743377|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743378|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743379|NCT00804336|Everolimus|everolimus|mesh-list
82743380|NCT00804336|Pasireotide|pasireotide|mesh-list
82743381|NCT00804336|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82743382|NCT00804336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82743383|NCT00804336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743384|NCT00804336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743385|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743386|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
82743387|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743388|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743389|NCT00804336|Hormones|hormones|mesh-ancestor
82743390|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82743391|NCT00942201|Dexamethasone|dexamethasone|mesh-list
82743392|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
82743393|NCT00942201|BB 1101|bb 1101|mesh-list
82743394|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82743395|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
82743396|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
82743397|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743398|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743399|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82743400|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
82743401|NCT00942201|Hormones|hormones|mesh-ancestor
82743402|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82743403|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82743404|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743405|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
82743406|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743407|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743408|NCT00942435|Darexaban|darexaban|mesh-list
82743409|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82743410|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
82743411|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82743412|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
82743413|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743414|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743415|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
82743416|NCT00946179|Vaccines|vaccines|mesh-list
82743417|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
82743418|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743419|NCT00950625|Lidocaine|lidocaine|mesh-list
82743420|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
82743421|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
82743422|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743423|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743424|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
82743425|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743426|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82743427|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82743428|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82743429|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82743430|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743431|NCT00942591|Interferons|interferons|mesh-list
82743432|NCT00942591|Interferon-beta|interferon-beta|mesh-list
82743433|NCT00942591|Atorvastatin|atorvastatin|mesh-list
82743434|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
82743435|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743436|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
82743437|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743438|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82743439|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82743440|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
82743441|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743442|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82743443|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82743444|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743445|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
82743446|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743447|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82743448|NCT00946335|Temozolomide|temozolomide|mesh-list
82743449|NCT00946335|Veliparib|veliparib|mesh-list
82743450|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82743451|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
82743452|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743453|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743454|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82743455|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743456|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
82743457|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82743458|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743459|NCT00762944|Cimetidine|cimetidine|mesh-list
82743460|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82743461|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82743462|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82743463|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
82743464|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
82743465|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743466|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743467|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743468|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82743469|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82743470|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743471|NCT00760448|Insulin|insulin|mesh-list
82743472|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82743473|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
82743474|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
82743475|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
82743476|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
82743477|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82743478|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743479|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82743480|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82743481|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82743482|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82743483|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743484|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743485|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743486|NCT00763178|Analgesics|analgesics|mesh-ancestor
82743487|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
82743637|NCT00764972|Vinorelbine|vinorelbine|mesh-list
82743488|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743489|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
82743490|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82743491|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
82743492|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82743493|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82743494|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743495|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
82743496|NCT00308581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82743497|NCT00308581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82743498|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743499|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
82743500|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743501|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82743502|NCT00678080|Metformin|metformin|mesh-list
82743503|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82743504|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743506|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
82743507|NCT00658320|Everolimus|everolimus|mesh-list
82743508|NCT00658320|Cyclosporins|cyclosporins|mesh-list
82743509|NCT00658320|Basiliximab|basiliximab|mesh-list
82743510|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743511|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743512|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743513|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
82743514|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743515|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
82743516|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743517|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
82743518|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82743519|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82743520|NCT00658320|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82743521|NCT00658320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82743522|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743523|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82743524|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82743525|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
82743526|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82743527|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
82743528|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82743529|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743530|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82743531|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743532|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82743533|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
82743534|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
82743535|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743536|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82743537|NCT00806754|Ciclesonide|ciclesonide|mesh-list
82743538|NCT00806754|Azelastine|azelastine|mesh-list
82743539|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
82743540|NCT00806754|Hormones|hormones|mesh-ancestor
82743541|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82743542|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743543|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82743544|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82743545|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
82743546|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743547|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82743548|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
82743549|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82743550|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743551|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743552|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82743553|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82743554|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
82743555|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
82743556|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743558|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
82743559|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
82743560|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743561|NCT00322153|Memantine|memantine|mesh-list
82743562|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82743563|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82743564|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
82743565|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743566|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743567|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743568|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82743569|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82743570|NCT00806910|Conivaptan|conivaptan|mesh-list
82743571|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82743572|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743573|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
82743574|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743575|NCT00807066|Gefitinib|gefitinib|mesh-list
82743576|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743577|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82743578|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743579|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743580|NCT00804960|Letrozole|letrozole|mesh-list
82743581|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743582|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82743583|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82743584|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743585|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743586|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82743587|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
82743588|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82743589|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743590|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
82743591|NCT00805116|Vitamins|vitamins|mesh-ancestor
82743592|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
82743593|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743594|NCT03985735|Anesthetics|anesthetics|mesh-list
82743595|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743596|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743597|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82743598|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82743599|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743600|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82743601|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82743602|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82743603|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743604|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
82743605|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743606|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
82743607|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82743608|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82743609|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743610|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
82743611|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82743612|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
82743613|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82743614|NCT00672620|Vortioxetine|vortioxetine|mesh-list
82743615|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82743616|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82743617|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82743618|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743619|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743620|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743621|NCT00672620|Analgesics|analgesics|mesh-ancestor
82743622|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
82743623|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743624|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
82743625|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82743626|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
82743627|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82743628|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82743629|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743630|NCT00672620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82743631|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
82743632|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82743633|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82743634|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82743635|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82743636|NCT00764972|Sorafenib|sorafenib|mesh-list
82743638|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743639|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82743640|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743641|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743642|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82743643|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
82743644|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
82743645|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
82743646|NCT00673790|Losartan|losartan|mesh-list
82743647|NCT00673790|Lisinopril|lisinopril|mesh-list
82743648|NCT00673790|Nebivolol|nebivolol|mesh-list
82743649|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82743650|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82743651|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82743652|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82743653|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743654|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82743656|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743657|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82743658|NCT00673790|Protective Agents|protective agents|mesh-ancestor
82743659|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743660|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
82743661|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82743662|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82743663|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82743664|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
82743665|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743666|NCT00763646|Docetaxel|docetaxel|mesh-list
82743667|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743668|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
82743669|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
82743670|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
82743671|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743672|NCT00763880|Lidocaine|lidocaine|mesh-list
82743673|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
82743674|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
82743675|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743676|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743677|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
82743678|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743679|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82743680|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82743681|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82743682|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82743683|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743684|NCT00657150|Enoxaparin|enoxaparin|mesh-list
82743685|NCT00657150|Dabigatran|dabigatran|mesh-list
82743686|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
82743687|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82743688|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82743689|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743690|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
82743691|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82743692|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
82743693|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743694|NCT00770354|Letrozole|letrozole|mesh-list
82743695|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743696|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82743697|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82743698|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743699|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743700|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82743701|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
82743702|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82743703|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743704|NCT00670748|Aldesleukin|aldesleukin|mesh-list
82743705|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
82743706|NCT00670748|Fludarabine|fludarabine|mesh-list
82743707|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
82743708|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743709|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
82743710|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743711|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82743712|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82743713|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
82743714|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743715|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743716|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82743717|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82743718|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
82743719|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82743720|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82743721|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
82743722|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743723|NCT00646776|Ritonavir|ritonavir|mesh-list
82743724|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82743725|NCT00646776|Rifabutin|rifabutin|mesh-list
82743726|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82743727|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82743728|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
82743729|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743730|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743732|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82743733|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
82743734|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743735|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82743736|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82743737|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82743738|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82743739|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
82743740|NCT02558114|Ribavirin|ribavirin|mesh-list
82743741|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
82743742|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743743|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
82743744|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743745|NCT00770666|Bupropion|bupropion|mesh-list
82743746|NCT00770666|Nicotine|nicotine|mesh-list
82743747|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82743748|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
82743749|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743750|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743751|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82743752|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82743753|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
82743754|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743755|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743756|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82743757|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
82743758|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82743759|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82743760|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82743761|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82743762|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
82743763|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82743764|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82743765|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743767|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
82743768|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82743769|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82743770|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743771|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743772|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
82743773|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
82743774|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82743775|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
82743776|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82743777|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743778|NCT00811200|Triamcinolone|triamcinolone|mesh-list
82743779|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82743780|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82743781|NCT00811200|Ranibizumab|ranibizumab|mesh-list
82743782|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82743783|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82743784|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82743785|NCT00811200|Growth Substances|growth substances|mesh-ancestor
82743786|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743787|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
82743788|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743789|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82743790|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
82743791|NCT00811200|Hormones|hormones|mesh-ancestor
82743792|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82743793|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743794|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
82743795|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743796|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743797|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
82743798|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82743799|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82743800|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82743801|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
82743802|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743803|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82743804|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82743805|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743806|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82743807|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743808|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82743809|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
82743810|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82743811|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743812|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82743813|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82743814|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82743815|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743816|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743817|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82743818|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82743819|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82743820|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
82743821|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743822|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743823|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82743824|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82743825|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
82743826|NCT00770744|Olanzapine|olanzapine|mesh-list
82743827|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
82743828|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
82743829|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743830|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743831|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82743832|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82743833|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82743834|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743835|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82743836|NCT00770744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82743837|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82743838|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82743839|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743840|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743841|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
82743842|NCT00655668|Lenalidomide|lenalidomide|mesh-list
82743843|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
82743844|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743845|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82743846|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82743847|NCT00655668|Growth Substances|growth substances|mesh-ancestor
82743848|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
82743849|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743850|NCT00770900|Montelukast|montelukast|mesh-list
82743851|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82743852|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
82743853|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82743854|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
82743855|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82743856|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743857|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82743858|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82743859|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743860|NCT00766220|Irinotecan|irinotecan|mesh-list
82743861|NCT00766220|Cetuximab|cetuximab|mesh-list
82743862|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82743863|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82743864|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743865|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743866|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743867|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82743868|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
82743869|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
82743870|NCT00770978|Cephalosporins|cephalosporins|mesh-list
82743871|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82743872|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743873|NCT00764426|Ethanol|ethanol|mesh-list
82743874|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82743875|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743876|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743877|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743878|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
82743879|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
82743880|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
82743881|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
82743882|NCT00764582|Levofloxacin|levofloxacin|mesh-list
82743883|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82743884|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82743885|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82743886|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743887|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82743888|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82743889|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743890|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743891|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743892|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82743893|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82743894|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82743895|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
82743896|NCT04048226|Ketamine|ketamine|mesh-list
82743897|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82743898|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743899|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743900|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82743901|NCT04048226|Analgesics|analgesics|mesh-ancestor
82743902|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
82743903|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743904|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82743905|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82743906|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82743907|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
82743908|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743909|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743910|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82743911|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82743912|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
82743913|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
82743914|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82743915|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82743916|NCT00811746|Eszopiclone|eszopiclone|mesh-list
82743917|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82743918|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743919|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743920|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
82743921|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
82743922|NCT04048070|Sufentanil|sufentanil|mesh-list
82743923|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82743924|NCT04048070|Narcotics|narcotics|mesh-ancestor
82743925|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82743926|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743927|NCT04048070|Analgesics|analgesics|mesh-ancestor
82743928|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
82743929|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743930|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82743931|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82743932|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
82743933|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
82743934|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82743935|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82743936|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82743937|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82743938|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82743939|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743940|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743942|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82743943|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743944|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743945|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
82743946|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743947|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743948|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
82743949|NCT00811980|Vancomycin|vancomycin|mesh-list
82743950|NCT00811980|Linezolid|linezolid|mesh-list
82743951|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82743952|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82743953|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82743954|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743955|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743956|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82743957|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
82743958|NCT00775034|Coagulants|coagulants|mesh-ancestor
82743959|NCT00813696|Gemcitabine|gemcitabine|mesh-list
82743960|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743961|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82743962|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
82743963|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743964|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
82743965|NCT00813774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82743966|NCT00813774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82743967|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82743968|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
82743969|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743970|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82743971|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
82743972|NCT02557490|Raltitrexed|raltitrexed|mesh-list
82743973|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82743974|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82743975|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
82743976|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743977|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82743978|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82743979|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
82743980|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82743981|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82743982|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82743983|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82743984|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82743985|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82743986|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
82743987|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82743988|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743989|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82743990|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743991|NCT00807534|Bromides|bromides|mesh-list
82743992|NCT00807534|Ipratropium|ipratropium|mesh-list
82743993|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
82743994|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82743995|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
82743996|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82743997|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82743998|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82743999|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
82744000|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82744001|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
82744002|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744003|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744004|NCT05589064|Vitamin D|vitamin d|mesh-list
82744005|NCT05589064|Cholecalciferol|cholecalciferol|mesh-list
82744006|NCT05589064|Vitamins|vitamins|mesh-ancestor
82744007|NCT05589064|Micronutrients|micronutrients|mesh-ancestor
82744008|NCT05589064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744009|NCT05589064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82744010|NCT05589064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82744011|NCT00807690|Tacrolimus|tacrolimus|mesh-list
82744012|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82744013|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
82744014|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744015|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82744016|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744017|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744018|NCT05355844|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82744019|NCT05355844|Dermatologic Agents|dermatologic agents|mesh-ancestor
82744021|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82744022|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744023|NCT00814086|Paclitaxel|paclitaxel|mesh-list
82744024|NCT00814086|Cisplatin|cisplatin|mesh-list
82744025|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82744026|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744027|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
82744028|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
82744029|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
82744030|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744031|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82744032|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82744033|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82744034|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82744035|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744036|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744037|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744038|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
82744039|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82744040|NCT00654732|Rituximab|rituximab|mesh-list
82744041|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82744042|NCT00654732|Doxorubicin|doxorubicin|mesh-list
82744043|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82744044|NCT00654732|Dacarbazine|dacarbazine|mesh-list
82744045|NCT00654732|Bleomycin|bleomycin|mesh-list
82744046|NCT00654732|Vinblastine|vinblastine|mesh-list
82744047|NCT00654732|Antibodies|antibodies|mesh-list
82744048|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
82744049|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82744050|NCT00654732|Imidazole|imidazole|mesh-list
82744051|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
82744052|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744053|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744054|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82744055|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82744056|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82744057|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82744058|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744059|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744060|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82744061|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
82744062|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82744063|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
82744064|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
82744065|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
82744066|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
82744067|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82744068|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
82744069|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744070|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744071|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82744072|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
82744073|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82744074|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
82744075|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744076|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744077|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82744078|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
82744079|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
82744080|NCT00771368|Protective Agents|protective agents|mesh-ancestor
82744081|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
82744082|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
82744083|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82744084|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744085|NCT00771680|Insulin|insulin|mesh-list
82744086|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82744087|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
82744088|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
82744164|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744089|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82744091|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
82744092|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82744093|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82744094|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744095|NCT00767468|Sorafenib|sorafenib|mesh-list
82744096|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744097|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82744098|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744099|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744100|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
82744101|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82744102|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
82744103|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744105|NCT00669032|Protective Agents|protective agents|mesh-ancestor
82744106|NCT00775580|Atenolol|atenolol|mesh-list
82744107|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82744108|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82744109|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
82744110|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
82744111|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744112|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744113|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82744114|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82744115|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82744116|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
82744117|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744118|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744119|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
82744120|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82744121|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82744122|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744123|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
82744124|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744125|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744126|NCT00654498|Pramipexole|pramipexole|mesh-list
82744127|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
82744128|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744129|NCT00654498|Protective Agents|protective agents|mesh-ancestor
82744130|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744131|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82744132|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82744133|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
82744134|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
82744135|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744136|NCT00670046|Valproic Acid|valproic acid|mesh-list
82744137|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
82744138|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744139|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744140|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
82744141|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744142|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744143|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
82744144|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82744145|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82744146|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82744147|NCT00560391|Dexamethasone|dexamethasone|mesh-list
82744148|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
82744149|NCT00560391|Lenalidomide|lenalidomide|mesh-list
82744150|NCT00560391|Dasatinib|dasatinib|mesh-list
82744151|NCT00560391|BB 1101|bb 1101|mesh-list
82744152|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82744153|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
82744154|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
82744155|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744156|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744157|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82744158|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
82744159|NCT00560391|Hormones|hormones|mesh-ancestor
82744160|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82744161|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82744162|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744163|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
82744165|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744166|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
82744167|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82744168|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82744169|NCT00560391|Growth Substances|growth substances|mesh-ancestor
82744170|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
82744171|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82744172|NCT00775736|Insulin|insulin|mesh-list
82744173|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82744174|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
82744175|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
82744176|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82744177|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
82744178|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82744179|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82744180|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744181|NCT04047914|Mupirocin|mupirocin|mesh-list
82744182|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82744183|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744184|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82744185|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744186|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744187|NCT00537238|Pregabalin|pregabalin|mesh-list
82744188|NCT00537238|Levetiracetam|levetiracetam|mesh-list
82744189|NCT00537238|Analgesics|analgesics|mesh-ancestor
82744190|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
82744191|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744192|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744193|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
82744194|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82744195|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82744196|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744197|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82744198|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82744199|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82744200|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82744201|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82744202|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
82744203|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
82744204|NCT03982771|Bortezomib|bortezomib|mesh-list
82744205|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82744206|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
82744207|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744208|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82744209|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82744210|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
82744211|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744212|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744213|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82744214|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82744215|NCT00775814|Candesartan|candesartan|mesh-list
82744216|NCT00775814|Candesartan cilexetil|candesartan cilexetil|mesh-list
82744217|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82744218|NCT00775814|Diuretics|diuretics|mesh-ancestor
82744219|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
82744220|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744221|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82744222|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82744223|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744224|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82744225|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82744227|NCT00942747|Temsirolimus|temsirolimus|mesh-list
82744228|NCT00942747|MTOR Inhibitors|mtor inhibitors|mesh-list
82744229|NCT00942747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82744230|NCT00942747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744231|NCT00942747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744232|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82744233|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
82744234|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744235|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744236|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82744237|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744238|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82744239|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
82744241|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
82744242|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
82744243|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
82744244|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744245|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744246|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82744247|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82744248|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82744249|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82744250|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82744251|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82744253|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744254|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744255|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82744256|NCT05355610|Gentamicins|gentamicins|mesh-list
82744257|NCT05355610|Dexamethasone|dexamethasone|mesh-list
82744258|NCT05355610|Dexamethasone acetate|dexamethasone acetate|mesh-list
82744259|NCT05355610|BB 1101|bb 1101|mesh-list
82744260|NCT05355610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82744261|NCT05355610|Antiemetics|antiemetics|mesh-ancestor
82744262|NCT05355610|Autonomic Agents|autonomic agents|mesh-ancestor
82744263|NCT05355610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744264|NCT05355610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744265|NCT05355610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82744266|NCT05355610|Glucocorticoids|glucocorticoids|mesh-ancestor
82744267|NCT05355610|Hormones|hormones|mesh-ancestor
82744268|NCT05355610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82744269|NCT05355610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82744270|NCT05355610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744271|NCT05355610|Protease Inhibitors|protease inhibitors|mesh-ancestor
82744272|NCT05355610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744273|NCT05355610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744274|NCT05355610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82744275|NCT05355610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744276|NCT05355610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82744277|NCT00552669|Sirolimus|sirolimus|mesh-list
82744278|NCT00552669|Paclitaxel|paclitaxel|mesh-list
82744279|NCT00552669|Temsirolimus|temsirolimus|mesh-list
82744280|NCT00552669|MTOR Inhibitors|mtor inhibitors|mesh-list
82744281|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82744282|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744283|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
82744284|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
82744285|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
82744286|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744287|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82744288|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744289|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82744290|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
82744291|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82744292|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
82744293|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744294|NCT00552669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82744295|NCT00552669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744296|NCT00943059|Acipimox|acipimox|mesh-list
82744297|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82744298|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
82744299|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744300|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82744301|NCT00943137|Fluorouracil|fluorouracil|mesh-list
82744302|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
82744303|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744304|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82744305|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744306|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82744307|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
82744308|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744309|NCT00772616|Sufentanil|sufentanil|mesh-list
82744310|NCT00772616|Remifentanil|remifentanil|mesh-list
82744311|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82744312|NCT00772616|Narcotics|narcotics|mesh-ancestor
82744313|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82744314|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744315|NCT00772616|Analgesics|analgesics|mesh-ancestor
82744316|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
82744317|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744318|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82744319|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82744320|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
82744321|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
82744322|NCT05488678|Ceftibuten|ceftibuten|mesh-list
82744323|NCT05488678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82744324|NCT05488678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744325|NCT05406700|Niraparib|niraparib|mesh-list
82744326|NCT05406700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82744327|NCT05406700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744328|NCT05406700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744329|NCT05406700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744331|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82744332|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744333|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
82744334|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82744335|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
82744336|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
82744337|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744338|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
82744339|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744340|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744341|NCT05406622|Sirolimus|sirolimus|mesh-list
82744342|NCT05406622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82744343|NCT05406622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744344|NCT05406622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82744345|NCT05406622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744346|NCT05406622|Antifungal Agents|antifungal agents|mesh-ancestor
82744347|NCT05406622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82744348|NCT05406622|Immunologic Factors|immunologic factors|mesh-ancestor
82744349|NCT05406622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744350|NCT00776282|Loratadine|loratadine|mesh-list
82744351|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
82744352|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
82744353|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82744354|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82744355|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82744356|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
82744357|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
82744358|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744359|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744360|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744361|NCT00943293|Fludarabine|fludarabine|mesh-list
82744362|NCT00943293|Melphalan|melphalan|mesh-list
82744363|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
82744364|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744365|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744366|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82744367|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
82744368|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744369|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82744370|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
82744371|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82744372|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82744373|NCT00776360|Oxytocin|oxytocin|mesh-list
82744374|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
82744375|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82744376|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744377|NCT00946725|Atenolol|atenolol|mesh-list
82744378|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82744379|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82744380|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
82744381|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
82744382|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744383|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744384|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82744385|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82744386|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82744387|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
82744388|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744389|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744390|NCT03041740|Perflubron|perflubron|mesh-list
82744391|NCT03041740|Bromides|bromides|mesh-list
82744392|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
82744393|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82744394|NCT00772694|Sorafenib|sorafenib|mesh-list
82744395|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744396|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82744397|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744398|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744399|NCT00776438|Vaccines|vaccines|mesh-list
82744400|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
82744401|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744402|NCT00943449|Sorafenib|sorafenib|mesh-list
82744403|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744404|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82744405|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744406|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744407|NCT00952029|Leucovorin|leucovorin|mesh-list
82744408|NCT00952029|Bevacizumab|bevacizumab|mesh-list
82744409|NCT00952029|Fluorouracil|fluorouracil|mesh-list
82744410|NCT00952029|Irinotecan|irinotecan|mesh-list
82744411|NCT00952029|Calcium|calcium|mesh-list
82744412|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
82744413|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82744414|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744415|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82744416|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82744417|NCT00952029|Growth Substances|growth substances|mesh-ancestor
82744418|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744419|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
82744420|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82744421|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
82744422|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744423|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82744424|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82744425|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
82744426|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82744427|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82744428|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744429|NCT00952029|Antidotes|antidotes|mesh-ancestor
82744430|NCT00952029|Protective Agents|protective agents|mesh-ancestor
82744431|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
82744432|NCT00952029|Vitamins|vitamins|mesh-ancestor
82744433|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
82744434|NCT00667862|Panobinostat|panobinostat|mesh-list
82744435|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744436|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82744437|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744438|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744439|NCT00952185|Antibodies|antibodies|mesh-list
82744440|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
82744441|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744442|NCT00776516|Rifampin|rifampin|mesh-list
82744443|NCT00776516|Mirabegron|mirabegron|mesh-list
82744444|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82744445|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
82744446|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82744447|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744448|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
82744449|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82744450|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744451|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744452|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82744453|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82744454|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82744455|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82744456|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82744457|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82744458|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82744459|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82744460|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82744461|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
82744462|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744463|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744464|NCT00776516|Urological Agents|urological agents|mesh-ancestor
82744465|NCT00768638|Atorvastatin|atorvastatin|mesh-list
82744466|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82744467|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82744468|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
82744469|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744470|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82744471|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82744472|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744473|NCT02557958|Azithromycin|azithromycin|mesh-list
82744474|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82744475|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744476|NCT00776672|Fosinopril|fosinopril|mesh-list
82744477|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82744478|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
82744479|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744480|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744481|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82744482|NCT00535132|Risperidone|risperidone|mesh-list
82744483|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82744484|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82744485|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
82744486|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744487|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744488|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744489|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82744490|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82744491|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82744492|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82744493|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82744494|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
82744495|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82744496|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82744497|NCT00570908|Capecitabine|capecitabine|mesh-list
82744498|NCT00570908|Sunitinib|sunitinib|mesh-list
82744499|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82744500|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
82744501|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744502|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744503|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82744504|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82744505|NCT00570908|Growth Substances|growth substances|mesh-ancestor
82744506|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744507|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
82744508|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82744509|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744510|NCT00773084|Lisinopril|lisinopril|mesh-list
82744511|NCT00773084|Spironolactone|spironolactone|mesh-list
82744512|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82744513|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
82744514|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82744515|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744516|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82744517|NCT00773084|Diuretics|diuretics|mesh-ancestor
82744518|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
82744519|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82744520|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
82744521|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744522|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744523|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82744524|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82744525|NCT00773084|Protective Agents|protective agents|mesh-ancestor
82744526|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
82744527|NCT00321919|Hematinics|hematinics|mesh-ancestor
82744528|NCT00781391|Warfarin|warfarin|mesh-list
82744529|NCT00781391|Edoxaban|edoxaban|mesh-list
82744530|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
82744531|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82744532|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
82744533|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82744534|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
82744535|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744536|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744537|NCT00534976|Montelukast|montelukast|mesh-list
82744538|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82744539|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
82744540|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82744541|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
82744617|NCT00777218|Propranolol|propranolol|mesh-list
82744542|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82744543|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744544|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82744545|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82744546|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744547|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82744548|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
82744549|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82744550|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82744551|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82744552|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82744553|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744555|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82744556|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
82744557|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744558|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744559|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82744560|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
82744561|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82744562|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82744563|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744564|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82744565|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
82744566|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82744567|NCT00776828|Protective Agents|protective agents|mesh-ancestor
82744568|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82744569|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82744570|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744571|NCT01063933|Peramivir|peramivir|mesh-list
82744572|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
82744573|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744574|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744575|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744576|NCT02556866|Prednisone|prednisone|mesh-list
82744577|NCT02556866|Rituximab|rituximab|mesh-list
82744578|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82744579|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744580|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
82744581|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744582|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82744583|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82744584|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
82744585|NCT02556866|Hormones|hormones|mesh-ancestor
82744586|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82744587|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82744588|NCT00308113|Ubiquinone|ubiquinone|mesh-list
82744589|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
82744590|NCT00308113|Prednisone|prednisone|mesh-list
82744591|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82744592|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
82744593|NCT00308113|Hormones|hormones|mesh-ancestor
82744594|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82744595|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744596|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82744597|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744598|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
82744599|NCT00308113|Vitamins|vitamins|mesh-ancestor
82744600|NCT03903640|Nivolumab|nivolumab|mesh-list
82744601|NCT03903640|Ipilimumab|ipilimumab|mesh-list
82744602|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82744603|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744604|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82744605|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744606|NCT03982849|Silymarin|silymarin|mesh-list
82744607|NCT03982849|Hydroquinone|hydroquinone|mesh-list
82744608|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
82744609|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744610|NCT03982849|Protective Agents|protective agents|mesh-ancestor
82744611|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744612|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82744613|NCT05357872|Anesthetics|anesthetics|mesh-list
82744614|NCT05357872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82744615|NCT05357872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744616|NCT00777218|Topiramate|topiramate|mesh-list
82744619|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82744620|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82744621|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
82744622|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744623|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744624|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744625|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82744626|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82744627|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
82744628|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
82744629|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82744630|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82744631|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82744632|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82744634|NCT04047758|Palbociclib|palbociclib|mesh-list
82744635|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744636|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82744637|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82744638|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744639|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744640|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82744641|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
82744642|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82744643|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744644|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82744645|NCT00307801|Dienogest|dienogest|mesh-list
82744646|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82744647|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82744648|NCT00307801|Estradiol|estradiol|mesh-list
82744649|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82744650|NCT00307801|Estrogens|estrogens|mesh-ancestor
82744651|NCT00307801|Hormones|hormones|mesh-ancestor
82744652|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82744653|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744654|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82744655|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
82744656|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82744657|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82744658|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82744659|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82744660|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82744661|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
82744662|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82744663|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744664|NCT00671060|Misoprostol|misoprostol|mesh-list
82744665|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82744666|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
82744667|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82744668|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744669|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82744670|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82744671|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
82744672|NCT05354986|Povidone|povidone|mesh-list
82744673|NCT05354986|Plasma Substitutes|plasma substitutes|mesh-ancestor
82744674|NCT05354986|Blood Substitutes|blood substitutes|mesh-ancestor
82744675|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
82744676|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82744677|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82744678|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
82744679|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744680|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744681|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744682|NCT00773552|Urological Agents|urological agents|mesh-ancestor
82744683|NCT04002700|Haloperidol|haloperidol|mesh-list
82744684|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
82744685|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
82744686|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
82744687|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
82744688|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744689|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744690|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82744691|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82744692|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82744693|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82744694|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82744695|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
82744696|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744697|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744698|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82744699|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
82744701|NCT04098653|Decitabine|decitabine|mesh-list
82744702|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82744703|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
82744704|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744705|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82744706|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82744707|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
82744708|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744709|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744710|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82744711|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82744712|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
82744713|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744714|NCT05297123|Tretinoin|tretinoin|mesh-list
82744715|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
82744716|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744717|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
82744718|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
82744719|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82744720|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744721|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82744722|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744723|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744724|NCT00773630|Cilostazol|cilostazol|mesh-list
82744725|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82744726|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
82744727|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744728|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744729|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82744730|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
82744731|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82744732|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82744733|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744734|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82744735|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
82744736|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82744737|NCT00773630|Protective Agents|protective agents|mesh-ancestor
82744738|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82744739|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82744740|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744741|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82744742|NCT04016922|Hematinics|hematinics|mesh-ancestor
82744743|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
82744744|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82744745|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82744746|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744747|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
82744748|NCT03646474|Coagulants|coagulants|mesh-ancestor
82744749|NCT00808002|Tenofovir|tenofovir|mesh-list
82744750|NCT00808002|Emtricitabine|emtricitabine|mesh-list
82744751|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
82744752|NCT00808002|Maraviroc|maraviroc|mesh-list
82744753|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
82744754|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744755|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82744756|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82744757|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744758|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744759|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82744760|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82744761|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82744762|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82744763|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82744764|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82744765|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82744766|NCT00307489|Tenofovir|tenofovir|mesh-list
82744767|NCT00307489|Emtricitabine|emtricitabine|mesh-list
82744768|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
82744769|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744770|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82744771|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82744772|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744773|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744775|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82744776|NCT00812292|Rilpivirine|rilpivirine|mesh-list
82744777|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82744778|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82744779|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744780|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744781|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
82744782|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744783|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82744784|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82744785|NCT00812370|Bivalirudin|bivalirudin|mesh-list
82744786|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
82744787|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82744788|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
82744789|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744790|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744791|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
82744792|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82744793|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82744794|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
82744795|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82744796|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82744797|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
82744798|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744799|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82744800|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82744801|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744802|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744803|NCT00762359|Lansoprazole|lansoprazole|mesh-list
82744804|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
82744805|NCT00762359|Gefarnate|gefarnate|mesh-list
82744806|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82744807|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82744808|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82744809|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744810|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744811|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
82744812|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
82744813|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82744814|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
82744815|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744816|NCT00770042|Ritonavir|ritonavir|mesh-list
82744817|NCT00770042|Ketoconazole|ketoconazole|mesh-list
82744818|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82744819|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82744820|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
82744821|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744822|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744823|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82744824|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82744825|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
82744826|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744827|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82744828|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82744829|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
82744830|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82744831|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82744832|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
82744833|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82744834|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744835|NCT00654186|Lenalidomide|lenalidomide|mesh-list
82744836|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
82744837|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744838|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82744839|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82744840|NCT00654186|Growth Substances|growth substances|mesh-ancestor
82744841|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
82744842|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744843|NCT03275818|Paclitaxel|paclitaxel|mesh-list
82744844|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82744845|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744846|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
82744847|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
82744848|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
82744849|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744850|NCT03979105|Ketamine|ketamine|mesh-list
82744851|NCT03979105|Analgesics|analgesics|mesh-ancestor
82744852|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
82744853|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744854|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744855|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82744856|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82744858|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
82744859|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82744860|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82744861|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82744862|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744863|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744864|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
82744865|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82744866|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744867|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
82744868|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82744869|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82744870|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744871|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
82744872|NCT04100447|Coagulants|coagulants|mesh-ancestor
82744873|NCT03274804|Maraviroc|maraviroc|mesh-list
82744874|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
82744875|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82744876|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744877|NCT03274804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82744878|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744879|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82744880|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82744881|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82744882|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82744883|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
82744884|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744885|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82744886|NCT00761891|Aspirin|aspirin|mesh-list
82744887|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82744888|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82744889|NCT00761891|Analgesics|analgesics|mesh-ancestor
82744890|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
82744891|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744892|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744893|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82744894|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82744895|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82744896|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82744897|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744898|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82744899|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82744900|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744901|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
82744902|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
82744903|NCT00321685|Leucovorin|leucovorin|mesh-list
82744904|NCT00321685|Folic Acid|folic acid|mesh-list
82744905|NCT00321685|Bevacizumab|bevacizumab|mesh-list
82744906|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82744907|NCT00321685|Fluorouracil|fluorouracil|mesh-list
82744908|NCT00321685|Capecitabine|capecitabine|mesh-list
82744909|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
82744910|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
82744911|NCT00321685|Antibodies|antibodies|mesh-list
82744912|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
82744913|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82744914|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
82744915|NCT00321685|Calcium|calcium|mesh-list
82744916|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
82744917|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744918|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82744919|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82744920|NCT00321685|Growth Substances|growth substances|mesh-ancestor
82744921|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744922|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
82744923|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
82744924|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82744925|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82744926|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
82744927|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744928|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82744929|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82744930|NCT00321685|Antidotes|antidotes|mesh-ancestor
82744931|NCT00321685|Protective Agents|protective agents|mesh-ancestor
82744932|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
82744933|NCT00321685|Vitamins|vitamins|mesh-ancestor
82744934|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
82744935|NCT00321685|Hematinics|hematinics|mesh-ancestor
82744936|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
82744937|NCT00777998|Thalidomide|thalidomide|mesh-list
82744938|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82744939|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
82744940|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744941|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
82744942|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82744943|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744944|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82744945|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82744946|NCT00777998|Growth Substances|growth substances|mesh-ancestor
82744947|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
82744948|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82744949|NCT00777998|Trace Elements|trace elements|mesh-ancestor
82744950|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
82744951|NCT05348200|Clobetasol|clobetasol|mesh-list
82744952|NCT05348200|Lidocaine|lidocaine|mesh-list
82744953|NCT05348200|Halobetasol|halobetasol|mesh-list
82744954|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
82744955|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
82744956|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82744957|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744958|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
82744959|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744960|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82744961|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82744962|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82744963|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82744964|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744965|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82744966|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82744967|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
82744969|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82744970|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
82744971|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82744972|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
82744973|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744974|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
82744975|NCT00778076|Protective Agents|protective agents|mesh-ancestor
82744976|NCT00306787|Valacyclovir|valacyclovir|mesh-list
82744977|NCT00306787|Famciclovir|famciclovir|mesh-list
82744978|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
82744979|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82744980|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82744981|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82744982|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744983|NCT00778232|Gabapentin|gabapentin|mesh-list
82744984|NCT00778232|Analgesics|analgesics|mesh-ancestor
82744985|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
82744986|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82744987|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82744988|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
82744989|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82744990|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82744991|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82744992|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82744993|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82744994|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82744995|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82744996|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744997|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
82744998|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
82744999|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82745000|NCT00774488|Incretins|incretins|mesh-ancestor
82745001|NCT00774488|Hormones|hormones|mesh-ancestor
82745002|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745003|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745005|NCT01066195|Gefitinib|gefitinib|mesh-list
82745006|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745007|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745008|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745009|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82745010|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82745011|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82745012|NCT00774644|Clarithromycin|clarithromycin|mesh-list
82745013|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82745014|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745015|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82745016|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745017|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745018|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82745019|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82745020|NCT05123092|Morphine|morphine|mesh-list
82745021|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82745022|NCT05123092|Narcotics|narcotics|mesh-ancestor
82745023|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82745024|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745025|NCT05123092|Analgesics|analgesics|mesh-ancestor
82745026|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
82745027|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745028|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82745029|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82745030|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745031|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82745032|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745033|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745034|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
82745035|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
82745036|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745037|NCT00667394|Bevacizumab|bevacizumab|mesh-list
82745038|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82745039|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745040|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82745041|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82745042|NCT00667394|Growth Substances|growth substances|mesh-ancestor
82745043|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745044|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
82745045|NCT05357326|Atropine|atropine|mesh-list
82745046|NCT05357326|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82745047|NCT05357326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82745048|NCT05357326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82745049|NCT05357326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82745050|NCT05357326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82745051|NCT05357326|Autonomic Agents|autonomic agents|mesh-ancestor
82745052|NCT05357326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745053|NCT05357326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745054|NCT05357326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82745055|NCT05357326|Respiratory System Agents|respiratory system agents|mesh-ancestor
82745056|NCT05357326|Mydriatics|mydriatics|mesh-ancestor
82745057|NCT05357326|Parasympatholytics|parasympatholytics|mesh-ancestor
82745058|NCT05357326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82745059|NCT05357326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82745060|NCT05357326|Cholinergic Agents|cholinergic agents|mesh-ancestor
82745061|NCT05357326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745062|NCT05357326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745063|NCT00778466|Metformin|metformin|mesh-list
82745064|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82745065|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745066|NCT00761735|Ribavirin|ribavirin|mesh-list
82745067|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82745068|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
82745069|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745070|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
82745071|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745072|NCT00569946|Axitinib|axitinib|mesh-list
82745073|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745074|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82745075|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745076|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745077|NCT00778544|Amoxicillin|amoxicillin|mesh-list
82745078|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
82745079|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
82745080|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82745081|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82745082|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745083|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745084|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745085|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82745086|NCT04001374|Ticagrelor|ticagrelor|mesh-list
82745087|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82745088|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82745089|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82745090|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82745091|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
82745092|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745093|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745094|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745095|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
82745096|NCT05265910|Loratadine|loratadine|mesh-list
82745097|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
82745098|NCT05265910|Dextrans|dextrans|mesh-list
82745099|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82745100|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82745101|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
82745102|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
82745103|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82745104|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82745105|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82745106|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
82745107|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
82745108|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745109|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745110|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745111|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82745112|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82745113|NCT05265910|Analgesics|analgesics|mesh-ancestor
82745114|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
82745115|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745116|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82745117|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82745118|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
82745119|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
82745120|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
82745121|NCT00814866|Adalimumab|adalimumab|mesh-list
82745122|NCT00814866|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82745123|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82745124|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82745125|NCT00991978|Bevacizumab|bevacizumab|mesh-list
82745126|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
82745127|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82745128|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745129|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82745130|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82745131|NCT00991978|Growth Substances|growth substances|mesh-ancestor
82745132|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745133|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
82745134|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82745135|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745136|NCT00645528|Insulin|insulin|mesh-list
82745137|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82745138|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745139|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82745140|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
82745141|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745142|NCT00812448|Protective Agents|protective agents|mesh-ancestor
82745143|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745144|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82745145|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82745146|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745147|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82745148|NCT00295633|Metformin|metformin|mesh-list
82745149|NCT00295633|Pioglitazone|pioglitazone|mesh-list
82745150|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
82745151|NCT00295633|Saxagliptin|saxagliptin|mesh-list
82745152|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82745153|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745154|NCT00295633|Incretins|incretins|mesh-ancestor
82745155|NCT00295633|Hormones|hormones|mesh-ancestor
82745156|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745157|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82745158|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
82745159|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745160|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745161|NCT00570674|Paclitaxel|paclitaxel|mesh-list
82745162|NCT00570674|Carboplatin|carboplatin|mesh-list
82745163|NCT00570674|Cetuximab|cetuximab|mesh-list
82745164|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82745165|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82745166|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745167|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
82745168|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
82745169|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
82745170|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745171|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82745172|NCT00808314|Dipyridamole|dipyridamole|mesh-list
82745173|NCT00808314|Regadenoson|regadenoson|mesh-list
82745174|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82745175|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745176|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745177|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82745178|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
82745179|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
82745180|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82745181|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
82745182|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
82745183|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745184|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745185|NCT04992052|Bone wax|bone wax|mesh-list
82745186|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
82745187|NCT04992052|Coagulants|coagulants|mesh-ancestor
82745188|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82745189|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82745190|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
82745191|NCT00768989|Ritonavir|ritonavir|mesh-list
82745192|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82745193|NCT00768989|Tenofovir|tenofovir|mesh-list
82745194|NCT00768989|Emtricitabine|emtricitabine|mesh-list
82745195|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
82745196|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82745197|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82745198|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
82745199|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745200|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745201|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82745202|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82745203|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
82745204|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745205|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82745206|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82745207|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82745208|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82745209|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82745210|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82745211|NCT00779714|Cytarabine|cytarabine|mesh-list
82745212|NCT00779714|Paclitaxel|paclitaxel|mesh-list
82745213|NCT00779714|Cisplatin|cisplatin|mesh-list
82745214|NCT00779714|Dacarbazine|dacarbazine|mesh-list
82745215|NCT00779714|Treosulfan|treosulfan|mesh-list
82745216|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82745217|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745218|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
82745219|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
82745220|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
82745221|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745222|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82745223|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
82745224|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
82745225|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745226|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82745227|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
82745228|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745229|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82745230|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
82745232|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82745233|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82745234|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
82745235|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745236|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745237|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745238|NCT00814944|Sirolimus|sirolimus|mesh-list
82745239|NCT00814944|Temsirolimus|temsirolimus|mesh-list
82745240|NCT00814944|MTOR Inhibitors|mtor inhibitors|mesh-list
82745241|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82745242|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745243|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82745244|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745245|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
82745246|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82745247|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
82745248|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745249|NCT00814944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82745250|NCT00814944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745251|NCT00814944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745252|NCT00779792|Triamcinolone|triamcinolone|mesh-list
82745253|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82745254|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82745255|NCT00779792|Clobetasol|clobetasol|mesh-list
82745256|NCT00779792|Mineral Oil|mineral oil|mesh-list
82745257|NCT00779792|Tacrolimus|tacrolimus|mesh-list
82745258|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82745259|NCT00779792|Glycerol|glycerol|mesh-list
82745260|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82745261|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
82745262|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745263|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82745264|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745265|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745266|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82745267|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
82745268|NCT00779792|Hormones|hormones|mesh-ancestor
82745269|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745270|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82745271|NCT00779792|Protective Agents|protective agents|mesh-ancestor
82745272|NCT00779792|Emollients|emollients|mesh-ancestor
82745273|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
82745274|NCT00992134|Cytarabine|cytarabine|mesh-list
82745275|NCT00992134|Rituximab|rituximab|mesh-list
82745276|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82745277|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82745278|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745279|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
82745280|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745281|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82745282|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82745283|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
82745284|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745285|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
82745286|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745287|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82745288|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82745289|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
82745290|NCT02551536|Fexofenadine|fexofenadine|mesh-list
82745291|NCT02551536|Montelukast|montelukast|mesh-list
82745292|NCT02551536|Levocetirizine|levocetirizine|mesh-list
82745293|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82745294|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
82745295|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82745296|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
82745297|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745298|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745299|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82745300|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82745301|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745302|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82745303|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82745304|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82745305|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
82745306|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
82745307|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745309|NCT00815022|Morphine|morphine|mesh-list
82745310|NCT00815022|Bupivacaine|bupivacaine|mesh-list
82745311|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
82745312|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
82745313|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82745314|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745315|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
82745316|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745317|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82745318|NCT00815022|Narcotics|narcotics|mesh-ancestor
82745319|NCT00815022|Analgesics|analgesics|mesh-ancestor
82745320|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82745321|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82745322|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
82745323|NCT00774722|Metronidazole|metronidazole|mesh-list
82745324|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745325|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82745326|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82745327|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82745328|NCT00808392|Vaccines|vaccines|mesh-list
82745329|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
82745330|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745331|NCT04045548|Dinoprostone|dinoprostone|mesh-list
82745332|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
82745333|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82745334|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745335|NCT00780104|Cytarabine|cytarabine|mesh-list
82745336|NCT00780104|Sirolimus|sirolimus|mesh-list
82745337|NCT00780104|Etoposide|etoposide|mesh-list
82745338|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
82745339|NCT00780104|Temsirolimus|temsirolimus|mesh-list
82745340|NCT00780104|MTOR Inhibitors|mtor inhibitors|mesh-list
82745341|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82745342|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745343|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82745344|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82745345|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745346|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745347|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82745348|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
82745349|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
82745350|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745351|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82745352|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
82745353|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745354|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82745355|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82745356|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
82745357|NCT00780104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82745358|NCT00780104|Analgesics|analgesics|mesh-ancestor
82745359|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
82745360|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745361|NCT04047680|Ritonavir|ritonavir|mesh-list
82745362|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
82745363|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
82745364|NCT04047680|Grazoprevir|grazoprevir|mesh-list
82745365|NCT04047680|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82745366|NCT04047680|Ledipasvir|ledipasvir|mesh-list
82745367|NCT04047680|Velpatasvir|velpatasvir|mesh-list
82745368|NCT04047680|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82745369|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82745370|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82745371|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
82745372|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745373|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745374|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82745375|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82745376|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
82745377|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745378|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82745456|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
82745379|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82745380|NCT00774878|Fulvestrant|fulvestrant|mesh-list
82745381|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82745382|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745383|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82745384|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82745385|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
82745386|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745387|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745388|NCT00815256|Riboflavin|riboflavin|mesh-list
82745389|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
82745390|NCT00815256|Vitamins|vitamins|mesh-ancestor
82745391|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
82745392|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745393|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82745394|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
82745395|NCT00778778|Cefprozil|cefprozil|mesh-list
82745396|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82745397|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745398|NCT00305773|Vorinostat|vorinostat|mesh-list
82745399|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745400|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82745401|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745402|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745403|NCT00780182|Brincidofovir|brincidofovir|mesh-list
82745404|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
82745405|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745406|NCT00812994|Escitalopram|escitalopram|mesh-list
82745407|NCT00812994|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82745408|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82745409|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82745410|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745411|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745412|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
82745413|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745414|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
82745415|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82745416|NCT00784394|Protective Agents|protective agents|mesh-ancestor
82745417|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745418|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745419|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
82745420|NCT00305695|Imidazole|imidazole|mesh-list
82745421|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82745422|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745423|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745424|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745425|NCT00784472|Morphine|morphine|mesh-list
82745426|NCT00784472|Oxycodone|oxycodone|mesh-list
82745427|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82745428|NCT00784472|Narcotics|narcotics|mesh-ancestor
82745429|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82745430|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745431|NCT00784472|Analgesics|analgesics|mesh-ancestor
82745432|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
82745433|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745434|NCT00779012|Infliximab|infliximab|mesh-list
82745435|NCT00779012|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82745436|NCT00779012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82745437|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
82745438|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82745439|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82745441|NCT00647556|Tretinoin|tretinoin|mesh-list
82745442|NCT00647556|Emollients|emollients|mesh-list
82745443|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82745444|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82745445|NCT00647556|Analgesics|analgesics|mesh-ancestor
82745446|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
82745447|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745448|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745449|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82745450|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82745451|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
82745452|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745453|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
82745454|NCT03978559|Trimethoprim|trimethoprim|mesh-list
82745455|NCT03978559|Caspofungin|caspofungin|mesh-list
82745457|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
82745458|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82745459|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
82745461|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745462|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745463|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82745464|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
82745465|NCT03978559|Hormones|hormones|mesh-ancestor
82745466|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745467|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82745468|NCT03978559|Protective Agents|protective agents|mesh-ancestor
82745469|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82745470|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745471|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
82745472|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82745473|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82745474|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82745475|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745476|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745477|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82745478|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82745479|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82745480|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
82745481|NCT00813072|Docetaxel|docetaxel|mesh-list
82745482|NCT00813072|Irinotecan|irinotecan|mesh-list
82745483|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745484|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
82745485|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
82745486|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
82745487|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745488|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82745489|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82745490|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745491|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82745492|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82745493|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745494|NCT00813228|Incretins|incretins|mesh-ancestor
82745495|NCT00813228|Hormones|hormones|mesh-ancestor
82745496|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745497|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82745498|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
82745499|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745500|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745501|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
82745502|NCT00808704|Hematinics|hematinics|mesh-ancestor
82745503|NCT00320515|Pemetrexed|pemetrexed|mesh-list
82745504|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745505|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745506|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745507|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82745508|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82745509|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
82745510|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82745511|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82745512|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745513|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
82745514|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82745515|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
82745517|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
82745518|NCT00815568|Busulfan|busulfan|mesh-list
82745519|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745520|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82745521|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
82745522|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745523|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82745524|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
82745525|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745526|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
82745527|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82745528|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82745529|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
82745530|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
82745531|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82745532|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82745533|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745534|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745536|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
82745537|NCT01066351|Hematinics|hematinics|mesh-ancestor
82745538|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82745539|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82745540|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745541|NCT00661778|Bevacizumab|bevacizumab|mesh-list
82745542|NCT00661778|Docetaxel|docetaxel|mesh-list
82745543|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82745544|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745545|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82745546|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82745547|NCT00661778|Growth Substances|growth substances|mesh-ancestor
82745548|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745549|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
82745550|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
82745551|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
82745552|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
82745553|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745554|NCT01062139|Cetirizine|cetirizine|mesh-list
82745555|NCT01062139|Levocetirizine|levocetirizine|mesh-list
82745556|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82745557|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82745558|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
82745559|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
82745560|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745561|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745562|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745563|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82745564|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82745565|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82745566|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82745567|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82745568|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745569|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
82745570|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745571|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745572|NCT00653328|Doxorubicin|doxorubicin|mesh-list
82745573|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82745574|NCT00653328|Atrasentan|atrasentan|mesh-list
82745575|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82745576|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745577|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82745578|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82745579|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745580|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745581|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82745582|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82745583|NCT01664182|Bevacizumab|bevacizumab|mesh-list
82745584|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82745585|NCT01664182|Sunitinib|sunitinib|mesh-list
82745586|NCT01664182|Trebananib|trebananib|mesh-list
82745587|NCT01664182|Sorafenib|sorafenib|mesh-list
82745588|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
82745589|NCT01664182|Antibodies|antibodies|mesh-list
82745590|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
82745591|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82745592|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
82745593|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745594|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82745595|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82745596|NCT01664182|Growth Substances|growth substances|mesh-ancestor
82745597|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745598|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
82745599|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
82745600|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82745601|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745602|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745603|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
82745604|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
82745605|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82745606|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82745607|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745608|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745609|NCT00780728|Urological Agents|urological agents|mesh-ancestor
82745610|NCT00809172|Cyclosporine|cyclosporine|mesh-list
82745611|NCT00809172|Methotrexate|methotrexate|mesh-list
82745612|NCT00809172|Cyclosporins|cyclosporins|mesh-list
82745613|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82745614|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
82745615|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82745616|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745617|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82745618|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
82745619|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745620|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745621|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
82745622|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745623|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82745624|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82745625|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
82745626|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82745627|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82745628|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
82745629|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745630|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82745631|NCT00784862|Tamoxifen|tamoxifen|mesh-list
82745632|NCT00784862|Anastrozole|anastrozole|mesh-list
82745633|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82745634|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
82745635|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745636|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745637|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82745638|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745639|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82745640|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82745641|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82745642|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82745643|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82745644|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745645|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745646|NCT00784940|Tamoxifen|tamoxifen|mesh-list
82745647|NCT00784940|Anastrozole|anastrozole|mesh-list
82745648|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82745649|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
82745650|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745651|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745652|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82745653|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745654|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82745655|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82745656|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82745657|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82745658|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82745659|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745660|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745661|NCT00790244|Doxorubicin|doxorubicin|mesh-list
82745662|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82745663|NCT00790244|Ifosfamide|ifosfamide|mesh-list
82745664|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
82745665|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82745666|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745667|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82745668|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82745669|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745670|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745671|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82745672|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
82745673|NCT00785018|Complement C1s|complement c1s|mesh-list
82745674|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
82745675|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
82745676|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
82745677|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745678|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82745679|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82745680|NCT00534352|Ritonavir|ritonavir|mesh-list
82745681|NCT00534352|Darunavir|darunavir|mesh-list
82745682|NCT00534352|Etravirine|etravirine|mesh-list
82745683|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82745684|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82745685|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
82745686|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745687|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745688|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82745689|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82745690|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
82745691|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745692|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82745693|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82745694|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82745695|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82745696|NCT00642174|Clopidogrel|clopidogrel|mesh-list
82745697|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82745698|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82745699|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82745700|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82745701|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82745702|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
82745703|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745704|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745705|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745706|NCT02550444|Clonidine|clonidine|mesh-list
82745707|NCT02550444|Analgesics|analgesics|mesh-ancestor
82745708|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
82745709|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745710|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745711|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82745712|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
82745713|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
82745714|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82745715|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82745716|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82745717|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
82745718|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745719|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745720|NCT00665366|Valproic Acid|valproic acid|mesh-list
82745721|NCT00665366|Aripiprazole|aripiprazole|mesh-list
82745722|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
82745723|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82745724|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82745725|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82745726|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82745727|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745728|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
82745729|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
82745730|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745731|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745732|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82745733|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82745734|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
82745735|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82745736|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82745737|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82745738|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82745739|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745740|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
82745741|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
82745742|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
82745743|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82745744|NCT00775684|Exenatide|exenatide|mesh-list
82745745|NCT00775684|Glimepiride|glimepiride|mesh-list
82745746|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82745747|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745748|NCT00775684|Incretins|incretins|mesh-ancestor
82745749|NCT00775684|Hormones|hormones|mesh-ancestor
82745750|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745751|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82745752|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
82745753|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745754|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745755|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82745756|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82745757|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82745758|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
82745760|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
82745761|NCT00992524|Misoprostol|misoprostol|mesh-list
82745762|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82745763|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
82745764|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82745765|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745766|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82745767|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82745768|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
82745769|NCT00642018|Prednisone|prednisone|mesh-list
82745770|NCT00642018|Docetaxel|docetaxel|mesh-list
82745771|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745772|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
82745773|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
82745774|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
82745775|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745776|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82745777|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
82745778|NCT00642018|Hormones|hormones|mesh-ancestor
82745779|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745780|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745781|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82745782|NCT00532948|Capecitabine|capecitabine|mesh-list
82745783|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82745784|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
82745785|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745786|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745787|NCT00998920|Equol|equol|mesh-list
82745788|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
82745789|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82745790|NCT00998920|Estrogens|estrogens|mesh-ancestor
82745791|NCT00998920|Hormones|hormones|mesh-ancestor
82745792|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745793|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745794|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
82745795|NCT00992758|Antibodies|antibodies|mesh-list
82745796|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
82745797|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745798|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745799|NCT00641706|Bortezomib|bortezomib|mesh-list
82745800|NCT00641706|Vorinostat|vorinostat|mesh-list
82745801|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745802|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82745803|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745804|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745805|NCT00995332|Cytarabine|cytarabine|mesh-list
82745806|NCT00995332|Tretinoin|tretinoin|mesh-list
82745807|NCT00995332|Valproic Acid|valproic acid|mesh-list
82745808|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82745809|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
82745810|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745811|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745812|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
82745813|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745814|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82745815|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
82745816|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745817|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
82745818|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
82745819|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
82745820|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745821|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
82745822|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745823|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
82745824|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82745825|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82745826|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82745827|NCT00992914|Lidocaine|lidocaine|mesh-list
82745828|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
82745829|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
82745830|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82745831|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745832|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
82745833|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745834|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82745835|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82745836|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82745837|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82745838|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745839|NCT00999232|Erythromycin|erythromycin|mesh-list
82745840|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
82745841|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82745842|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
82745843|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82745844|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745845|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82745846|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82745847|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745848|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745849|NCT00993070|Capsaicin|capsaicin|mesh-list
82745850|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
82745851|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
82745852|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
82745853|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745854|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745855|NCT00993304|Liraglutide|liraglutide|mesh-list
82745856|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82745857|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745858|NCT00993304|Incretins|incretins|mesh-ancestor
82745859|NCT00993304|Hormones|hormones|mesh-ancestor
82745860|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745861|NCT05189002|Dalteparin|dalteparin|mesh-list
82745862|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
82745863|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82745864|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82745865|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745866|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
82745867|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
82745868|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82745869|NCT00644358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82745870|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82745871|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82745872|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745873|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745874|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
82745875|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745876|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82745877|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82745878|NCT00993694|Dapsone|dapsone|mesh-list
82745879|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745880|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
82745881|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82745882|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82745883|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82745884|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745885|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745886|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
82745887|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82745888|NCT00640926|Radezolid|radezolid|mesh-list
82745889|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
82745890|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82745891|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82745892|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82745893|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82745894|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745895|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82745896|NCT00821496|Norethindrone|norethindrone|mesh-list
82745897|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
82745898|NCT00821496|Norinyl|norinyl|mesh-list
82745899|NCT00821496|Estradiol|estradiol|mesh-list
82745900|NCT00821496|Estrogens|estrogens|mesh-ancestor
82745901|NCT00821496|Hormones|hormones|mesh-ancestor
82745902|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82745903|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745904|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82745905|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
82745906|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82745907|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82745908|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82745909|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82745910|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82745911|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82745912|NCT02550912|Vitamin D|vitamin d|mesh-list
82745913|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
82745914|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
82745915|NCT02550912|Vitamins|vitamins|mesh-list
82745916|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
82745917|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745918|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82745919|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82745921|NCT00999700|Docetaxel|docetaxel|mesh-list
82745922|NCT00999700|Fluorouracil|fluorouracil|mesh-list
82745923|NCT00999700|Cetuximab|cetuximab|mesh-list
82745924|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82745925|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
82745926|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
82745927|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
82745928|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745929|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
82745930|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82745931|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82745932|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
82745933|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745934|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82745935|NCT00818298|Ziprasidone|ziprasidone|mesh-list
82745936|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82745937|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
82745938|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745939|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745940|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745941|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82745942|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82745943|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82745944|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82745945|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82745946|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
82745947|NCT00821574|Valsartan|valsartan|mesh-list
82745948|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82745949|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82745950|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82745951|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82745952|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745953|NCT00821574|Diuretics|diuretics|mesh-ancestor
82745954|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
82745955|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745956|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82745957|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82745958|NCT00995800|Fluticasone|fluticasone|mesh-list
82745959|NCT00995800|Xhance|xhance|mesh-list
82745960|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
82745961|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82745962|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82745963|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
82745964|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745965|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745966|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82745967|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
82745968|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
82745969|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82745970|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82745971|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82745972|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82745973|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
82745974|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82745975|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82745976|NCT00821652|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82745977|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
82745978|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82745979|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
82745980|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745981|NCT00319501|Diazepam|diazepam|mesh-list
82745982|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82745983|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
82745984|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
82745985|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
82745986|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82745987|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82745988|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82745989|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82745990|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82745991|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82745992|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82745993|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82745994|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82745995|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82745996|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82745997|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
82745998|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
82745999|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
82746000|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
82746001|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746002|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746003|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
82746004|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
82746005|NCT00994006|Levulinic acid|levulinic acid|mesh-list
82746006|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746007|NCT00994006|Cathartics|cathartics|mesh-ancestor
82746008|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82746010|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746011|NCT00818610|Amoxicillin|amoxicillin|mesh-list
82746012|NCT00818610|Clarithromycin|clarithromycin|mesh-list
82746013|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82746014|NCT00818610|Cefuroxime|cefuroxime|mesh-list
82746015|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
82746016|NCT00818610|Lactams|lactams|mesh-list
82746017|NCT00818610|beta-Lactams|beta-lactams|mesh-list
82746018|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82746019|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746020|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82746021|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746022|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746023|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82746024|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82746025|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82746026|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82746027|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82746028|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82746029|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746030|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746031|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82746032|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82746033|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82746034|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
82746035|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746036|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746037|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82746038|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82746039|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
82746040|NCT00627042|Ramucirumab|ramucirumab|mesh-list
82746041|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82746042|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746043|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
82746044|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746045|NCT00319111|Bosentan|bosentan|mesh-list
82746046|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82746047|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82746048|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746049|NCT00994396|Vitamin D|vitamin d|mesh-list
82746050|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
82746051|NCT00994396|Vitamins|vitamins|mesh-ancestor
82746052|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
82746053|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746054|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82746055|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82746057|NCT00816426|Rifampin|rifampin|mesh-list
82746058|NCT00816426|Isoniazid|isoniazid|mesh-list
82746059|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
82746061|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82746062|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746063|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82746064|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82746065|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746066|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746067|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746068|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82746069|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
82746070|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
82746071|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82746072|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82746073|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82746074|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82746075|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82746076|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82746077|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82746078|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82746079|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82746080|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
82746081|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82746082|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82746083|NCT00996190|Phenylephrine|phenylephrine|mesh-list
82746084|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
82746085|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82746086|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
82746087|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
82746088|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746089|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746090|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
82746091|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82746092|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
82746093|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
82746094|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82746095|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82746096|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82746097|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
82746098|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746099|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746100|NCT00996190|Protective Agents|protective agents|mesh-ancestor
82746101|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
82746102|NCT00640224|Drospirenone|drospirenone|mesh-list
82746103|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82746104|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
82746105|NCT00640224|Estradiol|estradiol|mesh-list
82746106|NCT00640224|Estrogens|estrogens|mesh-ancestor
82746107|NCT00640224|Hormones|hormones|mesh-ancestor
82746108|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746109|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746110|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82746111|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
82746112|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82746113|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82746114|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82746115|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82746116|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82746117|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82746118|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
82746119|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82746120|NCT00640224|Diuretics|diuretics|mesh-ancestor
82746121|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
82746122|NCT01000792|Cetirizine|cetirizine|mesh-list
82746123|NCT01000792|Levocetirizine|levocetirizine|mesh-list
82746124|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82746125|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82746126|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
82746127|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
82746128|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746129|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746130|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746131|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82746132|NCT02550756|Capsaicin|capsaicin|mesh-list
82746133|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
82746134|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
82746135|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
82746136|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746137|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746138|NCT01001260|Aspirin|aspirin|mesh-list
82746139|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82746140|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82746141|NCT01001260|Analgesics|analgesics|mesh-ancestor
82746142|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
82746143|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746144|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746145|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82746146|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82746147|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82746148|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82746149|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746150|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82746151|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82746152|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746153|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
82746154|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
82746155|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82746156|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
82746157|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746158|NCT00996424|Expectorants|expectorants|mesh-ancestor
82746159|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
82746160|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82746161|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
82746162|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746163|NCT00996424|Protective Agents|protective agents|mesh-ancestor
82746164|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746165|NCT00996424|Antidotes|antidotes|mesh-ancestor
82746166|NCT05220280|Infliximab|infliximab|mesh-list
82746167|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
82746168|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746169|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82746170|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746171|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746172|NCT05220280|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82746173|NCT05220280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82746174|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
82746175|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82746176|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82746177|NCT00318643|Mitomycins|mitomycins|mesh-list
82746178|NCT00318643|Mitomycin|mitomycin|mesh-list
82746179|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82746180|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746181|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
82746182|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746183|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82746184|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746185|NCT00994708|Esomeprazole|esomeprazole|mesh-list
82746186|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82746187|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82746188|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82746189|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746190|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746191|NCT01064557|Tretinoin|tretinoin|mesh-list
82746192|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746193|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
82746194|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
82746196|NCT01001962|Empagliflozin|empagliflozin|mesh-list
82746197|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82746198|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746199|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82746200|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746201|NCT01066429|Dexamethasone|dexamethasone|mesh-list
82746202|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
82746203|NCT01066429|BB 1101|bb 1101|mesh-list
82746204|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746205|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746206|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82746207|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
82746208|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
82746209|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746210|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82746211|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
82746212|NCT01066429|Hormones|hormones|mesh-ancestor
82746213|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746214|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82746215|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
82746216|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746217|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746218|NCT00994786|Pregabalin|pregabalin|mesh-list
82746219|NCT00994786|Analgesics|analgesics|mesh-ancestor
82746220|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
82746221|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746222|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746223|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
82746224|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82746225|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82746226|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746227|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82746228|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82746229|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82746230|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746231|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82746232|NCT00994942|Morphine|morphine|mesh-list
82746233|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82746234|NCT00994942|Narcotics|narcotics|mesh-ancestor
82746235|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746236|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746237|NCT00994942|Analgesics|analgesics|mesh-ancestor
82746238|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
82746239|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746240|NCT01002898|Ritonavir|ritonavir|mesh-list
82746241|NCT01002898|Lopinavir|lopinavir|mesh-list
82746242|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82746243|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82746244|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
82746245|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746246|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746247|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82746248|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82746249|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
82746250|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746251|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82746252|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82746253|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
82746254|NCT01003054|Busulfan|busulfan|mesh-list
82746255|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
82746256|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82746257|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
82746258|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746259|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82746260|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82746261|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
82746262|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746263|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746264|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82746265|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82746266|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746267|NCT01004068|Clomiphene|clomiphene|mesh-list
82746268|NCT01004068|Enclomiphene|enclomiphene|mesh-list
82746269|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
82746270|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82746271|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
82746272|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746273|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746274|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82746275|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
82746276|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82746277|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82746278|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82746279|NCT01004224|Infigratinib|infigratinib|mesh-list
82746280|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746281|NCT00530920|Ritonavir|ritonavir|mesh-list
82746282|NCT00530920|Tipranavir|tipranavir|mesh-list
82746283|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82746284|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82746285|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
82746286|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746287|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746288|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82746289|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82746290|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
82746291|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746292|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82746293|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82746294|NCT01004380|Carboplatin|carboplatin|mesh-list
82746295|NCT01004380|Farletuzumab|farletuzumab|mesh-list
82746296|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746297|NCT01003522|Anesthetics|anesthetics|mesh-list
82746298|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
82746299|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746300|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746301|NCT01003678|Clofarabine|clofarabine|mesh-list
82746302|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82746303|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
82746304|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746305|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746306|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
82746307|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746308|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
82746309|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
82746310|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
82746311|NCT04000126|Lidocaine|lidocaine|mesh-list
82746312|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
82746313|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
82746314|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746315|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746316|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
82746317|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746318|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82746319|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82746320|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82746321|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82746322|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746323|NCT01008982|Belimumab|belimumab|mesh-list
82746324|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82746325|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
82746326|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746327|NCT01005160|Metformin|metformin|mesh-list
82746328|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82746329|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746330|NCT05230810|Fulvestrant|fulvestrant|mesh-list
82746331|NCT05230810|Tucatinib|tucatinib|mesh-list
82746332|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82746333|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746334|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82746335|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82746336|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
82746337|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746338|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746339|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82746340|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746341|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746342|NCT01005238|Lamivudine|lamivudine|mesh-list
82746343|NCT01005238|Telbivudine|telbivudine|mesh-list
82746344|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82746345|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82746346|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746347|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746348|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
82746349|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746350|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82746351|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82746352|NCT01005472|Temozolomide|temozolomide|mesh-list
82746353|NCT01005472|Sunitinib|sunitinib|mesh-list
82746354|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82746355|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
82746356|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746357|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746358|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82746359|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82746360|NCT01005472|Growth Substances|growth substances|mesh-ancestor
82746361|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746362|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
82746363|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82746364|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746365|NCT01005550|Ropivacaine|ropivacaine|mesh-list
82746366|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
82746367|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
82746368|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746369|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746370|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
82746371|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746372|NCT03999580|Vitamin D|vitamin d|mesh-list
82746373|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
82746374|NCT03999580|Vitamins|vitamins|mesh-ancestor
82746375|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
82746376|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746377|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82746378|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82746379|NCT00768755|Pemetrexed|pemetrexed|mesh-list
82746380|NCT00768755|Axitinib|axitinib|mesh-list
82746381|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746382|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746383|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746384|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82746385|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82746386|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82746387|NCT01005628|Bortezomib|bortezomib|mesh-list
82746388|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746389|NCT00530842|Fluticasone|fluticasone|mesh-list
82746390|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
82746391|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82746392|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82746393|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82746394|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82746395|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
82746396|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746397|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746398|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82746399|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
82746400|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
82746401|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82746402|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
82746403|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82746404|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
82746405|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746406|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746407|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82746408|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82746409|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82746410|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
82746411|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
82746412|NCT00530842|Hormones|hormones|mesh-ancestor
82746413|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746414|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
82746415|NCT01005784|Cetrorelix|cetrorelix|mesh-list
82746416|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82746417|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
82746418|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82746419|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746420|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
82746421|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746422|NCT05154136|Itraconazole|itraconazole|mesh-list
82746423|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
82746424|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746425|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82746426|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82746427|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746428|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746429|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82746430|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
82746431|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746432|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746433|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82746434|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82746435|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746436|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82746437|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746438|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746439|NCT05733364|Vitamin B Complex|vitamin b complex|mesh-list
82746440|NCT05733364|Vitamins|vitamins|mesh-ancestor
82746441|NCT05733364|Micronutrients|micronutrients|mesh-ancestor
82746442|NCT05733364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746443|NCT01006720|Neostigmine|neostigmine|mesh-list
82746444|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82746445|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746446|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746447|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
82746448|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746449|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746450|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82746451|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
82746452|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746453|NCT01006798|Vaccines|vaccines|mesh-list
82746454|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
82746455|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746456|NCT01006876|Warfarin|warfarin|mesh-list
82746457|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
82746458|NCT03882424|Bevacizumab|bevacizumab|mesh-list
82746459|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82746460|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746461|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82746462|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82746463|NCT03882424|Growth Substances|growth substances|mesh-ancestor
82746464|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746465|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
82746466|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
82746467|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
82746468|NCT03879772|Beclomethasone|beclomethasone|mesh-list
82746469|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746470|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82746471|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
82746472|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82746473|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
82746474|NCT03879772|Hormones|hormones|mesh-ancestor
82746475|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746476|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746477|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82746478|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
82746479|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
82746480|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82746481|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
82746482|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
82746483|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746484|NCT01007500|Dexamethasone|dexamethasone|mesh-list
82746485|NCT01007500|Ondansetron|ondansetron|mesh-list
82746486|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82746487|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
82746488|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
82746489|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746490|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746491|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82746492|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
82746493|NCT01007500|Hormones|hormones|mesh-ancestor
82746494|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746495|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82746496|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746497|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
82746498|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
82746499|NCT01007500|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82746500|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82746501|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
82746502|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746503|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746504|NCT01007578|Paclitaxel|paclitaxel|mesh-list
82746505|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82746506|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746507|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
82746508|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
82746510|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746511|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
82746512|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82746513|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
82746591|NCT00530218|Ganciclovir|ganciclovir|mesh-list
82746514|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746515|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
82746516|NCT05130814|Protective Agents|protective agents|mesh-ancestor
82746517|NCT00642954|Dexamethasone|dexamethasone|mesh-list
82746518|NCT00642954|Lenalidomide|lenalidomide|mesh-list
82746519|NCT00642954|Vorinostat|vorinostat|mesh-list
82746520|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82746521|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
82746522|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
82746523|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746524|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746525|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82746526|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
82746527|NCT00642954|Hormones|hormones|mesh-ancestor
82746528|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746529|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82746530|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746531|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
82746532|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82746533|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82746534|NCT00642954|Growth Substances|growth substances|mesh-ancestor
82746535|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
82746536|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82746537|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746538|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746539|NCT00816660|Factor VIII|factor viii|mesh-list
82746540|NCT00816660|Coagulants|coagulants|mesh-ancestor
82746541|NCT00819000|Interferon-beta|interferon-beta|mesh-list
82746542|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
82746543|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
82746544|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
82746545|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82746546|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
82746547|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746548|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82746549|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82746550|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746551|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
82746552|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746553|NCT00640146|Bromides|bromides|mesh-list
82746554|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
82746555|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
82746556|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82746557|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746558|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
82746559|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746560|NCT00819078|Bupropion|bupropion|mesh-list
82746561|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82746562|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
82746563|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82746564|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82746565|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82746566|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82746567|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746568|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
82746569|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746570|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746571|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82746572|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82746573|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746574|NCT01008046|Metformin|metformin|mesh-list
82746575|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
82746576|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82746577|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82746578|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746579|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
82746580|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746581|NCT01008046|Expectorants|expectorants|mesh-ancestor
82746582|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
82746583|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82746584|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
82746585|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746586|NCT01008046|Protective Agents|protective agents|mesh-ancestor
82746587|NCT01008046|Antidotes|antidotes|mesh-ancestor
82746588|NCT00317473|Vaccines|vaccines|mesh-list
82746589|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
82746590|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746592|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
82746593|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
82746594|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746595|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82746596|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746597|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746598|NCT00761267|Fluconazole|fluconazole|mesh-list
82746599|NCT00761267|Anidulafungin|anidulafungin|mesh-list
82746600|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
82746601|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746602|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82746603|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82746604|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746605|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746606|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82746607|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
82746608|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746609|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746610|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82746611|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82746613|NCT00303667|Aldesleukin|aldesleukin|mesh-list
82746614|NCT00303667|Cyclosporine|cyclosporine|mesh-list
82746615|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
82746616|NCT00303667|Fludarabine|fludarabine|mesh-list
82746617|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
82746618|NCT00303667|Interleukin-2|interleukin-2|mesh-list
82746619|NCT00303667|Cyclosporins|cyclosporins|mesh-list
82746620|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
82746621|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82746622|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
82746623|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746624|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82746625|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82746626|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
82746627|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746628|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746629|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82746630|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82746631|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
82746632|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
82746633|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746634|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746635|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
82746636|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
82746637|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82746638|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82746639|NCT00303667|Analgesics|analgesics|mesh-ancestor
82746640|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
82746641|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746642|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82746643|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82746644|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82746645|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82746646|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82746647|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746648|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746649|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82746650|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82746651|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82746652|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
82746653|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746654|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746655|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82746656|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82746657|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
82746658|NCT01008358|Tremelimumab|tremelimumab|mesh-list
82746659|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746661|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82746662|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82746663|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
82746664|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
82746665|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746666|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746667|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746668|NCT01062529|Somatostatin|somatostatin|mesh-list
82746669|NCT01062529|Hormones|hormones|mesh-ancestor
82746670|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746671|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746672|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
82746673|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746674|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82746675|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746676|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746677|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82746678|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82746679|NCT00302731|Hormones|hormones|mesh-list
82746680|NCT00302731|Estradiol|estradiol|mesh-list
82746681|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82746682|NCT00302731|Progesterone|progesterone|mesh-list
82746683|NCT00302731|Estrogens|estrogens|mesh-list
82746684|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746685|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746686|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82746687|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
82746688|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82746689|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82746690|NCT00302731|Progestins|progestins|mesh-ancestor
82746691|NCT00780143|Cytarabine|cytarabine|mesh-list
82746692|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82746693|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
82746694|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746695|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746696|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
82746697|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746698|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82746699|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
82746700|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746701|NCT01007968|Panobinostat|panobinostat|mesh-list
82746702|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746703|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82746704|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746705|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746706|NCT00779909|Vitamin D|vitamin d|mesh-list
82746707|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
82746708|NCT00779909|Vitamins|vitamins|mesh-ancestor
82746709|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
82746710|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746711|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82746712|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82746713|NCT05559112|Vitamin D|vitamin d|mesh-list
82746714|NCT05559112|Vitamins|vitamins|mesh-ancestor
82746715|NCT05559112|Micronutrients|micronutrients|mesh-ancestor
82746716|NCT05559112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746717|NCT05559112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82746718|NCT00302107|Mirtazapine|mirtazapine|mesh-list
82746719|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
82746720|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82746721|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82746722|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
82746723|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
82746724|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746725|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746726|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746727|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82746728|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82746729|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746730|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82746731|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82746732|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82746733|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
82746734|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82746735|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82746736|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
82746737|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82746738|NCT02602301|Oxytocin|oxytocin|mesh-list
82746739|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
82746740|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82746741|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746743|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746744|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746745|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746746|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82746747|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82746748|NCT04988152|Sotrovimab|sotrovimab|mesh-list
82746749|NCT04988152|Antiviral Agents|antiviral agents|mesh-ancestor
82746750|NCT04988152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82746751|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
82746752|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82746753|NCT00636168|Ipilimumab|ipilimumab|mesh-list
82746754|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82746755|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746756|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82746757|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746758|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82746759|NCT00759941|Latanoprost|latanoprost|mesh-list
82746760|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82746761|NCT00759941|Brinzolamide|brinzolamide|mesh-list
82746762|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82746763|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746764|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746765|NCT00315445|Acetaminophen|acetaminophen|mesh-list
82746766|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82746767|NCT00315445|Oxycodone|oxycodone|mesh-list
82746768|NCT00315445|Buprenorphine|buprenorphine|mesh-list
82746769|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82746770|NCT00315445|Analgesics|analgesics|mesh-ancestor
82746771|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
82746772|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746773|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746774|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
82746775|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82746776|NCT00315445|Narcotics|narcotics|mesh-ancestor
82746777|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746778|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82746779|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82746780|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82746781|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82746782|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82746783|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82746784|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82746785|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82746786|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746787|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
82746788|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746789|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746790|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82746791|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746792|NCT00779675|Infliximab|infliximab|mesh-list
82746793|NCT00779675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82746794|NCT00779675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82746795|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
82746796|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82746797|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82746798|NCT04102943|Tacrolimus|tacrolimus|mesh-list
82746799|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82746800|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
82746801|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746802|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82746803|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746804|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746805|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82746806|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
82746807|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746808|NCT00315055|Vaccines|vaccines|mesh-list
82746809|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
82746810|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746811|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
82746812|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82746813|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746814|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
82746815|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746816|NCT00293293|Taxane|taxane|mesh-list
82746817|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746819|NCT05774639|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82746820|NCT05774639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82746821|NCT05774639|Respiratory System Agents|respiratory system agents|mesh-ancestor
82746822|NCT05774626|Contraceptive Agents|contraceptive agents|mesh-list
82746823|NCT05774626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82746824|NCT05774626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746825|NCT05774574|Cannabidiol|cannabidiol|mesh-list
82746826|NCT05774574|Anticonvulsants|anticonvulsants|mesh-ancestor
82746827|NCT05774275|Doxorubicin|doxorubicin|mesh-list
82746828|NCT05774275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82746829|NCT05774275|Antibodies|antibodies|mesh-list
82746830|NCT05774275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82746831|NCT05774275|Immunologic Factors|immunologic factors|mesh-ancestor
82746832|NCT05774275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746833|NCT05774275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82746834|NCT05774275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746835|NCT05774275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82746836|NCT05774275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82746837|NCT05774275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746838|NCT05774275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746839|NCT05774249|Bupivacaine|bupivacaine|mesh-list
82746840|NCT05774249|Anesthetics, Local|anesthetics, local|mesh-ancestor
82746841|NCT05774249|Anesthetics|anesthetics|mesh-ancestor
82746842|NCT05774249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746843|NCT05774249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746844|NCT05774249|Sensory System Agents|sensory system agents|mesh-ancestor
82746845|NCT05774249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746846|NCT05774028|Dexamethasone|dexamethasone|mesh-list
82746847|NCT05774028|Gemcitabine|gemcitabine|mesh-list
82746848|NCT05774028|Etoposide|etoposide|mesh-list
82746849|NCT05774028|Mitoxantrone|mitoxantrone|mesh-list
82746850|NCT05774028|Pegaspargase|pegaspargase|mesh-list
82746851|NCT05774028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82746852|NCT05774028|Antiemetics|antiemetics|mesh-ancestor
82746853|NCT05774028|Autonomic Agents|autonomic agents|mesh-ancestor
82746854|NCT05774028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746855|NCT05774028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746856|NCT05774028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82746857|NCT05774028|Glucocorticoids|glucocorticoids|mesh-ancestor
82746858|NCT05774028|Hormones|hormones|mesh-ancestor
82746859|NCT05774028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746860|NCT05774028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82746861|NCT05774028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746862|NCT05774028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82746863|NCT05774028|Antimetabolites|antimetabolites|mesh-ancestor
82746864|NCT05774028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746865|NCT05774028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82746866|NCT05774028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82746867|NCT05774028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82746868|NCT05774028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746869|NCT05774028|Analgesics|analgesics|mesh-ancestor
82746870|NCT05774028|Sensory System Agents|sensory system agents|mesh-ancestor
82746871|NCT05774015|Magnesium Oxide|magnesium oxide|mesh-list
82746872|NCT05774015|Antacids|antacids|mesh-ancestor
82746873|NCT05774015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746874|NCT05774015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82746875|NCT05773911|Chitosan|chitosan|mesh-list
82746876|NCT05773911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82746877|NCT05773911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82746878|NCT05773911|Antimetabolites|antimetabolites|mesh-ancestor
82746879|NCT05773911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746880|NCT05773911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82746881|NCT05773911|Chelating Agents|chelating agents|mesh-ancestor
82746882|NCT05773911|Sequestering Agents|sequestering agents|mesh-ancestor
82746883|NCT05773911|Hemostatics|hemostatics|mesh-ancestor
82746884|NCT05773911|Coagulants|coagulants|mesh-ancestor
82746885|NCT05773859|Vaccines|vaccines|mesh-list
82746886|NCT05773859|Immunologic Factors|immunologic factors|mesh-ancestor
82746887|NCT05773859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746888|NCT05773846|Ropivacaine|ropivacaine|mesh-list
82746889|NCT05773846|Anesthetics, Local|anesthetics, local|mesh-ancestor
82746890|NCT05773846|Anesthetics|anesthetics|mesh-ancestor
82746891|NCT05773846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746892|NCT05773846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746893|NCT05773846|Sensory System Agents|sensory system agents|mesh-ancestor
82746894|NCT05773846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746895|NCT05773807|Propofol|propofol|mesh-list
82746896|NCT05773807|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82746897|NCT05773807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746898|NCT05773807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746899|NCT05773807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82746900|NCT05773807|Anesthetics, General|anesthetics, general|mesh-ancestor
82746901|NCT05773807|Anesthetics|anesthetics|mesh-ancestor
82746902|NCT05773664|Dexamethasone|dexamethasone|mesh-list
82746903|NCT05773664|Dexamethasone acetate|dexamethasone acetate|mesh-list
82746904|NCT05773664|Ichthammol|ichthammol|mesh-list
82746905|NCT05773664|BB 1101|bb 1101|mesh-list
82746906|NCT05773664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82746907|NCT05773664|Antiemetics|antiemetics|mesh-ancestor
82746908|NCT05773664|Autonomic Agents|autonomic agents|mesh-ancestor
82746909|NCT05773664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746910|NCT05773664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746911|NCT05773664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82746912|NCT05773664|Glucocorticoids|glucocorticoids|mesh-ancestor
82746913|NCT05773664|Hormones|hormones|mesh-ancestor
82746914|NCT05773664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746915|NCT05773664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82746916|NCT05773664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746917|NCT05773664|Protease Inhibitors|protease inhibitors|mesh-ancestor
82746918|NCT05773664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746919|NCT05773664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746920|NCT05773664|Dermatologic Agents|dermatologic agents|mesh-ancestor
82746921|NCT05773183|Testosterone|testosterone|mesh-list
82746922|NCT05773183|Androgens|androgens|mesh-ancestor
82746923|NCT05773183|Hormones|hormones|mesh-ancestor
82746924|NCT05773183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82746925|NCT05773183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746926|NCT05773092|Osimertinib|osimertinib|mesh-list
82746927|NCT05773092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746928|NCT05773092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82746929|NCT05773092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746930|NCT05773092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746931|NCT05767398|Zanubrutinib|zanubrutinib|mesh-list
82746932|NCT05767398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746933|NCT05767398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82746934|NCT05767398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746935|NCT05767398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746936|NCT05742438|Lidocaine|lidocaine|mesh-list
82746937|NCT05742438|Dexmedetomidine|dexmedetomidine|mesh-list
82746938|NCT05742438|Morphine|morphine|mesh-list
82746939|NCT05742438|Anesthetics, Local|anesthetics, local|mesh-ancestor
82746940|NCT05742438|Anesthetics|anesthetics|mesh-ancestor
82746941|NCT05742438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82746942|NCT05742438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746943|NCT05742438|Sensory System Agents|sensory system agents|mesh-ancestor
82746944|NCT05742438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82746945|NCT05742438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82746946|NCT05742438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82746947|NCT05742438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82746948|NCT05742438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82746949|NCT05742438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746950|NCT05742438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82746951|NCT05742438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82746952|NCT05742438|Analgesics|analgesics|mesh-ancestor
82746953|NCT05742438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82746954|NCT05742438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82746955|NCT05742438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82746956|NCT05742438|Adrenergic Agents|adrenergic agents|mesh-ancestor
82746957|NCT05742438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82746958|NCT05742438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82746959|NCT05742438|Narcotics|narcotics|mesh-ancestor
82746960|NCT05732051|Niacinamide|niacinamide|mesh-list
82746961|NCT05732051|Niacin|niacin|mesh-list
82746962|NCT05732051|Nicotinic Acids|nicotinic acids|mesh-list
82746963|NCT05732051|Vitamin B Complex|vitamin b complex|mesh-ancestor
82746964|NCT05732051|Vitamins|vitamins|mesh-ancestor
82746965|NCT05732051|Micronutrients|micronutrients|mesh-ancestor
82746966|NCT05732051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746967|NCT05732051|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82746968|NCT05732051|Antimetabolites|antimetabolites|mesh-ancestor
82746969|NCT05732051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746970|NCT05732051|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82746971|NCT05732051|Vasodilator Agents|vasodilator agents|mesh-ancestor
82746972|NCT05695027|Niacinamide|niacinamide|mesh-list
82746973|NCT05695027|Niacin|niacin|mesh-list
82746974|NCT05695027|Nicotinic Acids|nicotinic acids|mesh-list
82746975|NCT05695027|Vitamin B Complex|vitamin b complex|mesh-ancestor
82746976|NCT05695027|Vitamins|vitamins|mesh-ancestor
82746977|NCT05695027|Micronutrients|micronutrients|mesh-ancestor
82746978|NCT05695027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746979|NCT05695027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82746980|NCT05695027|Antimetabolites|antimetabolites|mesh-ancestor
82746981|NCT05695027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746982|NCT05695027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82746983|NCT05695027|Vasodilator Agents|vasodilator agents|mesh-ancestor
82746984|NCT05667922|Tacrolimus|tacrolimus|mesh-list
82746985|NCT05667922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82746986|NCT05667922|Immunologic Factors|immunologic factors|mesh-ancestor
82746987|NCT05667922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746988|NCT05667922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82746989|NCT05667922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82746990|NCT05667922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82746991|NCT05667909|Rituximab|rituximab|mesh-list
82746992|NCT05667909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82746993|NCT05667909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82746994|NCT05667909|Immunologic Factors|immunologic factors|mesh-ancestor
82746995|NCT05667909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82746996|NCT05667909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82746997|NCT05667896|Tacrolimus|tacrolimus|mesh-list
82746998|NCT05667896|Glucocorticoids|glucocorticoids|mesh-list
82746999|NCT05667896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747000|NCT05667896|Immunologic Factors|immunologic factors|mesh-ancestor
82747001|NCT05667896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747002|NCT05667896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82747003|NCT05667896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747004|NCT05667896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747005|NCT05667896|Hormones|hormones|mesh-ancestor
82747006|NCT05667896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747007|NCT05667883|Cyclophosphamide|cyclophosphamide|mesh-list
82747008|NCT05667883|Glucocorticoids|glucocorticoids|mesh-list
82747009|NCT05667883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747010|NCT05667883|Immunologic Factors|immunologic factors|mesh-ancestor
82747011|NCT05667883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747012|NCT05667883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747013|NCT05667883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82747014|NCT05667883|Alkylating Agents|alkylating agents|mesh-ancestor
82747015|NCT05667883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747016|NCT05667883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747017|NCT05667883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82747018|NCT05667883|Hormones|hormones|mesh-ancestor
82747019|NCT05667883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747020|NCT05667805|Thrombin|thrombin|mesh-list
82747021|NCT05667805|Hemostatics|hemostatics|mesh-ancestor
82747022|NCT05667805|Coagulants|coagulants|mesh-ancestor
82747023|NCT05660746|Infliximab|infliximab|mesh-list
82747024|NCT05660746|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82747025|NCT05660746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82747026|NCT05660746|Dermatologic Agents|dermatologic agents|mesh-ancestor
82747027|NCT05660746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82747028|NCT05660746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747029|NCT05644496|Meloxicam|meloxicam|mesh-list
82747030|NCT05644496|Bupivacaine|bupivacaine|mesh-list
82747031|NCT05644496|Anesthetics, Local|anesthetics, local|mesh-ancestor
82747032|NCT05644496|Anesthetics|anesthetics|mesh-ancestor
82747033|NCT05644496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82747034|NCT05644496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747035|NCT05644496|Sensory System Agents|sensory system agents|mesh-ancestor
82747036|NCT05644496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747037|NCT05644496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82747038|NCT05644496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82747039|NCT05644496|Analgesics|analgesics|mesh-ancestor
82747040|NCT05644496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82747041|NCT05644496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747042|NCT05644496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82747043|NCT05644496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82747044|NCT05644496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747045|NCT05644496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747047|NCT05613608|Anticonvulsants|anticonvulsants|mesh-ancestor
82747048|NCT05592613|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82747049|NCT05592613|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82747050|NCT05592613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82747051|NCT05592613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82747052|NCT05592613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747053|NCT05592613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747054|NCT05592613|Antiviral Agents|antiviral agents|mesh-ancestor
82747055|NCT05592613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747056|NCT05592613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82747057|NCT05567562|Clopidogrel|clopidogrel|mesh-list
82747058|NCT05567562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747059|NCT05567562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747060|NCT05567562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82747061|NCT05567562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82747062|NCT05567562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82747063|NCT05567562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82747064|NCT05567562|Purinergic Agents|purinergic agents|mesh-ancestor
82747065|NCT05567562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82747066|NCT05554978|Landiolol|landiolol|mesh-list
82747067|NCT05554978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82747068|NCT05554978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82747069|NCT05554978|Adrenergic Agents|adrenergic agents|mesh-ancestor
82747070|NCT05554978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82747071|NCT05554978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747072|NCT05554978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747073|NCT05554978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82747074|NCT05546866|Osimertinib|osimertinib|mesh-list
82747075|NCT05546866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747076|NCT05546866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82747077|NCT05546866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747078|NCT05546866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747079|NCT05545969|Pembrolizumab|pembrolizumab|mesh-list
82747080|NCT05545969|Lenvatinib|lenvatinib|mesh-list
82747081|NCT05545969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747082|NCT05545969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747083|NCT05545969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747084|NCT05545969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747085|NCT05545969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82747086|NCT05545969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747087|NCT05543642|Vaccines|vaccines|mesh-list
82747088|NCT05543642|Immunologic Factors|immunologic factors|mesh-ancestor
82747089|NCT05543642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747090|NCT05525247|Gemcitabine|gemcitabine|mesh-list
82747091|NCT05525247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82747092|NCT05525247|Antimetabolites|antimetabolites|mesh-ancestor
82747093|NCT05525247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747094|NCT05525247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747096|NCT05476770|Dexamethasone|dexamethasone|mesh-list
82747097|NCT05476770|Hydrocortisone|hydrocortisone|mesh-list
82747098|NCT05476770|Methotrexate|methotrexate|mesh-list
82747099|NCT05476770|Fludarabine|fludarabine|mesh-list
82747100|NCT05476770|Vincristine|vincristine|mesh-list
82747101|NCT05476770|Azacitidine|azacitidine|mesh-list
82747102|NCT05476770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82747103|NCT05476770|Antiemetics|antiemetics|mesh-ancestor
82747104|NCT05476770|Autonomic Agents|autonomic agents|mesh-ancestor
82747105|NCT05476770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747106|NCT05476770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747107|NCT05476770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82747108|NCT05476770|Glucocorticoids|glucocorticoids|mesh-ancestor
82747109|NCT05476770|Hormones|hormones|mesh-ancestor
82747110|NCT05476770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747111|NCT05476770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82747112|NCT05476770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747113|NCT05476770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82747114|NCT05476770|Abortifacient Agents|abortifacient agents|mesh-ancestor
82747115|NCT05476770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82747116|NCT05476770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82747117|NCT05476770|Antimetabolites|antimetabolites|mesh-ancestor
82747118|NCT05476770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747119|NCT05476770|Dermatologic Agents|dermatologic agents|mesh-ancestor
82747120|NCT05476770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747121|NCT05476770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82747122|NCT05476770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747123|NCT05476770|Immunologic Factors|immunologic factors|mesh-ancestor
82747124|NCT05476770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747125|NCT05476770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82747126|NCT05476770|Antiviral Agents|antiviral agents|mesh-ancestor
82747127|NCT05476770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747128|NCT05476770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82747129|NCT05476770|Tubulin Modulators|tubulin modulators|mesh-ancestor
82747130|NCT05476770|Antimitotic Agents|antimitotic agents|mesh-ancestor
82747131|NCT05476770|Mitosis Modulators|mitosis modulators|mesh-ancestor
82747132|NCT05475678|Carboplatin|carboplatin|mesh-list
82747133|NCT05475678|Docetaxel|docetaxel|mesh-list
82747134|NCT05475678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747135|NCT05475678|Tubulin Modulators|tubulin modulators|mesh-ancestor
82747136|NCT05475678|Antimitotic Agents|antimitotic agents|mesh-ancestor
82747137|NCT05475678|Mitosis Modulators|mitosis modulators|mesh-ancestor
82747138|NCT05475678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747139|NCT05438888|Warfarin|warfarin|mesh-list
82747140|NCT05438888|Apixaban|apixaban|mesh-list
82747141|NCT05438888|Anticoagulants|anticoagulants|mesh-ancestor
82747142|NCT05438888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82747143|NCT05438888|Antithrombins|antithrombins|mesh-ancestor
82747144|NCT05438888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82747145|NCT05438888|Protease Inhibitors|protease inhibitors|mesh-ancestor
82747146|NCT05438888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747147|NCT05438888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747148|NCT05430074|Calpastatin|calpastatin|mesh-list
82747149|NCT05430074|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
82747150|NCT05430074|Protease Inhibitors|protease inhibitors|mesh-ancestor
82747151|NCT05430074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747152|NCT05430074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747153|NCT05418972|Nivolumab|nivolumab|mesh-list
82747154|NCT05418972|Relatlimab|relatlimab|mesh-list
82747155|NCT05418972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747156|NCT05418972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747157|NCT05418972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747158|NCT05418972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747159|NCT05414136|Trastuzumab|trastuzumab|mesh-list
82747160|NCT05414136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747161|NCT05414136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747162|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82747163|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82747164|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82747165|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82747166|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747167|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82747168|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82747169|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82747170|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82747171|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
82747172|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82747173|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747174|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82747175|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82747177|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82747178|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82747179|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
82747180|NCT05335928|Abatacept|abatacept|mesh-list
82747181|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747182|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747183|NCT05335928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747184|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747185|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747186|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
82747187|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747188|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747189|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82747190|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747207|NCT05286957|Tislelizumab|tislelizumab|mesh-list
82747208|NCT05286957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747209|NCT05286957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747210|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
82747211|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747212|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82747213|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747214|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747215|NCT05255276|Itraconazole|itraconazole|mesh-list
82747216|NCT05255276|Rifampin|rifampin|mesh-list
82747217|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
82747218|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747219|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82747220|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82747221|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747222|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747223|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82747224|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
82747225|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747226|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747227|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82747228|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82747229|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
82747230|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82747231|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
82747232|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82747233|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82747234|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82747235|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82747236|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82747237|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82747238|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82747239|NCT05253833|Allopurinol|allopurinol|mesh-list
82747240|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
82747241|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747242|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747243|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
82747244|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747245|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82747246|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
82747247|NCT05253833|Protective Agents|protective agents|mesh-ancestor
82747248|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747249|NCT05243199|Valsartan|valsartan|mesh-list
82747250|NCT05243199|Irbesartan|irbesartan|mesh-list
82747251|NCT05243199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82747252|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82747253|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82747254|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82747255|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747256|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
82747257|NCT05227716|Analgesics|analgesics|mesh-ancestor
82747258|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
82747259|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747260|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747262|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82747263|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82747264|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
82747265|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82747266|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82747267|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747268|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82747269|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
82747270|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82747271|NCT05201248|Prednisone|prednisone|mesh-list
82747272|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
82747273|NCT05201248|Rituximab|rituximab|mesh-list
82747274|NCT05201248|Doxorubicin|doxorubicin|mesh-list
82747275|NCT05201248|Vincristine|vincristine|mesh-list
82747276|NCT05201248|Lenalidomide|lenalidomide|mesh-list
82747277|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747278|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
82747279|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747280|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747281|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82747282|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
82747283|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747284|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747285|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82747286|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747287|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82747288|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82747289|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82747290|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747291|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82747292|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
82747293|NCT05201248|Hormones|hormones|mesh-ancestor
82747294|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747295|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82747296|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82747297|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
82747298|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
82747299|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
82747300|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82747301|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82747302|NCT05201248|Growth Substances|growth substances|mesh-ancestor
82747303|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
82747304|NCT05195996|Propranolol|propranolol|mesh-list
82747305|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82747306|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82747307|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
82747308|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82747309|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747310|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747311|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82747312|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82747313|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
82747314|NCT05194397|Niacinamide|niacinamide|mesh-list
82747316|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
82747317|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
82747318|NCT05194397|Vitamins|vitamins|mesh-ancestor
82747319|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
82747320|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747321|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82747322|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
82747323|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747324|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82747325|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
82747326|NCT05113966|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
82747327|NCT05113966|Immunoconjugates|immunoconjugates|mesh-ancestor
82747328|NCT05113966|Immunologic Factors|immunologic factors|mesh-ancestor
82747329|NCT05113966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747330|NCT05101564|Tamoxifen|tamoxifen|mesh-list
82747331|NCT05101564|Fulvestrant|fulvestrant|mesh-list
82747332|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82747333|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
82747334|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747335|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747336|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82747337|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747338|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82747339|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82747340|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82747341|NCT05101564|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82747342|NCT05073484|Antibodies|antibodies|mesh-list
82747343|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
82747344|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
82747345|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747346|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
82747347|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747348|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747349|NCT05071014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747350|NCT05071014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747351|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
82747352|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82747353|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
82747354|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747355|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
82747356|NCT05025865|Protective Agents|protective agents|mesh-ancestor
82747357|NCT05005741|Dulaglutide|dulaglutide|mesh-list
82747358|NCT05005741|Glucagon|glucagon|mesh-list
82747359|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82747360|NCT05005741|Incretins|incretins|mesh-ancestor
82747362|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747363|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747364|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82747365|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82747366|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82747367|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82747368|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747369|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
82747370|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82747371|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82747372|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82747373|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747374|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747375|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82747376|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82747377|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747378|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
82747379|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82747380|NCT04974216|Rituximab|rituximab|mesh-list
82747381|NCT04974216|Lenalidomide|lenalidomide|mesh-list
82747382|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747383|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747384|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
82747385|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747386|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747387|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82747388|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82747389|NCT04974216|Growth Substances|growth substances|mesh-ancestor
82747390|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
82747391|NCT04972552|Ubiquinone|ubiquinone|mesh-list
82747392|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
82747393|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
82747394|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747395|NCT04972552|Vitamins|vitamins|mesh-ancestor
82747396|NCT04936685|Vaccines|vaccines|mesh-list
82747397|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
82747398|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747399|NCT04924699|Trastuzumab|trastuzumab|mesh-list
82747400|NCT04924699|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82747401|NCT04924699|Maytansine|maytansine|mesh-list
82747402|NCT04924699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747403|NCT04924699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747404|NCT04924699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82747405|NCT04924699|Tubulin Modulators|tubulin modulators|mesh-ancestor
82747406|NCT04924699|Antimitotic Agents|antimitotic agents|mesh-ancestor
82747407|NCT04924699|Mitosis Modulators|mitosis modulators|mesh-ancestor
82747408|NCT04924699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747409|NCT04924699|Immunotoxins|immunotoxins|mesh-ancestor
82747410|NCT04924699|Immunoconjugates|immunoconjugates|mesh-ancestor
82747411|NCT04924699|Immunologic Factors|immunologic factors|mesh-ancestor
82747412|NCT04924699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747413|NCT04907539|Denosumab|denosumab|mesh-list
82747414|NCT04907539|Nivolumab|nivolumab|mesh-list
82747415|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747416|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747417|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747418|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747419|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82747420|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747421|NCT04877288|Cyclosporine|cyclosporine|mesh-list
82747422|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
82747423|NCT04877288|Abatacept|abatacept|mesh-list
82747424|NCT04877288|Tacrolimus|tacrolimus|mesh-list
82747425|NCT04877288|Cyclosporins|cyclosporins|mesh-list
82747426|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747427|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
82747428|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747429|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82747430|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747431|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747432|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
82747433|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747434|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
82747435|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747436|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82747437|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747438|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82747439|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
82747440|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82747441|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747442|NCT04877288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747443|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82747444|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747446|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747447|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82747448|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82747449|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
82747450|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82747451|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747452|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82747453|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82747454|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82747455|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747456|NCT04802590|Venetoclax|venetoclax|mesh-list
82747457|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747458|NCT04776993|Methimazole|methimazole|mesh-list
82747459|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
82747460|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
82747461|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747462|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747463|NCT04671875|Antibodies|antibodies|mesh-list
82747464|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82747465|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
82747466|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747467|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
82747468|NCT04664972|Docetaxel|docetaxel|mesh-list
82747469|NCT04664972|Doxorubicin|doxorubicin|mesh-list
82747470|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747471|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
82747472|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747473|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747474|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82747475|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
82747476|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747477|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747478|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82747479|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
82747480|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
82747481|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
82747482|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82747483|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82747484|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82747485|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747487|NCT04652076|Carboplatin|carboplatin|mesh-list
82747488|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
82747489|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82747490|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747491|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
82747492|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
82747493|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
82747494|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747495|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747496|NCT04652076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747497|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
82747498|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82747499|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
82747500|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747501|NCT04632069|Expectorants|expectorants|mesh-ancestor
82747502|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
82747503|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82747504|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
82747505|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747506|NCT04632069|Protective Agents|protective agents|mesh-ancestor
82747507|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747508|NCT04632069|Antidotes|antidotes|mesh-ancestor
82747509|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
82747510|NCT04618913|Apixaban|apixaban|mesh-list
82747511|NCT04618913|Edoxaban|edoxaban|mesh-list
82747512|NCT04618913|Dabigatran|dabigatran|mesh-list
82747513|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82747514|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
82747515|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82747516|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
82747517|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747518|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747519|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
82747520|NCT04592913|Durvalumab|durvalumab|mesh-list
82747521|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747522|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747523|NCT04547907|Paclitaxel|paclitaxel|mesh-list
82747524|NCT04547907|Docetaxel|docetaxel|mesh-list
82747525|NCT04547907|Carboplatin|carboplatin|mesh-list
82747526|NCT04547907|Trastuzumab|trastuzumab|mesh-list
82747527|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82747528|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747529|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
82747530|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
82747531|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
82747532|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747533|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747534|NCT04545944|Midazolam|midazolam|mesh-list
82747535|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82747536|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82747537|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82747538|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747553|NCT04460937|Adavosertib|adavosertib|mesh-list
82747554|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747555|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747556|NCT04454203|Anesthetics|anesthetics|mesh-list
82747557|NCT04454203|Mepivacaine|mepivacaine|mesh-list
82747558|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
82747559|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82747560|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747561|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
82747562|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747577|NCT04393285|Letrozole|letrozole|mesh-list
82747578|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747579|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82747580|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82747581|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747582|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747583|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82747584|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
82747585|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747586|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747587|NCT04391283|Osimertinib|osimertinib|mesh-list
82747588|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747589|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82747590|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747591|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747592|NCT04374799|Heparin|heparin|mesh-list
82747593|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
82747594|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82747595|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82747596|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747597|NCT04367311|Docetaxel|docetaxel|mesh-list
82747598|NCT04367311|Pemetrexed|pemetrexed|mesh-list
82747599|NCT04367311|Atezolizumab|atezolizumab|mesh-list
82747600|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747601|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
82747602|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
82747603|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
82747604|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747605|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747606|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82747607|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82747608|NCT04367311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747609|NCT04367311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747610|NCT04266275|Curcumin|curcumin|mesh-list
82747611|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82747612|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82747613|NCT04266275|Analgesics|analgesics|mesh-ancestor
82747614|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
82747615|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747616|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747617|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82747618|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747619|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747620|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747621|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747623|NCT04207086|Lenvatinib|lenvatinib|mesh-list
82747624|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747625|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747626|NCT04207086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747627|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747628|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82747629|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747630|NCT04194359|Bevacizumab|bevacizumab|mesh-list
82747631|NCT04194359|Capecitabine|capecitabine|mesh-list
82747632|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
82747633|NCT04194359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747634|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747635|NCT04194359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82747636|NCT04194359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82747637|NCT04194359|Growth Substances|growth substances|mesh-ancestor
82747638|NCT04194359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747639|NCT04194359|Growth Inhibitors|growth inhibitors|mesh-ancestor
82747640|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82747641|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
82747642|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747643|NCT04118010|Vitamin D|vitamin d|mesh-list
82747644|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
82747645|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
82747646|NCT04118010|Vitamins|vitamins|mesh-list
82747647|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
82747648|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747649|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82747650|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82747651|NCT04113863|Anastrozole|anastrozole|mesh-list
82747652|NCT04113863|Tretinoin|tretinoin|mesh-list
82747653|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82747654|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747655|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82747656|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82747657|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747658|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747659|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82747660|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
82747661|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747662|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747663|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
82747664|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
82747665|NCT04053491|Anesthetics|anesthetics|mesh-list
82747666|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82747667|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747668|NCT04041232|Glycerol|glycerol|mesh-list
82747669|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82747670|NCT04041232|Protective Agents|protective agents|mesh-ancestor
82747671|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747672|NCT04030000|Paclitaxel|paclitaxel|mesh-list
82747673|NCT04030000|Carboplatin|carboplatin|mesh-list
82747674|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82747675|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747676|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
82747677|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
82747678|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
82747679|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747680|NCT04010539|Azithromycin|azithromycin|mesh-list
82747681|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
82747682|NCT04010539|Gepotidacin|gepotidacin|mesh-list
82747683|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82747684|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747685|NCT04010539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82747686|NCT04010539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747687|NCT04010539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747688|NCT04010539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747689|NCT03957590|Paclitaxel|paclitaxel|mesh-list
82747690|NCT03957590|Tislelizumab|tislelizumab|mesh-list
82747691|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82747692|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747693|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
82747694|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
82747695|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
82747696|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747697|NCT03957590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747698|NCT03944941|Cetuximab|cetuximab|mesh-list
82747699|NCT03944941|Avelumab|avelumab|mesh-list
82747700|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747701|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747702|NCT03921866|Palbociclib|palbociclib|mesh-list
82747703|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747704|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82747705|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747706|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747707|NCT03919955|Oxybutynin|oxybutynin|mesh-list
82747708|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82747709|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82747710|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82747711|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82747712|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747713|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
82747714|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82747715|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747716|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
82747717|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
82747718|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747719|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82747720|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82747721|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
82747722|NCT03919955|Urological Agents|urological agents|mesh-ancestor
82747723|NCT03919799|Belumosudil|belumosudil|mesh-list
82747724|NCT03919799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82747725|NCT03919799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747726|NCT03919799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747727|NCT03885089|Infliximab|infliximab|mesh-list
82747728|NCT03885089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82747729|NCT03885089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82747730|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
82747731|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82747732|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747733|NCT03760588|Valsartan|valsartan|mesh-list
82747734|NCT03760588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82747735|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82747736|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82747737|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82747738|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747739|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82747740|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
82747741|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747742|NCT03710343|Metformin|metformin|mesh-list
82747743|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82747744|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747745|NCT03681561|Nivolumab|nivolumab|mesh-list
82747746|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747747|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747748|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747749|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747750|NCT03656081|Itraconazole|itraconazole|mesh-list
82747751|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82747752|NCT03656081|Amphotericin B|amphotericin b|mesh-list
82747753|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
82747754|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747755|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82747756|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82747757|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747758|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747759|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82747760|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
82747761|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747762|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747763|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82747764|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82747765|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82747767|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82747768|NCT03649048|Cisplatin|cisplatin|mesh-list
82747769|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747770|NCT03642626|Vidarabine|vidarabine|mesh-list
82747771|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
82747772|NCT03642626|Fludarabine|fludarabine|mesh-list
82747773|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
82747774|NCT03642626|Tisagenlecleucel|tisagenlecleucel|mesh-list
82747775|NCT03642626|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
82747776|NCT03642626|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
82747777|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747778|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
82747779|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747780|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747781|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82747782|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
82747783|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747784|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747785|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82747786|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82747788|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
82747789|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747790|NCT03642626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747791|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
82747792|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747793|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747794|NCT03621982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747795|NCT03621982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747796|NCT03609216|Gemcitabine|gemcitabine|mesh-list
82747797|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747798|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82747799|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
82747800|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747801|NCT03608163|Diazoxide|diazoxide|mesh-list
82747802|NCT03608163|Naloxone|naloxone|mesh-list
82747803|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82747804|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747805|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
82747806|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747807|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82747808|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
82747810|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
82747811|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747812|NCT03599635|Bupivacaine|bupivacaine|mesh-list
82747813|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
82747814|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
82747815|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82747816|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747817|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
82747818|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747819|NCT03581292|Temozolomide|temozolomide|mesh-list
82747820|NCT03581292|Veliparib|veliparib|mesh-list
82747821|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82747822|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
82747823|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747824|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747825|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82747826|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747827|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
82747828|NCT03573700|Fludarabine|fludarabine|mesh-list
82747829|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747830|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
82747831|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747832|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747833|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82747834|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
82747835|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747836|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747837|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82747838|NCT03573024|Azacitidine|azacitidine|mesh-list
82747839|NCT03573024|Venetoclax|venetoclax|mesh-list
82747840|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82747842|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747843|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747844|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747845|NCT03534947|Imiquimod|imiquimod|mesh-list
82747846|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82747847|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
82747848|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747849|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747850|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
82747851|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
82747852|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82747853|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82747854|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747855|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82747856|NCT03530371|Analgesics|analgesics|mesh-ancestor
82747857|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
82747858|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747859|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82747860|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82747861|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82747862|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
82747863|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82747864|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747866|NCT03521830|Ipilimumab|ipilimumab|mesh-list
82747867|NCT03521830|Relatlimab|relatlimab|mesh-list
82747868|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82747869|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747870|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82747871|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747872|NCT03496610|Bupivacaine|bupivacaine|mesh-list
82747873|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
82747874|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
82747875|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82747876|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747877|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
82747878|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747879|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
82747880|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82747881|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82747882|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82747883|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747884|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82747885|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82747886|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
82747887|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82747888|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747890|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82747891|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
82747892|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82747893|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
82747894|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747895|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747896|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
82747897|NCT03434730|Cyclosporine|cyclosporine|mesh-list
82747898|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
82747899|NCT03434730|Lenograstim|lenograstim|mesh-list
82747900|NCT03434730|Cyclosporins|cyclosporins|mesh-list
82747901|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82747902|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
82747903|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747904|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747905|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747906|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747907|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
82747908|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82747909|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
82747910|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747911|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82747912|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82747913|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747914|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82747915|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
82747916|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82747917|NCT03418649|Eplerenone|eplerenone|mesh-list
82747918|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82747919|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
82747920|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82747921|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747922|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82747923|NCT03418649|Diuretics|diuretics|mesh-ancestor
82747924|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
82747925|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82747926|NCT03406897|Vitamin D|vitamin d|mesh-list
82747927|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
82747928|NCT03406897|Vitamins|vitamins|mesh-ancestor
82747929|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
82747930|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747931|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82747932|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82747933|NCT03375307|Olaparib|olaparib|mesh-list
82747934|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
82747935|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747936|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747937|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747938|NCT03315832|Valsartan|valsartan|mesh-list
82747939|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82747940|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82747941|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82747942|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747943|NCT03260920|Oxytocin|oxytocin|mesh-list
82747944|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
82747945|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82747946|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747947|NCT03124355|Bromides|bromides|mesh-list
82747948|NCT03124355|Galantamine|galantamine|mesh-list
82747949|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
82747950|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
82747951|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82747952|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747953|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747954|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
82747955|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82747956|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747957|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82747958|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
82747959|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747960|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
82747961|NCT03122652|Teriflunomide|teriflunomide|mesh-list
82747962|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82747963|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82747964|NCT03122652|Analgesics|analgesics|mesh-ancestor
82747965|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
82747966|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747967|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747968|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82747969|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747970|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747971|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
82747972|NCT03011268|Adalimumab|adalimumab|mesh-list
82747973|NCT03011268|Infliximab|infliximab|mesh-list
82747974|NCT03011268|Golimumab|golimumab|mesh-list
82747975|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82747976|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82747977|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82747978|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747979|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
82747980|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82747981|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82747982|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
82747983|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747984|NCT02944578|Curcumin|curcumin|mesh-list
82747985|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82747986|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82747987|NCT02944578|Analgesics|analgesics|mesh-ancestor
82747988|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
82747989|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82747990|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82747991|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82747992|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82747993|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82747994|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82747995|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82747996|NCT02889523|Prednisolone|prednisolone|mesh-list
82747997|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
82747998|NCT02889523|Rituximab|rituximab|mesh-list
82747999|NCT02889523|Doxorubicin|doxorubicin|mesh-list
82748000|NCT02889523|Vincristine|vincristine|mesh-list
82748001|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82748002|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
82748003|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748004|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82748005|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82748006|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
82748007|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748008|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748009|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82748010|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748011|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82748012|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82748013|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82748014|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748015|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82748016|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
82748017|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
82748018|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
82748019|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82748021|NCT02889523|Hormones|hormones|mesh-ancestor
82748022|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748023|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82748024|NCT02771626|Nivolumab|nivolumab|mesh-list
82748025|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748026|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748027|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82748028|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748029|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
82748030|NCT02616302|Lansoprazole|lansoprazole|mesh-list
82748031|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82748032|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748033|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82748034|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748035|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748036|NCT02546661|Durvalumab|durvalumab|mesh-list
82748037|NCT02546661|Olaparib|olaparib|mesh-list
82748038|NCT02546661|Adavosertib|adavosertib|mesh-list
82748039|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748040|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748041|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82748042|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748043|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748044|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
82748045|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82748046|NCT02469753|Analgesics|analgesics|mesh-ancestor
82748047|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
82748048|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748049|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748050|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82748051|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82748052|NCT02375204|Paclitaxel|paclitaxel|mesh-list
82748053|NCT02375204|Etoposide|etoposide|mesh-list
82748054|NCT02375204|Carboplatin|carboplatin|mesh-list
82748055|NCT02375204|Ifosfamide|ifosfamide|mesh-list
82748056|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
82748057|NCT02375204|Lenograstim|lenograstim|mesh-list
82748058|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82748059|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748060|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
82748061|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
82748062|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
82748063|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748064|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82748065|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82748066|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748067|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82748068|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
82748069|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748070|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82748071|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
82748072|NCT02374242|Nivolumab|nivolumab|mesh-list
82748073|NCT02374242|Ipilimumab|ipilimumab|mesh-list
82748074|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748075|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748076|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82748077|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748078|NCT02370329|Interferons|interferons|mesh-list
82748079|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
82748080|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
82748081|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82748082|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82748083|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748084|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
82748085|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82748086|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
82748087|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748088|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
82748089|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82748090|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82748091|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748092|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
82748093|NCT02314988|Coagulants|coagulants|mesh-ancestor
82748094|NCT02272790|Paclitaxel|paclitaxel|mesh-list
82748095|NCT02272790|Carboplatin|carboplatin|mesh-list
82748096|NCT02272790|Gemcitabine|gemcitabine|mesh-list
82748097|NCT02272790|Adavosertib|adavosertib|mesh-list
82748098|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82748099|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748100|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
82748101|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
82748102|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
82748103|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748104|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82748105|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
82748106|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748107|NCT02113657|Ipilimumab|ipilimumab|mesh-list
82748108|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748109|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748110|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82748111|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748112|NCT02035787|Metformin|metformin|mesh-list
82748113|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82748114|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748115|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
82748116|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82748117|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82748118|NCT01850355|Buspirone|buspirone|mesh-list
82748119|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82748120|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82748121|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82748122|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748123|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82748124|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82748125|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
82748126|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748127|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748128|NCT01582776|Lenalidomide|lenalidomide|mesh-list
82748129|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
82748130|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
82748131|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748132|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82748133|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82748134|NCT01582776|Growth Substances|growth substances|mesh-ancestor
82748135|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
82748136|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748137|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748138|NCT01464164|Prednisone|prednisone|mesh-list
82748139|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82748140|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
82748141|NCT01464164|Hormones|hormones|mesh-ancestor
82748142|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748143|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748144|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82748145|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748146|NCT01377389|Ipilimumab|ipilimumab|mesh-list
82748147|NCT01377389|Leuprolide|leuprolide|mesh-list
82748148|NCT01377389|Goserelin|goserelin|mesh-list
82748149|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748150|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748151|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82748152|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748153|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82748154|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
82748155|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82748156|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748157|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82748158|NCT01194271|Ipilimumab|ipilimumab|mesh-list
82748159|NCT01194271|Leuprolide|leuprolide|mesh-list
82748160|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748161|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748162|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82748163|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748164|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82748165|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
82748166|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82748167|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748168|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82748169|NCT01119508|Temozolomide|temozolomide|mesh-list
82748170|NCT01119508|Ipilimumab|ipilimumab|mesh-list
82748171|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82748172|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
82748173|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748174|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748175|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748176|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82748177|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
82748178|NCT00602459|Rituximab|rituximab|mesh-list
82748179|NCT00602459|Fludarabine|fludarabine|mesh-list
82748180|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
82748181|NCT00602459|Lenalidomide|lenalidomide|mesh-list
82748182|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82748183|NCT00602459|Antibodies|antibodies|mesh-list
82748184|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
82748185|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82748186|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82748187|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
82748188|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748189|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82748190|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82748191|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
82748192|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748193|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748194|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82748195|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82748196|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
82748197|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82748198|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82748199|NCT00602459|Growth Substances|growth substances|mesh-ancestor
82748200|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
82748201|NCT00199069|Cytarabine|cytarabine|mesh-list
82748202|NCT00199069|Dexamethasone|dexamethasone|mesh-list
82748203|NCT00199069|Prednisolone|prednisolone|mesh-list
82748204|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
82748205|NCT00199069|Ifosfamide|ifosfamide|mesh-list
82748206|NCT00199069|Methotrexate|methotrexate|mesh-list
82748207|NCT00199069|Vincristine|vincristine|mesh-list
82748209|NCT00199069|Daunorubicin|daunorubicin|mesh-list
82748210|NCT00199069|Asparaginase|asparaginase|mesh-list
82748211|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
82748212|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
82748213|NCT00199069|Thioguanine|thioguanine|mesh-list
82748214|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82748215|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
82748216|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748217|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82748218|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82748219|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
82748220|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748221|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748222|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82748223|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82748224|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
82748225|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
82748226|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748227|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748228|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
82748229|NCT00199069|Hormones|hormones|mesh-ancestor
82748230|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748231|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82748232|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82748233|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
82748234|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82748235|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82748236|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
82748237|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
82748238|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748239|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82748240|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82748241|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
82748242|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82748243|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82748244|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
82748245|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
82748246|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
82748247|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82748248|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82748249|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82748250|NCT00199069|Analgesics|analgesics|mesh-ancestor
82748251|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
82748252|NCT00199043|Allopurinol|allopurinol|mesh-list
82748253|NCT00199043|Rasburicase|rasburicase|mesh-list
82748254|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
82748255|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748256|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748257|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
82748258|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82748259|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82748260|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
82748261|NCT00199043|Protective Agents|protective agents|mesh-ancestor
82748262|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748263|NCT02601989|Tadalafil|tadalafil|mesh-list
82748264|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
82748265|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82748266|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82748267|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748268|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748269|NCT02601989|Urological Agents|urological agents|mesh-ancestor
82748270|NCT01067053|Bevacizumab|bevacizumab|mesh-list
82748271|NCT01067053|Capecitabine|capecitabine|mesh-list
82748272|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
82748273|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748274|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748275|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82748276|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82748277|NCT01067053|Growth Substances|growth substances|mesh-ancestor
82748278|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748279|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
82748280|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82748281|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
82748282|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748283|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
82748284|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82748285|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82748286|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82748287|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748288|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748289|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
82748290|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748291|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748292|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82748293|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748295|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
82748296|NCT01067365|Enclomiphene|enclomiphene|mesh-list
82748297|NCT01067365|Clomiphene|clomiphene|mesh-list
82748298|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
82748299|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
82748300|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82748301|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
82748302|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
82748303|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748304|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82748305|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
82748306|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748307|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748308|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82748309|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
82748310|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82748311|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82748312|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82748313|NCT00568776|Inositol|inositol|mesh-list
82748314|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
82748315|NCT00568776|Vitamins|vitamins|mesh-ancestor
82748316|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
82748317|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748318|NCT01067443|Amphotericin B|amphotericin b|mesh-list
82748319|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82748320|NCT01067443|Miltefosine|miltefosine|mesh-list
82748321|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
82748322|NCT01067443|Amebicides|amebicides|mesh-ancestor
82748323|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82748324|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82748325|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82748326|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82748327|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
82748328|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748329|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
82748330|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82748331|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
82748332|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82748333|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82748334|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82748335|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748336|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748337|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
82748338|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748339|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748340|NCT00822666|Clopidogrel|clopidogrel|mesh-list
82748341|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82748342|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82748343|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82748344|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82748345|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
82748346|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748347|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748348|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748350|NCT00816816|Fluorouracil|fluorouracil|mesh-list
82748351|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748352|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
82748353|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
82748354|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
82748355|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748356|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
82748357|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82748358|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82748359|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
82748360|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748361|NCT00816894|Olanzapine|olanzapine|mesh-list
82748362|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
82748363|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
82748364|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748365|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748366|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748367|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82748368|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82748369|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82748370|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82748371|NCT00816894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82748372|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82748373|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748374|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748375|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748376|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
82748377|NCT00635154|Dexamethasone|dexamethasone|mesh-list
82748378|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
82748379|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82748380|NCT00635154|BB 1101|bb 1101|mesh-list
82748381|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82748382|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
82748383|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
82748384|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748385|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748386|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748387|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
82748389|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748390|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82748391|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748392|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82748393|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
82748394|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748395|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748396|NCT00822744|Escitalopram|escitalopram|mesh-list
82748397|NCT00822744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82748398|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82748399|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748400|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748401|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748402|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
82748403|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748404|NCT00819468|Teduglutide|teduglutide|mesh-list
82748405|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748406|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82748407|NCT00819468|Protective Agents|protective agents|mesh-ancestor
82748408|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748409|NCT01067599|Nicotine|nicotine|mesh-list
82748410|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82748411|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
82748412|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748413|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748414|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82748415|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82748416|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
82748417|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748418|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748419|NCT00778817|Mitotane|mitotane|mesh-list
82748420|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82748421|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748422|NCT00293059|Dienogest|dienogest|mesh-list
82748423|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82748424|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82748425|NCT00293059|Estradiol|estradiol|mesh-list
82748426|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82748427|NCT00293059|Estrogens|estrogens|mesh-ancestor
82748428|NCT00293059|Hormones|hormones|mesh-ancestor
82748429|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748430|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748431|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82748432|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
82748433|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82748434|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82748435|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82748436|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82748437|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82748438|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
82748439|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82748440|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748441|NCT00756275|Nicotine|nicotine|mesh-list
82748442|NCT00756275|Varenicline|varenicline|mesh-list
82748443|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82748444|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
82748445|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748446|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748447|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82748448|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82748449|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
82748450|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748451|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748452|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
82748453|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82748454|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
82748455|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82748456|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
82748457|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748458|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748459|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
82748460|NCT00298831|Rocuronium|rocuronium|mesh-list
82748461|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82748462|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82748463|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82748464|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748465|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748466|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82748467|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82748468|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748469|NCT00758069|Incretins|incretins|mesh-ancestor
82748470|NCT00758069|Hormones|hormones|mesh-ancestor
82748471|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748472|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82748473|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
82748474|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748475|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748476|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
82748477|NCT01067677|Promethazine|promethazine|mesh-list
82748478|NCT01067677|Ondansetron|ondansetron|mesh-list
82748479|NCT01067677|Metoclopramide|metoclopramide|mesh-list
82748480|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
82748481|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
82748482|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748483|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748484|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748485|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
82748486|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
82748487|NCT01067677|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82748488|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82748489|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
82748490|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748491|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748492|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82748493|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82748494|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82748495|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
82748496|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
82748497|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
82748498|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82748499|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
82748500|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
82748501|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82748502|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82748503|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82748504|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
82748505|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
82748506|NCT03979651|Trametinib|trametinib|mesh-list
82748507|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
82748508|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82748509|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82748510|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82748511|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748512|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748513|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82748514|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748515|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82748516|NCT02600741|Droperidol|droperidol|mesh-list
82748517|NCT02600741|Haloperidol|haloperidol|mesh-list
82748518|NCT02600741|Pimozide|pimozide|mesh-list
82748519|NCT02600741|Olanzapine|olanzapine|mesh-list
82748520|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
82748521|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
82748522|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
82748523|NCT02600741|Risperidone|risperidone|mesh-list
82748524|NCT02600741|Aripiprazole|aripiprazole|mesh-list
82748525|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82748526|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82748527|NCT02600741|Ziprasidone|ziprasidone|mesh-list
82748528|NCT02600741|Clozapine|clozapine|mesh-list
82748529|NCT02600741|Asenapine|asenapine|mesh-list
82748530|NCT02600741|Loxapine|loxapine|mesh-list
82748531|NCT02600741|Iloperidone|iloperidone|mesh-list
82748532|NCT02600741|Perphenazine|perphenazine|mesh-list
82748533|NCT02600741|Fluphenazine|fluphenazine|mesh-list
82748534|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
82748535|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
82748536|NCT02600741|Thioridazine|thioridazine|mesh-list
82748537|NCT02600741|Thiothixene|thiothixene|mesh-list
82748538|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82748539|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
82748540|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748541|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748542|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748543|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82748544|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82748545|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82748546|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82748547|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82748548|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
82748549|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
82748550|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
82748551|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748552|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748553|NCT02600741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82748554|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82748555|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748556|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
82748557|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
82748558|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82748559|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82748560|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82748561|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82748562|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82748563|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
82748564|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
82748565|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82748566|NCT01065649|Nortriptyline|nortriptyline|mesh-list
82748567|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82748568|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
82748569|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82748570|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82748571|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82748572|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748573|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748574|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
82748575|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748576|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748577|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
82748578|NCT01065727|Natalizumab|natalizumab|mesh-list
82748579|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
82748580|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
82748581|NCT01065727|Immunomodulating Agents|immunomodulating agents|mesh-list
82748582|NCT01065727|Analgesics|analgesics|mesh-ancestor
82748583|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
82748584|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748585|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748586|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748587|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82748588|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82748589|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748590|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748591|NCT01065805|Alovudine|alovudine|mesh-list
82748592|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
82748593|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82748594|NCT00311623|Sirolimus|sirolimus|mesh-list
82748595|NCT00311623|Temsirolimus|temsirolimus|mesh-list
82748596|NCT00311623|MTOR Inhibitors|mtor inhibitors|mesh-list
82748597|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82748598|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82748599|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82748600|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748601|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
82748602|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82748603|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
82748604|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748605|NCT00311623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82748606|NCT00311623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748607|NCT00311623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748608|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
82748609|NCT01067989|Pamidronate|pamidronate|mesh-list
82748610|NCT01067989|Celecoxib|celecoxib|mesh-list
82748611|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
82748612|NCT01067989|Capecitabine|capecitabine|mesh-list
82748613|NCT01067989|Methotrexate|methotrexate|mesh-list
82748614|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82748615|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
82748616|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748617|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82748618|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82748619|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
82748620|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748621|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748622|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82748623|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82748624|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
82748625|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82748626|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
82748627|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82748628|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
82748629|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748630|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82748631|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82748632|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82748633|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82748634|NCT01067989|Analgesics|analgesics|mesh-ancestor
82748635|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
82748636|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748637|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82748638|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82748639|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82748640|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82748641|NCT00633594|Rituximab|rituximab|mesh-list
82748642|NCT00633594|Lenalidomide|lenalidomide|mesh-list
82748643|NCT00633594|Bortezomib|bortezomib|mesh-list
82748644|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748645|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748646|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
82748647|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748648|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82748649|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82748650|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82748651|NCT00633594|Growth Substances|growth substances|mesh-ancestor
82748652|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
82748653|NCT04840888|Itraconazole|itraconazole|mesh-list
82748654|NCT04840888|Carbamazepine|carbamazepine|mesh-list
82748655|NCT04840888|Omeprazole|omeprazole|mesh-list
82748656|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82748657|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748658|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82748659|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748660|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748661|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
82748662|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82748663|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82748664|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82748665|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82748666|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
82748667|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748668|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748669|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82748670|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
82748671|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
82748672|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82748673|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82748674|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82748675|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82748676|NCT04840888|Analgesics|analgesics|mesh-ancestor
82748677|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
82748977|NCT05198050|Letrozole|letrozole|mesh-list
82748678|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748679|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82748680|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748681|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82748682|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82748683|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82748684|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82748685|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82748686|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748687|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748688|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748689|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748690|NCT00755807|Analgesics|analgesics|mesh-ancestor
82748691|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
82748692|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748693|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
82748694|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82748695|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
82748696|NCT05372224|Cholecalciferol|cholecalciferol|mesh-list
82748697|NCT05372224|Vitamin D|vitamin d|mesh-list
82748698|NCT05372224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82748699|NCT05372224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748700|NCT05372224|Vitamins|vitamins|mesh-ancestor
82748701|NCT05372224|Micronutrients|micronutrients|mesh-ancestor
82748702|NCT05372224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82748703|NCT00631410|Sunitinib|sunitinib|mesh-list
82748704|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748705|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82748706|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82748707|NCT00631410|Growth Substances|growth substances|mesh-ancestor
82748708|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748709|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
82748710|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82748711|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748712|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748713|NCT05301712|Naloxone|naloxone|mesh-list
82748714|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82748715|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748716|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
82748717|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748718|NCT00817284|Bevacizumab|bevacizumab|mesh-list
82748719|NCT00817284|Irinotecan|irinotecan|mesh-list
82748720|NCT00817284|Temozolomide|temozolomide|mesh-list
82748721|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82748722|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748723|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82748724|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82748725|NCT00817284|Growth Substances|growth substances|mesh-ancestor
82748726|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748727|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
82748728|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82748729|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82748730|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748731|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748732|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82748733|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
82748734|NCT04096157|Isavuconazole|isavuconazole|mesh-list
82748735|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
82748736|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82748737|NCT00823290|Sorafenib|sorafenib|mesh-list
82748738|NCT00823290|Panobinostat|panobinostat|mesh-list
82748739|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748740|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82748741|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748742|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748743|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82748744|NCT00755417|Gabapentin|gabapentin|mesh-list
82748745|NCT00755417|Analgesics|analgesics|mesh-ancestor
82748746|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
82748747|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748748|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748749|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
82748750|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82748751|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82748752|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82748753|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82748754|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82748755|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82748756|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748757|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748758|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
82748759|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
82748760|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82748761|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82748762|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82748763|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82748764|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748765|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748766|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
82748767|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748768|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748769|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82748770|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748771|NCT00825864|Dexamethasone|dexamethasone|mesh-list
82748772|NCT00825864|Diclofenac|diclofenac|mesh-list
82748773|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
82748774|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82748775|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82748776|NCT00825864|BB 1101|bb 1101|mesh-list
82748777|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82748778|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
82748779|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
82748780|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748781|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748782|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748783|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
82748784|NCT00825864|Hormones|hormones|mesh-ancestor
82748785|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748786|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82748787|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748788|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82748789|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82748790|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82748791|NCT00825864|Analgesics|analgesics|mesh-ancestor
82748792|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
82748793|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82748794|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82748795|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748796|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748797|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
82748798|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82748799|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82748800|NCT00527332|Fentanyl|fentanyl|mesh-list
82748801|NCT00527332|Morphine|morphine|mesh-list
82748802|NCT00527332|Bupivacaine|bupivacaine|mesh-list
82748803|NCT00527332|Propofol|propofol|mesh-list
82748804|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
82748805|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
82748806|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82748807|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748808|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
82748809|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748810|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82748811|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82748812|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
82748813|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82748814|NCT00527332|Narcotics|narcotics|mesh-ancestor
82748815|NCT00527332|Analgesics|analgesics|mesh-ancestor
82748816|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82748817|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
82748818|NCT00820092|Hormones|hormones|mesh-ancestor
82748819|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748820|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748822|NCT00823602|Ganirelix|ganirelix|mesh-list
82748823|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
82748824|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748825|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748826|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82748827|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
82748828|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82748829|NCT00820326|Dolasetron|dolasetron|mesh-list
82748830|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
82748831|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
82748832|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748833|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748834|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748835|NCT00820326|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82748836|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82748837|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
82748838|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748839|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748840|NCT00916097|Docetaxel|docetaxel|mesh-list
82748841|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748842|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
82748843|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
82748844|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
82748845|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748846|NCT00629772|Infliximab|infliximab|mesh-list
82748847|NCT00629772|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82748848|NCT00629772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82748849|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
82748850|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748851|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82748852|NCT00526630|Methylphenidate|methylphenidate|mesh-list
82748853|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82748854|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748855|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82748856|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82748857|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748858|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748859|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
82748860|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748861|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
82748862|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82748863|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82748864|NCT00755183|Testosterone|testosterone|mesh-list
82748865|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
82748866|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
82748867|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82748868|NCT00755183|Androgens|androgens|mesh-ancestor
82748869|NCT00755183|Hormones|hormones|mesh-ancestor
82748870|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748871|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748872|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82748873|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748874|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
82748875|NCT00826254|Vitamins|vitamins|mesh-list
82748876|NCT00826254|Vitamin K|vitamin k|mesh-list
82748877|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
82748878|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748879|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82748880|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82748881|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748882|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
82748883|NCT00826254|Coagulants|coagulants|mesh-ancestor
82748884|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82748885|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
82748886|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748887|NCT00820404|BLI-489|bli-489|mesh-list
82748888|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82748889|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748890|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748891|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82748892|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82748893|NCT00820482|Menotropins|menotropins|mesh-list
82748894|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82748895|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
82748896|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82748897|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748898|NCT00754793|Dexetimide|dexetimide|mesh-list
82748899|NCT00754793|Citalopram|citalopram|mesh-list
82748900|NCT00754793|Escitalopram|escitalopram|mesh-list
82748901|NCT00754793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82748902|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82748978|NCT05198050|Alprostadil|alprostadil|mesh-list
82748903|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748904|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748905|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748906|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
82748907|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748908|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82748909|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82748910|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
82748911|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
82748912|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748913|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82748914|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82748915|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
82748916|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82748917|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
82748918|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82748919|NCT00826566|Caffeine|caffeine|mesh-list
82748920|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82748921|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748922|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82748923|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748924|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748925|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82748926|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82748927|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
82748928|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748929|NCT03999190|Raclopride|raclopride|mesh-list
82748930|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
82748931|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82748932|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748933|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82748934|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82748935|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82748936|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748937|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
82748938|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748939|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82748940|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82748941|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82748942|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82748943|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82748944|NCT05244694|Insulin|insulin|mesh-list
82748945|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82748946|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748947|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
82748948|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82748949|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
82748950|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82748951|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748952|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82748953|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
82748954|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82748955|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
82748956|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748957|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82748958|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82748959|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
82748960|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
82748961|NCT00626028|Protective Agents|protective agents|mesh-ancestor
82748962|NCT00826644|Etoposide|etoposide|mesh-list
82748963|NCT00826644|Belotecan|belotecan|mesh-list
82748964|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748965|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82748966|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82748967|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82748968|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748969|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748970|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82748971|NCT00826722|Levetiracetam|levetiracetam|mesh-list
82748972|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
82748973|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
82748974|NCT04922944|Vaccines|vaccines|mesh-list
82748975|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
82748976|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748980|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82748981|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82748982|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82748983|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82748984|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82748985|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82748986|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
82748987|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82748988|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82748989|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82748990|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
82748991|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82748992|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82748993|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82748995|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82748996|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
82748997|NCT05198050|Urological Agents|urological agents|mesh-ancestor
82748998|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
82748999|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
82749000|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82749001|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749002|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749003|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
82749004|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82749005|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82749006|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749007|NCT04044378|Ifosfamide|ifosfamide|mesh-list
82749008|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82749009|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
82749010|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749011|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749012|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82749013|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
82749014|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82749015|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82749016|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
82749017|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82749018|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
82749019|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749020|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749021|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82749022|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82749023|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82749024|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
82749025|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749026|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749027|NCT00821028|Paclitaxel|paclitaxel|mesh-list
82749028|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82749029|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749030|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
82749031|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
82749032|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
82749033|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749034|NCT00826878|Tivozanib|tivozanib|mesh-list
82749035|NCT00826878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82749036|NCT00826878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749037|NCT00826878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749038|NCT00827034|Warfarin|warfarin|mesh-list
82749039|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
82749040|NCT02600585|Vaccines|vaccines|mesh-list
82749041|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
82749042|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749043|NCT00525148|Afatinib|afatinib|mesh-list
82749044|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749045|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82749046|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749047|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749048|NCT00754325|Dasatinib|dasatinib|mesh-list
82749049|NCT00754325|Fulvestrant|fulvestrant|mesh-list
82749050|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749051|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82749052|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749053|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749054|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82749055|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82749056|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82749057|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
82749058|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749059|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749060|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
82749061|NCT00524680|Vitamin D|vitamin d|mesh-list
82749062|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82749063|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749064|NCT00524680|Vitamins|vitamins|mesh-ancestor
82749065|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
82749066|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82749067|NCT00298363|Tenofovir|tenofovir|mesh-list
82749068|NCT00298363|Emtricitabine|emtricitabine|mesh-list
82749069|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82749070|NCT00298363|Entecavir|entecavir|mesh-list
82749071|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
82749072|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749073|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82749074|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82749075|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749076|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749077|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82749078|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82749079|NCT00821262|Propofol|propofol|mesh-list
82749080|NCT00821262|Sevoflurane|sevoflurane|mesh-list
82749081|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82749082|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82749083|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749084|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82749085|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
82749086|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
82749087|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82749088|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82749089|NCT00524368|Ritonavir|ritonavir|mesh-list
82749090|NCT00524368|Darunavir|darunavir|mesh-list
82749091|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82749092|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82749093|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
82749094|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749095|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749096|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82749097|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82749098|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
82749099|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749100|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82749101|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82749102|NCT00777101|Capecitabine|capecitabine|mesh-list
82749103|NCT00777101|Lapatinib|lapatinib|mesh-list
82749104|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82749105|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
82749106|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749107|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749108|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82749109|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749110|NCT00830856|Lamivudine|lamivudine|mesh-list
82749111|NCT00830856|Nevirapine|nevirapine|mesh-list
82749112|NCT00830856|Stavudine|stavudine|mesh-list
82749113|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
82749114|NCT00830856|Fluconazole|fluconazole|mesh-list
82749115|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82749116|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82749117|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749118|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749119|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
82749120|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749121|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82749122|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82749123|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
82749124|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82749125|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82749126|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82749127|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
82749128|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749129|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749130|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82749131|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82749132|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82749133|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82749136|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82749137|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
82749138|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749139|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82749140|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749141|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749142|NCT00524134|Carvedilol|carvedilol|mesh-list
82749143|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82749144|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82749145|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
82749146|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749147|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749148|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749149|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82749150|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
82749151|NCT00524134|Protective Agents|protective agents|mesh-ancestor
82749152|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82749153|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82749154|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82749155|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
82749156|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82749157|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82749158|NCT00777023|Gabapentin|gabapentin|mesh-list
82749159|NCT00777023|Analgesics|analgesics|mesh-ancestor
82749160|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
82749161|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749162|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749163|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
82749164|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82749165|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82749166|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82749167|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82749168|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82749169|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82749170|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749171|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749172|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
82749173|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82749174|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82749175|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
82749176|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82749177|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82749178|NCT00297037|Analgesics|analgesics|mesh-ancestor
82749179|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
82749180|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749181|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749182|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82749183|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82749184|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
82749185|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82749186|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
82749187|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82749188|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749189|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749190|NCT00292981|Complement C1s|complement c1s|mesh-list
82749191|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
82749192|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
82749193|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
82749194|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749195|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82749196|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82749197|NCT02598869|Triamcinolone|triamcinolone|mesh-list
82749198|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82749199|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82749200|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82749201|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82749204|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749205|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749207|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
82749208|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749209|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749210|NCT04095455|Ketamine|ketamine|mesh-list
82749211|NCT04095455|Analgesics|analgesics|mesh-ancestor
82749212|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
82749213|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749214|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749215|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82749216|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82749217|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
82749218|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
82749219|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82749220|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82749221|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82749222|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749223|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749224|NCT04095299|Capecitabine|capecitabine|mesh-list
82749225|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82749226|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
82749227|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749228|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749229|NCT00296725|Fluoxetine|fluoxetine|mesh-list
82749230|NCT00296725|Imipramine|imipramine|mesh-list
82749231|NCT00296725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82749232|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82749233|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82749234|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749235|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749236|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
82749237|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749238|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82749239|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
82749240|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82749241|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82749242|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82749243|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749244|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82749245|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82749246|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
82749247|NCT00523978|Sotalol|sotalol|mesh-list
82749248|NCT00523978|Flecainide|flecainide|mesh-list
82749249|NCT00523978|Propafenone|propafenone|mesh-list
82749250|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82749251|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82749252|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
82749253|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749254|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749255|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749256|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82749257|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
82749258|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
82749259|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749260|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82749261|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82749262|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82749263|NCT00296647|Bupropion|bupropion|mesh-list
82749264|NCT00296647|Nicotine|nicotine|mesh-list
82749265|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82749266|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
82749267|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749268|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749269|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82749270|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82749271|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
82749272|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749273|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749274|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82749275|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
82749276|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82749277|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82749278|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82749279|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82749280|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
82749281|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82749282|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82749283|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749284|NCT00754013|Donepezil|donepezil|mesh-list
82749285|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82749286|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749287|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749288|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
82749289|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749290|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749291|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
82749292|NCT00523744|Amlodipine|amlodipine|mesh-list
82749293|NCT00523744|Valsartan|valsartan|mesh-list
82749294|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82749295|NCT00523744|Olmesartan|olmesartan|mesh-list
82749296|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82749297|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82749298|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82749299|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82749300|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749301|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82749302|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749303|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
82749304|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82749305|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82749306|NCT00523744|Diuretics|diuretics|mesh-ancestor
82749307|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
82749308|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82749309|NCT03979625|Heparin|heparin|mesh-list
82749310|NCT03979625|Antibodies|antibodies|mesh-list
82749311|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
82749312|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749313|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
82749314|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82749315|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82749316|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749317|NCT02548494|Insulin|insulin|mesh-list
82749318|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
82749319|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82749320|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749321|NCT00752219|Metronidazole|metronidazole|mesh-list
82749322|NCT00752219|Meropenem|meropenem|mesh-list
82749323|NCT00752219|Ceftazidime|ceftazidime|mesh-list
82749324|NCT00752219|Avibactam|avibactam|mesh-list
82749325|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749326|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82749327|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82749328|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82749329|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82749330|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749331|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749332|NCT02598791|Glucagon|glucagon|mesh-list
82749333|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82749334|NCT02598791|Incretins|incretins|mesh-ancestor
82749336|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749337|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749338|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82749339|NCT00827346|Clopidogrel|clopidogrel|mesh-list
82749340|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82749341|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82749342|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82749343|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82749344|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
82749345|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749346|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749347|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749348|NCT00997750|Lornoxicam|lornoxicam|mesh-list
82749499|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
82749349|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82749350|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82749351|NCT00997750|Analgesics|analgesics|mesh-ancestor
82749352|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
82749353|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749354|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749355|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82749356|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82749357|NCT00622908|Besifloxacin|besifloxacin|mesh-list
82749358|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82749359|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749360|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82749361|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82749362|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749363|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749364|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749365|NCT00997828|Everolimus|everolimus|mesh-list
82749366|NCT00997828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82749367|NCT00997828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82749368|NCT00997828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749369|NCT00997828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749370|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82749371|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
82749372|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749373|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749374|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
82749375|NCT02598635|Vitamin D|vitamin d|mesh-list
82749376|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82749377|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749378|NCT02598635|Vitamins|vitamins|mesh-ancestor
82749379|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
82749380|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82749381|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
82749382|NCT04093271|Promethazine|promethazine|mesh-list
82749383|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82749384|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82749385|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82749386|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749387|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
82749388|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
82749389|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
82749390|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749391|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
82749392|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
82749393|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82749394|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82749395|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
82749396|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
82749397|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749398|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749399|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82749400|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
82749401|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
82749402|NCT00827580|Eniluracil|eniluracil|mesh-list
82749403|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749404|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749405|NCT04094909|Paclitaxel|paclitaxel|mesh-list
82749406|NCT04094909|Cisplatin|cisplatin|mesh-list
82749407|NCT04094909|Carboplatin|carboplatin|mesh-list
82749408|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
82749409|NCT04094909|Pemetrexed|pemetrexed|mesh-list
82749410|NCT04094909|Endostatins|endostatins|mesh-list
82749411|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82749412|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749413|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
82749414|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
82749415|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
82749416|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749417|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82749418|NCT04094909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82749419|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749420|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82749421|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82749422|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82749423|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82749424|NCT04094909|Growth Substances|growth substances|mesh-ancestor
82749425|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749426|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
82749427|NCT02599571|Nicotine|nicotine|mesh-list
82749428|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82749429|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
82749430|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749431|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749432|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82749433|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82749434|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
82749435|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749436|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749437|NCT00296491|Fluticasone|fluticasone|mesh-list
82749438|NCT00296491|Xhance|xhance|mesh-list
82749439|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82749440|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82749441|NCT00296491|Montelukast|montelukast|mesh-list
82749442|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82749443|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82749444|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
82749445|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749446|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749447|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82749448|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
82749449|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
82749450|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82749451|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82749452|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82749453|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82749454|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
82749455|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749456|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749457|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82749458|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
82749459|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749460|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82749461|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82749462|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
82749463|NCT00296491|Hormones|hormones|mesh-ancestor
82749464|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
82749465|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82749466|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82749467|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749468|NCT02599493|Rifampin|rifampin|mesh-list
82749469|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82749470|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
82749471|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82749472|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749473|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
82749474|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82749475|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749476|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749477|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82749478|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82749479|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82749480|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82749481|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82749482|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82749483|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
82749484|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
82749485|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749486|NCT00296335|Mitomycins|mitomycins|mesh-list
82749487|NCT00296335|Mitomycin|mitomycin|mesh-list
82749488|NCT00296335|Doxifluridine|doxifluridine|mesh-list
82749489|NCT00296335|Floxuridine|floxuridine|mesh-list
82749490|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749491|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82749492|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
82749493|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749494|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82749495|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749496|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82749497|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
82749498|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82749500|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749501|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
82749502|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82749504|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749505|NCT01065961|Dexamethasone|dexamethasone|mesh-list
82749506|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
82749507|NCT01065961|BB 1101|bb 1101|mesh-list
82749508|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82749509|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
82749510|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
82749511|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749512|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749513|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82749514|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
82749515|NCT01065961|Hormones|hormones|mesh-ancestor
82749516|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749517|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82749518|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749519|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
82749520|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749521|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749522|NCT01068223|Cetirizine|cetirizine|mesh-list
82749523|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82749524|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82749525|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82749526|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
82749527|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
82749528|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749529|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749530|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749531|NCT04234360|Prednisone|prednisone|mesh-list
82749532|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82749533|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
82749534|NCT04234360|Hormones|hormones|mesh-ancestor
82749535|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749536|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749537|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82749538|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749539|NCT02600273|Nicotine|nicotine|mesh-list
82749540|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82749541|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
82749542|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749543|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749544|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82749545|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82749546|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
82749547|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749548|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749549|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
82749550|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82749551|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749552|NCT04187872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82749553|NCT04187872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749554|NCT01068301|Plerixafor|plerixafor|mesh-list
82749555|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82749556|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82749557|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
82749558|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749559|NCT04999228|Infliximab|infliximab|mesh-list
82749560|NCT04999228|Mesalamine|mesalamine|mesh-list
82749561|NCT04999228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82749562|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82749563|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
82749564|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82749565|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82749566|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82749567|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82749568|NCT04999228|Analgesics|analgesics|mesh-ancestor
82749569|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
82749570|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749571|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749572|NCT01564810|Cetuximab|cetuximab|mesh-list
82749573|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82749574|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749575|NCT04092101|Nicotine|nicotine|mesh-list
82749576|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82749577|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
82749578|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749579|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749580|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82749581|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82749582|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
82749583|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749584|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749586|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749587|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82749588|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749589|NCT00624780|Pregabalin|pregabalin|mesh-list
82749590|NCT00624780|Lorazepam|lorazepam|mesh-list
82749591|NCT00624780|Analgesics|analgesics|mesh-ancestor
82749592|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
82749593|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749594|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749595|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
82749596|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82749597|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82749598|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749599|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82749600|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82749601|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82749602|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82749603|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82749604|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
82749605|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
82749606|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82749607|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82749608|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
82749609|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
82749610|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749611|NCT02599337|Sorafenib|sorafenib|mesh-list
82749612|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749613|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82749614|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749615|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749616|NCT00831636|Cytarabine|cytarabine|mesh-list
82749617|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82749618|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
82749619|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749620|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749621|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
82749622|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749623|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82749624|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
82749625|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749626|NCT00750737|Amphotericin B|amphotericin b|mesh-list
82749627|NCT00750737|Posaconazole|posaconazole|mesh-list
82749628|NCT00750737|Amebicides|amebicides|mesh-ancestor
82749629|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82749630|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82749631|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749632|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82749633|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
82749634|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82749635|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82749636|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82749637|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749638|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749639|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82749640|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
82749641|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749642|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749643|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
82749644|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82749645|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749646|NCT04093505|Immunotoxins|immunotoxins|mesh-ancestor
82749647|NCT04093505|Immunoconjugates|immunoconjugates|mesh-ancestor
82749648|NCT04093505|Immunologic Factors|immunologic factors|mesh-ancestor
82749649|NCT04093505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749650|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
82749651|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82749652|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
82749653|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82749654|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
82749655|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749656|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749657|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
82749658|NCT02597699|Lidocaine|lidocaine|mesh-list
82749659|NCT02597699|Sufentanil|sufentanil|mesh-list
82749660|NCT02597699|Remifentanil|remifentanil|mesh-list
82749661|NCT02597699|Dsuvia|dsuvia|mesh-list
82749662|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
82749663|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
82749664|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82749665|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749666|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
82749667|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749668|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82749669|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82749670|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82749671|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82749672|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749673|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82749674|NCT02597699|Narcotics|narcotics|mesh-ancestor
82749675|NCT02597699|Analgesics|analgesics|mesh-ancestor
82749676|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82749677|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82749678|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
82749679|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
82749680|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749681|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82749682|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749683|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749684|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
82749685|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749686|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749687|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82749688|NCT00744653|Bleomycin|bleomycin|mesh-list
82749689|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82749690|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749691|NCT00998218|Ranolazine|ranolazine|mesh-list
82749692|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82749693|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82749694|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749695|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82749696|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82749697|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
82749698|NCT00311311|Sirolimus|sirolimus|mesh-list
82749699|NCT00311311|Prednisone|prednisone|mesh-list
82749700|NCT00311311|Tacrolimus|tacrolimus|mesh-list
82749701|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82749702|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
82749703|NCT00311311|Hormones|hormones|mesh-ancestor
82749704|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749705|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749706|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82749707|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749708|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82749709|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
82749710|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82749711|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749712|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749713|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82749714|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82749715|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
82749716|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82749717|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749718|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
82749719|NCT04089605|Dexamethasone|dexamethasone|mesh-list
82749720|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
82749721|NCT04089605|Ranibizumab|ranibizumab|mesh-list
82749722|NCT04089605|BB 1101|bb 1101|mesh-list
82749723|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82749724|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
82749725|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
82749726|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749727|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749728|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82749729|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
82749731|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749732|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82749733|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749734|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
82749735|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749736|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749737|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82749738|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82749739|NCT04089605|Growth Substances|growth substances|mesh-ancestor
82749740|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
82749741|NCT00521404|Gemcitabine|gemcitabine|mesh-list
82749742|NCT00521404|Antibodies|antibodies|mesh-list
82749743|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
82749744|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749745|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82749746|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
82749747|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749748|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749749|NCT00311155|Amlodipine|amlodipine|mesh-list
82749750|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82749751|NCT00311155|Olmesartan|olmesartan|mesh-list
82749752|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82749753|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82749754|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82749755|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82749756|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749757|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82749758|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749759|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
82749760|NCT00311155|Diuretics|diuretics|mesh-ancestor
82749761|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
82749762|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82749763|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82749764|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82749765|NCT03981601|Lovastatin|lovastatin|mesh-list
82749766|NCT03981601|L 647318|l 647318|mesh-list
82749767|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
82749768|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82749769|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82749770|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
82749771|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749772|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82749773|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82749774|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749775|NCT00274651|Belinostat|belinostat|mesh-list
82749776|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749777|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82749778|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749779|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749780|NCT00274261|Nonoxynol|nonoxynol|mesh-list
82749781|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
82749782|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
82749783|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749784|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82749785|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
82749786|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82749787|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82749788|NCT00827814|Dutasteride|dutasteride|mesh-list
82749789|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82749790|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82749791|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749792|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749793|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
82749794|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749795|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749796|NCT01068847|Cycloserine|cycloserine|mesh-list
82749797|NCT01068847|Verapamil|verapamil|mesh-list
82749798|NCT01068847|Nifedipine|nifedipine|mesh-list
82749799|NCT01068847|Tizanidine|tizanidine|mesh-list
82749800|NCT01068847|Naloxone|naloxone|mesh-list
82749801|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82749802|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749803|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
82749804|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82749805|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82749806|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82749807|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749808|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82749809|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
82749810|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
82749811|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82749812|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82749813|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749814|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82749815|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
82749816|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82749817|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
82749818|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82749819|NCT01068847|Analgesics|analgesics|mesh-ancestor
82749820|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
82749821|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82749822|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82749823|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
82749824|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
82749825|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82749826|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82749827|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82749828|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
82749829|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749830|NCT00827892|Pioglitazone|pioglitazone|mesh-list
82749831|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82749832|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749833|NCT01070875|Heparin|heparin|mesh-list
82749834|NCT01070875|Calcium heparin|calcium heparin|mesh-list
82749835|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
82749836|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82749837|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82749838|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749839|NCT04043676|Ponatinib|ponatinib|mesh-list
82749840|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749841|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82749842|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749843|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749844|NCT01325935|Clopidogrel|clopidogrel|mesh-list
82749845|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82749846|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82749847|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82749848|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82749849|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
82749850|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749851|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749852|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749853|NCT02549742|Bleomycin|bleomycin|mesh-list
82749854|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82749855|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749856|NCT00521014|Cytarabine|cytarabine|mesh-list
82749857|NCT00521014|Rituximab|rituximab|mesh-list
82749858|NCT00521014|Etoposide|etoposide|mesh-list
82749859|NCT00521014|Melphalan|melphalan|mesh-list
82749860|NCT00521014|Carmustine|carmustine|mesh-list
82749861|NCT00521014|Sargramostim|sargramostim|mesh-list
82749862|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82749863|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749864|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
82749865|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749866|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82749867|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82749868|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82749869|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82749870|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749871|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749872|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82749873|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
82749874|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
82749875|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749877|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82749878|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
82749879|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82749880|NCT00825552|Risperidone|risperidone|mesh-list
82749881|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82749882|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
82749883|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749884|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749885|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749886|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82749887|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82749888|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82749889|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82749890|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82749891|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
82749892|NCT00291577|Docetaxel|docetaxel|mesh-list
82749893|NCT00291577|Sunitinib|sunitinib|mesh-list
82749894|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749895|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
82749896|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
82749897|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
82749898|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749899|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82749900|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82749901|NCT00291577|Growth Substances|growth substances|mesh-ancestor
82749902|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749903|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
82749904|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82749905|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749906|NCT00520936|Pemetrexed|pemetrexed|mesh-list
82749907|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749908|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749909|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749910|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82749911|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82749912|NCT02549430|Letrozole|letrozole|mesh-list
82749913|NCT02549430|Fulvestrant|fulvestrant|mesh-list
82749914|NCT02549430|Palbociclib|palbociclib|mesh-list
82749915|NCT02549430|Anastrozole|anastrozole|mesh-list
82749916|NCT02549430|Exemestane|exemestane|mesh-list
82749917|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749918|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82749919|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82749920|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749921|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749922|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82749923|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
82749924|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82749925|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749926|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82749927|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82749928|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82749929|NCT00943839|Sunitinib|sunitinib|mesh-list
82749930|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749931|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82749932|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82749933|NCT00943839|Growth Substances|growth substances|mesh-ancestor
82749934|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749935|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
82749936|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82749937|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749938|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749939|NCT00832182|Insulin|insulin|mesh-list
82749940|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82749941|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
82749942|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
82749943|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
82749944|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
82749945|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82749946|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749947|NCT00952497|Capecitabine|capecitabine|mesh-list
82749948|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82749949|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82749950|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
82749951|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749952|NCT00828282|Simvastatin|simvastatin|mesh-list
82749953|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82749954|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82749955|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
82749956|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749957|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82749958|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82749959|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749960|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
82749961|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82749962|NCT00952575|Antibodies|antibodies|mesh-list
82749963|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82749964|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
82749965|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
82749966|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749967|NCT03865732|Pregnanolone|pregnanolone|mesh-list
82749968|NCT03865732|Ganaxolone|ganaxolone|mesh-list
82749969|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
82749970|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82749971|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749972|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749973|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
82749974|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
82749975|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
82749976|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82749977|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
82749978|NCT00944307|Antacids|antacids|mesh-list
82749979|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
82749980|NCT00944307|TEMPO|tempo|mesh-list
82749981|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82749982|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82749983|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
82749984|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82749985|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82749986|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82749987|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749988|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749989|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82749990|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
82749991|NCT00944307|Protective Agents|protective agents|mesh-ancestor
82749992|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82749993|NCT00944385|Urinastatin|urinastatin|mesh-list
82749994|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82749995|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82749996|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
82749997|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82749998|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82749999|NCT00953355|Metformin|metformin|mesh-list
82750000|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82750001|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750002|NCT00944463|Gemcitabine|gemcitabine|mesh-list
82750003|NCT00944463|Simvastatin|simvastatin|mesh-list
82750004|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82750005|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
82750006|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750007|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750008|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82750009|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82750010|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82750011|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82750012|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750013|NCT00956397|Rifaximin|rifaximin|mesh-list
82750014|NCT00956397|Lactulose|lactulose|mesh-list
82750015|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82750016|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750017|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82750018|NCT05300373|Adenosine|adenosine|mesh-list
82750019|NCT05300373|Analgesics|analgesics|mesh-ancestor
82750020|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
82750021|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750022|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750023|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82750024|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
82750025|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82750026|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
82750027|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
82750028|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750029|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750030|NCT00953589|Ribavirin|ribavirin|mesh-list
82750031|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
82750032|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750033|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
82750034|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750035|NCT00947739|Camptothecin|camptothecin|mesh-list
82750036|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82750037|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750038|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82750039|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82750040|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750041|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750042|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
82750043|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82750044|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750045|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
82750046|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82750047|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82750048|NCT00947895|Prednisolone|prednisolone|mesh-list
82750049|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
82750050|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82750051|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
82750052|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82750053|NCT00947895|Hormones|hormones|mesh-ancestor
82750054|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750055|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750056|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82750057|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
82750058|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
82750059|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750060|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82750061|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
82750062|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82750063|NCT00947895|Protective Agents|protective agents|mesh-ancestor
82750064|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82750065|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750066|NCT00623766|Dexamethasone|dexamethasone|mesh-list
82750067|NCT00623766|Prednisone|prednisone|mesh-list
82750068|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
82750069|NCT00623766|Prednisolone|prednisolone|mesh-list
82750070|NCT00623766|Triamcinolone|triamcinolone|mesh-list
82750071|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
82750072|NCT00623766|Betamethasone|betamethasone|mesh-list
82750073|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
82750074|NCT00623766|Ipilimumab|ipilimumab|mesh-list
82750075|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82750076|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
82750077|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
82750078|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750079|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750080|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82750081|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
82750082|NCT00623766|Hormones|hormones|mesh-ancestor
82750083|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750084|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82750085|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750086|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82750087|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82750088|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750089|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82750090|NCT00623766|Protective Agents|protective agents|mesh-ancestor
82750091|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82750092|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
82750093|NCT00832494|Paclitaxel|paclitaxel|mesh-list
82750094|NCT00832494|Carboplatin|carboplatin|mesh-list
82750095|NCT00832494|Vadimezan|vadimezan|mesh-list
82750096|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82750097|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750098|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
82750099|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
82750100|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
82750101|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750102|NCT00837564|Escitalopram|escitalopram|mesh-list
82750103|NCT00837564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82750104|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82750105|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82750329|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82750106|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750107|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750109|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750110|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
82750112|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82750113|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
82750114|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750115|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82750116|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82750117|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
82750118|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750119|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750120|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82750121|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82750122|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750123|NCT00832806|Varenicline|varenicline|mesh-list
82750124|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82750125|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82750126|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
82750127|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750128|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750129|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750130|NCT00832884|Lacosamide|lacosamide|mesh-list
82750131|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
82750132|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82750133|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82750134|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82750135|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750136|NCT02549118|Tenoxicam|tenoxicam|mesh-list
82750137|NCT02549118|Meperidine|meperidine|mesh-list
82750138|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82750139|NCT02549118|Narcotics|narcotics|mesh-ancestor
82750140|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82750141|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750142|NCT02549118|Analgesics|analgesics|mesh-ancestor
82750143|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
82750144|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750145|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82750146|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82750147|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82750148|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82750149|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82750150|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82750151|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750152|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750153|NCT00957177|Pregabalin|pregabalin|mesh-list
82750154|NCT00957177|Analgesics|analgesics|mesh-ancestor
82750155|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
82750156|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750157|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750158|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
82750159|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82750160|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82750161|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750162|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82750163|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82750164|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82750165|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82750166|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82750167|NCT04337580|Omeprazole|omeprazole|mesh-list
82750168|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82750169|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82750170|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82750171|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750172|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750173|NCT00828594|Sorafenib|sorafenib|mesh-list
82750174|NCT00828594|Everolimus|everolimus|mesh-list
82750175|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750176|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82750177|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750178|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750179|NCT00828594|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82750180|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82750181|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
82750182|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750183|NCT00550407|Lamotrigine|lamotrigine|mesh-list
82750184|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
82750185|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82750186|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82750187|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750188|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82750189|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750190|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82750191|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82750192|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82750193|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82750194|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82750195|NCT00957411|Cetuximab|cetuximab|mesh-list
82750196|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750197|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82750198|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
82750199|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
82750200|NCT00837954|Coagulants|coagulants|mesh-ancestor
82750201|NCT00954525|Gemcitabine|gemcitabine|mesh-list
82750202|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82750203|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82750204|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
82750205|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750206|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750207|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82750208|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750209|NCT00838032|Haloperidol|haloperidol|mesh-list
82750210|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82750211|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
82750212|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
82750213|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82750214|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82750215|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82750216|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82750217|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750218|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
82750219|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
82750220|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750221|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82750222|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82750223|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
82750224|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750225|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750226|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82750227|NCT00954603|Haloperidol|haloperidol|mesh-list
82750228|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82750229|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
82750230|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
82750231|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82750232|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82750233|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82750234|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82750235|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750236|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
82750237|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
82750238|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750239|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82750240|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82750241|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
82750242|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750243|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750244|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82750245|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82750246|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750247|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82750248|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750249|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750250|NCT02548806|Clonidine|clonidine|mesh-list
82750251|NCT02548806|Analgesics|analgesics|mesh-ancestor
82750252|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
82750253|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750254|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750255|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82750256|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
82750257|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
82750258|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82750259|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82750260|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82750261|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
82750262|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750263|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750265|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82750266|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82750267|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82750268|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
82750269|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750270|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750271|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750272|NCT00549939|Urological Agents|urological agents|mesh-ancestor
82750273|NCT00272779|Emtricitabine|emtricitabine|mesh-list
82750274|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82750275|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
82750276|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750277|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82750278|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82750279|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750280|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750281|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82750282|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82750283|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82750284|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82750285|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
82750286|NCT00957879|Calcitriol|calcitriol|mesh-list
82750287|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
82750288|NCT00957879|Vitamin D|vitamin d|mesh-list
82750289|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82750290|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750291|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82750292|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82750293|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750294|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82750295|NCT00957879|Vitamins|vitamins|mesh-ancestor
82750296|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
82750297|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82750298|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
82750299|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82750300|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750302|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750303|NCT00838266|Protective Agents|protective agents|mesh-ancestor
82750304|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750305|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
82750306|NCT04011033|Interleukin-2|interleukin-2|mesh-list
82750307|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82750308|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
82750309|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750310|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82750311|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82750312|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
82750313|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750314|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750315|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82750316|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82750317|NCT04011033|Analgesics|analgesics|mesh-ancestor
82750318|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
82750319|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750320|NCT00998608|Risperidone|risperidone|mesh-list
82750321|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82750322|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
82750323|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750324|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750325|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750326|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82750327|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82750328|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82750330|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82750331|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
82750332|NCT04011813|Antioxidants|antioxidants|mesh-list
82750333|NCT04011813|Hypotaurine|hypotaurine|mesh-list
82750334|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750335|NCT04011813|Protective Agents|protective agents|mesh-ancestor
82750336|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750337|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82750338|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82750339|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750340|NCT00998686|Incretins|incretins|mesh-ancestor
82750341|NCT00998686|Hormones|hormones|mesh-ancestor
82750342|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750343|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82750344|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
82750345|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750346|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750347|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82750348|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82750349|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750350|NCT00958269|Incretins|incretins|mesh-ancestor
82750351|NCT00958269|Hormones|hormones|mesh-ancestor
82750352|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750353|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82750354|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
82750355|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750356|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750357|NCT02547402|CXA-10|cxa-10|mesh-list
82750358|NCT02547402|Simvastatin|simvastatin|mesh-list
82750359|NCT02547402|Ezetimibe|ezetimibe|mesh-list
82750360|NCT02547402|Pravastatin|pravastatin|mesh-list
82750361|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
82750362|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82750363|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82750364|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
82750365|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750366|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82750367|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82750368|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750369|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82750370|NCT01068925|Dolutegravir|dolutegravir|mesh-list
82750371|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82750372|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82750373|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750374|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750375|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82750376|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82750377|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
82750378|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750379|NCT00834600|Amlodipine|amlodipine|mesh-list
82750380|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82750381|NCT00834600|Olmesartan|olmesartan|mesh-list
82750382|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82750383|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82750384|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82750385|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82750386|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750387|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82750388|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750389|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
82750390|NCT00834600|Diuretics|diuretics|mesh-ancestor
82750391|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
82750392|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82750393|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82750394|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82750395|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
82750396|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82750397|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
82750398|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750399|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
82750400|NCT00958425|Protective Agents|protective agents|mesh-ancestor
82750401|NCT02547480|Irinotecan|irinotecan|mesh-list
82750402|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82750403|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82750404|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750405|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750406|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750407|NCT00838656|Paclitaxel|paclitaxel|mesh-list
82750408|NCT00838656|Carboplatin|carboplatin|mesh-list
82750409|NCT00838656|Gemcitabine|gemcitabine|mesh-list
82750410|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82750411|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750412|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
82750413|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
82750414|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
82750415|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750416|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82750417|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
82750418|NCT00829608|Vaccines|vaccines|mesh-list
82750419|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
82750420|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750421|NCT00553605|Ketoprofen|ketoprofen|mesh-list
82750422|NCT00553605|Parecoxib|parecoxib|mesh-list
82750423|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82750424|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82750425|NCT00553605|Analgesics|analgesics|mesh-ancestor
82750426|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
82750427|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750428|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750429|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82750430|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82750431|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82750432|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750433|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750434|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82750435|NCT00838968|Interferons|interferons|mesh-list
82750436|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
82750437|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750438|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
82750439|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750440|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
82750441|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750442|NCT04010955|Edoxaban|edoxaban|mesh-list
82750443|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82750444|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
82750445|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82750446|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
82750447|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750448|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750449|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
82750450|NCT00948987|Aspirin|aspirin|mesh-list
82750451|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82750452|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82750453|NCT00948987|Analgesics|analgesics|mesh-ancestor
82750454|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
82750455|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750456|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750457|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82750458|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82750459|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82750460|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82750461|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750462|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82750463|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82750464|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750465|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
82750466|NCT00744497|Prednisone|prednisone|mesh-list
82750467|NCT00744497|Docetaxel|docetaxel|mesh-list
82750468|NCT00744497|Dasatinib|dasatinib|mesh-list
82750469|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750470|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
82750471|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
82750472|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
82750473|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750474|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82750475|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
82750476|NCT00744497|Hormones|hormones|mesh-ancestor
82750477|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750478|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750479|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82750480|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82750481|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750482|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
82750483|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82750484|NCT00949065|Antibodies|antibodies|mesh-list
82750485|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
82750486|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82750487|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
82750488|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750489|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82750490|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750491|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82750492|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750493|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750494|NCT05351385|Dimercaprol|dimercaprol|mesh-list
82750495|NCT05351385|Chelating Agents|chelating agents|mesh-ancestor
82750496|NCT05351385|Sequestering Agents|sequestering agents|mesh-ancestor
82750497|NCT05351385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750498|NCT00955227|Ezetimibe|ezetimibe|mesh-list
82750499|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82750500|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82750501|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
82750502|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750503|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82750504|NCT00949299|Buprenorphine|buprenorphine|mesh-list
82750505|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82750506|NCT00949299|Narcotics|narcotics|mesh-ancestor
82750507|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82750508|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750509|NCT00949299|Analgesics|analgesics|mesh-ancestor
82750510|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
82750511|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750512|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82750513|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82750514|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82750515|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82750516|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
82750517|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750518|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82750519|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82750520|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750522|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82750523|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750524|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82750525|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82750526|NCT00271609|Growth Substances|growth substances|mesh-ancestor
82750527|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750528|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
82750529|NCT00548847|Interferons|interferons|mesh-list
82750530|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
82750531|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
82750532|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82750533|NCT00548847|Molgramostim|molgramostim|mesh-list
82750534|NCT00548847|Sargramostim|sargramostim|mesh-list
82750535|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750536|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
82750537|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750538|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
82750539|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750540|NCT00949377|Bromides|bromides|mesh-list
82750541|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
82750542|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
82750543|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82750544|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750545|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
82750546|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750547|NCT00290407|Rituximab|rituximab|mesh-list
82750548|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82750549|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750550|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
82750551|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750552|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82750553|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
82750554|NCT02597387|Analgesics|analgesics|mesh-ancestor
82750555|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
82750556|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750557|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750635|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82750558|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750559|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82750560|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82750561|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750562|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750563|NCT01069081|Cisplatin|cisplatin|mesh-list
82750565|NCT01069081|Esomeprazole|esomeprazole|mesh-list
82750566|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750567|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
82750568|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
82750569|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
82750570|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750571|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82750572|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82750573|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82750574|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750575|NCT00949455|Lapatinib|lapatinib|mesh-list
82750576|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750577|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82750578|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750579|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750580|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
82750581|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
82750582|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750583|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82750584|NCT00955695|Gefitinib|gefitinib|mesh-list
82750585|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750586|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82750587|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750588|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750589|NCT00955773|Everolimus|everolimus|mesh-list
82750590|NCT00955773|Trametinib|trametinib|mesh-list
82750591|NCT00955773|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82750592|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82750593|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750594|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750595|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82750596|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
82750597|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750598|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750599|NCT00549549|Celecoxib|celecoxib|mesh-list
82750600|NCT00549549|Indomethacin|indomethacin|mesh-list
82750601|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82750602|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82750603|NCT00549549|Analgesics|analgesics|mesh-ancestor
82750604|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
82750605|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750606|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750607|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82750608|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82750609|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82750610|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82750611|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750612|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750613|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
82750614|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
82750615|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82750616|NCT00622284|Glimepiride|glimepiride|mesh-list
82750617|NCT00622284|Linagliptin|linagliptin|mesh-list
82750618|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82750619|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82750620|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750621|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82750622|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
82750623|NCT00622284|Incretins|incretins|mesh-ancestor
82750624|NCT00622284|Hormones|hormones|mesh-ancestor
82750625|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750626|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82750627|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
82750628|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750629|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750631|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82750632|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750633|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
82750634|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750636|NCT01069159|Propranolol|propranolol|mesh-list
82750637|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82750638|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82750639|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
82750640|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750641|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750642|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750643|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82750644|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82750645|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
82750646|NCT03975205|Doxorubicin|doxorubicin|mesh-list
82750647|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82750648|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750649|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82750650|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82750651|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750652|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750653|NCT01325779|Heparin|heparin|mesh-list
82750654|NCT01325779|Enoxaparin|enoxaparin|mesh-list
82750655|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
82750656|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82750657|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82750658|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750659|NCT05170659|Relatlimab|relatlimab|mesh-list
82750660|NCT05170659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82750661|NCT05170659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750662|NCT05170659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82750663|NCT05170659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750664|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
82750665|NCT05352165|Fluorouracil|fluorouracil|mesh-list
82750666|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82750667|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750668|NCT05352165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82750669|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750670|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
82750671|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82750672|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82750673|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
82750674|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750675|NCT00956163|Diphosphonates|diphosphonates|mesh-list
82750676|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
82750677|NCT00956163|Listerine|listerine|mesh-list
82750678|NCT00956163|Fluorides|fluorides|mesh-list
82750679|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
82750680|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
82750681|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
82750682|NCT00956163|Protective Agents|protective agents|mesh-ancestor
82750683|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750684|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82750685|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750686|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82750687|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750688|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82750689|NCT00956319|Estazolam|estazolam|mesh-list
82750690|NCT00956319|Zolpidem|zolpidem|mesh-list
82750691|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82750692|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82750693|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82750694|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750695|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82750696|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
82750697|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
82750698|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750699|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750700|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
82750701|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82750702|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82750703|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82750704|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
82750705|NCT00835848|Exenatide|exenatide|mesh-list
82750706|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82750707|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750708|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82750709|NCT00835848|Incretins|incretins|mesh-ancestor
82750710|NCT00835848|Hormones|hormones|mesh-ancestor
82750786|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750711|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750712|NCT00961857|Metformin|metformin|mesh-list
82750713|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82750714|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82750715|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750716|NCT00961857|Incretins|incretins|mesh-ancestor
82750717|NCT00961857|Hormones|hormones|mesh-ancestor
82750718|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750719|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82750720|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
82750721|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750722|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750723|NCT02547792|Vaccines|vaccines|mesh-list
82750724|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
82750725|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750726|NCT00830466|Sirolimus|sirolimus|mesh-list
82750727|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82750728|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750729|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82750730|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750731|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
82750732|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82750733|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
82750734|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750735|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82750736|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82750737|NCT00843570|Nafarelin|nafarelin|mesh-list
82750738|NCT00843570|Estradiol|estradiol|mesh-list
82750739|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82750740|NCT00843570|Progesterone|progesterone|mesh-list
82750741|NCT00843570|Estrogens|estrogens|mesh-ancestor
82750742|NCT00843570|Hormones|hormones|mesh-ancestor
82750743|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750744|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750745|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82750746|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
82750747|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82750748|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82750749|NCT00843570|Progestins|progestins|mesh-ancestor
82750750|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82750751|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
82750752|NCT02547870|Rilpivirine|rilpivirine|mesh-list
82750753|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82750754|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82750755|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750756|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750757|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
82750758|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750759|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82750760|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82750761|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
82750762|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
82750763|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
82750764|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82750765|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750766|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
82750767|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750768|NCT00621504|Clarithromycin|clarithromycin|mesh-list
82750769|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
82750770|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
82750771|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82750772|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750773|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82750774|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750775|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750776|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82750777|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82750778|NCT00548145|Ezetimibe|ezetimibe|mesh-list
82750779|NCT00548145|Pitavastatin|pitavastatin|mesh-list
82750780|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82750781|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82750782|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
82750783|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750784|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82750785|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82750788|NCT00547911|Droxidopa|droxidopa|mesh-list
82750789|NCT00547911|Entacapone|entacapone|mesh-list
82750790|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82750791|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82750792|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
82750793|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750794|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750795|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750796|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82750797|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750798|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82750799|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
82750800|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
82750801|NCT00839280|Vitamins|vitamins|mesh-ancestor
82750802|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
82750803|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750804|NCT00836628|Busulfan|busulfan|mesh-list
82750805|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
82750806|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750807|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82750808|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
82750809|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750810|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82750811|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750812|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82750813|NCT00962637|Citric Acid|citric acid|mesh-list
82750814|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
82750815|NCT00962637|Enclomiphene|enclomiphene|mesh-list
82750816|NCT00962637|Clomiphene|clomiphene|mesh-list
82750817|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
82750818|NCT00962637|Testosterone|testosterone|mesh-list
82750819|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
82750820|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82750821|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
82750822|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
82750823|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750824|NCT00962637|Androgens|androgens|mesh-ancestor
82750825|NCT00962637|Hormones|hormones|mesh-ancestor
82750826|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750827|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750828|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82750829|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
82750830|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82750831|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
82750832|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82750833|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82750834|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82750835|NCT00839358|Midodrine|midodrine|mesh-list
82750836|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
82750837|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
82750838|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82750839|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750840|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82750841|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82750842|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82750843|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82750844|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
82750845|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750846|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750847|NCT00962715|Interferons|interferons|mesh-list
82750848|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
82750849|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
82750850|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82750851|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750852|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
82750853|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750854|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
82750855|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750856|NCT00963027|Treprostinil|treprostinil|mesh-list
82750857|NCT00963027|Esomeprazole|esomeprazole|mesh-list
82750858|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82750859|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82750860|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82750861|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750862|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750863|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82750864|NCT00837174|Bortezomib|bortezomib|mesh-list
82750865|NCT00837174|Vorinostat|vorinostat|mesh-list
82750866|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750867|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82750868|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750869|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750870|NCT04042974|Dinoprostone|dinoprostone|mesh-list
82750871|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
82750872|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82750873|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750874|NCT00844350|Letrozole|letrozole|mesh-list
82750875|NCT00844350|Oxytocin|oxytocin|mesh-list
82750876|NCT00844350|Clomiphene|clomiphene|mesh-list
82750877|NCT00844350|Enclomiphene|enclomiphene|mesh-list
82750878|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
82750879|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750880|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
82750881|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82750882|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750883|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750884|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82750885|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82750886|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750887|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82750888|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
82750889|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750890|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82750891|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
82750892|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82750893|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82750894|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
82750895|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82750896|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
82750897|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750898|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82750899|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82750900|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
82750901|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750902|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750903|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82750904|NCT00839826|Enoxaparin|enoxaparin|mesh-list
82750905|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
82750906|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82750907|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
82750908|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82750909|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
82750910|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750911|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750912|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
82750913|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82750914|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82750915|NCT00844662|Sevelamer|sevelamer|mesh-list
82750916|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
82750917|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
82750918|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750919|NCT04678089|Bortezomib|bortezomib|mesh-list
82750920|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750921|NCT00963573|Loratadine|loratadine|mesh-list
82750922|NCT00963573|Betamethasone|betamethasone|mesh-list
82750923|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82750924|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
82750925|NCT00963573|Hormones|hormones|mesh-ancestor
82750926|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750927|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750928|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82750929|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
82750930|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
82750931|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
82750932|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82750933|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82750934|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82750935|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
82750936|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
82750937|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750938|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750939|NCT05299593|Timolol|timolol|mesh-list
82750940|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82750941|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82750942|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
82750943|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82750944|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750945|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750946|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82750947|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82750948|NCT00844740|Cinacalcet|cinacalcet|mesh-list
82750949|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82750950|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750951|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82750952|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
82750953|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750954|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
82750955|NCT00963729|Docetaxel|docetaxel|mesh-list
82750956|NCT00963729|Fluorouracil|fluorouracil|mesh-list
82750957|NCT00963729|Letrozole|letrozole|mesh-list
82750958|NCT00963729|Epirubicin|epirubicin|mesh-list
82750959|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82750960|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
82750961|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82750962|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82750963|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82750964|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
82750965|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750966|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750967|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82750968|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
82750969|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
82750970|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
82750971|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
82750972|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82750973|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82750974|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82750975|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750976|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82750977|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
82750978|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82750979|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82750980|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82750981|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82750982|NCT00964041|Cycloserine|cycloserine|mesh-list
82750983|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82750984|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82750985|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82750986|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
82750987|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82750988|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
82750989|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750990|NCT04009317|Crizotinib|crizotinib|mesh-list
82750991|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750992|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82750993|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82750994|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82750995|NCT03641547|Capecitabine|capecitabine|mesh-list
82750996|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82750997|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82750998|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
82750999|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751000|NCT00851370|Omalizumab|omalizumab|mesh-list
82751001|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82751002|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82751003|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
82751004|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
82751005|NCT00967629|Calcium|calcium|mesh-list
82751006|NCT00967629|Sevelamer|sevelamer|mesh-list
82751007|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82751008|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751009|NCT00967629|Antacids|antacids|mesh-ancestor
82751010|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751011|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82751012|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
82751013|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
82751014|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82751015|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
82751016|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751018|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82751019|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82751020|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751021|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751022|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82751023|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82751024|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
82751025|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751026|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751027|NCT00840684|Cytarabine|cytarabine|mesh-list
82751028|NCT00840684|Melphalan|melphalan|mesh-list
82751029|NCT00840684|Busulfan|busulfan|mesh-list
82751030|NCT00840684|Daunorubicin|daunorubicin|mesh-list
82751031|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
82751032|NCT00840684|Amsacrine|amsacrine|mesh-list
82751033|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82751034|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
82751035|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751036|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751037|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
82751038|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751039|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751040|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
82751041|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751042|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82751043|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
82751044|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82751045|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82751046|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82751047|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82751048|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751049|NCT00840684|Analgesics|analgesics|mesh-ancestor
82751050|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
82751051|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751052|NCT00574080|Cytarabine|cytarabine|mesh-list
82751053|NCT00574080|Thalidomide|thalidomide|mesh-list
82751054|NCT00574080|Dexamethasone|dexamethasone|mesh-list
82751055|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
82751056|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
82751057|NCT00574080|Melphalan|melphalan|mesh-list
82751058|NCT00574080|Carmustine|carmustine|mesh-list
82751059|NCT00574080|Cisplatin|cisplatin|mesh-list
82751060|NCT00574080|Etoposide|etoposide|mesh-list
82751061|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
82751062|NCT00574080|Doxorubicin|doxorubicin|mesh-list
82751063|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82751064|NCT00574080|Bortezomib|bortezomib|mesh-list
82751065|NCT00574080|BB 1101|bb 1101|mesh-list
82751066|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751067|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
82751068|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751069|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751070|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82751071|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
82751072|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751073|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751074|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82751075|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82751076|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
82751077|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
82751078|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751079|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82751080|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
82751081|NCT00574080|Hormones|hormones|mesh-ancestor
82751082|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82751083|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82751084|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
82751085|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751086|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82751087|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82751088|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82751089|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82751090|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
82751091|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
82751092|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751093|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82751094|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
82751095|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82751096|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82751097|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82751098|NCT00574080|Growth Substances|growth substances|mesh-ancestor
82751099|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
82751100|NCT00845364|Perhexiline|perhexiline|mesh-list
82751101|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82751102|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82751103|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751104|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82751105|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751106|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
82751107|NCT00546351|Lacosamide|lacosamide|mesh-list
82751108|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
82751109|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82751110|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82751111|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82751112|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751113|NCT00267865|Leucovorin|leucovorin|mesh-list
82751114|NCT00267865|Rituximab|rituximab|mesh-list
82751115|NCT00267865|Methotrexate|methotrexate|mesh-list
82751116|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82751117|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751118|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
82751119|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751120|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751121|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82751122|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
82751123|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82751124|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82751125|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
82751126|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751127|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
82751128|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751129|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82751130|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751131|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82751132|NCT00267865|Antidotes|antidotes|mesh-ancestor
82751133|NCT00267865|Protective Agents|protective agents|mesh-ancestor
82751134|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
82751135|NCT00267865|Vitamins|vitamins|mesh-ancestor
82751136|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
82751137|NCT00840918|Lidocaine|lidocaine|mesh-list
82751138|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
82751139|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
82751140|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751141|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751142|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
82751143|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751144|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82751145|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82751146|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82751147|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82751148|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751149|NCT00546117|Lansoprazole|lansoprazole|mesh-list
82751150|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
82751151|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82751152|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82751153|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82751154|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751155|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751156|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82751157|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82751158|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82751159|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
82751160|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751161|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82751162|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82751163|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751164|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
82751165|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82751166|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82751167|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751168|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
82751169|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
82751172|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82751173|NCT00967707|Analgesics|analgesics|mesh-ancestor
82751174|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
82751175|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751176|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751177|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
82751178|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82751179|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82751180|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751181|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82751182|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82751183|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82751184|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751185|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751186|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
82751187|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82751188|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751189|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
82751190|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
82751191|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82751192|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82751193|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82751194|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82751195|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
82751196|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82751197|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82751198|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751199|NCT00845598|Fluticasone|fluticasone|mesh-list
82751200|NCT00845598|Xhance|xhance|mesh-list
82751201|NCT00845598|Azelastine|azelastine|mesh-list
82751202|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82751203|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82751204|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
82751205|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751206|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751207|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82751208|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
82751209|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
82751210|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82751211|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82751212|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751213|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751214|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82751215|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82751216|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
82751217|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
82751218|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751219|NCT00251719|Lansoprazole|lansoprazole|mesh-list
82751220|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
82751221|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82751222|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82751223|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82751224|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751225|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751226|NCT00845754|Ketorolac|ketorolac|mesh-list
82751227|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82751228|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82751229|NCT00845754|Analgesics|analgesics|mesh-ancestor
82751230|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
82751231|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751232|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751233|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82751234|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751235|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82751236|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751237|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751238|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82751239|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
82751240|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
82751241|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751242|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
82751243|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751244|NCT00841386|Riboflavin|riboflavin|mesh-list
82751245|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
82751246|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
82751247|NCT00841386|Vitamins|vitamins|mesh-ancestor
82751248|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
82751249|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751250|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82751251|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
82751252|NCT03952143|Insulin|insulin|mesh-list
82751253|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82751254|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
82751255|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
82751256|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82751257|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751258|NCT00968331|Rituximab|rituximab|mesh-list
82751259|NCT00968331|Lenalidomide|lenalidomide|mesh-list
82751260|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82751261|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751262|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
82751263|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751264|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751265|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82751266|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82751267|NCT00968331|Growth Substances|growth substances|mesh-ancestor
82751268|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
82751269|NCT00852228|Cetuximab|cetuximab|mesh-list
82751270|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
82751271|NCT00852228|Irinotecan|irinotecan|mesh-list
82751272|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82751273|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751274|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82751275|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82751276|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751277|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751278|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
82751279|NCT00267007|Hematinics|hematinics|mesh-ancestor
82751280|NCT00841854|Metronidazole|metronidazole|mesh-list
82751281|NCT00841854|Tetracycline|tetracycline|mesh-list
82751282|NCT00841854|Pantoprazole|pantoprazole|mesh-list
82751283|NCT00841854|Bismuth|bismuth|mesh-list
82751284|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751285|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82751286|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82751287|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82751288|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82751289|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82751290|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82751291|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751292|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751293|NCT00841854|Antacids|antacids|mesh-ancestor
82751294|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82751295|NCT00848562|Nicorandil|nicorandil|mesh-list
82751296|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82751297|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82751298|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
82751299|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
82751300|NCT00848562|Vitamins|vitamins|mesh-ancestor
82751301|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
82751302|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751303|NCT02879409|Insulin|insulin|mesh-list
82751304|NCT02879409|Metformin|metformin|mesh-list
82751305|NCT02879409|Pioglitazone|pioglitazone|mesh-list
82751306|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82751307|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
82751308|NCT02879409|Liraglutide|liraglutide|mesh-list
82751309|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82751310|NCT02879409|Gliclazide|gliclazide|mesh-list
82751311|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82751312|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751313|NCT02879409|Incretins|incretins|mesh-ancestor
82751314|NCT02879409|Hormones|hormones|mesh-ancestor
82751315|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82751316|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82751317|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
82751318|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751319|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751320|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82751321|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82751322|NCT02546154|Hematinics|hematinics|mesh-ancestor
82751323|NCT03943095|Fluorides|fluorides|mesh-list
82751324|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
82751325|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
82751326|NCT03943095|Protective Agents|protective agents|mesh-ancestor
82751327|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751328|NCT00848640|Sorafenib|sorafenib|mesh-list
82751329|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751330|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82751331|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751332|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751333|NCT00968565|Citric Acid|citric acid|mesh-list
82751334|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
82751335|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
82751336|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82751337|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
82751338|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
82751339|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751340|NCT00848796|Heparin|heparin|mesh-list
82751341|NCT00848796|Calcium heparin|calcium heparin|mesh-list
82751342|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
82751343|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82751344|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82751345|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751346|NCT00965289|Rituximab|rituximab|mesh-list
82751347|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82751348|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751349|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
82751350|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751351|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751352|NCT04042506|Nivolumab|nivolumab|mesh-list
82751353|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82751354|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751355|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82751356|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751357|NCT00251641|Infliximab|infliximab|mesh-list
82751358|NCT00251641|Methotrexate|methotrexate|mesh-list
82751359|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82751360|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
82751361|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82751362|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751363|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82751364|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
82751365|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751366|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751367|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
82751368|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751369|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82751370|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751371|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
82751372|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751373|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82751374|NCT00251641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82751375|NCT00251641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82751376|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82751377|NCT00250705|Aripiprazole|aripiprazole|mesh-list
82751378|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
82751379|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82751380|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82751381|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82751382|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751383|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751384|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
82751385|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
82751386|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751387|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751388|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82751389|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82751390|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
82751391|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82751392|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82751393|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82751394|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82751395|NCT00849030|Tamoxifen|tamoxifen|mesh-list
82751396|NCT00849030|Anastrozole|anastrozole|mesh-list
82751397|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82751398|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
82751399|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82751400|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751401|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82751402|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751403|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82751404|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82751405|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82751406|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82751407|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82751408|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751409|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751410|NCT00842400|Metformin|metformin|mesh-list
82751411|NCT00842400|Probenecid|probenecid|mesh-list
82751412|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82751413|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751414|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
82751415|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
82751416|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751417|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
82751418|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751419|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751420|NCT00849264|Fluorouracil|fluorouracil|mesh-list
82751421|NCT00849264|Endostar protein|endostar protein|mesh-list
82751422|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
82751423|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751424|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82751425|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751426|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751427|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
82751428|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751429|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82751430|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82751431|NCT00849264|Growth Substances|growth substances|mesh-ancestor
82751432|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
82751433|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
82751434|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82751435|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751436|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82751437|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
82751438|NCT00842556|Glimepiride|glimepiride|mesh-list
82751439|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82751440|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751441|NCT00842556|Incretins|incretins|mesh-ancestor
82751442|NCT00842556|Hormones|hormones|mesh-ancestor
82751443|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82751444|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82751445|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
82751446|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751447|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751448|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82751449|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82751450|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751451|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
82751452|NCT00849966|Celecoxib|celecoxib|mesh-list
82751453|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82751454|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82751455|NCT00849966|Analgesics|analgesics|mesh-ancestor
82751456|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
82751457|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751458|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751459|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82751460|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751461|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82751462|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82751463|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751464|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751465|NCT00853008|Cytarabine|cytarabine|mesh-list
82751466|NCT00853008|Dexamethasone|dexamethasone|mesh-list
82751467|NCT00853008|Prednisone|prednisone|mesh-list
82751468|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
82751469|NCT00853008|Methotrexate|methotrexate|mesh-list
82751470|NCT00853008|Vincristine|vincristine|mesh-list
82751471|NCT00853008|Daunorubicin|daunorubicin|mesh-list
82751472|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
82751473|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
82751474|NCT00853008|Teniposide|teniposide|mesh-list
82751475|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82751476|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
82751477|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
82751478|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751479|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751480|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82751481|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
82751482|NCT00853008|Hormones|hormones|mesh-ancestor
82751483|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82751484|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82751485|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751486|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82751487|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
82751488|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82751489|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82751490|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
82751491|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751492|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
82751493|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751494|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82751495|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751496|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
82751497|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751498|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82751499|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
82751500|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751501|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82751502|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
82751503|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
82751504|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
82751505|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82751506|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82751507|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82751508|NCT00853008|Analgesics|analgesics|mesh-ancestor
82751509|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
82751510|NCT02545530|Clonidine|clonidine|mesh-list
82751511|NCT02545530|Analgesics|analgesics|mesh-ancestor
82751512|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
82751513|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751514|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751515|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82751516|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
82751517|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
82751518|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82751519|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82751520|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82751521|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
82751522|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751523|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751524|NCT00853320|Oxycodone|oxycodone|mesh-list
82751525|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82751526|NCT00853320|Narcotics|narcotics|mesh-ancestor
82751527|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751528|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751529|NCT00853320|Analgesics|analgesics|mesh-ancestor
82751530|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
82751531|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751532|NCT00547521|Methotrexate|methotrexate|mesh-list
82751533|NCT00547521|Abatacept|abatacept|mesh-list
82751534|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82751535|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
82751536|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82751537|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751538|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82751540|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751541|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751542|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
82751543|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751544|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82751545|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751546|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
82751547|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751548|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82751549|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82751550|NCT00547521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82751551|NCT00850044|Ritonavir|ritonavir|mesh-list
82751552|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82751553|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82751554|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
82751555|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751556|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751557|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82751558|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82751559|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
82751560|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751561|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82751562|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82751563|NCT00266227|Rituximab|rituximab|mesh-list
82751564|NCT00266227|Methotrexate|methotrexate|mesh-list
82751565|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82751566|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751567|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
82751568|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751569|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751570|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82751571|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
82751572|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82751573|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82751574|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
82751575|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751576|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
82751577|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751578|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82751579|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751580|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82751582|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
82751583|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751584|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751585|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751586|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82751587|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82751588|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82751589|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
82751590|NCT00968877|Vitamin D|vitamin d|mesh-list
82751591|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82751592|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751593|NCT00968877|Vitamins|vitamins|mesh-ancestor
82751594|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
82751595|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82751596|NCT00850122|Cefazolin|cefazolin|mesh-list
82751597|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82751598|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751599|NCT00968955|Ropivacaine|ropivacaine|mesh-list
82751600|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
82751601|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
82751602|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751603|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751604|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
82751605|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751606|NCT00853554|Hydromorphone|hydromorphone|mesh-list
82751607|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82751608|NCT00853554|Narcotics|narcotics|mesh-ancestor
82751609|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751610|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751611|NCT00853554|Analgesics|analgesics|mesh-ancestor
82751612|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
82751613|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751614|NCT00969033|Irinotecan|irinotecan|mesh-list
82751615|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82751616|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82751617|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751618|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751619|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751620|NCT00573768|Diclofenac|diclofenac|mesh-list
82751621|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82751622|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82751623|NCT00573768|Analgesics|analgesics|mesh-ancestor
82751698|NCT00854178|Anesthetics|anesthetics|mesh-list
82751624|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
82751625|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751626|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751627|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82751628|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751629|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82751630|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751631|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751632|NCT00965913|Nicotine|nicotine|mesh-list
82751633|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82751634|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
82751635|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751636|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751637|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82751638|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82751639|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
82751640|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751641|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751642|NCT00853866|Reboxetine|reboxetine|mesh-list
82751643|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
82751644|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82751645|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82751646|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82751647|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82751648|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751649|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
82751650|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751651|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751652|NCT00855660|Riociguat|riociguat|mesh-list
82751653|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
82751654|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751655|NCT00965991|Metformin|metformin|mesh-list
82751656|NCT00965991|Glyburide|glyburide|mesh-list
82751657|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82751658|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751659|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82751660|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82751661|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82751662|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751663|NCT00853944|Incretins|incretins|mesh-ancestor
82751664|NCT00853944|Hormones|hormones|mesh-ancestor
82751665|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82751666|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
82751667|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751668|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751669|NCT02545452|Anastrozole|anastrozole|mesh-list
82751670|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
82751671|NCT02545452|Nonoxynol|nonoxynol|mesh-list
82751672|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82751673|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751674|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82751675|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82751676|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751677|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751678|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82751679|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
82751680|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82751681|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751682|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82751683|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
82751684|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82751685|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82751686|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82751687|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82751688|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
82751689|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
82751690|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82751691|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
82751692|NCT00547365|Antibodies|antibodies|mesh-list
82751693|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
82751694|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82751695|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82751696|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
82751697|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751699|NCT00854178|Isoflurane|isoflurane|mesh-list
82751700|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751701|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751702|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
82751703|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82751704|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
82751705|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
82751706|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751707|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
82751708|NCT00850746|Z 338|z 338|mesh-list
82751709|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82751710|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751711|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82751712|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82751713|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751714|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751715|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751716|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751717|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82751718|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
82751719|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751720|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82751721|NCT00969813|Tofacitinib|tofacitinib|mesh-list
82751722|NCT00969813|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82751723|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82751724|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751725|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751726|NCT00854256|Mitomycins|mitomycins|mesh-list
82751727|NCT00854256|Mitomycin|mitomycin|mesh-list
82751728|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82751729|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751730|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
82751731|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751732|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82751733|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751734|NCT00855972|Naltrexone|naltrexone|mesh-list
82751735|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82751736|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82751737|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751738|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
82751739|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751740|NCT02544906|Propofol|propofol|mesh-list
82751741|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82751742|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751743|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751744|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82751745|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
82751746|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
82751747|NCT00861276|Nicotine|nicotine|mesh-list
82751748|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82751749|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
82751750|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751751|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751752|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82751753|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82751754|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
82751755|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751756|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751757|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82751758|NCT02544828|Hematinics|hematinics|mesh-ancestor
82751759|NCT00861510|ON 01910|on 01910|mesh-list
82751760|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751761|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82751762|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751763|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751764|NCT01095003|Capecitabine|capecitabine|mesh-list
82751765|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82751766|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
82751767|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751768|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751769|NCT00854646|ON 01910|on 01910|mesh-list
82751770|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751771|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82751772|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751773|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751775|NCT00856362|Midazolam|midazolam|mesh-list
82751776|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82751777|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82751778|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751779|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751780|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82751781|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82751782|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82751783|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82751784|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
82751785|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
82751786|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
82751787|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
82751788|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751789|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751790|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
82751791|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82751792|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751793|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
82751794|NCT00854802|Ribavirin|ribavirin|mesh-list
82751795|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82751796|NCT00854802|Cyclosporine|cyclosporine|mesh-list
82751797|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
82751798|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751799|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
82751800|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751801|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
82751802|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
82751803|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751804|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751805|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
82751806|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751807|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751808|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82751809|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
82751810|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82751811|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751812|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
82751813|NCT04119024|Fludarabine|fludarabine|mesh-list
82751814|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
82751815|NCT04119024|Interleukin-2|interleukin-2|mesh-list
82751816|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751817|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
82751818|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751819|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751820|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82751821|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
82751822|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751823|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751824|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82751825|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82751826|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
82751827|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82751828|NCT04119024|Analgesics|analgesics|mesh-ancestor
82751829|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
82751830|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751831|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
82751832|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82751833|NCT00966771|Copper|copper|mesh-list
82751834|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
82751835|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82751836|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
82751837|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82751838|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751839|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82751840|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82751841|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82751842|NCT00966771|Trace Elements|trace elements|mesh-ancestor
82751843|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
82751844|NCT00856596|Sertaconazole|sertaconazole|mesh-list
82751845|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
82751846|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751847|NCT00855114|Everolimus|everolimus|mesh-list
82751848|NCT00855114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82751849|NCT00855114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82751850|NCT00855114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751851|NCT00855114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751852|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751853|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
82751854|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751855|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751856|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
82751857|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82751858|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
82751859|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82751860|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
82751861|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751862|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751863|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82751864|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
82751865|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
82751866|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82751867|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
82751868|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751869|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751870|NCT00970905|Ondansetron|ondansetron|mesh-list
82751871|NCT00970905|Aprepitant|aprepitant|mesh-list
82751872|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
82751873|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
82751874|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751875|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751876|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82751877|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
82751878|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
82751879|NCT00970905|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82751880|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82751881|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
82751882|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751883|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751884|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82751885|NCT00619476|Gabapentin|gabapentin|mesh-list
82751886|NCT00619476|Analgesics|analgesics|mesh-ancestor
82751887|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
82751888|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751889|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751890|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
82751891|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82751892|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82751893|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751894|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82751895|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82751896|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82751897|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82751898|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751899|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
82751900|NCT00973713|Everolimus|everolimus|mesh-list
82751901|NCT00973713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82751902|NCT00973713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82751903|NCT00973713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751904|NCT00973713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751905|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82751906|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
82751907|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751908|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751909|NCT00857142|Oxymorphone|oxymorphone|mesh-list
82751910|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82751911|NCT00857142|Narcotics|narcotics|mesh-ancestor
82751912|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751913|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751914|NCT00857142|Analgesics|analgesics|mesh-ancestor
82751915|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
82751916|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751917|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82751919|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82751920|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
82751921|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82751922|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751923|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82751924|NCT00865176|Diuretics|diuretics|mesh-ancestor
82751925|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
82751926|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82751927|NCT00973869|Curcumin|curcumin|mesh-list
82752228|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
82751928|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82751929|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82751930|NCT00973869|Analgesics|analgesics|mesh-ancestor
82751931|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
82751932|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751933|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751934|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82751935|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751936|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751937|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751938|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751939|NCT00959439|Naproxen|naproxen|mesh-list
82751940|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82751941|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82751942|NCT00959439|Analgesics|analgesics|mesh-ancestor
82751943|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
82751944|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751945|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751946|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82751947|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751948|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
82751949|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82751950|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751951|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751952|NCT04041492|Vitamin D|vitamin d|mesh-list
82751953|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
82751954|NCT04041492|Vitamins|vitamins|mesh-ancestor
82751955|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
82751956|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751957|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82751958|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82751959|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
82751960|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
82751961|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751962|NCT00857376|Protective Agents|protective agents|mesh-ancestor
82751963|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751964|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
82751965|NCT00857376|Vitamins|vitamins|mesh-ancestor
82751966|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
82751967|NCT00618072|Metformin|metformin|mesh-list
82751968|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
82751969|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82751970|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751971|NCT00959517|Artesunate|artesunate|mesh-list
82751972|NCT00959517|Chloroquine|chloroquine|mesh-list
82751973|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
82751974|NCT00959517|Primaquine|primaquine|mesh-list
82751975|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
82751976|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82751977|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
82751978|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82751979|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82751980|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82751981|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82751982|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
82751983|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
82751984|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82751985|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
82751986|NCT00959517|Amebicides|amebicides|mesh-ancestor
82751987|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82751988|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82751989|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82751990|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82751991|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82751992|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82751994|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
82751995|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82751996|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751997|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
82751998|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82751999|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82752000|NCT00865410|Bupropion|bupropion|mesh-list
82752001|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82752002|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
82752003|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82752004|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82752005|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82752006|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82752007|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752008|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
82752009|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752010|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752011|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82752012|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82752013|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752014|NCT00974181|Paclitaxel|paclitaxel|mesh-list
82752015|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82752016|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82752017|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752018|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
82752019|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
82752020|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
82752021|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752022|NCT00971607|Sevoflurane|sevoflurane|mesh-list
82752023|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82752024|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82752025|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
82752026|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
82752027|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752028|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752029|NCT00971685|Dexamethasone|dexamethasone|mesh-list
82752030|NCT00971685|Lenalidomide|lenalidomide|mesh-list
82752031|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82752032|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
82752033|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
82752034|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752035|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752036|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82752037|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
82752038|NCT00971685|Hormones|hormones|mesh-ancestor
82752039|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752040|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82752041|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752042|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
82752043|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82752044|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82752045|NCT00971685|Growth Substances|growth substances|mesh-ancestor
82752046|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
82752047|NCT03861052|Dulaglutide|dulaglutide|mesh-list
82752048|NCT03861052|Tirzepatide|tirzepatide|mesh-list
82752049|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82752050|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752051|NCT03861052|Incretins|incretins|mesh-ancestor
82752052|NCT03861052|Hormones|hormones|mesh-ancestor
82752053|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752054|NCT00971763|Prednisolone|prednisolone|mesh-list
82752055|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
82752056|NCT00971763|Rituximab|rituximab|mesh-list
82752057|NCT00971763|Gemcitabine|gemcitabine|mesh-list
82752058|NCT00971763|Vincristine|vincristine|mesh-list
82752059|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752060|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
82752061|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752062|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82752063|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82752064|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
82752065|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752066|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752067|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82752068|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82752069|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82752070|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
82752071|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82752072|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
82752073|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
82752074|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
82752075|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82752076|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
82752077|NCT00971763|Hormones|hormones|mesh-ancestor
82752078|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752229|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752079|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82752081|NCT00781196|Hematinics|hematinics|mesh-ancestor
82752082|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
82752083|NCT00781196|Vitamins|vitamins|mesh-ancestor
82752084|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
82752085|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752086|NCT00865644|Imiquimod|imiquimod|mesh-list
82752087|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82752088|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
82752089|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752090|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752091|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
82752092|NCT00785330|Rituximab|rituximab|mesh-list
82752093|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82752094|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752095|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
82752096|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752097|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82752098|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82752099|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82752100|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752101|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82752102|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82752103|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82752104|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752105|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
82752106|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752107|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
82752108|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82752109|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82752110|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752111|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
82752112|NCT05279469|Coagulants|coagulants|mesh-ancestor
82752113|NCT00790946|Valsartan|valsartan|mesh-list
82752114|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82752115|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82752116|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82752117|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752118|NCT05179239|Paclitaxel|paclitaxel|mesh-list
82752119|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82752120|NCT05179239|Cisplatin|cisplatin|mesh-list
82752121|NCT05179239|Carboplatin|carboplatin|mesh-list
82752122|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82752123|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752124|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
82752125|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
82752126|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
82752127|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752129|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
82752130|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752131|NCT00972075|Protective Agents|protective agents|mesh-ancestor
82752132|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752133|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752134|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82752135|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82752136|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
82752137|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752138|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752139|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82752140|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
82752141|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
82752142|NCT00974805|Hormones|hormones|mesh-ancestor
82752143|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752144|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
82752145|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
82752146|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82752147|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
82752148|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
82752149|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752150|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752151|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82752152|NCT00781352|Analgesics|analgesics|mesh-ancestor
82752153|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
82752154|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752155|NCT00791024|Lidocaine|lidocaine|mesh-list
82752156|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
82752157|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
82752158|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752159|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752160|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
82752161|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752162|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82752163|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82752164|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82752165|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82752166|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752167|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82752168|NCT03897244|Amoxicillin|amoxicillin|mesh-list
82752169|NCT03897244|Metronidazole|metronidazole|mesh-list
82752170|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82752171|NCT03897244|Rabeprazole|rabeprazole|mesh-list
82752172|NCT03897244|Bismuth|bismuth|mesh-list
82752173|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82752174|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82752175|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
82752176|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82752177|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82752178|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82752179|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82752180|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752181|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752182|NCT03897244|Antacids|antacids|mesh-ancestor
82752183|NCT00666536|Amlodipine|amlodipine|mesh-list
82752184|NCT00666536|Valsartan|valsartan|mesh-list
82752185|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
82752186|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82752187|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82752188|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82752189|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752190|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82752191|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752192|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
82752193|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82752194|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82752195|NCT00519532|Rotigotine|rotigotine|mesh-list
82752196|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
82752197|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
82752198|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752199|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752200|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752201|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82752202|NCT00666458|Saxagliptin|saxagliptin|mesh-list
82752203|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82752204|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752205|NCT00666458|Incretins|incretins|mesh-ancestor
82752206|NCT00666458|Hormones|hormones|mesh-ancestor
82752207|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752208|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82752209|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
82752210|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752211|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752212|NCT00974961|Bupivacaine|bupivacaine|mesh-list
82752213|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
82752214|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
82752215|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
82752216|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752217|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752218|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
82752219|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752220|NCT00511108|Pioglitazone|pioglitazone|mesh-list
82752221|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82752222|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82752223|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752224|NCT00511108|Incretins|incretins|mesh-ancestor
82752225|NCT00511108|Hormones|hormones|mesh-ancestor
82752226|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752227|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82752230|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752231|NCT00781586|Caffeine|caffeine|mesh-list
82752232|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752233|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82752234|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82752235|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752236|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752237|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82752238|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82752239|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
82752240|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752241|NCT00510952|Insulin|insulin|mesh-list
82752242|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82752243|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
82752244|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
82752245|NCT00510952|Protamines|protamines|mesh-list
82752246|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82752247|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752248|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
82752249|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752250|NCT00510952|Coagulants|coagulants|mesh-ancestor
82752251|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
82752252|NCT00617604|Alefacept|alefacept|mesh-list
82752253|NCT00617604|Tacrolimus|tacrolimus|mesh-list
82752254|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752255|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
82752256|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752257|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82752258|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752259|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752260|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82752261|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752262|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82752263|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
82752264|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82752265|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82752266|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
82752267|NCT01012570|Adalimumab|adalimumab|mesh-list
82752268|NCT01012570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82752269|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82752270|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82752271|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82752272|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82752273|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
82752274|NCT00661622|Molgramostim|molgramostim|mesh-list
82752275|NCT00661622|Sargramostim|sargramostim|mesh-list
82752276|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
82752277|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752278|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752279|NCT00781820|Bifonazole|bifonazole|mesh-list
82752280|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
82752281|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82752282|NCT00786110|Paclitaxel|paclitaxel|mesh-list
82752283|NCT00786110|Sorafenib|sorafenib|mesh-list
82752284|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82752285|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752286|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
82752287|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
82752288|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
82752289|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752290|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82752291|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752292|NCT00791804|Fentanyl|fentanyl|mesh-list
82752293|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82752294|NCT00791804|Narcotics|narcotics|mesh-ancestor
82752295|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752296|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752297|NCT00791804|Analgesics|analgesics|mesh-ancestor
82752298|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
82752299|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752300|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82752301|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82752302|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
82752303|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
82752304|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
82752305|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
82752306|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
82752608|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
82752307|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752308|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752309|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82752310|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82752311|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
82752312|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
82752313|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752314|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752315|NCT00792350|Sorafenib|sorafenib|mesh-list
82752316|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752317|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82752318|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752319|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752320|NCT00792584|Efavirenz|efavirenz|mesh-list
82752321|NCT00792584|Etravirine|etravirine|mesh-list
82752322|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82752323|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82752324|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752325|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752326|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
82752327|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82752328|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82752329|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82752330|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82752331|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82752332|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82752333|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82752334|NCT00792662|Methylphenidate|methylphenidate|mesh-list
82752335|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82752336|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752337|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82752338|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82752339|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82752340|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752341|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
82752342|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752343|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
82752344|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82752345|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752346|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752347|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
82752348|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
82752349|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82752350|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
82752351|NCT04093752|Tirzepatide|tirzepatide|mesh-list
82752352|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82752353|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752354|NCT04093752|Incretins|incretins|mesh-ancestor
82752355|NCT04093752|Hormones|hormones|mesh-ancestor
82752356|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752357|NCT02544282|Acetaminophen|acetaminophen|mesh-list
82752358|NCT02544282|Sufentanil|sufentanil|mesh-list
82752359|NCT02544282|Tramadol|tramadol|mesh-list
82752360|NCT02544282|Pirinitramide|pirinitramide|mesh-list
82752361|NCT02544282|Propofol|propofol|mesh-list
82752362|NCT02544282|Sevoflurane|sevoflurane|mesh-list
82752363|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
82752364|NCT02544282|Atracurium|atracurium|mesh-list
82752365|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82752366|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752367|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752368|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82752369|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
82752370|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
82752371|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82752372|NCT02544282|Analgesics|analgesics|mesh-ancestor
82752373|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
82752374|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752375|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
82752376|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82752377|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82752378|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82752379|NCT02544282|Narcotics|narcotics|mesh-ancestor
82752380|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82752381|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
82752382|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82752383|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82752384|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82752385|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82752386|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82752387|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
82752388|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752389|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752391|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82752392|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82752393|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
82752394|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
82752395|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82752396|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
82752397|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752398|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752399|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82752400|NCT00663962|Pregabalin|pregabalin|mesh-list
82752401|NCT00663962|Analgesics|analgesics|mesh-ancestor
82752402|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
82752403|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752404|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752405|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
82752406|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82752407|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82752408|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752409|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82752410|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82752411|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82752412|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752413|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82752414|NCT00858624|Ketamine|ketamine|mesh-list
82752415|NCT00858624|Analgesics|analgesics|mesh-ancestor
82752416|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
82752417|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752418|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752419|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82752420|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82752421|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
82752422|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
82752423|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752424|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82752425|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82752426|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752427|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752428|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82752429|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82752430|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752431|NCT00960453|Incretins|incretins|mesh-ancestor
82752432|NCT00960453|Hormones|hormones|mesh-ancestor
82752433|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752434|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82752435|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
82752436|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752437|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752438|NCT00265759|Letrozole|letrozole|mesh-list
82752439|NCT00265759|Anastrozole|anastrozole|mesh-list
82752440|NCT00265759|Exemestane|exemestane|mesh-list
82752441|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752442|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82752443|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82752444|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752445|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752446|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82752447|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
82752448|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752449|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752450|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82752451|NCT00972387|Prednisone|prednisone|mesh-list
82752452|NCT00972387|Prednisolone|prednisolone|mesh-list
82752453|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
82752454|NCT00972387|Doxorubicin|doxorubicin|mesh-list
82752455|NCT00972387|Vincristine|vincristine|mesh-list
82752456|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752457|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
82752458|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752459|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82752460|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82752461|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
82752462|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752463|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752464|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82752465|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82752466|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82752467|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82752468|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752469|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82752470|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
82752472|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752473|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82752474|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82752475|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
82752476|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
82752477|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
82752478|NCT00744263|Vaccines|vaccines|mesh-list
82752479|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82752480|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
82752481|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752482|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
82752483|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82752484|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82752485|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
82752486|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752487|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752488|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752489|NCT00866736|Dasatinib|dasatinib|mesh-list
82752490|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752491|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82752492|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752493|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752494|NCT00792818|Ibuprofen|ibuprofen|mesh-list
82752495|NCT00792818|Curcumin|curcumin|mesh-list
82752496|NCT00792818|Turmeric extract|turmeric extract|mesh-list
82752497|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82752498|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82752499|NCT00792818|Analgesics|analgesics|mesh-ancestor
82752500|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
82752501|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752502|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752503|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82752504|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82752505|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82752506|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752507|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752508|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752509|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
82752510|NCT00792818|Protective Agents|protective agents|mesh-ancestor
82752511|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
82752512|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82752513|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752514|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
82752515|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752517|NCT00975351|Vitamins|vitamins|mesh-ancestor
82752518|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
82752519|NCT01071187|Varenicline|varenicline|mesh-list
82752520|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82752521|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82752522|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
82752523|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752524|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752525|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752526|NCT00618774|Amlodipine|amlodipine|mesh-list
82752527|NCT00618774|Telmisartan|telmisartan|mesh-list
82752528|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82752529|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82752530|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82752531|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752532|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82752533|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752534|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
82752535|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82752536|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82752537|NCT00917345|Captopril|captopril|mesh-list
82752538|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82752539|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
82752540|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752541|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752542|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82752543|NCT00793052|Dexamethasone|dexamethasone|mesh-list
82752544|NCT00793052|Etoricoxib|etoricoxib|mesh-list
82752545|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82752546|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
82752547|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
82752548|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752549|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752550|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82752551|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
82752552|NCT00793052|Hormones|hormones|mesh-ancestor
82752553|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752554|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82752555|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752556|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82752557|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82752558|NCT00793052|Analgesics|analgesics|mesh-ancestor
82752559|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
82752560|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82752561|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82752562|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82752563|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752564|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752565|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
82752566|NCT02555852|Esomeprazole|esomeprazole|mesh-list
82752567|NCT02555852|Omeprazole|omeprazole|mesh-list
82752568|NCT02555852|Rabeprazole|rabeprazole|mesh-list
82752569|NCT02555852|Pantoprazole|pantoprazole|mesh-list
82752570|NCT02555852|Lansoprazole|lansoprazole|mesh-list
82752571|NCT02555852|Famotidine|famotidine|mesh-list
82752572|NCT02555852|Ranitidine|ranitidine|mesh-list
82752573|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
82752574|NCT02555852|Cimetidine|cimetidine|mesh-list
82752575|NCT02555852|Nizatidine|nizatidine|mesh-list
82752576|NCT02555852|Lafutidine|lafutidine|mesh-list
82752577|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
82752578|NCT02555852|Bismuth|bismuth|mesh-list
82752579|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82752580|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
82752581|NCT02555852|Histamine|histamine|mesh-list
82752582|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
82752583|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752584|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82752585|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82752586|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752587|NCT02555852|Antacids|antacids|mesh-ancestor
82752588|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
82752589|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
82752590|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752591|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752592|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
82752593|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82752594|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82752595|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82752596|NCT04091009|Buprenorphine|buprenorphine|mesh-list
82752597|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82752598|NCT04091009|Naloxone|naloxone|mesh-list
82752599|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82752600|NCT04091009|Narcotics|narcotics|mesh-ancestor
82752601|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752602|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752603|NCT04091009|Analgesics|analgesics|mesh-ancestor
82752604|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
82752605|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752606|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82752607|NCT02597231|Melatonin|melatonin|mesh-list
82752609|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752610|NCT02597231|Protective Agents|protective agents|mesh-ancestor
82752611|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752612|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752613|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
82752614|NCT00545571|Hematinics|hematinics|mesh-ancestor
82752615|NCT00783380|Vaccines|vaccines|mesh-list
82752616|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
82752617|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752618|NCT04008225|Dimercaprol|dimercaprol|mesh-list
82752619|NCT04008225|Chelating Agents|chelating agents|mesh-ancestor
82752620|NCT04008225|Sequestering Agents|sequestering agents|mesh-ancestor
82752621|NCT04008225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752622|NCT00748709|Afatinib|afatinib|mesh-list
82752623|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752624|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82752625|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752626|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752627|NCT02597309|Canagliflozin|canagliflozin|mesh-list
82752628|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82752629|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752630|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82752631|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752632|NCT00863148|Busulfan|busulfan|mesh-list
82752633|NCT00863148|Clofarabine|clofarabine|mesh-list
82752634|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
82752635|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752636|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752637|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
82752638|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752639|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82752640|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752641|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82752642|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82752643|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
82752644|NCT00786734|Pitavastatin|pitavastatin|mesh-list
82752645|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82752646|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82752647|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82752648|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
82752649|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752650|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752651|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82752652|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
82752653|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82752654|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752655|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752656|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82752657|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82752658|NCT00867126|Pioglitazone|pioglitazone|mesh-list
82752659|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82752660|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752661|NCT00748553|Paclitaxel|paclitaxel|mesh-list
82752662|NCT00748553|Azacitidine|azacitidine|mesh-list
82752663|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82752664|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82752665|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752666|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
82752667|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
82752669|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752670|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82752671|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
82752672|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752673|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
82752674|NCT00661388|Hematinics|hematinics|mesh-ancestor
82752675|NCT00972855|Bicalutamide|bicalutamide|mesh-list
82752676|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
82752677|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
82752678|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752679|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752680|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752681|NCT00972933|Ipilimumab|ipilimumab|mesh-list
82752682|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82752683|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752684|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82752685|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752686|NCT00263575|Fentanyl|fentanyl|mesh-list
82752687|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82752688|NCT00263575|Narcotics|narcotics|mesh-ancestor
82752689|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752690|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752691|NCT00263575|Analgesics|analgesics|mesh-ancestor
82752692|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
82752693|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752694|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82752695|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82752696|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
82752697|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
82752698|NCT00975663|Tacrolimus|tacrolimus|mesh-list
82752699|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752700|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
82752701|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752702|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82752703|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752704|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752705|NCT00570128|Donepezil|donepezil|mesh-list
82752706|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82752707|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752708|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752709|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
82752710|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752711|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752712|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
82752713|NCT00960921|Iron|iron|mesh-list
82752714|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82752715|NCT00960921|Trace Elements|trace elements|mesh-ancestor
82752716|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
82752717|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752718|NCT00960921|Hematinics|hematinics|mesh-ancestor
82752719|NCT00863460|Cytarabine|cytarabine|mesh-list
82752720|NCT00863460|Prednisone|prednisone|mesh-list
82752721|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
82752722|NCT00863460|Busulfan|busulfan|mesh-list
82752723|NCT00863460|Thiotepa|thiotepa|mesh-list
82752724|NCT00863460|Carmustine|carmustine|mesh-list
82752725|NCT00863460|Methotrexate|methotrexate|mesh-list
82752726|NCT00863460|Etoposide|etoposide|mesh-list
82752727|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752728|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
82752729|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752730|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82752731|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82752732|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
82752733|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752734|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752735|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82752736|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82752737|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
82752738|NCT00863460|Hormones|hormones|mesh-ancestor
82752739|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752740|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82752741|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82752742|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
82752743|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82752744|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82752745|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
82752746|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
82752747|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752748|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82752749|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82752750|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82752751|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82752752|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82752753|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
82752754|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82752755|NCT00262951|Interferons|interferons|mesh-list
82752756|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
82752757|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
82752758|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82752759|NCT00262951|Cisplatin|cisplatin|mesh-list
82752760|NCT00262951|Fluorouracil|fluorouracil|mesh-list
82752761|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752762|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
82752763|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752764|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82752765|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752766|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
82752767|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752768|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
82752769|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82752770|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
82752771|NCT02597153|Analgesics|analgesics|mesh-ancestor
82752772|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
82752773|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752774|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752775|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752776|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82752777|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82752778|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752779|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752780|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
82752781|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82752782|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
82752783|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82752785|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752786|NCT00975819|Sirolimus|sirolimus|mesh-list
82752787|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82752788|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82752789|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82752790|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752791|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
82752792|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752793|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
82752794|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752795|NCT00859872|Haloperidol|haloperidol|mesh-list
82752796|NCT00859872|Risperidone|risperidone|mesh-list
82752797|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
82752798|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82752799|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
82752800|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752801|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752802|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752803|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82752804|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82752805|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752806|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82752807|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82752808|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
82752809|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
82752810|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
82752811|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752812|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82752813|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82752814|NCT02555696|Paclitaxel|paclitaxel|mesh-list
82752815|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82752816|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752817|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
82752818|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
82752819|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
82752820|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752821|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
82752822|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752823|NCT05147493|Dexamethasone|dexamethasone|mesh-list
82752824|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
82752825|NCT05147493|Lenalidomide|lenalidomide|mesh-list
82752827|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752828|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
82752829|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752830|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82752831|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82752832|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
82752833|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752834|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752835|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82752836|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82752837|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
82752838|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
82752839|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752840|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82752841|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
82752842|NCT05147493|Hormones|hormones|mesh-ancestor
82752843|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752844|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82752845|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82752846|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82752847|NCT05147493|Growth Substances|growth substances|mesh-ancestor
82752848|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
82752849|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82752850|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82752851|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752852|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82752853|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82752854|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82752855|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752856|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
82752857|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752858|NCT03974425|Aflibercept|aflibercept|mesh-list
82752859|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82752860|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82752861|NCT03974425|Growth Substances|growth substances|mesh-ancestor
82752862|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752863|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
82752864|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752865|NCT00975897|Leucovorin|leucovorin|mesh-list
82752866|NCT00975897|Bevacizumab|bevacizumab|mesh-list
82752867|NCT00975897|Cetuximab|cetuximab|mesh-list
82752868|NCT00975897|Fluorouracil|fluorouracil|mesh-list
82752869|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
82752870|NCT00975897|Irinotecan|irinotecan|mesh-list
82752871|NCT00975897|Calcium|calcium|mesh-list
82752872|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
82752873|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82752874|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752875|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82752876|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82752877|NCT00975897|Growth Substances|growth substances|mesh-ancestor
82752878|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752879|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
82752880|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82752881|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
82752882|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752883|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82752884|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752885|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
82752886|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82752887|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82752888|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752889|NCT00975897|Antidotes|antidotes|mesh-ancestor
82752890|NCT00975897|Protective Agents|protective agents|mesh-ancestor
82752891|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
82752892|NCT00975897|Vitamins|vitamins|mesh-ancestor
82752893|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
82752894|NCT00867672|Decitabine|decitabine|mesh-list
82752895|NCT00867672|Tretinoin|tretinoin|mesh-list
82752896|NCT00867672|Valproic Acid|valproic acid|mesh-list
82752897|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82752898|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
82752899|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752900|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82752901|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752902|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
82752903|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
82752904|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
82752905|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
82752906|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752907|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752908|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
82752909|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82752910|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752911|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82752912|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
82752913|NCT00783926|Vaccines|vaccines|mesh-list
82752914|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
82752915|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752916|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
82752917|NCT00783926|Coagulants|coagulants|mesh-ancestor
82752918|NCT01071499|Morphine|morphine|mesh-list
82752919|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82752920|NCT01071499|Narcotics|narcotics|mesh-ancestor
82752921|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82752922|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752923|NCT01071499|Analgesics|analgesics|mesh-ancestor
82752924|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
82752925|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752926|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
82752927|NCT00961155|Montelukast|montelukast|mesh-list
82752928|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82752929|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
82752930|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752931|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752932|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82752933|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
82752934|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82752935|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82752936|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82752937|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
82752938|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752939|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752940|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82752941|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
82752942|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82752943|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82752944|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82752945|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82752946|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82752947|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82752948|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82752949|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752950|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
82752951|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752952|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752953|NCT00973245|Warfarin|warfarin|mesh-list
82752954|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
82752955|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
82752956|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82752957|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
82752958|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82752959|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
82752960|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752961|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752962|NCT00793754|Aspirin|aspirin|mesh-list
82752963|NCT00793754|Atorvastatin|atorvastatin|mesh-list
82752964|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82752965|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82752966|NCT00793754|Analgesics|analgesics|mesh-ancestor
82752967|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
82752968|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752969|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752970|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82752971|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82752972|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82752973|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82752974|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752975|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82752976|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82752977|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82752978|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
82752979|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82752980|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82752981|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
82752982|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82752983|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82752984|NCT02596763|Baclofen|baclofen|mesh-list
82752985|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82752986|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82752987|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82752988|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82752989|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82752990|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
82752991|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
82752992|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82752993|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82752994|NCT00973323|Warfarin|warfarin|mesh-list
82752995|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
82752996|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
82752997|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82752998|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
82752999|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82753000|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
82753001|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753002|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753003|NCT00793988|Anesthetics|anesthetics|mesh-list
82753004|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753005|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753006|NCT00973401|Insulin|insulin|mesh-list
82753007|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82753008|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753009|NCT04040322|Iloprost|iloprost|mesh-list
82753010|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82753011|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
82753012|NCT00787436|Thalidomide|thalidomide|mesh-list
82753013|NCT00787436|Timolol|timolol|mesh-list
82753014|NCT00787436|Propranolol|propranolol|mesh-list
82753015|NCT00787436|Nadolol|nadolol|mesh-list
82753016|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82753017|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
82753018|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753019|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
82753020|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82753021|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753022|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82753023|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82753024|NCT00787436|Growth Substances|growth substances|mesh-ancestor
82753025|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
82753026|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753027|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82753028|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82753029|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
82753030|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82753031|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753032|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82753033|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82753034|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
82753035|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
82753036|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
82753037|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753038|NCT03945981|Lamivudine|lamivudine|mesh-list
82753039|NCT03945981|Dolutegravir|dolutegravir|mesh-list
82753040|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82753041|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82753042|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753043|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753044|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
82753045|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753046|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82753047|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82753048|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82753049|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82753050|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
82753051|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753052|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
82753053|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753054|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753055|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82753056|NCT00979563|Irinotecan|irinotecan|mesh-list
82753057|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82753058|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82753059|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753060|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753061|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753062|NCT00745901|Drospirenone|drospirenone|mesh-list
82753063|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82753064|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82753065|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82753066|NCT00745901|Norgestimate|norgestimate|mesh-list
82753067|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
82753068|NCT00745901|Estradiol|estradiol|mesh-list
82753069|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82753070|NCT00745901|Estrogens|estrogens|mesh-ancestor
82753071|NCT00745901|Hormones|hormones|mesh-ancestor
82753072|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753073|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753074|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82753075|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
82753076|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82753077|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82753078|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82753079|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82753080|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82753081|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
82753082|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82753083|NCT00745901|Diuretics|diuretics|mesh-ancestor
82753084|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
82753085|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82753086|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82753087|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82753088|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
82753089|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753090|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753091|NCT00860340|Spironolactone|spironolactone|mesh-list
82753092|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82753093|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
82753094|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753095|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753096|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82753097|NCT00860340|Diuretics|diuretics|mesh-ancestor
82753098|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
82753099|NCT00784316|Metoprolol|metoprolol|mesh-list
82753100|NCT00784316|Amiodarone|amiodarone|mesh-list
82753101|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82753102|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82753103|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
82753104|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
82753105|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753106|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753107|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82753108|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82753109|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82753110|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
82753111|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82753112|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753113|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
82753114|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82753115|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82753116|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82753117|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82753118|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82753119|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753120|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82753121|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82753122|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82753124|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82753125|NCT00286429|Alogliptin|alogliptin|mesh-list
82753126|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82753127|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753128|NCT00286429|Incretins|incretins|mesh-ancestor
82753129|NCT00286429|Hormones|hormones|mesh-ancestor
82753130|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753131|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82753132|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
82753133|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753134|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753135|NCT00665444|Aripiprazole|aripiprazole|mesh-list
82753136|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
82753137|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82753138|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82753139|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82753140|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753141|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753142|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
82753143|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
82753144|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82753145|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753146|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82753147|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82753148|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
82753149|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82753150|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82753151|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82753152|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82753153|NCT00864006|Valproic Acid|valproic acid|mesh-list
82753154|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
82753155|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753156|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753157|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
82753158|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82753159|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753160|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
82753161|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82753162|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753163|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82753164|NCT00860496|Cyclosporine|cyclosporine|mesh-list
82753165|NCT00860496|Tacrolimus|tacrolimus|mesh-list
82753166|NCT00860496|Cyclosporins|cyclosporins|mesh-list
82753167|NCT00860496|Tofacitinib|tofacitinib|mesh-list
82753168|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82753169|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
82753170|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753171|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82753172|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753173|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753174|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
82753175|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753176|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
82753177|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82753178|NCT00860496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82753179|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82753180|NCT00864162|Ramipril|ramipril|mesh-list
82753181|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82753182|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
82753183|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753184|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753185|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82753186|NCT00787826|Vaccines|vaccines|mesh-list
82753187|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
82753188|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753189|NCT00795314|Fentanyl|fentanyl|mesh-list
82753190|NCT00795314|Butorphanol|butorphanol|mesh-list
82753191|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82753192|NCT00795314|Narcotics|narcotics|mesh-ancestor
82753193|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753194|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753195|NCT00795314|Analgesics|analgesics|mesh-ancestor
82753196|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
82753197|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753198|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82753199|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82753200|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
82753201|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
82753202|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
82753203|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
82753204|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82753205|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82753206|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
82753207|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753209|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82753210|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
82753211|NCT00864240|Hormones|hormones|mesh-ancestor
82753212|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753213|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753214|NCT00979641|Docetaxel|docetaxel|mesh-list
82753215|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753216|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
82753217|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
82753218|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
82753219|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753220|NCT00864318|Paclitaxel|paclitaxel|mesh-list
82753221|NCT00864318|Etoposide|etoposide|mesh-list
82753222|NCT00864318|Ifosfamide|ifosfamide|mesh-list
82753223|NCT00864318|Carboplatin|carboplatin|mesh-list
82753224|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82753225|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753226|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
82753227|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
82753228|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
82753229|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753230|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82753231|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82753232|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753233|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82753234|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
82753235|NCT00788060|Everolimus|everolimus|mesh-list
82753236|NCT00788060|Sunitinib|sunitinib|mesh-list
82753237|NCT00788060|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82753238|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82753239|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753240|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753241|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82753242|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
82753243|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753244|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753245|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82753246|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82753247|NCT00788060|Growth Substances|growth substances|mesh-ancestor
82753248|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
82753249|NCT00788138|Vitamin D|vitamin d|mesh-list
82753250|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
82753251|NCT00788138|Vitamins|vitamins|mesh-ancestor
82753252|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
82753253|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753254|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82753255|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82753256|NCT00864396|Lansoprazole|lansoprazole|mesh-list
82753257|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82753258|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82753259|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82753260|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753261|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753262|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
82753263|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82753264|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82753265|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82753266|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
82753267|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753268|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82753269|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82753270|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753271|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753272|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82753273|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82753274|NCT00961467|Thalidomide|thalidomide|mesh-list
82753275|NCT00961467|Prednisone|prednisone|mesh-list
82753276|NCT00961467|Melphalan|melphalan|mesh-list
82753277|NCT00961467|Lenalidomide|lenalidomide|mesh-list
82753278|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82753279|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
82753280|NCT00961467|Hormones|hormones|mesh-ancestor
82753281|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753282|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753283|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82753284|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753285|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82753286|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
82753287|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753288|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82753289|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82753290|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
82753291|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82753292|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82753293|NCT00961467|Growth Substances|growth substances|mesh-ancestor
82753294|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
82753295|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
82753296|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82753297|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753298|NCT00980031|Eplerenone|eplerenone|mesh-list
82753299|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82753300|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
82753301|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753302|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753303|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82753304|NCT00980031|Diuretics|diuretics|mesh-ancestor
82753305|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
82753306|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82753307|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
82753308|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82753309|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753310|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82753311|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753312|NCT00980109|Oseltamivir|oseltamivir|mesh-list
82753313|NCT00980109|Zanamivir|zanamivir|mesh-list
82753314|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
82753315|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753316|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753317|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753318|NCT04988841|Nivolumab|nivolumab|mesh-list
82753319|NCT04988841|Ipilimumab|ipilimumab|mesh-list
82753320|NCT04988841|Laxatives|laxatives|mesh-list
82753321|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82753322|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82753323|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753324|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82753325|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753326|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82753327|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82753328|NCT00980187|Indapamide|indapamide|mesh-list
82753329|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82753330|NCT00980187|Diuretics|diuretics|mesh-ancestor
82753331|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
82753332|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753333|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82753334|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82753335|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753336|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
82753337|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82753338|NCT00284089|Ranibizumab|ranibizumab|mesh-list
82753339|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82753340|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82753341|NCT00284089|Growth Substances|growth substances|mesh-ancestor
82753342|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753343|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
82753344|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753346|NCT00984633|Propofol|propofol|mesh-list
82753347|NCT00984633|Sevoflurane|sevoflurane|mesh-list
82753348|NCT00984633|Rocuronium|rocuronium|mesh-list
82753349|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82753350|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753351|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753352|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82753353|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
82753354|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
82753355|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82753356|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82753357|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
82753358|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82753359|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82753360|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82753361|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753362|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82753363|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753364|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753365|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753366|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82753367|NCT00976755|Everolimus|everolimus|mesh-list
82753368|NCT00976755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82753369|NCT00976755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82753370|NCT00976755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753371|NCT00976755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753372|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82753373|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
82753374|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753375|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753376|NCT00864474|Maraviroc|maraviroc|mesh-list
82753377|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82753378|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82753379|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753380|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82753381|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82753382|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
82753383|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753384|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82753385|NCT00283387|Betaine|betaine|mesh-list
82753386|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82753387|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
82753388|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82753389|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
82753390|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753391|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82753392|NCT00788294|Tanezumab|tanezumab|mesh-list
82753393|NCT00788294|Analgesics|analgesics|mesh-ancestor
82753394|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
82753395|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753396|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753397|NCT00795548|Azacitidine|azacitidine|mesh-list
82753398|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82753399|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
82753400|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753401|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753402|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753403|NCT00282919|Azithromycin|azithromycin|mesh-list
82753404|NCT00282919|Chloroquine|chloroquine|mesh-list
82753405|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82753406|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753407|NCT00282919|Amebicides|amebicides|mesh-ancestor
82753408|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82753409|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82753410|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
82753411|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82753412|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82753413|NCT00984789|Gestodene|gestodene|mesh-list
82753414|NCT00984789|Norelgestromin|norelgestromin|mesh-list
82753415|NCT00984789|Femovan|femovan|mesh-list
82753416|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82753417|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82753418|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82753419|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
82753420|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82753421|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753422|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82753423|NCT00984789|Estrogens|estrogens|mesh-ancestor
82753424|NCT00984789|Hormones|hormones|mesh-ancestor
82753425|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753426|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82753427|NCT00984789|Progestins|progestins|mesh-ancestor
82753428|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82753430|NCT00864552|Coagulants|coagulants|mesh-ancestor
82753431|NCT04046822|Liraglutide|liraglutide|mesh-list
82753432|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82753433|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753434|NCT04046822|Incretins|incretins|mesh-ancestor
82753435|NCT04046822|Hormones|hormones|mesh-ancestor
82753436|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753437|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82753438|NCT04007835|Gefitinib|gefitinib|mesh-list
82753439|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753440|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82753441|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753442|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753443|NCT00800930|Butyric Acid|butyric acid|mesh-list
82753444|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
82753445|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
82753446|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82753447|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753448|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753449|NCT00868062|Polygeline|polygeline|mesh-list
82753450|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
82753451|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
82753452|NCT00742859|Warfarin|warfarin|mesh-list
82753453|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
82753454|NCT00742859|Betrixaban|betrixaban|mesh-list
82753455|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
82753456|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82753457|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
82753458|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82753459|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
82753460|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753461|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753462|NCT00742781|Vitamin D|vitamin d|mesh-list
82753463|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
82753464|NCT00742781|Vitamins|vitamins|mesh-ancestor
82753465|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
82753466|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753467|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82753468|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82753469|NCT00280735|Carboplatin|carboplatin|mesh-list
82753470|NCT00280735|Docetaxel|docetaxel|mesh-list
82753471|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753472|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
82753473|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
82753474|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
82753475|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753476|NCT03975283|Bupivacaine|bupivacaine|mesh-list
82753477|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
82753478|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
82753479|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753480|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753481|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
82753482|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753483|NCT01070407|Cloricromen|cloricromen|mesh-list
82753484|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82753485|NCT00801086|Ethanol|ethanol|mesh-list
82753486|NCT00801086|Tempol|tempol|mesh-list
82753487|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82753488|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753489|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753490|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753491|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
82753492|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753493|NCT00801086|Protective Agents|protective agents|mesh-ancestor
82753494|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82753495|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753496|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82753497|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82753498|NCT00788606|Bevacizumab|bevacizumab|mesh-list
82753499|NCT00788606|Rituximab|rituximab|mesh-list
82753500|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82753501|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753502|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82753503|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82753504|NCT00788606|Growth Substances|growth substances|mesh-ancestor
82753505|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753506|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
82753507|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
82753508|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82753509|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
82753510|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
82753511|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82753512|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82753513|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753514|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753515|NCT00795938|Urological Agents|urological agents|mesh-ancestor
82753516|NCT00260065|Decitabine|decitabine|mesh-list
82753517|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82753518|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
82753519|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753520|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753521|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753522|NCT01071655|Fluorouracil|fluorouracil|mesh-list
82753523|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
82753524|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753525|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82753526|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753527|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82753528|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
82753529|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753530|NCT02531581|Furosemide|furosemide|mesh-list
82753531|NCT02531581|Diuretics|diuretics|mesh-list
82753532|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
82753533|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753534|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82753535|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82753536|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753537|NCT04046510|Oxytocin|oxytocin|mesh-list
82753538|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
82753539|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82753540|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753541|NCT00506350|Vaccines|vaccines|mesh-list
82753542|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
82753543|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753544|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
82753545|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
82753546|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
82753547|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82753548|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753549|NCT00742625|Cytarabine|cytarabine|mesh-list
82753550|NCT00742625|Bortezomib|bortezomib|mesh-list
82753551|NCT00742625|Daunorubicin|daunorubicin|mesh-list
82753552|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82753553|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
82753554|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753555|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753556|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
82753557|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753558|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82753559|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
82753560|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753561|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82753562|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82753563|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82753564|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753565|NCT00801788|Oxycodone|oxycodone|mesh-list
82753566|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82753567|NCT00801788|Narcotics|narcotics|mesh-ancestor
82753568|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753569|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753570|NCT00801788|Analgesics|analgesics|mesh-ancestor
82753571|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
82753572|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753573|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
82753574|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753575|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
82753576|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82753577|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82753578|NCT00796250|Prednisolone|prednisolone|mesh-list
82753579|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82753580|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
82753581|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82753582|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
82753583|NCT00796250|Infliximab|infliximab|mesh-list
82753584|NCT00796250|Azathioprine|azathioprine|mesh-list
82753585|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82753586|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
82753587|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82753588|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
82753589|NCT00796250|Hormones|hormones|mesh-ancestor
82753590|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753591|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753592|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82753593|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753594|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
82753595|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
82753596|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753597|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82753598|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82753599|NCT00796250|Protective Agents|protective agents|mesh-ancestor
82753600|NCT00796250|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82753601|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
82753602|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82753603|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
82753604|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753605|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82753606|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82753607|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
82753608|NCT00788918|Interferons|interferons|mesh-list
82753609|NCT00788918|Ribavirin|ribavirin|mesh-list
82753610|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753611|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
82753612|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753613|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
82753614|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753615|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
82753616|NCT02596373|Analgesics|analgesics|mesh-ancestor
82753617|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
82753618|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753619|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753620|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753621|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82753622|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82753623|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753624|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753625|NCT00801866|Bevacizumab|bevacizumab|mesh-list
82753626|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82753627|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753628|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82753629|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82753630|NCT00801866|Growth Substances|growth substances|mesh-ancestor
82753631|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753632|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
82753633|NCT03973879|Atezolizumab|atezolizumab|mesh-list
82753634|NCT03973879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82753635|NCT03973879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753636|NCT03973879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82753637|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753638|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82753639|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82753640|NCT00860964|Estradiol|estradiol|mesh-list
82753641|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82753642|NCT00860964|Estrogens|estrogens|mesh-ancestor
82753643|NCT00860964|Hormones|hormones|mesh-ancestor
82753644|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753645|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753646|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82753647|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
82753648|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82753649|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82753651|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
82753652|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82753653|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82753654|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82753655|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753656|NCT04088903|Daratumumab|daratumumab|mesh-list
82753657|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753658|NCT00861120|Doxorubicin|doxorubicin|mesh-list
82753659|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82753660|NCT00861120|Panitumumab|panitumumab|mesh-list
82753661|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82753662|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753663|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82753664|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82753665|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753666|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753667|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82753668|NCT00740051|Glimepiride|glimepiride|mesh-list
82753669|NCT00740051|Linagliptin|linagliptin|mesh-list
82753670|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82753671|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82753672|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753673|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82753674|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
82753675|NCT00740051|Incretins|incretins|mesh-ancestor
82753676|NCT00740051|Hormones|hormones|mesh-ancestor
82753677|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753678|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82753679|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
82753680|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753681|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753682|NCT00864864|Sunitinib|sunitinib|mesh-list
82753683|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753684|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82753685|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82753686|NCT00864864|Growth Substances|growth substances|mesh-ancestor
82753687|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753688|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
82753689|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82753690|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753691|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753692|NCT00868764|Granisetron|granisetron|mesh-list
82753693|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
82753694|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
82753695|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753696|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753697|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82753698|NCT00868764|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82753699|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82753700|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
82753701|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82753702|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753703|NCT00518986|Modafinil|modafinil|mesh-list
82753704|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82753705|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753706|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82753707|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82753708|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82753709|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753710|NCT00864942|Lenalidomide|lenalidomide|mesh-list
82753711|NCT00864942|Rituximab|rituximab|mesh-list
82753712|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82753713|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
82753714|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753715|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82753716|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82753717|NCT00864942|Growth Substances|growth substances|mesh-ancestor
82753718|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
82753719|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753720|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82753721|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82753722|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82753723|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
82753724|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753725|NCT00870402|Spironolactone|spironolactone|mesh-list
82753726|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82753727|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
82753728|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753729|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753730|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82753731|NCT00870402|Diuretics|diuretics|mesh-ancestor
82753732|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
82753733|NCT00742235|Vitamin D|vitamin d|mesh-list
82753734|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
82753735|NCT00742235|Vitamins|vitamins|mesh-ancestor
82753736|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
82753737|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753738|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82753739|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82753740|NCT00742079|Cycloserine|cycloserine|mesh-list
82753741|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82753742|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753743|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82753744|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
82753745|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82753746|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
82753747|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753748|NCT04730362|Propofol|propofol|mesh-list
82753749|NCT04730362|Sevoflurane|sevoflurane|mesh-list
82753750|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
82753751|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753752|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753753|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82753754|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82753755|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
82753756|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82753757|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82753758|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
82753759|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82753760|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82753761|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
82753762|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753763|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753764|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82753765|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
82753766|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
82753767|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82753768|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
82753769|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82753770|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753771|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82753772|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82753773|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82753774|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
82753775|NCT00870480|Finasteride|finasteride|mesh-list
82753776|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82753777|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82753778|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753779|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753780|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
82753781|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753782|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753783|NCT00870480|Urological Agents|urological agents|mesh-ancestor
82753784|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
82753785|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753786|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82753787|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82753788|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82753789|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82753790|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
82753791|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82753792|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753793|NCT00616902|Vitamins|vitamins|mesh-ancestor
82753794|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
82753795|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82753796|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
82753797|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82753798|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82753799|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
82753800|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82753801|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753802|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753803|NCT00801944|Urological Agents|urological agents|mesh-ancestor
82753804|NCT00870636|Bevacizumab|bevacizumab|mesh-list
82753805|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82753806|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753807|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82753808|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82753809|NCT00870636|Growth Substances|growth substances|mesh-ancestor
82753810|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753811|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
82753812|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
82753813|NCT00870714|Ketoconazole|ketoconazole|mesh-list
82753814|NCT00870714|Docetaxel|docetaxel|mesh-list
82753815|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753816|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
82753817|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
82753818|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
82753819|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753820|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
82753821|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753822|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82753823|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82753824|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753825|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82753826|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
82753827|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753828|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753829|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82753830|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82753831|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
82753832|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753833|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
82753834|NCT02598011|Flucytosine|flucytosine|mesh-list
82753835|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
82753836|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753837|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
82753838|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753839|NCT00869310|Dexamethasone|dexamethasone|mesh-list
82753840|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
82753841|NCT00869310|Aprepitant|aprepitant|mesh-list
82753842|NCT00869310|Metoclopramide|metoclopramide|mesh-list
82753843|NCT00869310|BB 1101|bb 1101|mesh-list
82753844|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82753845|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
82753846|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
82753847|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753848|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753849|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82753850|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
82753851|NCT00869310|Hormones|hormones|mesh-ancestor
82753852|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753853|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82753854|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753855|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
82753856|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753857|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753858|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82753859|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82753860|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82753861|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82753862|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
82753863|NCT00662558|Celecoxib|celecoxib|mesh-list
82753864|NCT00662558|Tramadol|tramadol|mesh-list
82753865|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82753866|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82753867|NCT00662558|Analgesics|analgesics|mesh-ancestor
82753868|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
82753869|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82753870|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753871|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82753872|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82753873|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82753874|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82753875|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753876|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753877|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82753878|NCT00662558|Narcotics|narcotics|mesh-ancestor
82753879|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753880|NCT00869700|Lumefantrine|lumefantrine|mesh-list
82753881|NCT00869700|Artemether|artemether|mesh-list
82753882|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82753883|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
82753884|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82753885|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82753886|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753887|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
82753888|NCT00869856|Hematinics|hematinics|mesh-ancestor
82753889|NCT00876486|genexol-PM|genexol-pm|mesh-list
82753890|NCT00876486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753891|NCT00876486|Tubulin Modulators|tubulin modulators|mesh-ancestor
82753892|NCT00876486|Antimitotic Agents|antimitotic agents|mesh-ancestor
82753893|NCT00876486|Mitosis Modulators|mitosis modulators|mesh-ancestor
82753894|NCT00876486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753895|NCT00802334|Ritonavir|ritonavir|mesh-list
82753896|NCT00802334|Lopinavir|lopinavir|mesh-list
82753897|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82753898|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82753899|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
82753900|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753901|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753902|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82753903|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82753904|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
82753905|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753906|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82753907|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82753908|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82753909|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82753910|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82753911|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753912|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753913|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82753914|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82753915|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82753916|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
82753917|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82753918|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753919|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82753920|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82753921|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
82753922|NCT00796796|Sirolimus|sirolimus|mesh-list
82753923|NCT00796796|Temsirolimus|temsirolimus|mesh-list
82753924|NCT00796796|MTOR Inhibitors|mtor inhibitors|mesh-list
82753925|NCT00796796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82753926|NCT00796796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82753927|NCT00796796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753928|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82753929|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
82753930|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753931|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753932|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82753933|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753934|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82753935|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
82753936|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
82753937|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
82753938|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
82753939|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753940|NCT03794076|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82753941|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82753942|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82753943|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
82753944|NCT00739973|Amlodipine|amlodipine|mesh-list
82753945|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82753946|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82753947|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82753948|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753949|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82753950|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753951|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
82753953|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
82753954|NCT00802568|Busulfan|busulfan|mesh-list
82753955|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82753956|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82753957|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82753958|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
82753959|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753960|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82753961|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
82753962|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753963|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
82753964|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82753965|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82753966|NCT00802802|Efavirenz|efavirenz|mesh-list
82753967|NCT00802802|Rifampin|rifampin|mesh-list
82753968|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82753969|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82753970|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754046|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82753971|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82753972|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
82753973|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82753974|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82753975|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82753976|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82753977|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82753978|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82753979|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82753980|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82753981|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
82753982|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82753983|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
82753984|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82753985|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82753986|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82753987|NCT00802958|Clobetasol|clobetasol|mesh-list
82753988|NCT00802958|Halobetasol|halobetasol|mesh-list
82753989|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82753990|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82753991|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
82753992|NCT00802958|Hormones|hormones|mesh-ancestor
82753993|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82753994|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82753995|NCT01565512|Bupivacaine|bupivacaine|mesh-list
82753996|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
82753997|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
82753998|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82753999|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754000|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
82754001|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754002|NCT04895930|Aflutinib|aflutinib|mesh-list
82754003|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82754004|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754005|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754006|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82754007|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82754008|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
82754009|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754010|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754011|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82754012|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
82754013|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82754014|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82754015|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82754016|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
82754017|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754018|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754019|NCT00789308|Cyclosporine|cyclosporine|mesh-list
82754020|NCT00789308|Sirolimus|sirolimus|mesh-list
82754021|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
82754022|NCT00789308|Etanercept|etanercept|mesh-list
82754023|NCT00789308|Heparin|heparin|mesh-list
82754024|NCT00789308|Dextrans|dextrans|mesh-list
82754025|NCT00789308|Tacrolimus|tacrolimus|mesh-list
82754026|NCT00789308|Cyclosporins|cyclosporins|mesh-list
82754027|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
82754028|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82754029|NCT00789308|Basiliximab|basiliximab|mesh-list
82754030|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82754031|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
82754032|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754033|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82754034|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754035|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754036|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
82754037|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754038|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
82754039|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754040|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82754041|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754042|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82754043|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
82754044|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82754045|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
82754047|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82754048|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82754049|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82754050|NCT00789308|Analgesics|analgesics|mesh-ancestor
82754051|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
82754052|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754053|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82754054|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82754055|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
82754056|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
82754057|NCT00518284|Paclitaxel|paclitaxel|mesh-list
82754058|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82754059|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82754060|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754061|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
82754062|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
82754063|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
82754064|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754065|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
82754066|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82754067|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754068|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82754069|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82754070|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754071|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754072|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754073|NCT00871104|Vancomycin|vancomycin|mesh-list
82754074|NCT00871104|Imipenem|imipenem|mesh-list
82754075|NCT00871104|Fosfomycin|fosfomycin|mesh-list
82754076|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82754077|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754078|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
82754079|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82754080|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754081|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
82754082|NCT00727415|Fludarabine|fludarabine|mesh-list
82754083|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
82754084|NCT00727415|Lenalidomide|lenalidomide|mesh-list
82754085|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82754086|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
82754087|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754088|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754089|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82754090|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
82754091|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754092|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754093|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82754094|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82754095|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
82754096|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82754097|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82754098|NCT00727415|Growth Substances|growth substances|mesh-ancestor
82754099|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
82754100|NCT00803192|Famotidine|famotidine|mesh-list
82754101|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82754102|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82754103|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82754104|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
82754105|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
82754106|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754107|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754108|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754109|NCT00544557|Etanercept|etanercept|mesh-list
82754110|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82754111|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82754112|NCT00544557|Analgesics|analgesics|mesh-ancestor
82754113|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
82754114|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754115|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754116|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82754117|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754118|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82754119|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82754120|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
82754121|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
82754122|NCT00877110|Vincristine|vincristine|mesh-list
82754123|NCT00877110|Topotecan|topotecan|mesh-list
82754124|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82754125|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
82754126|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754127|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754128|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82754129|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
82754130|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754131|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754132|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82754133|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82754134|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
82754135|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
82754136|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
82754137|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82754138|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82754139|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754140|NCT00727259|Ribavirin|ribavirin|mesh-list
82754141|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82754142|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
82754143|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754144|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
82754145|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754146|NCT00789386|Midazolam|midazolam|mesh-list
82754147|NCT00789386|Remifentanil|remifentanil|mesh-list
82754148|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82754149|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82754150|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82754151|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754152|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82754153|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82754154|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82754155|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82754156|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
82754157|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
82754158|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
82754159|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
82754160|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754161|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754162|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82754163|NCT00789386|Narcotics|narcotics|mesh-ancestor
82754164|NCT00789386|Analgesics|analgesics|mesh-ancestor
82754165|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
82754166|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754167|NCT00789464|Trimethoprim|trimethoprim|mesh-list
82754168|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
82754169|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82754170|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754171|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
82754173|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82754174|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82754175|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754176|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754177|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82754178|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82754179|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82754180|NCT00797030|Cyclosporine|cyclosporine|mesh-list
82754181|NCT00797030|Cyclosporins|cyclosporins|mesh-list
82754182|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754183|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754184|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82754185|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
82754186|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754187|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
82754188|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754189|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
82754190|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754191|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82754192|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
82754193|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
82754194|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754195|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
82754196|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
82754197|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82754198|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82754199|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82754200|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754201|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82754202|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82754203|NCT00877266|Mepivacaine|mepivacaine|mesh-list
82754204|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
82754205|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
82754206|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82754207|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754208|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
82754209|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754210|NCT02553824|Topiramate|topiramate|mesh-list
82754211|NCT02553824|Phentermine|phentermine|mesh-list
82754212|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
82754213|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82754214|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754215|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82754216|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
82754217|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82754218|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
82754219|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
82754220|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754221|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
82754222|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754223|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754224|NCT04039854|Propofol|propofol|mesh-list
82754225|NCT04039854|Sevoflurane|sevoflurane|mesh-list
82754226|NCT04039854|Desflurane|desflurane|mesh-list
82754227|NCT04039854|Isoflurane|isoflurane|mesh-list
82754228|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82754229|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82754230|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754231|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82754232|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
82754233|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
82754234|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82754235|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82754236|NCT04045730|Paclitaxel|paclitaxel|mesh-list
82754237|NCT04045730|Gemcitabine|gemcitabine|mesh-list
82754238|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
82754239|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82754240|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754241|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
82754242|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
82754243|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
82754244|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754245|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82754246|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
82754247|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82754248|NCT04045730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82754249|NCT00977223|Aprepitant|aprepitant|mesh-list
82754250|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
82754251|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
82754252|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
82754253|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754254|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754255|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82754256|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82754257|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754258|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754259|NCT00977301|Ritonavir|ritonavir|mesh-list
82754260|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
82754261|NCT00977301|Olanzapine|olanzapine|mesh-list
82754262|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82754263|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82754264|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
82754265|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754266|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754267|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82754268|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82754269|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
82754270|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754271|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82754272|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82754273|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
82754274|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
82754275|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754276|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754277|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82754278|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82754279|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82754280|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82754281|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82754282|NCT00977301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82754283|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82754284|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82754285|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754286|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
82754287|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82754288|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82754289|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754290|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82754291|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82754292|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82754293|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754294|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
82754295|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754296|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
82754297|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82754298|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
82754299|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754300|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754301|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82754302|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
82754303|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754304|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754305|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82754306|NCT00984945|Vaccines|vaccines|mesh-list
82754307|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
82754308|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754309|NCT00879918|Nicotine|nicotine|mesh-list
82754310|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82754311|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
82754312|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754313|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754314|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82754315|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82754316|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
82754317|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754318|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754319|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
82754320|NCT01565590|Propofol|propofol|mesh-list
82754321|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82754322|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82754323|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754324|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82754325|NCT01565590|Analgesics|analgesics|mesh-ancestor
82754326|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
82754327|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754328|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82754329|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82754330|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82754331|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
82754332|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754333|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754334|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82754335|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
82754336|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
82754337|NCT00877422|Vitamin D|vitamin d|mesh-list
82754338|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
82754339|NCT00877422|Vitamins|vitamins|mesh-ancestor
82754340|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
82754341|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754342|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82754343|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82754344|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
82754345|NCT04039698|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82754346|NCT04039698|Velpatasvir|velpatasvir|mesh-list
82754347|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
82754348|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754349|NCT04006821|Apatinib|apatinib|mesh-list
82754350|NCT04006821|Antibodies|antibodies|mesh-list
82754351|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
82754352|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754353|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754354|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82754355|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754356|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754357|NCT00803816|Everolimus|everolimus|mesh-list
82754358|NCT00803816|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82754359|NCT00803816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82754360|NCT00803816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754361|NCT00803816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754362|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82754363|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
82754364|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754365|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754366|NCT00797264|Ketamine|ketamine|mesh-list
82754367|NCT00797264|Morphine|morphine|mesh-list
82754368|NCT00797264|Analgesics|analgesics|mesh-ancestor
82754369|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
82754370|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754371|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754372|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82754373|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82754374|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
82754375|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
82754376|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82754377|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82754378|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82754379|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754380|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754381|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82754382|NCT00797264|Narcotics|narcotics|mesh-ancestor
82754383|NCT00981201|Celecoxib|celecoxib|mesh-list
82754384|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82754385|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82754386|NCT00981201|Analgesics|analgesics|mesh-ancestor
82754387|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
82754388|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754389|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754390|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82754391|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754392|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82754393|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82754394|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754395|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754396|NCT05279391|Dexamethasone|dexamethasone|mesh-list
82754397|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82754398|NCT05279391|Heparin|heparin|mesh-list
82754399|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82754400|NCT05279391|Tinzaparin|tinzaparin|mesh-list
82754401|NCT05279391|Dalteparin|dalteparin|mesh-list
82754402|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82754403|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
82754404|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
82754405|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754406|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754407|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82754408|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
82754409|NCT05279391|Hormones|hormones|mesh-ancestor
82754410|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82754411|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82754412|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754413|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
82754414|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82754415|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82754416|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754417|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754418|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82754419|NCT00789620|Lidocaine|lidocaine|mesh-list
82754420|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
82754421|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
82754422|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82754423|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754424|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
82754425|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754426|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82754427|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82754428|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82754429|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82754430|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754431|NCT03970265|Meropenem|meropenem|mesh-list
82754432|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82754433|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754434|NCT00877656|Zanolimumab|zanolimumab|mesh-list
82754435|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82754436|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754437|NCT00803894|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
82754438|NCT00803894|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82754439|NCT00803894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754440|NCT00803894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754441|NCT05371925|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
82754442|NCT05371925|Anticoagulants|anticoagulants|mesh-ancestor
82754443|NCT05371925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82754444|NCT05371925|Antimetabolites|antimetabolites|mesh-ancestor
82754445|NCT05371925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754446|NCT05371925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82754447|NCT05371925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82754448|NCT05371925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82754449|NCT05371925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82754450|NCT05371925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754451|NCT00797420|Fluconazole|fluconazole|mesh-list
82754452|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
82754453|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754454|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82754455|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82754456|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754457|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754458|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82754459|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
82754460|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82754461|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754462|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82754463|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82754465|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
82754466|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754467|NCT00872274|Sumatriptan|sumatriptan|mesh-list
82754468|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82754469|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82754470|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82754471|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
82754472|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754473|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754474|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754475|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82754476|NCT00872586|Olmesartan|olmesartan|mesh-list
82754477|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82754478|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82754479|NCT00872586|Diuretics|diuretics|mesh-ancestor
82754480|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
82754481|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754482|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82754483|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82754484|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754485|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82754486|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82754487|NCT00726557|Interferons|interferons|mesh-list
82754488|NCT00726557|Ribavirin|ribavirin|mesh-list
82754489|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
82754490|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
82754491|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82754492|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754493|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
82754494|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754495|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
82754571|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
82754496|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754497|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
82754498|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754500|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82754501|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
82754502|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82754503|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754504|NCT00880386|Losartan|losartan|mesh-list
82754505|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82754506|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82754507|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82754508|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82754509|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754510|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82754511|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82754512|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
82754513|NCT00804050|Vitamins|vitamins|mesh-list
82754514|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
82754515|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754516|NCT00877734|Baclofen|baclofen|mesh-list
82754517|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82754518|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754519|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82754520|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754521|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82754522|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
82754523|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
82754524|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754525|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754526|NCT00981591|Iloprost|iloprost|mesh-list
82754527|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82754528|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
82754529|NCT00978159|Esomeprazole|esomeprazole|mesh-list
82754530|NCT00978159|Famotidine|famotidine|mesh-list
82754531|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82754532|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82754533|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82754534|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754535|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754536|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82754537|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
82754538|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
82754539|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754540|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754541|NCT00804206|Bevacizumab|bevacizumab|mesh-list
82754542|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82754543|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754544|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82754545|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82754546|NCT00804206|Growth Substances|growth substances|mesh-ancestor
82754547|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754548|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
82754549|NCT00877812|Glycine|glycine|mesh-list
82754550|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
82754551|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754552|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754553|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754554|NCT00981903|Tinzaparin|tinzaparin|mesh-list
82754555|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82754556|NCT00981903|Dalteparin|dalteparin|mesh-list
82754557|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
82754558|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82754559|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82754560|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754561|NCT00738881|Pemetrexed|pemetrexed|mesh-list
82754562|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82754563|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754564|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754565|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754566|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82754567|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82754568|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82754569|NCT00657020|Nicotine|nicotine|mesh-list
82754570|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82754572|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754573|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754574|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82754575|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82754576|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
82754577|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754578|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754579|NCT03921723|Dolutegravir|dolutegravir|mesh-list
82754580|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82754581|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82754582|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754583|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754584|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82754585|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82754586|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
82754587|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754588|NCT00872664|Carotenoids|carotenoids|mesh-list
82754589|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
82754590|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754591|NCT00872664|Protective Agents|protective agents|mesh-ancestor
82754592|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754593|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
82754594|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82754595|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82754596|NCT00878124|Ubiquinone|ubiquinone|mesh-list
82754597|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
82754598|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
82754599|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754600|NCT00878124|Vitamins|vitamins|mesh-ancestor
82754601|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
82754602|NCT00978315|Vitamin D|vitamin d|mesh-list
82754603|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82754604|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754605|NCT00978315|Vitamins|vitamins|mesh-ancestor
82754606|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
82754607|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82754608|NCT00978393|Liraglutide|liraglutide|mesh-list
82754609|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82754610|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754611|NCT00978393|Incretins|incretins|mesh-ancestor
82754612|NCT00978393|Hormones|hormones|mesh-ancestor
82754613|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82754614|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
82754615|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82754616|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754617|NCT04740996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82754618|NCT04740996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754619|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82754620|NCT00872976|Dasatinib|dasatinib|mesh-list
82754621|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82754622|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
82754623|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754624|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754625|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82754626|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754627|NCT00544167|Paclitaxel|paclitaxel|mesh-list
82754628|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
82754629|NCT00544167|Doxorubicin|doxorubicin|mesh-list
82754630|NCT00544167|Sorafenib|sorafenib|mesh-list
82754631|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82754632|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754633|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
82754634|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
82754635|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
82754636|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754637|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82754638|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
82754639|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754640|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754641|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82754642|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
82754643|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82754644|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82754645|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82754646|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82754647|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754648|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82754649|NCT00659438|Bicalutamide|bicalutamide|mesh-list
82754650|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
82754651|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
82754652|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82754653|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754654|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754655|NCT05225844|Apatinib|apatinib|mesh-list
82754656|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754657|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82754658|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754659|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754660|NCT00878514|Alprazolam|alprazolam|mesh-list
82754661|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82754662|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82754663|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754664|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82754665|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82754666|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82754667|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
82754668|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
82754669|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754670|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754671|NCT00804440|Ibuprofen|ibuprofen|mesh-list
82754672|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82754673|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82754674|NCT00804440|Analgesics|analgesics|mesh-ancestor
82754675|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
82754676|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754677|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754678|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82754679|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754680|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82754681|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754682|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754683|NCT00880854|Tremelimumab|tremelimumab|mesh-list
82754684|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754685|NCT00543855|Donepezil|donepezil|mesh-list
82754686|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82754687|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754688|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754689|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
82754690|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754691|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754692|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
82754693|NCT00797810|Cytarabine|cytarabine|mesh-list
82754695|NCT00797810|Prednisone|prednisone|mesh-list
82754696|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
82754697|NCT00797810|Ifosfamide|ifosfamide|mesh-list
82754698|NCT00797810|Rituximab|rituximab|mesh-list
82754699|NCT00797810|Vincristine|vincristine|mesh-list
82754700|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82754701|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
82754702|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754703|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754704|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82754705|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
82754706|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754707|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754708|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82754709|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82754710|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82754711|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
82754712|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
82754713|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754714|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82754715|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
82754716|NCT00797810|Hormones|hormones|mesh-ancestor
82754717|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82754718|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82754719|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82754720|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
82754721|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
82754722|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754723|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82754724|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
82754725|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
82754726|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
82754727|NCT00873210|Sunitinib|sunitinib|mesh-list
82754728|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754729|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82754730|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82754731|NCT00873210|Growth Substances|growth substances|mesh-ancestor
82754732|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754733|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
82754734|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82754735|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754736|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754737|NCT00978471|Thiotepa|thiotepa|mesh-list
82754738|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82754739|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
82754740|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754741|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754742|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82754743|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82754744|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
82754745|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754746|NCT00804674|Bupivacaine|bupivacaine|mesh-list
82754747|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
82754748|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
82754749|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82754750|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754751|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
82754752|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754753|NCT00881088|PENTA|penta|mesh-list
82754754|NCT00881088|Nadroparin|nadroparin|mesh-list
82754755|NCT00881088|Fondaparinux|fondaparinux|mesh-list
82754756|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82754757|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
82754758|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82754759|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
82754760|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754761|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754762|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
82754763|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82754764|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82754765|NCT00978549|Docetaxel|docetaxel|mesh-list
82754766|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754767|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
82754768|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
82754769|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
82754770|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754771|NCT00656084|Rituximab|rituximab|mesh-list
82754772|NCT00656084|Gemcitabine|gemcitabine|mesh-list
82754773|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
82754774|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82754775|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754776|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
82754777|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754778|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754779|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82754780|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
82754781|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754782|NCT00656084|Analgesics|analgesics|mesh-ancestor
82754783|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
82754784|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754785|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82754786|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82754787|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754788|NCT00881166|Paclitaxel|paclitaxel|mesh-list
82754789|NCT00881166|Etoposide|etoposide|mesh-list
82754790|NCT00881166|Docetaxel|docetaxel|mesh-list
82754791|NCT00881166|Carboplatin|carboplatin|mesh-list
82754792|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82754793|NCT00881166|Topotecan|topotecan|mesh-list
82754794|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82754795|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754796|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
82754797|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
82754798|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
82754799|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754800|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82754801|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82754802|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754803|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82754804|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82754805|NCT00804752|Vitamin D|vitamin d|mesh-list
82754806|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
82754807|NCT00804752|Cholecalciferol|cholecalciferol|mesh-list
82754808|NCT00804752|Vitamins|vitamins|mesh-list
82754809|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
82754810|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754811|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82754812|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82754813|NCT05225766|Bupivacaine|bupivacaine|mesh-list
82754814|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
82754815|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
82754816|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82754817|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754818|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
82754819|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754820|NCT00804830|Bevacizumab|bevacizumab|mesh-list
82754821|NCT00804830|Doxorubicin|doxorubicin|mesh-list
82754822|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82754823|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754824|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82754825|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82754826|NCT00804830|Growth Substances|growth substances|mesh-ancestor
82754827|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754828|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
82754829|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82754830|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82754831|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82754832|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754833|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754834|NCT00982215|Acetaminophen|acetaminophen|mesh-list
82754835|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82754836|NCT00982215|Analgesics|analgesics|mesh-ancestor
82754837|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
82754838|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754839|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754840|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
82754841|NCT00613938|Oxycodone|oxycodone|mesh-list
82754842|NCT00613938|Tapentadol|tapentadol|mesh-list
82754843|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82754844|NCT00613938|Narcotics|narcotics|mesh-ancestor
82754845|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82754846|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754848|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
82754849|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754850|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82754851|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82754852|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82754853|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754854|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
82754855|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754856|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82754857|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82754858|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754859|NCT00805064|Triamcinolone|triamcinolone|mesh-list
82754860|NCT00805064|Bevacizumab|bevacizumab|mesh-list
82754861|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82754862|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754863|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82754864|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82754865|NCT00805064|Growth Substances|growth substances|mesh-ancestor
82754866|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754867|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
82754868|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82754869|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
82754870|NCT00805064|Hormones|hormones|mesh-ancestor
82754871|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82754872|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
82754873|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82754874|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
82754875|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754876|NCT00655928|Expectorants|expectorants|mesh-ancestor
82754877|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
82754878|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82754879|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
82754880|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754881|NCT00655928|Protective Agents|protective agents|mesh-ancestor
82754882|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754883|NCT00655928|Antidotes|antidotes|mesh-ancestor
82754884|NCT00873756|Bevacizumab|bevacizumab|mesh-list
82754885|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82754886|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754887|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82754888|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82754889|NCT00873756|Growth Substances|growth substances|mesh-ancestor
82754890|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754891|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
82754892|NCT00873834|Fluoxetine|fluoxetine|mesh-list
82754893|NCT00873834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82754894|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82754895|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82754896|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754897|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754898|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
82754899|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754900|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82754901|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
82754902|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82754903|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82754904|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82754905|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754906|NCT00655850|Paclitaxel|paclitaxel|mesh-list
82754907|NCT00655850|Gemcitabine|gemcitabine|mesh-list
82754908|NCT00655850|Bevacizumab|bevacizumab|mesh-list
82754909|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82754910|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754911|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
82754912|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
82754913|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
82754914|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754915|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82754916|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
82754917|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82754918|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82754919|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82754920|NCT00655850|Growth Substances|growth substances|mesh-ancestor
82754921|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754922|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
82754923|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
82754924|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754925|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754926|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
82754927|NCT00805298|Epinephrine|epinephrine|mesh-list
82754928|NCT00805298|Racepinephrine|racepinephrine|mesh-list
82754929|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
82754930|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82754931|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
82754932|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
82754933|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754934|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754935|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82754936|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
82754937|NCT00805298|Hormones|hormones|mesh-ancestor
82754938|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82754939|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82754940|NCT00805298|Protective Agents|protective agents|mesh-ancestor
82754941|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82754942|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82754943|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
82754944|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754945|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754946|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82754947|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82754948|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82754949|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
82754950|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
82754951|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
82754952|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82754953|NCT00881400|Cefprozil|cefprozil|mesh-list
82754954|NCT00881400|Cephalosporins|cephalosporins|mesh-list
82754955|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82754956|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82754957|NCT00246571|Sunitinib|sunitinib|mesh-list
82754958|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82754959|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82754960|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82754961|NCT00246571|Growth Substances|growth substances|mesh-ancestor
82754962|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754963|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
82754964|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82754965|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82754966|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754967|NCT02553044|Vitamin D|vitamin d|mesh-list
82754968|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
82754969|NCT02553044|Vitamins|vitamins|mesh-ancestor
82754970|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
82754971|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754972|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82754973|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82754974|NCT00545103|Mesalamine|mesalamine|mesh-list
82754975|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82754976|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82754977|NCT00545103|Analgesics|analgesics|mesh-ancestor
82754978|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
82754979|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82754980|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754981|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82754982|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82754983|NCT00586157|Methylphenidate|methylphenidate|mesh-list
82754984|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82754985|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754986|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82754987|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82754988|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82754989|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82754990|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
82754991|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82754992|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
82754993|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82754994|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
82754995|NCT00809744|Vitamin D|vitamin d|mesh-list
82754996|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82754997|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82754998|NCT00809744|Vitamins|vitamins|mesh-ancestor
82754999|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
82755000|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82755001|NCT00246337|Rizatriptan|rizatriptan|mesh-list
82755002|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82755003|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
82755004|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755005|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755006|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755007|NCT05012943|Vaccines|vaccines|mesh-list
82755008|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
82755009|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755010|NCT01581853|Ritonavir|ritonavir|mesh-list
82755011|NCT01581853|Lopinavir|lopinavir|mesh-list
82755012|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82755013|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82755014|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
82755015|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755016|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755017|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82755018|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82755019|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
82755020|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755021|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82755022|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82755023|NCT01070641|Carvedilol|carvedilol|mesh-list
82755024|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82755025|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82755026|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
82755027|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755028|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755029|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755030|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82755031|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
82755032|NCT01070641|Protective Agents|protective agents|mesh-ancestor
82755033|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82755034|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82755035|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82755036|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
82755037|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82755038|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82755039|NCT00982449|Fialuridine|fialuridine|mesh-list
82755040|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
82755041|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755042|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82755043|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755044|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755045|NCT02593721|Ibuprofen|ibuprofen|mesh-list
82755046|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82755047|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82755048|NCT02593721|Analgesics|analgesics|mesh-ancestor
82755049|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
82755050|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755051|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755052|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82755053|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82755054|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82755055|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755056|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755057|NCT00985647|Lamivudine|lamivudine|mesh-list
82755058|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82755059|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82755060|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755061|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755062|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
82755063|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755064|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82755065|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82755066|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82755067|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
82755068|NCT00806468|Coagulants|coagulants|mesh-ancestor
82755069|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82755071|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755072|NCT00982527|Fenoldopam|fenoldopam|mesh-list
82755073|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82755074|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
82755075|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
82755076|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
82755077|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755078|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755079|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755080|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
82755081|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82755082|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
82755083|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82755084|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755085|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82755086|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82755087|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82755088|NCT00725621|Infliximab|infliximab|mesh-list
82755089|NCT00725621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82755090|NCT00725621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82755091|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
82755092|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82755093|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82755094|NCT00613626|Etoposide|etoposide|mesh-list
82755095|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755096|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82755097|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82755098|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82755099|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755100|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755101|NCT00725543|Infliximab|infliximab|mesh-list
82755177|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755102|NCT00725543|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82755103|NCT00725543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82755104|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
82755105|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82755106|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82755108|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82755109|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755110|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82755111|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
82755112|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82755113|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755114|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755115|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755116|NCT00616434|Interferons|interferons|mesh-list
82755117|NCT00616434|Interferon-beta|interferon-beta|mesh-list
82755118|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
82755119|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755120|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
82755121|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755122|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
82755123|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755124|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82755125|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82755126|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755127|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82755128|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755129|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755130|NCT00257725|Methylphenidate|methylphenidate|mesh-list
82755131|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82755132|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755133|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82755134|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82755135|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82755136|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755138|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755139|NCT00544869|Tolvaptan|tolvaptan|mesh-list
82755140|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82755141|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755142|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
82755143|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755144|NCT02593643|Midazolam|midazolam|mesh-list
82755145|NCT02593643|Ketamine|ketamine|mesh-list
82755146|NCT02593643|Analgesics|analgesics|mesh-ancestor
82755147|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
82755148|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755149|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755150|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82755151|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82755152|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
82755153|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
82755154|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755155|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82755156|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82755157|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755158|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755159|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82755160|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82755161|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82755162|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82755163|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82755164|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
82755165|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
82755166|NCT00881556|Fludarabine|fludarabine|mesh-list
82755167|NCT00881556|Busulfan|busulfan|mesh-list
82755168|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
82755169|NCT00881556|Lorazepam|lorazepam|mesh-list
82755170|NCT00881556|Tacrolimus|tacrolimus|mesh-list
82755171|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755172|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755173|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82755174|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
82755175|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755176|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82755178|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
82755179|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82755180|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82755181|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82755182|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
82755184|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
82755185|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755186|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82755187|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82755188|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755189|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82755190|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82755191|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82755192|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
82755193|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
82755194|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755195|NCT00881634|Cetirizine|cetirizine|mesh-list
82755196|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
82755197|NCT00881634|Ephedrine|ephedrine|mesh-list
82755198|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82755199|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82755200|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82755201|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
82755202|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
82755203|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755204|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755205|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755206|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82755207|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
82755208|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755209|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82755210|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
82755211|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
82755212|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82755213|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82755214|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
82755215|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
82755216|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
82755217|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82755218|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82755220|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
82755221|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755222|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755223|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82755224|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82755225|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82755226|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
82755227|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755228|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82755229|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
82755230|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82755231|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82755232|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82755233|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82755234|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755235|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755236|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755237|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82755238|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
82755239|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82755241|NCT00652028|Midazolam|midazolam|mesh-list
82755242|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
82755243|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82755244|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755245|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755246|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82755247|NCT00652028|Analgesics|analgesics|mesh-ancestor
82755248|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
82755249|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755250|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82755251|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82755252|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82755253|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
82755254|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755255|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755256|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82755257|NCT00652028|Narcotics|narcotics|mesh-ancestor
82755258|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82755259|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82755260|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
82755261|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
82755262|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82755263|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82755264|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82755265|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
82755266|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
82755268|NCT00799136|Vincristine|vincristine|mesh-list
82755269|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82755270|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
82755271|NCT00799136|Hormones|hormones|mesh-ancestor
82755272|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82755273|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755274|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82755275|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755276|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82755277|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
82755278|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
82755279|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
82755280|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755281|NCT02592395|Folfirinox|folfirinox|mesh-list
82755282|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755283|NCT00799214|Metronidazole|metronidazole|mesh-list
82755284|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755285|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82755286|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82755287|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82755288|NCT00733421|Etoricoxib|etoricoxib|mesh-list
82755289|NCT00733421|Tramadol|tramadol|mesh-list
82755290|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82755291|NCT00733421|Narcotics|narcotics|mesh-ancestor
82755292|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755293|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755294|NCT00733421|Analgesics|analgesics|mesh-ancestor
82755295|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
82755296|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755297|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82755298|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82755299|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82755300|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82755301|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82755302|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82755303|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755304|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755305|NCT00613080|Leucovorin|leucovorin|mesh-list
82755306|NCT00613080|Fluorouracil|fluorouracil|mesh-list
82755307|NCT00613080|Capecitabine|capecitabine|mesh-list
82755308|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
82755309|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
82755310|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755311|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82755312|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755313|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82755314|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
82755315|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755316|NCT00613080|Antidotes|antidotes|mesh-ancestor
82755317|NCT00613080|Protective Agents|protective agents|mesh-ancestor
82755318|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
82755319|NCT00613080|Vitamins|vitamins|mesh-ancestor
82755320|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
82755321|NCT00917891|Dapivirine|dapivirine|mesh-list
82755322|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82755323|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82755324|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
82755325|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755326|NCT00732875|Infliximab|infliximab|mesh-list
82755327|NCT00732875|Methotrexate|methotrexate|mesh-list
82755328|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82755329|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
82755330|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82755331|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755332|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82755333|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
82755334|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755335|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755336|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
82755337|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755338|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82755339|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82755340|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
82755341|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82755342|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82755343|NCT00732875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82755344|NCT00732875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82755345|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82755346|NCT00881790|Fluorides|fluorides|mesh-list
82755347|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
82755348|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
82755349|NCT00881790|Protective Agents|protective agents|mesh-ancestor
82755350|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755351|NCT00810446|Rifabutin|rifabutin|mesh-list
82755352|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82755353|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755354|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82755355|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
82755356|NCT00810524|Lamivudine|lamivudine|mesh-list
82755357|NCT00810524|Adefovir|adefovir|mesh-list
82755358|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82755359|NCT00810524|Telbivudine|telbivudine|mesh-list
82755360|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82755361|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82755362|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755363|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755364|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
82755365|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755366|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82755367|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82755368|NCT00810680|Valproic Acid|valproic acid|mesh-list
82755369|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
82755370|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755371|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755372|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
82755373|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755374|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755375|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
82755376|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82755377|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755378|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82755379|NCT00799448|Insulin|insulin|mesh-list
82755380|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82755381|NCT00799448|Repaglinide|repaglinide|mesh-list
82755382|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
82755383|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
82755384|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
82755385|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82755386|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755387|NCT00806936|Insulin|insulin|mesh-list
82755388|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82755389|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82755390|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755391|NCT00799682|Travoprost|travoprost|mesh-list
82755392|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82755393|NCT00799682|Latanoprost|latanoprost|mesh-list
82755394|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82755395|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82755396|NCT03829020|Metformin|metformin|mesh-list
82755397|NCT03829020|Nelfinavir|nelfinavir|mesh-list
82755398|NCT03829020|Bortezomib|bortezomib|mesh-list
82755399|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82755400|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755401|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755402|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82755403|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82755404|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
82755405|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755406|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755407|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82755408|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82755409|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
82755410|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755411|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82755412|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
82755413|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82755414|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
82755415|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755416|NCT00874926|Factor VIII|factor viii|mesh-list
82755417|NCT00874926|Coagulants|coagulants|mesh-ancestor
82755418|NCT00810914|Bupivacaine|bupivacaine|mesh-list
82755419|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
82755420|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
82755421|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755422|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755423|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
82755424|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755425|NCT00878904|Epirubicin|epirubicin|mesh-list
82755426|NCT00878904|Panobinostat|panobinostat|mesh-list
82755427|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82755428|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755429|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82755430|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82755431|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755432|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755433|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82755434|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
82755435|NCT00737711|Hematinics|hematinics|mesh-ancestor
82755436|NCT00807326|Simethicone|simethicone|mesh-list
82755437|NCT00807326|Loperamide|loperamide|mesh-list
82755438|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
82755439|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82755440|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
82755441|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755442|NCT00807326|Emollients|emollients|mesh-ancestor
82755443|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
82755444|NCT00875082|Montelukast|montelukast|mesh-list
82755445|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82755446|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
82755447|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82755448|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
82755449|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82755450|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755451|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82755452|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82755453|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755454|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
82755455|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82755456|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82755457|NCT02552342|Prednisolone|prednisolone|mesh-list
82755458|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
82755459|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82755460|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
82755461|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82755462|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
82755463|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
82755464|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755465|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755466|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82755467|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
82755468|NCT02552342|Hormones|hormones|mesh-ancestor
82755469|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82755470|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82755471|NCT02552342|Protective Agents|protective agents|mesh-ancestor
82755472|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82755473|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755474|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82755475|NCT00811226|Olmesartan|olmesartan|mesh-list
82755476|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82755477|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82755478|NCT00811226|Diuretics|diuretics|mesh-ancestor
82755479|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
82755480|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755481|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82755482|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82755483|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755558|NCT00800150|Fludarabine|fludarabine|mesh-list
82755484|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82755485|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82755486|NCT00238303|Vorinostat|vorinostat|mesh-list
82755487|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755488|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82755489|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755490|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755491|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82755492|NCT00811460|Incretins|incretins|mesh-ancestor
82755493|NCT00811460|Hormones|hormones|mesh-ancestor
82755494|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82755495|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755496|NCT00875238|Doxorubicin|doxorubicin|mesh-list
82755497|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82755498|NCT00875238|Trastuzumab|trastuzumab|mesh-list
82755499|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82755500|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755501|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82755502|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82755503|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755504|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755505|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82755506|NCT00732251|Allopurinol|allopurinol|mesh-list
82755507|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
82755508|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755509|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755510|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
82755511|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82755512|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82755513|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
82755514|NCT00732251|Protective Agents|protective agents|mesh-ancestor
82755515|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755516|NCT00882024|Tranilast|tranilast|mesh-list
82755517|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82755518|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82755519|NCT00882024|Analgesics|analgesics|mesh-ancestor
82755520|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
82755521|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755522|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755523|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82755524|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82755525|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82755526|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82755527|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755528|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82755529|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82755530|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
82755531|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
82755532|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755533|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82755534|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82755535|NCT00799760|Oseltamivir|oseltamivir|mesh-list
82755536|NCT00799760|Zanamivir|zanamivir|mesh-list
82755537|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
82755538|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755539|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755540|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755541|NCT00799838|Amoxicillin|amoxicillin|mesh-list
82755542|NCT00799838|Ketoprofen|ketoprofen|mesh-list
82755543|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82755544|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755545|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82755546|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82755547|NCT00799838|Analgesics|analgesics|mesh-ancestor
82755548|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
82755549|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755550|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755551|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82755552|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82755553|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82755554|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755555|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755556|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
82755557|NCT00737477|Hematinics|hematinics|mesh-ancestor
82755559|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
82755561|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755562|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82755563|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
82755564|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755565|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82755566|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
82755567|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755568|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82755569|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
82755570|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82755571|NCT00800306|Simendan|simendan|mesh-list
82755572|NCT00800306|Dobutamine|dobutamine|mesh-list
82755573|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82755574|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
82755575|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82755576|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82755577|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755578|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755579|NCT00800306|Protective Agents|protective agents|mesh-ancestor
82755580|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755581|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
82755582|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
82755583|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755584|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82755585|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82755586|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82755587|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
82755588|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755589|NCT01581775|Valproic Acid|valproic acid|mesh-list
82755590|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
82755591|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755592|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755593|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
82755594|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755595|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755596|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
82755597|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82755598|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755599|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82755600|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82755601|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755602|NCT01072747|Heparin|heparin|mesh-list
82755603|NCT01072747|Calcium heparin|calcium heparin|mesh-list
82755604|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
82755605|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82755606|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82755607|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755608|NCT00879372|Tianeptine|tianeptine|mesh-list
82755609|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82755610|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
82755611|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82755612|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
82755613|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82755614|NCT00731783|Mupirocin|mupirocin|mesh-list
82755615|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82755616|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755617|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
82755618|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
82755619|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82755620|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82755621|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755622|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755623|NCT03691350|Nicotine|nicotine|mesh-list
82755624|NCT03691350|Dimercaprol|dimercaprol|mesh-list
82755625|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82755626|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
82755627|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755628|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755629|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82755630|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82755631|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
82755632|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755633|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755634|NCT03691350|Chelating Agents|chelating agents|mesh-ancestor
82755635|NCT03691350|Sequestering Agents|sequestering agents|mesh-ancestor
82755636|NCT02592083|Tamoxifen|tamoxifen|mesh-list
82755637|NCT02592083|Goserelin|goserelin|mesh-list
82755638|NCT02592083|Palbociclib|palbociclib|mesh-list
82755639|NCT02592083|Exemestane|exemestane|mesh-list
82755640|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82755641|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82755642|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
82755643|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82755644|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755645|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82755646|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755647|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82755648|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82755649|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82755650|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82755651|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755652|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755653|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82755654|NCT04589676|Naloxone|naloxone|mesh-list
82755655|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82755656|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755657|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
82755658|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755659|NCT00724451|Ribavirin|ribavirin|mesh-list
82755660|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82755661|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82755662|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
82755663|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755664|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
82755665|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755666|NCT00724373|Ribavirin|ribavirin|mesh-list
82755667|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82755668|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
82755669|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755670|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
82755671|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755672|NCT02594579|Vitamin D|vitamin d|mesh-list
82755673|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
82755674|NCT02594579|Vitamins|vitamins|mesh-ancestor
82755675|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
82755676|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755677|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82755678|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82755679|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82755680|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82755681|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82755682|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755683|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755684|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
82755685|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755686|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82755687|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82755688|NCT00724061|Interferons|interferons|mesh-list
82755689|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
82755690|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
82755691|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82755692|NCT00724061|Furocoumarins|furocoumarins|mesh-list
82755693|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755694|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
82755695|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755696|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
82755697|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755698|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
82755699|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82755700|NCT02594423|Bevacizumab|bevacizumab|mesh-list
82755701|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82755702|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755703|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82755704|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82755705|NCT02594423|Growth Substances|growth substances|mesh-ancestor
82755706|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755707|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
82755708|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
82755709|NCT00882414|Hematinics|hematinics|mesh-ancestor
82755710|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82755711|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82755712|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82755713|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
82755714|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755715|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82755716|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82755717|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755718|NCT00875784|Sumatriptan|sumatriptan|mesh-list
82755719|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82755720|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82755721|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82755722|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
82755723|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755724|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755725|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755726|NCT00731549|Aripiprazole|aripiprazole|mesh-list
82755727|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
82755728|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82755729|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82755730|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82755731|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755732|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755733|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
82755734|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
82755735|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755736|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755737|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82755738|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82755739|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
82755740|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82755741|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82755742|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82755743|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82755744|NCT00882570|Cefdinir|cefdinir|mesh-list
82755745|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82755746|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755747|NCT00882882|Metformin|metformin|mesh-list
82755748|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82755749|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755750|NCT00882960|Fentanyl|fentanyl|mesh-list
82755751|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82755752|NCT00882960|Narcotics|narcotics|mesh-ancestor
82755753|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755754|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755755|NCT00882960|Analgesics|analgesics|mesh-ancestor
82755756|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
82755757|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755758|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82755759|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82755760|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
82755761|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
82755762|NCT00883194|Ropivacaine|ropivacaine|mesh-list
82755763|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
82755764|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
82755765|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755766|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755767|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
82755768|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755770|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82755771|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
82755772|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
82755773|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82755774|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82755775|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755776|NCT00730925|Paclitaxel|paclitaxel|mesh-list
82755777|NCT00730925|Afatinib|afatinib|mesh-list
82755778|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82755779|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755780|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
82755781|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
82755782|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
82755783|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755784|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82755785|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755786|NCT00236899|Paclitaxel|paclitaxel|mesh-list
82755787|NCT00236899|Docetaxel|docetaxel|mesh-list
82755788|NCT00236899|Gemcitabine|gemcitabine|mesh-list
82755789|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82755790|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755791|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
82755792|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
82755793|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
82755794|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755795|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82755796|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
82755797|NCT00611130|Vigabatrin|vigabatrin|mesh-list
82755798|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
82755799|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755800|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755801|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
82755802|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755803|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755804|NCT00885690|Olanzapine|olanzapine|mesh-list
82755805|NCT00885690|Sertindole|sertindole|mesh-list
82755806|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
82755807|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
82755808|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755809|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755810|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82755811|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82755812|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82755813|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755814|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82755815|NCT00885690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82755816|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82755817|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82755818|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755819|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755820|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
82755821|NCT00888810|Topotecan|topotecan|mesh-list
82755822|NCT00888810|Lapatinib|lapatinib|mesh-list
82755823|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82755824|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82755825|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755826|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755827|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755828|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82755829|NCT00256243|Paclitaxel|paclitaxel|mesh-list
82755830|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
82755831|NCT00256243|Carboplatin|carboplatin|mesh-list
82755832|NCT00256243|Doxorubicin|doxorubicin|mesh-list
82755833|NCT00256243|Trastuzumab|trastuzumab|mesh-list
82755834|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82755835|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755836|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
82755837|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
82755838|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
82755839|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755840|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82755841|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
82755842|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755843|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82755844|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82755845|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
82755846|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82755847|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82755848|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82755849|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82755850|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755851|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82755853|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82755854|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82755855|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82755856|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755857|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755858|NCT02541708|Folic Acid|folic acid|mesh-list
82755859|NCT02541708|Hematinics|hematinics|mesh-ancestor
82755860|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
82755861|NCT02541708|Vitamins|vitamins|mesh-ancestor
82755862|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
82755863|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755864|NCT03973567|Norepinephrine|norepinephrine|mesh-list
82755865|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
82755866|NCT03973567|Serotonin|serotonin|mesh-list
82755867|NCT03973567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
82755868|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82755869|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82755870|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
82755871|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755872|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755873|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755874|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82755875|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82755876|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
82755877|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
82755878|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
82755879|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755880|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82755881|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82755882|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82755883|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82755884|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
82755885|NCT00885924|Coagulants|coagulants|mesh-ancestor
82755886|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82755887|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
82755888|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755889|NCT01071889|Flumazenil|flumazenil|mesh-list
82755890|NCT01071889|Antidotes|antidotes|mesh-ancestor
82755891|NCT01071889|Protective Agents|protective agents|mesh-ancestor
82755892|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755893|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
82755894|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
82755895|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755896|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755897|NCT03973411|Ondansetron|ondansetron|mesh-list
82755898|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
82755899|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
82755900|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755901|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755902|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82755903|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
82755904|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
82755905|NCT03973411|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82755906|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82755907|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
82755908|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755909|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755911|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82755912|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
82755913|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755914|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755915|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82755916|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82755917|NCT00883506|Protective Agents|protective agents|mesh-ancestor
82755918|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755919|NCT00278395|Vorinostat|vorinostat|mesh-list
82755920|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82755921|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82755922|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755923|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755924|NCT00889044|Clopidogrel|clopidogrel|mesh-list
82755925|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82755926|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82755927|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82755928|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82755929|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
82755930|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82755931|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755932|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755933|NCT00886002|Fentanyl|fentanyl|mesh-list
82755934|NCT00886002|Buprenorphine|buprenorphine|mesh-list
82755935|NCT00886002|Naloxone|naloxone|mesh-list
82755936|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82755937|NCT00886002|Narcotics|narcotics|mesh-ancestor
82755938|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82755939|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755940|NCT00886002|Analgesics|analgesics|mesh-ancestor
82755941|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
82755942|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82755943|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82755944|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82755945|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
82755946|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
82755947|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82755948|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
82755949|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82755950|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
82755951|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82755952|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755953|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82755954|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82755955|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82755956|NCT00883818|Azithromycin|azithromycin|mesh-list
82755957|NCT00883818|Doxycycline|doxycycline|mesh-list
82755958|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82755959|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755960|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
82755961|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82755962|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82755963|NCT00889356|Clindamycin|clindamycin|mesh-list
82755964|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
82755965|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
82755966|NCT00889356|Amphotericin B|amphotericin b|mesh-list
82755967|NCT00889356|Tetracycline|tetracycline|mesh-list
82755968|NCT00889356|Ketoconazole|ketoconazole|mesh-list
82755969|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82755970|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82755971|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82755972|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82755973|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82755974|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755975|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
82755976|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82755977|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82755978|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82755979|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
82755980|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82755981|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82755982|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82755983|NCT00889356|Amebicides|amebicides|mesh-ancestor
82755984|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82755985|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82755986|NCT00889434|Tocotrienols|tocotrienols|mesh-list
82755987|NCT00889434|Vitamin E|vitamin e|mesh-list
82755988|NCT00889434|Tocopherols|tocopherols|mesh-list
82755989|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
82755990|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82755991|NCT00889434|Protective Agents|protective agents|mesh-ancestor
82755999|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756000|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756001|NCT00612534|Analgesics|analgesics|mesh-ancestor
82756002|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
82756003|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756004|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82756005|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82756006|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
82756007|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
82756008|NCT02542254|Albuterol|albuterol|mesh-list
82756009|NCT02542254|Ipratropium|ipratropium|mesh-list
82756010|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82756011|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
82756012|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756013|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756014|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82756015|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
82756016|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
82756017|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82756018|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82756019|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82756020|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82756021|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
82756022|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756023|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756024|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82756025|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
82756031|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
82756032|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82756033|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756034|NCT00736853|Acetaminophen|acetaminophen|mesh-list
82756035|NCT00736853|Tramadol|tramadol|mesh-list
82756036|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82756037|NCT00736853|Analgesics|analgesics|mesh-ancestor
82756038|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
82756039|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756040|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756041|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
82756042|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82756043|NCT00736853|Narcotics|narcotics|mesh-ancestor
82756044|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756045|NCT04037514|Acetaminophen|acetaminophen|mesh-list
82756047|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82756048|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82756049|NCT04037514|Analgesics|analgesics|mesh-ancestor
82756050|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
82756051|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756052|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756053|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82756054|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82756055|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82756056|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756057|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756058|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
82756060|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
82756061|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756062|NCT04034004|Naloxone|naloxone|mesh-list
82756063|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82756064|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756065|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
82756066|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756067|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
82756068|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82756069|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756070|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756071|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82756072|NCT00573066|Analgesics|analgesics|mesh-ancestor
82756073|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
82756074|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756075|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82756076|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82756077|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82756078|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
82756079|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756080|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756081|NCT02541552|Ropivacaine|ropivacaine|mesh-list
82756082|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
82756083|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
82756084|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756085|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756086|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
82756087|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756088|NCT00886314|Midazolam|midazolam|mesh-list
82756089|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82756090|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82756091|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756092|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756093|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82756094|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82756095|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82756096|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82756097|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
82756098|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
82756099|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
82756100|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
82756101|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756102|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756103|NCT00890214|Epoprostenol|epoprostenol|mesh-list
82756104|NCT00890214|Heparin|heparin|mesh-list
82756105|NCT00890214|Calcium heparin|calcium heparin|mesh-list
82756106|NCT00890214|Tezosentan|tezosentan|mesh-list
82756107|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
82756108|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82756109|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82756110|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756111|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82756112|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82756113|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
82756114|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82756115|NCT00730691|Vortioxetine|vortioxetine|mesh-list
82756116|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82756117|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82756118|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82756119|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756120|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756121|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756122|NCT00730691|Analgesics|analgesics|mesh-ancestor
82756123|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
82756124|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756125|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
82756126|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82756127|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
82756128|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82756129|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82756130|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756131|NCT00730691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82756132|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
82756133|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82756134|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82756135|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82756136|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82756138|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82756139|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
82756140|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82756141|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756142|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82756143|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82756144|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
82756145|NCT00884442|Nifedipine|nifedipine|mesh-list
82756146|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82756147|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82756148|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756149|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82756150|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756151|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
82756152|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
82756153|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82756154|NCT02543034|Petrolatum|petrolatum|mesh-list
82756155|NCT02543034|Emollients|emollients|mesh-ancestor
82756156|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
82756157|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
82756158|NCT00278161|Rituximab|rituximab|mesh-list
82756159|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82756160|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
82756161|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756162|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82756163|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82756164|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
82756165|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756166|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756167|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82756168|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82756169|NCT02541396|Ketamine|ketamine|mesh-list
82756170|NCT02541396|Oxycodone|oxycodone|mesh-list
82756171|NCT02541396|Analgesics|analgesics|mesh-ancestor
82756172|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
82756173|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756174|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756175|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82756176|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82756177|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
82756178|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
82756179|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756180|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82756181|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82756182|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756183|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756184|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82756185|NCT02541396|Narcotics|narcotics|mesh-ancestor
82756186|NCT00890604|Acetaminophen|acetaminophen|mesh-list
82756187|NCT00890604|Ibuprofen|ibuprofen|mesh-list
82756188|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82756189|NCT00890604|Analgesics|analgesics|mesh-ancestor
82756190|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
82756191|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756192|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756193|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
82756194|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82756195|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82756196|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82756197|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82756198|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756199|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756200|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
82756201|NCT00255151|Lansoprazole|lansoprazole|mesh-list
82756202|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82756203|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82756204|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82756205|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756206|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756207|NCT03973957|Fentanyl|fentanyl|mesh-list
82756208|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82756209|NCT03973957|Narcotics|narcotics|mesh-ancestor
82756210|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756211|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756212|NCT03973957|Analgesics|analgesics|mesh-ancestor
82756213|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
82756214|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756215|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82756216|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82756217|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
82756218|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
82756219|NCT00658658|Panitumumab|panitumumab|mesh-list
82756220|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82756221|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756222|NCT00723203|Panobinostat|panobinostat|mesh-list
82756223|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756224|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82756225|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756226|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756227|NCT00891072|Acetic Acid|acetic acid|mesh-list
82756228|NCT00891072|Paclitaxel|paclitaxel|mesh-list
82756229|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
82756230|NCT00891072|Carboplatin|carboplatin|mesh-list
82756231|NCT00891072|Retinol acetate|retinol acetate|mesh-list
82756232|NCT00891072|Gossypol|gossypol|mesh-list
82756233|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82756234|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756235|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
82756236|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
82756237|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
82756238|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756239|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82756240|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756241|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82756242|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
82756243|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756244|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82756245|NCT00891072|Protective Agents|protective agents|mesh-ancestor
82756246|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82756247|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
82756248|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82756249|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82756250|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
82756251|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
82756252|NCT02591927|Insulin|insulin|mesh-list
82756253|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82756254|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756255|NCT00891150|Oxytocin|oxytocin|mesh-list
82756256|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
82756257|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82756258|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756260|NCT00800462|Oxybutynin|oxybutynin|mesh-list
82756261|NCT00800462|Darifenacin|darifenacin|mesh-list
82756262|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
82756263|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
82756264|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
82756265|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756266|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756267|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82756268|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82756269|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
82756270|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756271|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756272|NCT00800462|Urological Agents|urological agents|mesh-ancestor
82756273|NCT00233389|Rebamipide|rebamipide|mesh-list
82756274|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82756275|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82756276|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
82756277|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756278|NCT00233389|Protective Agents|protective agents|mesh-ancestor
82756279|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756280|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756281|NCT00891306|Cyclosporine|cyclosporine|mesh-list
82756282|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
82756283|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
82756284|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82756285|NCT00891306|Cyclosporins|cyclosporins|mesh-list
82756286|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756287|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756288|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82756289|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
82756290|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756291|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
82756292|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756293|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
82756294|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82756295|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82756296|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82756297|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756298|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82756299|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
82756300|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82756301|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82756302|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
82756303|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
82756304|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756305|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82756306|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
82756307|NCT00891306|Hormones|hormones|mesh-ancestor
82756308|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82756309|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82756310|NCT00891306|Protective Agents|protective agents|mesh-ancestor
82756311|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82756312|NCT00807872|Antibodies|antibodies|mesh-list
82756313|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82756314|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
82756315|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756316|NCT00813722|Losartan|losartan|mesh-list
82756317|NCT00813722|Atenolol|atenolol|mesh-list
82756318|NCT00813722|Amlodipine|amlodipine|mesh-list
82756319|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82756320|NCT00813722|Calcium|calcium|mesh-list
82756321|NCT00813722|Diuretics|diuretics|mesh-list
82756322|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82756323|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82756324|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756325|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82756326|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82756327|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82756328|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756329|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
82756330|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82756331|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82756332|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82756333|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
82756334|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82756335|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82756336|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
82756337|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756338|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
82756339|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
82756340|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756341|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82756342|NCT00812318|Cabotegravir|cabotegravir|mesh-list
82756343|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82756344|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82756345|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756346|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756347|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82756348|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82756349|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
82756350|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756351|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
82756352|NCT00812396|Testosterone|testosterone|mesh-list
82756353|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
82756354|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
82756355|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82756356|NCT00812396|Androgens|androgens|mesh-ancestor
82756357|NCT00812396|Hormones|hormones|mesh-ancestor
82756358|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82756359|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756360|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82756361|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756362|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
82756363|NCT00807950|Simvastatin|simvastatin|mesh-list
82756364|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82756365|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82756366|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
82756367|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756368|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82756369|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82756370|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756371|NCT00649220|Memantine|memantine|mesh-list
82756372|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82756373|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82756374|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
82756375|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756376|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756377|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756378|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82756379|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82756380|NCT00654368|Etanercept|etanercept|mesh-list
82756381|NCT00654368|Methotrexate|methotrexate|mesh-list
82756382|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82756383|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
82756384|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82756385|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756386|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82756387|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
82756388|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756389|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756390|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
82756391|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756392|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82756393|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82756394|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
82756395|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82756396|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82756397|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82756398|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82756399|NCT00654368|Analgesics|analgesics|mesh-ancestor
82756400|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
82756401|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756402|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82756403|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82756404|NCT00812864|Capecitabine|capecitabine|mesh-list
82756405|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82756406|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
82756407|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756408|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756409|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
82756411|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82756412|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82756413|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756414|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756415|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82756416|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82756417|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82756418|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82756419|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
82756420|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
82756421|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
82756422|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
82756423|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756424|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756425|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82756426|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82756427|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
82756428|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756429|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82756430|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82756431|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756432|NCT00647426|Carboplatin|carboplatin|mesh-list
82756433|NCT00647426|Docetaxel|docetaxel|mesh-list
82756434|NCT00647426|Sorafenib|sorafenib|mesh-list
82756435|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756436|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
82756437|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
82756438|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
82756439|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756440|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82756441|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756442|NCT00647348|Simvastatin|simvastatin|mesh-list
82756443|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82756444|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82756445|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
82756446|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756447|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82756448|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82756449|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756450|NCT00647270|Adalimumab|adalimumab|mesh-list
82756451|NCT00647270|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82756452|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82756453|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82756454|NCT00645944|Eszopiclone|eszopiclone|mesh-list
82756455|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82756456|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756457|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756458|NCT00813332|Docetaxel|docetaxel|mesh-list
82756459|NCT00813332|Endostar protein|endostar protein|mesh-list
82756460|NCT00813332|Endostatins|endostatins|mesh-list
82756461|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756462|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
82756463|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
82756464|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
82756465|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756466|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82756467|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82756468|NCT00813332|Growth Substances|growth substances|mesh-ancestor
82756469|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756470|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
82756471|NCT04708496|Efavirenz|efavirenz|mesh-list
82756472|NCT04708496|Dolutegravir|dolutegravir|mesh-list
82756473|NCT04708496|Lumefantrine|lumefantrine|mesh-list
82756474|NCT04708496|Artemether|artemether|mesh-list
82756475|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82756476|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82756477|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82756478|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756479|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756480|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
82756481|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756482|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82756483|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82756484|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82756485|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82756486|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82756487|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82756488|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82756489|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82756490|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82756491|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82756492|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
82756493|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82756494|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82756495|NCT00646958|Linezolid|linezolid|mesh-list
82756496|NCT00646958|Radezolid|radezolid|mesh-list
82756497|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
82756498|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82756499|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756500|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82756501|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756502|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756503|NCT00813410|Insulin|insulin|mesh-list
82756504|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82756505|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756506|NCT00642746|Leucovorin|leucovorin|mesh-list
82756507|NCT00642746|Fluorouracil|fluorouracil|mesh-list
82756508|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
82756510|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82756511|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
82756512|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756513|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82756514|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756515|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82756516|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
82756517|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756518|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82756519|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82756520|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756521|NCT00642746|Antidotes|antidotes|mesh-ancestor
82756522|NCT00642746|Protective Agents|protective agents|mesh-ancestor
82756523|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
82756524|NCT00642746|Vitamins|vitamins|mesh-ancestor
82756525|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
82756526|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82756527|NCT00814268|Aspirin|aspirin|mesh-list
82756528|NCT00814268|Clopidogrel|clopidogrel|mesh-list
82756529|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82756530|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82756531|NCT00814268|Analgesics|analgesics|mesh-ancestor
82756532|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
82756533|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756534|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756535|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82756536|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82756537|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82756538|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82756539|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756540|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82756541|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82756542|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756543|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
82756544|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82756545|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82756546|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82756547|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
82756548|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756549|NCT00817622|Vitamin E|vitamin e|mesh-list
82756550|NCT00817622|Vitamins|vitamins|mesh-ancestor
82756551|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
82756552|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756553|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
82756554|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756555|NCT00817622|Protective Agents|protective agents|mesh-ancestor
82756556|NCT00808418|Docetaxel|docetaxel|mesh-list
82756557|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756558|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
82756559|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
82756560|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
82756561|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756562|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
82756563|NCT00642668|Hematinics|hematinics|mesh-ancestor
82756564|NCT00817934|Bisacodyl|bisacodyl|mesh-list
82756565|NCT00817934|Cathartics|cathartics|mesh-ancestor
82756566|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82756567|NCT00817934|Laxatives|laxatives|mesh-ancestor
82756568|NCT00729833|Sunitinib|sunitinib|mesh-list
82756569|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756570|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82756571|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82756572|NCT00729833|Growth Substances|growth substances|mesh-ancestor
82756573|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756574|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
82756575|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82756576|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756577|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756578|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
82756579|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82756580|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756581|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82756582|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82756583|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756584|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756585|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756586|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82756587|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82756588|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
82756589|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
82756590|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82756591|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82756592|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756593|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756594|NCT00814736|Urological Agents|urological agents|mesh-ancestor
82756595|NCT00818090|Paclitaxel|paclitaxel|mesh-list
82756596|NCT00818090|Cisplatin|cisplatin|mesh-list
82756597|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82756598|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756599|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
82756600|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
82756601|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
82756602|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756603|NCT00642356|Levodopa|levodopa|mesh-list
82756604|NCT00642356|Carbidopa|carbidopa|mesh-list
82756605|NCT00642356|Entacapone|entacapone|mesh-list
82756606|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82756607|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82756608|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82756609|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
82756610|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756611|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756612|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756613|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82756614|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756615|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82756616|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82756617|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
82756618|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
82756619|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82756620|NCT00642278|Canagliflozin|canagliflozin|mesh-list
82756621|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82756622|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756623|NCT00642278|Incretins|incretins|mesh-ancestor
82756624|NCT00642278|Hormones|hormones|mesh-ancestor
82756625|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82756626|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82756627|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
82756628|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756629|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756630|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82756631|NCT00812786|Cyclosporine|cyclosporine|mesh-list
82756632|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
82756633|NCT00812786|Everolimus|everolimus|mesh-list
82756634|NCT00812786|Tacrolimus|tacrolimus|mesh-list
82756635|NCT00812786|Cyclosporins|cyclosporins|mesh-list
82756636|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82756637|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
82756638|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756639|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82756640|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756641|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756642|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
82756643|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756644|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
82756645|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82756646|NCT00812786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82756647|NCT00812786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82756648|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756649|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82756650|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82756651|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
82756652|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82756654|NCT00815048|Fentanyl|fentanyl|mesh-list
82756655|NCT00815048|Remifentanil|remifentanil|mesh-list
82756656|NCT00815048|Succinylcholine|succinylcholine|mesh-list
82756657|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82756658|NCT00815048|Narcotics|narcotics|mesh-ancestor
82756659|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756660|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756661|NCT00815048|Analgesics|analgesics|mesh-ancestor
82756662|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
82756663|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756664|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82756665|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82756666|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
82756667|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
82756668|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82756669|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82756670|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
82756671|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82756672|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
82756673|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
82756674|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
82756675|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82756676|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82756677|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
82756678|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756679|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756680|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
82756681|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82756682|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82756683|NCT02551796|Levofloxacin|levofloxacin|mesh-list
82756684|NCT02551796|Ofloxacin|ofloxacin|mesh-list
82756685|NCT02551796|Tobramycin|tobramycin|mesh-list
82756686|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
82756687|NCT02551796|Dexamethasone|dexamethasone|mesh-list
82756688|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
82756689|NCT02551796|BB 1101|bb 1101|mesh-list
82756690|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
82756691|NCT02551796|Dipivefrin|dipivefrin|mesh-list
82756692|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82756693|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
82756694|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
82756695|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756696|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756697|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82756698|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
82756699|NCT02551796|Hormones|hormones|mesh-ancestor
82756700|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82756701|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82756702|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756703|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
82756704|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756705|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756706|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82756707|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756708|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82756709|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82756710|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82756711|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82756712|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82756713|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82756714|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
82756715|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
82756716|NCT02551796|Protective Agents|protective agents|mesh-ancestor
82756717|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82756718|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
82756719|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756720|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82756721|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82756723|NCT00723125|Bevacizumab|bevacizumab|mesh-list
82756724|NCT00723125|Carboplatin|carboplatin|mesh-list
82756725|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82756726|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82756727|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756728|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
82756729|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
82756730|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
82756731|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756732|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82756733|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82756734|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82756735|NCT00723125|Growth Substances|growth substances|mesh-ancestor
82756736|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756737|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
82756738|NCT00640562|Risperidone|risperidone|mesh-list
82756739|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82756740|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82756741|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
82756742|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756743|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756744|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756745|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82756746|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82756747|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756748|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82756749|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82756750|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
82756751|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
82756752|NCT00815204|Dexamethasone|dexamethasone|mesh-list
82756753|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82756754|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
82756755|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
82756756|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756757|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756758|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82756759|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
82756760|NCT00815204|Hormones|hormones|mesh-ancestor
82756761|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82756762|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82756763|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756764|NCT00721955|Loxapine|loxapine|mesh-list
82756765|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82756766|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82756767|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756768|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756769|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82756770|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82756771|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
82756772|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756773|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756774|NCT00585689|Carboplatin|carboplatin|mesh-list
82756775|NCT00585689|Gemcitabine|gemcitabine|mesh-list
82756776|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82756777|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756778|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82756779|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
82756780|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756781|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
82756782|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82756783|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
82756784|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756785|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
82756786|NCT00653432|Protective Agents|protective agents|mesh-ancestor
82756787|NCT00815282|Vaccines|vaccines|mesh-list
82756788|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
82756789|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756790|NCT02593019|Adavosertib|adavosertib|mesh-list
82756791|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756792|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756794|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82756795|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
82756796|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756797|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756798|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82756799|NCT00818870|Omeprazole|omeprazole|mesh-list
82756800|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82756801|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82756802|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82756803|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756804|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756805|NCT00254293|Abatacept|abatacept|mesh-list
82756806|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82756807|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82756808|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756809|NCT00254293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82756810|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756811|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82756812|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
82756813|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756814|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82756816|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82756817|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756818|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82756819|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
82756820|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756821|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82756822|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756823|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756824|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
82756825|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756826|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
82756827|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82756828|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756829|NCT00253747|Methylphenidate|methylphenidate|mesh-list
82756830|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82756831|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756832|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82756833|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82756834|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82756835|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756836|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
82756837|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756838|NCT00252733|Candesartan|candesartan|mesh-list
82756839|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
82756840|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82756841|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82756842|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82756843|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756844|NCT03974035|Ropivacaine|ropivacaine|mesh-list
82756845|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
82756846|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
82756847|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756848|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756849|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
82756850|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756851|NCT00275821|Ranibizumab|ranibizumab|mesh-list
82756852|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82756853|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82756854|NCT00275821|Growth Substances|growth substances|mesh-ancestor
82756855|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756856|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
82756857|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756858|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
82756859|NCT00275509|Dexamethasone|dexamethasone|mesh-list
82756860|NCT00275509|Prednisone|prednisone|mesh-list
82756861|NCT00275509|Tacrolimus|tacrolimus|mesh-list
82756862|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
82756863|NCT00275509|Daclizumab|daclizumab|mesh-list
82756864|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82756865|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
82756866|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
82756867|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82756868|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756869|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82756870|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
82756871|NCT00275509|Hormones|hormones|mesh-ancestor
82756872|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82756873|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82756874|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756875|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82756876|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
82756877|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82756878|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756879|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756880|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82756881|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82756882|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
82756883|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82756884|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756885|NCT01072045|Prednisone|prednisone|mesh-list
82756886|NCT01072045|Propranolol|propranolol|mesh-list
82756887|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82756888|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
82756889|NCT01072045|Hormones|hormones|mesh-ancestor
82756890|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82756891|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756892|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82756893|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756894|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82756895|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82756896|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
82756897|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756898|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756899|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82756900|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82756901|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
82756902|NCT01073059|Ertapenem|ertapenem|mesh-list
82756903|NCT01073059|Valproic Acid|valproic acid|mesh-list
82756904|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
82756905|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756906|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756907|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
82756908|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82756909|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756910|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
82756911|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82756912|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756913|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82756914|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82756915|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756916|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
82756917|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
82756918|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82756919|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756920|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756921|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
82756922|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82756923|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82756924|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756925|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
82756926|NCT00252499|Fenofibrate|fenofibrate|mesh-list
82756927|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82756928|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756929|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82756930|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
82756931|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756932|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82756933|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82756934|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
82756935|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756936|NCT00163657|Cyclosporine|cyclosporine|mesh-list
82756937|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
82756938|NCT00163657|Tacrolimus|tacrolimus|mesh-list
82756939|NCT00163657|Cyclosporins|cyclosporins|mesh-list
82756940|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82756941|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
82756942|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756943|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82756944|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756945|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756946|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
82756947|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756948|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
82756949|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82756950|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82756951|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756952|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82756953|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
82756954|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82756955|NCT01073683|Docetaxel|docetaxel|mesh-list
82756956|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756957|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
82756958|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
82756959|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
82756960|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756961|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82756962|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
82756963|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756964|NCT00230971|Metronidazole|metronidazole|mesh-list
82756965|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
82756966|NCT00230971|Tigecycline|tigecycline|mesh-list
82756967|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82756968|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82756969|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82756970|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82756971|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82756972|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756973|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756974|NCT00211081|Spironolactone|spironolactone|mesh-list
82756975|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82756976|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
82756977|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82756978|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756979|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82756980|NCT00211081|Diuretics|diuretics|mesh-ancestor
82756981|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
82756982|NCT00884676|Sunitinib|sunitinib|mesh-list
82756983|NCT00884676|Epothilone B|epothilone b|mesh-list
82756984|NCT00884676|Epothilones|epothilones|mesh-list
82756985|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82756986|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82756987|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82756988|NCT00884676|Growth Substances|growth substances|mesh-ancestor
82756989|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82756990|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
82756991|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82756992|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82756993|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82756994|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
82756995|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
82756996|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
82756997|NCT00891384|Lenalidomide|lenalidomide|mesh-list
82756998|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
82756999|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757000|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82757001|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82757002|NCT00891384|Growth Substances|growth substances|mesh-ancestor
82757003|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
82757004|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757005|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82757006|NCT00887328|Plasminogen|plasminogen|mesh-list
82757007|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82757008|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82757009|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757010|NCT00609336|Gemcitabine|gemcitabine|mesh-list
82757011|NCT00609336|Capecitabine|capecitabine|mesh-list
82757012|NCT00609336|Docetaxel|docetaxel|mesh-list
82757013|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
82757014|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82757015|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
82757167|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82757016|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757017|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757018|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
82757019|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
82757020|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
82757021|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
82757022|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82757023|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757024|NCT02541084|Aflibercept|aflibercept|mesh-list
82757025|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82757026|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82757027|NCT02541084|Growth Substances|growth substances|mesh-ancestor
82757028|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757029|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
82757030|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757031|NCT04397406|Fentanyl|fentanyl|mesh-list
82757032|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
82757033|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
82757034|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82757035|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757036|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757037|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82757039|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
82757040|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757041|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82757042|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82757043|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82757044|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
82757045|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757046|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757047|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82757049|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82757050|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82757051|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
82757052|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
82757053|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
82757054|NCT00891540|Ropivacaine|ropivacaine|mesh-list
82757055|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
82757056|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
82757057|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757058|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757059|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
82757060|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757061|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82757062|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
82757063|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757064|NCT00891696|Sirolimus|sirolimus|mesh-list
82757065|NCT00891696|Nitroprusside|nitroprusside|mesh-list
82757066|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82757067|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757068|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82757069|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757070|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
82757071|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82757072|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
82757073|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757074|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757075|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82757076|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
82757077|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82757078|NCT00640328|Ofatumumab|ofatumumab|mesh-list
82757079|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82757080|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757081|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
82757082|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757083|NCT04036890|Minocycline|minocycline|mesh-list
82757084|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82757085|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757086|NCT00162097|Efavirenz|efavirenz|mesh-list
82757087|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82757088|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82757089|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82757090|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757091|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757092|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
82757168|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
82757093|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757094|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82757095|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82757096|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82757097|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82757098|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82757099|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82757100|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
82757102|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
82757103|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
82757104|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757105|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757106|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
82757107|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757108|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82757109|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82757110|NCT02550782|Analgesics|analgesics|mesh-ancestor
82757111|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82757112|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82757113|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82757114|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
82757115|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757116|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757118|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
82757119|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82757120|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82757121|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757122|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757123|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757124|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82757125|NCT01073761|Ritonavir|ritonavir|mesh-list
82757126|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82757127|NCT01073761|Darunavir|darunavir|mesh-list
82757128|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82757129|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82757130|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
82757131|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757132|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757133|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82757134|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82757135|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
82757136|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757137|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82757138|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82757139|NCT00819104|Metoprolol|metoprolol|mesh-list
82757140|NCT00819104|Amlodipine|amlodipine|mesh-list
82757141|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82757142|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82757143|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82757144|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757145|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82757146|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757147|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
82757148|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82757149|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
82757150|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
82757151|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757152|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82757153|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82757154|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82757155|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
82757156|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757157|NCT02542098|Hydrocodone|hydrocodone|mesh-list
82757158|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82757159|NCT02542098|Narcotics|narcotics|mesh-ancestor
82757160|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757161|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757162|NCT02542098|Analgesics|analgesics|mesh-ancestor
82757163|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
82757164|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757165|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
82757166|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
82757169|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757171|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82757172|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757173|NCT00885066|Gemcitabine|gemcitabine|mesh-list
82757174|NCT00885066|Capecitabine|capecitabine|mesh-list
82757175|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82757176|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82757177|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
82757178|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757179|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757180|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757181|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757183|NCT00888108|Navitoclax|navitoclax|mesh-list
82757184|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757185|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
82757186|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
82757187|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
82757188|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757189|NCT00885300|Cloxacillin|cloxacillin|mesh-list
82757190|NCT00885300|Heparin|heparin|mesh-list
82757191|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
82757192|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82757193|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82757194|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757195|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82757196|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757197|NCT00888186|Levodopa|levodopa|mesh-list
82757198|NCT00888186|Carbidopa|carbidopa|mesh-list
82757199|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82757200|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82757201|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
82757202|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757203|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757204|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757205|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82757206|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757207|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82757208|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82757209|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82757210|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757211|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757212|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82757213|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82757214|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82757215|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
82757216|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757217|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757218|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82757219|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82757220|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
82757221|NCT00892398|Ranibizumab|ranibizumab|mesh-list
82757222|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82757223|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82757224|NCT00892398|Growth Substances|growth substances|mesh-ancestor
82757225|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757226|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
82757227|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757228|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
82757229|NCT00892476|Calcium|calcium|mesh-list
82757230|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82757231|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757232|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82757233|NCT02541786|Rabeprazole|rabeprazole|mesh-list
82757234|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
82757235|NCT02541786|Lansoprazole|lansoprazole|mesh-list
82757236|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82757237|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82757238|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82757239|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757240|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757241|NCT00888342|Ethanol|ethanol|mesh-list
82757242|NCT00888342|Zopiclone|zopiclone|mesh-list
82757243|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82757244|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757245|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757246|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757247|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82757248|NCT00608868|Gefitinib|gefitinib|mesh-list
82757249|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757250|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757251|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757252|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757253|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82757254|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
82757255|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757256|NCT04036500|Estradiol|estradiol|mesh-list
82757257|NCT04036500|Estrogens|estrogens|mesh-ancestor
82757258|NCT04036500|Hormones|hormones|mesh-ancestor
82757259|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82757260|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757261|NCT00895674|Sorafenib|sorafenib|mesh-list
82757262|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757263|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757264|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757265|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757266|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
82757267|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82757268|NCT04035330|Eusol|eusol|mesh-list
82757269|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
82757270|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757271|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82757272|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757273|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
82757274|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
82757275|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757276|NCT04035096|Protective Agents|protective agents|mesh-ancestor
82757277|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757278|NCT04035096|Vitamins|vitamins|mesh-ancestor
82757279|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
82757280|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
82757281|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82757282|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
82757283|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757284|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757285|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82757286|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
82757287|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82757288|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
82757289|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757290|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757291|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82757292|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
82757303|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757304|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82757305|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757306|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757307|NCT00893100|Diltiazem|diltiazem|mesh-list
82757308|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82757309|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82757310|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82757311|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757312|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82757313|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757314|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
82757315|NCT03324984|Bupivacaine|bupivacaine|mesh-list
82757316|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
82757317|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
82757318|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
82757319|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757320|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757321|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
82757322|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757323|NCT00896376|Trastuzumab|trastuzumab|mesh-list
82757324|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82757325|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757326|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
82757327|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
82757328|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82757329|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757330|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82757331|NCT00893256|Risperidone|risperidone|mesh-list
82757332|NCT00893256|Citalopram|citalopram|mesh-list
82757333|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82757334|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
82757335|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757336|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757337|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757338|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82757339|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82757340|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757341|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82757342|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82757343|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
82757344|NCT00893256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82757345|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82757346|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82757347|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82757348|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
82757349|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82757350|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82757352|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757353|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757354|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82757355|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
82757356|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
82757357|NCT00901368|Hormones|hormones|mesh-ancestor
82757358|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82757359|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
82757360|NCT00901524|Interferons|interferons|mesh-list
82757361|NCT00901524|Ribavirin|ribavirin|mesh-list
82757362|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
82757363|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
82757364|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82757365|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757366|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
82757367|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757368|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
82757369|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757370|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
82757371|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757372|NCT00893412|Tramadol|tramadol|mesh-list
82757373|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82757374|NCT00893412|Narcotics|narcotics|mesh-ancestor
82757375|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757376|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757377|NCT00893412|Analgesics|analgesics|mesh-ancestor
82757378|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
82757379|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757380|NCT00893490|Mitomycins|mitomycins|mesh-list
82757381|NCT00893490|Mitomycin|mitomycin|mesh-list
82757382|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82757383|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757384|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
82757385|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757386|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82757387|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757388|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
82757389|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
82757390|NCT00638690|Prednisone|prednisone|mesh-list
82757391|NCT00638690|Prednisolone|prednisolone|mesh-list
82757392|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
82757393|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82757394|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
82757395|NCT00638690|Hormones|hormones|mesh-ancestor
82757396|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82757397|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757398|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82757399|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757400|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82757401|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757402|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757403|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
82757483|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757404|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82757405|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
82757406|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757407|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757408|NCT00893724|Tocopherols|tocopherols|mesh-list
82757409|NCT00893724|Vitamin E|vitamin e|mesh-list
82757410|NCT00893724|Tocotrienols|tocotrienols|mesh-list
82757411|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
82757412|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
82757413|NCT00893724|Niacinamide|niacinamide|mesh-list
82757415|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
82757416|NCT00893724|Ubiquinone|ubiquinone|mesh-list
82757417|NCT00893724|Minocycline|minocycline|mesh-list
82757418|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
82757419|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82757421|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
82757422|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757423|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
82757424|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757425|NCT00893724|Protective Agents|protective agents|mesh-ancestor
82757426|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82757427|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757428|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
82757429|NCT00893724|Expectorants|expectorants|mesh-ancestor
82757430|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
82757431|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82757432|NCT00893724|Antidotes|antidotes|mesh-ancestor
82757433|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
82757434|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82757435|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
82757436|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82757437|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
82757438|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
82757439|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82757440|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
82757441|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757442|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757443|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82757444|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
82757445|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82757446|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
82757447|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757448|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757449|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82757450|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
82757451|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
82757452|NCT00893880|Protective Agents|protective agents|mesh-ancestor
82757453|NCT00815594|Bevacizumab|bevacizumab|mesh-list
82757454|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82757455|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757456|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82757457|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82757458|NCT00815594|Growth Substances|growth substances|mesh-ancestor
82757459|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757460|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
82757461|NCT00897312|Interferons|interferons|mesh-list
82757462|NCT00897312|Ribavirin|ribavirin|mesh-list
82757463|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
82757464|NCT00897312|Infliximab|infliximab|mesh-list
82757465|NCT00897312|Tremelimumab|tremelimumab|mesh-list
82757466|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757467|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
82757468|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757469|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
82757470|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757471|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
82757472|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757473|NCT00897312|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82757474|NCT00897312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82757475|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
82757476|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82757477|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82757478|NCT02540460|Delpazolid|delpazolid|mesh-list
82757479|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
82757480|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82757481|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757482|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82757484|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757486|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757487|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
82757488|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
82757489|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
82757490|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757491|NCT03455556|Atezolizumab|atezolizumab|mesh-list
82757492|NCT03455556|Maytansine|maytansine|mesh-list
82757493|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82757494|NCT03455556|Anetumab ravtansine|anetumab ravtansine|mesh-list
82757495|NCT03455556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82757496|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757497|NCT03455556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82757498|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757499|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
82757500|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757501|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82757502|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
82757503|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
82757504|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
82757505|NCT03455556|Immunoconjugates|immunoconjugates|mesh-ancestor
82757506|NCT04017624|Nicotine|nicotine|mesh-list
82757507|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82757508|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
82757509|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757510|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757511|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82757512|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82757513|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
82757514|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757515|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757516|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
82757517|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757518|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
82757519|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757520|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757521|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82757522|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82757523|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
82757524|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757525|NCT00983151|Tramadol|tramadol|mesh-list
82757526|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82757527|NCT00983151|Narcotics|narcotics|mesh-ancestor
82757528|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757529|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757530|NCT00983151|Analgesics|analgesics|mesh-ancestor
82757531|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
82757532|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757533|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
82757534|NCT00635570|NuvaRing|nuvaring|mesh-list
82757535|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82757536|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82757537|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
82757538|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82757539|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757540|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82757541|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82757542|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82757543|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82757544|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757545|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82757546|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82757547|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757548|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757549|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757550|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
82757551|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82757552|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757553|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82757554|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
82757555|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82757556|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757557|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757631|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82757558|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757559|NCT00986115|Memantine|memantine|mesh-list
82757560|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82757561|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82757562|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
82757563|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757564|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757565|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757566|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82757567|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82757568|NCT04035876|Apatinib|apatinib|mesh-list
82757569|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757570|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757571|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757572|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757573|NCT00902070|Rocuronium|rocuronium|mesh-list
82757574|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82757575|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82757576|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82757577|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757578|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757579|NCT00635492|Insulin|insulin|mesh-list
82757580|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82757581|NCT00635492|Exenatide|exenatide|mesh-list
82757582|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82757583|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757584|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82757585|NCT00635492|Incretins|incretins|mesh-ancestor
82757586|NCT00635492|Hormones|hormones|mesh-ancestor
82757587|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82757588|NCT00543309|Milrinone|milrinone|mesh-list
82757589|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82757590|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82757591|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82757592|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
82757593|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82757594|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82757595|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757596|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757597|NCT00543309|Protective Agents|protective agents|mesh-ancestor
82757598|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757599|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
82757600|NCT00569582|Mifepristone|mifepristone|mesh-list
82757601|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82757602|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
82757603|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82757604|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757605|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82757606|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82757607|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82757608|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
82757609|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82757610|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82757611|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
82757612|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82757613|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
82757614|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82757615|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82757616|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
82757617|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82757618|NCT00988845|Protective Agents|protective agents|mesh-ancestor
82757619|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757620|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757621|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82757622|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82757623|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757624|NCT00902460|Midazolam|midazolam|mesh-list
82757625|NCT00902460|Tofacitinib|tofacitinib|mesh-list
82757626|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82757627|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82757628|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757629|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757630|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82757632|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82757633|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82757634|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
82757635|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
82757636|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
82757637|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
82757638|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757639|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757640|NCT00902460|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82757641|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757642|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757643|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
82757644|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82757645|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757646|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82757647|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757648|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82757649|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
82757650|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82757651|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
82757652|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757653|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
82757654|NCT00809198|Protective Agents|protective agents|mesh-ancestor
82757655|NCT00809198|Laxatives|laxatives|mesh-ancestor
82757656|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82757657|NCT00986505|Lidocaine|lidocaine|mesh-list
82757658|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
82757659|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
82757660|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757661|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757662|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
82757663|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757664|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82757665|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82757666|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82757667|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82757668|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757669|NCT03667443|Inositol|inositol|mesh-list
82757670|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
82757671|NCT03667443|Vitamins|vitamins|mesh-ancestor
82757672|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
82757673|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757674|NCT00902772|Lorazepam|lorazepam|mesh-list
82757675|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
82757676|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
82757677|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
82757678|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757679|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757680|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82757681|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82757682|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757683|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82757684|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82757685|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82757687|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
82757688|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757689|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757690|NCT00894660|Amodiaquine|amodiaquine|mesh-list
82757691|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
82757692|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82757693|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82757694|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757695|NCT00721409|Letrozole|letrozole|mesh-list
82757696|NCT00721409|Palbociclib|palbociclib|mesh-list
82757697|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757698|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82757699|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82757700|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757701|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757702|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82757703|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
82757704|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82757705|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757706|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757707|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
82757708|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82757709|NCT00542997|Antibodies|antibodies|mesh-list
82757710|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
82757711|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757712|NCT00903084|Tenofovir|tenofovir|mesh-list
82757713|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
82757714|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757715|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82757716|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82757717|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757718|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757719|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82757720|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82757721|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
82757722|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82757723|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
82757724|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757725|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757726|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82757727|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
82757728|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
82757729|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82757730|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
82757731|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757732|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757733|NCT02591771|Epinephrine|epinephrine|mesh-list
82757734|NCT02591771|Racepinephrine|racepinephrine|mesh-list
82757735|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
82757736|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82757737|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82757738|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
82757739|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757740|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757741|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757742|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82757743|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82757744|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
82757745|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757746|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82757747|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
82757748|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
82757749|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
82757750|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82757751|NCT00986817|Terlipressin|terlipressin|mesh-list
82757752|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82757753|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82757754|NCT00572832|Vaccines|vaccines|mesh-list
82757755|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
82757756|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757757|NCT02591849|Glucagon|glucagon|mesh-list
82757758|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82757759|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82757760|NCT02591849|Hormones|hormones|mesh-ancestor
82757761|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82757762|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757763|NCT02591849|Incretins|incretins|mesh-ancestor
82757764|NCT00898794|Bevacizumab|bevacizumab|mesh-list
82757765|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82757766|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757767|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82757768|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82757769|NCT00898794|Growth Substances|growth substances|mesh-ancestor
82757770|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757771|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
82757772|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
82757773|NCT04086719|Deucravacitinib|deucravacitinib|mesh-list
82757774|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
82757775|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82757776|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82757777|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757778|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82757779|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757780|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757781|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
82757782|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757783|NCT00898950|Aspirin|aspirin|mesh-list
82757784|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
82757785|NCT00898950|Salicylates|salicylates|mesh-list
82757786|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82757787|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82757788|NCT00898950|Analgesics|analgesics|mesh-ancestor
82757789|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
82757790|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757791|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757792|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82757793|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82757794|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82757795|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82757796|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757797|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82757798|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82757799|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757800|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
82757801|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757802|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
82757803|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
82757804|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
82757805|NCT03622515|Anesthetics|anesthetics|mesh-list
82757806|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757807|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757808|NCT05279235|Favipiravir|favipiravir|mesh-list
82757809|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
82757810|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757811|NCT00229723|Gefitinib|gefitinib|mesh-list
82757812|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757813|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757814|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757815|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757816|NCT04035798|Memantine|memantine|mesh-list
82757817|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82757818|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82757819|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
82757820|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757821|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757822|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757823|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82757824|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82757825|NCT01075477|Rituximab|rituximab|mesh-list
82757826|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82757827|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757828|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
82757829|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757830|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82757831|NCT01075555|Sorafenib|sorafenib|mesh-list
82757832|NCT01075555|Pravastatin|pravastatin|mesh-list
82757833|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757834|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757835|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757836|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757837|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82757838|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82757839|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
82757840|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82757841|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82757842|NCT00627926|Interferons|interferons|mesh-list
82757843|NCT00627926|Ribavirin|ribavirin|mesh-list
82757844|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
82757845|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
82757846|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82757847|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757848|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
82757849|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757850|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
82757851|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757852|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
82757853|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757854|NCT00228553|Modafinil|modafinil|mesh-list
82757855|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82757856|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757857|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82757858|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82757859|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82757932|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82757860|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757862|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82757863|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82757864|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82757865|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
82757866|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757867|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757868|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757869|NCT00922506|Urological Agents|urological agents|mesh-ancestor
82757870|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82757871|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82757872|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82757873|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82757874|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
82757875|NCT00816140|Clarithromycin|clarithromycin|mesh-list
82757876|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82757877|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757878|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82757879|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757880|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757881|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82757882|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82757883|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82757884|NCT00895128|Dasatinib|dasatinib|mesh-list
82757885|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757886|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757887|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757888|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757889|NCT00903942|Paclitaxel|paclitaxel|mesh-list
82757890|NCT00903942|Carboplatin|carboplatin|mesh-list
82757891|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82757892|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82757893|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757894|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
82757895|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
82757896|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
82757897|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757898|NCT00904020|Lidocaine|lidocaine|mesh-list
82757899|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
82757900|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
82757901|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757902|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757903|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
82757904|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757905|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82757906|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82757907|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82757908|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82757909|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757910|NCT00895362|Cetuximab|cetuximab|mesh-list
82757911|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82757912|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82757913|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757914|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757915|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757916|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757917|NCT00904098|Frovatriptan|frovatriptan|mesh-list
82757918|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82757919|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
82757920|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757921|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757922|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757923|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
82757924|NCT00904176|Digoxin|digoxin|mesh-list
82757925|NCT00904176|Warfarin|warfarin|mesh-list
82757926|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82757927|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757928|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82757929|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757930|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
82757931|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82757933|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757934|NCT00904176|Protective Agents|protective agents|mesh-ancestor
82757935|NCT02540070|Ketorolac|ketorolac|mesh-list
82757936|NCT02540070|Epinephrine|epinephrine|mesh-list
82757937|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
82757938|NCT02540070|Morphine|morphine|mesh-list
82757939|NCT02540070|Ropivacaine|ropivacaine|mesh-list
82757940|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82757941|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82757942|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757943|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82757945|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
82757946|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82757947|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82757948|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82757949|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82757950|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
82757951|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82757952|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757953|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82757954|NCT02540070|Narcotics|narcotics|mesh-ancestor
82757955|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
82757956|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
82757957|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82757958|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82757959|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
82757960|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82757961|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
82757962|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
82757963|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
82757964|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82757965|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82757966|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82757967|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82757968|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82757969|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757970|NCT00905814|Axitinib|axitinib|mesh-list
82757971|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82757972|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82757973|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757974|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757975|NCT00900510|Trimethoprim|trimethoprim|mesh-list
82757976|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82757977|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
82757978|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82757979|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82757980|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
82757981|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82757982|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82757983|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82757984|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82757985|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82757986|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82757987|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82757988|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82757989|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82757990|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
82757991|NCT00160693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82757992|NCT00160693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82757993|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82757994|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
82757995|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82757996|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82757997|NCT00906048|Levofloxacin|levofloxacin|mesh-list
82757998|NCT00906048|Rifampin|rifampin|mesh-list
82757999|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82758000|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758001|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82758002|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82758003|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82758004|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758005|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758006|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758007|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82758008|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82758009|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82758010|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
82758011|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
82758012|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82758013|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82758014|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82758015|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82758016|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82758017|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82758018|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82758019|NCT00906126|Misoprostol|misoprostol|mesh-list
82758020|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82758021|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
82758022|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82758023|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758024|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82758025|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82758026|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
82758027|NCT00900744|Tamoxifen|tamoxifen|mesh-list
82758028|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82758029|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
82758030|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82758031|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758032|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82758033|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758034|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82758035|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82758036|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82758037|NCT00643760|Pregabalin|pregabalin|mesh-list
82758038|NCT00643760|Gabapentin|gabapentin|mesh-list
82758039|NCT00643760|Analgesics|analgesics|mesh-ancestor
82758040|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
82758041|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758042|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758043|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
82758044|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82758045|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82758046|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758047|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82758048|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82758049|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82758050|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758051|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82758052|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82758053|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82758054|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758055|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
82758056|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
82758057|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82758058|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82758059|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
82758060|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758061|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82758062|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82758063|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758064|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758065|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82758066|NCT00906360|Cetuximab|cetuximab|mesh-list
82758067|NCT00906360|Sunitinib|sunitinib|mesh-list
82758068|NCT00906360|Antibodies|antibodies|mesh-list
82758069|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
82758070|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82758071|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
82758072|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758073|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758074|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82758075|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82758076|NCT00906360|Growth Substances|growth substances|mesh-ancestor
82758077|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
82758078|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82758079|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758080|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758081|NCT00643604|Treprostinil|treprostinil|mesh-list
82758160|NCT00627458|Vaccines|vaccines|mesh-list
82758082|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82758083|NCT00603798|Imiquimod|imiquimod|mesh-list
82758084|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82758085|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
82758086|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758087|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758088|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
82758090|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
82758091|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
82758092|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758093|NCT00630812|Mannitol|mannitol|mesh-list
82758094|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82758095|NCT00630812|Diuretics|diuretics|mesh-ancestor
82758096|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
82758097|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758098|NCT00906516|Bevacizumab|bevacizumab|mesh-list
82758099|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82758100|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758101|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82758102|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82758103|NCT00906516|Growth Substances|growth substances|mesh-ancestor
82758104|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758105|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
82758106|NCT00629798|Fludarabine|fludarabine|mesh-list
82758107|NCT00629798|Melphalan|melphalan|mesh-list
82758108|NCT00629798|Busulfan|busulfan|mesh-list
82758109|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82758110|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758111|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758112|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758113|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
82758114|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758115|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82758116|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
82758117|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82758118|NCT00160615|Levetiracetam|levetiracetam|mesh-list
82758119|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
82758120|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
82758121|NCT00906594|Latanoprost|latanoprost|mesh-list
82758122|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82758123|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82758124|NCT03970759|Fluorides|fluorides|mesh-list
82758125|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
82758126|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
82758127|NCT03970759|Protective Agents|protective agents|mesh-ancestor
82758128|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758129|NCT00905190|Ondansetron|ondansetron|mesh-list
82758130|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
82758131|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
82758132|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758133|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758134|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82758135|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
82758136|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
82758137|NCT00905190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82758138|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82758139|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
82758140|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758141|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758142|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82758143|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
82758144|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
82758145|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82758146|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
82758147|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758148|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758149|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82758150|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
82758151|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82758152|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82758153|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82758154|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
82758155|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758156|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758157|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82758158|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
82758159|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82758161|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
82758162|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758164|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82758165|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758166|NCT00909168|Immunotoxins|immunotoxins|mesh-ancestor
82758167|NCT00909168|Immunoconjugates|immunoconjugates|mesh-ancestor
82758168|NCT00909168|Immunologic Factors|immunologic factors|mesh-ancestor
82758169|NCT00909168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758170|NCT00816218|Pioglitazone|pioglitazone|mesh-list
82758171|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82758172|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758173|NCT00819728|Docetaxel|docetaxel|mesh-list
82758174|NCT00819728|Irinotecan|irinotecan|mesh-list
82758175|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758176|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
82758177|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
82758178|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
82758179|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758180|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82758181|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82758182|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758183|NCT00906828|Levodopa|levodopa|mesh-list
82758184|NCT00906828|Carbidopa|carbidopa|mesh-list
82758185|NCT00906828|Entacapone|entacapone|mesh-list
82758186|NCT00906828|Tolcapone|tolcapone|mesh-list
82758187|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82758188|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82758189|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
82758190|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758191|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758192|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758193|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82758194|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758195|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82758196|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
82758197|NCT00819806|Vaccines|vaccines|mesh-list
82758198|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
82758199|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758200|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758201|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82758202|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82758203|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
82758204|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758205|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758206|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82758207|NCT00909402|Capecitabine|capecitabine|mesh-list
82758208|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758209|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82758210|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
82758211|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758212|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
82758213|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82758214|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82758215|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758216|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
82758217|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
82758218|NCT00821444|Ziprasidone|ziprasidone|mesh-list
82758219|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82758220|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
82758221|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758222|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758223|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758224|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82758225|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82758226|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758227|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82758228|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82758229|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
82758230|NCT00909558|Immunomodulating Agents|immunomodulating agents|mesh-list
82758231|NCT00909558|Immunologic Factors|immunologic factors|mesh-ancestor
82758232|NCT00909558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758233|NCT00819962|Bupivacaine|bupivacaine|mesh-list
82758234|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
82758235|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
82758236|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758237|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758238|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
82758239|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758240|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82758242|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82758243|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82758244|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758245|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758246|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
82758247|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758248|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82758249|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82758250|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82758251|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82758252|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
82758253|NCT00927498|Cytarabine|cytarabine|mesh-list
82758254|NCT00927498|Daunorubicin|daunorubicin|mesh-list
82758255|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
82758256|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82758257|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758258|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82758259|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82758260|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758261|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758262|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82758263|NCT00927498|Immunotoxins|immunotoxins|mesh-ancestor
82758264|NCT00927498|Immunoconjugates|immunoconjugates|mesh-ancestor
82758265|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
82758266|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758267|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82758268|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
82758269|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
82758270|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758271|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758272|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
82758273|NCT00159913|Citric Acid|citric acid|mesh-list
82758274|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
82758275|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
82758276|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82758277|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
82758278|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
82758279|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758280|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
82758281|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82758282|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82758283|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758284|NCT00159913|Urological Agents|urological agents|mesh-ancestor
82758285|NCT05498259|Rituximab|rituximab|mesh-list
82758286|NCT05498259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82758287|NCT05498259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758288|NCT05498259|Immunologic Factors|immunologic factors|mesh-ancestor
82758289|NCT05498259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758290|NCT05498259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82758291|NCT00821600|Risperidone|risperidone|mesh-list
82758292|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82758293|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
82758294|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758295|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758296|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758297|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82758298|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82758299|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758300|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82758301|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82758302|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
82758303|NCT00987207|Cyclosporine|cyclosporine|mesh-list
82758304|NCT00987207|Cyclosporins|cyclosporins|mesh-list
82758305|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758306|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758307|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758308|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
82758309|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758310|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
82758311|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758312|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
82758313|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82758314|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82758315|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82758316|NCT00604188|Buprenorphine|buprenorphine|mesh-list
82758317|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82758318|NCT00604188|Narcotics|narcotics|mesh-ancestor
82758319|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758320|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758321|NCT00604188|Analgesics|analgesics|mesh-ancestor
82758322|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
82758323|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758324|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82758325|NCT00820352|Bosentan|bosentan|mesh-list
82758326|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82758327|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82758328|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758329|NCT00927654|Iloprost|iloprost|mesh-list
82758330|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82758331|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
82758332|NCT00927732|Quinidine|quinidine|mesh-list
82758333|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
82758334|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82758335|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
82758336|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
82758337|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758338|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758339|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82758340|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82758341|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
82758342|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758343|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758344|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
82758345|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82758346|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82758347|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758348|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758349|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82758350|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82758351|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
82758352|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82758353|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82758354|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82758355|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82758356|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82758357|NCT00227539|Pemetrexed|pemetrexed|mesh-list
82758358|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82758359|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758360|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758361|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758362|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82758363|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82758364|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82758365|NCT02936622|Paclitaxel|paclitaxel|mesh-list
82758366|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82758367|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82758368|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758369|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
82758370|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
82758371|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
82758372|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758373|NCT00927966|Everolimus|everolimus|mesh-list
82758374|NCT00927966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82758375|NCT00927966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82758376|NCT00927966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758377|NCT00927966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758378|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758379|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
82758380|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758381|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758382|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82758383|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
82758384|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82758385|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82758386|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82758462|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
82758387|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758388|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758390|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758391|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82758392|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82758393|NCT00720941|Growth Substances|growth substances|mesh-ancestor
82758394|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758395|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
82758396|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82758397|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758398|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758399|NCT00924222|Propofol|propofol|mesh-list
82758400|NCT00924222|Sevoflurane|sevoflurane|mesh-list
82758401|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82758402|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758403|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758404|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82758405|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
82758406|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
82758407|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82758408|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82758409|NCT01075711|Prednisone|prednisone|mesh-list
82758410|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82758411|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
82758412|NCT01075711|Hormones|hormones|mesh-ancestor
82758413|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82758414|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758415|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82758416|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758417|NCT01073371|Prilocaine|prilocaine|mesh-list
82758418|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
82758419|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
82758420|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758421|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758422|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
82758423|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758424|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
82758425|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82758426|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82758427|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758428|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
82758429|NCT03970213|Coagulants|coagulants|mesh-ancestor
82758430|NCT00821834|Ticlopidine|ticlopidine|mesh-list
82758431|NCT00821834|Clopidogrel|clopidogrel|mesh-list
82758432|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82758433|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82758434|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82758435|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82758436|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
82758437|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758438|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758439|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758440|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82758441|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82758442|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82758443|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82758444|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758445|NCT04005417|Fluorides|fluorides|mesh-list
82758446|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
82758447|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
82758448|NCT04005417|Protective Agents|protective agents|mesh-ancestor
82758449|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758450|NCT01073839|Gemcitabine|gemcitabine|mesh-list
82758451|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758452|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82758453|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
82758454|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758455|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82758456|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758457|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82758458|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758459|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758460|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
82758461|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82758463|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758464|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758465|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82758466|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
82758467|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82758468|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82758469|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82758470|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
82758471|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758472|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758473|NCT05420727|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82758474|NCT05420727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82758475|NCT05420727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758476|NCT00987441|Sufentanil|sufentanil|mesh-list
82758477|NCT00987441|Dsuvia|dsuvia|mesh-list
82758478|NCT00987441|Ropivacaine|ropivacaine|mesh-list
82758479|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
82758480|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
82758481|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758482|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758483|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
82758484|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758485|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82758486|NCT00987441|Narcotics|narcotics|mesh-ancestor
82758487|NCT00987441|Analgesics|analgesics|mesh-ancestor
82758488|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82758489|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82758490|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
82758491|NCT00584987|Fluticasone|fluticasone|mesh-list
82758492|NCT00584987|Xhance|xhance|mesh-list
82758493|NCT00584987|Phenylephrine|phenylephrine|mesh-list
82758494|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
82758495|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82758496|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82758497|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
82758498|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758499|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758500|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82758501|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
82758502|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
82758503|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82758504|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82758505|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82758506|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
82758507|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758508|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758509|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
82758510|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
82758511|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82758512|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82758513|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
82758514|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82758515|NCT00584987|Protective Agents|protective agents|mesh-ancestor
82758516|NCT00727961|Doxorubicin|doxorubicin|mesh-list
82758517|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82758518|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82758519|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758520|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82758521|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82758522|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758523|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758524|NCT00568958|Naltrexone|naltrexone|mesh-list
82758525|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82758526|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82758527|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758528|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
82758529|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758530|NCT00821912|Docetaxel|docetaxel|mesh-list
82758531|NCT00821912|Capecitabine|capecitabine|mesh-list
82758532|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758533|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
82758534|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
82758535|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
82758536|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758537|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82758538|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
82758539|NCT00727649|Loperamide|loperamide|mesh-list
82758540|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
82758541|NCT00727649|Psyllium|psyllium|mesh-list
82758542|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82758543|NCT00727649|Cathartics|cathartics|mesh-ancestor
82758544|NCT04006041|Paclitaxel|paclitaxel|mesh-list
82758545|NCT04006041|Cisplatin|cisplatin|mesh-list
82758546|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82758547|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758548|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
82758549|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
82758550|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
82758551|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758552|NCT00225277|Pioglitazone|pioglitazone|mesh-list
82758553|NCT00225277|Glimepiride|glimepiride|mesh-list
82758554|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82758555|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758556|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82758557|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758558|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
82758559|NCT00821054|Lapatinib|lapatinib|mesh-list
82758560|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758561|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82758562|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758563|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758564|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82758565|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82758566|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
82758567|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758568|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758569|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82758570|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
82758571|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82758572|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82758573|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82758574|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
82758575|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758576|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758577|NCT04388319|Zonisamide|zonisamide|mesh-list
82758578|NCT04388319|Bupropion|bupropion|mesh-list
82758579|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82758580|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
82758581|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82758582|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82758583|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82758584|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82758585|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758586|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
82758587|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758588|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758589|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82758590|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82758591|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758592|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
82758593|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82758594|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82758595|NCT04085627|Amlodipine|amlodipine|mesh-list
82758596|NCT04085627|Valsartan|valsartan|mesh-list
82758597|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
82758598|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82758599|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82758600|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82758601|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758602|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82758603|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758604|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
82758605|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82758606|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82758607|NCT04085393|Granisetron|granisetron|mesh-list
82758608|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
82758609|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
82758610|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758611|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758612|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82758613|NCT04085393|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82758614|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82758615|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
82758616|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758617|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758618|NCT00717275|Temozolomide|temozolomide|mesh-list
82758619|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82758620|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
82758621|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758622|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758623|NCT04006353|Rifampin|rifampin|mesh-list
82758624|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82758625|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
82758626|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82758627|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758628|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
82758629|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82758630|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758631|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758632|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82758633|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82758634|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82758635|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82758636|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82758637|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82758638|NCT01075789|Lidocaine|lidocaine|mesh-list
82758639|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
82758640|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
82758641|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758642|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758643|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
82758644|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758645|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82758646|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82758647|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82758648|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82758649|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758650|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
82758651|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82758652|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
82758653|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758654|NCT00584909|Paclitaxel|paclitaxel|mesh-list
82758655|NCT00584909|Carboplatin|carboplatin|mesh-list
82758656|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82758657|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758658|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
82758659|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
82758660|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
82758661|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758662|NCT03947099|Ketamine|ketamine|mesh-list
82758663|NCT03947099|Analgesics|analgesics|mesh-ancestor
82758664|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
82758665|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758666|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758667|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82758668|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82758669|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
82758670|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
82758671|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758672|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82758673|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82758674|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758675|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758676|NCT05361915|Abivertinib|abivertinib|mesh-list
82758677|NCT05361915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82758678|NCT05361915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758679|NCT05361915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758680|NCT00929058|Bevacizumab|bevacizumab|mesh-list
82758681|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82758682|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758683|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82758687|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
82758691|NCT00907452|Thalidomide|thalidomide|mesh-list
82758692|NCT00907452|Dexamethasone|dexamethasone|mesh-list
82758693|NCT00907452|Prednisone|prednisone|mesh-list
82758694|NCT00907452|Lenalidomide|lenalidomide|mesh-list
82758695|NCT00907452|Melphalan|melphalan|mesh-list
82758696|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82758697|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
82758698|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
82758699|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758700|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758701|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82758702|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
82758703|NCT00907452|Hormones|hormones|mesh-ancestor
82758704|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82758705|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82758706|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758707|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
82758708|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82758709|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82758710|NCT00907452|Growth Substances|growth substances|mesh-ancestor
82758711|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
82758712|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82758713|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
82758714|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758715|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82758716|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758717|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
82758718|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82758719|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758720|NCT00717197|Capecitabine|capecitabine|mesh-list
82758721|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82758722|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
82758723|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758724|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758725|NCT00925392|Doripenem|doripenem|mesh-list
82758726|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82758727|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758728|NCT05315271|Ketamine|ketamine|mesh-list
82758729|NCT05315271|Bupivacaine|bupivacaine|mesh-list
82758730|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
82758731|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
82758732|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758733|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758734|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
82758735|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758736|NCT05315271|Analgesics|analgesics|mesh-ancestor
82758737|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82758738|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82758739|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
82758740|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82758741|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82758742|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758743|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758744|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
82758745|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
82758746|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82758747|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758748|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82758749|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82758750|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
82758751|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758752|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82758753|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
82758754|NCT05313477|Vitamin D|vitamin d|mesh-list
82758755|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
82758756|NCT05313477|Calcium|calcium|mesh-list
82758757|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82758758|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758759|NCT05313477|Antacids|antacids|mesh-ancestor
82758760|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758761|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82758762|NCT05313477|Vitamins|vitamins|mesh-ancestor
82758763|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
82758764|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82758765|NCT00224107|Silodosin|silodosin|mesh-list
82758766|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82758767|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82758768|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82758769|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
82758770|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758771|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758772|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758773|NCT00224107|Urological Agents|urological agents|mesh-ancestor
82758774|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
82758775|NCT04696731|Fludarabine|fludarabine|mesh-list
82758776|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758777|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
82758778|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758779|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82758780|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82758781|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
82758782|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758783|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758784|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82758785|NCT04004871|Paclitaxel|paclitaxel|mesh-list
82758786|NCT04004871|Cisplatin|cisplatin|mesh-list
82758787|NCT04004871|Fluorouracil|fluorouracil|mesh-list
82758788|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82758789|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758790|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
82758791|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
82758792|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
82758793|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758794|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
82758795|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82758796|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758797|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
82758798|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758799|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82758800|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82758801|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82758802|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
82758803|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758804|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82758805|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82758806|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758807|NCT00987909|Immunomodulating Agents|immunomodulating agents|mesh-list
82758808|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
82758809|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758810|NCT00822380|Iron|iron|mesh-list
82758811|NCT00822380|Trace Elements|trace elements|mesh-list
82758812|NCT00822380|Folic Acid|folic acid|mesh-list
82758813|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
82758814|NCT00822380|Micronutrients|micronutrients|mesh-list
82758815|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758816|NCT00822380|Hematinics|hematinics|mesh-ancestor
82758817|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
82758818|NCT00822380|Vitamins|vitamins|mesh-ancestor
82758819|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
82758820|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758821|NCT00822380|Protective Agents|protective agents|mesh-ancestor
82758822|NCT00720083|Cisplatin|cisplatin|mesh-list
82758823|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758824|NCT05621811|ATI 7505|ati 7505|mesh-list
82758825|NCT05621811|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82758826|NCT05621811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82758827|NCT05621811|Serotonin Agents|serotonin agents|mesh-ancestor
82758828|NCT05621811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758829|NCT05621811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758830|NCT05621811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758831|NCT00209131|Tamsulosin|tamsulosin|mesh-list
82758832|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82758833|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82758834|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82758835|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
82758836|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758837|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758838|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758839|NCT00209131|Urological Agents|urological agents|mesh-ancestor
82758840|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
82758842|NCT00224029|Oxybutynin|oxybutynin|mesh-list
82758843|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
82758844|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
82758845|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758846|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758847|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82758848|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82758849|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
82758850|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758851|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758852|NCT00224029|Urological Agents|urological agents|mesh-ancestor
82758854|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
82758855|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758856|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758857|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758858|NCT00907764|Regadenoson|regadenoson|mesh-list
82758859|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
82758860|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82758861|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
82758862|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
82758863|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758864|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758865|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758866|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82758867|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
82758868|NCT02550314|Coagulants|coagulants|mesh-ancestor
82758869|NCT01073527|Adenosine|adenosine|mesh-list
82758870|NCT01073527|Albuterol|albuterol|mesh-list
82758871|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82758872|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
82758873|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758874|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758875|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82758876|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
82758877|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
82758878|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82758879|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82758880|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82758881|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82758882|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
82758883|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758884|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758885|NCT01073527|Analgesics|analgesics|mesh-ancestor
82758886|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
82758887|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82758888|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
82758889|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82758890|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
82758891|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
82758892|NCT02538432|Gemcitabine|gemcitabine|mesh-list
82758893|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82758894|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
82758895|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758896|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758897|NCT00719849|Cyclosporine|cyclosporine|mesh-list
82758898|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
82758899|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
82758900|NCT00719849|Fludarabine|fludarabine|mesh-list
82758901|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
82758902|NCT00719849|Cyclosporins|cyclosporins|mesh-list
82758903|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82758904|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758905|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
82758906|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758907|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82758908|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82758909|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
82758910|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758911|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758912|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82758913|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82758914|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
82758915|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758916|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
82758917|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758918|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
82758919|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82758920|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82758921|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82758922|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
82758923|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82758924|NCT00822536|Aspirin|aspirin|mesh-list
82758925|NCT00822536|Clopidogrel|clopidogrel|mesh-list
82758926|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82758927|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82758928|NCT00822536|Analgesics|analgesics|mesh-ancestor
82758929|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
82758930|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758931|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758932|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82758933|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82758934|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82758935|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82758936|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758937|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82758938|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82758939|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758940|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
82758941|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82758942|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82758943|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82758944|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
82758945|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82758946|NCT00826826|Amiodarone|amiodarone|mesh-list
82758947|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82758948|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
82758949|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82758950|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82758951|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758952|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82758953|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82758954|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82758955|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758956|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82758957|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82758958|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82758959|NCT02592941|Deflazacort|deflazacort|mesh-list
82758960|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82758961|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758962|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
82758963|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758964|NCT00822614|Fentanyl|fentanyl|mesh-list
82758965|NCT00822614|Morphine|morphine|mesh-list
82758966|NCT00822614|Oxycodone|oxycodone|mesh-list
82758967|NCT00822614|Hydromorphone|hydromorphone|mesh-list
82758968|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82758969|NCT00822614|Narcotics|narcotics|mesh-ancestor
82758970|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82758971|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758972|NCT00822614|Analgesics|analgesics|mesh-ancestor
82758973|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
82758974|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82758975|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82758976|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82758977|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
82758978|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
82758979|NCT04087967|Cytarabine|cytarabine|mesh-list
82758980|NCT04087967|Decitabine|decitabine|mesh-list
82758981|NCT04087967|Idarubicin|idarubicin|mesh-list
82758982|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82758983|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
82758984|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82758985|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82758986|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
82758987|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82758988|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82758989|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
82758990|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758991|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82758992|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82758993|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82758994|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82758995|NCT00926016|Pioglitazone|pioglitazone|mesh-list
82758996|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82758997|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82758998|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82758999|NCT04017104|Edotreotide|edotreotide|mesh-list
82759000|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82759001|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759002|NCT00827138|Rebastinib|rebastinib|mesh-list
82759003|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759004|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82759005|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759006|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759007|NCT00817466|Epinephrine|epinephrine|mesh-list
82759009|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
82759010|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82759011|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82759012|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
82759013|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759014|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759015|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759016|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82759017|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82759018|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
82759019|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759020|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82759021|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
82759022|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
82759023|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
82759024|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82759025|NCT00930072|Clonidine|clonidine|mesh-list
82759026|NCT00930072|Bupivacaine|bupivacaine|mesh-list
82759027|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
82759028|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
82759029|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82759030|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759031|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
82759032|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759033|NCT00930072|Analgesics|analgesics|mesh-ancestor
82759034|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82759035|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
82759036|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
82759037|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82759038|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82759039|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82759040|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
82759041|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759042|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759043|NCT00626522|Bromides|bromides|mesh-list
82759044|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
82759045|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82759046|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
82759047|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759048|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759049|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82759050|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
82759051|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82759052|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82759053|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82759054|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
82759055|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759056|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759057|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
82759058|NCT00926640|Etoposide|etoposide|mesh-list
82759059|NCT00926640|Belinostat|belinostat|mesh-list
82759060|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759061|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82759062|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82759063|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82759064|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759065|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759066|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82759067|NCT00931398|Methylphenidate|methylphenidate|mesh-list
82759068|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82759069|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759070|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82759071|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82759072|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82759073|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759074|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
82759075|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759077|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
82759078|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82759079|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
82759080|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82759081|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759082|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82759083|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82759084|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759085|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759086|NCT00822848|Sorafenib|sorafenib|mesh-list
82759087|NCT00822848|Epirubicin|epirubicin|mesh-list
82759088|NCT00822848|Ifosfamide|ifosfamide|mesh-list
82759089|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759090|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82759091|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759092|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759093|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82759094|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82759095|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82759096|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82759097|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
82759098|NCT00926718|Remifentanil|remifentanil|mesh-list
82759099|NCT00926718|Rocuronium|rocuronium|mesh-list
82759100|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82759101|NCT00926718|Narcotics|narcotics|mesh-ancestor
82759102|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82759103|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759104|NCT00926718|Analgesics|analgesics|mesh-ancestor
82759105|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
82759106|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759107|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82759108|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82759109|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82759110|NCT00823004|Letrozole|letrozole|mesh-list
82759111|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
82759112|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
82759113|NCT00823004|Buserelin|buserelin|mesh-list
82759114|NCT00823004|Ganirelix|ganirelix|mesh-list
82759115|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759116|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82759117|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82759118|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759119|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759120|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82759121|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
82759122|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82759123|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759124|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82759125|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82759126|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82759127|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
82759128|NCT00827450|Caffeine|caffeine|mesh-list
82759129|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82759130|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759131|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82759132|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759133|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759134|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82759135|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82759136|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
82759137|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759138|NCT00930306|Tolbutamide|tolbutamide|mesh-list
82759139|NCT00930306|Midazolam|midazolam|mesh-list
82759140|NCT00930306|Caffeine|caffeine|mesh-list
82759141|NCT00930306|Omeprazole|omeprazole|mesh-list
82759142|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82759143|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82759144|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82759145|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759146|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82759147|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82759148|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82759149|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82759150|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
82759152|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
82759153|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
82759154|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759155|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759156|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82759157|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82759158|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759159|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82759160|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82759161|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
82759162|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82759163|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82759164|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82759165|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82759166|NCT00830882|Albuterol|albuterol|mesh-list
82759167|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82759168|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
82759169|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759170|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759171|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82759172|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
82759173|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
82759174|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82759175|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82759176|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82759177|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82759178|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
82759179|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759180|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759181|NCT00823238|Tobramycin|tobramycin|mesh-list
82759182|NCT00823238|Ceftazidime|ceftazidime|mesh-list
82759183|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82759184|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759185|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
82759186|NCT00827684|Sirolimus|sirolimus|mesh-list
82759187|NCT00827684|Irinotecan|irinotecan|mesh-list
82759188|NCT00827684|Temsirolimus|temsirolimus|mesh-list
82759189|NCT00827684|MTOR Inhibitors|mtor inhibitors|mesh-list
82759190|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82759191|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82759192|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759193|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759194|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759195|NCT00827684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82759196|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82759197|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
82759198|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759199|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82759200|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759201|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82759202|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
82759203|NCT00927030|Melatonin|melatonin|mesh-list
82759204|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
82759205|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759206|NCT00927030|Protective Agents|protective agents|mesh-ancestor
82759207|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759208|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82759209|NCT00931866|Diclofenac|diclofenac|mesh-list
82759210|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82759211|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82759212|NCT00931866|Analgesics|analgesics|mesh-ancestor
82759213|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
82759214|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759215|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759216|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82759217|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82759218|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82759219|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759220|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759221|NCT00827840|Risperidone|risperidone|mesh-list
82759222|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82759223|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82759224|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
82759225|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759226|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759227|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759228|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82759229|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82759230|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82759231|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82759232|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82759233|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
82759234|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82759235|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82759236|NCT00827996|Adalimumab|adalimumab|mesh-list
82759237|NCT00827996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82759238|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82759239|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82759240|NCT00936780|Paclitaxel|paclitaxel|mesh-list
82759241|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82759242|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759243|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
82759244|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
82759245|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
82759246|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759247|NCT00823550|Lamivudine|lamivudine|mesh-list
82759248|NCT00823550|Entecavir|entecavir|mesh-list
82759249|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82759250|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82759251|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759252|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759253|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
82759254|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759255|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82759256|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82759257|NCT00932100|Heparin|heparin|mesh-list
82759258|NCT00932100|Calcium heparin|calcium heparin|mesh-list
82759259|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82759260|NCT00932100|Tinzaparin|tinzaparin|mesh-list
82759261|NCT00932100|Dalteparin|dalteparin|mesh-list
82759262|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
82759263|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82759264|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82759265|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759266|NCT00828230|Budesonide|budesonide|mesh-list
82759267|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82759268|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82759269|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
82759270|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759271|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759272|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82759273|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
82759274|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
82759275|NCT00828230|Hormones|hormones|mesh-ancestor
82759276|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82759277|NCT04469556|Leucovorin|leucovorin|mesh-list
82759278|NCT04469556|Paclitaxel|paclitaxel|mesh-list
82759279|NCT04469556|Gemcitabine|gemcitabine|mesh-list
82759280|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
82759281|NCT04469556|Irinotecan|irinotecan|mesh-list
82759282|NCT04469556|Folfirinox|folfirinox|mesh-list
82759283|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82759284|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759285|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
82759286|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
82759287|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
82759288|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759289|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82759290|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
82759291|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82759292|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82759293|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759294|NCT04469556|Antidotes|antidotes|mesh-ancestor
82759295|NCT04469556|Protective Agents|protective agents|mesh-ancestor
82759296|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759297|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
82759298|NCT04469556|Vitamins|vitamins|mesh-ancestor
82759299|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
82759300|NCT00937092|Dopamine|dopamine|mesh-list
82759301|NCT00937092|Furosemide|furosemide|mesh-list
82759302|NCT00937092|Diuretics|diuretics|mesh-ancestor
82759303|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
82759304|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759305|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82759306|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82759307|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759308|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82759309|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
82759310|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
82759311|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759312|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
82759313|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759314|NCT00937092|Protective Agents|protective agents|mesh-ancestor
82759315|NCT04124601|Nivolumab|nivolumab|mesh-list
82759316|NCT04124601|Ipilimumab|ipilimumab|mesh-list
82759317|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82759318|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759319|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82759320|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759321|NCT05046639|Lidocaine|lidocaine|mesh-list
82759322|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
82759323|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
82759324|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82759325|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759326|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
82759327|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759328|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82759329|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82759330|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82759331|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82759332|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759333|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
82759334|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82759335|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759336|NCT04521621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82759337|NCT04521621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759338|NCT00931008|Docetaxel|docetaxel|mesh-list
82759339|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759340|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
82759341|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
82759342|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
82759343|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759344|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
82759345|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82759346|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82759347|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759348|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82759349|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82759350|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759351|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759352|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759353|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82759354|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
82759355|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82759356|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759357|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82759358|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82759359|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82759360|NCT00932880|Amlodipine|amlodipine|mesh-list
82759361|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82759362|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82759363|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82759364|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759365|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82759366|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759367|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
82759368|NCT00937482|Cediranib|cediranib|mesh-list
82759369|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759370|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759371|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759372|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82759373|NCT03401853|Rituximab|rituximab|mesh-list
82759374|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82759375|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
82759376|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
82759377|NCT03401853|Antibodies|antibodies|mesh-list
82759378|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
82759379|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82759380|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
82759381|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759382|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759383|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82759384|NCT03401853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82759385|NCT03401853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759386|NCT00931086|Belimumab|belimumab|mesh-list
82759387|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82759388|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
82759389|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759390|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
82759391|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82759392|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
82759393|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82759394|NCT04453839|Protective Agents|protective agents|mesh-ancestor
82759395|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759396|NCT03977454|Ropivacaine|ropivacaine|mesh-list
82759397|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
82759398|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
82759399|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82759400|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759401|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
82759402|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759403|NCT02549066|Milrinone|milrinone|mesh-list
82759404|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82759405|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82759406|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
82759407|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82759408|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82759409|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759410|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759411|NCT02549066|Protective Agents|protective agents|mesh-ancestor
82759412|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759413|NCT00831350|Ranibizumab|ranibizumab|mesh-list
82759414|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82759415|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82759416|NCT00831350|Growth Substances|growth substances|mesh-ancestor
82759417|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759418|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
82759419|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759420|NCT00938184|Paroxetine|paroxetine|mesh-list
82759421|NCT00938184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82759422|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82759423|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82759424|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759425|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759426|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
82759427|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759428|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82759429|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
82759430|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82759431|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82759432|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82759433|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759434|NCT00938262|Rifampin|rifampin|mesh-list
82759435|NCT00938262|Ketoconazole|ketoconazole|mesh-list
82759436|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82759437|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
82759438|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82759439|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759440|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
82759441|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82759442|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759443|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759444|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82759445|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82759446|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82759447|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82759448|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82759449|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82759450|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
82759451|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82759452|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82759453|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82759454|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
82759455|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82759456|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759457|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82759458|NCT00933426|Paclitaxel|paclitaxel|mesh-list
82759459|NCT00933426|Lenalidomide|lenalidomide|mesh-list
82759460|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82759461|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759462|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
82759463|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
82759464|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
82759465|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759466|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
82759467|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759468|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82759469|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82759470|NCT00933426|Growth Substances|growth substances|mesh-ancestor
82759471|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
82759472|NCT04013958|Ketamine|ketamine|mesh-list
82759473|NCT04013958|Analgesics|analgesics|mesh-ancestor
82759474|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
82759475|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759476|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759477|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82759478|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82759479|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
82759480|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
82759481|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82759482|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82759483|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82759484|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759485|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759486|NCT00933582|Naproxen|naproxen|mesh-list
82759487|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82759488|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82759489|NCT00933582|Analgesics|analgesics|mesh-ancestor
82759490|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
82759491|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759492|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759493|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82759494|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82759495|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
82759496|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82759497|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759498|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759499|NCT00938730|Warfarin|warfarin|mesh-list
82759500|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
82759501|NCT00933816|Fluorouracil|fluorouracil|mesh-list
82759502|NCT00933816|Sorafenib|sorafenib|mesh-list
82759503|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759504|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
82759505|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759506|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82759507|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82759508|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
82759509|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759510|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82759511|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759512|NCT00538785|Palivizumab|palivizumab|mesh-list
82759513|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
82759514|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759515|NCT01563939|Remifentanil|remifentanil|mesh-list
82759516|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82759517|NCT01563939|Narcotics|narcotics|mesh-ancestor
82759518|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82759519|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759520|NCT01563939|Analgesics|analgesics|mesh-ancestor
82759521|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
82759522|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759523|NCT03287271|Paclitaxel|paclitaxel|mesh-list
82759524|NCT03287271|Carboplatin|carboplatin|mesh-list
82759525|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82759526|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759527|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
82759528|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
82759529|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
82759530|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759531|NCT00990405|Amoxicillin|amoxicillin|mesh-list
82759532|NCT00990405|Clarithromycin|clarithromycin|mesh-list
82759533|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82759534|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759535|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82759536|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759537|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759538|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82759539|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82759541|NCT00990639|Candesartan cilexetil|candesartan cilexetil|mesh-list
82759542|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82759543|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82759544|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82759545|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759546|NCT03742947|Hemostatics|hemostatics|mesh-list
82759547|NCT03742947|Coagulants|coagulants|mesh-ancestor
82759548|NCT05359497|Liver Extracts|liver extracts|mesh-list
82759549|NCT05359497|Hematinics|hematinics|mesh-ancestor
82759550|NCT00990795|Cyclosporine|cyclosporine|mesh-list
82759551|NCT00990795|Cyclosporins|cyclosporins|mesh-list
82759552|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759553|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759554|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82759555|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
82759556|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759557|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
82759558|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759559|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
82759560|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82759561|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82759562|NCT00622700|Teriflunomide|teriflunomide|mesh-list
82759563|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82759564|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82759565|NCT00622700|Analgesics|analgesics|mesh-ancestor
82759566|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
82759567|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759568|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759569|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82759570|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82759571|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82759572|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
82759573|NCT00831506|Digoxin|digoxin|mesh-list
82759574|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82759575|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82759576|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759577|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759578|NCT00831506|Protective Agents|protective agents|mesh-ancestor
82759579|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759580|NCT02842359|Irbesartan|irbesartan|mesh-list
82759581|NCT02842359|Atorvastatin|atorvastatin|mesh-list
82759582|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82759583|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82759584|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
82759585|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759586|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82759587|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82759588|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759589|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82759590|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82759591|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82759592|NCT02783625|Bortezomib|bortezomib|mesh-list
82759593|NCT02783625|Romidepsin|romidepsin|mesh-list
82759594|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759595|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82759596|NCT02783625|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82759597|NCT02783625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759598|NCT02783625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759599|NCT00828776|Heparin|heparin|mesh-list
82759600|NCT00828776|Calcium heparin|calcium heparin|mesh-list
82759601|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
82759602|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82759603|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82759604|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759605|NCT00622466|Paclitaxel|paclitaxel|mesh-list
82759606|NCT00622466|Sorafenib|sorafenib|mesh-list
82759607|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82759608|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759609|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
82759610|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
82759611|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
82759612|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759613|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82759614|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759615|NCT04043858|Midodrine|midodrine|mesh-list
82759616|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
82759617|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
82759618|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759619|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759620|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82759621|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82759622|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82759623|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82759624|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
82759625|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759626|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759627|NCT05359419|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82759628|NCT05359419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82759629|NCT05359419|Dermatologic Agents|dermatologic agents|mesh-ancestor
82759630|NCT00823862|Ribavirin|ribavirin|mesh-list
82759631|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
82759632|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759633|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
82759634|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759635|NCT00537771|Tamoxifen|tamoxifen|mesh-list
82759636|NCT00537771|Anastrozole|anastrozole|mesh-list
82759637|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82759638|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
82759639|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82759640|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759641|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82759642|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759643|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82759644|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82759645|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82759646|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82759647|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82759648|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759649|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759650|NCT00823940|Glucagon|glucagon|mesh-list
82759651|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82759652|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82759653|NCT00823940|Hormones|hormones|mesh-ancestor
82759654|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82759655|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759656|NCT00823940|Incretins|incretins|mesh-ancestor
82759657|NCT00829322|Modafinil|modafinil|mesh-list
82759658|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82759659|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759660|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82759661|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82759662|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82759663|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759664|NCT00623480|Factor VIII|factor viii|mesh-list
82759665|NCT00623480|Coagulants|coagulants|mesh-ancestor
82759666|NCT02513667|Ceritinib|ceritinib|mesh-list
82759667|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759668|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82759669|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759670|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759671|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
82759672|NCT03823911|Grazoprevir|grazoprevir|mesh-list
82759673|NCT03823911|Ledipasvir|ledipasvir|mesh-list
82759674|NCT03823911|Velpatasvir|velpatasvir|mesh-list
82759675|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82759676|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82759677|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
82759678|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759679|NCT00829634|Methamphetamine|methamphetamine|mesh-list
82759680|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82759681|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759682|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
82759683|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
82759684|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759685|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
82759686|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759687|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759688|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
82759689|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82759690|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82759691|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82759692|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82759693|NCT04003467|Teriparatide|teriparatide|mesh-list
82759694|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82759695|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759696|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82759697|NCT00832208|Amphotericin B|amphotericin b|mesh-list
82759698|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82759699|NCT00832208|Amebicides|amebicides|mesh-ancestor
82759700|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82759701|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82759702|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759703|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82759704|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
82759705|NCT05361057|Cytarabine|cytarabine|mesh-list
82759706|NCT05361057|Azacitidine|azacitidine|mesh-list
82759707|NCT05361057|Daunorubicin|daunorubicin|mesh-list
82759708|NCT05361057|Venetoclax|venetoclax|mesh-list
82759709|NCT05361057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82759710|NCT05361057|Antimetabolites|antimetabolites|mesh-ancestor
82759711|NCT05361057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759712|NCT05361057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759713|NCT05361057|Antiviral Agents|antiviral agents|mesh-ancestor
82759714|NCT05361057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759715|NCT05361057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82759716|NCT05361057|Immunologic Factors|immunologic factors|mesh-ancestor
82759717|NCT05361057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759718|NCT05361057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759719|NCT05361057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82759720|NCT05361057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82759721|NCT05361057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82759722|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
82759723|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82759724|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759725|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82759726|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82759727|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759728|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759729|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759730|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82759731|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82759732|NCT00832364|Etanercept|etanercept|mesh-list
82759733|NCT00832364|Acitretin|acitretin|mesh-list
82759734|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82759735|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82759736|NCT00832364|Analgesics|analgesics|mesh-ancestor
82759737|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
82759738|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759739|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759740|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82759741|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82759742|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82759743|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82759744|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
82759745|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
82759746|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
82759747|NCT00832442|Metoprolol|metoprolol|mesh-list
82759748|NCT00832442|Carvedilol|carvedilol|mesh-list
82759749|NCT00832442|Nebivolol|nebivolol|mesh-list
82759750|NCT00832442|Bisoprolol|bisoprolol|mesh-list
82759751|NCT00832442|Bucindolol|bucindolol|mesh-list
82759752|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82759753|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82759754|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82759755|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
82759756|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
82759757|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759758|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759759|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82759760|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82759761|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
82759762|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759763|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759764|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
82759765|NCT00832442|Protective Agents|protective agents|mesh-ancestor
82759766|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82759767|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82759768|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82759769|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
82759770|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82759771|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82759772|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82759773|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82759774|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82759775|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
82759776|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82759777|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
82759778|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82759779|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82759780|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82759781|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
82759782|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82759783|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759784|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82759785|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82759786|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82759787|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82759788|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759789|NCT00830492|Clomiphene|clomiphene|mesh-list
82759790|NCT00830492|Enclomiphene|enclomiphene|mesh-list
82759791|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
82759792|NCT00830492|Buserelin|buserelin|mesh-list
82759793|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82759794|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
82759795|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82759796|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759797|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82759798|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
82759799|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82759800|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82759801|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82759802|NCT00830570|Warfarin|warfarin|mesh-list
82759803|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
82759804|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
82759805|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82759806|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82759807|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759808|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82759809|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759810|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82759812|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
82759813|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82759814|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759815|NCT02550080|Dapsone|dapsone|mesh-list
82759816|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759817|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
82759818|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82759819|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82759820|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82759821|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759897|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82759822|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759823|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
82759824|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82759825|NCT02547350|Pirarubicin|pirarubicin|mesh-list
82759826|NCT02547350|Epirubicin|epirubicin|mesh-list
82759827|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759828|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82759829|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82759830|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82759831|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759832|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759833|NCT00838214|Prednisone|prednisone|mesh-list
82759834|NCT00838214|Budesonide|budesonide|mesh-list
82759835|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82759836|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
82759837|NCT00838214|Hormones|hormones|mesh-ancestor
82759838|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82759839|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759840|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82759841|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759842|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82759843|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
82759844|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759845|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82759846|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
82759847|NCT00621764|Vaccines|vaccines|mesh-list
82759848|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
82759849|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759850|NCT00838370|Fluorouracil|fluorouracil|mesh-list
82759851|NCT00838370|Capecitabine|capecitabine|mesh-list
82759852|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
82759853|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759854|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82759855|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759856|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82759857|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
82759858|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759859|NCT00537381|Prednisone|prednisone|mesh-list
82759860|NCT00537381|Docetaxel|docetaxel|mesh-list
82759861|NCT00537381|Intetumumab|intetumumab|mesh-list
82759862|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759863|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
82759864|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
82759865|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
82759866|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759867|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82759868|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
82759869|NCT00537381|Hormones|hormones|mesh-ancestor
82759870|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82759871|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759872|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82759873|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82759874|NCT00833300|Haloperidol|haloperidol|mesh-list
82759875|NCT00833300|Olanzapine|olanzapine|mesh-list
82759876|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
82759877|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
82759878|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
82759879|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759880|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759881|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82759882|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82759883|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82759884|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82759885|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82759886|NCT00833300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82759887|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82759888|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82759889|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759890|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759891|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
82759892|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82759893|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
82759894|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82759895|NCT00833378|Ritonavir|ritonavir|mesh-list
82759896|NCT00833378|Lopinavir|lopinavir|mesh-list
82759973|NCT05591001|Ketamine|ketamine|mesh-list
82759898|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82759899|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
82759900|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759901|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759902|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82759903|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82759904|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
82759905|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759906|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82759907|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82759908|NCT05359341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82759909|NCT05359341|Empagliflozin|empagliflozin|mesh-list
82759910|NCT05359341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82759911|NCT05359341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82759912|NCT05359341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82759913|NCT05359341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759914|NCT05359341|Incretins|incretins|mesh-ancestor
82759915|NCT05359341|Hormones|hormones|mesh-ancestor
82759916|NCT05359341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82759917|NCT05359341|Protease Inhibitors|protease inhibitors|mesh-ancestor
82759918|NCT05359341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759919|NCT05359341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759920|NCT05398731|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82759921|NCT05398731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82759922|NCT05398731|Adrenergic Agents|adrenergic agents|mesh-ancestor
82759923|NCT05398731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759924|NCT05398731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759925|NCT05398731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759926|NCT00838760|Darunavir|darunavir|mesh-list
82759927|NCT00838760|TMC-310911|tmc-310911|mesh-list
82759928|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82759929|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82759930|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
82759931|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759932|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759933|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82759934|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82759935|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
82759936|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82759938|NCT03791398|TIC10 compound|tic10 compound|mesh-list
82759939|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82759940|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759941|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82759942|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759943|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
82759944|NCT00838838|Testosterone|testosterone|mesh-list
82759945|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
82759946|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
82759947|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82759948|NCT00838838|Androgens|androgens|mesh-ancestor
82759949|NCT00838838|Hormones|hormones|mesh-ancestor
82759950|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82759951|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759952|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82759953|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759954|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
82759955|NCT05360979|Endostatins|endostatins|mesh-list
82759956|NCT05360979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759957|NCT05360979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82759958|NCT05360979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82759959|NCT05360979|Growth Substances|growth substances|mesh-ancestor
82759960|NCT05360979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759961|NCT05360979|Growth Inhibitors|growth inhibitors|mesh-ancestor
82759962|NCT00833534|Rituximab|rituximab|mesh-list
82759963|NCT00833534|Lenalidomide|lenalidomide|mesh-list
82759964|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82759965|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82759966|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
82759967|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759968|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82759969|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82759970|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82759971|NCT00833534|Growth Substances|growth substances|mesh-ancestor
82759972|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
82759974|NCT05591001|Propofol|propofol|mesh-list
82759975|NCT05591001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82759976|NCT05591001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82759977|NCT05591001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82759978|NCT05591001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82759979|NCT05591001|Anesthetics, General|anesthetics, general|mesh-ancestor
82759980|NCT05591001|Anesthetics|anesthetics|mesh-ancestor
82759981|NCT05591001|Analgesics|analgesics|mesh-ancestor
82759982|NCT05591001|Sensory System Agents|sensory system agents|mesh-ancestor
82759983|NCT05591001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82759984|NCT05591001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82759985|NCT05591001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82759986|NCT05591001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82759987|NCT05591001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82759988|NCT05591001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759989|NCT00517192|Ritonavir|ritonavir|mesh-list
82759990|NCT00517192|Darunavir|darunavir|mesh-list
82759991|NCT00517192|Tipranavir|tipranavir|mesh-list
82759992|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82759993|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82759994|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
82759995|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82759996|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82759997|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82759998|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82759999|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
82760000|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760001|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82760002|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82760003|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
82760004|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82760005|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760007|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
82760008|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
82760009|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760010|NCT00510484|Pancrelipase|pancrelipase|mesh-list
82760011|NCT00510484|Pancreatin|pancreatin|mesh-list
82760012|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82760013|NCT00839228|Perhexiline|perhexiline|mesh-list
82760014|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82760015|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82760016|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760017|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82760018|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760019|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
82760020|NCT05408481|Hydrocortisone|hydrocortisone|mesh-list
82760021|NCT05408481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760022|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
82760023|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
82760024|NCT00839462|Vitamins|vitamins|mesh-ancestor
82760025|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
82760026|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760027|NCT05590221|Cyclophosphamide|cyclophosphamide|mesh-list
82760028|NCT05590221|Fludarabine|fludarabine|mesh-list
82760029|NCT05590221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82760030|NCT05590221|Immunologic Factors|immunologic factors|mesh-ancestor
82760031|NCT05590221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760032|NCT05590221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760033|NCT05590221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82760034|NCT05590221|Alkylating Agents|alkylating agents|mesh-ancestor
82760035|NCT05590221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760036|NCT05590221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760037|NCT05590221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82760038|NCT05590143|Dapagliflozin|dapagliflozin|mesh-list
82760039|NCT05590143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82760040|NCT05590143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760041|NCT05590143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82760042|NCT05590143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760043|NCT00622388|Ofatumumab|ofatumumab|mesh-list
82760044|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760045|NCT01156389|Ritonavir|ritonavir|mesh-list
82760046|NCT01156389|Artesunate|artesunate|mesh-list
82760047|NCT01156389|Pyronaridine|pyronaridine|mesh-list
82760048|NCT01156389|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
82760049|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82760050|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82760051|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
82760052|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760053|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760054|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82760055|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82760056|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
82760057|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760058|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82760059|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82760060|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
82760061|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82760062|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82760063|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760064|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
82760065|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82760066|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
82760068|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
82760069|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
82760070|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760071|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760072|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
82760073|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760074|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82760075|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82760076|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82760077|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82760078|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760079|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
82760080|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82760081|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82760082|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760083|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
82760084|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
82760085|NCT00625742|Ibuprofen|ibuprofen|mesh-list
82760086|NCT00625742|Atenolol|atenolol|mesh-list
82760087|NCT00625742|Melatonin|melatonin|mesh-list
82760088|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82760089|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82760090|NCT00625742|Analgesics|analgesics|mesh-ancestor
82760091|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
82760092|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760093|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760094|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760095|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760096|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82760097|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760098|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760099|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
82760100|NCT00625742|Protective Agents|protective agents|mesh-ancestor
82760101|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760102|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82760103|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82760104|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
82760105|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
82760106|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82760107|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82760108|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82760109|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
82760110|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760111|NCT05589441|Insulin|insulin|mesh-list
82760112|NCT05589441|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82760113|NCT05589441|Albuterol|albuterol|mesh-list
82760114|NCT05589441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82760115|NCT05589441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760116|NCT05589441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82760117|NCT05589441|Autonomic Agents|autonomic agents|mesh-ancestor
82760118|NCT05589441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760119|NCT05589441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82760120|NCT05589441|Respiratory System Agents|respiratory system agents|mesh-ancestor
82760121|NCT05589441|Tocolytic Agents|tocolytic agents|mesh-ancestor
82760122|NCT05589441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82760123|NCT05589441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82760124|NCT05589441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82760125|NCT05589441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82760126|NCT05589441|Adrenergic Agents|adrenergic agents|mesh-ancestor
82760127|NCT05589441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760128|NCT05589441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760130|NCT00825188|Eplerenone|eplerenone|mesh-list
82760131|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82760132|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82760133|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82760134|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760135|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82760136|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760137|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
82760138|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82760139|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
82760140|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760141|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82760143|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
82760144|NCT05589363|Bupivacaine|bupivacaine|mesh-list
82760145|NCT05589363|Anesthetics, Local|anesthetics, local|mesh-ancestor
82760146|NCT05589363|Anesthetics|anesthetics|mesh-ancestor
82760147|NCT05589363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760148|NCT05589363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760149|NCT05589363|Sensory System Agents|sensory system agents|mesh-ancestor
82760150|NCT05589363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760151|NCT00834470|Atropine|atropine|mesh-list
82760152|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82760153|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82760154|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82760155|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
82760156|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760157|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760158|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82760159|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
82760160|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
82760161|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
82760162|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82760163|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82760164|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
82760165|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760166|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760167|NCT03997864|Prazosin|prazosin|mesh-list
82760168|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82760169|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82760170|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82760171|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82760172|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
82760173|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760174|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760175|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760176|NCT05407467|Curcumin|curcumin|mesh-list
82760177|NCT05407467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82760178|NCT05407467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82760179|NCT05407467|Analgesics|analgesics|mesh-ancestor
82760180|NCT05407467|Sensory System Agents|sensory system agents|mesh-ancestor
82760181|NCT05407467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760182|NCT05407467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760183|NCT05407467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760184|NCT05407467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760185|NCT05407467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760186|NCT05407467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760187|NCT05407467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760188|NCT01010152|Codeine|codeine|mesh-list
82760189|NCT01010152|Analgesics|analgesics|mesh-ancestor
82760190|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
82760191|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760192|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760193|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82760194|NCT01010152|Narcotics|narcotics|mesh-ancestor
82760195|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760196|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
82760197|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
82760198|NCT05407233|Insulin|insulin|mesh-list
82760199|NCT05407233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82760200|NCT05407233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82760201|NCT05407233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760202|NCT02549846|Atorvastatin|atorvastatin|mesh-list
82760203|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82760204|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82760205|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82760206|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
82760207|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760208|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82760209|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82760210|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760211|NCT05407155|Paclitaxel|paclitaxel|mesh-list
82760212|NCT05407155|Bevacizumab|bevacizumab|mesh-list
82760213|NCT05407155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82760214|NCT05407155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760215|NCT05407155|Tubulin Modulators|tubulin modulators|mesh-ancestor
82760216|NCT05407155|Antimitotic Agents|antimitotic agents|mesh-ancestor
82760217|NCT05407155|Mitosis Modulators|mitosis modulators|mesh-ancestor
82760218|NCT05407155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760219|NCT05407155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82760220|NCT05407155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82760221|NCT05407155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82760222|NCT05407155|Growth Substances|growth substances|mesh-ancestor
82760223|NCT05407155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760224|NCT05407155|Growth Inhibitors|growth inhibitors|mesh-ancestor
82760225|NCT00840242|Nicotine|nicotine|mesh-list
82760226|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82760227|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
82760228|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760229|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760230|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82760231|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82760232|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
82760233|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760234|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760235|NCT00840398|Buspirone|buspirone|mesh-list
82760236|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82760237|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82760238|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760239|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760240|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82760241|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82760242|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
82760243|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760244|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760245|NCT00537303|Insulin|insulin|mesh-list
82760246|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82760247|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
82760248|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
82760249|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82760250|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
82760251|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82760252|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760253|NCT02548286|Amlodipine|amlodipine|mesh-list
82760254|NCT02548286|Candesartan|candesartan|mesh-list
82760255|NCT02548286|Candesartan cilexetil|candesartan cilexetil|mesh-list
82760256|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82760257|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82760258|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82760259|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760260|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82760261|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760262|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
82760263|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82760264|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82760266|NCT05360433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82760267|NCT05360433|Narcotics|narcotics|mesh-ancestor
82760268|NCT05360433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760269|NCT05360433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760270|NCT05360433|Analgesics|analgesics|mesh-ancestor
82760271|NCT05360433|Sensory System Agents|sensory system agents|mesh-ancestor
82760272|NCT05360433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760273|NCT00834860|Ribavirin|ribavirin|mesh-list
82760274|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82760275|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
82760276|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760277|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
82760278|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760279|NCT04696575|Lamivudine|lamivudine|mesh-list
82760280|NCT04696575|Carboplatin|carboplatin|mesh-list
82760281|NCT04696575|Etoposide|etoposide|mesh-list
82760282|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
82760283|NCT04696575|Atezolizumab|atezolizumab|mesh-list
82760284|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
82760285|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82760286|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760287|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82760288|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82760289|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82760290|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760291|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760292|NCT04696575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82760293|NCT04696575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82760294|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82760295|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82760296|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
82760297|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760298|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82760299|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82760300|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
82760301|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760302|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
82760303|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
82760304|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
82760305|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
82760306|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
82760307|NCT00825422|Ropivacaine|ropivacaine|mesh-list
82760308|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
82760309|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
82760310|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760311|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760312|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
82760313|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760314|NCT00505414|Morphine|morphine|mesh-list
82760315|NCT00505414|Tapentadol|tapentadol|mesh-list
82760316|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82760317|NCT00505414|Narcotics|narcotics|mesh-ancestor
82760318|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760319|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760320|NCT00505414|Analgesics|analgesics|mesh-ancestor
82760321|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
82760322|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760323|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82760324|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82760325|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82760326|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760327|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
82760328|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760329|NCT02549924|Resveratrol|resveratrol|mesh-list
82760330|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
82760331|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760332|NCT02549924|Protective Agents|protective agents|mesh-ancestor
82760333|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760334|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760335|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82760337|NCT01813227|Rituximab|rituximab|mesh-list
82760338|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82760339|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760340|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
82760341|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760342|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760343|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760344|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
82760345|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
82760346|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760347|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82760348|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
82760349|NCT01813227|Hormones|hormones|mesh-ancestor
82760424|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760350|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760351|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82760352|NCT01012882|Immunomodulating Agents|immunomodulating agents|mesh-list
82760353|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
82760354|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760355|NCT00989469|Irinotecan|irinotecan|mesh-list
82760356|NCT00989469|Sorafenib|sorafenib|mesh-list
82760357|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82760358|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82760359|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760360|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760361|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760362|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82760363|NCT01010308|Nadolol|nadolol|mesh-list
82760364|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82760365|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82760366|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
82760367|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760368|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760369|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760370|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82760371|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82760372|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
82760373|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
82760374|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760375|NCT02548052|Betamethasone|betamethasone|mesh-list
82760376|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
82760377|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82760378|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
82760379|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82760380|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760381|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
82760382|NCT02548052|Hormones|hormones|mesh-ancestor
82760383|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760384|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760385|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82760386|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
82760387|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
82760388|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82760389|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82760390|NCT04590417|Estradiol|estradiol|mesh-list
82760391|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82760392|NCT04590417|Cyproterone|cyproterone|mesh-list
82760393|NCT04590417|Estrogens|estrogens|mesh-ancestor
82760394|NCT04590417|Hormones|hormones|mesh-ancestor
82760395|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760396|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760397|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82760398|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
82760399|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82760400|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82760401|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
82760402|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
82760403|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760404|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82760405|NCT00825656|Capsaicin|capsaicin|mesh-list
82760406|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
82760407|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
82760408|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
82760409|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760410|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760411|NCT00989625|Naproxen|naproxen|mesh-list
82760412|NCT00989625|Sumatriptan|sumatriptan|mesh-list
82760413|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82760414|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82760415|NCT00989625|Analgesics|analgesics|mesh-ancestor
82760416|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
82760417|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760418|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760419|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760420|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760421|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
82760422|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82760423|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760425|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82760426|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82760427|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82760428|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
82760429|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760430|NCT00841256|Glycerol|glycerol|mesh-list
82760431|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82760432|NCT00841256|Protective Agents|protective agents|mesh-ancestor
82760433|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760434|NCT00989703|Methotrexate|methotrexate|mesh-list
82760435|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82760436|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
82760437|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82760438|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760439|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82760440|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
82760441|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760442|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760443|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
82760444|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760445|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82760446|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82760447|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
82760448|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760449|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82760450|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
82760451|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82760452|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760453|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
82760454|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760455|NCT00625586|Gemcitabine|gemcitabine|mesh-list
82760456|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82760457|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
82760458|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760459|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760460|NCT02547116|Rifampin|rifampin|mesh-list
82760461|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82760462|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
82760463|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82760464|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760465|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
82760466|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82760467|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760468|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760469|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82760470|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82760471|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82760472|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82760473|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82760474|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82760475|NCT02549690|Testosterone|testosterone|mesh-list
82760476|NCT02549690|Androgens|androgens|mesh-ancestor
82760477|NCT02549690|Hormones|hormones|mesh-ancestor
82760478|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760479|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760480|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
82760481|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82760482|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760483|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760484|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82760485|NCT02549768|Analgesics|analgesics|mesh-ancestor
82760486|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
82760487|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760488|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82760489|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82760490|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82760491|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
82760492|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760493|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760494|NCT00841724|Fludarabine|fludarabine|mesh-list
82760495|NCT00841724|Busulfan|busulfan|mesh-list
82760496|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
82760497|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760498|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760499|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82760500|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
82760501|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760502|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
82760503|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82760504|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82760505|NCT00843362|Dinoprostone|dinoprostone|mesh-list
82760506|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
82760507|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82760508|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760509|NCT00841802|Prednisone|prednisone|mesh-list
82760510|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
82760511|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760512|NCT00841802|Hormones|hormones|mesh-ancestor
82760513|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760514|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760515|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82760516|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760517|NCT00621140|Linagliptin|linagliptin|mesh-list
82760518|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82760519|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760520|NCT00621140|Incretins|incretins|mesh-ancestor
82760521|NCT00621140|Hormones|hormones|mesh-ancestor
82760522|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760523|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82760524|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
82760525|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760526|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760527|NCT00207727|Ustekinumab|ustekinumab|mesh-list
82760528|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
82760530|NCT00841880|Ramipril|ramipril|mesh-list
82760531|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82760532|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
82760533|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760534|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760535|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82760536|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82760537|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82760538|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82760539|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82760540|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760541|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
82760542|NCT00843440|Bevacizumab|bevacizumab|mesh-list
82760543|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82760544|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760545|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82760546|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82760547|NCT00843440|Growth Substances|growth substances|mesh-ancestor
82760548|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760549|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
82760550|NCT00504556|Warfarin|warfarin|mesh-list
82760551|NCT00504556|Edoxaban|edoxaban|mesh-list
82760552|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
82760553|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82760554|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
82760555|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82760556|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
82760557|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760558|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760559|NCT00206323|Topiramate|topiramate|mesh-list
82760560|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
82760561|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82760562|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760563|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
82760564|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82760565|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760566|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
82760567|NCT00842114|Interferons|interferons|mesh-list
82760568|NCT00842114|Prednisone|prednisone|mesh-list
82760569|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
82760570|NCT00842114|Vincristine|vincristine|mesh-list
82760571|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82760572|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
82760573|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760574|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760575|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82760576|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
82760577|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760578|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760579|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82760580|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760582|NCT00842114|Hormones|hormones|mesh-ancestor
82760583|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760584|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82760585|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
82760586|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760587|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82760588|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
82760589|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
82760590|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
82760591|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
82760592|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82760593|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760594|NCT00536991|Calcitriol|calcitriol|mesh-list
82760595|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
82760596|NCT00536991|Ketoconazole|ketoconazole|mesh-list
82760597|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
82760598|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82760599|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82760600|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82760601|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760602|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
82760603|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760604|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82760605|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82760606|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760607|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760608|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82760609|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
82760610|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760611|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760612|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82760613|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82760614|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82760615|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82760616|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82760617|NCT00536991|Vitamins|vitamins|mesh-ancestor
82760618|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
82760619|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82760620|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82760621|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82760622|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82760623|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760624|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760625|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82760626|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82760627|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82760628|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82760629|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
82760630|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760631|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760632|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82760633|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82760634|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
82760635|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82760636|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82760637|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
82760638|NCT00504166|Alendronate|alendronate|mesh-list
82760639|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82760640|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760641|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
82760642|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82760643|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82760644|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82760645|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
82760646|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760647|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82760648|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82760649|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760650|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82760651|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82760652|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
82760653|NCT02546648|Coagulants|coagulants|mesh-ancestor
82760654|NCT00842504|Micafungin|micafungin|mesh-list
82760655|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
82760656|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760657|NCT00842582|Azacitidine|azacitidine|mesh-list
82760658|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82760659|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
82760660|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760661|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760662|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760663|NCT00843908|Imidacloprid|imidacloprid|mesh-list
82760664|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
82760665|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760666|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760667|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760668|NCT00842660|Gemcitabine|gemcitabine|mesh-list
82760669|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82760670|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
82760671|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760672|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760673|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82760674|NCT00509236|Glipizide|glipizide|mesh-list
82760675|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82760676|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760677|NCT00509236|Incretins|incretins|mesh-ancestor
82760678|NCT00509236|Hormones|hormones|mesh-ancestor
82760679|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760680|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82760681|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
82760682|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760683|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760684|NCT00842894|Insulin|insulin|mesh-list
82760685|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82760686|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
82760687|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
82760688|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
82760689|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82760690|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82760691|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760692|NCT00508924|Heparin|heparin|mesh-list
82760693|NCT00508924|Argatroban|argatroban|mesh-list
82760694|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
82760695|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82760696|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82760697|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760698|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
82760699|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82760700|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
82760701|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760702|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82760703|NCT00836576|Benazepril|benazepril|mesh-list
82760704|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82760705|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
82760706|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760707|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760708|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82760709|NCT00836654|Catumaxomab|catumaxomab|mesh-list
82760710|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82760711|NCT00844064|Trabedersen|trabedersen|mesh-list
82760712|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760713|NCT04688788|Fexofenadine|fexofenadine|mesh-list
82760714|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
82760715|NCT04688788|Rituximab|rituximab|mesh-list
82760716|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
82760717|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82760718|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760719|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
82760720|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760721|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760722|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760723|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
82760724|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
82760725|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760726|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82760727|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
82760728|NCT04688788|Hormones|hormones|mesh-ancestor
82760729|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760730|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82760731|NCT04688788|Protective Agents|protective agents|mesh-ancestor
82760732|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82760733|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82760734|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82760735|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
82760737|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760738|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760739|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
82760740|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
82760741|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82760742|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760743|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760744|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
82760745|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82760746|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760747|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760748|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
82760749|NCT00844142|Etanercept|etanercept|mesh-list
82760750|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82760751|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82760752|NCT00844142|Analgesics|analgesics|mesh-ancestor
82760753|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
82760754|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760755|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760756|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760757|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760758|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82760759|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82760760|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
82760761|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760762|NCT00837044|Naproxen|naproxen|mesh-list
82760763|NCT00837044|Sumatriptan|sumatriptan|mesh-list
82760764|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82760765|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82760766|NCT00837044|Analgesics|analgesics|mesh-ancestor
82760767|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
82760768|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760769|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760770|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760771|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760772|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
82760773|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82760774|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760775|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760776|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82760777|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82760778|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82760779|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
82760780|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760781|NCT01013272|Lamivudine|lamivudine|mesh-list
82760782|NCT01013272|Entecavir|entecavir|mesh-list
82760783|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82760784|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82760785|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760786|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760787|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
82760788|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760789|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82760790|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82760791|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
82760792|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
82760793|NCT04232085|Melphalan|melphalan|mesh-list
82760794|NCT04232085|Fludarabine|fludarabine|mesh-list
82760795|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
82760796|NCT04232085|Tacrolimus|tacrolimus|mesh-list
82760797|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82760798|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
82760799|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760800|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760801|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82760802|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
82760803|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760804|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760805|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82760806|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82760807|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760808|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82760809|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82760810|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
82760811|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82760812|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760813|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82760814|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
82760815|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82760816|NCT01010698|Acyclovir|acyclovir|mesh-list
82760817|NCT01010698|Cimetidine|cimetidine|mesh-list
82760818|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
82760819|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760820|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82760821|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82760822|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82760823|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
82760824|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
82760825|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82760826|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760827|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760828|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82760829|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82760830|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760831|NCT03541486|Gemcitabine|gemcitabine|mesh-list
82760832|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82760833|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
82760834|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760835|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760836|NCT00620750|Naltrexone|naltrexone|mesh-list
82760837|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82760838|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82760839|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760840|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
82760841|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760842|NCT04867707|Zanamivir|zanamivir|mesh-list
82760843|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
82760844|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760845|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760846|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760847|NCT02547896|Diclofenac|diclofenac|mesh-list
82760848|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
82760849|NCT02547896|Codeine|codeine|mesh-list
82760850|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82760851|NCT02547896|Analgesics|analgesics|mesh-ancestor
82760852|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
82760853|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760854|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760855|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82760856|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82760857|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82760858|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760859|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760860|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82760862|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760863|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
82760864|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
82760865|NCT01564251|Gemcitabine|gemcitabine|mesh-list
82760866|NCT01564251|GDC-0575|gdc-0575|mesh-list
82760867|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82760868|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
82760869|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760870|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760871|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82760872|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760873|NCT00508144|Pemetrexed|pemetrexed|mesh-list
82760874|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760875|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760955|NCT04849455|Narcotics|narcotics|mesh-ancestor
82760876|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760877|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82760878|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82760879|NCT00844454|Ethanol|ethanol|mesh-list
82760880|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82760881|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760882|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760883|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760884|NCT02545712|Ethanol|ethanol|mesh-list
82760885|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
82760886|NCT02545712|Sorbitol|sorbitol|mesh-list
82760887|NCT02545712|Glycerol|glycerol|mesh-list
82760888|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82760889|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760890|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760891|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760892|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82760893|NCT02545712|Protective Agents|protective agents|mesh-ancestor
82760894|NCT02545712|Cathartics|cathartics|mesh-ancestor
82760895|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82760896|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
82760897|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
82760898|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
82760899|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760900|NCT01011010|Doxorubicin|doxorubicin|mesh-list
82760901|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82760902|NCT01011010|Mitomycins|mitomycins|mesh-list
82760904|NCT01011010|Sorafenib|sorafenib|mesh-list
82760905|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82760906|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760907|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82760908|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82760909|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760910|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760911|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82760912|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
82760913|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82760914|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
82760915|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82760916|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
82760917|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760918|NCT00851708|Expectorants|expectorants|mesh-ancestor
82760919|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
82760920|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82760921|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
82760922|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760923|NCT00851708|Protective Agents|protective agents|mesh-ancestor
82760924|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760925|NCT00851708|Antidotes|antidotes|mesh-ancestor
82760926|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
82760927|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82760928|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
82760929|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760930|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
82760931|NCT05018481|Protective Agents|protective agents|mesh-ancestor
82760932|NCT01011166|Ribavirin|ribavirin|mesh-list
82760933|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82760934|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
82760935|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760937|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82760938|NCT00621842|Lamotrigine|lamotrigine|mesh-list
82760939|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
82760940|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82760941|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82760942|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760943|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82760944|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760945|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82760946|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82760947|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760948|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82760949|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82760950|NCT04849455|Morphine|morphine|mesh-list
82760951|NCT04849455|Ropivacaine|ropivacaine|mesh-list
82760952|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
82760953|NCT04849455|Anesthetics|anesthetics|mesh-list
82760954|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82760956|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82760957|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760958|NCT04849455|Analgesics|analgesics|mesh-ancestor
82760959|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
82760960|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82760961|NCT02545010|Paclitaxel|paclitaxel|mesh-list
82760962|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82760963|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760964|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
82760965|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
82760966|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
82760967|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760968|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82760969|NCT01013506|Letrozole|letrozole|mesh-list
82760970|NCT01013506|Goserelin|goserelin|mesh-list
82760971|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760972|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82760973|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760974|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760975|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82760976|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82760977|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82760978|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
82760979|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82760980|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760981|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82760982|NCT00844688|Gemcitabine|gemcitabine|mesh-list
82760983|NCT00844688|Sorafenib|sorafenib|mesh-list
82760984|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82760985|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
82760986|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760987|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760988|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82760989|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760990|NCT04541680|Nintedanib|nintedanib|mesh-list
82760991|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82760992|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82760993|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82760994|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82760995|NCT00855530|Amibegron|amibegron|mesh-list
82760996|NCT00855530|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
82760997|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82760998|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82760999|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
82761000|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761001|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761002|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761003|NCT00855530|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82761004|NCT00855608|Adalimumab|adalimumab|mesh-list
82761005|NCT00855608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82761006|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82761007|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82761008|NCT00851864|Tinzaparin|tinzaparin|mesh-list
82761009|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82761010|NCT00851864|Dalteparin|dalteparin|mesh-list
82761011|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
82761012|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82761013|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82761014|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761015|NCT00851942|Cosyntropin|cosyntropin|mesh-list
82761016|NCT00851942|Hormones|hormones|mesh-ancestor
82761017|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761018|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761019|NCT00503776|Amifostine|amifostine|mesh-list
82761020|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82761021|NCT00503776|Protective Agents|protective agents|mesh-ancestor
82761022|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761023|NCT02545634|Sulfalene|sulfalene|mesh-list
82761024|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761025|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82761026|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
82761027|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82761028|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82761029|NCT05260671|Cetuximab|cetuximab|mesh-list
82761030|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82761031|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761032|NCT00855686|Memantine|memantine|mesh-list
82761033|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82761034|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82761035|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
82761036|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761037|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761038|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761039|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82761040|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82761041|NCT00619112|Temozolomide|temozolomide|mesh-list
82761042|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82761043|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
82761044|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761045|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761046|NCT03457701|Iron|iron|mesh-list
82761047|NCT03457701|Trace Elements|trace elements|mesh-ancestor
82761048|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
82761049|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761050|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
82761051|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
82761052|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761053|NCT00845156|Protective Agents|protective agents|mesh-ancestor
82761054|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761055|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
82761056|NCT00845156|Vitamins|vitamins|mesh-ancestor
82761057|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
82761058|NCT00852332|Curcumin|curcumin|mesh-list
82761059|NCT00852332|Docetaxel|docetaxel|mesh-list
82761060|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761061|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
82761062|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
82761063|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
82761064|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761065|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82761066|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82761067|NCT00852332|Analgesics|analgesics|mesh-ancestor
82761068|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
82761069|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761070|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761071|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82761072|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82761073|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761074|NCT00852410|Lidocaine|lidocaine|mesh-list
82761075|NCT00852410|Epinephrine|epinephrine|mesh-list
82761076|NCT00852410|Racepinephrine|racepinephrine|mesh-list
82761077|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
82761078|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
82761079|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
82761080|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82761081|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761082|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
82761083|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761084|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82761085|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82761086|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82761087|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82761088|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761089|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82761090|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82761091|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
82761092|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761093|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82761094|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82761095|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
82761096|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82761097|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
82761098|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
82761099|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
82761100|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82761101|NCT00992121|Bevacizumab|bevacizumab|mesh-list
82761102|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82761103|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761104|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82761105|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82761106|NCT00992121|Growth Substances|growth substances|mesh-ancestor
82761107|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761108|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
82761109|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82761111|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
82761112|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82761113|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82761114|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761115|NCT00992199|Fluorouracil|fluorouracil|mesh-list
82761116|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761117|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
82761118|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761119|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82761120|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82761121|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
82761122|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761123|NCT00856310|Fasinumab|fasinumab|mesh-list
82761124|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82761125|NCT00856310|Analgesics|analgesics|mesh-ancestor
82761126|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
82761127|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761128|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761129|NCT02773485|Cisplatin|cisplatin|mesh-list
82761130|NCT02773485|Gemcitabine|gemcitabine|mesh-list
82761131|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761132|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82761133|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
82761134|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761135|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
82761136|NCT04042220|Hormones|hormones|mesh-ancestor
82761137|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761138|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761139|NCT00992355|Tobramycin|tobramycin|mesh-list
82761140|NCT00992355|Dexamethasone|dexamethasone|mesh-list
82761141|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
82761142|NCT00992355|Ketorolac|ketorolac|mesh-list
82761143|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82761144|NCT00992355|BB 1101|bb 1101|mesh-list
82761145|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82761146|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
82761147|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
82761148|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761149|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761150|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82761151|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
82761152|NCT00992355|Hormones|hormones|mesh-ancestor
82761153|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761154|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82761155|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761156|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
82761157|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761158|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761159|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82761160|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82761161|NCT00992355|Analgesics|analgesics|mesh-ancestor
82761162|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
82761163|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82761164|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82761165|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82761166|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761167|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
82761168|NCT00852566|Dasatinib|dasatinib|mesh-list
82761169|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761170|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82761171|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761172|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761173|NCT00856622|Timolol|timolol|mesh-list
82761174|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82761175|NCT00856622|Latanoprost|latanoprost|mesh-list
82761176|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82761177|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82761178|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82761179|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
82761180|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761181|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761182|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761183|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82761184|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82761185|NCT00856700|Incretins|incretins|mesh-list
82761186|NCT00856700|Hormones|hormones|mesh-ancestor
82761187|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761188|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761189|NCT00618956|Milnacipran|milnacipran|mesh-list
82761190|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
82761191|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82761192|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82761193|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82761194|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761195|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761196|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761197|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82761198|NCT00618956|Analgesics|analgesics|mesh-ancestor
82761199|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
82761200|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761201|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
82761202|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82761203|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82761204|NCT00845546|Loratadine|loratadine|mesh-list
82761205|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
82761206|NCT00845546|Ephedrine|ephedrine|mesh-list
82761207|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
82761208|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
82761209|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82761210|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82761211|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82761212|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
82761213|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
82761214|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761215|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761216|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761217|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82761218|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
82761219|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761220|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82761221|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
82761222|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
82761223|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82761224|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82761225|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
82761226|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
82761227|NCT00852956|Betahistine|betahistine|mesh-list
82761228|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
82761229|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
82761230|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
82761231|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761232|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761233|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761234|NCT00716417|Afatinib|afatinib|mesh-list
82761236|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82761237|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761238|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761239|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
82761240|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82761241|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761242|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761243|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82761244|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82761245|NCT02592863|Protective Agents|protective agents|mesh-ancestor
82761246|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761247|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
82761248|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82761249|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
82761250|NCT00719537|Aspirin|aspirin|mesh-list
82761251|NCT00719537|Progesterone|progesterone|mesh-list
82761252|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82761253|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82761254|NCT00719537|Analgesics|analgesics|mesh-ancestor
82761255|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
82761256|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761257|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761258|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82761259|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82761260|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82761261|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82761262|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761263|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82761264|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82761265|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761266|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
82761267|NCT00719537|Progestins|progestins|mesh-ancestor
82761268|NCT00719537|Hormones|hormones|mesh-ancestor
82761269|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761270|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
82761271|NCT00853190|Hydrocodone|hydrocodone|mesh-list
82761272|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761273|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82761274|NCT00853190|Narcotics|narcotics|mesh-ancestor
82761275|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82761276|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761277|NCT00853190|Analgesics|analgesics|mesh-ancestor
82761278|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
82761279|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761280|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
82761281|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
82761282|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
82761283|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
82761284|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82761285|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
82761286|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
82761287|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761288|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82761289|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
82761290|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
82761291|NCT00573794|Adalimumab|adalimumab|mesh-list
82761292|NCT00573794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82761293|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82761294|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82761295|NCT00715793|Temozolomide|temozolomide|mesh-list
82761296|NCT00715793|Decitabine|decitabine|mesh-list
82761297|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82761298|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
82761299|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761300|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761301|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82761302|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
82761303|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761304|NCT00924014|Furosemide|furosemide|mesh-list
82761305|NCT00924014|Conivaptan|conivaptan|mesh-list
82761306|NCT00924014|Diuretics|diuretics|mesh-ancestor
82761307|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
82761308|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761309|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82761310|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82761311|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761312|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82761313|NCT00853268|Oxycodone|oxycodone|mesh-list
82761314|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82761315|NCT00853268|Narcotics|narcotics|mesh-ancestor
82761316|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82761317|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761318|NCT00853268|Analgesics|analgesics|mesh-ancestor
82761319|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
82761320|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761321|NCT00845780|Amiodarone|amiodarone|mesh-list
82761322|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82761323|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
82761324|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82761325|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82761326|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761327|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82761328|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82761329|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82761330|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761331|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82761712|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761332|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82761333|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82761334|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
82761335|NCT00853502|Testosterone|testosterone|mesh-list
82761336|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
82761337|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
82761338|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82761339|NCT00853502|Androgens|androgens|mesh-ancestor
82761340|NCT00853502|Hormones|hormones|mesh-ancestor
82761341|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761342|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761343|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82761344|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761345|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
82761346|NCT00853736|Oxycodone|oxycodone|mesh-list
82761347|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82761348|NCT00853736|Narcotics|narcotics|mesh-ancestor
82761349|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82761350|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761351|NCT00853736|Analgesics|analgesics|mesh-ancestor
82761352|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
82761353|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761354|NCT00857168|Testosterone|testosterone|mesh-list
82761355|NCT00857168|Androgens|androgens|mesh-ancestor
82761356|NCT00857168|Hormones|hormones|mesh-ancestor
82761357|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761358|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761359|NCT00857324|Vorinostat|vorinostat|mesh-list
82761360|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761361|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82761362|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761363|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761364|NCT00853892|Oxycodone|oxycodone|mesh-list
82761365|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82761366|NCT00853892|Narcotics|narcotics|mesh-ancestor
82761367|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82761368|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761369|NCT00853892|Analgesics|analgesics|mesh-ancestor
82761370|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
82761371|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761372|NCT04164212|Vaccines|vaccines|mesh-list
82761373|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
82761374|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761375|NCT00857558|Saxagliptin|saxagliptin|mesh-list
82761376|NCT00857558|Incretins|incretins|mesh-ancestor
82761377|NCT00857558|Hormones|hormones|mesh-ancestor
82761378|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761379|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761380|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82761381|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
82761382|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761383|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761384|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82761385|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82761386|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
82761387|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761388|NCT00715559|Cysteamine|cysteamine|mesh-list
82761389|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
82761390|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761391|NCT05289869|Oxytocin|oxytocin|mesh-list
82761392|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
82761393|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82761394|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761395|NCT00620282|Liraglutide|liraglutide|mesh-list
82761396|NCT00620282|Glimepiride|glimepiride|mesh-list
82761397|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82761398|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761399|NCT00620282|Incretins|incretins|mesh-ancestor
82761400|NCT00620282|Hormones|hormones|mesh-ancestor
82761401|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761402|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82761403|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82761404|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
82761405|NCT05684861|Isotretinoin|isotretinoin|mesh-list
82761406|NCT05684861|Dermatologic Agents|dermatologic agents|mesh-ancestor
82761407|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
82761408|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82761409|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82761410|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761412|NCT04042688|Coagulants|coagulants|mesh-ancestor
82761413|NCT02590133|Fluorouracil|fluorouracil|mesh-list
82761414|NCT02590133|Endostar protein|endostar protein|mesh-list
82761415|NCT02590133|Endostatins|endostatins|mesh-list
82761416|NCT02590133|Nedaplatin|nedaplatin|mesh-list
82761417|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
82761418|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761419|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82761420|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761421|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82761422|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
82761423|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761424|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82761425|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82761426|NCT02590133|Growth Substances|growth substances|mesh-ancestor
82761427|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
82761428|NCT00854204|Darunavir|darunavir|mesh-list
82761429|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82761430|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82761431|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
82761432|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761433|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761434|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82761435|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82761436|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
82761437|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761438|NCT00857870|Metformin|metformin|mesh-list
82761439|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
82761440|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82761441|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761442|NCT00848432|Risperidone|risperidone|mesh-list
82761443|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82761444|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
82761445|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761446|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761447|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761448|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82761449|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82761450|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82761451|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82761452|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82761453|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
82761454|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82761455|NCT00854750|Hormones|hormones|mesh-ancestor
82761456|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761457|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761458|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82761459|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
82761460|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82761461|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761462|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
82761463|NCT00858338|Floxuridine|floxuridine|mesh-list
82761464|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82761465|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
82761466|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761467|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761468|NCT00515086|Everolimus|everolimus|mesh-list
82761469|NCT00515086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82761470|NCT00515086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82761471|NCT00515086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761472|NCT00515086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761473|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82761474|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
82761475|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761476|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761477|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
82761478|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761479|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82761480|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761481|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761482|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82761483|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82761484|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82761485|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
82761486|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761487|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82761488|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82761489|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761490|NCT00849368|Azathioprine|azathioprine|mesh-list
82761491|NCT00849368|Allopurinol|allopurinol|mesh-list
82761492|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
82761493|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761494|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761495|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
82761496|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82761497|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82761498|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
82761499|NCT00849368|Protective Agents|protective agents|mesh-ancestor
82761500|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761501|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82761502|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761503|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82761504|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
82761506|NCT02544932|Dabigatran|dabigatran|mesh-list
82761507|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
82761508|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
82761509|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82761510|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
82761511|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761512|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761513|NCT02544854|Propofol|propofol|mesh-list
82761514|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82761515|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82761516|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761517|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82761518|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
82761519|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
82761520|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
82761521|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
82761522|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761523|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82761524|NCT02544776|Amlodipine|amlodipine|mesh-list
82761525|NCT02544776|Clomiphene|clomiphene|mesh-list
82761526|NCT02544776|Enclomiphene|enclomiphene|mesh-list
82761527|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
82761528|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761529|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82761530|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82761531|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82761532|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82761533|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761534|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
82761535|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82761536|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
82761537|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761538|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82761539|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
82761540|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82761541|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82761542|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82761543|NCT00859118|Axitinib|axitinib|mesh-list
82761544|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761545|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82761546|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761547|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761548|NCT00849602|Chloroquine|chloroquine|mesh-list
82761549|NCT00849602|Amebicides|amebicides|mesh-ancestor
82761550|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82761551|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82761552|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761553|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
82761554|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82761555|NCT00859274|Budesonide|budesonide|mesh-list
82761556|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82761557|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82761558|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
82761559|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761560|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761561|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82761562|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
82761563|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
82761564|NCT00859274|Hormones|hormones|mesh-ancestor
82761565|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761566|NCT00859352|Midazolam|midazolam|mesh-list
82761567|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82761568|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82761569|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82761570|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761571|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82761572|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82761573|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82761574|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82761575|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
82761576|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
82761577|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
82761578|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
82761579|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761580|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761581|NCT00861926|Beclomethasone|beclomethasone|mesh-list
82761582|NCT00861926|Albuterol|albuterol|mesh-list
82761583|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
82761584|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82761585|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
82761586|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761587|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761588|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82761589|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
82761590|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82761591|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82761592|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82761593|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
82761594|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761595|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761596|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
82761597|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82761598|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82761599|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
82761600|NCT00861926|Hormones|hormones|mesh-ancestor
82761601|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761602|NCT00849992|Imiquimod|imiquimod|mesh-list
82761603|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82761604|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
82761605|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761606|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761607|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
82761608|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
82761609|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82761610|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82761612|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
82761613|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761614|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
82761615|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82761616|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
82761617|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761618|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761619|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82761620|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
82761621|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82761622|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82761623|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82761624|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
82761625|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761626|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761627|NCT00862472|Timolol|timolol|mesh-list
82761628|NCT00862472|Cloprostenol|cloprostenol|mesh-list
82761629|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
82761630|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82761631|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
82761632|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82761633|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761634|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82761635|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82761636|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82761637|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
82761638|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761639|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761640|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82761641|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82761642|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
82761643|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761644|NCT00850382|Cytarabine|cytarabine|mesh-list
82761645|NCT00850382|Daunorubicin|daunorubicin|mesh-list
82761646|NCT00850382|Dasatinib|dasatinib|mesh-list
82761647|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82761648|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
82761649|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761650|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761651|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
82761652|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761653|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82761654|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
82761655|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761656|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82761657|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82761658|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82761659|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761660|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82761661|NCT00860366|Uric Acid|uric acid|mesh-list
82761662|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
82761663|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761664|NCT00860366|Protective Agents|protective agents|mesh-ancestor
82761665|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761666|NCT00862628|Rebamipide|rebamipide|mesh-list
82761667|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82761668|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82761669|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
82761670|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761671|NCT00862628|Protective Agents|protective agents|mesh-ancestor
82761672|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761673|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761674|NCT00507442|Dexamethasone|dexamethasone|mesh-list
82761675|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
82761676|NCT00507442|Lenalidomide|lenalidomide|mesh-list
82761677|NCT00507442|Bortezomib|bortezomib|mesh-list
82761678|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82761679|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
82761680|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761681|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82761682|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82761683|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
82761684|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761685|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761686|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82761687|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82761688|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
82761689|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
82761690|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761691|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82761692|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
82761693|NCT00507442|Hormones|hormones|mesh-ancestor
82761694|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761695|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82761696|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82761697|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82761698|NCT00507442|Growth Substances|growth substances|mesh-ancestor
82761699|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
82761700|NCT00862706|Telbivudine|telbivudine|mesh-list
82761701|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
82761702|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761703|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82761704|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761705|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761706|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82761707|NCT04041362|UB-421|ub-421|mesh-list
82761708|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
82761709|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761710|NCT00850850|Physostigmine|physostigmine|mesh-list
82761711|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82761713|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761714|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
82761715|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761716|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761718|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
82761719|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761720|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82761721|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
82761722|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82761723|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82761724|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82761725|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82761726|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761727|NCT00863096|Vaccines|vaccines|mesh-list
82761728|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
82761729|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761730|NCT00870272|Misoprostol|misoprostol|mesh-list
82761731|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82761732|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
82761733|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82761734|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761735|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82761736|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82761737|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
82761738|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
82761739|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82761740|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761741|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82761742|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
82761743|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82761744|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761745|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761746|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761747|NCT00502996|Rituximab|rituximab|mesh-list
82761748|NCT00502996|Methotrexate|methotrexate|mesh-list
82761749|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82761750|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761751|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
82761752|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761753|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82761754|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82761755|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
82761756|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82761757|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82761758|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
82761759|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761760|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
82761761|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761762|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82761763|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82761764|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82761766|NCT00865436|Glyburide|glyburide|mesh-list
82761767|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82761768|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761769|NCT00715403|Nintedanib|nintedanib|mesh-list
82761770|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761771|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82761772|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761773|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761774|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
82761775|NCT01013584|Vitamin D|vitamin d|mesh-list
82761776|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82761777|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761778|NCT01013584|Vitamins|vitamins|mesh-ancestor
82761779|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
82761780|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82761781|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
82761782|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82761783|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82761784|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761785|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
82761786|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
82761787|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761788|NCT00864188|Beta Carotene|beta carotene|mesh-list
82761789|NCT00864188|Carotenoids|carotenoids|mesh-list
82761790|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
82761791|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761792|NCT00864188|Protective Agents|protective agents|mesh-ancestor
82761793|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761794|NCT00864188|Provitamins|provitamins|mesh-ancestor
82761795|NCT00864188|Vitamins|vitamins|mesh-ancestor
82761796|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
82761797|NCT00865670|Azithromycin|azithromycin|mesh-list
82761798|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82761799|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761800|NCT00864344|Sertraline|sertraline|mesh-list
82761801|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
82761802|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82761803|NCT00864344|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82761804|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82761805|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82761806|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761807|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761808|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
82761809|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761810|NCT00864500|Clobetasol|clobetasol|mesh-list
82761811|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82761812|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
82761813|NCT00864500|Hormones|hormones|mesh-ancestor
82761814|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761815|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761816|NCT00864734|Metformin|metformin|mesh-list
82761817|NCT00864734|Glyburide|glyburide|mesh-list
82761818|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82761819|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761820|NCT00864812|Fluticasone|fluticasone|mesh-list
82761821|NCT00864812|Xhance|xhance|mesh-list
82761822|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
82761823|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82761824|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82761825|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82761826|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82761827|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
82761828|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761829|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761830|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82761831|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
82761832|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
82761833|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82761834|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
82761835|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82761836|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
82761837|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761838|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761839|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82761840|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82761841|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82761842|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
82761843|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
82761844|NCT00864812|Hormones|hormones|mesh-ancestor
82761845|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761846|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
82761847|NCT02590055|Gemcitabine|gemcitabine|mesh-list
82761848|NCT02590055|Docetaxel|docetaxel|mesh-list
82761849|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82761850|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
82761851|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761852|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761853|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
82761854|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
82761855|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
82761856|NCT00864890|Dexetimide|dexetimide|mesh-list
82761857|NCT00864890|Citalopram|citalopram|mesh-list
82761858|NCT00864890|Escitalopram|escitalopram|mesh-list
82761859|NCT00864890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82761860|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82761861|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82761862|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761863|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761864|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
82761865|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761866|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82761867|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
82761868|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82761869|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82761870|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82761871|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
82761872|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
82761873|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761874|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82761875|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82761876|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
82761877|NCT00919295|Mirtazapine|mirtazapine|mesh-list
82761878|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
82761879|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82761880|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82761881|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
82761882|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
82761883|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761884|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761885|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761886|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82761887|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82761888|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82761889|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82761890|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82761891|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82761892|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
82761893|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82761894|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82761895|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
82761896|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82761897|NCT00865748|Metformin|metformin|mesh-list
82761898|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82761899|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761900|NCT00865982|Docetaxel|docetaxel|mesh-list
82761901|NCT00865982|Capecitabine|capecitabine|mesh-list
82761902|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761903|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
82761904|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
82761905|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
82761906|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761907|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82761908|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
82761909|NCT00866060|Memantine|memantine|mesh-list
82761910|NCT00866060|Donepezil|donepezil|mesh-list
82761911|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82761912|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761913|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761914|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
82761915|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82761916|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761917|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
82761918|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82761919|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82761920|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
82761921|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82761922|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82761923|NCT00871052|Vitamin D|vitamin d|mesh-list
82761924|NCT00871052|Calcipotriene|calcipotriene|mesh-list
82761925|NCT00871052|Vitamins|vitamins|mesh-ancestor
82761926|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
82761927|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761928|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82761929|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
82761930|NCT00502840|Rituximab|rituximab|mesh-list
82761931|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82761932|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761933|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
82761934|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761935|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82761936|NCT00514540|Carboplatin|carboplatin|mesh-list
82761937|NCT00514540|Docetaxel|docetaxel|mesh-list
82761938|NCT00514540|Etoposide|etoposide|mesh-list
82761939|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761940|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
82761941|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
82761942|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
82761943|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761944|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82761945|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82761946|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82761947|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761948|NCT00506662|Insulin|insulin|mesh-list
82761949|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82761950|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
82761951|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
82761952|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
82761953|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
82761954|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82761955|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761956|NCT03121534|Dexamethasone|dexamethasone|mesh-list
82761957|NCT03121534|Nivolumab|nivolumab|mesh-list
82761958|NCT03121534|Blinatumomab|blinatumomab|mesh-list
82761959|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82761960|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
82761961|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
82761962|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82761963|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761964|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82761965|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
82761966|NCT03121534|Hormones|hormones|mesh-ancestor
82761967|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82761968|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82761969|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82761970|NCT03121534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82761971|NCT03121534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82761972|NCT03121534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761973|NCT01012102|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82761974|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
82761975|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82761976|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
82761977|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761978|NCT04615624|Furosemide|furosemide|mesh-list
82761979|NCT04615624|Diuretics|diuretics|mesh-ancestor
82761980|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
82761981|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82761982|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82761983|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82761984|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761985|NCT00713609|Clindamycin|clindamycin|mesh-list
82761986|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
82761987|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
82761988|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82761989|NCT00713609|Tazarotene|tazarotene|mesh-list
82761990|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82761991|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82761992|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82761993|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82761994|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82761995|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
82761996|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
82761997|NCT00513682|Pancrelipase|pancrelipase|mesh-list
82761999|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82762000|NCT00493012|Vitamin D|vitamin d|mesh-list
82762001|NCT00493012|Vitamins|vitamins|mesh-ancestor
82762002|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
82762003|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762004|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82762005|NCT00918593|Bleomycin|bleomycin|mesh-list
82762006|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82762007|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762008|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
82762009|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
82762010|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
82762011|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762012|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762013|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
82762014|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762015|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82762016|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762017|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762018|NCT05684705|Rifabutin|rifabutin|mesh-list
82762019|NCT05684705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82762020|NCT05684705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762021|NCT05684705|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82762022|NCT05684705|Antitubercular Agents|antitubercular agents|mesh-ancestor
82762023|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
82762024|NCT05238233|Pilocarpine|pilocarpine|mesh-list
82762025|NCT05238233|Tropicamide|tropicamide|mesh-list
82762026|NCT05238233|Miotics|miotics|mesh-ancestor
82762027|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
82762028|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762029|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762030|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82762031|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82762032|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
82762033|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762034|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762035|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
82762036|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82762037|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82762038|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
82762039|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
82762040|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762041|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
82762042|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
82762043|NCT05232851|Vaccines|vaccines|mesh-list
82762044|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
82762045|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762046|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82762047|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762048|NCT05232851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82762049|NCT05232851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762050|NCT00617708|Gemcitabine|gemcitabine|mesh-list
82762051|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82762052|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82762053|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82762054|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
82762055|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762056|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762057|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82762058|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762059|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
82762060|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762061|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
82762062|NCT04083209|Narcotics|narcotics|mesh-ancestor
82762063|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762064|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762065|NCT04083209|Analgesics|analgesics|mesh-ancestor
82762066|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
82762067|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762068|NCT00864968|Nabumetone|nabumetone|mesh-list
82762069|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82762070|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82762071|NCT00864968|Analgesics|analgesics|mesh-ancestor
82762072|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
82762073|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762074|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762075|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82762076|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82762077|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82762078|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82762079|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762080|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762081|NCT00876044|Aflibercept|aflibercept|mesh-list
82762082|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82762083|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82762084|NCT00876044|Growth Substances|growth substances|mesh-ancestor
82762085|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762086|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
82762087|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762088|NCT00866216|Azithromycin|azithromycin|mesh-list
82762089|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82762090|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762091|NCT00871208|Retapamulin|retapamulin|mesh-list
82762092|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
82762093|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82762094|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82762095|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82762096|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
82762097|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
82762098|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82762099|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82762100|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762101|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82762102|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82762103|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82762104|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762105|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762106|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762107|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762108|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82762109|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
82762110|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82762111|NCT05113745|Reboxetine|reboxetine|mesh-list
82762112|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
82762113|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82762114|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82762115|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82762116|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762117|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762118|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
82762119|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762120|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762121|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
82762122|NCT00866450|Calcium|calcium|mesh-list
82762123|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82762124|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762125|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82762126|NCT03894969|Vaccines|vaccines|mesh-list
82762127|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
82762128|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762129|NCT00876434|Sirolimus|sirolimus|mesh-list
82762130|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82762131|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762132|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82762133|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762134|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
82762135|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82762136|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
82762137|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762138|NCT00871442|Fentanyl|fentanyl|mesh-list
82762139|NCT00871442|Bupivacaine|bupivacaine|mesh-list
82762140|NCT00871442|Anesthetics|anesthetics|mesh-list
82762141|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
82762142|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762143|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762144|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
82762145|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762146|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82762147|NCT00871442|Narcotics|narcotics|mesh-ancestor
82762148|NCT00871442|Analgesics|analgesics|mesh-ancestor
82762149|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82762150|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82762151|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
82762152|NCT05355597|Clonidine|clonidine|mesh-list
82762153|NCT05355597|Epinephrine|epinephrine|mesh-list
82762154|NCT05355597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82762155|NCT05355597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82762156|NCT05355597|Adrenergic Agents|adrenergic agents|mesh-ancestor
82762157|NCT05355597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762158|NCT05355597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762159|NCT05355597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762160|NCT05355597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82762161|NCT05355597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82762162|NCT05355597|Autonomic Agents|autonomic agents|mesh-ancestor
82762163|NCT05355597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762164|NCT05355597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82762165|NCT05355597|Respiratory System Agents|respiratory system agents|mesh-ancestor
82762166|NCT05355597|Mydriatics|mydriatics|mesh-ancestor
82762167|NCT05355597|Sympathomimetics|sympathomimetics|mesh-ancestor
82762168|NCT05355597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82762169|NCT05355597|Analgesics|analgesics|mesh-ancestor
82762170|NCT05355597|Sensory System Agents|sensory system agents|mesh-ancestor
82762171|NCT05355597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82762172|NCT05355597|Sympatholytics|sympatholytics|mesh-ancestor
82762173|NCT05355597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82762174|NCT00866528|Paclitaxel|paclitaxel|mesh-list
82762175|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82762176|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762177|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
82762178|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
82762179|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
82762180|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762181|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82762182|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
82762183|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762184|NCT00992667|Acetovanillone|acetovanillone|mesh-list
82762185|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82762186|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82762187|NCT00992667|Analgesics|analgesics|mesh-ancestor
82762188|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
82762189|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762190|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762191|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82762192|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82762193|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
82762194|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762195|NCT00992667|Protective Agents|protective agents|mesh-ancestor
82762196|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762197|NCT05171972|Ofatumumab|ofatumumab|mesh-list
82762198|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762199|NCT00992823|Iron|iron|mesh-list
82762200|NCT00992823|Trace Elements|trace elements|mesh-ancestor
82762201|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
82762202|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762203|NCT03894813|Metronidazole|metronidazole|mesh-list
82762204|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762205|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82762206|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82762207|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82762208|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
82762209|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82762210|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
82762211|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762212|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762213|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82762214|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
82762215|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
82762216|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82762217|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
82762218|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762219|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762220|NCT00876824|Amphotericin B|amphotericin b|mesh-list
82762221|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82762222|NCT00876824|Amebicides|amebicides|mesh-ancestor
82762223|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82762224|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82762225|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762226|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82762227|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
82762228|NCT00866684|Cyclosporine|cyclosporine|mesh-list
82762230|NCT00866684|Azathioprine|azathioprine|mesh-list
82762231|NCT00866684|Tacrolimus|tacrolimus|mesh-list
82762232|NCT00866684|Cyclosporins|cyclosporins|mesh-list
82762233|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82762234|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
82762235|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762236|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82762237|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762238|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762239|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
82762240|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762241|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
82762242|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82762243|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82762244|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762245|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82762246|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
82762247|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82762249|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82762250|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762251|NCT00866762|Vorinostat|vorinostat|mesh-list
82762252|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82762253|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762254|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762255|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762256|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
82762257|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82762258|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
82762259|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762260|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82762261|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762262|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
82762263|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762264|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
82762265|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82762266|NCT00876902|Protective Agents|protective agents|mesh-ancestor
82762267|NCT00993135|Methotrexate|methotrexate|mesh-list
82762268|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82762269|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
82762270|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82762271|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762272|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82762273|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
82762274|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762275|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762276|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
82762277|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762278|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82762279|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82762280|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
82762281|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82762282|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82762283|NCT00866996|Methylphenidate|methylphenidate|mesh-list
82762284|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82762285|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82762286|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762287|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82762288|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82762289|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762290|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762291|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
82762292|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762293|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82762295|NCT00871910|Dexamethasone|dexamethasone|mesh-list
82762296|NCT00871910|Ondansetron|ondansetron|mesh-list
82762297|NCT00871910|Aprepitant|aprepitant|mesh-list
82762298|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82762299|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
82762300|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
82762301|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762302|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762303|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82762304|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
82762305|NCT00871910|Hormones|hormones|mesh-ancestor
82762306|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82762307|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82762308|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762309|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
82762310|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
82762311|NCT00871910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82762312|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82762313|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
82762314|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762315|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762316|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82762317|NCT05355441|Analgesics|analgesics|mesh-list
82762318|NCT05355441|Sensory System Agents|sensory system agents|mesh-ancestor
82762319|NCT05355441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762320|NCT05355441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762321|NCT05155436|Amlodipine|amlodipine|mesh-list
82762322|NCT05155436|Telmisartan|telmisartan|mesh-list
82762323|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82762324|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82762325|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762326|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762327|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82762328|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762329|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
82762330|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82762331|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82762333|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82762334|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82762335|NCT01564329|Growth Substances|growth substances|mesh-ancestor
82762336|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762337|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
82762338|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762339|NCT05213481|Tepotinib|tepotinib|mesh-list
82762340|NCT05213481|Carbamazepine|carbamazepine|mesh-list
82762341|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
82762342|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
82762343|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82762344|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762345|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762346|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82762347|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82762348|NCT05213481|Analgesics|analgesics|mesh-ancestor
82762349|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
82762350|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762351|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82762352|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762353|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762354|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82762355|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82762356|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762357|NCT00993525|Ranibizumab|ranibizumab|mesh-list
82762358|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82762359|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82762360|NCT00993525|Growth Substances|growth substances|mesh-ancestor
82762361|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762362|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
82762363|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762364|NCT00993681|Vaccines|vaccines|mesh-list
82762365|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
82762366|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762367|NCT03892707|Folic Acid|folic acid|mesh-list
82762368|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
82762369|NCT03892707|Celecoxib|celecoxib|mesh-list
82762370|NCT03892707|Etoricoxib|etoricoxib|mesh-list
82762371|NCT03892707|Meloxicam|meloxicam|mesh-list
82762372|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
82762373|NCT03892707|Nimesulide|nimesulide|mesh-list
82762374|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82762375|NCT03892707|Benphothiamine|benphothiamine|mesh-list
82762376|NCT03892707|Vitamins|vitamins|mesh-ancestor
82762377|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
82762378|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762379|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82762380|NCT03892707|Analgesics|analgesics|mesh-ancestor
82762381|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
82762382|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762383|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82762384|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82762385|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82762386|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762387|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762388|NCT03892707|Hematinics|hematinics|mesh-ancestor
82762389|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82762390|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
82762391|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
82762392|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
82762393|NCT00513604|Aldesleukin|aldesleukin|mesh-list
82762394|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
82762395|NCT00513604|Fludarabine|fludarabine|mesh-list
82762396|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
82762397|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82762398|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
82762399|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762400|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82762401|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82762402|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
82762403|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762404|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762405|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82762406|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82762407|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
82762408|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82762409|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82762410|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
82762411|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762412|NCT00872144|Nabiximols|nabiximols|mesh-list
82762413|NCT00872144|Analgesics|analgesics|mesh-ancestor
82762414|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
82762415|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762416|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762417|NCT00867152|Ritonavir|ritonavir|mesh-list
82762418|NCT00867152|Lopinavir|lopinavir|mesh-list
82762419|NCT00867152|Darunavir|darunavir|mesh-list
82762420|NCT00867152|Dolutegravir|dolutegravir|mesh-list
82762421|NCT00867152|Etravirine|etravirine|mesh-list
82762422|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82762423|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82762424|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
82762425|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762426|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762427|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82762428|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82762429|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
82762430|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762431|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82762432|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82762433|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82762434|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82762435|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82762436|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82762437|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
82762438|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
82762439|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762440|NCT00872378|Exenatide|exenatide|mesh-list
82762441|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82762442|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762443|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82762444|NCT00872378|Incretins|incretins|mesh-ancestor
82762445|NCT00872378|Hormones|hormones|mesh-ancestor
82762446|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82762447|NCT00994071|Temozolomide|temozolomide|mesh-list
82762449|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82762450|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
82762451|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762452|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762453|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82762454|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762455|NCT00994149|Diazoxide|diazoxide|mesh-list
82762456|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82762457|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
82762458|NCT00573248|Nicotine|nicotine|mesh-list
82762459|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82762460|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
82762461|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762462|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762463|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82762464|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82762465|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
82762466|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762467|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762468|NCT04039880|Olorofim|olorofim|mesh-list
82762469|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
82762470|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762471|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
82762472|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82762473|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
82762474|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762475|NCT00994305|Expectorants|expectorants|mesh-ancestor
82762476|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
82762554|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82762477|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82762478|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
82762479|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762480|NCT00994305|Protective Agents|protective agents|mesh-ancestor
82762481|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762482|NCT00994305|Antidotes|antidotes|mesh-ancestor
82762483|NCT00877760|Interferons|interferons|mesh-list
82762484|NCT00877760|Entecavir|entecavir|mesh-list
82762485|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762486|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
82762487|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762488|NCT04083911|Cytarabine|cytarabine|mesh-list
82762489|NCT04083911|Decitabine|decitabine|mesh-list
82762490|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
82762491|NCT04083911|Aclarubicin|aclarubicin|mesh-list
82762492|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82762493|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
82762494|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762495|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762496|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
82762497|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762498|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82762499|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
82762500|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762501|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762502|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82762503|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82762504|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82762505|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82762506|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82762507|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
82762508|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82762509|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82762510|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
82762511|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762512|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82762513|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82762514|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762515|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762516|NCT00994383|Morphine|morphine|mesh-list
82762517|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82762518|NCT00994383|Narcotics|narcotics|mesh-ancestor
82762519|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762520|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762521|NCT00994383|Analgesics|analgesics|mesh-ancestor
82762522|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
82762523|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762524|NCT02588417|Dexamethasone|dexamethasone|mesh-list
82762525|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
82762526|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82762527|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
82762528|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
82762529|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762530|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762531|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82762532|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
82762533|NCT02588417|Hormones|hormones|mesh-ancestor
82762534|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82762535|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82762536|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762537|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
82762538|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
82762539|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762540|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
82762541|NCT00532935|Metformin|metformin|mesh-list
82762542|NCT00532935|Pioglitazone|pioglitazone|mesh-list
82762543|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82762544|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82762545|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762546|NCT00532935|Incretins|incretins|mesh-ancestor
82762547|NCT00532935|Hormones|hormones|mesh-ancestor
82762548|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82762549|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82762550|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
82762551|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762552|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762553|NCT00994539|Morphine|morphine|mesh-list
82762555|NCT00994539|Narcotics|narcotics|mesh-ancestor
82762556|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762557|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762558|NCT00994539|Analgesics|analgesics|mesh-ancestor
82762559|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
82762560|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762561|NCT00878306|Ritonavir|ritonavir|mesh-list
82762562|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82762563|NCT00878306|Efavirenz|efavirenz|mesh-list
82762564|NCT00878306|Disulfiram|disulfiram|mesh-list
82762565|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82762566|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82762567|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
82762568|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762569|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762570|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82762571|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82762572|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
82762573|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762574|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82762575|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82762576|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82762577|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82762578|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82762579|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82762580|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82762581|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82762582|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82762583|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82762584|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82762585|NCT00994617|Losartan|losartan|mesh-list
82762586|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82762587|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82762588|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82762589|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82762590|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82762591|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762592|NCT00994617|Diuretics|diuretics|mesh-ancestor
82762593|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
82762594|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762595|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82762596|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762597|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
82762598|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
82762599|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82762600|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
82762601|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
82762602|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762603|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762604|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762605|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
82762606|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
82762607|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82762608|NCT00919451|Cyclosporine|cyclosporine|mesh-list
82762609|NCT00919451|Cyclosporins|cyclosporins|mesh-list
82762610|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762611|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762612|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82762613|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
82762614|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762615|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
82762616|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762617|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
82762618|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82762619|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82762620|NCT03016312|Atezolizumab|atezolizumab|mesh-list
82762621|NCT03016312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82762622|NCT03016312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762623|NCT03016312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82762624|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762625|NCT05059223|Reboxetine|reboxetine|mesh-list
82762626|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
82762627|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82762701|NCT02587871|Cytarabine|cytarabine|mesh-list
82762628|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82762629|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82762630|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762631|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762632|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
82762633|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762634|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762635|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82762636|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
82762637|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82762638|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82762639|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82762640|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762641|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762642|NCT01014052|Retinol acetate|retinol acetate|mesh-list
82762643|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82762644|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
82762645|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762646|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82762647|NCT01014052|Protective Agents|protective agents|mesh-ancestor
82762648|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762649|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
82762650|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762651|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82762652|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762653|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762654|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
82762655|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82762656|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82762657|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82762658|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82762659|NCT01015300|Bevacizumab|bevacizumab|mesh-list
82762660|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82762661|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762662|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82762663|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82762664|NCT01015300|Growth Substances|growth substances|mesh-ancestor
82762665|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762666|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
82762667|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
82762668|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
82762669|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82762670|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
82762671|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762672|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82762673|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82762674|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
82762675|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762676|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762677|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82762678|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82762679|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82762680|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
82762681|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82762682|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762683|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762684|NCT02589041|Ropivacaine|ropivacaine|mesh-list
82762685|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
82762686|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
82762687|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762688|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762689|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
82762690|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762691|NCT00492232|Zolpidem|zolpidem|mesh-list
82762692|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82762693|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82762694|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762695|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762696|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82762697|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
82762698|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
82762699|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762700|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762702|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82762703|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
82762704|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762705|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762706|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
82762707|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762708|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82762709|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
82762710|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762711|NCT00919919|Progesterone|progesterone|mesh-list
82762712|NCT00919919|Progestins|progestins|mesh-ancestor
82762713|NCT00919919|Hormones|hormones|mesh-ancestor
82762714|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82762715|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762716|NCT00491764|Posaconazole|posaconazole|mesh-list
82762717|NCT00491764|Terbinafine|terbinafine|mesh-list
82762718|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
82762719|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762720|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82762721|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82762722|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82762723|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82762724|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82762725|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762726|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762727|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82762728|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
82762729|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82762730|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762731|NCT02586311|Amlodipine|amlodipine|mesh-list
82762732|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82762733|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82762734|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762735|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762736|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82762737|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762738|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
82762739|NCT05557721|Lidocaine|lidocaine|mesh-list
82762740|NCT05557721|Anesthetics, Local|anesthetics, local|mesh-ancestor
82762741|NCT05557721|Anesthetics|anesthetics|mesh-ancestor
82762742|NCT05557721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762743|NCT05557721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762744|NCT05557721|Sensory System Agents|sensory system agents|mesh-ancestor
82762745|NCT05557721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762746|NCT05557721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82762747|NCT05557721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82762748|NCT05557721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82762749|NCT05557721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762750|NCT05557721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762751|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82762752|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
82762753|NCT00615836|Coagulants|coagulants|mesh-ancestor
82762754|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82762755|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
82762756|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762757|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
82762758|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82762759|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762760|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762761|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82762762|NCT05139212|Analgesics|analgesics|mesh-ancestor
82762763|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
82762764|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762765|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82762766|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82762767|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82762768|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
82762769|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762770|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762771|NCT00872924|Sumatriptan|sumatriptan|mesh-list
82762772|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82762773|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82762774|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82762775|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
82762776|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762777|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762778|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762779|NCT00878540|Mirtazapine|mirtazapine|mesh-list
82762780|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
82762781|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82762782|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82762783|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
82762784|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
82762785|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762786|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762787|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762788|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82762789|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82762790|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762791|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82762792|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82762793|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82762794|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
82762795|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82762796|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82762797|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
82762798|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82762799|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
82762800|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82762801|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
82762802|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
82762803|NCT04018274|Estradiol|estradiol|mesh-list
82762804|NCT04018274|Estrogens|estrogens|mesh-ancestor
82762805|NCT04018274|Hormones|hormones|mesh-ancestor
82762806|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82762807|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762808|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82762809|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82762810|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82762811|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82762812|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82762813|NCT00873002|Sorafenib|sorafenib|mesh-list
82762814|NCT00873002|Panobinostat|panobinostat|mesh-list
82762815|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762816|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82762817|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762818|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762819|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82762820|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
82762821|NCT00491530|Atorvastatin|atorvastatin|mesh-list
82762822|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82762823|NCT00491530|Simvastatin|simvastatin|mesh-list
82762824|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
82762825|NCT00491530|Calcium|calcium|mesh-list
82762826|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82762827|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762828|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82762829|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82762830|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82762831|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
82762832|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762833|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82762834|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82762835|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762836|NCT00617240|Metformin|metformin|mesh-list
82762837|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82762838|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762839|NCT00615290|Tipranavir|tipranavir|mesh-list
82762840|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82762841|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82762842|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
82762843|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762844|NCT02587169|Doxorubicin|doxorubicin|mesh-list
82762845|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82762846|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82762847|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762848|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82762849|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82762850|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762851|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762852|NCT00873236|Interferons|interferons|mesh-list
82762853|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
82762854|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
82762855|NCT00873236|Bevacizumab|bevacizumab|mesh-list
82762856|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82762857|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762858|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82762859|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82762860|NCT00873236|Growth Substances|growth substances|mesh-ancestor
82762861|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762862|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
82762863|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
82762864|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762865|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
82762866|NCT00868010|Donepezil|donepezil|mesh-list
82762867|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82762868|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762869|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762870|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
82762871|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762872|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762873|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
82762874|NCT05683301|Amlodipine|amlodipine|mesh-list
82762875|NCT05683301|Perindopril|perindopril|mesh-list
82762876|NCT05683301|Indapamide|indapamide|mesh-list
82762877|NCT05683301|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
82762878|NCT05683301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82762879|NCT05683301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82762880|NCT05683301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762881|NCT05683301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762882|NCT05683301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82762883|NCT05683301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762884|NCT05683301|Vasodilator Agents|vasodilator agents|mesh-ancestor
82762885|NCT05683301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82762886|NCT05683301|Protease Inhibitors|protease inhibitors|mesh-ancestor
82762887|NCT05683301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762888|NCT05683301|Diuretics|diuretics|mesh-ancestor
82762889|NCT05683301|Natriuretic Agents|natriuretic agents|mesh-ancestor
82762890|NCT05683301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82762891|NCT04770623|Docetaxel|docetaxel|mesh-list
82762892|NCT04770623|Irinotecan|irinotecan|mesh-list
82762893|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762894|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
82762895|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
82762896|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
82762897|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762898|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82762899|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82762900|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762901|NCT05653661|Paclitaxel|paclitaxel|mesh-list
82762902|NCT05653661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82762903|NCT05653661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82762904|NCT05653661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762905|NCT05653661|Tubulin Modulators|tubulin modulators|mesh-ancestor
82762906|NCT05653661|Antimitotic Agents|antimitotic agents|mesh-ancestor
82762907|NCT05653661|Mitosis Modulators|mitosis modulators|mesh-ancestor
82762908|NCT05653661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762909|NCT00873392|Nicotine|nicotine|mesh-list
82762910|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82762911|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
82762912|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762913|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762914|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82762915|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82762916|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
82762917|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762918|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762919|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
82762920|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82762921|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82762922|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82762923|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82762924|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82762925|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762926|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762927|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762928|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82762929|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
82762930|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82762931|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762932|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82762933|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82762934|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82762936|NCT04658147|Relatlimab|relatlimab|mesh-list
82762937|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82762938|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762939|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82762940|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762941|NCT00879164|Bupivacaine|bupivacaine|mesh-list
82762942|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
82762943|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
82762944|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762945|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762946|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
82762947|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762948|NCT04731155|Alirocumab|alirocumab|mesh-list
82762949|NCT04731155|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
82762950|NCT04731155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82762951|NCT04731155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82762953|NCT04731155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762954|NCT04731155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82762955|NCT04731155|Protease Inhibitors|protease inhibitors|mesh-ancestor
82762956|NCT04731155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762957|NCT04731155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82762958|NCT04729049|Morphine|morphine|mesh-list
82762959|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82762960|NCT04729049|Narcotics|narcotics|mesh-ancestor
82762961|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82762962|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762963|NCT04729049|Analgesics|analgesics|mesh-ancestor
82762964|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
82762965|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762967|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82762968|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762969|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
82762970|NCT04634669|Bupropion|bupropion|mesh-list
82762971|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82762972|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
82762973|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82762974|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82762975|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82762976|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82762977|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762978|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
82762979|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82762980|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82762981|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82762982|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82762983|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82762984|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
82762985|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
82762986|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82762987|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82762988|NCT04575311|Quemliclustat|quemliclustat|mesh-list
82762989|NCT04575311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82762990|NCT04575311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82762991|NCT04575311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82762992|NCT04575311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82762993|NCT02585531|Dexamethasone|dexamethasone|mesh-list
82762994|NCT02585531|Epinephrine|epinephrine|mesh-list
82762995|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82762996|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
82762997|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
82762998|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82762999|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763000|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82763001|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
82763002|NCT02585531|Hormones|hormones|mesh-ancestor
82763003|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763004|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82763005|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763006|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82763007|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82763008|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
82763009|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763010|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763011|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82763012|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82763013|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82763014|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
82763015|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
82763016|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
82763017|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82763018|NCT00920153|Cytarabine|cytarabine|mesh-list
82763019|NCT00920153|Dexamethasone|dexamethasone|mesh-list
82763020|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
82763021|NCT00920153|Gemcitabine|gemcitabine|mesh-list
82763022|NCT00920153|Doxorubicin|doxorubicin|mesh-list
82763023|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82763024|NCT00920153|Etoposide|etoposide|mesh-list
82763025|NCT00920153|Vincristine|vincristine|mesh-list
82763026|NCT00920153|Melphalan|melphalan|mesh-list
82763027|NCT00920153|Vinorelbine|vinorelbine|mesh-list
82763028|NCT00920153|Ifosfamide|ifosfamide|mesh-list
82763029|NCT00920153|Dacarbazine|dacarbazine|mesh-list
82763030|NCT00920153|Carmustine|carmustine|mesh-list
82763031|NCT00920153|Bleomycin|bleomycin|mesh-list
82763032|NCT00920153|Vindesine|vindesine|mesh-list
82763033|NCT00920153|Mitoguazone|mitoguazone|mesh-list
82763034|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763035|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
82763036|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
82763037|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763038|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763039|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82763040|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
82763041|NCT00920153|Hormones|hormones|mesh-ancestor
82763042|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763043|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82763044|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763045|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82763046|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
82763047|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763048|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82763049|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82763050|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82763051|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763052|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82763053|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
82763054|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763055|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82763056|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
82763057|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
82763058|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
82763059|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
82763060|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82763061|NCT00920153|Protective Agents|protective agents|mesh-ancestor
82763062|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82763063|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
82763064|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82763065|NCT04080713|Budesonide|budesonide|mesh-list
82763066|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763067|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82763068|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
82763069|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763070|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763071|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82763072|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
82763073|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
82763074|NCT04080713|Hormones|hormones|mesh-ancestor
82763075|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763076|NCT04081805|Estradiol|estradiol|mesh-list
82763077|NCT04081805|Estrogens|estrogens|mesh-ancestor
82763078|NCT04081805|Hormones|hormones|mesh-ancestor
82763079|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763080|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763081|NCT05519189|Ropivacaine|ropivacaine|mesh-list
82763082|NCT05519189|Anesthetics, Local|anesthetics, local|mesh-ancestor
82763083|NCT05519189|Anesthetics|anesthetics|mesh-ancestor
82763084|NCT05519189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82763085|NCT05519189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763086|NCT05519189|Sensory System Agents|sensory system agents|mesh-ancestor
82763087|NCT05519189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763088|NCT04080323|Dinoprostone|dinoprostone|mesh-list
82763089|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
82763090|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82763091|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763092|NCT03930017|Vaccines|vaccines|mesh-list
82763093|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
82763094|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763095|NCT00533949|Paclitaxel|paclitaxel|mesh-list
82763096|NCT00533949|Carboplatin|carboplatin|mesh-list
82763097|NCT00533949|Cetuximab|cetuximab|mesh-list
82763098|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82763099|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763100|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
82763101|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
82763102|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
82763103|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763104|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82763105|NCT00485134|Vaccines|vaccines|mesh-list
82763106|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
82763107|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763108|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82763109|NCT02585141|Clindamycin|clindamycin|mesh-list
82763110|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
82763111|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
82763112|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763113|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82763114|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763115|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763116|NCT04079231|Aflibercept|aflibercept|mesh-list
82763117|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82763118|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82763119|NCT04079231|Growth Substances|growth substances|mesh-ancestor
82763120|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763121|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
82763122|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763124|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
82763125|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763126|NCT04521803|Rifampin|rifampin|mesh-list
82763127|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82763128|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
82763129|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82763130|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763131|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
82763132|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82763133|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763134|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763135|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82763136|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82763137|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82763138|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82763139|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82763140|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82763141|NCT00920465|Misoprostol|misoprostol|mesh-list
82763142|NCT00920465|Mifepristone|mifepristone|mesh-list
82763143|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82763144|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
82763145|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82763146|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763147|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82763148|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82763149|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
82763150|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82763151|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82763152|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82763153|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82763154|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
82763155|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82763156|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82763157|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
82763158|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763159|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
82763160|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82763161|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82763162|NCT03890367|Vaccines|vaccines|mesh-list
82763163|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
82763164|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763165|NCT00994773|Tenofovir|tenofovir|mesh-list
82763166|NCT00994773|Entecavir|entecavir|mesh-list
82763167|NCT00994773|Simvastatin|simvastatin|mesh-list
82763168|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
82763169|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763170|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82763171|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82763172|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763173|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763174|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82763175|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82763176|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82763177|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82763178|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
82763179|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82763180|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82763182|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82763183|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
82763184|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82763185|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
82763186|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763187|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763188|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
82763189|NCT03084237|Docetaxel|docetaxel|mesh-list
82763190|NCT03084237|Trastuzumab|trastuzumab|mesh-list
82763191|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763192|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
82763193|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
82763194|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
82763195|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763196|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82763197|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
82763198|NCT00996021|Dolutegravir|dolutegravir|mesh-list
82763199|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82763200|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82763201|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763202|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82763203|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82763204|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763205|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763206|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763207|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82763208|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
82763209|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82763210|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763211|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82763212|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82763213|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82763214|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82763215|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82763216|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82763217|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82763218|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
82763219|NCT00996099|Insulin|insulin|mesh-list
82763220|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82763221|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82763222|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763223|NCT04515329|Cyclosporine|cyclosporine|mesh-list
82763224|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
82763225|NCT04515329|Cyclosporins|cyclosporins|mesh-list
82763226|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763227|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763305|NCT05371223|Antimetabolites|antimetabolites|mesh-ancestor
82763228|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82763229|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
82763230|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763231|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
82763232|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763233|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
82763234|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82763235|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82763236|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82763237|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82763238|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
82763239|NCT02584751|Omeprazole|omeprazole|mesh-list
82763240|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82763241|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82763242|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82763243|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763244|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763245|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82763246|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
82763247|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763248|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763249|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82763250|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
82763251|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82763252|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
82763253|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763254|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82763255|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
82763256|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
82763257|NCT02584751|Protective Agents|protective agents|mesh-ancestor
82763259|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82763260|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82763261|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82763262|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763263|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82763264|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
82763265|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
82763266|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763267|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763268|NCT00996177|Fentanyl|fentanyl|mesh-list
82763269|NCT00996177|Morphine|morphine|mesh-list
82763270|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82763271|NCT00996177|Narcotics|narcotics|mesh-ancestor
82763272|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82763273|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763274|NCT00996177|Analgesics|analgesics|mesh-ancestor
82763275|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
82763276|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763277|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82763278|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82763279|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
82763280|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
82763281|NCT04079933|Nicotine|nicotine|mesh-list
82763282|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82763283|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
82763284|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763285|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763286|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82763287|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82763288|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
82763289|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763290|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763291|NCT00999297|Capsaicin|capsaicin|mesh-list
82763292|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
82763293|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
82763294|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
82763295|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763296|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763297|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
82763298|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763299|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82763300|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763301|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763302|NCT05371223|Gemcitabine|gemcitabine|mesh-list
82763303|NCT05371223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82763304|NCT05371223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82763306|NCT05371223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763307|NCT05371223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763308|NCT00532779|Naltrexone|naltrexone|mesh-list
82763309|NCT00532779|Bupropion|bupropion|mesh-list
82763310|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82763311|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82763312|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763313|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
82763314|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763315|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82763316|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
82763317|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82763318|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82763319|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82763320|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82763321|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763322|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
82763323|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763324|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82763325|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82763326|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763327|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82763328|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
82763329|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763330|NCT00996411|Salvinorin A|salvinorin a|mesh-list
82763331|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
82763332|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763333|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82763334|NCT00996567|Cetuximab|cetuximab|mesh-list
82763335|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82763336|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763337|NCT04120805|Hemostatics|hemostatics|mesh-list
82763338|NCT04120805|Coagulants|coagulants|mesh-ancestor
82763339|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
82763340|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82763341|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763342|NCT02852655|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82763343|NCT02852655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763344|NCT00500110|Docetaxel|docetaxel|mesh-list
82763345|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
82763346|NCT00500110|Leuprolide|leuprolide|mesh-list
82763347|NCT00500110|Goserelin|goserelin|mesh-list
82763348|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763349|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
82763350|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
82763351|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
82763352|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763353|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82763354|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763355|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82763356|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
82763357|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82763358|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763359|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82763360|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
82763361|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82763362|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763363|NCT04358237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82763364|NCT04358237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763365|NCT05304533|Itraconazole|itraconazole|mesh-list
82763366|NCT05304533|Verapamil|verapamil|mesh-list
82763367|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
82763368|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763369|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82763370|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82763371|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763372|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763373|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82763374|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
82763375|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763376|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763377|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82763378|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82763379|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82763380|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82763381|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82763382|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
82763383|NCT00534495|Rilonacept|rilonacept|mesh-list
82763384|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763385|NCT04077827|Propofol|propofol|mesh-list
82763386|NCT04077827|Desflurane|desflurane|mesh-list
82763387|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82763388|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82763389|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763390|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82763391|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
82763392|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
82763393|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82763394|NCT00996723|Dasatinib|dasatinib|mesh-list
82763395|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763396|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82763397|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763398|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763400|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82763401|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763402|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
82763403|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763404|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82763405|NCT00996879|Midazolam|midazolam|mesh-list
82763406|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82763407|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82763408|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82763409|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763410|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82763411|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82763412|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82763413|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82763414|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
82763415|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
82763416|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
82763417|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
82763418|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763419|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763420|NCT02582177|Ketoconazole|ketoconazole|mesh-list
82763421|NCT02582177|Clotrimazole|clotrimazole|mesh-list
82763423|NCT02582177|Dexamethasone|dexamethasone|mesh-list
82763424|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
82763425|NCT02582177|Betamethasone|betamethasone|mesh-list
82763426|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
82763427|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82763428|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
82763429|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82763430|NCT02582177|BB 1101|bb 1101|mesh-list
82763431|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763432|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
82763433|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
82763434|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763435|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763436|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82763437|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
82763438|NCT02582177|Hormones|hormones|mesh-ancestor
82763439|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763440|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82763441|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763442|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
82763443|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763444|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763445|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82763446|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
82763447|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
82763448|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763449|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82763450|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82763451|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82763452|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
82763453|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82763454|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82763455|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82763456|NCT02626715|Vidarabine|vidarabine|mesh-list
82763457|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
82763458|NCT02626715|Fludarabine|fludarabine|mesh-list
82763459|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
82763460|NCT02626715|Thiotepa|thiotepa|mesh-list
82763461|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82763462|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
82763463|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763464|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763465|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82763466|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
82763467|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763468|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
82763469|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763470|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82763471|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82763472|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
82763473|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82763475|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82763476|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82763477|NCT05325177|Analgesics|analgesics|mesh-ancestor
82763478|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
82763479|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763480|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763481|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763482|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82763483|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82763484|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763485|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763486|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
82763487|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
82763488|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82763489|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82763490|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82763491|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82763492|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763493|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
82763494|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763495|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763496|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82763497|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763498|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82763499|NCT00997191|Triamcinolone|triamcinolone|mesh-list
82763500|NCT00997191|Bevacizumab|bevacizumab|mesh-list
82763501|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82763502|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763503|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82763504|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82763505|NCT00997191|Growth Substances|growth substances|mesh-ancestor
82763506|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763507|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
82763508|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763509|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
82763510|NCT00997191|Hormones|hormones|mesh-ancestor
82763511|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763512|NCT00997269|Ubiquinone|ubiquinone|mesh-list
82763513|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
82763514|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
82763515|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763516|NCT00997269|Vitamins|vitamins|mesh-ancestor
82763517|NCT02582099|Gentamicins|gentamicins|mesh-list
82763518|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82763519|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763520|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82763521|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763522|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763523|NCT00997347|Misoprostol|misoprostol|mesh-list
82763524|NCT00997347|Mifepristone|mifepristone|mesh-list
82763525|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82763526|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
82763527|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82763528|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763529|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82763530|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82763531|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
82763532|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82763533|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82763534|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82763535|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82763536|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
82763537|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82763538|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82763539|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
82763540|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763541|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
82763542|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82763543|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82763544|NCT00997581|Apremilast|apremilast|mesh-list
82763545|NCT00997581|Indomethacin|indomethacin|mesh-list
82763546|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82763547|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82763548|NCT00997581|Analgesics|analgesics|mesh-ancestor
82763549|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
82763550|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763551|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763552|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763553|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82763554|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82763555|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82763556|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763557|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763558|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
82763559|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
82763560|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82763561|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82763562|NCT02044497|Oxycodone|oxycodone|mesh-list
82763563|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82763565|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82763566|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763567|NCT02044497|Analgesics|analgesics|mesh-ancestor
82763568|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
82763569|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763570|NCT05183139|Dexamethasone|dexamethasone|mesh-list
82763571|NCT05183139|Lenalidomide|lenalidomide|mesh-list
82763572|NCT05183139|Pomalidomide|pomalidomide|mesh-list
82763573|NCT05183139|Ixazomib|ixazomib|mesh-list
82763574|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763575|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
82763576|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
82763577|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763578|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763579|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82763580|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
82763581|NCT05183139|Hormones|hormones|mesh-ancestor
82763582|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763583|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82763584|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763585|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
82763586|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82763587|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82763588|NCT05183139|Growth Substances|growth substances|mesh-ancestor
82763589|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
82763590|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
82763591|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763592|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763593|NCT00999843|Sorafenib|sorafenib|mesh-list
82763594|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763595|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82763596|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763597|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763598|NCT00997659|Chromium|chromium|mesh-list
82763599|NCT00997659|Picolinic acid|picolinic acid|mesh-list
82763600|NCT00997659|Trace Elements|trace elements|mesh-ancestor
82763624|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
82763625|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763627|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82763628|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82763629|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82763630|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82763631|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763632|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
82763633|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763634|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763635|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82763636|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763638|NCT04077983|Gemcitabine|gemcitabine|mesh-list
82763639|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82763640|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763641|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
82763642|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
82763643|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
82763644|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763645|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82763646|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
82763647|NCT03822845|Edetic Acid|edetic acid|mesh-list
82763648|NCT03822845|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82763649|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
82763650|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
82763651|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763652|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
82763653|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82763654|NCT03822845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82763655|NCT01000233|Inositol|inositol|mesh-list
82763656|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
82763657|NCT01000233|Vitamins|vitamins|mesh-ancestor
82763658|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
82763659|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763660|NCT04075955|Olanzapine|olanzapine|mesh-list
82763661|NCT04075955|Aprepitant|aprepitant|mesh-list
82763662|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
82763663|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
82763664|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763665|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763666|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82763667|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82763668|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82763669|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82763670|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82763671|NCT04075955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82763672|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82763673|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82763674|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763675|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763676|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
82763677|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82763678|NCT00484198|Pioglitazone|pioglitazone|mesh-list
82763679|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82763680|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763681|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
82763682|NCT04077905|Doxorubicin|doxorubicin|mesh-list
82763683|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82763684|NCT04077905|Etoposide|etoposide|mesh-list
82763685|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82763686|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763687|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82763688|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82763689|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763690|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763691|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82763692|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763693|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
82763694|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
82763695|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763696|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763697|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82763698|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
82763699|NCT04077905|Hormones|hormones|mesh-ancestor
82763700|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763701|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82763702|NCT04077905|Protective Agents|protective agents|mesh-ancestor
82763703|NCT04282187|Azacitidine|azacitidine|mesh-list
82763704|NCT04282187|Decitabine|decitabine|mesh-list
82763705|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
82763706|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82763707|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
82763708|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763709|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763710|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763711|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82763713|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82763714|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763716|NCT04276259|Buprenorphine|buprenorphine|mesh-list
82763717|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82763718|NCT04276259|Narcotics|narcotics|mesh-ancestor
82763719|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82763720|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763721|NCT04276259|Analgesics|analgesics|mesh-ancestor
82763722|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
82763723|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763724|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82763725|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82763726|NCT00499486|Sirolimus|sirolimus|mesh-list
82763727|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82763728|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763729|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82763730|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763731|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
82763732|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82763733|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
82763734|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763735|NCT01019278|Cisplatin|cisplatin|mesh-list
82763736|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763737|NCT01014520|Gabapentin|gabapentin|mesh-list
82763738|NCT01014520|Amitriptyline|amitriptyline|mesh-list
82763739|NCT01014520|Analgesics|analgesics|mesh-ancestor
82763740|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
82763741|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763742|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763743|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
82763744|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82763745|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82763746|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82763747|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82763748|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82763749|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82763750|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763751|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763752|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
82763753|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82763754|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
82763755|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82763756|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82763757|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82763758|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82763759|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
82763760|NCT01016002|Temoporfin|temoporfin|mesh-list
82763761|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763762|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82763763|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
82763764|NCT01019434|Sirolimus|sirolimus|mesh-list
82763765|NCT01019434|Temozolomide|temozolomide|mesh-list
82763766|NCT01019434|Temsirolimus|temsirolimus|mesh-list
82763767|NCT01019434|MTOR Inhibitors|mtor inhibitors|mesh-list
82763768|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82763769|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
82763770|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763771|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763772|NCT01019434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82763773|NCT01019434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763774|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82763775|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
82763776|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763777|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82763778|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763779|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82763780|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
82763781|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82763782|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82763783|NCT00499252|Paclitaxel|paclitaxel|mesh-list
82763784|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82763785|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82763786|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763787|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
82763788|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
82763789|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
82763790|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763791|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82763792|NCT01019590|Olmesartan|olmesartan|mesh-list
82763793|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82763794|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82763795|NCT01019590|Diuretics|diuretics|mesh-ancestor
82763796|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
82763797|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763798|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82763799|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82763800|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763801|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82763802|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82763803|NCT03775421|Macitentan|macitentan|mesh-list
82763804|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82763805|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82763806|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763807|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82763808|NCT00532155|Dexamethasone|dexamethasone|mesh-list
82763809|NCT00532155|Docetaxel|docetaxel|mesh-list
82763810|NCT00532155|Aflibercept|aflibercept|mesh-list
82763811|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763812|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
82763813|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
82763814|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763815|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763816|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82763817|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
82763818|NCT00532155|Hormones|hormones|mesh-ancestor
82763819|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763820|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82763821|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763822|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
82763823|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
82763824|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
82763825|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763826|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82763827|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82763828|NCT00532155|Growth Substances|growth substances|mesh-ancestor
82763829|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
82763830|NCT01019668|Verteporfin|verteporfin|mesh-list
82763831|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82763832|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
82763834|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82763835|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82763836|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763837|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82763838|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
82763839|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
82763840|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
82763841|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82763842|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82763843|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
82763844|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82763845|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763846|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82763847|NCT03762395|CXA-10|cxa-10|mesh-list
82763848|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763849|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
82763850|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82763851|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
82763852|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82763853|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82763854|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763855|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
82763856|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
82763857|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763858|NCT01014832|Insulin|insulin|mesh-list
82763859|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82763860|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82763861|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763863|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
82763864|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82763865|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763866|NCT03996473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82763867|NCT03996473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763868|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
82763870|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82763871|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
82763872|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763873|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82763874|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82763875|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82763876|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82763877|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763878|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82763879|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
82763880|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763881|NCT00483574|Vaccines|vaccines|mesh-list
82763882|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
82763883|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763884|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82763885|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82763886|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82763887|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82763888|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763889|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763890|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763891|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82763892|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
82763893|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82763894|NCT00998439|Paclitaxel|paclitaxel|mesh-list
82763895|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82763896|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763897|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
82763898|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
82763899|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
82763900|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763901|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
82763902|NCT03996772|Apixaban|apixaban|mesh-list
82763903|NCT03996772|Edoxaban|edoxaban|mesh-list
82763904|NCT03996772|Dabigatran|dabigatran|mesh-list
82763905|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82763906|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
82763907|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82763908|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
82763909|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763910|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763911|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
82763912|NCT01000779|Propranolol|propranolol|mesh-list
82763913|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82763914|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82763915|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
82763916|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763917|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763918|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763919|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82763920|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82763921|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
82763922|NCT01000857|Paroxetine|paroxetine|mesh-list
82763923|NCT01000857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82763924|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82763925|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82763926|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763927|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82763928|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
82763929|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763930|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82763931|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
82763932|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82763933|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82763934|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82763935|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763936|NCT01004445|Amikacin|amikacin|mesh-list
82763937|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82763938|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82763940|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82763941|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763942|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
82763943|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82763944|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
82763945|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763946|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
82763947|NCT02580695|Protective Agents|protective agents|mesh-ancestor
82763948|NCT02581553|Allopurinol|allopurinol|mesh-list
82763949|NCT02581553|Lesinurad|lesinurad|mesh-list
82763950|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
82763951|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763952|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763953|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
82763954|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82763955|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82763956|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
82763957|NCT02581553|Protective Agents|protective agents|mesh-ancestor
82763958|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763959|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
82763960|NCT03666065|Insulin|insulin|mesh-list
82763961|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82763962|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
82763963|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82763964|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763965|NCT03944915|Paclitaxel|paclitaxel|mesh-list
82763966|NCT03944915|Carboplatin|carboplatin|mesh-list
82763967|NCT03944915|Fluorouracil|fluorouracil|mesh-list
82763968|NCT03944915|Nivolumab|nivolumab|mesh-list
82763969|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
82763970|NCT03944915|Lenograstim|lenograstim|mesh-list
82763971|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82763972|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82763973|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
82763974|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
82763975|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
82763976|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82763977|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
82763978|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82763979|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82763980|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
82763981|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763982|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82763983|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82763984|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82763985|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
82763986|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763987|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82763988|NCT00482170|Etanercept|etanercept|mesh-list
82763989|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82763990|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82763991|NCT00482170|Analgesics|analgesics|mesh-ancestor
82763992|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
82763993|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82763994|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82763995|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82763996|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82763997|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82763998|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82763999|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
82764000|NCT05228249|Cytarabine|cytarabine|mesh-list
82764001|NCT05228249|Etoposide|etoposide|mesh-list
82764002|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
82764003|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
82764004|NCT05228249|Melphalan|melphalan|mesh-list
82764005|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
82764006|NCT05228249|Carmustine|carmustine|mesh-list
82764007|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
82764008|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
82764009|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82764010|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764770|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82764011|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82764012|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82764013|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764014|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764015|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82764017|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
82764018|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764019|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82764020|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
82764021|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764022|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82764023|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
82764024|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82764025|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
82764026|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
82764027|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764028|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
82764029|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
82764030|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764031|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
82764032|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82764033|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82764034|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764035|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
82764036|NCT02580227|Coagulants|coagulants|mesh-ancestor
82764037|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
82764038|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82764039|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764040|NCT01001013|Pioglitazone|pioglitazone|mesh-list
82764041|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82764042|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764043|NCT01004601|Docetaxel|docetaxel|mesh-list
82764044|NCT01004601|Pemetrexed|pemetrexed|mesh-list
82764045|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764046|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764047|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
82764048|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
82764049|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764050|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764051|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82764052|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82764053|NCT01001247|Rilpivirine|rilpivirine|mesh-list
82764054|NCT01001247|Omeprazole|omeprazole|mesh-list
82764055|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82764056|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82764057|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82764058|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764059|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764060|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82764061|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82764062|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
82764063|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764064|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82764065|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82764066|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
82764067|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764068|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82764069|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82764070|NCT04205357|Analgesics|analgesics|mesh-ancestor
82764071|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
82764072|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764073|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764074|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82764075|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82764076|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82764077|NCT02580773|Tinzaparin|tinzaparin|mesh-list
82764078|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
82764079|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82764080|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82764081|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764082|NCT01008813|Vaccines|vaccines|mesh-list
82764083|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
82764084|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764085|NCT05674565|Magnesium Sulfate|magnesium sulfate|mesh-list
82764086|NCT05674565|Analgesics|analgesics|mesh-ancestor
82764087|NCT05674565|Sensory System Agents|sensory system agents|mesh-ancestor
82764088|NCT05674565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764089|NCT05674565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764090|NCT05674565|Anesthetics|anesthetics|mesh-ancestor
82764091|NCT05674565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82764092|NCT05674565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82764093|NCT05674565|Anticonvulsants|anticonvulsants|mesh-ancestor
82764094|NCT05674565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82764095|NCT05674565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82764096|NCT05674565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764097|NCT05674565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82764098|NCT05674565|Tocolytic Agents|tocolytic agents|mesh-ancestor
82764099|NCT05674565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82764100|NCT01001637|Curcumin|curcumin|mesh-list
82764101|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82764102|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82764103|NCT01001637|Analgesics|analgesics|mesh-ancestor
82764104|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
82764105|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764106|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764107|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82764108|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82764109|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764110|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764111|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764112|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
82764113|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82764114|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82764115|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764116|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
82764117|NCT01005147|Coagulants|coagulants|mesh-ancestor
82764118|NCT03603899|Xenon|xenon|mesh-list
82764119|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82764120|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
82764121|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
82764122|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82764123|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764124|NCT01001871|Vitamins|vitamins|mesh-list
82764125|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
82764126|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764127|NCT01005303|Vitamin D|vitamin d|mesh-list
82764128|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
82764129|NCT01005303|Vitamins|vitamins|mesh-ancestor
82764130|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
82764131|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764132|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82764133|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82764134|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
82764135|NCT01005381|Vitamin D|vitamin d|mesh-list
82764136|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
82764137|NCT01005381|Calcium|calcium|mesh-list
82764138|NCT01005381|Vitamins|vitamins|mesh-ancestor
82764139|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
82764140|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764141|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82764142|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82764143|NCT01005381|Antacids|antacids|mesh-ancestor
82764144|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764145|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82764146|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
82764147|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82764148|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764149|NCT05154279|Terlipressin|terlipressin|mesh-list
82764150|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82764151|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82764152|NCT01005537|Aldesleukin|aldesleukin|mesh-list
82764153|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
82764154|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82764155|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
82764156|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764157|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82764158|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82764159|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
82764160|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764161|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764162|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82764163|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82764164|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82764165|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
82764166|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764168|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82764169|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764170|NCT03742713|Docetaxel|docetaxel|mesh-list
82764171|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764172|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764173|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
82764174|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
82764175|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764176|NCT01002729|Oseltamivir|oseltamivir|mesh-list
82764177|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
82764178|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764179|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764180|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764181|NCT01002807|Metformin|metformin|mesh-list
82764182|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
82764183|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82764184|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764185|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82764186|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764187|NCT05733117|Vitamin D|vitamin d|mesh-list
82764188|NCT05733117|Vitamins|vitamins|mesh-ancestor
82764189|NCT05733117|Micronutrients|micronutrients|mesh-ancestor
82764190|NCT05733117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764191|NCT05733117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82764192|NCT05732961|Luspatercept|luspatercept|mesh-list
82764193|NCT05732961|Hematinics|hematinics|mesh-ancestor
82764194|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
82764195|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82764196|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764197|NCT00615056|Leucovorin|leucovorin|mesh-list
82764198|NCT00615056|Bevacizumab|bevacizumab|mesh-list
82764199|NCT00615056|Fluorouracil|fluorouracil|mesh-list
82764200|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
82764201|NCT00615056|Irinotecan|irinotecan|mesh-list
82764202|NCT00615056|Axitinib|axitinib|mesh-list
82764203|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
82764204|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764205|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764206|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82764207|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82764208|NCT00615056|Growth Substances|growth substances|mesh-ancestor
82764209|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764210|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
82764211|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
82764212|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764213|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82764214|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82764215|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
82764216|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82764217|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82764218|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764219|NCT00615056|Antidotes|antidotes|mesh-ancestor
82764220|NCT00615056|Protective Agents|protective agents|mesh-ancestor
82764221|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
82764222|NCT00615056|Vitamins|vitamins|mesh-ancestor
82764223|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
82764224|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82764225|NCT01006551|Ziprasidone|ziprasidone|mesh-list
82764226|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82764227|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
82764228|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82764229|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764230|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764231|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82764232|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82764233|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82764234|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82764235|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82764236|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
82764237|NCT05732727|Antihypertensive Agents|antihypertensive agents|mesh-list
82764238|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
82764239|NCT00873626|Levofloxacin|levofloxacin|mesh-list
82764240|NCT00873626|Ofloxacin|ofloxacin|mesh-list
82764241|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
82764242|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82764243|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764244|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82764245|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82764246|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764247|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764248|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764249|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82764250|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82764251|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82764252|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82764253|NCT00879242|Deferasirox|deferasirox|mesh-list
82764254|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82764255|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
82764256|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
82764257|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764258|NCT05732493|Capecitabine|capecitabine|mesh-list
82764259|NCT05732493|Oxaliplatin|oxaliplatin|mesh-list
82764260|NCT05732493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82764261|NCT05732493|Antimetabolites|antimetabolites|mesh-ancestor
82764262|NCT05732493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764263|NCT05732493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764264|NCT00868634|Bevacizumab|bevacizumab|mesh-list
82764265|NCT00868634|Capecitabine|capecitabine|mesh-list
82764266|NCT00868634|Vinorelbine|vinorelbine|mesh-list
82764267|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764268|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764269|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82764270|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82764271|NCT00868634|Growth Substances|growth substances|mesh-ancestor
82764272|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764273|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
82764274|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82764275|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
82764276|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764277|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82764278|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764279|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
82764280|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
82764281|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
82764282|NCT05232357|Methylene Blue|methylene blue|mesh-list
82764283|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764284|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764285|NCT05232357|Antidotes|antidotes|mesh-ancestor
82764286|NCT05232357|Protective Agents|protective agents|mesh-ancestor
82764287|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764288|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
82764289|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
82764290|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82764291|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764292|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
82764293|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
82764295|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82764296|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
82764297|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764298|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764299|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82764300|NCT00868946|Ribavirin|ribavirin|mesh-list
82764301|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
82764302|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764303|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
82764304|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764305|NCT00482014|Carboplatin|carboplatin|mesh-list
82764306|NCT00482014|Pemetrexed|pemetrexed|mesh-list
82764307|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764308|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764309|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764310|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82764311|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82764312|NCT00879788|Ramipril|ramipril|mesh-list
82764313|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82764314|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
82764315|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764316|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764317|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82764318|NCT03595553|Vancomycin|vancomycin|mesh-list
82764319|NCT03595553|Ridinilazole|ridinilazole|mesh-list
82764320|NCT03595553|Benzimidazole|benzimidazole|mesh-list
82764321|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82764322|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764323|NCT03595553|Anthelmintics|anthelmintics|mesh-ancestor
82764324|NCT03595553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82764325|NCT00874172|Analgesics|analgesics|mesh-list
82764326|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
82764327|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764328|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764329|NCT00614822|Bevacizumab|bevacizumab|mesh-list
82764330|NCT00614822|Carboplatin|carboplatin|mesh-list
82764331|NCT00614822|Pemetrexed|pemetrexed|mesh-list
82764332|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764333|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764334|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82764335|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82764336|NCT00614822|Growth Substances|growth substances|mesh-ancestor
82764337|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764338|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
82764339|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764340|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764341|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82764342|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82764343|NCT04861298|Quercetin|quercetin|mesh-list
82764344|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
82764345|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764346|NCT04861298|Protective Agents|protective agents|mesh-ancestor
82764347|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764348|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
82764349|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82764350|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82764351|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764352|NCT03582917|Vitamins|vitamins|mesh-ancestor
82764353|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
82764354|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
82764355|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764356|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764357|NCT05226728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82764358|NCT05226728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764359|NCT00869180|Diclofenac|diclofenac|mesh-list
82764360|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82764361|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82764362|NCT00869180|Analgesics|analgesics|mesh-ancestor
82764363|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
82764364|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764365|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764366|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82764367|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82764368|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82764369|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764370|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764371|NCT00874328|Irinotecan|irinotecan|mesh-list
82764372|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764373|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82764374|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82764375|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764376|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764377|NCT00874406|Leucovorin|leucovorin|mesh-list
82764378|NCT00874406|Fluorouracil|fluorouracil|mesh-list
82764379|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
82764380|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
82764381|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764382|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82764383|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764384|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82764385|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
82764386|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764387|NCT00874406|Antidotes|antidotes|mesh-ancestor
82764388|NCT00874406|Protective Agents|protective agents|mesh-ancestor
82764389|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
82764390|NCT00874406|Vitamins|vitamins|mesh-ancestor
82764391|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
82764392|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
82764393|NCT00880178|Niacin|niacin|mesh-list
82764394|NCT00880178|Niacinamide|niacinamide|mesh-list
82764395|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
82764397|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82764398|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82764399|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
82764400|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764401|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82764402|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82764403|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764404|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
82764405|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
82764406|NCT00880178|Vitamins|vitamins|mesh-ancestor
82764407|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
82764408|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764409|NCT04077125|Rifaximin|rifaximin|mesh-list
82764410|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82764411|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764412|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82764413|NCT04194203|Paclitaxel|paclitaxel|mesh-list
82764414|NCT04194203|Bevacizumab|bevacizumab|mesh-list
82764415|NCT04194203|Carboplatin|carboplatin|mesh-list
82764416|NCT04194203|Pemetrexed|pemetrexed|mesh-list
82764417|NCT04194203|Atezolizumab|atezolizumab|mesh-list
82764418|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82764419|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764420|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764421|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
82764422|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
82764423|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764424|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764425|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82764426|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82764427|NCT04194203|Growth Substances|growth substances|mesh-ancestor
82764428|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764429|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
82764430|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764431|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82764432|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82764433|NCT04194203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82764434|NCT05172401|Triamcinolone|triamcinolone|mesh-list
82764435|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82764436|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82764437|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82764438|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82764439|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
82764440|NCT05172401|Hormones|hormones|mesh-ancestor
82764441|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82764442|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764443|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82764444|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
82764445|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764446|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764447|NCT00143455|Cisplatin|cisplatin|mesh-list
82764448|NCT00143455|Irinotecan|irinotecan|mesh-list
82764449|NCT00143455|Etoposide|etoposide|mesh-list
82764450|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764451|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82764452|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82764453|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764454|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764455|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82764456|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82764457|NCT01006863|Phenylephrine|phenylephrine|mesh-list
82764458|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
82764459|NCT01006863|Ephedrine|ephedrine|mesh-list
82764460|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82764461|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
82764462|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
82764463|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764464|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764465|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
82764466|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82764467|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
82764468|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
82764469|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82764470|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82764471|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82764472|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
82764473|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82764474|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764475|NCT01006863|Protective Agents|protective agents|mesh-ancestor
82764476|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82764477|NCT03535727|Paclitaxel|paclitaxel|mesh-list
82764478|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82764479|NCT03535727|Cisplatin|cisplatin|mesh-list
82764480|NCT03535727|Gemcitabine|gemcitabine|mesh-list
82764481|NCT03535727|Capecitabine|capecitabine|mesh-list
82764482|NCT03535727|Irinotecan|irinotecan|mesh-list
82764483|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82764484|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764485|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764486|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
82764487|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
82764488|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764489|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82764490|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
82764491|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82764492|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82764493|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764494|NCT03529955|Apremilast|apremilast|mesh-list
82764495|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82764496|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82764497|NCT03529955|Analgesics|analgesics|mesh-ancestor
82764498|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
82764499|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764500|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764501|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82764502|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82764503|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82764504|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82764505|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764506|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764507|NCT00142909|Lofexidine|lofexidine|mesh-list
82764508|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82764509|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82764510|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764511|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
82764512|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764513|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82764514|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82764515|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82764516|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
82764517|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82764518|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764519|NCT01007019|Esomeprazole|esomeprazole|mesh-list
82764520|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82764521|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82764522|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82764523|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764524|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764525|NCT05633979|Trastuzumab|trastuzumab|mesh-list
82764526|NCT05633979|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82764527|NCT05633979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764528|NCT05633979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764529|NCT05633979|Immunoconjugates|immunoconjugates|mesh-ancestor
82764530|NCT05633979|Immunologic Factors|immunologic factors|mesh-ancestor
82764531|NCT05633979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764532|NCT03508739|Valsartan|valsartan|mesh-list
82764533|NCT03508739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82764534|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82764535|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82764536|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82764537|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764538|NCT00205699|Olanzapine|olanzapine|mesh-list
82764539|NCT00205699|Risperidone|risperidone|mesh-list
82764540|NCT00205699|Aripiprazole|aripiprazole|mesh-list
82764541|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82764542|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
82764543|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82764544|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764545|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764546|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82764547|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82764548|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82764549|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82764550|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82764551|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
82764552|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
82764553|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
82764554|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764555|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82764556|NCT00205699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82764557|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82764558|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82764559|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
82764560|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
82764561|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82764562|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82764563|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82764564|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82764565|NCT03503513|Gentamicins|gentamicins|mesh-list
82764566|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82764567|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764568|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82764569|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764570|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764571|NCT03498521|Bevacizumab|bevacizumab|mesh-list
82764572|NCT03498521|Carboplatin|carboplatin|mesh-list
82764573|NCT03498521|Gemcitabine|gemcitabine|mesh-list
82764574|NCT03498521|Trastuzumab|trastuzumab|mesh-list
82764575|NCT03498521|Atezolizumab|atezolizumab|mesh-list
82764576|NCT03498521|Olaparib|olaparib|mesh-list
82764577|NCT03498521|Pertuzumab|pertuzumab|mesh-list
82764578|NCT03498521|Vemurafenib|vemurafenib|mesh-list
82764579|NCT03498521|Ipatasertib|ipatasertib|mesh-list
82764580|NCT03498521|Ivosidenib|ivosidenib|mesh-list
82764581|NCT03498521|Entrectinib|entrectinib|mesh-list
82764582|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764583|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764584|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764585|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82764586|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82764587|NCT03498521|Growth Substances|growth substances|mesh-ancestor
82764588|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764589|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
82764590|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82764591|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
82764592|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82764593|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764594|NCT03498521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82764595|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82764596|NCT02580149|Clopidogrel|clopidogrel|mesh-list
82764597|NCT02580149|Ticagrelor|ticagrelor|mesh-list
82764598|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82764599|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82764600|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82764601|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82764602|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
82764603|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82764604|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764605|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764606|NCT05618925|Cyclophosphamide|cyclophosphamide|mesh-list
82764607|NCT05618925|Rituximab|rituximab|mesh-list
82764608|NCT05618925|Fludarabine|fludarabine|mesh-list
82764609|NCT05618925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82764610|NCT05618925|Immunologic Factors|immunologic factors|mesh-ancestor
82764611|NCT05618925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764612|NCT05618925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82764613|NCT05618925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82764614|NCT05618925|Alkylating Agents|alkylating agents|mesh-ancestor
82764615|NCT05618925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764616|NCT05618925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764617|NCT05618925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82764847|NCT00480532|Doxycycline|doxycycline|mesh-list
82764618|NCT05618925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764619|NCT04996017|Atezolizumab|atezolizumab|mesh-list
82764620|NCT04996017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82764621|NCT04996017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764622|NCT04996017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764623|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764624|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
82764625|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82764626|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
82764627|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82764628|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
82764629|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764630|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764631|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
82764632|NCT01007565|Anesthetics|anesthetics|mesh-list
82764633|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82764634|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764635|NCT05229003|Irinotecan|irinotecan|mesh-list
82764636|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82764637|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82764638|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764639|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764640|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764641|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
82764642|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82764643|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764644|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82764645|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
82764646|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82764647|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764648|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764649|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764650|NCT02798471|Heparin|heparin|mesh-list
82764651|NCT02798471|Enoxaparin|enoxaparin|mesh-list
82764652|NCT02798471|Warfarin|warfarin|mesh-list
82764653|NCT02798471|Edoxaban|edoxaban|mesh-list
82764654|NCT02798471|Fondaparinux|fondaparinux|mesh-list
82764655|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
82764656|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82764657|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82764658|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764659|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82764660|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
82764661|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82764662|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
82764663|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764664|NCT03443765|Vitamin D|vitamin d|mesh-list
82764665|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
82764666|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82764667|NCT03443765|Antibodies|antibodies|mesh-list
82764668|NCT03443765|Vitamins|vitamins|mesh-ancestor
82764669|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
82764670|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764671|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82764672|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
82764673|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
82764674|NCT03441893|Mesalamine|mesalamine|mesh-list
82764675|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82764676|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82764677|NCT03441893|Analgesics|analgesics|mesh-ancestor
82764678|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
82764679|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764680|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764681|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82764682|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82764683|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82764684|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764685|NCT03440177|Ramipril|ramipril|mesh-list
82764686|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82764687|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
82764688|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764689|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764690|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82764691|NCT00489736|Amiodarone|amiodarone|mesh-list
82764692|NCT00489736|Dronedarone|dronedarone|mesh-list
82764693|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82764694|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
82764695|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82764696|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82764697|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764698|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82764699|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82764700|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82764701|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764702|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82764703|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82764704|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82764706|NCT00617084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82764707|NCT00617084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82764708|NCT00617084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764709|NCT00617084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764710|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82764711|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
82764712|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764713|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764714|NCT02758847|Paclitaxel|paclitaxel|mesh-list
82764715|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82764716|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82764717|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764718|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764719|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
82764720|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
82764721|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764722|NCT01016860|Irinotecan|irinotecan|mesh-list
82764723|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82764724|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82764725|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764726|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764727|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764728|NCT00874484|Enoxaparin|enoxaparin|mesh-list
82764729|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
82764730|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82764731|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82764732|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764733|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82764734|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
82764735|NCT00489424|Acetaminophen|acetaminophen|mesh-list
82764736|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82764737|NCT00489424|Analgesics|analgesics|mesh-ancestor
82764738|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
82764739|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764740|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764741|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
82764742|NCT00869570|Capecitabine|capecitabine|mesh-list
82764743|NCT00869570|Sorafenib|sorafenib|mesh-list
82764744|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82764745|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
82764746|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764747|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764748|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82764749|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764750|NCT05127304|Bromides|bromides|mesh-list
82764751|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
82764752|NCT05127304|Olodaterol|olodaterol|mesh-list
82764753|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82764754|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
82764755|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764756|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764757|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82764758|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
82764759|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
82764760|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82764761|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
82764762|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82764763|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764764|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
82764765|NCT00880412|Etazolate|etazolate|mesh-list
82764766|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82764767|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764768|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764769|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82764771|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82764772|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764773|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82764775|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764776|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82764777|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764778|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764779|NCT03412643|Paclitaxel|paclitaxel|mesh-list
82764780|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
82764781|NCT03412643|Doxorubicin|doxorubicin|mesh-list
82764782|NCT03412643|Trastuzumab|trastuzumab|mesh-list
82764783|NCT03412643|Pertuzumab|pertuzumab|mesh-list
82764784|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82764785|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764786|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764787|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
82764788|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
82764789|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764790|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82764791|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
82764792|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764793|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82764794|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82764795|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
82764796|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82764797|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82764798|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82764799|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82764800|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764801|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764802|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
82764803|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82764804|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764805|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82764807|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82764808|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82764809|NCT01020214|Diuretics|diuretics|mesh-ancestor
82764810|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
82764811|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764812|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82764813|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82764814|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764815|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82764816|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82764817|NCT03970824|Adalimumab|adalimumab|mesh-list
82764818|NCT03970824|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82764819|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82764820|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82764821|NCT00933894|Escitalopram|escitalopram|mesh-list
82764822|NCT00933894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82764823|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82764824|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82764825|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764826|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82764827|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
82764828|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764829|NCT00564486|Acetaminophen|acetaminophen|mesh-list
82764830|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82764831|NCT00564486|Analgesics|analgesics|mesh-ancestor
82764832|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
82764833|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82764834|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764835|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
82764836|NCT00481078|Paclitaxel|paclitaxel|mesh-list
82764837|NCT00481078|Carboplatin|carboplatin|mesh-list
82764838|NCT00481078|Vorinostat|vorinostat|mesh-list
82764839|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82764840|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764841|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764842|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
82764843|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
82764844|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764845|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82764846|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764848|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
82764849|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82764850|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82764851|NCT00480532|Estradiol|estradiol|mesh-list
82764852|NCT00480532|Estrogens|estrogens|mesh-ancestor
82764853|NCT00480532|Hormones|hormones|mesh-ancestor
82764854|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82764855|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764856|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82764857|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
82764858|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82764859|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82764860|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82764861|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764862|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
82764863|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82764864|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82764865|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82764866|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82764867|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82764868|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82764869|NCT04013880|Decitabine|decitabine|mesh-list
82764870|NCT04013880|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
82764871|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82764872|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
82764873|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764874|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764875|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764876|NCT00934518|Cetuximab|cetuximab|mesh-list
82764877|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764878|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764879|NCT00496366|Capecitabine|capecitabine|mesh-list
82764880|NCT00496366|Lapatinib|lapatinib|mesh-list
82764881|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82764882|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
82764883|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764884|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764885|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82764886|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764887|NCT00934752|Paclitaxel|paclitaxel|mesh-list
82764888|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82764889|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764890|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764891|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
82764892|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
82764893|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764894|NCT01020292|Nelfinavir|nelfinavir|mesh-list
82764895|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82764896|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82764897|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
82764898|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764899|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764900|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82764901|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82764902|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
82764903|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764904|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82764905|NCT00934830|Amoxicillin|amoxicillin|mesh-list
82764906|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82764907|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
82764908|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82764909|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764910|NCT02575404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82764911|NCT02575404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764912|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
82764913|NCT00564018|Protamines|protamines|mesh-list
82764914|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82764915|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764916|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
82764917|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764918|NCT00564018|Coagulants|coagulants|mesh-ancestor
82764919|NCT00935298|Tacrolimus|tacrolimus|mesh-list
82764920|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82764921|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
82764922|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764923|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82764924|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764925|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764926|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
82764927|NCT04014192|Empagliflozin|empagliflozin|mesh-list
82764928|NCT04014192|Canagliflozin|canagliflozin|mesh-list
82764929|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82764930|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764931|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82764932|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764934|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
82764935|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
82764936|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764937|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
82764938|NCT04013646|Hematinics|hematinics|mesh-ancestor
82764939|NCT04074473|Propranolol|propranolol|mesh-list
82764940|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82764941|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82764942|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
82764943|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82764944|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764945|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764946|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82764947|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82764948|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
82764949|NCT03356483|Niacin|niacin|mesh-list
82764950|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
82764951|NCT03356483|Psilocybin|psilocybin|mesh-list
82764952|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82764953|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
82764954|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764955|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82764956|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
82764957|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
82764958|NCT03356483|Vitamins|vitamins|mesh-ancestor
82764959|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
82764960|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764961|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
82764962|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82764963|NCT03093480|Factor VIII|factor viii|mesh-list
82764964|NCT03093480|Coagulants|coagulants|mesh-ancestor
82764965|NCT02578511|Ixazomib|ixazomib|mesh-list
82764966|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764967|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
82764968|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764969|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764970|NCT00563784|Paclitaxel|paclitaxel|mesh-list
82764971|NCT00563784|Carboplatin|carboplatin|mesh-list
82764972|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82764973|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82764974|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764975|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764976|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
82764977|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
82764978|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82764979|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82764980|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82764981|NCT00203047|Prednisone|prednisone|mesh-list
82764982|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
82764983|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
82764984|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82764985|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
82764986|NCT00203047|Hormones|hormones|mesh-ancestor
82764987|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82764988|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82764989|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82764990|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764991|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82764992|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
82764993|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82764994|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82764996|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82764997|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82764998|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
82764999|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
82765000|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
82765077|NCT03967327|Narcotics|narcotics|mesh-ancestor
82765001|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765002|NCT04074551|Losartan|losartan|mesh-list
82765003|NCT04074551|Amlodipine|amlodipine|mesh-list
82765004|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82765005|NCT04074551|Ezetimibe|ezetimibe|mesh-list
82765006|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82765007|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82765008|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82765009|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765010|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82765011|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765012|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
82765013|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82765014|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82765015|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
82765016|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82765017|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82765018|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765019|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82765020|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82765021|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82765022|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
82765023|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82765024|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765025|NCT02608385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82765026|NCT02608385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765027|NCT00142519|Morphine|morphine|mesh-list
82765028|NCT00142519|Methadone|methadone|mesh-list
82765029|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82765030|NCT00142519|Narcotics|narcotics|mesh-ancestor
82765031|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82765032|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765033|NCT00142519|Analgesics|analgesics|mesh-ancestor
82765034|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
82765035|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765036|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
82765037|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
82765038|NCT03713294|Dexamethasone|dexamethasone|mesh-list
82765039|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
82765040|NCT03713294|Pomalidomide|pomalidomide|mesh-list
82765041|NCT03713294|Elotuzumab|elotuzumab|mesh-list
82765042|NCT03713294|Ichthammol|ichthammol|mesh-list
82765043|NCT03713294|BB 1101|bb 1101|mesh-list
82765044|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82765045|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
82765046|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
82765047|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765048|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765049|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82765050|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
82765051|NCT03713294|Hormones|hormones|mesh-ancestor
82765052|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765053|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82765054|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765055|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
82765056|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765057|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765058|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
82765059|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82765060|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82765061|NCT03713294|Growth Substances|growth substances|mesh-ancestor
82765062|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
82765063|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
82765064|NCT00141817|Pantoprazole|pantoprazole|mesh-list
82765065|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82765066|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82765067|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82765068|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765069|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765070|NCT03967171|Oxytocin|oxytocin|mesh-list
82765071|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
82765072|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82765073|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765074|NCT03967327|Morphine|morphine|mesh-list
82765075|NCT03967327|Buprenorphine|buprenorphine|mesh-list
82765076|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82765078|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82765079|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765080|NCT03967327|Analgesics|analgesics|mesh-ancestor
82765081|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
82765082|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765083|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82765084|NCT01075945|Lumefantrine|lumefantrine|mesh-list
82765085|NCT01075945|Artemether|artemether|mesh-list
82765086|NCT01075945|Piperaquine|piperaquine|mesh-list
82765087|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82765088|NCT01075945|Artenimol|artenimol|mesh-list
82765089|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
82765090|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82765091|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82765092|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765093|NCT00874562|Sirolimus|sirolimus|mesh-list
82765094|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82765095|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765096|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82765097|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765098|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
82765099|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82765100|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
82765101|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765102|NCT00201643|Dexamethasone|dexamethasone|mesh-list
82765103|NCT00201643|Betamethasone|betamethasone|mesh-list
82765104|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82765105|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
82765106|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
82765107|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765108|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765109|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82765110|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
82765111|NCT00201643|Hormones|hormones|mesh-ancestor
82765112|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765113|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82765114|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765115|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82765116|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
82765117|NCT03798314|Nivolumab|nivolumab|mesh-list
82765118|NCT03798314|Pomalidomide|pomalidomide|mesh-list
82765119|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82765120|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765121|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82765122|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765123|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
82765124|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765125|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82765126|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82765127|NCT03798314|Growth Substances|growth substances|mesh-ancestor
82765128|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
82765130|NCT01077427|Capecitabine|capecitabine|mesh-list
82765131|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765132|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82765133|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
82765134|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765135|NCT00883064|Lisinopril|lisinopril|mesh-list
82765136|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82765137|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
82765138|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765139|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765140|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82765141|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82765142|NCT00883064|Protective Agents|protective agents|mesh-ancestor
82765143|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765144|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
82765145|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
82765146|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
82765147|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
82765148|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82765149|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765150|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82765151|NCT01077505|Incretins|incretins|mesh-ancestor
82765152|NCT01077505|Hormones|hormones|mesh-ancestor
82765153|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765154|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82765155|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82765156|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82765157|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
82765158|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82765159|NCT01073995|Triamcinolone|triamcinolone|mesh-list
82765160|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82765161|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82765162|NCT01073995|Bupivacaine|bupivacaine|mesh-list
82765163|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82765164|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
82765165|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
82765166|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82765167|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765168|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
82765169|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765170|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82765171|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
82765172|NCT01073995|Hormones|hormones|mesh-ancestor
82765173|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765174|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82765175|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
82765176|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765177|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765178|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82765179|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82765180|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82765181|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82765182|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765183|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82765184|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82765185|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82765186|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82765187|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
82765188|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765189|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765190|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82765191|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82765192|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
82765193|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82765194|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82765195|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
82765196|NCT00874874|Sorafenib|sorafenib|mesh-list
82765197|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765198|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82765199|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765200|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765201|NCT04489628|Vitamin D|vitamin d|mesh-list
82765202|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
82765203|NCT04489628|Vitamins|vitamins|mesh-ancestor
82765204|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
82765205|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765206|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82765207|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82765208|NCT00130039|Cilostazol|cilostazol|mesh-list
82765209|NCT00130039|Clopidogrel|clopidogrel|mesh-list
82765210|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82765211|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82765212|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82765213|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82765214|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
82765215|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765216|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765217|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765218|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82765219|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
82765220|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765221|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82765222|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
82765223|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82765224|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82765225|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
82765226|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82765227|NCT00130039|Protective Agents|protective agents|mesh-ancestor
82765228|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82765229|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82765230|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765232|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
82765233|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82765234|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82765235|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765236|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765237|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
82765238|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
82765239|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82765240|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
82765241|NCT00883298|Bevacizumab|bevacizumab|mesh-list
82765242|NCT00883298|Temozolomide|temozolomide|mesh-list
82765243|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82765244|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765245|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82765246|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82765247|NCT00883298|Growth Substances|growth substances|mesh-ancestor
82765248|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765249|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
82765250|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82765251|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
82765252|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765253|NCT00881114|Cetuximab|cetuximab|mesh-list
82765254|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765255|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82765256|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82765257|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
82765258|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765259|NCT00141271|Ziprasidone|ziprasidone|mesh-list
82765260|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82765261|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
82765262|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765263|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765264|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765265|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82765266|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82765267|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82765268|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82765269|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82765270|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
82765271|NCT01017640|Mitomycins|mitomycins|mesh-list
82765272|NCT01017640|Mitomycin|mitomycin|mesh-list
82765273|NCT01017640|Veliparib|veliparib|mesh-list
82765274|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82765275|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765276|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
82765277|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765278|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82765279|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765280|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82765281|NCT00614120|Metformin|metformin|mesh-list
82765282|NCT00614120|Liraglutide|liraglutide|mesh-list
82765283|NCT00614120|Glimepiride|glimepiride|mesh-list
82765284|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82765285|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765286|NCT00614120|Incretins|incretins|mesh-ancestor
82765287|NCT00614120|Hormones|hormones|mesh-ancestor
82765288|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765289|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82765290|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82765291|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
82765292|NCT00496054|Vaccines|vaccines|mesh-list
82765293|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
82765294|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765295|NCT00495820|Methylphenidate|methylphenidate|mesh-list
82765296|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82765297|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765298|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82765299|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82765300|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82765301|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765302|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
82765303|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765304|NCT04387240|Artesunate|artesunate|mesh-list
82765305|NCT04387240|Artemisinins|artemisinins|mesh-list
82765306|NCT04387240|Artemisinin|artemisinin|mesh-list
82765307|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
82765308|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82765309|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82765310|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765311|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765312|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
82765313|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
82765314|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82765315|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
82765316|NCT00495586|Amoxicillin|amoxicillin|mesh-list
82765317|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
82765318|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
82765319|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82765320|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765321|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765322|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765323|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82765324|NCT00613730|Gemcitabine|gemcitabine|mesh-list
82765325|NCT00613730|Panitumumab|panitumumab|mesh-list
82765326|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82765327|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
82765328|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765329|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765330|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82765331|NCT00613574|Bromides|bromides|mesh-list
82765332|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
82765333|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82765334|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
82765335|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765336|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765337|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82765338|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
82765339|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
82765340|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82765341|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
82765342|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765343|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765344|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
82765345|NCT00881426|Cefprozil|cefprozil|mesh-list
82765346|NCT00881426|Cephalosporins|cephalosporins|mesh-list
82765347|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82765348|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765349|NCT00883532|Budesonide|budesonide|mesh-list
82765350|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82765351|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82765352|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82765353|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
82765354|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765355|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765356|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82765357|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
82765358|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
82765359|NCT00883532|Hormones|hormones|mesh-ancestor
82765360|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765361|NCT00881582|Interferons|interferons|mesh-list
82765362|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
82765363|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
82765364|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82765365|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765366|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
82765367|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765368|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
82765369|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765370|NCT00881738|Clarithromycin|clarithromycin|mesh-list
82765371|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82765372|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765373|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82765374|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765375|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765376|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82765377|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82765379|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82765380|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82765381|NCT00613106|Analgesics|analgesics|mesh-ancestor
82765382|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
82765383|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765384|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765385|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82765386|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82765387|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82765388|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765389|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765391|NCT00881816|Capecitabine|capecitabine|mesh-list
82765392|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82765393|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765394|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
82765395|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
82765396|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
82765397|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765398|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82765399|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
82765400|NCT03712904|Aflibercept|aflibercept|mesh-list
82765401|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
82765402|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82765403|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82765404|NCT03712904|Growth Substances|growth substances|mesh-ancestor
82765405|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765406|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
82765407|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765408|NCT00875966|Azithromycin|azithromycin|mesh-list
82765409|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82765410|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765411|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
82765412|NCT00141037|Trimethoprim|trimethoprim|mesh-list
82765413|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
82765414|NCT00141037|Valganciclovir|valganciclovir|mesh-list
82765415|NCT00141037|Ganciclovir|ganciclovir|mesh-list
82765416|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
82765417|NCT00141037|Prednisone|prednisone|mesh-list
82765418|NCT00141037|Tacrolimus|tacrolimus|mesh-list
82765419|NCT00141037|Daclizumab|daclizumab|mesh-list
82765420|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82765421|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
82765422|NCT00141037|Hormones|hormones|mesh-ancestor
82765423|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765424|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765425|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82765426|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765427|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82765428|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
82765429|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82765430|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765431|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765432|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82765433|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82765434|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
82765435|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82765436|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765437|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82765438|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
82765439|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82765440|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82765441|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82765442|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82765443|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82765444|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82765445|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
82765446|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82765447|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
82765448|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82765449|NCT01582555|Antidotes|antidotes|mesh-ancestor
82765450|NCT01582555|Protective Agents|protective agents|mesh-ancestor
82765451|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765452|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
82765453|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765454|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
82765455|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765456|NCT01582555|Expectorants|expectorants|mesh-ancestor
82765457|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
82765458|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82765459|NCT00923390|Aldesleukin|aldesleukin|mesh-list
82765460|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
82765461|NCT00923390|Fludarabine|fludarabine|mesh-list
82765462|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82765463|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
82765464|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765465|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82765466|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82765467|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
82765468|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765469|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765470|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82765471|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82765472|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82765473|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
82765474|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765475|NCT00885794|Ranibizumab|ranibizumab|mesh-list
82765476|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82765477|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82765478|NCT00885794|Growth Substances|growth substances|mesh-ancestor
82765479|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765480|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
82765481|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765483|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
82765484|NCT00888602|Cathartics|cathartics|mesh-ancestor
82765485|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82765486|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
82765487|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82765488|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82765489|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82765490|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
82765491|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765492|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82765493|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82765494|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765495|NCT00888758|Sirolimus|sirolimus|mesh-list
82765496|NCT00888758|Umirolimus|umirolimus|mesh-list
82765497|NCT00888758|Everolimus|everolimus|mesh-list
82765498|NCT00888758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82765499|NCT00888758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82765500|NCT00888758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765501|NCT00888758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765502|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82765503|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
82765504|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765505|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765506|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82765507|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82765508|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765509|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82765510|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
82765511|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82765512|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765513|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
82765514|NCT04038320|Ledipasvir|ledipasvir|mesh-list
82765515|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
82765516|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765517|NCT00563706|Risperidone|risperidone|mesh-list
82765518|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82765519|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
82765520|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765521|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765522|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765523|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82765524|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82765525|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82765526|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82765527|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82765528|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
82765529|NCT02543606|Esomeprazole|esomeprazole|mesh-list
82765530|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82765531|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82765532|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82765533|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765534|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765535|NCT00939588|Valsartan|valsartan|mesh-list
82765536|NCT00939588|Telmisartan|telmisartan|mesh-list
82765537|NCT00939588|Ramipril|ramipril|mesh-list
82765538|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82765539|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82765540|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82765541|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765542|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82765543|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
82765544|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765545|NCT00889148|Gabapentin|gabapentin|mesh-list
82765546|NCT00889148|Analgesics|analgesics|mesh-ancestor
82765547|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
82765548|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765549|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765550|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
82765551|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82765552|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82765553|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82765554|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82765555|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82765556|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82765557|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765558|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765559|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
82765560|NCT00936156|Carboplatin|carboplatin|mesh-list
82765561|NCT00936156|Etoposide|etoposide|mesh-list
82765562|NCT00936156|Thiotepa|thiotepa|mesh-list
82765563|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765564|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82765565|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82765566|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82765567|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765568|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765569|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82765570|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
82765571|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82765572|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82765573|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
82765574|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765575|NCT00129961|Cyclosporine|cyclosporine|mesh-list
82765576|NCT00129961|Sirolimus|sirolimus|mesh-list
82765577|NCT00129961|Tacrolimus|tacrolimus|mesh-list
82765578|NCT00129961|Cyclosporins|cyclosporins|mesh-list
82765579|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82765580|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
82765581|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765582|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82765583|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765584|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765585|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
82765586|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765587|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
82765588|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82765589|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82765590|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82765591|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765592|NCT00528567|Bevacizumab|bevacizumab|mesh-list
82765593|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82765594|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765595|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82765596|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82765597|NCT00528567|Growth Substances|growth substances|mesh-ancestor
82765598|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765599|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
82765600|NCT00936234|Vildagliptin|vildagliptin|mesh-list
82765601|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82765602|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765603|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82765604|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
82765605|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765606|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765607|NCT00886028|Doxorubicin|doxorubicin|mesh-list
82765608|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82765609|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765610|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82765611|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82765612|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82765613|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765614|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765616|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82765617|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765618|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
82765619|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765620|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82765621|NCT00936624|Montelukast|montelukast|mesh-list
82765622|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82765623|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
82765624|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82765625|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
82765626|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765627|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765628|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82765629|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82765630|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765631|NCT00138151|Interferons|interferons|mesh-list
82765632|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
82765633|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
82765634|NCT00138151|Paclitaxel|paclitaxel|mesh-list
82765635|NCT00138151|Isotretinoin|isotretinoin|mesh-list
82765636|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82765637|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765638|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
82765639|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
82765640|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
82765641|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765642|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
82765643|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765644|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
82765645|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765646|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
82765647|NCT02543060|Fluorides|fluorides|mesh-list
82765648|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
82765649|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
82765650|NCT02543060|Protective Agents|protective agents|mesh-ancestor
82765651|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765652|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82765653|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82765654|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
82765655|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765656|NCT00889616|Antacids|antacids|mesh-ancestor
82765657|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765658|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82765659|NCT02581631|Nivolumab|nivolumab|mesh-list
82765660|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82765661|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82765662|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765663|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82765664|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765665|NCT02581631|Immunotoxins|immunotoxins|mesh-ancestor
82765666|NCT02581631|Immunoconjugates|immunoconjugates|mesh-ancestor
82765667|NCT02581631|Immunologic Factors|immunologic factors|mesh-ancestor
82765668|NCT02581631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765669|NCT00884546|Dexamethasone|dexamethasone|mesh-list
82765670|NCT00884546|Lenalidomide|lenalidomide|mesh-list
82765671|NCT00884546|Bortezomib|bortezomib|mesh-list
82765672|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82765673|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
82765674|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
82765675|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765676|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765677|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82765678|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
82765679|NCT00884546|Hormones|hormones|mesh-ancestor
82765680|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765681|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82765682|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765683|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
82765684|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82765685|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82765686|NCT00884546|Growth Substances|growth substances|mesh-ancestor
82765687|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
82765688|NCT00886106|Midazolam|midazolam|mesh-list
82765689|NCT00886106|Remifentanil|remifentanil|mesh-list
82765690|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82765691|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82765692|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82765693|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765694|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82765695|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82765696|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82765697|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82765698|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
82765699|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
82765700|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
82765701|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
82765702|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765703|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765704|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82765705|NCT00886106|Narcotics|narcotics|mesh-ancestor
82765706|NCT00886106|Analgesics|analgesics|mesh-ancestor
82765707|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
82765708|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765709|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
82765710|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765711|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82765712|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82765713|NCT00889694|Analgesics|analgesics|mesh-ancestor
82765714|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
82765715|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765716|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765717|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82765718|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82765719|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82765720|NCT00529035|Interleukin-2|interleukin-2|mesh-list
82765721|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765722|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82765723|NCT00529035|Analgesics|analgesics|mesh-ancestor
82765724|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
82765725|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765726|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765727|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
82765728|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
82765729|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82765730|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82765731|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765732|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765733|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765734|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82765735|NCT02578043|Clindamycin|clindamycin|mesh-list
82765736|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
82765737|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
82765738|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82765739|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82765740|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765741|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82765742|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765743|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765744|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
82765745|NCT00889850|Esomeprazole|esomeprazole|mesh-list
82765746|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82765747|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82765748|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82765749|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765750|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765751|NCT04074317|Insulin|insulin|mesh-list
82765752|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82765753|NCT04074317|Pramlintide|pramlintide|mesh-list
82765754|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82765755|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765756|NCT00941148|Insulin|insulin|mesh-list
82765757|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82765758|NCT00941148|Metformin|metformin|mesh-list
82765759|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
82765760|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
82765761|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
82765762|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
82765763|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82765764|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765765|NCT02541500|Minocycline|minocycline|mesh-list
82765766|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82765767|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765768|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
82765769|NCT04073849|Hematinics|hematinics|mesh-ancestor
82765771|NCT03263429|Panitumumab|panitumumab|mesh-list
82765772|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82765773|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82765774|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765775|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765776|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765777|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82765778|NCT00609674|Fluticasone|fluticasone|mesh-list
82765779|NCT00609674|Xhance|xhance|mesh-list
82765780|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82765781|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82765782|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
82765783|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765784|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765785|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82765786|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
82765787|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
82765788|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82765789|NCT00941382|Metformin|metformin|mesh-list
82765790|NCT00941382|Sibutramine|sibutramine|mesh-list
82765791|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82765792|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765793|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
82765794|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82765795|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
82765796|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82765797|NCT03253679|Adavosertib|adavosertib|mesh-list
82765798|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765799|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765800|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82765801|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765802|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82765803|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765804|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765805|NCT00941460|Temozolomide|temozolomide|mesh-list
82765806|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82765807|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
82765808|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765809|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765810|NCT00890318|Ketoconazole|ketoconazole|mesh-list
82765811|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
82765812|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765813|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82765814|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82765815|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765816|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765817|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82765818|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
82765819|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765820|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765821|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82765822|NCT00563316|Irinotecan|irinotecan|mesh-list
82765823|NCT00563316|Panitumumab|panitumumab|mesh-list
82765824|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82765825|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82765826|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765827|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765828|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765829|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82765830|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
82765831|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82765832|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82765833|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765834|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82765835|NCT04037774|Analgesics|analgesics|mesh-ancestor
82765836|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
82765837|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765838|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82765839|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82765840|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82765841|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
82765842|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765843|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765845|NCT02542748|Ephedrine|ephedrine|mesh-list
82765846|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82765847|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82765848|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
82765849|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765850|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765851|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765852|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
82765853|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
82765854|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765855|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82765856|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82765857|NCT00941616|Factor VIII|factor viii|mesh-list
82765858|NCT00941616|Coagulants|coagulants|mesh-ancestor
82765859|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
82765860|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82765861|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82765862|NCT02542592|Prednisolone|prednisolone|mesh-list
82765863|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
82765864|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82765865|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
82765866|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82765867|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
82765868|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
82765869|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765870|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765871|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82765872|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
82765873|NCT02542592|Hormones|hormones|mesh-ancestor
82765874|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765875|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82765876|NCT02542592|Protective Agents|protective agents|mesh-ancestor
82765877|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82765878|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765879|NCT03178487|Upadacitinib|upadacitinib|mesh-list
82765880|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82765881|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82765882|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765883|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765884|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82765885|NCT04430036|Cisplatin|cisplatin|mesh-list
82765886|NCT04430036|Gemcitabine|gemcitabine|mesh-list
82765887|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765888|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82765889|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
82765890|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765891|NCT00528957|Tenofovir|tenofovir|mesh-list
82765892|NCT00528957|Zidovudine|zidovudine|mesh-list
82765893|NCT00528957|Stavudine|stavudine|mesh-list
82765894|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
82765895|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765896|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82765897|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82765898|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765899|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765900|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82765901|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82765902|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
82765903|NCT00890630|Oxytocin|oxytocin|mesh-list
82765904|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
82765905|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82765906|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765907|NCT00890708|Voriconazole|voriconazole|mesh-list
82765908|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
82765909|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765910|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82765911|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82765912|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765989|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
82765913|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765914|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82765915|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
82765916|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82765917|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765918|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82765919|NCT00890786|Bevacizumab|bevacizumab|mesh-list
82765921|NCT00890786|Temozolomide|temozolomide|mesh-list
82765922|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82765923|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765924|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82765925|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82765926|NCT00890786|Growth Substances|growth substances|mesh-ancestor
82765927|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765928|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
82765929|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82765930|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82765931|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82765932|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765933|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82765934|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
82765935|NCT00560508|Pramipexole|pramipexole|mesh-list
82765936|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
82765937|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765938|NCT00560508|Protective Agents|protective agents|mesh-ancestor
82765939|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765940|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82765941|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82765942|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
82765943|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
82765944|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765945|NCT00890942|Naloxone|naloxone|mesh-list
82765946|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82765947|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765948|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
82765949|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82765950|NCT00942006|Doxycycline|doxycycline|mesh-list
82765951|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
82765952|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82765953|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82765954|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
82765955|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82765956|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82765957|NCT02542124|Interleukin-12|interleukin-12|mesh-list
82765958|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82765959|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
82765960|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765961|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82765962|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82765963|NCT02542124|Growth Substances|growth substances|mesh-ancestor
82765964|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
82765965|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82765966|NCT00942318|Insulin|insulin|mesh-list
82765967|NCT00942318|Metformin|metformin|mesh-list
82765968|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
82765969|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82765970|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765971|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82765972|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82765973|NCT05280054|Probenecid|probenecid|mesh-list
82765974|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
82765975|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
82765976|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82765977|NCT03999099|Suvorexant|suvorexant|mesh-list
82765978|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82765979|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82765980|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82765981|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765982|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82765983|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82765984|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82765985|NCT01007799|Vitamin D|vitamin d|mesh-list
82765986|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
82765987|NCT01007799|Cholecalciferol|cholecalciferol|mesh-list
82765988|NCT01007799|Vitamins|vitamins|mesh-list
82765990|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82765991|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82765992|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82765993|NCT00609518|Folic Acid|folic acid|mesh-list
82765994|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
82765995|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
82765996|NCT00609518|Dexamethasone|dexamethasone|mesh-list
82765997|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
82765998|NCT00609518|Pemetrexed|pemetrexed|mesh-list
82765999|NCT00609518|BB 1101|bb 1101|mesh-list
82766000|NCT00609518|Vitamins|vitamins|mesh-ancestor
82766001|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
82766002|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766003|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766004|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
82766005|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
82766006|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766007|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82766008|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
82766009|NCT00609518|Hormones|hormones|mesh-ancestor
82766010|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766011|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82766012|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766013|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
82766014|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766015|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766016|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82766017|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82766018|NCT00609518|Hematinics|hematinics|mesh-ancestor
82766019|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82766020|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82766021|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766022|NCT00886496|Lectins|lectins|mesh-list
82766023|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
82766024|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
82766025|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766026|NCT00886496|Coagulants|coagulants|mesh-ancestor
82766027|NCT00884858|Maraviroc|maraviroc|mesh-list
82766028|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82766029|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82766030|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766031|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82766032|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82766033|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
82766034|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766035|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82766036|NCT00891332|Leucovorin|leucovorin|mesh-list
82766037|NCT00891332|Antidotes|antidotes|mesh-ancestor
82766038|NCT00891332|Protective Agents|protective agents|mesh-ancestor
82766039|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766040|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
82766041|NCT00891332|Vitamins|vitamins|mesh-ancestor
82766042|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
82766043|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
82766044|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82766045|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766046|NCT04038008|Fluconazole|fluconazole|mesh-list
82766047|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
82766048|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766049|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82766050|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82766051|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766052|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766053|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82766054|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
82766055|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766056|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766057|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82766058|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82766059|NCT00886574|Aspirin|aspirin|mesh-list
82766060|NCT00886574|Cilostazol|cilostazol|mesh-list
82766061|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82766062|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82766063|NCT00886574|Analgesics|analgesics|mesh-ancestor
82766064|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
82766065|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766290|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82766066|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766067|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766068|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82766069|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82766070|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82766071|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766072|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82766073|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82766074|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766075|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
82766076|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82766077|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
82766078|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82766079|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
82766080|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
82766081|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82766082|NCT00886574|Protective Agents|protective agents|mesh-ancestor
82766083|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82766084|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82766085|NCT00611858|Fluorouracil|fluorouracil|mesh-list
82766086|NCT00611858|Cetuximab|cetuximab|mesh-list
82766087|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
82766088|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766089|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82766090|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766091|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766092|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
82766093|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766094|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82766095|NCT00137449|Sunitinib|sunitinib|mesh-list
82766096|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766097|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82766098|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82766099|NCT00137449|Growth Substances|growth substances|mesh-ancestor
82766100|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766101|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
82766102|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82766103|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766104|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766105|NCT00886886|Reboxetine|reboxetine|mesh-list
82766106|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
82766107|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82766108|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82766109|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82766110|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82766111|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766112|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
82766113|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82766114|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766115|NCT00887042|Fludarabine|fludarabine|mesh-list
82766116|NCT00887042|Busulfan|busulfan|mesh-list
82766117|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
82766118|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766119|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766120|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766121|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
82766122|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766123|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
82766124|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82766125|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82766126|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
82766127|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
82766128|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82766129|NCT00892112|Antibodies|antibodies|mesh-list
82766130|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
82766131|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82766132|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
82766133|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766134|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
82766135|NCT00887120|Ritonavir|ritonavir|mesh-list
82766136|NCT00887120|Lopinavir|lopinavir|mesh-list
82766137|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82766138|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82766139|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
82766140|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766141|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766142|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82766143|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82766144|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
82766145|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766146|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82766147|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82766148|NCT00892190|Dasatinib|dasatinib|mesh-list
82766149|NCT00892190|Tretinoin|tretinoin|mesh-list
82766150|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766151|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82766152|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766153|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766154|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
82766155|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
82766156|NCT00887276|Amoxicillin|amoxicillin|mesh-list
82766157|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
82766158|NCT00887276|Ampicillin|ampicillin|mesh-list
82766159|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82766160|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766161|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82766162|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82766163|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766164|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766165|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766166|NCT00528879|Metformin|metformin|mesh-list
82766167|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
82766168|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82766169|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766170|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82766171|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766172|NCT00608894|Prednisone|prednisone|mesh-list
82766173|NCT00608894|Azathioprine|azathioprine|mesh-list
82766174|NCT00608894|Tacrolimus|tacrolimus|mesh-list
82766175|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766176|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
82766177|NCT00608894|Hormones|hormones|mesh-ancestor
82766178|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766179|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766180|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82766181|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766182|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766183|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
82766184|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82766185|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766186|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766187|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
82766188|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82766189|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82766190|NCT00892346|Thalidomide|thalidomide|mesh-list
82766191|NCT00892346|Melphalan|melphalan|mesh-list
82766192|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82766193|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
82766194|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766195|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766196|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82766197|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766198|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
82766199|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766200|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
82766201|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82766202|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766203|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82766204|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82766205|NCT00892346|Growth Substances|growth substances|mesh-ancestor
82766206|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
82766207|NCT00892424|Sorafenib|sorafenib|mesh-list
82766208|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766209|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82766210|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766211|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766212|NCT02541032|Minocycline|minocycline|mesh-list
82766213|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82766214|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766215|NCT00892502|Bismuth|bismuth|mesh-list
82766216|NCT00892502|Antacids|antacids|mesh-ancestor
82766217|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766218|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82766219|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82766221|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82766222|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82766223|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82766224|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
82766225|NCT00191113|Estradiol|estradiol|mesh-list
82766226|NCT00191113|Hormones|hormones|mesh-ancestor
82766227|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766228|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766229|NCT00191113|Estrogens|estrogens|mesh-ancestor
82766230|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82766231|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
82766232|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82766233|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82766234|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82766235|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82766236|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82766237|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82766238|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82766239|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766240|NCT03965052|Travoprost|travoprost|mesh-list
82766241|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82766242|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82766243|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82766244|NCT00892658|Sorafenib|sorafenib|mesh-list
82766245|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766246|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82766247|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766248|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766249|NCT00892736|Veliparib|veliparib|mesh-list
82766250|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82766251|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766252|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766253|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766254|NCT03966235|Melatonin|melatonin|mesh-list
82766255|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
82766256|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766257|NCT03966235|Protective Agents|protective agents|mesh-ancestor
82766258|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766259|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766260|NCT01077661|Nebivolol|nebivolol|mesh-list
82766261|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82766262|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
82766263|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82766264|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82766265|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82766266|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
82766267|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82766268|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766269|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766270|NCT00606320|Aripiprazole|aripiprazole|mesh-list
82766271|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
82766272|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82766273|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82766274|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82766275|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766276|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766277|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
82766278|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
82766279|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82766280|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766281|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82766282|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82766283|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
82766284|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82766285|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82766286|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82766287|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82766288|NCT03966079|Plasminogen|plasminogen|mesh-list
82766289|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82766291|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82766292|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766293|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
82766294|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
82766295|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82766296|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766297|NCT03966859|Atorvastatin|atorvastatin|mesh-list
82766298|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82766299|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82766300|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
82766301|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766302|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82766303|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82766304|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766305|NCT00528411|Aspirin|aspirin|mesh-list
82766306|NCT00528411|Clopidogrel|clopidogrel|mesh-list
82766307|NCT00528411|Ticagrelor|ticagrelor|mesh-list
82766308|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82766309|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82766310|NCT00528411|Analgesics|analgesics|mesh-ancestor
82766311|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
82766312|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766313|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766314|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766315|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82766316|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82766317|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82766318|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766319|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82766320|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82766321|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766322|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
82766323|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82766324|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82766325|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82766326|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
82766327|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82766328|NCT00895544|Vaccines|vaccines|mesh-list
82766329|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
82766330|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766331|NCT00895778|Rocuronium|rocuronium|mesh-list
82766332|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82766333|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82766334|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82766335|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766336|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766337|NCT00187135|Fentanyl|fentanyl|mesh-list
82766338|NCT00187135|Propofol|propofol|mesh-list
82766339|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82766340|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766341|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766342|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82766343|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
82766344|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
82766345|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82766346|NCT00187135|Narcotics|narcotics|mesh-ancestor
82766347|NCT00187135|Analgesics|analgesics|mesh-ancestor
82766348|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
82766349|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766350|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82766352|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
82766353|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82766354|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
82766355|NCT00896402|Povidone|povidone|mesh-list
82766356|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82766357|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766358|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
82766359|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
82766360|NCT00896402|Trace Elements|trace elements|mesh-ancestor
82766361|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
82766362|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766363|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
82766364|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
82766365|NCT00560352|Dexamethasone|dexamethasone|mesh-list
82766366|NCT00560352|Bortezomib|bortezomib|mesh-list
82766367|NCT00560352|Dasatinib|dasatinib|mesh-list
82766368|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766369|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
82766370|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
82766371|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766372|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766373|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82766374|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
82766376|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766377|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82766378|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766379|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82766380|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766381|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766382|NCT00892892|Nitrendipine|nitrendipine|mesh-list
82766383|NCT00892892|Rilmenidine|rilmenidine|mesh-list
82766384|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82766385|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82766386|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82766387|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766388|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82766389|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766390|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
82766391|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
82766392|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
82766393|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766394|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82766395|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82766396|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82766397|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
82766398|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82766399|NCT00944814|Zinc|zinc|mesh-list
82766400|NCT00944814|Trace Elements|trace elements|mesh-ancestor
82766401|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
82766402|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766403|NCT00527787|Naproxen|naproxen|mesh-list
82766404|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82766405|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82766406|NCT00527787|Analgesics|analgesics|mesh-ancestor
82766407|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
82766408|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766409|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766410|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766411|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82766412|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
82766413|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82766414|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766415|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766416|NCT00893048|Prednisone|prednisone|mesh-list
82766417|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766418|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
82766419|NCT00893048|Hormones|hormones|mesh-ancestor
82766420|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766421|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766422|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82766423|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766424|NCT00942864|Ranibizumab|ranibizumab|mesh-list
82766425|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82766426|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82766427|NCT00942864|Growth Substances|growth substances|mesh-ancestor
82766428|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766429|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
82766430|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766431|NCT04036448|Lenalidomide|lenalidomide|mesh-list
82766432|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
82766433|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766434|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82766435|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82766436|NCT04036448|Growth Substances|growth substances|mesh-ancestor
82766437|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
82766438|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766439|NCT00896558|Midazolam|midazolam|mesh-list
82766440|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82766441|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82766442|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766443|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766444|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82766445|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82766446|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82766447|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82766448|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
82766449|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
82766450|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
82766451|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
82766452|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82766453|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766454|NCT00943176|Modafinil|modafinil|mesh-list
82766455|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82766456|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766457|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82766458|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82766459|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82766460|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766461|NCT00129259|Iron|iron|mesh-list
82766462|NCT00129259|Trace Elements|trace elements|mesh-ancestor
82766463|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
82766464|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766465|NCT00896714|Anesthetics|anesthetics|mesh-list
82766466|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766467|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766468|NCT00940524|Cytarabine|cytarabine|mesh-list
82766469|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
82766470|NCT00940524|Methotrexate|methotrexate|mesh-list
82766471|NCT00940524|Etoposide|etoposide|mesh-list
82766472|NCT00940524|Asparaginase|asparaginase|mesh-list
82766473|NCT00940524|Dasatinib|dasatinib|mesh-list
82766474|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
82766475|NCT00940524|Pegaspargase|pegaspargase|mesh-list
82766476|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766477|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
82766478|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766479|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82766480|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82766481|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
82766482|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766483|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766484|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82766485|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82766486|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
82766487|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82766488|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82766490|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
82766491|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766492|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82766493|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82766494|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82766495|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82766496|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82766497|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
82766498|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766499|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82766500|NCT00940524|Analgesics|analgesics|mesh-ancestor
82766501|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
82766502|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766503|NCT00186901|Vitamin D|vitamin d|mesh-list
82766504|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
82766505|NCT00186901|Calcium|calcium|mesh-list
82766506|NCT00186901|Vitamins|vitamins|mesh-ancestor
82766507|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
82766508|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766509|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82766510|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82766511|NCT00186901|Antacids|antacids|mesh-ancestor
82766512|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766513|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82766514|NCT00943410|Trastuzumab|trastuzumab|mesh-list
82766515|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82766516|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766517|NCT00896948|Antibodies|antibodies|mesh-list
82766518|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
82766519|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766520|NCT00186121|Anastrozole|anastrozole|mesh-list
82766522|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82766523|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766524|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82766525|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82766526|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766527|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766528|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82766529|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
82766530|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766531|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766532|NCT00897026|Paclitaxel|paclitaxel|mesh-list
82766533|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
82766534|NCT00897026|Doxorubicin|doxorubicin|mesh-list
82766535|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82766536|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82766537|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766538|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
82766539|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
82766540|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
82766541|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766542|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766543|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
82766544|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766545|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82766546|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82766547|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
82766548|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82766549|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82766550|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82766551|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82766552|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766553|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82766554|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
82766555|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82766556|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82766557|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82766558|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766559|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766561|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82766562|NCT01076491|Diuretics|diuretics|mesh-ancestor
82766563|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
82766564|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766565|NCT00127933|Capecitabine|capecitabine|mesh-list
82766566|NCT00127933|Docetaxel|docetaxel|mesh-list
82766567|NCT00127933|Trastuzumab|trastuzumab|mesh-list
82766568|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82766569|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
82766570|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766571|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766572|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
82766573|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
82766574|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
82766575|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82766576|NCT03875313|Talazoparib|talazoparib|mesh-list
82766577|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82766578|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766579|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766580|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766581|NCT01008345|Ezetimibe|ezetimibe|mesh-list
82766582|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82766583|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82766584|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
82766585|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766586|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82766587|NCT05239533|Nivolumab|nivolumab|mesh-list
82766588|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82766589|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82766590|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766591|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82766592|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766593|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
82766594|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766595|NCT04828083|Lidocaine|lidocaine|mesh-list
82766596|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
82766597|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
82766598|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766599|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766600|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
82766601|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766602|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82766603|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82766604|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82766605|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82766606|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766607|NCT05225961|Aspirin|aspirin|mesh-list
82766608|NCT05225961|Tirofiban|tirofiban|mesh-list
82766609|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82766610|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82766611|NCT05225961|Analgesics|analgesics|mesh-ancestor
82766612|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
82766613|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766614|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766615|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766616|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82766617|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82766618|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82766619|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766620|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82766621|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82766622|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766623|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
82766624|NCT00556998|Voriconazole|voriconazole|mesh-list
82766625|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
82766626|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766627|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82766628|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82766629|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766630|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766631|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82766632|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
82766633|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766634|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766635|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82766636|NCT00945360|Letrozole|letrozole|mesh-list
82766637|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82766638|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766639|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82766640|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766641|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766642|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82766643|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
82766644|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766645|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766646|NCT00943566|Sufentanil|sufentanil|mesh-list
82766647|NCT00943566|Morphine|morphine|mesh-list
82766648|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82766649|NCT00943566|Narcotics|narcotics|mesh-ancestor
82766650|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766651|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766652|NCT00943566|Analgesics|analgesics|mesh-ancestor
82766653|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
82766654|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766655|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82766656|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82766657|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
82766658|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
82766659|NCT00940680|Losartan|losartan|mesh-list
82766660|NCT00940680|Amlodipine|amlodipine|mesh-list
82766661|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82766662|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82766663|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82766664|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766665|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82766666|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766667|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
82766745|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
82766668|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82766669|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82766670|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82766672|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
82766673|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766674|NCT00527397|Insulin|insulin|mesh-list
82766675|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82766676|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766677|NCT00943956|Everolimus|everolimus|mesh-list
82766678|NCT00943956|Leuprolide|leuprolide|mesh-list
82766679|NCT00943956|Bicalutamide|bicalutamide|mesh-list
82766680|NCT00943956|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82766681|NCT00943956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82766682|NCT00943956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766683|NCT00943956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766684|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766685|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
82766686|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766687|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766688|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82766689|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
82766690|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82766691|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82766692|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
82766693|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
82766694|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766695|NCT00944346|Metformin|metformin|mesh-list
82766696|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82766697|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766698|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82766699|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
82766700|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82766701|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82766702|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82766703|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766704|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766705|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82766706|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
82766707|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766708|NCT00940836|Acetaminophen|acetaminophen|mesh-list
82766709|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
82766710|NCT00940836|Phenylephrine|phenylephrine|mesh-list
82766711|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82766712|NCT00940836|Analgesics|analgesics|mesh-ancestor
82766713|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
82766714|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766715|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766716|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
82766717|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82766718|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
82766719|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
82766720|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
82766721|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82766722|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
82766723|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
82766724|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82766725|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82766726|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82766727|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
82766728|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82766729|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766730|NCT00940836|Protective Agents|protective agents|mesh-ancestor
82766731|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
82766732|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
82766733|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82766734|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
82766735|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
82766736|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82766737|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
82766738|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82766739|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766741|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
82766742|NCT00944424|Cholecalciferol|cholecalciferol|mesh-list
82766743|NCT00944424|Vitamins|vitamins|mesh-list
82766744|NCT00944424|Docetaxel|docetaxel|mesh-list
82766746|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766747|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766748|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
82766749|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
82766750|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
82766751|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766752|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82766753|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82766754|NCT04591353|Lidocaine|lidocaine|mesh-list
82766755|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
82766756|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
82766757|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766758|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766759|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
82766760|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766761|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82766762|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82766763|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82766764|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82766765|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766766|NCT00944502|Dexamethasone|dexamethasone|mesh-list
82766767|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766768|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
82766769|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
82766770|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766771|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766772|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82766773|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
82766774|NCT00944502|Hormones|hormones|mesh-ancestor
82766775|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766776|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82766777|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766778|NCT00949962|Leuprolide|leuprolide|mesh-list
82766779|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
82766780|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82766781|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
82766782|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82766783|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766784|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82766785|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766786|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
82766787|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766788|NCT00946374|Cyclosporine|cyclosporine|mesh-list
82766789|NCT00946374|Doxorubicin|doxorubicin|mesh-list
82766790|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82766791|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766792|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82766793|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82766794|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766795|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766796|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
82766797|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766798|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82766799|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766800|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
82766801|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766802|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
82766803|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82766804|NCT00950196|Amantadine|amantadine|mesh-list
82766805|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82766806|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82766807|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
82766808|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766809|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
82766810|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82766811|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766812|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766813|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82766814|NCT00950196|Analgesics|analgesics|mesh-ancestor
82766815|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
82766816|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766817|NCT01565109|Docetaxel|docetaxel|mesh-list
82766818|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766819|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
82766820|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
82766821|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
82766822|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766823|NCT00525915|Fluorouracil|fluorouracil|mesh-list
82766824|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
82766825|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
82766826|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766827|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82766828|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766829|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766830|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
82766831|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766832|NCT00521001|Everolimus|everolimus|mesh-list
82766833|NCT00521001|Temozolomide|temozolomide|mesh-list
82766834|NCT00521001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82766835|NCT00521001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82766836|NCT00521001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766837|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766838|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766839|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
82766840|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766841|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766842|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82766843|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
82766844|NCT00134563|Teriflunomide|teriflunomide|mesh-list
82766845|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82766846|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82766847|NCT00134563|Analgesics|analgesics|mesh-ancestor
82766848|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
82766849|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766850|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766851|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766852|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82766853|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766854|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
82766855|NCT03966547|Anesthetics|anesthetics|mesh-list
82766856|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
82766857|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766858|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766859|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
82766860|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766861|NCT01326325|Ketamine|ketamine|mesh-list
82766862|NCT01326325|Analgesics|analgesics|mesh-ancestor
82766863|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
82766864|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766865|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766866|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82766867|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82766868|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
82766869|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
82766870|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82766871|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82766872|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82766873|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82766874|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766875|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
82766876|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82766877|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82766878|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766879|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
82766880|NCT01326403|Coagulants|coagulants|mesh-ancestor
82766881|NCT00520845|Celecoxib|celecoxib|mesh-list
82766882|NCT00520845|Docetaxel|docetaxel|mesh-list
82766883|NCT00520845|Pemetrexed|pemetrexed|mesh-list
82766884|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766885|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
82766886|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
82766887|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
82766888|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766889|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766890|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82766891|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82766892|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82766893|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82766894|NCT00520845|Analgesics|analgesics|mesh-ancestor
82766895|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
82766896|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766897|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766898|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766899|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82766900|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82766901|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82766902|NCT00185731|Atorvastatin|atorvastatin|mesh-list
82766903|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82766904|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82766905|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
82766906|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766907|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82766908|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82766909|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766910|NCT00582491|Modafinil|modafinil|mesh-list
82766911|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82766912|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766913|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82766914|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82766915|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82766916|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766917|NCT00520767|Dexamethasone|dexamethasone|mesh-list
82766918|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
82766919|NCT00520767|Bortezomib|bortezomib|mesh-list
82766920|NCT00520767|Melphalan|melphalan|mesh-list
82766921|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82766922|NCT00520767|BB 1101|bb 1101|mesh-list
82766923|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82766924|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
82766925|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
82766926|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82766927|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766928|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82766929|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
82766930|NCT00520767|Hormones|hormones|mesh-ancestor
82766931|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82766932|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82766933|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766934|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
82766935|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766936|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766937|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82766938|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
82766939|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82766940|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766941|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
82766942|NCT03873987|Oritavancin|oritavancin|mesh-list
82766943|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82766944|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766945|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82766946|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
82766947|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766948|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
82766949|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766950|NCT00528645|Saracatinib|saracatinib|mesh-list
82766951|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766952|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766953|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766954|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
82766955|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
82766956|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82766957|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
82766958|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82766959|NCT01017796|Expectorants|expectorants|mesh-ancestor
82766960|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
82766961|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82766962|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
82766963|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766964|NCT01017796|Protective Agents|protective agents|mesh-ancestor
82766965|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766966|NCT01017796|Antidotes|antidotes|mesh-ancestor
82766967|NCT01017796|Vitamins|vitamins|mesh-ancestor
82766968|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
82766969|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
82766970|NCT01783535|Carboplatin|carboplatin|mesh-list
82766971|NCT01783535|Doxorubicin|doxorubicin|mesh-list
82766972|NCT01783535|Etoposide|etoposide|mesh-list
82766973|NCT01783535|Vincristine|vincristine|mesh-list
82766974|NCT01783535|Topotecan|topotecan|mesh-list
82766975|NCT01783535|Lenograstim|lenograstim|mesh-list
82766976|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82766977|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
82766978|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82766979|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82766980|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82766981|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
82766982|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82766983|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766984|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82766985|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82766986|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82766987|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82766988|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82766989|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82766990|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82766991|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
82766992|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
82766993|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
82766994|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82766996|NCT04073537|Carboplatin|carboplatin|mesh-list
82766997|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82766998|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82766999|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
82767000|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
82767001|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
82767002|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767003|NCT01020994|Octenidine|octenidine|mesh-list
82767004|NCT01020994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82767005|NCT01020994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82767006|NCT00494026|Carboplatin|carboplatin|mesh-list
82767007|NCT00494026|Pemetrexed|pemetrexed|mesh-list
82767008|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767009|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767010|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767011|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82767012|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82767013|NCT00524589|Calcitriol|calcitriol|mesh-list
82767014|NCT00524589|Dexamethasone|dexamethasone|mesh-list
82767015|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767016|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
82767017|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
82767018|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767019|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767020|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82767021|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
82767022|NCT00524589|Hormones|hormones|mesh-ancestor
82767023|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767024|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82767025|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767026|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82767027|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82767028|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82767029|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767030|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82767031|NCT00524589|Vitamins|vitamins|mesh-ancestor
82767032|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
82767033|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82767034|NCT01015066|Naltrexone|naltrexone|mesh-list
82767035|NCT01015066|Buprenorphine|buprenorphine|mesh-list
82767036|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82767037|NCT01015066|Naloxone|naloxone|mesh-list
82767038|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82767039|NCT01015066|Narcotics|narcotics|mesh-ancestor
82767040|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767041|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767042|NCT01015066|Analgesics|analgesics|mesh-ancestor
82767043|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
82767044|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767045|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82767046|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82767047|NCT00472030|Omalizumab|omalizumab|mesh-list
82767048|NCT00472030|Prednisone|prednisone|mesh-list
82767049|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767050|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
82767051|NCT00472030|Hormones|hormones|mesh-ancestor
82767052|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767053|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767054|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82767055|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767056|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82767057|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82767058|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
82767059|NCT00127855|Vaccines|vaccines|mesh-list
82767060|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82767061|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
82767062|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767063|NCT00493636|Gemcitabine|gemcitabine|mesh-list
82767064|NCT00493636|Capecitabine|capecitabine|mesh-list
82767065|NCT00493636|Sorafenib|sorafenib|mesh-list
82767066|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82767067|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
82767068|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767069|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767070|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82767071|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767072|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82767073|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767074|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82767075|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767076|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767077|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
82767078|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82767079|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82767080|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82767081|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
82767082|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82767083|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82767084|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767085|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
82767086|NCT03965767|Coagulants|coagulants|mesh-ancestor
82767087|NCT00133705|Mifepristone|mifepristone|mesh-list
82767088|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82767089|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
82767090|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82767091|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767092|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82767093|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82767094|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82767095|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
82767096|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82767097|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82767098|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
82767099|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767100|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
82767101|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82767102|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82767103|NCT00132769|MK 0873|mk 0873|mesh-list
82767104|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82767105|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82767106|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767107|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767108|NCT02478255|Xenon|xenon|mesh-list
82767109|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82767110|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
82767111|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
82767112|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767113|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767114|NCT00132691|Cyclosporine|cyclosporine|mesh-list
82767115|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
82767116|NCT00132691|Infliximab|infliximab|mesh-list
82767117|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
82767118|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
82767119|NCT00132691|Chlorambucil|chlorambucil|mesh-list
82767120|NCT00132691|Methotrexate|methotrexate|mesh-list
82767121|NCT00132691|Azathioprine|azathioprine|mesh-list
82767122|NCT00132691|Tacrolimus|tacrolimus|mesh-list
82767123|NCT00132691|Cyclosporins|cyclosporins|mesh-list
82767124|NCT00132691|Daclizumab|daclizumab|mesh-list
82767125|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82767126|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
82767127|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
82767128|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767129|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82767130|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82767131|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767132|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767133|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82767134|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82767135|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
82767136|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82767137|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82767138|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
82767139|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
82767140|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767141|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82767142|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82767143|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82767144|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
82767145|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82767146|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82767147|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82767148|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
82767149|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82767150|NCT00132691|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82767151|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767152|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82767153|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
82767155|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767156|NCT02390427|Paclitaxel|paclitaxel|mesh-list
82767157|NCT02390427|Maytansine|maytansine|mesh-list
82767158|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82767159|NCT02390427|Trastuzumab|trastuzumab|mesh-list
82767160|NCT02390427|Pertuzumab|pertuzumab|mesh-list
82767161|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82767162|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767163|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
82767164|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
82767165|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
82767166|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767167|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82767168|NCT02390427|Immunotoxins|immunotoxins|mesh-ancestor
82767169|NCT02390427|Immunoconjugates|immunoconjugates|mesh-ancestor
82767170|NCT02390427|Immunologic Factors|immunologic factors|mesh-ancestor
82767171|NCT02390427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767172|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82767173|NCT00125359|Bexarotene|bexarotene|mesh-list
82767174|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767175|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82767176|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767177|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767178|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82767179|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82767180|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82767181|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767182|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767183|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82767184|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82767185|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82767186|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
82767187|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767188|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767189|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82767190|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82767191|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
82767192|NCT01076803|Lanreotide|lanreotide|mesh-list
82767193|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767194|NCT00523419|Pemetrexed|pemetrexed|mesh-list
82767195|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767196|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767197|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767198|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82767199|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82767200|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
82767201|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82767202|NCT03868059|Testosterone|testosterone|mesh-list
82767203|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
82767204|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
82767205|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82767206|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767207|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
82767208|NCT03868059|Hormones|hormones|mesh-ancestor
82767209|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767210|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767211|NCT03868059|Androgens|androgens|mesh-ancestor
82767212|NCT04028115|Ixazomib|ixazomib|mesh-list
82767213|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767214|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
82767215|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767216|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767217|NCT03865407|Allopurinol|allopurinol|mesh-list
82767218|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
82767219|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767220|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767221|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
82767222|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82767223|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82767224|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
82767225|NCT03865407|Protective Agents|protective agents|mesh-ancestor
82767226|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767227|NCT00487942|Modafinil|modafinil|mesh-list
82767228|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82767229|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767230|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82767231|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82767232|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82767233|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767234|NCT00132301|Prednisone|prednisone|mesh-list
82767235|NCT00132301|Docetaxel|docetaxel|mesh-list
82767236|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767237|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
82767238|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
82767239|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
82767240|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767241|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767242|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
82767243|NCT00132301|Hormones|hormones|mesh-ancestor
82767244|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767245|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767246|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82767247|NCT00519831|Cetuximab|cetuximab|mesh-list
82767248|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82767249|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767250|NCT04303845|Erenumab|erenumab|mesh-list
82767251|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82767252|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767253|NCT04303845|Analgesics|analgesics|mesh-ancestor
82767254|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
82767255|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767256|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767257|NCT04187703|Azacitidine|azacitidine|mesh-list
82767258|NCT04187703|Decitabine|decitabine|mesh-list
82767259|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82767260|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
82767261|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767262|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767263|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767264|NCT00131911|Sorafenib|sorafenib|mesh-list
82767265|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767266|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82767267|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767268|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767269|NCT00184093|Gemcitabine|gemcitabine|mesh-list
82767270|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82767271|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
82767272|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767273|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767274|NCT01074619|Memantine|memantine|mesh-list
82767275|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82767276|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82767277|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
82767278|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767279|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767280|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767281|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82767282|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82767283|NCT00183625|Olanzapine|olanzapine|mesh-list
82767284|NCT00183625|Risperidone|risperidone|mesh-list
82767285|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82767286|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
82767287|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767288|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767289|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767290|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82767291|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82767292|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767293|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82767294|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82767296|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
82767297|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
82767298|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767299|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82767300|NCT00183625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82767301|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82767302|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82767303|NCT00511875|Doxycycline|doxycycline|mesh-list
82767304|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82767305|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82767306|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
82767307|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82767308|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82767309|NCT02576327|Dexamethasone|dexamethasone|mesh-list
82767310|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
82767312|NCT02576327|Tropisetron|tropisetron|mesh-list
82767313|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82767314|NCT02576327|BB 1101|bb 1101|mesh-list
82767315|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767316|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
82767317|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
82767318|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767319|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767320|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82767321|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
82767322|NCT02576327|Hormones|hormones|mesh-ancestor
82767323|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767324|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82767325|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767326|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
82767327|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767328|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767329|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82767330|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767331|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82767332|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82767333|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
82767334|NCT00183391|Methylphenidate|methylphenidate|mesh-list
82767335|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82767336|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82767337|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767338|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82767339|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82767340|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82767341|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767342|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
82767343|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767344|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82767345|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
82767346|NCT00493246|Acetaminophen|acetaminophen|mesh-list
82767347|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82767348|NCT00493246|Analgesics|analgesics|mesh-ancestor
82767427|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
82767349|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
82767350|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767351|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767352|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
82767353|NCT01021150|Cisplatin|cisplatin|mesh-list
82767354|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767355|NCT03997006|Atropine|atropine|mesh-list
82767356|NCT03997006|Aminophylline|aminophylline|mesh-list
82767357|NCT03997006|Neostigmine|neostigmine|mesh-list
82767358|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82767359|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82767360|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82767361|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
82767362|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767363|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767364|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82767365|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
82767366|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
82767367|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
82767368|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82767369|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82767370|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
82767371|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767372|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767373|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82767374|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767375|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82767376|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82767377|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82767378|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82767379|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82767380|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
82767381|NCT03997006|Protective Agents|protective agents|mesh-ancestor
82767382|NCT02281955|Cisplatin|cisplatin|mesh-list
82767383|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767384|NCT02272049|Xenon|xenon|mesh-list
82767385|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82767386|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
82767387|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
82767388|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767389|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767390|NCT03996538|Metformin|metformin|mesh-list
82767391|NCT03996538|Vaccines|vaccines|mesh-list
82767392|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
82767393|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767394|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82767395|NCT02576015|Lidocaine|lidocaine|mesh-list
82767396|NCT02576015|Ropivacaine|ropivacaine|mesh-list
82767397|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
82767398|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
82767399|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767400|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767401|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
82767402|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767403|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82767404|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82767405|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82767406|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82767407|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767409|NCT02577965|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82767410|NCT02577965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82767411|NCT02577965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767412|NCT02577965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767413|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82767414|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
82767415|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767416|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767417|NCT00182689|Sorafenib|sorafenib|mesh-list
82767418|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767419|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82767420|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767421|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767422|NCT02578121|Dexamethasone|dexamethasone|mesh-list
82767423|NCT02578121|Pomalidomide|pomalidomide|mesh-list
82767424|NCT02578121|Ixazomib|ixazomib|mesh-list
82767425|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767426|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
82767428|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767429|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767430|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82767431|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
82767432|NCT02578121|Hormones|hormones|mesh-ancestor
82767433|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767434|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82767435|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767436|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
82767437|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82767438|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82767439|NCT02578121|Growth Substances|growth substances|mesh-ancestor
82767440|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
82767441|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
82767442|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767443|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767444|NCT00487240|Insulin|insulin|mesh-list
82767445|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82767446|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
82767447|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
82767448|NCT00487240|Protamines|protamines|mesh-list
82767449|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82767450|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767451|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
82767452|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767453|NCT00487240|Coagulants|coagulants|mesh-ancestor
82767454|NCT02577809|Indomethacin|indomethacin|mesh-list
82767455|NCT02577809|Fentanyl|fentanyl|mesh-list
82767456|NCT02577809|Morphine|morphine|mesh-list
82767457|NCT02577809|Bupivacaine|bupivacaine|mesh-list
82767458|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
82767459|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
82767460|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767461|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767462|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
82767463|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767464|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82767465|NCT02577809|Narcotics|narcotics|mesh-ancestor
82767466|NCT02577809|Analgesics|analgesics|mesh-ancestor
82767467|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82767468|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82767469|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
82767470|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82767471|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82767472|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767473|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82767474|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
82767475|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
82767476|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82767477|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82767478|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767479|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767480|NCT02224391|Nicotine|nicotine|mesh-list
82767481|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82767482|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
82767483|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767484|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767485|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82767486|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82767487|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
82767488|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767489|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767490|NCT00487162|Insulin|insulin|mesh-list
82767491|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82767492|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767493|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
82767494|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82767495|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767496|NCT03871959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82767497|NCT03871959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767498|NCT00487084|Lidocaine|lidocaine|mesh-list
82767499|NCT00487084|Morphine|morphine|mesh-list
82767500|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
82767501|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
82767502|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767503|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767504|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
82767505|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767506|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82767507|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82767508|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82767509|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82767510|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767511|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82767512|NCT00487084|Narcotics|narcotics|mesh-ancestor
82767513|NCT00487084|Analgesics|analgesics|mesh-ancestor
82767514|NCT00466726|Sargramostim|sargramostim|mesh-list
82767515|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
82767516|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767517|NCT01721291|Albuterol|albuterol|mesh-list
82767518|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82767519|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
82767520|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767521|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767522|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82767523|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
82767524|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
82767525|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82767526|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82767527|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82767528|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82767529|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
82767530|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767531|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767532|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82767533|NCT01021540|Hormones|hormones|mesh-ancestor
82767534|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767535|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767536|NCT04840511|Lidocaine|lidocaine|mesh-list
82767537|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
82767538|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
82767539|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767540|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767541|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
82767542|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767543|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82767544|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82767545|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82767546|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82767547|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767548|NCT02199665|Dexamethasone|dexamethasone|mesh-list
82767549|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767550|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
82767551|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
82767552|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767553|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767554|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82767555|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
82767556|NCT02199665|Hormones|hormones|mesh-ancestor
82767557|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767558|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82767559|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767560|NCT01021696|Acetaminophen|acetaminophen|mesh-list
82767561|NCT01021696|Pregabalin|pregabalin|mesh-list
82767562|NCT01021696|Morphine|morphine|mesh-list
82767563|NCT01021696|Buprenorphine|buprenorphine|mesh-list
82767564|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82767565|NCT01021696|Narcotics|narcotics|mesh-ancestor
82767566|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767567|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767568|NCT01021696|Analgesics|analgesics|mesh-ancestor
82767569|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
82767570|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767571|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
82767572|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82767573|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82767574|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767575|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82767576|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82767577|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82767578|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82767579|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82767580|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
82767581|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82767582|NCT02577575|Oxytocin|oxytocin|mesh-list
82767583|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
82767584|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82767585|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767587|NCT00485758|Niacinamide|niacinamide|mesh-list
82767588|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
82767589|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82767590|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
82767591|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767592|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82767593|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
82767594|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
82767595|NCT00485758|Vitamins|vitamins|mesh-ancestor
82767596|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
82767597|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767598|NCT02577341|Docetaxel|docetaxel|mesh-list
82767599|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
82767600|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767601|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
82767602|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
82767603|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
82767604|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767605|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82767606|NCT02577497|Fluticasone|fluticasone|mesh-list
82767607|NCT02577497|Beclomethasone|beclomethasone|mesh-list
82767608|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767609|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82767610|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
82767611|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767612|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767613|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82767614|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
82767615|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
82767616|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82767617|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
82767619|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767620|NCT02575859|Cisplatin|cisplatin|mesh-list
82767621|NCT02575859|Mitomycins|mitomycins|mesh-list
82767622|NCT02575859|Mitomycin|mitomycin|mesh-list
82767623|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767624|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82767625|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
82767626|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767627|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82767628|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767629|NCT03850444|Paclitaxel|paclitaxel|mesh-list
82767630|NCT03850444|Carboplatin|carboplatin|mesh-list
82767631|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
82767632|NCT03850444|Pemetrexed|pemetrexed|mesh-list
82767633|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82767634|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767635|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
82767636|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
82767637|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
82767638|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767639|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82767640|NCT03850444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82767641|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767642|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82767643|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82767644|NCT00469456|Memantine|memantine|mesh-list
82767645|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82767646|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82767647|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
82767648|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767649|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767650|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767651|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82767652|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82767653|NCT00581555|Etanercept|etanercept|mesh-list
82767654|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82767655|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82767656|NCT00581555|Analgesics|analgesics|mesh-ancestor
82767657|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
82767658|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767659|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767660|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767661|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82767662|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82767663|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82767664|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
82767665|NCT00469144|Fludarabine|fludarabine|mesh-list
82767666|NCT00469144|Busulfan|busulfan|mesh-list
82767667|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767668|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767669|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82767670|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
82767671|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767672|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
82767673|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82767674|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82767675|NCT03987022|Acetaminophen|acetaminophen|mesh-list
82767676|NCT03987022|Ketorolac|ketorolac|mesh-list
82767677|NCT03987022|Oxycodone|oxycodone|mesh-list
82767678|NCT03987022|Hydromorphone|hydromorphone|mesh-list
82767679|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82767680|NCT03987022|Narcotics|narcotics|mesh-ancestor
82767681|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767682|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767683|NCT03987022|Analgesics|analgesics|mesh-ancestor
82767684|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
82767685|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767686|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82767687|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82767688|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767689|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82767690|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82767691|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767692|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767693|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
82767694|NCT01025128|Vitamin D|vitamin d|mesh-list
82767695|NCT01025128|Vitamins|vitamins|mesh-ancestor
82767696|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
82767697|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767698|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82767699|NCT00468910|Aspirin|aspirin|mesh-list
82767700|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82767701|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82767702|NCT00468910|Analgesics|analgesics|mesh-ancestor
82767703|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
82767704|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767705|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767706|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767707|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82767708|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82767709|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82767710|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767711|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82767712|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82767713|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767714|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
82767715|NCT01412333|Interferons|interferons|mesh-list
82767716|NCT01412333|Interferon-beta|interferon-beta|mesh-list
82767717|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
82767718|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
82767719|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767720|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
82767721|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82767722|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
82767723|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767724|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82767725|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
82767726|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82767727|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82767728|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82767729|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82767730|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767731|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
82767732|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767733|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767734|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82767735|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767736|NCT00519285|Prednisone|prednisone|mesh-list
82767737|NCT00519285|Prednisolone|prednisolone|mesh-list
82767738|NCT00519285|Docetaxel|docetaxel|mesh-list
82767739|NCT00519285|Aflibercept|aflibercept|mesh-list
82767740|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767741|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
82767742|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
82767743|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
82767744|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767745|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767746|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
82767747|NCT00519285|Hormones|hormones|mesh-ancestor
82767748|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767749|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767750|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82767751|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82767752|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82767753|NCT00519285|Growth Substances|growth substances|mesh-ancestor
82767754|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
82767755|NCT00464620|Dasatinib|dasatinib|mesh-list
82767756|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767757|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82767758|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767759|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767760|NCT05212857|Leuprolide|leuprolide|mesh-list
82767761|NCT05212857|Goserelin|goserelin|mesh-list
82767762|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82767763|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
82767764|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82767765|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
82767766|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82767767|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767768|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82767769|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767770|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82767771|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767772|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767773|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
82767774|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767775|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82767776|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
82767777|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82767778|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
82767779|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82767780|NCT02099123|Atorvastatin|atorvastatin|mesh-list
82767781|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82767782|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82767783|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
82767784|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767785|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82767786|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82767787|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767788|NCT00464542|Metronidazole|metronidazole|mesh-list
82767789|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82767790|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82767791|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82767792|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82767793|NCT02578823|Antipyretics|antipyretics|mesh-list
82767794|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767795|NCT01969643|Trastuzumab|trastuzumab|mesh-list
82767796|NCT01969643|SGN-LIV1A|sgn-liv1a|mesh-list
82767797|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82767798|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767799|NCT01969643|Immunoconjugates|immunoconjugates|mesh-ancestor
82767800|NCT01969643|Immunologic Factors|immunologic factors|mesh-ancestor
82767801|NCT01969643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767802|NCT00464308|Esomeprazole|esomeprazole|mesh-list
82767803|NCT00464308|Rabeprazole|rabeprazole|mesh-list
82767804|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82767805|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82767806|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82767807|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768331|NCT02573597|Bupivacaine|bupivacaine|mesh-list
82767808|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767809|NCT00463840|Fluorouracil|fluorouracil|mesh-list
82767810|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
82767811|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
82767812|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767813|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82767814|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767815|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82767816|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
82767817|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767818|NCT00129389|Paclitaxel|paclitaxel|mesh-list
82767819|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
82767820|NCT00129389|Doxorubicin|doxorubicin|mesh-list
82767821|NCT00129389|Fluorouracil|fluorouracil|mesh-list
82767822|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82767823|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767824|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
82767825|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
82767826|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
82767827|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767828|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82767829|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
82767830|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767831|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82767832|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82767833|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
82767834|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82767835|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82767836|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82767837|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82767838|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767839|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
82767840|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82767841|NCT00468052|Fentanyl|fentanyl|mesh-list
82767842|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
82767843|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82767844|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767845|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767846|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82767847|NCT00468052|Analgesics|analgesics|mesh-ancestor
82767848|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
82767849|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767850|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82767851|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82767852|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82767853|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
82767854|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767855|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767856|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82767857|NCT00468052|Narcotics|narcotics|mesh-ancestor
82767858|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82767859|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82767860|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
82767861|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
82767862|NCT00453310|Sunitinib|sunitinib|mesh-list
82767863|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767864|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82767865|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82767866|NCT00453310|Growth Substances|growth substances|mesh-ancestor
82767867|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767868|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
82767869|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82767870|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767871|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767872|NCT00128843|Anastrozole|anastrozole|mesh-list
82767873|NCT00128843|Exemestane|exemestane|mesh-list
82767874|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82767875|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767876|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82767877|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82767878|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767879|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767880|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82767881|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
82767957|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767882|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767883|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767884|NCT04073927|Butyric Acid|butyric acid|mesh-list
82767885|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
82767886|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
82767887|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767888|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767889|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767890|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82767891|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767892|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82767893|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767894|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767895|NCT02578277|BMS-955176|bms-955176|mesh-list
82767896|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82767897|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82767898|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
82767899|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82767900|NCT00555906|Dexamethasone|dexamethasone|mesh-list
82767901|NCT00555906|Bortezomib|bortezomib|mesh-list
82767902|NCT00555906|Palbociclib|palbociclib|mesh-list
82767903|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82767904|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
82767905|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
82767906|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767907|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767908|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82767909|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
82767910|NCT00555906|Hormones|hormones|mesh-ancestor
82767911|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82767912|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82767913|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767914|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82767915|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767916|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767917|NCT04071353|Interferons|interferons|mesh-list
82767918|NCT04071353|Ribavirin|ribavirin|mesh-list
82767919|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767920|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
82767921|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82767922|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
82767923|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767924|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
82767925|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82767926|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767927|NCT00555672|Fluorouracil|fluorouracil|mesh-list
82767928|NCT00555672|Sunitinib|sunitinib|mesh-list
82767929|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767930|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
82767931|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767932|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82767933|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82767934|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
82767935|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767936|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82767937|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82767938|NCT00555672|Growth Substances|growth substances|mesh-ancestor
82767939|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
82767940|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82767941|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767942|NCT02575547|Docetaxel|docetaxel|mesh-list
82767943|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767944|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
82767945|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
82767946|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
82767947|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767948|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
82767949|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
82767950|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82767951|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767952|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82767953|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
82767954|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
82767955|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82767956|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82767958|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767959|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82767961|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82767962|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82767963|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82767964|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767965|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82767966|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82767967|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82767968|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82767969|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
82767970|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
82767971|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
82767972|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
82767973|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82767974|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767975|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
82767976|NCT03958656|Fludarabine|fludarabine|mesh-list
82767977|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82767978|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
82767979|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767980|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82767981|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82767982|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
82767983|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767984|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767985|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82767986|NCT00561912|Interferons|interferons|mesh-list
82767987|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
82767988|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
82767989|NCT00561912|Decitabine|decitabine|mesh-list
82767990|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82767991|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
82767992|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82767993|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
82767994|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82767995|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82767996|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
82767997|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82767998|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82767999|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
82768000|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82768001|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82768002|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768003|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82768004|NCT00561678|Analgesics|analgesics|mesh-ancestor
82768005|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
82768006|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768007|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82768008|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82768009|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82768010|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
82768011|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768012|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768013|NCT00946608|Loratadine|loratadine|mesh-list
82768014|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
82768015|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
82768016|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82768017|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82768018|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82768019|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
82768020|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
82768021|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768022|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768023|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768024|NCT00463684|Vaccines|vaccines|mesh-list
82768025|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
82768026|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768027|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
82768028|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82768029|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
82768030|NCT00463606|Calcium|calcium|mesh-list
82768031|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82768032|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768256|NCT00463060|Growth Substances|growth substances|mesh-ancestor
82768033|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82768034|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82768035|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82768036|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
82768037|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768038|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82768039|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82768040|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768041|NCT03961308|Vedolizumab|vedolizumab|mesh-list
82768042|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82768043|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82768044|NCT00956436|Sorafenib|sorafenib|mesh-list
82768045|NCT00956436|Liver Extracts|liver extracts|mesh-list
82768046|NCT00956436|Antibodies|antibodies|mesh-list
82768047|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
82768048|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82768049|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
82768050|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768051|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768052|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82768053|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768054|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768055|NCT00956436|Hematinics|hematinics|mesh-ancestor
82768056|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
82768057|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
82768058|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
82768059|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82768060|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82768061|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768062|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768063|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768064|NCT00467896|Iloprost|iloprost|mesh-list
82768065|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82768066|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
82768067|NCT00946686|Leflunomide|leflunomide|mesh-list
82768068|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768069|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768070|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82768071|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
82768072|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768073|NCT02531737|Docetaxel|docetaxel|mesh-list
82768074|NCT02531737|Nintedanib|nintedanib|mesh-list
82768075|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768076|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
82768077|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
82768078|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
82768079|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768080|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82768081|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768082|NCT01326559|Docetaxel|docetaxel|mesh-list
82768083|NCT01326559|Cetuximab|cetuximab|mesh-list
82768084|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768085|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
82768086|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
82768087|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
82768088|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768089|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82768090|NCT04069949|Sorafenib|sorafenib|mesh-list
82768091|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768092|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82768093|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768094|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768095|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
82768096|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82768097|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768098|NCT00467740|Olodaterol|olodaterol|mesh-list
82768099|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82768100|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
82768101|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768102|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768103|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82768104|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
82768105|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
82768106|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
82768107|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82768108|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82768109|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768110|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768111|NCT00710099|Urological Agents|urological agents|mesh-ancestor
82768112|NCT03944044|Acetaminophen|acetaminophen|mesh-list
82768113|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82768114|NCT03944044|Analgesics|analgesics|mesh-ancestor
82768115|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
82768116|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768117|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768118|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
82768119|NCT00714623|Sirolimus|sirolimus|mesh-list
82768120|NCT00714623|Temsirolimus|temsirolimus|mesh-list
82768121|NCT00714623|MTOR Inhibitors|mtor inhibitors|mesh-list
82768122|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82768123|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768124|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82768125|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768126|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
82768127|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82768128|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
82768129|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768130|NCT00714623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82768131|NCT00714623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768132|NCT00714623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768133|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
82768134|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82768135|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82768136|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
82768137|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768138|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82768139|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82768140|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768141|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768142|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
82768143|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82768144|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82768145|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82768146|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82768147|NCT01021930|Sirolimus|sirolimus|mesh-list
82768148|NCT01021930|Paclitaxel|paclitaxel|mesh-list
82768149|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82768150|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768151|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
82768152|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
82768153|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
82768154|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768155|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82768156|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768157|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82768158|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
82768159|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82768160|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
82768161|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768162|NCT00946764|Imipramine|imipramine|mesh-list
82768163|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82768164|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
82768165|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82768166|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82768167|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82768168|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82768169|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768170|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
82768171|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768172|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768173|NCT00950820|Capecitabine|capecitabine|mesh-list
82768174|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
82768175|NCT00950820|Panitumumab|panitumumab|mesh-list
82768176|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82768177|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
82768178|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768179|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768180|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82768181|NCT00950898|Caffeine|caffeine|mesh-list
82768182|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82768183|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768184|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82768185|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768186|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768187|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82768188|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82768189|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
82768190|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768191|NCT00168805|Enoxaparin|enoxaparin|mesh-list
82768192|NCT00168805|Dabigatran|dabigatran|mesh-list
82768193|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
82768194|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82768195|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82768196|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768197|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
82768198|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82768199|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
82768200|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768201|NCT00467584|Aspirin|aspirin|mesh-list
82768202|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82768203|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82768204|NCT00467584|Analgesics|analgesics|mesh-ancestor
82768205|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
82768206|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768207|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768208|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82768209|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82768210|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82768211|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82768212|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768213|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82768214|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82768215|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768216|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
82768217|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
82768218|NCT02574611|Neostigmine|neostigmine|mesh-list
82768219|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82768220|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768221|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768222|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
82768223|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768224|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768225|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82768226|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
82768227|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768228|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82768229|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82768230|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82768231|NCT00714779|Fluoxetine|fluoxetine|mesh-list
82768232|NCT00714779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82768233|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82768234|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82768235|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768236|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768237|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
82768238|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768239|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82768240|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
82768241|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82768242|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82768243|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82768244|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768245|NCT00168103|Complement C1s|complement c1s|mesh-list
82768246|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
82768247|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
82768248|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
82768249|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768250|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82768251|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82768252|NCT00463060|Sunitinib|sunitinib|mesh-list
82768253|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768254|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82768255|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82768257|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768258|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
82768259|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82768260|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768261|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768262|NCT03964753|Paclitaxel|paclitaxel|mesh-list
82768263|NCT03964753|Cisplatin|cisplatin|mesh-list
82768264|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82768265|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768266|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
82768267|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
82768268|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
82768269|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768270|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
82768271|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
82768272|NCT00956748|Dexamethasone|dexamethasone|mesh-list
82768273|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82768274|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
82768275|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
82768276|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768277|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768278|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82768279|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
82768280|NCT00956748|Hormones|hormones|mesh-ancestor
82768281|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82768282|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82768283|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768284|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768285|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768286|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
82768287|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768288|NCT00956748|Expectorants|expectorants|mesh-ancestor
82768289|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
82768290|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82768291|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
82768292|NCT00956748|Protective Agents|protective agents|mesh-ancestor
82768293|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82768294|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82768295|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82768296|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82768297|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82768298|NCT01079923|Vitamin D|vitamin d|mesh-list
82768299|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
82768300|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
82768301|NCT01079923|Vitamins|vitamins|mesh-list
82768302|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
82768303|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768304|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82768305|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82768306|NCT00947076|Fluoxetine|fluoxetine|mesh-list
82768307|NCT00947076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82768308|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82768309|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82768310|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768311|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768312|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
82768313|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768314|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82768315|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
82768316|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82768317|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82768318|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82768319|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768320|NCT00462982|Sunitinib|sunitinib|mesh-list
82768321|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768322|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82768323|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82768324|NCT00462982|Growth Substances|growth substances|mesh-ancestor
82768325|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768326|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
82768327|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82768328|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768329|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768330|NCT02573597|Sufentanil|sufentanil|mesh-list
82768332|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
82768333|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
82768334|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82768335|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768336|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
82768337|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768338|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82768339|NCT02573597|Narcotics|narcotics|mesh-ancestor
82768340|NCT02573597|Analgesics|analgesics|mesh-ancestor
82768341|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82768342|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82768343|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
82768344|NCT05300958|Deferoxamine|deferoxamine|mesh-list
82768345|NCT05300958|Siderophores|siderophores|mesh-ancestor
82768346|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82768347|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
82768348|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
82768349|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768350|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
82768351|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82768352|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
82768353|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768354|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
82768355|NCT04070729|Protective Agents|protective agents|mesh-ancestor
82768356|NCT00467272|Daptomycin|daptomycin|mesh-list
82768357|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82768358|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768359|NCT00956982|Interferons|interferons|mesh-list
82768360|NCT00956982|Ribavirin|ribavirin|mesh-list
82768361|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
82768362|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
82768363|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82768364|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768365|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
82768366|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768367|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
82768368|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768369|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
82768370|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768371|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
82768372|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82768373|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82768374|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768375|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82768376|NCT00714857|Analgesics|analgesics|mesh-ancestor
82768377|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
82768378|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768379|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82768380|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82768381|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82768382|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
82768383|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768384|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768385|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82768386|NCT00957060|Glimepiride|glimepiride|mesh-list
82768387|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82768388|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768389|NCT00957060|Incretins|incretins|mesh-ancestor
82768390|NCT00957060|Hormones|hormones|mesh-ancestor
82768391|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82768392|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82768393|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
82768394|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768395|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768396|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82768397|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82768398|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
82768399|NCT02573519|Acetylcholine|acetylcholine|mesh-list
82768400|NCT02573519|Donepezil|donepezil|mesh-list
82768401|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
82768402|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82768403|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768404|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768405|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
82768406|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768407|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768408|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
82768409|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
82768410|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82768411|NCT02572583|Oseltamivir|oseltamivir|mesh-list
82768412|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
82768413|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768414|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768415|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768416|NCT00951444|Carboplatin|carboplatin|mesh-list
82768417|NCT00951444|Gemcitabine|gemcitabine|mesh-list
82768418|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768419|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82768420|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
82768421|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768422|NCT00462826|Aflibercept|aflibercept|mesh-list
82768423|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
82768424|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82768425|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82768426|NCT00462826|Growth Substances|growth substances|mesh-ancestor
82768427|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768428|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
82768429|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768431|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
82768432|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768433|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768434|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82768435|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82768436|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
82768437|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82768438|NCT00947388|Antibodies|antibodies|mesh-list
82768439|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
82768440|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82768441|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
82768442|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768443|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768444|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82768445|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
82768446|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768447|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
82768448|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
82768449|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82768450|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82768451|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82768452|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768453|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82768454|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82768455|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
82768456|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82768457|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
82768458|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768459|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768460|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82768461|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
82768462|NCT00957216|Ubiquinone|ubiquinone|mesh-list
82768463|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
82768464|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
82768465|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768466|NCT00957216|Vitamins|vitamins|mesh-ancestor
82768467|NCT00718757|Dexamethasone|dexamethasone|mesh-list
82768468|NCT00718757|Irinotecan|irinotecan|mesh-list
82768469|NCT00718757|Vincristine|vincristine|mesh-list
82768470|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82768471|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
82768472|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
82768473|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768474|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768475|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82768476|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
82768477|NCT00718757|Hormones|hormones|mesh-ancestor
82768478|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82768479|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82768480|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768481|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82768482|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82768483|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768484|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768485|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82768486|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
82768487|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
82768488|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
82768489|NCT00947466|Buprenorphine|buprenorphine|mesh-list
82768490|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82768491|NCT00947466|Narcotics|narcotics|mesh-ancestor
82768492|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82768493|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768494|NCT00947466|Analgesics|analgesics|mesh-ancestor
82768495|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
82768496|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768497|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82768498|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82768499|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
82768500|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768501|NCT00951834|Protective Agents|protective agents|mesh-ancestor
82768502|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768503|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82768504|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82768505|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768506|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82768507|NCT00715013|Epothilone B|epothilone b|mesh-list
82768508|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768509|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
82768510|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
82768511|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
82768512|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768513|NCT00715091|Diclofenac|diclofenac|mesh-list
82768514|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82768515|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82768516|NCT00715091|Analgesics|analgesics|mesh-ancestor
82768517|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
82768518|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768519|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768520|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82768521|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82768522|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82768523|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768524|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768525|NCT00718913|Docetaxel|docetaxel|mesh-list
82768526|NCT00718913|Capecitabine|capecitabine|mesh-list
82768527|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768528|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
82768529|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
82768530|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
82768531|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768532|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82768533|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
82768534|NCT04011930|Vitamin D|vitamin d|mesh-list
82768535|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
82768536|NCT04011930|Calcitriol|calcitriol|mesh-list
82768537|NCT04011930|Vitamins|vitamins|mesh-ancestor
82768538|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
82768539|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768540|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82768541|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82768542|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82768543|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82768544|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768545|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82768546|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
82768547|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82768548|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
82768549|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82768550|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768551|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82768552|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82768553|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82768554|NCT02574221|Fluorides|fluorides|mesh-list
82768555|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
82768556|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
82768557|NCT02574221|Protective Agents|protective agents|mesh-ancestor
82768558|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768560|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
82768561|NCT00452530|Apixaban|apixaban|mesh-list
82768562|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
82768563|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82768564|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82768565|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768566|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82768567|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
82768568|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82768569|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
82768570|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768571|NCT00549198|Tenofovir|tenofovir|mesh-list
82768572|NCT00549198|Lamivudine|lamivudine|mesh-list
82768573|NCT00549198|Emtricitabine|emtricitabine|mesh-list
82768574|NCT00549198|Efavirenz|efavirenz|mesh-list
82768575|NCT00549198|Abacavir|abacavir|mesh-list
82768576|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
82768577|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768578|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82768579|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82768580|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768581|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768582|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82768583|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82768584|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82768585|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82768586|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82768587|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82768588|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82768589|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82768590|NCT00506415|Rivastigmine|rivastigmine|mesh-list
82768591|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82768592|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768593|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768594|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
82768595|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768596|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768597|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82768598|NCT00506415|Protective Agents|protective agents|mesh-ancestor
82768600|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
82768601|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768602|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82768603|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
82768604|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768605|NCT01009437|Ritonavir|ritonavir|mesh-list
82768606|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82768607|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82768608|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
82768609|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768610|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768611|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82768612|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82768613|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
82768614|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768615|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82768616|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82768617|NCT00719381|Pioglitazone|pioglitazone|mesh-list
82768618|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82768619|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768620|NCT00510783|Phenytoin|phenytoin|mesh-list
82768621|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
82768622|NCT00510783|Levetiracetam|levetiracetam|mesh-list
82768623|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
82768624|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
82768625|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82768626|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82768627|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82768628|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768629|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82768630|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82768631|NCT00952302|Iron|iron|mesh-list
82768632|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82768633|NCT00952302|Trace Elements|trace elements|mesh-ancestor
82768634|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
82768635|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768636|NCT00952302|Hematinics|hematinics|mesh-ancestor
82768637|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82768638|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
82768639|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82768640|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82768641|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82768642|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82768643|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768645|NCT05300334|Analgesics|analgesics|mesh-ancestor
82768646|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
82768647|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768648|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768649|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82768650|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
82768651|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82768652|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
82768653|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
82768654|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768655|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768656|NCT00897884|Metformin|metformin|mesh-list
82768657|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82768658|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768659|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82768660|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
82768661|NCT01022164|Coagulants|coagulants|mesh-ancestor
82768662|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82768663|NCT01012479|Candesartan|candesartan|mesh-list
82768664|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
82768665|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82768666|NCT01012479|Diuretics|diuretics|mesh-ancestor
82768667|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
82768668|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768669|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82768670|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82768671|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768672|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82768673|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82768674|NCT02541734|Exenatide|exenatide|mesh-list
82768675|NCT02541734|Polygeline|polygeline|mesh-list
82768676|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82768677|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768678|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82768679|NCT02541734|Incretins|incretins|mesh-ancestor
82768680|NCT02541734|Hormones|hormones|mesh-ancestor
82768681|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82768682|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
82768683|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
82768684|NCT00462670|Tolvaptan|tolvaptan|mesh-list
82768685|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82768686|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768687|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
82768688|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768690|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768691|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82768692|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768693|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768694|NCT00719459|Iron|iron|mesh-list
82768695|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82768696|NCT00719459|Trace Elements|trace elements|mesh-ancestor
82768697|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
82768698|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768699|NCT00719459|Hematinics|hematinics|mesh-ancestor
82768700|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82768701|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82768702|NCT00948168|Exenatide|exenatide|mesh-list
82768703|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82768704|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768705|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82768706|NCT00948168|Incretins|incretins|mesh-ancestor
82768707|NCT00948168|Hormones|hormones|mesh-ancestor
82768708|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82768709|NCT00958386|Irinotecan|irinotecan|mesh-list
82768710|NCT00958386|Panitumumab|panitumumab|mesh-list
82768711|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82768712|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82768713|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768714|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768715|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768716|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82768717|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
82768718|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82768719|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
82768720|NCT00719693|Fenofibrate|fenofibrate|mesh-list
82768721|NCT00719693|Calcium|calcium|mesh-list
82768722|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82768723|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768724|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82768725|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82768726|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82768727|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
82768728|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768729|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82768730|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82768731|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768732|NCT00948402|Metformin|metformin|mesh-list
82768733|NCT00948402|Biguanides|biguanides|mesh-list
82768734|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
82768735|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
82768736|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82768737|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768738|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82768739|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82768741|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768742|NCT00948480|Sargramostim|sargramostim|mesh-list
82768743|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
82768744|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768745|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
82768746|NCT03753555|Atorvastatin|atorvastatin|mesh-list
82768747|NCT03753555|Probucol|probucol|mesh-list
82768748|NCT03753555|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
82768749|NCT03753555|Calcium|calcium|mesh-list
82768750|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82768751|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768752|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82768753|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82768754|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82768755|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
82768756|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768757|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82768758|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82768759|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768760|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
82768761|NCT03753555|Protective Agents|protective agents|mesh-ancestor
82768762|NCT03753555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82768763|NCT03753555|Protease Inhibitors|protease inhibitors|mesh-ancestor
82768764|NCT00606086|Interferons|interferons|mesh-list
82768765|NCT00606086|Ribavirin|ribavirin|mesh-list
82768766|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82768767|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
82768768|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768769|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
82768770|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768771|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
82768772|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768773|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
82768774|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768775|NCT02573363|Cytarabine|cytarabine|mesh-list
82768776|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
82768777|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82768778|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
82768779|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768780|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768781|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
82768782|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768783|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82768784|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
82768785|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768786|NCT02573363|Analgesics|analgesics|mesh-ancestor
82768787|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
82768788|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768789|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82768790|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82768791|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768792|NCT00715637|Cytarabine|cytarabine|mesh-list
82768793|NCT00715637|Amonafide|amonafide|mesh-list
82768794|NCT00715637|Daunorubicin|daunorubicin|mesh-list
82768795|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82768796|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
82768797|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768798|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768799|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
82768800|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768801|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82768802|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
82768803|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768804|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82768805|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82768806|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82768807|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768808|NCT05300490|Prednisolone|prednisolone|mesh-list
82768809|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82768810|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
82768811|NCT05300490|Hormones|hormones|mesh-ancestor
82768812|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82768813|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768814|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82768815|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768816|NCT00893594|Naproxen|naproxen|mesh-list
82768817|NCT00893594|Sumatriptan|sumatriptan|mesh-list
82768818|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82768819|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82768820|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82768821|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
82768822|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768823|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768824|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768825|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82768826|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82768827|NCT00893594|Analgesics|analgesics|mesh-ancestor
82768828|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
82768829|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768830|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82768831|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82768832|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
82768833|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82768834|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768835|NCT00715715|Prednisone|prednisone|mesh-list
82768836|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82768837|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
82768838|NCT00715715|Hormones|hormones|mesh-ancestor
82768839|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82768840|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768841|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82768842|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768843|NCT00953394|Octreotide|octreotide|mesh-list
82768844|NCT00953394|Fluorouracil|fluorouracil|mesh-list
82768845|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82768846|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82768847|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768848|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
82768849|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768850|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82768851|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82768852|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
82768853|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768854|NCT00720161|Metformin|metformin|mesh-list
82768855|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82768856|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768857|NCT00898508|Antibodies|antibodies|mesh-list
82768858|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
82768859|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768860|NCT00609986|Insulin|insulin|mesh-list
82768861|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82768862|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
82768863|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
82768864|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
82768865|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
82768866|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82768867|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768868|NCT00715871|Nicotine|nicotine|mesh-list
82768869|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82768870|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
82768871|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768872|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768873|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82768874|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82768875|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
82768876|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768877|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768878|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
82768879|NCT00712049|Niacin|niacin|mesh-list
82768880|NCT00712049|Niacinamide|niacinamide|mesh-list
82768881|NCT00712049|Simvastatin|simvastatin|mesh-list
82768882|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82768883|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82768884|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
82768885|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768886|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82768887|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82768888|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768889|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
82768890|NCT00712049|Vitamins|vitamins|mesh-ancestor
82768891|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
82768892|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768893|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
82768894|NCT00712205|Calcitriol|calcitriol|mesh-list
82768895|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82768896|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768897|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82768898|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82768899|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768900|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82768901|NCT00712205|Vitamins|vitamins|mesh-ancestor
82768902|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
82768903|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82768904|NCT00451906|Bevacizumab|bevacizumab|mesh-list
82768905|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82768906|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768907|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82768908|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82768909|NCT00451906|Growth Substances|growth substances|mesh-ancestor
82768910|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768911|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
82768912|NCT04070495|Clarithromycin|clarithromycin|mesh-list
82768914|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82768915|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768916|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82768917|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768918|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768919|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82768920|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82768921|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82768922|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
82768923|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
82768924|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82768925|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82768926|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82768927|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82768928|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82768929|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82768930|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82768931|NCT00712439|Gabapentin|gabapentin|mesh-list
82768932|NCT00712439|Analgesics|analgesics|mesh-ancestor
82768933|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
82768934|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82768935|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768936|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
82768937|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82768938|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82768939|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82768940|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82768941|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82768942|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82768943|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82768944|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768945|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
82768946|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82768947|NCT00716183|Amoxicillin|amoxicillin|mesh-list
82768948|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
82768949|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
82768950|NCT00716183|Lactams|lactams|mesh-list
82768951|NCT00716183|beta-Lactams|beta-lactams|mesh-list
82768952|NCT00716183|Cloxacillin|cloxacillin|mesh-list
82768953|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82768954|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768955|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768956|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82768957|NCT00712517|Propofol|propofol|mesh-list
82768958|NCT00712517|Sevoflurane|sevoflurane|mesh-list
82768959|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82768960|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82768961|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768962|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82768963|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
82768964|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
82768965|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82768966|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82768967|NCT00712595|Mifepristone|mifepristone|mesh-list
82768968|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82768969|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
82768970|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82768971|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768972|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82768973|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82768974|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82768975|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
82768976|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82768977|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82768978|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
82768979|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82768980|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
82768981|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82768982|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82768983|NCT00115765|Bevacizumab|bevacizumab|mesh-list
82768984|NCT00115765|Panitumumab|panitumumab|mesh-list
82768985|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
82768986|NCT00115765|Irinotecan|irinotecan|mesh-list
82768987|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82768988|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82768989|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82768990|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82768991|NCT00115765|Growth Substances|growth substances|mesh-ancestor
82768992|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82768993|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
82768994|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82768995|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82768996|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82768997|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82768998|NCT00606008|Sunitinib|sunitinib|mesh-list
82768999|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769000|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82769001|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82769002|NCT00606008|Growth Substances|growth substances|mesh-ancestor
82769003|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769004|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
82769005|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769006|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769007|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769008|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
82769009|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769010|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
82769011|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82769012|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
82769013|NCT00721331|Loratadine|loratadine|mesh-list
82769014|NCT00721331|Nortriptyline|nortriptyline|mesh-list
82769090|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
82769015|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769016|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
82769017|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82769018|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
82769019|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82769020|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82769021|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
82769022|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
82769023|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769024|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769025|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769026|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82769027|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
82769028|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82769029|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82769030|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82769031|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82769032|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
82769033|NCT00123955|Spironolactone|spironolactone|mesh-list
82769034|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82769035|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
82769036|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82769037|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769038|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82769039|NCT00123955|Diuretics|diuretics|mesh-ancestor
82769040|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
82769041|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
82769042|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82769043|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82769044|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769045|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
82769046|NCT01027546|Coagulants|coagulants|mesh-ancestor
82769047|NCT00115063|Orlistat|orlistat|mesh-list
82769048|NCT00115063|Sibutramine|sibutramine|mesh-list
82769049|NCT00115063|Diethylpropion|diethylpropion|mesh-list
82769050|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769051|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769052|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82769053|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82769054|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
82769055|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82769056|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
82769057|NCT01026064|Azithromycin|azithromycin|mesh-list
82769058|NCT01026064|Cantharidin|cantharidin|mesh-list
82769059|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82769060|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769061|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769062|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769063|NCT02571959|Amoxicillin|amoxicillin|mesh-list
82769064|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
82769065|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
82769066|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82769067|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769068|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769069|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769070|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82769071|NCT00461500|Fluticasone|fluticasone|mesh-list
82769072|NCT00461500|Xhance|xhance|mesh-list
82769073|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82769074|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769075|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82769076|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
82769077|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769078|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769079|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82769080|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
82769081|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
82769082|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82769083|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82769084|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82769085|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82769086|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
82769087|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769088|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769089|NCT00893906|Vaccines|vaccines|mesh-list
82769091|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769093|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
82769094|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769095|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82769096|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82769097|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769098|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769099|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82769100|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
82769101|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82769102|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769103|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82769104|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82769105|NCT00167245|Topiramate|topiramate|mesh-list
82769106|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
82769107|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82769108|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769109|NCT00894062|Everolimus|everolimus|mesh-list
82769110|NCT00894062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82769111|NCT00894062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769112|NCT00894062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769113|NCT00894062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769114|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82769115|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
82769116|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769117|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769118|NCT00443560|Fentanyl|fentanyl|mesh-list
82769119|NCT00443560|Bupivacaine|bupivacaine|mesh-list
82769120|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
82769121|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
82769122|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82769123|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769124|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
82769125|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769126|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82769127|NCT00443560|Narcotics|narcotics|mesh-ancestor
82769128|NCT00443560|Analgesics|analgesics|mesh-ancestor
82769129|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82769130|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82769131|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
82769132|NCT01022632|Curcumin|curcumin|mesh-list
82769133|NCT01022632|Fluoxetine|fluoxetine|mesh-list
82769134|NCT01022632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82769135|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82769136|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82769137|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769138|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769139|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
82769140|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769141|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82769142|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
82769143|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82769144|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82769145|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82769146|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769147|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82769148|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82769149|NCT01022632|Analgesics|analgesics|mesh-ancestor
82769150|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
82769151|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769152|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769153|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82769154|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769156|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82769157|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
82769158|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769159|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769160|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769161|NCT00716573|Everolimus|everolimus|mesh-list
82769162|NCT00716573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82769163|NCT00716573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769164|NCT00716573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769165|NCT00716573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769166|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82769167|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
82769168|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769169|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769170|NCT02539706|Rocuronium|rocuronium|mesh-list
82769171|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82769172|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82769173|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82769174|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769175|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769176|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
82769177|NCT00451204|Estrogens|estrogens|mesh-list
82769178|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
82769179|NCT00451204|Hormones|hormones|mesh-ancestor
82769180|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82769181|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769182|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82769183|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
82769184|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82769185|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82769186|NCT00721877|Resveratrol|resveratrol|mesh-list
82769187|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
82769188|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769189|NCT00721877|Protective Agents|protective agents|mesh-ancestor
82769190|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769191|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769192|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82769193|NCT03537586|Adenosine|adenosine|mesh-list
82769194|NCT03537586|Heparin|heparin|mesh-list
82769195|NCT03537586|Bivalirudin|bivalirudin|mesh-list
82769196|NCT03537586|Anticoagulants|anticoagulants|mesh-ancestor
82769197|NCT03537586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82769198|NCT03537586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82769199|NCT03537586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769200|NCT03537586|Analgesics|analgesics|mesh-ancestor
82769201|NCT03537586|Sensory System Agents|sensory system agents|mesh-ancestor
82769202|NCT03537586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769203|NCT03537586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769204|NCT03537586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82769205|NCT03537586|Vasodilator Agents|vasodilator agents|mesh-ancestor
82769206|NCT03537586|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82769207|NCT03537586|Purinergic Agonists|purinergic agonists|mesh-ancestor
82769208|NCT03537586|Purinergic Agents|purinergic agents|mesh-ancestor
82769209|NCT03537586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769210|NCT03537586|Antithrombins|antithrombins|mesh-ancestor
82769211|NCT03537586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82769212|NCT03537586|Protease Inhibitors|protease inhibitors|mesh-ancestor
82769213|NCT03537586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769214|NCT00722033|Indomethacin|indomethacin|mesh-list
82769215|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82769216|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82769217|NCT00722033|Analgesics|analgesics|mesh-ancestor
82769218|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
82769219|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769220|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769221|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769222|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82769223|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
82769224|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
82769225|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82769226|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82769227|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769228|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769229|NCT00894374|Artesunate|artesunate|mesh-list
82769230|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
82769231|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82769232|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82769233|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769234|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769235|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
82769236|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
82769237|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82769238|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
82769239|NCT04920149|Mesalamine|mesalamine|mesh-list
82769240|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82769241|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82769242|NCT04920149|Analgesics|analgesics|mesh-ancestor
82769243|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
82769244|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769245|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769246|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769247|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82769248|NCT01026610|Entecavir|entecavir|mesh-list
82769249|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
82769250|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769251|NCT00901550|Infliximab|infliximab|mesh-list
82769252|NCT00901550|Methotrexate|methotrexate|mesh-list
82769253|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82769254|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
82769255|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82769256|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769257|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82769258|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
82769259|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769260|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769261|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
82769262|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769263|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82769264|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82769265|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
82769266|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82769267|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82769268|NCT00901550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82769269|NCT00901550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769270|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82769271|NCT02573051|Isosorbide|isosorbide|mesh-list
82769272|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
82769273|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
82769274|NCT02573051|Misoprostol|misoprostol|mesh-list
82769275|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82769276|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
82769277|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82769278|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769279|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82769280|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82769281|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
82769282|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82769283|NCT02573051|Diuretics|diuretics|mesh-ancestor
82769284|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
82769285|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
82769286|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82769287|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769288|NCT02539940|Paclitaxel|paclitaxel|mesh-list
82769289|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82769290|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769291|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
82769292|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
82769293|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
82769294|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769295|NCT01028092|Cyclosporine|cyclosporine|mesh-list
82769296|NCT01028092|Everolimus|everolimus|mesh-list
82769297|NCT01028092|Interleukin-2|interleukin-2|mesh-list
82769298|NCT01028092|Cyclosporins|cyclosporins|mesh-list
82769299|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
82769300|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769301|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769302|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82769303|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
82769304|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769305|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
82769306|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769307|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
82769308|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82769309|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82769310|NCT01028092|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82769311|NCT01028092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769312|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769313|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82769314|NCT01028092|Analgesics|analgesics|mesh-ancestor
82769315|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
82769316|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769317|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
82769318|NCT00605306|Maleic acid|maleic acid|mesh-list
82769319|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769320|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769321|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769322|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
82769323|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82769324|NCT00905918|Vitamin E|vitamin e|mesh-list
82769325|NCT00905918|Vitamins|vitamins|mesh-ancestor
82769326|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
82769327|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769328|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
82769329|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769330|NCT00905918|Protective Agents|protective agents|mesh-ancestor
82769331|NCT00894608|Letrozole|letrozole|mesh-list
82769332|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769333|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82769334|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82769335|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769336|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769337|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82769338|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
82769339|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82769340|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769341|NCT00901784|Topiramate|topiramate|mesh-list
82769342|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
82769343|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82769344|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769345|NCT00905996|Propranolol|propranolol|mesh-list
82769346|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82769347|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82769348|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
82769349|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769350|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769351|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769352|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82769353|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82769354|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
82769355|NCT02539628|Ropivacaine|ropivacaine|mesh-list
82769356|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
82769357|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
82769358|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82769359|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769360|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
82769361|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769362|NCT02573987|Lidocaine|lidocaine|mesh-list
82769363|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
82769364|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
82769365|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
82769366|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82769367|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769368|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
82769369|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769370|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82769371|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82769372|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82769373|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82769374|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769375|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82769376|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
82769377|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82769378|NCT02573987|Analgesics|analgesics|mesh-ancestor
82769379|NCT00906386|Varenicline|varenicline|mesh-list
82769380|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82769381|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82769382|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
82769383|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769384|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769385|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769386|NCT00722579|Cobalt|cobalt|mesh-list
82769387|NCT00722579|Chromium|chromium|mesh-list
82769388|NCT00722579|Trace Elements|trace elements|mesh-ancestor
82769389|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
82769390|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769391|NCT00713687|Gemcitabine|gemcitabine|mesh-list
82769392|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
82769393|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82769394|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
82769395|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769396|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769397|NCT02540876|Ilorasertib|ilorasertib|mesh-list
82769398|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769399|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769400|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769401|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769403|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
82769404|NCT00894920|Vitamins|vitamins|mesh-ancestor
82769405|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
82769406|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769407|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
82769408|NCT00722735|Finafloxacin|finafloxacin|mesh-list
82769409|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82769410|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769411|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82769412|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82769413|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769414|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769415|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769416|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82769417|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82769418|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82769419|NCT04067531|Clindamycin|clindamycin|mesh-list
82769420|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
82769421|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
82769422|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82769423|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769424|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82769425|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769426|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769427|NCT00713765|Donepezil|donepezil|mesh-list
82769428|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82769429|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769430|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769431|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
82769432|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769433|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769434|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
82769435|NCT00717587|Sunitinib|sunitinib|mesh-list
82769436|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
82769437|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769438|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82769439|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82769440|NCT00717587|Growth Substances|growth substances|mesh-ancestor
82769441|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769442|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
82769443|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769444|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769445|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769446|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82769447|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
82769448|NCT00894998|Heparin|heparin|mesh-list
82769449|NCT00894998|Calcium heparin|calcium heparin|mesh-list
82769450|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
82769451|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82769452|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82769453|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769454|NCT00713921|Fesoterodine|fesoterodine|mesh-list
82769455|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82769456|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82769457|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
82769458|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769459|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769460|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769461|NCT00713921|Urological Agents|urological agents|mesh-ancestor
82769462|NCT00713999|Praziquantel|praziquantel|mesh-list
82769463|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
82769464|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82769465|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769466|NCT04072601|Atorvastatin|atorvastatin|mesh-list
82769467|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82769468|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82769469|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
82769470|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769471|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82769472|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82769473|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769474|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
82769475|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
82769476|NCT00717821|Hematinics|hematinics|mesh-ancestor
82769477|NCT03476369|Fentanyl|fentanyl|mesh-list
82769478|NCT03476369|Ticagrelor|ticagrelor|mesh-list
82769479|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82769480|NCT03476369|Narcotics|narcotics|mesh-ancestor
82769481|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82769482|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769483|NCT03476369|Analgesics|analgesics|mesh-ancestor
82769484|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
82769485|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769486|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82769487|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82769488|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
82769489|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
82769490|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82769491|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82769492|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82769493|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82769494|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
82769495|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769496|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769497|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82769498|NCT00722969|Sorafenib|sorafenib|mesh-list
82769499|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769500|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769501|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769502|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769503|NCT04069325|Febuxostat|febuxostat|mesh-list
82769504|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
82769505|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82769506|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82769507|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
82769508|NCT00723047|Coagulants|coagulants|mesh-ancestor
82769509|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
82769510|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82769511|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
82769512|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769513|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82769514|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82769515|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
82769516|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769517|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769518|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82769519|NCT02571491|Ketamine|ketamine|mesh-list
82769520|NCT02571491|Morphine|morphine|mesh-list
82769521|NCT02571491|Remifentanil|remifentanil|mesh-list
82769522|NCT02571491|Analgesics|analgesics|mesh-ancestor
82769523|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
82769524|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769525|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769526|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82769527|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82769528|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
82769529|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
82769530|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82769531|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82769532|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82769533|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769534|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769535|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82769536|NCT02571491|Narcotics|narcotics|mesh-ancestor
82769537|NCT00723437|Acitretin|acitretin|mesh-list
82769538|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
82769539|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
82769540|NCT00723515|Listerine|listerine|mesh-list
82769541|NCT00723515|Calcium|calcium|mesh-list
82769542|NCT00723515|Fluorides|fluorides|mesh-list
82769543|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
82769544|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82769545|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769546|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
82769547|NCT00723515|Protective Agents|protective agents|mesh-ancestor
82769548|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82769549|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769551|NCT01028170|Diuretics|diuretics|mesh-ancestor
82769552|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
82769553|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769554|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82769555|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82769556|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769557|NCT00518115|Exenatide|exenatide|mesh-list
82769558|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
82769559|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82769560|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769561|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82769562|NCT00518115|Incretins|incretins|mesh-ancestor
82769563|NCT00518115|Hormones|hormones|mesh-ancestor
82769564|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82769565|NCT00723983|Sumatriptan|sumatriptan|mesh-list
82769566|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82769567|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82769568|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82769569|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
82769570|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769571|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769572|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769573|NCT00450658|Ibuprofen|ibuprofen|mesh-list
82769574|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82769575|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82769576|NCT00450658|Analgesics|analgesics|mesh-ancestor
82769577|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
82769578|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769579|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769580|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769581|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82769582|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82769583|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769584|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769585|NCT02572505|Tenofovir|tenofovir|mesh-list
82769586|NCT02572505|Emtricitabine|emtricitabine|mesh-list
82769587|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82769588|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
82769589|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769590|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82769591|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82769592|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769593|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769594|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82769595|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82769596|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
82769597|NCT00517881|Hematinics|hematinics|mesh-ancestor
82769598|NCT01010139|Codeine|codeine|mesh-list
82769599|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82769600|NCT01010139|Narcotics|narcotics|mesh-ancestor
82769601|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82769602|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769603|NCT01010139|Analgesics|analgesics|mesh-ancestor
82769604|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
82769605|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769606|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
82769607|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
82769608|NCT00724295|Ribavirin|ribavirin|mesh-list
82769609|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82769610|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
82769611|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769612|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
82769613|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769614|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
82769615|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82769616|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
82769617|NCT00517413|Hematinics|hematinics|mesh-ancestor
82769618|NCT00724529|Infliximab|infliximab|mesh-list
82769619|NCT00724529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82769620|NCT00724529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769621|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
82769622|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82769623|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82769625|NCT01012869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82769626|NCT01012869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769627|NCT01012869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769628|NCT01012869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769629|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82769630|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
82769631|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769632|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769633|NCT01010295|Doxycycline|doxycycline|mesh-list
82769634|NCT01010295|Tetracycline|tetracycline|mesh-list
82769635|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82769636|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769637|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
82769638|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82769639|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82769640|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82769641|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769642|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769643|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
82769644|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82769645|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
82769646|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769647|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769648|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82769649|NCT01010373|Protective Agents|protective agents|mesh-ancestor
82769650|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82769651|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82769652|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769653|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769654|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
82769655|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769656|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
82769657|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82769658|NCT01010451|Calcium|calcium|mesh-list
82769659|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82769660|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769661|NCT02570789|Sunitinib|sunitinib|mesh-list
82769662|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769663|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82769664|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82769665|NCT02570789|Growth Substances|growth substances|mesh-ancestor
82769666|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769667|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
82769668|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769669|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769670|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769671|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
82769672|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769673|NCT00450580|Ritonavir|ritonavir|mesh-list
82769674|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
82769675|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82769676|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82769677|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
82769678|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769679|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769680|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82769681|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82769682|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
82769683|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769684|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82769685|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82769686|NCT00724685|Ropivacaine|ropivacaine|mesh-list
82769687|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
82769688|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
82769689|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82769690|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769691|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
82769692|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769693|NCT00123487|Dasatinib|dasatinib|mesh-list
82769694|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769695|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769696|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769697|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769698|NCT00509925|Insulin|insulin|mesh-list
82769699|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82769700|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
82769701|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
82769702|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
82769703|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
82769704|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
82769705|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82769706|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769707|NCT05277974|Dexamethasone|dexamethasone|mesh-list
82769708|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769709|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
82769710|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
82769711|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769712|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769713|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82769714|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
82769715|NCT05277974|Hormones|hormones|mesh-ancestor
82769716|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82769717|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82769718|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769719|NCT00504777|Rituximab|rituximab|mesh-list
82769720|NCT00504777|Methotrexate|methotrexate|mesh-list
82769721|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82769722|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769723|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
82769724|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769725|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82769726|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82769727|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
82769728|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82769729|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82769730|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
82769731|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769732|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
82769733|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769734|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82769735|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82769736|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82769737|NCT03968263|Hydrocodone|hydrocodone|mesh-list
82769738|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82769739|NCT03968263|Narcotics|narcotics|mesh-ancestor
82769740|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82769741|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769742|NCT03968263|Analgesics|analgesics|mesh-ancestor
82769743|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
82769744|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769745|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
82769746|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
82769747|NCT00895076|Dexamethasone|dexamethasone|mesh-list
82769748|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769749|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
82769750|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
82769751|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769752|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769753|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82769754|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
82769755|NCT00895076|Hormones|hormones|mesh-ancestor
82769756|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82769757|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82769758|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769759|NCT01078519|Anesthetics|anesthetics|mesh-list
82769760|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
82769761|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82769762|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769763|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
82769764|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769765|NCT02539316|SMOFlipid|smoflipid|mesh-list
82769766|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82769767|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82769768|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82769769|NCT03968185|Analgesics|analgesics|mesh-list
82769770|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
82769771|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769772|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769773|NCT00509769|Trastuzumab|trastuzumab|mesh-list
82769774|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82769775|NCT00509769|Maytansine|maytansine|mesh-list
82769776|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82769777|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769778|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82769779|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
82769780|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
82769781|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
82769782|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769783|NCT00509769|Immunotoxins|immunotoxins|mesh-ancestor
82769784|NCT00509769|Immunoconjugates|immunoconjugates|mesh-ancestor
82769785|NCT00509769|Immunologic Factors|immunologic factors|mesh-ancestor
82769786|NCT00509769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769788|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82769789|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82769790|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769791|NCT02977715|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82769792|NCT02977715|Antiviral Agents|antiviral agents|mesh-ancestor
82769793|NCT02977715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769795|NCT01074697|Palonosetron|palonosetron|mesh-list
82769796|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
82769797|NCT01074697|Aprepitant|aprepitant|mesh-list
82769798|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769799|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
82769800|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
82769801|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769802|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769803|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82769804|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
82769805|NCT01074697|Hormones|hormones|mesh-ancestor
82769806|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82769807|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82769808|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769809|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769810|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82769811|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82769812|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
82769813|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769814|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82769815|NCT05124275|Pilocarpine|pilocarpine|mesh-list
82769816|NCT05124275|Miotics|miotics|mesh-ancestor
82769817|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
82769818|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769819|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769820|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82769821|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82769822|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
82769823|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769824|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769825|NCT01080079|Terbinafine|terbinafine|mesh-list
82769826|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
82769827|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769828|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769829|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769830|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
82769831|NCT00725231|Doxorubicin|doxorubicin|mesh-list
82769832|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82769833|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82769834|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769835|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82769836|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82769837|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82769838|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769839|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769840|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82769841|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82769842|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82769843|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82769844|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769845|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769846|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769847|NCT00114127|Analgesics|analgesics|mesh-ancestor
82769848|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
82769849|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769850|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
82769851|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82769852|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
82769853|NCT00902954|Letrozole|letrozole|mesh-list
82769854|NCT00902954|Anastrozole|anastrozole|mesh-list
82769855|NCT00902954|Exemestane|exemestane|mesh-list
82769856|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769857|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82769858|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82769859|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769860|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769861|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82769862|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
82769863|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82769864|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769865|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82769866|NCT02540720|Dexamethasone|dexamethasone|mesh-list
82769867|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
82769868|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82769869|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82769870|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82769871|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
82769872|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
82769873|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769874|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769875|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82769876|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
82769877|NCT02540720|Hormones|hormones|mesh-ancestor
82769878|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82769879|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82769880|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769881|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
82769882|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
82769883|NCT02540642|Vitamins|vitamins|mesh-ancestor
82769884|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
82769885|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769886|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
82769887|NCT00122317|Eculizumab|eculizumab|mesh-list
82769888|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82769889|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82769890|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
82769891|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769892|NCT00908336|Docetaxel|docetaxel|mesh-list
82769893|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82769894|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769895|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
82769896|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
82769897|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
82769898|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769899|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769900|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769901|NCT00908414|TMC-310911|tmc-310911|mesh-list
82769902|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
82769903|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769904|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769905|NCT01074853|Propranolol|propranolol|mesh-list
82769906|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82769907|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82769908|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
82769909|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769910|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769911|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769912|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82769913|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82769914|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
82769915|NCT00725777|Lumefantrine|lumefantrine|mesh-list
82769917|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82769918|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
82769919|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82769920|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82769921|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82769922|NCT00165841|Rabeprazole|rabeprazole|mesh-list
82769923|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82769924|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82769925|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82769926|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769927|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769928|NCT00907166|Gemcitabine|gemcitabine|mesh-list
82769929|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82769930|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
82769931|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769932|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769933|NCT04984811|Atezolizumab|atezolizumab|mesh-list
82769934|NCT04984811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82769935|NCT04984811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769936|NCT04984811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82769937|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769938|NCT00460798|Sunitinib|sunitinib|mesh-list
82769939|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769940|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82769941|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82769942|NCT00460798|Growth Substances|growth substances|mesh-ancestor
82769943|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769944|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
82769945|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82769946|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769947|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769948|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
82769949|NCT03513406|Neostigmine|neostigmine|mesh-list
82769950|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82769951|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82769952|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769953|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
82769954|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769955|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769956|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82769957|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
82769958|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769959|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82769961|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82769962|NCT00726869|Elotuzumab|elotuzumab|mesh-list
82769963|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769964|NCT01028248|Ranibizumab|ranibizumab|mesh-list
82769965|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82769966|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82769967|NCT01028248|Growth Substances|growth substances|mesh-ancestor
82769968|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769969|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
82769970|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82769971|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
82769972|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
82769973|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
82769974|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82769975|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769976|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
82769977|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82769978|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82769979|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82769980|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769981|NCT00603980|Alprazolam|alprazolam|mesh-list
82769982|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82769983|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82769984|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769985|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82769986|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82769987|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82769988|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
82769989|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
82769990|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82769991|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82769992|NCT01028404|Insulin|insulin|mesh-list
82769993|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82769994|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
82769995|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
82769996|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82769997|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82769998|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82769999|NCT00727103|Varenicline|varenicline|mesh-list
82770000|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82770001|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82770002|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
82770003|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770004|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770005|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770007|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
82770008|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82770009|NCT01028482|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82770010|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82770011|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82770012|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770013|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770014|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
82770015|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770016|NCT00903188|Cyclosporine|cyclosporine|mesh-list
82770017|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
82770018|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
82770019|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82770020|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82770021|NCT00903188|Prednisolone|prednisolone|mesh-list
82770022|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
82770023|NCT00903188|Everolimus|everolimus|mesh-list
82770024|NCT00903188|Cyclosporins|cyclosporins|mesh-list
82770025|NCT00903188|Basiliximab|basiliximab|mesh-list
82770026|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82770027|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
82770028|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770029|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770030|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82770031|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
82770032|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770033|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
82770034|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770035|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
82770036|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82770037|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82770038|NCT00903188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82770039|NCT00903188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82770040|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770041|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82770042|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
82770043|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
82770044|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770045|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82770046|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
82770047|NCT00903188|Hormones|hormones|mesh-ancestor
82770048|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82770049|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82770050|NCT00903188|Protective Agents|protective agents|mesh-ancestor
82770051|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82770052|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82770053|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82770054|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
82770055|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82770056|NCT00908726|Propofol|propofol|mesh-list
82770057|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82770058|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82770059|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770060|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82770061|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
82770062|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
82770063|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
82770064|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770065|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82770066|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82770067|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
82770068|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770069|NCT00449956|Timolol|timolol|mesh-list
82770070|NCT00449956|Dorzolamide|dorzolamide|mesh-list
82770071|NCT00449956|Maleic acid|maleic acid|mesh-list
82770072|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770073|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770074|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82770075|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82770076|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
82770077|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770078|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770079|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82770080|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82770081|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82770082|NCT00907400|Naproxen|naproxen|mesh-list
82770083|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82770084|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82770085|NCT00907400|Analgesics|analgesics|mesh-ancestor
82770086|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
82770087|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770088|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770089|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82770090|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82770091|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
82770092|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82770093|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770094|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770095|NCT00727493|Alendronate|alendronate|mesh-list
82770096|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82770097|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770098|NCT00727727|Piribedil|piribedil|mesh-list
82770099|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82770100|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82770101|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
82770102|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
82770103|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770104|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770105|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770106|NCT00903656|Lapatinib|lapatinib|mesh-list
82770107|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770108|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82770109|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770110|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770111|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
82770112|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
82770113|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82770114|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82770115|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770116|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770117|NCT00730067|Urological Agents|urological agents|mesh-ancestor
82770118|NCT02538224|Doxycycline|doxycycline|mesh-list
82770119|NCT02538224|Ketoprofen|ketoprofen|mesh-list
82770120|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82770121|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770122|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
82770123|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82770124|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82770125|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82770126|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82770127|NCT02538224|Analgesics|analgesics|mesh-ancestor
82770128|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
82770129|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770130|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770131|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82770132|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82770133|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82770134|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770135|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770136|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82770137|NCT02538302|Oxybutynin|oxybutynin|mesh-list
82770138|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
82770139|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
82770140|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770141|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770142|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82770143|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82770144|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
82770145|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770146|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770147|NCT02538302|Urological Agents|urological agents|mesh-ancestor
82770148|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
82770149|NCT02538302|Coagulants|coagulants|mesh-ancestor
82770150|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82770151|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
82770152|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82770153|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770154|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82770155|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770156|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770157|NCT00509067|Olanzapine|olanzapine|mesh-list
82770158|NCT00509067|Risperidone|risperidone|mesh-list
82770159|NCT00509067|Aripiprazole|aripiprazole|mesh-list
82770160|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82770161|NCT00509067|Ziprasidone|ziprasidone|mesh-list
82770162|NCT00509067|Choline|choline|mesh-list
82770163|NCT00509067|Galantamine|galantamine|mesh-list
82770164|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
82770165|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82770166|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
82770167|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770168|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770169|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770170|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82770171|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82770172|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82770173|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82770174|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82770175|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
82770176|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
82770177|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
82770178|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770179|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82770180|NCT00509067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82770181|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82770182|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82770183|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
82770184|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
82770185|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82770186|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82770187|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82770188|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82770189|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
82770190|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82770191|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
82770192|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82770193|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
82770194|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82770195|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770196|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
82770197|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82770198|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
82770199|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
82770200|NCT02538146|Vitamins|vitamins|mesh-ancestor
82770201|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
82770202|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770203|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
82770204|NCT00908024|Cetuximab|cetuximab|mesh-list
82770205|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82770206|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770207|NCT00730223|Efavirenz|efavirenz|mesh-list
82770208|NCT00730223|Nevirapine|nevirapine|mesh-list
82770209|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82770210|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82770211|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770212|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770213|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
82770214|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770215|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82770216|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82770217|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82770218|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82770219|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82770220|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82770221|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82770222|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82770223|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
82770224|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82770225|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82770226|NCT02539394|Prednisolone|prednisolone|mesh-list
82770227|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
82770228|NCT02539394|Hemostatics|hemostatics|mesh-list
82770229|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82770230|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
82770231|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82770232|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
82770233|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
82770234|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770235|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770236|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82770237|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
82770238|NCT02539394|Hormones|hormones|mesh-ancestor
82770239|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82770240|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82770241|NCT02539394|Protective Agents|protective agents|mesh-ancestor
82770242|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82770243|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770244|NCT02539394|Coagulants|coagulants|mesh-ancestor
82770245|NCT00908180|Cytarabine|cytarabine|mesh-list
82770246|NCT00908180|Cyclosporine|cyclosporine|mesh-list
82770247|NCT00908180|Etoposide|etoposide|mesh-list
82770248|NCT00908180|Melphalan|melphalan|mesh-list
82770249|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
82770250|NCT00908180|Carmustine|carmustine|mesh-list
82770251|NCT00908180|Cyclosporins|cyclosporins|mesh-list
82770252|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82770253|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770254|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82770255|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82770256|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770257|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770258|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82770259|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
82770260|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
82770261|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770262|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82770263|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
82770264|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770265|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
82770266|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
82770267|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82770268|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82770269|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82770270|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
82770271|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82770272|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82770273|NCT04480463|Aflibercept|aflibercept|mesh-list
82770274|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82770275|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82770276|NCT04480463|Growth Substances|growth substances|mesh-ancestor
82770277|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770278|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
82770279|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770280|NCT00909506|Metformin|metformin|mesh-list
82770281|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82770282|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770283|NCT03997539|Vinorelbine|vinorelbine|mesh-list
82770284|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82770285|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770286|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
82770287|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
82770288|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
82770289|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770290|NCT02570243|Heparin|heparin|mesh-list
82770291|NCT02570243|Calcium heparin|calcium heparin|mesh-list
82770292|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
82770293|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82770294|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82770295|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770296|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
82770297|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82770298|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
82770299|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770300|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770301|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82770302|NCT00927212|Protective Agents|protective agents|mesh-ancestor
82770303|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82770304|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82770305|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770306|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770307|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
82770308|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770309|NCT00927290|Pioglitazone|pioglitazone|mesh-list
82770310|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82770311|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770312|NCT00728195|Olanzapine|olanzapine|mesh-list
82770313|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
82770314|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
82770315|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
82770316|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770317|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770318|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82770319|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82770320|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82770321|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82770322|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82770323|NCT00728195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82770324|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82770325|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82770326|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770327|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770328|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
82770329|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82770330|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82770331|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
82770332|NCT00927524|Insulin|insulin|mesh-list
82770333|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82770334|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
82770335|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82770336|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770337|NCT00728273|Micronutrients|micronutrients|mesh-list
82770338|NCT00728273|Trace Elements|trace elements|mesh-list
82770339|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770341|NCT00927602|Fondaparinux|fondaparinux|mesh-list
82770342|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82770343|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
82770344|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82770345|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
82770346|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770347|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770348|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
82770349|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82770350|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82770351|NCT04286867|Ethanol|ethanol|mesh-list
82770352|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82770353|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770354|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82770355|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770356|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82770357|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82770358|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82770359|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
82770360|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770361|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770362|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770363|NCT00730535|Urological Agents|urological agents|mesh-ancestor
82770364|NCT00904202|Lidocaine|lidocaine|mesh-list
82770365|NCT00904202|Gabapentin|gabapentin|mesh-list
82770366|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
82770367|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
82770368|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82770369|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770370|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
82770371|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770372|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82770373|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82770374|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82770375|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82770376|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770377|NCT00904202|Analgesics|analgesics|mesh-ancestor
82770378|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
82770379|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82770380|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82770381|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82770382|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82770383|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82770384|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770385|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
82770386|NCT00927836|Lenograstim|lenograstim|mesh-list
82770387|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82770388|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
82770389|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770390|NCT00904280|Oxymorphone|oxymorphone|mesh-list
82770391|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82770392|NCT00904280|Narcotics|narcotics|mesh-ancestor
82770393|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82770394|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770395|NCT00904280|Analgesics|analgesics|mesh-ancestor
82770396|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
82770397|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770398|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82770399|NCT00928148|Amphetamine|amphetamine|mesh-list
82770400|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82770401|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770402|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
82770403|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
82770404|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770405|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
82770406|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770407|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770408|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
82770409|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82770410|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82770411|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82770412|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82770413|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
82770414|NCT02430077|Cathartics|cathartics|mesh-ancestor
82770415|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82770416|NCT00904436|Ipratropium|ipratropium|mesh-list
82770417|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82770418|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
82770419|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770420|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770421|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82770422|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
82770423|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82770424|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
82770425|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770426|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770427|NCT00728585|Mitogens|mitogens|mesh-list
82770428|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
82770429|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770430|NCT00730769|Valganciclovir|valganciclovir|mesh-list
82770431|NCT00730769|Ganciclovir|ganciclovir|mesh-list
82770432|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
82770433|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
82770434|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770435|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82770436|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770437|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770438|NCT00728663|Docetaxel|docetaxel|mesh-list
82770439|NCT00728663|Cetuximab|cetuximab|mesh-list
82770440|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770441|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
82770442|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
82770443|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
82770444|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770445|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82770446|NCT00731003|Tryptophan|tryptophan|mesh-list
82770447|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
82770448|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82770449|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
82770450|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82770452|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82770453|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82770454|NCT00729131|Analgesics|analgesics|mesh-ancestor
82770455|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
82770456|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770457|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770458|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82770459|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82770460|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82770461|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82770462|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
82770463|NCT00729287|Selenium|selenium|mesh-list
82770464|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
82770465|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770466|NCT00729287|Protective Agents|protective agents|mesh-ancestor
82770467|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770468|NCT00729287|Trace Elements|trace elements|mesh-ancestor
82770469|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
82770470|NCT00731393|Vaccines|vaccines|mesh-list
82770471|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
82770472|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770473|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
82770474|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82770475|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82770476|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770477|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
82770478|NCT04390217|Coagulants|coagulants|mesh-ancestor
82770479|NCT02569463|Aldesleukin|aldesleukin|mesh-list
82770480|NCT02569463|Interleukin-2|interleukin-2|mesh-list
82770481|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770482|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82770483|NCT02569463|Analgesics|analgesics|mesh-ancestor
82770484|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
82770485|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770486|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770487|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82770488|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82770489|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
82770490|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770491|NCT00731627|Simvastatin|simvastatin|mesh-list
82770492|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82770493|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82770494|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
82770495|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770496|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82770497|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82770498|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770499|NCT00568178|Losartan|losartan|mesh-list
82770500|NCT00568178|Amlodipine|amlodipine|mesh-list
82770501|NCT00568178|Enalapril|enalapril|mesh-list
82770502|NCT00568178|Enalaprilat|enalaprilat|mesh-list
82770503|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82770504|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82770505|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82770506|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770507|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82770508|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770509|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
82770510|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82770511|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82770512|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82770513|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770514|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82770515|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
82770516|NCT00577889|Gemcitabine|gemcitabine|mesh-list
82770517|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82770518|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
82770519|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770520|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770521|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
82770522|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82770523|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770524|NCT02538926|Prednisone|prednisone|mesh-list
82770525|NCT02538926|Cortisone|cortisone|mesh-list
82770526|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
82770527|NCT02538926|Rituximab|rituximab|mesh-list
82770528|NCT02538926|Doxorubicin|doxorubicin|mesh-list
82770529|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82770530|NCT02538926|Etoposide|etoposide|mesh-list
82770531|NCT02538926|Vincristine|vincristine|mesh-list
82770532|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
82770533|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
82770534|NCT02538926|Asparaginase|asparaginase|mesh-list
82770535|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
82770536|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82770537|NCT02538926|Antibodies|antibodies|mesh-list
82770538|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
82770539|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82770540|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82770541|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
82770542|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770543|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82770544|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82770545|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
82770546|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770547|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770548|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82770549|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82770550|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82770551|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82770552|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770553|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82770554|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
82770555|NCT02538926|Hormones|hormones|mesh-ancestor
82770556|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82770557|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82770558|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82770559|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
82770560|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
82770561|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
82770562|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82770563|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
82770564|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
82770565|NCT00904904|Ketorolac|ketorolac|mesh-list
82770566|NCT00904904|Indomethacin|indomethacin|mesh-list
82770567|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82770568|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82770569|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82770570|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82770571|NCT00904904|Analgesics|analgesics|mesh-ancestor
82770572|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
82770573|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770574|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770575|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82770576|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82770577|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82770578|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770579|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770580|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
82770581|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
82770582|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82770583|NCT00731861|Paclitaxel|paclitaxel|mesh-list
82770584|NCT00731861|Vatalanib|vatalanib|mesh-list
82770585|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82770586|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770587|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
82770588|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
82770589|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
82770590|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770591|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82770592|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770593|NCT00567476|Omalizumab|omalizumab|mesh-list
82770594|NCT00567476|Terbutaline|terbutaline|mesh-list
82770595|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
82770596|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
82770597|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82770598|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
82770599|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770600|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770601|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82770602|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
82770603|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
82770604|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82770605|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82770606|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82770607|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770608|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770609|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82770610|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
82770611|NCT00729911|Amiodarone|amiodarone|mesh-list
82770612|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82770613|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
82770614|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82770615|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82770616|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770617|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82770618|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82770619|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82770620|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770621|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82770622|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82770623|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82770624|NCT04018703|Midazolam|midazolam|mesh-list
82770625|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
82770626|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82770627|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82770628|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770629|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82770630|NCT04018703|Analgesics|analgesics|mesh-ancestor
82770631|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
82770632|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770633|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82770634|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82770635|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82770636|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
82770637|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770638|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770639|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82770640|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82770641|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82770642|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82770643|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82770644|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
82770645|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
82770646|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
82770647|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
82770648|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82770649|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82770650|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770651|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82770652|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
82770653|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770654|NCT04065581|Metformin|metformin|mesh-list
82770655|NCT04065581|Acarbose|acarbose|mesh-list
82770656|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82770657|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770658|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82770659|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770660|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770661|NCT00733889|Docetaxel|docetaxel|mesh-list
82770662|NCT00733889|Fluorouracil|fluorouracil|mesh-list
82770663|NCT00733889|Cetuximab|cetuximab|mesh-list
82770664|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770665|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
82770666|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
82770667|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
82770668|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770669|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
82770670|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82770671|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82770672|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
82770673|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770674|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82770675|NCT00733967|Varenicline|varenicline|mesh-list
82770676|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82770677|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82770678|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
82770679|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770680|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770681|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770682|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82770683|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82770684|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82770685|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
82770686|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82770687|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82770688|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
82770689|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770690|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82770691|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82770692|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770693|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770694|NCT04644627|Gentamicins|gentamicins|mesh-list
82770695|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82770696|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770697|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82770698|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770699|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770700|NCT00732407|Losartan|losartan|mesh-list
82770701|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82770702|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82770703|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82770704|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82770705|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770706|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
82770707|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
82770708|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82770709|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82770710|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770711|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770712|NCT00507819|Urological Agents|urological agents|mesh-ancestor
82770713|NCT02569307|Minocycline|minocycline|mesh-list
82770714|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82770715|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770716|NCT01013103|Atorvastatin|atorvastatin|mesh-list
82770717|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82770718|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82770719|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
82770720|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770721|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82770722|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82770723|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770724|NCT00732485|Fenofibrate|fenofibrate|mesh-list
82770725|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82770726|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
82770727|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770728|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82770729|NCT02569073|Dronabinol|dronabinol|mesh-list
82770730|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
82770731|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770732|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82770733|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82770734|NCT02569073|Analgesics|analgesics|mesh-ancestor
82770735|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
82770736|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770737|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82770738|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82770739|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770740|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770741|NCT02569073|Hormones|hormones|mesh-ancestor
82770742|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82770743|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82770744|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82770745|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770746|NCT00734123|Aspirin|aspirin|mesh-list
82770747|NCT00734123|Rimonabant|rimonabant|mesh-list
82770748|NCT00734123|Enalapril|enalapril|mesh-list
82770749|NCT00734123|Clopidogrel|clopidogrel|mesh-list
82770750|NCT00734123|Atorvastatin|atorvastatin|mesh-list
82770752|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82770753|NCT00734123|Diuretics|diuretics|mesh-list
82770754|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82770755|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82770756|NCT00734123|Analgesics|analgesics|mesh-ancestor
82770757|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
82770758|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770759|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770760|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82770761|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82770762|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82770763|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82770764|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770765|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82770766|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82770767|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770768|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
82770769|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82770770|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82770771|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
82770772|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82770773|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82770774|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82770775|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82770776|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82770777|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
82770778|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770779|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
82770780|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82770781|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
82770782|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82770783|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
82770784|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82770785|NCT00734123|Hormones|hormones|mesh-ancestor
82770786|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82770787|NCT00734279|Leuprolide|leuprolide|mesh-list
82770788|NCT00734279|Ganirelix|ganirelix|mesh-list
82770789|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82770790|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
82770791|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82770792|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770793|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82770794|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770795|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
82770796|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82770797|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
82770798|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
82770799|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82770800|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82770801|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
82770802|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770803|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770804|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770805|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770806|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82770807|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770808|NCT03410043|Osimertinib|osimertinib|mesh-list
82770809|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770810|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82770811|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770812|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770813|NCT00732953|Paclitaxel|paclitaxel|mesh-list
82770814|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82770815|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770816|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
82770817|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
82770818|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
82770819|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770820|NCT00577655|Albuterol|albuterol|mesh-list
82770821|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82770822|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
82770823|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770824|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770825|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82770826|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
82770827|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
82770828|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82770829|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82770830|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82770831|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82770832|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
82770833|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770834|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770835|NCT00733031|Gemcitabine|gemcitabine|mesh-list
82770836|NCT00733031|Pemetrexed|pemetrexed|mesh-list
82770837|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82770838|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
82770839|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770840|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770841|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770842|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82770843|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82770844|NCT01327781|Tamoxifen|tamoxifen|mesh-list
82770845|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82770846|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
82770847|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82770848|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770849|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82770850|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770851|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82770852|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82770853|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82770854|NCT00734669|Glyburide|glyburide|mesh-list
82770855|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82770856|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770857|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
82770858|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
82770859|NCT00113269|Tacrolimus|tacrolimus|mesh-list
82770860|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
82770861|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82770862|NCT00113269|Basiliximab|basiliximab|mesh-list
82770863|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82770864|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
82770865|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770866|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82770867|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770868|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770869|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82770870|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770871|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82770872|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
82770873|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82770874|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770875|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82770876|NCT04065269|Olaparib|olaparib|mesh-list
82770877|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82770878|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770879|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770880|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770881|NCT00515619|Lacosamide|lacosamide|mesh-list
82770882|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
82770883|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82770884|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82770885|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82770886|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770887|NCT01815359|Leucovorin|leucovorin|mesh-list
82770888|NCT01815359|Mitomycins|mitomycins|mesh-list
82770889|NCT01815359|Mitomycin|mitomycin|mesh-list
82770890|NCT01815359|Antidotes|antidotes|mesh-ancestor
82770891|NCT01815359|Protective Agents|protective agents|mesh-ancestor
82770892|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770893|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
82770894|NCT01815359|Vitamins|vitamins|mesh-ancestor
82770895|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
82770896|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82770897|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770898|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
82770899|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770900|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82770901|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770902|NCT00449644|Bedaquiline|bedaquiline|mesh-list
82770903|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
82770904|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82770905|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770906|NCT00733265|Ticagrelor|ticagrelor|mesh-list
82770907|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82770908|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82770909|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82770910|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82770911|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
82770912|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82770913|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770914|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770915|NCT00112489|Paclitaxel|paclitaxel|mesh-list
82770916|NCT00112489|Carboplatin|carboplatin|mesh-list
82770917|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82770918|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770919|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
82770920|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
82770921|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
82770922|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770923|NCT01023100|Tofacitinib|tofacitinib|mesh-list
82770924|NCT01023100|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82770925|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82770926|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770927|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770928|NCT00515463|Denosumab|denosumab|mesh-list
82770929|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82770930|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770931|NCT01082731|Artesunate|artesunate|mesh-list
82770932|NCT01082731|Lumefantrine|lumefantrine|mesh-list
82770933|NCT01082731|Artemether|artemether|mesh-list
82770934|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82770935|NCT01082731|Mefloquine|mefloquine|mesh-list
82770936|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
82770937|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82770938|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82770939|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770940|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82770941|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
82770942|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
82770943|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82770944|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
82770945|NCT00739193|Amiodarone|amiodarone|mesh-list
82770946|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82770947|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
82770948|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82770949|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82770950|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770951|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82770952|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82770953|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82770954|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770955|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82770956|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82770957|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82770958|NCT01011543|Dimercaprol|dimercaprol|mesh-list
82770959|NCT01011543|Chelating Agents|chelating agents|mesh-ancestor
82770960|NCT01011543|Sequestering Agents|sequestering agents|mesh-ancestor
82770961|NCT01011543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770962|NCT00733811|Deferiprone|deferiprone|mesh-list
82770963|NCT00733811|Deferoxamine|deferoxamine|mesh-list
82770964|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82770965|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
82770966|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
82770967|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770968|NCT00733811|Siderophores|siderophores|mesh-ancestor
82770969|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
82770970|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
82770971|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770972|NCT00507507|Tenofovir|tenofovir|mesh-list
82770973|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
82770974|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82770975|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82770976|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82770977|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82770978|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82770979|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82770980|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82770981|NCT00459706|Etanercept|etanercept|mesh-list
82770982|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82770983|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82770984|NCT00459706|Analgesics|analgesics|mesh-ancestor
82770985|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
82770986|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770987|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770988|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82770989|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82770990|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82770991|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82770992|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
82770993|NCT00735527|Lorazepam|lorazepam|mesh-list
82770994|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
82770995|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
82770996|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
82770997|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82770998|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82770999|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82771000|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82771001|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771002|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82771003|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82771004|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82771005|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
82771006|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
82771007|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771008|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771009|NCT00735761|Acyclovir|acyclovir|mesh-list
82771010|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
82771011|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
82771012|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771013|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82771014|NCT00740285|Lidocaine|lidocaine|mesh-list
82771015|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
82771016|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
82771017|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771018|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771019|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
82771020|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771021|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82771022|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82771023|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82771024|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82771025|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771026|NCT00507429|Paclitaxel|paclitaxel|mesh-list
82771027|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
82771028|NCT00507429|Combretastatin|combretastatin|mesh-list
82771029|NCT00507429|Carboplatin|carboplatin|mesh-list
82771030|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82771031|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771032|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771033|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771034|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771035|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771036|NCT01011621|Prednisolone|prednisolone|mesh-list
82771037|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82771038|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
82771039|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82771040|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
82771041|NCT01011621|Betamethasone|betamethasone|mesh-list
82771042|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
82771043|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82771044|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
82771045|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82771046|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
82771047|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82771048|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82771049|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
82771050|NCT01011621|Hormones|hormones|mesh-ancestor
82771051|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82771052|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771053|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82771054|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771055|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
82771056|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
82771057|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771058|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82771059|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82771060|NCT01011621|Protective Agents|protective agents|mesh-ancestor
82771061|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82771062|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
82771063|NCT00449176|Oxycodone|oxycodone|mesh-list
82771064|NCT00449176|Tapentadol|tapentadol|mesh-list
82771065|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82771066|NCT00449176|Narcotics|narcotics|mesh-ancestor
82771067|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771068|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771069|NCT00449176|Analgesics|analgesics|mesh-ancestor
82771070|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
82771071|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771072|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82771073|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82771074|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82771075|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771076|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
82771077|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771078|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
82771079|NCT00515073|Promethazine|promethazine|mesh-list
82771080|NCT00515073|Dexamethasone|dexamethasone|mesh-list
82771081|NCT00515073|Paclitaxel|paclitaxel|mesh-list
82771082|NCT00515073|Cimetidine|cimetidine|mesh-list
82771083|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82771084|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771085|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771086|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771087|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771088|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771089|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82771090|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
82771091|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
82771092|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771093|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771094|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82771095|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
82771096|NCT00515073|Hormones|hormones|mesh-ancestor
82771097|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82771098|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82771099|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82771100|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82771101|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771102|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
82771103|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
82771104|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
82771105|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82771106|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
82771107|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
82771108|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771109|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82771110|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
82771111|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
82771112|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82771113|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82771114|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82771115|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82771116|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771117|NCT00710021|Vitamin D|vitamin d|mesh-list
82771118|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
82771119|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
82771120|NCT00710021|Vitamins|vitamins|mesh-list
82771121|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
82771122|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771123|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82771124|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82771125|NCT00504153|Dasatinib|dasatinib|mesh-list
82771126|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771127|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82771128|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771129|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771130|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82771131|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82771132|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771133|NCT00740363|Incretins|incretins|mesh-ancestor
82771134|NCT00740363|Hormones|hormones|mesh-ancestor
82771135|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82771136|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82771137|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
82771138|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771139|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771140|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
82771141|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82771142|NCT04065035|Protective Agents|protective agents|mesh-ancestor
82771143|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771144|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
82771145|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
82771146|NCT00442702|Hematinics|hematinics|mesh-ancestor
82771147|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
82771148|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82771149|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771150|NCT00514917|Docetaxel|docetaxel|mesh-list
82771151|NCT00514917|Leuprolide|leuprolide|mesh-list
82771152|NCT00514917|Bicalutamide|bicalutamide|mesh-list
82771153|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771154|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771155|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771156|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771157|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771158|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82771159|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
82771160|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82771161|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771162|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82771163|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
82771164|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
82771165|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82771166|NCT01011699|Niacinamide|niacinamide|mesh-list
82771168|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
82771169|NCT01011699|Sevelamer|sevelamer|mesh-list
82771170|NCT01011699|Cinacalcet|cinacalcet|mesh-list
82771171|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
82771172|NCT01011699|Vitamins|vitamins|mesh-ancestor
82771173|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
82771174|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771175|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82771176|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
82771177|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771178|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82771179|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
82771180|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
82771181|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
82771182|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82771183|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82771184|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
82771185|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82771186|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
82771187|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82771188|NCT00504075|Antibodies|antibodies|mesh-list
82771189|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
82771190|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82771191|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
82771192|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771193|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
82771194|NCT00503997|Pemetrexed|pemetrexed|mesh-list
82771195|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771196|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771197|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771198|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82771199|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82771200|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
82771201|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82771202|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
82771203|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
82771204|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771205|NCT00736463|Atorvastatin|atorvastatin|mesh-list
82771206|NCT00736463|Simvastatin|simvastatin|mesh-list
82771207|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82771208|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82771209|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
82771210|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771211|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82771212|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82771213|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771214|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
82771215|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82771216|NCT00736541|Cystatins|cystatins|mesh-list
82771217|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
82771218|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771219|NCT00736541|Expectorants|expectorants|mesh-ancestor
82771220|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
82771221|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82771222|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
82771223|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771224|NCT00736541|Protective Agents|protective agents|mesh-ancestor
82771225|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771226|NCT00736541|Antidotes|antidotes|mesh-ancestor
82771227|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
82771228|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
82771229|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771230|NCT00096265|Temozolomide|temozolomide|mesh-list
82771231|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82771232|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82771233|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
82771234|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771235|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771236|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82771237|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771238|NCT01082809|Sunitinib|sunitinib|mesh-list
82771239|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771240|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82771241|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82771242|NCT01082809|Growth Substances|growth substances|mesh-ancestor
82771243|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771244|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
82771245|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82771246|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771247|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771248|NCT01080469|Tacrolimus|tacrolimus|mesh-list
82771249|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82771250|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
82771251|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771252|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82771253|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771254|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771255|NCT01079065|Famotidine|famotidine|mesh-list
82771256|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82771257|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82771258|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82771259|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
82771260|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
82771261|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771262|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771263|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771264|NCT00711191|Antibodies|antibodies|mesh-list
82771265|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82771266|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
82771267|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771268|NCT00741221|Bevacizumab|bevacizumab|mesh-list
82771269|NCT00741221|Pemetrexed|pemetrexed|mesh-list
82771270|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82771271|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771272|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82771273|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82771274|NCT00741221|Growth Substances|growth substances|mesh-ancestor
82771275|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771276|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
82771277|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771278|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771279|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82771280|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82771281|NCT00736619|Paclitaxel|paclitaxel|mesh-list
82771282|NCT00736619|Cetuximab|cetuximab|mesh-list
82771283|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82771284|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82771285|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771286|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771287|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771288|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771289|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771290|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82771291|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
82771292|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82771293|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771294|NCT05742269|Atezolizumab|atezolizumab|mesh-list
82771295|NCT05742269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82771296|NCT05742269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771297|NCT05742269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82771298|NCT05742269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771299|NCT00448864|Ecallantide|ecallantide|mesh-list
82771300|NCT00448864|Analgesics|analgesics|mesh-ancestor
82771301|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
82771302|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771303|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771304|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82771305|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82771306|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82771307|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82771308|NCT00567398|Icodextrin|icodextrin|mesh-list
82771309|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
82771310|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82771311|NCT00448708|Paclitaxel|paclitaxel|mesh-list
82771312|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82771313|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82771314|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771315|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771316|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771317|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771318|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771319|NCT00925028|Warfarin|warfarin|mesh-list
82771320|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
82771321|NCT00905216|Heparin|heparin|mesh-list
82771322|NCT00905216|Calcium heparin|calcium heparin|mesh-list
82771323|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
82771324|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82771325|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82771326|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771327|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82771328|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
82771329|NCT00929630|Coagulants|coagulants|mesh-ancestor
82771330|NCT00925106|Celecoxib|celecoxib|mesh-list
82771331|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82771332|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82771333|NCT00925106|Analgesics|analgesics|mesh-ancestor
82771334|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
82771335|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771336|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771337|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82771338|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82771339|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82771340|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82771341|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771342|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771343|NCT00905528|Telmisartan|telmisartan|mesh-list
82771344|NCT00905528|Ramipril|ramipril|mesh-list
82771345|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82771346|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82771347|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82771348|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771349|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82771350|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
82771351|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771352|NCT00736697|Moxidectin|moxidectin|mesh-list
82771353|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
82771354|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82771355|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771356|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
82771357|NCT02568995|Ketorolac|ketorolac|mesh-list
82771358|NCT02568995|Epinephrine|epinephrine|mesh-list
82771359|NCT02568995|Racepinephrine|racepinephrine|mesh-list
82771360|NCT02568995|Ropivacaine|ropivacaine|mesh-list
82771361|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
82771362|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
82771363|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
82771364|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771365|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771366|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
82771367|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771368|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82771369|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82771370|NCT02568995|Analgesics|analgesics|mesh-ancestor
82771371|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82771372|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82771373|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82771374|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771375|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771376|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82771377|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82771378|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
82771379|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771380|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82771381|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82771382|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
82771383|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82771384|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
82771385|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
82771386|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
82771387|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82771388|NCT00930020|Minocycline|minocycline|mesh-list
82771389|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82771390|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771391|NCT00930098|Clofarabine|clofarabine|mesh-list
82771392|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82771393|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
82771394|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771395|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771396|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
82771397|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82771398|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771399|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
82771400|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
82771401|NCT00905762|Besifloxacin|besifloxacin|mesh-list
82771402|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82771403|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771404|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82771405|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82771406|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771407|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771408|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771409|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82771410|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82771411|NCT00930332|Methadone|methadone|mesh-list
82771412|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82771413|NCT00930332|Narcotics|narcotics|mesh-ancestor
82771414|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771415|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771416|NCT00930332|Analgesics|analgesics|mesh-ancestor
82771417|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
82771418|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771419|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
82771420|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
82771421|NCT02568839|Docetaxel|docetaxel|mesh-list
82771422|NCT02568839|Trastuzumab|trastuzumab|mesh-list
82771423|NCT02568839|Pertuzumab|pertuzumab|mesh-list
82771424|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771425|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771426|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771427|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771502|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771428|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771429|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82771430|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
82771431|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82771432|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82771433|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771434|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82771435|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82771436|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771437|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771438|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771439|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82771440|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
82771441|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82771442|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771443|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82771444|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82771445|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82771446|NCT00736931|Levetiracetam|levetiracetam|mesh-list
82771448|NCT00736931|Brivaracetam|brivaracetam|mesh-list
82771449|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
82771450|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
82771451|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
82771452|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
82771453|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771454|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771455|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82771456|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82771457|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771458|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82771459|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82771460|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82771461|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
82771462|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
82771463|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771464|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771465|NCT00567164|Drospirenone|drospirenone|mesh-list
82771466|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82771467|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
82771468|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82771469|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771470|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82771471|NCT00567164|Diuretics|diuretics|mesh-ancestor
82771472|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
82771473|NCT00920933|Prednisolone|prednisolone|mesh-list
82771474|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82771475|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
82771476|NCT00920933|Hormones|hormones|mesh-ancestor
82771477|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82771478|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771479|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82771480|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771481|NCT00930566|Methoxsalen|methoxsalen|mesh-list
82771482|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82771483|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
82771484|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
82771485|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82771486|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82771487|NCT00925730|Analgesics|analgesics|mesh-ancestor
82771488|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
82771489|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771490|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771491|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82771492|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82771493|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
82771494|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82771495|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
82771496|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82771497|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771498|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771499|NCT00713219|Docetaxel|docetaxel|mesh-list
82771500|NCT00713219|Cetuximab|cetuximab|mesh-list
82771501|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771503|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771504|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771505|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771506|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82771507|NCT00931580|Vitamin D|vitamin d|mesh-list
82771508|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
82771509|NCT00931580|Vitamins|vitamins|mesh-ancestor
82771510|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
82771511|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771512|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82771513|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82771514|NCT05661461|Sirolimus|sirolimus|mesh-list
82771515|NCT05661461|Temsirolimus|temsirolimus|mesh-list
82771516|NCT05661461|MTOR Inhibitors|mtor inhibitors|mesh-list
82771517|NCT05661461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82771518|NCT05661461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771519|NCT05661461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82771520|NCT05661461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771521|NCT05661461|Antifungal Agents|antifungal agents|mesh-ancestor
82771522|NCT05661461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82771523|NCT05661461|Immunologic Factors|immunologic factors|mesh-ancestor
82771524|NCT05661461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771525|NCT05661461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82771526|NCT05661461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771527|NCT05661461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771528|NCT00931736|Rifampin|rifampin|mesh-list
82771529|NCT00931736|Isoniazid|isoniazid|mesh-list
82771530|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82771531|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
82771532|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82771533|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771534|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
82771535|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82771536|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771537|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771538|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82771539|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82771540|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82771541|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82771542|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82771543|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82771544|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82771545|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82771546|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
82771547|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82771549|NCT02567981|Micronutrients|micronutrients|mesh-list
82771550|NCT02567981|Trace Elements|trace elements|mesh-list
82771551|NCT02567981|Vitamins|vitamins|mesh-ancestor
82771552|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771553|NCT00737555|Tosedostat|tosedostat|mesh-list
82771554|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771555|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771556|NCT00932048|Atorvastatin|atorvastatin|mesh-list
82771557|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82771558|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82771559|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
82771560|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771561|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82771562|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82771563|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771564|NCT04015778|Paclitaxel|paclitaxel|mesh-list
82771565|NCT04015778|Carboplatin|carboplatin|mesh-list
82771566|NCT04015778|Nivolumab|nivolumab|mesh-list
82771567|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82771568|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771569|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771570|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771571|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771572|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771573|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82771574|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82771575|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
82771576|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82771577|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
82771578|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771579|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771580|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82771581|NCT00926354|Protective Agents|protective agents|mesh-ancestor
82771582|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82771583|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82771584|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771585|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771587|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771588|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
82771589|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82771590|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771591|NCT05518877|Ketamine|ketamine|mesh-list
82771592|NCT05518877|Analgesics|analgesics|mesh-ancestor
82771593|NCT05518877|Sensory System Agents|sensory system agents|mesh-ancestor
82771594|NCT05518877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771595|NCT05518877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771596|NCT05518877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82771597|NCT05518877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82771598|NCT05518877|Anesthetics, General|anesthetics, general|mesh-ancestor
82771599|NCT05518877|Anesthetics|anesthetics|mesh-ancestor
82771600|NCT05518877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771601|NCT05518877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82771602|NCT05518877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82771603|NCT05518877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771604|NCT05518877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771605|NCT00737789|Mesalamine|mesalamine|mesh-list
82771606|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82771607|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82771608|NCT00737789|Analgesics|analgesics|mesh-ancestor
82771609|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
82771610|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771611|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771612|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82771613|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82771615|NCT00700115|Lopinavir|lopinavir|mesh-list
82771616|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
82771617|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82771618|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82771619|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82771620|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
82771621|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771622|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771623|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82771624|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
82771625|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771626|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82771627|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82771628|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82771629|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82771630|NCT05556473|Tryptophan|tryptophan|mesh-list
82771631|NCT05556473|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82771632|NCT05556473|Antidepressive Agents|antidepressive agents|mesh-ancestor
82771633|NCT05556473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82771634|NCT00566852|Memantine|memantine|mesh-list
82771635|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82771636|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82771637|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
82771638|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771639|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771640|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771641|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82771642|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82771643|NCT00936650|Cinacalcet|cinacalcet|mesh-list
82771644|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82771645|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771646|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82771647|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
82771648|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82771649|NCT00442546|Pregabalin|pregabalin|mesh-list
82771650|NCT00442546|Analgesics|analgesics|mesh-ancestor
82771651|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
82771652|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771653|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771654|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
82771655|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82771656|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82771657|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771658|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82771659|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82771660|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82771661|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771662|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82771664|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
82771665|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771666|NCT00514683|Nintedanib|nintedanib|mesh-list
82771667|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771668|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82771669|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771670|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771671|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
82771672|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
82771673|NCT00566696|Melphalan|melphalan|mesh-list
82771674|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
82771675|NCT00566696|Thiotepa|thiotepa|mesh-list
82771676|NCT00566696|Rituximab|rituximab|mesh-list
82771677|NCT00566696|Fludarabine|fludarabine|mesh-list
82771678|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
82771679|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
82771680|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82771681|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
82771682|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82771683|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
82771684|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771685|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82771686|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82771687|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
82771688|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771689|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771690|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82771691|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82771692|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82771693|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82771694|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
82771695|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82771696|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771697|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771698|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
82771699|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
82771700|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
82771701|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771702|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771703|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
82771704|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771705|NCT00926900|Cycloserine|cycloserine|mesh-list
82771706|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82771707|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771708|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82771709|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
82771710|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82771711|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
82771712|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771713|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82771714|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771715|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82771716|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771717|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771718|NCT00937508|Varenicline|varenicline|mesh-list
82771719|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82771720|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82771721|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
82771722|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771723|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771724|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771725|NCT00937664|Gemcitabine|gemcitabine|mesh-list
82771726|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82771727|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
82771728|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771729|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771730|NCT00937820|Darexaban|darexaban|mesh-list
82771731|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82771732|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
82771733|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82771734|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
82771735|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771736|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771737|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
82771738|NCT00506883|Colchicine|colchicine|mesh-list
82771739|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
82771740|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82771741|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771742|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771743|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771744|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771745|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771746|NCT01028638|Bevacizumab|bevacizumab|mesh-list
82771747|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
82771748|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82771749|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771750|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82771751|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82771752|NCT01028638|Growth Substances|growth substances|mesh-ancestor
82771753|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771754|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
82771755|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82771756|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771757|NCT00938132|Warfarin|warfarin|mesh-list
82771758|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
82771759|NCT01023334|Lidocaine|lidocaine|mesh-list
82771760|NCT01023334|Anesthetics|anesthetics|mesh-list
82771761|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
82771762|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771763|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771764|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
82771765|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771766|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82771767|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82771768|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82771769|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82771770|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771771|NCT00938522|Cilostazol|cilostazol|mesh-list
82771772|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82771773|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
82771774|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771775|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771776|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82771777|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
82771778|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82771779|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82771780|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771781|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82771782|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
82771783|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82771784|NCT00938522|Protective Agents|protective agents|mesh-ancestor
82771785|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82771786|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82771787|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771788|NCT00938600|Vitamin D|vitamin d|mesh-list
82771789|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
82771790|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
82771791|NCT00938600|Vitamins|vitamins|mesh-list
82771792|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
82771793|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771794|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82771795|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82771796|NCT00503685|Cetuximab|cetuximab|mesh-list
82771797|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82771798|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771799|NCT00712673|Metformin|metformin|mesh-list
82771800|NCT00712673|Lixisenatide|lixisenatide|mesh-list
82771801|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82771802|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771803|NCT01562990|Rituximab|rituximab|mesh-list
82771804|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82771805|NCT01562990|Gemcitabine|gemcitabine|mesh-list
82771806|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
82771807|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82771808|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771809|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
82771810|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771811|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82771812|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82771813|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
82771814|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771815|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82771816|NCT01562990|Immunotoxins|immunotoxins|mesh-ancestor
82771817|NCT01562990|Immunoconjugates|immunoconjugates|mesh-ancestor
82771818|NCT00737867|Carboplatin|carboplatin|mesh-list
82771819|NCT00737867|Gemcitabine|gemcitabine|mesh-list
82771820|NCT00737867|Vinorelbine|vinorelbine|mesh-list
82771821|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771822|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82771823|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
82771824|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771825|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82771826|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771827|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771828|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771829|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82771830|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82771831|NCT03976466|Calcium|calcium|mesh-list
82771832|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82771833|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771834|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771835|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
82771836|NCT02536755|Eliglustat|eliglustat|mesh-list
82771837|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771838|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771839|NCT02567279|Denosumab|denosumab|mesh-list
82771840|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82771841|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771842|NCT00933374|Paclitaxel|paclitaxel|mesh-list
82771843|NCT00933374|Everolimus|everolimus|mesh-list
82771844|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82771845|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771846|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771847|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771848|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771849|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771850|NCT00933374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82771851|NCT00933374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82771852|NCT00933374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771853|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82771854|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
82771855|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771856|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82771857|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
82771858|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771859|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82771860|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82771861|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82771862|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82771863|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771864|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771865|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771866|NCT00933452|Analgesics|analgesics|mesh-ancestor
82771867|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
82771868|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771869|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
82771870|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82771871|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
82771872|NCT00447694|Deferasirox|deferasirox|mesh-list
82771873|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82771874|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
82771875|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
82771876|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771877|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
82771878|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82771879|NCT00447382|Insulin|insulin|mesh-list
82771880|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82771881|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
82771882|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
82771883|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82771884|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771885|NCT00938990|Midazolam|midazolam|mesh-list
82771886|NCT00938990|Etomidate|etomidate|mesh-list
82771887|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82771888|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82771889|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771890|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771891|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82771892|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82771893|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82771894|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82771895|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
82771896|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
82771897|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
82771898|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
82771899|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771900|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771901|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
82771902|NCT00933998|Pyridoxal|pyridoxal|mesh-list
82771903|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
82771904|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
82771905|NCT00933998|Vitamins|vitamins|mesh-ancestor
82771906|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
82771907|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771908|NCT00447226|Lapatinib|lapatinib|mesh-list
82771909|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771910|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82771911|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771912|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771913|NCT03360916|Atorvastatin|atorvastatin|mesh-list
82771914|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82771915|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82771916|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
82771917|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771918|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82771919|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82771920|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771921|NCT00446992|Olanzapine|olanzapine|mesh-list
82771922|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
82771923|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
82771924|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771925|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771926|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82771927|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82771928|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82771929|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82771930|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82771931|NCT00446992|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82771932|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82771933|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82771934|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771935|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82771936|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
82771937|NCT00503139|Etanercept|etanercept|mesh-list
82771938|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82771939|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82771940|NCT00503139|Analgesics|analgesics|mesh-ancestor
82771941|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
82771942|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82771943|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771944|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82771945|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82771946|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82771947|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82771948|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
82771949|NCT00577031|Bevacizumab|bevacizumab|mesh-list
82771950|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
82771951|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82771952|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771953|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82771954|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82771955|NCT00577031|Growth Substances|growth substances|mesh-ancestor
82771956|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771957|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
82771959|NCT00565448|Fluorouracil|fluorouracil|mesh-list
82771960|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771961|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
82771962|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
82771963|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
82771964|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771965|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
82771966|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82771967|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82771968|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
82771969|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771970|NCT01012011|Sorafenib|sorafenib|mesh-list
82771971|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771972|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82771973|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771974|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771975|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82771976|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771977|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82771978|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82771979|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771980|NCT00934154|Thalidomide|thalidomide|mesh-list
82771981|NCT00934154|Prednisolone|prednisolone|mesh-list
82771982|NCT00934154|Melphalan|melphalan|mesh-list
82771983|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82771984|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
82771985|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82771986|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82771987|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82771988|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82771989|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
82771990|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82771991|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82771992|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
82771993|NCT00934154|Hormones|hormones|mesh-ancestor
82771994|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82771995|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82771996|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
82771997|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82771998|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82771999|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82772000|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82772001|NCT00934154|Growth Substances|growth substances|mesh-ancestor
82772002|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
82772004|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82772005|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772006|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
82772007|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82772008|NCT05078255|Incretins|incretins|mesh-ancestor
82772009|NCT05078255|Hormones|hormones|mesh-ancestor
82772010|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82772011|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772012|NCT00939458|Lamotrigine|lamotrigine|mesh-list
82772013|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
82772014|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82772015|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82772016|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772017|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82772018|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772019|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82772020|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82772021|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772022|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82772023|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82772024|NCT02566967|Tofacitinib|tofacitinib|mesh-list
82772025|NCT02566967|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82772026|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82772027|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772028|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772029|NCT00939068|Telbivudine|telbivudine|mesh-list
82772030|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
82772031|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772032|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82772033|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772034|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772036|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
82772037|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772038|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82772039|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
82772040|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772041|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82772042|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772043|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82772044|NCT01013571|Insulin|insulin|mesh-list
82772045|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82772046|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
82772047|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
82772048|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82772049|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772050|NCT00514449|Valacyclovir|valacyclovir|mesh-list
82772051|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
82772052|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772053|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
82772054|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82772055|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
82772056|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772057|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82772058|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82772059|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
82772060|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772061|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772062|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82772063|NCT00738257|Pamidronate|pamidronate|mesh-list
82772064|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82772065|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772066|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82772067|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772068|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82772069|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772070|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772071|NCT00502671|Capecitabine|capecitabine|mesh-list
82772072|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82772073|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
82772074|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772075|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772076|NCT00738413|Deferasirox|deferasirox|mesh-list
82772077|NCT00738413|Deferoxamine|deferoxamine|mesh-list
82772078|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82772079|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
82772080|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
82772081|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772082|NCT00738413|Siderophores|siderophores|mesh-ancestor
82772083|NCT00697463|Teriparatide|teriparatide|mesh-list
82772084|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82772085|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772086|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82772087|NCT04409795|Metformin|metformin|mesh-list
82772088|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82772089|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82772090|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772091|NCT04409795|Incretins|incretins|mesh-ancestor
82772092|NCT04409795|Hormones|hormones|mesh-ancestor
82772093|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82772094|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82772095|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
82772096|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772097|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772098|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
82772099|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
82772100|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
82772101|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82772102|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772103|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772104|NCT00492531|Urological Agents|urological agents|mesh-ancestor
82772105|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
82772106|NCT01015209|Chitosan|chitosan|mesh-list
82772107|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82772108|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82772109|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82772110|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
82772111|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772112|NCT01015209|Expectorants|expectorants|mesh-ancestor
82772113|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
82772114|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82772115|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
82772116|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772117|NCT01015209|Protective Agents|protective agents|mesh-ancestor
82772118|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772119|NCT01015209|Antidotes|antidotes|mesh-ancestor
82772120|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82772121|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82772122|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
82772123|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82772124|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
82772125|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
82772126|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
82772127|NCT01015209|Coagulants|coagulants|mesh-ancestor
82772128|NCT04948463|Vancomycin|vancomycin|mesh-list
82772129|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
82772130|NCT04948463|Tazobactam|tazobactam|mesh-list
82772131|NCT04948463|Piperacillin|piperacillin|mesh-list
82772132|NCT04948463|Amikacin|amikacin|mesh-list
82772133|NCT04948463|Ceftazidime|ceftazidime|mesh-list
82772134|NCT04948463|Cefepime|cefepime|mesh-list
82772135|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82772136|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772137|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82772138|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82772139|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772140|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772141|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772142|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82772143|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82772144|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82772145|NCT01080547|Capecitabine|capecitabine|mesh-list
82772146|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
82772147|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82772148|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
82772149|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772150|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772151|NCT04930991|Omeprazole|omeprazole|mesh-list
82772152|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82772153|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82772154|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82772155|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772156|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772157|NCT00111241|Letrozole|letrozole|mesh-list
82772158|NCT00111241|Anastrozole|anastrozole|mesh-list
82772159|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82772160|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772161|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82772162|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772163|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772164|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82772165|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
82772166|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82772167|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772168|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82772169|NCT00492297|Sorafenib|sorafenib|mesh-list
82772170|NCT00492297|Dacarbazine|dacarbazine|mesh-list
82772171|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772172|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82772173|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772174|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772175|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82772176|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
82772177|NCT00446134|Ribavirin|ribavirin|mesh-list
82772178|NCT00446134|Taribavirin|taribavirin|mesh-list
82772179|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
82772330|NCT04013048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772180|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772181|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
82772182|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772183|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
82772184|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
82772185|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
82772186|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82772187|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82772188|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772189|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772190|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772191|NCT00921245|Darifenacin|darifenacin|mesh-list
82772192|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82772193|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82772194|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
82772195|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772196|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772197|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772198|NCT00921245|Urological Agents|urological agents|mesh-ancestor
82772199|NCT00940238|Dexetimide|dexetimide|mesh-list
82772200|NCT00940238|Citalopram|citalopram|mesh-list
82772201|NCT00940238|Escitalopram|escitalopram|mesh-list
82772202|NCT00940238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82772203|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82772204|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82772205|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772206|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772207|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
82772208|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772209|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82772210|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
82772211|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82772212|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82772213|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82772214|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
82772215|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
82772216|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772217|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82772218|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82772219|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
82772220|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82772221|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82772222|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
82772223|NCT04013438|Estradiol|estradiol|mesh-list
82772224|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82772225|NCT04013438|Estrogens|estrogens|mesh-ancestor
82772226|NCT04013438|Hormones|hormones|mesh-ancestor
82772227|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82772228|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772229|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82772230|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
82772231|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82772232|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82772233|NCT04013438|Urological Agents|urological agents|mesh-ancestor
82772234|NCT02565719|Interferons|interferons|mesh-list
82772235|NCT02565719|Tenofovir|tenofovir|mesh-list
82772236|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
82772237|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
82772238|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82772239|NCT02565719|REP 2139|rep 2139|mesh-list
82772240|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772241|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
82772242|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772243|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82772244|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82772245|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772246|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772247|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82772248|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82772249|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
82772250|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772251|NCT00111007|Paclitaxel|paclitaxel|mesh-list
82772252|NCT00111007|Carboplatin|carboplatin|mesh-list
82772253|NCT00111007|Sorafenib|sorafenib|mesh-list
82772254|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82772255|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772256|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
82772257|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
82772258|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
82772259|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772260|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82772261|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772263|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82772264|NCT00699335|Narcotics|narcotics|mesh-ancestor
82772265|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772266|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772267|NCT00699335|Analgesics|analgesics|mesh-ancestor
82772268|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
82772269|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772270|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82772271|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82772272|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
82772273|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
82772274|NCT00939614|Lamotrigine|lamotrigine|mesh-list
82772275|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
82772276|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82772277|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82772278|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772279|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82772280|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772281|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82772282|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82772283|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772284|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82772285|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82772286|NCT03962881|Vaccines|vaccines|mesh-list
82772287|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
82772288|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772289|NCT00935246|Dexetimide|dexetimide|mesh-list
82772290|NCT00935246|Citalopram|citalopram|mesh-list
82772291|NCT00935246|Escitalopram|escitalopram|mesh-list
82772292|NCT00935246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82772293|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82772294|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82772295|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772296|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772297|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
82772298|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772299|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82772300|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82772301|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
82772302|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
82772303|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772304|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82772305|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82772306|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
82772307|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82772308|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
82772309|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82772310|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
82772311|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82772312|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82772313|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
82772314|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772315|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82772316|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82772317|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772318|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772319|NCT00939848|Cisplatin|cisplatin|mesh-list
82772320|NCT00939848|Gemcitabine|gemcitabine|mesh-list
82772321|NCT00939848|Cediranib|cediranib|mesh-list
82772322|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772323|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82772324|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
82772325|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772326|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82772327|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772328|NCT04013048|Fluzoparib|fluzoparib|mesh-list
82772329|NCT04013048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82772331|NCT04013048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772332|NCT04013048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772334|NCT00935558|Exemestane|exemestane|mesh-list
82772335|NCT00935558|Anastrozole|anastrozole|mesh-list
82772336|NCT00935558|Letrozole|letrozole|mesh-list
82772337|NCT00935558|Lactitol|lactitol|mesh-list
82772338|NCT00935558|Vaccines|vaccines|mesh-list
82772339|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82772340|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
82772341|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772342|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772343|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82772344|NCT00935558|Analgesics|analgesics|mesh-ancestor
82772345|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
82772346|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772347|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82772348|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772349|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772350|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82772351|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
82772352|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82772353|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82772354|NCT00935558|Cathartics|cathartics|mesh-ancestor
82772355|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82772356|NCT05280236|Propofol|propofol|mesh-list
82772357|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82772358|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772359|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772360|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82772361|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
82772362|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
82772363|NCT00940472|Metformin|metformin|mesh-list
82772364|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82772365|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772366|NCT00939926|Risperidone|risperidone|mesh-list
82772367|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82772368|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
82772369|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772370|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772371|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772372|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82772373|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82772374|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772375|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82772376|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82772377|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
82772379|NCT00940550|Zolpidem|zolpidem|mesh-list
82772380|NCT00940550|Temazepam|temazepam|mesh-list
82772381|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
82772382|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772383|NCT00940550|Protective Agents|protective agents|mesh-ancestor
82772384|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772385|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772386|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82772387|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82772388|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82772389|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
82772390|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
82772391|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772392|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82772393|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82772394|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82772395|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
82772396|NCT00940628|Orlistat|orlistat|mesh-list
82772397|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772398|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772399|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82772400|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82772401|NCT00936182|Fluconazole|fluconazole|mesh-list
82772402|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
82772403|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772404|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82772405|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82772406|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772407|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772408|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82772409|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
82772410|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82772411|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772412|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82772413|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82772414|NCT00936260|Alendronate|alendronate|mesh-list
82772415|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82772416|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772417|NCT00445978|Verapamil|verapamil|mesh-list
82772418|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82772419|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82772420|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82772421|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772422|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82772423|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772424|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
82772425|NCT02566733|Remifentanil|remifentanil|mesh-list
82772426|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82772427|NCT02566733|Narcotics|narcotics|mesh-ancestor
82772428|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772429|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772430|NCT02566733|Analgesics|analgesics|mesh-ancestor
82772431|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
82772432|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772433|NCT01028950|Darexaban|darexaban|mesh-list
82772434|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82772435|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
82772436|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82772437|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
82772438|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772439|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772440|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
82772441|NCT00940784|Aspirin|aspirin|mesh-list
82772442|NCT00940784|Clopidogrel|clopidogrel|mesh-list
82772443|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82772444|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82772445|NCT00940784|Analgesics|analgesics|mesh-ancestor
82772446|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
82772447|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772448|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772449|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82772450|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82772451|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82772452|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82772453|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772454|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82772455|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82772456|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772457|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
82772458|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82772459|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82772460|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82772461|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
82772462|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772463|NCT01023490|Vitamin D|vitamin d|mesh-list
82772464|NCT01023490|Vitamins|vitamins|mesh-ancestor
82772465|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
82772466|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772467|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82772468|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
82772469|NCT00698009|Fludarabine|fludarabine|mesh-list
82772470|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
82772471|NCT00698009|Interleukin-2|interleukin-2|mesh-list
82772472|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82772473|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
82772474|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772475|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82772476|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82772477|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
82772478|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772479|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772480|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82772481|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82772482|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
82772483|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82772484|NCT00698009|Analgesics|analgesics|mesh-ancestor
82772485|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
82772486|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772487|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82772488|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
82772489|NCT00944606|Vitamin D|vitamin d|mesh-list
82772490|NCT00944606|Vitamins|vitamins|mesh-ancestor
82772491|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
82772492|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772493|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82772494|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
82772495|NCT05257655|Narcotics|narcotics|mesh-ancestor
82772496|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772497|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772498|NCT05257655|Analgesics|analgesics|mesh-ancestor
82772499|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
82772500|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772501|NCT00944684|Ribavirin|ribavirin|mesh-list
82772502|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
82772503|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772504|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
82772505|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772506|NCT04061057|Lidocaine|lidocaine|mesh-list
82772507|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
82772508|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
82772509|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772510|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772511|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
82772512|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772513|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82772514|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82772515|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82772516|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82772517|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772518|NCT00921167|Bevacizumab|bevacizumab|mesh-list
82772519|NCT00921167|Irinotecan|irinotecan|mesh-list
82772520|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82772521|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772522|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82772523|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82772524|NCT00921167|Growth Substances|growth substances|mesh-ancestor
82772525|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772526|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
82772527|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82772528|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82772529|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772530|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772531|NCT04061447|Clarithromycin|clarithromycin|mesh-list
82772532|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82772533|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772534|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82772535|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772536|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772537|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82772538|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82772539|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82772540|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
82772541|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772542|NCT05472779|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82772543|NCT05472779|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82772544|NCT05472779|Estradiol|estradiol|mesh-list
82772545|NCT05472779|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82772546|NCT05472779|Estrogens|estrogens|mesh-ancestor
82772547|NCT05472779|Hormones|hormones|mesh-ancestor
82772548|NCT05472779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82772549|NCT05472779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772550|NCT05472779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82772551|NCT05472779|Contraceptive Agents|contraceptive agents|mesh-ancestor
82772552|NCT05472779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82772553|NCT05472779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82772554|NCT02565953|Paclitaxel|paclitaxel|mesh-list
82772555|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82772556|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772557|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
82772558|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
82772559|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
82772560|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772561|NCT00562718|Capecitabine|capecitabine|mesh-list
82772562|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82772563|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
82772564|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772565|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772566|NCT05222165|Infigratinib|infigratinib|mesh-list
82772567|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772568|NCT04555811|Rituximab|rituximab|mesh-list
82772569|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82772570|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772571|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
82772572|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772573|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82772574|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
82772575|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82772576|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772577|NCT02566187|Atorvastatin|atorvastatin|mesh-list
82772578|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82772579|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82772580|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
82772581|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772582|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82772583|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82772584|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772585|NCT05324891|Fentanyl|fentanyl|mesh-list
82772586|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
82772587|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82772588|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772589|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772590|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82772591|NCT05324891|Analgesics|analgesics|mesh-ancestor
82772592|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
82772593|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772594|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82772595|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82772596|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82772597|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
82772598|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772599|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772600|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82772601|NCT05324891|Narcotics|narcotics|mesh-ancestor
82772602|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82772603|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82772604|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
82772605|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
82772606|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82772607|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
82772608|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
82772609|NCT04482803|Hormones|hormones|mesh-ancestor
82772610|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82772611|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772612|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772613|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772614|NCT05451329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82772615|NCT05451329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82772616|NCT00445432|Adalimumab|adalimumab|mesh-list
82772617|NCT00445432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82772618|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82772619|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82772620|NCT03370133|Ustekinumab|ustekinumab|mesh-list
82772621|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
82772622|NCT00696137|Fentanyl|fentanyl|mesh-list
82772623|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82772624|NCT00696137|Narcotics|narcotics|mesh-ancestor
82772625|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772626|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772627|NCT00696137|Analgesics|analgesics|mesh-ancestor
82772628|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
82772629|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772630|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82772631|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82772632|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
82772633|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
82772634|NCT02565641|Gemcitabine|gemcitabine|mesh-list
82772635|NCT02565641|Capecitabine|capecitabine|mesh-list
82772636|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82772637|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
82772638|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772639|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772640|NCT04036721|Prednisone|prednisone|mesh-list
82772641|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82772642|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
82772643|NCT04036721|Hormones|hormones|mesh-ancestor
82772644|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82772645|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772646|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82772647|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772648|NCT00441142|Temozolomide|temozolomide|mesh-list
82772649|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82772650|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
82772651|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772652|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772653|NCT03848416|Ixekizumab|ixekizumab|mesh-list
82772654|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
82772655|NCT01029418|Sorafenib|sorafenib|mesh-list
82772656|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772657|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82772658|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772659|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772660|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
82772661|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82772662|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
82772663|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772664|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772665|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82772666|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
82772667|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82772668|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
82772669|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772670|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772671|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82772672|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
82772673|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
82772674|NCT04060979|Protective Agents|protective agents|mesh-ancestor
82772675|NCT00458302|Darunavir|darunavir|mesh-list
82772676|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82772677|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82772678|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
82772679|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772680|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772681|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82772682|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82772683|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
82772684|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772685|NCT00444106|Artesunate|artesunate|mesh-list
82772686|NCT00444106|Lumefantrine|lumefantrine|mesh-list
82772687|NCT00444106|Artemether|artemether|mesh-list
82772688|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82772689|NCT00444106|Mefloquine|mefloquine|mesh-list
82772690|NCT00444106|Atovaquone|atovaquone|mesh-list
82772691|NCT00444106|Proguanil|proguanil|mesh-list
82772692|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
82772693|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
82772694|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82772695|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82772696|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772697|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772698|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
82772699|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
82772700|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82772701|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
82772702|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772703|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772704|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
82772705|NCT00561470|Leucovorin|leucovorin|mesh-list
82772706|NCT00561470|Fluorouracil|fluorouracil|mesh-list
82772707|NCT00561470|Irinotecan|irinotecan|mesh-list
82772708|NCT00561470|Aflibercept|aflibercept|mesh-list
82772709|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
82772710|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
82772711|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772712|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82772713|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772714|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82772715|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
82772716|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772717|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82772718|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82772719|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772720|NCT00561470|Antidotes|antidotes|mesh-ancestor
82772721|NCT00561470|Protective Agents|protective agents|mesh-ancestor
82772722|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
82772723|NCT00561470|Vitamins|vitamins|mesh-ancestor
82772724|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
82772725|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82772726|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82772727|NCT00561470|Growth Substances|growth substances|mesh-ancestor
82772728|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
82772729|NCT00443872|Selegiline|selegiline|mesh-list
82772730|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
82772731|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82772732|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82772733|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82772734|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82772735|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772736|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772737|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82772738|NCT00443872|Protective Agents|protective agents|mesh-ancestor
82772739|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772740|NCT01323244|Simeprevir|simeprevir|mesh-list
82772741|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
82772742|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772743|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
82772744|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772745|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772746|NCT03034642|Dimercaprol|dimercaprol|mesh-list
82772747|NCT03034642|Chelating Agents|chelating agents|mesh-ancestor
82772748|NCT03034642|Sequestering Agents|sequestering agents|mesh-ancestor
82772749|NCT03034642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772750|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
82772751|NCT03840226|Antacids|antacids|mesh-ancestor
82772752|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772753|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82772754|NCT03962738|Lasmiditan|lasmiditan|mesh-list
82772755|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82772756|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
82772757|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772758|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772759|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772760|NCT00561392|Rivastigmine|rivastigmine|mesh-list
82772761|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82772762|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772763|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772764|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
82772765|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772766|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772767|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82772768|NCT00561392|Protective Agents|protective agents|mesh-ancestor
82772769|NCT00694109|Mipomersen|mipomersen|mesh-list
82772770|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82772771|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82772772|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
82772773|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772774|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82772775|NCT03070301|Everolimus|everolimus|mesh-list
82772776|NCT03070301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82772777|NCT03070301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82772778|NCT03070301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772779|NCT03070301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772780|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82772781|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
82772782|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772783|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772784|NCT00940862|Adalimumab|adalimumab|mesh-list
82772785|NCT00940862|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82772786|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82772787|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82772788|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
82772789|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82772790|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772791|NCT00561080|Vaccines|vaccines|mesh-list
82772792|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
82772793|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772794|NCT01307306|Metformin|metformin|mesh-list
82772795|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82772796|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772797|NCT00941096|Timolol|timolol|mesh-list
82772798|NCT00941096|Bimatoprost|bimatoprost|mesh-list
82772799|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82772800|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82772801|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
82772802|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772803|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772804|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772805|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82772806|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82772807|NCT04012424|Curcumin|curcumin|mesh-list
82772808|NCT04012424|Analgesics|analgesics|mesh-list
82772809|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82772810|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82772811|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
82772812|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772813|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772814|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82772815|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82772816|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772817|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772818|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772819|NCT00562094|Pantoprazole|pantoprazole|mesh-list
82772820|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82772821|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82772822|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82772823|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772824|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772825|NCT03817853|Prednisone|prednisone|mesh-list
82772826|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
82772827|NCT03817853|Prednisolone|prednisolone|mesh-list
82772828|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
82772829|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82772830|NCT03817853|Doxorubicin|doxorubicin|mesh-list
82772831|NCT03817853|Vincristine|vincristine|mesh-list
82772832|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
82772833|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82772834|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
82772835|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772836|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82772837|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82772838|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
82772839|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772840|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772841|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82772842|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82772843|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82772844|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82772845|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772846|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82772847|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
82772848|NCT03817853|Hormones|hormones|mesh-ancestor
82772849|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82772850|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82772851|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82772852|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
82772853|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
82772854|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
82772855|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
82772856|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
82772857|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772858|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82772859|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82772860|NCT03817853|Protective Agents|protective agents|mesh-ancestor
82772861|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82772862|NCT00944840|Amodiaquine|amodiaquine|mesh-list
82772863|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
82772864|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82772865|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82772866|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772867|NCT00439270|Docetaxel|docetaxel|mesh-list
82772868|NCT00439270|Dasatinib|dasatinib|mesh-list
82772869|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772870|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
82772871|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
82772872|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
82772873|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772874|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82772875|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772876|NCT00944918|Fulvestrant|fulvestrant|mesh-list
82772877|NCT00944918|Anastrozole|anastrozole|mesh-list
82772878|NCT00944918|Exemestane|exemestane|mesh-list
82772879|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82772880|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772881|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82772882|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82772883|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
82772884|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82772885|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772886|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82772887|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82772888|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772889|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772891|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82772892|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82772893|NCT04012268|Analgesics|analgesics|mesh-ancestor
82772894|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
82772895|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772896|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772897|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82772898|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82772899|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82772900|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82772901|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772902|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82772903|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82772904|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772905|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
82772906|NCT03995134|Remifentanil|remifentanil|mesh-list
82772907|NCT03995134|Propofol|propofol|mesh-list
82772908|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82772909|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772910|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772911|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82772912|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
82772913|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
82772914|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82772915|NCT03995134|Narcotics|narcotics|mesh-ancestor
82772916|NCT03995134|Analgesics|analgesics|mesh-ancestor
82772917|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
82772918|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772919|NCT00553280|Pregabalin|pregabalin|mesh-list
82772920|NCT00553280|Analgesics|analgesics|mesh-ancestor
82772921|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
82772922|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82772923|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772924|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
82772925|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82772926|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82772927|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772928|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82772929|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82772930|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82772931|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772932|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82772933|NCT01024192|Zolpidem|zolpidem|mesh-list
82772934|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82772935|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82772936|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82772937|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772938|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82772939|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
82772941|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772942|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772943|NCT01024270|Misoprostol|misoprostol|mesh-list
82772944|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82772945|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
82772946|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82772947|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772948|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82772949|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82772950|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
82772951|NCT00944996|Citalopram|citalopram|mesh-list
82772952|NCT00944996|Fluoxetine|fluoxetine|mesh-list
82772953|NCT00944996|Paroxetine|paroxetine|mesh-list
82772954|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82772955|NCT00944996|Sertraline|sertraline|mesh-list
82772956|NCT00944996|Clomipramine|clomipramine|mesh-list
82772957|NCT00944996|Escitalopram|escitalopram|mesh-list
82772958|NCT00944996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82772959|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82772960|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82772961|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772962|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82772963|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
82772964|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772965|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82772966|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
82772967|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82772968|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82772969|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82772970|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82772971|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82772972|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82772973|NCT00950066|Amlodipine|amlodipine|mesh-list
82772974|NCT00950066|Irbesartan|irbesartan|mesh-list
82772975|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82772976|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82772977|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82772978|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772979|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82772980|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82772981|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
82772982|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82772983|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82772984|NCT01031212|Acetic Acid|acetic acid|mesh-list
82772985|NCT01031212|Paclitaxel|paclitaxel|mesh-list
82772986|NCT01031212|Carboplatin|carboplatin|mesh-list
82772987|NCT01031212|Cetuximab|cetuximab|mesh-list
82772988|NCT01031212|Vadimezan|vadimezan|mesh-list
82772989|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82772990|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82772991|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
82772992|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
82772993|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
82772994|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82772995|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82772996|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82772997|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82772998|NCT01024348|Acetaminophen|acetaminophen|mesh-list
82772999|NCT01024348|Tramadol|tramadol|mesh-list
82773000|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82773001|NCT01024348|Analgesics|analgesics|mesh-ancestor
82773002|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
82773003|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773004|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773005|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
82773006|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82773007|NCT01024348|Narcotics|narcotics|mesh-ancestor
82773008|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82773009|NCT03994744|Metformin|metformin|mesh-list
82773010|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82773011|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82773012|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773013|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773014|NCT03994744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82773015|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773016|NCT00950222|Imipenem|imipenem|mesh-list
82773017|NCT00950222|Amikacin|amikacin|mesh-list
82773018|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82773019|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773020|NCT05301530|Docetaxel|docetaxel|mesh-list
82773021|NCT05301530|Trastuzumab|trastuzumab|mesh-list
82773022|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773023|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
82773024|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
82773025|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
82773026|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773027|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82773028|NCT00941174|Leucovorin|leucovorin|mesh-list
82773029|NCT00941174|Calcium|calcium|mesh-list
82773030|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
82773031|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82773032|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773033|NCT00941174|Antidotes|antidotes|mesh-ancestor
82773034|NCT00941174|Protective Agents|protective agents|mesh-ancestor
82773035|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
82773036|NCT00941174|Vitamins|vitamins|mesh-ancestor
82773037|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
82773038|NCT00440518|Lacosamide|lacosamide|mesh-list
82773039|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
82773040|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82773041|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82773042|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82773043|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773044|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
82773045|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82773046|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773047|NCT00941252|Imiquimod|imiquimod|mesh-list
82773048|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82773049|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
82773050|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773051|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773052|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
82773053|NCT01031368|Cytarabine|cytarabine|mesh-list
82773054|NCT01031368|Clofarabine|clofarabine|mesh-list
82773055|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82773056|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
82773057|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773058|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773059|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
82773060|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773061|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773062|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
82773063|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773064|NCT00945308|Eptifibatide|eptifibatide|mesh-list
82773065|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82773066|NCT03172936|Spartalizumab|spartalizumab|mesh-list
82773067|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82773068|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773069|NCT03172936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82773070|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773071|NCT01030042|Leucovorin|leucovorin|mesh-list
82773072|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
82773073|NCT01030042|Irinotecan|irinotecan|mesh-list
82773074|NCT01030042|Cetuximab|cetuximab|mesh-list
82773075|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773076|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82773077|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82773078|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773079|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773080|NCT01030042|Antidotes|antidotes|mesh-ancestor
82773081|NCT01030042|Protective Agents|protective agents|mesh-ancestor
82773082|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773083|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
82773084|NCT01030042|Vitamins|vitamins|mesh-ancestor
82773085|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
82773086|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82773087|NCT01024504|Bevacizumab|bevacizumab|mesh-list
82773088|NCT01024504|Capecitabine|capecitabine|mesh-list
82773089|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
82773090|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82773091|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773092|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82773093|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82773094|NCT01024504|Growth Substances|growth substances|mesh-ancestor
82773095|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773096|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
82773097|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82773098|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
82773099|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773101|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82773102|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82773103|NCT01030120|Analgesics|analgesics|mesh-ancestor
82773104|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
82773105|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773106|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773107|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82773108|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773109|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82773110|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773111|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
82773112|NCT00951236|Cortisone|cortisone|mesh-list
82773113|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82773114|NCT00945542|Hemostatics|hemostatics|mesh-list
82773115|NCT00945542|Coagulants|coagulants|mesh-ancestor
82773116|NCT00438256|Capecitabine|capecitabine|mesh-list
82773117|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82773118|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
82773119|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773120|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773121|NCT01031524|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82773122|NCT01031524|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82773123|NCT01031524|Immunologic Factors|immunologic factors|mesh-ancestor
82773124|NCT01031524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773125|NCT00945620|Ropivacaine|ropivacaine|mesh-list
82773126|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
82773127|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
82773128|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82773129|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773130|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
82773131|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773132|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
82773133|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773134|NCT01030510|Rocuronium|rocuronium|mesh-list
82773135|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82773136|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82773137|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82773138|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773139|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773140|NCT04813822|Miconazole|miconazole|mesh-list
82773141|NCT04813822|Clotrimazole|clotrimazole|mesh-list
82773142|NCT04813822|Bromides|bromides|mesh-list
82773143|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
82773144|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
82773145|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773146|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82773147|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82773148|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773149|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773150|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82773151|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
82773152|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82773153|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773154|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82773155|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82773156|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82773157|NCT02917564|Triamcinolone|triamcinolone|mesh-list
82773158|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82773159|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82773160|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82773161|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82773162|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
82773163|NCT02917564|Hormones|hormones|mesh-ancestor
82773164|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82773165|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773166|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773167|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
82773168|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773169|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773170|NCT00952016|Methotrexate|methotrexate|mesh-list
82773171|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82773172|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
82773173|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82773174|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773175|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82773176|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
82773177|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773178|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773179|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
82773180|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773181|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82773182|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773183|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
82773184|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773185|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82773187|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82773188|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773189|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82773190|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
82773191|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82773192|NCT00942344|Losartan|losartan|mesh-list
82773193|NCT00942344|Amlodipine|amlodipine|mesh-list
82773194|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82773195|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82773196|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82773197|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773198|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82773199|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773200|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
82773201|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82773202|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82773203|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82773204|NCT00946166|Simvastatin|simvastatin|mesh-list
82773205|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82773206|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82773207|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
82773208|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773209|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82773210|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82773211|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773212|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
82773213|NCT00952562|Vitamin D|vitamin d|mesh-list
82773214|NCT00952562|Vitamins|vitamins|mesh-ancestor
82773215|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
82773216|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773217|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82773218|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82773219|NCT00952640|Vitamin A|vitamin a|mesh-list
82773220|NCT00952640|Vitamins|vitamins|mesh-ancestor
82773221|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
82773222|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773223|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
82773224|NCT00952796|Ampicillin|ampicillin|mesh-list
82773225|NCT00952796|Sulbactam|sulbactam|mesh-list
82773226|NCT00952796|Sultamicillin|sultamicillin|mesh-list
82773227|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82773228|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773229|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82773230|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82773231|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773232|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773233|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773234|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82773235|NCT00952952|Mesalamine|mesalamine|mesh-list
82773236|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82773237|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82773238|NCT00952952|Analgesics|analgesics|mesh-ancestor
82773239|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
82773240|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773241|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773242|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82773243|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773244|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82773245|NCT00953108|Escitalopram|escitalopram|mesh-list
82773246|NCT00953108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82773247|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82773248|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82773249|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773250|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773251|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
82773252|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773253|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
82773254|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82773255|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82773256|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82773257|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82773258|NCT00953498|Pioglitazone|pioglitazone|mesh-list
82773259|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
82773260|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82773261|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773262|NCT00943358|Vaccines|vaccines|mesh-list
82773263|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
82773264|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773265|NCT00120289|Niacin|niacin|mesh-list
82773266|NCT00120289|Simvastatin|simvastatin|mesh-list
82773267|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82773268|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82773269|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
82773270|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773271|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82773272|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82773273|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773274|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
82773275|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
82773276|NCT00120289|Vitamins|vitamins|mesh-ancestor
82773277|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
82773278|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773279|NCT00946556|Valacyclovir|valacyclovir|mesh-list
82773280|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
82773281|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773282|NCT00943748|Deferiprone|deferiprone|mesh-list
82773283|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82773284|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
82773285|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
82773286|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773287|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
82773288|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
82773289|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82773290|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82773291|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773292|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773293|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773294|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773295|NCT00954200|Ibuprofen|ibuprofen|mesh-list
82773296|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82773297|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82773298|NCT00954200|Analgesics|analgesics|mesh-ancestor
82773299|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
82773300|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773301|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773302|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82773303|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773304|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82773305|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773306|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773307|NCT00954278|Sorafenib|sorafenib|mesh-list
82773308|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773309|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82773310|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773311|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773312|NCT00550446|Adalimumab|adalimumab|mesh-list
82773313|NCT00550446|Tofacitinib|tofacitinib|mesh-list
82773314|NCT00550446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82773315|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82773316|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773317|NCT00550446|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82773318|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82773319|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773320|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773321|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82773322|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
82773323|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773324|NCT00953550|Rocuronium|rocuronium|mesh-list
82773325|NCT00953550|Succinylcholine|succinylcholine|mesh-list
82773326|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82773327|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82773328|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82773329|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773330|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773331|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
82773332|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82773333|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82773334|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773336|NCT00949026|Temsirolimus|temsirolimus|mesh-list
82773337|NCT00949026|MTOR Inhibitors|mtor inhibitors|mesh-list
82773338|NCT00949026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82773339|NCT00949026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773340|NCT00949026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773341|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773342|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
82773343|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773344|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773345|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82773346|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773347|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82773348|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
82773349|NCT00436618|Everolimus|everolimus|mesh-list
82773350|NCT00436618|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82773351|NCT00436618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82773352|NCT00436618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773353|NCT00436618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773354|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773355|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
82773356|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773357|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773358|NCT01024660|Donepezil|donepezil|mesh-list
82773359|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82773360|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773361|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773362|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
82773363|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773364|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773365|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
82773366|NCT01751126|Cyclosporine|cyclosporine|mesh-list
82773367|NCT01751126|Cyclosporins|cyclosporins|mesh-list
82773368|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773369|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773370|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773371|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
82773372|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773373|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
82773374|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773375|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
82773376|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773377|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82773378|NCT00943982|Interferons|interferons|mesh-list
82773379|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
82773380|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773381|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
82773382|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773383|NCT00548808|Insulin|insulin|mesh-list
82773384|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82773385|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
82773386|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
82773387|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82773388|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773389|NCT04011878|Mitomycins|mitomycins|mesh-list
82773390|NCT04011878|Mitomycin|mitomycin|mesh-list
82773391|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82773392|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773393|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
82773394|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773395|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82773396|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773397|NCT00954096|Nicotine|nicotine|mesh-list
82773398|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82773399|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
82773400|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773401|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773402|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82773403|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82773404|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
82773405|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773406|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773407|NCT00954252|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
82773408|NCT00954252|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82773409|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773410|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773411|NCT00110617|Deferasirox|deferasirox|mesh-list
82773412|NCT00110617|Deferoxamine|deferoxamine|mesh-list
82773413|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82773414|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
82773415|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
82773416|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773417|NCT00110617|Siderophores|siderophores|mesh-ancestor
82773419|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
82773420|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
82773421|NCT00949494|Protective Agents|protective agents|mesh-ancestor
82773422|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773423|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82773424|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
82773425|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
82773426|NCT00954486|Hematinics|hematinics|mesh-ancestor
82773427|NCT00550238|Pimavanserin|pimavanserin|mesh-list
82773428|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82773429|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82773430|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82773431|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82773432|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82773433|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773434|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82773435|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82773436|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82773437|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
82773438|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773439|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773440|NCT02903680|Dexamethasone|dexamethasone|mesh-list
82773441|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
82773442|NCT02903680|BB 1101|bb 1101|mesh-list
82773443|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82773444|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
82773445|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
82773446|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773447|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773448|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82773449|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
82773450|NCT02903680|Hormones|hormones|mesh-ancestor
82773451|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82773452|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82773453|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773454|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
82773455|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773456|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773457|NCT00946946|Mesalamine|mesalamine|mesh-list
82773458|NCT00946946|Azathioprine|azathioprine|mesh-list
82773459|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
82773460|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773461|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82773462|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773463|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773464|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
82773465|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773466|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773467|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82773468|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82773469|NCT00946946|Analgesics|analgesics|mesh-ancestor
82773470|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
82773471|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773472|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82773473|NCT00947024|Glipizide|glipizide|mesh-list
82773474|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82773475|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773476|NCT00949572|Vaccines|vaccines|mesh-list
82773477|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
82773478|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
82773479|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773480|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82773481|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
82773482|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82773483|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82773484|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773485|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
82773486|NCT01031992|Coagulants|coagulants|mesh-ancestor
82773487|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82773488|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82773489|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773490|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773491|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82773492|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
82773493|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82773494|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773495|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82773496|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
82773497|NCT00949728|Coagulants|coagulants|mesh-ancestor
82773498|NCT00954902|Antioxidants|antioxidants|mesh-list
82773499|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773500|NCT00954902|Protective Agents|protective agents|mesh-ancestor
82773501|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773502|NCT01034020|Nicotine|nicotine|mesh-list
82773503|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82773504|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
82773505|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773506|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773507|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82773508|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82773509|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
82773510|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773511|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773512|NCT01032148|Panobinostat|panobinostat|mesh-list
82773513|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773514|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82773515|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773516|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773517|NCT01032304|Erdosteine|erdosteine|mesh-list
82773518|NCT01032304|Expectorants|expectorants|mesh-ancestor
82773519|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
82773520|NCT00954642|Paclitaxel|paclitaxel|mesh-list
82773521|NCT00954642|Bevacizumab|bevacizumab|mesh-list
82773522|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82773523|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773524|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
82773525|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
82773526|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
82773527|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773528|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82773529|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82773530|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82773531|NCT00954642|Growth Substances|growth substances|mesh-ancestor
82773532|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773533|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
82773534|NCT00954798|Vaccines|vaccines|mesh-list
82773535|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
82773536|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773537|NCT00110305|Efavirenz|efavirenz|mesh-list
82773538|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
82773540|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82773541|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773542|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773543|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
82773544|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773545|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82773546|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82773547|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82773548|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82773549|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82773550|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82773551|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82773552|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82773553|NCT00560066|Vaccines|vaccines|mesh-list
82773554|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
82773555|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773556|NCT00549900|Vaccines|vaccines|mesh-list
82773557|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
82773558|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773559|NCT00435994|Epinephrine|epinephrine|mesh-list
82773560|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82773561|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82773562|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
82773563|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773564|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773565|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773566|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82773567|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82773568|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
82773569|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773570|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82773571|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
82773572|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
82773573|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
82773574|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82773575|NCT01563120|Metformin|metformin|mesh-list
82773576|NCT01563120|Glyburide|glyburide|mesh-list
82773577|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82773578|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773579|NCT00435370|Tropisetron|tropisetron|mesh-list
82773580|NCT00435370|Risperidone|risperidone|mesh-list
82773581|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82773582|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
82773583|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773584|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773585|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773586|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82773587|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82773588|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82773589|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82773590|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82773591|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
82773592|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
82773593|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
82773594|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773595|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82773596|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82773597|NCT00096031|Cetuximab|cetuximab|mesh-list
82773598|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82773599|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773600|NCT00118417|Clonazepam|clonazepam|mesh-list
82773601|NCT00118417|Sertraline|sertraline|mesh-list
82773602|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
82773603|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82773604|NCT00118417|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82773605|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82773606|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82773607|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773608|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773609|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
82773610|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773611|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
82773612|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
82773614|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82773615|NCT01079455|Corticosterone|corticosterone|mesh-list
82773616|NCT01079455|Bupivacaine|bupivacaine|mesh-list
82773617|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
82773618|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
82773619|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
82773620|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82773621|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773622|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
82773623|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773624|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82773625|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
82773626|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
82773627|NCT01079455|Protective Agents|protective agents|mesh-ancestor
82773628|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82773629|NCT00549848|Cytarabine|cytarabine|mesh-list
82773630|NCT00549848|Dexamethasone|dexamethasone|mesh-list
82773631|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
82773632|NCT00549848|Prednisone|prednisone|mesh-list
82773633|NCT00549848|Prednisolone|prednisolone|mesh-list
82773634|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
82773635|NCT00549848|Doxorubicin|doxorubicin|mesh-list
82773636|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82773637|NCT00549848|Methotrexate|methotrexate|mesh-list
82773638|NCT00549848|Etoposide|etoposide|mesh-list
82773639|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
82773640|NCT00549848|Vincristine|vincristine|mesh-list
82773641|NCT00549848|Daunorubicin|daunorubicin|mesh-list
82773642|NCT00549848|Asparaginase|asparaginase|mesh-list
82773643|NCT00549848|Dasatinib|dasatinib|mesh-list
82773644|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
82773645|NCT00549848|Clofarabine|clofarabine|mesh-list
82773646|NCT00549848|Pegaspargase|pegaspargase|mesh-list
82773647|NCT00549848|Thioguanine|thioguanine|mesh-list
82773648|NCT00549848|BB 1101|bb 1101|mesh-list
82773649|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773650|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
82773651|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773652|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773653|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82773654|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
82773655|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773656|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773657|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82773658|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82773659|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
82773660|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
82773661|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773662|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82773663|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
82773664|NCT00549848|Hormones|hormones|mesh-ancestor
82773665|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82773666|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82773667|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
82773668|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773669|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82773670|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82773671|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82773672|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82773673|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
82773674|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82773675|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82773676|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
82773677|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
82773678|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82773679|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82773680|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82773681|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
82773682|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773683|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
82773684|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
82773685|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
82773686|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82773687|NCT01083589|Docetaxel|docetaxel|mesh-list
82773688|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
82773689|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773690|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
82773691|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
82773692|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
82773693|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773694|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82773695|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773696|NCT00949182|Doxorubicin|doxorubicin|mesh-list
82773697|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82773698|NCT00949182|Mitomycins|mitomycins|mesh-list
82773699|NCT00949182|Mitomycin|mitomycin|mesh-list
82773700|NCT00949182|Sorafenib|sorafenib|mesh-list
82773701|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82773702|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773703|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82773704|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82773705|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773706|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773707|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82773708|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
82773709|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82773710|NCT00549770|Valsartan|valsartan|mesh-list
82773711|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82773712|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82773713|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82773714|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82773715|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773716|NCT00548184|Trastuzumab|trastuzumab|mesh-list
82773717|NCT00548184|Lapatinib|lapatinib|mesh-list
82773718|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82773719|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773720|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82773721|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773722|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773724|NCT00454636|Docetaxel|docetaxel|mesh-list
82773725|NCT00454636|Capecitabine|capecitabine|mesh-list
82773726|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
82773727|NCT00454636|Epirubicin|epirubicin|mesh-list
82773728|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773729|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
82773730|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
82773731|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
82773732|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773733|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82773734|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
82773735|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82773736|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82773737|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82773738|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773739|NCT00427960|Atorvastatin|atorvastatin|mesh-list
82773740|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82773741|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82773742|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82773743|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
82773744|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773745|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82773746|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82773747|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773748|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
82773749|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82773750|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773751|NCT04768686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82773752|NCT04768686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773753|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
82773754|NCT00955890|Razoxane|razoxane|mesh-list
82773755|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773756|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82773757|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82773758|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82773759|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773760|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773761|NCT00955890|Protective Agents|protective agents|mesh-ancestor
82773762|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773763|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
82773764|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
82773765|NCT00956046|Vaccines|vaccines|mesh-list
82773766|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
82773767|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773768|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
82773769|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
82773770|NCT00454246|Hematinics|hematinics|mesh-ancestor
82773771|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
82773772|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82773773|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773774|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82773775|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
82773776|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82773777|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773778|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773779|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773781|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
82773782|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773783|NCT00695903|Vancomycin|vancomycin|mesh-list
82773784|NCT00695903|Daptomycin|daptomycin|mesh-list
82773785|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82773786|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773787|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
82773788|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
82773789|NCT02759861|Ledipasvir|ledipasvir|mesh-list
82773790|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
82773791|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773792|NCT00548262|Voriconazole|voriconazole|mesh-list
82773793|NCT00548262|Anidulafungin|anidulafungin|mesh-list
82773794|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
82773795|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773796|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82773797|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82773798|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773799|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773800|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82773801|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
82773802|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82773803|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773804|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82773805|NCT02565173|Timolol|timolol|mesh-list
82773806|NCT02565173|Adenosine|adenosine|mesh-list
82773807|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82773808|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82773809|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
82773810|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773811|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773812|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773813|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82773814|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82773815|NCT02565173|Analgesics|analgesics|mesh-ancestor
82773816|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
82773817|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773818|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
82773819|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82773820|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
82773821|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
82773822|NCT02730923|Anastrozole|anastrozole|mesh-list
82773823|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82773824|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773825|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82773826|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82773827|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773828|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773829|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82773830|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
82773831|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82773832|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773833|NCT04619082|Tenofovir|tenofovir|mesh-list
82773834|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
82773835|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773836|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82773837|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82773838|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773839|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773840|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82773841|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82773842|NCT03717623|Posaconazole|posaconazole|mesh-list
82773843|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
82773844|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773845|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82773846|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82773847|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82773848|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82773849|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82773850|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773851|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773852|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82773853|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
82773854|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82773855|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773857|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82773858|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773859|NCT00095173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82773860|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773861|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773862|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
82773863|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773864|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773865|NCT03704753|Ropivacaine|ropivacaine|mesh-list
82773866|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
82773867|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
82773868|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82773869|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773870|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
82773871|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773872|NCT00690443|Atorvastatin|atorvastatin|mesh-list
82773873|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82773874|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82773875|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
82773876|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773877|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82773878|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82773879|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773880|NCT03954834|Tirzepatide|tirzepatide|mesh-list
82773881|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82773882|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773883|NCT03954834|Incretins|incretins|mesh-ancestor
82773884|NCT03954834|Hormones|hormones|mesh-ancestor
82773885|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82773886|NCT00693017|Zonisamide|zonisamide|mesh-list
82773887|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
82773888|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82773889|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82773890|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773891|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82773892|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773893|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
82773894|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82773895|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
82773896|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
82773897|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82773898|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82773899|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773900|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773901|NCT00692237|Urological Agents|urological agents|mesh-ancestor
82773902|NCT00110149|Rituximab|rituximab|mesh-list
82773903|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82773904|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773905|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
82773906|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773907|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773908|NCT01084057|Vorinostat|vorinostat|mesh-list
82773909|NCT01084057|Epothilone B|epothilone b|mesh-list
82773910|NCT01084057|Epothilones|epothilones|mesh-list
82773911|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773912|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82773913|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773914|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773915|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
82773916|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
82773917|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
82773918|NCT03954444|Phenylephrine|phenylephrine|mesh-list
82773919|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
82773920|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82773921|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82773922|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
82773923|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773924|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773925|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773926|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
82773927|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
82773928|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773929|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
82773930|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82773931|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
82773932|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82773933|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
82773934|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82773935|NCT03954444|Protective Agents|protective agents|mesh-ancestor
82773936|NCT03953820|Diazepam|diazepam|mesh-list
82773937|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82773938|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
82773939|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
82773940|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
82773941|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82773942|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773943|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82773944|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82773945|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82773946|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82773947|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82773948|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82773949|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82773950|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82773951|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82773952|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
82773953|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
82773954|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
82773955|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
82773956|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773957|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773958|NCT02611037|Gemcitabine|gemcitabine|mesh-list
82773959|NCT02611037|Methotrexate|methotrexate|mesh-list
82773960|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82773961|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82773962|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
82773963|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773964|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82773965|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
82773966|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82773967|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773968|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
82773969|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773970|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82773971|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82773972|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
82773973|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82773974|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82773975|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
82773976|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82773977|NCT04492956|Ecopipam|ecopipam|mesh-list
82773978|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82773979|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82773980|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82773981|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773982|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82773983|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82773984|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
82773985|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82773986|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82773987|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82773988|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
82773989|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82773990|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82773991|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82773992|NCT00742937|Vitamin A|vitamin a|mesh-list
82773993|NCT00742937|Vitamins|vitamins|mesh-ancestor
82773994|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
82773995|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82773996|NCT00692003|Zonisamide|zonisamide|mesh-list
82773997|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
82773998|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82773999|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82774000|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774001|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82774002|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774003|NCT02564315|Nicotine|nicotine|mesh-list
82774004|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82774005|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
82774006|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774007|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774008|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82774009|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82774010|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
82774011|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774012|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774013|NCT02564237|Vaccines|vaccines|mesh-list
82774014|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
82774015|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774016|NCT00427648|Lidocaine|lidocaine|mesh-list
82774017|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
82774018|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
82774019|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82774020|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774021|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
82774022|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774023|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82774024|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82774025|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82774026|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82774027|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774028|NCT02153177|Acetaminophen|acetaminophen|mesh-list
82774029|NCT02153177|Ibuprofen|ibuprofen|mesh-list
82774030|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82774031|NCT02153177|Hydrocodone|hydrocodone|mesh-list
82774032|NCT02153177|Oxycodone|oxycodone|mesh-list
82774033|NCT02153177|Omeprazole|omeprazole|mesh-list
82774034|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82774035|NCT02153177|Analgesics|analgesics|mesh-ancestor
82774036|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
82774037|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774038|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774039|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
82774040|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82774041|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82774042|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82774043|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82774044|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774045|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774046|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82774047|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82774048|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82774049|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82774050|NCT02153177|Narcotics|narcotics|mesh-ancestor
82774051|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82774052|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
82774053|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
82774054|NCT00743327|Pioglitazone|pioglitazone|mesh-list
82774055|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82774056|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774057|NCT02564861|DS-1971a|ds-1971a|mesh-list
82774058|NCT02564861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82774059|NCT02564861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82774060|NCT02564861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82774061|NCT02564861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774062|NCT00416884|Fludarabine|fludarabine|mesh-list
82774063|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
82774064|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774065|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82774066|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82774067|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82774068|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774069|NCT00555620|Capecitabine|capecitabine|mesh-list
82774070|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
82774071|NCT00555620|Sunitinib|sunitinib|mesh-list
82774072|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774073|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82774074|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
82774075|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774076|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82774077|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82774078|NCT00555620|Growth Substances|growth substances|mesh-ancestor
82774079|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774080|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
82774081|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82774082|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774083|NCT00433966|Paclitaxel|paclitaxel|mesh-list
82774084|NCT00433966|Heparin|heparin|mesh-list
82774085|NCT00433966|Calcium heparin|calcium heparin|mesh-list
82774086|NCT00433966|Bivalirudin|bivalirudin|mesh-list
82774087|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82774088|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774089|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
82774090|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
82774091|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
82774092|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774093|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
82774094|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82774095|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82774096|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
82774097|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82774098|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
82774099|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774100|NCT03463265|Sirolimus|sirolimus|mesh-list
82774101|NCT03463265|Bevacizumab|bevacizumab|mesh-list
82774102|NCT03463265|Temozolomide|temozolomide|mesh-list
82774103|NCT03463265|Temsirolimus|temsirolimus|mesh-list
82774104|NCT03463265|Lomustine|lomustine|mesh-list
82774105|NCT03463265|MTOR Inhibitors|mtor inhibitors|mesh-list
82774106|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82774107|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774108|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82774109|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82774110|NCT03463265|Growth Substances|growth substances|mesh-ancestor
82774111|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774112|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
82774113|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82774114|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
82774115|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774116|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82774117|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774118|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82774119|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
82774120|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82774121|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
82774122|NCT03463265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82774123|NCT03463265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774125|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82774126|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774127|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82774128|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82774129|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774130|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774131|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774132|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82774133|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82774134|NCT00955214|Paclitaxel|paclitaxel|mesh-list
82774135|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82774136|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774137|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
82774138|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
82774139|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
82774140|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774141|NCT00956462|Dexamethasone|dexamethasone|mesh-list
82774142|NCT00956462|Ketorolac|ketorolac|mesh-list
82774143|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
82774144|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82774145|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
82774146|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
82774147|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774148|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774149|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82774150|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
82774151|NCT00956462|Hormones|hormones|mesh-ancestor
82774152|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82774153|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82774154|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774155|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82774156|NCT00956462|Analgesics|analgesics|mesh-ancestor
82774157|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
82774158|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82774159|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82774160|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774161|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774162|NCT05300360|Adenosine|adenosine|mesh-list
82774163|NCT05300360|Analgesics|analgesics|mesh-ancestor
82774164|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
82774165|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774166|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774167|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82774168|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
82774169|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82774170|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
82774171|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
82774172|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774173|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774174|NCT00956696|Topiramate|topiramate|mesh-list
82774175|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
82774176|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82774177|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774178|NCT03952650|Chloroquine|chloroquine|mesh-list
82774179|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
82774180|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
82774181|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82774182|NCT03952650|Ibuprofen|ibuprofen|mesh-list
82774183|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82774184|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82774185|NCT03952650|Analgesics|analgesics|mesh-ancestor
82774186|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
82774187|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774188|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774189|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82774190|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82774191|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82774192|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774193|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774194|NCT03952650|Amebicides|amebicides|mesh-ancestor
82774195|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82774196|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82774197|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774198|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
82774199|NCT03952650|Filaricides|filaricides|mesh-ancestor
82774200|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
82774201|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
82774202|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82774203|NCT00955526|Istradefylline|istradefylline|mesh-list
82774204|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
82774205|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82774206|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82774207|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
82774208|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774209|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774210|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774211|NCT00955604|Rasagiline|rasagiline|mesh-list
82774212|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
82774213|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82774214|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82774215|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774216|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774217|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82774218|NCT00955604|Protective Agents|protective agents|mesh-ancestor
82774219|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774220|NCT03623646|Immunomodulating Agents|immunomodulating agents|mesh-list
82774221|NCT03623646|Immunologic Factors|immunologic factors|mesh-ancestor
82774222|NCT03623646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774223|NCT00962286|Furosemide|furosemide|mesh-list
82774224|NCT00962286|Diuretics|diuretics|mesh-ancestor
82774225|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
82774226|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774227|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82774228|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82774229|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774230|NCT00691301|Pemetrexed|pemetrexed|mesh-list
82774231|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774232|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774233|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774234|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82774235|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82774236|NCT05277480|Apatinib|apatinib|mesh-list
82774237|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774238|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82774239|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774240|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774241|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
82774242|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774243|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82774244|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774245|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774246|NCT02564003|Oxycodone|oxycodone|mesh-list
82774247|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82774248|NCT02564003|Narcotics|narcotics|mesh-ancestor
82774249|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82774250|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774251|NCT02564003|Analgesics|analgesics|mesh-ancestor
82774252|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
82774253|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774254|NCT00956150|Rifaximin|rifaximin|mesh-list
82774255|NCT00956150|Lactulose|lactulose|mesh-list
82774256|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82774257|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774258|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82774259|NCT00923663|Lenalidomide|lenalidomide|mesh-list
82774260|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
82774261|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774262|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82774263|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82774264|NCT00923663|Growth Substances|growth substances|mesh-ancestor
82774265|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
82774266|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774267|NCT03284502|Cetuximab|cetuximab|mesh-list
82774268|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82774269|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774270|NCT00743873|Mitogens|mitogens|mesh-list
82774271|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
82774272|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774273|NCT04011098|Fentanyl|fentanyl|mesh-list
82774274|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82774275|NCT04011098|Narcotics|narcotics|mesh-ancestor
82774276|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82774277|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774278|NCT04011098|Analgesics|analgesics|mesh-ancestor
82774279|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
82774280|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774281|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82774282|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82774283|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
82774284|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
82774285|NCT00927563|Tolcapone|tolcapone|mesh-list
82774286|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82774287|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82774288|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82774289|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774290|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774291|NCT00956306|Udenafil|udenafil|mesh-list
82774292|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82774293|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82774294|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774295|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774296|NCT00775229|Naltrexone|naltrexone|mesh-list
82774297|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82774298|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82774299|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774300|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
82774301|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774302|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
82774303|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82774304|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
82774305|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774306|NCT00962442|Expectorants|expectorants|mesh-ancestor
82774307|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
82774308|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82774309|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
82774310|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774311|NCT00962442|Protective Agents|protective agents|mesh-ancestor
82774312|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774313|NCT00962442|Antidotes|antidotes|mesh-ancestor
82774314|NCT00957320|Sirolimus|sirolimus|mesh-list
82774315|NCT00957320|Asparaginase|asparaginase|mesh-list
82774316|NCT00957320|Pegaspargase|pegaspargase|mesh-list
82774317|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82774318|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774319|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82774320|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774321|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
82774322|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82774323|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
82774324|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774326|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
82774327|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82774328|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
82774329|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82774330|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774331|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82774332|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82774333|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82774334|NCT00653159|Trace Elements|trace elements|mesh-ancestor
82774335|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
82774336|NCT03047070|Lidocaine|lidocaine|mesh-list
82774337|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
82774338|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
82774339|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82774340|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774341|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
82774342|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774343|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82774344|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82774345|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82774346|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82774347|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774348|NCT00948272|Vaccines|vaccines|mesh-list
82774349|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
82774350|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774351|NCT00957554|Amlodipine|amlodipine|mesh-list
82774352|NCT00957554|Irbesartan|irbesartan|mesh-list
82774353|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82774354|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82774355|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82774356|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774357|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82774358|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774359|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
82774360|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82774361|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82774362|NCT03024684|Atorvastatin|atorvastatin|mesh-list
82774363|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82774364|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82774365|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
82774366|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774367|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82774368|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82774369|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774371|NCT00744107|Trace Elements|trace elements|mesh-ancestor
82774372|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
82774373|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774374|NCT00117637|Interferons|interferons|mesh-list
82774375|NCT00117637|Sorafenib|sorafenib|mesh-list
82774376|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774377|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
82774378|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774379|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82774380|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774381|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774382|NCT00744185|Propranolol|propranolol|mesh-list
82774383|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82774384|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82774385|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
82774386|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774387|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774388|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774389|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82774390|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82774391|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
82774392|NCT02897778|Entinostat|entinostat|mesh-list
82774393|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774394|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82774395|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774396|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774397|NCT01084291|Vaccines|vaccines|mesh-list
82774398|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
82774399|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774400|NCT00741767|Fluticasone|fluticasone|mesh-list
82774401|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82774402|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82774403|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82774404|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82774405|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
82774406|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774407|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774408|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82774409|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
82774410|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
82774411|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82774412|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82774413|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82774414|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82774415|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
82774416|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774417|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774418|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
82774419|NCT00741767|Hormones|hormones|mesh-ancestor
82774420|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82774421|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
82774422|NCT00741845|Metronidazole|metronidazole|mesh-list
82774423|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774424|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82774425|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82774426|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82774427|NCT00746447|Mesalamine|mesalamine|mesh-list
82774428|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82774429|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82774430|NCT00746447|Analgesics|analgesics|mesh-ancestor
82774431|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
82774432|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774433|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774434|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82774435|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82774436|NCT00744419|Pantoprazole|pantoprazole|mesh-list
82774437|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82774438|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82774439|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82774440|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774441|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774442|NCT00742157|Hormones|hormones|mesh-list
82774443|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82774444|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774445|NCT00549302|Tadalafil|tadalafil|mesh-list
82774446|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
82774674|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
82774447|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82774448|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82774449|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774450|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774451|NCT00549302|Urological Agents|urological agents|mesh-ancestor
82774452|NCT04277858|Cisplatin|cisplatin|mesh-list
82774453|NCT04277858|Docetaxel|docetaxel|mesh-list
82774454|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774455|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
82774456|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
82774457|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
82774458|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774459|NCT00957866|Interferons|interferons|mesh-list
82774460|NCT00957866|Ribavirin|ribavirin|mesh-list
82774461|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774462|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
82774463|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774464|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
82774465|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774466|NCT00958022|Carboplatin|carboplatin|mesh-list
82774467|NCT00958022|Etoposide|etoposide|mesh-list
82774468|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
82774469|NCT00958022|Panobinostat|panobinostat|mesh-list
82774470|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
82774471|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774472|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82774473|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82774474|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82774475|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774476|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774477|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82774478|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
82774479|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
82774480|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
82774481|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
82774482|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
82774483|NCT00958100|Tenofovir|tenofovir|mesh-list
82774484|NCT00958100|Lamivudine|lamivudine|mesh-list
82774485|NCT00958100|Emtricitabine|emtricitabine|mesh-list
82774486|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
82774487|NCT00958100|Abacavir|abacavir|mesh-list
82774488|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
82774489|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
82774490|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774491|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82774492|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82774493|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774494|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774495|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82774496|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82774497|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82774498|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82774499|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
82774500|NCT00948584|Insulin|insulin|mesh-list
82774501|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82774502|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
82774503|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82774504|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774505|NCT00948662|Ketoconazole|ketoconazole|mesh-list
82774506|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
82774507|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774508|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82774509|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82774510|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774511|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774512|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82774513|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
82774514|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82774515|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774516|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82774517|NCT00948740|Vitamin D|vitamin d|mesh-list
82774518|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
82774519|NCT00948740|Vitamins|vitamins|mesh-ancestor
82774520|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
82774521|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774522|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82774902|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
82774523|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82774524|NCT00108433|Vancomycin|vancomycin|mesh-list
82774525|NCT00108433|Cefazolin|cefazolin|mesh-list
82774526|NCT00108433|Linezolid|linezolid|mesh-list
82774527|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82774528|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774529|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82774530|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774531|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774532|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
82774533|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82774534|NCT01084369|Testosterone|testosterone|mesh-list
82774535|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
82774536|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
82774537|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82774538|NCT01084369|Androgens|androgens|mesh-ancestor
82774539|NCT01084369|Hormones|hormones|mesh-ancestor
82774540|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82774541|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774542|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82774543|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774544|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
82774545|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
82774546|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82774547|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82774548|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774549|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774550|NCT01084369|Urological Agents|urological agents|mesh-ancestor
82774551|NCT00949130|Linezolid|linezolid|mesh-list
82774552|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82774553|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774554|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82774555|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774556|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774557|NCT02815592|Carboplatin|carboplatin|mesh-list
82774558|NCT02815592|Etoposide|etoposide|mesh-list
82774559|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774560|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82774561|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82774562|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82774563|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774564|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774565|NCT04010318|Anesthetics|anesthetics|mesh-list
82774566|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82774567|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774568|NCT00108355|Octreotide|octreotide|mesh-list
82774569|NCT00108355|Midodrine|midodrine|mesh-list
82774570|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82774571|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82774572|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774573|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
82774574|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
82774575|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774576|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774577|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82774578|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82774579|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82774580|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82774581|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
82774582|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774583|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774585|NCT00963222|Vitamins|vitamins|mesh-ancestor
82774586|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
82774587|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774588|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82774589|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82774590|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774591|NCT00968682|Trastuzumab|trastuzumab|mesh-list
82774592|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82774593|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774594|NCT00968760|Cytarabine|cytarabine|mesh-list
82774595|NCT00968760|Etoposide|etoposide|mesh-list
82774596|NCT00968760|Melphalan|melphalan|mesh-list
82774597|NCT00968760|Interleukin-2|interleukin-2|mesh-list
82774598|NCT00968760|Carmustine|carmustine|mesh-list
82774599|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82774600|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774601|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82774602|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82774603|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774604|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774605|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82774606|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
82774607|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
82774608|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774609|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82774610|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
82774611|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774612|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82774613|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
82774614|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82774615|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82774617|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
82774618|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774619|NCT02465138|Ketorolac|ketorolac|mesh-list
82774620|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82774621|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82774622|NCT02465138|Analgesics|analgesics|mesh-ancestor
82774623|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
82774624|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774625|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774626|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82774627|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82774628|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82774629|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774630|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774631|NCT00968994|Petrolatum|petrolatum|mesh-list
82774632|NCT00968994|Emollients|emollients|mesh-ancestor
82774633|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
82774634|NCT00969072|Dutasteride|dutasteride|mesh-list
82774635|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82774636|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82774637|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774638|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774639|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
82774640|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82774641|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774642|NCT00094861|Paclitaxel|paclitaxel|mesh-list
82774643|NCT00094861|Carboplatin|carboplatin|mesh-list
82774644|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82774645|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774646|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
82774647|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
82774648|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
82774649|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774650|NCT00963534|Rituximab|rituximab|mesh-list
82774651|NCT00963534|Lenalidomide|lenalidomide|mesh-list
82774652|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82774653|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82774654|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774655|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
82774656|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774657|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82774658|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82774659|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82774660|NCT00963534|Growth Substances|growth substances|mesh-ancestor
82774661|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
82774662|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82774663|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
82774664|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774665|NCT00963690|Hemostatics|hemostatics|mesh-list
82774666|NCT00963690|Coagulants|coagulants|mesh-ancestor
82774667|NCT01079767|Sirolimus|sirolimus|mesh-list
82774668|NCT01079767|Temsirolimus|temsirolimus|mesh-list
82774669|NCT01079767|MTOR Inhibitors|mtor inhibitors|mesh-list
82774670|NCT01079767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82774671|NCT01079767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774672|NCT01079767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774673|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82774675|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774676|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774677|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82774678|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774679|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82774680|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
82774681|NCT00969306|Chloroquine|chloroquine|mesh-list
82774682|NCT00969306|Amebicides|amebicides|mesh-ancestor
82774683|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82774684|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82774685|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774686|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
82774687|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82774688|NCT00963768|Canagliflozin|canagliflozin|mesh-list
82774689|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82774690|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774691|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82774692|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774693|NCT00969462|Doxorubicin|doxorubicin|mesh-list
82774694|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82774695|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774696|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82774697|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82774698|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774699|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774700|NCT00963846|Huperzine A|huperzine a|mesh-list
82774701|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82774702|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774703|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774704|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
82774705|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774706|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774707|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82774708|NCT00963846|Protective Agents|protective agents|mesh-ancestor
82774709|NCT00969696|Galantamine|galantamine|mesh-list
82774710|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82774711|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774712|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774713|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
82774714|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774715|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774716|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82774717|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
82774718|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774719|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
82774720|NCT00958854|Thalidomide|thalidomide|mesh-list
82774721|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
82774722|NCT00958854|Fludarabine|fludarabine|mesh-list
82774723|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
82774724|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82774725|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
82774726|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774727|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82774728|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82774729|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
82774730|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774731|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774732|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82774733|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82774734|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
82774735|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
82774736|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82774737|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774738|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82774739|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82774740|NCT00958854|Growth Substances|growth substances|mesh-ancestor
82774741|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
82774743|NCT00964080|Fluorouracil|fluorouracil|mesh-list
82774744|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
82774745|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
82774746|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774747|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82774748|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774749|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82774750|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
82774751|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774752|NCT00964080|Antidotes|antidotes|mesh-ancestor
82774753|NCT00964080|Protective Agents|protective agents|mesh-ancestor
82774754|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
82774756|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
82774757|NCT00969852|Sertraline|sertraline|mesh-list
82774758|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
82774759|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82774760|NCT00969852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82774761|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82774762|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82774763|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774764|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774765|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
82774766|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774767|NCT00426556|Paclitaxel|paclitaxel|mesh-list
82774768|NCT00426556|Trastuzumab|trastuzumab|mesh-list
82774769|NCT00426556|Everolimus|everolimus|mesh-list
82774770|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82774771|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774772|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
82774773|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
82774774|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
82774775|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774776|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82774777|NCT00426556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82774778|NCT00426556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82774779|NCT00426556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774780|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82774781|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
82774782|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774783|NCT00107653|Ribavirin|ribavirin|mesh-list
82774784|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82774785|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
82774786|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
82774787|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774788|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
82774789|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774790|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
82774791|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774792|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82774793|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
82774794|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774795|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
82774796|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82774797|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82774798|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
82774799|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774800|NCT00970086|Bupivacaine|bupivacaine|mesh-list
82774801|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
82774802|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
82774803|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
82774804|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82774805|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774806|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
82774807|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774808|NCT00689351|Vaccines|vaccines|mesh-list
82774809|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82774810|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
82774811|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774812|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82774813|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
82774814|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774815|NCT02563847|Erythritol|erythritol|mesh-list
82774816|NCT02563847|Tryptophan|tryptophan|mesh-list
82774817|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82774818|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
82774819|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82774820|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
82774821|NCT00746681|Pregabalin|pregabalin|mesh-list
82774822|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82774823|NCT00746681|Analgesics|analgesics|mesh-ancestor
82774824|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
82774825|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774826|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774827|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
82774828|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82774829|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82774830|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774831|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82774832|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82774833|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82774834|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82774835|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82774836|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82774837|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82774838|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
82774839|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774840|NCT00746681|Urological Agents|urological agents|mesh-ancestor
82774841|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
82774842|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82774843|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774844|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82774845|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82774846|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
82774847|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774848|NCT00749099|Pancrelipase|pancrelipase|mesh-list
82774849|NCT00749099|Pancreatin|pancreatin|mesh-list
82774850|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82774851|NCT00959400|Fentanyl|fentanyl|mesh-list
82774852|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82774853|NCT00959400|Narcotics|narcotics|mesh-ancestor
82774854|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82774855|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774856|NCT00959400|Analgesics|analgesics|mesh-ancestor
82774857|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
82774858|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774859|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82774860|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82774861|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
82774862|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
82774863|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
82774864|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
82774865|NCT02563769|Cocaine|cocaine|mesh-list
82774866|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82774867|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774868|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774869|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774870|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82774871|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
82774872|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
82774873|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82774874|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774875|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
82774876|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774877|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82774878|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82774879|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82774880|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82774881|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
82774882|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774883|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
82774884|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
82774885|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774886|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
82774887|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774888|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774889|NCT00964626|Paclitaxel|paclitaxel|mesh-list
82774890|NCT00964626|Cisplatin|cisplatin|mesh-list
82774891|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82774892|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774893|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
82774894|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
82774895|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
82774896|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774897|NCT02562287|Olanzapine|olanzapine|mesh-list
82774898|NCT02562287|Risperidone|risperidone|mesh-list
82774899|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82774900|NCT02562287|Clozapine|clozapine|mesh-list
82774901|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82774903|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774904|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774905|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774906|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82774907|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82774908|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82774909|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82774910|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82774911|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
82774912|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
82774913|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
82774914|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82774915|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82774916|NCT02562287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82774917|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82774918|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82774919|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
82774920|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
82774921|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
82774922|NCT02562053|Fluoxetine|fluoxetine|mesh-list
82774923|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
82774924|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
82774925|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82774926|NCT02562053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82774927|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82774928|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82774929|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774930|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82774931|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
82774932|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774933|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82774934|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
82774935|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82774936|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82774937|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82774938|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774939|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82774940|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82774941|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
82774942|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82774943|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774944|NCT04060043|Goserelin|goserelin|mesh-list
82774945|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82774946|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774947|NCT00553358|Paclitaxel|paclitaxel|mesh-list
82774948|NCT00553358|Trastuzumab|trastuzumab|mesh-list
82774949|NCT00553358|Lapatinib|lapatinib|mesh-list
82774950|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82774951|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774952|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
82774953|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
82774954|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
82774955|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774956|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82774957|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82774958|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774959|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
82774960|NCT00744809|Efavirenz|efavirenz|mesh-list
82774961|NCT00744809|Rilpivirine|rilpivirine|mesh-list
82774962|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82774963|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774964|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82774965|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82774966|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774967|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774968|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774969|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82774970|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82774971|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
82774972|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82774973|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82774974|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82774975|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82774976|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82774977|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82774978|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82774979|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82774980|NCT00744887|Darunavir|darunavir|mesh-list
82774981|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82774982|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82774983|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
82774984|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82774985|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774986|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82774987|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82774988|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
82774989|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82774990|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
82774991|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82774992|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82774993|NCT00749567|Bevacizumab|bevacizumab|mesh-list
82774994|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82774995|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82774996|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82774997|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82774998|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82774999|NCT00749567|Growth Substances|growth substances|mesh-ancestor
82775000|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775001|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
82775002|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82775003|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775004|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775005|NCT04010942|Metformin|metformin|mesh-list
82775006|NCT04010942|Clomiphene|clomiphene|mesh-list
82775007|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82775008|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775009|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82775010|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
82775011|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775012|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82775013|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
82775014|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82775015|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82775016|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82775017|NCT00949364|Pomalidomide|pomalidomide|mesh-list
82775018|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
82775019|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775020|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82775021|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82775022|NCT00949364|Growth Substances|growth substances|mesh-ancestor
82775023|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
82775024|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775025|NCT00689117|Clindamycin|clindamycin|mesh-list
82775026|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
82775027|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
82775028|NCT00689117|Tretinoin|tretinoin|mesh-list
82775029|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82775030|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775031|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82775032|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775033|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775034|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775035|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
82775036|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
82775037|NCT00949442|Insulin|insulin|mesh-list
82775038|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82775039|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
82775040|NCT00949442|Glimepiride|glimepiride|mesh-list
82775041|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82775042|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775043|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82775044|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775045|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
82775046|NCT00749723|Carboplatin|carboplatin|mesh-list
82775047|NCT00749723|Etoposide|etoposide|mesh-list
82775048|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
82775049|NCT00749723|Temozolomide|temozolomide|mesh-list
82775050|NCT00749723|Thiotepa|thiotepa|mesh-list
82775051|NCT00749723|Trofosfamide|trofosfamide|mesh-list
82775052|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
82775053|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775054|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82775055|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82775056|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82775057|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775058|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775059|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82775060|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
82775061|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82775062|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775063|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
82775064|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775065|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82775066|NCT00547248|Vaccines|vaccines|mesh-list
82775067|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82775068|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
82775069|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775070|NCT00688103|Etanercept|etanercept|mesh-list
82775071|NCT00688103|Methotrexate|methotrexate|mesh-list
82775072|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82775073|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
82775074|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82775075|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775076|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82775077|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
82775078|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775079|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775080|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
82775081|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775082|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82775083|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775084|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
82775085|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82775086|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82775087|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82775088|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82775089|NCT00688103|Analgesics|analgesics|mesh-ancestor
82775090|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
82775091|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775092|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82775093|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82775094|NCT00949598|Tamoxifen|tamoxifen|mesh-list
82775095|NCT00949598|Letrozole|letrozole|mesh-list
82775096|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775097|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775098|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82775099|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82775100|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775101|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82775102|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
82775103|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775104|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775105|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82775106|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82775107|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82775108|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82775110|NCT00964704|Trastuzumab|trastuzumab|mesh-list
82775111|NCT00964704|Docetaxel|docetaxel|mesh-list
82775112|NCT00964704|Capecitabine|capecitabine|mesh-list
82775113|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82775114|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775115|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82775116|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82775117|NCT00964704|Growth Substances|growth substances|mesh-ancestor
82775118|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775119|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
82775120|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
82775121|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
82775122|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
82775123|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775124|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82775125|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
82775126|NCT00686855|Dexamethasone|dexamethasone|mesh-list
82775127|NCT00686855|Tacrolimus|tacrolimus|mesh-list
82775128|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82775129|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
82775130|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
82775131|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775132|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775133|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82775134|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
82775135|NCT00686855|Hormones|hormones|mesh-ancestor
82775136|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775137|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82775138|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775139|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775140|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
82775141|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82775142|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775143|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775144|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
82775145|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
82775146|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775147|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775148|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82775149|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
82775150|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
82775151|NCT00949832|Vitamin D|vitamin d|mesh-list
82775152|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
82775153|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
82775154|NCT00949832|Vitamins|vitamins|mesh-list
82775155|NCT00949832|Calcium|calcium|mesh-list
82775156|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
82775157|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775158|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82775159|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82775160|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
82775161|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
82775162|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
82775163|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775164|NCT00745199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82775165|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82775166|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82775167|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
82775168|NCT00961844|Temozolomide|temozolomide|mesh-list
82775169|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82775170|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
82775171|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775172|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775173|NCT00686777|Interferons|interferons|mesh-list
82775174|NCT00686777|Ribavirin|ribavirin|mesh-list
82775175|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
82775176|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
82775177|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82775178|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775179|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
82775180|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775181|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
82775182|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775183|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
82775184|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775185|NCT04009772|Metronidazole|metronidazole|mesh-list
82775187|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
82775188|NCT04009772|Cefepime|cefepime|mesh-list
82775189|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775190|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82775191|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82775192|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82775193|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82775194|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82775195|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775196|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
82775197|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
82775198|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
82775199|NCT01563068|Calcipotriene|calcipotriene|mesh-list
82775200|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
82775201|NCT00747305|Sunitinib|sunitinib|mesh-list
82775202|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775203|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82775204|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82775205|NCT00747305|Growth Substances|growth substances|mesh-ancestor
82775206|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775207|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
82775208|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82775209|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775210|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775212|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82775213|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775214|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
82775215|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
82775216|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
82775217|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775218|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82775219|NCT00747383|Glimepiride|glimepiride|mesh-list
82775220|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82775221|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775222|NCT00747383|Incretins|incretins|mesh-ancestor
82775223|NCT00747383|Hormones|hormones|mesh-ancestor
82775224|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775225|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82775226|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
82775227|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775228|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775229|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82775230|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775231|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
82775232|NCT00106639|Tacrolimus|tacrolimus|mesh-list
82775233|NCT00106639|Tofacitinib|tofacitinib|mesh-list
82775234|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775235|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
82775236|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775237|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82775238|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775239|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775240|NCT00106639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82775241|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82775242|NCT00747539|Interferons|interferons|mesh-list
82775243|NCT00747539|Ribavirin|ribavirin|mesh-list
82775244|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
82775245|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775246|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
82775247|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775248|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
82775249|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775250|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
82775251|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775252|NCT00745433|Metformin|metformin|mesh-list
82775253|NCT00745433|Repaglinide|repaglinide|mesh-list
82775254|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82775255|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775256|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
82775257|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775258|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82775259|NCT00962234|Protective Agents|protective agents|mesh-ancestor
82775260|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775261|NCT00747695|Rabeprazole|rabeprazole|mesh-list
82775262|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82775263|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82775264|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82775265|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775266|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775267|NCT00959972|Nicotine|nicotine|mesh-list
82775268|NCT00959972|Varenicline|varenicline|mesh-list
82775269|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82775270|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
82775271|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775272|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775273|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82775274|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82775275|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
82775276|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775277|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775278|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
82775279|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82775280|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775281|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
82775282|NCT00960284|Gemcitabine|gemcitabine|mesh-list
82775283|NCT00960284|Fluorouracil|fluorouracil|mesh-list
82775284|NCT00960284|Capecitabine|capecitabine|mesh-list
82775285|NCT00960284|Epirubicin|epirubicin|mesh-list
82775286|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775287|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82775288|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
82775289|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775290|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775291|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
82775292|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775293|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82775294|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82775295|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82775296|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775297|NCT00105469|Tobramycin|tobramycin|mesh-list
82775298|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82775299|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775300|NCT00962312|Capecitabine|capecitabine|mesh-list
82775301|NCT00962312|Lapatinib|lapatinib|mesh-list
82775302|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82775303|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
82775304|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775305|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775306|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82775307|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775308|NCT00960518|Adefovir|adefovir|mesh-list
82775309|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
82775310|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775311|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82775312|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82775313|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775314|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775315|NCT00960830|Mirtazapine|mirtazapine|mesh-list
82775316|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
82775317|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82775318|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82775319|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
82775320|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
82775321|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775322|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775323|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775324|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82775325|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82775326|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82775327|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82775328|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82775329|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82775330|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
82775331|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82775332|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82775333|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
82775334|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82775335|NCT00962624|Vaccines|vaccines|mesh-list
82775336|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
82775337|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775338|NCT00105235|Cyclosporine|cyclosporine|mesh-list
82775339|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
82775340|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
82775341|NCT00105235|Tacrolimus|tacrolimus|mesh-list
82775342|NCT00105235|Cyclosporins|cyclosporins|mesh-list
82775343|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775344|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
82775345|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775346|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82775347|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775348|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775349|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
82775350|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775351|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
82775352|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82775353|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82775354|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775355|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82775356|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
82775357|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82775358|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82775359|NCT03962803|Vaccines|vaccines|mesh-list
82775360|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
82775361|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775363|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82775364|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
82775365|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82775366|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775367|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775368|NCT00547118|Hormones|hormones|mesh-ancestor
82775369|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775370|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775371|NCT00962936|Pidilizumab|pidilizumab|mesh-list
82775372|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82775373|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775374|NCT01087099|Albendazole|albendazole|mesh-list
82775375|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
82775376|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82775377|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775378|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
82775379|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82775380|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82775381|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
82775382|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
82775383|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
82775384|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775385|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775386|NCT00686543|Posaconazole|posaconazole|mesh-list
82775387|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
82775388|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775389|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82775390|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82775391|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82775392|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82775393|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82775394|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775395|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775396|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82775397|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
82775398|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775399|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775400|NCT00750113|Telmisartan|telmisartan|mesh-list
82775401|NCT00750113|Nifedipine|nifedipine|mesh-list
82775402|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82775403|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82775404|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82775405|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775406|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82775407|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82775408|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82775409|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775410|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
82775411|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
82775412|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82775413|NCT00745511|Bevacizumab|bevacizumab|mesh-list
82775414|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82775415|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775416|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82775417|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82775418|NCT00745511|Growth Substances|growth substances|mesh-ancestor
82775419|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775420|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
82775421|NCT00545688|Docetaxel|docetaxel|mesh-list
82775422|NCT00545688|Trastuzumab|trastuzumab|mesh-list
82775423|NCT00545688|Pertuzumab|pertuzumab|mesh-list
82775424|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775425|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
82775426|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
82775427|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
82775428|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775429|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82775430|NCT00502203|Paclitaxel|paclitaxel|mesh-list
82775431|NCT00502203|Carboplatin|carboplatin|mesh-list
82775432|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82775433|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775434|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
82775435|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
82775436|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
82775437|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775438|NCT00546078|Vaccines|vaccines|mesh-list
82775439|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
82775440|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775441|NCT00967772|Naftopidil|naftopidil|mesh-list
82775442|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82775443|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82775444|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
82775445|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775446|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775447|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775448|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82775449|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82775450|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82775451|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82775452|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82775453|NCT00967850|Verteporfin|verteporfin|mesh-list
82775454|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82775455|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
82775456|NCT00967928|Everolimus|everolimus|mesh-list
82775457|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775458|NCT00967928|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82775459|NCT00967928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82775460|NCT00967928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775461|NCT00967928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775462|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775463|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
82775464|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775465|NCT00546000|Fluticasone|fluticasone|mesh-list
82775467|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82775468|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82775469|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
82775470|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775471|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775472|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82775473|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
82775474|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
82775475|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82775476|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82775477|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82775478|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775480|NCT00968006|Hormones|hormones|mesh-ancestor
82775481|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775482|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82775483|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
82775484|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775485|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775486|NCT00968162|Fludarabine|fludarabine|mesh-list
82775487|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775488|NCT00968240|Bevacizumab|bevacizumab|mesh-list
82775489|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82775490|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775491|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82775492|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82775493|NCT00968240|Growth Substances|growth substances|mesh-ancestor
82775494|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775495|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
82775496|NCT00501969|Rotigotine|rotigotine|mesh-list
82775497|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
82775498|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
82775499|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775500|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775501|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775502|NCT03942042|Ixekizumab|ixekizumab|mesh-list
82775503|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
82775504|NCT00968396|Melphalan|melphalan|mesh-list
82775505|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82775506|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
82775507|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775508|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775509|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82775510|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775511|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
82775512|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775513|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
82775514|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
82775515|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
82775516|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82775517|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775518|NCT05299580|Trametinib|trametinib|mesh-list
82775519|NCT05299580|Dabrafenib|dabrafenib|mesh-list
82775520|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775521|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82775522|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775523|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775524|NCT01013805|Leucovorin|leucovorin|mesh-list
82775525|NCT01013805|Fluorouracil|fluorouracil|mesh-list
82775526|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
82775527|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
82775528|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775529|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82775530|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775531|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775532|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
82775533|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775534|NCT01013805|Antidotes|antidotes|mesh-ancestor
82775535|NCT01013805|Protective Agents|protective agents|mesh-ancestor
82775536|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
82775537|NCT01013805|Vitamins|vitamins|mesh-ancestor
82775538|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
82775539|NCT00104299|Prednisone|prednisone|mesh-list
82775540|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
82775541|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
82775542|NCT00104299|Rituximab|rituximab|mesh-list
82775543|NCT00104299|Azathioprine|azathioprine|mesh-list
82775544|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
82775545|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775546|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
82775547|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775548|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82775549|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82775550|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
82775551|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775552|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775553|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82775554|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82775555|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82775556|NCT00104299|Hormones|hormones|mesh-ancestor
82775557|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775558|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82775559|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
82775560|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
82775561|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775562|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82775563|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82775564|NCT00104299|Protective Agents|protective agents|mesh-ancestor
82775565|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
82775566|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82775567|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82775568|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82775569|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775570|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775571|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82775572|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82775573|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775574|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
82775575|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775576|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
82775577|NCT00082381|Exenatide|exenatide|mesh-list
82775578|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82775579|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775580|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82775581|NCT00082381|Incretins|incretins|mesh-ancestor
82775582|NCT00082381|Hormones|hormones|mesh-ancestor
82775583|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775584|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
82775586|NCT00964106|Fluconazole|fluconazole|mesh-list
82775587|NCT00964106|Ketoconazole|ketoconazole|mesh-list
82775588|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
82775589|NCT00964106|Midazolam|midazolam|mesh-list
82775590|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
82775591|NCT00964106|Caffeine|caffeine|mesh-list
82775592|NCT00964106|Omeprazole|omeprazole|mesh-list
82775593|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82775594|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82775595|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82775596|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82775597|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775598|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82775599|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82775600|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82775601|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82775602|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
82775603|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
82775604|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
82775605|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
82775606|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775607|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775608|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82775609|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82775610|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
82775611|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82775612|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82775613|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775614|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82775615|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82775616|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82775617|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82775618|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
82775619|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82775620|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82775621|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82775622|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82775623|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
82775624|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82775625|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775626|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
82775627|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82775628|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82775629|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82775630|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82775631|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82775632|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82775633|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82775634|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
82775635|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82775636|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82775637|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82775638|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
82775639|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775640|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82775641|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82775642|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82775643|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82775644|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
82775645|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
82775646|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82775647|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82775648|NCT00964106|Analgesics|analgesics|mesh-ancestor
82775649|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
82775650|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775651|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82775652|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82775653|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82775654|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82775655|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82775656|NCT00960336|Doxorubicin|doxorubicin|mesh-list
82775657|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82775658|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82775659|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775660|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82775661|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82775662|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775663|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775665|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82775666|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775667|NCT01084837|Bortezomib|bortezomib|mesh-list
82775668|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775669|NCT00545844|Montelukast|montelukast|mesh-list
82775670|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82775671|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
82775672|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82775673|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
82775674|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775675|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775676|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82775677|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82775678|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775679|NCT01084993|Heparin|heparin|mesh-list
82775680|NCT01084993|Bivalirudin|bivalirudin|mesh-list
82775681|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
82775682|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82775683|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82775684|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775685|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
82775686|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82775687|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
82775688|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775689|NCT00492063|Vaccines|vaccines|mesh-list
82775690|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
82775691|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775692|NCT00960492|Temozolomide|temozolomide|mesh-list
82775693|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82775694|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
82775695|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775696|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775697|NCT00971724|Prednisolone|prednisolone|mesh-list
82775698|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82775699|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
82775700|NCT00971724|Hormones|hormones|mesh-ancestor
82775701|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775702|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775703|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82775704|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775705|NCT02976909|Paclitaxel|paclitaxel|mesh-list
82775706|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82775707|NCT02976909|Cisplatin|cisplatin|mesh-list
82775708|NCT02976909|Fluorouracil|fluorouracil|mesh-list
82775709|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82775710|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775711|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
82775712|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
82775713|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
82775714|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775715|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
82775716|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82775717|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775718|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
82775719|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775720|NCT02878083|Adalimumab|adalimumab|mesh-list
82775721|NCT02878083|Vedolizumab|vedolizumab|mesh-list
82775722|NCT02878083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82775723|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82775724|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82775725|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82775726|NCT00093145|Paclitaxel|paclitaxel|mesh-list
82775727|NCT00093145|Carboplatin|carboplatin|mesh-list
82775728|NCT00093145|Trastuzumab|trastuzumab|mesh-list
82775729|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82775730|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82775731|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775732|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
82775733|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
82775734|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
82775735|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775736|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82775737|NCT00965406|Insulin|insulin|mesh-list
82775738|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82775739|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775740|NCT00513357|Melatonin|melatonin|mesh-list
82775741|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
82775742|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775743|NCT00513357|Protective Agents|protective agents|mesh-ancestor
82775744|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775745|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82775746|NCT00960960|Paclitaxel|paclitaxel|mesh-list
82775747|NCT00960960|Bevacizumab|bevacizumab|mesh-list
82775748|NCT00960960|Trastuzumab|trastuzumab|mesh-list
82775749|NCT00960960|Letrozole|letrozole|mesh-list
82775750|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82775751|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775752|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
82775753|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
82775754|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
82775755|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775756|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82775757|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82775758|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82775759|NCT00960960|Growth Substances|growth substances|mesh-ancestor
82775760|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775761|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
82775762|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82775763|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82775764|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775765|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82775766|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
82775767|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775768|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
82775769|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82775770|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82775771|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775772|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
82775773|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775774|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775775|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
82775776|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82775777|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775778|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82775779|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82775780|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775781|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775782|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775783|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82775784|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82775785|NCT00961194|Ketamine|ketamine|mesh-list
82775786|NCT00961194|Analgesics|analgesics|mesh-ancestor
82775787|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
82775788|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775789|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775790|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82775791|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82775792|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
82775793|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
82775794|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82775795|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82775796|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82775797|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775798|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775799|NCT05279586|Colistin|colistin|mesh-list
82775800|NCT05279586|Lactulose|lactulose|mesh-list
82775801|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82775802|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82775803|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775804|NCT00965796|Lidocaine|lidocaine|mesh-list
82775805|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
82775806|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
82775807|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82775808|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775809|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
82775810|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775811|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82775812|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82775813|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82775814|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82775815|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775816|NCT00415636|Pemetrexed|pemetrexed|mesh-list
82775817|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775818|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775819|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775820|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82775821|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82775822|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
82775823|NCT00965874|Analgesics|analgesics|mesh-ancestor
82775824|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
82775825|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775826|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775827|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
82775828|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82775829|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82775830|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
82775831|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82775832|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82775833|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775834|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82775835|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
82775836|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82775837|NCT00972426|Timolol|timolol|mesh-list
82775838|NCT00972426|Carteolol|carteolol|mesh-list
82775839|NCT00972426|Latanoprost|latanoprost|mesh-list
82775840|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82775841|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82775842|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
82775843|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775844|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775845|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775846|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82775847|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82775848|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82775849|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82775850|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
82775851|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
82775852|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775853|NCT00972660|Cyclosporine|cyclosporine|mesh-list
82775854|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
82775856|NCT00972660|Cyclosporins|cyclosporins|mesh-list
82775857|NCT00972660|Tacrolimus|tacrolimus|mesh-list
82775858|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82775859|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
82775860|NCT00972660|Hormones|hormones|mesh-ancestor
82775861|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775862|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775863|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82775864|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775865|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775866|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775867|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775868|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
82775869|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
82775870|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775871|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
82775872|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82775873|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82775874|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82775875|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82775876|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
82775877|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82775878|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82775879|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82775880|NCT04008966|Cetrorelix|cetrorelix|mesh-list
82775881|NCT04008966|Progesterone|progesterone|mesh-list
82775882|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82775883|NCT04008966|Progestins|progestins|mesh-ancestor
82775884|NCT04008966|Hormones|hormones|mesh-ancestor
82775885|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775886|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775887|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
82775888|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82775889|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
82775890|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82775891|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82775892|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82775893|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775894|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82775895|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
82775896|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
82775897|NCT00425854|Afatinib|afatinib|mesh-list
82775898|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775899|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82775900|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775901|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775902|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
82775903|NCT00425698|Hematinics|hematinics|mesh-ancestor
82775904|NCT01037530|Ramipril|ramipril|mesh-list
82775905|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82775906|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
82775907|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775908|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775909|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82775910|NCT00973050|Bicalutamide|bicalutamide|mesh-list
82775911|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
82775912|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
82775913|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775914|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775915|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775916|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
82775917|NCT00973128|Sargramostim|sargramostim|mesh-list
82775918|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
82775919|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775920|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82775921|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82775922|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775923|NCT00973986|Atorvastatin|atorvastatin|mesh-list
82775924|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82775925|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82775926|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
82775927|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775928|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82775929|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82775930|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775932|NCT00966576|Brinzolamide|brinzolamide|mesh-list
82775933|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775934|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775935|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82775936|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82775937|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
82775938|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775939|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775940|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82775941|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82775942|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82775943|NCT00425308|Cyclosporine|cyclosporine|mesh-list
82775944|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
82775945|NCT00425308|Everolimus|everolimus|mesh-list
82775946|NCT00425308|Cyclosporins|cyclosporins|mesh-list
82775947|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775948|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775949|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775950|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
82775951|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775952|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
82775953|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82775954|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
82775955|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82775956|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82775958|NCT00425308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82775959|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775960|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82775961|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82775962|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
82775963|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82775964|NCT04008888|Dexamethasone|dexamethasone|mesh-list
82775965|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
82775966|NCT04008888|Fludarabine|fludarabine|mesh-list
82775967|NCT04008888|Melphalan|melphalan|mesh-list
82775968|NCT04008888|BB 1101|bb 1101|mesh-list
82775969|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82775970|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
82775971|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
82775972|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82775973|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775974|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82775975|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
82775976|NCT04008888|Hormones|hormones|mesh-ancestor
82775977|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82775978|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82775979|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82775980|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
82775981|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775982|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775983|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82775984|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
82775985|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82775986|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
82775987|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82775988|NCT01033084|Sertraline|sertraline|mesh-list
82775989|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
82775990|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82775991|NCT01033084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82775992|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82775993|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82775994|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775995|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82775996|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
82775997|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82775998|NCT00979758|Atorvastatin|atorvastatin|mesh-list
82775999|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82776000|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82776001|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
82776002|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776003|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82776004|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82776005|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776006|NCT00545064|Timolol|timolol|mesh-list
82776007|NCT00545064|Dorzolamide|dorzolamide|mesh-list
82776008|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776009|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776010|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82776011|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82776012|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
82776013|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776014|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776015|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82776016|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82776017|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82776018|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
82776019|NCT00979836|Calcium|calcium|mesh-list
82776020|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82776021|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776022|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
82776023|NCT00979836|Coagulants|coagulants|mesh-ancestor
82776024|NCT01588912|Tenofovir|tenofovir|mesh-list
82776025|NCT01588912|Entecavir|entecavir|mesh-list
82776026|NCT01588912|Telbivudine|telbivudine|mesh-list
82776027|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
82776028|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776029|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82776030|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82776031|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776032|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776033|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82776034|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82776035|NCT01589068|Nicotine|nicotine|mesh-list
82776036|NCT01589068|Progesterone|progesterone|mesh-list
82776037|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82776038|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
82776039|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776040|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776041|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82776042|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82776043|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
82776044|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776045|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776046|NCT01589068|Progestins|progestins|mesh-ancestor
82776047|NCT01589068|Hormones|hormones|mesh-ancestor
82776048|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776049|NCT00432562|Vinorelbine|vinorelbine|mesh-list
82776050|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82776051|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776052|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
82776053|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
82776054|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
82776055|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776056|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
82776057|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82776058|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
82776059|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776060|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82776061|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82776062|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82776063|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776064|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
82776065|NCT00974532|Calcium|calcium|mesh-list
82776066|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82776067|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776068|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82776069|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
82776070|NCT00432172|Carboplatin|carboplatin|mesh-list
82776071|NCT00432172|Docetaxel|docetaxel|mesh-list
82776072|NCT00432172|Epirubicin|epirubicin|mesh-list
82776073|NCT00432172|Exemestane|exemestane|mesh-list
82776074|NCT00432172|Goserelin|goserelin|mesh-list
82776075|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82776076|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
82776077|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776078|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82776079|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82776080|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
82776081|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776082|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776083|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82776084|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
82776085|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
82776086|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
82776087|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82776088|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82776089|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82776090|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776091|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82776092|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82776093|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82776094|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
82776095|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776096|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82776097|NCT01034410|Cytarabine|cytarabine|mesh-list
82776098|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82776099|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
82776100|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776101|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776102|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
82776103|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776104|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82776105|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
82776106|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776107|NCT00415168|Pemetrexed|pemetrexed|mesh-list
82776108|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776109|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776110|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776111|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82776112|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82776113|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
82776114|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82776115|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776116|NCT00980304|Rituximab|rituximab|mesh-list
82776117|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82776118|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776119|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
82776120|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776121|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82776122|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
82776123|NCT00974766|Hormones|hormones|mesh-ancestor
82776124|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776125|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776126|NCT00980382|Docetaxel|docetaxel|mesh-list
82776127|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776128|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
82776129|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
82776130|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
82776131|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776132|NCT00967434|Atorvastatin|atorvastatin|mesh-list
82776133|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82776134|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82776135|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
82776136|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776137|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82776138|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82776139|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776140|NCT00967512|Cytarabine|cytarabine|mesh-list
82776141|NCT00967512|Idarubicin|idarubicin|mesh-list
82776142|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82776143|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
82776144|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776145|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776146|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
82776147|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776148|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82776149|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
82776150|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776151|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82776152|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82776153|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82776154|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776155|NCT04082910|Infliximab|infliximab|mesh-list
82776156|NCT04082910|Etanercept|etanercept|mesh-list
82776157|NCT04082910|Metoprolol|metoprolol|mesh-list
82776158|NCT04082910|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82776159|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82776160|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
82776161|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82776162|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82776163|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82776164|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82776165|NCT04082910|Analgesics|analgesics|mesh-ancestor
82776166|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
82776167|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776168|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776169|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82776170|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
82776171|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82776172|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82776173|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
82776174|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
82776175|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82776176|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82776177|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82776178|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
82776179|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776180|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776181|NCT00975078|Prednisone|prednisone|mesh-list
82776182|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82776183|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
82776184|NCT00975078|Hormones|hormones|mesh-ancestor
82776185|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776186|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776187|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82776188|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776189|NCT00980616|Ropivacaine|ropivacaine|mesh-list
82776190|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
82776191|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
82776192|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82776193|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776194|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
82776195|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776196|NCT00980850|Vaccines|vaccines|mesh-list
82776197|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
82776198|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776199|NCT00414466|Gabapentin|gabapentin|mesh-list
82776200|NCT00414466|Analgesics|analgesics|mesh-ancestor
82776201|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
82776202|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776203|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776204|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
82776205|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82776206|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82776207|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82776208|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82776209|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82776210|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82776211|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776212|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776213|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
82776214|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
82776215|NCT00984750|Simvastatin|simvastatin|mesh-list
82776216|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82776217|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82776218|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
82776219|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776220|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82776221|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82776222|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776223|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
82776224|NCT00984750|Vitamins|vitamins|mesh-ancestor
82776225|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
82776226|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776227|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
82776228|NCT00975312|Tretinoin|tretinoin|mesh-list
82776229|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776230|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
82776231|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
82776232|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
82776233|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
82776234|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82776235|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
82776236|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776237|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776238|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82776239|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
82776240|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
82776241|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82776242|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
82776243|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776244|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776245|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82776246|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82776247|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82776248|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
82776249|NCT04974996|Prednisone|prednisone|mesh-list
82776250|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
82776251|NCT04974996|Rituximab|rituximab|mesh-list
82776252|NCT04974996|Doxorubicin|doxorubicin|mesh-list
82776253|NCT04974996|Vincristine|vincristine|mesh-list
82776254|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
82776255|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82776256|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
82776257|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776258|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82776259|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82776260|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
82776261|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776262|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776263|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82776264|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82776265|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82776266|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82776267|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82776268|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776269|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82776270|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
82776271|NCT04974996|Hormones|hormones|mesh-ancestor
82776272|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776273|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82776274|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82776275|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
82776276|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
82776277|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
82776278|NCT00981006|Mitogens|mitogens|mesh-list
82776279|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
82776280|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776281|NCT00975390|Caffeine|caffeine|mesh-list
82776282|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82776283|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776284|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82776285|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776286|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776287|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82776288|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82776289|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
82776290|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776291|NCT00981318|Ritonavir|ritonavir|mesh-list
82776292|NCT00981318|Lopinavir|lopinavir|mesh-list
82776293|NCT00981318|Maraviroc|maraviroc|mesh-list
82776294|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82776295|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82776296|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
82776297|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776298|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776301|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
82776302|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776303|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82776304|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82776305|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82776306|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82776307|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82776308|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
82776309|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82776310|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82776311|NCT00984984|Prednisolone|prednisolone|mesh-list
82776312|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
82776313|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82776314|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
82776315|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82776316|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
82776317|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
82776318|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776319|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776320|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82776321|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
82776322|NCT00984984|Hormones|hormones|mesh-ancestor
82776323|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776324|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82776325|NCT00984984|Protective Agents|protective agents|mesh-ancestor
82776326|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82776327|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776328|NCT00545532|Oseltamivir|oseltamivir|mesh-list
82776329|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
82776330|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776331|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776332|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776333|NCT00544440|Prednisone|prednisone|mesh-list
82776334|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
82776335|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82776336|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
82776337|NCT00544440|Hormones|hormones|mesh-ancestor
82776338|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776339|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776340|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82776341|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776342|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82776343|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776344|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776345|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
82776346|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82776347|NCT00981708|Dexamethasone|dexamethasone|mesh-list
82776348|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
82776349|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
82776350|NCT00981708|Lenalidomide|lenalidomide|mesh-list
82776351|NCT00981708|BB 1101|bb 1101|mesh-list
82776352|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82776353|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
82776354|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776355|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82776356|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82776357|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
82776358|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776359|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776360|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82776361|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82776362|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
82776363|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
82776364|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776365|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82776366|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
82776367|NCT00981708|Hormones|hormones|mesh-ancestor
82776368|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776369|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82776370|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
82776371|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776372|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82776373|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82776374|NCT00981708|Growth Substances|growth substances|mesh-ancestor
82776375|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
82776376|NCT00981786|Timolol|timolol|mesh-list
82776377|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82776378|NCT00981786|Travoprost|travoprost|mesh-list
82776379|NCT00981786|Brinzolamide|brinzolamide|mesh-list
82776380|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82776381|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82776382|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
82776383|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776384|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776385|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776386|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82776387|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82776388|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82776389|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82776390|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82776391|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82776392|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776393|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
82776394|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
82776395|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82776396|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82776397|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776398|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776399|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776400|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82776401|NCT00985374|Everolimus|everolimus|mesh-list
82776402|NCT00985374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82776403|NCT00985374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82776404|NCT00985374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776405|NCT00985374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776406|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82776407|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
82776408|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776409|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776410|NCT00975936|Ketoconazole|ketoconazole|mesh-list
82776411|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
82776412|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776413|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82776414|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82776415|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776416|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776417|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82776418|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
82776419|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776420|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776421|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82776422|NCT00976092|Heparin|heparin|mesh-list
82776423|NCT00976092|Calcium heparin|calcium heparin|mesh-list
82776424|NCT00976092|Bivalirudin|bivalirudin|mesh-list
82776425|NCT00976092|Clopidogrel|clopidogrel|mesh-list
82776426|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82776427|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82776428|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82776429|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82776430|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82776431|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
82776432|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776433|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776434|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776435|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
82776436|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82776437|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82776438|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
82776439|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82776440|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
82776441|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776442|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
82776443|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776444|NCT04006470|Fluorides|fluorides|mesh-list
82776445|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
82776446|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
82776447|NCT04006470|Protective Agents|protective agents|mesh-ancestor
82776448|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776450|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
82776451|NCT01323712|Vitamins|vitamins|mesh-ancestor
82776452|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
82776453|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776454|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82776455|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82776456|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
82776457|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776458|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82776459|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776460|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776461|NCT03927144|Erenumab|erenumab|mesh-list
82776462|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82776463|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776464|NCT03927144|Analgesics|analgesics|mesh-ancestor
82776465|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
82776466|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776467|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776468|NCT00976170|Sorafenib|sorafenib|mesh-list
82776469|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776470|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82776471|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776472|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776473|NCT00982254|Insulin|insulin|mesh-list
82776474|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82776475|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82776476|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776477|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82776478|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82776479|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776480|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
82776481|NCT00976326|Insulin|insulin|mesh-list
82776482|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82776483|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776484|NCT00982332|Betamethasone|betamethasone|mesh-list
82776485|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
82776486|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82776487|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
82776488|NCT00982332|Hormones|hormones|mesh-ancestor
82776489|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776490|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776491|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82776492|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
82776493|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
82776494|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82776495|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82776496|NCT04007328|Prednisolone|prednisolone|mesh-list
82776497|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
82776498|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82776499|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
82776500|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82776501|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
82776502|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
82776503|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776504|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776505|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82776506|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
82776507|NCT04007328|Hormones|hormones|mesh-ancestor
82776508|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776509|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82776510|NCT04007328|Protective Agents|protective agents|mesh-ancestor
82776511|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82776512|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776513|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
82776514|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82776515|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82776516|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776518|NCT00985920|Coagulants|coagulants|mesh-ancestor
82776519|NCT00976794|Carbamazepine|carbamazepine|mesh-list
82776520|NCT00976794|Valproic Acid|valproic acid|mesh-list
82776521|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
82776522|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
82776523|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82776524|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776525|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776526|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
82776527|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82776528|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82776529|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776530|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
82776532|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776533|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82776534|NCT00976794|Analgesics|analgesics|mesh-ancestor
82776535|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
82776536|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776537|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82776538|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82776539|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82776540|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82776541|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
82776542|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82776543|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776544|NCT04008186|Metformin|metformin|mesh-list
82776545|NCT04008186|Repaglinide|repaglinide|mesh-list
82776546|NCT04008186|Itraconazole|itraconazole|mesh-list
82776547|NCT04008186|Digoxin|digoxin|mesh-list
82776548|NCT04008186|Verapamil|verapamil|mesh-list
82776549|NCT04008186|Midazolam|midazolam|mesh-list
82776550|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82776551|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
82776552|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82776553|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776554|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82776555|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82776556|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82776557|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82776558|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82776559|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82776560|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82776561|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
82776563|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
82776564|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
82776565|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776566|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776567|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82776568|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82776569|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
82776570|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82776571|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82776572|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776573|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
82776574|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776575|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82776576|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82776577|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82776578|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
82776579|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776580|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82776581|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82776582|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82776583|NCT04008186|Protective Agents|protective agents|mesh-ancestor
82776584|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82776585|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82776586|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82776587|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
82776588|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82776589|NCT00982566|Navitoclax|navitoclax|mesh-list
82776590|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776591|NCT00977028|Lidocaine|lidocaine|mesh-list
82776592|NCT00977028|Epinephrine|epinephrine|mesh-list
82776593|NCT00977028|Racepinephrine|racepinephrine|mesh-list
82776594|NCT00977028|Anesthetics|anesthetics|mesh-list
82776595|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
82776596|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
82776597|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82776598|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776599|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
82776600|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776601|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82776602|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82776603|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82776604|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82776605|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776606|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82776607|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82776608|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
82776609|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776610|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82776611|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82776612|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
82776613|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82776614|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
82776615|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
82776616|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
82776617|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82776618|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
82776619|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
82776620|NCT00982722|Vitamin D|vitamin d|mesh-list
82776621|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
82776622|NCT00982722|Calcium|calcium|mesh-list
82776623|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82776624|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776625|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82776626|NCT00982722|Vitamins|vitamins|mesh-ancestor
82776627|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
82776628|NCT00982722|Antacids|antacids|mesh-ancestor
82776629|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776630|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82776631|NCT00982800|Gabapentin|gabapentin|mesh-list
82776632|NCT00982800|Analgesics|analgesics|mesh-ancestor
82776633|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
82776634|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776635|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776636|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
82776637|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82776638|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82776639|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82776640|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82776641|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82776642|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82776643|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776644|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776645|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
82776646|NCT00986076|Enoxaparin|enoxaparin|mesh-list
82776647|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
82776648|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82776649|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82776650|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776651|NCT00984828|Bortezomib|bortezomib|mesh-list
82776652|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776653|NCT00983034|Amoxicillin|amoxicillin|mesh-list
82776654|NCT00983034|Clarithromycin|clarithromycin|mesh-list
82776655|NCT00983034|Lansoprazole|lansoprazole|mesh-list
82776656|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
82776657|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82776658|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776659|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82776660|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776661|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776662|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82776663|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82776664|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82776665|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82776666|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82776667|NCT00983112|Thrombin|thrombin|mesh-list
82776668|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
82776669|NCT00983112|Coagulants|coagulants|mesh-ancestor
82776670|NCT00986466|Vitamin D|vitamin d|mesh-list
82776671|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
82776672|NCT00986466|Cholecalciferol|cholecalciferol|mesh-list
82776673|NCT00986466|Vitamins|vitamins|mesh-list
82776674|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
82776675|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776676|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82776677|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82776678|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
82776679|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82776680|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
82776681|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776682|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776683|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82776684|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
82776685|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82776686|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
82776687|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776688|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776689|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82776690|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
82776691|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
82776692|NCT00545298|Protective Agents|protective agents|mesh-ancestor
82776693|NCT00983268|Capecitabine|capecitabine|mesh-list
82776694|NCT00983268|Vorinostat|vorinostat|mesh-list
82776695|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82776696|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
82776697|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776698|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776699|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82776700|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776701|NCT00977964|Caseins|caseins|mesh-list
82776702|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
82776703|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
82776704|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776705|NCT00983424|Cyclosporine|cyclosporine|mesh-list
82776706|NCT00983424|Paclitaxel|paclitaxel|mesh-list
82776707|NCT00983424|Cyclosporins|cyclosporins|mesh-list
82776708|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82776709|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776710|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
82776711|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
82776712|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
82778061|NCT05392452|Insulin|insulin|mesh-list
82776713|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776714|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776715|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82776716|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
82776717|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776718|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
82776719|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776720|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
82776721|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82776722|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82776723|NCT00983736|Tramadol|tramadol|mesh-list
82776724|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82776725|NCT00983736|Narcotics|narcotics|mesh-ancestor
82776726|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82776727|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776728|NCT00983736|Analgesics|analgesics|mesh-ancestor
82776729|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
82776730|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776731|NCT00986778|Lamivudine|lamivudine|mesh-list
82776732|NCT00986778|Adefovir|adefovir|mesh-list
82776733|NCT00986778|Entecavir|entecavir|mesh-list
82776734|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82776735|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82776736|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776737|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776738|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
82776739|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776740|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82776741|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82776742|NCT00429364|Losartan|losartan|mesh-list
82776743|NCT00429364|Atenolol|atenolol|mesh-list
82776744|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82776745|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82776746|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82776747|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82776748|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776749|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
82776751|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776752|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776753|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82776754|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82776755|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82776756|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
82776757|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776758|NCT00978354|Furosemide|furosemide|mesh-list
82776759|NCT00978354|Diuretics|diuretics|mesh-ancestor
82776760|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
82776761|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776762|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82776763|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82776764|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776765|NCT00984360|Naltrexone|naltrexone|mesh-list
82776766|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82776767|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82776768|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776769|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
82776770|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776771|NCT00414388|Sorafenib|sorafenib|mesh-list
82776772|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776773|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82776774|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776775|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776776|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
82776777|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
82776778|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
82776779|NCT01037608|Nabiximols|nabiximols|mesh-list
82776780|NCT01037608|Analgesics|analgesics|mesh-ancestor
82776781|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
82776782|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776783|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776784|NCT04006080|Vedolizumab|vedolizumab|mesh-list
82776785|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82776786|NCT00984438|Bevacizumab|bevacizumab|mesh-list
82776787|NCT00984438|Irinotecan|irinotecan|mesh-list
82776788|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82776789|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776790|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82776791|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82776792|NCT00984438|Growth Substances|growth substances|mesh-ancestor
82776793|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776794|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
82776795|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82776796|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82776797|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776798|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776799|NCT00424372|Pregabalin|pregabalin|mesh-list
82776800|NCT00424372|Analgesics|analgesics|mesh-ancestor
82776801|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
82776802|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776803|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776804|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
82776805|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82776806|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82776807|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776808|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82776809|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82776810|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82776811|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82776812|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82776813|NCT00987168|Octreotide|octreotide|mesh-list
82776814|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82776815|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82776816|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776817|NCT00978978|Fentanyl|fentanyl|mesh-list
82776818|NCT00978978|Midazolam|midazolam|mesh-list
82776819|NCT00978978|Propofol|propofol|mesh-list
82776820|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82776821|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82776822|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776823|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82776824|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
82776825|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
82776826|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82776827|NCT00978978|Narcotics|narcotics|mesh-ancestor
82776828|NCT00978978|Analgesics|analgesics|mesh-ancestor
82776829|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
82776830|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776831|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82776832|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82776833|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82776834|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82776835|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
82776836|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
82776837|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776838|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776839|NCT00414310|Decitabine|decitabine|mesh-list
82776840|NCT00414310|Valproic Acid|valproic acid|mesh-list
82776841|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82776842|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
82776843|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776844|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776845|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776846|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
82776847|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
82776848|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776849|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776850|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
82776851|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82776852|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82776853|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82776854|NCT00542880|Fluticasone|fluticasone|mesh-list
82776855|NCT00542880|Budesonide|budesonide|mesh-list
82776856|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
82776857|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82776858|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82776859|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82776860|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82776861|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82776862|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
82776863|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776864|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776865|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82776866|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
82776867|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
82776868|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82776869|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
82776870|NCT00542880|Hormones|hormones|mesh-ancestor
82776871|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776872|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82776873|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82776874|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82776875|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
82776876|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776877|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776878|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
82776879|NCT00414076|Letrozole|letrozole|mesh-list
82776880|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776881|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82776882|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82776883|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776884|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776885|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82776886|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
82776887|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82776888|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776889|NCT01033318|Losartan|losartan|mesh-list
82776890|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82776891|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82776892|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82776893|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82776894|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776895|NCT01033396|Fexofenadine|fexofenadine|mesh-list
82776896|NCT01033396|Terfenadine|terfenadine|mesh-list
82776897|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82776898|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82776899|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82776900|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
82776901|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
82776902|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776903|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776904|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776905|NCT00979056|Rifaximin|rifaximin|mesh-list
82776906|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82776907|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776908|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82776909|NCT00092677|Simvastatin|simvastatin|mesh-list
82776910|NCT00092677|Ezetimibe|ezetimibe|mesh-list
82776911|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82776912|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82776913|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
82776914|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776915|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82776916|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82776917|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776918|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82776919|NCT00542178|Simvastatin|simvastatin|mesh-list
82776920|NCT00542178|Fenofibrate|fenofibrate|mesh-list
82776921|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82776922|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82776923|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
82776924|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776925|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82776926|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82776927|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776928|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776929|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
82776930|NCT00987636|Diphosphonates|diphosphonates|mesh-list
82776931|NCT00987636|Busulfan|busulfan|mesh-list
82776932|NCT00987636|Treosulfan|treosulfan|mesh-list
82776933|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
82776934|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776935|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82776936|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
82776937|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776938|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82776939|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776940|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82776941|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82776942|NCT00424294|Celecoxib|celecoxib|mesh-list
82776943|NCT00424294|Methotrexate|methotrexate|mesh-list
82776944|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82776945|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
82776946|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82776947|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776948|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82776949|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
82776950|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776951|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82776952|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
82776953|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776954|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82776955|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82776956|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
82776957|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82776958|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82776959|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82776960|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82776961|NCT00424294|Analgesics|analgesics|mesh-ancestor
82776962|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
82776963|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776964|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82776965|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82776966|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82776967|NCT00988728|Olanzapine|olanzapine|mesh-list
82776968|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
82776969|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
82776970|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82776971|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776972|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82776973|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82776974|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82776975|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82776976|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82776977|NCT00988728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82776978|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82776979|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82776980|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776981|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82776982|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
82776983|NCT00988806|Simendan|simendan|mesh-list
82776984|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82776985|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
82776986|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82776987|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82776988|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776989|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776990|NCT00988806|Protective Agents|protective agents|mesh-ancestor
82776991|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82776992|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
82776993|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
82776994|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82776995|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82776996|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82776997|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82776998|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82776999|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82777000|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
82777001|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82777002|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82777003|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777004|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82777005|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82777006|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777007|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777008|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777009|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82777010|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
82777011|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82777012|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777013|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82777014|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82777015|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82777016|NCT00987870|Betamethasone|betamethasone|mesh-list
82777017|NCT00987870|Calcipotriene|calcipotriene|mesh-list
82777018|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82777019|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
82777021|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82777022|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777023|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82777024|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
82777025|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
82777026|NCT00988026|Minocycline|minocycline|mesh-list
82777027|NCT00988026|Lymecycline|lymecycline|mesh-list
82777028|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82777029|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777030|NCT05578170|Pembrolizumab|pembrolizumab|mesh-list
82777031|NCT05578170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777032|NCT05578170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777033|NCT05578170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82777034|NCT05578170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777035|NCT00989274|Vaccines|vaccines|mesh-list
82777036|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
82777037|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777038|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82777039|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82777040|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777041|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82777042|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777043|NCT05712642|Bevacizumab|bevacizumab|mesh-list
82777044|NCT05712642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777045|NCT05712642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777046|NCT05712642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82777047|NCT05712642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82777048|NCT05712642|Growth Substances|growth substances|mesh-ancestor
82777049|NCT05712642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777050|NCT05712642|Growth Inhibitors|growth inhibitors|mesh-ancestor
82777051|NCT05492682|Cyclophosphamide|cyclophosphamide|mesh-list
82777052|NCT05492682|Pembrolizumab|pembrolizumab|mesh-list
82777053|NCT05492682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82777054|NCT05492682|Immunologic Factors|immunologic factors|mesh-ancestor
82777055|NCT05492682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777056|NCT05492682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82777057|NCT05492682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82777058|NCT05492682|Alkylating Agents|alkylating agents|mesh-ancestor
82777059|NCT05492682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777060|NCT05492682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777061|NCT05492682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82777062|NCT05492682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777063|NCT05492682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82777064|NCT01085149|Simvastatin|simvastatin|mesh-list
82777065|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82777066|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82777067|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
82777068|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777069|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82777070|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82777071|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777072|NCT04005612|Vitamin D|vitamin d|mesh-list
82777073|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
82777074|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
82777075|NCT04005612|Vitamins|vitamins|mesh-list
82777076|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
82777077|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777078|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82777079|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82777080|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
82777081|NCT00413920|Prednisone|prednisone|mesh-list
82777082|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82777083|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
82777084|NCT00413920|Hormones|hormones|mesh-ancestor
82777085|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82777086|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777087|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82777088|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777089|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82777090|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82777091|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
82777092|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82777093|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777094|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777095|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777096|NCT00091819|Vancomycin|vancomycin|mesh-list
82777097|NCT00091819|Telavancin|telavancin|mesh-list
82777098|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82777099|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777100|NCT01326871|Gemcitabine|gemcitabine|mesh-list
82777101|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777102|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82777103|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
82777104|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777105|NCT01081561|Riboflavin|riboflavin|mesh-list
82777106|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
82777107|NCT01081561|Vitamins|vitamins|mesh-ancestor
82777108|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
82777109|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777110|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82777111|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
82777112|NCT04004754|Miltefosine|miltefosine|mesh-list
82777113|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
82777114|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777115|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777116|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82777117|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82777118|NCT05919888|Povidone-Iodine|povidone-iodine|mesh-list
82777119|NCT05919888|Povidone|povidone|mesh-list
82777120|NCT05919888|Plasma Substitutes|plasma substitutes|mesh-ancestor
82777121|NCT05919888|Blood Substitutes|blood substitutes|mesh-ancestor
82777122|NCT05919888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82777123|NCT05919888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777140|NCT05919797|Naltrexone|naltrexone|mesh-list
82777141|NCT05919797|Bupropion|bupropion|mesh-list
82777142|NCT05919797|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82777143|NCT05919797|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82777144|NCT05919797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777145|NCT05919797|Sensory System Agents|sensory system agents|mesh-ancestor
82777146|NCT05919797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777147|NCT05919797|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82777148|NCT05919797|Antidepressive Agents|antidepressive agents|mesh-ancestor
82777149|NCT05919797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82777150|NCT05919797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82777151|NCT05919797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82777152|NCT05919797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82777153|NCT05919797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777154|NCT05919797|Dopamine Agents|dopamine agents|mesh-ancestor
82777155|NCT05919797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82777156|NCT05919797|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82777157|NCT05919797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82777158|NCT05919797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777173|NCT05919732|Epinephrine|epinephrine|mesh-list
82777174|NCT05919732|Bupivacaine|bupivacaine|mesh-list
82777175|NCT05919732|Anesthetics, Local|anesthetics, local|mesh-ancestor
82777176|NCT05919732|Anesthetics|anesthetics|mesh-ancestor
82777177|NCT05919732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82777178|NCT05919732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777179|NCT05919732|Sensory System Agents|sensory system agents|mesh-ancestor
82777180|NCT05919732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777181|NCT05919732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82777182|NCT05919732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82777183|NCT05919732|Adrenergic Agents|adrenergic agents|mesh-ancestor
82777184|NCT05919732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82777185|NCT05919732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777186|NCT05919732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82777187|NCT05919732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82777188|NCT05919732|Autonomic Agents|autonomic agents|mesh-ancestor
82777189|NCT05919732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82777190|NCT05919732|Respiratory System Agents|respiratory system agents|mesh-ancestor
82777191|NCT05919732|Mydriatics|mydriatics|mesh-ancestor
82777192|NCT05919732|Sympathomimetics|sympathomimetics|mesh-ancestor
82777193|NCT05919732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82777194|NCT05919615|Tranexamic Acid|tranexamic acid|mesh-list
82777195|NCT05919615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82777196|NCT05919615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82777197|NCT05919615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777198|NCT05919615|Hemostatics|hemostatics|mesh-ancestor
82777199|NCT05919615|Coagulants|coagulants|mesh-ancestor
82777200|NCT05919550|Clozapine|clozapine|mesh-list
82777201|NCT05919550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82777202|NCT05919550|Serotonin Agents|serotonin agents|mesh-ancestor
82777203|NCT05919550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82777204|NCT05919550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777205|NCT05919550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777206|NCT05919550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82777207|NCT05919550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82777208|NCT05919550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82777209|NCT05919550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82777210|NCT05919550|GABA Antagonists|gaba antagonists|mesh-ancestor
82777211|NCT05919550|GABA Agents|gaba agents|mesh-ancestor
82777212|NCT05919537|Paclitaxel|paclitaxel|mesh-list
82777213|NCT05919537|Docetaxel|docetaxel|mesh-list
82777214|NCT05919537|Gemcitabine|gemcitabine|mesh-list
82777215|NCT05919537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82777216|NCT05919537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777217|NCT05919537|Tubulin Modulators|tubulin modulators|mesh-ancestor
82777218|NCT05919537|Antimitotic Agents|antimitotic agents|mesh-ancestor
82777219|NCT05919537|Mitosis Modulators|mitosis modulators|mesh-ancestor
82777220|NCT05919537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777221|NCT05919537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82777222|NCT05919537|Antimetabolites|antimetabolites|mesh-ancestor
82777223|NCT05919472|Iron|iron|mesh-list
82777224|NCT05919472|Vaccines|vaccines|mesh-list
82777225|NCT05919472|Immunologic Factors|immunologic factors|mesh-ancestor
82777226|NCT05919472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777227|NCT05919472|Trace Elements|trace elements|mesh-ancestor
82777270|NCT05919147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777271|NCT05919121|Hydrocortisone|hydrocortisone|mesh-list
82777272|NCT05919121|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82777273|NCT05919121|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82777274|NCT05919121|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82777275|NCT05919121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82777276|NCT05919030|Paclitaxel|paclitaxel|mesh-list
82777277|NCT05919030|Tislelizumab|tislelizumab|mesh-list
82777278|NCT05919030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82777279|NCT05919030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777280|NCT05919030|Tubulin Modulators|tubulin modulators|mesh-ancestor
82777281|NCT05919030|Antimitotic Agents|antimitotic agents|mesh-ancestor
82777282|NCT05919030|Mitosis Modulators|mitosis modulators|mesh-ancestor
82777283|NCT05919030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777284|NCT05919030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777285|NCT05919017|Naltrexone|naltrexone|mesh-list
82777286|NCT05919017|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82777287|NCT05919017|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82777288|NCT05919017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777289|NCT05919017|Sensory System Agents|sensory system agents|mesh-ancestor
82777290|NCT05919017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777291|NCT05918952|Antibodies|antibodies|mesh-list
82777292|NCT05918952|Immunologic Factors|immunologic factors|mesh-ancestor
82777293|NCT05918952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777294|NCT05918861|Dalcetrapib|dalcetrapib|mesh-list
82777295|NCT05918861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82777296|NCT05918861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82777297|NCT05918861|Antimetabolites|antimetabolites|mesh-ancestor
82777298|NCT05918861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777299|NCT05918861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82777300|NCT05918822|Maribavir|maribavir|mesh-list
82777301|NCT05918822|Rabeprazole|rabeprazole|mesh-list
82777302|NCT05918822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82777303|NCT05918822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82777304|NCT05918822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82777305|NCT05918822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777306|NCT05918822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777308|NCT05918822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777309|NCT05918796|Dexamethasone|dexamethasone|mesh-list
82777310|NCT05918796|Bupivacaine|bupivacaine|mesh-list
82777311|NCT05918796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82777313|NCT05918796|Autonomic Agents|autonomic agents|mesh-ancestor
82777314|NCT05918796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777315|NCT05918796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777316|NCT05918796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82777317|NCT05918796|Glucocorticoids|glucocorticoids|mesh-ancestor
82777318|NCT05918796|Hormones|hormones|mesh-ancestor
82777319|NCT05918796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82777320|NCT05918796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82777321|NCT05918796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777322|NCT05918796|Anesthetics, Local|anesthetics, local|mesh-ancestor
82777323|NCT05918796|Anesthetics|anesthetics|mesh-ancestor
82777324|NCT05918796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82777325|NCT05918796|Sensory System Agents|sensory system agents|mesh-ancestor
82777326|NCT05918718|Methotrexate|methotrexate|mesh-list
82777327|NCT05918718|Letrozole|letrozole|mesh-list
82777328|NCT05918718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82777329|NCT05918718|Abortifacient Agents|abortifacient agents|mesh-ancestor
82777330|NCT05918718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82777331|NCT05918718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777332|NCT05918718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82777333|NCT05918718|Antimetabolites|antimetabolites|mesh-ancestor
82777334|NCT05918718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777335|NCT05918718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777336|NCT05918718|Dermatologic Agents|dermatologic agents|mesh-ancestor
82777337|NCT05918718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777338|NCT05918718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82777339|NCT05918718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82777340|NCT05918718|Immunologic Factors|immunologic factors|mesh-ancestor
82777341|NCT05918718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82777342|NCT05918718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82777343|NCT05918718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82777344|NCT05918718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82777345|NCT05918718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82777346|NCT05918718|Hormone Antagonists|hormone antagonists|mesh-ancestor
82777347|NCT05918718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82777348|NCT05918627|Belumosudil|belumosudil|mesh-list
82777349|NCT05918627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82777350|NCT05918627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777351|NCT05918627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777352|NCT05918614|Belumosudil|belumosudil|mesh-list
82777353|NCT05918614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82777354|NCT05918614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777355|NCT05918614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777356|NCT05918588|Belumosudil|belumosudil|mesh-list
82777357|NCT05918588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82777358|NCT05918588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777359|NCT05918588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777360|NCT05918341|Piracetam|piracetam|mesh-list
82777361|NCT05918341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82777362|NCT05918341|Protective Agents|protective agents|mesh-ancestor
82777363|NCT05918341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777364|NCT05918341|Nootropic Agents|nootropic agents|mesh-ancestor
82777365|NCT05918328|Paclitaxel|paclitaxel|mesh-list
82777366|NCT05918328|Docetaxel|docetaxel|mesh-list
82777367|NCT05918328|Carboplatin|carboplatin|mesh-list
82777381|NCT05918302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777382|NCT05918302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777383|NCT05918302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82777384|NCT05918302|Immunologic Factors|immunologic factors|mesh-ancestor
82777385|NCT05918302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777386|NCT05918302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777387|NCT05918302|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82777388|NCT05918211|Udenafil|udenafil|mesh-list
82777389|NCT05918211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82777390|NCT05918211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82777391|NCT05918211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777392|NCT05918211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777393|NCT05918198|Venetoclax|venetoclax|mesh-list
82777394|NCT05918198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777409|NCT05918094|Fluorouracil|fluorouracil|mesh-list
82777410|NCT05918094|Antimetabolites|antimetabolites|mesh-ancestor
82777411|NCT05918094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777412|NCT05918094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82777413|NCT05918094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777414|NCT05918094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82777415|NCT05918094|Immunologic Factors|immunologic factors|mesh-ancestor
82777416|NCT05918094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777417|NCT05918068|Vitamin B 6|vitamin b 6|mesh-list
82777418|NCT05918068|Pyridoxal|pyridoxal|mesh-list
82777419|NCT05918068|Pyridoxine|pyridoxine|mesh-list
82777420|NCT05918068|Metformin|metformin|mesh-list
82777421|NCT05918068|Vitamins|vitamins|mesh-ancestor
82777422|NCT05918068|Micronutrients|micronutrients|mesh-ancestor
82777423|NCT05918068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777424|NCT05918068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82777431|NCT05918029|Potassium Citrate|potassium citrate|mesh-list
82777432|NCT05918029|Diuretics|diuretics|mesh-ancestor
82777433|NCT05918029|Natriuretic Agents|natriuretic agents|mesh-ancestor
82777434|NCT05918029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777435|NCT05918029|Expectorants|expectorants|mesh-ancestor
82777436|NCT05918029|Respiratory System Agents|respiratory system agents|mesh-ancestor
82777437|NCT05917912|Amitriptyline|amitriptyline|mesh-list
82777438|NCT05917912|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82777439|NCT05917912|Antidepressive Agents|antidepressive agents|mesh-ancestor
82777440|NCT05917912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82777441|NCT05917912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82777442|NCT05917912|Analgesics|analgesics|mesh-ancestor
82777443|NCT05917912|Sensory System Agents|sensory system agents|mesh-ancestor
82777450|NCT05917912|Adrenergic Agents|adrenergic agents|mesh-ancestor
82777451|NCT05917912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82777453|NCT05917691|Anesthetics, General|anesthetics, general|mesh-list
82777454|NCT05917691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82777455|NCT05917691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777456|NCT05917587|Metformin|metformin|mesh-list
82777457|NCT05917587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82777458|NCT05917587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777459|NCT05917522|Abatacept|abatacept|mesh-list
82777460|NCT05917522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82777461|NCT05917522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777462|NCT05917522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777463|NCT05917522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777464|NCT05917522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82777465|NCT05917522|Immunologic Factors|immunologic factors|mesh-ancestor
82777466|NCT05917522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777467|NCT05917522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82777468|NCT05917509|Rilpivirine|rilpivirine|mesh-list
82777469|NCT05917509|Cabotegravir|cabotegravir|mesh-list
82777470|NCT05917509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82777471|NCT05917509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82777472|NCT05917509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777473|NCT05917509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777474|NCT05917509|Antiviral Agents|antiviral agents|mesh-ancestor
82777475|NCT05917509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777476|NCT05917509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82777477|NCT05917509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82777478|NCT05917509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82777479|NCT05917509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82777480|NCT05914506|Xenon|xenon|mesh-list
82777481|NCT05914506|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82777482|NCT05914506|Anesthetics, General|anesthetics, general|mesh-ancestor
82777483|NCT05914506|Anesthetics|anesthetics|mesh-ancestor
82777484|NCT05914506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82777485|NCT05914506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777486|NCT05913817|Adalimumab|adalimumab|mesh-list
82777487|NCT05913817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82777488|NCT05913817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82777489|NCT05913817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82777490|NCT05912244|Nivolumab|nivolumab|mesh-list
82777491|NCT05912244|Relatlimab|relatlimab|mesh-list
82777492|NCT05912244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777493|NCT05912244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777494|NCT05912244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82777495|NCT05912244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777496|NCT05909683|Anti-Infective Agents|anti-infective agents|mesh-list
82777497|NCT05909683|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82777498|NCT05907993|Ibuprofen|ibuprofen|mesh-list
82777499|NCT05907993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82777500|NCT05907993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82777501|NCT05907993|Analgesics|analgesics|mesh-ancestor
82777502|NCT05907993|Sensory System Agents|sensory system agents|mesh-ancestor
82777503|NCT05907993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777504|NCT05907993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777505|NCT05907993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82777506|NCT05907993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82777507|NCT05907993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82777508|NCT05907993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777509|NCT05907993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777569|NCT05883241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82777570|NCT05883241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777571|NCT05883241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777573|NCT05882812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82777574|NCT05882812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82777575|NCT05882812|Analgesics|analgesics|mesh-ancestor
82777576|NCT05882812|Sensory System Agents|sensory system agents|mesh-ancestor
82777577|NCT05882812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777578|NCT05882812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777579|NCT05882812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82777580|NCT05882812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82777581|NCT05882812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82777582|NCT05882812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777583|NCT05882812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777589|NCT05879107|Vaccines|vaccines|mesh-list
82777604|NCT05874245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82777605|NCT05874245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82777606|NCT05874245|Adrenergic Agents|adrenergic agents|mesh-ancestor
82777607|NCT05874245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82777608|NCT05874245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777609|NCT05874245|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82777610|NCT05874245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82777611|NCT05874245|Anesthetics, General|anesthetics, general|mesh-ancestor
82777612|NCT05874245|Anesthetics|anesthetics|mesh-ancestor
82777613|NCT05874245|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82777614|NCT05874245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82777615|NCT05874245|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82777616|NCT05874245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82777617|NCT05874245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82777618|NCT05874245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82777619|NCT05874245|GABA Modulators|gaba modulators|mesh-ancestor
82777620|NCT05874245|GABA Agents|gaba agents|mesh-ancestor
82777635|NCT05824351|Propolis|propolis|mesh-list
82777636|NCT05824351|Pycnogenols|pycnogenols|mesh-list
82777637|NCT05824351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82777638|NCT05824351|Immunologic Factors|immunologic factors|mesh-ancestor
82777639|NCT05824351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777640|NCT05824351|Antioxidants|antioxidants|mesh-ancestor
82777641|NCT05824351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777642|NCT05824351|Protective Agents|protective agents|mesh-ancestor
82777643|NCT05824351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82777644|NCT05824351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777645|NCT05824143|Carbamazepine|carbamazepine|mesh-list
82777646|NCT05824143|Anticonvulsants|anticonvulsants|mesh-ancestor
82777647|NCT05824143|Antimanic Agents|antimanic agents|mesh-ancestor
82777648|NCT05824143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82777649|NCT05824143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82777650|NCT05824143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777651|NCT05824143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82777652|NCT05824143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82777653|NCT05824143|Analgesics|analgesics|mesh-ancestor
82777654|NCT05824143|Sensory System Agents|sensory system agents|mesh-ancestor
82777655|NCT05824143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777656|NCT05824143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82777657|NCT05824143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82777658|NCT05824143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777659|NCT05824143|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82777660|NCT05824143|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82777715|NCT05763823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777716|NCT05763823|Antiviral Agents|antiviral agents|mesh-ancestor
82777717|NCT05763823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777723|NCT05740982|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82777724|NCT05740982|Antiviral Agents|antiviral agents|mesh-ancestor
82777725|NCT05740982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777726|NCT05730712|Trastuzumab|trastuzumab|mesh-list
82777728|NCT05730712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777729|NCT05730712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777759|NCT05687136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777761|NCT05687110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82777762|NCT05687110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777763|NCT05687110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777764|NCT05687110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777765|NCT05687110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82777766|NCT05687032|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82777767|NCT05687032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777768|NCT05687032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777769|NCT05687032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82777770|NCT05687032|Immunotoxins|immunotoxins|mesh-ancestor
82777771|NCT05687032|Immunoconjugates|immunoconjugates|mesh-ancestor
82777772|NCT05687032|Immunologic Factors|immunologic factors|mesh-ancestor
82777773|NCT05687032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777774|NCT05664568|Amoxicillin|amoxicillin|mesh-list
82777775|NCT05664568|Clavulanic Acid|clavulanic acid|mesh-list
82777776|NCT05664568|Clavulanic Acids|clavulanic acids|mesh-list
82777777|NCT05664568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82777778|NCT05664568|Cephalexin|cephalexin|mesh-list
82777779|NCT05664568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82777780|NCT05664568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777781|NCT05664568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82777782|NCT05664568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777783|NCT05664568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777796|NCT05645692|Atezolizumab|atezolizumab|mesh-list
82777797|NCT05645692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82777798|NCT05645692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777799|NCT05645692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777800|NCT05645692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777805|NCT05630755|Islatravir|islatravir|mesh-list
82777806|NCT05630755|Antiviral Agents|antiviral agents|mesh-ancestor
82777821|NCT05600894|Venetoclax|venetoclax|mesh-list
82777822|NCT05600894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82777823|NCT05600894|Antimetabolites|antimetabolites|mesh-ancestor
82777824|NCT05600894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777825|NCT05600894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777826|NCT05600894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777827|NCT05593328|Bevacizumab|bevacizumab|mesh-list
82777828|NCT05593328|Onvansertib|onvansertib|mesh-list
82777829|NCT05593328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777830|NCT05593328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777831|NCT05593328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82777832|NCT05593328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82777833|NCT05593328|Growth Substances|growth substances|mesh-ancestor
82777834|NCT05593328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777835|NCT05593328|Growth Inhibitors|growth inhibitors|mesh-ancestor
82777836|NCT05593328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82777837|NCT05593328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777838|NCT05593328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777839|NCT05592379|Psilocybin|psilocybin|mesh-list
82777840|NCT05592379|Hallucinogens|hallucinogens|mesh-ancestor
82777841|NCT05592379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777842|NCT05592379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82777847|NCT05580562|TIC10 compound|tic10 compound|mesh-list
82777848|NCT05580562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777889|NCT05547542|Carfentanil|carfentanil|mesh-list
82777890|NCT05547542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82777891|NCT05547542|Narcotics|narcotics|mesh-ancestor
82777892|NCT05547542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82777893|NCT05547542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777894|NCT05547542|Analgesics|analgesics|mesh-ancestor
82777895|NCT05547542|Sensory System Agents|sensory system agents|mesh-ancestor
82777896|NCT05547542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777897|NCT05525858|Bevacizumab|bevacizumab|mesh-list
82777898|NCT05525858|Trastuzumab|trastuzumab|mesh-list
82777899|NCT05525858|Atezolizumab|atezolizumab|mesh-list
82777900|NCT05525858|Pertuzumab|pertuzumab|mesh-list
82777901|NCT05525858|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82777902|NCT05525858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82777903|NCT05525858|Vemurafenib|vemurafenib|mesh-list
82777904|NCT05525858|Maytansine|maytansine|mesh-list
82777905|NCT05525858|Pralsetinib|pralsetinib|mesh-list
82777906|NCT05525858|Entrectinib|entrectinib|mesh-list
82777907|NCT05525858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777908|NCT05525858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777909|NCT05525858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82777910|NCT05525858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82777911|NCT05525858|Growth Substances|growth substances|mesh-ancestor
82777912|NCT05525858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777913|NCT05525858|Growth Inhibitors|growth inhibitors|mesh-ancestor
82777914|NCT05525858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82777915|NCT05525858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777916|NCT05525858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777917|NCT05525858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82777918|NCT05525858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82777919|NCT05525858|Tubulin Modulators|tubulin modulators|mesh-ancestor
82777920|NCT05525858|Antimitotic Agents|antimitotic agents|mesh-ancestor
82777921|NCT05525858|Mitosis Modulators|mitosis modulators|mesh-ancestor
82777922|NCT05525858|Immunotoxins|immunotoxins|mesh-ancestor
82777923|NCT05525858|Immunoconjugates|immunoconjugates|mesh-ancestor
82777924|NCT05525858|Immunologic Factors|immunologic factors|mesh-ancestor
82777925|NCT05524584|Fulvestrant|fulvestrant|mesh-list
82777926|NCT05524584|Anastrozole|anastrozole|mesh-list
82777927|NCT05524584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82777928|NCT05524584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777929|NCT05524584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82777930|NCT05524584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82777931|NCT05524584|Hormone Antagonists|hormone antagonists|mesh-ancestor
82777932|NCT05524584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82777933|NCT05524584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777934|NCT05524584|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82777935|NCT05524584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82777936|NCT05524584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777937|NCT05524584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777938|NCT05512949|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82777939|NCT05512949|Antiviral Agents|antiviral agents|mesh-ancestor
82777940|NCT05512949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82777947|NCT05507541|Pembrolizumab|pembrolizumab|mesh-list
82777948|NCT05507541|Immunoglobulin G|immunoglobulin g|mesh-list
82777949|NCT05507541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777950|NCT05507541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777951|NCT05507541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82777952|NCT05507541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777953|NCT05507541|Immunologic Factors|immunologic factors|mesh-ancestor
82777954|NCT05507541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777955|NCT05498220|Dexamethasone|dexamethasone|mesh-list
82777956|NCT05498220|Rituximab|rituximab|mesh-list
82777957|NCT05498220|Gemcitabine|gemcitabine|mesh-list
82777958|NCT05498220|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
82777959|NCT05498220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82777960|NCT05498220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82777961|NCT05498220|Immunologic Factors|immunologic factors|mesh-ancestor
82777962|NCT05498220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777963|NCT05498220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82777964|NCT05498220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82777965|NCT05498220|Antiemetics|antiemetics|mesh-ancestor
82777966|NCT05498220|Autonomic Agents|autonomic agents|mesh-ancestor
82777967|NCT05498220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777968|NCT05498220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82777969|NCT05498220|Glucocorticoids|glucocorticoids|mesh-ancestor
82777970|NCT05498220|Hormones|hormones|mesh-ancestor
82777971|NCT05498220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82777972|NCT05498220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82777973|NCT05498220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82777974|NCT05498220|Antimetabolites|antimetabolites|mesh-ancestor
82777975|NCT05498220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777976|NCT05498220|Immunoconjugates|immunoconjugates|mesh-ancestor
82777977|NCT05494437|Gabapentin|gabapentin|mesh-list
82777978|NCT05494437|Nabilone|nabilone|mesh-list
82777979|NCT05494437|Analgesics|analgesics|mesh-ancestor
82777980|NCT05494437|Sensory System Agents|sensory system agents|mesh-ancestor
82777981|NCT05494437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82777982|NCT05494437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777983|NCT05494437|Anticonvulsants|anticonvulsants|mesh-ancestor
82777984|NCT05494437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82777985|NCT05494437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82777986|NCT05494437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82777987|NCT05494437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82777988|NCT05494437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82777989|NCT05494437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82777990|NCT05494437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82777991|NCT05494437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82777992|NCT05494437|Antimanic Agents|antimanic agents|mesh-ancestor
82777993|NCT05494437|Antiemetics|antiemetics|mesh-ancestor
82777994|NCT05494437|Autonomic Agents|autonomic agents|mesh-ancestor
82777995|NCT05494437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82777996|NCT05461053|Lidocaine|lidocaine|mesh-list
82777997|NCT05461053|Anesthetics, Local|anesthetics, local|mesh-ancestor
82777998|NCT05461053|Anesthetics|anesthetics|mesh-ancestor
82777999|NCT05461053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82778000|NCT05461053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778001|NCT05461053|Sensory System Agents|sensory system agents|mesh-ancestor
82778002|NCT05461053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778003|NCT05461053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82778004|NCT05461053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82778005|NCT05461053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82778006|NCT05461053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82778007|NCT05461053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778008|NCT05440708|Bevacizumab|bevacizumab|mesh-list
82778009|NCT05440708|Pembrolizumab|pembrolizumab|mesh-list
82778010|NCT05440708|Atezolizumab|atezolizumab|mesh-list
82778011|NCT05440708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778012|NCT05440708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778013|NCT05440708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82778014|NCT05440708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82778015|NCT05440708|Growth Substances|growth substances|mesh-ancestor
82778016|NCT05440708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778017|NCT05440708|Growth Inhibitors|growth inhibitors|mesh-ancestor
82778018|NCT05440708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778019|NCT05440708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778020|NCT05428488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
82778021|NCT05428488|Abatacept|abatacept|mesh-list
82778022|NCT05428488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778023|NCT05428488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778024|NCT05428488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778025|NCT05428488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778026|NCT05428488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82778027|NCT05428488|Immunologic Factors|immunologic factors|mesh-ancestor
82778028|NCT05428488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778029|NCT05428488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82778030|NCT05428488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778031|NCT05414201|Adalimumab|adalimumab|mesh-list
82778032|NCT05414201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82778033|NCT05414201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778034|NCT05414201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82778035|NCT05412004|Tirzepatide|tirzepatide|mesh-list
82778036|NCT05412004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82778037|NCT05412004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778038|NCT05412004|Incretins|incretins|mesh-ancestor
82778039|NCT05412004|Hormones|hormones|mesh-ancestor
82778040|NCT05412004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82778041|NCT05405751|Tenofovir|tenofovir|mesh-list
82778042|NCT05405751|Emtricitabine|emtricitabine|mesh-list
82778043|NCT05405751|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
82778044|NCT05405751|Antiviral Agents|antiviral agents|mesh-ancestor
82778045|NCT05405751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82778046|NCT05405751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82778047|NCT05405751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82778048|NCT05405751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778049|NCT05405751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778050|NCT05405751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82778051|NCT05405751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82778052|NCT05405309|Olaparib|olaparib|mesh-list
82778053|NCT05405309|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82778054|NCT05405309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778055|NCT05405309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778056|NCT05405309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778057|NCT05403476|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82778058|NCT05403476|Hormones|hormones|mesh-ancestor
82778059|NCT05403476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82778060|NCT05403476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778062|NCT05392452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82778063|NCT05392452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778098|NCT05387187|Pentoxifylline|pentoxifylline|mesh-list
82778099|NCT05387187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82778107|NCT05387187|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82778108|NCT05387187|Antioxidants|antioxidants|mesh-ancestor
82778109|NCT05382325|Pembrolizumab|pembrolizumab|mesh-list
82778110|NCT05382325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778111|NCT05382325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778112|NCT05382325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778113|NCT05382325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778118|NCT05365893|Hydroxychloroquine|hydroxychloroquine|mesh-list
82778120|NCT05365893|Antimalarials|antimalarials|mesh-ancestor
82778121|NCT05365893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82778122|NCT05365893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82778123|NCT05365893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82778124|NCT05365893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778125|NCT05365893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778126|NCT05365893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82778127|NCT05365893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82778128|NCT05365893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82778129|NCT05365893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82778130|NCT05365893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82778131|NCT05364073|Aflutinib|aflutinib|mesh-list
82778132|NCT05364073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82778133|NCT05364073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778134|NCT05364073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778142|NCT05317416|Lenalidomide|lenalidomide|mesh-list
82778143|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
82778144|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778145|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82778146|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82778147|NCT05317416|Growth Substances|growth substances|mesh-ancestor
82778148|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
82778149|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778150|NCT05312671|Cisplatin|cisplatin|mesh-list
82778151|NCT05312671|Carboplatin|carboplatin|mesh-list
82778152|NCT05312671|Etoposide|etoposide|mesh-list
82778153|NCT05312671|Atezolizumab|atezolizumab|mesh-list
82778154|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
82778155|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778156|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82778157|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82778158|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82778159|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778160|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778161|NCT05312671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778162|NCT05312671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778163|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
82778164|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
82778165|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
82778166|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
82778167|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
82778173|NCT05283720|Prednisone|prednisone|mesh-list
82778174|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
82778175|NCT05283720|Rituximab|rituximab|mesh-list
82778176|NCT05283720|Doxorubicin|doxorubicin|mesh-list
82778177|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82778178|NCT05283720|Lenalidomide|lenalidomide|mesh-list
82778179|NCT05283720|Venetoclax|venetoclax|mesh-list
82778180|NCT05283720|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
82778181|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82778182|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
82778183|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778184|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82778185|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82778186|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
82778187|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778188|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778189|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82778190|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778191|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82778192|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82778193|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82778194|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778195|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778196|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
82778198|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82778199|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82778200|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82778201|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82778202|NCT05283720|Growth Substances|growth substances|mesh-ancestor
82778203|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
82778204|NCT05283720|Immunoconjugates|immunoconjugates|mesh-ancestor
82778205|NCT05262270|Naltrexone|naltrexone|mesh-list
82778206|NCT05262270|Buprenorphine|buprenorphine|mesh-list
82778207|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82778208|NCT05262270|Narcotics|narcotics|mesh-ancestor
82778209|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82778210|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778211|NCT05262270|Analgesics|analgesics|mesh-ancestor
82778212|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
82778213|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778214|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82778215|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82778216|NCT05259839|Dexamethasone|dexamethasone|mesh-list
82778217|NCT05259839|Lenalidomide|lenalidomide|mesh-list
82778218|NCT05259839|Daratumumab|daratumumab|mesh-list
82778219|NCT05259839|Pomalidomide|pomalidomide|mesh-list
82778220|NCT05259839|Nirogacestat|nirogacestat|mesh-list
82778221|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778222|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
82778223|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
82778224|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778225|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778226|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82778227|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
82778228|NCT05259839|Hormones|hormones|mesh-ancestor
82778229|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82778230|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82778231|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778232|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
82778233|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82778234|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82778235|NCT05259839|Growth Substances|growth substances|mesh-ancestor
82778236|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
82778237|NCT05259839|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82778238|NCT05259839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778239|NCT05259839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778240|NCT05257408|Paclitaxel|paclitaxel|mesh-list
82778241|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82778242|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82778243|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778244|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
82778245|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
82778246|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
82778247|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778248|NCT05254574|Diclofenac|diclofenac|mesh-list
82778249|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82778250|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82778251|NCT05254574|Analgesics|analgesics|mesh-ancestor
82778252|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
82778253|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778254|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778255|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778256|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82778257|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82778258|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778259|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778260|NCT05219929|Tetracycline|tetracycline|mesh-list
82778261|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82778262|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82778263|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82778264|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778265|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778266|NCT05205382|Nicotine|nicotine|mesh-list
82778267|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82778268|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
82778269|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778270|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778271|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82778272|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82778273|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
82778274|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82778275|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778276|NCT05198843|Dasatinib|dasatinib|mesh-list
82778277|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
82778278|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778279|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82778280|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778281|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778282|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82778283|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82778291|NCT05145413|Xanomeline|xanomeline|mesh-list
82778292|NCT05145413|Trospium chloride|trospium chloride|mesh-list
82778293|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
82778294|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
82778295|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778296|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778297|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82778298|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82778299|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
82778300|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82778301|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778302|NCT05145413|Urological Agents|urological agents|mesh-ancestor
82778303|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82778304|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82778305|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82778306|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82778307|NCT05139225|Daratumumab|daratumumab|mesh-list
82778308|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778309|NCT05132829|Azithromycin|azithromycin|mesh-list
82778310|NCT05132829|Cefazolin|cefazolin|mesh-list
82778311|NCT05132829|Indomethacin|indomethacin|mesh-list
82778312|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82778313|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82778314|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82778315|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82778316|NCT05132829|Analgesics|analgesics|mesh-ancestor
82778317|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
82778318|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778319|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778320|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778321|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82778322|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
82778323|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
82778324|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82778325|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82778326|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778327|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778328|NCT05117450|Heparin|heparin|mesh-list
82778329|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
82778330|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82778331|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82778332|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778333|NCT05102669|Antibodies|antibodies|mesh-list
82778334|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
82778335|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778336|NCT05090566|Dexamethasone|dexamethasone|mesh-list
82778337|NCT05090566|Lenalidomide|lenalidomide|mesh-list
82778338|NCT05090566|Nirogacestat|nirogacestat|mesh-list
82778339|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778340|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
82778341|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
82778342|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778343|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778344|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82778345|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
82778346|NCT05090566|Hormones|hormones|mesh-ancestor
82778347|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82778348|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82778349|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778350|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
82778351|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82778352|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82778353|NCT05090566|Growth Substances|growth substances|mesh-ancestor
82778354|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
82778355|NCT05090566|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82778356|NCT05090566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778357|NCT05090566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778358|NCT05050448|Diclofenac|diclofenac|mesh-list
82778359|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82778360|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82778361|NCT05050448|Analgesics|analgesics|mesh-ancestor
82778362|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
82778363|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778364|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778365|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778366|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82778367|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82778368|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778369|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778370|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
82778371|NCT04949256|Leucovorin|leucovorin|mesh-list
82778372|NCT04949256|Paclitaxel|paclitaxel|mesh-list
82778373|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
82778374|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
82778375|NCT04949256|Lenvatinib|lenvatinib|mesh-list
82778376|NCT04949256|Calcium|calcium|mesh-list
82778377|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
82778378|NCT04949256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82778379|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778384|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778385|NCT04949256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778386|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82778387|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778388|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82778389|NCT04949256|Antidotes|antidotes|mesh-ancestor
82778390|NCT04949256|Protective Agents|protective agents|mesh-ancestor
82778391|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
82778392|NCT04949256|Vitamins|vitamins|mesh-ancestor
82778393|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
82778394|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82778395|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778402|NCT04919226|Leucovorin|leucovorin|mesh-list
82778403|NCT04919226|Folic Acid|folic acid|mesh-list
82778404|NCT04919226|Fluorouracil|fluorouracil|mesh-list
82778405|NCT04919226|Capecitabine|capecitabine|mesh-list
82778406|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
82778407|NCT04919226|Everolimus|everolimus|mesh-list
82778408|NCT04919226|Temozolomide|temozolomide|mesh-list
82778409|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82778410|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
82778411|NCT04919226|Edotreotide|edotreotide|mesh-list
82778412|NCT04919226|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
82778413|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
82778414|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778415|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82778416|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778417|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82778418|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
82778419|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778420|NCT04919226|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82778421|NCT04919226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82778422|NCT04919226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778423|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82778424|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
82778425|NCT04919226|Antidotes|antidotes|mesh-ancestor
82778426|NCT04919226|Protective Agents|protective agents|mesh-ancestor
82778427|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
82778428|NCT04919226|Vitamins|vitamins|mesh-ancestor
82778429|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
82778430|NCT04919226|Hematinics|hematinics|mesh-ancestor
82778431|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82778440|NCT04899388|Fentanyl|fentanyl|mesh-list
82778441|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82778442|NCT04899388|Narcotics|narcotics|mesh-ancestor
82778443|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82778444|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778445|NCT04899388|Analgesics|analgesics|mesh-ancestor
82778446|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
82778447|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778448|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82778449|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82778450|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
82778451|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
82778520|NCT04793958|Cetuximab|cetuximab|mesh-list
82778521|NCT04793958|Adagrasib|adagrasib|mesh-list
82778522|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778523|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778524|NCT04781088|Paclitaxel|paclitaxel|mesh-list
82778525|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
82778526|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82778527|NCT04781088|Lenvatinib|lenvatinib|mesh-list
82778528|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82778529|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778530|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
82778531|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
82778532|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
82778533|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778534|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778535|NCT04781088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778536|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82778537|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778538|NCT04777006|Amitriptyline|amitriptyline|mesh-list
82778540|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
82778541|NCT04777006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82778542|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82778543|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82778544|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778545|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82778546|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
82778547|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778548|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82778549|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82778550|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82778551|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82778552|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778553|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82778554|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82778555|NCT04777006|Analgesics|analgesics|mesh-ancestor
82778556|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
82778557|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778558|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82778559|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
82778560|NCT04776252|Islatravir|islatravir|mesh-list
82778561|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
82778562|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82778563|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778564|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778565|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82778566|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82778567|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82778568|NCT04766086|Vaccines|vaccines|mesh-list
82778569|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
82778570|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778571|NCT04733547|Furosemide|furosemide|mesh-list
82778572|NCT04733547|Diuretics|diuretics|mesh-ancestor
82778573|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
82778574|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778575|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82778576|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82778577|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778578|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
82778579|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82778580|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778581|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82778582|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778585|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
82778586|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778587|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778588|NCT04708418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778589|NCT04708418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778590|NCT04680910|Propofol|propofol|mesh-list
82778591|NCT04680910|Anesthetics|anesthetics|mesh-list
82778592|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82778593|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82778594|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778595|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82778596|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
82778597|NCT04678102|PHI-101|phi-101|mesh-list
82778598|NCT04678102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778599|NCT04678102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778600|NCT04678102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778601|NCT04678102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778602|NCT04653246|Dexamethasone|dexamethasone|mesh-list
82778603|NCT04653246|Lenalidomide|lenalidomide|mesh-list
82778604|NCT04653246|Bortezomib|bortezomib|mesh-list
82778605|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778606|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
82778607|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
82778608|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778609|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778610|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82778611|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
82778612|NCT04653246|Hormones|hormones|mesh-ancestor
82778613|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82778614|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82778615|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778616|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
82778617|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82778618|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82778619|NCT04653246|Growth Substances|growth substances|mesh-ancestor
82778620|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
82778621|NCT04643106|Hemostatics|hemostatics|mesh-list
82778622|NCT04643106|Coagulants|coagulants|mesh-ancestor
82778623|NCT04636437|Tenofovir|tenofovir|mesh-list
82778624|NCT04636437|Lamivudine|lamivudine|mesh-list
82778625|NCT04636437|Emtricitabine|emtricitabine|mesh-list
82778626|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
82778627|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
82778628|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82778629|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82778630|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82778631|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778632|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778633|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82778634|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82778635|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
82778636|NCT04624204|Etoposide|etoposide|mesh-list
82778637|NCT04624204|Olaparib|olaparib|mesh-list
82778638|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778639|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778640|NCT04624204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778641|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778642|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82778643|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82778644|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82778645|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778646|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82778647|NCT04619797|Carboplatin|carboplatin|mesh-list
82778648|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
82778649|NCT04619797|Pemetrexed|pemetrexed|mesh-list
82778650|NCT04619797|Atezolizumab|atezolizumab|mesh-list
82778651|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778652|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778653|NCT04619797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778654|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778655|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778656|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82778657|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82778658|NCT04618016|Vitamins|vitamins|mesh-list
82778659|NCT04618016|Vitamin E|vitamin e|mesh-list
82778660|NCT04618016|Tocopherols|tocopherols|mesh-list
82778661|NCT04618016|Tocotrienols|tocotrienols|mesh-list
82778662|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
82778663|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
82778664|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778665|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
82778666|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778667|NCT04618016|Protective Agents|protective agents|mesh-ancestor
82778668|NCT04606914|Maytansine|maytansine|mesh-list
82778669|NCT04606914|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
82778670|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82778671|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778672|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
82778673|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
82778674|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
82778675|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778676|NCT04606914|Immunoconjugates|immunoconjugates|mesh-ancestor
82778677|NCT04606914|Immunologic Factors|immunologic factors|mesh-ancestor
82778678|NCT04606914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778684|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82778686|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
82778687|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778688|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778689|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778690|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82778691|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82778692|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
82778698|NCT04564885|Meloxicam|meloxicam|mesh-list
82778699|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82778700|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82778701|NCT04564885|Analgesics|analgesics|mesh-ancestor
82778702|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
82778703|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778705|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778706|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82778707|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82778708|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82778709|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778710|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778711|NCT04564157|Paclitaxel|paclitaxel|mesh-list
82778712|NCT04564157|Carboplatin|carboplatin|mesh-list
82778713|NCT04564157|Nivolumab|nivolumab|mesh-list
82778714|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82778715|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778716|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
82778717|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
82778718|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
82778719|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778720|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778721|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778722|NCT04555577|Temozolomide|temozolomide|mesh-list
82778723|NCT04555577|Peposertib|peposertib|mesh-list
82778724|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82778725|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
82778726|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778727|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778728|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82778729|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778730|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
82778731|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82778732|NCT04509791|Antibodies|antibodies|mesh-list
82778733|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
82778734|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
82778735|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778736|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82778737|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82778738|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82778739|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82778740|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82778741|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778742|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82778743|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778744|NCT04504812|Analgesics|analgesics|mesh-ancestor
82778745|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
82778746|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778747|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
82778748|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82778749|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
82778750|NCT04497584|Prednisone|prednisone|mesh-list
82778751|NCT04497584|Afatinib|afatinib|mesh-list
82778752|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778753|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
82778754|NCT04497584|Hormones|hormones|mesh-ancestor
82778755|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82778756|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778757|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82778758|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778759|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82778760|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778761|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778762|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
82778763|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778764|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82778765|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778766|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778767|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
82778768|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82778769|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778770|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82778772|NCT04491942|Gemcitabine|gemcitabine|mesh-list
82778773|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778774|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82778775|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
82778776|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778778|NCT04484623|Bortezomib|bortezomib|mesh-list
82778779|NCT04484623|Pomalidomide|pomalidomide|mesh-list
82778780|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778781|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
82778782|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
82778783|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778784|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778785|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82778786|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
82778787|NCT04484623|Hormones|hormones|mesh-ancestor
82778788|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82778789|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82778790|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778791|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
82778792|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82778793|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82778794|NCT04484623|Growth Substances|growth substances|mesh-ancestor
82778795|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
82778796|NCT04474366|Ropivacaine|ropivacaine|mesh-list
82778797|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
82778798|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
82778799|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82778800|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778801|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
82778802|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82778803|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
82778804|NCT04469595|Aflibercept|aflibercept|mesh-list
82778805|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82778806|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82778807|NCT04469595|Growth Substances|growth substances|mesh-ancestor
82778808|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778809|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
82778810|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778811|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82778812|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
82778813|NCT04469595|Hormones|hormones|mesh-ancestor
82778814|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82778815|NCT04428151|Paclitaxel|paclitaxel|mesh-list
82778816|NCT04428151|Docetaxel|docetaxel|mesh-list
82778817|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
82778818|NCT04428151|Capecitabine|capecitabine|mesh-list
82778819|NCT04428151|Cetuximab|cetuximab|mesh-list
82778820|NCT04428151|Lenvatinib|lenvatinib|mesh-list
82778821|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82778822|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778823|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
82778824|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
82778854|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778856|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82778857|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82778858|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778859|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82778860|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82778861|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82778863|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778864|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778865|NCT04374877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778866|NCT04374877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778886|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
82778887|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
82778888|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82778889|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82778890|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778891|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82778895|NCT04294810|Atezolizumab|atezolizumab|mesh-list
82778904|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
82778905|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778906|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778907|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778908|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82778909|NCT04250636|Antibodies|antibodies|mesh-list
82778910|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
82778911|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82778912|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
82778913|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778914|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778915|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
82778916|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82778917|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82778918|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778919|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
82778920|NCT04233749|Coagulants|coagulants|mesh-ancestor
82778921|NCT04231851|Cytarabine|cytarabine|mesh-list
82778922|NCT04231851|Daunorubicin|daunorubicin|mesh-list
82778923|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82778924|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
82778925|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778926|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778928|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82778929|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82778930|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
82778931|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778932|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82778933|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82778934|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82778935|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82778944|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
82778945|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778946|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778947|NCT04214067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778948|NCT04214067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778949|NCT04201561|Selenious Acid|selenious acid|mesh-list
82778950|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
82778951|NCT04201561|Paclitaxel|paclitaxel|mesh-list
82778952|NCT04201561|Carboplatin|carboplatin|mesh-list
82778953|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82778954|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778955|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
82778956|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
82778957|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
82778958|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778959|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82778960|NCT04201561|Trace Elements|trace elements|mesh-ancestor
82778976|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778991|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82778992|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82778993|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82778994|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82778995|NCT04162873|Celecoxib|celecoxib|mesh-list
82778996|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
82778997|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82778998|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82778999|NCT04162873|Analgesics|analgesics|mesh-ancestor
82779000|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
82779001|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779002|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779003|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82779004|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82779005|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82779213|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779006|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82779007|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779008|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779009|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82779010|NCT04157348|Benralizumab|benralizumab|mesh-list
82779011|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82779012|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
82779029|NCT04100018|Prednisone|prednisone|mesh-list
82779030|NCT04100018|Docetaxel|docetaxel|mesh-list
82779031|NCT04100018|Nivolumab|nivolumab|mesh-list
82779032|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779033|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
82779034|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
82779035|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
82779036|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779037|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82779038|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
82779039|NCT04100018|Hormones|hormones|mesh-ancestor
82779040|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82779041|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779042|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82779043|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779044|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82779045|NCT04061421|Decitabine|decitabine|mesh-list
82779046|NCT04061421|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
82779047|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82779048|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
82779049|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779050|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779051|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779052|NCT04046900|Metronidazole|metronidazole|mesh-list
82779053|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779054|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82779055|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82779056|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82779057|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
82779058|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82779059|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82779060|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82779061|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82779062|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82779063|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779064|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
82779065|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82779066|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779067|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82779068|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779069|NCT03989115|Osimertinib|osimertinib|mesh-list
82779070|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779071|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82779072|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779073|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779074|NCT03971071|Erenumab|erenumab|mesh-list
82779075|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82779076|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82779077|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779078|NCT03971071|Analgesics|analgesics|mesh-ancestor
82779079|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
82779080|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779081|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779082|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
82779083|NCT03969901|Relebactam|relebactam|mesh-list
82779084|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82779085|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779086|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779087|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82779088|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779107|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82779108|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779109|NCT03937843|Carboplatin|carboplatin|mesh-list
82779110|NCT03937843|Etoposide|etoposide|mesh-list
82779111|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779112|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82779113|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82779114|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82779115|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779116|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779117|NCT03919071|Trametinib|trametinib|mesh-list
82779118|NCT03919071|Dabrafenib|dabrafenib|mesh-list
82779119|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
82779120|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779121|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82779122|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779123|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779124|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82779125|NCT03919071|Protective Agents|protective agents|mesh-ancestor
82779126|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779127|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82779128|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
82779134|NCT03899155|Nivolumab|nivolumab|mesh-list
82779135|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779136|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779137|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82779138|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779139|NCT03839823|Paclitaxel|paclitaxel|mesh-list
82779140|NCT03839823|Vinorelbine|vinorelbine|mesh-list
82779141|NCT03839823|Docetaxel|docetaxel|mesh-list
82779142|NCT03839823|Gemcitabine|gemcitabine|mesh-list
82779143|NCT03839823|Capecitabine|capecitabine|mesh-list
82779144|NCT03839823|Letrozole|letrozole|mesh-list
82779145|NCT03839823|Anastrozole|anastrozole|mesh-list
82779146|NCT03839823|Goserelin|goserelin|mesh-list
82779147|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82779148|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779149|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
82779151|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
82779152|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779153|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82779154|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
82779155|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82779156|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82779157|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779158|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82779159|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
82779160|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82779161|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779162|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82779163|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
82779164|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779165|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779166|NCT03833167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82779176|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82779177|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82779178|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82779179|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779180|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779181|NCT03811002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82779182|NCT03811002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779183|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
82779184|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779185|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
82779186|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
82779187|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
82779188|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
82779189|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
82779200|NCT03787680|Olaparib|olaparib|mesh-list
82779201|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82779202|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779203|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779204|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779205|NCT03743636|Niacinamide|niacinamide|mesh-list
82779207|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
82779208|NCT03743636|Resveratrol|resveratrol|mesh-list
82779209|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
82779210|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779211|NCT03743636|Protective Agents|protective agents|mesh-ancestor
82779212|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779214|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82779215|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
82779216|NCT03743636|Vitamins|vitamins|mesh-ancestor
82779217|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
82779218|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82779219|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
82779220|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82779221|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
82779231|NCT03726775|Durvalumab|durvalumab|mesh-list
82779232|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779233|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779234|NCT03718039|Aprepitant|aprepitant|mesh-list
82779235|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
82779236|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
82779237|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779238|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779239|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82779240|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82779241|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82779242|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779243|NCT03672292|Voriconazole|voriconazole|mesh-list
82779244|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
82779245|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
82779246|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779247|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82779248|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82779249|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779250|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779251|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82779252|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
82779253|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82779254|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779255|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82779256|NCT03653507|Capecitabine|capecitabine|mesh-list
82779257|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
82779258|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82779259|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
82779260|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779261|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779262|NCT03635164|Durvalumab|durvalumab|mesh-list
82779263|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779264|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779265|NCT03602014|Droxidopa|droxidopa|mesh-list
82779266|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82779267|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82779268|NCT03559868|Digoxin|digoxin|mesh-list
82779269|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82779270|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82779271|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779272|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779273|NCT03559868|Protective Agents|protective agents|mesh-ancestor
82779274|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779275|NCT03559192|Aticaprant|aticaprant|mesh-list
82779276|NCT03559192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82779277|NCT03559192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779278|NCT03559192|Sensory System Agents|sensory system agents|mesh-ancestor
82779279|NCT03559192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779280|NCT03552471|Rucaparib|rucaparib|mesh-list
82779281|NCT03552471|Maytansine|maytansine|mesh-list
82779282|NCT03552471|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
82779283|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82779284|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779285|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779286|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779287|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82779288|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
82779289|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
82779290|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
82779291|NCT03552471|Immunoconjugates|immunoconjugates|mesh-ancestor
82779292|NCT03552471|Immunologic Factors|immunologic factors|mesh-ancestor
82779293|NCT03552471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779294|NCT03533946|Rucaparib|rucaparib|mesh-list
82779295|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82779296|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779372|NCT03407144|Doxorubicin|doxorubicin|mesh-list
82779297|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779298|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779299|NCT03523585|Capecitabine|capecitabine|mesh-list
82779300|NCT03523585|Trastuzumab|trastuzumab|mesh-list
82779301|NCT03523585|Lapatinib|lapatinib|mesh-list
82779302|NCT03523585|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82779303|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82779304|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
82779305|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779306|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779307|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779308|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82779309|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779310|NCT03523585|Immunoconjugates|immunoconjugates|mesh-ancestor
82779311|NCT03523585|Immunologic Factors|immunologic factors|mesh-ancestor
82779312|NCT03523585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779313|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
82779314|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779315|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779316|NCT03486873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82779317|NCT03486873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779318|NCT03485911|Berotralstat|berotralstat|mesh-list
82779319|NCT03485911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82779320|NCT03485911|Protease Inhibitors|protease inhibitors|mesh-ancestor
82779321|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779322|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779323|NCT03436745|Zolpidem|zolpidem|mesh-list
82779324|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82779325|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82779326|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82779327|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779328|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82779329|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
82779330|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
82779331|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82779332|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779333|NCT03435250|Paclitaxel|paclitaxel|mesh-list
82779334|NCT03435250|Docetaxel|docetaxel|mesh-list
82779335|NCT03435250|Gemcitabine|gemcitabine|mesh-list
82779336|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82779337|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779338|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
82779339|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
82779340|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
82779341|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779342|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82779343|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
82779344|NCT03422822|Abrocitinib|abrocitinib|mesh-list
82779345|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82779346|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779347|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779348|NCT03416153|Paclitaxel|paclitaxel|mesh-list
82779349|NCT03416153|Carboplatin|carboplatin|mesh-list
82779350|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82779351|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779352|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
82779353|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
82779354|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
82779355|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779356|NCT03409718|Cimetidine|cimetidine|mesh-list
82779357|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82779358|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82779359|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82779360|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
82779361|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
82779362|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82779363|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779364|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779365|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82779366|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82779367|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779368|NCT03407144|Prednisone|prednisone|mesh-list
82779369|NCT03407144|Prednisolone|prednisolone|mesh-list
82779370|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
82779371|NCT03407144|Dacarbazine|dacarbazine|mesh-list
82779373|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
82779375|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
82779376|NCT03407144|Vincristine|vincristine|mesh-list
82779377|NCT03407144|Bleomycin|bleomycin|mesh-list
82779378|NCT03407144|Vinblastine|vinblastine|mesh-list
82779379|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779380|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
82779381|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779382|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82779383|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82779384|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
82779385|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779386|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779387|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82779388|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82779389|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82779390|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82779391|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779392|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779393|NCT03407144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82779394|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82779395|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
82779396|NCT03407144|Hormones|hormones|mesh-ancestor
82779397|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82779398|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82779399|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82779400|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
82779401|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
82779402|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
82779403|NCT03395314|Midazolam|midazolam|mesh-list
82779404|NCT03395314|Ketamine|ketamine|mesh-list
82779405|NCT03395314|Analgesics|analgesics|mesh-ancestor
82779406|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
82779407|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779408|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779409|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82779410|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82779411|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
82779412|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
82779413|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82779414|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82779415|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82779416|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82779417|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779418|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82779419|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82779420|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82779421|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82779422|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82779423|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
82779424|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
82779425|NCT03386500|Manganese|manganese|mesh-list
82779426|NCT03386500|Trace Elements|trace elements|mesh-ancestor
82779427|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
82779428|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779429|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
82779430|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779431|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779432|NCT03293680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82779433|NCT03293680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779434|NCT03245541|Durvalumab|durvalumab|mesh-list
82779435|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779436|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779437|NCT03239340|Osimertinib|osimertinib|mesh-list
82779438|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779439|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82779440|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779441|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779442|NCT03187106|Metronidazole|metronidazole|mesh-list
82779443|NCT03187106|Cephalexin|cephalexin|mesh-list
82779444|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779445|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82779446|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82779447|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82779448|NCT03172975|Albendazole|albendazole|mesh-list
82779449|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82779450|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
82779451|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82779452|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779453|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
82779454|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82779455|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82779456|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
82779457|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
82779458|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
82779459|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779460|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779461|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82779462|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
82779463|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779464|NCT03172975|Antacids|antacids|mesh-ancestor
82779465|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82779466|NCT03114527|Everolimus|everolimus|mesh-list
82779467|NCT03114527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82779468|NCT03114527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82779469|NCT03114527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779470|NCT03114527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779471|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779472|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
82779473|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779474|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779475|NCT03109288|Pioglitazone|pioglitazone|mesh-list
82779476|NCT03109288|Clemastine|clemastine|mesh-list
82779477|NCT03109288|Pirfenidone|pirfenidone|mesh-list
82779478|NCT03109288|Dantrolene|dantrolene|mesh-list
82779479|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82779480|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779481|NCT03109288|Analgesics|analgesics|mesh-ancestor
82779482|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
82779483|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779484|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82779485|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82779486|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82779487|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82779488|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779489|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
82779490|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
82779491|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82779492|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
82779493|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
82779494|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82779495|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779496|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82779497|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82779498|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82779499|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
82779500|NCT03073785|Fluorouracil|fluorouracil|mesh-list
82779501|NCT03073785|Capecitabine|capecitabine|mesh-list
82779502|NCT03073785|Imidazole|imidazole|mesh-list
82779503|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
82779504|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779505|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82779506|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779507|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779508|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
82779509|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779510|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82779511|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779512|NCT03065335|Ketamine|ketamine|mesh-list
82779513|NCT03065335|Analgesics|analgesics|mesh-ancestor
82779514|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
82779515|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779516|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779517|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82779518|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82779519|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
82779520|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
82779521|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82779522|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82779523|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82779524|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82779525|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779526|NCT03028103|Repaglinide|repaglinide|mesh-list
82779527|NCT03028103|Fluconazole|fluconazole|mesh-list
82779528|NCT03028103|Omeprazole|omeprazole|mesh-list
82779529|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82779530|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82779531|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82779532|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779533|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779534|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
82779535|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779536|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82779537|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82779538|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82779539|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
82779540|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82779541|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779542|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82779543|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82779544|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82779545|NCT03020589|Tacrolimus|tacrolimus|mesh-list
82779546|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779547|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
82779548|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779549|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82779550|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779551|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779552|NCT02932475|Metformin|metformin|mesh-list
82779553|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82779554|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779555|NCT02919917|Midodrine|midodrine|mesh-list
82779556|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
82779557|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
82779558|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779559|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779560|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82779561|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82779562|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82779563|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82779564|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
82779565|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82779566|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779567|NCT02915198|Metformin|metformin|mesh-list
82779568|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82779569|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779570|NCT02893553|Midodrine|midodrine|mesh-list
82779571|NCT02893553|Bromides|bromides|mesh-list
82779572|NCT02893553|Mirabegron|mirabegron|mesh-list
82779573|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
82779574|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
82779575|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82779576|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82779577|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82779578|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
82779579|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82779580|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779581|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779582|NCT02893553|Urological Agents|urological agents|mesh-ancestor
82779583|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
82779584|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
82779585|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779586|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82779587|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82779588|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82779589|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82779590|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779591|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
82779592|NCT02861573|Dexamethasone|dexamethasone|mesh-list
82779593|NCT02861573|Prednisone|prednisone|mesh-list
82779594|NCT02861573|Carboplatin|carboplatin|mesh-list
82779595|NCT02861573|Docetaxel|docetaxel|mesh-list
82779596|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
82779597|NCT02861573|Etoposide|etoposide|mesh-list
82779598|NCT02861573|Lenvatinib|lenvatinib|mesh-list
82779599|NCT02861573|Olaparib|olaparib|mesh-list
82779600|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
82779601|NCT02861573|Belzutifan|belzutifan|mesh-list
82779603|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
82779604|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
82779605|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779606|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779607|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82779608|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
82779609|NCT02861573|Hormones|hormones|mesh-ancestor
82779610|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82779611|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82779612|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779613|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
82779614|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
82779615|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
82779616|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779617|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779618|NCT02861573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82779619|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82779620|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82779621|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82779622|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779623|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82779624|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82779625|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82779626|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
82779627|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82779628|NCT02858310|Aldesleukin|aldesleukin|mesh-list
82779629|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
82779630|NCT02858310|Fludarabine|fludarabine|mesh-list
82779631|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779632|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
82779633|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779634|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82779635|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82779636|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
82779637|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779638|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779639|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82779640|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82779641|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82779642|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
82779643|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779644|NCT02755272|Carboplatin|carboplatin|mesh-list
82779645|NCT02755272|Gemcitabine|gemcitabine|mesh-list
82779646|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
82779647|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779648|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82779649|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
82779650|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779651|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779652|NCT02755272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82779653|NCT02629120|Sirolimus|sirolimus|mesh-list
82779654|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
82779655|NCT02629120|Busulfan|busulfan|mesh-list
82779656|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
82779657|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779658|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
82779659|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779660|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82779661|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82779662|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
82779663|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779664|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779665|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82779666|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82779667|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779668|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82779669|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
82779670|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779671|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
82779672|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779673|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779674|NCT02628067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82779675|NCT02628067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779677|NCT02542293|Cisplatin|cisplatin|mesh-list
82779678|NCT02542293|Carboplatin|carboplatin|mesh-list
82779679|NCT02542293|Gemcitabine|gemcitabine|mesh-list
82779680|NCT02542293|Pemetrexed|pemetrexed|mesh-list
82779681|NCT02542293|Durvalumab|durvalumab|mesh-list
82779682|NCT02542293|Tremelimumab|tremelimumab|mesh-list
82779683|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82779684|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779685|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
82779686|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
82779687|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
82779688|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779689|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82779690|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
82779691|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779692|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82779693|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82779694|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779695|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
82779696|NCT02511028|Hematinics|hematinics|mesh-ancestor
82779697|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82779698|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82779699|NCT02507687|Bimatoprost|bimatoprost|mesh-list
82779700|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82779701|NCT02466971|Cisplatin|cisplatin|mesh-list
82779702|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779703|NCT02453282|Paclitaxel|paclitaxel|mesh-list
82779704|NCT02453282|Cisplatin|cisplatin|mesh-list
82779705|NCT02453282|Carboplatin|carboplatin|mesh-list
82779706|NCT02453282|Gemcitabine|gemcitabine|mesh-list
82779707|NCT02453282|Pemetrexed|pemetrexed|mesh-list
82779708|NCT02453282|Durvalumab|durvalumab|mesh-list
82779709|NCT02453282|Tremelimumab|tremelimumab|mesh-list
82779710|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82779711|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82779712|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779713|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
82779714|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
82779715|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
82779716|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779717|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82779718|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
82779719|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779720|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82779721|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82779722|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779723|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
82779724|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779725|NCT02393859|Dexamethasone|dexamethasone|mesh-list
82779726|NCT02393859|Methotrexate|methotrexate|mesh-list
82779727|NCT02393859|Daunorubicin|daunorubicin|mesh-list
82779728|NCT02393859|Asparaginase|asparaginase|mesh-list
82779729|NCT02393859|Ifosfamide|ifosfamide|mesh-list
82779730|NCT02393859|Blinatumomab|blinatumomab|mesh-list
82779731|NCT02393859|Pegaspargase|pegaspargase|mesh-list
82779741|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82779742|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779743|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82779744|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
82779745|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82779746|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82779747|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
82779748|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779749|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
82779750|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779751|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82779752|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779753|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
82779754|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82779755|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82779756|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82779757|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82779758|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82779759|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82779760|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
82779770|NCT02321501|Everolimus|everolimus|mesh-list
82779771|NCT02321501|Ceritinib|ceritinib|mesh-list
82779772|NCT02321501|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82779773|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82779774|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779775|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779776|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779777|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
82779778|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779779|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779780|NCT02242942|Venetoclax|venetoclax|mesh-list
82779781|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
82779782|NCT02242942|Chlorambucil|chlorambucil|mesh-list
82779783|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779784|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779785|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82779786|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
82779787|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779788|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
82779789|NCT02237079|Estrogens|estrogens|mesh-list
82779790|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82779791|NCT02237079|Hormones|hormones|mesh-ancestor
82779792|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82779793|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779794|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82779795|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82779796|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
82779797|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82779798|NCT02233829|Dopamine|dopamine|mesh-list
82779799|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82779800|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
82779801|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
82779802|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82779803|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779804|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
82779805|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82779853|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82779854|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82779855|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82779856|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82779857|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
82779858|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82779859|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779860|NCT01767675|Carboplatin|carboplatin|mesh-list
82779861|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779862|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82779863|NCT01728363|Rifampin|rifampin|mesh-list
82779864|NCT01728363|Clindamycin|clindamycin|mesh-list
82779865|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
82779866|NCT01728363|Ticarcillin|ticarcillin|mesh-list
82779867|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
82779868|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779869|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82779870|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
82779871|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
82779872|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82779873|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779874|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779875|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82779876|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82779877|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82779878|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82779879|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82779880|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82779881|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82779882|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82779883|NCT01419561|Zidovudine|zidovudine|mesh-list
82779884|NCT01419561|Rituximab|rituximab|mesh-list
82779885|NCT01419561|Doxorubicin|doxorubicin|mesh-list
82779886|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82779887|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779888|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779889|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
82779890|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779891|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82779892|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82779893|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82779894|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82779895|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779896|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779897|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
82779898|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82779899|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82779900|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
82779901|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779902|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82779903|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82779920|NCT01267448|Metformin|metformin|mesh-list
82779921|NCT01267448|Saxagliptin|saxagliptin|mesh-list
82779922|NCT01267448|Glipizide|glipizide|mesh-list
82779923|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82779924|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779925|NCT01267448|Incretins|incretins|mesh-ancestor
82779926|NCT01267448|Hormones|hormones|mesh-ancestor
82779927|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82779928|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82779929|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
82779930|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779931|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779932|NCT01265030|Sirolimus|sirolimus|mesh-list
82779933|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82779934|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779935|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82779936|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779937|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
82779938|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779939|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
82779940|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779941|NCT01174121|Aldesleukin|aldesleukin|mesh-list
82779942|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
82779943|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
82779944|NCT01174121|Fludarabine|fludarabine|mesh-list
82779945|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779946|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
82779947|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779948|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82779949|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82779950|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
82779951|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779952|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779953|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82779954|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779955|NCT01174121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82779956|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82779957|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82779958|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
82779959|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779960|NCT01125228|Interferons|interferons|mesh-list
82779961|NCT01125228|Interferon-alpha|interferon-alpha|mesh-list
82779962|NCT01125228|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82779963|NCT01125228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779964|NCT01125228|Antiviral Agents|antiviral agents|mesh-ancestor
82779965|NCT01125228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779966|NCT01125228|Immunologic Factors|immunologic factors|mesh-ancestor
82779967|NCT01125228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779968|NCT00977977|Cyclosporine|cyclosporine|mesh-list
82779969|NCT00977977|Rituximab|rituximab|mesh-list
82779970|NCT00977977|Cyclosporins|cyclosporins|mesh-list
82779971|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82779972|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82779973|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
82779974|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779975|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82779976|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82779977|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779978|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779979|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
82779980|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82779981|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
82779982|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82779983|NCT00901511|Sargramostim|sargramostim|mesh-list
82779984|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
82779985|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779986|NCT00862433|Vitamins|vitamins|mesh-list
82779987|NCT00862433|Vitamin E|vitamin e|mesh-list
82779988|NCT00862433|Tocopherols|tocopherols|mesh-list
82779989|NCT00862433|Tocotrienols|tocotrienols|mesh-list
82779990|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
82779991|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
82779992|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82779993|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
82779994|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82779995|NCT00862433|Protective Agents|protective agents|mesh-ancestor
82779996|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
82779997|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82779998|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
82779999|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780000|NCT00775476|Expectorants|expectorants|mesh-ancestor
82780001|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
82780002|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82780003|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
82780004|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780005|NCT00775476|Protective Agents|protective agents|mesh-ancestor
82780006|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780007|NCT00775476|Antidotes|antidotes|mesh-ancestor
82780008|NCT00578721|Aspirin|aspirin|mesh-list
82780009|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82780010|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82780011|NCT00578721|Analgesics|analgesics|mesh-ancestor
82780012|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
82780013|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780014|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780015|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780016|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780017|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82780018|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82780019|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780020|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82780021|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82780031|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
82780032|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82780033|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82780034|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780035|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780036|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82780037|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
82780038|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780039|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780040|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82780041|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
82780042|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82780043|NCT00025935|Lithium Carbonate|lithium carbonate|mesh-list
82780044|NCT00025935|Antidepressive Agents|antidepressive agents|mesh-ancestor
82780045|NCT00025935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82780046|NCT00025935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780047|NCT00025935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780048|NCT00025935|Antimanic Agents|antimanic agents|mesh-ancestor
82780049|NCT00025935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82780050|NCT00025935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82780051|NCT00025935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780052|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
82780053|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82780054|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780055|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
82780056|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
82780057|NCT00001521|Letrozole|letrozole|mesh-list
82780058|NCT00001521|Flutamide|flutamide|mesh-list
82780059|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780060|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82780061|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82780062|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780063|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780064|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82780065|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
82780066|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780067|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780068|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780069|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
82780070|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82780071|NCT00001481|Estradiol|estradiol|mesh-list
82780072|NCT00001481|Progesterone|progesterone|mesh-list
82780073|NCT00001481|Estrogens|estrogens|mesh-ancestor
82710628|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
82710629|NCT04063839|Grazoprevir|grazoprevir|mesh-list
82710630|NCT04063839|Ledipasvir|ledipasvir|mesh-list
82710708|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
82711117|NCT00698841|Cetuximab|cetuximab|mesh-list
82712234|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
82712460|NCT00749385|Naproxen|naproxen|mesh-list
82713752|NCT02586194|Peficitinib|peficitinib|mesh-list
82713826|NCT02677545|Ticagrelor|ticagrelor|mesh-list
82714064|NCT00764907|Vitamins|vitamins|mesh-ancestor
82714524|NCT00768729|Sirolimus|sirolimus|mesh-list
82714898|NCT02579642|Ketamine|ketamine|mesh-list
82716476|NCT02578550|Darunavir|darunavir|mesh-list
82718061|NCT00620854|Calcitonin|calcitonin|mesh-list
82719083|NCT05556200|Apatinib|apatinib|mesh-list
82719372|NCT05303844|Tislelizumab|tislelizumab|mesh-list
82719528|NCT05049707|Analgesics|analgesics|mesh-ancestor
82719608|NCT04977830|Xenon|xenon|mesh-list
82719723|NCT04586348|Iodine|iodine|mesh-list
82719907|NCT04306900|Gemcitabine|gemcitabine|mesh-list
82720139|NCT03917420|Tenofovir|tenofovir|mesh-list
82720213|NCT03642990|Niacinamide|niacinamide|mesh-list
82720748|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
82723279|NCT00734318|Xhance|xhance|mesh-list
82723555|NCT00869752|Etoposide|etoposide|mesh-list
82723723|NCT00734448|Inositol|inositol|mesh-list
82723865|NCT05575440|Fluorides|fluorides|mesh-list
82724101|NCT00424021|Ambrisentan|ambrisentan|mesh-list
82725302|NCT00612508|Desogestrel|desogestrel|mesh-list
82725453|NCT02542852|Ritonavir|ritonavir|mesh-list
82725543|NCT00810381|Isosorbide|isosorbide|mesh-list
82725916|NCT00610714|Paclitaxel|paclitaxel|mesh-list
82726519|NCT00610168|Vaccines|vaccines|mesh-list
82726671|NCT04061538|Zinc|zinc|mesh-list
82726743|NCT00822081|Timolol|timolol|mesh-list
82727184|NCT00817011|Analgesics|analgesics|mesh-ancestor
82727260|NCT02550483|Vitamins|vitamins|mesh-ancestor
82727561|NCT02962050|Capsaicin|capsaicin|mesh-list
82727942|NCT02550249|Nivolumab|nivolumab|mesh-list
82728245|NCT00900874|Albuterol|albuterol|mesh-list
82728452|NCT04035070|Eusol|eusol|mesh-list
82728616|NCT00906724|Insulin|insulin|mesh-list
82729516|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
82729589|NCT00365365|Bevacizumab|bevacizumab|mesh-list
82729762|NCT00937300|Fludarabine|fludarabine|mesh-list
82729896|NCT00833157|Ibuprofen|ibuprofen|mesh-list
82731716|NCT00755976|Sulindac|sulindac|mesh-list
82732475|NCT02565602|Vitamin D|vitamin d|mesh-list
82732627|NCT04049916|Artesunate|artesunate|mesh-list
82733455|NCT02559648|Denosumab|denosumab|mesh-list
82733830|NCT00676650|Prednisone|prednisone|mesh-list
82733910|NCT00369967|NuvaRing|nuvaring|mesh-list
82734675|NCT02558868|Irinotecan|irinotecan|mesh-list
82734737|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
82734961|NCT04392921|Amiodarone|amiodarone|mesh-list
82735110|NCT00762918|Vitamin D|vitamin d|mesh-list
82735871|NCT00764556|Insulin|insulin|mesh-list
82735947|NCT00893451|Vitamin D|vitamin d|mesh-list
82736096|NCT00975988|Lapatinib|lapatinib|mesh-list
82736447|NCT00971074|Hylan|hylan|mesh-list
82736747|NCT00544882|Oviol|oviol|mesh-list
82736995|NCT00350545|Prednisone|prednisone|mesh-list
82737219|NCT00905931|Lycopene|lycopene|mesh-list
82737317|NCT01055821|Ribavirin|ribavirin|mesh-list
82737675|NCT00906867|Miotics|miotics|mesh-ancestor
82737903|NCT00769470|Docetaxel|docetaxel|mesh-list
82738295|NCT00907179|Pemetrexed|pemetrexed|mesh-list
82738580|NCT00540046|Copper|copper|mesh-list
82738848|NCT04050436|Cemiplimab|cemiplimab|mesh-list
82739446|NCT04034199|Denosumab|denosumab|mesh-list
82739593|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
82739746|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
82739827|NCT00778596|Prednisolone|prednisolone|mesh-list
82739898|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
82740437|NCT00663858|Cetrorelix|cetrorelix|mesh-list
82741048|NCT00755066|Xhance|xhance|mesh-list
82741450|NCT00325897|Azithromycin|azithromycin|mesh-list
82742136|NCT05590312|Anesthetics|anesthetics|mesh-list
82742209|NCT00794898|Infliximab|infliximab|mesh-list
82742505|NCT00352417|Atreleuton|atreleuton|mesh-list
82742956|NCT00575588|Metformin|metformin|mesh-list
82743042|NCT02558816|Venetoclax|venetoclax|mesh-list
82743941|NCT00571064|Donepezil|donepezil|mesh-list
82744090|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
82744240|NCT00946491|Haloperidol|haloperidol|mesh-list
82744618|NCT00777218|Zonisamide|zonisamide|mesh-list
82744774|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82745759|NCT02556008|Cannabidiol|cannabidiol|mesh-list
82746612|NCT00303667|Vidarabine|vidarabine|mesh-list
82746742|NCT00316225|Pemetrexed|pemetrexed|mesh-list
82746818|NCT05774639|Omalizumab|omalizumab|mesh-list
82747046|NCT05613608|Cannabidiol|cannabidiol|mesh-list
82747315|NCT05194397|Niacin|niacin|mesh-list
82747361|NCT05005741|Hormones|hormones|mesh-ancestor
82747445|NCT04830397|Timolol|timolol|mesh-list
82747622|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
82747766|NCT03656081|Amebicides|amebicides|mesh-ancestor
82747841|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
82748979|NCT05198050|Misoprostol|misoprostol|mesh-list
82749135|NCT01068067|Tacrolimus|tacrolimus|mesh-list
82749202|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
82750108|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
82750264|NCT00549939|Alfuzosin|alfuzosin|mesh-list
82751017|NCT00840606|Buspirone|buspirone|mesh-list
82751171|NCT00967707|Donepezil|donepezil|mesh-list
82752080|NCT00781196|Folic Acid|folic acid|mesh-list
82752390|NCT04041648|Treprostinil|treprostinil|mesh-list
82752471|NCT00972387|Hormones|hormones|mesh-ancestor
82752784|NCT00262873|Bortezomib|bortezomib|mesh-list
82754499|NCT00803972|Insulin|insulin|mesh-list
82755107|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
82755183|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
82755267|NCT00799136|Prednisone|prednisone|mesh-list
82756259|NCT00800462|Bromides|bromides|mesh-list
82756410|NCT00808184|Midazolam|midazolam|mesh-list
82756722|NCT00723125|Paclitaxel|paclitaxel|mesh-list
82756793|NCT00729365|Ramipril|ramipril|mesh-list
82757101|NCT02550782|Bupivacaine|bupivacaine|mesh-list
82757170|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
82757414|NCT00893724|Niacin|niacin|mesh-list
82757861|NCT00922506|Doxazosin|doxazosin|mesh-list
82758163|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
82758853|NCT00929370|Glycine|glycine|mesh-list
82759151|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
82760067|NCT04043624|Lidocaine|lidocaine|mesh-list
82760129|NCT00825188|Amlodipine|amlodipine|mesh-list
82760581|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
82761411|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
82761717|NCT00850850|Miotics|miotics|mesh-ancestor
82762332|NCT01564329|Endostar protein|endostar protein|mesh-list
82762935|NCT04658147|Nivolumab|nivolumab|mesh-list
82763637|NCT04077983|Paclitaxel|paclitaxel|mesh-list
82763712|NCT04471246|Cephalexin|cephalexin|mesh-list
82763862|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
82764167|NCT01005927|Calcium|calcium|mesh-list
82764294|NCT00879476|Ramipril|ramipril|mesh-list
82765390|NCT00881816|Paclitaxel|paclitaxel|mesh-list
82765482|NCT00888602|Psyllium|psyllium|mesh-list
82765770|NCT03263429|Irinotecan|irinotecan|mesh-list
82765920|NCT00890786|Irinotecan|irinotecan|mesh-list
82766220|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
82766375|NCT00560352|Hormones|hormones|mesh-ancestor
82766521|NCT00186121|Goserelin|goserelin|mesh-list
82766671|NCT00945438|Vaccines|vaccines|mesh-list
82767154|NCT00132691|Hormones|hormones|mesh-ancestor
82768430|NCT00718601|Imetelstat|imetelstat|mesh-list
82768559|NCT00452530|Enoxaparin|enoxaparin|mesh-list
82769092|NCT00721487|Fluconazole|fluconazole|mesh-list
82769402|NCT00894920|Biotin|biotin|mesh-list
82769550|NCT01028170|Furosemide|furosemide|mesh-list
82769624|NCT01012869|Everolimus|everolimus|mesh-list
82770006|NCT01028482|Sertraline|sertraline|mesh-list
82770340|NCT00927602|PENTA|penta|mesh-list
82770451|NCT00729131|Etanercept|etanercept|mesh-list
82770751|NCT00734123|Simvastatin|simvastatin|mesh-list
82771167|NCT01011699|Niacin|niacin|mesh-list
82771447|NCT00736931|Lorazepam|lorazepam|mesh-list
82771586|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
82771958|NCT00565448|Docetaxel|docetaxel|mesh-list
82772035|NCT00934232|Busulfan|busulfan|mesh-list
82772262|NCT00699335|Fentanyl|fentanyl|mesh-list
82772333|NCT00935558|Interleukin-2|interleukin-2|mesh-list
82772940|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
82773100|NCT01030120|Etanercept|etanercept|mesh-list
82773186|NCT00952094|Cinacalcet|cinacalcet|mesh-list
82773780|NCT00956202|Vaccines|vaccines|mesh-list
82773856|NCT00095173|Abatacept|abatacept|mesh-list
82774370|NCT00744107|Cobalt|cobalt|mesh-list
82774616|NCT00968760|Analgesics|analgesics|mesh-ancestor
82775211|NCT05254106|Paclitaxel|paclitaxel|mesh-list
82775585|NCT00964106|Rifampin|rifampin|mesh-list
82775664|NCT00965172|Calcium|calcium|mesh-list
82775957|NCT00425308|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82776562|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
82777020|NCT00987870|Hormones|hormones|mesh-ancestor
82777312|NCT05918796|Antiemetics|antiemetics|mesh-ancestor
82777572|NCT05882812|Diclofenac|diclofenac|mesh-list
82778197|NCT05283720|Hormones|hormones|mesh-ancestor
82779206|NCT03743636|Niacin|niacin|mesh-list
82780074|NCT00001481|Hormones|hormones|mesh-ancestor
82780075|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780076|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780077|NCT00001481|Progestins|progestins|mesh-ancestor
82780087|NCT00001247|Sirolimus|sirolimus|mesh-list
82780088|NCT00001247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82780089|NCT00001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780090|NCT00001247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82780091|NCT00001247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780092|NCT00001247|Antifungal Agents|antifungal agents|mesh-ancestor
82780093|NCT00001247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780094|NCT00001247|Immunologic Factors|immunologic factors|mesh-ancestor
82780095|NCT00001247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
